diff --git a/input/GEO/HIV_Resistance/GSE117748/GSE117748-GPL571_series_matrix.txt.gz b/input/GEO/HIV_Resistance/GSE117748/GSE117748-GPL571_series_matrix.txt.gz new file mode 100644 index 0000000000000000000000000000000000000000..ceab9652aef4ce903918e894bdf17e911af61199 --- /dev/null +++ b/input/GEO/HIV_Resistance/GSE117748/GSE117748-GPL571_series_matrix.txt.gz @@ -0,0 +1,3 @@ +version https://git-lfs.github.com/spec/v1 +oid sha256:a328d7787b6bd03d2d833b72b5b01407723981f27eb355c2bdfda2b1c8f0257b +size 1139807 diff --git a/input/GEO/HIV_Resistance/GSE117748/GSE117748_family.soft.gz b/input/GEO/HIV_Resistance/GSE117748/GSE117748_family.soft.gz new file mode 100644 index 0000000000000000000000000000000000000000..286690d6ad79001dc9c7fd44ebe6af97fab07acc --- /dev/null +++ b/input/GEO/HIV_Resistance/GSE117748/GSE117748_family.soft.gz @@ -0,0 +1,3 @@ +version https://git-lfs.github.com/spec/v1 +oid sha256:60df74950c3ed9bf043527d253b0c7e530ccc4ba0935dc4477bb331ee6a72b5b +size 8213010 diff --git a/input/GEO/HIV_Resistance/GSE33580/GSE33580_family.soft.gz b/input/GEO/HIV_Resistance/GSE33580/GSE33580_family.soft.gz new file mode 100644 index 0000000000000000000000000000000000000000..d7f554082c8e78299d39acac9a38fd0585367068 --- /dev/null +++ b/input/GEO/HIV_Resistance/GSE33580/GSE33580_family.soft.gz @@ -0,0 +1,3 @@ +version https://git-lfs.github.com/spec/v1 +oid sha256:f6c508a5118e697332ff8817cd98ee7d5c0b3d4f1e138587494c543a38be6cf3 +size 52833700 diff --git a/input/GEO/HIV_Resistance/GSE33580/GSE33580_series_matrix.txt.gz b/input/GEO/HIV_Resistance/GSE33580/GSE33580_series_matrix.txt.gz new file mode 100644 index 0000000000000000000000000000000000000000..da3a325603e61131b8927585fd949088e17add81 --- /dev/null +++ b/input/GEO/HIV_Resistance/GSE33580/GSE33580_series_matrix.txt.gz @@ -0,0 +1,3 @@ +version https://git-lfs.github.com/spec/v1 +oid sha256:c60d216ec48d947cd861198182fc60c5fa8b779cf25c2069bc9f045f2a0e36a2 +size 17549385 diff --git a/input/GEO/HIV_Resistance/GSE46599/GSE46599_family.soft.gz b/input/GEO/HIV_Resistance/GSE46599/GSE46599_family.soft.gz new file mode 100644 index 0000000000000000000000000000000000000000..110bfc5f97529b2c58db4c6fb5ca5af54af35fac --- /dev/null +++ b/input/GEO/HIV_Resistance/GSE46599/GSE46599_family.soft.gz @@ -0,0 +1,3 @@ +version https://git-lfs.github.com/spec/v1 +oid sha256:49763253bd36cafbde858442fdfc3dcf00faa2697568eade1d915a2f737b5c59 +size 34504790 diff --git a/input/GEO/HIV_Resistance/GSE46599/GSE46599_series_matrix.txt.gz b/input/GEO/HIV_Resistance/GSE46599/GSE46599_series_matrix.txt.gz new file mode 100644 index 0000000000000000000000000000000000000000..fe7997ef76883ff760ac257f620c62be795c6de0 --- /dev/null +++ b/input/GEO/HIV_Resistance/GSE46599/GSE46599_series_matrix.txt.gz @@ -0,0 +1,3 @@ +version https://git-lfs.github.com/spec/v1 +oid sha256:ae9acbfef34f9f85a22d9c80df45f6d8a7576a1ba150b4661d28d44dceba843c +size 8968142 diff --git a/input/GEO/Head_and_Neck_Cancer/GSE148320/GSE148320_family.soft.gz b/input/GEO/Head_and_Neck_Cancer/GSE148320/GSE148320_family.soft.gz new file mode 100644 index 0000000000000000000000000000000000000000..6c116d2e77728b3b03d621cf2be38c6c144d1853 --- /dev/null +++ b/input/GEO/Head_and_Neck_Cancer/GSE148320/GSE148320_family.soft.gz @@ -0,0 +1,3 @@ +version https://git-lfs.github.com/spec/v1 +oid sha256:e82709ac295b626d2a605196f1948f925def440bc8ca3840b48f736d34694d98 +size 64539466 diff --git a/input/GEO/Head_and_Neck_Cancer/GSE148320/GSE148320_series_matrix.txt.gz b/input/GEO/Head_and_Neck_Cancer/GSE148320/GSE148320_series_matrix.txt.gz new file mode 100644 index 0000000000000000000000000000000000000000..595e718b2f1f40b4be369454504958f65535eabc --- /dev/null +++ b/input/GEO/Head_and_Neck_Cancer/GSE148320/GSE148320_series_matrix.txt.gz @@ -0,0 +1,3 @@ +version https://git-lfs.github.com/spec/v1 +oid sha256:682d459c32d4066d3429e5d236b677cb202006c2718ed6a51f8695e2a3807646 +size 15496830 diff --git a/input/GEO/Head_and_Neck_Cancer/GSE151179/GSE151179_family.soft.gz b/input/GEO/Head_and_Neck_Cancer/GSE151179/GSE151179_family.soft.gz new file mode 100644 index 0000000000000000000000000000000000000000..2a73e5ac151fc7b3e6fe72c7f54c2c8acb6d8b66 --- /dev/null +++ b/input/GEO/Head_and_Neck_Cancer/GSE151179/GSE151179_family.soft.gz @@ -0,0 +1,3 @@ +version https://git-lfs.github.com/spec/v1 +oid sha256:f95c9e318692d2ac609c1ae568fe283d66f571f26724b0534dc64bda2d425e7b +size 19940499 diff --git a/input/GEO/Head_and_Neck_Cancer/GSE151179/GSE151179_series_matrix.txt.gz b/input/GEO/Head_and_Neck_Cancer/GSE151179/GSE151179_series_matrix.txt.gz new file mode 100644 index 0000000000000000000000000000000000000000..f91743cfcc2d33b1d3fb4ec3ce7355c590511c7e --- /dev/null +++ b/input/GEO/Head_and_Neck_Cancer/GSE151179/GSE151179_series_matrix.txt.gz @@ -0,0 +1,3 @@ +version https://git-lfs.github.com/spec/v1 +oid sha256:dfcb49e4118de7e129228f17ee5df07e8635b363a76b4fac9d19aa0aa25ce56c +size 7793213 diff --git a/input/GEO/Head_and_Neck_Cancer/GSE151181/GSE151181-GPL21575_series_matrix.txt.gz b/input/GEO/Head_and_Neck_Cancer/GSE151181/GSE151181-GPL21575_series_matrix.txt.gz new file mode 100644 index 0000000000000000000000000000000000000000..5ef234b71ef77a9eeba0742ec4a0e36e357a6232 --- /dev/null +++ b/input/GEO/Head_and_Neck_Cancer/GSE151181/GSE151181-GPL21575_series_matrix.txt.gz @@ -0,0 +1,3 @@ +version https://git-lfs.github.com/spec/v1 +oid sha256:4121c9e6e0656bc826f3b944ee05bd873a2a1597920a8bd344df92a6e0935dad +size 11981190 diff --git a/input/GEO/Head_and_Neck_Cancer/GSE151181/GSE151181-GPL23159_series_matrix.txt.gz b/input/GEO/Head_and_Neck_Cancer/GSE151181/GSE151181-GPL23159_series_matrix.txt.gz new file mode 100644 index 0000000000000000000000000000000000000000..1612d4f706b900fd6683d55c0c26615b30bcf396 --- /dev/null +++ b/input/GEO/Head_and_Neck_Cancer/GSE151181/GSE151181-GPL23159_series_matrix.txt.gz @@ -0,0 +1,3 @@ +version https://git-lfs.github.com/spec/v1 +oid sha256:cdbe07f2567038794c7746d8fcea1ff92ccea4a48d110c94a97989e4859a4005 +size 7792868 diff --git a/input/GEO/Head_and_Neck_Cancer/GSE151181/GSE151181_family.soft.gz b/input/GEO/Head_and_Neck_Cancer/GSE151181/GSE151181_family.soft.gz new file mode 100644 index 0000000000000000000000000000000000000000..331bee0a5d095d185395d9a4546002c3d5808256 --- /dev/null +++ b/input/GEO/Head_and_Neck_Cancer/GSE151181/GSE151181_family.soft.gz @@ -0,0 +1,3 @@ +version https://git-lfs.github.com/spec/v1 +oid sha256:98fa7cc40665a60cfa1171abec4d5d2f3281876b2981c8f22d27c79ac2647869 +size 36376811 diff --git a/input/GEO/Head_and_Neck_Cancer/GSE156915/GSE156915_family.soft.gz b/input/GEO/Head_and_Neck_Cancer/GSE156915/GSE156915_family.soft.gz new file mode 100644 index 0000000000000000000000000000000000000000..a247612d9225fdc4473b026123f4ee656657dca9 --- /dev/null +++ b/input/GEO/Head_and_Neck_Cancer/GSE156915/GSE156915_family.soft.gz @@ -0,0 +1,3 @@ +version https://git-lfs.github.com/spec/v1 +oid sha256:2ac61cac1a4d53b59943511f8ec8f6ff304c742defb28b4d434feb38f0f5f08e +size 92844293 diff --git a/input/GEO/Head_and_Neck_Cancer/GSE156915/GSE156915_series_matrix.txt.gz b/input/GEO/Head_and_Neck_Cancer/GSE156915/GSE156915_series_matrix.txt.gz new file mode 100644 index 0000000000000000000000000000000000000000..a81c28a0234ac3a6676fefa25ce0b1340b0d3dd7 --- /dev/null +++ b/input/GEO/Head_and_Neck_Cancer/GSE156915/GSE156915_series_matrix.txt.gz @@ -0,0 +1,3 @@ +version https://git-lfs.github.com/spec/v1 +oid sha256:46a8567598bdce334090e8c6720669fbf533bf39ca7d99ff14b04c89680f3da2 +size 53422180 diff --git a/input/GEO/Head_and_Neck_Cancer/GSE184944/GSE184944_family.soft.gz b/input/GEO/Head_and_Neck_Cancer/GSE184944/GSE184944_family.soft.gz new file mode 100644 index 0000000000000000000000000000000000000000..449f59a61aa255181daa0fec4d49a0da8a72d905 --- /dev/null +++ b/input/GEO/Head_and_Neck_Cancer/GSE184944/GSE184944_family.soft.gz @@ -0,0 +1,3 @@ +version https://git-lfs.github.com/spec/v1 +oid sha256:05b50577ea3b96d0cfe0a4f039595b8a3dc1f6a51dcee1ef9831c9f4c9222227 +size 228878 diff --git a/input/GEO/Head_and_Neck_Cancer/GSE184944/GSE184944_series_matrix.txt.gz b/input/GEO/Head_and_Neck_Cancer/GSE184944/GSE184944_series_matrix.txt.gz new file mode 100644 index 0000000000000000000000000000000000000000..b37765b0c87d402543792c54723b1044de059d4c --- /dev/null +++ b/input/GEO/Head_and_Neck_Cancer/GSE184944/GSE184944_series_matrix.txt.gz @@ -0,0 +1,3 @@ +version https://git-lfs.github.com/spec/v1 +oid sha256:4c06af2680396c0858f835fc6d13a24842fcbc07f53c54880e8840a45abd25d6 +size 175665 diff --git a/input/GEO/Head_and_Neck_Cancer/GSE201777/GSE201777_family.soft.gz b/input/GEO/Head_and_Neck_Cancer/GSE201777/GSE201777_family.soft.gz new file mode 100644 index 0000000000000000000000000000000000000000..067ddcef6a3007647fa1566ae6f36d51419cfa1f --- /dev/null +++ b/input/GEO/Head_and_Neck_Cancer/GSE201777/GSE201777_family.soft.gz @@ -0,0 +1,3 @@ +version https://git-lfs.github.com/spec/v1 +oid sha256:9723f5287133bb5815835bef60806be5cb10dcd2243d50c0aa2441a5d67a1cb3 +size 54512282 diff --git a/input/GEO/Head_and_Neck_Cancer/GSE201777/GSE201777_series_matrix.txt.gz b/input/GEO/Head_and_Neck_Cancer/GSE201777/GSE201777_series_matrix.txt.gz new file mode 100644 index 0000000000000000000000000000000000000000..d887b9ec6bcd6f91fd18a8b83dbb70d3975d83f9 --- /dev/null +++ b/input/GEO/Head_and_Neck_Cancer/GSE201777/GSE201777_series_matrix.txt.gz @@ -0,0 +1,3 @@ +version https://git-lfs.github.com/spec/v1 +oid sha256:62a9f87af11f0184a06643dbbe71d8e15659b3d4ceb6cff877faf458db672298 +size 7748508 diff --git a/input/GEO/Head_and_Neck_Cancer/GSE212250/GSE212250-GPL15520_series_matrix.txt.gz b/input/GEO/Head_and_Neck_Cancer/GSE212250/GSE212250-GPL15520_series_matrix.txt.gz new file mode 100644 index 0000000000000000000000000000000000000000..9722c9ce29ac5ff7665d00af5661062b9542566c --- /dev/null +++ b/input/GEO/Head_and_Neck_Cancer/GSE212250/GSE212250-GPL15520_series_matrix.txt.gz @@ -0,0 +1,3 @@ +version https://git-lfs.github.com/spec/v1 +oid sha256:97a213eefe2b5baf48569b4da56592ed52e6d2c7c31a55b7d2cfe1b4c99eea9a +size 114529 diff --git a/input/GEO/Head_and_Neck_Cancer/GSE212250/GSE212250_family.soft.gz b/input/GEO/Head_and_Neck_Cancer/GSE212250/GSE212250_family.soft.gz new file mode 100644 index 0000000000000000000000000000000000000000..2a71120618b393ba8d157d20a28ee2226dabf1c0 --- /dev/null +++ b/input/GEO/Head_and_Neck_Cancer/GSE212250/GSE212250_family.soft.gz @@ -0,0 +1,3 @@ +version https://git-lfs.github.com/spec/v1 +oid sha256:c3feeffd2b75cd65692905f6e905e664522f590045253923cd4e6a4e238ab522 +size 188106 diff --git a/input/GEO/Head_and_Neck_Cancer/GSE218109/GSE218109_family.soft.gz b/input/GEO/Head_and_Neck_Cancer/GSE218109/GSE218109_family.soft.gz new file mode 100644 index 0000000000000000000000000000000000000000..07fd99fdb06b25889b2a38f711816272155abd04 --- /dev/null +++ b/input/GEO/Head_and_Neck_Cancer/GSE218109/GSE218109_family.soft.gz @@ -0,0 +1,3 @@ +version https://git-lfs.github.com/spec/v1 +oid sha256:455b34eba55746aceb35a5f49ae8a5a83546557265fb59e8afa4c7b71453f4f3 +size 13497108 diff --git a/input/GEO/Head_and_Neck_Cancer/GSE218109/GSE218109_series_matrix.txt.gz b/input/GEO/Head_and_Neck_Cancer/GSE218109/GSE218109_series_matrix.txt.gz new file mode 100644 index 0000000000000000000000000000000000000000..d91ba466c9bb472366b27e30848b71439f2a3928 --- /dev/null +++ b/input/GEO/Head_and_Neck_Cancer/GSE218109/GSE218109_series_matrix.txt.gz @@ -0,0 +1,3 @@ +version https://git-lfs.github.com/spec/v1 +oid sha256:bc9dfd782a606303cce86ef5b67b21477bb297d356cf24d28e7809ade2872cee +size 2633400 diff --git a/input/GEO/Head_and_Neck_Cancer/GSE244580/GSE244580_family.soft.gz b/input/GEO/Head_and_Neck_Cancer/GSE244580/GSE244580_family.soft.gz new file mode 100644 index 0000000000000000000000000000000000000000..1e1bc7b8048eb688adc497af753adb665595cd68 --- /dev/null +++ b/input/GEO/Head_and_Neck_Cancer/GSE244580/GSE244580_family.soft.gz @@ -0,0 +1,3 @@ +version https://git-lfs.github.com/spec/v1 +oid sha256:b84b6b5be4d6f0a08fd05de517dca2d80d1f2e2334a139ffedb791e6b4d1883d +size 11894872 diff --git a/input/GEO/Head_and_Neck_Cancer/GSE244580/GSE244580_series_matrix.txt.gz b/input/GEO/Head_and_Neck_Cancer/GSE244580/GSE244580_series_matrix.txt.gz new file mode 100644 index 0000000000000000000000000000000000000000..c18b00ec120efa695a2fd3b97af7fb7b129a3056 --- /dev/null +++ b/input/GEO/Head_and_Neck_Cancer/GSE244580/GSE244580_series_matrix.txt.gz @@ -0,0 +1,3 @@ +version https://git-lfs.github.com/spec/v1 +oid sha256:d18728896daf70710565ebeb458e847160ab27dace9808d7152870a8e320901b +size 6420843 diff --git a/input/GEO/Heart_rate/GSE117070/GSE117070_family.soft.gz b/input/GEO/Heart_rate/GSE117070/GSE117070_family.soft.gz new file mode 100644 index 0000000000000000000000000000000000000000..dd1d95e8806013bdd9a5068ca289e2066f2a8940 --- /dev/null +++ b/input/GEO/Heart_rate/GSE117070/GSE117070_family.soft.gz @@ -0,0 +1,3 @@ +version https://git-lfs.github.com/spec/v1 +oid sha256:bf49b52d145533097b35383a5dccb3a2fe230ba11620fec10de87ed61b75f05a +size 49769042 diff --git a/input/GEO/Heart_rate/GSE117070/GSE117070_series_matrix.txt.gz b/input/GEO/Heart_rate/GSE117070/GSE117070_series_matrix.txt.gz new file mode 100644 index 0000000000000000000000000000000000000000..46d2e0195806f9253af5012fa112693aed26e84e --- /dev/null +++ b/input/GEO/Heart_rate/GSE117070/GSE117070_series_matrix.txt.gz @@ -0,0 +1,3 @@ +version https://git-lfs.github.com/spec/v1 +oid sha256:a5fc315280890655f4e15266063d537b56283ebd9d009596391ce09875234faa +size 24560354 diff --git a/input/GEO/Heart_rate/GSE12385/GSE12385_family.soft.gz b/input/GEO/Heart_rate/GSE12385/GSE12385_family.soft.gz new file mode 100644 index 0000000000000000000000000000000000000000..5d5926325d7a1e4c2e7232e718f044e441322891 --- /dev/null +++ b/input/GEO/Heart_rate/GSE12385/GSE12385_family.soft.gz @@ -0,0 +1,3 @@ +version https://git-lfs.github.com/spec/v1 +oid sha256:162a156a9ff4c38a11044adb778a1b362515a900d4ba5512f960e1e7fb0d1dea +size 14966491 diff --git a/input/GEO/Heart_rate/GSE12385/GSE12385_series_matrix.txt.gz b/input/GEO/Heart_rate/GSE12385/GSE12385_series_matrix.txt.gz new file mode 100644 index 0000000000000000000000000000000000000000..da67be3bd7f87c847ab45801c984563e77b08f89 --- /dev/null +++ b/input/GEO/Heart_rate/GSE12385/GSE12385_series_matrix.txt.gz @@ -0,0 +1,3 @@ +version https://git-lfs.github.com/spec/v1 +oid sha256:b69a7af55a0c5ffc6989dc55fce416d1277dbb0f8927a9f685dd9064a7fa68fd +size 3677906 diff --git a/input/GEO/Heart_rate/GSE18583/GSE18583_family.soft.gz b/input/GEO/Heart_rate/GSE18583/GSE18583_family.soft.gz new file mode 100644 index 0000000000000000000000000000000000000000..6fc3807ed2b5061aa7e08d9674691a63fb3d508a --- /dev/null +++ b/input/GEO/Heart_rate/GSE18583/GSE18583_family.soft.gz @@ -0,0 +1,3 @@ +version https://git-lfs.github.com/spec/v1 +oid sha256:082681ef8361801154237715da41e4a6a4c25b7b8d99e5cff117b8a1290a90e0 +size 6550097 diff --git a/input/GEO/Heart_rate/GSE18583/GSE18583_series_matrix.txt.gz b/input/GEO/Heart_rate/GSE18583/GSE18583_series_matrix.txt.gz new file mode 100644 index 0000000000000000000000000000000000000000..fee82c7c2d808ac3fc02c30f293349d0d48b74bc --- /dev/null +++ b/input/GEO/Heart_rate/GSE18583/GSE18583_series_matrix.txt.gz @@ -0,0 +1,3 @@ +version https://git-lfs.github.com/spec/v1 +oid sha256:dbe0cdcb4ea6eb0b92ded0d09b5422e301c2ca7d797189594734c2550ce049b3 +size 2913290 diff --git a/input/GEO/Heart_rate/GSE236927/GSE236927_family.soft.gz b/input/GEO/Heart_rate/GSE236927/GSE236927_family.soft.gz new file mode 100644 index 0000000000000000000000000000000000000000..a1376d19961d8a1b99e9bf4e1b69bfa54d579258 --- /dev/null +++ b/input/GEO/Heart_rate/GSE236927/GSE236927_family.soft.gz @@ -0,0 +1,3 @@ +version https://git-lfs.github.com/spec/v1 +oid sha256:684e02c4ab1ea01339655d45e014090acd459b36f85783294868f00138d2cee5 +size 26472731 diff --git a/input/GEO/Heart_rate/GSE236927/GSE236927_series_matrix.txt.gz b/input/GEO/Heart_rate/GSE236927/GSE236927_series_matrix.txt.gz new file mode 100644 index 0000000000000000000000000000000000000000..9e64c1507bb2a9763f671cca8958b51eac206c15 --- /dev/null +++ b/input/GEO/Heart_rate/GSE236927/GSE236927_series_matrix.txt.gz @@ -0,0 +1,3 @@ +version https://git-lfs.github.com/spec/v1 +oid sha256:ce50d9494b33c330a8e8c50fbe41eabe0cc57d38959b4fb64f61370e3c764471 +size 6204286 diff --git a/input/GEO/Heart_rate/GSE34788/GSE34788_family.soft.gz b/input/GEO/Heart_rate/GSE34788/GSE34788_family.soft.gz new file mode 100644 index 0000000000000000000000000000000000000000..333f25b0b4e6f5192d2fce7d3e4f7efb423f9700 --- /dev/null +++ b/input/GEO/Heart_rate/GSE34788/GSE34788_family.soft.gz @@ -0,0 +1,3 @@ +version https://git-lfs.github.com/spec/v1 +oid sha256:b5ee6534472e08f656758fae7f2d473c17fe3d7461d0b4e904e3817afae0a015 +size 37480468 diff --git a/input/GEO/Heart_rate/GSE34788/GSE34788_series_matrix.txt.gz b/input/GEO/Heart_rate/GSE34788/GSE34788_series_matrix.txt.gz new file mode 100644 index 0000000000000000000000000000000000000000..b903a17c47a9f32c0fce8b991f0421c61760e46e --- /dev/null +++ b/input/GEO/Heart_rate/GSE34788/GSE34788_series_matrix.txt.gz @@ -0,0 +1,3 @@ +version https://git-lfs.github.com/spec/v1 +oid sha256:02502ad8cb6ea48ecbfa15c7b31de5dcdc6672c8b23a08d7e67ed8a4a5bbb704 +size 12983331 diff --git a/input/GEO/Heart_rate/GSE35661/GSE35661-GPL570_series_matrix.txt.gz b/input/GEO/Heart_rate/GSE35661/GSE35661-GPL570_series_matrix.txt.gz new file mode 100644 index 0000000000000000000000000000000000000000..9a1e3b65c85fad24adb17ef4beaa5f81b05c60ff --- /dev/null +++ b/input/GEO/Heart_rate/GSE35661/GSE35661-GPL570_series_matrix.txt.gz @@ -0,0 +1,3 @@ +version https://git-lfs.github.com/spec/v1 +oid sha256:5e093af280517370fa2dcaadb2b7089750d1caf1653d972881cc866393d3cd73 +size 3937230 diff --git a/input/GEO/Heart_rate/GSE35661/GSE35661-GPL9454_series_matrix.txt.gz b/input/GEO/Heart_rate/GSE35661/GSE35661-GPL9454_series_matrix.txt.gz new file mode 100644 index 0000000000000000000000000000000000000000..687bc23a19fcb85fb7c9fa6b38ee5dfb9758f6eb --- /dev/null +++ b/input/GEO/Heart_rate/GSE35661/GSE35661-GPL9454_series_matrix.txt.gz @@ -0,0 +1,3 @@ +version https://git-lfs.github.com/spec/v1 +oid sha256:4f2b791c9e231d9ae72275d8749efbb9dc0ac9934e8348fa77e56ce670600e30 +size 2913567 diff --git a/input/GEO/Heart_rate/GSE35661/GSE35661_family.soft.gz b/input/GEO/Heart_rate/GSE35661/GSE35661_family.soft.gz new file mode 100644 index 0000000000000000000000000000000000000000..eb664d1e4a894cd259002a2cc96375d56758c49b --- /dev/null +++ b/input/GEO/Heart_rate/GSE35661/GSE35661_family.soft.gz @@ -0,0 +1,3 @@ +version https://git-lfs.github.com/spec/v1 +oid sha256:9ca29f0139eeb67c5d064be131c1cb2a140b7078df87f314cc96a42ee03ef544 +size 25816465 diff --git a/input/GEO/Heart_rate/GSE72462/GSE72462_family.soft.gz b/input/GEO/Heart_rate/GSE72462/GSE72462_family.soft.gz new file mode 100644 index 0000000000000000000000000000000000000000..e9e4ef46026ddb4d475202277f2a081b5f39868c --- /dev/null +++ b/input/GEO/Heart_rate/GSE72462/GSE72462_family.soft.gz @@ -0,0 +1,3 @@ +version https://git-lfs.github.com/spec/v1 +oid sha256:e3591bbf7a9957c03eefeb10200f25b8156ee45876eb171d0124f2564f91d44d +size 27661988 diff --git a/input/GEO/Heart_rate/GSE72462/GSE72462_series_matrix.txt.gz b/input/GEO/Heart_rate/GSE72462/GSE72462_series_matrix.txt.gz new file mode 100644 index 0000000000000000000000000000000000000000..e5d1f6e9c6944b1602758c2a9244fe39fbb2f704 --- /dev/null +++ b/input/GEO/Heart_rate/GSE72462/GSE72462_series_matrix.txt.gz @@ -0,0 +1,3 @@ +version https://git-lfs.github.com/spec/v1 +oid sha256:a60a9e7607d21376f2d658053b13ec588ce127a936087175f54e77f0941d1717 +size 5583074 diff --git a/input/GEO/Height/GSE101709/GSE101709_family.soft.gz b/input/GEO/Height/GSE101709/GSE101709_family.soft.gz new file mode 100644 index 0000000000000000000000000000000000000000..4c7b219364d70b18c8edbbae6edb5c22947dbddd --- /dev/null +++ b/input/GEO/Height/GSE101709/GSE101709_family.soft.gz @@ -0,0 +1,3 @@ +version https://git-lfs.github.com/spec/v1 +oid sha256:19b8ae8bedd523d65657ec1dd3e597e446d10d5e34ce03ca0647b3f441b2280a +size 80260770 diff --git a/input/GEO/Height/GSE101709/GSE101709_series_matrix.txt.gz b/input/GEO/Height/GSE101709/GSE101709_series_matrix.txt.gz new file mode 100644 index 0000000000000000000000000000000000000000..63e5abd7f07f3fd870c0ed79f72bedb12604602b --- /dev/null +++ b/input/GEO/Height/GSE101709/GSE101709_series_matrix.txt.gz @@ -0,0 +1,3 @@ +version https://git-lfs.github.com/spec/v1 +oid sha256:60585df9ba41d6b3e8fe175bbecc6c74b20122f3122229989f13e6d74ff914ae +size 34589368 diff --git a/input/GEO/Height/GSE101710/GSE101710_family.soft.gz b/input/GEO/Height/GSE101710/GSE101710_family.soft.gz new file mode 100644 index 0000000000000000000000000000000000000000..d64e039cab8df87c8f4ed3a8913bd428ca1172e5 --- /dev/null +++ b/input/GEO/Height/GSE101710/GSE101710_family.soft.gz @@ -0,0 +1,3 @@ +version https://git-lfs.github.com/spec/v1 +oid sha256:0edf189229aed0b2cbbc747ad9933a0a801d2da74e700b3c063d400b87dfce72 +size 67673962 diff --git a/input/GEO/Height/GSE101710/GSE101710_series_matrix.txt.gz b/input/GEO/Height/GSE101710/GSE101710_series_matrix.txt.gz new file mode 100644 index 0000000000000000000000000000000000000000..11acd76e91bac411060a29a5729ffd643d73b965 --- /dev/null +++ b/input/GEO/Height/GSE101710/GSE101710_series_matrix.txt.gz @@ -0,0 +1,3 @@ +version https://git-lfs.github.com/spec/v1 +oid sha256:c24f7bcdd4d6270e0613aae3bbe0f817c8697f2565fc39f4b0ba58ed12c1829b +size 27976466 diff --git a/input/GEO/Height/GSE102130/GSE102130_family.soft.gz b/input/GEO/Height/GSE102130/GSE102130_family.soft.gz new file mode 100644 index 0000000000000000000000000000000000000000..6a126ba55447161834cbd057c76af4e37f538b09 --- /dev/null +++ b/input/GEO/Height/GSE102130/GSE102130_family.soft.gz @@ -0,0 +1,3 @@ +version https://git-lfs.github.com/spec/v1 +oid sha256:0178086177c6b7d4b9863491312aefe7519007d7cdfcd94c8bfb082a2e1d3570 +size 231312 diff --git a/input/GEO/Height/GSE102130/GSE102130_series_matrix.txt.gz b/input/GEO/Height/GSE102130/GSE102130_series_matrix.txt.gz new file mode 100644 index 0000000000000000000000000000000000000000..145b862681a5b9c570b8fca8c2f6da8bf31ec776 --- /dev/null +++ b/input/GEO/Height/GSE102130/GSE102130_series_matrix.txt.gz @@ -0,0 +1,3 @@ +version https://git-lfs.github.com/spec/v1 +oid sha256:47fb7511d1b2e854eb97386b669b5f900930dd1cd33a8a146d67c9dab21f7c9a +size 159095 diff --git a/input/GEO/Height/GSE106800/GSE106800_family.soft.gz b/input/GEO/Height/GSE106800/GSE106800_family.soft.gz new file mode 100644 index 0000000000000000000000000000000000000000..6d6e94e8939003292f33a915b8308eae2f2e615e --- /dev/null +++ b/input/GEO/Height/GSE106800/GSE106800_family.soft.gz @@ -0,0 +1,3 @@ +version https://git-lfs.github.com/spec/v1 +oid sha256:b90e2ae04f8d35056339918fbec31bf7fc85aa93168fcbb78ce8614a113dfcfd +size 53495461 diff --git a/input/GEO/Height/GSE106800/GSE106800_series_matrix.txt.gz b/input/GEO/Height/GSE106800/GSE106800_series_matrix.txt.gz new file mode 100644 index 0000000000000000000000000000000000000000..bec24f92ac166e65f22b87413d9c5c4299b9aa54 --- /dev/null +++ b/input/GEO/Height/GSE106800/GSE106800_series_matrix.txt.gz @@ -0,0 +1,3 @@ +version https://git-lfs.github.com/spec/v1 +oid sha256:14595aa30617ca95082615ab7911156afb2f4d36f751bbc57677819096f04cfa +size 13803866 diff --git a/input/GEO/Height/GSE117525/GSE117525_family.soft.gz b/input/GEO/Height/GSE117525/GSE117525_family.soft.gz new file mode 100644 index 0000000000000000000000000000000000000000..093b33586fc0d1f244c4eef5458338fbd6145a5d --- /dev/null +++ b/input/GEO/Height/GSE117525/GSE117525_family.soft.gz @@ -0,0 +1,3 @@ +version https://git-lfs.github.com/spec/v1 +oid sha256:4a133ebe511939b719b1d836f49959ff4559c7e15d4586faf6c8acd2cc6654f7 +size 43641607 diff --git a/input/GEO/Height/GSE117525/GSE117525_series_matrix.txt.gz b/input/GEO/Height/GSE117525/GSE117525_series_matrix.txt.gz new file mode 100644 index 0000000000000000000000000000000000000000..dae9a4fdf49c1bd86bc5773ac5f26cd75d93ec13 --- /dev/null +++ b/input/GEO/Height/GSE117525/GSE117525_series_matrix.txt.gz @@ -0,0 +1,3 @@ +version https://git-lfs.github.com/spec/v1 +oid sha256:54130cc4bbf305e900defa2d85f3ee18c56f92dc6d5355745e0a84353b313ed9 +size 27579436 diff --git a/input/GEO/Height/GSE131835/GSE131835_family.soft.gz b/input/GEO/Height/GSE131835/GSE131835_family.soft.gz new file mode 100644 index 0000000000000000000000000000000000000000..024dbcd2cea07a230c72d9e8f21a4d870ca16cb7 --- /dev/null +++ b/input/GEO/Height/GSE131835/GSE131835_family.soft.gz @@ -0,0 +1,3 @@ +version https://git-lfs.github.com/spec/v1 +oid sha256:de6d7be3abfe7fde142435c9f5f587dc2a2f6fef02e4b8e1f8c93a8eea4cefae +size 7971120 diff --git a/input/GEO/Height/GSE131835/GSE131835_series_matrix.txt.gz b/input/GEO/Height/GSE131835/GSE131835_series_matrix.txt.gz new file mode 100644 index 0000000000000000000000000000000000000000..968f6065cc8427e2601645a8f84d3317f0b89699 --- /dev/null +++ b/input/GEO/Height/GSE131835/GSE131835_series_matrix.txt.gz @@ -0,0 +1,3 @@ +version https://git-lfs.github.com/spec/v1 +oid sha256:b9656c8cac110909047ad3305500ae8918e9131fdc3bc199c613e32b014fe4ce +size 4616084 diff --git a/input/GEO/Height/GSE152073/GSE152073_family.soft.gz b/input/GEO/Height/GSE152073/GSE152073_family.soft.gz new file mode 100644 index 0000000000000000000000000000000000000000..e3e2738d2529d6bdb8b139ec8be38d00345353a3 --- /dev/null +++ b/input/GEO/Height/GSE152073/GSE152073_family.soft.gz @@ -0,0 +1,3 @@ +version https://git-lfs.github.com/spec/v1 +oid sha256:117c90a60ccf598ef636752aa86256db0da9b83262c373b2b1d0bffe2cd6cd60 +size 43557111 diff --git a/input/GEO/Height/GSE152073/GSE152073_series_matrix.txt.gz b/input/GEO/Height/GSE152073/GSE152073_series_matrix.txt.gz new file mode 100644 index 0000000000000000000000000000000000000000..2d05c3c7f1647c01b8f71ed56c2335df083dce4e --- /dev/null +++ b/input/GEO/Height/GSE152073/GSE152073_series_matrix.txt.gz @@ -0,0 +1,3 @@ +version https://git-lfs.github.com/spec/v1 +oid sha256:5ed008044f7fd033edab835b67446e5a55c15398d8a7d3b82d7f09bb144f92fa +size 16349648 diff --git a/input/GEO/Height/GSE181339/GSE181339_family.soft.gz b/input/GEO/Height/GSE181339/GSE181339_family.soft.gz new file mode 100644 index 0000000000000000000000000000000000000000..25aad0ddaa7c86489be62c0bee8c65620938e6f0 --- /dev/null +++ b/input/GEO/Height/GSE181339/GSE181339_family.soft.gz @@ -0,0 +1,3 @@ +version https://git-lfs.github.com/spec/v1 +oid sha256:57350168745adf697d6fe327224ffd408d33d8a4dabca48912098b06df9fbd56 +size 22301447 diff --git a/input/GEO/Height/GSE181339/GSE181339_series_matrix.txt.gz b/input/GEO/Height/GSE181339/GSE181339_series_matrix.txt.gz new file mode 100644 index 0000000000000000000000000000000000000000..37566de49cdb30c237c125b1a70f8caaf4a09fb0 --- /dev/null +++ b/input/GEO/Height/GSE181339/GSE181339_series_matrix.txt.gz @@ -0,0 +1,3 @@ +version https://git-lfs.github.com/spec/v1 +oid sha256:e6e594426993662698cd0562002f5f6b2b6ac2417ccff60a21221b2e80dd052a +size 7057706 diff --git a/input/GEO/Height/GSE71994/GSE71994_family.soft.gz b/input/GEO/Height/GSE71994/GSE71994_family.soft.gz new file mode 100644 index 0000000000000000000000000000000000000000..413f55305b0c545c050107f6917f4fdc1966e346 --- /dev/null +++ b/input/GEO/Height/GSE71994/GSE71994_family.soft.gz @@ -0,0 +1,3 @@ +version https://git-lfs.github.com/spec/v1 +oid sha256:e1600a7f019ee09e8212dded63a40f00a26ef7f16634026d2af9f0a4ff921bd3 +size 21653720 diff --git a/input/GEO/Height/GSE71994/GSE71994_series_matrix.txt.gz b/input/GEO/Height/GSE71994/GSE71994_series_matrix.txt.gz new file mode 100644 index 0000000000000000000000000000000000000000..8703da7890398e1fd32c9f8bf208394aaaa25309 --- /dev/null +++ b/input/GEO/Height/GSE71994/GSE71994_series_matrix.txt.gz @@ -0,0 +1,3 @@ +version https://git-lfs.github.com/spec/v1 +oid sha256:1a26e1959b5bc0ab81ba674295b69be0dec042e7c70306d0292b5e42854f793d +size 6290466 diff --git a/input/GEO/Height/GSE97475/GSE97475_family.soft.gz b/input/GEO/Height/GSE97475/GSE97475_family.soft.gz new file mode 100644 index 0000000000000000000000000000000000000000..0f3eed66c64293e4b9a3c66509f4dbb02218e63c --- /dev/null +++ b/input/GEO/Height/GSE97475/GSE97475_family.soft.gz @@ -0,0 +1,3 @@ +version https://git-lfs.github.com/spec/v1 +oid sha256:65bffc11783fe17ab90de354a2647edfa5d5ad7a54ff0ca4128754c7626887be +size 26635445 diff --git a/input/GEO/Height/GSE97475/GSE97475_series_matrix.txt.gz b/input/GEO/Height/GSE97475/GSE97475_series_matrix.txt.gz new file mode 100644 index 0000000000000000000000000000000000000000..57407708b371433b949b142039adebbaf407a41c --- /dev/null +++ b/input/GEO/Height/GSE97475/GSE97475_series_matrix.txt.gz @@ -0,0 +1,3 @@ +version https://git-lfs.github.com/spec/v1 +oid sha256:d6f6100e41f969680ed6721587a459d2f995319cda3c9f56ae99cf2419309010 +size 15595994 diff --git a/input/GEO/Hemochromatosis/GSE159676/GSE159676_family.soft.gz b/input/GEO/Hemochromatosis/GSE159676/GSE159676_family.soft.gz new file mode 100644 index 0000000000000000000000000000000000000000..b31a732a4a56b44738dbac4e3bf9356b5cabc43b --- /dev/null +++ b/input/GEO/Hemochromatosis/GSE159676/GSE159676_family.soft.gz @@ -0,0 +1,3 @@ +version https://git-lfs.github.com/spec/v1 +oid sha256:1dd919bc0d757bc8316ab247da665d40b54b0d5357132485cecd4a4f3fcd6152 +size 16271007 diff --git a/input/GEO/Hemochromatosis/GSE159676/GSE159676_series_matrix.txt.gz b/input/GEO/Hemochromatosis/GSE159676/GSE159676_series_matrix.txt.gz new file mode 100644 index 0000000000000000000000000000000000000000..468975d96db9d5cfde53b3eca41314433052748f --- /dev/null +++ b/input/GEO/Hemochromatosis/GSE159676/GSE159676_series_matrix.txt.gz @@ -0,0 +1,3 @@ +version https://git-lfs.github.com/spec/v1 +oid sha256:431071d39c24db9ba985873e916f03ef992ed8b5e0de1b4b1e5fe2f298fc186f +size 2252130 diff --git a/input/GEO/Hemochromatosis/GSE50579/GSE50579_family.soft.gz b/input/GEO/Hemochromatosis/GSE50579/GSE50579_family.soft.gz new file mode 100644 index 0000000000000000000000000000000000000000..61198307ace3b32b7eb6d006f9fc9b28972fe2aa --- /dev/null +++ b/input/GEO/Hemochromatosis/GSE50579/GSE50579_family.soft.gz @@ -0,0 +1,3 @@ +version https://git-lfs.github.com/spec/v1 +oid sha256:abcd8bbeef11ff3e9c01a0bc81c28081d3d0595d6b75fcbff654f6abe2a49e13 +size 36888417 diff --git a/input/GEO/Hemochromatosis/GSE50579/GSE50579_series_matrix.txt.gz b/input/GEO/Hemochromatosis/GSE50579/GSE50579_series_matrix.txt.gz new file mode 100644 index 0000000000000000000000000000000000000000..5d17c6d78491defe8b497a6176f2d7922d58bb47 --- /dev/null +++ b/input/GEO/Hemochromatosis/GSE50579/GSE50579_series_matrix.txt.gz @@ -0,0 +1,3 @@ +version https://git-lfs.github.com/spec/v1 +oid sha256:34cfcd51373a0acd9c8bd55fc7d2930f4b6136eac06ca1557c6bd2c04b2a4dbc +size 14707147 diff --git a/input/GEO/Hepatitis/GSE114783/GSE114783_family.soft.gz b/input/GEO/Hepatitis/GSE114783/GSE114783_family.soft.gz new file mode 100644 index 0000000000000000000000000000000000000000..dc2a0b286a0d7fa56efad5e81ec2c6ae5be38a19 --- /dev/null +++ b/input/GEO/Hepatitis/GSE114783/GSE114783_family.soft.gz @@ -0,0 +1,3 @@ +version https://git-lfs.github.com/spec/v1 +oid sha256:4eead6910d0cb718655e43a0f4540f34c66182695f676898e5062b7129c5f097 +size 9529439 diff --git a/input/GEO/Hepatitis/GSE114783/GSE114783_series_matrix.txt.gz b/input/GEO/Hepatitis/GSE114783/GSE114783_series_matrix.txt.gz new file mode 100644 index 0000000000000000000000000000000000000000..4b8a906cf574977cde54a06f4d75488c7f6fa2d5 --- /dev/null +++ b/input/GEO/Hepatitis/GSE114783/GSE114783_series_matrix.txt.gz @@ -0,0 +1,3 @@ +version https://git-lfs.github.com/spec/v1 +oid sha256:79d6b8f681bc5cadf3aa006623644a43b2e40269e3b24ade6a0322c9880bad22 +size 6036095 diff --git a/input/GEO/Hepatitis/GSE124719/GSE124719_family.soft.gz b/input/GEO/Hepatitis/GSE124719/GSE124719_family.soft.gz new file mode 100644 index 0000000000000000000000000000000000000000..bbed8a9461e61e6dca71ec455aa2d2b8f56bd007 --- /dev/null +++ b/input/GEO/Hepatitis/GSE124719/GSE124719_family.soft.gz @@ -0,0 +1,3 @@ +version https://git-lfs.github.com/spec/v1 +oid sha256:af372773568553e40ccf25f53518dd21a1ab1d85c526adaf4dde43f647897684 +size 82957792 diff --git a/input/GEO/Hepatitis/GSE124719/GSE124719_series_matrix.txt.gz b/input/GEO/Hepatitis/GSE124719/GSE124719_series_matrix.txt.gz new file mode 100644 index 0000000000000000000000000000000000000000..a2cd98168a7b7afe61d6c8f070016ade934f5012 --- /dev/null +++ b/input/GEO/Hepatitis/GSE124719/GSE124719_series_matrix.txt.gz @@ -0,0 +1,3 @@ +version https://git-lfs.github.com/spec/v1 +oid sha256:2a245ede3eb86f2b746776999db29e8383c651f41022d7718e5868f2ec1c2366 +size 85956507 diff --git a/input/GEO/Hepatitis/GSE125860/GSE125860_family.soft.gz b/input/GEO/Hepatitis/GSE125860/GSE125860_family.soft.gz new file mode 100644 index 0000000000000000000000000000000000000000..5d277aebfc1647113c8a9ba8eb2e39944cf72e7a --- /dev/null +++ b/input/GEO/Hepatitis/GSE125860/GSE125860_family.soft.gz @@ -0,0 +1,3 @@ +version https://git-lfs.github.com/spec/v1 +oid sha256:5800035a2f47ad68ecbf4101539d96ae1b55a72382179e229099e9a332b09f19 +size 103466373 diff --git a/input/GEO/Hepatitis/GSE125860/GSE125860_series_matrix.txt.gz b/input/GEO/Hepatitis/GSE125860/GSE125860_series_matrix.txt.gz new file mode 100644 index 0000000000000000000000000000000000000000..c0b2ab2ad653af82b77dd043a740e29fb7b799bd --- /dev/null +++ b/input/GEO/Hepatitis/GSE125860/GSE125860_series_matrix.txt.gz @@ -0,0 +1,3 @@ +version https://git-lfs.github.com/spec/v1 +oid sha256:11c9bc32ae3ff4b1527c956ce78260410b8e05803714302b67143a60305a0783 +size 57475075 diff --git a/input/GEO/Hepatitis/GSE152738/GSE152738_family.soft.gz b/input/GEO/Hepatitis/GSE152738/GSE152738_family.soft.gz new file mode 100644 index 0000000000000000000000000000000000000000..ed9045b5fcacb82ca116491da8f50e11f1b1fe6a --- /dev/null +++ b/input/GEO/Hepatitis/GSE152738/GSE152738_family.soft.gz @@ -0,0 +1,3 @@ +version https://git-lfs.github.com/spec/v1 +oid sha256:5eb8180cfd89866f7355553f0bb2f426a05919cf8f7e26670bbdb7aa3c37d623 +size 14379186 diff --git a/input/GEO/Hepatitis/GSE152738/GSE152738_series_matrix.txt.gz b/input/GEO/Hepatitis/GSE152738/GSE152738_series_matrix.txt.gz new file mode 100644 index 0000000000000000000000000000000000000000..6526abe6933268d998a84092458bce83c344ced7 --- /dev/null +++ b/input/GEO/Hepatitis/GSE152738/GSE152738_series_matrix.txt.gz @@ -0,0 +1,3 @@ +version https://git-lfs.github.com/spec/v1 +oid sha256:016798ff5c1bedd4cb7f3c7fa5ba2deaf0d8f8ddf417057f6ae7c142ac1c661f +size 1663923 diff --git a/input/GEO/Hepatitis/GSE159676/GSE159676_family.soft.gz b/input/GEO/Hepatitis/GSE159676/GSE159676_family.soft.gz new file mode 100644 index 0000000000000000000000000000000000000000..b31a732a4a56b44738dbac4e3bf9356b5cabc43b --- /dev/null +++ b/input/GEO/Hepatitis/GSE159676/GSE159676_family.soft.gz @@ -0,0 +1,3 @@ +version https://git-lfs.github.com/spec/v1 +oid sha256:1dd919bc0d757bc8316ab247da665d40b54b0d5357132485cecd4a4f3fcd6152 +size 16271007 diff --git a/input/GEO/Hepatitis/GSE159676/GSE159676_series_matrix.txt.gz b/input/GEO/Hepatitis/GSE159676/GSE159676_series_matrix.txt.gz new file mode 100644 index 0000000000000000000000000000000000000000..468975d96db9d5cfde53b3eca41314433052748f --- /dev/null +++ b/input/GEO/Hepatitis/GSE159676/GSE159676_series_matrix.txt.gz @@ -0,0 +1,3 @@ +version https://git-lfs.github.com/spec/v1 +oid sha256:431071d39c24db9ba985873e916f03ef992ed8b5e0de1b4b1e5fe2f298fc186f +size 2252130 diff --git a/input/GEO/Hepatitis/GSE168049/GSE168049-GPL21185_series_matrix.txt.gz b/input/GEO/Hepatitis/GSE168049/GSE168049-GPL21185_series_matrix.txt.gz new file mode 100644 index 0000000000000000000000000000000000000000..31706a0f6d23a69cbe0d80d2ad2f80a294830a24 --- /dev/null +++ b/input/GEO/Hepatitis/GSE168049/GSE168049-GPL21185_series_matrix.txt.gz @@ -0,0 +1,3 @@ +version https://git-lfs.github.com/spec/v1 +oid sha256:8f1323f19490dc7dd55526627fc13b843e92512c2bbf966681a939cbd2a5e253 +size 4533795 diff --git a/input/GEO/Hepatitis/GSE168049/GSE168049_family.soft.gz b/input/GEO/Hepatitis/GSE168049/GSE168049_family.soft.gz new file mode 100644 index 0000000000000000000000000000000000000000..2fdd192cb4c3ffb6ca001123026e3449a70bd432 --- /dev/null +++ b/input/GEO/Hepatitis/GSE168049/GSE168049_family.soft.gz @@ -0,0 +1,3 @@ +version https://git-lfs.github.com/spec/v1 +oid sha256:3c55f8c6824ce1707027c19e50046568b2faf1192d843b11774e8a59e08a9962 +size 16691737 diff --git a/input/GEO/Hepatitis/GSE45032/GSE45032_family.soft.gz b/input/GEO/Hepatitis/GSE45032/GSE45032_family.soft.gz new file mode 100644 index 0000000000000000000000000000000000000000..4ee33c38abb04773a6f477e3bd9dcde7158bb7c7 --- /dev/null +++ b/input/GEO/Hepatitis/GSE45032/GSE45032_family.soft.gz @@ -0,0 +1,3 @@ +version https://git-lfs.github.com/spec/v1 +oid sha256:91f2cfc1f201d63c35bdb8db75cd4b59a9fbff26d51e6307b85ddea73d9aab0b +size 25073037 diff --git a/input/GEO/Hepatitis/GSE45032/GSE45032_series_matrix.txt.gz b/input/GEO/Hepatitis/GSE45032/GSE45032_series_matrix.txt.gz new file mode 100644 index 0000000000000000000000000000000000000000..1c01a8d471c8a6991044f3285dc79750d5ee51b9 --- /dev/null +++ b/input/GEO/Hepatitis/GSE45032/GSE45032_series_matrix.txt.gz @@ -0,0 +1,3 @@ +version https://git-lfs.github.com/spec/v1 +oid sha256:fe037501a0ee1261146e6c74daf42fb6c76c4affefd4fcf6f11d863485daf854 +size 12812154 diff --git a/input/GEO/Hepatitis/GSE66843/GSE66843-GPL10558_series_matrix.txt.gz b/input/GEO/Hepatitis/GSE66843/GSE66843-GPL10558_series_matrix.txt.gz new file mode 100644 index 0000000000000000000000000000000000000000..fe19189ea1ea848c5d29d34e4a17b2ed7a7a744f --- /dev/null +++ b/input/GEO/Hepatitis/GSE66843/GSE66843-GPL10558_series_matrix.txt.gz @@ -0,0 +1,3 @@ +version https://git-lfs.github.com/spec/v1 +oid sha256:8311e351f5b57b1d47e0d29b0822d7064258be1eead8e39aed42b8fee1727e14 +size 3786735 diff --git a/input/GEO/Hepatitis/GSE66843/GSE66843_family.soft.gz b/input/GEO/Hepatitis/GSE66843/GSE66843_family.soft.gz new file mode 100644 index 0000000000000000000000000000000000000000..a594573b73db040e3c17f16dd4d56f51e36809b8 --- /dev/null +++ b/input/GEO/Hepatitis/GSE66843/GSE66843_family.soft.gz @@ -0,0 +1,3 @@ +version https://git-lfs.github.com/spec/v1 +oid sha256:d74a4cb32e6863a4297b834d74d2007565672cc343af002861de6b657e885b8f +size 20624761 diff --git a/input/GEO/Hepatitis/GSE85550/GSE85550-GPL19886_series_matrix.txt.gz b/input/GEO/Hepatitis/GSE85550/GSE85550-GPL19886_series_matrix.txt.gz new file mode 100644 index 0000000000000000000000000000000000000000..73ea67e99f957a60cb559bf0647860757506c64c --- /dev/null +++ b/input/GEO/Hepatitis/GSE85550/GSE85550-GPL19886_series_matrix.txt.gz @@ -0,0 +1,3 @@ +version https://git-lfs.github.com/spec/v1 +oid sha256:e5bff90b2d213f457a1a32eb9d68f9f1009ca667f12b2912d4fea10928c34673 +size 597850 diff --git a/input/GEO/Hepatitis/GSE85550/GSE85550-GPL30511_series_matrix.txt.gz b/input/GEO/Hepatitis/GSE85550/GSE85550-GPL30511_series_matrix.txt.gz new file mode 100644 index 0000000000000000000000000000000000000000..d8aa46d0d6583be835ae009a43cf303ae686f124 --- /dev/null +++ b/input/GEO/Hepatitis/GSE85550/GSE85550-GPL30511_series_matrix.txt.gz @@ -0,0 +1,3 @@ +version https://git-lfs.github.com/spec/v1 +oid sha256:af37bac9aed036f5078284acd4eecaaff02fa3e11058eefec8aad4027094ceeb +size 137233 diff --git a/input/GEO/Hepatitis/GSE85550/GSE85550_family.soft.gz b/input/GEO/Hepatitis/GSE85550/GSE85550_family.soft.gz new file mode 100644 index 0000000000000000000000000000000000000000..e65e2a140712d4f92d902349bd988a3b5ff892f1 --- /dev/null +++ b/input/GEO/Hepatitis/GSE85550/GSE85550_family.soft.gz @@ -0,0 +1,3 @@ +version https://git-lfs.github.com/spec/v1 +oid sha256:1597753852b08a0d86a605bfa8b0d2272c47c87d9cb49ed9b02d3062d88eee21 +size 1102503 diff --git a/input/GEO/Hepatitis/GSE97475/GSE97475_family.soft.gz b/input/GEO/Hepatitis/GSE97475/GSE97475_family.soft.gz new file mode 100644 index 0000000000000000000000000000000000000000..0f3eed66c64293e4b9a3c66509f4dbb02218e63c --- /dev/null +++ b/input/GEO/Hepatitis/GSE97475/GSE97475_family.soft.gz @@ -0,0 +1,3 @@ +version https://git-lfs.github.com/spec/v1 +oid sha256:65bffc11783fe17ab90de354a2647edfa5d5ad7a54ff0ca4128754c7626887be +size 26635445 diff --git a/input/GEO/Hepatitis/GSE97475/GSE97475_series_matrix.txt.gz b/input/GEO/Hepatitis/GSE97475/GSE97475_series_matrix.txt.gz new file mode 100644 index 0000000000000000000000000000000000000000..57407708b371433b949b142039adebbaf407a41c --- /dev/null +++ b/input/GEO/Hepatitis/GSE97475/GSE97475_series_matrix.txt.gz @@ -0,0 +1,3 @@ +version https://git-lfs.github.com/spec/v1 +oid sha256:d6f6100e41f969680ed6721587a459d2f995319cda3c9f56ae99cf2419309010 +size 15595994 diff --git a/input/GEO/High-Density_Lipoprotein_Deficiency/GSE34945/GSE34945_family.soft.gz b/input/GEO/High-Density_Lipoprotein_Deficiency/GSE34945/GSE34945_family.soft.gz new file mode 100644 index 0000000000000000000000000000000000000000..ec9589367450a111672c6fde71038be5003a1edf --- /dev/null +++ b/input/GEO/High-Density_Lipoprotein_Deficiency/GSE34945/GSE34945_family.soft.gz @@ -0,0 +1,3 @@ +version https://git-lfs.github.com/spec/v1 +oid sha256:b8746fca1e8f3408d59cd5779c35b6355d25a4290eded727a8ca19e500c65029 +size 9804374 diff --git a/input/GEO/High-Density_Lipoprotein_Deficiency/GSE34945/GSE34945_series_matrix.txt.gz b/input/GEO/High-Density_Lipoprotein_Deficiency/GSE34945/GSE34945_series_matrix.txt.gz new file mode 100644 index 0000000000000000000000000000000000000000..ebc3f2b1fed5877c04a7b32f269343074e476f28 --- /dev/null +++ b/input/GEO/High-Density_Lipoprotein_Deficiency/GSE34945/GSE34945_series_matrix.txt.gz @@ -0,0 +1,3 @@ +version https://git-lfs.github.com/spec/v1 +oid sha256:5623e36560b9bc6e2e47b6b4dae42d15dcea4a6d53127ad224928146eaef8904 +size 157187 diff --git a/input/GEO/Huntingtons_Disease/GSE135589/GSE135589_family.soft.gz b/input/GEO/Huntingtons_Disease/GSE135589/GSE135589_family.soft.gz new file mode 100644 index 0000000000000000000000000000000000000000..b1788da83f8591bcea5cc0ab1fd74e65ce8093c1 --- /dev/null +++ b/input/GEO/Huntingtons_Disease/GSE135589/GSE135589_family.soft.gz @@ -0,0 +1,3 @@ +version https://git-lfs.github.com/spec/v1 +oid sha256:657520294ac8bf71f330de742c937e8af6e86c416c8782d5c9eb3f9eb6148f86 +size 95480845 diff --git a/input/GEO/Huntingtons_Disease/GSE135589/GSE135589_series_matrix.txt.gz b/input/GEO/Huntingtons_Disease/GSE135589/GSE135589_series_matrix.txt.gz new file mode 100644 index 0000000000000000000000000000000000000000..7f23756fbd3b1f04de9da37e2a011c3625655642 --- /dev/null +++ b/input/GEO/Huntingtons_Disease/GSE135589/GSE135589_series_matrix.txt.gz @@ -0,0 +1,3 @@ +version https://git-lfs.github.com/spec/v1 +oid sha256:765834e60f01ccd83c96ad1da1a2390b566fb90fa4fdab99b978d1ba16a0840f +size 52741106 diff --git a/input/GEO/Huntingtons_Disease/GSE154141/GSE154141-GPL1261_series_matrix.txt.gz b/input/GEO/Huntingtons_Disease/GSE154141/GSE154141-GPL1261_series_matrix.txt.gz new file mode 100644 index 0000000000000000000000000000000000000000..3f037d35932c4ba57a4e95a55f20f7065969dabc --- /dev/null +++ b/input/GEO/Huntingtons_Disease/GSE154141/GSE154141-GPL1261_series_matrix.txt.gz @@ -0,0 +1,3 @@ +version https://git-lfs.github.com/spec/v1 +oid sha256:38f8258800336c05b7a876cca6336b89f41d0031ce8e997fef5bcebd7b06c600 +size 27519666 diff --git a/input/GEO/Huntingtons_Disease/GSE154141/GSE154141-GPL16686_series_matrix.txt.gz b/input/GEO/Huntingtons_Disease/GSE154141/GSE154141-GPL16686_series_matrix.txt.gz new file mode 100644 index 0000000000000000000000000000000000000000..d74c9bc44eaa7b17bad3483f089133e4467e9e7f --- /dev/null +++ b/input/GEO/Huntingtons_Disease/GSE154141/GSE154141-GPL16686_series_matrix.txt.gz @@ -0,0 +1,3 @@ +version https://git-lfs.github.com/spec/v1 +oid sha256:1c2fe3dd785f8f509e9ec88290e74cee614f6422c1cc543e1a7cec7050826461 +size 5442395 diff --git a/input/GEO/Huntingtons_Disease/GSE154141/GSE154141_family.soft.gz b/input/GEO/Huntingtons_Disease/GSE154141/GSE154141_family.soft.gz new file mode 100644 index 0000000000000000000000000000000000000000..5b34e155bb5e2885263900c3ac62d6e153eb6351 --- /dev/null +++ b/input/GEO/Huntingtons_Disease/GSE154141/GSE154141_family.soft.gz @@ -0,0 +1,3 @@ +version https://git-lfs.github.com/spec/v1 +oid sha256:4b418b8d98d1e5971272c650eac69d1557321c0093b36180eebdbf34f0354d6b +size 61948917 diff --git a/input/GEO/Huntingtons_Disease/GSE26927/GSE26927_family.soft.gz b/input/GEO/Huntingtons_Disease/GSE26927/GSE26927_family.soft.gz new file mode 100644 index 0000000000000000000000000000000000000000..9fd578a0971dbd6464d9e97f2a637dcd2f36edfd --- /dev/null +++ b/input/GEO/Huntingtons_Disease/GSE26927/GSE26927_family.soft.gz @@ -0,0 +1,3 @@ +version https://git-lfs.github.com/spec/v1 +oid sha256:b383740e25736a7a876898d1106561e314645fb3acf871b972edad2ec3ad987a +size 23384924 diff --git a/input/GEO/Huntingtons_Disease/GSE26927/GSE26927_series_matrix.txt.gz b/input/GEO/Huntingtons_Disease/GSE26927/GSE26927_series_matrix.txt.gz new file mode 100644 index 0000000000000000000000000000000000000000..d246de9ab0b0858c300acc17d0f5af6d647c1e39 --- /dev/null +++ b/input/GEO/Huntingtons_Disease/GSE26927/GSE26927_series_matrix.txt.gz @@ -0,0 +1,3 @@ +version https://git-lfs.github.com/spec/v1 +oid sha256:b31cd1135ca5d934c01094ccab2ff092aba37ef2921ab3b64226fcac43be3c12 +size 8141201 diff --git a/input/GEO/Huntingtons_Disease/GSE34201/GSE34201_family.soft.gz b/input/GEO/Huntingtons_Disease/GSE34201/GSE34201_family.soft.gz new file mode 100644 index 0000000000000000000000000000000000000000..41cc0efdc02782f96fccf455d0cf31a4267affa9 --- /dev/null +++ b/input/GEO/Huntingtons_Disease/GSE34201/GSE34201_family.soft.gz @@ -0,0 +1,3 @@ +version https://git-lfs.github.com/spec/v1 +oid sha256:81ef7f89099e031713aded110fed4901739cb05399fefc3aa8a188dff8fe6236 +size 44291072 diff --git a/input/GEO/Huntingtons_Disease/GSE34201/GSE34201_series_matrix.txt.gz b/input/GEO/Huntingtons_Disease/GSE34201/GSE34201_series_matrix.txt.gz new file mode 100644 index 0000000000000000000000000000000000000000..767ece108741cf728e694410b1d87f303d78b365 --- /dev/null +++ b/input/GEO/Huntingtons_Disease/GSE34201/GSE34201_series_matrix.txt.gz @@ -0,0 +1,3 @@ +version https://git-lfs.github.com/spec/v1 +oid sha256:1f3bd4a37d4ed4c5a32a4f9e22172bd8ced48cfa4274ab76fc191d8220bf85b5 +size 15235821 diff --git a/input/GEO/Huntingtons_Disease/GSE34721/GSE34721_family.soft.gz b/input/GEO/Huntingtons_Disease/GSE34721/GSE34721_family.soft.gz new file mode 100644 index 0000000000000000000000000000000000000000..8422af362780277ba23d54a3d82af9d3b305dff4 --- /dev/null +++ b/input/GEO/Huntingtons_Disease/GSE34721/GSE34721_family.soft.gz @@ -0,0 +1,3 @@ +version https://git-lfs.github.com/spec/v1 +oid sha256:0ceeda6d38b8825d215832d48b2b05dc3cb74e3e3538e3e8d1c9622064865049 +size 82366118 diff --git a/input/GEO/Huntingtons_Disease/GSE34721/GSE34721_series_matrix.txt.gz b/input/GEO/Huntingtons_Disease/GSE34721/GSE34721_series_matrix.txt.gz new file mode 100644 index 0000000000000000000000000000000000000000..cbac3181766c8498564b7239b54e2d2d710073ba --- /dev/null +++ b/input/GEO/Huntingtons_Disease/GSE34721/GSE34721_series_matrix.txt.gz @@ -0,0 +1,3 @@ +version https://git-lfs.github.com/spec/v1 +oid sha256:a2b304d6ea8f21c05e4dac7a0ac5059c868780f3ef950072db1a621f64e6d5df +size 32911555 diff --git a/input/GEO/Huntingtons_Disease/GSE71220/GSE71220_family.soft.gz b/input/GEO/Huntingtons_Disease/GSE71220/GSE71220_family.soft.gz new file mode 100644 index 0000000000000000000000000000000000000000..7a2f09a1ecde5be78bdfe746aca750b85c64b43a --- /dev/null +++ b/input/GEO/Huntingtons_Disease/GSE71220/GSE71220_family.soft.gz @@ -0,0 +1,3 @@ +version https://git-lfs.github.com/spec/v1 +oid sha256:12b084f6c4ea35f10d9cb4bb62ab82cd5c80aa4c57138d12f7b4160c4474a37c +size 71982482 diff --git a/input/GEO/Huntingtons_Disease/GSE71220/GSE71220_series_matrix.txt.gz b/input/GEO/Huntingtons_Disease/GSE71220/GSE71220_series_matrix.txt.gz new file mode 100644 index 0000000000000000000000000000000000000000..06513bfbca980375928b6b17237c7b5bafab673e --- /dev/null +++ b/input/GEO/Huntingtons_Disease/GSE71220/GSE71220_series_matrix.txt.gz @@ -0,0 +1,3 @@ +version https://git-lfs.github.com/spec/v1 +oid sha256:fd059a06d5e0946d91defc88b1e8df047b69d5e8469c9fe18c366322ab7f181c +size 40269478 diff --git a/input/GEO/Huntingtons_Disease/GSE95843/GSE95843-GPL23148_series_matrix.txt.gz b/input/GEO/Huntingtons_Disease/GSE95843/GSE95843-GPL23148_series_matrix.txt.gz new file mode 100644 index 0000000000000000000000000000000000000000..10b670a8971a450914c26801bca95c6a7bd5df45 --- /dev/null +++ b/input/GEO/Huntingtons_Disease/GSE95843/GSE95843-GPL23148_series_matrix.txt.gz @@ -0,0 +1,3 @@ +version https://git-lfs.github.com/spec/v1 +oid sha256:62cf70bfc576d3e724694f813e92123af0fce0db75ae8beac2d2a4cfec79b240 +size 10546184 diff --git a/input/GEO/Huntingtons_Disease/GSE95843/GSE95843-GPL23166_series_matrix.txt.gz b/input/GEO/Huntingtons_Disease/GSE95843/GSE95843-GPL23166_series_matrix.txt.gz new file mode 100644 index 0000000000000000000000000000000000000000..c51e507c00483981e2cc6d6427276681d2236560 --- /dev/null +++ b/input/GEO/Huntingtons_Disease/GSE95843/GSE95843-GPL23166_series_matrix.txt.gz @@ -0,0 +1,3 @@ +version https://git-lfs.github.com/spec/v1 +oid sha256:f158a51a2f924cf3a9bfdce44d18318d43e3b0177de5f2d51ae6b834fbe32e65 +size 11653847 diff --git a/input/GEO/Huntingtons_Disease/GSE95843/GSE95843_family.soft.gz b/input/GEO/Huntingtons_Disease/GSE95843/GSE95843_family.soft.gz new file mode 100644 index 0000000000000000000000000000000000000000..f2743aad2b922612d4e31b0af0543f24433b2618 --- /dev/null +++ b/input/GEO/Huntingtons_Disease/GSE95843/GSE95843_family.soft.gz @@ -0,0 +1,3 @@ +version https://git-lfs.github.com/spec/v1 +oid sha256:77a5451a012067c3b56bc69b4dc93d4c7d44253ee129d4f093be74b1854d0f9e +size 34854843 diff --git a/input/GEO/Hutchinson-Gilford_Progeria_Syndrome/GSE84351/GSE84351_family.soft.gz b/input/GEO/Hutchinson-Gilford_Progeria_Syndrome/GSE84351/GSE84351_family.soft.gz new file mode 100644 index 0000000000000000000000000000000000000000..988098dfc1b7f4fa8685266a53f638e0d2a39f4b --- /dev/null +++ b/input/GEO/Hutchinson-Gilford_Progeria_Syndrome/GSE84351/GSE84351_family.soft.gz @@ -0,0 +1,3 @@ +version https://git-lfs.github.com/spec/v1 +oid sha256:e21850d8bfad38128ebfcf6606094364c5ac85b22849124f16bdef33bdd8c126 +size 25545889 diff --git a/input/GEO/Hutchinson-Gilford_Progeria_Syndrome/GSE84351/GSE84351_series_matrix.txt.gz b/input/GEO/Hutchinson-Gilford_Progeria_Syndrome/GSE84351/GSE84351_series_matrix.txt.gz new file mode 100644 index 0000000000000000000000000000000000000000..1d24280c4279052c91970e57d99b66362715f578 --- /dev/null +++ b/input/GEO/Hutchinson-Gilford_Progeria_Syndrome/GSE84351/GSE84351_series_matrix.txt.gz @@ -0,0 +1,3 @@ +version https://git-lfs.github.com/spec/v1 +oid sha256:4e3d73d044afa92d5f67739f90347785553ad1b4826701f4041a055d78f325d2 +size 15997601 diff --git a/input/GEO/Hutchinson-Gilford_Progeria_Syndrome/GSE84360/GSE84360-GPL16686_series_matrix.txt.gz b/input/GEO/Hutchinson-Gilford_Progeria_Syndrome/GSE84360/GSE84360-GPL16686_series_matrix.txt.gz new file mode 100644 index 0000000000000000000000000000000000000000..49cfc1fe637496b7abc59672f888fecf6a644b68 --- /dev/null +++ b/input/GEO/Hutchinson-Gilford_Progeria_Syndrome/GSE84360/GSE84360-GPL16686_series_matrix.txt.gz @@ -0,0 +1,3 @@ +version https://git-lfs.github.com/spec/v1 +oid sha256:015bc592f4c8459ce9baa58bfcf41762418ec29f972002e4d8eef0fdf386980a +size 15997233 diff --git a/input/GEO/Hutchinson-Gilford_Progeria_Syndrome/GSE84360/GSE84360_family.soft.gz b/input/GEO/Hutchinson-Gilford_Progeria_Syndrome/GSE84360/GSE84360_family.soft.gz new file mode 100644 index 0000000000000000000000000000000000000000..92c4f98328e7d5052d783c1ba4e99c52c019d595 --- /dev/null +++ b/input/GEO/Hutchinson-Gilford_Progeria_Syndrome/GSE84360/GSE84360_family.soft.gz @@ -0,0 +1,3 @@ +version https://git-lfs.github.com/spec/v1 +oid sha256:c2a784b20b8605bfd53499d8d9091793c938c09b3d65682c11363ccfb89d7999 +size 25548712 diff --git a/input/GEO/Hypertension/GSE117261/GSE117261_family.soft.gz b/input/GEO/Hypertension/GSE117261/GSE117261_family.soft.gz new file mode 100644 index 0000000000000000000000000000000000000000..111bc5a5a93ccef88e94013282436935fa3088fb --- /dev/null +++ b/input/GEO/Hypertension/GSE117261/GSE117261_family.soft.gz @@ -0,0 +1,3 @@ +version https://git-lfs.github.com/spec/v1 +oid sha256:05ea7db38d51a7611812f5b3f1b44360ff155de644d0a6ba7e166c9ecfc6ae92 +size 29087588 diff --git a/input/GEO/Hypertension/GSE117261/GSE117261_series_matrix.txt.gz b/input/GEO/Hypertension/GSE117261/GSE117261_series_matrix.txt.gz new file mode 100644 index 0000000000000000000000000000000000000000..2d50fa1064336d7672a0099e57468e2d7445cb68 --- /dev/null +++ b/input/GEO/Hypertension/GSE117261/GSE117261_series_matrix.txt.gz @@ -0,0 +1,3 @@ +version https://git-lfs.github.com/spec/v1 +oid sha256:89310eedd250e4f57469021bda53a7a76d460b9c7d46b139a55f9c387b104e61 +size 9125329 diff --git a/input/GEO/Hypertension/GSE128381/GSE128381_family.soft.gz b/input/GEO/Hypertension/GSE128381/GSE128381_family.soft.gz new file mode 100644 index 0000000000000000000000000000000000000000..799166ecf8bebb32f8bd789bc89c8d46b08e8d3b --- /dev/null +++ b/input/GEO/Hypertension/GSE128381/GSE128381_family.soft.gz @@ -0,0 +1,3 @@ +version https://git-lfs.github.com/spec/v1 +oid sha256:1c3d8ebfe910670a126c69f9410979d82c3c4ab91152e41f3dbd08f7b5a60a56 +size 27816413 diff --git a/input/GEO/Hypertension/GSE128381/GSE128381_series_matrix.txt.gz b/input/GEO/Hypertension/GSE128381/GSE128381_series_matrix.txt.gz new file mode 100644 index 0000000000000000000000000000000000000000..49f2d4a0fdcf01ca553fa772d3c3b2b1237c2b74 --- /dev/null +++ b/input/GEO/Hypertension/GSE128381/GSE128381_series_matrix.txt.gz @@ -0,0 +1,3 @@ +version https://git-lfs.github.com/spec/v1 +oid sha256:7dcea79558ee357487b70d3cb80b4a379691aa490c2c41f915a5d5542fd719f1 +size 10112540 diff --git a/input/GEO/Hypertension/GSE149256/GSE149256_family.soft.gz b/input/GEO/Hypertension/GSE149256/GSE149256_family.soft.gz new file mode 100644 index 0000000000000000000000000000000000000000..61e10fe3d921b1944ecbc4d202e0ddcd91ee5519 --- /dev/null +++ b/input/GEO/Hypertension/GSE149256/GSE149256_family.soft.gz @@ -0,0 +1,3 @@ +version https://git-lfs.github.com/spec/v1 +oid sha256:0aee8cdf783ef051501d431256be432ddf4d9194e6834c60918cd9899e1abd18 +size 20717936 diff --git a/input/GEO/Hypertension/GSE149256/GSE149256_series_matrix.txt.gz b/input/GEO/Hypertension/GSE149256/GSE149256_series_matrix.txt.gz new file mode 100644 index 0000000000000000000000000000000000000000..01ce4f35ec920c0bb462e524c780681749f8aafc --- /dev/null +++ b/input/GEO/Hypertension/GSE149256/GSE149256_series_matrix.txt.gz @@ -0,0 +1,3 @@ +version https://git-lfs.github.com/spec/v1 +oid sha256:1fbbf02daf37325a922ffcc5ff7188801b847264bd4b7d1e2f9c6af9d715b126 +size 3465056 diff --git a/input/GEO/Hypertension/GSE151158/GSE151158_family.soft.gz b/input/GEO/Hypertension/GSE151158/GSE151158_family.soft.gz new file mode 100644 index 0000000000000000000000000000000000000000..77f2694d53c80147f8282888eace5a6a80103fa0 --- /dev/null +++ b/input/GEO/Hypertension/GSE151158/GSE151158_family.soft.gz @@ -0,0 +1,3 @@ +version https://git-lfs.github.com/spec/v1 +oid sha256:3a607f9dc7320d877a4d36fc2cc5a6d11b2a551ca67ccc45cb159fbe3535eda5 +size 217041 diff --git a/input/GEO/Hypertension/GSE151158/GSE151158_series_matrix.txt.gz b/input/GEO/Hypertension/GSE151158/GSE151158_series_matrix.txt.gz new file mode 100644 index 0000000000000000000000000000000000000000..d9b317334eea20d28792536206dc4bb05188da54 --- /dev/null +++ b/input/GEO/Hypertension/GSE151158/GSE151158_series_matrix.txt.gz @@ -0,0 +1,3 @@ +version https://git-lfs.github.com/spec/v1 +oid sha256:cb24b619a64fe7910ea22ead83cbfdad7c34fa9283120d166866f1a7e448025f +size 119050 diff --git a/input/GEO/Hypertension/GSE161533/GSE161533_family.soft.gz b/input/GEO/Hypertension/GSE161533/GSE161533_family.soft.gz new file mode 100644 index 0000000000000000000000000000000000000000..0928ccdcc4c461f9f5c932f23bd1a13935e8ad7a --- /dev/null +++ b/input/GEO/Hypertension/GSE161533/GSE161533_family.soft.gz @@ -0,0 +1,3 @@ +version https://git-lfs.github.com/spec/v1 +oid sha256:28aefba4c48f4708514d94bf3dd4ef7bf35f1558a6f2851d071174cc8b7ffeda +size 42692586 diff --git a/input/GEO/Hypertension/GSE161533/GSE161533_series_matrix.txt.gz b/input/GEO/Hypertension/GSE161533/GSE161533_series_matrix.txt.gz new file mode 100644 index 0000000000000000000000000000000000000000..8d1fe5c7b582d52aa055dcd1e3dfdf7f01284b77 --- /dev/null +++ b/input/GEO/Hypertension/GSE161533/GSE161533_series_matrix.txt.gz @@ -0,0 +1,3 @@ +version https://git-lfs.github.com/spec/v1 +oid sha256:cab6ea8ac4c7d12bcc29614e667782f3358ab16a93454420faff2251f0938314 +size 16097648 diff --git a/input/GEO/Hypertension/GSE181339/GSE181339_family.soft.gz b/input/GEO/Hypertension/GSE181339/GSE181339_family.soft.gz new file mode 100644 index 0000000000000000000000000000000000000000..25aad0ddaa7c86489be62c0bee8c65620938e6f0 --- /dev/null +++ b/input/GEO/Hypertension/GSE181339/GSE181339_family.soft.gz @@ -0,0 +1,3 @@ +version https://git-lfs.github.com/spec/v1 +oid sha256:57350168745adf697d6fe327224ffd408d33d8a4dabca48912098b06df9fbd56 +size 22301447 diff --git a/input/GEO/Hypertension/GSE181339/GSE181339_series_matrix.txt.gz b/input/GEO/Hypertension/GSE181339/GSE181339_series_matrix.txt.gz new file mode 100644 index 0000000000000000000000000000000000000000..37566de49cdb30c237c125b1a70f8caaf4a09fb0 --- /dev/null +++ b/input/GEO/Hypertension/GSE181339/GSE181339_series_matrix.txt.gz @@ -0,0 +1,3 @@ +version https://git-lfs.github.com/spec/v1 +oid sha256:e6e594426993662698cd0562002f5f6b2b6ac2417ccff60a21221b2e80dd052a +size 7057706 diff --git a/input/GEO/Hypertension/GSE256539/GSE256539_family.soft.gz b/input/GEO/Hypertension/GSE256539/GSE256539_family.soft.gz new file mode 100644 index 0000000000000000000000000000000000000000..719d8606e7b42ba934dc492fc35030e9c521e432 --- /dev/null +++ b/input/GEO/Hypertension/GSE256539/GSE256539_family.soft.gz @@ -0,0 +1,3 @@ +version https://git-lfs.github.com/spec/v1 +oid sha256:98eb39298b370d76d069b31e6bf575f16ec66abe4b3b99736570b891923092ab +size 17607565 diff --git a/input/GEO/Hypertension/GSE256539/GSE256539_series_matrix.txt.gz b/input/GEO/Hypertension/GSE256539/GSE256539_series_matrix.txt.gz new file mode 100644 index 0000000000000000000000000000000000000000..c58e78172ffbf50e48d4fab4972fa7e8c89bc470 --- /dev/null +++ b/input/GEO/Hypertension/GSE256539/GSE256539_series_matrix.txt.gz @@ -0,0 +1,3 @@ +version https://git-lfs.github.com/spec/v1 +oid sha256:81ce04f764e839438e4998b7ca2d66a88c3c27f0c917641d69777ec804b2f74e +size 9858479 diff --git a/input/GEO/Hypertension/GSE71994/GSE71994_family.soft.gz b/input/GEO/Hypertension/GSE71994/GSE71994_family.soft.gz new file mode 100644 index 0000000000000000000000000000000000000000..413f55305b0c545c050107f6917f4fdc1966e346 --- /dev/null +++ b/input/GEO/Hypertension/GSE71994/GSE71994_family.soft.gz @@ -0,0 +1,3 @@ +version https://git-lfs.github.com/spec/v1 +oid sha256:e1600a7f019ee09e8212dded63a40f00a26ef7f16634026d2af9f0a4ff921bd3 +size 21653720 diff --git a/input/GEO/Hypertension/GSE71994/GSE71994_series_matrix.txt.gz b/input/GEO/Hypertension/GSE71994/GSE71994_series_matrix.txt.gz new file mode 100644 index 0000000000000000000000000000000000000000..8703da7890398e1fd32c9f8bf208394aaaa25309 --- /dev/null +++ b/input/GEO/Hypertension/GSE71994/GSE71994_series_matrix.txt.gz @@ -0,0 +1,3 @@ +version https://git-lfs.github.com/spec/v1 +oid sha256:1a26e1959b5bc0ab81ba674295b69be0dec042e7c70306d0292b5e42854f793d +size 6290466 diff --git a/input/GEO/Hypertension/GSE74144/GSE74144_family.soft.gz b/input/GEO/Hypertension/GSE74144/GSE74144_family.soft.gz new file mode 100644 index 0000000000000000000000000000000000000000..419b195f0b0fae6a95c1c9a7361cad3d2faf900b --- /dev/null +++ b/input/GEO/Hypertension/GSE74144/GSE74144_family.soft.gz @@ -0,0 +1,3 @@ +version https://git-lfs.github.com/spec/v1 +oid sha256:9b6174cf67539c4bfca4e489e952309af02824142c63f5fac1ff512a555dcd4c +size 12163379 diff --git a/input/GEO/Hypertension/GSE74144/GSE74144_series_matrix.txt.gz b/input/GEO/Hypertension/GSE74144/GSE74144_series_matrix.txt.gz new file mode 100644 index 0000000000000000000000000000000000000000..1932d5ffd16bb9504e035aba3041c536ab1e4516 --- /dev/null +++ b/input/GEO/Hypertension/GSE74144/GSE74144_series_matrix.txt.gz @@ -0,0 +1,3 @@ +version https://git-lfs.github.com/spec/v1 +oid sha256:728a5d42fe4252d582aa69f1f7fd651933ea8c007002a37816e8bec4d37a6979 +size 1667638 diff --git a/input/GEO/Hypertension/GSE77627/GSE77627_family.soft.gz b/input/GEO/Hypertension/GSE77627/GSE77627_family.soft.gz new file mode 100644 index 0000000000000000000000000000000000000000..bd3bdc058c51e67b05907db0018cf59dcfe5f6ea --- /dev/null +++ b/input/GEO/Hypertension/GSE77627/GSE77627_family.soft.gz @@ -0,0 +1,3 @@ +version https://git-lfs.github.com/spec/v1 +oid sha256:8149c13febe4210652f4f4f8301396c35c1097a96ba6e2466aedf915dace0fb3 +size 26854579 diff --git a/input/GEO/Hypertension/GSE77627/GSE77627_series_matrix.txt.gz b/input/GEO/Hypertension/GSE77627/GSE77627_series_matrix.txt.gz new file mode 100644 index 0000000000000000000000000000000000000000..79445f2a3ba048897be3e2f42bf33d854c3700f5 --- /dev/null +++ b/input/GEO/Hypertension/GSE77627/GSE77627_series_matrix.txt.gz @@ -0,0 +1,3 @@ +version https://git-lfs.github.com/spec/v1 +oid sha256:89dee23ccd9bd726688f644b558968347c01572b241f4f8540464f05f4e38551 +size 8633949 diff --git a/input/GEO/Hypertrophic_Cardiomyopathy/GSE36961/GSE36961_family.soft.gz b/input/GEO/Hypertrophic_Cardiomyopathy/GSE36961/GSE36961_family.soft.gz new file mode 100644 index 0000000000000000000000000000000000000000..f96c86aa5e45ba0a0d3fa950f27e8088aec48371 --- /dev/null +++ b/input/GEO/Hypertrophic_Cardiomyopathy/GSE36961/GSE36961_family.soft.gz @@ -0,0 +1,3 @@ +version https://git-lfs.github.com/spec/v1 +oid sha256:c748703546c3de1e7e28435c3f632d9cd2ea97e1698974eaa2817705fa1cbf81 +size 63583608 diff --git a/input/GEO/Hypertrophic_Cardiomyopathy/GSE36961/GSE36961_series_matrix.txt.gz b/input/GEO/Hypertrophic_Cardiomyopathy/GSE36961/GSE36961_series_matrix.txt.gz new file mode 100644 index 0000000000000000000000000000000000000000..1ed6e87a1053f8e2341983481e43551e3a7a30b5 --- /dev/null +++ b/input/GEO/Hypertrophic_Cardiomyopathy/GSE36961/GSE36961_series_matrix.txt.gz @@ -0,0 +1,3 @@ +version https://git-lfs.github.com/spec/v1 +oid sha256:bc8bd7e5a5c87d7f8a187d500ec8118ba4b147e0295c26f9aac00b01db6a5e9b +size 28898140 diff --git a/input/GEO/Hypothyroidism/GSE151158/GSE151158_family.soft.gz b/input/GEO/Hypothyroidism/GSE151158/GSE151158_family.soft.gz new file mode 100644 index 0000000000000000000000000000000000000000..77f2694d53c80147f8282888eace5a6a80103fa0 --- /dev/null +++ b/input/GEO/Hypothyroidism/GSE151158/GSE151158_family.soft.gz @@ -0,0 +1,3 @@ +version https://git-lfs.github.com/spec/v1 +oid sha256:3a607f9dc7320d877a4d36fc2cc5a6d11b2a551ca67ccc45cb159fbe3535eda5 +size 217041 diff --git a/input/GEO/Hypothyroidism/GSE151158/GSE151158_series_matrix.txt.gz b/input/GEO/Hypothyroidism/GSE151158/GSE151158_series_matrix.txt.gz new file mode 100644 index 0000000000000000000000000000000000000000..d9b317334eea20d28792536206dc4bb05188da54 --- /dev/null +++ b/input/GEO/Hypothyroidism/GSE151158/GSE151158_series_matrix.txt.gz @@ -0,0 +1,3 @@ +version https://git-lfs.github.com/spec/v1 +oid sha256:cb24b619a64fe7910ea22ead83cbfdad7c34fa9283120d166866f1a7e448025f +size 119050 diff --git a/input/GEO/Hypothyroidism/GSE224330/GSE224330_family.soft.gz b/input/GEO/Hypothyroidism/GSE224330/GSE224330_family.soft.gz new file mode 100644 index 0000000000000000000000000000000000000000..a85c66612fda21f818dc9cfd52aa35acefc3bab7 --- /dev/null +++ b/input/GEO/Hypothyroidism/GSE224330/GSE224330_family.soft.gz @@ -0,0 +1,3 @@ +version https://git-lfs.github.com/spec/v1 +oid sha256:2b328594f929caaa75af93534169890b7ff8dd21b33a994d7ef718fa6e297a8b +size 22923613 diff --git a/input/GEO/Hypothyroidism/GSE224330/GSE224330_series_matrix.txt.gz b/input/GEO/Hypothyroidism/GSE224330/GSE224330_series_matrix.txt.gz new file mode 100644 index 0000000000000000000000000000000000000000..64d5a64e3153f644394c7c004fb3e3ddb162a906 --- /dev/null +++ b/input/GEO/Hypothyroidism/GSE224330/GSE224330_series_matrix.txt.gz @@ -0,0 +1,3 @@ +version https://git-lfs.github.com/spec/v1 +oid sha256:65c9ac54a4a83f3a1a713763adae7fb091e07510ee2d68a61de507ae0db88456 +size 7450455 diff --git a/input/GEO/Hypothyroidism/GSE32445/GSE32445-GPL571_series_matrix.txt.gz b/input/GEO/Hypothyroidism/GSE32445/GSE32445-GPL571_series_matrix.txt.gz new file mode 100644 index 0000000000000000000000000000000000000000..d72e72249c5ae4179d4ddf256062e35cc77acc79 --- /dev/null +++ b/input/GEO/Hypothyroidism/GSE32445/GSE32445-GPL571_series_matrix.txt.gz @@ -0,0 +1,3 @@ +version https://git-lfs.github.com/spec/v1 +oid sha256:09f8f75c853205dacb9f68a637210a37a8da3a0c6a03b70388330c3e759b47fc +size 529130 diff --git a/input/GEO/Hypothyroidism/GSE32445/GSE32445-GPL6887_series_matrix.txt.gz b/input/GEO/Hypothyroidism/GSE32445/GSE32445-GPL6887_series_matrix.txt.gz new file mode 100644 index 0000000000000000000000000000000000000000..9b4c73691c31b1dc3f40dc32bc9725543790173d --- /dev/null +++ b/input/GEO/Hypothyroidism/GSE32445/GSE32445-GPL6887_series_matrix.txt.gz @@ -0,0 +1,3 @@ +version https://git-lfs.github.com/spec/v1 +oid sha256:55fa36ca3ae01d86f46a786800b8a6ffa7ac20366569199d2edbeea3b68d12ff +size 4439500 diff --git a/input/GEO/Hypothyroidism/GSE32445/GSE32445_family.soft.gz b/input/GEO/Hypothyroidism/GSE32445/GSE32445_family.soft.gz new file mode 100644 index 0000000000000000000000000000000000000000..063e823e75c5cbf046e0a0f2c94cd39e3b21faa9 --- /dev/null +++ b/input/GEO/Hypothyroidism/GSE32445/GSE32445_family.soft.gz @@ -0,0 +1,3 @@ +version https://git-lfs.github.com/spec/v1 +oid sha256:e4c0096a7145aeee5168e77f0870a7dd428fe7817136df4bbdf9414f8aa0e92e +size 27073582 diff --git a/input/GEO/Hypothyroidism/GSE75678/GSE75678_family.soft.gz b/input/GEO/Hypothyroidism/GSE75678/GSE75678_family.soft.gz new file mode 100644 index 0000000000000000000000000000000000000000..fcc6ed931cbfde0180eebbdfb65ec672aeab85f6 --- /dev/null +++ b/input/GEO/Hypothyroidism/GSE75678/GSE75678_family.soft.gz @@ -0,0 +1,3 @@ +version https://git-lfs.github.com/spec/v1 +oid sha256:6f298a014f25b54cb41d7ebc9535bdf080b603af1c6b64a838d2ab49496c0568 +size 21116495 diff --git a/input/GEO/Hypothyroidism/GSE75678/GSE75678_series_matrix.txt.gz b/input/GEO/Hypothyroidism/GSE75678/GSE75678_series_matrix.txt.gz new file mode 100644 index 0000000000000000000000000000000000000000..641b41821251ee105d98b49e73e3fe434d67f285 --- /dev/null +++ b/input/GEO/Hypothyroidism/GSE75678/GSE75678_series_matrix.txt.gz @@ -0,0 +1,3 @@ +version https://git-lfs.github.com/spec/v1 +oid sha256:4a3c85f32813d440834df0287282ba4efb0e1c21549f72b6e898b60389e700e5 +size 11532644 diff --git a/input/GEO/Hypothyroidism/GSE75685/GSE75685-GPL4133_series_matrix.txt.gz b/input/GEO/Hypothyroidism/GSE75685/GSE75685-GPL4133_series_matrix.txt.gz new file mode 100644 index 0000000000000000000000000000000000000000..808adb0497e6dd17021b025da469151f153b5b03 --- /dev/null +++ b/input/GEO/Hypothyroidism/GSE75685/GSE75685-GPL4133_series_matrix.txt.gz @@ -0,0 +1,3 @@ +version https://git-lfs.github.com/spec/v1 +oid sha256:95d534247c61d8ac0aaff4da32e884684267613b5a38cab302cbc7968e267b73 +size 11532688 diff --git a/input/GEO/Hypothyroidism/GSE75685/GSE75685-GPL7731_series_matrix.txt.gz b/input/GEO/Hypothyroidism/GSE75685/GSE75685-GPL7731_series_matrix.txt.gz new file mode 100644 index 0000000000000000000000000000000000000000..23b5a41f86aec1427ee4b5b115522dd6b903a766 --- /dev/null +++ b/input/GEO/Hypothyroidism/GSE75685/GSE75685-GPL7731_series_matrix.txt.gz @@ -0,0 +1,3 @@ +version https://git-lfs.github.com/spec/v1 +oid sha256:7b8e3a688f413d8166aebdcdb4b68feca8fe1be1a702960f125eb5c3e44d788b +size 3607939 diff --git a/input/GEO/Hypothyroidism/GSE75685/GSE75685_family.soft.gz b/input/GEO/Hypothyroidism/GSE75685/GSE75685_family.soft.gz new file mode 100644 index 0000000000000000000000000000000000000000..445dc688a6143842c27d566afb7266a8a0a42635 --- /dev/null +++ b/input/GEO/Hypothyroidism/GSE75685/GSE75685_family.soft.gz @@ -0,0 +1,3 @@ +version https://git-lfs.github.com/spec/v1 +oid sha256:5fa1b02a0a14237f2308813adf5831b4e87f2518f677540eac34f81f6b5adf71 +size 25675094 diff --git a/input/TCGA/TCGA_Liver_Cancer_(LIHC)/TCGA.LIHC.sampleMap_HiSeqV2_PANCAN.gz b/input/TCGA/TCGA_Liver_Cancer_(LIHC)/TCGA.LIHC.sampleMap_HiSeqV2_PANCAN.gz new file mode 100644 index 0000000000000000000000000000000000000000..26b1918a2713a43c812e90d8327ee9ea9dc68c00 --- /dev/null +++ b/input/TCGA/TCGA_Liver_Cancer_(LIHC)/TCGA.LIHC.sampleMap_HiSeqV2_PANCAN.gz @@ -0,0 +1,3 @@ +version https://git-lfs.github.com/spec/v1 +oid sha256:5aed579b158c333791246fa9e8d3eb886c7d33dd068f64e2c96a44bb4dbbc22b +size 29194488 diff --git a/input/TCGA/TCGA_Liver_Cancer_(LIHC)/TCGA.LIHC.sampleMap_LIHC_clinicalMatrix b/input/TCGA/TCGA_Liver_Cancer_(LIHC)/TCGA.LIHC.sampleMap_LIHC_clinicalMatrix new file mode 100644 index 0000000000000000000000000000000000000000..eb5e90e3452d595e9a1cbb82987a3705284f87ca --- /dev/null +++ b/input/TCGA/TCGA_Liver_Cancer_(LIHC)/TCGA.LIHC.sampleMap_LIHC_clinicalMatrix @@ -0,0 +1,439 @@ +sampleID _INTEGRATION _PATIENT _cohort _primary_disease _primary_site additional_pharmaceutical_therapy additional_radiation_therapy adjacent_hepatic_tissue_inflammation_extent_type age_at_initial_pathologic_diagnosis albumin_result_lower_limit albumin_result_specified_value albumin_result_upper_limit bcr_followup_barcode bcr_patient_barcode bcr_sample_barcode bilirubin_lower_limit bilirubin_upper_limit cancer_first_degree_relative child_pugh_classification_grade creatinine_lower_level creatinine_upper_limit creatinine_value_in_mg_dl days_to_birth days_to_collection days_to_death days_to_initial_pathologic_diagnosis days_to_last_followup days_to_new_tumor_event_additional_surgery_procedure days_to_new_tumor_event_after_initial_treatment eastern_cancer_oncology_group fetoprotein_outcome_lower_limit fetoprotein_outcome_upper_limit fetoprotein_outcome_value fibrosis_ishak_score followup_case_report_form_submission_reason form_completion_date gender height hist_hepato_carc_fact hist_hepato_carcinoma_risk histological_type history_of_neoadjuvant_treatment icd_10 icd_o_3_histology icd_o_3_site informed_consent_verified initial_weight inter_norm_ratio_lower_limit intern_norm_ratio_upper_limit is_ffpe lost_follow_up neoplasm_histologic_grade new_neoplasm_event_occurrence_anatomic_site new_neoplasm_event_type new_neoplasm_occurrence_anatomic_site_text new_tumor_event_ablation_embo_tx new_tumor_event_additional_surgery_procedure new_tumor_event_after_initial_treatment new_tumor_event_liver_transplant oct_embedded other_dx pathologic_M pathologic_N pathologic_T pathologic_stage pathology_report_file_name patient_id person_neoplasm_cancer_status platelet_result_count platelet_result_lower_limit platelet_result_upper_limit post_op_ablation_embolization_tx postoperative_rx_tx prothrombin_time_result_value radiation_therapy relative_family_cancer_history residual_disease_post_new_tumor_event_margin_status residual_tumor sample_type sample_type_id specimen_collection_method_name system_version tissue_prospective_collection_indicator tissue_retrospective_collection_indicator tissue_source_site total_bilirubin_upper_limit tumor_tissue_site vascular_tumor_cell_type vial_number viral_hepatitis_serology vital_status weight year_of_initial_pathologic_diagnosis _GENOMIC_ID_TCGA_LIHC_gistic2 _GENOMIC_ID_TCGA_LIHC_gistic2thd _GENOMIC_ID_TCGA_LIHC_mutation_bcm_gene _GENOMIC_ID_TCGA_LIHC_miRNA_HiSeq _GENOMIC_ID_TCGA_LIHC_PDMRNAseq _GENOMIC_ID_TCGA_LIHC_RPPA _GENOMIC_ID_TCGA_LIHC_exp_HiSeqV2_percentile _GENOMIC_ID_TCGA_LIHC_mutation_bcgsc_gene _GENOMIC_ID_data/public/TCGA/LIHC/miRNA_HiSeq_gene _GENOMIC_ID_TCGA_LIHC_PDMRNAseqCNV _GENOMIC_ID_TCGA_LIHC_exp_HiSeqV2_exon _GENOMIC_ID_TCGA_LIHC_mutation_ucsc_maf_gene _GENOMIC_ID_TCGA_LIHC_exp_HiSeqV2 _GENOMIC_ID_TCGA_LIHC_exp_HiSeqV2_PANCAN _GENOMIC_ID_TCGA_LIHC_mutation_broad_gene _GENOMIC_ID_TCGA_LIHC_hMethyl450 +TCGA-2V-A95S-01 TCGA-2V-A95S-01 TCGA-2V-A95S TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver Severe 3.5 4.2 5.2 TCGA-2V-A95S TCGA-2V-A95S-01A 0 1.5 A .7 1.2 .6 4 0 8 10793 6 - Established Cirrhosis 2015-6-15 MALE 173 Other former smoker Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 170 2 3 NO G3 false No MX NX T2 Stage II TCGA-2V-A95S.BE263DC7-2250-42E2-8AD6-D99A6DF679B6.pdf A95S WITH TUMOR 107 140 370 NO NO 2.0 NO NO R0 Primary Tumor 01 Lobectomy 7th NO YES 2V .2 Liver Micro A LIVING 78 TCGA-2V-A95S-01A-11D-A36W-01 TCGA-2V-A95S-01A-11D-A36W-01 TCGA-2V-A95S-01A-11D-A36X-10 TCGA-2V-A95S-01 TCGA-2V-A95S-01 53796be6-1c87-448a-9928-3c640e9d3414 TCGA-2V-A95S-01 TCGA-2V-A95S-01 53796be6-1c87-448a-9928-3c640e9d3414 53796be6-1c87-448a-9928-3c640e9d3414 53796be6-1c87-448a-9928-3c640e9d3414 TCGA-2V-A95S-01A-11D-A36Y-05 +TCGA-2Y-A9GS-01 TCGA-2Y-A9GS-01 TCGA-2Y-A9GS TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver None 58 3.5 4 5 TCGA-2Y-A9GS TCGA-2Y-A9GS-01A 0.2 0.7 0.8 1.5 1.6 -21318 2558 724 0 0 6 74 2014-11-3 MALE 162 Alcohol consumption Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 80 8.3 11.5 NO G2 YES true No MX NX T2 [Discrepancy] TCGA-2Y-A9GS.DAA3D158-0488-41C9-8B3F-BE6D05E036D8.pdf A9GS WITH TUMOR 168 143 382 NO NO 9.9 NO R0 Primary Tumor 01 Segmentectomy, Single 6th NO YES 2Y 1.3 Liver A HCV Genotype|Hepatitis B Surface Antigen|HBV Core Antibody DECEASED 92 2006 TCGA-2Y-A9GS-01A-12D-A381-01 TCGA-2Y-A9GS-01A-12D-A381-01 TCGA-2Y-A9GS-01A-12D-A382-10 TCGA-2Y-A9GS-01 TCGA-2Y-A9GS-01 7b0d0cd1-3770-4e1c-9a64-93e41825a3b7 TCGA-2Y-A9GS-01 TCGA-2Y-A9GS-01 7b0d0cd1-3770-4e1c-9a64-93e41825a3b7 7b0d0cd1-3770-4e1c-9a64-93e41825a3b7 7b0d0cd1-3770-4e1c-9a64-93e41825a3b7 TCGA-2Y-A9GS-01A-12D-A383-05 +TCGA-2Y-A9GT-01 TCGA-2Y-A9GT-01 TCGA-2Y-A9GT TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver None 51 3.5 3.7 5 TCGA-2Y-A9GT 0.2 0.4 1 C 0.8 1.5 0.8 -18768 1624 0 0 7 17 2014-11-3 MALE 182 Alcohol consumption|Hepatitis B|Hepatitis C Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 8.3 11.5 G2 YES No MX NX T1 Stage I A9GT WITH TUMOR 187 143 382 NO 9.8 NO YES R0 Primary Tumor 01 Segmentectomy, Single 6th NO YES 2Y 1.3 Liver None Hepatitis C Virus R|Hepatitis B Surface Antigen|HBV Core Antibody|HBV D DECEASED 122 2006 TCGA-2Y-A9GT-01A-11D-A381-01 TCGA-2Y-A9GT-01A-11D-A381-01 TCGA-2Y-A9GT-01A-11D-A382-10 TCGA-2Y-A9GT-01 TCGA-2Y-A9GT-01 e1ab65b5-ee17-4e86-93aa-446c8f387ef1 TCGA-2Y-A9GT-01 TCGA-2Y-A9GT-01 e1ab65b5-ee17-4e86-93aa-446c8f387ef1 e1ab65b5-ee17-4e86-93aa-446c8f387ef1 e1ab65b5-ee17-4e86-93aa-446c8f387ef1 TCGA-2Y-A9GT-01A-11D-A383-05 +TCGA-2Y-A9GU-01 TCGA-2Y-A9GU-01 TCGA-2Y-A9GU TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver None 55 3.5 4.4 5 TCGA-2Y-A9GU-F69082 TCGA-2Y-A9GU TCGA-2Y-A9GU-01A 0.2 0.3 2 0.8 1.5 0.9 -20187 1752 0 1939 0 0 6 304 2014-12-29 FEMALE 154 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 120 8.3 11.5 NO NO G2 NO true No MX NX T1 Stage I TCGA-2Y-A9GU.5585C485-B57A-4CA8-A3E3-F093A7E6AC76.pdf A9GU TUMOR FREE 281 143 382 NO NO 10.8 NO YES R0 Primary Tumor 01 Segmentectomy, Single 6th NO YES 2Y 1.3 Liver A Hepatitis C Antibody|Hepatitis B Surface Antigen|HBV Core Antibody LIVING 78 2009 TCGA-2Y-A9GU-01A-11D-A381-01 TCGA-2Y-A9GU-01A-11D-A381-01 TCGA-2Y-A9GU-01A-11D-A382-10 TCGA-2Y-A9GU-01 TCGA-2Y-A9GU-01 6f3f7f73-b031-424e-ba7c-263f802dd6cf TCGA-2Y-A9GU-01 TCGA-2Y-A9GU-01 6f3f7f73-b031-424e-ba7c-263f802dd6cf 6f3f7f73-b031-424e-ba7c-263f802dd6cf 6f3f7f73-b031-424e-ba7c-263f802dd6cf TCGA-2Y-A9GU-01A-11D-A383-05 +TCGA-2Y-A9GV-01 TCGA-2Y-A9GV-01 TCGA-2Y-A9GV TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 54 3.5 4.2 5 TCGA-2Y-A9GV 0.2 0.3 0.8 1.5 0.6 -20011 2532 0 2 7 6 2014-11-3 FEMALE 167 Alcohol consumption Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 8.3 11.5 G1 YES Yes MX NX T1 Stage I A9GV WITH TUMOR 370 143 382 NO YES 9.5 NO NO R0 Primary Tumor 01 Segmentectomy, Multiple 6th NO YES 2Y 1.3 Liver Hepatitis C Antibody|Hepatitis B Surface Antigen|HBV Core Antibody DECEASED 85 2007 TCGA-2Y-A9GV-01A-11D-A381-01 TCGA-2Y-A9GV-01A-11D-A381-01 TCGA-2Y-A9GV-01A-11D-A382-10 TCGA-2Y-A9GV-01 TCGA-2Y-A9GV-01 c0bcdbc7-9bed-49b7-93ca-f82ffc2929a1 TCGA-2Y-A9GV-01 TCGA-2Y-A9GV-01 c0bcdbc7-9bed-49b7-93ca-f82ffc2929a1 c0bcdbc7-9bed-49b7-93ca-f82ffc2929a1 c0bcdbc7-9bed-49b7-93ca-f82ffc2929a1 TCGA-2Y-A9GV-01A-11D-A383-05 +TCGA-2Y-A9GW-01 TCGA-2Y-A9GW-01 TCGA-2Y-A9GW TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver None 64 3.5 4.5 5 TCGA-2Y-A9GW TCGA-2Y-A9GW-01A 0.2 0.6 1 0.8 1.5 1 -23587 2375 1271 0 0 6 2 2014-11-3 MALE 182 Alcohol consumption Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 80 8.3 11.5 NO G2 YES true No MX N0 T1 Stage I TCGA-2Y-A9GW.5846FA3D-E3AD-4530-8A5F-5D90CD17F539.pdf A9GW WITH TUMOR 175 143 382 NO NO 9.7 NO YES R0 Primary Tumor 01 Segmentectomy, Multiple 6th NO YES 2Y 1.3 Liver A DECEASED 139 2007 TCGA-2Y-A9GW-01A-11D-A381-01 TCGA-2Y-A9GW-01A-11D-A381-01 TCGA-2Y-A9GW-01A-11D-A382-10 TCGA-2Y-A9GW-01 TCGA-2Y-A9GW-01 6d979d21-8d92-40aa-a19f-f4a6c55384cf TCGA-2Y-A9GW-01 TCGA-2Y-A9GW-01 6d979d21-8d92-40aa-a19f-f4a6c55384cf 6d979d21-8d92-40aa-a19f-f4a6c55384cf 6d979d21-8d92-40aa-a19f-f4a6c55384cf TCGA-2Y-A9GW-01A-11D-A383-05 +TCGA-2Y-A9GX-01 TCGA-2Y-A9GX-01 TCGA-2Y-A9GX TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO None 68 3.5 4.3 5 TCGA-2Y-A9GX-F69170 TCGA-2Y-A9GX 0.2 0.4 0.8 1.5 0.7 -24963 0 2442 2133 1 0 7 1 2014-12-30 MALE 175 Alcohol consumption Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 8.3 11.5 NO G2 Liver Locoregional Recurrence No NO YES No No MX NX T1 Stage I A9GX WITH TUMOR 155 143 382 NO NO 10.3 NO NO R1 Primary Tumor 01 Segmentectomy, Single 6th NO YES 2Y 1.3 Liver Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody LIVING 104 2007 TCGA-2Y-A9GX-01A-11D-A381-01 TCGA-2Y-A9GX-01A-11D-A381-01 TCGA-2Y-A9GX-01A-11D-A382-10 TCGA-2Y-A9GX-01 TCGA-2Y-A9GX-01 c4b50fbc-9dbb-4670-88b7-93c77d7d3547 TCGA-2Y-A9GX-01 TCGA-2Y-A9GX-01 c4b50fbc-9dbb-4670-88b7-93c77d7d3547 c4b50fbc-9dbb-4670-88b7-93c77d7d3547 c4b50fbc-9dbb-4670-88b7-93c77d7d3547 TCGA-2Y-A9GX-01A-11D-A383-05 +TCGA-2Y-A9GY-01 TCGA-2Y-A9GY-01 TCGA-2Y-A9GY TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver None 64 3.5 4.2 5 TCGA-2Y-A9GY 0.2 0.4 2 0.8 1.5 0.6 -23435 757 0 0 7 27600 2014-11-3 FEMALE 161 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 8.3 11.5 G3 YES No MX NX T2 Stage II A9GY WITH TUMOR 207 143 382 NO NO 9.5 NO YES R0 Primary Tumor 01 Segmentectomy, Multiple 6th NO YES 2Y 1.3 Liver DECEASED 92 2007 TCGA-2Y-A9GY-01A-11D-A381-01 TCGA-2Y-A9GY-01A-11D-A381-01 TCGA-2Y-A9GY-01A-11D-A382-10 TCGA-2Y-A9GY-01 TCGA-2Y-A9GY-01 f21c811b-a31a-4b4b-88a0-2488fa59b20d TCGA-2Y-A9GY-01 TCGA-2Y-A9GY-01 f21c811b-a31a-4b4b-88a0-2488fa59b20d f21c811b-a31a-4b4b-88a0-2488fa59b20d f21c811b-a31a-4b4b-88a0-2488fa59b20d TCGA-2Y-A9GY-01A-11D-A383-05 +TCGA-2Y-A9GZ-01 TCGA-2Y-A9GZ-01 TCGA-2Y-A9GZ TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver None 82 3.5 4.5 5 TCGA-2Y-A9GZ 0.2 0.7 4 A 0.8 1.5 1.1 -30082 848 0 0 7 7 2014-11-3 FEMALE 153 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 8.3 11.5 G2 YES No MX NX T2 Stage II A9GZ WITH TUMOR 318 143 382 NO YES 9.9 NO YES R0 Primary Tumor 01 Lobectomy 6th NO YES 2Y 1.3 Liver Hepatitis C Antibody|HBV Core Antibody DECEASED 51 2007 TCGA-2Y-A9GZ-01A-11D-A38W-01 TCGA-2Y-A9GZ-01A-11D-A38W-01 TCGA-2Y-A9GZ-01A-11D-A38X-10 TCGA-2Y-A9GZ-01 TCGA-2Y-A9GZ-01 b40fc694-28d2-4b49-a5ff-4182156a9654 TCGA-2Y-A9GZ-01 TCGA-2Y-A9GZ-01 b40fc694-28d2-4b49-a5ff-4182156a9654 b40fc694-28d2-4b49-a5ff-4182156a9654 b40fc694-28d2-4b49-a5ff-4182156a9654 TCGA-2Y-A9GZ-01A-11D-A39G-05 +TCGA-2Y-A9H0-01 TCGA-2Y-A9H0-01 TCGA-2Y-A9H0 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver None 49 3.5 2 5 TCGA-2Y-A9H0-F69171 TCGA-2Y-A9H0 TCGA-2Y-A9H0-01A 0.2 0.8 0.8 1.5 0.8 -18109 3538 0 3675 0 0 8 7598 2014-12-30 MALE 180 Alcohol consumption|Hepatitis B|Hepatitis C Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 130 8.3 11.5 NO NO G1 NO true No M0 N0 T3 Stage IIIA TCGA-2Y-A9H0.33EB4235-F58D-4AB6-8944-F2B59374A5F0.pdf A9H0 TUMOR FREE 207 143 382 NO NO 12.2 NO R0 Primary Tumor 01 Segmentectomy, Single 6th NO YES 2Y 1.3 Liver A LIVING 89 2004 TCGA-2Y-A9H0-01A-11D-A381-01 TCGA-2Y-A9H0-01A-11D-A381-01 TCGA-2Y-A9H0-01A-11D-A382-10 TCGA-2Y-A9H0-01 TCGA-2Y-A9H0-01 73769c40-ad9d-4b11-925e-46e3e762d3f4 TCGA-2Y-A9H0-01 TCGA-2Y-A9H0-01 73769c40-ad9d-4b11-925e-46e3e762d3f4 73769c40-ad9d-4b11-925e-46e3e762d3f4 73769c40-ad9d-4b11-925e-46e3e762d3f4 TCGA-2Y-A9H0-01A-11D-A383-05 +TCGA-2Y-A9H1-01 TCGA-2Y-A9H1-01 TCGA-2Y-A9H1 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 58 3.5 4.4 5 TCGA-2Y-A9H1 0.2 0.5 0.8 1.5 0.9 -21222 1229 0 1 0 7 3 1,2 - Portal Fibrosis 2014-11-3 MALE 171 Alcohol consumption|Hepatitis C Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 8.3 11.5 G2 YES No MX NX T1 Stage I A9H1 WITH TUMOR 213 143 382 YES NO 10 NO NO R0 Primary Tumor 01 Segmentectomy, Single 7th NO YES 2Y 1.3 Liver Hepatitis C Antibody DECEASED 89 2010 TCGA-2Y-A9H1-01A-11D-A381-01 TCGA-2Y-A9H1-01A-11D-A381-01 TCGA-2Y-A9H1-01A-11D-A382-10 TCGA-2Y-A9H1-01 TCGA-2Y-A9H1-01 dd08761a-17e5-4d03-820d-2ee5d8d6c2b8 TCGA-2Y-A9H1-01 TCGA-2Y-A9H1-01 dd08761a-17e5-4d03-820d-2ee5d8d6c2b8 dd08761a-17e5-4d03-820d-2ee5d8d6c2b8 dd08761a-17e5-4d03-820d-2ee5d8d6c2b8 TCGA-2Y-A9H1-01A-11D-A383-05 +TCGA-2Y-A9H2-01 TCGA-2Y-A9H2-01 TCGA-2Y-A9H2 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver None 64 3.5 4.5 5 TCGA-2Y-A9H2-F69173 TCGA-2Y-A9H2 TCGA-2Y-A9H2-01A 0.2 0.4 0.8 1.5 1.4 -23653 1443 0 1731 0 0 7 2 2014-12-30 FEMALE 176 Alcohol consumption Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 80 8.3 11.5 NO NO G3 NO true No MX N0 T1 Stage I TCGA-2Y-A9H2.4C19CF84-5E30-4854-A084-F6EE53A80543.pdf A9H2 TUMOR FREE 386 143 382 NO NO 10.8 NO NO R0 Primary Tumor 01 Segmentectomy, Single 7th NO YES 2Y 1.3 Liver None A Hepatitis C Antibody|Hepatitis B Surface Antigen|HBV Core Antibody LIVING 55 2010 TCGA-2Y-A9H2-01A-12D-A381-01 TCGA-2Y-A9H2-01A-12D-A381-01 TCGA-2Y-A9H2-01A-12D-A382-10 TCGA-2Y-A9H2-01 TCGA-2Y-A9H2-01 959e5067-014b-4a33-92d6-6827383efb00 TCGA-2Y-A9H2-01 TCGA-2Y-A9H2-01 959e5067-014b-4a33-92d6-6827383efb00 959e5067-014b-4a33-92d6-6827383efb00 959e5067-014b-4a33-92d6-6827383efb00 TCGA-2Y-A9H2-01A-12D-A383-05 +TCGA-2Y-A9H3-01 TCGA-2Y-A9H3-01 TCGA-2Y-A9H3 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver None 45 3.5 5.3 5 TCGA-2Y-A9H3-F69086 TCGA-2Y-A9H3 0.2 0.3 3 0.8 1.5 0.9 -16443 0 1516 2 0 7 5640 1,2 - Portal Fibrosis 2014-12-29 MALE 179 Alcohol consumption|Non-Alcoholic Fatty Liver Disease Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 8.3 11.5 NO G1 NO No MX NX T2 Stage II A9H3 TUMOR FREE 245 143 382 [Discrepancy] NO 10.5 NO YES R0 Primary Tumor 01 Segmentectomy, Multiple 7th NO YES 2Y 1.3 Liver Micro Hepatitis C Antibody|Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody LIVING 105 2010 TCGA-2Y-A9H3-01A-11D-A381-01 TCGA-2Y-A9H3-01A-11D-A381-01 TCGA-2Y-A9H3-01A-11D-A382-10 TCGA-2Y-A9H3-01 TCGA-2Y-A9H3-01 a9559d4e-1403-4d7f-8638-d74d31dafcd3 TCGA-2Y-A9H3-01 TCGA-2Y-A9H3-01 a9559d4e-1403-4d7f-8638-d74d31dafcd3 a9559d4e-1403-4d7f-8638-d74d31dafcd3 a9559d4e-1403-4d7f-8638-d74d31dafcd3 TCGA-2Y-A9H3-01A-11D-A383-05 +TCGA-2Y-A9H4-01 TCGA-2Y-A9H4-01 TCGA-2Y-A9H4 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 68 3.5 4.6 5 TCGA-2Y-A9H4-F69087 TCGA-2Y-A9H4 TCGA-2Y-A9H4-01A 0.2 0.3 2 A 0.8 1.5 1.2 -25096 1210 0 1452 0 0 7 11 2014-12-29 MALE 167 Alcohol consumption|Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 100 8.3 11.5 NO NO G2 NO true No MX N0 T1 Stage I TCGA-2Y-A9H4.8A93B07B-8DCC-4DF4-B792-212C80E203FB.pdf A9H4 TUMOR FREE 223 143 382 NO NO 11 NO YES R0 Primary Tumor 01 Lobectomy 7th NO YES 2Y 1.3 Liver None A Hepatitis C Antibody|Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody LIVING 61 2010 TCGA-2Y-A9H4-01A-11D-A381-01 TCGA-2Y-A9H4-01A-11D-A381-01 TCGA-2Y-A9H4-01A-11D-A382-10 TCGA-2Y-A9H4-01 TCGA-2Y-A9H4-01 5b8cde2d-a8bf-4f84-b4c4-9515a2b97226 TCGA-2Y-A9H4-01 TCGA-2Y-A9H4-01 5b8cde2d-a8bf-4f84-b4c4-9515a2b97226 5b8cde2d-a8bf-4f84-b4c4-9515a2b97226 5b8cde2d-a8bf-4f84-b4c4-9515a2b97226 TCGA-2Y-A9H4-01A-11D-A383-05 +TCGA-2Y-A9H5-01 TCGA-2Y-A9H5-01 TCGA-2Y-A9H5 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 59 3.5 4.9 5 TCGA-2Y-A9H5 TCGA-2Y-A9H5-01A 0.2 0.3 2 0.8 1.5 0.6 -21818 1101 555 0 0 7 11700 1,2 - Portal Fibrosis 2014-11-3 FEMALE 157 Alcohol consumption|Hepatitis C Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 30 8.3 11.5 NO G3 YES true No MX N0 T1 Stage I TCGA-2Y-A9H5.99FC2CC9-19F1-4BCB-81E6-5FED4619B331.pdf A9H5 WITH TUMOR 204 143 382 NO NO 10.2 NO YES R0 Primary Tumor 01 Segmentectomy, Multiple 7th NO YES 2Y 1.3 Liver None A Hepatitis C Antibody|Hepatitis C Virus R|HCV Genotype DECEASED 69 2010 TCGA-2Y-A9H5-01A-11D-A381-01 TCGA-2Y-A9H5-01A-11D-A381-01 TCGA-2Y-A9H5-01A-11D-A382-10 TCGA-2Y-A9H5-01 TCGA-2Y-A9H5-01 2599cb92-686e-4939-a97f-c17f2065adcc TCGA-2Y-A9H5-01 TCGA-2Y-A9H5-01 2599cb92-686e-4939-a97f-c17f2065adcc 2599cb92-686e-4939-a97f-c17f2065adcc 2599cb92-686e-4939-a97f-c17f2065adcc TCGA-2Y-A9H5-01A-11D-A383-05 +TCGA-2Y-A9H6-01 TCGA-2Y-A9H6-01 TCGA-2Y-A9H6 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver None 68 3.5 4 5 TCGA-2Y-A9H6-F69088 TCGA-2Y-A9H6 TCGA-2Y-A9H6-01A 0.3 0.3 1 0.8 1.5 1.8 -24982 982 0 357 0 0 7 114 2014-12-29 FEMALE 156 Alcohol consumption Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 100 8.3 11.5 NO YES G2 NO true Yes MX NX T1 Stage I TCGA-2Y-A9H6.0B39CB6A-D208-4128-AB46-50C7DB072865.pdf A9H6 224 143 382 NO NO 10.5 NO YES R0 Primary Tumor 01 Segmentectomy, Single 7th NO YES 2Y 1.3 Liver Macro A LIVING 99 2011 TCGA-2Y-A9H6-01A-11D-A38W-01 TCGA-2Y-A9H6-01A-11D-A38W-01 TCGA-2Y-A9H6-01A-11D-A38X-10 TCGA-2Y-A9H6-01 TCGA-2Y-A9H6-01 1493a0e1-08ca-4054-b432-f8103e47563c TCGA-2Y-A9H6-01 TCGA-2Y-A9H6-01 1493a0e1-08ca-4054-b432-f8103e47563c 1493a0e1-08ca-4054-b432-f8103e47563c 1493a0e1-08ca-4054-b432-f8103e47563c TCGA-2Y-A9H6-01A-11D-A39G-05 +TCGA-2Y-A9H7-01 TCGA-2Y-A9H7-01 TCGA-2Y-A9H7 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO None 81 3.5 3.4 5 TCGA-2Y-A9H7-F69176 TCGA-2Y-A9H7 TCGA-2Y-A9H7-01A 0.2 0.3 A 0.8 1.5 1.2 -29752 846 0 1168 1117 2 0 7 6 3,4 - Fibrous Speta 2014-12-30 FEMALE 157 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 140 8.3 11.5 NO NO G2 Liver Locoregional Recurrence Yes NO YES No true Yes MX N0 T1 Stage I TCGA-2Y-A9H7.80E07DD4-2925-4F58-B4DA-07041673A13F.pdf A9H7 WITH TUMOR 165 143 382 [Discrepancy] NO 10.8 NO NO R0 Primary Tumor 01 Lobectomy 7th NO YES 2Y 1.3 Liver None A Hepatitis C Antibody|Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody LIVING 104 2011 TCGA-2Y-A9H7-01A-11D-A38W-01 TCGA-2Y-A9H7-01A-11D-A38W-01 TCGA-2Y-A9H7-01A-11D-A38X-10 TCGA-2Y-A9H7-01 TCGA-2Y-A9H7-01 185beb02-4b0d-457c-8eee-4e4c51362feb TCGA-2Y-A9H7-01 TCGA-2Y-A9H7-01 185beb02-4b0d-457c-8eee-4e4c51362feb 185beb02-4b0d-457c-8eee-4e4c51362feb 185beb02-4b0d-457c-8eee-4e4c51362feb TCGA-2Y-A9H7-01A-11D-A39G-05 +TCGA-2Y-A9H8-01 TCGA-2Y-A9H8-01 TCGA-2Y-A9H8 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 85 3.5 4.2 5 TCGA-2Y-A9H8 TCGA-2Y-A9H8-01A 0.2 0.3 2 0.8 1.5 0.6 -31322 792 633 0 2 0 7 234000 2014-11-3 FEMALE 150 Alcohol consumption Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 80 8.3 11.5 NO G2 YES true No MX NX T1 [Discrepancy] TCGA-2Y-A9H8.61B5E3D4-727D-45ED-BAC3-9125A0E03F40.pdf A9H8 WITH TUMOR 255 143 382 NO NO 10.3 NO YES R0 Primary Tumor 01 Lobectomy 7th NO YES 2Y 1.3 Liver A Hepatitis C Virus R|HBV Surface Antibody|HBV D DECEASED 40 2011 TCGA-2Y-A9H8-01A-11D-A38W-01 TCGA-2Y-A9H8-01A-11D-A38W-01 TCGA-2Y-A9H8-01A-11D-A38X-10 TCGA-2Y-A9H8-01 TCGA-2Y-A9H8-01 327757e4-c3b3-4be0-bdbf-2ad718f92da0 TCGA-2Y-A9H8-01 TCGA-2Y-A9H8-01 327757e4-c3b3-4be0-bdbf-2ad718f92da0 327757e4-c3b3-4be0-bdbf-2ad718f92da0 327757e4-c3b3-4be0-bdbf-2ad718f92da0 TCGA-2Y-A9H8-01A-11D-A39G-05 +TCGA-2Y-A9H9-01 TCGA-2Y-A9H9-01 TCGA-2Y-A9H9 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver YES NO None 70 3.5 4.7 5 TCGA-2Y-A9H9-F69092 TCGA-2Y-A9H9 TCGA-2Y-A9H9-01A 0.2 0.6 2 A 0.8 1.2 0.8 -25670 731 0 697 701 0 0 7 12 2014-12-29 MALE 178 Alcohol consumption|Hepatitis C Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 120 8.3 11.5 NO NO G2 Liver Intrahepatic Recurrence No NO YES No true No MX N0 T1 Stage I TCGA-2Y-A9H9.36C343AC-443B-4196-8B6D-7D9213F2DAE1.pdf A9H9 WITH TUMOR 203 143 382 NO NO 11 NO YES R0 Primary Tumor 01 Segmentectomy, Multiple 7th NO YES 2Y 1.3 Liver A LIVING 88 2011 TCGA-2Y-A9H9-01A-21D-A38W-01 TCGA-2Y-A9H9-01A-21D-A38W-01 TCGA-2Y-A9H9-01A-21D-A38X-10 TCGA-2Y-A9H9-01 TCGA-2Y-A9H9-01 946a3961-1616-4f45-a10a-2c6778491fb9 TCGA-2Y-A9H9-01 TCGA-2Y-A9H9-01 946a3961-1616-4f45-a10a-2c6778491fb9 946a3961-1616-4f45-a10a-2c6778491fb9 946a3961-1616-4f45-a10a-2c6778491fb9 TCGA-2Y-A9H9-01A-21D-A39G-05 +TCGA-2Y-A9HA-01 TCGA-2Y-A9HA-01 TCGA-2Y-A9HA TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver None 70 3.5 3.5 5 TCGA-2Y-A9HA TCGA-2Y-A9HA-01A 0.2 0.6 A 0.8 1.5 0.8 -25892 713 36 0 0 0 7 114 3,4 - Fibrous Speta 2014-11-3 MALE 169 Alcohol consumption|Hepatitis C Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 90 8.3 11.5 NO G2 NO true No MX NX T2 Stage II TCGA-2Y-A9HA.C07BBEDC-59CE-41B9-9D47-EDFD8AEB26B9.pdf A9HA WITH TUMOR 153 143 382 YES NO 10.6 NO NO R0 Primary Tumor 01 Segmentectomy, Multiple 7th NO YES 2Y 1.3 Liver A Hepatitis C Antibody DECEASED 69 2012 TCGA-2Y-A9HA-01A-11D-A38W-01 TCGA-2Y-A9HA-01A-11D-A38W-01 TCGA-2Y-A9HA-01A-11D-A38X-10 TCGA-2Y-A9HA-01 TCGA-2Y-A9HA-01 8a5081d6-358e-4e94-a794-5d9fcdf467fb TCGA-2Y-A9HA-01 TCGA-2Y-A9HA-01 8a5081d6-358e-4e94-a794-5d9fcdf467fb 8a5081d6-358e-4e94-a794-5d9fcdf467fb 8a5081d6-358e-4e94-a794-5d9fcdf467fb TCGA-2Y-A9HA-01A-11D-A39G-05 +TCGA-2Y-A9HB-01 TCGA-2Y-A9HB-01 TCGA-2Y-A9HB TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver None 66 3.5 3.9 5 TCGA-2Y-A9HB-F69098 TCGA-2Y-A9HB 0.2 0.6 0.8 1.5 0.8 -24359 0 260 0 0 7 21 2014-12-29 MALE 167 Alcohol consumption Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 8.3 11.5 YES G2 NO No MX NX T1 Stage I A9HB TUMOR FREE 124 143 382 NO NO 11.1 NO NO R0 Primary Tumor 01 Segmentectomy, Single 7th NO YES 2Y 1.3 Liver None Hepatitis C Virus R|HCV Genotype LIVING 74 2012 TCGA-2Y-A9HB-01A-11D-A38W-01 TCGA-2Y-A9HB-01A-11D-A38W-01 TCGA-2Y-A9HB-01A-11D-A38X-10 TCGA-2Y-A9HB-01 TCGA-2Y-A9HB-01 fca9f607-7939-4f89-bf60-785f6e848c24 TCGA-2Y-A9HB-01 TCGA-2Y-A9HB-01 fca9f607-7939-4f89-bf60-785f6e848c24 fca9f607-7939-4f89-bf60-785f6e848c24 fca9f607-7939-4f89-bf60-785f6e848c24 TCGA-2Y-A9HB-01A-11D-A39G-05 +TCGA-3K-AAZ8-01 TCGA-3K-AAZ8-01 TCGA-3K-AAZ8 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO 65 TCGA-3K-AAZ8-F69330 TCGA-3K-AAZ8 -24046 0 396 304 5 - Nodular Formation and Incomplete Cirrhosis 2015-1-5 MALE 172 Hepatitis C Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES NO G1 Liver Locoregional Recurrence No NO YES No No MX NX T3b Stage IIIB AAZ8 WITH TUMOR NO YES NO NO RX Primary Tumor 01 Segmentectomy, Multiple 7th YES NO 3K Liver LIVING 84 2013 TCGA-3K-AAZ8-01A-12D-A38W-01 TCGA-3K-AAZ8-01A-12D-A38W-01 TCGA-3K-AAZ8-01A-12D-A38X-10 TCGA-3K-AAZ8-01 TCGA-3K-AAZ8-01 ab14829c-defd-41b9-b35d-2876049cb46b TCGA-3K-AAZ8-01 TCGA-3K-AAZ8-01 ab14829c-defd-41b9-b35d-2876049cb46b ab14829c-defd-41b9-b35d-2876049cb46b ab14829c-defd-41b9-b35d-2876049cb46b TCGA-3K-AAZ8-01A-12D-A39G-05 +TCGA-4R-AA8I-01 TCGA-4R-AA8I-01 TCGA-4R-AA8I TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver None 66 3.5 3.8 4.8 TCGA-4R-AA8I-F67448 TCGA-4R-AA8I 0.4 1.2 A 0.6 1.3 0.7 -24279 262 0 216 247 1 0 9 5 6 - Established Cirrhosis 2014-11-5 MALE 171 Non-Alcoholic Fatty Liver Disease Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 0.8 1.1 NO G2 Liver Locoregional Recurrence NO YES No Yes MX NX T2 Stage II AA8I WITH TUMOR 96 150 450 NO NO 1.1 NO NO R0 Primary Tumor 01 Segmentectomy, Single 7th NO YES 4R 1.5 Liver Micro Hepatitis C Antibody|Hepatitis B Surface Antigen DECEASED 103 2013 TCGA-4R-AA8I-01A-11D-A381-01 TCGA-4R-AA8I-01A-11D-A381-01 TCGA-4R-AA8I-01A-11D-A382-10 TCGA-4R-AA8I-01 TCGA-4R-AA8I-01 da85d30e-2db7-45eb-8a28-6416c0e07b1f TCGA-4R-AA8I-01 TCGA-4R-AA8I-01 da85d30e-2db7-45eb-8a28-6416c0e07b1f da85d30e-2db7-45eb-8a28-6416c0e07b1f da85d30e-2db7-45eb-8a28-6416c0e07b1f TCGA-4R-AA8I-01A-11D-A383-05 +TCGA-5C-A9VG-01 TCGA-5C-A9VG-01 TCGA-5C-A9VG TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver None 58 TCGA-5C-A9VG-F68936 TCGA-5C-A9VG A -21273 0 328 0 2014-12-23 MALE 170 Other Worker at steel factory Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES NO G2 NO No M0 N0 T2 Stage II A9VG TUMOR FREE NO NO NO NO R0 Primary Tumor 01 Lobectomy 7th YES NO 5C Liver Micro LIVING 73 2013 TCGA-5C-A9VG-01A-11D-A36W-01 TCGA-5C-A9VG-01A-11D-A36W-01 TCGA-5C-A9VG-01A-11D-A36X-10 TCGA-5C-A9VG-01 TCGA-5C-A9VG-01 c0c2c272-ac73-445e-85a9-d7ba6ff53391 TCGA-5C-A9VG-01 TCGA-5C-A9VG-01 c0c2c272-ac73-445e-85a9-d7ba6ff53391 c0c2c272-ac73-445e-85a9-d7ba6ff53391 c0c2c272-ac73-445e-85a9-d7ba6ff53391 TCGA-5C-A9VG-01A-11D-A36Y-05 +TCGA-5C-A9VH-01 TCGA-5C-A9VH-01 TCGA-5C-A9VH TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver None 70 TCGA-5C-A9VH-F68937 TCGA-5C-A9VH TCGA-5C-A9VH-01A A -25608 127 0 322 0 2014-12-23 MALE 165 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 90 NO NO G2 NO true No M0 N0 T1 Stage I TCGA-5C-A9VH.938BCE76-BF7D-4470-A409-805FD012D05D.pdf A9VH TUMOR FREE NO NO NO NO R0 Primary Tumor 01 Segmentectomy, Single 7th YES NO 5C Liver None A LIVING 69 2013 TCGA-5C-A9VH-01A-11D-A36W-01 TCGA-5C-A9VH-01A-11D-A36W-01 TCGA-5C-A9VH-01A-11D-A36X-10 TCGA-5C-A9VH-01 TCGA-5C-A9VH-01 859c895b-14f8-4155-9b35-bf6e7abb2c5d TCGA-5C-A9VH-01 TCGA-5C-A9VH-01 859c895b-14f8-4155-9b35-bf6e7abb2c5d 859c895b-14f8-4155-9b35-bf6e7abb2c5d 859c895b-14f8-4155-9b35-bf6e7abb2c5d TCGA-5C-A9VH-01A-11D-A36Y-05 +TCGA-5C-AAPD-01 TCGA-5C-AAPD-01 TCGA-5C-AAPD TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver None 61 TCGA-5C-AAPD-F68938 TCGA-5C-AAPD TCGA-5C-AAPD-01A A -22552 55 0 20 1 2014-12-23 MALE 172 Hepatitis B Hepatocholangiocarcinoma (Mixed) No C22.0 8180/3 C22.0 YES 140 NO NO G1 NO true No M0 N0 T2 Stage II TCGA-5C-AAPD.E4DB31C4-89F3-4D8D-A32E-B42C599904E1.pdf AAPD TUMOR FREE NO NO NO NO R0 Primary Tumor 01 Lobectomy 7th YES NO 5C Liver None A HBV Surface Antibody LIVING 69 2013 TCGA-5C-AAPD-01A-21D-A38W-01 TCGA-5C-AAPD-01A-21D-A38W-01 TCGA-5C-AAPD-01A-21D-A38X-10 TCGA-5C-AAPD-01 TCGA-5C-AAPD-01 4aced91c-f8c4-4eb7-8911-4924c1ffcd99 TCGA-5C-AAPD-01 TCGA-5C-AAPD-01 4aced91c-f8c4-4eb7-8911-4924c1ffcd99 4aced91c-f8c4-4eb7-8911-4924c1ffcd99 4aced91c-f8c4-4eb7-8911-4924c1ffcd99 TCGA-5C-AAPD-01A-21D-A39G-05 +TCGA-5R-AA1C-01 TCGA-5R-AA1C-01 TCGA-5R-AA1C TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver None 57 3.2 3.0 4.6 TCGA-5R-AA1C-F72055 TCGA-5R-AA1C TCGA-5R-AA1C-01A 0 1.8 B 0.5 1.3 1.0 -21073 60 0 520 1 0 15 2 1,2 - Portal Fibrosis 2015-4-6 MALE 174 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 750 11 15 NO NO G2 NO false No M0 N0 T2 Stage II TCGA-5R-AA1C.AF0BACCE-3975-4E9F-9272-404229EC77C9.pdf AA1C TUMOR FREE 223000 150000 450000 NO NO 18 NO NO R0 Primary Tumor 01 Extended Lobectomy 7th YES NO 5R 1.2 Liver Micro A Hepatitis C Antibody|Hepatitis B Surface Antigen LIVING 90 2013 TCGA-5R-AA1C-01A-11D-A40Q-01 TCGA-5R-AA1C-01A-11D-A40Q-01 TCGA-5R-AA1C-01A-11D-A40R-10 TCGA-5R-AA1C-01 TCGA-5R-AA1C-01 55844917-3a31-4f8b-a955-14ca0f139368 TCGA-5R-AA1C-01 TCGA-5R-AA1C-01 55844917-3a31-4f8b-a955-14ca0f139368 55844917-3a31-4f8b-a955-14ca0f139368 55844917-3a31-4f8b-a955-14ca0f139368 TCGA-5R-AA1C-01A-11D-A40S-05 +TCGA-5R-AA1D-01 TCGA-5R-AA1D-01 TCGA-5R-AA1D TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver None 17 3.2 3.3 4.6 TCGA-5R-AA1D-F70155 TCGA-5R-AA1D 0 0.5 B 0.5 1.3 0.7 -6545 0 449 1 0 15 5 0 - No Fibrosis 2015-1-28 FEMALE 161 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 11 15 NO G3 NO No M0 N0 T3a Stage IIIA AA1D TUMOR FREE 333000 150000 450000 NO NO 19 YES NO R0 Primary Tumor 01 Extended Lobectomy 7th YES NO 5R 1.2 Liver Micro Hepatitis C Antibody|Hepatitis B Surface Antigen LIVING 59 2013 TCGA-5R-AA1D-01A-11D-A381-01 TCGA-5R-AA1D-01A-11D-A381-01 TCGA-5R-AA1D-01A-11D-A382-10 TCGA-5R-AA1D-01 TCGA-5R-AA1D-01 cd5cb20c-a12b-44e2-8ebc-874b1296758b TCGA-5R-AA1D-01 TCGA-5R-AA1D-01 cd5cb20c-a12b-44e2-8ebc-874b1296758b cd5cb20c-a12b-44e2-8ebc-874b1296758b cd5cb20c-a12b-44e2-8ebc-874b1296758b TCGA-5R-AA1D-01A-11D-A383-05 +TCGA-5R-AAAM-01 TCGA-5R-AAAM-01 TCGA-5R-AAAM TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver Severe 65 3.2 3.0 4.6 TCGA-5R-AAAM TCGA-5R-AAAM-01A 0 0.6 A 0.5 1.3 0.7 -24020 35 46 0 1 0 15 32 6 - Established Cirrhosis 2014-11-14 FEMALE 163 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 730 11 15 NO G2 NO true No M0 N0 T2 Stage II TCGA-5R-AAAM.B07C5DBA-634E-4028-A32D-61FE7445BDEE.pdf AAAM TUMOR FREE 68000 150000 450000 NO NO NO NO R0 Primary Tumor 01 Segmentectomy, Single 7th YES NO 5R 1.2 Liver Micro A Hepatitis C Antibody|Hepatitis B Surface Antigen DECEASED 80 2013 TCGA-5R-AAAM-01A-12D-A40Q-01 TCGA-5R-AAAM-01A-12D-A40Q-01 TCGA-5R-AAAM-01A-12D-A40R-10 TCGA-5R-AAAM-01 TCGA-5R-AAAM-01 9bfa35f8-31cf-4644-b860-b7aba3de3e5d TCGA-5R-AAAM-01 TCGA-5R-AAAM-01 9bfa35f8-31cf-4644-b860-b7aba3de3e5d 9bfa35f8-31cf-4644-b860-b7aba3de3e5d 9bfa35f8-31cf-4644-b860-b7aba3de3e5d TCGA-5R-AAAM-01A-12D-A40S-05 +TCGA-BC-4072-01 TCGA-BC-4072-01 TCGA-BC-4072 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO 74 3.5 4.4 5.0 TCGA-BC-4072-F6875 TCGA-BC-4072 TCGA-BC-4072-01B 0 .5 7 .7 1.1 1 -27162 2256 1490 0 475 2010-12-20 FEMALE No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 270 NO G3 Lymph Node(s) Extrahepatic Recurrence No NO YES false No M0 N0 T3 Stage IIIA TCGA-BC-4072.CF0E1E81-A89B-4D33-A02E-C77DAE5E8E30.pdf 4072 WITH TUMOR 268 150 440 NO NO 1 NO YES R1 Primary Tumor 01 Segmentectomy, Multiple 6th NO YES BC 1.2 Liver Macro B DECEASED 2005 TCGA-BC-4072-01B-11D-A151-01 TCGA-BC-4072-01B-11D-A151-01 TCGA-BC-4072-01 TCGA-BC-4072-01 6A51966A-B269-41D9-94AF-B46475CDB7A4 091c332c-1596-4db6-88e7-e40ef85f15dd TCGA-BC-4072-01 TCGA-BC-4072-01 091c332c-1596-4db6-88e7-e40ef85f15dd 091c332c-1596-4db6-88e7-e40ef85f15dd 091c332c-1596-4db6-88e7-e40ef85f15dd TCGA-BC-4072-01B-11D-A153-05 +TCGA-BC-4073-01 TCGA-BC-4073-01 TCGA-BC-4073 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 73 TCGA-BC-4073-F30829 TCGA-BC-4073 TCGA-BC-4073-01B 0.0 0.7 3 0.7 1.3 1.5 -26795 398 0 849 0 Scheduled Follow-up Submission 2012-4-17 MALE Hemochromatosis Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 230 NO G3 NO true No MX N0 T3 Stage IIIA TCGA-BC-4073.1C53BF2E-0AA8-477F-8281-63455E0D36E2.pdf 4073 WITH TUMOR 253 150 440 NO NO 1.0 NO YES R1 Primary Tumor 01 Segmentectomy, Multiple 6th NO YES BC 1.2 Liver Macro B LIVING 2009 TCGA-BC-4073-01B-02D-A12Y-01 TCGA-BC-4073-01B-02D-A12Y-01 TCGA-BC-4073-01B-02D-A12Z-10 TCGA-BC-4073-01 TCGA-BC-4073-01 8b3062fd-dd51-4bc0-a858-6783b3b5fe08 TCGA-BC-4073-01B-02D-A12Z-10 TCGA-BC-4073-01 TCGA-BC-4073-01 8b3062fd-dd51-4bc0-a858-6783b3b5fe08 TCGA-BC-4073-01B-02D-A12Z-10 8b3062fd-dd51-4bc0-a858-6783b3b5fe08 8b3062fd-dd51-4bc0-a858-6783b3b5fe08 TCGA-BC-4073-01B-02D-A12Z-10 TCGA-BC-4073-01B-02D-A132-05 +TCGA-BC-A10Q-01 TCGA-BC-A10Q-01 TCGA-BC-A10Q TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver YES NO 72 3.5 4.1 5.0 TCGA-BC-A10Q-F9852 TCGA-BC-A10Q TCGA-BC-A10Q-01A .5 1 0.7 1.1 0.6 -26400 4437 1135 0 340 2011-4-1 FEMALE No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 340 NO Intrahepatic Recurrence No NO YES false No MX NX T2 TCGA-BC-A10Q.10117C34-85C2-49DE-B2AD-F8D0D4570DA9.pdf A10Q WITH TUMOR 287000 150 440 YES YES 0.9 NO YES R1 Primary Tumor 01 Extended Lobectomy 5th NO YES BC Liver None A DECEASED 1998 TCGA-BC-A10Q-01A-11D-A12Y-01 TCGA-BC-A10Q-01A-11D-A12Y-01 TCGA-BC-A10Q-01A-11D-A12Z-10 TCGA-BC-A10Q-01 TCGA-BC-A10Q-01 A21E10AF-3D45-45A0-B2E4-14BC5FA33FA5 19c97e3d-f5af-4301-92f4-be8ac9e27427 TCGA-BC-A10Q-01A-11D-A12Z-10 TCGA-BC-A10Q-01 TCGA-BC-A10Q-01 19c97e3d-f5af-4301-92f4-be8ac9e27427 TCGA-BC-A10Q-01A-11D-A12Z-10 19c97e3d-f5af-4301-92f4-be8ac9e27427 19c97e3d-f5af-4301-92f4-be8ac9e27427 TCGA-BC-A10Q-01A-11D-A12Z-10 TCGA-BC-A10Q-01A-11D-A132-05 +TCGA-BC-A10Q-11 TCGA-BC-A10Q-11 TCGA-BC-A10Q TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver YES NO 72 3.5 4.1 5.0 TCGA-BC-A10Q-F9852 TCGA-BC-A10Q TCGA-BC-A10Q-11A .5 1 0.7 1.1 0.6 -26400 4437 1135 0 340 2011-4-1 FEMALE No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 340 NO Intrahepatic Recurrence No NO YES false No MX NX T2 A10Q WITH TUMOR 287000 150 440 YES YES 0.9 NO YES R1 Solid Tissue Normal 11 Extended Lobectomy 5th NO YES BC Liver None A DECEASED 1998 TCGA-BC-A10Q-11 469f052a-477e-498a-ba3b-f288dcbc306f TCGA-BC-A10Q-11 469f052a-477e-498a-ba3b-f288dcbc306f 469f052a-477e-498a-ba3b-f288dcbc306f 469f052a-477e-498a-ba3b-f288dcbc306f TCGA-BC-A10Q-11A-11D-A132-05 +TCGA-BC-A10R-01 TCGA-BC-A10R-01 TCGA-BC-A10R TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver YES NO Mild 66 4.0 TCGA-BC-A10R-F9867 TCGA-BC-A10R TCGA-BC-A10R-01A 1 0.7 1.1 0.7 -24274 4316 308 0 199 27 2011-4-1 FEMALE No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 180 NO G2 Intrahepatic Recurrence Yes NO YES No false No MX NX T3 TCGA-BC-A10R.65BE2C95-CADA-44FC-9313-14529AFF773E.pdf A10R WITH TUMOR 209000 150 440 NO NO 0.9 NO YES R0 Primary Tumor 01 Lobectomy 5th NO YES BC Liver Micro A DECEASED 1999 TCGA-BC-A10R-01A-11D-A12Y-01 TCGA-BC-A10R-01A-11D-A12Y-01 TCGA-BC-A10R-01A-11D-A12Z-10 TCGA-BC-A10R-01 TCGA-BC-A10R-01 E9E08287-5807-4E84-B5A8-59DE0295A4E2 d6cb14d4-1ee1-4d83-ad3f-efa19969c00f TCGA-BC-A10R-01A-11D-A12Z-10 TCGA-BC-A10R-01 TCGA-BC-A10R-01 d6cb14d4-1ee1-4d83-ad3f-efa19969c00f TCGA-BC-A10R-01A-11D-A12Z-10 d6cb14d4-1ee1-4d83-ad3f-efa19969c00f d6cb14d4-1ee1-4d83-ad3f-efa19969c00f TCGA-BC-A10R-01A-11D-A12Z-10 TCGA-BC-A10R-01A-11D-A132-05 +TCGA-BC-A10R-11 TCGA-BC-A10R-11 TCGA-BC-A10R TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver YES NO Mild 66 4.0 TCGA-BC-A10R-F9867 TCGA-BC-A10R TCGA-BC-A10R-11A 1 0.7 1.1 0.7 -24274 4316 308 0 199 27 2011-4-1 FEMALE No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 1620 NO G2 Intrahepatic Recurrence Yes NO YES No false No MX NX T3 A10R WITH TUMOR 209000 150 440 NO NO 0.9 NO YES R0 Solid Tissue Normal 11 Lobectomy 5th NO YES BC Liver Micro A DECEASED 1999 TCGA-BC-A10R-11 4d49b039-f1fa-4892-8439-4155e72dd7c5 TCGA-BC-A10R-11 4d49b039-f1fa-4892-8439-4155e72dd7c5 4d49b039-f1fa-4892-8439-4155e72dd7c5 4d49b039-f1fa-4892-8439-4155e72dd7c5 TCGA-BC-A10R-11A-11D-A132-05 +TCGA-BC-A10S-01 TCGA-BC-A10S-01 TCGA-BC-A10S TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO None 81 3.6 TCGA-BC-A10S-F9875 TCGA-BC-A10S TCGA-BC-A10S-01A 0.6 -29842 4284 1423 0 1130 2011-4-1 MALE Alcohol consumption Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 550 NO G1 Intrahepatic Recurrence No NO YES No false No MX NX T3 TCGA-BC-A10S.A0F69833-CBDD-492D-9564-AE8FB2F9CE3B.pdf A10S WITH TUMOR 217000 150 440 NO NO 1.1 NO NO R0 Primary Tumor 01 Segmentectomy, Multiple 5th NO YES BC Liver Micro A DECEASED 74 1999 TCGA-BC-A10S-01A-22D-A12Y-01 TCGA-BC-A10S-01A-22D-A12Y-01 TCGA-BC-A10S-01 TCGA-BC-A10S-01 C13F11E1-2E92-4548-B41E-EA189E440DDE 68f75980-9246-46b2-82d2-41abd9a72998 TCGA-BC-A10S-01A-22D-A12Z-10 TCGA-BC-A10S-01 TCGA-BC-A10S-01 68f75980-9246-46b2-82d2-41abd9a72998 TCGA-BC-A10S-01A-22D-A12Z-10 68f75980-9246-46b2-82d2-41abd9a72998 68f75980-9246-46b2-82d2-41abd9a72998 TCGA-BC-A10S-01A-22D-A12Z-10 TCGA-BC-A10S-01A-22D-A132-05 +TCGA-BC-A10S-11 TCGA-BC-A10S-11 TCGA-BC-A10S TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO None 81 3.6 TCGA-BC-A10S-F9875 TCGA-BC-A10S TCGA-BC-A10S-11A 0.6 -29842 4284 1423 0 1130 2011-4-1 MALE Alcohol consumption Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 680 NO G1 Intrahepatic Recurrence No NO YES No false No MX NX T3 A10S WITH TUMOR 217000 150 440 NO NO 1.1 NO NO R0 Solid Tissue Normal 11 Segmentectomy, Multiple 5th NO YES BC Liver Micro A DECEASED 74 1999 TCGA-BC-A10S-11A-11D-A132-05 +TCGA-BC-A10T-01 TCGA-BC-A10T-01 TCGA-BC-A10T TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO 76 3.0 TCGA-BC-A10T-F9882 TCGA-BC-A10T TCGA-BC-A10T-01A 0.7 1.2 -27944 3660 837 0 598 1,2 - Portal Fibrosis 2011-4-1 MALE No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 1000 NO G1 Pulmonary Extrahepatic Recurrence No NO YES No false No MX NX T4 TCGA-BC-A10T.D8103C33-F303-4D97-81AF-CC3D06E79285.pdf A10T WITH TUMOR 450000 150 440 NO NO 1.1 NO NO R1 Primary Tumor 01 Other (specify) 5th NO YES BC Liver None A DECEASED 86 2000 TCGA-BC-A10T-01A-11D-A12Y-01 TCGA-BC-A10T-01A-11D-A12Y-01 TCGA-BC-A10T-01A-11D-A12Z-10 TCGA-BC-A10T-01 TCGA-BC-A10T-01 52FB12B7-8108-4EE8-AA7A-409225D0702A a4afd001-11fa-4bce-8766-b60b54566fcd TCGA-BC-A10T-01A-11D-A12Z-10 TCGA-BC-A10T-01 TCGA-BC-A10T-01 a4afd001-11fa-4bce-8766-b60b54566fcd TCGA-BC-A10T-01A-11D-A12Z-10 a4afd001-11fa-4bce-8766-b60b54566fcd a4afd001-11fa-4bce-8766-b60b54566fcd TCGA-BC-A10T-01A-11D-A12Z-10 TCGA-BC-A10T-01A-11D-A132-05 +TCGA-BC-A10T-11 TCGA-BC-A10T-11 TCGA-BC-A10T TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO 76 3.0 TCGA-BC-A10T-F9882 TCGA-BC-A10T TCGA-BC-A10T-11A 0.7 1.2 -27944 3660 837 0 598 1,2 - Portal Fibrosis 2011-4-1 MALE No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 480 NO G1 Pulmonary Extrahepatic Recurrence No NO YES No false No MX NX T4 A10T WITH TUMOR 450000 150 440 NO NO 1.1 NO NO R1 Solid Tissue Normal 11 Other (specify) 5th NO YES BC Liver None A DECEASED 86 2000 TCGA-BC-A10T-11 3497c0d8-c7b0-43ca-92a2-30ea6cd61bde TCGA-BC-A10T-11 3497c0d8-c7b0-43ca-92a2-30ea6cd61bde 3497c0d8-c7b0-43ca-92a2-30ea6cd61bde 3497c0d8-c7b0-43ca-92a2-30ea6cd61bde TCGA-BC-A10T-11A-11D-A132-05 +TCGA-BC-A10U-01 TCGA-BC-A10U-01 TCGA-BC-A10U TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO 69 3.5 4.3 5.0 TCGA-BC-A10U-F9923 TCGA-BC-A10U TCGA-BC-A10U-01A 0.0 0.4 4 0.8 1.4 0.9 -25305 3645 837 0 586 38 2011-4-4 MALE Alcohol consumption Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 510 NO G2 Intrahepatic Recurrence Yes NO YES No false No MX NX T2 TCGA-BC-A10U.57EB75F3-6F48-4CFB-86CF-F694C390C86A.pdf A10U WITH TUMOR 204000 150 440 NO NO 1.1 NO YES R1 Primary Tumor 01 Lobectomy 5th NO YES BC 1.2 Liver A DECEASED 2000 TCGA-BC-A10U-01A-11D-A12Y-01 TCGA-BC-A10U-01A-11D-A12Y-01 TCGA-BC-A10U-01A-11D-A12Z-10 TCGA-BC-A10U-01 TCGA-BC-A10U-01 DFCC1105-AC9E-4DD6-944A-CB6F4FE4EA3C 45684bfb-a8c1-4224-a632-a93aa7f70b47 TCGA-BC-A10U-01A-11D-A12Z-10 TCGA-BC-A10U-01 TCGA-BC-A10U-01 45684bfb-a8c1-4224-a632-a93aa7f70b47 TCGA-BC-A10U-01A-11D-A12Z-10 45684bfb-a8c1-4224-a632-a93aa7f70b47 45684bfb-a8c1-4224-a632-a93aa7f70b47 TCGA-BC-A10U-01A-11D-A12Z-10 TCGA-BC-A10U-01A-11D-A132-05 +TCGA-BC-A10U-11 TCGA-BC-A10U-11 TCGA-BC-A10U TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO 69 3.5 4.3 5.0 TCGA-BC-A10U-F9923 TCGA-BC-A10U TCGA-BC-A10U-11A 0.0 0.4 4 0.8 1.4 0.9 -25305 3645 837 0 586 38 2011-4-4 MALE Alcohol consumption Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 1130 NO G2 Intrahepatic Recurrence Yes NO YES No false No MX NX T2 A10U WITH TUMOR 204000 150 440 NO NO 1.1 NO YES R1 Solid Tissue Normal 11 Lobectomy 5th NO YES BC 1.2 Liver A DECEASED 2000 TCGA-BC-A10U-11 1c2972fc-456c-4567-be96-bde9d39a0b76 TCGA-BC-A10U-11 1c2972fc-456c-4567-be96-bde9d39a0b76 1c2972fc-456c-4567-be96-bde9d39a0b76 1c2972fc-456c-4567-be96-bde9d39a0b76 TCGA-BC-A10U-11A-11D-A132-05 +TCGA-BC-A10W-01 TCGA-BC-A10W-01 TCGA-BC-A10W TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 50 3.5 2.8 5.0 TCGA-BC-A10W-F9925 TCGA-BC-A10W TCGA-BC-A10W-01A 0.0 1.4 1 0.8 1.4 0.8 -18562 3100 91 0 79 2011-4-4 MALE Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 460 NO G3 No New Tumor Event NO false No MX NX T4 TCGA-BC-A10W.A7F79765-5038-47AA-87B0-40E2D802E535.pdf A10W WITH TUMOR 401 150 440 NO YES 0.9 NO YES R1 Primary Tumor 01 Lobectomy 5th NO YES BC 1.2 Liver A Hepatitis B Surface Antigen DECEASED 71 2002 TCGA-BC-A10W-01A-11D-A12Y-01 TCGA-BC-A10W-01A-11D-A12Y-01 TCGA-BC-A10W-01A-11D-A12Z-10 TCGA-BC-A10W-01 TCGA-BC-A10W-01 2F3ED728-EF5C-4987-A0FA-052947A658D3 affaf79d-f5a4-45a3-9cbf-181c473a8b2a TCGA-BC-A10W-01A-11D-A12Z-10 TCGA-BC-A10W-01 TCGA-BC-A10W-01 affaf79d-f5a4-45a3-9cbf-181c473a8b2a TCGA-BC-A10W-01A-11D-A12Z-10 affaf79d-f5a4-45a3-9cbf-181c473a8b2a affaf79d-f5a4-45a3-9cbf-181c473a8b2a TCGA-BC-A10W-01A-11D-A12Z-10 TCGA-BC-A10W-01A-11D-A132-05 +TCGA-BC-A10W-11 TCGA-BC-A10W-11 TCGA-BC-A10W TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 50 3.5 2.8 5.0 TCGA-BC-A10W-F9925 TCGA-BC-A10W TCGA-BC-A10W-11A 0.0 1.4 1 0.8 1.4 0.8 -18562 3100 91 0 79 2011-4-4 MALE Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 390 NO G3 No New Tumor Event NO false No MX NX T4 A10W WITH TUMOR 401 150 440 NO YES 0.9 NO YES R1 Solid Tissue Normal 11 Lobectomy 5th NO YES BC 1.2 Liver A Hepatitis B Surface Antigen DECEASED 71 2002 TCGA-BC-A10W-11 2436079d-3e40-4c50-9f99-85d4a8c2ddac TCGA-BC-A10W-11 2436079d-3e40-4c50-9f99-85d4a8c2ddac 2436079d-3e40-4c50-9f99-85d4a8c2ddac 2436079d-3e40-4c50-9f99-85d4a8c2ddac TCGA-BC-A10W-11A-11D-A132-05 +TCGA-BC-A10X-01 TCGA-BC-A10X-01 TCGA-BC-A10X TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver None 52 3.5 3.6 5.0 TCGA-BC-A10X-F9946 TCGA-BC-A10X TCGA-BC-A10X-01A 0.0 0.3 2 0.7 1.1 0.7 -19140 3080 770 0 264 2011-4-4 FEMALE No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 520 NO G2 No New Tumor Event NO false No MX N0 T3a Stage IIIA TCGA-BC-A10X.671F5D97-36F3-40BA-9E28-1B65B21EF3D4.pdf A10X TUMOR FREE 602 150 440 NO NO 1.0 NO YES R0 Primary Tumor 01 Lobectomy 5th NO YES BC 1.2 Liver Micro A DECEASED 65 2002 TCGA-BC-A10X-01A-11D-A12Y-01 TCGA-BC-A10X-01A-11D-A12Y-01 TCGA-BC-A10X-01A-11D-A12Z-10 TCGA-BC-A10X-01 TCGA-BC-A10X-01 586E5071-D93B-4D0D-B732-999FC8995A4A 92c0e4e0-e7a5-486b-82f9-ba7621a10b83 TCGA-BC-A10X-01A-11D-A12Z-10 TCGA-BC-A10X-01 TCGA-BC-A10X-01 92c0e4e0-e7a5-486b-82f9-ba7621a10b83 TCGA-BC-A10X-01A-11D-A12Z-10 92c0e4e0-e7a5-486b-82f9-ba7621a10b83 92c0e4e0-e7a5-486b-82f9-ba7621a10b83 TCGA-BC-A10X-01A-11D-A12Z-10 TCGA-BC-A10X-01A-11D-A132-05 +TCGA-BC-A10X-11 TCGA-BC-A10X-11 TCGA-BC-A10X TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver None 52 3.5 3.6 5.0 TCGA-BC-A10X-F9946 TCGA-BC-A10X TCGA-BC-A10X-11A 0.0 0.3 2 0.7 1.1 0.7 -19140 3080 770 0 264 2011-4-4 FEMALE No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 430 NO G2 No New Tumor Event NO false No MX N0 T3a Stage IIIA A10X TUMOR FREE 602 150 440 NO NO 1.0 NO YES R0 Solid Tissue Normal 11 Lobectomy 5th NO YES BC 1.2 Liver Micro A DECEASED 65 2002 TCGA-BC-A10X-11 608bf540-a094-441e-9329-9e759ff5d84d TCGA-BC-A10X-11 608bf540-a094-441e-9329-9e759ff5d84d 608bf540-a094-441e-9329-9e759ff5d84d 608bf540-a094-441e-9329-9e759ff5d84d TCGA-BC-A10X-11A-11D-A132-05 +TCGA-BC-A10Y-01 TCGA-BC-A10Y-01 TCGA-BC-A10Y TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO None 76 3.5 4.0 5.0 TCGA-BC-A10Y-F9958 TCGA-BC-A10Y TCGA-BC-A10Y-01A 0.0 0.5 0.9 1.4 1.0 -28049 2961 711 0 400 0 10 10575 2011-4-4 MALE 175 Alcohol consumption Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 340 NO G3 Intrahepatic Recurrence Yes NO YES No false No MX NX T4 TCGA-BC-A10Y.20CD1D6D-C4ED-43AD-9FCD-0A683FD96C6E.pdf A10Y WITH TUMOR 239 150 440 YES NO 1.0 NO NO R0 Primary Tumor 01 Lobectomy 5th NO YES BC 1.2 Liver Micro A DECEASED 77 2002 TCGA-BC-A10Y-01A-11D-A12Y-01 TCGA-BC-A10Y-01A-11D-A12Y-01 TCGA-BC-A10Y-01A-11D-A12Z-10 TCGA-BC-A10Y-01 TCGA-BC-A10Y-01 89EA706C-7252-4E64-9A4E-97F2E6744EE4 dd37c309-81f0-4d3d-863d-a16aa505e346 TCGA-BC-A10Y-01A-11D-A12Z-10 TCGA-BC-A10Y-01 TCGA-BC-A10Y-01 dd37c309-81f0-4d3d-863d-a16aa505e346 TCGA-BC-A10Y-01A-11D-A12Z-10 dd37c309-81f0-4d3d-863d-a16aa505e346 dd37c309-81f0-4d3d-863d-a16aa505e346 TCGA-BC-A10Y-01A-11D-A12Z-10 TCGA-BC-A10Y-01A-11D-A132-05 +TCGA-BC-A10Y-11 TCGA-BC-A10Y-11 TCGA-BC-A10Y TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO None 76 3.5 4.0 5.0 TCGA-BC-A10Y-F9958 TCGA-BC-A10Y 0.0 0.5 0.9 1.4 1.0 -28049 711 0 400 0 10 10575 2011-4-4 MALE 175 Alcohol consumption Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES G3 Intrahepatic Recurrence Yes NO YES No No MX NX T4 A10Y WITH TUMOR 239 150 440 YES NO 1.0 NO NO R0 Solid Tissue Normal 11 Lobectomy 5th NO YES BC 1.2 Liver Micro DECEASED 77 2002 TCGA-BC-A10Y-11 b8e62048-d0a6-4b0f-8e57-e406b783f698 TCGA-BC-A10Y-11 b8e62048-d0a6-4b0f-8e57-e406b783f698 b8e62048-d0a6-4b0f-8e57-e406b783f698 b8e62048-d0a6-4b0f-8e57-e406b783f698 TCGA-BC-A10Y-11A-11D-A132-05 +TCGA-BC-A10Z-01 TCGA-BC-A10Z-01 TCGA-BC-A10Z TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver None 62 3.5 3.1 5.0 TCGA-BC-A10Z-F9962 TCGA-BC-A10Z TCGA-BC-A10Z-01A 0.0 0.6 1 0.7 1.1 1.2 -22913 2652 34 0 0 10 779 2011-4-4 FEMALE No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 160 NO G2 No New Tumor Event NO false No MX N0 T1 Stage I TCGA-BC-A10Z.427BA175-823D-4C68-B659-D53CFEB5EA45.pdf A10Z TUMOR FREE 260 150 440 NO NO 0.9 NO YES R0 Primary Tumor 01 Extended Lobectomy 6th NO YES BC 1.2 Liver None A DECEASED 79 2003 TCGA-BC-A10Z-01A-11D-A12Y-01 TCGA-BC-A10Z-01A-11D-A12Y-01 TCGA-BC-A10Z-01A-11D-A12Z-10 TCGA-BC-A10Z-01 TCGA-BC-A10Z-01 9E0546BB-8A10-4B59-8083-5CD4F3FD6072 388a996e-0fb1-4274-905d-074ff0058d80 TCGA-BC-A10Z-01A-11D-A12Z-10 TCGA-BC-A10Z-01 TCGA-BC-A10Z-01 388a996e-0fb1-4274-905d-074ff0058d80 TCGA-BC-A10Z-01A-11D-A12Z-10 388a996e-0fb1-4274-905d-074ff0058d80 388a996e-0fb1-4274-905d-074ff0058d80 TCGA-BC-A10Z-01A-11D-A12Z-10 TCGA-BC-A10Z-01A-11D-A132-05 +TCGA-BC-A10Z-11 TCGA-BC-A10Z-11 TCGA-BC-A10Z TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver None 62 3.5 3.1 5.0 TCGA-BC-A10Z-F9962 TCGA-BC-A10Z TCGA-BC-A10Z-11A 0.0 0.6 1 0.7 1.1 1.2 -22913 2652 34 0 0 10 779 2011-4-4 FEMALE No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 160 NO G2 No New Tumor Event NO false No MX N0 T1 Stage I A10Z TUMOR FREE 260 150 440 NO NO 0.9 NO YES R0 Solid Tissue Normal 11 Extended Lobectomy 6th NO YES BC 1.2 Liver None A DECEASED 79 2003 TCGA-BC-A10Z-11 07653b81-7194-4348-8ef9-1a7660c95376 TCGA-BC-A10Z-11 07653b81-7194-4348-8ef9-1a7660c95376 07653b81-7194-4348-8ef9-1a7660c95376 07653b81-7194-4348-8ef9-1a7660c95376 TCGA-BC-A10Z-11A-11D-A132-05 +TCGA-BC-A110-01 TCGA-BC-A110-01 TCGA-BC-A110 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO 51 3.5 3.7 5.0 TCGA-BC-A110-F9979 TCGA-BC-A110 TCGA-BC-A110-01A 0.0 0.3 2 0.7 1.1 3.5 -18951 2629 2116 0 2057 0 10 2011-4-4 FEMALE 155 Alcohol consumption Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 280 NO G1 Other, specify Extrahepatic Recurrence spleen No NO YES No false Yes MX NX T1 TCGA-BC-A110.DCC8DAE3-E0AF-4B37-8E5F-A2004ACA1F9B.pdf A110 WITH TUMOR 288 150 440 NO YES 0.9 NO YES R0 Primary Tumor 01 Segmentectomy, Single 6th NO YES BC 1.2 Liver None A DECEASED 91 2003 TCGA-BC-A110-01A-11D-A12Y-01 TCGA-BC-A110-01A-11D-A12Y-01 TCGA-BC-A110-01A-11D-A12Z-10 TCGA-BC-A110-01 TCGA-BC-A110-01 202A1EE8-759B-4A19-BC8E-FEDD6EF80192 3f4ab9a7-3a43-4601-a21f-2ee63b10efee TCGA-BC-A110-01A-11D-A12Z-10 TCGA-BC-A110-01 TCGA-BC-A110-01 3f4ab9a7-3a43-4601-a21f-2ee63b10efee TCGA-BC-A110-01A-11D-A12Z-10 3f4ab9a7-3a43-4601-a21f-2ee63b10efee 3f4ab9a7-3a43-4601-a21f-2ee63b10efee TCGA-BC-A110-01A-11D-A12Z-10 TCGA-BC-A110-01A-11D-A132-05 +TCGA-BC-A110-11 TCGA-BC-A110-11 TCGA-BC-A110 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO 51 3.5 3.7 5.0 TCGA-BC-A110-F9979 TCGA-BC-A110 0.0 0.3 2 0.7 1.1 3.5 -18951 2116 0 2057 0 10 2011-4-4 FEMALE 155 Alcohol consumption Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES G1 Other, specify Extrahepatic Recurrence spleen No NO YES No Yes MX NX T1 A110 WITH TUMOR 288 150 440 NO YES 0.9 NO YES R0 Solid Tissue Normal 11 Segmentectomy, Single 6th NO YES BC 1.2 Liver None DECEASED 91 2003 TCGA-BC-A110-11 edcc32ad-1375-4502-822e-defcea52b943 TCGA-BC-A110-11 edcc32ad-1375-4502-822e-defcea52b943 edcc32ad-1375-4502-822e-defcea52b943 edcc32ad-1375-4502-822e-defcea52b943 TCGA-BC-A110-11A-11D-A132-05 +TCGA-BC-A112-01 TCGA-BC-A112-01 TCGA-BC-A112 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 80 3.5 4.1 5.0 TCGA-BC-A112-F9980 TCGA-BC-A112 0.0 0.3 0.7 1.3 2.1 -29511 153 0 0 10 233 0 - No Fibrosis 2011-4-4 MALE 165 Alcohol consumption Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES G2 No New Tumor Event NO Yes MX NX T3 A112 TUMOR FREE 218 150 440 NO NO 1.1 NO NO R0 Primary Tumor 01 Segmentectomy, Multiple 6th NO YES BC 1.2 Liver None DECEASED 97 2009 TCGA-BC-A112-01A-11D-A12Y-01 TCGA-BC-A112-01A-11D-A12Y-01 TCGA-BC-A112-01A-11D-A12Z-10 TCGA-BC-A112-01 TCGA-BC-A112-01 f2b83833-c94a-4fc1-ae6a-7caf4f3a1353 TCGA-BC-A112-01A-11D-A12Z-10 TCGA-BC-A112-01 TCGA-BC-A112-01 f2b83833-c94a-4fc1-ae6a-7caf4f3a1353 TCGA-BC-A112-01A-11D-A12Z-10 f2b83833-c94a-4fc1-ae6a-7caf4f3a1353 f2b83833-c94a-4fc1-ae6a-7caf4f3a1353 TCGA-BC-A112-01A-11D-A12Z-10 TCGA-BC-A112-01A-11D-A132-05 +TCGA-BC-A112-11 TCGA-BC-A112-11 TCGA-BC-A112 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 80 3.5 4.1 5.0 TCGA-BC-A112-F9980 TCGA-BC-A112 TCGA-BC-A112-11A 0.0 0.3 0.7 1.3 2.1 -29511 538 153 0 0 10 233 0 - No Fibrosis 2011-4-4 MALE 165 Alcohol consumption Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 100 NO G2 No New Tumor Event NO false Yes MX NX T3 A112 TUMOR FREE 218 150 440 NO NO 1.1 NO NO R0 Solid Tissue Normal 11 Segmentectomy, Multiple 6th NO YES BC 1.2 Liver None A DECEASED 97 2009 TCGA-BC-A112-11A-11D-A132-05 +TCGA-BC-A216-01 TCGA-BC-A216-01 TCGA-BC-A216 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver Mild 62 3.5 3.4 5.0 TCGA-BC-A216-F22055 TCGA-BC-A216 TCGA-BC-A216-01A 0.0 0.6 2 0.5 1.5 0.9 -22968 1052 0 1351 0 8 831 0 - No Fibrosis Scheduled Follow-up Submission 2012-2-23 FEMALE 164 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 100 NO G2 NO false No M0 NX T3 Stage IIIA TCGA-BC-A216.28CDABB8-3172-4676-8F4A-8B91F2B8D85F.pdf A216 TUMOR FREE 211000 140000 440000 NO NO 1.4 NO YES R0 Primary Tumor 01 Extended Lobectomy 6th NO YES BC 1.5 Liver None A LIVING 151 2008 TCGA-BC-A216-01A-11D-A151-01 TCGA-BC-A216-01A-11D-A151-01 TCGA-BC-A216-01A-11D-A152-10 TCGA-BC-A216-01 TCGA-BC-A216-01 DA2496AC-30CA-4682-BEF4-B37CD691156E 2da5bdd2-23ba-4f3f-93f6-90951a889955 TCGA-BC-A216-01A-11D-A152-10 TCGA-BC-A216-01 TCGA-BC-A216-01 2da5bdd2-23ba-4f3f-93f6-90951a889955 TCGA-BC-A216-01A-11D-A152-10 2da5bdd2-23ba-4f3f-93f6-90951a889955 2da5bdd2-23ba-4f3f-93f6-90951a889955 TCGA-BC-A216-01A-11D-A152-10 TCGA-BC-A216-01A-11D-A153-05 +TCGA-BC-A216-11 TCGA-BC-A216-11 TCGA-BC-A216 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver Mild 62 3.5 3.4 5.0 TCGA-BC-A216-F22055 TCGA-BC-A216 TCGA-BC-A216-11A 0.0 0.6 2 0.5 1.5 0.9 -22968 1052 0 1351 0 8 831 0 - No Fibrosis Scheduled Follow-up Submission 2012-2-23 FEMALE 164 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 120 NO G2 NO false No M0 NX T3 Stage IIIA A216 TUMOR FREE 211000 140000 440000 NO NO 1.4 NO YES R0 Solid Tissue Normal 11 Extended Lobectomy 6th NO YES BC 1.5 Liver None A LIVING 151 2008 TCGA-BC-A216-11 1ec66ae2-e78a-4eb8-891a-7f8b6b061dca TCGA-BC-A216-11 1ec66ae2-e78a-4eb8-891a-7f8b6b061dca 1ec66ae2-e78a-4eb8-891a-7f8b6b061dca 1ec66ae2-e78a-4eb8-891a-7f8b6b061dca TCGA-BC-A216-11A-11D-A153-05 +TCGA-BC-A217-01 TCGA-BC-A217-01 TCGA-BC-A217 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver None 75 3.5 4.4 5.0 TCGA-BC-A217-F70242 TCGA-BC-A217 TCGA-BC-A217-01A 0.0 0.2 0.6 1.0 0.8 -27411 408 1397 0 421 0 10 28 0 - No Fibrosis 2015-2-2 FEMALE 163 Alcohol consumption Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 240 NO NO G3 NO false No M0 NX T2 Stage II TCGA-BC-A217.FEA652A1-DD1E-4D78-87DF-FC2162267A96.pdf A217 TUMOR FREE 243000 150000 440000 NO NO 1.0 NO NO R0 Primary Tumor 01 7th YES NO BC 1.2 Liver Micro A DECEASED 81 2010 TCGA-BC-A217-01A-11D-A151-01 TCGA-BC-A217-01A-11D-A151-01 TCGA-BC-A217-01A-11D-A152-10 TCGA-BC-A217-01 TCGA-BC-A217-01 FAB6855B-0EB9-4C94-8D56-C2E357024779 84f24356-27a3-4321-a58d-f1f6b135c954 TCGA-BC-A217-01A-11D-A152-10 TCGA-BC-A217-01 TCGA-BC-A217-01 84f24356-27a3-4321-a58d-f1f6b135c954 TCGA-BC-A217-01A-11D-A152-10 84f24356-27a3-4321-a58d-f1f6b135c954 84f24356-27a3-4321-a58d-f1f6b135c954 TCGA-BC-A217-01A-11D-A152-10 TCGA-BC-A217-01A-11D-A153-05 +TCGA-BC-A3KF-01 TCGA-BC-A3KF-01 TCGA-BC-A3KF TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 66 TCGA-BC-A3KF-F38204 TCGA-BC-A3KF TCGA-BC-A3KF-01A 2 0.6 1.0 0.8 -24328 91 0 8 2012-12-11 FEMALE 173 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 340 NO YES G2 false No M0 NX T1 Stage I TCGA-BC-A3KF.AFBED89A-FA3F-45E9-9824-AEE5F891C5B2.pdf A3KF TUMOR FREE 171000 150000 440000 1.0 YES R0 Primary Tumor 01 Segmentectomy, Single 7th YES NO BC Liver None A LIVING 58 2011 TCGA-BC-A3KF-01A-11D-A20V-01 TCGA-BC-A3KF-01A-11D-A20V-01 TCGA-BC-A3KF-01A-11D-A20W-10 TCGA-BC-A3KF-01 TCGA-BC-A3KF-01 6563285F-CE8B-40B7-AD37-7F1EC9704D87 82ac64bb-6cca-4f17-942a-3108995245a0 TCGA-BC-A3KF-01A-11D-A20W-10 TCGA-BC-A3KF-01 TCGA-BC-A3KF-01 82ac64bb-6cca-4f17-942a-3108995245a0 TCGA-BC-A3KF-01A-11D-A20W-10 82ac64bb-6cca-4f17-942a-3108995245a0 82ac64bb-6cca-4f17-942a-3108995245a0 TCGA-BC-A3KF-01A-11D-A20W-10 TCGA-BC-A3KF-01A-11D-A20Z-05 +TCGA-BC-A3KG-01 TCGA-BC-A3KG-01 TCGA-BC-A3KG TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver YES 68 3.5 3.6 5.0 TCGA-BC-A3KG-F38205 TCGA-BC-A3KG TCGA-BC-A3KG-01A 0.0 0.5 0.6 1.0 0.7 -25061 140 0 680 209 0 10 618 2013-6-27 FEMALE 159 Alcohol consumption Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 790 NO NO G3 Liver Intrahepatic Recurrence NO YES No false No M0 N0 T2 Stage II TCGA-BC-A3KG.67A81454-06A8-451D-B855-F9D146CC0348.pdf A3KG WITH TUMOR 499000 150000 440000 NO NO 1.1 NO NO R0 Primary Tumor 01 Lobectomy 7th YES NO BC 1.2 Liver Micro A LIVING 64 2011 TCGA-BC-A3KG-01A-11D-A20V-01 TCGA-BC-A3KG-01A-11D-A20V-01 TCGA-BC-A3KG-01A-11D-A20W-10 TCGA-BC-A3KG-01 TCGA-BC-A3KG-01 96E60A73-A334-453E-BB34-A1A3361E19A1 46deaeee-1e58-4eae-8aaf-94500ec4a6de TCGA-BC-A3KG-01A-11D-A20W-10 TCGA-BC-A3KG-01 TCGA-BC-A3KG-01 46deaeee-1e58-4eae-8aaf-94500ec4a6de TCGA-BC-A3KG-01A-11D-A20W-10 46deaeee-1e58-4eae-8aaf-94500ec4a6de 46deaeee-1e58-4eae-8aaf-94500ec4a6de TCGA-BC-A3KG-01A-11D-A20W-10 TCGA-BC-A3KG-01A-11D-A20Z-05 +TCGA-BC-A5W4-01 TCGA-BC-A5W4-01 TCGA-BC-A5W4 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO None 69 3.5 4.2 5.0 TCGA-BC-A5W4-F57584 TCGA-BC-A5W4 TCGA-BC-A5W4-01A 0.0 0.6 A 0.70 1.30 -25503 224 547 0 289 384 2014-3-17 MALE 183 Alcohol consumption Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 540 9.9 13.0 NO NO G3 Locoregional Recurrence Yes NO YES No false Yes M0 NX T3a Stage IIIA TCGA-BC-A5W4.6BCF821F-1993-4BA9-A9D2-EB4DEACD402C.pdf A5W4 TUMOR FREE 102000 150000 440000 NO NO 12.9 NO NO R1 Primary Tumor 01 Segmentectomy, Multiple 7th YES NO BC 1.2 Liver Micro A DECEASED 106 2012 TCGA-BC-A5W4-01A-11D-A28W-01 TCGA-BC-A5W4-01A-11D-A28W-01 TCGA-BC-A5W4-01A-11D-A28X-10 TCGA-BC-A5W4-01 TCGA-BC-A5W4-01 19439DF2-E133-4612-8AB5-F10CBA286F8C 440b70b1-0313-4c54-bfb4-e1f44a336aba TCGA-BC-A5W4-01A-11D-A28X-10 TCGA-BC-A5W4-01 TCGA-BC-A5W4-01 440b70b1-0313-4c54-bfb4-e1f44a336aba TCGA-BC-A5W4-01A-11D-A28X-10 440b70b1-0313-4c54-bfb4-e1f44a336aba 440b70b1-0313-4c54-bfb4-e1f44a336aba TCGA-BC-A5W4-01A-11D-A28X-10 TCGA-BC-A5W4-01A-11D-A28Y-05 +TCGA-BC-A69H-01 TCGA-BC-A69H-01 TCGA-BC-A69H TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver None 64 3.6 4.3 4.8 TCGA-BC-A69H-F59404 TCGA-BC-A69H TCGA-BC-A69H-01A 0.0 0.4 A 0.8 1.3 0.8 -23380 94 0 444 1 0 103900 2014-5-12 MALE 173 Alcohol consumption Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 610 9.1 12.0 NO NO G3 NO false No M0 NX T2 Stage II TCGA-BC-A69H.AE56DFF8-AF71-4217-A491-8F78543E186D.pdf A69H TUMOR FREE 194000 140000 440000 NO NO 10.7 NO NO R0 Primary Tumor 01 Segmentectomy, Multiple 7th YES NO BC 1.2 Liver Micro A LIVING 70 2013 TCGA-BC-A69H-01A-11D-A30U-01 TCGA-BC-A69H-01A-11D-A30U-01 TCGA-BC-A69H-01A-11D-A30V-10 TCGA-BC-A69H-01 TCGA-BC-A69H-01 9ECE0636-589F-4452-85F6-FF9EEC933374 d61e6c10-4515-4cd1-9bc7-884db524ebca TCGA-BC-A69H-01A-11D-A30V-10 TCGA-BC-A69H-01 TCGA-BC-A69H-01 d61e6c10-4515-4cd1-9bc7-884db524ebca TCGA-BC-A69H-01A-11D-A30V-10 d61e6c10-4515-4cd1-9bc7-884db524ebca d61e6c10-4515-4cd1-9bc7-884db524ebca TCGA-BC-A69H-01A-11D-A30V-10 TCGA-BC-A69H-01A-11D-A30Y-05 +TCGA-BC-A69I-01 TCGA-BC-A69I-01 TCGA-BC-A69I TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver None 69 TCGA-BC-A69I-F59405 TCGA-BC-A69I TCGA-BC-A69I-01A 0.0 1.2 1 0.7 1.3 1.2 -25370 80 0 387 0 0 10 2 2014-5-12 MALE 180 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 500 9.9 13.0 NO NO G1 NO false No M0 N0 T1 Stage I TCGA-BC-A69I.94F0B317-494A-4467-94A2-5004010E133F.pdf A69I TUMOR FREE 171000 150000 440000 NO NO 10.4 NO YES R0 Primary Tumor 01 Segmentectomy, Multiple 7th YES NO BC 1.2 Liver None A LIVING 95 2013 TCGA-BC-A69I-01A-11D-A30U-01 TCGA-BC-A69I-01A-11D-A30U-01 TCGA-BC-A69I-01 TCGA-BC-A69I-01 545DE8B9-4DE8-484B-A8A6-986E674473A6 7f765ffb-6d9d-4cfe-a5b6-8a83d8839d42 TCGA-BC-A69I-01A-11D-A30V-10 TCGA-BC-A69I-01 TCGA-BC-A69I-01 7f765ffb-6d9d-4cfe-a5b6-8a83d8839d42 TCGA-BC-A69I-01A-11D-A30V-10 7f765ffb-6d9d-4cfe-a5b6-8a83d8839d42 7f765ffb-6d9d-4cfe-a5b6-8a83d8839d42 TCGA-BC-A69I-01A-11D-A30V-10 TCGA-BC-A69I-01A-11D-A30Y-05 +TCGA-BC-A8YO-01 TCGA-BC-A8YO-01 TCGA-BC-A8YO TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver None 66 3.5 4.3 5.0 TCGA-BC-A8YO-F70635 TCGA-BC-A8YO TCGA-BC-A8YO-01A 0.0 0.3 3 0.6 1.0 0.8 -24189 141 0 562 2015-2-26 FEMALE 170 Alcohol consumption|Other Chronic hepatitis, either viral or autoimmune Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 680 NO NO G3 YES false No M0 N0 T4 Stage IIIC TCGA-BC-A8YO.BF3E21AE-D9DC-4011-908A-32C6C1FE10FB.pdf A8YO WITH TUMOR 441000 150000 440000 NO YES 1.0 NO YES R0 Primary Tumor 01 Segmentectomy, Multiple 7th YES NO BC 1.2 Liver Macro A LIVING 74 2013 TCGA-BC-A8YO-01A-11D-A36W-01 TCGA-BC-A8YO-01A-11D-A36W-01 TCGA-BC-A8YO-01A-11D-A36X-10 TCGA-BC-A8YO-01 TCGA-BC-A8YO-01 AC4E92CC-7921-4165-A7A7-30C29F8BB86F c10552f3-93ad-4f50-a420-3b5277416aef TCGA-BC-A8YO-01 TCGA-BC-A8YO-01 c10552f3-93ad-4f50-a420-3b5277416aef c10552f3-93ad-4f50-a420-3b5277416aef c10552f3-93ad-4f50-a420-3b5277416aef TCGA-BC-A8YO-01A-11D-A36Y-05 +TCGA-BD-A2L6-01 TCGA-BD-A2L6-01 TCGA-BD-A2L6 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver YES NO None 69 3.4 3.7 5.0 TCGA-BD-A2L6-F34562 TCGA-BD-A2L6 TCGA-BD-A2L6-01A 0.3 0.9 A 0.5 1.4 1.2 -25489 148 0 1363 415 1 0 20 53 3,4 - Fibrous Speta 2012-8-23 MALE 168 Alcohol consumption Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 480 0.8 1.2 NO NO G2 Liver Intrahepatic Recurrence Yes NO YES No true No MX NX T2 TCGA-BD-A2L6.6E795E68-4CFC-4DC9-A072-9A78C59CE10A.pdf A2L6 WITH TUMOR 222 156 369 NO NO 1.0 NO R0 Primary Tumor 01 Lobectomy 7th YES NO BD 1.5 Liver Micro A Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody LIVING 110 2011 TCGA-BD-A2L6-01A-11D-A20V-01 TCGA-BD-A2L6-01A-11D-A20V-01 TCGA-BD-A2L6-01A-11D-A20W-10 TCGA-BD-A2L6-01 TCGA-BD-A2L6-01 895D7028-99A7-4CC8-B3E0-A1E4601A4AE2 887e3dc8-2c4b-4b56-b43a-fc2b0ba4e478 TCGA-BD-A2L6-01A-11D-A20W-10 TCGA-BD-A2L6-01 TCGA-BD-A2L6-01 887e3dc8-2c4b-4b56-b43a-fc2b0ba4e478 TCGA-BD-A2L6-01A-11D-A20W-10 887e3dc8-2c4b-4b56-b43a-fc2b0ba4e478 887e3dc8-2c4b-4b56-b43a-fc2b0ba4e478 TCGA-BD-A2L6-01A-11D-A20W-10 TCGA-BD-A2L6-01A-11D-A20Z-05 +TCGA-BD-A2L6-11 TCGA-BD-A2L6-11 TCGA-BD-A2L6 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver YES NO None 69 3.4 3.7 5.0 TCGA-BD-A2L6-F34562 TCGA-BD-A2L6 TCGA-BD-A2L6-11A 0.3 0.9 A 0.5 1.4 1.2 -25489 148 0 1363 415 1 0 20 53 3,4 - Fibrous Speta 2012-8-23 MALE 168 Alcohol consumption Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 310 0.8 1.2 NO NO G2 Liver Intrahepatic Recurrence Yes NO YES No true No MX NX T2 A2L6 WITH TUMOR 222 156 369 NO NO 1.0 NO R0 Solid Tissue Normal 11 Lobectomy 7th YES NO BD 1.5 Liver Micro A Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody LIVING 110 2011 TCGA-BD-A2L6-11 66811a13-8463-429b-87ae-298455ee961a TCGA-BD-A2L6-11 66811a13-8463-429b-87ae-298455ee961a 66811a13-8463-429b-87ae-298455ee961a 66811a13-8463-429b-87ae-298455ee961a TCGA-BD-A2L6-11A-21D-A20Z-05 +TCGA-BD-A3EP-01 TCGA-BD-A3EP-01 TCGA-BD-A3EP TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver Mild 75 3.4 3.8 5.0 TCGA-BD-A3EP-F68680 TCGA-BD-A3EP TCGA-BD-A3EP-01A 0.3 0.6 0 A 0.5 1.4 1.1 -27756 398 0 409 1 0 20 17 1,2 - Portal Fibrosis 2014-12-10 FEMALE 168 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 140 0.8 1.2 NO YES G2 NO true No M0 N0 T1 Stage I TCGA-BD-A3EP.4560D451-6F7E-4F3F-8AF7-F393DB000ABD.pdf A3EP TUMOR FREE 333 156 369 NO NO 1.0 NO NO R0 Primary Tumor 01 Lobectomy 7th YES NO BD 1.5 Liver None A LIVING 71 2010 TCGA-BD-A3EP-01A-11D-A22E-01 TCGA-BD-A3EP-01A-11D-A22E-01 TCGA-BD-A3EP-01A-11D-A22F-10 TCGA-BD-A3EP-01 TCGA-BD-A3EP-01 3AB8FEB7-1994-4767-8649-B594C45B352F 22142880-0e1a-4e12-98b1-2597e9d14def TCGA-BD-A3EP-01A-11D-A22F-10 TCGA-BD-A3EP-01 TCGA-BD-A3EP-01 22142880-0e1a-4e12-98b1-2597e9d14def TCGA-BD-A3EP-01A-11D-A22F-10 22142880-0e1a-4e12-98b1-2597e9d14def 22142880-0e1a-4e12-98b1-2597e9d14def TCGA-BD-A3EP-01A-11D-A22F-10 TCGA-BD-A3EP-01A-11D-A22H-05 +TCGA-BD-A3EP-11 TCGA-BD-A3EP-11 TCGA-BD-A3EP TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver Mild 75 3.4 3.8 5.0 TCGA-BD-A3EP-F68680 TCGA-BD-A3EP TCGA-BD-A3EP-11A 0.3 0.6 0 A 0.5 1.4 1.1 -27756 398 0 409 1 0 20 17 1,2 - Portal Fibrosis 2014-12-10 FEMALE 168 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 120 0.8 1.2 NO YES G2 NO true No M0 N0 T1 Stage I A3EP TUMOR FREE 333 156 369 NO NO 1.0 NO NO R0 Solid Tissue Normal 11 Lobectomy 7th YES NO BD 1.5 Liver None A LIVING 71 2010 TCGA-BD-A3EP-11 58067780-a21b-4eeb-b061-caef50ea0650 TCGA-BD-A3EP-11 58067780-a21b-4eeb-b061-caef50ea0650 58067780-a21b-4eeb-b061-caef50ea0650 58067780-a21b-4eeb-b061-caef50ea0650 TCGA-BD-A3EP-11A-12D-A22H-05 +TCGA-BD-A3ER-01 TCGA-BD-A3ER-01 TCGA-BD-A3ER TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO Mild 62 3.4 3.9 5.0 TCGA-BD-A3ER-F68681 TCGA-BD-A3ER TCGA-BD-A3ER-01A 0.3 0.7 0 A 0.5 1.4 0.9 -22657 23 0 1115 226 0 0 20 5 6 - Established Cirrhosis 2014-12-10 MALE 188 Hemochromatosis Alcohol Consumption Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 90 0.8 1.2 NO NO G2 Liver Locoregional Recurrence Yes NO YES No true Yes MX NX T2 Stage II TCGA-BD-A3ER.2CD158D7-48E7-43D6-8E0F-2D56FC6F5256.pdf A3ER WITH TUMOR 208 156 369 NO NO 1.2 NO NO R0 Primary Tumor 01 Segmentectomy, Multiple 7th YES NO BD 1.5 Liver None A Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody LIVING 111 2011 TCGA-BD-A3ER-01A-11D-A20V-01 TCGA-BD-A3ER-01A-11D-A20V-01 TCGA-BD-A3ER-01A-11D-A20W-10 TCGA-BD-A3ER-01 22616236-E7D6-4905-A80C-4D3776310CCB 459ab827-f9c7-4b30-9b6a-86bee706c6e0 TCGA-BD-A3ER-01A-11D-A20W-10 TCGA-BD-A3ER-01 459ab827-f9c7-4b30-9b6a-86bee706c6e0 TCGA-BD-A3ER-01A-11D-A20W-10 459ab827-f9c7-4b30-9b6a-86bee706c6e0 459ab827-f9c7-4b30-9b6a-86bee706c6e0 TCGA-BD-A3ER-01A-11D-A20W-10 TCGA-BD-A3ER-01A-11D-A20Z-05 +TCGA-BW-A5NO-01 TCGA-BW-A5NO-01 TCGA-BW-A5NO TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 50 TCGA-BW-A5NO TCGA-BW-A5NO-01A -18510 840 0 20 1 3,4 - Fibrous Speta 2014-3-26 MALE Hepatitis C Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 110 NO G2 NO false No MX NX T3a Stage IIIA TCGA-BW-A5NO.39E090EF-9EA0-4362-BB47-432DE5AA1393.pdf A5NO TUMOR FREE NO NO NO RX Primary Tumor 01 Lobectomy 7th YES NO BW Liver None A LIVING 2010 TCGA-BW-A5NO-01A-11D-A27H-01 TCGA-BW-A5NO-01A-11D-A27H-01 TCGA-BW-A5NO-01A-11D-A27I-10 TCGA-BW-A5NO-01 TCGA-BW-A5NO-01 3520231E-6D3B-4514-AA06-E73D1BEAAF53 38bb0662-ec22-4b4f-9264-69957e582b33 TCGA-BW-A5NO-01A-11D-A27I-10 TCGA-BW-A5NO-01 TCGA-BW-A5NO-01 38bb0662-ec22-4b4f-9264-69957e582b33 TCGA-BW-A5NO-01A-11D-A27I-10 38bb0662-ec22-4b4f-9264-69957e582b33 38bb0662-ec22-4b4f-9264-69957e582b33 TCGA-BW-A5NO-01A-11D-A27I-10 TCGA-BW-A5NO-01A-11D-A27W-05 +TCGA-BW-A5NP-01 TCGA-BW-A5NP-01 TCGA-BW-A5NP TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver Mild 26 TCGA-BW-A5NP TCGA-BW-A5NP-01A -9809 1057 0 0 2 143684 3,4 - Fibrous Speta 2014-3-26 FEMALE Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 290 NO G3 YES false No M1 N0 T2 Stage IV TCGA-BW-A5NP.D13029B5-B160-48FC-A556-9FBF8CAF4EDB.pdf A5NP WITH TUMOR NO YES NO RX Primary Tumor 01 7th YES NO BW Liver Micro A LIVING 2010 TCGA-BW-A5NP-01A-11D-A27H-01 TCGA-BW-A5NP-01A-11D-A27H-01 TCGA-BW-A5NP-01A-11D-A27I-10 TCGA-BW-A5NP-01 TCGA-BW-A5NP-01 E66505C6-DD0D-4EC9-BA9F-21968A5747F6 d2b612ea-bc88-4b16-971d-6f0141bed0b9 TCGA-BW-A5NP-01A-11D-A27I-10 TCGA-BW-A5NP-01 TCGA-BW-A5NP-01 d2b612ea-bc88-4b16-971d-6f0141bed0b9 TCGA-BW-A5NP-01A-11D-A27I-10 d2b612ea-bc88-4b16-971d-6f0141bed0b9 d2b612ea-bc88-4b16-971d-6f0141bed0b9 TCGA-BW-A5NP-01A-11D-A27I-10 TCGA-BW-A5NP-01A-11D-A27W-05 +TCGA-BW-A5NQ-01 TCGA-BW-A5NQ-01 TCGA-BW-A5NQ TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 63 TCGA-BW-A5NQ TCGA-BW-A5NQ-01A -23353 1022 0 0 6 - Established Cirrhosis 2014-3-26 MALE Alcohol consumption|Other cirrhosis Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 160 NO G3 false Yes MX NX T1 Stage I TCGA-BW-A5NQ.D56121DE-22A7-44D8-97EF-E33D395ABAF9.pdf A5NQ TUMOR FREE RX Primary Tumor 01 Segmentectomy, Multiple 7th YES NO BW Liver None A LIVING 2010 TCGA-BW-A5NQ-01A-11D-A27H-01 TCGA-BW-A5NQ-01A-11D-A27H-01 TCGA-BW-A5NQ-01A-11D-A27I-10 TCGA-BW-A5NQ-01 TCGA-BW-A5NQ-01 48D0CECD-3B95-44BD-A5B0-9F56216B17F3 818ed3ec-2c9c-41cc-8c01-18c9a95e9a02 TCGA-BW-A5NQ-01A-11D-A27I-10 TCGA-BW-A5NQ-01 TCGA-BW-A5NQ-01 818ed3ec-2c9c-41cc-8c01-18c9a95e9a02 TCGA-BW-A5NQ-01A-11D-A27I-10 818ed3ec-2c9c-41cc-8c01-18c9a95e9a02 818ed3ec-2c9c-41cc-8c01-18c9a95e9a02 TCGA-BW-A5NQ-01A-11D-A27I-10 TCGA-BW-A5NQ-01A-11D-A27W-05 +TCGA-CC-5258-01 TCGA-CC-5258-01 TCGA-CC-5258 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 48 TCGA-CC-5258-F20327 TCGA-CC-5258 TCGA-CC-5258-01A -17586 147 129 0 0 3 Scheduled Follow-up Submission 2012-1-9 MALE Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 1700 NO G2 NO true No M0 N0 T2 Stage II TCGA-CC-5258.F63EEB94-37AE-43FC-97B9-8EBF328C2134.pdf 5258 TUMOR FREE NO NO NO NO RX Primary Tumor 01 Other (specify) 6th YES NO CC Liver None A Hepatitis C Antibody|HBV Surface Antibody DECEASED 55 2010 TCGA-CC-5258-01A-01D-A12Y-01 TCGA-CC-5258-01A-01D-A12Y-01 TCGA-CC-5258-01A-01D-A12Z-10 TCGA-CC-5258-01 TCGA-CC-5258-01 3E1812C6-00C2-437C-8BA6-39A2B0C610EC 54315bb5-c78e-4b9c-b9c1-8d0a944a854f TCGA-CC-5258-01A-01D-A12Z-10 TCGA-CC-5258-01 TCGA-CC-5258-01 54315bb5-c78e-4b9c-b9c1-8d0a944a854f TCGA-CC-5258-01A-01D-A12Z-10 54315bb5-c78e-4b9c-b9c1-8d0a944a854f 54315bb5-c78e-4b9c-b9c1-8d0a944a854f TCGA-CC-5258-01A-01D-A12Z-10 TCGA-CC-5258-01A-01D-A132-05 +TCGA-CC-5259-01 TCGA-CC-5259-01 TCGA-CC-5259 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO 60 TCGA-CC-5259-F70915 TCGA-CC-5259 -21946 0 250 180 2015-3-10 FEMALE 153 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES NO G2 Liver Locoregional Recurrence No NO YES No No M0 N0 T4 Stage IIIC 5259 WITH TUMOR NO NO NO NO R0 Primary Tumor 01 Segmentectomy, Single 7th YES NO CC Liver Hepatitis C Antibody|Hepatitis B Surface Antigen LIVING 49 2010 TCGA-CC-5259-01A-31D-A20W-10 TCGA-CC-5259-01 TCGA-CC-5259-01 e39040d8-cdb2-4ead-9e93-224ba7c37dbc TCGA-CC-5259-01A-31D-A20W-10 TCGA-CC-5259-01 e39040d8-cdb2-4ead-9e93-224ba7c37dbc TCGA-CC-5259-01A-31D-A20W-10 e39040d8-cdb2-4ead-9e93-224ba7c37dbc e39040d8-cdb2-4ead-9e93-224ba7c37dbc TCGA-CC-5259-01A-31D-A20W-10 TCGA-CC-5259-01A-31D-A20Z-05 +TCGA-CC-5260-01 TCGA-CC-5260-01 TCGA-CC-5260 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 61 TCGA-CC-5260-F20330 TCGA-CC-5260 TCGA-CC-5260-01A -22345 105 87 0 0 Scheduled Follow-up Submission 2012-1-9 FEMALE 153 Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 600 NO G1 NO true No M0 N0 T4 Stage IIIC TCGA-CC-5260.2E6A53F8-D019-4B4A-894F-CF21BEE91EDD.pdf 5260 TUMOR FREE NO NO NO NO RX Primary Tumor 01 Other (specify) 7th YES NO CC Liver None A Hepatitis C Antibody|Hepatitis B Surface Antigen DECEASED 46 2010 TCGA-CC-5260-01A-01D-A12Y-01 TCGA-CC-5260-01A-01D-A12Y-01 TCGA-CC-5260-01A-01D-A12Z-10 TCGA-CC-5260-01 TCGA-CC-5260-01 254C5E95-8AE2-44E6-89BF-56DB0E056A71 108f1509-bd7e-4a10-8989-f20f7b45bb09 TCGA-CC-5260-01A-01D-A12Z-10 TCGA-CC-5260-01 TCGA-CC-5260-01 108f1509-bd7e-4a10-8989-f20f7b45bb09 TCGA-CC-5260-01A-01D-A12Z-10 108f1509-bd7e-4a10-8989-f20f7b45bb09 108f1509-bd7e-4a10-8989-f20f7b45bb09 TCGA-CC-5260-01A-01D-A12Z-10 TCGA-CC-5260-01A-01D-A132-05 +TCGA-CC-5261-01 TCGA-CC-5261-01 TCGA-CC-5261 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 44 TCGA-CC-5261-F20332 TCGA-CC-5261 TCGA-CC-5261-01A -16373 110 97 0 12 Scheduled Follow-up Submission 2012-1-9 MALE 175 Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 450 NO G2 NO true No M0 N0 T2 Stage II TCGA-CC-5261.30B90892-0231-450E-8A93-28F387047463.pdf 5261 TUMOR FREE NO NO NO RX Primary Tumor 01 Other (specify) 7th YES NO CC Liver None A Hepatitis C Antibody|Hepatitis B Surface Antigen DECEASED 58 2010 TCGA-CC-5261-01A-01D-A12Y-01 TCGA-CC-5261-01A-01D-A12Y-01 TCGA-CC-5261-01A-01D-A12Z-10 TCGA-CC-5261-01 TCGA-CC-5261-01 76CB0776-E9E6-475F-9C3D-C8E60205528F 04beffef-0cd3-4935-8f2e-9e11c5638973 TCGA-CC-5261-01A-01D-A12Z-10 TCGA-CC-5261-01 TCGA-CC-5261-01 04beffef-0cd3-4935-8f2e-9e11c5638973 TCGA-CC-5261-01A-01D-A12Z-10 04beffef-0cd3-4935-8f2e-9e11c5638973 04beffef-0cd3-4935-8f2e-9e11c5638973 TCGA-CC-5261-01A-01D-A12Z-10 TCGA-CC-5261-01A-01D-A132-05 +TCGA-CC-5262-01 TCGA-CC-5262-01 TCGA-CC-5262 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 67 TCGA-CC-5262-F20334 TCGA-CC-5262 TCGA-CC-5262-01A -24787 97 103 0 0 Scheduled Follow-up Submission 2012-1-9 MALE 170 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 800 NO G1 NO true No M0 N0 T4 Stage IIIC TCGA-CC-5262.B09509A2-A902-4298-AEDF-66BA21C584BB.pdf 5262 TUMOR FREE NO NO NO NO Primary Tumor 01 Other (specify) 7th YES NO CC Liver A Hepatitis C Antibody|Hepatitis B Surface Antigen DECEASED 62 2010 TCGA-CC-5262-01A-01D-A12Y-01 TCGA-CC-5262-01A-01D-A12Y-01 TCGA-CC-5262-01A-01D-A12Z-10 TCGA-CC-5262-01 TCGA-CC-5262-01 6AF7DF38-5308-4618-90F5-44A6882CD6DD 5b1b9e38-e00a-462b-976a-c540c13718ca TCGA-CC-5262-01A-01D-A12Z-10 TCGA-CC-5262-01 TCGA-CC-5262-01 5b1b9e38-e00a-462b-976a-c540c13718ca TCGA-CC-5262-01A-01D-A12Z-10 5b1b9e38-e00a-462b-976a-c540c13718ca 5b1b9e38-e00a-462b-976a-c540c13718ca TCGA-CC-5262-01A-01D-A12Z-10 TCGA-CC-5262-01A-01D-A132-05 +TCGA-CC-5263-01 TCGA-CC-5263-01 TCGA-CC-5263 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 35 TCGA-CC-5263-F20328 TCGA-CC-5263 TCGA-CC-5263-01A -12863 91 129 0 Scheduled Follow-up Submission 2012-1-9 MALE 163 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 900 NO G1 NO true No M0 N0 T3 Stage IIIA TCGA-CC-5263.3136CA38-995E-4B6B-97F2-D37AF68EFA4C.pdf 5263 TUMOR FREE NO NO NO NO RX Primary Tumor 01 Other (specify) 6th YES NO CC Liver None A Hepatitis C Antibody|Hepatitis B Surface Antigen DECEASED 59 2010 TCGA-CC-5263-01A-01D-A12Y-01 TCGA-CC-5263-01A-01D-A12Y-01 TCGA-CC-5263-01A-01D-A12Z-10 TCGA-CC-5263-01 TCGA-CC-5263-01 6B4F8CDA-B879-4BF0-9AD5-317CEB6AA090 038e0d7b-8f46-40fb-bfec-74dab7a6fe59 TCGA-CC-5263-01A-01D-A12Z-10 TCGA-CC-5263-01 TCGA-CC-5263-01 038e0d7b-8f46-40fb-bfec-74dab7a6fe59 TCGA-CC-5263-01A-01D-A12Z-10 038e0d7b-8f46-40fb-bfec-74dab7a6fe59 038e0d7b-8f46-40fb-bfec-74dab7a6fe59 TCGA-CC-5263-01A-01D-A12Z-10 TCGA-CC-5263-01A-01D-A132-05 +TCGA-CC-5264-01 TCGA-CC-5264-01 TCGA-CC-5264 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 71 TCGA-CC-5264-F20329 TCGA-CC-5264 TCGA-CC-5264-01A -25979 84 102 0 0 Scheduled Follow-up Submission 2012-1-9 MALE 160 Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 550 NO G2 NO true No M0 N0 T3 Stage IIIA TCGA-CC-5264.4D5CD8E8-DAD7-4392-A44C-BBDF3DAD872F.pdf 5264 TUMOR FREE NO NO NO RX Primary Tumor 01 Other (specify) 6th YES NO CC Liver None A Hepatitis C Antibody|Hepatitis B Surface Antigen DECEASED 52 2010 TCGA-CC-5264-01A-01D-A12Y-01 TCGA-CC-5264-01A-01D-A12Y-01 TCGA-CC-5264-01A-01D-A12Z-10 TCGA-CC-5264-01 TCGA-CC-5264-01 D7CA2572-EA6A-4E9E-8E11-43FF0976EA17 06a52d13-3cb4-4d5f-94ef-55d980562486 TCGA-CC-5264-01A-01D-A12Z-10 TCGA-CC-5264-01 TCGA-CC-5264-01 06a52d13-3cb4-4d5f-94ef-55d980562486 TCGA-CC-5264-01A-01D-A12Z-10 06a52d13-3cb4-4d5f-94ef-55d980562486 06a52d13-3cb4-4d5f-94ef-55d980562486 TCGA-CC-5264-01A-01D-A12Z-10 TCGA-CC-5264-01A-01D-A132-05 +TCGA-CC-A123-01 TCGA-CC-A123-01 TCGA-CC-A123 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO 24 TCGA-CC-A123-F70913 TCGA-CC-A123 TCGA-CC-A123-01A -9107 49 0 219 145 3 2015-3-10 FEMALE Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 280 NO NO G1 Lung New Primary Tumor No NO YES true No M0 N0 T3 Stage IIIA TCGA-CC-A123.65D669CE-291F-489A-9B25-AD619B906900.pdf A123 WITH TUMOR NO NO NO RX Primary Tumor 01 Other (specify) 6th YES NO CC Liver None A Hepatitis C Antibody|Hepatitis B Surface Antigen LIVING 2010 TCGA-CC-A123-01A-11D-A12Z-10 TCGA-CC-A123-01 TCGA-CC-A123-01 BB3F83AE-BA9B-44B2-998F-2D184242DD98 3e205fbf-b9e5-470d-9c6f-68ff88640c45 TCGA-CC-A123-01A-11D-A12Z-10 TCGA-CC-A123-01 3e205fbf-b9e5-470d-9c6f-68ff88640c45 TCGA-CC-A123-01A-11D-A12Z-10 3e205fbf-b9e5-470d-9c6f-68ff88640c45 3e205fbf-b9e5-470d-9c6f-68ff88640c45 TCGA-CC-A123-01A-11D-A12Z-10 TCGA-CC-A123-01A-11D-A132-05 +TCGA-CC-A1HT-01 TCGA-CC-A1HT-01 TCGA-CC-A1HT TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 50 TCGA-CC-A1HT-F20333 TCGA-CC-A1HT TCGA-CC-A1HT-01A -18553 86 101 0 0 4 Scheduled Follow-up Submission 2012-1-9 MALE 163 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 470 NO G3 NO true No M0 N0 T3 Stage IIIA TCGA-CC-A1HT.81F0F911-C2C1-48AD-A67F-FD455503CB46.pdf A1HT TUMOR FREE NO NO NO NO Primary Tumor 01 Other (specify) 6th YES NO CC Liver A Hepatitis C Antibody|Hepatitis B Surface Antigen DECEASED 54 2010 TCGA-CC-A1HT-01A-11D-A12Y-01 TCGA-CC-A1HT-01A-11D-A12Y-01 TCGA-CC-A1HT-01A-11D-A12Z-10 TCGA-CC-A1HT-01 TCGA-CC-A1HT-01 C7A6791C-7141-42F9-8AFA-5083CCE10124 63a48c81-2b6c-4f68-a76b-69ff2fc449ed TCGA-CC-A1HT-01A-11D-A12Z-10 TCGA-CC-A1HT-01 TCGA-CC-A1HT-01 63a48c81-2b6c-4f68-a76b-69ff2fc449ed TCGA-CC-A1HT-01A-11D-A12Z-10 63a48c81-2b6c-4f68-a76b-69ff2fc449ed 63a48c81-2b6c-4f68-a76b-69ff2fc449ed TCGA-CC-A1HT-01A-11D-A12Z-10 TCGA-CC-A1HT-01A-11D-A132-05 +TCGA-CC-A3M9-01 TCGA-CC-A3M9-01 TCGA-CC-A3M9 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO 45 TCGA-CC-A3M9-F70909 TCGA-CC-A3M9 TCGA-CC-A3M9-01A -16460 226 300 0 3 219 2 2015-3-10 MALE 174 Alcohol consumption Hepatocellular Carcinoma No C22.0 8173/3 C22.0 YES 200 NO NO G3 Locoregional Recurrence No NO YES No true No M0 N0 T3 Stage IIIA TCGA-CC-A3M9.9529CF47-D435-4CA9-B8B4-069CA2FCD3CD.pdf A3M9 WITH TUMOR NO NO NO NO R0 Primary Tumor 01 Lobectomy 7th YES NO CC Liver A Hepatitis C Antibody|Hepatitis B Surface Antigen DECEASED 61 2011 TCGA-CC-A3M9-01A-11D-A20V-01 TCGA-CC-A3M9-01A-11D-A20V-01 TCGA-CC-A3M9-01A-11D-A20W-10 TCGA-CC-A3M9-01 TCGA-CC-A3M9-01 4A85474C-9DD3-4576-BC28-53D26AB6E49B faec0e24-6bcd-4388-b227-b8d4b73bb110 TCGA-CC-A3M9-01A-11D-A20W-10 TCGA-CC-A3M9-01 TCGA-CC-A3M9-01 faec0e24-6bcd-4388-b227-b8d4b73bb110 TCGA-CC-A3M9-01A-11D-A20W-10 faec0e24-6bcd-4388-b227-b8d4b73bb110 faec0e24-6bcd-4388-b227-b8d4b73bb110 TCGA-CC-A3M9-01A-11D-A20W-10 TCGA-CC-A3M9-01A-11D-A20Z-05 +TCGA-CC-A3MA-01 TCGA-CC-A3MA-01 TCGA-CC-A3MA TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO 61 TCGA-CC-A3MA-F70907 TCGA-CC-A3MA TCGA-CC-A3MA-01A -22375 177 303 0 2 261 3 2015-3-10 MALE 168 Alcohol consumption Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 530 NO NO G2 Locoregional Recurrence No NO YES No true No M0 N0 T3 Stage IIIA TCGA-CC-A3MA.B631A61B-4550-47DE-9240-0FCFAEF47BC6.pdf A3MA WITH TUMOR NO NO NO NO R0 Primary Tumor 01 Lobectomy 7th YES NO CC Liver A Hepatitis C Antibody|Hepatitis B Surface Antigen DECEASED 66 2011 TCGA-CC-A3MA-01A-11D-A20V-01 TCGA-CC-A3MA-01A-11D-A20V-01 TCGA-CC-A3MA-01A-11D-A20W-10 TCGA-CC-A3MA-01 TCGA-CC-A3MA-01 9DC784BA-8DD4-4B84-9D5B-D0288C2312AE 86cde8fe-ca8b-47f6-b121-df5a05d3ec4c TCGA-CC-A3MA-01A-11D-A20W-10 TCGA-CC-A3MA-01 TCGA-CC-A3MA-01 86cde8fe-ca8b-47f6-b121-df5a05d3ec4c TCGA-CC-A3MA-01A-11D-A20W-10 86cde8fe-ca8b-47f6-b121-df5a05d3ec4c 86cde8fe-ca8b-47f6-b121-df5a05d3ec4c TCGA-CC-A3MA-01A-11D-A20W-10 TCGA-CC-A3MA-01A-11D-A20Z-05 +TCGA-CC-A3MB-01 TCGA-CC-A3MB-01 TCGA-CC-A3MB TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO 36 TCGA-CC-A3MB-F70908 TCGA-CC-A3MB TCGA-CC-A3MB-01A -13255 205 315 0 3 260 3 2015-3-10 MALE 176 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 460 NO NO G1 Lung New Primary Tumor No NO YES No true No M0 N0 T3 Stage IIIA TCGA-CC-A3MB.62A01956-C6F4-4FCB-AC43-052EEC8AE7AE.pdf A3MB WITH TUMOR NO NO NO NO R0 Primary Tumor 01 Lobectomy 7th YES NO CC Liver A Hepatitis C Antibody|Hepatitis B Surface Antigen DECEASED 58 2011 TCGA-CC-A3MB-01A-11D-A20V-01 TCGA-CC-A3MB-01A-11D-A20V-01 TCGA-CC-A3MB-01A-11D-A20W-10 TCGA-CC-A3MB-01 TCGA-CC-A3MB-01 7E1DF0FD-6902-42B5-B4CE-BC7D69F5CC3C 97a9402f-537a-4767-bee3-72e1bebcdd97 TCGA-CC-A3MB-01A-11D-A20W-10 TCGA-CC-A3MB-01 TCGA-CC-A3MB-01 97a9402f-537a-4767-bee3-72e1bebcdd97 TCGA-CC-A3MB-01A-11D-A20W-10 97a9402f-537a-4767-bee3-72e1bebcdd97 97a9402f-537a-4767-bee3-72e1bebcdd97 TCGA-CC-A3MB-01A-11D-A20W-10 TCGA-CC-A3MB-01A-11D-A20Z-05 +TCGA-CC-A3MC-01 TCGA-CC-A3MC-01 TCGA-CC-A3MC TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO 54 TCGA-CC-A3MC-F70912 TCGA-CC-A3MC TCGA-CC-A3MC-01A -20067 268 0 363 297 3 2015-3-10 MALE 163 Alcohol consumption Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 400 NO NO G2 Liver Locoregional Recurrence No NO YES No true No M0 N0 T3 Stage IIIA TCGA-CC-A3MC.3D0D4B1A-1340-488C-B231-F18CC1BC3783.pdf A3MC WITH TUMOR NO NO NO NO R0 Primary Tumor 01 Lobectomy 7th YES NO CC Liver A Hepatitis C Antibody|Hepatitis B Surface Antigen LIVING 52 2011 TCGA-CC-A3MC-01A-11D-A22E-01 TCGA-CC-A3MC-01A-11D-A22E-01 TCGA-CC-A3MC-01A-11D-A22F-10 TCGA-CC-A3MC-01 TCGA-CC-A3MC-01 F0DE71AB-1E83-49F4-9335-7601B45D2FE1 19377cf4-aafe-449a-b10b-f637b4eef29f TCGA-CC-A3MC-01A-11D-A22F-10 TCGA-CC-A3MC-01 TCGA-CC-A3MC-01 19377cf4-aafe-449a-b10b-f637b4eef29f TCGA-CC-A3MC-01A-11D-A22F-10 19377cf4-aafe-449a-b10b-f637b4eef29f 19377cf4-aafe-449a-b10b-f637b4eef29f TCGA-CC-A3MC-01A-11D-A22F-10 TCGA-CC-A3MC-01A-11D-A22H-05 +TCGA-CC-A5UC-01 TCGA-CC-A5UC-01 TCGA-CC-A5UC TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO 63 TCGA-CC-A5UC-F69917 TCGA-CC-A5UC TCGA-CC-A5UC-01A -23156 99 347 0 0 312 2 2015-1-22 MALE 165 Alcohol consumption Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 210 NO NO G3 Lung New Primary Tumor No NO YES No true No M0 N0 T3 Stage IIIA TCGA-CC-A5UC.21B4A68D-F76C-49BB-81D7-423E957852E1.pdf A5UC WITH TUMOR NO NO NO NO R0 Primary Tumor 01 Lobectomy 6th YES NO CC Liver A Hepatitis C Antibody|Hepatitis B Surface Antigen DECEASED 57 2012 TCGA-CC-A5UC-01A-11D-A28W-01 TCGA-CC-A5UC-01A-11D-A28W-01 TCGA-CC-A5UC-01A-11D-A28X-10 TCGA-CC-A5UC-01 TCGA-CC-A5UC-01 D2A8F8C2-65A2-4CF1-9635-CEB3AC787FFF 04ecdbec-f452-4bff-986c-23b414d92252 TCGA-CC-A5UC-01A-11D-A28X-10 TCGA-CC-A5UC-01 TCGA-CC-A5UC-01 04ecdbec-f452-4bff-986c-23b414d92252 TCGA-CC-A5UC-01A-11D-A28X-10 04ecdbec-f452-4bff-986c-23b414d92252 04ecdbec-f452-4bff-986c-23b414d92252 TCGA-CC-A5UC-01A-11D-A28X-10 TCGA-CC-A5UC-01A-11D-A28Y-05 +TCGA-CC-A5UD-01 TCGA-CC-A5UD-01 TCGA-CC-A5UD TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO 45 TCGA-CC-A5UD-F69700 TCGA-CC-A5UD TCGA-CC-A5UD-01A -16702 92 304 0 0 182 1 2015-1-16 MALE 170 Alcohol consumption Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 310 NO NO G2 Locoregional Recurrence No NO YES No true No M0 N0 T3 Stage IIIA TCGA-CC-A5UD.77BF208C-F5ED-4A05-BFDE-36063F43E022.pdf A5UD WITH TUMOR NO NO NO NO R0 Primary Tumor 01 Lobectomy 6th YES NO CC Liver A Hepatitis C Antibody|Hepatitis B Surface Antigen DECEASED 62 2012 TCGA-CC-A5UD-01A-11D-A28W-01 TCGA-CC-A5UD-01A-11D-A28W-01 TCGA-CC-A5UD-01A-11D-A28X-10 TCGA-CC-A5UD-01 TCGA-CC-A5UD-01 EDBB5D86-ACB6-4404-993E-CA4B015846B1 cdb1c4a5-5d21-4ab7-aeb3-e65dc5d739c6 TCGA-CC-A5UD-01A-11D-A28X-10 TCGA-CC-A5UD-01 TCGA-CC-A5UD-01 cdb1c4a5-5d21-4ab7-aeb3-e65dc5d739c6 TCGA-CC-A5UD-01A-11D-A28X-10 cdb1c4a5-5d21-4ab7-aeb3-e65dc5d739c6 cdb1c4a5-5d21-4ab7-aeb3-e65dc5d739c6 TCGA-CC-A5UD-01A-11D-A28X-10 TCGA-CC-A5UD-01A-11D-A28Y-05 +TCGA-CC-A5UE-01 TCGA-CC-A5UE-01 TCGA-CC-A5UE TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO 48 TCGA-CC-A5UE-F69701 TCGA-CC-A5UE TCGA-CC-A5UE-01A -17805 85 272 0 0 175 3 2015-1-16 MALE 175 Alcohol consumption Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 300 NO NO G2 Locoregional Recurrence No NO YES No true No M0 N0 T4 Stage IIIB TCGA-CC-A5UE.3D729315-DE44-441D-9CB2-3CFB827C2808.pdf A5UE WITH TUMOR NO NO NO NO R0 Primary Tumor 01 Lobectomy 6th YES NO CC Liver A Hepatitis C Antibody|Hepatitis B Surface Antigen DECEASED 65 2012 TCGA-CC-A5UE-01A-11D-A28W-01 TCGA-CC-A5UE-01A-11D-A28W-01 TCGA-CC-A5UE-01A-11D-A28X-10 TCGA-CC-A5UE-01 TCGA-CC-A5UE-01 04DD2C1C-27F8-4CF7-B2E0-28FAF54A3A83 dff668bd-b423-4ab8-961c-93c0bc093763 TCGA-CC-A5UE-01A-11D-A28X-10 TCGA-CC-A5UE-01 TCGA-CC-A5UE-01 dff668bd-b423-4ab8-961c-93c0bc093763 TCGA-CC-A5UE-01A-11D-A28X-10 dff668bd-b423-4ab8-961c-93c0bc093763 dff668bd-b423-4ab8-961c-93c0bc093763 TCGA-CC-A5UE-01A-11D-A28X-10 TCGA-CC-A5UE-01A-11D-A28Y-05 +TCGA-CC-A7IE-01 TCGA-CC-A7IE-01 TCGA-CC-A7IE TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO 57 TCGA-CC-A7IE-F69923 TCGA-CC-A7IE -20985 217 0 0 169 3 2015-1-22 MALE 172 Alcohol consumption Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES NO G2 Lung New Primary Tumor No NO YES No No M0 N0 T3 Stage IIIA A7IE WITH TUMOR NO NO NO NO R0 Primary Tumor 01 Lobectomy 6th YES NO CC Liver Hepatitis C Antibody|Hepatitis B Surface Antigen DECEASED 62 2012 TCGA-CC-A7IE-01A-21D-A381-01 TCGA-CC-A7IE-01A-21D-A381-01 TCGA-CC-A7IE-01A-21D-A382-10 TCGA-CC-A7IE-01 TCGA-CC-A7IE-01 b4e476f1-17f7-4af3-9076-8bcd783324a7 TCGA-CC-A7IE-01 TCGA-CC-A7IE-01 b4e476f1-17f7-4af3-9076-8bcd783324a7 b4e476f1-17f7-4af3-9076-8bcd783324a7 b4e476f1-17f7-4af3-9076-8bcd783324a7 TCGA-CC-A7IE-01A-21D-A383-05 +TCGA-CC-A7IF-01 TCGA-CC-A7IF-01 TCGA-CC-A7IF TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO 59 TCGA-CC-A7IF-F69922 TCGA-CC-A7IF TCGA-CC-A7IF-01A -21845 236 649 0 0 254 3 2015-1-22 MALE 169 Alcohol consumption Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 380 NO NO G1 Lung New Primary Tumor No NO YES No true No M0 N0 T3 Stage IIIA TCGA-CC-A7IF.4CD1A49C-2243-4F21-BF19-EB6F069D431E.pdf A7IF WITH TUMOR NO NO NO NO R0 Primary Tumor 01 Lobectomy 6th YES NO CC Liver A Hepatitis C Antibody|Hepatitis B Surface Antigen DECEASED 58 2013 TCGA-CC-A7IF-01A-11D-A33B-01 TCGA-CC-A7IF-01A-11D-A33B-01 TCGA-CC-A7IF-01A-11D-A33K-10 TCGA-CC-A7IF-01 TCGA-CC-A7IF-01 0CC0E36D-2924-43A0-BE95-40D8B37E6D94 cb8ca883-8695-48c3-9ab4-2f3a84e562ef TCGA-CC-A7IF-01A-11D-A33K-10 TCGA-CC-A7IF-01 TCGA-CC-A7IF-01 cb8ca883-8695-48c3-9ab4-2f3a84e562ef TCGA-CC-A7IF-01A-11D-A33K-10 cb8ca883-8695-48c3-9ab4-2f3a84e562ef cb8ca883-8695-48c3-9ab4-2f3a84e562ef TCGA-CC-A7IF-01A-11D-A33K-10 TCGA-CC-A7IF-01A-11D-A33L-05 +TCGA-CC-A7IG-01 TCGA-CC-A7IG-01 TCGA-CC-A7IG TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO 47 TCGA-CC-A7IG-F69702 TCGA-CC-A7IG TCGA-CC-A7IG-01A -17453 239 299 0 0 195 2 2015-1-16 MALE 174 Alcohol consumption Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 210 NO NO G2 Locoregional Recurrence No NO YES No true No M0 N0 T2 Stage II TCGA-CC-A7IG.FF015D7F-02CD-485E-83B6-8C533DE83B2A.pdf A7IG WITH TUMOR NO NO NO NO R0 Primary Tumor 01 Lobectomy 6th YES NO CC Liver A Hepatitis C Antibody|Hepatitis B Surface Antigen DECEASED 62 2013 TCGA-CC-A7IG-01A-11D-A33B-01 TCGA-CC-A7IG-01A-11D-A33B-01 TCGA-CC-A7IG-01A-11D-A33K-10 TCGA-CC-A7IG-01 TCGA-CC-A7IG-01 7567BCA8-9934-401C-A0C2-F835EB05C5B8 0caa8897-d988-4898-8c6a-c706598b9b94 TCGA-CC-A7IG-01A-11D-A33K-10 TCGA-CC-A7IG-01 TCGA-CC-A7IG-01 0caa8897-d988-4898-8c6a-c706598b9b94 TCGA-CC-A7IG-01A-11D-A33K-10 0caa8897-d988-4898-8c6a-c706598b9b94 0caa8897-d988-4898-8c6a-c706598b9b94 TCGA-CC-A7IG-01A-11D-A33K-10 TCGA-CC-A7IG-01A-11D-A33L-05 +TCGA-CC-A7IH-01 TCGA-CC-A7IH-01 TCGA-CC-A7IH TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 58 TCGA-CC-A7IH-F69920 TCGA-CC-A7IH TCGA-CC-A7IH-01A -21381 181 0 365 3 2015-1-22 MALE 175 Alcohol consumption Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 190 NO NO G1 NO true No M0 N0 T3 Stage IIIA TCGA-CC-A7IH.643C84D1-C247-4CA6-84C3-38ED99E886F6.pdf A7IH TUMOR FREE NO NO NO NO R0 Primary Tumor 01 Lobectomy 6th YES NO CC Liver A Hepatitis C Antibody|Hepatitis B Surface Antigen LIVING 56 2013 TCGA-CC-A7IH-01A-11D-A33B-01 TCGA-CC-A7IH-01A-11D-A33B-01 TCGA-CC-A7IH-01A-11D-A33K-10 TCGA-CC-A7IH-01 TCGA-CC-A7IH-01 0012F1FF-DA7A-46FD-895D-6AFE2F19CF89 8d017f32-1008-4312-b94e-a98be428973f TCGA-CC-A7IH-01A-11D-A33K-10 TCGA-CC-A7IH-01 TCGA-CC-A7IH-01 8d017f32-1008-4312-b94e-a98be428973f TCGA-CC-A7IH-01A-11D-A33K-10 8d017f32-1008-4312-b94e-a98be428973f 8d017f32-1008-4312-b94e-a98be428973f TCGA-CC-A7IH-01A-11D-A33K-10 TCGA-CC-A7IH-01A-11D-A33L-05 +TCGA-CC-A7II-01 TCGA-CC-A7II-01 TCGA-CC-A7II TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO 54 TCGA-CC-A7II-F69918 TCGA-CC-A7II TCGA-CC-A7II-01A -20079 169 0 399 278 2 2015-1-22 MALE 168 Alcohol consumption Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 400 NO NO G3 Locoregional Recurrence No NO YES No true No M0 N0 T3 Stage IIIA TCGA-CC-A7II.A5E3C73D-B84B-4D1C-858F-4B4392341610.pdf A7II WITH TUMOR NO NO NO NO R0 Primary Tumor 01 Lobectomy 6th YES NO CC Liver A Hepatitis C Antibody|Hepatitis B Surface Antigen LIVING 52 2013 TCGA-CC-A7II-01A-11D-A33B-01 TCGA-CC-A7II-01A-11D-A33B-01 TCGA-CC-A7II-01A-11D-A33K-10 TCGA-CC-A7II-01 TCGA-CC-A7II-01 7BBE03C6-0221-4D78-829D-75FE8E98D5C0 097f54ce-6270-4e1f-bd7a-f55ed185bead TCGA-CC-A7II-01A-11D-A33K-10 TCGA-CC-A7II-01 TCGA-CC-A7II-01 097f54ce-6270-4e1f-bd7a-f55ed185bead TCGA-CC-A7II-01A-11D-A33K-10 097f54ce-6270-4e1f-bd7a-f55ed185bead 097f54ce-6270-4e1f-bd7a-f55ed185bead TCGA-CC-A7II-01A-11D-A33K-10 TCGA-CC-A7II-01A-11D-A33L-05 +TCGA-CC-A7IJ-01 TCGA-CC-A7IJ-01 TCGA-CC-A7IJ TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 56 TCGA-CC-A7IJ-F69704 TCGA-CC-A7IJ TCGA-CC-A7IJ-01A -20751 168 0 382 2 2015-1-16 MALE 165 Alcohol consumption Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 270 NO NO G3 NO true No M0 N0 T2 Stage II TCGA-CC-A7IJ.0FF7D013-EAEC-4406-B314-0ECEA7B59E69.pdf A7IJ TUMOR FREE NO NO NO NO R0 Primary Tumor 01 Lobectomy 6th YES NO CC Liver A Hepatitis C Antibody|Hepatitis B Surface Antigen LIVING 54 2013 TCGA-CC-A7IJ-01A-11D-A33P-01 TCGA-CC-A7IJ-01A-11D-A33P-01 TCGA-CC-A7IJ-01A-11D-A33Q-10 TCGA-CC-A7IJ-01 TCGA-CC-A7IJ-01 3C457C98-F4B2-4C93-8127-0CCC18DC0600 96863e50-5c9b-4bee-8870-8c938aa66633 TCGA-CC-A7IJ-01A-11D-A33Q-10 TCGA-CC-A7IJ-01 TCGA-CC-A7IJ-01 96863e50-5c9b-4bee-8870-8c938aa66633 TCGA-CC-A7IJ-01A-11D-A33Q-10 96863e50-5c9b-4bee-8870-8c938aa66633 96863e50-5c9b-4bee-8870-8c938aa66633 TCGA-CC-A7IJ-01A-11D-A33Q-10 TCGA-CC-A7IJ-01A-11D-A341-05 +TCGA-CC-A7IK-01 TCGA-CC-A7IK-01 TCGA-CC-A7IK TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO 59 TCGA-CC-A7IK-F69705 TCGA-CC-A7IK TCGA-CC-A7IK-01A -21552 163 262 0 0 150 2 2015-1-16 MALE 168 Alcohol consumption Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 470 NO NO G3 Locoregional Recurrence No NO YES No true No M0 N0 T3 Stage IIIA TCGA-CC-A7IK.6944ABF0-8C64-48D5-920A-6FA6DAC8A57B.pdf A7IK WITH TUMOR NO NO NO NO R0 Primary Tumor 01 Lobectomy 6th YES NO CC Liver A Hepatitis C Antibody|Hepatitis B Surface Antigen DECEASED 57 2013 TCGA-CC-A7IK-01A-12D-A33P-01 TCGA-CC-A7IK-01A-12D-A33P-01 TCGA-CC-A7IK-01A-12D-A33Q-10 TCGA-CC-A7IK-01 TCGA-CC-A7IK-01 E37E4FA6-4FFA-439E-9AC5-973B0B09546E acaa569c-eed9-471d-8eb2-4723eb07c00b TCGA-CC-A7IK-01A-12D-A33Q-10 TCGA-CC-A7IK-01 TCGA-CC-A7IK-01 acaa569c-eed9-471d-8eb2-4723eb07c00b TCGA-CC-A7IK-01A-12D-A33Q-10 acaa569c-eed9-471d-8eb2-4723eb07c00b acaa569c-eed9-471d-8eb2-4723eb07c00b TCGA-CC-A7IK-01A-12D-A33Q-10 TCGA-CC-A7IK-01A-12D-A341-05 +TCGA-CC-A7IL-01 TCGA-CC-A7IL-01 TCGA-CC-A7IL TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO 61 TCGA-CC-A7IL-F69706 TCGA-CC-A7IL TCGA-CC-A7IL-01A -22319 161 278 0 0 179 2 2015-1-16 MALE 174 Alcohol consumption Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 230 NO NO G1 Locoregional Recurrence No NO YES No true No M0 N0 T3 Stage IIIA TCGA-CC-A7IL.2C629C1E-6849-47F6-B9B4-A97BC0453EFF.pdf A7IL WITH TUMOR NO NO NO NO R0 Primary Tumor 01 Lobectomy 6th YES NO CC Liver A Hepatitis C Antibody|Hepatitis B Surface Antigen DECEASED 63 2013 TCGA-CC-A7IL-01A-11D-A33P-01 TCGA-CC-A7IL-01A-11D-A33P-01 TCGA-CC-A7IL-01A-11D-A33Q-10 TCGA-CC-A7IL-01 TCGA-CC-A7IL-01 89E30AE9-EC3D-41A9-B00C-AAC64C23348D e198c43b-5d3f-4fe6-8f3c-09642a2b4995 TCGA-CC-A7IL-01A-11D-A33Q-10 TCGA-CC-A7IL-01 TCGA-CC-A7IL-01 e198c43b-5d3f-4fe6-8f3c-09642a2b4995 TCGA-CC-A7IL-01A-11D-A33Q-10 e198c43b-5d3f-4fe6-8f3c-09642a2b4995 e198c43b-5d3f-4fe6-8f3c-09642a2b4995 TCGA-CC-A7IL-01A-11D-A33Q-10 TCGA-CC-A7IL-01A-11D-A341-05 +TCGA-CC-A8HS-01 TCGA-CC-A8HS-01 TCGA-CC-A8HS TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO 18 TCGA-CC-A8HS-F69707 TCGA-CC-A8HS TCGA-CC-A8HS-01A -6617 223 300 0 0 201 3 2015-1-16 MALE 172 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 240 NO NO G1 Locoregional Recurrence No NO YES No true No M0 N1 T3 Stage IIIC TCGA-CC-A8HS.D7967904-FE4B-4BB5-92B2-5354404AC939.pdf A8HS WITH TUMOR NO NO NO NO R0 Primary Tumor 01 Lobectomy 6th YES NO CC Liver A Hepatitis C Antibody|Hepatitis B Surface Antigen DECEASED 62 2013 TCGA-CC-A8HS-01A-11D-A35Z-10 TCGA-CC-A8HS-01 TCGA-CC-A8HS-01 5FDE4663-91E1-4017-ABF8-9B5A895A772D c8c2f5d3-a744-4bff-acdb-ada38d8dd074 TCGA-CC-A8HS-01 c8c2f5d3-a744-4bff-acdb-ada38d8dd074 c8c2f5d3-a744-4bff-acdb-ada38d8dd074 c8c2f5d3-a744-4bff-acdb-ada38d8dd074 TCGA-CC-A8HS-01A-11D-A369-05 +TCGA-CC-A8HT-01 TCGA-CC-A8HT-01 TCGA-CC-A8HT TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO 74 TCGA-CC-A8HT-F69842 TCGA-CC-A8HT TCGA-CC-A8HT-01A -27334 197 140 0 0 83 4 2015-1-21 MALE 159 Alcohol consumption Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 170 NO NO G2 Locoregional Recurrence No NO YES No true No M0 N0 T3 Stage IIIA TCGA-CC-A8HT.0D2B4676-F045-4259-A18C-47EA5DF8E7A2.pdf A8HT WITH TUMOR NO NO NO NO R0 Primary Tumor 01 Lobectomy 6th YES NO CC Liver A Hepatitis C Antibody|Hepatitis B Surface Antigen DECEASED 48 2013 TCGA-CC-A8HT-01A-11D-A35Y-01 TCGA-CC-A8HT-01A-11D-A35Y-01 TCGA-CC-A8HT-01A-11D-A35Z-10 TCGA-CC-A8HT-01 TCGA-CC-A8HT-01 F16A4EEA-9AE9-4C17-AE6E-4FEA4F3A6611 33b64021-96cf-4916-92db-948b9a767d1b TCGA-CC-A8HT-01 TCGA-CC-A8HT-01 33b64021-96cf-4916-92db-948b9a767d1b 33b64021-96cf-4916-92db-948b9a767d1b 33b64021-96cf-4916-92db-948b9a767d1b TCGA-CC-A8HT-01A-11D-A369-05 +TCGA-CC-A8HU-01 TCGA-CC-A8HU-01 TCGA-CC-A8HU TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO 39 TCGA-CC-A8HU-F69708 TCGA-CC-A8HU TCGA-CC-A8HU-01A -14367 141 344 0 0 301 3 2015-1-16 FEMALE 163 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 360 NO NO G3 Locoregional Recurrence No NO YES No true No M0 N0 T3 Stage IIIA TCGA-CC-A8HU.CBCE823C-E6F5-4718-97F0-2705BE3C855A.pdf A8HU WITH TUMOR NO NO NO NO R0 Primary Tumor 01 Lobectomy 6th YES NO CC Liver A Hepatitis C Antibody|Hepatitis B Surface Antigen DECEASED 42 2013 TCGA-CC-A8HU-01A-11D-A35Y-01 TCGA-CC-A8HU-01A-11D-A35Y-01 TCGA-CC-A8HU-01A-11D-A35Z-10 TCGA-CC-A8HU-01 TCGA-CC-A8HU-01 55506EEF-798F-408E-96D6-E687AB8C340B 81b1e9c2-4184-42bd-86ac-a8452d7ca9ec TCGA-CC-A8HU-01 TCGA-CC-A8HU-01 81b1e9c2-4184-42bd-86ac-a8452d7ca9ec 81b1e9c2-4184-42bd-86ac-a8452d7ca9ec 81b1e9c2-4184-42bd-86ac-a8452d7ca9ec TCGA-CC-A8HU-01A-11D-A369-05 +TCGA-CC-A8HV-01 TCGA-CC-A8HV-01 TCGA-CC-A8HV TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver YES NO 51 TCGA-CC-A8HV-F69784 TCGA-CC-A8HV TCGA-CC-A8HV-01A -18935 140 279 0 0 149 2 2015-1-19 FEMALE 159 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 230 NO NO G2 Locoregional Recurrence No NO YES No true No M0 N0 T2 Stage II TCGA-CC-A8HV.8C178CD4-7D29-4584-B41B-BAE67890DBEB.pdf A8HV WITH TUMOR NO NO NO NO R0 Primary Tumor 01 Lobectomy 6th YES NO CC Liver A Hepatitis C Antibody|Hepatitis B Surface Antigen DECEASED 51 2013 TCGA-CC-A8HV-01A-11D-A40C-01 TCGA-CC-A8HV-01A-11D-A40C-01 TCGA-CC-A8HV-01A-11D-A35Z-10 TCGA-CC-A8HV-01 TCGA-CC-A8HV-01 B4CB08BD-E5B7-4266-B8DC-AF5DBA49E929 2eabe1cd-7b0a-4a9f-a26b-c43dd0f61e44 TCGA-CC-A8HV-01 TCGA-CC-A8HV-01 2eabe1cd-7b0a-4a9f-a26b-c43dd0f61e44 2eabe1cd-7b0a-4a9f-a26b-c43dd0f61e44 2eabe1cd-7b0a-4a9f-a26b-c43dd0f61e44 TCGA-CC-A8HV-01A-11D-A369-05 +TCGA-CC-A9FS-01 TCGA-CC-A9FS-01 TCGA-CC-A9FS TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO 55 TCGA-CC-A9FS-F69914 TCGA-CC-A9FS -20157 0 211 109 2 2015-1-22 MALE 174 Alcohol consumption Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES NO G2 Lung New Primary Tumor No NO YES No No M0 N0 T2 Stage II A9FS WITH TUMOR NO NO NO NO R0 Primary Tumor 01 Lobectomy 6th YES NO CC Liver Hepatitis C Antibody|Hepatitis B Surface Antigen LIVING 72 2013 TCGA-CC-A9FS-01A-11D-A36W-01 TCGA-CC-A9FS-01A-11D-A36W-01 TCGA-CC-A9FS-01A-11D-A36X-10 TCGA-CC-A9FS-01 TCGA-CC-A9FS-01 cebcb67f-7a10-479f-a49a-b60030e0cc11 TCGA-CC-A9FS-01 TCGA-CC-A9FS-01 cebcb67f-7a10-479f-a49a-b60030e0cc11 cebcb67f-7a10-479f-a49a-b60030e0cc11 cebcb67f-7a10-479f-a49a-b60030e0cc11 TCGA-CC-A9FS-01A-11D-A36Y-05 +TCGA-CC-A9FU-01 TCGA-CC-A9FU-01 TCGA-CC-A9FU TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 52 TCGA-CC-A9FU TCGA-CC-A9FU-01A -19326 205 0 0 2014-8-22 FEMALE 153 Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 220 NO G2 NO true No M0 N0 T3a Stage IIIA TCGA-CC-A9FU.95F22F75-89A6-4B67-BDF2-A357825453EF.pdf A9FU TUMOR FREE NO R0 Primary Tumor 01 Lobectomy 7th YES NO CC Liver A Hepatitis C Antibody|Hepatitis B Surface Antigen LIVING 48 2013 TCGA-CC-A9FU-01A-11D-A36W-01 TCGA-CC-A9FU-01A-11D-A36W-01 TCGA-CC-A9FU-01A-11D-A36X-10 TCGA-CC-A9FU-01 TCGA-CC-A9FU-01 654a532f-71be-4ce2-9102-e73dde083ab1 TCGA-CC-A9FU-01 TCGA-CC-A9FU-01 654a532f-71be-4ce2-9102-e73dde083ab1 654a532f-71be-4ce2-9102-e73dde083ab1 654a532f-71be-4ce2-9102-e73dde083ab1 TCGA-CC-A9FU-01A-11D-A36Y-05 +TCGA-CC-A9FV-01 TCGA-CC-A9FV-01 TCGA-CC-A9FV TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 57 TCGA-CC-A9FV TCGA-CC-A9FV-01A -21044 184 0 0 2014-8-22 MALE 165 Alcohol consumption Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 420 NO G2 NO true No M0 N0 T3 Stage IIIA TCGA-CC-A9FV.01A31339-0FAD-4D49-ACD1-E357D32C887B.pdf A9FV TUMOR FREE NO R0 Primary Tumor 01 Lobectomy 6th YES NO CC Liver A Hepatitis C Antibody|Hepatitis B Surface Antigen LIVING 59 2013 TCGA-CC-A9FV-01A-11D-A36W-01 TCGA-CC-A9FV-01A-11D-A36W-01 TCGA-CC-A9FV-01A-11D-A36X-10 TCGA-CC-A9FV-01 TCGA-CC-A9FV-01 6fdf4f1c-5fac-46b4-bb5c-c23dae9bf215 TCGA-CC-A9FV-01 TCGA-CC-A9FV-01 6fdf4f1c-5fac-46b4-bb5c-c23dae9bf215 6fdf4f1c-5fac-46b4-bb5c-c23dae9bf215 6fdf4f1c-5fac-46b4-bb5c-c23dae9bf215 TCGA-CC-A9FV-01A-11D-A36Y-05 +TCGA-CC-A9FW-01 TCGA-CC-A9FW-01 TCGA-CC-A9FW TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO 68 TCGA-CC-A9FW-F69912 TCGA-CC-A9FW -24891 0 248 153 3 2015-1-22 MALE 175 Alcohol consumption Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES NO G2 Locoregional Recurrence No NO YES No No M0 N0 T3 Stage IIIA A9FW WITH TUMOR NO NO NO NO R0 Primary Tumor 01 Lobectomy 6th YES NO CC Liver Hepatitis C Antibody|Hepatitis B Surface Antigen LIVING 67 2013 TCGA-CC-A9FW-01A-11D-A36W-01 TCGA-CC-A9FW-01A-11D-A36W-01 TCGA-CC-A9FW-01A-11D-A36X-10 TCGA-CC-A9FW-01 TCGA-CC-A9FW-01 c05ba7f7-a80f-4cea-ac20-5935edc5c4d1 TCGA-CC-A9FW-01 TCGA-CC-A9FW-01 c05ba7f7-a80f-4cea-ac20-5935edc5c4d1 c05ba7f7-a80f-4cea-ac20-5935edc5c4d1 c05ba7f7-a80f-4cea-ac20-5935edc5c4d1 TCGA-CC-A9FW-01A-11D-A36Y-05 +TCGA-DD-A113-01 TCGA-DD-A113-01 TCGA-DD-A113 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO None 55 3.5 4.3 5.0 TCGA-DD-A113-F38777 TCGA-DD-A113 TCGA-DD-A113-01A 0.1 0.5 A 0.7 1.2 0.8 -20188 1650 0 2425 1678 1676 1 0 6 133 0 - No Fibrosis 2012-12-21 FEMALE 154 Other Smoking Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 110 0.9 1.2 NO NO G3 Liver Intrahepatic Recurrence Yes YES YES No false No M0 N0 T2 Stage II TCGA-DD-A113.F0D7BCB4-D3C3-491A-BDE2-8E77E77F1655.pdf A113 WITH TUMOR 365 150 450 NO NO 0.9 NO R0 R0 Primary Tumor 01 Segmentectomy, Multiple 6th NO YES DD 1.0 Liver Micro A Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody LIVING 56 2006 TCGA-DD-A113-01A-11D-A12Y-01 TCGA-DD-A113-01A-11D-A12Y-01 TCGA-DD-A113-01A-11D-A12Z-10 TCGA-DD-A113-01 TCGA-DD-A113-01 32faf34e-96a7-4668-9edb-a9addeceda95 TCGA-DD-A113-01A-11D-A12Z-10 TCGA-DD-A113-01 TCGA-DD-A113-01 32faf34e-96a7-4668-9edb-a9addeceda95 TCGA-DD-A113-01A-11D-A12Z-10 32faf34e-96a7-4668-9edb-a9addeceda95 32faf34e-96a7-4668-9edb-a9addeceda95 TCGA-DD-A113-01A-11D-A12Z-10 TCGA-DD-A113-01A-11D-A132-05 +TCGA-DD-A113-11 TCGA-DD-A113-11 TCGA-DD-A113 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO None 55 3.5 4.3 5.0 TCGA-DD-A113-F38777 TCGA-DD-A113 0.1 0.5 A 0.7 1.2 0.8 -20188 0 2425 1678 1676 1 0 6 133 0 - No Fibrosis 2012-12-21 FEMALE 154 Other Smoking Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 0.9 1.2 NO G3 Liver Intrahepatic Recurrence Yes YES YES No No M0 N0 T2 Stage II A113 WITH TUMOR 365 150 450 NO NO 0.9 NO R0 R0 Solid Tissue Normal 11 Segmentectomy, Multiple 6th NO YES DD 1.0 Liver Micro Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody LIVING 56 2006 TCGA-DD-A113-11 c6842e1d-4f63-458c-9287-0326c03a69c9 TCGA-DD-A113-11 c6842e1d-4f63-458c-9287-0326c03a69c9 c6842e1d-4f63-458c-9287-0326c03a69c9 c6842e1d-4f63-458c-9287-0326c03a69c9 TCGA-DD-A113-11A-12D-A132-05 +TCGA-DD-A114-01 TCGA-DD-A114-01 TCGA-DD-A114 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver Mild 42 3.5 3.5 5.0 TCGA-DD-A114-F38779 TCGA-DD-A114 TCGA-DD-A114-01A 0.1 2.5 A 0.9 1.4 1.2 -15410 2063 1149 0 1 0 6 21 5 - Nodular Formation and Incomplete Cirrhosis 2012-12-21 MALE 173 Hepatitis C Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 250 0.9 1.2 NO NO G3 NO false No M0 T2 Stage II TCGA-DD-A114.BACAFF9B-FAC1-49A8-8C56-A0A26794AA1E.pdf A114 TUMOR FREE 185 150 450 NO NO 1.0 NO NO R0 Primary Tumor 01 Lobectomy 6th NO YES DD 1.0 Liver Micro A Hepatitis C Virus R|HCV Genotype|Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody DECEASED 74 2005 TCGA-DD-A114-01A-11D-A12Y-01 TCGA-DD-A114-01A-11D-A12Y-01 TCGA-DD-A114-01A-11D-A12Z-10 TCGA-DD-A114-01 TCGA-DD-A114-01 63446327-F5E2-4CEA-909A-0E67787B85F0 6cff6851-4d3c-479d-a83a-e579953f6b18 TCGA-DD-A114-01A-11D-A12Z-10 TCGA-DD-A114-01 TCGA-DD-A114-01 6cff6851-4d3c-479d-a83a-e579953f6b18 TCGA-DD-A114-01A-11D-A12Z-10 6cff6851-4d3c-479d-a83a-e579953f6b18 6cff6851-4d3c-479d-a83a-e579953f6b18 TCGA-DD-A114-01A-11D-A12Z-10 TCGA-DD-A114-01A-11D-A132-05 +TCGA-DD-A114-11 TCGA-DD-A114-11 TCGA-DD-A114 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver Mild 42 3.5 3.5 5.0 TCGA-DD-A114-F38779 TCGA-DD-A114 0.1 2.5 A 0.9 1.4 1.2 -15410 1149 0 1 0 6 21 5 - Nodular Formation and Incomplete Cirrhosis 2012-12-21 MALE 173 Hepatitis C Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 0.9 1.2 NO G3 NO No M0 T2 Stage II A114 TUMOR FREE 185 150 450 NO NO 1.0 NO NO R0 Solid Tissue Normal 11 Lobectomy 6th NO YES DD 1.0 Liver Micro Hepatitis C Virus R|HCV Genotype|Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody DECEASED 74 2005 TCGA-DD-A114-11 fbeec4cf-0ad3-4e9e-bfc1-d112b1e51b3a TCGA-DD-A114-11 fbeec4cf-0ad3-4e9e-bfc1-d112b1e51b3a fbeec4cf-0ad3-4e9e-bfc1-d112b1e51b3a fbeec4cf-0ad3-4e9e-bfc1-d112b1e51b3a TCGA-DD-A114-11A-12D-A132-05 +TCGA-DD-A115-01 TCGA-DD-A115-01 TCGA-DD-A115 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver YES NO None 53 3.5 4.1 5.0 TCGA-DD-A115-F38780 TCGA-DD-A115 TCGA-DD-A115-01A 0.1 0.6 A 0.1 1.2 1.1 -19697 3198 2542 0 469 0 0 6 10 0 - No Fibrosis 2012-12-21 MALE 168 Alcohol consumption Smoking Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 230 NO NO G2 Liver Intrahepatic Recurrence Yes NO YES No false No M0 N0 T3 Stage IIIA TCGA-DD-A115.C0EAB9A6-AAA3-48D5-AE3F-A428D828D63C.pdf A115 WITH TUMOR 337 150 450 NO NO 1.0 NO NO R0 Primary Tumor 01 Extended Lobectomy 5th NO YES DD 1.0 Liver None A Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody DECEASED 79 2002 TCGA-DD-A115-01A-11D-A12Y-01 TCGA-DD-A115-01A-11D-A12Y-01 TCGA-DD-A115-01A-11D-A12Z-10 TCGA-DD-A115-01 TCGA-DD-A115-01 BD79C5A6-BBA6-424B-BFB8-9F4D495E31F4 bb55462c-2475-4a92-98e4-9119b26c0c82 TCGA-DD-A115-01A-11D-A12Z-10 TCGA-DD-A115-01 TCGA-DD-A115-01 bb55462c-2475-4a92-98e4-9119b26c0c82 TCGA-DD-A115-01A-11D-A12Z-10 bb55462c-2475-4a92-98e4-9119b26c0c82 bb55462c-2475-4a92-98e4-9119b26c0c82 TCGA-DD-A115-01A-11D-A12Z-10 TCGA-DD-A115-01A-11D-A132-05 +TCGA-DD-A115-11 TCGA-DD-A115-11 TCGA-DD-A115 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver YES NO None 53 3.5 4.1 5.0 TCGA-DD-A115-F38780 TCGA-DD-A115 TCGA-DD-A115-11A 0.1 0.6 A 0.1 1.2 1.1 -19697 3198 2542 0 469 0 0 6 10 0 - No Fibrosis 2012-12-21 MALE 168 Alcohol consumption Smoking Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 170 NO NO G2 Liver Intrahepatic Recurrence Yes NO YES No false No M0 N0 T3 Stage IIIA A115 WITH TUMOR 337 150 450 NO NO 1.0 NO NO R0 Solid Tissue Normal 11 Extended Lobectomy 5th NO YES DD 1.0 Liver None A Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody DECEASED 79 2002 TCGA-DD-A115-11A-12D-A132-05 +TCGA-DD-A116-01 TCGA-DD-A116-01 TCGA-DD-A116 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO YES 68 3.5 4.1 5.0 TCGA-DD-A116-F38781 TCGA-DD-A116 TCGA-DD-A116-01A 0.1 1.1 0 A 0.8 1.4 1.1 -24934 3208 1622 0 1023 828 1 0 6 24 3,4 - Fibrous Speta 2012-12-21 MALE 175 Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 170 NO NO G3 Other, specify Extrahepatic Recurrence sternum No YES YES No false No M0 N0 T3 Stage IIIA TCGA-DD-A116.0914680E-B846-4370-920D-FEB06F609EE5.pdf A116 TUMOR FREE 157 150 450 NO NO 1.0 YES NO R0 R0 Primary Tumor 01 Segmentectomy, Multiple 5th NO YES DD 1.0 Liver A Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody DECEASED 73 2002 TCGA-DD-A116-01A-11D-A12Y-01 TCGA-DD-A116-01A-11D-A12Y-01 TCGA-DD-A116-01A-11D-A12Z-10 TCGA-DD-A116-01 TCGA-DD-A116-01 A1871661-C3B8-42AA-B48F-765AD96F0ADB 6dcfd83a-74cb-447c-ab0d-40894fa9d359 TCGA-DD-A116-01A-11D-A12Z-10 TCGA-DD-A116-01 TCGA-DD-A116-01 6dcfd83a-74cb-447c-ab0d-40894fa9d359 TCGA-DD-A116-01A-11D-A12Z-10 6dcfd83a-74cb-447c-ab0d-40894fa9d359 6dcfd83a-74cb-447c-ab0d-40894fa9d359 TCGA-DD-A116-01A-11D-A12Z-10 TCGA-DD-A116-01A-11D-A132-05 +TCGA-DD-A116-11 TCGA-DD-A116-11 TCGA-DD-A116 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO YES 68 3.5 4.1 5.0 TCGA-DD-A116-F38781 TCGA-DD-A116 TCGA-DD-A116-11A 0.1 1.1 0 A 0.8 1.4 1.1 -24934 3208 1622 0 1023 828 1 0 6 24 3,4 - Fibrous Speta 2012-12-21 MALE 175 Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 170 NO NO G3 Other, specify Extrahepatic Recurrence sternum No YES YES No false No M0 N0 T3 Stage IIIA A116 TUMOR FREE 157 150 450 NO NO 1.0 YES NO R0 R0 Solid Tissue Normal 11 Segmentectomy, Multiple 5th NO YES DD 1.0 Liver A Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody DECEASED 73 2002 f099f7fb-f07a-4529-83dc-e7023c52a999 f099f7fb-f07a-4529-83dc-e7023c52a999 f099f7fb-f07a-4529-83dc-e7023c52a999 f099f7fb-f07a-4529-83dc-e7023c52a999 TCGA-DD-A116-11A-11D-A132-05 +TCGA-DD-A118-01 TCGA-DD-A118-01 TCGA-DD-A118 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO None 77 3.4 3.4 4.8 TCGA-DD-A118-F38782 TCGA-DD-A118 TCGA-DD-A118-01A 0.1 0.5 A 0.7 1.2 0.9 -28406 2854 0 3437 659 658 1 0 6 85150 0 - No Fibrosis 2012-12-21 FEMALE 169 Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 30 NO NO G2 Other, specify Extrahepatic Recurrence lateral to the C-loop of the duodenum, anterior to the right kidney No YES YES No false No M0 N0 T2 Stage II TCGA-DD-A118.74D4EB64-F12B-470D-8A7C-EDD24CD1448D.pdf A118 381 150 450 NO NO 1.0 NO NO R0 R0 Primary Tumor 01 Lobectomy 6th NO YES DD 1.0 Liver None A Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody LIVING 75 2003 TCGA-DD-A118-01A-11D-A12Y-01 TCGA-DD-A118-01A-11D-A12Y-01 TCGA-DD-A118-01A-11D-A12Z-10 TCGA-DD-A118-01 TCGA-DD-A118-01 443B7BF5-9A6A-43F6-BCD9-DDF6498FEF31 20d6834b-5766-4f4a-b30d-8c14195ec7ed TCGA-DD-A118-01A-11D-A12Z-10 TCGA-DD-A118-01 TCGA-DD-A118-01 20d6834b-5766-4f4a-b30d-8c14195ec7ed TCGA-DD-A118-01A-11D-A12Z-10 20d6834b-5766-4f4a-b30d-8c14195ec7ed 20d6834b-5766-4f4a-b30d-8c14195ec7ed TCGA-DD-A118-01A-11D-A12Z-10 TCGA-DD-A118-01A-11D-A132-05 +TCGA-DD-A118-11 TCGA-DD-A118-11 TCGA-DD-A118 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO None 77 3.4 3.4 4.8 TCGA-DD-A118-F38782 TCGA-DD-A118 TCGA-DD-A118-11A 0.1 0.5 A 0.7 1.2 0.9 -28406 2854 0 3437 659 658 1 0 6 85150 0 - No Fibrosis 2012-12-21 FEMALE 169 Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 60 NO NO G2 Other, specify Extrahepatic Recurrence lateral to the C-loop of the duodenum, anterior to the right kidney No YES YES No false No M0 N0 T2 Stage II A118 381 150 450 NO NO 1.0 NO NO R0 R0 Solid Tissue Normal 11 Lobectomy 6th NO YES DD 1.0 Liver None A Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody LIVING 75 2003 TCGA-DD-A118-11 485b184d-15f1-4858-9e06-330d5258cfff TCGA-DD-A118-11 485b184d-15f1-4858-9e06-330d5258cfff 485b184d-15f1-4858-9e06-330d5258cfff 485b184d-15f1-4858-9e06-330d5258cfff TCGA-DD-A118-11A-11D-A132-05 +TCGA-DD-A119-01 TCGA-DD-A119-01 TCGA-DD-A119 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver None 40 3.5 3.9 5.0 TCGA-DD-A119-F38783 TCGA-DD-A119 TCGA-DD-A119-01A 0.1 1.6 2 A 0.9 1.4 1.3 -14613 2738 223 0 1 0 6 1836 0 - No Fibrosis 2012-12-21 MALE 160 Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 160 NO NO G3 false No M1 N0 T3a Stage IV TCGA-DD-A119.F8B8C948-933A-4B28-A0D1-98166C9B16EF.pdf A119 572 150 450 1.0 YES R2 Primary Tumor 01 Extended Lobectomy 6th NO YES DD 1.0 Liver Micro A Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody DECEASED 58 2003 TCGA-DD-A119-01A-11D-A12Y-01 TCGA-DD-A119-01A-11D-A12Y-01 TCGA-DD-A119-01A-11D-A12Z-10 TCGA-DD-A119-01 TCGA-DD-A119-01 7E545BB7-0EB0-4AC5-AC91-9B50DFA1A13B 3d0d0f6b-4caa-4c53-b971-17466f076e95 TCGA-DD-A119-01A-11D-A12Z-10 TCGA-DD-A119-01 TCGA-DD-A119-01 3d0d0f6b-4caa-4c53-b971-17466f076e95 TCGA-DD-A119-01A-11D-A12Z-10 3d0d0f6b-4caa-4c53-b971-17466f076e95 3d0d0f6b-4caa-4c53-b971-17466f076e95 TCGA-DD-A119-01A-11D-A12Z-10 TCGA-DD-A119-01A-11D-A132-05 +TCGA-DD-A119-11 TCGA-DD-A119-11 TCGA-DD-A119 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver None 40 3.5 3.9 5.0 TCGA-DD-A119-F38783 TCGA-DD-A119 0.1 1.6 2 A 0.9 1.4 1.3 -14613 223 0 1 0 6 1836 0 - No Fibrosis 2012-12-21 MALE 160 Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES NO G3 No M1 N0 T3a Stage IV A119 572 150 450 1.0 YES R2 Solid Tissue Normal 11 Extended Lobectomy 6th NO YES DD 1.0 Liver Micro Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody DECEASED 58 2003 TCGA-DD-A119-11 d5e600a3-d273-4879-ac33-1a72a02073e5 TCGA-DD-A119-11 d5e600a3-d273-4879-ac33-1a72a02073e5 d5e600a3-d273-4879-ac33-1a72a02073e5 d5e600a3-d273-4879-ac33-1a72a02073e5 TCGA-DD-A119-11A-11D-A132-05 +TCGA-DD-A11A-01 TCGA-DD-A11A-01 TCGA-DD-A11A TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver None 67 TCGA-DD-A11A-F38784 TCGA-DD-A11A TCGA-DD-A11A-01A 0.1 3.6 0.9 1.4 1.1 -24646 2184 0 79 0 0 6 223 0 - No Fibrosis 2012-12-21 MALE 156 Other HBcAB total (+), HBsAg (-), HBcIgm Ab (-) Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 260 NO YES G3 false No M0 N0 T1 Stage I TCGA-DD-A11A.E1571DB1-B1B2-4B0E-9A0A-01A4470353DF.pdf A11A 513 150 450 1.0 NO R0 Primary Tumor 01 Lobectomy 6th NO YES DD 1.0 Liver None A Hepatitis B Surface Antigen|HBV Core Antibody LIVING 67 2004 TCGA-DD-A11A-01A-11D-A12Y-01 TCGA-DD-A11A-01A-11D-A12Y-01 TCGA-DD-A11A-01A-11D-A12Z-10 TCGA-DD-A11A-01 TCGA-DD-A11A-01 789AC9AF-D425-4708-98CF-E6656BE1CCCB 2e96d65b-0247-40fc-a0e3-90fcb6feac3d TCGA-DD-A11A-01A-11D-A12Z-10 TCGA-DD-A11A-01 TCGA-DD-A11A-01 2e96d65b-0247-40fc-a0e3-90fcb6feac3d TCGA-DD-A11A-01A-11D-A12Z-10 2e96d65b-0247-40fc-a0e3-90fcb6feac3d 2e96d65b-0247-40fc-a0e3-90fcb6feac3d TCGA-DD-A11A-01A-11D-A12Z-10 TCGA-DD-A11A-01A-11D-A132-05 +TCGA-DD-A11A-11 TCGA-DD-A11A-11 TCGA-DD-A11A TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver None 67 TCGA-DD-A11A-F38784 TCGA-DD-A11A TCGA-DD-A11A-11A 0.1 3.6 0.9 1.4 1.1 -24646 2184 0 79 0 0 6 223 0 - No Fibrosis 2012-12-21 MALE 156 Other HBcAB total (+), HBsAg (-), HBcIgm Ab (-) Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 240 NO YES G3 false No M0 N0 T1 Stage I A11A 513 150 450 1.0 NO R0 Solid Tissue Normal 11 Lobectomy 6th NO YES DD 1.0 Liver None A Hepatitis B Surface Antigen|HBV Core Antibody LIVING 67 2004 TCGA-DD-A11A-11 1f1a8329-397c-4ec8-a7cc-46ec9c48fa42 TCGA-DD-A11A-11 1f1a8329-397c-4ec8-a7cc-46ec9c48fa42 1f1a8329-397c-4ec8-a7cc-46ec9c48fa42 1f1a8329-397c-4ec8-a7cc-46ec9c48fa42 TCGA-DD-A11A-11A-11D-A132-05 +TCGA-DD-A11B-01 TCGA-DD-A11B-01 TCGA-DD-A11B TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver Mild 73 3.5 3.9 5.0 TCGA-DD-A11B-F38785 TCGA-DD-A11B TCGA-DD-A11B-01A 0.1 1.6 A 0.9 1.4 1.0 -26857 1975 14 0 1 0 6 15 6 - Established Cirrhosis 2012-12-21 MALE 181 Non-Alcoholic Fatty Liver Disease Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 280 8.4 12.0 NO NO G2 NO false No M0 N0 T1 Stage I TCGA-DD-A11B.B53C4282-5266-43FE-A958-19097FD20290.pdf A11B TUMOR FREE 90 150 450 NO NO 10.2 NO NO RX Primary Tumor 01 Segmentectomy, Single 6th NO YES DD 1.0 Liver None A Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody DECEASED 134 2005 TCGA-DD-A11B-01A-11D-A12Y-01 TCGA-DD-A11B-01A-11D-A12Y-01 TCGA-DD-A11B-01A-11D-A12Z-10 TCGA-DD-A11B-01 TCGA-DD-A11B-01 76061131-4963-4848-8B8D-771C892D21D9 92802474-4e5b-46c9-a000-a4451ad43582 TCGA-DD-A11B-01A-11D-A12Z-10 TCGA-DD-A11B-01 TCGA-DD-A11B-01 92802474-4e5b-46c9-a000-a4451ad43582 TCGA-DD-A11B-01A-11D-A12Z-10 92802474-4e5b-46c9-a000-a4451ad43582 92802474-4e5b-46c9-a000-a4451ad43582 TCGA-DD-A11B-01A-11D-A12Z-10 TCGA-DD-A11B-01A-11D-A132-05 +TCGA-DD-A11B-11 TCGA-DD-A11B-11 TCGA-DD-A11B TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver Mild 73 3.5 3.9 5.0 TCGA-DD-A11B-F38785 TCGA-DD-A11B TCGA-DD-A11B-11A 0.1 1.6 A 0.9 1.4 1.0 -26857 1975 14 0 1 0 6 15 6 - Established Cirrhosis 2012-12-21 MALE 181 Non-Alcoholic Fatty Liver Disease Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 320 8.4 12.0 NO NO G2 NO false No M0 N0 T1 Stage I A11B TUMOR FREE 90 150 450 NO NO 10.2 NO NO RX Solid Tissue Normal 11 Segmentectomy, Single 6th NO YES DD 1.0 Liver None A Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody DECEASED 134 2005 TCGA-DD-A11B-11 5b37433a-6415-497f-bf36-0f0b5c2ad21e TCGA-DD-A11B-11 5b37433a-6415-497f-bf36-0f0b5c2ad21e 5b37433a-6415-497f-bf36-0f0b5c2ad21e 5b37433a-6415-497f-bf36-0f0b5c2ad21e TCGA-DD-A11B-11A-11D-A132-05 +TCGA-DD-A11C-01 TCGA-DD-A11C-01 TCGA-DD-A11C TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver None 69 3.5 3.6 5.0 TCGA-DD-A11C-F38786 TCGA-DD-A11C TCGA-DD-A11C-01A 0.1 2.3 1 A 0.9 1.4 0.9 -25403 1703 0 662 1 0 6 11 0 - No Fibrosis 2012-12-21 MALE 186 Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 220 NO YES G3 NO false No M0 N0 T1 Stage I TCGA-DD-A11C.35CD5B20-BF61-4D28-AC7F-2CDC959382CD.pdf A11C TUMOR FREE 391 150 450 NO NO 1.0 NO YES RX Primary Tumor 01 Lobectomy 6th NO YES DD 1.0 Liver None A Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody LIVING 123 2006 TCGA-DD-A11C-01A-11D-A12Y-01 TCGA-DD-A11C-01A-11D-A12Y-01 TCGA-DD-A11C-01A-11D-A12Z-10 TCGA-DD-A11C-01 TCGA-DD-A11C-01 76C64559-2722-42D3-9C42-1734DB8DEF08 edc609e1-c791-4d5f-8ca1-272ce9b34289 TCGA-DD-A11C-01A-11D-A12Z-10 TCGA-DD-A11C-01 TCGA-DD-A11C-01 edc609e1-c791-4d5f-8ca1-272ce9b34289 TCGA-DD-A11C-01A-11D-A12Z-10 edc609e1-c791-4d5f-8ca1-272ce9b34289 edc609e1-c791-4d5f-8ca1-272ce9b34289 TCGA-DD-A11C-01A-11D-A12Z-10 TCGA-DD-A11C-01A-11D-A132-05 +TCGA-DD-A11C-11 TCGA-DD-A11C-11 TCGA-DD-A11C TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver None 69 3.5 3.6 5.0 TCGA-DD-A11C-F38786 TCGA-DD-A11C 0.1 2.3 1 A 0.9 1.4 0.9 -25403 0 662 1 0 6 11 0 - No Fibrosis 2012-12-21 MALE 186 Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES YES G3 NO No M0 N0 T1 Stage I A11C TUMOR FREE 391 150 450 NO NO 1.0 NO YES RX Solid Tissue Normal 11 Lobectomy 6th NO YES DD 1.0 Liver None Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody LIVING 123 2006 TCGA-DD-A11C-11 ba72262f-9361-4d4c-8fa0-cc44e26320f6 TCGA-DD-A11C-11 ba72262f-9361-4d4c-8fa0-cc44e26320f6 ba72262f-9361-4d4c-8fa0-cc44e26320f6 ba72262f-9361-4d4c-8fa0-cc44e26320f6 TCGA-DD-A11C-11A-11D-A132-05 +TCGA-DD-A11D-01 TCGA-DD-A11D-01 TCGA-DD-A11D TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver YES NO None 57 3.5 4.5 5.0 TCGA-DD-A11D-F38787 TCGA-DD-A11D TCGA-DD-A11D-01A 0.1 0.5 2 A 0.6 1.1 1.1 -21003 1731 1560 0 498 1 0 6 8 6 - Established Cirrhosis 2012-12-21 FEMALE 163 Non-Alcoholic Fatty Liver Disease Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 300 0.9 1.2 NO NO G2 Liver Intrahepatic Recurrence Yes NO YES No false No M0 N0 T1 Stage I TCGA-DD-A11D.8D1A74F7-E6C3-4557-917A-CA7273929ADF.pdf A11D WITH TUMOR 249 150 450 NO NO 0.9 NO YES R0 Primary Tumor 01 Lobectomy 6th NO YES DD 1.0 Liver None A DECEASED 73 2006 TCGA-DD-A11D-01A-11D-A12Y-01 TCGA-DD-A11D-01A-11D-A12Y-01 TCGA-DD-A11D-01A-11D-A12Z-10 TCGA-DD-A11D-01 TCGA-DD-A11D-01 808949E2-ABA5-44F8-A479-D21599DEC5AB 62a6d38d-34a2-4d06-962f-95cc89d582d4 TCGA-DD-A11D-01A-11D-A12Z-10 TCGA-DD-A11D-01 TCGA-DD-A11D-01 62a6d38d-34a2-4d06-962f-95cc89d582d4 TCGA-DD-A11D-01A-11D-A12Z-10 62a6d38d-34a2-4d06-962f-95cc89d582d4 62a6d38d-34a2-4d06-962f-95cc89d582d4 TCGA-DD-A11D-01A-11D-A12Z-10 TCGA-DD-A11D-01A-11D-A132-05 +TCGA-DD-A11D-11 TCGA-DD-A11D-11 TCGA-DD-A11D TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver YES NO None 57 3.5 4.5 5.0 TCGA-DD-A11D-F38787 TCGA-DD-A11D TCGA-DD-A11D-11A 0.1 0.5 2 A 0.6 1.1 1.1 -21003 1731 1560 0 498 1 0 6 8 6 - Established Cirrhosis 2012-12-21 FEMALE 163 Non-Alcoholic Fatty Liver Disease Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 240 0.9 1.2 NO NO G2 Liver Intrahepatic Recurrence Yes NO YES No false No M0 N0 T1 Stage I A11D WITH TUMOR 249 150 450 NO NO 0.9 NO YES R0 Solid Tissue Normal 11 Lobectomy 6th NO YES DD 1.0 Liver None A DECEASED 73 2006 TCGA-DD-A11D-11 8e70d12c-38fd-4da2-ad1e-b7f860959aa2 TCGA-DD-A11D-11 8e70d12c-38fd-4da2-ad1e-b7f860959aa2 8e70d12c-38fd-4da2-ad1e-b7f860959aa2 8e70d12c-38fd-4da2-ad1e-b7f860959aa2 TCGA-DD-A11D-11A-12D-A132-05 +TCGA-DD-A1E9-01 TCGA-DD-A1E9-01 TCGA-DD-A1E9 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO Severe 70 3.5 4.1 5.0 TCGA-DD-A1E9-F42012 TCGA-DD-A1E9 TCGA-DD-A1E9-01A 0.1 13 4 A 0.8 1.3 0.9 -25808 3234 2759 0 720 1 0 6 202 6 - Established Cirrhosis 2013-4-9 MALE 172 Alcohol consumption Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 100 8.4 12.0 NO NO G2 Liver Intrahepatic Recurrence Yes NO NO No true No M0 N0 T1 Stage I TCGA-DD-A1E9.07CF8AAC-8A8A-4E4C-BBDA-EDCD78608723.pdf A1E9 110 150 450 NO NO 10.4 NO YES R0 Primary Tumor 01 Segmentectomy, Multiple 5th NO YES DD 1.0 Liver None A Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody DECEASED 101 2002 TCGA-DD-A1E9-01A-21D-A151-01 TCGA-DD-A1E9-01A-21D-A151-01 TCGA-DD-A1E9-01A-21D-A152-10 D93BA981-49B7-4E84-82FE-5AAF95EAA05C TCGA-DD-A1E9-01A-21D-A152-10 TCGA-DD-A1E9-01A-21D-A152-10 TCGA-DD-A1E9-01A-21D-A152-10 TCGA-DD-A1E9-01A-21D-A153-05 +TCGA-DD-A1E9-11 TCGA-DD-A1E9-11 TCGA-DD-A1E9 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO Severe 70 3.5 4.1 5.0 TCGA-DD-A1E9-F42012 TCGA-DD-A1E9 TCGA-DD-A1E9-11A 0.1 13 4 A 0.8 1.3 0.9 -25808 3234 2759 0 720 1 0 6 202 6 - Established Cirrhosis 2013-4-9 MALE 172 Alcohol consumption Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 120 8.4 12.0 NO NO G2 Liver Intrahepatic Recurrence Yes NO NO No true No M0 N0 T1 Stage I A1E9 110 150 450 NO NO 10.4 NO YES R0 Solid Tissue Normal 11 Segmentectomy, Multiple 5th NO YES DD 1.0 Liver None A Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody DECEASED 101 2002 TCGA-DD-A1E9-11A-11D-A153-05 +TCGA-DD-A1EA-01 TCGA-DD-A1EA-01 TCGA-DD-A1EA TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO Mild 68 3.5 3.3 5.0 TCGA-DD-A1EA-F42204 TCGA-DD-A1EA TCGA-DD-A1EA-01A 0.1 0.9 1 A 0.8 1.3 1.2 -24925 3298 0 2415 754 0 0 6 3 1,2 - Portal Fibrosis 2013-4-15 MALE 168 Hepatitis B smoking Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 80 8.3 10.8 NO NO G2 Liver Locoregional Recurrence Yes NO YES No true No M0 N0 T2 Stage II TCGA-DD-A1EA.0B2D3D3C-78CC-4DB7-9A8C-92BF05CFB68B.pdf A1EA WITH TUMOR 209 150 450 NO NO 10.2 NO YES R0 Primary Tumor 01 Segmentectomy, Multiple 5th NO YES DD 1.0 Liver Micro A Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody|HBV D LIVING 94 2002 TCGA-DD-A1EA-01A-11D-A12Y-01 TCGA-DD-A1EA-01A-11D-A12Y-01 TCGA-DD-A1EA-01A-11D-A12Z-10 TCGA-DD-A1EA-01 TCGA-DD-A1EA-01 4e8c2054-b8f7-4754-b42d-4714edcee3c7 TCGA-DD-A1EA-01A-11D-A12Z-10 TCGA-DD-A1EA-01 TCGA-DD-A1EA-01 4e8c2054-b8f7-4754-b42d-4714edcee3c7 TCGA-DD-A1EA-01A-11D-A12Z-10 4e8c2054-b8f7-4754-b42d-4714edcee3c7 4e8c2054-b8f7-4754-b42d-4714edcee3c7 TCGA-DD-A1EA-01A-11D-A12Z-10 TCGA-DD-A1EA-01A-11D-A132-05 +TCGA-DD-A1EB-01 TCGA-DD-A1EB-01 TCGA-DD-A1EB TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO None 72 3.5 3.7 5.0 TCGA-DD-A1EB-F42225 TCGA-DD-A1EB TCGA-DD-A1EB-01A 0.1 0.3 1 B 0.6 1.1 1.3 -26471 3538 0 2017 505 1 0 6 7 0 - No Fibrosis 2013-4-15 FEMALE 164 Other smoking Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 180 8.4 12.0 NO YES G2 Liver Intrahepatic Recurrence Yes NO YES No true No M0 N0 T1 Stage I TCGA-DD-A1EB.40ABAF02-60C0-4997-AB0F-2B9A90F1FE3B.pdf A1EB TUMOR FREE 204 150 450 NO NO 8.7 NO YES R0 Primary Tumor 01 Lobectomy 5th NO YES DD 1.0 Liver None A Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody LIVING 57 2001 TCGA-DD-A1EB-01A-11D-A12Y-01 TCGA-DD-A1EB-01A-11D-A12Y-01 TCGA-DD-A1EB-01A-11D-A12Z-10 TCGA-DD-A1EB-01 TCGA-DD-A1EB-01 17D465CF-A283-416B-B948-91BFE18168C2 bb931f9d-802e-4e02-b503-a637aa369e8b TCGA-DD-A1EB-01A-11D-A12Z-10 TCGA-DD-A1EB-01 TCGA-DD-A1EB-01 bb931f9d-802e-4e02-b503-a637aa369e8b TCGA-DD-A1EB-01A-11D-A12Z-10 bb931f9d-802e-4e02-b503-a637aa369e8b bb931f9d-802e-4e02-b503-a637aa369e8b TCGA-DD-A1EB-01A-11D-A12Z-10 TCGA-DD-A1EB-01A-11D-A132-05 +TCGA-DD-A1EB-11 TCGA-DD-A1EB-11 TCGA-DD-A1EB TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO None 72 3.5 3.7 5.0 TCGA-DD-A1EB-F42225 TCGA-DD-A1EB 0.1 0.3 1 B 0.6 1.1 1.3 -26471 0 2017 505 1 0 6 7 0 - No Fibrosis 2013-4-15 FEMALE 164 Other smoking Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 8.4 12.0 YES G2 Liver Intrahepatic Recurrence Yes NO YES No No M0 N0 T1 Stage I A1EB TUMOR FREE 204 150 450 NO NO 8.7 NO YES R0 Solid Tissue Normal 11 Lobectomy 5th NO YES DD 1.0 Liver None Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody LIVING 57 2001 TCGA-DD-A1EB-11 e55a12d6-3ec4-4346-8849-cf7525fff740 TCGA-DD-A1EB-11 e55a12d6-3ec4-4346-8849-cf7525fff740 e55a12d6-3ec4-4346-8849-cf7525fff740 e55a12d6-3ec4-4346-8849-cf7525fff740 TCGA-DD-A1EB-11A-11D-A132-05 +TCGA-DD-A1EC-01 TCGA-DD-A1EC-01 TCGA-DD-A1EC TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver YES NO None 20 3.5 3.2 5.0 TCGA-DD-A1EC-F42201 TCGA-DD-A1EC TCGA-DD-A1EC-01A 0.1 0.4 A 0.7 1.2 0.8 -7363 2254 0 602 299 1 0 6 2 0 - No Fibrosis 2013-4-15 FEMALE 157 Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 110 8.4 12.0 NO YES G3 Other, specify Extrahepatic Recurrence peritoneal No NO YES No true No M0 N0 T1 Stage I TCGA-DD-A1EC.7CF5361C-34F3-496F-A7FC-AF4E9F2BD859.pdf A1EC 556 150 450 NO NO 11.0 NO NO R0 Primary Tumor 01 Segmentectomy, Multiple 6th NO YES DD 1.0 Liver None A LIVING 50 2004 TCGA-DD-A1EC-01A-21D-A12Y-01 TCGA-DD-A1EC-01A-21D-A12Y-01 TCGA-DD-A1EC-01A-21D-A12Z-10 TCGA-DD-A1EC-01 TCGA-DD-A1EC-01 E364D0C2-AC0F-47AD-A720-ED09E8270F5E 7d73dcf5-7ddc-4df8-82f8-19fbb1f719ed TCGA-DD-A1EC-01A-21D-A12Z-10 TCGA-DD-A1EC-01 TCGA-DD-A1EC-01 7d73dcf5-7ddc-4df8-82f8-19fbb1f719ed TCGA-DD-A1EC-01A-21D-A12Z-10 7d73dcf5-7ddc-4df8-82f8-19fbb1f719ed 7d73dcf5-7ddc-4df8-82f8-19fbb1f719ed TCGA-DD-A1EC-01A-21D-A12Z-10 TCGA-DD-A1EC-01A-21D-A132-05 +TCGA-DD-A1EC-11 TCGA-DD-A1EC-11 TCGA-DD-A1EC TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver YES NO None 20 3.5 3.2 5.0 TCGA-DD-A1EC-F42201 TCGA-DD-A1EC 0.1 0.4 A 0.7 1.2 0.8 -7363 0 602 299 1 0 6 2 0 - No Fibrosis 2013-4-15 FEMALE 157 Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 8.4 12.0 YES G3 Other, specify Extrahepatic Recurrence peritoneal No NO YES No No M0 N0 T1 Stage I A1EC 556 150 450 NO NO 11.0 NO NO R0 Solid Tissue Normal 11 Segmentectomy, Multiple 6th NO YES DD 1.0 Liver None LIVING 50 2004 TCGA-DD-A1EC-11 d3041275-6a41-4974-a082-9b261b65c81f TCGA-DD-A1EC-11 d3041275-6a41-4974-a082-9b261b65c81f d3041275-6a41-4974-a082-9b261b65c81f d3041275-6a41-4974-a082-9b261b65c81f TCGA-DD-A1EC-11A-11D-A132-05 +TCGA-DD-A1ED-01 TCGA-DD-A1ED-01 TCGA-DD-A1ED TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver None 68 3.5 4.2 5.0 TCGA-DD-A1ED-F42202 TCGA-DD-A1ED TCGA-DD-A1ED-01A 0.1 0.8 A 0.8 1.3 1.3 -25039 1525 0 2301 1 0 6 3 0 - No Fibrosis 2013-4-15 MALE 168 Alcohol consumption tattoos Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 60 8.4 12.0 NO NO G1 NO true No M0 N0 T1 Stage I TCGA-DD-A1ED.6C4C27E3-EB96-48E4-BDF8-6E93C1557707.pdf A1ED TUMOR FREE 219 150 450 NO NO 8.9 NO NO R0 Primary Tumor 01 Segmentectomy, Multiple 6th NO YES DD 1.0 Liver None A Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody LIVING 85 2006 TCGA-DD-A1ED-01A-11D-A151-01 TCGA-DD-A1ED-01A-11D-A151-01 TCGA-DD-A1ED-01A-11D-A152-10 TCGA-DD-A1ED-01 TCGA-DD-A1ED-01 37114D9C-9279-40B4-B2CE-513F96895267 24f42719-6ad5-48fb-b27d-5812c3447b46 TCGA-DD-A1ED-01A-11D-A152-10 TCGA-DD-A1ED-01 TCGA-DD-A1ED-01 24f42719-6ad5-48fb-b27d-5812c3447b46 TCGA-DD-A1ED-01A-11D-A152-10 24f42719-6ad5-48fb-b27d-5812c3447b46 24f42719-6ad5-48fb-b27d-5812c3447b46 TCGA-DD-A1ED-01A-11D-A152-10 TCGA-DD-A1ED-01A-11D-A153-05 +TCGA-DD-A1ED-11 TCGA-DD-A1ED-11 TCGA-DD-A1ED TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver None 68 3.5 4.2 5.0 TCGA-DD-A1ED-F42202 TCGA-DD-A1ED TCGA-DD-A1ED-11A 0.1 0.8 A 0.8 1.3 1.3 -25039 1525 0 2301 1 0 6 3 0 - No Fibrosis 2013-4-15 MALE 168 Alcohol consumption tattoos Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 170 8.4 12.0 NO NO G1 NO true No M0 N0 T1 Stage I A1ED TUMOR FREE 219 150 450 NO NO 8.9 NO NO R0 Solid Tissue Normal 11 Segmentectomy, Multiple 6th NO YES DD 1.0 Liver None A Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody LIVING 85 2006 TCGA-DD-A1ED-11A-11D-A153-05 +TCGA-DD-A1EE-01 TCGA-DD-A1EE-01 TCGA-DD-A1EE TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO Severe 73 3.5 2.7 5.0 TCGA-DD-A1EE-F42208 TCGA-DD-A1EE TCGA-DD-A1EE-01A 0.1 0.5 B 0.8 1.3 1.2 -26858 1521 349 0 204 44 2 0 6 3 6 - Established Cirrhosis 2013-4-15 MALE 175 Hepatitis C Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 110 8.4 12.0 NO NO G3 Liver Intrahepatic Recurrence No NO YES No true No M0 N0 T3 Stage IIIA TCGA-DD-A1EE.EC55BB6D-4704-48D6-9C37-E82AADE685F7.pdf A1EE WITH TUMOR 208 150 450 NO NO 14.3 NO NO R0 Primary Tumor 01 Segmentectomy, Multiple 6th NO YES DD 1.0 Liver None A Hepatitis C Virus R|HCV Genotype|Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody DECEASED 77 2006 TCGA-DD-A1EE-01A-11D-A12Y-01 TCGA-DD-A1EE-01A-11D-A12Y-01 TCGA-DD-A1EE-01A-11D-A12Z-10 TCGA-DD-A1EE-01 TCGA-DD-A1EE-01 4D09C18B-8451-4B2D-BB83-7688A4B19389 b5ef133a-86de-4cd1-9ff2-52e6cbbeaae8 TCGA-DD-A1EE-01 TCGA-DD-A1EE-01 b5ef133a-86de-4cd1-9ff2-52e6cbbeaae8 b5ef133a-86de-4cd1-9ff2-52e6cbbeaae8 b5ef133a-86de-4cd1-9ff2-52e6cbbeaae8 TCGA-DD-A1EE-01A-11D-A132-05 +TCGA-DD-A1EE-11 TCGA-DD-A1EE-11 TCGA-DD-A1EE TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO Severe 73 3.5 2.7 5.0 TCGA-DD-A1EE-F42208 TCGA-DD-A1EE TCGA-DD-A1EE-11A 0.1 0.5 B 0.8 1.3 1.2 -26858 1521 349 0 204 44 2 0 6 3 6 - Established Cirrhosis 2013-4-15 MALE 175 Hepatitis C Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 190 8.4 12.0 NO NO G3 Liver Intrahepatic Recurrence No NO YES No true No M0 N0 T3 Stage IIIA A1EE WITH TUMOR 208 150 450 NO NO 14.3 NO NO R0 Solid Tissue Normal 11 Segmentectomy, Multiple 6th NO YES DD 1.0 Liver None A Hepatitis C Virus R|HCV Genotype|Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody DECEASED 77 2006 TCGA-DD-A1EE-11 78eb93c7-0300-4f16-ab32-7489715e3353 TCGA-DD-A1EE-11 78eb93c7-0300-4f16-ab32-7489715e3353 78eb93c7-0300-4f16-ab32-7489715e3353 78eb93c7-0300-4f16-ab32-7489715e3353 TCGA-DD-A1EE-11A-11D-A132-05 +TCGA-DD-A1EF-01 TCGA-DD-A1EF-01 TCGA-DD-A1EF TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver Mild 57 3.5 4.5 5.0 TCGA-DD-A1EF-F42200 TCGA-DD-A1EF TCGA-DD-A1EF-01A 0.1 1.0 9 B 0.6 1.1 0.9 -21165 1382 394 0 2 0 6 16211 3,4 - Fibrous Speta 2013-4-15 FEMALE 164 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 190 8.4 12.0 NO NO G3 true No M0 N0 T1 Stage I TCGA-DD-A1EF.002B24F9-22DB-4504-A048-BF9790A4837E.pdf A1EF WITH TUMOR 337 150 450 8.5 YES R0 Primary Tumor 01 Lobectomy 6th NO YES DD 1.0 Liver None A Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody DECEASED 81 2007 TCGA-DD-A1EF-01A-11D-A12Y-01 TCGA-DD-A1EF-01A-11D-A12Y-01 TCGA-DD-A1EF-01A-11D-A12Z-10 TCGA-DD-A1EF-01 TCGA-DD-A1EF-01 062D49C8-C170-4837-9CC6-13C6D665122D 5da8b83f-c43b-46c3-9667-022d7e0a6f2b TCGA-DD-A1EF-01A-11D-A12Z-10 TCGA-DD-A1EF-01 TCGA-DD-A1EF-01 5da8b83f-c43b-46c3-9667-022d7e0a6f2b TCGA-DD-A1EF-01A-11D-A12Z-10 5da8b83f-c43b-46c3-9667-022d7e0a6f2b 5da8b83f-c43b-46c3-9667-022d7e0a6f2b TCGA-DD-A1EF-01A-11D-A12Z-10 TCGA-DD-A1EF-01A-11D-A132-05 +TCGA-DD-A1EF-11 TCGA-DD-A1EF-11 TCGA-DD-A1EF TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver Mild 57 3.5 4.5 5.0 TCGA-DD-A1EF-F42200 TCGA-DD-A1EF TCGA-DD-A1EF-11A 0.1 1.0 9 B 0.6 1.1 0.9 -21165 1382 394 0 2 0 6 16211 3,4 - Fibrous Speta 2013-4-15 FEMALE 164 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 70 8.4 12.0 NO NO G3 true No M0 N0 T1 Stage I A1EF WITH TUMOR 337 150 450 8.5 YES R0 Solid Tissue Normal 11 Lobectomy 6th NO YES DD 1.0 Liver None A Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody DECEASED 81 2007 TCGA-DD-A1EF-11A-11D-A132-05 +TCGA-DD-A1EG-01 TCGA-DD-A1EG-01 TCGA-DD-A1EG TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO Mild 76 3.5 4.2 5.0 TCGA-DD-A1EG-F42003 TCGA-DD-A1EG 0.1 0.7 1 A 0.8 1.3 0.6 -28108 1372 0 880 875 0 0 6 16 1,2 - Portal Fibrosis 2013-4-9 MALE 168 Alcohol consumption|Non-Alcoholic Fatty Liver Disease Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 8.4 12.0 NO G3 Liver Intrahepatic Recurrence No YES YES No No M0 N0 T1 Stage I A1EG WITH TUMOR 146 150 450 YES YES 9.1 NO YES R0 R0 Primary Tumor 01 Lobectomy 7th NO YES DD 1.0 Liver None Hepatitis B Surface Antigen DECEASED 82 2007 TCGA-DD-A1EG-01A-11D-A20V-01 TCGA-DD-A1EG-01A-11D-A20V-01 TCGA-DD-A1EG-01A-11D-A20W-10 TCGA-DD-A1EG-01 TCGA-DD-A1EG-01 caf05305-45bc-4858-b8b5-21fe37061a5c TCGA-DD-A1EG-01A-11D-A20W-10 TCGA-DD-A1EG-01 TCGA-DD-A1EG-01 caf05305-45bc-4858-b8b5-21fe37061a5c TCGA-DD-A1EG-01A-11D-A20W-10 caf05305-45bc-4858-b8b5-21fe37061a5c caf05305-45bc-4858-b8b5-21fe37061a5c TCGA-DD-A1EG-01A-11D-A20W-10 TCGA-DD-A1EG-01A-11D-A20Z-05 +TCGA-DD-A1EG-11 TCGA-DD-A1EG-11 TCGA-DD-A1EG TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO Mild 76 3.5 4.2 5.0 TCGA-DD-A1EG-F42003 TCGA-DD-A1EG 0.1 0.7 1 A 0.8 1.3 0.6 -28108 1372 0 880 875 0 0 6 16 1,2 - Portal Fibrosis 2013-4-9 MALE 168 Alcohol consumption|Non-Alcoholic Fatty Liver Disease Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 8.4 12.0 NO G3 Liver Intrahepatic Recurrence No YES YES No No M0 N0 T1 Stage I A1EG WITH TUMOR 146 150 450 YES YES 9.1 NO YES R0 R0 Solid Tissue Normal 11 Lobectomy 7th NO YES DD 1.0 Liver None Hepatitis B Surface Antigen DECEASED 82 2007 TCGA-DD-A1EG-11 b80a257d-9c8b-4c49-87bc-30f74ff9cd3e TCGA-DD-A1EG-11 b80a257d-9c8b-4c49-87bc-30f74ff9cd3e b80a257d-9c8b-4c49-87bc-30f74ff9cd3e b80a257d-9c8b-4c49-87bc-30f74ff9cd3e TCGA-DD-A1EG-11A-11D-A20Z-05 +TCGA-DD-A1EH-01 TCGA-DD-A1EH-01 TCGA-DD-A1EH TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver YES NO None 23 3.5 4.7 5.0 TCGA-DD-A1EH-F42567 TCGA-DD-A1EH TCGA-DD-A1EH-01A 0.1 1.0 1 B 0.8 1.3 1.0 -8499 933 0 1495 120 1 0 6 94340 3,4 - Fibrous Speta 2013-4-24 MALE 179 Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 220 9.5 13.8 NO NO G3 Liver Intrahepatic Recurrence Yes NO YES No true No M0 N0 T3 Stage III TCGA-DD-A1EH.951E7AFB-F380-4FA8-B213-CB766A60FF5B.pdf A1EH WITH TUMOR 212 150 450 YES YES 10.4 NO YES R0 Primary Tumor 01 Lobectomy 6th NO YES DD 1.0 Liver Macro A Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody|HBV D LIVING 70 2008 TCGA-DD-A1EH-01A-11D-A12Y-01 TCGA-DD-A1EH-01A-11D-A12Y-01 TCGA-DD-A1EH-01A-11D-A12Z-10 TCGA-DD-A1EH-01 TCGA-DD-A1EH-01 D64DEA8B-1FBC-463F-B634-BB8AD46FA286 0559ff1c-6aee-491f-9b58-747732a10755 TCGA-DD-A1EH-01A-11D-A12Z-10 TCGA-DD-A1EH-01 TCGA-DD-A1EH-01 0559ff1c-6aee-491f-9b58-747732a10755 TCGA-DD-A1EH-01A-11D-A12Z-10 0559ff1c-6aee-491f-9b58-747732a10755 0559ff1c-6aee-491f-9b58-747732a10755 TCGA-DD-A1EH-01A-11D-A12Z-10 TCGA-DD-A1EH-01A-11D-A132-05 +TCGA-DD-A1EH-11 TCGA-DD-A1EH-11 TCGA-DD-A1EH TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver YES NO None 23 3.5 4.7 5.0 TCGA-DD-A1EH-F42567 TCGA-DD-A1EH 0.1 1.0 1 B 0.8 1.3 1.0 -8499 0 1495 120 1 0 6 94340 3,4 - Fibrous Speta 2013-4-24 MALE 179 Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 9.5 13.8 NO G3 Liver Intrahepatic Recurrence Yes NO YES No No M0 N0 T3 Stage III A1EH WITH TUMOR 212 150 450 YES YES 10.4 NO YES R0 Solid Tissue Normal 11 Lobectomy 6th NO YES DD 1.0 Liver Macro Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody|HBV D LIVING 70 2008 TCGA-DD-A1EH-11 ac77b52b-6f6c-41ec-b998-6d23250d0516 TCGA-DD-A1EH-11 ac77b52b-6f6c-41ec-b998-6d23250d0516 ac77b52b-6f6c-41ec-b998-6d23250d0516 ac77b52b-6f6c-41ec-b998-6d23250d0516 TCGA-DD-A1EH-11A-11D-A132-05 +TCGA-DD-A1EI-01 TCGA-DD-A1EI-01 TCGA-DD-A1EI TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver Mild 46 3.5 5.1 5.0 TCGA-DD-A1EI-F42222 TCGA-DD-A1EI TCGA-DD-A1EI-01A 0.1 0.7 0 B 0.8 1.3 0.9 -17097 926 0 183 2 0 6 24 6 - Established Cirrhosis 2013-4-15 MALE 175 Hepatitis B cirrhosis Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 80 8.3 10.8 NO YES G2 NO true No M0 N0 T1 Stage I TCGA-DD-A1EI.C253EB16-129F-4442-8C88-8A132E610E8C.pdf A1EI TUMOR FREE 148 150 450 10.9 NO R0 Primary Tumor 01 Lobectomy 6th NO YES DD 1.0 Liver None A Hepatitis B Surface Antigen|HBV D LIVING 69 2008 TCGA-DD-A1EI-01A-11D-A12Y-01 TCGA-DD-A1EI-01A-11D-A12Y-01 TCGA-DD-A1EI-01A-11D-A12Z-10 TCGA-DD-A1EI-01 TCGA-DD-A1EI-01 95cdfdf7-26d2-41b6-bac7-a6305a91ec3c TCGA-DD-A1EI-01A-11D-A12Z-10 TCGA-DD-A1EI-01 TCGA-DD-A1EI-01 95cdfdf7-26d2-41b6-bac7-a6305a91ec3c TCGA-DD-A1EI-01A-11D-A12Z-10 95cdfdf7-26d2-41b6-bac7-a6305a91ec3c 95cdfdf7-26d2-41b6-bac7-a6305a91ec3c TCGA-DD-A1EI-01A-11D-A12Z-10 TCGA-DD-A1EI-01A-11D-A132-05 +TCGA-DD-A1EI-11 TCGA-DD-A1EI-11 TCGA-DD-A1EI TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver Mild 46 3.5 5.1 5.0 TCGA-DD-A1EI-F42222 TCGA-DD-A1EI TCGA-DD-A1EI-11A 0.1 0.7 0 B 0.8 1.3 0.9 -17097 926 0 183 2 0 6 24 6 - Established Cirrhosis 2013-4-15 MALE 175 Hepatitis B cirrhosis Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 190 8.3 10.8 NO YES G2 NO true No M0 N0 T1 Stage I A1EI TUMOR FREE 148 150 450 10.9 NO R0 Solid Tissue Normal 11 Lobectomy 6th NO YES DD 1.0 Liver None A Hepatitis B Surface Antigen|HBV D LIVING 69 2008 TCGA-DD-A1EI-11 196f7a32-4d09-4e8b-9aa4-7964baf951d7 TCGA-DD-A1EI-11 196f7a32-4d09-4e8b-9aa4-7964baf951d7 196f7a32-4d09-4e8b-9aa4-7964baf951d7 196f7a32-4d09-4e8b-9aa4-7964baf951d7 TCGA-DD-A1EI-11A-11D-A132-05 +TCGA-DD-A1EJ-01 TCGA-DD-A1EJ-01 TCGA-DD-A1EJ TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver YES NO Mild 71 3.2 3.5 5.0 TCGA-DD-A1EJ-F42209 TCGA-DD-A1EJ TCGA-DD-A1EJ-01A 0.1 0.7 1 B 0.6 1.1 0.6 -26009 909 1005 0 887 263 2 0 6 18840 0 - No Fibrosis 2013-4-15 FEMALE 154 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 290 8.3 10.8 NO NO G2 Liver Intrahepatic Recurrence Yes NO YES No true No M0 N1 T1 Stage IIIC TCGA-DD-A1EJ.A34C7F12-5EB1-4B7C-890C-FD2DFF41E85C.pdf A1EJ WITH TUMOR 608 150 450 NO NO 10.2 NO YES R0 Primary Tumor 01 Lobectomy 6th NO YES DD 1.0 Liver None A Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody DECEASED 64 2008 TCGA-DD-A1EJ-01A-11D-A151-01 TCGA-DD-A1EJ-01A-11D-A151-01 TCGA-DD-A1EJ-01A-11D-A152-10 TCGA-DD-A1EJ-01 TCGA-DD-A1EJ-01 ECCFCC47-BC5E-437D-9AD7-BB7E39A6016B c8b3eddd-f3cf-42eb-bb30-ccc3943eadec TCGA-DD-A1EJ-01A-11D-A152-10 TCGA-DD-A1EJ-01 TCGA-DD-A1EJ-01 c8b3eddd-f3cf-42eb-bb30-ccc3943eadec TCGA-DD-A1EJ-01A-11D-A152-10 c8b3eddd-f3cf-42eb-bb30-ccc3943eadec c8b3eddd-f3cf-42eb-bb30-ccc3943eadec TCGA-DD-A1EJ-01A-11D-A152-10 TCGA-DD-A1EJ-01A-11D-A153-05 +TCGA-DD-A1EJ-11 TCGA-DD-A1EJ-11 TCGA-DD-A1EJ TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver YES NO Mild 71 3.2 3.5 5.0 TCGA-DD-A1EJ-F42209 TCGA-DD-A1EJ TCGA-DD-A1EJ-11A 0.1 0.7 1 B 0.6 1.1 0.6 -26009 909 1005 0 887 263 2 0 6 18840 0 - No Fibrosis 2013-4-15 FEMALE 154 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 130 8.3 10.8 NO NO G2 Liver Intrahepatic Recurrence Yes NO YES No true No M0 N1 T1 Stage IIIC A1EJ WITH TUMOR 608 150 450 NO NO 10.2 NO YES R0 Solid Tissue Normal 11 Lobectomy 6th NO YES DD 1.0 Liver None A Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody DECEASED 64 2008 TCGA-DD-A1EJ-11 8e48cff2-5edd-4ce6-9531-5dc594ae78ff TCGA-DD-A1EJ-11 8e48cff2-5edd-4ce6-9531-5dc594ae78ff 8e48cff2-5edd-4ce6-9531-5dc594ae78ff 8e48cff2-5edd-4ce6-9531-5dc594ae78ff TCGA-DD-A1EJ-11A-11D-A153-05 +TCGA-DD-A1EK-01 TCGA-DD-A1EK-01 TCGA-DD-A1EK TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver YES NO Mild 64 3.5 4.3 5.0 TCGA-DD-A1EK-F42001 TCGA-DD-A1EK TCGA-DD-A1EK-01A 0.1 0.5 1 A 0.6 1.1 0.7 -23437 819 558 0 167 0 0 6 19 0 - No Fibrosis 2013-4-9 FEMALE 159 Other tobacco, birth control bills Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 40 8.3 10.8 NO NO G2 Liver Locoregional Recurrence Yes NO YES No true No M1 N0 T4 Stage IVB TCGA-DD-A1EK.AE199A35-2585-4363-8896-9B55B12C1BDF.pdf A1EK WITH TUMOR 387 150 450 YES NO 10.3 NO YES R0 Primary Tumor 01 Segmentectomy, Multiple 6th NO YES DD 1.0 Liver None A Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody DECEASED 97 2008 TCGA-DD-A1EK-01A-11D-A20V-01 TCGA-DD-A1EK-01A-11D-A20V-01 TCGA-DD-A1EK-01A-11D-A20W-10 TCGA-DD-A1EK-01 TCGA-DD-A1EK-01 24214ac8-46a2-44c2-9ce8-8514b9c61181 TCGA-DD-A1EK-01A-11D-A20W-10 TCGA-DD-A1EK-01 TCGA-DD-A1EK-01 24214ac8-46a2-44c2-9ce8-8514b9c61181 TCGA-DD-A1EK-01A-11D-A20W-10 24214ac8-46a2-44c2-9ce8-8514b9c61181 24214ac8-46a2-44c2-9ce8-8514b9c61181 TCGA-DD-A1EK-01A-11D-A20W-10 TCGA-DD-A1EK-01A-11D-A20Z-05 +TCGA-DD-A1EL-01 TCGA-DD-A1EL-01 TCGA-DD-A1EL TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO Mild 23 3.5 4.4 5.0 TCGA-DD-A1EL-F42229 TCGA-DD-A1EL TCGA-DD-A1EL-01A 0.1 0.5 A 0.8 1.3 1.0 -8573 577 415 0 [Discrepancy] 0 0 6 5 0 - No Fibrosis 2013-4-15 MALE 182 Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 130 8.3 10.8 NO NO G3 Liver Intrahepatic Recurrence Yes NO YES No true No M0 N0 T2 Stage II TCGA-DD-A1EL.C8A1098A-0717-4801-A3E5-C13C42C65936.pdf A1EL WITH TUMOR 153 150 450 YES NO 10.8 NO NO R0 Primary Tumor 01 Segmentectomy, Multiple 6th NO YES DD 1.0 Liver None A Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody|HBV D DECEASED 54 2009 TCGA-DD-A1EL-01A-11D-A151-01 TCGA-DD-A1EL-01A-11D-A151-01 TCGA-DD-A1EL-01A-11D-A152-10 TCGA-DD-A1EL-01 TCGA-DD-A1EL-01 2FACE58F-5F20-4DDA-921C-E6DB5744DC09 4e27ce05-b76a-4d5a-b070-78c508f509a3 TCGA-DD-A1EL-01A-11D-A152-10 TCGA-DD-A1EL-01 TCGA-DD-A1EL-01 4e27ce05-b76a-4d5a-b070-78c508f509a3 TCGA-DD-A1EL-01A-11D-A152-10 4e27ce05-b76a-4d5a-b070-78c508f509a3 4e27ce05-b76a-4d5a-b070-78c508f509a3 TCGA-DD-A1EL-01A-11D-A152-10 TCGA-DD-A1EL-01A-11D-A153-05 +TCGA-DD-A1EL-11 TCGA-DD-A1EL-11 TCGA-DD-A1EL TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO Mild 23 3.5 4.4 5.0 TCGA-DD-A1EL-F42229 TCGA-DD-A1EL 0.1 0.5 A 0.8 1.3 1.0 -8573 415 0 [Discrepancy] 0 0 6 5 0 - No Fibrosis 2013-4-15 MALE 182 Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 8.3 10.8 NO G3 Liver Intrahepatic Recurrence Yes NO YES No No M0 N0 T2 Stage II A1EL WITH TUMOR 153 150 450 YES NO 10.8 NO NO R0 Solid Tissue Normal 11 Segmentectomy, Multiple 6th NO YES DD 1.0 Liver None Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody|HBV D DECEASED 54 2009 TCGA-DD-A1EL-11 ddd83e9a-35cb-4539-8141-7557eccd3b34 TCGA-DD-A1EL-11 ddd83e9a-35cb-4539-8141-7557eccd3b34 ddd83e9a-35cb-4539-8141-7557eccd3b34 ddd83e9a-35cb-4539-8141-7557eccd3b34 TCGA-DD-A1EL-11A-11D-A153-05 +TCGA-DD-A39V-01 TCGA-DD-A39V-01 TCGA-DD-A39V TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO YES None 77 3.5 4.0 5.0 TCGA-DD-A39V-F42707 TCGA-DD-A39V TCGA-DD-A39V-01A 3 A 0.8 1.2 0.9 -28254 4180 643 0 455 1 0 - No Fibrosis 2013-4-27 MALE 174 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 180 8.4 12.0 NO NO G3 Other, specify Extrahepatic Recurrence second or third rib posteriorly No NO YES No false No M0 NX T2 Stage II TCGA-DD-A39V.AB7EF7A1-F8F1-404A-BF15-2CC53F63C033.pdf A39V WITH TUMOR 193 150 450 NO NO 11.4 YES YES R0 Primary Tumor 01 Lobectomy 5th NO YES DD Liver None A DECEASED 79 2000 TCGA-DD-A39V-01A-11D-A20V-01 TCGA-DD-A39V-01A-11D-A20V-01 TCGA-DD-A39V-01A-11D-A20W-10 TCGA-DD-A39V-01 TCGA-DD-A39V-01 97B93870-5348-422B-83D9-9A64A2EF3E30 f2a077e8-1dd2-4a7b-b832-0f7367818044 TCGA-DD-A39V-01A-11D-A20W-10 TCGA-DD-A39V-01 TCGA-DD-A39V-01 f2a077e8-1dd2-4a7b-b832-0f7367818044 TCGA-DD-A39V-01A-11D-A20W-10 f2a077e8-1dd2-4a7b-b832-0f7367818044 f2a077e8-1dd2-4a7b-b832-0f7367818044 TCGA-DD-A39V-01A-11D-A20W-10 TCGA-DD-A39V-01A-11D-A20Z-05 +TCGA-DD-A39V-11 TCGA-DD-A39V-11 TCGA-DD-A39V TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO YES None 77 3.5 4.0 5.0 TCGA-DD-A39V-F42707 TCGA-DD-A39V TCGA-DD-A39V-11A 3 A 0.8 1.2 0.9 -28254 4180 643 0 455 1 0 - No Fibrosis 2013-4-27 MALE 174 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 140 8.4 12.0 NO NO G3 Other, specify Extrahepatic Recurrence second or third rib posteriorly No NO YES No false No M0 NX T2 Stage II A39V WITH TUMOR 193 150 450 NO NO 11.4 YES YES R0 Solid Tissue Normal 11 Lobectomy 5th NO YES DD Liver None A DECEASED 79 2000 TCGA-DD-A39V-11 9e3df1b0-dba1-4423-976e-99aab5b7d5e2 TCGA-DD-A39V-11 9e3df1b0-dba1-4423-976e-99aab5b7d5e2 9e3df1b0-dba1-4423-976e-99aab5b7d5e2 9e3df1b0-dba1-4423-976e-99aab5b7d5e2 TCGA-DD-A39V-11A-11D-A20Z-05 +TCGA-DD-A39W-01 TCGA-DD-A39W-01 TCGA-DD-A39W TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 29 TCGA-DD-A39W-F42705 TCGA-DD-A39W TCGA-DD-A39W-01A -10699 6014 827 0 2013-5-8 FEMALE 177 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 180 NO NO G2 false No M0 N0 T3 Stage III TCGA-DD-A39W.3EE9248B-64B4-4B76-A427-73C254D6489D.pdf A39W R0 Primary Tumor 01 Segmentectomy, Multiple 4th NO YES DD Liver None A DECEASED 74 1995 TCGA-DD-A39W-01A-11D-A20V-01 TCGA-DD-A39W-01A-11D-A20V-01 TCGA-DD-A39W-01A-11D-A20W-10 TCGA-DD-A39W-01 TCGA-DD-A39W-01 95A7A30E-A9BC-4197-8142-4F4C70B041CE 6f393dc9-7002-4fa7-8d05-c390e95e81e0 TCGA-DD-A39W-01A-11D-A20W-10 TCGA-DD-A39W-01 TCGA-DD-A39W-01 6f393dc9-7002-4fa7-8d05-c390e95e81e0 TCGA-DD-A39W-01A-11D-A20W-10 6f393dc9-7002-4fa7-8d05-c390e95e81e0 6f393dc9-7002-4fa7-8d05-c390e95e81e0 TCGA-DD-A39W-01A-11D-A20W-10 TCGA-DD-A39W-01A-11D-A20Z-05 +TCGA-DD-A39W-11 TCGA-DD-A39W-11 TCGA-DD-A39W TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 29 TCGA-DD-A39W-F42705 TCGA-DD-A39W -10699 827 0 2013-5-8 FEMALE 177 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES NO G2 No M0 N0 T3 Stage III A39W R0 Solid Tissue Normal 11 Segmentectomy, Multiple 4th NO YES DD Liver None DECEASED 74 1995 TCGA-DD-A39W-11 e66b878f-0a33-4edf-ba17-e0ec9f41e589 TCGA-DD-A39W-11 e66b878f-0a33-4edf-ba17-e0ec9f41e589 e66b878f-0a33-4edf-ba17-e0ec9f41e589 e66b878f-0a33-4edf-ba17-e0ec9f41e589 TCGA-DD-A39W-11A-11D-A20Z-05 +TCGA-DD-A39X-01 TCGA-DD-A39X-01 TCGA-DD-A39X TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO None 78 3.5 4.1 5.0 TCGA-DD-A39X-F42568 TCGA-DD-A39X TCGA-DD-A39X-01A 0.1 0.5 2 A 0.6 0.9 0.9 -28528 4705 1694 0 1032 1 0 6 10 0 - No Fibrosis 2013-4-24 FEMALE 152 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 120 8.4 12.0 NO NO G2 Liver Intrahepatic Recurrence Yes NO YES No false No M0 NX T1 Stage I TCGA-DD-A39X.B9919D23-7D65-4295-84D5-6678B26BEA01.pdf A39X WITH TUMOR 180 150 450 YES NO 9.8 NO YES R0 Primary Tumor 01 Segmentectomy, Multiple 5th NO YES DD 1.0 Liver None A Hepatitis B Surface Antigen|HBV Surface Antibody DECEASED 48 1998 TCGA-DD-A39X-01A-11D-A20V-01 TCGA-DD-A39X-01A-11D-A20V-01 TCGA-DD-A39X-01A-11D-A20W-10 TCGA-DD-A39X-01 TCGA-DD-A39X-01 5D51C3D9-4693-4108-B601-BCC8C59743A5 2a624b0d-4dc2-4c00-8984-b256a69643c7 TCGA-DD-A39X-01A-11D-A20W-10 TCGA-DD-A39X-01 TCGA-DD-A39X-01 2a624b0d-4dc2-4c00-8984-b256a69643c7 TCGA-DD-A39X-01A-11D-A20W-10 2a624b0d-4dc2-4c00-8984-b256a69643c7 2a624b0d-4dc2-4c00-8984-b256a69643c7 TCGA-DD-A39X-01A-11D-A20W-10 TCGA-DD-A39X-01A-11D-A20Z-05 +TCGA-DD-A39X-11 TCGA-DD-A39X-11 TCGA-DD-A39X TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO None 78 3.5 4.1 5.0 TCGA-DD-A39X-F42568 TCGA-DD-A39X TCGA-DD-A39X-11A 0.1 0.5 2 A 0.6 0.9 0.9 -28528 4705 1694 0 1032 1 0 6 10 0 - No Fibrosis 2013-4-24 FEMALE 152 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 230 8.4 12.0 NO NO G2 Liver Intrahepatic Recurrence Yes NO YES No false No M0 NX T1 Stage I A39X WITH TUMOR 180 150 450 YES NO 9.8 NO YES R0 Solid Tissue Normal 11 Segmentectomy, Multiple 5th NO YES DD 1.0 Liver None A Hepatitis B Surface Antigen|HBV Surface Antibody DECEASED 48 1998 TCGA-DD-A39X-11 9815693f-418d-4517-9a7e-5c708c157b0c TCGA-DD-A39X-11 9815693f-418d-4517-9a7e-5c708c157b0c 9815693f-418d-4517-9a7e-5c708c157b0c 9815693f-418d-4517-9a7e-5c708c157b0c TCGA-DD-A39X-11A-11D-A20Z-05 +TCGA-DD-A39Y-01 TCGA-DD-A39Y-01 TCGA-DD-A39Y TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver None 67 3.5 4.0 5.0 TCGA-DD-A39Y-F42701 TCGA-DD-A39Y TCGA-DD-A39Y-01A 0.1 1.1 A 1.2 12.0 0.8 -24769 3530 171 0 2 0 6 5600 0 - No Fibrosis 2013-4-27 MALE 176 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 220 8.4 12.0 NO NO G3 NO false No M0 NX T1 Stage I TCGA-DD-A39Y.2674265B-6B9D-49B3-9BD2-DF4E77AD4B26.pdf A39Y TUMOR FREE 243 150 450 NO NO 10.2 NO YES R0 Primary Tumor 01 Extended Lobectomy 5th NO YES DD 1.0 Liver None A Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody DECEASED 85 2002 TCGA-DD-A39Y-01A-11D-A20V-01 TCGA-DD-A39Y-01A-11D-A20V-01 TCGA-DD-A39Y-01A-11D-A20W-10 TCGA-DD-A39Y-01 TCGA-DD-A39Y-01 2BEF3FF0-41EC-4939-AC16-6E32F2C94D1E 6a169722-0dcb-4df7-82c5-8f8b7a512d32 TCGA-DD-A39Y-01A-11D-A20W-10 TCGA-DD-A39Y-01 TCGA-DD-A39Y-01 6a169722-0dcb-4df7-82c5-8f8b7a512d32 TCGA-DD-A39Y-01A-11D-A20W-10 6a169722-0dcb-4df7-82c5-8f8b7a512d32 6a169722-0dcb-4df7-82c5-8f8b7a512d32 TCGA-DD-A39Y-01A-11D-A20W-10 TCGA-DD-A39Y-01A-11D-A20Z-05 +TCGA-DD-A39Z-01 TCGA-DD-A39Z-01 TCGA-DD-A39Z TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 43 3.5 3.1 5.0 TCGA-DD-A39Z-F42006 TCGA-DD-A39Z TCGA-DD-A39Z-01A 0.1 1.2 1 B 0.6 0.9 0.7 -15930 5728 601 0 2 2013-4-24 FEMALE 165 Alcohol consumption extensive tobacco history Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 250 8.4 12.0 NO NO G2 false No M0 NX T2 Stage II TCGA-DD-A39Z.1976B0D8-E1F2-468F-9AB0-242E9507AB0D.pdf A39Z TUMOR FREE 437 150 450 12.6 YES R0 Primary Tumor 01 Segmentectomy, Single 4th NO YES DD 1.1 Liver None A DECEASED 61 1996 TCGA-DD-A39Z-01A-11D-A20V-01 TCGA-DD-A39Z-01A-11D-A20V-01 TCGA-DD-A39Z-01A-11D-A20W-10 TCGA-DD-A39Z-01 TCGA-DD-A39Z-01 A17BEA72-BD38-493A-98EA-C7768718E81D 2bbf9181-a71f-4714-b1b5-0d23a47d1306 TCGA-DD-A39Z-01A-11D-A20W-10 TCGA-DD-A39Z-01 TCGA-DD-A39Z-01 2bbf9181-a71f-4714-b1b5-0d23a47d1306 TCGA-DD-A39Z-01A-11D-A20W-10 2bbf9181-a71f-4714-b1b5-0d23a47d1306 2bbf9181-a71f-4714-b1b5-0d23a47d1306 TCGA-DD-A39Z-01A-11D-A20W-10 TCGA-DD-A39Z-01A-11D-A20Z-05 +TCGA-DD-A39Z-11 TCGA-DD-A39Z-11 TCGA-DD-A39Z TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 43 3.5 3.1 5.0 TCGA-DD-A39Z-F42006 TCGA-DD-A39Z 0.1 1.2 1 B 0.6 0.9 0.7 -15930 601 0 2 2013-4-24 FEMALE 165 Alcohol consumption extensive tobacco history Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 8.4 12.0 NO G2 No M0 NX T2 Stage II A39Z TUMOR FREE 437 150 450 12.6 YES R0 Solid Tissue Normal 11 Segmentectomy, Single 4th NO YES DD 1.1 Liver None DECEASED 61 1996 TCGA-DD-A39Z-11 f847f8c8-7a39-4327-ad12-3aac2c331be8 TCGA-DD-A39Z-11 f847f8c8-7a39-4327-ad12-3aac2c331be8 f847f8c8-7a39-4327-ad12-3aac2c331be8 f847f8c8-7a39-4327-ad12-3aac2c331be8 TCGA-DD-A39Z-11A-21D-A20Z-05 +TCGA-DD-A3A0-01 TCGA-DD-A3A0-01 TCGA-DD-A3A0 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO YES None 70 3.5 3.3 5.0 TCGA-DD-A3A0-F42710 TCGA-DD-A3A0 TCGA-DD-A3A0-01A 0.1 1.4 A 0.8 1.2 2.7 -25889 3586 785 0 359 1 0 6 1 0 - No Fibrosis 2013-4-27 MALE 178 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 220 8.4 12.0 NO NO G2 New Primary Tumor No NO YES No false No M0 NX T1 Stage I TCGA-DD-A3A0.C9E146D4-77FF-4877-8DA6-2E5D912F33C6.pdf A3A0 WITH TUMOR 138 150 450 NO NO 13.2 NO NO R0 Primary Tumor 01 Segmentectomy, Multiple 5th NO YES DD 1.0 Liver None A Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody DECEASED 88 2001 TCGA-DD-A3A0-01A-11D-A20V-01 TCGA-DD-A3A0-01A-11D-A20V-01 TCGA-DD-A3A0-01A-11D-A20W-10 TCGA-DD-A3A0-01 053627EF-A775-4F28-85F8-CDCFE4DCDDF7 TCGA-DD-A3A0-01A-11D-A20W-10 TCGA-DD-A3A0-01 TCGA-DD-A3A0-01A-11D-A20W-10 TCGA-DD-A3A0-01A-11D-A20W-10 TCGA-DD-A3A0-01A-11D-A20Z-05 +TCGA-DD-A3A1-01 TCGA-DD-A3A1-01 TCGA-DD-A3A1 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver None 65 3.5 3.8 5.0 TCGA-DD-A3A1-F42704 TCGA-DD-A3A1 TCGA-DD-A3A1-01A 0.1 0.8 1 A 0.8 1.2 1.1 -24046 3753 233 0 0 0 6 6 0 - No Fibrosis 2013-4-27 MALE 185 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 240 8.4 12.0 NO NO G2 false No M0 N0 T3b Stage IIIA TCGA-DD-A3A1.EAB38F5C-4399-48DE-A4F5-18B7CB982689.pdf A3A1 TUMOR FREE 178 150 450 NO NO 11.2 NO YES R0 Primary Tumor 01 Extended Lobectomy 5th NO YES DD 1.1 Liver Macro A DECEASED 78 2001 TCGA-DD-A3A1-01A-11D-A20V-01 TCGA-DD-A3A1-01A-11D-A20V-01 TCGA-DD-A3A1-01A-11D-A20W-10 TCGA-DD-A3A1-01 TCGA-DD-A3A1-01 8F14D825-2D09-4F5C-A2CD-0FAFC2104791 578e5ec2-7091-4f3e-a440-1fcd5585a704 TCGA-DD-A3A1-01A-11D-A20W-10 TCGA-DD-A3A1-01 TCGA-DD-A3A1-01 578e5ec2-7091-4f3e-a440-1fcd5585a704 TCGA-DD-A3A1-01A-11D-A20W-10 578e5ec2-7091-4f3e-a440-1fcd5585a704 578e5ec2-7091-4f3e-a440-1fcd5585a704 TCGA-DD-A3A1-01A-11D-A20W-10 TCGA-DD-A3A1-01A-11D-A20Z-05 +TCGA-DD-A3A1-11 TCGA-DD-A3A1-11 TCGA-DD-A3A1 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver None 65 3.5 3.8 5.0 TCGA-DD-A3A1-F42704 TCGA-DD-A3A1 TCGA-DD-A3A1-11A 0.1 0.8 1 A 0.8 1.2 1.1 -24046 3753 233 0 0 0 6 6 0 - No Fibrosis 2013-4-27 MALE 185 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 180 8.4 12.0 NO NO G2 false No M0 N0 T3b Stage IIIA A3A1 TUMOR FREE 178 150 450 NO NO 11.2 NO YES R0 Solid Tissue Normal 11 Extended Lobectomy 5th NO YES DD 1.1 Liver Macro A DECEASED 78 2001 TCGA-DD-A3A1-11 5573955b-f0ec-4cfe-ad02-4f9f91693770 TCGA-DD-A3A1-11 5573955b-f0ec-4cfe-ad02-4f9f91693770 5573955b-f0ec-4cfe-ad02-4f9f91693770 5573955b-f0ec-4cfe-ad02-4f9f91693770 TCGA-DD-A3A1-11A-11D-A20Z-05 +TCGA-DD-A3A2-01 TCGA-DD-A3A2-01 TCGA-DD-A3A2 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver None 76 3.5 4.2 5.0 TCGA-DD-A3A2-F42706 TCGA-DD-A3A2 TCGA-DD-A3A2-01A 0.1 0.5 A 0.6 0.9 0.8 -27930 4962 2131 0 0 0 - No Fibrosis 2013-4-27 FEMALE 178 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 250 8.4 12.0 NO NO G1 false No M0 N0 T1 Stage I TCGA-DD-A3A2.91B547FA-DAB2-4B65-9AC4-5151D4524001.pdf A3A2 TUMOR FREE 326 150 450 NO NO 8.8 NO NO R0 Primary Tumor 01 Segmentectomy, Multiple 5th NO YES DD 1.1 Liver None A DECEASED 85 1998 TCGA-DD-A3A2-01A-11D-A20V-01 TCGA-DD-A3A2-01A-11D-A20V-01 TCGA-DD-A3A2-01A-11D-A20W-10 TCGA-DD-A3A2-01 TCGA-DD-A3A2-01 694C11EB-8C14-41FF-AD29-B0029EE9A218 b532e040-8d89-458b-a13c-3da835918813 TCGA-DD-A3A2-01A-11D-A20W-10 TCGA-DD-A3A2-01 TCGA-DD-A3A2-01 b532e040-8d89-458b-a13c-3da835918813 TCGA-DD-A3A2-01A-11D-A20W-10 b532e040-8d89-458b-a13c-3da835918813 b532e040-8d89-458b-a13c-3da835918813 TCGA-DD-A3A2-01A-11D-A20W-10 TCGA-DD-A3A2-01A-11D-A20Z-05 +TCGA-DD-A3A2-11 TCGA-DD-A3A2-11 TCGA-DD-A3A2 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver None 76 3.5 4.2 5.0 TCGA-DD-A3A2-F42706 TCGA-DD-A3A2 TCGA-DD-A3A2-11A 0.1 0.5 A 0.6 0.9 0.8 -27930 4962 2131 0 0 0 - No Fibrosis 2013-4-27 FEMALE 178 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 160 8.4 12.0 NO NO G1 false No M0 N0 T1 Stage I A3A2 TUMOR FREE 326 150 450 NO NO 8.8 NO NO R0 Solid Tissue Normal 11 Segmentectomy, Multiple 5th NO YES DD 1.1 Liver None A DECEASED 85 1998 TCGA-DD-A3A2-11 6d9b3d3a-2dd0-477e-aaf2-504ecd6c3de3 TCGA-DD-A3A2-11 6d9b3d3a-2dd0-477e-aaf2-504ecd6c3de3 6d9b3d3a-2dd0-477e-aaf2-504ecd6c3de3 6d9b3d3a-2dd0-477e-aaf2-504ecd6c3de3 TCGA-DD-A3A2-11A-11D-A20Z-05 +TCGA-DD-A3A3-01 TCGA-DD-A3A3-01 TCGA-DD-A3A3 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver None 45 TCGA-DD-A3A3-F42700 TCGA-DD-A3A3 TCGA-DD-A3A3-01A 0.1 0.9 B 0.8 1.2 1.2 -16708 4397 535 0 1 0 6 6 0 - No Fibrosis 2013-4-27 MALE 167 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 250 8.4 12.0 NO NO G2 false No M0 N0 T1 Stage I TCGA-DD-A3A3.A37A1F44-D2AD-457C-8292-3E7A6667268D.pdf A3A3 276 150 450 8.8 NO R0 Primary Tumor 01 Extended Lobectomy 5th NO YES DD 1.1 Liver Macro A DECEASED 71 1999 TCGA-DD-A3A3-01A-11D-A22E-01 TCGA-DD-A3A3-01A-11D-A22E-01 TCGA-DD-A3A3-01A-11D-A22F-10 TCGA-DD-A3A3-01 TCGA-DD-A3A3-01 12B1E429-5B1A-40A2-BEBD-65CAECD789C3 3d39e165-1def-4a5e-b011-b2ceb033d415 TCGA-DD-A3A3-01A-11D-A22F-10 TCGA-DD-A3A3-01 TCGA-DD-A3A3-01 3d39e165-1def-4a5e-b011-b2ceb033d415 TCGA-DD-A3A3-01A-11D-A22F-10 3d39e165-1def-4a5e-b011-b2ceb033d415 3d39e165-1def-4a5e-b011-b2ceb033d415 TCGA-DD-A3A3-01A-11D-A22F-10 TCGA-DD-A3A3-01A-11D-A22H-05 +TCGA-DD-A3A3-11 TCGA-DD-A3A3-11 TCGA-DD-A3A3 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver None 45 TCGA-DD-A3A3-F42700 TCGA-DD-A3A3 TCGA-DD-A3A3-11A 0.1 0.9 B 0.8 1.2 1.2 -16708 4397 535 0 1 0 6 6 0 - No Fibrosis 2013-4-27 MALE 167 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 190 8.4 12.0 NO NO G2 false No M0 N0 T1 Stage I A3A3 276 150 450 8.8 NO R0 Solid Tissue Normal 11 Extended Lobectomy 5th NO YES DD 1.1 Liver Macro A DECEASED 71 1999 TCGA-DD-A3A3-11 13d4c229-cf05-4fca-a52d-798dc7894ba1 TCGA-DD-A3A3-11 13d4c229-cf05-4fca-a52d-798dc7894ba1 13d4c229-cf05-4fca-a52d-798dc7894ba1 13d4c229-cf05-4fca-a52d-798dc7894ba1 TCGA-DD-A3A3-11A-11D-A22H-05 +TCGA-DD-A3A4-01 TCGA-DD-A3A4-01 TCGA-DD-A3A4 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver YES NO None 37 3.5 3.3 5.0 TCGA-DD-A3A4-F42697 TCGA-DD-A3A4 TCGA-DD-A3A4-01A 0.1 1.0 2 B 0.4 1.2 1.0 -13739 4776 612 0 87 0 0 - No Fibrosis 2013-4-27 MALE 189 Other Tobacco use Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 160 8.4 12.0 NO NO G3 Liver Intrahepatic Recurrence Yes NO YES No false No M0 N0 T3 Stage IIIA TCGA-DD-A3A4.C755324B-9B82-4319-BDD8-EB8A24107AAC.pdf A3A4 WITH TUMOR 283 150 450 YES NO 11.0 NO YES R0 Primary Tumor 01 Extended Lobectomy 5th NO YES DD 1.0 Liver None A DECEASED 65 1998 TCGA-DD-A3A4-01A-11D-A22E-01 TCGA-DD-A3A4-01A-11D-A22E-01 TCGA-DD-A3A4-01A-11D-A22F-10 TCGA-DD-A3A4-01 TCGA-DD-A3A4-01 953B1312-01CF-4CB4-8916-F3813C9FE832 3bf58509-d849-492e-85cc-665f1db2ccc7 TCGA-DD-A3A4-01A-11D-A22F-10 TCGA-DD-A3A4-01 TCGA-DD-A3A4-01 3bf58509-d849-492e-85cc-665f1db2ccc7 TCGA-DD-A3A4-01A-11D-A22F-10 3bf58509-d849-492e-85cc-665f1db2ccc7 3bf58509-d849-492e-85cc-665f1db2ccc7 TCGA-DD-A3A4-01A-11D-A22F-10 TCGA-DD-A3A4-01A-11D-A22H-05 +TCGA-DD-A3A4-11 TCGA-DD-A3A4-11 TCGA-DD-A3A4 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver YES NO None 37 3.5 3.3 5.0 TCGA-DD-A3A4-F42697 TCGA-DD-A3A4 0.1 1.0 2 B 0.4 1.2 1.0 -13739 612 0 87 0 0 - No Fibrosis 2013-4-27 MALE 189 Other Tobacco use Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 8.4 12.0 NO G3 Liver Intrahepatic Recurrence Yes NO YES No No M0 N0 T3 Stage IIIA A3A4 WITH TUMOR 283 150 450 YES NO 11.0 NO YES R0 Solid Tissue Normal 11 Extended Lobectomy 5th NO YES DD 1.0 Liver None DECEASED 65 1998 TCGA-DD-A3A4-11 b706b36a-2bcf-405c-aa18-30cbb54fac73 TCGA-DD-A3A4-11 b706b36a-2bcf-405c-aa18-30cbb54fac73 b706b36a-2bcf-405c-aa18-30cbb54fac73 b706b36a-2bcf-405c-aa18-30cbb54fac73 +TCGA-DD-A3A5-01 TCGA-DD-A3A5-01 TCGA-DD-A3A5 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO None 66 3.5 4.2 5.0 TCGA-DD-A3A5-F42571 TCGA-DD-A3A5 TCGA-DD-A3A5-01A 0.1 0.8 A 0.6 0.9 0.7 -24288 5538 3125 0 84 1 0 6 55 0 - No Fibrosis 2013-4-24 FEMALE 170 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 250 8.4 12.0 NO NO G2 Liver Intrahepatic Recurrence Yes NO YES No false No M0 N0 T3 Stage III TCGA-DD-A3A5.646F2FED-EA95-4758-B454-4B0E638553B4.pdf A3A5 WITH TUMOR 312 150 450 NO NO 8.7 NO NO R0 Primary Tumor 01 Segmentectomy, Multiple 4th NO YES DD 1.1 Liver None A DECEASED 58 1996 TCGA-DD-A3A5-01A-11D-A22E-01 TCGA-DD-A3A5-01A-11D-A22E-01 TCGA-DD-A3A5-01A-11D-A22F-10 TCGA-DD-A3A5-01 TCGA-DD-A3A5-01 EB836FD0-DB80-410C-8C1E-8F713772CE75 a2367aee-0cd5-473e-b799-77970c0ceea3 TCGA-DD-A3A5-01A-11D-A22F-10 TCGA-DD-A3A5-01 TCGA-DD-A3A5-01 a2367aee-0cd5-473e-b799-77970c0ceea3 TCGA-DD-A3A5-01A-11D-A22F-10 a2367aee-0cd5-473e-b799-77970c0ceea3 a2367aee-0cd5-473e-b799-77970c0ceea3 TCGA-DD-A3A5-01A-11D-A22F-10 TCGA-DD-A3A5-01A-11D-A22H-05 +TCGA-DD-A3A5-11 TCGA-DD-A3A5-11 TCGA-DD-A3A5 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO None 66 3.5 4.2 5.0 TCGA-DD-A3A5-F42571 TCGA-DD-A3A5 0.1 0.8 A 0.6 0.9 0.7 -24288 3125 0 84 1 0 6 55 0 - No Fibrosis 2013-4-24 FEMALE 170 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 8.4 12.0 NO G2 Liver Intrahepatic Recurrence Yes NO YES No No M0 N0 T3 Stage III A3A5 WITH TUMOR 312 150 450 NO NO 8.7 NO NO R0 Solid Tissue Normal 11 Segmentectomy, Multiple 4th NO YES DD 1.1 Liver None DECEASED 58 1996 TCGA-DD-A3A5-11 dfeaa69b-72ec-4a2e-8f26-7c4d826a1aa0 TCGA-DD-A3A5-11 dfeaa69b-72ec-4a2e-8f26-7c4d826a1aa0 dfeaa69b-72ec-4a2e-8f26-7c4d826a1aa0 dfeaa69b-72ec-4a2e-8f26-7c4d826a1aa0 +TCGA-DD-A3A6-01 TCGA-DD-A3A6-01 TCGA-DD-A3A6 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver None 72 3.5 4.3 5.0 TCGA-DD-A3A6-F42703 TCGA-DD-A3A6 TCGA-DD-A3A6-01A 0.1 0.4 A 0.6 0.9 1.0 -26319 5304 3258 0 0 0 - No Fibrosis 2013-4-27 FEMALE 175 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 150 8.4 12.0 NO NO G2 NO false No M0 N0 T2 Stage II TCGA-DD-A3A6.EEA9EFFB-B5F9-42D9-B452-E165E018C33C.pdf A3A6 TUMOR FREE 4 0 6 NO NO 9.3 NO NO R0 Primary Tumor 01 Extended Lobectomy 4th NO YES DD 1.1 Liver Micro A Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody DECEASED 52 1997 TCGA-DD-A3A6-01A-11D-A22E-01 TCGA-DD-A3A6-01A-11D-A22E-01 TCGA-DD-A3A6-01A-11D-A22F-10 TCGA-DD-A3A6-01 TCGA-DD-A3A6-01 BA568908-D423-4039-87E8-B5597CB65AB9 56e6f602-0afb-434e-b28e-665d923ad781 TCGA-DD-A3A6-01A-11D-A22F-10 TCGA-DD-A3A6-01 TCGA-DD-A3A6-01 56e6f602-0afb-434e-b28e-665d923ad781 TCGA-DD-A3A6-01A-11D-A22F-10 56e6f602-0afb-434e-b28e-665d923ad781 56e6f602-0afb-434e-b28e-665d923ad781 TCGA-DD-A3A6-01A-11D-A22F-10 TCGA-DD-A3A6-01A-11D-A22H-05 +TCGA-DD-A3A6-11 TCGA-DD-A3A6-11 TCGA-DD-A3A6 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver None 72 3.5 4.3 5.0 TCGA-DD-A3A6-F42703 TCGA-DD-A3A6 TCGA-DD-A3A6-11A 0.1 0.4 A 0.6 0.9 1.0 -26319 5304 3258 0 0 0 - No Fibrosis 2013-4-27 FEMALE 175 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 20 8.4 12.0 NO NO G2 NO false No M0 N0 T2 Stage II A3A6 TUMOR FREE 4 0 6 NO NO 9.3 NO NO R0 Solid Tissue Normal 11 Extended Lobectomy 4th NO YES DD 1.1 Liver Micro A Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody DECEASED 52 1997 TCGA-DD-A3A6-11 809db606-7929-48aa-ae6b-c2c9597a31c7 TCGA-DD-A3A6-11 809db606-7929-48aa-ae6b-c2c9597a31c7 809db606-7929-48aa-ae6b-c2c9597a31c7 809db606-7929-48aa-ae6b-c2c9597a31c7 +TCGA-DD-A3A7-01 TCGA-DD-A3A7-01 TCGA-DD-A3A7 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver YES NO Mild 67 TCGA-DD-A3A7-F42004 TCGA-DD-A3A7 TCGA-DD-A3A7-01A 0.1 0.8 4 0.8 1.2 1.4 -24599 4772 419 0 144 1 0 6 120 0 - No Fibrosis 2013-4-9 MALE 188 Alcohol consumption|Other tobacco Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 130 8.4 12.0 NO NO G3 Liver Intrahepatic Recurrence No NO YES No false No M0 N0 T3b Stage IIIB TCGA-DD-A3A7.B520F88D-4004-4DFA-BF8D-7CE96777C5A3.pdf A3A7 WITH TUMOR 562 150 450 NO NO 10.6 NO YES R0 Primary Tumor 01 Lobectomy 7th NO YES DD 1.1 Liver Micro A Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody DECEASED 80 1998 TCGA-DD-A3A7-01A-11D-A22E-01 TCGA-DD-A3A7-01A-11D-A22E-01 TCGA-DD-A3A7-01A-11D-A22F-10 TCGA-DD-A3A7-01 TCGA-DD-A3A7-01 DC935FAC-6F3A-4861-A820-4F0A5D7D8CEA 5bd6ca42-16ca-484f-877f-cda4fb3f93a8 TCGA-DD-A3A7-01A-11D-A22F-10 TCGA-DD-A3A7-01 TCGA-DD-A3A7-01 5bd6ca42-16ca-484f-877f-cda4fb3f93a8 TCGA-DD-A3A7-01A-11D-A22F-10 5bd6ca42-16ca-484f-877f-cda4fb3f93a8 5bd6ca42-16ca-484f-877f-cda4fb3f93a8 TCGA-DD-A3A7-01A-11D-A22F-10 TCGA-DD-A3A7-01A-11D-A22H-05 +TCGA-DD-A3A8-01 TCGA-DD-A3A8-01 TCGA-DD-A3A8 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver None 75 TCGA-DD-A3A8-F42570 TCGA-DD-A3A8 TCGA-DD-A3A8-01A 0.1 1.0 3 A 0.8 1.2 0.9 -27524 3708 11 0 1 0 6 4 0 - No Fibrosis 2013-4-24 MALE 177 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 290 NO NO G2 NO false Yes M0 N0 T2 Stage II TCGA-DD-A3A8.5D143B3D-AC64-4C1C-A276-D12111750C67.pdf A3A8 TUMOR FREE 251 150 450 NO NO NO YES R0 Primary Tumor 01 Lobectomy 5th NO YES DD 1.0 Liver None A Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody DECEASED 99 2001 TCGA-DD-A3A8-01A-11D-A22E-01 TCGA-DD-A3A8-01A-11D-A22E-01 TCGA-DD-A3A8-01A-11D-A22F-10 TCGA-DD-A3A8-01 TCGA-DD-A3A8-01 D0C214D0-9A29-41AE-9FC4-1FE0D7B5428A 41e90e6f-0afe-433e-a13d-cc5fc758c55b TCGA-DD-A3A8-01A-11D-A22F-10 TCGA-DD-A3A8-01 TCGA-DD-A3A8-01 41e90e6f-0afe-433e-a13d-cc5fc758c55b TCGA-DD-A3A8-01A-11D-A22F-10 41e90e6f-0afe-433e-a13d-cc5fc758c55b 41e90e6f-0afe-433e-a13d-cc5fc758c55b TCGA-DD-A3A8-01A-11D-A22F-10 TCGA-DD-A3A8-01A-11D-A22H-05 +TCGA-DD-A3A8-11 TCGA-DD-A3A8-11 TCGA-DD-A3A8 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver None 75 TCGA-DD-A3A8-F42570 TCGA-DD-A3A8 0.1 1.0 3 A 0.8 1.2 0.9 -27524 11 0 1 0 6 4 0 - No Fibrosis 2013-4-24 MALE 177 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES NO G2 NO Yes M0 N0 T2 Stage II A3A8 TUMOR FREE 251 150 450 NO NO NO YES R0 Solid Tissue Normal 11 Lobectomy 5th NO YES DD 1.0 Liver None Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody DECEASED 99 2001 TCGA-DD-A3A8-11 cf95e020-748c-474d-baba-68ca888d2f4f TCGA-DD-A3A8-11 cf95e020-748c-474d-baba-68ca888d2f4f cf95e020-748c-474d-baba-68ca888d2f4f cf95e020-748c-474d-baba-68ca888d2f4f +TCGA-DD-A3A9-01 TCGA-DD-A3A9-01 TCGA-DD-A3A9 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver None 64 3.5 4.0 5.0 TCGA-DD-A3A9-F42709 TCGA-DD-A3A9 TCGA-DD-A3A9-01A 0.1 0.3 A 0.6 0.9 0.9 -23526 3584 931 0 289 1 0 6 19930 0 - No Fibrosis 2013-4-27 FEMALE 168 Other smoker Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 230 8.4 12.0 NO NO G2 Lung Extrahepatic Recurrence NO YES false No M1 N0 T4 Stage IVB TCGA-DD-A3A9.59B64E76-42CB-421D-B8A7-36F7050BA5E5.pdf A3A9 WITH TUMOR 317 150 450 9.3 NO R0 Primary Tumor 01 Lobectomy 5th NO YES DD 1.0 Liver None A DECEASED 62 2001 TCGA-DD-A3A9-01A-11D-A25U-01 TCGA-DD-A3A9-01A-11D-A25U-01 TCGA-DD-A3A9-01A-11D-A25V-10 TCGA-DD-A3A9-01 TCGA-DD-A3A9-01 8021FC77-6677-4784-83FA-19CF2ECBDC1F e53f26c4-eb37-4a21-823e-98000f26309d TCGA-DD-A3A9-01A-11D-A25V-10 TCGA-DD-A3A9-01 TCGA-DD-A3A9-01 e53f26c4-eb37-4a21-823e-98000f26309d TCGA-DD-A3A9-01A-11D-A25V-10 e53f26c4-eb37-4a21-823e-98000f26309d e53f26c4-eb37-4a21-823e-98000f26309d TCGA-DD-A3A9-01A-11D-A25V-10 TCGA-DD-A3A9-01A-11D-A264-05 +TCGA-DD-A4NA-01 TCGA-DD-A4NA-01 TCGA-DD-A4NA TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver None 67 TCGA-DD-A4-F49640 TCGA-DD-A4 TCGA-DD-A4-01A 2 0.6 1.1 0.8 -24603 1198 0 1008 0 0 6 3 5 - Nodular Formation and Incomplete Cirrhosis 2013-10-7 FEMALE 166 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 110 8.3 10.8 NO YES G3 NO true No M0 N1 T2 Stage IIIC TCGA-DD-A4.48C11C04-947E-4954-9687-DF275D897F79.pdf A4 TUMOR FREE 332 150 450 NO NO 9.6 NO YES R0 Primary Tumor 01 Extended Lobectomy 6th NO YES DD Liver A Hepatitis B Surface Antigen|HBV Surface Antibody LIVING 93 2009 TCGA-DD-A4NA-01A-11D-A25U-01 TCGA-DD-A4NA-01A-11D-A25U-01 TCGA-DD-A4NA-01A-11D-A25V-10 TCGA-DD-A4NA-01 TCGA-DD-A4NA-01 C7C5E4DB-1B88-4A44-8048-7E87E1540459 59b320d5-a277-4723-b9f0-d1e7fe2a20af TCGA-DD-A4NA-01A-11D-A25V-10 TCGA-DD-A4NA-01 TCGA-DD-A4NA-01 59b320d5-a277-4723-b9f0-d1e7fe2a20af TCGA-DD-A4NA-01A-11D-A25V-10 59b320d5-a277-4723-b9f0-d1e7fe2a20af 59b320d5-a277-4723-b9f0-d1e7fe2a20af TCGA-DD-A4NA-01A-11D-A25V-10 TCGA-DD-A4NA-01A-11D-A264-05 +TCGA-DD-A4NB-01 TCGA-DD-A4NB-01 TCGA-DD-A4NB TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO Mild 25 TCGA-DD-A4NB-F59448 TCGA-DD-A4NB TCGA-DD-A4NB-01A 0.1 1.0 2 0.8 1.3 0.8 -9426 464 0 989 913 912 1 0 6 3 2014-5-13 MALE 185 No History of Primary Risk Factors Fibrolamellar Carcinoma No C22.0 8171/3 C22.0 YES 180 9.5 13.8 NO NO G2 Other, specify Extrahepatic Recurrence retroperitoneal lymph nodes No YES YES No true No M0 N0 T1 Stage I TCGA-DD-A4NB.963CA9F8-DA47-4E2E-892E-14E7AB0EB76E.pdf A4NB TUMOR FREE 296 150 450 NO NO 13.9 NO YES R0 R0 Primary Tumor 01 Segmentectomy, Multiple 7th NO YES DD 1.0 Liver None A LIVING 69 2011 TCGA-DD-A4NB-01A-12D-A25U-01 TCGA-DD-A4NB-01A-12D-A25U-01 TCGA-DD-A4NB-01A-12D-A25V-10 TCGA-DD-A4NB-01 TCGA-DD-A4NB-01 45787358-74F0-4C4F-85E9-984864B87439 173a2cc4-0d27-4a27-857f-97a0e53fa8d1 TCGA-DD-A4NB-01A-12D-A25V-10 TCGA-DD-A4NB-01 TCGA-DD-A4NB-01 173a2cc4-0d27-4a27-857f-97a0e53fa8d1 TCGA-DD-A4NB-01A-12D-A25V-10 173a2cc4-0d27-4a27-857f-97a0e53fa8d1 173a2cc4-0d27-4a27-857f-97a0e53fa8d1 TCGA-DD-A4NB-01A-12D-A25V-10 TCGA-DD-A4NB-01A-12D-A264-05 +TCGA-DD-A4ND-01 TCGA-DD-A4ND-01 TCGA-DD-A4ND TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO None 56 3.5 3.9 5 TCGA-DD-A4ND-F43021 TCGA-DD-A4ND TCGA-DD-A4ND-01A 0.1 0.5 3 A 0.6 1.1 0.7 -20782 2088 0 2746 20 1 0 - No Fibrosis 2014-10-21 FEMALE 162 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 140 8.4 12 NO NO G3 Other, specify New Primary Tumor stage IV breast carcinoma No NO NO No true Yes M0 N0 T1 Stage I TCGA-DD-A4ND.64D878AE-DEEA-4C56-854C-3774038E2914.pdf A4ND TUMOR FREE NO NO 8.8 NO YES R0 Primary Tumor 01 Lobectomy 6th NO YES DD 1 Liver None A LIVING 89 2007 TCGA-DD-A4ND-01A-11D-A25U-01 TCGA-DD-A4ND-01A-11D-A25U-01 TCGA-DD-A4ND-01A-11D-A25V-10 TCGA-DD-A4ND-01 TCGA-DD-A4ND-01 BED220BC-C4F4-407D-A237-BB3ADCAB45CB b3d02a68-fde3-42cd-8ca2-7e3565f85632 TCGA-DD-A4ND-01A-11D-A25V-10 TCGA-DD-A4ND-01 TCGA-DD-A4ND-01 b3d02a68-fde3-42cd-8ca2-7e3565f85632 TCGA-DD-A4ND-01A-11D-A25V-10 b3d02a68-fde3-42cd-8ca2-7e3565f85632 b3d02a68-fde3-42cd-8ca2-7e3565f85632 TCGA-DD-A4ND-01A-11D-A25V-10 TCGA-DD-A4ND-01A-11D-A264-05 +TCGA-DD-A4NE-01 TCGA-DD-A4NE-01 TCGA-DD-A4NE TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO None 75 3.5 4.2 5.0 TCGA-DD-A4NE-F49644 TCGA-DD-A4NE TCGA-DD-A4NE-01A 0.1 0.9 3 A 0.6 1.0 0.8 -27549 631 660 0 190 0 0 6 28 0 - No Fibrosis 2013-10-7 FEMALE 170 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 200 8.3 10.8 NO NO G3 Liver Locoregional Recurrence No NO YES No true No M0 N0 T3a Stage IIIA TCGA-DD-A4NE.8E3E5E19-6A21-44B1-B000-F90EA27F6EE0.pdf A4NE WITH TUMOR 348 150 450 NO NO 10.2 NO YES R0 Primary Tumor 01 Extended Lobectomy 7th NO YES DD 1.0 Liver None A Hepatitis C Virus R|Hepatitis B Surface Antigen|HBV Core Antibody DECEASED 79 2011 TCGA-DD-A4NE-01A-11D-A27I-10 TCGA-DD-A4NE-01 TCGA-DD-A4NE-01 A13ADCC3-E48C-4BFA-8AC2-654490756B65 050080ae-44db-4056-8df1-eae4d9014ac9 TCGA-DD-A4NE-01A-11D-A27I-10 TCGA-DD-A4NE-01 050080ae-44db-4056-8df1-eae4d9014ac9 TCGA-DD-A4NE-01A-11D-A27I-10 050080ae-44db-4056-8df1-eae4d9014ac9 050080ae-44db-4056-8df1-eae4d9014ac9 TCGA-DD-A4NE-01A-11D-A27I-10 TCGA-DD-A4NE-01A-11D-A27W-05 +TCGA-DD-A4NF-01 TCGA-DD-A4NF-01 TCGA-DD-A4NF TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO YES Mild 72 3.5 4 5.0 TCGA-DD-A4NF-F59456 TCGA-DD-A4NF TCGA-DD-A4NF-01A 0.1 0.5 A 0.8 1.3 0.9 -26330 364 0 942 656 0 0 6 6 6 - Established Cirrhosis 2014-5-13 MALE 173 Hepatitis C Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 200 9.5 13.8 NO NO G2 Bone Extrahepatic Recurrence No NO YES No true No M0 N0 T1 Stage I TCGA-DD-A4NF.7381633C-866A-4440-93B1-BC7102B59C93.pdf A4NF WITH TUMOR 97 150 450 NO NO 12.7 NO NO R0 Primary Tumor 01 Segmentectomy, Single 7th NO YES DD 1.0 Liver None A Hepatitis C Virus R|HCV Genotype|Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody LIVING 86 2011 TCGA-DD-A4NF-01A-11D-A27H-01 TCGA-DD-A4NF-01A-11D-A27H-01 TCGA-DD-A4NF-01A-11D-A27I-10 TCGA-DD-A4NF-01 TCGA-DD-A4NF-01 F89D6497-C924-4C3A-953D-6DCA31C8764A 23ac1fcb-a802-468b-8a25-639f2b221aba TCGA-DD-A4NF-01A-11D-A27I-10 TCGA-DD-A4NF-01 TCGA-DD-A4NF-01 23ac1fcb-a802-468b-8a25-639f2b221aba TCGA-DD-A4NF-01A-11D-A27I-10 23ac1fcb-a802-468b-8a25-639f2b221aba 23ac1fcb-a802-468b-8a25-639f2b221aba TCGA-DD-A4NF-01A-11D-A27I-10 TCGA-DD-A4NF-01A-11D-A27W-05 +TCGA-DD-A4NG-01 TCGA-DD-A4NG-01 TCGA-DD-A4NG TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver None 77 3.5 4.5 5.0 TCGA-DD-A4NG-F49648 TCGA-DD-A4NG TCGA-DD-A4NG-01A 0.1 0.5 1 A 0.8 1.3 0.9 -28234 629 802 0 445 430 1 0 6 3 2013-10-7 MALE 164 Alcohol consumption Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 280 8.3 10.8 NO NO G2 Liver Locoregional Recurrence NO YES No true No M0 NX T3a Stage IIIA TCGA-DD-A4NG.4E4F148F-7C70-43DE-802E-271078BDFB4F.pdf A4NG WITH TUMOR 220 150 450 NO NO 10.6 NO YES R0 Primary Tumor 01 Segmentectomy, Multiple 7th NO YES DD 1.0 Liver Micro A Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody DECEASED 94 2011 TCGA-DD-A4NG-01A-11D-A27I-10 TCGA-DD-A4NG-01 TCGA-DD-A4NG-01 43087284-F231-4802-AA2D-34B8622D1846 0fd0cbba-815e-4087-aa44-39c4b271ff49 TCGA-DD-A4NG-01A-11D-A27I-10 TCGA-DD-A4NG-01 0fd0cbba-815e-4087-aa44-39c4b271ff49 TCGA-DD-A4NG-01A-11D-A27I-10 0fd0cbba-815e-4087-aa44-39c4b271ff49 0fd0cbba-815e-4087-aa44-39c4b271ff49 TCGA-DD-A4NG-01A-11D-A27I-10 TCGA-DD-A4NG-01A-11D-A27W-05 +TCGA-DD-A4NH-01 TCGA-DD-A4NH-01 TCGA-DD-A4NH TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver YES NO None 65 3.5 4.0 5.0 TCGA-DD-A4NH-F59474 TCGA-DD-A4NH TCGA-DD-A4NH-01A 0.1 0.6 1 A 0.6 1.1 0.8 -23865 335 0 917 161 0 0 6 92889 1,2 - Portal Fibrosis 2014-5-13 FEMALE 157 Alcohol consumption Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 270 9.5 13.8 NO NO G3 Lung Extrahepatic Recurrence No NO YES No true No M0 N0 T3b Stage IIIB TCGA-DD-A4NH.C9179EC7-2990-4581-B652-60289CC895F5.pdf A4NH WITH TUMOR 226 150 450 NO NO 11.8 NO YES R0 Primary Tumor 01 Extended Lobectomy 7th NO YES DD 1.0 Liver Macro A Hepatitis B Surface Antigen LIVING 81 2011 TCGA-DD-A4NH-01A-11D-A27H-01 TCGA-DD-A4NH-01A-11D-A27H-01 TCGA-DD-A4NH-01A-11D-A27I-10 TCGA-DD-A4NH-01 TCGA-DD-A4NH-01 DAC12730-5AF5-47EB-9DC6-008E0D3C2CD6 8d1c5ea4-08dd-4f4f-9876-ca5316e233b5 TCGA-DD-A4NH-01A-11D-A27I-10 TCGA-DD-A4NH-01 TCGA-DD-A4NH-01 8d1c5ea4-08dd-4f4f-9876-ca5316e233b5 TCGA-DD-A4NH-01A-11D-A27I-10 8d1c5ea4-08dd-4f4f-9876-ca5316e233b5 8d1c5ea4-08dd-4f4f-9876-ca5316e233b5 TCGA-DD-A4NH-01A-11D-A27I-10 TCGA-DD-A4NH-01A-11D-A27W-05 +TCGA-DD-A4NI-01 TCGA-DD-A4NI-01 TCGA-DD-A4NI TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 67 3.5 4.4 5.0 TCGA-DD-A4NI-F59476 TCGA-DD-A4NI TCGA-DD-A4NI-01A 0.1 0.6 6 A 0.8 1.3 1.1 -24516 357 0 816 0 0 6 6 0 - No Fibrosis 2014-5-13 MALE 172 Alcohol consumption|Non-Alcoholic Fatty Liver Disease tobacco Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 130 9.5 13.8 NO YES G2 NO true Yes M0 NX T2 Stage II TCGA-DD-A4NI.7D4F801A-187C-4B20-96B3-98313D5252E3.pdf A4NI TUMOR FREE 187 150 450 NO NO 12.4 NO YES R0 Primary Tumor 01 Lobectomy 7th NO YES DD 1.0 Liver None A Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody LIVING 99 2011 TCGA-DD-A4NI-01A-11D-A27H-01 TCGA-DD-A4NI-01A-11D-A27H-01 TCGA-DD-A4NI-01A-11D-A27I-10 TCGA-DD-A4NI-01 TCGA-DD-A4NI-01 C8A5BC94-6611-4B36-918E-0D26304CFCBA 49d9e652-b4e1-4858-b21e-256c17623f50 TCGA-DD-A4NI-01A-11D-A27I-10 TCGA-DD-A4NI-01 TCGA-DD-A4NI-01 49d9e652-b4e1-4858-b21e-256c17623f50 TCGA-DD-A4NI-01A-11D-A27I-10 49d9e652-b4e1-4858-b21e-256c17623f50 49d9e652-b4e1-4858-b21e-256c17623f50 TCGA-DD-A4NI-01A-11D-A27I-10 TCGA-DD-A4NI-01A-11D-A27W-05 +TCGA-DD-A4NJ-01 TCGA-DD-A4NJ-01 TCGA-DD-A4NJ TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO Mild 54 3.5 4.7 5.0 TCGA-DD-A4NJ-F59477 TCGA-DD-A4NJ TCGA-DD-A4NJ-01A 0.1 0.4 1 A 0.6 1.1 0.7 -19964 416 0 928 549 0 0 6 5 1,2 - Portal Fibrosis 2014-5-13 FEMALE 164 Non-Alcoholic Fatty Liver Disease Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 140 9.5 13.8 NO NO G2 Liver Intrahepatic Recurrence Yes NO YES No true No M0 N0 T2 Stage II TCGA-DD-A4NJ.36C3150D-343E-4B3F-A5D7-1AE978246648.pdf A4NJ WITH TUMOR 303 150 450 NO NO 11.5 NO YES R0 Primary Tumor 01 Lobectomy 7th NO YES DD 1.0 Liver None A Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody LIVING 88 2011 TCGA-DD-A4NJ-01A-11D-A27H-01 TCGA-DD-A4NJ-01A-11D-A27H-01 TCGA-DD-A4NJ-01A-11D-A27I-10 TCGA-DD-A4NJ-01 DCF080D8-9F50-4DB3-B327-0C52F23FCE8D 1dc20bf4-f17d-4b26-88c0-86aff9ddfc7a TCGA-DD-A4NJ-01A-11D-A27I-10 TCGA-DD-A4NJ-01 1dc20bf4-f17d-4b26-88c0-86aff9ddfc7a TCGA-DD-A4NJ-01A-11D-A27I-10 1dc20bf4-f17d-4b26-88c0-86aff9ddfc7a 1dc20bf4-f17d-4b26-88c0-86aff9ddfc7a TCGA-DD-A4NJ-01A-11D-A27I-10 TCGA-DD-A4NJ-01A-11D-A27W-05 +TCGA-DD-A4NK-01 TCGA-DD-A4NK-01 TCGA-DD-A4NK TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO None 80 3.5 4.1 5.0 TCGA-DD-A4NK-F49654 TCGA-DD-A4NK TCGA-DD-A4NK-01A 0.1 0.5 3 A 0.7 1.2 1.1 -29244 3143 1210 0 89 0 0 6 3 0 - No Fibrosis 2013-10-7 FEMALE No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 130 8.4 12.0 NO NO G2 Liver Intrahepatic Recurrence Yes NO YES No true No M0 N0 T3 Stage IIIA TCGA-DD-A4NK.0521278C-B2AC-4D7D-BC1F-5003B630808E.pdf A4NK WITH TUMOR 372 150 450 YES NO 8.7 NO YES R0 Primary Tumor 01 Lobectomy 6th NO YES DD 1.0 Liver None A Hepatitis B Surface Antigen DECEASED 84 2004 TCGA-DD-A4NK-01A-11D-A28W-01 TCGA-DD-A4NK-01A-11D-A28W-01 TCGA-DD-A4NK-01A-11D-A28X-10 TCGA-DD-A4NK-01 65645058-B639-4FBA-9204-6CC07D139290 28e2f8ef-14bf-4965-82a5-1d2e33a19af3 TCGA-DD-A4NK-01A-11D-A28X-10 TCGA-DD-A4NK-01 28e2f8ef-14bf-4965-82a5-1d2e33a19af3 TCGA-DD-A4NK-01A-11D-A28X-10 28e2f8ef-14bf-4965-82a5-1d2e33a19af3 28e2f8ef-14bf-4965-82a5-1d2e33a19af3 TCGA-DD-A4NK-01A-11D-A28X-10 TCGA-DD-A4NK-01A-11D-A28Y-05 +TCGA-DD-A4NL-01 TCGA-DD-A4NL-01 TCGA-DD-A4NL TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver None 46 3.5 4.4 5.0 TCGA-DD-A4NL-F59645 TCGA-DD-A4NL TCGA-DD-A4NL-01A 0.1 0.3 0.8 1.3 1.0 -16874 1896 0 1711 1 0 6 2 0 - No Fibrosis 2014-5-17 MALE 173 Alcohol consumption|Other Tobacco use Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 80 NO YES G1 NO true No M0 N0 T1 Stage I TCGA-DD-A4NL.54C7EDE1-EDBE-44A4-A3BE-FD639D6891DA.pdf A4NL TUMOR FREE 266 150 450 NO NO NO NO R0 Primary Tumor 01 Segmentectomy, Single 6th NO YES DD 1.0 Liver None A Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody LIVING 113 2007 TCGA-DD-A4NL-01A-11D-A28W-01 TCGA-DD-A4NL-01A-11D-A28W-01 TCGA-DD-A4NL-01A-11D-A28X-10 TCGA-DD-A4NL-01 TCGA-DD-A4NL-01 90779b87-ec28-4c54-b98e-3d70e132b7b3 TCGA-DD-A4NL-01A-11D-A28X-10 TCGA-DD-A4NL-01 TCGA-DD-A4NL-01 90779b87-ec28-4c54-b98e-3d70e132b7b3 TCGA-DD-A4NL-01A-11D-A28X-10 90779b87-ec28-4c54-b98e-3d70e132b7b3 90779b87-ec28-4c54-b98e-3d70e132b7b3 TCGA-DD-A4NL-01A-11D-A28X-10 TCGA-DD-A4NL-01A-11D-A28Y-05 +TCGA-DD-A4NN-01 TCGA-DD-A4NN-01 TCGA-DD-A4NN TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO 56 3.5 4.3 5.0 TCGA-DD-A4NN-F49659 TCGA-DD-A4NN TCGA-DD-A4NN-01A 0.1 0.5 1 A 0.7 1.2 0.9 -20548 3053 899 0 166 0 0 6 4223 0 - No Fibrosis 2013-10-7 FEMALE 163 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 240 8.0 12.0 NO NO G3 Lung Extrahepatic Recurrence No NO YES No true No M0 N0 T1 Stage I TCGA-DD-A4NN.16053CE8-B3B1-4925-AEAA-5B118E1C2E45.pdf A4NN WITH TUMOR 307 150 450 NO NO 8.8 NO YES R0 Primary Tumor 01 Segmentectomy, Multiple 6th NO YES DD 1.0 Liver None A DECEASED 59 2004 TCGA-DD-A4NN-01A-11D-A28W-01 TCGA-DD-A4NN-01A-11D-A28W-01 TCGA-DD-A4NN-01A-11D-A28X-10 TCGA-DD-A4NN-01 TCGA-DD-A4NN-01 9D74528E-5389-4281-B73A-894B9B356E0E 362c086d-ce73-408a-afcf-f129d54af1e9 TCGA-DD-A4NN-01A-11D-A28X-10 TCGA-DD-A4NN-01 TCGA-DD-A4NN-01 362c086d-ce73-408a-afcf-f129d54af1e9 TCGA-DD-A4NN-01A-11D-A28X-10 362c086d-ce73-408a-afcf-f129d54af1e9 362c086d-ce73-408a-afcf-f129d54af1e9 TCGA-DD-A4NN-01A-11D-A28X-10 TCGA-DD-A4NN-01A-11D-A28Y-05 +TCGA-DD-A4NO-01 TCGA-DD-A4NO-01 TCGA-DD-A4NO TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO Mild 65 3.5 4.5 5.0 TCGA-DD-A4NO-F49662 TCGA-DD-A4NO TCGA-DD-A4NO-01A 0.1 0.4 A 0.8 1.3 1.6 -24090 1879 0 2245 990 0 0 6 3 0 - No Fibrosis 2013-10-7 MALE 176 Hepatitis C|Other Tobacco use Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 190 8.4 12.0 NO NO G1 Liver Locoregional Recurrence Yes NO YES No true No M0 N0 T1 Stage I TCGA-DD-A4NO.0B108361-E361-4A8B-9F5C-FC3ACB992DB9.pdf A4NO WITH TUMOR 201 150 450 NO NO 9.9 NO NO R0 Primary Tumor 01 Segmentectomy, Multiple 6th NO YES DD 1.0 Liver None A Hepatitis C Virus R|Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody LIVING 109 2007 TCGA-DD-A4NO-01A-11D-A28W-01 TCGA-DD-A4NO-01A-11D-A28W-01 TCGA-DD-A4NO-01A-11D-A28X-10 TCGA-DD-A4NO-01 TCGA-DD-A4NO-01 4382BDF1-B3AD-44F1-92B0-1C7DC3CD4CE2 830be6d6-82f7-4085-88a4-060f01c267fb TCGA-DD-A4NO-01A-11D-A28X-10 TCGA-DD-A4NO-01 TCGA-DD-A4NO-01 830be6d6-82f7-4085-88a4-060f01c267fb TCGA-DD-A4NO-01A-11D-A28X-10 830be6d6-82f7-4085-88a4-060f01c267fb 830be6d6-82f7-4085-88a4-060f01c267fb TCGA-DD-A4NO-01A-11D-A28X-10 TCGA-DD-A4NO-01A-11D-A28Y-05 +TCGA-DD-A4NP-01 TCGA-DD-A4NP-01 TCGA-DD-A4NP TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO None 32 3.5 2.4 5.0 TCGA-DD-A4NP-F59646 TCGA-DD-A4NP TCGA-DD-A4NP-01A 0.1 0.7 B 0.9 1.4 1.9 -11838 2736 0 3308 1286 0 0 6 2 0 - No Fibrosis 2014-5-17 MALE 177 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 160 8.4 12.0 NO NO G3 Liver Intrahepatic Recurrence Yes NO YES No true No M0 N0 T1 Stage I TCGA-DD-A4NP.6C7AE628-1BC9-453D-A1C2-5F2F63A295FC.pdf A4NP TUMOR FREE 348 150 450 NO NO 8.9 NO NO R0 Primary Tumor 01 Lobectomy 6th NO YES DD 1.0 Liver None A Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody LIVING 79 2005 TCGA-DD-A4NP-01A-11D-A28W-01 TCGA-DD-A4NP-01A-11D-A28W-01 TCGA-DD-A4NP-01A-11D-A28X-10 TCGA-DD-A4NP-01 TCGA-DD-A4NP-01 BCE78D42-7476-4889-B557-651EE0EBACA7 3101309f-f0e5-42d8-88ca-a44d37d240f0 TCGA-DD-A4NP-01A-11D-A28X-10 TCGA-DD-A4NP-01 TCGA-DD-A4NP-01 3101309f-f0e5-42d8-88ca-a44d37d240f0 TCGA-DD-A4NP-01A-11D-A28X-10 3101309f-f0e5-42d8-88ca-a44d37d240f0 3101309f-f0e5-42d8-88ca-a44d37d240f0 TCGA-DD-A4NP-01A-11D-A28X-10 TCGA-DD-A4NP-01A-11D-A28Y-05 +TCGA-DD-A4NQ-01 TCGA-DD-A4NQ-01 TCGA-DD-A4NQ TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver YES NO Mild 60 3.5 4.4 5.0 TCGA-DD-A4NQ-F49669 TCGA-DD-A4NQ TCGA-DD-A4NQ-01A 0.1 0.7 1 A 0.8 1.3 0.8 -22111 2030 373 0 126 0 0 6 141 2013-10-7 MALE 159 Hepatitis B|Other tobacco Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 120 8.4 12.0 NO NO G3 Liver Intrahepatic Recurrence Yes NO YES No true No M0 N0 T2 Stage II TCGA-DD-A4NQ.D79DB738-2DA3-43F6-898C-4A212964FA03.pdf A4NQ WITH TUMOR 283 150 450 NO NO 10.1 NO YES R0 Primary Tumor 01 Segmentectomy, Multiple 6th NO YES DD 1.0 Liver Macro A Hepatitis C Virus R|Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody DECEASED 75 2007 TCGA-DD-A4NQ-01A-21D-A28W-01 TCGA-DD-A4NQ-01A-21D-A28W-01 TCGA-DD-A4NQ-01A-21D-A28X-10 TCGA-DD-A4NQ-01 TCGA-DD-A4NQ-01 A206D8AA-F54A-47BB-B0DA-E8D95F719D63 15a72f2f-83c5-4264-8103-5c3e28445d12 TCGA-DD-A4NQ-01A-21D-A28X-10 TCGA-DD-A4NQ-01 TCGA-DD-A4NQ-01 15a72f2f-83c5-4264-8103-5c3e28445d12 TCGA-DD-A4NQ-01A-21D-A28X-10 15a72f2f-83c5-4264-8103-5c3e28445d12 15a72f2f-83c5-4264-8103-5c3e28445d12 TCGA-DD-A4NQ-01A-21D-A28X-10 TCGA-DD-A4NQ-01A-21D-A28Y-05 +TCGA-DD-A4NR-01 TCGA-DD-A4NR-01 TCGA-DD-A4NR TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 85 3.5 3.1 5.0 TCGA-DD-A4NR-F49670 TCGA-DD-A4NR TCGA-DD-A4NR-01A 0.1 0.8 1 A 0.7 1.2 1.0 -31386 2652 9 0 0 0 6 40250 6 - Established Cirrhosis 2013-10-7 FEMALE 64 Other primary biliary cirrhosis Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 240 8.4 12.0 NO NO G3 NO true No M0 N0 T1 Stage I TCGA-DD-A4NR.93133C58-B1BF-4A5C-8EFC-AE17EC6A0B64.pdf A4NR TUMOR FREE 239 150 450 NO NO 9.3 NO YES R0 Primary Tumor 01 Segmentectomy, Single 6th NO YES DD 1.0 Liver None A Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody DECEASED 54 2005 TCGA-DD-A4NR-01A-11D-A30U-01 TCGA-DD-A4NR-01A-11D-A30U-01 TCGA-DD-A4NR-01A-11D-A30V-10 TCGA-DD-A4NR-01 TCGA-DD-A4NR-01 D99B1488-C4F1-46C5-BCEF-675E8FFB31D1 6af2d20a-bab8-4f0c-ac22-c1454619ef46 TCGA-DD-A4NR-01A-11D-A30V-10 TCGA-DD-A4NR-01 TCGA-DD-A4NR-01 6af2d20a-bab8-4f0c-ac22-c1454619ef46 TCGA-DD-A4NR-01A-11D-A30V-10 6af2d20a-bab8-4f0c-ac22-c1454619ef46 6af2d20a-bab8-4f0c-ac22-c1454619ef46 TCGA-DD-A4NR-01A-11D-A30V-10 TCGA-DD-A4NR-01A-11D-A30Y-05 +TCGA-DD-A4NS-01 TCGA-DD-A4NS-01 TCGA-DD-A4NS TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO None 61 TCGA-DD-A4NS-F49671 TCGA-DD-A4NS TCGA-DD-A4NS-01A 0.1 0.9 2 0.7 1.2 1.1 -22638 2596 2456 0 913 893 0 0 6 2 0 - No Fibrosis 2013-10-7 FEMALE 167 Alcohol consumption Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 140 8.4 12.0 NO NO G2 Bone Extrahepatic Recurrence No YES YES No true No M0 N0 T1 Stage I TCGA-DD-A4NS.97CA96D5-990E-41F9-949D-CCCCFFB78CBD.pdf A4NS WITH TUMOR 270 150 450 NO NO 8.8 NO YES R0 Primary Tumor 01 Lobectomy 6th NO YES DD 1.0 Liver None A Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody DECEASED 58 2005 TCGA-DD-A4NS-01A-11D-A30U-01 TCGA-DD-A4NS-01A-11D-A30U-01 TCGA-DD-A4NS-01A-11D-A30V-10 TCGA-DD-A4NS-01 TCGA-DD-A4NS-01 75C04C4C-1A60-4B07-B987-76598237D3E0 c3b5e80e-398b-4390-ae78-4f2cb9be4497 TCGA-DD-A4NS-01A-11D-A30V-10 TCGA-DD-A4NS-01 TCGA-DD-A4NS-01 c3b5e80e-398b-4390-ae78-4f2cb9be4497 TCGA-DD-A4NS-01A-11D-A30V-10 c3b5e80e-398b-4390-ae78-4f2cb9be4497 c3b5e80e-398b-4390-ae78-4f2cb9be4497 TCGA-DD-A4NS-01A-11D-A30V-10 TCGA-DD-A4NS-01A-11D-A30Y-05 +TCGA-DD-A4NV-01 TCGA-DD-A4NV-01 TCGA-DD-A4NV TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver None 61 3.5 3.9 5.0 TCGA-DD-A4NV-F59879 TCGA-DD-A4NV 0.1 0.5 1 A 0.8 1.3 0.8 -22438 0 2398 1 0 6 3 0 - No Fibrosis 2014-5-22 MALE 179 Non-Alcoholic Fatty Liver Disease|Other morbid obesity, tobacco use Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 8.4 12.0 NO G1 NO No M0 N0 T3 Stage IIIA A4NV TUMOR FREE 240 150 450 NO NO 9.0 NO YES R0 Primary Tumor 01 Segmentectomy, Multiple 6th NO YES DD 1.0 Liver None Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody LIVING 129 2007 TCGA-DD-A4NV-01A-11D-A30U-01 TCGA-DD-A4NV-01A-11D-A30U-01 TCGA-DD-A4NV-01A-11D-A30V-10 TCGA-DD-A4NV-01 TCGA-DD-A4NV-01 cabf0153-dac2-48ae-a225-19147772ddfe TCGA-DD-A4NV-01A-11D-A30V-10 TCGA-DD-A4NV-01 TCGA-DD-A4NV-01 cabf0153-dac2-48ae-a225-19147772ddfe TCGA-DD-A4NV-01A-11D-A30V-10 cabf0153-dac2-48ae-a225-19147772ddfe cabf0153-dac2-48ae-a225-19147772ddfe TCGA-DD-A4NV-01A-11D-A30V-10 TCGA-DD-A4NV-01A-11D-A30Y-05 +TCGA-DD-A73A-01 TCGA-DD-A73A-01 TCGA-DD-A73A TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver Mild 71 3.5 4.4 5.0 TCGA-DD-A73A-F66593 TCGA-DD-A73A 0.1 1.2 A 0.8 1.3 1.4 -26136 0 728 1 0 6 4 3,4 - Fibrous Speta 2014-10-21 MALE 174 Alcohol consumption Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 9.5 13.8 NO G2 NO No M0 N0 T1 Stage I A73A TUMOR FREE 89 150 450 NO NO 12.8 NO NO R0 Primary Tumor 01 Segmentectomy, Single 7th NO YES DD 1.0 Liver None Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody LIVING 102 2012 TCGA-DD-A73A-01A-12D-A32F-01 TCGA-DD-A73A-01A-12D-A32F-01 TCGA-DD-A73A-01A-12D-A32G-10 TCGA-DD-A73A-01 TCGA-DD-A73A-01 b2ae2c3b-87c2-47e1-9d66-ae23a3f83919 TCGA-DD-A73A-01A-12D-A32G-10 TCGA-DD-A73A-01 TCGA-DD-A73A-01 b2ae2c3b-87c2-47e1-9d66-ae23a3f83919 TCGA-DD-A73A-01A-12D-A32G-10 b2ae2c3b-87c2-47e1-9d66-ae23a3f83919 b2ae2c3b-87c2-47e1-9d66-ae23a3f83919 TCGA-DD-A73A-01A-12D-A32G-10 TCGA-DD-A73A-01A-12D-A32R-05 +TCGA-DD-A73B-01 TCGA-DD-A73B-01 TCGA-DD-A73B TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 72 3.5 3.5 5.0 TCGA-DD-A73B TCGA-DD-A73B-01A 0.1 2.1 1 B 0.6 1.1 0.9 -26390 345 283 0 0 0 6 30 6 - Established Cirrhosis 2013-9-30 FEMALE 154 Alpha-1 Antitrypsin Deficiency|Other Gilberts syndrome. Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 150 0.8 1.2 NO G2 YES false No M0 N0 T1 Stage I TCGA-DD-A73B.B1C57A75-7C86-49D9-B143-09E60824F508.pdf A73B WITH TUMOR 88 150 450 NO NO 1.1 NO YES R0 Primary Tumor 01 Segmentectomy, Multiple 7th NO YES DD 1.0 Liver None A Hepatitis B Surface Antigen DECEASED 74 2012 TCGA-DD-A73B-01A-12D-A32F-01 TCGA-DD-A73B-01A-12D-A32F-01 TCGA-DD-A73B-01A-12D-A32G-10 TCGA-DD-A73B-01 TCGA-DD-A73B-01 9C91FA76-A8F5-499C-9D32-2D8B107013D7 4ed5467c-be43-4125-a6c4-7b7aad6ea5f6 TCGA-DD-A73B-01A-12D-A32G-10 TCGA-DD-A73B-01 TCGA-DD-A73B-01 4ed5467c-be43-4125-a6c4-7b7aad6ea5f6 TCGA-DD-A73B-01A-12D-A32G-10 4ed5467c-be43-4125-a6c4-7b7aad6ea5f6 4ed5467c-be43-4125-a6c4-7b7aad6ea5f6 TCGA-DD-A73B-01A-12D-A32G-10 TCGA-DD-A73B-01A-12D-A32R-05 +TCGA-DD-A73C-01 TCGA-DD-A73C-01 TCGA-DD-A73C TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO None 65 3.5 4.9 5.0 TCGA-DD-A73C-F66595 TCGA-DD-A73C TCGA-DD-A73C-01A 0.1 0.7 1 A 0.6 1.1 0.8 -23782 288 0 701 566 0 0 6 3 0 - No Fibrosis 2014-10-21 FEMALE 159 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 160 9.5 13.8 NO NO G1 Liver Locoregional Recurrence No YES No false No M0 N0 T3a Stage IIIA TCGA-DD-A73C.FE051CD7-9C34-4A45-934C-DD8BB00C717A.pdf A73C WITH TUMOR 247 150 450 NO NO 11.7 NO YES R0 Primary Tumor 01 Segmentectomy, Multiple 7th NO YES DD 1.0 Liver None A Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody LIVING 49 2012 TCGA-DD-A73C-01A-12D-A33B-01 TCGA-DD-A73C-01A-12D-A33B-01 TCGA-DD-A73C-01A-12D-A33K-10 TCGA-DD-A73C-01 TCGA-DD-A73C-01 35C56771-BADA-4231-99BB-BA79C363A7B6 b518428e-84c5-4dbe-a608-c7d55e35067a TCGA-DD-A73C-01A-12D-A33K-10 TCGA-DD-A73C-01 TCGA-DD-A73C-01 b518428e-84c5-4dbe-a608-c7d55e35067a TCGA-DD-A73C-01A-12D-A33K-10 b518428e-84c5-4dbe-a608-c7d55e35067a b518428e-84c5-4dbe-a608-c7d55e35067a TCGA-DD-A73C-01A-12D-A33K-10 TCGA-DD-A73C-01A-12D-A33L-05 +TCGA-DD-A73D-01 TCGA-DD-A73D-01 TCGA-DD-A73D TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO Mild 68 3.5 4.5 5.0 TCGA-DD-A73D-F66596 TCGA-DD-A73D TCGA-DD-A73D-01A 0.1 0.3 1 A 0.6 1.1 0.8 -24941 313 0 693 592 0 0 6 4 6 - Established Cirrhosis 2014-10-21 FEMALE 170 Hepatitis C Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 250 9.5 13.8 NO NO G1 Liver Intrahepatic Recurrence Yes YES No false No MX NX T2 Stage II TCGA-DD-A73D.6C9BA4B3-78FD-4D16-A420-5C98BCEFD55D.pdf A73D WITH TUMOR 214 150 450 NO NO 12.5 NO YES R0 Primary Tumor 01 Segmentectomy, Single 7th NO YES DD 1.0 Liver Micro A Hepatitis C Virus R|Hepatitis B Surface Antigen LIVING 102 2012 TCGA-DD-A73D-01A-12D-A32F-01 TCGA-DD-A73D-01A-12D-A32F-01 TCGA-DD-A73D-01A-12D-A32G-10 TCGA-DD-A73D-01 TCGA-DD-A73D-01 E2A3DCDC-788C-4A4E-BA7B-4E77BA910ED6 3470b46c-4f18-47fe-a18f-f98c97e8996a TCGA-DD-A73D-01A-12D-A32G-10 TCGA-DD-A73D-01 TCGA-DD-A73D-01 3470b46c-4f18-47fe-a18f-f98c97e8996a TCGA-DD-A73D-01A-12D-A32G-10 3470b46c-4f18-47fe-a18f-f98c97e8996a 3470b46c-4f18-47fe-a18f-f98c97e8996a TCGA-DD-A73D-01A-12D-A32G-10 TCGA-DD-A73D-01A-12D-A32R-05 +TCGA-DD-A73E-01 TCGA-DD-A73E-01 TCGA-DD-A73E TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver Mild 66 3.5 4.7 5.0 TCGA-DD-A73E-F66598 TCGA-DD-A73E TCGA-DD-A73E-01A 0.1 0.4 2 A 0.8 1.3 1.2 -24377 336 0 44 0 0 6 1 0 - No Fibrosis 2014-10-21 MALE 172 Alcohol consumption|Non-Alcoholic Fatty Liver Disease Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 170 9.5 13.8 NO YES G1 NO false No M0 N0 T1 Stage I TCGA-DD-A73E.10881D8D-1C62-4F3D-ACF6-36AD1F23B0A9.pdf A73E TUMOR FREE 190 150 450 NO NO 11.5 NO YES R0 Primary Tumor 01 Segmentectomy, Single 7th NO YES DD 1.0 Liver None A Hepatitis B Surface Antigen|HBV Surface Antibody LIVING 108 2012 TCGA-DD-A73E-01A-12D-A32F-01 TCGA-DD-A73E-01A-12D-A32F-01 TCGA-DD-A73E-01A-12D-A32G-10 TCGA-DD-A73E-01 TCGA-DD-A73E-01 3E71F43C-97E0-417A-855A-8280181B8197 c5adfcce-a4a4-47bc-8b9e-7e81819b80a1 TCGA-DD-A73E-01A-12D-A32G-10 TCGA-DD-A73E-01 TCGA-DD-A73E-01 c5adfcce-a4a4-47bc-8b9e-7e81819b80a1 TCGA-DD-A73E-01A-12D-A32G-10 c5adfcce-a4a4-47bc-8b9e-7e81819b80a1 c5adfcce-a4a4-47bc-8b9e-7e81819b80a1 TCGA-DD-A73E-01A-12D-A32G-10 TCGA-DD-A73E-01A-12D-A32R-05 +TCGA-DD-A73F-01 TCGA-DD-A73F-01 TCGA-DD-A73F TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver None 77 3.5 4.6 5.0 TCGA-DD-A73F-F71152 TCGA-DD-A73F TCGA-DD-A73F-01A 0.1 0.5 1 A 0.6 1.1 1.0 -28234 975 0 1085 1 0 6 283 0 - No Fibrosis 2015-3-18 FEMALE 164 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 250 9.5 13.8 NO YES G1 NO false No M0 N0 T1 Stage I TCGA-DD-A73F.2FCC867C-91AD-40B3-8046-FFB84BDD2EA7.pdf A73F TUMOR FREE 243 150 450 NO NO 10.9 NO YES R0 Primary Tumor 01 Segmentectomy, Multiple 7th NO YES DD 1.0 Liver None A LIVING 69 2010 TCGA-DD-A73F-01A-11D-A32F-01 TCGA-DD-A73F-01A-11D-A32F-01 TCGA-DD-A73F-01A-11D-A32G-10 TCGA-DD-A73F-01 TCGA-DD-A73F-01 D6B6C02A-C3BB-400A-91F6-ACA8D71A8E25 ea6f7f61-d66c-47c9-a67a-e0d65af36815 TCGA-DD-A73F-01A-11D-A32G-10 TCGA-DD-A73F-01 TCGA-DD-A73F-01 ea6f7f61-d66c-47c9-a67a-e0d65af36815 TCGA-DD-A73F-01A-11D-A32G-10 ea6f7f61-d66c-47c9-a67a-e0d65af36815 ea6f7f61-d66c-47c9-a67a-e0d65af36815 TCGA-DD-A73F-01A-11D-A32G-10 TCGA-DD-A73F-01A-11D-A32R-05 +TCGA-DD-A73G-01 TCGA-DD-A73G-01 TCGA-DD-A73G TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver None 73 3.5 3.2 5.0 TCGA-DD-A73G-F66600 TCGA-DD-A73G TCGA-DD-A73G-01A 0.1 0.5 1 A 0.7 1.2 0.7 -26949 3045 0 3478 0 0 6 2035400 0 - No Fibrosis 2014-10-21 FEMALE 155 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 240 8.4 12.0 NO NO G3 NO false No M0 N0 T1 Stage I TCGA-DD-A73G.C7A70BE1-34F6-4500-8C6C-A0D4FBBBD251.pdf A73G TUMOR FREE 460 150 450 NO NO 11.7 NO YES R0 Primary Tumor 01 Segmentectomy, Multiple 6th NO YES DD 1.0 Liver None A Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody LIVING 44 2005 TCGA-DD-A73G-01A-22D-A32F-01 TCGA-DD-A73G-01A-22D-A32F-01 TCGA-DD-A73G-01A-22D-A32G-10 TCGA-DD-A73G-01 TCGA-DD-A73G-01 77B45158-4306-4D86-9FE3-E1068745AC41 b44b63e6-5163-4df8-b82b-80401b703167 TCGA-DD-A73G-01A-22D-A32G-10 TCGA-DD-A73G-01 TCGA-DD-A73G-01 b44b63e6-5163-4df8-b82b-80401b703167 TCGA-DD-A73G-01A-22D-A32G-10 b44b63e6-5163-4df8-b82b-80401b703167 b44b63e6-5163-4df8-b82b-80401b703167 TCGA-DD-A73G-01A-22D-A32G-10 TCGA-DD-A73G-01A-22D-A32R-05 +TCGA-DD-AA3A-01 TCGA-DD-AA3A-01 TCGA-DD-AA3A TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver None 81 3.5 4.9 5.0 TCGA-DD-AA3A TCGA-DD-AA3A-01A 0.1 0.8 1 A 0.6 1.1 0.7 -29712 1559 410 0 1 0 8 1 0 - No Fibrosis 2014-5-27 FEMALE 151 No History of Primary Risk Factors Hepatocholangiocarcinoma (Mixed) No C22.0 8180/3 C22.0 YES 100 0.9 1.2 NO G4 true No MX N0 T1 Stage I TCGA-DD-AA3A.F1055545-91C4-4397-BD34-FE995A3E9B05.pdf AA3A TUMOR FREE 256 150 450 NO NO 1.1 NO YES R0 Primary Tumor 01 Extended Lobectomy 6th NO YES DD 1.0 Liver None A Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody DECEASED 60 2009 TCGA-DD-AA3A-01A-11D-A36W-01 TCGA-DD-AA3A-01A-11D-A36W-01 TCGA-DD-AA3A-01A-11D-A36X-10 TCGA-DD-AA3A-01 TCGA-DD-AA3A-01 8AB78FE1-CF2C-4A91-A1BE-4C038A0E2A8E 99fb714e-01a3-4aa0-8792-39df3be95a1d TCGA-DD-AA3A-01 TCGA-DD-AA3A-01 99fb714e-01a3-4aa0-8792-39df3be95a1d 99fb714e-01a3-4aa0-8792-39df3be95a1d 99fb714e-01a3-4aa0-8792-39df3be95a1d TCGA-DD-AA3A-01A-11D-A36Y-05 +TCGA-DD-AAC8-01 TCGA-DD-AAC8-01 TCGA-DD-AAC8 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver Mild 72 3.8 4.3 5.3 TCGA-DD-AAC8 TCGA-DD-AAC8-01A 0.2 0.6 A 0.7 1.5 1.1 -26322 2080 16 0 0 0 8 1 1,2 - Portal Fibrosis 2014-6-28 MALE 156 Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 570 1.0 1.0 NO G3 NO true No M0 N0 T1 Stage I TCGA-DD-AAC8.2751F570-A1CE-4F6A-98CD-56C8B31AB0FF.pdf AAC8 TUMOR FREE 177 130 400 NO NO 0.9 NO NO R0 Primary Tumor 01 Lobectomy 6th NO YES DD 1.2 Liver Micro A DECEASED 57 2008 TCGA-DD-AAC8-01A-11D-A40Q-01 TCGA-DD-AAC8-01A-11D-A40Q-01 TCGA-DD-AAC8-01A-11D-A40R-10 TCGA-DD-AAC8-01 TCGA-DD-AAC8-01 3c6ca697-64ab-43d8-99ab-10ecbc0e8313 TCGA-DD-AAC8-01 TCGA-DD-AAC8-01 3c6ca697-64ab-43d8-99ab-10ecbc0e8313 3c6ca697-64ab-43d8-99ab-10ecbc0e8313 3c6ca697-64ab-43d8-99ab-10ecbc0e8313 TCGA-DD-AAC8-01A-11D-A40S-05 +TCGA-DD-AAC9-01 TCGA-DD-AAC9-01 TCGA-DD-AAC9 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver Mild 51 3.8 4.2 5.3 TCGA-DD-AAC9-F68363 TCGA-DD-AAC9 TCGA-DD-AAC9-01A 0.2 0.7 A 0.7 1.5 1.3 -18911 2069 0 347 0 0 8 5 6 - Established Cirrhosis 2014-11-17 MALE 174 Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 130 1.0 1.0 NO YES G2 NO true No M0 N0 T1 Stage I TCGA-DD-AAC9.A993CEA3-6AA2-4CE7-A9EC-8318B1377E99.pdf AAC9 TUMOR FREE 149 130 400 NO NO 0.9 NO NO R0 Primary Tumor 01 Segmentectomy, Single 6th NO YES DD 1.2 Liver None A LIVING 81 2008 TCGA-DD-AAC9-01A-11D-A40Q-01 TCGA-DD-AAC9-01A-11D-A40Q-01 TCGA-DD-AAC9-01A-11D-A40R-10 TCGA-DD-AAC9-01 TCGA-DD-AAC9-01 49d7b78f-7841-4969-b063-5bc57099283c TCGA-DD-AAC9-01 TCGA-DD-AAC9-01 49d7b78f-7841-4969-b063-5bc57099283c 49d7b78f-7841-4969-b063-5bc57099283c 49d7b78f-7841-4969-b063-5bc57099283c TCGA-DD-AAC9-01A-11D-A40S-05 +TCGA-DD-AACA-01 TCGA-DD-AACA-01 TCGA-DD-AACA TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO Mild 65 3.8 3.7 5.3 TCGA-DD-AACA-F68364 TCGA-DD-AACA TCGA-DD-AACA-01A 0.2 0.7 A 0.7 1.5 1.2 -23973 2057 0 2301 797 776 0 0 8 7 6 - Established Cirrhosis 2014-11-17 MALE 165 Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 120 1.0 1.0 NO NO G3 Liver Locoregional Recurrence No YES YES No true No M0 N0 T1 Stage I TCGA-DD-AACA.6600D758-13D7-4925-BC34-F2A90EE0CFE5.pdf AACA WITH TUMOR 136 130 400 NO NO 0.9 NO NO R0 R0 Primary Tumor 01 Segmentectomy, Single 6th NO YES DD 1.2 Liver None A LIVING 70 2008 TCGA-DD-AACA-01A-11D-A40Q-01 TCGA-DD-AACA-01A-11D-A40Q-01 TCGA-DD-AACA-01A-11D-A40R-10 TCGA-DD-AACA-01 TCGA-DD-AACA-01 57f193de-ae4f-4ac9-aab2-a5e275b3501e TCGA-DD-AACA-01 TCGA-DD-AACA-01 57f193de-ae4f-4ac9-aab2-a5e275b3501e 57f193de-ae4f-4ac9-aab2-a5e275b3501e 57f193de-ae4f-4ac9-aab2-a5e275b3501e TCGA-DD-AACA-01A-11D-A40S-05 +TCGA-DD-AACA-02 TCGA-DD-AACA-02 TCGA-DD-AACA TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO Mild 65 3.8 3.7 5.3 TCGA-DD-AACA-F68364 TCGA-DD-AACA TCGA-DD-AACA-02A 0.2 0.7 A 0.7 1.5 1.2 -23973 2057 0 2301 797 776 0 0 8 7 6 - Established Cirrhosis 2014-11-17 MALE 165 Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 20 1.0 1.0 NO NO G3 Liver Locoregional Recurrence No YES YES No true No M0 N0 T1 Stage I TCGA-DD-AACA.C4260237-1E27-45C7-ADE8-41939D1324A8.pdf AACA WITH TUMOR 136 130 400 NO NO 0.9 NO NO R0 R0 Recurrent Tumor 02 Segmentectomy, Single 6th NO YES DD 1.2 Liver None A LIVING 70 2008 TCGA-DD-AACA-02 3f1addce-3a5a-4b68-ae77-df6191c9ba57,b1bab5f2-614b-436b-b53f-b2910b70c487 TCGA-DD-AACA-02 3f1addce-3a5a-4b68-ae77-df6191c9ba57,b1bab5f2-614b-436b-b53f-b2910b70c487 3f1addce-3a5a-4b68-ae77-df6191c9ba57,b1bab5f2-614b-436b-b53f-b2910b70c487 3f1addce-3a5a-4b68-ae77-df6191c9ba57,b1bab5f2-614b-436b-b53f-b2910b70c487 TCGA-DD-AACA-02A-11D-A40S-05,TCGA-DD-AACA-02B-11D-A40S-05 +TCGA-DD-AACB-01 TCGA-DD-AACB-01 TCGA-DD-AACB TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver Mild 74 3.8 4.1 5.3 TCGA-DD-AACB-F68365 TCGA-DD-AACB TCGA-DD-AACB-01A 0.2 0.8 A 0.7 1.5 1.1 -27103 2045 0 2324 0 0 8 1902 6 - Established Cirrhosis 2014-11-17 FEMALE 156 Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 410 1.0 1.0 NO NO G3 NO true No M0 N0 T1 Stage I TCGA-DD-AACB.40E83F82-43B5-426D-A120-2F2F597332C6.pdf AACB TUMOR FREE 179 130 400 NO NO 0.8 NO NO R0 Primary Tumor 01 Lobectomy 6th NO YES DD 1.2 Liver Micro A LIVING 72 2008 TCGA-DD-AACB-01A-11D-A40Q-01 TCGA-DD-AACB-01A-11D-A40Q-01 TCGA-DD-AACB-01A-11D-A40R-10 TCGA-DD-AACB-01 TCGA-DD-AACB-01 09c2a2ad-2174-4ebc-b356-628af5e05799 TCGA-DD-AACB-01 TCGA-DD-AACB-01 09c2a2ad-2174-4ebc-b356-628af5e05799 09c2a2ad-2174-4ebc-b356-628af5e05799 09c2a2ad-2174-4ebc-b356-628af5e05799 TCGA-DD-AACB-01A-11D-A40S-05 +TCGA-DD-AACC-01 TCGA-DD-AACC-01 TCGA-DD-AACC TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver Mild 61 3.8 3.9 5.3 TCGA-DD-AACC 0.2 0.5 A 0.7 1.5 1.3 -22499 1685 0 0 0 8 24 6 - Established Cirrhosis 2014-6-28 MALE 165 Hepatitis B Hepatocellular Carcinoma No C22.0 8180/3 C22.0 YES 1.0 1.0 G2 YES No M0 N0 T1 Stage I AACC WITH TUMOR 208 130 400 NO NO 1.0 NO NO R0 Primary Tumor 01 Segmentectomy, Single 6th NO YES DD 1.2 Liver None DECEASED 61 2008 TCGA-DD-AACC-01A-11D-A40Q-01 TCGA-DD-AACC-01A-11D-A40Q-01 TCGA-DD-AACC-01A-11D-A40R-10 TCGA-DD-AACC-01 TCGA-DD-AACC-01 bffa7652-8069-4a46-9796-26be43eb1d54 TCGA-DD-AACC-01 TCGA-DD-AACC-01 bffa7652-8069-4a46-9796-26be43eb1d54 bffa7652-8069-4a46-9796-26be43eb1d54 bffa7652-8069-4a46-9796-26be43eb1d54 TCGA-DD-AACC-01A-11D-A40S-05 +TCGA-DD-AACD-01 TCGA-DD-AACD-01 TCGA-DD-AACD TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver Mild 48 3.8 3.9 5.3 TCGA-DD-AACD TCGA-DD-AACD-01A 0.2 0.3 3 A 0.7 1.5 1.0 -17828 2015 381 0 1 0 8 2 1,2 - Portal Fibrosis 2014-6-28 MALE 182 Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 230 1.0 1.0 NO G4 YES true No M0 N0 T1 Stage I TCGA-DD-AACD.0494EF97-6D76-4DC7-8642-880C889C2C24.pdf AACD WITH TUMOR 268 130 400 NO NO 6.9 NO YES R0 Primary Tumor 01 Lobectomy 6th NO YES DD 1.2 Liver Micro A DECEASED 66 2008 TCGA-DD-AACD-01A-11D-A40Q-01 TCGA-DD-AACD-01A-11D-A40Q-01 TCGA-DD-AACD-01A-11D-A40R-10 TCGA-DD-AACD-01 TCGA-DD-AACD-01 84d26646-771b-4d61-95a1-61c695c9f6fc TCGA-DD-AACD-01 TCGA-DD-AACD-01 84d26646-771b-4d61-95a1-61c695c9f6fc 84d26646-771b-4d61-95a1-61c695c9f6fc 84d26646-771b-4d61-95a1-61c695c9f6fc TCGA-DD-AACD-01A-11D-A40S-05 +TCGA-DD-AACE-01 TCGA-DD-AACE-01 TCGA-DD-AACE TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO Mild 62 3.8 4.4 5.3 TCGA-DD-AACE-F68366 TCGA-DD-AACE TCGA-DD-AACE-01A 0.2 0.9 A 0.7 1.5 1.2 -22727 1973 0 2184 1279 0 0 8 2 6 - Established Cirrhosis 2014-12-30 MALE 162 Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 170 1.0 1.0 NO NO G3 Liver Intrahepatic Recurrence Yes NO YES No true No M0 N0 T1 Stage I TCGA-DD-AACE.63AE7F04-F180-486A-89FB-6E509AF91E0B.pdf AACE TUMOR FREE 175 130 400 [Discrepancy] NO 0.9 NO NO R0 Primary Tumor 01 Segmentectomy, Single 6th NO YES DD 1.2 Liver None A LIVING 62 2008 TCGA-DD-AACE-01A-11D-A40Q-01 TCGA-DD-AACE-01A-11D-A40Q-01 TCGA-DD-AACE-01A-11D-A40R-10 TCGA-DD-AACE-01 TCGA-DD-AACE-01 087f71fd-fbd5-47c6-92ed-23286b2ed945 TCGA-DD-AACE-01 TCGA-DD-AACE-01 087f71fd-fbd5-47c6-92ed-23286b2ed945 087f71fd-fbd5-47c6-92ed-23286b2ed945 087f71fd-fbd5-47c6-92ed-23286b2ed945 TCGA-DD-AACE-01A-11D-A40S-05 +TCGA-DD-AACF-01 TCGA-DD-AACF-01 TCGA-DD-AACF TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver Mild 68 3.8 3.5 5.3 TCGA-DD-AACF 0.2 0.5 A 0.7 1.5 1.1 -25172 365 0 0 0 8 16 6 - Established Cirrhosis 2014-6-28 MALE 168 Hepatitis C Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 1.0 1.0 G3 YES No M0 N0 T1 Stage I AACF WITH TUMOR 99 130 400 NO NO 1.1 NO NO R0 Primary Tumor 01 Lobectomy 6th NO YES DD 1.2 Liver None DECEASED 60 2008 TCGA-DD-AACF-01A-11D-A40Q-01 TCGA-DD-AACF-01A-11D-A40Q-01 TCGA-DD-AACF-01A-11D-A40R-10 TCGA-DD-AACF-01 TCGA-DD-AACF-01 be1c653d-1f9a-41fd-b53c-024216355721 TCGA-DD-AACF-01 TCGA-DD-AACF-01 be1c653d-1f9a-41fd-b53c-024216355721 be1c653d-1f9a-41fd-b53c-024216355721 be1c653d-1f9a-41fd-b53c-024216355721 TCGA-DD-AACF-01A-11D-A40S-05 +TCGA-DD-AACG-01 TCGA-DD-AACG-01 TCGA-DD-AACG TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver Mild 52 3.8 3.6 5.3 TCGA-DD-AACG TCGA-DD-AACG-01A 0.2 1.0 A 0.7 1.5 1.5 -19174 1931 469 0 0 0 8 11718 6 - Established Cirrhosis 2014-6-28 MALE 168 Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 280 1.0 1.0 NO G4 YES true No M0 N0 T2 Stage II TCGA-DD-AACG.8B0FA2B9-F484-4D9C-AFAE-BDD90DA6A7A8.pdf AACG WITH TUMOR 196 130 400 NO NO 0.9 NO NO R0 Primary Tumor 01 Lobectomy 6th NO YES DD 1.2 Liver Micro A DECEASED 65 2008 TCGA-DD-AACG-01A-11D-A40Q-01 TCGA-DD-AACG-01A-11D-A40Q-01 TCGA-DD-AACG-01A-11D-A40R-10 TCGA-DD-AACG-01 TCGA-DD-AACG-01 73815125-e38b-4244-99f0-e630c6ea5fff TCGA-DD-AACG-01 TCGA-DD-AACG-01 73815125-e38b-4244-99f0-e630c6ea5fff 73815125-e38b-4244-99f0-e630c6ea5fff 73815125-e38b-4244-99f0-e630c6ea5fff TCGA-DD-AACG-01A-11D-A40S-05 +TCGA-DD-AACH-01 TCGA-DD-AACH-01 TCGA-DD-AACH TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver Mild 69 3.8 4.3 5.3 TCGA-DD-AACH 0.2 1.5 A 0.7 15 1.2 -25544 195 0 0 0 8 7 6 - Established Cirrhosis 2014-6-28 MALE 160 Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 1.0 1.0 G3 YES No M0 N0 T2 Stage II AACH TUMOR FREE 290 130 400 NO NO 0.9 NO NO R0 Primary Tumor 01 Lobectomy 6th NO YES DD 1.2 Liver Micro DECEASED 53 2008 TCGA-DD-AACH-01A-11D-A40Q-01 TCGA-DD-AACH-01A-11D-A40Q-01 TCGA-DD-AACH-01A-11D-A40R-10 TCGA-DD-AACH-01 TCGA-DD-AACH-01 e23ff6ac-2fdf-4838-aaa3-27e012bbf6ed TCGA-DD-AACH-01 TCGA-DD-AACH-01 e23ff6ac-2fdf-4838-aaa3-27e012bbf6ed e23ff6ac-2fdf-4838-aaa3-27e012bbf6ed e23ff6ac-2fdf-4838-aaa3-27e012bbf6ed TCGA-DD-AACH-01A-11D-A40S-05 +TCGA-DD-AACI-01 TCGA-DD-AACI-01 TCGA-DD-AACI TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO Mild 69 3.8 3.6 5.3 TCGA-DD-AACI-F68367 TCGA-DD-AACI TCGA-DD-AACI-01A 0.2 0.5 A 0.7 1.5 1.0 -25236 1870 0 1618 1432 1 0 8 1 5 - Nodular Formation and Incomplete Cirrhosis 2014-11-17 MALE 155 Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 320 1.0 1.0 NO NO G3 Liver Intrahepatic Recurrence No NO YES No true No M0 N0 T2 Stage II TCGA-DD-AACI.54CDEB1D-8CF9-4723-9A7D-CD9DFEDFD659.pdf AACI WITH TUMOR 106 130 400 NO NO 1.0 NO NO R0 Primary Tumor 01 Segmentectomy, Single 6th NO YES DD 1.2 Liver None A LIVING 48 2008 TCGA-DD-AACI-01A-11D-A40Q-01 TCGA-DD-AACI-01A-11D-A40Q-01 TCGA-DD-AACI-01A-11D-A40R-10 TCGA-DD-AACI-01 TCGA-DD-AACI-01 6cf6f149-a805-4f83-90cc-a3cf6eee7317 TCGA-DD-AACI-01 TCGA-DD-AACI-01 6cf6f149-a805-4f83-90cc-a3cf6eee7317 6cf6f149-a805-4f83-90cc-a3cf6eee7317 6cf6f149-a805-4f83-90cc-a3cf6eee7317 TCGA-DD-AACI-01A-11D-A40S-05 +TCGA-DD-AACJ-01 TCGA-DD-AACJ-01 TCGA-DD-AACJ TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO 75 3.8 3.6 5.3 TCGA-DD-AACJ-F68368 TCGA-DD-AACJ TCGA-DD-AACJ-01A 0.2 1.0 A 0.7 1.5 1.0 -27528 1835 0 2102 100 2 0 8 25 2014-11-17 MALE 159 Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 380 1.0 1.0 NO NO G2 Liver Locoregional Recurrence No NO YES No true No M0 N0 T2 Stage II TCGA-DD-AACJ.2CD482F0-0882-4A61-9B40-1D7B3DBC625E.pdf AACJ WITH TUMOR 213 130 400 NO NO 0.8 NO NO R0 Primary Tumor 01 Lobectomy 6th NO YES DD 1.2 Liver Micro A LIVING 73 2008 TCGA-DD-AACJ-01A-11D-A40Q-01 TCGA-DD-AACJ-01A-11D-A40Q-01 TCGA-DD-AACJ-01A-11D-A40R-10 TCGA-DD-AACJ-01 TCGA-DD-AACJ-01 9db8d89d-ef37-49a5-81ed-3ae95aa3c920 TCGA-DD-AACJ-01 TCGA-DD-AACJ-01 9db8d89d-ef37-49a5-81ed-3ae95aa3c920 9db8d89d-ef37-49a5-81ed-3ae95aa3c920 9db8d89d-ef37-49a5-81ed-3ae95aa3c920 TCGA-DD-AACJ-01A-11D-A40S-05 +TCGA-DD-AACK-01 TCGA-DD-AACK-01 TCGA-DD-AACK TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver None 70 3.8 4.6 5.3 TCGA-DD-AACK-F68369 TCGA-DD-AACK TCGA-DD-AACK-01A 0.2 0.9 A 0.7 1.5 1.3 -25796 1828 0 9 2 0 8 5 6 - Established Cirrhosis 2014-11-17 MALE 172 Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 140 1.0 1.0 NO YES G2 NO true No M0 N0 T1 Stage I TCGA-DD-AACK.B41B7C44-ED04-46EB-AD41-271456ECA762.pdf AACK TUMOR FREE 98 130 400 NO NO 0.9 NO NO R0 Primary Tumor 01 Lobectomy 6th NO YES DD 1.2 Liver Micro A LIVING 68 2008 TCGA-DD-AACK-01A-11D-A40Q-01 TCGA-DD-AACK-01A-11D-A40Q-01 TCGA-DD-AACK-01A-11D-A40R-10 TCGA-DD-AACK-01 TCGA-DD-AACK-01 1eb7d71a-045d-4c79-8375-100de27caafd TCGA-DD-AACK-01 TCGA-DD-AACK-01 1eb7d71a-045d-4c79-8375-100de27caafd 1eb7d71a-045d-4c79-8375-100de27caafd 1eb7d71a-045d-4c79-8375-100de27caafd TCGA-DD-AACK-01A-11D-A40S-05 +TCGA-DD-AACL-01 TCGA-DD-AACL-01 TCGA-DD-AACL TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 66 3.8 3.3 5.3 TCGA-DD-AACL-F68370 TCGA-DD-AACL 0.2 0.7 A 0.7 1.5 1.0 -24355 107 0 58 1 0 8 1368 2014-11-17 FEMALE 150 Hepatitis C Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 1.0 1.0 NO G3 No M0 N0 T1 Stage I AACL 99 130 400 NO NO 0.9 NO NO R0 Primary Tumor 01 Segmentectomy, Single 6th NO YES DD 1.2 Liver None DECEASED 69 2008 TCGA-DD-AACL-01A-11D-A40Q-01 TCGA-DD-AACL-01A-11D-A40Q-01 TCGA-DD-AACL-01A-11D-A40R-10 TCGA-DD-AACL-01 TCGA-DD-AACL-01 ece2a45a-7c07-44a2-baca-4a62aa38592f TCGA-DD-AACL-01 TCGA-DD-AACL-01 ece2a45a-7c07-44a2-baca-4a62aa38592f ece2a45a-7c07-44a2-baca-4a62aa38592f ece2a45a-7c07-44a2-baca-4a62aa38592f TCGA-DD-AACL-01A-11D-A40S-05 +TCGA-DD-AACM-01 TCGA-DD-AACM-01 TCGA-DD-AACM TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO Mild 48 3.8 4.2 5.3 TCGA-DD-AACM-F68371 TCGA-DD-AACM 0.2 1.6 A 0.7 1.5 1.2 -17590 0 1769 1126 1097 0 0 8 2 3,4 - Fibrous Speta 2014-11-17 MALE 177 Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 1.0 1.0 NO G3 Lung Extrahepatic Recurrence No YES YES No No M0 N0 T2 Stage II AACM WITH TUMOR 113 130 400 NO NO 0.9 NO NO R0 R0 Primary Tumor 01 Lobectomy 6th NO YES DD 1.2 Liver None LIVING 68 2009 TCGA-DD-AACM-01A-11D-A40Q-01 TCGA-DD-AACM-01A-11D-A40Q-01 TCGA-DD-AACM-01A-11D-A40R-10 TCGA-DD-AACM-01 TCGA-DD-AACM-01 TCGA-DD-AACM-01A-11D-A40S-05 +TCGA-DD-AACN-01 TCGA-DD-AACN-01 TCGA-DD-AACN TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO 32 3.8 3.9 5.3 TCGA-DD-AACN-F68372 TCGA-DD-AACN 0.2 2.2 A 0.7 1.5 1.5 -12007 0 1302 357 0 0 9 699 2014-11-17 MALE 171 Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 1.0 1.0 NO G3 Liver Intrahepatic Recurrence Yes NO YES No No M0 N0 T1 Stage I AACN WITH TUMOR 185 130 400 YES NO 1.0 NO NO R0 Primary Tumor 01 Segmentectomy, Multiple 6th NO YES DD 1.2 Liver None LIVING 70 2009 TCGA-DD-AACN-01A-11D-A40Q-01 TCGA-DD-AACN-01A-11D-A40Q-01 TCGA-DD-AACN-01A-11D-A40R-10 TCGA-DD-AACN-01 TCGA-DD-AACN-01 d3633d63-7cbe-4014-b051-211240a29ac8 TCGA-DD-AACN-01 TCGA-DD-AACN-01 d3633d63-7cbe-4014-b051-211240a29ac8 d3633d63-7cbe-4014-b051-211240a29ac8 d3633d63-7cbe-4014-b051-211240a29ac8 TCGA-DD-AACN-01A-11D-A40S-05 +TCGA-DD-AACO-01 TCGA-DD-AACO-01 TCGA-DD-AACO TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO Mild 40 3.8 3.7 5.3 TCGA-DD-AACO-F68373 TCGA-DD-AACO TCGA-DD-AACO-01A 0.2 0.6 A 0.7 1.5 1.4 -14796 1637 0 1876 479 0 0 9 5 6 - Established Cirrhosis 2014-11-17 MALE 164 Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 110 1.0 1.0 NO NO G3 Liver Intrahepatic Recurrence No NO YES No true No M0 N0 T1 Stage I TCGA-DD-AACO.B5BE83AC-C974-422B-91E7-A69057BA26C9.pdf AACO WITH TUMOR 88 130 400 NO NO 1.0 NO NO R0 Primary Tumor 01 Segmentectomy, Single 6th NO YES DD 1.2 Liver None A LIVING 43 2009 TCGA-DD-AACO-01A-11D-A40Q-01 TCGA-DD-AACO-01A-11D-A40Q-01 TCGA-DD-AACO-01A-11D-A40R-10 TCGA-DD-AACO-01 TCGA-DD-AACO-01 032ec32d-66ca-4792-9132-2e61d918c3c2 TCGA-DD-AACO-01 TCGA-DD-AACO-01 032ec32d-66ca-4792-9132-2e61d918c3c2 032ec32d-66ca-4792-9132-2e61d918c3c2 032ec32d-66ca-4792-9132-2e61d918c3c2 TCGA-DD-AACO-01A-11D-A40S-05 +TCGA-DD-AACP-01 TCGA-DD-AACP-01 TCGA-DD-AACP TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver None 64 3.8 4.1 5.3 TCGA-DD-AACP-F68374 TCGA-DD-AACP TCGA-DD-AACP-01A 0.2 1.1 A 0.7 1.5 1.1 -23728 1625 0 415 0 0 8 227 2014-11-17 MALE 155 Alcohol consumption Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 20 1.0 1.0 NO NO G3 NO true No M0 N0 T1 Stage I TCGA-DD-AACP.7FDD120A-A5AD-4209-B167-34BA2289A784.pdf AACP 151 130 400 NO NO 0.9 NO NO R0 Primary Tumor 01 Segmentectomy, Single 6th NO YES DD 1.2 Liver None A LIVING 62 2009 TCGA-DD-AACP-01A-11D-A40Q-01 TCGA-DD-AACP-01A-11D-A40Q-01 TCGA-DD-AACP-01A-11D-A40R-10 TCGA-DD-AACP-01 TCGA-DD-AACP-01 6aafc1f6-257e-4105-b032-457bcc52dc1b TCGA-DD-AACP-01 TCGA-DD-AACP-01 6aafc1f6-257e-4105-b032-457bcc52dc1b 6aafc1f6-257e-4105-b032-457bcc52dc1b 6aafc1f6-257e-4105-b032-457bcc52dc1b TCGA-DD-AACP-01A-11D-A40S-05 +TCGA-DD-AACQ-01 TCGA-DD-AACQ-01 TCGA-DD-AACQ TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO 50 3.8 4.2 5.3 TCGA-DD-AACQ-F68375 TCGA-DD-AACQ TCGA-DD-AACQ-01A 0.2 0.8 A 0.7 1.5 1.3 -18429 1665 432 0 429 105 0 0 8 7 2014-11-17 MALE 169 Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 40 1.0 1.0 NO NO G3 Liver Locoregional Recurrence Yes NO YES No true No M0 N0 T2 Stage II TCGA-DD-AACQ.3BBE2BEA-D346-4EA8-82CB-9305EC49A331.pdf AACQ WITH TUMOR 157 130 400 NO NO 1.0 NO NO R0 Primary Tumor 01 Lobectomy 6th NO YES DD 1.2 Liver None A DECEASED 64 2009 TCGA-DD-AACQ-01A-11D-A40Q-01 TCGA-DD-AACQ-01A-11D-A40Q-01 TCGA-DD-AACQ-01A-11D-A40R-10 TCGA-DD-AACQ-01 TCGA-DD-AACQ-01 3e6d35a3-3a10-4629-a316-8df8cc951678 TCGA-DD-AACQ-01 TCGA-DD-AACQ-01 3e6d35a3-3a10-4629-a316-8df8cc951678 3e6d35a3-3a10-4629-a316-8df8cc951678 3e6d35a3-3a10-4629-a316-8df8cc951678 TCGA-DD-AACQ-01A-11D-A40S-05 +TCGA-DD-AACS-01 TCGA-DD-AACS-01 TCGA-DD-AACS TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 39 3.8 4.3 5.3 TCGA-DD-AACS-F68376 TCGA-DD-AACS TCGA-DD-AACS-01A 0.2 1.0 A 0.7 1.5 1.1 -14473 1532 0 1804 0 0 8 1 2014-11-17 MALE 172 Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 20 1.0 1.0 NO NO G3 NO true No M0 N0 T1 Stage I TCGA-DD-AACS.EA952B6F-851C-4675-A933-80325945E7EC.pdf AACS TUMOR FREE 223 130 400 NO NO 1.0 NO NO R0 Primary Tumor 01 Segmentectomy, Single 6th NO YES DD 1.2 Liver None A LIVING 80 2009 TCGA-DD-AACS-01A-11D-A40Q-01 TCGA-DD-AACS-01A-11D-A40Q-01 TCGA-DD-AACS-01A-11D-A40R-10 TCGA-DD-AACS-01 TCGA-DD-AACS-01 078cb900-3686-4894-9e1f-cc4bb1e39eae TCGA-DD-AACS-01 TCGA-DD-AACS-01 078cb900-3686-4894-9e1f-cc4bb1e39eae 078cb900-3686-4894-9e1f-cc4bb1e39eae 078cb900-3686-4894-9e1f-cc4bb1e39eae TCGA-DD-AACS-01A-11D-A40S-05 +TCGA-DD-AACT-01 TCGA-DD-AACT-01 TCGA-DD-AACT TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver Mild 69 3.8 4.4 5.3 TCGA-DD-AACT-F68377 TCGA-DD-AACT TCGA-DD-AACT-01A 0.2 0.8 A 0.7 1.5 0.7 -25292 1317 0 1562 0 0 8 4 2014-11-17 FEMALE 158 Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 60 1.0 1.0 NO NO G2 NO true No M0 N0 T1 Stage I TCGA-DD-AACT.0A9193A6-4600-44F8-88AD-264F8F2D7B4E.pdf AACT TUMOR FREE 213 130 400 NO NO 1.0 NO NO R0 Primary Tumor 01 Segmentectomy, Single 7th NO YES DD 1.2 Liver None A LIVING 62 2010 TCGA-DD-AACT-01A-11D-A40Q-01 TCGA-DD-AACT-01A-11D-A40Q-01 TCGA-DD-AACT-01A-11D-A40R-10 TCGA-DD-AACT-01 TCGA-DD-AACT-01 0e370e53-c3cc-4191-a6f5-68c932ee7641 TCGA-DD-AACT-01 TCGA-DD-AACT-01 0e370e53-c3cc-4191-a6f5-68c932ee7641 0e370e53-c3cc-4191-a6f5-68c932ee7641 0e370e53-c3cc-4191-a6f5-68c932ee7641 TCGA-DD-AACT-01A-11D-A40S-05 +TCGA-DD-AACU-01 TCGA-DD-AACU-01 TCGA-DD-AACU TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 59 3.8 4.4 5.3 TCGA-DD-AACU-F68378 TCGA-DD-AACU TCGA-DD-AACU-01A 0.2 0.3 A 0.7 1.5 1.1 -21606 1272 0 1567 0 0 8 22 2014-11-17 MALE 166 Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 40 1.0 1.0 NO NO G3 NO true No M0 N0 T1 Stage I TCGA-DD-AACU.3CA9651B-35BE-4D1E-9C91-BF3029931F32.pdf AACU TUMOR FREE 166 130 400 NO NO 0.9 NO NO R0 Primary Tumor 01 Segmentectomy, Single 7th NO YES DD 1.2 Liver None A LIVING 67 2010 TCGA-DD-AACU-01A-11D-A40Q-01 TCGA-DD-AACU-01A-11D-A40Q-01 TCGA-DD-AACU-01A-11D-A40R-10 TCGA-DD-AACU-01 TCGA-DD-AACU-01 3fea9924-e623-43ef-a003-0821bf2e3013 TCGA-DD-AACU-01 TCGA-DD-AACU-01 3fea9924-e623-43ef-a003-0821bf2e3013 3fea9924-e623-43ef-a003-0821bf2e3013 3fea9924-e623-43ef-a003-0821bf2e3013 TCGA-DD-AACU-01A-11D-A40S-05 +TCGA-DD-AACV-01 TCGA-DD-AACV-01 TCGA-DD-AACV TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO 53 3.8 4.3 5.3 TCGA-DD-AACV-F68379 TCGA-DD-AACV 0.2 0.6 A 0.7 1.5 1.2 -19660 0 1531 344 0 0 8 9 2014-11-17 MALE 169 Alcohol consumption Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 1.0 1.0 NO G3 Liver Intrahepatic Recurrence Yes NO YES No No M0 N0 T1 Stage I AACV WITH TUMOR 164 130 400 YES NO 1.0 NO NO R0 Primary Tumor 01 Segmentectomy, Single 7th NO YES DD 1.2 Liver Micro LIVING 70 2010 TCGA-DD-AACV-01A-11D-A40Q-01 TCGA-DD-AACV-01A-11D-A40Q-01 TCGA-DD-AACV-01A-11D-A40R-10 TCGA-DD-AACV-01 TCGA-DD-AACV-01 cd9bf80a-84dc-4ffa-8b82-6d298d9931e7 TCGA-DD-AACV-01 TCGA-DD-AACV-01 cd9bf80a-84dc-4ffa-8b82-6d298d9931e7 cd9bf80a-84dc-4ffa-8b82-6d298d9931e7 cd9bf80a-84dc-4ffa-8b82-6d298d9931e7 TCGA-DD-AACV-01A-11D-A40S-05 +TCGA-DD-AACW-01 TCGA-DD-AACW-01 TCGA-DD-AACW TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 43 3.8 4.0 5.3 TCGA-DD-AACW-F68380 TCGA-DD-AACW TCGA-DD-AACW-01A 0.2 0.6 A 0.7 1.5 1.0 -15872 1184 0 1424 0 0 8 1726 2014-11-17 MALE 166 Alcohol consumption|Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 40 1.0 1.0 NO NO G3 NO true No M0 N0 T1 Stage I TCGA-DD-AACW.04474C44-102B-4514-BC48-468B9ED478A2.pdf AACW TUMOR FREE 137 130 400 NO NO 1.1 NO NO R0 Primary Tumor 01 Segmentectomy, Single 7th NO YES DD 1.2 Liver None A LIVING 65 2010 TCGA-DD-AACW-01A-11D-A40Q-01 TCGA-DD-AACW-01A-11D-A40Q-01 TCGA-DD-AACW-01A-11D-A40R-10 TCGA-DD-AACW-01 TCGA-DD-AACW-01 6dd11614-cfb8-46ae-ad65-75fb407306e4 TCGA-DD-AACW-01 TCGA-DD-AACW-01 6dd11614-cfb8-46ae-ad65-75fb407306e4 6dd11614-cfb8-46ae-ad65-75fb407306e4 6dd11614-cfb8-46ae-ad65-75fb407306e4 TCGA-DD-AACW-01A-11D-A40S-05 +TCGA-DD-AACX-01 TCGA-DD-AACX-01 TCGA-DD-AACX TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver YES NO Mild 66 3.8 4.2 5.3 TCGA-DD-AACX-F68381 TCGA-DD-AACX 0.2 0.5 A 0.7 1.5 0.8 -24329 0 170 42 1 0 8 3 3,4 - Fibrous Speta 2014-11-17 MALE 155 Alcohol consumption|Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 1.0 1.0 NO G3 Other, specify Extrahepatic Recurrence lymph node No NO YES No No M0 N0 T2 Stage II AACX WITH TUMOR 179 130 400 NO NO 0.9 NO NO R0 Primary Tumor 01 Lobectomy 7th NO YES DD 1.2 Liver None LIVING 53 2010 TCGA-DD-AACX-01A-11D-A40Q-01 TCGA-DD-AACX-01A-11D-A40Q-01 TCGA-DD-AACX-01A-11D-A40R-10 TCGA-DD-AACX-01 TCGA-DD-AACX-01 be86bc67-ccbb-4565-adc3-4577b8067a33 TCGA-DD-AACX-01 TCGA-DD-AACX-01 be86bc67-ccbb-4565-adc3-4577b8067a33 be86bc67-ccbb-4565-adc3-4577b8067a33 be86bc67-ccbb-4565-adc3-4577b8067a33 TCGA-DD-AACX-01A-11D-A40S-05 +TCGA-DD-AACY-01 TCGA-DD-AACY-01 TCGA-DD-AACY TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO Mild 61 3.8 3.1 5.3 TCGA-DD-AACY-F68382 TCGA-DD-AACY 0.2 1.3 A 0.7 1.5 0.6 -22332 0 1450 776 0 0 8 290 3,4 - Fibrous Speta 2014-11-17 MALE 162 Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 1.0 1.0 NO G3 Liver Intrahepatic Recurrence No NO YES No No M0 N0 T1 Stage I AACY WITH TUMOR 114 130 400 YES NO 1.1 NO NO R0 Primary Tumor 01 Extended Lobectomy 7th NO YES DD 1.2 Liver None LIVING 62 2010 TCGA-DD-AACY-01A-11D-A40Q-01 TCGA-DD-AACY-01A-11D-A40Q-01 TCGA-DD-AACY-01A-11D-A40R-10 TCGA-DD-AACY-01 TCGA-DD-AACY-01 c9dcf079-d32b-47d6-807f-988628c13c92 TCGA-DD-AACY-01 TCGA-DD-AACY-01 c9dcf079-d32b-47d6-807f-988628c13c92 c9dcf079-d32b-47d6-807f-988628c13c92 c9dcf079-d32b-47d6-807f-988628c13c92 TCGA-DD-AACY-01A-11D-A40S-05 +TCGA-DD-AACZ-01 TCGA-DD-AACZ-01 TCGA-DD-AACZ TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 63 3.8 4.5 5.3 TCGA-DD-AACZ 0.2 0.4 A 0.7 1.5 0.6 -23230 171 0 1 0 8 25 2014-6-29 FEMALE 149 Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 1.0 1.0 G4 YES No M0 N0 T1 Stage I AACZ TUMOR FREE 412 130 400 NO NO 1.0 NO NO R0 Primary Tumor 01 Extended Lobectomy 7th NO YES DD 1.2 Liver Macro DECEASED 52 2010 TCGA-DD-AACZ-01A-11D-A40Q-01 TCGA-DD-AACZ-01A-11D-A40Q-01 TCGA-DD-AACZ-01A-11D-A40R-10 TCGA-DD-AACZ-01 TCGA-DD-AACZ-01 c037b79c-c02f-474e-be9d-6c9ca4cfd633 TCGA-DD-AACZ-01 TCGA-DD-AACZ-01 c037b79c-c02f-474e-be9d-6c9ca4cfd633 c037b79c-c02f-474e-be9d-6c9ca4cfd633 c037b79c-c02f-474e-be9d-6c9ca4cfd633 TCGA-DD-AACZ-01A-11D-A40S-05 +TCGA-DD-AAD0-01 TCGA-DD-AAD0-01 TCGA-DD-AAD0 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO Mild 73 3.8 3.4 5.3 TCGA-DD-AAD0-F68383 TCGA-DD-AAD0 0.2 0.8 A 0.7 1.5 0.5 -26781 0 137 47 0 0 8 4 2014-11-17 FEMALE 150 Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 1.0 1.0 YES G2 Liver Intrahepatic Recurrence Yes NO YES No No M0 N0 T1 Stage I AAD0 WITH TUMOR 86 130 400 NO NO 1.0 NO NO R0 Primary Tumor 01 Lobectomy 7th NO YES DD 1.2 Liver None LIVING 54 2010 TCGA-DD-AAD0-01A-11D-A40Q-01 TCGA-DD-AAD0-01A-11D-A40Q-01 TCGA-DD-AAD0-01A-11D-A40R-10 TCGA-DD-AAD0-01 TCGA-DD-AAD0-01 d9971596-7f19-4d41-ad23-688e1051c85c TCGA-DD-AAD0-01 TCGA-DD-AAD0-01 d9971596-7f19-4d41-ad23-688e1051c85c d9971596-7f19-4d41-ad23-688e1051c85c d9971596-7f19-4d41-ad23-688e1051c85c TCGA-DD-AAD0-01A-11D-A40S-05 +TCGA-DD-AAD1-01 TCGA-DD-AAD1-01 TCGA-DD-AAD1 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO 51 3.8 4.5 5.3 TCGA-DD-AAD1-F68384 TCGA-DD-AAD1 0.2 0.6 A 0.7 1.5 0.5 -18794 0 564 127 1 0 8 451 2014-12-21 FEMALE 161 Hepatitis B|Hepatitis C Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 1.0 1.0 NO G4 Liver Intrahepatic Recurrence Yes NO YES No No M0 N0 T1 Stage I AAD1 WITH TUMOR 157 130 400 NO NO 0.9 NO NO R1 Primary Tumor 01 Segmentectomy, Single 7th NO YES DD 1.2 Liver None LIVING 44 2010 TCGA-DD-AAD1-01A-11D-A40Q-01 TCGA-DD-AAD1-01A-11D-A40Q-01 TCGA-DD-AAD1-01A-11D-A40R-10 TCGA-DD-AAD1-01 TCGA-DD-AAD1-01 d416dda9-edc6-4dae-b563-23a546e70b8a TCGA-DD-AAD1-01 TCGA-DD-AAD1-01 d416dda9-edc6-4dae-b563-23a546e70b8a d416dda9-edc6-4dae-b563-23a546e70b8a d416dda9-edc6-4dae-b563-23a546e70b8a TCGA-DD-AAD1-01A-11D-A40S-05 +TCGA-DD-AAD2-01 TCGA-DD-AAD2-01 TCGA-DD-AAD2 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver Mild 66 3.8 3.5 5.3 TCGA-DD-AAD2-F68385 TCGA-DD-AAD2 TCGA-DD-AAD2-01A 0.2 0.3 A 0.7 1.5 0.8 -24221 1105 0 658 0 0 8 25 1,2 - Portal Fibrosis 2014-11-17 MALE 156 Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 30 1.0 1.0 NO YES G2 NO true No M0 N0 T1 Stage I TCGA-DD-AAD2.3F50DE59-F830-4D51-90C6-7B275AF0876F.pdf AAD2 TUMOR FREE 172 130 400 NO NO 1.0 NO NO R0 Primary Tumor 01 Lobectomy 7th NO YES DD 1.2 Liver Micro A LIVING 52 2010 TCGA-DD-AAD2-01A-11D-A40Q-01 TCGA-DD-AAD2-01A-11D-A40Q-01 TCGA-DD-AAD2-01A-11D-A40R-10 TCGA-DD-AAD2-01 TCGA-DD-AAD2-01 2c10e17e-58c2-445c-9306-ca22625bdc38 TCGA-DD-AAD2-01 TCGA-DD-AAD2-01 2c10e17e-58c2-445c-9306-ca22625bdc38 2c10e17e-58c2-445c-9306-ca22625bdc38 2c10e17e-58c2-445c-9306-ca22625bdc38 TCGA-DD-AAD2-01A-11D-A40S-05 +TCGA-DD-AAD3-01 TCGA-DD-AAD3-01 TCGA-DD-AAD3 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver Mild 43 3.8 3.9 5.3 TCGA-DD-AAD3-F68386 TCGA-DD-AAD3 TCGA-DD-AAD3-01A 0.2 0.4 A 0.7 1.5 0.8 -15706 1072 0 1295 0 1,2 - Portal Fibrosis 2014-11-17 MALE 178 Alcohol consumption|Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 20 1.0 1.0 NO NO G2 NO true No M0 N0 T1 Stage I TCGA-DD-AAD3.03056B3E-B81F-44C0-B21E-6C850D67DB43.pdf AAD3 TUMOR FREE 181 130 400 NO NO 1.0 NO NO R0 Primary Tumor 01 Segmentectomy, Multiple 7th NO YES DD 1.2 Liver None A LIVING 77 2011 TCGA-DD-AAD3-01A-11D-A40Q-01 TCGA-DD-AAD3-01A-11D-A40Q-01 TCGA-DD-AAD3-01A-11D-A40R-10 TCGA-DD-AAD3-01 TCGA-DD-AAD3-01 9aa788e8-ff29-49a1-bec4-282c728de83e TCGA-DD-AAD3-01 TCGA-DD-AAD3-01 9aa788e8-ff29-49a1-bec4-282c728de83e 9aa788e8-ff29-49a1-bec4-282c728de83e 9aa788e8-ff29-49a1-bec4-282c728de83e TCGA-DD-AAD3-01A-11D-A40S-05 +TCGA-DD-AAD5-01 TCGA-DD-AAD5-01 TCGA-DD-AAD5 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO Mild 54 3.8 3.7 5.3 TCGA-DD-AAD5-F68387 TCGA-DD-AAD5 TCGA-DD-AAD5-01A 0.2 0.6 A 0.7 1.5 0.6 -19748 1058 0 1345 130 0 0 8 73 3,4 - Fibrous Speta 2014-11-17 MALE 170 Alcohol consumption|Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 70 1.0 1.0 NO NO G3 Liver Intrahepatic Recurrence No NO YES No true No M0 N0 T1 Stage I TCGA-DD-AAD5.7F74E08A-C14B-413E-9D75-FCDBFC2F67C5.pdf AAD5 WITH TUMOR 349 130 400 NO NO 1.2 NO NO R0 Primary Tumor 01 Lobectomy 7th NO YES DD 1.2 Liver None A LIVING 70 2011 TCGA-DD-AAD5-01A-11D-A40Q-01 TCGA-DD-AAD5-01A-11D-A40Q-01 TCGA-DD-AAD5-01A-11D-A40R-10 TCGA-DD-AAD5-01 TCGA-DD-AAD5-01 6b62b19f-8a09-4042-83e9-f86399aac7d1 TCGA-DD-AAD5-01 TCGA-DD-AAD5-01 6b62b19f-8a09-4042-83e9-f86399aac7d1 6b62b19f-8a09-4042-83e9-f86399aac7d1 6b62b19f-8a09-4042-83e9-f86399aac7d1 TCGA-DD-AAD5-01A-11D-A40S-05 +TCGA-DD-AAD6-01 TCGA-DD-AAD6-01 TCGA-DD-AAD6 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO 66 3.8 2.7 5.3 TCGA-DD-AAD6-F68388 TCGA-DD-AAD6 TCGA-DD-AAD6-01A 0.2 0.6 A 0.7 1.5 1.1 -24185 1035 0 672 50 1 2014-11-17 MALE 167 Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 70 1.0 1.0 NO NO G3 Liver Locoregional Recurrence Yes NO YES No true No M0 N0 T3a Stage IIIA TCGA-DD-AAD6.B246AEB4-8035-4114-9F1E-3E076809A896.pdf AAD6 TUMOR FREE 185 130 400 NO NO 1.0 NO NO R0 Primary Tumor 01 Segmentectomy, Single 7th NO YES DD 1.2 Liver None A LIVING 93 2011 TCGA-DD-AAD6-01A-11D-A40Q-01 TCGA-DD-AAD6-01A-11D-A40Q-01 TCGA-DD-AAD6-01A-11D-A40R-10 TCGA-DD-AAD6-01 TCGA-DD-AAD6-01 14edee70-32c0-41f3-a8f1-1b641ab548cb TCGA-DD-AAD6-01 TCGA-DD-AAD6-01 14edee70-32c0-41f3-a8f1-1b641ab548cb 14edee70-32c0-41f3-a8f1-1b641ab548cb 14edee70-32c0-41f3-a8f1-1b641ab548cb TCGA-DD-AAD6-01A-11D-A40S-05 +TCGA-DD-AAD8-01 TCGA-DD-AAD8-01 TCGA-DD-AAD8 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver Mild 73 3.8 4.3 5.3 TCGA-DD-AAD8-F68389 TCGA-DD-AAD8 TCGA-DD-AAD8-01A 0.2 0.3 A 0.7 1.5 0.6 -26781 981 0 1219 0 0 8 4 1,2 - Portal Fibrosis 2014-11-17 FEMALE 152 Hepatitis B|Hepatitis C Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 30 1.0 1.0 NO NO G2 NO true No M0 N0 T1 Stage I TCGA-DD-AAD8.5536ED7C-6CC3-442D-A8FD-5EE91C98F358.pdf AAD8 TUMOR FREE 130 130 400 NO NO 1.1 NO NO R0 Primary Tumor 01 Segmentectomy, Single 7th NO YES DD 1.2 Liver None A LIVING 57 2011 TCGA-DD-AAD8-01A-11D-A40Q-01 TCGA-DD-AAD8-01A-11D-A40Q-01 TCGA-DD-AAD8-01A-11D-A40R-10 TCGA-DD-AAD8-01 TCGA-DD-AAD8-01 6c2960e2-ad7a-4c08-a453-1bf747483d42 TCGA-DD-AAD8-01 TCGA-DD-AAD8-01 6c2960e2-ad7a-4c08-a453-1bf747483d42 6c2960e2-ad7a-4c08-a453-1bf747483d42 6c2960e2-ad7a-4c08-a453-1bf747483d42 TCGA-DD-AAD8-01A-11D-A40S-05 +TCGA-DD-AADA-01 TCGA-DD-AADA-01 TCGA-DD-AADA TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 66 3.8 4.1 5.3 TCGA-DD-AADA-F68390 TCGA-DD-AADA TCGA-DD-AADA-01A 0.2 0.5 A 0.7 1.5 0.6 -24288 959 0 1233 0 0 8 8698 2014-11-17 FEMALE 147 Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 40 1.0 1.0 NO NO G3 NO true No M0 N0 T1 Stage I TCGA-DD-AADA.624DA15E-ADC6-4F09-9DCB-3B4C42F3B453.pdf AADA TUMOR FREE 173 130 400 NO NO 1.1 NO NO R0 Primary Tumor 01 Segmentectomy, Single 7th NO YES DD 1.2 Liver Macro A LIVING 59 2011 TCGA-DD-AADA-01A-11D-A40Q-01 TCGA-DD-AADA-01A-11D-A40Q-01 TCGA-DD-AADA-01A-11D-A40R-10 TCGA-DD-AADA-01 TCGA-DD-AADA-01 392aa482-9a49-403c-817e-7b429e1d82f9 TCGA-DD-AADA-01 TCGA-DD-AADA-01 392aa482-9a49-403c-817e-7b429e1d82f9 392aa482-9a49-403c-817e-7b429e1d82f9 392aa482-9a49-403c-817e-7b429e1d82f9 TCGA-DD-AADA-01A-11D-A40S-05 +TCGA-DD-AADB-01 TCGA-DD-AADB-01 TCGA-DD-AADB TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 51 3.8 4.5 5.3 TCGA-DD-AADB-F68391 TCGA-DD-AADB TCGA-DD-AADB-01A 0.2 1.5 A 0.7 1.5 0.8 -18728 946 0 1242 0 0 8 419 2014-11-17 MALE 165 Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 20 1.0 1.0 NO NO G4 NO true No M0 N0 T1 Stage I TCGA-DD-AADB.3963D999-C204-45C2-8515-B922BEBA7C9D.pdf AADB TUMOR FREE 180 130 400 NO NO 1.0 NO NO R0 Primary Tumor 01 Segmentectomy, Single 7th NO YES DD 1.2 Liver None A LIVING 68 2011 TCGA-DD-AADB-01A-11D-A40Q-01 TCGA-DD-AADB-01A-11D-A40Q-01 TCGA-DD-AADB-01A-11D-A40R-10 TCGA-DD-AADB-01 TCGA-DD-AADB-01 89ad7202-565f-4459-a1ca-946dd27d07b7 TCGA-DD-AADB-01 TCGA-DD-AADB-01 89ad7202-565f-4459-a1ca-946dd27d07b7 89ad7202-565f-4459-a1ca-946dd27d07b7 89ad7202-565f-4459-a1ca-946dd27d07b7 TCGA-DD-AADB-01A-11D-A40S-05 +TCGA-DD-AADC-01 TCGA-DD-AADC-01 TCGA-DD-AADC TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 53 3.8 3.8 5.3 TCGA-DD-AADC TCGA-DD-AADC-01A 0.2 0.7 A 0.7 1.5 0.8 -19527 945 425 0 0 0 8 36 2014-7-7 MALE 176 Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 40 1.0 1.0 NO G3 YES true No M0 N0 T1 Stage I TCGA-DD-AADC.2A33A2FB-4491-43AA-8C6D-8173FB1D2179.pdf AADC WITH TUMOR 212 130 400 NO NO 1.2 NO NO R0 Primary Tumor 01 Segmentectomy, Multiple 7th NO YES DD 1.2 Liver Macro A DECEASED 81 2011 TCGA-DD-AADC-01A-11D-A40Q-01 TCGA-DD-AADC-01A-11D-A40Q-01 TCGA-DD-AADC-01A-11D-A40R-10 TCGA-DD-AADC-01 TCGA-DD-AADC-01 577cf129-d44e-4dda-bc23-bcbe2c55cfcc TCGA-DD-AADC-01 TCGA-DD-AADC-01 577cf129-d44e-4dda-bc23-bcbe2c55cfcc 577cf129-d44e-4dda-bc23-bcbe2c55cfcc 577cf129-d44e-4dda-bc23-bcbe2c55cfcc TCGA-DD-AADC-01A-11D-A40S-05 +TCGA-DD-AADD-01 TCGA-DD-AADD-01 TCGA-DD-AADD TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 51 3.8 4.1 5.3 TCGA-DD-AADD-F68392 TCGA-DD-AADD TCGA-DD-AADD-01A 0.2 0.4 A 0.7 1.5 0.9 -18752 931 0 1231 1 0 8 9804 2014-11-17 MALE 168 Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 30 1.0 1.0 NO NO G4 NO true No M0 N0 T1 Stage I TCGA-DD-AADD.DCDE4D46-AB4E-4C21-9F01-35A304FFF8D5.pdf AADD TUMOR FREE 299 130 400 NO NO 1.1 NO NO R0 Primary Tumor 01 Segmentectomy, Multiple 7th NO YES DD 1.2 Liver None A LIVING 68 2011 TCGA-DD-AADD-01A-11D-A40Q-01 TCGA-DD-AADD-01A-11D-A40Q-01 TCGA-DD-AADD-01A-11D-A40R-10 TCGA-DD-AADD-01 TCGA-DD-AADD-01 439c718c-5d13-4516-9343-0a0b8c5869c4 TCGA-DD-AADD-01 TCGA-DD-AADD-01 439c718c-5d13-4516-9343-0a0b8c5869c4 439c718c-5d13-4516-9343-0a0b8c5869c4 439c718c-5d13-4516-9343-0a0b8c5869c4 TCGA-DD-AADD-01A-11D-A40S-05 +TCGA-DD-AADE-01 TCGA-DD-AADE-01 TCGA-DD-AADE TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO Mild 50 3.8 3.9 5.3 TCGA-DD-AADE-F68393 TCGA-DD-AADE 0.2 0.5 A 0.7 1.5 1.1 -18482 0 1202 168 0 0 8 7 3,4 - Fibrous Speta 2014-11-17 MALE 166 Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 1.0 1.0 NO G4 Liver Intrahepatic Recurrence Yes NO YES No No M0 N0 T1 Stage I AADE WITH TUMOR 148 130 400 NO NO 1.1 NO NO R0 Primary Tumor 01 Lobectomy 7th NO YES DD 1.2 Liver Micro LIVING 63 2011 TCGA-DD-AADE-01A-11D-A40Q-01 TCGA-DD-AADE-01A-11D-A40Q-01 TCGA-DD-AADE-01A-11D-A40R-10 TCGA-DD-AADE-01 TCGA-DD-AADE-01 TCGA-DD-AADE-01A-11D-A40S-05 +TCGA-DD-AADF-01 TCGA-DD-AADF-01 TCGA-DD-AADF TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 64 3.8 3.5 5.3 TCGA-DD-AADF TCGA-DD-AADF-01A 0.2 1.1 A 0.7 1.5 0.6 -23614 865 115 0 1 0 8 725 2014-7-7 FEMALE 145 Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 30 1.0 1.0 NO G4 NO true No M0 N0 T1 Stage I TCGA-DD-AADF.046D3A59-FFB8-40B1-8ED2-6853F42CF611.pdf AADF TUMOR FREE 174 130 400 NO NO 1.2 NO NO R0 Primary Tumor 01 Segmentectomy, Multiple 7th NO YES DD 1.2 Liver None A DECEASED 55 2011 TCGA-DD-AADF-01A-11D-A40Q-01 TCGA-DD-AADF-01A-11D-A40Q-01 TCGA-DD-AADF-01A-11D-A40R-10 TCGA-DD-AADF-01 TCGA-DD-AADF-01 3213d854-0c94-4958-94e6-d3ada06b0ed2 TCGA-DD-AADF-01 TCGA-DD-AADF-01 3213d854-0c94-4958-94e6-d3ada06b0ed2 3213d854-0c94-4958-94e6-d3ada06b0ed2 3213d854-0c94-4958-94e6-d3ada06b0ed2 TCGA-DD-AADF-01A-11D-A40S-05 +TCGA-DD-AADG-01 TCGA-DD-AADG-01 TCGA-DD-AADG TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO Mild 70 3.8 4.2 5.3 TCGA-DD-AADG-F68394 TCGA-DD-AADG TCGA-DD-AADG-01A 0.2 0.9 A 0.7 1.5 1.0 -25887 862 0 1145 386 270 0 0 8 2256 3,4 - Fibrous Speta 2014-11-17 MALE 160 Alcohol consumption|Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 80 1.0 1.0 NO NO G3 Liver Intrahepatic Recurrence No YES YES No true No M0 N0 T3a Stage IIIA TCGA-DD-AADG.E6130559-E3EA-4010-9031-071D55816383.pdf AADG TUMOR FREE 170 130 400 NO NO 1.0 NO NO R0 R0 Primary Tumor 01 Lobectomy 7th NO YES DD 1.2 Liver None A LIVING 61 2011 TCGA-DD-AADG-01A-11D-A40Q-01 TCGA-DD-AADG-01A-11D-A40Q-01 TCGA-DD-AADG-01A-11D-A40R-10 TCGA-DD-AADG-01 TCGA-DD-AADG-01 8f27c933-b86c-4d95-8d17-75f0861ecc10 TCGA-DD-AADG-01 TCGA-DD-AADG-01 8f27c933-b86c-4d95-8d17-75f0861ecc10 8f27c933-b86c-4d95-8d17-75f0861ecc10 8f27c933-b86c-4d95-8d17-75f0861ecc10 TCGA-DD-AADG-01A-11D-A40S-05 +TCGA-DD-AADI-01 TCGA-DD-AADI-01 TCGA-DD-AADI TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 43 3.8 3.8 5.3 TCGA-DD-AADI-F68395 TCGA-DD-AADI 0.2 0.5 A 0.7 1.5 0.8 -15928 0 1085 0 0 8 27 2014-11-17 FEMALE 165 Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 1.0 1.0 NO G3 NO No M0 N0 T1 Stage I AADI TUMOR FREE 141 130 400 NO NO 1.1 NO NO R0 Primary Tumor 01 Segmentectomy, Single 7th NO YES DD 1.2 Liver None LIVING 64 2011 TCGA-DD-AADI-01A-11D-A40Q-01 TCGA-DD-AADI-01A-11D-A40Q-01 TCGA-DD-AADI-01A-11D-A40R-10 TCGA-DD-AADI-01 TCGA-DD-AADI-01 e4311714-b7a4-47b2-81a2-bddd0775f1e6 TCGA-DD-AADI-01 TCGA-DD-AADI-01 e4311714-b7a4-47b2-81a2-bddd0775f1e6 e4311714-b7a4-47b2-81a2-bddd0775f1e6 e4311714-b7a4-47b2-81a2-bddd0775f1e6 TCGA-DD-AADI-01A-11D-A40S-05 +TCGA-DD-AADJ-01 TCGA-DD-AADJ-01 TCGA-DD-AADJ TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 70 3.8 4.2 5.3 TCGA-DD-AADJ-F68396 TCGA-DD-AADJ 0.2 0.6 A 0.7 1.5 0.6 -25863 0 1066 0 0 8 708 2014-11-17 FEMALE 154 Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 1.0 1.0 NO G3 NO No M0 N0 T1 Stage I AADJ TUMOR FREE 203 130 400 NO NO 1.0 NO NO R0 Primary Tumor 01 Lobectomy 7th NO YES DD 1.2 Liver None LIVING 59 2011 TCGA-DD-AADJ-01A-11D-A40Q-01 TCGA-DD-AADJ-01A-11D-A40Q-01 TCGA-DD-AADJ-01A-11D-A40R-10 TCGA-DD-AADJ-01 TCGA-DD-AADJ-01 d3582fe8-0633-449d-969d-8e0e4c06bfd8 TCGA-DD-AADJ-01 TCGA-DD-AADJ-01 d3582fe8-0633-449d-969d-8e0e4c06bfd8 d3582fe8-0633-449d-969d-8e0e4c06bfd8 d3582fe8-0633-449d-969d-8e0e4c06bfd8 TCGA-DD-AADJ-01A-11D-A40S-05 +TCGA-DD-AADK-01 TCGA-DD-AADK-01 TCGA-DD-AADK TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver None 68 3.8 4.4 5.3 TCGA-DD-AADK-F68397 TCGA-DD-AADK 0.2 0.5 A 0.7 1.5 1.2 -25046 0 1049 0 0 8 236 6 - Established Cirrhosis 2014-11-17 FEMALE 150 Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 1.0 1.0 NO G3 NO No M0 N0 T2 Stage II AADK TUMOR FREE 197 130 400 NO NO 1.0 NO NO R0 Primary Tumor 01 Segmentectomy, Multiple 7th NO YES DD 1.2 Liver Micro LIVING 51 2011 TCGA-DD-AADK-01A-11D-A40Q-01 TCGA-DD-AADK-01A-11D-A40Q-01 TCGA-DD-AADK-01A-11D-A40R-10 TCGA-DD-AADK-01 TCGA-DD-AADK-01 b57c62f8-10b1-47cc-af66-9ba1d281661f TCGA-DD-AADK-01 TCGA-DD-AADK-01 b57c62f8-10b1-47cc-af66-9ba1d281661f b57c62f8-10b1-47cc-af66-9ba1d281661f b57c62f8-10b1-47cc-af66-9ba1d281661f TCGA-DD-AADK-01A-11D-A40S-05 +TCGA-DD-AADL-01 TCGA-DD-AADL-01 TCGA-DD-AADL TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 58 3.8 3.5 5.3 TCGA-DD-AADL-F68398 TCGA-DD-AADL TCGA-DD-AADL-01A 0.2 0.5 2 A 0.7 1.5 0.5 -21512 720 0 636 0 0 8 14 2014-11-17 MALE 159 Alcohol consumption|Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 20 1.0 1.0 NO NO G4 NO true No M0 N0 T1 Stage I TCGA-DD-AADL.248AF6DC-85A7-4334-B282-B7B0102C4596.pdf AADL TUMOR FREE 204 130 400 NO NO 0.9 NO YES R0 Primary Tumor 01 Segmentectomy, Single 7th NO YES DD 1.2 Liver Micro A LIVING 53 2012 TCGA-DD-AADL-01A-11D-A40Q-01 TCGA-DD-AADL-01A-11D-A40Q-01 TCGA-DD-AADL-01A-11D-A40R-10 TCGA-DD-AADL-01 TCGA-DD-AADL-01 5381c623-bc22-4f71-8ce1-4f8a4d354826 TCGA-DD-AADL-01 TCGA-DD-AADL-01 5381c623-bc22-4f71-8ce1-4f8a4d354826 5381c623-bc22-4f71-8ce1-4f8a4d354826 5381c623-bc22-4f71-8ce1-4f8a4d354826 TCGA-DD-AADL-01A-11D-A40S-05 +TCGA-DD-AADM-01 TCGA-DD-AADM-01 TCGA-DD-AADM TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 58 3.8 4.1 5.3 TCGA-DD-AADM TCGA-DD-AADM-01A 0.2 0.5 A 0.7 1.5 0.8 -21349 704 12 0 0 0 8 112 2014-7-7 MALE 159 Alcohol consumption|Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 20 1.0 1.0 NO G3 NO true No M0 N0 T2 Stage II TCGA-DD-AADM.36839A87-47E6-4E63-8683-A1549549AECE.pdf AADM TUMOR FREE 126 130 400 NO NO 1.0 NO NO R0 Primary Tumor 01 Segmentectomy, Multiple 7th NO YES DD 1.2 Liver None A DECEASED 55 2012 TCGA-DD-AADM-01A-11D-A40Q-01 TCGA-DD-AADM-01A-11D-A40Q-01 TCGA-DD-AADM-01A-11D-A40R-10 TCGA-DD-AADM-01 TCGA-DD-AADM-01 377c868a-4176-4c2b-b1bb-9f97b8d85739 TCGA-DD-AADM-01 TCGA-DD-AADM-01 377c868a-4176-4c2b-b1bb-9f97b8d85739 377c868a-4176-4c2b-b1bb-9f97b8d85739 377c868a-4176-4c2b-b1bb-9f97b8d85739 TCGA-DD-AADM-01A-11D-A40S-05 +TCGA-DD-AADN-01 TCGA-DD-AADN-01 TCGA-DD-AADN TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 59 3.8 3.5 5.3 TCGA-DD-AADN-F68400 TCGA-DD-AADN TCGA-DD-AADN-01A 0.2 1.1 A 0.7 1.5 0.8 -21632 602 0 898 0 0 8 151367 2014-11-17 MALE 160 Alcohol consumption|Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 70 1.0 1.0 NO NO G4 NO true No MX NX T1 Stage I TCGA-DD-AADN.043E7A50-2122-42D4-BB6F-9AAC61FE8CBE.pdf AADN TUMOR FREE 176 130 400 NO NO 1.1 NO NO R0 Primary Tumor 01 Lobectomy 7th NO YES DD 1.2 Liver Micro A LIVING 62 2012 TCGA-DD-AADN-01A-11D-A40Q-01 TCGA-DD-AADN-01A-11D-A40Q-01 TCGA-DD-AADN-01A-11D-A40R-10 TCGA-DD-AADN-01 TCGA-DD-AADN-01 972a081e-7a07-4b85-93d9-b58ad38229f7 TCGA-DD-AADN-01 TCGA-DD-AADN-01 972a081e-7a07-4b85-93d9-b58ad38229f7 972a081e-7a07-4b85-93d9-b58ad38229f7 972a081e-7a07-4b85-93d9-b58ad38229f7 TCGA-DD-AADN-01A-11D-A40S-05 +TCGA-DD-AADO-01 TCGA-DD-AADO-01 TCGA-DD-AADO TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 55 3.8 4.5 5.3 TCGA-DD-AADO-F68401 TCGA-DD-AADO 0.2 0.4 A 0.7 1.5 0.6 -20139 0 453 0 0 8 176037 2014-11-17 MALE 168 Alcohol consumption|Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 1.0 1.0 NO G3 NO No M0 N0 T1 Stage I AADO TUMOR FREE 180 130 400 NO NO 1.0 NO NO R0 Primary Tumor 01 Lobectomy 7th NO YES DD 1.2 Liver Micro LIVING 58 2013 TCGA-DD-AADO-01A-11D-A40Q-01 TCGA-DD-AADO-01A-11D-A40Q-01 TCGA-DD-AADO-01A-11D-A40R-10 TCGA-DD-AADO-01 TCGA-DD-AADO-01 dc8b6cb8-c320-4f72-8e12-0177cecffc87 TCGA-DD-AADO-01 TCGA-DD-AADO-01 dc8b6cb8-c320-4f72-8e12-0177cecffc87 dc8b6cb8-c320-4f72-8e12-0177cecffc87 dc8b6cb8-c320-4f72-8e12-0177cecffc87 TCGA-DD-AADO-01A-11D-A40S-05 +TCGA-DD-AADP-01 TCGA-DD-AADP-01 TCGA-DD-AADP TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 45 3.8 3.7 5.3 TCGA-DD-AADP-F68402 TCGA-DD-AADP TCGA-DD-AADP-01A 0.2 0.6 A 0.7 1.5 0.5 -16760 161 0 458 0 0 8 9 2014-11-17 MALE 167 Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 20 1.0 1.0 NO NO G3 NO true No M0 N0 T1 Stage I TCGA-DD-AADP.11B44F97-2332-4CB7-B57C-063B1C6127EF.pdf AADP TUMOR FREE 102 130 400 NO NO 1.1 NO NO R0 Primary Tumor 01 Lobectomy 7th NO YES DD 1.2 Liver Micro A LIVING 67 2013 TCGA-DD-AADP-01A-11D-A38W-01 TCGA-DD-AADP-01A-11D-A38W-01 TCGA-DD-AADP-01A-11D-A38X-10 TCGA-DD-AADP-01 TCGA-DD-AADP-01 6b57a5b6-2306-493a-aecf-0de8d2f098a8 TCGA-DD-AADP-01 TCGA-DD-AADP-01 6b57a5b6-2306-493a-aecf-0de8d2f098a8 6b57a5b6-2306-493a-aecf-0de8d2f098a8 6b57a5b6-2306-493a-aecf-0de8d2f098a8 TCGA-DD-AADP-01A-11D-A39G-05 +TCGA-DD-AADQ-01 TCGA-DD-AADQ-01 TCGA-DD-AADQ TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 59 3.8 4.4 5.3 TCGA-DD-AADQ-F68403 TCGA-DD-AADQ 0.2 0.3 A 0.7 1.5 0.7 -21756 0 436 0 0 8 7 2014-11-17 MALE 165 Alcohol consumption|Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 1.0 1.0 NO G3 NO No M0 N0 T2 Stage II AADQ TUMOR FREE 163 130 400 NO NO 1.1 NO NO R0 Primary Tumor 01 Lobectomy 7th NO YES DD 1.2 Liver None LIVING 64 2013 TCGA-DD-AADQ-01A-11D-A40Q-01 TCGA-DD-AADQ-01A-11D-A40Q-01 TCGA-DD-AADQ-01A-11D-A40R-10 TCGA-DD-AADQ-01 TCGA-DD-AADQ-01 c623f952-e487-4d8d-a5c3-eef8bac53a05 TCGA-DD-AADQ-01 TCGA-DD-AADQ-01 c623f952-e487-4d8d-a5c3-eef8bac53a05 c623f952-e487-4d8d-a5c3-eef8bac53a05 c623f952-e487-4d8d-a5c3-eef8bac53a05 TCGA-DD-AADQ-01A-11D-A40S-05 +TCGA-DD-AADR-01 TCGA-DD-AADR-01 TCGA-DD-AADR TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO Mild 58 3.8 4.4 5.3 TCGA-DD-AADR-F68404 TCGA-DD-AADR 0.2 0.9 A 0.7 1.5 1.0 -21217 0 2028 2028 0 0 8 3 6 - Established Cirrhosis 2014-11-17 MALE 170 Alcohol consumption|Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 1.0 1.0 NO G3 Liver Intrahepatic Recurrence No NO YES No No M0 N0 T1 Stage I AADR TUMOR FREE 75 130 400 NO NO 1.1 NO NO R0 Primary Tumor 01 Segmentectomy, Single 6th NO YES DD 1.2 Liver None LIVING 75 2009 TCGA-DD-AADR-01A-11D-A40Q-01 TCGA-DD-AADR-01A-11D-A40Q-01 TCGA-DD-AADR-01A-11D-A40R-10 TCGA-DD-AADR-01 TCGA-DD-AADR-01 fcea51b1-3899-4c1d-bcc1-b0fbefe01661 TCGA-DD-AADR-01 TCGA-DD-AADR-01 fcea51b1-3899-4c1d-bcc1-b0fbefe01661 fcea51b1-3899-4c1d-bcc1-b0fbefe01661 fcea51b1-3899-4c1d-bcc1-b0fbefe01661 TCGA-DD-AADR-01A-11D-A40S-05 +TCGA-DD-AADS-01 TCGA-DD-AADS-01 TCGA-DD-AADS TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 63 3.8 3.7 5.3 TCGA-DD-AADS-F68405 TCGA-DD-AADS 0.2 0.7 1 A 0.7 1.5 0.9 -23227 0 474 0 0 8 11 2014-11-17 MALE 164 Alcohol consumption|Hepatitis C Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 1.0 1.0 NO G2 NO No M0 N0 T1 Stage I AADS TUMOR FREE 120 130 400 NO NO 1.2 NO YES R0 Primary Tumor 01 Lobectomy 7th NO YES DD 1.2 Liver None LIVING 53 2013 TCGA-DD-AADS-01A-11D-A40Q-01 TCGA-DD-AADS-01A-11D-A40Q-01 TCGA-DD-AADS-01A-11D-A40R-10 TCGA-DD-AADS-01 TCGA-DD-AADS-01 b05b2c69-27f3-46db-891a-9d2f8b0d8b97 TCGA-DD-AADS-01 TCGA-DD-AADS-01 b05b2c69-27f3-46db-891a-9d2f8b0d8b97 b05b2c69-27f3-46db-891a-9d2f8b0d8b97 b05b2c69-27f3-46db-891a-9d2f8b0d8b97 TCGA-DD-AADS-01A-11D-A40S-05 +TCGA-DD-AADU-01 TCGA-DD-AADU-01 TCGA-DD-AADU TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver None 60 3.8 4.3 5.3 TCGA-DD-AADU-F68406 TCGA-DD-AADU 0.2 1.8 A 0.7 1.5 0.8 -21940 0 554 0 0 8 52 3,4 - Fibrous Speta 2014-11-17 MALE 166 Alcohol consumption Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 1.0 1.0 NO G3 NO No M0 N0 T2 Stage II AADU TUMOR FREE 223 130 400 NO NO 1.0 NO YES R0 Primary Tumor 01 Lobectomy 7th NO YES DD 1.2 Liver Micro LIVING 73 2013 TCGA-DD-AADU-01A-11D-A40Q-01 TCGA-DD-AADU-01A-11D-A40Q-01 TCGA-DD-AADU-01A-11D-A40R-10 TCGA-DD-AADU-01 TCGA-DD-AADU-01 e0178b54-86f9-45e7-949d-2c4132ac9822 TCGA-DD-AADU-01 TCGA-DD-AADU-01 e0178b54-86f9-45e7-949d-2c4132ac9822 e0178b54-86f9-45e7-949d-2c4132ac9822 e0178b54-86f9-45e7-949d-2c4132ac9822 TCGA-DD-AADU-01A-11D-A40S-05 +TCGA-DD-AADV-01 TCGA-DD-AADV-01 TCGA-DD-AADV TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver None 50 3.8 3.8 5.3 TCGA-DD-AADV-F68407 TCGA-DD-AADV TCGA-DD-AADV-01A 0.2 0.8 A 0.7 1.5 0.9 -18300 286 0 574 0 0 8 11 6 - Established Cirrhosis 2014-11-17 MALE 176 Alcohol consumption|Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 20 1.0 1.0 NO NO G3 NO true Yes M0 N0 T1 Stage I TCGA-DD-AADV.750CC634-8874-488C-B20D-6B636978156A.pdf AADV TUMOR FREE 187 130 400 NO NO 1.0 NO NO R0 Primary Tumor 01 Segmentectomy, Multiple 7th NO YES DD 1.2 Liver None A LIVING 64 2013 TCGA-DD-AADV-01A-11D-A38W-01 TCGA-DD-AADV-01A-11D-A38W-01 TCGA-DD-AADV-01A-11D-A38X-10 TCGA-DD-AADV-01 TCGA-DD-AADV-01 31ca8dd5-ebff-496f-b9ea-e62a96449238 TCGA-DD-AADV-01 TCGA-DD-AADV-01 31ca8dd5-ebff-496f-b9ea-e62a96449238 31ca8dd5-ebff-496f-b9ea-e62a96449238 31ca8dd5-ebff-496f-b9ea-e62a96449238 TCGA-DD-AADV-01A-11D-A39G-05 +TCGA-DD-AADW-01 TCGA-DD-AADW-01 TCGA-DD-AADW TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO YES None 48 3.8 4.3 4.3 TCGA-DD-AADW-F68408 TCGA-DD-AADW TCGA-DD-AADW-01A 0.2 1.0 A 0.7 1.5 0.8 -17781 287 0 587 386 1 0 8 250 6 - Established Cirrhosis 2014-11-17 MALE 163 Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 30 1.0 1.0 NO NO G3 Liver Locoregional Recurrence No NO YES No true No M0 N0 T1 Stage I TCGA-DD-AADW.18DA1A83-81E4-462C-AA58-FBB1298F86F9.pdf AADW TUMOR FREE 102 130 400 NO NO 1.0 NO NO R0 Primary Tumor 01 Lobectomy 7th NO YES DD 1.2 Liver None A LIVING 49 2013 TCGA-DD-AADW-01A-11D-A38W-01 TCGA-DD-AADW-01A-11D-A38W-01 TCGA-DD-AADW-01A-11D-A38X-10 TCGA-DD-AADW-01 TCGA-DD-AADW-01 64842a3f-2584-4d55-9e6c-bb976485476a TCGA-DD-AADW-01 TCGA-DD-AADW-01 64842a3f-2584-4d55-9e6c-bb976485476a 64842a3f-2584-4d55-9e6c-bb976485476a 64842a3f-2584-4d55-9e6c-bb976485476a TCGA-DD-AADW-01A-11D-A39G-05 +TCGA-DD-AADY-01 TCGA-DD-AADY-01 TCGA-DD-AADY TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver None 55 3.8 3.5 5.3 TCGA-DD-AADY-F68409 TCGA-DD-AADY 0.2 0.8 A 0.7 1.5 0.6 -20233 0 555 0 0 8 9 6 - Established Cirrhosis 2014-11-17 FEMALE 161 Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 1.0 1.0 NO G2 NO No M0 N0 T1 Stage I AADY TUMOR FREE 159 130 400 NO NO 1.3 NO NO R0 Primary Tumor 01 Lobectomy 7th NO YES DD 1.2 Liver None LIVING 55 2013 TCGA-DD-AADY-01A-11D-A40Q-01 TCGA-DD-AADY-01A-11D-A40Q-01 TCGA-DD-AADY-01A-11D-A40R-10 TCGA-DD-AADY-01 TCGA-DD-AADY-01 a7a49062-5a0f-4a5f-bcac-9673538f975d TCGA-DD-AADY-01 TCGA-DD-AADY-01 a7a49062-5a0f-4a5f-bcac-9673538f975d a7a49062-5a0f-4a5f-bcac-9673538f975d a7a49062-5a0f-4a5f-bcac-9673538f975d TCGA-DD-AADY-01A-11D-A40S-05 +TCGA-DD-AAE0-01 TCGA-DD-AAE0-01 TCGA-DD-AAE0 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver Mild 45 3.8 4.8 5.3 TCGA-DD-AAE0-F68410 TCGA-DD-AAE0 TCGA-DD-AAE0-01A 0.2 0.9 A 0.7 1.5 0.5 -16732 314 0 555 0 0 8 8751 3,4 - Fibrous Speta 2014-11-17 FEMALE 159 Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 40 1.0 1.0 NO NO G4 NO true No M0 N0 T3a Stage IIIA TCGA-DD-AAE0.C8EB705D-E9F9-4101-9B7F-EE4968CA5781.pdf AAE0 TUMOR FREE 226 130 400 NO NO 0.9 NO NO R0 Primary Tumor 01 Lobectomy 7th NO YES DD 1.2 Liver None A LIVING 56 2013 TCGA-DD-AAE0-01A-11D-A40Q-01 TCGA-DD-AAE0-01A-11D-A40Q-01 TCGA-DD-AAE0-01A-11D-A40R-10 TCGA-DD-AAE0-01 TCGA-DD-AAE0-01 848b19c6-7761-48b9-9f22-ab31d5aadba1 TCGA-DD-AAE0-01 TCGA-DD-AAE0-01 848b19c6-7761-48b9-9f22-ab31d5aadba1 848b19c6-7761-48b9-9f22-ab31d5aadba1 848b19c6-7761-48b9-9f22-ab31d5aadba1 TCGA-DD-AAE0-01A-11D-A40S-05 +TCGA-DD-AAE1-01 TCGA-DD-AAE1-01 TCGA-DD-AAE1 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver Mild 52 3.8 4.1 5.3 TCGA-DD-AAE1-F68411 TCGA-DD-AAE1 0.2 0.4 A 0.7 1.5 0.8 -19073 0 552 0 0 8 2693 6 - Established Cirrhosis 2014-11-17 MALE 169 Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 1.0 1.0 NO G3 NO No M0 N0 T1 Stage I AAE1 TUMOR FREE 102 130 400 NO NO 0.9 NO NO R0 Primary Tumor 01 Lobectomy 7th NO YES DD 1.2 Liver None LIVING 62 2013 TCGA-DD-AAE1-01A-11D-A40Q-01 TCGA-DD-AAE1-01A-11D-A40Q-01 TCGA-DD-AAE1-01A-11D-A40R-10 TCGA-DD-AAE1-01 TCGA-DD-AAE1-01 ba7eaaac-b25a-4f83-b8f8-885b172ac44c TCGA-DD-AAE1-01 TCGA-DD-AAE1-01 ba7eaaac-b25a-4f83-b8f8-885b172ac44c ba7eaaac-b25a-4f83-b8f8-885b172ac44c ba7eaaac-b25a-4f83-b8f8-885b172ac44c TCGA-DD-AAE1-01A-11D-A40S-05 +TCGA-DD-AAE2-01 TCGA-DD-AAE2-01 TCGA-DD-AAE2 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver None 51 3.8 4.4 5.3 TCGA-DD-AAE2-F68412 TCGA-DD-AAE2 TCGA-DD-AAE2-01A 0.2 0.4 A 0.7 1.5 0.8 -18695 337 0 638 0 0 8 41 6 - Established Cirrhosis 2014-11-17 MALE 174 Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 20 1.0 1.0 NO NO G3 NO true No M0 N0 T1 Stage I TCGA-DD-AAE2.C70F898B-E3C1-42C1-BF50-38E126A5B708.pdf AAE2 TUMOR FREE 238 130 400 NO NO 1.0 NO NO R0 Primary Tumor 01 Lobectomy 7th NO YES DD 1.2 Liver None A LIVING 82 2013 TCGA-DD-AAE2-01A-11D-A40Q-01 TCGA-DD-AAE2-01A-11D-A40Q-01 TCGA-DD-AAE2-01A-11D-A40R-10 TCGA-DD-AAE2-01 TCGA-DD-AAE2-01 1ee97326-1e6c-4c92-ab9f-c4eb6aeb5c46 TCGA-DD-AAE2-01 TCGA-DD-AAE2-01 1ee97326-1e6c-4c92-ab9f-c4eb6aeb5c46 1ee97326-1e6c-4c92-ab9f-c4eb6aeb5c46 1ee97326-1e6c-4c92-ab9f-c4eb6aeb5c46 TCGA-DD-AAE2-01A-11D-A40S-05 +TCGA-DD-AAE3-01 TCGA-DD-AAE3-01 TCGA-DD-AAE3 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver None 50 3.8 4.7 5.3 TCGA-DD-AAE3-F68413 TCGA-DD-AAE3 TCGA-DD-AAE3-01A 0.2 1.1 A 0.7 1.5 0.8 -18271 342 0 566 0 0 8 2 1,2 - Portal Fibrosis 2014-11-17 MALE 165 Alcohol consumption|Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 30 1.0 1.0 NO NO G2 NO true No M0 N0 T1 Stage I TCGA-DD-AAE3.FED7CE87-1B13-4035-A76B-CEC1045B93C4.pdf AAE3 TUMOR FREE 180 130 400 NO NO 1.1 NO NO R0 Primary Tumor 01 Lobectomy 7th NO YES DD 1.2 Liver None A LIVING 73 2013 TCGA-DD-AAE3-01A-11D-A40Q-01 TCGA-DD-AAE3-01A-11D-A40Q-01 TCGA-DD-AAE3-01A-11D-A40R-10 TCGA-DD-AAE3-01 TCGA-DD-AAE3-01 5b1caa21-6281-47b4-b11f-fbe5458f1ffb TCGA-DD-AAE3-01 TCGA-DD-AAE3-01 5b1caa21-6281-47b4-b11f-fbe5458f1ffb 5b1caa21-6281-47b4-b11f-fbe5458f1ffb 5b1caa21-6281-47b4-b11f-fbe5458f1ffb TCGA-DD-AAE3-01A-11D-A40S-05 +TCGA-DD-AAE4-01 TCGA-DD-AAE4-01 TCGA-DD-AAE4 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO None 49 3.8 4.0 5.3 TCGA-DD-AAE4-F68414 TCGA-DD-AAE4 0.2 0.8 A 0.7 1.5 0.5 -18009 0 608 111 0 0 8 7 6 - Established Cirrhosis 2014-11-17 FEMALE 157 Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 1.0 1.0 NO G1 Liver Locoregional Recurrence Yes NO YES No No M0 N0 T1 Stage I AAE4 WITH TUMOR 113 130 400 NO NO 1.1 NO NO R0 Primary Tumor 01 Lobectomy 7th NO YES DD 1.2 Liver None LIVING 62 2013 TCGA-DD-AAE4-01A-11D-A40Q-01 TCGA-DD-AAE4-01A-11D-A40Q-01 TCGA-DD-AAE4-01A-11D-A40R-10 TCGA-DD-AAE4-01 TCGA-DD-AAE4-01 e1aa2737-5bf3-4348-b3bf-07d881e71e6e TCGA-DD-AAE4-01 TCGA-DD-AAE4-01 e1aa2737-5bf3-4348-b3bf-07d881e71e6e e1aa2737-5bf3-4348-b3bf-07d881e71e6e e1aa2737-5bf3-4348-b3bf-07d881e71e6e TCGA-DD-AAE4-01A-11D-A40S-05 +TCGA-DD-AAE6-01 TCGA-DD-AAE6-01 TCGA-DD-AAE6 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO None 59 3.8 4.4 5.3 TCGA-DD-AAE6-F68416 TCGA-DD-AAE6 TCGA-DD-AAE6-01A 0.2 0.9 A 0.7 1.5 0.8 -21764 399 0 141 105 0 0 8 113 6 - Established Cirrhosis 2014-11-17 FEMALE 159 Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 80 1.0 1.0 NO NO G2 Liver Intrahepatic Recurrence Yes NO YES No true No M0 N0 T1 Stage I TCGA-DD-AAE6.1B3F62E9-8E87-43FA-AEA8-00C89D678F8F.pdf AAE6 WITH TUMOR 209 130 400 NO NO 1.1 NO NO R0 Primary Tumor 01 Lobectomy 7th NO YES DD 1.2 Liver Micro A LIVING 46 2012 TCGA-DD-AAE6-01A-11D-A40Q-01 TCGA-DD-AAE6-01A-11D-A40Q-01 TCGA-DD-AAE6-01A-11D-A40R-10 TCGA-DD-AAE6-01 TCGA-DD-AAE6-01 8d639a44-445c-440c-8452-bafba2df33fc TCGA-DD-AAE6-01 TCGA-DD-AAE6-01 8d639a44-445c-440c-8452-bafba2df33fc 8d639a44-445c-440c-8452-bafba2df33fc 8d639a44-445c-440c-8452-bafba2df33fc TCGA-DD-AAE6-01A-11D-A40S-05 +TCGA-DD-AAE7-01 TCGA-DD-AAE7-01 TCGA-DD-AAE7 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver Severe 72 3.8 4.7 5.3 TCGA-DD-AAE7-F68418 TCGA-DD-AAE7 TCGA-DD-AAE7-01A 0.2 1.1 A 0.7 1.5 0.9 -26568 410 0 644 0 0 8 1 3,4 - Fibrous Speta 2014-11-17 MALE 172 Alcohol consumption|Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 20 1.0 1.0 NO NO G2 NO true Yes M0 N0 T1 Stage I TCGA-DD-AAE7.1861F2A9-334D-4C4E-A7D0-D010712D6096.pdf AAE7 TUMOR FREE 188 130 400 NO NO 1.0 NO NO R0 Primary Tumor 01 Lobectomy 7th NO YES DD 1.2 Liver None A LIVING 74 2012 TCGA-DD-AAE7-01A-11D-A40Q-01 TCGA-DD-AAE7-01A-11D-A40Q-01 TCGA-DD-AAE7-01A-11D-A40R-10 TCGA-DD-AAE7-01 TCGA-DD-AAE7-01 2c7587fc-5549-4888-abe9-b989e216e9c4 TCGA-DD-AAE7-01 TCGA-DD-AAE7-01 2c7587fc-5549-4888-abe9-b989e216e9c4 2c7587fc-5549-4888-abe9-b989e216e9c4 2c7587fc-5549-4888-abe9-b989e216e9c4 TCGA-DD-AAE7-01A-11D-A40S-05 +TCGA-DD-AAE8-01 TCGA-DD-AAE8-01 TCGA-DD-AAE8 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO 45 3.8 4.3 5.3 TCGA-DD-AAE8-F68419 TCGA-DD-AAE8 0.2 3.0 A 0.7 1.5 0.6 -16549 0 664 113 0 0 8 3 6 - Established Cirrhosis 2014-11-17 MALE 170 Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 1.0 1.0 NO G3 Liver Intrahepatic Recurrence Yes NO YES No Yes M0 N0 T1 Stage I AAE8 TUMOR FREE 125 130 400 NO NO 1.1 NO NO R0 Primary Tumor 01 Lobectomy 7th NO YES DD 1.2 Liver None LIVING 78 2012 TCGA-DD-AAE8-01A-11D-A40Q-01 TCGA-DD-AAE8-01A-11D-A40Q-01 TCGA-DD-AAE8-01A-11D-A40R-10 TCGA-DD-AAE8-01 TCGA-DD-AAE8-01 TCGA-DD-AAE8-01A-11D-A40S-05 +TCGA-DD-AAE9-01 TCGA-DD-AAE9-01 TCGA-DD-AAE9 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver Mild 69 3.8 4.1 5.3 TCGA-DD-AAE9-F68857 TCGA-DD-AAE9 TCGA-DD-AAE9-01A 0.2 0.7 A 0.7 1.5 0.9 -25451 419 0 722 0 0 8 3 1,2 - Portal Fibrosis 2014-12-21 MALE 165 Alcohol consumption|Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 40 1.0 1.0 NO NO G3 NO true No M0 N0 T1 Stage I TCGA-DD-AAE9.64700E97-F031-49DE-83F0-8CCDBDEE23AF.pdf AAE9 TUMOR FREE 138 130 400 NO NO 1.1 NO NO R0 Primary Tumor 01 Lobectomy 7th NO YES DD 1.2 Liver None A LIVING 63 2012 TCGA-DD-AAE9-01A-11D-A40Q-01 TCGA-DD-AAE9-01A-11D-A40Q-01 TCGA-DD-AAE9-01A-11D-A40R-10 TCGA-DD-AAE9-01 TCGA-DD-AAE9-01 134b8660-251e-428f-9057-b385b122c5ec TCGA-DD-AAE9-01 TCGA-DD-AAE9-01 134b8660-251e-428f-9057-b385b122c5ec 134b8660-251e-428f-9057-b385b122c5ec 134b8660-251e-428f-9057-b385b122c5ec TCGA-DD-AAE9-01A-11D-A40S-05 +TCGA-DD-AAEA-01 TCGA-DD-AAEA-01 TCGA-DD-AAEA TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 65 3.8 4.5 5.3 TCGA-DD-AAEA-F68421 TCGA-DD-AAEA 0.2 0.6 A 0.7 1.5 0.9 -24027 0 575 0 0 8 2 1,2 - Portal Fibrosis 2014-11-17 MALE 163 Alcohol consumption|Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 1.0 1.0 NO G3 NO Yes M0 N0 T1 Stage I AAEA TUMOR FREE 255 130 400 NO NO 1.0 NO NO R0 Primary Tumor 01 Segmentectomy, Single 7th NO YES DD 1.2 Liver None LIVING 66 2012 TCGA-DD-AAEA-01A-11D-A40Q-01 TCGA-DD-AAEA-01A-11D-A40Q-01 TCGA-DD-AAEA-01A-11D-A40R-10 TCGA-DD-AAEA-01 TCGA-DD-AAEA-01 c23a2426-2763-4088-b85b-e9cfcfc7959d TCGA-DD-AAEA-01 TCGA-DD-AAEA-01 c23a2426-2763-4088-b85b-e9cfcfc7959d c23a2426-2763-4088-b85b-e9cfcfc7959d c23a2426-2763-4088-b85b-e9cfcfc7959d TCGA-DD-AAEA-01A-11D-A40S-05 +TCGA-DD-AAEB-01 TCGA-DD-AAEB-01 TCGA-DD-AAEB TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 60 3.8 4.1 5.3 TCGA-DD-AAEB-F68423 TCGA-DD-AAEB TCGA-DD-AAEB-01A 0.2 0.3 A 0.7 1.5 0.6 -22121 468 0 478 1 0 8 1 2014-11-17 MALE 161 Alcohol consumption|Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 70 1.0 1.0 NO NO G2 NO true No M0 N0 T1 Stage I TCGA-DD-AAEB.E991576A-60BD-4C11-9B4E-EA43F19D06C3.pdf AAEB TUMOR FREE 270 130 400 NO NO 1.0 NO NO R0 Primary Tumor 01 Lobectomy 7th NO YES DD 1.2 Liver None A LIVING 75 2012 TCGA-DD-AAEB-01A-11D-A40Q-01 TCGA-DD-AAEB-01A-11D-A40Q-01 TCGA-DD-AAEB-01A-11D-A40R-10 TCGA-DD-AAEB-01 TCGA-DD-AAEB-01 34dd06ab-c00e-4e24-8c92-eae9c430216a TCGA-DD-AAEB-01 TCGA-DD-AAEB-01 34dd06ab-c00e-4e24-8c92-eae9c430216a 34dd06ab-c00e-4e24-8c92-eae9c430216a 34dd06ab-c00e-4e24-8c92-eae9c430216a TCGA-DD-AAEB-01A-11D-A40S-05 +TCGA-DD-AAED-01 TCGA-DD-AAED-01 TCGA-DD-AAED TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO Mild 51 3.8 4.0 5.3 TCGA-DD-AAED-F68424 TCGA-DD-AAED 0.2 0.6 A 0.7 1.5 0.5 -18722 0 763 198 0 0 8 2405 1,2 - Portal Fibrosis 2014-11-17 MALE 166 Alcohol consumption|Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 1.0 1.0 NO G3 Liver Intrahepatic Recurrence Yes NO YES No No M0 N0 T1 Stage I AAED WITH TUMOR 211 130 400 NO NO 1.1 NO NO R0 Primary Tumor 01 Lobectomy 7th NO YES DD 1.2 Liver None LIVING 69 2012 TCGA-DD-AAED-01A-12D-A40Q-01 TCGA-DD-AAED-01A-12D-A40Q-01 TCGA-DD-AAED-01A-12D-A40R-10 TCGA-DD-AAED-01 TCGA-DD-AAED-01 ccf74279-b0d5-45ca-9a90-fd7d3d2fa630 TCGA-DD-AAED-01 TCGA-DD-AAED-01 ccf74279-b0d5-45ca-9a90-fd7d3d2fa630 ccf74279-b0d5-45ca-9a90-fd7d3d2fa630 ccf74279-b0d5-45ca-9a90-fd7d3d2fa630 TCGA-DD-AAED-01A-12D-A40S-05 +TCGA-DD-AAEE-01 TCGA-DD-AAEE-01 TCGA-DD-AAEE TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO None 55 3.8 4.7 5.3 TCGA-DD-AAEE-F68427 TCGA-DD-AAEE TCGA-DD-AAEE-01A 0.2 0.8 A 0.7 1.5 0.9 -20396 509 0 810 298 224 0 0 8 3 6 - Established Cirrhosis 2014-11-17 MALE 160 Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 40 1.0 1.0 NO NO G4 Liver Intrahepatic Recurrence Yes YES YES No true No M0 N0 T1 Stage I TCGA-DD-AAEE.D857BF5A-E2C6-4A6E-88CA-E8707E6FF3D9.pdf AAEE WITH TUMOR 221 130 400 NO NO 1.0 NO NO RX R0 Primary Tumor 01 Lobectomy 7th NO YES DD 1.2 Liver None A LIVING 58 2012 TCGA-DD-AAEE-01A-11D-A40Q-01 TCGA-DD-AAEE-01A-11D-A40Q-01 TCGA-DD-AAEE-01A-11D-A40R-10 TCGA-DD-AAEE-01 TCGA-DD-AAEE-01 6624447f-0954-4488-b8f7-2e73162ef22b TCGA-DD-AAEE-01 TCGA-DD-AAEE-01 6624447f-0954-4488-b8f7-2e73162ef22b 6624447f-0954-4488-b8f7-2e73162ef22b 6624447f-0954-4488-b8f7-2e73162ef22b TCGA-DD-AAEE-01A-11D-A40S-05 +TCGA-DD-AAEG-01 TCGA-DD-AAEG-01 TCGA-DD-AAEG TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver None 59 3.8 3.0 5.3 TCGA-DD-AAEG-F68430 TCGA-DD-AAEG TCGA-DD-AAEG-01A 0.2 0.6 A 0.7 1.5 0.6 -21853 529 0 719 0 0 8 1 6 - Established Cirrhosis 2014-11-17 FEMALE 149 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 20 1.0 1.0 NO NO G3 NO true Yes M0 N0 T1 Stage I TCGA-DD-AAEG.B48B65B0-92F9-4B49-B8A8-563EA5AF70F1.pdf AAEG TUMOR FREE 69 130 400 NO NO 1.3 NO NO R0 Primary Tumor 01 Segmentectomy, Single 7th NO YES DD 1.2 Liver None A LIVING 40 2012 TCGA-DD-AAEG-01A-11D-A38W-01 TCGA-DD-AAEG-01A-11D-A38W-01 TCGA-DD-AAEG-01A-11D-A38X-10 TCGA-DD-AAEG-01 TCGA-DD-AAEG-01 700bf3b6-dff8-4de7-877f-1c742620f896 TCGA-DD-AAEG-01 TCGA-DD-AAEG-01 700bf3b6-dff8-4de7-877f-1c742620f896 700bf3b6-dff8-4de7-877f-1c742620f896 700bf3b6-dff8-4de7-877f-1c742620f896 TCGA-DD-AAEG-01A-11D-A39G-05 +TCGA-DD-AAEH-01 TCGA-DD-AAEH-01 TCGA-DD-AAEH TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO None 73 3.8 2.9 5.3 TCGA-DD-AAEH-F68431 TCGA-DD-AAEH TCGA-DD-AAEH-01A 0.2 0.9 A 0.7 1.5 0.6 -26894 553 0 784 660 644 2 1,2 - Portal Fibrosis 2014-11-17 MALE 163 Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 10 1.0 1.0 NO NO G2 Bone Extrahepatic Recurrence No YES YES No true No M0 N0 T1 Stage I TCGA-DD-AAEH.D6F3E1F8-27F3-47F9-88CC-F4145C983073.pdf AAEH TUMOR FREE 223 130 400 NO NO 1.1 NO NO RX R0 Primary Tumor 01 Lobectomy 7th NO YES DD 1.2 Liver Micro A LIVING 62 2012 TCGA-DD-AAEH-01A-11D-A40Q-01 TCGA-DD-AAEH-01A-11D-A40Q-01 TCGA-DD-AAEH-01A-11D-A40R-10 TCGA-DD-AAEH-01 TCGA-DD-AAEH-01 5be075bb-9fa0-4821-8e61-672f28e2b833 TCGA-DD-AAEH-01 TCGA-DD-AAEH-01 5be075bb-9fa0-4821-8e61-672f28e2b833 5be075bb-9fa0-4821-8e61-672f28e2b833 5be075bb-9fa0-4821-8e61-672f28e2b833 TCGA-DD-AAEH-01A-11D-A40S-05 +TCGA-DD-AAEI-01 TCGA-DD-AAEI-01 TCGA-DD-AAEI TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO YES None 72 3.8 3.6 5.3 TCGA-DD-AAEI-F68433 TCGA-DD-AAEI 0.2 0.5 A 0.7 1.5 0.9 -26465 0 1531 491 0 0 8 24 6 - Established Cirrhosis 2014-11-17 MALE 166 Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 1.0 1.0 NO G2 Bone Extrahepatic Recurrence No NO YES No No M0 N0 T1 Stage I AAEI WITH TUMOR 161 130 400 YES NO 1.1 NO NO R0 Primary Tumor 01 Segmentectomy, Single 7th NO YES DD 1.2 Liver None LIVING 79 2010 TCGA-DD-AAEI-01A-11D-A40Q-01 TCGA-DD-AAEI-01A-11D-A40Q-01 TCGA-DD-AAEI-01A-11D-A40R-10 TCGA-DD-AAEI-01 TCGA-DD-AAEI-01 ab0da649-e0c0-497a-a20b-4d1a618dba72 TCGA-DD-AAEI-01 TCGA-DD-AAEI-01 ab0da649-e0c0-497a-a20b-4d1a618dba72 ab0da649-e0c0-497a-a20b-4d1a618dba72 ab0da649-e0c0-497a-a20b-4d1a618dba72 TCGA-DD-AAEI-01A-11D-A40S-05 +TCGA-DD-AAEK-01 TCGA-DD-AAEK-01 TCGA-DD-AAEK TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver None 51 3.8 4.1 5.3 TCGA-DD-AAEK-F68434 TCGA-DD-AAEK TCGA-DD-AAEK-01A 0.2 1.0 A 0.7 1.5 0.7 -18757 1162 0 1067 0 0 8 5166 6 - Established Cirrhosis 2014-11-17 MALE 169 Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 10 1.0 1.0 NO YES G3 NO true No M0 N0 T2 Stage II TCGA-DD-AAEK.C174382E-E3FB-456E-B5B7-1949B3086967.pdf AAEK TUMOR FREE 202 130 400 NO NO 1.0 NO NO R0 Primary Tumor 01 Segmentectomy, Multiple 7th NO YES DD 1.2 Liver None A LIVING 64 2010 TCGA-DD-AAEK-01A-11D-A40Q-01 TCGA-DD-AAEK-01A-11D-A40Q-01 TCGA-DD-AAEK-01A-11D-A40R-10 TCGA-DD-AAEK-01 TCGA-DD-AAEK-01 099fe601-12b3-4e3d-8d01-322ef9ac9e5a TCGA-DD-AAEK-01 TCGA-DD-AAEK-01 099fe601-12b3-4e3d-8d01-322ef9ac9e5a 099fe601-12b3-4e3d-8d01-322ef9ac9e5a 099fe601-12b3-4e3d-8d01-322ef9ac9e5a TCGA-DD-AAEK-01A-11D-A40S-05 +TCGA-DD-AAVP-01 TCGA-DD-AAVP-01 TCGA-DD-AAVP TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO Severe 48 3.3 4.3 5.0 TCGA-DD-AAVP-F67571 TCGA-DD-AAVP TCGA-DD-AAVP-01A 0.2 1.1 1 A 0.7 1.4 1.2 -17833 2467 0 2752 903 0 0 15 2 6 - Established Cirrhosis 2014-11-6 MALE 167 Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 100 0.8 1.2 NO NO G1 Liver Locoregional Recurrence Yes NO YES Yes true No M0 N0 T1 Stage I TCGA-DD-AAVP.E930F87E-767F-4413-909E-97F7ABAD3D51.pdf AAVP TUMOR FREE 189 130 400 YES NO 1 NO YES RX R0 Primary Tumor 01 Extended Lobectomy 6th NO YES DD 1.2 Liver None A LIVING 62 2007 TCGA-DD-AAVP-01A-11D-A40Q-01 TCGA-DD-AAVP-01A-11D-A40Q-01 TCGA-DD-AAVP-01A-11D-A40R-10 TCGA-DD-AAVP-01 TCGA-DD-AAVP-01 6c3a4f09-1862-4fed-9977-759ec00a5aeb TCGA-DD-AAVP-01 TCGA-DD-AAVP-01 6c3a4f09-1862-4fed-9977-759ec00a5aeb 6c3a4f09-1862-4fed-9977-759ec00a5aeb 6c3a4f09-1862-4fed-9977-759ec00a5aeb TCGA-DD-AAVP-01A-11D-A40S-05 +TCGA-DD-AAVQ-01 TCGA-DD-AAVQ-01 TCGA-DD-AAVQ TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO Severe 38 3.3 3.0 5.2 TCGA-DD-AAVQ-F67572 TCGA-DD-AAVQ 0.2 1.0 A 0.7 1.4 1.1 -13911 0 2728 1509 1 0 15 1456 6 - Established Cirrhosis 2014-11-6 MALE 171 Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 0.8 1.2 NO G2 Liver Locoregional Recurrence Yes NO YES Yes No M0 N0 T1 Stage I AAVQ TUMOR FREE 128 130 400 YES NO 1.2 NO NO RX R0 Primary Tumor 01 Segmentectomy, Single 6th NO YES DD 1.2 Liver None LIVING 72 2007 TCGA-DD-AAVQ-01A-11D-A40Q-01 TCGA-DD-AAVQ-01A-11D-A40Q-01 TCGA-DD-AAVQ-01A-11D-A40R-10 TCGA-DD-AAVQ-01 TCGA-DD-AAVQ-01 d01e30b3-9f94-47f6-8a4e-0b4f84ad5eb2 TCGA-DD-AAVQ-01 TCGA-DD-AAVQ-01 d01e30b3-9f94-47f6-8a4e-0b4f84ad5eb2 d01e30b3-9f94-47f6-8a4e-0b4f84ad5eb2 d01e30b3-9f94-47f6-8a4e-0b4f84ad5eb2 TCGA-DD-AAVQ-01A-11D-A40S-05 +TCGA-DD-AAVR-01 TCGA-DD-AAVR-01 TCGA-DD-AAVR TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver None 44 3.3 3.6 5.2 TCGA-DD-AAVR-F67574 TCGA-DD-AAVR 0.2 1.2 1 A 0.0 1.4 1.1 -16157 0 2513 1 0 15 36 6 - Established Cirrhosis 2014-11-6 MALE 165 Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 0.8 1.2 NO G2 NO No M0 N0 T1 Stage I AAVR TUMOR FREE 174 130 400 NO NO 1.0 NO YES R0 Primary Tumor 01 Segmentectomy, Multiple 6th NO YES DD 1.2 Liver None LIVING 69 2007 TCGA-DD-AAVR-01A-11D-A40Q-01 TCGA-DD-AAVR-01A-11D-A40Q-01 TCGA-DD-AAVR-01A-11D-A40R-10 TCGA-DD-AAVR-01 TCGA-DD-AAVR-01 c0c50e3a-973e-429d-b93f-dd7ff2aebbcc TCGA-DD-AAVR-01 TCGA-DD-AAVR-01 c0c50e3a-973e-429d-b93f-dd7ff2aebbcc c0c50e3a-973e-429d-b93f-dd7ff2aebbcc c0c50e3a-973e-429d-b93f-dd7ff2aebbcc TCGA-DD-AAVR-01A-11D-A40S-05 +TCGA-DD-AAVS-01 TCGA-DD-AAVS-01 TCGA-DD-AAVS TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver Mild 56 3.3 3.0 5.2 TCGA-DD-AAVS-F67576 TCGA-DD-AAVS 0.2 1.0 A 0 1.4 1.0 -20586 0 1823 1 0 15 50149 3,4 - Fibrous Speta 2014-11-6 MALE 169 Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 0.8 1.2 NO G2 NO No M0 N0 T1 Stage I AAVS TUMOR FREE 281 130 400 NO NO 1.1 NO NO R0 Primary Tumor 01 Segmentectomy, Multiple 6th NO YES DD 1.2 Liver None LIVING 72 2007 TCGA-DD-AAVS-01A-11D-A40Q-01 TCGA-DD-AAVS-01A-11D-A40Q-01 TCGA-DD-AAVS-01A-11D-A40R-10 TCGA-DD-AAVS-01 TCGA-DD-AAVS-01 b510c5b5-c31a-4d90-9674-994fd9c50ff1 TCGA-DD-AAVS-01 TCGA-DD-AAVS-01 b510c5b5-c31a-4d90-9674-994fd9c50ff1 b510c5b5-c31a-4d90-9674-994fd9c50ff1 b510c5b5-c31a-4d90-9674-994fd9c50ff1 TCGA-DD-AAVS-01A-11D-A40S-05 +TCGA-DD-AAVU-01 TCGA-DD-AAVU-01 TCGA-DD-AAVU TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO Mild 46 3.3 4.6 5.2 TCGA-DD-AAVU-F67577 TCGA-DD-AAVU 0.2 0.6 A 0 1.4 1.2 -16889 0 2202 1630 1 0 15 2 3,4 - Fibrous Speta 2014-11-6 MALE 160 Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 0.8 1.2 NO G2 Liver Intrahepatic Recurrence No NO YES Yes No M0 N0 T2 Stage II AAVU TUMOR FREE 166 130 400 NO NO 1.0 NO NO R0 Primary Tumor 01 Segmentectomy, Multiple 6th NO YES DD 1.2 Liver Micro LIVING 88 2008 TCGA-DD-AAVU-01A-11D-A40Q-01 TCGA-DD-AAVU-01A-11D-A40Q-01 TCGA-DD-AAVU-01A-11D-A40R-10 TCGA-DD-AAVU-01 TCGA-DD-AAVU-01 ef6ecdbb-20df-4c7b-bb47-5f14af908008 TCGA-DD-AAVU-01 TCGA-DD-AAVU-01 ef6ecdbb-20df-4c7b-bb47-5f14af908008 ef6ecdbb-20df-4c7b-bb47-5f14af908008 ef6ecdbb-20df-4c7b-bb47-5f14af908008 TCGA-DD-AAVU-01A-11D-A40S-05 +TCGA-DD-AAVV-01 TCGA-DD-AAVV-01 TCGA-DD-AAVV TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver Mild 56 3.3 4.6 5.2 TCGA-DD-AAVV-F68858 TCGA-DD-AAVV TCGA-DD-AAVV-01A 0.2 0.9 A 0 1.4 1.3 -20751 2513 0 2455 1 0 15 7 3,4 - Fibrous Speta 2014-12-21 MALE 158 Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 70 0.8 1.2 NO YES G3 NO true No M0 N0 T2 Stage II TCGA-DD-AAVV.5F24D049-6BE5-403B-9E5A-399921814C68.pdf AAVV TUMOR FREE 244 130 400 NO NO 1.1 NO NO R0 Primary Tumor 01 Segmentectomy, Single 6th NO YES DD 1.2 Liver Micro A LIVING 71 2007 TCGA-DD-AAVV-01A-11D-A40Q-01 TCGA-DD-AAVV-01A-11D-A40Q-01 TCGA-DD-AAVV-01A-11D-A40R-10 TCGA-DD-AAVV-01 TCGA-DD-AAVV-01 45baf47b-b48d-44b4-b97d-1e2955a91f1c TCGA-DD-AAVV-01 TCGA-DD-AAVV-01 45baf47b-b48d-44b4-b97d-1e2955a91f1c 45baf47b-b48d-44b4-b97d-1e2955a91f1c 45baf47b-b48d-44b4-b97d-1e2955a91f1c TCGA-DD-AAVV-01A-11D-A40S-05 +TCGA-DD-AAVW-01 TCGA-DD-AAVW-01 TCGA-DD-AAVW TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver None 35 3.3 4.6 5.2 TCGA-DD-AAVW-F67582 TCGA-DD-AAVW TCGA-DD-AAVW-01A 0.2 1.4 A 0.7 1.4 1.1 -12986 2156 0 2317 0 0 15 927 6 - Established Cirrhosis 2014-11-6 MALE 162 Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 20 0.8 1.2 NO NO G2 NO true No M0 N0 T1 Stage I TCGA-DD-AAVW.922707E9-9F68-458F-B1FC-E95CA2876420.pdf AAVW TUMOR FREE 212 130 400 NO NO 1.0 NO NO R0 Primary Tumor 01 Segmentectomy, Multiple 6th NO YES DD 1.2 Liver None A LIVING 62 2008 TCGA-DD-AAVW-01A-11D-A40Q-01 TCGA-DD-AAVW-01A-11D-A40Q-01 TCGA-DD-AAVW-01A-11D-A40R-10 TCGA-DD-AAVW-01 TCGA-DD-AAVW-01 931985c4-6972-4fa5-9890-ba58b4ab3b6a TCGA-DD-AAVW-01 TCGA-DD-AAVW-01 931985c4-6972-4fa5-9890-ba58b4ab3b6a 931985c4-6972-4fa5-9890-ba58b4ab3b6a 931985c4-6972-4fa5-9890-ba58b4ab3b6a TCGA-DD-AAVW-01A-11D-A40S-05 +TCGA-DD-AAVX-01 TCGA-DD-AAVX-01 TCGA-DD-AAVX TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver YES NO Severe 38 3.3 3.9 5.2 TCGA-DD-AAVX-F67583 TCGA-DD-AAVX TCGA-DD-AAVX-01A 0.2 1.1 2 A 0.7 1.4 1.0 -14016 2039 0 1570 393 0 0 15 1 6 - Established Cirrhosis 2014-12-30 MALE 178 Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 50 0.8 1.2 NO NO G2 Liver Intrahepatic Recurrence Yes NO YES No true No M0 N0 T2 Stage II TCGA-DD-AAVX.C62E123A-5AFC-47FA-AE6A-E16C22ACD374.pdf AAVX WITH TUMOR 186 130 400 YES YES 1.0 YES YES R0 Primary Tumor 01 Segmentectomy, Multiple 6th NO YES DD 1.2 Liver Micro A LIVING 65 2008 TCGA-DD-AAVX-01A-11D-A40Q-01 TCGA-DD-AAVX-01A-11D-A40Q-01 TCGA-DD-AAVX-01A-11D-A40R-10 TCGA-DD-AAVX-01 TCGA-DD-AAVX-01 7ac6a0a3-3c2a-4e47-a248-690ac73d4593 TCGA-DD-AAVX-01 TCGA-DD-AAVX-01 7ac6a0a3-3c2a-4e47-a248-690ac73d4593 7ac6a0a3-3c2a-4e47-a248-690ac73d4593 7ac6a0a3-3c2a-4e47-a248-690ac73d4593 TCGA-DD-AAVX-01A-11D-A40S-05 +TCGA-DD-AAVY-01 TCGA-DD-AAVY-01 TCGA-DD-AAVY TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver None 56 3.3 3.0 5.2 TCGA-DD-AAVY-F67586 TCGA-DD-AAVY TCGA-DD-AAVY-01A 0.2 1.0 2 A 0.7 1.4 1.2 -20709 1826 0 1970 0 0 15 11 0 - No Fibrosis 2014-11-6 MALE 161 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 40 0.8 1.2 NO NO G2 NO true No M0 N0 T3 Stage IIIA TCGA-DD-AAVY.ADDCC231-66AE-4136-AAEC-DCA3DA1C4159.pdf AAVY TUMOR FREE 210 130 400 NO NO 1.0 NO YES R0 Primary Tumor 01 Segmentectomy, Multiple 6th NO YES DD 1.2 Liver Micro A LIVING 63 2009 TCGA-DD-AAVY-01A-11D-A40Q-01 TCGA-DD-AAVY-01A-11D-A40Q-01 TCGA-DD-AAVY-01A-11D-A40R-10 TCGA-DD-AAVY-01 TCGA-DD-AAVY-01 1e91fe2c-87a8-44b1-ba40-f8d92d470a40 TCGA-DD-AAVY-01 TCGA-DD-AAVY-01 1e91fe2c-87a8-44b1-ba40-f8d92d470a40 1e91fe2c-87a8-44b1-ba40-f8d92d470a40 1e91fe2c-87a8-44b1-ba40-f8d92d470a40 TCGA-DD-AAVY-01A-11D-A40S-05 +TCGA-DD-AAVZ-01 TCGA-DD-AAVZ-01 TCGA-DD-AAVZ TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver None 38 3.3 3.8 5.2 TCGA-DD-AAVZ-F67588 TCGA-DD-AAVZ 0.2 1.0 1 A 0.7 1.4 1.2 -14005 0 1900 0 0 15 945 6 - Established Cirrhosis 2014-11-6 MALE 171 Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 0.8 1.2 NO G2 NO No M0 N0 T1 Stage I AAVZ TUMOR FREE 98 130 400 NO NO 1.2 NO YES R0 Primary Tumor 01 Segmentectomy, Multiple 6th NO YES DD 1.2 Liver None LIVING 62 2009 TCGA-DD-AAVZ-01A-11D-A40Q-01 TCGA-DD-AAVZ-01A-11D-A40Q-01 TCGA-DD-AAVZ-01A-11D-A40R-10 TCGA-DD-AAVZ-01 TCGA-DD-AAVZ-01 ab1ad0d6-3d4e-463c-9ff2-c355602506c5 TCGA-DD-AAVZ-01 TCGA-DD-AAVZ-01 ab1ad0d6-3d4e-463c-9ff2-c355602506c5 ab1ad0d6-3d4e-463c-9ff2-c355602506c5 ab1ad0d6-3d4e-463c-9ff2-c355602506c5 TCGA-DD-AAVZ-01A-11D-A40S-05 +TCGA-DD-AAW0-01 TCGA-DD-AAW0-01 TCGA-DD-AAW0 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver Mild 54 3.3 4.6 5.2 TCGA-DD-AAW0-F67590 TCGA-DD-AAW0 TCGA-DD-AAW0-01A 0.2 0.2 A 0.7 1.4 1.3 -19981 1737 0 2015 0 0 15 3 3,4 - Fibrous Speta 2014-11-6 MALE 172 Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 70 0.8 1.2 NO NO G2 NO true No M0 N0 T1 Stage I TCGA-DD-AAW0.75F8B93A-4839-4A9B-92CD-98147D025D31.pdf AAW0 TUMOR FREE 183 130 400 NO NO 1.0 NO YES R0 Primary Tumor 01 Total Hepatectomy with Transplant 6th NO YES DD 1.2 Liver None A LIVING 75 2009 TCGA-DD-AAW0-01A-11D-A40Q-01 TCGA-DD-AAW0-01A-11D-A40Q-01 TCGA-DD-AAW0-01A-11D-A40R-10 TCGA-DD-AAW0-01 TCGA-DD-AAW0-01 7095ba1c-4133-4612-86bf-c3b4dea188ba TCGA-DD-AAW0-01 TCGA-DD-AAW0-01 7095ba1c-4133-4612-86bf-c3b4dea188ba 7095ba1c-4133-4612-86bf-c3b4dea188ba 7095ba1c-4133-4612-86bf-c3b4dea188ba TCGA-DD-AAW0-01A-11D-A40S-05 +TCGA-DD-AAW1-01 TCGA-DD-AAW1-01 TCGA-DD-AAW1 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver Severe 55 3.3 4.0 5.3 TCGA-DD-AAW1-F67591 TCGA-DD-AAW1 TCGA-DD-AAW1-01A 0.2 0.7 A 0.7 1.4 1.2 -20288 1703 0 1989 0 0 15 4 6 - Established Cirrhosis 2014-11-6 MALE 167 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 40 0.8 1.2 NO NO G2 NO true No M0 N0 T3 Stage IIIA TCGA-DD-AAW1.3ED5891B-FD39-4F88-94AA-D040867A51B5.pdf AAW1 TUMOR FREE 126 130 400 NO NO 1.0 NO NO R0 Primary Tumor 01 Segmentectomy, Multiple 6th NO YES DD 1.2 Liver Micro A LIVING 60 2009 TCGA-DD-AAW1-01A-11D-A40O-01 TCGA-DD-AAW1-01A-11D-A40O-01 TCGA-DD-AAW1-01A-11D-A40P-10 TCGA-DD-AAW1-01 TCGA-DD-AAW1-01 898a30f1-75df-4503-a586-c2cb43fe1db9 TCGA-DD-AAW1-01 TCGA-DD-AAW1-01 898a30f1-75df-4503-a586-c2cb43fe1db9 898a30f1-75df-4503-a586-c2cb43fe1db9 898a30f1-75df-4503-a586-c2cb43fe1db9 TCGA-DD-AAW1-01A-11D-A40X-05 +TCGA-DD-AAW2-01 TCGA-DD-AAW2-01 TCGA-DD-AAW2 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver YES NO None 69 3.3 4.0 5.2 TCGA-DD-AAW2-F67592 TCGA-DD-AAW2 TCGA-DD-AAW2-01A 0.2 0.4 1 A 0.7 1.4 1.1 -25420 1575 0 1855 391 1 0 15 3 6 - Established Cirrhosis 2014-12-30 MALE 156 Non-Alcoholic Fatty Liver Disease Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 70 0.8 1.2 NO NO G2 Liver Intrahepatic Recurrence Yes NO YES No true No M0 N0 T1 Stage I TCGA-DD-AAW2.74C2D5FA-1FDF-424A-BEE2-DE602A4F6DA7.pdf AAW2 WITH TUMOR 164 130 400 [Discrepancy] YES 1.0 [Discrepancy] YES R0 Primary Tumor 01 Segmentectomy, Multiple 6th NO YES DD 1.2 Liver None A LIVING 50 2009 TCGA-DD-AAW2-01A-11D-A40O-01 TCGA-DD-AAW2-01A-11D-A40O-01 TCGA-DD-AAW2-01A-11D-A40P-10 TCGA-DD-AAW2-01 TCGA-DD-AAW2-01 3c1b3db3-89b5-479d-8ddf-4765b46934f4 TCGA-DD-AAW2-01 TCGA-DD-AAW2-01 3c1b3db3-89b5-479d-8ddf-4765b46934f4 3c1b3db3-89b5-479d-8ddf-4765b46934f4 3c1b3db3-89b5-479d-8ddf-4765b46934f4 TCGA-DD-AAW2-01A-11D-A40X-05 +TCGA-DD-AAW3-01 TCGA-DD-AAW3-01 TCGA-DD-AAW3 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver None 69 3.3 4.1 5.2 TCGA-DD-AAW3-F67593 TCGA-DD-AAW3 0.2 0.6 1 0.0 1.4 1.0 -25254 0 1633 0 0 15 3 0 - No Fibrosis 2014-11-6 MALE 162 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES NO G2 NO No M0 N0 T1 Stage I AAW3 TUMOR FREE 241 130 400 NO NO NO YES R0 Primary Tumor 01 Segmentectomy, Single 6th NO YES DD 1.2 Liver None LIVING 64 2009 TCGA-DD-AAW3-01A-11D-A40O-01 TCGA-DD-AAW3-01A-11D-A40O-01 TCGA-DD-AAW3-01A-11D-A40P-10 TCGA-DD-AAW3-01 TCGA-DD-AAW3-01 e08177f4-46ff-4f46-94bc-e58870fdfc23 TCGA-DD-AAW3-01 TCGA-DD-AAW3-01 e08177f4-46ff-4f46-94bc-e58870fdfc23 e08177f4-46ff-4f46-94bc-e58870fdfc23 e08177f4-46ff-4f46-94bc-e58870fdfc23 TCGA-DD-AAW3-01A-11D-A40X-05 +TCGA-ED-A459-01 TCGA-ED-A459-01 TCGA-ED-A459 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 47 3800 5200 5100 TCGA-ED-A459-F68559 TCGA-ED-A459 TCGA-ED-A459-01A .3 1.4 .7 1.1 1.1 -17402 87 0 910 0 20 267 2014-11-26 MALE 167 Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 1800 .9 1.3 NO NO G2 NO true No M0 N0 T2 Stage II TCGA-ED-A459.289EC60C-0AAB-4E61-A8AB-A199D4663AE6.pdf A459 TUMOR FREE 200 150 400 NO YES .9 YES NO R0 Primary Tumor 01 Lobectomy 7th YES NO ED 1.2 Liver Micro A Hepatitis B Surface Antigen LIVING 51 2012 TCGA-ED-A459-01A-11D-A25U-01 TCGA-ED-A459-01A-11D-A25U-01 TCGA-ED-A459-01A-11D-A25V-10 TCGA-ED-A459-01 TCGA-ED-A459-01 1FC886B4-8512-4C36-A4AE-280B704566C4 31c9c8be-6cde-4db6-b9fd-6173b41bedc8 TCGA-ED-A459-01A-11D-A25V-10 TCGA-ED-A459-01 TCGA-ED-A459-01 31c9c8be-6cde-4db6-b9fd-6173b41bedc8 TCGA-ED-A459-01A-11D-A25V-10 31c9c8be-6cde-4db6-b9fd-6173b41bedc8 31c9c8be-6cde-4db6-b9fd-6173b41bedc8 TCGA-ED-A459-01A-11D-A25V-10 TCGA-ED-A459-01A-11D-A264-05 +TCGA-ED-A4XI-01 TCGA-ED-A4XI-01 TCGA-ED-A4XI TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver None 58 3.8 2.9 5.1 TCGA-ED-A4XI-F68085 TCGA-ED-A4XI TCGA-ED-A4XI-01A 0.1 1.3 4.1 5.9 54 -21497 70 0 819 0 20 573 2014-11-13 MALE 170 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 2000 0.3 1.3 NO NO G3 NO true No M0 N0 T2 Stage II TCGA-ED-A4XI.40130FAC-455F-49B7-A97E-CFFED2202925.pdf A4XI TUMOR FREE 276 150 400 NO NO 0.9 NO NO R0 Primary Tumor 01 Lobectomy 7th YES NO ED 1.3 Liver Micro A Hepatitis B Surface Antigen LIVING 55 2012 TCGA-ED-A4XI-01A-11D-A25U-01 TCGA-ED-A4XI-01A-11D-A25U-01 TCGA-ED-A4XI-01A-11D-A25V-10 TCGA-ED-A4XI-01 TCGA-ED-A4XI-01 DEFFD9B3-D2EB-424A-A537-732A89EA4EC0 0baf2ded-0f46-4e37-83ae-9e0b99af41c9 TCGA-ED-A4XI-01A-11D-A25V-10 TCGA-ED-A4XI-01 TCGA-ED-A4XI-01 0baf2ded-0f46-4e37-83ae-9e0b99af41c9 TCGA-ED-A4XI-01A-11D-A25V-10 0baf2ded-0f46-4e37-83ae-9e0b99af41c9 0baf2ded-0f46-4e37-83ae-9e0b99af41c9 TCGA-ED-A4XI-01A-11D-A25V-10 TCGA-ED-A4XI-01A-11D-A264-05 +TCGA-ED-A5KG-01 TCGA-ED-A5KG-01 TCGA-ED-A5KG TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO Severe 60 3.8 6.0 5.1 TCGA-ED-A5KG-F56100 TCGA-ED-A5KG TCGA-ED-A5KG-01A 0.1 0.4 4.1 5.8 3.9 -22258 112 0 854 110 0 20 3177 2015-3-30 FEMALE 160 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 1810 0.3 1.3 NO NO G2 Other, specify New Primary Tumor Kidney No NO NO No true No M0 N0 T2 Stage II TCGA-ED-A5KG.87394A2B-7AF7-49E0-9ED0-6FFCC899EC38.pdf A5KG WITH TUMOR 147 150 400 NO NO 0.9 NO NO R0 Primary Tumor 01 Lobectomy 7th YES NO ED 1.3 Liver Micro A Hepatitis B Surface Antigen LIVING 61 2012 TCGA-ED-A5KG-01A-11D-A27H-01 TCGA-ED-A5KG-01A-11D-A27H-01 TCGA-ED-A5KG-01A-11D-A27I-10 TCGA-ED-A5KG-01 TCGA-ED-A5KG-01 ED389F30-65B0-49AA-B262-4F4DA5FE2B78 658b2281-9818-48dc-846d-8cad2bae42f0 TCGA-ED-A5KG-01A-11D-A27I-10 TCGA-ED-A5KG-01 TCGA-ED-A5KG-01 658b2281-9818-48dc-846d-8cad2bae42f0 TCGA-ED-A5KG-01A-11D-A27I-10 658b2281-9818-48dc-846d-8cad2bae42f0 658b2281-9818-48dc-846d-8cad2bae42f0 TCGA-ED-A5KG-01A-11D-A27I-10 TCGA-ED-A5KG-01A-11D-A27W-05 +TCGA-ED-A627-01 TCGA-ED-A627-01 TCGA-ED-A627 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 74 TCGA-ED-A627-F55716 TCGA-ED-A627 TCGA-ED-A627-01A -27303 157 0 423 2 2014-1-14 MALE 176 Alcohol consumption Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 1140 NO NO G2 NO true No M0 NX T1 Stage I TCGA-ED-A627.104D5D1C-E6E3-4806-9E6C-4C949865F713.pdf A627 TUMOR FREE NO NO NO R0 Primary Tumor 01 Lobectomy 7th YES NO ED Liver A Hepatitis C Antibody|Hepatitis B Surface Antigen LIVING 74 2012 TCGA-ED-A627-01A-12D-A30U-01 TCGA-ED-A627-01A-12D-A30U-01 TCGA-ED-A627-01A-12D-A30V-10 TCGA-ED-A627-01 TCGA-ED-A627-01 6DC93090-A39B-4360-9B6D-46E0F2888801 bd4be8e6-c06f-493f-84f4-e434be3a24d4 TCGA-ED-A627-01A-12D-A30V-10 TCGA-ED-A627-01 TCGA-ED-A627-01 bd4be8e6-c06f-493f-84f4-e434be3a24d4 TCGA-ED-A627-01A-12D-A30V-10 bd4be8e6-c06f-493f-84f4-e434be3a24d4 bd4be8e6-c06f-493f-84f4-e434be3a24d4 TCGA-ED-A627-01A-12D-A30V-10 TCGA-ED-A627-01A-12D-A30Y-05 +TCGA-ED-A66X-01 TCGA-ED-A66X-01 TCGA-ED-A66X TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO Mild 35 3.8 4.7 5.1 TCGA-ED-A66X-F56838 TCGA-ED-A66X TCGA-ED-A66X-01A 0.1 9 4.1 5.6 4.5 -12947 89 0 406 124 124 0 20 5840 2014-2-24 MALE 170 Alcohol consumption Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 2190 0.3 1.3 NO NO G3 Liver Intrahepatic Recurrence No YES YES No true No M0 N0 T3a Stage IIIA TCGA-ED-A66X.F83A9A75-387A-4A66-9817-084A8E633E37.pdf A66X TUMOR FREE 268 150 400 NO NO 1 NO NO R0 R0 Primary Tumor 01 Lobectomy 7th YES NO ED 1.3 Liver Micro A Hepatitis B Surface Antigen LIVING 61 2013 TCGA-ED-A66X-01A-11D-A30U-01 TCGA-ED-A66X-01A-11D-A30U-01 TCGA-ED-A66X-01A-11D-A30V-10 TCGA-ED-A66X-01 TCGA-ED-A66X-01 3C51801A-12EB-499D-8D7B-05DDE844A1C5 9c49cf78-bf9b-4562-a8c1-9e8e4203b548 TCGA-ED-A66X-01A-11D-A30V-10 TCGA-ED-A66X-01 TCGA-ED-A66X-01 9c49cf78-bf9b-4562-a8c1-9e8e4203b548 TCGA-ED-A66X-01A-11D-A30V-10 9c49cf78-bf9b-4562-a8c1-9e8e4203b548 9c49cf78-bf9b-4562-a8c1-9e8e4203b548 TCGA-ED-A66X-01A-11D-A30V-10 TCGA-ED-A66X-01A-11D-A30Y-05 +TCGA-ED-A66Y-01 TCGA-ED-A66Y-01 TCGA-ED-A66Y TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver Mild 51 3.8 6 5.1 TCGA-ED-A66Y-F56839 TCGA-ED-A66Y TCGA-ED-A66Y-01A 0.1 1 4.1 5.9 4.4 -18797 75 296 0 7 0 20 12100 2014-2-24 FEMALE 160 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 1670 0.3 1.3 NO NO G3 NO true No M0 N0 T3a Stage IIIA TCGA-ED-A66Y.14F29317-F7B9-49D4-B215-EF489A4283CA.pdf A66Y TUMOR FREE 289 150 400 NO NO 0.9 NO NO R0 Primary Tumor 01 Lobectomy 7th YES NO ED 1.3 Liver Micro A Hepatitis B Surface Antigen DECEASED 59 2013 TCGA-ED-A66Y-01A-11D-A30U-01 TCGA-ED-A66Y-01A-11D-A30U-01 TCGA-ED-A66Y-01A-11D-A30V-10 TCGA-ED-A66Y-01 TCGA-ED-A66Y-01 098B1DB6-9847-438F-9541-0FD535A43F1E 920735ec-0932-408d-8132-8a30ba8aa160 TCGA-ED-A66Y-01A-11D-A30V-10 TCGA-ED-A66Y-01 TCGA-ED-A66Y-01 920735ec-0932-408d-8132-8a30ba8aa160 TCGA-ED-A66Y-01A-11D-A30V-10 920735ec-0932-408d-8132-8a30ba8aa160 920735ec-0932-408d-8132-8a30ba8aa160 TCGA-ED-A66Y-01A-11D-A30V-10 TCGA-ED-A66Y-01A-11D-A30Y-05 +TCGA-ED-A7PX-01 TCGA-ED-A7PX-01 TCGA-ED-A7PX TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver None 48 TCGA-ED-A7PX-F62650 TCGA-ED-A7PX TCGA-ED-A7PX-01A 0.1 0.9 4.1 5.8 17.0 -17638 86 0 6 0 20 24 2014-9-30 FEMALE 161 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 830 NO YES G3 NO true No M0 NX T2 Stage II TCGA-ED-A7PX.AF42396C-2DC9-4885-B7B1-D59BA1D2949A.pdf A7PX TUMOR FREE 239 150 400 NO NO NO R0 Primary Tumor 01 Lobectomy 7th YES NO ED 1.3 Liver Micro A Hepatitis B Surface Antigen LIVING 43 2013 TCGA-ED-A7PX-01A-51D-A34Y-01 TCGA-ED-A7PX-01A-51D-A34Y-01 TCGA-ED-A7PX-01A-51D-A34Z-10 TCGA-ED-A7PX-01 TCGA-ED-A7PX-01 DC921D8F-D56C-4CAB-B842-6FA7E8164347 cb358266-8d3e-4089-88f1-25e8eaaf6d7c TCGA-ED-A7PX-01A-51D-A34Z-10 TCGA-ED-A7PX-01 TCGA-ED-A7PX-01 cb358266-8d3e-4089-88f1-25e8eaaf6d7c TCGA-ED-A7PX-01A-51D-A34Z-10 cb358266-8d3e-4089-88f1-25e8eaaf6d7c cb358266-8d3e-4089-88f1-25e8eaaf6d7c TCGA-ED-A7PX-01A-51D-A34Z-10 TCGA-ED-A7PX-01A-51D-A356-05 +TCGA-ED-A7PY-01 TCGA-ED-A7PY-01 TCGA-ED-A7PY TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver Mild 20 TCGA-ED-A7PY-F62651 TCGA-ED-A7PY TCGA-ED-A7PY-01A 0.1 0.6 4.0 5.8 3.9 -7556 83 0 390 0 20 2 2014-7-23 FEMALE 156 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 1380 0.3 1.3 NO NO G3 NO true No M0 NX T2 Stage II TCGA-ED-A7PY.B6D3F89E-C1A5-445A-B9BD-047B2FB92E4C.pdf A7PY TUMOR FREE 282 150 400 YES NO 0.9 NO NO R0 Primary Tumor 01 Lobectomy 7th YES NO ED 1.3 Liver Micro A Hepatitis B Surface Antigen LIVING 40 2013 TCGA-ED-A7PY-01A-11D-A33P-01 TCGA-ED-A7PY-01A-11D-A33P-01 TCGA-ED-A7PY-01A-11D-A33Q-10 TCGA-ED-A7PY-01 TCGA-ED-A7PY-01 D734D536-23CF-4054-A46E-4B6E29E72204 9800881e-b8ee-4e3f-83fc-f5d7d6b31259 TCGA-ED-A7PY-01A-11D-A33Q-10 TCGA-ED-A7PY-01 TCGA-ED-A7PY-01 9800881e-b8ee-4e3f-83fc-f5d7d6b31259 TCGA-ED-A7PY-01A-11D-A33Q-10 9800881e-b8ee-4e3f-83fc-f5d7d6b31259 9800881e-b8ee-4e3f-83fc-f5d7d6b31259 TCGA-ED-A7PY-01A-11D-A33Q-10 TCGA-ED-A7PY-01A-11D-A341-05 +TCGA-ED-A7PZ-01 TCGA-ED-A7PZ-01 TCGA-ED-A7PZ TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver Mild 61 3.8 4.2 5.1 TCGA-ED-A7PZ-F62652 TCGA-ED-A7PZ TCGA-ED-A7PZ-01A 0.1 0.9 4.0 5.8 7.0 -22601 78 0 6 0 20 2 2014-9-30 MALE 159 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 1350 0.3 1.3 NO YES G2 NO true No M0 NX T2 Stage II TCGA-ED-A7PZ.85F0B753-BB67-4836-92DC-81F602C0CC8C.pdf A7PZ TUMOR FREE 289 150 400 NO NO 0.9 NO NO R0 Primary Tumor 01 Lobectomy 7th YES NO ED 1.3 Liver Micro A Hepatitis B Surface Antigen LIVING 50 2013 TCGA-ED-A7PZ-01A-11D-A33P-01 TCGA-ED-A7PZ-01A-11D-A33P-01 TCGA-ED-A7PZ-01A-11D-A33Q-10 TCGA-ED-A7PZ-01 TCGA-ED-A7PZ-01 B3158C1C-6EBD-44FB-B18D-EC780AF191AE 847c0750-c025-4c3d-be34-3721eff0b1b7 TCGA-ED-A7PZ-01A-11D-A33Q-10 TCGA-ED-A7PZ-01 TCGA-ED-A7PZ-01 847c0750-c025-4c3d-be34-3721eff0b1b7 TCGA-ED-A7PZ-01A-11D-A33Q-10 847c0750-c025-4c3d-be34-3721eff0b1b7 847c0750-c025-4c3d-be34-3721eff0b1b7 TCGA-ED-A7PZ-01A-11D-A33Q-10 TCGA-ED-A7PZ-01A-11D-A341-05 +TCGA-ED-A7XO-01 TCGA-ED-A7XO-01 TCGA-ED-A7XO TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO Mild 29 3.8 4.2 5.1 TCGA-ED-A7XO-F65727 TCGA-ED-A7XO TCGA-ED-A7XO-01A 0.1 0.6 4.1 5.9 4.9 -10828 77 0 427 262 0 4 2014-10-8 MALE 175 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 1430 NO NO G2 Liver Locoregional Recurrence No NO YES No true No M0 N0 T3a Stage IIIA TCGA-ED-A7XO.3FC3BB34-8E4A-4422-BFEF-58B15947F032.pdf A7XO WITH TUMOR NO NO NO NO R0 Primary Tumor 01 Lobectomy 7th YES NO ED 1.3 Liver Micro A Hepatitis C Antibody|Hepatitis B Surface Antigen LIVING 64 2013 TCGA-ED-A7XO-01A-11D-A34Y-01 TCGA-ED-A7XO-01A-11D-A34Y-01 TCGA-ED-A7XO-01A-11D-A34Z-10 TCGA-ED-A7XO-01 TCGA-ED-A7XO-01 8AB5B223-7E37-42E0-AFF5-5FAA283348E6 22e11be6-f4ce-47a6-8c50-5eb957834906 TCGA-ED-A7XO-01A-11D-A34Z-10 TCGA-ED-A7XO-01 TCGA-ED-A7XO-01 22e11be6-f4ce-47a6-8c50-5eb957834906 TCGA-ED-A7XO-01A-11D-A34Z-10 22e11be6-f4ce-47a6-8c50-5eb957834906 22e11be6-f4ce-47a6-8c50-5eb957834906 TCGA-ED-A7XO-01A-11D-A34Z-10 TCGA-ED-A7XO-01A-11D-A356-05 +TCGA-ED-A7XP-01 TCGA-ED-A7XP-01 TCGA-ED-A7XP TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO Mild 53 3.8 6.9 5.1 TCGA-ED-A7XP-F65353 TCGA-ED-A7XP TCGA-ED-A7XP-01A 0.1 0.1 4.1 5.9 4.8 -19504 62 0 400 187 0 20 18 2014-9-22 FEMALE 157 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 780 0.3 1.3 NO NO G3 Liver Locoregional Recurrence Yes NO YES No true No M0 N0 T2 Stage II TCGA-ED-A7XP.70432A18-BDAF-465D-9311-66E37E3F941E.pdf A7XP WITH TUMOR 108 150 400 NO NO 1 NO NO R0 Primary Tumor 01 Lobectomy 7th YES NO ED 1.3 Liver Micro A Hepatitis B Surface Antigen LIVING 54 2013 TCGA-ED-A7XP-01A-11D-A34Y-01 TCGA-ED-A7XP-01A-11D-A34Y-01 TCGA-ED-A7XP-01A-11D-A34Z-10 TCGA-ED-A7XP-01 TCGA-ED-A7XP-01 61951975-5873-4365-B1DB-F64554C07D3A 932e8866-4903-4541-a239-8318abbca064 TCGA-ED-A7XP-01A-11D-A34Z-10 TCGA-ED-A7XP-01 TCGA-ED-A7XP-01 932e8866-4903-4541-a239-8318abbca064 TCGA-ED-A7XP-01A-11D-A34Z-10 932e8866-4903-4541-a239-8318abbca064 932e8866-4903-4541-a239-8318abbca064 TCGA-ED-A7XP-01A-11D-A34Z-10 TCGA-ED-A7XP-01A-11D-A356-05 +TCGA-ED-A82E-01 TCGA-ED-A82E-01 TCGA-ED-A82E TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver Mild 60 3.8 4.3 5.1 TCGA-ED-A82E-F65333 TCGA-ED-A82E TCGA-ED-A82E-01A 0.1 0.4 4.1 5.8 2.8 -22234 78 0 408 0 20 4 2014-9-22 FEMALE 150 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 1320 0.3 1.3 NO NO G2 NO true No M0 N0 T3a Stage IIIA TCGA-ED-A82E.2FE90807-3C01-4956-B565-A5A18A08C93C.pdf A82E TUMOR FREE 261 150 400 NO NO 0.9 NO NO R0 Primary Tumor 01 Lobectomy 7th YES NO ED 1.3 Liver Micro A Hepatitis C Antibody|Hepatitis B Surface Antigen LIVING 44 2013 TCGA-ED-A82E-01A-11D-A34Y-01 TCGA-ED-A82E-01A-11D-A34Y-01 TCGA-ED-A82E-01A-11D-A34Z-10 TCGA-ED-A82E-01 TCGA-ED-A82E-01 9BE4B145-9FD9-4A59-A317-9A969CF1A280 443ec308-d974-4e36-96f4-b7c0101bf5d5 TCGA-ED-A82E-01A-11D-A34Z-10 TCGA-ED-A82E-01 TCGA-ED-A82E-01 443ec308-d974-4e36-96f4-b7c0101bf5d5 TCGA-ED-A82E-01A-11D-A34Z-10 443ec308-d974-4e36-96f4-b7c0101bf5d5 443ec308-d974-4e36-96f4-b7c0101bf5d5 TCGA-ED-A82E-01A-11D-A34Z-10 TCGA-ED-A82E-01A-11D-A356-05 +TCGA-ED-A8O5-01 TCGA-ED-A8O5-01 TCGA-ED-A8O5 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver Mild 59 3.8 4.2 5.1 TCGA-ED-A8O5-F67146 TCGA-ED-A8O5 TCGA-ED-A8O5-01A 0.1 0.4 4.1 5.8 3.4 -21648 100 0 406 0 20 498 2014-10-31 FEMALE 165 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 950 0.3 1.3 NO NO G3 NO true No M0 N0 T3a Stage IIIA TCGA-ED-A8O5.6C198F5C-9B63-45D9-A83D-4CFEC01DDC8C.pdf A8O5 TUMOR FREE 171 150 400 NO NO 1.3 NO NO R0 Primary Tumor 01 Lobectomy 7th YES NO ED 1.3 Liver Micro A Hepatitis C Antibody|Hepatitis B Surface Antigen LIVING 63 2013 TCGA-ED-A8O5-01A-11D-A35Y-01 TCGA-ED-A8O5-01A-11D-A35Y-01 TCGA-ED-A8O5-01A-11D-A35Z-10 TCGA-ED-A8O5-01 TCGA-ED-A8O5-01 92E61221-9B0A-411F-BA5F-B923CA216B07 0636fc10-cfb4-427b-b3fc-cd9d7c0c7db6 TCGA-ED-A8O5-01 TCGA-ED-A8O5-01 0636fc10-cfb4-427b-b3fc-cd9d7c0c7db6 0636fc10-cfb4-427b-b3fc-cd9d7c0c7db6 0636fc10-cfb4-427b-b3fc-cd9d7c0c7db6 TCGA-ED-A8O5-01A-11D-A369-05 +TCGA-ED-A8O6-01 TCGA-ED-A8O6-01 TCGA-ED-A8O6 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver Mild 50 3.8 2.8 5.1 TCGA-ED-A8O6-F68512 TCGA-ED-A8O6 TCGA-ED-A8O6-01A 0.1 2.3 4.1 5.8 2.8 -18572 97 56 0 6 0 20 3000 2014-11-21 FEMALE 165 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 1030 0.3 1.3 NO NO G3 NO true No M0 N0 T3a Stage IIIA TCGA-ED-A8O6.0ABB9050-0248-42F0-AFEB-98FA5CE2DD55.pdf A8O6 TUMOR FREE 150 400 NO NO NO NO R0 Primary Tumor 01 Lobectomy 7th YES NO ED 1.3 Liver Micro A Hepatitis C Antibody|Hepatitis B Surface Antigen DECEASED 45 2013 TCGA-ED-A8O6-01A-11D-A35Y-01 TCGA-ED-A8O6-01A-11D-A35Y-01 TCGA-ED-A8O6-01A-11D-A35Z-10 TCGA-ED-A8O6-01 TCGA-ED-A8O6-01 C22BF46A-9552-41FD-A467-E6DB6A14831B 7de41172-ca92-4cb9-b7de-b92fbeb5b3ef TCGA-ED-A8O6-01 TCGA-ED-A8O6-01 7de41172-ca92-4cb9-b7de-b92fbeb5b3ef 7de41172-ca92-4cb9-b7de-b92fbeb5b3ef 7de41172-ca92-4cb9-b7de-b92fbeb5b3ef TCGA-ED-A8O6-01A-11D-A369-05 +TCGA-ED-A97K-01 TCGA-ED-A97K-01 TCGA-ED-A97K TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver Mild 54 3.8 8 5.1 TCGA-ED-A97K-F68560 TCGA-ED-A97K TCGA-ED-A97K-01A 0.1 1.0 4.0 5.8 4.6 -20073 92 0 6 0 20 3 2014-12-2 MALE 170 Alcohol consumption Hepatocholangiocarcinoma (Mixed) No C22.0 8180/3 C22.0 YES 1650 0.3 1.3 NO YES G2 NO true No M0 N0 T3a Stage IIIA TCGA-ED-A97K.518E0619-1C4F-475C-904E-009300CF1768.pdf A97K TUMOR FREE 264 150 400 NO 0.9 NO NO R0 Primary Tumor 01 Lobectomy 7th YES NO ED 1.3 Liver Micro A Hepatitis B Surface Antigen LIVING 64 2013 TCGA-ED-A97K-01A-21D-A381-01 TCGA-ED-A97K-01A-21D-A381-01 TCGA-ED-A97K-01A-21D-A382-10 TCGA-ED-A97K-01 TCGA-ED-A97K-01 169bde29-467d-44b1-9260-6dc8cfb1e207 TCGA-ED-A97K-01 TCGA-ED-A97K-01 169bde29-467d-44b1-9260-6dc8cfb1e207 169bde29-467d-44b1-9260-6dc8cfb1e207 169bde29-467d-44b1-9260-6dc8cfb1e207 TCGA-ED-A97K-01A-21D-A383-05 +TCGA-EP-A12J-01 TCGA-EP-A12J-01 TCGA-EP-A12J TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 62 3.8 4.2 5.1 TCGA-EP-A12J-F40456 TCGA-EP-A12J TCGA-EP-A12J-01A 0.2 0.4 1 B 0.7 1.3 0.8 -22997 59 0 570 2013-2-20 MALE 173 Hepatitis C Sarcoidosis Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 300 NO NO G1 NO false No MX NX T1 Stage I TCGA-EP-A12J.CC7D4052-0068-425B-A5C3-873059716D44.pdf A12J TUMOR FREE 187 150 400 NO NO 1.1 NO YES R0 Primary Tumor 01 Segmentectomy, Single 7th YES NO EP 1.0 Liver None A LIVING 2010 TCGA-EP-A12J-01A-11D-A12Y-01 TCGA-EP-A12J-01A-11D-A12Y-01 TCGA-EP-A12J-01A-11D-A12Z-10 TCGA-EP-A12J-01 TCGA-EP-A12J-01 DAC6BB4F-6DDB-4478-A92E-C46567F9B24F 5453b1a0-b5c0-4d85-95b4-4591fdf05874 TCGA-EP-A12J-01A-11D-A12Z-10 TCGA-EP-A12J-01 TCGA-EP-A12J-01 5453b1a0-b5c0-4d85-95b4-4591fdf05874 TCGA-EP-A12J-01A-11D-A12Z-10 5453b1a0-b5c0-4d85-95b4-4591fdf05874 5453b1a0-b5c0-4d85-95b4-4591fdf05874 TCGA-EP-A12J-01A-11D-A12Z-10 TCGA-EP-A12J-01A-11D-A132-05 +TCGA-EP-A12J-11 TCGA-EP-A12J-11 TCGA-EP-A12J TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 62 3.8 4.2 5.1 TCGA-EP-A12J-F40456 TCGA-EP-A12J TCGA-EP-A12J-11A 0.2 0.4 1 B 0.7 1.3 0.8 -22997 59 0 570 2013-2-20 MALE 173 Hepatitis C Sarcoidosis Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 410 NO NO G1 NO false No MX NX T1 Stage I A12J TUMOR FREE 187 150 400 NO NO 1.1 NO YES R0 Solid Tissue Normal 11 Segmentectomy, Single 7th YES NO EP 1.0 Liver None A LIVING 2010 TCGA-EP-A12J-11 5a1a1f96-bf4f-415d-b2a2-4481a72914cf TCGA-EP-A12J-11 5a1a1f96-bf4f-415d-b2a2-4481a72914cf 5a1a1f96-bf4f-415d-b2a2-4481a72914cf 5a1a1f96-bf4f-415d-b2a2-4481a72914cf TCGA-EP-A12J-11A-11D-A132-05 +TCGA-EP-A26S-01 TCGA-EP-A26S-01 TCGA-EP-A26S TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver Mild 70 3.8 3.5 5.1 TCGA-EP-A26S-F39041 TCGA-EP-A26S TCGA-EP-A26S-01A 0.2 0.4 -25677 91 0 608 1 0 0 - No Fibrosis 2013-1-9 MALE 168 Alcohol consumption Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 520 9.5 12.5 NO NO G2 NO false No MX N0 T1 Stage I TCGA-EP-A26S.078A6815-B1E3-47F5-A49B-C06B7D47F5E8.pdf A26S TUMOR FREE 234 140 415 NO NO 12.9 NO NO Primary Tumor 01 Segmentectomy, Single 7th YES NO EP 1.0 Liver None A LIVING 41 2011 TCGA-EP-A26S-01A-11D-A16U-01 TCGA-EP-A26S-01A-11D-A16U-01 TCGA-EP-A26S-01A-11D-A16V-10 TCGA-EP-A26S-01 TCGA-EP-A26S-01 98FBF2C6-DB11-4522-BD97-FC1C9546023D 7e6e755a-5503-4729-a3f4-249183687647 TCGA-EP-A26S-01A-11D-A16V-10 TCGA-EP-A26S-01 TCGA-EP-A26S-01 7e6e755a-5503-4729-a3f4-249183687647 TCGA-EP-A26S-01A-11D-A16V-10 7e6e755a-5503-4729-a3f4-249183687647 7e6e755a-5503-4729-a3f4-249183687647 TCGA-EP-A26S-01A-11D-A16V-10 TCGA-EP-A26S-01A-11D-A16X-05 +TCGA-EP-A26S-11 TCGA-EP-A26S-11 TCGA-EP-A26S TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver Mild 70 3.8 3.5 5.1 TCGA-EP-A26S-F39041 TCGA-EP-A26S TCGA-EP-A26S-11A 0.2 0.4 -25677 91 0 608 1 0 0 - No Fibrosis 2013-1-9 MALE 168 Alcohol consumption Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 1140 9.5 12.5 NO NO G2 NO false No MX N0 T1 Stage I A26S TUMOR FREE 234 140 415 NO NO 12.9 NO NO Solid Tissue Normal 11 Segmentectomy, Single 7th YES NO EP 1.0 Liver None A LIVING 41 2011 TCGA-EP-A26S-11 3e1411dc-8c6d-4a87-bb4f-44ef5ff8761b TCGA-EP-A26S-11 3e1411dc-8c6d-4a87-bb4f-44ef5ff8761b 3e1411dc-8c6d-4a87-bb4f-44ef5ff8761b 3e1411dc-8c6d-4a87-bb4f-44ef5ff8761b TCGA-EP-A26S-11A-12D-A16X-05 +TCGA-EP-A2KA-01 TCGA-EP-A2KA-01 TCGA-EP-A2KA TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO YES 52 TCGA-EP-A2KA-F41362 TCGA-EP-A2KA TCGA-EP-A2KA-01A 2 1.0 0.7 -19214 106 627 0 111 433 433 0 0 13 1,2 - Portal Fibrosis 2013-3-15 FEMALE 178 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 400 NO NO G3 Brain Extrahepatic Recurrence No YES YES No false No MX NX T3a Stage IIIA TCGA-EP-A2KA.CCEFF8C5-E949-4F3F-93DA-67ECF5503C1C.pdf A2KA WITH TUMOR 435 140 415 NO NO NO YES R0 Primary Tumor 01 Lobectomy 7th YES NO EP Liver A DECEASED 2011 TCGA-EP-A2KA-01A-11D-A182-01 TCGA-EP-A2KA-01A-11D-A182-01 TCGA-EP-A2KA-01A-11D-A183-10 TCGA-EP-A2KA-01 TCGA-EP-A2KA-01 CF4018AA-83D5-4E96-B473-BAACD5D686FA e41bb478-2e81-4ce3-a0c7-e5412ea80490 TCGA-EP-A2KA-01A-11D-A183-10 TCGA-EP-A2KA-01 TCGA-EP-A2KA-01 e41bb478-2e81-4ce3-a0c7-e5412ea80490 TCGA-EP-A2KA-01A-11D-A183-10 e41bb478-2e81-4ce3-a0c7-e5412ea80490 e41bb478-2e81-4ce3-a0c7-e5412ea80490 TCGA-EP-A2KA-01A-11D-A183-10 TCGA-EP-A2KA-01A-11D-A17Z-05 +TCGA-EP-A2KB-01 TCGA-EP-A2KB-01 TCGA-EP-A2KB TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO 46 3.8 3.8 5.1 TCGA-EP-A2KB-F41390 TCGA-EP-A2KB TCGA-EP-A2KB-01A 0.2 1.4 A 1.0 -16835 50 596 0 60 161 1 0 9 2128 2013-3-18 FEMALE 165 Hepatitis C Cirrhosis, Alcohol abuse Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 1210 NO NO G2 Liver Locoregional Recurrence Yes NO YES No false No MX NX T1 Stage I TCGA-EP-A2KB.DF650AE0-E9E8-48A7-8D39-88A3F7EC2AC7.pdf A2KB WITH TUMOR 133 140 415 NO NO 1.4 NO NO R0 Primary Tumor 01 Other (specify) 7th YES NO EP 1.0 Liver None A DECEASED 81 2011 TCGA-EP-A2KB-01A-11D-A182-01 TCGA-EP-A2KB-01A-11D-A182-01 TCGA-EP-A2KB-01A-11D-A183-10 TCGA-EP-A2KB-01 TCGA-EP-A2KB-01 0C00E15C-9E8B-4BAA-9A46-4BA04403456A 0b233eab-4541-4b62-b9ae-baebf672403e TCGA-EP-A2KB-01A-11D-A183-10 TCGA-EP-A2KB-01 TCGA-EP-A2KB-01 0b233eab-4541-4b62-b9ae-baebf672403e TCGA-EP-A2KB-01A-11D-A183-10 0b233eab-4541-4b62-b9ae-baebf672403e 0b233eab-4541-4b62-b9ae-baebf672403e TCGA-EP-A2KB-01A-11D-A183-10 TCGA-EP-A2KB-01A-11D-A17Z-05 +TCGA-EP-A2KC-01 TCGA-EP-A2KC-01 TCGA-EP-A2KC TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 62 3.6 3.1 4.8 TCGA-EP-A2KC-F17206 TCGA-EP-A2KC TCGA-EP-A2KC-01A A -22677 30 19 0 0 0 43 2011-10-5 MALE 171 Hepatitis C Liver Cirrhosis, Moderate alcohol use on weekends Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 260 0.8 1.2 NO G3 NO false No MX NX T1 Stage I TCGA-EP-A2KC.F45A4E99-3856-4455-BF21-B767A0A4FA82.pdf A2KC TUMOR FREE 193 140 415 NO NO 1.1 NO NO R0 Primary Tumor 01 Segmentectomy, Single 7th YES NO EP Liver None A DECEASED 2011 TCGA-EP-A2KC-01A-11D-A20V-01 TCGA-EP-A2KC-01A-11D-A20V-01 TCGA-EP-A2KC-01A-11D-A20W-10 TCGA-EP-A2KC-01 TCGA-EP-A2KC-01 5D6AB371-9255-4290-A182-CF58291CB2F7 43426760-46b7-422e-ab1b-d29d6c2ee21e TCGA-EP-A2KC-01A-11D-A20W-10 TCGA-EP-A2KC-01 TCGA-EP-A2KC-01 43426760-46b7-422e-ab1b-d29d6c2ee21e TCGA-EP-A2KC-01A-11D-A20W-10 43426760-46b7-422e-ab1b-d29d6c2ee21e 43426760-46b7-422e-ab1b-d29d6c2ee21e TCGA-EP-A2KC-01A-11D-A20W-10 TCGA-EP-A2KC-01A-11D-A20Z-05 +TCGA-EP-A3JL-01 TCGA-EP-A3JL-01 TCGA-EP-A3JL TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 76 3.2 4.1 4.8 TCGA-EP-A3JL-F37140 TCGA-EP-A3JL TCGA-EP-A3JL-01A 0 0.6 A 0.60 1.10 -27886 22 0 303 0 0 9 13 2012-11-27 MALE 168 Alcohol consumption Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 570 0.9 1.10 NO NO G2 NO false Yes MX NX T1 Stage I TCGA-EP-A3JL.B277ACF9-B233-474B-975A-52FDE44F27E3.pdf A3JL TUMOR FREE 149 130 386 NO NO NO NO Primary Tumor 01 Other (specify) 7th YES NO EP 1.2 Liver None A LIVING 73 2011 TCGA-EP-A3JL-01A-11D-A20V-01 TCGA-EP-A3JL-01A-11D-A20V-01 TCGA-EP-A3JL-01A-11D-A20W-10 TCGA-EP-A3JL-01 TCGA-EP-A3JL-01 7032F53E-C4EE-4462-819B-D9AE04F88821 0b20024b-a8dd-4683-9a3b-00fe4cb14f71 TCGA-EP-A3JL-01A-11D-A20W-10 TCGA-EP-A3JL-01 TCGA-EP-A3JL-01 0b20024b-a8dd-4683-9a3b-00fe4cb14f71 TCGA-EP-A3JL-01A-11D-A20W-10 0b20024b-a8dd-4683-9a3b-00fe4cb14f71 0b20024b-a8dd-4683-9a3b-00fe4cb14f71 TCGA-EP-A3JL-01A-11D-A20W-10 TCGA-EP-A3JL-01A-11D-A20Z-05 +TCGA-EP-A3RK-01 TCGA-EP-A3RK-01 TCGA-EP-A3RK TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver YES 73 3.5 4.3 4.8 TCGA-EP-A3RK-F40454 TCGA-EP-A3RK TCGA-EP-A3RK-01A 0.0 0.6 A -26985 14 0 363 320 0 0 7 1,2 - Portal Fibrosis 2013-2-20 MALE 178 Alcohol consumption Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 1040 0.9 1.2 NO NO G2 Liver Locoregional Recurrence NO YES No false No MX NX T3a Stage IIIA TCGA-EP-A3RK.49F4E752-EFBE-458F-85C0-1B81B9506D91.pdf A3RK WITH TUMOR 234 140 415 NO NO 1.1 NO NO Primary Tumor 01 Other (specify) 7th YES NO EP 1.2 Liver A LIVING 101 2012 TCGA-EP-A3RK-01A-11D-A22E-01 TCGA-EP-A3RK-01A-11D-A22E-01 TCGA-EP-A3RK-01A-11D-A22F-10 TCGA-EP-A3RK-01 TCGA-EP-A3RK-01 EC810F3B-2F51-41DC-9A52-4605BE1BA1B4 2412baac-c345-465e-9c6e-bd17d3797129 TCGA-EP-A3RK-01A-11D-A22F-10 TCGA-EP-A3RK-01 TCGA-EP-A3RK-01 2412baac-c345-465e-9c6e-bd17d3797129 TCGA-EP-A3RK-01A-11D-A22F-10 2412baac-c345-465e-9c6e-bd17d3797129 2412baac-c345-465e-9c6e-bd17d3797129 TCGA-EP-A3RK-01A-11D-A22F-10 TCGA-EP-A3RK-01A-11D-A22H-05 +TCGA-EP-A3RK-11 TCGA-EP-A3RK-11 TCGA-EP-A3RK TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver YES 73 3.5 4.3 4.8 TCGA-EP-A3RK-F40454 TCGA-EP-A3RK 0.0 0.6 A -26985 0 363 320 0 0 7 1,2 - Portal Fibrosis 2013-2-20 MALE 178 Alcohol consumption Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 0.9 1.2 NO G2 Liver Locoregional Recurrence NO YES No No MX NX T3a Stage IIIA A3RK WITH TUMOR 234 140 415 NO NO 1.1 NO NO Solid Tissue Normal 11 Other (specify) 7th YES NO EP 1.2 Liver LIVING 101 2012 TCGA-EP-A3RK-11 ce3a2fa7-905e-491d-ade0-c8d5712c4afa TCGA-EP-A3RK-11 ce3a2fa7-905e-491d-ade0-c8d5712c4afa ce3a2fa7-905e-491d-ade0-c8d5712c4afa ce3a2fa7-905e-491d-ade0-c8d5712c4afa +TCGA-ES-A2HS-01 TCGA-ES-A2HS-01 TCGA-ES-A2HS TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver Mild 80 3.5 3.8 5.0 TCGA-ES-A2HS TCGA-ES-A2HS-01A 0 1.9 0 A 0.8 1.2 0.6 -29268 1113 688 0 1 0 8 1 0 - No Fibrosis 2011-9-28 MALE 180 No History of Primary Risk Factors No Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 320 0.8 1.2 NO G2 true Yes MX NX T1 Stage I TCGA-ES-A2HS.53AB28EC-71C0-4AF0-93DA-FE72CD7FE19B.pdf A2HS TUMOR FREE 119 150 450 1.3 NO R0 Primary Tumor 01 Segmentectomy, Single 6th NO YES ES 1.0 Liver None A DECEASED 97 2008 TCGA-ES-A2HS-01A-11D-A182-01 TCGA-ES-A2HS-01A-11D-A182-01 TCGA-ES-A2HS-01A-11D-A183-10 TCGA-ES-A2HS-01 TCGA-ES-A2HS-01 4ADDC326-6E3D-420E-86B8-22FCD02FF7C7 e642839c-9891-4ff0-93c4-556d81572af9 TCGA-ES-A2HS-01A-11D-A183-10 TCGA-ES-A2HS-01 TCGA-ES-A2HS-01 e642839c-9891-4ff0-93c4-556d81572af9 TCGA-ES-A2HS-01A-11D-A183-10 e642839c-9891-4ff0-93c4-556d81572af9 e642839c-9891-4ff0-93c4-556d81572af9 TCGA-ES-A2HS-01A-11D-A183-10 TCGA-ES-A2HS-01A-11D-A17Z-05 +TCGA-ES-A2HS-11 TCGA-ES-A2HS-11 TCGA-ES-A2HS TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver Mild 80 3.5 3.8 5.0 TCGA-ES-A2HS TCGA-ES-A2HS-11A 0 1.9 0 A 0.8 1.2 0.6 -29268 1113 688 0 1 0 8 1 0 - No Fibrosis 2011-9-28 MALE 180 No History of Primary Risk Factors No Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 230 0.8 1.2 NO G2 true Yes MX NX T1 Stage I A2HS TUMOR FREE 119 150 450 1.3 NO R0 Solid Tissue Normal 11 Segmentectomy, Single 6th NO YES ES 1.0 Liver None A DECEASED 97 2008 TCGA-ES-A2HS-11A-11D-A17Z-05 +TCGA-ES-A2HT-01 TCGA-ES-A2HT-01 TCGA-ES-A2HT TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver Mild 54 3.5 4.1 5.0 TCGA-ES-A2HT TCGA-ES-A2HT-01A 0 0.6 0 A 0.8 1.2 0.7 -20023 1392 438 0 1 0 10 4 0 - No Fibrosis 2011-9-30 MALE 174 Hepatitis C no Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 340 0.3 1.1 NO G2 true No MX NX T1 Stage I TCGA-ES-A2HT.FF97C711-0686-480B-BC53-3CADCAA4C4C1.pdf A2HT TUMOR FREE 135 150 450 1.1 NO R0 Primary Tumor 01 Segmentectomy, Multiple 6th NO YES ES 1.0 Liver None A DECEASED 80 2007 TCGA-ES-A2HT-01A-12D-A182-01 TCGA-ES-A2HT-01A-12D-A182-01 TCGA-ES-A2HT-01A-12D-A183-10 TCGA-ES-A2HT-01 TCGA-ES-A2HT-01 2BB535EF-7136-49C8-AFF4-3045F4E37B8C e5e12896-2cf3-4d5d-8f79-00cd964fc132 TCGA-ES-A2HT-01A-12D-A183-10 TCGA-ES-A2HT-01 TCGA-ES-A2HT-01 e5e12896-2cf3-4d5d-8f79-00cd964fc132 TCGA-ES-A2HT-01A-12D-A183-10 e5e12896-2cf3-4d5d-8f79-00cd964fc132 e5e12896-2cf3-4d5d-8f79-00cd964fc132 TCGA-ES-A2HT-01A-12D-A183-10 TCGA-ES-A2HT-01A-12D-A17Z-05 +TCGA-ES-A2HT-11 TCGA-ES-A2HT-11 TCGA-ES-A2HT TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver Mild 54 3.5 4.1 5.0 TCGA-ES-A2HT 0 0.6 0 A 0.8 1.2 0.7 -20023 438 0 1 0 10 4 0 - No Fibrosis 2011-9-30 MALE 174 Hepatitis C no Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 0.3 1.1 G2 No MX NX T1 Stage I A2HT TUMOR FREE 135 150 450 1.1 NO R0 Solid Tissue Normal 11 Segmentectomy, Multiple 6th NO YES ES 1.0 Liver None DECEASED 80 2007 TCGA-ES-A2HT-11 d5e3a3be-c4d9-41de-a39c-ae7aad3f3826 TCGA-ES-A2HT-11 d5e3a3be-c4d9-41de-a39c-ae7aad3f3826 d5e3a3be-c4d9-41de-a39c-ae7aad3f3826 d5e3a3be-c4d9-41de-a39c-ae7aad3f3826 TCGA-ES-A2HT-11A-11D-A17Z-05 +TCGA-FV-A23B-01 TCGA-FV-A23B-01 TCGA-FV-A23B TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO 70 TCGA-FV-A23B-F45565 TCGA-FV-A23B TCGA-FV-A23B-01A -25788 2030 1852 0 987 1453 2013-7-17 FEMALE Hepatitis C Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 110 NO NO Liver Locoregional Recurrence Yes NO YES No false No M0 N0 T2 Stage II TCGA-FV-A23B.82010944-23DA-4FC5-934B-05AB3C238467.pdf A23B WITH TUMOR NO NO NO R0 Primary Tumor 01 Other (specify) 6th NO YES FV Liver A DECEASED 2005 TCGA-FV-A23B-01A-11D-A16U-01 TCGA-FV-A23B-01A-11D-A16U-01 TCGA-FV-A23B-01A-11D-A16V-10 TCGA-FV-A23B-01 TCGA-FV-A23B-01 C7818FEE-D630-4B0A-824A-6423A2251C05 5343646d-bb46-4acc-9361-7432813a886f TCGA-FV-A23B-01A-11D-A16V-10 TCGA-FV-A23B-01 TCGA-FV-A23B-01 5343646d-bb46-4acc-9361-7432813a886f TCGA-FV-A23B-01A-11D-A16V-10 5343646d-bb46-4acc-9361-7432813a886f 5343646d-bb46-4acc-9361-7432813a886f TCGA-FV-A23B-01A-11D-A16V-10 TCGA-FV-A23B-01A-11D-A16X-05 +TCGA-FV-A23B-11 TCGA-FV-A23B-11 TCGA-FV-A23B TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO 70 TCGA-FV-A23B-F45565 TCGA-FV-A23B -25788 1852 0 987 1453 2013-7-17 FEMALE Hepatitis C Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES NO Liver Locoregional Recurrence Yes NO YES No No M0 N0 T2 Stage II A23B WITH TUMOR NO NO NO R0 Solid Tissue Normal 11 Other (specify) 6th NO YES FV Liver DECEASED 2005 TCGA-FV-A23B-11 a3eef529-ed7d-438c-b0be-ce569a846a8f TCGA-FV-A23B-11 a3eef529-ed7d-438c-b0be-ce569a846a8f a3eef529-ed7d-438c-b0be-ce569a846a8f a3eef529-ed7d-438c-b0be-ce569a846a8f TCGA-FV-A23B-11A-11D-A16X-05 +TCGA-FV-A2QQ-01 TCGA-FV-A2QQ-01 TCGA-FV-A2QQ TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 80 TCGA-FV-A2QQ-F57856 TCGA-FV-A2QQ TCGA-FV-A2QQ-01A -29354 71 0 729 2014-3-27 MALE Alcohol consumption Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 150 NO NO G2 NO false No MX N0 T1 Stage I TCGA-FV-A2QQ.350B10AF-C17B-41DA-BB21-A672DBB683B2.pdf A2QQ TUMOR FREE NO NO NO R0 Primary Tumor 01 Segmentectomy, Multiple 7th YES NO FV Liver None A LIVING 2011 TCGA-FV-A2QQ-01A-11D-A22E-01 TCGA-FV-A2QQ-01A-11D-A22E-01 TCGA-FV-A2QQ-01A-11D-A22F-10 TCGA-FV-A2QQ-01 TCGA-FV-A2QQ-01 2B60F8A5-1528-4569-9B3E-40B28A275302 9ac9a050-720a-45bc-94d4-87802c8f0aba TCGA-FV-A2QQ-01A-11D-A22F-10 TCGA-FV-A2QQ-01 TCGA-FV-A2QQ-01 9ac9a050-720a-45bc-94d4-87802c8f0aba TCGA-FV-A2QQ-01A-11D-A22F-10 9ac9a050-720a-45bc-94d4-87802c8f0aba 9ac9a050-720a-45bc-94d4-87802c8f0aba TCGA-FV-A2QQ-01A-11D-A22F-10 TCGA-FV-A2QQ-01A-11D-A22H-05 +TCGA-FV-A2QR-01 TCGA-FV-A2QR-01 TCGA-FV-A2QR TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO 75 TCGA-FV-A2QR-F42770 TCGA-FV-A2QR TCGA-FV-A2QR-01A 1 1764 581 0 561 2013-4-30 MALE Other Male, IDDM for 30+years Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 100 NO NO G1 Extrahepatic Recurrence No NO YES No false No M0 N0 T1 Stage I TCGA-FV-A2QR.DE38B13D-FD4D-4077-ADBE-D034C2F5F003.pdf A2QR WITH TUMOR NO NO NO YES RX Primary Tumor 01 Lobectomy 6th NO YES FV Liver A DECEASED 2006 TCGA-FV-A2QR-01A-11D-A20V-01 TCGA-FV-A2QR-01A-11D-A20V-01 TCGA-FV-A2QR-01A-11D-A20W-10 TCGA-FV-A2QR-01 TCGA-FV-A2QR-01 3F858642-BFA2-4D05-B9CB-2233AFE9C0A3 4850e928-80c5-4ad3-9291-2e9d80fde8c6 TCGA-FV-A2QR-01A-11D-A20W-10 TCGA-FV-A2QR-01 TCGA-FV-A2QR-01 4850e928-80c5-4ad3-9291-2e9d80fde8c6 TCGA-FV-A2QR-01A-11D-A20W-10 4850e928-80c5-4ad3-9291-2e9d80fde8c6 4850e928-80c5-4ad3-9291-2e9d80fde8c6 TCGA-FV-A2QR-01A-11D-A20W-10 TCGA-FV-A2QR-01A-11D-A20Z-05 +TCGA-FV-A2QR-11 TCGA-FV-A2QR-11 TCGA-FV-A2QR TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO 75 TCGA-FV-A2QR-F42770 TCGA-FV-A2QR TCGA-FV-A2QR-11A 1 1764 581 0 561 2013-4-30 MALE Other Male, IDDM for 30+years Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 30 NO NO G1 Extrahepatic Recurrence No NO YES No false No M0 N0 T1 Stage I A2QR WITH TUMOR NO NO NO YES RX Solid Tissue Normal 11 Lobectomy 6th NO YES FV Liver A DECEASED 2006 TCGA-FV-A2QR-11 6fca2b4e-2aa2-42bb-9991-b0a69e6155cd TCGA-FV-A2QR-11 6fca2b4e-2aa2-42bb-9991-b0a69e6155cd 6fca2b4e-2aa2-42bb-9991-b0a69e6155cd 6fca2b4e-2aa2-42bb-9991-b0a69e6155cd TCGA-FV-A2QR-11A-11D-A20Z-05 +TCGA-FV-A3I0-01 TCGA-FV-A3I0-01 TCGA-FV-A3I0 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver YES NO 76 4.40 TCGA-FV-A3I0-F57854 TCGA-FV-A3I0 TCGA-FV-A3I0-01A 0.4 -28101 70 0 848 159 2014-3-27 FEMALE No History of Primary Risk Factors Hepatocholangiocarcinoma (Mixed) No C22.0 8171/3 C22.0 YES 190 NO NO G2 Liver Intrahepatic Recurrence Yes NO YES No false No M0 NX T2 Stage II TCGA-FV-A3I0.B4DB59E9-FFBB-4716-9235-90A1DF17455B.pdf A3I0 WITH TUMOR NO NO NO R0 Primary Tumor 01 Lobectomy 7th YES NO FV Liver Micro A LIVING 2011 TCGA-FV-A3I0-01A-11D-A22E-01 TCGA-FV-A3I0-01A-11D-A22E-01 TCGA-FV-A3I0-01A-11D-A22F-10 TCGA-FV-A3I0-01 TCGA-FV-A3I0-01 51d59e9b-2f54-4a54-b5f5-81376be2eb82 TCGA-FV-A3I0-01A-11D-A22F-10 TCGA-FV-A3I0-01 TCGA-FV-A3I0-01 51d59e9b-2f54-4a54-b5f5-81376be2eb82 TCGA-FV-A3I0-01A-11D-A22F-10 51d59e9b-2f54-4a54-b5f5-81376be2eb82 51d59e9b-2f54-4a54-b5f5-81376be2eb82 TCGA-FV-A3I0-01A-11D-A22F-10 TCGA-FV-A3I0-01A-11D-A22H-05 +TCGA-FV-A3I0-11 TCGA-FV-A3I0-11 TCGA-FV-A3I0 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver YES NO 76 4.40 TCGA-FV-A3I0-F57854 TCGA-FV-A3I0 TCGA-FV-A3I0-11A 0.4 -28101 70 0 848 159 2014-3-27 FEMALE No History of Primary Risk Factors Hepatocholangiocarcinoma (Mixed) No C22.0 8171/3 C22.0 YES 40 NO NO G2 Liver Intrahepatic Recurrence Yes NO YES No false No M0 NX T2 Stage II A3I0 WITH TUMOR NO NO NO R0 Solid Tissue Normal 11 Lobectomy 7th YES NO FV Liver Micro A LIVING 2011 TCGA-FV-A3I0-11 07401514-29ef-43a8-8a7f-a4e147852470 TCGA-FV-A3I0-11 07401514-29ef-43a8-8a7f-a4e147852470 07401514-29ef-43a8-8a7f-a4e147852470 07401514-29ef-43a8-8a7f-a4e147852470 +TCGA-FV-A3I1-01 TCGA-FV-A3I1-01 TCGA-FV-A3I1 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 81 TCGA-FV-A3I1-F42771 TCGA-FV-A3I1 TCGA-FV-A3I1-01A 76 247 0 0 0 - No Fibrosis 2013-4-30 FEMALE Alcohol consumption Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 70 NO NO G2 NO false Yes MX N0 T2 Stage II TCGA-FV-A3I1.B40A8E73-2904-4C68-B2AD-6FC27211654B.pdf A3I1 TUMOR FREE NO NO NO NO R0 Primary Tumor 01 Segmentectomy, Multiple 7th YES NO FV Liver Micro A Hepatitis C Antibody|Hepatitis B Surface Antigen|HBV Surface Antibody DECEASED 2011 TCGA-FV-A3I1-01A-11D-A22E-01 TCGA-FV-A3I1-01A-11D-A22E-01 TCGA-FV-A3I1-01A-11D-A22F-10 TCGA-FV-A3I1-01 TCGA-FV-A3I1-01 1cc4f319-fc1d-46bb-9fbb-469d66bd23f2 TCGA-FV-A3I1-01A-11D-A22F-10 TCGA-FV-A3I1-01 TCGA-FV-A3I1-01 1cc4f319-fc1d-46bb-9fbb-469d66bd23f2 TCGA-FV-A3I1-01A-11D-A22F-10 1cc4f319-fc1d-46bb-9fbb-469d66bd23f2 1cc4f319-fc1d-46bb-9fbb-469d66bd23f2 TCGA-FV-A3I1-01A-11D-A22F-10 TCGA-FV-A3I1-01A-11D-A22H-05 +TCGA-FV-A3I1-11 TCGA-FV-A3I1-11 TCGA-FV-A3I1 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 81 TCGA-FV-A3I1-F42771 TCGA-FV-A3I1 TCGA-FV-A3I1-11A 76 247 0 0 0 - No Fibrosis 2013-4-30 FEMALE Alcohol consumption Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 70 NO NO G2 NO false Yes MX N0 T2 Stage II A3I1 TUMOR FREE NO NO NO NO R0 Solid Tissue Normal 11 Segmentectomy, Multiple 7th YES NO FV Liver Micro A Hepatitis C Antibody|Hepatitis B Surface Antigen|HBV Surface Antibody DECEASED 2011 TCGA-FV-A3I1-11 61fcdecf-52ca-465a-b8f1-262b6540117f TCGA-FV-A3I1-11 61fcdecf-52ca-465a-b8f1-262b6540117f 61fcdecf-52ca-465a-b8f1-262b6540117f 61fcdecf-52ca-465a-b8f1-262b6540117f +TCGA-FV-A3R2-01 TCGA-FV-A3R2-01 TCGA-FV-A3R2 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 75 TCGA-FV-A3R2-F47054 TCGA-FV-A3R2 TCGA-FV-A3R2-01A 4 -27530 2555 194 0 2013-8-21 MALE No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 120 NO NO NO true Yes MX NX T1 Stage I TCGA-FV-A3R2.6F330991-CD7E-4387-AFE8-B9C6C8D98396.pdf A3R2 TUMOR FREE NO YES NO YES R0 Primary Tumor 01 Segmentectomy, Multiple 6th NO YES FV Liver A Hepatitis C Antibody|Hepatitis B Surface Antigen|HBV Surface Antibody DECEASED 75 2005 TCGA-FV-A3R2-01A-11D-A22E-01 TCGA-FV-A3R2-01A-11D-A22E-01 TCGA-FV-A3R2-01A-11D-A22F-10 TCGA-FV-A3R2-01 92F08485-2808-4F9B-8F1F-A893D3CF6FD3 4cda696b-42da-43fd-9f6f-95dfc748a0ca TCGA-FV-A3R2-01A-11D-A22F-10 TCGA-FV-A3R2-01 4cda696b-42da-43fd-9f6f-95dfc748a0ca TCGA-FV-A3R2-01A-11D-A22F-10 4cda696b-42da-43fd-9f6f-95dfc748a0ca 4cda696b-42da-43fd-9f6f-95dfc748a0ca TCGA-FV-A3R2-01A-11D-A22F-10 TCGA-FV-A3R2-01A-11D-A22H-05 +TCGA-FV-A3R2-11 TCGA-FV-A3R2-11 TCGA-FV-A3R2 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 75 TCGA-FV-A3R2-F47054 TCGA-FV-A3R2 TCGA-FV-A3R2-11A 4 -27530 2555 194 0 2013-8-21 MALE No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 80 NO NO NO true Yes MX NX T1 Stage I A3R2 TUMOR FREE NO YES NO YES R0 Solid Tissue Normal 11 Segmentectomy, Multiple 6th NO YES FV Liver A Hepatitis C Antibody|Hepatitis B Surface Antigen|HBV Surface Antibody DECEASED 75 2005 TCGA-FV-A3R2-11 92462e76-eed1-4eab-8c38-4cf9897be417 TCGA-FV-A3R2-11 92462e76-eed1-4eab-8c38-4cf9897be417 92462e76-eed1-4eab-8c38-4cf9897be417 92462e76-eed1-4eab-8c38-4cf9897be417 +TCGA-FV-A3R3-01 TCGA-FV-A3R3-01 TCGA-FV-A3R3 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 38 3.4 2.0 5.0 TCGA-FV-A3R3-F64062 TCGA-FV-A3R3 TCGA-FV-A3R3-01A 0.0 0.4 0.6 1.3 1.3 -14231 28 366 0 4 1 2014-8-25 FEMALE 161 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 90 9.5 11.9 NO NO G2 NO true No MX NX T1 Stage I TCGA-FV-A3R3.FF0E1601-BC87-4E61-95BE-1776C9F85002.pdf A3R3 TUMOR FREE 323 150 450 NO NO 10.7 NO NO R0 Primary Tumor 01 Other (specify) 7th YES NO FV 1.0 Liver None A DECEASED 97 2012 TCGA-FV-A3R3-01A-11D-A22E-01 TCGA-FV-A3R3-01A-11D-A22E-01 TCGA-FV-A3R3-01A-11D-A22F-10 TCGA-FV-A3R3-01 91FC95B8-388B-4B2F-B3BC-0F1B5783E815 db848332-4ee8-4f22-b6c9-b2634bd35918 TCGA-FV-A3R3-01A-11D-A22F-10 TCGA-FV-A3R3-01 db848332-4ee8-4f22-b6c9-b2634bd35918 TCGA-FV-A3R3-01A-11D-A22F-10 db848332-4ee8-4f22-b6c9-b2634bd35918 db848332-4ee8-4f22-b6c9-b2634bd35918 TCGA-FV-A3R3-01A-11D-A22F-10 TCGA-FV-A3R3-01A-11D-A22H-05 +TCGA-FV-A495-01 TCGA-FV-A495-01 TCGA-FV-A495 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver Mild 51 3.8 4.0 5.0 TCGA-FV-A495 TCGA-FV-A495-01A 0.3 1.0 1 0.6 1.1 1.0 -18740 56 0 1 0 8 39 3,4 - Fibrous Speta 2013-2-21 FEMALE 172 Hepatitis C Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 70 NO G2 NO false No M0 NX T2 Stage II TCGA-FV-A495.99D80D8A-88F7-445D-9B87-9B4B96C3C010.pdf A495 TUMOR FREE 258 140 440 YES R0 Primary Tumor 01 Segmentectomy, Multiple 7th YES NO FV 1.9 Liver None A LIVING 70 2012 TCGA-FV-A495-01A-11D-A25U-01 TCGA-FV-A495-01A-11D-A25U-01 TCGA-FV-A495-01A-11D-A25V-10 TCGA-FV-A495-01 TCGA-FV-A495-01 6a2cafbb-2824-4727-b950-0c2bdcf26358 TCGA-FV-A495-01A-11D-A25V-10 TCGA-FV-A495-01 TCGA-FV-A495-01 6a2cafbb-2824-4727-b950-0c2bdcf26358 TCGA-FV-A495-01A-11D-A25V-10 6a2cafbb-2824-4727-b950-0c2bdcf26358 6a2cafbb-2824-4727-b950-0c2bdcf26358 TCGA-FV-A495-01A-11D-A25V-10 TCGA-FV-A495-01A-11D-A264-05 +TCGA-FV-A496-01 TCGA-FV-A496-01 TCGA-FV-A496 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver None 84 3.8 2.8 5.0 TCGA-FV-A496 TCGA-FV-A496-01A 0.3 0.9 3 0.9 1.1 1.0 -30950 51 0 10 0 8 67 0 - No Fibrosis 2013-2-21 FEMALE 162 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 70 0.9 1.1 NO G2 NO false No M0 NX T1 Stage I TCGA-FV-A496.358A0018-5731-45D3-97B8-502A3BF95FA8.pdf A496 TUMOR FREE 167 140 440 1.0 YES R0 Primary Tumor 01 Segmentectomy, Multiple 7th YES NO FV 1.9 Liver None A LIVING 54 2012 TCGA-FV-A496-01A-11D-A25U-01 TCGA-FV-A496-01A-11D-A25U-01 TCGA-FV-A496-01A-11D-A25V-10 TCGA-FV-A496-01 TCGA-FV-A496-01 DD8FB046-5CCE-442F-AEB9-748965BFD520 5c6d857a-55c1-4365-b8de-bde7e769ce77 TCGA-FV-A496-01A-11D-A25V-10 TCGA-FV-A496-01 TCGA-FV-A496-01 5c6d857a-55c1-4365-b8de-bde7e769ce77 TCGA-FV-A496-01A-11D-A25V-10 5c6d857a-55c1-4365-b8de-bde7e769ce77 5c6d857a-55c1-4365-b8de-bde7e769ce77 TCGA-FV-A496-01A-11D-A25V-10 TCGA-FV-A496-01A-11D-A264-05 +TCGA-FV-A4ZP-01 TCGA-FV-A4ZP-01 TCGA-FV-A4ZP TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO 78 TCGA-FV-A4ZP-F64063 TCGA-FV-A4ZP TCGA-FV-A4ZP-01A -28771 2519 2486 0 1836 20326 2014-8-25 MALE 168 Alcohol consumption Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 210 NO NO G2 Other, specify Extrahepatic Recurrence Adrenal Gland No YES YES No false Yes M0 NX T3 Stage IIIA TCGA-FV-A4ZP.B6B41E65-9EFD-4F60-A4F0-68270AC39D15.pdf A4ZP TUMOR FREE NO NO NO RX R1 Primary Tumor 01 Segmentectomy, Single 6th NO YES FV Liver Micro A DECEASED 69 2005 TCGA-FV-A4ZP-01A-12D-A25U-01 TCGA-FV-A4ZP-01A-12D-A25U-01 TCGA-FV-A4ZP-01A-12D-A25V-10 TCGA-FV-A4ZP-01 TCGA-FV-A4ZP-01 CC0156B0-2373-4CE8-83DC-B84FF14E29D9 36bb7b6e-9a6f-4215-b362-93b6db73c819 TCGA-FV-A4ZP-01A-12D-A25V-10 TCGA-FV-A4ZP-01 TCGA-FV-A4ZP-01 36bb7b6e-9a6f-4215-b362-93b6db73c819 TCGA-FV-A4ZP-01A-12D-A25V-10 36bb7b6e-9a6f-4215-b362-93b6db73c819 36bb7b6e-9a6f-4215-b362-93b6db73c819 TCGA-FV-A4ZP-01A-12D-A25V-10 TCGA-FV-A4ZP-01A-12D-A264-05 +TCGA-FV-A4ZQ-01 TCGA-FV-A4ZQ-01 TCGA-FV-A4ZQ TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 52 3.8 2.4 5.0 TCGA-FV-A4ZQ TCGA-FV-A4ZQ-01A 0.2 1.8 0.7 1.0 1.0 -19090 224 0 12 2013-3-15 MALE Hepatitis C Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 160 2.0 3.0 NO G2 NO false No M0 NX T1 Stage I TCGA-FV-A4ZQ.C0B03F38-09C0-4B87-94BC-E2E8D9F7F922.pdf A4ZQ TUMOR FREE 1.1 R0 Primary Tumor 01 Segmentectomy, Single 7th YES NO FV 1.2 Liver None A Hepatitis C Virus R LIVING 2012 TCGA-FV-A4ZQ-01A-11D-A25U-01 TCGA-FV-A4ZQ-01A-11D-A25U-01 TCGA-FV-A4ZQ-01A-11D-A25V-10 TCGA-FV-A4ZQ-01 TCGA-FV-A4ZQ-01 DFBDE418-4B11-4B96-A6AD-3A6A54F3D96D 43a21e6a-8b4e-4589-9236-0835dd7d7a00 TCGA-FV-A4ZQ-01A-11D-A25V-10 TCGA-FV-A4ZQ-01 TCGA-FV-A4ZQ-01 43a21e6a-8b4e-4589-9236-0835dd7d7a00 TCGA-FV-A4ZQ-01A-11D-A25V-10 43a21e6a-8b4e-4589-9236-0835dd7d7a00 43a21e6a-8b4e-4589-9236-0835dd7d7a00 TCGA-FV-A4ZQ-01A-11D-A25V-10 TCGA-FV-A4ZQ-01A-11D-A264-05 +TCGA-G3-A25S-01 TCGA-G3-A25S-01 TCGA-G3-A25S TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver YES YES Mild 64 0.3 0.4 0.5 TCGA-G3-A25S-F33638 TCGA-G3-A25S TCGA-G3-A25S-01A 0 1.2 0 A 0.6 1.4 1.0 -23571 707 416 0 37 37 1 0 10 281 6 - Established Cirrhosis Scheduled Follow-up Submission 2012-7-11 MALE 166 Alcohol consumption Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 480 0.9 1.1 NO G2 Other, specify Extrahepatic Recurrence Bone and Lung NO YES true No M0 N0 T1 Stage I TCGA-G3-A25S.F4DAEF13-D4B0-4C12-9617-04878D3FC98D.pdf A25S WITH TUMOR 313 150 400 NO NO 1.0 NO NO R1 Primary Tumor 01 Extended Lobectomy 6th NO YES G3 1.4 Liver Micro A DECEASED 73 2009 TCGA-G3-A25S-01A-11D-A16U-01 TCGA-G3-A25S-01A-11D-A16U-01 TCGA-G3-A25S-01A-11D-A16V-10 TCGA-G3-A25S-01 TCGA-G3-A25S-01 F0CB0DB4-1B18-4DC9-A779-F144ACE7265E 4fd1e10d-c21a-49f8-9d77-a5aa7850d883 TCGA-G3-A25S-01A-11D-A16V-10 TCGA-G3-A25S-01 TCGA-G3-A25S-01 4fd1e10d-c21a-49f8-9d77-a5aa7850d883 TCGA-G3-A25S-01A-11D-A16V-10 4fd1e10d-c21a-49f8-9d77-a5aa7850d883 4fd1e10d-c21a-49f8-9d77-a5aa7850d883 TCGA-G3-A25S-01A-11D-A16V-10 TCGA-G3-A25S-01A-11D-A16X-05 +TCGA-G3-A25T-01 TCGA-G3-A25T-01 TCGA-G3-A25T TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO None 45 0.3 0.4 0.5 TCGA-G3-A25T-F33639 TCGA-G3-A25T 0 2.0 A 0.4 1.4 0.7 -16461 0 1553 452 452 0 0 10 7 0 - No Fibrosis Scheduled Follow-up Submission 2012-7-11 FEMALE 167 Hepatitis C Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 0.9 1.1 G2 Liver Intrahepatic Recurrence No YES YES No No M0 N0 T3 Stage IIIA A25T WITH TUMOR 306 150 400 NO NO 1.1 NO NO R0 R0 Primary Tumor 01 Lobectomy 6th NO YES G3 1.4 Liver None LIVING 64 2007 TCGA-G3-A25T-01A-11D-A16U-01 TCGA-G3-A25T-01A-11D-A16U-01 TCGA-G3-A25T-01A-11D-A16V-10 TCGA-G3-A25T-01 TCGA-G3-A25T-01 e54a0934-1fc9-4a54-98a1-63063dc61a1b TCGA-G3-A25T-01A-11D-A16V-10 TCGA-G3-A25T-01 TCGA-G3-A25T-01 e54a0934-1fc9-4a54-98a1-63063dc61a1b TCGA-G3-A25T-01A-11D-A16V-10 e54a0934-1fc9-4a54-98a1-63063dc61a1b e54a0934-1fc9-4a54-98a1-63063dc61a1b TCGA-G3-A25T-01A-11D-A16V-10 TCGA-G3-A25T-01A-11D-A16X-05 +TCGA-G3-A25U-01 TCGA-G3-A25U-01 TCGA-G3-A25U TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver Mild 63 0.3 0.3 0.5 TCGA-G3-A25U-F33636 TCGA-G3-A25U TCGA-G3-A25U-01A 0 0.3 A 0.4 1.1 0.5 -23207 1281 0 1636 0 0 10 10 0 - No Fibrosis Scheduled Follow-up Submission 2012-7-11 FEMALE 153 Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 350 0.9 1.1 NO G3 NO true No M0 N0 T1 Stage I TCGA-G3-A25U.2781ABF5-FC79-4973-BE15-037BC685FAFC.pdf A25U TUMOR FREE 113 150 400 NO NO 1.0 NO NO R0 Primary Tumor 01 Lobectomy 6th NO YES G3 1.2 Liver None A LIVING 47 2007 TCGA-G3-A25U-01A-11D-A16U-01 TCGA-G3-A25U-01A-11D-A16U-01 TCGA-G3-A25U-01A-11D-A16V-10 TCGA-G3-A25U-01 TCGA-G3-A25U-01 67D384C8-9C42-4304-BFB3-1930B4422EAC 9d462109-5858-4282-abc2-81282089bc6a TCGA-G3-A25U-01A-11D-A16V-10 TCGA-G3-A25U-01 TCGA-G3-A25U-01 9d462109-5858-4282-abc2-81282089bc6a TCGA-G3-A25U-01A-11D-A16V-10 9d462109-5858-4282-abc2-81282089bc6a 9d462109-5858-4282-abc2-81282089bc6a TCGA-G3-A25U-01A-11D-A16V-10 TCGA-G3-A25U-01A-11D-A16X-05 +TCGA-G3-A25V-01 TCGA-G3-A25V-01 TCGA-G3-A25V TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO None 68 0.3 0.4 0.5 TCGA-G3-A25V-F40088 TCGA-G3-A25V TCGA-G3-A25V-01A 0 0.6 0 A 0.6 1.4 0.7 -25144 223 0 860 489 2 0 10 15 6 - Established Cirrhosis 2013-2-12 MALE 187 Alcohol consumption Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 100 0.9 1.1 NO NO G2 Liver Intrahepatic Recurrence Yes NO YES No false No M0 N0 T1 Stage I TCGA-G3-A25V.F52224B9-1FAF-4F71-B017-22AAEBA8F75D.pdf A25V WITH TUMOR 139 150 400 NO NO 1.1 NO NO R0 Primary Tumor 01 Segmentectomy, Single 7th NO YES G3 1.4 Liver None A LIVING 90 2010 TCGA-G3-A25V-01A-11D-A16U-01 TCGA-G3-A25V-01A-11D-A16U-01 TCGA-G3-A25V-01A-11D-A16V-10 TCGA-G3-A25V-01 TCGA-G3-A25V-01 43C544E8-3188-4140-BCAF-74B978F13CEF b3cf1b9e-aa69-452a-a9cc-f463ab4885be TCGA-G3-A25V-01A-11D-A16V-10 TCGA-G3-A25V-01 TCGA-G3-A25V-01 b3cf1b9e-aa69-452a-a9cc-f463ab4885be TCGA-G3-A25V-01A-11D-A16V-10 b3cf1b9e-aa69-452a-a9cc-f463ab4885be b3cf1b9e-aa69-452a-a9cc-f463ab4885be TCGA-G3-A25V-01A-11D-A16V-10 TCGA-G3-A25V-01A-11D-A16X-05 +TCGA-G3-A25W-01 TCGA-G3-A25W-01 TCGA-G3-A25W TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver None 79 0.3 0.4 0.5 TCGA-G3-A25W-F40230 TCGA-G3-A25W TCGA-G3-A25W-01A 0 0.3 3 A 0.4 1.1 1.5 -29018 419 0 935 0 0 9 6 0 - No Fibrosis 2013-2-14 FEMALE 157 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 260 0.8 1.2 NO NO G2 NO true Yes M0 N0 T3b Stage IIIB TCGA-G3-A25W.F92FE7A0-15D4-45FD-BB39-E3022E30EB77.pdf A25W TUMOR FREE 308 150 400 NO NO 0.9 NO YES R0 Primary Tumor 01 Segmentectomy, Single 7th NO YES G3 1.2 Liver Macro A LIVING 48 2010 TCGA-G3-A25W-01A-11D-A16U-01 TCGA-G3-A25W-01A-11D-A16U-01 TCGA-G3-A25W-01A-11D-A16V-10 TCGA-G3-A25W-01 EBBA3C7B-D8A5-46DF-B278-39B1A8A8F25C TCGA-G3-A25W-01A-11D-A16V-10 TCGA-G3-A25W-01 TCGA-G3-A25W-01A-11D-A16V-10 TCGA-G3-A25W-01A-11D-A16V-10 TCGA-G3-A25W-01A-11D-A16X-05 +TCGA-G3-A25W-11 TCGA-G3-A25W-11 TCGA-G3-A25W TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver None 79 0.3 0.4 0.5 TCGA-G3-A25W-F40230 TCGA-G3-A25W TCGA-G3-A25W-11A 0 0.3 3 A 0.4 1.1 1.5 -29018 419 0 935 0 0 9 6 0 - No Fibrosis 2013-2-14 FEMALE 157 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 440 0.8 1.2 NO NO G2 NO true Yes M0 N0 T3b Stage IIIB A25W TUMOR FREE 308 150 400 NO NO 0.9 NO YES R0 Solid Tissue Normal 11 Segmentectomy, Single 7th NO YES G3 1.2 Liver Macro A LIVING 48 2010 TCGA-G3-A25W-11A-12D-A16X-05 +TCGA-G3-A25X-01 TCGA-G3-A25X-01 TCGA-G3-A25X TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver Mild 73 0.3 0.4 0.5 TCGA-G3-A25X-F33634 TCGA-G3-A25X TCGA-G3-A25X-01A 0.0 1.1 A 0.4 1.4 0.8 -26988 1346 0 1779 0 0 10 11 1,2 - Portal Fibrosis Scheduled Follow-up Submission 2012-7-11 MALE 165 Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 160 0.9 1.1 NO G3 NO true No M0 N0 T2 Stage II TCGA-G3-A25X.7DF1A9E2-3A8F-4A9B-B918-4133D60E4F0A.pdf A25X TUMOR FREE 102 150 400 NO NO 1.0 NO NO R0 Primary Tumor 01 Segmentectomy, Single 6th NO YES G3 1.4 Liver None A LIVING 65 2007 TCGA-G3-A25X-01A-11D-A16U-01 TCGA-G3-A25X-01A-11D-A16U-01 TCGA-G3-A25X-01 TCGA-G3-A25X-01 35B0DFC0-56DE-4318-AD0F-3FA0745DB6D9 11cbdb5a-82fd-471a-9b33-c5c1b9393716 TCGA-G3-A25X-01 TCGA-G3-A25X-01 11cbdb5a-82fd-471a-9b33-c5c1b9393716 11cbdb5a-82fd-471a-9b33-c5c1b9393716 11cbdb5a-82fd-471a-9b33-c5c1b9393716 TCGA-G3-A25X-01A-11D-A16X-05 +TCGA-G3-A25X-11 TCGA-G3-A25X-11 TCGA-G3-A25X TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver Mild 73 0.3 0.4 0.5 TCGA-G3-A25X-F33634 TCGA-G3-A25X TCGA-G3-A25X-11A 0.0 1.1 A 0.4 1.4 0.8 -26988 1346 0 1779 0 0 10 11 1,2 - Portal Fibrosis Scheduled Follow-up Submission 2012-7-11 MALE 165 Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 220 0.9 1.1 NO G3 NO true No M0 N0 T2 Stage II A25X TUMOR FREE 102 150 400 NO NO 1.0 NO NO R0 Solid Tissue Normal 11 Segmentectomy, Single 6th NO YES G3 1.4 Liver None A LIVING 65 2007 TCGA-G3-A25X-11A-11D-A16X-05 +TCGA-G3-A25Y-01 TCGA-G3-A25Y-01 TCGA-G3-A25Y TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO Mild 52 0.3 0.4 0.5 TCGA-G3-A25Y-F40098 TCGA-G3-A25Y TCGA-G3-A25Y-01A 0.0 0.7 A 0.4 1.1 0.6 -19055 1595 452 0 355 0 0 10 35 3,4 - Fibrous Speta 2013-2-12 FEMALE 158 Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 440 0.9 1.1 NO NO G3 Liver Locoregional Recurrence No NO YES No true No M0 N0 T1 Stage I TCGA-G3-A25Y.5AEEF060-BA18-416A-BE3F-604891A9A6D2.pdf A25Y WITH TUMOR 166 150 400 NO NO 1.1 NO NO R0 Primary Tumor 01 Segmentectomy, Multiple 6th NO YES G3 1.2 Liver None A DECEASED 57 2006 TCGA-G3-A25Y-01A-11D-A16U-01 TCGA-G3-A25Y-01A-11D-A16U-01 TCGA-G3-A25Y-01A-11D-A16V-10 TCGA-G3-A25Y-01 TCGA-G3-A25Y-01 9929B349-9D83-4C81-BA8A-D48236C70505 ca7f7d18-3f39-4454-8f72-eb432b800103 TCGA-G3-A25Y-01A-11D-A16V-10 TCGA-G3-A25Y-01 TCGA-G3-A25Y-01 ca7f7d18-3f39-4454-8f72-eb432b800103 TCGA-G3-A25Y-01A-11D-A16V-10 ca7f7d18-3f39-4454-8f72-eb432b800103 ca7f7d18-3f39-4454-8f72-eb432b800103 TCGA-G3-A25Y-01A-11D-A16V-10 TCGA-G3-A25Y-01A-11D-A16X-05 +TCGA-G3-A25Z-01 TCGA-G3-A25Z-01 TCGA-G3-A25Z TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver Mild 58 0.3 0.4 0.5 TCGA-G3-A25Z-F33635 TCGA-G3-A25Z TCGA-G3-A25Z-01A 0 0.9 1 A 0.6 1.4 1.1 -21509 233 0 655 0 0 15 44 5 - Nodular Formation and Incomplete Cirrhosis Scheduled Follow-up Submission 2012-7-11 MALE 173 Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 300 0.9 1.1 NO G2 NO true No M0 N0 T1 Stage I TCGA-G3-A25Z.001A2553-3F5F-4A74-88E6-03B42C061E6D.pdf A25Z TUMOR FREE 115 150 400 NO NO 1.0 NO YES R0 Primary Tumor 01 Segmentectomy, Multiple 7th NO YES G3 1.4 Liver None A LIVING 69 2010 TCGA-G3-A25Z-01A-11D-A16U-01 TCGA-G3-A25Z-01A-11D-A16U-01 TCGA-G3-A25Z-01A-11D-A16V-10 TCGA-G3-A25Z-01 TCGA-G3-A25Z-01 EA21A265-56D5-4C72-8665-00BF82A67B7D 859fc4fb-40f5-40ce-8784-13eae0fa446a TCGA-G3-A25Z-01A-11D-A16V-10 TCGA-G3-A25Z-01 TCGA-G3-A25Z-01 859fc4fb-40f5-40ce-8784-13eae0fa446a TCGA-G3-A25Z-01A-11D-A16V-10 859fc4fb-40f5-40ce-8784-13eae0fa446a 859fc4fb-40f5-40ce-8784-13eae0fa446a TCGA-G3-A25Z-01A-11D-A16V-10 TCGA-G3-A25Z-01A-11D-A16X-05 +TCGA-G3-A3CG-01 TCGA-G3-A3CG-01 TCGA-G3-A3CG TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver YES NO Severe 80 0.3 0.4 0.5 TCGA-G3-A3CG-F40228 TCGA-G3-A3CG TCGA-G3-A3CG-01A 0.3 0.3 A 0.6 1.4 0.9 -29432 261 0 673 329 1 0 10 67 6 - Established Cirrhosis 2013-2-14 MALE 168 Hepatitis C Hepatocellular Carcinoma Yes C22.0 8170/3 C22.0 YES 270 0.9 1.1 NO NO G2 Liver Intrahepatic Recurrence No NO YES No false Yes M0 N0 T1 Stage I TCGA-G3-A3CG.6E2F9CE1-6D48-42DF-8737-64ED53BF8646.pdf A3CG WITH TUMOR 131 150 400 NO NO 1.1 NO NO R1 Primary Tumor 01 Lobectomy 7th NO YES G3 1.4 Liver Micro A LIVING 93 2011 TCGA-G3-A3CG-01A-11D-A20V-01 TCGA-G3-A3CG-01A-11D-A20V-01 TCGA-G3-A3CG-01A-11D-A20W-10 TCGA-G3-A3CG-01 203A6526-64B9-4978-8D9F-884898C1E79D b29ea742-8e19-4cdb-b237-5a7934f01381 TCGA-G3-A3CG-01A-11D-A20W-10 TCGA-G3-A3CG-01 b29ea742-8e19-4cdb-b237-5a7934f01381 TCGA-G3-A3CG-01A-11D-A20W-10 b29ea742-8e19-4cdb-b237-5a7934f01381 b29ea742-8e19-4cdb-b237-5a7934f01381 TCGA-G3-A3CG-01A-11D-A20W-10 TCGA-G3-A3CG-01A-11D-A20Z-05 +TCGA-G3-A3CH-01 TCGA-G3-A3CH-01 TCGA-G3-A3CH TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO Severe 53 0.3 0.3 0.5 TCGA-G3-A3CH-F40093 TCGA-G3-A3CH TCGA-G3-A3CH-01A 0 0.7 A 0.6 1.4 0.9 -19473 296 0 780 180 116 0 0 10 41 6 - Established Cirrhosis 2013-2-12 MALE 178 Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 120 0.9 1.1 NO NO G2 Liver Intrahepatic Recurrence No YES YES No false No M0 N0 T3a Stage IIIA TCGA-G3-A3CH.735AAE4A-21E1-4481-9D86-385CCE5712D1.pdf A3CH WITH TUMOR 142 150 400 NO NO 1.2 NO NO R0 Primary Tumor 01 Segmentectomy, Multiple 7th NO YES G3 1.4 Liver None A LIVING 74 2010 TCGA-G3-A3CH-01A-11D-A22E-01 TCGA-G3-A3CH-01A-11D-A22E-01 TCGA-G3-A3CH-01A-11D-A22F-10 TCGA-G3-A3CH-01 TCGA-G3-A3CH-01 FB66ADBF-865D-44FD-8ACB-4362226607ED 7e48e392-4196-4188-bb39-bba65e88c2d5 TCGA-G3-A3CH-01A-11D-A22F-10 TCGA-G3-A3CH-01 TCGA-G3-A3CH-01 7e48e392-4196-4188-bb39-bba65e88c2d5 TCGA-G3-A3CH-01A-11D-A22F-10 7e48e392-4196-4188-bb39-bba65e88c2d5 7e48e392-4196-4188-bb39-bba65e88c2d5 TCGA-G3-A3CH-01A-11D-A22F-10 TCGA-G3-A3CH-01A-11D-A22H-05 +TCGA-G3-A3CH-11 TCGA-G3-A3CH-11 TCGA-G3-A3CH TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO Severe 53 0.3 0.3 0.5 TCGA-G3-A3CH-F40093 TCGA-G3-A3CH 0 0.7 A 0.6 1.4 0.9 -19473 0 780 180 116 0 0 10 41 6 - Established Cirrhosis 2013-2-12 MALE 178 Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 0.9 1.1 NO G2 Liver Intrahepatic Recurrence No YES YES No No M0 N0 T3a Stage IIIA A3CH WITH TUMOR 142 150 400 NO NO 1.2 NO NO R0 Solid Tissue Normal 11 Segmentectomy, Multiple 7th NO YES G3 1.4 Liver None LIVING 74 2010 TCGA-G3-A3CH-11 c8de0c98-c69a-44a1-bdf7-e6c731359aac TCGA-G3-A3CH-11 c8de0c98-c69a-44a1-bdf7-e6c731359aac c8de0c98-c69a-44a1-bdf7-e6c731359aac c8de0c98-c69a-44a1-bdf7-e6c731359aac +TCGA-G3-A3CI-01 TCGA-G3-A3CI-01 TCGA-G3-A3CI TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver Mild 71 0.3 0.4 0.5 TCGA-G3-A3CI-F40231 TCGA-G3-A3CI TCGA-G3-A3CI-01A 0 0.3 A 0.6 1.4 0.9 -26224 258 0 180 1 0 10 2 0 - No Fibrosis 2013-2-14 MALE 167 Non-Alcoholic Fatty Liver Disease Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 370 0.9 1.1 NO YES G2 false No M0 N0 T1 Stage I TCGA-G3-A3CI.42613B77-F014-4AE9-AEF8-C5E632125EFA.pdf A3CI TUMOR FREE 186 150 400 1.3 NO R0 Primary Tumor 01 Segmentectomy, Multiple 7th NO YES G3 0.8 Liver None A LIVING 98 2011 TCGA-G3-A3CI-01A-11D-A20V-01 TCGA-G3-A3CI-01A-11D-A20V-01 TCGA-G3-A3CI-01A-11D-A20W-10 TCGA-G3-A3CI-01 TCGA-G3-A3CI-01 BC4F74DA-B45D-4D4B-AF29-E458B09200A6 b1ad5501-06e7-48c7-9fa9-f76527ae39f1 TCGA-G3-A3CI-01A-11D-A20W-10 TCGA-G3-A3CI-01 TCGA-G3-A3CI-01 b1ad5501-06e7-48c7-9fa9-f76527ae39f1 TCGA-G3-A3CI-01A-11D-A20W-10 b1ad5501-06e7-48c7-9fa9-f76527ae39f1 b1ad5501-06e7-48c7-9fa9-f76527ae39f1 TCGA-G3-A3CI-01A-11D-A20W-10 TCGA-G3-A3CI-01A-11D-A20Z-05 +TCGA-G3-A3CJ-01 TCGA-G3-A3CJ-01 TCGA-G3-A3CJ TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver YES NO Severe 52 0.3 0.4 0.5 TCGA-G3-A3CJ-F40234 TCGA-G3-A3CJ TCGA-G3-A3CJ-01A 0 1.0 A 0.5 1.4 0.8 -19305 113 0 594 296 0 0 10 3 5 - Nodular Formation and Incomplete Cirrhosis 2013-2-14 MALE 174 Hepatitis C Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 20 0.9 1.1 NO NO G2 Lung Extrahepatic Recurrence No NO YES No false No M0 N0 T2 Stage II TCGA-G3-A3CJ.191868C4-3299-4E65-9DB2-C8C43CB83963.pdf A3CJ WITH TUMOR 185 150 400 NO NO 1.0 NO NO R0 Primary Tumor 01 Lobectomy 7th NO YES G3 1.4 Liver Micro A LIVING 72 2011 TCGA-G3-A3CJ-01A-11D-A20V-01 TCGA-G3-A3CJ-01A-11D-A20V-01 TCGA-G3-A3CJ-01A-11D-A20W-10 TCGA-G3-A3CJ-01 TCGA-G3-A3CJ-01 699fc209-b99a-48f4-a8c5-ace6ca7e30a6 TCGA-G3-A3CJ-01A-11D-A20W-10 TCGA-G3-A3CJ-01 TCGA-G3-A3CJ-01 699fc209-b99a-48f4-a8c5-ace6ca7e30a6 TCGA-G3-A3CJ-01A-11D-A20W-10 699fc209-b99a-48f4-a8c5-ace6ca7e30a6 699fc209-b99a-48f4-a8c5-ace6ca7e30a6 TCGA-G3-A3CJ-01A-11D-A20W-10 TCGA-G3-A3CJ-01A-11D-A20Z-05 +TCGA-G3-A3CK-01 TCGA-G3-A3CK-01 TCGA-G3-A3CK TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver Mild 61 0.3 0.2 0.5 TCGA-G3-A3CK-F40227 TCGA-G3-A3CK TCGA-G3-A3CK-01A 0 0.8 1 A 0.6 1.4 1.1 -22462 132 0 585 0 0 10 3 6 - Established Cirrhosis 2013-2-14 MALE 170 Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 520 0.9 1.1 NO NO G2 NO true No M0 N0 T1 Stage I TCGA-G3-A3CK.ED5E5458-1E88-4126-B46B-96297F5A0FFF.pdf A3CK TUMOR FREE 143 150 400 NO NO 1.0 NO YES R0 Primary Tumor 01 Segmentectomy, Multiple 7th NO YES G3 1.4 Liver None A LIVING 67 2011 TCGA-G3-A3CK-01A-11D-A20V-01 TCGA-G3-A3CK-01A-11D-A20V-01 TCGA-G3-A3CK-01A-11D-A20W-10 TCGA-G3-A3CK-01 TCGA-G3-A3CK-01 5987458A-335D-4EC2-ABCC-48F89ED707B0 33da53e2-4fc2-4689-a651-1c596481af74 TCGA-G3-A3CK-01A-11D-A20W-10 TCGA-G3-A3CK-01 TCGA-G3-A3CK-01 33da53e2-4fc2-4689-a651-1c596481af74 TCGA-G3-A3CK-01A-11D-A20W-10 33da53e2-4fc2-4689-a651-1c596481af74 33da53e2-4fc2-4689-a651-1c596481af74 TCGA-G3-A3CK-01A-11D-A20W-10 TCGA-G3-A3CK-01A-11D-A20Z-05 +TCGA-G3-A5SI-01 TCGA-G3-A5SI-01 TCGA-G3-A5SI TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver Mild 44 3.3 2.8 4.8 TCGA-G3-A5SI-F59276 TCGA-G3-A5SI 0 0.7 A 0.6 1.4 0.4 -16126 768 0 447 1 0 10 9 6 - Established Cirrhosis 2014-5-7 MALE 177 Hepatitis C Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 0.9 1.1 NO G2 NO No M0 N0 T2 Stage II A5SI WITH TUMOR 145 150 400 NO NO 1.4 NO R0 Primary Tumor 01 Segmentectomy, Multiple 7th NO YES G3 1.4 Liver None DECEASED 74 2011 TCGA-G3-A5SI-01A-31D-A27H-01 TCGA-G3-A5SI-01A-31D-A27H-01 TCGA-G3-A5SI-01A-31D-A27I-10 TCGA-G3-A5SI-01 TCGA-G3-A5SI-01 ddb29159-cbe9-4b6d-a86f-8115b859b2bb TCGA-G3-A5SI-01A-31D-A27I-10 TCGA-G3-A5SI-01 TCGA-G3-A5SI-01 ddb29159-cbe9-4b6d-a86f-8115b859b2bb TCGA-G3-A5SI-01A-31D-A27I-10 ddb29159-cbe9-4b6d-a86f-8115b859b2bb ddb29159-cbe9-4b6d-a86f-8115b859b2bb TCGA-G3-A5SI-01A-31D-A27I-10 TCGA-G3-A5SI-01A-31D-A27W-05 +TCGA-G3-A5SJ-01 TCGA-G3-A5SJ-01 TCGA-G3-A5SJ TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver Mild 59 3.3 4.1 4.8 TCGA-G3-A5SJ-F62744 TCGA-G3-A5SJ TCGA-G3-A5SJ-01A 0 0.5 B 0.6 1.4 1.3 -21848 285 0 698 0 0 10 3 6 - Established Cirrhosis 2014-7-24 MALE 171 Alcohol consumption|Hepatitis C Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 290 0.9 1.1 NO NO G2 NO true No M0 NX T1 Stage I TCGA-G3-A5SJ.5237C744-2C11-4340-BC70-9AD10238F1E6.pdf A5SJ TUMOR FREE 136 150 400 NO NO 1 NO NO R0 Primary Tumor 01 Segmentectomy, Multiple 7th NO YES G3 1.4 Liver None A LIVING 87 2012 TCGA-G3-A5SJ-01A-11D-A27H-01 TCGA-G3-A5SJ-01A-11D-A27H-01 TCGA-G3-A5SJ-01A-11D-A27I-10 TCGA-G3-A5SJ-01 TCGA-G3-A5SJ-01 5AB22DCE-8485-42C1-A2E0-99B19FCD6E1A 9fc02f84-548e-42a4-8857-717cd8426575 TCGA-G3-A5SJ-01A-11D-A27I-10 TCGA-G3-A5SJ-01 TCGA-G3-A5SJ-01 9fc02f84-548e-42a4-8857-717cd8426575 TCGA-G3-A5SJ-01A-11D-A27I-10 9fc02f84-548e-42a4-8857-717cd8426575 9fc02f84-548e-42a4-8857-717cd8426575 TCGA-G3-A5SJ-01A-11D-A27I-10 TCGA-G3-A5SJ-01A-11D-A27W-05 +TCGA-G3-A5SK-01 TCGA-G3-A5SK-01 TCGA-G3-A5SK TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO Mild 58 3.3 3.3 4.8 TCGA-G3-A5SK-F62745 TCGA-G3-A5SK TCGA-G3-A5SK-01A A 0.6 1.4 0.6 -21320 251 0 744 483 0 6 - Established Cirrhosis 2014-7-24 MALE 169 Hepatitis C Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 650 0.9 1.1 NO NO G1 Liver Intrahepatic Recurrence Yes NO YES No true No M0 NX T1 Stage I TCGA-G3-A5SK.6FB76663-58FA-48DD-A0F8-136C975FE067.pdf A5SK WITH TUMOR 106 150 400 YES NO 1.1 NO R0 Primary Tumor 01 Segmentectomy, Single 7th NO YES G3 Liver A LIVING 67 2012 TCGA-G3-A5SK-01A-11D-A27I-10 TCGA-G3-A5SK-01 TCGA-G3-A5SK-01 3B1F0D3C-CBF1-4992-A25B-FFBC4480E5A0 602123eb-3790-4882-b8b1-f118838d3027 TCGA-G3-A5SK-01A-11D-A27I-10 TCGA-G3-A5SK-01 602123eb-3790-4882-b8b1-f118838d3027 TCGA-G3-A5SK-01A-11D-A27I-10 602123eb-3790-4882-b8b1-f118838d3027 602123eb-3790-4882-b8b1-f118838d3027 TCGA-G3-A5SK-01A-11D-A27I-10 TCGA-G3-A5SK-01A-11D-A27W-05 +TCGA-G3-A5SL-01 TCGA-G3-A5SL-01 TCGA-G3-A5SL TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver None 70 3.1 4.2 4.7 TCGA-G3-A5SL-F62747 TCGA-G3-A5SL TCGA-G3-A5SL-01A 0 0.8 0.6 1.4 1 -25671 236 0 621 0 0 10 4 0 - No Fibrosis 2014-7-24 MALE 180 Alcohol consumption Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 220 0.9 1.3 NO NO G2 NO true No M0 NX T2 Stage II TCGA-G3-A5SL.7DB1AFB2-69C9-4277-904E-4CF9CBAE8360.pdf A5SL TUMOR FREE 295 150 400 NO NO 1 NO NO R0 Primary Tumor 01 Other (specify) 7th YES NO G3 1.40 Liver Micro A LIVING 88 2012 TCGA-G3-A5SL-01A-11D-A27H-01 TCGA-G3-A5SL-01A-11D-A27H-01 TCGA-G3-A5SL-01A-11D-A27I-10 TCGA-G3-A5SL-01 TCGA-G3-A5SL-01 37EB6B47-7ECB-45C7-9519-307452A2FC72 0856a2e8-f139-4809-a7c6-29546080c333 TCGA-G3-A5SL-01A-11D-A27I-10 TCGA-G3-A5SL-01 TCGA-G3-A5SL-01 0856a2e8-f139-4809-a7c6-29546080c333 TCGA-G3-A5SL-01A-11D-A27I-10 0856a2e8-f139-4809-a7c6-29546080c333 0856a2e8-f139-4809-a7c6-29546080c333 TCGA-G3-A5SL-01A-11D-A27I-10 TCGA-G3-A5SL-01A-11D-A27W-05 +TCGA-G3-A5SM-01 TCGA-G3-A5SM-01 TCGA-G3-A5SM TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO 58 3.3 3.2 4.8 TCGA-G3-A5SM-F62748 TCGA-G3-A5SM TCGA-G3-A5SM-01A 0 0.6 A 0.5 1.4 0.5 -21236 111 0 520 252 1 0 10 12 6 - Established Cirrhosis 2014-7-24 MALE 184 Alcohol consumption|Hepatitis C Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 160 0.9 1.1 NO NO G3 Liver Intrahepatic Recurrence Yes NO YES No true No M0 NX T2 Stage II TCGA-G3-A5SM.791E29AD-22A6-402E-978C-69407C6B748F.pdf A5SM TUMOR FREE 260 150 400 YES NO 0.9 NO NO R0 Primary Tumor 01 Other (specify) 7th YES NO G3 1.4 Liver None A LIVING 106 2012 TCGA-G3-A5SM-01A-12D-A28W-01 TCGA-G3-A5SM-01A-12D-A28W-01 TCGA-G3-A5SM-01A-12D-A28X-10 TCGA-G3-A5SM-01 TCGA-G3-A5SM-01 506FD114-C312-4ADC-8DB8-3D004F3A72C1 cccf48e7-af9d-4039-9ed1-ae859f692678 TCGA-G3-A5SM-01A-12D-A28X-10 TCGA-G3-A5SM-01 TCGA-G3-A5SM-01 cccf48e7-af9d-4039-9ed1-ae859f692678 TCGA-G3-A5SM-01A-12D-A28X-10 cccf48e7-af9d-4039-9ed1-ae859f692678 cccf48e7-af9d-4039-9ed1-ae859f692678 TCGA-G3-A5SM-01A-12D-A28X-10 TCGA-G3-A5SM-01A-12D-A28Y-05 +TCGA-G3-A6UC-01 TCGA-G3-A6UC-01 TCGA-G3-A6UC TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO Mild 65 3.3 4.6 4.8 TCGA-G3-A6UC-F64551 TCGA-G3-A6UC TCGA-G3-A6UC-01A 0 1.0 A 0.6 1.4 0.9 -23793 266 0 671 639 0 0 10 4 6 - Established Cirrhosis 2014-9-4 MALE 182 Alcohol consumption Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 410 0.9 1.1 NO NO G2 Liver Intrahepatic Recurrence No NO YES No true Yes M0 N0 T3b Stage IIIB TCGA-G3-A6UC.08415C4C-C645-4911-BA53-6E562E562FD4.pdf A6UC WITH TUMOR 257 150 400 NO NO 1.1 NO R0 Primary Tumor 01 Segmentectomy, Single 7th YES NO G3 1.4 Liver Micro A Hepatitis C Antibody|Hepatitis B Surface Antigen|HBV Surface Antibody LIVING 91 2012 TCGA-G3-A6UC-01A-21D-A33B-01 TCGA-G3-A6UC-01A-21D-A33B-01 TCGA-G3-A6UC-01A-21D-A33K-10 TCGA-G3-A6UC-01 TCGA-G3-A6UC-01 914e6f58-48b5-40aa-9336-69166bd6970b TCGA-G3-A6UC-01A-21D-A33K-10 TCGA-G3-A6UC-01 TCGA-G3-A6UC-01 914e6f58-48b5-40aa-9336-69166bd6970b TCGA-G3-A6UC-01A-21D-A33K-10 914e6f58-48b5-40aa-9336-69166bd6970b 914e6f58-48b5-40aa-9336-69166bd6970b TCGA-G3-A6UC-01A-21D-A33K-10 TCGA-G3-A6UC-01A-21D-A33L-05 +TCGA-G3-A7M5-01 TCGA-G3-A7M5-01 TCGA-G3-A7M5 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver None 76 3.3 4.1 4.8 TCGA-G3-A7M5-F65810 TCGA-G3-A7M5 TCGA-G3-A7M5-01A 0 0.5 A 0.6 1.4 1.9 -27963 217 0 447 0 0 10 6 0 - No Fibrosis 2014-9-30 MALE 164 Alcohol consumption Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 720 0.9 1.1 NO NO G2 NO true No MX NX T1 Stage I TCGA-G3-A7M5.9441C376-F0CE-4A84-A9C0-5FB1917216F2.pdf A7M5 TUMOR FREE 181 150 400 NO NO 0.9 NO NO R0 Primary Tumor 01 Segmentectomy, Multiple 7th YES NO G3 1.4 Liver None A Hepatitis C Antibody|Hepatitis B Surface Antigen|HBV Surface Antibody LIVING 68 2013 TCGA-G3-A7M5-01A-11D-A33P-01 TCGA-G3-A7M5-01A-11D-A33P-01 TCGA-G3-A7M5-01A-11D-A33Q-10 TCGA-G3-A7M5-01 TCGA-G3-A7M5-01 1EB5B0C8-DBD5-4380-9721-A1FDA5225BFA a439fc68-c013-4f3a-9be7-2e3243938e12 TCGA-G3-A7M5-01A-11D-A33Q-10 TCGA-G3-A7M5-01 TCGA-G3-A7M5-01 a439fc68-c013-4f3a-9be7-2e3243938e12 TCGA-G3-A7M5-01A-11D-A33Q-10 a439fc68-c013-4f3a-9be7-2e3243938e12 a439fc68-c013-4f3a-9be7-2e3243938e12 TCGA-G3-A7M5-01A-11D-A33Q-10 TCGA-G3-A7M5-01A-11D-A341-05 +TCGA-G3-A7M6-01 TCGA-G3-A7M6-01 TCGA-G3-A7M6 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO Mild 60 3.3 3.6 4.8 TCGA-G3-A7M6-F67241 TCGA-G3-A7M6 TCGA-G3-A7M6-01A 0 0.5 A 0.4 1.1 0.6 -22205 212 0 632 584 0 0 10 24 1,2 - Portal Fibrosis 2014-11-3 FEMALE 158 Hepatitis C Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 680 0.9 1.1 NO NO G3 Liver Locoregional Recurrence No NO YES No true No MX NX T1 Stage I TCGA-G3-A7M6.BE9902BC-2818-4A37-AF40-768208EA15B9.pdf A7M6 WITH TUMOR 273 150 400 NO NO 0.9 NO R0 Primary Tumor 01 Segmentectomy, Single 7th YES NO G3 1.2 Liver None A LIVING 77 2013 TCGA-G3-A7M6-01A-11D-A33P-01 TCGA-G3-A7M6-01A-11D-A33P-01 TCGA-G3-A7M6-01A-11D-A33Q-10 TCGA-G3-A7M6-01 TCGA-G3-A7M6-01 F9487472-3D9B-4E48-AF59-20F5268794EC b23af964-65f4-4f37-a750-16a7d460fb38 TCGA-G3-A7M6-01A-11D-A33Q-10 TCGA-G3-A7M6-01 TCGA-G3-A7M6-01 b23af964-65f4-4f37-a750-16a7d460fb38 TCGA-G3-A7M6-01A-11D-A33Q-10 b23af964-65f4-4f37-a750-16a7d460fb38 b23af964-65f4-4f37-a750-16a7d460fb38 TCGA-G3-A7M6-01A-11D-A33Q-10 TCGA-G3-A7M6-01A-11D-A341-05 +TCGA-G3-A7M7-01 TCGA-G3-A7M7-01 TCGA-G3-A7M7 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver Severe 65 3.2 3.5 4.6 TCGA-G3-A7M7-F67243 TCGA-G3-A7M7 TCGA-G3-A7M7-01A 0 0.5 A 0.7 1.2 0.6 -24002 112 0 361 0 0 7 4 3,4 - Fibrous Speta 2014-11-3 MALE 181 Alcohol consumption Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 750 0.9 1.1 NO NO G1 NO true No MX NX T1 Stage I TCGA-G3-A7M7.9EC72408-F4C7-4D95-ACE3-3BF44E10FF8C.pdf A7M7 TUMOR FREE 145 150 450 NO NO 1.1 NO R0 Primary Tumor 01 Lobectomy 7th YES NO G3 1.2 Liver None A Hepatitis C Antibody|Hepatitis B Surface Antigen LIVING 77 2013 TCGA-G3-A7M7-01A-12D-A34Y-01 TCGA-G3-A7M7-01A-12D-A34Y-01 TCGA-G3-A7M7-01A-12D-A34Z-10 TCGA-G3-A7M7-01 TCGA-G3-A7M7-01 2495B0BD-2941-4F5F-9C7D-2CE9F4075927 0c31e1a3-2920-48f3-8609-f2e7ecd5ec51 TCGA-G3-A7M7-01A-12D-A34Z-10 TCGA-G3-A7M7-01 TCGA-G3-A7M7-01 0c31e1a3-2920-48f3-8609-f2e7ecd5ec51 TCGA-G3-A7M7-01A-12D-A34Z-10 0c31e1a3-2920-48f3-8609-f2e7ecd5ec51 0c31e1a3-2920-48f3-8609-f2e7ecd5ec51 TCGA-G3-A7M7-01A-12D-A34Z-10 TCGA-G3-A7M7-01A-12D-A356-05 +TCGA-G3-A7M8-01 TCGA-G3-A7M8-01 TCGA-G3-A7M8 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 31 3.3 3.5 4.8 TCGA-G3-A7M8-F65814 TCGA-G3-A7M8 TCGA-G3-A7M8-01A 0 1.8 A 0.6 1.4 0.7 -11527 97 0 430 0 0 10 5 6 - Established Cirrhosis 2014-9-30 MALE Alcohol consumption Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 180 0.9 1.1 NO NO G1 NO true No MX NX T1 Stage I TCGA-G3-A7M8.77483096-0271-4EBD-BC39-2232A3DEFF69.pdf A7M8 TUMOR FREE 136 150 400 NO NO 1.1 NO RX Primary Tumor 01 Segmentectomy, Multiple 7th YES NO G3 1.2 Liver None A Hepatitis C Antibody|Hepatitis B Surface Antigen|HBV Surface Antibody LIVING 2013 TCGA-G3-A7M8-01A-11D-A33P-01 TCGA-G3-A7M8-01A-11D-A33P-01 TCGA-G3-A7M8-01A-11D-A33Q-10 TCGA-G3-A7M8-01 TCGA-G3-A7M8-01 E72366C0-4D1A-4197-B39D-BFA404F70675 26e8978a-77bb-459f-b727-51d3fc361670 TCGA-G3-A7M8-01A-11D-A33Q-10 TCGA-G3-A7M8-01 TCGA-G3-A7M8-01 26e8978a-77bb-459f-b727-51d3fc361670 TCGA-G3-A7M8-01A-11D-A33Q-10 26e8978a-77bb-459f-b727-51d3fc361670 26e8978a-77bb-459f-b727-51d3fc361670 TCGA-G3-A7M8-01A-11D-A33Q-10 TCGA-G3-A7M8-01A-11D-A341-05 +TCGA-G3-A7M9-01 TCGA-G3-A7M9-01 TCGA-G3-A7M9 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver None 70 3.3 3.3 4.8 TCGA-G3-A7M9-F65815 TCGA-G3-A7M9 TCGA-G3-A7M9-01A 0 0.4 A 0.6 1.4 1 -25588 86 56 0 0 0 10 22868 6 - Established Cirrhosis 2014-9-30 MALE 170 Hemochromatosis Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 1500 0.9 1.1 NO NO G2 NO true Yes MX NX T3b Stage IIIB TCGA-G3-A7M9.0759EEFA-E337-43A5-A6B8-7FDB5FE579EB.pdf A7M9 187 150 400 NO NO 1.1 NO R0 Primary Tumor 01 Lobectomy 7th YES NO G3 1.4 Liver Macro A Hepatitis C Antibody|Hepatitis B Surface Antigen|HBV Surface Antibody DECEASED 73 2013 TCGA-G3-A7M9-01A-23D-A34Y-01 TCGA-G3-A7M9-01A-23D-A34Y-01 TCGA-G3-A7M9-01A-23D-A34Z-10 TCGA-G3-A7M9-01 TCGA-G3-A7M9-01 E22249BF-0815-4034-B171-A69670314312 8bc6822e-7701-4719-a42a-3b7916cde80b TCGA-G3-A7M9-01A-23D-A34Z-10 TCGA-G3-A7M9-01 TCGA-G3-A7M9-01 8bc6822e-7701-4719-a42a-3b7916cde80b TCGA-G3-A7M9-01A-23D-A34Z-10 8bc6822e-7701-4719-a42a-3b7916cde80b 8bc6822e-7701-4719-a42a-3b7916cde80b TCGA-G3-A7M9-01A-23D-A34Z-10 TCGA-G3-A7M9-01A-23D-A356-05 +TCGA-G3-AAUZ-01 TCGA-G3-AAUZ-01 TCGA-G3-AAUZ TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver Severe 48 3.3 3.8 4.8 TCGA-G3-AAUZ-F67244 TCGA-G3-AAUZ 0 0.3 A 0.6 1.4 0.8 -17760 0 480 0 0 10 3 1,2 - Portal Fibrosis 2014-11-3 MALE 160 Hepatitis B|Non-Alcoholic Fatty Liver Disease Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 0.9 1.1 NO G2 NO No M0 N0 T1 Stage I AAUZ TUMOR FREE 214 150 400 NO NO 1 NO R0 Primary Tumor 01 Segmentectomy, Multiple 7th YES NO G3 1.4 Liver None Hepatitis C Antibody|Hepatitis B Surface Antigen|HBV Surface Antibody|HBV D LIVING 77 2013 TCGA-G3-AAUZ-01A-11D-A381-01 TCGA-G3-AAUZ-01A-11D-A381-01 TCGA-G3-AAUZ-01A-11D-A382-10 TCGA-G3-AAUZ-01 TCGA-G3-AAUZ-01 fe0ae39e-cbfd-416c-9485-036d0f77531f TCGA-G3-AAUZ-01 TCGA-G3-AAUZ-01 fe0ae39e-cbfd-416c-9485-036d0f77531f fe0ae39e-cbfd-416c-9485-036d0f77531f fe0ae39e-cbfd-416c-9485-036d0f77531f TCGA-G3-AAUZ-01A-11D-A383-05 +TCGA-G3-AAV0-01 TCGA-G3-AAV0-01 TCGA-G3-AAV0 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver None 58 3.3 4.2 4.8 TCGA-G3-AAV0-F67245 TCGA-G3-AAV0 0 0.6 A 0.6 1.4 0.9 -21249 0 476 0 0 10 4 0 - No Fibrosis 2014-11-3 MALE 158 Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 0.9 1.1 NO G2 NO No M0 N0 T1 Stage I AAV0 TUMOR FREE 193 150 400 NO NO 0.9 NO R0 Primary Tumor 01 Segmentectomy, Multiple 7th YES NO G3 1.4 Liver None Hepatitis C Antibody|Hepatitis B Surface Antigen|HBV Surface Antibody LIVING 58 2013 TCGA-G3-AAV0-01A-11D-A36W-01 TCGA-G3-AAV0-01A-11D-A36W-01 TCGA-G3-AAV0-01A-11D-A36X-10 TCGA-G3-AAV0-01 TCGA-G3-AAV0-01 cc064dfb-026a-45a9-bf02-f57f473f21a0 TCGA-G3-AAV0-01 TCGA-G3-AAV0-01 cc064dfb-026a-45a9-bf02-f57f473f21a0 cc064dfb-026a-45a9-bf02-f57f473f21a0 cc064dfb-026a-45a9-bf02-f57f473f21a0 TCGA-G3-AAV0-01A-11D-A36Y-05 +TCGA-G3-AAV1-01 TCGA-G3-AAV1-01 TCGA-G3-AAV1 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO Severe 51 3.3 3.2 4.8 TCGA-G3-AAV1-F65936 TCGA-G3-AAV1 0 0.7 B 0.6 1.4 0.7 -18973 359 0 49 1 0 10 8 6 - Established Cirrhosis 2014-10-1 MALE 181 Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 0.9 1.1 NO G3 Liver Locoregional Recurrence Yes NO YES No No M0 N0 T4 Stage IIIC AAV1 WITH TUMOR 115 150 400 NO NO 1.2 NO R0 Primary Tumor 01 Lobectomy 7th YES NO G3 1.4 Liver Micro Hepatitis C Antibody|Hepatitis B Surface Antigen|HBV Surface Antibody|HBV D DECEASED 99 2013 TCGA-G3-AAV1-01A-11D-A381-01 TCGA-G3-AAV1-01A-11D-A381-01 TCGA-G3-AAV1-01A-11D-A382-10 TCGA-G3-AAV1-01 TCGA-G3-AAV1-01 b7999182-43bb-4c38-a543-a0bc4dd5a3e3 TCGA-G3-AAV1-01 TCGA-G3-AAV1-01 b7999182-43bb-4c38-a543-a0bc4dd5a3e3 b7999182-43bb-4c38-a543-a0bc4dd5a3e3 b7999182-43bb-4c38-a543-a0bc4dd5a3e3 TCGA-G3-AAV1-01A-11D-A383-05 +TCGA-G3-AAV2-01 TCGA-G3-AAV2-01 TCGA-G3-AAV2 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 50 3.3 4.2 4.8 TCGA-G3-AAV2-F67246 TCGA-G3-AAV2 TCGA-G3-AAV2-01A 0 0.7 A 0.6 1.4 1 -18363 136 0 372 0 0 10 4 6 - Established Cirrhosis 2014-11-3 MALE Alcohol consumption|Hepatitis C Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 500 0.9 1.1 NO NO G1 NO true No M0 N0 T1 Stage I TCGA-G3-AAV2.A323CDD5-4022-486C-B77E-F0552FB9076B.pdf AAV2 TUMOR FREE 110 150 400 NO NO 1 NO R0 Primary Tumor 01 Lobectomy 7th YES NO G3 1.4 Liver None A Hepatitis C Antibody|Hepatitis C Virus R|Hepatitis B Surface Antigen|HBV Surface Antibody LIVING 2013 TCGA-G3-AAV2-01A-11D-A36W-01 TCGA-G3-AAV2-01A-11D-A36W-01 TCGA-G3-AAV2-01A-11D-A36X-10 TCGA-G3-AAV2-01 TCGA-G3-AAV2-01 5d587eff-228f-49e0-a132-da031a81ad0b TCGA-G3-AAV2-01 TCGA-G3-AAV2-01 5d587eff-228f-49e0-a132-da031a81ad0b 5d587eff-228f-49e0-a132-da031a81ad0b 5d587eff-228f-49e0-a132-da031a81ad0b TCGA-G3-AAV2-01A-11D-A36Y-05 +TCGA-G3-AAV3-01 TCGA-G3-AAV3-01 TCGA-G3-AAV3 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver Severe 58 3.4 4.4 4.8 TCGA-G3-AAV3-F67247 TCGA-G3-AAV3 TCGA-G3-AAV3-01A 0 0.6 1 A 0.5 0.9 0.6 -21449 98 0 412 1 0 7 5 6 - Established Cirrhosis 2014-11-3 FEMALE 168 Alcohol consumption|Hepatitis C|Non-Alcoholic Fatty Liver Disease Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 150 0.9 1.1 NO NO G2 NO true No M0 N0 T2 Stage II TCGA-G3-AAV3.275E9EDA-413F-40BE-943C-9521F8CC297A.pdf AAV3 TUMOR FREE 113 150 450 NO NO 1.1 NO YES R0 Primary Tumor 01 Segmentectomy, Single 7th YES NO G3 1.4 Liver None A LIVING 85 2013 TCGA-G3-AAV3-01A-11D-A36W-01 TCGA-G3-AAV3-01A-11D-A36W-01 TCGA-G3-AAV3-01A-11D-A36X-10 TCGA-G3-AAV3-01 TCGA-G3-AAV3-01 25225fb1-c5ff-4edf-9895-11a7aa21d390 TCGA-G3-AAV3-01 TCGA-G3-AAV3-01 25225fb1-c5ff-4edf-9895-11a7aa21d390 25225fb1-c5ff-4edf-9895-11a7aa21d390 25225fb1-c5ff-4edf-9895-11a7aa21d390 TCGA-G3-AAV3-01A-11D-A36Y-05 +TCGA-G3-AAV4-01 TCGA-G3-AAV4-01 TCGA-G3-AAV4 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 83 3.3 2.7 4.8 TCGA-G3-AAV4-F65940 TCGA-G3-AAV4 TCGA-G3-AAV4-01A 0 0.8 2 A 0.4 1.1 1.1 -30466 423 27 0 0 0 10 4 3,4 - Fibrous Speta 2014-10-1 FEMALE 156 Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 470 0.9 1.1 NO NO G1 NO true No M0 N0 T1 Stage I TCGA-G3-AAV4.85CCE331-652C-4D5B-9ED6-ECA8B57AE1AF.pdf AAV4 TUMOR FREE 79 150 400 NO NO 1.2 NO YES R0 Primary Tumor 01 Segmentectomy, Multiple 7th YES NO G3 1.2 Liver None A DECEASED 56 2012 TCGA-G3-AAV4-01A-11D-A381-01 TCGA-G3-AAV4-01A-11D-A381-01 TCGA-G3-AAV4-01A-11D-A382-10 TCGA-G3-AAV4-01 TCGA-G3-AAV4-01 30325cae-b955-45a1-9803-84a42c37d130 TCGA-G3-AAV4-01 TCGA-G3-AAV4-01 30325cae-b955-45a1-9803-84a42c37d130 30325cae-b955-45a1-9803-84a42c37d130 30325cae-b955-45a1-9803-84a42c37d130 TCGA-G3-AAV4-01A-11D-A383-05 +TCGA-G3-AAV5-01 TCGA-G3-AAV5-01 TCGA-G3-AAV5 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver YES NO 67 3.3 4.2 4.8 TCGA-G3-AAV5-F65955 TCGA-G3-AAV5 0 0.4 A 0.6 1.4 0.8 -24655 0 354 117 1 6 - Established Cirrhosis 2014-10-1 MALE 165 Alcohol consumption Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 0.9 1.1 NO G2 Liver Locoregional Recurrence Yes NO YES No No M0 N0 T2 Stage II AAV5 WITH TUMOR 326 150 400 YES YES 1 [Discrepancy] R0 Primary Tumor 01 Lobectomy 7th YES NO G3 1.4 Liver Macro Hepatitis C Antibody|Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody LIVING 88 2013 TCGA-G3-AAV5-01A-11D-A36W-01 TCGA-G3-AAV5-01A-11D-A36W-01 TCGA-G3-AAV5-01A-11D-A36X-10 TCGA-G3-AAV5-01 TCGA-G3-AAV5-01 e155a2ba-8842-417b-ab5a-e49339136236 TCGA-G3-AAV5-01 TCGA-G3-AAV5-01 e155a2ba-8842-417b-ab5a-e49339136236 e155a2ba-8842-417b-ab5a-e49339136236 e155a2ba-8842-417b-ab5a-e49339136236 TCGA-G3-AAV5-01A-11D-A36Y-05 +TCGA-G3-AAV6-01 TCGA-G3-AAV6-01 TCGA-G3-AAV6 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO Severe 53 3.4 3.9 5.2 TCGA-G3-AAV6-F65959 TCGA-G3-AAV6 0 1.6 A 0.6 1.4 0.9 -19556 65 0 44 0 0 10 57875 0 - No Fibrosis 2014-10-1 FEMALE 165 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 0.8 1.2 NO G3 Liver Intrahepatic Recurrence No NO YES No No M0 N0 T3a Stage IIIA AAV6 WITH TUMOR 303 150 400 NO NO 1 NO R0 Primary Tumor 01 Extended Lobectomy 7th YES NO G3 1.2 Liver Micro Hepatitis B Surface Antigen DECEASED 78 2013 TCGA-G3-AAV6-01A-21D-A36W-01 TCGA-G3-AAV6-01A-21D-A36W-01 TCGA-G3-AAV6-01A-21D-A36X-10 TCGA-G3-AAV6-01 TCGA-G3-AAV6-01 ebb77266-2b85-4413-b433-4c8db194467a TCGA-G3-AAV6-01 TCGA-G3-AAV6-01 ebb77266-2b85-4413-b433-4c8db194467a ebb77266-2b85-4413-b433-4c8db194467a ebb77266-2b85-4413-b433-4c8db194467a TCGA-G3-AAV6-01A-21D-A36Y-05 +TCGA-G3-AAV7-01 TCGA-G3-AAV7-01 TCGA-G3-AAV7 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver Mild 38 3.3 4 4.8 TCGA-G3-AAV7-F67249 TCGA-G3-AAV7 TCGA-G3-AAV7-01A 0 0.9 A 0.6 1.4 1.1 -14229 52 0 361 0 0 10 3 5 - Nodular Formation and Incomplete Cirrhosis 2014-11-3 MALE 165 Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 120 0.9 1.1 NO NO G2 NO true No M0 N0 T2 Stage II TCGA-G3-AAV7.0F368084-04F6-4DCE-9ADF-6B3B94D274AB.pdf AAV7 TUMOR FREE 179 150 400 NO NO 1 NO R0 Primary Tumor 01 Segmentectomy, Multiple 7th YES NO G3 1.4 Liver Micro A Hepatitis B Surface Antigen|HBV Surface Antibody|HBV D LIVING 58 2013 TCGA-G3-AAV7-01A-11D-A381-01 TCGA-G3-AAV7-01A-11D-A381-01 TCGA-G3-AAV7-01A-11D-A382-10 TCGA-G3-AAV7-01 TCGA-G3-AAV7-01 33a8bccc-6989-4882-828b-1d8c0b5aa91a TCGA-G3-AAV7-01 TCGA-G3-AAV7-01 33a8bccc-6989-4882-828b-1d8c0b5aa91a 33a8bccc-6989-4882-828b-1d8c0b5aa91a 33a8bccc-6989-4882-828b-1d8c0b5aa91a TCGA-G3-AAV7-01A-11D-A383-05 +TCGA-GJ-A3OU-01 TCGA-GJ-A3OU-01 TCGA-GJ-A3OU TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 59 3.5 3.2 5.0 TCGA-GJ-A3OU-F70294 TCGA-GJ-A3OU TCGA-GJ-A3OU-01A 0.0 0.9 1 0.6 1.4 0.6 -21671 69 0 879 879 0 25 8 2015-3-27 MALE 167 Alcohol consumption|Non-Alcoholic Fatty Liver Disease|Other hepatic cirrhosis Hepatocellular Carcinoma No C22.0 8174/3 C22.0 YES 130 0.8 1.2 NO NO G2 Liver Intrahepatic Recurrence NO YES No false No MX NX T1 Stage I TCGA-GJ-A3OU.4ABC92BD-6D5C-462D-8DDC-2A3CEE065C13.pdf A3OU [Discrepancy] 178 150 450 NO NO 1.1 NO YES RX Primary Tumor 01 Segmentectomy, Single 7th YES NO GJ 1.0 Liver None A Hepatitis C Antibody LIVING 172 2011 TCGA-GJ-A3OU-01A-31D-A381-01 TCGA-GJ-A3OU-01A-31D-A381-01 TCGA-GJ-A3OU-01A-31D-A382-10 TCGA-GJ-A3OU-01 TCGA-GJ-A3OU-01 5eeb70ae-b09e-4b6d-80f1-23ed3e20b33c TCGA-GJ-A3OU-01 TCGA-GJ-A3OU-01 5eeb70ae-b09e-4b6d-80f1-23ed3e20b33c 5eeb70ae-b09e-4b6d-80f1-23ed3e20b33c 5eeb70ae-b09e-4b6d-80f1-23ed3e20b33c TCGA-GJ-A3OU-01A-31D-A383-05 +TCGA-GJ-A6C0-01 TCGA-GJ-A6C0-01 TCGA-GJ-A6C0 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 75 TCGA-GJ-A6C0 TCGA-GJ-A6C0-01A 1 -27626 310 31 0 2013-11-27 FEMALE 160 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 170 NO G2 NO false No MX NX T2 Stage II TCGA-GJ-A6C0.D9F106D7-C163-46C5-8DDC-FF60ED1CF17B.pdf A6C0 NO NO NO YES RX Primary Tumor 01 Other (specify) 7th YES NO GJ Liver Micro A DECEASED 90 2012 TCGA-GJ-A6C0-01A-12D-A30U-01 TCGA-GJ-A6C0-01A-12D-A30U-01 TCGA-GJ-A6C0-01A-12D-A30V-10 TCGA-GJ-A6C0-01 TCGA-GJ-A6C0-01 FB0BE047-479A-4F5D-80F6-4654E627B05F 896ab3e0-3ea4-4459-b0bf-9ccd6b74578c TCGA-GJ-A6C0-01A-12D-A30V-10 TCGA-GJ-A6C0-01 TCGA-GJ-A6C0-01 896ab3e0-3ea4-4459-b0bf-9ccd6b74578c TCGA-GJ-A6C0-01A-12D-A30V-10 896ab3e0-3ea4-4459-b0bf-9ccd6b74578c 896ab3e0-3ea4-4459-b0bf-9ccd6b74578c TCGA-GJ-A6C0-01A-12D-A30V-10 TCGA-GJ-A6C0-01A-12D-A30Y-05 +TCGA-GJ-A9DB-01 TCGA-GJ-A9DB-01 TCGA-GJ-A9DB TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 68 3.5 4.5 5 TCGA-GJ-A9DB TCGA-GJ-A9DB-01A 0.0 0.5 1 0.8 1.4 1.1 -25020 132 67 0 2014-5-7 MALE 187 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 540 0.7 1.2 NO G2 NO false No MX N0 T1 Stage I TCGA-GJ-A9DB.8B2D3FA5-D673-4B70-B153-7EACE17A50E0.pdf A9DB 144 150 450 NO NO 0.9 NO YES R0 Primary Tumor 01 Other (specify) 7th YES NO GJ 1.0 Liver None A DECEASED 96 2013 TCGA-GJ-A9DB-01A-11D-A36W-01 TCGA-GJ-A9DB-01A-11D-A36W-01 TCGA-GJ-A9DB-01A-11D-A36X-10 TCGA-GJ-A9DB-01 TCGA-GJ-A9DB-01 6C5CDCF6-58BB-4CD3-BFA5-1F07E29A8E1C 60f5dada-7b3d-49b8-8a96-f2143e1d4c71 TCGA-GJ-A9DB-01 TCGA-GJ-A9DB-01 60f5dada-7b3d-49b8-8a96-f2143e1d4c71 60f5dada-7b3d-49b8-8a96-f2143e1d4c71 60f5dada-7b3d-49b8-8a96-f2143e1d4c71 TCGA-GJ-A9DB-01A-11D-A36Y-05 +TCGA-HP-A5MZ-01 TCGA-HP-A5MZ-01 TCGA-HP-A5MZ TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 78 TCGA-HP-A5MZ-F64772 TCGA-HP-A5MZ TCGA-HP-A5MZ-01A 62 120 124 -22702 91 0 2014-9-11 MALE 185 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 160 0.9 1.1 NO NO G2 NO false No M0 NX T1 Stage I TCGA-HP-A5MZ.BD5F2C9B-16EE-42B2-B09B-F9BE4FCB2F75.pdf A5MZ TUMOR FREE 231 150 400 NO NO 1.0 NO R0 Primary Tumor 01 Lobectomy 6th NO YES HP Liver None A Hepatitis C Antibody|Hepatitis B Surface Antigen|HBV Surface Antibody DECEASED 82 TCGA-HP-A5MZ-01A-21D-A27H-01 TCGA-HP-A5MZ-01A-21D-A27H-01 TCGA-HP-A5MZ-01A-21D-A27I-10 TCGA-HP-A5MZ-01 TCGA-HP-A5MZ-01 EE037571-4D80-4766-81A9-7E1214F43496 c3d40f5f-e3df-4bf7-867d-7d17fa8fc3ad TCGA-HP-A5MZ-01A-21D-A27I-10 TCGA-HP-A5MZ-01 TCGA-HP-A5MZ-01 c3d40f5f-e3df-4bf7-867d-7d17fa8fc3ad TCGA-HP-A5MZ-01A-21D-A27I-10 c3d40f5f-e3df-4bf7-867d-7d17fa8fc3ad c3d40f5f-e3df-4bf7-867d-7d17fa8fc3ad TCGA-HP-A5MZ-01A-21D-A27I-10 TCGA-HP-A5MZ-01A-21D-A27W-05 +TCGA-HP-A5N0-01 TCGA-HP-A5N0-01 TCGA-HP-A5N0 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO None 90 3.5 2.6 4.8 TCGA-HP-A5N0-F70727 TCGA-HP-A5N0 TCGA-HP-A5N0-01A 3 0 0.9 0.5 -32120 1147 0 179 0 0 - No Fibrosis 2015-3-2 FEMALE 156 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8174/3 C22.0 YES 350 0.9 1.2 NO NO Liver Locoregional Recurrence No NO YES No false No M0 NX TX TCGA-HP-A5N0.0221A6F3-34F5-407E-8548-B62F27F66FCE.pdf A5N0 WITH TUMOR NO NO 1.2 NO YES R0 Primary Tumor 01 Lobectomy 6th NO YES HP Liver A DECEASED 65 TCGA-HP-A5N0-01A-11D-A28W-01 TCGA-HP-A5N0-01A-11D-A28W-01 TCGA-HP-A5N0-01A-11D-A28X-10 TCGA-HP-A5N0-01 TCGA-HP-A5N0-01 3630E5F3-9CEF-49D8-BFE5-2B3EDC4E200D 10285abf-91af-443f-8e5e-61b87c003165 TCGA-HP-A5N0-01A-11D-A28X-10 TCGA-HP-A5N0-01 TCGA-HP-A5N0-01 10285abf-91af-443f-8e5e-61b87c003165 TCGA-HP-A5N0-01A-11D-A28X-10 10285abf-91af-443f-8e5e-61b87c003165 10285abf-91af-443f-8e5e-61b87c003165 TCGA-HP-A5N0-01A-11D-A28X-10 TCGA-HP-A5N0-01A-11D-A28Y-05 +TCGA-K7-A5RF-01 TCGA-K7-A5RF-01 TCGA-K7-A5RF TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 64 TCGA-K7-A5RF-F64037 TCGA-K7-A5RF TCGA-K7-A5RF-01A -23557 102 0 631 5 2014-8-25 MALE 177 Hepatitis C Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 1350 NO NO G1 NO true No MX NX T1 Stage I TCGA-K7-A5RF.04C26B7B-66EE-4F20-A059-52E19557C268.pdf A5RF TUMOR FREE YES NO NO NO R0 Primary Tumor 01 Segmentectomy, Single 7th YES NO K7 Liver A Hepatitis C Virus R LIVING 75 2012 TCGA-K7-A5RF-01A-11D-A28W-01 TCGA-K7-A5RF-01A-11D-A28W-01 TCGA-K7-A5RF-01A-11D-A28X-10 TCGA-K7-A5RF-01 TCGA-K7-A5RF-01 6DBDC9AF-E565-46A3-BA78-14CE7C982DBF af1ae913-a82c-4d3f-9705-b45685a434ab TCGA-K7-A5RF-01A-11D-A28X-10 TCGA-K7-A5RF-01 TCGA-K7-A5RF-01 af1ae913-a82c-4d3f-9705-b45685a434ab TCGA-K7-A5RF-01A-11D-A28X-10 af1ae913-a82c-4d3f-9705-b45685a434ab af1ae913-a82c-4d3f-9705-b45685a434ab TCGA-K7-A5RF-01A-11D-A28X-10 TCGA-K7-A5RF-01A-11D-A28Y-05 +TCGA-K7-A5RG-01 TCGA-K7-A5RG-01 TCGA-K7-A5RG TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 66 TCGA-K7-A5RG-F64039 TCGA-K7-A5RG TCGA-K7-A5RG-01A 1 -24218 100 0 519 19 2014-8-25 MALE 173 Alcohol consumption|Hepatitis C Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 630 NO NO G1 NO true No MX NX T1 Stage I TCGA-K7-A5RG.AADEAE33-3867-4F77-AAA6-072471B5A397.pdf A5RG TUMOR FREE NO NO NO YES R0 Primary Tumor 01 Segmentectomy, Single 7th YES NO K7 Liver None A HCV Genotype LIVING 123 2012 TCGA-K7-A5RG-01A-11D-A28W-01 TCGA-K7-A5RG-01A-11D-A28W-01 TCGA-K7-A5RG-01A-11D-A28X-10 TCGA-K7-A5RG-01 TCGA-K7-A5RG-01 5046E74A-24C1-4365-A29E-1E5D89869E92 a8a41ad6-263c-4c76-987f-2f8a7dffefa1 TCGA-K7-A5RG-01A-11D-A28X-10 TCGA-K7-A5RG-01 TCGA-K7-A5RG-01 a8a41ad6-263c-4c76-987f-2f8a7dffefa1 TCGA-K7-A5RG-01A-11D-A28X-10 a8a41ad6-263c-4c76-987f-2f8a7dffefa1 a8a41ad6-263c-4c76-987f-2f8a7dffefa1 TCGA-K7-A5RG-01A-11D-A28X-10 TCGA-K7-A5RG-01A-11D-A28Y-05 +TCGA-K7-A6G5-01 TCGA-K7-A6G5-01 TCGA-K7-A6G5 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 66 TCGA-K7-A6G5-F64040 TCGA-K7-A6G5 TCGA-K7-A6G5-01A -24233 31 0 512 0 2014-8-25 MALE 184 Alcohol consumption|Hepatitis B|Hepatitis C|Hemochromatosis Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 60 NO NO G2 NO true No MX N0 T1 Stage I TCGA-K7-A6G5.BA14915C-0D72-4A11-AAFA-DD51FC6309B2.pdf A6G5 TUMOR FREE NO NO NO RX Primary Tumor 01 Lobectomy 7th YES NO K7 Liver None A HCV Genotype LIVING 80 2013 TCGA-K7-A6G5-01A-11D-A30U-01 TCGA-K7-A6G5-01A-11D-A30U-01 TCGA-K7-A6G5-01A-11D-A30V-10 TCGA-K7-A6G5-01 TCGA-K7-A6G5-01 42e83563-54b2-4848-b657-6367e71eac65 TCGA-K7-A6G5-01A-11D-A30V-10 TCGA-K7-A6G5-01 TCGA-K7-A6G5-01 42e83563-54b2-4848-b657-6367e71eac65 TCGA-K7-A6G5-01A-11D-A30V-10 42e83563-54b2-4848-b657-6367e71eac65 42e83563-54b2-4848-b657-6367e71eac65 TCGA-K7-A6G5-01A-11D-A30V-10 TCGA-K7-A6G5-01A-11D-A30Y-05 +TCGA-K7-AAU7-01 TCGA-K7-AAU7-01 TCGA-K7-AAU7 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 61 TCGA-K7-AAU7-F70895 TCGA-K7-AAU7 2 A -22476 0 359 58 0 0 10 290 2015-3-10 MALE Hepatitis C|Hemochromatosis Hepatocholangiocarcinoma (Mixed) No C22.0 8180/3 C22.0 YES 0 1.9 NO G2 Liver Intrahepatic Recurrence YES No MX NX T2a Stage II AAU7 WITH TUMOR 87 150 450 NO YES 0.9 NO YES RX Primary Tumor 01 Segmentectomy, Multiple 7th YES NO K7 Liver Micro LIVING 2013 TCGA-K7-AAU7-01A-11D-A381-01 TCGA-K7-AAU7-01A-11D-A381-01 TCGA-K7-AAU7-01A-11D-A382-10 TCGA-K7-AAU7-01 TCGA-K7-AAU7-01 e9f1e235-52ff-45fd-84ad-52135124cec9 TCGA-K7-AAU7-01 TCGA-K7-AAU7-01 e9f1e235-52ff-45fd-84ad-52135124cec9 e9f1e235-52ff-45fd-84ad-52135124cec9 e9f1e235-52ff-45fd-84ad-52135124cec9 TCGA-K7-AAU7-01A-11D-A383-05 +TCGA-KR-A7K0-01 TCGA-KR-A7K0-01 TCGA-KR-A7K0 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 65 3.5 2.8 4.9 TCGA-KR-A7K0 0.2 1.3 0.7 1.3 0.7 -23974 65 0 0 8 11 2014-5-28 MALE 174 Alcohol consumption|Hepatitis C Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES G1 NO Yes M0 N0 T1 Stage I A7K0 TUMOR FREE 102 150 400 NO NO 1.4 NO NO R0 Primary Tumor 01 Segmentectomy, Multiple 7th NO YES KR 1.2 Liver None Hepatitis C Antibody DECEASED 66 2013 TCGA-KR-A7K0-01A-12D-A33P-01 TCGA-KR-A7K0-01A-12D-A33P-01 TCGA-KR-A7K0-01A-12D-A33Q-10 TCGA-KR-A7K0-01 TCGA-KR-A7K0-01 e926e7f1-c849-47b4-b466-b1c2d187fdd2 TCGA-KR-A7K0-01A-12D-A33Q-10 TCGA-KR-A7K0-01 TCGA-KR-A7K0-01 e926e7f1-c849-47b4-b466-b1c2d187fdd2 TCGA-KR-A7K0-01A-12D-A33Q-10 e926e7f1-c849-47b4-b466-b1c2d187fdd2 e926e7f1-c849-47b4-b466-b1c2d187fdd2 TCGA-KR-A7K0-01A-12D-A33Q-10 TCGA-KR-A7K0-01A-12D-A341-05 +TCGA-KR-A7K2-01 TCGA-KR-A7K2-01 TCGA-KR-A7K2 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 64 3.5 3.3 4.9 TCGA-KR-A7K2-F72748 TCGA-KR-A7K2 TCGA-KR-A7K2-01A 0.2 1.5 0.7 1.3 1.1 -23699 85 0 829 0 8 14 2015-11-24 MALE 166 Hepatitis C Hepatocholangiocarcinoma (Mixed) No C22.0 8180/3 C22.0 YES 70 NO NO G1 NO false No M0 N0 T1 Stage I TCGA-KR-A7K2.5121C5D6-3BCB-4A0F-B18A-51BA4E87778B.pdf A7K2 TUMOR FREE 178 150 400 NO NO 1 NO R0 Primary Tumor 01 Other (specify) 7th NO YES KR 1.2 Liver None A HCV Genotype LIVING 79 2013 TCGA-KR-A7K2-01A-12D-A33P-01 TCGA-KR-A7K2-01A-12D-A33P-01 TCGA-KR-A7K2-01A-12D-A33Q-10 TCGA-KR-A7K2-01 TCGA-KR-A7K2-01 2242b367-081f-4369-9761-bcd225c05124 TCGA-KR-A7K2-01A-12D-A33Q-10 TCGA-KR-A7K2-01 TCGA-KR-A7K2-01 2242b367-081f-4369-9761-bcd225c05124 TCGA-KR-A7K2-01A-12D-A33Q-10 2242b367-081f-4369-9761-bcd225c05124 2242b367-081f-4369-9761-bcd225c05124 TCGA-KR-A7K2-01A-12D-A33Q-10 TCGA-KR-A7K2-01A-12D-A341-05 +TCGA-KR-A7K7-01 TCGA-KR-A7K7-01 TCGA-KR-A7K7 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver YES NO 61 3.5 3.4 4.9 TCGA-KR-A7K7-F71440 TCGA-KR-A7K7 TCGA-KR-A7K7-01A 0.2 1.4 0.5 1.0 0.8 -22587 461 0 951 239 0 8 308836 2015-3-25 FEMALE 168 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 140 NO NO G1 Other, specify Extrahepatic Recurrence Adrenal No NO YES No false Yes M0 N0 T2 Stage II TCGA-KR-A7K7.8CE97410-9210-4B15-97FE-E61722535975.pdf A7K7 WITH TUMOR 130 150 400 NO NO 1.0 NO R0 Primary Tumor 01 Segmentectomy, Single 7th NO YES KR 1.2 Liver Micro A LIVING 125 2012 TCGA-KR-A7K7-01A-11D-A33B-01 TCGA-KR-A7K7-01A-11D-A33B-01 TCGA-KR-A7K7-01A-11D-A33K-10 TCGA-KR-A7K7-01 TCGA-KR-A7K7-01 351556A0-38B2-41BD-8B08-8532588F0A8F c926906f-e63c-41e4-b117-87cf91206132 TCGA-KR-A7K7-01A-11D-A33K-10 TCGA-KR-A7K7-01 TCGA-KR-A7K7-01 c926906f-e63c-41e4-b117-87cf91206132 TCGA-KR-A7K7-01A-11D-A33K-10 c926906f-e63c-41e4-b117-87cf91206132 c926906f-e63c-41e4-b117-87cf91206132 TCGA-KR-A7K7-01A-11D-A33K-10 TCGA-KR-A7K7-01A-11D-A33L-05 +TCGA-KR-A7K8-01 TCGA-KR-A7K8-01 TCGA-KR-A7K8 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver None 57 3.5 3.3 4.9 TCGA-KR-A7K8-F71274 TCGA-KR-A7K8 TCGA-KR-A7K8-01A 0.2 1.9 1 0.7 1.3 1.1 -20914 435 0 906 0 8 154 2015-3-24 MALE 170 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 80 NO NO G1 NO false No M0 N0 T1 Stage I TCGA-KR-A7K8.9B449A83-1172-4EE0-9337-27BD5D3ECF4D.pdf A7K8 TUMOR FREE 103 150 400 NO NO 1.3 NO YES R0 Primary Tumor 01 Lobectomy 7th NO YES KR 1.2 Liver None A LIVING 109 2012 TCGA-KR-A7K8-01A-11D-A33B-01 TCGA-KR-A7K8-01A-11D-A33B-01 TCGA-KR-A7K8-01A-11D-A33K-10 TCGA-KR-A7K8-01 TCGA-KR-A7K8-01 1fbb2486-5c98-42af-a8b7-3c771a30702c TCGA-KR-A7K8-01A-11D-A33K-10 TCGA-KR-A7K8-01 TCGA-KR-A7K8-01 1fbb2486-5c98-42af-a8b7-3c771a30702c TCGA-KR-A7K8-01A-11D-A33K-10 1fbb2486-5c98-42af-a8b7-3c771a30702c 1fbb2486-5c98-42af-a8b7-3c771a30702c TCGA-KR-A7K8-01A-11D-A33K-10 TCGA-KR-A7K8-01A-11D-A33L-05 +TCGA-LG-A6GG-01 TCGA-LG-A6GG-01 TCGA-LG-A6GG TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver None 79 3.4 3.7 4.8 TCGA-LG-A6GG-F59890 TCGA-LG-A6GG TCGA-LG-A6GG-01A 0.2 0.8 A 0.4 1.1 0.6 -28871 35 0 387 0 2014-5-22 FEMALE 158 Other Cryptogenic Cirrhosis Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 1140 9.4 12.2 NO NO G2 NO true Yes M0 NX T2 Stage II TCGA-LG-A6GG.A7F1EA5C-5797-42D1-AD35-E2E529B26409.pdf A6GG TUMOR FREE 93 150 450 NO NO 12.2 NO R0 Primary Tumor 01 Segmentectomy, Single 7th YES NO LG 1.0 Liver Micro A LIVING 65 2013 TCGA-LG-A6GG-01A-11D-A30U-01 TCGA-LG-A6GG-01A-11D-A30U-01 TCGA-LG-A6GG-01A-11D-A30V-10 TCGA-LG-A6GG-01 TCGA-LG-A6GG-01 471985D8-4D5A-44A6-9659-B1B3F286BCA5 dc1a8da9-58bf-4394-a9f8-8e14da005ba7 TCGA-LG-A6GG-01A-11D-A30V-10 TCGA-LG-A6GG-01 TCGA-LG-A6GG-01 dc1a8da9-58bf-4394-a9f8-8e14da005ba7 TCGA-LG-A6GG-01A-11D-A30V-10 dc1a8da9-58bf-4394-a9f8-8e14da005ba7 dc1a8da9-58bf-4394-a9f8-8e14da005ba7 TCGA-LG-A6GG-01A-11D-A30V-10 TCGA-LG-A6GG-01A-11D-A30Y-05 +TCGA-LG-A9QC-01 TCGA-LG-A9QC-01 TCGA-LG-A9QC TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver Mild 48 3.5 4.7 5.0 TCGA-LG-A9QC-F69223 TCGA-LG-A9QC TCGA-LG-A9QC-01A 0.2 2.8 1 0.5 1.3 0.8 -17842 62 0 425 2014-12-30 MALE 188 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 1080 9.4 12.2 NO NO G2 NO true No M0 NX T1 Stage I TCGA-LG-A9QC.AD8045A1-61EA-4713-9C8D-9AF200DB1424.pdf A9QC TUMOR FREE 275 150 450 NO NO 12.1 NO YES R0 Primary Tumor 01 Segmentectomy, Single 7th YES NO LG 1.0 Liver Micro A LIVING 103 2013 TCGA-LG-A9QC-01A-11D-A36W-01 TCGA-LG-A9QC-01A-11D-A36W-01 TCGA-LG-A9QC-01A-11D-A36X-10 TCGA-LG-A9QC-01 TCGA-LG-A9QC-01 84c348d8-a1a8-4ffe-938d-3a6789004e7a TCGA-LG-A9QC-01 TCGA-LG-A9QC-01 84c348d8-a1a8-4ffe-938d-3a6789004e7a 84c348d8-a1a8-4ffe-938d-3a6789004e7a 84c348d8-a1a8-4ffe-938d-3a6789004e7a TCGA-LG-A9QC-01A-11D-A36Y-05 +TCGA-LG-A9QD-01 TCGA-LG-A9QD-01 TCGA-LG-A9QD TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver Mild 68 3.4 2.9 4.8 TCGA-LG-A9QD-F69200 TCGA-LG-A9QD TCGA-LG-A9QD-01A 0.0 0.5 3 0.7 1.5 0.9 -24969 28 0 366 2014-12-30 MALE 168 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 1580 NO NO G2 NO true No M0 N0 T3a Stage IIIA TCGA-LG-A9QD.D5BAD949-7001-4FAC-A7B4-E9B426A53A76.pdf A9QD WITH TUMOR 320 150 450 NO YES NO YES R0 Primary Tumor 01 Segmentectomy, Single 7th YES NO LG 1.2 Liver None A LIVING 74 2013 TCGA-LG-A9QD-01A-11D-A381-01 TCGA-LG-A9QD-01A-11D-A381-01 TCGA-LG-A9QD-01A-11D-A382-10 TCGA-LG-A9QD-01 TCGA-LG-A9QD-01 42f6b380-6c70-41ec-bac2-54fec52b4a49 TCGA-LG-A9QD-01 TCGA-LG-A9QD-01 42f6b380-6c70-41ec-bac2-54fec52b4a49 42f6b380-6c70-41ec-bac2-54fec52b4a49 42f6b380-6c70-41ec-bac2-54fec52b4a49 TCGA-LG-A9QD-01A-11D-A383-05 +TCGA-MI-A75C-01 TCGA-MI-A75C-01 TCGA-MI-A75C TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 64 3.5 4.0 4.9 TCGA-MI-A75C-F62894 TCGA-MI-A75C 0.2 1.1 A 0.6 1.3 1.0 -23441 0 291 1 0 9 4 2014-7-28 MALE 175 Hepatitis C Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES YES G3 NO No M0 N0 T1 Stage I A75C TUMOR FREE 243 150 450 NO NO NO R0 Primary Tumor 01 Segmentectomy, Single 7th NO YES MI 1.2 Liver None HBV Surface Antibody LIVING 84 2012 TCGA-MI-A75C-01A-11D-A32F-01 TCGA-MI-A75C-01A-11D-A32F-01 TCGA-MI-A75C-01A-11D-A32G-10 TCGA-MI-A75C-01 TCGA-MI-A75C-01 fe4a54d5-3270-4b53-a813-159b68764037 TCGA-MI-A75C-01A-11D-A32G-10 TCGA-MI-A75C-01 TCGA-MI-A75C-01 fe4a54d5-3270-4b53-a813-159b68764037 TCGA-MI-A75C-01A-11D-A32G-10 fe4a54d5-3270-4b53-a813-159b68764037 fe4a54d5-3270-4b53-a813-159b68764037 TCGA-MI-A75C-01A-11D-A32G-10 TCGA-MI-A75C-01A-11D-A32R-05 +TCGA-MI-A75E-01 TCGA-MI-A75E-01 TCGA-MI-A75E TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 61 3.5 3.0 4.9 TCGA-MI-A75E-F62895 TCGA-MI-A75E TCGA-MI-A75E-01A 0.2 1.1 1 A 0.6 1.3 -22457 157 0 507 1 0 9 5 1,2 - Portal Fibrosis 2014-7-28 MALE 175 Alcohol consumption|Hepatitis C Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 80 NO NO G2 NO true No M0 N0 T4 Stage IIIC TCGA-MI-A75E.F88435AB-695B-4481-BE6C-93FEE7954465.pdf A75E TUMOR FREE 158 150 450 NO NO NO YES R0 Primary Tumor 01 Segmentectomy, Single 7th NO YES MI 1.2 Liver Micro A HCV Genotype LIVING 103 2013 TCGA-MI-A75E-01A-11D-A32F-01 TCGA-MI-A75E-01A-11D-A32F-01 TCGA-MI-A75E-01A-11D-A32G-10 TCGA-MI-A75E-01 TCGA-MI-A75E-01 1be67822-b74f-4321-b7b9-2d85032d3ce6 TCGA-MI-A75E-01A-11D-A32G-10 TCGA-MI-A75E-01 TCGA-MI-A75E-01 1be67822-b74f-4321-b7b9-2d85032d3ce6 TCGA-MI-A75E-01A-11D-A32G-10 1be67822-b74f-4321-b7b9-2d85032d3ce6 1be67822-b74f-4321-b7b9-2d85032d3ce6 TCGA-MI-A75E-01A-11D-A32G-10 TCGA-MI-A75E-01A-11D-A32R-05 +TCGA-MI-A75G-01 TCGA-MI-A75G-01 TCGA-MI-A75G TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 63 3.5 2.3 4.9 TCGA-MI-A75G-F58603 TCGA-MI-A75G TCGA-MI-A75G-01A 0.2 1.7 1 B 0.6 1.3 0.5 -23284 427 0 698 1 0 9 6 6 - Established Cirrhosis 2014-7-28 MALE 178 Alcohol consumption|Hepatitis C Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 80 NO YES G2 NO true No M0 N0 T2 Stage II TCGA-MI-A75G.30FAEBBF-0EEE-40F5-9463-50FDDE258D4B.pdf A75G TUMOR FREE 160 150 450 NO NO NO YES R0 Primary Tumor 01 Lobectomy 7th NO YES MI 1.2 Liver None A HCV Genotype LIVING 69 2012 TCGA-MI-A75G-01A-11D-A32F-01 TCGA-MI-A75G-01A-11D-A32F-01 TCGA-MI-A75G-01A-11D-A32G-10 TCGA-MI-A75G-01 TCGA-MI-A75G-01 5d93dde1-846e-4ba9-b27e-107a9570deed TCGA-MI-A75G-01A-11D-A32G-10 TCGA-MI-A75G-01 TCGA-MI-A75G-01 5d93dde1-846e-4ba9-b27e-107a9570deed TCGA-MI-A75G-01A-11D-A32G-10 5d93dde1-846e-4ba9-b27e-107a9570deed 5d93dde1-846e-4ba9-b27e-107a9570deed TCGA-MI-A75G-01A-11D-A32G-10 TCGA-MI-A75G-01A-11D-A32R-05 +TCGA-MI-A75H-01 TCGA-MI-A75H-01 TCGA-MI-A75H TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO 77 3.5 3.3 4.9 TCGA-MI-A75H-F68684 TCGA-MI-A75H TCGA-MI-A75H-01A 0.2 2.3 B 0.6 1.3 -28371 287 0 747 307 1 0 9 11 6 - Established Cirrhosis 2015-1-9 MALE 173 Hepatitis C Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 30 NO NO Liver Intrahepatic Recurrence Yes NO YES No true Yes MX NX TCGA-MI-A75H.57959509-A138-4131-BE87-9A77ED365702.pdf A75H WITH TUMOR 138 150 450 YES NO 1.1 NO R0 R0 Primary Tumor 01 Segmentectomy, Single 7th NO YES MI 1.2 Liver Micro A HCV Genotype LIVING 84 2012 TCGA-MI-A75H-01A-11D-A32F-01 TCGA-MI-A75H-01A-11D-A32F-01 TCGA-MI-A75H-01A-11D-A32G-10 TCGA-MI-A75H-01 TCGA-MI-A75H-01 5abe35ae-90bf-411e-b96f-b92c00718696 TCGA-MI-A75H-01A-11D-A32G-10 TCGA-MI-A75H-01 TCGA-MI-A75H-01 5abe35ae-90bf-411e-b96f-b92c00718696 TCGA-MI-A75H-01A-11D-A32G-10 5abe35ae-90bf-411e-b96f-b92c00718696 5abe35ae-90bf-411e-b96f-b92c00718696 TCGA-MI-A75H-01A-11D-A32G-10 TCGA-MI-A75H-01A-11D-A32R-05 +TCGA-MI-A75I-01 TCGA-MI-A75I-01 TCGA-MI-A75I TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 61 TCGA-MI-A75I-F62897 TCGA-MI-A75I TCGA-MI-A75I-01A 3 A -22341 665 0 630 265 1 2014-7-28 MALE 188 Hepatitis C Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 50 NO NO G1 Liver YES true No MX NX T2 TCGA-MI-A75I.4630A897-45DC-4122-BB86-A2943FE27CEA.pdf A75I 153 150 450 NO NO NO YES R0 Primary Tumor 01 Lobectomy 7th NO YES MI Liver A LIVING 100 2011 TCGA-MI-A75I-01A-11D-A32F-01 TCGA-MI-A75I-01A-11D-A32F-01 TCGA-MI-A75I-01A-11D-A32G-10 TCGA-MI-A75I-01 TCGA-MI-A75I-01 4b2926c2-e50c-43ed-93df-a85901fcf0a2 TCGA-MI-A75I-01A-11D-A32G-10 TCGA-MI-A75I-01 TCGA-MI-A75I-01 4b2926c2-e50c-43ed-93df-a85901fcf0a2 TCGA-MI-A75I-01A-11D-A32G-10 4b2926c2-e50c-43ed-93df-a85901fcf0a2 4b2926c2-e50c-43ed-93df-a85901fcf0a2 TCGA-MI-A75I-01A-11D-A32G-10 TCGA-MI-A75I-01A-11D-A32R-05 +TCGA-MR-A520-01 TCGA-MR-A520-01 TCGA-MR-A520 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 58 TCGA-MR-A520-F48052 TCGA-MR-A520 TCGA-MR-A520-01A -21398 106 0 229 2012-9-14 MALE 179 Other Moderate alcohol consumption, anti TB drug used for TB positive testing Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 270 NO NO G1 NO true No MX NX T1 Stage I TCGA-MR-A520.FA4ACC09-F22B-4253-8667-6C04369E5DCA.pdf A520 TUMOR FREE NO NO NO Primary Tumor 01 Lobectomy 7th YES NO MR Liver A Hepatitis C Antibody|Hepatitis B Surface Antigen|HBV Core Antibody LIVING 104 2012 TCGA-MR-A520-01A-11D-A25U-01 TCGA-MR-A520-01A-11D-A25U-01 TCGA-MR-A520-01A-11D-A25V-10 TCGA-MR-A520-01 TCGA-MR-A520-01 997F554C-50F9-482F-B08B-6AD76043FCA4 ee0b8b56-4246-45c7-800c-e8d37c8d6c4d TCGA-MR-A520-01A-11D-A25V-10 TCGA-MR-A520-01 TCGA-MR-A520-01 ee0b8b56-4246-45c7-800c-e8d37c8d6c4d TCGA-MR-A520-01A-11D-A25V-10 ee0b8b56-4246-45c7-800c-e8d37c8d6c4d ee0b8b56-4246-45c7-800c-e8d37c8d6c4d TCGA-MR-A520-01A-11D-A25V-10 TCGA-MR-A520-01A-11D-A264-05 +TCGA-MR-A8JO-01 TCGA-MR-A8JO-01 TCGA-MR-A8JO TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 34 3.9 4.1 5.1 TCGA-MR-A8JO-F58923 TCGA-MR-A8JO TCGA-MR-A8JO-01A 0.2 0.8 -12669 184 0 330 2 2014-4-28 MALE 196 Alcohol consumption Fibrolamellar Carcinoma No C22.0 8171/3 C22.0 YES 350 NO NO G3 NO true No MX N0 T1 Stage I TCGA-MR-A8JO.DA03F6F5-2579-45B7-954B-8C0F8EFD0F75.pdf A8JO TUMOR FREE 162 150 450 NO NO NO NO RX Primary Tumor 01 Lobectomy 7th YES NO MR 1.3 Liver None A Hepatitis C Antibody|Hepatitis B Surface Antigen|HBV Core Antibody LIVING 90 2013 TCGA-MR-A8JO-01A-12D-A35Y-01 TCGA-MR-A8JO-01A-12D-A35Y-01 TCGA-MR-A8JO-01A-12D-A35Z-10 TCGA-MR-A8JO-01 TCGA-MR-A8JO-01 B029C2F8-1F50-49BF-B2F1-84B6D973AE0E c43df6db-5556-449c-bbc6-a337873c588b TCGA-MR-A8JO-01 TCGA-MR-A8JO-01 c43df6db-5556-449c-bbc6-a337873c588b c43df6db-5556-449c-bbc6-a337873c588b c43df6db-5556-449c-bbc6-a337873c588b TCGA-MR-A8JO-01A-12D-A369-05 +TCGA-NI-A4U2-01 TCGA-NI-A4U2-01 TCGA-NI-A4U2 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver None 71 TCGA-NI-A4U2 TCGA-NI-A4U2-01A 3 0.8 -26011 2802 1791 0 0 5 1,2 - Portal Fibrosis 2013-6-28 MALE 171 Alcohol consumption Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 320 NO G1 YES false No MX NX T3 Stage IIIA TCGA-NI-A4U2.3AC56788-7CF9-4E6E-B1B8-7620A33E32A0.pdf A4U2 WITH TUMOR 299 NO NO 1.0 NO YES R0 Primary Tumor 01 Lobectomy 6th NO YES NI Liver None A DECEASED 82 2005 TCGA-NI-A4U2-01A-11D-A28W-01 TCGA-NI-A4U2-01A-11D-A28W-01 TCGA-NI-A4U2-01A-11D-A28X-10 TCGA-NI-A4U2-01 TCGA-NI-A4U2-01 5CFD632E-6487-4356-AF69-2AB9F0CDA1A9 16336ca0-8d66-4a19-8a1a-3778aac6f291 TCGA-NI-A4U2-01A-11D-A28X-10 TCGA-NI-A4U2-01 TCGA-NI-A4U2-01 16336ca0-8d66-4a19-8a1a-3778aac6f291 TCGA-NI-A4U2-01A-11D-A28X-10 16336ca0-8d66-4a19-8a1a-3778aac6f291 16336ca0-8d66-4a19-8a1a-3778aac6f291 TCGA-NI-A4U2-01A-11D-A28X-10 TCGA-NI-A4U2-01A-11D-A28Y-05 +TCGA-NI-A8LF-01 TCGA-NI-A8LF-01 TCGA-NI-A8LF TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver None 74 1.2 TCGA-NI-A8LF-F69826 TCGA-NI-A8LF TCGA-NI-A8LF-01A 0.6 1 15 -27162 422 0 799 1 2015-1-21 MALE 171 Alcohol consumption Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 240 NO NO G3 NO true No MX NX T1 Stage I TCGA-NI-A8LF.5B4751DF-719F-4F2B-8D27-D69E480F6881.pdf A8LF TUMOR FREE 132 NO NO NO YES R0 Primary Tumor 01 Other (specify) 7th NO YES NI Liver None A LIVING 104 2012 TCGA-NI-A8LF-01A-11D-A35Y-01 TCGA-NI-A8LF-01A-11D-A35Y-01 TCGA-NI-A8LF-01A-11D-A35Z-10 TCGA-NI-A8LF-01 TCGA-NI-A8LF-01 BFC51C69-BAF3-4872-A2F5-EDC4BC83FAF4 137c4106-77b9-4834-a060-6bf0af71ae08 TCGA-NI-A8LF-01 TCGA-NI-A8LF-01 137c4106-77b9-4834-a060-6bf0af71ae08 137c4106-77b9-4834-a060-6bf0af71ae08 137c4106-77b9-4834-a060-6bf0af71ae08 TCGA-NI-A8LF-01A-11D-A369-05 +TCGA-O8-A75V-01 TCGA-O8-A75V-01 TCGA-O8-A75V TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver Mild 54 2.9 3.8 4.4 TCGA-O8-A75V-F66431 TCGA-O8-A75V TCGA-O8-A75V-01A 0.3 1.9 1 A 0.50 1.50 1 -19850 142 0 538 0 7 7 6 - Established Cirrhosis 2014-10-16 MALE 180 Alcohol consumption|Hepatitis B|Hepatitis C Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 270 9.3 13.1 NO NO G2 NO true No MX NX T1 Stage I TCGA-O8-A75V.F3642560-1DE2-43D1-A8B5-06308AFF325E.pdf A75V TUMOR FREE 211 140 450 NO NO 9.1 NO YES R1 Primary Tumor 01 Other (specify) 7th YES NO O8 1.2 Liver None A LIVING 92 2013 TCGA-O8-A75V-01A-11D-A32F-01 TCGA-O8-A75V-01A-11D-A32F-01 TCGA-O8-A75V-01A-11D-A32G-10 TCGA-O8-A75V-01 TCGA-O8-A75V-01 AB81048A-7344-493B-85D3-CDAC61D6D6AB a76c84d3-7243-465b-bbfe-087dbfba4b24 TCGA-O8-A75V-01A-11D-A32G-10 TCGA-O8-A75V-01 TCGA-O8-A75V-01 a76c84d3-7243-465b-bbfe-087dbfba4b24 TCGA-O8-A75V-01A-11D-A32G-10 a76c84d3-7243-465b-bbfe-087dbfba4b24 a76c84d3-7243-465b-bbfe-087dbfba4b24 TCGA-O8-A75V-01A-11D-A32G-10 TCGA-O8-A75V-01A-11D-A32R-05 +TCGA-PD-A5DF-01 TCGA-PD-A5DF-01 TCGA-PD-A5DF TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 58 TCGA-PD-A5DF TCGA-PD-A5DF-01A -21414 1906 639 0 2013-4-30 FEMALE 167 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 140 NO G2 NO true No M0 N0 T4 Stage IIIB TCGA-PD-A5DF.8D63D119-DC81-45FE-9F02-8228A7160C55.pdf A5DF WITH TUMOR NO YES NO YES Primary Tumor 01 6th NO YES PD Liver A DECEASED 72 2007 TCGA-PD-A5DF-01A-11D-A27H-01 TCGA-PD-A5DF-01A-11D-A27H-01 TCGA-PD-A5DF-01A-11D-A27I-10 TCGA-PD-A5DF-01 TCGA-PD-A5DF-01 0137FBC4-317A-4E7E-9D21-66DDB73097A7 41d56421-a998-43b9-b319-18535315c820 TCGA-PD-A5DF-01A-11D-A27I-10 TCGA-PD-A5DF-01 TCGA-PD-A5DF-01 41d56421-a998-43b9-b319-18535315c820 TCGA-PD-A5DF-01A-11D-A27I-10 41d56421-a998-43b9-b319-18535315c820 41d56421-a998-43b9-b319-18535315c820 TCGA-PD-A5DF-01A-11D-A27I-10 TCGA-PD-A5DF-01A-11D-A27W-05 +TCGA-QA-A7B7-01 TCGA-QA-A7B7-01 TCGA-QA-A7B7 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO Mild 48 3.5 4.2 4.8 TCGA-QA-A7B7-F65031 TCGA-QA-A7B7 0.3 1.0 A 0.7 1.2 1 -17636 0 94 88 1 0 8 1751 0 - No Fibrosis 2014-10-30 MALE 180 Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 10.4 13.1 NO G2 Liver Locoregional Recurrence No NO YES No No MX NX T2 Stage II A7B7 WITH TUMOR 218 150 400 NO NO 11.5 NO NO RX Primary Tumor 01 Other (specify) 7th YES NO QA 1.2 Liver Micro LIVING 108 2013 TCGA-QA-A7B7-01A-11D-A32F-01 TCGA-QA-A7B7-01A-11D-A32F-01 TCGA-QA-A7B7-01A-11D-A32G-10 TCGA-QA-A7B7-01 TCGA-QA-A7B7-01 c30c0452-81d2-453d-91e2-2be1a07d02c7 TCGA-QA-A7B7-01A-11D-A32G-10 TCGA-QA-A7B7-01 TCGA-QA-A7B7-01 c30c0452-81d2-453d-91e2-2be1a07d02c7 TCGA-QA-A7B7-01A-11D-A32G-10 c30c0452-81d2-453d-91e2-2be1a07d02c7 c30c0452-81d2-453d-91e2-2be1a07d02c7 TCGA-QA-A7B7-01A-11D-A32G-10 TCGA-QA-A7B7-01A-11D-A32R-05 +TCGA-RC-A6M3-01 TCGA-RC-A6M3-01 TCGA-RC-A6M3 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 24 TCGA-RC-A6M3 -8899 0 0 2015-7-9 MALE 175 Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES G3 No M0 N0 T2 Stage II A6M3 NO NO R0 Primary Tumor 01 Lobectomy 6th NO YES RC Liver Micro LIVING 2009 TCGA-RC-A6M3-01A-11D-A32F-01 TCGA-RC-A6M3-01A-11D-A32F-01 TCGA-RC-A6M3-01A-11D-A32G-10 TCGA-RC-A6M3-01 TCGA-RC-A6M3-01 e4fcb1f0-4637-49c4-ba32-3d037ccc25f2 TCGA-RC-A6M3-01A-11D-A32G-10 TCGA-RC-A6M3-01 TCGA-RC-A6M3-01 e4fcb1f0-4637-49c4-ba32-3d037ccc25f2 TCGA-RC-A6M3-01A-11D-A32G-10 e4fcb1f0-4637-49c4-ba32-3d037ccc25f2 e4fcb1f0-4637-49c4-ba32-3d037ccc25f2 TCGA-RC-A6M3-01A-11D-A32G-10 TCGA-RC-A6M3-01A-11D-A32R-05 +TCGA-RC-A6M4-01 TCGA-RC-A6M4-01 TCGA-RC-A6M4 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 74 3.5 2.3 4.8 TCGA-RC-A6M4 0.2 0.6 2 A 0.8 1.3 0.9 -27327 0 22 1 0 44 5 2015-7-9 FEMALE No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES G2 No MX NX T3 Stage IIIA A6M4 NO YES R1 Primary Tumor 01 Segmentectomy, Multiple 7th NO YES RC 1.3 Liver None LIVING 87 2010 TCGA-RC-A6M4-01A-11D-A32F-01 TCGA-RC-A6M4-01A-11D-A32F-01 TCGA-RC-A6M4-01A-11D-A32G-10 TCGA-RC-A6M4-01 TCGA-RC-A6M4-01 e447c057-5e90-4fef-a916-6ab71092fcb5 TCGA-RC-A6M4-01A-11D-A32G-10 TCGA-RC-A6M4-01 TCGA-RC-A6M4-01 e447c057-5e90-4fef-a916-6ab71092fcb5 TCGA-RC-A6M4-01A-11D-A32G-10 e447c057-5e90-4fef-a916-6ab71092fcb5 e447c057-5e90-4fef-a916-6ab71092fcb5 TCGA-RC-A6M4-01A-11D-A32G-10 TCGA-RC-A6M4-01A-11D-A32R-05 +TCGA-RC-A6M5-01 TCGA-RC-A6M5-01 TCGA-RC-A6M5 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 20 3.5 3.9 4.8 TCGA-RC-A6M5 TCGA-RC-A6M5-01A 0.2 0.5 A 0.8 1.3 0.4 -7634 484 0 15 2015-7-9 FEMALE No History of Primary Risk Factors Fibrolamellar Carcinoma No C22.0 8171/3 C22.0 YES 50 0.9 1.2 NO G2 true No M0 N1 T1 Stage IVA TCGA-RC-A6M5.CFE4CEBF-2B23-4ABD-8F50-2B7C4A432AA6.pdf A6M5 317000 150000 400000 NO 1.2 NO R0 Primary Tumor 01 Lobectomy 7th NO YES RC 1.3 Liver None A LIVING 2012 TCGA-RC-A6M5-01A-11D-A32F-01 TCGA-RC-A6M5-01A-11D-A32F-01 TCGA-RC-A6M5-01A-11D-A32G-10 TCGA-RC-A6M5-01 TCGA-RC-A6M5-01 05246bfa-faf4-4d63-9890-88bb6f7a6546 TCGA-RC-A6M5-01A-11D-A32G-10 TCGA-RC-A6M5-01 TCGA-RC-A6M5-01 05246bfa-faf4-4d63-9890-88bb6f7a6546 TCGA-RC-A6M5-01A-11D-A32G-10 05246bfa-faf4-4d63-9890-88bb6f7a6546 05246bfa-faf4-4d63-9890-88bb6f7a6546 TCGA-RC-A6M5-01A-11D-A32G-10 TCGA-RC-A6M5-01A-11D-A32R-05 +TCGA-RC-A6M6-01 TCGA-RC-A6M6-01 TCGA-RC-A6M6 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 75 3.5 2.8 4.8 TCGA-RC-A6M6 TCGA-RC-A6M6-01A 0.2 2.3 B 0.8 1.3 0.8 -27649 748 0 9 0 44 12986 2015-7-9 MALE Alcohol consumption Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 110 0.9 1.2 NO G3 true No M0 NX T2 Stage II TCGA-RC-A6M6.210AAA2E-0B18-4C08-815D-BC523FF2A7D5.pdf A6M6 235000 150000 400000 NO 1.3 R1 Primary Tumor 01 Segmentectomy, Multiple 7th NO YES RC 1.3 Liver None A LIVING 2011 TCGA-RC-A6M6-01A-11D-A32F-01 TCGA-RC-A6M6-01A-11D-A32F-01 TCGA-RC-A6M6-01A-11D-A32G-10 TCGA-RC-A6M6-01 TCGA-RC-A6M6-01 2D8C0C39-04E8-4B11-9CFE-E0650D8C090A 8cb97760-f404-486a-9957-f90d1026bc08 TCGA-RC-A6M6-01A-11D-A32G-10 TCGA-RC-A6M6-01 TCGA-RC-A6M6-01 8cb97760-f404-486a-9957-f90d1026bc08 TCGA-RC-A6M6-01A-11D-A32G-10 8cb97760-f404-486a-9957-f90d1026bc08 8cb97760-f404-486a-9957-f90d1026bc08 TCGA-RC-A6M6-01A-11D-A32G-10 TCGA-RC-A6M6-01A-11D-A32R-05 +TCGA-RC-A7S9-01 TCGA-RC-A7S9-01 TCGA-RC-A7S9 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver Mild 47 3.1 4.3 5.2 TCGA-RC-A7S9 TCGA-RC-A7S9-01A 0.1 0.8 A 0.3 1.20 0.7 -17403 383 0 640 0 0 20 10 6 - Established Cirrhosis 2014-7-21 FEMALE 161 Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 20 0.8 1.30 NO G3 NO true No M0 N0 T1 Stage I TCGA-RC-A7S9.A537996A-E747-4906-B488-43181F3C7E17.pdf A7S9 TUMOR FREE 178000 150000 400000 NO NO 1.1 NO R0 Primary Tumor 01 Segmentectomy, Single 7th YES NO RC 1.3 Liver None A LIVING 58 2012 TCGA-RC-A7S9-01A-11D-A33P-01 TCGA-RC-A7S9-01A-11D-A33P-01 TCGA-RC-A7S9-01A-11D-A33Q-10 TCGA-RC-A7S9-01 TCGA-RC-A7S9-01 811d94b6-2802-44ff-915f-7344886d93bb TCGA-RC-A7S9-01A-11D-A33Q-10 TCGA-RC-A7S9-01 TCGA-RC-A7S9-01 811d94b6-2802-44ff-915f-7344886d93bb TCGA-RC-A7S9-01A-11D-A33Q-10 811d94b6-2802-44ff-915f-7344886d93bb 811d94b6-2802-44ff-915f-7344886d93bb TCGA-RC-A7S9-01A-11D-A33Q-10 TCGA-RC-A7S9-01A-11D-A341-05 +TCGA-RC-A7SB-01 TCGA-RC-A7SB-01 TCGA-RC-A7SB TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver None 53 3.1 4.8 5.2 TCGA-RC-A7SB 0.1 3.7 B 0.3 1.20 1.1 -19698 0 588 0 0 20 3 0 - No Fibrosis 2014-7-21 MALE 166 Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 0.8 1.30 G2 NO No M0 N0 T2 Stage II A7SB TUMOR FREE 196000 150000 400000 NO NO 1 NO R0 Primary Tumor 01 Lobectomy 7th YES NO RC 1.3 Liver None LIVING 61 2012 TCGA-RC-A7SB-01A-21D-A34Y-01 TCGA-RC-A7SB-01A-21D-A34Y-01 TCGA-RC-A7SB-01A-21D-A34Z-10 TCGA-RC-A7SB-01 TCGA-RC-A7SB-01 d1d1393b-5eda-4484-8254-a6bf11a19908 TCGA-RC-A7SB-01A-21D-A34Z-10 TCGA-RC-A7SB-01 TCGA-RC-A7SB-01 d1d1393b-5eda-4484-8254-a6bf11a19908 TCGA-RC-A7SB-01A-21D-A34Z-10 d1d1393b-5eda-4484-8254-a6bf11a19908 d1d1393b-5eda-4484-8254-a6bf11a19908 TCGA-RC-A7SB-01A-21D-A34Z-10 TCGA-RC-A7SB-01A-21D-A356-05 +TCGA-RC-A7SF-01 TCGA-RC-A7SF-01 TCGA-RC-A7SF TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver None 66 3.1 4.4 5.2 TCGA-RC-A7SF TCGA-RC-A7SF-01A 0.1 0.8 A 0.3 1.20 1.0 -24432 285 0 579 0 0 20 87 3,4 - Fibrous Speta 2014-7-21 MALE 170 Hepatitis C Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 20 0.8 1.30 NO G2 YES true No M0 N0 T1 Stage I TCGA-RC-A7SF.D4F398CC-0003-4C08-989F-3C60762B100F.pdf A7SF WITH TUMOR 209000 150000 400000 NO NO 0.9 NO R0 Primary Tumor 01 Segmentectomy, Single 7th YES NO RC 1.3 Liver None A LIVING 76 2012 TCGA-RC-A7SF-01A-11D-A34Y-01 TCGA-RC-A7SF-01A-11D-A34Y-01 TCGA-RC-A7SF-01A-11D-A34Z-10 TCGA-RC-A7SF-01 TCGA-RC-A7SF-01 136abc20-19ec-4049-96f9-7fe8dcda7029 TCGA-RC-A7SF-01A-11D-A34Z-10 TCGA-RC-A7SF-01 TCGA-RC-A7SF-01 136abc20-19ec-4049-96f9-7fe8dcda7029 TCGA-RC-A7SF-01A-11D-A34Z-10 136abc20-19ec-4049-96f9-7fe8dcda7029 136abc20-19ec-4049-96f9-7fe8dcda7029 TCGA-RC-A7SF-01A-11D-A34Z-10 TCGA-RC-A7SF-01A-11D-A356-05 +TCGA-RC-A7SH-01 TCGA-RC-A7SH-01 TCGA-RC-A7SH TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver None 42 3.1 4.1 5.2 TCGA-RC-A7SH TCGA-RC-A7SH-01A 0.1 0.5 A 0.3 1.20 0.8 -15560 271 0 468 1 0 20 2466 3,4 - Fibrous Speta 2014-7-21 MALE 174 Hepatitis B Hepatocellular Carcinoma No C22.0 8174/3 C22.0 YES 10 0.8 1.30 NO G3 YES true No M0 N0 T2 Stage II TCGA-RC-A7SH.F862582D-03E2-41AB-85C8-B637C2573E74.pdf A7SH WITH TUMOR 225 150000 400000 NO NO 1.0 NO R0 Primary Tumor 01 Lobectomy 7th YES NO RC 1.3 Liver Micro A LIVING 68 2012 TCGA-RC-A7SH-01A-11D-A381-01 TCGA-RC-A7SH-01A-11D-A381-01 TCGA-RC-A7SH-01A-11D-A382-10 TCGA-RC-A7SH-01 TCGA-RC-A7SH-01 6bda7fe9-c8e8-4f79-8e4b-015ca56760b0 TCGA-RC-A7SH-01 TCGA-RC-A7SH-01 6bda7fe9-c8e8-4f79-8e4b-015ca56760b0 6bda7fe9-c8e8-4f79-8e4b-015ca56760b0 6bda7fe9-c8e8-4f79-8e4b-015ca56760b0 TCGA-RC-A7SH-01A-11D-A383-05 +TCGA-RC-A7SK-01 TCGA-RC-A7SK-01 TCGA-RC-A7SK TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver None 59 3.1 4.3 5.2 TCGA-RC-A7SK TCGA-RC-A7SK-01A 0.1 0.6 A 0.3 1.20 1 -21814 232 0 472 0 0 20 25 1,2 - Portal Fibrosis 2014-7-21 MALE 169 Hepatitis C Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 40 0.8 1.30 NO G3 YES true No M0 N0 T1 Stage I TCGA-RC-A7SK.5C08444C-DD26-44C1-BDF3-E6E581126F38.pdf A7SK TUMOR FREE 138000 150000 400000 NO NO 1 NO R0 Primary Tumor 01 Lobectomy 7th YES NO RC 1.3 Liver Micro A LIVING 60 2013 TCGA-RC-A7SK-01A-11D-A34Y-01 TCGA-RC-A7SK-01A-11D-A34Y-01 TCGA-RC-A7SK-01A-11D-A34Z-10 TCGA-RC-A7SK-01 TCGA-RC-A7SK-01 34982e2a-db69-4bc1-ac82-39ea181190d2 TCGA-RC-A7SK-01A-11D-A34Z-10 TCGA-RC-A7SK-01 TCGA-RC-A7SK-01 34982e2a-db69-4bc1-ac82-39ea181190d2 TCGA-RC-A7SK-01A-11D-A34Z-10 34982e2a-db69-4bc1-ac82-39ea181190d2 34982e2a-db69-4bc1-ac82-39ea181190d2 TCGA-RC-A7SK-01A-11D-A34Z-10 TCGA-RC-A7SK-01A-11D-A356-05 +TCGA-RG-A7D4-01 TCGA-RG-A7D4-01 TCGA-RG-A7D4 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 69 3 3 5 TCGA-RG-A7D4-F71159 TCGA-RG-A7D4 TCGA-RG-A7D4-01A 1 1 2 A 1 2 1 -25302 530 0 1098 0 9 5650 2015-3-19 MALE 172 Hepatitis C Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 250 1 2 NO NO G2 NO true No M0 N0 T2 Stage II TCGA-RG-A7D4.C8724B8E-5FC3-419B-9CC8-E6046D671D96.pdf A7D4 TUMOR FREE 175 150 400 NO NO 1 NO YES R0 Primary Tumor 01 Segmentectomy, Single 7th YES NO RG 2 Liver A Hepatitis C Antibody LIVING 87 2012 TCGA-RG-A7D4-01A-12D-A33P-01 TCGA-RG-A7D4-01A-12D-A33P-01 TCGA-RG-A7D4-01A-12D-A33Q-10 TCGA-RG-A7D4-01 TCGA-RG-A7D4-01 DFF361AE-94B2-4034-BFC1-B8BD4CE3A9A0 7796772d-d52f-4909-ae88-e961e827c962 TCGA-RG-A7D4-01A-12D-A33Q-10 TCGA-RG-A7D4-01 TCGA-RG-A7D4-01 7796772d-d52f-4909-ae88-e961e827c962 TCGA-RG-A7D4-01A-12D-A33Q-10 7796772d-d52f-4909-ae88-e961e827c962 7796772d-d52f-4909-ae88-e961e827c962 TCGA-RG-A7D4-01A-12D-A33Q-10 TCGA-RG-A7D4-01A-12D-A341-05 +TCGA-T1-A6J8-01 TCGA-T1-A6J8-01 TCGA-T1-A6J8 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 68 TCGA-T1-A6J8-F68334 TCGA-T1-A6J8 TCGA-T1-A6J8-01A -24853 77 0 23 2014-11-14 MALE 188 Alcohol consumption Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 340 NO YES G2 true Yes M0 NX T1 TCGA-T1-A6J8.CEAA3A97-FE48-4408-9DCA-21D924287CAC.pdf A6J8 TUMOR FREE RX Primary Tumor 01 Segmentectomy, Multiple 7th NO YES T1 Liver None A LIVING 65 2013 TCGA-T1-A6J8-01A-11D-A32F-01 TCGA-T1-A6J8-01A-11D-A32F-01 TCGA-T1-A6J8-01A-11D-A32G-10 TCGA-T1-A6J8-01 6CF069EB-CE3B-4706-AC56-8E556CDCE42C 366c514e-877d-4aa6-bb14-610c8a93191b TCGA-T1-A6J8-01A-11D-A32G-10 TCGA-T1-A6J8-01 366c514e-877d-4aa6-bb14-610c8a93191b TCGA-T1-A6J8-01A-11D-A32G-10 366c514e-877d-4aa6-bb14-610c8a93191b 366c514e-877d-4aa6-bb14-610c8a93191b TCGA-T1-A6J8-01A-11D-A32G-10 TCGA-T1-A6J8-01A-11D-A32R-05 +TCGA-UB-A7MA-01 TCGA-UB-A7MA-01 TCGA-UB-A7MA TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver YES NO None 62 3.4 4.0 5.0 TCGA-UB-A7MA-F67133 TCGA-UB-A7MA TCGA-UB-A7MA-01A 0 1.2 A 0.4 0.90 0.7 -22843 109 0 848 478 0 0 8 2008 0 - No Fibrosis 2015-11-24 FEMALE 165 No History of Primary Risk Factors Hepatocholangiocarcinoma (Mixed) No C22.0 8180/3 C22.0 YES 500 0.9 1.2 NO NO G2 Liver Intrahepatic Recurrence No NO YES No true No M0 N0 T2b Stage II TCGA-UB-A7MA.82349CD5-39AA-42F8-80A1-B438B2300D09.pdf A7MA WITH TUMOR 600 140 450 NO YES 0.9 NO NO R1 Primary Tumor 01 Extended Lobectomy 7th YES NO UB 1.0 Liver Micro A Hepatitis C Antibody|Hepatitis B Surface Antigen|HBV Core Antibody LIVING 85 2013 TCGA-UB-A7MA-01A-11D-A33P-01 TCGA-UB-A7MA-01A-11D-A33P-01 TCGA-UB-A7MA-01A-11D-A33Q-10 TCGA-UB-A7MA-01 TCGA-UB-A7MA-01 79D472C1-7A6A-4AAE-8252-CE0DA5ED5FDC a23fd611-d413-4ea7-9061-8caeba4b39ff TCGA-UB-A7MA-01A-11D-A33Q-10 TCGA-UB-A7MA-01 TCGA-UB-A7MA-01 a23fd611-d413-4ea7-9061-8caeba4b39ff TCGA-UB-A7MA-01A-11D-A33Q-10 a23fd611-d413-4ea7-9061-8caeba4b39ff a23fd611-d413-4ea7-9061-8caeba4b39ff TCGA-UB-A7MA-01A-11D-A33Q-10 TCGA-UB-A7MA-01A-11D-A341-05 +TCGA-UB-A7MB-01 TCGA-UB-A7MB-01 TCGA-UB-A7MB TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver YES NO None 24 3.5 3.1 4.8 TCGA-UB-A7MB-F67159 TCGA-UB-A7MB TCGA-UB-A7MB-01A 0.2 0.4 A 0.7 1.2 0.4 -8951 176 0 601 48 0 0 8 1865 0 - No Fibrosis 2014-10-31 MALE 180 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 140 0.9 1.2 NO NO G3 Liver Intrahepatic Recurrence Yes NO YES No true No MX NX T2 Stage II TCGA-UB-A7MB.8B239487-4D0E-45EF-84EB-F61B23C42FE7.pdf A7MB WITH TUMOR 583 140 450 NO NO 1.0 NO NO R0 Primary Tumor 01 Lobectomy 7th YES NO UB 1.3 Liver Micro A Hepatitis C Antibody|Hepatitis B Surface Antigen|HBV Core Antibody LIVING 62 2013 TCGA-UB-A7MB-01A-11D-A33P-01 TCGA-UB-A7MB-01A-11D-A33P-01 TCGA-UB-A7MB-01A-11D-A33Q-10 TCGA-UB-A7MB-01 TCGA-UB-A7MB-01 4E09D005-7D96-4F25-8386-F2E64E95B561 a18a49c7-e3e8-422a-b8e5-e5632604191a TCGA-UB-A7MB-01A-11D-A33Q-10 TCGA-UB-A7MB-01 TCGA-UB-A7MB-01 a18a49c7-e3e8-422a-b8e5-e5632604191a TCGA-UB-A7MB-01A-11D-A33Q-10 a18a49c7-e3e8-422a-b8e5-e5632604191a a18a49c7-e3e8-422a-b8e5-e5632604191a TCGA-UB-A7MB-01A-11D-A33Q-10 TCGA-UB-A7MB-01A-11D-A341-05 +TCGA-UB-A7MC-01 TCGA-UB-A7MC-01 TCGA-UB-A7MC TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO YES Mild 59 3.5 3.9 4.8 TCGA-UB-A7MC-F67161 TCGA-UB-A7MC TCGA-UB-A7MC-01A 0.2 1.5 A 0.7 1.2 0.7 -21733 88 0 500 359 0 0 8 126 1,2 - Portal Fibrosis 2014-10-31 MALE 176 Alcohol consumption|Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 540 0.9 1.2 NO NO G3 Other, specify Extrahepatic Recurrence Adrenal glands Yes NO YES No true No MX N0 T3a Stage IIIA TCGA-UB-A7MC.B391B6EA-425D-411D-AA4C-EE43B861E807.pdf A7MC WITH TUMOR 200 140 450 NO NO 0.9 NO NO R0 Primary Tumor 01 Lobectomy 7th YES NO UB 1.3 Liver Micro A Hepatitis C Antibody|Hepatitis B Surface Antigen|HBV D LIVING 78 2013 TCGA-UB-A7MC-01A-11D-A33P-01 TCGA-UB-A7MC-01A-11D-A33P-01 TCGA-UB-A7MC-01A-11D-A33Q-10 TCGA-UB-A7MC-01 TCGA-UB-A7MC-01 85185E12-7503-412A-BDE8-972CF9657638 86eb0a1e-45f3-4bc1-a2f8-6e369292b113 TCGA-UB-A7MC-01A-11D-A33Q-10 TCGA-UB-A7MC-01 TCGA-UB-A7MC-01 86eb0a1e-45f3-4bc1-a2f8-6e369292b113 TCGA-UB-A7MC-01A-11D-A33Q-10 86eb0a1e-45f3-4bc1-a2f8-6e369292b113 86eb0a1e-45f3-4bc1-a2f8-6e369292b113 TCGA-UB-A7MC-01A-11D-A33Q-10 TCGA-UB-A7MC-01A-11D-A341-05 +TCGA-UB-A7MD-01 TCGA-UB-A7MD-01 TCGA-UB-A7MD TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 67 3.5 3.5 4.8 TCGA-UB-A7MD-F63729 TCGA-UB-A7MD TCGA-UB-A7MD-01A 0.2 0.8 A 0.7 1.2 1.0 -24717 128 52 0 0 0 8 23 6 - Established Cirrhosis 2014-8-15 MALE 175 Alcohol consumption|Hepatitis C Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 140 0.9 1.2 NO NO G3 NO true No MX N0 T1 Stage I TCGA-UB-A7MD.DF3145A4-6311-4DCD-914F-3B3AABE4DAE7.pdf A7MD TUMOR FREE 201 140 450 NO NO 1.0 NO NO R0 Primary Tumor 01 Segmentectomy, Multiple 7th YES NO UB 1.3 Liver Micro A Hepatitis C Antibody|Hepatitis C Virus R|HCV Genotype|Hepatitis B Surface Antigen DECEASED 57 2013 TCGA-UB-A7MD-01A-12D-A34Y-01 TCGA-UB-A7MD-01A-12D-A34Y-01 TCGA-UB-A7MD-01A-12D-A34Z-10 TCGA-UB-A7MD-01 TCGA-UB-A7MD-01 3C88AF72-B1F7-4099-B99B-67ECD6F24E6C 8a1c649e-43ae-4024-83d5-7ec8da50667f TCGA-UB-A7MD-01A-12D-A34Z-10 TCGA-UB-A7MD-01 TCGA-UB-A7MD-01 8a1c649e-43ae-4024-83d5-7ec8da50667f TCGA-UB-A7MD-01A-12D-A34Z-10 8a1c649e-43ae-4024-83d5-7ec8da50667f 8a1c649e-43ae-4024-83d5-7ec8da50667f TCGA-UB-A7MD-01A-12D-A34Z-10 TCGA-UB-A7MD-01A-12D-A356-05 +TCGA-UB-A7ME-01 TCGA-UB-A7ME-01 TCGA-UB-A7ME TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver Mild 51 3.5 4.2 4.8 TCGA-UB-A7ME-F67165 TCGA-UB-A7ME 0.2 0.6 B 0.7 1.2 1.1 -18846 0 486 0 0 8 1388 1,2 - Portal Fibrosis 2014-10-31 MALE 165 Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 0.9 1.2 NO G2 NO No MX NX T1 Stage I A7ME TUMOR FREE 181 140 450 NO NO 1.0 NO NO R0 Primary Tumor 01 Segmentectomy, Single 7th YES NO UB 1.3 Liver None Hepatitis B Surface Antigen|HBV Core Antibody|HBV D LIVING 75 2013 TCGA-UB-A7ME-01A-11D-A33B-01 TCGA-UB-A7ME-01A-11D-A33B-01 TCGA-UB-A7ME-01A-11D-A33K-10 TCGA-UB-A7ME-01 TCGA-UB-A7ME-01 c9e807fc-4988-461d-a918-bff25f639bac TCGA-UB-A7ME-01A-11D-A33K-10 TCGA-UB-A7ME-01 TCGA-UB-A7ME-01 c9e807fc-4988-461d-a918-bff25f639bac TCGA-UB-A7ME-01A-11D-A33K-10 c9e807fc-4988-461d-a918-bff25f639bac c9e807fc-4988-461d-a918-bff25f639bac TCGA-UB-A7ME-01A-11D-A33K-10 TCGA-UB-A7ME-01A-11D-A33L-05 +TCGA-UB-A7MF-01 TCGA-UB-A7MF-01 TCGA-UB-A7MF TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 56 3.5 3.6 4.8 TCGA-UB-A7MF TCGA-UB-A7MF-01A 0.2 1.1 1 A 0.7 1.2 0.9 -20815 240 214 0 0 8 2505 6 - Established Cirrhosis 2014-8-16 MALE 195 Hepatitis B|Hepatitis C Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 380 0.9 1.2 NO G2 YES true Yes MX NX T3a Stage IIIA TCGA-UB-A7MF.7A3E5345-5272-4D82-8E97-40CCE9BAF330.pdf A7MF WITH TUMOR 130 140 450 NO NO 1.0 NO YES R0 Primary Tumor 01 Segmentectomy, Single 7th YES NO UB 1.3 Liver Micro A Hepatitis C Antibody|Hepatitis B Surface Antigen|HBV Core Antibody|HBV D DECEASED 95 2013 TCGA-UB-A7MF-01A-11D-A33B-01 TCGA-UB-A7MF-01A-11D-A33B-01 TCGA-UB-A7MF-01A-11D-A33K-10 TCGA-UB-A7MF-01 TCGA-UB-A7MF-01 98F4D8EA-6240-4134-A6C1-6E1D60DDF427 0fd5e345-f535-42ef-9cf5-0db512d2ad73 TCGA-UB-A7MF-01A-11D-A33K-10 TCGA-UB-A7MF-01 TCGA-UB-A7MF-01 0fd5e345-f535-42ef-9cf5-0db512d2ad73 TCGA-UB-A7MF-01A-11D-A33K-10 0fd5e345-f535-42ef-9cf5-0db512d2ad73 0fd5e345-f535-42ef-9cf5-0db512d2ad73 TCGA-UB-A7MF-01A-11D-A33K-10 TCGA-UB-A7MF-01A-11D-A33L-05 +TCGA-UB-AA0U-01 TCGA-UB-AA0U-01 TCGA-UB-AA0U TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO YES Mild 60 3.5 3.9 4.8 TCGA-UB-AA0U-F67166 TCGA-UB-AA0U TCGA-UB-AA0U-01A 0.2 0.7 2 A 0.7 1.2 0.6 -21985 18 0 327 106 0 0 8 26 0 - No Fibrosis 2014-10-31 MALE 178 Non-Alcoholic Fatty Liver Disease Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 730 0.9 1.2 NO NO G2 Liver Intrahepatic Recurrence Yes NO YES No true No MX NX T2 Stage II TCGA-UB-AA0U.00C0CD33-615E-47A6-8CEF-EE3A67F277D3.pdf AA0U TUMOR FREE 227 140 450 NO NO 1.1 NO YES R1 Primary Tumor 01 Segmentectomy, Single 7th YES NO UB 1.3 Liver None A Hepatitis C Antibody|Hepatitis B Surface Antigen|HBV Core Antibody LIVING 93 2013 TCGA-UB-AA0U-01A-11D-A381-01 TCGA-UB-AA0U-01A-11D-A381-01 TCGA-UB-AA0U-01A-11D-A382-10 TCGA-UB-AA0U-01 TCGA-UB-AA0U-01 5055524c-95b9-40d3-a373-401ce12ec223 TCGA-UB-AA0U-01 TCGA-UB-AA0U-01 5055524c-95b9-40d3-a373-401ce12ec223 5055524c-95b9-40d3-a373-401ce12ec223 5055524c-95b9-40d3-a373-401ce12ec223 TCGA-UB-AA0U-01A-11D-A383-05 +TCGA-UB-AA0V-01 TCGA-UB-AA0V-01 TCGA-UB-AA0V TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver Mild 69 3.5 3.8 4.8 TCGA-UB-AA0V-F67169 TCGA-UB-AA0V TCGA-UB-AA0V-01A 0.2 1.0 1 A 0.5 1.0 0.7 -25340 7 0 314 0 0 8 3 0 - No Fibrosis 2014-10-31 FEMALE 175 Hemochromatosis Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 110 0.9 1.2 NO NO G1 NO true Yes MX NX [Discrepancy] Stage I TCGA-UB-AA0V.0BEA5A64-9DDE-45A8-A788-5EE2CEC6F6E4.pdf AA0V TUMOR FREE 273 140 450 NO NO 0.9 NO YES R0 Primary Tumor 01 Segmentectomy, Single 7th YES NO UB 1.3 Liver None A Hepatitis C Antibody|Hepatitis B Surface Antigen|HBV Core Antibody LIVING 57 2013 TCGA-UB-AA0V-01A-11D-A381-01 TCGA-UB-AA0V-01A-11D-A381-01 TCGA-UB-AA0V-01A-11D-A382-10 TCGA-UB-AA0V-01 TCGA-UB-AA0V-01 9e1bd81b-74bb-4909-ba0d-1e6bdf98b066 TCGA-UB-AA0V-01 TCGA-UB-AA0V-01 9e1bd81b-74bb-4909-ba0d-1e6bdf98b066 9e1bd81b-74bb-4909-ba0d-1e6bdf98b066 9e1bd81b-74bb-4909-ba0d-1e6bdf98b066 TCGA-UB-AA0V-01A-11D-A383-05 +TCGA-WJ-A86L-01 TCGA-WJ-A86L-01 TCGA-WJ-A86L TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver None 68 3.4 4.2 4.8 TCGA-WJ-A86L-F65568 TCGA-WJ-A86L TCGA-WJ-A86L-01A 0.1 0.5 A 0.5 1.1 0.9 -25018 95 0 345 1 6 16 0 - No Fibrosis 2014-9-26 FEMALE 159 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8310/3 C22.0 YES 270 2.0 3.0 NO NO G2 NO false No MX NX T1 Stage I TCGA-WJ-A86L.2C93F65E-88FD-405F-86F1-0E35C7F46DC2.pdf A86L TUMOR FREE 257000 125000 415000 NO NO 0.9 NO NO R0 Primary Tumor 01 Segmentectomy, Single 7th YES NO WJ 1.2 Liver None A Hepatitis C Antibody|Hepatitis B Surface Antigen|HBV Surface Antibody LIVING 56 2013 TCGA-WJ-A86L-01A-12D-A38W-01 TCGA-WJ-A86L-01A-12D-A38W-01 TCGA-WJ-A86L-01A-12D-A45V-10 TCGA-WJ-A86L-01 TCGA-WJ-A86L-01 24863244-1cee-4da9-b730-742a0269ee58 TCGA-WJ-A86L-01 TCGA-WJ-A86L-01 24863244-1cee-4da9-b730-742a0269ee58 24863244-1cee-4da9-b730-742a0269ee58 24863244-1cee-4da9-b730-742a0269ee58 TCGA-WJ-A86L-01A-12D-A39G-05 +TCGA-WQ-A9G7-01 TCGA-WQ-A9G7-01 TCGA-WQ-A9G7 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 71 3.5 3.5 5 TCGA-WQ-A9G7-F66632 TCGA-WQ-A9G7 TCGA-WQ-A9G7-01A 0.3 0.7 0.4 1 0.4 165 0 30 2014-10-21 FEMALE 157 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 160 0.8 1.2 NO NO G3 NO false No M0 NX T3a TCGA-WQ-A9G7.211B2C4B-7DEB-4031-A3D2-5464A7386245.pdf A9G7 TUMOR FREE 266 150 400 NO NO 1.3 NO NO R0 Primary Tumor 01 Other (specify) 7th NO YES WQ 1.2 Liver None A LIVING 69 2013 TCGA-WQ-A9G7-01A-11D-A36W-01 TCGA-WQ-A9G7-01A-11D-A36W-01 TCGA-WQ-A9G7-01A-11D-A36X-10 TCGA-WQ-A9G7-01 TCGA-WQ-A9G7-01 0EF14962-BDC1-4ECB-9947-3E8A600899EA a27a9d35-4804-4b24-8889-4128e4434487 TCGA-WQ-A9G7-01 TCGA-WQ-A9G7-01 a27a9d35-4804-4b24-8889-4128e4434487 a27a9d35-4804-4b24-8889-4128e4434487 a27a9d35-4804-4b24-8889-4128e4434487 TCGA-WQ-A9G7-01A-11D-A36Y-05 +TCGA-WQ-AB4B-01 TCGA-WQ-AB4B-01 TCGA-WQ-AB4B TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO 62 3.5 3.3 5 TCGA-WQ-AB4B-F66633 TCGA-WQ-AB4B 0.3 1.7 A 0.4 1.2 1.1 -22769 0 395 273 0 15 5 2014-10-21 MALE 175 Alcohol consumption|Non-Alcoholic Fatty Liver Disease|Other Hepatic Encephalopathy Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 0.8 1.2 NO G2 Intrahepatic Recurrence No YES No No M0 NX T2 Stage II AB4B WITH TUMOR NO NO 1.3 NO NO R0 Primary Tumor 01 Segmentectomy, Single 7th NO YES WQ 1.2 Liver Micro LIVING 122 2013 TCGA-WQ-AB4B-01A-11D-A40O-01 TCGA-WQ-AB4B-01A-11D-A40O-01 TCGA-WQ-AB4B-01A-11D-A40P-10 TCGA-WQ-AB4B-01 TCGA-WQ-AB4B-01 a2dee72c-85ab-44fc-b37f-bb8c82ced8a2 TCGA-WQ-AB4B-01 TCGA-WQ-AB4B-01 a2dee72c-85ab-44fc-b37f-bb8c82ced8a2 a2dee72c-85ab-44fc-b37f-bb8c82ced8a2 a2dee72c-85ab-44fc-b37f-bb8c82ced8a2 TCGA-WQ-AB4B-01A-11D-A40X-05 +TCGA-WX-AA44-01 TCGA-WX-AA44-01 TCGA-WX-AA44 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver None 64 3.5 4.4 5.0 TCGA-WX-AA44-F68251 TCGA-WX-AA44 TCGA-WX-AA44-01A 0 0.5 A 0.5 1.2 0.6 -23654 924 0 615 1 0 6 48 6 - Established Cirrhosis 2014-11-14 FEMALE 152 Non-Alcoholic Fatty Liver Disease Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 90 0.9 1.2 NO YES G3 YES true No MX NX T1 Stage I TCGA-WX-AA44.759F0B44-92DC-4E47-BA10-7B19C4272485.pdf AA44 WITH TUMOR 215 150 350 YES YES 0.9 YES NO RX Primary Tumor 01 Other (specify) 7th YES NO WX 1.20 Liver None A Hepatitis C Antibody LIVING 61 2011 TCGA-WX-AA44-01A-11D-A38W-01 TCGA-WX-AA44-01A-11D-A38W-01 TCGA-WX-AA44-01A-11D-A38X-10 TCGA-WX-AA44-01 TCGA-WX-AA44-01 8f0b105f-e2de-4433-bd6a-dd81cb6c0c93 TCGA-WX-AA44-01 TCGA-WX-AA44-01 8f0b105f-e2de-4433-bd6a-dd81cb6c0c93 8f0b105f-e2de-4433-bd6a-dd81cb6c0c93 8f0b105f-e2de-4433-bd6a-dd81cb6c0c93 TCGA-WX-AA44-01A-11D-A39G-05 +TCGA-WX-AA46-01 TCGA-WX-AA46-01 TCGA-WX-AA46 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver None 61 3.5 4.6 5.0 TCGA-WX-AA46-F68250 TCGA-WX-AA46 TCGA-WX-AA46-01A 0 1.3 3 A 0.5 1.2 1.2 -22639 456 0 756 0 0 6 1 0 - No Fibrosis 2014-11-14 MALE 156 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 80 0.8 1.1 NO NO G1 NO true No MX NX T2 Stage II TCGA-WX-AA46.A767B73F-5C51-47E8-A569-E112DBB987FF.pdf AA46 TUMOR FREE 205 150 350 NO NO 1.0 NO YES R0 Primary Tumor 01 Other (specify) 7th NO YES WX 1.2 Liver Macro A Hepatitis C Antibody LIVING 75 2012 TCGA-WX-AA46-01A-11D-A38W-01 TCGA-WX-AA46-01A-11D-A38W-01 TCGA-WX-AA46-01A-11D-A38X-10 TCGA-WX-AA46-01 TCGA-WX-AA46-01 1c666252-0438-4c4d-bbb8-99a06b90ab76 TCGA-WX-AA46-01 TCGA-WX-AA46-01 1c666252-0438-4c4d-bbb8-99a06b90ab76 1c666252-0438-4c4d-bbb8-99a06b90ab76 1c666252-0438-4c4d-bbb8-99a06b90ab76 TCGA-WX-AA46-01A-11D-A39G-05 +TCGA-WX-AA47-01 TCGA-WX-AA47-01 TCGA-WX-AA47 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver Mild 33 3.5 2.8 5.0 TCGA-WX-AA47 TCGA-WX-AA47-01A 0.2 A 0.5 1.2 0.6 -12056 626 556 0 2 0 6 1 0 - No Fibrosis 2014-6-10 FEMALE 168 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 60 0.8 1.1 NO G2 YES true No MX NX T3a Stage IIIA TCGA-WX-AA47.473868C8-CFDF-42E6-B6DC-48A737697D07.pdf AA47 WITH TUMOR 423 150 350 NO YES 0.9 YES NO R0 Primary Tumor 01 Lobectomy 7th NO YES WX 1.2 Liver Macro A Hepatitis C Antibody DECEASED 63 2012 TCGA-WX-AA47-01A-11D-A38W-01 TCGA-WX-AA47-01A-11D-A38W-01 TCGA-WX-AA47-01A-11D-A38X-10 TCGA-WX-AA47-01 TCGA-WX-AA47-01 676d126f-b0c7-4c79-b4b6-852207b31437 TCGA-WX-AA47-01 TCGA-WX-AA47-01 676d126f-b0c7-4c79-b4b6-852207b31437 676d126f-b0c7-4c79-b4b6-852207b31437 676d126f-b0c7-4c79-b4b6-852207b31437 TCGA-WX-AA47-01A-11D-A39G-05 +TCGA-XR-A8TC-01 TCGA-XR-A8TC-01 TCGA-XR-A8TC TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver Mild 43 3.5 3.9 4.8 TCGA-XR-A8TC-F72317 TCGA-XR-A8TC TCGA-XR-A8TC-01A 0.2 0.2 A 0.7 1.5 0.7 -15817 908 0 1339 0 6 6 47 6 - Established Cirrhosis 2015-5-20 FEMALE 155 Hepatitis B Hepatocellular Carcinoma Yes C22.0 8170/3 C22.0 YES 110 1.3 1.3 NO NO G2 NO true Yes MX NX T1 Stage I TCGA-XR-A8TC.681B14A0-98E6-4F74-89B0-3DFB3A97C0E1.pdf A8TC WITH TUMOR 318000 150000 450000 YES NO 1.0 NO NO R0 Primary Tumor 01 Segmentectomy, Multiple 7th NO YES XR 1.2 Liver None A LIVING 52 2011 TCGA-XR-A8TC-01A-11D-A35Z-10 TCGA-XR-A8TC-01 TCGA-XR-A8TC-01 81166064-A9F8-462A-9563-F72A39C24E59 7e61e7f1-2c5e-45e4-a0cc-b0ab27c29bc3 TCGA-XR-A8TC-01 7e61e7f1-2c5e-45e4-a0cc-b0ab27c29bc3 7e61e7f1-2c5e-45e4-a0cc-b0ab27c29bc3 7e61e7f1-2c5e-45e4-a0cc-b0ab27c29bc3 TCGA-XR-A8TC-01A-11D-A369-05 +TCGA-XR-A8TD-01 TCGA-XR-A8TD-01 TCGA-XR-A8TD TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO None 49 3.5 3.8 4.8 TCGA-XR-A8TD-F72319 TCGA-XR-A8TD 0.2 0.7 A 0.7 1.5 0.5 -17908 0 1030 1 6 6 188 0 - No Fibrosis 2015-5-20 FEMALE 156 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8174/3 C22.0 YES 0 1.3 NO G3 No NO NO No No M0 N0 T3 Stage IIIB A8TD TUMOR FREE 334000 150000 450000 NO NO 1.1 NO R0 Primary Tumor 01 Extended Lobectomy 7th NO YES XR 1.2 Liver None LIVING 69 2012 TCGA-XR-A8TD-01A-12D-A38W-01 TCGA-XR-A8TD-01A-12D-A38W-01 TCGA-XR-A8TD-01A-12D-A38X-10 TCGA-XR-A8TD-01 TCGA-XR-A8TD-01 ed43b946-0700-4e19-8a04-d2a5720a7cdb TCGA-XR-A8TD-01 TCGA-XR-A8TD-01 ed43b946-0700-4e19-8a04-d2a5720a7cdb ed43b946-0700-4e19-8a04-d2a5720a7cdb ed43b946-0700-4e19-8a04-d2a5720a7cdb TCGA-XR-A8TD-01A-12D-A39G-05 +TCGA-XR-A8TE-01 TCGA-XR-A8TE-01 TCGA-XR-A8TE TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver YES NO None 16 3.2 3.9 4.5 TCGA-XR-A8TE-F72321 TCGA-XR-A8TE 0.7 1.5 0.4 -5862 0 925 244 210 0 6 6 809 0 - No Fibrosis 2015-5-20 MALE 157 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 1.3 1.3 NO G1 Liver Intrahepatic Recurrence No YES YES No No MX N0 T3 Stage IIIA A8TE WITH TUMOR 206000 150000 450000 NO YES 1.0 NO NO R0 R0 Primary Tumor 01 Extended Lobectomy 7th NO YES XR Liver None LIVING 43 2012 TCGA-XR-A8TE-01A-11D-A35Y-01 TCGA-XR-A8TE-01A-11D-A35Y-01 TCGA-XR-A8TE-01A-11D-A35Z-10 TCGA-XR-A8TE-01 TCGA-XR-A8TE-01 b9ddaaef-028b-4db4-ad31-e70931bd8e44 TCGA-XR-A8TE-01 TCGA-XR-A8TE-01 b9ddaaef-028b-4db4-ad31-e70931bd8e44 b9ddaaef-028b-4db4-ad31-e70931bd8e44 b9ddaaef-028b-4db4-ad31-e70931bd8e44 TCGA-XR-A8TE-01A-11D-A369-05 +TCGA-XR-A8TF-01 TCGA-XR-A8TF-01 TCGA-XR-A8TF TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO None 74 3.5 3.9 4.8 TCGA-XR-A8TF-F72323 TCGA-XR-A8TF TCGA-XR-A8TF-01A 0.2 0.8 A 0.7 1.5 0.8 -27145 481 693 0 271 231 0 6 6 39 3,4 - Fibrous Speta 2015-5-20 MALE 166 Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 250 0 1.3 NO NO G1 Liver Intrahepatic Recurrence No YES YES No true No MX NX T1 Stage I TCGA-XR-A8TF.A0557F82-3ACC-43E5-9ED3-902BEDD36939.pdf A8TF TUMOR FREE 194000 150000 450000 NO NO 1.1 NO NO R1 R0 Primary Tumor 01 Segmentectomy, Multiple 7th NO YES XR 1.2 Liver None A DECEASED 57 2012 TCGA-XR-A8TF-01A-11D-A35Y-01 TCGA-XR-A8TF-01A-11D-A35Y-01 TCGA-XR-A8TF-01A-11D-A35Z-10 TCGA-XR-A8TF-01 TCGA-XR-A8TF-01 B132756A-0CF8-4DFB-B839-AF3E192AC614 1f676139-c73f-49d7-95c1-f5f955a27669 TCGA-XR-A8TF-01 TCGA-XR-A8TF-01 1f676139-c73f-49d7-95c1-f5f955a27669 1f676139-c73f-49d7-95c1-f5f955a27669 1f676139-c73f-49d7-95c1-f5f955a27669 TCGA-XR-A8TF-01A-11D-A369-05 +TCGA-XR-A8TG-01 TCGA-XR-A8TG-01 TCGA-XR-A8TG TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO Mild 58 3.5 4.3 4.8 TCGA-XR-A8TG-F72325 TCGA-XR-A8TG TCGA-XR-A8TG-01A 0.2 0.5 2 0.7 1.5 0.9 -21544 439 0 898 350 0 6 6 1 6 - Established Cirrhosis 2015-5-20 MALE 184 Hepatitis C Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 20 0 1.5 NO NO G2 Liver Intrahepatic Recurrence Yes NO YES Yes true Yes M0 NX T1 Stage I TCGA-XR-A8TG.B6CBB321-E73F-4A24-8557-E10E94B2B8C6.pdf A8TG TUMOR FREE 80000 150000 450000 YES NO 1.1 YES YES R0 R0 Primary Tumor 01 Segmentectomy, Single 7th NO YES XR 1.2 Liver None A LIVING 71 2012 TCGA-XR-A8TG-01A-11D-A35Y-01 TCGA-XR-A8TG-01A-11D-A35Y-01 TCGA-XR-A8TG-01A-11D-A35Z-10 TCGA-XR-A8TG-01 TCGA-XR-A8TG-01 7cbc59c1-c767-4b50-a6fe-fc3e3365b5cf TCGA-XR-A8TG-01 TCGA-XR-A8TG-01 7cbc59c1-c767-4b50-a6fe-fc3e3365b5cf 7cbc59c1-c767-4b50-a6fe-fc3e3365b5cf 7cbc59c1-c767-4b50-a6fe-fc3e3365b5cf TCGA-XR-A8TG-01A-11D-A369-05 +TCGA-YA-A8S7-01 TCGA-YA-A8S7-01 TCGA-YA-A8S7 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver Mild 68 3.5 2.1 5.0 TCGA-YA-A8S7 TCGA-YA-A8S7-01A 0.2 3.8 0.60 1.3 0.7 -25188 383 412 0 8 56 2014-4-8 MALE 164 Hepatitis C Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 160 0.9 1.2 NO G3 YES false No MX N0 T3a Stage IIIA TCGA-YA-A8S7.CFF98B7F-C09E-441D-BE5F-48A06036735B.pdf A8S7 WITH TUMOR NO YES 1.2 NO NO R0 Primary Tumor 01 Other (specify) 7th NO YES YA 1.0 Liver None A DECEASED 73 2012 TCGA-YA-A8S7-01A-11D-A36W-01 TCGA-YA-A8S7-01A-11D-A36W-01 TCGA-YA-A8S7-01A-11D-A36X-10 TCGA-YA-A8S7-01 TCGA-YA-A8S7-01 F2A3D58A-4976-4B4B-A693-39EC9D7641AB 8f1e9042-ffcf-44b4-9854-7f7be7e92f24 TCGA-YA-A8S7-01 TCGA-YA-A8S7-01 8f1e9042-ffcf-44b4-9854-7f7be7e92f24 8f1e9042-ffcf-44b4-9854-7f7be7e92f24 8f1e9042-ffcf-44b4-9854-7f7be7e92f24 TCGA-YA-A8S7-01A-11D-A36Y-05 +TCGA-ZP-A9CV-01 TCGA-ZP-A9CV-01 TCGA-ZP-A9CV TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver Severe 59 3.5 4 5.7 TCGA-ZP-A9CV-F57756 TCGA-ZP-A9CV TCGA-ZP-A9CV-01A 0.2 0.5 A 0.7 1.3 0.8 -21633 955 1088 0 142 1 0 8 48 2014-3-28 MALE 173 Alcohol consumption|Hepatitis C Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 40 NO NO G1 NO false No MX NX T1 TCGA-ZP-A9CV.382219F6-24AD-49BD-96D1-FC7A9B2CDFDB.pdf A9CV WITH TUMOR 114000 163000 369000 NO NO NO NO R0 Primary Tumor 01 Segmentectomy, Single 7th NO YES ZP 1.0 Liver None A DECEASED 59 2011 TCGA-ZP-A9CV-01A-11D-A381-01 TCGA-ZP-A9CV-01A-11D-A381-01 TCGA-ZP-A9CV-01A-11D-A382-10 TCGA-ZP-A9CV-01 TCGA-ZP-A9CV-01 86f6c86d-d218-4721-86fd-1dd70ee454eb TCGA-ZP-A9CV-01 TCGA-ZP-A9CV-01 86f6c86d-d218-4721-86fd-1dd70ee454eb 86f6c86d-d218-4721-86fd-1dd70ee454eb 86f6c86d-d218-4721-86fd-1dd70ee454eb TCGA-ZP-A9CV-01A-11D-A383-05 +TCGA-ZP-A9CY-01 TCGA-ZP-A9CY-01 TCGA-ZP-A9CY TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver Mild 66 3.5 3.9 5.2 TCGA-ZP-A9CY-F57752 TCGA-ZP-A9CY 0.2 0.9 1 A -24223 0 782 1 6 - Established Cirrhosis 2014-3-28 FEMALE 152 Non-Alcoholic Fatty Liver Disease Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 9.6 12.6 NO G1 NO No MX NX T1 A9CY TUMOR FREE 93000 163000 369000 NO NO 11 NO YES R0 Primary Tumor 01 Segmentectomy, Single 7th NO YES ZP 1.2 Liver None LIVING 83 2011 TCGA-ZP-A9CY-01A-11D-A381-01 TCGA-ZP-A9CY-01A-11D-A381-01 TCGA-ZP-A9CY-01A-11D-A382-10 TCGA-ZP-A9CY-01 TCGA-ZP-A9CY-01 f3490052-6688-4279-9d92-0aca9fe94382 TCGA-ZP-A9CY-01 TCGA-ZP-A9CY-01 f3490052-6688-4279-9d92-0aca9fe94382 f3490052-6688-4279-9d92-0aca9fe94382 f3490052-6688-4279-9d92-0aca9fe94382 TCGA-ZP-A9CY-01A-11D-A383-05 +TCGA-ZP-A9CZ-01 TCGA-ZP-A9CZ-01 TCGA-ZP-A9CZ TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 72 3.5 4.4 5.2 TCGA-ZP-A9CZ-F57754 TCGA-ZP-A9CZ TCGA-ZP-A9CZ-01A 0.2 0.5 2 A -26403 797 0 706 0 0 8 8 3,4 - Fibrous Speta 2014-3-28 MALE 167 Hepatitis B Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 50 9.6 12.6 NO NO G1 NO false No MX NX T1 TCGA-ZP-A9CZ.C3F4669C-9E5D-4A46-84A8-E78BF2D5EA92.pdf A9CZ TUMOR FREE NO NO 11.5 NO YES R0 Primary Tumor 01 Segmentectomy, Single 7th NO YES ZP 1.2 Liver None A Hepatitis B Surface Antigen LIVING 73 2011 TCGA-ZP-A9CZ-01A-11D-A381-01 TCGA-ZP-A9CZ-01A-11D-A381-01 TCGA-ZP-A9CZ-01A-11D-A382-10 TCGA-ZP-A9CZ-01 TCGA-ZP-A9CZ-01 7d467df3-8ea8-4979-a609-775baef7a680 TCGA-ZP-A9CZ-01 TCGA-ZP-A9CZ-01 7d467df3-8ea8-4979-a609-775baef7a680 7d467df3-8ea8-4979-a609-775baef7a680 7d467df3-8ea8-4979-a609-775baef7a680 TCGA-ZP-A9CZ-01A-11D-A383-05 +TCGA-ZP-A9D0-01 TCGA-ZP-A9D0-01 TCGA-ZP-A9D0 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver Mild 67 3.5 4.1 5.2 TCGA-ZP-A9D0-F69077 TCGA-ZP-A9D0 TCGA-ZP-A9D0-01A 0.2 1.4 A 0.5 1.1 0.9 -24525 723 0 1091 0 0 - No Fibrosis 2014-12-29 FEMALE 165 Non-Alcoholic Fatty Liver Disease Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 100 9.6 12.6 NO NO G1 NO false No MX NX T1 TCGA-ZP-A9D0.38325470-AA90-4CA4-A8C0-8BF1A9D595F9.pdf A9D0 TUMOR FREE 185000 163000 369000 NO NO 11 NO NO R0 Primary Tumor 01 Segmentectomy, Multiple 7th NO YES ZP 1.2 Liver None A LIVING 78 2011 TCGA-ZP-A9D0-01A-11D-A36W-01 TCGA-ZP-A9D0-01A-11D-A36W-01 TCGA-ZP-A9D0-01A-11D-A36X-10 TCGA-ZP-A9D0-01 TCGA-ZP-A9D0-01 78a9c934-1a9a-42a4-95ba-c99565afccd0 TCGA-ZP-A9D0-01 TCGA-ZP-A9D0-01 78a9c934-1a9a-42a4-95ba-c99565afccd0 78a9c934-1a9a-42a4-95ba-c99565afccd0 78a9c934-1a9a-42a4-95ba-c99565afccd0 TCGA-ZP-A9D0-01A-11D-A36Y-05 +TCGA-ZP-A9D1-01 TCGA-ZP-A9D1-01 TCGA-ZP-A9D1 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver 56 TCGA-ZP-A9D1-F57746 TCGA-ZP-A9D1 TCGA-ZP-A9D1-01A 1 A -20584 699 0 21 0 0 8 8 5 - Nodular Formation and Incomplete Cirrhosis 2014-3-28 FEMALE 170 Non-Alcoholic Fatty Liver Disease Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 70 9.6 12.6 NO NO G2 NO false Yes MX NX T1 TCGA-ZP-A9D1.2FA60C52-0164-432D-BB08-A8638AAF2C2F.pdf A9D1 TUMOR FREE NO NO 12 NO YES R0 Primary Tumor 01 Segmentectomy, Single 7th NO YES ZP Liver None A LIVING 130 2012 TCGA-ZP-A9D1-01A-11D-A381-01 TCGA-ZP-A9D1-01A-11D-A381-01 TCGA-ZP-A9D1-01A-11D-A382-10 TCGA-ZP-A9D1-01 TCGA-ZP-A9D1-01 8a5804cb-d45f-4a6c-b7a0-af505b4b4237 TCGA-ZP-A9D1-01 TCGA-ZP-A9D1-01 8a5804cb-d45f-4a6c-b7a0-af505b4b4237 8a5804cb-d45f-4a6c-b7a0-af505b4b4237 8a5804cb-d45f-4a6c-b7a0-af505b4b4237 TCGA-ZP-A9D1-01A-11D-A383-05 +TCGA-ZP-A9D2-01 TCGA-ZP-A9D2-01 TCGA-ZP-A9D2 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO Mild 51 TCGA-ZP-A9D2-F57748 TCGA-ZP-A9D2 TCGA-ZP-A9D2-01A 1 A -18717 654 765 0 743 315 0 1,2 - Portal Fibrosis 2015-1-16 MALE 172 Hepatitis C Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 60 NO NO G2 Liver Intrahepatic Recurrence Yes NO NO No false No MX NX T2 TCGA-ZP-A9D2.260D67D7-9E8C-4A3B-B031-8AB4A05BC688.pdf A9D2 WITH TUMOR YES NO NO YES R0 Primary Tumor 01 Segmentectomy, Multiple 7th NO YES ZP Liver Micro A Hepatitis C Virus R DECEASED 74 2012 TCGA-ZP-A9D2-01A-11D-A381-01 TCGA-ZP-A9D2-01A-11D-A381-01 TCGA-ZP-A9D2-01A-11D-A382-10 TCGA-ZP-A9D2-01 TCGA-ZP-A9D2-01 159b00ee-9db8-4de9-bd94-16e65b917502 TCGA-ZP-A9D2-01 TCGA-ZP-A9D2-01 159b00ee-9db8-4de9-bd94-16e65b917502 159b00ee-9db8-4de9-bd94-16e65b917502 159b00ee-9db8-4de9-bd94-16e65b917502 TCGA-ZP-A9D2-01A-11D-A383-05 +TCGA-ZP-A9D4-01 TCGA-ZP-A9D4-01 TCGA-ZP-A9D4 TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver Mild 64 3.5 4.3 5.2 TCGA-ZP-A9D4-F57750 TCGA-ZP-A9D4 0.2 0.4 A 0.5 1.1 0.6 -23656 0 395 0 0 8 2 0 - No Fibrosis 2014-3-28 FEMALE 155 No History of Primary Risk Factors Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES NO G1 NO No MX NX T1 A9D4 TUMOR FREE 292000 163000 369000 NO NO NO NO R0 Primary Tumor 01 Lobectomy 7th NO YES ZP 1.2 Liver None LIVING 55 2012 TCGA-ZP-A9D4-01A-11D-A36W-01 TCGA-ZP-A9D4-01A-11D-A36W-01 TCGA-ZP-A9D4-01A-11D-A36X-10 TCGA-ZP-A9D4-01 TCGA-ZP-A9D4-01 da0eec5b-54d6-421c-b850-c7d75e0a8a46 TCGA-ZP-A9D4-01 TCGA-ZP-A9D4-01 da0eec5b-54d6-421c-b850-c7d75e0a8a46 da0eec5b-54d6-421c-b850-c7d75e0a8a46 da0eec5b-54d6-421c-b850-c7d75e0a8a46 TCGA-ZP-A9D4-01A-11D-A36Y-05 +TCGA-ZS-A9CD-01 TCGA-ZS-A9CD-01 TCGA-ZS-A9CD TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver Mild 73 36 48 50 TCGA-ZS-A9CD TCGA-ZS-A9CD-01A 0 8 A 62 106 73 -26915 1268 1386 0 1 5 - Nodular Formation and Incomplete Cirrhosis 2014-4-30 MALE Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 30 9 12 NO G2 YES true No MX NX T2 Stage II TCGA-ZS-A9CD.11C6E09D-89C3-43B9-B884-247278242067.pdf A9CD 198 150 400 NO NO 11.7 NO R0 Primary Tumor 01 Lobectomy 7th NO YES ZS 17 Liver None A Hepatitis C Antibody|Hepatitis B Surface Antigen DECEASED 2010 TCGA-ZS-A9CD-01A-11D-A36W-01 TCGA-ZS-A9CD-01A-11D-A36W-01 TCGA-ZS-A9CD-01A-11D-A36X-10 TCGA-ZS-A9CD-01 TCGA-ZS-A9CD-01 35c7281c-ffe6-4fc4-b3de-da4f6a113397 TCGA-ZS-A9CD-01 TCGA-ZS-A9CD-01 35c7281c-ffe6-4fc4-b3de-da4f6a113397 35c7281c-ffe6-4fc4-b3de-da4f6a113397 35c7281c-ffe6-4fc4-b3de-da4f6a113397 TCGA-ZS-A9CD-01A-11D-A36Y-05 +TCGA-ZS-A9CE-01 TCGA-ZS-A9CE-01 TCGA-ZS-A9CE TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO None 79 36 44 50 TCGA-ZS-A9CE-F68444 TCGA-ZS-A9CE 0 5 A 44 80 78 -29051 0 1241 892 892 0 0 - No Fibrosis 2014-11-18 FEMALE Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 9 12 NO G1 Other, specify New Primary Tumor Right Temple No YES YES No Yes MX NX T2 Stage II A9CE TUMOR FREE 310 150 400 NO NO 36.4 NO R0 R0 Primary Tumor 01 Segmentectomy, Single 7th NO YES ZS 15 Liver Micro Hepatitis C Antibody|Hepatitis B Surface Antigen LIVING 2011 TCGA-ZS-A9CE-01A-11D-A36W-01 TCGA-ZS-A9CE-01A-11D-A36W-01 TCGA-ZS-A9CE-01A-11D-A36X-10 TCGA-ZS-A9CE-01 TCGA-ZS-A9CE-01 d8b053f6-2674-43ec-9c36-ed652fe5ff7e TCGA-ZS-A9CE-01 TCGA-ZS-A9CE-01 d8b053f6-2674-43ec-9c36-ed652fe5ff7e d8b053f6-2674-43ec-9c36-ed652fe5ff7e d8b053f6-2674-43ec-9c36-ed652fe5ff7e TCGA-ZS-A9CE-01A-11D-A36Y-05 +TCGA-ZS-A9CF-01 TCGA-ZS-A9CF-01 TCGA-ZS-A9CF TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO None 64 36 51 50 TCGA-ZS-A9CF-F68445 TCGA-ZS-A9CF 0 19 62 106 89 -23510 0 2412 700 636 0 0 - No Fibrosis 2014-11-18 MALE Hemochromatosis Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 9 12 NO G2 Liver Intrahepatic Recurrence Yes YES YES No No MX NX T2 Stage II A9CF TUMOR FREE 259 150 400 NO NO 10.2 NO RX R0 Primary Tumor 01 Lobectomy 7th NO YES ZS 17 Liver Micro Hepatitis C Antibody|Hepatitis B Surface Antigen LIVING 2008 TCGA-ZS-A9CF-01A-11D-A381-01 TCGA-ZS-A9CF-01A-11D-A381-01 TCGA-ZS-A9CF-01A-11D-A382-10 TCGA-ZS-A9CF-01 TCGA-ZS-A9CF-01 b6a5831d-1a97-49f1-8dbc-c833abb60a20 TCGA-ZS-A9CF-01 TCGA-ZS-A9CF-01 b6a5831d-1a97-49f1-8dbc-c833abb60a20 b6a5831d-1a97-49f1-8dbc-c833abb60a20 b6a5831d-1a97-49f1-8dbc-c833abb60a20 TCGA-ZS-A9CF-01A-11D-A383-05 +TCGA-ZS-A9CF-02 TCGA-ZS-A9CF-02 TCGA-ZS-A9CF TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver NO NO None 64 36 51 50 TCGA-ZS-A9CF-F68445 TCGA-ZS-A9CF TCGA-ZS-A9CF-02A 0 19 62 106 89 -23510 2217 0 2412 700 636 0 0 - No Fibrosis 2014-11-18 MALE Hemochromatosis Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 30 9 12 NO NO G2 Liver Intrahepatic Recurrence Yes YES YES No false No MX NX T2 Stage II TCGA-ZS-A9CF.5D79D370-F174-4CCB-AF64-5617EBF352BE.pdf A9CF TUMOR FREE 259 150 400 NO NO 10.2 NO RX R0 Recurrent Tumor 02 Lobectomy 7th NO YES ZS 17 Liver Micro A Hepatitis C Antibody|Hepatitis B Surface Antigen LIVING 2008 TCGA-ZS-A9CF-02 3c670523-5f34-4518-bf25-cc0d725de814 TCGA-ZS-A9CF-02 3c670523-5f34-4518-bf25-cc0d725de814 3c670523-5f34-4518-bf25-cc0d725de814 3c670523-5f34-4518-bf25-cc0d725de814 TCGA-ZS-A9CF-02A-11D-A383-05 +TCGA-ZS-A9CG-01 TCGA-ZS-A9CG-01 TCGA-ZS-A9CG TCGA Liver Cancer (LIHC) liver hepatocellular carcinoma Liver Mild 55 35 40 50 TCGA-ZS-A9CG-F68446 TCGA-ZS-A9CG TCGA-ZS-A9CG-01A 0 5 A 62 106 72 -20100 201 0 341 0 0 - No Fibrosis 2014-11-18 MALE 179 Hepatocellular Carcinoma No C22.0 8170/3 C22.0 YES 50 9.5 14 NO NO G2 NO true No MX NX T2 Stage II TCGA-ZS-A9CG.8A0E7BA8-7262-4832-89DA-61893BE4B458.pdf A9CG TUMOR FREE 382 150 400 NO NO 10.8 NO R0 Primary Tumor 01 Extended Lobectomy 7th NO YES ZS 21 Liver Micro A Hepatitis C Antibody|Hepatitis B Surface Antigen LIVING 94 2013 TCGA-ZS-A9CG-01A-11D-A36W-01 TCGA-ZS-A9CG-01A-11D-A36W-01 TCGA-ZS-A9CG-01A-11D-A36X-10 TCGA-ZS-A9CG-01 TCGA-ZS-A9CG-01 23b47813-7a77-44ca-b650-31a319c1f497 TCGA-ZS-A9CG-01 TCGA-ZS-A9CG-01 23b47813-7a77-44ca-b650-31a319c1f497 23b47813-7a77-44ca-b650-31a319c1f497 23b47813-7a77-44ca-b650-31a319c1f497 TCGA-ZS-A9CG-01A-11D-A36Y-05 diff --git a/input/TCGA/TCGA_Lower_Grade_Glioma_(LGG)/TCGA.LGG.sampleMap_HiSeqV2_PANCAN.gz b/input/TCGA/TCGA_Lower_Grade_Glioma_(LGG)/TCGA.LGG.sampleMap_HiSeqV2_PANCAN.gz new file mode 100644 index 0000000000000000000000000000000000000000..35807cc06104f2af5b720a761158d4cbaa4393cd --- /dev/null +++ b/input/TCGA/TCGA_Lower_Grade_Glioma_(LGG)/TCGA.LGG.sampleMap_HiSeqV2_PANCAN.gz @@ -0,0 +1,3 @@ +version https://git-lfs.github.com/spec/v1 +oid sha256:dcb03b804e02f799618bb9e88715b79e138e7a1f23e191c9e54926ba5f3bb00a +size 36337957 diff --git a/input/TCGA/TCGA_Lower_Grade_Glioma_(LGG)/TCGA.LGG.sampleMap_LGG_clinicalMatrix b/input/TCGA/TCGA_Lower_Grade_Glioma_(LGG)/TCGA.LGG.sampleMap_LGG_clinicalMatrix new file mode 100644 index 0000000000000000000000000000000000000000..932a5cc98b63626d8bcc64936646993cd4f74904 --- /dev/null +++ b/input/TCGA/TCGA_Lower_Grade_Glioma_(LGG)/TCGA.LGG.sampleMap_LGG_clinicalMatrix @@ -0,0 +1,531 @@ +sampleID _INTEGRATION _PATIENT _cohort _primary_disease _primary_site additional_pharmaceutical_therapy additional_radiation_therapy additional_surgery_locoregional_procedure additional_surgery_metastatic_procedure age_at_initial_pathologic_diagnosis animal_insect_allergy_history animal_insect_allergy_types asthma_history bcr_followup_barcode bcr_patient_barcode bcr_sample_barcode days_to_additional_surgery_locoregional_procedure days_to_additional_surgery_metastatic_procedure days_to_birth days_to_collection days_to_death days_to_initial_pathologic_diagnosis days_to_last_followup days_to_new_tumor_event_after_initial_treatment days_to_performance_status_assessment eastern_cancer_oncology_group eczema_history family_history_of_cancer family_history_of_primary_brain_tumor first_diagnosis_age_asth_ecz_hay_fev_mold_dust first_diagnosis_age_of_animal_insect_allergy first_diagnosis_age_of_food_allergy first_presenting_symptom first_presenting_symptom_longest_duration followup_case_report_form_submission_reason followup_treatment_success food_allergy_history food_allergy_types form_completion_date gender hay_fever_history headache_history histological_type history_ionizing_rt_to_head history_of_neoadjuvant_treatment icd_10 icd_o_3_histology icd_o_3_site informed_consent_verified inherited_genetic_syndrome_found inherited_genetic_syndrome_result initial_weight intermediate_dimension is_ffpe karnofsky_performance_score laterality ldh1_mutation_found ldh1_mutation_test_method ldh1_mutation_tested longest_dimension lost_follow_up mental_status_changes mold_or_dust_allergy_history motor_movement_changes neoplasm_histologic_grade new_tumor_event_after_initial_treatment oct_embedded other_dx pathology_report_file_name patient_id performance_status_scale_timing person_neoplasm_cancer_status preoperative_antiseizure_meds preoperative_corticosteroids primary_therapy_outcome_success radiation_therapy sample_type sample_type_id seizure_history sensory_changes shortest_dimension supratentorial_localization targeted_molecular_therapy tissue_prospective_collection_indicator tissue_retrospective_collection_indicator tissue_source_site tumor_location tumor_tissue_site vial_number visual_changes vital_status year_of_initial_pathologic_diagnosis _GENOMIC_ID_TCGA_LGG_mutation _GENOMIC_ID_TCGA_LGG_PDMRNAseq _GENOMIC_ID_TCGA_LGG_RPPA _GENOMIC_ID_TCGA_LGG_mutation_broad_gene _GENOMIC_ID_TCGA_LGG_gistic2 _GENOMIC_ID_TCGA_LGG_exp_HiSeqV2_exon _GENOMIC_ID_TCGA_LGG_miRNA_HiSeq _GENOMIC_ID_TCGA_LGG_PDMarrayCNV _GENOMIC_ID_data/public/TCGA/LGG/miRNA_HiSeq_gene _GENOMIC_ID_TCGA_LGG_mutation_curated_broad_gene _GENOMIC_ID_TCGA_LGG_exp_HiSeqV2_percentile _GENOMIC_ID_TCGA_LGG_hMethyl450_MethylMix _GENOMIC_ID_TCGA_LGG_PDMRNAseqCNV _GENOMIC_ID_TCGA_LGG_mutation_bcm_gene _GENOMIC_ID_TCGA_LGG_hMethyl450 _GENOMIC_ID_TCGA_LGG_PDMarray _GENOMIC_ID_TCGA_LGG_exp_HiSeqV2 _GENOMIC_ID_TCGA_LGG_G4502A_07_3 _GENOMIC_ID_TCGA_LGG_exp_HiSeqV2_PANCAN _GENOMIC_ID_TCGA_LGG_gistic2thd _GENOMIC_ID_TCGA_LGG_mutation_ucsc_maf_gene +TCGA-CS-4938-01 TCGA-CS-4938-01 TCGA-CS-4938 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 31 YES Dog, Cat NO TCGA-CS-4938-F71559 TCGA-CS-4938 TCGA-CS-4938-01B -11509 0 3574 -1 1 NO YES YES 12 - 20 Years Seizures > 181 Days Stable Disease NO 2015-3-30 FEMALE NO NO Astrocytoma NO No C71.9 9400/3 C71.9 YES 0.6 NO 90 Right NO 1.5 NO NO NO NO G2 No TCGA-CS-4938.36632fe7-c93d-4cad-bd58-2d259d36127c.pdf 4938 Preoperative WITH TUMOR NO NO Primary Tumor 01 YES NO 0.3 Cerebral Cortex NO YES CS Supratentorial, Frontal Lobe Central nervous system B NO LIVING 2005 TCGA-CS-4938-01B-11D-1893-08 TCGA-CS-4938-01 D295D82A-5B2B-4DC5-A2B6-4D8321DB9C5F TCGA-CS-4938-01B-11D-1893-08 TCGA-CS-4938-01B-11D-1892-01 0270b7ae-ef7f-4dd7-b019-3e10afa191ff TCGA-CS-4938-01 TCGA-CS-4938-01 TCGA-CS-4938-01B-11D-1893-08 0270b7ae-ef7f-4dd7-b019-3e10afa191ff TCGA-CS-4938-01 TCGA-CS-4938-01 TCGA-CS-4938-01B-11D-1893-08 TCGA-CS-4938-01B-11D-1894-05 0270b7ae-ef7f-4dd7-b019-3e10afa191ff 0270b7ae-ef7f-4dd7-b019-3e10afa191ff TCGA-CS-4938-01B-11D-1892-01 TCGA-CS-4938-01B-11D-1893-08 +TCGA-CS-4941-01 TCGA-CS-4941-01 TCGA-CS-4941 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain NO YES YES NO 67 NO NO TCGA-CS-4941-F10024 TCGA-CS-4941 77 77 -24578 234 0 9 82 1 NO Headaches 0 - 30 Days Progressive Disease NO 2011-3-16 MALE NO YES Astrocytoma NO No C71.9 9401/3 C71.9 YES NO 90 Right NO NO G3 YES No 4941 Post-Adjuvant Therapy WITH TUMOR Stable Disease YES Primary Tumor 01 Cerebral Cortex YES NO YES CS Supratentorial, Frontal Lobe Central nervous system DECEASED 2005 TCGA-CS-4941-01A-01D-1468-08 TCGA-CS-4941-01 TCGA-CS-4941-01A-01D-1468-08 TCGA-CS-4941-01A-01D-1466-01 f48c7bd0-048b-411e-a99c-4a6af9df51e4 TCGA-CS-4941-01 TCGA-CS-4941-01 TCGA-CS-4941-01A-01D-1468-08 f48c7bd0-048b-411e-a99c-4a6af9df51e4 TCGA-CS-4941-01 TCGA-CS-4941-01 TCGA-CS-4941-01A-01D-1468-08 TCGA-CS-4941-01A-01D-1467-05 f48c7bd0-048b-411e-a99c-4a6af9df51e4 f48c7bd0-048b-411e-a99c-4a6af9df51e4 TCGA-CS-4941-01A-01D-1466-01 TCGA-CS-4941-01A-01D-1468-08 +TCGA-CS-4942-01 TCGA-CS-4942-01 TCGA-CS-4942 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain YES YES YES NO 44 NO NO TCGA-CS-4942-F10210 TCGA-CS-4942 TCGA-CS-4942-01A 1189 1189 -16297 1335 0 1184 1226 2 NO NO NO Mental Status Changes 0 - 30 Days Progressive Disease NO 2011-3-14 FEMALE NO NO Astrocytoma NO No C71.9 9401/3 C71.9 YES NO 0.4 NO 70 Right NO 0.5 YES NO YES G3 YES No TCGA-CS-4942.052c9ff3-16ad-4219-8839-488297bead1f.pdf 4942 Preoperative WITH TUMOR NO NO Progressive Disease YES Primary Tumor 01 YES YES 0.4 White Matter NO NO YES CS Supratentorial, Frontal Lobe Central nervous system A NO DECEASED 2006 TCGA-CS-4942-01A-01D-1468-08 TCGA-CS-4942-01 397A17DF-035A-4A5B-BB01-0B4EBB2A0435 TCGA-CS-4942-01A-01D-1468-08 TCGA-CS-4942-01A-01D-1466-01 ff2d7d80-5256-4f05-bcd8-aa9d2816676d TCGA-CS-4942-01 TCGA-CS-4942-01 TCGA-CS-4942-01 TCGA-CS-4942-01A-01D-1468-08 ff2d7d80-5256-4f05-bcd8-aa9d2816676d TCGA-CS-4942-01 TCGA-CS-4942-01 TCGA-CS-4942-01A-01D-1468-08 TCGA-CS-4942-01A-01D-1467-05 TCGA-CS-4942-01 ff2d7d80-5256-4f05-bcd8-aa9d2816676d TCGA-CS-4942-01A-01R-1470-07 ff2d7d80-5256-4f05-bcd8-aa9d2816676d TCGA-CS-4942-01A-01D-1466-01 TCGA-CS-4942-01A-01D-1468-08 +TCGA-CS-4943-01 TCGA-CS-4943-01 TCGA-CS-4943 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 37 TCGA-CS-4943-F71549 TCGA-CS-4943 TCGA-CS-4943-01A -13565 1106 0 481 9 4 Seizures > 181 Days 2015-3-26 MALE YES Astrocytoma NO No C71.9 9401/3 C71.9 YES 0.5 NO 50 Left NO 0.6 NO G3 No TCGA-CS-4943.c7cbbdb2-8ec4-4e6e-836e-2577cda328dc.pdf 4943 Preoperative WITH TUMOR YES Primary Tumor 01 YES 0.1 Cerebral Cortex NO YES CS Supratentorial, Frontal Lobe Central nervous system A DECEASED 2009 TCGA-CS-4943-01A-01D-1468-08 TCGA-CS-4943-01 1E6888CE-202E-4E77-98F8-65368D60ECE8 TCGA-CS-4943-01A-01D-1468-08 TCGA-CS-4943-01A-01D-1466-01 910af7ad-94b5-478e-a2ac-e9f524ef020b TCGA-CS-4943-01 TCGA-CS-4943-01 TCGA-CS-4943-01 TCGA-CS-4943-01A-01D-1468-08 910af7ad-94b5-478e-a2ac-e9f524ef020b TCGA-CS-4943-01 TCGA-CS-4943-01 TCGA-CS-4943-01A-01D-1468-08 TCGA-CS-4943-01A-01D-1467-05 TCGA-CS-4943-01 910af7ad-94b5-478e-a2ac-e9f524ef020b TCGA-CS-4943-01A-01R-1470-07 910af7ad-94b5-478e-a2ac-e9f524ef020b TCGA-CS-4943-01A-01D-1466-01 TCGA-CS-4943-01A-01D-1468-08 +TCGA-CS-4944-01 TCGA-CS-4944-01 TCGA-CS-4944 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 50 TCGA-CS-4944-F71553 TCGA-CS-4944 TCGA-CS-4944-01A -18494 0 1828 -2 1 Mental Status Changes Progressive Disease 2015-3-30 MALE NO Astrocytoma NO No C71.9 9400/3 C71.9 YES NO 0.7 NO 90 Right NO 1 NO YES NO G2 NO No TCGA-CS-4944.6845998b-b702-4f92-85bb-ed8405bf0051.pdf 4944 Preoperative WITH TUMOR Primary Tumor 01 NO 0.3 Cerebral Cortex NO YES CS Supratentorial, Temporal Lobe Central nervous system A NO LIVING 2010 TCGA-CS-4944-01A-01D-1468-08 TCGA-CS-4944-01 E2624955-8A1D-432F-BB77-31C9E1B00F75 TCGA-CS-4944-01A-01D-1468-08 TCGA-CS-4944-01A-01D-1466-01 3ddd5316-2077-41c0-87fa-80be17d77f2b TCGA-CS-4944-01 TCGA-CS-4944-01 TCGA-CS-4944-01 TCGA-CS-4944-01A-01D-1468-08 3ddd5316-2077-41c0-87fa-80be17d77f2b TCGA-CS-4944-01 TCGA-CS-4944-01 TCGA-CS-4944-01A-01D-1468-08 TCGA-CS-4944-01A-01D-1467-05 TCGA-CS-4944-01 3ddd5316-2077-41c0-87fa-80be17d77f2b TCGA-CS-4944-01A-01R-1470-07 3ddd5316-2077-41c0-87fa-80be17d77f2b TCGA-CS-4944-01A-01D-1466-01 TCGA-CS-4944-01A-01D-1468-08 +TCGA-CS-5390-01 TCGA-CS-5390-01 TCGA-CS-5390 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 47 NO TCGA-CS-5390-F71691 TCGA-CS-5390 TCGA-CS-5390-01A -17460 0 1848 0 NO NO NO Sensory Changes Stable Disease 2015-3-30 FEMALE NO Oligodendroglioma NO No C71.9 9450/3 C71.9 YES 0.6 NO 100 Right NO 1.1 NO NO NO YES G2 [Discrepancy] No TCGA-CS-5390.9162696a-6132-4fe2-b3ee-a13e006225ba.pdf 5390 Post-Adjuvant Therapy WITH TUMOR NO [Discrepancy] Primary Tumor 01 NO YES 0.4 Cerebral Cortex NO YES CS Supratentorial, Parietal Lobe Central nervous system A DECEASED 2005 TCGA-CS-5390-01A-02D-1468-08 TCGA-CS-5390-01 570F011A-96FE-484B-992C-6B4CD3E99F94 TCGA-CS-5390-01A-02D-1468-08 TCGA-CS-5390-01A-02D-1466-01 d6d3dab0-2580-41f9-975b-f12b390034fd TCGA-CS-5390-01 TCGA-CS-5390-01 TCGA-CS-5390-01 TCGA-CS-5390-01A-02D-1468-08 d6d3dab0-2580-41f9-975b-f12b390034fd TCGA-CS-5390-01 TCGA-CS-5390-01 TCGA-CS-5390-01A-02D-1468-08 TCGA-CS-5390-01A-02D-1467-05 TCGA-CS-5390-01 d6d3dab0-2580-41f9-975b-f12b390034fd TCGA-CS-5390-01A-02R-1470-07 d6d3dab0-2580-41f9-975b-f12b390034fd TCGA-CS-5390-01A-02D-1466-01 TCGA-CS-5390-01A-02D-1468-08 +TCGA-CS-5393-01 TCGA-CS-5393-01 TCGA-CS-5393 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 39 NO TCGA-CS-5393-F10073 TCGA-CS-5393 TCGA-CS-5393-01A -14418 0 1222 857 0 NO NO Headaches 91 - 180 Days Complete Remission/Response 2011-3-13 MALE YES Astrocytoma YES No C71.9 9401/3 C71.9 YES 1 NO 100 Left NO 1.6 NO NO G3 NO No TCGA-CS-5393.760b381f-f65d-4a68-a1e6-381afda2d805.pdf 5393 Post-Adjuvant Therapy TUMOR FREE NO Complete Remission/Response YES Primary Tumor 01 NO NO 0.3 Cerebral Cortex YES NO YES CS Supratentorial, Temporal Lobe Central nervous system A NO LIVING 2008 TCGA-CS-5393-01A-01D-1468-08 TCGA-CS-5393-01 2E792F0D-CAAF-4EA5-8F4C-91BCD84464CD TCGA-CS-5393-01A-01D-1468-08 TCGA-CS-5393-01A-01D-1466-01 05e8c2a3-20fa-4324-b147-8a94948bda68 TCGA-CS-5393-01 TCGA-CS-5393-01 TCGA-CS-5393-01A-01D-1468-08 05e8c2a3-20fa-4324-b147-8a94948bda68 TCGA-CS-5393-01 TCGA-CS-5393-01 TCGA-CS-5393-01A-01D-1468-08 TCGA-CS-5393-01A-01D-1467-05 05e8c2a3-20fa-4324-b147-8a94948bda68 05e8c2a3-20fa-4324-b147-8a94948bda68 TCGA-CS-5393-01A-01D-1466-01 TCGA-CS-5393-01A-01D-1468-08 +TCGA-CS-5394-01 TCGA-CS-5394-01 TCGA-CS-5394 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 40 NO NO TCGA-CS-5394-F71692 TCGA-CS-5394 TCGA-CS-5394-01A -14920 0 8 -1 NO Seizures 0 - 30 Days NO 2015-3-31 MALE NO NO Astrocytoma NO No C71.9 9401/3 C71.9 YES 0.7 NO Left 1.2 YES NO NO NO G3 No TCGA-CS-5394.e2716cb5-e02c-4867-ba99-fe8337878d9c.pdf 5394 YES YES Primary Tumor 01 YES NO 0.6 Cerebral Cortex NO YES CS Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2005 TCGA-CS-5394-01 2A654C18-F0DB-46EB-B0B4-30153215AF1A TCGA-CS-5394-01A-01D-1468-08 TCGA-CS-5394-01A-01D-1466-01 84c59879-1b8a-4750-8069-9d0e434fa0dc TCGA-CS-5394-01 TCGA-CS-5394-01 TCGA-CS-5394-01 TCGA-CS-5394-01A-01D-1468-08 84c59879-1b8a-4750-8069-9d0e434fa0dc TCGA-CS-5394-01 TCGA-CS-5394-01 TCGA-CS-5394-01A-01D-1468-08 TCGA-CS-5394-01A-01D-1467-05 TCGA-CS-5394-01 84c59879-1b8a-4750-8069-9d0e434fa0dc TCGA-CS-5394-01A-01R-1470-07 84c59879-1b8a-4750-8069-9d0e434fa0dc TCGA-CS-5394-01A-01D-1466-01 TCGA-CS-5394-01A-01D-1468-08 +TCGA-CS-5395-01 TCGA-CS-5395-01 TCGA-CS-5395 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain NO NO YES YES 43 TCGA-CS-5395-F10075 TCGA-CS-5395 TCGA-CS-5395-01A 287 287 -15848 639 0 287 379 2 Progressive Disease 2011-3-13 MALE Oligodendroglioma NO No C71.9 9382/3 C71.9 YES 1 NO 80 Right NO 1.5 G2 YES No TCGA-CS-5395.509c2da8-c6cf-4803-a643-e42ad2e4d1f0.pdf 5395 Preoperative WITH TUMOR Progressive Disease YES Primary Tumor 01 0.1 Cerebral Cortex YES NO YES CS Supratentorial, Parietal Lobe Central nervous system A DECEASED 2007 TCGA-CS-5395-01A-01D-1468-08 TCGA-CS-5395-01 TCGA-CS-5395-01A-01D-1468-08 TCGA-CS-5395-01A-01D-1466-01 6ff35e89-30b4-447e-9ef5-b67210b7859d TCGA-CS-5395-01 TCGA-CS-5395-01 TCGA-CS-5395-01 TCGA-CS-5395-01A-01D-1468-08 6ff35e89-30b4-447e-9ef5-b67210b7859d TCGA-CS-5395-01 TCGA-CS-5395-01 TCGA-CS-5395-01A-01D-1468-08 TCGA-CS-5395-01A-01D-1467-05 TCGA-CS-5395-01 6ff35e89-30b4-447e-9ef5-b67210b7859d TCGA-CS-5395-01A-01R-1470-07 6ff35e89-30b4-447e-9ef5-b67210b7859d TCGA-CS-5395-01A-01D-1466-01 TCGA-CS-5395-01A-01D-1468-08 +TCGA-CS-5396-01 TCGA-CS-5396-01 TCGA-CS-5396 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 53 NO TCGA-CS-5396-F71560 TCGA-CS-5396 TCGA-CS-5396-01A -19399 0 1631 20 1 NO YES YES Headaches Stable Disease 2015-3-30 FEMALE YES Oligodendroglioma NO No C71.9 9451/3 C71.9 YES NO 0.9 NO 90 Right NO 1.6 NO NO NO G3 No TCGA-CS-5396.7ae9d388-1145-4549-91fe-0b8dc6d180fa.pdf 5396 Preoperative WITH TUMOR [Discrepancy] Primary Tumor 01 NO 0.8 Cerebral Cortex NO YES CS Supratentorial, Frontal Lobe Central nervous system A LIVING 2010 TCGA-CS-5396-01A-02D-1468-08 TCGA-CS-5396-01 3B279454-9B42-4401-B737-C3EEACC7A398 TCGA-CS-5396-01A-02D-1468-08 TCGA-CS-5396-01A-02D-1466-01 772424b5-73f8-434e-a565-1cde4aaa1126 TCGA-CS-5396-01 TCGA-CS-5396-01 TCGA-CS-5396-01 TCGA-CS-5396-01A-02D-1468-08 772424b5-73f8-434e-a565-1cde4aaa1126 TCGA-CS-5396-01 TCGA-CS-5396-01 TCGA-CS-5396-01A-02D-1468-08 TCGA-CS-5396-01A-02D-1467-05 TCGA-CS-5396-01 772424b5-73f8-434e-a565-1cde4aaa1126 TCGA-CS-5396-01A-02R-1470-07 772424b5-73f8-434e-a565-1cde4aaa1126 TCGA-CS-5396-01A-02D-1466-01 TCGA-CS-5396-01A-02D-1468-08 +TCGA-CS-5397-01 TCGA-CS-5397-01 TCGA-CS-5397 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 54 NO NO TCGA-CS-5397-F17567 TCGA-CS-5397 TCGA-CS-5397-01A -19866 194 0 -1 1 NO YES NO Sensory Changes NO 2011-9-23 FEMALE NO NO Astrocytoma NO No C71.9 9401/3 C71.9 YES 0.6 NO 80 Left NO 1.4 NO NO YES G3 NO No TCGA-CS-5397.7082a52b-e688-4642-9bcc-e9c0b2eaf79a.pdf 5397 Preoperative WITH TUMOR NO NO Progressive Disease YES Primary Tumor 01 NO YES 0.5 Cerebral Cortex YES NO YES CS Supratentorial, Temporal Lobe Central nervous system A NO DECEASED 2010 TCGA-CS-5397-01A-01D-1893-08 TCGA-CS-5397-01 82EEB28D-BF7F-406E-BD9D-C8944F0D7B08 TCGA-CS-5397-01A-01D-1893-08 TCGA-CS-5397-01A-01D-1892-01 c1d8d162-5154-4d6a-8166-6e4e8bf5cc8d TCGA-CS-5397-01 TCGA-CS-5397-01 TCGA-CS-5397-01A-01D-1893-08 c1d8d162-5154-4d6a-8166-6e4e8bf5cc8d TCGA-CS-5397-01 TCGA-CS-5397-01 TCGA-CS-5397-01A-01D-1893-08 TCGA-CS-5397-01A-01D-1894-05 c1d8d162-5154-4d6a-8166-6e4e8bf5cc8d c1d8d162-5154-4d6a-8166-6e4e8bf5cc8d TCGA-CS-5397-01A-01D-1892-01 TCGA-CS-5397-01A-01D-1893-08 +TCGA-CS-6186-01 TCGA-CS-6186-01 TCGA-CS-6186 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain YES YES YES NO 58 NO NO TCGA-CS-6186-F18628 TCGA-CS-6186 TCGA-CS-6186-01A 213 -21321 538 0 188 212 1 NO NO NO Seizures 0 - 30 Days Scheduled Follow-up Submission Progressive Disease NO 2011-11-18 MALE NO NO Oligoastrocytoma NO No C71.9 9382/3 C71.9 YES NO 0.7 NO 80 Right NO 1 NO NO NO G3 YES No TCGA-CS-6186.ae1d6c04-b80b-4da5-9c19-0a0ffaf9a332.pdf 6186 Post-Adjuvant Therapy WITH TUMOR NO NO Progressive Disease YES Primary Tumor 01 YES NO 0.3 Cerebral Cortex YES NO YES CS Supratentorial, Frontal Lobe Central nervous system A NO DECEASED 2009 TCGA-CS-6186-01A-12D-2024-08 TCGA-CS-6186-01 E4977A26-88C1-416B-9F93-F761BEC4C4A6 TCGA-CS-6186-01A-12D-2024-08 TCGA-CS-6186-01A-12D-2023-01 f09a51df-011a-419e-b90a-7cd2037c5690 TCGA-CS-6186-01 TCGA-CS-6186-01 TCGA-CS-6186-01A-12D-2024-08 f09a51df-011a-419e-b90a-7cd2037c5690 TCGA-CS-6186-01 TCGA-CS-6186-01 TCGA-CS-6186-01A-12D-2024-08 TCGA-CS-6186-01A-12D-2025-05 f09a51df-011a-419e-b90a-7cd2037c5690 f09a51df-011a-419e-b90a-7cd2037c5690 TCGA-CS-6186-01A-12D-2023-01 TCGA-CS-6186-01A-12D-2024-08 +TCGA-CS-6188-01 TCGA-CS-6188-01 TCGA-CS-6188 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 48 NO NO TCGA-CS-6188-F71551 TCGA-CS-6188 TCGA-CS-6188-01A -17729 814 0 725 -1 1 NO YES YES Seizures 0 - 30 Days NO 2015-3-26 MALE NO NO Astrocytoma NO No C71.9 9401/3 C71.9 YES 0.8 NO 90 Right NO 1.2 NO NO NO NO G3 No TCGA-CS-6188.e85d2ddf-98e1-4a02-bde1-47603463f7fd.pdf 6188 Preoperative WITH TUMOR NO NO Primary Tumor 01 YES NO 0.4 Cerebral Cortex NO YES CS Supratentorial, Temporal Lobe Central nervous system A NO DECEASED 2009 TCGA-CS-6188-01A-11D-1893-08 TCGA-CS-6188-01 9F910CB8-882B-4CC9-B489-CD56DBFC4453 TCGA-CS-6188-01A-11D-1893-08 TCGA-CS-6188-01A-11D-1892-01 66770b06-2cd6-4773-b8e8-5b38faa4f5a4 TCGA-CS-6188-01 TCGA-CS-6188-01 TCGA-CS-6188-01A-11D-1893-08 66770b06-2cd6-4773-b8e8-5b38faa4f5a4 TCGA-CS-6188-01 TCGA-CS-6188-01A-11D-1893-08 TCGA-CS-6188-01A-11D-1894-05 66770b06-2cd6-4773-b8e8-5b38faa4f5a4 66770b06-2cd6-4773-b8e8-5b38faa4f5a4 TCGA-CS-6188-01A-11D-1892-01 TCGA-CS-6188-01A-11D-1893-08 +TCGA-CS-6290-01 TCGA-CS-6290-01 TCGA-CS-6290 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 31 NO NO TCGA-CS-6290-F71693 TCGA-CS-6290 TCGA-CS-6290-01A -11666 1137 0 546 -1 1 NO YES NO Seizures 0 - 30 Days NO 2015-3-30 MALE NO NO Astrocytoma NO No C71.9 9401/3 C71.9 YES 0.4 NO 90 Left NO 0.4 NO NO NO NO G3 No TCGA-CS-6290.4d5bdf18-7799-463d-a33a-beb8322b0621.pdf 6290 Preoperative NO NO Primary Tumor 01 YES NO 0.4 Cerebral Cortex NO YES CS Supratentorial, Temporal Lobe Central nervous system A NO DECEASED 2009 TCGA-CS-6290-01A-11D-1705-08 TCGA-CS-6290-01 TCGA-CS-6290-01A-11D-1705-08 TCGA-CS-6290-01A-11D-1704-01 59b2f45a-f731-4ebc-9e7c-c9748aee3f60 TCGA-CS-6290-01 TCGA-CS-6290-01 TCGA-CS-6290-01A-11D-1705-08 59b2f45a-f731-4ebc-9e7c-c9748aee3f60 TCGA-CS-6290-01 TCGA-CS-6290-01 TCGA-CS-6290-01A-11D-1705-08 TCGA-CS-6290-01A-11D-1706-05 59b2f45a-f731-4ebc-9e7c-c9748aee3f60 59b2f45a-f731-4ebc-9e7c-c9748aee3f60 TCGA-CS-6290-01A-11D-1704-01 TCGA-CS-6290-01A-11D-1705-08 +TCGA-CS-6665-01 TCGA-CS-6665-01 TCGA-CS-6665 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 51 NO NO TCGA-CS-6665-F71561 TCGA-CS-6665 TCGA-CS-6665-01A -18977 0 1568 -1 1 NO NO NO Seizures 0 - 30 Days Stable Disease YES Hazelnuts 2015-3-30 FEMALE NO NO Astrocytoma NO No C71.9 9401/3 C71.9 YES 0.8 NO 90 Right NO 0.8 NO NO NO NO G3 Yes TCGA-CS-6665.733dd970-ddcd-40d4-903d-c8fa7b725cf1.pdf 6665 Preoperative WITH TUMOR NO NO Stable Disease Primary Tumor 01 YES NO 0.2 Cerebral Cortex NO YES CS Supratentorial, Temporal Lobe Central nervous system A NO LIVING 2010 TCGA-CS-6665-01A-11D-1893-08 TCGA-CS-6665-01 28DA5602-6C77-44F4-8CD9-05CBD1631606 TCGA-CS-6665-01A-11D-1893-08 TCGA-CS-6665-01A-11D-1892-01 cb2bd908-4900-4fc2-93c6-7f7ef3efbbed TCGA-CS-6665-01 TCGA-CS-6665-01 TCGA-CS-6665-01A-11D-1893-08 cb2bd908-4900-4fc2-93c6-7f7ef3efbbed TCGA-CS-6665-01 TCGA-CS-6665-01 TCGA-CS-6665-01A-11D-1893-08 TCGA-CS-6665-01A-11D-1894-05 cb2bd908-4900-4fc2-93c6-7f7ef3efbbed cb2bd908-4900-4fc2-93c6-7f7ef3efbbed TCGA-CS-6665-01A-11D-1892-01 TCGA-CS-6665-01A-11D-1893-08 +TCGA-CS-6666-01 TCGA-CS-6666-01 TCGA-CS-6666 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 22 NO NO TCGA-CS-6666-F71562 TCGA-CS-6666 TCGA-CS-6666-01A -8340 0 1428 -1 1 NO YES NO Headaches Complete Remission/Response NO 2015-3-30 MALE NO YES Astrocytoma NO No C71.9 9401/3 C71.9 YES 0.9 NO 90 Right NO 1.8 NO NO NO NO G3 NO No TCGA-CS-6666.9bc50bcf-b22b-4516-b8a9-aec943756116.pdf 6666 Preoperative TUMOR FREE NO NO Complete Remission/Response Primary Tumor 01 NO NO 0.4 Cerebral Cortex NO YES CS Supratentorial, Parietal Lobe Central nervous system A NO LIVING 2010 TCGA-CS-6666-01A-11D-1893-08 TCGA-CS-6666-01 ABC07C18-4A42-4CA5-BF9A-E70935D2B250 TCGA-CS-6666-01A-11D-1893-08 TCGA-CS-6666-01A-11D-1892-01 a990f055-6b58-49c2-8424-4a3f3f5f91f9 TCGA-CS-6666-01 TCGA-CS-6666-01 TCGA-CS-6666-01A-11D-1893-08 a990f055-6b58-49c2-8424-4a3f3f5f91f9 TCGA-CS-6666-01 TCGA-CS-6666-01 TCGA-CS-6666-01A-11D-1893-08 TCGA-CS-6666-01A-11D-1894-05 a990f055-6b58-49c2-8424-4a3f3f5f91f9 a990f055-6b58-49c2-8424-4a3f3f5f91f9 TCGA-CS-6666-01A-11D-1892-01 TCGA-CS-6666-01A-11D-1893-08 +TCGA-CS-6667-01 TCGA-CS-6667-01 TCGA-CS-6667 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 39 NO NO TCGA-CS-6667-F71563 TCGA-CS-6667 TCGA-CS-6667-01A -14375 0 1469 -1 1 NO YES NO Motor/Movement Changes 91 - 180 Days Stable Disease NO 2015-3-30 FEMALE YES NO Astrocytoma NO No C71.9 9400/3 C71.9 YES 0.6 NO 90 Left NO 0.6 NO NO YES YES G2 No TCGA-CS-6667.18c7ebd7-0bdc-42e2-97a7-bf8715b01183.pdf 6667 Preoperative WITH TUMOR NO NO Stable Disease Primary Tumor 01 NO YES 0.2 Cerebral Cortex NO YES CS Supratentorial, Parietal Lobe Central nervous system A NO LIVING 2010 TCGA-CS-6667-01A-12D-2024-08 TCGA-CS-6667-01 TCGA-CS-6667-01A-12D-2024-08 TCGA-CS-6667-01A-12D-2023-01 20108871-61a3-4160-8a9d-c5e4481143a6 TCGA-CS-6667-01 TCGA-CS-6667-01 TCGA-CS-6667-01A-12D-2024-08 20108871-61a3-4160-8a9d-c5e4481143a6 TCGA-CS-6667-01 TCGA-CS-6667-01 TCGA-CS-6667-01A-12D-2024-08 TCGA-CS-6667-01A-12D-2025-05 20108871-61a3-4160-8a9d-c5e4481143a6 20108871-61a3-4160-8a9d-c5e4481143a6 TCGA-CS-6667-01A-12D-2023-01 TCGA-CS-6667-01A-12D-2024-08 +TCGA-CS-6668-01 TCGA-CS-6668-01 TCGA-CS-6668 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 57 NO NO TCGA-CS-6668-F71564 TCGA-CS-6668 TCGA-CS-6668-01A -20836 0 1519 -1 1 NO YES NO Seizures > 181 Days Stable Disease NO 2015-3-30 FEMALE NO NO Oligodendroglioma NO No C71.9 9450/3 C71.9 YES 0.6 NO 90 Left NO 1 NO NO NO YES G2 No TCGA-CS-6668.d5604d22-f9c7-4eb3-af92-44d0f999a905.pdf 6668 Preoperative WITH TUMOR NO NO Stable Disease Primary Tumor 01 YES NO 0.5 Cerebral Cortex NO YES CS Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2011 TCGA-CS-6668-01A-11D-1893-08 TCGA-CS-6668-01 79F0BA6A-4929-4418-9E52-BAE243587418 TCGA-CS-6668-01A-11D-1893-08 TCGA-CS-6668-01A-11D-1892-01 129df624-1d84-49b8-ab0e-0001cc150607 TCGA-CS-6668-01 TCGA-CS-6668-01 TCGA-CS-6668-01A-11D-1893-08 129df624-1d84-49b8-ab0e-0001cc150607 TCGA-CS-6668-01 TCGA-CS-6668-01 TCGA-CS-6668-01A-11D-1893-08 TCGA-CS-6668-01A-11D-1894-05 129df624-1d84-49b8-ab0e-0001cc150607 129df624-1d84-49b8-ab0e-0001cc150607 TCGA-CS-6668-01A-11D-1892-01 TCGA-CS-6668-01A-11D-1893-08 +TCGA-CS-6669-01 TCGA-CS-6669-01 TCGA-CS-6669 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 26 NO NO TCGA-CS-6669-F71567 TCGA-CS-6669 TCGA-CS-6669-01A -9809 0 1494 0 1 NO YES NO Headaches 31 - 90 Days Stable Disease NO 2015-3-30 FEMALE NO YES Oligodendroglioma NO No C71.9 9450/3 C71.9 YES 0.4 NO 90 Right NO 1.3 NO NO NO NO G2 No TCGA-CS-6669.4d8abb1c-f9a3-4e9b-8140-1b8f7cc9ba5b.pdf 6669 Preoperative WITH TUMOR NO NO Stable Disease Primary Tumor 01 YES NO 0.2 Cerebral Cortex NO YES CS Supratentorial, Temporal Lobe Central nervous system A NO LIVING 2011 TCGA-CS-6669-01A-11D-1893-08 TCGA-CS-6669-01 3A87E4E5-5804-472B-BD19-1DA36BE9D920 TCGA-CS-6669-01A-11D-1893-08 TCGA-CS-6669-01A-11D-1892-01 f107ba9e-f52a-4a6b-b659-8dabf17c9120 TCGA-CS-6669-01 TCGA-CS-6669-01 f107ba9e-f52a-4a6b-b659-8dabf17c9120 TCGA-CS-6669-01 TCGA-CS-6669-01 TCGA-CS-6669-01A-11D-1893-08 TCGA-CS-6669-01A-11D-1894-05 f107ba9e-f52a-4a6b-b659-8dabf17c9120 f107ba9e-f52a-4a6b-b659-8dabf17c9120 TCGA-CS-6669-01A-11D-1892-01 TCGA-CS-6669-01A-11D-1893-08 +TCGA-CS-6670-01 TCGA-CS-6670-01 TCGA-CS-6670 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 43 NO NO TCGA-CS-6670-F71568 TCGA-CS-6670 TCGA-CS-6670-01A -16066 0 1426 NO NO NO Headaches 31 - 90 Days Progressive Disease NO 2015-3-30 MALE NO YES Oligodendroglioma NO Yes C71.9 9451/3 C71.9 YES 0.8 NO Right NO 1 NO NO NO NO G3 Yes TCGA-CS-6670.925aeb6b-7ed0-40b5-b2bb-52efbdab0748.pdf 6670 WITH TUMOR NO NO [Discrepancy] Primary Tumor 01 NO NO 0.3 Cerebral Cortex CS Supratentorial, Temporal Lobe Central nervous system A NO LIVING 2011 TCGA-CS-6670-01A-11D-1893-08 TCGA-CS-6670-01 F9ABBF27-F31B-4823-BF8B-F728848FFF29 TCGA-CS-6670-01A-11D-1893-08 TCGA-CS-6670-01A-11D-1892-01 a51a4c9e-c160-4a29-8b72-3c1ff60b0107 TCGA-CS-6670-01 TCGA-CS-6670-01 a51a4c9e-c160-4a29-8b72-3c1ff60b0107 TCGA-CS-6670-01 TCGA-CS-6670-01 TCGA-CS-6670-01A-11D-1894-05 a51a4c9e-c160-4a29-8b72-3c1ff60b0107 a51a4c9e-c160-4a29-8b72-3c1ff60b0107 TCGA-CS-6670-01A-11D-1892-01 TCGA-CS-6670-01A-11D-1893-08 +TCGA-DB-5270-01 TCGA-DB-5270-01 TCGA-DB-5270 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 38 YES Bee/Wasp NO TCGA-DB-5270-F42829 TCGA-DB-5270 TCGA-DB-5270-01A -13904 0 3733 NO NO Seizures 0 - 30 Days Scheduled Follow-up Submission Complete Remission/Response NO 2013-5-1 FEMALE NO NO Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES NO 1 NO Left NO 1 NO NO NO NO G3 NO No TCGA-DB-5270.dd42d675-2630-4ae6-9f3b-9595dafee3ea.pdf 5270 TUMOR FREE YES NO Complete Remission/Response NO Primary Tumor 01 YES NO 0.7 Cerebral Cortex NO NO YES DB Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2002 TCGA-DB-5270-01A-02D-1468-08 TCGA-DB-5270-01 2190C47A-5960-44BE-B636-EA19FCFEBD5F TCGA-DB-5270-01A-02D-1468-08 TCGA-DB-5270-01A-02D-1466-01 6679ab80-6b49-4779-88e8-a311e16c96f7 TCGA-DB-5270-01 TCGA-DB-5270-01 TCGA-DB-5270-01 6679ab80-6b49-4779-88e8-a311e16c96f7 TCGA-DB-5270-01 TCGA-DB-5270-01 TCGA-DB-5270-01A-02D-1467-05 TCGA-DB-5270-01 6679ab80-6b49-4779-88e8-a311e16c96f7 TCGA-DB-5270-01A-02R-1470-07 6679ab80-6b49-4779-88e8-a311e16c96f7 TCGA-DB-5270-01A-02D-1466-01 TCGA-DB-5270-01A-02D-1468-08 +TCGA-DB-5273-01 TCGA-DB-5273-01 TCGA-DB-5273 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 33 NO NO TCGA-DB-5273-F42830 TCGA-DB-5273 TCGA-DB-5273-01A -12152 0 2493 NO NO NO Seizures 0 - 30 Days Scheduled Follow-up Submission Complete Remission/Response NO 2013-5-1 MALE NO NO Astrocytoma NO No C71.0 9401/3 C71.0 YES NO 1 NO Right NO 1.5 NO NO NO YES G3 NO No TCGA-DB-5273.a415e3dd-3b4f-4e69-b1c8-474d38e98a83.pdf 5273 TUMOR FREE YES NO Complete Remission/Response YES Primary Tumor 01 YES NO 0.3 Cerebral Cortex YES NO YES DB Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2006 TCGA-DB-5273-01A-01D-1468-08 TCGA-DB-5273-01 709291CF-3A51-4A96-B683-A7F624E8AE90 TCGA-DB-5273-01A-01D-1468-08 TCGA-DB-5273-01A-01D-1466-01 ed075623-6495-4eab-a15d-ab68d5ca0999 TCGA-DB-5273-01 TCGA-DB-5273-01 TCGA-DB-5273-01 TCGA-DB-5273-01A-01D-1468-08 ed075623-6495-4eab-a15d-ab68d5ca0999 TCGA-DB-5273-01 TCGA-DB-5273-01 TCGA-DB-5273-01A-01D-1468-08 TCGA-DB-5273-01A-01D-1467-05 TCGA-DB-5273-01 ed075623-6495-4eab-a15d-ab68d5ca0999 TCGA-DB-5273-01A-01R-1470-07 ed075623-6495-4eab-a15d-ab68d5ca0999 TCGA-DB-5273-01A-01D-1466-01 TCGA-DB-5273-01A-01D-1468-08 +TCGA-DB-5274-01 TCGA-DB-5274-01 TCGA-DB-5274 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 37 NO TCGA-DB-5274-F42834 TCGA-DB-5274 TCGA-DB-5274-01A -13680 0 2289 12 1 NO NO NO Headaches 31 - 90 Days Scheduled Follow-up Submission Complete Remission/Response NO 2013-5-1 FEMALE NO YES Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES NO 1.6 NO 80 Left 1.7 NO NO NO NO G3 NO No TCGA-DB-5274.e287cee7-9711-450c-817e-238d8c3978ed.pdf 5274 Preoperative TUMOR FREE YES YES Complete Remission/Response YES Primary Tumor 01 NO NO 0.7 Cerebral Cortex YES NO YES DB Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2006 TCGA-DB-5274-01A-01D-1468-08 TCGA-DB-5274-01 60BFBB27-8B99-4433-9EB2-9C6ACB6F9B86 TCGA-DB-5274-01A-01D-1468-08 TCGA-DB-5274-01A-01D-1466-01 e42fd909-d0b3-4b6d-8b2b-008ad7b7945c TCGA-DB-5274-01 TCGA-DB-5274-01 TCGA-DB-5274-01 TCGA-DB-5274-01A-01D-1468-08 e42fd909-d0b3-4b6d-8b2b-008ad7b7945c TCGA-DB-5274-01 TCGA-DB-5274-01 TCGA-DB-5274-01A-01D-1468-08 TCGA-DB-5274-01A-01D-1467-05 TCGA-DB-5274-01 e42fd909-d0b3-4b6d-8b2b-008ad7b7945c TCGA-DB-5274-01A-01R-1470-07 e42fd909-d0b3-4b6d-8b2b-008ad7b7945c TCGA-DB-5274-01A-01D-1466-01 TCGA-DB-5274-01A-01D-1468-08 +TCGA-DB-5275-01 TCGA-DB-5275-01 TCGA-DB-5275 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 36 NO NO TCGA-DB-5275-F67391 TCGA-DB-5275 TCGA-DB-5275-01A -13371 0 1458 NO NO NO Headaches Scheduled Follow-up Submission YES lactose containing products 2014-11-4 MALE NO YES Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES NO 1 NO Right 1.7 YES YES NO NO G3 No TCGA-DB-5275.a034b295-7764-4732-94ea-a11a467642dd.pdf 5275 TUMOR FREE NO NO Complete Remission/Response YES Primary Tumor 01 NO NO 0.3 Cerebral Cortex YES NO YES DB Supratentorial, Temporal Lobe Central nervous system A NO LIVING 2006 TCGA-DB-5275-01A-01D-1468-08 TCGA-DB-5275-01 4D46B518-C02F-4888-83A7-C53D26FAB0BE TCGA-DB-5275-01A-01D-1468-08 TCGA-DB-5275-01A-01D-1466-01 eecd47a0-bde3-438b-b87a-f4e440228579 TCGA-DB-5275-01 TCGA-DB-5275-01 TCGA-DB-5275-01 TCGA-DB-5275-01A-01D-1468-08 eecd47a0-bde3-438b-b87a-f4e440228579 TCGA-DB-5275-01 TCGA-DB-5275-01 TCGA-DB-5275-01A-01D-1468-08 TCGA-DB-5275-01A-01D-1467-05 TCGA-DB-5275-01 eecd47a0-bde3-438b-b87a-f4e440228579 TCGA-DB-5275-01A-01R-1470-07 eecd47a0-bde3-438b-b87a-f4e440228579 TCGA-DB-5275-01A-01D-1466-01 TCGA-DB-5275-01A-01D-1468-08 +TCGA-DB-5276-01 TCGA-DB-5276-01 TCGA-DB-5276 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 32 NO TCGA-DB-5276-F42832 TCGA-DB-5276 TCGA-DB-5276-01A -11738 0 2218 NO NO NO Seizures 0 - 30 Days Scheduled Follow-up Submission Complete Remission/Response NO 2013-5-1 MALE NO NO Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES NO 1.3 NO Left 1.4 NO NO NO NO G3 NO No TCGA-DB-5276.b1f076d6-2b5c-43b9-8240-973c74ebf958.pdf 5276 TUMOR FREE YES YES Complete Remission/Response YES Primary Tumor 01 YES NO 0.4 Cerebral Cortex YES NO YES DB Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2007 TCGA-DB-5276-01A-01D-1468-08 TCGA-DB-5276-01 D5430D67-0596-4578-8B65-4FFA88EC524C TCGA-DB-5276-01A-01D-1468-08 TCGA-DB-5276-01A-01D-1466-01 e93a5c0b-9c66-46d2-a8d6-ae969b28a501 TCGA-DB-5276-01 TCGA-DB-5276-01 TCGA-DB-5276-01 TCGA-DB-5276-01A-01D-1468-08 e93a5c0b-9c66-46d2-a8d6-ae969b28a501 TCGA-DB-5276-01 TCGA-DB-5276-01 TCGA-DB-5276-01A-01D-1468-08 TCGA-DB-5276-01A-01D-1467-05 TCGA-DB-5276-01 e93a5c0b-9c66-46d2-a8d6-ae969b28a501 TCGA-DB-5276-01A-01R-1470-07 e93a5c0b-9c66-46d2-a8d6-ae969b28a501 TCGA-DB-5276-01A-01D-1466-01 TCGA-DB-5276-01A-01D-1468-08 +TCGA-DB-5277-01 TCGA-DB-5277-01 TCGA-DB-5277 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain YES YES NO 34 NO TCGA-DB-5277-F42826 TCGA-DB-5277 TCGA-DB-5277-01A -12725 1547 0 1419 1156 YES YES NO Seizures 0 - 30 Days Scheduled Follow-up Submission Progressive Disease YES seafood 2013-5-1 MALE YES YES Astrocytoma NO No C71.0 9401/3 C71.0 YES NO 1 NO Left 1.5 NO NO YES NO G3 YES No TCGA-DB-5277.5dd3f674-5ffa-45ce-98fd-db55ac716f8e.pdf 5277 WITH TUMOR YES NO Complete Remission/Response YES Primary Tumor 01 YES NO 0.1 Cerebral Cortex YES NO YES DB Supratentorial, Frontal Lobe Central nervous system A NO DECEASED 2007 TCGA-DB-5277-01A-01D-1468-08 TCGA-DB-5277-01 EF884859-661A-483A-BD6F-0B82BDA1E70A TCGA-DB-5277-01A-01D-1468-08 TCGA-DB-5277-01A-01D-1466-01 6a2acb28-0ccb-4f10-aba9-4d8b2aa29b1d TCGA-DB-5277-01 TCGA-DB-5277-01 TCGA-DB-5277-01 TCGA-DB-5277-01A-01D-1468-08 6a2acb28-0ccb-4f10-aba9-4d8b2aa29b1d TCGA-DB-5277-01 TCGA-DB-5277-01 TCGA-DB-5277-01A-01D-1468-08 TCGA-DB-5277-01A-01D-1467-05 TCGA-DB-5277-01 6a2acb28-0ccb-4f10-aba9-4d8b2aa29b1d TCGA-DB-5277-01A-01R-1470-07 6a2acb28-0ccb-4f10-aba9-4d8b2aa29b1d TCGA-DB-5277-01A-01D-1466-01 TCGA-DB-5277-01A-01D-1468-08 +TCGA-DB-5278-01 TCGA-DB-5278-01 TCGA-DB-5278 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 17 NO NO TCGA-DB-5278-F67393 TCGA-DB-5278 TCGA-DB-5278-01A -6480 0 2772 NO NO NO Seizures > 181 Days Scheduled Follow-up Submission NO 2014-11-7 MALE NO NO Oligodendroglioma NO No C71.0 9450/3 C71.0 YES NO 1.3 NO Left 1.8 NO YES NO YES G2 NO No TCGA-DB-5278.b9380181-eb0c-458b-b0c4-38cdf7e06edc.pdf 5278 WITH TUMOR YES NO Stable Disease NO Primary Tumor 01 YES NO 0.4 Cerebral Cortex NO NO YES DB Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2007 TCGA-DB-5278-01A-01D-1468-08 TCGA-DB-5278-01 CAF8FDC9-4576-4401-B7F3-818E2BDE89B5 TCGA-DB-5278-01A-01D-1468-08 TCGA-DB-5278-01A-01D-1466-01 3cd458e4-4e4a-4360-b667-5953c1425f75 TCGA-DB-5278-01 TCGA-DB-5278-01 TCGA-DB-5278-01 TCGA-DB-5278-01A-01D-1468-08 3cd458e4-4e4a-4360-b667-5953c1425f75 TCGA-DB-5278-01 TCGA-DB-5278-01 TCGA-DB-5278-01A-01D-1468-08 TCGA-DB-5278-01A-01D-1467-05 TCGA-DB-5278-01 3cd458e4-4e4a-4360-b667-5953c1425f75 TCGA-DB-5278-01A-01R-1470-07 3cd458e4-4e4a-4360-b667-5953c1425f75 TCGA-DB-5278-01A-01D-1466-01 TCGA-DB-5278-01A-01D-1468-08 +TCGA-DB-5279-01 TCGA-DB-5279-01 TCGA-DB-5279 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 59 NO NO TCGA-DB-5279-F67396 TCGA-DB-5279 TCGA-DB-5279-01A -21908 0 1354 NO NO NO Seizures > 181 Days Scheduled Follow-up Submission Complete Remission/Response NO 2014-11-4 MALE NO NO Oligodendroglioma NO No C71.0 9450/3 C71.0 YES NO 1 NO Right 1.3 YES NO NO NO G2 No TCGA-DB-5279.74052ac9-36de-45e7-8716-c3e74245d43d.pdf 5279 TUMOR FREE YES YES Complete Remission/Response NO Primary Tumor 01 YES NO 0.4 Cerebral Cortex NO NO YES DB Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2007 TCGA-DB-5279-01A-01D-1468-08 TCGA-DB-5279-01 28DCAF30-8DA5-4A90-B572-352050DB9504 TCGA-DB-5279-01A-01D-1468-08 TCGA-DB-5279-01A-01D-1466-01 4af34323-4cc9-4b69-b0cf-558bb9d8ee1a TCGA-DB-5279-01 TCGA-DB-5279-01 TCGA-DB-5279-01A-01D-1468-08 4af34323-4cc9-4b69-b0cf-558bb9d8ee1a TCGA-DB-5279-01 TCGA-DB-5279-01 TCGA-DB-5279-01A-01D-1468-08 TCGA-DB-5279-01A-01D-1467-05 4af34323-4cc9-4b69-b0cf-558bb9d8ee1a 4af34323-4cc9-4b69-b0cf-558bb9d8ee1a TCGA-DB-5279-01A-01D-1466-01 TCGA-DB-5279-01A-01D-1468-08 +TCGA-DB-5280-01 TCGA-DB-5280-01 TCGA-DB-5280 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 43 NO NO TCGA-DB-5280-F42831 TCGA-DB-5280 TCGA-DB-5280-01A -15836 0 1112 NO NO NO Seizures 0 - 30 Days Scheduled Follow-up Submission Complete Remission/Response NO 2013-5-1 MALE NO NO Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES NO 1.5 NO Right 1.6 NO NO NO NO G2 NO No TCGA-DB-5280.9592281f-2fae-4376-9f64-ef19027cb4c3.pdf 5280 TUMOR FREE YES NO Complete Remission/Response NO Primary Tumor 01 YES NO 0.3 Cerebral Cortex NO NO YES DB Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2007 TCGA-DB-5280-01A-01D-1468-08 TCGA-DB-5280-01 8EF8A7ED-4DFD-427D-A8D0-81963AA1E694 TCGA-DB-5280-01A-01D-1468-08 TCGA-DB-5280-01A-01D-1466-01 b946f1d5-835d-4d78-a74d-2d19fa78eb0a TCGA-DB-5280-01 TCGA-DB-5280-01 TCGA-DB-5280-01 TCGA-DB-5280-01A-01D-1468-08 b946f1d5-835d-4d78-a74d-2d19fa78eb0a TCGA-DB-5280-01 TCGA-DB-5280-01 TCGA-DB-5280-01A-01D-1468-08 TCGA-DB-5280-01A-01D-1467-05 TCGA-DB-5280-01 b946f1d5-835d-4d78-a74d-2d19fa78eb0a TCGA-DB-5280-01A-01R-1470-07 b946f1d5-835d-4d78-a74d-2d19fa78eb0a TCGA-DB-5280-01A-01D-1466-01 TCGA-DB-5280-01A-01D-1468-08 +TCGA-DB-5281-01 TCGA-DB-5281-01 TCGA-DB-5281 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 61 NO NO TCGA-DB-5281-F42828 TCGA-DB-5281 TCGA-DB-5281-01A -22342 0 2381 NO NO NO Seizures 91 - 180 Days Scheduled Follow-up Submission Stable Disease NO 2013-5-1 MALE NO NO Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES NO 1 NO Left NO 2 NO YES NO NO G3 NO No TCGA-DB-5281.40462852-7dc3-4a3f-a4f3-7cd5a4adbd0d.pdf 5281 WITH TUMOR YES NO Stable Disease YES Primary Tumor 01 YES NO 0.5 Deep Gray (e.g.basal ganglia, thalamus) YES NO YES DB Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2006 TCGA-DB-5281-01A-01D-1468-08 TCGA-DB-5281-01 57808539-9243-4158-B8D3-87A5866D0C9E TCGA-DB-5281-01A-01D-1468-08 TCGA-DB-5281-01A-01D-1466-01 59da9ec2-3d50-4c01-94ce-6da99d100adb TCGA-DB-5281-01 TCGA-DB-5281-01 TCGA-DB-5281-01 TCGA-DB-5281-01A-01D-1468-08 59da9ec2-3d50-4c01-94ce-6da99d100adb TCGA-DB-5281-01 TCGA-DB-5281-01 TCGA-DB-5281-01A-01D-1468-08 TCGA-DB-5281-01A-01D-1467-05 TCGA-DB-5281-01 59da9ec2-3d50-4c01-94ce-6da99d100adb TCGA-DB-5281-01A-01R-1470-07 59da9ec2-3d50-4c01-94ce-6da99d100adb TCGA-DB-5281-01A-01D-1466-01 TCGA-DB-5281-01A-01D-1468-08 +TCGA-DB-A4X9-01 TCGA-DB-A4X9-01 TCGA-DB-A4X9 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 33 NO TCGA-DB-A4X9-F60941 TCGA-DB-A4X9 TCGA-DB-A4X9-01A -12131 832 0 1412 NO YES NO Seizures > 181 Days Scheduled Follow-up Submission Complete Remission/Response 2014-6-19 FEMALE NO NO Oligoastrocytoma NO No C71.2 9382/3 C71.2 YES NO 460 NO Left YES IHC YES NO NO NO NO G2 NO true No TCGA-DB-A4X9.8C541033-3F59-4F35-9BA8-C5499B944094.pdf A4X9 TUMOR FREE YES NO Complete Remission/Response NO Primary Tumor 01 YES NO Cerebral Cortex NO YES NO DB Supratentorial, Temporal Lobe Central nervous system A NO LIVING 2010 TCGA-DB-A4X9-01 29575E19-9783-4B09-9D05-69C0C279752E TCGA-DB-A4X9-01A-11D-A26M-08 TCGA-DB-A4X9-01A-11D-A26L-01 66a0dece-b8d0-4d6a-a6d9-53985a507f77 TCGA-DB-A4X9-01 TCGA-DB-A4X9-01 TCGA-DB-A4X9-01A-11D-A26M-08 66a0dece-b8d0-4d6a-a6d9-53985a507f77 TCGA-DB-A4X9-01 TCGA-DB-A4X9-01A-11D-A26M-08 TCGA-DB-A4X9-01A-11D-A26N-05 66a0dece-b8d0-4d6a-a6d9-53985a507f77 66a0dece-b8d0-4d6a-a6d9-53985a507f77 TCGA-DB-A4X9-01A-11D-A26L-01 TCGA-DB-A4X9-01A-11D-A26M-08 +TCGA-DB-A4XA-01 TCGA-DB-A4XA-01 TCGA-DB-A4XA TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 30 NO NO TCGA-DB-A4XA-F60947 TCGA-DB-A4XA TCGA-DB-A4XA-01A -11195 224 0 573 NO NO NO Seizures > 181 Days Scheduled Follow-up Submission NO 2014-6-19 MALE NO NO Oligoastrocytoma NO No C71.2 9382/3 C71.2 YES NO 140 NO Left YES IHC YES YES NO NO NO G2 NO true No TCGA-DB-A4XA.8DCE6400-9767-46DD-A965-5B02FEB3F156.pdf A4XA WITH TUMOR YES NO Stable Disease YES Primary Tumor 01 YES NO Cerebral Cortex NO YES NO DB Supratentorial, Parietal Lobe Central nervous system A NO LIVING 2012 TCGA-DB-A4XA-01 C25F3CB3-62F5-446A-9814-DE9929FECB1B TCGA-DB-A4XA-01A-11D-A26M-08 TCGA-DB-A4XA-01A-11D-A26L-01 9ea1bff8-51a1-4773-851c-5c8da0e79565 TCGA-DB-A4XA-01 TCGA-DB-A4XA-01 TCGA-DB-A4XA-01A-11D-A26M-08 9ea1bff8-51a1-4773-851c-5c8da0e79565 TCGA-DB-A4XA-01 TCGA-DB-A4XA-01A-11D-A26M-08 TCGA-DB-A4XA-01A-11D-A26N-05 9ea1bff8-51a1-4773-851c-5c8da0e79565 9ea1bff8-51a1-4773-851c-5c8da0e79565 TCGA-DB-A4XA-01A-11D-A26L-01 TCGA-DB-A4XA-01A-11D-A26M-08 +TCGA-DB-A4XB-01 TCGA-DB-A4XB-01 TCGA-DB-A4XB TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 38 NO TCGA-DB-A4XB-F60944 TCGA-DB-A4XB TCGA-DB-A4XB-01A -13990 372 0 919 NO NO NO Seizures 31 - 90 Days Scheduled Follow-up Submission Complete Remission/Response 2014-6-19 MALE NO Astrocytoma NO No C71.4 9401/3 C71.4 YES NO 120 NO Left YES IHC YES NO NO NO G3 NO true No TCGA-DB-A4XB.EAFB98CA-3206-4193-9FA9-3ECDC5B3A388.pdf A4XB TUMOR FREE YES NO Stable Disease YES Primary Tumor 01 YES NO Cerebral Cortex YES YES NO DB Supratentorial, Parietal Lobe Central nervous system A NO LIVING 2011 TCGA-DB-A4XB-01 5F4BB489-9C6C-41E0-81E2-2621B4D6C6A5 TCGA-DB-A4XB-01A-11D-A26M-08 TCGA-DB-A4XB-01A-11D-A26L-01 e10cc5f8-4d2e-4de5-a31c-5df6889e4ba8 TCGA-DB-A4XB-01 TCGA-DB-A4XB-01 TCGA-DB-A4XB-01A-11D-A26M-08 e10cc5f8-4d2e-4de5-a31c-5df6889e4ba8 TCGA-DB-A4XB-01 TCGA-DB-A4XB-01A-11D-A26M-08 TCGA-DB-A4XB-01A-11D-A26N-05 e10cc5f8-4d2e-4de5-a31c-5df6889e4ba8 e10cc5f8-4d2e-4de5-a31c-5df6889e4ba8 TCGA-DB-A4XB-01A-11D-A26L-01 TCGA-DB-A4XB-01A-11D-A26M-08 +TCGA-DB-A4XC-01 TCGA-DB-A4XC-01 TCGA-DB-A4XC TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 26 NO TCGA-DB-A4XC-F60948 TCGA-DB-A4XC TCGA-DB-A4XC-01A -9705 849 0 1421 NO YES NO Seizures 0 - 30 Days Scheduled Follow-up Submission Stable Disease 2014-6-19 MALE NO Oligoastrocytoma NO No C71.2 9382/3 C71.2 YES NO 230 NO Left NO NO NO NO G2 NO true Yes, History of Synchronous/Bilateral Malignancy TCGA-DB-A4XC.26BC05CE-7A4F-4E5C-84A5-7BA6EC72505D.pdf A4XC TUMOR FREE Partial Remission/Response YES Primary Tumor 01 YES NO Cerebral Cortex NO YES NO DB Supratentorial, Temporal Lobe Central nervous system A NO LIVING 2010 TCGA-DB-A4XC-01 FED4C1DC-5E11-4678-B41B-C31F9E5B47A7 TCGA-DB-A4XC-01A-11D-A26M-08 TCGA-DB-A4XC-01A-11D-A26L-01 ae83a679-8155-4f3a-9c9b-a3b73c8cd332 TCGA-DB-A4XC-01 TCGA-DB-A4XC-01 TCGA-DB-A4XC-01A-11D-A26M-08 ae83a679-8155-4f3a-9c9b-a3b73c8cd332 TCGA-DB-A4XC-01 TCGA-DB-A4XC-01A-11D-A26M-08 TCGA-DB-A4XC-01A-11D-A26N-05 ae83a679-8155-4f3a-9c9b-a3b73c8cd332 ae83a679-8155-4f3a-9c9b-a3b73c8cd332 TCGA-DB-A4XC-01A-11D-A26L-01 TCGA-DB-A4XC-01A-11D-A26M-08 +TCGA-DB-A4XD-01 TCGA-DB-A4XD-01 TCGA-DB-A4XD TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 32 NO TCGA-DB-A4XD-F60950 TCGA-DB-A4XD TCGA-DB-A4XD-01A -11741 719 0 1210 YES NO NO 0 - 30 Days Scheduled Follow-up Submission Complete Remission/Response 2014-6-19 MALE NO Astrocytoma NO No C71.2 9401/3 C71.2 YES NO 280 NO Right NO NO NO NO G3 NO true No TCGA-DB-A4XD.5D9BCE5F-0490-4504-B5A2-AB31EDD13605.pdf A4XD TUMOR FREE NO NO Complete Remission/Response YES Primary Tumor 01 NO NO Cerebral Cortex YES YES NO DB Supratentorial, Temporal Lobe Central nervous system A NO LIVING 2010 TCGA-DB-A4XD-01 0372E089-248A-4CC5-8A3D-08B480B6228F TCGA-DB-A4XD-01A-11D-A27K-08 TCGA-DB-A4XD-01A-11D-A27J-01 e948362f-2ae6-437b-a01b-6a1026a8da72 TCGA-DB-A4XD-01 TCGA-DB-A4XD-01 TCGA-DB-A4XD-01A-11D-A27K-08 e948362f-2ae6-437b-a01b-6a1026a8da72 TCGA-DB-A4XD-01 TCGA-DB-A4XD-01A-11D-A27K-08 TCGA-DB-A4XD-01A-11D-A27L-05 e948362f-2ae6-437b-a01b-6a1026a8da72 e948362f-2ae6-437b-a01b-6a1026a8da72 TCGA-DB-A4XD-01A-11D-A27J-01 TCGA-DB-A4XD-01A-11D-A27K-08 +TCGA-DB-A4XE-01 TCGA-DB-A4XE-01 TCGA-DB-A4XE TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 27 NO NO TCGA-DB-A4XE-F60953 TCGA-DB-A4XE TCGA-DB-A4XE-01A -10150 635 0 1139 294 0 NO NO NO Seizures 31 - 90 Days Scheduled Follow-up Submission Complete Remission/Response NO 2014-6-19 FEMALE NO NO Oligoastrocytoma NO No C71.2 9382/3 C71.2 YES NO 170 NO 90 Left NO NO NO NO G3 NO true No TCGA-DB-A4XE.1D110C27-320E-4C5D-A8E1-9DF4F257543D.pdf A4XE Preoperative TUMOR FREE YES NO Complete Remission/Response YES Primary Tumor 01 YES NO Cerebral Cortex NO YES NO DB Supratentorial, Temporal Lobe Central nervous system A NO LIVING 2011 TCGA-DB-A4XE-01 BED139BD-07C0-4762-A27C-851FEAA08EDF TCGA-DB-A4XE-01A-11D-A27K-08 TCGA-DB-A4XE-01A-11D-A27J-01 a622534d-0108-4890-a0c5-4d1e12c25e44 TCGA-DB-A4XE-01 TCGA-DB-A4XE-01 TCGA-DB-A4XE-01A-11D-A27K-08 a622534d-0108-4890-a0c5-4d1e12c25e44 TCGA-DB-A4XE-01 TCGA-DB-A4XE-01A-11D-A27K-08 TCGA-DB-A4XE-01A-11D-A27L-05 a622534d-0108-4890-a0c5-4d1e12c25e44 a622534d-0108-4890-a0c5-4d1e12c25e44 TCGA-DB-A4XE-01A-11D-A27J-01 TCGA-DB-A4XE-01A-11D-A27K-08 +TCGA-DB-A4XF-01 TCGA-DB-A4XF-01 TCGA-DB-A4XF TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 41 NO TCGA-DB-A4XF-F60956 TCGA-DB-A4XF TCGA-DB-A4XF-01A -15066 456 0 1021 NO YES NO Seizures 0 - 30 Days Scheduled Follow-up Submission Complete Remission/Response 2014-6-19 FEMALE YES Astrocytoma NO No C71.1 9401/3 C71.1 YES NO 300 NO Right NO NO NO NO G3 NO true No TCGA-DB-A4XF.E9D4CC67-D5FC-4E81-91EB-869D93114475.pdf A4XF TUMOR FREE YES NO Stable Disease YES Primary Tumor 01 YES NO Cerebral Cortex YES YES NO DB Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2011 TCGA-DB-A4XF-01 961C7E35-6F32-4E35-83BA-26A41C6F94EF TCGA-DB-A4XF-01A-11D-A27K-08 TCGA-DB-A4XF-01A-11D-A27J-01 276b4801-2b93-4224-99a2-d3fb73fca361 TCGA-DB-A4XF-01 TCGA-DB-A4XF-01 TCGA-DB-A4XF-01A-11D-A27K-08 276b4801-2b93-4224-99a2-d3fb73fca361 TCGA-DB-A4XF-01 TCGA-DB-A4XF-01A-11D-A27K-08 TCGA-DB-A4XF-01A-11D-A27L-05 276b4801-2b93-4224-99a2-d3fb73fca361 276b4801-2b93-4224-99a2-d3fb73fca361 TCGA-DB-A4XF-01A-11D-A27J-01 TCGA-DB-A4XF-01A-11D-A27K-08 +TCGA-DB-A4XG-01 TCGA-DB-A4XG-01 TCGA-DB-A4XG TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 34 NO NO TCGA-DB-A4XG-F60957 TCGA-DB-A4XG TCGA-DB-A4XG-01A -12550 2137 0 2219 NO NO NO Seizures 0 - 30 Days Scheduled Follow-up Submission NO 2014-6-19 MALE NO NO Oligodendroglioma NO No C71.1 9451/3 C71.1 YES NO 210 NO Right NO IHC YES YES NO NO NO G3 NO true No TCGA-DB-A4XG.A0776539-C1FE-4798-9F65-F807B3414E7C.pdf A4XG WITH TUMOR YES Stable Disease NO Primary Tumor 01 YES NO Cerebral Cortex YES YES NO DB Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2006 TCGA-DB-A4XG-01 C1AD0CEF-C79E-4C88-B311-2EF3A793C36D TCGA-DB-A4XG-01A-11D-A27K-08 TCGA-DB-A4XG-01A-11D-A27J-01 10bc3c22-c4ff-4d44-a44b-dc8dd2cbec2d TCGA-DB-A4XG-01 TCGA-DB-A4XG-01 TCGA-DB-A4XG-01A-11D-A27K-08 10bc3c22-c4ff-4d44-a44b-dc8dd2cbec2d TCGA-DB-A4XG-01 TCGA-DB-A4XG-01A-11D-A27K-08 TCGA-DB-A4XG-01A-11D-A27L-05 10bc3c22-c4ff-4d44-a44b-dc8dd2cbec2d 10bc3c22-c4ff-4d44-a44b-dc8dd2cbec2d TCGA-DB-A4XG-01A-11D-A27J-01 TCGA-DB-A4XG-01A-11D-A27K-08 +TCGA-DB-A4XH-01 TCGA-DB-A4XH-01 TCGA-DB-A4XH TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 53 NO TCGA-DB-A4XH-F60959 TCGA-DB-A4XH TCGA-DB-A4XH-01A -19710 397 0 962 NO NO NO Seizures 0 - 30 Days Scheduled Follow-up Submission Complete Remission/Response 2014-7-22 FEMALE NO Oligoastrocytoma NO No C71.1 9382/3 C71.1 YES NO 160 NO Left NO NO NO NO G2 NO true No TCGA-DB-A4XH.5AD2C9F3-9A4A-4974-98F8-90AA632C1B8D.pdf A4XH TUMOR FREE YES YES Stable Disease NO Primary Tumor 01 YES NO Cerebral Cortex NO YES NO DB Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2011 TCGA-DB-A4XH-01 BBAE0426-DC1A-423A-8B60-C9419E74A412 TCGA-DB-A4XH-01A-11D-A27K-08 TCGA-DB-A4XH-01A-11D-A27J-01 c335d5b6-f135-4bbc-825a-f6ed1746fa0e TCGA-DB-A4XH-01 TCGA-DB-A4XH-01 TCGA-DB-A4XH-01A-11D-A27K-08 c335d5b6-f135-4bbc-825a-f6ed1746fa0e TCGA-DB-A4XH-01 TCGA-DB-A4XH-01A-11D-A27K-08 TCGA-DB-A4XH-01A-11D-A27L-05 c335d5b6-f135-4bbc-825a-f6ed1746fa0e c335d5b6-f135-4bbc-825a-f6ed1746fa0e TCGA-DB-A4XH-01A-11D-A27J-01 TCGA-DB-A4XH-01A-11D-A27K-08 +TCGA-DB-A64L-01 TCGA-DB-A64L-01 TCGA-DB-A64L TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain NO NO NO NO 67 NO NO TCGA-DB-A64L-F62609 TCGA-DB-A64L TCGA-DB-A64L-01A -24690 289 0 736 724 8 NO YES NO Seizures 0 - 30 Days Scheduled Follow-up Submission Stable Disease 2014-11-7 FEMALE NO NO Oligodendroglioma NO No C71.0 9450/3 C71.0 YES YES 150 NO 70 Right YES IHC YES NO NO NO NO G2 YES true No TCGA-DB-A64L.B8075A84-8641-4085-9B51-DF2E1BC37A18.pdf A64L Preoperative WITH TUMOR YES Complete Remission/Response NO Primary Tumor 01 YES NO Cerebral Cortex NO YES NO DB Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2012 TCGA-DB-A64L-01 17FAC5D6-22E6-4FB4-86A5-B19383CD020D TCGA-DB-A64L-01A-11D-A29Q-08 TCGA-DB-A64L-01A-11D-A323-01 c0727365-8495-4a96-85b0-4a685627839e TCGA-DB-A64L-01 TCGA-DB-A64L-01 TCGA-DB-A64L-01A-11D-A29Q-08 c0727365-8495-4a96-85b0-4a685627839e TCGA-DB-A64L-01 TCGA-DB-A64L-01A-11D-A29Q-08 TCGA-DB-A64L-01A-11D-A29T-05 c0727365-8495-4a96-85b0-4a685627839e c0727365-8495-4a96-85b0-4a685627839e TCGA-DB-A64L-01A-11D-A323-01 TCGA-DB-A64L-01A-11D-A29Q-08 +TCGA-DB-A64O-01 TCGA-DB-A64O-01 TCGA-DB-A64O TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 59 NO TCGA-DB-A64O-F62610 TCGA-DB-A64O TCGA-DB-A64O-01A -21811 533 775 0 573 NO YES NO Motor/Movement Changes 91 - 180 Days Scheduled Follow-up Submission 2014-7-22 MALE NO NO Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES NO 290 NO Left NO IHC YES YES NO YES G2 YES true No TCGA-DB-A64O.67251C0F-7DD0-4736-A614-523DFD359C63.pdf A64O WITH TUMOR YES YES Stable Disease YES Primary Tumor 01 NO NO Cerebral Cortex NO YES NO DB Supratentorial, Temporal Lobe Central nervous system A NO DECEASED 2011 TCGA-DB-A64O-01 4D770136-6E25-4FD7-81E5-141E03739BD5 TCGA-DB-A64O-01A-11D-A29Q-08 TCGA-DB-A64O-01A-11D-A323-01 3eca387f-17e0-438d-8bae-f31f0ce7396d TCGA-DB-A64O-01 TCGA-DB-A64O-01 TCGA-DB-A64O-01A-11D-A29Q-08 3eca387f-17e0-438d-8bae-f31f0ce7396d TCGA-DB-A64O-01 TCGA-DB-A64O-01A-11D-A29Q-08 TCGA-DB-A64O-01A-11D-A29T-05 3eca387f-17e0-438d-8bae-f31f0ce7396d 3eca387f-17e0-438d-8bae-f31f0ce7396d TCGA-DB-A64O-01A-11D-A323-01 TCGA-DB-A64O-01A-11D-A29Q-08 +TCGA-DB-A64P-01 TCGA-DB-A64P-01 TCGA-DB-A64P TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 40 NO TCGA-DB-A64P-F62612 TCGA-DB-A64P TCGA-DB-A64P-01A -14936 443 0 916 NO YES NO Seizures 0 - 30 Days Scheduled Follow-up Submission Complete Remission/Response 2014-7-22 MALE NO NO Oligodendroglioma NO No C71.0 9451/3 C71.0 YES NO 280 NO Left YES IHC YES NO NO NO G3 NO true No TCGA-DB-A64P.3D2EEE2E-B4EB-4603-B4D2-AA4B0F790200.pdf A64P TUMOR FREE YES YES Complete Remission/Response NO Primary Tumor 01 YES NO Cerebral Cortex YES YES NO DB Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2012 TCGA-DB-A64P-01 FCD2F885-601A-4661-BCBD-A96270E275B9 TCGA-DB-A64P-01A-11D-A29Q-08 TCGA-DB-A64P-01A-11D-A323-01 5635d2de-4a0b-4988-8ff7-2056857d0d34 TCGA-DB-A64P-01 TCGA-DB-A64P-01 TCGA-DB-A64P-01A-11D-A29Q-08 5635d2de-4a0b-4988-8ff7-2056857d0d34 TCGA-DB-A64P-01 TCGA-DB-A64P-01A-11D-A29Q-08 TCGA-DB-A64P-01A-11D-A29T-05 5635d2de-4a0b-4988-8ff7-2056857d0d34 5635d2de-4a0b-4988-8ff7-2056857d0d34 TCGA-DB-A64P-01A-11D-A323-01 TCGA-DB-A64P-01A-11D-A29Q-08 +TCGA-DB-A64Q-01 TCGA-DB-A64Q-01 TCGA-DB-A64Q TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 31 NO TCGA-DB-A64Q-F62614 TCGA-DB-A64Q TCGA-DB-A64Q-01A -11637 251 0 182 -3 NO NO NO Seizures 31 - 90 Days Scheduled Follow-up Submission 2014-7-22 FEMALE NO NO Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES NO 200 NO 90 Left YES IHC YES YES NO NO G2 NO true No TCGA-DB-A64Q.1650DAE4-352B-4BDD-A48E-109FDE2CD3F9.pdf A64Q Preoperative TUMOR FREE YES NO Stable Disease NO Primary Tumor 01 YES NO Cerebral Cortex YES YES NO DB Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2012 TCGA-DB-A64Q-01 424A09FC-9175-4F00-9EAE-0046DE578145 TCGA-DB-A64Q-01A-11D-A29Q-08 TCGA-DB-A64Q-01A-11D-A323-01 f2249fe9-e838-4895-9e46-98fa8f30655e TCGA-DB-A64Q-01 TCGA-DB-A64Q-01 TCGA-DB-A64Q-01A-11D-A29Q-08 f2249fe9-e838-4895-9e46-98fa8f30655e TCGA-DB-A64Q-01 TCGA-DB-A64Q-01A-11D-A29Q-08 TCGA-DB-A64Q-01A-11D-A29T-05 f2249fe9-e838-4895-9e46-98fa8f30655e f2249fe9-e838-4895-9e46-98fa8f30655e TCGA-DB-A64Q-01A-11D-A323-01 TCGA-DB-A64Q-01A-11D-A29Q-08 +TCGA-DB-A64R-01 TCGA-DB-A64R-01 TCGA-DB-A64R TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 24 YES NO TCGA-DB-A64R-F62622 TCGA-DB-A64R TCGA-DB-A64R-01A -8947 436 0 955 -6 NO NO NO Seizures 91 - 180 Days Scheduled Follow-up Submission Complete Remission/Response YES lactose 2014-11-4 FEMALE NO Oligodendroglioma NO No C71.0 9450/3 C71.0 YES NO 90 NO 90 Right YES IHC YES NO NO NO G2 NO true No TCGA-DB-A64R.A9F5EDE4-1FC5-4E6D-BEA1-70B6223A49FE.pdf A64R Preoperative TUMOR FREE YES NO Complete Remission/Response NO Primary Tumor 01 YES NO Cerebral Cortex NO YES NO DB Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2012 TCGA-DB-A64R-01 BB85420D-66FA-4EA9-9C2C-27C48F301368 TCGA-DB-A64R-01A-11D-A29Q-08 TCGA-DB-A64R-01A-11D-A323-01 6589bdbc-b3a3-4949-8a08-3fd17952bf24 TCGA-DB-A64R-01 TCGA-DB-A64R-01 TCGA-DB-A64R-01A-11D-A29Q-08 6589bdbc-b3a3-4949-8a08-3fd17952bf24 TCGA-DB-A64R-01 TCGA-DB-A64R-01A-11D-A29Q-08 TCGA-DB-A64R-01A-11D-A29T-05 6589bdbc-b3a3-4949-8a08-3fd17952bf24 6589bdbc-b3a3-4949-8a08-3fd17952bf24 TCGA-DB-A64R-01A-11D-A323-01 TCGA-DB-A64R-01A-11D-A29Q-08 +TCGA-DB-A64S-01 TCGA-DB-A64S-01 TCGA-DB-A64S TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 20 NO NO TCGA-DB-A64S-F67351 TCGA-DB-A64S TCGA-DB-A64S-01A -7389 352 0 835 -29 NO NO NO Scheduled Follow-up Submission Complete Remission/Response 2014-11-4 MALE NO NO Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES NO 220 NO 100 NO NO NO NO G2 NO true No TCGA-DB-A64S.31AB0B8C-9300-4508-B653-CB898986E68F.pdf A64S Preoperative TUMOR FREE NO NO Complete Remission/Response NO Primary Tumor 01 NO NO Cerebral Cortex NO YES NO DB Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2012 TCGA-DB-A64S-01 50C26A7F-17AB-4BF3-9663-446E70CAE7B1 TCGA-DB-A64S-01A-11D-A29Q-08 TCGA-DB-A64S-01A-11D-A323-01 7ac5d653-615d-4ace-a94a-2c1e09b598f4 TCGA-DB-A64S-01 TCGA-DB-A64S-01 TCGA-DB-A64S-01A-11D-A29Q-08 7ac5d653-615d-4ace-a94a-2c1e09b598f4 TCGA-DB-A64S-01 TCGA-DB-A64S-01A-11D-A29Q-08 TCGA-DB-A64S-01A-11D-A29T-05 7ac5d653-615d-4ace-a94a-2c1e09b598f4 7ac5d653-615d-4ace-a94a-2c1e09b598f4 TCGA-DB-A64S-01A-11D-A323-01 TCGA-DB-A64S-01A-11D-A29Q-08 +TCGA-DB-A64U-01 TCGA-DB-A64U-01 TCGA-DB-A64U TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 38 YES ant stings NO TCGA-DB-A64U-F67353 TCGA-DB-A64U TCGA-DB-A64U-01A -14019 806 0 846 118 NO NO NO Scheduled Follow-up Submission YES shellfish 2014-11-4 FEMALE NO NO Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES NO 340 NO 90 Right NO YES NO NO NO G2 NO true No TCGA-DB-A64U.7BE25474-4E80-403D-A999-EB2ADE02755C.pdf A64U Preoperative TUMOR FREE YES NO Complete Remission/Response NO Primary Tumor 01 NO NO Cerebral Cortex NO YES NO DB Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2011 TCGA-DB-A64U-01 A2EF7F9A-E2AE-4A7A-92E2-3864826B397E TCGA-DB-A64U-01A-11D-A29Q-08 TCGA-DB-A64U-01A-11D-A323-01 cc3a055a-6e86-43d1-9266-b16c172b27d6 TCGA-DB-A64U-01 TCGA-DB-A64U-01 TCGA-DB-A64U-01A-11D-A29Q-08 cc3a055a-6e86-43d1-9266-b16c172b27d6 TCGA-DB-A64U-01 TCGA-DB-A64U-01A-11D-A29Q-08 TCGA-DB-A64U-01A-11D-A29T-05 cc3a055a-6e86-43d1-9266-b16c172b27d6 cc3a055a-6e86-43d1-9266-b16c172b27d6 TCGA-DB-A64U-01A-11D-A323-01 TCGA-DB-A64U-01A-11D-A29Q-08 +TCGA-DB-A64V-01 TCGA-DB-A64V-01 TCGA-DB-A64V TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 54 NO TCGA-DB-A64V-F67368 TCGA-DB-A64V TCGA-DB-A64V-01A -19950 352 0 889 -17 NO YES NO Seizures 0 - 30 Days Scheduled Follow-up Submission Complete Remission/Response 2014-11-4 MALE NO NO Oligodendroglioma NO No C71.0 9450/3 C71.0 YES NO 200 NO 90 Left NO NO NO NO G2 NO true No TCGA-DB-A64V.9675813D-E747-4768-835C-447B53418966.pdf A64V Preoperative TUMOR FREE YES NO Stable Disease NO Primary Tumor 01 YES NO Cerebral Cortex YES YES NO DB Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2012 TCGA-DB-A64V-01 AC56FF0F-A198-4E00-AB0D-DBF4471ADFCA TCGA-DB-A64V-01A-11D-A29Q-08 TCGA-DB-A64V-01A-11D-A323-01 72b6a847-016f-4565-a5aa-e277c5cffb08 TCGA-DB-A64V-01 TCGA-DB-A64V-01 TCGA-DB-A64V-01A-11D-A29Q-08 72b6a847-016f-4565-a5aa-e277c5cffb08 TCGA-DB-A64V-01 TCGA-DB-A64V-01A-11D-A29Q-08 TCGA-DB-A64V-01A-11D-A29T-05 72b6a847-016f-4565-a5aa-e277c5cffb08 72b6a847-016f-4565-a5aa-e277c5cffb08 TCGA-DB-A64V-01A-11D-A323-01 TCGA-DB-A64V-01A-11D-A29Q-08 +TCGA-DB-A64W-01 TCGA-DB-A64W-01 TCGA-DB-A64W TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 65 NO TCGA-DB-A64W-F62623 TCGA-DB-A64W TCGA-DB-A64W-01A -23936 289 438 0 415 -20 NO Seizures > 181 Days Scheduled Follow-up Submission Stable Disease 2014-7-22 FEMALE NO Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES NO 100 NO 90 Right YES IHC YES NO NO NO G3 NO true No TCGA-DB-A64W.9F52D767-A4C4-4D70-BB04-0BED173FA2D6.pdf A64W Preoperative TUMOR FREE YES YES Stable Disease YES Primary Tumor 01 YES NO Cerebral Cortex YES YES NO DB Supratentorial, Frontal Lobe Central nervous system A NO DECEASED 2012 TCGA-DB-A64W-01 999832C0-9B13-4269-8167-9DE6C5525B63 TCGA-DB-A64W-01A-11D-A29Q-08 TCGA-DB-A64W-01A-11D-A323-01 b8ee7519-8052-4ac2-b331-7196e3f0d30f TCGA-DB-A64W-01 TCGA-DB-A64W-01 TCGA-DB-A64W-01A-11D-A29Q-08 b8ee7519-8052-4ac2-b331-7196e3f0d30f TCGA-DB-A64W-01 TCGA-DB-A64W-01A-11D-A29Q-08 TCGA-DB-A64W-01A-11D-A29T-05 b8ee7519-8052-4ac2-b331-7196e3f0d30f b8ee7519-8052-4ac2-b331-7196e3f0d30f TCGA-DB-A64W-01A-11D-A323-01 TCGA-DB-A64W-01A-11D-A29Q-08 +TCGA-DB-A64X-01 TCGA-DB-A64X-01 TCGA-DB-A64X TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 56 NO TCGA-DB-A64X-F67369 TCGA-DB-A64X TCGA-DB-A64X-01A -20625 247 0 563 -19 NO YES NO Motor/Movement Changes 91 - 180 Days Scheduled Follow-up Submission Complete Remission/Response 2014-11-7 FEMALE NO NO Astrocytoma NO No C71.0 9401/3 C71.0 YES NO 280 NO 90 Right YES IHC YES NO NO YES G3 NO true No TCGA-DB-A64X.2B5E76F9-FEC7-4238-AF98-BEDD20CD8731.pdf A64X Preoperative TUMOR FREE NO NO Stable Disease YES Primary Tumor 01 NO NO Cerebral Cortex YES YES NO DB Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2012 TCGA-DB-A64X-01 6FC5910D-8570-4680-A2C3-15F73118FA7F TCGA-DB-A64X-01A-11D-A29Q-08 TCGA-DB-A64X-01A-11D-A323-01 fd77ef17-3190-4889-a51b-456313411882 TCGA-DB-A64X-01 TCGA-DB-A64X-01 TCGA-DB-A64X-01A-11D-A29Q-08 fd77ef17-3190-4889-a51b-456313411882 TCGA-DB-A64X-01 TCGA-DB-A64X-01A-11D-A29Q-08 TCGA-DB-A64X-01A-11D-A29T-05 fd77ef17-3190-4889-a51b-456313411882 fd77ef17-3190-4889-a51b-456313411882 TCGA-DB-A64X-01A-11D-A323-01 TCGA-DB-A64X-01A-11D-A29Q-08 +TCGA-DB-A75K-01 TCGA-DB-A75K-01 TCGA-DB-A75K TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 55 NO NO TCGA-DB-A75K-F67635 TCGA-DB-A75K TCGA-DB-A75K-01A -20241 114 0 368 NO NO NO Seizures 0 - 30 Days Scheduled Follow-up Submission Complete Remission/Response NO 2014-11-7 FEMALE NO NO Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES NO 330 NO Right YES IHC YES NO NO NO NO G3 NO true No TCGA-DB-A75K.9ED9A0B1-8854-4E44-BD86-986EE3B6D7A6.pdf A75K TUMOR FREE YES Complete Remission/Response YES Primary Tumor 01 YES NO Cerebral Cortex YES YES NO DB Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2013 TCGA-DB-A75K-01 F06B95EE-078E-4873-8AAD-C691437C54C8 TCGA-DB-A75K-01A-11D-A32B-08 TCGA-DB-A75K-01A-11D-A32A-01 a956aa35-fb64-4fce-bece-044bd71692f5 TCGA-DB-A75K-01 TCGA-DB-A75K-01 a956aa35-fb64-4fce-bece-044bd71692f5 TCGA-DB-A75K-01 TCGA-DB-A75K-01A-11D-A32C-05 a956aa35-fb64-4fce-bece-044bd71692f5 a956aa35-fb64-4fce-bece-044bd71692f5 TCGA-DB-A75K-01A-11D-A32A-01 TCGA-DB-A75K-01A-11D-A32B-08 +TCGA-DB-A75L-01 TCGA-DB-A75L-01 TCGA-DB-A75L TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 36 NO NO TCGA-DB-A75L-F67636 TCGA-DB-A75L TCGA-DB-A75L-01A -13338 75 0 342 NO NO NO Seizures 91 - 180 Days Scheduled Follow-up Submission Complete Remission/Response YES lactose intolerance 2014-11-7 FEMALE NO NO Astrocytoma NO No C71.0 9401/3 C71.0 YES NO 100 NO 90 Left YES IHC YES NO NO NO NO G3 NO true No TCGA-DB-A75L.A725AA31-18ED-47A2-9393-E811952AD9B3.pdf A75L Preoperative TUMOR FREE YES NO Complete Remission/Response YES Primary Tumor 01 YES NO Cerebral Cortex YES YES NO DB Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2013 TCGA-DB-A75L-01 18F70946-2EC0-4739-9DC2-3FDE69122E26 TCGA-DB-A75L-01A-11D-A32B-08 TCGA-DB-A75L-01A-11D-A32A-01 05b85bc7-87db-49bb-85cf-e494554ab191 TCGA-DB-A75L-01 TCGA-DB-A75L-01 05b85bc7-87db-49bb-85cf-e494554ab191 TCGA-DB-A75L-01 TCGA-DB-A75L-01A-11D-A32C-05 05b85bc7-87db-49bb-85cf-e494554ab191 05b85bc7-87db-49bb-85cf-e494554ab191 TCGA-DB-A75L-01A-11D-A32A-01 TCGA-DB-A75L-01A-11D-A32B-08 +TCGA-DB-A75M-01 TCGA-DB-A75M-01 TCGA-DB-A75M TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 47 NO NO TCGA-DB-A75M-F67637 TCGA-DB-A75M TCGA-DB-A75M-01A -17289 189 0 544 NO YES NO Seizures > 181 Days Scheduled Follow-up Submission Complete Remission/Response NO 2014-11-7 MALE NO NO Astrocytoma NO No C71.0 9400/3 C71.0 YES NO 250 NO Right YES Sequence Analysis YES NO NO NO NO G2 NO true No TCGA-DB-A75M.C19F2C06-B479-44A0-8BE2-A7DDD650D879.pdf A75M TUMOR FREE YES NO Complete Remission/Response YES Primary Tumor 01 YES NO Cerebral Cortex YES YES NO DB Supratentorial, Parietal Lobe Central nervous system A NO LIVING 2013 TCGA-DB-A75M-01 47EFD98B-80E7-4FDA-B6F5-2040A765529D TCGA-DB-A75M-01A-11D-A32B-08 TCGA-DB-A75M-01A-11D-A32A-01 6bcd916f-8522-40d7-bd66-bf509789e34d 6bcd916f-8522-40d7-bd66-bf509789e34d TCGA-DB-A75M-01 TCGA-DB-A75M-01A-11D-A32C-05 6bcd916f-8522-40d7-bd66-bf509789e34d 6bcd916f-8522-40d7-bd66-bf509789e34d TCGA-DB-A75M-01A-11D-A32A-01 TCGA-DB-A75M-01A-11D-A32B-08 +TCGA-DB-A75O-01 TCGA-DB-A75O-01 TCGA-DB-A75O TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 29 NO NO TCGA-DB-A75O-F67378 TCGA-DB-A75O TCGA-DB-A75O-01A -10812 981 0 935 NO NO NO Seizures 31 - 90 Days Scheduled Follow-up Submission NO 2014-11-4 MALE NO NO Astrocytoma NO No C71.0 9401/3 C71.0 YES NO 240 NO 90 Left NO YES NO NO NO G3 true No TCGA-DB-A75O.CADF06CC-B405-4CFF-AB8D-92DA06CB345C.pdf A75O Preoperative YES NO Partial Remission/Response Primary Tumor 01 YES NO Cerebral Cortex YES NO DB Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2010 TCGA-DB-A75O-01 50041E63-3BEB-4AE7-BED0-8938ECDFB1DB TCGA-DB-A75O-01A-11D-A32B-08 TCGA-DB-A75O-01A-11D-A32A-01 46154213-1bd9-4de6-b396-bb0016d56bbd TCGA-DB-A75O-01 TCGA-DB-A75O-01 46154213-1bd9-4de6-b396-bb0016d56bbd TCGA-DB-A75O-01 TCGA-DB-A75O-01A-11D-A32C-05 46154213-1bd9-4de6-b396-bb0016d56bbd 46154213-1bd9-4de6-b396-bb0016d56bbd TCGA-DB-A75O-01A-11D-A32A-01 TCGA-DB-A75O-01A-11D-A32B-08 +TCGA-DB-A75P-01 TCGA-DB-A75P-01 TCGA-DB-A75P TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 25 NO NO TCGA-DB-A75P-F67380 TCGA-DB-A75P TCGA-DB-A75P-01A -9413 163 0 492 NO NO NO Seizures 31 - 90 Days Scheduled Follow-up Submission Complete Remission/Response NO 2014-11-4 FEMALE NO NO Astrocytoma NO No C71.0 9400/3 C71.0 YES NO 190 NO Right NO IHC YES NO NO NO NO G2 NO true No TCGA-DB-A75P.6CD48114-C318-4450-AADD-62E3CE7ED427.pdf A75P TUMOR FREE YES NO Complete Remission/Response NO Primary Tumor 01 YES NO Cerebral Cortex NO YES NO DB Supratentorial, Temporal Lobe Central nervous system A NO LIVING 2013 TCGA-DB-A75P-01 2B5DF191-456A-483C-8FB3-658AE8228F1A TCGA-DB-A75P-01A-11D-A32B-08 TCGA-DB-A75P-01A-11D-A32A-01 eaf06648-a8ec-4813-8618-0ccf86d0f809 TCGA-DB-A75P-01 TCGA-DB-A75P-01 eaf06648-a8ec-4813-8618-0ccf86d0f809 TCGA-DB-A75P-01 TCGA-DB-A75P-01A-11D-A32C-05 eaf06648-a8ec-4813-8618-0ccf86d0f809 eaf06648-a8ec-4813-8618-0ccf86d0f809 TCGA-DB-A75P-01A-11D-A32A-01 TCGA-DB-A75P-01A-11D-A32B-08 +TCGA-DH-5140-01 TCGA-DH-5140-01 TCGA-DH-5140 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 38 NO NO TCGA-DH-5140-F6484 TCGA-DH-5140 TCGA-DH-5140-01A -13943 607 0 259 1 NO YES NO Headaches 91 - 180 Days Progressive Disease NO 2010-12-8 FEMALE NO YES Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES 0.5 NO 90 Left NO 0.6 NO NO NO G3 NO No TCGA-DH-5140.4f8b82c9-5185-4994-ac3d-a0f3a9eefd61.pdf 5140 Other WITH TUMOR YES YES Progressive Disease YES Primary Tumor 01 NO NO 0.2 Cerebral Cortex YES NO YES DH Supratentorial, Temporal Lobe Central nervous system A NO DECEASED 2007 TCGA-DH-5140-01A-01D-1468-08 TCGA-DH-5140-01 5CF195B4-4222-44C3-8A00-24EB4E71AAB8 TCGA-DH-5140-01A-01D-1468-08 TCGA-DH-5140-01A-01D-1466-01 be3eca27-9d48-4e21-9146-fb47c7ac4233 TCGA-DH-5140-01 TCGA-DH-5140-01 TCGA-DH-5140-01 TCGA-DH-5140-01A-01D-1468-08 be3eca27-9d48-4e21-9146-fb47c7ac4233 TCGA-DH-5140-01 TCGA-DH-5140-01 TCGA-DH-5140-01A-01D-1468-08 TCGA-DH-5140-01A-01D-1467-05 TCGA-DH-5140-01 be3eca27-9d48-4e21-9146-fb47c7ac4233 TCGA-DH-5140-01A-01R-1470-07 be3eca27-9d48-4e21-9146-fb47c7ac4233 TCGA-DH-5140-01A-01D-1466-01 TCGA-DH-5140-01A-01D-1468-08 +TCGA-DH-5141-01 TCGA-DH-5141-01 TCGA-DH-5141 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 32 NO NO TCGA-DH-5141-F66668 TCGA-DH-5141 TCGA-DH-5141-01A -11846 0 968 NO YES NO Headaches Scheduled Follow-up Submission NO 2014-10-22 MALE NO YES Oligodendroglioma NO No C71.0 9451/3 C71.0 YES 0.3 NO Left NO 0.6 YES YES NO NO G3 No TCGA-DH-5141.15a0f3ec-2bdc-4fb9-ae65-e1c38277ff11.pdf 5141 YES YES Stable Disease YES Primary Tumor 01 NO NO 0.2 Cerebral Cortex YES NO YES DH Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2005 TCGA-DH-5141-01A-01D-1468-08 TCGA-DH-5141-01 5F2789A0-81D0-4D83-BFE3-3587EC9DD074 TCGA-DH-5141-01A-01D-1468-08 TCGA-DH-5141-01A-01D-1466-01 9e952754-f768-47fd-9580-d9770e9eb45e TCGA-DH-5141-01 TCGA-DH-5141-01 TCGA-DH-5141-01 TCGA-DH-5141-01A-01D-1468-08 9e952754-f768-47fd-9580-d9770e9eb45e TCGA-DH-5141-01 TCGA-DH-5141-01 TCGA-DH-5141-01A-01D-1468-08 TCGA-DH-5141-01A-01D-1467-05 TCGA-DH-5141-01 9e952754-f768-47fd-9580-d9770e9eb45e TCGA-DH-5141-01A-01R-1470-07 9e952754-f768-47fd-9580-d9770e9eb45e TCGA-DH-5141-01A-01D-1466-01 TCGA-DH-5141-01A-01D-1468-08 +TCGA-DH-5142-01 TCGA-DH-5142-01 TCGA-DH-5142 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain YES NO NO 29 NO YES TCGA-DH-5142-F66689 TCGA-DH-5142 TCGA-DH-5142-01A -10678 0 1943 1627 10 0 NO Seizures 0 - 30 Days Scheduled Follow-up Submission NO 2014-10-22 MALE NO NO Astrocytoma NO No C71.0 9401/3 C71.0 YES 0.4 NO 90 Left NO 0.4 YES NO NO NO G3 YES No TCGA-DH-5142.d6bad55b-31f4-416a-8775-e3439c0f6918.pdf 5142 Pre-Adjuvant Therapy WITH TUMOR NO NO Stable Disease YES Primary Tumor 01 YES NO 0.3 Cerebral Cortex YES NO YES DH Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2008 TCGA-DH-5142-01A-01D-1468-08 TCGA-DH-5142-01 8C8CE05D-D96D-412C-963B-204CA7D45A41 TCGA-DH-5142-01A-01D-1468-08 TCGA-DH-5142-01A-01D-1466-01 ce2a4f0a-e77f-446b-9412-432daaf5d351 TCGA-DH-5142-01 TCGA-DH-5142-01 TCGA-DH-5142-01 TCGA-DH-5142-01A-01D-1468-08 ce2a4f0a-e77f-446b-9412-432daaf5d351 TCGA-DH-5142-01 TCGA-DH-5142-01 TCGA-DH-5142-01A-01D-1468-08 TCGA-DH-5142-01A-01D-1467-05 TCGA-DH-5142-01 ce2a4f0a-e77f-446b-9412-432daaf5d351 TCGA-DH-5142-01A-01R-1470-07 ce2a4f0a-e77f-446b-9412-432daaf5d351 TCGA-DH-5142-01A-01D-1466-01 TCGA-DH-5142-01A-01D-1468-08 +TCGA-DH-5143-01 TCGA-DH-5143-01 TCGA-DH-5143 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 30 TCGA-DH-5143-F66710 TCGA-DH-5143 TCGA-DH-5143-01A -11291 0 1401 13 1 Seizures 91 - 180 Days Scheduled Follow-up Submission Stable Disease 2014-10-22 MALE NO Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES 0.7 NO 80 Left NO 1 YES YES G3 NO No TCGA-DH-5143.5cec11b4-9ba5-4a49-8c7c-6e9fdde87c13.pdf 5143 Pre-Adjuvant Therapy WITH TUMOR YES YES Stable Disease YES Primary Tumor 01 YES 0.7 Cerebral Cortex YES NO YES DH Supratentorial, Temporal Lobe Central nervous system A NO LIVING 2009 TCGA-DH-5143-01A-01D-1468-08 TCGA-DH-5143-01 C645B218-12C0-4FE3-AFA2-F0F08008DF88 TCGA-DH-5143-01A-01D-1468-08 TCGA-DH-5143-01A-01D-1466-01 ae0546ae-4f2e-4824-94d6-91fefd7fddbb TCGA-DH-5143-01 TCGA-DH-5143-01 TCGA-DH-5143-01 TCGA-DH-5143-01A-01D-1468-08 ae0546ae-4f2e-4824-94d6-91fefd7fddbb TCGA-DH-5143-01 TCGA-DH-5143-01 TCGA-DH-5143-01A-01D-1468-08 TCGA-DH-5143-01A-01D-1467-05 TCGA-DH-5143-01 ae0546ae-4f2e-4824-94d6-91fefd7fddbb TCGA-DH-5143-01A-01R-1470-07 ae0546ae-4f2e-4824-94d6-91fefd7fddbb TCGA-DH-5143-01A-01D-1466-01 TCGA-DH-5143-01A-01D-1468-08 +TCGA-DH-5144-01 TCGA-DH-5144-01 TCGA-DH-5144 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 56 NO NO TCGA-DH-5144-F66726 TCGA-DH-5144 TCGA-DH-5144-01A -20558 0 748 19 0 NO NO Seizures 0 - 30 Days Scheduled Follow-up Submission Stable Disease NO 2014-10-22 FEMALE NO NO Oligodendroglioma NO No C71.0 9451/3 C71.0 YES 0.6 NO 100 Right NO 1.1 NO NO NO NO G3 NO No TCGA-DH-5144.95ca5a19-cf38-49f1-afac-06a9186c9e97.pdf 5144 Pre-Adjuvant Therapy TUMOR FREE YES NO Complete Remission/Response YES Primary Tumor 01 YES NO 0.3 Cerebral Cortex NO NO YES DH Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2009 TCGA-DH-5144-01A-01D-1468-08 TCGA-DH-5144-01 37068A65-A073-4666-9153-D2CE015AA157 TCGA-DH-5144-01A-01D-1468-08 TCGA-DH-5144-01A-01D-1466-01 c0a8b929-166d-4227-a0e1-fe8ab8abac11 TCGA-DH-5144-01 TCGA-DH-5144-01 TCGA-DH-5144-01 TCGA-DH-5144-01A-01D-1468-08 c0a8b929-166d-4227-a0e1-fe8ab8abac11 TCGA-DH-5144-01 TCGA-DH-5144-01 TCGA-DH-5144-01A-01D-1468-08 TCGA-DH-5144-01A-01D-1467-05 TCGA-DH-5144-01 c0a8b929-166d-4227-a0e1-fe8ab8abac11 TCGA-DH-5144-01A-01R-1470-07 c0a8b929-166d-4227-a0e1-fe8ab8abac11 TCGA-DH-5144-01A-01D-1466-01 TCGA-DH-5144-01A-01D-1468-08 +TCGA-DH-A669-01 TCGA-DH-A669-01 TCGA-DH-A669 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 70 NO TCGA-DH-A669 -25809 919 0 NO NO NO Mental Status Changes > 181 Days NO 2013-6-25 MALE NO NO Oligodendroglioma NO No C71.0 9451/3 C71.0 YES NO Left NO YES NO YES G3 YES No A669 TUMOR FREE NO YES Stable Disease NO Primary Tumor 01 NO NO Not listed in Medical Record NO NO YES DH Supratentorial, Parietal Lobe Central nervous system NO DECEASED 2007 TCGA-DH-A669-01 TCGA-DH-A669-01A-12D-A31L-08 TCGA-DH-A669-01A-12D-A31K-01 cb9ff749-d103-418f-b0f3-52ef1f5fcb7d TCGA-DH-A669-01 TCGA-DH-A669-01 cb9ff749-d103-418f-b0f3-52ef1f5fcb7d TCGA-DH-A669-01 TCGA-DH-A669-01A-12D-A31M-05 cb9ff749-d103-418f-b0f3-52ef1f5fcb7d cb9ff749-d103-418f-b0f3-52ef1f5fcb7d TCGA-DH-A669-01A-12D-A31K-01 TCGA-DH-A669-01A-12D-A31L-08 +TCGA-DH-A669-02 TCGA-DH-A669-02 TCGA-DH-A669 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 70 NO TCGA-DH-A669 TCGA-DH-A669-02A -25809 2274 919 0 NO NO NO Mental Status Changes > 181 Days NO 2013-6-25 MALE NO NO Oligodendroglioma NO No C71.0 9451/3 C71.0 YES NO 50 NO Left NO YES NO YES G3 YES false No TCGA-DH-A669.B34CDA94-75EB-42E4-AAF8-70C69BBDDD84.pdf A669 TUMOR FREE NO YES Stable Disease NO Recurrent Tumor 02 NO NO Not listed in Medical Record NO NO YES DH Supratentorial, Parietal Lobe Central nervous system A NO DECEASED 2007 TCGA-DH-A669-02A-11D-A31L-08 2b35c088-4a94-44a1-9809-6666bc0c877f TCGA-DH-A669-02 TCGA-DH-A669-02 2b35c088-4a94-44a1-9809-6666bc0c877f TCGA-DH-A669-02A-11D-A31M-05 2b35c088-4a94-44a1-9809-6666bc0c877f 2b35c088-4a94-44a1-9809-6666bc0c877f +TCGA-DH-A66B-01 TCGA-DH-A66B-01 TCGA-DH-A66B TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 52 NO TCGA-DH-A66B-F60629 TCGA-DH-A66B TCGA-DH-A66B-01A -19156 845 0 1279 901 1 NO YES NO Mental Status Changes > 181 Days Scheduled Follow-up Submission Stable Disease NO 2014-6-13 MALE NO NO Astrocytoma NO No C71.0 9401/3 C71.0 YES NO 100 NO 90 Left NO NO YES NO NO G3 NO false Yes, History of Prior Malignancy TCGA-DH-A66B.7D6D3FE4-FA4C-4827-B141-9E323AC6B1A8.pdf A66B Post-Adjuvant Therapy WITH TUMOR YES NO Stable Disease YES Primary Tumor 01 NO NO Not listed in Medical Record YES NO YES DH Supratentorial, Temporal Lobe Central nervous system A NO LIVING 2010 TCGA-DH-A66B-01 DA84B2BD-3CB7-472D-8F15-770AE5455DB5 TCGA-DH-A66B-01A-11D-A29Q-08 TCGA-DH-A66B-01A-11D-A323-01 90199c77-d6ef-4a7a-b08c-28bed0c888b1 TCGA-DH-A66B-01 TCGA-DH-A66B-01 TCGA-DH-A66B-01A-11D-A29Q-08 90199c77-d6ef-4a7a-b08c-28bed0c888b1 TCGA-DH-A66B-01 TCGA-DH-A66B-01A-11D-A29Q-08 TCGA-DH-A66B-01A-11D-A29T-05 90199c77-d6ef-4a7a-b08c-28bed0c888b1 90199c77-d6ef-4a7a-b08c-28bed0c888b1 TCGA-DH-A66B-01A-11D-A323-01 TCGA-DH-A66B-01A-11D-A29Q-08 +TCGA-DH-A66D-01 TCGA-DH-A66D-01 TCGA-DH-A66D TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 43 NO TCGA-DH-A66D-F60638 TCGA-DH-A66D TCGA-DH-A66D-01A -15866 404 0 846 404 1 NO NO NO Seizures 0 - 30 Days Scheduled Follow-up Submission Stable Disease YES lactose, cheese, gluten 2014-6-13 FEMALE NO NO Astrocytoma NO No C71.0 9401/3 C71.0 YES NO 380 NO 80 Right YES IHC YES NO YES NO NO G3 NO false No TCGA-DH-A66D.44D22FE9-2B47-4638-A97F-3C89890D9504.pdf A66D Post-Adjuvant Therapy WITH TUMOR NO NO Stable Disease YES Primary Tumor 01 YES NO Not listed in Medical Record YES NO YES DH Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2012 TCGA-DH-A66D-01 C07519DD-9A30-44E7-BA8A-8D435204A583 TCGA-DH-A66D-01A-11D-A31L-08 TCGA-DH-A66D-01A-11D-A31K-01 a3ea8ef1-79f5-48fc-906d-dfb2b550c466 TCGA-DH-A66D-01 TCGA-DH-A66D-01 a3ea8ef1-79f5-48fc-906d-dfb2b550c466 TCGA-DH-A66D-01 TCGA-DH-A66D-01A-11D-A31M-05 a3ea8ef1-79f5-48fc-906d-dfb2b550c466 a3ea8ef1-79f5-48fc-906d-dfb2b550c466 TCGA-DH-A66D-01A-11D-A31K-01 TCGA-DH-A66D-01A-11D-A31L-08 +TCGA-DH-A66F-01 TCGA-DH-A66F-01 TCGA-DH-A66F TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 49 NO TCGA-DH-A66F-F68872 TCGA-DH-A66F TCGA-DH-A66F-01A -18193 166 0 523 18 1 NO NO NO Seizures 0 - 30 Days Scheduled Follow-up Submission NO 2015-3-12 MALE NO Oligodendroglioma NO No C71.0 9450/3 C71.0 YES NO 90 NO 90 Left YES IHC YES YES NO NO G2 NO false No TCGA-DH-A66F.8D9C9718-7904-4C45-8217-D8110552BA51.pdf A66F Other TUMOR FREE YES YES Complete Remission/Response NO Primary Tumor 01 YES NO Not listed in Medical Record NO YES NO DH Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2012 TCGA-DH-A66F-01 576F6850-75B1-4440-BF65-8BC148473569 TCGA-DH-A66F-01A-11D-A29Q-08 TCGA-DH-A66F-01A-11D-A323-01 10b6c170-88d1-4cea-87c7-b23d6810ea6a TCGA-DH-A66F-01 TCGA-DH-A66F-01 TCGA-DH-A66F-01A-11D-A29Q-08 10b6c170-88d1-4cea-87c7-b23d6810ea6a TCGA-DH-A66F-01 TCGA-DH-A66F-01A-11D-A29Q-08 TCGA-DH-A66F-01A-11D-A29T-05 10b6c170-88d1-4cea-87c7-b23d6810ea6a 10b6c170-88d1-4cea-87c7-b23d6810ea6a TCGA-DH-A66F-01A-11D-A323-01 TCGA-DH-A66F-01A-11D-A29Q-08 +TCGA-DH-A66G-01 TCGA-DH-A66G-01 TCGA-DH-A66G TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 49 NO TCGA-DH-A66G-F61145 TCGA-DH-A66G TCGA-DH-A66G-01A -18199 77 0 523 19 1 NO YES NO Headaches > 181 Days Scheduled Follow-up Submission Partial Remission/Response NO 2014-6-25 FEMALE NO YES Oligodendroglioma NO No C71.0 9451/3 C71.0 YES NO 320 NO 80 Left YES IHC YES NO NO NO NO G3 NO false No TCGA-DH-A66G.6A01BF6C-E171-4D0A-977B-B22293ED02D6.pdf A66G Pre-Adjuvant Therapy WITH TUMOR YES YES Stable Disease YES Primary Tumor 01 YES NO Not listed in Medical Record YES YES NO DH Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2013 TCGA-DH-A66G-01 A944D057-48DB-4A17-AD6A-FEDEB55A1115 TCGA-DH-A66G-01A-21D-A31L-08 TCGA-DH-A66G-01A-21D-A31K-01 eab993b0-cf52-4a95-8da3-8e1c5eaa3eff TCGA-DH-A66G-01 TCGA-DH-A66G-01 eab993b0-cf52-4a95-8da3-8e1c5eaa3eff TCGA-DH-A66G-01 TCGA-DH-A66G-01A-21D-A31M-05 eab993b0-cf52-4a95-8da3-8e1c5eaa3eff eab993b0-cf52-4a95-8da3-8e1c5eaa3eff TCGA-DH-A66G-01A-21D-A31K-01 TCGA-DH-A66G-01A-21D-A31L-08 +TCGA-DH-A7UR-01 TCGA-DH-A7UR-01 TCGA-DH-A7UR TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 59 NO TCGA-DH-A7UR-F64479 TCGA-DH-A7UR -21803 0 1650 1174 0 NO NO NO Headaches > 181 Days Scheduled Follow-up Submission NO 2014-9-3 FEMALE NO YES Oligodendroglioma NO No C71.0 9451/3 C71.0 YES NO 90 Right NO YES YES NO NO G3 NO No A7UR Post-Adjuvant Therapy TUMOR FREE YES NO Complete Remission/Response YES Primary Tumor 01 YES NO Not listed in Medical Record YES NO YES DH Supratentorial, Frontal Lobe Central nervous system NO LIVING 2008 TCGA-DH-A7UR-01 TCGA-DH-A7UR-01A-11D-A33T-08 TCGA-DH-A7UR-01A-11D-A33S-01 b9eab491-6fa4-4eee-a2f6-ef923935845e TCGA-DH-A7UR-01 TCGA-DH-A7UR-01 b9eab491-6fa4-4eee-a2f6-ef923935845e TCGA-DH-A7UR-01 TCGA-DH-A7UR-01A-11D-A33U-05 b9eab491-6fa4-4eee-a2f6-ef923935845e b9eab491-6fa4-4eee-a2f6-ef923935845e TCGA-DH-A7UR-01A-11D-A33S-01 TCGA-DH-A7UR-01A-11D-A33T-08 +TCGA-DH-A7US-01 TCGA-DH-A7US-01 TCGA-DH-A7US TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 50 NO TCGA-DH-A7US-F70994 TCGA-DH-A7US TCGA-DH-A7US-01A -18429 208 0 706 NO NO NO Seizures > 181 Days Scheduled Follow-up Submission Stable Disease NO 2015-3-12 MALE NO NO Oligodendroglioma NO No C71.0 9450/3 C71.0 YES NO 160 NO Right YES IHC YES NO NO NO NO G2 NO false No TCGA-DH-A7US.1078C5C3-CA98-48D7-B810-162029AC4238.pdf A7US WITH TUMOR YES NO Stable Disease NO Primary Tumor 01 YES NO Not listed in Medical Record NO YES NO DH Supratentorial, Temporal Lobe Central nervous system A NO LIVING 2013 TCGA-DH-A7US-01 EBBD7AB4-92B8-40E7-ABA9-B65486D3F832 TCGA-DH-A7US-01A-11D-A33T-08 TCGA-DH-A7US-01A-11D-A33S-01 f2996be3-1bd5-43c8-9d91-728948c78994 TCGA-DH-A7US-01 TCGA-DH-A7US-01 f2996be3-1bd5-43c8-9d91-728948c78994 TCGA-DH-A7US-01 TCGA-DH-A7US-01A-11D-A33U-05 f2996be3-1bd5-43c8-9d91-728948c78994 f2996be3-1bd5-43c8-9d91-728948c78994 TCGA-DH-A7US-01A-11D-A33S-01 TCGA-DH-A7US-01A-11D-A33T-08 +TCGA-DH-A7UT-01 TCGA-DH-A7UT-01 TCGA-DH-A7UT TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 30 NO TCGA-DH-A7UT-F70996 TCGA-DH-A7UT TCGA-DH-A7UT-01A -11014 118 531 0 200 407 NO NO NO Seizures 31 - 90 Days Scheduled Follow-up Submission NO 2015-3-12 MALE NO NO Astrocytoma NO No C71.0 9401/3 C71.0 YES NO 70 NO Left YES IHC YES NO NO NO NO G3 YES false No TCGA-DH-A7UT.D737A708-EBF5-41F9-9245-7438F71891F1.pdf A7UT WITH TUMOR YES YES Stable Disease YES Primary Tumor 01 YES NO Not listed in Medical Record YES YES NO DH Supratentorial, Frontal Lobe Central nervous system A NO DECEASED 2013 TCGA-DH-A7UT-01 TCGA-DH-A7UT-01A-12D-A34A-08 TCGA-DH-A7UT-01A-12D-A349-01 4c09b51b-d52a-49f2-b5df-5fc38193bd3c TCGA-DH-A7UT-01 TCGA-DH-A7UT-01 4c09b51b-d52a-49f2-b5df-5fc38193bd3c TCGA-DH-A7UT-01 TCGA-DH-A7UT-01A-12D-A34D-05 4c09b51b-d52a-49f2-b5df-5fc38193bd3c 4c09b51b-d52a-49f2-b5df-5fc38193bd3c TCGA-DH-A7UT-01A-12D-A349-01 TCGA-DH-A7UT-01A-12D-A34A-08 +TCGA-DH-A7UU-01 TCGA-DH-A7UU-01 TCGA-DH-A7UU TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 43 NO TCGA-DH-A7UU-F66738 TCGA-DH-A7UU -16037 0 417 18 NO YES NO Sensory Changes 91 - 180 Days Scheduled Follow-up Submission Stable Disease NO 2014-10-22 MALE YES NO Astrocytoma NO No C71.0 9401/3 C71.0 YES NO 90 Right YES IHC YES NO YES YES NO G3 NO No A7UU Pre-Adjuvant Therapy WITH TUMOR NO NO Stable Disease YES Primary Tumor 01 NO YES Not listed in Medical Record YES YES NO DH Supratentorial, Frontal Lobe Central nervous system YES LIVING 2013 TCGA-DH-A7UU-01 TCGA-DH-A7UU-01A-12D-A34A-08 TCGA-DH-A7UU-01A-12D-A349-01 b2641e23-6021-4679-90d9-1cfd67619dbc TCGA-DH-A7UU-01 TCGA-DH-A7UU-01 b2641e23-6021-4679-90d9-1cfd67619dbc TCGA-DH-A7UU-01 TCGA-DH-A7UU-01A-12D-A34D-05 b2641e23-6021-4679-90d9-1cfd67619dbc b2641e23-6021-4679-90d9-1cfd67619dbc TCGA-DH-A7UU-01A-12D-A349-01 TCGA-DH-A7UU-01A-12D-A34A-08 +TCGA-DH-A7UV-01 TCGA-DH-A7UV-01 TCGA-DH-A7UV TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 49 TCGA-DH-A7UV-F68876 TCGA-DH-A7UV -18161 0 566 19 NO NO Headaches 91 - 180 Days Scheduled Follow-up Submission Stable Disease 2014-12-22 MALE YES Astrocytoma NO No C71.0 9401/3 C71.0 YES NO 90 Right NO IHC YES NO YES YES G3 NO No A7UV Pre-Adjuvant Therapy WITH TUMOR YES NO Stable Disease YES Primary Tumor 01 NO NO Not listed in Medical Record YES YES NO DH Supratentorial, Temporal Lobe Central nervous system NO LIVING 2013 TCGA-DH-A7UV-01 TCGA-DH-A7UV-01A-12D-A34A-08 TCGA-DH-A7UV-01A-12D-A349-01 ca0eaf1f-36a4-4322-b262-118d4cfc6ae2 TCGA-DH-A7UV-01 TCGA-DH-A7UV-01 ca0eaf1f-36a4-4322-b262-118d4cfc6ae2 TCGA-DH-A7UV-01 TCGA-DH-A7UV-01A-12D-A34D-05 ca0eaf1f-36a4-4322-b262-118d4cfc6ae2 ca0eaf1f-36a4-4322-b262-118d4cfc6ae2 TCGA-DH-A7UV-01A-12D-A349-01 TCGA-DH-A7UV-01A-12D-A34A-08 +TCGA-DU-5847-01 TCGA-DU-5847-01 TCGA-DU-5847 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 34 NO NO TCGA-DU-5847-F14822 TCGA-DU-5847 TCGA-DU-5847-01A -12606 0 548 YES NO NO Seizures 0 - 30 Days NO 2011-5-25 FEMALE NO Astrocytoma NO No C71.9 9401/3 C71.9 YES 0.8 NO Right NO 1 NO NO NO G3 NO No TCGA-DU-5847.d9f2d994-5d17-46c6-a6c9-0f25703ffb22.pdf 5847 WITH TUMOR YES NO Stable Disease YES Primary Tumor 01 YES NO 0.4 White Matter YES YES NO DU Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2009 TCGA-DU-5847-01A-11D-1705-08 TCGA-DU-5847-01 21A33839-A5ED-481F-8C81-F92CB931C34D TCGA-DU-5847-01A-11D-1705-08 TCGA-DU-5847-01A-11D-1704-01 5a559e30-17cb-4467-b54c-18dcfdb93fde TCGA-DU-5847-01 TCGA-DU-5847-01 TCGA-DU-5847-01A-11D-1705-08 5a559e30-17cb-4467-b54c-18dcfdb93fde TCGA-DU-5847-01 TCGA-DU-5847-01 TCGA-DU-5847-01A-11D-1705-08 TCGA-DU-5847-01A-11D-1706-05 5a559e30-17cb-4467-b54c-18dcfdb93fde 5a559e30-17cb-4467-b54c-18dcfdb93fde TCGA-DU-5847-01A-11D-1704-01 TCGA-DU-5847-01A-11D-1705-08 +TCGA-DU-5849-01 TCGA-DU-5849-01 TCGA-DU-5849 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 48 TCGA-DU-5849-F14889 TCGA-DU-5849 TCGA-DU-5849-01A -17663 0 443 NO Seizures 0 - 30 Days 2011-5-25 MALE NO Oligodendroglioma NO No C71.9 9450/3 C71.9 YES 0.9 NO Left NO 0.9 NO NO G2 NO No TCGA-DU-5849.7ec64754-8800-44dd-a5cc-2a9e8fc8bb27.pdf 5849 TUMOR FREE YES YES Stable Disease NO Primary Tumor 01 YES NO 0.4 White Matter YES YES NO DU Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2010 TCGA-DU-5849-01A-11D-1705-08 TCGA-DU-5849-01 3DE6AD12-FFE9-4552-A120-3C6973DECDEA TCGA-DU-5849-01A-11D-1705-08 TCGA-DU-5849-01A-11D-1704-01 e1ecb6d0-8ceb-46b8-9959-86f8d53b0882 TCGA-DU-5849-01 TCGA-DU-5849-01 TCGA-DU-5849-01A-11D-1705-08 e1ecb6d0-8ceb-46b8-9959-86f8d53b0882 TCGA-DU-5849-01 TCGA-DU-5849-01 TCGA-DU-5849-01A-11D-1705-08 TCGA-DU-5849-01A-11D-1706-05 e1ecb6d0-8ceb-46b8-9959-86f8d53b0882 e1ecb6d0-8ceb-46b8-9959-86f8d53b0882 TCGA-DU-5849-01A-11D-1704-01 TCGA-DU-5849-01A-11D-1705-08 +TCGA-DU-5851-01 TCGA-DU-5851-01 TCGA-DU-5851 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 40 TCGA-DU-5851-F15071 TCGA-DU-5851 TCGA-DU-5851-01A -14802 0 531 17 Seizures 0 - 30 Days 2011-8-8 FEMALE NO Oligoastrocytoma NO No C71.9 9382/3 C71.9 YES 1 NO 90 Right NO 1 NO NO G3 NO No TCGA-DU-5851.beb751ed-b79d-43de-93b6-bcbbb47ea6f4.pdf 5851 Pre-Adjuvant Therapy WITH TUMOR YES YES Stable Disease YES Primary Tumor 01 YES YES 1 Cerebral Cortex YES YES NO DU Supratentorial, Temporal Lobe Central nervous system A NO LIVING 2010 TCGA-DU-5851-01A-13D-1893-08 TCGA-DU-5851-01 0F9FB190-0199-4583-BC6E-DF8370F3064F TCGA-DU-5851-01A-13D-1893-08 TCGA-DU-5851-01A-13D-1892-01 5966170d-1c88-4b55-ad39-2ace3c9230d3 TCGA-DU-5851-01 TCGA-DU-5851-01 TCGA-DU-5851-01A-13D-1893-08 5966170d-1c88-4b55-ad39-2ace3c9230d3 TCGA-DU-5851-01 TCGA-DU-5851-01 TCGA-DU-5851-01A-13D-1893-08 TCGA-DU-5851-01A-13D-1894-05 5966170d-1c88-4b55-ad39-2ace3c9230d3 5966170d-1c88-4b55-ad39-2ace3c9230d3 TCGA-DU-5851-01A-13D-1892-01 TCGA-DU-5851-01A-13D-1893-08 +TCGA-DU-5852-01 TCGA-DU-5852-01 TCGA-DU-5852 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain YES YES NO NO 61 TCGA-DU-5852-F17044 TCGA-DU-5852 TCGA-DU-5852-01A -22348 205 0 24 26 Seizures > 181 Days Progressive Disease 2011-9-26 FEMALE NO Oligoastrocytoma NO No C71.9 9382/3 C71.9 YES 0.9 NO 50 Left NO 1 NO YES G3 YES No TCGA-DU-5852.a6c1f30a-8350-4fbc-9af2-5333cbe273e6.pdf 5852 Pre-Adjuvant Therapy WITH TUMOR YES NO Progressive Disease NO Primary Tumor 01 YES NO 0.9 White Matter NO NO YES DU Supratentorial, Temporal Lobe Central nervous system A NO DECEASED 2010 TCGA-DU-5852-01A-11D-1705-08 TCGA-DU-5852-01 EE52EB8F-EC54-4C21-9054-B9778D19C908 TCGA-DU-5852-01A-11D-1705-08 TCGA-DU-5852-01A-11D-1704-01 dad44966-2a17-4813-abf8-16b476984948 TCGA-DU-5852-01 TCGA-DU-5852-01 TCGA-DU-5852-01A-11D-1705-08 dad44966-2a17-4813-abf8-16b476984948 TCGA-DU-5852-01 TCGA-DU-5852-01 TCGA-DU-5852-01A-11D-1705-08 TCGA-DU-5852-01A-11D-1706-05 dad44966-2a17-4813-abf8-16b476984948 dad44966-2a17-4813-abf8-16b476984948 TCGA-DU-5852-01A-11D-1704-01 TCGA-DU-5852-01A-11D-1705-08 +TCGA-DU-5853-01 TCGA-DU-5853-01 TCGA-DU-5853 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 29 TCGA-DU-5853-F16881 TCGA-DU-5853 TCGA-DU-5853-01A -10624 0 407 18 YES NO Seizures 0 - 30 Days 2011-9-20 MALE NO Oligoastrocytoma NO No C71.9 9382/3 C71.9 YES 0.9 NO 100 Left NO 0.9 NO NO G2 NO No TCGA-DU-5853.d4bda6a8-21ef-4395-9091-dcd87e011d9d.pdf 5853 Pre-Adjuvant Therapy WITH TUMOR YES NO Stable Disease YES Primary Tumor 01 YES NO 0.8 Not listed in Medical Record YES YES NO DU Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2010 TCGA-DU-5853-01A-11D-1893-08 TCGA-DU-5853-01 63AC3523-B799-49F2-AC6C-4CE0A8DB29F5 TCGA-DU-5853-01A-11D-1893-08 TCGA-DU-5853-01A-11D-1892-01 3fd8286a-b9a6-42b8-9ecd-7ed96744251a TCGA-DU-5853-01 TCGA-DU-5853-01 TCGA-DU-5853-01A-11D-1893-08 3fd8286a-b9a6-42b8-9ecd-7ed96744251a TCGA-DU-5853-01 TCGA-DU-5853-01A-11D-1893-08 TCGA-DU-5853-01A-11D-1894-05 3fd8286a-b9a6-42b8-9ecd-7ed96744251a 3fd8286a-b9a6-42b8-9ecd-7ed96744251a TCGA-DU-5853-01A-11D-1892-01 TCGA-DU-5853-01A-11D-1893-08 +TCGA-DU-5854-01 TCGA-DU-5854-01 TCGA-DU-5854 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain YES NO NO NO 57 TCGA-DU-5854-F14893 TCGA-DU-5854 TCGA-DU-5854-01A -21106 0 257 202 202 YES NO Motor/Movement Changes 91 - 180 Days 2011-5-25 FEMALE NO Astrocytoma NO No C71.9 9401/3 C71.9 YES 0.9 NO 100 Right NO 1 NO YES G3 YES No TCGA-DU-5854.e057679f-9741-4a4e-bb60-e03879b1c723.pdf 5854 Pre-Adjuvant Therapy WITH TUMOR YES YES Progressive Disease YES Primary Tumor 01 NO YES 0.7 Not listed in Medical Record YES YES NO DU Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2010 TCGA-DU-5854-01A-11D-1705-08 TCGA-DU-5854-01 9A55D294-2F09-4D30-B9E3-FF0F3F524BC4 TCGA-DU-5854-01A-11D-1705-08 TCGA-DU-5854-01A-11D-1704-01 10fb1701-1d93-4b24-aa8b-2814e80de197 TCGA-DU-5854-01 TCGA-DU-5854-01 TCGA-DU-5854-01A-11D-1705-08 10fb1701-1d93-4b24-aa8b-2814e80de197 TCGA-DU-5854-01 TCGA-DU-5854-01 TCGA-DU-5854-01A-11D-1705-08 TCGA-DU-5854-01A-11D-1706-05 10fb1701-1d93-4b24-aa8b-2814e80de197 10fb1701-1d93-4b24-aa8b-2814e80de197 TCGA-DU-5854-01A-11D-1704-01 TCGA-DU-5854-01A-11D-1705-08 +TCGA-DU-5855-01 TCGA-DU-5855-01 TCGA-DU-5855 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 49 TCGA-DU-5855-F14801 TCGA-DU-5855 TCGA-DU-5855-01A -18234 0 207 19 NO NO Headaches 0 - 30 Days 2011-5-25 FEMALE YES Oligoastrocytoma NO No C71.9 9382/3 C71.9 YES 0.7 NO 100 Right NO 1.1 YES NO G3 NO No TCGA-DU-5855.ba07cd68-b0ac-4e98-bc4b-abe3b9c9d4f6.pdf 5855 Pre-Adjuvant Therapy WITH TUMOR YES YES Stable Disease YES Primary Tumor 01 NO NO 0.7 Not listed in Medical Record YES YES NO DU Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2010 TCGA-DU-5855-01A-11D-1705-08 TCGA-DU-5855-01 87BC7D75-6611-4CDF-B49C-11FC781BF4B9 TCGA-DU-5855-01A-11D-1705-08 TCGA-DU-5855-01A-11D-1704-01 9f678cb6-26c7-4c76-831c-e541319648d1 TCGA-DU-5855-01 TCGA-DU-5855-01 TCGA-DU-5855-01A-11D-1705-08 9f678cb6-26c7-4c76-831c-e541319648d1 TCGA-DU-5855-01 TCGA-DU-5855-01 TCGA-DU-5855-01A-11D-1705-08 TCGA-DU-5855-01A-11D-1706-05 9f678cb6-26c7-4c76-831c-e541319648d1 9f678cb6-26c7-4c76-831c-e541319648d1 TCGA-DU-5855-01A-11D-1704-01 TCGA-DU-5855-01A-11D-1705-08 +TCGA-DU-5870-01 TCGA-DU-5870-01 TCGA-DU-5870 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain YES YES YES NO 34 TCGA-DU-5870-F14719 TCGA-DU-5870 TCGA-DU-5870-01A 4437 -12764 0 5546 4347 4671 NO Headaches > 181 Days Stable Disease 2011-7-27 FEMALE YES Oligodendroglioma NO No C71.9 9450/3 C71.9 YES 0.8 NO 70 Right NO 0.9 YES NO G2 YES No TCGA-DU-5870.5A7D5219-AFF1-4DC0-9A8B-F6403D021501.pdf 5870 Post-Adjuvant Therapy WITH TUMOR Progressive Disease YES Primary Tumor 01 NO YES 0.7 Not listed in Medical Record NO NO YES DU Supratentorial, Temporal Lobe Central nervous system A NO LIVING 1995 TCGA-DU-5870-01A-11D-1705-08 TCGA-DU-5870-01 158DCF38-6765-44CC-8C2E-732A4627CD6A TCGA-DU-5870-01A-11D-1705-08 TCGA-DU-5870-01A-11D-1704-01 f0b0d0c2-4b26-4cf9-b3c7-2f973f958729 TCGA-DU-5870-01 TCGA-DU-5870-01 TCGA-DU-5870-01A-11D-1705-08 f0b0d0c2-4b26-4cf9-b3c7-2f973f958729 TCGA-DU-5870-01 TCGA-DU-5870-01 TCGA-DU-5870-01A-11D-1705-08 TCGA-DU-5870-01A-11D-1706-05 f0b0d0c2-4b26-4cf9-b3c7-2f973f958729 f0b0d0c2-4b26-4cf9-b3c7-2f973f958729 TCGA-DU-5870-01A-11D-1704-01 TCGA-DU-5870-01A-11D-1705-08 +TCGA-DU-5870-02 TCGA-DU-5870-02 TCGA-DU-5870 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain YES YES YES NO 34 TCGA-DU-5870-F14719 TCGA-DU-5870 TCGA-DU-5870-02A 4437 -12764 6469 0 5546 4347 4671 NO Headaches > 181 Days Stable Disease 2011-7-27 FEMALE YES Oligodendroglioma NO No C71.9 9450/3 C71.9 YES 390 NO 70 Right NO YES NO G2 YES false No TCGA-DU-5870.5A7D5219-AFF1-4DC0-9A8B-F6403D021501.pdf 5870 Post-Adjuvant Therapy WITH TUMOR Progressive Disease YES Recurrent Tumor 02 NO YES Not listed in Medical Record NO NO YES DU Supratentorial, Temporal Lobe Central nervous system A NO LIVING 1995 TCGA-DU-5870-02A-12D-A36O-08 387f62fd-dfeb-4f05-88d1-64d8de9a031a TCGA-DU-5870-02 TCGA-DU-5870-02 387f62fd-dfeb-4f05-88d1-64d8de9a031a TCGA-DU-5870-02A-12D-A368-05 387f62fd-dfeb-4f05-88d1-64d8de9a031a 387f62fd-dfeb-4f05-88d1-64d8de9a031a +TCGA-DU-5871-01 TCGA-DU-5871-01 TCGA-DU-5871 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain NO NO NO NO 37 TCGA-DU-5871-F15057 TCGA-DU-5871 TCGA-DU-5871-01A -13673 0 576 -6 YES NO Seizures 0 - 30 Days 2011-5-27 FEMALE NO Oligoastrocytoma NO No C71.9 9382/3 C71.9 YES 1 NO 100 Left NO 1.7 NO NO G2 NO No TCGA-DU-5871.fc11347a-6c78-46ed-a07d-46d44a165260.pdf 5871 Preoperative TUMOR FREE YES YES Stable Disease YES Primary Tumor 01 YES NO 0.9 White Matter YES YES NO DU Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2009 TCGA-DU-5871-01A-12D-1705-08 TCGA-DU-5871-01 16E4485B-0FCA-4DA9-9066-08F0D379A875 TCGA-DU-5871-01A-12D-1705-08 TCGA-DU-5871-01A-12D-1704-01 e04bbaf8-d646-4c00-8d72-72fcdb073ec3 TCGA-DU-5871-01 TCGA-DU-5871-01 TCGA-DU-5871-01A-12D-1705-08 e04bbaf8-d646-4c00-8d72-72fcdb073ec3 TCGA-DU-5871-01 TCGA-DU-5871-01 TCGA-DU-5871-01A-12D-1705-08 TCGA-DU-5871-01A-12D-1706-05 e04bbaf8-d646-4c00-8d72-72fcdb073ec3 e04bbaf8-d646-4c00-8d72-72fcdb073ec3 TCGA-DU-5871-01A-12D-1704-01 TCGA-DU-5871-01A-12D-1705-08 +TCGA-DU-5872-01 TCGA-DU-5872-01 TCGA-DU-5872 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain YES NO YES NO 43 TCGA-DU-5872-F14771 TCGA-DU-5872 TCGA-DU-5872-01A 283 -15986 0 532 265 NO NO Headaches 0 - 30 Days Progressive Disease 2011-6-20 FEMALE YES Oligoastrocytoma NO No C71.9 9382/3 C71.9 YES 1 NO Left NO 1.2 NO NO G2 YES No TCGA-DU-5872.86EEC915-5F91-4C9E-B243-A26C2ACC04CF.pdf 5872 WITH TUMOR YES YES Progressive Disease YES Primary Tumor 01 NO NO 1 Not listed in Medical Record YES YES NO DU Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2009 TCGA-DU-5872-01A-11D-1705-08 TCGA-DU-5872-01 8E0C43AA-9F74-4CE0-A5D7-83A4AB02AF9C TCGA-DU-5872-01A-11D-1705-08 TCGA-DU-5872-01A-11D-1704-01 bf5bd9e6-0623-4aac-9336-4ff9dd538c7c TCGA-DU-5872-01 TCGA-DU-5872-01 TCGA-DU-5872-01A-11D-1705-08 bf5bd9e6-0623-4aac-9336-4ff9dd538c7c TCGA-DU-5872-01 TCGA-DU-5872-01 TCGA-DU-5872-01A-11D-1705-08 TCGA-DU-5872-01A-11D-1706-05 bf5bd9e6-0623-4aac-9336-4ff9dd538c7c bf5bd9e6-0623-4aac-9336-4ff9dd538c7c TCGA-DU-5872-01A-11D-1704-01 TCGA-DU-5872-01A-11D-1705-08 +TCGA-DU-5872-02 TCGA-DU-5872-02 TCGA-DU-5872 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain YES NO YES NO 43 TCGA-DU-5872-F14771 TCGA-DU-5872 TCGA-DU-5872-02A 283 -15986 1317 0 532 265 NO NO Headaches 0 - 30 Days Progressive Disease 2011-6-20 FEMALE YES Oligoastrocytoma NO No C71.9 9382/3 C71.9 YES 430 NO Left NO NO NO G2 YES false No TCGA-DU-5872.86EEC915-5F91-4C9E-B243-A26C2ACC04CF.pdf 5872 WITH TUMOR YES YES Progressive Disease YES Recurrent Tumor 02 NO NO Not listed in Medical Record YES YES NO DU Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2009 TCGA-DU-5872-02A-21D-A36O-08 0d0edd5c-226b-4dae-a881-24dba9d3caab TCGA-DU-5872-02 TCGA-DU-5872-02 0d0edd5c-226b-4dae-a881-24dba9d3caab TCGA-DU-5872-02A-21D-A368-05 0d0edd5c-226b-4dae-a881-24dba9d3caab 0d0edd5c-226b-4dae-a881-24dba9d3caab +TCGA-DU-5874-01 TCGA-DU-5874-01 TCGA-DU-5874 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 62 TCGA-DU-5874-F14706 TCGA-DU-5874 TCGA-DU-5874-01A -22847 0 461 380 Seizures 31 - 90 Days 2011-6-17 FEMALE NO Oligodendroglioma NO No C71.9 9450/3 C71.9 YES 1 NO 100 Left NO 1 NO NO G2 NO No TCGA-DU-5874.edd1c152-5b40-4f2f-a7bc-454f1837142a.pdf 5874 Pre-Adjuvant Therapy TUMOR FREE YES NO Stable Disease NO Primary Tumor 01 YES NO 0.7 Not listed in Medical Record YES YES NO DU Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2010 TCGA-DU-5874-01A-11D-1705-08 TCGA-DU-5874-01 DBB84254-CE0B-4E9D-9906-56A3304F247D TCGA-DU-5874-01A-11D-1705-08 TCGA-DU-5874-01A-11D-1704-01 40b5eda3-8b01-4cd7-acb5-0ea4e9ff4312 TCGA-DU-5874-01 TCGA-DU-5874-01 TCGA-DU-5874-01A-11D-1705-08 40b5eda3-8b01-4cd7-acb5-0ea4e9ff4312 TCGA-DU-5874-01 TCGA-DU-5874-01 TCGA-DU-5874-01A-11D-1705-08 TCGA-DU-5874-01A-11D-1706-05 40b5eda3-8b01-4cd7-acb5-0ea4e9ff4312 40b5eda3-8b01-4cd7-acb5-0ea4e9ff4312 TCGA-DU-5874-01A-11D-1704-01 TCGA-DU-5874-01A-11D-1705-08 +TCGA-DU-6392-01 TCGA-DU-6392-01 TCGA-DU-6392 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain NO NO YES YES 35 TCGA-DU-6392-F14726 TCGA-DU-6392 TCGA-DU-6392-01A 950 1055 -12836 0 6423 950 Seizures 0 - 30 Days Stable Disease 2011-5-27 FEMALE Astrocytoma NO No C71.0 9401/3 C71.0 YES 1 NO Right NO 1 G3 YES No TCGA-DU-6392.ebd2fe7e-1d87-4831-b605-b6837c3da443.pdf 6392 TUMOR FREE Progressive Disease YES Primary Tumor 01 YES 0.6 White Matter YES NO YES DU Supratentorial, Parietal Lobe Central nervous system A LIVING 1993 TCGA-DU-6392-01A-11D-1705-08 TCGA-DU-6392-01 EC048662-2CFB-45E5-B8F4-948872E71268 TCGA-DU-6392-01A-11D-1705-08 TCGA-DU-6392-01A-11D-1704-01 d224765a-980f-4212-acf8-c38d0d9b7610 TCGA-DU-6392-01 TCGA-DU-6392-01 d224765a-980f-4212-acf8-c38d0d9b7610 TCGA-DU-6392-01 TCGA-DU-6392-01 TCGA-DU-6392-01A-11D-1706-05 d224765a-980f-4212-acf8-c38d0d9b7610 d224765a-980f-4212-acf8-c38d0d9b7610 TCGA-DU-6392-01A-11D-1704-01 TCGA-DU-6392-01A-11D-1705-08 +TCGA-DU-6393-01 TCGA-DU-6393-01 TCGA-DU-6393 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 66 TCGA-DU-6393-F14735 TCGA-DU-6393 TCGA-DU-6393-01A -24282 1585 0 2011-5-27 MALE Oligodendroglioma NO No C71.0 9451/3 C71.0 YES 0.7 NO Left NO 0.7 G3 No TCGA-DU-6393.13d53e5b-0ff2-4903-91a4-b183b2a4fd62.pdf 6393 YES Primary Tumor 01 0.5 White Matter YES NO YES DU Supratentorial, Occipital Lobe Central nervous system A DECEASED 1993 TCGA-DU-6393-01A-11D-1705-08 TCGA-DU-6393-01 EF999DCC-CE50-42BE-8855-EBF4A41FA165 TCGA-DU-6393-01A-11D-1705-08 TCGA-DU-6393-01A-11D-1704-01 1bb006de-b90b-43fe-8f1e-2357faf7c73f TCGA-DU-6393-01 TCGA-DU-6393-01 TCGA-DU-6393-01A-11D-1705-08 1bb006de-b90b-43fe-8f1e-2357faf7c73f TCGA-DU-6393-01 TCGA-DU-6393-01 TCGA-DU-6393-01A-11D-1705-08 TCGA-DU-6393-01A-11D-1706-05 1bb006de-b90b-43fe-8f1e-2357faf7c73f 1bb006de-b90b-43fe-8f1e-2357faf7c73f TCGA-DU-6393-01A-11D-1704-01 TCGA-DU-6393-01A-11D-1705-08 +TCGA-DU-6394-01 TCGA-DU-6394-01 TCGA-DU-6394 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain YES YES NO NO 53 TCGA-DU-6394-F14761 TCGA-DU-6394 TCGA-DU-6394-01A -19541 682 0 353 Progressive Disease 2011-5-27 MALE Oligodendroglioma NO No C71.0 9451/3 C71.0 YES 1 NO Midline 1 G3 YES No TCGA-DU-6394.300d6b45-ff77-493d-9b07-9921ae4569bd.pdf 6394 WITH TUMOR Progressive Disease YES Primary Tumor 01 1 White Matter YES NO YES DU Supratentorial, Frontal Lobe Central nervous system A DECEASED 1994 TCGA-DU-6394-01A-11D-1705-08 TCGA-DU-6394-01 4F42D254-03C5-4614-BFCE-67B74FEE6E2C TCGA-DU-6394-01A-11D-1705-08 TCGA-DU-6394-01A-11D-1704-01 fb8d125a-badb-4b4a-ab74-916c93ebbf21 TCGA-DU-6394-01 TCGA-DU-6394-01 TCGA-DU-6394-01A-11D-1705-08 fb8d125a-badb-4b4a-ab74-916c93ebbf21 TCGA-DU-6394-01 TCGA-DU-6394-01A-11D-1705-08 TCGA-DU-6394-01A-11D-1706-05 fb8d125a-badb-4b4a-ab74-916c93ebbf21 fb8d125a-badb-4b4a-ab74-916c93ebbf21 TCGA-DU-6394-01A-11D-1704-01 TCGA-DU-6394-01A-11D-1705-08 +TCGA-DU-6395-01 TCGA-DU-6395-01 TCGA-DU-6395 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain YES NO YES NO 31 TCGA-DU-6395-F14942 TCGA-DU-6395 TCGA-DU-6395-01A 1197 -11584 1491 0 1197 NO NO Seizures 91 - 180 Days Progressive Disease 2011-5-26 MALE NO Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES 0.9 NO Left NO 1 NO NO G2 YES No TCGA-DU-6395.06DC35CF-0317-47F4-9F85-AAD0768C40B0.pdf 6395 WITH TUMOR Progressive Disease YES Primary Tumor 01 YES NO 0.4 Not listed in Medical Record NO NO YES DU Supratentorial, Frontal Lobe Central nervous system A NO DECEASED 1994 TCGA-DU-6395-01A-12D-1705-08 TCGA-DU-6395-01 34DF4C17-9FEB-44F0-BBD8-A6EB2FE194FC TCGA-DU-6395-01A-12D-1705-08 TCGA-DU-6395-01A-12D-1704-01 c1c9f44f-935f-47b9-80cd-5116d52001c3 TCGA-DU-6395-01 TCGA-DU-6395-01 TCGA-DU-6395-01A-12D-1705-08 c1c9f44f-935f-47b9-80cd-5116d52001c3 TCGA-DU-6395-01 TCGA-DU-6395-01 TCGA-DU-6395-01A-12D-1705-08 TCGA-DU-6395-01A-12D-1706-05 c1c9f44f-935f-47b9-80cd-5116d52001c3 c1c9f44f-935f-47b9-80cd-5116d52001c3 TCGA-DU-6395-01A-12D-1704-01 TCGA-DU-6395-01A-12D-1705-08 +TCGA-DU-6396-01 TCGA-DU-6396-01 TCGA-DU-6396 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain YES YES YES NO 31 TCGA-DU-6396-F14916 TCGA-DU-6396 TCGA-DU-6396-01A 169 -11427 2286 0 106 19 0 NO NO Motor/Movement Changes 0 - 30 Days Progressive Disease 2011-7-27 FEMALE YES Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES 1 NO 90 Right NO 1 NO YES G3 YES No TCGA-DU-6396.23ea2bb8-e87f-4956-8a97-b53537885a69.pdf 6396 Post-Adjuvant Therapy WITH TUMOR Progressive Disease YES Primary Tumor 01 NO YES 1 White Matter YES NO YES DU Supratentorial, Frontal Lobe Central nervous system A NO DECEASED 1996 TCGA-DU-6396-01A-11D-1705-08 TCGA-DU-6396-01 62EAE321-122B-452D-AC50-5C518D756AF1 TCGA-DU-6396-01A-11D-1705-08 TCGA-DU-6396-01A-11D-1704-01 128dd28f-7f33-4fc2-a131-e64adbab6ba8 TCGA-DU-6396-01 TCGA-DU-6396-01 TCGA-DU-6396-01A-11D-1705-08 128dd28f-7f33-4fc2-a131-e64adbab6ba8 TCGA-DU-6396-01 TCGA-DU-6396-01 TCGA-DU-6396-01A-11D-1705-08 TCGA-DU-6396-01A-11D-1706-05 128dd28f-7f33-4fc2-a131-e64adbab6ba8 128dd28f-7f33-4fc2-a131-e64adbab6ba8 TCGA-DU-6396-01A-11D-1704-01 TCGA-DU-6396-01A-11D-1705-08 +TCGA-DU-6397-01 TCGA-DU-6397-01 TCGA-DU-6397 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain YES YES YES NO 45 TCGA-DU-6397-F14794 TCGA-DU-6397 TCGA-DU-6397-01A 837 -16695 1401 0 837 YES NO Headaches 0 - 30 Days Progressive Disease 2011-5-26 MALE YES Oligodendroglioma NO No C71.0 9451/3 C71.0 YES 1 NO Right NO 1.3 YES G3 YES No TCGA-DU-6397.54C5D9F8-8737-49DA-81CF-F9A95B0DB456.pdf 6397 WITH TUMOR Progressive Disease YES Primary Tumor 01 NO 0.8 Not listed in Medical Record NO NO YES DU Supratentorial, Temporal Lobe Central nervous system A YES DECEASED 1997 TCGA-DU-6397-01A-11D-1705-08 TCGA-DU-6397-01 6263B9E0-70FC-4554-9A4D-5CDD338FAB60 TCGA-DU-6397-01A-11D-1705-08 TCGA-DU-6397-01A-11D-1704-01 32192c9c-9ab2-4709-b419-9beb7853ca2f TCGA-DU-6397-01 TCGA-DU-6397-01 TCGA-DU-6397-01A-11D-1705-08 32192c9c-9ab2-4709-b419-9beb7853ca2f TCGA-DU-6397-01 TCGA-DU-6397-01A-11D-1705-08 TCGA-DU-6397-01A-11D-1706-05 32192c9c-9ab2-4709-b419-9beb7853ca2f 32192c9c-9ab2-4709-b419-9beb7853ca2f TCGA-DU-6397-01A-11D-1704-01 TCGA-DU-6397-01A-11D-1705-08 +TCGA-DU-6397-02 TCGA-DU-6397-02 TCGA-DU-6397 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain YES YES YES NO 45 TCGA-DU-6397-F14794 TCGA-DU-6397 TCGA-DU-6397-02A 837 -16695 5830 1401 0 837 YES NO Headaches 0 - 30 Days Progressive Disease 2011-5-26 MALE YES Oligodendroglioma NO No C71.0 9451/3 C71.0 YES 200 NO Right NO YES G3 YES false No TCGA-DU-6397.54C5D9F8-8737-49DA-81CF-F9A95B0DB456.pdf 6397 WITH TUMOR Progressive Disease YES Recurrent Tumor 02 NO Not listed in Medical Record NO NO YES DU Supratentorial, Temporal Lobe Central nervous system A YES DECEASED 1997 TCGA-DU-6397-02A-12D-A36O-08 5154656a-156d-4118-8415-75b9253ad3f9 TCGA-DU-6397-02 TCGA-DU-6397-02 5154656a-156d-4118-8415-75b9253ad3f9 TCGA-DU-6397-02A-12D-A368-05 5154656a-156d-4118-8415-75b9253ad3f9 5154656a-156d-4118-8415-75b9253ad3f9 +TCGA-DU-6399-01 TCGA-DU-6399-01 TCGA-DU-6399 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain NO NO YES NO 54 TCGA-DU-6399-F14710 TCGA-DU-6399 TCGA-DU-6399-01A 1629 -19906 2000 0 1629 NO 31 - 90 Days Progressive Disease 2011-5-31 MALE NO Oligodendroglioma NO No C71.0 9450/3 C71.0 YES 1 NO Right NO 2 NO NO G2 YES No TCGA-DU-6399.e0803e30-ae37-4c26-8d3b-bc0a3ee88a51.pdf 6399 WITH TUMOR Progressive Disease YES Primary Tumor 01 NO NO 1 White Matter NO NO YES DU Supratentorial, Temporal Lobe Central nervous system A NO DECEASED 1998 TCGA-DU-6399-01A-12D-1705-08 TCGA-DU-6399-01 3746A9E5-8F81-4DF5-8045-98ACFA90F91C TCGA-DU-6399-01A-12D-1705-08 TCGA-DU-6399-01A-12D-1704-01 f1a80ad7-316b-4bf7-a428-3d46f498b571 TCGA-DU-6399-01 TCGA-DU-6399-01 TCGA-DU-6399-01A-12D-1705-08 f1a80ad7-316b-4bf7-a428-3d46f498b571 TCGA-DU-6399-01 TCGA-DU-6399-01 TCGA-DU-6399-01A-12D-1705-08 TCGA-DU-6399-01A-12D-1706-05 f1a80ad7-316b-4bf7-a428-3d46f498b571 f1a80ad7-316b-4bf7-a428-3d46f498b571 TCGA-DU-6399-01A-12D-1704-01 TCGA-DU-6399-01A-12D-1705-08 +TCGA-DU-6400-01 TCGA-DU-6400-01 TCGA-DU-6400 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 66 TCGA-DU-6400-F14782 TCGA-DU-6400 TCGA-DU-6400-01A -24122 37 0 Mental Status Changes 91 - 180 Days 2011-5-31 FEMALE YES Oligodendroglioma NO No C71.0 9450/3 C71.0 YES 0.6 NO Left NO 1 YES YES G2 NO No TCGA-DU-6400.a61be291-6258-47f2-8404-18615093f168.pdf 6400 WITH TUMOR YES YES NO Primary Tumor 01 NO NO 0.5 Not listed in Medical Record NO NO YES DU Supratentorial, Temporal Lobe Central nervous system A NO DECEASED 1998 TCGA-DU-6400-01A-12D-1705-08 TCGA-DU-6400-01 136D68A9-CFB2-44C8-BF8B-EC4B63FED8FB TCGA-DU-6400-01A-12D-1705-08 TCGA-DU-6400-01A-12D-1704-01 3e095f21-2bc5-4ee8-bf9f-0035164d2113 TCGA-DU-6400-01 TCGA-DU-6400-01 TCGA-DU-6400-01A-12D-1705-08 3e095f21-2bc5-4ee8-bf9f-0035164d2113 TCGA-DU-6400-01 TCGA-DU-6400-01 TCGA-DU-6400-01A-12D-1705-08 TCGA-DU-6400-01A-12D-1706-05 3e095f21-2bc5-4ee8-bf9f-0035164d2113 3e095f21-2bc5-4ee8-bf9f-0035164d2113 TCGA-DU-6400-01A-12D-1704-01 TCGA-DU-6400-01A-12D-1705-08 +TCGA-DU-6401-01 TCGA-DU-6401-01 TCGA-DU-6401 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain YES NO YES NO 31 TCGA-DU-6401-F14751 TCGA-DU-6401 TCGA-DU-6401-01A 2464 -11595 2660 0 1886 2454 Headaches > 181 Days Progressive Disease 2011-5-31 FEMALE YES Oligodendroglioma NO No C71.0 9450/3 C71.0 YES 0.8 NO 100 Left NO 1.5 NO NO G2 YES No TCGA-DU-6401.8B65EAA0-2BE6-4648-9CF0-9E97AAB0073C.pdf 6401 Preoperative WITH TUMOR YES YES Progressive Disease YES Primary Tumor 01 NO NO 0.5 Not listed in Medical Record NO NO YES DU Supratentorial, Frontal Lobe Central nervous system A YES DECEASED 1998 TCGA-DU-6401-01A-11D-1705-08 TCGA-DU-6401-01 63DD6FF4-61CA-466A-885B-EA93F4EF6725 TCGA-DU-6401-01A-11D-1705-08 TCGA-DU-6401-01A-11D-1704-01 2692f7b0-3203-455f-b9b8-23b18eff2de1 TCGA-DU-6401-01 TCGA-DU-6401-01 TCGA-DU-6401-01A-11D-1705-08 2692f7b0-3203-455f-b9b8-23b18eff2de1 TCGA-DU-6401-01 TCGA-DU-6401-01 TCGA-DU-6401-01A-11D-1705-08 TCGA-DU-6401-01A-11D-1706-05 2692f7b0-3203-455f-b9b8-23b18eff2de1 2692f7b0-3203-455f-b9b8-23b18eff2de1 TCGA-DU-6401-01A-11D-1704-01 TCGA-DU-6401-01A-11D-1705-08 +TCGA-DU-6402-01 TCGA-DU-6402-01 TCGA-DU-6402 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain NO NO NO 52 TCGA-DU-6402-F14714 TCGA-DU-6402 TCGA-DU-6402-01A -19207 214 0 103 Seizures 0 - 30 Days Progressive Disease 2011-5-31 MALE Astrocytoma NO No C71.0 9401/3 C71.0 YES 1 NO Right NO 1.5 G3 YES No TCGA-DU-6402.cf00fc85-c4be-4d4a-987a-074fcf53aca3.pdf 6402 WITH TUMOR Progressive Disease YES Primary Tumor 01 YES 0.5 Not listed in Medical Record YES NO YES DU Supratentorial, Frontal Lobe Central nervous system A DECEASED 1998 TCGA-DU-6402-01A-11D-1705-08 TCGA-DU-6402-01 E74171CA-2267-4ADD-8917-3D19954839AC TCGA-DU-6402-01A-11D-1705-08 TCGA-DU-6402-01A-11D-1704-01 51f1ccc5-2481-4a1a-8892-c0728d1c9869 TCGA-DU-6402-01 TCGA-DU-6402-01 TCGA-DU-6402-01A-11D-1705-08 51f1ccc5-2481-4a1a-8892-c0728d1c9869 TCGA-DU-6402-01 TCGA-DU-6402-01A-11D-1705-08 TCGA-DU-6402-01A-11D-1706-05 51f1ccc5-2481-4a1a-8892-c0728d1c9869 51f1ccc5-2481-4a1a-8892-c0728d1c9869 TCGA-DU-6402-01A-11D-1704-01 TCGA-DU-6402-01A-11D-1705-08 +TCGA-DU-6403-01 TCGA-DU-6403-01 TCGA-DU-6403 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 60 TCGA-DU-6403-F14743 TCGA-DU-6403 TCGA-DU-6403-01A -22031 354 0 207 Headaches 0 - 30 Days 2011-5-31 FEMALE YES Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES 0.6 NO 90 Right NO 0.9 NO NO G3 No TCGA-DU-6403.86c8b229-d75e-48ce-849e-bcc995b186a1.pdf 6403 Post-Adjuvant Therapy WITH TUMOR YES YES Primary Tumor 01 NO NO 0.5 Not listed in Medical Record YES NO YES DU Supratentorial, Temporal Lobe Central nervous system A NO DECEASED 1999 TCGA-DU-6403-01A-11D-1705-08 TCGA-DU-6403-01 42EF4AAB-93AB-4DF8-90D4-7B14115FD8D1 TCGA-DU-6403-01A-11D-1705-08 TCGA-DU-6403-01A-11D-1704-01 d4cd474d-abe3-423c-9772-a8edce3bb8c7 TCGA-DU-6403-01 TCGA-DU-6403-01 TCGA-DU-6403-01A-11D-1705-08 d4cd474d-abe3-423c-9772-a8edce3bb8c7 TCGA-DU-6403-01 TCGA-DU-6403-01 TCGA-DU-6403-01A-11D-1705-08 TCGA-DU-6403-01A-11D-1706-05 d4cd474d-abe3-423c-9772-a8edce3bb8c7 d4cd474d-abe3-423c-9772-a8edce3bb8c7 TCGA-DU-6403-01A-11D-1704-01 TCGA-DU-6403-01A-11D-1705-08 +TCGA-DU-6404-01 TCGA-DU-6404-01 TCGA-DU-6404 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain YES YES YES NO 24 NO NO TCGA-DU-6404-F14781 TCGA-DU-6404 TCGA-DU-6404-01A 1194 -9021 4068 0 1154 1398 NO YES NO 12 - 20 Years Seizures 31 - 90 Days Progressive Disease YES beef 2011-5-31 FEMALE NO NO Oligodendroglioma NO No C71.0 9451/3 C71.0 YES 0.6 NO 100 Right NO 1 NO NO NO G3 YES No 6404 Post-Adjuvant Therapy WITH TUMOR YES NO Progressive Disease YES Primary Tumor 01 YES NO 0.3 Not listed in Medical Record YES NO YES DU Supratentorial, Frontal Lobe Central nervous system A NO DECEASED 2000 TCGA-DU-6404-01A-11D-1705-08 TCGA-DU-6404-01 32F61243-FAAD-4FC0-BB65-2E996AE5C4BC TCGA-DU-6404-01A-11D-1705-08 TCGA-DU-6404-01A-11D-1704-01 50ec944a-3bb5-41b1-965e-e5cf7f5bd24b TCGA-DU-6404-01 TCGA-DU-6404-01 TCGA-DU-6404-01A-11D-1705-08 50ec944a-3bb5-41b1-965e-e5cf7f5bd24b TCGA-DU-6404-01 TCGA-DU-6404-01 TCGA-DU-6404-01A-11D-1705-08 TCGA-DU-6404-01A-11D-1706-05 50ec944a-3bb5-41b1-965e-e5cf7f5bd24b 50ec944a-3bb5-41b1-965e-e5cf7f5bd24b TCGA-DU-6404-01A-11D-1704-01 TCGA-DU-6404-01A-11D-1705-08 +TCGA-DU-6404-02 TCGA-DU-6404-02 TCGA-DU-6404 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain YES YES YES NO 24 NO NO TCGA-DU-6404-F14781 TCGA-DU-6404 TCGA-DU-6404-02A 1194 -9021 4892 4068 0 1154 1398 NO YES NO 12 - 20 Years Seizures 31 - 90 Days Progressive Disease YES beef 2011-5-31 FEMALE NO NO Oligodendroglioma NO No C71.0 9451/3 C71.0 YES 200 NO 100 Right NO NO NO NO G3 YES false No TCGA-DU-6404.C13F0838-3BA3-4C58-BDCC-926F470FFD34.pdf 6404 Post-Adjuvant Therapy WITH TUMOR YES NO Progressive Disease YES Recurrent Tumor 02 YES NO Not listed in Medical Record YES NO YES DU Supratentorial, Frontal Lobe Central nervous system A NO DECEASED 2000 TCGA-DU-6404-02A-21D-A36O-08,TCGA-DU-6404-02B-11D-A36O-08 6297b8d1-8f4e-499c-b95f-422f0a574b35,af6191bb-b4c3-42ea-adc9-f6d45b00f0b0 TCGA-DU-6404-02 TCGA-DU-6404-02 6297b8d1-8f4e-499c-b95f-422f0a574b35,af6191bb-b4c3-42ea-adc9-f6d45b00f0b0 TCGA-DU-6404-02B-11D-A368-05,TCGA-DU-6404-02A-21D-A368-05 6297b8d1-8f4e-499c-b95f-422f0a574b35,af6191bb-b4c3-42ea-adc9-f6d45b00f0b0 6297b8d1-8f4e-499c-b95f-422f0a574b35,af6191bb-b4c3-42ea-adc9-f6d45b00f0b0 +TCGA-DU-6405-01 TCGA-DU-6405-01 TCGA-DU-6405 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain YES NO NO 51 TCGA-DU-6405-F14683 TCGA-DU-6405 TCGA-DU-6405-01A -18686 605 0 486 571 Seizures 0 - 30 Days Progressive Disease 2011-6-20 FEMALE Astrocytoma NO No C71.0 9401/3 C71.0 YES 1 NO 60 Right NO 1 G3 YES No TCGA-DU-6405.5a26ce1c-d97c-4123-a573-a1f4ef1a6fea.pdf 6405 Post-Adjuvant Therapy WITH TUMOR YES NO Progressive Disease YES Primary Tumor 01 YES 0.6 Not listed in Medical Record YES NO YES DU Supratentorial, Frontal Lobe Central nervous system A DECEASED 2000 TCGA-DU-6405-01A-11D-1705-08 TCGA-DU-6405-01 DA43E43D-B4D2-42AE-84C8-867E2A187F4B TCGA-DU-6405-01A-11D-1705-08 TCGA-DU-6405-01A-11D-1704-01 ab2b78d1-773b-4935-b458-60befcf470af TCGA-DU-6405-01 TCGA-DU-6405-01 TCGA-DU-6405-01A-11D-1705-08 ab2b78d1-773b-4935-b458-60befcf470af TCGA-DU-6405-01 TCGA-DU-6405-01 TCGA-DU-6405-01A-11D-1705-08 TCGA-DU-6405-01A-11D-1706-05 ab2b78d1-773b-4935-b458-60befcf470af ab2b78d1-773b-4935-b458-60befcf470af TCGA-DU-6405-01A-11D-1704-01 TCGA-DU-6405-01A-11D-1705-08 +TCGA-DU-6406-01 TCGA-DU-6406-01 TCGA-DU-6406 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 59 TCGA-DU-6406-F14899 TCGA-DU-6406 TCGA-DU-6406-01A -21634 512 0 Motor/Movement Changes 91 - 180 Days 2011-6-1 FEMALE NO Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES 0.5 NO Left NO 1 NO YES G3 No TCGA-DU-6406.84775a3e-6deb-477c-bd7b-65f84d5701dd.pdf 6406 YES Primary Tumor 01 NO YES 0.5 Not listed in Medical Record YES NO YES DU Supratentorial, Frontal Lobe Central nervous system A YES DECEASED 2001 TCGA-DU-6406-01A-11D-1705-08 TCGA-DU-6406-01 EEF6D49B-C2B0-4778-AE38-217A84327285 TCGA-DU-6406-01A-11D-1705-08 TCGA-DU-6406-01A-11D-1704-01 9af14bce-1e74-4b8a-aa17-049ff4d45db6 TCGA-DU-6406-01 TCGA-DU-6406-01 9af14bce-1e74-4b8a-aa17-049ff4d45db6 TCGA-DU-6406-01 TCGA-DU-6406-01 TCGA-DU-6406-01A-11D-1706-05 9af14bce-1e74-4b8a-aa17-049ff4d45db6 9af14bce-1e74-4b8a-aa17-049ff4d45db6 TCGA-DU-6406-01A-11D-1704-01 TCGA-DU-6406-01A-11D-1705-08 +TCGA-DU-6407-01 TCGA-DU-6407-01 TCGA-DU-6407 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain YES YES YES YES 35 TCGA-DU-6407-F14950 TCGA-DU-6407 TCGA-DU-6407-01A 2415 2797 -13021 2875 0 2397 2838 NO NO Seizures Progressive Disease 2011-6-20 FEMALE NO Oligodendroglioma NO No C71.0 9450/3 C71.0 YES 0.8 NO 80 Right NO 0.8 NO NO G2 YES No 6407 Pre-Adjuvant Therapy WITH TUMOR YES NO Progressive Disease YES Primary Tumor 01 YES NO 0.5 Not listed in Medical Record NO NO YES DU [Discrepancy] Central nervous system A NO DECEASED 2001 TCGA-DU-6407-01A-13D-1705-08 TCGA-DU-6407-01 E09DDBCC-81D9-4C71-B73F-ADA48A322591 TCGA-DU-6407-01A-13D-1705-08 TCGA-DU-6407-01A-13D-1704-01 106c0a27-64c4-4496-83f3-1c05df492fd2 TCGA-DU-6407-01 TCGA-DU-6407-01 TCGA-DU-6407-01A-13D-1705-08 106c0a27-64c4-4496-83f3-1c05df492fd2 TCGA-DU-6407-01 TCGA-DU-6407-01 TCGA-DU-6407-01A-13D-1705-08 TCGA-DU-6407-01A-13D-1706-05 106c0a27-64c4-4496-83f3-1c05df492fd2 106c0a27-64c4-4496-83f3-1c05df492fd2 TCGA-DU-6407-01A-13D-1704-01 TCGA-DU-6407-01A-13D-1705-08 +TCGA-DU-6407-02 TCGA-DU-6407-02 TCGA-DU-6407 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain YES YES YES YES 35 TCGA-DU-6407-F14950 TCGA-DU-6407 TCGA-DU-6407-02B 2415 2797 -13021 4524 2875 0 2397 2838 NO NO Seizures Progressive Disease 2011-6-20 FEMALE NO Oligodendroglioma NO No C71.0 9450/3 C71.0 YES 390 NO 80 Right NO NO NO G2 YES false No TCGA-DU-6407.49BAF246-AE0A-4627-AF91-35932D00F105.pdf 6407 Pre-Adjuvant Therapy WITH TUMOR YES NO Progressive Disease YES Recurrent Tumor 02 YES NO Not listed in Medical Record NO NO YES DU [Discrepancy] Central nervous system B NO DECEASED 2001 TCGA-DU-6407-02A-12D-A36O-08,TCGA-DU-6407-02B-11D-A36O-08 1cd76b6a-a698-46cd-9594-decc4ebf24e4,d63ec2f9-d8ca-4738-9d0f-00f93e7ac897 TCGA-DU-6407-02 TCGA-DU-6407-02 1cd76b6a-a698-46cd-9594-decc4ebf24e4,d63ec2f9-d8ca-4738-9d0f-00f93e7ac897 TCGA-DU-6407-02A-12D-A368-05,TCGA-DU-6407-02B-11D-A368-05 1cd76b6a-a698-46cd-9594-decc4ebf24e4,d63ec2f9-d8ca-4738-9d0f-00f93e7ac897 1cd76b6a-a698-46cd-9594-decc4ebf24e4,d63ec2f9-d8ca-4738-9d0f-00f93e7ac897 +TCGA-DU-6408-01 TCGA-DU-6408-01 TCGA-DU-6408 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain YES YES YES 23 TCGA-DU-6408-F14907 TCGA-DU-6408 TCGA-DU-6408-01A 2552 2552 -8752 3470 0 2097 NO Motor/Movement Changes 0 - 30 Days Progressive Disease 2011-6-20 FEMALE NO Oligodendroglioma NO No C71.0 9451/3 C71.0 YES 1 NO 90 Right NO 1 YES YES G3 YES No TCGA-DU-6408.83c5c547-8f79-4b30-9883-3a146c5053ef.pdf 6408 Post-Adjuvant Therapy YES YES Progressive Disease YES Primary Tumor 01 YES NO 0.5 Not listed in Medical Record YES NO YES DU Supratentorial, Frontal Lobe Central nervous system A NO DECEASED 1998 TCGA-DU-6408-01A-11D-1705-08 TCGA-DU-6408-01 358B2C15-EDFB-42BA-AABD-A34D0357CC2F TCGA-DU-6408-01A-11D-1705-08 TCGA-DU-6408-01A-11D-1704-01 0c562903-7b09-49f2-b59e-fa697d69f810 TCGA-DU-6408-01 TCGA-DU-6408-01 TCGA-DU-6408-01A-11D-1705-08 0c562903-7b09-49f2-b59e-fa697d69f810 TCGA-DU-6408-01 TCGA-DU-6408-01 TCGA-DU-6408-01A-11D-1705-08 TCGA-DU-6408-01A-11D-1706-05 0c562903-7b09-49f2-b59e-fa697d69f810 0c562903-7b09-49f2-b59e-fa697d69f810 TCGA-DU-6408-01A-11D-1704-01 TCGA-DU-6408-01A-11D-1705-08 +TCGA-DU-6410-01 TCGA-DU-6410-01 TCGA-DU-6410 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 56 TCGA-DU-6410-F15160 TCGA-DU-6410 TCGA-DU-6410-01A -20567 0 242 35 Mental Status Changes 0 - 30 Days 2011-6-20 MALE Oligodendroglioma NO No C71.0 9451/3 C71.0 YES 0.8 NO 50 Midline NO 0.8 YES G3 NO No TCGA-DU-6410.d7745e3b-3ccd-40ff-8634-9a0f71e088d4.pdf 6410 Pre-Adjuvant Therapy WITH TUMOR NO Primary Tumor 01 0.6 Not listed in Medical Record YES YES NO DU Supratentorial, Frontal Lobe Central nervous system A LIVING 2010 TCGA-DU-6410-01A-11D-1893-08 TCGA-DU-6410-01 55D38B2B-5EF9-4FB9-99A2-86454D41AD07 TCGA-DU-6410-01A-11D-1893-08 TCGA-DU-6410-01A-11D-1892-01 015b3ae9-dee4-495a-9c4d-78ee51082715 TCGA-DU-6410-01 TCGA-DU-6410-01 TCGA-DU-6410-01A-11D-1893-08 015b3ae9-dee4-495a-9c4d-78ee51082715 TCGA-DU-6410-01 TCGA-DU-6410-01 TCGA-DU-6410-01A-11D-1893-08 TCGA-DU-6410-01A-11D-1894-05 015b3ae9-dee4-495a-9c4d-78ee51082715 015b3ae9-dee4-495a-9c4d-78ee51082715 TCGA-DU-6410-01A-11D-1892-01 TCGA-DU-6410-01A-11D-1893-08 +TCGA-DU-6542-01 TCGA-DU-6542-01 TCGA-DU-6542 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 25 TCGA-DU-6542-F46623 TCGA-DU-6542 TCGA-DU-6542-01A -9380 0 73 Visual Changes 31 - 90 Days Scheduled Follow-up Submission 2013-8-13 MALE YES Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES 0.9 NO Right NO 1 YES NO NO G3 No TCGA-DU-6542.bd0d6d1b-bdcd-4c33-9adc-ecf34ce24d6e.pdf 6542 WITH TUMOR YES YES YES Primary Tumor 01 NO NO 0.9 Not listed in Medical Record YES YES NO DU Supratentorial, Temporal Lobe Central nervous system A YES LIVING 2011 TCGA-DU-6542-01A-11D-1893-08 TCGA-DU-6542-01 D0C95E93-30D9-40CA-B7E1-D0E7A1D444F1 TCGA-DU-6542-01A-11D-1893-08 TCGA-DU-6542-01A-11D-1892-01 da02270f-1191-446e-af1d-eabc4e1c3556 TCGA-DU-6542-01 TCGA-DU-6542-01 TCGA-DU-6542-01A-11D-1893-08 da02270f-1191-446e-af1d-eabc4e1c3556 TCGA-DU-6542-01 TCGA-DU-6542-01 TCGA-DU-6542-01A-11D-1893-08 TCGA-DU-6542-01A-11D-1894-05 da02270f-1191-446e-af1d-eabc4e1c3556 da02270f-1191-446e-af1d-eabc4e1c3556 TCGA-DU-6542-01A-11D-1892-01 TCGA-DU-6542-01A-11D-1893-08 +TCGA-DU-7006-01 TCGA-DU-7006-01 TCGA-DU-7006 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 60 TCGA-DU-7006-F17927 TCGA-DU-7006 TCGA-DU-7006-01A -21990 349 0 Seizures 2011-10-25 FEMALE NO Astrocytoma NO No C71.0 9401/3 C71.0 YES 0.8 NO Left NO 1 NO NO G3 No TCGA-DU-7006.1341bbae-b2bf-43fb-be7e-c49cfd28fbb2.pdf 7006 WITH TUMOR Progressive Disease YES Primary Tumor 01 YES NO 0.4 Cerebral Cortex YES NO YES DU Supratentorial, Temporal Lobe Central nervous system A NO DECEASED 1995 TCGA-DU-7006-01A-11D-2024-08 TCGA-DU-7006-01 44F33FFA-14AF-4CD4-BA32-B2DCBEDACFBB TCGA-DU-7006-01A-11D-2024-08 TCGA-DU-7006-01A-11D-2023-01 2c1bdff1-365e-42f2-8fc6-772e9e5fa274 TCGA-DU-7006-01 TCGA-DU-7006-01 TCGA-DU-7006-01A-11D-2024-08 2c1bdff1-365e-42f2-8fc6-772e9e5fa274 TCGA-DU-7006-01 TCGA-DU-7006-01 TCGA-DU-7006-01A-11D-2024-08 TCGA-DU-7006-01A-11D-2025-05 2c1bdff1-365e-42f2-8fc6-772e9e5fa274 2c1bdff1-365e-42f2-8fc6-772e9e5fa274 TCGA-DU-7006-01A-11D-2023-01 TCGA-DU-7006-01A-11D-2024-08 +TCGA-DU-7007-01 TCGA-DU-7007-01 TCGA-DU-7007 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 33 YES TCGA-DU-7007-F17216 TCGA-DU-7007 TCGA-DU-7007-01A -12245 1915 0 Headaches > 181 Days 2011-9-28 MALE YES Astrocytoma NO No C71.0 9400/3 C71.0 YES 1 NO Right 1 NO NO G2 NO No TCGA-DU-7007.ffbbe732-9a5a-4269-b0a7-99f993906030.pdf 7007 Primary Tumor 01 NO YES 0.6 Not listed in Medical Record NO YES DU Supratentorial, Frontal Lobe Central nervous system A NO DECEASED 1997 TCGA-DU-7007-01A-11D-2024-08 TCGA-DU-7007-01 8F1CC0F0-C202-43A3-9530-E93B2419EF75 TCGA-DU-7007-01A-11D-2024-08 TCGA-DU-7007-01A-11D-2023-01 338cef4b-d790-4823-8dad-40bf78c29c68 TCGA-DU-7007-01 TCGA-DU-7007-01 TCGA-DU-7007-01A-11D-2024-08 338cef4b-d790-4823-8dad-40bf78c29c68 TCGA-DU-7007-01 TCGA-DU-7007-01 TCGA-DU-7007-01A-11D-2024-08 TCGA-DU-7007-01A-11D-2025-05 338cef4b-d790-4823-8dad-40bf78c29c68 338cef4b-d790-4823-8dad-40bf78c29c68 TCGA-DU-7007-01A-11D-2023-01 TCGA-DU-7007-01A-11D-2024-08 +TCGA-DU-7008-01 TCGA-DU-7008-01 TCGA-DU-7008 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain NO YES YES NO 41 TCGA-DU-7008-F17219 TCGA-DU-7008 TCGA-DU-7008-01A 330 -15289 0 4752 330 Seizures > 181 Days Stable Disease 2011-9-28 FEMALE YES Oligodendroglioma NO No C71.0 9450/3 C71.0 YES 0.6 NO Right NO 0.8 NO NO G2 YES No TCGA-DU-7008.70aff058-6c24-488c-89ae-3bd311595820.pdf 7008 TUMOR FREE YES YES Progressive Disease NO Primary Tumor 01 YES NO 0.5 Not listed in Medical Record YES NO YES DU Supratentorial, Frontal Lobe Central nervous system A NO LIVING 1998 TCGA-DU-7008-01A-11D-2024-08 TCGA-DU-7008-01 D76A47B7-A421-40F3-BE1D-E43263A5D146 TCGA-DU-7008-01A-11D-2024-08 TCGA-DU-7008-01A-11D-2023-01 a5a2a97b-91dd-45a8-b76c-05d6d40cbe9f TCGA-DU-7008-01 TCGA-DU-7008-01 TCGA-DU-7008-01A-11D-2024-08 a5a2a97b-91dd-45a8-b76c-05d6d40cbe9f TCGA-DU-7008-01 TCGA-DU-7008-01 TCGA-DU-7008-01A-11D-2024-08 TCGA-DU-7008-01A-11D-2025-05 a5a2a97b-91dd-45a8-b76c-05d6d40cbe9f a5a2a97b-91dd-45a8-b76c-05d6d40cbe9f TCGA-DU-7008-01A-11D-2023-01 TCGA-DU-7008-01A-11D-2024-08 +TCGA-DU-7009-01 TCGA-DU-7009-01 TCGA-DU-7009 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain YES YES YES 32 TCGA-DU-7009-F46593 TCGA-DU-7009 TCGA-DU-7009-01A 3091 -11854 4695 0 4206 2960 NO NO Sensory Changes 31 - 90 Days Additional New Tumor Event Progressive Disease 2013-8-12 FEMALE NO Oligodendroglioma NO No C71.0 9450/3 C71.0 YES 1 NO Left NO 1 NO NO NO G2 YES No TCGA-DU-7009.bc350788-3a70-47d5-b2ef-45deebd89fa0.pdf 7009 WITH TUMOR Progressive Disease YES Primary Tumor 01 NO YES 0.5 Cerebral Cortex YES NO YES DU Supratentorial, Frontal Lobe Central nervous system A NO DECEASED 2000 TCGA-DU-7009-01A-11D-2024-08 TCGA-DU-7009-01 FE6E8B5C-75C2-4F13-8A63-6787FCBFAF1F TCGA-DU-7009-01A-11D-2024-08 TCGA-DU-7009-01A-11D-2023-01 748811da-49b0-4ff6-a718-0549921871be TCGA-DU-7009-01 TCGA-DU-7009-01 TCGA-DU-7009-01A-11D-2024-08 748811da-49b0-4ff6-a718-0549921871be TCGA-DU-7009-01 TCGA-DU-7009-01 TCGA-DU-7009-01A-11D-2024-08 TCGA-DU-7009-01A-11D-2025-05 748811da-49b0-4ff6-a718-0549921871be 748811da-49b0-4ff6-a718-0549921871be TCGA-DU-7009-01A-11D-2023-01 TCGA-DU-7009-01A-11D-2024-08 +TCGA-DU-7010-01 TCGA-DU-7010-01 TCGA-DU-7010 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain YES NO 58 TCGA-DU-7010-F17059 TCGA-DU-7010 TCGA-DU-7010-01A 193 -21199 456 0 193 Seizures 31 - 90 Days Progressive Disease 2011-9-28 FEMALE NO Astrocytoma NO No C71.0 9401/3 C71.0 YES 1 NO Left NO 1.1 NO NO G3 YES No TCGA-DU-7010.B62E7173-FC3E-4D4C-B9C0-37110B1B58E8.pdf 7010 WITH TUMOR YES YES Progressive Disease YES Primary Tumor 01 YES NO 0.5 Not listed in Medical Record YES NO YES DU Supratentorial, Frontal Lobe Central nervous system A NO DECEASED 2001 TCGA-DU-7010-01 41385035-0020-4B98-8FF0-F15DBAF98776 TCGA-DU-7010-01A-11D-2024-08 TCGA-DU-7010-01A-11D-2023-01 72721695-e7f3-48c8-82a1-84156e174cad TCGA-DU-7010-01 TCGA-DU-7010-01 TCGA-DU-7010-01A-11D-2024-08 72721695-e7f3-48c8-82a1-84156e174cad TCGA-DU-7010-01 TCGA-DU-7010-01 TCGA-DU-7010-01A-11D-2024-08 TCGA-DU-7010-01A-11D-2025-05 72721695-e7f3-48c8-82a1-84156e174cad 72721695-e7f3-48c8-82a1-84156e174cad TCGA-DU-7010-01A-11D-2023-01 TCGA-DU-7010-01A-11D-2024-08 +TCGA-DU-7011-01 TCGA-DU-7011-01 TCGA-DU-7011 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 25 TCGA-DU-7011-F17074 TCGA-DU-7011 TCGA-DU-7011-01A -9322 3200 0 149 Seizures 91 - 180 Days 2011-9-28 MALE NO Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES 1 NO 80 Right NO 1 NO NO G2 No TCGA-DU-7011.4f0cbf0f-f9f0-44f4-b498-c0d821dc4f53.pdf 7011 Pre-Adjuvant Therapy WITH TUMOR YES YES Stable Disease YES Primary Tumor 01 YES NO 0.3 Cerebral Cortex NO YES DU Supratentorial, Frontal Lobe Central nervous system A NO DECEASED 2000 TCGA-DU-7011-01 8BE2D6BB-1697-4627-8D82-BC555515C0F9 TCGA-DU-7011-01A-11D-2024-08 TCGA-DU-7011-01A-11D-2023-01 ef7cd9b2-f363-40db-bdc1-a07c10e31fd2 ef7cd9b2-f363-40db-bdc1-a07c10e31fd2 TCGA-DU-7011-01 TCGA-DU-7011-01A-11D-2025-05 ef7cd9b2-f363-40db-bdc1-a07c10e31fd2 ef7cd9b2-f363-40db-bdc1-a07c10e31fd2 TCGA-DU-7011-01A-11D-2023-01 TCGA-DU-7011-01A-11D-2024-08 +TCGA-DU-7012-01 TCGA-DU-7012-01 TCGA-DU-7012 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain NO NO 74 TCGA-DU-7012-F17089 TCGA-DU-7012 TCGA-DU-7012-01A -27039 199 0 Mental Status Changes 0 - 30 Days Progressive Disease 2011-9-28 FEMALE NO Astrocytoma NO No C71.0 9401/3 C71.0 YES 1 NO Left NO 1.1 YES NO G3 NO No TCGA-DU-7012.097539a1-a885-478d-9a11-087d6dbf8970.pdf 7012 WITH TUMOR Progressive Disease YES Primary Tumor 01 YES NO 0.9 Not listed in Medical Record NO NO YES DU Supratentorial, Temporal Lobe Central nervous system A NO DECEASED 2001 TCGA-DU-7012-01 E2C93793-DFC7-4701-A34B-536B0F219F47 TCGA-DU-7012-01A-11D-2024-08 TCGA-DU-7012-01A-11D-2023-01 61051f5f-b74b-4b31-ae20-b91491f571d6 TCGA-DU-7012-01 TCGA-DU-7012-01 TCGA-DU-7012-01A-11D-2024-08 61051f5f-b74b-4b31-ae20-b91491f571d6 TCGA-DU-7012-01 TCGA-DU-7012-01 TCGA-DU-7012-01A-11D-2024-08 TCGA-DU-7012-01A-11D-2025-05 61051f5f-b74b-4b31-ae20-b91491f571d6 61051f5f-b74b-4b31-ae20-b91491f571d6 TCGA-DU-7012-01A-11D-2023-01 TCGA-DU-7012-01A-11D-2024-08 +TCGA-DU-7013-01 TCGA-DU-7013-01 TCGA-DU-7013 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain NO NO NO NO 59 TCGA-DU-7013-F17092 TCGA-DU-7013 TCGA-DU-7013-01A -21824 269 0 187 211 Seizures 31 - 90 Days Progressive Disease 2011-9-26 MALE NO Astrocytoma NO No C71.0 9401/3 C71.0 YES 1 NO 70 Left NO 1 NO NO G3 YES No TCGA-DU-7013.a39cad6f-249d-4bc5-8d67-9a3fa7e4dcd6.pdf 7013 Post-Adjuvant Therapy WITH TUMOR YES YES Progressive Disease YES Primary Tumor 01 YES NO 0.5 White Matter YES NO YES DU Supratentorial, Temporal Lobe Central nervous system A NO DECEASED 2001 TCGA-DU-7013-01A-11D-2024-08 TCGA-DU-7013-01 5704634A-8D47-4BE8-8514-1049C91B1B27 TCGA-DU-7013-01A-11D-2024-08 TCGA-DU-7013-01A-11D-2023-01 5fd57857-2f5d-4cfd-a365-bf4d5369f926 TCGA-DU-7013-01 TCGA-DU-7013-01 TCGA-DU-7013-01A-11D-2024-08 5fd57857-2f5d-4cfd-a365-bf4d5369f926 TCGA-DU-7013-01 TCGA-DU-7013-01 TCGA-DU-7013-01A-11D-2024-08 TCGA-DU-7013-01A-11D-2025-05 5fd57857-2f5d-4cfd-a365-bf4d5369f926 5fd57857-2f5d-4cfd-a365-bf4d5369f926 TCGA-DU-7013-01A-11D-2023-01 TCGA-DU-7013-01A-11D-2024-08 +TCGA-DU-7014-01 TCGA-DU-7014-01 TCGA-DU-7014 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain NO NO NO NO 59 TCGA-DU-7014-F17101 TCGA-DU-7014 TCGA-DU-7014-01A -21865 3571 0 3437 3558 Seizures 0 - 30 Days Progressive Disease 2011-9-26 MALE YES Oligodendroglioma NO No C71.0 9450/3 C71.0 YES 1 NO 50 Right YES 1 NO NO G2 YES No TCGA-DU-7014.a848a22c-c92d-42cc-8e0b-8e260b1f5622.pdf 7014 Pre-Adjuvant Therapy WITH TUMOR YES YES Progressive Disease YES Primary Tumor 01 YES NO 0.6 White Matter NO NO YES DU Supratentorial, Frontal Lobe Central nervous system A NO DECEASED 2001 TCGA-DU-7014-01 C01CB29C-25D3-4E7F-B5FF-368B337BE5A7 TCGA-DU-7014-01A-11D-2024-08 TCGA-DU-7014-01A-11D-2023-01 e1355ed5-ae8c-47ba-9b60-a72038142b89 TCGA-DU-7014-01 TCGA-DU-7014-01 e1355ed5-ae8c-47ba-9b60-a72038142b89 TCGA-DU-7014-01 TCGA-DU-7014-01 TCGA-DU-7014-01A-11D-2025-05 e1355ed5-ae8c-47ba-9b60-a72038142b89 e1355ed5-ae8c-47ba-9b60-a72038142b89 TCGA-DU-7014-01A-11D-2023-01 TCGA-DU-7014-01A-11D-2024-08 +TCGA-DU-7015-01 TCGA-DU-7015-01 TCGA-DU-7015 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain YES YES YES NO 41 TCGA-DU-7015-F18631 TCGA-DU-7015 TCGA-DU-7015-01A 591 -15041 0 2761 591 613 YES NO Seizures 0 - 30 Days Progressive Disease 2011-11-8 FEMALE NO Oligodendroglioma NO No C71.0 9450/3 C71.0 YES 1 NO 90 Right NO 1 NO NO G2 YES No TCGA-DU-7015.15dbad7b-e2ae-42b0-92a1-5ccfc3090c2d.pdf 7015 Pre-Adjuvant Therapy WITH TUMOR YES YES Progressive Disease NO Primary Tumor 01 YES NO 0.9 Cerebral Cortex NO NO YES DU Supratentorial, Temporal Lobe Central nervous system A NO LIVING 2004 TCGA-DU-7015-01 3C03E22C-BBEE-44AF-941C-E01852225A05 TCGA-DU-7015-01A-11D-2024-08 TCGA-DU-7015-01A-11D-2023-01 c036ae2f-3de5-49ba-a7f6-32d8c5d78a4e TCGA-DU-7015-01 TCGA-DU-7015-01 TCGA-DU-7015-01A-11D-2024-08 c036ae2f-3de5-49ba-a7f6-32d8c5d78a4e TCGA-DU-7015-01 TCGA-DU-7015-01 TCGA-DU-7015-01A-11D-2024-08 TCGA-DU-7015-01A-11D-2025-05 c036ae2f-3de5-49ba-a7f6-32d8c5d78a4e c036ae2f-3de5-49ba-a7f6-32d8c5d78a4e TCGA-DU-7015-01A-11D-2023-01 TCGA-DU-7015-01A-11D-2024-08 +TCGA-DU-7018-01 TCGA-DU-7018-01 TCGA-DU-7018 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain YES NO YES NO 57 TCGA-DU-7018-F17070 TCGA-DU-7018 TCGA-DU-7018-01A 844 -21019 933 0 338 343 Seizures > 181 Days Progressive Disease 2011-9-23 FEMALE NO Oligodendroglioma NO No C71.0 9451/3 C71.0 YES 1 NO 90 Right YES 1 YES NO G3 YES No TCGA-DU-7018.caa41707-cb2e-4c3f-bae9-ddf6b21d5d4f.pdf 7018 Pre-Adjuvant Therapy WITH TUMOR YES Progressive Disease NO Primary Tumor 01 YES NO 0.5 Not listed in Medical Record YES NO YES DU Supratentorial, Frontal Lobe Central nervous system A NO DECEASED 2006 TCGA-DU-7018-01A-11D-2024-08 TCGA-DU-7018-01 48D344D4-F1EB-4CED-8F5D-22F0D25C2216 TCGA-DU-7018-01A-11D-2024-08 TCGA-DU-7018-01A-11D-2023-01 2ef476c6-ffb6-45b0-b92c-47808e9b4f10 TCGA-DU-7018-01 TCGA-DU-7018-01 TCGA-DU-7018-01A-11D-2024-08 2ef476c6-ffb6-45b0-b92c-47808e9b4f10 TCGA-DU-7018-01 TCGA-DU-7018-01 TCGA-DU-7018-01A-11D-2024-08 TCGA-DU-7018-01A-11D-2025-05 2ef476c6-ffb6-45b0-b92c-47808e9b4f10 2ef476c6-ffb6-45b0-b92c-47808e9b4f10 TCGA-DU-7018-01A-11D-2023-01 TCGA-DU-7018-01A-11D-2024-08 +TCGA-DU-7019-01 TCGA-DU-7019-01 TCGA-DU-7019 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 39 TCGA-DU-7019-F17096 TCGA-DU-7019 TCGA-DU-7019-01A -14279 0 800 21 Headaches 0 - 30 Days 2011-9-26 MALE YES Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES 1 NO 100 Right NO 1 NO NO [Discrepancy] NO No TCGA-DU-7019.a389c9c9-e639-49c6-a8d8-56f79834e6a7.pdf 7019 Pre-Adjuvant Therapy TUMOR FREE YES YES Stable Disease YES Primary Tumor 01 NO NO 1 Cerebral Cortex YES YES NO DU Supratentorial, Temporal Lobe Central nervous system A YES LIVING 2009 TCGA-DU-7019-01A-11D-2024-08 TCGA-DU-7019-01 BA643375-6F99-4256-9875-CD28E0282A2A TCGA-DU-7019-01A-11D-2024-08 TCGA-DU-7019-01A-11D-2023-01 dbd2c9f3-4a21-4f9f-8346-62551d1c609b TCGA-DU-7019-01 TCGA-DU-7019-01 TCGA-DU-7019-01A-11D-2024-08 dbd2c9f3-4a21-4f9f-8346-62551d1c609b TCGA-DU-7019-01 TCGA-DU-7019-01 TCGA-DU-7019-01A-11D-2024-08 TCGA-DU-7019-01A-11D-2025-05 dbd2c9f3-4a21-4f9f-8346-62551d1c609b dbd2c9f3-4a21-4f9f-8346-62551d1c609b TCGA-DU-7019-01A-11D-2023-01 TCGA-DU-7019-01A-11D-2024-08 +TCGA-DU-7290-01 TCGA-DU-7290-01 TCGA-DU-7290 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 45 TCGA-DU-7290-F17541 TCGA-DU-7290 TCGA-DU-7290-01A -16667 315 0 Headaches 0 - 30 Days 2011-10-11 FEMALE YES Astrocytoma NO No C71.0 9401/3 C71.0 YES 0.8 NO Right NO 1.1 NO NO G3 No TCGA-DU-7290.06977359-42d7-453c-9ed3-46a58a7f5726.pdf 7290 WITH TUMOR NO Primary Tumor 01 NO YES 0.6 Cerebral Cortex NO NO YES DU Supratentorial, Temporal Lobe Central nervous system A YES DECEASED 1995 TCGA-DU-7290-01A-11D-2024-08 TCGA-DU-7290-01 2260613E-62C1-42F2-A5D7-481337B531D2 TCGA-DU-7290-01A-11D-2024-08 TCGA-DU-7290-01A-11D-2023-01 fbf30d45-d36c-49f8-8f5b-7ebcd226f777 TCGA-DU-7290-01 TCGA-DU-7290-01 TCGA-DU-7290-01A-11D-2024-08 fbf30d45-d36c-49f8-8f5b-7ebcd226f777 TCGA-DU-7290-01 TCGA-DU-7290-01 TCGA-DU-7290-01A-11D-2024-08 TCGA-DU-7290-01A-11D-2025-05 fbf30d45-d36c-49f8-8f5b-7ebcd226f777 fbf30d45-d36c-49f8-8f5b-7ebcd226f777 TCGA-DU-7290-01A-11D-2023-01 TCGA-DU-7290-01A-11D-2024-08 +TCGA-DU-7292-01 TCGA-DU-7292-01 TCGA-DU-7292 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain YES YES NO NO 69 YES TCGA-DU-7292-F17515 TCGA-DU-7292 TCGA-DU-7292-01A -25266 242 0 91 < 12 Years Seizures 91 - 180 Days Progressive Disease 2011-10-5 MALE NO Astrocytoma NO No C71.0 9401/3 C71.0 YES NO 1 NO Left NO 1.2 NO NO G3 YES No TCGA-DU-7292.13d45e58-4eb6-405e-916f-36bec44d23e2.pdf 7292 WITH TUMOR Progressive Disease YES Primary Tumor 01 YES NO 0.4 Not listed in Medical Record NO NO YES DU Supratentorial, Temporal Lobe Central nervous system A NO DECEASED 1997 TCGA-DU-7292-01A-11D-2024-08 TCGA-DU-7292-01 650AF87A-4D57-414B-8783-DAD6E2060C44 TCGA-DU-7292-01A-11D-2024-08 TCGA-DU-7292-01A-11D-2023-01 fe9eb79d-a750-4830-9db4-32ea4034cb39 TCGA-DU-7292-01 TCGA-DU-7292-01 TCGA-DU-7292-01A-11D-2024-08 fe9eb79d-a750-4830-9db4-32ea4034cb39 TCGA-DU-7292-01 TCGA-DU-7292-01 TCGA-DU-7292-01A-11D-2024-08 TCGA-DU-7292-01A-11D-2025-05 fe9eb79d-a750-4830-9db4-32ea4034cb39 fe9eb79d-a750-4830-9db4-32ea4034cb39 TCGA-DU-7292-01A-11D-2023-01 TCGA-DU-7292-01A-11D-2024-08 +TCGA-DU-7294-01 TCGA-DU-7294-01 TCGA-DU-7294 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 53 TCGA-DU-7294-F17513 TCGA-DU-7294 TCGA-DU-7294-01A -19616 0 2869 793 Stable Disease 2011-10-5 FEMALE NO Oligodendroglioma NO No C71.0 9450/3 C71.0 YES 1 NO 100 Right NO 1.1 NO NO G2 NO No TCGA-DU-7294.3f73eaa4-67da-4c34-98a1-8d4db2997272.pdf 7294 Pre-Adjuvant Therapy TUMOR FREE NO NO Stable Disease NO Primary Tumor 01 NO NO 0.9 Not listed in Medical Record NO NO YES DU Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2003 TCGA-DU-7294-01A-11D-2024-08 TCGA-DU-7294-01 314BE247-8B0A-46F5-B3AF-5D8152CDFD55 TCGA-DU-7294-01A-11D-2024-08 TCGA-DU-7294-01A-11D-2023-01 25a13ca2-fb62-40aa-bec5-a8bf83a9360b TCGA-DU-7294-01 TCGA-DU-7294-01 TCGA-DU-7294-01A-11D-2024-08 25a13ca2-fb62-40aa-bec5-a8bf83a9360b TCGA-DU-7294-01 TCGA-DU-7294-01 TCGA-DU-7294-01A-11D-2024-08 TCGA-DU-7294-01A-11D-2025-05 25a13ca2-fb62-40aa-bec5-a8bf83a9360b 25a13ca2-fb62-40aa-bec5-a8bf83a9360b TCGA-DU-7294-01A-11D-2023-01 TCGA-DU-7294-01A-11D-2024-08 +TCGA-DU-7298-01 TCGA-DU-7298-01 TCGA-DU-7298 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain NO NO YES NO 38 TCGA-DU-7298-F17497 TCGA-DU-7298 TCGA-DU-7298-01A 546 -14205 576 0 200 -2 Headaches 0 - 30 Days 2011-10-12 FEMALE YES Astrocytoma NO No C71.0 9401/3 C71.0 YES 0.7 NO 80 Left NO 1 NO NO G3 YES No TCGA-DU-7298.14bf3d59-284e-40d0-ba0b-0f88815a8a3f.pdf 7298 Preoperative WITH TUMOR YES YES Progressive Disease YES Primary Tumor 01 NO NO 0.5 Cerebral Cortex YES NO YES DU Supratentorial, Temporal Lobe Central nervous system A YES DECEASED 2006 TCGA-DU-7298-01A-11D-2024-08 TCGA-DU-7298-01 5F4D62DD-ECD5-4A16-9AE1-0A22A5EFC251 TCGA-DU-7298-01A-11D-2024-08 TCGA-DU-7298-01A-11D-2023-01 796ff6a5-e27c-4e86-8ac3-7aa29d3b6bd8 TCGA-DU-7298-01 TCGA-DU-7298-01 TCGA-DU-7298-01A-11D-2024-08 796ff6a5-e27c-4e86-8ac3-7aa29d3b6bd8 TCGA-DU-7298-01 TCGA-DU-7298-01 TCGA-DU-7298-01A-11D-2024-08 TCGA-DU-7298-01A-11D-2025-05 796ff6a5-e27c-4e86-8ac3-7aa29d3b6bd8 796ff6a5-e27c-4e86-8ac3-7aa29d3b6bd8 TCGA-DU-7298-01A-11D-2023-01 TCGA-DU-7298-01A-11D-2024-08 +TCGA-DU-7299-01 TCGA-DU-7299-01 TCGA-DU-7299 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain YES YES NO NO 33 TCGA-DU-7299-F18389 TCGA-DU-7299 TCGA-DU-7299-01A -12266 1339 0 675 428 NO NO Seizures 31 - 90 Days Progressive Disease 2011-11-8 MALE NO Astrocytoma NO No C71.0 9401/3 C71.0 YES 1 NO 90 Left NO 1 NO NO G3 YES No TCGA-DU-7299.36ca34b7-04ee-4cbb-aba8-1171ae076abd.pdf 7299 Post-Adjuvant Therapy WITH TUMOR YES YES Progressive Disease YES Primary Tumor 01 YES NO 0.3 Not listed in Medical Record YES NO YES DU Supratentorial, Parietal Lobe Central nervous system A NO DECEASED 2006 TCGA-DU-7299-01A-21D-2024-08 TCGA-DU-7299-01 TCGA-DU-7299-01A-21D-2024-08 TCGA-DU-7299-01A-21D-2023-01 118ba2f8-3a61-41f3-9b4c-18a34181b1bb TCGA-DU-7299-01 TCGA-DU-7299-01 TCGA-DU-7299-01A-21D-2024-08 118ba2f8-3a61-41f3-9b4c-18a34181b1bb TCGA-DU-7299-01 TCGA-DU-7299-01 TCGA-DU-7299-01A-21D-2024-08 TCGA-DU-7299-01A-21D-2025-05 118ba2f8-3a61-41f3-9b4c-18a34181b1bb 118ba2f8-3a61-41f3-9b4c-18a34181b1bb TCGA-DU-7299-01A-21D-2023-01 TCGA-DU-7299-01A-21D-2024-08 +TCGA-DU-7300-01 TCGA-DU-7300-01 TCGA-DU-7300 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain YES YES NO NO 53 TCGA-DU-7300-F17524 TCGA-DU-7300 TCGA-DU-7300-01A -19610 1886 0 317 317 NO NO Seizures 0 - 30 Days Progressive Disease 2011-10-9 FEMALE NO Oligodendroglioma NO No C71.0 9451/3 C71.0 YES 1 NO 100 Right NO 1 NO NO G3 YES Yes TCGA-DU-7300.6a6a701f-4276-4ee8-9d47-9dd470f1f3ea.pdf 7300 Post-Adjuvant Therapy WITH TUMOR YES NO Progressive Disease NO Primary Tumor 01 YES NO 0.4 Not listed in Medical Record YES NO YES DU Supratentorial, Frontal Lobe Central nervous system A NO DECEASED 2006 TCGA-DU-7300-01A-21D-2086-08 TCGA-DU-7300-01 4866C8C0-2FE7-4747-9D07-E1D0843BE27C TCGA-DU-7300-01A-21D-2086-08 TCGA-DU-7300-01A-21D-2085-01 94bf61a3-9b70-4429-b538-a32163d186cb TCGA-DU-7300-01 TCGA-DU-7300-01 TCGA-DU-7300-01A-21D-2086-08 94bf61a3-9b70-4429-b538-a32163d186cb TCGA-DU-7300-01 TCGA-DU-7300-01 TCGA-DU-7300-01A-21D-2086-08 TCGA-DU-7300-01A-21D-2087-05 94bf61a3-9b70-4429-b538-a32163d186cb 94bf61a3-9b70-4429-b538-a32163d186cb TCGA-DU-7300-01A-21D-2085-01 TCGA-DU-7300-01A-21D-2086-08 +TCGA-DU-7301-01 TCGA-DU-7301-01 TCGA-DU-7301 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain YES NO NO NO 53 TCGA-DU-7301-F17533 TCGA-DU-7301 TCGA-DU-7301-01A -19644 788 0 366 366 Seizures > 181 Days Progressive Disease 2011-10-12 MALE NO Oligodendroglioma NO No C71.0 9450/3 C71.0 YES 1 NO 60 Left NO 1 NO NO G2 YES No TCGA-DU-7301.8ff62d9f-003f-4194-8cc6-bce45a7cdf1d.pdf 7301 Post-Adjuvant Therapy WITH TUMOR YES NO Progressive Disease YES Primary Tumor 01 YES YES 0.5 Not listed in Medical Record YES NO YES DU Supratentorial, Temporal Lobe Central nervous system A NO DECEASED 2006 TCGA-DU-7301-01A-11D-2086-08 TCGA-DU-7301-01 A6FFA327-AB80-428C-B7ED-8212739B1435 TCGA-DU-7301-01A-11D-2086-08 TCGA-DU-7301-01A-11D-2085-01 46359f28-97f8-42ee-9b7b-6652ac0f469a TCGA-DU-7301-01 TCGA-DU-7301-01 TCGA-DU-7301-01A-11D-2086-08 46359f28-97f8-42ee-9b7b-6652ac0f469a TCGA-DU-7301-01 TCGA-DU-7301-01 TCGA-DU-7301-01A-11D-2086-08 TCGA-DU-7301-01A-11D-2087-05 46359f28-97f8-42ee-9b7b-6652ac0f469a 46359f28-97f8-42ee-9b7b-6652ac0f469a TCGA-DU-7301-01A-11D-2085-01 TCGA-DU-7301-01A-11D-2086-08 +TCGA-DU-7302-01 TCGA-DU-7302-01 TCGA-DU-7302 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain YES NO NO NO 48 TCGA-DU-7302-F17543 TCGA-DU-7302 TCGA-DU-7302-01A -17656 0 1834 1374 1404 Seizures 0 - 30 Days Progressive Disease 2011-10-11 FEMALE NO Oligodendroglioma NO No C71.0 9451/3 C71.0 YES 0.9 NO 70 Left NO 1 NO NO G3 YES No TCGA-DU-7302.ad715b7b-52a2-493a-99d2-b5ec2b18a709.pdf 7302 Post-Adjuvant Therapy WITH TUMOR YES YES Progressive Disease NO Primary Tumor 01 YES NO 0.7 Not listed in Medical Record YES NO YES DU Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2006 TCGA-DU-7302-01A-11D-2086-08 TCGA-DU-7302-01 F0870022-BCF5-4CA4-83E4-63BE167C7867 TCGA-DU-7302-01A-11D-2086-08 TCGA-DU-7302-01A-11D-2085-01 10336d59-9732-4305-9062-75bc76ee9c93 TCGA-DU-7302-01 TCGA-DU-7302-01 TCGA-DU-7302-01A-11D-2086-08 10336d59-9732-4305-9062-75bc76ee9c93 TCGA-DU-7302-01 TCGA-DU-7302-01 TCGA-DU-7302-01A-11D-2086-08 TCGA-DU-7302-01A-11D-2087-05 10336d59-9732-4305-9062-75bc76ee9c93 10336d59-9732-4305-9062-75bc76ee9c93 TCGA-DU-7302-01A-11D-2085-01 TCGA-DU-7302-01A-11D-2086-08 +TCGA-DU-7304-01 TCGA-DU-7304-01 TCGA-DU-7304 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain YES NO YES NO 43 TCGA-DU-7304-F17502 TCGA-DU-7304 TCGA-DU-7304-01A 332 -15931 709 0 309 350 NO NO Seizures 0 - 30 Days Progressive Disease 2011-10-4 MALE NO Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES 0.8 NO 80 Left NO 1 NO NO G3 YES No TCGA-DU-7304.EFF2E68D-4795-413F-B5B1-EF9E5703A2B2.pdf 7304 Post-Adjuvant Therapy WITH TUMOR YES YES Progressive Disease YES Primary Tumor 01 YES NO 0.6 Not listed in Medical Record YES NO YES DU Supratentorial, Frontal Lobe Central nervous system A NO DECEASED 2008 TCGA-DU-7304-01A-12D-2086-08 TCGA-DU-7304-01 07A5D1C6-0DDC-4813-B5F0-BE805030D77F TCGA-DU-7304-01A-12D-2086-08 TCGA-DU-7304-01A-12D-2085-01 9e8a108f-c2a6-4947-9512-72609d13ade1 TCGA-DU-7304-01 TCGA-DU-7304-01 TCGA-DU-7304-01A-12D-2086-08 9e8a108f-c2a6-4947-9512-72609d13ade1 TCGA-DU-7304-01 TCGA-DU-7304-01 TCGA-DU-7304-01A-12D-2086-08 TCGA-DU-7304-01A-12D-2087-05 9e8a108f-c2a6-4947-9512-72609d13ade1 9e8a108f-c2a6-4947-9512-72609d13ade1 TCGA-DU-7304-01A-12D-2085-01 TCGA-DU-7304-01A-12D-2086-08 +TCGA-DU-7304-02 TCGA-DU-7304-02 TCGA-DU-7304 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain YES NO YES NO 43 TCGA-DU-7304-F17502 TCGA-DU-7304 TCGA-DU-7304-02A 332 -15931 2066 709 0 309 350 NO NO Seizures 0 - 30 Days Progressive Disease 2011-10-4 MALE NO Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES 280 NO 80 Left NO NO NO G3 YES false No TCGA-DU-7304.EFF2E68D-4795-413F-B5B1-EF9E5703A2B2.pdf 7304 Post-Adjuvant Therapy WITH TUMOR YES YES Progressive Disease YES Recurrent Tumor 02 YES NO Not listed in Medical Record YES NO YES DU Supratentorial, Frontal Lobe Central nervous system A NO DECEASED 2008 TCGA-DU-7304-02A-12D-A36O-08 44b1a976-76e2-4c4d-9348-bb399d986794 TCGA-DU-7304-02 TCGA-DU-7304-02 44b1a976-76e2-4c4d-9348-bb399d986794 TCGA-DU-7304-02A-12D-A368-05 44b1a976-76e2-4c4d-9348-bb399d986794 44b1a976-76e2-4c4d-9348-bb399d986794 +TCGA-DU-7306-01 TCGA-DU-7306-01 TCGA-DU-7306 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain YES NO NO NO 67 TCGA-DU-7306-F17490 TCGA-DU-7306 TCGA-DU-7306-01A -24800 0 1277 1250 -11 Seizures 0 - 30 Days 2011-10-11 MALE NO Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES 1.1 NO 100 Right NO 1.1 NO NO G2 YES No TCGA-DU-7306.dfe1d2e3-a9c7-4d49-984d-5956eea6ccf3.pdf 7306 Preoperative WITH TUMOR YES YES Progressive Disease YES Primary Tumor 01 YES NO 0.7 Not listed in Medical Record YES NO YES DU Supratentorial, Temporal Lobe Central nervous system A NO LIVING 2008 TCGA-DU-7306-01A-11D-2086-08 TCGA-DU-7306-01 2ADCA37E-C44D-465D-B664-C4FD0C0BA29B TCGA-DU-7306-01A-11D-2086-08 TCGA-DU-7306-01A-11D-2085-01 12113ec4-2f73-488b-9926-89f1301e1fb9 TCGA-DU-7306-01 TCGA-DU-7306-01 TCGA-DU-7306-01A-11D-2086-08 12113ec4-2f73-488b-9926-89f1301e1fb9 TCGA-DU-7306-01 TCGA-DU-7306-01 TCGA-DU-7306-01A-11D-2086-08 TCGA-DU-7306-01A-11D-2087-05 12113ec4-2f73-488b-9926-89f1301e1fb9 12113ec4-2f73-488b-9926-89f1301e1fb9 TCGA-DU-7306-01A-11D-2085-01 TCGA-DU-7306-01A-11D-2086-08 +TCGA-DU-7309-01 TCGA-DU-7309-01 TCGA-DU-7309 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain NO NO NO NO 41 TCGA-DU-7309-F17509 TCGA-DU-7309 TCGA-DU-7309-01A -15197 0 84 11 YES YES Seizures 31 - 90 Days 2011-10-4 FEMALE YES Oligodendroglioma NO No C71.0 9451/3 C71.0 YES 0.9 NO 90 Left NO 1 NO YES G3 NO No TCGA-DU-7309.0b731266-908e-477b-8228-99d3f1d510e7.pdf 7309 Pre-Adjuvant Therapy WITH TUMOR YES NO Stable Disease YES Primary Tumor 01 YES YES 0.6 Cerebral Cortex YES YES NO DU Supratentorial, Frontal Lobe Central nervous system A YES LIVING 2011 TCGA-DU-7309-01A-11D-2086-08 TCGA-DU-7309-01 9E6F5DC7-F72E-42E7-A38D-C6BFD09AEC15 TCGA-DU-7309-01A-11D-2086-08 TCGA-DU-7309-01A-11D-2085-01 ef3a0956-e7bf-4f1b-bc54-7e21fd318bbd TCGA-DU-7309-01 TCGA-DU-7309-01 TCGA-DU-7309-01A-11D-2086-08 ef3a0956-e7bf-4f1b-bc54-7e21fd318bbd TCGA-DU-7309-01 TCGA-DU-7309-01 TCGA-DU-7309-01A-11D-2086-08 TCGA-DU-7309-01A-11D-2087-05 ef3a0956-e7bf-4f1b-bc54-7e21fd318bbd ef3a0956-e7bf-4f1b-bc54-7e21fd318bbd TCGA-DU-7309-01A-11D-2085-01 TCGA-DU-7309-01A-11D-2086-08 +TCGA-DU-8158-01 TCGA-DU-8158-01 TCGA-DU-8158 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 57 TCGA-DU-8158 TCGA-DU-8158-01A -21129 155 0 8 Mental Status Changes 0 - 30 Days 2012-6-15 FEMALE Astrocytoma NO No C71.0 9401/3 C71.0 YES 0.9 NO 80 Left NO 0.9 YES G3 No TCGA-DU-8158.83e22d80-b93f-48cc-9f4f-f6dc0186246c.pdf 8158 Pre-Adjuvant Therapy WITH TUMOR Primary Tumor 01 0.5 NO YES DU Supratentorial, Frontal Lobe Central nervous system A DECEASED 2001 TCGA-DU-8158-01A-11D-2253-08 TCGA-DU-8158-01 726CFEAE-7A84-4523-B17A-38402D879518 TCGA-DU-8158-01A-11D-2253-08 TCGA-DU-8158-01A-11D-2252-01 ba2365d8-1217-4630-8181-b46bfeed3207 TCGA-DU-8158-01 TCGA-DU-8158-01 TCGA-DU-8158-01A-11D-2253-08 ba2365d8-1217-4630-8181-b46bfeed3207 TCGA-DU-8158-01 TCGA-DU-8158-01 TCGA-DU-8158-01A-11D-2253-08 TCGA-DU-8158-01A-11D-2254-05 ba2365d8-1217-4630-8181-b46bfeed3207 ba2365d8-1217-4630-8181-b46bfeed3207 TCGA-DU-8158-01A-11D-2252-01 TCGA-DU-8158-01A-11D-2253-08 +TCGA-DU-8161-01 TCGA-DU-8161-01 TCGA-DU-8161 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain YES NO YES 63 TCGA-DU-8161-F51985 TCGA-DU-8161 TCGA-DU-8161-01A 113 -23064 722 0 111 14 Sensory Changes 31 - 90 Days Scheduled Follow-up Submission Progressive Disease 2013-11-26 FEMALE NO Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES 1 NO 70 Left NO 1 NO NO NO G3 YES No TCGA-DU-8161.867daa2d-0b54-4ac8-9203-ea592ea23953.pdf 8161 Pre-Adjuvant Therapy WITH TUMOR YES Progressive Disease YES Primary Tumor 01 NO YES 0.7 Not listed in Medical Record YES NO YES DU Supratentorial, Not Otherwise Specified Central nervous system A NO DECEASED 2009 TCGA-DU-8161-01A-11D-2253-08 TCGA-DU-8161-01 7792E97F-00AD-4B97-A451-F1109CBF4C39 TCGA-DU-8161-01A-11D-2253-08 TCGA-DU-8161-01A-11D-2252-01 6928f894-9d97-40c9-8284-3fd9456152de TCGA-DU-8161-01 TCGA-DU-8161-01 TCGA-DU-8161-01A-11D-2253-08 6928f894-9d97-40c9-8284-3fd9456152de TCGA-DU-8161-01 TCGA-DU-8161-01 TCGA-DU-8161-01A-11D-2253-08 TCGA-DU-8161-01A-11D-2254-05 6928f894-9d97-40c9-8284-3fd9456152de 6928f894-9d97-40c9-8284-3fd9456152de TCGA-DU-8161-01A-11D-2252-01 TCGA-DU-8161-01A-11D-2253-08 +TCGA-DU-8162-01 TCGA-DU-8162-01 TCGA-DU-8162 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain NO YES 61 TCGA-DU-8162-F44364 TCGA-DU-8162 TCGA-DU-8162-01A -22596 444 0 121 402 21 1 YES NO Headaches 0 - 30 Days Scheduled Follow-up Submission 2013-6-19 FEMALE YES Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES 0.9 NO 80 Right NO 1.2 NO NO NO G3 YES No TCGA-DU-8162.a9f8f064-c21c-4d7e-ae38-5ff6214995be.pdf 8162 Pre-Adjuvant Therapy WITH TUMOR Progressive Disease YES Primary Tumor 01 NO NO 0.9 Not listed in Medical Record YES YES NO DU Supratentorial, Temporal Lobe Central nervous system A NO DECEASED 2011 TCGA-DU-8162-01A-21D-2253-08 TCGA-DU-8162-01 A4352B46-FABC-4D1B-A17D-BC27DE3F3407 TCGA-DU-8162-01A-21D-2253-08 TCGA-DU-8162-01A-21D-2252-01 c67538d7-7e64-4325-878e-53fd324a11f9 TCGA-DU-8162-01 TCGA-DU-8162-01 TCGA-DU-8162-01A-21D-2253-08 c67538d7-7e64-4325-878e-53fd324a11f9 TCGA-DU-8162-01 TCGA-DU-8162-01 TCGA-DU-8162-01A-21D-2253-08 TCGA-DU-8162-01A-21D-2254-05 c67538d7-7e64-4325-878e-53fd324a11f9 c67538d7-7e64-4325-878e-53fd324a11f9 TCGA-DU-8162-01A-21D-2252-01 TCGA-DU-8162-01A-21D-2253-08 +TCGA-DU-8163-01 TCGA-DU-8163-01 TCGA-DU-8163 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain YES NO 29 TCGA-DU-8163-F44371 TCGA-DU-8163 TCGA-DU-8163-01A -10824 0 629 509 106 NO NO Seizures 31 - 90 Days Scheduled Follow-up Submission 2013-6-19 MALE NO Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES 1 NO 90 Left NO 1 NO NO NO G3 YES No TCGA-DU-8163.7c9b671f-e8f9-4b12-b497-6bc252fe9b15.pdf 8163 WITH TUMOR YES NO Progressive Disease YES Primary Tumor 01 YES NO 0.6 Not listed in Medical Record YES YES NO DU Supratentorial, Temporal Lobe Central nervous system A NO LIVING 2011 TCGA-DU-8163-01A-11D-2253-08 TCGA-DU-8163-01 D822390B-1EBE-4924-B651-B76C1E051F39 TCGA-DU-8163-01A-11D-2253-08 TCGA-DU-8163-01A-11D-2252-01 654ea6d9-1a5b-442a-8627-5d6f4baa8460 TCGA-DU-8163-01 TCGA-DU-8163-01 TCGA-DU-8163-01A-11D-2253-08 654ea6d9-1a5b-442a-8627-5d6f4baa8460 TCGA-DU-8163-01 TCGA-DU-8163-01 TCGA-DU-8163-01A-11D-2253-08 TCGA-DU-8163-01A-11D-2254-05 654ea6d9-1a5b-442a-8627-5d6f4baa8460 654ea6d9-1a5b-442a-8627-5d6f4baa8460 TCGA-DU-8163-01A-11D-2252-01 TCGA-DU-8163-01A-11D-2253-08 +TCGA-DU-8164-01 TCGA-DU-8164-01 TCGA-DU-8164 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 51 TCGA-DU-8164-F44373 TCGA-DU-8164 TCGA-DU-8164-01A -18735 0 651 NO NO Seizures 31 - 90 Days Scheduled Follow-up Submission Stable Disease 2013-6-19 MALE NO Oligodendroglioma NO No C71.0 9450/3 C71.0 YES NO 0.8 NO Right YES IHC YES 0.8 NO NO NO G2 NO No TCGA-DU-8164.452cb553-ee9b-44e3-bbc4-fcb36f015309.pdf 8164 TUMOR FREE YES NO Stable Disease NO Primary Tumor 01 YES NO 0.6 Cerebral Cortex YES YES NO DU Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2011 TCGA-DU-8164-01A-11D-2253-08 TCGA-DU-8164-01 D8B2247A-C268-410D-AB99-5393669794D7 TCGA-DU-8164-01A-11D-2253-08 TCGA-DU-8164-01A-11D-2252-01 7fcd4e64-e758-4418-b19e-02a4e7ee1fef TCGA-DU-8164-01 TCGA-DU-8164-01 TCGA-DU-8164-01A-11D-2253-08 7fcd4e64-e758-4418-b19e-02a4e7ee1fef TCGA-DU-8164-01 TCGA-DU-8164-01 TCGA-DU-8164-01A-11D-2253-08 TCGA-DU-8164-01A-11D-2254-05 7fcd4e64-e758-4418-b19e-02a4e7ee1fef 7fcd4e64-e758-4418-b19e-02a4e7ee1fef TCGA-DU-8164-01A-11D-2252-01 TCGA-DU-8164-01A-11D-2253-08 +TCGA-DU-8165-01 TCGA-DU-8165-01 TCGA-DU-8165 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 60 TCGA-DU-8165-F46668 TCGA-DU-8165 TCGA-DU-8165-01A -21964 0 582 11 YES NO Seizures 31 - 90 Days Scheduled Follow-up Submission Stable Disease 2013-8-13 FEMALE NO Oligodendroglioma NO No C71.0 9450/3 C71.0 YES 1 NO 90 Left NO 1.1 NO NO NO G3 NO No TCGA-DU-8165.611a4975-123d-470e-afa7-4a17dbea7a9d.pdf 8165 Pre-Adjuvant Therapy TUMOR FREE YES NO Stable Disease YES Primary Tumor 01 YES NO 1 Not listed in Medical Record YES YES NO DU Supratentorial, Temporal Lobe Central nervous system A NO LIVING 2011 TCGA-DU-8165-01A-11D-2253-08 TCGA-DU-8165-01 B648C276-B4E8-4D49-8FF9-60B8045AA071 TCGA-DU-8165-01A-11D-2253-08 TCGA-DU-8165-01A-11D-2252-01 a6f7a064-b3af-41aa-9e80-fc2f728b0d83 TCGA-DU-8165-01 TCGA-DU-8165-01 TCGA-DU-8165-01A-11D-2253-08 a6f7a064-b3af-41aa-9e80-fc2f728b0d83 TCGA-DU-8165-01 TCGA-DU-8165-01 TCGA-DU-8165-01A-11D-2253-08 TCGA-DU-8165-01A-11D-2254-05 a6f7a064-b3af-41aa-9e80-fc2f728b0d83 a6f7a064-b3af-41aa-9e80-fc2f728b0d83 TCGA-DU-8165-01A-11D-2252-01 TCGA-DU-8165-01A-11D-2253-08 +TCGA-DU-8166-01 TCGA-DU-8166-01 TCGA-DU-8166 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain YES NO NO 29 TCGA-DU-8166-F46665 TCGA-DU-8166 TCGA-DU-8166-01A -10641 0 516 193 NO NO Seizures 0 - 30 Days Scheduled Follow-up Submission Stable Disease 2013-8-13 FEMALE NO Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES 0.9 NO Left NO 0.9 NO NO NO G2 YES No TCGA-DU-8166.d4140f71-f42d-4b23-bff6-9f0c00a7e6ff.pdf 8166 WITH TUMOR YES YES Progressive Disease YES Primary Tumor 01 YES NO 0.5 Cerebral Cortex YES YES NO DU Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2012 TCGA-DU-8166-01A-11D-2253-08 TCGA-DU-8166-01 79BB6750-9D06-4790-BF4E-9DFCB070B371 TCGA-DU-8166-01A-11D-2253-08 TCGA-DU-8166-01A-11D-2252-01 12953bc4-8704-4fcc-9efa-3801a1a6c4b7 TCGA-DU-8166-01 TCGA-DU-8166-01 TCGA-DU-8166-01A-11D-2253-08 12953bc4-8704-4fcc-9efa-3801a1a6c4b7 TCGA-DU-8166-01 TCGA-DU-8166-01 TCGA-DU-8166-01A-11D-2253-08 TCGA-DU-8166-01A-11D-2254-05 12953bc4-8704-4fcc-9efa-3801a1a6c4b7 12953bc4-8704-4fcc-9efa-3801a1a6c4b7 TCGA-DU-8166-01A-11D-2252-01 TCGA-DU-8166-01A-11D-2253-08 +TCGA-DU-8167-01 TCGA-DU-8167-01 TCGA-DU-8167 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 69 TCGA-DU-8167-F44357 TCGA-DU-8167 TCGA-DU-8167-01A -25262 0 471 -69 Seizures > 181 Days Scheduled Follow-up Submission Stable Disease 2013-6-19 FEMALE NO Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES 1.2 NO 100 Right NO 1.2 NO NO NO G2 NO No TCGA-DU-8167.8c93cc66-38b1-451f-b941-fca73c10c651.pdf 8167 Preoperative TUMOR FREE YES NO Stable Disease YES Primary Tumor 01 YES NO 0.4 Not listed in Medical Record NO YES NO DU Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2012 TCGA-DU-8167-01A-11D-2253-08 TCGA-DU-8167-01 FB9544D5-1417-4635-AE0F-F49613C35BE7 TCGA-DU-8167-01A-11D-2253-08 TCGA-DU-8167-01A-11D-2252-01 62ddc24c-ffff-4459-95e7-bc2cb08769c9 TCGA-DU-8167-01 TCGA-DU-8167-01 TCGA-DU-8167-01A-11D-2253-08 62ddc24c-ffff-4459-95e7-bc2cb08769c9 TCGA-DU-8167-01 TCGA-DU-8167-01 TCGA-DU-8167-01A-11D-2253-08 TCGA-DU-8167-01A-11D-2254-05 62ddc24c-ffff-4459-95e7-bc2cb08769c9 62ddc24c-ffff-4459-95e7-bc2cb08769c9 TCGA-DU-8167-01A-11D-2252-01 TCGA-DU-8167-01A-11D-2253-08 +TCGA-DU-8168-01 TCGA-DU-8168-01 TCGA-DU-8168 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 55 TCGA-DU-8168-F44360 TCGA-DU-8168 TCGA-DU-8168-01A -20136 0 431 14 1 YES NO Headaches 0 - 30 Days Scheduled Follow-up Submission Stable Disease 2013-6-19 FEMALE YES Oligodendroglioma NO No C71.0 9451/3 C71.0 YES 0.9 NO 70 Right NO 0.9 NO NO NO G3 NO No TCGA-DU-8168.e96918fc-f639-46eb-b87a-769402a4d1ab.pdf 8168 Pre-Adjuvant Therapy TUMOR FREE NO YES Stable Disease YES Primary Tumor 01 NO NO 0.8 Not listed in Medical Record YES YES NO DU Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2012 TCGA-DU-8168-01A-11D-2253-08 TCGA-DU-8168-01 AA96BE61-B0DF-4E24-8BF7-16E486F78597 TCGA-DU-8168-01A-11D-2253-08 TCGA-DU-8168-01A-11D-2252-01 dd69f2af-4ec7-4fb5-bc82-cc93686e2790 TCGA-DU-8168-01 TCGA-DU-8168-01 TCGA-DU-8168-01A-11D-2253-08 dd69f2af-4ec7-4fb5-bc82-cc93686e2790 TCGA-DU-8168-01 TCGA-DU-8168-01 TCGA-DU-8168-01A-11D-2253-08 TCGA-DU-8168-01A-11D-2254-05 dd69f2af-4ec7-4fb5-bc82-cc93686e2790 dd69f2af-4ec7-4fb5-bc82-cc93686e2790 TCGA-DU-8168-01A-11D-2252-01 TCGA-DU-8168-01A-11D-2253-08 +TCGA-DU-A5TP-01 TCGA-DU-A5TP-01 TCGA-DU-A5TP TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain YES NO 33 NO NO TCGA-DU-A5TP-F71612 TCGA-DU-A5TP TCGA-DU-A5TP-01A -12111 301 0 1012 203 6 YES YES YES > 20 Years Seizures 0 - 30 Days Scheduled Follow-up Submission Stable Disease NO 2015-3-27 MALE YES NO Astrocytoma YES No C71.0 9401/3 C71.0 YES 280 NO 70 Right NO NO NO NO NO G3 YES false No TCGA-DU-A5TP.CD515D5F-80C5-4571-B431-6091CA4B4848.pdf A5TP Pre-Adjuvant Therapy TUMOR FREE YES NO [Discrepancy] YES Primary Tumor 01 YES NO Not listed in Medical Record YES YES NO DU Supratentorial, Parietal Lobe Central nervous system A NO LIVING 2012 TCGA-DU-A5TP-01 11234D71-1578-405F-AF7A-95560B4B3047 TCGA-DU-A5TP-01A-11D-A289-08 TCGA-DU-A5TP-01A-11D-A288-01 9eaedfe9-a6f0-46e3-8961-7a222df9127c TCGA-DU-A5TP-01 TCGA-DU-A5TP-01 TCGA-DU-A5TP-01A-11D-A289-08 9eaedfe9-a6f0-46e3-8961-7a222df9127c TCGA-DU-A5TP-01 TCGA-DU-A5TP-01A-11D-A289-08 TCGA-DU-A5TP-01A-11D-A28N-05 9eaedfe9-a6f0-46e3-8961-7a222df9127c 9eaedfe9-a6f0-46e3-8961-7a222df9127c TCGA-DU-A5TP-01A-11D-A288-01 TCGA-DU-A5TP-01A-11D-A289-08 +TCGA-DU-A5TR-01 TCGA-DU-A5TR-01 TCGA-DU-A5TR TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain NO NO YES 51 NO NO TCGA-DU-A5TR-F71611 TCGA-DU-A5TR TCGA-DU-A5TR-01A 848 -18791 259 0 908 848 11 NO YES YES Seizures 0 - 30 Days Scheduled Follow-up Submission Stable Disease NO 2015-3-27 MALE NO NO Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES 280 NO 90 Left NO NO YES NO NO G2 YES false No TCGA-DU-A5TR.7BF16354-F6FD-428D-ACB3-E9F930F06C46.pdf A5TR Pre-Adjuvant Therapy TUMOR FREE YES YES [Discrepancy] NO Primary Tumor 01 YES NO Not listed in Medical Record YES YES NO DU Supratentorial, Temporal Lobe Central nervous system A NO LIVING 2012 TCGA-DU-A5TR-01 7A4DC9B6-4130-44F1-87DE-CF883CF0A86B TCGA-DU-A5TR-01A-11D-A289-08 TCGA-DU-A5TR-01A-11D-A288-01 f23834b0-13c3-4dd5-a20b-0f20cd92ec23 TCGA-DU-A5TR-01 TCGA-DU-A5TR-01 TCGA-DU-A5TR-01A-11D-A289-08 f23834b0-13c3-4dd5-a20b-0f20cd92ec23 TCGA-DU-A5TR-01 TCGA-DU-A5TR-01A-11D-A289-08 TCGA-DU-A5TR-01A-11D-A28N-05 f23834b0-13c3-4dd5-a20b-0f20cd92ec23 f23834b0-13c3-4dd5-a20b-0f20cd92ec23 TCGA-DU-A5TR-01A-11D-A288-01 TCGA-DU-A5TR-01A-11D-A289-08 +TCGA-DU-A5TS-01 TCGA-DU-A5TS-01 TCGA-DU-A5TS TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain YES NO NO NO 42 TCGA-DU-A5TS-F71496 TCGA-DU-A5TS TCGA-DU-A5TS-01A -15650 259 0 964 551 13 YES NO Headaches > 181 Days Scheduled Follow-up Submission Stable Disease 2015-3-26 MALE YES Oligodendroglioma NO No C71.0 9450/3 C71.0 YES 360 NO 100 Right NO NO NO NO G2 YES false No TCGA-DU-A5TS.1D94A4FE-F273-4DD4-AB30-FE47A22542B9.pdf A5TS Pre-Adjuvant Therapy TUMOR FREE NO YES Stable Disease YES Primary Tumor 01 NO NO Not listed in Medical Record YES YES NO DU Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2012 TCGA-DU-A5TS-01 F805EAFF-C2AE-4365-B5D0-015E1CD7FD83 TCGA-DU-A5TS-01A-11D-A289-08 TCGA-DU-A5TS-01A-11D-A288-01 03fd710d-d09a-4cf1-b513-5eaaa37d56da TCGA-DU-A5TS-01 TCGA-DU-A5TS-01 TCGA-DU-A5TS-01A-11D-A289-08 03fd710d-d09a-4cf1-b513-5eaaa37d56da TCGA-DU-A5TS-01 TCGA-DU-A5TS-01A-11D-A289-08 TCGA-DU-A5TS-01A-11D-A28N-05 03fd710d-d09a-4cf1-b513-5eaaa37d56da 03fd710d-d09a-4cf1-b513-5eaaa37d56da TCGA-DU-A5TS-01A-11D-A288-01 TCGA-DU-A5TS-01A-11D-A289-08 +TCGA-DU-A5TT-01 TCGA-DU-A5TT-01 TCGA-DU-A5TT TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain NO YES NO NO 70 YES cat NO TCGA-DU-A5TT-F71494 TCGA-DU-A5TT TCGA-DU-A5TT-01A -25726 24 0 743 584 NO YES NO > 20 Years > 20 Years Seizures 91 - 180 Days Scheduled Follow-up Submission Progressive Disease NO 2015-3-26 MALE YES NO Oligodendroglioma NO No C71.0 9451/3 C71.0 YES 420 NO Left NO IHC YES NO NO NO NO G3 YES false No TCGA-DU-A5TT.6E55B698-D0BA-4834-91EE-0210657A9791.pdf A5TT WITH TUMOR YES NO [Discrepancy] YES Primary Tumor 01 YES NO Not listed in Medical Record YES YES NO DU Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2013 TCGA-DU-A5TT-01 B851875C-3589-45FE-92E0-402C6DD81F1A TCGA-DU-A5TT-01A-11D-A289-08 TCGA-DU-A5TT-01A-11D-A288-01 8d1c0907-a5f9-4fcb-a04a-d554e40c23d3 TCGA-DU-A5TT-01 TCGA-DU-A5TT-01 TCGA-DU-A5TT-01A-11D-A289-08 8d1c0907-a5f9-4fcb-a04a-d554e40c23d3 TCGA-DU-A5TT-01 TCGA-DU-A5TT-01A-11D-A289-08 TCGA-DU-A5TT-01A-11D-A28N-05 8d1c0907-a5f9-4fcb-a04a-d554e40c23d3 8d1c0907-a5f9-4fcb-a04a-d554e40c23d3 TCGA-DU-A5TT-01A-11D-A288-01 TCGA-DU-A5TT-01A-11D-A289-08 +TCGA-DU-A5TU-01 TCGA-DU-A5TU-01 TCGA-DU-A5TU TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain YES NO NO 62 NO NO TCGA-DU-A5TU-F71322 TCGA-DU-A5TU TCGA-DU-A5TU-01A -22811 21 0 796 186 47 NO YES NO 12 - 20 Years Mental Status Changes 0 - 30 Days Scheduled Follow-up Submission Stable Disease YES Eggs 2015-3-24 FEMALE NO NO Astrocytoma NO No C71.0 9400/3 C71.0 YES NO 300 NO 50 Left NO NO YES NO NO G2 YES false No TCGA-DU-A5TU.6F62570D-D7DE-45F2-8025-49883C35BD82.pdf A5TU Other WITH TUMOR NO YES Progressive Disease YES Primary Tumor 01 NO NO Cerebral Cortex NO YES NO DU Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2013 TCGA-DU-A5TU-01 DC016651-C6BF-4098-ADCB-7264D814A2C1 TCGA-DU-A5TU-01A-11D-A289-08 TCGA-DU-A5TU-01A-11D-A288-01 ac3caaa0-3464-4a39-aa98-fe0e82d6d36c TCGA-DU-A5TU-01 TCGA-DU-A5TU-01 TCGA-DU-A5TU-01A-11D-A289-08 ac3caaa0-3464-4a39-aa98-fe0e82d6d36c TCGA-DU-A5TU-01 TCGA-DU-A5TU-01A-11D-A289-08 TCGA-DU-A5TU-01A-11D-A28N-05 ac3caaa0-3464-4a39-aa98-fe0e82d6d36c ac3caaa0-3464-4a39-aa98-fe0e82d6d36c TCGA-DU-A5TU-01A-11D-A288-01 TCGA-DU-A5TU-01A-11D-A289-08 +TCGA-DU-A5TW-01 TCGA-DU-A5TW-01 TCGA-DU-A5TW TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain NO NO NO 33 TCGA-DU-A5TW-F71321 TCGA-DU-A5TW TCGA-DU-A5TW-01A -12107 42 0 760 53 Seizures > 181 Days Scheduled Follow-up Submission Progressive Disease 2015-3-24 FEMALE NO Astrocytoma NO No C71.0 9401/3 C71.0 YES 320 NO 100 Right YES IHC YES NO YES NO G3 NO false No TCGA-DU-A5TW.CE930C5F-0F10-4CC9-AF72-C38273BEF1E4.pdf A5TW Other WITH TUMOR YES YES Progressive Disease NO Primary Tumor 01 YES NO Not listed in Medical Record NO YES NO DU Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2012 TCGA-DU-A5TW-01 20AD5224-49A7-45C5-8287-DE848F4ED7B6 TCGA-DU-A5TW-01A-11D-A289-08 TCGA-DU-A5TW-01A-11D-A288-01 88c0efcd-cbd2-4c36-b19e-dcb675c4aaae TCGA-DU-A5TW-01 TCGA-DU-A5TW-01 TCGA-DU-A5TW-01A-11D-A289-08 88c0efcd-cbd2-4c36-b19e-dcb675c4aaae TCGA-DU-A5TW-01 TCGA-DU-A5TW-01A-11D-A289-08 TCGA-DU-A5TW-01A-11D-A28N-05 88c0efcd-cbd2-4c36-b19e-dcb675c4aaae 88c0efcd-cbd2-4c36-b19e-dcb675c4aaae TCGA-DU-A5TW-01A-11D-A288-01 TCGA-DU-A5TW-01A-11D-A289-08 +TCGA-DU-A5TY-01 TCGA-DU-A5TY-01 TCGA-DU-A5TY TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain YES YES YES YES 46 NO TCGA-DU-A5TY-F71302 TCGA-DU-A5TY TCGA-DU-A5TY-01A 536 955 -16945 276 1033 0 371 526 NO NO NO Seizures 0 - 30 Days Scheduled Follow-up Submission Progressive Disease NO 2015-3-24 FEMALE NO NO Astrocytoma NO No C71.0 9401/3 C71.0 YES 130 NO Left NO IHC YES NO YES NO NO G3 YES false No TCGA-DU-A5TY.70236BAA-BD1E-4AA3-A8D8-63F27289B160.pdf A5TY WITH TUMOR YES YES [Discrepancy] YES Primary Tumor 01 YES NO Not listed in Medical Record YES YES NO DU Supratentorial, Parietal Lobe Central nervous system A NO DECEASED 2012 TCGA-DU-A5TY-01 4C42785C-5CDF-47F4-81A1-F9C191399099 TCGA-DU-A5TY-01A-11D-A289-08 TCGA-DU-A5TY-01A-11D-A288-01 c38bbaa0-6752-4301-9e44-c1cd13c03625 TCGA-DU-A5TY-01 TCGA-DU-A5TY-01 TCGA-DU-A5TY-01A-11D-A289-08 c38bbaa0-6752-4301-9e44-c1cd13c03625 TCGA-DU-A5TY-01 TCGA-DU-A5TY-01A-11D-A289-08 TCGA-DU-A5TY-01A-11D-A28N-05 c38bbaa0-6752-4301-9e44-c1cd13c03625 c38bbaa0-6752-4301-9e44-c1cd13c03625 TCGA-DU-A5TY-01A-11D-A288-01 TCGA-DU-A5TY-01A-11D-A289-08 +TCGA-DU-A6S2-01 TCGA-DU-A6S2-01 TCGA-DU-A6S2 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain NO NO 37 YES long hair cats NO TCGA-DU-A6S2-F71620 TCGA-DU-A6S2 TCGA-DU-A6S2-01A -13597 153 0 777 11 YES YES NO > 20 Years < 12 Years Headaches 31 - 90 Days Scheduled Follow-up Submission Stable Disease NO 2015-3-27 FEMALE NO YES Oligodendroglioma NO No C71.0 9450/3 C71.0 YES NO 110 NO 70 Right YES IHC YES NO NO YES NO G2 NO false No TCGA-DU-A6S2.163325D0-4CEA-4AC4-AC8A-117D492E4B06.pdf A6S2 Pre-Adjuvant Therapy TUMOR FREE NO YES Stable Disease NO Primary Tumor 01 NO NO Cerebral Cortex NO YES NO DU Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2013 TCGA-DU-A6S2-01 010C591E-C0BF-4068-B4F4-769567A0D801 TCGA-DU-A6S2-01A-21D-A32B-08 TCGA-DU-A6S2-01A-21D-A32A-01 4c7061f2-ff48-4079-97b6-7ae3c7c0f905 TCGA-DU-A6S2-01 TCGA-DU-A6S2-01 4c7061f2-ff48-4079-97b6-7ae3c7c0f905 TCGA-DU-A6S2-01 TCGA-DU-A6S2-01A-21D-A32C-05 4c7061f2-ff48-4079-97b6-7ae3c7c0f905 4c7061f2-ff48-4079-97b6-7ae3c7c0f905 TCGA-DU-A6S2-01A-21D-A32A-01 TCGA-DU-A6S2-01A-21D-A32B-08 +TCGA-DU-A6S3-01 TCGA-DU-A6S3-01 TCGA-DU-A6S3 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain NO NO 60 TCGA-DU-A6S3-F71619 TCGA-DU-A6S3 TCGA-DU-A6S3-01A -22038 55 0 656 Motor/Movement Changes 91 - 180 Days Scheduled Follow-up Submission 2015-3-27 MALE NO Oligodendroglioma NO No C71.0 9450/3 C71.0 YES NO 270 NO Right NO NO NO YES G2 NO false No TCGA-DU-A6S3.913A3754-B550-431A-B9B7-2825D1B51015.pdf A6S3 TUMOR FREE NO NO Stable Disease NO Primary Tumor 01 NO NO Not listed in Medical Record YES YES NO DU Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2013 TCGA-DU-A6S3-01 F10ED544-55E2-42B1-86FA-F05AC814DB7B TCGA-DU-A6S3-01A-12D-A32B-08 TCGA-DU-A6S3-01A-12D-A32A-01 b8244afb-224b-4bd4-bd6d-caf6619f0e2a TCGA-DU-A6S3-01 TCGA-DU-A6S3-01 b8244afb-224b-4bd4-bd6d-caf6619f0e2a TCGA-DU-A6S3-01 TCGA-DU-A6S3-01A-12D-A32C-05 b8244afb-224b-4bd4-bd6d-caf6619f0e2a b8244afb-224b-4bd4-bd6d-caf6619f0e2a TCGA-DU-A6S3-01A-12D-A32A-01 TCGA-DU-A6S3-01A-12D-A32B-08 +TCGA-DU-A6S6-01 TCGA-DU-A6S6-01 TCGA-DU-A6S6 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain YES NO YES 35 NO NO TCGA-DU-A6S6-F71617 TCGA-DU-A6S6 2277 -12809 0 2893 2277 184 NO NO NO < 12 Years Headaches 31 - 90 Days Scheduled Follow-up Submission Stable Disease NO 2015-3-27 FEMALE YES YES Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES NO 90 Right NO NO NO NO NO G2 YES No A6S6 Other TUMOR FREE NO NO [Discrepancy] NO Primary Tumor 01 NO NO White Matter YES NO YES DU Supratentorial, Frontal Lobe Central nervous system NO LIVING 2007 TCGA-DU-A6S6-01 TCGA-DU-A6S6-01A-21D-A32B-08 TCGA-DU-A6S6-01A-21D-A32A-01 f523f957-9d71-49a4-8c2d-b6a1301f49ed TCGA-DU-A6S6-01 TCGA-DU-A6S6-01 f523f957-9d71-49a4-8c2d-b6a1301f49ed TCGA-DU-A6S6-01 TCGA-DU-A6S6-01A-21D-A32C-05 f523f957-9d71-49a4-8c2d-b6a1301f49ed f523f957-9d71-49a4-8c2d-b6a1301f49ed TCGA-DU-A6S6-01A-21D-A32A-01 TCGA-DU-A6S6-01A-21D-A32B-08 +TCGA-DU-A6S7-01 TCGA-DU-A6S7-01 TCGA-DU-A6S7 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain NO NO 27 NO NO TCGA-DU-A6S7-F71615 TCGA-DU-A6S7 -10170 0 638 -14 NO NO NO 12 - 20 Years Seizures > 181 Days Scheduled Follow-up Submission Stable Disease NO 2015-3-27 FEMALE YES NO Astrocytoma NO No C71.0 9401/3 C71.0 YES NO 90 Left YES IHC YES NO NO NO NO G3 NO No A6S7 Preoperative TUMOR FREE YES NO Stable Disease YES Primary Tumor 01 YES NO Not listed in Medical Record YES YES NO DU Supratentorial, Frontal Lobe Central nervous system NO LIVING 2013 TCGA-DU-A6S7-01 TCGA-DU-A6S7-01A-21D-A32B-08 TCGA-DU-A6S7-01A-21D-A32A-01 b3450230-a250-4c22-ac3b-639abe51fc7b TCGA-DU-A6S7-01 TCGA-DU-A6S7-01 b3450230-a250-4c22-ac3b-639abe51fc7b TCGA-DU-A6S7-01 TCGA-DU-A6S7-01A-21D-A32C-05 b3450230-a250-4c22-ac3b-639abe51fc7b b3450230-a250-4c22-ac3b-639abe51fc7b TCGA-DU-A6S7-01A-21D-A32A-01 TCGA-DU-A6S7-01A-21D-A32B-08 +TCGA-DU-A6S8-01 TCGA-DU-A6S8-01 TCGA-DU-A6S8 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain NO NO 74 NO NO TCGA-DU-A6S8-F71614 TCGA-DU-A6S8 TCGA-DU-A6S8-01A -27084 76 0 678 641 14 NO NO NO Mental Status Changes > 181 Days Scheduled Follow-up Submission NO 2015-3-27 FEMALE NO NO Oligodendroglioma NO No C71.0 9451/3 C71.0 YES NO 390 NO 90 Right YES IHC YES NO YES NO NO G3 YES false No TCGA-DU-A6S8.CCEA4518-483F-48A1-92C5-811EC8B66256.pdf A6S8 Pre-Adjuvant Therapy WITH TUMOR NO NO Progressive Disease NO Primary Tumor 01 NO NO Not listed in Medical Record YES YES NO DU Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2013 TCGA-DU-A6S8-01 7D56773C-255E-4FCD-945A-7C383DE6D7DE TCGA-DU-A6S8-01A-12D-A32B-08 TCGA-DU-A6S8-01A-12D-A32A-01 a4d5d968-7d95-4f41-b0ce-b2dcc9a073ea TCGA-DU-A6S8-01 TCGA-DU-A6S8-01 a4d5d968-7d95-4f41-b0ce-b2dcc9a073ea TCGA-DU-A6S8-01 TCGA-DU-A6S8-01A-12D-A32C-05 a4d5d968-7d95-4f41-b0ce-b2dcc9a073ea a4d5d968-7d95-4f41-b0ce-b2dcc9a073ea TCGA-DU-A6S8-01A-12D-A32A-01 TCGA-DU-A6S8-01A-12D-A32B-08 +TCGA-DU-A76K-01 TCGA-DU-A76K-01 TCGA-DU-A76K TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 87 TCGA-DU-A76K TCGA-DU-A76K-01A -31776 5192 347 0 Headaches > 181 Days 2013-10-22 MALE YES Oligodendroglioma NO No C71.0 9450/3 C71.0 YES 340 NO Right NO NO NO G2 YES false No TCGA-DU-A76K.E30A6271-8007-4457-A48E-87EFAD8871D0.pdf A76K WITH TUMOR Progressive Disease YES Primary Tumor 01 NO NO Not listed in Medical Record NO NO YES DU Supratentorial, Parietal Lobe Central nervous system A NO DECEASED 1999 TCGA-DU-A76K-01 015E3BC4-BB5F-4B95-9E20-331F3FD55A95 TCGA-DU-A76K-01A-11D-A33T-08 TCGA-DU-A76K-01A-11D-A33S-01 f547ce5b-634d-4faa-b662-70de36194dfc TCGA-DU-A76K-01 TCGA-DU-A76K-01 f547ce5b-634d-4faa-b662-70de36194dfc TCGA-DU-A76K-01 TCGA-DU-A76K-01A-11D-A33U-05 f547ce5b-634d-4faa-b662-70de36194dfc f547ce5b-634d-4faa-b662-70de36194dfc TCGA-DU-A76K-01A-11D-A33S-01 TCGA-DU-A76K-01A-11D-A33T-08 +TCGA-DU-A76L-01 TCGA-DU-A76L-01 TCGA-DU-A76L TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 54 TCGA-DU-A76L TCGA-DU-A76L-01A -19823 4769 814 0 YES Headaches 0 - 30 Days 2013-10-22 MALE YES Oligodendroglioma NO No C71.0 9451/3 C71.0 YES 290 NO Right NO NO NO G3 YES false No TCGA-DU-A76L.E66BD7A0-E6D5-4773-9718-154F4D4253A2.pdf A76L WITH TUMOR Progressive Disease YES Primary Tumor 01 NO NO Not listed in Medical Record YES NO YES DU Supratentorial, Temporal Lobe Central nervous system A NO DECEASED 2000 TCGA-DU-A76L-01 523E7DA7-1D81-4620-8184-84A56F599570 TCGA-DU-A76L-01A-11D-A32B-08 TCGA-DU-A76L-01A-11D-A32A-01 8e2c16f2-38cc-49ad-adca-dbe5f4e0bf7f TCGA-DU-A76L-01 TCGA-DU-A76L-01 8e2c16f2-38cc-49ad-adca-dbe5f4e0bf7f TCGA-DU-A76L-01 TCGA-DU-A76L-01A-11D-A32C-05 8e2c16f2-38cc-49ad-adca-dbe5f4e0bf7f 8e2c16f2-38cc-49ad-adca-dbe5f4e0bf7f TCGA-DU-A76L-01A-11D-A32A-01 TCGA-DU-A76L-01A-11D-A32B-08 +TCGA-DU-A76O-01 TCGA-DU-A76O-01 TCGA-DU-A76O TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 30 NO NO TCGA-DU-A76O-F71621 TCGA-DU-A76O TCGA-DU-A76O-01A -10960 138 0 522 NO NO NO Seizures > 181 Days Scheduled Follow-up Submission NO 2015-3-27 MALE NO NO Astrocytoma NO No C71.0 9400/3 C71.0 YES NO 150 NO Left NO IHC YES YES NO NO NO G2 NO false Yes, History of Prior Malignancy TCGA-DU-A76O.64ED6980-61B9-4F1C-B7EE-B3459BD7E398.pdf A76O WITH TUMOR YES NO YES Primary Tumor 01 YES NO Not listed in Medical Record YES YES NO DU Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2013 TCGA-DU-A76O-01 91ACD226-6FD5-45F7-AFA4-D13BFB785D6F TCGA-DU-A76O-01A-11D-A32B-08 TCGA-DU-A76O-01A-11D-A32A-01 481d7eb6-90ed-4d5c-8b98-4a46777a1b8c TCGA-DU-A76O-01 TCGA-DU-A76O-01 481d7eb6-90ed-4d5c-8b98-4a46777a1b8c TCGA-DU-A76O-01 TCGA-DU-A76O-01A-11D-A32C-05 481d7eb6-90ed-4d5c-8b98-4a46777a1b8c 481d7eb6-90ed-4d5c-8b98-4a46777a1b8c TCGA-DU-A76O-01A-11D-A32A-01 TCGA-DU-A76O-01A-11D-A32B-08 +TCGA-DU-A76R-01 TCGA-DU-A76R-01 TCGA-DU-A76R TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 51 TCGA-DU-A76R TCGA-DU-A76R-01A -18939 2739 648 0 60 Mental Status Changes 0 - 30 Days 2013-10-22 MALE NO Oligodendroglioma NO No C71.0 9451/3 C71.0 YES 250 NO 50 Right NO YES YES G3 YES false No TCGA-DU-A76R.7D334156-3FCB-4C90-AD99-60778721193D.pdf A76R Pre-Adjuvant Therapy WITH TUMOR YES YES Progressive Disease YES Primary Tumor 01 NO NO Not listed in Medical Record NO NO YES DU Supratentorial, Frontal Lobe Central nervous system A NO DECEASED 2006 TCGA-DU-A76R-01 14B5D6B4-02A6-42FC-A4D9-EA5C0357C2A4 TCGA-DU-A76R-01A-11D-A32B-08 TCGA-DU-A76R-01A-11D-A32A-01 22609052-fb11-4d62-bbfa-4837b30f37ac TCGA-DU-A76R-01 TCGA-DU-A76R-01 22609052-fb11-4d62-bbfa-4837b30f37ac TCGA-DU-A76R-01 TCGA-DU-A76R-01A-11D-A32C-05 22609052-fb11-4d62-bbfa-4837b30f37ac 22609052-fb11-4d62-bbfa-4837b30f37ac TCGA-DU-A76R-01A-11D-A32A-01 TCGA-DU-A76R-01A-11D-A32B-08 +TCGA-DU-A7T6-01 TCGA-DU-A7T6-01 TCGA-DU-A7T6 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 73 TCGA-DU-A7T6 TCGA-DU-A7T6-01A -26766 4265 547 0 53 Headaches > 181 Days 2013-12-23 FEMALE YES Oligodendroglioma NO No C71.0 9451/3 C71.0 YES 250 NO 60 Right NO NO NO G3 false No TCGA-DU-A7T6.B14319BC-DB5D-41E4-9954-5E6641791D54.pdf A7T6 Pre-Adjuvant Therapy WITH TUMOR Primary Tumor 01 NO NO Not listed in Medical Record NO YES DU Supratentorial, Frontal Lobe Central nervous system A NO DECEASED 2002 TCGA-DU-A7T6-01 615FCE95-CC8D-4AA2-AFE1-B087D0E101C7 TCGA-DU-A7T6-01A-11D-A33T-08 TCGA-DU-A7T6-01A-11D-A33S-01 063e82c8-a923-4ca5-94cb-9fce3cccd226 TCGA-DU-A7T6-01 TCGA-DU-A7T6-01 063e82c8-a923-4ca5-94cb-9fce3cccd226 TCGA-DU-A7T6-01 TCGA-DU-A7T6-01A-11D-A33U-05 063e82c8-a923-4ca5-94cb-9fce3cccd226 063e82c8-a923-4ca5-94cb-9fce3cccd226 TCGA-DU-A7T6-01A-11D-A33S-01 TCGA-DU-A7T6-01A-11D-A33T-08 +TCGA-DU-A7T8-01 TCGA-DU-A7T8-01 TCGA-DU-A7T8 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain YES NO YES YES 35 NO NO TCGA-DU-A7T8-F71629 TCGA-DU-A7T8 TCGA-DU-A7T8-01A 3028 3759 -13108 3705 4229 0 3787 3009 80 YES NO NO < 12 Years Mental Status Changes 91 - 180 Days Scheduled Follow-up Submission Progressive Disease NO 2015-3-27 MALE NO YES Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES 280 NO 100 Right NO NO YES NO YES G3 YES false No TCGA-DU-A7T8.342A92BA-BEF9-40C6-85FF-71328B8C1DCF.pdf A7T8 Other WITH TUMOR Progressive Disease YES Primary Tumor 01 NO YES Not listed in Medical Record YES NO YES DU Supratentorial, Frontal Lobe Central nervous system A NO DECEASED 2003 TCGA-DU-A7T8-01 TCGA-DU-A7T8-01A-21D-A34J-08 TCGA-DU-A7T8-01A-21D-A34I-01 05c3a0c4-87d0-409d-a4d4-7b5f6c3ab9e2 TCGA-DU-A7T8-01 TCGA-DU-A7T8-01 05c3a0c4-87d0-409d-a4d4-7b5f6c3ab9e2 TCGA-DU-A7T8-01 TCGA-DU-A7T8-01A-21D-A34K-05 05c3a0c4-87d0-409d-a4d4-7b5f6c3ab9e2 05c3a0c4-87d0-409d-a4d4-7b5f6c3ab9e2 TCGA-DU-A7T8-01A-21D-A34I-01 TCGA-DU-A7T8-01A-21D-A34J-08 +TCGA-DU-A7TA-01 TCGA-DU-A7TA-01 TCGA-DU-A7TA TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 32 NO NO TCGA-DU-A7TA-F71628 TCGA-DU-A7TA TCGA-DU-A7TA-01A -11764 2287 0 2565 17 NO NO NO 12 - 20 Years Visual Changes > 181 Days Scheduled Follow-up Submission NO 2015-3-27 MALE YES NO Oligodendroglioma NO No C71.0 9450/3 C71.0 YES 380 NO 80 Right NO NO NO NO NO G2 NO false No TCGA-DU-A7TA.4E9DD63D-7C18-4922-93B5-37B0BB2CCB8F.pdf A7TA Pre-Adjuvant Therapy TUMOR FREE NO NO Stable Disease YES Primary Tumor 01 NO NO Not listed in Medical Record YES NO YES DU Supratentorial, Occipital Lobe Central nervous system A YES LIVING 2007 TCGA-DU-A7TA-01 C5F26B21-30B7-4F5A-A449-CF66F9BDE496 TCGA-DU-A7TA-01A-11D-A33T-08 TCGA-DU-A7TA-01A-11D-A33S-01 a3966107-19e4-467c-a692-9a154cc09c20 TCGA-DU-A7TA-01 TCGA-DU-A7TA-01 a3966107-19e4-467c-a692-9a154cc09c20 TCGA-DU-A7TA-01 TCGA-DU-A7TA-01A-11D-A33U-05 a3966107-19e4-467c-a692-9a154cc09c20 a3966107-19e4-467c-a692-9a154cc09c20 TCGA-DU-A7TA-01A-11D-A33S-01 TCGA-DU-A7TA-01A-11D-A33T-08 +TCGA-DU-A7TB-01 TCGA-DU-A7TB-01 TCGA-DU-A7TB TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain YES YES NO 56 TCGA-DU-A7TB-F71627 TCGA-DU-A7TB TCGA-DU-A7TB-01A -20704 1168 0 1567 74 1111 NO NO Seizures 0 - 30 Days Scheduled Follow-up Submission Stable Disease 2015-3-27 MALE NO Oligodendroglioma NO No C71.0 9450/3 C71.0 YES 250 NO 100 Right NO NO NO NO G2 YES false No TCGA-DU-A7TB.3D167AD9-276F-47F4-9C77-D7AD8B24D59F.pdf A7TB Post-Adjuvant Therapy TUMOR FREE YES YES Progressive Disease NO Primary Tumor 01 YES NO Not listed in Medical Record YES YES NO DU Supratentorial, Temporal Lobe Central nervous system A NO LIVING 2010 TCGA-DU-A7TB-01 0336AB72-D4C8-465D-B783-A31EEBEAD016 TCGA-DU-A7TB-01A-11D-A33T-08 TCGA-DU-A7TB-01A-11D-A33S-01 08199c9b-9dc5-4f59-a1b8-324bd0a5f7c3 TCGA-DU-A7TB-01 TCGA-DU-A7TB-01 08199c9b-9dc5-4f59-a1b8-324bd0a5f7c3 TCGA-DU-A7TB-01 TCGA-DU-A7TB-01A-11D-A33U-05 08199c9b-9dc5-4f59-a1b8-324bd0a5f7c3 08199c9b-9dc5-4f59-a1b8-324bd0a5f7c3 TCGA-DU-A7TB-01A-11D-A33S-01 TCGA-DU-A7TB-01A-11D-A33T-08 +TCGA-DU-A7TC-01 TCGA-DU-A7TC-01 TCGA-DU-A7TC TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 32 NO TCGA-DU-A7TC-F71626 TCGA-DU-A7TC -11884 0 1137 1114 [Discrepancy] NO YES NO Headaches > 181 Days Scheduled Follow-up Submission 2015-3-27 MALE NO YES Astrocytoma No C71.0 9400/3 C71.0 YES 90 Right NO NO YES NO NO G2 YES No A7TC [Discrepancy] WITH TUMOR NO NO [Discrepancy] NO Primary Tumor 01 NO NO Not listed in Medical Record NO YES NO DU Supratentorial, Frontal Lobe Central nervous system NO LIVING 2011 TCGA-DU-A7TC-01 TCGA-DU-A7TC-01A-21D-A34J-08 TCGA-DU-A7TC-01A-21D-A34I-01 aa0da5cf-b997-4e3e-83eb-b01e7488b714 TCGA-DU-A7TC-01 TCGA-DU-A7TC-01 aa0da5cf-b997-4e3e-83eb-b01e7488b714 TCGA-DU-A7TC-01 TCGA-DU-A7TC-01A-21D-A34K-05 aa0da5cf-b997-4e3e-83eb-b01e7488b714 aa0da5cf-b997-4e3e-83eb-b01e7488b714 TCGA-DU-A7TC-01A-21D-A34I-01 TCGA-DU-A7TC-01A-21D-A34J-08 +TCGA-DU-A7TD-01 TCGA-DU-A7TD-01 TCGA-DU-A7TD TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 52 TCGA-DU-A7TD TCGA-DU-A7TD-01A -19025 616 228 0 170 Motor/Movement Changes 0 - 30 Days 2014-2-3 MALE NO Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES 530 NO 60 Right NO NO YES G3 YES false No TCGA-DU-A7TD.0DDAB8E8-54DA-495A-9A4B-9D9A3CFE5DB7.pdf A7TD Post-Adjuvant Therapy WITH TUMOR YES YES Progressive Disease YES Primary Tumor 01 NO NO YES YES NO DU Supratentorial, Temporal Lobe Central nervous system A NO DECEASED 2012 TCGA-DU-A7TD-01 A170CA34-5B99-4116-B6DE-42AF69B8F648 TCGA-DU-A7TD-01A-12D-A34A-08 TCGA-DU-A7TD-01A-12D-A349-01 03eb7467-7dd5-4228-86b9-7b3b31ba1496 TCGA-DU-A7TD-01 TCGA-DU-A7TD-01 03eb7467-7dd5-4228-86b9-7b3b31ba1496 TCGA-DU-A7TD-01 TCGA-DU-A7TD-01A-12D-A34D-05 03eb7467-7dd5-4228-86b9-7b3b31ba1496 03eb7467-7dd5-4228-86b9-7b3b31ba1496 TCGA-DU-A7TD-01A-12D-A349-01 TCGA-DU-A7TD-01A-12D-A34A-08 +TCGA-DU-A7TG-01 TCGA-DU-A7TG-01 TCGA-DU-A7TG TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 40 TCGA-DU-A7TG TCGA-DU-A7TG-01A -14671 1804 1351 0 59 YES NO Mental Status Changes 0 - 30 Days 2014-2-3 MALE NO Oligodendroglioma NO No C71.0 9450/3 C71.0 YES 300 NO 70 Right NO YES NO G2 false No TCGA-DU-A7TG.B8C5F2FE-1618-4AB8-924E-4C2C60EF7611.pdf A7TG Post-Adjuvant Therapy NO Primary Tumor 01 NO NO Not listed in Medical Record YES NO YES DU Supratentorial, Frontal Lobe Central nervous system A NO DECEASED 2008 TCGA-DU-A7TG-01 60B209B9-D422-4D4D-8B3E-C0B4344DE990 TCGA-DU-A7TG-01A-21D-A34J-08 TCGA-DU-A7TG-01A-21D-A34I-01 32d4e5fa-74d7-40c7-96ae-a6fb0707524d TCGA-DU-A7TG-01 TCGA-DU-A7TG-01 32d4e5fa-74d7-40c7-96ae-a6fb0707524d TCGA-DU-A7TG-01 TCGA-DU-A7TG-01A-21D-A34K-05 32d4e5fa-74d7-40c7-96ae-a6fb0707524d 32d4e5fa-74d7-40c7-96ae-a6fb0707524d TCGA-DU-A7TG-01A-21D-A34I-01 TCGA-DU-A7TG-01A-21D-A34J-08 +TCGA-DU-A7TI-01 TCGA-DU-A7TI-01 TCGA-DU-A7TI TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 32 TCGA-DU-A7TI TCGA-DU-A7TI-01A -11906 5441 1183 0 Seizures 91 - 180 Days 2014-2-5 MALE NO Astrocytoma No C71.0 9401/3 C71.0 YES 180 NO Left NO YES NO G3 YES false No TCGA-DU-A7TI.F365952B-D839-4B07-953A-7EBE3B9A45BF.pdf A7TI WITH TUMOR YES Progressive Disease YES Primary Tumor 01 YES NO Cerebral Cortex YES NO YES DU Supratentorial, Frontal Lobe Central nervous system A NO DECEASED 1998 TCGA-DU-A7TI-01 AF57C3F8-F00E-4BE0-BD56-139E355F22BC TCGA-DU-A7TI-01A-11D-A33T-08 TCGA-DU-A7TI-01A-11D-A33S-01 4b078458-3461-4e86-974f-11b677908e29 TCGA-DU-A7TI-01 TCGA-DU-A7TI-01 4b078458-3461-4e86-974f-11b677908e29 TCGA-DU-A7TI-01 TCGA-DU-A7TI-01A-11D-A33U-05 4b078458-3461-4e86-974f-11b677908e29 4b078458-3461-4e86-974f-11b677908e29 TCGA-DU-A7TI-01A-11D-A33S-01 TCGA-DU-A7TI-01A-11D-A33T-08 +TCGA-DU-A7TJ-01 TCGA-DU-A7TJ-01 TCGA-DU-A7TJ TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 55 TCGA-DU-A7TJ-F71624 TCGA-DU-A7TJ TCGA-DU-A7TJ-01A -20394 29 0 17 Seizures 31 - 90 Days Scheduled Follow-up Submission 2015-3-27 MALE YES Astrocytoma NO No C71.0 9401/3 C71.0 YES NO 470 NO Right YES IHC YES YES G3 false No TCGA-DU-A7TJ.039F34B6-70E4-42E2-A93C-AD9BEDAC507D.pdf A7TJ WITH TUMOR YES YES Primary Tumor 01 YES Not listed in Medical Record YES NO DU Supratentorial, Temporal Lobe Central nervous system A LIVING 2013 TCGA-DU-A7TJ-01 613B0D13-C828-4512-B953-6D7DA1FED733 TCGA-DU-A7TJ-01A-11D-A34J-08 TCGA-DU-A7TJ-01A-11D-A34I-01 9b0933e8-1da1-427b-8d3f-ef4742888ebd TCGA-DU-A7TJ-01 TCGA-DU-A7TJ-01 9b0933e8-1da1-427b-8d3f-ef4742888ebd TCGA-DU-A7TJ-01 TCGA-DU-A7TJ-01A-11D-A34K-05 9b0933e8-1da1-427b-8d3f-ef4742888ebd 9b0933e8-1da1-427b-8d3f-ef4742888ebd TCGA-DU-A7TJ-01A-11D-A34I-01 TCGA-DU-A7TJ-01A-11D-A34J-08 +TCGA-E1-5302-01 TCGA-E1-5302-01 TCGA-E1-5302 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain YES YES NO NO 41 NO TCGA-E1-5302-F7572 TCGA-E1-5302 TCGA-E1-5302-01A -15230 1525 0 1242 1254 NO YES NO Seizures 0 - 30 Days Progressive Disease 2011-1-13 MALE NO Astrocytoma NO No C71.9 9401/3 C71.9 YES 0.7 NO 100 Left NO 1.1 NO NO G3 YES No TCGA-E1-5302.cd1ef6bc-41bf-4b2c-80dc-ad9c7169f4c3.pdf 5302 Post-Adjuvant Therapy WITH TUMOR YES YES Stable Disease YES Primary Tumor 01 YES NO 0.3 Not listed in Medical Record YES NO YES E1 Supratentorial, Frontal Lobe Central nervous system A NO DECEASED 1998 TCGA-E1-5302-01A-01D-1468-08 TCGA-E1-5302-01 7AC2E841-EB22-4997-A656-41628D20BBF8 TCGA-E1-5302-01A-01D-1468-08 TCGA-E1-5302-01A-01D-1466-01 468e10c6-3ce9-4334-97d4-55d91799daf9 TCGA-E1-5302-01 TCGA-E1-5302-01 TCGA-E1-5302-01 TCGA-E1-5302-01A-01D-1468-08 468e10c6-3ce9-4334-97d4-55d91799daf9 TCGA-E1-5302-01 TCGA-E1-5302-01 TCGA-E1-5302-01A-01D-1468-08 TCGA-E1-5302-01A-01D-1467-05 TCGA-E1-5302-01 468e10c6-3ce9-4334-97d4-55d91799daf9 TCGA-E1-5302-01A-01R-1470-07 468e10c6-3ce9-4334-97d4-55d91799daf9 TCGA-E1-5302-01A-01D-1466-01 TCGA-E1-5302-01A-01D-1468-08 +TCGA-E1-5303-01 TCGA-E1-5303-01 TCGA-E1-5303 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain YES NO NO NO 38 NO TCGA-E1-5303-F7453 TCGA-E1-5303 TCGA-E1-5303-01A -14212 2052 0 156 582 NO YES NO Seizures 0 - 30 Days Progressive Disease 2011-1-19 MALE NO Astrocytoma NO No C71.9 9401/3 C71.9 YES NO 0.6 NO 80 Left 0.8 NO NO G3 YES No TCGA-E1-5303.20e5b4f2-6555-4bf9-80c3-9b472fe8eedb.pdf 5303 Post-Adjuvant Therapy WITH TUMOR YES YES Progressive Disease YES Primary Tumor 01 YES NO 0.6 Not listed in Medical Record [Discrepancy] NO YES E1 Supratentorial, Frontal Lobe Central nervous system A NO DECEASED 1998 TCGA-E1-5303-01A-01D-1468-08 TCGA-E1-5303-01 8E9D15B6-E3C9-480A-A732-2DD3FCEF37A8 TCGA-E1-5303-01A-01D-1468-08 TCGA-E1-5303-01A-01D-1466-01 0edca07e-a874-4cfc-ae79-1080fee6a5f7 TCGA-E1-5303-01 TCGA-E1-5303-01 TCGA-E1-5303-01 TCGA-E1-5303-01A-01D-1468-08 0edca07e-a874-4cfc-ae79-1080fee6a5f7 TCGA-E1-5303-01 TCGA-E1-5303-01 TCGA-E1-5303-01A-01D-1468-08 TCGA-E1-5303-01A-01D-1467-05 TCGA-E1-5303-01 0edca07e-a874-4cfc-ae79-1080fee6a5f7 TCGA-E1-5303-01A-01R-1470-07 0edca07e-a874-4cfc-ae79-1080fee6a5f7 TCGA-E1-5303-01A-01D-1466-01 TCGA-E1-5303-01A-01D-1468-08 +TCGA-E1-5304-01 TCGA-E1-5304-01 TCGA-E1-5304 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain YES YES NO 42 NO NO TCGA-E1-5304-F7470 TCGA-E1-5304 TCGA-E1-5304-01A 980 -15481 1251 0 903 160 NO YES NO Headaches > 181 Days Stable Disease NO 2011-1-20 MALE NO YES Astrocytoma NO No C71.9 9401/3 C71.9 YES 0.6 NO 90 Right 0.8 NO NO NO G3 YES No TCGA-E1-5304.4180deb2-569a-49d5-9b0c-769fb2451409.pdf 5304 Post-Adjuvant Therapy WITH TUMOR YES YES Stable Disease YES Primary Tumor 01 NO YES 0.6 Not listed in Medical Record YES NO YES E1 Supratentorial, Frontal Lobe Central nervous system A NO DECEASED 1999 TCGA-E1-5304-01A-01D-1468-08 TCGA-E1-5304-01 E546B1F2-BFE5-4610-919A-B877DC125CF7 TCGA-E1-5304-01A-01D-1468-08 TCGA-E1-5304-01A-01D-1466-01 b6e08ea4-8a3b-4e8e-9a3a-387e6fc6a94a TCGA-E1-5304-01 TCGA-E1-5304-01 TCGA-E1-5304-01 TCGA-E1-5304-01A-01D-1468-08 b6e08ea4-8a3b-4e8e-9a3a-387e6fc6a94a TCGA-E1-5304-01 TCGA-E1-5304-01 TCGA-E1-5304-01A-01D-1468-08 TCGA-E1-5304-01A-01D-1467-05 TCGA-E1-5304-01 b6e08ea4-8a3b-4e8e-9a3a-387e6fc6a94a TCGA-E1-5304-01A-01R-1470-07 b6e08ea4-8a3b-4e8e-9a3a-387e6fc6a94a TCGA-E1-5304-01A-01D-1466-01 TCGA-E1-5304-01A-01D-1468-08 +TCGA-E1-5305-01 TCGA-E1-5305-01 TCGA-E1-5305 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain YES NO YES NO 34 YES TCGA-E1-5305-F16185 TCGA-E1-5305 TCGA-E1-5305-01A 1623 -12655 2433 0 1604 1631 NO YES NO Seizures 0 - 30 Days Progressive Disease 2011-8-8 MALE NO NO Astrocytoma NO No C71.9 9401/3 C71.9 YES 0.8 NO 90 Right 1 NO YES NO G3 YES No TCGA-E1-5305.7c854147-edeb-47ca-9b46-444a18d12c43.pdf 5305 Post-Adjuvant Therapy WITH TUMOR YES YES Stable Disease YES Primary Tumor 01 YES NO 0.4 Not listed in Medical Record [Discrepancy] NO YES E1 Supratentorial, Frontal Lobe Central nervous system A NO DECEASED 2000 TCGA-E1-5305-01A-01D-1893-08 TCGA-E1-5305-01 39829D5D-B032-40CB-B342-3BE7F4E4CC0B TCGA-E1-5305-01A-01D-1893-08 TCGA-E1-5305-01A-01D-1892-01 35db896d-9e7c-47df-933f-4eb547913394 TCGA-E1-5305-01 TCGA-E1-5305-01 TCGA-E1-5305-01A-01D-1893-08 35db896d-9e7c-47df-933f-4eb547913394 TCGA-E1-5305-01 TCGA-E1-5305-01 TCGA-E1-5305-01A-01D-1893-08 TCGA-E1-5305-01A-01D-1894-05 35db896d-9e7c-47df-933f-4eb547913394 35db896d-9e7c-47df-933f-4eb547913394 TCGA-E1-5305-01A-01D-1892-01 TCGA-E1-5305-01A-01D-1893-08 +TCGA-E1-5307-01 TCGA-E1-5307-01 TCGA-E1-5307 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain YES YES NO NO 62 NO TCGA-E1-5307-F16198 TCGA-E1-5307 TCGA-E1-5307-01A -22837 1762 0 1452 [Discrepancy] NO Mental Status Changes > 181 Days Progressive Disease 2011-8-12 FEMALE YES Astrocytoma NO No C71.9 9401/3 C71.9 YES 1 NO 80 Left 1.3 YES NO G3 YES No TCGA-E1-5307.60b202db-3c7c-4c86-be48-9ef37c9039a8.pdf 5307 Pre-Adjuvant Therapy WITH TUMOR YES YES Stable Disease YES Primary Tumor 01 NO NO 0.6 Not listed in Medical Record YES NO YES E1 Supratentorial, Temporal Lobe Central nervous system A NO DECEASED 2000 TCGA-E1-5307-01A-01D-1893-08 TCGA-E1-5307-01 9095342D-760C-4BA1-BD58-BC80B2DF4E98 TCGA-E1-5307-01A-01D-1893-08 TCGA-E1-5307-01A-01D-1892-01 8f248b27-4433-493d-87d7-e9e174317470 TCGA-E1-5307-01 TCGA-E1-5307-01 TCGA-E1-5307-01A-01D-1893-08 8f248b27-4433-493d-87d7-e9e174317470 TCGA-E1-5307-01 TCGA-E1-5307-01 TCGA-E1-5307-01A-01D-1893-08 TCGA-E1-5307-01A-01D-1894-05 8f248b27-4433-493d-87d7-e9e174317470 8f248b27-4433-493d-87d7-e9e174317470 TCGA-E1-5307-01A-01D-1892-01 TCGA-E1-5307-01A-01D-1893-08 +TCGA-E1-5311-01 TCGA-E1-5311-01 TCGA-E1-5311 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain YES YES YES NO 31 NO NO TCGA-E1-5311-F7600 TCGA-E1-5311 TCGA-E1-5311-01A 2602 -11332 4084 0 2602 -8 NO NO NO Headaches > 181 Days Progressive Disease NO 2011-1-25 MALE NO YES Oligodendroglioma NO No C71.9 9451/3 C71.9 YES 0.6 NO 100 Right 1.1 NO NO NO G3 YES No TCGA-E1-5311.f4d55755-105e-4740-b13e-801c5d3bde5c.pdf 5311 Pre-Adjuvant Therapy WITH TUMOR YES YES Stable Disease YES Primary Tumor 01 NO NO 0.2 Not listed in Medical Record YES NO YES E1 Supratentorial, Temporal Lobe Central nervous system A NO DECEASED 1994 TCGA-E1-5311-01A-01D-1468-08 TCGA-E1-5311-01 FD2FBD98-E139-485F-9367-A458F13285B2 TCGA-E1-5311-01A-01D-1468-08 TCGA-E1-5311-01A-01D-1466-01 4daa80a9-f1f3-4b9e-ac8c-e5ee9f276360 TCGA-E1-5311-01 TCGA-E1-5311-01 TCGA-E1-5311-01 TCGA-E1-5311-01A-01D-1468-08 4daa80a9-f1f3-4b9e-ac8c-e5ee9f276360 TCGA-E1-5311-01 TCGA-E1-5311-01 TCGA-E1-5311-01A-01D-1468-08 TCGA-E1-5311-01A-01D-1467-05 TCGA-E1-5311-01 4daa80a9-f1f3-4b9e-ac8c-e5ee9f276360 TCGA-E1-5311-01A-01R-1470-07 4daa80a9-f1f3-4b9e-ac8c-e5ee9f276360 TCGA-E1-5311-01A-01D-1466-01 TCGA-E1-5311-01A-01D-1468-08 +TCGA-E1-5318-01 TCGA-E1-5318-01 TCGA-E1-5318 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain YES YES YES NO 42 NO NO TCGA-E1-5318-F7616 TCGA-E1-5318 TCGA-E1-5318-01A 362 -15372 2379 0 2379 362 362 NO YES NO Headaches 31 - 90 Days Stable Disease NO 2011-1-26 FEMALE NO YES Oligodendroglioma NO No C71.9 9450/3 C71.9 YES 0.5 NO 100 Left 0.7 NO NO NO G2 YES No TCGA-E1-5318.9a5db4fd-190b-448c-a22a-1b599b9007c5.pdf 5318 Pre-Adjuvant Therapy WITH TUMOR YES YES Progressive Disease YES Primary Tumor 01 NO NO 0.2 Not listed in Medical Record YES NO YES E1 Supratentorial, Frontal Lobe Central nervous system A NO DECEASED 1997 TCGA-E1-5318-01A-01D-1468-08 TCGA-E1-5318-01 22936D14-3266-454C-A49C-1612F6FADC87 TCGA-E1-5318-01A-01D-1468-08 TCGA-E1-5318-01A-01D-1466-01 149fe971-260e-4cbf-a5aa-41eca339847a TCGA-E1-5318-01 TCGA-E1-5318-01 TCGA-E1-5318-01 TCGA-E1-5318-01A-01D-1468-08 149fe971-260e-4cbf-a5aa-41eca339847a TCGA-E1-5318-01 TCGA-E1-5318-01 TCGA-E1-5318-01A-01D-1468-08 TCGA-E1-5318-01A-01D-1467-05 TCGA-E1-5318-01 149fe971-260e-4cbf-a5aa-41eca339847a TCGA-E1-5318-01A-01R-1470-07 149fe971-260e-4cbf-a5aa-41eca339847a TCGA-E1-5318-01A-01D-1466-01 TCGA-E1-5318-01A-01D-1468-08 +TCGA-E1-5319-01 TCGA-E1-5319-01 TCGA-E1-5319 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain YES YES YES NO 48 NO TCGA-E1-5319-F16173 TCGA-E1-5319 TCGA-E1-5319-01A 923 -17612 2907 0 923 952 NO YES Visual Changes 0 - 30 Days Stable Disease 2011-8-17 FEMALE NO NO Oligodendroglioma NO No C71.9 9450/3 C71.9 YES 0.8 NO 100 Right 1 NO NO G2 YES No TCGA-E1-5319.31d5346f-9f29-4eee-86e4-bd01faf9935d.pdf 5319 Pre-Adjuvant Therapy WITH TUMOR YES YES Stable Disease NO Primary Tumor 01 NO NO 0.5 Not listed in Medical Record NO NO YES E1 Supratentorial, Frontal Lobe Central nervous system A YES DECEASED 1998 TCGA-E1-5319-01A-01D-1893-08 TCGA-E1-5319-01 AA7B153B-E955-4F94-AC68-44722193CD30 TCGA-E1-5319-01A-01D-1893-08 TCGA-E1-5319-01A-01D-1892-01 927d20e2-da09-42ca-a70c-2b203a8297a6 TCGA-E1-5319-01 TCGA-E1-5319-01 TCGA-E1-5319-01A-01D-1893-08 927d20e2-da09-42ca-a70c-2b203a8297a6 TCGA-E1-5319-01 TCGA-E1-5319-01 TCGA-E1-5319-01A-01D-1893-08 TCGA-E1-5319-01A-01D-1894-05 927d20e2-da09-42ca-a70c-2b203a8297a6 927d20e2-da09-42ca-a70c-2b203a8297a6 TCGA-E1-5319-01A-01D-1892-01 TCGA-E1-5319-01A-01D-1893-08 +TCGA-E1-5322-01 TCGA-E1-5322-01 TCGA-E1-5322 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain YES YES YES NO 38 TCGA-E1-5322-F7464 TCGA-E1-5322 TCGA-E1-5322-01A 1085 -13903 3978 0 1085 3305 NO NO Seizures Stable Disease 2011-1-27 FEMALE Oligoastrocytoma NO No C71.9 9382/3 C71.9 YES 0.4 NO 90 Right 0.7 G2 YES No TCGA-E1-5322.68735214-8bff-497f-8157-0eff26a678f7.pdf 5322 Post-Adjuvant Therapy YES YES Stable Disease [Discrepancy] Primary Tumor 01 YES 0.2 Not listed in Medical Record [Discrepancy] NO YES E1 Supratentorial, Temporal Lobe Central nervous system A DECEASED 1999 TCGA-E1-5322-01A-01D-1468-08 TCGA-E1-5322-01 AF51F163-079B-4808-B21B-B6B655C1BD16 TCGA-E1-5322-01A-01D-1468-08 TCGA-E1-5322-01A-01D-1466-01 d7d5e04b-d563-418b-b312-0fe69b4bec29 TCGA-E1-5322-01 TCGA-E1-5322-01 TCGA-E1-5322-01 TCGA-E1-5322-01A-01D-1468-08 d7d5e04b-d563-418b-b312-0fe69b4bec29 TCGA-E1-5322-01 TCGA-E1-5322-01 TCGA-E1-5322-01A-01D-1468-08 TCGA-E1-5322-01A-01D-1467-05 TCGA-E1-5322-01 d7d5e04b-d563-418b-b312-0fe69b4bec29 TCGA-E1-5322-01A-01R-1470-07 d7d5e04b-d563-418b-b312-0fe69b4bec29 TCGA-E1-5322-01A-01D-1466-01 TCGA-E1-5322-01A-01D-1468-08 +TCGA-E1-A7YD-01 TCGA-E1-A7YD-01 TCGA-E1-A7YD TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 57 NO TCGA-E1-A7YD TCGA-E1-A7YD-01A -21020 5445 435 0 NO NO NO Headaches 0 - 30 Days 2014-5-12 MALE YES Astrocytoma NO No C71.0 9401/3 C71.0 YES NO 80 NO Left NO NO NO G3 YES true No TCGA-E1-A7YD.B371FF08-C874-4A6E-9CF9-C1931F28ADED.pdf A7YD WITH TUMOR YES Stable Disease YES Primary Tumor 01 YES NO Not listed in Medical Record YES NO YES E1 Supratentorial, Temporal Lobe Central nervous system A NO DECEASED 1998 TCGA-E1-A7YD-01 TCGA-E1-A7YD-01A-11D-A34A-08 TCGA-E1-A7YD-01A-11D-A349-01 0eb7a942-eea5-4de3-add4-724f69a6f80c TCGA-E1-A7YD-01 TCGA-E1-A7YD-01 0eb7a942-eea5-4de3-add4-724f69a6f80c TCGA-E1-A7YD-01 TCGA-E1-A7YD-01A-11D-A34D-05 0eb7a942-eea5-4de3-add4-724f69a6f80c 0eb7a942-eea5-4de3-add4-724f69a6f80c TCGA-E1-A7YD-01A-11D-A349-01 TCGA-E1-A7YD-01A-11D-A34A-08 +TCGA-E1-A7YE-01 TCGA-E1-A7YE-01 TCGA-E1-A7YE TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain NO NO NO NO 32 NO NO TCGA-E1-A7YE-F61220 TCGA-E1-A7YE -11971 886 0 846 81 NO NO NO Seizures 0 - 30 Days Additional New Tumor Event Progressive Disease NO 2014-8-14 FEMALE NO NO Astrocytoma NO No C71.0 9401/3 C71.0 YES 90 Left NO NO NO NO NO G3 YES No A7YE Post-Adjuvant Therapy WITH TUMOR YES NO Stable Disease YES Primary Tumor 01 YES YES Not listed in Medical Record YES NO YES E1 Supratentorial, Frontal Lobe Central nervous system NO DECEASED 2001 TCGA-E1-A7YE-01 TCGA-E1-A7YE-01A-11D-A34A-08 TCGA-E1-A7YE-01A-11D-A349-01 cd935b60-ed16-4f34-98ad-1e6cf0671683 TCGA-E1-A7YE-01 TCGA-E1-A7YE-01 cd935b60-ed16-4f34-98ad-1e6cf0671683 TCGA-E1-A7YE-01 TCGA-E1-A7YE-01A-11D-A34D-05 cd935b60-ed16-4f34-98ad-1e6cf0671683 cd935b60-ed16-4f34-98ad-1e6cf0671683 TCGA-E1-A7YE-01A-11D-A349-01 TCGA-E1-A7YE-01A-11D-A34A-08 +TCGA-E1-A7YH-01 TCGA-E1-A7YH-01 TCGA-E1-A7YH TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain NO NO NO NO 47 NO TCGA-E1-A7YH-F61239 TCGA-E1-A7YH TCGA-E1-A7YH-01A -17465 3127 2835 0 1629 17 NO YES NO Seizures > 181 Days Additional New Tumor Event Progressive Disease 2014-8-14 FEMALE NO Astrocytoma NO No C71.0 9401/3 C71.0 YES NO 130 NO 80 Right NO NO NO NO G3 YES true No TCGA-E1-A7YH.4E589046-F21D-4822-8243-8805D07E3410.pdf A7YH Pre-Adjuvant Therapy WITH TUMOR YES NO Stable Disease YES Primary Tumor 01 YES NO White Matter YES NO YES E1 Supratentorial, Temporal Lobe Central nervous system A NO DECEASED 2005 TCGA-E1-A7YH-01 4772CBBE-1FFD-4AE5-9592-E465C1AC05EE TCGA-E1-A7YH-01A-11D-A34A-08 TCGA-E1-A7YH-01A-11D-A349-01 b5c4c513-4800-405f-94d6-9fa4303292ef TCGA-E1-A7YH-01 TCGA-E1-A7YH-01 b5c4c513-4800-405f-94d6-9fa4303292ef TCGA-E1-A7YH-01 TCGA-E1-A7YH-01A-11D-A34D-05 b5c4c513-4800-405f-94d6-9fa4303292ef b5c4c513-4800-405f-94d6-9fa4303292ef TCGA-E1-A7YH-01A-11D-A349-01 TCGA-E1-A7YH-01A-11D-A34A-08 +TCGA-E1-A7YI-01 TCGA-E1-A7YI-01 TCGA-E1-A7YI TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 33 NO TCGA-E1-A7YI TCGA-E1-A7YI-01A -12229 2022 111 0 11 NO YES NO Motor/Movement Changes 31 - 90 Days 2014-5-12 FEMALE NO Astrocytoma NO No C71.0 9401/3 C71.0 YES NO 330 NO 80 Right NO NO YES G3 YES true No TCGA-E1-A7YI.17841D2A-99A8-4F1D-900B-70F6324591DC.pdf A7YI Pre-Adjuvant Therapy WITH TUMOR YES NO Primary Tumor 01 NO YES Not listed in Medical Record NO NO YES E1 Supratentorial, Occipital Lobe Central nervous system A YES DECEASED 2008 TCGA-E1-A7YI-01 5AF58C28-ECDF-4777-B742-AD3FCB64604F TCGA-E1-A7YI-01A-11D-A34A-08 TCGA-E1-A7YI-01A-11D-A349-01 696dc339-8d57-4b97-bce3-7bd3b2746dcc TCGA-E1-A7YI-01 TCGA-E1-A7YI-01 696dc339-8d57-4b97-bce3-7bd3b2746dcc TCGA-E1-A7YI-01 TCGA-E1-A7YI-01A-11D-A34D-05 696dc339-8d57-4b97-bce3-7bd3b2746dcc 696dc339-8d57-4b97-bce3-7bd3b2746dcc TCGA-E1-A7YI-01A-11D-A349-01 TCGA-E1-A7YI-01A-11D-A34A-08 +TCGA-E1-A7YJ-01 TCGA-E1-A7YJ-01 TCGA-E1-A7YJ TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain NO NO NO NO 55 NO TCGA-E1-A7YJ-F61259 TCGA-E1-A7YJ TCGA-E1-A7YJ-01A -20180 1847 592 0 573 12 NO NO NO Motor/Movement Changes 0 - 30 Days Additional New Tumor Event Progressive Disease 2014-8-15 MALE YES Astrocytoma NO No C71.0 9401/3 C71.0 YES NO 190 NO 80 Right NO NO NO YES G3 YES true No TCGA-E1-A7YJ.CF66C60F-354C-4BB5-9A07-8891FC553184.pdf A7YJ Pre-Adjuvant Therapy WITH TUMOR YES YES Stable Disease YES Primary Tumor 01 NO NO White Matter YES NO YES E1 Supratentorial, Frontal Lobe Central nervous system A NO DECEASED 2008 TCGA-E1-A7YJ-01 20532227-E92A-4FC7-A548-C2FD20F36D1D TCGA-E1-A7YJ-01A-11D-A34A-08 TCGA-E1-A7YJ-01A-11D-A349-01 f786ecc3-b6e1-4fb2-9658-25d2831982d9 TCGA-E1-A7YJ-01 TCGA-E1-A7YJ-01 f786ecc3-b6e1-4fb2-9658-25d2831982d9 TCGA-E1-A7YJ-01 TCGA-E1-A7YJ-01A-11D-A34D-05 f786ecc3-b6e1-4fb2-9658-25d2831982d9 f786ecc3-b6e1-4fb2-9658-25d2831982d9 TCGA-E1-A7YJ-01A-11D-A349-01 TCGA-E1-A7YJ-01A-11D-A34A-08 +TCGA-E1-A7YK-01 TCGA-E1-A7YK-01 TCGA-E1-A7YK TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 52 NO TCGA-E1-A7YK-F61287 TCGA-E1-A7YK -19236 378 0 6 NO NO NO Seizures 0 - 30 Days 2014-8-15 MALE NO Astrocytoma NO No C71.0 9401/3 C71.0 YES 90 Left NO NO NO G3 NO No A7YK Pre-Adjuvant Therapy YES YES Stable Disease YES Primary Tumor 01 YES NO Cerebral Cortex YES NO YES E1 Supratentorial, Temporal Lobe Central nervous system NO DECEASED 2009 TCGA-E1-A7YK-01 TCGA-E1-A7YK-01A-11D-A34A-08 TCGA-E1-A7YK-01A-11D-A349-01 b42c2efe-b9d1-49da-8aa0-3d49bb3fb02f TCGA-E1-A7YK-01 TCGA-E1-A7YK-01 b42c2efe-b9d1-49da-8aa0-3d49bb3fb02f TCGA-E1-A7YK-01 TCGA-E1-A7YK-01A-11D-A34D-05 b42c2efe-b9d1-49da-8aa0-3d49bb3fb02f b42c2efe-b9d1-49da-8aa0-3d49bb3fb02f TCGA-E1-A7YK-01A-11D-A349-01 TCGA-E1-A7YK-01A-11D-A34A-08 +TCGA-E1-A7YL-01 TCGA-E1-A7YL-01 TCGA-E1-A7YL TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain NO NO NO NO 46 NO NO TCGA-E1-A7YL-F61302 TCGA-E1-A7YL TCGA-E1-A7YL-01A -16982 1372 492 0 329 14 NO YES YES Headaches 31 - 90 Days Additional New Tumor Event Progressive Disease NO 2014-8-15 MALE NO YES Astrocytoma NO No C71.0 9401/3 C71.0 YES NO 150 NO 80 Right NO IHC YES NO NO NO NO G3 YES true No TCGA-E1-A7YL.4965D7EE-815C-40D9-8071-F017FA7DF335.pdf A7YL Pre-Adjuvant Therapy WITH TUMOR YES YES Progressive Disease YES Primary Tumor 01 NO YES Not listed in Medical Record YES NO YES E1 Supratentorial, Frontal Lobe Central nervous system A YES DECEASED 2009 TCGA-E1-A7YL-01 F98FFF78-D8F1-4D58-9E0E-2A7F9F0880E6 TCGA-E1-A7YL-01A-11D-A34A-08 TCGA-E1-A7YL-01A-11D-A349-01 f42762c7-478e-497f-82c2-fc36a359a6ba TCGA-E1-A7YL-01 TCGA-E1-A7YL-01 f42762c7-478e-497f-82c2-fc36a359a6ba TCGA-E1-A7YL-01 TCGA-E1-A7YL-01A-11D-A34D-05 f42762c7-478e-497f-82c2-fc36a359a6ba f42762c7-478e-497f-82c2-fc36a359a6ba TCGA-E1-A7YL-01A-11D-A349-01 TCGA-E1-A7YL-01A-11D-A34A-08 +TCGA-E1-A7YM-01 TCGA-E1-A7YM-01 TCGA-E1-A7YM TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain YES NO NO NO 63 NO NO TCGA-E1-A7YM-F61425 TCGA-E1-A7YM TCGA-E1-A7YM-01A -23263 1280 648 0 497 11 NO YES NO Headaches > 181 Days Additional New Tumor Event Progressive Disease NO 2014-8-15 MALE NO YES Astrocytoma NO No C71.0 9401/3 C71.0 YES NO 180 NO 80 Left YES IHC YES NO YES NO NO G3 YES true No TCGA-E1-A7YM.FC2E7F8E-0C21-457D-92A1-0052057DF808.pdf A7YM Pre-Adjuvant Therapy WITH TUMOR NO YES Progressive Disease YES Primary Tumor 01 YES NO Not listed in Medical Record YES NO YES E1 Supratentorial, Temporal Lobe Central nervous system A NO DECEASED 2010 TCGA-E1-A7YM-01 212A894B-6035-4926-AD02-0E60AFDD5426 TCGA-E1-A7YM-01A-11D-A34A-08 TCGA-E1-A7YM-01A-11D-A349-01 a51ba688-a2f0-4ad4-82eb-d549e99d1acb TCGA-E1-A7YM-01 TCGA-E1-A7YM-01 a51ba688-a2f0-4ad4-82eb-d549e99d1acb TCGA-E1-A7YM-01 TCGA-E1-A7YM-01A-11D-A34D-05 a51ba688-a2f0-4ad4-82eb-d549e99d1acb a51ba688-a2f0-4ad4-82eb-d549e99d1acb TCGA-E1-A7YM-01A-11D-A349-01 TCGA-E1-A7YM-01A-11D-A34A-08 +TCGA-E1-A7YN-01 TCGA-E1-A7YN-01 TCGA-E1-A7YN TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain YES YES NO NO 63 NO NO TCGA-E1-A7YN-F61445 TCGA-E1-A7YN TCGA-E1-A7YN-01A -23180 1148 727 0 485 20 NO YES NO Visual Changes 0 - 30 Days Additional New Tumor Event Progressive Disease NO 2014-8-15 FEMALE NO NO Astrocytoma NO No C71.0 9401/3 C71.0 YES NO 140 NO 80 Right NO IHC YES NO NO NO NO G3 YES true Yes, History of Prior Malignancy TCGA-E1-A7YN.2C9A41BE-767B-4929-9186-E7821015AC42.pdf A7YN Pre-Adjuvant Therapy WITH TUMOR YES YES Stable Disease YES Primary Tumor 01 NO YES Not listed in Medical Record YES NO YES E1 Supratentorial, Temporal Lobe Central nervous system A YES DECEASED 2010 TCGA-E1-A7YN-01 FD77DB0D-9537-4214-A748-8D51A24E5043 TCGA-E1-A7YN-01A-11D-A34A-08 TCGA-E1-A7YN-01A-11D-A349-01 cf481f1e-9bb2-4682-ac16-31b0db7f444e TCGA-E1-A7YN-01 TCGA-E1-A7YN-01 cf481f1e-9bb2-4682-ac16-31b0db7f444e TCGA-E1-A7YN-01 TCGA-E1-A7YN-01A-11D-A34D-05 cf481f1e-9bb2-4682-ac16-31b0db7f444e cf481f1e-9bb2-4682-ac16-31b0db7f444e TCGA-E1-A7YN-01A-11D-A349-01 TCGA-E1-A7YN-01A-11D-A34A-08 +TCGA-E1-A7YO-01 TCGA-E1-A7YO-01 TCGA-E1-A7YO TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain NO NO NO NO 45 NO NO TCGA-E1-A7YO-F61455 TCGA-E1-A7YO TCGA-E1-A7YO-01A -16770 6582 2282 0 2192 1408 NO Seizures 0 - 30 Days Additional New Tumor Event Progressive Disease NO 2014-8-15 MALE NO NO Oligodendroglioma NO No C71.0 9451/3 C71.0 YES NO 50 NO 100 Right NO NO NO NO NO G3 YES true No TCGA-E1-A7YO.3A005836-F7CF-4423-8548-06C956BC96B9.pdf A7YO Post-Adjuvant Therapy WITH TUMOR YES Stable Disease NO Primary Tumor 01 YES NO Not listed in Medical Record YES NO YES E1 Supratentorial, Frontal Lobe Central nervous system A NO DECEASED 1995 TCGA-E1-A7YO-01 TCGA-E1-A7YO-01A-11D-A34A-08 TCGA-E1-A7YO-01A-11D-A349-01 47b76f26-6ac6-482c-bb3d-315a18400927 TCGA-E1-A7YO-01 TCGA-E1-A7YO-01 47b76f26-6ac6-482c-bb3d-315a18400927 TCGA-E1-A7YO-01 TCGA-E1-A7YO-01A-11D-A34D-05 47b76f26-6ac6-482c-bb3d-315a18400927 47b76f26-6ac6-482c-bb3d-315a18400927 TCGA-E1-A7YO-01A-11D-A349-01 TCGA-E1-A7YO-01A-11D-A34A-08 +TCGA-E1-A7YQ-01 TCGA-E1-A7YQ-01 TCGA-E1-A7YQ TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain NO NO NO NO 58 NO NO TCGA-E1-A7YQ-F61543 TCGA-E1-A7YQ TCGA-E1-A7YQ-01A -21341 4796 1578 0 1149 346 NO Headaches 91 - 180 Days Additional New Tumor Event Progressive Disease NO 2014-8-15 FEMALE NO YES Oligodendroglioma NO No C71.0 9451/3 C71.0 YES NO 180 NO 60 Right NO NO NO NO NO G3 YES true No TCGA-E1-A7YQ.FECABDF2-3EBF-4C3C-AEAD-08D5494852FA.pdf A7YQ Post-Adjuvant Therapy WITH TUMOR YES YES Stable Disease YES Primary Tumor 01 NO NO White Matter YES NO YES E1 Supratentorial, Temporal Lobe Central nervous system A YES DECEASED 2000 TCGA-E1-A7YQ-01 0A209DD2-9214-489C-8865-5D23AE8FEC39 TCGA-E1-A7YQ-01A-11D-A34J-08 TCGA-E1-A7YQ-01A-11D-A34I-01 0c179490-c0fc-4ac1-abdb-f5256abf1ef6 TCGA-E1-A7YQ-01 TCGA-E1-A7YQ-01 0c179490-c0fc-4ac1-abdb-f5256abf1ef6 TCGA-E1-A7YQ-01 TCGA-E1-A7YQ-01A-11D-A34K-05 0c179490-c0fc-4ac1-abdb-f5256abf1ef6 0c179490-c0fc-4ac1-abdb-f5256abf1ef6 TCGA-E1-A7YQ-01A-11D-A34I-01 TCGA-E1-A7YQ-01A-11D-A34J-08 +TCGA-E1-A7YS-01 TCGA-E1-A7YS-01 TCGA-E1-A7YS TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 71 NO NO TCGA-E1-A7YS-F61561 TCGA-E1-A7YS TCGA-E1-A7YS-01A -26159 2123 466 0 16 NO NO NO Mental Status Changes 0 - 30 Days Stable Disease NO 2014-8-15 MALE NO NO Oligodendroglioma NO No C71.0 9451/3 C71.0 YES NO 180 NO 80 Left NO NO YES NO G3 NO true No TCGA-E1-A7YS.8C44E399-41A8-455E-86EA-CA05A8105540.pdf A7YS Pre-Adjuvant Therapy WITH TUMOR YES YES Stable Disease YES Primary Tumor 01 NO NO Not listed in Medical Record YES NO YES E1 Supratentorial, Temporal Lobe Central nervous system A NO DECEASED 2007 TCGA-E1-A7YS-01 E5ABE639-6DBC-46AC-9C58-42A9D94B0C9B TCGA-E1-A7YS-01A-11D-A34A-08 TCGA-E1-A7YS-01A-11D-A349-01 6a8d76ce-107a-48a4-ada7-d136ef547915 TCGA-E1-A7YS-01 TCGA-E1-A7YS-01 6a8d76ce-107a-48a4-ada7-d136ef547915 TCGA-E1-A7YS-01 TCGA-E1-A7YS-01A-11D-A34D-05 6a8d76ce-107a-48a4-ada7-d136ef547915 6a8d76ce-107a-48a4-ada7-d136ef547915 TCGA-E1-A7YS-01A-11D-A349-01 TCGA-E1-A7YS-01A-11D-A34A-08 +TCGA-E1-A7YU-01 TCGA-E1-A7YU-01 TCGA-E1-A7YU TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 42 NO TCGA-E1-A7YU -15345 23 0 NO YES YES Headaches 31 - 90 Days 2014-8-11 MALE YES Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES NO NO NO NO G3 No A7YU WITH TUMOR YES NO Primary Tumor 01 YES Not listed in Medical Record YES NO YES E1 Supratentorial, Frontal Lobe Central nervous system NO DECEASED 1996 TCGA-E1-A7YU-01 TCGA-E1-A7YU-01A-11D-A34J-08 TCGA-E1-A7YU-01A-11D-A34I-01 e6ae4f3a-a375-424d-8f22-b07d1b4904ef TCGA-E1-A7YU-01 TCGA-E1-A7YU-01 e6ae4f3a-a375-424d-8f22-b07d1b4904ef TCGA-E1-A7YU-01 TCGA-E1-A7YU-01A-11D-A34K-05 e6ae4f3a-a375-424d-8f22-b07d1b4904ef e6ae4f3a-a375-424d-8f22-b07d1b4904ef TCGA-E1-A7YU-01A-11D-A34I-01 TCGA-E1-A7YU-01A-11D-A34J-08 +TCGA-E1-A7YV-01 TCGA-E1-A7YV-01 TCGA-E1-A7YV TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain NO NO NO NO 26 NO NO TCGA-E1-A7YV-F61594 TCGA-E1-A7YV TCGA-E1-A7YV-01A -9546 1314 987 0 948 6 NO NO NO Headaches 0 - 30 Days Additional New Tumor Event Progressive Disease NO 2014-8-15 FEMALE NO YES Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES YES 3 X chromosomes (super female) Osler-Weber-Rendu syndrome 230 NO 90 Left YES IHC YES NO NO NO NO G3 YES true No TCGA-E1-A7YV.96974491-20AD-491B-A475-80DB896312C8.pdf A7YV Pre-Adjuvant Therapy WITH TUMOR NO YES Progressive Disease YES Primary Tumor 01 NO NO Not listed in Medical Record YES NO YES E1 Supratentorial, Frontal Lobe Central nervous system A NO DECEASED 2010 TCGA-E1-A7YV-01 B7BA49EF-E9C1-493E-8634-CE61A563BDA0 TCGA-E1-A7YV-01A-11D-A34J-08 TCGA-E1-A7YV-01A-11D-A34I-01 234d1db1-82a5-4b7d-b5f3-044a440b4233 TCGA-E1-A7YV-01 TCGA-E1-A7YV-01 234d1db1-82a5-4b7d-b5f3-044a440b4233 TCGA-E1-A7YV-01 TCGA-E1-A7YV-01A-11D-A34K-05 234d1db1-82a5-4b7d-b5f3-044a440b4233 234d1db1-82a5-4b7d-b5f3-044a440b4233 TCGA-E1-A7YV-01A-11D-A34I-01 TCGA-E1-A7YV-01A-11D-A34J-08 +TCGA-E1-A7YW-01 TCGA-E1-A7YW-01 TCGA-E1-A7YW TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain NO YES NO NO 28 NO NO TCGA-E1-A7YW-F61613 TCGA-E1-A7YW TCGA-E1-A7YW-01A -10571 4072 1120 0 613 13 NO NO NO Seizures 91 - 180 Days Additional New Tumor Event Progressive Disease NO 2014-8-15 MALE NO NO Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES NO 100 NO 90 Left NO NO NO NO NO G2 YES true No TCGA-E1-A7YW.821A037A-B968-4A91-9D3F-6DD2BD09B05F.pdf A7YW Pre-Adjuvant Therapy WITH TUMOR YES Progressive Disease YES Primary Tumor 01 YES NO Cerebral Cortex YES NO YES E1 Supratentorial, Parietal Lobe Central nervous system A NO DECEASED 2002 TCGA-E1-A7YW-01 0F937E94-FB45-4AC5-A3D2-FAF6E86299C5 TCGA-E1-A7YW-01A-11D-A34J-08 TCGA-E1-A7YW-01A-11D-A34I-01 5db0c888-986f-4a3e-af64-c15ad413e14d TCGA-E1-A7YW-01 TCGA-E1-A7YW-01 5db0c888-986f-4a3e-af64-c15ad413e14d TCGA-E1-A7YW-01 TCGA-E1-A7YW-01A-11D-A34K-05 5db0c888-986f-4a3e-af64-c15ad413e14d 5db0c888-986f-4a3e-af64-c15ad413e14d TCGA-E1-A7YW-01A-11D-A34I-01 TCGA-E1-A7YW-01A-11D-A34J-08 +TCGA-E1-A7YY-01 TCGA-E1-A7YY-01 TCGA-E1-A7YY TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain YES NO NO NO 27 NO YES TCGA-E1-A7YY-F61637 TCGA-E1-A7YY TCGA-E1-A7YY-01A -9867 5621 4445 0 4266 428 NO Seizures 0 - 30 Days Additional New Tumor Event Progressive Disease NO 2014-8-15 FEMALE NO NO Oligodendroglioma NO No C71.0 9450/3 C71.0 YES NO 140 NO 100 Right NO NO NO NO NO G2 YES true No TCGA-E1-A7YY.EBCF38D8-E69D-4F12-B7F5-29578E560B44.pdf A7YY Pre-Adjuvant Therapy WITH TUMOR YES YES Stable Disease YES Primary Tumor 01 YES NO Not listed in Medical Record YES NO YES E1 Supratentorial, Frontal Lobe Central nervous system A NO DECEASED 1998 TCGA-E1-A7YY-01 F9C89236-7F2F-422B-8949-57EB793A21E5 TCGA-E1-A7YY-01A-11D-A34J-08 TCGA-E1-A7YY-01A-11D-A34I-01 701fe7aa-5ad5-489d-be6f-54a39afe9e0e TCGA-E1-A7YY-01 TCGA-E1-A7YY-01 701fe7aa-5ad5-489d-be6f-54a39afe9e0e TCGA-E1-A7YY-01 TCGA-E1-A7YY-01A-11D-A34K-05 701fe7aa-5ad5-489d-be6f-54a39afe9e0e 701fe7aa-5ad5-489d-be6f-54a39afe9e0e TCGA-E1-A7YY-01A-11D-A34I-01 TCGA-E1-A7YY-01A-11D-A34J-08 +TCGA-E1-A7Z2-01 TCGA-E1-A7Z2-01 TCGA-E1-A7Z2 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain YES YES NO NO 58 NO NO TCGA-E1-A7Z2-F61680 TCGA-E1-A7Z2 TCGA-E1-A7Z2-01A -21341 614 398 0 269 39 NO YES NO Seizures 31 - 90 Days Additional New Tumor Event Progressive Disease YES clams 2014-8-15 FEMALE NO NO Oligodendroglioma NO No C71.0 9450/3 C71.0 YES NO 160 NO 80 Left NO IHC YES NO NO NO NO G2 YES true No TCGA-E1-A7Z2.2729C641-D25B-4C92-94C8-0BC4C7CE74DE.pdf A7Z2 Pre-Adjuvant Therapy WITH TUMOR YES YES Progressive Disease NO Primary Tumor 01 YES NO Cerebral Cortex YES NO YES E1 Supratentorial, Frontal Lobe Central nervous system A NO DECEASED 2012 TCGA-E1-A7Z2-01 F16913E3-DB1D-4835-8A7E-B281C81C8C31 TCGA-E1-A7Z2-01A-21D-A34J-08 TCGA-E1-A7Z2-01A-21D-A34I-01 4976d0a2-11d3-4132-96c9-b418ffe0e5e7 TCGA-E1-A7Z2-01 TCGA-E1-A7Z2-01 4976d0a2-11d3-4132-96c9-b418ffe0e5e7 TCGA-E1-A7Z2-01 TCGA-E1-A7Z2-01A-21D-A34K-05 4976d0a2-11d3-4132-96c9-b418ffe0e5e7 4976d0a2-11d3-4132-96c9-b418ffe0e5e7 TCGA-E1-A7Z2-01A-21D-A34I-01 TCGA-E1-A7Z2-01A-21D-A34J-08 +TCGA-E1-A7Z3-01 TCGA-E1-A7Z3-01 TCGA-E1-A7Z3 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain NO NO NO 31 NO TCGA-E1-A7Z3-F61703 TCGA-E1-A7Z3 TCGA-E1-A7Z3-01A -11330 7912 2235 0 2072 NO Seizures 0 - 30 Days Additional New Tumor Event Progressive Disease 2014-8-18 FEMALE NO Astrocytoma NO No C71.0 9400/3 C71.0 YES NO 260 NO Right NO NO NO NO G2 YES true No TCGA-E1-A7Z3.A522B02B-1349-44FD-9AEA-3FDA3BBFE4D8.pdf A7Z3 WITH TUMOR YES Progressive Disease YES Primary Tumor 01 YES NO Cerebral Cortex YES NO YES E1 Supratentorial, Parietal Lobe Central nervous system A NO DECEASED 1992 TCGA-E1-A7Z3-01 119ECD3D-45C2-488C-815F-191BE2BF5665 TCGA-E1-A7Z3-01A-11D-A34J-08 TCGA-E1-A7Z3-01A-11D-A34I-01 6967eb73-0b93-48d3-bb43-583652eef2a4 TCGA-E1-A7Z3-01 TCGA-E1-A7Z3-01 6967eb73-0b93-48d3-bb43-583652eef2a4 TCGA-E1-A7Z3-01 TCGA-E1-A7Z3-01A-11D-A34K-05 6967eb73-0b93-48d3-bb43-583652eef2a4 6967eb73-0b93-48d3-bb43-583652eef2a4 TCGA-E1-A7Z3-01A-11D-A34I-01 TCGA-E1-A7Z3-01A-11D-A34J-08 +TCGA-E1-A7Z4-01 TCGA-E1-A7Z4-01 TCGA-E1-A7Z4 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain NO NO NO NO 35 NO NO TCGA-E1-A7Z4-F61765 TCGA-E1-A7Z4 -12849 4412 0 4339 974 NO YES NO Headaches 31 - 90 Days Additional New Tumor Event Progressive Disease NO 2014-8-18 MALE NO YES Astrocytoma NO No C71.0 9400/3 C71.0 YES NO 90 Left YES IHC YES NO NO NO NO G2 YES No A7Z4 Post-Adjuvant Therapy WITH TUMOR YES YES Progressive Disease YES Primary Tumor 01 NO NO Not listed in Medical Record YES NO YES E1 Supratentorial, Frontal Lobe Central nervous system YES DECEASED 1999 TCGA-E1-A7Z4-01 TCGA-E1-A7Z4-01A-11D-A34J-08 TCGA-E1-A7Z4-01A-11D-A34I-01 e53c6e65-37e8-4523-b336-d1bc89381a80 TCGA-E1-A7Z4-01 TCGA-E1-A7Z4-01 e53c6e65-37e8-4523-b336-d1bc89381a80 TCGA-E1-A7Z4-01 TCGA-E1-A7Z4-01A-11D-A34K-05 e53c6e65-37e8-4523-b336-d1bc89381a80 e53c6e65-37e8-4523-b336-d1bc89381a80 TCGA-E1-A7Z4-01A-11D-A34I-01 TCGA-E1-A7Z4-01A-11D-A34J-08 +TCGA-E1-A7Z6-01 TCGA-E1-A7Z6-01 TCGA-E1-A7Z6 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain NO NO NO NO 41 NO NO TCGA-E1-A7Z6-F61776 TCGA-E1-A7Z6 TCGA-E1-A7Z6-01A -14985 1588 984 0 971 19 NO YES NO Headaches > 181 Days Additional New Tumor Event Progressive Disease NO 2014-8-19 FEMALE NO YES Astrocytoma NO No C71.0 9400/3 C71.0 YES NO 160 NO 90 Right YES IHC YES NO NO NO NO G2 YES true No TCGA-E1-A7Z6.096B03E5-82A9-41E6-BC6D-CA25D748EBDC.pdf A7Z6 Pre-Adjuvant Therapy WITH TUMOR NO YES Progressive Disease YES Primary Tumor 01 NO NO Not listed in Medical Record YES NO YES E1 Supratentorial, Frontal Lobe Central nervous system A NO DECEASED 2009 TCGA-E1-A7Z6-01 8F935C1F-D18E-4476-A8B0-C88DD45E6992 TCGA-E1-A7Z6-01A-11D-A34J-08 TCGA-E1-A7Z6-01A-11D-A34I-01 1adce1ae-0823-4259-82bf-2b8b72827d58 TCGA-E1-A7Z6-01 TCGA-E1-A7Z6-01 1adce1ae-0823-4259-82bf-2b8b72827d58 TCGA-E1-A7Z6-01 TCGA-E1-A7Z6-01A-11D-A34K-05 1adce1ae-0823-4259-82bf-2b8b72827d58 1adce1ae-0823-4259-82bf-2b8b72827d58 TCGA-E1-A7Z6-01A-11D-A34I-01 TCGA-E1-A7Z6-01A-11D-A34J-08 +TCGA-EZ-7264-01 TCGA-EZ-7264-01 TCGA-EZ-7264 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 47 NO NO TCGA-EZ-7264-F66594 TCGA-EZ-7264 TCGA-EZ-7264-01A -17432 0 1201 NO NO NO Mental Status Changes 0 - 30 Days Scheduled Follow-up Submission Stable Disease NO 2014-10-21 FEMALE NO NO Oligodendroglioma NO No C71.0 9450/3 C71.0 YES 0.9 NO Right 1 NO YES NO NO G2 NO No TCGA-EZ-7264.1a18641e-75f5-4601-8d9b-4536805a9aeb.pdf 7264 WITH TUMOR YES YES Stable Disease NO Primary Tumor 01 YES NO 0.5 White Matter NO YES NO EZ Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2011 TCGA-EZ-7264-01A-11D-2024-08 TCGA-EZ-7264-01 05FC070A-6529-4621-BCA4-38356E9172F2 TCGA-EZ-7264-01A-11D-2024-08 TCGA-EZ-7264-01A-11D-2023-01 c34a63cc-746b-4502-a1ff-d7bece07b679 TCGA-EZ-7264-01 TCGA-EZ-7264-01 TCGA-EZ-7264-01A-11D-2024-08 c34a63cc-746b-4502-a1ff-d7bece07b679 TCGA-EZ-7264-01 TCGA-EZ-7264-01 TCGA-EZ-7264-01A-11D-2024-08 TCGA-EZ-7264-01A-11D-2025-05 c34a63cc-746b-4502-a1ff-d7bece07b679 c34a63cc-746b-4502-a1ff-d7bece07b679 TCGA-EZ-7264-01A-11D-2023-01 TCGA-EZ-7264-01A-11D-2024-08 +TCGA-F6-A8O3-01 TCGA-F6-A8O3-01 TCGA-F6-A8O3 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 34 NO NO TCGA-F6-A8O3-F67155 TCGA-F6-A8O3 TCGA-F6-A8O3-01A -12578 105 0 7 NO NO NO Headaches Scheduled Follow-up Submission NO 2014-11-24 MALE NO YES Oligodendroglioma NO No C71.0 9450/3 C71.0 YES NO 550 NO NO YES NO NO NO G2 NO true No TCGA-F6-A8O3.79D96BBD-E399-4928-A86A-FF5086045841.pdf A8O3 TUMOR FREE NO NO Complete Remission/Response Primary Tumor 01 NO NO Not listed in Medical Record YES NO F6 Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2013 TCGA-F6-A8O3-01 5C1B8741-FF7D-42FA-AA90-A31403CE2167 TCGA-F6-A8O3-01A-11D-A36O-08 TCGA-F6-A8O3-01A-11D-A36N-01 c7a90fef-6f1f-49ea-a8b8-b0e03e7584b1 TCGA-F6-A8O3-01 TCGA-F6-A8O3-01 c7a90fef-6f1f-49ea-a8b8-b0e03e7584b1 TCGA-F6-A8O3-01 TCGA-F6-A8O3-01A-11D-A368-05 c7a90fef-6f1f-49ea-a8b8-b0e03e7584b1 c7a90fef-6f1f-49ea-a8b8-b0e03e7584b1 TCGA-F6-A8O3-01A-11D-A36N-01 TCGA-F6-A8O3-01A-11D-A36O-08 +TCGA-F6-A8O4-01 TCGA-F6-A8O4-01 TCGA-F6-A8O4 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 44 NO NO TCGA-F6-A8O4-F67156 TCGA-F6-A8O4 TCGA-F6-A8O4-01A -16202 100 0 6 NO NO NO Headaches Scheduled Follow-up Submission NO 2014-11-24 MALE NO YES Astrocytoma NO No C71.9 9400/3 C71.9 YES NO 970 NO Left NO YES NO NO NO G2 NO true No TCGA-F6-A8O4.4CDE1CF9-1B5E-4838-8417-916F1E8E8D97.pdf A8O4 TUMOR FREE NO NO Complete Remission/Response Primary Tumor 01 NO NO Not listed in Medical Record YES NO F6 Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2013 TCGA-F6-A8O4-01 5FBA6F55-5FD7-4C06-8AB1-0CE621E53CDB TCGA-F6-A8O4-01A-11D-A36O-08 TCGA-F6-A8O4-01A-11D-A36N-01 f46aa5a4-ff0e-42cf-aea9-fd776ebf04cd TCGA-F6-A8O4-01 TCGA-F6-A8O4-01 f46aa5a4-ff0e-42cf-aea9-fd776ebf04cd TCGA-F6-A8O4-01 TCGA-F6-A8O4-01A-11D-A368-05 f46aa5a4-ff0e-42cf-aea9-fd776ebf04cd f46aa5a4-ff0e-42cf-aea9-fd776ebf04cd TCGA-F6-A8O4-01A-11D-A36N-01 TCGA-F6-A8O4-01A-11D-A36O-08 +TCGA-FG-5962-01 TCGA-FG-5962-01 TCGA-FG-5962 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 54 NO NO TCGA-FG-5962-F43040 TCGA-FG-5962 TCGA-FG-5962-01B -19818 0 1453 NO YES NO > 20 Years Visual Changes > 181 Days Scheduled Follow-up Submission Stable Disease NO 2013-5-9 MALE YES NO Oligodendroglioma NO No C71.0 9451/3 C71.0 YES NO 1 NO Left NO 1 NO NO NO NO G3 NO No TCGA-FG-5962.1ed7f628-f222-41e4-a83c-b0884c4c4d81.pdf 5962 WITH TUMOR NO NO Stable Disease YES Primary Tumor 01 NO NO 0.5 White Matter YES NO YES FG Supratentorial, Occipital Lobe Central nervous system B YES LIVING 2009 TCGA-FG-5962-01B-11D-1893-08 TCGA-FG-5962-01 3F0A1BA9-51EA-43A2-8AAA-1674707ABAB7 TCGA-FG-5962-01B-11D-1893-08 TCGA-FG-5962-01B-11D-1892-01 2480b239-1454-4f49-9c13-381b9f0d0506 TCGA-FG-5962-01 TCGA-FG-5962-01 TCGA-FG-5962-01B-11D-1893-08 2480b239-1454-4f49-9c13-381b9f0d0506 TCGA-FG-5962-01 TCGA-FG-5962-01 TCGA-FG-5962-01B-11D-1893-08 TCGA-FG-5962-01B-11D-1894-05 2480b239-1454-4f49-9c13-381b9f0d0506 2480b239-1454-4f49-9c13-381b9f0d0506 TCGA-FG-5962-01B-11D-1892-01 TCGA-FG-5962-01B-11D-1893-08 +TCGA-FG-5963-01 TCGA-FG-5963-01 TCGA-FG-5963 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain YES NO NO 23 YES NO TCGA-FG-5963-F42259 TCGA-FG-5963 TCGA-FG-5963-01A -8571 775 0 547 497 0 NO YES NO 12 - 20 Years 12 - 20 Years Seizures 0 - 30 Days Scheduled Follow-up Submission Progressive Disease NO 2013-5-7 MALE NO NO Astrocytoma NO No C71.0 9401/3 C71.0 YES NO 0.9 NO 90 Right NO 0.9 NO YES YES NO G3 YES No TCGA-FG-5963.6BDCE0AC-CDC9-45A2-B796-7A06284251FB.pdf 5963 Post-Adjuvant Therapy WITH TUMOR YES Progressive Disease YES Primary Tumor 01 YES NO 0.7 White Matter YES NO YES FG Supratentorial, Frontal Lobe Central nervous system A NO DECEASED 2009 TCGA-FG-5963-01A-11D-1705-08 TCGA-FG-5963-01 C93FC2C9-D507-4079-94BE-B1CB1C4BE6B9 TCGA-FG-5963-01A-11D-1705-08 TCGA-FG-5963-01A-11D-1704-01 b6bdb9e4-c456-4d5b-8aa1-22c8c33b77ef TCGA-FG-5963-01 TCGA-FG-5963-01 TCGA-FG-5963-01A-11D-1705-08 b6bdb9e4-c456-4d5b-8aa1-22c8c33b77ef TCGA-FG-5963-01 TCGA-FG-5963-01 TCGA-FG-5963-01A-11D-1705-08 TCGA-FG-5963-01A-11D-1706-05 b6bdb9e4-c456-4d5b-8aa1-22c8c33b77ef b6bdb9e4-c456-4d5b-8aa1-22c8c33b77ef TCGA-FG-5963-01A-11D-1704-01 TCGA-FG-5963-01A-11D-1705-08 +TCGA-FG-5963-02 TCGA-FG-5963-02 TCGA-FG-5963 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain YES NO NO 23 YES NO TCGA-FG-5963-F42259 TCGA-FG-5963 TCGA-FG-5963-02A -8571 1095 775 0 547 497 0 NO YES NO 12 - 20 Years 12 - 20 Years Seizures 0 - 30 Days Scheduled Follow-up Submission Progressive Disease NO 2013-5-7 MALE NO NO Astrocytoma NO No C71.0 9401/3 C71.0 YES NO 130 NO 90 Right NO NO YES YES NO G3 YES false No TCGA-FG-5963.6BDCE0AC-CDC9-45A2-B796-7A06284251FB.pdf 5963 Post-Adjuvant Therapy WITH TUMOR YES Progressive Disease YES Recurrent Tumor 02 YES NO White Matter YES NO YES FG Supratentorial, Frontal Lobe Central nervous system A NO DECEASED 2009 5ADBA17E-856C-4C74-B31D-88B0EC3A1B16 TCGA-FG-5963-02A-12D-A29Q-08 d231f3e4-48e2-4e94-a995-dcbfc9f0d471 TCGA-FG-5963-02 TCGA-FG-5963-02 d231f3e4-48e2-4e94-a995-dcbfc9f0d471 TCGA-FG-5963-02A-12D-A29T-05 d231f3e4-48e2-4e94-a995-dcbfc9f0d471 d231f3e4-48e2-4e94-a995-dcbfc9f0d471 +TCGA-FG-5964-01 TCGA-FG-5964-01 TCGA-FG-5964 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 62 NO NO TCGA-FG-5964-F63736 TCGA-FG-5964 TCGA-FG-5964-01A -22735 0 1588 NO YES NO > 20 Years > 20 Years Seizures 0 - 30 Days Scheduled Follow-up Submission Stable Disease YES Processed food 2014-8-15 MALE NO NO Oligodendroglioma NO No C71.0 9450/3 C71.0 YES NO 0.7 NO Left NO 0.7 NO NO YES NO G2 NO No TCGA-FG-5964.bcaff494-0ef3-42b0-8d93-54d6a8598397.pdf 5964 WITH TUMOR YES YES Stable Disease YES Primary Tumor 01 YES NO 0.6 White Matter NO NO YES FG Supratentorial, Parietal Lobe Central nervous system A NO LIVING 2010 TCGA-FG-5964-01A-11D-1705-08 TCGA-FG-5964-01 E32D1F93-F368-4E5A-8D19-BB480B05A471 TCGA-FG-5964-01A-11D-1705-08 TCGA-FG-5964-01A-11D-1704-01 69f6df2f-7cd7-4477-b464-1fd06bd1e9c8 TCGA-FG-5964-01 TCGA-FG-5964-01 TCGA-FG-5964-01A-11D-1705-08 69f6df2f-7cd7-4477-b464-1fd06bd1e9c8 TCGA-FG-5964-01 TCGA-FG-5964-01 TCGA-FG-5964-01A-11D-1705-08 TCGA-FG-5964-01A-11D-1706-05 69f6df2f-7cd7-4477-b464-1fd06bd1e9c8 69f6df2f-7cd7-4477-b464-1fd06bd1e9c8 TCGA-FG-5964-01A-11D-1704-01 TCGA-FG-5964-01A-11D-1705-08 +TCGA-FG-5965-01 TCGA-FG-5965-01 TCGA-FG-5965 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain YES NO YES NO 39 NO NO TCGA-FG-5965-F32837 TCGA-FG-5965 TCGA-FG-5965-01B 1069 -14249 1120 0 979 1035 259 NO YES NO Seizures 0 - 30 Days Additional New Tumor Event Progressive Disease NO 2012-6-13 FEMALE NO YES Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES NO 1 NO 90 Right NO 1.1 NO NO NO G2 YES No 5965 Post-Adjuvant Therapy WITH TUMOR NO NO Progressive Disease NO Primary Tumor 01 YES NO 0.8 White Matter YES NO YES FG Supratentorial, Frontal Lobe Central nervous system B YES DECEASED 2008 TCGA-FG-5965-01B-11D-1893-08 TCGA-FG-5965-01 5DAF0C0A-26D2-41AD-B469-782D0212BC65 TCGA-FG-5965-01B-11D-1893-08 TCGA-FG-5965-01B-11D-1892-01 54cd0c71-61e8-47b1-a03b-9badeac15ca2 TCGA-FG-5965-01 TCGA-FG-5965-01 TCGA-FG-5965-01B-11D-1893-08 54cd0c71-61e8-47b1-a03b-9badeac15ca2 TCGA-FG-5965-01 TCGA-FG-5965-01 TCGA-FG-5965-01B-11D-1893-08 TCGA-FG-5965-01B-11D-1894-05 54cd0c71-61e8-47b1-a03b-9badeac15ca2 54cd0c71-61e8-47b1-a03b-9badeac15ca2 TCGA-FG-5965-01B-11D-1892-01 TCGA-FG-5965-01B-11D-1893-08 +TCGA-FG-5965-02 TCGA-FG-5965-02 TCGA-FG-5965 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain YES NO YES NO 39 NO NO TCGA-FG-5965-F32837 TCGA-FG-5965 TCGA-FG-5965-02B 1069 -14249 1437 1120 0 979 1035 259 NO YES NO Seizures 0 - 30 Days Additional New Tumor Event Progressive Disease NO 2012-6-13 FEMALE NO YES Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES NO 120 NO 90 Right NO NO NO NO G2 YES false No TCGA-FG-5965.DD2349DD-E128-4C2D-962B-F8644121FB16.pdf 5965 Post-Adjuvant Therapy WITH TUMOR NO NO Progressive Disease NO Recurrent Tumor 02 YES NO White Matter YES NO YES FG Supratentorial, Frontal Lobe Central nervous system B YES DECEASED 2008 TCGA-FG-5965-02B-11D-A29Q-08,TCGA-FG-5965-02A-11D-A29Q-08 74361c55-c785-4d24-8687-be8adbd75de7,013bac31-4670-460a-9108-7b4ae57a2e21 TCGA-FG-5965-02 TCGA-FG-5965-02 013bac31-4670-460a-9108-7b4ae57a2e21,74361c55-c785-4d24-8687-be8adbd75de7 TCGA-FG-5965-02A-11D-A29T-05,TCGA-FG-5965-02B-11D-A29T-05 013bac31-4670-460a-9108-7b4ae57a2e21,74361c55-c785-4d24-8687-be8adbd75de7 013bac31-4670-460a-9108-7b4ae57a2e21,74361c55-c785-4d24-8687-be8adbd75de7 +TCGA-FG-6688-01 TCGA-FG-6688-01 TCGA-FG-6688 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain YES NO NO NO 59 NO NO TCGA-FG-6688-F32791 TCGA-FG-6688 TCGA-FG-6688-01A -21745 0 571 405 405 NO YES NO Seizures 0 - 30 Days Additional New Tumor Event Stable Disease NO 2012-6-12 FEMALE NO NO Astrocytoma NO No C71.0 9401/3 C71.0 YES NO 1 NO 50 Left NO 1 NO NO NO G3 YES No TCGA-FG-6688.b889306a-615a-4c0e-8acd-6bfbf08c8bf4.pdf 6688 Post-Adjuvant Therapy WITH TUMOR YES YES Progressive Disease YES Primary Tumor 01 YES YES 0.8 Not listed in Medical Record YES YES NO FG Supratentorial, Parietal Lobe Central nervous system A YES LIVING 2010 TCGA-FG-6688-01A-11D-1893-08 TCGA-FG-6688-01 28B3A74E-96A2-4E61-8C5B-DB057B5384CC TCGA-FG-6688-01A-11D-1893-08 TCGA-FG-6688-01A-11D-1892-01 3cf6d88f-d583-448e-a3c1-fd8131738114 TCGA-FG-6688-01 TCGA-FG-6688-01 TCGA-FG-6688-01A-11D-1893-08 3cf6d88f-d583-448e-a3c1-fd8131738114 TCGA-FG-6688-01 TCGA-FG-6688-01 TCGA-FG-6688-01A-11D-1893-08 TCGA-FG-6688-01A-11D-1894-05 3cf6d88f-d583-448e-a3c1-fd8131738114 3cf6d88f-d583-448e-a3c1-fd8131738114 TCGA-FG-6688-01A-11D-1892-01 TCGA-FG-6688-01A-11D-1893-08 +TCGA-FG-6689-01 TCGA-FG-6689-01 TCGA-FG-6689 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain NO 30 YES cats NO TCGA-FG-6689-F43039 TCGA-FG-6689 TCGA-FG-6689-01A -11312 0 190 218 -10 NO YES NO < 12 Years > 20 Years Headaches 31 - 90 Days Scheduled Follow-up Submission NO 2013-5-20 MALE YES YES Astrocytoma NO No C71.0 9400/3 C71.0 YES NO 1 NO 70 Right NO 1 YES YES YES NO G2 YES No TCGA-FG-6689.cc32ee60-c475-48dd-acd3-7e9c817507ba.pdf 6689 Preoperative WITH TUMOR NO YES Progressive Disease YES Primary Tumor 01 NO NO 1 Not listed in Medical Record NO YES NO FG Supratentorial, Frontal Lobe Central nervous system A YES LIVING 2011 TCGA-FG-6689-01A-11D-1893-08 TCGA-FG-6689-01 0C043EE0-C617-4183-8322-311FB0405935 TCGA-FG-6689-01A-11D-1893-08 TCGA-FG-6689-01A-11D-1892-01 625da09e-ed21-4b10-95f2-c889171194d1 TCGA-FG-6689-01 TCGA-FG-6689-01 TCGA-FG-6689-01A-11D-1893-08 625da09e-ed21-4b10-95f2-c889171194d1 TCGA-FG-6689-01 TCGA-FG-6689-01 TCGA-FG-6689-01A-11D-1893-08 TCGA-FG-6689-01A-11D-1894-05 625da09e-ed21-4b10-95f2-c889171194d1 625da09e-ed21-4b10-95f2-c889171194d1 TCGA-FG-6689-01A-11D-1892-01 TCGA-FG-6689-01A-11D-1893-08 +TCGA-FG-6690-01 TCGA-FG-6690-01 TCGA-FG-6690 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 70 NO NO TCGA-FG-6690-F63742 TCGA-FG-6690 TCGA-FG-6690-01A -25667 0 1294 -23 NO NO NO Seizures 0 - 30 Days Scheduled Follow-up Submission Stable Disease NO 2014-8-15 MALE NO NO Oligodendroglioma NO No C71.0 9450/3 C71.0 YES NO 0.6 NO 90 Left NO 1.7 NO NO NO NO G2 NO No TCGA-FG-6690.d4c3d026-59a3-4b34-9d49-afd53d2d783d.pdf 6690 Preoperative WITH TUMOR YES YES Stable Disease YES Primary Tumor 01 YES NO 0.5 Not listed in Medical Record NO YES NO FG Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2011 TCGA-FG-6690-01A-11D-1893-08 TCGA-FG-6690-01 4BC64B90-9748-4FDC-937A-207A25276B92 TCGA-FG-6690-01A-11D-1893-08 TCGA-FG-6690-01A-11D-1892-01 d90e0cc1-db21-49e6-87f4-a3328ffc1396 TCGA-FG-6690-01 TCGA-FG-6690-01 TCGA-FG-6690-01A-11D-1893-08 d90e0cc1-db21-49e6-87f4-a3328ffc1396 TCGA-FG-6690-01 TCGA-FG-6690-01 TCGA-FG-6690-01A-11D-1893-08 TCGA-FG-6690-01A-11D-1894-05 d90e0cc1-db21-49e6-87f4-a3328ffc1396 d90e0cc1-db21-49e6-87f4-a3328ffc1396 TCGA-FG-6690-01A-11D-1892-01 TCGA-FG-6690-01A-11D-1893-08 +TCGA-FG-6691-01 TCGA-FG-6691-01 TCGA-FG-6691 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain YES YES YES 23 NO NO TCGA-FG-6691-F63744 TCGA-FG-6691 TCGA-FG-6691-01A 984 -8403 0 1257 913 -9 NO NO NO Headaches 0 - 30 Days Scheduled Follow-up Submission Stable Disease NO 2014-8-15 FEMALE NO YES Astrocytoma NO No C71.0 9400/3 C71.0 YES NO 0.9 NO 100 Right NO 1.1 NO NO NO NO G2 YES No TCGA-FG-6691.799a7cc3-b435-4208-9996-f4360f80e5be.pdf 6691 Preoperative WITH TUMOR NO NO Complete Remission/Response NO Primary Tumor 01 NO NO 0.9 White Matter NO YES NO FG Supratentorial, Temporal Lobe Central nervous system A NO LIVING 2011 TCGA-FG-6691-01A-11D-1893-08 TCGA-FG-6691-01 AD21C2CE-0D1A-4AA1-A185-3389633E6690 TCGA-FG-6691-01A-11D-1893-08 TCGA-FG-6691-01A-11D-1892-01 58c05288-0bc7-4e19-8055-5284c2714c21 TCGA-FG-6691-01 TCGA-FG-6691-01 TCGA-FG-6691-01A-11D-1893-08 58c05288-0bc7-4e19-8055-5284c2714c21 TCGA-FG-6691-01 TCGA-FG-6691-01 TCGA-FG-6691-01A-11D-1893-08 TCGA-FG-6691-01A-11D-1894-05 58c05288-0bc7-4e19-8055-5284c2714c21 58c05288-0bc7-4e19-8055-5284c2714c21 TCGA-FG-6691-01A-11D-1892-01 TCGA-FG-6691-01A-11D-1893-08 +TCGA-FG-6692-01 TCGA-FG-6692-01 TCGA-FG-6692 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 63 TCGA-FG-6692-F41569 TCGA-FG-6692 -23374 561 0 126 42 1 YES NO Seizures 0 - 30 Days Scheduled Follow-up Submission 2013-3-21 MALE NO Oligodendroglioma NO No C71.0 9451/3 C71.0 YES NO Right NO NO YES NO G3 No 6692 Pre-Adjuvant Therapy WITH TUMOR YES NO Stable Disease YES Primary Tumor 01 YES NO Not listed in Medical Record YES YES NO FG Supratentorial, Frontal Lobe Central nervous system NO DECEASED 2011 TCGA-FG-6692-01A-11D-1893-08 TCGA-FG-6692-01 TCGA-FG-6692-01A-11D-1893-08 TCGA-FG-6692-01A-11D-1892-01 fca6dae9-687d-418d-bf8b-61bbf6927f61 TCGA-FG-6692-01 TCGA-FG-6692-01 TCGA-FG-6692-01A-11D-1893-08 fca6dae9-687d-418d-bf8b-61bbf6927f61 TCGA-FG-6692-01 TCGA-FG-6692-01 TCGA-FG-6692-01A-11D-1893-08 TCGA-FG-6692-01A-11D-1894-05 fca6dae9-687d-418d-bf8b-61bbf6927f61 fca6dae9-687d-418d-bf8b-61bbf6927f61 TCGA-FG-6692-01A-11D-1892-01 TCGA-FG-6692-01A-11D-1893-08 +TCGA-FG-7634-01 TCGA-FG-7634-01 TCGA-FG-7634 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 28 NO NO TCGA-FG-7634-F41580 TCGA-FG-7634 TCGA-FG-7634-01A -10476 0 467 NO YES NO Seizures 0 - 30 Days Scheduled Follow-up Submission NO 2013-3-21 MALE NO NO Oligodendroglioma NO No C71.0 9450/3 C71.0 YES NO 0.9 NO Left NO 1 YES NO NO NO G2 No TCGA-FG-7634.b6184ded-a667-44ea-a0d3-32ec6df38516.pdf 7634 WITH TUMOR YES NO Stable Disease Primary Tumor 01 YES NO 0.6 Not listed in Medical Record YES NO FG Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2008 TCGA-FG-7634-01A-11D-2086-08 TCGA-FG-7634-01 1FB04AAB-2F42-41E4-8D3D-FDBDF42332EF TCGA-FG-7634-01A-11D-2086-08 TCGA-FG-7634-01A-11D-2085-01 afbe6025-3c74-403b-ad84-c89f312d50c5 TCGA-FG-7634-01 TCGA-FG-7634-01 TCGA-FG-7634-01A-11D-2086-08 afbe6025-3c74-403b-ad84-c89f312d50c5 TCGA-FG-7634-01 TCGA-FG-7634-01 TCGA-FG-7634-01A-11D-2086-08 TCGA-FG-7634-01A-11D-2087-05 afbe6025-3c74-403b-ad84-c89f312d50c5 afbe6025-3c74-403b-ad84-c89f312d50c5 TCGA-FG-7634-01A-11D-2085-01 TCGA-FG-7634-01A-11D-2086-08 +TCGA-FG-7636-01 TCGA-FG-7636-01 TCGA-FG-7636 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 48 NO NO TCGA-FG-7636-F43425 TCGA-FG-7636 TCGA-FG-7636-01A -17843 0 544 -7 0 NO NO NO Headaches > 181 Days Scheduled Follow-up Submission Complete Remission/Response NO 2013-5-21 MALE NO YES Astrocytoma NO No C71.0 9401/3 C71.0 YES NO 0.6 NO 90 Left NO 1.1 NO YES NO YES G3 NO No TCGA-FG-7636.f257e22a-45d4-4c1d-b18e-8dcd42ac04b4.pdf 7636 Preoperative TUMOR FREE YES YES Complete Remission/Response YES Primary Tumor 01 YES YES 0.4 Not listed in Medical Record YES YES NO FG Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2011 TCGA-FG-7636-01A-11D-2086-08 TCGA-FG-7636-01 8C4D4CDB-A109-4EA0-8E2A-E820769B5935 TCGA-FG-7636-01A-11D-2086-08 TCGA-FG-7636-01A-11D-2085-01 89e158ef-3b5a-4d90-9206-b2200a5a343e TCGA-FG-7636-01 TCGA-FG-7636-01 TCGA-FG-7636-01A-11D-2086-08 89e158ef-3b5a-4d90-9206-b2200a5a343e TCGA-FG-7636-01 TCGA-FG-7636-01 TCGA-FG-7636-01A-11D-2086-08 TCGA-FG-7636-01A-11D-2087-05 89e158ef-3b5a-4d90-9206-b2200a5a343e 89e158ef-3b5a-4d90-9206-b2200a5a343e TCGA-FG-7636-01A-11D-2085-01 TCGA-FG-7636-01A-11D-2086-08 +TCGA-FG-7637-01 TCGA-FG-7637-01 TCGA-FG-7637 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 49 NO NO TCGA-FG-7637-F41579 TCGA-FG-7637 TCGA-FG-7637-01A -18084 0 1219 NO YES NO > 20 Years Seizures > 181 Days Scheduled Follow-up Submission Stable Disease NO 2013-3-21 MALE YES NO Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES NO 0.6 NO Right NO 1 NO YES NO NO G2 NO No TCGA-FG-7637.9fdc723f-1cba-4660-8b6e-9c81e86a24e1.pdf 7637 WITH TUMOR YES NO Stable Disease NO Primary Tumor 01 YES NO 0.5 Not listed in Medical Record NO YES NO FG Supratentorial, Temporal Lobe Central nervous system A NO LIVING 2009 TCGA-FG-7637-01A-11D-2086-08 TCGA-FG-7637-01 E2009B7D-065B-49B8-8BB1-883594016A1F TCGA-FG-7637-01A-11D-2086-08 8204b99d-4224-4bb9-b297-413956b203ee TCGA-FG-7637-01 TCGA-FG-7637-01 TCGA-FG-7637-01A-11D-2086-08 8204b99d-4224-4bb9-b297-413956b203ee TCGA-FG-7637-01 TCGA-FG-7637-01A-11D-2086-08 TCGA-FG-7637-01A-11D-2087-05 8204b99d-4224-4bb9-b297-413956b203ee 8204b99d-4224-4bb9-b297-413956b203ee TCGA-FG-7637-01A-11D-2086-08 +TCGA-FG-7638-01 TCGA-FG-7638-01 TCGA-FG-7638 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain YES NO NO 31 NO NO TCGA-FG-7638-F43363 TCGA-FG-7638 TCGA-FG-7638-01B -11528 0 686 407 -13 0 NO NO NO Headaches 0 - 30 Days Scheduled Follow-up Submission Stable Disease NO 2013-5-20 FEMALE NO YES Oligodendroglioma NO No C71.0 9451/3 C71.0 YES NO 1 NO 100 Left NO 1.3 NO NO NO YES G3 YES No TCGA-FG-7638.2a94afdc-2504-4b73-8b1e-c9be3183654d.pdf 7638 Preoperative WITH TUMOR YES YES Stable Disease YES Primary Tumor 01 YES NO 0.6 Not listed in Medical Record YES YES NO FG Supratentorial, Frontal Lobe Central nervous system B NO LIVING 2011 TCGA-FG-7638-01B-11D-2086-08 TCGA-FG-7638-01 A7385FA8-9716-4318-BDDD-59D4A33C6F4A TCGA-FG-7638-01B-11D-2086-08 TCGA-FG-7638-01B-11D-2085-01 11b3ce08-d237-4e4e-8656-a235d3964f8f TCGA-FG-7638-01 TCGA-FG-7638-01 TCGA-FG-7638-01B-11D-2086-08 11b3ce08-d237-4e4e-8656-a235d3964f8f TCGA-FG-7638-01 TCGA-FG-7638-01 TCGA-FG-7638-01B-11D-2086-08 TCGA-FG-7638-01B-11D-2087-05 11b3ce08-d237-4e4e-8656-a235d3964f8f 11b3ce08-d237-4e4e-8656-a235d3964f8f TCGA-FG-7638-01B-11D-2085-01 TCGA-FG-7638-01B-11D-2086-08 +TCGA-FG-7641-01 TCGA-FG-7641-01 TCGA-FG-7641 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 31 NO NO TCGA-FG-7641-F43341 TCGA-FG-7641 TCGA-FG-7641-01B -11357 0 627 NO NO NO Headaches > 181 Days Scheduled Follow-up Submission Stable Disease NO 2013-5-17 MALE NO YES Oligodendroglioma NO No C71.0 9450/3 C71.0 YES NO 0.9 NO Left NO 1 NO NO NO NO G2 NO No TCGA-FG-7641.0f5772cf-b2c8-4872-a05d-58457e1e7875.pdf 7641 TUMOR FREE NO YES Complete Remission/Response NO Primary Tumor 01 NO NO 0.6 Not listed in Medical Record NO YES NO FG Supratentorial, Frontal Lobe Central nervous system B YES LIVING 2011 TCGA-FG-7641-01B-11D-2253-08 TCGA-FG-7641-01 690D2C7A-699A-4319-A13B-AB9B2D4B1521 TCGA-FG-7641-01B-11D-2253-08 TCGA-FG-7641-01B-11D-2252-01 ce5f6628-79c7-414b-8ad1-5714016c44ab TCGA-FG-7641-01 TCGA-FG-7641-01 TCGA-FG-7641-01B-11D-2253-08 ce5f6628-79c7-414b-8ad1-5714016c44ab TCGA-FG-7641-01 TCGA-FG-7641-01 TCGA-FG-7641-01B-11D-2253-08 TCGA-FG-7641-01B-11D-2254-05 ce5f6628-79c7-414b-8ad1-5714016c44ab ce5f6628-79c7-414b-8ad1-5714016c44ab TCGA-FG-7641-01B-11D-2252-01 TCGA-FG-7641-01B-11D-2253-08 +TCGA-FG-7643-01 TCGA-FG-7643-01 TCGA-FG-7643 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain NO NO YES 49 YES Cats NO TCGA-FG-7643-F45156 TCGA-FG-7643 TCGA-FG-7643-01A 286 -18206 0 611 254 NO YES NO > 20 Years > 20 Years Seizures 91 - 180 Days Scheduled Follow-up Submission Stable Disease NO 2013-7-10 FEMALE YES NO Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES NO 0.8 NO Right NO 1.3 NO NO YES NO G2 YES No TCGA-FG-7643.e6f58f35-8608-4620-b170-552a8a4ff85d.pdf 7643 WITH TUMOR YES NO Progressive Disease NO Primary Tumor 01 YES NO 0.6 Cerebral Cortex NO YES NO FG Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2011 TCGA-FG-7643-01A-11D-2086-08 TCGA-FG-7643-01 44737C44-02D6-44D8-B8F1-FE2AA60AED07 TCGA-FG-7643-01A-11D-2086-08 TCGA-FG-7643-01A-11D-2085-01 5a558400-4b95-4d48-abb3-a7b9576d9d94 TCGA-FG-7643-01 TCGA-FG-7643-01 TCGA-FG-7643-01A-11D-2086-08 5a558400-4b95-4d48-abb3-a7b9576d9d94 TCGA-FG-7643-01 TCGA-FG-7643-01 TCGA-FG-7643-01A-11D-2086-08 TCGA-FG-7643-01A-11D-2087-05 5a558400-4b95-4d48-abb3-a7b9576d9d94 5a558400-4b95-4d48-abb3-a7b9576d9d94 TCGA-FG-7643-01A-11D-2085-01 TCGA-FG-7643-01A-11D-2086-08 +TCGA-FG-8181-01 TCGA-FG-8181-01 TCGA-FG-8181 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 23 TCGA-FG-8181-F64421 TCGA-FG-8181 TCGA-FG-8181-01A -8642 0 862 -13 Scheduled Follow-up Submission Stable Disease 2014-9-2 MALE Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES NO 1.7 NO 90 Left NO 1.9 NO G3 NO No TCGA-FG-8181.6b2e8993-f8a8-400a-bc49-b283ca7221fe.pdf 8181 Preoperative WITH TUMOR Stable Disease YES Primary Tumor 01 0.7 Not listed in Medical Record YES YES NO FG Supratentorial, Frontal Lobe Central nervous system A LIVING 2012 TCGA-FG-8181-01A-11D-2253-08 TCGA-FG-8181-01 B612DFF8-FE8A-4315-BECD-A221C6AC36DE TCGA-FG-8181-01A-11D-2253-08 TCGA-FG-8181-01A-11D-2252-01 8d64e025-7822-4888-bd98-dd39ab8c73f1 TCGA-FG-8181-01 TCGA-FG-8181-01 8d64e025-7822-4888-bd98-dd39ab8c73f1 TCGA-FG-8181-01 TCGA-FG-8181-01 TCGA-FG-8181-01A-11D-2253-08 TCGA-FG-8181-01A-11D-2254-05 8d64e025-7822-4888-bd98-dd39ab8c73f1 8d64e025-7822-4888-bd98-dd39ab8c73f1 TCGA-FG-8181-01A-11D-2252-01 TCGA-FG-8181-01A-11D-2253-08 +TCGA-FG-8182-01 TCGA-FG-8182-01 TCGA-FG-8182 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 35 NO NO TCGA-FG-8182-F43399 TCGA-FG-8182 TCGA-FG-8182-01A -12972 0 416 NO NO NO Seizures 0 - 30 Days Scheduled Follow-up Submission Stable Disease NO 2013-5-20 MALE NO NO Oligodendroglioma NO No C71.0 9450/3 C71.0 YES NO 1.1 NO Left NO 1.4 NO NO NO NO G2 NO No TCGA-FG-8182.e5be5e58-2293-4328-a626-08e497fe6f33.pdf 8182 WITH TUMOR Stable Disease NO Primary Tumor 01 YES NO 0.3 Not listed in Medical Record NO YES NO FG Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2012 TCGA-FG-8182-01A-11D-2253-08 TCGA-FG-8182-01 3D0362CB-756A-4ADB-B5BE-CB7759E2A018 TCGA-FG-8182-01A-11D-2253-08 TCGA-FG-8182-01A-11D-2252-01 e47cae41-4eee-4164-a58c-4aeb83fed7fc TCGA-FG-8182-01 TCGA-FG-8182-01 TCGA-FG-8182-01A-11D-2253-08 e47cae41-4eee-4164-a58c-4aeb83fed7fc TCGA-FG-8182-01 TCGA-FG-8182-01 TCGA-FG-8182-01A-11D-2253-08 TCGA-FG-8182-01A-11D-2254-05 e47cae41-4eee-4164-a58c-4aeb83fed7fc e47cae41-4eee-4164-a58c-4aeb83fed7fc TCGA-FG-8182-01A-11D-2252-01 TCGA-FG-8182-01A-11D-2253-08 +TCGA-FG-8185-01 TCGA-FG-8185-01 TCGA-FG-8185 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 37 NO NO TCGA-FG-8185-F43366 TCGA-FG-8185 TCGA-FG-8185-01A -13621 0 433 21 NO NO NO > 20 Years Headaches 91 - 180 Days Scheduled Follow-up Submission Complete Remission/Response YES 2013-5-20 MALE NO YES Astrocytoma NO No C71.0 9401/3 C71.0 YES NO 0.9 NO 90 Right 1.3 NO NO NO NO G3 NO No TCGA-FG-8185.74a335ae-a23d-4cc8-abb1-b8eb6db90787.pdf 8185 Pre-Adjuvant Therapy TUMOR FREE Complete Remission/Response YES Primary Tumor 01 NO NO 0.3 White Matter YES YES NO FG Supratentorial, Frontal Lobe Central nervous system A YES LIVING 2012 TCGA-FG-8185-01A-11D-2253-08 TCGA-FG-8185-01 2381F478-4247-4706-B01E-F8454327E956 TCGA-FG-8185-01A-11D-2253-08 TCGA-FG-8185-01A-11D-2252-01 fa83a73a-1157-42a7-9ed6-7eb73f71724c TCGA-FG-8185-01 TCGA-FG-8185-01 TCGA-FG-8185-01A-11D-2253-08 fa83a73a-1157-42a7-9ed6-7eb73f71724c TCGA-FG-8185-01 TCGA-FG-8185-01 TCGA-FG-8185-01A-11D-2253-08 TCGA-FG-8185-01A-11D-2254-05 fa83a73a-1157-42a7-9ed6-7eb73f71724c fa83a73a-1157-42a7-9ed6-7eb73f71724c TCGA-FG-8185-01A-11D-2252-01 TCGA-FG-8185-01A-11D-2253-08 +TCGA-FG-8186-01 TCGA-FG-8186-01 TCGA-FG-8186 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 42 NO NO TCGA-FG-8186-F42521 TCGA-FG-8186 TCGA-FG-8186-01A -15431 0 487 13 NO YES NO Seizures 0 - 30 Days Scheduled Follow-up Submission Stable Disease NO 2013-4-23 FEMALE NO YES Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES NO 1 NO 70 Right NO 1.5 NO NO NO NO G3 NO No TCGA-FG-8186.7e694f9c-b221-40a9-a63a-f5d2db4e9761.pdf 8186 Pre-Adjuvant Therapy WITH TUMOR YES NO Stable Disease YES Primary Tumor 01 YES NO 0.9 Not listed in Medical Record NO YES NO FG Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2011 TCGA-FG-8186-01A-11D-2253-08 TCGA-FG-8186-01 9602088F-9E1F-4AD7-B64E-FD5E6DD62E1D TCGA-FG-8186-01A-11D-2253-08 TCGA-FG-8186-01A-11D-2252-01 7f5d8015-9a38-4d1c-b63d-2d5a0b882259 TCGA-FG-8186-01 TCGA-FG-8186-01 TCGA-FG-8186-01A-11D-2253-08 7f5d8015-9a38-4d1c-b63d-2d5a0b882259 TCGA-FG-8186-01 TCGA-FG-8186-01 TCGA-FG-8186-01A-11D-2253-08 TCGA-FG-8186-01A-11D-2254-05 7f5d8015-9a38-4d1c-b63d-2d5a0b882259 7f5d8015-9a38-4d1c-b63d-2d5a0b882259 TCGA-FG-8186-01A-11D-2252-01 TCGA-FG-8186-01A-11D-2253-08 +TCGA-FG-8187-01 TCGA-FG-8187-01 TCGA-FG-8187 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 31 TCGA-FG-8187-F43456 TCGA-FG-8187 TCGA-FG-8187-01A -11684 0 611 0 Scheduled Follow-up Submission Stable Disease 2013-5-22 MALE Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES NO 1.2 NO 90 Right NO 1.4 NO G2 NO Yes TCGA-FG-8187.7fee5178-b1ff-4d7c-beed-673236f8d485.pdf 8187 Other TUMOR FREE Complete Remission/Response NO Primary Tumor 01 0.7 Not listed in Medical Record NO YES NO FG Supratentorial, Frontal Lobe Central nervous system A LIVING 2011 TCGA-FG-8187-01A-11D-2253-08 TCGA-FG-8187-01 AC84F421-75B7-45F0-B3B5-8C010B56F6DE TCGA-FG-8187-01A-11D-2253-08 TCGA-FG-8187-01A-11D-2252-01 642ac0c8-44f2-452b-98d8-3ad56c82e3b1 TCGA-FG-8187-01 TCGA-FG-8187-01 TCGA-FG-8187-01A-11D-2253-08 642ac0c8-44f2-452b-98d8-3ad56c82e3b1 TCGA-FG-8187-01 TCGA-FG-8187-01 TCGA-FG-8187-01A-11D-2253-08 TCGA-FG-8187-01A-11D-2254-05 642ac0c8-44f2-452b-98d8-3ad56c82e3b1 642ac0c8-44f2-452b-98d8-3ad56c82e3b1 TCGA-FG-8187-01A-11D-2252-01 TCGA-FG-8187-01A-11D-2253-08 +TCGA-FG-8188-01 TCGA-FG-8188-01 TCGA-FG-8188 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain NO YES NO 41 NO NO TCGA-FG-8188-F43454 TCGA-FG-8188 TCGA-FG-8188-01A -15051 0 455 384 -15 NO NO NO Mental Status Changes 0 - 30 Days Scheduled Follow-up Submission NO 2013-5-22 MALE NO NO Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES NO 0.6 NO 90 Left NO 1.1 NO YES NO NO G2 YES No TCGA-FG-8188.7f0c279e-aecb-4bb2-925b-53a3b9bd866d.pdf 8188 Preoperative WITH TUMOR YES Stable Disease NO Primary Tumor 01 NO NO 0.6 Not listed in Medical Record NO YES NO FG Supratentorial, Temporal Lobe Central nervous system A NO LIVING 2012 TCGA-FG-8188-01A-11D-2253-08 TCGA-FG-8188-01 A5325077-0950-4012-9ECA-440D478994C9 TCGA-FG-8188-01A-11D-2253-08 TCGA-FG-8188-01A-11D-2252-01 42862121-daed-47fa-932d-3df4c9efa4cb TCGA-FG-8188-01 TCGA-FG-8188-01 TCGA-FG-8188-01A-11D-2253-08 42862121-daed-47fa-932d-3df4c9efa4cb TCGA-FG-8188-01 TCGA-FG-8188-01 TCGA-FG-8188-01A-11D-2253-08 TCGA-FG-8188-01A-11D-2254-05 42862121-daed-47fa-932d-3df4c9efa4cb 42862121-daed-47fa-932d-3df4c9efa4cb TCGA-FG-8188-01A-11D-2252-01 TCGA-FG-8188-01A-11D-2253-08 +TCGA-FG-8189-01 TCGA-FG-8189-01 TCGA-FG-8189 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 33 NO YES TCGA-FG-8189-F58503 TCGA-FG-8189 TCGA-FG-8189-01B -12384 203 0 685 83 YES NO NO > 20 Years Seizures > 181 Days Scheduled Follow-up Submission Stable Disease NO 2014-4-11 FEMALE YES NO Oligodendroglioma NO No C71.0 9450/3 C71.0 YES NO 370 NO 70 Right NO NO NO NO NO G2 NO false No TCGA-FG-8189.0645C7FA-38CE-48A5-B873-FEB4D4CF5952.pdf 8189 Pre-Adjuvant Therapy WITH TUMOR YES NO Stable Disease YES Primary Tumor 01 YES NO Not listed in Medical Record YES YES NO FG Supratentorial, Temporal Lobe Central nervous system B NO LIVING 2012 TCGA-FG-8189-01 E1938849-0827-4683-944D-B72026D22ABD TCGA-FG-8189-01B-11D-A289-08 TCGA-FG-8189-01B-11D-A288-01 bd0752a4-59b6-4f0d-b08c-45d12ae97a3e TCGA-FG-8189-01 TCGA-FG-8189-01 TCGA-FG-8189-01B-11D-A289-08 bd0752a4-59b6-4f0d-b08c-45d12ae97a3e TCGA-FG-8189-01 TCGA-FG-8189-01B-11D-A289-08 TCGA-FG-8189-01B-11D-A28N-05 bd0752a4-59b6-4f0d-b08c-45d12ae97a3e bd0752a4-59b6-4f0d-b08c-45d12ae97a3e TCGA-FG-8189-01B-11D-A288-01 TCGA-FG-8189-01B-11D-A289-08 +TCGA-FG-8191-01 TCGA-FG-8191-01 TCGA-FG-8191 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 30 NO NO TCGA-FG-8191-F66698 TCGA-FG-8191 TCGA-FG-8191-01A -11252 0 992 NO NO NO Sensory Changes > 181 Days Scheduled Follow-up Submission Stable Disease NO 2014-10-22 MALE NO NO Oligodendroglioma NO No C71.0 9451/3 C71.0 YES NO 0.7 NO Right NO 1.3 NO NO NO NO G3 NO No TCGA-FG-8191.33d30363-b7fb-479f-a985-a9f3c468ab95.pdf 8191 WITH TUMOR Stable Disease YES Primary Tumor 01 NO YES 0.7 Not listed in Medical Record YES YES NO FG Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2011 TCGA-FG-8191-01A-11D-2253-08 TCGA-FG-8191-01 E4F1ADA2-8EF0-4BA6-A499-E417AEF71A45 TCGA-FG-8191-01A-11D-2253-08 TCGA-FG-8191-01A-11D-2252-01 355c3ccb-f1c3-4e73-a41a-7a3ece9a5f6b TCGA-FG-8191-01 TCGA-FG-8191-01 TCGA-FG-8191-01A-11D-2253-08 355c3ccb-f1c3-4e73-a41a-7a3ece9a5f6b TCGA-FG-8191-01 TCGA-FG-8191-01 TCGA-FG-8191-01A-11D-2253-08 TCGA-FG-8191-01A-11D-2254-05 355c3ccb-f1c3-4e73-a41a-7a3ece9a5f6b 355c3ccb-f1c3-4e73-a41a-7a3ece9a5f6b TCGA-FG-8191-01A-11D-2252-01 TCGA-FG-8191-01A-11D-2253-08 +TCGA-FG-A4MT-01 TCGA-FG-A4MT-01 TCGA-FG-A4MT TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain NO YES YES 27 NO NO TCGA-FG-A4MT-F56666 TCGA-FG-A4MT TCGA-FG-A4MT-01A 647 -10082 661 0 1164 499 499 NO NO NO Seizures 0 - 30 Days Scheduled Follow-up Submission Complete Remission/Response NO 2014-2-17 FEMALE NO YES Oligodendroglioma NO No C71.2 9450/3 C71.2 YES NO 520 NO 100 Left NO NO NO NO NO G2 YES false No TCGA-FG-A4MT.5FBDAD09-6FC1-41FF-9361-0184C122246B.pdf A4MT Pre-Adjuvant Therapy TUMOR FREE YES YES Complete Remission/Response NO Primary Tumor 01 YES NO Not listed in Medical Record NO YES NO FG Supratentorial, Temporal Lobe Central nervous system A NO LIVING 2010 TCGA-FG-A4MT-01 9DD60AC8-29EE-4338-94C5-71784BA7C413 TCGA-FG-A4MT-01A-11D-A26M-08 TCGA-FG-A4MT-01A-11D-A26L-01 f7f89edd-0409-43c7-ab5d-3d35337de34f TCGA-FG-A4MT-01 TCGA-FG-A4MT-01 TCGA-FG-A4MT-01A-11D-A26M-08 f7f89edd-0409-43c7-ab5d-3d35337de34f TCGA-FG-A4MT-01 TCGA-FG-A4MT-01A-11D-A26M-08 TCGA-FG-A4MT-01A-11D-A26N-05 f7f89edd-0409-43c7-ab5d-3d35337de34f f7f89edd-0409-43c7-ab5d-3d35337de34f TCGA-FG-A4MT-01A-11D-A26L-01 TCGA-FG-A4MT-01A-11D-A26M-08 +TCGA-FG-A4MT-02 TCGA-FG-A4MT-02 TCGA-FG-A4MT TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain NO YES YES 27 NO NO TCGA-FG-A4MT-F56666 TCGA-FG-A4MT TCGA-FG-A4MT-02A 647 -10082 827 0 1164 499 499 NO NO NO Seizures 0 - 30 Days Scheduled Follow-up Submission Complete Remission/Response NO 2014-2-17 FEMALE NO YES Oligodendroglioma NO No C71.2 9450/3 C71.2 YES NO 250 NO 100 Left NO NO NO NO NO G2 YES false No TCGA-FG-A4MT.592AF347-5CB0-43E7-8950-D78B9A2D670B.pdf A4MT Pre-Adjuvant Therapy TUMOR FREE YES YES Complete Remission/Response NO Recurrent Tumor 02 YES NO Not listed in Medical Record NO YES NO FG Supratentorial, Temporal Lobe Central nervous system A NO LIVING 2010 040DC80A-12F9-497E-809A-2B993A1CFAF3 TCGA-FG-A4MT-02A-11D-A29Q-08 9f4e522f-d1c3-4fa9-9ab4-b6886426a77c TCGA-FG-A4MT-02 TCGA-FG-A4MT-02 9f4e522f-d1c3-4fa9-9ab4-b6886426a77c TCGA-FG-A4MT-02A-11D-A29T-05 9f4e522f-d1c3-4fa9-9ab4-b6886426a77c 9f4e522f-d1c3-4fa9-9ab4-b6886426a77c +TCGA-FG-A4MU-01 TCGA-FG-A4MU-01 TCGA-FG-A4MU TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 58 NO NO TCGA-FG-A4MU-F63739 TCGA-FG-A4MU TCGA-FG-A4MU-01B -21450 258 0 326 NO NO NO Headaches 0 - 30 Days Scheduled Follow-up Submission NO 2014-8-15 MALE NO YES Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES NO 700 NO Right NO IHC YES NO YES NO NO G3 false No TCGA-FG-A4MU.25B6CCE5-DF7C-483D-AA5D-C6870FB6EFC5.pdf A4MU WITH TUMOR NO YES Primary Tumor 01 NO NO Not listed in Medical Record YES NO FG Supratentorial, Temporal Lobe Central nervous system B YES LIVING 2012 TCGA-FG-A4MU-01 C46204A9-9228-425F-8C8B-CA68846F2DED TCGA-FG-A4MU-01B-11D-A289-08 TCGA-FG-A4MU-01B-11D-A288-01 554bddc2-3afe-47d6-83c7-46cb30352df1 TCGA-FG-A4MU-01 TCGA-FG-A4MU-01 TCGA-FG-A4MU-01B-11D-A289-08 554bddc2-3afe-47d6-83c7-46cb30352df1 TCGA-FG-A4MU-01 TCGA-FG-A4MU-01B-11D-A289-08 TCGA-FG-A4MU-01B-11D-A28N-05 554bddc2-3afe-47d6-83c7-46cb30352df1 554bddc2-3afe-47d6-83c7-46cb30352df1 TCGA-FG-A4MU-01B-11D-A288-01 TCGA-FG-A4MU-01B-11D-A289-08 +TCGA-FG-A4MW-01 TCGA-FG-A4MW-01 TCGA-FG-A4MW TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain YES NO NO 63 NO YES TCGA-FG-A4MW-F61644 TCGA-FG-A4MW TCGA-FG-A4MW-01A -23077 64 559 0 160 226 141 1 NO YES NO Seizures 0 - 30 Days Scheduled Follow-up Submission Progressive Disease NO 2014-7-2 MALE NO NO Oligoastrocytoma NO No C71.1 9382/3 C71.1 YES NO 220 NO 80 Right NO IHC YES NO NO NO NO G3 YES false No TCGA-FG-A4MW.E9D4D450-3905-4D11-A814-7B1049A8F3A4.pdf A4MW Post-Adjuvant Therapy WITH TUMOR YES YES Stable Disease YES Primary Tumor 01 YES NO Not listed in Medical Record YES YES NO FG Supratentorial, Frontal Lobe Central nervous system A NO DECEASED 2012 TCGA-FG-A4MW-01 75EABDBC-67D0-46CE-BE62-1211DDBD4033 TCGA-FG-A4MW-01A-11D-A26M-08 TCGA-FG-A4MW-01A-11D-A26L-01 4f8e3c28-cdc9-43bb-a27c-2dd02c4c9c71 TCGA-FG-A4MW-01 TCGA-FG-A4MW-01 TCGA-FG-A4MW-01A-11D-A26M-08 4f8e3c28-cdc9-43bb-a27c-2dd02c4c9c71 TCGA-FG-A4MW-01 TCGA-FG-A4MW-01A-11D-A26M-08 TCGA-FG-A4MW-01A-11D-A26N-05 4f8e3c28-cdc9-43bb-a27c-2dd02c4c9c71 4f8e3c28-cdc9-43bb-a27c-2dd02c4c9c71 TCGA-FG-A4MW-01A-11D-A26L-01 TCGA-FG-A4MW-01A-11D-A26M-08 +TCGA-FG-A4MX-01 TCGA-FG-A4MX-01 TCGA-FG-A4MX TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 47 NO NO TCGA-FG-A4MX-F57707 TCGA-FG-A4MX TCGA-FG-A4MX-01A -17381 115 0 569 -23 0 NO NO NO Motor/Movement Changes 0 - 30 Days Scheduled Follow-up Submission Complete Remission/Response NO 2014-3-21 MALE NO NO Astrocytoma NO No C71.1 9400/3 C71.1 YES NO 170 NO 100 Right NO IHC YES NO NO NO YES G2 NO false No TCGA-FG-A4MX.E88FF565-EFD8-4E5D-87BC-A7210DE9F29C.pdf A4MX Preoperative TUMOR FREE NO NO Complete Remission/Response YES Primary Tumor 01 NO NO Not listed in Medical Record NO YES NO FG Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2012 TCGA-FG-A4MX-01 482276B7-438A-4542-909C-6E1D78E8EC17 TCGA-FG-A4MX-01A-11D-A26M-08 TCGA-FG-A4MX-01A-11D-A26L-01 ccf08a46-d1e6-4f3d-a511-6a1560a8dc52 TCGA-FG-A4MX-01 TCGA-FG-A4MX-01 TCGA-FG-A4MX-01A-11D-A26M-08 ccf08a46-d1e6-4f3d-a511-6a1560a8dc52 TCGA-FG-A4MX-01 TCGA-FG-A4MX-01A-11D-A26M-08 TCGA-FG-A4MX-01A-11D-A26N-05 ccf08a46-d1e6-4f3d-a511-6a1560a8dc52 ccf08a46-d1e6-4f3d-a511-6a1560a8dc52 TCGA-FG-A4MX-01A-11D-A26L-01 TCGA-FG-A4MX-01A-11D-A26M-08 +TCGA-FG-A4MY-01 TCGA-FG-A4MY-01 TCGA-FG-A4MY TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 44 NO NO TCGA-FG-A4MY-F58505 TCGA-FG-A4MY TCGA-FG-A4MY-01A -16310 212 0 721 NO NO NO Seizures 31 - 90 Days Scheduled Follow-up Submission Stable Disease NO 2014-4-11 FEMALE NO YES Oligoastrocytoma NO No C71.3 9382/3 C71.3 YES NO 480 NO Right NO NO YES NO NO G2 NO false No TCGA-FG-A4MY.485F752A-74F7-4E4B-B921-E4E5D1AE712D.pdf A4MY WITH TUMOR Stable Disease YES Primary Tumor 01 YES NO Not listed in Medical Record NO YES NO FG Supratentorial, Parietal Lobe Central nervous system A NO LIVING 2012 TCGA-FG-A4MY-01 F619A1A6-10C9-4329-BFC5-1BEEF7081894 TCGA-FG-A4MY-01A-11D-A26M-08 TCGA-FG-A4MY-01A-11D-A26L-01 c58aae77-ec2e-4988-b6c6-4cde7f4b60e1 TCGA-FG-A4MY-01 TCGA-FG-A4MY-01 TCGA-FG-A4MY-01A-11D-A26M-08 c58aae77-ec2e-4988-b6c6-4cde7f4b60e1 TCGA-FG-A4MY-01 TCGA-FG-A4MY-01A-11D-A26M-08 TCGA-FG-A4MY-01A-11D-A26N-05 c58aae77-ec2e-4988-b6c6-4cde7f4b60e1 c58aae77-ec2e-4988-b6c6-4cde7f4b60e1 TCGA-FG-A4MY-01A-11D-A26L-01 TCGA-FG-A4MY-01A-11D-A26M-08 +TCGA-FG-A60J-01 TCGA-FG-A60J-01 TCGA-FG-A60J TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 47 NO NO TCGA-FG-A60J-F65604 TCGA-FG-A60J TCGA-FG-A60J-01A -17339 240 0 449 -18 1 NO NO NO Seizures 31 - 90 Days Scheduled Follow-up Submission NO 2014-9-25 FEMALE NO NO Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES NO 240 NO 90 Left YES IHC YES YES NO NO NO G2 NO false No TCGA-FG-A60J.0EE45912-9058-4883-922E-1B788D3A7A68.pdf A60J Preoperative TUMOR FREE YES NO Complete Remission/Response NO Primary Tumor 01 YES NO Not listed in Medical Record NO YES NO FG Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2012 TCGA-FG-A60J-01 7DCF4272-F1E0-4723-A3BE-F8B8B8D80D98 TCGA-FG-A60J-01A-11D-A289-08 TCGA-FG-A60J-01A-11D-A288-01 d1c8d59f-1ab1-4450-8d3f-b7bc6e05cd7f TCGA-FG-A60J-01 TCGA-FG-A60J-01 TCGA-FG-A60J-01A-11D-A289-08 d1c8d59f-1ab1-4450-8d3f-b7bc6e05cd7f TCGA-FG-A60J-01 TCGA-FG-A60J-01A-11D-A289-08 TCGA-FG-A60J-01A-11D-A28N-05 d1c8d59f-1ab1-4450-8d3f-b7bc6e05cd7f d1c8d59f-1ab1-4450-8d3f-b7bc6e05cd7f TCGA-FG-A60J-01A-11D-A288-01 TCGA-FG-A60J-01A-11D-A289-08 +TCGA-FG-A60K-01 TCGA-FG-A60K-01 TCGA-FG-A60K TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 34 YES Dogs NO TCGA-FG-A60K-F61189 TCGA-FG-A60K -12445 0 542 NO YES NO > 20 Years > 20 Years Mental Status Changes 0 - 30 Days Scheduled Follow-up Submission Stable Disease NO 2014-6-25 FEMALE YES NO Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES NO Right NO NO YES NO NO G2 NO Yes, History of Prior Malignancy A60K WITH TUMOR NO NO Stable Disease NO Primary Tumor 01 NO NO Not listed in Medical Record NO YES NO FG Supratentorial, Frontal Lobe Central nervous system NO LIVING 2012 TCGA-FG-A60K-01 TCGA-FG-A60K-01A-11D-A29Q-08 TCGA-FG-A60K-01A-11D-A323-01 a8be2bbb-f0a6-40e6-af7a-ee9289e8ad44 TCGA-FG-A60K-01 TCGA-FG-A60K-01 TCGA-FG-A60K-01A-11D-A29Q-08 a8be2bbb-f0a6-40e6-af7a-ee9289e8ad44 TCGA-FG-A60K-01 TCGA-FG-A60K-01A-11D-A29Q-08 TCGA-FG-A60K-01A-11D-A29T-05 a8be2bbb-f0a6-40e6-af7a-ee9289e8ad44 a8be2bbb-f0a6-40e6-af7a-ee9289e8ad44 TCGA-FG-A60K-01A-11D-A323-01 TCGA-FG-A60K-01A-11D-A29Q-08 +TCGA-FG-A60L-01 TCGA-FG-A60L-01 TCGA-FG-A60L TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 34 NO TCGA-FG-A60L-F65511 TCGA-FG-A60L TCGA-FG-A60L-01A -12580 121 0 655 8 0 NO NO Seizures 0 - 30 Days Scheduled Follow-up Submission Complete Remission/Response 2014-9-24 FEMALE NO Astrocytoma NO No C71.0 9400/3 C71.0 YES NO 220 NO 100 Left NO NO NO NO G2 NO false No TCGA-FG-A60L.E6DA1846-7274-44A3-99DE-65EE1FC91D6E.pdf A60L Other TUMOR FREE YES NO Complete Remission/Response NO Primary Tumor 01 YES NO Not listed in Medical Record NO YES NO FG Supratentorial, Temporal Lobe Central nervous system A NO LIVING 2012 TCGA-FG-A60L-01 B2E9B22E-7739-4D44-B6DA-9476E4AC75A2 TCGA-FG-A60L-01A-12D-A31L-08 TCGA-FG-A60L-01A-12D-A31K-01 d215a4d3-4990-4771-8665-de92aaeb454b TCGA-FG-A60L-01 TCGA-FG-A60L-01 d215a4d3-4990-4771-8665-de92aaeb454b TCGA-FG-A60L-01 TCGA-FG-A60L-01A-12D-A31M-05 d215a4d3-4990-4771-8665-de92aaeb454b d215a4d3-4990-4771-8665-de92aaeb454b TCGA-FG-A60L-01A-12D-A31K-01 TCGA-FG-A60L-01A-12D-A31L-08 +TCGA-FG-A6IZ-01 TCGA-FG-A6IZ-01 TCGA-FG-A6IZ TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 60 NO NO TCGA-FG-A6IZ-F63721 TCGA-FG-A6IZ TCGA-FG-A6IZ-01A -22275 157 0 457 NO NO NO > 20 Years Seizures 0 - 30 Days Scheduled Follow-up Submission Complete Remission/Response NO 2014-8-15 MALE YES NO Oligodendroglioma NO No C71.0 9450/3 C71.0 YES NO 240 NO Left YES IHC YES NO NO NO YES G2 NO true No TCGA-FG-A6IZ.999D85F3-3DE0-4A08-BCB7-46078C8349A8.pdf A6IZ TUMOR FREE YES NO Complete Remission/Response YES Primary Tumor 01 YES NO Cerebral Cortex NO YES NO FG Supratentorial, Not Otherwise Specified Central nervous system A NO LIVING 2013 TCGA-FG-A6IZ-01 3FEC042A-1692-4BB9-84E7-4127B8807AB4 TCGA-FG-A6IZ-01A-11D-A31L-08 TCGA-FG-A6IZ-01A-11D-A31K-01 3730c75e-f1cc-46ca-a26e-92f74858663b TCGA-FG-A6IZ-01 TCGA-FG-A6IZ-01 3730c75e-f1cc-46ca-a26e-92f74858663b TCGA-FG-A6IZ-01 TCGA-FG-A6IZ-01A-11D-A31M-05 3730c75e-f1cc-46ca-a26e-92f74858663b 3730c75e-f1cc-46ca-a26e-92f74858663b TCGA-FG-A6IZ-01A-11D-A31K-01 TCGA-FG-A6IZ-01A-11D-A31L-08 +TCGA-FG-A6J1-01 TCGA-FG-A6J1-01 TCGA-FG-A6J1 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 44 NO NO TCGA-FG-A6J1-F63724 TCGA-FG-A6J1 TCGA-FG-A6J1-01A -16106 91 0 500 27 NO YES NO Seizures 0 - 30 Days Scheduled Follow-up Submission Stable Disease NO 2014-8-15 FEMALE NO NO Oligodendroglioma NO No C71.0 9450/3 C71.0 YES NO 60 NO 70 Left YES IHC YES NO NO NO NO G2 NO true No TCGA-FG-A6J1.9421C492-5E69-4641-B4CD-29A4D2C7A4CD.pdf A6J1 Pre-Adjuvant Therapy WITH TUMOR NO NO Stable Disease YES Primary Tumor 01 YES NO Not listed in Medical Record NO YES NO FG Supratentorial, Not Otherwise Specified Central nervous system A NO LIVING 2013 TCGA-FG-A6J1-01 TCGA-FG-A6J1-01A-11D-A31L-08 TCGA-FG-A6J1-01A-11D-A31K-01 16b68870-facd-4071-ba84-b30b2c60bc81 TCGA-FG-A6J1-01 TCGA-FG-A6J1-01 16b68870-facd-4071-ba84-b30b2c60bc81 TCGA-FG-A6J1-01 TCGA-FG-A6J1-01A-11D-A31M-05 16b68870-facd-4071-ba84-b30b2c60bc81 16b68870-facd-4071-ba84-b30b2c60bc81 TCGA-FG-A6J1-01A-11D-A31K-01 TCGA-FG-A6J1-01A-11D-A31L-08 +TCGA-FG-A6J3-01 TCGA-FG-A6J3-01 TCGA-FG-A6J3 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 52 NO TCGA-FG-A6J3-F64032 TCGA-FG-A6J3 TCGA-FG-A6J3-01A -19138 267 0 677 106 1 NO Sensory Changes 0 - 30 Days Scheduled Follow-up Submission Stable Disease NO 2014-8-25 FEMALE NO NO Astrocytoma NO No C71.0 9401/3 C71.0 YES 170 NO 90 Right YES IHC YES NO NO NO NO G3 NO true No TCGA-FG-A6J3.480EE630-15DD-4346-84FF-B96E973E6583.pdf A6J3 Post-Adjuvant Therapy WITH TUMOR YES NO Progressive Disease YES Primary Tumor 01 NO YES Cerebral Cortex YES YES NO FG Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2012 TCGA-FG-A6J3-01 D207E3A8-670B-4F4C-8367-35F22B691B93 TCGA-FG-A6J3-01A-11D-A31L-08 TCGA-FG-A6J3-01A-11D-A31K-01 eba2b96d-21f8-4091-b8c4-0ef2b9c00075 TCGA-FG-A6J3-01 TCGA-FG-A6J3-01 eba2b96d-21f8-4091-b8c4-0ef2b9c00075 TCGA-FG-A6J3-01 TCGA-FG-A6J3-01A-11D-A31M-05 eba2b96d-21f8-4091-b8c4-0ef2b9c00075 eba2b96d-21f8-4091-b8c4-0ef2b9c00075 TCGA-FG-A6J3-01A-11D-A31K-01 TCGA-FG-A6J3-01A-11D-A31L-08 +TCGA-FG-A70Y-01 TCGA-FG-A70Y-01 TCGA-FG-A70Y TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 20 NO TCGA-FG-A70Y-F65608 TCGA-FG-A70Y TCGA-FG-A70Y-01A -7421 804 0 868 NO NO NO Headaches 0 - 30 Days Scheduled Follow-up Submission 2014-9-25 FEMALE YES Oligodendroglioma NO No C71.0 9450/3 C71.0 YES NO 170 NO Left NO YES NO YES G2 YES false No TCGA-FG-A70Y.C736A839-8853-478E-BB5E-2A1ADCB0A46C.pdf A70Y WITH TUMOR NO NO Complete Remission/Response NO Primary Tumor 01 NO NO Not listed in Medical Record NO YES NO FG Supratentorial, Temporal Lobe Central nervous system A YES LIVING 2011 TCGA-FG-A70Y-01 09F97221-7556-4F4E-8B54-D4B637FC32FD TCGA-FG-A70Y-01A-12D-A34J-08 TCGA-FG-A70Y-01A-12D-A34I-01 74d15e51-1d60-4e97-ae99-e412e454d6b1 TCGA-FG-A70Y-01 TCGA-FG-A70Y-01 74d15e51-1d60-4e97-ae99-e412e454d6b1 TCGA-FG-A70Y-01 TCGA-FG-A70Y-01A-12D-A34K-05 74d15e51-1d60-4e97-ae99-e412e454d6b1 74d15e51-1d60-4e97-ae99-e412e454d6b1 TCGA-FG-A70Y-01A-12D-A34I-01 TCGA-FG-A70Y-01A-12D-A34J-08 +TCGA-FG-A70Z-01 TCGA-FG-A70Z-01 TCGA-FG-A70Z TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 53 NO TCGA-FG-A70Z-F64424 TCGA-FG-A70Z TCGA-FG-A70Z-01A -19717 720 0 328 NO YES Headaches 31 - 90 Days Scheduled Follow-up Submission Stable Disease 2014-9-2 FEMALE YES Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES NO 300 NO Left NO YES NO NO G3 false No TCGA-FG-A70Z.E2908E5D-A017-41AE-AF5F-367A1D4C868B.pdf A70Z WITH TUMOR NO YES Stable Disease YES Primary Tumor 01 NO YES Not listed in Medical Record YES YES NO FG Supratentorial, Temporal Lobe Central nervous system A YES LIVING 2011 TCGA-FG-A70Z-01 C97E0A03-C6F6-4414-87D1-55F5C3178D60 TCGA-FG-A70Z-01A-12D-A33T-08 TCGA-FG-A70Z-01A-12D-A33S-01 bf983be3-abeb-44d7-a9e5-12186d6d303d TCGA-FG-A70Z-01 TCGA-FG-A70Z-01 bf983be3-abeb-44d7-a9e5-12186d6d303d TCGA-FG-A70Z-01 TCGA-FG-A70Z-01A-12D-A33U-05 bf983be3-abeb-44d7-a9e5-12186d6d303d bf983be3-abeb-44d7-a9e5-12186d6d303d TCGA-FG-A70Z-01A-12D-A33S-01 TCGA-FG-A70Z-01A-12D-A33T-08 +TCGA-FG-A710-01 TCGA-FG-A710-01 TCGA-FG-A710 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 50 TCGA-FG-A710-F64423 TCGA-FG-A710 TCGA-FG-A710-01A -18415 823 0 1115 NO NO Headaches 91 - 180 Days Scheduled Follow-up Submission Stable Disease 2014-9-2 FEMALE YES Oligodendroglioma NO No C71.0 9450/3 C71.0 YES NO 460 NO Left NO NO NO YES G2 NO false No TCGA-FG-A710.0D50F154-43CC-4916-9D8E-A5C16F626971.pdf A710 WITH TUMOR YES NO Stable Disease NO Primary Tumor 01 YES NO Not listed in Medical Record YES YES NO FG Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2011 TCGA-FG-A710-01 0F6722CF-F0F0-42C6-A791-88BEB7697EEE TCGA-FG-A710-01A-12D-A33T-08 TCGA-FG-A710-01A-12D-A33S-01 0aefc6e0-fd5e-430d-b4b7-e1d6c2168ae7 TCGA-FG-A710-01 TCGA-FG-A710-01 0aefc6e0-fd5e-430d-b4b7-e1d6c2168ae7 TCGA-FG-A710-01 TCGA-FG-A710-01A-12D-A33U-05 0aefc6e0-fd5e-430d-b4b7-e1d6c2168ae7 0aefc6e0-fd5e-430d-b4b7-e1d6c2168ae7 TCGA-FG-A710-01A-12D-A33S-01 TCGA-FG-A710-01A-12D-A33T-08 +TCGA-FG-A711-01 TCGA-FG-A711-01 TCGA-FG-A711 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain YES NO NO 33 NO NO TCGA-FG-A711-F65436 TCGA-FG-A711 TCGA-FG-A711-01A -12248 1265 1481 0 1329 1277 871 YES NO NO < 12 Years Seizures 0 - 30 Days Scheduled Follow-up Submission Progressive Disease NO 2014-9-23 FEMALE NO NO Oligodendroglioma NO No C71.0 9450/3 C71.0 YES NO 410 NO 90 Left NO NO YES NO NO G2 YES false No TCGA-FG-A711.5E5F767F-755E-4361-AA92-42D09DE41386.pdf A711 Post-Adjuvant Therapy WITH TUMOR YES YES Progressive Disease NO Primary Tumor 01 YES YES Not listed in Medical Record NO YES NO FG Supratentorial, Frontal Lobe Central nervous system A NO DECEASED 2010 TCGA-FG-A711-01 TCGA-FG-A711-01A-21D-A33T-08 TCGA-FG-A711-01A-21D-A33S-01 9f0c08da-bb32-4888-b560-0f5762594304 TCGA-FG-A711-01 TCGA-FG-A711-01 9f0c08da-bb32-4888-b560-0f5762594304 TCGA-FG-A711-01 TCGA-FG-A711-01A-21D-A33U-05 9f0c08da-bb32-4888-b560-0f5762594304 9f0c08da-bb32-4888-b560-0f5762594304 TCGA-FG-A711-01A-21D-A33S-01 TCGA-FG-A711-01A-21D-A33T-08 +TCGA-FG-A713-01 TCGA-FG-A713-01 TCGA-FG-A713 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 74 NO NO TCGA-FG-A713-F70642 TCGA-FG-A713 TCGA-FG-A713-01A -27232 82 0 622 13 YES NO NO > 20 Years > 20 Years Headaches > 181 Days Scheduled Follow-up Submission Complete Remission/Response YES Melon 2015-2-27 FEMALE YES YES Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES NO 200 NO 60 Right NO NO YES YES NO G2 NO false Yes, History of Prior Malignancy TCGA-FG-A713.B44387B9-C120-4F55-87B5-484C23D6070C.pdf A713 Pre-Adjuvant Therapy TUMOR FREE NO NO Complete Remission/Response YES Primary Tumor 01 NO NO Not listed in Medical Record NO YES NO FG Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2013 TCGA-FG-A713-01 BDE249A1-F0DE-4B4B-9D77-D59A76FBE375 TCGA-FG-A713-01A-11D-A32B-08 TCGA-FG-A713-01A-11D-A32A-01 570cae57-25b0-401d-a911-da8d44e8b291 TCGA-FG-A713-01 TCGA-FG-A713-01 570cae57-25b0-401d-a911-da8d44e8b291 TCGA-FG-A713-01 TCGA-FG-A713-01A-11D-A32C-05 570cae57-25b0-401d-a911-da8d44e8b291 570cae57-25b0-401d-a911-da8d44e8b291 TCGA-FG-A713-01A-11D-A32A-01 TCGA-FG-A713-01A-11D-A32B-08 +TCGA-FG-A87N-01 TCGA-FG-A87N-01 TCGA-FG-A87N TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 37 NO TCGA-FG-A87N-F70255 TCGA-FG-A87N TCGA-FG-A87N-01A -13606 113 0 567 NO NO NO Seizures 0 - 30 Days Scheduled Follow-up Submission Stable Disease NO 2015-2-2 FEMALE NO YES Astrocytoma NO No C71.0 9401/3 C71.0 YES NO 130 NO Left YES IHC YES NO NO YES G3 NO true Yes, History of Prior Malignancy TCGA-FG-A87N.061C4D2D-340B-4F59-9B6F-C552E4BF75C6.pdf A87N WITH TUMOR Stable Disease YES Primary Tumor 01 YES Not listed in Medical Record YES YES NO FG Supratentorial, Frontal Lobe Central nervous system A YES LIVING 2013 TCGA-FG-A87N-01 09F1DD55-2E3C-4905-9526-72C5A706AB00 TCGA-FG-A87N-01A-11D-A36O-08 TCGA-FG-A87N-01A-11D-A36N-01 e5686a63-293f-4d7e-bb7a-c0ad2769cfb4 TCGA-FG-A87N-01 TCGA-FG-A87N-01 e5686a63-293f-4d7e-bb7a-c0ad2769cfb4 TCGA-FG-A87N-01 TCGA-FG-A87N-01A-11D-A368-05 e5686a63-293f-4d7e-bb7a-c0ad2769cfb4 e5686a63-293f-4d7e-bb7a-c0ad2769cfb4 TCGA-FG-A87N-01A-11D-A36N-01 TCGA-FG-A87N-01A-11D-A36O-08 +TCGA-FG-A87Q-01 TCGA-FG-A87Q-01 TCGA-FG-A87Q TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 61 NO TCGA-FG-A87Q-F72685 TCGA-FG-A87Q TCGA-FG-A87Q-01A -22565 90 0 174 174 NO Seizures 0 - 30 Days Scheduled Follow-up Submission YES Dairy/lactose 2015-7-31 FEMALE NO NO Astrocytoma NO No C71.0 9401/3 C71.0 YES NO 250 NO 80 Right NO IHC YES YES NO NO NO G3 NO true No TCGA-FG-A87Q.072A2905-3E7F-4C11-87A2-3D4577F1F8A3.pdf A87Q Post-Adjuvant Therapy TUMOR FREE YES YES Complete Remission/Response YES Primary Tumor 01 YES NO White Matter YES YES NO FG Supratentorial, Parietal Lobe Central nervous system A NO LIVING 2013 TCGA-FG-A87Q-01 8476F6BE-1672-4D24-AA7E-98894C80B887 TCGA-FG-A87Q-01A-11D-A36O-08 TCGA-FG-A87Q-01A-11D-A36N-01 d1d2cb40-28df-41a6-af66-1d11168e0803 TCGA-FG-A87Q-01 TCGA-FG-A87Q-01 d1d2cb40-28df-41a6-af66-1d11168e0803 TCGA-FG-A87Q-01 TCGA-FG-A87Q-01A-11D-A368-05 d1d2cb40-28df-41a6-af66-1d11168e0803 d1d2cb40-28df-41a6-af66-1d11168e0803 TCGA-FG-A87Q-01A-11D-A36N-01 TCGA-FG-A87Q-01A-11D-A36O-08 +TCGA-FN-7833-01 TCGA-FN-7833-01 TCGA-FN-7833 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 25 TCGA-FN-7833-F66000 TCGA-FN-7833 TCGA-FN-7833-01A -9228 0 837 Mental Status Changes Scheduled Follow-up Submission Complete Remission/Response 2014-10-1 MALE NO Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES 0.3 NO Midline 0.5 NO YES YES G3 NO No TCGA-FN-7833.a6b649b5-cf85-4f4e-bf5f-4870a16c1f93.pdf 7833 TUMOR FREE Complete Remission/Response YES Primary Tumor 01 YES NO 0.2 Not listed in Medical Record YES YES NO FN Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2011 TCGA-FN-7833-01A-11D-2086-08 TCGA-FN-7833-01 TCGA-FN-7833-01A-11D-2086-08 TCGA-FN-7833-01A-11D-2085-01 8ddbc97b-376a-4851-906d-efe41fa45eee TCGA-FN-7833-01 TCGA-FN-7833-01 TCGA-FN-7833-01A-11D-2086-08 8ddbc97b-376a-4851-906d-efe41fa45eee TCGA-FN-7833-01 TCGA-FN-7833-01 TCGA-FN-7833-01A-11D-2086-08 TCGA-FN-7833-01A-11D-2087-05 8ddbc97b-376a-4851-906d-efe41fa45eee 8ddbc97b-376a-4851-906d-efe41fa45eee TCGA-FN-7833-01A-11D-2085-01 TCGA-FN-7833-01A-11D-2086-08 +TCGA-HT-7467-01 TCGA-HT-7467-01 TCGA-HT-7467 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 54 NO NO TCGA-HT-7467-F28641 TCGA-HT-7467 TCGA-HT-7467-01A -19944 0 3 NO YES NO Sensory Changes 0 - 30 Days Scheduled Follow-up Submission Complete Remission/Response NO 2012-2-27 MALE NO NO Oligodendroglioma NO No C71.9 9450/3 C71.9 YES NO 0.8 NO Right NO 3 NO NO YES G2 No TCGA-HT-7467.440fce7d-5d39-4e81-8b2d-11726cbd3481.pdf 7467 TUMOR FREE YES NO Complete Remission/Response Primary Tumor 01 NO YES 0.4 White Matter NO YES HT Supratentorial, Parietal Lobe Central nervous system A YES LIVING 2011 TCGA-HT-7467-01A-11D-2024-08 TCGA-HT-7467-01 FC15EBC7-8A11-4346-B41D-E02B25B0F3E8 TCGA-HT-7467-01A-11D-2024-08 TCGA-HT-7467-01A-11D-2023-01 e752561a-f5e2-4390-93f1-a487447b6557 TCGA-HT-7467-01 TCGA-HT-7467-01 TCGA-HT-7467-01A-11D-2024-08 e752561a-f5e2-4390-93f1-a487447b6557 TCGA-HT-7467-01 TCGA-HT-7467-01 TCGA-HT-7467-01A-11D-2024-08 TCGA-HT-7467-01A-11D-2025-05 e752561a-f5e2-4390-93f1-a487447b6557 e752561a-f5e2-4390-93f1-a487447b6557 TCGA-HT-7467-01A-11D-2023-01 TCGA-HT-7467-01A-11D-2024-08 +TCGA-HT-7468-01 TCGA-HT-7468-01 TCGA-HT-7468 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 30 NO NO TCGA-HT-7468-F21233 TCGA-HT-7468 TCGA-HT-7468-01A -11209 0 203 203 NO NO NO Seizures > 181 Days Scheduled Follow-up Submission Stable Disease YES shellfish 2012-2-7 MALE NO YES Oligodendroglioma NO No C71.0 9451/3 C71.0 YES NO 1p and 19Q deleted 0.7 NO 80 Right NO 1.3 NO NO NO G3 NO No TCGA-HT-7468.f56fcc2c-db3d-4ae5-b8dc-975b98fb4675.pdf 7468 Post-Adjuvant Therapy TUMOR FREE YES NO Stable Disease NO Primary Tumor 01 YES NO 0.7 White Matter YES NO YES HT Supratentorial, Parietal Lobe Central nervous system A NO LIVING 2011 TCGA-HT-7468-01A-11D-2024-08 TCGA-HT-7468-01 F001BEEE-191E-4829-85B3-3B6F18DB50F2 TCGA-HT-7468-01A-11D-2024-08 TCGA-HT-7468-01A-11D-2023-01 a40ec658-73b1-48d5-b9d1-51931e76bff0 TCGA-HT-7468-01 TCGA-HT-7468-01 TCGA-HT-7468-01A-11D-2024-08 a40ec658-73b1-48d5-b9d1-51931e76bff0 TCGA-HT-7468-01 TCGA-HT-7468-01 TCGA-HT-7468-01A-11D-2024-08 TCGA-HT-7468-01A-11D-2025-05 a40ec658-73b1-48d5-b9d1-51931e76bff0 a40ec658-73b1-48d5-b9d1-51931e76bff0 TCGA-HT-7468-01A-11D-2023-01 TCGA-HT-7468-01A-11D-2024-08 +TCGA-HT-7469-01 TCGA-HT-7469-01 TCGA-HT-7469 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain YES NO YES NO 30 NO NO TCGA-HT-7469-F28780 TCGA-HT-7469 TCGA-HT-7469-01A 92 -11097 351 0 238 92 NO YES NO Motor/Movement Changes 0 - 30 Days Additional New Tumor Event Progressive Disease NO 2012-4-6 MALE NO YES Oligodendroglioma NO No C71.0 9451/3 C71.0 YES 1 NO Left NO 1.5 NO YES G3 YES No TCGA-HT-7469.d79ea6e7-ce40-4e9a-9e82-61a6a517a571.pdf 7469 WITH TUMOR NO NO Progressive Disease YES Primary Tumor 01 1 Cerebral Cortex YES NO YES HT Supratentorial, Temporal Lobe Central nervous system A DECEASED 2011 TCGA-HT-7469-01A-11D-2253-08 TCGA-HT-7469-01 BE83F0FA-7544-4D3D-88ED-5D79B45076C1 TCGA-HT-7469-01A-11D-2253-08 TCGA-HT-7469-01A-11D-2252-01 905404ec-68c8-45d8-a9ad-ec08cbe207f4 TCGA-HT-7469-01 TCGA-HT-7469-01 TCGA-HT-7469-01A-11D-2253-08 905404ec-68c8-45d8-a9ad-ec08cbe207f4 TCGA-HT-7469-01 TCGA-HT-7469-01 TCGA-HT-7469-01A-11D-2253-08 TCGA-HT-7469-01A-11D-2254-05 905404ec-68c8-45d8-a9ad-ec08cbe207f4 905404ec-68c8-45d8-a9ad-ec08cbe207f4 TCGA-HT-7469-01A-11D-2252-01 TCGA-HT-7469-01A-11D-2253-08 +TCGA-HT-7470-01 TCGA-HT-7470-01 TCGA-HT-7470 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 37 NO NO TCGA-HT-7470-F66413 TCGA-HT-7470 TCGA-HT-7470-01A -13611 1220 0 268 133 0 NO NO NO Headaches > 181 Days Scheduled Follow-up Submission Progressive Disease NO 2014-10-14 MALE NO YES Oligodendroglioma NO No C71.9 9451/3 C71.9 YES 1 NO 90 Right NO 1.3 NO NO NO NO G3 NO No TCGA-HT-7470.55af0dfb-afa8-4333-a0be-cb7addf4fee6.pdf 7470 Post-Adjuvant Therapy TUMOR FREE NO NO Progressive Disease YES Primary Tumor 01 YES YES 0.8 White Matter YES NO YES HT Supratentorial, Temporal Lobe Central nervous system A YES DECEASED 2011 TCGA-HT-7470-01A-12D-2086-08 TCGA-HT-7470-01 88CDB1FF-9953-4070-9700-5BF6503361EF TCGA-HT-7470-01A-12D-2086-08 TCGA-HT-7470-01A-12D-2085-01 31f32186-f631-434d-9c00-f2bbd4cced40 TCGA-HT-7470-01 TCGA-HT-7470-01 TCGA-HT-7470-01A-12D-2086-08 31f32186-f631-434d-9c00-f2bbd4cced40 TCGA-HT-7470-01 TCGA-HT-7470-01 TCGA-HT-7470-01A-12D-2086-08 TCGA-HT-7470-01A-12D-2087-05 31f32186-f631-434d-9c00-f2bbd4cced40 31f32186-f631-434d-9c00-f2bbd4cced40 TCGA-HT-7470-01A-12D-2085-01 TCGA-HT-7470-01A-12D-2086-08 +TCGA-HT-7471-01 TCGA-HT-7471-01 TCGA-HT-7471 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 37 NO NO TCGA-HT-7471-F50543 TCGA-HT-7471 TCGA-HT-7471-01A -13564 0 4 NO Motor/Movement Changes 0 - 30 Days Scheduled Follow-up Submission NO 2013-10-24 FEMALE NO NO Oligodendroglioma NO No C71.9 9451/3 C71.9 YES 0.9 NO Left 1.5 YES NO NO YES G3 No TCGA-HT-7471.424d1ea1-6333-45bb-b04e-027b47e6581e.pdf 7471 TUMOR FREE YES NO Primary Tumor 01 YES NO 0.4 Not listed in Medical Record NO YES HT Supratentorial, Temporal Lobe Central nervous system A NO LIVING 2010 TCGA-HT-7471-01A-11D-2253-08 TCGA-HT-7471-01 EE779B22-8F39-40BD-AB23-0CCEA58626CC TCGA-HT-7471-01A-11D-2253-08 TCGA-HT-7471-01A-11D-2252-01 80dac2db-4e32-4854-ba10-2d9aa059bf45 TCGA-HT-7471-01 TCGA-HT-7471-01 TCGA-HT-7471-01A-11D-2253-08 80dac2db-4e32-4854-ba10-2d9aa059bf45 TCGA-HT-7471-01 TCGA-HT-7471-01 TCGA-HT-7471-01A-11D-2253-08 TCGA-HT-7471-01A-11D-2254-05 80dac2db-4e32-4854-ba10-2d9aa059bf45 80dac2db-4e32-4854-ba10-2d9aa059bf45 TCGA-HT-7471-01A-11D-2252-01 TCGA-HT-7471-01A-11D-2253-08 +TCGA-HT-7472-01 TCGA-HT-7472-01 TCGA-HT-7472 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 38 NO NO TCGA-HT-7472-F28774 TCGA-HT-7472 TCGA-HT-7472-01A -13968 0 1 NO NO NO Seizures 91 - 180 Days Scheduled Follow-up Submission Stable Disease NO 2012-3-1 MALE NO NO Oligodendroglioma NO No C71.0 9450/3 C71.0 YES NO 1 NO Right NO 2.7 NO NO NO G2 NO No TCGA-HT-7472.5842f023-208b-48dd-9c9d-6644a928f4c2.pdf 7472 TUMOR FREE YES NO Stable Disease NO Primary Tumor 01 YES NO 1 Cerebral Cortex NO NO YES HT Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2010 TCGA-HT-7472-01A-11D-2024-08 TCGA-HT-7472-01 AEC5E7A2-6B1E-4047-B4FB-E0AF35CC61C0 TCGA-HT-7472-01A-11D-2024-08 TCGA-HT-7472-01A-11D-2023-01 cf6bfd15-1f21-48ab-975d-5e211c8b2fba TCGA-HT-7472-01 TCGA-HT-7472-01 TCGA-HT-7472-01A-11D-2024-08 cf6bfd15-1f21-48ab-975d-5e211c8b2fba TCGA-HT-7472-01 TCGA-HT-7472-01 TCGA-HT-7472-01A-11D-2024-08 TCGA-HT-7472-01A-11D-2025-05 cf6bfd15-1f21-48ab-975d-5e211c8b2fba cf6bfd15-1f21-48ab-975d-5e211c8b2fba TCGA-HT-7472-01A-11D-2023-01 TCGA-HT-7472-01A-11D-2024-08 +TCGA-HT-7473-01 TCGA-HT-7473-01 TCGA-HT-7473 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 28 NO NO TCGA-HT-7473-F29569 TCGA-HT-7473 TCGA-HT-7473-01A -10306 0 503 NO NO NO Headaches 0 - 30 Days Scheduled Follow-up Submission NO 2012-3-19 MALE NO YES Oligoastrocytoma NO No C71.9 9382/3 C71.9 YES 1.2 NO Right NO 1.5 NO NO YES G2 NO No TCGA-HT-7473.6f87a2ee-cb07-4d62-9f16-f5a47c866b01.pdf 7473 TUMOR FREE YES YES Complete Remission/Response YES Primary Tumor 01 NO NO 0.5 White Matter NO NO YES HT Supratentorial, Temporal Lobe Central nervous system A NO LIVING 2010 TCGA-HT-7473-01A-11D-2024-08 TCGA-HT-7473-01 2FA0161D-95ED-4CD3-8E61-DF9BBC46906B TCGA-HT-7473-01A-11D-2024-08 TCGA-HT-7473-01A-11D-2023-01 34f24020-97fd-4ead-a681-fb4d3957ea83 TCGA-HT-7473-01 TCGA-HT-7473-01 TCGA-HT-7473-01A-11D-2024-08 34f24020-97fd-4ead-a681-fb4d3957ea83 TCGA-HT-7473-01 TCGA-HT-7473-01 TCGA-HT-7473-01A-11D-2024-08 TCGA-HT-7473-01A-11D-2025-05 34f24020-97fd-4ead-a681-fb4d3957ea83 34f24020-97fd-4ead-a681-fb4d3957ea83 TCGA-HT-7473-01A-11D-2023-01 TCGA-HT-7473-01A-11D-2024-08 +TCGA-HT-7474-01 TCGA-HT-7474-01 TCGA-HT-7474 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 52 NO NO TCGA-HT-7474-F28779 TCGA-HT-7474 TCGA-HT-7474-01A -19149 0 114 NO YES NO Seizures 0 - 30 Days Scheduled Follow-up Submission Stable Disease NO 2012-3-1 MALE NO NO Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES NO 0.9 NO Right NO 1.4 NO NO YES G2 NO No TCGA-HT-7474.cef17048-e651-4025-b26e-8d1fc30d0af9.pdf 7474 TUMOR FREE YES NO Stable Disease NO Primary Tumor 01 YES NO 0.8 Not listed in Medical Record NO NO YES HT Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2011 TCGA-HT-7474-01A-11D-2024-08 TCGA-HT-7474-01 80D6A710-465A-4E93-8777-CBCB64288113 TCGA-HT-7474-01A-11D-2024-08 TCGA-HT-7474-01A-11D-2023-01 f6a8512b-7649-4ca0-aa55-5bf468e8931e TCGA-HT-7474-01 TCGA-HT-7474-01 TCGA-HT-7474-01A-11D-2024-08 f6a8512b-7649-4ca0-aa55-5bf468e8931e TCGA-HT-7474-01 TCGA-HT-7474-01 TCGA-HT-7474-01A-11D-2024-08 TCGA-HT-7474-01A-11D-2025-05 f6a8512b-7649-4ca0-aa55-5bf468e8931e f6a8512b-7649-4ca0-aa55-5bf468e8931e TCGA-HT-7474-01A-11D-2023-01 TCGA-HT-7474-01A-11D-2024-08 +TCGA-HT-7475-01 TCGA-HT-7475-01 TCGA-HT-7475 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 67 NO NO TCGA-HT-7475-F29411 TCGA-HT-7475 TCGA-HT-7475-01A -24686 0 530 209 NO YES NO Seizures 0 - 30 Days Scheduled Follow-up Submission Complete Remission/Response NO 2012-3-16 MALE NO NO Oligoastrocytoma NO No C71.9 9382/3 C71.9 YES NO 1.7 NO 70 Right NO 1.7 NO NO NO G3 NO No TCGA-HT-7475.5662d09d-0abc-4365-a532-9a620abb06e9.pdf 7475 Post-Adjuvant Therapy TUMOR FREE NO NO Complete Remission/Response YES Primary Tumor 01 YES NO 0.9 White Matter YES NO YES HT Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2010 TCGA-HT-7475-01A-11D-2024-08 TCGA-HT-7475-01 3DDAAA2A-F98F-452F-A0D5-CDDFE9E6BA93 TCGA-HT-7475-01A-11D-2024-08 TCGA-HT-7475-01A-11D-2023-01 c57ba10b-0485-4566-be4b-def8197360a4 TCGA-HT-7475-01 TCGA-HT-7475-01 TCGA-HT-7475-01A-11D-2024-08 c57ba10b-0485-4566-be4b-def8197360a4 TCGA-HT-7475-01 TCGA-HT-7475-01 TCGA-HT-7475-01A-11D-2024-08 TCGA-HT-7475-01A-11D-2025-05 c57ba10b-0485-4566-be4b-def8197360a4 c57ba10b-0485-4566-be4b-def8197360a4 TCGA-HT-7475-01A-11D-2023-01 TCGA-HT-7475-01A-11D-2024-08 +TCGA-HT-7476-01 TCGA-HT-7476-01 TCGA-HT-7476 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 26 NO NO TCGA-HT-7476-F21240 TCGA-HT-7476 TCGA-HT-7476-01A -9614 0 199 NO YES NO Seizures 31 - 90 Days Scheduled Follow-up Submission NO 2012-2-7 MALE NO YES Astrocytoma NO No C71.0 9400/3 C71.0 YES NO 0.7 NO Left NO 1.3 YES NO NO G2 NO No TCGA-HT-7476.8b010189-b14a-458f-98b9-8934205460fc.pdf 7476 TUMOR FREE YES NO Stable Disease YES Primary Tumor 01 YES YES 0.2 Cerebral Cortex YES NO YES HT Supratentorial, Temporal Lobe Central nervous system A NO LIVING 2011 TCGA-HT-7476-01A-11D-2024-08 TCGA-HT-7476-01 0443FBD2-70AF-473C-804B-D310A3180B7E TCGA-HT-7476-01A-11D-2024-08 TCGA-HT-7476-01A-11D-2023-01 cda7debf-70f9-4ea5-9018-35c560bd5ab0 TCGA-HT-7476-01 TCGA-HT-7476-01 TCGA-HT-7476-01A-11D-2024-08 cda7debf-70f9-4ea5-9018-35c560bd5ab0 TCGA-HT-7476-01 TCGA-HT-7476-01 TCGA-HT-7476-01A-11D-2024-08 TCGA-HT-7476-01A-11D-2025-05 cda7debf-70f9-4ea5-9018-35c560bd5ab0 cda7debf-70f9-4ea5-9018-35c560bd5ab0 TCGA-HT-7476-01A-11D-2023-01 TCGA-HT-7476-01A-11D-2024-08 +TCGA-HT-7477-01 TCGA-HT-7477-01 TCGA-HT-7477 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 62 NO NO TCGA-HT-7477-F45880 TCGA-HT-7477 TCGA-HT-7477-01B -22948 417 0 738 24 NO NO NO Motor/Movement Changes 31 - 90 Days Scheduled Follow-up Submission Complete Remission/Response NO 2013-7-24 MALE NO NO Astrocytoma NO No C71.0 9401/3 C71.0 YES 280 NO 80 Left NO NO NO YES G3 NO true No TCGA-HT-7477.0BCE1BFA-C7D1-4A3E-A9DE-E24ABF6E5C4F.pdf 7477 Post-Adjuvant Therapy TUMOR FREE Complete Remission/Response YES Primary Tumor 01 YES NO Not listed in Medical Record YES NO YES HT Supratentorial, Frontal Lobe Central nervous system B NO LIVING 2011 TCGA-HT-7477-01 D1DC89BE-35D2-4BD0-ACFB-53743F1E3476 TCGA-HT-7477-01B-11D-A289-08 TCGA-HT-7477-01B-11D-A288-01 5acf54e5-2288-4b40-b6f1-3ce549eceb36 TCGA-HT-7477-01 TCGA-HT-7477-01 TCGA-HT-7477-01B-11D-A289-08 5acf54e5-2288-4b40-b6f1-3ce549eceb36 TCGA-HT-7477-01 TCGA-HT-7477-01B-11D-A289-08 TCGA-HT-7477-01B-11D-A28N-05 5acf54e5-2288-4b40-b6f1-3ce549eceb36 5acf54e5-2288-4b40-b6f1-3ce549eceb36 TCGA-HT-7477-01B-11D-A288-01 TCGA-HT-7477-01B-11D-A289-08 +TCGA-HT-7478-01 TCGA-HT-7478-01 TCGA-HT-7478 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 36 NO NO TCGA-HT-7478-F29409 TCGA-HT-7478 TCGA-HT-7478-01A -13216 0 194 NO Seizures > 181 Days Scheduled Follow-up Submission Complete Remission/Response NO 2012-3-16 MALE NO YES Astrocytoma NO No C71.0 9400/3 C71.0 YES NO 0.8 NO Left NO 0.8 YES NO YES G2 NO No TCGA-HT-7478.9be4b6b7-f32a-413d-adb9-3ca98802e71b.pdf 7478 TUMOR FREE YES NO Complete Remission/Response YES Primary Tumor 01 YES YES 0.5 White Matter NO NO YES HT Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2011 TCGA-HT-7478-01 CD1443D8-5BD6-4E63-9580-E8A1FE3004ED TCGA-HT-7478-01A-11D-2024-08 TCGA-HT-7478-01A-11D-2023-01 ced731fa-332e-4c23-b3f9-2cea76a73029 TCGA-HT-7478-01 TCGA-HT-7478-01 TCGA-HT-7478-01A-11D-2024-08 ced731fa-332e-4c23-b3f9-2cea76a73029 TCGA-HT-7478-01 TCGA-HT-7478-01 TCGA-HT-7478-01A-11D-2024-08 TCGA-HT-7478-01A-11D-2025-05 ced731fa-332e-4c23-b3f9-2cea76a73029 ced731fa-332e-4c23-b3f9-2cea76a73029 TCGA-HT-7478-01A-11D-2023-01 TCGA-HT-7478-01A-11D-2024-08 +TCGA-HT-7479-01 TCGA-HT-7479-01 TCGA-HT-7479 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain NO NO YES 44 NO NO TCGA-HT-7479-F66425 TCGA-HT-7479 TCGA-HT-7479-01A 705 -16137 0 1227 705 NO YES YES Headaches > 181 Days Scheduled Follow-up Submission Complete Remission/Response NO 2014-10-14 MALE YES YES Astrocytoma NO No C71.9 9401/3 C71.9 YES NO 0.8 NO Right NO 1 NO NO NO NO G3 YES No TCGA-HT-7479.9bdf94b6-7e28-4c01-a392-c1ff7fd150d7.pdf 7479 TUMOR FREE NO NO Complete Remission/Response YES Primary Tumor 01 NO NO 0.6 White Matter YES NO YES HT Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2011 TCGA-HT-7479-01 88944C81-C0F4-41D1-BAFE-474DBD9AE895 TCGA-HT-7479-01A-11D-2024-08 TCGA-HT-7479-01A-11D-2023-01 52c20e74-8d7a-4e11-8981-8d2d32a33a32 TCGA-HT-7479-01 TCGA-HT-7479-01 TCGA-HT-7479-01A-11D-2024-08 52c20e74-8d7a-4e11-8981-8d2d32a33a32 TCGA-HT-7479-01 TCGA-HT-7479-01 TCGA-HT-7479-01A-11D-2024-08 TCGA-HT-7479-01A-11D-2025-05 52c20e74-8d7a-4e11-8981-8d2d32a33a32 52c20e74-8d7a-4e11-8981-8d2d32a33a32 TCGA-HT-7479-01A-11D-2023-01 TCGA-HT-7479-01A-11D-2024-08 +TCGA-HT-7480-01 TCGA-HT-7480-01 TCGA-HT-7480 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain YES NO YES 33 NO NO TCGA-HT-7480-F28787 TCGA-HT-7480 TCGA-HT-7480-01A 1943 -12291 0 2287 1943 NO YES NO Seizures > 181 Days Scheduled Follow-up Submission Progressive Disease NO 2012-3-1 MALE YES NO Oligodendroglioma NO No C71.9 9450/3 C71.9 YES NO 1.2 NO Right NO 1.8 NO NO YES G2 YES No TCGA-HT-7480.289b59d0-0a44-4d34-a991-b94846e470c3.pdf 7480 WITH TUMOR YES NO Stable Disease YES Primary Tumor 01 YES NO 0.3 Cerebral Cortex YES NO YES HT Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2005 TCGA-HT-7480-01A-11D-2086-08 TCGA-HT-7480-01 AB875836-F1E1-491A-BBE4-D117185A7CDF TCGA-HT-7480-01A-11D-2086-08 TCGA-HT-7480-01A-11D-2085-01 1eb669bc-04cc-474a-baae-cba7bea98a18 TCGA-HT-7480-01 TCGA-HT-7480-01 TCGA-HT-7480-01A-11D-2086-08 1eb669bc-04cc-474a-baae-cba7bea98a18 TCGA-HT-7480-01 TCGA-HT-7480-01 TCGA-HT-7480-01A-11D-2086-08 TCGA-HT-7480-01A-11D-2087-05 1eb669bc-04cc-474a-baae-cba7bea98a18 1eb669bc-04cc-474a-baae-cba7bea98a18 TCGA-HT-7480-01A-11D-2085-01 TCGA-HT-7480-01A-11D-2086-08 +TCGA-HT-7481-01 TCGA-HT-7481-01 TCGA-HT-7481 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain NO NO YES 39 NO NO TCGA-HT-7481-F66422 TCGA-HT-7481 TCGA-HT-7481-01A 3071 -14306 0 2918 3071 NO NO NO Seizures 0 - 30 Days Scheduled Follow-up Submission Partial Remission/Response NO 2014-10-14 MALE NO YES Oligodendroglioma NO No C71.9 9450/3 C71.9 YES NO 1 NO Right NO 2 NO NO NO YES G2 YES No TCGA-HT-7481.879a7f04-519f-44c0-bad3-32c637ab5955.pdf 7481 WITH TUMOR YES YES Partial Remission/Response YES Primary Tumor 01 YES NO 0.9 White Matter NO NO YES HT Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2006 TCGA-HT-7481-01 019C47B2-C021-469C-8681-F9F9A02A5F59 TCGA-HT-7481-01A-11D-2024-08 TCGA-HT-7481-01A-11D-2023-01 82a92ead-9cb1-473e-9a21-a6be1ddfbaba TCGA-HT-7481-01 TCGA-HT-7481-01 TCGA-HT-7481-01A-11D-2024-08 82a92ead-9cb1-473e-9a21-a6be1ddfbaba TCGA-HT-7481-01 TCGA-HT-7481-01 TCGA-HT-7481-01A-11D-2024-08 TCGA-HT-7481-01A-11D-2025-05 82a92ead-9cb1-473e-9a21-a6be1ddfbaba 82a92ead-9cb1-473e-9a21-a6be1ddfbaba TCGA-HT-7481-01A-11D-2023-01 TCGA-HT-7481-01A-11D-2024-08 +TCGA-HT-7482-01 TCGA-HT-7482-01 TCGA-HT-7482 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain NO NO YES 18 NO NO TCGA-HT-7482-F66423 TCGA-HT-7482 TCGA-HT-7482-01A 377 -6857 0 3253 374 NO NO NO Seizures 0 - 30 Days Scheduled Follow-up Submission Complete Remission/Response NO 2014-10-14 FEMALE NO NO Oligoastrocytoma NO No C71.9 9382/3 C71.9 YES NO 1 NO Left NO 1.7 NO NO NO NO G2 YES No TCGA-HT-7482.79a1bd03-dd03-4d45-9bd6-34b246eb3294.pdf 7482 TUMOR FREE YES NO Partial Remission/Response YES Primary Tumor 01 YES NO 1 Not listed in Medical Record YES NO YES HT Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2005 TCGA-HT-7482-01A-11D-2024-08 TCGA-HT-7482-01 56D1FF75-E7B1-4FDF-8A3E-873906C21AB3 TCGA-HT-7482-01A-11D-2024-08 TCGA-HT-7482-01A-11D-2023-01 ba0661be-f70f-4273-af82-911f189b2adb TCGA-HT-7482-01 TCGA-HT-7482-01 TCGA-HT-7482-01A-11D-2024-08 ba0661be-f70f-4273-af82-911f189b2adb TCGA-HT-7482-01 TCGA-HT-7482-01 TCGA-HT-7482-01A-11D-2024-08 TCGA-HT-7482-01A-11D-2025-05 ba0661be-f70f-4273-af82-911f189b2adb ba0661be-f70f-4273-af82-911f189b2adb TCGA-HT-7482-01A-11D-2023-01 TCGA-HT-7482-01A-11D-2024-08 +TCGA-HT-7483-01 TCGA-HT-7483-01 TCGA-HT-7483 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 14 NO NO TCGA-HT-7483-F45917 TCGA-HT-7483 TCGA-HT-7483-01A -5267 0 5255 NO YES NO Seizures Scheduled Follow-up Submission Complete Remission/Response NO 2013-7-25 MALE NO YES Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES 1 NO Right NO 1.3 NO YES NO YES G2 NO No TCGA-HT-7483.a5c5d547-2d3d-41df-a490-76350dc7e7c8.pdf 7483 TUMOR FREE Complete Remission/Response YES Primary Tumor 01 YES NO 0.5 White Matter YES NO YES HT Supratentorial, Frontal Lobe Central nervous system A NO LIVING 1998 TCGA-HT-7483-01A-11D-2024-08 TCGA-HT-7483-01 A34EF522-551F-4C68-95F3-4448BA82552F TCGA-HT-7483-01A-11D-2024-08 TCGA-HT-7483-01A-11D-2023-01 9dae5e73-aec6-461b-94e7-785065eea36e TCGA-HT-7483-01 TCGA-HT-7483-01 TCGA-HT-7483-01A-11D-2024-08 9dae5e73-aec6-461b-94e7-785065eea36e TCGA-HT-7483-01 TCGA-HT-7483-01 TCGA-HT-7483-01A-11D-2024-08 TCGA-HT-7483-01A-11D-2025-05 9dae5e73-aec6-461b-94e7-785065eea36e 9dae5e73-aec6-461b-94e7-785065eea36e TCGA-HT-7483-01A-11D-2023-01 TCGA-HT-7483-01A-11D-2024-08 +TCGA-HT-7485-01 TCGA-HT-7485-01 TCGA-HT-7485 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 42 NO NO TCGA-HT-7485-F28639 TCGA-HT-7485 TCGA-HT-7485-01A -15589 0 122 24 NO NO NO Headaches 91 - 180 Days Scheduled Follow-up Submission Complete Remission/Response NO 2012-3-2 MALE NO YES Astrocytoma NO No C71.9 9400/3 C71.9 YES NO 1.1 NO 100 Right NO 1.6 NO NO YES G2 NO No TCGA-HT-7485.5af016f0-9c44-4b57-8477-26e25f087c0f.pdf 7485 Post-Adjuvant Therapy TUMOR FREE NO NO Complete Remission/Response NO Primary Tumor 01 NO YES 0.7 White Matter NO NO YES HT Supratentorial, Parietal Lobe Central nervous system A NO LIVING 2006 TCGA-HT-7485-01 D90CF31B-39B1-4B2A-9493-1FF1583C9932 TCGA-HT-7485-01A-11D-2024-08 TCGA-HT-7485-01A-11D-2023-01 33ceeccf-d800-4e8b-928a-35765299cbaf TCGA-HT-7485-01 TCGA-HT-7485-01 TCGA-HT-7485-01A-11D-2024-08 33ceeccf-d800-4e8b-928a-35765299cbaf TCGA-HT-7485-01 TCGA-HT-7485-01 TCGA-HT-7485-01A-11D-2024-08 TCGA-HT-7485-01A-11D-2025-05 33ceeccf-d800-4e8b-928a-35765299cbaf 33ceeccf-d800-4e8b-928a-35765299cbaf TCGA-HT-7485-01A-11D-2023-01 TCGA-HT-7485-01A-11D-2024-08 +TCGA-HT-7601-01 TCGA-HT-7601-01 TCGA-HT-7601 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 30 NO NO TCGA-HT-7601-F29577 TCGA-HT-7601 TCGA-HT-7601-01A -10989 0 153 NO NO NO Seizures 0 - 30 Days Scheduled Follow-up Submission NO 2012-3-8 FEMALE NO NO Astrocytoma NO No C71.9 9401/3 C71.9 YES NO 1 NO Left NO 2.7 NO NO YES G3 NO No TCGA-HT-7601.2a8341ad-9d93-4a5f-b3f8-0ff0dfda1be7.pdf 7601 TUMOR FREE YES NO Partial Remission/Response YES Primary Tumor 01 YES NO 0.9 White Matter YES NO YES HT Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2008 TCGA-HT-7601-01A-11D-2086-08 TCGA-HT-7601-01 DE137AC1-21CB-407A-A168-43B123768C2C TCGA-HT-7601-01A-11D-2086-08 TCGA-HT-7601-01A-11D-2085-01 0b28fcb7-a5a5-41d1-b830-5f7c52d18e25 TCGA-HT-7601-01 TCGA-HT-7601-01 TCGA-HT-7601-01A-11D-2086-08 0b28fcb7-a5a5-41d1-b830-5f7c52d18e25 TCGA-HT-7601-01 TCGA-HT-7601-01 TCGA-HT-7601-01A-11D-2086-08 TCGA-HT-7601-01A-11D-2087-05 0b28fcb7-a5a5-41d1-b830-5f7c52d18e25 0b28fcb7-a5a5-41d1-b830-5f7c52d18e25 TCGA-HT-7601-01A-11D-2085-01 TCGA-HT-7601-01A-11D-2086-08 +TCGA-HT-7602-01 TCGA-HT-7602-01 TCGA-HT-7602 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 21 NO NO TCGA-HT-7602-F29573 TCGA-HT-7602 TCGA-HT-7602-01A -7946 0 908 NO NO NO Headaches 0 - 30 Days Scheduled Follow-up Submission NO 2012-3-16 MALE NO YES Oligodendroglioma NO No C71.9 9450/3 C71.9 YES NO 1 NO Right NO 2.8 NO NO NO G2 No TCGA-HT-7602.0ae8d27a-943e-48ac-8c70-c7fa3511ad2f.pdf 7602 TUMOR FREE NO Primary Tumor 01 NO NO 1 White Matter NO NO YES HT Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2008 TCGA-HT-7602-01A-21D-2086-08 TCGA-HT-7602-01 613AE1B5-CB65-487A-91D3-1991AFCA5A21 TCGA-HT-7602-01A-21D-2086-08 TCGA-HT-7602-01A-21D-2085-01 71fddbd0-c910-40f0-80fb-09148065220b TCGA-HT-7602-01 TCGA-HT-7602-01 TCGA-HT-7602-01A-21D-2086-08 71fddbd0-c910-40f0-80fb-09148065220b TCGA-HT-7602-01 TCGA-HT-7602-01 TCGA-HT-7602-01A-21D-2086-08 TCGA-HT-7602-01A-21D-2087-05 71fddbd0-c910-40f0-80fb-09148065220b 71fddbd0-c910-40f0-80fb-09148065220b TCGA-HT-7602-01A-21D-2085-01 TCGA-HT-7602-01A-21D-2086-08 +TCGA-HT-7603-01 TCGA-HT-7603-01 TCGA-HT-7603 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 29 NO NO TCGA-HT-7603-F29571 TCGA-HT-7603 TCGA-HT-7603-01A -10883 0 705 NO NO NO Headaches 0 - 30 Days Scheduled Follow-up Submission NO 2012-3-7 MALE NO YES Oligodendroglioma NO No C71.9 9450/3 C71.9 YES NO 1.2 NO NO 1.4 NO NO NO G2 NO No TCGA-HT-7603.1bae23f1-0f8d-4dcc-b47d-afb522675e88.pdf 7603 TUMOR FREE NO YES Complete Remission/Response YES Primary Tumor 01 NO NO 0.4 White Matter NO NO YES HT Supratentorial, Frontal Lobe Central nervous system A YES LIVING 2008 TCGA-HT-7603-01A-21D-2086-08 TCGA-HT-7603-01 786AD478-C3A7-4203-8DF8-2D0ABC0986AD TCGA-HT-7603-01A-21D-2086-08 TCGA-HT-7603-01A-21D-2085-01 fb8000a5-63e3-44ec-813d-e81482d53d07 TCGA-HT-7603-01 TCGA-HT-7603-01 TCGA-HT-7603-01A-21D-2086-08 fb8000a5-63e3-44ec-813d-e81482d53d07 TCGA-HT-7603-01 TCGA-HT-7603-01 TCGA-HT-7603-01A-21D-2086-08 TCGA-HT-7603-01A-21D-2087-05 fb8000a5-63e3-44ec-813d-e81482d53d07 fb8000a5-63e3-44ec-813d-e81482d53d07 TCGA-HT-7603-01A-21D-2085-01 TCGA-HT-7603-01A-21D-2086-08 +TCGA-HT-7604-01 TCGA-HT-7604-01 TCGA-HT-7604 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 50 NO NO TCGA-HT-7604-F48641 TCGA-HT-7604 TCGA-HT-7604-01A -18443 0 3725 NO NO NO Headaches 31 - 90 Days Scheduled Follow-up Submission Partial Remission/Response NO 2013-9-18 MALE NO YES Astrocytoma NO No C71.0 9400/3 C71.0 YES 1.2 NO Left NO 1.7 NO YES NO YES G2 NO No TCGA-HT-7604.ecac7160-5404-42f2-90d3-c43d1b8bb747.pdf 7604 TUMOR FREE YES YES Partial Remission/Response YES Primary Tumor 01 YES NO 0.4 Not listed in Medical Record YES NO YES HT Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2003 TCGA-HT-7604-01A-11D-2086-08 TCGA-HT-7604-01 1C756426-0444-4055-B7B3-CB817D8E69BE TCGA-HT-7604-01A-11D-2086-08 TCGA-HT-7604-01A-11D-2085-01 09500c89-0578-415c-9df3-73ae02acbdab TCGA-HT-7604-01 TCGA-HT-7604-01 TCGA-HT-7604-01A-11D-2086-08 09500c89-0578-415c-9df3-73ae02acbdab TCGA-HT-7604-01 TCGA-HT-7604-01 TCGA-HT-7604-01A-11D-2086-08 TCGA-HT-7604-01A-11D-2087-05 09500c89-0578-415c-9df3-73ae02acbdab 09500c89-0578-415c-9df3-73ae02acbdab TCGA-HT-7604-01A-11D-2085-01 TCGA-HT-7604-01A-11D-2086-08 +TCGA-HT-7605-01 TCGA-HT-7605-01 TCGA-HT-7605 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 38 NO NO TCGA-HT-7605-F29603 TCGA-HT-7605 TCGA-HT-7605-01A -13892 0 139 NO YES NO < 12 Years Motor/Movement Changes Scheduled Follow-up Submission NO 2012-3-15 MALE YES NO Oligodendroglioma NO No C71.9 9450/3 C71.9 YES 0.9 NO Right NO 2 NO YES YES G2 NO No TCGA-HT-7605.820c0259-c976-48cc-af5a-3e2bc11bd4e8.pdf 7605 NO Primary Tumor 01 NO NO 0.8 White Matter NO NO YES HT Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2008 TCGA-HT-7605-01A-11D-2086-08 TCGA-HT-7605-01 800F3EE7-B19F-4892-BF74-7FDC6C10C77C TCGA-HT-7605-01A-11D-2086-08 TCGA-HT-7605-01A-11D-2085-01 ba1613b5-3076-4fc5-8da0-f0e951d077ef TCGA-HT-7605-01 TCGA-HT-7605-01 TCGA-HT-7605-01A-11D-2086-08 ba1613b5-3076-4fc5-8da0-f0e951d077ef TCGA-HT-7605-01 TCGA-HT-7605-01 TCGA-HT-7605-01A-11D-2086-08 TCGA-HT-7605-01A-11D-2087-05 ba1613b5-3076-4fc5-8da0-f0e951d077ef ba1613b5-3076-4fc5-8da0-f0e951d077ef TCGA-HT-7605-01A-11D-2085-01 TCGA-HT-7605-01A-11D-2086-08 +TCGA-HT-7606-01 TCGA-HT-7606-01 TCGA-HT-7606 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 30 NO TCGA-HT-7606-F29692 TCGA-HT-7606 TCGA-HT-7606-01A -11233 0 526 NO NO NO Headaches > 181 Days Scheduled Follow-up Submission NO 2012-3-27 FEMALE NO YES Astrocytoma NO No C71.9 9400/3 C71.9 YES 0.8 NO Left 1.2 NO NO NO G2 NO No TCGA-HT-7606.4f988b76-fc06-45af-a537-a90d72713a70.pdf 7606 TUMOR FREE Complete Remission/Response YES Primary Tumor 01 NO NO 0.7 Not listed in Medical Record YES NO YES HT Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2008 TCGA-HT-7606-01A-11D-2086-08 TCGA-HT-7606-01 FCD74548-97A4-4793-B0C1-0387D2F6A0CD TCGA-HT-7606-01A-11D-2086-08 TCGA-HT-7606-01A-11D-2085-01 faeb1918-077c-417e-9acc-9733b756511c TCGA-HT-7606-01 TCGA-HT-7606-01 TCGA-HT-7606-01A-11D-2086-08 faeb1918-077c-417e-9acc-9733b756511c TCGA-HT-7606-01 TCGA-HT-7606-01 TCGA-HT-7606-01A-11D-2086-08 TCGA-HT-7606-01A-11D-2087-05 faeb1918-077c-417e-9acc-9733b756511c faeb1918-077c-417e-9acc-9733b756511c TCGA-HT-7606-01A-11D-2085-01 TCGA-HT-7606-01A-11D-2086-08 +TCGA-HT-7607-01 TCGA-HT-7607-01 TCGA-HT-7607 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 61 NO NO TCGA-HT-7607-F35003 TCGA-HT-7607 TCGA-HT-7607-01A -22585 96 0 8 NO NO NO Seizures 31 - 90 Days Scheduled Follow-up Submission Progressive Disease NO 2012-9-12 FEMALE YES YES Astrocytoma NO No C71.0 9400/3 C71.0 YES NO 1p19q codeleted 1 NO 70 Left NO 2.2 NO YES NO NO G2 NO No TCGA-HT-7607.564d0fdc-517d-4cc7-817b-af5f9280f4bd.pdf 7607 Pre-Adjuvant Therapy WITH TUMOR YES NO Progressive Disease NO Primary Tumor 01 YES NO 0.8 White Matter NO NO YES HT Supratentorial, Frontal Lobe Central nervous system A NO DECEASED 2008 TCGA-HT-7607-01A-11D-2086-08 TCGA-HT-7607-01 5C348AD3-A5B9-4B50-880D-7AC80082CB4F TCGA-HT-7607-01A-11D-2086-08 TCGA-HT-7607-01A-11D-2085-01 a0187097-fff8-497c-87df-ae5d5cc151c1 TCGA-HT-7607-01 TCGA-HT-7607-01 TCGA-HT-7607-01A-11D-2086-08 a0187097-fff8-497c-87df-ae5d5cc151c1 TCGA-HT-7607-01 TCGA-HT-7607-01 TCGA-HT-7607-01A-11D-2086-08 TCGA-HT-7607-01A-11D-2087-05 a0187097-fff8-497c-87df-ae5d5cc151c1 a0187097-fff8-497c-87df-ae5d5cc151c1 TCGA-HT-7607-01A-11D-2085-01 TCGA-HT-7607-01A-11D-2086-08 +TCGA-HT-7608-01 TCGA-HT-7608-01 TCGA-HT-7608 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 61 NO NO TCGA-HT-7608-F28803 TCGA-HT-7608 TCGA-HT-7608-01A -22302 0 671 NO NO NO Motor/Movement Changes 0 - 30 Days Scheduled Follow-up Submission Stable Disease NO 2012-3-1 MALE NO NO Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES NO 1p19q deletion 0.9 NO Right NO 2.2 NO NO YES G2 NO No TCGA-HT-7608.3e9306b1-c5bc-48e4-9bc2-cd928aef0584.pdf 7608 TUMOR FREE NO NO Stable Disease NO Primary Tumor 01 YES NO 0.5 White Matter NO NO YES HT Supratentorial, Temporal Lobe Central nervous system A NO LIVING 2007 TCGA-HT-7608-01A-11D-2086-08 TCGA-HT-7608-01 E58537BF-4EAA-42E6-9D0C-01B8B8129633 TCGA-HT-7608-01A-11D-2086-08 TCGA-HT-7608-01A-11D-2085-01 65a188b3-1fc9-4021-bc3e-158c0cce2c8e TCGA-HT-7608-01 TCGA-HT-7608-01 TCGA-HT-7608-01A-11D-2086-08 65a188b3-1fc9-4021-bc3e-158c0cce2c8e TCGA-HT-7608-01 TCGA-HT-7608-01A-11D-2086-08 TCGA-HT-7608-01A-11D-2087-05 65a188b3-1fc9-4021-bc3e-158c0cce2c8e 65a188b3-1fc9-4021-bc3e-158c0cce2c8e TCGA-HT-7608-01A-11D-2085-01 TCGA-HT-7608-01A-11D-2086-08 +TCGA-HT-7609-01 TCGA-HT-7609-01 TCGA-HT-7609 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 34 NO YES TCGA-HT-7609-F28823 TCGA-HT-7609 TCGA-HT-7609-01A -12607 0 1399 1 NO NO NO Headaches 31 - 90 Days Scheduled Follow-up Submission Stable Disease NO 2012-3-1 MALE NO YES Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES NO 1 NO 90 Right NO 3.5 YES NO NO G3 NO No TCGA-HT-7609.d6e4b412-5a31-4cac-be39-ce4342f73be6.pdf 7609 Pre-Adjuvant Therapy TUMOR FREE NO NO Stable Disease YES Primary Tumor 01 NO NO 1 White Matter YES NO YES HT Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2007 TCGA-HT-7609-01A-11D-2086-08 TCGA-HT-7609-01 01B98B0E-BBFC-4E0F-934A-3A6AC9486342 TCGA-HT-7609-01A-11D-2086-08 TCGA-HT-7609-01A-11D-2085-01 b520d7b8-846f-4ba1-93eb-4891a0d99e72 TCGA-HT-7609-01 TCGA-HT-7609-01 TCGA-HT-7609-01A-11D-2086-08 b520d7b8-846f-4ba1-93eb-4891a0d99e72 TCGA-HT-7609-01 TCGA-HT-7609-01 TCGA-HT-7609-01A-11D-2086-08 TCGA-HT-7609-01A-11D-2087-05 b520d7b8-846f-4ba1-93eb-4891a0d99e72 b520d7b8-846f-4ba1-93eb-4891a0d99e72 TCGA-HT-7609-01A-11D-2085-01 TCGA-HT-7609-01A-11D-2086-08 +TCGA-HT-7610-01 TCGA-HT-7610-01 TCGA-HT-7610 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain NO YES YES 25 NO NO TCGA-HT-7610-F28944 TCGA-HT-7610 TCGA-HT-7610-01A 1205 -9447 0 1706 1205 NO NO NO Seizures > 181 Days Scheduled Follow-up Submission Stable Disease NO 2012-3-2 FEMALE NO YES Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES NO 0.9 NO Left NO 1.5 NO NO NO G2 YES No TCGA-HT-7610.f33a23ff-73c6-4aea-a9c0-9a794368ddc1.pdf 7610 TUMOR FREE YES NO Stable Disease NO Primary Tumor 01 YES NO 0.6 White Matter NO NO YES HT Supratentorial, Temporal Lobe Central nervous system A NO LIVING 2007 TCGA-HT-7610-01A-21D-2086-08 TCGA-HT-7610-01 EBB1C603-076A-4346-9900-050E079F3D29 TCGA-HT-7610-01A-21D-2086-08 TCGA-HT-7610-01A-21D-2085-01 a48f9376-bff1-4939-8d52-349e471b650f TCGA-HT-7610-01 TCGA-HT-7610-01 TCGA-HT-7610-01A-21D-2086-08 a48f9376-bff1-4939-8d52-349e471b650f TCGA-HT-7610-01 TCGA-HT-7610-01 TCGA-HT-7610-01A-21D-2086-08 TCGA-HT-7610-01A-21D-2087-05 a48f9376-bff1-4939-8d52-349e471b650f a48f9376-bff1-4939-8d52-349e471b650f TCGA-HT-7610-01A-21D-2085-01 TCGA-HT-7610-01A-21D-2086-08 +TCGA-HT-7611-01 TCGA-HT-7611-01 TCGA-HT-7611 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 36 NO NO TCGA-HT-7611-F51026 TCGA-HT-7611 TCGA-HT-7611-01A -13314 0 1752 NO NO NO Scheduled Follow-up Submission NO 2013-11-5 MALE NO NO Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES 0.9 NO 90 Right 2 YES NO NO NO G2 NO No TCGA-HT-7611.3010cc40-0d85-403e-b6fa-d4ee92f58ecb.pdf 7611 Other TUMOR FREE Complete Remission/Response NO Primary Tumor 01 NO NO 0.8 Not listed in Medical Record NO NO YES HT Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2007 TCGA-HT-7611-01 383AC2F2-4CA0-4660-9AD2-99A2BEDF08B3 TCGA-HT-7611-01A-11D-2395-08 TCGA-HT-7611-01A-11D-2391-01 e4762187-c19b-40d5-8385-ecb21f3ec6c3 TCGA-HT-7611-01 TCGA-HT-7611-01 TCGA-HT-7611-01A-11D-2395-08 e4762187-c19b-40d5-8385-ecb21f3ec6c3 TCGA-HT-7611-01 TCGA-HT-7611-01 TCGA-HT-7611-01A-11D-2395-08 TCGA-HT-7611-01A-11D-2399-05 e4762187-c19b-40d5-8385-ecb21f3ec6c3 e4762187-c19b-40d5-8385-ecb21f3ec6c3 TCGA-HT-7611-01A-11D-2391-01 TCGA-HT-7611-01A-11D-2395-08 +TCGA-HT-7616-01 TCGA-HT-7616-01 TCGA-HT-7616 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 75 NO NO TCGA-HT-7616-F28640 TCGA-HT-7616 TCGA-HT-7616-01A -27685 7 0 NO NO NO Seizures 0 - 30 Days Scheduled Follow-up Submission Progressive Disease 2012-2-27 MALE NO NO Oligodendroglioma NO No C71.9 9451/3 C71.9 YES NO 0.9 NO Right NO 1.3 YES NO YES G3 NO No TCGA-HT-7616.d8e58500-52b1-4fad-8a36-7ddec42b5632.pdf 7616 WITH TUMOR NO NO Progressive Disease NO Primary Tumor 01 YES NO 0.3 Not listed in Medical Record NO NO YES HT Supratentorial, Frontal Lobe Central nervous system A NO DECEASED 2007 TCGA-HT-7616-01A-11D-2253-08 TCGA-HT-7616-01 91E4F8C1-4FDD-4FBD-B031-CF4C7CC9A14E TCGA-HT-7616-01A-11D-2253-08 TCGA-HT-7616-01A-11D-2252-01 31a34ec1-460d-4768-a8aa-03c81c3226be TCGA-HT-7616-01 TCGA-HT-7616-01 TCGA-HT-7616-01A-11D-2253-08 31a34ec1-460d-4768-a8aa-03c81c3226be TCGA-HT-7616-01 TCGA-HT-7616-01 TCGA-HT-7616-01A-11D-2253-08 TCGA-HT-7616-01A-11D-2254-05 31a34ec1-460d-4768-a8aa-03c81c3226be 31a34ec1-460d-4768-a8aa-03c81c3226be TCGA-HT-7616-01A-11D-2252-01 TCGA-HT-7616-01A-11D-2253-08 +TCGA-HT-7620-01 TCGA-HT-7620-01 TCGA-HT-7620 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain YES NO NO 40 NO NO TCGA-HT-7620-F29125 TCGA-HT-7620 TCGA-HT-7620-01A -14659 0 434 280 NO NO NO Headaches 0 - 30 Days Scheduled Follow-up Submission Progressive Disease NO 2012-3-8 MALE YES YES Oligodendroglioma NO No C71.9 9451/3 C71.9 YES NO 1.1 NO Left NO 3.7 NO NO YES G3 YES No TCGA-HT-7620.4115a114-29b2-4f53-a7df-fb4e60b3e76a.pdf 7620 TUMOR FREE YES YES Complete Remission/Response YES Primary Tumor 01 NO YES 0.6 White Matter YES NO YES HT Supratentorial, Frontal Lobe Central nervous system A YES LIVING 2007 TCGA-HT-7620-01A-11D-2253-08 TCGA-HT-7620-01 084D218F-2567-4141-859A-5387F89F0301 TCGA-HT-7620-01A-11D-2253-08 TCGA-HT-7620-01A-11D-2252-01 62b17846-7d74-4a34-bbed-48c4c9e462f9 TCGA-HT-7620-01 TCGA-HT-7620-01 TCGA-HT-7620-01A-11D-2253-08 62b17846-7d74-4a34-bbed-48c4c9e462f9 TCGA-HT-7620-01 TCGA-HT-7620-01 TCGA-HT-7620-01A-11D-2253-08 TCGA-HT-7620-01A-11D-2254-05 62b17846-7d74-4a34-bbed-48c4c9e462f9 62b17846-7d74-4a34-bbed-48c4c9e462f9 TCGA-HT-7620-01A-11D-2252-01 TCGA-HT-7620-01A-11D-2253-08 +TCGA-HT-7676-01 TCGA-HT-7676-01 TCGA-HT-7676 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 26 TCGA-HT-7676-F51023 TCGA-HT-7676 TCGA-HT-7676-01A -9667 0 5 Headaches 0 - 30 Days Scheduled Follow-up Submission 2013-11-5 MALE YES Oligodendroglioma NO No C71.0 9450/3 C71.0 YES 1.2 NO Left 1.9 YES NO NO G2 No TCGA-HT-7676.275566dc-510f-46f1-8e3d-7141885f4754.pdf 7676 TUMOR FREE Primary Tumor 01 YES NO 0.4 Not listed in Medical Record NO YES HT Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2009 TCGA-HT-7676-01 44056024-7893-4AEE-AF5E-C103BEA90B4B TCGA-HT-7676-01A-11D-2395-08 TCGA-HT-7676-01A-11D-2391-01 cb18ceb5-73e7-44d7-8ab0-96b832e980bd TCGA-HT-7676-01 TCGA-HT-7676-01 TCGA-HT-7676-01A-11D-2395-08 cb18ceb5-73e7-44d7-8ab0-96b832e980bd TCGA-HT-7676-01 TCGA-HT-7676-01 TCGA-HT-7676-01A-11D-2395-08 TCGA-HT-7676-01A-11D-2399-05 cb18ceb5-73e7-44d7-8ab0-96b832e980bd cb18ceb5-73e7-44d7-8ab0-96b832e980bd TCGA-HT-7676-01A-11D-2391-01 TCGA-HT-7676-01A-11D-2395-08 +TCGA-HT-7677-01 TCGA-HT-7677-01 TCGA-HT-7677 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 53 NO NO TCGA-HT-7677-F28945 TCGA-HT-7677 TCGA-HT-7677-01A -19610 0 494 NO NO NO Motor/Movement Changes > 181 Days Scheduled Follow-up Submission Stable Disease NO 2012-3-2 MALE NO NO Oligodendroglioma NO No C71.0 9451/3 C71.0 YES NO 1.1 NO Left NO 2.1 YES NO YES G3 NO No TCGA-HT-7677.816ea52a-dca4-48f4-8fbb-4a6ff64d1fb4.pdf 7677 WITH TUMOR NO NO Stable Disease YES Primary Tumor 01 NO NO 0.7 White Matter YES NO YES HT Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2009 TCGA-HT-7677-01A-11D-2253-08 TCGA-HT-7677-01 C5156875-559B-443E-A7FA-7BA5CBBC83A2 TCGA-HT-7677-01A-11D-2253-08 TCGA-HT-7677-01A-11D-2252-01 22dcbc1b-95f2-4343-b1e4-18daacd66e28 TCGA-HT-7677-01 TCGA-HT-7677-01 TCGA-HT-7677-01A-11D-2253-08 22dcbc1b-95f2-4343-b1e4-18daacd66e28 TCGA-HT-7677-01 TCGA-HT-7677-01 TCGA-HT-7677-01A-11D-2253-08 TCGA-HT-7677-01A-11D-2254-05 22dcbc1b-95f2-4343-b1e4-18daacd66e28 22dcbc1b-95f2-4343-b1e4-18daacd66e28 TCGA-HT-7677-01A-11D-2252-01 TCGA-HT-7677-01A-11D-2253-08 +TCGA-HT-7680-01 TCGA-HT-7680-01 TCGA-HT-7680 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain NO NO 32 NO NO TCGA-HT-7680-F28949 TCGA-HT-7680 TCGA-HT-7680-01A -11970 0 23 NO NO NO Headaches > 181 Days Scheduled Follow-up Submission Stable Disease NO 2012-3-2 FEMALE NO YES Astrocytoma NO No C71.9 9400/3 C71.9 YES NO 1 NO Midline NO 1.6 NO NO YES G2 NO No TCGA-HT-7680.156c9439-4f38-45cb-ab67-d0be08fa04fc.pdf 7680 TUMOR FREE NO NO Stable Disease NO Primary Tumor 01 NO NO 0.5 White Matter NO NO YES HT Posterior Fossa, Cerebellum Central nervous system A NO LIVING 2010 TCGA-HT-7680-01A-11D-2253-08 TCGA-HT-7680-01 49523293-2CDD-4404-A5FA-9DC7A820EBF0 TCGA-HT-7680-01A-11D-2253-08 TCGA-HT-7680-01A-11D-2252-01 3042bdd7-5fc9-4428-afcc-ecd76f71d68d TCGA-HT-7680-01 TCGA-HT-7680-01 TCGA-HT-7680-01A-11D-2253-08 3042bdd7-5fc9-4428-afcc-ecd76f71d68d TCGA-HT-7680-01 TCGA-HT-7680-01 TCGA-HT-7680-01A-11D-2253-08 TCGA-HT-7680-01A-11D-2254-05 3042bdd7-5fc9-4428-afcc-ecd76f71d68d 3042bdd7-5fc9-4428-afcc-ecd76f71d68d TCGA-HT-7680-01A-11D-2252-01 TCGA-HT-7680-01A-11D-2253-08 +TCGA-HT-7681-01 TCGA-HT-7681-01 TCGA-HT-7681 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 29 TCGA-HT-7681-F45882 TCGA-HT-7681 TCGA-HT-7681-01A -10790 0 1359 Scheduled Follow-up Submission Complete Remission/Response 2013-7-24 FEMALE Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES 0.9 NO Right 2.8 NO G2 NO No TCGA-HT-7681.d6ca1fd7-edd7-432c-a296-1cce50ce71df.pdf 7681 TUMOR FREE Complete Remission/Response NO Primary Tumor 01 0.6 Not listed in Medical Record NO NO YES HT Supratentorial, Frontal Lobe Central nervous system A LIVING 2009 TCGA-HT-7681-01 CA7D50C5-A1F3-4529-865E-F7EE78926BC4 TCGA-HT-7681-01A-11D-2395-08 TCGA-HT-7681-01A-11D-2391-01 12391798-07e4-44bd-9689-db2f95f6d710 TCGA-HT-7681-01 TCGA-HT-7681-01 TCGA-HT-7681-01A-11D-2395-08 12391798-07e4-44bd-9689-db2f95f6d710 TCGA-HT-7681-01 TCGA-HT-7681-01 TCGA-HT-7681-01A-11D-2395-08 TCGA-HT-7681-01A-11D-2399-05 12391798-07e4-44bd-9689-db2f95f6d710 12391798-07e4-44bd-9689-db2f95f6d710 TCGA-HT-7681-01A-11D-2391-01 TCGA-HT-7681-01A-11D-2395-08 +TCGA-HT-7684-01 TCGA-HT-7684-01 TCGA-HT-7684 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 58 NO NO TCGA-HT-7684-F29412 TCGA-HT-7684 TCGA-HT-7684-01A -21352 0 184 NO NO NO Headaches 0 - 30 Days Scheduled Follow-up Submission Complete Remission/Response NO 2012-3-16 MALE NO YES Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES NO 0.9 NO Left NO 1.7 YES NO NO G3 NO No TCGA-HT-7684.02500cb1-2f28-4624-b001-f5913284295e.pdf 7684 TUMOR FREE NO NO Complete Remission/Response NO Primary Tumor 01 NO YES 0.9 White Matter NO NO YES HT Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2008 TCGA-HT-7684-01A-11D-2253-08 TCGA-HT-7684-01 07F5EC8D-F856-42D1-9843-D072B2F8B15E TCGA-HT-7684-01A-11D-2253-08 TCGA-HT-7684-01A-11D-2252-01 2d0cb65e-cd71-431a-9eaa-9e0844446d63 TCGA-HT-7684-01 TCGA-HT-7684-01 TCGA-HT-7684-01A-11D-2253-08 2d0cb65e-cd71-431a-9eaa-9e0844446d63 TCGA-HT-7684-01 TCGA-HT-7684-01 TCGA-HT-7684-01A-11D-2253-08 TCGA-HT-7684-01A-11D-2254-05 2d0cb65e-cd71-431a-9eaa-9e0844446d63 2d0cb65e-cd71-431a-9eaa-9e0844446d63 TCGA-HT-7684-01A-11D-2252-01 TCGA-HT-7684-01A-11D-2253-08 +TCGA-HT-7686-01 TCGA-HT-7686-01 TCGA-HT-7686 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 29 NO NO TCGA-HT-7686-F29415 TCGA-HT-7686 TCGA-HT-7686-01A -10724 0 1300 231 NO Headaches > 181 Days Scheduled Follow-up Submission Complete Remission/Response NO 2012-3-16 FEMALE NO YES Astrocytoma NO No C71.0 9401/3 C71.0 YES NO 0.9 NO 90 Left NO 2 NO NO NO G3 NO No TCGA-HT-7686.1be5b4db-9b53-4b2f-b44b-1383788d473c.pdf 7686 Post-Adjuvant Therapy TUMOR FREE YES YES Complete Remission/Response YES Primary Tumor 01 NO NO 0.6 Not listed in Medical Record YES NO YES HT Supratentorial, Parietal Lobe Central nervous system A YES LIVING 2008 TCGA-HT-7686-01A-11D-2253-08 TCGA-HT-7686-01 B1DD4831-D9F0-466C-8999-D2792C6899AC TCGA-HT-7686-01A-11D-2253-08 TCGA-HT-7686-01A-11D-2252-01 65955c38-4907-4b09-8ef6-94a6b9ff5817 TCGA-HT-7686-01 TCGA-HT-7686-01 TCGA-HT-7686-01A-11D-2253-08 65955c38-4907-4b09-8ef6-94a6b9ff5817 TCGA-HT-7686-01 TCGA-HT-7686-01 TCGA-HT-7686-01A-11D-2253-08 TCGA-HT-7686-01A-11D-2254-05 65955c38-4907-4b09-8ef6-94a6b9ff5817 65955c38-4907-4b09-8ef6-94a6b9ff5817 TCGA-HT-7686-01A-11D-2252-01 TCGA-HT-7686-01A-11D-2253-08 +TCGA-HT-7687-01 TCGA-HT-7687-01 TCGA-HT-7687 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 74 TCGA-HT-7687-F28642 TCGA-HT-7687 TCGA-HT-7687-01A -27186 0 3 YES NO Visual Changes > 181 Days Scheduled Follow-up Submission 2012-2-27 MALE NO Oligodendroglioma NO No C71.0 9451/3 C71.0 YES NO 1.1 NO Right NO 1.9 NO NO G3 No TCGA-HT-7687.f1bff6bc-cba4-4986-b4a1-e04dae6f259e.pdf 7687 TUMOR FREE NO NO Stable Disease Primary Tumor 01 NO YES 0.4 Not listed in Medical Record NO YES HT Supratentorial, Frontal Lobe Central nervous system A YES LIVING 2010 TCGA-HT-7687-01A-11D-2253-08 TCGA-HT-7687-01 93995BE4-E0CF-4133-BCB3-C47938C46651 TCGA-HT-7687-01A-11D-2253-08 TCGA-HT-7687-01A-11D-2252-01 fc4a13f0-831a-4e31-a2a1-29486bf9d006 TCGA-HT-7687-01 TCGA-HT-7687-01 TCGA-HT-7687-01A-11D-2253-08 fc4a13f0-831a-4e31-a2a1-29486bf9d006 TCGA-HT-7687-01 TCGA-HT-7687-01 TCGA-HT-7687-01A-11D-2253-08 TCGA-HT-7687-01A-11D-2254-05 fc4a13f0-831a-4e31-a2a1-29486bf9d006 fc4a13f0-831a-4e31-a2a1-29486bf9d006 TCGA-HT-7687-01A-11D-2252-01 TCGA-HT-7687-01A-11D-2253-08 +TCGA-HT-7688-01 TCGA-HT-7688-01 TCGA-HT-7688 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 59 NO NO TCGA-HT-7688-F29413 TCGA-HT-7688 TCGA-HT-7688-01A -21844 0 964 NO YES NO Headaches > 181 Days Scheduled Follow-up Submission Complete Remission/Response NO 2012-3-16 MALE YES YES Oligodendroglioma NO No C71.0 9451/3 C71.0 YES NO 0.9 NO Left NO 2.3 NO NO YES G3 NO No TCGA-HT-7688.35d09648-037f-4e5e-b70b-4f17cc8f2fb3.pdf 7688 TUMOR FREE YES YES Complete Remission/Response YES Primary Tumor 01 YES NO 0.6 White Matter YES NO YES HT Supratentorial, Frontal Lobe Central nervous system A YES LIVING 2009 TCGA-HT-7688-01A-11D-2253-08 TCGA-HT-7688-01 14F61525-8EAB-45C3-891C-46281D68E64C TCGA-HT-7688-01A-11D-2253-08 TCGA-HT-7688-01A-11D-2252-01 049ee2d6-c67a-42e2-a39d-2eb15650ca63 TCGA-HT-7688-01 TCGA-HT-7688-01 TCGA-HT-7688-01A-11D-2253-08 049ee2d6-c67a-42e2-a39d-2eb15650ca63 TCGA-HT-7688-01 TCGA-HT-7688-01 TCGA-HT-7688-01A-11D-2253-08 TCGA-HT-7688-01A-11D-2254-05 049ee2d6-c67a-42e2-a39d-2eb15650ca63 049ee2d6-c67a-42e2-a39d-2eb15650ca63 TCGA-HT-7688-01A-11D-2252-01 TCGA-HT-7688-01A-11D-2253-08 +TCGA-HT-7689-01 TCGA-HT-7689-01 TCGA-HT-7689 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 58 NO NO TCGA-HT-7689-F29648 TCGA-HT-7689 TCGA-HT-7689-01A -21331 0 455 455 NO NO NO Mental Status Changes 0 - 30 Days Scheduled Follow-up Submission NO 2012-3-27 FEMALE NO NO Oligodendroglioma NO No C71.0 9450/3 C71.0 YES 1 NO 70 Left 1.2 YES NO YES G2 NO No TCGA-HT-7689.21e316fb-fd2b-4890-a34a-832781031216.pdf 7689 Post-Adjuvant Therapy TUMOR FREE Complete Remission/Response YES Primary Tumor 01 NO NO 0.7 Not listed in Medical Record YES NO YES HT Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2009 TCGA-HT-7689-01A-11D-2253-08 TCGA-HT-7689-01 C617BDCE-7C2E-4DAE-8EDD-DB0E8153D287 TCGA-HT-7689-01A-11D-2253-08 TCGA-HT-7689-01A-11D-2252-01 477e059b-1b0a-4f2b-b14d-8e1362fc38ee TCGA-HT-7689-01 TCGA-HT-7689-01 TCGA-HT-7689-01A-11D-2253-08 477e059b-1b0a-4f2b-b14d-8e1362fc38ee TCGA-HT-7689-01 TCGA-HT-7689-01 TCGA-HT-7689-01A-11D-2253-08 TCGA-HT-7689-01A-11D-2254-05 477e059b-1b0a-4f2b-b14d-8e1362fc38ee 477e059b-1b0a-4f2b-b14d-8e1362fc38ee TCGA-HT-7689-01A-11D-2252-01 TCGA-HT-7689-01A-11D-2253-08 +TCGA-HT-7690-01 TCGA-HT-7690-01 TCGA-HT-7690 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 29 NO NO TCGA-HT-7690-F29644 TCGA-HT-7690 TCGA-HT-7690-01A -10673 0 3 NO NO NO Headaches 31 - 90 Days Scheduled Follow-up Submission NO 2012-3-15 MALE NO YES Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES 0.9 NO Right NO 1.5 YES NO NO G3 NO No TCGA-HT-7690.cc74dde4-33c1-4a77-a773-970c0f1ed142.pdf 7690 TUMOR FREE NO Primary Tumor 01 NO NO 0.7 White Matter NO NO YES HT Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2009 TCGA-HT-7690-01A-11D-2253-08 TCGA-HT-7690-01 4AA12BE4-C645-4C89-85FF-6BC9073400B4 TCGA-HT-7690-01A-11D-2253-08 TCGA-HT-7690-01A-11D-2252-01 a00de36d-7c6d-453a-b791-08c752ccfefc TCGA-HT-7690-01 TCGA-HT-7690-01 TCGA-HT-7690-01A-11D-2253-08 a00de36d-7c6d-453a-b791-08c752ccfefc TCGA-HT-7690-01 TCGA-HT-7690-01 TCGA-HT-7690-01A-11D-2253-08 TCGA-HT-7690-01A-11D-2254-05 a00de36d-7c6d-453a-b791-08c752ccfefc a00de36d-7c6d-453a-b791-08c752ccfefc TCGA-HT-7690-01A-11D-2252-01 TCGA-HT-7690-01A-11D-2253-08 +TCGA-HT-7691-01 TCGA-HT-7691-01 TCGA-HT-7691 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 31 NO NO TCGA-HT-7691-F29641 TCGA-HT-7691 TCGA-HT-7691-01A -11465 0 3 NO NO NO Headaches > 181 Days Scheduled Follow-up Submission NO 2012-3-27 FEMALE NO YES Astrocytoma NO No C71.0 9400/3 C71.0 YES 1 NO Right NO 1.4 NO NO NO G2 NO No TCGA-HT-7691.f6b38096-6209-4c37-a545-b4d1643dcc58.pdf 7691 TUMOR FREE NO NO NO Primary Tumor 01 NO NO 0.8 Not listed in Medical Record NO NO YES HT Supratentorial, Not Otherwise Specified Central nervous system A YES LIVING 2008 TCGA-HT-7691-01A-11D-2253-08 TCGA-HT-7691-01 4B1E444C-5DEF-444C-8728-8D3F43338B41 TCGA-HT-7691-01A-11D-2253-08 TCGA-HT-7691-01A-11D-2252-01 162b8ed0-de59-46cd-8e16-52b55e0f5467 TCGA-HT-7691-01 TCGA-HT-7691-01 TCGA-HT-7691-01A-11D-2253-08 162b8ed0-de59-46cd-8e16-52b55e0f5467 TCGA-HT-7691-01 TCGA-HT-7691-01 TCGA-HT-7691-01A-11D-2253-08 TCGA-HT-7691-01A-11D-2254-05 162b8ed0-de59-46cd-8e16-52b55e0f5467 162b8ed0-de59-46cd-8e16-52b55e0f5467 TCGA-HT-7691-01A-11D-2252-01 TCGA-HT-7691-01A-11D-2253-08 +TCGA-HT-7692-01 TCGA-HT-7692-01 TCGA-HT-7692 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 43 NO NO TCGA-HT-7692-F29616 TCGA-HT-7692 TCGA-HT-7692-01A -15727 0 90 29 NO YES YES Seizures 0 - 30 Days Scheduled Follow-up Submission NO 2012-3-16 MALE NO YES Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES 0.8 NO 100 Left 1.1 YES NO NO G2 NO No TCGA-HT-7692.c5f0a360-5011-4ede-b4b5-bbd30b54b21f.pdf 7692 Pre-Adjuvant Therapy TUMOR FREE YES YES Complete Remission/Response YES Primary Tumor 01 YES NO 0.5 YES NO YES HT Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2009 TCGA-HT-7692-01A-12D-2253-08 TCGA-HT-7692-01 F5E58354-70BD-4B53-A06D-CDC31055E812 TCGA-HT-7692-01A-12D-2253-08 TCGA-HT-7692-01A-12D-2252-01 b497a736-d140-47f4-8429-f53a7c005334 TCGA-HT-7692-01 TCGA-HT-7692-01 TCGA-HT-7692-01A-12D-2253-08 b497a736-d140-47f4-8429-f53a7c005334 TCGA-HT-7692-01 TCGA-HT-7692-01 TCGA-HT-7692-01A-12D-2253-08 TCGA-HT-7692-01A-12D-2254-05 b497a736-d140-47f4-8429-f53a7c005334 b497a736-d140-47f4-8429-f53a7c005334 TCGA-HT-7692-01A-12D-2252-01 TCGA-HT-7692-01A-12D-2253-08 +TCGA-HT-7693-01 TCGA-HT-7693-01 TCGA-HT-7693 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 51 NO YES TCGA-HT-7693-F29610 TCGA-HT-7693 TCGA-HT-7693-01A -18956 0 533 472 NO YES NO Seizures 0 - 30 Days Scheduled Follow-up Submission NO 2012-3-16 FEMALE NO YES Oligodendroglioma NO No C71.0 9450/3 C71.0 YES 1 NO 90 Right 1.1 NO NO YES G2 NO No TCGA-HT-7693.7ad7aac7-df39-4f13-9038-a6685012e8b0.pdf 7693 Post-Adjuvant Therapy TUMOR FREE Partial Remission/Response YES Primary Tumor 01 YES NO 0.7 YES NO YES HT Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2008 TCGA-HT-7693-01A-11D-2253-08 TCGA-HT-7693-01 218991DC-9A5A-4046-AE20-DA7E7078F6A6 TCGA-HT-7693-01A-11D-2253-08 TCGA-HT-7693-01A-11D-2252-01 26c57d9f-1ee1-4c64-9b42-e00aed49d22d TCGA-HT-7693-01 TCGA-HT-7693-01 TCGA-HT-7693-01A-11D-2253-08 26c57d9f-1ee1-4c64-9b42-e00aed49d22d TCGA-HT-7693-01 TCGA-HT-7693-01 TCGA-HT-7693-01A-11D-2253-08 TCGA-HT-7693-01A-11D-2254-05 26c57d9f-1ee1-4c64-9b42-e00aed49d22d 26c57d9f-1ee1-4c64-9b42-e00aed49d22d TCGA-HT-7693-01A-11D-2252-01 TCGA-HT-7693-01A-11D-2253-08 +TCGA-HT-7694-01 TCGA-HT-7694-01 TCGA-HT-7694 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 60 NO NO TCGA-HT-7694-F29607 TCGA-HT-7694 TCGA-HT-7694-01A -21930 0 210 210 NO YES NO Motor/Movement Changes 0 - 30 Days Scheduled Follow-up Submission NO 2012-3-9 MALE NO NO Oligodendroglioma NO No C71.0 9451/3 C71.0 YES 0.9 NO 90 Right NO 2.5 YES NO YES G3 NO No TCGA-HT-7694.09cb8fc6-43e0-484f-9897-b2df70d0a16e.pdf 7694 Post-Adjuvant Therapy TUMOR FREE NO YES Complete Remission/Response YES Primary Tumor 01 NO NO 0.5 White Matter YES NO YES HT Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2008 TCGA-HT-7694-01A-11D-2253-08 TCGA-HT-7694-01 FBBACEE8-B3CA-41CE-9B62-D89B39DCA2E8 TCGA-HT-7694-01A-11D-2253-08 TCGA-HT-7694-01A-11D-2252-01 17d328ce-367a-47c4-8f70-7f4644b37506 TCGA-HT-7694-01 TCGA-HT-7694-01 TCGA-HT-7694-01A-11D-2253-08 17d328ce-367a-47c4-8f70-7f4644b37506 TCGA-HT-7694-01 TCGA-HT-7694-01 TCGA-HT-7694-01A-11D-2253-08 TCGA-HT-7694-01A-11D-2254-05 17d328ce-367a-47c4-8f70-7f4644b37506 17d328ce-367a-47c4-8f70-7f4644b37506 TCGA-HT-7694-01A-11D-2252-01 TCGA-HT-7694-01A-11D-2253-08 +TCGA-HT-7695-01 TCGA-HT-7695-01 TCGA-HT-7695 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 29 NO NO TCGA-HT-7695-F29604 TCGA-HT-7695 TCGA-HT-7695-01A -10827 0 442 NO YES NO Seizures 31 - 90 Days Scheduled Follow-up Submission NO 2012-3-16 FEMALE NO NO Oligodendroglioma NO No C71.0 9450/3 C71.0 YES 0.9 NO Left NO 1.8 NO NO NO G2 NO No TCGA-HT-7695.351859ed-9826-4414-958d-dafc1f741a33.pdf 7695 TUMOR FREE Complete Remission/Response YES Primary Tumor 01 YES NO 0.7 White Matter YES NO YES HT Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2009 TCGA-HT-7695-01A-11D-2253-08 TCGA-HT-7695-01 93368AAC-0C9B-4339-8698-47CEE3FFB2B8 TCGA-HT-7695-01A-11D-2253-08 TCGA-HT-7695-01A-11D-2252-01 4ae49c4c-909f-48f0-8905-f27879c29426 TCGA-HT-7695-01 TCGA-HT-7695-01 TCGA-HT-7695-01A-11D-2253-08 4ae49c4c-909f-48f0-8905-f27879c29426 TCGA-HT-7695-01 TCGA-HT-7695-01 TCGA-HT-7695-01A-11D-2253-08 TCGA-HT-7695-01A-11D-2254-05 4ae49c4c-909f-48f0-8905-f27879c29426 4ae49c4c-909f-48f0-8905-f27879c29426 TCGA-HT-7695-01A-11D-2252-01 TCGA-HT-7695-01A-11D-2253-08 +TCGA-HT-7854-01 TCGA-HT-7854-01 TCGA-HT-7854 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain NO NO YES 62 NO NO TCGA-HT-7854-F48001 TCGA-HT-7854 TCGA-HT-7854-01A 1191 -22738 0 1201 1147 208 NO NO NO Visual Changes 31 - 90 Days Scheduled Follow-up Submission NO 2013-9-3 MALE NO YES Astrocytoma NO No C71.0 9400/3 C71.0 YES NO 1.1 NO 100 Left NO 1.5 NO YES NO NO G2 YES No TCGA-HT-7854.abff42e8-3d5d-438c-91a8-6ddca2225169.pdf 7854 Post-Adjuvant Therapy TUMOR FREE YES YES YES Primary Tumor 01 NO NO 0.6 White Matter NO NO YES HT Supratentorial, Temporal Lobe Central nervous system A YES LIVING 2010 TCGA-HT-7854-01A-11D-2253-08 TCGA-HT-7854-01 1F776330-C46B-4908-B684-0D911226303F TCGA-HT-7854-01A-11D-2253-08 TCGA-HT-7854-01A-11D-2252-01 3e7df498-0263-483e-98e8-e09324b5fae8 TCGA-HT-7854-01 TCGA-HT-7854-01 TCGA-HT-7854-01A-11D-2253-08 3e7df498-0263-483e-98e8-e09324b5fae8 TCGA-HT-7854-01 TCGA-HT-7854-01 TCGA-HT-7854-01A-11D-2253-08 TCGA-HT-7854-01A-11D-2254-05 3e7df498-0263-483e-98e8-e09324b5fae8 3e7df498-0263-483e-98e8-e09324b5fae8 TCGA-HT-7854-01A-11D-2252-01 TCGA-HT-7854-01A-11D-2253-08 +TCGA-HT-7855-01 TCGA-HT-7855-01 TCGA-HT-7855 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 39 NO NO TCGA-HT-7855-F29420 TCGA-HT-7855 TCGA-HT-7855-01A -14496 0 585 151 NO NO NO Headaches 91 - 180 Days Scheduled Follow-up Submission Complete Remission/Response NO 2012-3-16 MALE NO YES Astrocytoma NO No C71.0 9401/3 C71.0 YES NO 1.5 NO 80 Left NO 1.6 YES NO YES G3 NO No TCGA-HT-7855.77a245ba-4e68-4215-86d4-2cba5a981189.pdf 7855 Post-Adjuvant Therapy TUMOR FREE NO YES Complete Remission/Response YES Primary Tumor 01 NO NO 0.6 Cerebral Cortex YES NO YES HT Supratentorial, Parietal Lobe Central nervous system A NO LIVING 2008 TCGA-HT-7855-01 2A7DE5C6-BA7D-47D5-959C-7EDC2BD62BCD TCGA-HT-7855-01A-11D-2395-08 TCGA-HT-7855-01A-11D-2391-01 3fea413e-d892-461c-b0e3-cf07efaf860c TCGA-HT-7855-01 TCGA-HT-7855-01 TCGA-HT-7855-01A-11D-2395-08 3fea413e-d892-461c-b0e3-cf07efaf860c TCGA-HT-7855-01 TCGA-HT-7855-01 TCGA-HT-7855-01A-11D-2395-08 TCGA-HT-7855-01A-11D-2399-05 3fea413e-d892-461c-b0e3-cf07efaf860c 3fea413e-d892-461c-b0e3-cf07efaf860c TCGA-HT-7855-01A-11D-2391-01 TCGA-HT-7855-01A-11D-2395-08 +TCGA-HT-7856-01 TCGA-HT-7856-01 TCGA-HT-7856 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 35 NO NO TCGA-HT-7856-F29423 TCGA-HT-7856 TCGA-HT-7856-01A -13145 0 1189 383 NO NO NO Mental Status Changes > 181 Days Scheduled Follow-up Submission Complete Remission/Response NO 2012-3-16 MALE NO YES Oligodendroglioma NO No C71.0 9451/3 C71.0 YES NO 1 NO 80 Left NO 3.1 YES NO YES G3 NO No TCGA-HT-7856.0c4f151b-9d73-46a3-94ee-0b63b648bf0e.pdf 7856 Adjuvant therapy TUMOR FREE YES YES Complete Remission/Response YES Primary Tumor 01 NO NO 0.8 White Matter YES NO YES HT Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2008 TCGA-HT-7856-01 72D7858E-764B-49B8-8820-6EDA8ED1C98C TCGA-HT-7856-01A-11D-2395-08 TCGA-HT-7856-01A-11D-2391-01 b64f0c76-9109-4e22-9070-0e43837a10b3 TCGA-HT-7856-01 TCGA-HT-7856-01 TCGA-HT-7856-01A-11D-2395-08 b64f0c76-9109-4e22-9070-0e43837a10b3 TCGA-HT-7856-01 TCGA-HT-7856-01 TCGA-HT-7856-01A-11D-2395-08 TCGA-HT-7856-01A-11D-2399-05 b64f0c76-9109-4e22-9070-0e43837a10b3 b64f0c76-9109-4e22-9070-0e43837a10b3 TCGA-HT-7856-01A-11D-2391-01 TCGA-HT-7856-01A-11D-2395-08 +TCGA-HT-7857-01 TCGA-HT-7857-01 TCGA-HT-7857 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 24 NO NO TCGA-HT-7857-F29669 TCGA-HT-7857 TCGA-HT-7857-01A -8912 0 7 NO Motor/Movement Changes 0 - 30 Days Scheduled Follow-up Submission NO 2012-3-15 FEMALE NO YES Astrocytoma NO No C71.0 9401/3 C71.0 YES 1 NO Left 2.3 NO NO YES G3 NO No TCGA-HT-7857.3779c43d-34b9-426a-a59e-9e2379dc2634.pdf 7857 TUMOR FREE YES YES NO Primary Tumor 01 NO NO 0.3 Not listed in Medical Record NO HT Supratentorial, Not Otherwise Specified Central nervous system A YES LIVING 2006 TCGA-HT-7857-01 954026E1-6BB0-4B2B-A74F-1615E7E1E62B TCGA-HT-7857-01A-11D-2395-08 TCGA-HT-7857-01A-11D-2391-01 7acf607e-4078-49ff-b3f3-8dcd8eee5db5 TCGA-HT-7857-01 TCGA-HT-7857-01 TCGA-HT-7857-01A-11D-2395-08 7acf607e-4078-49ff-b3f3-8dcd8eee5db5 TCGA-HT-7857-01 TCGA-HT-7857-01 TCGA-HT-7857-01A-11D-2395-08 TCGA-HT-7857-01A-11D-2399-05 7acf607e-4078-49ff-b3f3-8dcd8eee5db5 7acf607e-4078-49ff-b3f3-8dcd8eee5db5 TCGA-HT-7857-01A-11D-2391-01 TCGA-HT-7857-01A-11D-2395-08 +TCGA-HT-7858-01 TCGA-HT-7858-01 TCGA-HT-7858 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 28 NO NO TCGA-HT-7858-F29426 TCGA-HT-7858 TCGA-HT-7858-01A -10422 0 1540 673 NO NO NO Headaches > 181 Days Scheduled Follow-up Submission Complete Remission/Response NO 2012-3-16 MALE NO YES Astrocytoma NO No C71.0 9400/3 C71.0 YES NO 1.8 NO 90 Right NO 2.3 NO NO NO G2 NO No TCGA-HT-7858.203f03ef-f7ed-46ce-9f5f-1c7a41b7fc4f.pdf 7858 Post-Adjuvant Therapy TUMOR FREE Complete Remission/Response YES Primary Tumor 01 NO NO 0.6 White Matter NO NO YES HT Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2007 TCGA-HT-7858-01 88585B8F-41AE-420E-8EAA-11ECCF2A7987 TCGA-HT-7858-01A-11D-2395-08 TCGA-HT-7858-01A-11D-2391-01 80d3ddd2-1dbe-4f47-b1f1-b1ea99970332 TCGA-HT-7858-01 TCGA-HT-7858-01 TCGA-HT-7858-01A-11D-2395-08 80d3ddd2-1dbe-4f47-b1f1-b1ea99970332 TCGA-HT-7858-01 TCGA-HT-7858-01 TCGA-HT-7858-01A-11D-2395-08 TCGA-HT-7858-01A-11D-2399-05 80d3ddd2-1dbe-4f47-b1f1-b1ea99970332 80d3ddd2-1dbe-4f47-b1f1-b1ea99970332 TCGA-HT-7858-01A-11D-2391-01 TCGA-HT-7858-01A-11D-2395-08 +TCGA-HT-7860-01 TCGA-HT-7860-01 TCGA-HT-7860 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 60 NO NO TCGA-HT-7860-F28643 TCGA-HT-7860 TCGA-HT-7860-01A -22034 0 15 NO Seizures > 181 Days Scheduled Follow-up Submission NO 2012-2-27 FEMALE NO NO Astrocytoma NO No C71.0 9401/3 C71.0 YES NO 1.1 NO Left NO 1.1 NO NO YES G3 No TCGA-HT-7860.281dc713-88c3-485f-96a9-3b84b49d5d6a.pdf 7860 TUMOR FREE YES YES Primary Tumor 01 YES NO 0.6 White Matter NO YES HT Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2009 TCGA-HT-7860-01 4B29756C-DCE2-4C19-93EB-BF3E7F8BAEDC TCGA-HT-7860-01A-11D-2395-08 TCGA-HT-7860-01A-11D-2391-01 5ee6524b-9289-45a8-949e-ba0ce44913fe TCGA-HT-7860-01 TCGA-HT-7860-01 TCGA-HT-7860-01A-11D-2395-08 5ee6524b-9289-45a8-949e-ba0ce44913fe TCGA-HT-7860-01 TCGA-HT-7860-01 TCGA-HT-7860-01A-11D-2395-08 TCGA-HT-7860-01A-11D-2399-05 5ee6524b-9289-45a8-949e-ba0ce44913fe 5ee6524b-9289-45a8-949e-ba0ce44913fe TCGA-HT-7860-01A-11D-2391-01 TCGA-HT-7860-01A-11D-2395-08 +TCGA-HT-7873-01 TCGA-HT-7873-01 TCGA-HT-7873 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain NO NO 29 NO NO TCGA-HT-7873-F48004 TCGA-HT-7873 TCGA-HT-7873-01B -10805 0 718 NO NO NO Headaches > 181 Days Scheduled Follow-up Submission 2013-9-3 MALE NO YES Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES NO 0.6 NO Right NO 1 NO YES NO YES G2 NO No TCGA-HT-7873.0efa1cbb-8b95-4b63-94bd-3e8829316a90.pdf 7873 WITH TUMOR NO NO Stable Disease YES Primary Tumor 01 NO NO 0.3 White Matter NO NO YES HT Supratentorial, Frontal Lobe Central nervous system B YES LIVING 2011 TCGA-HT-7873-01 9C90A522-4F95-409D-AEE3-7EACAF244D00 TCGA-HT-7873-01B-11D-2395-08 TCGA-HT-7873-01B-11D-2391-01 6c47a99a-ad05-4478-82fd-d57fe8f54f32 TCGA-HT-7873-01 TCGA-HT-7873-01 TCGA-HT-7873-01B-11D-2395-08 6c47a99a-ad05-4478-82fd-d57fe8f54f32 TCGA-HT-7873-01 TCGA-HT-7873-01 TCGA-HT-7873-01B-11D-2395-08 TCGA-HT-7873-01B-11D-2399-05 6c47a99a-ad05-4478-82fd-d57fe8f54f32 6c47a99a-ad05-4478-82fd-d57fe8f54f32 TCGA-HT-7873-01B-11D-2391-01 TCGA-HT-7873-01B-11D-2395-08 +TCGA-HT-7874-01 TCGA-HT-7874-01 TCGA-HT-7874 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 41 NO NO TCGA-HT-7874-F29422 TCGA-HT-7874 TCGA-HT-7874-01A -15045 0 1130 NO YES NO Headaches > 181 Days Scheduled Follow-up Submission Complete Remission/Response NO 2012-3-16 FEMALE NO YES Oligodendroglioma NO No C71.0 9451/3 C71.0 YES NO 1 NO Right NO 2 YES NO NO G3 NO No TCGA-HT-7874.dee7aaf7-0e9a-454b-a9aa-c31eaed09359.pdf 7874 TUMOR FREE YES YES Complete Remission/Response YES Primary Tumor 01 YES NO 0.6 Not listed in Medical Record YES NO YES HT Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2008 TCGA-HT-7874-01 6142CCDA-0A61-4CD2-8C09-88A69E15B358 TCGA-HT-7874-01A-11D-2395-08 TCGA-HT-7874-01A-11D-2391-01 77366e1e-618f-433c-8e6b-e2046a876231 TCGA-HT-7874-01 TCGA-HT-7874-01 TCGA-HT-7874-01A-11D-2395-08 77366e1e-618f-433c-8e6b-e2046a876231 TCGA-HT-7874-01 TCGA-HT-7874-01 TCGA-HT-7874-01A-11D-2395-08 TCGA-HT-7874-01A-11D-2399-05 77366e1e-618f-433c-8e6b-e2046a876231 77366e1e-618f-433c-8e6b-e2046a876231 TCGA-HT-7874-01A-11D-2391-01 TCGA-HT-7874-01A-11D-2395-08 +TCGA-HT-7875-01 TCGA-HT-7875-01 TCGA-HT-7875 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 56 NO NO TCGA-HT-7875-F28953 TCGA-HT-7875 TCGA-HT-7875-01A -20613 0 10 0 NO YES NO Seizures 91 - 180 Days Scheduled Follow-up Submission Stable Disease NO 2012-3-2 MALE NO NO Oligodendroglioma NO No C71.0 9450/3 C71.0 YES NO 1.1 NO 80 Left NO 2.4 NO NO NO G2 NO No TCGA-HT-7875.f247c5ba-6d4d-4d31-b3c5-c0dfc3211e9d.pdf 7875 Pre-Adjuvant Therapy TUMOR FREE YES NO Stable Disease YES Primary Tumor 01 YES NO 0.6 White Matter NO NO YES HT Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2008 TCGA-HT-7875-01 F778CE87-5246-4745-ADC0-F403D21AC172 TCGA-HT-7875-01A-11D-2395-08 TCGA-HT-7875-01A-11D-2391-01 8028a19b-10cf-4eb9-84ec-d61558b9976b TCGA-HT-7875-01 TCGA-HT-7875-01 TCGA-HT-7875-01A-11D-2395-08 8028a19b-10cf-4eb9-84ec-d61558b9976b TCGA-HT-7875-01 TCGA-HT-7875-01 TCGA-HT-7875-01A-11D-2395-08 TCGA-HT-7875-01A-11D-2399-05 8028a19b-10cf-4eb9-84ec-d61558b9976b 8028a19b-10cf-4eb9-84ec-d61558b9976b TCGA-HT-7875-01A-11D-2391-01 TCGA-HT-7875-01A-11D-2395-08 +TCGA-HT-7877-01 TCGA-HT-7877-01 TCGA-HT-7877 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 20 NO NO TCGA-HT-7877-F29672 TCGA-HT-7877 TCGA-HT-7877-01A -7581 0 4 NO NO NO Headaches > 181 Days Scheduled Follow-up Submission NO 2012-3-19 FEMALE YES YES Oligodendroglioma NO No C71.0 9450/3 C71.0 YES 0.8 NO Left 1.2 NO NO YES G2 NO No TCGA-HT-7877.c9bdae23-9523-46e1-8f14-e3c2a94e0200.pdf 7877 TUMOR FREE NO NO NO Primary Tumor 01 NO NO 0.6 White Matter NO NO YES HT Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2011 TCGA-HT-7877-01 5A142A58-03E6-4E4E-ABF7-3216D8BF9BC6 TCGA-HT-7877-01A-11D-2395-08 TCGA-HT-7877-01A-11D-2391-01 266003f1-3a9d-413b-9d18-1b2c40c48a22 TCGA-HT-7877-01 TCGA-HT-7877-01 TCGA-HT-7877-01A-11D-2395-08 266003f1-3a9d-413b-9d18-1b2c40c48a22 TCGA-HT-7877-01 TCGA-HT-7877-01 TCGA-HT-7877-01A-11D-2395-08 TCGA-HT-7877-01A-11D-2399-05 266003f1-3a9d-413b-9d18-1b2c40c48a22 266003f1-3a9d-413b-9d18-1b2c40c48a22 TCGA-HT-7877-01A-11D-2391-01 TCGA-HT-7877-01A-11D-2395-08 +TCGA-HT-7879-01 TCGA-HT-7879-01 TCGA-HT-7879 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 31 NO NO TCGA-HT-7879-F29673 TCGA-HT-7879 TCGA-HT-7879-01A -11622 0 112 NO NO NO Seizures 0 - 30 Days Scheduled Follow-up Submission NO 2012-3-19 MALE NO YES Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES 0.8 NO Right 1 NO NO NO G3 NO No TCGA-HT-7879.632e55f9-34bc-455e-98b8-f00c6a975f22.pdf 7879 TUMOR FREE YES NO Complete Remission/Response YES Primary Tumor 01 YES NO 0.5 YES NO YES HT Supratentorial, Temporal Lobe Central nervous system A YES LIVING 2011 TCGA-HT-7879-01 B861B47E-89B7-4A6F-8A11-65892C63958C TCGA-HT-7879-01A-11D-2395-08 TCGA-HT-7879-01A-11D-2391-01 b74282a3-9f58-4342-8ae5-2fc1cbb4933c TCGA-HT-7879-01 TCGA-HT-7879-01 TCGA-HT-7879-01A-11D-2395-08 b74282a3-9f58-4342-8ae5-2fc1cbb4933c TCGA-HT-7879-01 TCGA-HT-7879-01 TCGA-HT-7879-01A-11D-2395-08 TCGA-HT-7879-01A-11D-2399-05 b74282a3-9f58-4342-8ae5-2fc1cbb4933c b74282a3-9f58-4342-8ae5-2fc1cbb4933c TCGA-HT-7879-01A-11D-2391-01 TCGA-HT-7879-01A-11D-2395-08 +TCGA-HT-7880-01 TCGA-HT-7880-01 TCGA-HT-7880 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 30 NO NO TCGA-HT-7880-F29680 TCGA-HT-7880 TCGA-HT-7880-01A -11043 0 162 NO NO NO Seizures 31 - 90 Days Scheduled Follow-up Submission YES peanuts 2012-3-19 MALE NO YES Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES 0.8 NO Right 1.1 NO NO NO G2 NO No TCGA-HT-7880.1c00de9e-c2c1-4b57-b0a1-1f043d9de032.pdf 7880 TUMOR FREE YES YES NO Primary Tumor 01 YES YES 0.7 White Matter NO NO YES HT Supratentorial, Parietal Lobe Central nervous system A NO LIVING 2011 TCGA-HT-7880-01 6933655F-FCB5-4BD1-A54E-BC46E2958939 TCGA-HT-7880-01A-11D-2395-08 TCGA-HT-7880-01A-11D-2391-01 aed81cc7-515a-45f8-9017-bf6df58f2235 TCGA-HT-7880-01 TCGA-HT-7880-01 TCGA-HT-7880-01A-11D-2395-08 aed81cc7-515a-45f8-9017-bf6df58f2235 TCGA-HT-7880-01 TCGA-HT-7880-01 TCGA-HT-7880-01A-11D-2395-08 TCGA-HT-7880-01A-11D-2399-05 aed81cc7-515a-45f8-9017-bf6df58f2235 aed81cc7-515a-45f8-9017-bf6df58f2235 TCGA-HT-7880-01A-11D-2391-01 TCGA-HT-7880-01A-11D-2395-08 +TCGA-HT-7881-01 TCGA-HT-7881-01 TCGA-HT-7881 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 38 NO NO TCGA-HT-7881-F66426 TCGA-HT-7881 TCGA-HT-7881-01A -14171 0 1079 NO YES NO Seizures > 181 Days Scheduled Follow-up Submission Complete Remission/Response 2014-10-14 MALE NO NO Oligodendroglioma NO No C71.0 9450/3 C71.0 YES 0.8 NO Left 1.4 NO NO NO NO G2 NO No TCGA-HT-7881.8c9a3353-4d77-4d26-8522-da3869660c35.pdf 7881 TUMOR FREE YES YES Complete Remission/Response YES Primary Tumor 01 YES NO 0.3 Not listed in Medical Record YES NO YES HT Supratentorial, Temporal Lobe Central nervous system A NO LIVING 2011 TCGA-HT-7881-01 313D16DA-50DD-4306-9B73-549E63E40333 TCGA-HT-7881-01A-11D-2395-08 TCGA-HT-7881-01A-11D-2391-01 b675a1c5-e16c-427d-9c47-1b75e8e51f4d TCGA-HT-7881-01 TCGA-HT-7881-01 TCGA-HT-7881-01A-11D-2395-08 b675a1c5-e16c-427d-9c47-1b75e8e51f4d TCGA-HT-7881-01 TCGA-HT-7881-01 TCGA-HT-7881-01A-11D-2395-08 TCGA-HT-7881-01A-11D-2399-05 b675a1c5-e16c-427d-9c47-1b75e8e51f4d b675a1c5-e16c-427d-9c47-1b75e8e51f4d TCGA-HT-7881-01A-11D-2391-01 TCGA-HT-7881-01A-11D-2395-08 +TCGA-HT-7882-01 TCGA-HT-7882-01 TCGA-HT-7882 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 66 NO NO TCGA-HT-7882-F28952 TCGA-HT-7882 TCGA-HT-7882-01A -24450 113 0 52 NO NO NO Seizures > 181 Days Scheduled Follow-up Submission Progressive Disease NO 2012-3-2 MALE NO NO Oligodendroglioma NO No C71.0 9451/3 C71.0 YES NO 1 NO Left NO 2.4 YES NO YES G3 NO No TCGA-HT-7882.6ef48ba9-cdeb-4279-bd24-9dc228671262.pdf 7882 WITH TUMOR YES NO Progressive Disease NO Primary Tumor 01 YES NO 0.3 Not listed in Medical Record NO NO YES HT Supratentorial, Frontal Lobe Central nervous system A NO DECEASED 2010 TCGA-HT-7882-01 4A2504A9-ABC2-41AB-93A4-E8D4DE335DD3 TCGA-HT-7882-01A-11D-2395-08 TCGA-HT-7882-01A-11D-2391-01 ad6cc53a-1a99-4e1b-8701-9abf0c975adb TCGA-HT-7882-01 TCGA-HT-7882-01 TCGA-HT-7882-01A-11D-2395-08 ad6cc53a-1a99-4e1b-8701-9abf0c975adb TCGA-HT-7882-01 TCGA-HT-7882-01 TCGA-HT-7882-01A-11D-2395-08 TCGA-HT-7882-01A-11D-2399-05 ad6cc53a-1a99-4e1b-8701-9abf0c975adb ad6cc53a-1a99-4e1b-8701-9abf0c975adb TCGA-HT-7882-01A-11D-2391-01 TCGA-HT-7882-01A-11D-2395-08 +TCGA-HT-7884-01 TCGA-HT-7884-01 TCGA-HT-7884 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 44 NO YES TCGA-HT-7884-F35005 TCGA-HT-7884 TCGA-HT-7884-01B -16280 0 343 112 NO NO NO < 12 Years Mental Status Changes 0 - 30 Days Scheduled Follow-up Submission Stable Disease NO 2012-9-12 FEMALE NO YES Astrocytoma NO No C71.0 9400/3 C71.0 YES NO 0.8 NO 80 Left NO 1.3 NO YES NO NO G2 NO No TCGA-HT-7884.9294057d-1aba-44d6-a756-4cb48671e45e.pdf 7884 Post-Adjuvant Therapy TUMOR FREE YES NO Stable Disease YES Primary Tumor 01 YES NO 0.3 White Matter YES NO YES HT Supratentorial, Frontal Lobe Central nervous system B YES LIVING 2011 TCGA-HT-7884-01 1395169A-11DB-4569-AB17-929FB491A905 TCGA-HT-7884-01B-11D-2395-08 TCGA-HT-7884-01B-11D-2391-01 aedec7d6-da5f-414f-b200-3b2dc7535182 TCGA-HT-7884-01 TCGA-HT-7884-01 TCGA-HT-7884-01B-11D-2395-08 aedec7d6-da5f-414f-b200-3b2dc7535182 TCGA-HT-7884-01 TCGA-HT-7884-01 TCGA-HT-7884-01B-11D-2395-08 TCGA-HT-7884-01B-11D-2399-05 aedec7d6-da5f-414f-b200-3b2dc7535182 aedec7d6-da5f-414f-b200-3b2dc7535182 TCGA-HT-7884-01B-11D-2391-01 TCGA-HT-7884-01B-11D-2395-08 +TCGA-HT-7902-01 TCGA-HT-7902-01 TCGA-HT-7902 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 30 NO YES TCGA-HT-7902-F28951 TCGA-HT-7902 TCGA-HT-7902-01A -11118 0 956 NO YES YES Visual Changes 31 - 90 Days Scheduled Follow-up Submission Stable Disease NO 2012-3-2 FEMALE NO YES Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES NO 0.8 NO Right NO 1.5 NO NO NO G2 NO No TCGA-HT-7902.bb55771d-e5dc-4625-8c3c-0a6c1aae487d.pdf 7902 TUMOR FREE NO NO Stable Disease NO Primary Tumor 01 NO NO 0.8 Cerebral Cortex NO NO YES HT Supratentorial, Frontal Lobe Central nervous system A YES LIVING 2009 TCGA-HT-7902-01 5D500BF7-3D72-4B81-B010-5D7F7AFE1D27 TCGA-HT-7902-01A-12D-2395-08 TCGA-HT-7902-01A-12D-2391-01 6fbc1aba-a377-4b7e-90ee-d86053187a67 TCGA-HT-7902-01 TCGA-HT-7902-01 TCGA-HT-7902-01A-12D-2395-08 6fbc1aba-a377-4b7e-90ee-d86053187a67 TCGA-HT-7902-01 TCGA-HT-7902-01 TCGA-HT-7902-01A-12D-2395-08 TCGA-HT-7902-01A-12D-2399-05 6fbc1aba-a377-4b7e-90ee-d86053187a67 6fbc1aba-a377-4b7e-90ee-d86053187a67 TCGA-HT-7902-01A-12D-2391-01 TCGA-HT-7902-01A-12D-2395-08 +TCGA-HT-8010-01 TCGA-HT-8010-01 TCGA-HT-8010 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 64 NO NO TCGA-HT-8010-F32622 TCGA-HT-8010 TCGA-HT-8010-01A -23680 0 50 NO YES NO Motor/Movement Changes > 181 Days Scheduled Follow-up Submission Stable Disease NO 2012-6-4 FEMALE NO YES Oligodendroglioma NO No C71.0 9450/3 C71.0 YES NO 0.4 NO Right NO 1.3 NO NO YES G2 NO No TCGA-HT-8010.ec4dae3c-9d46-48cb-9201-a8199139986f.pdf 8010 TUMOR FREE NO NO Stable Disease NO Primary Tumor 01 NO NO 0.3 Not listed in Medical Record NO NO YES HT Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2011 TCGA-HT-8010-01 A93C9DA7-D0E0-4BC0-B73F-4B4F43F83D38 TCGA-HT-8010-01A-11D-2395-08 TCGA-HT-8010-01A-11D-2391-01 f4a540b2-5ad6-442b-b454-cdb23a4cbacc TCGA-HT-8010-01 TCGA-HT-8010-01 TCGA-HT-8010-01A-11D-2395-08 f4a540b2-5ad6-442b-b454-cdb23a4cbacc TCGA-HT-8010-01 TCGA-HT-8010-01 TCGA-HT-8010-01A-11D-2395-08 TCGA-HT-8010-01A-11D-2399-05 f4a540b2-5ad6-442b-b454-cdb23a4cbacc f4a540b2-5ad6-442b-b454-cdb23a4cbacc TCGA-HT-8010-01A-11D-2391-01 TCGA-HT-8010-01A-11D-2395-08 +TCGA-HT-8011-01 TCGA-HT-8011-01 TCGA-HT-8011 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain NO NO YES NO 55 NO NO TCGA-HT-8011-F32623 TCGA-HT-8011 TCGA-HT-8011-01A 278 -20175 0 494 278 NO YES YES Seizures 0 - 30 Days Scheduled Follow-up Submission Progressive Disease NO 2012-6-4 MALE NO YES Astrocytoma NO No C71.0 9401/3 C71.0 YES NO 1 NO Right NO 1.3 NO NO NO G3 YES No TCGA-HT-8011.67c30fd5-6ff5-49b7-b0e6-4006ef4510fc.pdf 8011 WITH TUMOR YES NO Stable Disease YES Primary Tumor 01 YES NO 0.6 Not listed in Medical Record YES NO YES HT Supratentorial, Temporal Lobe Central nervous system A NO LIVING 2009 TCGA-HT-8011-01 95260E95-7380-477A-B941-5C36C898E0D2 TCGA-HT-8011-01A-11D-2395-08 TCGA-HT-8011-01A-11D-2391-01 11a26b32-d4df-468f-9a17-b89fba51cf88 TCGA-HT-8011-01 TCGA-HT-8011-01 TCGA-HT-8011-01A-11D-2395-08 11a26b32-d4df-468f-9a17-b89fba51cf88 TCGA-HT-8011-01 TCGA-HT-8011-01 TCGA-HT-8011-01A-11D-2395-08 TCGA-HT-8011-01A-11D-2399-05 11a26b32-d4df-468f-9a17-b89fba51cf88 11a26b32-d4df-468f-9a17-b89fba51cf88 TCGA-HT-8011-01A-11D-2391-01 TCGA-HT-8011-01A-11D-2395-08 +TCGA-HT-8012-01 TCGA-HT-8012-01 TCGA-HT-8012 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain NO NO YES NO 30 NO NO TCGA-HT-8012-F32626 TCGA-HT-8012 TCGA-HT-8012-01A 133 -11295 0 286 133 NO NO NO Seizures 0 - 30 Days Scheduled Follow-up Submission Stable Disease NO 2012-6-4 FEMALE NO NO Oligodendroglioma NO No C71.0 9450/3 C71.0 YES NO 0.8 NO Right NO 1.3 NO NO NO G2 YES No TCGA-HT-8012.d968744b-5830-4320-9143-58e4c4cb90a4.pdf 8012 WITH TUMOR YES NO Stable Disease NO Primary Tumor 01 YES NO 0.6 Not listed in Medical Record NO NO YES HT Supratentorial, Temporal Lobe Central nervous system A NO LIVING 2010 TCGA-HT-8012-01 CAF2B8C0-1B4C-4E7F-A692-EC644CB32E7B TCGA-HT-8012-01A-11D-2395-08 TCGA-HT-8012-01A-11D-2391-01 f389cc26-dd87-44ca-8ceb-fc926d073f4a TCGA-HT-8012-01 TCGA-HT-8012-01 TCGA-HT-8012-01A-11D-2395-08 f389cc26-dd87-44ca-8ceb-fc926d073f4a TCGA-HT-8012-01 TCGA-HT-8012-01 TCGA-HT-8012-01A-11D-2395-08 TCGA-HT-8012-01A-11D-2399-05 f389cc26-dd87-44ca-8ceb-fc926d073f4a f389cc26-dd87-44ca-8ceb-fc926d073f4a TCGA-HT-8012-01A-11D-2391-01 TCGA-HT-8012-01A-11D-2395-08 +TCGA-HT-8013-01 TCGA-HT-8013-01 TCGA-HT-8013 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain YES YES YES NO 37 NO NO TCGA-HT-8013-F32627 TCGA-HT-8013 TCGA-HT-8013-01A 1306 -13753 1933 0 1306 1587 NO NO NO Seizures 0 - 30 Days Scheduled Follow-up Submission NO 2012-6-4 FEMALE NO NO Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES NO 0.8 NO 70 Left NO 0.8 YES NO NO G2 YES No TCGA-HT-8013.9f364b5b-ead4-42a4-a802-f398e08f1dfc.pdf 8013 Post-Adjuvant Therapy WITH TUMOR YES NO Stable Disease YES Primary Tumor 01 YES NO 0.8 Cerebral Cortex YES NO YES HT Supratentorial, Frontal Lobe Central nervous system A NO DECEASED 2005 TCGA-HT-8013-01 F3AC7855-90DA-4513-9727-5C4CB10AF614 TCGA-HT-8013-01A-11D-2395-08 TCGA-HT-8013-01A-11D-2391-01 2181e8a6-db87-49e9-ad56-582b345abcc2 TCGA-HT-8013-01 TCGA-HT-8013-01 TCGA-HT-8013-01A-11D-2395-08 2181e8a6-db87-49e9-ad56-582b345abcc2 TCGA-HT-8013-01 TCGA-HT-8013-01 TCGA-HT-8013-01A-11D-2395-08 TCGA-HT-8013-01A-11D-2399-05 2181e8a6-db87-49e9-ad56-582b345abcc2 2181e8a6-db87-49e9-ad56-582b345abcc2 TCGA-HT-8013-01A-11D-2391-01 TCGA-HT-8013-01A-11D-2395-08 +TCGA-HT-8015-01 TCGA-HT-8015-01 TCGA-HT-8015 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 21 TCGA-HT-8015 TCGA-HT-8015-01B -7760 1483 0 3 2013-9-12 MALE Astrocytoma NO No C71.0 9400/3 C71.0 YES 660 NO Left G2 true No TCGA-HT-8015.555DEE9A-4BA2-4E0A-A76E-06972079094A.pdf 8015 TUMOR FREE Complete Remission/Response Primary Tumor 01 Deep Gray (e.g.basal ganglia, thalamus) NO YES HT Supratentorial, Temporal Lobe Central nervous system B LIVING 2008 TCGA-HT-8015-01 32583B8E-58B4-4208-A2A7-5162BB0E88FD TCGA-HT-8015-01B-11D-A289-08 TCGA-HT-8015-01B-11D-A288-01 32791ace-3fb3-43cb-8f98-278ac1e18a25 TCGA-HT-8015-01 TCGA-HT-8015-01 TCGA-HT-8015-01B-11D-A289-08 32791ace-3fb3-43cb-8f98-278ac1e18a25 TCGA-HT-8015-01 TCGA-HT-8015-01B-11D-A289-08 TCGA-HT-8015-01B-11D-A28N-05 32791ace-3fb3-43cb-8f98-278ac1e18a25 32791ace-3fb3-43cb-8f98-278ac1e18a25 TCGA-HT-8015-01B-11D-A288-01 TCGA-HT-8015-01B-11D-A289-08 +TCGA-HT-8018-01 TCGA-HT-8018-01 TCGA-HT-8018 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 40 NO NO TCGA-HT-8018-F45912 TCGA-HT-8018 TCGA-HT-8018-01A -14910 1152 0 654 NO NO NO Seizures 0 - 30 Days Scheduled Follow-up Submission Progressive Disease NO 2013-7-25 FEMALE NO YES Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES NO 0.9 NO Left NO 1.3 NO NO NO YES G2 NO No TCGA-HT-8018.3c1686b7-7a13-43cd-9d42-e4f564b75423.pdf 8018 TUMOR FREE Partial Remission/Response YES Primary Tumor 01 YES NO 0.9 White Matter YES NO YES HT Supratentorial, Temporal Lobe Central nervous system A NO DECEASED 2010 TCGA-HT-8018-01 1EB8C097-CD74-4DE8-948C-B4329BE25BBA TCGA-HT-8018-01A-11D-2395-08 TCGA-HT-8018-01A-11D-2391-01 2398c528-0e80-4c72-a5cc-cd82c7895468 TCGA-HT-8018-01 TCGA-HT-8018-01 TCGA-HT-8018-01A-11D-2395-08 2398c528-0e80-4c72-a5cc-cd82c7895468 TCGA-HT-8018-01 TCGA-HT-8018-01 TCGA-HT-8018-01A-11D-2395-08 TCGA-HT-8018-01A-11D-2399-05 2398c528-0e80-4c72-a5cc-cd82c7895468 2398c528-0e80-4c72-a5cc-cd82c7895468 TCGA-HT-8018-01A-11D-2391-01 TCGA-HT-8018-01A-11D-2395-08 +TCGA-HT-8019-01 TCGA-HT-8019-01 TCGA-HT-8019 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 34 NO NO TCGA-HT-8019-F46178 TCGA-HT-8019 TCGA-HT-8019-01A -12669 0 1004 NO YES NO Seizures 0 - 30 Days Scheduled Follow-up Submission Complete Remission/Response NO 2013-9-18 FEMALE NO YES Oligodendroglioma NO No C71.0 9451/3 C71.0 YES NO 1 NO Right NO 1.6 NO NO NO NO G3 NO No TCGA-HT-8019.18eba3ff-f941-4a98-8603-e40ce199aa27.pdf 8019 TUMOR FREE Complete Remission/Response YES Primary Tumor 01 YES NO 0.8 White Matter YES NO YES HT Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2009 TCGA-HT-8019-01 652EDB62-15F8-47D4-A9A9-93A96AECDAE3 TCGA-HT-8019-01A-21D-2395-08 TCGA-HT-8019-01A-21D-2391-01 e73d9fe9-8abb-454e-9b62-90bde2e5c5a9 TCGA-HT-8019-01 TCGA-HT-8019-01 TCGA-HT-8019-01A-21D-2395-08 e73d9fe9-8abb-454e-9b62-90bde2e5c5a9 TCGA-HT-8019-01 TCGA-HT-8019-01 TCGA-HT-8019-01A-21D-2395-08 TCGA-HT-8019-01A-21D-2399-05 e73d9fe9-8abb-454e-9b62-90bde2e5c5a9 e73d9fe9-8abb-454e-9b62-90bde2e5c5a9 TCGA-HT-8019-01A-21D-2391-01 TCGA-HT-8019-01A-21D-2395-08 +TCGA-HT-8104-01 TCGA-HT-8104-01 TCGA-HT-8104 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 51 NO NO TCGA-HT-8104-F45987 TCGA-HT-8104 TCGA-HT-8104-01A -18748 0 372 NO NO NO Motor/Movement Changes 0 - 30 Days Scheduled Follow-up Submission NO 2013-7-26 FEMALE NO NO Astrocytoma NO No C71.0 9401/3 C71.0 YES NO 0.7 NO Left NO 1.3 YES NO NO YES G3 No TCGA-HT-8104.be808788-d11d-4e91-8b52-6d830d1cb5ce.pdf 8104 TUMOR FREE NO NO Primary Tumor 01 NO NO 0.7 White Matter NO YES HT Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2010 TCGA-HT-8104-01 8A30A27E-5BDF-4E42-8C9C-91BD1723E7C1 TCGA-HT-8104-01A-11D-2395-08 TCGA-HT-8104-01A-11D-2391-01 3c4590d9-788e-4e04-a7e8-b912698ebb74 TCGA-HT-8104-01 TCGA-HT-8104-01 TCGA-HT-8104-01A-11D-2395-08 3c4590d9-788e-4e04-a7e8-b912698ebb74 TCGA-HT-8104-01 TCGA-HT-8104-01 TCGA-HT-8104-01A-11D-2395-08 TCGA-HT-8104-01A-11D-2399-05 3c4590d9-788e-4e04-a7e8-b912698ebb74 3c4590d9-788e-4e04-a7e8-b912698ebb74 TCGA-HT-8104-01A-11D-2391-01 TCGA-HT-8104-01A-11D-2395-08 +TCGA-HT-8105-01 TCGA-HT-8105-01 TCGA-HT-8105 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 54 NO NO TCGA-HT-8105-F32624 TCGA-HT-8105 TCGA-HT-8105-01A -20041 0 190 190 NO NO NO Mental Status Changes 31 - 90 Days Scheduled Follow-up Submission Stable Disease NO 2012-6-4 MALE NO NO Oligodendroglioma NO No C71.0 9451/3 C71.0 YES NO 1 NO 70 Right NO 1.6 YES NO YES G3 NO No TCGA-HT-8105.d7c51467-5baa-4858-86bd-cfb6d9344a05.pdf 8105 TUMOR FREE NO NO Stable Disease YES Primary Tumor 01 YES NO 1 Not listed in Medical Record NO NO YES HT Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2011 TCGA-HT-8105-01 E3060383-9FB2-48F1-B8CC-419461903882 TCGA-HT-8105-01A-11D-2395-08 TCGA-HT-8105-01A-11D-2391-01 75016f4c-257e-4e24-9e91-5ab4b8c53e5a TCGA-HT-8105-01 TCGA-HT-8105-01 TCGA-HT-8105-01A-11D-2395-08 75016f4c-257e-4e24-9e91-5ab4b8c53e5a TCGA-HT-8105-01 TCGA-HT-8105-01 TCGA-HT-8105-01A-11D-2395-08 TCGA-HT-8105-01A-11D-2399-05 75016f4c-257e-4e24-9e91-5ab4b8c53e5a 75016f4c-257e-4e24-9e91-5ab4b8c53e5a TCGA-HT-8105-01A-11D-2391-01 TCGA-HT-8105-01A-11D-2395-08 +TCGA-HT-8106-01 TCGA-HT-8106-01 TCGA-HT-8106 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 53 NO NO TCGA-HT-8106-F32632 TCGA-HT-8106 TCGA-HT-8106-01A -19555 0 3 NO NO NO Seizures 0 - 30 Days Scheduled Follow-up Submission Stable Disease NO 2012-6-4 MALE NO NO Astrocytoma NO No C71.0 9401/3 C71.0 YES NO 0.9 NO Midline NO 1.2 NO NO NO G3 NO No TCGA-HT-8106.aebc4408-92f6-404c-b9e6-9bb7e46c700f.pdf 8106 TUMOR FREE NO NO Stable Disease NO Primary Tumor 01 YES NO 0.5 Not listed in Medical Record NO NO YES HT Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2010 TCGA-HT-8106-01 236A3A27-3921-48AE-8326-2B027CF2D7CE TCGA-HT-8106-01A-11D-2395-08 TCGA-HT-8106-01A-11D-2391-01 1b95fcab-d55c-49b8-b3eb-0b156ca02812 TCGA-HT-8106-01 TCGA-HT-8106-01 TCGA-HT-8106-01A-11D-2395-08 1b95fcab-d55c-49b8-b3eb-0b156ca02812 TCGA-HT-8106-01 TCGA-HT-8106-01 TCGA-HT-8106-01A-11D-2395-08 TCGA-HT-8106-01A-11D-2399-05 1b95fcab-d55c-49b8-b3eb-0b156ca02812 1b95fcab-d55c-49b8-b3eb-0b156ca02812 TCGA-HT-8106-01A-11D-2391-01 TCGA-HT-8106-01A-11D-2395-08 +TCGA-HT-8107-01 TCGA-HT-8107-01 TCGA-HT-8107 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 62 NO NO TCGA-HT-8107-F32633 TCGA-HT-8107 TCGA-HT-8107-01A -22880 0 14 NO NO NO Mental Status Changes 0 - 30 Days Scheduled Follow-up Submission Stable Disease NO 2012-6-4 MALE NO NO Oligodendroglioma NO No C71.0 9450/3 C71.0 YES NO 0.6 NO Left NO 1 YES NO NO G2 NO No TCGA-HT-8107.4e4564f4-1ebf-4d0d-a461-90f866c4ec42.pdf 8107 TUMOR FREE YES NO Stable Disease NO Primary Tumor 01 YES NO 0.4 Not listed in Medical Record NO NO YES HT Supratentorial, Parietal Lobe Central nervous system A NO LIVING 2011 TCGA-HT-8107-01 6D842142-A6AC-4A2B-860B-31C62FD4AF90 TCGA-HT-8107-01A-13D-2395-08 TCGA-HT-8107-01A-13D-2391-01 3129849c-97e6-4e22-b7d1-dd3ab7fb81d8 TCGA-HT-8107-01 TCGA-HT-8107-01 3129849c-97e6-4e22-b7d1-dd3ab7fb81d8 TCGA-HT-8107-01 TCGA-HT-8107-01 TCGA-HT-8107-01A-13D-2395-08 TCGA-HT-8107-01A-13D-2399-05 3129849c-97e6-4e22-b7d1-dd3ab7fb81d8 3129849c-97e6-4e22-b7d1-dd3ab7fb81d8 TCGA-HT-8107-01A-13D-2391-01 TCGA-HT-8107-01A-13D-2395-08 +TCGA-HT-8108-01 TCGA-HT-8108-01 TCGA-HT-8108 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 26 NO NO TCGA-HT-8108-F32634 TCGA-HT-8108 TCGA-HT-8108-01A -9539 0 76 NO YES YES Headaches 0 - 30 Days Scheduled Follow-up Submission Stable Disease NO 2012-6-4 FEMALE NO YES Oligodendroglioma NO No C71.0 9450/3 C71.0 YES NO 0.6 NO Left NO 0.7 NO NO NO G2 NO No TCGA-HT-8108.8e2e0a3b-afd5-4077-b95f-ddc7014c08cb.pdf 8108 TUMOR FREE NO NO Stable Disease NO Primary Tumor 01 NO NO 0.3 White Matter NO NO YES HT Supratentorial, Parietal Lobe Central nervous system A YES LIVING 2011 TCGA-HT-8108-01 TCGA-HT-8108-01A-11D-2395-08 TCGA-HT-8108-01A-11D-2391-01 4743ae20-4a24-475b-9d1a-3def852738b3 TCGA-HT-8108-01 TCGA-HT-8108-01 TCGA-HT-8108-01A-11D-2395-08 4743ae20-4a24-475b-9d1a-3def852738b3 TCGA-HT-8108-01 TCGA-HT-8108-01 TCGA-HT-8108-01A-11D-2395-08 TCGA-HT-8108-01A-11D-2399-05 4743ae20-4a24-475b-9d1a-3def852738b3 4743ae20-4a24-475b-9d1a-3def852738b3 TCGA-HT-8108-01A-11D-2391-01 TCGA-HT-8108-01A-11D-2395-08 +TCGA-HT-8109-01 TCGA-HT-8109-01 TCGA-HT-8109 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 64 NO NO TCGA-HT-8109-F45921 TCGA-HT-8109 TCGA-HT-8109-01A -23486 0 169 NO NO NO Mental Status Changes > 181 Days Scheduled Follow-up Submission NO 2013-7-25 MALE NO NO Oligodendroglioma NO No C71.0 9451/3 C71.0 YES NO 0.8 NO Right NO 1.1 YES YES NO NO G3 No TCGA-HT-8109.ae84e661-5ec1-46e2-ac49-4b01e0bc288a.pdf 8109 TUMOR FREE YES YES YES Primary Tumor 01 NO NO 0.6 White Matter YES NO YES HT Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2011 TCGA-HT-8109-01 48F308A4-75B1-47C3-AAEB-B93102F62954 TCGA-HT-8109-01A-11D-2395-08 TCGA-HT-8109-01A-11D-2391-01 2242fa55-5ea8-4143-92aa-f5bab77f6cec TCGA-HT-8109-01 TCGA-HT-8109-01 TCGA-HT-8109-01A-11D-2395-08 2242fa55-5ea8-4143-92aa-f5bab77f6cec TCGA-HT-8109-01 TCGA-HT-8109-01 TCGA-HT-8109-01A-11D-2395-08 TCGA-HT-8109-01A-11D-2399-05 2242fa55-5ea8-4143-92aa-f5bab77f6cec 2242fa55-5ea8-4143-92aa-f5bab77f6cec TCGA-HT-8109-01A-11D-2391-01 TCGA-HT-8109-01A-11D-2395-08 +TCGA-HT-8110-01 TCGA-HT-8110-01 TCGA-HT-8110 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 57 NO NO TCGA-HT-8110-F43794 TCGA-HT-8110 TCGA-HT-8110-01A -21183 0 419 NO YES NO Visual Changes 0 - 30 Days Scheduled Follow-up Submission Complete Remission/Response NO 2013-7-26 MALE NO YES Astrocytoma NO No C71.0 9401/3 C71.0 YES NO 0.9 NO Right NO 1.6 NO YES NO NO G3 NO No TCGA-HT-8110.c423008b-608e-4260-b36c-21135a7fcd82.pdf 8110 TUMOR FREE Complete Remission/Response YES Primary Tumor 01 NO NO 0.9 White Matter NO YES HT Supratentorial, Parietal Lobe Central nervous system A YES LIVING 2011 TCGA-HT-8110-01 F763CA1A-BE97-4426-A362-9D67B2149AC5 TCGA-HT-8110-01A-11D-2395-08 TCGA-HT-8110-01A-11D-2391-01 3a1dd504-78ab-4d25-8f28-2f077a511946 TCGA-HT-8110-01 TCGA-HT-8110-01 TCGA-HT-8110-01A-11D-2395-08 3a1dd504-78ab-4d25-8f28-2f077a511946 TCGA-HT-8110-01 TCGA-HT-8110-01 TCGA-HT-8110-01A-11D-2395-08 TCGA-HT-8110-01A-11D-2399-05 3a1dd504-78ab-4d25-8f28-2f077a511946 3a1dd504-78ab-4d25-8f28-2f077a511946 TCGA-HT-8110-01A-11D-2391-01 TCGA-HT-8110-01A-11D-2395-08 +TCGA-HT-8111-01 TCGA-HT-8111-01 TCGA-HT-8111 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 32 NO NO TCGA-HT-8111-F66396 TCGA-HT-8111 TCGA-HT-8111-01A -11810 0 7 NO NO Seizures 0 - 30 Days Scheduled Follow-up Submission NO 2014-10-14 MALE NO YES Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES 0.9 NO Left NO 2.2 YES YES NO NO G3 No TCGA-HT-8111.9de92ba0-f9d6-4f7b-8a92-548082b49288.pdf 8111 YES NO Primary Tumor 01 YES NO 0.9 White Matter NO YES HT Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2011 TCGA-HT-8111-01 8CFDAC8E-8F42-4CD7-ACE0-5C8547A4FDF0 TCGA-HT-8111-01A-11D-2395-08 TCGA-HT-8111-01A-11D-2391-01 f68cffac-4db9-470c-b726-01fb876a381a TCGA-HT-8111-01 TCGA-HT-8111-01 TCGA-HT-8111-01A-11D-2395-08 f68cffac-4db9-470c-b726-01fb876a381a TCGA-HT-8111-01 TCGA-HT-8111-01 TCGA-HT-8111-01A-11D-2395-08 TCGA-HT-8111-01A-11D-2399-05 f68cffac-4db9-470c-b726-01fb876a381a f68cffac-4db9-470c-b726-01fb876a381a TCGA-HT-8111-01A-11D-2391-01 TCGA-HT-8111-01A-11D-2395-08 +TCGA-HT-8113-01 TCGA-HT-8113-01 TCGA-HT-8113 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 49 NO YES TCGA-HT-8113-F32197 TCGA-HT-8113 TCGA-HT-8113-01A -18173 0 900 102 NO NO NO Seizures 0 - 30 Days Scheduled Follow-up Submission NO 2012-5-17 FEMALE NO YES Oligodendroglioma NO No C71.0 9450/3 C71.0 YES 0.9 NO 90 Left 2.2 NO NO NO G2 NO No TCGA-HT-8113.93ef4c6d-e0a1-48f0-b6af-6f529478dbf9.pdf 8113 TUMOR FREE YES NO Complete Remission/Response YES Primary Tumor 01 YES NO 0.6 White Matter YES NO YES HT Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2006 TCGA-HT-8113-01 18E6678D-5C3E-4F2C-8A97-DE616053AE10 TCGA-HT-8113-01A-11D-2395-08 TCGA-HT-8113-01A-11D-2391-01 fad69aee-febe-4893-86a4-e71c0b22b9f4 TCGA-HT-8113-01 TCGA-HT-8113-01 TCGA-HT-8113-01A-11D-2395-08 fad69aee-febe-4893-86a4-e71c0b22b9f4 TCGA-HT-8113-01 TCGA-HT-8113-01 TCGA-HT-8113-01A-11D-2395-08 TCGA-HT-8113-01A-11D-2399-05 fad69aee-febe-4893-86a4-e71c0b22b9f4 fad69aee-febe-4893-86a4-e71c0b22b9f4 TCGA-HT-8113-01A-11D-2391-01 TCGA-HT-8113-01A-11D-2395-08 +TCGA-HT-8114-01 TCGA-HT-8114-01 TCGA-HT-8114 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 36 NO NO TCGA-HT-8114-F66394 TCGA-HT-8114 TCGA-HT-8114-01A -13198 0 1040 NO NO NO Headaches 0 - 30 Days Scheduled Follow-up Submission Complete Remission/Response NO 2014-10-14 MALE NO YES Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES 0.8 NO Left NO 2 NO YES NO YES G3 NO No TCGA-HT-8114.8aa9d827-a738-4750-af50-c0886cc64aeb.pdf 8114 TUMOR FREE NO NO Complete Remission/Response YES Primary Tumor 01 NO NO 0.6 White Matter YES NO YES HT Supratentorial, Parietal Lobe Central nervous system A YES LIVING 2011 TCGA-HT-8114-01 3B7103C8-1496-464B-8FB0-D82CAE07E9C6 TCGA-HT-8114-01A-11D-2395-08 TCGA-HT-8114-01A-11D-2391-01 5007c6f5-2134-4d0e-8d53-13a0f1439d9e TCGA-HT-8114-01 TCGA-HT-8114-01 TCGA-HT-8114-01A-11D-2395-08 5007c6f5-2134-4d0e-8d53-13a0f1439d9e TCGA-HT-8114-01 TCGA-HT-8114-01 TCGA-HT-8114-01A-11D-2395-08 TCGA-HT-8114-01A-11D-2399-05 5007c6f5-2134-4d0e-8d53-13a0f1439d9e 5007c6f5-2134-4d0e-8d53-13a0f1439d9e TCGA-HT-8114-01A-11D-2391-01 TCGA-HT-8114-01A-11D-2395-08 +TCGA-HT-8558-01 TCGA-HT-8558-01 TCGA-HT-8558 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 29 NO NO TCGA-HT-8558-F48474 TCGA-HT-8558 TCGA-HT-8558-01A -10950 0 418 Seizures 31 - 90 Days Scheduled Follow-up Submission Complete Remission/Response NO 2013-9-13 FEMALE NO YES Oligodendroglioma NO No C71.0 9450/3 C71.0 YES 0.8 NO Left 1.2 YES NO NO NO G2 NO No TCGA-HT-8558.3F364926-441B-435D-BDF5-E055B46A1B1C.pdf 8558 TUMOR FREE YES YES Complete Remission/Response NO Primary Tumor 01 YES NO 0.5 Not listed in Medical Record NO NO YES HT Supratentorial, Temporal Lobe Central nervous system A NO LIVING 2011 TCGA-HT-8558-01 8C99C424-8415-4C1E-A72D-051BEFA94380 TCGA-HT-8558-01A-21D-2395-08 db75b249-f02e-47d8-ba4c-37a5ba7c4b33 TCGA-HT-8558-01 TCGA-HT-8558-01 TCGA-HT-8558-01A-21D-2395-08 db75b249-f02e-47d8-ba4c-37a5ba7c4b33 TCGA-HT-8558-01 TCGA-HT-8558-01A-21D-2395-08 TCGA-HT-8558-01A-21D-2399-05 db75b249-f02e-47d8-ba4c-37a5ba7c4b33 db75b249-f02e-47d8-ba4c-37a5ba7c4b33 TCGA-HT-8558-01A-21D-2395-08 +TCGA-HT-8563-01 TCGA-HT-8563-01 TCGA-HT-8563 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 30 TCGA-HT-8563-F61084 TCGA-HT-8563 TCGA-HT-8563-01A -11305 0 860 NO > 20 Years Headaches 0 - 30 Days Scheduled Follow-up Submission Complete Remission/Response 2014-6-23 FEMALE YES YES Astrocytoma NO No C71.0 9401/3 C71.0 YES 0.6 NO Right 0.7 NO NO NO G3 NO No TCGA-HT-8563.5a5ea09f-fbc2-43a7-a135-7db5b681ae76.pdf 8563 TUMOR FREE Complete Remission/Response YES Primary Tumor 01 NO NO 0.2 Cerebral Cortex NO NO YES HT Supratentorial, Frontal Lobe Central nervous system A YES LIVING 2011 TCGA-HT-8563-01 TCGA-HT-8563-01A-11D-2395-08 TCGA-HT-8563-01A-11D-2391-01 456b83a3-79b9-41ec-8745-95c57c67ab60 TCGA-HT-8563-01 TCGA-HT-8563-01 TCGA-HT-8563-01A-11D-2395-08 456b83a3-79b9-41ec-8745-95c57c67ab60 TCGA-HT-8563-01 TCGA-HT-8563-01 TCGA-HT-8563-01A-11D-2395-08 TCGA-HT-8563-01A-11D-2399-05 456b83a3-79b9-41ec-8745-95c57c67ab60 456b83a3-79b9-41ec-8745-95c57c67ab60 TCGA-HT-8563-01A-11D-2391-01 TCGA-HT-8563-01A-11D-2395-08 +TCGA-HT-8564-01 TCGA-HT-8564-01 TCGA-HT-8564 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain YES NO 47 NO NO TCGA-HT-8564-F48467 TCGA-HT-8564 TCGA-HT-8564-01A -17499 0 478 120 NO NO NO Mental Status Changes > 181 Days Scheduled Follow-up Submission Progressive Disease NO 2013-9-13 MALE NO NO Astrocytoma NO No C71.0 9401/3 C71.0 YES 0.4 NO 80 Left 0.7 NO YES NO NO G3 YES No TCGA-HT-8564.2809249b-fed4-4b7a-b221-10a606c30bce.pdf 8564 Post-Adjuvant Therapy WITH TUMOR Progressive Disease NO Primary Tumor 01 NO NO 0.3 Not listed in Medical Record YES NO YES HT Supratentorial, Temporal Lobe Central nervous system A NO LIVING 2012 TCGA-HT-8564-01 49B3E416-7961-4995-9AA0-A5ADAC95AF8E TCGA-HT-8564-01A-11D-2395-08 TCGA-HT-8564-01A-11D-2391-01 6899de21-8648-45fa-a519-679b0438f848 TCGA-HT-8564-01 TCGA-HT-8564-01 TCGA-HT-8564-01A-11D-2395-08 6899de21-8648-45fa-a519-679b0438f848 TCGA-HT-8564-01 TCGA-HT-8564-01 TCGA-HT-8564-01A-11D-2395-08 TCGA-HT-8564-01A-11D-2399-05 6899de21-8648-45fa-a519-679b0438f848 6899de21-8648-45fa-a519-679b0438f848 TCGA-HT-8564-01A-11D-2391-01 TCGA-HT-8564-01A-11D-2395-08 +TCGA-HT-A4DS-01 TCGA-HT-A4DS-01 TCGA-HT-A4DS TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 55 TCGA-HT-A4DS-F61277 TCGA-HT-A4DS TCGA-HT-A4DS-01A -20296 137 0 7 NO YES NO Seizures 0 - 30 Days Scheduled Follow-up Submission 2014-6-26 FEMALE NO Astrocytoma NO No C71.0 9401/3 C71.0 YES 80 NO Right NO YES NO NO G3 true No TCGA-HT-A4DS.3E2FDB9A-0295-493E-8F8D-C501FA1B3172.pdf A4DS TUMOR FREE YES YES Primary Tumor 01 YES YES Not listed in Medical Record NO YES HT Supratentorial, Temporal Lobe Central nervous system A NO LIVING 2012 TCGA-HT-A4DS-01 TCGA-HT-A4DS-01A-11D-A26M-08 TCGA-HT-A4DS-01A-11D-A26L-01 8aa3351e-ac40-409f-a2b9-4febbf3e0c47 TCGA-HT-A4DS-01 TCGA-HT-A4DS-01 TCGA-HT-A4DS-01A-11D-A26M-08 8aa3351e-ac40-409f-a2b9-4febbf3e0c47 TCGA-HT-A4DS-01 TCGA-HT-A4DS-01A-11D-A26M-08 TCGA-HT-A4DS-01A-11D-A26N-05 8aa3351e-ac40-409f-a2b9-4febbf3e0c47 8aa3351e-ac40-409f-a2b9-4febbf3e0c47 TCGA-HT-A4DS-01A-11D-A26L-01 TCGA-HT-A4DS-01A-11D-A26M-08 +TCGA-HT-A4DV-01 TCGA-HT-A4DV-01 TCGA-HT-A4DV TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 51 TCGA-HT-A4DV-F61274 TCGA-HT-A4DV TCGA-HT-A4DV-01A -18799 141 0 792 14 YES NO Seizures 31 - 90 Days Scheduled Follow-up Submission 2014-6-26 FEMALE NO Oligodendroglioma NO No C71.0 9451/3 C71.0 YES 360 NO 90 Left NO NO NO NO G3 NO true No TCGA-HT-A4DV.A5D9C1B2-9F81-42BD-927B-F6FC22F38F62.pdf A4DV Post-Adjuvant Therapy TUMOR FREE YES YES Partial Remission/Response YES Primary Tumor 01 YES NO White Matter YES NO YES HT Supratentorial, Frontal Lobe Central nervous system A YES LIVING 2012 TCGA-HT-A4DV-01 DA530F9E-42D0-4B8D-9E50-EF0FB98F3238 TCGA-HT-A4DV-01A-11D-A26M-08 TCGA-HT-A4DV-01A-11D-A26L-01 8d03eb0d-b6f2-4b28-aa26-4de13bd37270 TCGA-HT-A4DV-01 TCGA-HT-A4DV-01 TCGA-HT-A4DV-01A-11D-A26M-08 8d03eb0d-b6f2-4b28-aa26-4de13bd37270 TCGA-HT-A4DV-01 TCGA-HT-A4DV-01A-11D-A26M-08 TCGA-HT-A4DV-01A-11D-A26N-05 8d03eb0d-b6f2-4b28-aa26-4de13bd37270 8d03eb0d-b6f2-4b28-aa26-4de13bd37270 TCGA-HT-A4DV-01A-11D-A26L-01 TCGA-HT-A4DV-01A-11D-A26M-08 +TCGA-HT-A5R5-01 TCGA-HT-A5R5-01 TCGA-HT-A5R5 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 33 TCGA-HT-A5R5-F61085 TCGA-HT-A5R5 TCGA-HT-A5R5-01A -12403 194 0 4 NO NO Seizures 31 - 90 Days Scheduled Follow-up Submission 2014-6-23 FEMALE Oligodendroglioma NO No C71.0 9450/3 C71.0 YES 260 NO Left YES NO YES G2 true No TCGA-HT-A5R5.9A308F04-2E34-40CB-97FC-A3A5D111FA25.pdf A5R5 TUMOR FREE Complete Remission/Response Primary Tumor 01 YES NO Not listed in Medical Record NO YES HT Supratentorial, Temporal Lobe Central nervous system A NO LIVING 2012 TCGA-HT-A5R5-01 8602068A-5801-4681-A1B5-6B4A2F2BADF7 TCGA-HT-A5R5-01A-11D-A289-08 TCGA-HT-A5R5-01A-11D-A288-01 3d55fa54-f618-4790-840a-7d2a02ee3b3d TCGA-HT-A5R5-01 TCGA-HT-A5R5-01 TCGA-HT-A5R5-01A-11D-A289-08 3d55fa54-f618-4790-840a-7d2a02ee3b3d TCGA-HT-A5R5-01 TCGA-HT-A5R5-01A-11D-A289-08 TCGA-HT-A5R5-01A-11D-A28N-05 3d55fa54-f618-4790-840a-7d2a02ee3b3d 3d55fa54-f618-4790-840a-7d2a02ee3b3d TCGA-HT-A5R5-01A-11D-A288-01 TCGA-HT-A5R5-01A-11D-A289-08 +TCGA-HT-A5R7-01 TCGA-HT-A5R7-01 TCGA-HT-A5R7 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 33 TCGA-HT-A5R7-F61086 TCGA-HT-A5R7 TCGA-HT-A5R7-01A -12092 147 0 615 YES NO Seizures 0 - 30 Days Scheduled Follow-up Submission Complete Remission/Response 2014-6-23 FEMALE NO Astrocytoma NO No C71.0 9401/3 C71.0 YES 310 NO 90 Right YES NO NO YES G3 NO true No TCGA-HT-A5R7.0C8ED6F2-0B6A-4316-A53C-EF42BCB47E39.pdf A5R7 Post-Adjuvant Therapy TUMOR FREE YES Complete Remission/Response YES Primary Tumor 01 YES NO Not listed in Medical Record YES NO YES HT Supratentorial, Parietal Lobe Central nervous system A NO LIVING 2012 TCGA-HT-A5R7-01 9D5EB879-0BDE-4A80-BA80-6CC800A0E172 TCGA-HT-A5R7-01A-11D-A289-08 TCGA-HT-A5R7-01A-11D-A288-01 8022301e-d815-4601-922b-027399c9d279 TCGA-HT-A5R7-01 TCGA-HT-A5R7-01 TCGA-HT-A5R7-01A-11D-A289-08 8022301e-d815-4601-922b-027399c9d279 TCGA-HT-A5R7-01 TCGA-HT-A5R7-01A-11D-A289-08 TCGA-HT-A5R7-01A-11D-A28N-05 8022301e-d815-4601-922b-027399c9d279 8022301e-d815-4601-922b-027399c9d279 TCGA-HT-A5R7-01A-11D-A288-01 TCGA-HT-A5R7-01A-11D-A289-08 +TCGA-HT-A5R9-01 TCGA-HT-A5R9-01 TCGA-HT-A5R9 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 48 NO TCGA-HT-A5R9-F61080 TCGA-HT-A5R9 TCGA-HT-A5R9-01A -17775 79 0 2 NO NO NO Seizures 0 - 30 Days Scheduled Follow-up Submission 2014-6-26 FEMALE NO NO Oligodendroglioma NO No C71.0 9451/3 C71.0 YES 390 NO Right NO YES NO NO NO G3 true No TCGA-HT-A5R9.D35BB9FB-030C-4B30-AE08-FFB1B39CAD6D.pdf A5R9 Primary Tumor 01 YES NO Not listed in Medical Record NO YES HT Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2012 TCGA-HT-A5R9-01 1CC76211-AA8E-4FBC-9138-F024AFD6CD11 TCGA-HT-A5R9-01A-11D-A289-08 TCGA-HT-A5R9-01A-11D-A288-01 922a7345-64a7-43e8-9c11-bb0bd85dd847 TCGA-HT-A5R9-01 TCGA-HT-A5R9-01 TCGA-HT-A5R9-01A-11D-A289-08 922a7345-64a7-43e8-9c11-bb0bd85dd847 TCGA-HT-A5R9-01 TCGA-HT-A5R9-01A-11D-A289-08 TCGA-HT-A5R9-01A-11D-A28N-05 922a7345-64a7-43e8-9c11-bb0bd85dd847 922a7345-64a7-43e8-9c11-bb0bd85dd847 TCGA-HT-A5R9-01A-11D-A288-01 TCGA-HT-A5R9-01A-11D-A289-08 +TCGA-HT-A5RA-01 TCGA-HT-A5RA-01 TCGA-HT-A5RA TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 65 NO NO TCGA-HT-A5RA-F61263 TCGA-HT-A5RA TCGA-HT-A5RA-01A -23769 385 0 832 244 NO YES NO Seizures 31 - 90 Days Scheduled Follow-up Submission Partial Remission/Response NO 2014-6-26 FEMALE NO NO Astrocytoma NO No C71.0 9401/3 C71.0 YES 70 NO 70 Right NO NO NO NO G3 NO true No TCGA-HT-A5RA.4FF0C3AD-41E6-4814-9ED9-ED40691DE316.pdf A5RA Post-Adjuvant Therapy WITH TUMOR Partial Remission/Response YES Primary Tumor 01 YES NO Not listed in Medical Record YES NO YES HT Supratentorial, Temporal Lobe Central nervous system A NO LIVING 2012 TCGA-HT-A5RA-01 TCGA-HT-A5RA-01A-11D-A289-08 TCGA-HT-A5RA-01A-11D-A288-01 2b4e9c4e-0f22-4251-947f-0e23a1fbbe62 TCGA-HT-A5RA-01 TCGA-HT-A5RA-01 TCGA-HT-A5RA-01A-11D-A289-08 2b4e9c4e-0f22-4251-947f-0e23a1fbbe62 TCGA-HT-A5RA-01 TCGA-HT-A5RA-01A-11D-A289-08 TCGA-HT-A5RA-01A-11D-A28N-05 2b4e9c4e-0f22-4251-947f-0e23a1fbbe62 2b4e9c4e-0f22-4251-947f-0e23a1fbbe62 TCGA-HT-A5RA-01A-11D-A288-01 TCGA-HT-A5RA-01A-11D-A289-08 +TCGA-HT-A5RB-01 TCGA-HT-A5RB-01 TCGA-HT-A5RB TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 24 NO TCGA-HT-A5RB-F61266 TCGA-HT-A5RB TCGA-HT-A5RB-01A -8820 597 0 3 NO NO NO Seizures 0 - 30 Days Scheduled Follow-up Submission 2014-6-26 MALE NO NO Astrocytoma NO No C71.0 9400/3 C71.0 YES 320 NO Right YES NO NO NO G2 true No TCGA-HT-A5RB.3DDDF9B9-4EB3-4098-8898-98868D2416D3.pdf A5RB YES NO Primary Tumor 01 YES NO Not listed in Medical Record NO YES HT Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2011 TCGA-HT-A5RB-01 3D0A3566-84B8-44E8-8670-CEAF524BAB9A TCGA-HT-A5RB-01A-11D-A289-08 TCGA-HT-A5RB-01A-11D-A288-01 53caa54a-c88e-423e-a33c-9e8d69daf2cd TCGA-HT-A5RB-01 TCGA-HT-A5RB-01 TCGA-HT-A5RB-01A-11D-A289-08 53caa54a-c88e-423e-a33c-9e8d69daf2cd TCGA-HT-A5RB-01 TCGA-HT-A5RB-01A-11D-A289-08 TCGA-HT-A5RB-01A-11D-A28N-05 53caa54a-c88e-423e-a33c-9e8d69daf2cd 53caa54a-c88e-423e-a33c-9e8d69daf2cd TCGA-HT-A5RB-01A-11D-A288-01 TCGA-HT-A5RB-01A-11D-A289-08 +TCGA-HT-A5RC-01 TCGA-HT-A5RC-01 TCGA-HT-A5RC TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 70 TCGA-HT-A5RC TCGA-HT-A5RC-01A -25772 140 162 0 NO NO Mental Status Changes 0 - 30 Days 2013-7-29 FEMALE NO Astrocytoma NO No C71.0 9401/3 C71.0 YES 60 NO 40 Left YES YES G3 NO true No TCGA-HT-A5RC.A17D7270-D512-4F3F-B40C-588337E9222E.pdf A5RC Post-Adjuvant Therapy WITH TUMOR Progressive Disease YES Primary Tumor 01 NO NO Not listed in Medical Record YES NO YES HT Supratentorial, Frontal Lobe Central nervous system A NO DECEASED 2012 TCGA-HT-A5RC-01 TCGA-HT-A5RC-01A-11D-A289-08 TCGA-HT-A5RC-01A-11D-A288-01 07c85322-ff5e-4e17-b6d8-bec6305fe14e TCGA-HT-A5RC-01 TCGA-HT-A5RC-01 TCGA-HT-A5RC-01A-11D-A289-08 07c85322-ff5e-4e17-b6d8-bec6305fe14e TCGA-HT-A5RC-01 TCGA-HT-A5RC-01A-11D-A289-08 TCGA-HT-A5RC-01A-11D-A28N-05 07c85322-ff5e-4e17-b6d8-bec6305fe14e 07c85322-ff5e-4e17-b6d8-bec6305fe14e TCGA-HT-A5RC-01A-11D-A288-01 TCGA-HT-A5RC-01A-11D-A289-08 +TCGA-HT-A614-01 TCGA-HT-A614-01 TCGA-HT-A614 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 47 TCGA-HT-A614-F61087 TCGA-HT-A614 TCGA-HT-A614-01A -17392 78 0 82 Headaches > 181 Days Scheduled Follow-up Submission Partial Remission/Response 2014-6-23 MALE YES Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES 130 NO Right YES YES YES G2 false No TCGA-HT-A614.9E38FBA2-A9D8-4428-B586-A0C7E711EA14.pdf A614 WITH TUMOR YES Partial Remission/Response Primary Tumor 01 YES YES Not listed in Medical Record NO YES HT Supratentorial, Not Otherwise Specified Central nervous system A NO LIVING 2013 TCGA-HT-A614-01 3CAF3AA9-BA74-4A49-9124-634EA729AC41 TCGA-HT-A614-01A-11D-A29Q-08 TCGA-HT-A614-01A-11D-A323-01 5a3d8ba7-dea1-4155-9345-c542719b29f4 TCGA-HT-A614-01 TCGA-HT-A614-01 TCGA-HT-A614-01A-11D-A29Q-08 5a3d8ba7-dea1-4155-9345-c542719b29f4 TCGA-HT-A614-01 TCGA-HT-A614-01A-11D-A29Q-08 TCGA-HT-A614-01A-11D-A29T-05 5a3d8ba7-dea1-4155-9345-c542719b29f4 5a3d8ba7-dea1-4155-9345-c542719b29f4 TCGA-HT-A614-01A-11D-A323-01 TCGA-HT-A614-01A-11D-A29Q-08 +TCGA-HT-A615-01 TCGA-HT-A615-01 TCGA-HT-A615 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 38 NO TCGA-HT-A615-F66402 TCGA-HT-A615 TCGA-HT-A615-01A -13892 300 0 515 271 NO YES NO Seizures 0 - 30 Days Scheduled Follow-up Submission Complete Remission/Response 2014-10-14 FEMALE NO Oligodendroglioma NO No C71.0 9450/3 C71.0 YES 140 NO 90 Left NO NO NO G2 NO false No TCGA-HT-A615.34BD1967-CF9D-4B21-866A-BB100739E1C9.pdf A615 Post-Adjuvant Therapy TUMOR FREE Complete Remission/Response YES Primary Tumor 01 YES NO Not listed in Medical Record NO NO YES HT Supratentorial, Temporal Lobe Central nervous system A NO LIVING 2012 TCGA-HT-A615-01 39099FDA-F07D-474B-9E01-C7291292DB70 TCGA-HT-A615-01A-11D-A29Q-08 TCGA-HT-A615-01A-11D-A323-01 6a2adcf5-fc75-46a4-a029-dd84d1a019c0 TCGA-HT-A615-01 TCGA-HT-A615-01 TCGA-HT-A615-01A-11D-A29Q-08 6a2adcf5-fc75-46a4-a029-dd84d1a019c0 TCGA-HT-A615-01 TCGA-HT-A615-01A-11D-A29Q-08 TCGA-HT-A615-01A-11D-A29T-05 6a2adcf5-fc75-46a4-a029-dd84d1a019c0 6a2adcf5-fc75-46a4-a029-dd84d1a019c0 TCGA-HT-A615-01A-11D-A323-01 TCGA-HT-A615-01A-11D-A29Q-08 +TCGA-HT-A616-01 TCGA-HT-A616-01 TCGA-HT-A616 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 36 NO NO TCGA-HT-A616-F61270 TCGA-HT-A616 TCGA-HT-A616-01A -13222 70 0 55 NO YES NO Seizures 31 - 90 Days Scheduled Follow-up Submission 2014-6-26 FEMALE NO NO Astrocytoma NO No C71.0 9400/3 C71.0 YES 290 NO Left YES NO NO NO G2 false No TCGA-HT-A616.65CCB3E5-56CE-4D6F-A6F5-4D1729A9BBF8.pdf A616 NO Primary Tumor 01 YES NO Not listed in Medical Record NO NO YES HT Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2013 TCGA-HT-A616-01 8A249C47-6E14-4D38-BB59-AC0C257F4808 TCGA-HT-A616-01A-11D-A29Q-08 TCGA-HT-A616-01A-11D-A323-01 80f78f2f-4e63-4561-905e-a81528b79cab TCGA-HT-A616-01 TCGA-HT-A616-01 TCGA-HT-A616-01A-11D-A29Q-08 80f78f2f-4e63-4561-905e-a81528b79cab TCGA-HT-A616-01 TCGA-HT-A616-01A-11D-A29Q-08 TCGA-HT-A616-01A-11D-A29T-05 80f78f2f-4e63-4561-905e-a81528b79cab 80f78f2f-4e63-4561-905e-a81528b79cab TCGA-HT-A616-01A-11D-A323-01 TCGA-HT-A616-01A-11D-A29Q-08 +TCGA-HT-A617-01 TCGA-HT-A617-01 TCGA-HT-A617 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 47 NO TCGA-HT-A617-F61272 TCGA-HT-A617 TCGA-HT-A617-01A -17331 961 0 491 486 NO NO NO Seizures 31 - 90 Days Scheduled Follow-up Submission 2014-6-26 MALE NO NO Oligodendroglioma NO No C71.0 9450/3 C71.0 YES 230 NO 60 Right NO YES NO NO NO G2 YES false No TCGA-HT-A617.0DF6A8BE-1AE0-40CE-98D1-5B17DCB44FE7.pdf A617 Post-Adjuvant Therapy YES NO Progressive Disease Primary Tumor 01 YES NO Not listed in Medical Record NO YES HT Supratentorial, Not Otherwise Specified Central nervous system A NO LIVING 2010 TCGA-HT-A617-01 71AAEDA2-5F97-4B71-8A8F-D55F0A2B8CD4 TCGA-HT-A617-01A-11D-A29Q-08 TCGA-HT-A617-01A-11D-A323-01 e621d7be-8167-4260-adff-ce1b57202eaf TCGA-HT-A617-01 TCGA-HT-A617-01 TCGA-HT-A617-01A-11D-A29Q-08 e621d7be-8167-4260-adff-ce1b57202eaf TCGA-HT-A617-01 TCGA-HT-A617-01A-11D-A29Q-08 TCGA-HT-A617-01A-11D-A29T-05 e621d7be-8167-4260-adff-ce1b57202eaf e621d7be-8167-4260-adff-ce1b57202eaf TCGA-HT-A617-01A-11D-A323-01 TCGA-HT-A617-01A-11D-A29Q-08 +TCGA-HT-A618-01 TCGA-HT-A618-01 TCGA-HT-A618 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 37 TCGA-HT-A618-F61273 TCGA-HT-A618 TCGA-HT-A618-01A -13595 71 0 512 62 NO NO Mental Status Changes 0 - 30 Days Scheduled Follow-up Submission Complete Remission/Response 2014-6-26 FEMALE NO Astrocytoma NO No C71.0 9401/3 C71.0 YES 130 NO 80 NO YES YES G3 NO false No TCGA-HT-A618.1E45E711-0DF2-43BD-8E84-888813B93769.pdf A618 Pre-Adjuvant Therapy TUMOR FREE Complete Remission/Response NO Primary Tumor 01 YES Not listed in Medical Record NO NO YES HT Supratentorial, Temporal Lobe Central nervous system A NO LIVING 2013 TCGA-HT-A618-01 DA7D48C4-4546-4A96-B149-DA367482ACE0 TCGA-HT-A618-01A-11D-A29Q-08 TCGA-HT-A618-01A-11D-A323-01 08a9d6fb-2367-4bd2-b828-c1d970dc62a8 TCGA-HT-A618-01 TCGA-HT-A618-01 TCGA-HT-A618-01A-11D-A29Q-08 08a9d6fb-2367-4bd2-b828-c1d970dc62a8 TCGA-HT-A618-01 TCGA-HT-A618-01A-11D-A29Q-08 TCGA-HT-A618-01A-11D-A29T-05 08a9d6fb-2367-4bd2-b828-c1d970dc62a8 08a9d6fb-2367-4bd2-b828-c1d970dc62a8 TCGA-HT-A618-01A-11D-A323-01 TCGA-HT-A618-01A-11D-A29Q-08 +TCGA-HT-A619-01 TCGA-HT-A619-01 TCGA-HT-A619 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 51 TCGA-HT-A619-F66412 TCGA-HT-A619 TCGA-HT-A619-01A -18857 84 0 651 Motor/Movement Changes 0 - 30 Days Scheduled Follow-up Submission Complete Remission/Response 2014-10-14 FEMALE NO Oligodendroglioma YES Yes, Radiation Prior to Resection C71.0 9451/3 C71.0 YES 130 NO Left NO NO YES G3 NO false Yes, History of Prior Malignancy TCGA-HT-A619.1425BF47-215A-486A-BA84-73E0F3F34A57.pdf A619 Preoperative TUMOR FREE Complete Remission/Response NO Primary Tumor 01 NO NO Not listed in Medical Record YES NO YES HT Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2012 TCGA-HT-A619-01 8BDD21BE-DC1D-4162-ACD2-D9126E3B43D9 TCGA-HT-A619-01A-11D-A29Q-08 TCGA-HT-A619-01A-11D-A323-01 56d6ee3a-08b5-41ad-8ec2-574870987201 TCGA-HT-A619-01A-11D-A29Q-08 56d6ee3a-08b5-41ad-8ec2-574870987201 TCGA-HT-A619-01 TCGA-HT-A619-01A-11D-A29Q-08 TCGA-HT-A619-01A-11D-A29T-05 56d6ee3a-08b5-41ad-8ec2-574870987201 56d6ee3a-08b5-41ad-8ec2-574870987201 TCGA-HT-A619-01A-11D-A323-01 TCGA-HT-A619-01A-11D-A29Q-08 +TCGA-HT-A61A-01 TCGA-HT-A61A-01 TCGA-HT-A61A TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 20 TCGA-HT-A61A TCGA-HT-A61A-01A -7664 41 0 194 NO Seizures 31 - 90 Days 2013-9-18 FEMALE NO Oligodendroglioma NO No C71.0 9450/3 C71.0 YES 110 NO 80 Left NO NO G2 false No TCGA-HT-A61A.52DE6BC7-B83B-4C8A-AAAD-2B6D0AB0E614.pdf A61A Other TUMOR FREE YES Complete Remission/Response YES Primary Tumor 01 YES NO Not listed in Medical Record YES NO YES HT Supratentorial, Temporal Lobe Central nervous system A NO LIVING 2013 TCGA-HT-A61A-01 5CBB67A7-15B8-4E3A-84BE-37FF2072F131 TCGA-HT-A61A-01A-11D-A29Q-08 c68ca414-0567-4349-8ad4-55df8cbcc35d TCGA-HT-A61A-01 TCGA-HT-A61A-01 TCGA-HT-A61A-01A-11D-A29Q-08 c68ca414-0567-4349-8ad4-55df8cbcc35d TCGA-HT-A61A-01A-11D-A29Q-08 TCGA-HT-A61A-01A-11D-A29T-05 c68ca414-0567-4349-8ad4-55df8cbcc35d c68ca414-0567-4349-8ad4-55df8cbcc35d TCGA-HT-A61A-01A-11D-A29Q-08 +TCGA-HT-A61B-01 TCGA-HT-A61B-01 TCGA-HT-A61B TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 22 TCGA-HT-A61B-F61305 TCGA-HT-A61B TCGA-HT-A61B-01A -8335 101 0 533 NO NO Seizures 0 - 30 Days Scheduled Follow-up Submission Complete Remission/Response 2014-6-26 MALE NO Astrocytoma NO No C71.0 9401/3 C71.0 YES 260 NO 80 Left NO YES NO G3 NO false No TCGA-HT-A61B.24042BE1-BDC3-41A3-93EE-872D5E3B99F3.pdf A61B Post-Adjuvant Therapy TUMOR FREE YES Complete Remission/Response YES Primary Tumor 01 YES NO Not listed in Medical Record YES NO YES HT Supratentorial, Temporal Lobe Central nervous system A NO LIVING 2012 TCGA-HT-A61B-01 404DA82D-CF5F-462E-A88E-B678DF2C320F TCGA-HT-A61B-01A-11D-A29Q-08 TCGA-HT-A61B-01A-11D-A323-01 6740d6ab-1321-4806-961a-116ce5be8d29 TCGA-HT-A61B-01 TCGA-HT-A61B-01 TCGA-HT-A61B-01A-11D-A29Q-08 6740d6ab-1321-4806-961a-116ce5be8d29 TCGA-HT-A61B-01 TCGA-HT-A61B-01A-11D-A29Q-08 TCGA-HT-A61B-01A-11D-A29T-05 6740d6ab-1321-4806-961a-116ce5be8d29 6740d6ab-1321-4806-961a-116ce5be8d29 TCGA-HT-A61B-01A-11D-A323-01 TCGA-HT-A61B-01A-11D-A29Q-08 +TCGA-HT-A61C-01 TCGA-HT-A61C-01 TCGA-HT-A61C TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain YES 66 NO NO TCGA-HT-A61C-F61306 TCGA-HT-A61C TCGA-HT-A61C-01A 501 -24276 56 537 0 103 476 19 NO YES Motor/Movement Changes 0 - 30 Days Scheduled Follow-up Submission Progressive Disease NO 2014-7-15 MALE NO NO Oligodendroglioma NO No C71.0 9451/3 C71.0 YES 40 NO 100 Left NO NO NO YES G3 YES false No TCGA-HT-A61C.D3039C78-0727-4215-8EE9-DBADCA775531.pdf A61C Post-Adjuvant Therapy WITH TUMOR YES YES Complete Remission/Response YES Primary Tumor 01 YES NO Not listed in Medical Record YES NO YES HT Supratentorial, Temporal Lobe Central nervous system A NO DECEASED 2013 TCGA-HT-A61C-01 TCGA-HT-A61C-01A-11D-A29Q-08 TCGA-HT-A61C-01A-11D-A323-01 8139b1af-5d6d-4fd4-b834-08cc4a18d0a9 TCGA-HT-A61C-01 TCGA-HT-A61C-01 TCGA-HT-A61C-01A-11D-A29Q-08 8139b1af-5d6d-4fd4-b834-08cc4a18d0a9 TCGA-HT-A61C-01 TCGA-HT-A61C-01A-11D-A29Q-08 TCGA-HT-A61C-01A-11D-A29T-05 8139b1af-5d6d-4fd4-b834-08cc4a18d0a9 8139b1af-5d6d-4fd4-b834-08cc4a18d0a9 TCGA-HT-A61C-01A-11D-A323-01 TCGA-HT-A61C-01A-11D-A29Q-08 +TCGA-HT-A74H-01 TCGA-HT-A74H-01 TCGA-HT-A74H TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 62 NO NO TCGA-HT-A74H-F65103 TCGA-HT-A74H TCGA-HT-A74H-01A -22850 121 0 74 NO NO NO Seizures > 181 Days Scheduled Follow-up Submission NO 2014-9-18 MALE NO NO Astrocytoma NO No C71.0 9401/3 C71.0 YES 220 NO Left NO YES YES NO NO G3 true No TCGA-HT-A74H.436222D6-7870-4C4A-8F3A-50562E9AB8A3.pdf A74H YES NO Stable Disease YES Primary Tumor 01 YES NO Not listed in Medical Record YES NO YES HT Supratentorial, Temporal Lobe Central nervous system A NO LIVING 2013 TCGA-HT-A74H-01 21C70DA7-5AE9-464F-A4A2-BB8426396D71 TCGA-HT-A74H-01A-11D-A32B-08 TCGA-HT-A74H-01A-11D-A32A-01 d450a178-59b3-4dd1-9eeb-8ef305df02ef TCGA-HT-A74H-01 TCGA-HT-A74H-01 d450a178-59b3-4dd1-9eeb-8ef305df02ef TCGA-HT-A74H-01 TCGA-HT-A74H-01A-11D-A32C-05 d450a178-59b3-4dd1-9eeb-8ef305df02ef d450a178-59b3-4dd1-9eeb-8ef305df02ef TCGA-HT-A74H-01A-11D-A32A-01 TCGA-HT-A74H-01A-11D-A32B-08 +TCGA-HT-A74J-01 TCGA-HT-A74J-01 TCGA-HT-A74J TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 33 TCGA-HT-A74J TCGA-HT-A74J-01A -12393 91 0 320 Seizures 0 - 30 Days 2014-6-26 MALE YES Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES 160 NO Left YES IHC YES NO YES G2 NO true No TCGA-HT-A74J.458CC740-C271-4F99-99CE-3101FF24D4B7.pdf A74J YES Partial Remission/Response NO Primary Tumor 01 YES NO Cerebral Cortex NO NO YES HT Supratentorial, Temporal Lobe Central nervous system A NO LIVING 2013 TCGA-HT-A74J-01 E2268697-CCD5-4EE2-AEE4-F5559AF46BF9 TCGA-HT-A74J-01A-12D-A32B-08 TCGA-HT-A74J-01A-12D-A32A-01 fec08c47-a556-4bef-a20f-b3985d30a500 fec08c47-a556-4bef-a20f-b3985d30a500 TCGA-HT-A74J-01 TCGA-HT-A74J-01A-12D-A32C-05 fec08c47-a556-4bef-a20f-b3985d30a500 fec08c47-a556-4bef-a20f-b3985d30a500 TCGA-HT-A74J-01A-12D-A32A-01 TCGA-HT-A74J-01A-12D-A32B-08 +TCGA-HT-A74K-01 TCGA-HT-A74K-01 TCGA-HT-A74K TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 58 TCGA-HT-A74K TCGA-HT-A74K-01A -21189 293 0 467 Seizures > 181 Days 2014-6-26 FEMALE NO Oligodendroglioma NO No C71.0 9451/3 C71.0 YES 80 NO Right NO NO G3 NO true No TCGA-HT-A74K.CB30199B-FBD0-494A-8A61-5B58E5D61BB9.pdf A74K TUMOR FREE Complete Remission/Response YES Primary Tumor 01 YES NO Cerebral Cortex YES NO YES HT Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2012 TCGA-HT-A74K-01 TCGA-HT-A74K-01A-11D-A32B-08 TCGA-HT-A74K-01A-11D-A32A-01 46bc5230-2912-4e5e-a5c0-7a2f5aa6b682 TCGA-HT-A74K-01 TCGA-HT-A74K-01 46bc5230-2912-4e5e-a5c0-7a2f5aa6b682 TCGA-HT-A74K-01 TCGA-HT-A74K-01A-11D-A32C-05 46bc5230-2912-4e5e-a5c0-7a2f5aa6b682 46bc5230-2912-4e5e-a5c0-7a2f5aa6b682 TCGA-HT-A74K-01A-11D-A32A-01 TCGA-HT-A74K-01A-11D-A32B-08 +TCGA-HT-A74L-01 TCGA-HT-A74L-01 TCGA-HT-A74L TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 22 NO NO TCGA-HT-A74L-F65345 TCGA-HT-A74L TCGA-HT-A74L-01A -8240 103 0 336 NO YES NO Seizures 31 - 90 Days Scheduled Follow-up Submission Partial Remission/Response NO 2014-9-22 FEMALE NO NO Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES 230 NO 90 Right YES IHC YES NO NO NO YES G2 NO true No TCGA-HT-A74L.FFB289B9-552E-4232-B2F7-9E93D72A7DD0.pdf A74L Pre-Adjuvant Therapy WITH TUMOR Partial Remission/Response Primary Tumor 01 YES NO Cerebral Cortex NO YES HT Supratentorial, Parietal Lobe Central nervous system A NO LIVING 2013 TCGA-HT-A74L-01 9D81EF0D-678B-44DA-8B1C-29DAD54952F9 TCGA-HT-A74L-01A-11D-A32B-08 TCGA-HT-A74L-01A-11D-A32A-01 5e6fdaa5-ce70-4f0a-a2d8-d66854cb9875 TCGA-HT-A74L-01 TCGA-HT-A74L-01 5e6fdaa5-ce70-4f0a-a2d8-d66854cb9875 TCGA-HT-A74L-01 TCGA-HT-A74L-01A-11D-A32C-05 5e6fdaa5-ce70-4f0a-a2d8-d66854cb9875 5e6fdaa5-ce70-4f0a-a2d8-d66854cb9875 TCGA-HT-A74L-01A-11D-A32A-01 TCGA-HT-A74L-01A-11D-A32B-08 +TCGA-HT-A74O-01 TCGA-HT-A74O-01 TCGA-HT-A74O TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 34 NO NO TCGA-HT-A74O-F63075 TCGA-HT-A74O TCGA-HT-A74O-01A -12460 124 0 3 NO NO NO Headaches > 181 Days Scheduled Follow-up Submission NO 2014-7-30 MALE NO YES Astrocytoma NO No C71.0 9401/3 C71.0 YES 140 NO Left NO YES NO NO YES G3 true No TCGA-HT-A74O.0EA28E1A-D342-4149-95BB-EF81B43DA423.pdf A74O YES NO Primary Tumor 01 NO YES Not listed in Medical Record NO YES HT Supratentorial, Temporal Lobe Central nervous system A YES LIVING 2013 TCGA-HT-A74O-01 1F36ECF3-AF5B-4C9A-B247-EB4BB74E3708 TCGA-HT-A74O-01A-11D-A32B-08 TCGA-HT-A74O-01A-11D-A32A-01 6563f101-9cbe-4126-a5dd-fa33c694c257 TCGA-HT-A74O-01 TCGA-HT-A74O-01 6563f101-9cbe-4126-a5dd-fa33c694c257 TCGA-HT-A74O-01 TCGA-HT-A74O-01A-11D-A32C-05 6563f101-9cbe-4126-a5dd-fa33c694c257 6563f101-9cbe-4126-a5dd-fa33c694c257 TCGA-HT-A74O-01A-11D-A32A-01 TCGA-HT-A74O-01A-11D-A32B-08 +TCGA-HW-7486-01 TCGA-HW-7486-01 TCGA-HW-7486 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 37 TCGA-HW-7486-F71504 TCGA-HW-7486 TCGA-HW-7486-01A -13546 0 1721 Scheduled Follow-up Submission Stable Disease 2015-3-31 MALE Oligodendroglioma NO No C71.0 9450/3 C71.0 YES 0.9 NO Right NO 1 NO G2 NO No TCGA-HW-7486.d98d840c-4acf-4312-98b5-c9f35f3517f4.pdf 7486 TUMOR FREE NO Stable Disease NO Primary Tumor 01 YES 0.8 White Matter YES HW Supratentorial, Frontal Lobe Central nervous system A LIVING 2010 TCGA-HW-7486-01A-11D-2024-08 TCGA-HW-7486-01 A3BE1996-AC72-45B6-B367-C9F3B0C8F458 TCGA-HW-7486-01A-11D-2024-08 TCGA-HW-7486-01A-11D-2023-01 2c56dc64-28cf-4b56-ac9d-1d7b906fd56d TCGA-HW-7486-01 TCGA-HW-7486-01 TCGA-HW-7486-01A-11D-2024-08 2c56dc64-28cf-4b56-ac9d-1d7b906fd56d TCGA-HW-7486-01 TCGA-HW-7486-01 TCGA-HW-7486-01A-11D-2024-08 TCGA-HW-7486-01A-11D-2025-05 2c56dc64-28cf-4b56-ac9d-1d7b906fd56d 2c56dc64-28cf-4b56-ac9d-1d7b906fd56d TCGA-HW-7486-01A-11D-2023-01 TCGA-HW-7486-01A-11D-2024-08 +TCGA-HW-7487-01 TCGA-HW-7487-01 TCGA-HW-7487 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain YES NO 39 TCGA-HW-7487-F63127 TCGA-HW-7487 TCGA-HW-7487-01A -14535 0 1382 1356 Additional New Tumor Event 2014-7-31 MALE Oligodendroglioma NO No C71.0 9450/3 C71.0 YES 0.9 NO Left NO 0.9 NO G2 YES No TCGA-HW-7487.1aa8b50f-bce6-4ce5-9922-7a852a1d57ea.pdf 7487 WITH TUMOR YES Progressive Disease NO Primary Tumor 01 YES 0.2 White Matter YES HW Supratentorial, Frontal Lobe Central nervous system A LIVING 2010 TCGA-HW-7487-01A-11D-2024-08 TCGA-HW-7487-01 349A4486-5E72-43B2-ACB4-43AED717B684 TCGA-HW-7487-01A-11D-2024-08 TCGA-HW-7487-01A-11D-2023-01 75082199-c190-4838-8570-d172058bc98b TCGA-HW-7487-01 TCGA-HW-7487-01 TCGA-HW-7487-01A-11D-2024-08 75082199-c190-4838-8570-d172058bc98b TCGA-HW-7487-01 TCGA-HW-7487-01 TCGA-HW-7487-01A-11D-2024-08 TCGA-HW-7487-01A-11D-2025-05 75082199-c190-4838-8570-d172058bc98b 75082199-c190-4838-8570-d172058bc98b TCGA-HW-7487-01A-11D-2023-01 TCGA-HW-7487-01A-11D-2024-08 +TCGA-HW-7489-01 TCGA-HW-7489-01 TCGA-HW-7489 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 38 TCGA-HW-7489-F65183 TCGA-HW-7489 TCGA-HW-7489-01A -14201 1262 0 142 Scheduled Follow-up Submission 2014-9-19 MALE Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES 0.8 NO Right YES Sequence Analysis YES 1.2 NO G2 NO No TCGA-HW-7489.e79ae11e-5076-4e1e-a077-c0488606af9f.pdf 7489 WITH TUMOR YES Progressive Disease NO Primary Tumor 01 YES 0.3 White Matter NO HW Supratentorial, Frontal Lobe Central nervous system A DECEASED 2011 TCGA-HW-7489-01A-11D-2024-08 TCGA-HW-7489-01 5B44D403-A1A7-4D50-8B70-222AA8251D87 TCGA-HW-7489-01A-11D-2024-08 TCGA-HW-7489-01A-11D-2023-01 9ebc9830-2f01-4528-bd95-ae8dfcb2c0a6 TCGA-HW-7489-01 TCGA-HW-7489-01 TCGA-HW-7489-01A-11D-2024-08 9ebc9830-2f01-4528-bd95-ae8dfcb2c0a6 TCGA-HW-7489-01 TCGA-HW-7489-01 TCGA-HW-7489-01A-11D-2024-08 TCGA-HW-7489-01A-11D-2025-05 9ebc9830-2f01-4528-bd95-ae8dfcb2c0a6 9ebc9830-2f01-4528-bd95-ae8dfcb2c0a6 TCGA-HW-7489-01A-11D-2023-01 TCGA-HW-7489-01A-11D-2024-08 +TCGA-HW-7490-01 TCGA-HW-7490-01 TCGA-HW-7490 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 41 TCGA-HW-7490-F71515 TCGA-HW-7490 TCGA-HW-7490-01A -15092 0 1387 Scheduled Follow-up Submission Progressive Disease 2015-3-31 MALE Astrocytoma NO No C71.0 9400/3 C71.0 YES 1.1 NO Left YES YES 1.3 NO G2 NO Yes TCGA-HW-7490.d3358d25-968e-4814-8b2f-6d1203f1861a.pdf 7490 WITH TUMOR NO Progressive Disease NO Primary Tumor 01 NO 0.7 White Matter NO HW Supratentorial, Occipital Lobe Central nervous system A LIVING 2011 TCGA-HW-7490-01A-11D-2024-08 TCGA-HW-7490-01 6EA84AA5-7BDD-4C2D-9E45-751DF886F609 TCGA-HW-7490-01A-11D-2024-08 TCGA-HW-7490-01A-11D-2023-01 cb3b19a0-fb0a-49c8-a4e1-c2e3215a192f TCGA-HW-7490-01 TCGA-HW-7490-01 TCGA-HW-7490-01A-11D-2024-08 cb3b19a0-fb0a-49c8-a4e1-c2e3215a192f TCGA-HW-7490-01 TCGA-HW-7490-01 TCGA-HW-7490-01A-11D-2024-08 TCGA-HW-7490-01A-11D-2025-05 cb3b19a0-fb0a-49c8-a4e1-c2e3215a192f cb3b19a0-fb0a-49c8-a4e1-c2e3215a192f TCGA-HW-7490-01A-11D-2023-01 TCGA-HW-7490-01A-11D-2024-08 +TCGA-HW-7491-01 TCGA-HW-7491-01 TCGA-HW-7491 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain NO NO 35 TCGA-HW-7491-F71510 TCGA-HW-7491 TCGA-HW-7491-01A -12874 0 2078 2197 Scheduled Follow-up Submission 2015-3-31 MALE Oligodendroglioma NO No C71.0 9450/3 C71.0 YES 0.7 NO Right NO 1.1 NO G2 YES No TCGA-HW-7491.8e93a347-6300-4a66-b5f2-c462867c5801.pdf 7491 WITH TUMOR NO Progressive Disease NO Primary Tumor 01 NO 0.5 White Matter YES HW Supratentorial, Frontal Lobe Central nervous system A LIVING 2009 TCGA-HW-7491-01A-11D-2024-08 TCGA-HW-7491-01 8853867D-3899-4F36-A368-1A3C1698042B TCGA-HW-7491-01A-11D-2024-08 TCGA-HW-7491-01A-11D-2023-01 1a2ee9d7-2ef4-4247-9f29-cc1caaabaa5f TCGA-HW-7491-01 TCGA-HW-7491-01 TCGA-HW-7491-01A-11D-2024-08 1a2ee9d7-2ef4-4247-9f29-cc1caaabaa5f TCGA-HW-7491-01 TCGA-HW-7491-01 TCGA-HW-7491-01A-11D-2024-08 TCGA-HW-7491-01A-11D-2025-05 1a2ee9d7-2ef4-4247-9f29-cc1caaabaa5f 1a2ee9d7-2ef4-4247-9f29-cc1caaabaa5f TCGA-HW-7491-01A-11D-2023-01 TCGA-HW-7491-01A-11D-2024-08 +TCGA-HW-7493-01 TCGA-HW-7493-01 TCGA-HW-7493 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 40 TCGA-HW-7493-F71516 TCGA-HW-7493 TCGA-HW-7493-01A -14767 0 2107 Scheduled Follow-up Submission Stable Disease 2015-3-31 FEMALE Astrocytoma NO No C71.0 9400/3 C71.0 YES 0.8 NO Right NO 1.1 NO G2 NO No TCGA-HW-7493.19b2a34c-33d1-49a2-ac5b-2775542ff1e2.pdf 7493 WITH TUMOR YES Stable Disease YES Primary Tumor 01 YES 0.7 White Matter NO HW Supratentorial, Temporal Lobe Central nervous system A LIVING 2009 TCGA-HW-7493-01 088093E0-17FE-472A-8DE4-05AE02AAEDCB TCGA-HW-7493-01A-11D-2024-08 TCGA-HW-7493-01A-11D-2023-01 663ec986-6cdd-4b8c-8d16-5f2afb5caad0 TCGA-HW-7493-01 TCGA-HW-7493-01 663ec986-6cdd-4b8c-8d16-5f2afb5caad0 TCGA-HW-7493-01 TCGA-HW-7493-01 TCGA-HW-7493-01A-11D-2025-05 663ec986-6cdd-4b8c-8d16-5f2afb5caad0 663ec986-6cdd-4b8c-8d16-5f2afb5caad0 TCGA-HW-7493-01A-11D-2023-01 TCGA-HW-7493-01A-11D-2024-08 +TCGA-HW-7495-01 TCGA-HW-7495-01 TCGA-HW-7495 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 45 TCGA-HW-7495-F66931 TCGA-HW-7495 TCGA-HW-7495-01A -16460 0 1078 Scheduled Follow-up Submission Progressive Disease 2014-10-28 FEMALE Oligodendroglioma NO No C71.0 9450/3 C71.0 YES 1.1 NO Right NO 1.7 NO G2 NO No TCGA-HW-7495.c5ad0f30-8b83-4d3b-b695-c177f251ebc6.pdf 7495 WITH TUMOR NO Progressive Disease NO Primary Tumor 01 YES 0.9 White Matter NO HW Supratentorial, Frontal Lobe Central nervous system A LIVING 2011 TCGA-HW-7495-01A-11D-2024-08 TCGA-HW-7495-01 093E540D-E6D3-407E-BF46-B7656B830764 TCGA-HW-7495-01A-11D-2024-08 TCGA-HW-7495-01A-11D-2023-01 ba53832f-dfbc-4581-b7b1-cdc476174d72 TCGA-HW-7495-01 TCGA-HW-7495-01 TCGA-HW-7495-01A-11D-2024-08 ba53832f-dfbc-4581-b7b1-cdc476174d72 TCGA-HW-7495-01 TCGA-HW-7495-01 TCGA-HW-7495-01A-11D-2024-08 TCGA-HW-7495-01A-11D-2025-05 ba53832f-dfbc-4581-b7b1-cdc476174d72 ba53832f-dfbc-4581-b7b1-cdc476174d72 TCGA-HW-7495-01A-11D-2023-01 TCGA-HW-7495-01A-11D-2024-08 +TCGA-HW-8319-01 TCGA-HW-8319-01 TCGA-HW-8319 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain YES NO 34 TCGA-HW-8319-F71526 TCGA-HW-8319 TCGA-HW-8319-01A -12557 1209 0 262 997 Scheduled Follow-up Submission 2015-3-31 FEMALE Astrocytoma NO No C71.0 9401/3 C71.0 YES 1.2 NO Left 1.3 NO G3 YES No TCGA-HW-8319.c90e82a8-f877-40d8-b75f-f67e1714f58e.pdf 8319 WITH TUMOR NO Progressive Disease YES Primary Tumor 01 NO 0.6 YES YES NO HW Supratentorial, Frontal Lobe Central nervous system A DECEASED 2011 TCGA-HW-8319-01 EDCA479A-5F8C-4538-9FAF-2F339F389D4C TCGA-HW-8319-01A-11D-2395-08 TCGA-HW-8319-01A-11D-2391-01 196025a7-8bda-4361-b2f6-8ac98c753564 TCGA-HW-8319-01 TCGA-HW-8319-01 TCGA-HW-8319-01A-11D-2395-08 196025a7-8bda-4361-b2f6-8ac98c753564 TCGA-HW-8319-01 TCGA-HW-8319-01 TCGA-HW-8319-01A-11D-2395-08 TCGA-HW-8319-01A-11D-2399-05 196025a7-8bda-4361-b2f6-8ac98c753564 196025a7-8bda-4361-b2f6-8ac98c753564 TCGA-HW-8319-01A-11D-2391-01 TCGA-HW-8319-01A-11D-2395-08 +TCGA-HW-8320-01 TCGA-HW-8320-01 TCGA-HW-8320 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 36 TCGA-HW-8320-F71522 TCGA-HW-8320 TCGA-HW-8320-01A -13503 0 1217 Scheduled Follow-up Submission Stable Disease 2015-3-31 MALE Astrocytoma NO No C71.0 9401/3 C71.0 YES 1 NO Right Sequence Analysis YES 1.7 NO G3 NO No TCGA-HW-8320.75564dac-fb13-4214-b588-ec14c3550880.pdf 8320 WITH TUMOR YES Stable Disease YES Primary Tumor 01 YES 1 YES YES NO HW Supratentorial, Parietal Lobe Central nervous system A LIVING 2011 TCGA-HW-8320-01 B3A688CE-865F-4AD2-A50B-93A3036ECAF6 TCGA-HW-8320-01A-11D-2395-08 TCGA-HW-8320-01A-11D-2391-01 8fe3cf69-3d71-4d77-aa05-60e619708e06 TCGA-HW-8320-01 TCGA-HW-8320-01 TCGA-HW-8320-01A-11D-2395-08 8fe3cf69-3d71-4d77-aa05-60e619708e06 TCGA-HW-8320-01 TCGA-HW-8320-01 TCGA-HW-8320-01A-11D-2395-08 TCGA-HW-8320-01A-11D-2399-05 8fe3cf69-3d71-4d77-aa05-60e619708e06 8fe3cf69-3d71-4d77-aa05-60e619708e06 TCGA-HW-8320-01A-11D-2391-01 TCGA-HW-8320-01A-11D-2395-08 +TCGA-HW-8321-01 TCGA-HW-8321-01 TCGA-HW-8321 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 31 TCGA-HW-8321-F71520 TCGA-HW-8321 TCGA-HW-8321-01A -11474 0 1294 Scheduled Follow-up Submission Stable Disease 2015-3-31 MALE Astrocytoma NO No C71.0 9400/3 C71.0 YES 1 NO Left 1.6 NO G3 NO No TCGA-HW-8321.985f7f28-3f83-4cda-bfc8-6676bbffd7b2.pdf 8321 WITH TUMOR YES Stable Disease YES Primary Tumor 01 NO 0.5 YES YES NO HW Supratentorial, Frontal Lobe Central nervous system A LIVING 2011 TCGA-HW-8321-01 366D423E-BBBD-43EB-9F75-9443CE44673D TCGA-HW-8321-01A-11D-2395-08 TCGA-HW-8321-01A-11D-2391-01 1c2c32ad-2bd5-4e5f-9784-014d41b96196 TCGA-HW-8321-01 TCGA-HW-8321-01 TCGA-HW-8321-01A-11D-2395-08 1c2c32ad-2bd5-4e5f-9784-014d41b96196 TCGA-HW-8321-01 TCGA-HW-8321-01 TCGA-HW-8321-01A-11D-2395-08 TCGA-HW-8321-01A-11D-2399-05 1c2c32ad-2bd5-4e5f-9784-014d41b96196 1c2c32ad-2bd5-4e5f-9784-014d41b96196 TCGA-HW-8321-01A-11D-2391-01 TCGA-HW-8321-01A-11D-2395-08 +TCGA-HW-8322-01 TCGA-HW-8322-01 TCGA-HW-8322 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 39 TCGA-HW-8322-F71499 TCGA-HW-8322 TCGA-HW-8322-01A -14548 0 758 Scheduled Follow-up Submission Progressive Disease 2015-3-31 MALE Oligodendroglioma NO No C71.0 9450/3 C71.0 YES 0.9 NO Left 1.5 NO G2 NO No TCGA-HW-8322.43aea5c8-29ec-4f1e-b948-101b645b4cf1.pdf 8322 WITH TUMOR NO Stable Disease NO Primary Tumor 01 YES 0.5 YES YES NO HW Supratentorial, Frontal Lobe Central nervous system A LIVING 2012 TCGA-HW-8322-01 7FA99954-5EBD-49AB-9ADE-70216F8570B7 TCGA-HW-8322-01A-11D-2395-08 TCGA-HW-8322-01A-11D-2391-01 83071fd2-bdb5-4135-97cd-dc6d68120a02 TCGA-HW-8322-01 TCGA-HW-8322-01 TCGA-HW-8322-01A-11D-2395-08 83071fd2-bdb5-4135-97cd-dc6d68120a02 TCGA-HW-8322-01 TCGA-HW-8322-01 TCGA-HW-8322-01A-11D-2395-08 TCGA-HW-8322-01A-11D-2399-05 83071fd2-bdb5-4135-97cd-dc6d68120a02 83071fd2-bdb5-4135-97cd-dc6d68120a02 TCGA-HW-8322-01A-11D-2391-01 TCGA-HW-8322-01A-11D-2395-08 +TCGA-HW-A5KJ-01 TCGA-HW-A5KJ-01 TCGA-HW-A5KJ TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 68 TCGA-HW-A5KJ-F71524 TCGA-HW-A5KJ TCGA-HW-A5KJ-01A -24966 286 962 0 321 Scheduled Follow-up Submission Stable Disease 2015-3-31 MALE Oligodendroglioma NO No C71.0 9451/3 C71.0 YES 640 NO Right NO G3 NO true No TCGA-HW-A5KJ.5A607989-F1E0-45AD-A669-D68967ED7670.pdf A5KJ WITH TUMOR NO Progressive Disease YES Primary Tumor 01 NO White Matter YES YES NO HW Supratentorial, Frontal Lobe Central nervous system A DECEASED 2012 TCGA-HW-A5KJ-01 9659E8A6-A535-4433-B7B7-5ACB6058DFDC TCGA-HW-A5KJ-01A-12D-A27K-08 TCGA-HW-A5KJ-01A-12D-A27J-01 c026a9de-ad2b-4959-89c0-484f9d622dd9 TCGA-HW-A5KJ-01 TCGA-HW-A5KJ-01 TCGA-HW-A5KJ-01A-12D-A27K-08 c026a9de-ad2b-4959-89c0-484f9d622dd9 TCGA-HW-A5KJ-01 TCGA-HW-A5KJ-01A-12D-A27K-08 TCGA-HW-A5KJ-01A-12D-A27L-05 c026a9de-ad2b-4959-89c0-484f9d622dd9 c026a9de-ad2b-4959-89c0-484f9d622dd9 TCGA-HW-A5KJ-01A-12D-A27J-01 TCGA-HW-A5KJ-01A-12D-A27K-08 +TCGA-HW-A5KK-01 TCGA-HW-A5KK-01 TCGA-HW-A5KK TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 64 TCGA-HW-A5KK-F59869 TCGA-HW-A5KK TCGA-HW-A5KK-01A -23484 171 388 0 240 Scheduled Follow-up Submission 2014-5-22 MALE Astrocytoma NO No C71.0 9401/3 C71.0 YES 360 NO Right NO G3 NO true No TCGA-HW-A5KK.3F8E4F24-CEB2-4B96-B251-DC0C2B8A6205.pdf A5KK WITH TUMOR YES Progressive Disease YES Primary Tumor 01 YES White Matter YES YES NO HW Supratentorial, Temporal Lobe Central nervous system A DECEASED 2012 TCGA-HW-A5KK-01 8648A6B7-DA82-46CE-A39E-65D6DD1CFEE0 TCGA-HW-A5KK-01A-11D-A27K-08 TCGA-HW-A5KK-01A-11D-A27J-01 bff2060f-591c-4634-a9cb-06d3538d532a TCGA-HW-A5KK-01 TCGA-HW-A5KK-01 TCGA-HW-A5KK-01A-11D-A27K-08 bff2060f-591c-4634-a9cb-06d3538d532a TCGA-HW-A5KK-01 TCGA-HW-A5KK-01A-11D-A27K-08 TCGA-HW-A5KK-01A-11D-A27L-05 bff2060f-591c-4634-a9cb-06d3538d532a bff2060f-591c-4634-a9cb-06d3538d532a TCGA-HW-A5KK-01A-11D-A27J-01 TCGA-HW-A5KK-01A-11D-A27K-08 +TCGA-HW-A5KL-01 TCGA-HW-A5KL-01 TCGA-HW-A5KL TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 42 TCGA-HW-A5KL-F71508 TCGA-HW-A5KL -15513 0 878 Scheduled Follow-up Submission Stable Disease 2015-3-31 FEMALE Astrocytoma NO No C71.0 9400/3 C71.0 YES Right NO G2 NO No A5KL WITH TUMOR NO Stable Disease YES Primary Tumor 01 YES White Matter YES YES NO HW Supratentorial, Temporal Lobe Central nervous system LIVING 2012 TCGA-HW-A5KL-01 TCGA-HW-A5KL-01A-11D-A27K-08 TCGA-HW-A5KL-01A-11D-A27J-01 f9caf12e-40d1-4eec-ae39-2067f78c86c6 TCGA-HW-A5KL-01 TCGA-HW-A5KL-01 TCGA-HW-A5KL-01A-11D-A27K-08 f9caf12e-40d1-4eec-ae39-2067f78c86c6 TCGA-HW-A5KL-01 TCGA-HW-A5KL-01A-11D-A27K-08 TCGA-HW-A5KL-01A-11D-A27L-05 f9caf12e-40d1-4eec-ae39-2067f78c86c6 f9caf12e-40d1-4eec-ae39-2067f78c86c6 TCGA-HW-A5KL-01A-11D-A27J-01 TCGA-HW-A5KL-01A-11D-A27K-08 +TCGA-HW-A5KM-01 TCGA-HW-A5KM-01 TCGA-HW-A5KM TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 35 TCGA-HW-A5KM-F59872 TCGA-HW-A5KM TCGA-HW-A5KM-01A -12845 139 0 630 Scheduled Follow-up Submission Progressive Disease 2014-5-22 MALE Astrocytoma NO No C71.0 9400/3 C71.0 YES 160 NO Left NO G2 NO true No TCGA-HW-A5KM.1DA8A802-EC7A-4452-91AD-720ECCE85D8A.pdf A5KM WITH TUMOR NO Progressive Disease NO Primary Tumor 01 YES White Matter NO YES NO HW Supratentorial, Frontal Lobe Central nervous system A LIVING 2012 TCGA-HW-A5KM-01 1DCD543E-12E7-4C2E-B552-A165BC01FBB3 TCGA-HW-A5KM-01A-11D-A27K-08 TCGA-HW-A5KM-01A-11D-A27J-01 65913e2c-bc8a-44b3-9f14-a4ca9c49042d TCGA-HW-A5KM-01 TCGA-HW-A5KM-01 TCGA-HW-A5KM-01A-11D-A27K-08 65913e2c-bc8a-44b3-9f14-a4ca9c49042d TCGA-HW-A5KM-01 TCGA-HW-A5KM-01A-11D-A27K-08 TCGA-HW-A5KM-01A-11D-A27L-05 65913e2c-bc8a-44b3-9f14-a4ca9c49042d 65913e2c-bc8a-44b3-9f14-a4ca9c49042d TCGA-HW-A5KM-01A-11D-A27J-01 TCGA-HW-A5KM-01A-11D-A27K-08 +TCGA-IK-7675-01 TCGA-IK-7675-01 TCGA-IK-7675 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain YES 43 NO TCGA-IK-7675-F33064 TCGA-IK-7675 TCGA-IK-7675-01A -15900 578 0 123 48 NO NO Motor/Movement Changes 0 - 30 Days Scheduled Follow-up Submission Progressive Disease 2012-6-19 MALE YES Oligodendroglioma NO No C71.0 9450/3 C71.0 YES 0.8 NO 90 Right 1 NO YES G2 YES No TCGA-IK-7675.bb5fc5df-bc8d-4603-a924-c2cbe7cd2e7d.pdf 7675 Other WITH TUMOR YES YES Progressive Disease YES Primary Tumor 01 NO NO 0.4 White Matter NO YES NO IK Supratentorial, Frontal Lobe Central nervous system A NO DECEASED 2009 TCGA-IK-7675-01A-11D-2086-08 TCGA-IK-7675-01 B78F718A-98FF-43A0-88E7-046844B36658 TCGA-IK-7675-01A-11D-2086-08 TCGA-IK-7675-01A-11D-2085-01 97d4524f-bd35-4dfe-9ef5-e1298713aaa4 TCGA-IK-7675-01 TCGA-IK-7675-01 TCGA-IK-7675-01A-11D-2086-08 97d4524f-bd35-4dfe-9ef5-e1298713aaa4 TCGA-IK-7675-01 TCGA-IK-7675-01 TCGA-IK-7675-01A-11D-2086-08 TCGA-IK-7675-01A-11D-2087-05 97d4524f-bd35-4dfe-9ef5-e1298713aaa4 97d4524f-bd35-4dfe-9ef5-e1298713aaa4 TCGA-IK-7675-01A-11D-2085-01 TCGA-IK-7675-01A-11D-2086-08 +TCGA-IK-8125-01 TCGA-IK-8125-01 TCGA-IK-8125 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 62 NO TCGA-IK-8125-F40395 TCGA-IK-8125 TCGA-IK-8125-01A -22745 0 1301 42 0 YES YES NO > 20 Years Seizures 0 - 30 Days Scheduled Follow-up Submission Complete Remission/Response NO 2013-2-18 MALE NO Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES 0.8 NO Left 0.9 NO NO NO G3 NO Yes TCGA-IK-8125.77a2c310-8f8b-4e45-92d8-52379e34f11f.pdf 8125 Pre-Adjuvant Therapy TUMOR FREE YES YES Complete Remission/Response YES Primary Tumor 01 YES NO 0.6 YES YES NO IK Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2009 TCGA-IK-8125-01A-11D-2253-08 TCGA-IK-8125-01 69DCF5FB-263F-4CBC-BE6B-849D9E264D46 TCGA-IK-8125-01A-11D-2253-08 TCGA-IK-8125-01A-11D-2252-01 65c41ecc-29dc-4deb-bfbc-11ca732065f7 TCGA-IK-8125-01 TCGA-IK-8125-01 TCGA-IK-8125-01A-11D-2253-08 65c41ecc-29dc-4deb-bfbc-11ca732065f7 TCGA-IK-8125-01 TCGA-IK-8125-01 TCGA-IK-8125-01A-11D-2253-08 TCGA-IK-8125-01A-11D-2254-05 65c41ecc-29dc-4deb-bfbc-11ca732065f7 65c41ecc-29dc-4deb-bfbc-11ca732065f7 TCGA-IK-8125-01A-11D-2252-01 TCGA-IK-8125-01A-11D-2253-08 +TCGA-KT-A74X-01 TCGA-KT-A74X-01 TCGA-KT-A74X TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 26 YES Cat Dander TCGA-KT-A74X-F69145 TCGA-KT-A74X TCGA-KT-A74X-01A -9590 21 0 438 NO NO Seizures Scheduled Follow-up Submission Stable Disease 2014-12-30 MALE NO YES Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES 210 NO 90 Left YES IHC YES NO YES NO YES G3 NO true No TCGA-KT-A74X.70559888-99AB-44B6-8553-AF8EF504268A.pdf A74X WITH TUMOR Stable Disease YES Primary Tumor 01 YES Not listed in Medical Record YES YES NO KT Supratentorial, Parietal Lobe Central nervous system A NO LIVING 2013 TCGA-KT-A74X-01 480EB0B8-F15B-4B63-9FA9-1AD46759FB99 TCGA-KT-A74X-01A-11D-A32B-08 TCGA-KT-A74X-01A-11D-A32A-01 bc32671c-a95d-4a44-a42a-dcc617cf68f1 TCGA-KT-A74X-01 TCGA-KT-A74X-01 bc32671c-a95d-4a44-a42a-dcc617cf68f1 TCGA-KT-A74X-01 TCGA-KT-A74X-01A-11D-A32C-05 bc32671c-a95d-4a44-a42a-dcc617cf68f1 bc32671c-a95d-4a44-a42a-dcc617cf68f1 TCGA-KT-A74X-01A-11D-A32A-01 TCGA-KT-A74X-01A-11D-A32B-08 +TCGA-KT-A7W1-01 TCGA-KT-A7W1-01 TCGA-KT-A7W1 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 45 TCGA-KT-A7W1-F69146 TCGA-KT-A7W1 -16560 0 438 10 YES NO Seizures 0 - 30 Days Scheduled Follow-up Submission Stable Disease 2014-12-30 FEMALE Astrocytoma NO No C71.0 9401/3 C71.0 YES NO 80 Right NO IHC YES NO NO YES G3 NO No A7W1 Pre-Adjuvant Therapy TUMOR FREE YES YES Progressive Disease YES Primary Tumor 01 YES NO White Matter YES YES NO KT Supratentorial, Frontal Lobe Central nervous system NO LIVING 2013 TCGA-KT-A7W1-01 TCGA-KT-A7W1-01A-11D-A34A-08 TCGA-KT-A7W1-01A-11D-A349-01 b817310e-3a4b-4622-8564-350ccb0a9e69 TCGA-KT-A7W1-01 TCGA-KT-A7W1-01 b817310e-3a4b-4622-8564-350ccb0a9e69 TCGA-KT-A7W1-01 TCGA-KT-A7W1-01A-11D-A34D-05 b817310e-3a4b-4622-8564-350ccb0a9e69 b817310e-3a4b-4622-8564-350ccb0a9e69 TCGA-KT-A7W1-01A-11D-A349-01 TCGA-KT-A7W1-01A-11D-A34A-08 +TCGA-P5-A5ET-01 TCGA-P5-A5ET-01 TCGA-P5-A5ET TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 27 NO NO TCGA-P5-A5ET-F69038 TCGA-P5-A5ET TCGA-P5-A5ET-01A -10027 98 0 -10 NO Headaches 91 - 180 Days Scheduled Follow-up Submission NO 2014-12-24 MALE NO YES Oligodendroglioma NO No C71.0 9450/3 C71.0 YES NO 400 NO Right NO YES NO G2 NO true No TCGA-P5-A5ET.A28115C7-0F60-442C-BE10-8B93D06F5CEB.pdf A5ET TUMOR FREE YES Primary Tumor 01 Not listed in Medical Record YES NO P5 Supratentorial, Frontal Lobe Central nervous system A LIVING 2012 TCGA-P5-A5ET-01 9FFEA697-CF7B-427B-AC56-B2694E2C6DC5 TCGA-P5-A5ET-01A-11D-A27K-08 TCGA-P5-A5ET-01A-11D-A27J-01 669947ca-d955-4bcd-b593-bf86f1edb8df TCGA-P5-A5ET-01 TCGA-P5-A5ET-01 TCGA-P5-A5ET-01A-11D-A27K-08 669947ca-d955-4bcd-b593-bf86f1edb8df TCGA-P5-A5ET-01 TCGA-P5-A5ET-01A-11D-A27K-08 TCGA-P5-A5ET-01A-11D-A27L-05 669947ca-d955-4bcd-b593-bf86f1edb8df 669947ca-d955-4bcd-b593-bf86f1edb8df TCGA-P5-A5ET-01A-11D-A27J-01 TCGA-P5-A5ET-01A-11D-A27K-08 +TCGA-P5-A5EU-01 TCGA-P5-A5EU-01 TCGA-P5-A5EU TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 35 TCGA-P5-A5EU-F69039 TCGA-P5-A5EU TCGA-P5-A5EU-01A -12851 86 0 0 Headaches > 181 Days Scheduled Follow-up Submission 2014-12-24 MALE YES Astrocytoma NO No C71.0 9401/3 C71.0 YES 500 NO 60 Right NO YES NO G3 true No TCGA-P5-A5EU.47CE1D35-2BA2-472B-AF22-42EBEAF45C19.pdf A5EU YES YES NO Primary Tumor 01 YES Not listed in Medical Record NO YES NO P5 Supratentorial, Frontal Lobe Central nervous system A YES LIVING 2012 TCGA-P5-A5EU-01 21E0B1BE-6F6F-4C55-A9CB-E6BD0EF01CA5 TCGA-P5-A5EU-01A-11D-A27K-08 TCGA-P5-A5EU-01A-11D-A27J-01 af4c730b-9886-4cf1-b859-735c424bc06a TCGA-P5-A5EU-01 TCGA-P5-A5EU-01 TCGA-P5-A5EU-01A-11D-A27K-08 af4c730b-9886-4cf1-b859-735c424bc06a TCGA-P5-A5EU-01 TCGA-P5-A5EU-01A-11D-A27K-08 TCGA-P5-A5EU-01A-11D-A27L-05 af4c730b-9886-4cf1-b859-735c424bc06a af4c730b-9886-4cf1-b859-735c424bc06a TCGA-P5-A5EU-01A-11D-A27J-01 TCGA-P5-A5EU-01A-11D-A27K-08 +TCGA-P5-A5EV-01 TCGA-P5-A5EV-01 TCGA-P5-A5EV TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 39 TCGA-P5-A5EV-F69040 TCGA-P5-A5EV TCGA-P5-A5EV-01A -14310 86 0 7 Seizures 31 - 90 Days Scheduled Follow-up Submission 2014-12-24 MALE YES Astrocytoma NO No C71.0 9400/3 C71.0 YES 130 NO 60 Left YES YES YES G2 true No TCGA-P5-A5EV.FDEF19AA-E140-405F-8BF4-76DB956CCFCE.pdf A5EV WITH TUMOR YES YES Primary Tumor 01 YES YES Not listed in Medical Record NO YES NO P5 Supratentorial, Temporal Lobe Central nervous system A YES LIVING 2012 TCGA-P5-A5EV-01 512DED00-E719-4504-BD83-326637A8ACDF TCGA-P5-A5EV-01A-11D-A27K-08 TCGA-P5-A5EV-01A-11D-A27J-01 c19b30b4-b9cc-41cb-ac23-b27a1b6e6889 TCGA-P5-A5EV-01 TCGA-P5-A5EV-01 TCGA-P5-A5EV-01A-11D-A27K-08 c19b30b4-b9cc-41cb-ac23-b27a1b6e6889 TCGA-P5-A5EV-01 TCGA-P5-A5EV-01A-11D-A27K-08 TCGA-P5-A5EV-01A-11D-A27L-05 c19b30b4-b9cc-41cb-ac23-b27a1b6e6889 c19b30b4-b9cc-41cb-ac23-b27a1b6e6889 TCGA-P5-A5EV-01A-11D-A27J-01 TCGA-P5-A5EV-01A-11D-A27K-08 +TCGA-P5-A5EW-01 TCGA-P5-A5EW-01 TCGA-P5-A5EW TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 20 YES cats TCGA-P5-A5EW-F69041 TCGA-P5-A5EW TCGA-P5-A5EW-01A -7612 77 0 204 -2 < 12 Years Headaches 91 - 180 Days Scheduled Follow-up Submission NO 2014-12-24 FEMALE NO YES Astrocytoma NO No C71.0 9400/3 C71.0 YES 240 NO 80 Right NO YES NO G2 NO true No TCGA-P5-A5EW.604A50C0-CFE0-4D48-87ED-EFEFFAB05043.pdf A5EW Preoperative TUMOR FREE YES NO Primary Tumor 01 Not listed in Medical Record YES NO P5 Supratentorial, Frontal Lobe Central nervous system A LIVING 2012 TCGA-P5-A5EW-01 999B1121-F68B-4E58-AFB1-4EB829302C6C TCGA-P5-A5EW-01A-11D-A27K-08 TCGA-P5-A5EW-01A-11D-A27J-01 ab00d03b-2579-491b-a23a-7ec63d0852ff TCGA-P5-A5EW-01 TCGA-P5-A5EW-01 TCGA-P5-A5EW-01A-11D-A27K-08 ab00d03b-2579-491b-a23a-7ec63d0852ff TCGA-P5-A5EW-01 TCGA-P5-A5EW-01A-11D-A27K-08 TCGA-P5-A5EW-01A-11D-A27L-05 ab00d03b-2579-491b-a23a-7ec63d0852ff ab00d03b-2579-491b-a23a-7ec63d0852ff TCGA-P5-A5EW-01A-11D-A27J-01 TCGA-P5-A5EW-01A-11D-A27K-08 +TCGA-P5-A5EX-01 TCGA-P5-A5EX-01 TCGA-P5-A5EX TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 41 NO TCGA-P5-A5EX-F69042 TCGA-P5-A5EX TCGA-P5-A5EX-01A -15091 65 0 243 NO Headaches > 181 Days Scheduled Follow-up Submission 2014-12-24 FEMALE NO YES Oligodendroglioma NO No C71.0 9451/3 C71.0 YES NO 280 NO 80 Right NO NO NO NO NO G3 NO true No TCGA-P5-A5EX.C2C64F70-4E69-4A52-97AE-04E0D8D627EC.pdf A5EX TUMOR FREE NO NO Partial Remission/Response YES Primary Tumor 01 NO YES Not listed in Medical Record YES YES NO P5 Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2012 TCGA-P5-A5EX-01 17EEAD77-26A5-46EB-B84D-15652EAF84F6 TCGA-P5-A5EX-01A-12D-A289-08 TCGA-P5-A5EX-01A-12D-A288-01 7b4d9c91-80eb-4d3e-8e3f-76a13c7fbf76 TCGA-P5-A5EX-01 TCGA-P5-A5EX-01 TCGA-P5-A5EX-01A-12D-A289-08 7b4d9c91-80eb-4d3e-8e3f-76a13c7fbf76 TCGA-P5-A5EX-01 TCGA-P5-A5EX-01A-12D-A289-08 TCGA-P5-A5EX-01A-12D-A28N-05 7b4d9c91-80eb-4d3e-8e3f-76a13c7fbf76 7b4d9c91-80eb-4d3e-8e3f-76a13c7fbf76 TCGA-P5-A5EX-01A-12D-A288-01 TCGA-P5-A5EX-01A-12D-A289-08 +TCGA-P5-A5EY-01 TCGA-P5-A5EY-01 TCGA-P5-A5EY TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 21 TCGA-P5-A5EY-F69043 TCGA-P5-A5EY TCGA-P5-A5EY-01A -7716 65 0 72 Seizures 0 - 30 Days Scheduled Follow-up Submission 2014-12-24 MALE Astrocytoma No C71.0 9400/3 C71.0 YES 550 NO Right YES G2 true No TCGA-P5-A5EY.13BDC5C7-92EB-4FCD-ACAB-8005C2F099D4.pdf A5EY YES Primary Tumor 01 YES Not listed in Medical Record YES NO P5 Supratentorial, Temporal Lobe Central nervous system A LIVING 2012 TCGA-P5-A5EY-01 13C9B14C-DF33-4EF2-831F-F01EFA74D89B TCGA-P5-A5EY-01A-11D-A27K-08 TCGA-P5-A5EY-01A-11D-A27J-01 c0c1d679-b9d4-4146-bf2e-7816648ef557 TCGA-P5-A5EY-01 TCGA-P5-A5EY-01 TCGA-P5-A5EY-01A-11D-A27K-08 c0c1d679-b9d4-4146-bf2e-7816648ef557 TCGA-P5-A5EY-01 TCGA-P5-A5EY-01A-11D-A27K-08 TCGA-P5-A5EY-01A-11D-A27L-05 c0c1d679-b9d4-4146-bf2e-7816648ef557 c0c1d679-b9d4-4146-bf2e-7816648ef557 TCGA-P5-A5EY-01A-11D-A27J-01 TCGA-P5-A5EY-01A-11D-A27K-08 +TCGA-P5-A5EZ-01 TCGA-P5-A5EZ-01 TCGA-P5-A5EZ TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 39 YES bee TCGA-P5-A5EZ-F69044 TCGA-P5-A5EZ TCGA-P5-A5EZ-01A -14375 65 0 70 > 20 Years Seizures 31 - 90 Days Scheduled Follow-up Submission 2014-12-24 MALE YES Astrocytoma NO No C71.0 9401/3 C71.0 YES 200 NO Left NO YES G3 NO true No TCGA-P5-A5EZ.F12771D2-103F-423A-A619-D648A8443DF1.pdf A5EZ TUMOR FREE Primary Tumor 01 YES Not listed in Medical Record YES NO P5 Supratentorial, Frontal Lobe Central nervous system A LIVING 2012 TCGA-P5-A5EZ-01 94CAFBA5-57EB-4F4E-B6AB-5370EA9BF01F TCGA-P5-A5EZ-01A-11D-A27K-08 TCGA-P5-A5EZ-01A-11D-A27J-01 3b93e6fa-c53b-4f8d-8d28-43926a1dae9d TCGA-P5-A5EZ-01 TCGA-P5-A5EZ-01 TCGA-P5-A5EZ-01A-11D-A27K-08 3b93e6fa-c53b-4f8d-8d28-43926a1dae9d TCGA-P5-A5EZ-01 TCGA-P5-A5EZ-01A-11D-A27K-08 TCGA-P5-A5EZ-01A-11D-A27L-05 3b93e6fa-c53b-4f8d-8d28-43926a1dae9d 3b93e6fa-c53b-4f8d-8d28-43926a1dae9d TCGA-P5-A5EZ-01A-11D-A27J-01 TCGA-P5-A5EZ-01A-11D-A27K-08 +TCGA-P5-A5F0-01 TCGA-P5-A5F0-01 TCGA-P5-A5F0 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 33 NO TCGA-P5-A5F0-F69045 TCGA-P5-A5F0 TCGA-P5-A5F0-01A -12157 62 0 287 NO Seizures > 181 Days Scheduled Follow-up Submission 2014-12-24 MALE NO YES Oligodendroglioma NO No C71.9 9450/3 C71.9 YES NO 110 NO 80 Right NO NO NO NO YES G2 NO true No TCGA-P5-A5F0.6E1C12F5-85C4-4A43-8F05-F08A774CC9E4.pdf A5F0 TUMOR FREE NO NO Partial Remission/Response YES Primary Tumor 01 YES YES Not listed in Medical Record YES YES NO P5 Supratentorial, Frontal Lobe Central nervous system A YES LIVING 2012 TCGA-P5-A5F0-01 3C0F51D1-C467-481F-926C-D5ACF1FC37C5 TCGA-P5-A5F0-01A-11D-A289-08 TCGA-P5-A5F0-01A-11D-A288-01 35d073e9-06bc-4ccd-af39-c9fb4c268d7a TCGA-P5-A5F0-01 TCGA-P5-A5F0-01 TCGA-P5-A5F0-01A-11D-A289-08 35d073e9-06bc-4ccd-af39-c9fb4c268d7a TCGA-P5-A5F0-01 TCGA-P5-A5F0-01A-11D-A289-08 TCGA-P5-A5F0-01A-11D-A28N-05 35d073e9-06bc-4ccd-af39-c9fb4c268d7a 35d073e9-06bc-4ccd-af39-c9fb4c268d7a TCGA-P5-A5F0-01A-11D-A288-01 TCGA-P5-A5F0-01A-11D-A289-08 +TCGA-P5-A5F1-01 TCGA-P5-A5F1-01 TCGA-P5-A5F1 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 30 TCGA-P5-A5F1-F69046 TCGA-P5-A5F1 TCGA-P5-A5F1-01A -11070 55 0 179 Motor/Movement Changes 31 - 90 Days Scheduled Follow-up Submission 2014-12-24 MALE Astrocytoma NO No C71.0 9400/3 C71.0 YES 500 NO Left NO YES YES G2 NO true No TCGA-P5-A5F1.FA13A2CB-015F-4302-88ED-3314A2433616.pdf A5F1 TUMOR FREE Primary Tumor 01 Not listed in Medical Record YES NO P5 Supratentorial, Temporal Lobe Central nervous system A LIVING 2012 TCGA-P5-A5F1-01 D04AA6C3-6A56-4908-88CF-8772187C0269 TCGA-P5-A5F1-01A-11D-A289-08 TCGA-P5-A5F1-01A-11D-A288-01 a9db06e4-4069-4533-b85e-9e2fbbaaec7d TCGA-P5-A5F1-01 TCGA-P5-A5F1-01 TCGA-P5-A5F1-01A-11D-A289-08 a9db06e4-4069-4533-b85e-9e2fbbaaec7d TCGA-P5-A5F1-01 TCGA-P5-A5F1-01A-11D-A289-08 TCGA-P5-A5F1-01A-11D-A28N-05 a9db06e4-4069-4533-b85e-9e2fbbaaec7d a9db06e4-4069-4533-b85e-9e2fbbaaec7d TCGA-P5-A5F1-01A-11D-A288-01 TCGA-P5-A5F1-01A-11D-A289-08 +TCGA-P5-A5F2-01 TCGA-P5-A5F2-01 TCGA-P5-A5F2 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 36 TCGA-P5-A5F2-F69047 TCGA-P5-A5F2 TCGA-P5-A5F2-01A -13396 48 0 242 Seizures 91 - 180 Days Scheduled Follow-up Submission 2014-12-24 FEMALE YES Astrocytoma NO No C71.0 9400/3 C71.0 YES 610 NO 80 Right NO NO NO G2 NO true No TCGA-P5-A5F2.0DC839C0-415F-48FB-92A8-44B06A7A5309.pdf A5F2 WITH TUMOR Partial Remission/Response NO Primary Tumor 01 YES NO Not listed in Medical Record YES YES NO P5 Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2012 TCGA-P5-A5F2-01 C752E78E-9433-47D9-8E0E-32E2FC4DE992 TCGA-P5-A5F2-01A-11D-A289-08 TCGA-P5-A5F2-01A-11D-A288-01 52284719-7a37-4969-905b-dde2068409c2 TCGA-P5-A5F2-01 TCGA-P5-A5F2-01 TCGA-P5-A5F2-01A-11D-A289-08 52284719-7a37-4969-905b-dde2068409c2 TCGA-P5-A5F2-01 TCGA-P5-A5F2-01A-11D-A289-08 TCGA-P5-A5F2-01A-11D-A28N-05 52284719-7a37-4969-905b-dde2068409c2 52284719-7a37-4969-905b-dde2068409c2 TCGA-P5-A5F2-01A-11D-A288-01 TCGA-P5-A5F2-01A-11D-A289-08 +TCGA-P5-A5F4-01 TCGA-P5-A5F4-01 TCGA-P5-A5F4 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 35 TCGA-P5-A5F4-F69048 TCGA-P5-A5F4 TCGA-P5-A5F4-01A -12851 37 0 231 Headaches 31 - 90 Days Scheduled Follow-up Submission 2014-12-24 FEMALE YES Oligodendroglioma NO No C71.0 9451/3 C71.0 YES 700 NO 70 Right NO G3 true No TCGA-P5-A5F4.52CF242F-7062-4258-A991-BB69FD3EE06C.pdf A5F4 TUMOR FREE Partial Remission/Response YES Primary Tumor 01 YES Not listed in Medical Record YES YES NO P5 Supratentorial, Temporal Lobe Central nervous system A YES LIVING 2012 TCGA-P5-A5F4-01 75DDBE8B-BEC5-4C76-B520-1CA9E25998B5 TCGA-P5-A5F4-01A-11D-A289-08 TCGA-P5-A5F4-01A-11D-A288-01 77b73b66-5ad9-49f4-9e75-f242cd316e2e TCGA-P5-A5F4-01 TCGA-P5-A5F4-01 TCGA-P5-A5F4-01A-11D-A289-08 77b73b66-5ad9-49f4-9e75-f242cd316e2e TCGA-P5-A5F4-01 TCGA-P5-A5F4-01A-11D-A289-08 TCGA-P5-A5F4-01A-11D-A28N-05 77b73b66-5ad9-49f4-9e75-f242cd316e2e 77b73b66-5ad9-49f4-9e75-f242cd316e2e TCGA-P5-A5F4-01A-11D-A288-01 TCGA-P5-A5F4-01A-11D-A289-08 +TCGA-P5-A5F6-01 TCGA-P5-A5F6-01 TCGA-P5-A5F6 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 26 TCGA-P5-A5F6-F69049 TCGA-P5-A5F6 TCGA-P5-A5F6-01A -9575 35 0 39 Headaches Scheduled Follow-up Submission 2014-12-24 MALE YES Oligodendroglioma NO No C71.0 9450/3 C71.0 YES 140 NO 70 Left YES G2 NO true No TCGA-P5-A5F6.1CAB6A23-C768-4790-9597-80E18A5EE80A.pdf A5F6 TUMOR FREE Primary Tumor 01 Not listed in Medical Record YES NO P5 Supratentorial, Frontal Lobe Central nervous system A LIVING 2012 TCGA-P5-A5F6-01 C3587911-9E81-44B1-82CF-D0557E9E085C TCGA-P5-A5F6-01A-11D-A289-08 TCGA-P5-A5F6-01A-11D-A288-01 c66d3098-98b5-4e0a-a592-39ce259b2c86 TCGA-P5-A5F6-01 TCGA-P5-A5F6-01 TCGA-P5-A5F6-01A-11D-A289-08 c66d3098-98b5-4e0a-a592-39ce259b2c86 TCGA-P5-A5F6-01 TCGA-P5-A5F6-01A-11D-A289-08 TCGA-P5-A5F6-01A-11D-A28N-05 c66d3098-98b5-4e0a-a592-39ce259b2c86 c66d3098-98b5-4e0a-a592-39ce259b2c86 TCGA-P5-A5F6-01A-11D-A288-01 TCGA-P5-A5F6-01A-11D-A289-08 +TCGA-P5-A72U-01 TCGA-P5-A72U-01 TCGA-P5-A72U TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 71 TCGA-P5-A72U-F69015 TCGA-P5-A72U TCGA-P5-A72U-01A -26002 196 0 7 Additional New Tumor Event 2014-12-24 FEMALE Oligodendroglioma No C71.0 9451/3 C71.0 YES 240 NO Right NO G3 NO true No TCGA-P5-A72U.5C661E0D-6AC0-47DD-851F-8ED068BEF14D.pdf A72U TUMOR FREE Complete Remission/Response NO Primary Tumor 01 NO YES NO P5 Supratentorial, Parietal Lobe Central nervous system A LIVING 2013 TCGA-P5-A72U-01 65074102-3EC2-4869-BD75-99BC219A2962 TCGA-P5-A72U-01A-31D-A32B-08 TCGA-P5-A72U-01A-31D-A32A-01 0c53d4ad-c5b9-4bdc-8154-99cf0b715dd5 TCGA-P5-A72U-01 TCGA-P5-A72U-01 0c53d4ad-c5b9-4bdc-8154-99cf0b715dd5 TCGA-P5-A72U-01 TCGA-P5-A72U-01A-31D-A32C-05 0c53d4ad-c5b9-4bdc-8154-99cf0b715dd5 0c53d4ad-c5b9-4bdc-8154-99cf0b715dd5 TCGA-P5-A72U-01A-31D-A32A-01 TCGA-P5-A72U-01A-31D-A32B-08 +TCGA-P5-A72W-01 TCGA-P5-A72W-01 TCGA-P5-A72W TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 35 TCGA-P5-A72W-F69016 TCGA-P5-A72W TCGA-P5-A72W-01A -12848 185 0 317 Scheduled Follow-up Submission 2014-12-24 MALE Astrocytoma No C71.0 9401/3 C71.0 YES 500 NO Left NO G3 NO true No TCGA-P5-A72W.5BBDAFDC-37F6-4750-9F67-EF32F7B023FA.pdf A72W TUMOR FREE Complete Remission/Response YES Primary Tumor 01 YES NO P5 Supratentorial, Frontal Lobe Central nervous system A LIVING 2013 TCGA-P5-A72W-01 04523083-0725-4265-A753-03935C3730BD TCGA-P5-A72W-01A-11D-A32B-08 TCGA-P5-A72W-01A-11D-A32A-01 e60804b1-edc8-40e6-b9a1-9a02682f30d6 TCGA-P5-A72W-01 TCGA-P5-A72W-01 e60804b1-edc8-40e6-b9a1-9a02682f30d6 TCGA-P5-A72W-01 TCGA-P5-A72W-01A-11D-A32C-05 e60804b1-edc8-40e6-b9a1-9a02682f30d6 e60804b1-edc8-40e6-b9a1-9a02682f30d6 TCGA-P5-A72W-01A-11D-A32A-01 TCGA-P5-A72W-01A-11D-A32B-08 +TCGA-P5-A72X-01 TCGA-P5-A72X-01 TCGA-P5-A72X TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 21 TCGA-P5-A72X-F69018 TCGA-P5-A72X TCGA-P5-A72X-01A -7913 178 0 403 Scheduled Follow-up Submission 2014-12-24 MALE Astrocytoma No C71.0 9401/3 C71.0 YES 1150 NO Left NO G3 true No TCGA-P5-A72X.6553F280-EF4A-4FAA-9FA8-38CC66A1AD40.pdf A72X TUMOR FREE Complete Remission/Response YES Primary Tumor 01 YES NO P5 Supratentorial, Temporal Lobe Central nervous system A LIVING 2013 TCGA-P5-A72X-01 86440854-E969-44B3-B088-F6F1BD15F0F1 TCGA-P5-A72X-01A-11D-A32B-08 TCGA-P5-A72X-01A-11D-A32A-01 c5284e5c-9566-4248-a168-362eb039ffe7 TCGA-P5-A72X-01 TCGA-P5-A72X-01 c5284e5c-9566-4248-a168-362eb039ffe7 TCGA-P5-A72X-01 TCGA-P5-A72X-01A-11D-A32C-05 c5284e5c-9566-4248-a168-362eb039ffe7 c5284e5c-9566-4248-a168-362eb039ffe7 TCGA-P5-A72X-01A-11D-A32A-01 TCGA-P5-A72X-01A-11D-A32B-08 +TCGA-P5-A72Z-01 TCGA-P5-A72Z-01 TCGA-P5-A72Z TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 64 TCGA-P5-A72Z-F69020 TCGA-P5-A72Z TCGA-P5-A72Z-01A -23482 178 0 354 Scheduled Follow-up Submission 2014-12-24 FEMALE Oligodendroglioma No C71.0 9451/3 C71.0 YES 160 NO Left NO G3 true No TCGA-P5-A72Z.99B1BF7C-E68F-4546-B13B-BF603738796C.pdf A72Z TUMOR FREE Complete Remission/Response YES Primary Tumor 01 YES YES NO P5 Supratentorial, Temporal Lobe Central nervous system A LIVING 2013 TCGA-P5-A72Z-01 0A6EA3D4-4B7E-4807-92AD-08273E8B6F82 TCGA-P5-A72Z-01A-11D-A32B-08 TCGA-P5-A72Z-01A-11D-A32A-01 7b9b3507-bd43-4915-8f53-89cee202ad6e TCGA-P5-A72Z-01 TCGA-P5-A72Z-01 7b9b3507-bd43-4915-8f53-89cee202ad6e TCGA-P5-A72Z-01 TCGA-P5-A72Z-01A-11D-A32C-05 7b9b3507-bd43-4915-8f53-89cee202ad6e 7b9b3507-bd43-4915-8f53-89cee202ad6e TCGA-P5-A72Z-01A-11D-A32A-01 TCGA-P5-A72Z-01A-11D-A32B-08 +TCGA-P5-A730-01 TCGA-P5-A730-01 TCGA-P5-A730 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 22 TCGA-P5-A730-F69023 TCGA-P5-A730 TCGA-P5-A730-01A -8043 161 0 333 Scheduled Follow-up Submission 2014-12-24 MALE Oligoastrocytoma No C71.0 9382/3 C71.0 YES 510 NO Right NO G3 NO true No TCGA-P5-A730.D03B2072-0B67-431A-9C5E-0D0B4191E846.pdf A730 TUMOR FREE Complete Remission/Response NO Primary Tumor 01 NO YES NO P5 Supratentorial, Occipital Lobe Central nervous system A LIVING 2013 TCGA-P5-A730-01 DD18038F-5DB0-4D4C-AE02-3972319BF397 TCGA-P5-A730-01A-11D-A32B-08 TCGA-P5-A730-01A-11D-A32A-01 059686a6-baf9-4609-a26f-2d0fa3b7a685 TCGA-P5-A730-01 TCGA-P5-A730-01 059686a6-baf9-4609-a26f-2d0fa3b7a685 TCGA-P5-A730-01 TCGA-P5-A730-01A-11D-A32C-05 059686a6-baf9-4609-a26f-2d0fa3b7a685 059686a6-baf9-4609-a26f-2d0fa3b7a685 TCGA-P5-A730-01A-11D-A32A-01 TCGA-P5-A730-01A-11D-A32B-08 +TCGA-P5-A731-01 TCGA-P5-A731-01 TCGA-P5-A731 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 59 TCGA-P5-A731-F69010 TCGA-P5-A731 TCGA-P5-A731-01A -21715 143 0 274 Scheduled Follow-up Submission 2014-12-24 FEMALE YES Oligoastrocytoma No C71.0 9382/3 C71.0 YES 220 NO 90 Right NO YES G2 true No TCGA-P5-A731.F22D0DFD-A361-4735-B391-82975EA64AE5.pdf A731 TUMOR FREE YES Primary Tumor 01 NO YES NO P5 Supratentorial, Frontal Lobe Central nervous system A LIVING 2013 TCGA-P5-A731-01 192CAE82-26DC-478C-AC04-B7ABFCD6F4D5 TCGA-P5-A731-01A-11D-A32B-08 TCGA-P5-A731-01A-11D-A32A-01 5a57bf22-5617-4ea0-887e-0610fff74790 TCGA-P5-A731-01 TCGA-P5-A731-01 5a57bf22-5617-4ea0-887e-0610fff74790 TCGA-P5-A731-01 TCGA-P5-A731-01A-11D-A32C-05 5a57bf22-5617-4ea0-887e-0610fff74790 5a57bf22-5617-4ea0-887e-0610fff74790 TCGA-P5-A731-01A-11D-A32A-01 TCGA-P5-A731-01A-11D-A32B-08 +TCGA-P5-A733-01 TCGA-P5-A733-01 TCGA-P5-A733 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 52 TCGA-P5-A733-F69012 TCGA-P5-A733 TCGA-P5-A733-01A -19142 134 0 414 Scheduled Follow-up Submission 2014-12-24 FEMALE Astrocytoma No C71.0 9400/3 C71.0 YES 300 NO Left NO G2 true No TCGA-P5-A733.4F732BEF-ADE0-4381-8D60-FB0034115C6D.pdf A733 TUMOR FREE Complete Remission/Response YES Primary Tumor 01 YES YES NO P5 Supratentorial, Frontal Lobe Central nervous system A LIVING 2013 TCGA-P5-A733-01 7DD81596-0564-4A3D-8808-67CB54080DFC TCGA-P5-A733-01A-11D-A32B-08 TCGA-P5-A733-01A-11D-A32A-01 0d3127f8-b7f0-4752-af62-4b093f959b27 TCGA-P5-A733-01 TCGA-P5-A733-01 0d3127f8-b7f0-4752-af62-4b093f959b27 TCGA-P5-A733-01 TCGA-P5-A733-01A-11D-A32C-05 0d3127f8-b7f0-4752-af62-4b093f959b27 0d3127f8-b7f0-4752-af62-4b093f959b27 TCGA-P5-A733-01A-11D-A32A-01 TCGA-P5-A733-01A-11D-A32B-08 +TCGA-P5-A735-01 TCGA-P5-A735-01 TCGA-P5-A735 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 38 TCGA-P5-A735-F69024 TCGA-P5-A735 TCGA-P5-A735-01A -14152 134 0 292 Scheduled Follow-up Submission Complete Remission/Response 2014-12-24 FEMALE Astrocytoma No C71.0 9400/3 C71.0 YES 510 NO Left NO G2 true No TCGA-P5-A735.7950CF04-F8C0-4855-A108-BB15B1B65B0D.pdf A735 TUMOR FREE Complete Remission/Response NO Primary Tumor 01 NO YES NO P5 Supratentorial, Temporal Lobe Central nervous system A LIVING 2013 TCGA-P5-A735-01 3ED2288B-576F-4C53-ACDF-333E4AF5D2D4 TCGA-P5-A735-01A-11D-A32B-08 TCGA-P5-A735-01A-11D-A32A-01 cc2965b7-e059-4cf7-8f10-133903d70a4c TCGA-P5-A735-01 TCGA-P5-A735-01 cc2965b7-e059-4cf7-8f10-133903d70a4c TCGA-P5-A735-01 TCGA-P5-A735-01A-11D-A32C-05 cc2965b7-e059-4cf7-8f10-133903d70a4c cc2965b7-e059-4cf7-8f10-133903d70a4c TCGA-P5-A735-01A-11D-A32A-01 TCGA-P5-A735-01A-11D-A32B-08 +TCGA-P5-A736-01 TCGA-P5-A736-01 TCGA-P5-A736 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 44 TCGA-P5-A736-F69025 TCGA-P5-A736 TCGA-P5-A736-01A -16300 126 0 230 Scheduled Follow-up Submission Complete Remission/Response 2014-12-24 FEMALE Astrocytoma No C71.0 9401/3 C71.0 YES 1110 NO Right NO G3 true No TCGA-P5-A736.46EF7549-943C-45E2-98AA-8A75A518FE51.pdf A736 TUMOR FREE Complete Remission/Response YES Primary Tumor 01 NO YES NO P5 Supratentorial, Parietal Lobe Central nervous system A LIVING 2013 TCGA-P5-A736-01 972D6390-C725-48D2-8F2E-64A6BF442BAE TCGA-P5-A736-01A-11D-A32B-08 TCGA-P5-A736-01A-11D-A32A-01 322513c4-e082-45aa-82c4-930f0ca2bada TCGA-P5-A736-01 TCGA-P5-A736-01 322513c4-e082-45aa-82c4-930f0ca2bada TCGA-P5-A736-01 TCGA-P5-A736-01A-11D-A32C-05 322513c4-e082-45aa-82c4-930f0ca2bada 322513c4-e082-45aa-82c4-930f0ca2bada TCGA-P5-A736-01A-11D-A32A-01 TCGA-P5-A736-01A-11D-A32B-08 +TCGA-P5-A737-01 TCGA-P5-A737-01 TCGA-P5-A737 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 47 TCGA-P5-A737-F69027 TCGA-P5-A737 TCGA-P5-A737-01A -17390 217 0 372 Scheduled Follow-up Submission 2014-12-24 MALE Oligoastrocytoma No C71.0 9400/3 C71.0 YES 310 NO Right NO G2 true No TCGA-P5-A737.3DD50AE3-0357-4D02-9AAD-589B5D87DFF2.pdf A737 TUMOR FREE Complete Remission/Response NO Primary Tumor 01 NO YES NO P5 Supratentorial, Frontal Lobe Central nervous system A LIVING 2012 TCGA-P5-A737-01 43E4E67B-41E3-4473-8238-9A3CDF1989CC TCGA-P5-A737-01A-11D-A32B-08 TCGA-P5-A737-01A-11D-A32A-01 f2efed52-3995-4a64-a845-2b50517c9554 TCGA-P5-A737-01 TCGA-P5-A737-01 f2efed52-3995-4a64-a845-2b50517c9554 TCGA-P5-A737-01 TCGA-P5-A737-01A-11D-A32C-05 f2efed52-3995-4a64-a845-2b50517c9554 f2efed52-3995-4a64-a845-2b50517c9554 TCGA-P5-A737-01A-11D-A32A-01 TCGA-P5-A737-01A-11D-A32B-08 +TCGA-P5-A77W-01 TCGA-P5-A77W-01 TCGA-P5-A77W TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 37 TCGA-P5-A77W-F69028 TCGA-P5-A77W TCGA-P5-A77W-01A -13545 114 0 584 Scheduled Follow-up Submission 2014-12-24 FEMALE Oligoastrocytoma No C71.0 9382/3 C71.0 YES 300 NO Left NO G3 true No TCGA-P5-A77W.E3E86605-648A-4153-A364-A2C313B9FFF2.pdf A77W TUMOR FREE Complete Remission/Response NO Primary Tumor 01 NO YES NO P5 Supratentorial, Frontal Lobe Central nervous system A LIVING 2013 TCGA-P5-A77W-01 33908580-6E49-4968-8F4D-F396FC5EF605 TCGA-P5-A77W-01A-11D-A32B-08 TCGA-P5-A77W-01A-11D-A32A-01 4ecc68c5-c6d1-4c12-a026-1eed1a40e28d TCGA-P5-A77W-01 TCGA-P5-A77W-01 4ecc68c5-c6d1-4c12-a026-1eed1a40e28d TCGA-P5-A77W-01 TCGA-P5-A77W-01A-11D-A32C-05 4ecc68c5-c6d1-4c12-a026-1eed1a40e28d 4ecc68c5-c6d1-4c12-a026-1eed1a40e28d TCGA-P5-A77W-01A-11D-A32A-01 TCGA-P5-A77W-01A-11D-A32B-08 +TCGA-P5-A77X-01 TCGA-P5-A77X-01 TCGA-P5-A77X TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 55 TCGA-P5-A77X-F69029 TCGA-P5-A77X TCGA-P5-A77X-01A -20128 111 0 105 Scheduled Follow-up Submission Complete Remission/Response 2014-12-24 FEMALE Oligoastrocytoma No C71.0 9382/3 C71.0 YES 1480 NO Right NO G2 true No TCGA-P5-A77X.E1A92E19-6BC7-4AA0-AC3D-590305FC4FF9.pdf A77X TUMOR FREE Complete Remission/Response YES Primary Tumor 01 NO YES NO P5 Supratentorial, Frontal Lobe Central nervous system A LIVING 2013 TCGA-P5-A77X-01 4CB18EC1-9F65-49F5-8EA4-698460C84050 TCGA-P5-A77X-01A-11D-A32B-08 TCGA-P5-A77X-01A-11D-A32A-01 ef9256b0-f4e0-4a1e-9ea2-d4afb75b7ba9 TCGA-P5-A77X-01 TCGA-P5-A77X-01 ef9256b0-f4e0-4a1e-9ea2-d4afb75b7ba9 TCGA-P5-A77X-01 TCGA-P5-A77X-01A-11D-A32C-05 ef9256b0-f4e0-4a1e-9ea2-d4afb75b7ba9 ef9256b0-f4e0-4a1e-9ea2-d4afb75b7ba9 TCGA-P5-A77X-01A-11D-A32A-01 TCGA-P5-A77X-01A-11D-A32B-08 +TCGA-P5-A780-01 TCGA-P5-A780-01 TCGA-P5-A780 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 44 TCGA-P5-A780-F69031 TCGA-P5-A780 TCGA-P5-A780-01A -16161 92 0 72 Scheduled Follow-up Submission Complete Remission/Response 2014-12-24 FEMALE Astrocytoma No C71.0 9401/3 C71.0 YES 230 NO Right NO G3 true No TCGA-P5-A780.6EBF635A-6875-4843-815A-3E4E25B61BA6.pdf A780 TUMOR FREE Complete Remission/Response YES Primary Tumor 01 YES NO P5 Supratentorial, Temporal Lobe Central nervous system A LIVING 2013 TCGA-P5-A780-01 D499332D-83AD-4435-8277-FC27CF653420 TCGA-P5-A780-01A-12D-A32B-08 TCGA-P5-A780-01A-12D-A32A-01 05511b6c-4529-4081-a8aa-aeed061c5159 TCGA-P5-A780-01 TCGA-P5-A780-01 05511b6c-4529-4081-a8aa-aeed061c5159 TCGA-P5-A780-01 TCGA-P5-A780-01A-12D-A32C-05 05511b6c-4529-4081-a8aa-aeed061c5159 05511b6c-4529-4081-a8aa-aeed061c5159 TCGA-P5-A780-01A-12D-A32A-01 TCGA-P5-A780-01A-12D-A32B-08 +TCGA-P5-A781-01 TCGA-P5-A781-01 TCGA-P5-A781 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 34 TCGA-P5-A781-F69033 TCGA-P5-A781 TCGA-P5-A781-01A -12757 86 0 134 Scheduled Follow-up Submission Complete Remission/Response 2014-12-24 FEMALE Astrocytoma No C71.0 9401/3 C71.0 YES 2980 NO Right NO G3 true No TCGA-P5-A781.32064991-35D2-489F-836E-8646482DA73D.pdf A781 TUMOR FREE Complete Remission/Response YES Primary Tumor 01 NO YES NO P5 Supratentorial, Temporal Lobe Central nervous system A LIVING 2013 TCGA-P5-A781-01 31618509-4188-49F4-A847-6A58D8EAF5CA TCGA-P5-A781-01A-11D-A32B-08 TCGA-P5-A781-01A-11D-A32A-01 7e4fcbe3-07e2-4f26-8a7d-5655d0be0f6a TCGA-P5-A781-01 TCGA-P5-A781-01 7e4fcbe3-07e2-4f26-8a7d-5655d0be0f6a TCGA-P5-A781-01 TCGA-P5-A781-01A-11D-A32C-05 7e4fcbe3-07e2-4f26-8a7d-5655d0be0f6a 7e4fcbe3-07e2-4f26-8a7d-5655d0be0f6a TCGA-P5-A781-01A-11D-A32A-01 TCGA-P5-A781-01A-11D-A32B-08 +TCGA-QH-A65R-01 TCGA-QH-A65R-01 TCGA-QH-A65R TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 38 YES CAT NO TCGA-QH-A65R-F59571 TCGA-QH-A65R -14073 0 461 -10 0 NO YES NO < 12 Years > 20 Years Scheduled Follow-up Submission Stable Disease NO 2014-6-10 FEMALE YES NO Oligodendroglioma NO No C71.9 9451/3 C71.9 YES NO 100 Left YES IHC YES NO NO YES NO G3 NO No A65R Preoperative WITH TUMOR NO NO Partial Remission/Response YES Primary Tumor 01 NO NO White Matter YES NO YES QH Supratentorial, Frontal Lobe Central nervous system NO LIVING 2013 TCGA-QH-A65R-01 TCGA-QH-A65R-01A-21D-A31L-08 TCGA-QH-A65R-01A-21D-A31K-01 b168cb27-2676-40ed-9743-5046d5b0eb8c TCGA-QH-A65R-01 TCGA-QH-A65R-01 b168cb27-2676-40ed-9743-5046d5b0eb8c TCGA-QH-A65R-01 TCGA-QH-A65R-01A-21D-A31M-05 b168cb27-2676-40ed-9743-5046d5b0eb8c b168cb27-2676-40ed-9743-5046d5b0eb8c TCGA-QH-A65R-01A-21D-A31K-01 TCGA-QH-A65R-01A-21D-A31L-08 +TCGA-QH-A65S-01 TCGA-QH-A65S-01 TCGA-QH-A65S TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain NO NO 32 NO NO TCGA-QH-A65S-F42106 TCGA-QH-A65S TCGA-QH-A65S-01A -11861 56 0 77 -7 1 NO YES NO Seizures 0 - 30 Days Scheduled Follow-up Submission Partial Remission/Response NO 2014-11-14 FEMALE NO NO Oligoastrocytoma NO No C71.9 9382/3 C71.9 YES NO 100 NO 90 Left YES IHC YES NO YES NO NO G2 NO false No TCGA-QH-A65S.D970F3D5-D401-4BC0-A2FF-DBF7D0EDBA81.pdf A65S Preoperative WITH TUMOR YES YES Partial Remission/Response NO Primary Tumor 01 YES NO White Matter NO NO YES QH Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2013 TCGA-QH-A65S-01 7BA9AEB2-A7E7-4BBE-A96D-5E18A5E65141 TCGA-QH-A65S-01A-11D-A29Q-08 TCGA-QH-A65S-01A-11D-A323-01 7ee7ec4c-236b-4d28-94ee-a9e284f03afd TCGA-QH-A65S-01 TCGA-QH-A65S-01 TCGA-QH-A65S-01A-11D-A29Q-08 7ee7ec4c-236b-4d28-94ee-a9e284f03afd TCGA-QH-A65S-01 TCGA-QH-A65S-01A-11D-A29Q-08 TCGA-QH-A65S-01A-11D-A29T-05 7ee7ec4c-236b-4d28-94ee-a9e284f03afd 7ee7ec4c-236b-4d28-94ee-a9e284f03afd TCGA-QH-A65S-01A-11D-A323-01 TCGA-QH-A65S-01A-11D-A29Q-08 +TCGA-QH-A65V-01 TCGA-QH-A65V-01 TCGA-QH-A65V TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain NO NO NO 43 NO NO TCGA-QH-A65V-F59561 TCGA-QH-A65V TCGA-QH-A65V-01A -15850 48 0 384 -9 1 NO NO NO Seizures 0 - 30 Days Scheduled Follow-up Submission NO 2014-5-15 FEMALE NO NO Oligodendroglioma NO No C71.0 9450/3 C71.0 YES NO 380 NO 90 Right YES IHC YES NO NO NO NO G2 NO false No TCGA-QH-A65V.32E7C9B3-CC0B-4D62-9798-F48CDD2A1746.pdf A65V Preoperative WITH TUMOR YES YES Stable Disease NO Primary Tumor 01 YES NO White Matter YES YES NO QH Supratentorial, Temporal Lobe Central nervous system A NO LIVING 2013 TCGA-QH-A65V-01 576B9F25-BE1E-4659-A145-ABB2FEEE1AB8 TCGA-QH-A65V-01A-11D-A29Q-08 TCGA-QH-A65V-01A-11D-A323-01 dbee8779-dd28-4a2b-a485-9fa8b3a9fc88 TCGA-QH-A65V-01 TCGA-QH-A65V-01 TCGA-QH-A65V-01A-11D-A29Q-08 dbee8779-dd28-4a2b-a485-9fa8b3a9fc88 TCGA-QH-A65V-01 TCGA-QH-A65V-01A-11D-A29Q-08 TCGA-QH-A65V-01A-11D-A29T-05 dbee8779-dd28-4a2b-a485-9fa8b3a9fc88 dbee8779-dd28-4a2b-a485-9fa8b3a9fc88 TCGA-QH-A65V-01A-11D-A323-01 TCGA-QH-A65V-01A-11D-A29Q-08 +TCGA-QH-A65X-01 TCGA-QH-A65X-01 TCGA-QH-A65X TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 28 NO NO TCGA-QH-A65X-F67754 TCGA-QH-A65X TCGA-QH-A65X-01A -10440 39 0 482 237 1 NO NO NO Seizures 0 - 30 Days Scheduled Follow-up Submission Stable Disease NO 2014-11-11 FEMALE NO NO Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES NO 230 NO 90 Right NO Sequence Analysis YES NO NO NO NO G3 NO false No TCGA-QH-A65X.D7B970B7-6910-4926-AD60-F24EEFAFE54A.pdf A65X Post-Adjuvant Therapy TUMOR FREE YES NO Stable Disease YES Primary Tumor 01 YES NO White Matter YES YES NO QH Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2013 TCGA-QH-A65X-01 99256B9C-EDCE-435B-AE43-A16F9DDD9E85 TCGA-QH-A65X-01A-11D-A32B-08 TCGA-QH-A65X-01A-11D-A32A-01 551f30d8-5382-4705-b81f-9d29ea31178d TCGA-QH-A65X-01 TCGA-QH-A65X-01 551f30d8-5382-4705-b81f-9d29ea31178d TCGA-QH-A65X-01 TCGA-QH-A65X-01A-11D-A32C-05 551f30d8-5382-4705-b81f-9d29ea31178d 551f30d8-5382-4705-b81f-9d29ea31178d TCGA-QH-A65X-01A-11D-A32A-01 TCGA-QH-A65X-01A-11D-A32B-08 +TCGA-QH-A65Z-01 TCGA-QH-A65Z-01 TCGA-QH-A65Z TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain NO NO 54 NO NO TCGA-QH-A65Z-F59568 TCGA-QH-A65Z TCGA-QH-A65Z-01A -19921 19 0 427 -10 1 NO YES NO Seizures 0 - 30 Days Scheduled Follow-up Submission NO 2014-6-10 MALE NO NO Oligodendroglioma NO No C71.0 9450/3 C71.0 YES NO 210 NO 90 Right YES IHC YES NO NO NO YES G2 NO false No TCGA-QH-A65Z.BA60EA12-509F-4699-AADC-BA0CA105BDAB.pdf A65Z Preoperative TUMOR FREE YES YES Stable Disease YES Primary Tumor 01 YES YES White Matter YES YES NO QH Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2013 TCGA-QH-A65Z-01 CF9FA4A9-94AB-4DB8-8902-49805439FCE8 TCGA-QH-A65Z-01A-11D-A29Q-08 TCGA-QH-A65Z-01A-11D-A323-01 671edd73-dbd4-4ab5-8988-864b8a7fe01a TCGA-QH-A65Z-01 TCGA-QH-A65Z-01 TCGA-QH-A65Z-01A-11D-A29Q-08 671edd73-dbd4-4ab5-8988-864b8a7fe01a TCGA-QH-A65Z-01 TCGA-QH-A65Z-01A-11D-A29Q-08 TCGA-QH-A65Z-01A-11D-A29T-05 671edd73-dbd4-4ab5-8988-864b8a7fe01a 671edd73-dbd4-4ab5-8988-864b8a7fe01a TCGA-QH-A65Z-01A-11D-A323-01 TCGA-QH-A65Z-01A-11D-A29Q-08 +TCGA-QH-A6CS-01 TCGA-QH-A6CS-01 TCGA-QH-A6CS TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain YES NO NO 41 NO NO TCGA-QH-A6CS-F67755 TCGA-QH-A6CS TCGA-QH-A6CS-01A -15092 53 0 588 498 -25 1 NO YES NO Seizures 0 - 30 Days Scheduled Follow-up Submission NO 2014-11-13 MALE NO YES Astrocytoma NO No C71.0 9401/3 C71.0 YES NO 490 NO 90 Right NO IHC YES NO NO NO YES G3 YES false No TCGA-QH-A6CS.0C4238FC-0A3C-46B5-8FFF-08D66878521A.pdf A6CS Preoperative WITH TUMOR YES YES Stable Disease YES Primary Tumor 01 YES NO White Matter YES YES NO QH Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2013 TCGA-QH-A6CS-01 AE655142-F9F1-4D1A-9C54-8461750F391E TCGA-QH-A6CS-01A-11D-A31L-08 TCGA-QH-A6CS-01A-11D-A31K-01 a3ea6fd3-7570-4cf5-93c9-33dccdc3d026 TCGA-QH-A6CS-01 TCGA-QH-A6CS-01 a3ea6fd3-7570-4cf5-93c9-33dccdc3d026 TCGA-QH-A6CS-01 TCGA-QH-A6CS-01A-11D-A31M-05 a3ea6fd3-7570-4cf5-93c9-33dccdc3d026 a3ea6fd3-7570-4cf5-93c9-33dccdc3d026 TCGA-QH-A6CS-01A-11D-A31K-01 TCGA-QH-A6CS-01A-11D-A31L-08 +TCGA-QH-A6CU-01 TCGA-QH-A6CU-01 TCGA-QH-A6CU TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain NO NO NO 52 NO NO TCGA-QH-A6CU-F60341 TCGA-QH-A6CU TCGA-QH-A6CU-01A -19149 59 0 451 -13 1 NO YES NO > 20 Years Seizures 0 - 30 Days Scheduled Follow-up Submission Stable Disease NO 2014-6-6 FEMALE YES NO Oligodendroglioma NO No C71.0 9451/3 C71.0 YES NO 470 NO 90 Left YES IHC YES NO YES YES NO G3 NO false No TCGA-QH-A6CU.F87EBF56-A3DC-4790-98AB-1B93FB917CAC.pdf A6CU Preoperative TUMOR FREE YES YES Stable Disease YES Primary Tumor 01 YES NO White Matter YES YES NO QH Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2013 TCGA-QH-A6CU-01 740E8AFD-0040-410A-A0A8-EBDB309487B9 TCGA-QH-A6CU-01A-11D-A31L-08 TCGA-QH-A6CU-01A-11D-A31K-01 43d6f3d2-2bd6-41e1-9d85-735f5f60e25a TCGA-QH-A6CU-01 TCGA-QH-A6CU-01 43d6f3d2-2bd6-41e1-9d85-735f5f60e25a TCGA-QH-A6CU-01 TCGA-QH-A6CU-01A-11D-A31M-05 43d6f3d2-2bd6-41e1-9d85-735f5f60e25a 43d6f3d2-2bd6-41e1-9d85-735f5f60e25a TCGA-QH-A6CU-01A-11D-A31K-01 TCGA-QH-A6CU-01A-11D-A31L-08 +TCGA-QH-A6CV-01 TCGA-QH-A6CV-01 TCGA-QH-A6CV TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain NO NO NO 51 NO NO TCGA-QH-A6CV-F60218 TCGA-QH-A6CV TCGA-QH-A6CV-01A -18955 52 0 442 -42 1 NO NO NO Headaches 0 - 30 Days Scheduled Follow-up Submission Stable Disease NO 2014-6-6 MALE NO YES Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES 190 NO 90 Right YES Sequence Analysis YES NO NO NO NO G3 NO false No TCGA-QH-A6CV.DC5685CF-74DF-45C6-B530-831FC33228C6.pdf A6CV Preoperative WITH TUMOR YES NO Stable Disease YES Primary Tumor 01 YES NO White Matter NO YES NO QH Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2013 TCGA-QH-A6CV-01 5EC0B1AC-BAA4-4C77-846C-02730E6786A6 TCGA-QH-A6CV-01A-11D-A31L-08 TCGA-QH-A6CV-01A-11D-A31K-01 3dd53b9a-6683-42ed-9594-5458c655cf8f TCGA-QH-A6CV-01 TCGA-QH-A6CV-01 3dd53b9a-6683-42ed-9594-5458c655cf8f TCGA-QH-A6CV-01 TCGA-QH-A6CV-01A-11D-A31M-05 3dd53b9a-6683-42ed-9594-5458c655cf8f 3dd53b9a-6683-42ed-9594-5458c655cf8f TCGA-QH-A6CV-01A-11D-A31K-01 TCGA-QH-A6CV-01A-11D-A31L-08 +TCGA-QH-A6CW-01 TCGA-QH-A6CW-01 TCGA-QH-A6CW TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain NO NO NO 43 NO YES TCGA-QH-A6CW-F60337 TCGA-QH-A6CW TCGA-QH-A6CW-01A -15847 24 0 414 -8 1 NO NO NO > 20 Years Seizures 31 - 90 Days Scheduled Follow-up Submission Partial Remission/Response NO 2014-6-6 MALE YES NO Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES 270 NO 90 Right YES IHC YES NO NO YES NO G3 NO false No TCGA-QH-A6CW.0D917D08-E23D-4158-8049-1B0A9775868B.pdf A6CW Preoperative TUMOR FREE YES NO Partial Remission/Response NO Primary Tumor 01 YES NO White Matter NO YES NO QH Supratentorial, Temporal Lobe Central nervous system A NO LIVING 2013 TCGA-QH-A6CW-01 F21CB0C4-C25E-42FE-B861-523DB3020231 TCGA-QH-A6CW-01A-11D-A32B-08 TCGA-QH-A6CW-01A-11D-A32A-01 6cc3ae71-fe99-4dcb-b5c6-b4e8eb7b336c 6cc3ae71-fe99-4dcb-b5c6-b4e8eb7b336c TCGA-QH-A6CW-01 TCGA-QH-A6CW-01A-11D-A32C-05 6cc3ae71-fe99-4dcb-b5c6-b4e8eb7b336c 6cc3ae71-fe99-4dcb-b5c6-b4e8eb7b336c TCGA-QH-A6CW-01A-11D-A32A-01 TCGA-QH-A6CW-01A-11D-A32B-08 +TCGA-QH-A6CX-01 TCGA-QH-A6CX-01 TCGA-QH-A6CX TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain NO NO NO 66 NO NO TCGA-QH-A6CX-F60335 TCGA-QH-A6CX TCGA-QH-A6CX-01A -24252 23 372 0 -1 273 -7 1 NO NO NO Seizures 0 - 30 Days Scheduled Follow-up Submission NO 2014-6-6 MALE NO NO Astrocytoma NO No C71.0 9400/3 C71.0 YES NO 270 NO 90 Left NO IHC YES NO NO NO NO G2 YES false No TCGA-QH-A6CX.FD9CC0AD-0EDC-4B6F-BE5E-ACBB0154EA3F.pdf A6CX Preoperative WITH TUMOR YES YES Progressive Disease YES Primary Tumor 01 YES NO White Matter NO YES NO QH Supratentorial, Temporal Lobe Central nervous system A NO DECEASED 2013 TCGA-QH-A6CX-01 8AFE23C4-34D0-4D8D-850D-61CB10ACF909 TCGA-QH-A6CX-01A-11D-A32B-08 TCGA-QH-A6CX-01A-11D-A32A-01 caba02b8-ffcf-440f-ab03-6141aa19752f TCGA-QH-A6CX-01 TCGA-QH-A6CX-01 caba02b8-ffcf-440f-ab03-6141aa19752f TCGA-QH-A6CX-01 TCGA-QH-A6CX-01A-11D-A32C-05 caba02b8-ffcf-440f-ab03-6141aa19752f caba02b8-ffcf-440f-ab03-6141aa19752f TCGA-QH-A6CX-01A-11D-A32A-01 TCGA-QH-A6CX-01A-11D-A32B-08 +TCGA-QH-A6CY-01 TCGA-QH-A6CY-01 TCGA-QH-A6CY TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 38 NO NO TCGA-QH-A6CY-F60215 TCGA-QH-A6CY TCGA-QH-A6CY-01A -14140 18 0 408 -26 1 NO NO NO Headaches 0 - 30 Days Scheduled Follow-up Submission Stable Disease NO 2014-6-6 MALE NO YES Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES 360 NO 90 Right YES IHC YES NO NO NO NO G3 NO false No TCGA-QH-A6CY.F47D9AFD-E511-450E-9F15-E1EDBF0FC87F.pdf A6CY Preoperative WITH TUMOR YES YES Stable Disease YES Primary Tumor 01 YES NO White Matter YES YES NO QH Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2013 TCGA-QH-A6CY-01 78E4A448-ED6E-4C2C-AB60-D6612D03577F TCGA-QH-A6CY-01A-11D-A32B-08 TCGA-QH-A6CY-01A-11D-A32A-01 6369f5c8-dbd0-4c80-a621-5c3310ebad45 TCGA-QH-A6CY-01 TCGA-QH-A6CY-01 6369f5c8-dbd0-4c80-a621-5c3310ebad45 TCGA-QH-A6CY-01 TCGA-QH-A6CY-01A-11D-A32C-05 6369f5c8-dbd0-4c80-a621-5c3310ebad45 6369f5c8-dbd0-4c80-a621-5c3310ebad45 TCGA-QH-A6CY-01A-11D-A32A-01 TCGA-QH-A6CY-01A-11D-A32B-08 +TCGA-QH-A6CZ-01 TCGA-QH-A6CZ-01 TCGA-QH-A6CZ TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain NO NO NO 38 NO NO TCGA-QH-A6CZ-F60216 TCGA-QH-A6CZ TCGA-QH-A6CZ-01A -14007 16 0 279 -51 1 NO NO NO Seizures 0 - 30 Days Scheduled Follow-up Submission Stable Disease NO 2014-6-3 MALE NO NO Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES 360 NO 90 Right YES IHC YES NO NO NO NO G2 NO false No TCGA-QH-A6CZ.B346A105-9790-4B51-B83E-7272FF381FA1.pdf A6CZ Preoperative TUMOR FREE YES YES Stable Disease NO Primary Tumor 01 YES NO White Matter NO YES NO QH Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2013 TCGA-QH-A6CZ-01 1042F21C-31AE-4D19-8528-4DBB14741BBD TCGA-QH-A6CZ-01A-11D-A32B-08 TCGA-QH-A6CZ-01A-11D-A32A-01 3d2e42a7-d83f-471b-ac4c-19f3d62eb0ee TCGA-QH-A6CZ-01 TCGA-QH-A6CZ-01 3d2e42a7-d83f-471b-ac4c-19f3d62eb0ee TCGA-QH-A6CZ-01 TCGA-QH-A6CZ-01A-11D-A32C-05 3d2e42a7-d83f-471b-ac4c-19f3d62eb0ee 3d2e42a7-d83f-471b-ac4c-19f3d62eb0ee TCGA-QH-A6CZ-01A-11D-A32A-01 TCGA-QH-A6CZ-01A-11D-A32B-08 +TCGA-QH-A6X3-01 TCGA-QH-A6X3-01 TCGA-QH-A6X3 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 27 NO TCGA-QH-A6X3-F67748 TCGA-QH-A6X3 -10184 0 313 16 1 NO NO NO Seizures 0 - 30 Days Scheduled Follow-up Submission Complete Remission/Response 2014-11-11 MALE NO NO Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES NO 90 Right YES IHC YES NO NO NO NO G2 NO No A6X3 Other TUMOR FREE NO NO Complete Remission/Response NO Primary Tumor 01 YES NO White Matter NO YES NO QH Supratentorial, Parietal Lobe Central nervous system NO LIVING 2013 TCGA-QH-A6X3-01 TCGA-QH-A6X3-01A-21D-A32B-08 TCGA-QH-A6X3-01A-21D-A32A-01 f514a04f-e20a-497f-98a0-747474815ecd TCGA-QH-A6X3-01 TCGA-QH-A6X3-01 f514a04f-e20a-497f-98a0-747474815ecd TCGA-QH-A6X3-01 TCGA-QH-A6X3-01A-21D-A32C-05 f514a04f-e20a-497f-98a0-747474815ecd f514a04f-e20a-497f-98a0-747474815ecd TCGA-QH-A6X3-01A-21D-A32A-01 TCGA-QH-A6X3-01A-21D-A32B-08 +TCGA-QH-A6X4-01 TCGA-QH-A6X4-01 TCGA-QH-A6X4 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 47 NO NO TCGA-QH-A6X4-F67744 TCGA-QH-A6X4 TCGA-QH-A6X4-01A -17258 129 0 442 192 1 NO NO NO Sensory Changes 0 - 30 Days Scheduled Follow-up Submission Complete Remission/Response 2014-11-11 MALE NO NO Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES NO 550 NO 90 Left YES Sequence Analysis YES NO NO NO YES G3 NO false No TCGA-QH-A6X4.638A5F85-FA2A-4E1D-B1BC-DC1922E9BAD9.pdf A6X4 Pre-Adjuvant Therapy TUMOR FREE YES YES Complete Remission/Response YES Primary Tumor 01 YES YES Cerebral Cortex YES YES NO QH Supratentorial, Temporal Lobe Central nervous system A NO LIVING 2013 TCGA-QH-A6X4-01 A3566525-5C5A-4021-963D-19F9A8BCA469 TCGA-QH-A6X4-01A-51D-A32B-08 TCGA-QH-A6X4-01A-51D-A32A-01 0ba1f5ce-704d-4a40-854a-fcde2b4dee86 TCGA-QH-A6X4-01 TCGA-QH-A6X4-01 0ba1f5ce-704d-4a40-854a-fcde2b4dee86 TCGA-QH-A6X4-01 TCGA-QH-A6X4-01A-51D-A32C-05 0ba1f5ce-704d-4a40-854a-fcde2b4dee86 0ba1f5ce-704d-4a40-854a-fcde2b4dee86 TCGA-QH-A6X4-01A-51D-A32A-01 TCGA-QH-A6X4-01A-51D-A32B-08 +TCGA-QH-A6X5-01 TCGA-QH-A6X5-01 TCGA-QH-A6X5 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 58 NO NO TCGA-QH-A6X5-F67745 TCGA-QH-A6X5 TCGA-QH-A6X5-01A -21239 65 0 497 119 1 NO NO NO Seizures 0 - 30 Days Scheduled Follow-up Submission 2014-11-11 FEMALE NO NO Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES NO 320 NO 90 Left YES Sequence Analysis YES NO NO NO YES G2 NO false No TCGA-QH-A6X5.5125411F-F380-4367-8A21-9284B5779B9D.pdf A6X5 Other NO NO NO Primary Tumor 01 YES NO White Matter NO YES NO QH Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2013 TCGA-QH-A6X5-01 D0EB6797-D12B-40ED-9DC3-3F36CD1BD384 TCGA-QH-A6X5-01A-12D-A32B-08 TCGA-QH-A6X5-01A-12D-A32A-01 d6e91e40-d498-45eb-8cc7-e191c50f077e TCGA-QH-A6X5-01 TCGA-QH-A6X5-01 d6e91e40-d498-45eb-8cc7-e191c50f077e TCGA-QH-A6X5-01 TCGA-QH-A6X5-01A-12D-A32C-05 d6e91e40-d498-45eb-8cc7-e191c50f077e d6e91e40-d498-45eb-8cc7-e191c50f077e TCGA-QH-A6X5-01A-12D-A32A-01 TCGA-QH-A6X5-01A-12D-A32B-08 +TCGA-QH-A6X8-01 TCGA-QH-A6X8-01 TCGA-QH-A6X8 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 56 NO NO TCGA-QH-A6X8-F67753 TCGA-QH-A6X8 TCGA-QH-A6X8-01A -20771 54 0 509 144 0 NO NO NO Mental Status Changes 0 - 30 Days Scheduled Follow-up Submission Stable Disease 2014-11-11 FEMALE NO NO Oligodendroglioma NO No C71.0 9451/3 C71.0 YES NO 330 NO 100 Left YES IHC YES NO YES NO YES G3 NO false No TCGA-QH-A6X8.01982953-8F6F-4BDE-B645-824E04C6CAAB.pdf A6X8 Post-Adjuvant Therapy WITH TUMOR YES NO Stable Disease YES Primary Tumor 01 YES NO White Matter YES YES NO QH Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2013 TCGA-QH-A6X8-01 B9FF9622-B795-4204-B3E0-6E72B80FF48E TCGA-QH-A6X8-01A-12D-A32B-08 TCGA-QH-A6X8-01A-12D-A32A-01 701594b8-2848-4c06-be1b-ab49c2ca71ea TCGA-QH-A6X8-01 TCGA-QH-A6X8-01 701594b8-2848-4c06-be1b-ab49c2ca71ea TCGA-QH-A6X8-01 TCGA-QH-A6X8-01A-12D-A32C-05 701594b8-2848-4c06-be1b-ab49c2ca71ea 701594b8-2848-4c06-be1b-ab49c2ca71ea TCGA-QH-A6X8-01A-12D-A32A-01 TCGA-QH-A6X8-01A-12D-A32B-08 +TCGA-QH-A6X9-01 TCGA-QH-A6X9-01 TCGA-QH-A6X9 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 73 NO NO TCGA-QH-A6X9-F67996 TCGA-QH-A6X9 TCGA-QH-A6X9-01A -26992 22 0 58 58 3 NO YES NO Seizures 0 - 30 Days Scheduled Follow-up Submission NO 2014-11-13 FEMALE NO NO Oligodendroglioma NO No C71.0 9450/3 C71.0 YES NO 190 NO 40 Right YES Sequence Analysis YES NO YES NO NO G2 NO false No TCGA-QH-A6X9.62469927-D0A5-4C27-9ABA-1DEFAB93B304.pdf A6X9 Pre-Adjuvant Therapy YES NO NO Primary Tumor 01 YES NO White Matter NO YES NO QH Supratentorial, Temporal Lobe Central nervous system A NO LIVING 2013 TCGA-QH-A6X9-01 B8351492-BB67-4F0B-A5AA-EFE358E9071C TCGA-QH-A6X9-01A-12D-A32B-08 TCGA-QH-A6X9-01A-12D-A32A-01 5089e59f-7c52-4c4d-a1f3-a4cbd84877ae TCGA-QH-A6X9-01 TCGA-QH-A6X9-01 5089e59f-7c52-4c4d-a1f3-a4cbd84877ae TCGA-QH-A6X9-01 TCGA-QH-A6X9-01A-12D-A32C-05 5089e59f-7c52-4c4d-a1f3-a4cbd84877ae 5089e59f-7c52-4c4d-a1f3-a4cbd84877ae TCGA-QH-A6X9-01A-12D-A32A-01 TCGA-QH-A6X9-01A-12D-A32B-08 +TCGA-QH-A6XA-01 TCGA-QH-A6XA-01 TCGA-QH-A6XA TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 23 NO NO TCGA-QH-A6XA-F67837 TCGA-QH-A6XA TCGA-QH-A6XA-01A -8508 19 0 502 7 0 NO NO NO Scheduled Follow-up Submission Complete Remission/Response NO 2014-11-12 FEMALE NO NO Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES NO 230 NO 100 Left YES Sequence Analysis YES NO NO YES NO G2 NO false No TCGA-QH-A6XA.9B2B37D4-EF00-4EC5-A549-FADFA7B45BD0.pdf A6XA Pre-Adjuvant Therapy TUMOR FREE NO NO Complete Remission/Response NO Primary Tumor 01 NO NO White Matter NO YES NO QH Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2013 TCGA-QH-A6XA-01 90121A20-2F4E-4F6D-891B-6B4AE77D50B3 TCGA-QH-A6XA-01A-12D-A32B-08 TCGA-QH-A6XA-01A-12D-A32A-01 fdced5ba-d0d5-4e07-b001-9d740cc48898 TCGA-QH-A6XA-01 TCGA-QH-A6XA-01 fdced5ba-d0d5-4e07-b001-9d740cc48898 TCGA-QH-A6XA-01 TCGA-QH-A6XA-01A-12D-A32C-05 fdced5ba-d0d5-4e07-b001-9d740cc48898 fdced5ba-d0d5-4e07-b001-9d740cc48898 TCGA-QH-A6XA-01A-12D-A32A-01 TCGA-QH-A6XA-01A-12D-A32B-08 +TCGA-QH-A6XC-01 TCGA-QH-A6XC-01 TCGA-QH-A6XC TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain YES YES YES 48 YES TCGA-QH-A6XC-F67756 TCGA-QH-A6XC TCGA-QH-A6XC-01A 440 -17692 27 0 508 438 153 1 NO YES NO Seizures 0 - 30 Days Scheduled Follow-up Submission NO 2014-11-12 MALE NO NO Astrocytoma NO No C71.0 9401/3 C71.0 YES NO 310 NO 70 Right NO Sequence Analysis YES NO NO NO G3 YES false No TCGA-QH-A6XC.27080340-615E-489D-932B-75AAD5C7D379.pdf A6XC Post-Adjuvant Therapy WITH TUMOR YES NO [Discrepancy] YES Primary Tumor 01 YES NO White Matter YES YES NO QH Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2013 TCGA-QH-A6XC-01 F73B50FA-7E24-4936-9FE9-A56E0C3DEF0A TCGA-QH-A6XC-01A-12D-A32B-08 TCGA-QH-A6XC-01A-12D-A32A-01 acf520e1-55ec-41e7-a2a5-1e9eabac0b93 TCGA-QH-A6XC-01 TCGA-QH-A6XC-01 acf520e1-55ec-41e7-a2a5-1e9eabac0b93 TCGA-QH-A6XC-01 TCGA-QH-A6XC-01A-12D-A32C-05 acf520e1-55ec-41e7-a2a5-1e9eabac0b93 acf520e1-55ec-41e7-a2a5-1e9eabac0b93 TCGA-QH-A6XC-01A-12D-A32A-01 TCGA-QH-A6XC-01A-12D-A32B-08 +TCGA-QH-A86X-01 TCGA-QH-A86X-01 TCGA-QH-A86X TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 33 NO NO TCGA-QH-A86X-F67829 TCGA-QH-A86X TCGA-QH-A86X-01A -12385 7 0 337 106 0 NO YES Seizures 91 - 180 Days Scheduled Follow-up Submission Complete Remission/Response NO 2014-11-12 MALE NO NO Oligodendroglioma NO No C71.0 9450/3 C71.0 YES NO 240 NO 100 Left YES IHC YES NO NO NO NO G2 NO false No TCGA-QH-A86X.CC0201F5-5747-4A46-A364-8EC6F16D67C1.pdf A86X Other TUMOR FREE YES NO Complete Remission/Response NO Primary Tumor 01 YES NO Cerebral Cortex NO YES NO QH Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2013 TCGA-QH-A86X-01 90351234-3F7B-48A0-965F-DC5F682BCE4B TCGA-QH-A86X-01A-11D-A36O-08 TCGA-QH-A86X-01A-11D-A36N-01 3c8ebeb7-68ef-4d11-80b0-fc5560dd01d6 TCGA-QH-A86X-01 TCGA-QH-A86X-01 3c8ebeb7-68ef-4d11-80b0-fc5560dd01d6 TCGA-QH-A86X-01 TCGA-QH-A86X-01A-11D-A368-05 3c8ebeb7-68ef-4d11-80b0-fc5560dd01d6 3c8ebeb7-68ef-4d11-80b0-fc5560dd01d6 TCGA-QH-A86X-01A-11D-A36N-01 TCGA-QH-A86X-01A-11D-A36O-08 +TCGA-QH-A870-01 TCGA-QH-A870-01 TCGA-QH-A870 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain YES NO NO 38 NO NO TCGA-QH-A870-F67994 TCGA-QH-A870 TCGA-QH-A870-01A -14082 1 0 395 335 2 1 NO YES NO Headaches > 181 Days Scheduled Follow-up Submission Progressive Disease 2014-11-14 FEMALE NO YES Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES NO 450 NO 80 Right YES IHC YES NO NO NO NO G3 YES false No TCGA-QH-A870.C84F6D0C-3879-4D63-8CE8-10D03D3C71A3.pdf A870 Other WITH TUMOR YES YES Complete Remission/Response NO Primary Tumor 01 NO NO White Matter NO YES NO QH Supratentorial, Occipital Lobe Central nervous system A YES LIVING 2013 TCGA-QH-A870-01 62655036-0CAE-4DBA-8453-945BB78DC1CE TCGA-QH-A870-01A-11D-A36O-08 TCGA-QH-A870-01A-11D-A36N-01 2c8a4bf0-f9dd-4fb3-8415-782434a12ceb TCGA-QH-A870-01 TCGA-QH-A870-01 2c8a4bf0-f9dd-4fb3-8415-782434a12ceb TCGA-QH-A870-01 TCGA-QH-A870-01A-11D-A368-05 2c8a4bf0-f9dd-4fb3-8415-782434a12ceb 2c8a4bf0-f9dd-4fb3-8415-782434a12ceb TCGA-QH-A870-01A-11D-A36N-01 TCGA-QH-A870-01A-11D-A36O-08 +TCGA-R8-A6MK-01 TCGA-R8-A6MK-01 TCGA-R8-A6MK TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 40 TCGA-R8-A6MK TCGA-R8-A6MK-01A -14716 2841 0 2702 YES NO 2013-12-30 MALE Oligodendroglioma NO No C71.0 9450/3 C71.0 YES 260 NO Right G2 true No TCGA-R8-A6MK.0E083D5C-1EE1-4BDA-9D6E-93420C3BAE39.pdf A6MK NO Primary Tumor 01 YES YES NO YES R8 Supratentorial, Frontal Lobe Central nervous system A LIVING 2005 TCGA-R8-A6MK-01 0FA7F55B-9B49-401A-8B10-DAB34D75360C TCGA-R8-A6MK-01A-11D-A32B-08 TCGA-R8-A6MK-01A-11D-A32A-01 849208d7-caaf-488e-a489-5638858f6883 TCGA-R8-A6MK-01 TCGA-R8-A6MK-01 849208d7-caaf-488e-a489-5638858f6883 TCGA-R8-A6MK-01 TCGA-R8-A6MK-01A-11D-A32C-05 849208d7-caaf-488e-a489-5638858f6883 849208d7-caaf-488e-a489-5638858f6883 TCGA-R8-A6MK-01A-11D-A32A-01 TCGA-R8-A6MK-01A-11D-A32B-08 +TCGA-R8-A6ML-01 TCGA-R8-A6ML-01 TCGA-R8-A6ML TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 52 TCGA-R8-A6ML TCGA-R8-A6ML-01A -19185 2735 0 2860 NO NO 2013-12-30 MALE Oligodendroglioma Yes, Pharmaceutical Treatment Prior to Resection C71.0 9451/3 C71.0 YES 130 NO Left G3 true No TCGA-R8-A6ML.E87BD3AD-C060-4DF5-8396-0DE9A036C5EB.pdf A6ML YES Primary Tumor 01 YES YES NO YES R8 Supratentorial, Frontal Lobe Central nervous system A LIVING 2005 TCGA-R8-A6ML-01 A2C08926-7E50-4DAE-A5C2-ABF0587D9A8D TCGA-R8-A6ML-01A-11D-A32B-08 TCGA-R8-A6ML-01A-11D-A32A-01 58e03221-6257-4bf1-984f-ee7a92418c13 TCGA-R8-A6ML-01 TCGA-R8-A6ML-01 58e03221-6257-4bf1-984f-ee7a92418c13 TCGA-R8-A6ML-01 TCGA-R8-A6ML-01A-11D-A32C-05 58e03221-6257-4bf1-984f-ee7a92418c13 58e03221-6257-4bf1-984f-ee7a92418c13 TCGA-R8-A6ML-01A-11D-A32A-01 TCGA-R8-A6ML-01A-11D-A32B-08 +TCGA-R8-A6MO-01 TCGA-R8-A6MO-01 TCGA-R8-A6MO TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 53 TCGA-R8-A6MO TCGA-R8-A6MO-01A -19432 1519 0 993 NO NO 2013-12-30 FEMALE Oligodendroglioma No C71.0 9450/3 C71.0 YES 380 NO Right G2 true No TCGA-R8-A6MO.333C073F-08C4-475A-B622-6491FDA57205.pdf A6MO NO Primary Tumor 01 YES NO NO YES R8 Supratentorial, Frontal Lobe Central nervous system A LIVING 2009 TCGA-R8-A6MO-01 64E27469-EE75-4AC7-8B90-ACF798365096 TCGA-R8-A6MO-01A-11D-A33T-08 TCGA-R8-A6MO-01A-11D-A33S-01 cfdc2b0d-f87c-46fd-81b0-0eab963f8871 TCGA-R8-A6MO-01 TCGA-R8-A6MO-01 cfdc2b0d-f87c-46fd-81b0-0eab963f8871 TCGA-R8-A6MO-01 TCGA-R8-A6MO-01A-11D-A33U-05 cfdc2b0d-f87c-46fd-81b0-0eab963f8871 cfdc2b0d-f87c-46fd-81b0-0eab963f8871 TCGA-R8-A6MO-01A-11D-A33S-01 TCGA-R8-A6MO-01A-11D-A33T-08 +TCGA-R8-A6YH-01 TCGA-R8-A6YH-01 TCGA-R8-A6YH TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain TCGA-R8-A6YH-01A 200 NO true TCGA-R8-A6YH.911537EB-E3CE-4D30-B3A2-90932D94A4DA.pdf Primary Tumor 01 A TCGA-R8-A6YH-01 E0599C30-ED7E-484A-A07E-4FD36EAD7FDF TCGA-R8-A6YH-01A-21D-A32B-08 TCGA-R8-A6YH-01A-21D-A32A-01 500000a8-420b-43e1-9ed1-e0d66fe2aece TCGA-R8-A6YH-01 TCGA-R8-A6YH-01 500000a8-420b-43e1-9ed1-e0d66fe2aece TCGA-R8-A6YH-01 TCGA-R8-A6YH-01A-21D-A32C-05 500000a8-420b-43e1-9ed1-e0d66fe2aece 500000a8-420b-43e1-9ed1-e0d66fe2aece TCGA-R8-A6YH-01A-21D-A32A-01 TCGA-R8-A6YH-01A-21D-A32B-08 +TCGA-R8-A73M-01 TCGA-R8-A73M-01 TCGA-R8-A73M TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 48 TCGA-R8-A73M -17610 0 1806 YES NO 2013-12-30 FEMALE YES Oligodendroglioma No C71.0 9450/3 C71.0 YES Left G2 NO Yes, History of Prior Malignancy A73M NO Primary Tumor 01 YES NO YES R8 Supratentorial, Parietal Lobe Central nervous system YES LIVING 2008 TCGA-R8-A73M-01 TCGA-R8-A73M-01A-11D-A32B-08 TCGA-R8-A73M-01A-11D-A32A-01 e49a9619-3446-4862-8b91-d429d95197cb e49a9619-3446-4862-8b91-d429d95197cb TCGA-R8-A73M-01 TCGA-R8-A73M-01A-11D-A32C-05 e49a9619-3446-4862-8b91-d429d95197cb e49a9619-3446-4862-8b91-d429d95197cb TCGA-R8-A73M-01A-11D-A32A-01 TCGA-R8-A73M-01A-11D-A32B-08 +TCGA-RY-A83X-01 TCGA-RY-A83X-01 TCGA-RY-A83X TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 46 NO TCGA-RY-A83X-F69371 TCGA-RY-A83X TCGA-RY-A83X-01A -16911 486 0 939 NO NO NO Mental Status Changes > 181 Days Scheduled Follow-up Submission Stable Disease 2015-1-7 FEMALE NO NO Oligodendroglioma NO No C71.0 9450/3 C71.0 YES NO 130 NO Right YES IHC YES NO YES NO NO G2 NO false No TCGA-RY-A83X.0964A173-152D-4C42-BBBC-19AFB12DC8E6.pdf A83X TUMOR FREE NO Primary Tumor 01 NO NO Cerebral Cortex NO YES NO RY Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2012 TCGA-RY-A83X-01 DA8C6FE9-6B59-4602-9A9C-870745092053 TCGA-RY-A83X-01A-11D-A36O-08 TCGA-RY-A83X-01A-11D-A36N-01 c44e9cfc-d595-4098-b55b-8275d7284f05 TCGA-RY-A83X-01 TCGA-RY-A83X-01 c44e9cfc-d595-4098-b55b-8275d7284f05 TCGA-RY-A83X-01 TCGA-RY-A83X-01A-11D-A368-05 c44e9cfc-d595-4098-b55b-8275d7284f05 c44e9cfc-d595-4098-b55b-8275d7284f05 TCGA-RY-A83X-01A-11D-A36N-01 TCGA-RY-A83X-01A-11D-A36O-08 +TCGA-RY-A83Y-01 TCGA-RY-A83Y-01 TCGA-RY-A83Y TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 45 NO TCGA-RY-A83Y-F69684 TCGA-RY-A83Y TCGA-RY-A83Y-01A -16470 485 0 166 2 NO NO NO Seizures 0 - 30 Days Scheduled Follow-up Submission 2015-1-15 MALE NO NO Oligodendroglioma NO No C71.0 9450/3 C71.0 YES NO 150 NO 80 Left YES IHC YES YES YES NO NO G2 false No TCGA-RY-A83Y.EEC58176-5007-4A8F-9BBB-ABE5B1D13772.pdf A83Y Other TUMOR FREE NO Primary Tumor 01 YES NO Cerebral Cortex YES NO RY Supratentorial, Parietal Lobe Central nervous system A NO LIVING 2012 TCGA-RY-A83Y-01 CBD0FEA3-1632-4132-A18A-8B039FC9B6A4 TCGA-RY-A83Y-01A-11D-A36O-08 TCGA-RY-A83Y-01A-11D-A36N-01 55c39d1f-7300-42e9-8205-d919cdddf558 TCGA-RY-A83Y-01 TCGA-RY-A83Y-01 55c39d1f-7300-42e9-8205-d919cdddf558 TCGA-RY-A83Y-01 TCGA-RY-A83Y-01A-11D-A368-05 55c39d1f-7300-42e9-8205-d919cdddf558 55c39d1f-7300-42e9-8205-d919cdddf558 TCGA-RY-A83Y-01A-11D-A36N-01 TCGA-RY-A83Y-01A-11D-A36O-08 +TCGA-RY-A83Z-01 TCGA-RY-A83Z-01 TCGA-RY-A83Z TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 54 NO TCGA-RY-A83Z-F69683 TCGA-RY-A83Z TCGA-RY-A83Z-01A -19903 375 0 301 NO NO NO Seizures 0 - 30 Days Scheduled Follow-up Submission 2015-1-15 FEMALE NO NO Astrocytoma NO No C71.9 9401/3 C71.9 YES NO 160 NO Left YES IHC NO YES NO NO NO G3 NO false No TCGA-RY-A83Z.923A22A4-A05E-4B5E-B682-1027A84B9EF2.pdf A83Z WITH TUMOR Stable Disease YES Primary Tumor 01 YES NO Cerebral Cortex YES YES NO RY Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2012 TCGA-RY-A83Z-01 BAEE95E8-A9C6-4FB8-8E44-7F89FA3BF05F TCGA-RY-A83Z-01A-11D-A36O-08 TCGA-RY-A83Z-01A-11D-A36N-01 f5dd58db-4834-4d0e-aeb6-15d6b8f05826 TCGA-RY-A83Z-01 TCGA-RY-A83Z-01 f5dd58db-4834-4d0e-aeb6-15d6b8f05826 TCGA-RY-A83Z-01 TCGA-RY-A83Z-01A-11D-A368-05 f5dd58db-4834-4d0e-aeb6-15d6b8f05826 f5dd58db-4834-4d0e-aeb6-15d6b8f05826 TCGA-RY-A83Z-01A-11D-A36N-01 TCGA-RY-A83Z-01A-11D-A36O-08 +TCGA-RY-A840-01 TCGA-RY-A840-01 TCGA-RY-A840 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 47 NO TCGA-RY-A840-F69714 TCGA-RY-A840 TCGA-RY-A840-01A -17501 444 0 854 22 0 NO NO NO < 12 Years Seizures 0 - 30 Days Scheduled Follow-up Submission Stable Disease NO 2015-1-16 MALE YES YES Oligodendroglioma NO No C71.0 9451/3 C71.0 YES NO 60 NO 90 Left YES IHC YES NO NO NO NO G3 NO false No TCGA-RY-A840.D0ABD0C6-7F14-4CC3-9B44-0566D3384727.pdf A840 Pre-Adjuvant Therapy WITH TUMOR Stable Disease NO Primary Tumor 01 YES NO Cerebral Cortex YES YES NO RY Supratentorial, Temporal Lobe Central nervous system A NO LIVING 2012 TCGA-RY-A840-01 TCGA-RY-A840-01A-11D-A36O-08 TCGA-RY-A840-01A-11D-A36N-01 2e4d2d19-c416-4ff3-986e-66e40fca946c TCGA-RY-A840-01 TCGA-RY-A840-01 2e4d2d19-c416-4ff3-986e-66e40fca946c TCGA-RY-A840-01 TCGA-RY-A840-01A-11D-A368-05 2e4d2d19-c416-4ff3-986e-66e40fca946c 2e4d2d19-c416-4ff3-986e-66e40fca946c TCGA-RY-A840-01A-11D-A36N-01 TCGA-RY-A840-01A-11D-A36O-08 +TCGA-RY-A843-01 TCGA-RY-A843-01 TCGA-RY-A843 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 30 NO TCGA-RY-A843-F69739 TCGA-RY-A843 TCGA-RY-A843-01A -11083 312 0 63 NO NO NO Seizures > 181 Days Scheduled Follow-up Submission Stable Disease 2015-1-16 MALE NO NO Astrocytoma NO No C71.0 9401/3 C71.0 YES NO 300 NO Left NO IHC YES YES NO NO NO G3 NO false No TCGA-RY-A843.2C380241-843C-4301-8891-78345D97CC08.pdf A843 WITH TUMOR NO Primary Tumor 01 YES NO Cerebral Cortex YES YES NO RY Supratentorial, Temporal Lobe Central nervous system A NO LIVING 2012 TCGA-RY-A843-01 E87072C2-D66F-47BB-B007-F905BC131604 TCGA-RY-A843-01A-11D-A36O-08 TCGA-RY-A843-01A-11D-A36N-01 2dc97660-d26f-49a4-9e47-3678a3768724 TCGA-RY-A843-01 TCGA-RY-A843-01 2dc97660-d26f-49a4-9e47-3678a3768724 TCGA-RY-A843-01 TCGA-RY-A843-01A-11D-A368-05 2dc97660-d26f-49a4-9e47-3678a3768724 2dc97660-d26f-49a4-9e47-3678a3768724 TCGA-RY-A843-01A-11D-A36N-01 TCGA-RY-A843-01A-11D-A36O-08 +TCGA-RY-A845-01 TCGA-RY-A845-01 TCGA-RY-A845 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 40 NO TCGA-RY-A845-F69753 TCGA-RY-A845 TCGA-RY-A845-01A -14617 193 0 596 1 NO NO NO < 12 Years Mental Status Changes 0 - 30 Days Scheduled Follow-up Submission NO 2015-1-16 FEMALE YES NO Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES NO 250 NO 80 Left NO IHC YES NO YES NO NO G2 NO false No TCGA-RY-A845.E4FBBEC7-8717-4D7D-B390-0BB242D05C2C.pdf A845 TUMOR FREE NO Primary Tumor 01 YES NO Cerebral Cortex NO YES NO RY Supratentorial, Parietal Lobe Central nervous system A NO LIVING 2013 TCGA-RY-A845-01 3BEA2AF5-5C51-410B-BC84-3A283CEF02F6 TCGA-RY-A845-01A-11D-A36O-08 TCGA-RY-A845-01A-11D-A36N-01 a57d41bc-71b6-4215-804a-d66071f60594 TCGA-RY-A845-01 TCGA-RY-A845-01 a57d41bc-71b6-4215-804a-d66071f60594 TCGA-RY-A845-01 TCGA-RY-A845-01A-11D-A368-05 a57d41bc-71b6-4215-804a-d66071f60594 a57d41bc-71b6-4215-804a-d66071f60594 TCGA-RY-A845-01A-11D-A36N-01 TCGA-RY-A845-01A-11D-A36O-08 +TCGA-RY-A847-01 TCGA-RY-A847-01 TCGA-RY-A847 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 45 TCGA-RY-A847-F69806 TCGA-RY-A847 TCGA-RY-A847-01A -16732 471 0 933 62 NO NO Scheduled Follow-up Submission Stable Disease 2015-1-20 MALE NO Oligodendroglioma NO No C71.0 9450/3 C71.0 YES NO 60 NO 90 Right YES IHC YES NO NO NO G2 NO false No TCGA-RY-A847.E1F9B39F-DE08-45CD-ABCC-5D7C3B6CE090.pdf A847 Other TUMOR FREE NO Primary Tumor 01 NO NO Cerebral Cortex NO YES NO RY Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2012 TCGA-RY-A847-01 TCGA-RY-A847-01A-11D-A36O-08 TCGA-RY-A847-01A-11D-A36N-01 1d7d22de-0bfc-4357-8c5a-7289aa0d97b8 TCGA-RY-A847-01 TCGA-RY-A847-01 1d7d22de-0bfc-4357-8c5a-7289aa0d97b8 TCGA-RY-A847-01 TCGA-RY-A847-01A-11D-A368-05 1d7d22de-0bfc-4357-8c5a-7289aa0d97b8 1d7d22de-0bfc-4357-8c5a-7289aa0d97b8 TCGA-RY-A847-01A-11D-A36N-01 TCGA-RY-A847-01A-11D-A36O-08 +TCGA-S9-A6TS-01 TCGA-S9-A6TS-01 TCGA-S9-A6TS TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain YES NO YES 48 NO NO TCGA-S9-A6TS-F51945 TCGA-S9-A6TS TCGA-S9-A6TS-01A 1324 -17857 2402 1891 0 1324 -10 0 NO Scheduled Follow-up Submission Progressive Disease NO 2013-11-26 FEMALE NO NO Astrocytoma NO No C71.0 9401/3 C71.0 YES NO 150 NO 100 Right NO NO NO NO NO G3 YES false No TCGA-S9-A6TS.A6DF65CD-E78C-4CF8-ACC7-B35F2EF33ECA.pdf A6TS Preoperative WITH TUMOR NO NO Progressive Disease YES Primary Tumor 01 NO NO Cerebral Cortex NO NO YES S9 Supratentorial, Frontal Lobe Central nervous system A NO DECEASED 2006 TCGA-S9-A6TS-01 823BB327-D4B7-41EF-87C0-18D805D8798C TCGA-S9-A6TS-01A-12D-A33T-08 TCGA-S9-A6TS-01A-12D-A33S-01 735919a3-a98f-41d9-84cf-0bc3983b9f3b TCGA-S9-A6TS-01 TCGA-S9-A6TS-01 735919a3-a98f-41d9-84cf-0bc3983b9f3b TCGA-S9-A6TS-01 TCGA-S9-A6TS-01A-12D-A33U-05 735919a3-a98f-41d9-84cf-0bc3983b9f3b 735919a3-a98f-41d9-84cf-0bc3983b9f3b TCGA-S9-A6TS-01A-12D-A33S-01 TCGA-S9-A6TS-01A-12D-A33T-08 +TCGA-S9-A6TU-01 TCGA-S9-A6TU-01 TCGA-S9-A6TU TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain NO NO NO 38 NO NO TCGA-S9-A6TU-F63758 TCGA-S9-A6TU TCGA-S9-A6TU-01A -14108 2301 0 2650 2650 -2 0 NO Sensory Changes 31 - 90 Days Additional New Tumor Event Progressive Disease NO 2014-8-18 MALE NO NO Astrocytoma NO No C71.0 9400/3 C71.0 YES 170 NO 100 Left YES IHC YES NO NO NO NO G2 YES false No TCGA-S9-A6TU.8CD1578E-88C2-4328-97B8-C3DD437C15A1.pdf A6TU Preoperative WITH TUMOR NO NO Partial Remission/Response NO Primary Tumor 01 YES YES Cerebral Cortex NO NO YES S9 Supratentorial, Temporal Lobe Central nervous system A NO LIVING 2007 TCGA-S9-A6TU-01 911DFF86-C93D-47AD-8E9E-B852149BFC7F TCGA-S9-A6TU-01A-12D-A32B-08 TCGA-S9-A6TU-01A-12D-A32A-01 deff8fdc-d2f8-422a-b5bb-57a65241cf51 TCGA-S9-A6TU-01 TCGA-S9-A6TU-01 deff8fdc-d2f8-422a-b5bb-57a65241cf51 TCGA-S9-A6TU-01 TCGA-S9-A6TU-01A-12D-A32C-05 deff8fdc-d2f8-422a-b5bb-57a65241cf51 deff8fdc-d2f8-422a-b5bb-57a65241cf51 TCGA-S9-A6TU-01A-12D-A32A-01 TCGA-S9-A6TU-01A-12D-A32B-08 +TCGA-S9-A6TV-01 TCGA-S9-A6TV-01 TCGA-S9-A6TV TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 50 NO NO TCGA-S9-A6TV-F67222 TCGA-S9-A6TV TCGA-S9-A6TV-01A -18321 936 0 571 -14 1 NO Headaches 0 - 30 Days Scheduled Follow-up Submission NO 2014-11-3 MALE NO YES Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES 140 NO 90 Right YES IHC YES YES NO NO YES G3 NO false No TCGA-S9-A6TV.0D9D6080-A0B2-4198-ACDF-6F47D25491B7.pdf A6TV Preoperative TUMOR FREE NO YES Complete Remission/Response YES Primary Tumor 01 NO NO Cerebral Cortex YES NO YES S9 Supratentorial, Frontal Lobe Central nervous system A YES LIVING 2010 TCGA-S9-A6TV-01 FB6461FE-3EDD-4DBC-A053-2171A589941D TCGA-S9-A6TV-01A-12D-A34J-08 TCGA-S9-A6TV-01A-12D-A34I-01 d5c2aa43-35e2-41b9-9b55-c0a6618dfb20 TCGA-S9-A6TV-01 TCGA-S9-A6TV-01 d5c2aa43-35e2-41b9-9b55-c0a6618dfb20 TCGA-S9-A6TV-01 TCGA-S9-A6TV-01A-12D-A34K-05 d5c2aa43-35e2-41b9-9b55-c0a6618dfb20 d5c2aa43-35e2-41b9-9b55-c0a6618dfb20 TCGA-S9-A6TV-01A-12D-A34I-01 TCGA-S9-A6TV-01A-12D-A34J-08 +TCGA-S9-A6TW-01 TCGA-S9-A6TW-01 TCGA-S9-A6TW TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 40 NO NO TCGA-S9-A6TW-F69523 TCGA-S9-A6TW -14679 0 1250 -8 1 NO Motor/Movement Changes 31 - 90 Days Scheduled Follow-up Submission Complete Remission/Response NO 2015-1-13 MALE YES YES Oligodendroglioma NO No C71.0 9451/3 C71.0 YES 90 Left YES IHC YES NO NO NO YES G3 NO No A6TW Preoperative TUMOR FREE NO YES Partial Remission/Response NO Primary Tumor 01 NO YES Cerebral Cortex YES NO YES S9 Supratentorial, Frontal Lobe Central nervous system NO LIVING 2011 TCGA-S9-A6TW-01 TCGA-S9-A6TW-01A-12D-A32B-08 TCGA-S9-A6TW-01A-12D-A32A-01 e32dbf45-c066-454e-8b38-85d52151f623 TCGA-S9-A6TW-01 TCGA-S9-A6TW-01 e32dbf45-c066-454e-8b38-85d52151f623 TCGA-S9-A6TW-01 TCGA-S9-A6TW-01A-12D-A32C-05 e32dbf45-c066-454e-8b38-85d52151f623 e32dbf45-c066-454e-8b38-85d52151f623 TCGA-S9-A6TW-01A-12D-A32A-01 TCGA-S9-A6TW-01A-12D-A32B-08 +TCGA-S9-A6TX-01 TCGA-S9-A6TX-01 TCGA-S9-A6TX TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 46 NO NO TCGA-S9-A6TX-F69524 TCGA-S9-A6TX TCGA-S9-A6TX-01A -17025 776 0 1245 -34 0 NO Headaches 0 - 30 Days Scheduled Follow-up Submission Partial Remission/Response NO 2015-1-13 MALE NO YES Oligodendroglioma NO No C71.0 9451/3 C71.0 YES 150 NO 100 Left YES IHC YES NO NO NO NO G3 NO false No TCGA-S9-A6TX.B2F18877-6F79-40BE-8F35-38713A54DD58.pdf A6TX Preoperative WITH TUMOR NO NO Complete Remission/Response NO Primary Tumor 01 NO YES Cerebral Cortex YES NO YES S9 Supratentorial, Temporal Lobe Central nervous system A NO LIVING 2011 TCGA-S9-A6TX-01 A81352B5-DC69-4CBA-9733-812C481BCE7A TCGA-S9-A6TX-01A-21D-A32B-08 TCGA-S9-A6TX-01A-21D-A32A-01 0eba2b04-9c32-4432-999a-ba53fe1137ea TCGA-S9-A6TX-01 TCGA-S9-A6TX-01 0eba2b04-9c32-4432-999a-ba53fe1137ea TCGA-S9-A6TX-01 TCGA-S9-A6TX-01A-21D-A32C-05 0eba2b04-9c32-4432-999a-ba53fe1137ea 0eba2b04-9c32-4432-999a-ba53fe1137ea TCGA-S9-A6TX-01A-21D-A32A-01 TCGA-S9-A6TX-01A-21D-A32B-08 +TCGA-S9-A6TY-01 TCGA-S9-A6TY-01 TCGA-S9-A6TY TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 50 YES hair of animals, not further specified NO TCGA-S9-A6TY-F69979 TCGA-S9-A6TY TCGA-S9-A6TY-01A -18564 614 0 1076 -18 0 NO Seizures 0 - 30 Days Scheduled Follow-up Submission Stable Disease NO 2015-1-26 MALE NO NO Oligodendroglioma NO No C71.0 9450/3 C71.0 YES 130 NO 100 Left NO IHC YES NO NO YES NO G2 NO false No TCGA-S9-A6TY.13C1027F-56A6-4710-946D-25B496BA6315.pdf A6TY Preoperative WITH TUMOR YES NO Partial Remission/Response NO Primary Tumor 01 YES NO Cerebral Cortex YES NO YES S9 Supratentorial, Temporal Lobe Central nervous system A NO LIVING 2011 TCGA-S9-A6TY-01 FF8EDB38-FB8E-4FC0-8D77-95EC93B6525A TCGA-S9-A6TY-01A-12D-A32B-08 TCGA-S9-A6TY-01A-12D-A32A-01 fcac06b5-0096-4004-b3a6-1af7c708b82d TCGA-S9-A6TY-01 TCGA-S9-A6TY-01 fcac06b5-0096-4004-b3a6-1af7c708b82d TCGA-S9-A6TY-01 TCGA-S9-A6TY-01A-12D-A32C-05 fcac06b5-0096-4004-b3a6-1af7c708b82d fcac06b5-0096-4004-b3a6-1af7c708b82d TCGA-S9-A6TY-01A-12D-A32A-01 TCGA-S9-A6TY-01A-12D-A32B-08 +TCGA-S9-A6TZ-01 TCGA-S9-A6TZ-01 TCGA-S9-A6TZ TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 39 NO NO TCGA-S9-A6TZ-F69980 TCGA-S9-A6TZ -14592 0 1120 -15 0 NO Mental Status Changes > 181 Days Scheduled Follow-up Submission Stable Disease 2015-1-26 FEMALE NO NO Astrocytoma NO No C71.0 9400/3 C71.0 YES 100 Left YES IHC YES NO YES NO NO G2 NO No A6TZ Preoperative WITH TUMOR NO YES Partial Remission/Response NO Primary Tumor 01 NO NO Cerebral Cortex NO NO YES S9 Supratentorial, Frontal Lobe Central nervous system NO LIVING 2011 TCGA-S9-A6TZ-01 TCGA-S9-A6TZ-01A-21D-A32B-08 TCGA-S9-A6TZ-01A-21D-A32A-01 ede9effc-6462-4ecc-9be3-2ec0bb4d7c2f TCGA-S9-A6TZ-01 TCGA-S9-A6TZ-01 ede9effc-6462-4ecc-9be3-2ec0bb4d7c2f TCGA-S9-A6TZ-01 TCGA-S9-A6TZ-01A-21D-A32C-05 ede9effc-6462-4ecc-9be3-2ec0bb4d7c2f ede9effc-6462-4ecc-9be3-2ec0bb4d7c2f TCGA-S9-A6TZ-01A-21D-A32A-01 TCGA-S9-A6TZ-01A-21D-A32B-08 +TCGA-S9-A6U0-01 TCGA-S9-A6U0-01 TCGA-S9-A6U0 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 46 NO NO TCGA-S9-A6U0-F72340 TCGA-S9-A6U0 TCGA-S9-A6U0-01A -16890 495 742 0 498 -18 0 NO Seizures 0 - 30 Days Scheduled Follow-up Submission Progressive Disease NO 2015-5-27 MALE NO NO Astrocytoma NO No C71.0 9401/3 C71.0 YES 140 NO 100 Right NO IHC YES NO NO NO NO G3 NO false No TCGA-S9-A6U0.D07453BE-76A4-42D0-B075-BDEA24A294E3.pdf A6U0 Preoperative WITH TUMOR NO NO Partial Remission/Response YES Primary Tumor 01 YES NO Cerebral Cortex YES NO YES S9 Supratentorial, Temporal Lobe Central nervous system A NO DECEASED 2012 TCGA-S9-A6U0-01 FA80EC62-73F8-4F27-AFA6-A1CD2D4517AB TCGA-S9-A6U0-01A-12D-A32B-08 TCGA-S9-A6U0-01A-12D-A32A-01 f64b490b-d38e-4c20-aa98-a6c636d81123 TCGA-S9-A6U0-01 TCGA-S9-A6U0-01 f64b490b-d38e-4c20-aa98-a6c636d81123 TCGA-S9-A6U0-01 TCGA-S9-A6U0-01A-12D-A32C-05 f64b490b-d38e-4c20-aa98-a6c636d81123 f64b490b-d38e-4c20-aa98-a6c636d81123 TCGA-S9-A6U0-01A-12D-A32A-01 TCGA-S9-A6U0-01A-12D-A32B-08 +TCGA-S9-A6U1-01 TCGA-S9-A6U1-01 TCGA-S9-A6U1 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 22 NO NO TCGA-S9-A6U1-F69560 TCGA-S9-A6U1 TCGA-S9-A6U1-01A -8271 260 0 785 -13 0 NO NO NO Sensory Changes 0 - 30 Days Scheduled Follow-up Submission Complete Remission/Response NO 2015-1-14 FEMALE NO NO Astrocytoma NO No C71.0 9401/3 C71.0 YES 230 NO 100 Right NO IHC YES NO NO NO NO G3 NO false No TCGA-S9-A6U1.400A5278-9C45-4FF9-AEF8-2155624D1168.pdf A6U1 Preoperative TUMOR FREE NO NO Complete Remission/Response NO Primary Tumor 01 NO YES Cerebral Cortex YES NO YES S9 Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2012 TCGA-S9-A6U1-01 3DF29E06-0AF2-4275-8E42-C826744E05AC TCGA-S9-A6U1-01A-21D-A33T-08 TCGA-S9-A6U1-01A-21D-A33S-01 25e9f832-aae2-463f-ad18-9d5ac9fb506c TCGA-S9-A6U1-01 TCGA-S9-A6U1-01 25e9f832-aae2-463f-ad18-9d5ac9fb506c TCGA-S9-A6U1-01 TCGA-S9-A6U1-01A-21D-A33U-05 25e9f832-aae2-463f-ad18-9d5ac9fb506c 25e9f832-aae2-463f-ad18-9d5ac9fb506c TCGA-S9-A6U1-01A-21D-A33S-01 TCGA-S9-A6U1-01A-21D-A33T-08 +TCGA-S9-A6U2-01 TCGA-S9-A6U2-01 TCGA-S9-A6U2 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 48 NO NO TCGA-S9-A6U2-F69983 TCGA-S9-A6U2 TCGA-S9-A6U2-01A -17800 430 0 908 -6 0 NO Seizures 0 - 30 Days Scheduled Follow-up Submission Stable Disease NO 2015-1-26 FEMALE NO NO Oligodendroglioma NO No C71.0 9450/3 C71.0 YES 140 NO 100 Right YES IHC YES NO NO NO NO G2 NO false No TCGA-S9-A6U2.C9E09216-EB85-433E-897C-874F3BBBC252.pdf A6U2 Preoperative WITH TUMOR YES NO Partial Remission/Response YES Primary Tumor 01 YES NO Cerebral Cortex NO NO YES S9 Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2012 TCGA-S9-A6U2-01 TCGA-S9-A6U2-01A-21D-A33T-08 TCGA-S9-A6U2-01A-21D-A33S-01 108d720f-7f3f-481e-ad11-5a30f4c4f9a4 TCGA-S9-A6U2-01 TCGA-S9-A6U2-01 108d720f-7f3f-481e-ad11-5a30f4c4f9a4 TCGA-S9-A6U2-01 TCGA-S9-A6U2-01A-21D-A33U-05 108d720f-7f3f-481e-ad11-5a30f4c4f9a4 108d720f-7f3f-481e-ad11-5a30f4c4f9a4 TCGA-S9-A6U2-01A-21D-A33S-01 TCGA-S9-A6U2-01A-21D-A33T-08 +TCGA-S9-A6U5-01 TCGA-S9-A6U5-01 TCGA-S9-A6U5 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain NO NO 33 NO NO TCGA-S9-A6U5-F62932 TCGA-S9-A6U5 TCGA-S9-A6U5-01A -12417 636 0 992 -6 0 NO Seizures 31 - 90 Days Scheduled Follow-up Submission Stable Disease NO 2014-7-29 MALE NO NO Astrocytoma NO No C71.0 9400/3 C71.0 YES 130 NO 100 Right YES IHC YES NO NO NO NO G2 NO false No TCGA-S9-A6U5.0A1B0FCA-6B68-4BA3-946D-0B05A99ABEC4.pdf A6U5 Preoperative TUMOR FREE YES NO Complete Remission/Response NO Primary Tumor 01 YES NO Cerebral Cortex NO NO YES S9 Supratentorial, Temporal Lobe Central nervous system A NO LIVING 2011 TCGA-S9-A6U5-01 4A0A7A8F-045F-4820-87F3-CF115A5352FC TCGA-S9-A6U5-01A-12D-A33T-08 TCGA-S9-A6U5-01A-12D-A33S-01 bf011a58-857d-4191-ab61-56e2a0b9e181 TCGA-S9-A6U5-01 TCGA-S9-A6U5-01 bf011a58-857d-4191-ab61-56e2a0b9e181 TCGA-S9-A6U5-01 TCGA-S9-A6U5-01A-12D-A33U-05 bf011a58-857d-4191-ab61-56e2a0b9e181 bf011a58-857d-4191-ab61-56e2a0b9e181 TCGA-S9-A6U5-01A-12D-A33S-01 TCGA-S9-A6U5-01A-12D-A33T-08 +TCGA-S9-A6U6-01 TCGA-S9-A6U6-01 TCGA-S9-A6U6 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 28 NO NO TCGA-S9-A6U6-F72342 TCGA-S9-A6U6 TCGA-S9-A6U6-01A -10253 382 0 1069 -3 0 NO Scheduled Follow-up Submission NO 2015-5-27 MALE NO NO Astrocytoma NO No C71.0 9401/3 C71.0 YES NO 170 NO 100 Left YES IHC YES NO NO NO NO G3 NO false No TCGA-S9-A6U6.741221A4-D7C5-45F8-9D69-8FDD835D019A.pdf A6U6 Preoperative TUMOR FREE NO NO Complete Remission/Response YES Primary Tumor 01 NO NO Cerebral Cortex NO NO YES S9 Supratentorial, Temporal Lobe Central nervous system A NO LIVING 2012 TCGA-S9-A6U6-01 7C717FD3-D4C6-424C-B88E-91132138B1F6 TCGA-S9-A6U6-01A-12D-A33T-08 TCGA-S9-A6U6-01A-12D-A33S-01 dfcfc10d-04ed-495a-9fc4-a5d7af4d5b03 TCGA-S9-A6U6-01 TCGA-S9-A6U6-01 dfcfc10d-04ed-495a-9fc4-a5d7af4d5b03 TCGA-S9-A6U6-01 TCGA-S9-A6U6-01A-12D-A33U-05 dfcfc10d-04ed-495a-9fc4-a5d7af4d5b03 dfcfc10d-04ed-495a-9fc4-a5d7af4d5b03 TCGA-S9-A6U6-01A-12D-A33S-01 TCGA-S9-A6U6-01A-12D-A33T-08 +TCGA-S9-A6U8-01 TCGA-S9-A6U8-01 TCGA-S9-A6U8 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain NO NO 24 NO NO TCGA-S9-A6U8-F65495 TCGA-S9-A6U8 TCGA-S9-A6U8-01A -9044 2962 2988 0 2878 367 -31 0 NO Seizures > 181 Days Scheduled Follow-up Submission Progressive Disease NO 2014-9-24 MALE NO NO Astrocytoma NO No C71.0 9400/3 C71.0 YES 100 NO 100 Left NO NO NO NO NO G2 YES false No TCGA-S9-A6U8.6999D0D0-E961-478C-8935-71765A100941.pdf A6U8 Preoperative WITH TUMOR NO NO Partial Remission/Response NO Primary Tumor 01 YES NO White Matter NO NO YES S9 Supratentorial, Temporal Lobe Central nervous system A NO DECEASED 2005 TCGA-S9-A6U8-01 TCGA-S9-A6U8-01A-21D-A33T-08 TCGA-S9-A6U8-01A-21D-A33S-01 6ff9c39a-7992-411e-a14a-631589199c3a TCGA-S9-A6U8-01 TCGA-S9-A6U8-01 6ff9c39a-7992-411e-a14a-631589199c3a TCGA-S9-A6U8-01 TCGA-S9-A6U8-01A-21D-A33U-05 6ff9c39a-7992-411e-a14a-631589199c3a 6ff9c39a-7992-411e-a14a-631589199c3a TCGA-S9-A6U8-01A-21D-A33S-01 TCGA-S9-A6U8-01A-21D-A33T-08 +TCGA-S9-A6U9-01 TCGA-S9-A6U9-01 TCGA-S9-A6U9 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain NO NO 36 NO NO TCGA-S9-A6U9-F62934 TCGA-S9-A6U9 TCGA-S9-A6U9-01A -13460 2706 0 2918 NO NO NO Seizures > 181 Days Scheduled Follow-up Submission Stable Disease NO 2014-7-29 MALE NO NO Astrocytoma NO No C71.0 9401/3 C71.0 YES 160 NO Right NO NO YES NO NO G3 NO false No TCGA-S9-A6U9.3F2EBA7C-1491-4995-9AE4-CE0875950F1E.pdf A6U9 WITH TUMOR YES NO Partial Remission/Response YES Primary Tumor 01 YES NO White Matter NO NO YES S9 Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2006 TCGA-S9-A6U9-01 0FC15F66-C25A-4BA1-9C7C-2DC7CB1B4844 TCGA-S9-A6U9-01A-11D-A32B-08 TCGA-S9-A6U9-01A-11D-A32A-01 9070435a-8d76-4107-8d96-900db04b0d94 TCGA-S9-A6U9-01 TCGA-S9-A6U9-01 9070435a-8d76-4107-8d96-900db04b0d94 TCGA-S9-A6U9-01 TCGA-S9-A6U9-01A-11D-A32C-05 9070435a-8d76-4107-8d96-900db04b0d94 9070435a-8d76-4107-8d96-900db04b0d94 TCGA-S9-A6U9-01A-11D-A32A-01 TCGA-S9-A6U9-01A-11D-A32B-08 +TCGA-S9-A6UA-01 TCGA-S9-A6UA-01 TCGA-S9-A6UA TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain NO NO NO 66 NO NO TCGA-S9-A6UA-F51947 TCGA-S9-A6UA TCGA-S9-A6UA-01A -24242 1989 178 0 161 -6 2 NO Mental Status Changes > 181 Days Scheduled Follow-up Submission Progressive Disease NO 2013-11-26 MALE NO NO Astrocytoma NO No C71.0 9401/3 C71.0 YES 80 NO 60 Right NO NO YES NO NO G3 YES false No TCGA-S9-A6UA.7F0ED679-C54A-4B51-ACD8-CF1E2EB2BCFA.pdf A6UA Preoperative WITH TUMOR NO NO Progressive Disease NO Primary Tumor 01 NO NO Deep Gray (e.g.basal ganglia, thalamus) NO NO YES S9 Supratentorial, Temporal Lobe Central nervous system A NO DECEASED 2008 TCGA-S9-A6UA-01 TCGA-S9-A6UA-01A-12D-A33T-08 TCGA-S9-A6UA-01A-12D-A33S-01 73227e22-1131-49b2-90d6-f30a6a076d8b TCGA-S9-A6UA-01 TCGA-S9-A6UA-01 73227e22-1131-49b2-90d6-f30a6a076d8b TCGA-S9-A6UA-01 TCGA-S9-A6UA-01A-12D-A33U-05 73227e22-1131-49b2-90d6-f30a6a076d8b 73227e22-1131-49b2-90d6-f30a6a076d8b TCGA-S9-A6UA-01A-12D-A33S-01 TCGA-S9-A6UA-01A-12D-A33T-08 +TCGA-S9-A6UB-01 TCGA-S9-A6UB-01 TCGA-S9-A6UB TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 52 NO YES TCGA-S9-A6UB-F72418 TCGA-S9-A6UB TCGA-S9-A6UB-01A -19223 3073 0 3761 -1 0 NO Scheduled Follow-up Submission NO 2015-6-15 MALE NO NO Oligodendroglioma NO No C71.0 9450/3 C71.0 YES 120 NO 100 Right NO NO NO NO NO G2 NO false No TCGA-S9-A6UB.F71CEABA-8472-49C7-B618-47CDE4C43AC3.pdf A6UB Preoperative TUMOR FREE NO NO Complete Remission/Response NO Primary Tumor 01 NO NO Cerebral Cortex NO NO YES S9 Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2005 TCGA-S9-A6UB-01 TCGA-S9-A6UB-01A-21D-A33T-08 TCGA-S9-A6UB-01A-21D-A33S-01 0836116d-5b2e-4445-9019-a5c5ad7aac50 TCGA-S9-A6UB-01 TCGA-S9-A6UB-01 0836116d-5b2e-4445-9019-a5c5ad7aac50 TCGA-S9-A6UB-01 TCGA-S9-A6UB-01A-21D-A33U-05 0836116d-5b2e-4445-9019-a5c5ad7aac50 0836116d-5b2e-4445-9019-a5c5ad7aac50 TCGA-S9-A6UB-01A-21D-A33S-01 TCGA-S9-A6UB-01A-21D-A33T-08 +TCGA-S9-A6WD-01 TCGA-S9-A6WD-01 TCGA-S9-A6WD TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 58 NO NO TCGA-S9-A6WD-F69986 TCGA-S9-A6WD TCGA-S9-A6WD-01A -21231 1922 0 2289 -2 0 NO Seizures > 181 Days Scheduled Follow-up Submission Stable Disease NO 2015-1-26 MALE NO NO Oligodendroglioma NO No C71.0 9451/3 C71.0 YES 160 NO 100 Left NO NO NO NO NO G3 NO false No TCGA-S9-A6WD.5F24A61F-39AA-426A-89D2-03205E9563D7.pdf A6WD Preoperative WITH TUMOR YES NO Partial Remission/Response NO Primary Tumor 01 YES NO Cerebral Cortex YES NO YES S9 Supratentorial, Parietal Lobe Central nervous system A NO LIVING 2008 TCGA-S9-A6WD-01 E7D8C7BD-EABB-47D3-A057-159774E6D312 TCGA-S9-A6WD-01A-12D-A33T-08 TCGA-S9-A6WD-01A-12D-A33S-01 450ee18e-9d9b-4873-a882-8b8f123d104c TCGA-S9-A6WD-01 TCGA-S9-A6WD-01 450ee18e-9d9b-4873-a882-8b8f123d104c TCGA-S9-A6WD-01 TCGA-S9-A6WD-01A-12D-A33U-05 450ee18e-9d9b-4873-a882-8b8f123d104c 450ee18e-9d9b-4873-a882-8b8f123d104c TCGA-S9-A6WD-01A-12D-A33S-01 TCGA-S9-A6WD-01A-12D-A33T-08 +TCGA-S9-A6WE-01 TCGA-S9-A6WE-01 TCGA-S9-A6WE TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 34 NO NO TCGA-S9-A6WE-F72356 TCGA-S9-A6WE TCGA-S9-A6WE-01A -12488 3434 0 4113 -4 0 NO Sensory Changes > 181 Days Scheduled Follow-up Submission NO 2015-6-2 MALE NO NO Oligodendroglioma NO No C71.0 9450/3 C71.0 YES 140 NO 100 Right NO NO NO NO NO G2 NO false No TCGA-S9-A6WE.F17B7D4A-F22C-472A-A84F-51CABBA8BE44.pdf A6WE Preoperative WITH TUMOR YES YES Partial Remission/Response NO Primary Tumor 01 NO YES Cerebral Cortex YES NO YES S9 Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2004 TCGA-S9-A6WE-01 C9B58729-A4A4-411C-9E57-05A6E8686E0E TCGA-S9-A6WE-01A-12D-A33T-08 TCGA-S9-A6WE-01A-12D-A33S-01 617f1516-010f-4eaf-95cf-f27de12eb2c4 TCGA-S9-A6WE-01 TCGA-S9-A6WE-01 617f1516-010f-4eaf-95cf-f27de12eb2c4 TCGA-S9-A6WE-01 TCGA-S9-A6WE-01A-12D-A33U-05 617f1516-010f-4eaf-95cf-f27de12eb2c4 617f1516-010f-4eaf-95cf-f27de12eb2c4 TCGA-S9-A6WE-01A-12D-A33S-01 TCGA-S9-A6WE-01A-12D-A33T-08 +TCGA-S9-A6WG-01 TCGA-S9-A6WG-01 TCGA-S9-A6WG TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 31 NO NO TCGA-S9-A6WG-F69988 TCGA-S9-A6WG TCGA-S9-A6WG-01A -11509 2098 0 2602 -12 0 NO Seizures 0 - 30 Days Scheduled Follow-up Submission Stable Disease NO 2015-1-26 MALE NO NO Astrocytoma NO No C71.0 9401/3 C71.0 YES 90 NO 100 Right NO NO NO NO NO G3 NO false No TCGA-S9-A6WG.82E91E98-4371-46DC-912C-6D4B3621601E.pdf A6WG Preoperative WITH TUMOR YES YES Progressive Disease YES Primary Tumor 01 YES NO Cerebral Cortex YES NO YES S9 Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2007 TCGA-S9-A6WG-01 73068E02-64C8-45F2-A6D4-C066479D3293 TCGA-S9-A6WG-01A-11D-A33T-08 TCGA-S9-A6WG-01A-11D-A33S-01 93b27804-df60-4755-928c-88a156ae008c TCGA-S9-A6WG-01 TCGA-S9-A6WG-01 93b27804-df60-4755-928c-88a156ae008c TCGA-S9-A6WG-01 TCGA-S9-A6WG-01A-11D-A33U-05 93b27804-df60-4755-928c-88a156ae008c 93b27804-df60-4755-928c-88a156ae008c TCGA-S9-A6WG-01A-11D-A33S-01 TCGA-S9-A6WG-01A-11D-A33T-08 +TCGA-S9-A6WH-01 TCGA-S9-A6WH-01 TCGA-S9-A6WH TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 73 NO NO TCGA-S9-A6WH-F69989 TCGA-S9-A6WH TCGA-S9-A6WH-01A -26904 697 0 1173 -14 1 NO Motor/Movement Changes Scheduled Follow-up Submission Stable Disease NO 2015-1-26 FEMALE NO NO Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES 180 NO 80 Right YES IHC YES NO YES NO YES G2 NO false No TCGA-S9-A6WH.ED9DEB9C-4DC6-4743-8402-2CF3B0D171B3.pdf A6WH Preoperative WITH TUMOR NO NO Partial Remission/Response YES Primary Tumor 01 NO YES Cerebral Cortex NO NO YES S9 Supratentorial, Temporal Lobe Central nervous system A NO LIVING 2011 TCGA-S9-A6WH-01 71FE4A9D-29B5-4396-AF34-56FE921C6B2A TCGA-S9-A6WH-01A-12D-A33T-08 TCGA-S9-A6WH-01A-12D-A33S-01 99fc1613-6b74-4177-a326-e8442a489571 TCGA-S9-A6WH-01 TCGA-S9-A6WH-01 99fc1613-6b74-4177-a326-e8442a489571 TCGA-S9-A6WH-01 TCGA-S9-A6WH-01A-12D-A33U-05 99fc1613-6b74-4177-a326-e8442a489571 99fc1613-6b74-4177-a326-e8442a489571 TCGA-S9-A6WH-01A-12D-A33S-01 TCGA-S9-A6WH-01A-12D-A33T-08 +TCGA-S9-A6WI-01 TCGA-S9-A6WI-01 TCGA-S9-A6WI TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain NO NO 56 NO NO TCGA-S9-A6WI-F63762 TCGA-S9-A6WI -20609 0 2585 -1 0 NO Headaches Scheduled Follow-up Submission Stable Disease NO 2014-8-18 FEMALE YES YES Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES 100 Right NO NO YES NO NO G2 NO No A6WI Preoperative WITH TUMOR NO NO Partial Remission/Response YES Primary Tumor 01 NO NO White Matter NO NO YES S9 Supratentorial, Frontal Lobe Central nervous system NO LIVING 2006 TCGA-S9-A6WI-01 TCGA-S9-A6WI-01A-21D-A33T-08 TCGA-S9-A6WI-01A-21D-A33S-01 fc484082-81a8-4feb-bd85-c0f067ad2f4f TCGA-S9-A6WI-01 TCGA-S9-A6WI-01 fc484082-81a8-4feb-bd85-c0f067ad2f4f TCGA-S9-A6WI-01 TCGA-S9-A6WI-01A-21D-A33U-05 fc484082-81a8-4feb-bd85-c0f067ad2f4f fc484082-81a8-4feb-bd85-c0f067ad2f4f TCGA-S9-A6WI-01A-21D-A33S-01 TCGA-S9-A6WI-01A-21D-A33T-08 +TCGA-S9-A6WL-01 TCGA-S9-A6WL-01 TCGA-S9-A6WL TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain NO YES 52 NO NO TCGA-S9-A6WL-F67227 TCGA-S9-A6WL -19234 0 946 -2 0 NO Seizures 0 - 30 Days Scheduled Follow-up Submission NO 2014-11-3 MALE NO NO Astrocytoma NO No C71.0 9401/3 C71.0 YES 100 Right YES IHC YES NO NO NO NO G3 NO No A6WL Preoperative WITH TUMOR YES NO Progressive Disease NO Primary Tumor 01 YES NO Cerebral Cortex NO NO YES S9 Supratentorial, Frontal Lobe Central nervous system NO LIVING 2012 TCGA-S9-A6WL-01 TCGA-S9-A6WL-01A-21D-A33T-08 TCGA-S9-A6WL-01A-21D-A33S-01 e6d20c89-a4d1-4c0f-b31d-8e1262e425d5 TCGA-S9-A6WL-01 TCGA-S9-A6WL-01 e6d20c89-a4d1-4c0f-b31d-8e1262e425d5 TCGA-S9-A6WL-01 TCGA-S9-A6WL-01A-21D-A33U-05 e6d20c89-a4d1-4c0f-b31d-8e1262e425d5 e6d20c89-a4d1-4c0f-b31d-8e1262e425d5 TCGA-S9-A6WL-01A-21D-A33S-01 TCGA-S9-A6WL-01A-21D-A33T-08 +TCGA-S9-A6WM-01 TCGA-S9-A6WM-01 TCGA-S9-A6WM TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain YES NO NO 59 NO NO TCGA-S9-A6WM-F63843 TCGA-S9-A6WM -21761 0 604 505 -9 1 NO Headaches 0 - 30 Days Additional New Tumor Event Progressive Disease NO 2014-8-20 FEMALE NO YES Astrocytoma NO No C71.0 9401/3 C71.0 YES 90 Left NO IHC YES NO NO NO NO G3 YES No A6WM Preoperative WITH TUMOR NO NO Partial Remission/Response YES Primary Tumor 01 NO NO Cerebral Cortex YES NO YES S9 Supratentorial, Temporal Lobe Central nervous system NO LIVING 2012 TCGA-S9-A6WM-01 TCGA-S9-A6WM-01A-12D-A33T-08 TCGA-S9-A6WM-01A-12D-A33S-01 fcbffc2c-702c-4c32-95ae-beac08a46f2b TCGA-S9-A6WM-01 TCGA-S9-A6WM-01 fcbffc2c-702c-4c32-95ae-beac08a46f2b TCGA-S9-A6WM-01 TCGA-S9-A6WM-01A-12D-A33U-05 fcbffc2c-702c-4c32-95ae-beac08a46f2b fcbffc2c-702c-4c32-95ae-beac08a46f2b TCGA-S9-A6WM-01A-12D-A33S-01 TCGA-S9-A6WM-01A-12D-A33T-08 +TCGA-S9-A6WN-01 TCGA-S9-A6WN-01 TCGA-S9-A6WN TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain YES NO 38 NO NO TCGA-S9-A6WN-F72374 TCGA-S9-A6WN TCGA-S9-A6WN-01A -13961 181 0 805 805 -14 1 NO Seizures 0 - 30 Days Additional New Tumor Event Progressive Disease NO 2015-6-9 FEMALE NO NO Astrocytoma NO No C71.0 9401/3 C71.0 YES 140 NO 90 Left NO IHC YES NO NO NO NO G3 YES false No TCGA-S9-A6WN.DF6F3A7F-700B-4AB7-8E0A-87F81AEB3C59.pdf A6WN Preoperative WITH TUMOR YES YES Progressive Disease YES Primary Tumor 01 YES YES Cerebral Cortex YES NO YES S9 Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2013 TCGA-S9-A6WN-01 2DB9E872-702F-40F0-9D2B-D816DA9E95C4 TCGA-S9-A6WN-01A-12D-A33T-08 TCGA-S9-A6WN-01A-12D-A33S-01 74cb268c-d8bc-44f2-8872-f176fa8221be TCGA-S9-A6WN-01 TCGA-S9-A6WN-01 74cb268c-d8bc-44f2-8872-f176fa8221be TCGA-S9-A6WN-01 TCGA-S9-A6WN-01A-12D-A33U-05 74cb268c-d8bc-44f2-8872-f176fa8221be 74cb268c-d8bc-44f2-8872-f176fa8221be TCGA-S9-A6WN-01A-12D-A33S-01 TCGA-S9-A6WN-01A-12D-A33T-08 +TCGA-S9-A6WO-01 TCGA-S9-A6WO-01 TCGA-S9-A6WO TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain NO NO 29 NO NO TCGA-S9-A6WO-F65749 TCGA-S9-A6WO -10933 0 566 -4 0 NO Seizures 31 - 90 Days Scheduled Follow-up Submission Stable Disease NO 2014-9-30 MALE NO NO Astrocytoma NO No C71.0 9400/3 C71.0 YES 100 Left YES IHC YES NO NO NO NO G2 NO No A6WO Preoperative WITH TUMOR YES NO Progressive Disease NO Primary Tumor 01 YES NO White Matter NO NO YES S9 Supratentorial, Frontal Lobe Central nervous system NO LIVING 2013 TCGA-S9-A6WO-01 TCGA-S9-A6WO-01A-21D-A34A-08 TCGA-S9-A6WO-01A-21D-A349-01 da513205-f0c5-4649-9db4-edf417fbf53f TCGA-S9-A6WO-01 TCGA-S9-A6WO-01 da513205-f0c5-4649-9db4-edf417fbf53f TCGA-S9-A6WO-01 TCGA-S9-A6WO-01A-21D-A34D-05 da513205-f0c5-4649-9db4-edf417fbf53f da513205-f0c5-4649-9db4-edf417fbf53f TCGA-S9-A6WO-01A-21D-A349-01 TCGA-S9-A6WO-01A-21D-A34A-08 +TCGA-S9-A6WP-01 TCGA-S9-A6WP-01 TCGA-S9-A6WP TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 42 NO NO TCGA-S9-A6WP-F69994 TCGA-S9-A6WP TCGA-S9-A6WP-01A -15658 111 0 567 -3 0 NO Seizures 0 - 30 Days Scheduled Follow-up Submission Stable Disease NO 2015-1-26 MALE NO NO Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES 180 NO 100 Right YES IHC YES NO NO NO NO G3 NO false No TCGA-S9-A6WP.55030C3A-6D25-4EB0-9B6C-FC0096472EE1.pdf A6WP Preoperative WITH TUMOR NO NO Partial Remission/Response NO Primary Tumor 01 YES NO Cerebral Cortex YES NO YES S9 Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2013 TCGA-S9-A6WP-01 0E2081D8-A910-46B7-B53A-C3EF36CF3D35 TCGA-S9-A6WP-01A-12D-A34A-08 TCGA-S9-A6WP-01A-12D-A349-01 6c13f651-a7da-46b9-b422-7fa8f314b901 TCGA-S9-A6WP-01 TCGA-S9-A6WP-01 6c13f651-a7da-46b9-b422-7fa8f314b901 TCGA-S9-A6WP-01 TCGA-S9-A6WP-01A-12D-A34D-05 6c13f651-a7da-46b9-b422-7fa8f314b901 6c13f651-a7da-46b9-b422-7fa8f314b901 TCGA-S9-A6WP-01A-12D-A349-01 TCGA-S9-A6WP-01A-12D-A34A-08 +TCGA-S9-A6WQ-01 TCGA-S9-A6WQ-01 TCGA-S9-A6WQ TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain NO NO 57 NO NO TCGA-S9-A6WQ-F62938 TCGA-S9-A6WQ TCGA-S9-A6WQ-01A -21133 104 0 428 -7 0 NO Seizures 91 - 180 Days Scheduled Follow-up Submission Stable Disease NO 2014-7-29 FEMALE NO NO Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES NO 150 NO 100 Left YES IHC YES NO YES YES NO G2 NO false No TCGA-S9-A6WQ.E2BDCD9B-B785-46F6-A55C-7F6AE6456BFA.pdf A6WQ Preoperative WITH TUMOR NO NO Partial Remission/Response NO Primary Tumor 01 YES YES Cerebral Cortex NO NO YES S9 Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2013 TCGA-S9-A6WQ-01 46BD7F99-FBC5-489A-8E48-35E0F6C94087 TCGA-S9-A6WQ-01A-12D-A34A-08 TCGA-S9-A6WQ-01A-12D-A349-01 be1d4fc0-02a0-4932-b836-bf68f89455c7 TCGA-S9-A6WQ-01 TCGA-S9-A6WQ-01 be1d4fc0-02a0-4932-b836-bf68f89455c7 TCGA-S9-A6WQ-01 TCGA-S9-A6WQ-01A-12D-A34D-05 be1d4fc0-02a0-4932-b836-bf68f89455c7 be1d4fc0-02a0-4932-b836-bf68f89455c7 TCGA-S9-A6WQ-01A-12D-A349-01 TCGA-S9-A6WQ-01A-12D-A34A-08 +TCGA-S9-A7IQ-01 TCGA-S9-A7IQ-01 TCGA-S9-A7IQ TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain NO NO 45 NO NO TCGA-S9-A7IQ-F65750 TCGA-S9-A7IQ TCGA-S9-A7IQ-01A -16512 735 0 1099 -14 0 NO Sensory Changes 0 - 30 Days Scheduled Follow-up Submission Stable Disease NO 2014-9-30 FEMALE NO NO Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES 150 NO 100 Left YES IHC YES NO NO NO NO G2 NO false No TCGA-S9-A7IQ.2E181A31-FB43-4A8C-87E2-F34AA6B14784.pdf A7IQ Preoperative WITH TUMOR NO NO Partial Remission/Response NO Primary Tumor 01 NO YES Cerebral Cortex NO NO YES S9 Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2011 TCGA-S9-A7IQ-01 02C2CE68-C9B8-449B-A7B5-6564DBE92388 TCGA-S9-A7IQ-01A-21D-A34A-08 TCGA-S9-A7IQ-01A-21D-A349-01 a107f9da-3537-4adf-a543-39cb692bdb80 TCGA-S9-A7IQ-01 TCGA-S9-A7IQ-01 a107f9da-3537-4adf-a543-39cb692bdb80 TCGA-S9-A7IQ-01 TCGA-S9-A7IQ-01A-21D-A34D-05 a107f9da-3537-4adf-a543-39cb692bdb80 a107f9da-3537-4adf-a543-39cb692bdb80 TCGA-S9-A7IQ-01A-21D-A349-01 TCGA-S9-A7IQ-01A-21D-A34A-08 +TCGA-S9-A7IS-01 TCGA-S9-A7IS-01 TCGA-S9-A7IS TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 33 NO NO TCGA-S9-A7IS-F51948 TCGA-S9-A7IS TCGA-S9-A7IS-01A -12402 3506 241 0 -2 2 NO Mental Status Changes Scheduled Follow-up Submission Progressive Disease NO 2013-11-26 FEMALE NO NO Astrocytoma NO No C71.0 9401/3 C71.0 YES 160 NO 60 Right NO NO YES NO NO G3 NO false No TCGA-S9-A7IS.B8C99516-595F-4A10-B400-BEA806E9A6FA.pdf A7IS Preoperative WITH TUMOR NO NO Progressive Disease YES Primary Tumor 01 NO NO Not listed in Medical Record NO NO YES S9 Supratentorial, Frontal Lobe Central nervous system A NO DECEASED 2004 TCGA-S9-A7IS-01 F1E8D9F8-D078-42F3-825D-4EC7E9215BA0 TCGA-S9-A7IS-01A-11D-A34A-08 TCGA-S9-A7IS-01A-11D-A349-01 2550796d-132e-4387-a730-b7fb2e1ee16e TCGA-S9-A7IS-01 TCGA-S9-A7IS-01 2550796d-132e-4387-a730-b7fb2e1ee16e TCGA-S9-A7IS-01 TCGA-S9-A7IS-01A-11D-A34D-05 2550796d-132e-4387-a730-b7fb2e1ee16e 2550796d-132e-4387-a730-b7fb2e1ee16e TCGA-S9-A7IS-01A-11D-A349-01 TCGA-S9-A7IS-01A-11D-A34A-08 +TCGA-S9-A7IX-01 TCGA-S9-A7IX-01 TCGA-S9-A7IX TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 57 NO NO TCGA-S9-A7IX-F72344 TCGA-S9-A7IX TCGA-S9-A7IX-01A -21095 540 819 0 597 -2 0 NO Motor/Movement Changes 31 - 90 Days Scheduled Follow-up Submission NO 2015-5-27 MALE YES NO Astrocytoma NO No C71.0 9401/3 C71.0 YES 80 NO 100 Right NO NO NO NO YES G3 YES false No TCGA-S9-A7IX.BCA5F1A6-7BAB-416F-81A1-C88B83511A2D.pdf A7IX Preoperative WITH TUMOR YES NO Progressive Disease YES Primary Tumor 01 NO NO White Matter NO NO YES S9 Supratentorial, Temporal Lobe Central nervous system A NO DECEASED 2012 TCGA-S9-A7IX-01 TCGA-S9-A7IX-01A-12D-A34A-08 TCGA-S9-A7IX-01A-12D-A349-01 89b94310-c189-405f-8d43-5c52922f2eea TCGA-S9-A7IX-01 TCGA-S9-A7IX-01 89b94310-c189-405f-8d43-5c52922f2eea TCGA-S9-A7IX-01 TCGA-S9-A7IX-01A-12D-A34D-05 89b94310-c189-405f-8d43-5c52922f2eea 89b94310-c189-405f-8d43-5c52922f2eea TCGA-S9-A7IX-01A-12D-A349-01 TCGA-S9-A7IX-01A-12D-A34A-08 +TCGA-S9-A7IY-01 TCGA-S9-A7IY-01 TCGA-S9-A7IY TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain NO NO 39 NO NO TCGA-S9-A7IY-F65751 TCGA-S9-A7IY TCGA-S9-A7IY-01A -14422 398 0 715 -6 2 NO Motor/Movement Changes 0 - 30 Days Scheduled Follow-up Submission Partial Remission/Response NO 2014-9-30 MALE NO NO Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES 100 NO 80 Right YES IHC YES NO YES NO YES G3 NO false No TCGA-S9-A7IY.9223C347-C93C-4B31-BEEE-40B481139D7B.pdf A7IY Preoperative WITH TUMOR NO YES Partial Remission/Response YES Primary Tumor 01 NO NO White Matter YES NO YES S9 Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2012 TCGA-S9-A7IY-01 7579C938-48E4-47FF-8DD0-16911F3AB253 TCGA-S9-A7IY-01A-11D-A34A-08 TCGA-S9-A7IY-01A-11D-A349-01 10f6eea5-bfb0-4203-92c8-5572a81d0b8e TCGA-S9-A7IY-01 TCGA-S9-A7IY-01 10f6eea5-bfb0-4203-92c8-5572a81d0b8e TCGA-S9-A7IY-01 TCGA-S9-A7IY-01A-11D-A34D-05 10f6eea5-bfb0-4203-92c8-5572a81d0b8e 10f6eea5-bfb0-4203-92c8-5572a81d0b8e TCGA-S9-A7IY-01A-11D-A349-01 TCGA-S9-A7IY-01A-11D-A34A-08 +TCGA-S9-A7IZ-01 TCGA-S9-A7IZ-01 TCGA-S9-A7IZ TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain YES NO 48 NO NO TCGA-S9-A7IZ-F69998 TCGA-S9-A7IZ TCGA-S9-A7IZ-01A -17874 140 0 608 467 -5 1 NO Seizures 0 - 30 Days Additional New Tumor Event Stable Disease NO 2015-1-26 FEMALE NO NO Astrocytoma NO No C71.0 9401/3 C71.0 YES 130 NO 90 Left YES IHC YES NO NO NO NO G3 YES false No TCGA-S9-A7IZ.82CF208A-A8F2-4BE1-85DF-C6145FCC6B19.pdf A7IZ Preoperative WITH TUMOR YES NO Partial Remission/Response YES Primary Tumor 01 YES NO Cerebral Cortex NO NO YES S9 Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2013 TCGA-S9-A7IZ-01 A7DEE561-4DB9-4CAF-8328-780D6713B987 TCGA-S9-A7IZ-01A-11D-A34A-08 TCGA-S9-A7IZ-01A-11D-A349-01 dfe8bcb5-829d-4f70-8731-e3289383bc95 TCGA-S9-A7IZ-01 TCGA-S9-A7IZ-01 dfe8bcb5-829d-4f70-8731-e3289383bc95 TCGA-S9-A7IZ-01 TCGA-S9-A7IZ-01A-11D-A34D-05 dfe8bcb5-829d-4f70-8731-e3289383bc95 dfe8bcb5-829d-4f70-8731-e3289383bc95 TCGA-S9-A7IZ-01A-11D-A349-01 TCGA-S9-A7IZ-01A-11D-A34A-08 +TCGA-S9-A7J0-01 TCGA-S9-A7J0-01 TCGA-S9-A7J0 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain YES NO 30 NO NO TCGA-S9-A7J0-F65752 TCGA-S9-A7J0 TCGA-S9-A7J0-01A -10989 229 0 609 390 -7 0 NO Seizures 0 - 30 Days Additional New Tumor Event Progressive Disease YES Citrus fruits 2014-9-30 FEMALE NO NO Oligodendroglioma NO No C71.0 9451/3 C71.0 YES 140 NO 100 Right NO IHC YES NO NO NO NO G3 YES false No TCGA-S9-A7J0.B1D1504E-B9FB-4974-A8B6-24B6A86C780B.pdf A7J0 Preoperative WITH TUMOR YES NO Partial Remission/Response YES Primary Tumor 01 YES NO Cerebral Cortex YES NO YES S9 Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2013 TCGA-S9-A7J0-01 21AFA7D2-B77F-4919-8127-A2997B9A8E4E TCGA-S9-A7J0-01A-11D-A34A-08 TCGA-S9-A7J0-01A-11D-A349-01 a29047f8-3b74-4bf4-87ec-2f8b5435eba7 TCGA-S9-A7J0-01 TCGA-S9-A7J0-01 a29047f8-3b74-4bf4-87ec-2f8b5435eba7 TCGA-S9-A7J0-01 TCGA-S9-A7J0-01A-11D-A34D-05 a29047f8-3b74-4bf4-87ec-2f8b5435eba7 a29047f8-3b74-4bf4-87ec-2f8b5435eba7 TCGA-S9-A7J0-01A-11D-A349-01 TCGA-S9-A7J0-01A-11D-A34A-08 +TCGA-S9-A7J1-01 TCGA-S9-A7J1-01 TCGA-S9-A7J1 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 43 NO NO TCGA-S9-A7J1-F71265 TCGA-S9-A7J1 TCGA-S9-A7J1-01A -15926 184 0 249 -17 3 NO Seizures 31 - 90 Days Scheduled Follow-up Submission NO 2015-3-24 MALE NO NO Oligodendroglioma NO No C71.0 9450/3 C71.0 YES 250 NO 60 Right YES IHC YES YES NO NO NO G2 NO false No TCGA-S9-A7J1.60CE3E08-7253-47C7-B7FF-567CF0974988.pdf A7J1 Preoperative WITH TUMOR YES NO Partial Remission/Response NO Primary Tumor 01 YES NO Cerebral Cortex NO NO YES S9 Supratentorial, Temporal Lobe Central nervous system A NO LIVING 2013 TCGA-S9-A7J1-01 C8358389-E77E-48C5-8270-7CE90FD60FD0 TCGA-S9-A7J1-01A-21D-A34J-08 TCGA-S9-A7J1-01A-21D-A34I-01 ba3ea21e-4806-4eaa-99df-d7544248cb37 TCGA-S9-A7J1-01 TCGA-S9-A7J1-01 ba3ea21e-4806-4eaa-99df-d7544248cb37 TCGA-S9-A7J1-01 TCGA-S9-A7J1-01A-21D-A34K-05 ba3ea21e-4806-4eaa-99df-d7544248cb37 ba3ea21e-4806-4eaa-99df-d7544248cb37 TCGA-S9-A7J1-01A-21D-A34I-01 TCGA-S9-A7J1-01A-21D-A34J-08 +TCGA-S9-A7J2-01 TCGA-S9-A7J2-01 TCGA-S9-A7J2 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 25 NO NO TCGA-S9-A7J2-F71266 TCGA-S9-A7J2 TCGA-S9-A7J2-01A -9345 194 0 62 -4 1 NO Mental Status Changes > 181 Days Scheduled Follow-up Submission NO 2015-3-24 MALE NO NO Oligodendroglioma NO No C71.0 9451/3 C71.0 YES 200 NO 80 Left YES IHC YES YES YES NO NO G3 NO false No TCGA-S9-A7J2.F7F8D6E7-0C27-4FAC-96E0-66EED6274122.pdf A7J2 Preoperative WITH TUMOR YES NO Partial Remission/Response NO Primary Tumor 01 YES NO Cerebral Cortex YES NO YES S9 Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2013 TCGA-S9-A7J2-01 DD89E745-2E82-4B19-AE51-B257337E96E5 TCGA-S9-A7J2-01A-11D-A34A-08 TCGA-S9-A7J2-01A-11D-A349-01 8b99cc75-d8cc-4d18-9a6b-c66f8bd7ea0d TCGA-S9-A7J2-01 TCGA-S9-A7J2-01 8b99cc75-d8cc-4d18-9a6b-c66f8bd7ea0d TCGA-S9-A7J2-01 TCGA-S9-A7J2-01A-11D-A34D-05 8b99cc75-d8cc-4d18-9a6b-c66f8bd7ea0d 8b99cc75-d8cc-4d18-9a6b-c66f8bd7ea0d TCGA-S9-A7J2-01A-11D-A349-01 TCGA-S9-A7J2-01A-11D-A34A-08 +TCGA-S9-A7J3-01 TCGA-S9-A7J3-01 TCGA-S9-A7J3 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 52 NO NO TCGA-S9-A7J3-F70008 TCGA-S9-A7J3 TCGA-S9-A7J3-01A -19056 182 0 629 -14 0 NO Seizures 31 - 90 Days Scheduled Follow-up Submission Stable Disease NO 2015-1-26 FEMALE NO NO Oligodendroglioma NO No C71.0 9451/3 C71.0 YES 120 NO 100 Left YES IHC YES NO NO NO NO G3 NO false No TCGA-S9-A7J3.EC6B158C-2D75-43CF-8D80-7FF9DEBCB199.pdf A7J3 Preoperative WITH TUMOR YES YES Partial Remission/Response YES Primary Tumor 01 YES NO White Matter YES NO YES S9 Supratentorial, Parietal Lobe Central nervous system A NO LIVING 2013 TCGA-S9-A7J3-01 TCGA-S9-A7J3-01A-21D-A34J-08 TCGA-S9-A7J3-01A-21D-A34I-01 4799ffc2-7be5-48f3-9ab1-624eeb3ec6ee TCGA-S9-A7J3-01 TCGA-S9-A7J3-01 4799ffc2-7be5-48f3-9ab1-624eeb3ec6ee TCGA-S9-A7J3-01 TCGA-S9-A7J3-01A-21D-A34K-05 4799ffc2-7be5-48f3-9ab1-624eeb3ec6ee 4799ffc2-7be5-48f3-9ab1-624eeb3ec6ee TCGA-S9-A7J3-01A-21D-A34I-01 TCGA-S9-A7J3-01A-21D-A34J-08 +TCGA-S9-A7QW-01 TCGA-S9-A7QW-01 TCGA-S9-A7QW TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain YES NO 54 NO NO TCGA-S9-A7QW-F66223 TCGA-S9-A7QW -19869 0 458 382 -4 0 NO Additional New Tumor Event Stable Disease NO 2014-10-6 FEMALE NO NO Astrocytoma NO No C71.0 9401/3 C71.0 YES 100 Left YES IHC YES NO NO NO NO G3 YES No A7QW Preoperative WITH TUMOR NO NO Complete Remission/Response YES Primary Tumor 01 NO NO Cerebral Cortex NO YES NO S9 Supratentorial, Frontal Lobe Central nervous system NO LIVING 2013 TCGA-S9-A7QW-01 TCGA-S9-A7QW-01A-11D-A34A-08 TCGA-S9-A7QW-01A-11D-A349-01 f2dba2e9-157b-494b-9650-e17d0ccc421b TCGA-S9-A7QW-01 TCGA-S9-A7QW-01 f2dba2e9-157b-494b-9650-e17d0ccc421b TCGA-S9-A7QW-01 TCGA-S9-A7QW-01A-11D-A34D-05 f2dba2e9-157b-494b-9650-e17d0ccc421b f2dba2e9-157b-494b-9650-e17d0ccc421b TCGA-S9-A7QW-01A-11D-A349-01 TCGA-S9-A7QW-01A-11D-A34A-08 +TCGA-S9-A7QX-01 TCGA-S9-A7QX-01 TCGA-S9-A7QX TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 36 NO NO TCGA-S9-A7QX-F70010 TCGA-S9-A7QX TCGA-S9-A7QX-01A -13332 81 0 564 -3 0 NO NO NO Sensory Changes > 181 Days Scheduled Follow-up Submission Stable Disease NO 2015-1-26 FEMALE NO NO Astrocytoma NO No C71.0 9401/3 C71.0 YES 150 NO 100 Right YES IHC YES NO NO NO NO G3 NO false No TCGA-S9-A7QX.C0F30532-18DA-4E77-A2CC-EFE67B476FA9.pdf A7QX Preoperative WITH TUMOR YES NO Partial Remission/Response YES Primary Tumor 01 YES YES Cerebral Cortex YES YES NO S9 Supratentorial, Temporal Lobe Central nervous system A NO LIVING 2013 TCGA-S9-A7QX-01 541CBE70-57FF-40C8-B30E-57169100D10F TCGA-S9-A7QX-01A-11D-A34A-08 TCGA-S9-A7QX-01A-11D-A349-01 61e3d965-e391-4699-b862-37000eadef7f TCGA-S9-A7QX-01 TCGA-S9-A7QX-01 61e3d965-e391-4699-b862-37000eadef7f TCGA-S9-A7QX-01 TCGA-S9-A7QX-01A-11D-A34D-05 61e3d965-e391-4699-b862-37000eadef7f 61e3d965-e391-4699-b862-37000eadef7f TCGA-S9-A7QX-01A-11D-A349-01 TCGA-S9-A7QX-01A-11D-A34A-08 +TCGA-S9-A7QY-01 TCGA-S9-A7QY-01 TCGA-S9-A7QY TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain NO NO 35 NO NO TCGA-S9-A7QY-F62949 TCGA-S9-A7QY TCGA-S9-A7QY-01A -12853 560 0 863 -2 0 NO Seizures > 181 Days Scheduled Follow-up Submission Stable Disease NO 2014-7-29 FEMALE NO NO Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES 60 NO 100 Left NO IHC YES NO NO NO NO G2 NO false No TCGA-S9-A7QY.7833FCD6-2858-4428-9E9C-A8AEA10F42F8.pdf A7QY Preoperative WITH TUMOR YES YES Partial Remission/Response NO Primary Tumor 01 YES NO Cerebral Cortex YES NO YES S9 Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2012 TCGA-S9-A7QY-01 TCGA-S9-A7QY-01A-11D-A34A-08 TCGA-S9-A7QY-01A-11D-A349-01 4df02ab4-fe42-4f21-9678-858ecd99763c TCGA-S9-A7QY-01 TCGA-S9-A7QY-01 4df02ab4-fe42-4f21-9678-858ecd99763c TCGA-S9-A7QY-01 TCGA-S9-A7QY-01A-11D-A34D-05 4df02ab4-fe42-4f21-9678-858ecd99763c 4df02ab4-fe42-4f21-9678-858ecd99763c TCGA-S9-A7QY-01A-11D-A349-01 TCGA-S9-A7QY-01A-11D-A34A-08 +TCGA-S9-A7QZ-01 TCGA-S9-A7QZ-01 TCGA-S9-A7QZ TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain NO NO YES 41 NO NO TCGA-S9-A7QZ-F70012 TCGA-S9-A7QZ TCGA-S9-A7QZ-01A 826 -15300 368 0 826 774 -3 0 NO Seizures > 181 Days Additional New Tumor Event Partial Remission/Response NO 2015-1-26 MALE YES NO Oligodendroglioma NO No C71.0 9450/3 C71.0 YES 120 NO 100 Left YES IHC YES NO NO NO NO G2 YES false No TCGA-S9-A7QZ.2DBE4A35-E160-47C2-B000-B44DC125BAEB.pdf A7QZ Preoperative WITH TUMOR YES NO Partial Remission/Response NO Primary Tumor 01 YES NO Cerebral Cortex NO NO YES S9 Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2012 TCGA-S9-A7QZ-01 89C7BF15-0F9E-4540-B1EB-3CD4ECA8691D TCGA-S9-A7QZ-01A-12D-A34J-08 TCGA-S9-A7QZ-01A-12D-A34I-01 738ae7fd-6fa8-4aa4-b01f-34a519dc279f TCGA-S9-A7QZ-01 TCGA-S9-A7QZ-01 738ae7fd-6fa8-4aa4-b01f-34a519dc279f TCGA-S9-A7QZ-01 TCGA-S9-A7QZ-01A-12D-A34K-05 738ae7fd-6fa8-4aa4-b01f-34a519dc279f 738ae7fd-6fa8-4aa4-b01f-34a519dc279f TCGA-S9-A7QZ-01A-12D-A34I-01 TCGA-S9-A7QZ-01A-12D-A34J-08 +TCGA-S9-A7R1-01 TCGA-S9-A7R1-01 TCGA-S9-A7R1 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain NO NO 35 NO NO TCGA-S9-A7R1-F67312 TCGA-S9-A7R1 TCGA-S9-A7R1-01A -12828 5213 5166 0 5000 -122 1 NO Seizures > 181 Days Scheduled Follow-up Submission NO 2014-11-4 MALE NO NO Oligodendroglioma NO No C71.0 9450/3 C71.0 YES 200 NO 90 Midline NO NO NO NO NO G2 NO false No TCGA-S9-A7R1.7E6FECAF-5861-4BE0-B867-17AEC6FF9E0B.pdf A7R1 Preoperative WITH TUMOR NO NO Partial Remission/Response YES Primary Tumor 01 YES NO Not listed in Medical Record NO NO YES S9 Supratentorial, Frontal Lobe Central nervous system A YES DECEASED 1999 TCGA-S9-A7R1-01 4B588035-D102-4387-B284-FD238D367492 TCGA-S9-A7R1-01A-12D-A34J-08 TCGA-S9-A7R1-01A-12D-A34I-01 e07c8a75-c54b-4b5e-bec3-f1df709c16d8 TCGA-S9-A7R1-01 TCGA-S9-A7R1-01 e07c8a75-c54b-4b5e-bec3-f1df709c16d8 TCGA-S9-A7R1-01 TCGA-S9-A7R1-01A-12D-A34K-05 e07c8a75-c54b-4b5e-bec3-f1df709c16d8 e07c8a75-c54b-4b5e-bec3-f1df709c16d8 TCGA-S9-A7R1-01A-12D-A34I-01 TCGA-S9-A7R1-01A-12D-A34J-08 +TCGA-S9-A7R2-01 TCGA-S9-A7R2-01 TCGA-S9-A7R2 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 69 NO NO TCGA-S9-A7R2 TCGA-S9-A7R2-01A -25419 2027 316 0 -2 1 NO Seizures > 181 Days NO 2013-12-12 MALE NO NO Astrocytoma NO No C71.0 9401/3 C71.0 YES 120 NO 90 Left NO NO NO NO G3 NO false No TCGA-S9-A7R2.2907EB1D-32CC-4BB7-B485-AFF04CA01E7F.pdf A7R2 Preoperative WITH TUMOR YES NO Progressive Disease YES Primary Tumor 01 YES NO White Matter NO NO YES S9 Supratentorial, Temporal Lobe Central nervous system A NO DECEASED 2008 TCGA-S9-A7R2-01 TCGA-S9-A7R2-01A-21D-A34J-08 TCGA-S9-A7R2-01A-21D-A34I-01 315a7141-0f36-4cac-94a7-748849ee8926 TCGA-S9-A7R2-01 TCGA-S9-A7R2-01 315a7141-0f36-4cac-94a7-748849ee8926 TCGA-S9-A7R2-01 TCGA-S9-A7R2-01A-21D-A34K-05 315a7141-0f36-4cac-94a7-748849ee8926 315a7141-0f36-4cac-94a7-748849ee8926 TCGA-S9-A7R2-01A-21D-A34I-01 TCGA-S9-A7R2-01A-21D-A34J-08 +TCGA-S9-A7R3-01 TCGA-S9-A7R3-01 TCGA-S9-A7R3 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain NO NO 28 NO NO TCGA-S9-A7R3-F62951 TCGA-S9-A7R3 TCGA-S9-A7R3-01A -10342 2706 0 3013 -2 0 NO Headaches > 181 Days Scheduled Follow-up Submission Stable Disease NO 2014-7-29 FEMALE NO YES Astrocytoma NO No C71.0 9400/3 C71.0 YES 80 NO 100 Left NO NO NO NO NO G2 NO false No TCGA-S9-A7R3.769B080E-C2D2-492E-9B82-89BB55627F2B.pdf A7R3 Preoperative TUMOR FREE NO NO Partial Remission/Response NO Primary Tumor 01 NO NO Cerebral Cortex NO NO YES S9 Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2006 TCGA-S9-A7R3-01 TCGA-S9-A7R3-01A-11D-A34J-08 TCGA-S9-A7R3-01A-11D-A34I-01 2a73d13f-1bbb-4591-9524-181d9539d3ae TCGA-S9-A7R3-01 TCGA-S9-A7R3-01 2a73d13f-1bbb-4591-9524-181d9539d3ae TCGA-S9-A7R3-01 TCGA-S9-A7R3-01A-11D-A34K-05 2a73d13f-1bbb-4591-9524-181d9539d3ae 2a73d13f-1bbb-4591-9524-181d9539d3ae TCGA-S9-A7R3-01A-11D-A34I-01 TCGA-S9-A7R3-01A-11D-A34J-08 +TCGA-S9-A7R4-01 TCGA-S9-A7R4-01 TCGA-S9-A7R4 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 46 NO NO TCGA-S9-A7R4-F67313 TCGA-S9-A7R4 TCGA-S9-A7R4-01A -17134 565 0 914 -8 1 NO Seizures 0 - 30 Days Scheduled Follow-up Submission NO 2014-11-4 MALE NO NO Astrocytoma NO No C71.0 9401/3 C71.0 YES 120 NO 90 Left YES IHC YES NO NO NO NO G3 NO false No TCGA-S9-A7R4.6AE37879-1BB7-4C4A-B318-D9F2D75B552C.pdf A7R4 Preoperative WITH TUMOR YES NO Partial Remission/Response YES Primary Tumor 01 YES NO Cerebral Cortex YES NO YES S9 Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2012 TCGA-S9-A7R4-01 DE17C889-8CE5-4808-A383-FBB109DA817C TCGA-S9-A7R4-01A-12D-A34J-08 TCGA-S9-A7R4-01A-12D-A34I-01 eeaff3a7-d9d4-41b9-8c58-52e16f6a71a0 TCGA-S9-A7R4-01 TCGA-S9-A7R4-01 eeaff3a7-d9d4-41b9-8c58-52e16f6a71a0 TCGA-S9-A7R4-01 TCGA-S9-A7R4-01A-12D-A34K-05 eeaff3a7-d9d4-41b9-8c58-52e16f6a71a0 eeaff3a7-d9d4-41b9-8c58-52e16f6a71a0 TCGA-S9-A7R4-01A-12D-A34I-01 TCGA-S9-A7R4-01A-12D-A34J-08 +TCGA-S9-A7R7-01 TCGA-S9-A7R7-01 TCGA-S9-A7R7 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain YES YES YES 27 NO NO TCGA-S9-A7R7-F66258 TCGA-S9-A7R7 TCGA-S9-A7R7-01A 2976 -10108 2647 0 3000 2894 -8 1 NO Seizures 0 - 30 Days Additional New Tumor Event Progressive Disease NO 2014-10-7 MALE NO NO Astrocytoma NO No C71.0 9400/3 C71.0 YES 70 NO 80 Left YES IHC YES NO NO NO NO G2 YES false No TCGA-S9-A7R7.0C30BB62-F9E0-4702-B488-79621EA74BFA.pdf A7R7 Preoperative WITH TUMOR YES YES Progressive Disease YES Primary Tumor 01 YES NO Cerebral Cortex NO NO YES S9 Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2006 TCGA-S9-A7R7-01 TCGA-S9-A7R7-01A-11D-A34J-08 TCGA-S9-A7R7-01A-11D-A34I-01 2f398759-636a-4d58-9fbc-deb15e5beff6 TCGA-S9-A7R7-01 TCGA-S9-A7R7-01 2f398759-636a-4d58-9fbc-deb15e5beff6 TCGA-S9-A7R7-01 TCGA-S9-A7R7-01A-11D-A34K-05 2f398759-636a-4d58-9fbc-deb15e5beff6 2f398759-636a-4d58-9fbc-deb15e5beff6 TCGA-S9-A7R7-01A-11D-A34I-01 TCGA-S9-A7R7-01A-11D-A34J-08 +TCGA-S9-A7R8-01 TCGA-S9-A7R8-01 TCGA-S9-A7R8 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 44 NO NO TCGA-S9-A7R8 TCGA-S9-A7R8-01A -16275 3282 961 0 -1 1 NO Seizures 31 - 90 Days NO 2013-12-11 FEMALE NO NO Astrocytoma NO No C71.0 9401/3 C71.0 YES 110 NO 90 Right NO NO NO NO G3 YES false No TCGA-S9-A7R8.7287E887-2783-4416-8C61-718C6247C982.pdf A7R8 Preoperative WITH TUMOR YES YES Progressive Disease YES Primary Tumor 01 YES NO Not listed in Medical Record NO NO YES S9 Supratentorial, Frontal Lobe Central nervous system A NO DECEASED 2004 TCGA-S9-A7R8-01 26A69339-EFE7-4F78-871C-8338A3F92B5E TCGA-S9-A7R8-01A-11D-A34J-08 TCGA-S9-A7R8-01A-11D-A34I-01 28107f81-2e82-4bc9-99e4-f1b24444c811 TCGA-S9-A7R8-01 TCGA-S9-A7R8-01 28107f81-2e82-4bc9-99e4-f1b24444c811 TCGA-S9-A7R8-01 TCGA-S9-A7R8-01A-11D-A34K-05 28107f81-2e82-4bc9-99e4-f1b24444c811 28107f81-2e82-4bc9-99e4-f1b24444c811 TCGA-S9-A7R8-01A-11D-A34I-01 TCGA-S9-A7R8-01A-11D-A34J-08 +TCGA-S9-A89V-01 TCGA-S9-A89V-01 TCGA-S9-A89V TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 70 NO NO TCGA-S9-A89V-F67315 TCGA-S9-A89V -25570 0 569 221 -32 1 NO Motor/Movement Changes > 181 Days Additional New Tumor Event NO 2014-11-4 MALE NO NO Astrocytoma NO No C71.0 9401/3 C71.0 YES 80 Right NO IHC YES NO NO NO YES G3 YES No A89V Preoperative WITH TUMOR NO NO Progressive Disease YES Primary Tumor 01 NO YES Cerebral Cortex YES NO YES S9 Posterior Fossa, Cerebellum Central nervous system NO LIVING 2012 TCGA-S9-A89V-01 TCGA-S9-A89V-01A-11D-A36O-08 TCGA-S9-A89V-01A-11D-A36N-01 b5f07863-11fa-46c7-a915-7f643ac57711 TCGA-S9-A89V-01 TCGA-S9-A89V-01 b5f07863-11fa-46c7-a915-7f643ac57711 TCGA-S9-A89V-01 TCGA-S9-A89V-01A-11D-A368-05 b5f07863-11fa-46c7-a915-7f643ac57711 b5f07863-11fa-46c7-a915-7f643ac57711 TCGA-S9-A89V-01A-11D-A36N-01 TCGA-S9-A89V-01A-11D-A36O-08 +TCGA-S9-A89Z-01 TCGA-S9-A89Z-01 TCGA-S9-A89Z TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 40 NO NO TCGA-S9-A89Z-F72341 TCGA-S9-A89Z TCGA-S9-A89Z-01A -14858 63 0 623 -10 1 NO YES NO Seizures 31 - 90 Days Scheduled Follow-up Submission Stable Disease NO 2015-5-27 MALE NO NO Astrocytoma NO No C71.0 9401/3 C71.0 YES NO 70 NO 70 Right YES IHC YES NO NO NO NO G3 NO false No TCGA-S9-A89Z.DAAF016F-5C66-4E31-B57A-1F0857B181AD.pdf A89Z Preoperative WITH TUMOR YES YES Partial Remission/Response YES Primary Tumor 01 YES NO White Matter YES YES NO S9 Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2013 TCGA-S9-A89Z-01 TCGA-S9-A89Z-01A-11D-A36O-08 TCGA-S9-A89Z-01A-11D-A36N-01 58ecffdf-6f33-4a8e-b983-f6f4261cde2b TCGA-S9-A89Z-01 TCGA-S9-A89Z-01 58ecffdf-6f33-4a8e-b983-f6f4261cde2b TCGA-S9-A89Z-01 TCGA-S9-A89Z-01A-11D-A368-05 58ecffdf-6f33-4a8e-b983-f6f4261cde2b 58ecffdf-6f33-4a8e-b983-f6f4261cde2b TCGA-S9-A89Z-01A-11D-A36N-01 TCGA-S9-A89Z-01A-11D-A36O-08 +TCGA-TM-A7C3-01 TCGA-TM-A7C3-01 TCGA-TM-A7C3 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 43 NO YES TCGA-TM-A7C3-F63557 TCGA-TM-A7C3 TCGA-TM-A7C3-01A -16021 1409 1666 0 1504 0 0 YES YES NO < 12 Years Seizures 0 - 30 Days Scheduled Follow-up Submission Progressive Disease NO 2014-8-12 FEMALE YES NO Astrocytoma NO No C71.0 9401/3 C71.0 YES NO 80 NO 90 Left NO NO NO NO NO G3 NO false No TCGA-TM-A7C3.8716B17F-6119-4999-8F12-F9C123FEA60F.pdf A7C3 Preoperative WITH TUMOR Complete Remission/Response NO Primary Tumor 01 YES NO Not listed in Medical Record NO NO YES TM Supratentorial, Temporal Lobe Central nervous system A NO DECEASED 2009 TCGA-TM-A7C3-01 TCGA-TM-A7C3-01A-11D-A32B-08 TCGA-TM-A7C3-01A-11D-A32A-01 5f56116d-79cb-4213-ae59-1b2922d79d17 TCGA-TM-A7C3-01 TCGA-TM-A7C3-01 5f56116d-79cb-4213-ae59-1b2922d79d17 TCGA-TM-A7C3-01 TCGA-TM-A7C3-01A-11D-A32C-05 5f56116d-79cb-4213-ae59-1b2922d79d17 5f56116d-79cb-4213-ae59-1b2922d79d17 TCGA-TM-A7C3-01A-11D-A32A-01 TCGA-TM-A7C3-01A-11D-A32B-08 +TCGA-TM-A7C4-01 TCGA-TM-A7C4-01 TCGA-TM-A7C4 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 39 NO NO TCGA-TM-A7C4-F63553 TCGA-TM-A7C4 TCGA-TM-A7C4-01A -14603 1215 0 1470 0 0 YES NO NO > 20 Years Seizures 0 - 30 Days Scheduled Follow-up Submission Complete Remission/Response NO 2014-8-12 FEMALE NO NO Astrocytoma NO No C71.0 9400/3 C71.0 YES NO 80 NO 90 Right NO NO NO NO G2 NO false No TCGA-TM-A7C4.4097D689-A950-486D-9CDA-30C81E56722D.pdf A7C4 Preoperative TUMOR FREE Complete Remission/Response NO Primary Tumor 01 YES NO Not listed in Medical Record NO NO YES TM Supratentorial, Temporal Lobe Central nervous system A NO LIVING 2010 TCGA-TM-A7C4-01 TCGA-TM-A7C4-01A-11D-A32B-08 TCGA-TM-A7C4-01A-11D-A32A-01 21ff9c47-d971-4c0f-b9ff-103a817f5eb4 TCGA-TM-A7C4-01 TCGA-TM-A7C4-01 21ff9c47-d971-4c0f-b9ff-103a817f5eb4 TCGA-TM-A7C4-01 TCGA-TM-A7C4-01A-11D-A32C-05 21ff9c47-d971-4c0f-b9ff-103a817f5eb4 21ff9c47-d971-4c0f-b9ff-103a817f5eb4 TCGA-TM-A7C4-01A-11D-A32A-01 TCGA-TM-A7C4-01A-11D-A32B-08 +TCGA-TM-A7C5-01 TCGA-TM-A7C5-01 TCGA-TM-A7C5 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 30 NO YES TCGA-TM-A7C5-F63554 TCGA-TM-A7C5 TCGA-TM-A7C5-01A -11286 1194 0 1500 0 0 NO NO NO < 12 Years Seizures 0 - 30 Days Scheduled Follow-up Submission Complete Remission/Response NO 2014-8-12 MALE NO NO Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES NO 140 NO 100 Left NO NO NO NO NO G2 NO false No TCGA-TM-A7C5.CEA3E51F-5E16-4778-9684-C670C8E4DC8E.pdf A7C5 Preoperative TUMOR FREE Complete Remission/Response NO Primary Tumor 01 YES NO Not listed in Medical Record NO NO YES TM Supratentorial, Parietal Lobe Central nervous system A NO LIVING 2010 TCGA-TM-A7C5-01 D4905482-B354-4E64-8963-4CC4ED9B096F TCGA-TM-A7C5-01A-11D-A32B-08 TCGA-TM-A7C5-01A-11D-A32A-01 4e7bf9e5-e1a5-4a5b-8e32-0768fdf4a3cf TCGA-TM-A7C5-01 TCGA-TM-A7C5-01 4e7bf9e5-e1a5-4a5b-8e32-0768fdf4a3cf TCGA-TM-A7C5-01 TCGA-TM-A7C5-01A-11D-A32C-05 4e7bf9e5-e1a5-4a5b-8e32-0768fdf4a3cf 4e7bf9e5-e1a5-4a5b-8e32-0768fdf4a3cf TCGA-TM-A7C5-01A-11D-A32A-01 TCGA-TM-A7C5-01A-11D-A32B-08 +TCGA-TM-A7CA-01 TCGA-TM-A7CA-01 TCGA-TM-A7CA TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 44 NO YES TCGA-TM-A7CA-F63555 TCGA-TM-A7CA TCGA-TM-A7CA-01A -16415 830 0 1058 0 0 NO YES NO > 20 Years Seizures 0 - 30 Days Scheduled Follow-up Submission Complete Remission/Response NO 2014-8-12 MALE NO NO Astrocytoma NO No C71.0 9400/3 C71.0 YES NO 60 NO 100 Left NO NO NO NO NO G2 NO false No TCGA-TM-A7CA.FA7FFEBC-9D1C-42E6-BD8E-BB957EE8C870.pdf A7CA Preoperative TUMOR FREE Complete Remission/Response NO Primary Tumor 01 YES NO Not listed in Medical Record NO NO YES TM Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2011 TCGA-TM-A7CA-01 TCGA-TM-A7CA-01A-21D-A33T-08 TCGA-TM-A7CA-01A-21D-A33S-01 3fa4bf80-8a79-4a49-9b1e-40cf5696ad28 TCGA-TM-A7CA-01 TCGA-TM-A7CA-01 3fa4bf80-8a79-4a49-9b1e-40cf5696ad28 TCGA-TM-A7CA-01 TCGA-TM-A7CA-01A-21D-A33U-05 3fa4bf80-8a79-4a49-9b1e-40cf5696ad28 3fa4bf80-8a79-4a49-9b1e-40cf5696ad28 TCGA-TM-A7CA-01A-21D-A33S-01 TCGA-TM-A7CA-01A-21D-A33T-08 +TCGA-TM-A7CF-01 TCGA-TM-A7CF-01 TCGA-TM-A7CF TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 41 NO YES TCGA-TM-A7CF-F70345 TCGA-TM-A7CF TCGA-TM-A7CF-01A -15178 1453 0 1989 0 0 NO NO NO < 12 Years Seizures 0 - 30 Days Scheduled Follow-up Submission Stable Disease NO 2015-2-5 FEMALE YES NO Astrocytoma NO No C71.0 9400/3 C71.0 YES 80 NO 100 Right NO NO NO NO NO G2 NO false No TCGA-TM-A7CF.CC5699A6-8FC6-438D-ACC4-907481E6A580.pdf A7CF Preoperative WITH TUMOR Complete Remission/Response YES Primary Tumor 01 YES NO Not listed in Medical Record YES NO YES TM Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2009 TCGA-TM-A7CF-01 TCGA-TM-A7CF-01A-11D-A32B-08 TCGA-TM-A7CF-01A-11D-A32A-01 413a35b5-9151-44ca-85af-543683c8194b TCGA-TM-A7CF-01 TCGA-TM-A7CF-01 413a35b5-9151-44ca-85af-543683c8194b TCGA-TM-A7CF-01 TCGA-TM-A7CF-01A-11D-A32C-05 413a35b5-9151-44ca-85af-543683c8194b 413a35b5-9151-44ca-85af-543683c8194b TCGA-TM-A7CF-01A-11D-A32A-01 TCGA-TM-A7CF-01A-11D-A32B-08 +TCGA-TM-A7CF-02 TCGA-TM-A7CF-02 TCGA-TM-A7CF TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 41 NO YES TCGA-TM-A7CF-F70345 TCGA-TM-A7CF TCGA-TM-A7CF-02A -15178 1453 0 1989 0 0 NO NO NO < 12 Years Seizures 0 - 30 Days Scheduled Follow-up Submission Stable Disease NO 2015-2-5 FEMALE YES NO Astrocytoma NO No C71.0 9400/3 C71.0 YES 100 NO 100 Right NO NO NO NO NO G2 NO false No TCGA-TM-A7CF.E7D22CFE-C4C9-4E2F-AB45-713180E95C00.pdf A7CF Preoperative WITH TUMOR Complete Remission/Response YES Recurrent Tumor 02 YES NO Not listed in Medical Record YES NO YES TM Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2009 D9E5F0D2-8378-46CF-9530-CBBF84BA16E7 TCGA-TM-A7CF-02A-11D-A32B-08 f5bb6d6f-70b2-495b-9638-2527ba6b8aa1 TCGA-TM-A7CF-02 TCGA-TM-A7CF-02 f5bb6d6f-70b2-495b-9638-2527ba6b8aa1 TCGA-TM-A7CF-02A-11D-A32C-05 f5bb6d6f-70b2-495b-9638-2527ba6b8aa1 f5bb6d6f-70b2-495b-9638-2527ba6b8aa1 +TCGA-TM-A84B-01 TCGA-TM-A84B-01 TCGA-TM-A84B TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 40 NO NO TCGA-TM-A84B-F65302 TCGA-TM-A84B -14933 758 0 365 0 0 NO NO NO Seizures 0 - 30 Days Scheduled Follow-up Submission Progressive Disease NO 2014-9-22 MALE NO NO Astrocytoma NO No C71.0 9401/3 C71.0 YES 90 Left NO IHC YES NO NO NO YES G3 NO No A84B Preoperative WITH TUMOR Progressive Disease NO Primary Tumor 01 YES YES Not listed in Medical Record YES NO YES TM Supratentorial, Parietal Lobe Central nervous system NO DECEASED 2012 TCGA-TM-A84B-01 TCGA-TM-A84B-01A-11D-A36O-08 TCGA-TM-A84B-01A-11D-A36N-01 c7554894-f361-4d97-8c1b-91925679143c TCGA-TM-A84B-01 TCGA-TM-A84B-01 c7554894-f361-4d97-8c1b-91925679143c TCGA-TM-A84B-01 TCGA-TM-A84B-01A-11D-A368-05 c7554894-f361-4d97-8c1b-91925679143c c7554894-f361-4d97-8c1b-91925679143c TCGA-TM-A84B-01A-11D-A36N-01 TCGA-TM-A84B-01A-11D-A36O-08 +TCGA-TM-A84C-01 TCGA-TM-A84C-01 TCGA-TM-A84C TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 32 NO YES TCGA-TM-A84C-F64988 TCGA-TM-A84C TCGA-TM-A84C-01A -11849 459 492 0 459 0 1 NO YES NO < 12 Years Visual Changes 31 - 90 Days Scheduled Follow-up Submission Progressive Disease NO 2014-9-17 MALE NO NO Astrocytoma NO No C71.0 9400/3 C71.0 YES 80 NO 80 Midline NO IHC YES NO YES NO YES G2 NO false No TCGA-TM-A84C.506E57F2-58E8-44D0-BEBC-CA06F874ABFD.pdf A84C Preoperative WITH TUMOR Progressive Disease NO Primary Tumor 01 NO YES Not listed in Medical Record YES NO YES TM Posterior Fossa, Brain Stem Central nervous system A YES DECEASED 2012 TCGA-TM-A84C-01 TCGA-TM-A84C-01A-11D-A36O-08 TCGA-TM-A84C-01A-11D-A36N-01 2111b1a5-6018-4647-83dc-96a70dac667b TCGA-TM-A84C-01 TCGA-TM-A84C-01 2111b1a5-6018-4647-83dc-96a70dac667b TCGA-TM-A84C-01 TCGA-TM-A84C-01A-11D-A368-05 2111b1a5-6018-4647-83dc-96a70dac667b 2111b1a5-6018-4647-83dc-96a70dac667b TCGA-TM-A84C-01A-11D-A36N-01 TCGA-TM-A84C-01A-11D-A36O-08 +TCGA-TM-A84F-01 TCGA-TM-A84F-01 TCGA-TM-A84F TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 48 NO NO TCGA-TM-A84F-F65393 TCGA-TM-A84F TCGA-TM-A84F-01A -17744 1471 0 1796 0 0 NO NO NO Visual Changes 0 - 30 Days Scheduled Follow-up Submission Complete Remission/Response NO 2014-10-8 MALE NO YES Astrocytoma NO No C71.0 9401/3 C71.0 YES 60 NO 100 Right NO NO NO NO NO G3 NO false No TCGA-TM-A84F.5142804B-6A45-44E9-99A1-711C9C14F576.pdf A84F Preoperative TUMOR FREE Complete Remission/Response YES Primary Tumor 01 NO NO Not listed in Medical Record NO NO YES TM Supratentorial, Frontal Lobe Central nervous system A YES LIVING 2009 TCGA-TM-A84F-01 TCGA-TM-A84F-01A-11D-A36O-08 TCGA-TM-A84F-01A-11D-A36N-01 56d2252e-b66f-405f-9d97-7ea5432f1f68 TCGA-TM-A84F-01 TCGA-TM-A84F-01 56d2252e-b66f-405f-9d97-7ea5432f1f68 TCGA-TM-A84F-01 TCGA-TM-A84F-01A-11D-A368-05 56d2252e-b66f-405f-9d97-7ea5432f1f68 56d2252e-b66f-405f-9d97-7ea5432f1f68 TCGA-TM-A84F-01A-11D-A36N-01 TCGA-TM-A84F-01A-11D-A36O-08 +TCGA-TM-A84G-01 TCGA-TM-A84G-01 TCGA-TM-A84G TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 54 NO NO TCGA-TM-A84G-F65394 TCGA-TM-A84G -20014 0 1236 0 0 NO NO NO Headaches 0 - 30 Days Scheduled Follow-up Submission Complete Remission/Response NO 2014-9-23 FEMALE NO YES Oligodendroglioma NO No C71.0 9451/3 C71.0 YES 100 Right NO NO NO NO NO G3 NO No A84G Preoperative TUMOR FREE Complete Remission/Response YES Primary Tumor 01 NO NO Not listed in Medical Record NO NO YES TM Supratentorial, Frontal Lobe Central nervous system YES LIVING 2010 TCGA-TM-A84G-01 TCGA-TM-A84G-01A-11D-A36O-08 TCGA-TM-A84G-01A-11D-A36N-01 bdbde24d-9270-4e7b-84f3-1ba0b7d54e55 TCGA-TM-A84G-01 TCGA-TM-A84G-01 bdbde24d-9270-4e7b-84f3-1ba0b7d54e55 TCGA-TM-A84G-01 TCGA-TM-A84G-01A-11D-A368-05 bdbde24d-9270-4e7b-84f3-1ba0b7d54e55 bdbde24d-9270-4e7b-84f3-1ba0b7d54e55 TCGA-TM-A84G-01A-11D-A36N-01 TCGA-TM-A84G-01A-11D-A36O-08 +TCGA-TM-A84H-01 TCGA-TM-A84H-01 TCGA-TM-A84H TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 44 NO NO TCGA-TM-A84H-F65389 TCGA-TM-A84H TCGA-TM-A84H-01A -16277 627 0 926 0 0 NO YES NO Headaches 0 - 30 Days Scheduled Follow-up Submission Complete Remission/Response NO 2014-9-22 FEMALE NO YES Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES 60 NO 90 Right NO NO YES NO NO G3 NO false No TCGA-TM-A84H.654A67F7-8755-4BF6-9674-69ADA7C976DA.pdf A84H Preoperative TUMOR FREE Complete Remission/Response YES Primary Tumor 01 NO NO Not listed in Medical Record NO NO YES TM Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2012 TCGA-TM-A84H-01 TCGA-TM-A84H-01A-11D-A36O-08 TCGA-TM-A84H-01A-11D-A36N-01 784d798d-12cd-4714-ab4d-2191011c4a44 TCGA-TM-A84H-01 TCGA-TM-A84H-01 784d798d-12cd-4714-ab4d-2191011c4a44 TCGA-TM-A84H-01 TCGA-TM-A84H-01A-11D-A368-05 784d798d-12cd-4714-ab4d-2191011c4a44 784d798d-12cd-4714-ab4d-2191011c4a44 TCGA-TM-A84H-01A-11D-A36N-01 TCGA-TM-A84H-01A-11D-A36O-08 +TCGA-TM-A84I-01 TCGA-TM-A84I-01 TCGA-TM-A84I TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 30 NO NO TCGA-TM-A84I-F65390 TCGA-TM-A84I -11221 0 854 0 0 NO YES NO Motor/Movement Changes 0 - 30 Days Scheduled Follow-up Submission Complete Remission/Response NO 2014-9-22 MALE NO NO Astrocytoma NO No C71.0 9401/3 C71.0 YES 90 Left NO NO NO NO YES G3 NO No A84I Preoperative TUMOR FREE Complete Remission/Response YES Primary Tumor 01 NO NO Not listed in Medical Record NO NO YES TM Supratentorial, Parietal Lobe Central nervous system NO LIVING 2012 TCGA-TM-A84I-01 TCGA-TM-A84I-01A-11D-A36O-08 TCGA-TM-A84I-01A-11D-A36N-01 e7549428-1144-41c1-98cd-d077fc258567 TCGA-TM-A84I-01 TCGA-TM-A84I-01 e7549428-1144-41c1-98cd-d077fc258567 TCGA-TM-A84I-01 TCGA-TM-A84I-01A-11D-A368-05 e7549428-1144-41c1-98cd-d077fc258567 e7549428-1144-41c1-98cd-d077fc258567 TCGA-TM-A84I-01A-11D-A36N-01 TCGA-TM-A84I-01A-11D-A36O-08 +TCGA-TM-A84J-01 TCGA-TM-A84J-01 TCGA-TM-A84J TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain YES NO 63 NO NO TCGA-TM-A84J-F65391 TCGA-TM-A84J TCGA-TM-A84J-01A -23091 415 0 735 454 0 1 NO NO NO Visual Changes 0 - 30 Days Scheduled Follow-up Submission Progressive Disease NO 2014-9-30 MALE NO NO Oligodendroglioma NO No C71.0 9451/3 C71.0 YES 50 NO 80 Left NO NO YES NO YES G3 YES false No TCGA-TM-A84J.D3563493-4083-479F-A172-8E856AD793C2.pdf A84J Preoperative WITH TUMOR Progressive Disease YES Primary Tumor 01 YES NO Not listed in Medical Record YES NO YES TM Supratentorial, Occipital Lobe Central nervous system A YES LIVING 2012 TCGA-TM-A84J-01 TCGA-TM-A84J-01A-11D-A36O-08 TCGA-TM-A84J-01A-11D-A36N-01 549b2c27-188c-4c0b-b451-4507ef46a561 TCGA-TM-A84J-01 TCGA-TM-A84J-01 549b2c27-188c-4c0b-b451-4507ef46a561 TCGA-TM-A84J-01 TCGA-TM-A84J-01A-11D-A368-05 549b2c27-188c-4c0b-b451-4507ef46a561 549b2c27-188c-4c0b-b451-4507ef46a561 TCGA-TM-A84J-01A-11D-A36N-01 TCGA-TM-A84J-01A-11D-A36O-08 +TCGA-TM-A84L-01 TCGA-TM-A84L-01 TCGA-TM-A84L TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain YES YES YES 31 NO NO TCGA-TM-A84L-F56505 TCGA-TM-A84L 1045 -11498 1242 0 1045 0 0 NO NO NO Seizures 31 - 90 Days Scheduled Follow-up Submission Progressive Disease NO 2014-2-17 MALE NO NO Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES 90 Left NO NO NO NO NO G2 YES No A84L Preoperative WITH TUMOR Complete Remission/Response NO Primary Tumor 01 YES NO Not listed in Medical Record NO NO YES TM Supratentorial, Temporal Lobe Central nervous system NO DECEASED 2010 TCGA-TM-A84L-01 TCGA-TM-A84L-01A-11D-A36O-08 TCGA-TM-A84L-01A-11D-A36N-01 d0f9781b-f735-4dd2-8813-f513692c0525 TCGA-TM-A84L-01 TCGA-TM-A84L-01 d0f9781b-f735-4dd2-8813-f513692c0525 TCGA-TM-A84L-01 TCGA-TM-A84L-01A-11D-A368-05 d0f9781b-f735-4dd2-8813-f513692c0525 d0f9781b-f735-4dd2-8813-f513692c0525 TCGA-TM-A84L-01A-11D-A36N-01 TCGA-TM-A84L-01A-11D-A36O-08 +TCGA-TM-A84M-01 TCGA-TM-A84M-01 TCGA-TM-A84M TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 40 NO NO TCGA-TM-A84M-F65392 TCGA-TM-A84M TCGA-TM-A84M-01A -14660 455 0 754 0 0 NO NO NO Motor/Movement Changes 31 - 90 Days Scheduled Follow-up Submission Complete Remission/Response NO 2014-9-23 MALE NO NO Oligodendroglioma NO No C71.0 9451/3 C71.0 YES 10 NO 100 Right NO NO NO NO YES G3 NO false No TCGA-TM-A84M.A9063552-B6AE-4CD9-9A0C-BF7BA476411C.pdf A84M Preoperative TUMOR FREE Complete Remission/Response YES Primary Tumor 01 NO NO Not listed in Medical Record YES NO YES TM Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2012 TCGA-TM-A84M-01 TCGA-TM-A84M-01A-11D-A36O-08 TCGA-TM-A84M-01A-11D-A36N-01 4d4f086b-9706-4fc5-b19b-33270daf8970 TCGA-TM-A84M-01 TCGA-TM-A84M-01 4d4f086b-9706-4fc5-b19b-33270daf8970 TCGA-TM-A84M-01 TCGA-TM-A84M-01A-11D-A368-05 4d4f086b-9706-4fc5-b19b-33270daf8970 4d4f086b-9706-4fc5-b19b-33270daf8970 TCGA-TM-A84M-01A-11D-A36N-01 TCGA-TM-A84M-01A-11D-A36O-08 +TCGA-TM-A84O-01 TCGA-TM-A84O-01 TCGA-TM-A84O TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 61 NO NO TCGA-TM-A84O-F65303 TCGA-TM-A84O TCGA-TM-A84O-01A -22327 920 1011 0 0 0 NO Seizures 0 - 30 Days Scheduled Follow-up Submission Progressive Disease NO 2014-9-22 FEMALE NO NO Oligodendroglioma NO No C71.0 9451/3 C71.0 YES 60 NO 90 Right NO NO NO NO NO G3 NO false No TCGA-TM-A84O.6E28D951-BB27-4E32-A681-46D1DEF900BB.pdf A84O Preoperative WITH TUMOR Complete Remission/Response YES Primary Tumor 01 YES NO Not listed in Medical Record NO NO YES TM Supratentorial, Not Otherwise Specified Central nervous system A NO DECEASED 2011 TCGA-TM-A84O-01 TCGA-TM-A84O-01A-11D-A36O-08 TCGA-TM-A84O-01A-11D-A36N-01 4ad229f0-dae4-485e-8f36-a79dd071a812 TCGA-TM-A84O-01 TCGA-TM-A84O-01 4ad229f0-dae4-485e-8f36-a79dd071a812 TCGA-TM-A84O-01 TCGA-TM-A84O-01A-11D-A368-05 4ad229f0-dae4-485e-8f36-a79dd071a812 4ad229f0-dae4-485e-8f36-a79dd071a812 TCGA-TM-A84O-01A-11D-A36N-01 TCGA-TM-A84O-01A-11D-A36O-08 +TCGA-TM-A84Q-01 TCGA-TM-A84Q-01 TCGA-TM-A84Q TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain NO NO 31 NO YES TCGA-TM-A84Q-F65305 TCGA-TM-A84Q TCGA-TM-A84Q-01A -11668 592 0 772 455 0 1 NO NO NO > 20 Years Mental Status Changes 0 - 30 Days Scheduled Follow-up Submission Complete Remission/Response NO 2014-9-22 MALE NO NO Astrocytoma NO No C71.0 9400/3 C71.0 YES 50 NO 80 Left NO NO YES NO NO G2 YES false No TCGA-TM-A84Q.CE780D35-9DBE-4596-812C-D44B2B57466D.pdf A84Q Preoperative TUMOR FREE Complete Remission/Response YES Primary Tumor 01 NO NO Not listed in Medical Record NO NO YES TM Supratentorial, Temporal Lobe Central nervous system A NO LIVING 2012 TCGA-TM-A84Q-01 TCGA-TM-A84Q-01A-11D-A36O-08 TCGA-TM-A84Q-01A-11D-A36N-01 31cec6a7-3560-4837-a220-a34d1e45ed24 TCGA-TM-A84Q-01 TCGA-TM-A84Q-01 31cec6a7-3560-4837-a220-a34d1e45ed24 TCGA-TM-A84Q-01 TCGA-TM-A84Q-01A-11D-A368-05 31cec6a7-3560-4837-a220-a34d1e45ed24 31cec6a7-3560-4837-a220-a34d1e45ed24 TCGA-TM-A84Q-01A-11D-A36N-01 TCGA-TM-A84Q-01A-11D-A36O-08 +TCGA-TM-A84R-01 TCGA-TM-A84R-01 TCGA-TM-A84R TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 46 NO NO TCGA-TM-A84R-F65388 TCGA-TM-A84R TCGA-TM-A84R-01A -16843 346 0 566 0 1 NO NO NO Seizures 0 - 30 Days Scheduled Follow-up Submission Complete Remission/Response NO 2014-9-22 MALE NO YES Oligodendroglioma NO No C71.0 9450/3 C71.0 YES 140 NO 80 Left NO Sequence Analysis YES NO NO NO NO G2 NO false No TCGA-TM-A84R.3182D6DB-4B2D-49B0-A907-5DD62812D470.pdf A84R Preoperative TUMOR FREE Complete Remission/Response NO Primary Tumor 01 YES NO Not listed in Medical Record NO NO YES TM Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2012 TCGA-TM-A84R-01 6B8E6F5D-4B10-4B2B-BC18-3B867679C81A TCGA-TM-A84R-01A-21D-A36O-08 TCGA-TM-A84R-01A-21D-A36N-01 67eda5bc-a945-480a-8d69-c517cb265f5d TCGA-TM-A84R-01 TCGA-TM-A84R-01 67eda5bc-a945-480a-8d69-c517cb265f5d TCGA-TM-A84R-01 TCGA-TM-A84R-01A-21D-A368-05 67eda5bc-a945-480a-8d69-c517cb265f5d 67eda5bc-a945-480a-8d69-c517cb265f5d TCGA-TM-A84R-01A-21D-A36N-01 TCGA-TM-A84R-01A-21D-A36O-08 +TCGA-TM-A84S-01 TCGA-TM-A84S-01 TCGA-TM-A84S TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 36 NO NO TCGA-TM-A84S-F65304 TCGA-TM-A84S TCGA-TM-A84S-01A -13424 163 0 454 0 1 NO YES YES Seizures 31 - 90 Days Scheduled Follow-up Submission Complete Remission/Response NO 2014-9-22 MALE NO NO Oligodendroglioma NO No C71.0 9451/3 C71.0 YES 110 NO 80 Left YES IHC YES NO NO NO YES G3 NO false No TCGA-TM-A84S.286FC4C6-07CD-4056-B6EE-C30619069A34.pdf A84S Preoperative TUMOR FREE Complete Remission/Response NO Primary Tumor 01 YES NO Not listed in Medical Record NO NO YES TM Supratentorial, Frontal Lobe Central nervous system A YES LIVING 2013 TCGA-TM-A84S-01 D4DC8A42-1DFD-4FB7-BC2E-3A11B232D791 TCGA-TM-A84S-01A-11D-A36O-08 TCGA-TM-A84S-01A-11D-A36N-01 b37064bc-6eec-4387-a09b-8d7b853e0a90 TCGA-TM-A84S-01 TCGA-TM-A84S-01 b37064bc-6eec-4387-a09b-8d7b853e0a90 TCGA-TM-A84S-01 TCGA-TM-A84S-01A-11D-A368-05 b37064bc-6eec-4387-a09b-8d7b853e0a90 b37064bc-6eec-4387-a09b-8d7b853e0a90 TCGA-TM-A84S-01A-11D-A36N-01 TCGA-TM-A84S-01A-11D-A36O-08 +TCGA-TM-A84T-01 TCGA-TM-A84T-01 TCGA-TM-A84T TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 19 NO NO TCGA-TM-A84T-F65306 TCGA-TM-A84T -6994 0 724 0 0 NO NO NO Seizures 0 - 30 Days Scheduled Follow-up Submission Stable Disease NO 2014-9-22 MALE NO NO Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES 90 Left YES IHC YES NO NO NO NO G2 NO No A84T Preoperative WITH TUMOR Stable Disease NO Primary Tumor 01 YES YES Not listed in Medical Record NO NO YES TM Supratentorial, Frontal Lobe Central nervous system NO LIVING 2012 TCGA-TM-A84T-01 TCGA-TM-A84T-01A-11D-A36O-08 TCGA-TM-A84T-01A-11D-A36N-01 c1ccfad6-dc2b-49ea-97bd-044b1bf195dd TCGA-TM-A84T-01 TCGA-TM-A84T-01 c1ccfad6-dc2b-49ea-97bd-044b1bf195dd TCGA-TM-A84T-01 TCGA-TM-A84T-01A-11D-A368-05 c1ccfad6-dc2b-49ea-97bd-044b1bf195dd c1ccfad6-dc2b-49ea-97bd-044b1bf195dd TCGA-TM-A84T-01A-11D-A36N-01 TCGA-TM-A84T-01A-11D-A36O-08 +TCGA-TQ-A7RF-01 TCGA-TQ-A7RF-01 TCGA-TQ-A7RF TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 27 NO NO TCGA-TQ-A7RF-F61331 TCGA-TQ-A7RF TCGA-TQ-A7RF-01A -9919 373 0 650 NO NO NO Headaches > 181 Days NO 2015-2-19 FEMALE NO YES Oligodendroglioma NO No C71.0 9451/3 C71.0 YES 130 NO Right NO NO YES NO NO G3 NO false No TCGA-TQ-A7RF.F4103666-DB5D-4286-8769-F51F08D61FBA.pdf A7RF Preoperative WITH TUMOR YES YES Partial Remission/Response YES Primary Tumor 01 YES YES White Matter YES NO YES TQ Supratentorial, Temporal Lobe Central nervous system A YES LIVING 2012 TCGA-TQ-A7RF-01 113691BE-6032-49E8-9B85-C913604A1E0E TCGA-TQ-A7RF-01A-11D-A33T-08 TCGA-TQ-A7RF-01A-11D-A33S-01 b3c8bb05-15a1-483a-a93e-a7733e32f983 TCGA-TQ-A7RF-01 TCGA-TQ-A7RF-01 b3c8bb05-15a1-483a-a93e-a7733e32f983 TCGA-TQ-A7RF-01 TCGA-TQ-A7RF-01A-11D-A33U-05 b3c8bb05-15a1-483a-a93e-a7733e32f983 b3c8bb05-15a1-483a-a93e-a7733e32f983 TCGA-TQ-A7RF-01A-11D-A33S-01 TCGA-TQ-A7RF-01A-11D-A33T-08 +TCGA-TQ-A7RG-01 TCGA-TQ-A7RG-01 TCGA-TQ-A7RG TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 36 NO NO TCGA-TQ-A7RG-F65500 TCGA-TQ-A7RG TCGA-TQ-A7RG-01A -13227 287 0 599 -32 NO NO NO Seizures > 181 Days NO 2015-2-19 MALE NO Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES NO 530 NO 100 Left NO NO NO NO G2 NO false No TCGA-TQ-A7RG.396F6EAB-2B8F-4054-AACA-31BC916FB9D4.pdf A7RG Preoperative WITH TUMOR YES YES Partial Remission/Response NO Primary Tumor 01 YES NO White Matter YES NO YES TQ Supratentorial, Temporal Lobe Central nervous system A YES LIVING 2012 TCGA-TQ-A7RG-01 1D5D61F9-539F-49B5-BC82-600DA6F23F8F TCGA-TQ-A7RG-01A-11D-A33T-08 TCGA-TQ-A7RG-01A-11D-A33S-01 3e1936a4-80e8-42a0-8af6-4db305987cb0 TCGA-TQ-A7RG-01 TCGA-TQ-A7RG-01 3e1936a4-80e8-42a0-8af6-4db305987cb0 TCGA-TQ-A7RG-01 TCGA-TQ-A7RG-01A-11D-A33U-05 3e1936a4-80e8-42a0-8af6-4db305987cb0 3e1936a4-80e8-42a0-8af6-4db305987cb0 TCGA-TQ-A7RG-01A-11D-A33S-01 TCGA-TQ-A7RG-01A-11D-A33T-08 +TCGA-TQ-A7RH-01 TCGA-TQ-A7RH-01 TCGA-TQ-A7RH TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 39 NO NO TCGA-TQ-A7RH-F65502 TCGA-TQ-A7RH TCGA-TQ-A7RH-01A -14524 167 0 486 NO NO NO Seizures > 181 Days NO 2014-9-25 MALE NO YES Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES NO 130 NO Right NO NO YES NO NO G2 NO false No TCGA-TQ-A7RH.489D1069-B12F-4250-9FD0-BA5997ADAC8D.pdf A7RH WITH TUMOR YES YES Partial Remission/Response YES Primary Tumor 01 YES NO White Matter YES NO YES TQ Supratentorial, Temporal Lobe Central nervous system A NO LIVING 2013 TCGA-TQ-A7RH-01 F3D2D2D8-D5F3-4348-A11B-FC68D575FED9 TCGA-TQ-A7RH-01A-12D-A34A-08 TCGA-TQ-A7RH-01A-12D-A349-01 2797760a-c82d-44d8-bec2-92fe1d6ef271 TCGA-TQ-A7RH-01 TCGA-TQ-A7RH-01 2797760a-c82d-44d8-bec2-92fe1d6ef271 TCGA-TQ-A7RH-01 TCGA-TQ-A7RH-01A-12D-A34D-05 2797760a-c82d-44d8-bec2-92fe1d6ef271 2797760a-c82d-44d8-bec2-92fe1d6ef271 TCGA-TQ-A7RH-01A-12D-A349-01 TCGA-TQ-A7RH-01A-12D-A34A-08 +TCGA-TQ-A7RI-01 TCGA-TQ-A7RI-01 TCGA-TQ-A7RI TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 37 NO NO TCGA-TQ-A7RI-F65497 TCGA-TQ-A7RI -13799 0 62 NO NO NO Seizures 0 - 30 Days NO 2014-9-25 FEMALE NO NO Oligodendroglioma NO No C71.0 9450/3 C71.0 YES NO Left NO YES NO NO NO G2 NO No A7RI Preoperative TUMOR FREE YES YES NO Primary Tumor 01 YES NO White Matter NO NO YES TQ Supratentorial, Parietal Lobe Central nervous system NO LIVING 2012 TCGA-TQ-A7RI-01 TCGA-TQ-A7RI-01A-11D-A33T-08 TCGA-TQ-A7RI-01A-11D-A33S-01 d071f7d9-cc1c-4b7d-8555-b8aab5730bb6 TCGA-TQ-A7RI-01 TCGA-TQ-A7RI-01 d071f7d9-cc1c-4b7d-8555-b8aab5730bb6 TCGA-TQ-A7RI-01 TCGA-TQ-A7RI-01A-11D-A33U-05 d071f7d9-cc1c-4b7d-8555-b8aab5730bb6 d071f7d9-cc1c-4b7d-8555-b8aab5730bb6 TCGA-TQ-A7RI-01A-11D-A33S-01 TCGA-TQ-A7RI-01A-11D-A33T-08 +TCGA-TQ-A7RJ-01 TCGA-TQ-A7RJ-01 TCGA-TQ-A7RJ TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 25 NO NO TCGA-TQ-A7RJ-F65494 TCGA-TQ-A7RJ TCGA-TQ-A7RJ-01A -9209 924 0 1229 NO NO NO Sensory Changes > 181 Days NO 2014-9-25 FEMALE NO NO Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES NO 50 NO Left NO NO NO NO YES G2 NO false No TCGA-TQ-A7RJ.9C4E4467-F9B6-456F-8138-B81D42E6A5AA.pdf A7RJ Preoperative WITH TUMOR NO NO Stable Disease YES Primary Tumor 01 NO YES White Matter YES NO YES TQ Supratentorial, Parietal Lobe Central nervous system A NO LIVING 2011 TCGA-TQ-A7RJ-01 TCGA-TQ-A7RJ-01A-11D-A33T-08 TCGA-TQ-A7RJ-01A-11D-A33S-01 2ad4f620-2c9a-4bc0-a24d-fddfee88ba32 TCGA-TQ-A7RJ-01 TCGA-TQ-A7RJ-01 2ad4f620-2c9a-4bc0-a24d-fddfee88ba32 TCGA-TQ-A7RJ-01 TCGA-TQ-A7RJ-01A-11D-A33U-05 2ad4f620-2c9a-4bc0-a24d-fddfee88ba32 2ad4f620-2c9a-4bc0-a24d-fddfee88ba32 TCGA-TQ-A7RJ-01A-11D-A33S-01 TCGA-TQ-A7RJ-01A-11D-A33T-08 +TCGA-TQ-A7RK-01 TCGA-TQ-A7RK-01 TCGA-TQ-A7RK TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain YES YES YES 29 NO NO TCGA-TQ-A7RK-F61519 TCGA-TQ-A7RK TCGA-TQ-A7RK-01A 882 -10742 1057 0 1341 858 -115 0 NO NO NO Mental Status Changes 0 - 30 Days Additional New Tumor Event Complete Remission/Response NO 2014-6-30 MALE NO NO Oligoastrocytoma NO No C71.0 9450/3 C71.0 YES NO 330 NO 90 Left NO NO YES NO NO G2 YES false No TCGA-TQ-A7RK.740E07A6-7579-4967-827C-7DC0D56EFF98.pdf A7RK Preoperative TUMOR FREE YES NO Complete Remission/Response NO Primary Tumor 01 NO NO White Matter NO NO YES TQ Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2010 TCGA-TQ-A7RK-01 C336491C-71C1-420B-B1BE-DC570D673B20 TCGA-TQ-A7RK-01A-11D-A33T-08 TCGA-TQ-A7RK-01A-11D-A33S-01 9730d6b2-f458-4475-a66c-e99aa49e4161 TCGA-TQ-A7RK-01 TCGA-TQ-A7RK-01 9730d6b2-f458-4475-a66c-e99aa49e4161 TCGA-TQ-A7RK-01 TCGA-TQ-A7RK-01A-11D-A33U-05 9730d6b2-f458-4475-a66c-e99aa49e4161 9730d6b2-f458-4475-a66c-e99aa49e4161 TCGA-TQ-A7RK-01A-11D-A33S-01 TCGA-TQ-A7RK-01A-11D-A33T-08 +TCGA-TQ-A7RK-02 TCGA-TQ-A7RK-02 TCGA-TQ-A7RK TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain YES YES YES 29 NO NO TCGA-TQ-A7RK-F61519 TCGA-TQ-A7RK TCGA-TQ-A7RK-02B 882 -10742 1131 0 1341 858 -115 0 NO NO NO Mental Status Changes 0 - 30 Days Additional New Tumor Event Complete Remission/Response NO 2014-6-30 MALE NO NO Oligoastrocytoma NO No C71.0 9450/3 C71.0 YES NO 60 NO 90 Left NO NO YES NO NO G2 YES true No TCGA-TQ-A7RK.5452FDC5-EB15-49DE-A0CC-9A9CA7018A5B.pdf A7RK Preoperative TUMOR FREE YES NO Complete Remission/Response NO Recurrent Tumor 02 NO NO White Matter NO NO YES TQ Supratentorial, Frontal Lobe Central nervous system B NO LIVING 2010 D27EDE41-ECB0-4A86-8205-0DC1CD246FA4 TCGA-TQ-A7RK-02A-11D-A36O-08 25aa5be1-62ec-4bd7-9509-bafbcd1adddb,707a0918-ae88-4c3c-9a94-e9fad5cdbc7b TCGA-TQ-A7RK-02 TCGA-TQ-A7RK-02 25aa5be1-62ec-4bd7-9509-bafbcd1adddb,707a0918-ae88-4c3c-9a94-e9fad5cdbc7b TCGA-TQ-A7RK-02B-11D-A408-05,TCGA-TQ-A7RK-02A-11D-A368-05 25aa5be1-62ec-4bd7-9509-bafbcd1adddb,707a0918-ae88-4c3c-9a94-e9fad5cdbc7b 25aa5be1-62ec-4bd7-9509-bafbcd1adddb,707a0918-ae88-4c3c-9a94-e9fad5cdbc7b +TCGA-TQ-A7RM-01 TCGA-TQ-A7RM-01 TCGA-TQ-A7RM TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 41 NO NO TCGA-TQ-A7RM-F65552 TCGA-TQ-A7RM -15154 0 1116 45 0 NO NO NO Seizures > 181 Days Scheduled Follow-up Submission Partial Remission/Response NO 2015-2-17 FEMALE NO NO Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES NO 90 Left NO NO YES NO NO G3 NO No A7RM Pre-Adjuvant Therapy WITH TUMOR YES NO Partial Remission/Response YES Primary Tumor 01 YES NO Cerebral Cortex YES NO YES TQ Supratentorial, Temporal Lobe Central nervous system NO LIVING 2011 TCGA-TQ-A7RM-01 TCGA-TQ-A7RM-01A-11D-A33T-08 TCGA-TQ-A7RM-01A-11D-A33S-01 ea076ed3-74cd-4313-83d0-a99873058fd7 TCGA-TQ-A7RM-01 TCGA-TQ-A7RM-01 ea076ed3-74cd-4313-83d0-a99873058fd7 TCGA-TQ-A7RM-01 TCGA-TQ-A7RM-01A-11D-A33U-05 ea076ed3-74cd-4313-83d0-a99873058fd7 ea076ed3-74cd-4313-83d0-a99873058fd7 TCGA-TQ-A7RM-01A-11D-A33S-01 TCGA-TQ-A7RM-01A-11D-A33T-08 +TCGA-TQ-A7RN-01 TCGA-TQ-A7RN-01 TCGA-TQ-A7RN TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 32 NO NO TCGA-TQ-A7RN-F65559 TCGA-TQ-A7RN TCGA-TQ-A7RN-01A -11823 714 0 1026 11 0 NO NO NO Headaches > 181 Days Scheduled Follow-up Submission Partial Remission/Response NO 2015-2-17 MALE NO YES Oligodendroglioma NO No C71.0 9450/3 C71.0 YES NO 150 NO 100 Left NO NO NO NO NO G2 NO false No TCGA-TQ-A7RN.87A66ECE-00EE-4D45-83BF-1A9F26D1DA8F.pdf A7RN Pre-Adjuvant Therapy WITH TUMOR YES NO Partial Remission/Response YES Primary Tumor 01 YES NO Cerebral Cortex YES NO YES TQ Supratentorial, Temporal Lobe Central nervous system A NO LIVING 2011 TCGA-TQ-A7RN-01 713F041C-9019-445C-8B3B-319634BBF6D5 TCGA-TQ-A7RN-01A-11D-A33T-08 TCGA-TQ-A7RN-01A-11D-A33S-01 e6d2870a-4ba2-4064-a5a9-d701e6b5e3dd TCGA-TQ-A7RN-01 TCGA-TQ-A7RN-01 e6d2870a-4ba2-4064-a5a9-d701e6b5e3dd TCGA-TQ-A7RN-01 TCGA-TQ-A7RN-01A-11D-A33U-05 e6d2870a-4ba2-4064-a5a9-d701e6b5e3dd e6d2870a-4ba2-4064-a5a9-d701e6b5e3dd TCGA-TQ-A7RN-01A-11D-A33S-01 TCGA-TQ-A7RN-01A-11D-A33T-08 +TCGA-TQ-A7RO-01 TCGA-TQ-A7RO-01 TCGA-TQ-A7RO TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 29 NO NO TCGA-TQ-A7RO-F65562 TCGA-TQ-A7RO TCGA-TQ-A7RO-01A -10890 665 0 949 123 0 NO YES NO 12 - 20 Years Seizures 31 - 90 Days Scheduled Follow-up Submission Partial Remission/Response YES Seafood 2015-2-17 MALE NO NO Oligoastrocytoma YES No C71.0 9382/3 C71.0 YES NO 80 NO 100 Left NO NO NO NO NO G2 NO false No TCGA-TQ-A7RO.41735167-9814-4D95-A3D4-E1C0B8575C9D.pdf A7RO Other WITH TUMOR YES YES Partial Remission/Response NO Primary Tumor 01 YES NO Cerebral Cortex NO NO YES TQ Supratentorial, Temporal Lobe Central nervous system A NO LIVING 2011 TCGA-TQ-A7RO-01 TCGA-TQ-A7RO-01A-11D-A33T-08 TCGA-TQ-A7RO-01A-11D-A33S-01 1de2f338-b16d-40ab-ac9b-8b175c9bb459 TCGA-TQ-A7RO-01 TCGA-TQ-A7RO-01 1de2f338-b16d-40ab-ac9b-8b175c9bb459 TCGA-TQ-A7RO-01 TCGA-TQ-A7RO-01A-11D-A33U-05 1de2f338-b16d-40ab-ac9b-8b175c9bb459 1de2f338-b16d-40ab-ac9b-8b175c9bb459 TCGA-TQ-A7RO-01A-11D-A33S-01 TCGA-TQ-A7RO-01A-11D-A33T-08 +TCGA-TQ-A7RP-01 TCGA-TQ-A7RP-01 TCGA-TQ-A7RP TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 66 NO NO TCGA-TQ-A7RP-F65564 TCGA-TQ-A7RP TCGA-TQ-A7RP-01A -24109 553 0 914 152 0 NO NO NO Seizures > 181 Days Scheduled Follow-up Submission Partial Remission/Response NO 2015-2-17 MALE NO NO Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES NO 400 NO 90 Left NO YES NO NO NO G2 NO false No TCGA-TQ-A7RP.27A97401-6DB1-4439-A06D-E0CC46BD5CC0.pdf A7RP Pre-Adjuvant Therapy WITH TUMOR YES NO Partial Remission/Response YES Primary Tumor 01 YES NO Cerebral Cortex YES NO YES TQ Supratentorial, Temporal Lobe Central nervous system A NO LIVING 2012 TCGA-TQ-A7RP-01 TCGA-TQ-A7RP-01A-21D-A34A-08 TCGA-TQ-A7RP-01A-21D-A349-01 264d433e-545e-47cd-9779-7fce4237278b TCGA-TQ-A7RP-01 TCGA-TQ-A7RP-01 264d433e-545e-47cd-9779-7fce4237278b TCGA-TQ-A7RP-01 TCGA-TQ-A7RP-01A-21D-A34D-05 264d433e-545e-47cd-9779-7fce4237278b 264d433e-545e-47cd-9779-7fce4237278b TCGA-TQ-A7RP-01A-21D-A349-01 TCGA-TQ-A7RP-01A-21D-A34A-08 +TCGA-TQ-A7RQ-01 TCGA-TQ-A7RQ-01 TCGA-TQ-A7RQ TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 38 NO NO TCGA-TQ-A7RQ-F65566 TCGA-TQ-A7RQ TCGA-TQ-A7RQ-01A -14187 504 0 795 53 0 NO Seizures 91 - 180 Days Scheduled Follow-up Submission Complete Remission/Response NO 2014-10-30 FEMALE NO NO Oligodendroglioma NO No C71.0 9450/3 C71.0 YES NO 140 NO 90 Left NO NO NO NO NO G2 NO false No TCGA-TQ-A7RQ.627A2B25-6FC6-4CF3-9EA8-D9159B49B205.pdf A7RQ Pre-Adjuvant Therapy TUMOR FREE YES YES Complete Remission/Response NO Primary Tumor 01 YES NO Cerebral Cortex YES NO YES TQ Supratentorial, Temporal Lobe Central nervous system A NO LIVING 2012 TCGA-TQ-A7RQ-01 A13473E3-E80D-43F0-AF6E-2B53924D76BB TCGA-TQ-A7RQ-01A-11D-A33T-08 TCGA-TQ-A7RQ-01A-11D-A33S-01 02221ced-8f59-4a00-ae01-6096648b34fc TCGA-TQ-A7RQ-01 TCGA-TQ-A7RQ-01 02221ced-8f59-4a00-ae01-6096648b34fc TCGA-TQ-A7RQ-01 TCGA-TQ-A7RQ-01A-11D-A33U-05 02221ced-8f59-4a00-ae01-6096648b34fc 02221ced-8f59-4a00-ae01-6096648b34fc TCGA-TQ-A7RQ-01A-11D-A33S-01 TCGA-TQ-A7RQ-01A-11D-A33T-08 +TCGA-TQ-A7RR-01 TCGA-TQ-A7RR-01 TCGA-TQ-A7RR TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 38 NO NO TCGA-TQ-A7RR-F65569 TCGA-TQ-A7RR TCGA-TQ-A7RR-01A -14022 454 0 787 31 0 NO NO NO Seizures > 181 Days Scheduled Follow-up Submission Partial Remission/Response NO 2014-10-30 MALE NO NO Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES NO 220 NO 100 Right NO NO NO NO NO G2 NO false No TCGA-TQ-A7RR.34C9D741-8075-4FE1-8144-318C2AB176E2.pdf A7RR Pre-Adjuvant Therapy TUMOR FREE NO NO Partial Remission/Response YES Primary Tumor 01 YES NO Cerebral Cortex YES NO YES TQ Supratentorial, Parietal Lobe Central nervous system A NO LIVING 2012 TCGA-TQ-A7RR-01 68E9A4A9-F338-4A59-BFC6-290349B2E9DC TCGA-TQ-A7RR-01A-21D-A34A-08 TCGA-TQ-A7RR-01A-21D-A349-01 76a648cc-8673-478f-a2f5-c0830378f1e4 TCGA-TQ-A7RR-01 TCGA-TQ-A7RR-01 76a648cc-8673-478f-a2f5-c0830378f1e4 TCGA-TQ-A7RR-01 TCGA-TQ-A7RR-01A-21D-A34D-05 76a648cc-8673-478f-a2f5-c0830378f1e4 76a648cc-8673-478f-a2f5-c0830378f1e4 TCGA-TQ-A7RR-01A-21D-A349-01 TCGA-TQ-A7RR-01A-21D-A34A-08 +TCGA-TQ-A7RS-01 TCGA-TQ-A7RS-01 TCGA-TQ-A7RS TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 25 NO NO TCGA-TQ-A7RS-F65577 TCGA-TQ-A7RS TCGA-TQ-A7RS-01A -9172 398 0 -1 -1 0 NO Motor/Movement Changes > 181 Days Scheduled Follow-up Submission Complete Remission/Response 2014-10-30 FEMALE NO NO Oligodendroglioma NO No C71.0 9450/3 C71.0 YES NO 250 NO 90 Left NO YES NO NO YES G2 NO false No TCGA-TQ-A7RS.90135819-8DF8-4410-BC80-816551A3AE46.pdf A7RS Preoperative TUMOR FREE NO NO Complete Remission/Response NO Primary Tumor 01 NO NO Cerebral Cortex NO NO YES TQ Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2012 TCGA-TQ-A7RS-01 99CB56CF-F512-4B26-8593-6F02BB6F8880 TCGA-TQ-A7RS-01A-12D-A33T-08 TCGA-TQ-A7RS-01A-12D-A33S-01 65f141fb-b893-4254-83e8-b8989bf01cf1 TCGA-TQ-A7RS-01 TCGA-TQ-A7RS-01 65f141fb-b893-4254-83e8-b8989bf01cf1 TCGA-TQ-A7RS-01 TCGA-TQ-A7RS-01A-12D-A33U-05 65f141fb-b893-4254-83e8-b8989bf01cf1 65f141fb-b893-4254-83e8-b8989bf01cf1 TCGA-TQ-A7RS-01A-12D-A33S-01 TCGA-TQ-A7RS-01A-12D-A33T-08 +TCGA-TQ-A7RU-01 TCGA-TQ-A7RU-01 TCGA-TQ-A7RU TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 51 NO NO TCGA-TQ-A7RU-F65649 TCGA-TQ-A7RU -18990 0 1032 158 0 NO NO NO Seizures > 181 Days Scheduled Follow-up Submission Partial Remission/Response NO 2014-10-30 MALE NO YES Oligodendroglioma NO No C71.0 9450/3 C71.0 YES NO 80 Left NO NO NO NO NO G2 NO No A7RU Preoperative WITH TUMOR YES NO Partial Remission/Response NO Primary Tumor 01 YES NO Cerebral Cortex NO NO YES TQ Supratentorial, Temporal Lobe Central nervous system NO LIVING 2011 TCGA-TQ-A7RU-01 TCGA-TQ-A7RU-01A-21D-A34A-08 TCGA-TQ-A7RU-01A-21D-A349-01 c1132808-3c5c-47d8-90ad-b47f8d2d48c7 TCGA-TQ-A7RU-01 TCGA-TQ-A7RU-01 c1132808-3c5c-47d8-90ad-b47f8d2d48c7 TCGA-TQ-A7RU-01 TCGA-TQ-A7RU-01A-21D-A34D-05 c1132808-3c5c-47d8-90ad-b47f8d2d48c7 c1132808-3c5c-47d8-90ad-b47f8d2d48c7 TCGA-TQ-A7RU-01A-21D-A349-01 TCGA-TQ-A7RU-01A-21D-A34A-08 +TCGA-TQ-A7RV-01 TCGA-TQ-A7RV-01 TCGA-TQ-A7RV TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain YES YES 27 NO NO TCGA-TQ-A7RV-F61501 TCGA-TQ-A7RV TCGA-TQ-A7RV-01A 1141 -10167 1470 0 1868 530 -42 1 NO NO NO Sensory Changes > 181 Days Scheduled Follow-up Submission Progressive Disease NO 2014-10-7 MALE NO YES Astrocytoma NO No C71.0 9382/3 C71.0 YES NO 120 NO 80 Left NO NO YES NO YES G2 YES false No TCGA-TQ-A7RV.5316A44B-CF13-4A3B-AE9D-115383B906E2.pdf A7RV Preoperative WITH TUMOR YES NO Partial Remission/Response NO Primary Tumor 01 YES YES White Matter NO NO YES TQ Supratentorial, Temporal Lobe Central nervous system A NO LIVING 2009 TCGA-TQ-A7RV-01 79978CF1-31B5-487B-A07B-D603DFE0E2AA TCGA-TQ-A7RV-01A-21D-A34A-08 TCGA-TQ-A7RV-01A-21D-A349-01 44347235-2162-41f1-892e-1cf85f157ece TCGA-TQ-A7RV-01 TCGA-TQ-A7RV-01 44347235-2162-41f1-892e-1cf85f157ece TCGA-TQ-A7RV-01 TCGA-TQ-A7RV-01A-21D-A34D-05 44347235-2162-41f1-892e-1cf85f157ece 44347235-2162-41f1-892e-1cf85f157ece TCGA-TQ-A7RV-01A-21D-A349-01 TCGA-TQ-A7RV-01A-21D-A34A-08 +TCGA-TQ-A7RV-02 TCGA-TQ-A7RV-02 TCGA-TQ-A7RV TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain YES YES 27 NO NO TCGA-TQ-A7RV-F61501 TCGA-TQ-A7RV TCGA-TQ-A7RV-02A 1141 -10167 1544 0 1868 530 -42 1 NO NO NO Sensory Changes > 181 Days Scheduled Follow-up Submission Progressive Disease NO 2014-10-7 MALE NO YES Astrocytoma NO No C71.0 9382/3 C71.0 YES NO 200 NO 80 Left NO NO YES NO YES G2 YES true No TCGA-TQ-A7RV.98CC2EDE-4503-4D22-8F18-50E97255B658.pdf A7RV Preoperative WITH TUMOR YES NO Partial Remission/Response NO Recurrent Tumor 02 YES YES White Matter NO NO YES TQ Supratentorial, Temporal Lobe Central nervous system A NO LIVING 2009 D437652C-DCB7-406A-A528-8DAA24ED0771 TCGA-TQ-A7RV-02A-11D-A36O-08 5f1ec365-a309-4042-abc8-b8937497804f TCGA-TQ-A7RV-02 TCGA-TQ-A7RV-02 5f1ec365-a309-4042-abc8-b8937497804f TCGA-TQ-A7RV-02A-11D-A368-05 5f1ec365-a309-4042-abc8-b8937497804f 5f1ec365-a309-4042-abc8-b8937497804f +TCGA-TQ-A7RW-01 TCGA-TQ-A7RW-01 TCGA-TQ-A7RW TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain YES YES YES 32 NO NO TCGA-TQ-A7RW-F65651 TCGA-TQ-A7RW TCGA-TQ-A7RW-01A [Discrepancy] -11804 1022 821 0 511 529 0 NO NO NO Seizures 31 - 90 Days Scheduled Follow-up Submission Progressive Disease NO 2014-9-26 MALE NO NO Oligodendroglioma NO No C71.0 9382/3 C71.0 YES NO 90 NO 90 Left NO NO NO NO NO G2 YES false No TCGA-TQ-A7RW.CD826C0A-8057-4BD6-A79A-51277F0E09A7.pdf A7RW Pre-Adjuvant Therapy WITH TUMOR YES NO Progressive Disease YES Primary Tumor 01 YES NO Cerebral Cortex YES NO YES TQ Supratentorial, Temporal Lobe Central nervous system A NO DECEASED 2010 TCGA-TQ-A7RW-01 EA21636A-CEB6-4F29-8066-26C18499738B TCGA-TQ-A7RW-01A-11D-A33T-08 TCGA-TQ-A7RW-01A-11D-A33S-01 5c27c4d4-b3e7-4e44-a2c4-764b665d1bc0 TCGA-TQ-A7RW-01 TCGA-TQ-A7RW-01 5c27c4d4-b3e7-4e44-a2c4-764b665d1bc0 TCGA-TQ-A7RW-01 TCGA-TQ-A7RW-01A-11D-A33U-05 5c27c4d4-b3e7-4e44-a2c4-764b665d1bc0 5c27c4d4-b3e7-4e44-a2c4-764b665d1bc0 TCGA-TQ-A7RW-01A-11D-A33S-01 TCGA-TQ-A7RW-01A-11D-A33T-08 +TCGA-TQ-A8XE-01 TCGA-TQ-A8XE-01 TCGA-TQ-A8XE TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain YES YES NO 42 NO NO TCGA-TQ-A8XE-F61509 TCGA-TQ-A8XE TCGA-TQ-A8XE-01A -15629 1308 954 0 455 0 1 NO NO NO Headaches 91 - 180 Days Additional New Tumor Event Progressive Disease 2014-6-30 FEMALE NO YES Oligodendroglioma NO No C71.0 9450/3 C71.0 YES NO 130 NO 70 Left NO NO NO YES G2 YES true No TCGA-TQ-A8XE.431037B9-36D3-4978-AEED-F316933DC782.pdf A8XE Preoperative WITH TUMOR NO NO Partial Remission/Response NO Primary Tumor 01 NO YES White Matter NO NO NO TQ Supratentorial, Temporal Lobe Central nervous system A NO DECEASED 2010 TCGA-TQ-A8XE-01 F593DE74-5738-4BC0-A3F4-2442C39F1EC8 TCGA-TQ-A8XE-01A-11D-A36O-08 TCGA-TQ-A8XE-01A-11D-A36N-01 2593a422-98ab-4221-b22b-476e05df9ca0 TCGA-TQ-A8XE-01 TCGA-TQ-A8XE-01 2593a422-98ab-4221-b22b-476e05df9ca0 TCGA-TQ-A8XE-01 TCGA-TQ-A8XE-01A-11D-A368-05 2593a422-98ab-4221-b22b-476e05df9ca0 2593a422-98ab-4221-b22b-476e05df9ca0 TCGA-TQ-A8XE-01A-11D-A36N-01 TCGA-TQ-A8XE-01A-11D-A36O-08 +TCGA-TQ-A8XE-02 TCGA-TQ-A8XE-02 TCGA-TQ-A8XE TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain YES YES NO 42 NO NO TCGA-TQ-A8XE-F61509 TCGA-TQ-A8XE TCGA-TQ-A8XE-02A -15629 1308 954 0 455 0 1 NO NO NO Headaches 91 - 180 Days Additional New Tumor Event Progressive Disease 2014-6-30 FEMALE NO YES Oligodendroglioma NO No C71.0 9450/3 C71.0 YES NO 200 NO 70 Left NO NO NO YES G2 YES true No TCGA-TQ-A8XE.845B196D-DB8C-4AA6-A506-ED4D4364B51B.pdf A8XE Preoperative WITH TUMOR NO NO Partial Remission/Response NO Recurrent Tumor 02 NO YES White Matter NO NO NO TQ Supratentorial, Temporal Lobe Central nervous system A NO DECEASED 2010 F5B9878B-60B3-40F2-B63B-1D3F5A4236B6 TCGA-TQ-A8XE-02A-11D-A36O-08 10d307ce-8b3b-4486-b199-d2722a964a35 TCGA-TQ-A8XE-02 TCGA-TQ-A8XE-02 10d307ce-8b3b-4486-b199-d2722a964a35 TCGA-TQ-A8XE-02A-11D-A368-05 10d307ce-8b3b-4486-b199-d2722a964a35 10d307ce-8b3b-4486-b199-d2722a964a35 +TCGA-VM-A8C8-01 TCGA-VM-A8C8-01 TCGA-VM-A8C8 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain NO NO 50 TCGA-VM-A8C8-F69643 TCGA-VM-A8C8 TCGA-VM-A8C8-01A -18494 959 0 1397 19 YES NO Motor/Movement Changes > 181 Days Scheduled Follow-up Submission 2015-1-15 FEMALE YES NO Oligodendroglioma NO No C71.0 9450/3 C71.0 YES NO 90 Right YES IHC YES NO NO YES G2 NO false No TCGA-VM-A8C8.11BD5D8D-FB5B-4D96-A421-EC8524E8AA6C.pdf A8C8 Pre-Adjuvant Therapy YES Primary Tumor 01 NO NO Not listed in Medical Record YES NO YES VM Supratentorial, Temporal Lobe Central nervous system A NO LIVING 2011 TCGA-VM-A8C8-01 24E532BC-DBF4-4D67-9EC5-F237DC75482C TCGA-VM-A8C8-01A-11D-A36O-08 TCGA-VM-A8C8-01A-11D-A36N-01 23a4b76d-a3d3-4206-acd5-2eab6bd4face TCGA-VM-A8C8-01 TCGA-VM-A8C8-01 23a4b76d-a3d3-4206-acd5-2eab6bd4face TCGA-VM-A8C8-01 TCGA-VM-A8C8-01A-11D-A368-05 23a4b76d-a3d3-4206-acd5-2eab6bd4face 23a4b76d-a3d3-4206-acd5-2eab6bd4face TCGA-VM-A8C8-01A-11D-A36N-01 TCGA-VM-A8C8-01A-11D-A36O-08 +TCGA-VM-A8C9-01 TCGA-VM-A8C9-01 TCGA-VM-A8C9 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain NO NO 37 TCGA-VM-A8C9-F70437 TCGA-VM-A8C9 TCGA-VM-A8C9-01A -13663 847 0 1314 NO NO Seizures > 181 Days Scheduled Follow-up Submission Complete Remission/Response 2015-2-16 FEMALE YES Astrocytoma NO No C71.0 9400/3 C71.0 YES 120 NO Left NO NO NO NO G2 NO false No TCGA-VM-A8C9.572BF80A-ECDD-4EAF-A28D-7BFB0137A598.pdf A8C9 TUMOR FREE Complete Remission/Response NO Primary Tumor 01 YES NO Not listed in Medical Record NO NO YES VM Supratentorial, Temporal Lobe Central nervous system A NO LIVING 2011 TCGA-VM-A8C9-01 D9C62709-AE09-4083-92E1-4F8D5E85D305 TCGA-VM-A8C9-01A-11D-A36O-08 TCGA-VM-A8C9-01A-11D-A36N-01 ea214bab-dd3f-4594-9c93-e60fa586b3a4 TCGA-VM-A8C9-01 TCGA-VM-A8C9-01 ea214bab-dd3f-4594-9c93-e60fa586b3a4 TCGA-VM-A8C9-01 TCGA-VM-A8C9-01A-11D-A368-05 ea214bab-dd3f-4594-9c93-e60fa586b3a4 ea214bab-dd3f-4594-9c93-e60fa586b3a4 TCGA-VM-A8C9-01A-11D-A36N-01 TCGA-VM-A8C9-01A-11D-A36O-08 +TCGA-VM-A8CA-01 TCGA-VM-A8CA-01 TCGA-VM-A8CA TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 54 NO TCGA-VM-A8CA-F63647 TCGA-VM-A8CA TCGA-VM-A8CA-01A -19991 798 0 411 19 NO NO Mental Status Changes 0 - 30 Days Scheduled Follow-up Submission 2014-10-24 MALE NO Oligodendroglioma NO No C71.0 9450/3 C71.0 YES NO 160 NO 70 Left NO YES YES NO G2 false No TCGA-VM-A8CA.44E81259-80C6-4665-95DE-6D114AEE7761.pdf A8CA Pre-Adjuvant Therapy WITH TUMOR NO Primary Tumor 01 NO NO Not listed in Medical Record YES NO YES VM Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2011 TCGA-VM-A8CA-01 D73967F3-8696-4489-9445-255084106916 TCGA-VM-A8CA-01A-11D-A36O-08 TCGA-VM-A8CA-01A-11D-A36N-01 9fd5e9bf-8c29-4efc-bd33-1ed483153175 TCGA-VM-A8CA-01 TCGA-VM-A8CA-01 9fd5e9bf-8c29-4efc-bd33-1ed483153175 TCGA-VM-A8CA-01 TCGA-VM-A8CA-01A-11D-A368-05 9fd5e9bf-8c29-4efc-bd33-1ed483153175 9fd5e9bf-8c29-4efc-bd33-1ed483153175 TCGA-VM-A8CA-01A-11D-A36N-01 TCGA-VM-A8CA-01A-11D-A36O-08 +TCGA-VM-A8CB-01 TCGA-VM-A8CB-01 TCGA-VM-A8CB TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 33 TCGA-VM-A8CB-F66847 TCGA-VM-A8CB TCGA-VM-A8CB-01A -12340 738 0 3 NO NO Seizures 0 - 30 Days Scheduled Follow-up Submission 2014-10-24 MALE YES Oligodendroglioma NO No C71.0 9451/3 C71.0 YES NO 100 NO Left NO YES NO NO G3 false No TCGA-VM-A8CB.581F6861-4408-48DF-BBAB-62707C31090B.pdf A8CB TUMOR FREE YES YES Primary Tumor 01 YES NO Not listed in Medical Record NO YES VM Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2011 TCGA-VM-A8CB-01 B4478012-2551-431A-A612-37372DB433FD TCGA-VM-A8CB-01A-11D-A36O-08 TCGA-VM-A8CB-01A-11D-A36N-01 b22b56c2-3e66-430b-b1a5-3441b30551c3 TCGA-VM-A8CB-01 TCGA-VM-A8CB-01 b22b56c2-3e66-430b-b1a5-3441b30551c3 TCGA-VM-A8CB-01 TCGA-VM-A8CB-01A-11D-A368-05 b22b56c2-3e66-430b-b1a5-3441b30551c3 b22b56c2-3e66-430b-b1a5-3441b30551c3 TCGA-VM-A8CB-01A-11D-A36N-01 TCGA-VM-A8CB-01A-11D-A36O-08 +TCGA-VM-A8CD-01 TCGA-VM-A8CD-01 TCGA-VM-A8CD TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain NO NO 58 NO TCGA-VM-A8CD-F66848 TCGA-VM-A8CD TCGA-VM-A8CD-01A -21200 517 240 0 -43 YES NO Seizures > 181 Days Scheduled Follow-up Submission 2014-10-24 MALE YES Astrocytoma NO No C71.0 9401/3 C71.0 YES 110 NO 100 Right NO IHC YES NO YES NO G3 NO false No TCGA-VM-A8CD.CB64BE55-522F-4634-A7B4-17603D50EA3D.pdf A8CD Pre-Adjuvant Therapy WITH TUMOR YES NO YES Primary Tumor 01 YES NO Not listed in Medical Record NO NO YES VM Supratentorial, Temporal Lobe Central nervous system A YES DECEASED 2012 TCGA-VM-A8CD-01 1516F9F6-9BA3-46F2-A344-754491C8192E TCGA-VM-A8CD-01A-11D-A36O-08 TCGA-VM-A8CD-01A-11D-A36N-01 721a570e-56ea-4054-98c1-9ac2105c33ca TCGA-VM-A8CD-01 TCGA-VM-A8CD-01 721a570e-56ea-4054-98c1-9ac2105c33ca TCGA-VM-A8CD-01 TCGA-VM-A8CD-01A-11D-A368-05 721a570e-56ea-4054-98c1-9ac2105c33ca 721a570e-56ea-4054-98c1-9ac2105c33ca TCGA-VM-A8CD-01A-11D-A36N-01 TCGA-VM-A8CD-01A-11D-A36O-08 +TCGA-VM-A8CE-01 TCGA-VM-A8CE-01 TCGA-VM-A8CE TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain NO NO 25 NO TCGA-VM-A8CE-F69636 TCGA-VM-A8CE TCGA-VM-A8CE-01A -9363 780 0 1191 15 NO NO Seizures 0 - 30 Days Scheduled Follow-up Submission 2015-1-15 MALE NO Oligodendroglioma NO No C71.0 9450/3 C71.0 YES NO 100 NO 90 Left NO NO NO NO G2 NO false No TCGA-VM-A8CE.E89B7ED7-D8CA-4112-B0D9-0B2A72941DC8.pdf A8CE Pre-Adjuvant Therapy WITH TUMOR YES NO NO Primary Tumor 01 YES NO Not listed in Medical Record YES NO YES VM Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2011 TCGA-VM-A8CE-01 7F194143-201B-40DA-934B-D1126CE12FFB TCGA-VM-A8CE-01A-11D-A36O-08 TCGA-VM-A8CE-01A-11D-A36N-01 fc4a708f-1f6c-4ee8-bbc1-0a0ce1f37044 TCGA-VM-A8CE-01 TCGA-VM-A8CE-01 fc4a708f-1f6c-4ee8-bbc1-0a0ce1f37044 TCGA-VM-A8CE-01 TCGA-VM-A8CE-01A-11D-A368-05 fc4a708f-1f6c-4ee8-bbc1-0a0ce1f37044 fc4a708f-1f6c-4ee8-bbc1-0a0ce1f37044 TCGA-VM-A8CE-01A-11D-A36N-01 TCGA-VM-A8CE-01A-11D-A36O-08 +TCGA-VM-A8CF-01 TCGA-VM-A8CF-01 TCGA-VM-A8CF TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 44 TCGA-VM-A8CF-F66857 TCGA-VM-A8CF TCGA-VM-A8CF-01A -16334 280 0 609 26 NO NO Motor/Movement Changes > 181 Days Scheduled Follow-up Submission Stable Disease 2014-10-24 FEMALE NO Astrocytoma NO No C71.0 9401/3 C71.0 YES NO 90 NO 60 Left YES IHC YES NO NO YES G3 NO false No TCGA-VM-A8CF.3D01CE9E-83E3-4D46-A3C2-43D63BAE212B.pdf A8CF Pre-Adjuvant Therapy TUMOR FREE NO NO YES Primary Tumor 01 NO NO Not listed in Medical Record YES NO YES VM Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2013 TCGA-VM-A8CF-01 TCGA-VM-A8CF-01A-11D-A36O-08 TCGA-VM-A8CF-01A-11D-A36N-01 6f1fe75a-f3ef-4f1b-9781-e340db9bab45 TCGA-VM-A8CF-01 TCGA-VM-A8CF-01 6f1fe75a-f3ef-4f1b-9781-e340db9bab45 TCGA-VM-A8CF-01 TCGA-VM-A8CF-01A-11D-A368-05 6f1fe75a-f3ef-4f1b-9781-e340db9bab45 6f1fe75a-f3ef-4f1b-9781-e340db9bab45 TCGA-VM-A8CF-01A-11D-A36N-01 TCGA-VM-A8CF-01A-11D-A36O-08 +TCGA-VM-A8CH-01 TCGA-VM-A8CH-01 TCGA-VM-A8CH TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 24 TCGA-VM-A8CH-F69641 TCGA-VM-A8CH TCGA-VM-A8CH-01A -9005 300 0 714 -38 YES NO Seizures > 181 Days Scheduled Follow-up Submission 2015-1-15 FEMALE YES Astrocytoma NO No C71.0 9400/3 C71.0 YES NO 110 NO 90 Right YES IHC YES NO NO YES G2 NO false No TCGA-VM-A8CH.A289AB8D-8051-48E9-91FE-0420ED724E93.pdf A8CH Preoperative TUMOR FREE YES NO Complete Remission/Response NO Primary Tumor 01 YES YES Not listed in Medical Record NO NO YES VM Supratentorial, Frontal Lobe Central nervous system A YES LIVING 2013 TCGA-VM-A8CH-01 540778AF-4BA9-4CB9-8E7B-F28DA1446E78 TCGA-VM-A8CH-01A-12D-A36O-08 TCGA-VM-A8CH-01A-12D-A36N-01 bd46f867-070c-49a3-9180-8c78b72183a8 TCGA-VM-A8CH-01 TCGA-VM-A8CH-01 bd46f867-070c-49a3-9180-8c78b72183a8 TCGA-VM-A8CH-01 TCGA-VM-A8CH-01A-12D-A368-05 bd46f867-070c-49a3-9180-8c78b72183a8 bd46f867-070c-49a3-9180-8c78b72183a8 TCGA-VM-A8CH-01A-12D-A36N-01 TCGA-VM-A8CH-01A-12D-A36O-08 +TCGA-VV-A829-01 TCGA-VV-A829-01 TCGA-VV-A829 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 44 NO NO TCGA-VV-A829-F65521 TCGA-VV-A829 TCGA-VV-A829-01A -16163 720 0 1127 YES NO Motor/Movement Changes 0 - 30 Days Scheduled Follow-up Submission Complete Remission/Response NO 2014-10-2 MALE NO NO Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES 140 NO Left NO NO NO NO YES G3 NO true No TCGA-VV-A829.CD914F13-6DA0-47EE-90AD-DD2C3F2A727B.pdf A829 TUMOR FREE Stable Disease YES Primary Tumor 01 NO NO Not listed in Medical Record YES NO YES VV Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2011 TCGA-VV-A829-01 42A5874A-AA76-4B75-A853-5081F1EAC89F TCGA-VV-A829-01A-21D-A36O-08 TCGA-VV-A829-01A-21D-A36N-01 13d82ac1-eecc-41bb-af05-4fd4f614f260 TCGA-VV-A829-01 TCGA-VV-A829-01 13d82ac1-eecc-41bb-af05-4fd4f614f260 TCGA-VV-A829-01 TCGA-VV-A829-01A-21D-A368-05 13d82ac1-eecc-41bb-af05-4fd4f614f260 13d82ac1-eecc-41bb-af05-4fd4f614f260 TCGA-VV-A829-01A-21D-A36N-01 TCGA-VV-A829-01A-21D-A36O-08 +TCGA-VV-A86M-01 TCGA-VV-A86M-01 TCGA-VV-A86M TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 36 NO NO TCGA-VV-A86M-F66128 TCGA-VV-A86M TCGA-VV-A86M-01A -13453 111 0 487 Sensory Changes > 181 Days Scheduled Follow-up Submission Complete Remission/Response NO 2014-10-2 FEMALE NO NO Astrocytoma NO No C71.0 9401/3 C71.0 YES 270 NO Left NO YES NO NO G3 NO true No TCGA-VV-A86M.866E82BA-87CA-408F-A0E5-13ECE3AC8059.pdf A86M TUMOR FREE YES Primary Tumor 01 YES YES Not listed in Medical Record YES NO YES VV Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2013 TCGA-VV-A86M-01 1D07DB0A-2848-4435-BA00-F487A4C96CAB TCGA-VV-A86M-01A-11D-A36O-08 TCGA-VV-A86M-01A-11D-A36N-01 b1a7c6af-dc87-43c9-9394-5907e610446f TCGA-VV-A86M-01 TCGA-VV-A86M-01 b1a7c6af-dc87-43c9-9394-5907e610446f TCGA-VV-A86M-01 TCGA-VV-A86M-01A-11D-A368-05 b1a7c6af-dc87-43c9-9394-5907e610446f b1a7c6af-dc87-43c9-9394-5907e610446f TCGA-VV-A86M-01A-11D-A36N-01 TCGA-VV-A86M-01A-11D-A36O-08 +TCGA-VW-A7QS-01 TCGA-VW-A7QS-01 TCGA-VW-A7QS TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 35 NO NO TCGA-VW-A7QS TCGA-VW-A7QS-01A -12820 805 0 706 NO NO NO Headaches 31 - 90 Days NO 2013-12-12 FEMALE NO YES Oligodendroglioma NO No C71.0 9451/3 C71.0 YES NO 260 NO Right NO YES NO NO G3 NO true No TCGA-VW-A7QS.47DD727D-85CE-4CBC-8FE6-7003BF110D4A.pdf A7QS WITH TUMOR YES YES Stable Disease NO Primary Tumor 01 NO NO Not listed in Medical Record YES NO YES VW Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2011 TCGA-VW-A7QS-01 9FF8F7FE-F59D-4869-8A06-546941288B62 TCGA-VW-A7QS-01A-12D-A33T-08 TCGA-VW-A7QS-01A-12D-A33S-01 adb5aa16-9fe9-4369-a80e-e6eecda07322 TCGA-VW-A7QS-01 TCGA-VW-A7QS-01 adb5aa16-9fe9-4369-a80e-e6eecda07322 TCGA-VW-A7QS-01 TCGA-VW-A7QS-01A-12D-A33U-05 adb5aa16-9fe9-4369-a80e-e6eecda07322 adb5aa16-9fe9-4369-a80e-e6eecda07322 TCGA-VW-A7QS-01A-12D-A33S-01 TCGA-VW-A7QS-01A-12D-A33T-08 +TCGA-VW-A8FI-01 TCGA-VW-A8FI-01 TCGA-VW-A8FI TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 66 NO NO TCGA-VW-A8FI TCGA-VW-A8FI-01A -24411 154 245 0 NO NO NO Mental Status Changes 31 - 90 Days NO 2014-3-10 MALE NO NO Astrocytoma NO No C71.0 9401/3 C71.0 YES NO 40 NO Left NO YES NO NO G3 NO true No TCGA-VW-A8FI.B073A7FE-1986-4EF7-B186-F6017EE50452.pdf A8FI WITH TUMOR NO NO Stable Disease YES Primary Tumor 01 NO NO White Matter YES YES NO VW Supratentorial, Temporal Lobe Central nervous system A NO DECEASED 2013 TCGA-VW-A8FI-01 TCGA-VW-A8FI-01A-11D-A36O-08 TCGA-VW-A8FI-01A-11D-A36N-01 9b6fc8d2-b1a5-4b8e-81d3-18258860b4b5 TCGA-VW-A8FI-01 TCGA-VW-A8FI-01 9b6fc8d2-b1a5-4b8e-81d3-18258860b4b5 TCGA-VW-A8FI-01 TCGA-VW-A8FI-01A-11D-A368-05 9b6fc8d2-b1a5-4b8e-81d3-18258860b4b5 9b6fc8d2-b1a5-4b8e-81d3-18258860b4b5 TCGA-VW-A8FI-01A-11D-A36N-01 TCGA-VW-A8FI-01A-11D-A36O-08 +TCGA-W9-A837-01 TCGA-W9-A837-01 TCGA-W9-A837 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 47 NO TCGA-W9-A837-F66176 TCGA-W9-A837 TCGA-W9-A837-01A 1298 0 1553 610 1 NO NO NO Seizures > 181 Days Scheduled Follow-up Submission Stable Disease 2014-10-3 MALE NO NO Oligodendroglioma NO No C71.0 9450/3 C71.0 YES 530 NO Right NO NO NO NO NO G2 NO false No TCGA-W9-A837.278CE30B-6EAA-47C3-9D21-F3F7142852D8.pdf A837 WITH TUMOR YES Stable Disease NO Primary Tumor 01 YES NO Not listed in Medical Record NO NO YES W9 Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2010 TCGA-W9-A837-01 B997883B-B7A5-4BD3-AC89-AD1DCEA8E01B TCGA-W9-A837-01A-11D-A36O-08 TCGA-W9-A837-01A-11D-A36N-01 d48e6a92-05f9-4400-828c-e3fdb17c99ac TCGA-W9-A837-01 TCGA-W9-A837-01 d48e6a92-05f9-4400-828c-e3fdb17c99ac TCGA-W9-A837-01 TCGA-W9-A837-01A-11D-A368-05 d48e6a92-05f9-4400-828c-e3fdb17c99ac d48e6a92-05f9-4400-828c-e3fdb17c99ac TCGA-W9-A837-01A-11D-A36N-01 TCGA-W9-A837-01A-11D-A36O-08 +TCGA-WH-A86K-01 TCGA-WH-A86K-01 TCGA-WH-A86K TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 65 NO NO TCGA-WH-A86K-F67062 TCGA-WH-A86K TCGA-WH-A86K-01A -24055 112 0 405 20 0 NO NO NO Motor/Movement Changes 0 - 30 Days Scheduled Follow-up Submission Stable Disease NO 2014-11-4 MALE NO NO Astrocytoma NO No C71.0 9400/3 C71.0 YES 30 NO Right YES IHC YES NO NO NO YES G2 NO false No TCGA-WH-A86K.BA54C0C4-01A6-4764-ABEC-F38C6F89F1BA.pdf A86K Pre-Adjuvant Therapy WITH TUMOR Stable Disease NO Primary Tumor 01 YES NO Not listed in Medical Record NO NO YES WH Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2013 TCGA-WH-A86K-01 TCGA-WH-A86K-01A-11D-A36O-08 TCGA-WH-A86K-01A-11D-A36N-01 9102949f-fd0d-4b62-bc30-6451f6dd8fb4 TCGA-WH-A86K-01 TCGA-WH-A86K-01 9102949f-fd0d-4b62-bc30-6451f6dd8fb4 TCGA-WH-A86K-01 TCGA-WH-A86K-01A-11D-A368-05 9102949f-fd0d-4b62-bc30-6451f6dd8fb4 9102949f-fd0d-4b62-bc30-6451f6dd8fb4 TCGA-WH-A86K-01A-11D-A36N-01 TCGA-WH-A86K-01A-11D-A36O-08 +TCGA-WY-A858-01 TCGA-WY-A858-01 TCGA-WY-A858 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 32 NO TCGA-WY-A858 -11855 0 1337 45 0 NO NO Headaches 0 - 30 Days YES fresh pitted fruit 2014-2-10 FEMALE YES YES Astrocytoma NO No C71.0 9401/3 C71.0 YES NO 100 Left NO NO G3 NO No A858 Pre-Adjuvant Therapy TUMOR FREE NO NO Complete Remission/Response YES Primary Tumor 01 NO NO Not listed in Medical Record YES NO YES WY Supratentorial, Frontal Lobe Central nervous system NO LIVING 2010 TCGA-WY-A858-01 TCGA-WY-A858-01A-11D-A36O-08 TCGA-WY-A858-01A-11D-A36N-01 cd61bf43-fca1-49b2-824e-133484a6e069 TCGA-WY-A858-01 TCGA-WY-A858-01 cd61bf43-fca1-49b2-824e-133484a6e069 TCGA-WY-A858-01 TCGA-WY-A858-01A-11D-A368-05 cd61bf43-fca1-49b2-824e-133484a6e069 cd61bf43-fca1-49b2-824e-133484a6e069 TCGA-WY-A858-01A-11D-A36N-01 TCGA-WY-A858-01A-11D-A36O-08 +TCGA-WY-A859-01 TCGA-WY-A859-01 TCGA-WY-A859 TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 34 NO NO TCGA-WY-A859 -12631 0 1213 293 0 NO NO Seizures 0 - 30 Days NO 2014-2-20 FEMALE NO NO Astrocytoma NO No C71.0 9400/3 C71.0 YES NO 100 Left NO NO NO G2 NO No A859 Pre-Adjuvant Therapy WITH TUMOR YES Stable Disease YES Primary Tumor 01 YES NO Not listed in Medical Record NO NO YES WY Supratentorial, Frontal Lobe Central nervous system NO LIVING 2010 TCGA-WY-A859-01 TCGA-WY-A859-01A-12D-A36O-08 TCGA-WY-A859-01A-12D-A36N-01 d8c06e36-816f-420e-9b5b-68f2e9417e96 TCGA-WY-A859-01 TCGA-WY-A859-01 d8c06e36-816f-420e-9b5b-68f2e9417e96 TCGA-WY-A859-01 TCGA-WY-A859-01A-12D-A368-05 d8c06e36-816f-420e-9b5b-68f2e9417e96 d8c06e36-816f-420e-9b5b-68f2e9417e96 TCGA-WY-A859-01A-12D-A36N-01 TCGA-WY-A859-01A-12D-A36O-08 +TCGA-WY-A85A-01 TCGA-WY-A85A-01 TCGA-WY-A85A TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 20 NO NO TCGA-WY-A85A TCGA-WY-A85A-01A -7380 1203 0 1320 718 0 NO NO NO Seizures 0 - 30 Days NO 2014-2-27 MALE NO NO Astrocytoma NO No C71.0 9400/3 C71.0 YES NO 500 NO Right NO NO NO NO G2 NO true No TCGA-WY-A85A.AEC260E5-995F-439A-8042-788A2EEAB136.pdf A85A TUMOR FREE YES YES Partial Remission/Response NO Primary Tumor 01 YES NO Not listed in Medical Record NO NO YES WY Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2010 TCGA-WY-A85A-01 TCGA-WY-A85A-01A-21D-A36O-08 TCGA-WY-A85A-01A-21D-A36N-01 055357fc-1a16-4ff4-a826-2e87a9e99190 TCGA-WY-A85A-01 TCGA-WY-A85A-01 055357fc-1a16-4ff4-a826-2e87a9e99190 TCGA-WY-A85A-01 TCGA-WY-A85A-01A-21D-A368-05 055357fc-1a16-4ff4-a826-2e87a9e99190 055357fc-1a16-4ff4-a826-2e87a9e99190 TCGA-WY-A85A-01A-21D-A36N-01 TCGA-WY-A85A-01A-21D-A36O-08 +TCGA-WY-A85B-01 TCGA-WY-A85B-01 TCGA-WY-A85B TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 24 NO NO TCGA-WY-A85B-F65769 TCGA-WY-A85B TCGA-WY-A85B-01A -8817 1073 0 1393 0 YES NO Seizures 0 - 30 Days Scheduled Follow-up Submission NO 2015-1-22 MALE NO YES Astrocytoma NO No C71.0 9400/3 C71.0 YES NO 420 NO Right NO NO NO NO G2 NO true No TCGA-WY-A85B.3BB27604-CFD2-4C1D-A53A-BB6EFA5F1D67.pdf A85B TUMOR FREE YES Complete Remission/Response NO Primary Tumor 01 YES YES Not listed in Medical Record NO NO YES WY Supratentorial, Temporal Lobe Central nervous system A NO LIVING 2010 TCGA-WY-A85B-01 CFAD9888-5EBD-4B3D-AD26-7F8F5A704FED TCGA-WY-A85B-01A-11D-A36O-08 TCGA-WY-A85B-01A-11D-A36N-01 48ffe5e4-5aec-41fd-8b5f-78466a593eef TCGA-WY-A85B-01 TCGA-WY-A85B-01 48ffe5e4-5aec-41fd-8b5f-78466a593eef TCGA-WY-A85B-01 TCGA-WY-A85B-01A-11D-A368-05 48ffe5e4-5aec-41fd-8b5f-78466a593eef 48ffe5e4-5aec-41fd-8b5f-78466a593eef TCGA-WY-A85B-01A-11D-A36N-01 TCGA-WY-A85B-01A-11D-A36O-08 +TCGA-WY-A85C-01 TCGA-WY-A85C-01 TCGA-WY-A85C TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain YES 36 NO NO TCGA-WY-A85C-F65786 TCGA-WY-A85C TCGA-WY-A85C-01A 1337 -13506 1119 0 1426 1261 1 NO NO Headaches 0 - 30 Days Scheduled Follow-up Submission Progressive Disease NO 2015-1-22 MALE NO YES Astrocytoma NO No C71.0 9400/3 C71.0 YES NO 300 NO Right NO NO NO NO YES G2 YES true No TCGA-WY-A85C.2CB63EDD-F6C4-4CE9-AB8D-E6A5172E43FD.pdf A85C WITH TUMOR YES YES Progressive Disease YES Primary Tumor 01 NO YES Not listed in Medical Record YES NO YES WY Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2010 TCGA-WY-A85C-01 3C5DF087-EDD2-4A7B-8CC5-DC3DB994C7FE TCGA-WY-A85C-01A-11D-A36O-08 TCGA-WY-A85C-01A-11D-A36N-01 5a4d2d74-6bf6-455c-87ad-5b51725bd04f TCGA-WY-A85C-01 TCGA-WY-A85C-01 5a4d2d74-6bf6-455c-87ad-5b51725bd04f TCGA-WY-A85C-01 TCGA-WY-A85C-01A-11D-A368-05 5a4d2d74-6bf6-455c-87ad-5b51725bd04f 5a4d2d74-6bf6-455c-87ad-5b51725bd04f TCGA-WY-A85C-01A-11D-A36N-01 TCGA-WY-A85C-01A-11D-A36O-08 +TCGA-WY-A85D-01 TCGA-WY-A85D-01 TCGA-WY-A85D TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain 60 NO NO TCGA-WY-A85D TCGA-WY-A85D-01A -21979 1035 0 1147 1 NO YES NO Sensory Changes > 181 Days NO 2014-2-26 MALE NO NO Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES NO 120 NO Right NO NO NO NO G2 YES true No TCGA-WY-A85D.82FFEB3D-5C1C-4FF0-A824-5C24F3B82B3C.pdf A85D WITH TUMOR NO YES Partial Remission/Response NO Primary Tumor 01 NO YES Not listed in Medical Record NO NO YES WY Supratentorial, Frontal Lobe Central nervous system A YES LIVING 2010 TCGA-WY-A85D-01 BE656A23-20F3-42C7-B376-D6FA03389E49 TCGA-WY-A85D-01A-11D-A36O-08 TCGA-WY-A85D-01A-11D-A36N-01 0b4aa4f0-32cb-4974-892c-6dba516cc85b TCGA-WY-A85D-01 TCGA-WY-A85D-01 0b4aa4f0-32cb-4974-892c-6dba516cc85b TCGA-WY-A85D-01 TCGA-WY-A85D-01A-11D-A368-05 0b4aa4f0-32cb-4974-892c-6dba516cc85b 0b4aa4f0-32cb-4974-892c-6dba516cc85b TCGA-WY-A85D-01A-11D-A36N-01 TCGA-WY-A85D-01A-11D-A36O-08 +TCGA-WY-A85E-01 TCGA-WY-A85E-01 TCGA-WY-A85E TCGA Lower Grade Glioma (LGG) brain lower grade glioma Brain YES YES YES 48 NO NO TCGA-WY-A85E-F65805 TCGA-WY-A85E TCGA-WY-A85E-01A 536 -17878 794 0 633 532 311 1 NO NO Seizures 31 - 90 Days Scheduled Follow-up Submission Progressive Disease YES seafood, nuts 2015-1-22 FEMALE NO NO Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES NO 60 NO Left NO NO NO NO NO G2 YES true No TCGA-WY-A85E.BD5E04AC-1E0D-400E-B5A8-A08844543CE4.pdf A85E WITH TUMOR YES NO Partial Remission/Response NO Primary Tumor 01 YES NO NO NO YES WY Supratentorial, Frontal Lobe Central nervous system A YES LIVING 2011 TCGA-WY-A85E-01 TCGA-WY-A85E-01A-11D-A36O-08 TCGA-WY-A85E-01A-11D-A40C-01 478c54a0-9aff-4f34-adfd-477eaf62b896 TCGA-WY-A85E-01 TCGA-WY-A85E-01 478c54a0-9aff-4f34-adfd-477eaf62b896 TCGA-WY-A85E-01 TCGA-WY-A85E-01A-11D-A368-05 478c54a0-9aff-4f34-adfd-477eaf62b896 478c54a0-9aff-4f34-adfd-477eaf62b896 TCGA-WY-A85E-01A-11D-A40C-01 TCGA-WY-A85E-01A-11D-A36O-08 diff --git a/input/TCGA/TCGA_Lung_Adenocarcinoma_(LUAD)/TCGA.LUAD.sampleMap_HiSeqV2_PANCAN.gz b/input/TCGA/TCGA_Lung_Adenocarcinoma_(LUAD)/TCGA.LUAD.sampleMap_HiSeqV2_PANCAN.gz new file mode 100644 index 0000000000000000000000000000000000000000..f5d58d0df96090da051573895fe6197298346200 --- /dev/null +++ b/input/TCGA/TCGA_Lung_Adenocarcinoma_(LUAD)/TCGA.LUAD.sampleMap_HiSeqV2_PANCAN.gz @@ -0,0 +1,3 @@ +version https://git-lfs.github.com/spec/v1 +oid sha256:c015d5a90f82eba66e63065f7a6ef06853d405dd7983dfb1f1addefbc146a9d9 +size 40920908 diff --git a/input/TCGA/TCGA_Lung_Adenocarcinoma_(LUAD)/TCGA.LUAD.sampleMap_LUAD_clinicalMatrix b/input/TCGA/TCGA_Lung_Adenocarcinoma_(LUAD)/TCGA.LUAD.sampleMap_LUAD_clinicalMatrix new file mode 100644 index 0000000000000000000000000000000000000000..5e3dcad39f5e3a670f6890d858f28321494f3bb4 --- /dev/null +++ b/input/TCGA/TCGA_Lung_Adenocarcinoma_(LUAD)/TCGA.LUAD.sampleMap_LUAD_clinicalMatrix @@ -0,0 +1,707 @@ +sampleID ABSOLUTE_Ploidy ABSOLUTE_Purity AKT1 ALK_translocation BRAF CBL CTNNB1 Canonical_mut_in_KRAS_EGFR_ALK Cnncl_mt_n_KRAS_EGFR_ALK_RET_ROS1_BRAF_ERBB2_HRAS_NRAS_AKT1_MAP2 EGFR ERBB2 ERBB4 Estimated_allele_fraction_of_a_clonal_varnt_prsnt_t_1_cpy_pr_cll Expression_Subtype HRAS KRAS MAP2K1 MET NRAS PIK3CA PTPN11 Pathology Pathology_Updated RET_translocation ROS1_translocation STK11 WGS_as_of_20120731_0_no_1_yes _INTEGRATION _PANCAN_CNA_PANCAN_K8 _PANCAN_Cluster_Cluster_PANCAN _PANCAN_DNAMethyl_LUAD _PANCAN_DNAMethyl_PANCAN _PANCAN_RPPA_PANCAN_K8 _PANCAN_UNC_RNAseq_PANCAN_K16 _PANCAN_miRNA_PANCAN _PANCAN_mirna_LUAD _PANCAN_mutation_PANCAN _PATIENT _cohort _primary_disease _primary_site additional_pharmaceutical_therapy additional_radiation_therapy additional_surgery_locoregional_procedure additional_surgery_metastatic_procedure age_at_initial_pathologic_diagnosis anatomic_neoplasm_subdivision anatomic_neoplasm_subdivision_other bcr_followup_barcode bcr_patient_barcode bcr_sample_barcode days_to_additional_surgery_locoregional_procedure days_to_additional_surgery_metastatic_procedure days_to_birth days_to_collection days_to_death days_to_initial_pathologic_diagnosis days_to_last_followup days_to_new_tumor_event_after_initial_treatment disease_code dlco_predictive_percent eastern_cancer_oncology_group egfr_mutation_performed egfr_mutation_result eml4_alk_translocation_method eml4_alk_translocation_performed followup_case_report_form_submission_reason followup_treatment_success form_completion_date gender histological_type history_of_neoadjuvant_treatment icd_10 icd_o_3_histology icd_o_3_site informed_consent_verified initial_weight intermediate_dimension is_ffpe karnofsky_performance_score kras_gene_analysis_performed kras_mutation_found kras_mutation_result location_in_lung_parenchyma longest_dimension lost_follow_up new_neoplasm_event_type new_tumor_event_after_initial_treatment number_pack_years_smoked oct_embedded other_dx pathologic_M pathologic_N pathologic_T pathologic_stage pathology_report_file_name patient_id performance_status_scale_timing person_neoplasm_cancer_status post_bronchodilator_fev1_fvc_percent post_bronchodilator_fev1_percent pre_bronchodilator_fev1_fvc_percent pre_bronchodilator_fev1_percent primary_therapy_outcome_success progression_determined_by project_code pulmonary_function_test_performed radiation_therapy residual_tumor sample_type sample_type_id shortest_dimension stopped_smoking_year system_version targeted_molecular_therapy tissue_prospective_collection_indicator tissue_retrospective_collection_indicator tissue_source_site tobacco_smoking_history tobacco_smoking_history_indicator tumor_tissue_site vial_number vital_status year_of_initial_pathologic_diagnosis year_of_tobacco_smoking_onset _GENOMIC_ID_TCGA_LUAD_mutation _GENOMIC_ID_TCGA_LUAD_mutation_curated_broad_gene _GENOMIC_ID_TCGA_LUAD_PDMarray _GENOMIC_ID_TCGA_LUAD_exp_HiSeqV2 _GENOMIC_ID_TCGA_LUAD_G4502A_07_3 _GENOMIC_ID_TCGA_LUAD_hMethyl27 _GENOMIC_ID_data/public/TCGA/LUAD/miRNA_GA_gene _GENOMIC_ID_TCGA_LUAD_gistic2 _GENOMIC_ID_TCGA_LUAD_hMethyl450 _GENOMIC_ID_TCGA_LUAD_PDMRNAseqCNV _GENOMIC_ID_TCGA_LUAD_gistic2thd _GENOMIC_ID_TCGA_LUAD_PDMarrayCNV _GENOMIC_ID_TCGA_LUAD_exp_HiSeqV2_exon _GENOMIC_ID_TCGA_LUAD_miRNA_HiSeq _GENOMIC_ID_TCGA_LUAD_RPPA_RBN _GENOMIC_ID_TCGA_LUAD_exp_HiSeqV2_PANCAN _GENOMIC_ID_TCGA_LUAD_PDMRNAseq _GENOMIC_ID_TCGA_LUAD_RPPA _GENOMIC_ID_TCGA_LUAD_exp_HiSeqV2_percentile _GENOMIC_ID_TCGA_LUAD_mutation_broad_gene _GENOMIC_ID_data/public/TCGA/LUAD/miRNA_HiSeq_gene _GENOMIC_ID_TCGA_LUAD_miRNA_GA +TCGA-05-4244-01 TCGA-05-4244-01 High C1-LUAD-enriched Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 4 mutation cluster 12 TCGA-05-4244 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 70 R-Lower TCGA-05-4244 TCGA-05-4244-01A -25752 0 0 2010-7-22 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 0.9 NO Peripheral Lung 1.1 38 No M1 N2 T2 Stage IV TCGA-05-4244.3a844132-f813-4d8e-8f7d-dbae0b23d7fd.pdf 4244 TUMOR FREE RX Primary Tumor 01 0.3 6th NO YES 05 4 Lung A LIVING 2009 TCGA-05-4244-01A-01D-1105-08 TCGA-05-4244-01 e6a101b9-61f9-4ed1-a59f-d9db3fdb4555 TCGA-05-4244-01A-01R-1107-07 TCGA-05-4244-01A-01D-1104-05 TCGA-05-4244-01 TCGA-05-4244-01A-01D-1877-01 TCGA-05-4244-01 TCGA-05-4244-01A-01D-1877-01 TCGA-05-4244-01 e6a101b9-61f9-4ed1-a59f-d9db3fdb4555 TCGA-05-4244-01A-21-2190-20 e6a101b9-61f9-4ed1-a59f-d9db3fdb4555 TCGA-05-4244-01 59881fe3-70f4-4fa0-9355-f50250872752 e6a101b9-61f9-4ed1-a59f-d9db3fdb4555 TCGA-05-4244-01A-01D-1105-08 TCGA-05-4244-01 +TCGA-05-4249-01 3.77 0.46 none p.A762E none none Y Y none none none 0.16 Bronchioid none p.G12C none none none p.E545K none Papillary predominant Adc Papillary predominant Adc none 0 TCGA-05-4249-01 BRCA-LUAD+ C1-LUAD-enriched Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 4 cluster 1 mutation cluster 1 TCGA-05-4249 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 67 R-Lower TCGA-05-4249-F36327 TCGA-05-4249 TCGA-05-4249-01A -24532 0 1523 Scheduled Follow-up Submission Complete Remission/Response 2012-10-29 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 0.8 NO Peripheral Lung 1.4 NO NO 52 No M0 N0 T2 Stage IB TCGA-05-4249.7e920317-d5c2-4160-9e2b-ef0101eb5a23.pdf 4249 TUMOR FREE NO R0 Primary Tumor 01 0.4 6th NO NO YES 05 3 Current reformed smoker for > 15 years Lung A LIVING 2007 TCGA-05-4249-01A-01D-1105-08 TCGA-05-4249-01A-01D-1105-08 TCGA-05-4249-01 d1a8d88d-1708-4959-9695-6f2e67853bd5 TCGA-05-4249-01A-01R-1107-07 TCGA-05-4249-01A-01D-1104-05 TCGA-05-4249-01 TCGA-05-4249-01A-01D-1877-01 TCGA-05-4249-01 TCGA-05-4249-01A-01D-1877-01 TCGA-05-4249-01 d1a8d88d-1708-4959-9695-6f2e67853bd5 TCGA-05-4249-01A-21-2190-20 d1a8d88d-1708-4959-9695-6f2e67853bd5 TCGA-05-4249-01 5b46a235-49a6-43ea-91b6-82a384702477 d1a8d88d-1708-4959-9695-6f2e67853bd5 TCGA-05-4249-01A-01D-1105-08 TCGA-05-4249-01 +TCGA-05-4250-01 TCGA-05-4250-01 High C1-LUAD-enriched Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 4 mutation cluster 12 TCGA-05-4250 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 79 R-Lower TCGA-05-4250 TCGA-05-4250-01A -29068 121 0 2010-7-22 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 0.7 NO 1.2 47 No M0 N1 T3 Stage IIIA TCGA-05-4250.5574f2f8-f247-40e6-a285-7793edcf5358.pdf 4250 R2 Primary Tumor 01 0.3 6th NO YES 05 4 Lung A DECEASED 2007 TCGA-05-4250-01A-01D-1105-08 TCGA-05-4250-01 bba9333a-09f7-4585-b22e-e4ae4049f7da TCGA-05-4250-01A-01R-1107-07 TCGA-05-4250-01A-01D-1104-05 TCGA-05-4250-01 TCGA-05-4250-01A-01D-1877-01 TCGA-05-4250-01 TCGA-05-4250-01A-01D-1877-01 TCGA-05-4250-01 bba9333a-09f7-4585-b22e-e4ae4049f7da TCGA-05-4250-01A-21-2190-20 bba9333a-09f7-4585-b22e-e4ae4049f7da TCGA-05-4250-01 3f069d62-c371-4f30-bdb4-c58093bbb1d7 bba9333a-09f7-4585-b22e-e4ae4049f7da TCGA-05-4250-01A-01D-1105-08 TCGA-05-4250-01 +TCGA-05-4382-01 none p.L613F none none N N p.R222L, p.E545Q none p.D922E Squamoid none none none none none none none Solid predominant Adc Solid predominant Adc none 0 TCGA-05-4382-01 High C1-LUAD-enriched Cluster 5 LUAD-like c10 miRNA cluster 4 cluster 2 mutation cluster 11 TCGA-05-4382 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung YES 68 L-Upper TCGA-05-4382-F36329 TCGA-05-4382 -24868 0 607 334 Scheduled Follow-up Submission Complete Remission/Response 2012-10-29 MALE Lung Adenocarcinoma Mixed Subtype No C34.1 8255/3 C34.1 YES NO Distant Metastasis YES 62 Yes M0 N0 T2 Stage IB 4382 TUMOR FREE Complete Remission/Response YES R0 Primary Tumor 01 6th NO NO YES 05 4 Current reformed smoker for < or = 15 years Lung LIVING 2009 TCGA-05-4382-01A-01D-1265-08 TCGA-05-4382-01A-01D-1265-08 e4177b01-6898-4bb7-b38d-0c09f85c5668 TCGA-05-4382-01A-01D-1205-05 TCGA-05-4382-01 TCGA-05-4382-01A-01D-1204-01 TCGA-05-4382-01 TCGA-05-4382-01A-01D-1204-01 e4177b01-6898-4bb7-b38d-0c09f85c5668 e4177b01-6898-4bb7-b38d-0c09f85c5668 TCGA-05-4382-01 e4177b01-6898-4bb7-b38d-0c09f85c5668 TCGA-05-4382-01A-01D-1931-08 TCGA-05-4382-01 +TCGA-05-4384-01 2.04 0.48 none none none p.F777S N N none p.S633_splice none 0.24 Bronchioid none none none none none none none Papillary predominant Adc Papillary predominant Adc none 0 TCGA-05-4384-01 Iq C1-LUAD-enriched cluster 3 Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 5 cluster 3 mutation cluster 5 TCGA-05-4384 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung YES 66 R-Lower TCGA-05-4384-F36330 TCGA-05-4384 TCGA-05-4384-01A -24411 0 426 183 Scheduled Follow-up Submission Progressive Disease 2012-10-29 MALE Lung Adenocarcinoma Mixed Subtype No C34.3 8255/3 C34.3 YES 0.8 NO 0.8 NO Distant Metastasis YES 20 Yes M0 N2 T2 Stage IIIA TCGA-05-4384.b70e95c5-2e6c-4409-8bbd-80e03e302b4c.pdf 4384 WITH TUMOR Progressive Disease YES RX Primary Tumor 01 0.4 1987 6th YES NO YES 05 3 Current reformed smoker for > 15 years Lung A LIVING 2009 1963 TCGA-05-4384-01A-01D-1753-08 TCGA-05-4384-01A-01D-1753-08 7d6cf896-b04a-431a-a192-aaf540eeaf77 TCGA-05-4384-01A-01D-1752-01 TCGA-05-4384-01A-01D-1756-05 TCGA-05-4384-01 TCGA-05-4384-01A-01D-1752-01 7d6cf896-b04a-431a-a192-aaf540eeaf77 TCGA-05-4384-01 TCGA-05-4384-01A-21-2190-20 7d6cf896-b04a-431a-a192-aaf540eeaf77 TCGA-05-4384-01 5e735c28-5f2b-47ec-98fb-2f57cc8a5d6a 7d6cf896-b04a-431a-a192-aaf540eeaf77 TCGA-05-4384-01A-01D-1753-08 TCGA-05-4384-01 +TCGA-05-4389-01 3.29 0.48 none p.G469V none p.T41A N Y none none none 0.18 Magnoid none none none none none none none Solid predominant Adc Solid predominant Adc none 1 TCGA-05-4389-01 High C1-LUAD-enriched Cluster 5 LUAD-like c10 miRNA cluster 4 cluster 2 mutation c1uster 9 TCGA-05-4389 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 70 R-Upper TCGA-05-4389-F36455 TCGA-05-4389 -25660 0 1369 Scheduled Follow-up Submission Complete Remission/Response 2012-10-31 MALE Lung Adenocarcinoma Mixed Subtype No C34.1 8255/3 C34.1 YES NO NO 43 No M0 N0 T1 Stage IA 4389 TUMOR FREE NO R0 Primary Tumor 01 5th NO NO YES 05 3 Current reformed smoker for > 15 years Lung LIVING 2005 TCGA-05-4389-01A-01D-1265-08 TCGA-05-4389-01A-01D-1265-08 a588764f-f972-4d3a-b8f8-d0209fc7d2a1 TCGA-05-4389-01A-01D-1205-05 TCGA-05-4389-01 TCGA-05-4389-01A-01D-1204-01 TCGA-05-4389-01 TCGA-05-4389-01A-01D-1204-01 a588764f-f972-4d3a-b8f8-d0209fc7d2a1 a588764f-f972-4d3a-b8f8-d0209fc7d2a1 TCGA-05-4389-01 a588764f-f972-4d3a-b8f8-d0209fc7d2a1 TCGA-05-4389-01A-01D-1265-08 TCGA-05-4389-01 +TCGA-05-4390-01 3.99 0.57 none none none none Y Y none none none 0.18 Magnoid none p.G12V none none none none none Acinar predominant Adc Acinar predominant Adc none 0 TCGA-05-4390-01 COAD-READ C1-LUAD-enriched cluster 2 Cluster 6 LUAD-like c10 miRNA cluster 6 cluster 1 mutation cluster 12 TCGA-05-4390 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 58 R-Upper TCGA-05-4390-F36456 TCGA-05-4390 TCGA-05-4390-01A -21430 0 1126 395 Scheduled Follow-up Submission Complete Remission/Response 2012-10-31 FEMALE Lung Adenocarcinoma Mixed Subtype No C34.1 8255/3 C34.1 YES 0.9 NO 1.8 NO YES 15 No M0 N0 T2 Stage IB TCGA-05-4390.2e3faad1-3a5e-4efb-96ea-8c44839fec6e.pdf 4390 TUMOR FREE Progressive Disease NO R0 Primary Tumor 01 0.3 1996 5th YES NO YES 05 4 Current reformed smoker for < or = 15 years Lung A LIVING 2005 1966 TCGA-05-4390-01A-02D-1753-08 TCGA-05-4390-01A-02D-1753-08 6b6d7855-8621-45f8-98c9-5ad5b924b15e TCGA-05-4390-01A-02D-1752-01 TCGA-05-4390-01A-02D-1756-05 TCGA-05-4390-01 TCGA-05-4390-01A-02D-1752-01 6b6d7855-8621-45f8-98c9-5ad5b924b15e TCGA-05-4390-01 6b6d7855-8621-45f8-98c9-5ad5b924b15e TCGA-05-4390-01 6b6d7855-8621-45f8-98c9-5ad5b924b15e TCGA-05-4390-01A-02D-1753-08 TCGA-05-4390-01 +TCGA-05-4395-01 3.24 0.61 none none none none Y Y none none none 0.22 Squamoid none p.G12V none none none none none Solid predominant Adc Solid predominant Adc p.G56W 0 TCGA-05-4395-01 BRCA-LUAD+ C1-LUAD-enriched Cluster 6 LUAD-like c10 miRNA cluster 4 cluster 2 mutation cluster 2 TCGA-05-4395 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 76 L-Upper TCGA-05-4395 TCGA-05-4395-01A -27971 0 0 2010-7-22 MALE Lung Adenocarcinoma Mixed Subtype No C34.1 8255/3 C34.1 YES 0.4 NO 1 No M0 N2 T4 Stage IIIB TCGA-05-4395.601b48ca-e99c-4d4b-854e-4aa923b63237.pdf 4395 TUMOR FREE R0 Primary Tumor 01 0.4 1983 5th NO YES 05 3 Lifelong Non-smoker Lung A DECEASED 2006 TCGA-05-4395-01A-01D-1265-08 TCGA-05-4395-01A-01D-1265-08 3ae6f6d4-ae90-4572-9bd5-ed8700570b96 TCGA-05-4395-01A-01D-1205-05 TCGA-05-4395-01 TCGA-05-4395-01A-01D-1204-01 TCGA-05-4395-01 TCGA-05-4395-01A-01D-1204-01 3ae6f6d4-ae90-4572-9bd5-ed8700570b96 3ae6f6d4-ae90-4572-9bd5-ed8700570b96 TCGA-05-4395-01 3ae6f6d4-ae90-4572-9bd5-ed8700570b96 TCGA-05-4395-01A-01D-1265-08 TCGA-05-4395-01 +TCGA-05-4396-01 1.86 0.74 none none none none N N none none none 0.39 Magnoid none none none none none none none Papillary predominant Adc Papillary predominant Adc none 0 TCGA-05-4396-01 Squamous C1-LUAD-enriched cluster 1 Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 6 cluster 1 mutation cluster 11 TCGA-05-4396 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 76 R-Lower TCGA-05-4396 TCGA-05-4396-01A -28094 303 0 2010-7-22 MALE Lung Adenocarcinoma Mixed Subtype No C34.3 8255/3 C34.3 YES 0.9 NO 1.6 19 Yes M0 N1 T4 Stage IIIB TCGA-05-4396.96f3b48a-c5c4-40c3-a3d1-64477499c6e6.pdf 4396 R0 Primary Tumor 01 0.5 1984 5th NO YES 05 3 Current reformed smoker for > 15 years Lung A DECEASED 2006 1947 TCGA-05-4396-01A-21D-1855-08 TCGA-05-4396-01A-21D-1855-08 82b154a5-b4d5-4737-8f79-10d252741963 TCGA-05-4396-01A-21D-1854-01 TCGA-05-4396-01A-21D-1856-05 TCGA-05-4396-01 TCGA-05-4396-01A-21D-1854-01 82b154a5-b4d5-4737-8f79-10d252741963 TCGA-05-4396-01 TCGA-05-4396-01A-22-2190-20 82b154a5-b4d5-4737-8f79-10d252741963 TCGA-05-4396-01 b7cb4257-cc52-4219-8e7b-0a6e881532af 82b154a5-b4d5-4737-8f79-10d252741963 TCGA-05-4396-01A-21D-1855-08 TCGA-05-4396-01 +TCGA-05-4397-01 TCGA-05-4397-01 Squamous C1-LUAD-enriched Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 7 mutation cluster 8 TCGA-05-4397 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 65 R-Middle TCGA-05-4397 -23833 731 0 2010-7-22 MALE Lung Adenocarcinoma Mixed Subtype No C34.2 8255/3 C34.2 YES 45 No M0 N1 T2 Stage IIB 4397 R0 Primary Tumor 01 5th NO YES 05 2 Lung DECEASED 2006 TCGA-05-4397-01A-01D-1265-08 e8fb125c-3249-44f4-9bc7-5cd086011d89 TCGA-05-4397-01A-01D-1205-05 TCGA-05-4397-01 TCGA-05-4397-01A-01D-1204-01 TCGA-05-4397-01 TCGA-05-4397-01A-01D-1204-01 e8fb125c-3249-44f4-9bc7-5cd086011d89 TCGA-05-4397-01A-21-2190-20 e8fb125c-3249-44f4-9bc7-5cd086011d89 TCGA-05-4397-01 e2c7eef9-5765-4ee9-92dd-a632be207eba e8fb125c-3249-44f4-9bc7-5cd086011d89 TCGA-05-4397-01A-01D-1265-08 TCGA-05-4397-01 +TCGA-05-4398-01 4.86 0.33 none none none none N N none none none 0.11 Squamoid none none none none none none none Solid predominant Adc Solid predominant Adc none 1 TCGA-05-4398-01 Squamous C1-LUAD-enriched Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 4 cluster 4 mutation cluster 2 TCGA-05-4398 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 47 R-Upper TCGA-05-4398-F36462 TCGA-05-4398 TCGA-05-4398-01A -17471 0 1431 Scheduled Follow-up Submission Complete Remission/Response 2012-10-31 FEMALE Lung Adenocarcinoma Mixed Subtype No C34.1 8255/3 C34.1 YES 0.9 NO 1.5 NO NO 72 No M0 N3 T4 Stage IIIB TCGA-05-4398.37d9ee69-f24e-4dda-a283-078243db1fa8.pdf 4398 TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 0.4 5th YES NO YES 05 2 Current smoker Lung A LIVING 2006 TCGA-05-4398-01A-01D-1265-08 TCGA-05-4398-01A-01D-1265-08 8835ae28-831e-49da-a046-a1a43b626a4e TCGA-05-4398-01A-01D-1205-05 TCGA-05-4398-01 TCGA-05-4398-01A-01D-1204-01 TCGA-05-4398-01 TCGA-05-4398-01A-01D-1204-01 8835ae28-831e-49da-a046-a1a43b626a4e TCGA-05-4398-01A-21-2190-20 8835ae28-831e-49da-a046-a1a43b626a4e TCGA-05-4398-01 33467565-286d-4be1-a430-d1a74a5752f0 8835ae28-831e-49da-a046-a1a43b626a4e TCGA-05-4398-01A-01D-1265-08 TCGA-05-4398-01 +TCGA-05-4402-01 3.24 0.44 none none none none Y Y p.TSPKANKE751del none none 0.17 Bronchioid none none none none none none none Acinar predominant Adc Acinar predominant Adc none 0 TCGA-05-4402-01 BRCA-LUAD+ C1-LUAD-enriched Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 4 cluster 4 mutation cluster 8 TCGA-05-4402 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 57 R-Lower TCGA-05-4402-F36466 TCGA-05-4402 TCGA-05-4402-01A -20819 244 0 Scheduled Follow-up Submission Complete Remission/Response 2012-10-31 FEMALE Lung Adenocarcinoma Mixed Subtype No C34.3 8255/3 C34.3 YES 0.6 NO 1.6 NO NO Yes M1 NX T2 Stage IV TCGA-05-4402.8099c860-5c8d-4200-8c8f-07f9e1b71780.pdf 4402 TUMOR FREE Complete Remission/Response NO R2 Primary Tumor 01 0.2 6th YES NO YES 05 1 Lifelong Non-smoker Lung A DECEASED 2007 TCGA-05-4402-01A-01D-1265-08 TCGA-05-4402-01A-01D-1265-08 86973b83-4077-414a-ad8d-dbf32b6707d1 TCGA-05-4402-01A-01D-1205-05 TCGA-05-4402-01 TCGA-05-4402-01A-01D-1204-01 TCGA-05-4402-01 TCGA-05-4402-01A-01D-1204-01 86973b83-4077-414a-ad8d-dbf32b6707d1 TCGA-05-4402-01A-21-2190-20 86973b83-4077-414a-ad8d-dbf32b6707d1 TCGA-05-4402-01 4e5d6d6d-af25-4b7c-bb75-357b90e36434 86973b83-4077-414a-ad8d-dbf32b6707d1 TCGA-05-4402-01A-01D-1265-08 TCGA-05-4402-01 +TCGA-05-4403-01 2.06 0.46 none none none none Y Y none none none 0.23 Bronchioid none p.G12C none p.H476Y none none none Invasive mucinous Invasive mucinous none 0 TCGA-05-4403-01 Kirc+ C1-LUAD-enriched Cluster 6 LUAD-like c10 miRNA cluster 8 cluster 1 mutation cluster 12 TCGA-05-4403 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 76 R-Upper TCGA-05-4403 TCGA-05-4403-01A -27881 0 578 2010-7-22 MALE Lung Adenocarcinoma Mixed Subtype No C34.1 8255/3 C34.1 YES 1 NO 1.5 No M0 N0 T2 Stage IB TCGA-05-4403.96181bb6-7944-4674-83ba-5268ef8b10a5.pdf 4403 R0 Primary Tumor 01 0.4 1975 5th NO YES 05 3 Current reformed smoker for > 15 years Lung A LIVING 2006 TCGA-05-4403-01A-01D-1265-08 TCGA-05-4403-01A-01D-1265-08 89059faf-e38c-49d0-890e-47c455f19dc7 TCGA-05-4403-01A-01D-1205-05 TCGA-05-4403-01 TCGA-05-4403-01A-01D-1204-01 TCGA-05-4403-01 TCGA-05-4403-01A-01D-1204-01 89059faf-e38c-49d0-890e-47c455f19dc7 89059faf-e38c-49d0-890e-47c455f19dc7 TCGA-05-4403-01 89059faf-e38c-49d0-890e-47c455f19dc7 TCGA-05-4403-01A-01D-1265-08 TCGA-05-4403-01 +TCGA-05-4405-01 3.34 0.38 none none none none N N none none none 0.15 Bronchioid none none none none none none none Acinar predominant Adc Acinar predominant Adc none 0 TCGA-05-4405-01 High C1-LUAD-enriched cluster 1 Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 4 cluster 2 mutation cluster 2 TCGA-05-4405 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 74 R-Lower TCGA-05-4405-F36494 TCGA-05-4405 TCGA-05-4405-01A -27241 0 610 Scheduled Follow-up Submission Complete Remission/Response 2012-10-31 FEMALE Lung Adenocarcinoma Mixed Subtype No C34.3 8255/3 C34.3 YES 0.7 NO 0.9 NO NO 65 Yes M0 N0 T2 Stage IB TCGA-05-4405.AB2C32B2-3CB1-4977-8C79-7B19F9022DFB.pdf 4405 TUMOR FREE NO R0 Primary Tumor 01 0.3 1994 5th NO NO YES 05 4 Current reformed smoker for < or = 15 years Lung A LIVING 2006 1951 TCGA-05-4405-01A-21D-1855-08 TCGA-05-4405-01A-21D-1855-08 a1510fc9-aff1-4cc2-8d8e-9aafce9319f7 TCGA-05-4405-01A-21D-1854-01 TCGA-05-4405-01A-21D-1856-05 TCGA-05-4405-01 TCGA-05-4405-01A-21D-1854-01 a1510fc9-aff1-4cc2-8d8e-9aafce9319f7 TCGA-05-4405-01 TCGA-05-4405-01A-22-2190-20 a1510fc9-aff1-4cc2-8d8e-9aafce9319f7 TCGA-05-4405-01 86533c79-3f76-4293-ac1e-cbe3482a1765 a1510fc9-aff1-4cc2-8d8e-9aafce9319f7 TCGA-05-4405-01A-21D-1855-08 TCGA-05-4405-01 +TCGA-05-4410-01 none p.G466V none none N Y p.R377S none none Bronchioid none none none none none none none Micropapillary predom Adc Micropapillary predom Adc none 0 TCGA-05-4410-01 High C1-LUAD-enriched cluster 1 Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 4 cluster 2 mutation cluster 11 TCGA-05-4410 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 62 L-Upper TCGA-05-4410 TCGA-05-4410-01A -22888 0 0 2010-7-22 MALE Lung Adenocarcinoma Mixed Subtype No C34.1 8255/3 C34.1 YES 0.8 NO 1 98 Yes M0 N0 T2 Stage IB TCGA-05-4410.13c40632-79e2-485c-9ef2-da6d075b054c.pdf 4410 RX Primary Tumor 01 0.4 2007 6th NO YES 05 4 Current reformed smoker for < or = 15 years Lung A LIVING 2007 1958 TCGA-05-4410-01A-21D-1855-08 TCGA-05-4410-01A-21D-1855-08 149e2d5d-3d6c-410e-b435-7e37b3f96661 TCGA-05-4410-01A-21D-1854-01 TCGA-05-4410-01A-21D-1856-05 TCGA-05-4410-01 TCGA-05-4410-01A-21D-1854-01 149e2d5d-3d6c-410e-b435-7e37b3f96661 TCGA-05-4410-01 TCGA-05-4410-01A-22-2190-20 149e2d5d-3d6c-410e-b435-7e37b3f96661 TCGA-05-4410-01 b5ff5d37-3c6b-4fdb-9d52-668269d77d4c 149e2d5d-3d6c-410e-b435-7e37b3f96661 TCGA-05-4410-01A-21D-1855-08 TCGA-05-4410-01 +TCGA-05-4415-01 3.65 0.65 none none none none Y Y none none none 0.21 Magnoid none p.G12C none none none none none Micropapillary predom Adc Micropapillary predom Adc p.G227fs 0 TCGA-05-4415-01 GBM C1-LUAD-enriched cluster 3 Cluster 5 LUAD-like c10 miRNA cluster 4 cluster 5 mutation cluster 12 TCGA-05-4415 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 57 L-Lower TCGA-05-4415-F36499 TCGA-05-4415 TCGA-05-4415-01A -20880 91 0 60 Scheduled Follow-up Submission Progressive Disease 2012-10-31 MALE Lung Adenocarcinoma Mixed Subtype No C34.3 8255/3 C34.3 YES 1 NO 1.1 NO YES 29 No M0 N2 T4 Stage IIIB TCGA-05-4415.e8871f29-3623-4975-be19-bda98dbbc33b.pdf 4415 WITH TUMOR Progressive Disease NO R0 Primary Tumor 01 0.4 2007 6th NO NO YES 05 4 Current reformed smoker for < or = 15 years Lung A DECEASED 2008 1997 TCGA-05-4415-01A-22D-1855-08 TCGA-05-4415-01A-22D-1855-08 7f9f381e-edb1-4a5e-b5f7-c31b2a769912 TCGA-05-4415-01A-22D-1854-01 TCGA-05-4415-01A-22D-1856-05 TCGA-05-4415-01 TCGA-05-4415-01A-22D-1854-01 7f9f381e-edb1-4a5e-b5f7-c31b2a769912 TCGA-05-4415-01 7f9f381e-edb1-4a5e-b5f7-c31b2a769912 TCGA-05-4415-01 7f9f381e-edb1-4a5e-b5f7-c31b2a769912 TCGA-05-4415-01A-22D-1855-08 TCGA-05-4415-01 +TCGA-05-4417-01 2.96 0.39 none none none none Y Y none none none 0.16 Magnoid none p.G12C none none none none none Solid predominant Adc Solid predominant Adc p.H168R 0 TCGA-05-4417-01 BRCA-LUAD+ C1-LUAD-enriched cluster 2 Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 4 cluster 2 mutation cluster 12 TCGA-05-4417 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 51 R-Upper TCGA-05-4417-F36502 TCGA-05-4417 TCGA-05-4417-01A -18780 0 455 Scheduled Follow-up Submission Partial Remission/Response 2012-10-31 FEMALE Lung Adenocarcinoma Mixed Subtype No C34.1 8255/3 C34.1 YES 0.8 NO 1.4 NO NO 56 No M0 N0 T2 Stage IB TCGA-05-4417.0b795830-d3bf-4a94-8355-b76a5f4469a5.pdf 4417 TUMOR FREE Partial Remission/Response NO R0 Primary Tumor 01 0.3 2008 6th NO NO YES 05 4 Current reformed smoker for < or = 15 years Lung A LIVING 2008 1971 TCGA-05-4417-01A-22D-1855-08 TCGA-05-4417-01A-22D-1855-08 c5c76768-3b14-4d6e-9455-13783631d796 TCGA-05-4417-01A-22D-1854-01 TCGA-05-4417-01A-22D-1856-05 TCGA-05-4417-01 TCGA-05-4417-01A-22D-1854-01 c5c76768-3b14-4d6e-9455-13783631d796 TCGA-05-4417-01 TCGA-05-4417-01A-23-2190-20 c5c76768-3b14-4d6e-9455-13783631d796 TCGA-05-4417-01 9d52cd8c-4ff7-44fb-8abc-441150545c46 c5c76768-3b14-4d6e-9455-13783631d796 TCGA-05-4417-01A-22D-1855-08 TCGA-05-4417-01 +TCGA-05-4418-01 2.01 0.53 none none none none Y Y none none none 0.26 Magnoid none p.G12C none none none none none Solid predominant Adc Solid predominant Adc none 0 TCGA-05-4418-01 BRCA-LUAD+ C1-LUAD-enriched Cluster 5 squamous c3 LUAD-like c10 miRNA c1uster 9 cluster 4 mutation cluster 12 TCGA-05-4418 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 69 L-Lower TCGA-05-4418 TCGA-05-4418-01A -25417 274 0 2010-7-22 MALE Lung Adenocarcinoma Mixed Subtype No C34.3 8255/3 C34.3 YES 1 NO 1.2 25 Yes M0 N2 T3 Stage IIIA TCGA-05-4418.4d77e536-98f2-4e34-9e76-adb4bc79bf5e.pdf 4418 R0 Primary Tumor 01 0.4 6th NO YES 05 2 Current smoker Lung A DECEASED 2008 TCGA-05-4418-01A-01D-1265-08 TCGA-05-4418-01A-01D-1265-08 271766c9-819e-4555-89d7-dc7a52203386 TCGA-05-4418-01A-01D-1205-05 TCGA-05-4418-01 TCGA-05-4418-01A-01D-1204-01 TCGA-05-4418-01 TCGA-05-4418-01A-01D-1204-01 271766c9-819e-4555-89d7-dc7a52203386 TCGA-05-4418-01A-21-2190-20 271766c9-819e-4555-89d7-dc7a52203386 TCGA-05-4418-01 51411ac1-143c-428b-8a13-22ececc4d2f0 271766c9-819e-4555-89d7-dc7a52203386 TCGA-05-4418-01A-01D-1265-08 TCGA-05-4418-01 +TCGA-05-4420-01 3.53 0.6 none none none none N Y none none none 0.21 Magnoid p.Q61L none none none none none none Invasive mucinous Invasive mucinous none 1 TCGA-05-4420-01 High C1-LUAD-enriched Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 6 cluster 1 mutation cluster 3 TCGA-05-4420 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 41 R-Lower TCGA-05-4420-F36531 TCGA-05-4420 TCGA-05-4420-01A -15159 0 912 Scheduled Follow-up Submission Complete Remission/Response 2012-11-1 MALE Lung Adenocarcinoma Mixed Subtype No C34.3 8255/3 C34.3 YES 0.8 NO 0.8 NO NO 38 No M0 N0 T2 Stage IB TCGA-05-4420.682a1fdc-41dd-441b-831c-fe3cf834638e.pdf 4420 TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 0.3 6th NO NO YES 05 2 Current smoker Lung A LIVING 2008 TCGA-05-4420-01A-01D-1265-08 TCGA-05-4420-01A-01D-1265-08 89dda3b6-2905-4577-9b74-965fb7f77c98 TCGA-05-4420-01A-01D-1205-05 TCGA-05-4420-01 TCGA-05-4420-01A-01D-1204-01 TCGA-05-4420-01 TCGA-05-4420-01A-01D-1204-01 89dda3b6-2905-4577-9b74-965fb7f77c98 TCGA-05-4420-01A-21-2190-20 89dda3b6-2905-4577-9b74-965fb7f77c98 TCGA-05-4420-01 17a82652-9990-4947-998e-ac10b35923d2 89dda3b6-2905-4577-9b74-965fb7f77c98 TCGA-05-4420-01A-01D-1265-08 TCGA-05-4420-01 +TCGA-05-4422-01 2.09 0.63 none none none p.S37F N N none none none 0.31 Magnoid none none none none none none none Acinar predominant Adc Acinar predominant Adc p.G251V 1 TCGA-05-4422-01 COAD-READ C1-LUAD-enriched Low purity c2 squamous c3 LUAD-like c10 miRNA cluster 7 cluster 4 mutation c1uster 9 TCGA-05-4422 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 68 L-Lower TCGA-05-4422 TCGA-05-4422-01A -24837 0 365 2010-7-22 MALE Lung Adenocarcinoma Mixed Subtype No C34.3 8255/3 C34.3 YES 0.8 NO 1.5 147 No M0 N0 T2 Stage IB TCGA-05-4422.b51045ca-f7ae-459f-90b7-631683d84e0f.pdf 4422 R0 Primary Tumor 01 0.4 6th NO YES 05 4 Current reformed smoker for < or = 15 years Lung A LIVING 2008 TCGA-05-4422-01A-01D-1265-08 TCGA-05-4422-01A-01D-1265-08 2662f59e-0959-4fbf-a8bf-6ad639e44005 TCGA-05-4422-01A-01D-1205-05 TCGA-05-4422-01 TCGA-05-4422-01A-01D-1204-01 TCGA-05-4422-01 TCGA-05-4422-01A-01D-1204-01 2662f59e-0959-4fbf-a8bf-6ad639e44005 TCGA-05-4422-01A-21-2190-20 2662f59e-0959-4fbf-a8bf-6ad639e44005 TCGA-05-4422-01 6fd0d313-a9a6-46e2-b37f-d2bc537bed19 2662f59e-0959-4fbf-a8bf-6ad639e44005 TCGA-05-4422-01A-01D-1265-08 TCGA-05-4422-01 +TCGA-05-4424-01 none none none none N N none none none Bronchioid none none none none none none none Acinar predominant Adc Acinar predominant Adc none 0 TCGA-05-4424-01 High C1-LUAD-enriched cluster 3 Low purity c2 LUAD-like c10 miRNA cluster 5 cluster 5 mutation cluster 2 TCGA-05-4424 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung YES 70 R-Upper TCGA-05-4424-F36536 TCGA-05-4424 -25689 0 913 153 Scheduled Follow-up Submission Partial Remission/Response 2012-11-1 MALE Lung Adenocarcinoma Mixed Subtype No C34.1 8255/3 C34.1 YES NO Distant Metastasis YES 50 No M0 N0 T3 Stage IIB 4424 WITH TUMOR Progressive Disease YES R1 Primary Tumor 01 2007 6th YES NO YES 05 4 Current reformed smoker for < or = 15 years Lung LIVING 2008 1957 TCGA-05-4424-01A-22D-1855-08 TCGA-05-4424-01A-22D-1855-08 c4da944d-4055-493e-bb87-7ccd1e5d1a87 TCGA-05-4424-01A-22D-1854-01 TCGA-05-4424-01A-22D-1856-05 TCGA-05-4424-01 TCGA-05-4424-01A-22D-1854-01 c4da944d-4055-493e-bb87-7ccd1e5d1a87 TCGA-05-4424-01 c4da944d-4055-493e-bb87-7ccd1e5d1a87 TCGA-05-4424-01 c4da944d-4055-493e-bb87-7ccd1e5d1a87 TCGA-05-4424-01A-22D-1855-08 TCGA-05-4424-01 +TCGA-05-4425-01 1.96 0.61 none none none p.S45F N N none none none 0.31 Squamoid none none none none none none none Papillary predominant Adc Papillary predominant Adc none 0 TCGA-05-4425-01 Kirc+ C1-LUAD-enriched cluster 1 Cluster 6 LUAD-like c10 miRNA cluster 4 cluster 1 mutation c1uster 9 TCGA-05-4425 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 70 R-Middle TCGA-05-4425 -25902 0 669 2010-7-22 FEMALE Lung Adenocarcinoma Mixed Subtype No C34.2 8255/3 C34.2 YES 28 No M1 N0 T2 Stage IV 4425 R1 Primary Tumor 01 6th NO YES 05 3 Current reformed smoker for > 15 years Lung LIVING 2008 TCGA-05-4425-01A-01D-1753-08 TCGA-05-4425-01A-01D-1753-08 ac9dd948-4352-4869-85a1-639151a4bffb TCGA-05-4425-01A-01D-1752-01 TCGA-05-4425-01A-01D-1756-05 TCGA-05-4425-01 TCGA-05-4425-01A-01D-1752-01 ac9dd948-4352-4869-85a1-639151a4bffb TCGA-05-4425-01 ac9dd948-4352-4869-85a1-639151a4bffb TCGA-05-4425-01 ac9dd948-4352-4869-85a1-639151a4bffb TCGA-05-4425-01 +TCGA-05-4426-01 1.99 0.71 none none none none N Y none none none 0.36 Squamoid none none none none none none none Solid predominant Adc Solid predominant Adc Y none 0 TCGA-05-4426-01 Kirc+ C1-LUAD-enriched Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 4 cluster 2 mutation cluster 5 TCGA-05-4426 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 71 L-Lower TCGA-05-4426-F36562 TCGA-05-4426 -26084 0 791 457 Scheduled Follow-up Submission Complete Remission/Response 2012-11-2 MALE Lung Adenocarcinoma Mixed Subtype No C34.3 8255/3 C34.3 YES NO YES 20 No M0 N0 T2 Stage IB 4426 TUMOR FREE Complete Remission/Response R0 Primary Tumor 01 6th NO YES 05 3 Current reformed smoker for > 15 years Lung LIVING 2008 TCGA-05-4426-01A-01D-1265-08 TCGA-05-4426-01A-01D-1265-08 b2aba2a6-3b30-41bb-a4cc-74f36b60a114 TCGA-05-4426-01A-01D-1205-05 TCGA-05-4426-01 TCGA-05-4426-01A-01D-1204-01 TCGA-05-4426-01 TCGA-05-4426-01A-01D-1204-01 b2aba2a6-3b30-41bb-a4cc-74f36b60a114 TCGA-05-4426-01A-21-2190-20 b2aba2a6-3b30-41bb-a4cc-74f36b60a114 TCGA-05-4426-01 c737047d-6c28-4463-84b6-dd585bb960fc b2aba2a6-3b30-41bb-a4cc-74f36b60a114 TCGA-05-4426-01A-01D-1265-08 TCGA-05-4426-01 +TCGA-05-4427-01 TCGA-05-4427-01 BRCA-LUAD+ C1-LUAD-enriched Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 4 mutation cluster 11 TCGA-05-4427 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 65 L-Upper TCGA-05-4427-F36564 TCGA-05-4427 TCGA-05-4427-01A -23893 0 791 Scheduled Follow-up Submission Complete Remission/Response 2012-11-2 FEMALE Lung Adenocarcinoma Mixed Subtype No C34.1 8255/3 C34.1 YES 0.6 NO 1.7 NO NO 8 Yes M0 N1 T2 Stage IIB TCGA-05-4427.06c7cdb1-5048-4c75-9002-090997275eff.pdf 4427 TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 0.3 2008 6th YES NO YES 05 4 Lung A LIVING 2008 1993 TCGA-05-4427-01A-21D-1855-08 fd4a3155-ca05-464c-b8d9-816103de489d TCGA-05-4427-01A-21D-1854-01 TCGA-05-4427-01A-21D-1856-05 TCGA-05-4427-01 TCGA-05-4427-01A-21D-1854-01 fd4a3155-ca05-464c-b8d9-816103de489d TCGA-05-4427-01 TCGA-05-4427-01A-22-2190-20 fd4a3155-ca05-464c-b8d9-816103de489d TCGA-05-4427-01 8d0744f3-398b-485e-a564-092cc3d1a268 fd4a3155-ca05-464c-b8d9-816103de489d TCGA-05-4427-01A-21D-1855-08 TCGA-05-4427-01 +TCGA-05-4430-01 3.44 0.2 none none none none N N none none none 0.09 Bronchioid none none none none none none none Solid predominant Adc Solid predominant Adc none 0 TCGA-05-4430-01 High C1-LUAD-enriched Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 4 cluster 2 mutation cluster 2 TCGA-05-4430 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 59 L-Lower TCGA-05-4430-F36427 TCGA-05-4430 -21884 0 761 Scheduled Follow-up Submission Complete Remission/Response 2012-10-30 FEMALE Lung Adenocarcinoma Mixed Subtype No C34.3 8255/3 C34.3 YES NO NO 80 No M0 N0 T2 Stage IB 4430 TUMOR FREE R0 Primary Tumor 01 6th NO YES 05 4 Current reformed smoker for < or = 15 years Lung LIVING 2008 TCGA-05-4430-01A-02D-1265-08 TCGA-05-4430-01A-02D-1265-08 bda96534-9900-4f6f-ab17-a09f52dfada4 TCGA-05-4430-01A-02D-1205-05 TCGA-05-4430-01 TCGA-05-4430-01A-02D-1204-01 TCGA-05-4430-01 TCGA-05-4430-01A-02D-1204-01 bda96534-9900-4f6f-ab17-a09f52dfada4 TCGA-05-4430-01A-11-2190-20 bda96534-9900-4f6f-ab17-a09f52dfada4 TCGA-05-4430-01 c4a810c3-91fc-4010-a669-cb616238d295 bda96534-9900-4f6f-ab17-a09f52dfada4 TCGA-05-4430-01A-02D-1265-08 TCGA-05-4430-01 +TCGA-05-4432-01 3.33 0.37 none none none none N N none none p.P1206L 0.15 Magnoid none none none none none none none Solid predominant Adc Solid predominant Adc p.137_138QE>H* 1 TCGA-05-4432-01 High C1-LUAD-enriched Low purity c2 LUAD-like c10 miRNA cluster 7 cluster 4 mutation cluster 2 TCGA-05-4432 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 66 R-Upper TCGA-05-4432-F36424 TCGA-05-4432 TCGA-05-4432-01A -24350 0 761 Scheduled Follow-up Submission Complete Remission/Response 2012-10-30 MALE Lung Adenocarcinoma Mixed Subtype No C34.1 8255/3 C34.1 YES 0.7 NO 1 NO NO 58 No M0 N1 T2 Stage IIB TCGA-05-4432.f99933b1-6f7b-4e5e-87a4-4f902d031c76.pdf 4432 TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 0.3 6th YES NO YES 05 2 Current smoker Lung A LIVING 2008 TCGA-05-4432-01A-01D-1265-08 TCGA-05-4432-01A-01D-1265-08 31769d4d-64f5-4a2b-b8da-d5b2252badb3 TCGA-05-4432-01A-01D-1205-05 TCGA-05-4432-01 TCGA-05-4432-01A-01D-1204-01 TCGA-05-4432-01 TCGA-05-4432-01A-01D-1204-01 31769d4d-64f5-4a2b-b8da-d5b2252badb3 31769d4d-64f5-4a2b-b8da-d5b2252badb3 TCGA-05-4432-01 31769d4d-64f5-4a2b-b8da-d5b2252badb3 TCGA-05-4432-01A-01D-1265-08 TCGA-05-4432-01 +TCGA-05-4433-01 1.9 0.61 none none none none Y Y none none none 0.31 Bronchioid none p.G12V none none none none none Invasive mucinous Invasive mucinous none 0 TCGA-05-4433-01 Squamous C1-LUAD-enriched cluster 2 Cluster 5 LUAD-like c10 miRNA cluster 4 cluster 1 mutation cluster 2 TCGA-05-4433 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 82 L-Lower TCGA-05-4433-F36530 TCGA-05-4433 TCGA-05-4433-01A -30194 0 730 Scheduled Follow-up Submission Complete Remission/Response 2012-11-1 MALE Lung Adenocarcinoma Mixed Subtype No C34.3 8255/3 C34.3 YES 1 NO 1.1 NO NO 1 No M0 N0 T2 Stage IB TCGA-05-4433.eeae318d-a517-48b6-9a21-5c72dc4bd510.pdf 4433 TUMOR FREE R0 Primary Tumor 01 0.3 1948 6th NO YES 05 3 Current reformed smoker for > 15 years Lung A LIVING 2008 1946 TCGA-05-4433-01A-22D-1855-08 TCGA-05-4433-01A-22D-1855-08 013f7a4f-eec9-4ba8-8473-6515cdc9be68 TCGA-05-4433-01A-22D-1854-01 TCGA-05-4433-01A-22D-1856-05 TCGA-05-4433-01 TCGA-05-4433-01A-22D-1854-01 013f7a4f-eec9-4ba8-8473-6515cdc9be68 TCGA-05-4433-01 013f7a4f-eec9-4ba8-8473-6515cdc9be68 TCGA-05-4433-01 013f7a4f-eec9-4ba8-8473-6515cdc9be68 TCGA-05-4433-01A-22D-1855-08 TCGA-05-4433-01 +TCGA-05-4434-01 TCGA-05-4434-01 Kirc+ C1-LUAD-enriched Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 4 mutation c1uster 9 TCGA-05-4434 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 67 R-Lower TCGA-05-4434 TCGA-05-4434-01A -24472 457 0 2010-7-22 FEMALE Lung Adenocarcinoma Mixed Subtype No C34.3 8255/3 C34.3 YES 0.8 NO 1.3 15 Yes M1 N1 T4 Stage IV TCGA-05-4434.0e9e74b2-7fd5-47b0-adf5-83c83b0c2d3d.pdf 4434 R2 Primary Tumor 01 0.3 6th NO YES 05 2 Lung A DECEASED 2008 TCGA-05-4434-01A-01D-1265-08 49511397-f9b7-4946-98b7-d26f9a2ec0c2 TCGA-05-4434-01A-01D-1205-05 TCGA-05-4434-01 TCGA-05-4434-01A-01D-1204-01 TCGA-05-4434-01 TCGA-05-4434-01A-01D-1204-01 49511397-f9b7-4946-98b7-d26f9a2ec0c2 TCGA-05-4434-01A-21-2190-20 49511397-f9b7-4946-98b7-d26f9a2ec0c2 TCGA-05-4434-01 a1067628-2a22-4bbf-8978-7ae9b7953e39 49511397-f9b7-4946-98b7-d26f9a2ec0c2 TCGA-05-4434-01A-01D-1265-08 TCGA-05-4434-01 +TCGA-05-5420-01 1.83 0.25 none none none none N N none none none 0.13 Squamoid none none none none none none none Solid predominant Adc Solid predominant Adc none 0 TCGA-05-5420-01 High C1-LUAD-enriched cluster 3 Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 4 cluster 4 mutation c1uster 9 TCGA-05-5420 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 67 L-Upper TCGA-05-5420-F36422 TCGA-05-5420 TCGA-05-5420-01A -24472 0 457 245 Scheduled Follow-up Submission Progressive Disease 2012-10-30 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.9 YES 0.9 NO 1 NO YES 40 Yes M0 N2 T2 Stage IIIA TCGA-05-5420.0777F8E7-46DF-4C9C-8CE9-B9B6E36DBAF5.pdf 5420 WITH TUMOR Progressive Disease R0 Primary Tumor 01 0.3 2001 6th NO YES 05 4 Current reformed smoker for < or = 15 years Lung A LIVING 2008 1961 TCGA-05-5420-01A-01D-1625-08 TCGA-05-5420-01A-01D-1625-08 8d78dad5-81bc-41d5-83db-10bec2cf114e TCGA-05-5420-01A-01D-1624-01 TCGA-05-5420-01A-01D-1626-05 TCGA-05-5420-01 TCGA-05-5420-01A-01D-1624-01 8d78dad5-81bc-41d5-83db-10bec2cf114e TCGA-05-5420-01A-21-2190-20 8d78dad5-81bc-41d5-83db-10bec2cf114e TCGA-05-5420-01 24209db7-f1fb-41fd-9f5e-de3f6480a606 8d78dad5-81bc-41d5-83db-10bec2cf114e TCGA-05-5420-01A-01D-1625-08 +TCGA-05-5420-11 1.83 0.25 none none none none N N none none none 0.13 Squamoid none none none none none none none Solid predominant Adc Solid predominant Adc none 0 TCGA-05-5420-11 C1-LUAD-enriched mutation c1uster 9 TCGA-05-5420 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 67 L-Upper TCGA-05-5420-F36422 TCGA-05-5420 TCGA-05-5420-11A -24472 0 457 245 Scheduled Follow-up Submission Progressive Disease 2012-10-30 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.9 YES 0.9 NO 0.9 NO YES 40 Yes M0 N2 T2 Stage IIIA 5420 WITH TUMOR Progressive Disease R0 Solid Tissue Normal 11 0.9 2001 6th NO YES 05 4 Current reformed smoker for < or = 15 years Lung A LIVING 2008 1961 TCGA-05-5420-11A-01D-1626-05 +TCGA-05-5423-01 2.36 0.6 none none none none Y Y p.L833F, p.L861Q none none 0.27 Bronchioid none none none none none none none Acinar predominant Adc Acinar predominant Adc none 0 TCGA-05-5423-01 High C1-LUAD-enriched cluster 3 Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 4 cluster 4 mutation cluster 8 TCGA-05-5423 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 65 L-Upper TCGA-05-5423 TCGA-05-5423-01A -23863 0 151 2011-3-22 MALE Lung Adenocarcinoma Mixed Subtype No C34.9 8255/3 C34.9 YES 0.8 NO 1.4 72 No M0 N1 T2 Stage IIB TCGA-05-5423.37823CCB-824B-4761-A520-A9F2C8D457EF.pdf 5423 TUMOR FREE R0 Primary Tumor 01 0.3 1980 6th NO YES 05 3 Current reformed smoker for > 15 years Lung A LIVING 2006 1956 TCGA-05-5423-01A-01D-1625-08 TCGA-05-5423-01A-01D-1625-08 44d80508-53d8-4ba3-b263-8c31e4b58096 TCGA-05-5423-01A-01D-1624-01 TCGA-05-5423-01A-01D-1626-05 TCGA-05-5423-01 TCGA-05-5423-01A-01D-1624-01 44d80508-53d8-4ba3-b263-8c31e4b58096 TCGA-05-5423-01 TCGA-05-5423-01A-21-2190-20 44d80508-53d8-4ba3-b263-8c31e4b58096 TCGA-05-5423-01 4c1ed504-6b5d-49d4-bc1d-5844ae2e7f8b 44d80508-53d8-4ba3-b263-8c31e4b58096 TCGA-05-5423-01A-01D-1625-08 TCGA-05-5423-01 +TCGA-05-5425-01 TCGA-05-5425-01 High C1-LUAD-enriched Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 4 mutation c1uster 9 TCGA-05-5425 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 68 R-Upper TCGA-05-5425-F36403 TCGA-05-5425 TCGA-05-5425-01A -25020 0 882 486 Scheduled Follow-up Submission Progressive Disease 2012-10-30 MALE Lung Adenocarcinoma Mixed Subtype No C34.9 8255/3 C34.9 YES 0.9 NO 1.2 NO YES 40 No M0 N1 T2b Stage IIB TCGA-05-5425.6367B293-BF9C-4651-9B73-7B9D1764948D.pdf 5425 WITH TUMOR YES R0 Primary Tumor 01 0.4 1985 7th YES NO YES 05 3 Lung A LIVING 2009 1965 TCGA-05-5425-01A-02D-1625-08 46b786be-8c30-4025-aa29-708c76bb4bcf TCGA-05-5425-01A-02D-1624-01 TCGA-05-5425-01A-02D-1626-05 TCGA-05-5425-01 TCGA-05-5425-01A-02D-1624-01 46b786be-8c30-4025-aa29-708c76bb4bcf TCGA-05-5425-01 TCGA-05-5425-01A-11-2190-20 46b786be-8c30-4025-aa29-708c76bb4bcf TCGA-05-5425-01 591cdbcf-f93b-4ae6-b1ad-7cc69a11862b 46b786be-8c30-4025-aa29-708c76bb4bcf TCGA-05-5425-01A-02D-1625-08 TCGA-05-5425-01 +TCGA-05-5428-01 3.37 0.63 none p.D594N none none N Y none none none 0.22 Squamoid none none none none none none none Solid predominant Adc Solid predominant Adc none 0 TCGA-05-5428-01 BRCA-LUAD+ C1-LUAD-enriched cluster 1 Cluster 6 LUAD-like c10 miRNA cluster 4 cluster 2 mutation cluster 8 TCGA-05-5428 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 57 R-Upper TCGA-05-5428-F36401 TCGA-05-5428 TCGA-05-5428-01A -21061 0 670 Scheduled Follow-up Submission Complete Remission/Response 2012-10-30 MALE Lung Adenocarcinoma Mixed Subtype No C34.9 8255/3 C34.9 YES 0.8 NO 1 NO NO 30 No M0 N1 T1b Stage IIA TCGA-05-5428.E5422AE1-E0E5-470E-A6E2-E66BF61B157B.pdf 5428 TUMOR FREE Complete Remission/Response YES R0 Primary Tumor 01 0.2 1993 7th YES NO YES 05 3 Current reformed smoker for > 15 years Lung A LIVING 2010 1969 TCGA-05-5428-01A-01D-1625-08 TCGA-05-5428-01A-01D-1625-08 7dfdb65a-8f75-4223-8e5c-bb13f1d8eb3b TCGA-05-5428-01A-01D-1624-01 TCGA-05-5428-01A-01D-1626-05 TCGA-05-5428-01 TCGA-05-5428-01A-01D-1624-01 7dfdb65a-8f75-4223-8e5c-bb13f1d8eb3b TCGA-05-5428-01 7dfdb65a-8f75-4223-8e5c-bb13f1d8eb3b TCGA-05-5428-01 7dfdb65a-8f75-4223-8e5c-bb13f1d8eb3b TCGA-05-5428-01A-01D-1625-08 TCGA-05-5428-01 +TCGA-05-5429-01 2.07 0.47 none none none none N N none none none 0.23 Magnoid none none none none none none none Acinar predominant Adc Acinar predominant Adc none 0 TCGA-05-5429-01 Iq C1-LUAD-enriched cluster 1 Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 8 cluster 1 mutation c1uster 9 TCGA-05-5429 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 60 L-Upper TCGA-05-5429-F36396 TCGA-05-5429 TCGA-05-5429-01A -22066 275 0 30 Scheduled Follow-up Submission 2012-10-30 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.9 YES 0.9 NO 1 NO No M0 N2 T3 Stage IIIA TCGA-05-5429.087C433B-9B20-439A-932C-4C852341A052.pdf 5429 TUMOR FREE R0 Primary Tumor 01 0.3 7th NO YES 05 1 Lifelong Non-smoker Lung A DECEASED 2010 TCGA-05-5429-01A-01D-1625-08 TCGA-05-5429-01A-01D-1625-08 33f213fa-6fa4-48ed-bd7e-a63ed8c3a8da TCGA-05-5429-01A-01D-1624-01 TCGA-05-5429-01A-01D-1626-05 TCGA-05-5429-01 TCGA-05-5429-01A-01D-1624-01 33f213fa-6fa4-48ed-bd7e-a63ed8c3a8da TCGA-05-5429-01 TCGA-05-5429-01A-21-2190-20 33f213fa-6fa4-48ed-bd7e-a63ed8c3a8da TCGA-05-5429-01 88f95b94-582d-4db9-82d1-f6253c6c9837 33f213fa-6fa4-48ed-bd7e-a63ed8c3a8da TCGA-05-5429-01A-01D-1625-08 TCGA-05-5429-01 +TCGA-05-5715-01 1.82 0.74 none none none none N Y none p.774_775insAYVM none 0.4 Bronchioid none none none none none none none Micropapillary predom Adc Micropapillary predom Adc none 0 TCGA-05-5715-01 BRCA-LUAD+ C1-LUAD-enriched cluster 2 Cluster 6 KIRC-like c1 LUAD-like c10 miRNA c1uster 10 cluster 5 mutation c1uster 10 TCGA-05-5715 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 69 L-Upper TCGA-05-5715 TCGA-05-5715-01A -25383 0 62 2011-3-22 FEMALE Lung Adenocarcinoma Mixed Subtype No C34.1 8255/3 C34.1 YES 0.6 NO 0.9 No M0 N0 T2a Stage IB TCGA-05-5715.b764fced-b638-48c6-82a6-4d3663bb2168.pdf 5715 TUMOR FREE R0 Primary Tumor 01 0.6 7th NO YES 05 1 Lifelong Non-smoker Lung A LIVING 2010 TCGA-05-5715-01A-01D-1625-08 TCGA-05-5715-01A-01D-1625-08 a9c81a18-bc29-4fac-83b2-bbd8047599bd TCGA-05-5715-01A-01D-1624-01 TCGA-05-5715-01A-01D-1626-05 TCGA-05-5715-01 TCGA-05-5715-01A-01D-1624-01 a9c81a18-bc29-4fac-83b2-bbd8047599bd TCGA-05-5715-01 TCGA-05-5715-01A-41-2191-20 a9c81a18-bc29-4fac-83b2-bbd8047599bd TCGA-05-5715-01 4f36ddf4-4d4a-4733-9809-d4fd53d8457a a9c81a18-bc29-4fac-83b2-bbd8047599bd TCGA-05-5715-01A-01D-1625-08 TCGA-05-5715-01 +TCGA-17-Z000-01 TCGA-17-Z000-01 Cluster 5 mutation c1uster 9 TCGA-17-Z000 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung TCGA-17-Z000-01A-01W-0746-08 TCGA-17-Z000-01A-01D-0752-05 TCGA-17-Z000-01A-01W-0746-08 +TCGA-17-Z001-01 TCGA-17-Z001-01 Cluster 5 mutation cluster 8 TCGA-17-Z001 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung TCGA-17-Z001-01A-01W-0746-08 TCGA-17-Z001-01A-01D-0752-05 TCGA-17-Z001-01A-01W-0746-08 +TCGA-17-Z002-01 TCGA-17-Z002-01 Cluster 6 TCGA-17-Z002 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung TCGA-17-Z002-01A-01D-0752-05 TCGA-17-Z002-01A-01W-0746-08 +TCGA-17-Z003-01 TCGA-17-Z003-01 Cluster 5 mutation cluster 5 TCGA-17-Z003 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung TCGA-17-Z003-01A-01W-0746-08 TCGA-17-Z003-01A-01D-0752-05 TCGA-17-Z003-01A-01W-0746-08 +TCGA-17-Z004-01 TCGA-17-Z004-01 Low purity c2 mutation c1uster 9 TCGA-17-Z004 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung TCGA-17-Z004-01A-01W-0746-08 TCGA-17-Z004-01A-01D-0752-05 TCGA-17-Z004-01A-01W-0746-08 +TCGA-17-Z005-01 TCGA-17-Z005-01 Cluster 6 mutation cluster 5 TCGA-17-Z005 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung TCGA-17-Z005-01A-01W-0746-08 TCGA-17-Z005-01A-01D-0752-05 TCGA-17-Z005-01A-01W-0746-08 +TCGA-17-Z006-01 TCGA-17-Z006-01 Cluster 5 TCGA-17-Z006 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung TCGA-17-Z006-01A-01D-0752-05 +TCGA-17-Z007-01 TCGA-17-Z007-01 COADREAD non-CIMP c11 mutation cluster 5 TCGA-17-Z007 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung TCGA-17-Z007-01A-01W-0746-08 TCGA-17-Z007-01A-01D-0752-05 TCGA-17-Z007-01A-01W-0746-08 +TCGA-17-Z008-01 TCGA-17-Z008-01 Cluster 5 mutation cluster 7 TCGA-17-Z008 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung TCGA-17-Z008-01A-01W-0746-08 TCGA-17-Z008-01A-01D-0752-05 +TCGA-17-Z009-01 TCGA-17-Z009-01 Low purity c2 mutation cluster 14 TCGA-17-Z009 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung TCGA-17-Z009-01A-01W-0746-08 TCGA-17-Z009-01A-01D-0752-05 TCGA-17-Z009-01A-01W-0746-08 +TCGA-17-Z010-01 TCGA-17-Z010-01 Cluster 6 mutation cluster 7 TCGA-17-Z010 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung TCGA-17-Z010-01A-01W-0746-08 TCGA-17-Z010-01A-01D-0752-05 TCGA-17-Z010-01A-01W-0746-08 +TCGA-17-Z011-01 TCGA-17-Z011-01 Cluster 5 mutation c1uster 9 TCGA-17-Z011 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung TCGA-17-Z011-01A-01W-0746-08 TCGA-17-Z011-01A-01D-0752-05 TCGA-17-Z011-01A-01W-0746-08 +TCGA-17-Z012-01 TCGA-17-Z012-01 Cluster 5 mutation cluster 5 TCGA-17-Z012 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung TCGA-17-Z012-01A-01W-0746-08 TCGA-17-Z012-01A-01D-0752-05 +TCGA-17-Z013-01 TCGA-17-Z013-01 Cluster 5 mutation c1uster 9 TCGA-17-Z013 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung TCGA-17-Z013-01A-01W-0746-08 TCGA-17-Z013-01A-01D-0752-05 TCGA-17-Z013-01A-01W-0746-08 +TCGA-17-Z014-01 TCGA-17-Z014-01 Cluster 6 mutation cluster 12 TCGA-17-Z014 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung TCGA-17-Z014-01A-01W-0746-08 TCGA-17-Z014-01A-01D-0752-05 TCGA-17-Z014-01A-01W-0746-08 +TCGA-17-Z015-01 TCGA-17-Z015-01 Cluster 6 mutation cluster 8 TCGA-17-Z015 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung TCGA-17-Z015-01A-01W-0746-08 TCGA-17-Z015-01A-01D-0752-05 TCGA-17-Z015-01A-01W-0746-08 +TCGA-17-Z016-01 TCGA-17-Z016-01 Cluster 5 mutation cluster 12 TCGA-17-Z016 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung TCGA-17-Z016-01A-01W-0746-08 TCGA-17-Z016-01A-01D-0752-05 TCGA-17-Z016-01A-01W-0746-08 +TCGA-17-Z017-01 TCGA-17-Z017-01 Cluster 6 mutation cluster 2 TCGA-17-Z017 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung TCGA-17-Z017-01A-01W-0746-08 TCGA-17-Z017-01A-01D-0752-05 TCGA-17-Z017-01A-01W-0746-08 +TCGA-17-Z018-01 TCGA-17-Z018-01 Cluster 5 mutation cluster 6 TCGA-17-Z018 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung TCGA-17-Z018-01A-01W-0746-08 TCGA-17-Z018-01A-01D-0752-05 TCGA-17-Z018-01A-01W-0746-08 +TCGA-17-Z019-01 TCGA-17-Z019-01 Cluster 5 TCGA-17-Z019 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung TCGA-17-Z019-01A-01D-0752-05 TCGA-17-Z019-01A-01W-0746-08 +TCGA-17-Z020-01 TCGA-17-Z020-01 Cluster 5 mutation cluster 2 TCGA-17-Z020 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung TCGA-17-Z020-01A-01W-0746-08 TCGA-17-Z020-01A-01D-0752-05 TCGA-17-Z020-01A-01W-0746-08 +TCGA-17-Z021-01 TCGA-17-Z021-01 Cluster 5 mutation cluster 5 TCGA-17-Z021 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung TCGA-17-Z021-01A-01W-0746-08 TCGA-17-Z021-01A-01D-0752-05 TCGA-17-Z021-01A-01W-0746-08 +TCGA-17-Z022-01 TCGA-17-Z022-01 Cluster 5 mutation cluster 11 TCGA-17-Z022 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung TCGA-17-Z022-01A-01W-0746-08 TCGA-17-Z022-01A-01D-0752-05 TCGA-17-Z022-01A-01W-0746-08 +TCGA-17-Z023-01 TCGA-17-Z023-01 Low purity c2 mutation cluster 2 TCGA-17-Z023 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung TCGA-17-Z023-01A-01W-0746-08 TCGA-17-Z023-01A-01D-0752-05 TCGA-17-Z023-01A-01W-0746-08 +TCGA-17-Z024-01 TCGA-17-Z024-01 Cluster 5 TCGA-17-Z024 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung TCGA-17-Z024-01A-01D-0752-05 +TCGA-17-Z025-01 TCGA-17-Z025-01 Cluster 6 mutation cluster 12 TCGA-17-Z025 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung TCGA-17-Z025-01A-01W-0746-08 TCGA-17-Z025-01A-01D-0752-05 TCGA-17-Z025-01A-01W-0746-08 +TCGA-17-Z026-01 TCGA-17-Z026-01 Cluster 5 mutation cluster 11 TCGA-17-Z026 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung TCGA-17-Z026-01A-01W-0746-08 TCGA-17-Z026-01A-01D-0752-05 TCGA-17-Z026-01A-01W-0746-08 +TCGA-17-Z027-01 TCGA-17-Z027-01 Cluster 5 mutation cluster 8 TCGA-17-Z027 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung TCGA-17-Z027-01A-01W-0746-08 TCGA-17-Z027-01A-01D-0752-05 TCGA-17-Z027-01A-01W-0746-08 +TCGA-17-Z028-01 TCGA-17-Z028-01 Cluster 5 mutation cluster 8 TCGA-17-Z028 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung TCGA-17-Z028-01A-01W-0746-08 TCGA-17-Z028-01A-01D-0752-05 TCGA-17-Z028-01A-01W-0746-08 +TCGA-17-Z029-01 TCGA-17-Z029-01 Low purity c2 TCGA-17-Z029 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung TCGA-17-Z029-01A-01D-0752-05 +TCGA-17-Z030-01 TCGA-17-Z030-01 Cluster 5 mutation cluster 11 TCGA-17-Z030 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung TCGA-17-Z030-01A-01W-0746-08 TCGA-17-Z030-01A-01D-0752-05 TCGA-17-Z030-01A-01W-0746-08 +TCGA-17-Z031-01 TCGA-17-Z031-01 Cluster 6 mutation cluster 11 TCGA-17-Z031 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung TCGA-17-Z031-01A-01W-0746-08 TCGA-17-Z031-01A-01D-0752-05 TCGA-17-Z031-01A-01W-0746-08 +TCGA-17-Z032-01 TCGA-17-Z032-01 Cluster 5 mutation cluster 14 TCGA-17-Z032 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung TCGA-17-Z032-01A-01W-0746-08 TCGA-17-Z032-01A-01D-0752-05 TCGA-17-Z032-01A-01W-0746-08 +TCGA-17-Z033-01 TCGA-17-Z033-01 Cluster 6 mutation cluster 12 TCGA-17-Z033 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung TCGA-17-Z033-01A-01W-0746-08 TCGA-17-Z033-01A-01D-0752-05 TCGA-17-Z033-01A-01W-0746-08 +TCGA-17-Z034-01 TCGA-17-Z034-01 Low purity c2 TCGA-17-Z034 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung TCGA-17-Z034-01A-01D-0752-05 +TCGA-17-Z035-01 TCGA-17-Z035-01 Cluster 5 mutation cluster 8 TCGA-17-Z035 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung TCGA-17-Z035-01A-01W-0746-08 TCGA-17-Z035-01A-01D-0752-05 +TCGA-17-Z036-01 TCGA-17-Z036-01 Cluster 5 mutation cluster 12 TCGA-17-Z036 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung TCGA-17-Z036-01A-01W-0746-08 TCGA-17-Z036-01A-01D-0752-05 TCGA-17-Z036-01A-01W-0746-08 +TCGA-17-Z037-01 TCGA-17-Z037-01 COADREAD non-CIMP c11 mutation cluster 2 TCGA-17-Z037 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung TCGA-17-Z037-01A-01W-0746-08 TCGA-17-Z037-01A-01D-0752-05 TCGA-17-Z037-01A-01W-0746-08 +TCGA-17-Z038-01 TCGA-17-Z038-01 Cluster 5 mutation c1uster 9 TCGA-17-Z038 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung TCGA-17-Z038-01A-01W-0746-08 TCGA-17-Z038-01A-01D-0752-05 +TCGA-17-Z039-01 TCGA-17-Z039-01 Low purity c2 mutation c1uster 9 TCGA-17-Z039 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung TCGA-17-Z039-01A-01W-0746-08 TCGA-17-Z039-01A-01D-0752-05 +TCGA-17-Z040-01 TCGA-17-Z040-01 Cluster 5 mutation c1uster 9 TCGA-17-Z040 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung TCGA-17-Z040-01A-01W-0746-08 TCGA-17-Z040-01A-01D-0752-05 +TCGA-17-Z041-01 TCGA-17-Z041-01 Cluster 5 mutation c1uster 9 TCGA-17-Z041 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung TCGA-17-Z041-01A-01W-0746-08 TCGA-17-Z041-01A-01D-0752-05 TCGA-17-Z041-01A-01W-0746-08 +TCGA-17-Z042-01 TCGA-17-Z042-01 Cluster 6 mutation cluster 11 TCGA-17-Z042 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung TCGA-17-Z042-01A-01W-0746-08 TCGA-17-Z042-01A-01D-0752-05 TCGA-17-Z042-01A-01W-0746-08 +TCGA-17-Z043-01 TCGA-17-Z043-01 Cluster 5 mutation cluster 5 TCGA-17-Z043 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung TCGA-17-Z043-01A-01W-0746-08 TCGA-17-Z043-01A-01D-0752-05 TCGA-17-Z043-01A-01W-0746-08 +TCGA-17-Z044-01 TCGA-17-Z044-01 Cluster 5 mutation cluster 8 TCGA-17-Z044 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung TCGA-17-Z044-01A-01W-0746-08 TCGA-17-Z044-01A-01D-0752-05 TCGA-17-Z044-01A-01W-0746-08 +TCGA-17-Z045-01 TCGA-17-Z045-01 Cluster 5 mutation cluster 2 TCGA-17-Z045 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung TCGA-17-Z045-01A-01W-0746-08 TCGA-17-Z045-01A-01D-0752-05 TCGA-17-Z045-01A-01W-0746-08 +TCGA-17-Z046-01 TCGA-17-Z046-01 Cluster 6 mutation cluster 11 TCGA-17-Z046 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung TCGA-17-Z046-01A-01W-0746-08 TCGA-17-Z046-01A-01D-0752-05 +TCGA-17-Z047-01 TCGA-17-Z047-01 Cluster 5 mutation cluster 8 TCGA-17-Z047 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung TCGA-17-Z047-01A-01W-0747-08 TCGA-17-Z047-01A-01D-0752-05 TCGA-17-Z047-01A-01W-0747-08 +TCGA-17-Z048-01 TCGA-17-Z048-01 Cluster 5 mutation cluster 14 TCGA-17-Z048 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung TCGA-17-Z048-01A-01W-0746-08 TCGA-17-Z048-01A-01D-0752-05 TCGA-17-Z048-01A-01W-0746-08 +TCGA-17-Z049-01 TCGA-17-Z049-01 Cluster 5 mutation cluster 2 TCGA-17-Z049 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung TCGA-17-Z049-01A-01W-0746-08 TCGA-17-Z049-01A-01D-0752-05 TCGA-17-Z049-01A-01W-0746-08 +TCGA-17-Z050-01 TCGA-17-Z050-01 Cluster 6 mutation cluster 7 TCGA-17-Z050 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung TCGA-17-Z050-01A-01W-0747-08 TCGA-17-Z050-01A-01D-0752-05 TCGA-17-Z050-01A-01W-0747-08 +TCGA-17-Z051-01 TCGA-17-Z051-01 Cluster 5 mutation c1uster 9 TCGA-17-Z051 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung TCGA-17-Z051-01A-01W-0747-08 TCGA-17-Z051-01A-01D-0752-05 TCGA-17-Z051-01A-01W-0747-08 +TCGA-17-Z052-01 TCGA-17-Z052-01 Low purity c2 mutation cluster 5 TCGA-17-Z052 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung TCGA-17-Z052-01A-01W-0747-08 TCGA-17-Z052-01A-01D-0752-05 TCGA-17-Z052-01A-01W-0747-08 +TCGA-17-Z053-01 TCGA-17-Z053-01 Cluster 13 (HNSC-LUSC) mutation cluster 2 TCGA-17-Z053 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung TCGA-17-Z053-01A-01W-0747-08 TCGA-17-Z053-01A-01D-0752-05 TCGA-17-Z053-01A-01W-0747-08 +TCGA-17-Z054-01 TCGA-17-Z054-01 Cluster 5 mutation c1uster 9 TCGA-17-Z054 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung TCGA-17-Z054-01A-01W-0747-08 TCGA-17-Z054-01A-01D-0752-05 TCGA-17-Z054-01A-01W-0747-08 +TCGA-17-Z055-01 TCGA-17-Z055-01 mutation cluster 2 TCGA-17-Z055 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung TCGA-17-Z055-01A-01W-0747-08 TCGA-17-Z055-01A-01W-0747-08 +TCGA-17-Z056-01 TCGA-17-Z056-01 Cluster 5 mutation cluster 8 TCGA-17-Z056 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung TCGA-17-Z056-01A-01W-0747-08 TCGA-17-Z056-01A-01D-0752-05 TCGA-17-Z056-01A-01W-0747-08 +TCGA-17-Z057-01 TCGA-17-Z057-01 mutation cluster 5 TCGA-17-Z057 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung TCGA-17-Z057-01A-01W-0747-08 TCGA-17-Z057-01A-01W-0747-08 +TCGA-17-Z058-01 TCGA-17-Z058-01 Cluster 5 mutation cluster 12 TCGA-17-Z058 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung TCGA-17-Z058-01A-01W-0747-08 TCGA-17-Z058-01A-01D-0752-05 TCGA-17-Z058-01A-01W-0747-08 +TCGA-17-Z059-01 TCGA-17-Z059-01 Cluster 6 mutation c1uster 9 TCGA-17-Z059 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung TCGA-17-Z059-01A-01W-0747-08 TCGA-17-Z059-01A-01D-0752-05 TCGA-17-Z059-01A-01W-0747-08 +TCGA-17-Z060-01 TCGA-17-Z060-01 Cluster 5 mutation cluster 12 TCGA-17-Z060 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung TCGA-17-Z060-01A-01W-0747-08 TCGA-17-Z060-01A-01D-0752-05 TCGA-17-Z060-01A-01W-0747-08 +TCGA-17-Z061-01 TCGA-17-Z061-01 Cluster 5 mutation cluster 13 TCGA-17-Z061 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung TCGA-17-Z061-01A-01W-0747-08 TCGA-17-Z061-01A-01D-0752-05 TCGA-17-Z061-01A-01W-0747-08 +TCGA-17-Z062-01 TCGA-17-Z062-01 Cluster 5 mutation cluster 11 TCGA-17-Z062 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung TCGA-17-Z062-01A-01W-0747-08 TCGA-17-Z062-01A-01D-0752-05 TCGA-17-Z062-01A-01W-0747-08 +TCGA-35-3615-01 2.07 0.68 none none none none Y Y none none none 0.33 Magnoid none p.G12C none none none none none Lepidic predominant Adc Lepidic predominant Adc p.L245_splice 0 TCGA-35-3615-01 Iq C1-LUAD-enriched Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 7 cluster 4 mutation cluster 12 TCGA-35-3615 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 57 R-Upper TCGA-35-3615-F68919 TCGA-35-3615 -21076 0 14 NO NO Scheduled Follow-up Submission 2015-8-24 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES NO Peripheral Lung YES No M0 N0 T2 Stage IB 3615 TUMOR FREE R0 Primary Tumor 01 NO YES 35 1 Lifelong Non-smoker Lung LIVING 2007 TCGA-35-3615-01 TCGA-35-3615-01A-01D-1040-01 TCGA-35-3615-01 c3fb15e3-4fca-413f-86e8-24cb073ef3f1 TCGA-35-3615-01A-01R-0946-07 TCGA-35-3615-01A-01D-0945-05 TCGA-35-3615-01 TCGA-35-3615-01A-01D-0944-01 TCGA-35-3615-01 TCGA-35-3615-01A-01D-0944-01 TCGA-35-3615-01 c3fb15e3-4fca-413f-86e8-24cb073ef3f1 TCGA-35-3615-01A-21-2190-20 c3fb15e3-4fca-413f-86e8-24cb073ef3f1 TCGA-35-3615-01 f47527bd-86b0-4807-818c-6b4971222e06 c3fb15e3-4fca-413f-86e8-24cb073ef3f1 TCGA-35-3615-01A-01W-0928-08,TCGA-35-3615-01A-01D-1040-01 TCGA-35-3615-01 +TCGA-35-3621-01 TCGA-35-3621-01 TCGA-35-3621 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung TCGA-35-3621-01A 0.4 NO 0.8 Primary Tumor 01 0.3 A TCGA-35-3621-01A-01D-0969-08 TCGA-35-3621-01A-01R-1107-07 TCGA-35-3621-01A-01D-1104-05 +TCGA-35-4122-01 TCGA-35-4122-01 High C1-LUAD-enriched Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 4 mutation cluster 5 TCGA-35-4122 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 69 L-Upper TCGA-35-4122-F68915 TCGA-35-4122 TCGA-35-4122-01A -25491 0 225 1 NO NO Scheduled Follow-up Submission 2014-12-23 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.7 NO 80 NO Peripheral Lung 1 YES 45 No M0 N0 T1 Stage IA TCGA-35-4122.a970d363-3ea8-4f28-a3a5-81c28dcb799f.pdf 4122 Preoperative TUMOR FREE YES R0 Primary Tumor 01 0.5 2010 7th NO YES 35 4 Lung A LIVING 2010 1965 TCGA-35-4122-01A-01D-1105-08 TCGA-35-4122-01 9d983613-1588-48a2-a515-7afae7aafc92 TCGA-35-4122-01A-01R-1107-07 TCGA-35-4122-01A-01D-1104-05 TCGA-35-4122-01 TCGA-35-4122-01A-01D-1877-01 TCGA-35-4122-01 TCGA-35-4122-01A-01D-1877-01 TCGA-35-4122-01 9d983613-1588-48a2-a515-7afae7aafc92 TCGA-35-4122-01A-21-2190-20 9d983613-1588-48a2-a515-7afae7aafc92 TCGA-35-4122-01 a0dded2b-3083-4aea-a9b1-c8376ddf0db1 9d983613-1588-48a2-a515-7afae7aafc92 TCGA-35-4122-01A-01D-1105-08 TCGA-35-4122-01 +TCGA-35-4123-01 TCGA-35-4123-01 Squamous C1-LUAD-enriched Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 4 mutation cluster 3 TCGA-35-4123 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 38 R-Upper TCGA-35-4123-F68918 TCGA-35-4123 TCGA-35-4123-01A -14064 0 182 1 NO NO Scheduled Follow-up Submission 2014-12-23 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.4 NO 90 NO Peripheral Lung 0.9 YES 20 No M0 N0 T1 Stage IA TCGA-35-4123.7f74ee3b-0ecf-468d-9280-d30686d67d3a.pdf 4123 Preoperative TUMOR FREE YES R0 Primary Tumor 01 0.3 2010 7th NO YES 35 4 Lung A LIVING 2010 1990 TCGA-35-4123-01A-01D-1105-08 TCGA-35-4123-01 2ef846b1-a0f9-412e-a72e-6dab6543d41f TCGA-35-4123-01A-01R-1107-07 TCGA-35-4123-01A-01D-1104-05 TCGA-35-4123-01 TCGA-35-4123-01A-01D-1877-01 TCGA-35-4123-01 TCGA-35-4123-01A-01D-1877-01 TCGA-35-4123-01 2ef846b1-a0f9-412e-a72e-6dab6543d41f TCGA-35-4123-01A-21-2190-20 2ef846b1-a0f9-412e-a72e-6dab6543d41f TCGA-35-4123-01 b3627ae3-6960-4e37-b443-bc30986e9d0d 2ef846b1-a0f9-412e-a72e-6dab6543d41f TCGA-35-4123-01A-01D-1105-08 TCGA-35-4123-01 +TCGA-35-5375-01 TCGA-35-5375-01 High C2-Squamous-like BRCA CIMP c7 squamous c3 squamous-like c4 miRNA cluster 12 mutation cluster 11 TCGA-35-5375 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 61 L-Upper TCGA-35-5375-F68920 TCGA-35-5375 TCGA-35-5375-01A -22628 0 264 1 Scheduled Follow-up Submission 2015-8-24 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 1 NO 90 Peripheral Lung 1.3 YES 35 No M0 N2 T2 Stage IIIA TCGA-35-5375.a93477c8-5ebe-436b-978a-61b573f65471.pdf 5375 Post-Adjuvant Therapy TUMOR FREE R0 Primary Tumor 01 0.3 2006 NO YES 35 4 Lung A LIVING 2010 1971 TCGA-35-5375-01A-01D-1625-08 ab215c47-4678-4ca9-8cd3-ac6e3e804c05 TCGA-35-5375-01A-01D-1624-01 TCGA-35-5375-01A-01D-1626-05 TCGA-35-5375-01 TCGA-35-5375-01A-01D-1624-01 ab215c47-4678-4ca9-8cd3-ac6e3e804c05 TCGA-35-5375-01 TCGA-35-5375-01A-21-2190-20 ab215c47-4678-4ca9-8cd3-ac6e3e804c05 TCGA-35-5375-01 1dec822b-8282-4b95-8d3b-76bd5ed3fbe0 ab215c47-4678-4ca9-8cd3-ac6e3e804c05 TCGA-35-5375-01A-01D-1625-08 TCGA-35-5375-01 +TCGA-38-4625-01 TCGA-38-4625-01 Squamous C1-LUAD-enriched Cluster 6 squamous c3 LUAD-like c10 miRNA c1uster 9 mutation cluster 13 TCGA-38-4625 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 66 R-Upper TCGA-38-4625-F33407 TCGA-38-4625 -24241 0 2973 68 NO NO Scheduled Follow-up Submission Complete Remission/Response 2012-7-26 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES NO Peripheral Lung YES 50 No M0 N0 T2a Stage IB 4625 66 66 68 64 YES R0 Primary Tumor 01 5th NO YES 38 2 Lung LIVING 2002 1952 TCGA-38-4625-01A-01D-1553-08 bc6c762f-727f-43c8-a4bc-4c41351c7f13 TCGA-38-4625-01A-01D-1205-05 TCGA-38-4625-01 TCGA-38-4625-01A-01D-1204-01 TCGA-38-4625-01 TCGA-38-4625-01A-01D-1204-01 bc6c762f-727f-43c8-a4bc-4c41351c7f13 TCGA-38-4625-01A-21-2190-20 bc6c762f-727f-43c8-a4bc-4c41351c7f13 TCGA-38-4625-01 f5f1b4e7-6b05-4d28-a55b-8719ebb6a9c0 bc6c762f-727f-43c8-a4bc-4c41351c7f13 TCGA-38-4625-01A-01D-1553-08 TCGA-38-4625-01 +TCGA-38-4625-11 TCGA-38-4625-11 C1-LUAD-enriched mutation cluster 13 TCGA-38-4625 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 66 R-Upper TCGA-38-4625-F33407 TCGA-38-4625 TCGA-38-4625-11A -24241 0 2973 68 NO NO Scheduled Follow-up Submission Complete Remission/Response 2012-7-26 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.6 NO NO Peripheral Lung 0.9 YES 50 No M0 N0 T2a Stage IB 4625 66 66 68 64 YES R0 Solid Tissue Normal 11 0.2 5th NO YES 38 2 Lung A LIVING 2002 1952 cc556dfb-6bd4-4d53-a33b-6dae9407d7c4 cc556dfb-6bd4-4d53-a33b-6dae9407d7c4 cc556dfb-6bd4-4d53-a33b-6dae9407d7c4 cc556dfb-6bd4-4d53-a33b-6dae9407d7c4 +TCGA-38-4626-01 none none none none Y Y none none none Bronchioid none p.G12V none none none none none Solid predominant Adc Solid predominant Adc none 0 TCGA-38-4626-01 BRCA-LUAD+ C1-LUAD-enriched Cluster 5 squamous c3 LUAD-like c10 miRNA c1uster 9 cluster 4 mutation cluster 12 TCGA-38-4626 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung NO NO NO 57 L-Upper TCGA-38-4626-F33409 TCGA-38-4626 -20903 0 3674 2518 57 Scheduled Follow-up Submission Complete Remission/Response 2012-7-26 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES Central Lung NO New Primary Tumor YES 40 No M0 N0 T2b [Discrepancy] 4626 TUMOR FREE 68 85 71 85 Complete Remission/Response YES NO R0 Primary Tumor 01 6th NO NO YES 38 2 Current smoker Lung LIVING 2003 1962 TCGA-38-4626-01A-01D-1553-08 TCGA-38-4626-01A-01D-1553-08 abc25621-f98e-4bce-968b-df64793b2daf TCGA-38-4626-01A-01D-1205-05 TCGA-38-4626-01 TCGA-38-4626-01A-01D-1204-01 TCGA-38-4626-01 TCGA-38-4626-01A-01D-1204-01 abc25621-f98e-4bce-968b-df64793b2daf TCGA-38-4626-01A-21-2190-20 abc25621-f98e-4bce-968b-df64793b2daf TCGA-38-4626-01 f1a33481-d34e-4a5b-8b60-9bb49b4584b1 abc25621-f98e-4bce-968b-df64793b2daf TCGA-38-4626-01A-01D-1553-08 TCGA-38-4626-01 +TCGA-38-4626-11 none none none none Y Y none none none Bronchioid none p.G12V none none none none none Solid predominant Adc Solid predominant Adc none 0 TCGA-38-4626-11 C1-LUAD-enriched mutation cluster 12 TCGA-38-4626 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung NO NO NO 57 L-Upper TCGA-38-4626-F33409 TCGA-38-4626 TCGA-38-4626-11A -20903 0 3674 2518 57 Scheduled Follow-up Submission Complete Remission/Response 2012-7-26 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.6 NO Central Lung 0.6 NO New Primary Tumor YES 40 No M0 N0 T2b [Discrepancy] 4626 TUMOR FREE 68 85 71 85 Complete Remission/Response YES NO R0 Solid Tissue Normal 11 0.3 6th NO NO YES 38 2 Current smoker Lung A LIVING 2003 1962 aad6bc48-5020-41e4-a2d0-f994c08170a9 aad6bc48-5020-41e4-a2d0-f994c08170a9 aad6bc48-5020-41e4-a2d0-f994c08170a9 aad6bc48-5020-41e4-a2d0-f994c08170a9 +TCGA-38-4627-01 none none none none Y Y p.L62R, p.L858R none none Squamoid none none none none none none none Acinar predominant Adc Acinar predominant Adc none 0 TCGA-38-4627-01 Quiet C1-LUAD-enriched Cluster 5 squamous c3 LUAD-like c10 miRNA c1uster 9 cluster 2 mutation cluster 14 TCGA-38-4627 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 64 R-Upper TCGA-38-4627-F4508 TCGA-38-4627 -23510 1147 0 2010-12-8 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES Central Lung No M0 N1 T1b Stage IIA 4627 Complete Remission/Response NO R0 Primary Tumor 01 NO NO YES 38 4 Current reformed smoker for < or = 15 years Lung DECEASED 2003 TCGA-38-4627-01A-01D-1553-08 TCGA-38-4627-01A-01D-1553-08 ca296fb4-2d1e-4ce9-acc8-81bd4cd11e58 TCGA-38-4627-01A-01D-1205-05 TCGA-38-4627-01 TCGA-38-4627-01A-01D-1549-01 TCGA-38-4627-01 TCGA-38-4627-01A-01D-1549-01 ca296fb4-2d1e-4ce9-acc8-81bd4cd11e58 TCGA-38-4627-01A-21-2190-20 ca296fb4-2d1e-4ce9-acc8-81bd4cd11e58 TCGA-38-4627-01 a7ef03a9-2a95-43d7-8dc4-3e98decdb223 ca296fb4-2d1e-4ce9-acc8-81bd4cd11e58 TCGA-38-4627-01A-01D-1553-08 TCGA-38-4627-01 +TCGA-38-4627-11 none none none none Y Y p.L62R, p.L858R none none Squamoid none none none none none none none Acinar predominant Adc Acinar predominant Adc none 0 TCGA-38-4627-11 C1-LUAD-enriched mutation cluster 14 TCGA-38-4627 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 64 R-Upper TCGA-38-4627-F4508 TCGA-38-4627 TCGA-38-4627-11A -23510 1147 0 2010-12-8 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.8 NO Central Lung 1 No M0 N1 T1b Stage IIA 4627 Complete Remission/Response NO R0 Solid Tissue Normal 11 0.1 NO NO YES 38 4 Current reformed smoker for < or = 15 years Lung A DECEASED 2003 90a1abbc-6287-48f9-a669-10033380c9db 90a1abbc-6287-48f9-a669-10033380c9db 90a1abbc-6287-48f9-a669-10033380c9db 90a1abbc-6287-48f9-a669-10033380c9db +TCGA-38-4628-01 5.05 0.5 none none none none Y Y p.ELREA746del none none 0.14 Squamoid none none none none none none none Acinar predominant Adc Acinar predominant Adc none 1 TCGA-38-4628-01 High C1-LUAD-enriched Cluster 6 LUAD-like c10 miRNA cluster 4 cluster 5 mutation cluster 14 TCGA-38-4628 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung YES NO NO YES 65 R-Upper TCGA-38-4628-F4676 TCGA-38-4628 TCGA-38-4628-01A 1118 -24057 1492 0 1083 72 NO NO Stable Disease 2010-12-9 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.5 NO NO Central Lung 0.8 YES No M0 N1 T2 Stage IIB TCGA-38-4628.0a4269d2-d168-4750-ab8c-3c27907c45ef.pdf 4628 WITH TUMOR 78 85 74 86 Complete Remission/Response YES NO R0 Primary Tumor 01 0.2 5th NO NO YES 38 1 Lifelong Non-smoker Lung A DECEASED 2002 TCGA-38-4628-01A-01D-1265-08 TCGA-38-4628-01A-01D-1265-08 20c29e50-f961-465c-aa22-12e9ab187e71 TCGA-38-4628-01A-01D-1205-05 TCGA-38-4628-01 TCGA-38-4628-01A-01D-1204-01 TCGA-38-4628-01 TCGA-38-4628-01A-01D-1204-01 20c29e50-f961-465c-aa22-12e9ab187e71 20c29e50-f961-465c-aa22-12e9ab187e71 TCGA-38-4628-01 20c29e50-f961-465c-aa22-12e9ab187e71 TCGA-38-4628-01A-01D-1265-08 TCGA-38-4628-01 +TCGA-38-4628-11 5.05 0.5 none none none none Y Y p.ELREA746del none none 0.14 Squamoid none none none none none none none Acinar predominant Adc Acinar predominant Adc none 1 TCGA-38-4628-11 C1-LUAD-enriched mutation cluster 14 TCGA-38-4628 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung YES NO NO YES 65 R-Upper TCGA-38-4628-F4676 TCGA-38-4628 TCGA-38-4628-11A 1118 -24057 1492 0 1083 72 NO NO Stable Disease 2010-12-9 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.9 NO NO Central Lung 1 YES No M0 N1 T2 Stage IIB 4628 WITH TUMOR 78 85 74 86 Complete Remission/Response YES NO R0 Solid Tissue Normal 11 0.4 5th NO NO YES 38 1 Lifelong Non-smoker Lung A DECEASED 2002 TCGA-38-4628-11A-01D-1205-05 +TCGA-38-4629-01 TCGA-38-4629-01 High C1-LUAD-enriched Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 4 mutation cluster 11 TCGA-38-4629 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung NO NO NO NO 68 R-Upper TCGA-38-4629-F4887 TCGA-38-4629 TCGA-38-4629-01A -25104 864 0 379 NO NO 2010-12-14 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 1 NO NO Peripheral Lung 1.3 YES 100 Yes M0 N0 T3 Stage IIB TCGA-38-4629.9546e974-686d-4d97-b5bd-771972cb4b82.pdf 4629 WITH TUMOR Complete Remission/Response NO R0 Primary Tumor 01 0.2 2003 NO NO YES 38 4 Lung A DECEASED 2003 TCGA-38-4629-01A-02D-1265-08 6ed236e4-faf1-4d23-bccd-341688b034c3 TCGA-38-4629-01A-02D-1205-05 TCGA-38-4629-01A-02D-1204-01 TCGA-38-4629-01 TCGA-38-4629-01A-02D-1204-01 6ed236e4-faf1-4d23-bccd-341688b034c3 TCGA-38-4629-01A-11-2190-20 6ed236e4-faf1-4d23-bccd-341688b034c3 TCGA-38-4629-01 b78fa417-a0aa-4ebf-b75f-6891c541fb6d 6ed236e4-faf1-4d23-bccd-341688b034c3 TCGA-38-4629-01A-02D-1265-08 +TCGA-38-4629-11 TCGA-38-4629-11 C1-LUAD-enriched mutation cluster 11 TCGA-38-4629 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung NO NO NO NO 68 R-Upper TCGA-38-4629-F4887 TCGA-38-4629 TCGA-38-4629-11A -25104 864 0 379 NO NO 2010-12-14 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.6 NO NO Peripheral Lung 1 YES 100 Yes M0 N0 T3 Stage IIB 4629 WITH TUMOR Complete Remission/Response NO R0 Solid Tissue Normal 11 0.1 2003 NO NO YES 38 4 Lung A DECEASED 2003 TCGA-38-4629-11A-01D-1205-05 +TCGA-38-4630-01 TCGA-38-4630-01 High C6-UCEC UCEC Serous c4 UCEC-like c11 miRNA c1uster 10 mutation cluster 5 TCGA-38-4630 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung NO YES NO NO 75 R-Upper TCGA-38-4630-F4972 TCGA-38-4630 TCGA-38-4630-01A -27667 1073 0 836 NO NO Stable Disease 2010-12-16 FEMALE Lung Papillary Adenocarcinoma No C34.1 8260/3 C34.1 YES 0.8 NO NO Peripheral Lung 1.6 YES Yes M0 N0 T2 Stage IB TCGA-38-4630.63d133eb-0aa7-4c76-bf48-b9206df8975f.pdf 4630 WITH TUMOR Complete Remission/Response NO NO R1 Primary Tumor 01 0.3 6th NO NO YES 38 1 Lung A DECEASED 2000 TCGA-38-4630-01A-01D-1265-08 09a88dca-7503-4fcb-b42a-ac5af9fdbca7 TCGA-38-4630-01A-01D-1205-05 TCGA-38-4630-01A-01D-1204-01 TCGA-38-4630-01 TCGA-38-4630-01A-01D-1204-01 09a88dca-7503-4fcb-b42a-ac5af9fdbca7 09a88dca-7503-4fcb-b42a-ac5af9fdbca7 TCGA-38-4630-01 09a88dca-7503-4fcb-b42a-ac5af9fdbca7 TCGA-38-4630-01A-01D-1265-08 +TCGA-38-4630-11 TCGA-38-4630-11 C6-UCEC mutation cluster 5 TCGA-38-4630 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung NO YES NO NO 75 R-Upper TCGA-38-4630-F4972 TCGA-38-4630 TCGA-38-4630-11A -27667 1073 0 836 NO NO Stable Disease 2010-12-16 FEMALE Lung Papillary Adenocarcinoma No C34.1 8260/3 C34.1 YES 0.7 NO NO Peripheral Lung 1.2 YES Yes M0 N0 T2 Stage IB 4630 WITH TUMOR Complete Remission/Response NO NO R1 Solid Tissue Normal 11 0.2 6th NO NO YES 38 1 Lung A DECEASED 2000 TCGA-38-4630-11A-01D-1205-05 +TCGA-38-4631-01 none none none none N N none none p.P610T Magnoid none none none none none none none NSCLC, favor Adeno NSCLC, favor Adeno none 0 TCGA-38-4631-01 BRCA-LUAD+ C1-LUAD-enriched cluster 3 Cluster 5 LUAD-like c10 miRNA cluster 5 cluster 5 mutation cluster 5 TCGA-38-4631 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung NO YES NO NO 72 L-Upper TCGA-38-4631-F4892 TCGA-38-4631 -26538 354 0 NO NO 2010-12-14 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES NO Peripheral Lung YES 40 Yes M0 N0 T2 Stage IB 4631 WITH TUMOR Progressive Disease NO R0 Primary Tumor 01 NO NO YES 38 4 Current reformed smoker for < or = 15 years Lung DECEASED 1997 TCGA-38-4631-01A-01D-1753-08 TCGA-38-4631-01A-01D-1753-08 c436fa86-ae7e-490e-a52c-5004a8643b50 TCGA-38-4631-01A-01D-1752-01 TCGA-38-4631-01A-01D-1756-05 TCGA-38-4631-01 TCGA-38-4631-01A-01D-1752-01 c436fa86-ae7e-490e-a52c-5004a8643b50 TCGA-38-4631-01 c436fa86-ae7e-490e-a52c-5004a8643b50 TCGA-38-4631-01 c436fa86-ae7e-490e-a52c-5004a8643b50 TCGA-38-4631-01A-01D-1753-08 TCGA-38-4631-01 +TCGA-38-4631-11 none none none none N N none none p.P610T Magnoid none none none none none none none NSCLC, favor Adeno NSCLC, favor Adeno none 0 TCGA-38-4631-11 C1-LUAD-enriched mutation cluster 5 TCGA-38-4631 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung NO YES NO NO 72 L-Upper TCGA-38-4631-F4892 TCGA-38-4631 TCGA-38-4631-11A -26538 354 0 NO NO 2010-12-14 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.6 NO NO Peripheral Lung 1.1 YES 40 Yes M0 N0 T2 Stage IB 4631 WITH TUMOR Progressive Disease NO R0 Solid Tissue Normal 11 0.3 NO NO YES 38 4 Current reformed smoker for < or = 15 years Lung A DECEASED 1997 TCGA-38-4631-11A-01D-1756-05 +TCGA-38-4632-01 none none none none N Y none none none Squamoid none none none none p.Q61L none none Solid predominant Adc Solid predominant Adc none 0 TCGA-38-4632-01 High C1-LUAD-enriched cluster 1 Cluster 6 LUAD-like c10 miRNA cluster 4 cluster 2 mutation cluster 11 TCGA-38-4632 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung YES YES NO NO 42 L-Upper TCGA-38-4632-F4842 TCGA-38-4632 -15418 1357 0 925 NO NO Progressive Disease 2010-12-13 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES NO Peripheral Lung YES 10 No M1 N1 T2 Stage IV 4632 WITH TUMOR Complete Remission/Response NO NO R0 Primary Tumor 01 1991 5th NO NO YES 38 4 Current reformed smoker for < or = 15 years Lung DECEASED 1998 TCGA-38-4632-01A-01D-1753-08 TCGA-38-4632-01A-01D-1753-08 b3cb327b-b0d4-478f-8dac-75abdb6365eb TCGA-38-4632-01A-01D-1752-01 TCGA-38-4632-01A-01D-1756-05 TCGA-38-4632-01 TCGA-38-4632-01A-01D-1752-01 b3cb327b-b0d4-478f-8dac-75abdb6365eb TCGA-38-4632-01 b3cb327b-b0d4-478f-8dac-75abdb6365eb TCGA-38-4632-01 b3cb327b-b0d4-478f-8dac-75abdb6365eb TCGA-38-4632-01A-01D-1753-08 TCGA-38-4632-01 +TCGA-38-4632-11 none none none none N Y none none none Squamoid none none none none p.Q61L none none Solid predominant Adc Solid predominant Adc none 0 TCGA-38-4632-11 C1-LUAD-enriched mutation cluster 11 TCGA-38-4632 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung YES YES NO NO 42 L-Upper TCGA-38-4632-F4842 TCGA-38-4632 TCGA-38-4632-11A -15418 1357 0 925 NO NO Progressive Disease 2010-12-13 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 1 NO NO Peripheral Lung 1.6 YES 10 No M1 N1 T2 Stage IV 4632 WITH TUMOR Complete Remission/Response NO NO R0 Solid Tissue Normal 11 0.4 1991 5th NO NO YES 38 4 Current reformed smoker for < or = 15 years Lung A DECEASED 1998 190cca34-43f6-4d87-93fc-e36220f1782f TCGA-38-4632-11A-01D-1756-05 190cca34-43f6-4d87-93fc-e36220f1782f 190cca34-43f6-4d87-93fc-e36220f1782f 190cca34-43f6-4d87-93fc-e36220f1782f +TCGA-38-6178-01 3.91 0.33 none none none none Y Y p.ELREA746del none none 0.13 Bronchioid none none none none none none none Acinar predominant Adc Acinar predominant Adc none 0 TCGA-38-6178-01 BRCA-LUAD+ C1-LUAD-enriched cluster 2 Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 5 cluster 3 mutation cluster 8 TCGA-38-6178 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 70 L-Upper TCGA-38-6178-F22078 TCGA-38-6178 TCGA-38-6178-01A -25593 0 448 YES Exon 19 Deletion NO Scheduled Follow-up Submission 2012-2-23 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.6 NO YES NO Central Lung 1.5 NO Yes N2 T2b Stage IIIA TCGA-38-6178.c2b33805-c417-4d5b-97ff-ec0d93afee8c.pdf 6178 WITH TUMOR Stable Disease NO R1 Primary Tumor 01 0.3 YES YES NO 38 1 Lifelong Non-smoker Lung A LIVING 2010 TCGA-38-6178-01A-11D-1753-08 TCGA-38-6178-01A-11D-1753-08 b73f5912-d163-4812-995c-0a273f543af1 TCGA-38-6178-01A-11D-1752-01 TCGA-38-6178-01A-11D-1756-05 TCGA-38-6178-01 TCGA-38-6178-01A-11D-1752-01 b73f5912-d163-4812-995c-0a273f543af1 TCGA-38-6178-01 TCGA-38-6178-01A-13-2191-20 b73f5912-d163-4812-995c-0a273f543af1 TCGA-38-6178-01 672018b4-22a2-4763-8ce7-19bff0256138 b73f5912-d163-4812-995c-0a273f543af1 TCGA-38-6178-01A-11D-1753-08 TCGA-38-6178-01 +TCGA-38-7271-01 TCGA-38-7271-01 Iq Cluster 5 LUAD-like c10 miRNA cluster 5 TCGA-38-7271 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung NO YES NO NO 72 R-Upper TCGA-38-7271-F18312 TCGA-38-7271 TCGA-38-7271-01A -26440 800 0 633 76 NO NO Additional New Tumor Event Progressive Disease 2011-11-10 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.8 NO NO 1.1 YES 25 Yes M0 N0 T1 Stage IA TCGA-38-7271.7eb95f4d-3fb0-4312-89d1-4d5ec9f4f677.pdf 7271 WITH TUMOR 46 45 43 40 YES R0 Primary Tumor 01 0.5 1999 6th NO YES 38 4 Lung A DECEASED 2006 1971 8d895d3d-9598-459b-813e-3fc84dd3efe8 TCGA-38-7271-01A-11D-2035-01 TCGA-38-7271-01A-11D-2037-05 TCGA-38-7271-01 TCGA-38-7271-01A-11D-2035-01 8d895d3d-9598-459b-813e-3fc84dd3efe8 TCGA-38-7271-01 8d895d3d-9598-459b-813e-3fc84dd3efe8 TCGA-38-7271-01 8d895d3d-9598-459b-813e-3fc84dd3efe8 TCGA-38-7271-01A-11D-2036-08 TCGA-38-7271-01 +TCGA-38-A44F-01 TCGA-38-A44F-01 TCGA-38-A44F TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 80 R-Upper TCGA-38-A44F-F47557 TCGA-38-A44F TCGA-38-A44F-01A -29534 127 0 133 35 NO FISH YES Scheduled Follow-up Submission 2013-8-26 MALE Lung Adenocarcinoma Mixed Subtype No C34.1 8550/3 C34.1 YES 580 NO NO Peripheral Lung YES NO 12 false No M0 N0 T2a Stage IB TCGA-38-A44F.FC3ACA4F-AA49-47F4-9BA3-7B18C56F64AD.pdf A44F TUMOR FREE 71 72 52 Complete Remission/Response YES NO R0 Primary Tumor 01 1977 7th NO YES NO 38 3 Lung A LIVING 2012 1965 c8762ae1-49de-496d-a00f-4cde20bbd3af TCGA-38-A44F-01A-11D-A24C-01 TCGA-38-A44F-01A-11D-A24I-05 TCGA-38-A44F-01 TCGA-38-A44F-01A-11D-A24C-01 c8762ae1-49de-496d-a00f-4cde20bbd3af TCGA-38-A44F-01 c8762ae1-49de-496d-a00f-4cde20bbd3af TCGA-38-A44F-01 C59BEC58-FE3B-4F16-B6A0-169F621575B5 c8762ae1-49de-496d-a00f-4cde20bbd3af TCGA-38-A44F-01A-11D-A24D-08 TCGA-38-A44F-01 +TCGA-44-2655-01 2.05 0.3 none none none none N N none none none 0.15 Bronchioid none none none none none none none Acinar predominant Adc Acinar predominant Adc none 0 TCGA-44-2655-01 Iq C1-LUAD-enriched Cluster 5 LUAD-like c10 miRNA cluster 5 cluster 4 mutation c1uster 9 TCGA-44-2655 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung NO NO NO NO 65 R-Upper TCGA-44-2655-F39289 TCGA-44-2655 TCGA-44-2655-01A -23854 0 1324 1009 73 0 Scheduled Follow-up Submission Complete Remission/Response 2013-1-16 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.5 NO NO 0.5 NO New Primary Tumor YES 30 Yes M0 N0 T1 Stage IA TCGA-44-2655.ebae1e0e-18fb-48c8-b2f3-282dab7352d4.pdf 2655 Pre-Adjuvant Therapy TUMOR FREE 100 91 Complete Remission/Response YES NO R0 Primary Tumor 01 0.3 1988 6th NO YES NO 44 3 Current reformed smoker for > 15 years Lung A LIVING 2009 1958 TCGA-44-2655-01 TCGA-44-2655-01A-01D-1553-08 TCGA-44-2655-01 785a76b0-7ae7-44ed-a8a6-519fe6e15f04 TCGA-44-2655-01A-01R-0946-07 TCGA-44-2655-01A-01D-0945-05 TCGA-44-2655-01 TCGA-44-2655-01A-01D-0944-01 TCGA-44-2655-01 TCGA-44-2655-01A-01D-0944-01 TCGA-44-2655-01 785a76b0-7ae7-44ed-a8a6-519fe6e15f04 785a76b0-7ae7-44ed-a8a6-519fe6e15f04 TCGA-44-2655-01 785a76b0-7ae7-44ed-a8a6-519fe6e15f04 TCGA-44-2655-01A-01W-0928-08,TCGA-44-2655-01A-01D-1553-08 TCGA-44-2655-01 +TCGA-44-2655-11 2.05 0.3 none none none none N N none none none 0.15 Bronchioid none none none none none none none Acinar predominant Adc Acinar predominant Adc none 0 TCGA-44-2655-11 C1-LUAD-enriched mutation c1uster 9 TCGA-44-2655 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung NO NO NO NO 65 R-Upper TCGA-44-2655-F39289 TCGA-44-2655 -23854 0 1324 1009 73 0 Scheduled Follow-up Submission Complete Remission/Response 2013-1-16 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES NO NO New Primary Tumor YES 30 Yes M0 N0 T1 Stage IA 2655 Pre-Adjuvant Therapy TUMOR FREE 100 91 Complete Remission/Response YES NO R0 Solid Tissue Normal 11 1988 6th NO YES NO 44 3 Current reformed smoker for > 15 years Lung LIVING 2009 1958 e218db14-8225-450d-92b1-865d46ab59bf TCGA-44-2655-11A-01D-1551-05 e218db14-8225-450d-92b1-865d46ab59bf TCGA-44-2655-11 e218db14-8225-450d-92b1-865d46ab59bf e218db14-8225-450d-92b1-865d46ab59bf TCGA-44-2655-11 +TCGA-44-2656-01 3.14 0.31 none none none none N Y none p.S310F none 0.13 Squamoid none none none none none none none Solid predominant Adc Solid predominant Adc none 0 TCGA-44-2656-01 BRCA-LUAD+ C1-LUAD-enriched Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 4 cluster 2 mutation cluster 11 TCGA-44-2656 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung YES YES 59 R-Upper TCGA-44-2656-F39934 TCGA-44-2656 TCGA-44-2656-01A -21766 0 1429 568 FPPP 72 0 Scheduled Follow-up Submission Complete Remission/Response 2013-2-6 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 50 0.8 NO NO 0.8 NO New Primary Tumor YES 23 No M0 N0 T2 Stage IB TCGA-44-2656.3c7e7f0d-f1b6-42cf-895e-df6cc52f4c2a.pdf 2656 Pre-Adjuvant Therapy TUMOR FREE 86 84 86 79 Complete Remission/Response Biopsy with Histologic Confirmation TCGA YES NO Primary Tumor 01 0.4 2009 6th NO YES NO 44 4 Current reformed smoker for < or = 15 years Lung A LIVING 2009 1994 TCGA-44-2656-01 TCGA-44-2656-01A-02W-0928-08 TCGA-44-2656-01 7b9dc578-8869-4322-a705-bfb9942d9b65 TCGA-44-2656-01A-02R-0946-07 TCGA-44-2656-01A-02D-0945-05 TCGA-44-2656-01 TCGA-44-2656-01A-02D-A273-01 TCGA-44-2656-01A-02D-A276-05,TCGA-44-2656-01B-06D-A276-05 TCGA-44-2656-01 TCGA-44-2656-01A-02D-A273-01 TCGA-44-2656-01 7b9dc578-8869-4322-a705-bfb9942d9b65 TCGA-44-2656-01A-11-2190-20 7b9dc578-8869-4322-a705-bfb9942d9b65 TCGA-44-2656-01 84750167-98a3-4be6-a407-39a6c9629a14 7b9dc578-8869-4322-a705-bfb9942d9b65 TCGA-44-2656-01A-02W-0928-08,TCGA-44-2656-01A-02D-0969-08 TCGA-44-2656-01 +TCGA-44-2656-11 3.14 0.31 none none none none N Y none p.S310F none 0.13 Squamoid none none none none none none none Solid predominant Adc Solid predominant Adc none 0 TCGA-44-2656-11 C1-LUAD-enriched mutation cluster 11 TCGA-44-2656 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung YES YES 59 R-Upper TCGA-44-2656-F39934 TCGA-44-2656 TCGA-44-2656-11A -21766 0 1429 568 FPPP 72 0 Scheduled Follow-up Submission Complete Remission/Response 2013-2-6 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 530 0.9 NO NO 2 NO New Primary Tumor YES 23 No M0 N0 T2 Stage IB 2656 Pre-Adjuvant Therapy TUMOR FREE 86 84 86 79 Complete Remission/Response Biopsy with Histologic Confirmation TCGA YES NO Solid Tissue Normal 11 0.9 2009 6th NO YES NO 44 4 Current reformed smoker for < or = 15 years Lung A LIVING 2009 1994 TCGA-44-2656-11A-01D-1551-05 +TCGA-44-2657-01 1.74 0.33 none none none none N N none none none 0.17 Bronchioid none none none p.N315S none none none Acinar predominant Adc Acinar predominant Adc none 0 TCGA-44-2657-01 BRCA-LUAD+ C1-LUAD-enriched Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 7 cluster 4 mutation c1uster 10 TCGA-44-2657 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 74 L-Upper TCGA-44-2657-F39296 TCGA-44-2657 TCGA-44-2657-01A -27298 0 1351 96 0 Scheduled Follow-up Submission Complete Remission/Response 2013-1-16 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.6 NO NO 1 NO NO 25 No M0 NX T2 Stage IB TCGA-44-2657.d31fa48b-949c-48b7-bc78-6954ede98172.pdf 2657 Pre-Adjuvant Therapy TUMOR FREE 87 147 78 120 Complete Remission/Response YES NO R0 Primary Tumor 01 0.3 2006 6th NO YES NO 44 4 Current reformed smoker for < or = 15 years Lung A LIVING 2009 1959 TCGA-44-2657-01A-01D-1105-08 TCGA-44-2657-01A-01D-1105-08 TCGA-44-2657-01 e1a6b655-0a09-4a79-b86b-8ff65b2bbceb TCGA-44-2657-01A-01R-1107-07 TCGA-44-2657-01A-01D-1104-05 TCGA-44-2657-01 TCGA-44-2657-01A-01D-1877-01 TCGA-44-2657-01 TCGA-44-2657-01A-01D-1877-01 TCGA-44-2657-01 e1a6b655-0a09-4a79-b86b-8ff65b2bbceb TCGA-44-2657-01A-21-2190-20 e1a6b655-0a09-4a79-b86b-8ff65b2bbceb TCGA-44-2657-01 54935339-ba0b-4d0e-ae3a-5805916ef135 e1a6b655-0a09-4a79-b86b-8ff65b2bbceb TCGA-44-2657-01A-01D-1105-08 TCGA-44-2657-01 +TCGA-44-2657-11 1.74 0.33 none none none none N N none none none 0.17 Bronchioid none none none p.N315S none none none Acinar predominant Adc Acinar predominant Adc none 0 TCGA-44-2657-11 C1-LUAD-enriched mutation c1uster 10 TCGA-44-2657 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 74 L-Upper TCGA-44-2657-F39296 TCGA-44-2657 -27298 0 1351 96 0 Scheduled Follow-up Submission Complete Remission/Response 2013-1-16 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES NO NO NO 25 No M0 NX T2 Stage IB 2657 Pre-Adjuvant Therapy TUMOR FREE 87 147 78 120 Complete Remission/Response YES NO R0 Solid Tissue Normal 11 2006 6th NO YES NO 44 4 Current reformed smoker for < or = 15 years Lung LIVING 2009 1959 ca16fef9-9795-4a33-899f-9bf111ee093e ca16fef9-9795-4a33-899f-9bf111ee093e TCGA-44-2657-11 ca16fef9-9795-4a33-899f-9bf111ee093e ca16fef9-9795-4a33-899f-9bf111ee093e TCGA-44-2657-11 +TCGA-44-2659-01 3.6 0.41 none none none none N N none none none 0.15 Bronchioid none none none none none none none Solid predominant Adc Solid predominant Adc none 1 TCGA-44-2659-01 BRCA-LUAD+ LUAD-like c10 miRNA cluster 7 cluster 4 mutation cluster 5 TCGA-44-2659 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 65 [Discrepancy] TCGA-44-2659-F40300 TCGA-44-2659 TCGA-44-2659-01A -23808 0 1367 67 1 Scheduled Follow-up Submission Complete Remission/Response 2013-2-15 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 0.8 NO NO 1.3 NO NO 57 No M0 N1 T1 Stage IIB TCGA-44-2659.9015ab9c-ad9f-44f1-af94-3c7bf34f12fd.pdf 2659 Other TUMOR FREE 87 73 77 64 Complete Remission/Response YES NO R0 Primary Tumor 01 0.3 2003 6th YES YES NO 44 4 Current reformed smoker for < or = 15 years Lung A LIVING 2009 1965 TCGA-44-2659-01 TCGA-44-2659-01A-01D-0969-08 TCGA-44-2659-01 6f748364-2a6a-4fd4-af87-3de643719577 TCGA-44-2659-01A-01R-0946-07 TCGA-44-2659-01 TCGA-44-2659-01A-01D-0944-01 TCGA-44-2659-01 TCGA-44-2659-01A-01D-0944-01 TCGA-44-2659-01 6f748364-2a6a-4fd4-af87-3de643719577 6f748364-2a6a-4fd4-af87-3de643719577 TCGA-44-2659-01 6f748364-2a6a-4fd4-af87-3de643719577 TCGA-44-2659-01A-01W-0928-08,TCGA-44-2659-01A-01D-0969-08 TCGA-44-2659-01 +TCGA-44-2659-11 3.6 0.41 none none none none N N none none none 0.15 Bronchioid none none none none none none none Solid predominant Adc Solid predominant Adc none 1 TCGA-44-2659-11 mutation cluster 5 TCGA-44-2659 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 65 [Discrepancy] TCGA-44-2659-F40300 TCGA-44-2659 TCGA-44-2659-11A -23808 0 1367 67 1 Scheduled Follow-up Submission Complete Remission/Response 2013-2-15 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 0.9 NO NO 1.5 NO NO 57 No M0 N1 T1 Stage IIB 2659 Other TUMOR FREE 87 73 77 64 Complete Remission/Response YES NO R0 Solid Tissue Normal 11 0.7 2003 6th YES YES NO 44 4 Current reformed smoker for < or = 15 years Lung A LIVING 2009 1965 TCGA-44-2659-11A-01D-1551-05 +TCGA-44-2661-01 1.86 0.27 none none none none Y Y p.ELREA746del none none 0.14 Bronchioid none none none none none none none Acinar predominant Adc Acinar predominant Adc none 0 TCGA-44-2661-01 Kirc+ C1-LUAD-enriched Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 4 cluster 4 mutation cluster 14 TCGA-44-2661 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 69 L-Upper TCGA-44-2661-F41293 TCGA-44-2661 TCGA-44-2661-01A -25313 0 1159 1 Scheduled Follow-up Submission Complete Remission/Response 2013-3-14 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.7 NO NO 1.5 NO NO Yes M0 N0 T1 Stage IA TCGA-44-2661.17e596f5-74fe-46cc-bee2-fa1355b01721.pdf 2661 Pre-Adjuvant Therapy TUMOR FREE Complete Remission/Response YES NO R0 Primary Tumor 01 0.4 6th NO YES NO 44 1 Lifelong Non-smoker Lung A LIVING 2009 TCGA-44-2661-01A-01D-1105-08 TCGA-44-2661-01A-01D-1105-08 TCGA-44-2661-01 847f00ce-5f09-4e12-90c5-ebdf7612d707 TCGA-44-2661-01A-01R-1107-07 TCGA-44-2661-01A-01D-1104-05 TCGA-44-2661-01A-01D-1877-01 TCGA-44-2661-01 TCGA-44-2661-01A-01D-1877-01 TCGA-44-2661-01 847f00ce-5f09-4e12-90c5-ebdf7612d707 TCGA-44-2661-01A-21-2190-20 847f00ce-5f09-4e12-90c5-ebdf7612d707 TCGA-44-2661-01 39162d9a-aa2f-4aa6-a495-9d3d5f159771 847f00ce-5f09-4e12-90c5-ebdf7612d707 TCGA-44-2661-01A-01D-1105-08 +TCGA-44-2661-11 1.86 0.27 none none none none Y Y p.ELREA746del none none 0.14 Bronchioid none none none none none none none Acinar predominant Adc Acinar predominant Adc none 0 TCGA-44-2661-11 C1-LUAD-enriched mutation cluster 14 TCGA-44-2661 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 69 L-Upper TCGA-44-2661-F41293 TCGA-44-2661 TCGA-44-2661-11A -25313 0 1159 1 Scheduled Follow-up Submission Complete Remission/Response 2013-3-14 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.9 NO NO 1.3 NO NO Yes M0 N0 T1 Stage IA 2661 Pre-Adjuvant Therapy TUMOR FREE Complete Remission/Response YES NO R0 Solid Tissue Normal 11 0.4 6th NO YES NO 44 1 Lifelong Non-smoker Lung A LIVING 2009 90b503db-13ca-4257-bda3-31d4e7bc69b4 90b503db-13ca-4257-bda3-31d4e7bc69b4 90b503db-13ca-4257-bda3-31d4e7bc69b4 90b503db-13ca-4257-bda3-31d4e7bc69b4 +TCGA-44-2662-01 3.33 0.25 none p.N581S none none N N none none none 0.11 Squamoid none none none none none none none Solid predominant Adc Solid predominant Adc none 0 TCGA-44-2662-01 BRCA-LUAD+ C1-LUAD-enriched Cluster 5 LUAD-like c10 miRNA cluster 4 cluster 2 mutation cluster 2 TCGA-44-2662 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung NO 65 R-Upper TCGA-44-2662-F39415 TCGA-44-2662 TCGA-44-2662-01A -24014 0 1280 FPPP 78 Scheduled Follow-up Submission Complete Remission/Response 2013-1-22 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.9 NO NO 1 NO NO 56 Yes M0 N0 T2 Stage IB TCGA-44-2662.76bab538-e95a-48a6-9f83-36b9a472252b.pdf 2662 TUMOR FREE 94 73 88 67 Progressive Disease TCGA YES NO R0 Primary Tumor 01 0.2 1984 6th YES YES NO 44 3 Current reformed smoker for > 15 years Lung A LIVING 2009 1956 TCGA-44-2662-01 TCGA-44-2662-01A-01D-0969-08 TCGA-44-2662-01 5ec48286-3f47-49eb-83ba-a1169f734bba TCGA-44-2662-01A-01R-0946-07 TCGA-44-2662-01A-01D-0945-05 TCGA-44-2662-01 TCGA-44-2662-01A-01D-A273-01 TCGA-44-2662-01 TCGA-44-2662-01A-01D-A273-01 TCGA-44-2662-01 5ec48286-3f47-49eb-83ba-a1169f734bba 5ec48286-3f47-49eb-83ba-a1169f734bba TCGA-44-2662-01 5ec48286-3f47-49eb-83ba-a1169f734bba TCGA-44-2662-01A-01W-0928-08,TCGA-44-2662-01A-01D-0969-08 TCGA-44-2662-01 +TCGA-44-2662-11 3.33 0.25 none p.N581S none none N N none none none 0.11 Squamoid none none none none none none none Solid predominant Adc Solid predominant Adc none 0 TCGA-44-2662-11 C1-LUAD-enriched mutation cluster 2 TCGA-44-2662 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung NO 65 R-Upper TCGA-44-2662-F39415 TCGA-44-2662 TCGA-44-2662-11A -24014 0 1280 FPPP 78 Scheduled Follow-up Submission Complete Remission/Response 2013-1-22 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.8 NO NO 1 NO NO 56 Yes M0 N0 T2 Stage IB 2662 TUMOR FREE 94 73 88 67 Progressive Disease TCGA YES NO R0 Solid Tissue Normal 11 0.4 1984 6th YES YES NO 44 3 Current reformed smoker for > 15 years Lung A LIVING 2009 1956 b548a64b-0275-4beb-9b67-ce8bad3ccd63 TCGA-44-2662-11A-01D-1551-05 b548a64b-0275-4beb-9b67-ce8bad3ccd63 b548a64b-0275-4beb-9b67-ce8bad3ccd63 b548a64b-0275-4beb-9b67-ce8bad3ccd63 +TCGA-44-2664-01 TCGA-44-2664-01 squamous c3 TCGA-44-2664 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung NO YES NO 66 R-Lower TCGA-44-2664-F34138 TCGA-44-2664 TCGA-44-2664-01A -24468 0 1251 832 74 2 Additional New Tumor Event Complete Remission/Response 2012-7-30 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 0.6 NO NO 1 NO Locoregional Recurrence YES 23 No M0 N0 T1 Stage IA TCGA-44-2664.8ac6aec3-d709-411f-9233-f264bac80972.pdf 2664 Other TUMOR FREE 109 113 Complete Remission/Response Convincing Imaging YES NO R0 Primary Tumor 01 0.4 6th NO YES NO 44 2 Lung A LIVING 2009 1964 TCGA-44-2664-01A-21-2190-20 d81b36d5-1923-49b3-8881-306793fb7c77 +TCGA-44-2665-01 2.12 0.44 none none none none N Y none none none 0.21 Squamoid none none none none none none none Solid predominant Adc Solid predominant Adc Y none 1 TCGA-44-2665-01 Iq C1-LUAD-enriched Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 4 cluster 2 mutation c1uster 9 TCGA-44-2665 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 55 R-Upper TCGA-44-2665-F40281 TCGA-44-2665 TCGA-44-2665-01A -20349 0 1301 FPPP 71 0 Scheduled Follow-up Submission Complete Remission/Response 2013-2-15 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.6 NO NO 1.1 NO NO No M0 N1 T2 Stage IIB TCGA-44-2665.262e300a-7b16-4f2b-80bf-29decfe84d33.pdf 2665 Other TUMOR FREE 79 105 79 114 Stable Disease TCGA YES NO R0 Primary Tumor 01 0.3 6th YES YES NO 44 1 Lifelong Non-smoker Lung A LIVING 2009 TCGA-44-2665-01 TCGA-44-2665-01A-01D-1040-01 TCGA-44-2665-01 9a6962a2-0a32-44d5-a2bf-c28c5f1a9cd0 TCGA-44-2665-01A-01R-0946-07 TCGA-44-2665-01A-01D-0945-05 TCGA-44-2665-01 TCGA-44-2665-01A-01D-A273-01 TCGA-44-2665-01B-06D-A276-05,TCGA-44-2665-01A-01D-A276-05 TCGA-44-2665-01 TCGA-44-2665-01A-01D-A273-01 TCGA-44-2665-01 9a6962a2-0a32-44d5-a2bf-c28c5f1a9cd0 TCGA-44-2665-01A-21-2190-20 9a6962a2-0a32-44d5-a2bf-c28c5f1a9cd0 TCGA-44-2665-01 80b4100c-7cdf-42f6-a01f-056acc9f2244 9a6962a2-0a32-44d5-a2bf-c28c5f1a9cd0 TCGA-44-2665-01A-01W-0928-08,TCGA-44-2665-01A-01D-1040-01 TCGA-44-2665-01 +TCGA-44-2665-11 2.12 0.44 none none none none N Y none none none 0.21 Squamoid none none none none none none none Solid predominant Adc Solid predominant Adc Y none 1 TCGA-44-2665-11 C1-LUAD-enriched mutation c1uster 9 TCGA-44-2665 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 55 R-Upper TCGA-44-2665-F40281 TCGA-44-2665 TCGA-44-2665-11A -20349 0 1301 FPPP 71 0 Scheduled Follow-up Submission Complete Remission/Response 2013-2-15 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.8 NO NO 1.9 NO NO No M0 N1 T2 Stage IIB 2665 Other TUMOR FREE 79 105 79 114 Stable Disease TCGA YES NO R0 Solid Tissue Normal 11 0.6 6th YES YES NO 44 1 Lifelong Non-smoker Lung A LIVING 2009 756942cf-3ba1-456e-8086-57f710247b8e TCGA-44-2665-11A-01D-1551-05 756942cf-3ba1-456e-8086-57f710247b8e TCGA-44-2665-11 756942cf-3ba1-456e-8086-57f710247b8e 756942cf-3ba1-456e-8086-57f710247b8e TCGA-44-2665-11 +TCGA-44-2666-01 1.94 0.58 none p.V600E none none N Y none none none 0.3 Bronchioid none none none none none none none Papillary predominant Adc Papillary predominant Adc none 1 TCGA-44-2666-01 Kirc+ C1-LUAD-enriched Cluster 6 LUAD-like c10 miRNA cluster 5 cluster 4 mutation cluster 5 TCGA-44-2666 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung NO NO NO NO 43 R-Upper TCGA-44-2666-F5304 TCGA-44-2666 -15970 97 0 97 FPPP 66 2010-10-12 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES NO NO 30 No M0 N0 T2 Stage IB 2666 WITH TUMOR 86 87 TCGA YES NO R0 Primary Tumor 01 6th NO YES NO 44 2 Current smoker Lung DECEASED 2009 1979 TCGA-44-2666-01 TCGA-44-2666-01A-01D-1489-08 TCGA-44-2666-01 bfad522f-6130-424d-8497-99cac9714966 TCGA-44-2666-01A-01R-0946-07 TCGA-44-2666-01A-01D-0945-05 TCGA-44-2666-01 TCGA-44-2666-01A-01D-A273-01 TCGA-44-2666-01B-02D-A276-05,TCGA-44-2666-01A-01D-A276-05 TCGA-44-2666-01 TCGA-44-2666-01A-01D-A273-01 TCGA-44-2666-01 bfad522f-6130-424d-8497-99cac9714966 bfad522f-6130-424d-8497-99cac9714966 TCGA-44-2666-01 bfad522f-6130-424d-8497-99cac9714966 TCGA-44-2666-01A-01W-0928-08,TCGA-44-2666-01A-01D-1489-08 TCGA-44-2666-01 +TCGA-44-2668-01 TCGA-44-2668-01 High C1-LUAD-enriched Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 4 mutation cluster 2 TCGA-44-2668 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung YES YES NO 51 R-Upper TCGA-44-2668-F18688 TCGA-44-2668 TCGA-44-2668-01A 453 -18856 761 0 246 433 FPPP 53 0 Additional New Tumor Event Progressive Disease 2011-11-22 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 1 NO NO 1.2 YES 60 No M0 N0 T2 Stage IB TCGA-44-2668.d5ebaec8-79c6-493b-ae2a-bbc96e6e5ddc.pdf 2668 Other WITH TUMOR 104 82 TCGA YES R0 Primary Tumor 01 0.3 2009 6th YES NO 44 4 Lung A DECEASED 2009 1979 TCGA-44-2668-01 TCGA-44-2668-01 4c5c1c05-b9d1-4073-9d91-5c4e552928ae TCGA-44-2668-01A-01R-0946-07 TCGA-44-2668-01A-01D-0945-05 TCGA-44-2668-01 TCGA-44-2668-01A-01D-A273-01 TCGA-44-2668-01B-02D-A276-05,TCGA-44-2668-01A-01D-A276-05 TCGA-44-2668-01 TCGA-44-2668-01A-01D-A273-01 TCGA-44-2668-01 4c5c1c05-b9d1-4073-9d91-5c4e552928ae TCGA-44-2668-01A-21-2190-20 4c5c1c05-b9d1-4073-9d91-5c4e552928ae TCGA-44-2668-01 2e058de2-768c-4a90-9105-a30e5a3cd627 4c5c1c05-b9d1-4073-9d91-5c4e552928ae TCGA-44-2668-01A-01W-0928-08,TCGA-44-2668-01A-01D-0969-08 TCGA-44-2668-01 +TCGA-44-2668-11 TCGA-44-2668-11 C1-LUAD-enriched mutation cluster 2 TCGA-44-2668 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung YES YES NO 51 R-Upper TCGA-44-2668-F18688 TCGA-44-2668 TCGA-44-2668-11A 453 -18856 761 0 246 433 FPPP 53 0 Additional New Tumor Event Progressive Disease 2011-11-22 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 1 NO NO 1.5 YES 60 No M0 N0 T2 Stage IB 2668 Other WITH TUMOR 104 82 TCGA YES R0 Solid Tissue Normal 11 0.5 2009 6th YES NO 44 4 Lung A DECEASED 2009 1979 2170c29a-1256-45eb-b08e-e1192dad3560 TCGA-44-2668-11A-01D-1551-05 2170c29a-1256-45eb-b08e-e1192dad3560 TCGA-44-2668-11 2170c29a-1256-45eb-b08e-e1192dad3560 2170c29a-1256-45eb-b08e-e1192dad3560 TCGA-44-2668-11 +TCGA-44-3396-01 none none none none N N none none none Squamoid none none none none none none none Solid predominant Adc Solid predominant Adc none 0 TCGA-44-3396-01 Kirc+ C1-LUAD-enriched Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 7 cluster 4 mutation cluster 5 TCGA-44-3396 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 74 [Discrepancy] TCGA-44-3396-F39080 TCGA-44-3396 TCGA-44-3396-01A -27073 0 1130 48 1 Scheduled Follow-up Submission Complete Remission/Response 2013-1-11 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 1 NO 80 NO 1.3 NO NO 50 No M0 N2 T2 Stage IIIA TCGA-44-3396.6a7ec9e8-ea86-4c3b-9d0e-9564e41311b5.pdf 3396 Other TUMOR FREE 98 89 Complete Remission/Response YES NO R0 Primary Tumor 01 0.4 7th YES YES NO 44 2 Current smoker Lung A LIVING 2009 1959 TCGA-44-3396-01A-01D-1265-08 TCGA-44-3396-01A-01D-1265-08 8b0a1ab6-e7ea-45f9-9e3a-bd98b3f59972 TCGA-44-3396-01A-01D-1205-05 TCGA-44-3396-01 TCGA-44-3396-01A-01D-1204-01 TCGA-44-3396-01 TCGA-44-3396-01A-01D-1204-01 8b0a1ab6-e7ea-45f9-9e3a-bd98b3f59972 TCGA-44-3396-01A-31-2190-20 8b0a1ab6-e7ea-45f9-9e3a-bd98b3f59972 TCGA-44-3396-01 a9183121-98c3-4e97-942d-85eb5b1255f5 8b0a1ab6-e7ea-45f9-9e3a-bd98b3f59972 TCGA-44-3396-01A-01D-1553-08 TCGA-44-3396-01 +TCGA-44-3396-11 none none none none N N none none none Squamoid none none none none none none none Solid predominant Adc Solid predominant Adc none 0 TCGA-44-3396-11 C1-LUAD-enriched mutation cluster 5 TCGA-44-3396 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 74 [Discrepancy] TCGA-44-3396-F39080 TCGA-44-3396 -27073 0 1130 48 1 Scheduled Follow-up Submission Complete Remission/Response 2013-1-11 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 80 NO NO NO 50 No M0 N2 T2 Stage IIIA 3396 Other TUMOR FREE 98 89 Complete Remission/Response YES NO R0 Solid Tissue Normal 11 7th YES YES NO 44 2 Current smoker Lung LIVING 2009 1959 f879b84d-a2e7-4189-bcf6-9286b52e19dd f879b84d-a2e7-4189-bcf6-9286b52e19dd TCGA-44-3396-11 f879b84d-a2e7-4189-bcf6-9286b52e19dd f879b84d-a2e7-4189-bcf6-9286b52e19dd TCGA-44-3396-11 +TCGA-44-3398-01 TCGA-44-3398-01 Kirc+ C1-LUAD-enriched Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 4 mutation c1uster 9 TCGA-44-3398 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 77 R-Lower TCGA-44-3398-F38762 TCGA-44-3398 TCGA-44-3398-01A -28392 0 1163 60 Scheduled Follow-up Submission Complete Remission/Response 2012-12-21 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 0.9 NO NO 1.7 NO NO 60 No M0 N0 T1b Stage IA TCGA-44-3398.7dc9c668-3304-47d8-9c33-5b72352672db.pdf 3398 TUMOR FREE 89 96 84 87 Complete Remission/Response YES NO R0 Primary Tumor 01 0.5 2009 6th NO YES NO 44 4 Lung A LIVING 2009 1959 TCGA-44-3398-01A-01D-1105-08 TCGA-44-3398-01 c63e6cf3-936d-4d14-ab87-11aa4ef51242 TCGA-44-3398-01A-01R-1107-07 TCGA-44-3398-01A-01D-1104-05 TCGA-44-3398-01 TCGA-44-3398-01A-01D-1877-01 TCGA-44-3398-01 TCGA-44-3398-01A-01D-1877-01 TCGA-44-3398-01 c63e6cf3-936d-4d14-ab87-11aa4ef51242 TCGA-44-3398-01A-31-2190-20 c63e6cf3-936d-4d14-ab87-11aa4ef51242 TCGA-44-3398-01 16bb1a7a-a8b2-44a0-bccc-574b6e418d1c c63e6cf3-936d-4d14-ab87-11aa4ef51242 TCGA-44-3398-01A-01D-1105-08 TCGA-44-3398-01 +TCGA-44-3398-11 TCGA-44-3398-11 C1-LUAD-enriched mutation c1uster 9 TCGA-44-3398 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 77 R-Lower TCGA-44-3398-F38762 TCGA-44-3398 TCGA-44-3398-11B -28392 0 1163 60 Scheduled Follow-up Submission Complete Remission/Response 2012-12-21 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 0.8 NO NO 1.8 NO NO 60 No M0 N0 T1b Stage IA 3398 TUMOR FREE 89 96 84 87 Complete Remission/Response YES NO R0 Solid Tissue Normal 11 0.8 2009 6th NO YES NO 44 4 Lung B LIVING 2009 1959 453cdfcc-52a8-4ab0-80ac-ce1dc1bc1bf8 453cdfcc-52a8-4ab0-80ac-ce1dc1bc1bf8 TCGA-44-3398-11 453cdfcc-52a8-4ab0-80ac-ce1dc1bc1bf8 453cdfcc-52a8-4ab0-80ac-ce1dc1bc1bf8 TCGA-44-3398-11 +TCGA-44-3917-01 TCGA-44-3917-01 squamous c3 TCGA-44-3917 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 33 R-Upper TCGA-44-3917-F38799 TCGA-44-3917 TCGA-44-3917-01A -12179 0 1183 FPPP 83 Scheduled Follow-up Submission Complete Remission/Response 2012-12-24 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.6 NO 100 NO 1.2 NO NO 16 No M0 N0 T2 Stage IB TCGA-44-3917.240f6268-ffef-488e-855d-9c39e3969c65.pdf 3917 Post-Adjuvant Therapy TUMOR FREE 87 106 Complete Remission/Response TCGA YES NO R0 Primary Tumor 01 0.2 6th NO YES NO 44 2 Lung A LIVING 2009 1993 TCGA-44-3917-01A-01D-A273-01 TCGA-44-3917-01B-02D-A276-05,TCGA-44-3917-01A-01D-A276-05 TCGA-44-3917-01A-01D-A273-01 TCGA-44-3917-01A-21-2190-20 b32ab08b-b364-456f-8494-46ca48fb5352 +TCGA-44-3918-01 TCGA-44-3918-01 High C1-LUAD-enriched Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 4 mutation cluster 11 TCGA-44-3918 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung YES YES NO 60 L-Upper TCGA-44-3918-F38999 TCGA-44-3918 TCGA-44-3918-01A -22236 0 1036 511 FPPP 76 Scheduled Follow-up Submission Stable Disease 2013-1-10 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 280 0.8 NO 90 NO 2 NO Locoregional Recurrence YES 20 No M0 N0 T1 Stage IA TCGA-44-3918.da381e6d-f69d-424f-ab84-5c300ca19435.pdf 3918 Other WITH TUMOR 103 104 Complete Remission/Response Biopsy with Histologic Confirmation|Convincing Imaging TCGA YES NO R0 Primary Tumor 01 0.8 1994 6th NO YES NO 44 3 Lung A LIVING 2010 1974 TCGA-44-3918-01A-01D-1105-08 TCGA-44-3918-01 d9f5e680-b72e-4a64-942b-191154d8012a TCGA-44-3918-01A-01R-1107-07 TCGA-44-3918-01A-01D-1104-05 TCGA-44-3918-01 TCGA-44-3918-01A-01D-A273-01 TCGA-44-3918-01B-02D-A276-05,TCGA-44-3918-01A-01D-A276-05 TCGA-44-3918-01 TCGA-44-3918-01A-01D-A273-01 TCGA-44-3918-01 d9f5e680-b72e-4a64-942b-191154d8012a TCGA-44-3918-01A-21-2190-20 d9f5e680-b72e-4a64-942b-191154d8012a TCGA-44-3918-01 4f270bce-0b0e-4f5d-bc5d-1524fbea5234 d9f5e680-b72e-4a64-942b-191154d8012a TCGA-44-3918-01A-01D-1105-08 TCGA-44-3918-01 +TCGA-44-3918-11 TCGA-44-3918-11 C1-LUAD-enriched mutation cluster 11 TCGA-44-3918 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung YES YES NO 60 L-Upper TCGA-44-3918-F38999 TCGA-44-3918 TCGA-44-3918-11A -22236 0 1036 511 FPPP 76 Scheduled Follow-up Submission Stable Disease 2013-1-10 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 600 0.8 NO 90 NO 2 NO Locoregional Recurrence YES 20 No M0 N0 T1 Stage IA 3918 Other WITH TUMOR 103 104 Complete Remission/Response Biopsy with Histologic Confirmation|Convincing Imaging TCGA YES NO R0 Solid Tissue Normal 11 0.8 1994 6th NO YES NO 44 3 Lung A LIVING 2010 1974 TCGA-44-3918-11A-01D-1104-05 +TCGA-44-3919-01 1.94 0.49 none none none none N Y none p.774_775insAYVM none 0.25 Bronchioid none none none none none none none Solid predominant Adc Solid predominant Adc none 0 TCGA-44-3919-01 High C1-LUAD-enriched Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 4 cluster 2 mutation c1uster 9 TCGA-44-3919 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung NO YES NO NO 71 R-Upper TCGA-44-3919-F38530 TCGA-44-3919 -26081 1026 0 190 984 103 2 Additional New Tumor Event 2012-12-19 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES NO NO Distant Metastasis YES No M0 N0 T1 Stage IA 3919 Other WITH TUMOR 99 100 Complete Remission/Response Convincing Imaging YES NO R0 Primary Tumor 01 7th NO YES NO 44 1 Lifelong Non-smoker Lung DECEASED 2010 TCGA-44-3919-01 TCGA-44-3919-01A-02D-1458-08 TCGA-44-3919-01 fa3183f2-b71c-4837-8b1e-5e29336caf62 TCGA-44-3919-01A-02R-1107-07 TCGA-44-3919-01A-02D-1104-05 TCGA-44-3919-01 TCGA-44-3919-01A-02D-1877-01 TCGA-44-3919-01 TCGA-44-3919-01A-02D-1877-01 TCGA-44-3919-01 fa3183f2-b71c-4837-8b1e-5e29336caf62 TCGA-44-3919-01A-11-2190-20 fa3183f2-b71c-4837-8b1e-5e29336caf62 TCGA-44-3919-01 e72f62a3-8f58-4df4-b339-198051b6c95f fa3183f2-b71c-4837-8b1e-5e29336caf62 TCGA-44-3919-01A-02D-1105-08,TCGA-44-3919-01A-02D-1458-08 TCGA-44-3919-01 +TCGA-44-3919-11 1.94 0.49 none none none none N Y none p.774_775insAYVM none 0.25 Bronchioid none none none none none none none Solid predominant Adc Solid predominant Adc none 0 TCGA-44-3919-11 C1-LUAD-enriched mutation c1uster 9 TCGA-44-3919 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung NO YES NO NO 71 R-Upper TCGA-44-3919-F38530 TCGA-44-3919 TCGA-44-3919-11A -26081 1026 0 190 984 103 2 Additional New Tumor Event 2012-12-19 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.7 NO NO 1.3 NO Distant Metastasis YES No M0 N0 T1 Stage IA 3919 Other WITH TUMOR 99 100 Complete Remission/Response Convincing Imaging YES NO R0 Solid Tissue Normal 11 0.4 7th NO YES NO 44 1 Lifelong Non-smoker Lung A DECEASED 2010 TCGA-44-3919-11A-01D-1104-05 +TCGA-44-4112-01 2.13 0.56 none none none p.G367V N N none none p.C304F 0.27 Squamoid none none none none none none none Solid predominant Adc Solid predominant Adc none 0 TCGA-44-4112-01 BRCA-LUAD+ C1-LUAD-enriched Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 4 cluster 2 mutation cluster 12 TCGA-44-4112 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung NO 60 R-Upper TCGA-44-4112-F32266 TCGA-44-4112 TCGA-44-4112-01A -22106 808 0 141 FPPP 2012-5-22 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 220 1 NO NO 2 NO 30 No M0 N0 T2a Stage IB TCGA-44-4112.9f214c90-f9a8-458c-8a53-ca8e8b09a2b2.pdf 4112 WITH TUMOR TCGA YES R0 Primary Tumor 01 0.4 1992 6th YES NO 44 3 Current reformed smoker for > 15 years Lung A DECEASED 2010 1972 TCGA-44-4112-01 TCGA-44-4112-01A-01D-1105-08 TCGA-44-4112-01 220d4f21-012b-4e06-aabf-a32d23f28a78 TCGA-44-4112-01A-01R-1107-07 TCGA-44-4112-01A-01D-1104-05 TCGA-44-4112-01 TCGA-44-4112-01A-01D-A273-01 TCGA-44-4112-01B-06D-A276-05,TCGA-44-4112-01A-01D-A276-05 TCGA-44-4112-01 TCGA-44-4112-01A-01D-A273-01 TCGA-44-4112-01 220d4f21-012b-4e06-aabf-a32d23f28a78 TCGA-44-4112-01A-21-2190-20 220d4f21-012b-4e06-aabf-a32d23f28a78 TCGA-44-4112-01 cc482acb-598e-44b9-86f9-c287fd6766d5 220d4f21-012b-4e06-aabf-a32d23f28a78 TCGA-44-4112-01A-01D-1105-08,TCGA-44-4112-01A-01D-1458-08 TCGA-44-4112-01 +TCGA-44-4112-11 2.13 0.56 none none none p.G367V N N none none p.C304F 0.27 Squamoid none none none none none none none Solid predominant Adc Solid predominant Adc none 0 TCGA-44-4112-11 C1-LUAD-enriched mutation cluster 12 TCGA-44-4112 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung NO 60 R-Upper TCGA-44-4112-F32266 TCGA-44-4112 TCGA-44-4112-11A -22106 808 0 141 FPPP 2012-5-22 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 520 1 NO NO 1.5 NO 30 No M0 N0 T2a Stage IB 4112 WITH TUMOR TCGA YES R0 Solid Tissue Normal 11 0.4 1992 6th YES NO 44 3 Current reformed smoker for > 15 years Lung A DECEASED 2010 1972 TCGA-44-4112-11A-01D-1104-05 +TCGA-44-5643-01 TCGA-44-5643-01 Squamous C2-Squamous-like Cluster 13 (HNSC-LUSC) BRCA basal-like c6 squamous-like c4 miRNA cluster 11 mutation cluster 3 TCGA-44-5643 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung NO 53 R-Lower TCGA-44-5643-F39742 TCGA-44-5643 TCGA-44-5643-01A -19426 0 1013 75 1 Scheduled Follow-up Submission Complete Remission/Response 2013-2-25 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 0.8 NO 1.2 NO NO 20 No M0 N2 T2b Stage IIIA TCGA-44-5643.3117a24b-6125-47a8-a05b-4ada99e68dfa.pdf 5643 Other TUMOR FREE 92 66 YES Primary Tumor 01 0.8 7th YES NO 44 2 Lung A LIVING 2010 TCGA-44-5643-01A-01D-1625-08 a8ef928f-7321-4355-b136-cec50ebd9481 TCGA-44-5643-01A-01D-1624-01 TCGA-44-5643-01A-01D-1626-05 TCGA-44-5643-01 TCGA-44-5643-01A-01D-1624-01 a8ef928f-7321-4355-b136-cec50ebd9481 TCGA-44-5643-01 TCGA-44-5643-01A-41-2191-20 a8ef928f-7321-4355-b136-cec50ebd9481 TCGA-44-5643-01 65fa1532-4925-48b2-888f-3509654957e7 a8ef928f-7321-4355-b136-cec50ebd9481 TCGA-44-5643-01A-01D-1625-08 TCGA-44-5643-01 +TCGA-44-5643-11 TCGA-44-5643-11 C2-Squamous-like mutation cluster 3 TCGA-44-5643 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung NO 53 R-Lower TCGA-44-5643-F39742 TCGA-44-5643 TCGA-44-5643-11A -19426 0 1013 75 1 Scheduled Follow-up Submission Complete Remission/Response 2013-2-25 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 0.9 NO 1.9 NO NO 20 No M0 N2 T2b Stage IIIA 5643 Other TUMOR FREE 92 66 YES Solid Tissue Normal 11 0.7 7th YES NO 44 2 Lung A LIVING 2010 TCGA-44-5643-11A-01D-1626-05 +TCGA-44-5644-01 TCGA-44-5644-01 High C1-LUAD-enriched Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 6 TCGA-44-5644 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung NO 51 R-Lower TCGA-44-5644-F38817 TCGA-44-5644 TCGA-44-5644-01A -18644 0 863 61 Scheduled Follow-up Submission Complete Remission/Response 2012-12-26 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 1 NO 1 NO NO 17.5 No N0 T2a Stage IB TCGA-44-5644.041e212a-2fdd-42af-9326-9fb5fef07126.pdf 5644 TUMOR FREE 103 59 Complete Remission/Response YES NO Primary Tumor 01 0.2 7th NO YES NO 44 2 Lung A LIVING 2010 1975 44205bf0-b593-4c0d-9aeb-4e604314e10f TCGA-44-5644-01A-21D-2035-01 TCGA-44-5644-01A-21D-2037-05 TCGA-44-5644-01 TCGA-44-5644-01A-21D-2035-01 44205bf0-b593-4c0d-9aeb-4e604314e10f TCGA-44-5644-01 TCGA-44-5644-01A-41-2191-20 44205bf0-b593-4c0d-9aeb-4e604314e10f TCGA-44-5644-01 07d9b06a-f8d3-46d8-b864-4dfd4430540b 44205bf0-b593-4c0d-9aeb-4e604314e10f TCGA-44-5644-01A-21D-2036-08 TCGA-44-5644-01 +TCGA-44-5645-01 2.38 0.54 none none none none N N none none none 0.24 Bronchioid none none none none none p.H1047R none Lepidic predominant Adc Lepidic predominant Adc none 0 TCGA-44-5645-01 Iq C1-LUAD-enriched cluster 3 Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 5 cluster 4 mutation cluster 3 TCGA-44-5645 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung NO 61 L-Upper TCGA-44-5645-F38800 TCGA-44-5645 -22471 0 852 FPPP 82 Scheduled Follow-up Submission Complete Remission/Response 2012-12-24 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES NO NO 5 No NX T1 Stage IA 5645 TUMOR FREE 90 100 Complete Remission/Response TCGA YES NO Primary Tumor 01 1973 7th NO YES NO 44 3 Current reformed smoker for > 15 years Lung LIVING 2010 1963 TCGA-44-5645-01A-01D-1625-08 TCGA-44-5645-01A-01D-1625-08 b4bbc93a-5460-476d-a663-61299fddfab2 TCGA-44-5645-01A-01D-A273-01 TCGA-44-5645-01B-04D-A276-05,TCGA-44-5645-01A-01D-A276-05,TCGA-44-5645-01A-01D-1626-05 TCGA-44-5645-01 TCGA-44-5645-01A-01D-A273-01 b4bbc93a-5460-476d-a663-61299fddfab2 TCGA-44-5645-01 TCGA-44-5645-01A-41-2191-20 b4bbc93a-5460-476d-a663-61299fddfab2 TCGA-44-5645-01 ec945497-65c8-47ca-81d7-22be0f1f8c7c b4bbc93a-5460-476d-a663-61299fddfab2 TCGA-44-5645-01A-01D-1625-08 TCGA-44-5645-01 +TCGA-44-5645-11 2.38 0.54 none none none none N N none none none 0.24 Bronchioid none none none none none p.H1047R none Lepidic predominant Adc Lepidic predominant Adc none 0 TCGA-44-5645-11 C1-LUAD-enriched mutation cluster 3 TCGA-44-5645 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung NO 61 L-Upper TCGA-44-5645-F38800 TCGA-44-5645 TCGA-44-5645-11A -22471 0 852 FPPP 82 Scheduled Follow-up Submission Complete Remission/Response 2012-12-24 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 860 1 NO 2.4 NO NO 5 No NX T1 Stage IA 5645 TUMOR FREE 90 100 Complete Remission/Response TCGA YES NO Solid Tissue Normal 11 0.8 1973 7th NO YES NO 44 3 Current reformed smoker for > 15 years Lung A LIVING 2010 1963 cafb7a81-9e7a-49c0-8a55-96cb32ad273e TCGA-44-5645-11A-01D-1626-05 cafb7a81-9e7a-49c0-8a55-96cb32ad273e cafb7a81-9e7a-49c0-8a55-96cb32ad273e cafb7a81-9e7a-49c0-8a55-96cb32ad273e +TCGA-44-6144-01 TCGA-44-6144-01 BRCA-LUAD+ C1-LUAD-enriched Cluster 5 squamous c3 miRNA cluster 5 mutation cluster 2 TCGA-44-6144 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung YES NO NO NO 58 R-Upper TCGA-44-6144-F39034 TCGA-44-6144 -21283 0 723 399 82 0 Scheduled Follow-up Submission Progressive Disease 2013-1-9 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 70 NO Locoregional Recurrence|Distant Metastasis YES 67.5 No M0 N0 T1a Stage IA 6144 Other WITH TUMOR 97 77 87 63 Complete Remission/Response Biopsy with Histologic Confirmation|Convincing Imaging YES NO RX Primary Tumor 01 7th NO YES NO 44 2 Lung LIVING 2011 1968 TCGA-44-6144-01A-11D-1753-08 TCGA-44-6144-01A-11D-1752-01 TCGA-44-6144-01A-11D-1756-05 TCGA-44-6144-01A-11D-1752-01 TCGA-44-6144-01 TCGA-44-6144-01A-13-2191-20 faa409af-7bc8-4e0e-8c38-7ab58e895727 TCGA-44-6144-01A-11D-1753-08 TCGA-44-6144-01 +TCGA-44-6144-11 TCGA-44-6144-11 C1-LUAD-enriched mutation cluster 2 TCGA-44-6144 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung YES NO NO NO 58 R-Upper TCGA-44-6144-F39034 TCGA-44-6144 -21283 0 723 399 82 0 Scheduled Follow-up Submission Progressive Disease 2013-1-9 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 70 NO Locoregional Recurrence|Distant Metastasis YES 67.5 No M0 N0 T1a Stage IA 6144 Other WITH TUMOR 97 77 87 63 Complete Remission/Response Biopsy with Histologic Confirmation|Convincing Imaging YES NO RX Solid Tissue Normal 11 7th NO YES NO 44 2 Lung LIVING 2011 1968 e9c07b6c-0a18-44ff-90cd-d39ae6c47fd6 TCGA-44-6144-11A-01D-1756-05 e9c07b6c-0a18-44ff-90cd-d39ae6c47fd6 TCGA-44-6144-11 e9c07b6c-0a18-44ff-90cd-d39ae6c47fd6 e9c07b6c-0a18-44ff-90cd-d39ae6c47fd6 TCGA-44-6144-11 +TCGA-44-6145-01 1.66 0.31 none none none none Y Y none none none 0.16 Squamoid none p.G12V none none none none none Solid predominant Adc Solid predominant Adc none 0 TCGA-44-6145-01 High C1-LUAD-enriched cluster 3 Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 4 cluster 3 mutation cluster 11 TCGA-44-6145 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 62 R-Upper TCGA-44-6145-F38802 TCGA-44-6145 TCGA-44-6145-01A -22745 0 595 73 0 Scheduled Follow-up Submission Complete Remission/Response 2012-12-24 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 1 NO NO NO 1.5 NO NO 75 No M0 N0 T1 Stage IA TCGA-44-6145.57537882-084b-4082-bcf0-f7d297a877e6.pdf 6145 Preoperative TUMOR FREE 91 90 77 71 Complete Remission/Response YES NO Primary Tumor 01 0.5 1999 7th NO YES NO 44 4 Current reformed smoker for < or = 15 years Lung A LIVING 2011 1963 TCGA-44-6145-01A-11D-1753-08 TCGA-44-6145-01A-11D-1753-08 2d452408-9d25-49e1-81db-542021eb28cb TCGA-44-6145-01A-11D-1752-01 TCGA-44-6145-01A-11D-1756-05 TCGA-44-6145-01 TCGA-44-6145-01A-11D-1752-01 2d452408-9d25-49e1-81db-542021eb28cb TCGA-44-6145-01 TCGA-44-6145-01A-13-2191-20 2d452408-9d25-49e1-81db-542021eb28cb TCGA-44-6145-01 6dda9f9a-db50-4dfe-90e5-2c06a8f65018 2d452408-9d25-49e1-81db-542021eb28cb TCGA-44-6145-01A-11D-1753-08 TCGA-44-6145-01 +TCGA-44-6145-11 1.66 0.31 none none none none Y Y none none none 0.16 Squamoid none p.G12V none none none none none Solid predominant Adc Solid predominant Adc none 0 TCGA-44-6145-11 C1-LUAD-enriched mutation cluster 11 TCGA-44-6145 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 62 R-Upper TCGA-44-6145-F38802 TCGA-44-6145 TCGA-44-6145-11A -22745 0 595 73 0 Scheduled Follow-up Submission Complete Remission/Response 2012-12-24 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 1 NO NO NO 2 NO NO 75 No M0 N0 T1 Stage IA 6145 Preoperative TUMOR FREE 91 90 77 71 Complete Remission/Response YES NO Solid Tissue Normal 11 1 1999 7th NO YES NO 44 4 Current reformed smoker for < or = 15 years Lung A LIVING 2011 1963 3b3948f2-e93e-4d89-8611-3cde3b962193 TCGA-44-6145-11A-01D-1756-05 3b3948f2-e93e-4d89-8611-3cde3b962193 3b3948f2-e93e-4d89-8611-3cde3b962193 3b3948f2-e93e-4d89-8611-3cde3b962193 +TCGA-44-6146-01 1.87 0.74 none none none none Y Y none none none 0.39 Bronchioid none p.G12V none none none none none Invasive mucinous Invasive mucinous none 0 TCGA-44-6146-01 BRCA-LUAD+ C1-LUAD-enriched cluster 2 Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 6 cluster 1 mutation cluster 12 TCGA-44-6146 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung YES NO NO 64 L-Lower TCGA-44-6146-F34551 TCGA-44-6146 TCGA-44-6146-01A -23378 0 728 631 FPPP 76 0 Additional New Tumor Event 2012-8-22 MALE Lung Mucinous Adenocarcinoma No C34.30 8480/3 C34.3 YES 420 0.8 NO 2 NO Locoregional Recurrence YES 15 Yes M0 N0 T3 Stage IIB TCGA-44-6146.51a479ab-4c21-4189-a682-e6976d509ed3.pdf 6146 Other TUMOR FREE 95 94 88 87 Convincing Imaging TCGA YES Primary Tumor 01 0.8 1980 7th YES NO 44 3 Current reformed smoker for > 15 years Lung A LIVING 2010 TCGA-44-6146-01A-11D-1753-08 TCGA-44-6146-01A-11D-1753-08 c18d4714-5af9-4370-8b6d-f86b0c43b285 TCGA-44-6146-01A-11D-A273-01 TCGA-44-6146-01A-11D-1756-05,TCGA-44-6146-01A-11D-A276-05,TCGA-44-6146-01B-04D-A276-05 TCGA-44-6146-01 TCGA-44-6146-01A-11D-A273-01 c18d4714-5af9-4370-8b6d-f86b0c43b285 TCGA-44-6146-01 TCGA-44-6146-01A-13-2191-20 c18d4714-5af9-4370-8b6d-f86b0c43b285 TCGA-44-6146-01 39d5ffa0-85ff-4d42-a064-1c083c1c24fd c18d4714-5af9-4370-8b6d-f86b0c43b285 TCGA-44-6146-01A-11D-1753-08 TCGA-44-6146-01 +TCGA-44-6146-11 1.87 0.74 none none none none Y Y none none none 0.39 Bronchioid none p.G12V none none none none none Invasive mucinous Invasive mucinous none 0 TCGA-44-6146-11 C1-LUAD-enriched mutation cluster 12 TCGA-44-6146 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung YES NO NO 64 L-Lower TCGA-44-6146-F34551 TCGA-44-6146 TCGA-44-6146-11A -23378 0 728 631 FPPP 76 0 Additional New Tumor Event 2012-8-22 MALE Lung Mucinous Adenocarcinoma No C34.30 8480/3 C34.3 YES 400 0.9 NO 1.5 NO Locoregional Recurrence YES 15 Yes M0 N0 T3 Stage IIB 6146 Other TUMOR FREE 95 94 88 87 Convincing Imaging TCGA YES Solid Tissue Normal 11 0.9 1980 7th YES NO 44 3 Current reformed smoker for > 15 years Lung A LIVING 2010 488285fc-5482-46b7-b97e-2f5e7330311a TCGA-44-6146-11A-01D-1756-05 488285fc-5482-46b7-b97e-2f5e7330311a 488285fc-5482-46b7-b97e-2f5e7330311a 488285fc-5482-46b7-b97e-2f5e7330311a +TCGA-44-6147-01 2.19 0.36 none none none none Y Y p.S768I, p.V769L none none 0.17 Bronchioid none none none none none none none Acinar predominant Adc Acinar predominant Adc none 0 TCGA-44-6147-01 High C1-LUAD-enriched cluster 2 Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 5 cluster 5 mutation cluster 8 TCGA-44-6147 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung NO NO NO 67 R-Upper TCGA-44-6147-F38947 TCGA-44-6147 TCGA-44-6147-01A -24631 0 845 FPPP 68 Scheduled Follow-up Submission Complete Remission/Response 2013-1-4 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 80 0.8 NO 80 1 NO NO Yes M0 NX T1b Stage IA TCGA-44-6147.06f76ecf-14db-4228-b413-f6b4e187a1e4.pdf 6147 Other TUMOR FREE 105 97 Complete Remission/Response TCGA YES NO Primary Tumor 01 0.6 1980 7th NO YES NO 44 3 Current reformed smoker for > 15 years Lung A LIVING 2010 1976 TCGA-44-6147-01A-11D-1753-08 TCGA-44-6147-01A-11D-1753-08 29af0307-5d76-462d-beee-18e8c4f179b8 TCGA-44-6147-01A-11D-A273-01 TCGA-44-6147-01A-11D-1756-05,TCGA-44-6147-01B-06D-A276-05,TCGA-44-6147-01A-11D-A276-05 TCGA-44-6147-01 TCGA-44-6147-01A-11D-A273-01 29af0307-5d76-462d-beee-18e8c4f179b8 TCGA-44-6147-01A-13-2191-20 29af0307-5d76-462d-beee-18e8c4f179b8 TCGA-44-6147-01 af82f02d-660f-4906-9b42-be16c0615693 29af0307-5d76-462d-beee-18e8c4f179b8 TCGA-44-6147-01A-11D-1753-08 +TCGA-44-6147-11 2.19 0.36 none none none none Y Y p.S768I, p.V769L none none 0.17 Bronchioid none none none none none none none Acinar predominant Adc Acinar predominant Adc none 0 TCGA-44-6147-11 C1-LUAD-enriched mutation cluster 8 TCGA-44-6147 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung NO NO NO 67 R-Upper TCGA-44-6147-F38947 TCGA-44-6147 TCGA-44-6147-11A -24631 0 845 FPPP 68 Scheduled Follow-up Submission Complete Remission/Response 2013-1-4 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 720 1 NO 80 2.2 NO NO Yes M0 NX T1b Stage IA 6147 Other TUMOR FREE 105 97 Complete Remission/Response TCGA YES NO Solid Tissue Normal 11 1 1980 7th NO YES NO 44 3 Current reformed smoker for > 15 years Lung A LIVING 2010 1976 2f16ddcc-8a98-4734-9878-645ff102fb14 TCGA-44-6147-11A-01D-1756-05 2f16ddcc-8a98-4734-9878-645ff102fb14 2f16ddcc-8a98-4734-9878-645ff102fb14 2f16ddcc-8a98-4734-9878-645ff102fb14 +TCGA-44-6148-01 TCGA-44-6148-01 Kirc+ C1-LUAD-enriched Low purity c2 squamous c3 LUAD-like c10 mutation c1uster 9 TCGA-44-6148 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung NO 60 L-Lower TCGA-44-6148-F38967 TCGA-44-6148 TCGA-44-6148-01A -22138 0 704 1 Scheduled Follow-up Submission Complete Remission/Response 2013-1-7 MALE Lung Mucinous Adenocarcinoma No C34.30 8480/3 C34.3 YES 0.8 NO NO NO 1.5 NO NO 60 No M0 N0 T1b Stage IA TCGA-44-6148.5407ff6d-a042-47db-998b-60e6f15109ab.pdf 6148 Preoperative TUMOR FREE 110 77 98 74 Complete Remission/Response YES NO RX Primary Tumor 01 0.4 1994 7th NO YES NO 44 3 Lung A LIVING 2011 1963 TCGA-44-6148-01A-11D-1753-08 472518f5-c62b-4e50-9ea9-077a44a8f117 TCGA-44-6148-01A-11D-1752-01 TCGA-44-6148-01A-11D-1756-05 TCGA-44-6148-01 TCGA-44-6148-01A-11D-1752-01 472518f5-c62b-4e50-9ea9-077a44a8f117 TCGA-44-6148-01 TCGA-44-6148-01A-13-2191-20 472518f5-c62b-4e50-9ea9-077a44a8f117 TCGA-44-6148-01 2227fc80-a405-473b-b25c-dbcfe1624040 472518f5-c62b-4e50-9ea9-077a44a8f117 TCGA-44-6148-01A-11D-1753-08 TCGA-44-6148-01 +TCGA-44-6148-11 TCGA-44-6148-11 C1-LUAD-enriched mutation c1uster 9 TCGA-44-6148 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung NO 60 L-Lower TCGA-44-6148-F38967 TCGA-44-6148 TCGA-44-6148-11A -22138 0 704 1 Scheduled Follow-up Submission Complete Remission/Response 2013-1-7 MALE Lung Mucinous Adenocarcinoma No C34.30 8480/3 C34.3 YES 0.9 NO NO NO 2.3 NO NO 60 No M0 N0 T1b Stage IA 6148 Preoperative TUMOR FREE 110 77 98 74 Complete Remission/Response YES NO RX Solid Tissue Normal 11 0.9 1994 7th NO YES NO 44 3 Lung A LIVING 2011 1963 0391cb59-6ceb-4d9a-be02-5d68b4ddafc3 TCGA-44-6148-11A-01D-1756-05 0391cb59-6ceb-4d9a-be02-5d68b4ddafc3 0391cb59-6ceb-4d9a-be02-5d68b4ddafc3 0391cb59-6ceb-4d9a-be02-5d68b4ddafc3 +TCGA-44-6774-01 2.13 0.36 none p.N581S none none N N none none none 0.18 Squamoid none none none none none none none Acinar predominant Adc Acinar predominant Adc none 0 TCGA-44-6774-01 High C1-LUAD-enriched cluster 3 Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 5 cluster 3 mutation cluster 13 TCGA-44-6774 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung NO 56 L-Lower TCGA-44-6774-F39646 TCGA-44-6774 TCGA-44-6774-01A -20462 0 658 101 1 Scheduled Follow-up Submission Complete Remission/Response 2013-1-28 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 1 NO 1.5 NO NO 20 No M0 N2 T1 Stage IIIA TCGA-44-6774.f9587269-4f32-497a-a95a-42d505af2434.pdf 6774 Other TUMOR FREE 84 96 Complete Remission/Response YES YES Primary Tumor 01 0.3 7th YES YES NO 44 2 Current smoker Lung A LIVING 2011 1971 TCGA-44-6774-01A-21D-1855-08 TCGA-44-6774-01A-21D-1855-08 7d27cfbf-870f-45e8-80a9-7e3848f414dc TCGA-44-6774-01A-21D-1854-01 TCGA-44-6774-01A-21D-1856-05 TCGA-44-6774-01 TCGA-44-6774-01A-21D-1854-01 7d27cfbf-870f-45e8-80a9-7e3848f414dc TCGA-44-6774-01 TCGA-44-6774-01A-23-2191-20 7d27cfbf-870f-45e8-80a9-7e3848f414dc TCGA-44-6774-01 dafb8264-54ef-4fe8-b549-3c5079a42773 7d27cfbf-870f-45e8-80a9-7e3848f414dc TCGA-44-6774-01A-21D-1855-08 TCGA-44-6774-01 +TCGA-44-6775-01 2.24 0.38 none none none none N N none none none 0.18 Squamoid none none none exon 14 skipping by RSeq none none none Acinar predominant Adc Acinar predominant Adc none 0 TCGA-44-6775-01 BRCA-LUAD+ C1-LUAD-enriched cluster 2 Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 4 cluster 2 mutation cluster 13 TCGA-44-6775 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung NO NO NO 72 R-Upper TCGA-44-6775-F40408 TCGA-44-6775 TCGA-44-6775-01A -26415 0 705 684 FPPP 66 Scheduled Follow-up Submission Progressive Disease 2013-2-19 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 70 1.1 NO 100 1.1 NO Locoregional Recurrence YES 25 No MX N0 T2a Stage IB TCGA-44-6775.cd641541-f607-49de-8f57-fa54b0561721.pdf 6775 Other WITH TUMOR 89 72 84 68 Complete Remission/Response Convincing Imaging TCGA YES NO RX Primary Tumor 01 0.2 2005 7th NO YES NO 44 4 Current reformed smoker for < or = 15 years Lung A LIVING 2011 1955 TCGA-44-6775-01A-11D-1855-08 TCGA-44-6775-01A-11D-1855-08 6a4b7295-a738-4d4a-a264-72fba462e60c TCGA-44-6775-01A-11D-A273-01 TCGA-44-6775-01A-11D-1856-05,TCGA-44-6775-01A-11D-A276-05,TCGA-44-6775-01C-02D-A276-05 TCGA-44-6775-01 TCGA-44-6775-01A-11D-A273-01 6a4b7295-a738-4d4a-a264-72fba462e60c TCGA-44-6775-01 TCGA-44-6775-01A-13-2191-20 6a4b7295-a738-4d4a-a264-72fba462e60c TCGA-44-6775-01 f098943b-8859-4329-b980-14784b42131f 6a4b7295-a738-4d4a-a264-72fba462e60c TCGA-44-6775-01A-11D-1855-08 TCGA-44-6775-01 +TCGA-44-6776-01 1.95 0.64 none none none none Y Y none none none 0.33 Bronchioid none p.G12D none none none none none Papillary predominant Adc Papillary predominant Adc p.Q220* 0 TCGA-44-6776-01 BRCA-LUAD+ C1-LUAD-enriched cluster 3 Cluster 5 squamous c3 LUAD-like c10 miRNA c1uster 9 cluster 5 mutation cluster 7 TCGA-44-6776 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung NO 60 R-Upper TCGA-44-6776-F39378 TCGA-44-6776 -22150 0 2616 80 Scheduled Follow-up Submission Complete Remission/Response 2013-1-21 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES NO NO 45 Yes MX N0 T1 Stage IA 6776 TUMOR FREE 85 82 95 74 Complete Remission/Response YES NO Primary Tumor 01 2005 6th NO NO YES 44 4 Current reformed smoker for < or = 15 years Lung LIVING 2005 1960 TCGA-44-6776-01A-11D-1855-08 TCGA-44-6776-01A-11D-1855-08 aae03245-71cc-4081-87b6-925f96bee9ef TCGA-44-6776-01A-11D-1854-01 TCGA-44-6776-01A-11D-1856-05 TCGA-44-6776-01 TCGA-44-6776-01A-11D-1854-01 aae03245-71cc-4081-87b6-925f96bee9ef TCGA-44-6776-01 TCGA-44-6776-01A-13-2191-20 aae03245-71cc-4081-87b6-925f96bee9ef TCGA-44-6776-01 b08fc3a5-06b6-42af-8195-585acfcf1d4e aae03245-71cc-4081-87b6-925f96bee9ef TCGA-44-6776-01A-11D-1855-08 TCGA-44-6776-01 +TCGA-44-6776-11 1.95 0.64 none none none none Y Y none none none 0.33 Bronchioid none p.G12D none none none none none Papillary predominant Adc Papillary predominant Adc p.Q220* 0 TCGA-44-6776-11 C1-LUAD-enriched mutation cluster 7 TCGA-44-6776 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung NO 60 R-Upper TCGA-44-6776-F39378 TCGA-44-6776 -22150 0 2616 80 Scheduled Follow-up Submission Complete Remission/Response 2013-1-21 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES NO NO 45 Yes MX N0 T1 Stage IA 6776 TUMOR FREE 85 82 95 74 Complete Remission/Response YES NO Solid Tissue Normal 11 2005 6th NO NO YES 44 4 Current reformed smoker for < or = 15 years Lung LIVING 2005 1960 d3402ac8-0188-4fb8-8054-ba3145120952 d3402ac8-0188-4fb8-8054-ba3145120952 TCGA-44-6776-11 d3402ac8-0188-4fb8-8054-ba3145120952 d3402ac8-0188-4fb8-8054-ba3145120952 TCGA-44-6776-11 +TCGA-44-6777-01 1.91 0.34 none none none none Y Y none none p.D335Y 0.17 Squamoid none p.G12C none none none none none Solid predominant Adc Solid predominant Adc none 0 TCGA-44-6777-01 High C1-LUAD-enriched cluster 2 Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 4 cluster 2 mutation cluster 2 TCGA-44-6777 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 85 L-Upper TCGA-44-6777-F15694 TCGA-44-6777 TCGA-44-6777-01A -31234 987 0 178 3 Scheduled Follow-up Submission 2011-8-30 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 1 NO 1.8 NO 64 No MX NX T2 Stage IB TCGA-44-6777.600a1078-21f2-4267-9d3c-03f292fa6a32.pdf 6777 Post-Adjuvant Therapy TUMOR FREE 77 71 68 62 Complete Remission/Response YES YES Primary Tumor 01 0.4 2006 6th NO NO YES 44 4 Current reformed smoker for < or = 15 years Lung A DECEASED 2006 1942 TCGA-44-6777-01A-11D-1855-08 TCGA-44-6777-01A-11D-1855-08 25f0eee1-8f38-4e75-accf-7e7bb686405c TCGA-44-6777-01A-11D-1854-01 TCGA-44-6777-01A-11D-1856-05 TCGA-44-6777-01 TCGA-44-6777-01A-11D-1854-01 25f0eee1-8f38-4e75-accf-7e7bb686405c TCGA-44-6777-01 TCGA-44-6777-01A-13-2191-20 25f0eee1-8f38-4e75-accf-7e7bb686405c TCGA-44-6777-01 137825b5-a029-4638-8150-bca2c02f6ded 25f0eee1-8f38-4e75-accf-7e7bb686405c TCGA-44-6777-01A-11D-1855-08 TCGA-44-6777-01 +TCGA-44-6777-11 1.91 0.34 none none none none Y Y none none p.D335Y 0.17 Squamoid none p.G12C none none none none none Solid predominant Adc Solid predominant Adc none 0 TCGA-44-6777-11 C1-LUAD-enriched mutation cluster 2 TCGA-44-6777 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 85 L-Upper TCGA-44-6777-F15694 TCGA-44-6777 -31234 987 0 178 3 Scheduled Follow-up Submission 2011-8-30 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES NO 64 No MX NX T2 Stage IB 6777 Post-Adjuvant Therapy TUMOR FREE 77 71 68 62 Complete Remission/Response YES YES Solid Tissue Normal 11 2006 6th NO NO YES 44 4 Current reformed smoker for < or = 15 years Lung DECEASED 2006 1942 f3bb69da-304f-462d-b020-f479a866381e f3bb69da-304f-462d-b020-f479a866381e TCGA-44-6777-11 f3bb69da-304f-462d-b020-f479a866381e f3bb69da-304f-462d-b020-f479a866381e TCGA-44-6777-11 +TCGA-44-6778-01 TCGA-44-6778-01 High C1-LUAD-enriched Low purity c2 squamous c3 LUAD-like c10 miRNA cluster 6 mutation cluster 2 TCGA-44-6778 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 59 [Discrepancy] TCGA-44-6778-F39376 TCGA-44-6778 TCGA-44-6778-01A -21725 0 1864 53 Scheduled Follow-up Submission Complete Remission/Response 2013-1-21 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.9 YES 0.9 NO 1 NO NO 15 No MX N0 T1 Stage IA TCGA-44-6778.b1f41c0e-a2a1-4945-85b3-a2ef6a994cbe.pdf 6778 TUMOR FREE 90 74 Complete Remission/Response YES NO Primary Tumor 01 0.8 2004 6th NO NO YES 44 4 Lung A LIVING 2007 1974 TCGA-44-6778-01A-11D-1855-08 ee90d7cd-4ac9-4be0-b9a8-49329890f69d TCGA-44-6778-01A-11D-1854-01 TCGA-44-6778-01A-11D-1856-05 TCGA-44-6778-01 TCGA-44-6778-01A-11D-1854-01 ee90d7cd-4ac9-4be0-b9a8-49329890f69d TCGA-44-6778-01 TCGA-44-6778-01A-13-2191-20 ee90d7cd-4ac9-4be0-b9a8-49329890f69d TCGA-44-6778-01 3380c662-2c5f-4dc7-b438-5286e2984b36 ee90d7cd-4ac9-4be0-b9a8-49329890f69d TCGA-44-6778-01A-11D-1855-08 TCGA-44-6778-01 +TCGA-44-6778-11 TCGA-44-6778-11 C1-LUAD-enriched mutation cluster 2 TCGA-44-6778 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 59 [Discrepancy] TCGA-44-6778-F39376 TCGA-44-6778 -21725 0 1864 53 Scheduled Follow-up Submission Complete Remission/Response 2013-1-21 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.9 YES NO NO 15 No MX N0 T1 Stage IA 6778 TUMOR FREE 90 74 Complete Remission/Response YES NO Solid Tissue Normal 11 2004 6th NO NO YES 44 4 Lung LIVING 2007 1974 a89e4f9e-0dfe-449d-a215-6c770cc5ea55 TCGA-44-6778-11A-01D-1856-05 a89e4f9e-0dfe-449d-a215-6c770cc5ea55 TCGA-44-6778-11 a89e4f9e-0dfe-449d-a215-6c770cc5ea55 a89e4f9e-0dfe-449d-a215-6c770cc5ea55 TCGA-44-6778-11 +TCGA-44-6779-01 3.12 0.43 none none none none N N none none none 0.17 Squamoid none none none none none none none Solid predominant Adc Solid predominant Adc p.K235* 0 TCGA-44-6779-01 High C1-LUAD-enriched cluster 1 Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 4 cluster 2 mutation cluster 8 TCGA-44-6779 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung YES NO NO 50 [Discrepancy] TCGA-44-6779-F15758 TCGA-44-6779 TCGA-44-6779-01A -18469 500 0 232 44 Scheduled Follow-up Submission 2011-9-12 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.9 YES 0.7 NO 1 YES 15 No MX N1 T2 Stage IIB TCGA-44-6779.7f7b5635-2f0e-4f0e-b56a-5c19cfe0593c.pdf 6779 WITH TUMOR 83 48 83 49 Progressive Disease YES NO Primary Tumor 01 0.5 2008 6th YES NO YES 44 4 Current reformed smoker for < or = 15 years Lung A DECEASED 2008 1978 TCGA-44-6779-01A-11D-1855-08 TCGA-44-6779-01A-11D-1855-08 57f72fed-dcb9-4bba-8810-30c254f4635c TCGA-44-6779-01A-11D-1854-01 TCGA-44-6779-01A-11D-1856-05 TCGA-44-6779-01 TCGA-44-6779-01A-11D-1854-01 57f72fed-dcb9-4bba-8810-30c254f4635c TCGA-44-6779-01 TCGA-44-6779-01A-13-2191-20 57f72fed-dcb9-4bba-8810-30c254f4635c TCGA-44-6779-01 1976e376-25dc-481c-b1b0-ba2b390944d5 57f72fed-dcb9-4bba-8810-30c254f4635c TCGA-44-6779-01A-11D-1855-08 TCGA-44-6779-01 +TCGA-44-7659-01 2.09 0.59 none none none none Y Y none none none 0.29 Bronchioid none p.G12C none none none none none Acinar predominant Adc Acinar predominant Adc none 0 TCGA-44-7659-01 Iq C1-LUAD-enriched cluster 1 Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 5 cluster 3 TCGA-44-7659 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung NO 70 L-Upper TCGA-44-7659-F39654 TCGA-44-7659 TCGA-44-7659-01A -25730 0 691 43 Scheduled Follow-up Submission Complete Remission/Response 2013-1-29 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.8 NO NO 1.2 NO NO 40 No MX N0 T1b Stage IA TCGA-44-7659.ca4281d7-0cd7-4ebc-8050-9dd81fbbefbc.pdf 7659 TUMOR FREE 60 47 55 42 Complete Remission/Response YES NO Primary Tumor 01 0.4 7th NO YES NO 44 2 Current smoker Lung A LIVING 2010 1989 TCGA-44-7659-01A-11D-2063-08 e01db349-84f5-4e73-a356-3460d3267f03 TCGA-44-7659-01A-11D-2062-01 TCGA-44-7659-01A-11D-2064-05 TCGA-44-7659-01 TCGA-44-7659-01A-11D-2062-01 e01db349-84f5-4e73-a356-3460d3267f03 TCGA-44-7659-01 TCGA-44-7659-01A-13-2192-20 e01db349-84f5-4e73-a356-3460d3267f03 TCGA-44-7659-01 15ecd6a2-ab28-4b96-b20f-5a9163f6c14a e01db349-84f5-4e73-a356-3460d3267f03 TCGA-44-7659-01A-11D-2063-08 TCGA-44-7659-01 +TCGA-44-7659-11 2.09 0.59 none none none none Y Y none none none 0.29 Bronchioid none p.G12C none none none none none Acinar predominant Adc Acinar predominant Adc none 0 TCGA-44-7659-11 C1-LUAD-enriched TCGA-44-7659 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung NO 70 L-Upper TCGA-44-7659-F39654 TCGA-44-7659 -25730 0 691 43 Scheduled Follow-up Submission Complete Remission/Response 2013-1-29 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES NO NO NO 40 No MX N0 T1b Stage IA 7659 TUMOR FREE 60 47 55 42 Complete Remission/Response YES NO Solid Tissue Normal 11 7th NO YES NO 44 2 Current smoker Lung LIVING 2010 1989 TCGA-44-7659-11 TCGA-44-7659-11 +TCGA-44-7660-01 TCGA-44-7660-01 Squamous C2-Squamous-like OV-like c1 squamous c3 squamous-like c4 miRNA cluster 4 TCGA-44-7660 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung NO 72 R-Upper TCGA-44-7660-F40409 TCGA-44-7660 -26594 0 592 80 1 Scheduled Follow-up Submission Stable Disease 2013-2-19 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 70 NO NO NO 124 No MX N0 T2 Stage IB 7660 Other WITH TUMOR 95 94 92 83 Progressive Disease YES NO Primary Tumor 01 7th YES YES NO 44 2 Lung LIVING 2011 1949 bbf1f651-44f0-42c9-a519-64f3d47b42dc TCGA-44-7660-01A-11D-2062-01 TCGA-44-7660-01A-11D-2064-05 TCGA-44-7660-01 TCGA-44-7660-01A-11D-2062-01 bbf1f651-44f0-42c9-a519-64f3d47b42dc TCGA-44-7660-01 TCGA-44-7660-01A-13-2192-20 bbf1f651-44f0-42c9-a519-64f3d47b42dc TCGA-44-7660-01 c423ffaa-5b81-4218-b7bb-85c8e7be4efe bbf1f651-44f0-42c9-a519-64f3d47b42dc TCGA-44-7660-01A-11D-2063-08 TCGA-44-7660-01 +TCGA-44-7660-11 TCGA-44-7660-11 C2-Squamous-like TCGA-44-7660 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung NO 72 R-Upper TCGA-44-7660-F40409 TCGA-44-7660 -26594 0 592 80 1 Scheduled Follow-up Submission Stable Disease 2013-2-19 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 70 NO NO NO 124 No MX N0 T2 Stage IB 7660 Other WITH TUMOR 95 94 92 83 Progressive Disease YES NO Solid Tissue Normal 11 7th YES YES NO 44 2 Lung LIVING 2011 1949 TCGA-44-7660-11 TCGA-44-7660-11 +TCGA-44-7661-01 TCGA-44-7661-01 Kirc+ C1-LUAD-enriched Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 5 TCGA-44-7661 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung YES YES NO NO 69 R-Lower TCGA-44-7661-F39321 TCGA-44-7661 -25483 557 0 153 335 0 YES YES Scheduled Follow-up Submission Progressive Disease 2013-1-17 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES Peripheral Lung NO Locoregional Recurrence YES 22 Yes M0 N0 T2a Stage IB 7661 Preoperative WITH TUMOR 95 81 92 68 Complete Remission/Response Convincing Imaging YES NO Primary Tumor 01 1976 7th NO YES NO 44 3 Lung DECEASED 2011 1961 d037d7f2-3277-4dc3-954b-503f906bc467 TCGA-44-7661-01A-11D-2062-01 TCGA-44-7661-01A-11D-2064-05 TCGA-44-7661-01 TCGA-44-7661-01A-11D-2062-01 d037d7f2-3277-4dc3-954b-503f906bc467 TCGA-44-7661-01 TCGA-44-7661-01A-13-2192-20 d037d7f2-3277-4dc3-954b-503f906bc467 TCGA-44-7661-01 ad484c0c-edb6-47f3-8e06-3adf0a4c3654 d037d7f2-3277-4dc3-954b-503f906bc467 TCGA-44-7661-01A-11D-2063-08 TCGA-44-7661-01 +TCGA-44-7661-11 TCGA-44-7661-11 C1-LUAD-enriched TCGA-44-7661 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung YES YES NO NO 69 R-Lower TCGA-44-7661-F39321 TCGA-44-7661 -25483 557 0 153 335 0 YES YES Scheduled Follow-up Submission Progressive Disease 2013-1-17 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES Peripheral Lung NO Locoregional Recurrence YES 22 Yes M0 N0 T2a Stage IB 7661 Preoperative WITH TUMOR 95 81 92 68 Complete Remission/Response Convincing Imaging YES NO Solid Tissue Normal 11 1976 7th NO YES NO 44 3 Lung DECEASED 2011 1961 TCGA-44-7661-11 TCGA-44-7661-11 +TCGA-44-7662-01 2.9 0.33 none none none none N N none none p.A828D 0.14 Squamoid none none none none none none none Solid predominant Adc Solid predominant Adc none 0 TCGA-44-7662-01 High C1-LUAD-enriched cluster 2 Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 4 cluster 2 TCGA-44-7662 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 61 L-Upper TCGA-44-7662-F34016 TCGA-44-7662 TCGA-44-7662-01A -22543 0 218 57 Scheduled Follow-up Submission Complete Remission/Response 2012-7-25 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.7 NO NO 1 NO NO 50 No MX N0 T2a Stage IB TCGA-44-7662.7b34e153-7bc5-4ba6-8445-bac63ca2dcc6.pdf 7662 TUMOR FREE 66 68 68 60 Complete Remission/Response YES NO Primary Tumor 01 0.3 7th NO YES NO 44 2 Current smoker Lung A LIVING 2011 1961 TCGA-44-7662-01A-11D-2063-08 0216208c-fbbd-4370-93dd-19fbb7703568 TCGA-44-7662-01A-11D-2062-01 TCGA-44-7662-01A-11D-2064-05 TCGA-44-7662-01 TCGA-44-7662-01A-11D-2062-01 0216208c-fbbd-4370-93dd-19fbb7703568 TCGA-44-7662-01 TCGA-44-7662-01A-13-2192-20 0216208c-fbbd-4370-93dd-19fbb7703568 TCGA-44-7662-01 318204fb-9dc7-4024-b09a-5b507bf8f217 0216208c-fbbd-4370-93dd-19fbb7703568 TCGA-44-7662-01A-11D-2063-08 TCGA-44-7662-01 +TCGA-44-7662-11 2.9 0.33 none none none none N N none none p.A828D 0.14 Squamoid none none none none none none none Solid predominant Adc Solid predominant Adc none 0 TCGA-44-7662-11 C1-LUAD-enriched TCGA-44-7662 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 61 L-Upper TCGA-44-7662-F34016 TCGA-44-7662 -22543 0 218 57 Scheduled Follow-up Submission Complete Remission/Response 2012-7-25 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES NO NO NO 50 No MX N0 T2a Stage IB 7662 TUMOR FREE 66 68 68 60 Complete Remission/Response YES NO Solid Tissue Normal 11 7th NO YES NO 44 2 Current smoker Lung LIVING 2011 1961 TCGA-44-7662-11 TCGA-44-7662-11 +TCGA-44-7667-01 TCGA-44-7667-01 High C1-LUAD-enriched Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 6 TCGA-44-7667 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 49 R-Lower TCGA-44-7667-F39968 TCGA-44-7667 TCGA-44-7667-01A -18062 0 1097 50 Scheduled Follow-up Submission Complete Remission/Response 2013-2-7 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 0.8 NO NO 1.7 NO NO 50 No MX N0 T3 Stage IIB TCGA-44-7667.9722e13c-6ac6-415b-a84f-997d301cea49.pdf 7667 TUMOR FREE 104 74 Complete Remission/Response YES NO Primary Tumor 01 0.5 6th NO YES NO 44 2 Lung A LIVING 2009 1974 7dcc9d07-9af9-405e-b75a-c0e7ffdff5c0 TCGA-44-7667-01A-31D-2062-01 TCGA-44-7667-01A-31D-2064-05 TCGA-44-7667-01 TCGA-44-7667-01A-31D-2062-01 7dcc9d07-9af9-405e-b75a-c0e7ffdff5c0 TCGA-44-7667-01 TCGA-44-7667-01A-23-2192-20 7dcc9d07-9af9-405e-b75a-c0e7ffdff5c0 TCGA-44-7667-01 6ab603ca-baa9-46a5-a40f-367048fb7cc9 7dcc9d07-9af9-405e-b75a-c0e7ffdff5c0 TCGA-44-7667-01A-31D-2063-08 TCGA-44-7667-01 +TCGA-44-7667-11 TCGA-44-7667-11 C1-LUAD-enriched TCGA-44-7667 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 49 R-Lower TCGA-44-7667-F39968 TCGA-44-7667 -18062 0 1097 50 Scheduled Follow-up Submission Complete Remission/Response 2013-2-7 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES NO NO NO 50 No MX N0 T3 Stage IIB 7667 TUMOR FREE 104 74 Complete Remission/Response YES NO Solid Tissue Normal 11 6th NO YES NO 44 2 Lung LIVING 2009 1974 TCGA-44-7667-11 TCGA-44-7667-11 +TCGA-44-7669-01 TCGA-44-7669-01 GBM C1-LUAD-enriched Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 6 TCGA-44-7669 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung YES YES NO NO 59 R-Upper TCGA-44-7669-F20505 TCGA-44-7669 TCGA-44-7669-01A -21893 574 0 525 52 Additional New Tumor Event Progressive Disease 2012-1-16 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.9 NO NO 1.8 YES 20 No MX N1 T1b Stage IIA TCGA-44-7669.4b112ed4-a999-467d-aace-8bc2c13db1cb.pdf 7669 WITH TUMOR 84 80 80 73 YES Primary Tumor 01 0.7 7th YES NO 44 2 Lung A DECEASED 2010 1970 109f2b77-1742-4afa-bcba-b763746fe080 TCGA-44-7669-01A-21D-2062-01 TCGA-44-7669-01A-21D-2064-05 TCGA-44-7669-01 TCGA-44-7669-01A-21D-2062-01 109f2b77-1742-4afa-bcba-b763746fe080 TCGA-44-7669-01 TCGA-44-7669-01A-23-2192-20 109f2b77-1742-4afa-bcba-b763746fe080 TCGA-44-7669-01 58a516e2-5056-4dbf-b60e-76ce109984db 109f2b77-1742-4afa-bcba-b763746fe080 TCGA-44-7669-01A-21D-2063-08 TCGA-44-7669-01 +TCGA-44-7669-11 TCGA-44-7669-11 C1-LUAD-enriched TCGA-44-7669 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung YES YES NO NO 59 R-Upper TCGA-44-7669-F20505 TCGA-44-7669 -21893 574 0 525 52 Additional New Tumor Event Progressive Disease 2012-1-16 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES NO YES 20 No MX N1 T1b Stage IIA 7669 WITH TUMOR 84 80 80 73 YES Solid Tissue Normal 11 7th YES NO 44 2 Lung DECEASED 2010 1970 TCGA-44-7669-11 TCGA-44-7669-11 +TCGA-44-7670-01 2.76 0.68 none none none none N N none none p.R866K 0.27 Magnoid none none none none none p.E600K none Lepidic predominant Adc Lepidic predominant Adc none 0 TCGA-44-7670-01 High C1-LUAD-enriched cluster 3 Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 5 cluster 3 TCGA-44-7670 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung NO 47 L-Upper TCGA-44-7670-F39052 TCGA-44-7670 TCGA-44-7670-01A -17392 0 882 50 Scheduled Follow-up Submission Complete Remission/Response 2013-1-9 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.8 NO 1.5 NO NO 30 Yes M0 N1 T1b Stage IIA TCGA-44-7670.b93c87ac-5344-408e-a0e1-763b998a55b7.pdf 7670 TUMOR FREE 90 82 86 80 Complete Remission/Response YES NO Primary Tumor 01 0.7 7th YES YES NO 44 2 Current smoker Lung A LIVING 2010 1980 TCGA-44-7670-01A-11D-2063-08 0b8ef0be-c6fb-4ca9-9da0-f97dd22767bf TCGA-44-7670-01A-11D-2062-01 TCGA-44-7670-01A-11D-2064-05 TCGA-44-7670-01 TCGA-44-7670-01A-11D-2062-01 0b8ef0be-c6fb-4ca9-9da0-f97dd22767bf TCGA-44-7670-01 TCGA-44-7670-01A-11-2192-20 0b8ef0be-c6fb-4ca9-9da0-f97dd22767bf TCGA-44-7670-01 3a023cd3-de1f-4b19-afd9-685baf90aab7 0b8ef0be-c6fb-4ca9-9da0-f97dd22767bf TCGA-44-7670-01A-11D-2063-08 TCGA-44-7670-01 +TCGA-44-7670-11 2.76 0.68 none none none none N N none none p.R866K 0.27 Magnoid none none none none none p.E600K none Lepidic predominant Adc Lepidic predominant Adc none 0 TCGA-44-7670-11 C1-LUAD-enriched TCGA-44-7670 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung NO 47 L-Upper TCGA-44-7670-F39052 TCGA-44-7670 -17392 0 882 50 Scheduled Follow-up Submission Complete Remission/Response 2013-1-9 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES NO NO 30 Yes M0 N1 T1b Stage IIA 7670 TUMOR FREE 90 82 86 80 Complete Remission/Response YES NO Solid Tissue Normal 11 7th YES YES NO 44 2 Current smoker Lung LIVING 2010 1980 TCGA-44-7670-11 TCGA-44-7670-11 +TCGA-44-7671-01 3.03 0.67 none none none none Y Y none none none 0.25 Magnoid none p.G12C none p.T660R none none none Acinar predominant Adc Acinar predominant Adc p.K262* 0 TCGA-44-7671-01 BRCA-LUAD+ C1-LUAD-enriched cluster 3 Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 5 cluster 3 TCGA-44-7671 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung NO NO 64 TCGA-44-7671-F38982 TCGA-44-7671 -23538 0 889 883 65 Scheduled Follow-up Submission 2013-1-8 MALE Lung Adenocarcinoma Mixed Subtype No C34.2 8255/3 C34.2 YES NO Locoregional Recurrence YES Yes M0 N0 T2a Stage IB 7671 WITH TUMOR 103 82 97 76 Complete Remission/Response Convincing Imaging YES NO Primary Tumor 01 1995 7th NO YES NO 44 3 Current reformed smoker for > 15 years Lung LIVING 2010 TCGA-44-7671-01A-11D-2063-08 b294ae61-dd94-40a4-8cda-1001658d986f TCGA-44-7671-01A-11D-2062-01 TCGA-44-7671-01A-11D-2064-05 TCGA-44-7671-01 TCGA-44-7671-01A-11D-2062-01 b294ae61-dd94-40a4-8cda-1001658d986f TCGA-44-7671-01 TCGA-44-7671-01A-21-2192-20 b294ae61-dd94-40a4-8cda-1001658d986f TCGA-44-7671-01 d73aab66-a9f7-4bf5-969a-aceb01abb8ff b294ae61-dd94-40a4-8cda-1001658d986f TCGA-44-7671-01A-11D-2063-08 TCGA-44-7671-01 +TCGA-44-7671-11 3.03 0.67 none none none none Y Y none none none 0.25 Magnoid none p.G12C none p.T660R none none none Acinar predominant Adc Acinar predominant Adc p.K262* 0 TCGA-44-7671-11 C1-LUAD-enriched TCGA-44-7671 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung NO NO 64 TCGA-44-7671-F38982 TCGA-44-7671 -23538 0 889 883 65 Scheduled Follow-up Submission 2013-1-8 MALE Lung Adenocarcinoma Mixed Subtype No C34.2 8255/3 C34.2 YES NO Locoregional Recurrence YES Yes M0 N0 T2a Stage IB 7671 WITH TUMOR 103 82 97 76 Complete Remission/Response Convincing Imaging YES NO Solid Tissue Normal 11 1995 7th NO YES NO 44 3 Current reformed smoker for > 15 years Lung LIVING 2010 TCGA-44-7671-11 TCGA-44-7671-11 +TCGA-44-7672-01 2.88 0.19 none none none none Y Y none none none 0.09 Squamoid none p.G12A none none none none none Solid predominant Adc Solid predominant Adc none 0 TCGA-44-7672-01 High C1-LUAD-enriched cluster 2 Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 4 cluster 2 TCGA-44-7672 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 52 L-Upper TCGA-44-7672-F39074 TCGA-44-7672 -19200 0 719 82 Scheduled Follow-up Submission Complete Remission/Response 2013-1-10 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES NO NO 20 No M0 N0 T1b Stage IA 7672 TUMOR FREE 90 105 Complete Remission/Response YES NO Primary Tumor 01 7th NO YES NO 44 2 Current smoker Lung LIVING 2010 1980 TCGA-44-7672-01A-11D-2063-08 e0c25421-eda1-4204-8d86-37613a005180 TCGA-44-7672-01A-11D-2062-01 TCGA-44-7672-01A-11D-2064-05 TCGA-44-7672-01 TCGA-44-7672-01A-11D-2062-01 e0c25421-eda1-4204-8d86-37613a005180 TCGA-44-7672-01 TCGA-44-7672-01A-21-2192-20 e0c25421-eda1-4204-8d86-37613a005180 TCGA-44-7672-01 ee5f6e2a-0d90-4e2c-8631-00b3a10b0d43 e0c25421-eda1-4204-8d86-37613a005180 TCGA-44-7672-01A-11D-2063-08 TCGA-44-7672-01 +TCGA-44-7672-11 2.88 0.19 none none none none Y Y none none none 0.09 Squamoid none p.G12A none none none none none Solid predominant Adc Solid predominant Adc none 0 TCGA-44-7672-11 C1-LUAD-enriched TCGA-44-7672 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 52 L-Upper TCGA-44-7672-F39074 TCGA-44-7672 -19200 0 719 82 Scheduled Follow-up Submission Complete Remission/Response 2013-1-10 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES NO NO 20 No M0 N0 T1b Stage IA 7672 TUMOR FREE 90 105 Complete Remission/Response YES NO Solid Tissue Normal 11 7th NO YES NO 44 2 Current smoker Lung LIVING 2010 1980 TCGA-44-7672-11 TCGA-44-7672-11 +TCGA-44-8117-01 TCGA-44-8117-01 High Cluster 6 LUAD-like c10 miRNA cluster 4 TCGA-44-8117 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 54 R-Upper TCGA-44-8117-F36070 TCGA-44-8117 TCGA-44-8117-01A -19855 0 385 86 1 Scheduled Follow-up Submission Complete Remission/Response 2012-10-18 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.7 NO 1.1 NO NO 54 No M0 N0 T2a Stage IB TCGA-44-8117.af49cbe4-eb8a-46df-bd70-4023acee6ae1.pdf 8117 Post-Adjuvant Therapy TUMOR FREE 88 65 83 60 Complete Remission/Response YES NO Primary Tumor 01 0.4 2011 7th YES YES NO 44 4 Lung A LIVING 2011 1975 4bd54818-dbda-44f7-837e-0235716712d9 TCGA-44-8117-01A-11D-2237-01 TCGA-44-8117-01A-11D-2239-05 TCGA-44-8117-01 TCGA-44-8117-01A-11D-2237-01 4bd54818-dbda-44f7-837e-0235716712d9 TCGA-44-8117-01 4bd54818-dbda-44f7-837e-0235716712d9 TCGA-44-8117-01 5A8A836A-C37A-444B-B289-98C815E58096 4bd54818-dbda-44f7-837e-0235716712d9 TCGA-44-8117-01A-11D-2238-08 TCGA-44-8117-01 +TCGA-44-8119-01 TCGA-44-8119-01 High Cluster 5 LUAD-like c10 miRNA cluster 4 TCGA-44-8119 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung NO 73 R-Upper TCGA-44-8119-F38976 TCGA-44-8119 TCGA-44-8119-01A -27003 0 285 40 0 Scheduled Follow-up Submission Complete Remission/Response 2013-1-8 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 1 NO 2.6 NO NO 50 Yes, History of Prior Malignancy M0 N0 T3 Stage IIB TCGA-44-8119.c40ea4c8-8cbe-4a44-96d4-ae524a916449.pdf 8119 Preoperative TUMOR FREE 74 59 73 55 Complete Remission/Response YES NO Primary Tumor 01 1 7th NO YES NO 44 2 Lung A LIVING 2012 1961 b524809c-72a5-4e46-a3d9-7a838fbc4f02 TCGA-44-8119-01A-11D-2237-01 TCGA-44-8119-01A-11D-2239-05 TCGA-44-8119-01 TCGA-44-8119-01A-11D-2237-01 b524809c-72a5-4e46-a3d9-7a838fbc4f02 TCGA-44-8119-01 b524809c-72a5-4e46-a3d9-7a838fbc4f02 TCGA-44-8119-01 A9E94589-B427-4B44-98BB-315D8372D36C b524809c-72a5-4e46-a3d9-7a838fbc4f02 TCGA-44-8119-01A-11D-2238-08 TCGA-44-8119-01 +TCGA-44-8120-01 TCGA-44-8120-01 Squamous Cluster 6 LUAD-like c10 miRNA cluster 4 TCGA-44-8120 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 58 R-Upper TCGA-44-8120-F36757 TCGA-44-8120 TCGA-44-8120-01A -21188 0 260 0 Scheduled Follow-up Submission Complete Remission/Response 2012-11-13 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.9 NO 1 NO NO 30 No M0 N0 T2a Stage IB TCGA-44-8120.6996d5eb-bdfd-4b9b-9517-40c28e439834.pdf 8120 Preoperative TUMOR FREE 100 101 98 97 Complete Remission/Response YES NO Primary Tumor 01 0.4 7th NO YES NO 44 5 Lung A LIVING 2011 1981 8af91e43-8345-432a-a758-1ce8aa55c664 TCGA-44-8120-01A-11D-2237-01 TCGA-44-8120-01A-11D-2239-05 TCGA-44-8120-01 TCGA-44-8120-01A-11D-2237-01 8af91e43-8345-432a-a758-1ce8aa55c664 TCGA-44-8120-01 8af91e43-8345-432a-a758-1ce8aa55c664 TCGA-44-8120-01 8af91e43-8345-432a-a758-1ce8aa55c664 TCGA-44-8120-01A-11D-2238-08 TCGA-44-8120-01 +TCGA-44-A479-01 TCGA-44-A479-01 TCGA-44-A479 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung NO NO YES NO 73 R-Upper TCGA-44-A479-F45874 TCGA-44-A479 TCGA-44-A479-01A 437 -27024 193 0 486 437 60 0 YES NO Additional New Tumor Event Complete Remission/Response 2013-8-12 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 280 NO NO NO New Primary Tumor YES 40 false No MX N0 T2 Stage IB TCGA-44-A479.FFCFD93C-1D69-4DF8-9E1B-E2A4EEA66613.pdf A479 Preoperative TUMOR FREE 115 102 Complete Remission/Response YES NO R0 Primary Tumor 01 2002 7th NO YES NO 44 4 Lung A LIVING 2012 1962 9de618ee-04ff-49da-830a-f82eff981616 TCGA-44-A479-01A-31D-A24C-01 TCGA-44-A479-01A-31D-A24I-05 TCGA-44-A479-01 TCGA-44-A479-01A-31D-A24C-01 9de618ee-04ff-49da-830a-f82eff981616 TCGA-44-A479-01 9de618ee-04ff-49da-830a-f82eff981616 TCGA-44-A479-01 601BAE6B-FD1C-497B-AE9F-C6346E131BD5 9de618ee-04ff-49da-830a-f82eff981616 TCGA-44-A479-01A-31D-A24D-08 TCGA-44-A479-01 +TCGA-44-A47A-01 TCGA-44-A47A-01 TCGA-44-A47A TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung NO YES NO NO 78 R-Upper TCGA-44-A47A-F46609 TCGA-44-A47A TCGA-44-A47A-01A -28782 117 0 466 397 1 NO NO Additional New Tumor Event 2013-8-12 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 290 NO NO NO Distant Metastasis YES 80 false No MX N0 T2a Stage IB TCGA-44-A47A.3F92B4C0-ED5F-486D-A751-730136B1D9A8.pdf A47A Preoperative WITH TUMOR Complete Remission/Response Convincing Imaging NO NO R0 Primary Tumor 01 2010 7th NO YES NO 44 4 Lung A LIVING 2012 1970 99268491-1400-4982-8aa4-7b8c3c815727 TCGA-44-A47A-01A-21D-A24C-01 TCGA-44-A47A-01A-21D-A24I-05 TCGA-44-A47A-01 TCGA-44-A47A-01A-21D-A24C-01 99268491-1400-4982-8aa4-7b8c3c815727 TCGA-44-A47A-01 99268491-1400-4982-8aa4-7b8c3c815727 TCGA-44-A47A-01 76C3B1B4-0866-4179-B14B-3CF3C1A50242 99268491-1400-4982-8aa4-7b8c3c815727 TCGA-44-A47A-01A-21D-A24D-08 TCGA-44-A47A-01 +TCGA-44-A47B-01 TCGA-44-A47B-01 TCGA-44-A47B TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 79 R-Upper TCGA-44-A47B-F41746 TCGA-44-A47B -28869 0 287 73 0 NO NO Scheduled Follow-up Submission Complete Remission/Response 2013-3-27 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES NO NO NO 4.5 No M0 N0 T2a Stage IB A47B Preoperative TUMOR FREE 102 96 98 96 Complete Remission/Response YES NO R0 Primary Tumor 01 1965 7th NO YES NO 44 3 Lung LIVING 2012 1956 ec29675b-7379-44ee-981b-458fe9aca616 TCGA-44-A47B-01A-11D-A24C-01 TCGA-44-A47B-01A-11D-A24I-05 TCGA-44-A47B-01 TCGA-44-A47B-01A-11D-A24C-01 ec29675b-7379-44ee-981b-458fe9aca616 TCGA-44-A47B-01 ec29675b-7379-44ee-981b-458fe9aca616 TCGA-44-A47B-01 ec29675b-7379-44ee-981b-458fe9aca616 TCGA-44-A47B-01A-11D-A24D-08 TCGA-44-A47B-01 +TCGA-44-A47F-01 TCGA-44-A47F-01 TCGA-44-A47F TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 74 L-Upper TCGA-44-A47F-F41750 TCGA-44-A47F TCGA-44-A47F-01A -27122 169 0 337 0 Scheduled Follow-up Submission Complete Remission/Response 2013-3-27 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 370 NO 90 NO NO 20 false Yes, History of Prior Malignancy M0 N1 T2b Stage IIB TCGA-44-A47F.FC0E596B-733C-4532-AF0D-94B4A4ECB90C.pdf A47F Post-Adjuvant Therapy TUMOR FREE 127 84 122 81 Complete Remission/Response YES NO Primary Tumor 01 1987 7th YES YES NO 44 3 Lung A LIVING 2012 1955 TCGA-44-A47F-01A-11D-A24C-01 TCGA-44-A47F-01A-11D-A24I-05 TCGA-44-A47F-01A-11D-A24C-01 TCGA-44-A47F-01 19C331EE-AB15-4A56-961A-3CF1B3441CD8 TCGA-44-A47F-01A-11D-A24D-08 TCGA-44-A47F-01 +TCGA-44-A47G-01 TCGA-44-A47G-01 TCGA-44-A47G TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 73 R-Upper TCGA-44-A47G-F49023 TCGA-44-A47G TCGA-44-A47G-01A -26800 71 0 351 85 0 NO NO Scheduled Follow-up Submission Complete Remission/Response 2013-9-25 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 170 NO NO NO NO 28 false No M0 N0 T1 Stage IA TCGA-44-A47G.103CEC27-11AE-4E7F-88F4-530A94CB5278.pdf A47G Preoperative TUMOR FREE 113 100 Complete Remission/Response YES NO R0 Primary Tumor 01 2012 7th NO YES NO 44 4 Lung A LIVING 2012 1956 64f41383-d668-489a-9fe7-f00235015442 TCGA-44-A47G-01A-21D-A24C-01 TCGA-44-A47G-01A-21D-A24I-05 TCGA-44-A47G-01 TCGA-44-A47G-01A-21D-A24C-01 64f41383-d668-489a-9fe7-f00235015442 TCGA-44-A47G-01 64f41383-d668-489a-9fe7-f00235015442 TCGA-44-A47G-01 732A0498-D142-4529-AB3C-350AB6685787 64f41383-d668-489a-9fe7-f00235015442 TCGA-44-A47G-01A-21D-A24D-08 TCGA-44-A47G-01 +TCGA-44-A4SS-01 TCGA-44-A4SS-01 TCGA-44-A4SS TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 73 L-Upper TCGA-44-A4SS-F49165 TCGA-44-A4SS TCGA-44-A4SS-01A -26991 86 0 415 54 0 Scheduled Follow-up Submission Complete Remission/Response 2013-9-26 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 200 NO NO NO 90 false No M0 N0 T1b Stage IA TCGA-44-A4SS.12F30C5F-91F0-4ECD-A073-74CDEA147097.pdf A4SS Preoperative TUMOR FREE 88 71 86 69 Complete Remission/Response YES NO Primary Tumor 01 2012 7th NO YES NO 44 4 Lung A LIVING 2012 1952 89b3869c-aacb-4882-8aa0-4d9058cf5625 TCGA-44-A4SS-01A-11D-A24O-01 TCGA-44-A4SS-01A-11D-A24U-05 TCGA-44-A4SS-01 TCGA-44-A4SS-01A-11D-A24O-01 89b3869c-aacb-4882-8aa0-4d9058cf5625 TCGA-44-A4SS-01 89b3869c-aacb-4882-8aa0-4d9058cf5625 TCGA-44-A4SS-01 4E72B580-DC3A-45FB-BC7E-92C092EBE4F3 89b3869c-aacb-4882-8aa0-4d9058cf5625 TCGA-44-A4SS-01A-11D-A24P-08 TCGA-44-A4SS-01 +TCGA-44-A4SU-01 TCGA-44-A4SU-01 TCGA-44-A4SU TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung NO NO NO 67 R-Lower TCGA-44-A4SU-F49438 TCGA-44-A4SU TCGA-44-A4SU-01A -24820 55 409 0 76 260 74 3 Scheduled Follow-up Submission Progressive Disease 2013-10-3 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 140 NO NO Locoregional Recurrence YES 50 false No MX N0 T1a Stage IA TCGA-44-A4SU.14019D02-C4EC-4EA7-8AEB-255A14EB8D07.pdf A4SU Other WITH TUMOR 100 95 100 88 Complete Remission/Response Biopsy with Histologic Confirmation|Convincing Imaging YES NO R0 Primary Tumor 01 2011 7th NO YES NO 44 4 Lung A DECEASED 2012 1961 5f83fb8f-01d8-4deb-89d1-2fe9fb69255e TCGA-44-A4SU-01A-11D-A24O-01 TCGA-44-A4SU-01A-11D-A24U-05 TCGA-44-A4SU-01 TCGA-44-A4SU-01A-11D-A24O-01 5f83fb8f-01d8-4deb-89d1-2fe9fb69255e TCGA-44-A4SU-01 5f83fb8f-01d8-4deb-89d1-2fe9fb69255e TCGA-44-A4SU-01 B8370710-087D-4599-8996-C85308670455 5f83fb8f-01d8-4deb-89d1-2fe9fb69255e TCGA-44-A4SU-01A-11D-A24P-08 TCGA-44-A4SU-01 +TCGA-49-4486-01 2.1 0.72 none none none none N N none none none 0.35 Bronchioid none none none none none none none Lepidic predominant Adc Lepidic predominant Adc p.N181I 1 TCGA-49-4486-01 Iq C1-LUAD-enriched Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 7 cluster 4 mutation cluster 5 TCGA-49-4486 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung NO NO NO NO 72 R-Lower TCGA-49-4486-F58843 TCGA-49-4486 TCGA-49-4486-01A -26415 2318 0 2045 2 Scheduled Follow-up Submission Progressive Disease 2014-4-25 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 0.6 NO 60 1.6 NO Distant Metastasis YES 17.5 No M0 N0 T1 Stage IA TCGA-49-4486.30b3b92c-c810-4cf8-8342-f6e9d87bacfe.pdf 4486 Other WITH TUMOR 69 96 77 108 Complete Remission/Response Convincing Imaging YES NO R0 Primary Tumor 01 0.6 1967 3rd NO NO YES 49 3 Current reformed smoker for > 15 years Lung A DECEASED 1992 1932 TCGA-49-4486-01A-01D-1265-08 TCGA-49-4486-01A-01D-1265-08 0c0cfdfb-107b-4a20-bfda-7922453c041e TCGA-49-4486-01A-01D-1205-05 TCGA-49-4486-01 TCGA-49-4486-01A-01D-1204-01 TCGA-49-4486-01 TCGA-49-4486-01A-01D-1204-01 0c0cfdfb-107b-4a20-bfda-7922453c041e TCGA-49-4486-01A-21-2190-20 0c0cfdfb-107b-4a20-bfda-7922453c041e TCGA-49-4486-01 5c48d536-cfad-4535-a47d-08c42362aae5 0c0cfdfb-107b-4a20-bfda-7922453c041e TCGA-49-4486-01A-01D-1265-08 TCGA-49-4486-01 +TCGA-49-4486-11 2.1 0.72 none none none none N N none none none 0.35 Bronchioid none none none none none none none Lepidic predominant Adc Lepidic predominant Adc p.N181I 1 TCGA-49-4486-11 C1-LUAD-enriched mutation cluster 5 TCGA-49-4486 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung NO NO NO NO 72 R-Lower TCGA-49-4486-F58843 TCGA-49-4486 TCGA-49-4486-11A -26415 2318 0 2045 2 Scheduled Follow-up Submission Progressive Disease 2014-4-25 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 0.7 NO 60 1 NO Distant Metastasis YES 17.5 No M0 N0 T1 Stage IA 4486 Other WITH TUMOR 69 96 77 108 Complete Remission/Response Convincing Imaging YES NO R0 Solid Tissue Normal 11 0.2 1967 3rd NO NO YES 49 3 Current reformed smoker for > 15 years Lung A DECEASED 1992 1932 TCGA-49-4486-11A-01D-1205-05 +TCGA-49-4487-01 none none none none N N none none none Squamoid none none none none none none none Adenocarcinoma, NOS Adenocarcinoma, NOS p.E70* 0 TCGA-49-4487-01 High C1-LUAD-enriched cluster 3 Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 4 cluster 2 mutation cluster 11 TCGA-49-4487 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung NO YES YES YES 72 L-Upper TCGA-49-4487-F14693 TCGA-49-4487 TCGA-49-4487-01A 697 712 -26583 855 0 697 Scheduled Follow-up Submission Progressive Disease 2011-8-9 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.7 NO 0.9 YES 40 No M0 N0 T1 Stage IA TCGA-49-4487.c67031fc-f601-4bd2-b8fd-429a0664cc65.pdf 4487 WITH TUMOR Complete Remission/Response YES R0 Primary Tumor 01 0.3 3rd NO NO YES 49 4 Current reformed smoker for < or = 15 years Lung A DECEASED 1992 TCGA-49-4487-01A-21D-1855-08 TCGA-49-4487-01A-21D-1855-08 3cc3fe41-c7e8-4dcf-99a0-a488f7763e93 TCGA-49-4487-01A-21D-1854-01 TCGA-49-4487-01A-21D-1856-05 TCGA-49-4487-01 TCGA-49-4487-01A-21D-1854-01 3cc3fe41-c7e8-4dcf-99a0-a488f7763e93 TCGA-49-4487-01 TCGA-49-4487-01A-22-2190-20 3cc3fe41-c7e8-4dcf-99a0-a488f7763e93 TCGA-49-4487-01 09b4e4df-58df-4faa-8e4d-21bc4799f467 3cc3fe41-c7e8-4dcf-99a0-a488f7763e93 TCGA-49-4487-01A-21D-1855-08 TCGA-49-4487-01 +TCGA-49-4488-01 none none none none N N none none none Squamoid none none none none none none none Papillary predominant Adc Papillary predominant Adc none 0 TCGA-49-4488-01 BRCA-LUAD+ C1-LUAD-enriched cluster 1 Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 12 cluster 5 mutation c1uster 10 TCGA-49-4488 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung NO YES 74 L-Lower TCGA-49-4488-F14699 TCGA-49-4488 TCGA-49-4488-01A 690 -27332 869 0 634 Scheduled Follow-up Submission 2011-8-9 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 0.8 NO 2 YES No MX N0 T1 Stage IA TCGA-49-4488.1aae91ef-85c6-49f4-a76a-3f09d5cabcb5.pdf 4488 NO R0 Primary Tumor 01 0.4 1964 3rd NO NO YES 49 3 Current reformed smoker for > 15 years Lung A DECEASED 1992 TCGA-49-4488-01A-01D-1753-08 TCGA-49-4488-01A-01D-1753-08 94a591be-8b32-4680-b2ad-fc856f3f0c8e TCGA-49-4488-01A-01D-1752-01 TCGA-49-4488-01A-01D-1756-05 TCGA-49-4488-01 TCGA-49-4488-01A-01D-1752-01 94a591be-8b32-4680-b2ad-fc856f3f0c8e TCGA-49-4488-01 TCGA-49-4488-01A-21-2190-20 94a591be-8b32-4680-b2ad-fc856f3f0c8e TCGA-49-4488-01 911a1ccb-8917-4b18-a0a4-65def5a2160b 94a591be-8b32-4680-b2ad-fc856f3f0c8e TCGA-49-4488-01A-01D-1753-08 TCGA-49-4488-01 +TCGA-49-4488-11 none none none none N N none none none Squamoid none none none none none none none Papillary predominant Adc Papillary predominant Adc none 0 TCGA-49-4488-11 C1-LUAD-enriched mutation c1uster 10 TCGA-49-4488 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung NO YES 74 L-Lower TCGA-49-4488-F14699 TCGA-49-4488 TCGA-49-4488-11A 690 -27332 869 0 634 Scheduled Follow-up Submission 2011-8-9 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 0.8 NO 1 YES No MX N0 T1 Stage IA 4488 NO R0 Solid Tissue Normal 11 0.4 1964 3rd NO NO YES 49 3 Current reformed smoker for > 15 years Lung A DECEASED 1992 TCGA-49-4488-11A-01D-1756-05 +TCGA-49-4490-01 none none none none Y Y p.L858R none none Bronchioid none none none none none none none Micropapillary predom Adc Micropapillary predom Adc none 0 TCGA-49-4490-01 BRCA-LUAD+ C1-LUAD-enriched cluster 3 Cluster 5 LUAD-like c10 miRNA cluster 4 cluster 2 mutation cluster 8 TCGA-49-4490 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 45 L-Upper TCGA-49-4490-F14703 TCGA-49-4490 TCGA-49-4490-01A -16634 385 0 Scheduled Follow-up Submission 2011-8-9 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.5 NO 0.5 NO 5 No M0 N2 T3 Stage IIIA TCGA-49-4490.d6ec6f67-0c16-4396-be41-aaa6868a6106.pdf 4490 WITH TUMOR YES Primary Tumor 01 0.5 4th YES NO YES 49 3 Current reformed smoker for > 15 years Lung A DECEASED 1993 TCGA-49-4490-01A-21D-1855-08 TCGA-49-4490-01A-21D-1855-08 5e45c9ab-f5fe-497b-b919-72b0d8dec83d TCGA-49-4490-01A-21D-1854-01 TCGA-49-4490-01A-21D-1856-05 TCGA-49-4490-01 TCGA-49-4490-01A-21D-1854-01 5e45c9ab-f5fe-497b-b919-72b0d8dec83d TCGA-49-4490-01 5e45c9ab-f5fe-497b-b919-72b0d8dec83d TCGA-49-4490-01 5e45c9ab-f5fe-497b-b919-72b0d8dec83d TCGA-49-4490-01A-21D-1855-08 TCGA-49-4490-01 +TCGA-49-4490-11 none none none none Y Y p.L858R none none Bronchioid none none none none none none none Micropapillary predom Adc Micropapillary predom Adc none 0 TCGA-49-4490-11 C1-LUAD-enriched mutation cluster 8 TCGA-49-4490 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 45 L-Upper TCGA-49-4490-F14703 TCGA-49-4490 TCGA-49-4490-11A -16634 385 0 Scheduled Follow-up Submission 2011-8-9 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.9 NO 1.9 NO 5 No M0 N2 T3 Stage IIIA 4490 WITH TUMOR YES Solid Tissue Normal 11 0.6 4th YES NO YES 49 3 Current reformed smoker for > 15 years Lung A DECEASED 1993 d0e9dd65-ec79-4eee-802a-3f5438168136 d0e9dd65-ec79-4eee-802a-3f5438168136 d0e9dd65-ec79-4eee-802a-3f5438168136 d0e9dd65-ec79-4eee-802a-3f5438168136 +TCGA-49-4494-01 4.06 0.3 none none none none Y Y p.T790M, p.L858R none none 0.11 Magnoid none none none none none none none Acinar predominant Adc Acinar predominant Adc none 0 TCGA-49-4494-01 BRCA-LUAD+ C1-LUAD-enriched Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 4 cluster 4 mutation cluster 7 TCGA-49-4494 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 77 L-Upper TCGA-49-4494-F58840 TCGA-49-4494 TCGA-49-4494-01A -28387 1081 0 1 Scheduled Follow-up Submission 2014-4-25 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 1 NO 90 2.5 NO 50 No M0 N2 T3 Stage IIIA TCGA-49-4494.178a8648-f3cd-46ae-b90a-a45d6715c889.pdf 4494 Preoperative WITH TUMOR Complete Remission/Response NO R0 Primary Tumor 01 0.4 1955 4th NO YES 49 3 Current reformed smoker for > 15 years Lung A DECEASED 1995 1930 TCGA-49-4494-01A-01D-1265-08 TCGA-49-4494-01A-01D-1265-08 f338175a-fa1e-4b98-91e2-f4f0ee349e8e TCGA-49-4494-01A-01D-1205-05 TCGA-49-4494-01 TCGA-49-4494-01A-01D-1204-01 TCGA-49-4494-01 TCGA-49-4494-01A-01D-1204-01 f338175a-fa1e-4b98-91e2-f4f0ee349e8e TCGA-49-4494-01A-21-2190-20 f338175a-fa1e-4b98-91e2-f4f0ee349e8e TCGA-49-4494-01 4af63e96-7fed-4a64-bf86-cdeb2dff3877 f338175a-fa1e-4b98-91e2-f4f0ee349e8e TCGA-49-4494-01A-01D-1265-08 TCGA-49-4494-01 +TCGA-49-4494-11 4.06 0.3 none none none none Y Y p.T790M, p.L858R none none 0.11 Magnoid none none none none none none none Acinar predominant Adc Acinar predominant Adc none 0 TCGA-49-4494-11 C1-LUAD-enriched mutation cluster 7 TCGA-49-4494 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 77 L-Upper TCGA-49-4494-F58840 TCGA-49-4494 TCGA-49-4494-11A -28387 1081 0 1 Scheduled Follow-up Submission 2014-4-25 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.9 NO 90 0.9 NO 50 No M0 N2 T3 Stage IIIA 4494 Preoperative WITH TUMOR Complete Remission/Response NO R0 Solid Tissue Normal 11 0.4 1955 4th NO YES 49 3 Current reformed smoker for > 15 years Lung A DECEASED 1995 1930 TCGA-49-4494-11A-01D-1205-05 +TCGA-49-4501-01 2.85 0.43 none none none none Y Y p.ELREA746del none none 0.18 Bronchioid none none none none none none none Acinar predominant Adc Acinar predominant Adc none 0 TCGA-49-4501-01 BRCA-LUAD+ C1-LUAD-enriched Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 4 cluster 4 mutation cluster 14 TCGA-49-4501 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung YES NO NO 67 R-Upper TCGA-49-4501-F7014 TCGA-49-4501 -24817 1421 0 545 1 Progressive Disease 2011-2-2 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES YES Yes M0 N0 T2 Stage IB 4501 Other WITH TUMOR Complete Remission/Response NO R0 Primary Tumor 01 NO NO YES 49 1 Lifelong Non-smoker Lung DECEASED 1996 TCGA-49-4501-01A-01D-1265-08 TCGA-49-4501-01A-01D-1265-08 f118c45b-544d-45eb-8acd-a4c8cfcab3fd TCGA-49-4501-01A-01D-1205-05 TCGA-49-4501-01 TCGA-49-4501-01A-01D-1204-01 TCGA-49-4501-01 TCGA-49-4501-01A-01D-1204-01 f118c45b-544d-45eb-8acd-a4c8cfcab3fd TCGA-49-4501-01A-21-2190-20 f118c45b-544d-45eb-8acd-a4c8cfcab3fd TCGA-49-4501-01 b9a9cb4c-96f6-47a0-adc8-55d6a6604b92 f118c45b-544d-45eb-8acd-a4c8cfcab3fd TCGA-49-4501-01A-01D-1265-08 TCGA-49-4501-01 +TCGA-49-4501-11 2.85 0.43 none none none none Y Y p.ELREA746del none none 0.18 Bronchioid none none none none none none none Acinar predominant Adc Acinar predominant Adc none 0 TCGA-49-4501-11 C1-LUAD-enriched mutation cluster 14 TCGA-49-4501 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung YES NO NO 67 R-Upper TCGA-49-4501-F7014 TCGA-49-4501 TCGA-49-4501-11A -24817 1421 0 545 1 Progressive Disease 2011-2-2 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.9 NO 1.2 YES Yes M0 N0 T2 Stage IB 4501 Other WITH TUMOR Complete Remission/Response NO R0 Solid Tissue Normal 11 0.5 NO NO YES 49 1 Lifelong Non-smoker Lung A DECEASED 1996 TCGA-49-4501-11A-01D-1205-05 +TCGA-49-4505-01 none none none none Y Y none none none Bronchioid none p.G12C none none none none none Micropapillary predom Adc Micropapillary predom Adc none 0 TCGA-49-4505-01 BRCA-LUAD+ C1-LUAD-enriched Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 4 cluster 2 mutation cluster 11 TCGA-49-4505 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 61 R-Lower TCGA-49-4505-F58844 TCGA-49-4505 TCGA-49-4505-01A -22628 428 0 417 1 Scheduled Follow-up Submission 2014-4-25 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 0.7 NO 80 1.5 NO Distant Metastasis|New Primary Tumor YES 74 No M0 N1 T2 Stage IIB TCGA-49-4505.1733d182-08f0-4426-9227-9f008893ac14.pdf 4505 Preoperative WITH TUMOR Complete Remission/Response Convincing Imaging NO NO R0 Primary Tumor 01 0.3 1986 4th NO NO YES 49 4 Current reformed smoker for < or = 15 years Lung A DECEASED 1996 1949 TCGA-49-4505-01A-01D-1265-08 TCGA-49-4505-01A-01D-1265-08 cb06be5e-7c1d-49a4-9818-e1cbc52de9b6 TCGA-49-4505-01A-01D-1205-05 TCGA-49-4505-01 TCGA-49-4505-01A-01D-1204-01 TCGA-49-4505-01 TCGA-49-4505-01A-01D-1204-01 cb06be5e-7c1d-49a4-9818-e1cbc52de9b6 TCGA-49-4505-01A-21-2190-20 cb06be5e-7c1d-49a4-9818-e1cbc52de9b6 TCGA-49-4505-01 1cb8eafc-ac9d-4901-a44f-a2dbb6ee7f8b cb06be5e-7c1d-49a4-9818-e1cbc52de9b6 TCGA-49-4505-01A-01D-1931-08 TCGA-49-4505-01 +TCGA-49-4505-11 none none none none Y Y none none none Bronchioid none p.G12C none none none none none Micropapillary predom Adc Micropapillary predom Adc none 0 TCGA-49-4505-11 C1-LUAD-enriched mutation cluster 11 TCGA-49-4505 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 61 R-Lower TCGA-49-4505-F58844 TCGA-49-4505 TCGA-49-4505-11A -22628 428 0 417 1 Scheduled Follow-up Submission 2014-4-25 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 1.1 NO 80 1.3 NO Distant Metastasis|New Primary Tumor YES 74 No M0 N1 T2 Stage IIB 4505 Preoperative WITH TUMOR Complete Remission/Response Convincing Imaging NO NO R0 Solid Tissue Normal 11 0.4 1986 4th NO NO YES 49 4 Current reformed smoker for < or = 15 years Lung A DECEASED 1996 1949 TCGA-49-4505-11A-01D-1205-05 +TCGA-49-4506-01 2.69 0.25 none none none none N N none none none 0.12 Magnoid none none none none none none none Micropapillary predom Adc Micropapillary predom Adc none 0 TCGA-49-4506-01 BRCA-LUAD+ C1-LUAD-enriched Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 4 cluster 4 mutation c1uster 9 TCGA-49-4506 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung NO NO NO 68 L-Upper TCGA-49-4506-F58841 TCGA-49-4506 TCGA-49-4506-01A -25132 999 0 692 2 Scheduled Follow-up Submission Progressive Disease 2014-4-25 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.4 NO 70 Peripheral Lung 0.8 NO Locoregional Recurrence YES 100 No M0 N1 T2 Stage IIB TCGA-49-4506.09fb40cf-afb5-4dd5-a1b6-6261ef27b65e.pdf 4506 Post-Adjuvant Therapy TUMOR FREE Complete Remission/Response Convincing Imaging NO YES R1 Primary Tumor 01 0.3 4th YES NO YES 49 2 Current smoker Lung A DECEASED 1997 TCGA-49-4506-01A-01D-1265-08 TCGA-49-4506-01A-01D-1265-08 7ce14f35-6404-4adc-8929-4d5cd3c85697 TCGA-49-4506-01A-01D-1205-05 TCGA-49-4506-01 TCGA-49-4506-01A-01D-1204-01 TCGA-49-4506-01 TCGA-49-4506-01A-01D-1204-01 7ce14f35-6404-4adc-8929-4d5cd3c85697 TCGA-49-4506-01A-21-2190-20 7ce14f35-6404-4adc-8929-4d5cd3c85697 TCGA-49-4506-01 4a70d495-2aa6-41b6-a4b9-535fb1741255 7ce14f35-6404-4adc-8929-4d5cd3c85697 TCGA-49-4506-01A-01D-1265-08 TCGA-49-4506-01 +TCGA-49-4506-11 2.69 0.25 none none none none N N none none none 0.12 Magnoid none none none none none none none Micropapillary predom Adc Micropapillary predom Adc none 0 TCGA-49-4506-11 C1-LUAD-enriched mutation c1uster 9 TCGA-49-4506 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung NO NO NO 68 L-Upper TCGA-49-4506-F58841 TCGA-49-4506 TCGA-49-4506-11A -25132 999 0 692 2 Scheduled Follow-up Submission Progressive Disease 2014-4-25 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.6 NO 70 Peripheral Lung 2.4 NO Locoregional Recurrence YES 100 No M0 N1 T2 Stage IIB 4506 Post-Adjuvant Therapy TUMOR FREE Complete Remission/Response Convincing Imaging NO YES R1 Solid Tissue Normal 11 0.5 4th YES NO YES 49 2 Current smoker Lung A DECEASED 1997 TCGA-49-4506-11A-01D-1205-05 +TCGA-49-4507-01 2.7 0.35 none none none none N N none none none 0.16 Squamoid none none none none none none none Solid predominant Adc Solid predominant Adc p.D176A 0 TCGA-49-4507-01 High C1-LUAD-enriched Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 4 cluster 2 mutation c1uster 9 TCGA-49-4507 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung YES NO NO NO 73 R-Middle TCGA-49-4507-F7007 TCGA-49-4507 TCGA-49-4507-01A -26851 268 0 158 1 Progressive Disease 2011-2-2 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.0 8140/3 C34.0 YES 0.7 NO 1 YES 78 No M0 N1 T3 Stage IIIA TCGA-49-4507.e37717f8-8175-4f30-a817-ae365097804a.pdf 4507 Preoperative WITH TUMOR Progressive Disease YES R0 Primary Tumor 01 0.3 1991 YES NO YES 49 4 Current reformed smoker for < or = 15 years Lung A DECEASED 1997 TCGA-49-4507-01A-01D-1265-08 TCGA-49-4507-01A-01D-1265-08 15f243f1-05de-4750-9826-d80ddc97d739 TCGA-49-4507-01A-01D-1205-05 TCGA-49-4507-01 TCGA-49-4507-01A-01D-1204-01 TCGA-49-4507-01 TCGA-49-4507-01A-01D-1204-01 15f243f1-05de-4750-9826-d80ddc97d739 TCGA-49-4507-01A-21-2190-20 15f243f1-05de-4750-9826-d80ddc97d739 TCGA-49-4507-01 bb4a85f4-2747-4228-b9fe-cc9057b6d9bd 15f243f1-05de-4750-9826-d80ddc97d739 TCGA-49-4507-01A-01D-1265-08 TCGA-49-4507-01 +TCGA-49-4507-11 2.7 0.35 none none none none N N none none none 0.16 Squamoid none none none none none none none Solid predominant Adc Solid predominant Adc p.D176A 0 TCGA-49-4507-11 C1-LUAD-enriched mutation c1uster 9 TCGA-49-4507 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung YES NO NO NO 73 R-Middle TCGA-49-4507-F7007 TCGA-49-4507 TCGA-49-4507-11A -26851 268 0 158 1 Progressive Disease 2011-2-2 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.0 8140/3 C34.0 YES 1.1 NO 1.4 YES 78 No M0 N1 T3 Stage IIIA 4507 Preoperative WITH TUMOR Progressive Disease YES R0 Solid Tissue Normal 11 0.3 1991 YES NO YES 49 4 Current reformed smoker for < or = 15 years Lung A DECEASED 1997 TCGA-49-4507-11A-01D-1205-05 +TCGA-49-4510-01 3.39 0.63 none none none none Y Y none none none 0.22 Bronchioid none p.G12D none none none none none Papillary predominant Adc Papillary predominant Adc none 1 TCGA-49-4510-01 High C1-LUAD-enriched Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 7 cluster 4 mutation cluster 12 TCGA-49-4510 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung YES NO NO NO 51 L-Upper TCGA-49-4510-F58842 TCGA-49-4510 TCGA-49-4510-01A -18762 896 0 502 1 Scheduled Follow-up Submission Stable Disease 2014-4-25 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.7 NO 80 0.9 NO Distant Metastasis YES 55.5 No M0 N1 T2 Stage IIB TCGA-49-4510.de27239d-52ae-4979-979f-51e1ce7a43e8.pdf 4510 Post-Adjuvant Therapy WITH TUMOR Stable Disease Convincing Imaging NO YES R0 Primary Tumor 01 0.3 5th YES NO YES 49 2 Current smoker Lung A DECEASED 2001 TCGA-49-4510-01A-01D-1265-08 TCGA-49-4510-01A-01D-1265-08 3739f699-5aef-4152-a918-36dc138c432e TCGA-49-4510-01A-01D-1205-05 TCGA-49-4510-01 TCGA-49-4510-01A-01D-1204-01 TCGA-49-4510-01 TCGA-49-4510-01A-01D-1204-01 3739f699-5aef-4152-a918-36dc138c432e TCGA-49-4510-01A-21-2190-20 3739f699-5aef-4152-a918-36dc138c432e TCGA-49-4510-01 b44fa59f-1f6d-4dfb-a709-c9eeb73258d8 3739f699-5aef-4152-a918-36dc138c432e TCGA-49-4510-01A-01D-1265-08 TCGA-49-4510-01 +TCGA-49-4510-11 3.39 0.63 none none none none Y Y none none none 0.22 Bronchioid none p.G12D none none none none none Papillary predominant Adc Papillary predominant Adc none 1 TCGA-49-4510-11 C1-LUAD-enriched mutation cluster 12 TCGA-49-4510 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung YES NO NO NO 51 L-Upper TCGA-49-4510-F58842 TCGA-49-4510 TCGA-49-4510-11A -18762 896 0 502 1 Scheduled Follow-up Submission Stable Disease 2014-4-25 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 1 NO 80 1.3 NO Distant Metastasis YES 55.5 No M0 N1 T2 Stage IIB 4510 Post-Adjuvant Therapy WITH TUMOR Stable Disease Convincing Imaging NO YES R0 Solid Tissue Normal 11 0.4 5th YES NO YES 49 2 Current smoker Lung A DECEASED 2001 TCGA-49-4510-11A-01D-1205-05 +TCGA-49-4512-01 2.43 0.48 none none none none N N none none none 0.22 Bronchioid none none none none none none none Micropapillary predom Adc Micropapillary predom Adc none 0 TCGA-49-4512-01 High C1-LUAD-enriched cluster 3 Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 4 cluster 3 mutation c1uster 9 TCGA-49-4512 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 69 R-Middle TCGA-49-4512-F14815 TCGA-49-4512 -25502 905 0 157 Scheduled Follow-up Submission 2011-8-10 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.2 8140/3 C34.2 YES NO No MX N2 T2 Stage IIIA 4512 WITH TUMOR Progressive Disease NO R1 Primary Tumor 01 6th YES NO YES 49 1 Lifelong Non-smoker Lung DECEASED 2007 TCGA-49-4512-01A-21D-1855-08 TCGA-49-4512-01A-21D-1855-08 c1796b57-c5e4-45dd-931d-bf533dcb9e1a TCGA-49-4512-01A-21D-1854-01 TCGA-49-4512-01A-21D-1856-05 TCGA-49-4512-01 TCGA-49-4512-01A-21D-1854-01 c1796b57-c5e4-45dd-931d-bf533dcb9e1a TCGA-49-4512-01 TCGA-49-4512-01A-22-2190-20 c1796b57-c5e4-45dd-931d-bf533dcb9e1a TCGA-49-4512-01 bd1ea6e2-9316-47f3-b830-e1ddb98e3190 c1796b57-c5e4-45dd-931d-bf533dcb9e1a TCGA-49-4512-01A-21D-1855-08 TCGA-49-4512-01 +TCGA-49-4512-11 2.43 0.48 none none none none N N none none none 0.22 Bronchioid none none none none none none none Micropapillary predom Adc Micropapillary predom Adc none 0 TCGA-49-4512-11 C1-LUAD-enriched mutation c1uster 9 TCGA-49-4512 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 69 R-Middle TCGA-49-4512-F14815 TCGA-49-4512 TCGA-49-4512-11A -25502 905 0 157 Scheduled Follow-up Submission 2011-8-10 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.2 8140/3 C34.2 YES 0.7 NO 1 NO No MX N2 T2 Stage IIIA 4512 WITH TUMOR Progressive Disease NO R1 Solid Tissue Normal 11 0.3 6th YES NO YES 49 1 Lifelong Non-smoker Lung A DECEASED 2007 a137e804-ed82-4ad8-b25e-f9dcb71331bb a137e804-ed82-4ad8-b25e-f9dcb71331bb a137e804-ed82-4ad8-b25e-f9dcb71331bb a137e804-ed82-4ad8-b25e-f9dcb71331bb +TCGA-49-4514-01 1.79 0.34 none none none none N N none none none 0.18 Magnoid none none none none none none none Papillary predominant Adc Papillary predominant Adc none 0 TCGA-49-4514-01 High C1-LUAD-enriched cluster 3 Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 4 cluster 3 mutation cluster 2 TCGA-49-4514 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 79 L-Upper TCGA-49-4514-F14817 TCGA-49-4514 TCGA-49-4514-01A -28908 0 1700 Scheduled Follow-up Submission 2011-8-10 FEMALE Lung Papillary Adenocarcinoma No C34.1 8260/3 C34.1 YES 0.8 NO 1.4 NO 65 No M0 N0 T1 Stage IA TCGA-49-4514.1d1c3125-05a9-4939-a296-f98d8f977ab7.pdf 4514 TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 0.4 6th NO NO YES 49 3 Current reformed smoker for > 15 years Lung A LIVING 2007 TCGA-49-4514-01A-21D-1855-08 TCGA-49-4514-01A-21D-1855-08 4b05bcbb-08b4-4cf5-bd31-798490e00f94 TCGA-49-4514-01A-21D-1854-01 TCGA-49-4514-01A-21D-1856-05 TCGA-49-4514-01 TCGA-49-4514-01A-21D-1854-01 4b05bcbb-08b4-4cf5-bd31-798490e00f94 TCGA-49-4514-01 TCGA-49-4514-01A-22-2190-20 4b05bcbb-08b4-4cf5-bd31-798490e00f94 TCGA-49-4514-01 d035e74e-e911-44a9-a749-b51b50693629 4b05bcbb-08b4-4cf5-bd31-798490e00f94 TCGA-49-4514-01A-21D-1855-08 TCGA-49-4514-01 +TCGA-49-6742-01 3.59 0.49 none none none none N N none none none 0.18 Magnoid none none none none none none none Acinar predominant Adc Acinar predominant Adc none 0 TCGA-49-6742-01 High C1-LUAD-enriched cluster 3 Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 5 cluster 3 mutation cluster 12 TCGA-49-6742 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung YES NO NO YES 70 L-Upper TCGA-49-6742-F70579 TCGA-49-6742 TCGA-49-6742-01A 214 -25839 488 0 1678 214 3 Scheduled Follow-up Submission Progressive Disease 2015-2-25 MALE Mucinous (Colloid) Carcinoma No C34.1 8480/3 C34.1 YES 0.8 NO 40 YES NO 2.1 NO Distant Metastasis YES 10 Yes M0 N1 T2a Stage IIA TCGA-49-6742.d9853b55-fd00-4a20-8181-5f4dad297724.pdf 6742 Post-Adjuvant Therapy WITH TUMOR Progressive Disease NO R0 Primary Tumor 01 0.4 7th YES NO YES 49 3 Current reformed smoker for > 15 years Lung A DECEASED 2010 TCGA-49-6742-01A-11D-1855-08 TCGA-49-6742-01A-11D-1855-08 6e3df59e-5d52-4ced-b9dd-785df1952339 TCGA-49-6742-01A-11D-1854-01 TCGA-49-6742-01A-11D-1856-05 TCGA-49-6742-01 TCGA-49-6742-01A-11D-1854-01 6e3df59e-5d52-4ced-b9dd-785df1952339 TCGA-49-6742-01 TCGA-49-6742-01A-13-2191-20 6e3df59e-5d52-4ced-b9dd-785df1952339 TCGA-49-6742-01 0dc5925e-c817-4e3a-8f07-864c4ef1df6d 6e3df59e-5d52-4ced-b9dd-785df1952339 TCGA-49-6742-01A-11D-1855-08 TCGA-49-6742-01 +TCGA-49-6742-11 3.59 0.49 none none none none N N none none none 0.18 Magnoid none none none none none none none Acinar predominant Adc Acinar predominant Adc none 0 TCGA-49-6742-11 C1-LUAD-enriched mutation cluster 12 TCGA-49-6742 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung YES NO NO YES 70 L-Upper TCGA-49-6742-F70579 TCGA-49-6742 TCGA-49-6742-11A 214 -25839 488 0 1678 214 3 Scheduled Follow-up Submission Progressive Disease 2015-2-25 MALE Mucinous (Colloid) Carcinoma No C34.1 8480/3 C34.1 YES 0.7 NO 40 YES NO 1 NO Distant Metastasis YES 10 Yes M0 N1 T2a Stage IIA 6742 Post-Adjuvant Therapy WITH TUMOR Progressive Disease NO R0 Solid Tissue Normal 11 0.4 7th YES NO YES 49 3 Current reformed smoker for > 15 years Lung A DECEASED 2010 98056d94-9c31-4cf7-9b0f-5ebe06be01bd 98056d94-9c31-4cf7-9b0f-5ebe06be01bd TCGA-49-6742-11 98056d94-9c31-4cf7-9b0f-5ebe06be01bd 98056d94-9c31-4cf7-9b0f-5ebe06be01bd TCGA-49-6742-11 +TCGA-49-6743-01 TCGA-49-6743-01 Squamous C1-LUAD-enriched Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 4 mutation cluster 6 TCGA-49-6743 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 81 R-Upper TCGA-49-6743-F71136 TCGA-49-6743 TCGA-49-6743-01A -29807 0 1621 Scheduled Follow-up Submission Complete Remission/Response 2015-3-18 FEMALE Lung Clear Cell Adenocarcinoma No C34.1 8310/3 C34.1 YES 0.4 NO 100 1.2 NO NO 50 No MX N2 T1 Stage IIIA TCGA-49-6743.bc777cb6-8409-4a25-a22a-a398c28ef065.pdf 6743 TUMOR FREE Complete Remission/Response NO Primary Tumor 01 0.4 7th YES NO YES 49 4 Lung A LIVING 2010 TCGA-49-6743-01A-11D-1855-08 93f3f561-056a-4036-afcf-4662b45e6965 TCGA-49-6743-01A-11D-1854-01 TCGA-49-6743-01A-11D-1856-05 TCGA-49-6743-01 TCGA-49-6743-01A-11D-1854-01 93f3f561-056a-4036-afcf-4662b45e6965 TCGA-49-6743-01 TCGA-49-6743-01A-13-2191-20 93f3f561-056a-4036-afcf-4662b45e6965 TCGA-49-6743-01 f61515e3-5fb1-4313-be4a-53e182f95765 93f3f561-056a-4036-afcf-4662b45e6965 TCGA-49-6743-01A-11D-1855-08 TCGA-49-6743-01 +TCGA-49-6743-11 TCGA-49-6743-11 C1-LUAD-enriched mutation cluster 6 TCGA-49-6743 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 81 R-Upper TCGA-49-6743-F71136 TCGA-49-6743 TCGA-49-6743-11A -29807 0 1621 Scheduled Follow-up Submission Complete Remission/Response 2015-3-18 FEMALE Lung Clear Cell Adenocarcinoma No C34.1 8310/3 C34.1 YES 0.4 NO 100 1.5 NO NO 50 No MX N2 T1 Stage IIIA 6743 TUMOR FREE Complete Remission/Response NO Solid Tissue Normal 11 0.3 7th YES NO YES 49 4 Lung A LIVING 2010 6eb0d705-8faf-476a-8062-afb1f927db99 6eb0d705-8faf-476a-8062-afb1f927db99 TCGA-49-6743-11 6eb0d705-8faf-476a-8062-afb1f927db99 6eb0d705-8faf-476a-8062-afb1f927db99 TCGA-49-6743-11 +TCGA-49-6744-01 none none none none N N none none none Bronchioid none none none none none none none Papillary predominant Adc Papillary predominant Adc none 0 TCGA-49-6744-01 BRCA-LUAD+ C1-LUAD-enriched cluster 3 Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 4 cluster 2 mutation cluster 12 TCGA-49-6744 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung NO NO 64 L-Upper TCGA-49-6744-F70580 TCGA-49-6744 TCGA-49-6744-01A -23484 0 1683 1 Scheduled Follow-up Submission Complete Remission/Response 2015-2-25 FEMALE Lung Adenocarcinoma Mixed Subtype No C34.1 8255/3 C34.1 YES 0.5 NO 90 YES YES 2.1 NO NO 20 No MX N1 T2a Stage IIA TCGA-49-6744.9a6d2cc6-3d78-42ec-b747-74bb6e96d22b.pdf 6744 Post-Adjuvant Therapy TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 0.5 7th YES NO YES 49 4 Current reformed smoker for < or = 15 years Lung A LIVING 2010 TCGA-49-6744-01A-11D-1855-08 TCGA-49-6744-01A-11D-1855-08 d4b90c1d-0d33-4845-bec2-ceedcace2dcb TCGA-49-6744-01A-11D-1854-01 TCGA-49-6744-01A-11D-1856-05 TCGA-49-6744-01 TCGA-49-6744-01A-11D-1854-01 d4b90c1d-0d33-4845-bec2-ceedcace2dcb TCGA-49-6744-01 TCGA-49-6744-01A-13-2191-20 d4b90c1d-0d33-4845-bec2-ceedcace2dcb TCGA-49-6744-01 85fe0aa0-d71a-43d8-bbb9-100597b54b04 d4b90c1d-0d33-4845-bec2-ceedcace2dcb TCGA-49-6744-01A-11D-1855-08 TCGA-49-6744-01 +TCGA-49-6744-11 none none none none N N none none none Bronchioid none none none none none none none Papillary predominant Adc Papillary predominant Adc none 0 TCGA-49-6744-11 C1-LUAD-enriched mutation cluster 12 TCGA-49-6744 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung NO NO 64 L-Upper TCGA-49-6744-F70580 TCGA-49-6744 TCGA-49-6744-11A -23484 0 1683 1 Scheduled Follow-up Submission Complete Remission/Response 2015-2-25 FEMALE Lung Adenocarcinoma Mixed Subtype No C34.1 8255/3 C34.1 YES 0.9 NO 90 YES YES 1 NO NO 20 No MX N1 T2a Stage IIA 6744 Post-Adjuvant Therapy TUMOR FREE Complete Remission/Response NO R0 Solid Tissue Normal 11 0.4 7th YES NO YES 49 4 Current reformed smoker for < or = 15 years Lung A LIVING 2010 6abcb12e-73c2-491e-b9f3-4f61f8a4e854 6abcb12e-73c2-491e-b9f3-4f61f8a4e854 TCGA-49-6744-11 6abcb12e-73c2-491e-b9f3-4f61f8a4e854 6abcb12e-73c2-491e-b9f3-4f61f8a4e854 TCGA-49-6744-11 +TCGA-49-6745-01 2.16 0.34 none none none none N N none none none 0.17 Squamoid none none none p.D1010_splice none none none Micropapillary predom Adc Micropapillary predom Adc none 0 TCGA-49-6745-01 BRCA-LUAD+ C1-LUAD-enriched cluster 1 Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 4 cluster 2 mutation c1uster 9 TCGA-49-6745 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 82 L-Upper TCGA-49-6745-F15015 TCGA-49-6745 TCGA-49-6745-01A -30133 0 522 YES Scheduled Follow-up Submission 2011-8-11 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8260/3 C34.1 YES 0.7 NO YES NO 1.1 NO 20 Yes M0 N2 T2a Stage IIIA TCGA-49-6745.e291ad97-8658-435d-ae71-f0eb80bbb816.pdf 6745 TUMOR FREE NO Primary Tumor 01 0.3 7th YES NO YES 49 4 Current reformed smoker for < or = 15 years Lung A LIVING 2011 TCGA-49-6745-01A-11D-1855-08 TCGA-49-6745-01A-11D-1855-08 5969b621-a81e-42aa-ac40-4849df285060 TCGA-49-6745-01A-11D-1854-01 TCGA-49-6745-01A-11D-1856-05 TCGA-49-6745-01 TCGA-49-6745-01A-11D-1854-01 5969b621-a81e-42aa-ac40-4849df285060 TCGA-49-6745-01 TCGA-49-6745-01A-13-2191-20 5969b621-a81e-42aa-ac40-4849df285060 TCGA-49-6745-01 98d5f3f8-4922-47c7-9f92-946acd7e9db8 5969b621-a81e-42aa-ac40-4849df285060 TCGA-49-6745-01A-11D-1855-08 TCGA-49-6745-01 +TCGA-49-6745-11 2.16 0.34 none none none none N N none none none 0.17 Squamoid none none none p.D1010_splice none none none Micropapillary predom Adc Micropapillary predom Adc none 0 TCGA-49-6745-11 C1-LUAD-enriched mutation c1uster 9 TCGA-49-6745 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 82 L-Upper TCGA-49-6745-F15015 TCGA-49-6745 TCGA-49-6745-11A -30133 0 522 YES Scheduled Follow-up Submission 2011-8-11 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8260/3 C34.1 YES 0.7 NO YES NO 2.5 NO 20 Yes M0 N2 T2a Stage IIIA 6745 TUMOR FREE NO Solid Tissue Normal 11 0.4 7th YES NO YES 49 4 Current reformed smoker for < or = 15 years Lung A LIVING 2011 1b4bb160-191b-4796-8759-339b11fe386d TCGA-49-6745-11A-01D-1856-05 1b4bb160-191b-4796-8759-339b11fe386d TCGA-49-6745-11 1b4bb160-191b-4796-8759-339b11fe386d 1b4bb160-191b-4796-8759-339b11fe386d TCGA-49-6745-11 +TCGA-49-6761-01 3.13 0.29 none none none none Y Y none none none 0.12 Squamoid none p.G12D none p.S441C none none none Solid predominant Adc Solid predominant Adc none 0 TCGA-49-6761-01 BRCA-LUAD+ C1-LUAD-enriched cluster 1 Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 4 cluster 4 TCGA-49-6761 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung NO NO 68 R-Upper TCGA-49-6761-F22056 TCGA-49-6761 TCGA-49-6761-01A -24849 0 354 1 Scheduled Follow-up Submission 2012-2-23 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.7 NO 2.3 NO 50 Yes MX N2 T1 Stage IIIA TCGA-49-6761.73669cba-81ee-4215-a938-32556c5a211a.pdf 6761 TUMOR FREE 64 56 64 52 Complete Remission/Response YES NO R0 Primary Tumor 01 0.4 6th NO NO YES 49 4 Current reformed smoker for < or = 15 years Lung A LIVING 2009 TCGA-49-6761-01A-31D-1945-08 ed630d55-aca9-4b8e-9128-f89177733bd5 TCGA-49-6761-01A-31D-1943-01 TCGA-49-6761-01A-31D-1947-05 TCGA-49-6761-01 TCGA-49-6761-01A-31D-1943-01 ed630d55-aca9-4b8e-9128-f89177733bd5 TCGA-49-6761-01 TCGA-49-6761-01A-13-2191-20 ed630d55-aca9-4b8e-9128-f89177733bd5 TCGA-49-6761-01 2ca5d0c2-9d41-40ec-95d1-ea7fb78a728c ed630d55-aca9-4b8e-9128-f89177733bd5 TCGA-49-6761-01A-31D-1945-08 TCGA-49-6761-01 +TCGA-49-6761-11 3.13 0.29 none none none none Y Y none none none 0.12 Squamoid none p.G12D none p.S441C none none none Solid predominant Adc Solid predominant Adc none 0 TCGA-49-6761-11 C1-LUAD-enriched TCGA-49-6761 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung NO NO 68 R-Upper TCGA-49-6761-F22056 TCGA-49-6761 TCGA-49-6761-11A -24849 0 354 1 Scheduled Follow-up Submission 2012-2-23 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.6 NO 1.4 NO 50 Yes MX N2 T1 Stage IIIA 6761 TUMOR FREE 64 56 64 52 Complete Remission/Response YES NO R0 Solid Tissue Normal 11 0.4 6th NO NO YES 49 4 Current reformed smoker for < or = 15 years Lung A LIVING 2009 0ab304f8-0976-4637-8955-199e1782ab16 0ab304f8-0976-4637-8955-199e1782ab16 0ab304f8-0976-4637-8955-199e1782ab16 0ab304f8-0976-4637-8955-199e1782ab16 +TCGA-49-6767-01 3.32 0.43 none none none none N N none none p.P645T 0.17 Squamoid none none none none none none none Adenocarcinoma, NOS Adenocarcinoma, NOS none 0 TCGA-49-6767-01 High C1-LUAD-enriched cluster 2 Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 4 cluster 2 mutation cluster 8 TCGA-49-6767 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 46 R-Middle TCGA-49-6767-F58822 TCGA-49-6767 TCGA-49-6767-01A -17108 0 677 Scheduled Follow-up Submission 2014-4-24 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.2 8140/3 C34.2 YES 0.5 NO 1.5 NO 30 No MX N0 T3 Stage IIB TCGA-49-6767.8e8171dc-1baa-4b81-8e05-e15714135c1f.pdf 6767 TUMOR FREE NO R0 Primary Tumor 01 0.4 7th NO YES 49 2 Current smoker Lung A LIVING 2010 TCGA-49-6767-01A-11D-1855-08 TCGA-49-6767-01A-11D-1855-08 6a1b9b24-7377-4807-a876-282f9d948473 TCGA-49-6767-01A-11D-1854-01 TCGA-49-6767-01A-11D-1856-05 TCGA-49-6767-01 TCGA-49-6767-01A-11D-1854-01 6a1b9b24-7377-4807-a876-282f9d948473 TCGA-49-6767-01 TCGA-49-6767-01A-13-2191-20 6a1b9b24-7377-4807-a876-282f9d948473 TCGA-49-6767-01 dfc22417-6b41-42df-b53e-3fea9dadcd19 6a1b9b24-7377-4807-a876-282f9d948473 TCGA-49-6767-01A-11D-1855-08 TCGA-49-6767-01 +TCGA-49-AAQV-01 TCGA-49-AAQV-01 TCGA-49-AAQV TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 63 L-Lower TCGA-49-AAQV TCGA-49-AAQV-01A -23370 717 677 0 95.5 1 YES Exon 19 Deletion FISH YES 2014-6-13 FEMALE Lung Adenocarcinoma Mixed Subtype No C34.3 8255/3 C34.3 YES 160 NO 90 YES true No MX N1 T1 Stage II TCGA-49-AAQV.4FE4DC74-AF70-4F6C-B290-561808DD7FAE.pdf AAQV Preoperative TUMOR FREE 77.29 81.7 78.80 83.3 Complete Remission/Response YES NO R0 Primary Tumor 01 7th NO NO YES 49 1 Lung A DECEASED 2012 a32fcc87-5473-43d5-9e4b-bad78719156c TCGA-49-AAQV-01A-11D-A396-01 TCGA-49-AAQV-01A-11D-A398-05 TCGA-49-AAQV-01 TCGA-49-AAQV-01A-11D-A396-01 a32fcc87-5473-43d5-9e4b-bad78719156c TCGA-49-AAQV-01 a32fcc87-5473-43d5-9e4b-bad78719156c TCGA-49-AAQV-01 47586EA8-3CDE-46FC-A744-C016A1512530 a32fcc87-5473-43d5-9e4b-bad78719156c TCGA-49-AAQV-01 +TCGA-49-AAR0-01 TCGA-49-AAR0-01 TCGA-49-AAR0 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 57 R-Upper TCGA-49-AAR0-F71576 TCGA-49-AAR0 TCGA-49-AAR0-01A -20932 4298 0 4765 107 1 Scheduled Follow-up Submission Complete Remission/Response 2015-4-10 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 200 NO 90 NO NO 37 true Yes, History of Prior Malignancy MX N0 T1 Stage IA TCGA-49-AAR0.FCCE5D5B-6AB6-441F-9FBF-65B23060C95B.pdf AAR0 Preoperative TUMOR FREE 80 62.5 58.6 85.4 Complete Remission/Response YES NO R0 Primary Tumor 01 5th NO NO YES 49 2 Lung A LIVING 2002 a90eef12-777c-4a46-b90e-1385807269f8 TCGA-49-AAR0-01A-21D-A396-01 TCGA-49-AAR0-01A-21D-A398-05 TCGA-49-AAR0-01 TCGA-49-AAR0-01A-21D-A396-01 a90eef12-777c-4a46-b90e-1385807269f8 TCGA-49-AAR0-01 a90eef12-777c-4a46-b90e-1385807269f8 TCGA-49-AAR0-01 B4E492F9-250C-4D37-A2BA-DAED1B3E1CE5 a90eef12-777c-4a46-b90e-1385807269f8 TCGA-49-AAR0-01 +TCGA-49-AAR2-01 TCGA-49-AAR2-01 TCGA-49-AAR2 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 64 R-Lower TCGA-49-AAR2-F72094 TCGA-49-AAR2 TCGA-49-AAR2-01A -23479 1778 0 2224 105.8 1 Scheduled Follow-up Submission Complete Remission/Response 2015-4-10 MALE Lung Acinar Adenocarcinoma No C34.3 8550/3 C34.3 YES 130 NO 90 NO NO true No MX N0 T2 Stage IB TCGA-49-AAR2.70CAA6C7-B5DB-449A-A151-EED87511DEE5.pdf AAR2 Preoperative TUMOR FREE 78.2 79.5 78.6 80 Complete Remission/Response YES NO R0 Primary Tumor 01 2006 6th YES NO YES 49 4 Lung A LIVING 2009 1c03d9f5-e222-48b2-afeb-dfdeeff246b0 TCGA-49-AAR2-01A-11D-A396-01 TCGA-49-AAR2-01A-11D-A398-05 TCGA-49-AAR2-01 TCGA-49-AAR2-01A-11D-A396-01 1c03d9f5-e222-48b2-afeb-dfdeeff246b0 TCGA-49-AAR2-01 1c03d9f5-e222-48b2-afeb-dfdeeff246b0 TCGA-49-AAR2-01 E9AF6E9A-3091-4D3C-A127-1E06A54A8B06 1c03d9f5-e222-48b2-afeb-dfdeeff246b0 TCGA-49-AAR2-01 +TCGA-49-AAR3-01 TCGA-49-AAR3-01 TCGA-49-AAR3 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 69 R-Upper TCGA-49-AAR3-F70567 TCGA-49-AAR3 TCGA-49-AAR3-01A -25469 1927 0 1893 0 Scheduled Follow-up Submission Complete Remission/Response 2015-2-25 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 140 NO 100 NO NO true No MX N1 T2 Stage IIB TCGA-49-AAR3.75D3436D-1CF9-4DC9-97EE-B93E2D6A3049.pdf AAR3 Post-Adjuvant Therapy TUMOR FREE Complete Remission/Response NO NO R0 Primary Tumor 01 6th YES NO YES 49 Lung A LIVING 2008 5c7d1e9d-56b8-4e54-a573-f7bd91f2afee TCGA-49-AAR3-01A-11D-A40Z-01 TCGA-49-AAR3-01A-11D-A411-05 TCGA-49-AAR3-01 TCGA-49-AAR3-01A-11D-A40Z-01 5c7d1e9d-56b8-4e54-a573-f7bd91f2afee TCGA-49-AAR3-01 5c7d1e9d-56b8-4e54-a573-f7bd91f2afee TCGA-49-AAR3-01 9077B43C-C052-46E8-81D5-76043606D3DD 5c7d1e9d-56b8-4e54-a573-f7bd91f2afee TCGA-49-AAR3-01 +TCGA-49-AAR4-01 TCGA-49-AAR4-01 TCGA-49-AAR4 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 51 L-Upper TCGA-49-AAR4 TCGA-49-AAR4-01A -18939 2842 879 0 109.4 1 2014-6-18 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 200 NO 80 NO 35 true No MX N2 T2 Stage IIIA TCGA-49-AAR4.8982CE18-FA5A-4882-AAC4-F2AC6ED60C49.pdf AAR4 Preoperative WITH TUMOR 79.0 97.5 81.2 100.2 Stable Disease YES YES R0 Primary Tumor 01 6th YES NO YES 49 2 Lung A DECEASED 2006 653f5c38-8795-4ed9-8c4a-aaf5597eee8c TCGA-49-AAR4-01A-12D-A40Z-01 TCGA-49-AAR4-01A-12D-A411-05 TCGA-49-AAR4-01 TCGA-49-AAR4-01A-12D-A40Z-01 653f5c38-8795-4ed9-8c4a-aaf5597eee8c TCGA-49-AAR4-01 653f5c38-8795-4ed9-8c4a-aaf5597eee8c TCGA-49-AAR4-01 BA9C8A6D-1668-43BB-8DDE-B9ABF414EF6F 653f5c38-8795-4ed9-8c4a-aaf5597eee8c TCGA-49-AAR4-01 +TCGA-49-AAR9-01 TCGA-49-AAR9-01 TCGA-49-AAR9 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 61 Other (please specify) ALL 3 LOBES OF RT Lung TCGA-49-AAR9 TCGA-49-AAR9-01A -22510 5308 260 0 1 2014-6-18 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.9 YES 260 NO 80 NO true No MX N0 T3 Stage IIB TCGA-49-AAR9.F2AB65ED-823F-446C-92CB-5F9DAB58D37A.pdf AAR9 Preoperative WITH TUMOR Progressive Disease NO NO R0 Primary Tumor 01 5th NO NO YES 49 2 Lung A DECEASED 1999 c3a5aa9d-5b4d-4c3a-9e4c-656f174e2a6e TCGA-49-AAR9-01A-21D-A40Z-01 TCGA-49-AAR9-01A-21D-A411-05 TCGA-49-AAR9-01 TCGA-49-AAR9-01A-21D-A40Z-01 c3a5aa9d-5b4d-4c3a-9e4c-656f174e2a6e TCGA-49-AAR9-01 c3a5aa9d-5b4d-4c3a-9e4c-656f174e2a6e TCGA-49-AAR9-01 707CCED4-A991-406A-A988-BDFF030229CD c3a5aa9d-5b4d-4c3a-9e4c-656f174e2a6e TCGA-49-AAR9-01 +TCGA-49-AARE-01 TCGA-49-AARE-01 TCGA-49-AARE TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 51 R-Upper TCGA-49-AARE TCGA-49-AARE-01A -18893 5455 1229 0 107.2 1 2014-6-19 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 180 NO 90 YES 15 true No MX N0 T1 Stage IA TCGA-49-AARE.D15D2040-F72D-4913-92FC-54741F573151.pdf AARE Other WITH TUMOR 55.2 41.7 81 61.2 Complete Remission/Response YES NO R0 Primary Tumor 01 1995 5th NO NO YES 49 4 Lung A DECEASED 1999 1980 fb2e021f-ebae-4f7a-a072-d14046a20ce6 TCGA-49-AARE-01A-11D-A40Z-01 TCGA-49-AARE-01A-11D-A411-05 TCGA-49-AARE-01 TCGA-49-AARE-01A-11D-A40Z-01 fb2e021f-ebae-4f7a-a072-d14046a20ce6 TCGA-49-AARE-01 fb2e021f-ebae-4f7a-a072-d14046a20ce6 TCGA-49-AARE-01 E4D9E21A-5783-4975-89BE-D1C38B197B9E fb2e021f-ebae-4f7a-a072-d14046a20ce6 TCGA-49-AARE-01 +TCGA-49-AARN-01 TCGA-49-AARN-01 TCGA-49-AARN TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 56 R-Lower TCGA-49-AARN TCGA-49-AARN-01A -20605 4882 1135 0 110.6 1 2014-6-19 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 210 NO 90 true Yes, History of Synchronous/Bilateral Malignancy MX N0 T1 Stage IA TCGA-49-AARN.19256999-CAE3-4D04-AA1C-758B4E80BCD1.pdf AARN Preoperative 85.9 101.1 80.2 94.4 Complete Remission/Response YES NO R0 Primary Tumor 01 5th NO NO YES 49 5 Lung A DECEASED 2000 b58ffa95-5a94-4b18-b149-8a0095c53bb8 TCGA-49-AARN-01A-21D-A40Z-01 TCGA-49-AARN-01A-21D-A411-05 TCGA-49-AARN-01 TCGA-49-AARN-01A-21D-A40Z-01 b58ffa95-5a94-4b18-b149-8a0095c53bb8 TCGA-49-AARN-01 b58ffa95-5a94-4b18-b149-8a0095c53bb8 TCGA-49-AARN-01 C59E1214-7FB0-490B-9B96-5AF733AAE26B b58ffa95-5a94-4b18-b149-8a0095c53bb8 TCGA-49-AARN-01 +TCGA-49-AARO-01 TCGA-49-AARO-01 TCGA-49-AARO TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung YES NO NO 39 L-Upper TCGA-49-AARO-F70571 TCGA-49-AARO TCGA-49-AARO-01A -14527 3838 0 3759 3521 103.3 3 Scheduled Follow-up Submission Stable Disease 2015-2-25 FEMALE Lung Papillary Adenocarcinoma No C34.1 8260/3 C34.1 YES 170 NO 40 NO Locoregional Recurrence YES true No MX N0 T1a Stage IA TCGA-49-AARO.5E71C822-2014-431A-B050-102C4A845321.pdf AARO Post-Adjuvant Therapy WITH TUMOR 84.4 83.9 83.6 83.0 Complete Remission/Response Convincing Imaging YES YES R0 Primary Tumor 01 6th YES NO YES 49 2 Lung A LIVING 2003 51122947-fc8a-4285-b83a-4d5eabbe7c87 TCGA-49-AARO-01A-12D-A40Z-01 TCGA-49-AARO-01A-12D-A411-05 TCGA-49-AARO-01 TCGA-49-AARO-01A-12D-A40Z-01 51122947-fc8a-4285-b83a-4d5eabbe7c87 TCGA-49-AARO-01 51122947-fc8a-4285-b83a-4d5eabbe7c87 TCGA-49-AARO-01 6B18D7BD-A031-41F3-9286-44C0FAB9088B 51122947-fc8a-4285-b83a-4d5eabbe7c87 TCGA-49-AARO-01 +TCGA-49-AARQ-01 TCGA-49-AARQ-01 TCGA-49-AARQ TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 41 R-Upper TCGA-49-AARQ-F72093 TCGA-49-AARQ TCGA-49-AARQ-01A -15065 6271 0 6732 99.9 1 Scheduled Follow-up Submission Complete Remission/Response 2015-4-10 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 60 NO 90 NO NO 60 true No MX N0 T2 Stage I TCGA-49-AARQ.9A745E52-5B6D-4209-9A05-E30D8CE40A3E.pdf AARQ Preoperative TUMOR FREE 56.8 56.1 83.2 82.2 Complete Remission/Response YES NO R0 Primary Tumor 01 2007 4th NO NO YES 49 4 Lung A LIVING 1996 1ec3463c-c56d-4b93-9873-1e7b9d2d4fc4 TCGA-49-AARQ-01A-11D-A40Z-01 TCGA-49-AARQ-01A-11D-A411-05 TCGA-49-AARQ-01 TCGA-49-AARQ-01A-11D-A40Z-01 1ec3463c-c56d-4b93-9873-1e7b9d2d4fc4 TCGA-49-AARQ-01 1ec3463c-c56d-4b93-9873-1e7b9d2d4fc4 TCGA-49-AARQ-01 1ec3463c-c56d-4b93-9873-1e7b9d2d4fc4 TCGA-49-AARQ-01 +TCGA-49-AARR-01 TCGA-49-AARR-01 TCGA-49-AARR TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung NO NO NO 68 L-Upper TCGA-49-AARR-F70574 TCGA-49-AARR TCGA-49-AARR-01A -24942 4634 0 4992 4812 103.5 1 Scheduled Follow-up Submission Stable Disease 2015-2-25 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 170 NO 80 NO Locoregional Recurrence YES true No MX N0 T1 Stage IA TCGA-49-AARR.55998E02-5285-4E6F-8BB8-7DB57F18C0D2.pdf AARR Preoperative WITH TUMOR 76.3 78.8 77.8 80.3 Complete Remission/Response Convincing Imaging YES NO R0 Primary Tumor 01 1987 5th NO NO YES 49 3 Lung A LIVING 2001 367f7d8f-d11e-4cec-8df8-ab4e23e1ed0c TCGA-49-AARR-01A-11D-A40Z-01 TCGA-49-AARR-01A-11D-A411-05 TCGA-49-AARR-01 TCGA-49-AARR-01A-11D-A40Z-01 367f7d8f-d11e-4cec-8df8-ab4e23e1ed0c TCGA-49-AARR-01 367f7d8f-d11e-4cec-8df8-ab4e23e1ed0c TCGA-49-AARR-01 179D0CD8-D62D-48A0-A3E5-8979901BA6A0 367f7d8f-d11e-4cec-8df8-ab4e23e1ed0c TCGA-49-AARR-01 +TCGA-4B-A93V-01 TCGA-4B-A93V-01 TCGA-4B-A93V TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung NO YES NO NO 52 R-Lower TCGA-4B-A93V-F67919 TCGA-4B-A93V TCGA-4B-A93V-01A -19035 84 300 0 254 251 0 Additional New Tumor Event Progressive Disease 2014-11-12 FEMALE Lung Adenocarcinoma Mixed Subtype No C34.3 8140/3 C34.3 YES 400 NO 0 Peripheral Lung YES Distant Metastasis YES 30 true No M0 N0 T1b Stage IA TCGA-4B-A93V.3723B92A-EFB6-4239-9D26-B88AF56252CE.pdf A93V Post-Adjuvant Therapy WITH TUMOR Progressive Disease Convincing Imaging NO YES R0 Primary Tumor 01 2013 7th NO YES NO 4B 4 Lung A DECEASED 2013 1984 924c4803-0337-4423-ab6c-7aa43a5f7874 TCGA-4B-A93V-01A-11D-A396-01 TCGA-4B-A93V-01A-11D-A398-05 TCGA-4B-A93V-01 TCGA-4B-A93V-01A-11D-A396-01 924c4803-0337-4423-ab6c-7aa43a5f7874 TCGA-4B-A93V-01 924c4803-0337-4423-ab6c-7aa43a5f7874 TCGA-4B-A93V-01 B6DF0BDD-E000-4495-8C89-00F2498DEC5D 924c4803-0337-4423-ab6c-7aa43a5f7874 TCGA-4B-A93V-01 +TCGA-50-5044-01 2.03 0.21 none p.D594H none none N Y none none none 0.1 Squamoid none none none none none p.E542K none Adenocarcinoma, NOS Adenocarcinoma, NOS none 0 TCGA-50-5044-01 Iq C1-LUAD-enriched cluster 2 Cluster 5 KIRC-like c1 LUAD-like c10 miRNA cluster 4 cluster 2 mutation cluster 14 TCGA-50-5044 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung YES YES NO NO 72 R-Lower TCGA-50-5044-F31976 TCGA-50-5044 -26567 624 0 483 Scheduled Follow-up Submission Progressive Disease 2012-5-14 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES NO Distant Metastasis YES No M0 N1 T4 Stage IIIB 5044 WITH TUMOR Progressive Disease Convincing Imaging YES Primary Tumor 01 5th NO NO YES 50 Lung DECEASED 2002 TCGA-50-5044-01A-21D-1855-08 TCGA-50-5044-01A-21D-1855-08 dac01b76-c2a3-4041-b704-97f1afc2c4d3 TCGA-50-5044-01A-21D-1854-01 TCGA-50-5044-01A-21D-1856-05 TCGA-50-5044-01 TCGA-50-5044-01A-21D-1854-01 dac01b76-c2a3-4041-b704-97f1afc2c4d3 TCGA-50-5044-01 TCGA-50-5044-01A-31-2190-20 dac01b76-c2a3-4041-b704-97f1afc2c4d3 TCGA-50-5044-01 fee0d27e-2ada-467b-b39e-e1ed30a27a9b dac01b76-c2a3-4041-b704-97f1afc2c4d3 TCGA-50-5044-01A-21D-1855-08 TCGA-50-5044-01 +TCGA-50-5045-01 TCGA-50-5045-01 BRCA-LUAD+ C1-LUAD-enriched Cluster 5 squamous c3 miRNA cluster 4 mutation cluster 5 TCGA-50-5045 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung YES YES NO 57 R-Lower TCGA-50-5045-F32015 TCGA-50-5045 TCGA-50-5045-01A -20961 2174 0 1433 Scheduled Follow-up Submission Progressive Disease 2012-5-15 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 1.5 NO 1.8 NO Locoregional Recurrence YES No M0 N1 T2 [Discrepancy] TCGA-50-5045.1d5c2f0f-4203-4db9-b63c-b6d80d04207e.pdf 5045 WITH TUMOR Progressive Disease Biopsy with Histologic Confirmation YES Primary Tumor 01 0.4 6th NO YES 50 Lung A DECEASED 2004 TCGA-50-5045-01A-01D-1625-08 7a4e94fa-09fb-4483-8816-f3ff2f1b2a6f TCGA-50-5045-01A-01D-1624-01 TCGA-50-5045-01A-01D-1626-05 TCGA-50-5045-01 TCGA-50-5045-01A-01D-1624-01 7a4e94fa-09fb-4483-8816-f3ff2f1b2a6f TCGA-50-5045-01 TCGA-50-5045-01A-31-2190-20 7a4e94fa-09fb-4483-8816-f3ff2f1b2a6f TCGA-50-5045-01 f5230fa4-0c05-484a-a17b-debebbcab1f4 7a4e94fa-09fb-4483-8816-f3ff2f1b2a6f TCGA-50-5045-01A-01D-1625-08 TCGA-50-5045-01 +TCGA-50-5049-01 none none none none N N none none p.Q1126* Squamoid none none none none none none p.D551N Acinar predominant Adc Acinar predominant Adc none 0 TCGA-50-5049-01 High C1-LUAD-enriched cluster 2 Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 4 cluster 4 mutation cluster 11 TCGA-50-5049 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung NO YES NO 70 R-Upper TCGA-50-5049-F70448 TCGA-50-5049 TCGA-50-5049-01A -25577 0 3094 2544 YES Scheduled Follow-up Submission 2015-2-16 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 1.5 NO YES NO 2 NO Locoregional Recurrence YES No M0 N0 T2 Stage IA TCGA-50-5049.3d60a219-3c2c-4e2a-ab29-5d61cd31478b.pdf 5049 WITH TUMOR Progressive Disease Convincing Imaging NO YES Primary Tumor 01 0.3 6th NO NO YES 50 Lung A LIVING 2006 TCGA-50-5049-01A-01D-1625-08 TCGA-50-5049-01A-01D-1625-08 299d2ad8-b54d-4ddb-b6c5-b80d8baf39f2 TCGA-50-5049-01A-01D-1624-01 TCGA-50-5049-01A-01D-1626-05 TCGA-50-5049-01 TCGA-50-5049-01A-01D-1624-01 299d2ad8-b54d-4ddb-b6c5-b80d8baf39f2 TCGA-50-5049-01 TCGA-50-5049-01A-21-2190-20 299d2ad8-b54d-4ddb-b6c5-b80d8baf39f2 TCGA-50-5049-01 db4fab65-7a1b-4386-b755-35ff900b9ca8 299d2ad8-b54d-4ddb-b6c5-b80d8baf39f2 TCGA-50-5049-01A-01D-1625-08 TCGA-50-5049-01 +TCGA-50-5051-01 2.99 0.59 none none none none Y Y none none none 0.23 Magnoid none p.G12C none none none none none Adenocarcinoma, NOS Adenocarcinoma, NOS none 0 TCGA-50-5051-01 High C1-LUAD-enriched cluster 2 Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 4 cluster 2 mutation cluster 12 TCGA-50-5051 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung NO NO NO NO 42 L-Upper TCGA-50-5051-F32019 TCGA-50-5051 TCGA-50-5051-01A -15585 478 0 455 184 YES Scheduled Follow-up Submission Progressive Disease 2012-5-15 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 1 NO YES YES Other 1.2 NO Distant Metastasis YES 30 No M0 N2 T2 Stage IIIA TCGA-50-5051.ff5f5187-c4da-482c-b6fe-cbde5c820a80.pdf 5051 WITH TUMOR Progressive Disease Convincing Imaging YES R0 Primary Tumor 01 0.4 2006 6th YES NO YES 50 4 Current reformed smoker for < or = 15 years Lung A DECEASED 2007 TCGA-50-5051-01A-21D-1855-08 TCGA-50-5051-01A-21D-1855-08 ebbb3b0d-c092-4af4-919a-25fcb49eac69 TCGA-50-5051-01A-21D-1854-01 TCGA-50-5051-01A-21D-1856-05 TCGA-50-5051-01 TCGA-50-5051-01A-21D-1854-01 ebbb3b0d-c092-4af4-919a-25fcb49eac69 TCGA-50-5051-01 TCGA-50-5051-01A-22-2190-20 ebbb3b0d-c092-4af4-919a-25fcb49eac69 TCGA-50-5051-01 55ebc73e-1a0b-4e52-872a-e0d8a1e13226 ebbb3b0d-c092-4af4-919a-25fcb49eac69 TCGA-50-5051-01A-21D-1855-08 TCGA-50-5051-01 +TCGA-50-5055-01 none none none none N N none none none Bronchioid none none none none none none none Acinar predominant Adc Acinar predominant Adc none 0 TCGA-50-5055-01 GBM C10-GBM cluster 3 Low purity c2 LUAD-like c10 miRNA cluster 5 cluster 4 mutation c1uster 9 TCGA-50-5055 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung YES YES YES NO 79 L-Lower TCGA-50-5055-F32023 TCGA-50-5055 TCGA-50-5055-01A 792 -28988 1830 0 785 771 YES Scheduled Follow-up Submission Progressive Disease 2012-5-15 FEMALE Lung Adenocarcinoma Mixed Subtype No C34.3 8255/3 C34.3 YES 1.5 NO YES NO 1.9 NO Locoregional Recurrence|Distant Metastasis YES No M0 N1 T1 Stage IIA TCGA-50-5055.847a0c64-cd3e-4a99-a6f7-b4ba1636ada1.pdf 5055 WITH TUMOR Stable Disease Biopsy with Histologic Confirmation|Convincing Imaging NO R0 Primary Tumor 01 0.1 6th NO NO YES 50 Lung A DECEASED 2008 TCGA-50-5055-01A-01D-1625-08 TCGA-50-5055-01A-01D-1625-08 15be34fa-d099-42d0-98ca-e66c83a16790 TCGA-50-5055-01A-01D-1624-01 TCGA-50-5055-01A-01D-1626-05 TCGA-50-5055-01 TCGA-50-5055-01A-01D-1624-01 15be34fa-d099-42d0-98ca-e66c83a16790 TCGA-50-5055-01 15be34fa-d099-42d0-98ca-e66c83a16790 TCGA-50-5055-01 15be34fa-d099-42d0-98ca-e66c83a16790 TCGA-50-5055-01A-01D-1625-08 TCGA-50-5055-01 +TCGA-50-5066-01 TCGA-50-5066-01 BRCA-LUAD+ C1-LUAD-enriched Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 4 mutation cluster 13 TCGA-50-5066 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 72 R-Upper TCGA-50-5066-F70450 TCGA-50-5066 TCGA-50-5066-01A -26385 0 1442 YES YES Scheduled Follow-up Submission Complete Remission/Response 2015-2-16 MALE Lung Adenocarcinoma Mixed Subtype No C34.1 8255/3 C34.1 YES 1 NO YES NO 1.5 NO NO No M0 N0 T2 Stage IB TCGA-50-5066.E00CB449-F980-4829-A006-32706F041E94.pdf 5066 TUMOR FREE Complete Remission/Response NO NO R0 Primary Tumor 01 0.2 6th YES NO YES 50 1 Lung A LIVING 2009 TCGA-50-5066-01A-01D-1625-08 554a301f-fbc8-41f2-96e9-5da2ee943727 TCGA-50-5066-01A-01D-1624-01 TCGA-50-5066-01A-01D-1626-05 TCGA-50-5066-01 TCGA-50-5066-01A-01D-1624-01 554a301f-fbc8-41f2-96e9-5da2ee943727 TCGA-50-5066-01 TCGA-50-5066-01A-21-2190-20 554a301f-fbc8-41f2-96e9-5da2ee943727 TCGA-50-5066-01 125106f7-3b1d-4bd3-ab00-f8cc72798de9 554a301f-fbc8-41f2-96e9-5da2ee943727 TCGA-50-5066-01A-01D-1625-08 TCGA-50-5066-01 +TCGA-50-5066-02 TCGA-50-5066-02 C1-LUAD-enriched Cluster 5 LUAD-like c10 miRNA cluster 5 mutation cluster 13 TCGA-50-5066 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 72 R-Upper TCGA-50-5066-F70450 TCGA-50-5066 -26385 0 1442 YES YES Scheduled Follow-up Submission Complete Remission/Response 2015-2-16 MALE Lung Adenocarcinoma Mixed Subtype No C34.1 8255/3 C34.1 YES YES NO NO NO No M0 N0 T2 Stage IB 5066 TUMOR FREE Complete Remission/Response NO NO R0 Recurrent Tumor 02 6th YES NO YES 50 1 Lung LIVING 2009 f274e34b-e111-47e0-8fff-5c338d387d76 TCGA-50-5066-02A-11D-2087-05 f274e34b-e111-47e0-8fff-5c338d387d76 TCGA-50-5066-02 f274e34b-e111-47e0-8fff-5c338d387d76 f274e34b-e111-47e0-8fff-5c338d387d76 TCGA-50-5066-02A-11D-2107-08 TCGA-50-5066-02 +TCGA-50-5068-01 1.62 0.38 none none none none N N none none none 0.2 Squamoid none none none none none none none Acinar predominant Adc Acinar predominant Adc none 0 TCGA-50-5068-01 High C1-LUAD-enriched cluster 2 Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 4 cluster 2 mutation cluster 5 TCGA-50-5068 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung YES NO YES NO 59 R-Lower TCGA-50-5068-F32057 TCGA-50-5068 TCGA-50-5068-01A 686 -21728 1499 0 1499 686 Scheduled Follow-up Submission Progressive Disease 2012-5-16 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 1.3 NO 1.4 NO Distant Metastasis YES No MX N1 T2 Stage IIB TCGA-50-5068.d8025f22-0b42-4204-bc58-56fc727c71ac.pdf 5068 WITH TUMOR Progressive Disease Biopsy with Histologic Confirmation|Convincing Imaging NO Primary Tumor 01 0.3 6th YES NO YES 50 Lung A DECEASED 2003 TCGA-50-5068-01A-01D-1625-08 TCGA-50-5068-01A-01D-1625-08 10c6a96f-b119-43a8-8dfa-9af13bce53b9 TCGA-50-5068-01A-01D-1624-01 TCGA-50-5068-01A-01D-1626-05 TCGA-50-5068-01 TCGA-50-5068-01A-01D-1624-01 10c6a96f-b119-43a8-8dfa-9af13bce53b9 TCGA-50-5068-01 TCGA-50-5068-01A-21-2190-20 10c6a96f-b119-43a8-8dfa-9af13bce53b9 TCGA-50-5068-01 72359d96-a06f-4d72-8d58-009a5d06d25b 10c6a96f-b119-43a8-8dfa-9af13bce53b9 TCGA-50-5068-01A-01D-1625-08 TCGA-50-5068-01 +TCGA-50-5072-01 2.1 0.45 none none none none N N none none none 0.22 Magnoid none none none none none none none Solid predominant Adc Solid predominant Adc p.K97_splice 0 TCGA-50-5072-01 High C1-LUAD-enriched cluster 3 Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 5 cluster 3 mutation c1uster 9 TCGA-50-5072 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung NO YES NO 74 L-Upper TCGA-50-5072-F32059 TCGA-50-5072 TCGA-50-5072-01A -27036 250 0 246 213 YES YES Scheduled Follow-up Submission Progressive Disease 2012-5-16 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) Yes C34.1 8140/3 C34.1 YES 0.9 NO YES 1.2 NO Distant Metastasis YES 15 No M0 N2 T2 Stage IIIA TCGA-50-5072.0e998d45-ba74-4a11-8a14-e394299c9bba.pdf 5072 WITH TUMOR Progressive Disease Convincing Imaging NO YES Primary Tumor 01 0.3 1974 6th YES NO YES 50 3 Current reformed smoker for > 15 years Lung A DECEASED 2009 TCGA-50-5072-01A-21D-1855-08 TCGA-50-5072-01A-21D-1855-08 d27e254c-1ccb-4b13-97f3-48d1e427d130 TCGA-50-5072-01A-21D-1854-01 TCGA-50-5072-01A-21D-1856-05 TCGA-50-5072-01 TCGA-50-5072-01A-21D-1854-01 d27e254c-1ccb-4b13-97f3-48d1e427d130 TCGA-50-5072-01 TCGA-50-5072-01A-22-2190-20 d27e254c-1ccb-4b13-97f3-48d1e427d130 TCGA-50-5072-01 5c0a5c7e-afab-4817-8118-46a95f8a8ae9 d27e254c-1ccb-4b13-97f3-48d1e427d130 TCGA-50-5072-01A-21D-1855-08 TCGA-50-5072-01 +TCGA-50-5930-01 TCGA-50-5930-01 BRCA-LUAD+ C1-LUAD-enriched Cluster 5 squamous c3 miRNA cluster 4 mutation c1uster 9 TCGA-50-5930 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung NO YES NO 47 [Discrepancy] TCGA-50-5930-F32064 TCGA-50-5930 -17238 282 0 177 Scheduled Follow-up Submission Progressive Disease 2012-5-16 MALE Lung Adenocarcinoma Mixed Subtype No C34.3 8255/3 C34.3 YES NO Distant Metastasis YES No M0 N2 T2 Stage IIIA 5930 WITH TUMOR Progressive Disease Convincing Imaging YES Primary Tumor 01 5th YES NO YES 50 Lung DECEASED 2001 TCGA-50-5930-01A-11D-1753-08 ea55c131-97f8-49cc-a445-87523ce1f075 TCGA-50-5930-01A-11D-1752-01 TCGA-50-5930-01A-11D-1756-05 TCGA-50-5930-01 TCGA-50-5930-01A-11D-1752-01 ea55c131-97f8-49cc-a445-87523ce1f075 TCGA-50-5930-01 TCGA-50-5930-01A-31-2191-20 ea55c131-97f8-49cc-a445-87523ce1f075 TCGA-50-5930-01 d78804ea-2fb0-415f-9c69-0db95fcade3f ea55c131-97f8-49cc-a445-87523ce1f075 TCGA-50-5930-01A-11D-1753-08 TCGA-50-5930-01 +TCGA-50-5930-11 TCGA-50-5930-11 C1-LUAD-enriched mutation c1uster 9 TCGA-50-5930 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung NO YES NO 47 [Discrepancy] TCGA-50-5930-F32064 TCGA-50-5930 -17238 282 0 177 Scheduled Follow-up Submission Progressive Disease 2012-5-16 MALE Lung Adenocarcinoma Mixed Subtype No C34.3 8255/3 C34.3 YES NO Distant Metastasis YES No M0 N2 T2 Stage IIIA 5930 WITH TUMOR Progressive Disease Convincing Imaging YES Solid Tissue Normal 11 5th YES NO YES 50 Lung DECEASED 2001 c019f320-2e0e-4f00-a393-2e5717d64cc0 TCGA-50-5930-11A-01D-1756-05 c019f320-2e0e-4f00-a393-2e5717d64cc0 TCGA-50-5930-11 c019f320-2e0e-4f00-a393-2e5717d64cc0 c019f320-2e0e-4f00-a393-2e5717d64cc0 TCGA-50-5930-11 +TCGA-50-5931-01 3.68 0.76 none none none none N N none none none 0.23 Magnoid none none none none none none none Solid predominant Adc Solid predominant Adc none 0 TCGA-50-5931-01 Squamous C1-LUAD-enriched cluster 3 Cluster 5 squamous c3 RNA cluster 12 miRNA cluster 5 cluster 3 mutation cluster 2 TCGA-50-5931 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung NO NO NO 75 L-Upper TCGA-50-5931-F32067 TCGA-50-5931 TCGA-50-5931-01A -27733 434 0 267 425 Scheduled Follow-up Submission Progressive Disease 2012-5-16 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 1 NO Central Lung 1.7 NO Distant Metastasis YES 40 No M0 N0 T2 Stage IB TCGA-50-5931.396c0f5f-1b86-4aa9-88ef-ca9220f4ccf3.pdf 5931 WITH TUMOR Progressive Disease Convincing Imaging NO R0 Primary Tumor 01 0.3 5th NO NO YES 50 4 Lung A DECEASED 2001 TCGA-50-5931-01A-11D-1753-08 TCGA-50-5931-01A-11D-1753-08 e2a7336c-5262-433a-ad52-8834eaee2e1e TCGA-50-5931-01A-11D-1752-01 TCGA-50-5931-01A-11D-1756-05 TCGA-50-5931-01 TCGA-50-5931-01A-11D-1752-01 e2a7336c-5262-433a-ad52-8834eaee2e1e TCGA-50-5931-01 TCGA-50-5931-01A-31-2191-20 e2a7336c-5262-433a-ad52-8834eaee2e1e TCGA-50-5931-01 10e7fc5f-f750-4d81-8314-5efd5d7e0efa e2a7336c-5262-433a-ad52-8834eaee2e1e TCGA-50-5931-01A-11D-1753-08 TCGA-50-5931-01 +TCGA-50-5931-11 3.68 0.76 none none none none N N none none none 0.23 Magnoid none none none none none none none Solid predominant Adc Solid predominant Adc none 0 TCGA-50-5931-11 C1-LUAD-enriched mutation cluster 2 TCGA-50-5931 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung NO NO NO 75 L-Upper TCGA-50-5931-F32067 TCGA-50-5931 TCGA-50-5931-11A -27733 434 0 267 425 Scheduled Follow-up Submission Progressive Disease 2012-5-16 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 1 NO Central Lung 1.2 NO Distant Metastasis YES 40 No M0 N0 T2 Stage IB 5931 WITH TUMOR Progressive Disease Convincing Imaging NO R0 Solid Tissue Normal 11 0.3 5th NO NO YES 50 4 Lung A DECEASED 2001 4cc61cbe-fa79-499b-9fd5-9b454030154c TCGA-50-5931-11A-01D-1756-05 4cc61cbe-fa79-499b-9fd5-9b454030154c 4cc61cbe-fa79-499b-9fd5-9b454030154c 4cc61cbe-fa79-499b-9fd5-9b454030154c +TCGA-50-5932-01 1.8 0.85 none none none none Y Y none none none 0.46 Magnoid none p.G12C none none none none none Papillary predominant Adc Papillary predominant Adc p.N181Y 0 TCGA-50-5932-01 BRCA-LUAD+ C1-LUAD-enriched cluster 3 Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 4 cluster 1 mutation cluster 12 TCGA-50-5932 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung YES NO NO NO 75 R-Upper TCGA-50-5932-F32080 TCGA-50-5932 TCGA-50-5932-01A -27454 1235 0 1091 1090 Scheduled Follow-up Submission Progressive Disease 2012-5-16 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 1.3 NO Central Lung 1.4 NO Locoregional Recurrence YES Yes M0 N1 T2 Stage IIB TCGA-50-5932.d7713068-4d83-4242-bae2-8035c1ba9b8d.pdf 5932 WITH TUMOR Progressive Disease Biopsy with Histologic Confirmation|Convincing Imaging NO Primary Tumor 01 0.5 5th NO NO YES 50 Lung A DECEASED 2001 TCGA-50-5932-01A-11D-1753-08 TCGA-50-5932-01A-11D-1753-08 80032260-febc-4069-9897-e36cf1118e68 TCGA-50-5932-01A-11D-1752-01 TCGA-50-5932-01A-11D-1756-05 TCGA-50-5932-01 TCGA-50-5932-01A-11D-1752-01 80032260-febc-4069-9897-e36cf1118e68 TCGA-50-5932-01 TCGA-50-5932-01A-31-2191-20 80032260-febc-4069-9897-e36cf1118e68 TCGA-50-5932-01 3bffc9f0-f53c-4f65-bdfc-9100a4d15510 80032260-febc-4069-9897-e36cf1118e68 TCGA-50-5932-01A-11D-1753-08 TCGA-50-5932-01 +TCGA-50-5932-11 1.8 0.85 none none none none Y Y none none none 0.46 Magnoid none p.G12C none none none none none Papillary predominant Adc Papillary predominant Adc p.N181Y 0 TCGA-50-5932-11 C1-LUAD-enriched mutation cluster 12 TCGA-50-5932 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung YES NO NO NO 75 R-Upper TCGA-50-5932-F32080 TCGA-50-5932 TCGA-50-5932-11A -27454 1235 0 1091 1090 Scheduled Follow-up Submission Progressive Disease 2012-5-16 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 1.3 NO Central Lung 2.2 NO Locoregional Recurrence YES Yes M0 N1 T2 Stage IIB 5932 WITH TUMOR Progressive Disease Biopsy with Histologic Confirmation|Convincing Imaging NO Solid Tissue Normal 11 0.5 5th NO NO YES 50 Lung A DECEASED 2001 7284cc3a-d5a1-42b1-8b1a-89665c4bc35f TCGA-50-5932-11A-01D-1756-05 7284cc3a-d5a1-42b1-8b1a-89665c4bc35f TCGA-50-5932-11 7284cc3a-d5a1-42b1-8b1a-89665c4bc35f 7284cc3a-d5a1-42b1-8b1a-89665c4bc35f TCGA-50-5932-11 +TCGA-50-5933-01 2.78 0.3 none none none none N N none none none 0.13 Squamoid none none none p.C98F none none none Solid predominant Adc Solid predominant Adc none 0 TCGA-50-5933-01 High C1-LUAD-enriched cluster 1 Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 5 cluster 3 mutation cluster 11 TCGA-50-5933 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 72 L-Lower TCGA-50-5933-F32104 TCGA-50-5933 TCGA-50-5933-01A -26377 2393 0 2370 Scheduled Follow-up Submission Complete Remission/Response 2012-5-17 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 1 NO Central Lung 1.7 NO NO No M0 N2 T4 Stage IIIB TCGA-50-5933.68d471f3-43c0-44cf-97ce-003ff111c35c.pdf 5933 TUMOR FREE Complete Remission/Response YES Primary Tumor 01 0.5 5th YES NO YES 50 Lung A DECEASED 2001 TCGA-50-5933-01A-11D-1753-08 TCGA-50-5933-01A-11D-1753-08 51eae0de-8f16-4093-b42e-5c34c4768459 TCGA-50-5933-01A-11D-1752-01 TCGA-50-5933-01A-11D-1756-05 TCGA-50-5933-01 TCGA-50-5933-01A-11D-1752-01 51eae0de-8f16-4093-b42e-5c34c4768459 TCGA-50-5933-01 TCGA-50-5933-01A-31-2191-20 51eae0de-8f16-4093-b42e-5c34c4768459 TCGA-50-5933-01 47959745-d225-4df7-b32c-e66bc6db4f7d 51eae0de-8f16-4093-b42e-5c34c4768459 TCGA-50-5933-01A-11D-1753-08 TCGA-50-5933-01 +TCGA-50-5933-11 2.78 0.3 none none none none N N none none none 0.13 Squamoid none none none p.C98F none none none Solid predominant Adc Solid predominant Adc none 0 TCGA-50-5933-11 C1-LUAD-enriched mutation cluster 11 TCGA-50-5933 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 72 L-Lower TCGA-50-5933-F32104 TCGA-50-5933 -26377 2393 0 2370 Scheduled Follow-up Submission Complete Remission/Response 2012-5-17 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES Central Lung NO NO No M0 N2 T4 Stage IIIB 5933 TUMOR FREE Complete Remission/Response YES Solid Tissue Normal 11 5th YES NO YES 50 Lung DECEASED 2001 af24ffd8-4d43-4f7a-ae49-590814d00f39 TCGA-50-5933-11A-01D-1756-05 af24ffd8-4d43-4f7a-ae49-590814d00f39 TCGA-50-5933-11 af24ffd8-4d43-4f7a-ae49-590814d00f39 af24ffd8-4d43-4f7a-ae49-590814d00f39 TCGA-50-5933-11 +TCGA-50-5935-01 3.08 0.58 none none none none N N none none none 0.22 Bronchioid none none none none none none none Acinar predominant Adc Acinar predominant Adc none 0 TCGA-50-5935-01 BRCA-LUAD+ C1-LUAD-enriched cluster 2 Cluster 6 LUAD-like c10 miRNA cluster 4 cluster 5 mutation cluster 12 TCGA-50-5935 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung NO 86 L-Upper TCGA-50-5935-F32108 TCGA-50-5935 -31610 653 0 653 YES Other Scheduled Follow-up Submission Complete Remission/Response 2012-5-17 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES YES YES NO NO Yes M0 N0 T1 Stage IA 5935 TUMOR FREE Complete Remission/Response YES Primary Tumor 01 6th NO NO YES 50 Lung DECEASED 2006 TCGA-50-5935-01A-11D-1753-08 TCGA-50-5935-01A-11D-1753-08 bf999d4c-d1e6-4e8b-8aa3-becb7b734037 TCGA-50-5935-01A-11D-1752-01 TCGA-50-5935-01A-11D-1756-05 TCGA-50-5935-01 TCGA-50-5935-01A-11D-1752-01 bf999d4c-d1e6-4e8b-8aa3-becb7b734037 TCGA-50-5935-01 bf999d4c-d1e6-4e8b-8aa3-becb7b734037 TCGA-50-5935-01 bf999d4c-d1e6-4e8b-8aa3-becb7b734037 TCGA-50-5935-01A-11D-1753-08 TCGA-50-5935-01 +TCGA-50-5935-11 3.08 0.58 none none none none N N none none none 0.22 Bronchioid none none none none none none none Acinar predominant Adc Acinar predominant Adc none 0 TCGA-50-5935-11 C1-LUAD-enriched mutation cluster 12 TCGA-50-5935 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung NO 86 L-Upper TCGA-50-5935-F32108 TCGA-50-5935 TCGA-50-5935-11A -31610 653 0 653 YES Other Scheduled Follow-up Submission Complete Remission/Response 2012-5-17 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 1.1 NO YES YES 1.5 NO NO Yes M0 N0 T1 Stage IA 5935 TUMOR FREE Complete Remission/Response YES Solid Tissue Normal 11 0.3 6th NO NO YES 50 Lung A DECEASED 2006 c6722ce9-8824-4721-9e95-96e9b0b09066 TCGA-50-5935-11A-01D-1756-05 c6722ce9-8824-4721-9e95-96e9b0b09066 c6722ce9-8824-4721-9e95-96e9b0b09066 c6722ce9-8824-4721-9e95-96e9b0b09066 +TCGA-50-5936-01 3.25 0.43 none none none none N N none none none 0.17 Magnoid none none none none none none none Acinar predominant Adc Acinar predominant Adc none 0 TCGA-50-5936-01 Squamous C1-LUAD-enriched cluster 3 Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 4 cluster 2 mutation cluster 12 TCGA-50-5936 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung YES NO YES NO 58 R-Lower TCGA-50-5936-F32110 TCGA-50-5936 TCGA-50-5936-01A 177 -21238 257 0 150 YES Scheduled Follow-up Submission Progressive Disease 2012-5-17 MALE Mucinous (Colloid) Carcinoma No C34.30 8480/3 C34.3 YES 0.8 NO YES YES G12C 0.9 NO YES No M0 N2 T2 Stage IIIA TCGA-50-5936.8d30d2aa-bef2-4329-944b-99ad5c9d8fc6.pdf 5936 WITH TUMOR Progressive Disease Biopsy with Histologic Confirmation|Convincing Imaging NO Primary Tumor 01 0.3 6th NO NO YES 50 Lung A DECEASED 2007 TCGA-50-5936-01A-11D-1625-08 TCGA-50-5936-01A-11D-1625-08 3bb181ee-960f-488b-b04b-c2acb7cfb127 TCGA-50-5936-01A-11D-1624-01 TCGA-50-5936-01A-11D-1626-05 TCGA-50-5936-01 TCGA-50-5936-01A-11D-1624-01 3bb181ee-960f-488b-b04b-c2acb7cfb127 TCGA-50-5936-01 TCGA-50-5936-01A-31-2191-20 3bb181ee-960f-488b-b04b-c2acb7cfb127 TCGA-50-5936-01 321627c2-4c05-4e79-ab55-5fe72402662c 3bb181ee-960f-488b-b04b-c2acb7cfb127 TCGA-50-5936-01A-11D-1625-08 TCGA-50-5936-01 +TCGA-50-5936-11 3.25 0.43 none none none none N N none none none 0.17 Magnoid none none none none none none none Acinar predominant Adc Acinar predominant Adc none 0 TCGA-50-5936-11 C1-LUAD-enriched mutation cluster 12 TCGA-50-5936 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung YES NO YES NO 58 R-Lower TCGA-50-5936-F32110 TCGA-50-5936 TCGA-50-5936-11A 177 -21238 257 0 150 YES Scheduled Follow-up Submission Progressive Disease 2012-5-17 MALE Mucinous (Colloid) Carcinoma No C34.30 8480/3 C34.3 YES 1.4 NO YES YES G12C 2.2 NO YES No M0 N2 T2 Stage IIIA 5936 WITH TUMOR Progressive Disease Biopsy with Histologic Confirmation|Convincing Imaging NO Solid Tissue Normal 11 0.1 6th NO NO YES 50 Lung A DECEASED 2007 81e8d16b-1a9b-4156-a438-07d89807f652 TCGA-50-5936-11A-01D-1626-05 81e8d16b-1a9b-4156-a438-07d89807f652 81e8d16b-1a9b-4156-a438-07d89807f652 81e8d16b-1a9b-4156-a438-07d89807f652 +TCGA-50-5939-01 1.72 0.33 none none none none N N none none none 0.17 Squamoid none none none none none none none Solid predominant Adc Solid predominant Adc none 0 TCGA-50-5939-01 Squamous C1-LUAD-enriched cluster 3 Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 4 cluster 2 mutation cluster 5 TCGA-50-5939 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 85 R-Upper TCGA-50-5939-F32124 TCGA-50-5939 TCGA-50-5939-01A -31236 460 0 Scheduled Follow-up Submission Complete Remission/Response 2012-5-17 MALE Lung Adenocarcinoma Mixed Subtype No C34.1 8255/3 C34.1 YES 0.8 NO 1.2 NO 15 No M0 N0 T2 Stage IB TCGA-50-5939.b8f00ba8-722f-4df1-bfcd-2ccfe6583abd.pdf 5939 TUMOR FREE Complete Remission/Response NO Primary Tumor 01 0.4 1968 6th NO NO YES 50 3 Current reformed smoker for > 15 years Lung A DECEASED 2008 TCGA-50-5939-01A-11D-1625-08 TCGA-50-5939-01A-11D-1625-08 3cafb1e5-9de0-4ced-8b87-d2299a207b97 TCGA-50-5939-01A-11D-1624-01 TCGA-50-5939-01A-11D-1626-05 TCGA-50-5939-01 TCGA-50-5939-01A-11D-1624-01 3cafb1e5-9de0-4ced-8b87-d2299a207b97 TCGA-50-5939-01 TCGA-50-5939-01A-31-2191-20 3cafb1e5-9de0-4ced-8b87-d2299a207b97 TCGA-50-5939-01 a1c702d2-d557-477f-9df0-f51e18f54163 3cafb1e5-9de0-4ced-8b87-d2299a207b97 TCGA-50-5939-01A-11D-1625-08 TCGA-50-5939-01 +TCGA-50-5939-11 1.72 0.33 none none none none N N none none none 0.17 Squamoid none none none none none none none Solid predominant Adc Solid predominant Adc none 0 TCGA-50-5939-11 C1-LUAD-enriched mutation cluster 5 TCGA-50-5939 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 85 R-Upper TCGA-50-5939-F32124 TCGA-50-5939 TCGA-50-5939-11A -31236 460 0 Scheduled Follow-up Submission Complete Remission/Response 2012-5-17 MALE Lung Adenocarcinoma Mixed Subtype No C34.1 8255/3 C34.1 YES 2 NO 2.5 NO 15 No M0 N0 T2 Stage IB 5939 TUMOR FREE Complete Remission/Response NO Solid Tissue Normal 11 0.2 1968 6th NO NO YES 50 3 Current reformed smoker for > 15 years Lung A DECEASED 2008 0569af63-9a1d-4f03-9a67-1269c7973677 TCGA-50-5939-11A-01D-1626-05 0569af63-9a1d-4f03-9a67-1269c7973677 0569af63-9a1d-4f03-9a67-1269c7973677 0569af63-9a1d-4f03-9a67-1269c7973677 +TCGA-50-5941-01 none p.G327_splice none none Y Y none none none Squamoid none p.G12A none none none none none Adenocarcinoma, NOS Adenocarcinoma, NOS none 0 TCGA-50-5941-01 High C1-LUAD-enriched cluster 2 Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 4 cluster 3 mutation cluster 2 TCGA-50-5941 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 55 R-Upper TCGA-50-5941-F70451 TCGA-50-5941 TCGA-50-5941-01A -20350 0 1474 Scheduled Follow-up Submission Complete Remission/Response 2015-2-16 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 1 NO 1 NO NO 25 No M0 N2 T2a Stage IIIA TCGA-50-5941.d49e610e-998f-4c6e-bb3d-b9c3a4221544.pdf 5941 TUMOR FREE Complete Remission/Response NO NO Primary Tumor 01 0.3 7th YES NO YES 50 2 Current smoker Lung A LIVING 2010 TCGA-50-5941-01A-11D-1753-08 TCGA-50-5941-01A-11D-1753-08 84138ee7-b120-4201-95b1-ccdc1c82ebda TCGA-50-5941-01A-11D-1752-01 TCGA-50-5941-01A-11D-1756-05 TCGA-50-5941-01 TCGA-50-5941-01A-11D-1752-01 84138ee7-b120-4201-95b1-ccdc1c82ebda TCGA-50-5941-01 TCGA-50-5941-01A-31-2191-20 84138ee7-b120-4201-95b1-ccdc1c82ebda TCGA-50-5941-01 ac85d41b-26b4-438a-86a6-94d8cc001368 84138ee7-b120-4201-95b1-ccdc1c82ebda TCGA-50-5941-01A-11D-1753-08 TCGA-50-5941-01 +TCGA-50-5942-01 1.95 0.7 none p.V600E none none N Y none none none 0.36 Bronchioid none none none none none none none Lepidic predominant Adc Lepidic predominant Adc none 0 TCGA-50-5942-01 Kirc+ C1-LUAD-enriched cluster 3 Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 5 cluster 3 mutation c1uster 9 TCGA-50-5942 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung NO YES 67 R-Upper TCGA-50-5942-F70452 TCGA-50-5942 TCGA-50-5942-01A -24781 0 1847 1378 Scheduled Follow-up Submission 2015-2-16 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.7 NO 1 NO Locoregional Recurrence YES 30 No M0 N0 T1 Stage IA TCGA-50-5942.915634e0-d38b-4a37-b96f-b9ac10507179.pdf 5942 WITH TUMOR Stable Disease Convincing Imaging NO YES R0 Primary Tumor 01 0.3 2009 7th NO NO YES 50 4 Current reformed smoker for < or = 15 years Lung A LIVING 2009 TCGA-50-5942-01A-21D-1753-08 TCGA-50-5942-01A-21D-1753-08 43a90c23-bff9-45ae-a5b5-c65f343d1cdc TCGA-50-5942-01A-21D-1752-01 TCGA-50-5942-01A-21D-1756-05 TCGA-50-5942-01 TCGA-50-5942-01A-21D-1752-01 43a90c23-bff9-45ae-a5b5-c65f343d1cdc TCGA-50-5942-01 TCGA-50-5942-01A-31-2191-20 43a90c23-bff9-45ae-a5b5-c65f343d1cdc TCGA-50-5942-01 41451a71-047f-4417-8d68-7cc15598a207 43a90c23-bff9-45ae-a5b5-c65f343d1cdc TCGA-50-5942-01A-21D-1753-08 TCGA-50-5942-01 +TCGA-50-5944-01 3.32 0.57 none none none none Y Y p.L858R none none 0.21 Bronchioid none none none none none none none Lepidic predominant Adc Lepidic predominant Adc none 0 TCGA-50-5944-01 High C1-LUAD-enriched cluster 3 Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 5 cluster 3 mutation cluster 8 TCGA-50-5944 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 69 R-Upper TCGA-50-5944-F70454 TCGA-50-5944 -25440 0 1750 Scheduled Follow-up Submission Complete Remission/Response 2015-2-16 FEMALE Lung Acinar Adenocarcinoma No C34.1 8550/3 C34.1 YES NO NO No M0 N0 T1 Stage IA 5944 TUMOR FREE Complete Remission/Response NO NO R0 Primary Tumor 01 7th NO NO YES 50 Lung LIVING 2010 TCGA-50-5944-01A-11D-1753-08 TCGA-50-5944-01A-11D-1753-08 c1859475-12fd-47f6-887d-136d334399cd TCGA-50-5944-01A-11D-1752-01 TCGA-50-5944-01A-11D-1756-05 TCGA-50-5944-01 TCGA-50-5944-01A-11D-1752-01 c1859475-12fd-47f6-887d-136d334399cd TCGA-50-5944-01 TCGA-50-5944-01A-13-2191-20 c1859475-12fd-47f6-887d-136d334399cd TCGA-50-5944-01 e17609bb-ee34-4c92-9a72-41f40b80fb45 c1859475-12fd-47f6-887d-136d334399cd TCGA-50-5944-01A-11D-1753-08 TCGA-50-5944-01 +TCGA-50-5946-01 TCGA-50-5946-01 High C1-LUAD-enriched Cluster 5 squamous c3 LUAD-like c10 mutation cluster 5 TCGA-50-5946 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung NO NO NO 62 R-Upper TCGA-50-5946-F70455 TCGA-50-5946 TCGA-50-5946-01A -22852 0 1617 811 Progressive Disease 2015-2-16 MALE Lung Adenocarcinoma Mixed Subtype No C34.1 8255/3 C34.1 YES 1.2 NO 1.5 NO Distant Metastasis YES No MX N0 T1 Stage IA TCGA-50-5946.E0329D21-475F-4C7D-9703-8297FF21B39F.pdf 5946 WITH TUMOR Progressive Disease Convincing Imaging NO NO Primary Tumor 01 0.3 2009 NO NO YES 50 4 Lung A LIVING 2010 TCGA-50-5946-01A-11D-1753-08 8a5cfa5b-2dab-4775-ae08-3d7e0b36e93f TCGA-50-5946-01A-11D-1752-01 TCGA-50-5946-01A-11D-1756-05 TCGA-50-5946-01 TCGA-50-5946-01A-11D-1752-01 8a5cfa5b-2dab-4775-ae08-3d7e0b36e93f TCGA-50-5946-01 TCGA-50-5946-01A-13-2191-20 8a5cfa5b-2dab-4775-ae08-3d7e0b36e93f TCGA-50-5946-01 754a4160-e44d-4f89-a135-c7400eb8badc 8a5cfa5b-2dab-4775-ae08-3d7e0b36e93f TCGA-50-5946-01A-11D-1753-08 TCGA-50-5946-01 +TCGA-50-5946-02 TCGA-50-5946-02 C1-LUAD-enriched Cluster 5 LUAD-like c10 miRNA cluster 5 mutation cluster 5 TCGA-50-5946 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung NO NO NO 62 R-Upper TCGA-50-5946-F70455 TCGA-50-5946 TCGA-50-5946-02A -22852 0 1617 811 Progressive Disease 2015-2-16 MALE Lung Adenocarcinoma Mixed Subtype No C34.1 8255/3 C34.1 YES 0.4 NO 1.9 NO Distant Metastasis YES No MX N0 T1 Stage IA TCGA-50-5946.E0329D21-475F-4C7D-9703-8297FF21B39F.pdf 5946 WITH TUMOR Progressive Disease Convincing Imaging NO NO Recurrent Tumor 02 0.2 2009 NO NO YES 50 4 Lung A LIVING 2010 0bfc47d8-bd48-49e9-8d37-6a418d049aef TCGA-50-5946-02A-11D-2087-05 0bfc47d8-bd48-49e9-8d37-6a418d049aef TCGA-50-5946-02 0bfc47d8-bd48-49e9-8d37-6a418d049aef 0bfc47d8-bd48-49e9-8d37-6a418d049aef TCGA-50-5946-02 +TCGA-50-6590-01 TCGA-50-6590-01 BRCA-LUAD+ C1-LUAD-enriched Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 4 mutation cluster 11 TCGA-50-6590 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 72 R-Upper TCGA-50-6590-F43827 TCGA-50-6590 TCGA-50-6590-01A -26444 1288 0 YES Scheduled Follow-up Submission Complete Remission/Response 2013-6-4 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 1 NO 1.6 NO NO 50 No M0 N0 T2 Stage IB TCGA-50-6590.13192955-ae90-4708-8f85-3b4e35781345.pdf 6590 TUMOR FREE Complete Remission/Response NO Primary Tumor 01 0.3 2002 6th YES NO YES 50 4 Lung A DECEASED 2005 TCGA-50-6590-01A-12D-1855-08 12fdf681-a6f5-4dfe-b556-d7e7f7e4d58a TCGA-50-6590-01A-12D-1854-01 TCGA-50-6590-01A-12D-1856-05 TCGA-50-6590-01 TCGA-50-6590-01A-12D-1854-01 12fdf681-a6f5-4dfe-b556-d7e7f7e4d58a TCGA-50-6590-01 TCGA-50-6590-01A-23-2191-20 12fdf681-a6f5-4dfe-b556-d7e7f7e4d58a TCGA-50-6590-01 b33cf148-e9bc-473b-b51f-037b348e7e49 12fdf681-a6f5-4dfe-b556-d7e7f7e4d58a TCGA-50-6590-01A-12D-1855-08 TCGA-50-6590-01 +TCGA-50-6591-01 TCGA-50-6591-01 BRCA-LUAD+ C1-LUAD-enriched Cluster 5 squamous c3 GBM-like c6 miRNA cluster 13 mutation cluster 8 TCGA-50-6591 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 63 L-Lower TCGA-50-6591-F43833 TCGA-50-6591 TCGA-50-6591-01A -23067 119 0 Scheduled Follow-up Submission Progressive Disease 2013-6-4 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 0.8 NO 0.9 NO NO No M1 N0 T2 Stage IV TCGA-50-6591.d1bb9feb-2cd4-40fd-a4d6-300d16b29d51.pdf 6591 WITH TUMOR Progressive Disease NO Primary Tumor 01 0.7 6th NO NO YES 50 1 Lung A DECEASED 2007 TCGA-50-6591-01A-11D-1753-08 92321ab5-8c77-4208-9daf-e6fcb01cc7a1 TCGA-50-6591-01A-11D-1752-01 TCGA-50-6591-01A-11D-1756-05 TCGA-50-6591-01 TCGA-50-6591-01A-11D-1752-01 92321ab5-8c77-4208-9daf-e6fcb01cc7a1 TCGA-50-6591-01 TCGA-50-6591-01A-13-2191-20 92321ab5-8c77-4208-9daf-e6fcb01cc7a1 TCGA-50-6591-01 4fdef60d-ba82-4b43-85b0-840c42622ab7 92321ab5-8c77-4208-9daf-e6fcb01cc7a1 TCGA-50-6591-01A-11D-1753-08 TCGA-50-6591-01 +TCGA-50-6591-11 TCGA-50-6591-11 C1-LUAD-enriched mutation cluster 8 TCGA-50-6591 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 63 L-Lower TCGA-50-6591-F43833 TCGA-50-6591 TCGA-50-6591-11A -23067 119 0 Scheduled Follow-up Submission Progressive Disease 2013-6-4 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 1.1 NO 1.8 NO NO No M1 N0 T2 Stage IV 6591 WITH TUMOR Progressive Disease NO Solid Tissue Normal 11 0.4 6th NO NO YES 50 1 Lung A DECEASED 2007 TCGA-50-6591-11A-01D-1756-05 +TCGA-50-6592-01 TCGA-50-6592-01 High C1-LUAD-enriched Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 4 mutation cluster 3 TCGA-50-6592 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 71 L-Lower TCGA-50-6592-F43835 TCGA-50-6592 TCGA-50-6592-01A -26191 777 0 Scheduled Follow-up Submission Progressive Disease 2013-6-4 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 1 NO 2 NO NO No M0 N0 T2 Stage IB TCGA-50-6592.9a5098a9-7600-4b77-9b16-d6c274affd77.pdf 6592 WITH TUMOR Progressive Disease YES Primary Tumor 01 0.3 6th NO NO YES 50 4 Lung A DECEASED 2007 TCGA-50-6592-01A-11D-1753-08 444662df-ae9b-4fec-9afc-df392ba3a88d TCGA-50-6592-01A-11D-1752-01 TCGA-50-6592-01A-11D-1756-05 TCGA-50-6592-01 TCGA-50-6592-01A-11D-1752-01 444662df-ae9b-4fec-9afc-df392ba3a88d TCGA-50-6592-01 TCGA-50-6592-01A-13-2191-20 444662df-ae9b-4fec-9afc-df392ba3a88d TCGA-50-6592-01 14deca38-5943-4ef6-8735-ba83e03eb3a7 444662df-ae9b-4fec-9afc-df392ba3a88d TCGA-50-6592-01A-11D-1753-08 TCGA-50-6592-01 +TCGA-50-6592-11 TCGA-50-6592-11 C1-LUAD-enriched mutation cluster 3 TCGA-50-6592 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 71 L-Lower TCGA-50-6592-F43835 TCGA-50-6592 TCGA-50-6592-11A -26191 777 0 Scheduled Follow-up Submission Progressive Disease 2013-6-4 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 1.5 NO 2 NO NO No M0 N0 T2 Stage IB 6592 WITH TUMOR Progressive Disease YES Solid Tissue Normal 11 0.1 6th NO NO YES 50 4 Lung A DECEASED 2007 TCGA-50-6592-11A-01D-1756-05 +TCGA-50-6593-01 2.9 0.31 none none none none N N none none none 0.14 Squamoid none none none none none none none Acinar predominant Adc Acinar predominant Adc none 0 TCGA-50-6593-01 High C1-LUAD-enriched cluster 2 Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 5 cluster 3 mutation cluster 13 TCGA-50-6593 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung NO NO NO 49 R-Upper TCGA-50-6593-F43840 TCGA-50-6593 -18152 336 0 266 YES YES Scheduled Follow-up Submission Progressive Disease 2013-6-13 FEMALE Lung Adenocarcinoma Mixed Subtype No C34.1 8255/3 C34.1 YES YES NO NO Distant Metastasis YES No M0 N2 T1 Stage IIIA 6593 WITH TUMOR Progressive Disease Convincing Imaging NO YES R0 Primary Tumor 01 6th NO NO YES 50 4 Current reformed smoker for < or = 15 years Lung DECEASED 2008 TCGA-50-6593-01A-11D-1753-08 TCGA-50-6593-01A-11D-1753-08 ace0aace-27ba-42a6-8d6b-3c29095ccbe5 TCGA-50-6593-01A-11D-1752-01 TCGA-50-6593-01A-11D-1756-05 TCGA-50-6593-01 TCGA-50-6593-01A-11D-1752-01 ace0aace-27ba-42a6-8d6b-3c29095ccbe5 TCGA-50-6593-01 TCGA-50-6593-01A-13-2191-20 ace0aace-27ba-42a6-8d6b-3c29095ccbe5 TCGA-50-6593-01 fc327353-7dfc-40e7-81ee-43307e7d12bf ace0aace-27ba-42a6-8d6b-3c29095ccbe5 TCGA-50-6593-01A-11D-1753-08 TCGA-50-6593-01 +TCGA-50-6593-11 2.9 0.31 none none none none N N none none none 0.14 Squamoid none none none none none none none Acinar predominant Adc Acinar predominant Adc none 0 TCGA-50-6593-11 C1-LUAD-enriched mutation cluster 13 TCGA-50-6593 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung NO NO NO 49 R-Upper TCGA-50-6593-F43840 TCGA-50-6593 TCGA-50-6593-11A -18152 336 0 266 YES YES Scheduled Follow-up Submission Progressive Disease 2013-6-13 FEMALE Lung Adenocarcinoma Mixed Subtype No C34.1 8255/3 C34.1 YES 0.6 NO YES NO 1.5 NO Distant Metastasis YES No M0 N2 T1 Stage IIIA 6593 WITH TUMOR Progressive Disease Convincing Imaging NO YES R0 Solid Tissue Normal 11 0.4 6th NO NO YES 50 4 Current reformed smoker for < or = 15 years Lung A DECEASED 2008 TCGA-50-6593-11A-01D-1756-05 +TCGA-50-6594-01 TCGA-50-6594-01 BRCA-LUAD+ C1-LUAD-enriched Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 4 mutation cluster 2 TCGA-50-6594 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung NO YES NO 79 L-Upper TCGA-50-6594-F44032 TCGA-50-6594 TCGA-50-6594-01A -28924 370 0 285 YES Scheduled Follow-up Submission Progressive Disease 2013-6-13 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 1 NO NO 1.5 NO Distant Metastasis YES No M0 N2 T3 Stage IIIA TCGA-50-6594.f0ca0fa2-8143-4d83-a82b-188c044d7071.pdf 6594 WITH TUMOR Progressive Disease Convincing Imaging NO Primary Tumor 01 0.3 1998 6th NO NO YES 50 4 Lung A DECEASED 2009 TCGA-50-6594-01A-11D-1753-08 7326b41e-46e0-47fb-895d-43ef08c91b97 TCGA-50-6594-01A-11D-1752-01 TCGA-50-6594-01A-11D-1756-05 TCGA-50-6594-01 TCGA-50-6594-01A-11D-1752-01 7326b41e-46e0-47fb-895d-43ef08c91b97 TCGA-50-6594-01 TCGA-50-6594-01A-13-2191-20 7326b41e-46e0-47fb-895d-43ef08c91b97 TCGA-50-6594-01 1b4ed202-75b7-4591-8b58-dbb2dba7376f 7326b41e-46e0-47fb-895d-43ef08c91b97 TCGA-50-6594-01A-11D-1753-08 TCGA-50-6594-01 +TCGA-50-6594-11 TCGA-50-6594-11 C1-LUAD-enriched mutation cluster 2 TCGA-50-6594 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung NO YES NO 79 L-Upper TCGA-50-6594-F44032 TCGA-50-6594 TCGA-50-6594-11A -28924 370 0 285 YES Scheduled Follow-up Submission Progressive Disease 2013-6-13 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 1 NO NO 1.5 NO Distant Metastasis YES No M0 N2 T3 Stage IIIA 6594 WITH TUMOR Progressive Disease Convincing Imaging NO Solid Tissue Normal 11 0.4 1998 6th NO NO YES 50 4 Lung A DECEASED 2009 TCGA-50-6594-11A-01D-1756-05 +TCGA-50-6595-01 none none none none Y Y p.G719A, p.S768I none none Squamoid none none none none none none none NSCLC, favor Adeno NSCLC, favor Adeno none 0 TCGA-50-6595-01 BRCA-LUAD+ C1-LUAD-enriched cluster 3 Cluster 5 squamous c3 squamous-like c4 miRNA cluster 4 cluster 2 mutation cluster 8 TCGA-50-6595 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung NO NO NO YES 74 R-Upper TCGA-50-6595-F44127 TCGA-50-6595 TCGA-50-6595-01A 187 -27197 189 0 182 YES YES Scheduled Follow-up Submission Progressive Disease 2013-6-13 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.8 NO YES 1.7 NO Distant Metastasis YES No M0 N2 T2 Stage IIIA TCGA-50-6595.13f36f42-a0d4-4cf3-b8ea-8cdeff292a91.pdf 6595 WITH TUMOR Progressive Disease Biopsy with Histologic Confirmation NO YES Primary Tumor 01 0.3 1979 6th YES NO YES 50 3 Current reformed smoker for > 15 years Lung A DECEASED 2009 TCGA-50-6595-01A-12D-1855-08 TCGA-50-6595-01A-12D-1855-08 cb72fb22-d492-432c-8188-82fce70c071c TCGA-50-6595-01A-12D-1854-01 TCGA-50-6595-01A-12D-1856-05 TCGA-50-6595-01 TCGA-50-6595-01A-12D-1854-01 cb72fb22-d492-432c-8188-82fce70c071c TCGA-50-6595-01 TCGA-50-6595-01A-23-2191-20 cb72fb22-d492-432c-8188-82fce70c071c TCGA-50-6595-01 9425139b-c220-4c94-a144-db0ab41b827a cb72fb22-d492-432c-8188-82fce70c071c TCGA-50-6595-01A-12D-1855-08 TCGA-50-6595-01 +TCGA-50-6595-11 none none none none Y Y p.G719A, p.S768I none none Squamoid none none none none none none none NSCLC, favor Adeno NSCLC, favor Adeno none 0 TCGA-50-6595-11 C1-LUAD-enriched mutation cluster 8 TCGA-50-6595 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung NO NO NO YES 74 R-Upper TCGA-50-6595-F44127 TCGA-50-6595 TCGA-50-6595-11A 187 -27197 189 0 182 YES YES Scheduled Follow-up Submission Progressive Disease 2013-6-13 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 1.1 NO YES 1.7 NO Distant Metastasis YES No M0 N2 T2 Stage IIIA 6595 WITH TUMOR Progressive Disease Biopsy with Histologic Confirmation NO YES Solid Tissue Normal 11 0.1 1979 6th YES NO YES 50 3 Current reformed smoker for > 15 years Lung A DECEASED 2009 44ffccc3-f2ba-4c7a-bc88-afbf93f63102 44ffccc3-f2ba-4c7a-bc88-afbf93f63102 44ffccc3-f2ba-4c7a-bc88-afbf93f63102 44ffccc3-f2ba-4c7a-bc88-afbf93f63102 +TCGA-50-6597-01 none none none none N N none none none Bronchioid none none none p.D1010_splice none none none Lepidic predominant Adc Lepidic predominant Adc none 0 TCGA-50-6597-01 High C1-LUAD-enriched cluster 1 Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 4 cluster 2 mutation c1uster 9 TCGA-50-6597 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 79 R-Lower TCGA-50-6597-F44134 TCGA-50-6597 TCGA-50-6597-01A -29195 1268 0 1015 YES Scheduled Follow-up Submission Complete Remission/Response 2013-6-13 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 0.9 NO YES NO 2 NO NO No M0 N0 T2 Stage IB TCGA-50-6597.6ba1ee6a-b37e-4f8d-9435-3d69ad1dbfdd.pdf 6597 TUMOR FREE Partial Remission/Response NO NO R0 Primary Tumor 01 0.1 6th NO NO YES 50 1 Lifelong Non-smoker Lung A DECEASED 2007 TCGA-50-6597-01A-11D-1855-08 TCGA-50-6597-01A-11D-1855-08 ce74929b-eae4-4e87-9a60-90230e28dadd TCGA-50-6597-01A-11D-1854-01 TCGA-50-6597-01A-11D-1856-05 TCGA-50-6597-01 TCGA-50-6597-01A-11D-1854-01 ce74929b-eae4-4e87-9a60-90230e28dadd TCGA-50-6597-01 TCGA-50-6597-01A-23-2191-20 ce74929b-eae4-4e87-9a60-90230e28dadd TCGA-50-6597-01 5971b955-c7c4-4efa-a0e5-4e27bd9abce9 ce74929b-eae4-4e87-9a60-90230e28dadd TCGA-50-6597-01A-11D-1855-08 TCGA-50-6597-01 +TCGA-50-6673-01 3.77 0.35 none none none none Y Y p.773_774insH none none 0.13 Bronchioid none none none none none none none Papillary predominant Adc Papillary predominant Adc none 0 TCGA-50-6673-01 Squamous C1-LUAD-enriched cluster 2 Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 7 cluster 4 TCGA-50-6673 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 84 R-Upper TCGA-50-6673-F44135 TCGA-50-6673 TCGA-50-6673-01A -30689 22 0 Scheduled Follow-up Submission 2013-6-13 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 1 NO 1.1 NO NO No M0 N0 T1 Stage I TCGA-50-6673.e2a03d91-afb5-4c25-99ae-e339660d7e2c.pdf 6673 YES R0 Primary Tumor 01 0.3 6th NO NO YES 50 1 Lifelong Non-smoker Lung A DECEASED 2004 TCGA-50-6673-01A-11D-1945-08 5655a240-2ed7-469e-af17-9997547ea119 TCGA-50-6673-01A-11D-1943-01 TCGA-50-6673-01A-11D-1947-05 TCGA-50-6673-01 TCGA-50-6673-01A-11D-1943-01 5655a240-2ed7-469e-af17-9997547ea119 TCGA-50-6673-01 TCGA-50-6673-01A-13-2191-20 5655a240-2ed7-469e-af17-9997547ea119 TCGA-50-6673-01 bbe974cc-029f-48c4-b5d6-7f489e831af7 5655a240-2ed7-469e-af17-9997547ea119 TCGA-50-6673-01A-11D-1945-08 TCGA-50-6673-01 +TCGA-50-7109-01 2.91 0.45 none none none none N N none none none 0.19 Magnoid none none none none none none none Solid predominant Adc Solid predominant Adc p.D194Y 0 TCGA-50-7109-01 High C1-LUAD-enriched cluster 2 Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 4 cluster 2 TCGA-50-7109 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung NO NO NO NO 60 R-Lower TCGA-50-7109-F44136 TCGA-50-7109 TCGA-50-7109-01A -21979 308 0 255 15 Scheduled Follow-up Submission Progressive Disease 2013-6-13 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 0.9 NO 1.3 NO Distant Metastasis YES 120 No M0 N0 T1 Stage IA TCGA-50-7109.a34c2391-f021-4b46-a4e9-8d9b7ee31402.pdf 7109 WITH TUMOR Progressive Disease Convincing Imaging NO NO Primary Tumor 01 0.2 7th NO NO YES 50 2 Current smoker Lung A DECEASED 2011 TCGA-50-7109-01A-11D-2036-08 330a29fe-e4ec-458b-8d1f-05f147ac98d9 TCGA-50-7109-01A-11D-2035-01 TCGA-50-7109-01A-11D-2037-05 TCGA-50-7109-01 TCGA-50-7109-01A-11D-2035-01 330a29fe-e4ec-458b-8d1f-05f147ac98d9 TCGA-50-7109-01 TCGA-50-7109-01A-13-2192-20 330a29fe-e4ec-458b-8d1f-05f147ac98d9 TCGA-50-7109-01 cd785e69-967c-4ae7-9137-aaf65ebab433 330a29fe-e4ec-458b-8d1f-05f147ac98d9 TCGA-50-7109-01A-11D-2036-08 TCGA-50-7109-01 +TCGA-50-7109-11 2.91 0.45 none none none none N N none none none 0.19 Magnoid none none none none none none none Solid predominant Adc Solid predominant Adc p.D194Y 0 TCGA-50-7109-11 C1-LUAD-enriched TCGA-50-7109 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung NO NO NO NO 60 R-Lower TCGA-50-7109-F44136 TCGA-50-7109 -21979 308 0 255 15 Scheduled Follow-up Submission Progressive Disease 2013-6-13 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES NO Distant Metastasis YES 120 No M0 N0 T1 Stage IA 7109 WITH TUMOR Progressive Disease Convincing Imaging NO NO Solid Tissue Normal 11 7th NO NO YES 50 2 Current smoker Lung DECEASED 2011 TCGA-50-7109-11 TCGA-50-7109-11 +TCGA-50-8457-01 TCGA-50-8457-01 Cluster 5 miRNA cluster 4 TCGA-50-8457 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 63 R-Upper TCGA-50-8457-F70409 TCGA-50-8457 TCGA-50-8457-01A -23055 0 1125 YES FISH YES Scheduled Follow-up Submission Complete Remission/Response 2015-2-11 FEMALE Lung Adenocarcinoma Mixed Subtype No C34.1 8255/3 C34.1 YES 0.9 NO YES YES G12A 1.2 NO NO 30 No M0 N0 T1a Stage IA TCGA-50-8457.21529b79-5b5b-46e6-8deb-e4e6460a4695.pdf 8457 TUMOR FREE Complete Remission/Response NO NO Primary Tumor 01 0.3 1997 7th NO YES NO 50 4 Lung A LIVING 2011 9475bf3a-ae1b-482c-88d8-3f0c90ff18f6 TCGA-50-8457-01A-11D-2322-01 TCGA-50-8457-01A-11D-2324-05 TCGA-50-8457-01 TCGA-50-8457-01A-11D-2322-01 9475bf3a-ae1b-482c-88d8-3f0c90ff18f6 TCGA-50-8457-01 9475bf3a-ae1b-482c-88d8-3f0c90ff18f6 TCGA-50-8457-01 D9B469C0-1645-49E0-B652-C4515203021F 9475bf3a-ae1b-482c-88d8-3f0c90ff18f6 TCGA-50-8457-01A-11D-2323-08 TCGA-50-8457-01 +TCGA-50-8459-01 TCGA-50-8459-01 Cluster 5 miRNA cluster 4 TCGA-50-8459 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 68 R-Lower TCGA-50-8459-F70410 TCGA-50-8459 TCGA-50-8459-01A -24859 0 1119 70 YES Scheduled Follow-up Submission Progressive Disease 2015-2-11 MALE Mucinous (Colloid) Carcinoma No C34.30 8480/3 C34.3 YES 0.7 NO YES YES G12C 1.2 NO NO 10 No M0 N0 T3 Stage IIB TCGA-50-8459.be87241c-fcb4-416f-a8a4-74b09033ca0b.pdf 8459 WITH TUMOR 70 72 Progressive Disease YES NO Primary Tumor 01 0.3 7th YES YES NO 50 2 Lung A LIVING 2012 defb83d5-ba61-435f-a8bf-98daaa1c546f TCGA-50-8459-01A-11D-2322-01 TCGA-50-8459-01A-11D-2324-05 TCGA-50-8459-01 TCGA-50-8459-01A-11D-2322-01 defb83d5-ba61-435f-a8bf-98daaa1c546f TCGA-50-8459-01 defb83d5-ba61-435f-a8bf-98daaa1c546f TCGA-50-8459-01 B312A3EE-242B-4B69-B4F6-265317315D2D defb83d5-ba61-435f-a8bf-98daaa1c546f TCGA-50-8459-01A-11D-2323-08 TCGA-50-8459-01 +TCGA-50-8460-01 TCGA-50-8460-01 Cluster 5 miRNA cluster 4 TCGA-50-8460 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 74 R-Upper TCGA-50-8460-F69335 TCGA-50-8460 TCGA-50-8460-01A -27270 0 829 YES Scheduled Follow-up Submission Complete Remission/Response 2015-1-5 MALE Lung Papillary Adenocarcinoma No C34.1 8260/3 C34.1 YES 0.9 NO YES NO 1.3 NO NO No M0 N0 T1a Stage IA TCGA-50-8460.fc79e8c5-c79b-46d3-ab41-03399a68999a.pdf 8460 TUMOR FREE Complete Remission/Response NO YES R0 Primary Tumor 01 0.3 7th NO YES NO 50 Lung A LIVING 2012 42a4a133-ec9d-4f5a-8b95-be83cbddb148 TCGA-50-8460-01A-11D-2322-01 TCGA-50-8460-01A-11D-2324-05 TCGA-50-8460-01 TCGA-50-8460-01A-11D-2322-01 42a4a133-ec9d-4f5a-8b95-be83cbddb148 TCGA-50-8460-01 42a4a133-ec9d-4f5a-8b95-be83cbddb148 TCGA-50-8460-01 12DA9D1D-1F9A-44E5-BB0A-7787ED4456F8 42a4a133-ec9d-4f5a-8b95-be83cbddb148 TCGA-50-8460-01A-11D-2323-08 TCGA-50-8460-01 +TCGA-53-7624-01 TCGA-53-7624-01 High C8-BLCA Cluster 5 squamous c3 BLCA nonsquamous-like c1 miRNA cluster 4 TCGA-53-7624 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung YES YES YES 40 R-Upper TCGA-53-7624-F39722 TCGA-53-7624 TCGA-53-7624-01A 593 -14794 1043 0 400 0 NO NO Scheduled Follow-up Submission Progressive Disease 2013-1-31 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES NO 0 NO Peripheral Lung NO Distant Metastasis YES 50 No M1 N0 T2 Stage IV TCGA-53-7624.b108a209-518b-4271-a90c-7f3857044581.pdf 7624 Post-Adjuvant Therapy WITH TUMOR Progressive Disease Biopsy with Histologic Confirmation NO R0 Primary Tumor 01 6th YES NO YES 53 2 Lung A DECEASED 2008 1986 50d03646-1082-4ae3-9853-f5295006f11a TCGA-53-7624-01A-11D-2062-01 TCGA-53-7624-01A-11D-2064-05 TCGA-53-7624-01 TCGA-53-7624-01A-11D-2062-01 50d03646-1082-4ae3-9853-f5295006f11a TCGA-53-7624-01 TCGA-53-7624-01A-13-2192-20 50d03646-1082-4ae3-9853-f5295006f11a TCGA-53-7624-01 4ca5de57-b4b9-4bdb-8272-40b134e5f812 50d03646-1082-4ae3-9853-f5295006f11a TCGA-53-7624-01A-11D-2063-08 TCGA-53-7624-01 +TCGA-53-7626-01 3.58 0.26 none none none none N N none none p.C589F 0.11 Bronchioid none none none none none none none Adenocarcinoma, NOS Adenocarcinoma, NOS none 0 TCGA-53-7626-01 BRCA-LUAD+ C1-LUAD-enriched cluster 2 Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 4 cluster 3 TCGA-53-7626 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung NO NO NO 76 R-Upper TCGA-53-7626-F38969 TCGA-53-7626 TCGA-53-7626-01A -28024 929 0 865 0 NO NO Scheduled Follow-up Submission Progressive Disease 2013-1-15 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES NO NO Peripheral Lung NO Locoregional Recurrence YES 35 No M0 N1 T1 Stage IIA TCGA-53-7626.23a82f88-d450-4546-88e0-c26cf8de267e.pdf 7626 Post-Adjuvant Therapy WITH TUMOR Progressive Disease Biopsy with Histologic Confirmation NO R0 Primary Tumor 01 2006 6th YES NO YES 53 4 Current reformed smoker for < or = 15 years Lung A DECEASED 2008 1971 TCGA-53-7626-01A-12D-2063-08 f3196cf4-2cda-4377-9089-e29434cbd4d4 TCGA-53-7626-01A-12D-2062-01 TCGA-53-7626-01A-12D-2064-05 TCGA-53-7626-01 TCGA-53-7626-01A-12D-2062-01 f3196cf4-2cda-4377-9089-e29434cbd4d4 TCGA-53-7626-01 TCGA-53-7626-01A-23-2192-20 f3196cf4-2cda-4377-9089-e29434cbd4d4 TCGA-53-7626-01 431635c1-f187-4a27-9013-502373adccd8 f3196cf4-2cda-4377-9089-e29434cbd4d4 TCGA-53-7626-01A-12D-2063-08 TCGA-53-7626-01 +TCGA-53-7813-01 none none none none Y Y none none none Magnoid none p.G12A none none none none none p.Y60fs TCGA-53-7813-01 BRCA-LUAD+ C1-LUAD-enriched cluster 3 Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 6 cluster 1 TCGA-53-7813 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 51 R-Upper TCGA-53-7813-F39281 TCGA-53-7813 -18875 0 424 88 1 NO NO Scheduled Follow-up Submission 2013-1-31 FEMALE Lung Bronchioloalveolar Carcinoma Nonmucinous No C34.1 8252/3 C34.1 YES NO YES 35 No M0 N0 T4 Stage IIIB 7813 Pre-Adjuvant Therapy TUMOR FREE 69 91 67 90 Progressive Disease YES NO Primary Tumor 01 2008 6th YES NO YES 53 4 Lung LIVING 2008 1973 TCGA-53-7813-01A-11D-2167-08 f8d65338-5f5e-4cf5-a119-25faf54453d4 TCGA-53-7813-01A-11D-2166-01 TCGA-53-7813-01A-11D-2168-05 TCGA-53-7813-01 TCGA-53-7813-01A-11D-2166-01 f8d65338-5f5e-4cf5-a119-25faf54453d4 TCGA-53-7813-01 TCGA-53-7813-01A-13-2192-20 f8d65338-5f5e-4cf5-a119-25faf54453d4 TCGA-53-7813-01 a9fcd075-f885-4617-b67a-11b039062e93 f8d65338-5f5e-4cf5-a119-25faf54453d4 TCGA-53-7813-01A-11D-2167-08 TCGA-53-7813-01 +TCGA-53-A4EZ-01 TCGA-53-A4EZ-01 TCGA-53-A4EZ TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 63 L-Upper TCGA-53-A4EZ-F61081 TCGA-53-A4EZ TCGA-53-A4EZ-01A -23201 163 0 1071 86 1 YES FISH YES Scheduled Follow-up Submission Complete Remission/Response 2015-3-19 MALE Lung Acinar Adenocarcinoma No C34.1 8550/3 C34.1 YES 120 NO 80 YES NO Peripheral Lung NO NO 40 true No MX N1 T2a Stage IIA TCGA-53-A4EZ.E4CB6C1D-9774-47BE-989E-F9CD05D9EED8.pdf A4EZ Post-Adjuvant Therapy TUMOR FREE 73 75 73 76 Stable Disease YES YES RX Primary Tumor 01 1996 7th YES YES NO 53 3 Lung A LIVING 2012 1956 465ce132-c1f4-490f-b1f1-46300fde4441 TCGA-53-A4EZ-01A-12D-A24O-01 TCGA-53-A4EZ-01A-12D-A24U-05 TCGA-53-A4EZ-01 TCGA-53-A4EZ-01A-12D-A24O-01 465ce132-c1f4-490f-b1f1-46300fde4441 TCGA-53-A4EZ-01 465ce132-c1f4-490f-b1f1-46300fde4441 TCGA-53-A4EZ-01 8620B021-C8FD-4814-991D-71B4D1906835 465ce132-c1f4-490f-b1f1-46300fde4441 TCGA-53-A4EZ-01A-12D-A24P-08 TCGA-53-A4EZ-01 +TCGA-55-1592-01 3.24 0.49 none none none none N N none none none 0.19 Bronchioid none none none none none none none Adenocarcinoma, NOS Adenocarcinoma, NOS none 0 TCGA-55-1592-01 High C1-LUAD-enriched Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 4 cluster 4 mutation cluster 11 TCGA-55-1592 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung NO NO NO NO 65 L-Upper TCGA-55-1592-F9167 TCGA-55-1592 TCGA-55-1592-01A 701 0 452 Progressive Disease 2011-3-15 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.8 NO 1.8 YES Yes M0 N0 T2 Stage IA TCGA-55-1592.99ae36ee-bb6c-4934-8e5c-388ff5a69c46.pdf 1592 WITH TUMOR Complete Remission/Response NO R0 Primary Tumor 01 0.5 1997 NO NO YES 55 4 Current reformed smoker for < or = 15 years Lung A DECEASED 2005 1957 TCGA-55-1592-01 TCGA-55-1592-01A-01D-0969-08 TCGA-55-1592-01 f215665e-3c8d-4746-a18a-859ac95b2fdb TCGA-55-1592-01A-01R-0946-07 TCGA-55-1592-01A-01D-0945-05 TCGA-55-1592-01 TCGA-55-1592-01A-01D-0944-01 TCGA-55-1592-01 TCGA-55-1592-01A-01D-0944-01 TCGA-55-1592-01 f215665e-3c8d-4746-a18a-859ac95b2fdb TCGA-55-1592-01A-21-2190-20 f215665e-3c8d-4746-a18a-859ac95b2fdb TCGA-55-1592-01 08e59b04-61a9-4a1b-9fd9-bb07ffe2551a f215665e-3c8d-4746-a18a-859ac95b2fdb TCGA-55-1592-01A-01W-0928-08,TCGA-55-1592-01A-01D-0969-08 TCGA-55-1592-01 +TCGA-55-1592-11 3.24 0.49 none none none none N N none none none 0.19 Bronchioid none none none none none none none Adenocarcinoma, NOS Adenocarcinoma, NOS none 0 TCGA-55-1592-11 C1-LUAD-enriched mutation cluster 11 TCGA-55-1592 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung NO NO NO NO 65 L-Upper TCGA-55-1592-F9167 TCGA-55-1592 TCGA-55-1592-11A 701 0 452 Progressive Disease 2011-3-15 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.4 NO 1 YES Yes M0 N0 T2 Stage IA 1592 WITH TUMOR Complete Remission/Response NO R0 Solid Tissue Normal 11 0.2 1997 NO NO YES 55 4 Current reformed smoker for < or = 15 years Lung A DECEASED 2005 1957 TCGA-55-1592-11A-01D-0945-05 +TCGA-55-1594-01 3.28 0.54 none none none none N N none none none 0.2 Magnoid none none none none none none none Solid predominant Adc Solid predominant Adc none 1 TCGA-55-1594-01 High C1-LUAD-enriched Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 6 cluster 1 mutation cluster 5 TCGA-55-1594 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 68 R-Lower TCGA-55-1594 TCGA-55-1594-01A -25008 0 1178 2010-9-14 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 0.5 NO 2 No M0 N2 T2 Stage IIIA TCGA-55-1594.bdbfef54-ca5a-4b4f-809d-4de379232a8a.pdf 1594 TUMOR FREE R0 Primary Tumor 01 0.2 NO YES 55 2 Current smoker Lung A LIVING 2005 1965 TCGA-55-1594-01 TCGA-55-1594-01A-01D-1040-01 TCGA-55-1594-01 63b6924e-921f-4fac-9866-dd97e996d7ac TCGA-55-1594-01A-01R-0946-07 TCGA-55-1594-01A-01D-0945-05 TCGA-55-1594-01 TCGA-55-1594-01A-01D-0944-01 TCGA-55-1594-01 TCGA-55-1594-01A-01D-0944-01 TCGA-55-1594-01 63b6924e-921f-4fac-9866-dd97e996d7ac TCGA-55-1594-01A-21-2190-20 63b6924e-921f-4fac-9866-dd97e996d7ac TCGA-55-1594-01 273089ef-4fc5-462c-a77e-e3076a998e4d 63b6924e-921f-4fac-9866-dd97e996d7ac TCGA-55-1594-01A-01W-0928-08,TCGA-55-1594-01A-01D-1040-01 TCGA-55-1594-01 +TCGA-55-1594-11 3.28 0.54 none none none none N N none none none 0.2 Magnoid none none none none none none none Solid predominant Adc Solid predominant Adc none 1 TCGA-55-1594-11 C1-LUAD-enriched mutation cluster 5 TCGA-55-1594 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 68 R-Lower TCGA-55-1594 TCGA-55-1594-11A -25008 0 1178 2010-9-14 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 1 NO 3 No M0 N2 T2 Stage IIIA 1594 TUMOR FREE R0 Solid Tissue Normal 11 0.6 NO YES 55 2 Current smoker Lung A LIVING 2005 1965 TCGA-55-1594-11A-01D-0945-05 +TCGA-55-1595-01 TCGA-55-1595-01 High C1-LUAD-enriched Cluster 6 LUAD-like c10 miRNA cluster 4 mutation cluster 12 TCGA-55-1595 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 74 L-Lower TCGA-55-1595-F9159 TCGA-55-1595 0 1479 2011-3-15 FEMALE Lung Clear Cell Adenocarcinoma No C34.3 8310/3 C34.3 YES NO Yes M0 N0 T1 Stage IA 1595 TUMOR FREE Complete Remission/Response NO Primary Tumor 01 1993 6th NO 55 4 Lung LIVING 2004 1964 TCGA-55-1595-01A-01D-0969-08 TCGA-55-1595-01 e7db32c0-8d04-4ab7-9c64-c4590d62539b TCGA-55-1595-01A-01R-0946-07 TCGA-55-1595-01A-01D-0945-05 TCGA-55-1595-01 TCGA-55-1595-01A-01D-0944-01 TCGA-55-1595-01 TCGA-55-1595-01A-01D-0944-01 TCGA-55-1595-01 e7db32c0-8d04-4ab7-9c64-c4590d62539b e7db32c0-8d04-4ab7-9c64-c4590d62539b TCGA-55-1595-01 e7db32c0-8d04-4ab7-9c64-c4590d62539b TCGA-55-1595-01A-01D-0969-08 TCGA-55-1595-01 +TCGA-55-1595-11 TCGA-55-1595-11 C1-LUAD-enriched mutation cluster 12 TCGA-55-1595 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 74 L-Lower TCGA-55-1595-F9159 TCGA-55-1595 TCGA-55-1595-11A 0 1479 2011-3-15 FEMALE Lung Clear Cell Adenocarcinoma No C34.3 8310/3 C34.3 YES 0.4 NO 0.4 NO Yes M0 N0 T1 Stage IA 1595 TUMOR FREE Complete Remission/Response NO Solid Tissue Normal 11 0.4 1993 6th NO 55 4 Lung A LIVING 2004 1964 TCGA-55-1595-11A-01D-0945-05 +TCGA-55-1596-01 3.45 0.62 none none none none N N none none none 0.21 Magnoid none none none none none none none Solid predominant Adc Solid predominant Adc p.S216F, p.G242W 1 TCGA-55-1596-01 Squamous C1-LUAD-enriched Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 4 cluster 2 mutation cluster 5 TCGA-55-1596 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 55 R-Upper TCGA-55-1596-F40544 TCGA-55-1596 TCGA-55-1596-01A -20381 0 2065 Scheduled Follow-up Submission Complete Remission/Response 2013-2-22 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.6 NO 0.9 NO NO 50 No M0 N1 T2 Stage IIB TCGA-55-1596.200ccd8b-b3dc-4e3f-8c1e-ed9fa31ae9da.pdf 1596 TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 0.4 6th YES NO YES 55 2 Current smoker Lung A LIVING 2004 1979 TCGA-55-1596-01 TCGA-55-1596-01A-01D-1040-01 TCGA-55-1596-01 8b2f9a82-4c0d-496b-a46c-15d20d069e11 TCGA-55-1596-01A-01R-0946-07 TCGA-55-1596-01A-01D-0945-05 TCGA-55-1596-01 TCGA-55-1596-01A-01D-0944-01 TCGA-55-1596-01 TCGA-55-1596-01A-01D-0944-01 TCGA-55-1596-01 8b2f9a82-4c0d-496b-a46c-15d20d069e11 TCGA-55-1596-01A-21-2190-20 8b2f9a82-4c0d-496b-a46c-15d20d069e11 TCGA-55-1596-01 443a13de-0a5e-4da3-8913-e8c6fbc51aa2 8b2f9a82-4c0d-496b-a46c-15d20d069e11 TCGA-55-1596-01A-01W-0928-08,TCGA-55-1596-01A-01D-1040-01 TCGA-55-1596-01 +TCGA-55-1596-11 3.45 0.62 none none none none N N none none none 0.21 Magnoid none none none none none none none Solid predominant Adc Solid predominant Adc p.S216F, p.G242W 1 TCGA-55-1596-11 C1-LUAD-enriched mutation cluster 5 TCGA-55-1596 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 55 R-Upper TCGA-55-1596-F40544 TCGA-55-1596 TCGA-55-1596-11A -20381 0 2065 Scheduled Follow-up Submission Complete Remission/Response 2013-2-22 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.5 NO 1 NO NO 50 No M0 N1 T2 Stage IIB 1596 TUMOR FREE Complete Remission/Response NO R0 Solid Tissue Normal 11 0.2 6th YES NO YES 55 2 Current smoker Lung A LIVING 2004 1979 TCGA-55-1596-11A-01D-0945-05 +TCGA-55-5899-01 TCGA-55-5899-01 Squamous C1-LUAD-enriched Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 6 mutation cluster 3 TCGA-55-5899 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 58 R-Upper TCGA-55-5899-F43194 TCGA-55-5899 TCGA-55-5899-01A 0 930 0 Scheduled Follow-up Submission Complete Remission/Response 2013-5-15 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.6 NO 100 1 NO NO No M0 N1 T1a [Discrepancy] TCGA-55-5899.8fcdc599-a63e-4774-a58d-8b1b19d13980.pdf 5899 Post-Adjuvant Therapy TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 0.3 7th YES NO YES 55 2 Lung A LIVING 2010 1985 TCGA-55-5899-01A-11D-1625-08 f51ff2e2-bc0a-4cdd-b008-933a8f7fa8fc TCGA-55-5899-01A-11D-1624-01 TCGA-55-5899-01A-11D-1626-05 TCGA-55-5899-01 TCGA-55-5899-01A-11D-1624-01 f51ff2e2-bc0a-4cdd-b008-933a8f7fa8fc TCGA-55-5899-01 TCGA-55-5899-01A-21-2190-20 f51ff2e2-bc0a-4cdd-b008-933a8f7fa8fc TCGA-55-5899-01 53a204a4-caa0-4a30-b31d-5e408a4a4df1 f51ff2e2-bc0a-4cdd-b008-933a8f7fa8fc TCGA-55-5899-01A-11D-1625-08 TCGA-55-5899-01 +TCGA-55-6543-01 2.29 0.65 none none none none N Y none none none 0.3 Bronchioid none none none none none none none Acinar predominant Adc Acinar predominant Adc Y none 0 TCGA-55-6543-01 Kirc+ C1-LUAD-enriched cluster 3 Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 5 cluster 3 mutation c1uster 9 TCGA-55-6543 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 60 R-Upper TCGA-55-6543-F46659 TCGA-55-6543 TCGA-55-6543-01A 0 435 Scheduled Follow-up Submission Complete Remission/Response 2013-8-13 FEMALE Lung Bronchioloalveolar Carcinoma Mucinous No C34.1 8253/3 C34.1 YES 0.4 NO Peripheral Lung 1 NO NO 60 No MX N0 T1b Stage IA TCGA-55-6543.b1b81957-278c-4c30-af49-821ab7e0429c.pdf 6543 TUMOR FREE Complete Remission/Response NO Primary Tumor 01 0.4 2004 7th NO NO YES 55 4 Current reformed smoker for < or = 15 years Lung A LIVING 2010 TCGA-55-6543-01A-11D-1753-08 TCGA-55-6543-01A-11D-1753-08 991a6ea6-32cf-479b-87a6-cc930baeddfa TCGA-55-6543-01A-11D-1752-01 TCGA-55-6543-01A-11D-1756-05 TCGA-55-6543-01 TCGA-55-6543-01A-11D-1752-01 991a6ea6-32cf-479b-87a6-cc930baeddfa TCGA-55-6543-01 TCGA-55-6543-01A-13-2191-20 991a6ea6-32cf-479b-87a6-cc930baeddfa TCGA-55-6543-01 094e7995-ee01-40b2-aced-0db808ad9a56 991a6ea6-32cf-479b-87a6-cc930baeddfa TCGA-55-6543-01A-11D-1753-08 TCGA-55-6543-01 +TCGA-55-6642-01 2.66 0.36 none none none none Y Y none none none 0.16 Magnoid none p.G12V none none none none none Micropapillary predom Adc Micropapillary predom Adc none 0 TCGA-55-6642-01 Squamous C1-LUAD-enriched cluster 2 Cluster 5 LUAD-like c10 miRNA cluster 4 cluster 2 mutation cluster 12 TCGA-55-6642 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 63 R-Lower TCGA-55-6642-F45614 TCGA-55-6642 TCGA-55-6642-01A -23107 0 2449 Scheduled Follow-up Submission Complete Remission/Response 2013-7-17 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 0.9 NO 1 NO NO No MX N0 T2 Stage IB TCGA-55-6642.5d390c9f-0f12-4ed2-a7ec-d9e7c8f05320.pdf 6642 TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 0.4 6th NO NO YES 55 2 Current smoker Lung A LIVING 2006 1961 TCGA-55-6642-01A-11D-1855-08 TCGA-55-6642-01A-11D-1855-08 891aefa4-e7f1-482f-a2f5-b2d5c7d9e179 TCGA-55-6642-01A-11D-1854-01 TCGA-55-6642-01A-11D-1856-05 TCGA-55-6642-01 TCGA-55-6642-01A-11D-1854-01 891aefa4-e7f1-482f-a2f5-b2d5c7d9e179 TCGA-55-6642-01 891aefa4-e7f1-482f-a2f5-b2d5c7d9e179 TCGA-55-6642-01 891aefa4-e7f1-482f-a2f5-b2d5c7d9e179 TCGA-55-6642-01A-11D-1855-08 TCGA-55-6642-01 +TCGA-55-6712-01 3.31 0.29 none none none none N N none none none 0.12 Squamoid none none none p.E1314G none none none Adenocarcinoma, NOS Adenocarcinoma, NOS none 0 TCGA-55-6712-01 High C1-LUAD-enriched cluster 1 Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 4 cluster 2 mutation cluster 5 TCGA-55-6712 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 71 L-Upper TCGA-55-6712-F46639 TCGA-55-6712 TCGA-55-6712-01A 171 0 24 Scheduled Follow-up Submission Progressive Disease 2013-8-13 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.8 NO 0.9 NO NO No MX N1 T2a Stage IIA TCGA-55-6712.156f5763-3bc6-47a8-b579-6d767fa3fd00.pdf 6712 WITH TUMOR Progressive Disease NO R1 Primary Tumor 01 0.4 2003 7th YES NO YES 55 4 Current reformed smoker for < or = 15 years Lung A DECEASED 2010 1970 TCGA-55-6712-01A-11D-1855-08 TCGA-55-6712-01A-11D-1855-08 f5a01f2f-247a-42a0-a713-ba6f8bb8d03e TCGA-55-6712-01A-11D-1854-01 TCGA-55-6712-01A-11D-1856-05 TCGA-55-6712-01 TCGA-55-6712-01A-11D-1854-01 f5a01f2f-247a-42a0-a713-ba6f8bb8d03e TCGA-55-6712-01 TCGA-55-6712-01A-13-2191-20 f5a01f2f-247a-42a0-a713-ba6f8bb8d03e TCGA-55-6712-01 55dfe466-08c8-4196-9e3e-61851f50100e f5a01f2f-247a-42a0-a713-ba6f8bb8d03e TCGA-55-6712-01A-11D-1855-08 TCGA-55-6712-01 +TCGA-55-6968-01 TCGA-55-6968-01 Squamous Cluster 5 LUAD-like c10 miRNA cluster 6 TCGA-55-6968 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 61 R-Lower TCGA-55-6968-F56247 TCGA-55-6968 TCGA-55-6968-01A -22344 1293 0 Scheduled Follow-up Submission Stable Disease 2014-1-30 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 0.4 NO 0.7 NO NO No M1 N0 T1 Stage IV TCGA-55-6968.87f5cbe6-cce1-4a8c-8189-c6feabd3b4bb.pdf 6968 WITH TUMOR Stable Disease YES Primary Tumor 01 0.2 6th YES NO YES 55 2 Lung A DECEASED 2004 09fba9fa-29d2-41a1-b3aa-4bfd97be3fc8 TCGA-55-6968-01A-11D-1943-01 TCGA-55-6968-01A-11D-1947-05 TCGA-55-6968-01 TCGA-55-6968-01A-11D-1943-01 09fba9fa-29d2-41a1-b3aa-4bfd97be3fc8 TCGA-55-6968-01 09fba9fa-29d2-41a1-b3aa-4bfd97be3fc8 TCGA-55-6968-01 09fba9fa-29d2-41a1-b3aa-4bfd97be3fc8 TCGA-55-6968-01A-11D-1945-08 TCGA-55-6968-01 +TCGA-55-6968-11 TCGA-55-6968-11 TCGA-55-6968 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 61 R-Lower TCGA-55-6968-F56247 TCGA-55-6968 TCGA-55-6968-11A -22344 1293 0 Scheduled Follow-up Submission Stable Disease 2014-1-30 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 0.9 NO 0.9 NO NO No M1 N0 T1 Stage IV 6968 WITH TUMOR Stable Disease YES Solid Tissue Normal 11 0.3 6th YES NO YES 55 2 Lung A DECEASED 2004 372ec0c3-ab4c-421b-acc4-6fecf473d2fb 372ec0c3-ab4c-421b-acc4-6fecf473d2fb 372ec0c3-ab4c-421b-acc4-6fecf473d2fb 372ec0c3-ab4c-421b-acc4-6fecf473d2fb +TCGA-55-6969-01 TCGA-55-6969-01 High C1-LUAD-enriched Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 7 TCGA-55-6969 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 52 L-Upper TCGA-55-6969 TCGA-55-6969-01A -19270 0 1239 NO NO 2011-7-25 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.5 NO NO 0.9 No M0 N0 T2 Stage IB TCGA-55-6969.96b7d4c4-6513-4249-a6d5-b5cf0bf49ab4.pdf 6969 TUMOR FREE Primary Tumor 01 0.3 2004 6th NO YES 55 4 Lung A LIVING 2004 a4c1e9e8-a335-47b0-afc6-c2b490da4e58 TCGA-55-6969-01A-11D-1943-01 TCGA-55-6969-01A-11D-1947-05 TCGA-55-6969-01 TCGA-55-6969-01A-11D-1943-01 a4c1e9e8-a335-47b0-afc6-c2b490da4e58 TCGA-55-6969-01 TCGA-55-6969-01A-13-2191-20 a4c1e9e8-a335-47b0-afc6-c2b490da4e58 TCGA-55-6969-01 4d784c19-acc2-42e0-a078-396eeb07c20c a4c1e9e8-a335-47b0-afc6-c2b490da4e58 TCGA-55-6969-01A-11D-1945-08 TCGA-55-6969-01 +TCGA-55-6969-11 TCGA-55-6969-11 C1-LUAD-enriched TCGA-55-6969 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 52 L-Upper TCGA-55-6969 TCGA-55-6969-11A -19270 0 1239 NO NO 2011-7-25 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.7 NO NO 0.9 No M0 N0 T2 Stage IB 6969 TUMOR FREE Solid Tissue Normal 11 0.5 2004 6th NO YES 55 4 Lung A LIVING 2004 7921e917-f743-4813-8fcf-2145dce93c37 7921e917-f743-4813-8fcf-2145dce93c37 7921e917-f743-4813-8fcf-2145dce93c37 7921e917-f743-4813-8fcf-2145dce93c37 +TCGA-55-6970-01 1.39 0.56 none none none none Y Y none none none 0.34 Magnoid none p.G12V none none none none none Papillary predominant Adc Papillary predominant Adc p.T250fs 0 TCGA-55-6970-01 High C1-LUAD-enriched cluster 3 Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 4 cluster 4 TCGA-55-6970 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung NO NO NO 67 R-Upper TCGA-55-6970-F57904 TCGA-55-6970 TCGA-55-6970-01A -24773 464 0 457 NO NO Scheduled Follow-up Submission Progressive Disease 2014-3-28 FEMALE Lung Papillary Adenocarcinoma No C34.1 8260/3 C34.1 YES 0.8 NO NO 1.1 NO Locoregional Recurrence YES No MX N2 T2 Stage IIIA TCGA-55-6970.1662fe4b-da42-444a-b7fa-4990d9e8aa9d.pdf 6970 WITH TUMOR Stable Disease Convincing Imaging YES R1 Primary Tumor 01 0.4 6th YES NO YES 55 4 Current reformed smoker for < or = 15 years Lung A DECEASED 2004 TCGA-55-6970-01A-11D-1945-08 4f5215c3-7763-49f8-afe7-b3ce3474afe2 TCGA-55-6970-01A-11D-1943-01 TCGA-55-6970-01A-11D-1947-05 TCGA-55-6970-01 TCGA-55-6970-01A-11D-1943-01 4f5215c3-7763-49f8-afe7-b3ce3474afe2 TCGA-55-6970-01 TCGA-55-6970-01A-13-2191-20 4f5215c3-7763-49f8-afe7-b3ce3474afe2 TCGA-55-6970-01 978d1436-06b6-4591-8538-a8504b820bcd 4f5215c3-7763-49f8-afe7-b3ce3474afe2 TCGA-55-6970-01A-11D-1945-08 TCGA-55-6970-01 +TCGA-55-6970-11 1.39 0.56 none none none none Y Y none none none 0.34 Magnoid none p.G12V none none none none none Papillary predominant Adc Papillary predominant Adc p.T250fs 0 TCGA-55-6970-11 C1-LUAD-enriched TCGA-55-6970 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung NO NO NO 67 R-Upper TCGA-55-6970-F57904 TCGA-55-6970 TCGA-55-6970-11A -24773 464 0 457 NO NO Scheduled Follow-up Submission Progressive Disease 2014-3-28 FEMALE Lung Papillary Adenocarcinoma No C34.1 8260/3 C34.1 YES 0.4 NO NO 0.8 NO Locoregional Recurrence YES No MX N2 T2 Stage IIIA 6970 WITH TUMOR Stable Disease Convincing Imaging YES R1 Solid Tissue Normal 11 0.4 6th YES NO YES 55 4 Current reformed smoker for < or = 15 years Lung A DECEASED 2004 fc4df3f7-2c4b-4a4d-9e5d-faac9e84fde8 fc4df3f7-2c4b-4a4d-9e5d-faac9e84fde8 fc4df3f7-2c4b-4a4d-9e5d-faac9e84fde8 fc4df3f7-2c4b-4a4d-9e5d-faac9e84fde8 +TCGA-55-6971-01 3.34 0.22 none none none none N N none none none 0.1 Magnoid none none none none none none none Acinar predominant Adc Acinar predominant Adc p.G251F 0 TCGA-55-6971-01 BRCA-LUAD+ C1-LUAD-enriched cluster 3 Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 4 cluster 4 TCGA-55-6971 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 59 L-Lower TCGA-55-6971-F56190 TCGA-55-6971 TCGA-55-6971-01A -21734 0 1400 NO NO Scheduled Follow-up Submission Complete Remission/Response 2014-1-29 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 0.5 NO NO 1.1 NO NO 60 No MX N0 T2 Stage IB TCGA-55-6971.c270e56a-dfc6-41a5-9cfc-3c302c4ccc13.pdf 6971 TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 0.2 2010 7th NO NO YES 55 4 Current reformed smoker for < or = 15 years Lung A LIVING 2010 1970 TCGA-55-6971-01A-11D-1945-08 50b1d328-57c8-44ab-9c1a-a2bdbc40c6a4 TCGA-55-6971-01A-11D-1943-01 TCGA-55-6971-01A-11D-1947-05 TCGA-55-6971-01 TCGA-55-6971-01A-11D-1943-01 50b1d328-57c8-44ab-9c1a-a2bdbc40c6a4 TCGA-55-6971-01 TCGA-55-6971-01A-13-2191-20 50b1d328-57c8-44ab-9c1a-a2bdbc40c6a4 TCGA-55-6971-01 324f133e-3269-4bea-939d-2c5ebac520cf 50b1d328-57c8-44ab-9c1a-a2bdbc40c6a4 TCGA-55-6971-01A-11D-1945-08 TCGA-55-6971-01 +TCGA-55-6971-11 3.34 0.22 none none none none N N none none none 0.1 Magnoid none none none none none none none Acinar predominant Adc Acinar predominant Adc p.G251F 0 TCGA-55-6971-11 C1-LUAD-enriched TCGA-55-6971 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 59 L-Lower TCGA-55-6971-F56190 TCGA-55-6971 TCGA-55-6971-11A -21734 0 1400 NO NO Scheduled Follow-up Submission Complete Remission/Response 2014-1-29 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 0.5 NO NO 1 NO NO 60 No MX N0 T2 Stage IB 6971 TUMOR FREE Complete Remission/Response NO R0 Solid Tissue Normal 11 0.4 2010 7th NO NO YES 55 4 Current reformed smoker for < or = 15 years Lung A LIVING 2010 1970 0b78c265-393c-4e3a-a53e-3ba76556c506 0b78c265-393c-4e3a-a53e-3ba76556c506 0b78c265-393c-4e3a-a53e-3ba76556c506 0b78c265-393c-4e3a-a53e-3ba76556c506 +TCGA-55-6972-01 none none none none N N none none none Magnoid none none none none none none none Acinar predominant Adc Acinar predominant Adc none 0 TCGA-55-6972-01 High cluster 3 Low purity c2 LUAD-like c10 miRNA cluster 7 cluster 4 TCGA-55-6972 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 72 R-Upper TCGA-55-6972-F56187 TCGA-55-6972 TCGA-55-6972-01A -26625 1632 0 1475 NO NO Scheduled Follow-up Submission Complete Remission/Response 2014-1-29 MALE Lung Papillary Adenocarcinoma No C34.1 8260/3 C34.1 YES 0.4 NO NO 0.6 NO NO No M0 N0 T2 Stage IB TCGA-55-6972.7d2c5e22-45d5-404c-97c5-5523ea656d75.pdf 6972 TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 0.2 6th NO NO YES 55 2 Current smoker Lung A DECEASED 2005 TCGA-55-6972-01A-11D-1945-08 13e20aec-d506-4fa0-a6e1-121e76dcedc4 TCGA-55-6972-01A-11D-1943-01 TCGA-55-6972-01A-11D-1947-05 TCGA-55-6972-01 TCGA-55-6972-01A-11D-1943-01 13e20aec-d506-4fa0-a6e1-121e76dcedc4 TCGA-55-6972-01 13e20aec-d506-4fa0-a6e1-121e76dcedc4 TCGA-55-6972-01 13e20aec-d506-4fa0-a6e1-121e76dcedc4 TCGA-55-6972-01A-11D-1945-08 TCGA-55-6972-01 +TCGA-55-6972-11 none none none none N N none none none Magnoid none none none none none none none Acinar predominant Adc Acinar predominant Adc none 0 TCGA-55-6972-11 TCGA-55-6972 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 72 R-Upper TCGA-55-6972-F56187 TCGA-55-6972 TCGA-55-6972-11A -26625 1632 0 1475 NO NO Scheduled Follow-up Submission Complete Remission/Response 2014-1-29 MALE Lung Papillary Adenocarcinoma No C34.1 8260/3 C34.1 YES 0.7 NO NO 0.7 NO NO No M0 N0 T2 Stage IB 6972 TUMOR FREE Complete Remission/Response NO R0 Solid Tissue Normal 11 0.4 6th NO NO YES 55 2 Current smoker Lung A DECEASED 2005 e448d6d2-be85-4164-be3f-fd7e5a0c53ec e448d6d2-be85-4164-be3f-fd7e5a0c53ec e448d6d2-be85-4164-be3f-fd7e5a0c53ec e448d6d2-be85-4164-be3f-fd7e5a0c53ec +TCGA-55-6975-01 TCGA-55-6975-01 Squamous Cluster 5 LUAD-like c10 TCGA-55-6975 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 61 L-Lower TCGA-55-6975-F45635 TCGA-55-6975 TCGA-55-6975-01A 118 0 NO NO Scheduled Follow-up Submission Progressive Disease 2013-7-17 MALE Lung Adenocarcinoma Mixed Subtype No C34.3 8255/3 C34.3 YES 0.2 NO NO 0.2 NO NO No M0 N1 T2 Stage IIB TCGA-55-6975.7c03cf6a-c871-4c53-af4d-cb931f6d8b72.pdf 6975 WITH TUMOR Progressive Disease NO Primary Tumor 01 0.1 2004 6th NO NO YES 55 4 Lung A DECEASED 2004 7ee4963f-9682-46b1-8946-4c726fd81c39 TCGA-55-6975-01A-11D-1943-01 TCGA-55-6975-01A-11D-1947-05 TCGA-55-6975-01 TCGA-55-6975-01A-11D-1943-01 7ee4963f-9682-46b1-8946-4c726fd81c39 7ee4963f-9682-46b1-8946-4c726fd81c39 TCGA-55-6975-01 7ee4963f-9682-46b1-8946-4c726fd81c39 TCGA-55-6975-01A-11D-1945-08 +TCGA-55-6975-11 TCGA-55-6975-11 TCGA-55-6975 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 61 L-Lower TCGA-55-6975-F45635 TCGA-55-6975 TCGA-55-6975-11A 118 0 NO NO Scheduled Follow-up Submission Progressive Disease 2013-7-17 MALE Lung Adenocarcinoma Mixed Subtype No C34.3 8255/3 C34.3 YES 0.9 NO NO 0.9 NO NO No M0 N1 T2 Stage IIB 6975 WITH TUMOR Progressive Disease NO Solid Tissue Normal 11 0.8 2004 6th NO NO YES 55 4 Lung A DECEASED 2004 9ae0702d-672e-44c0-b548-25e11c198887 9ae0702d-672e-44c0-b548-25e11c198887 9ae0702d-672e-44c0-b548-25e11c198887 9ae0702d-672e-44c0-b548-25e11c198887 +TCGA-55-6978-01 none none none none N N none none none Squamoid none none none none none none none NSCLC, favor Adeno NSCLC, favor Adeno none 0 TCGA-55-6978-01 Squamous C1-LUAD-enriched cluster 2 Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 4 cluster 2 TCGA-55-6978 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung NO YES NO NO 81 R-Middle TCGA-55-6978-F45607 TCGA-55-6978 TCGA-55-6978-01A 176 0 42 NO NO Scheduled Follow-up Submission Progressive Disease 2013-7-17 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.2 8140/3 C34.2 YES 0.6 NO NO 0.7 NO YES Yes MX N0 T2b Stage IIA TCGA-55-6978.3e3c1e82-ee09-4eeb-873a-9b6580274f97.pdf 6978 WITH TUMOR Progressive Disease NO Primary Tumor 01 0.2 7th NO NO YES 55 1 Lifelong Non-smoker Lung A DECEASED 2010 TCGA-55-6978-01A-11D-1945-08 7a25f591-c475-4bc4-a0ad-85f41e072608 TCGA-55-6978-01A-11D-1943-01 TCGA-55-6978-01A-11D-1947-05 TCGA-55-6978-01 TCGA-55-6978-01A-11D-1943-01 7a25f591-c475-4bc4-a0ad-85f41e072608 TCGA-55-6978-01 TCGA-55-6978-01A-13-2191-20 7a25f591-c475-4bc4-a0ad-85f41e072608 TCGA-55-6978-01 d49d649a-ddee-4f58-b56f-2e0fe6bf220e 7a25f591-c475-4bc4-a0ad-85f41e072608 TCGA-55-6978-01A-11D-1945-08 TCGA-55-6978-01 +TCGA-55-6978-11 none none none none N N none none none Squamoid none none none none none none none NSCLC, favor Adeno NSCLC, favor Adeno none 0 TCGA-55-6978-11 C1-LUAD-enriched TCGA-55-6978 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung NO YES NO NO 81 R-Middle TCGA-55-6978-F45607 TCGA-55-6978 TCGA-55-6978-11A 176 0 42 NO NO Scheduled Follow-up Submission Progressive Disease 2013-7-17 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.2 8140/3 C34.2 YES 0.7 NO NO 1.1 NO YES Yes MX N0 T2b Stage IIA 6978 WITH TUMOR Progressive Disease NO Solid Tissue Normal 11 0.5 7th NO NO YES 55 1 Lifelong Non-smoker Lung A DECEASED 2010 b3b1d4f3-1511-40a5-bf62-0ddf0893eac5 b3b1d4f3-1511-40a5-bf62-0ddf0893eac5 b3b1d4f3-1511-40a5-bf62-0ddf0893eac5 b3b1d4f3-1511-40a5-bf62-0ddf0893eac5 +TCGA-55-6979-01 3.35 0.18 none p.P367R none none N N none none none 0.08 Squamoid none none none none none none none Solid predominant Adc Solid predominant Adc none 0 TCGA-55-6979-01 High C1-LUAD-enriched cluster 3 Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 7 cluster 4 TCGA-55-6979 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung YES YES NO 59 L-Upper TCGA-55-6979-F37057 TCGA-55-6979 TCGA-55-6979-01A -21780 237 0 195 NO NO Scheduled Follow-up Submission Progressive Disease 2013-2-22 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.7 NO NO 1 NO Distant Metastasis YES Yes M0 N1 T2 Stage IIB TCGA-55-6979.c7896f40-c1a5-4e4c-bfea-7e80c94c66ad.pdf 6979 WITH TUMOR Progressive Disease Convincing Imaging NO Primary Tumor 01 0.4 6th YES NO YES 55 3 Current reformed smoker for > 15 years Lung A DECEASED 2006 TCGA-55-6979-01A-11D-1945-08 a7a6d133-a7d0-44ea-bac5-3a8b7ddd9cd8 TCGA-55-6979-01A-11D-1943-01 TCGA-55-6979-01A-11D-1947-05 TCGA-55-6979-01 TCGA-55-6979-01A-11D-1943-01 a7a6d133-a7d0-44ea-bac5-3a8b7ddd9cd8 TCGA-55-6979-01 TCGA-55-6979-01A-13-2191-20 a7a6d133-a7d0-44ea-bac5-3a8b7ddd9cd8 TCGA-55-6979-01 4283cc72-754c-4dec-b8c3-93b5cbaf6a95 a7a6d133-a7d0-44ea-bac5-3a8b7ddd9cd8 TCGA-55-6979-01A-11D-1945-08 TCGA-55-6979-01 +TCGA-55-6979-11 3.35 0.18 none p.P367R none none N N none none none 0.08 Squamoid none none none none none none none Solid predominant Adc Solid predominant Adc none 0 TCGA-55-6979-11 C1-LUAD-enriched TCGA-55-6979 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung YES YES NO 59 L-Upper TCGA-55-6979-F37057 TCGA-55-6979 TCGA-55-6979-11A -21780 237 0 195 NO NO Scheduled Follow-up Submission Progressive Disease 2013-2-22 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.5 NO NO 1 NO Distant Metastasis YES Yes M0 N1 T2 Stage IIB 6979 WITH TUMOR Progressive Disease Convincing Imaging NO Solid Tissue Normal 11 0.1 6th YES NO YES 55 3 Current reformed smoker for > 15 years Lung A DECEASED 2006 3d563365-c563-4fba-b67b-8aad1af89eab 3d563365-c563-4fba-b67b-8aad1af89eab 3d563365-c563-4fba-b67b-8aad1af89eab 3d563365-c563-4fba-b67b-8aad1af89eab +TCGA-55-6980-01 2.15 0.3 none none none none Y Y p.709_710ET>D none none 0.15 Bronchioid none none none none none none none Other see comment Acinar predominant Adc none 0 TCGA-55-6980-01 High cluster 3 Cluster 5 LUAD-like c10 miRNA cluster 4 cluster 5 TCGA-55-6980 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 56 R-Lower TCGA-55-6980-F46642 TCGA-55-6980 TCGA-55-6980-01A 0 2109 NO NO Scheduled Follow-up Submission Complete Remission/Response 2013-8-13 MALE Lung Bronchioloalveolar Carcinoma Nonmucinous No C34.3 8252/3 C34.3 YES 0.3 NO NO 0.7 NO NO No M0 N0 T1 Stage IA TCGA-55-6980.e73aad2d-83d3-46b2-b2e9-cc93c5fbd670.pdf 6980 TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 0.1 6th NO NO YES 55 1 Lifelong Non-smoker Lung A LIVING 2006 TCGA-55-6980-01A-11D-1945-08 5eae1d0f-5ca1-499b-963f-2fce4807ccc6 TCGA-55-6980-01A-11D-1943-01 TCGA-55-6980-01A-11D-1947-05 TCGA-55-6980-01 TCGA-55-6980-01A-11D-1943-01 5eae1d0f-5ca1-499b-963f-2fce4807ccc6 TCGA-55-6980-01 5eae1d0f-5ca1-499b-963f-2fce4807ccc6 TCGA-55-6980-01 5eae1d0f-5ca1-499b-963f-2fce4807ccc6 TCGA-55-6980-01A-11D-1945-08 TCGA-55-6980-01 +TCGA-55-6980-11 2.15 0.3 none none none none Y Y p.709_710ET>D none none 0.15 Bronchioid none none none none none none none Other see comment Acinar predominant Adc none 0 TCGA-55-6980-11 TCGA-55-6980 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 56 R-Lower TCGA-55-6980-F46642 TCGA-55-6980 TCGA-55-6980-11A 0 2109 NO NO Scheduled Follow-up Submission Complete Remission/Response 2013-8-13 MALE Lung Bronchioloalveolar Carcinoma Nonmucinous No C34.3 8252/3 C34.3 YES 0.9 NO NO 1 NO NO No M0 N0 T1 Stage IA 6980 TUMOR FREE Complete Remission/Response NO R0 Solid Tissue Normal 11 0.2 6th NO NO YES 55 1 Lifelong Non-smoker Lung A LIVING 2006 cdc81d17-1d85-42e5-a3ec-f458e6ab83f6 cdc81d17-1d85-42e5-a3ec-f458e6ab83f6 cdc81d17-1d85-42e5-a3ec-f458e6ab83f6 cdc81d17-1d85-42e5-a3ec-f458e6ab83f6 +TCGA-55-6981-01 3.42 0.27 none none none none Y Y p.LREAT747del none none 0.11 Squamoid none none none none none none none Solid predominant Adc Solid predominant Adc none 0 TCGA-55-6981-01 BRCA-LUAD+ C1-LUAD-enriched cluster 2 Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 4 cluster 5 TCGA-55-6981 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 53 L-Upper TCGA-55-6981-F56243 TCGA-55-6981 TCGA-55-6981-01A -19497 1379 0 NO NO Scheduled Follow-up Submission Complete Remission/Response 2014-1-30 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.6 NO NO 0.8 NO NO No M0 N2 T1 Stage IIIA TCGA-55-6981.84738cad-3b17-456c-a9a0-21f6e044a688.pdf 6981 TUMOR FREE Complete Remission/Response YES R0 Primary Tumor 01 0.4 6th YES NO YES 55 3 Current reformed smoker for > 15 years Lung A DECEASED 2005 TCGA-55-6981-01A-11D-1945-08 af2f26d9-617a-42f3-a083-352d5e576460 TCGA-55-6981-01A-11D-1943-01 TCGA-55-6981-01A-11D-1947-05 TCGA-55-6981-01 TCGA-55-6981-01A-11D-1943-01 af2f26d9-617a-42f3-a083-352d5e576460 TCGA-55-6981-01 TCGA-55-6981-01A-13-2191-20 af2f26d9-617a-42f3-a083-352d5e576460 TCGA-55-6981-01 1ee6ed8b-3ce5-4565-9948-33bdc5e40c92 af2f26d9-617a-42f3-a083-352d5e576460 TCGA-55-6981-01A-11D-1945-08 TCGA-55-6981-01 +TCGA-55-6981-11 3.42 0.27 none none none none Y Y p.LREAT747del none none 0.11 Squamoid none none none none none none none Solid predominant Adc Solid predominant Adc none 0 TCGA-55-6981-11 C1-LUAD-enriched TCGA-55-6981 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 53 L-Upper TCGA-55-6981-F56243 TCGA-55-6981 TCGA-55-6981-11A -19497 1379 0 NO NO Scheduled Follow-up Submission Complete Remission/Response 2014-1-30 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.8 NO NO 1.1 NO NO No M0 N2 T1 Stage IIIA 6981 TUMOR FREE Complete Remission/Response YES R0 Solid Tissue Normal 11 0.4 6th YES NO YES 55 3 Current reformed smoker for > 15 years Lung A DECEASED 2005 988e9e29-398e-45af-a4da-b6e7d119b776 988e9e29-398e-45af-a4da-b6e7d119b776 988e9e29-398e-45af-a4da-b6e7d119b776 988e9e29-398e-45af-a4da-b6e7d119b776 +TCGA-55-6982-01 2.7 0.25 none none none none N N none none none 0.11 Squamoid none none none p.D1010_splice none none none Solid predominant Adc Solid predominant Adc none 0 TCGA-55-6982-01 BRCA-LUAD+ C1-LUAD-enriched cluster 2 Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 4 cluster 4 TCGA-55-6982 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung YES YES NO YES 79 R-Lower TCGA-55-6982-F46626 TCGA-55-6982 TCGA-55-6982-01A 183 995 0 183 NO NO Scheduled Follow-up Submission Progressive Disease 2013-8-13 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 0.3 NO NO 0.5 NO Distant Metastasis YES No M0 N1 T2 Stage IIB TCGA-55-6982.54e65072-9bea-41d0-b976-5f5723379c51.pdf 6982 WITH TUMOR Progressive Disease Convincing Imaging NO Primary Tumor 01 0.1 6th NO NO YES 55 1 Lifelong Non-smoker Lung A DECEASED 2004 TCGA-55-6982-01A-11D-1945-08 681fbd5b-5bff-434d-8ff4-d995fc517e93 TCGA-55-6982-01A-11D-1943-01 TCGA-55-6982-01A-11D-1947-05 TCGA-55-6982-01 TCGA-55-6982-01A-11D-1943-01 681fbd5b-5bff-434d-8ff4-d995fc517e93 TCGA-55-6982-01 TCGA-55-6982-01A-13-2191-20 681fbd5b-5bff-434d-8ff4-d995fc517e93 TCGA-55-6982-01 1615fbef-fcaa-4509-a01f-0f00f69c6106 681fbd5b-5bff-434d-8ff4-d995fc517e93 TCGA-55-6982-01A-11D-1945-08 TCGA-55-6982-01 +TCGA-55-6982-11 2.7 0.25 none none none none N N none none none 0.11 Squamoid none none none p.D1010_splice none none none Solid predominant Adc Solid predominant Adc none 0 TCGA-55-6982-11 C1-LUAD-enriched TCGA-55-6982 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung YES YES NO YES 79 R-Lower TCGA-55-6982-F46626 TCGA-55-6982 TCGA-55-6982-11A 183 995 0 183 NO NO Scheduled Follow-up Submission Progressive Disease 2013-8-13 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 0.7 NO NO 0.8 NO Distant Metastasis YES No M0 N1 T2 Stage IIB 6982 WITH TUMOR Progressive Disease Convincing Imaging NO Solid Tissue Normal 11 0.5 6th NO NO YES 55 1 Lifelong Non-smoker Lung A DECEASED 2004 2b7e9552-e34f-4c68-96af-1c01a605df60 2b7e9552-e34f-4c68-96af-1c01a605df60 2b7e9552-e34f-4c68-96af-1c01a605df60 2b7e9552-e34f-4c68-96af-1c01a605df60 +TCGA-55-6983-01 none none none none Y Y none none none Magnoid none p.G12C none none none none none Colloid adenoca Colloid adenoca p.R75fs 0 TCGA-55-6983-01 Iq cluster 2 Cluster 6 LUAD-like c10 miRNA cluster 6 cluster 1 TCGA-55-6983 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 81 L-Lower TCGA-55-6983-F47805 TCGA-55-6983 TCGA-55-6983-01A 0 2823 NO NO Scheduled Follow-up Submission Complete Remission/Response 2013-8-28 MALE Mucinous (Colloid) Carcinoma No C34.30 8480/3 C34.3 YES 0.3 NO NO 0.5 NO NO 60 No M0 N1 T2 Stage IIB TCGA-55-6983.5428a18c-8db6-4dbc-bec0-b55658f3302b.pdf 6983 TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 0.2 6th YES NO YES 55 4 Current reformed smoker for < or = 15 years Lung A LIVING 2005 TCGA-55-6983-01A-11D-1945-08 3f4a27fd-378a-4d74-91c1-eda773c26b79 TCGA-55-6983-01A-11D-1943-01 TCGA-55-6983-01A-11D-1947-05 TCGA-55-6983-01 TCGA-55-6983-01A-11D-1943-01 3f4a27fd-378a-4d74-91c1-eda773c26b79 TCGA-55-6983-01 3f4a27fd-378a-4d74-91c1-eda773c26b79 TCGA-55-6983-01 3f4a27fd-378a-4d74-91c1-eda773c26b79 TCGA-55-6983-01A-11D-1945-08 TCGA-55-6983-01 +TCGA-55-6983-11 none none none none Y Y none none none Magnoid none p.G12C none none none none none Colloid adenoca Colloid adenoca p.R75fs 0 TCGA-55-6983-11 TCGA-55-6983 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 81 L-Lower TCGA-55-6983-F47805 TCGA-55-6983 TCGA-55-6983-11A 0 2823 NO NO Scheduled Follow-up Submission Complete Remission/Response 2013-8-28 MALE Mucinous (Colloid) Carcinoma No C34.30 8480/3 C34.3 YES 0.9 NO NO 1.1 NO NO 60 No M0 N1 T2 Stage IIB 6983 TUMOR FREE Complete Remission/Response NO R0 Solid Tissue Normal 11 0.4 6th YES NO YES 55 4 Current reformed smoker for < or = 15 years Lung A LIVING 2005 97a84c2b-7832-479c-8d01-a9ff610e7bf4 97a84c2b-7832-479c-8d01-a9ff610e7bf4 97a84c2b-7832-479c-8d01-a9ff610e7bf4 97a84c2b-7832-479c-8d01-a9ff610e7bf4 +TCGA-55-6984-01 TCGA-55-6984-01 BRCA-LUAD+ BRCA non-CIMP c9 LUAD-like c10 miRNA cluster 4 TCGA-55-6984 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung YES NO NO NO 71 L-Lower TCGA-55-6984-F45632 TCGA-55-6984 760 0 724 NO NO Scheduled Follow-up Submission Progressive Disease 2013-7-17 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES NO NO YES No M0 N1 T2 Stage IIB 6984 WITH TUMOR Complete Remission/Response NO Primary Tumor 01 6th YES NO YES 55 Lung DECEASED 2006 bf920e10-514e-4623-b92e-c83a3e32485f TCGA-55-6984-01A-11D-1943-01 TCGA-55-6984-01A-11D-1947-05 TCGA-55-6984-01 TCGA-55-6984-01A-11D-1943-01 bf920e10-514e-4623-b92e-c83a3e32485f TCGA-55-6984-01 bf920e10-514e-4623-b92e-c83a3e32485f TCGA-55-6984-01 bf920e10-514e-4623-b92e-c83a3e32485f TCGA-55-6984-01A-11D-1945-08 TCGA-55-6984-01 +TCGA-55-6984-11 TCGA-55-6984-11 TCGA-55-6984 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung YES NO NO NO 71 L-Lower TCGA-55-6984-F45632 TCGA-55-6984 TCGA-55-6984-11A 760 0 724 NO NO Scheduled Follow-up Submission Progressive Disease 2013-7-17 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 0.6 NO NO 1 NO YES No M0 N1 T2 Stage IIB 6984 WITH TUMOR Complete Remission/Response NO Solid Tissue Normal 11 0.4 6th YES NO YES 55 Lung A DECEASED 2006 d777ced1-c519-4281-b0c0-9e9188303e87 d777ced1-c519-4281-b0c0-9e9188303e87 d777ced1-c519-4281-b0c0-9e9188303e87 d777ced1-c519-4281-b0c0-9e9188303e87 +TCGA-55-6985-01 none none none none N N none none none Squamoid none none none none none none none Acinar predominant Adc Acinar predominant Adc none 0 TCGA-55-6985-01 Squamous cluster 2 Cluster 6 LUAD-like c10 miRNA cluster 4 cluster 5 TCGA-55-6985 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 58 L-Upper TCGA-55-6985-F37056 TCGA-55-6985 -21381 0 1233 NO NO Scheduled Follow-up Submission 2013-2-22 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES NO YES NO 50 No MX N0 T2 Stage IB 6985 TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 2004 6th NO NO YES 55 4 Current reformed smoker for < or = 15 years Lung LIVING 2004 TCGA-55-6985-01A-11D-1945-08 fc852193-d692-4a36-83bd-30f49df5f973 TCGA-55-6985-01A-11D-1943-01 TCGA-55-6985-01A-11D-1947-05 TCGA-55-6985-01 TCGA-55-6985-01A-11D-1943-01 fc852193-d692-4a36-83bd-30f49df5f973 TCGA-55-6985-01 fc852193-d692-4a36-83bd-30f49df5f973 TCGA-55-6985-01 fc852193-d692-4a36-83bd-30f49df5f973 TCGA-55-6985-01A-11D-1945-08 TCGA-55-6985-01 +TCGA-55-6985-11 none none none none N N none none none Squamoid none none none none none none none Acinar predominant Adc Acinar predominant Adc none 0 TCGA-55-6985-11 TCGA-55-6985 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 58 L-Upper TCGA-55-6985-F37056 TCGA-55-6985 TCGA-55-6985-11A -21381 0 1233 NO NO Scheduled Follow-up Submission 2013-2-22 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.9 NO NO 1.2 YES NO 50 No MX N0 T2 Stage IB 6985 TUMOR FREE Complete Remission/Response NO R0 Solid Tissue Normal 11 0.4 2004 6th NO NO YES 55 4 Current reformed smoker for < or = 15 years Lung A LIVING 2004 6cc31d25-1d4e-4f17-9321-2474befc3232 6cc31d25-1d4e-4f17-9321-2474befc3232 6cc31d25-1d4e-4f17-9321-2474befc3232 6cc31d25-1d4e-4f17-9321-2474befc3232 +TCGA-55-6986-01 1.96 0.39 none none none none N Y none none none 0.2 Bronchioid none none none none none none none Micropapillary predom Adc Micropapillary predom Adc Y none 0 TCGA-55-6986-01 Kirc+ cluster 2 Cluster 6 LUAD-like c10 miRNA c1uster 9 cluster 4 TCGA-55-6986 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 74 R-Lower TCGA-55-6986-F45606 TCGA-55-6986 0 3261 NO NO Scheduled Follow-up Submission Complete Remission/Response 2013-7-17 FEMALE Lung Bronchioloalveolar Carcinoma Nonmucinous No C34.3 8252/3 C34.3 YES NO NO NO No M0 N0 T2 Stage IB 6986 TUMOR FREE Complete Remission/Response NO Primary Tumor 01 6th NO NO YES 55 1 Lifelong Non-smoker Lung LIVING 2004 TCGA-55-6986-01A-11D-1945-08 c2711074-5019-4c8f-a5d7-7bf4654f5647 TCGA-55-6986-01A-11D-1943-01 TCGA-55-6986-01A-11D-1947-05 TCGA-55-6986-01 TCGA-55-6986-01A-11D-1943-01 c2711074-5019-4c8f-a5d7-7bf4654f5647 TCGA-55-6986-01 c2711074-5019-4c8f-a5d7-7bf4654f5647 TCGA-55-6986-01 c2711074-5019-4c8f-a5d7-7bf4654f5647 TCGA-55-6986-01A-11D-1945-08 TCGA-55-6986-01 +TCGA-55-6986-11 1.96 0.39 none none none none N Y none none none 0.2 Bronchioid none none none none none none none Micropapillary predom Adc Micropapillary predom Adc Y none 0 TCGA-55-6986-11 TCGA-55-6986 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 74 R-Lower TCGA-55-6986-F45606 TCGA-55-6986 TCGA-55-6986-11A 0 3261 NO NO Scheduled Follow-up Submission Complete Remission/Response 2013-7-17 FEMALE Lung Bronchioloalveolar Carcinoma Nonmucinous No C34.3 8252/3 C34.3 YES 0.6 NO NO 0.7 NO NO No M0 N0 T2 Stage IB 6986 TUMOR FREE Complete Remission/Response NO Solid Tissue Normal 11 0.5 6th NO NO YES 55 1 Lifelong Non-smoker Lung A LIVING 2004 e1adae95-dfa9-4279-8fc1-2f899f432360 e1adae95-dfa9-4279-8fc1-2f899f432360 e1adae95-dfa9-4279-8fc1-2f899f432360 e1adae95-dfa9-4279-8fc1-2f899f432360 +TCGA-55-6987-01 TCGA-55-6987-01 High Cluster 5 LUAD-like c10 miRNA cluster 7 TCGA-55-6987 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 77 L-Lower TCGA-55-6987-F47803 TCGA-55-6987 TCGA-55-6987-01A -28382 0 2137 NO NO Scheduled Follow-up Submission Complete Remission/Response 2013-8-28 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 0.1 NO NO 0.2 NO NO No M0 N0 T1 Stage IA TCGA-55-6987.345eb11f-9520-4463-8a84-07aeb26ce559.pdf 6987 TUMOR FREE Complete Remission/Response NO Primary Tumor 01 0.1 2006 6th NO NO YES 55 4 Lung A LIVING 2006 779acc52-4279-4249-b993-88ed032ccefa TCGA-55-6987-01A-11D-1943-01 TCGA-55-6987-01A-11D-1947-05 TCGA-55-6987-01 TCGA-55-6987-01A-11D-1943-01 779acc52-4279-4249-b993-88ed032ccefa TCGA-55-6987-01 779acc52-4279-4249-b993-88ed032ccefa TCGA-55-6987-01 779acc52-4279-4249-b993-88ed032ccefa TCGA-55-6987-01A-11D-1945-08 TCGA-55-6987-01 +TCGA-55-7227-01 TCGA-55-7227-01 Kirc+ Cluster 6 LUAD-like c10 miRNA cluster 4 TCGA-55-7227 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung YES NO NO 77 R-Lower TCGA-55-7227-F65704 TCGA-55-7227 TCGA-55-7227-01A -28458 952 0 53 255 Scheduled Follow-up Submission Progressive Disease 2014-9-26 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 0.3 NO 0.5 NO Locoregional Recurrence YES No MX N1 T3 Stage IIIA TCGA-55-7227.7910979d-a635-4ef5-ab00-84df0455df66.pdf 7227 WITH TUMOR Complete Remission/Response Convincing Imaging NO R0 Primary Tumor 01 0.1 1993 7th NO YES NO 55 3 Lung A DECEASED 2011 1953 987c7eea-648f-4feb-8239-0b9151a74331 TCGA-55-7227-01A-11D-2037-05 987c7eea-648f-4feb-8239-0b9151a74331 TCGA-55-7227-01 987c7eea-648f-4feb-8239-0b9151a74331 TCGA-55-7227-01 987c7eea-648f-4feb-8239-0b9151a74331 TCGA-55-7227-01A-11D-2036-08 TCGA-55-7227-01 +TCGA-55-7281-01 1.85 0.59 none none none none Y Y none none none 0.31 Bronchioid none p.G12C none none none none none Acinar predominant Adc Acinar predominant Adc none 0 TCGA-55-7281-01 BRCA-LUAD+ cluster 2 Cluster 6 LUAD-like c10 miRNA cluster 4 cluster 2 TCGA-55-7281 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung YES YES NO NO 70 R-Middle TCGA-55-7281-F47807 TCGA-55-7281 -25870 0 872 339 Scheduled Follow-up Submission Partial Remission/Response 2013-8-28 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.2 8140/3 C34.2 YES NO NO Distant Metastasis YES 20 No M0 N0 T1b Stage IA 7281 WITH TUMOR Complete Remission/Response Convincing Imaging NO R0 Primary Tumor 01 7th NO YES NO 55 4 Current reformed smoker for < or = 15 years Lung LIVING 2011 TCGA-55-7281-01A-11D-2036-08 b4a82c9e-4b14-42ed-8d33-6494ec475827 TCGA-55-7281-01A-11D-2035-01 TCGA-55-7281-01A-11D-2037-05 TCGA-55-7281-01 TCGA-55-7281-01A-11D-2035-01 b4a82c9e-4b14-42ed-8d33-6494ec475827 TCGA-55-7281-01 b4a82c9e-4b14-42ed-8d33-6494ec475827 TCGA-55-7281-01 b4a82c9e-4b14-42ed-8d33-6494ec475827 TCGA-55-7281-01A-11D-2036-08 TCGA-55-7281-01 +TCGA-55-7283-01 p.D323Y none none none Y Y none none none Bronchioid none p.G12S none none none none none Adenocarcinoma, NOS Adenocarcinoma, NOS none 0 TCGA-55-7283-01 BRCA-LUAD+ cluster 1 Cluster 6 LUAD-like c10 miRNA cluster 5 cluster 3 TCGA-55-7283 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 76 R-Upper TCGA-55-7283-F46988 TCGA-55-7283 TCGA-55-7283-01A -27946 0 609 64 0 NO NO Scheduled Follow-up Submission Partial Remission/Response 2013-8-21 FEMALE Lung Bronchioloalveolar Carcinoma Nonmucinous No C34.1 8252/3 C34.1 YES 0.1 NO 100 NO Central Lung 0.1 NO NO 5 No MX N2 T3 Stage IIIA TCGA-55-7283.39929fe3-b87c-413c-8613-f5a15b407b28.pdf 7283 Preoperative WITH TUMOR 105 82 Partial Remission/Response YES NO Primary Tumor 01 0.1 1961 7th YES YES NO 55 3 Current reformed smoker for > 15 years Lung A LIVING 2011 1950 TCGA-55-7283-01A-11D-2036-08 91449ec2-a03f-4cc8-8738-4819564d9dae TCGA-55-7283-01A-11D-2035-01 TCGA-55-7283-01A-11D-2037-05 TCGA-55-7283-01 TCGA-55-7283-01A-11D-2035-01 91449ec2-a03f-4cc8-8738-4819564d9dae TCGA-55-7283-01 91449ec2-a03f-4cc8-8738-4819564d9dae TCGA-55-7283-01 91449ec2-a03f-4cc8-8738-4819564d9dae TCGA-55-7283-01A-11D-2036-08 TCGA-55-7283-01 +TCGA-55-7283-11 p.D323Y none none none Y Y none none none Bronchioid none p.G12S none none none none none Adenocarcinoma, NOS Adenocarcinoma, NOS none 0 TCGA-55-7283-11 TCGA-55-7283 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 76 R-Upper TCGA-55-7283-F46988 TCGA-55-7283 -27946 0 609 64 0 NO NO Scheduled Follow-up Submission Partial Remission/Response 2013-8-21 FEMALE Lung Bronchioloalveolar Carcinoma Nonmucinous No C34.1 8252/3 C34.1 YES 100 NO Central Lung NO NO 5 No MX N2 T3 Stage IIIA 7283 Preoperative WITH TUMOR 105 82 Partial Remission/Response YES NO Solid Tissue Normal 11 1961 7th YES YES NO 55 3 Current reformed smoker for > 15 years Lung LIVING 2011 1950 TCGA-55-7283-11 TCGA-55-7283-11 +TCGA-55-7284-01 TCGA-55-7284-01 Iq Cluster 5 LUAD-like c10 miRNA cluster 4 TCGA-55-7284 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung NO NO NO NO 74 R-Lower TCGA-55-7284-F61486 TCGA-55-7284 TCGA-55-7284-01B -27087 243 0 121 231 89 Scheduled Follow-up Submission Progressive Disease 2014-6-30 MALE Lung Bronchioloalveolar Carcinoma Nonmucinous No C34.8 8252/3 C34.8 YES 0.5 NO 0.9 NO Distant Metastasis YES Yes, History of Synchronous/Bilateral Malignancy MX N0 T3 Stage IIB TCGA-55-7284.ca201579-79b6-4a03-a982-9f43bf16471b.pdf 7284 WITH TUMOR 102 70 108 74 Complete Remission/Response Convincing Imaging YES NO R0 Primary Tumor 01 0.3 7th NO YES NO 55 3 Lung B DECEASED 2011 43d4cf00-5ed1-4f50-a2a4-31ee7c387eb9 TCGA-55-7284-01B-11D-2237-01 TCGA-55-7284-01B-11D-2239-05 TCGA-55-7284-01 TCGA-55-7284-01B-11D-2237-01 43d4cf00-5ed1-4f50-a2a4-31ee7c387eb9 TCGA-55-7284-01 43d4cf00-5ed1-4f50-a2a4-31ee7c387eb9 TCGA-55-7284-01 43d4cf00-5ed1-4f50-a2a4-31ee7c387eb9 TCGA-55-7284-01B-11D-2238-08 TCGA-55-7284-01 +TCGA-55-7570-01 TCGA-55-7570-01 Squamous Cluster 5 RNA cluster 3 miRNA cluster 4 TCGA-55-7570 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 60 R-Upper TCGA-55-7570-F56185 TCGA-55-7570 TCGA-55-7570-01A -22218 0 824 Scheduled Follow-up Submission Complete Remission/Response 2014-1-29 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.2 NO 0.3 NO NO No MX N0 T1a Stage IA TCGA-55-7570.95cb32d6-2999-44eb-a93f-31aa65a6c51c.pdf 7570 TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 0.2 7th NO YES NO 55 2 Lung A LIVING 2011 1971 56982118-0f10-47b2-af05-18b037c73f22 TCGA-55-7570-01A-11D-2035-01 TCGA-55-7570-01A-11D-2037-05 TCGA-55-7570-01 TCGA-55-7570-01A-11D-2035-01 56982118-0f10-47b2-af05-18b037c73f22 TCGA-55-7570-01 56982118-0f10-47b2-af05-18b037c73f22 TCGA-55-7570-01 56982118-0f10-47b2-af05-18b037c73f22 TCGA-55-7570-01A-11D-2036-08 TCGA-55-7570-01 +TCGA-55-7570-11 TCGA-55-7570-11 TCGA-55-7570 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 60 R-Upper TCGA-55-7570-F56185 TCGA-55-7570 -22218 0 824 Scheduled Follow-up Submission Complete Remission/Response 2014-1-29 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES NO NO No MX N0 T1a Stage IA 7570 TUMOR FREE Complete Remission/Response NO R0 Solid Tissue Normal 11 7th NO YES NO 55 2 Lung LIVING 2011 1971 TCGA-55-7570-11 TCGA-55-7570-11 +TCGA-55-7573-01 3.2 0.33 none none none none Y Y p.K754E, p.ELR746del none none 0.14 Bronchioid none none none none none none none Acinar predominant Adc Acinar predominant Adc none 0 TCGA-55-7573-01 Iq C1-LUAD-enriched cluster 3 Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 5 cluster 3 TCGA-55-7573 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 72 R-Upper TCGA-55-7573-F46657 TCGA-55-7573 TCGA-55-7573-01A -26302 0 487 51 1 NO NO Scheduled Follow-up Submission Complete Remission/Response 2013-8-13 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.7 NO 90 NO Central Lung 0.9 NO NO Yes MX N0 T1b Stage IA TCGA-55-7573.3eda2065-31da-49d1-8974-9d004ed26113.pdf 7573 Preoperative TUMOR FREE 119 134 115 130 Complete Remission/Response YES NO Primary Tumor 01 0.2 1983 7th NO YES NO 55 3 Current reformed smoker for > 15 years Lung A LIVING 2011 TCGA-55-7573-01A-11D-2036-08 f9faf081-c497-44a3-9df1-da2be95e41d0 TCGA-55-7573-01A-11D-2035-01 TCGA-55-7573-01A-11D-2037-05 TCGA-55-7573-01 TCGA-55-7573-01A-11D-2035-01 f9faf081-c497-44a3-9df1-da2be95e41d0 TCGA-55-7573-01 TCGA-55-7573-01A-11-2192-20 f9faf081-c497-44a3-9df1-da2be95e41d0 TCGA-55-7573-01 8a3614c0-ea67-4f95-97af-e64ef9de981a f9faf081-c497-44a3-9df1-da2be95e41d0 TCGA-55-7573-01A-11D-2036-08 TCGA-55-7573-01 +TCGA-55-7574-01 2.12 0.16 none none none none N N none none none 0.08 Bronchioid none none none none none p.R87T none Solid predominant Adc Solid predominant Adc p.K97_splice 0 TCGA-55-7574-01 Squamous C1-LUAD-enriched cluster 2 Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 5 cluster 3 TCGA-55-7574 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung YES YES NO NO 64 R-Upper TCGA-55-7574-F64279 TCGA-55-7574 TCGA-55-7574-01A -23703 995 0 95 478 3 Scheduled Follow-up Submission Progressive Disease 2014-8-28 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.7 NO 50 NO 0.9 NO Distant Metastasis YES 2 No M0 N0 T2a Stage IB TCGA-55-7574.7bf6ed4b-a0da-4bcd-ba62-211d2d2a86e7.pdf 7574 Post-Adjuvant Therapy WITH TUMOR Complete Remission/Response Convincing Imaging YES R1 Primary Tumor 01 0.4 2011 7th YES YES NO 55 4 Current reformed smoker for < or = 15 years Lung A DECEASED 2011 1971 TCGA-55-7574-01A-11D-2036-08 bbf4c600-a4c5-4ad6-8842-d90639aab690 TCGA-55-7574-01A-11D-2035-01 TCGA-55-7574-01A-11D-2037-05 TCGA-55-7574-01 TCGA-55-7574-01A-11D-2035-01 bbf4c600-a4c5-4ad6-8842-d90639aab690 TCGA-55-7574-01 TCGA-55-7574-01A-11-2192-20 bbf4c600-a4c5-4ad6-8842-d90639aab690 TCGA-55-7574-01 253ddce6-582d-4108-9c27-1575e415d37f bbf4c600-a4c5-4ad6-8842-d90639aab690 TCGA-55-7574-01A-11D-2036-08 TCGA-55-7574-01 +TCGA-55-7574-11 2.12 0.16 none none none none N N none none none 0.08 Bronchioid none none none none none p.R87T none Solid predominant Adc Solid predominant Adc p.K97_splice 0 TCGA-55-7574-11 C1-LUAD-enriched TCGA-55-7574 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung YES YES NO NO 64 R-Upper TCGA-55-7574-F64279 TCGA-55-7574 -23703 995 0 95 478 3 Scheduled Follow-up Submission Progressive Disease 2014-8-28 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 50 NO NO Distant Metastasis YES 2 No M0 N0 T2a Stage IB 7574 Post-Adjuvant Therapy WITH TUMOR Complete Remission/Response Convincing Imaging YES R1 Solid Tissue Normal 11 2011 7th YES YES NO 55 4 Current reformed smoker for < or = 15 years Lung DECEASED 2011 1971 TCGA-55-7574-11 TCGA-55-7574-11 +TCGA-55-7576-01 2.86 0.47 none none none none Y Y none none none 0.2 Squamoid none p.G12S none none none none none Acinar predominant Adc Acinar predominant Adc none 0 TCGA-55-7576-01 Squamous cluster 1 Cluster 6 LUAD-like c10 miRNA cluster 4 cluster 2 TCGA-55-7576 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 54 R-Upper TCGA-55-7576-F45603 TCGA-55-7576 TCGA-55-7576-01A -19917 0 670 Scheduled Follow-up Submission Complete Remission/Response 2013-7-17 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.5 NO 0.5 NO NO No M0 N0 T2a Stage IB TCGA-55-7576.feac18c2-ce79-4092-ad5a-98143981a24e.pdf 7576 TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 0.2 7th YES YES NO 55 2 Current smoker Lung A LIVING 2011 1972 TCGA-55-7576-01A-11D-2063-08 829b31ba-7ab2-475e-bad9-1d1a9b6ab13f TCGA-55-7576-01A-11D-2062-01 TCGA-55-7576-01A-11D-2064-05 TCGA-55-7576-01 TCGA-55-7576-01A-11D-2062-01 829b31ba-7ab2-475e-bad9-1d1a9b6ab13f TCGA-55-7576-01 829b31ba-7ab2-475e-bad9-1d1a9b6ab13f TCGA-55-7576-01 829b31ba-7ab2-475e-bad9-1d1a9b6ab13f TCGA-55-7576-01A-11D-2063-08 TCGA-55-7576-01 +TCGA-55-7576-11 2.86 0.47 none none none none Y Y none none none 0.2 Squamoid none p.G12S none none none none none Acinar predominant Adc Acinar predominant Adc none 0 TCGA-55-7576-11 TCGA-55-7576 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 54 R-Upper TCGA-55-7576-F45603 TCGA-55-7576 -19917 0 670 Scheduled Follow-up Submission Complete Remission/Response 2013-7-17 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES NO NO No M0 N0 T2a Stage IB 7576 TUMOR FREE Complete Remission/Response NO R0 Solid Tissue Normal 11 7th YES YES NO 55 2 Current smoker Lung LIVING 2011 1972 TCGA-55-7576-11 TCGA-55-7576-11 +TCGA-55-7724-01 p.E17K none none none N Y none none none Squamoid none none none none none p.E542K none Solid predominant Adc Solid predominant Adc none TCGA-55-7724-01 Squamous cluster 3 Cluster 5 squamous-like c4 miRNA cluster 5 cluster 3 TCGA-55-7724 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 76 L-Upper TCGA-55-7724-F56186 TCGA-55-7724 TCGA-55-7724-01A -27891 0 705 49 Scheduled Follow-up Submission Complete Remission/Response 2014-1-29 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.4 NO 0.7 NO NO 50 Yes MX N0 T2a Stage IB TCGA-55-7724.2d61169f-eaf9-4a67-afef-0dd4c2ffe0c5.pdf 7724 TUMOR FREE 36 33 Complete Remission/Response YES NO R0 Primary Tumor 01 0.2 2008 7th NO YES NO 55 4 Lung A LIVING 2011 1958 TCGA-55-7724-01A-11D-2167-08 4be7594c-c6ff-47c3-bb57-22ba6489b0f4 TCGA-55-7724-01A-11D-2166-01 TCGA-55-7724-01A-11D-2168-05 TCGA-55-7724-01 TCGA-55-7724-01A-11D-2166-01 4be7594c-c6ff-47c3-bb57-22ba6489b0f4 TCGA-55-7724-01 4be7594c-c6ff-47c3-bb57-22ba6489b0f4 TCGA-55-7724-01 4be7594c-c6ff-47c3-bb57-22ba6489b0f4 TCGA-55-7724-01A-11D-2167-08 TCGA-55-7724-01 +TCGA-55-7724-11 p.E17K none none none N Y none none none Squamoid none none none none none p.E542K none Solid predominant Adc Solid predominant Adc none TCGA-55-7724-11 TCGA-55-7724 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 76 L-Upper TCGA-55-7724-F56186 TCGA-55-7724 -27891 0 705 49 Scheduled Follow-up Submission Complete Remission/Response 2014-1-29 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES NO NO 50 Yes MX N0 T2a Stage IB 7724 TUMOR FREE 36 33 Complete Remission/Response YES NO R0 Solid Tissue Normal 11 2008 7th NO YES NO 55 4 Lung LIVING 2011 1958 TCGA-55-7724-11 TCGA-55-7724-11 +TCGA-55-7725-01 none none none none Y Y none none none Bronchioid none p.G12V none none none none none Acinar predominant Adc Acinar predominant Adc none 0 TCGA-55-7725-01 Kirc+ cluster 2 Cluster 5 LUAD-like c10 miRNA cluster 5 cluster 3 TCGA-55-7725 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 68 R-Lower TCGA-55-7725-F46647 TCGA-55-7725 TCGA-55-7725-01A -24848 0 442 0 NO NO Scheduled Follow-up Submission Complete Remission/Response 2013-8-13 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 0.4 NO 100 NO Central Lung 0.5 NO NO 16 Yes MX N0 T1a Stage IA TCGA-55-7725.e25ffd17-6064-4eef-acd4-5e26475cd842.pdf 7725 Post-Adjuvant Therapy TUMOR FREE 88 64 89 61 Complete Remission/Response YES NO R0 Primary Tumor 01 0.2 1994 7th NO YES NO 55 3 Current reformed smoker for > 15 years Lung A LIVING 2011 1963 TCGA-55-7725-01A-11D-2167-08 8b1695b3-8abd-4bfc-98e4-7d0ad20a5acc TCGA-55-7725-01A-11D-2166-01 TCGA-55-7725-01A-11D-2168-05 TCGA-55-7725-01 TCGA-55-7725-01A-11D-2166-01 8b1695b3-8abd-4bfc-98e4-7d0ad20a5acc TCGA-55-7725-01 8b1695b3-8abd-4bfc-98e4-7d0ad20a5acc TCGA-55-7725-01 8b1695b3-8abd-4bfc-98e4-7d0ad20a5acc TCGA-55-7725-01A-11D-2167-08 TCGA-55-7725-01 +TCGA-55-7725-11 none none none none Y Y none none none Bronchioid none p.G12V none none none none none Acinar predominant Adc Acinar predominant Adc none 0 TCGA-55-7725-11 TCGA-55-7725 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 68 R-Lower TCGA-55-7725-F46647 TCGA-55-7725 -24848 0 442 0 NO NO Scheduled Follow-up Submission Complete Remission/Response 2013-8-13 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 100 NO Central Lung NO NO 16 Yes MX N0 T1a Stage IA 7725 Post-Adjuvant Therapy TUMOR FREE 88 64 89 61 Complete Remission/Response YES NO R0 Solid Tissue Normal 11 1994 7th NO YES NO 55 3 Current reformed smoker for > 15 years Lung LIVING 2011 1963 TCGA-55-7725-11 TCGA-55-7725-11 +TCGA-55-7726-01 none none none none Y Y none none none Squamoid none p.G12C none none none none none none TCGA-55-7726-01 BRCA-LUAD+ cluster 3 Cluster 5 squamous-like c4 miRNA cluster 5 cluster 3 TCGA-55-7726 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 72 L-Lower TCGA-55-7726-F47844 TCGA-55-7726 -26451 0 652 72 Scheduled Follow-up Submission Complete Remission/Response 2013-8-29 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES NO NO 30 Yes MX N0 T1b Stage IA 7726 TUMOR FREE 59 61 55 49 Complete Remission/Response YES NO R0 Primary Tumor 01 1979 7th NO YES NO 55 3 Lung LIVING 2011 1955 TCGA-55-7726-01A-11D-2167-08 b2d849d8-f837-43e4-b06c-051f041172ae TCGA-55-7726-01A-11D-2166-01 TCGA-55-7726-01A-11D-2168-05 TCGA-55-7726-01 TCGA-55-7726-01A-11D-2166-01 b2d849d8-f837-43e4-b06c-051f041172ae TCGA-55-7726-01 b2d849d8-f837-43e4-b06c-051f041172ae TCGA-55-7726-01 b2d849d8-f837-43e4-b06c-051f041172ae TCGA-55-7726-01A-11D-2167-08 TCGA-55-7726-01 +TCGA-55-7726-11 none none none none Y Y none none none Squamoid none p.G12C none none none none none none TCGA-55-7726-11 TCGA-55-7726 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 72 L-Lower TCGA-55-7726-F47844 TCGA-55-7726 -26451 0 652 72 Scheduled Follow-up Submission Complete Remission/Response 2013-8-29 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES NO NO 30 Yes MX N0 T1b Stage IA 7726 TUMOR FREE 59 61 55 49 Complete Remission/Response YES NO R0 Solid Tissue Normal 11 1979 7th NO YES NO 55 3 Lung LIVING 2011 1955 TCGA-55-7726-11 TCGA-55-7726-11 +TCGA-55-7727-01 none none none none N N none none none Magnoid none none none none none none none Micropapillary predom Adc Micropapillary predom Adc none 0 TCGA-55-7727-01 BRCA-LUAD+ cluster 1 Cluster 6 LUAD-like c10 miRNA cluster 4 cluster 2 TCGA-55-7727 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 70 L-Upper TCGA-55-7727-F66030 TCGA-55-7727 -25929 0 119 86 Scheduled Follow-up Submission Complete Remission/Response 2014-10-1 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES YES NO No MX N2 T1a Stage IIIA 7727 TUMOR FREE 48 73 49 74 Complete Remission/Response YES NO R0 Primary Tumor 01 7th YES YES NO 55 2 Current smoker Lung LIVING 2011 TCGA-55-7727-01A-11D-2167-08 d4349207-30b1-44ad-b460-14db8ea58cc4 TCGA-55-7727-01A-11D-2166-01 TCGA-55-7727-01A-11D-2168-05 TCGA-55-7727-01 TCGA-55-7727-01A-11D-2166-01 d4349207-30b1-44ad-b460-14db8ea58cc4 TCGA-55-7727-01 d4349207-30b1-44ad-b460-14db8ea58cc4 TCGA-55-7727-01 d4349207-30b1-44ad-b460-14db8ea58cc4 TCGA-55-7727-01A-11D-2167-08 TCGA-55-7727-01 +TCGA-55-7728-01 none none none none Y Y none none p.H841Q Bronchioid none p.G12V none none none none none Invasive mucinous Invasive mucinous none 0 TCGA-55-7728-01 Kirc+ C1-LUAD-enriched cluster 3 Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 4 cluster 2 TCGA-55-7728 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 64 L-Upper TCGA-55-7728-F47841 TCGA-55-7728 TCGA-55-7728-01A -23505 0 704 64 NO NO Scheduled Follow-up Submission Complete Remission/Response 2013-8-29 FEMALE Mucinous (Colloid) Carcinoma No C34.1 8480/3 C34.1 YES 0.8 NO NO 1 NO NO 30 No MX N0 T2a Stage IB TCGA-55-7728.d12721b3-53dc-47e8-a9c2-03343ec7a4bb.pdf 7728 TUMOR FREE 74 67 Complete Remission/Response YES NO R0 Primary Tumor 01 0.5 1996 7th NO YES NO 55 4 Current reformed smoker for < or = 15 years Lung A LIVING 2011 1980 TCGA-55-7728-01A-11D-2184-08 d54aa159-e398-4fd4-bd2c-a437e7766582 TCGA-55-7728-01A-11D-2183-01 TCGA-55-7728-01A-11D-2185-05 TCGA-55-7728-01 TCGA-55-7728-01A-11D-2183-01 d54aa159-e398-4fd4-bd2c-a437e7766582 TCGA-55-7728-01 TCGA-55-7728-01A-13-2192-20 d54aa159-e398-4fd4-bd2c-a437e7766582 TCGA-55-7728-01 95cddb98-de35-4aa2-898f-427b5d9c34bf d54aa159-e398-4fd4-bd2c-a437e7766582 TCGA-55-7728-01A-11D-2184-08 TCGA-55-7728-01 +TCGA-55-7815-01 none none none none Y Y none none none Magnoid none p.G12V none none none none none none TCGA-55-7815-01 BRCA-LUAD+ C1-LUAD-enriched cluster 2 Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 4 cluster 2 TCGA-55-7815 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung YES YES NO NO 76 R-Lower TCGA-55-7815-F61497 TCGA-55-7815 -28119 0 773 592 59 Additional New Tumor Event Progressive Disease 2014-6-30 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES NO Distant Metastasis YES No MX N0 T2a Stage IB 7815 WITH TUMOR 76 72 Complete Remission/Response YES NO R0 Primary Tumor 01 7th NO YES NO 55 1 Lung LIVING 2011 TCGA-55-7815-01A-11D-2167-08 ea6af137-a116-4a32-9436-a9470abb3b10 TCGA-55-7815-01A-11D-2166-01 TCGA-55-7815-01A-11D-2168-05 TCGA-55-7815-01 TCGA-55-7815-01A-11D-2166-01 ea6af137-a116-4a32-9436-a9470abb3b10 TCGA-55-7815-01 TCGA-55-7815-01A-13-2192-20 ea6af137-a116-4a32-9436-a9470abb3b10 TCGA-55-7815-01 dc4e6e89-07fb-418a-b96c-14825cd8bca2 ea6af137-a116-4a32-9436-a9470abb3b10 TCGA-55-7815-01A-11D-2167-08 TCGA-55-7815-01 +TCGA-55-7816-01 TCGA-55-7816-01 Low purity c2 miRNA cluster 5 TCGA-55-7816 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 49 R-Upper TCGA-55-7816-F60131 TCGA-55-7816 TCGA-55-7816-01A -18170 468 0 44 Scheduled Follow-up Submission Progressive Disease 2014-5-29 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.3 NO 0.3 NO NO No MX NX TX Stage IV TCGA-55-7816.ca0d6f7a-fee3-49c5-8239-8a2583cecdd1.pdf 7816 WITH TUMOR Progressive Disease NO NO Primary Tumor 01 0.2 7th NO YES NO 55 1 Lung A DECEASED 2011 94beac77-4ba2-4465-9f42-813e7de4df3e TCGA-55-7816-01A-11D-2168-05 94beac77-4ba2-4465-9f42-813e7de4df3e TCGA-55-7816-01 94beac77-4ba2-4465-9f42-813e7de4df3e TCGA-55-7816-01 94beac77-4ba2-4465-9f42-813e7de4df3e TCGA-55-7816-01A-11D-2167-08 TCGA-55-7816-01 +TCGA-55-7903-01 none p.R146W, p.V600E none none N Y none none none Squamoid none none none none none none none Solid predominant Adc Solid predominant Adc none 0 TCGA-55-7903-01 BRCA-LUAD+ cluster 1 Cluster 6 LUAD-like c10 miRNA cluster 4 cluster 2 TCGA-55-7903 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 64 R-Lower TCGA-55-7903-F47840 TCGA-55-7903 TCGA-55-7903-01A -23509 0 567 83 NO NO Scheduled Follow-up Submission Complete Remission/Response 2013-8-29 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 0.2 NO NO 0.5 NO NO 40 No MX N0 T1b Stage IA TCGA-55-7903.f044afa0-43c8-4047-a6bf-d46bfb42433c.pdf 7903 TUMOR FREE 63 66 Complete Remission/Response YES NO R0 Primary Tumor 01 0.2 7th NO YES NO 55 2 Current smoker Lung A LIVING 2011 TCGA-55-7903-01A-11D-2167-08 514e90fa-113f-48d7-9166-41096e0ad209 TCGA-55-7903-01A-11D-2166-01 TCGA-55-7903-01A-11D-2168-05 TCGA-55-7903-01 TCGA-55-7903-01A-11D-2166-01 514e90fa-113f-48d7-9166-41096e0ad209 TCGA-55-7903-01 514e90fa-113f-48d7-9166-41096e0ad209 TCGA-55-7903-01 514e90fa-113f-48d7-9166-41096e0ad209 TCGA-55-7903-01A-11D-2167-08 TCGA-55-7903-01 +TCGA-55-7903-11 none p.R146W, p.V600E none none N Y none none none Squamoid none none none none none none none Solid predominant Adc Solid predominant Adc none 0 TCGA-55-7903-11 TCGA-55-7903 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 64 R-Lower TCGA-55-7903-F47840 TCGA-55-7903 -23509 0 567 83 NO NO Scheduled Follow-up Submission Complete Remission/Response 2013-8-29 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES NO NO NO 40 No MX N0 T1b Stage IA 7903 TUMOR FREE 63 66 Complete Remission/Response YES NO R0 Solid Tissue Normal 11 7th NO YES NO 55 2 Current smoker Lung LIVING 2011 TCGA-55-7903-11 TCGA-55-7903-11 +TCGA-55-7907-01 none none none none Y Y none none p.L805V Squamoid none p.G12C none none none none none Micropapillary predom Adc Micropapillary predom Adc none 0 TCGA-55-7907-01 High cluster 1 Cluster 6 LUAD-like c10 miRNA cluster 5 cluster 3 TCGA-55-7907 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung NO NO NO 77 L-Upper TCGA-55-7907-F60132 TCGA-55-7907 TCGA-55-7907-01A -28201 343 0 16 294 75 Scheduled Follow-up Submission Progressive Disease 2014-5-29 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.3 NO 0.3 NO Distant Metastasis YES 80 No MX N1 T2a Stage IIA TCGA-55-7907.233ef961-8050-47e5-bb53-260a7de4174d.pdf 7907 WITH TUMOR 80 87 75 76 Complete Remission/Response Convincing Imaging YES NO R0 Primary Tumor 01 0.1 1994 7th NO YES NO 55 3 Current reformed smoker for > 15 years Lung A DECEASED 2011 1954 TCGA-55-7907-01A-11D-2167-08 0168f22b-6d11-4492-9aea-5ffa451bff3e TCGA-55-7907-01A-11D-2166-01 TCGA-55-7907-01A-11D-2168-05 TCGA-55-7907-01 TCGA-55-7907-01A-11D-2166-01 0168f22b-6d11-4492-9aea-5ffa451bff3e TCGA-55-7907-01 0168f22b-6d11-4492-9aea-5ffa451bff3e TCGA-55-7907-01 0168f22b-6d11-4492-9aea-5ffa451bff3e TCGA-55-7907-01A-11D-2167-08 TCGA-55-7907-01 +TCGA-55-7910-01 TCGA-55-7910-01 High C1-LUAD-enriched Low purity c2 squamous c3 LUAD-like c10 miRNA cluster 5 TCGA-55-7910 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung NO YES 50 L-Lower TCGA-55-7910-F66140 TCGA-55-7910 TCGA-55-7910-01A -18289 0 1040 1018 44 1 Scheduled Follow-up Submission 2014-10-3 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 0.6 NO 80 Peripheral Lung 0.9 NO YES 15 No M0 N0 T2b Stage IIA TCGA-55-7910.c205abda-dfe0-43b1-a265-4c41125216fe.pdf 7910 Preoperative WITH TUMOR 91 91 97 86 Complete Remission/Response YES NO R0 Primary Tumor 01 0.5 2011 7th YES YES NO 55 4 Lung A LIVING 2011 1996 4ff760c4-074e-4876-b63f-71098942c780 TCGA-55-7910-01A-11D-2166-01 TCGA-55-7910-01A-11D-2168-05 TCGA-55-7910-01 TCGA-55-7910-01A-11D-2166-01 4ff760c4-074e-4876-b63f-71098942c780 TCGA-55-7910-01 TCGA-55-7910-01A-13-2192-20 4ff760c4-074e-4876-b63f-71098942c780 TCGA-55-7910-01 8454f2fd-cc01-4eb8-b206-9499ed8f7bbb 4ff760c4-074e-4876-b63f-71098942c780 TCGA-55-7910-01A-11D-2167-08 TCGA-55-7910-01 +TCGA-55-7910-11 TCGA-55-7910-11 C1-LUAD-enriched TCGA-55-7910 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung NO YES 50 L-Lower TCGA-55-7910-F66140 TCGA-55-7910 -18289 0 1040 1018 44 1 Scheduled Follow-up Submission 2014-10-3 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 80 Peripheral Lung NO YES 15 No M0 N0 T2b Stage IIA 7910 Preoperative WITH TUMOR 91 91 97 86 Complete Remission/Response YES NO R0 Solid Tissue Normal 11 2011 7th YES YES NO 55 4 Lung LIVING 2011 1996 TCGA-55-7910-11 TCGA-55-7910-11 +TCGA-55-7911-01 none none none none Y Y none none none Squamoid none p.G12V, p.K88* none none none none none Solid predominant Adc Solid predominant Adc none 0 TCGA-55-7911-01 BRCA-LUAD+ C1-LUAD-enriched cluster 1 Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 4 cluster 2 TCGA-55-7911 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung NO YES NO NO 70 R-Middle TCGA-55-7911-F48785 TCGA-55-7911 TCGA-55-7911-01A -25746 0 537 515 NO NO Scheduled Follow-up Submission Complete Remission/Response 2013-9-20 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.2 8140/3 C34.2 YES 0.5 NO NO 0.8 NO New Primary Tumor YES 96 No MX N0 T1a Stage IA TCGA-55-7911.0c8ea3a9-23b7-4c43-8972-3660048b8537.pdf 7911 TUMOR FREE 86 64 Complete Remission/Response YES NO R0 Primary Tumor 01 0.4 1981 7th NO YES NO 55 3 Current reformed smoker for > 15 years Lung A LIVING 2011 1959 TCGA-55-7911-01A-11D-2167-08 9142e848-c5cb-41c1-b80f-5f7674f9a1cb TCGA-55-7911-01A-11D-2166-01 TCGA-55-7911-01A-11D-2168-05 TCGA-55-7911-01 TCGA-55-7911-01A-11D-2166-01 9142e848-c5cb-41c1-b80f-5f7674f9a1cb TCGA-55-7911-01 TCGA-55-7911-01A-13-2192-20 9142e848-c5cb-41c1-b80f-5f7674f9a1cb TCGA-55-7911-01 75ec6f61-ec15-409e-a0a6-e4b5618375e5 9142e848-c5cb-41c1-b80f-5f7674f9a1cb TCGA-55-7911-01A-11D-2167-08 TCGA-55-7911-01 +TCGA-55-7911-11 none none none none Y Y none none none Squamoid none p.G12V, p.K88* none none none none none Solid predominant Adc Solid predominant Adc none 0 TCGA-55-7911-11 C1-LUAD-enriched TCGA-55-7911 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung NO YES NO NO 70 R-Middle TCGA-55-7911-F48785 TCGA-55-7911 -25746 0 537 515 NO NO Scheduled Follow-up Submission Complete Remission/Response 2013-9-20 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.2 8140/3 C34.2 YES NO NO New Primary Tumor YES 96 No MX N0 T1a Stage IA 7911 TUMOR FREE 86 64 Complete Remission/Response YES NO R0 Solid Tissue Normal 11 1981 7th NO YES NO 55 3 Current reformed smoker for > 15 years Lung LIVING 2011 1959 TCGA-55-7911-11 TCGA-55-7911-11 +TCGA-55-7913-01 TCGA-55-7913-01 BRCA-LUAD+ Cluster 5 LUAD-like c10 miRNA cluster 6 TCGA-55-7913 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung NO YES NO 61 L-Lower TCGA-55-7913-F57911 TCGA-55-7913 TCGA-55-7913-01B -22326 561 0 62 480 1 YES FISH YES Scheduled Follow-up Submission Progressive Disease 2014-3-28 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 0.4 NO 90 YES NO Central Lung 0.7 NO Distant Metastasis YES 40 No MX N0 T1b Stage IA TCGA-55-7913.7ce361fa-ad56-4e0e-95e3-ea977a513e98.pdf 7913 Preoperative WITH TUMOR Complete Remission/Response Convincing Imaging NO R0 Primary Tumor 01 0.2 7th NO YES NO 55 2 Lung B DECEASED 2011 1971 168efb85-ed48-4e77-ba13-90674218c506 TCGA-55-7913-01B-11D-2237-01 TCGA-55-7913-01B-11D-2239-05 TCGA-55-7913-01 TCGA-55-7913-01B-11D-2237-01 168efb85-ed48-4e77-ba13-90674218c506 TCGA-55-7913-01 168efb85-ed48-4e77-ba13-90674218c506 TCGA-55-7913-01 168efb85-ed48-4e77-ba13-90674218c506 TCGA-55-7913-01B-11D-2238-08 TCGA-55-7913-01 +TCGA-55-7914-01 none none none none Y Y none none none Bronchioid none p.G12C none none none none none Acinar predominant Adc Acinar predominant Adc none 0 TCGA-55-7914-01 Squamous cluster 1 Cluster 6 LUAD-like c10 miRNA cluster 5 cluster 3 TCGA-55-7914 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 71 R-Upper TCGA-55-7914-F59091 TCGA-55-7914 TCGA-55-7914-01A -26105 187 0 3 56 1 YES FISH YES Scheduled Follow-up Submission Progressive Disease 2014-4-30 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.2 NO 80 YES YES G12C Central Lung 0.4 NO NO 5 Yes MX N1 T1b Stage IIA TCGA-55-7914.eaabadac-ea5e-47c3-9db7-d2c0c77b7b68.pdf 7914 Preoperative WITH TUMOR 88 73 Progressive Disease YES NO R0 Primary Tumor 01 0.2 7th YES YES NO 55 2 Current smoker Lung A DECEASED 2011 1990 TCGA-55-7914-01A-11D-2167-08 5bfe179e-eae2-4d2a-9f2a-b4af4602a2b5 TCGA-55-7914-01A-11D-2166-01 TCGA-55-7914-01A-11D-2168-05 TCGA-55-7914-01 TCGA-55-7914-01A-11D-2166-01 5bfe179e-eae2-4d2a-9f2a-b4af4602a2b5 TCGA-55-7914-01 5bfe179e-eae2-4d2a-9f2a-b4af4602a2b5 TCGA-55-7914-01 5bfe179e-eae2-4d2a-9f2a-b4af4602a2b5 TCGA-55-7914-01A-11D-2167-08 TCGA-55-7914-01 +TCGA-55-7914-11 none none none none Y Y none none none Bronchioid none p.G12C none none none none none Acinar predominant Adc Acinar predominant Adc none 0 TCGA-55-7914-11 TCGA-55-7914 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 71 R-Upper TCGA-55-7914-F59091 TCGA-55-7914 -26105 187 0 3 56 1 YES FISH YES Scheduled Follow-up Submission Progressive Disease 2014-4-30 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 80 YES YES G12C Central Lung NO NO 5 Yes MX N1 T1b Stage IIA 7914 Preoperative WITH TUMOR 88 73 Progressive Disease YES NO R0 Solid Tissue Normal 11 7th YES YES NO 55 2 Current smoker Lung DECEASED 2011 1990 TCGA-55-7914-11 TCGA-55-7914-11 +TCGA-55-7994-01 TCGA-55-7994-01 Squamous Cluster 6 LUAD-like c10 miRNA cluster 4 TCGA-55-7994 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 81 R-Upper TCGA-55-7994-F47823 TCGA-55-7994 -29858 0 603 NO NO Scheduled Follow-up Submission Complete Remission/Response 2013-8-28 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES NO NO NO 28 No MX N0 T3 Stage IIB 7994 TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 7th YES YES NO 55 2 Lung LIVING 2011 c857b341-4021-48e6-a9e7-fff0525cdb96 TCGA-55-7994-01A-11D-2183-01 TCGA-55-7994-01A-11D-2185-05 TCGA-55-7994-01 TCGA-55-7994-01A-11D-2183-01 c857b341-4021-48e6-a9e7-fff0525cdb96 TCGA-55-7994-01 c857b341-4021-48e6-a9e7-fff0525cdb96 TCGA-55-7994-01 c857b341-4021-48e6-a9e7-fff0525cdb96 TCGA-55-7994-01A-11D-2184-08 TCGA-55-7994-01 +TCGA-55-7995-01 TCGA-55-7995-01 High BRCA basal-like c8 LUAD-like c10 miRNA cluster 4 TCGA-55-7995 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung YES YES NO 73 L-Upper TCGA-55-7995-F65700 TCGA-55-7995 TCGA-55-7995-01A -26837 0 889 468 51 1 NO NO Scheduled Follow-up Submission Complete Remission/Response 2014-9-26 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.7 NO 80 Peripheral Lung 0.8 NO Locoregional Recurrence YES 60 No M0 N0 T1b Stage IA TCGA-55-7995.3f3f4bdf-75f6-4b5b-988e-cebc4f098cbd.pdf 7995 Post-Adjuvant Therapy TUMOR FREE 71 77 Complete Remission/Response Convincing Imaging YES NO R0 Primary Tumor 01 0.2 2002 7th NO YES NO 55 4 Lung A LIVING 2012 956590e9-4962-497b-a59f-81ee0a1c0caf TCGA-55-7995-01A-11D-2183-01 TCGA-55-7995-01A-11D-2185-05 TCGA-55-7995-01 TCGA-55-7995-01A-11D-2183-01 956590e9-4962-497b-a59f-81ee0a1c0caf TCGA-55-7995-01 956590e9-4962-497b-a59f-81ee0a1c0caf TCGA-55-7995-01 956590e9-4962-497b-a59f-81ee0a1c0caf TCGA-55-7995-01A-11D-2184-08 TCGA-55-7995-01 +TCGA-55-8085-01 TCGA-55-8085-01 BRCA-LUAD+ Cluster 5 LUAD-like c10 miRNA cluster 7 TCGA-55-8085 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 64 L-Lower TCGA-55-8085-F65697 TCGA-55-8085 TCGA-55-8085-01A -23596 0 904 51 1 Scheduled Follow-up Submission Complete Remission/Response 2014-9-26 MALE Lung Papillary Adenocarcinoma No C34.3 8260/3 C34.3 YES 0.5 NO 0.7 NO NO No M0 N0 T1b Stage IA TCGA-55-8085.16f4298e-d5f3-4503-bdad-a15531c3635c.pdf 8085 TUMOR FREE 46 45 39 35 Complete Remission/Response YES NO R0 Primary Tumor 01 0.3 7th NO YES NO 55 2 Lung A LIVING 2011 04104d50-dcf7-4e77-9038-8fed73db6a12 TCGA-55-8085-01A-11D-2237-01 TCGA-55-8085-01A-11D-2239-05 TCGA-55-8085-01 TCGA-55-8085-01A-11D-2237-01 04104d50-dcf7-4e77-9038-8fed73db6a12 TCGA-55-8085-01 04104d50-dcf7-4e77-9038-8fed73db6a12 TCGA-55-8085-01 04104d50-dcf7-4e77-9038-8fed73db6a12 TCGA-55-8085-01A-11D-2238-08 TCGA-55-8085-01 +TCGA-55-8087-01 TCGA-55-8087-01 Iq Cluster 5 LUAD-like c10 miRNA c1uster 9 TCGA-55-8087 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 59 R-Upper TCGA-55-8087-F47822 TCGA-55-8087 -21655 0 462 142 NO NO Scheduled Follow-up Submission Complete Remission/Response 2013-8-28 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES NO NO NO No MX N0 T2a Stage IB 8087 TUMOR FREE 126 Complete Remission/Response YES NO R0 Primary Tumor 01 7th NO YES NO 55 1 Lung LIVING 2011 ce03cab8-df0a-433b-bc39-96203ab061a1 TCGA-55-8087-01A-11D-2237-01 TCGA-55-8087-01A-11D-2239-05 TCGA-55-8087-01 TCGA-55-8087-01A-11D-2237-01 ce03cab8-df0a-433b-bc39-96203ab061a1 TCGA-55-8087-01 ce03cab8-df0a-433b-bc39-96203ab061a1 TCGA-55-8087-01 ce03cab8-df0a-433b-bc39-96203ab061a1 TCGA-55-8087-01A-11D-2238-08 TCGA-55-8087-01 +TCGA-55-8089-01 TCGA-55-8089-01 High Cluster 6 LUAD-like c10 miRNA cluster 4 TCGA-55-8089 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 56 R-Upper TCGA-55-8089-F59075 TCGA-55-8089 TCGA-55-8089-01A -20576 702 0 100 90 0 YES YES Scheduled Follow-up Submission Complete Remission/Response 2014-4-30 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.2 NO 100 YES NO Peripheral Lung 0.2 NO NO 97 No M0 N0 T1a Stage IA TCGA-55-8089.af442cea-76df-4233-b3d6-134b1e91c607.pdf 8089 Preoperative TUMOR FREE 85 70 Complete Remission/Response YES NO R0 Primary Tumor 01 0.1 7th NO YES NO 55 2 Lung A DECEASED 2011 1973 671a4dd5-cb2a-4d9b-aec7-c5963d50f2ab TCGA-55-8089-01A-11D-2237-01 TCGA-55-8089-01A-11D-2239-05 TCGA-55-8089-01 TCGA-55-8089-01A-11D-2237-01 671a4dd5-cb2a-4d9b-aec7-c5963d50f2ab TCGA-55-8089-01 671a4dd5-cb2a-4d9b-aec7-c5963d50f2ab TCGA-55-8089-01 671a4dd5-cb2a-4d9b-aec7-c5963d50f2ab TCGA-55-8089-01A-11D-2238-08 TCGA-55-8089-01 +TCGA-55-8090-01 TCGA-55-8090-01 BRCA-LUAD+ Cluster 6 LUAD-like c10 miRNA c1uster 9 TCGA-55-8090 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung NO NO NO 80 R-Lower TCGA-55-8090-F56189 TCGA-55-8090 TCGA-55-8090-01A -29235 598 0 6 548 58 Scheduled Follow-up Submission Progressive Disease 2014-1-29 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 0.4 NO 1 NO Distant Metastasis YES Yes, History of Synchronous/Bilateral Malignancy M0 N0 T1a Stage IA TCGA-55-8090.8f75f207-fe12-44ba-86b2-444ab5578d45.pdf 8090 WITH TUMOR 4 6 103 83 Complete Remission/Response Convincing Imaging YES NO R0 Primary Tumor 01 0.2 7th NO YES NO 55 2 Lung A DECEASED 2011 5877248b-dff8-494d-a5c1-7721072ec225 TCGA-55-8090-01A-11D-2237-01 TCGA-55-8090-01A-11D-2239-05 TCGA-55-8090-01 TCGA-55-8090-01A-11D-2237-01 5877248b-dff8-494d-a5c1-7721072ec225 TCGA-55-8090-01 5877248b-dff8-494d-a5c1-7721072ec225 TCGA-55-8090-01 5877248b-dff8-494d-a5c1-7721072ec225 TCGA-55-8090-01A-11D-2238-08 TCGA-55-8090-01 +TCGA-55-8091-01 TCGA-55-8091-01 Kirc+ Cluster 5 LUAD-like c10 miRNA c1uster 9 TCGA-55-8091 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 74 R-Lower TCGA-55-8091-F47820 TCGA-55-8091 TCGA-55-8091-01A -27385 0 600 65 NO NO Scheduled Follow-up Submission Complete Remission/Response 2013-8-28 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 0.8 NO NO 1.1 NO NO Yes, History of Prior Malignancy MX N0 T2 Stage IB TCGA-55-8091.33902b19-5be6-47ff-81a7-b945ae674a2f.pdf 8091 TUMOR FREE 79 82 Complete Remission/Response YES NO R0 Primary Tumor 01 0.6 1985 7th NO YES NO 55 3 Lung A LIVING 2011 40adb8fd-ac1d-4f5d-98a4-3bb5256626c4 TCGA-55-8091-01A-11D-2237-01 TCGA-55-8091-01A-11D-2239-05 TCGA-55-8091-01 TCGA-55-8091-01A-11D-2237-01 40adb8fd-ac1d-4f5d-98a4-3bb5256626c4 TCGA-55-8091-01 40adb8fd-ac1d-4f5d-98a4-3bb5256626c4 TCGA-55-8091-01 40adb8fd-ac1d-4f5d-98a4-3bb5256626c4 TCGA-55-8091-01A-11D-2238-08 TCGA-55-8091-01 +TCGA-55-8092-01 TCGA-55-8092-01 High Cluster 6 LUAD-like c10 miRNA cluster 7 TCGA-55-8092 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung NO NO NO 75 R-Upper TCGA-55-8092-F46643 TCGA-55-8092 -27597 154 0 26 127 19 Scheduled Follow-up Submission Progressive Disease 2013-8-13 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES NO Locoregional Recurrence YES 40 No MX N0 T3 Stage IIB 8092 WITH TUMOR 2 19 66 68 Complete Remission/Response Convincing Imaging YES NO R0 Primary Tumor 01 2012 7th NO YES NO 55 4 Lung DECEASED 2012 1972 add23090-21e1-4cc2-a833-539b1db1e05f TCGA-55-8092-01A-11D-2237-01 TCGA-55-8092-01A-11D-2239-05 TCGA-55-8092-01 TCGA-55-8092-01A-11D-2237-01 add23090-21e1-4cc2-a833-539b1db1e05f TCGA-55-8092-01 add23090-21e1-4cc2-a833-539b1db1e05f TCGA-55-8092-01 add23090-21e1-4cc2-a833-539b1db1e05f TCGA-55-8092-01A-11D-2238-08 TCGA-55-8092-01 +TCGA-55-8094-01 TCGA-55-8094-01 High Cluster 5 LUAD-like c10 miRNA cluster 6 TCGA-55-8094 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 51 L-Upper TCGA-55-8094-F66029 TCGA-55-8094 -18903 0 541 YES FISH YES Scheduled Follow-up Submission Partial Remission/Response 2014-10-1 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES NO Peripheral Lung NO NO 70 No M1b N0 T2b Stage IV 8094 WITH TUMOR Progressive Disease YES R0 Primary Tumor 01 2011 7th YES YES NO 55 4 Lung LIVING 2012 1976 b08923df-9b70-48eb-bc2b-023d1e1b0eeb TCGA-55-8094-01A-11D-2237-01 TCGA-55-8094-01A-11D-2239-05 TCGA-55-8094-01 TCGA-55-8094-01A-11D-2237-01 b08923df-9b70-48eb-bc2b-023d1e1b0eeb TCGA-55-8094-01 b08923df-9b70-48eb-bc2b-023d1e1b0eeb TCGA-55-8094-01 b08923df-9b70-48eb-bc2b-023d1e1b0eeb TCGA-55-8094-01A-11D-2238-08 TCGA-55-8094-01 +TCGA-55-8096-01 TCGA-55-8096-01 High Low purity c2 LUAD-like c10 miRNA cluster 4 TCGA-55-8096 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung NO YES NO 67 L-Upper TCGA-55-8096-F59097 TCGA-55-8096 TCGA-55-8096-01A -24684 719 0 47 566 2 NO NO Scheduled Follow-up Submission Progressive Disease 2014-4-30 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.9 NO 70 NO Central Lung 0.9 NO Distant Metastasis YES 104 No MX N0 T2a Stage IB TCGA-55-8096.d27900ae-8cf6-4d92-84e8-5247df7d46b4.pdf 8096 Preoperative WITH TUMOR 77 55 Complete Remission/Response Convincing Imaging YES NO Primary Tumor 01 0.4 7th NO YES NO 55 2 Lung A DECEASED 2011 1959 22366c3f-bf63-421e-b086-0ffb87945bf9 TCGA-55-8096-01A-11D-2237-01 TCGA-55-8096-01A-11D-2239-05 TCGA-55-8096-01 TCGA-55-8096-01A-11D-2237-01 22366c3f-bf63-421e-b086-0ffb87945bf9 TCGA-55-8096-01 22366c3f-bf63-421e-b086-0ffb87945bf9 TCGA-55-8096-01 22366c3f-bf63-421e-b086-0ffb87945bf9 TCGA-55-8096-01A-11D-2238-08 TCGA-55-8096-01 +TCGA-55-8097-01 TCGA-55-8097-01 COAD-READ Cluster 5 LUAD-like c10 miRNA cluster 4 TCGA-55-8097 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 60 R-Upper TCGA-55-8097-F47821 TCGA-55-8097 TCGA-55-8097-01A -22260 0 476 74 NO NO Scheduled Follow-up Submission Complete Remission/Response 2013-8-28 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.4 NO NO 0.5 NO NO 35 No MX N0 T1a Stage IA TCGA-55-8097.3e2989f4-213d-4f64-be03-9b967f1fcc08.pdf 8097 TUMOR FREE 87 79 Complete Remission/Response YES NO R0 Primary Tumor 01 0.1 2008 7th NO YES NO 55 4 Lung A LIVING 2012 1973 6191a9e8-7ed1-49d0-b582-e38b29c61649 TCGA-55-8097-01A-11D-2237-01 TCGA-55-8097-01A-11D-2239-05 TCGA-55-8097-01 TCGA-55-8097-01A-11D-2237-01 6191a9e8-7ed1-49d0-b582-e38b29c61649 TCGA-55-8097-01 6191a9e8-7ed1-49d0-b582-e38b29c61649 TCGA-55-8097-01 6191a9e8-7ed1-49d0-b582-e38b29c61649 TCGA-55-8097-01A-11D-2238-08 TCGA-55-8097-01 +TCGA-55-8203-01 TCGA-55-8203-01 BRCA-LUAD+ Cluster 6 LUAD-like c10 miRNA cluster 6 TCGA-55-8203 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 69 R-Lower TCGA-55-8203-F47819 TCGA-55-8203 TCGA-55-8203-01A -25477 0 547 39 NO NO Scheduled Follow-up Submission Complete Remission/Response 2013-8-28 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 0.3 NO NO 0.4 NO NO 50 Yes, History of Prior Malignancy M0 N0 T1b Stage IA TCGA-55-8203.079475a1-b61d-4cb3-b1e1-a5a890d3073b.pdf 8203 TUMOR FREE 50 48 52 49 Complete Remission/Response YES NO R0 Primary Tumor 01 0.2 7th NO YES NO 55 2 Lung A LIVING 2011 26900eb0-165e-463e-84ad-51321287d2c3 TCGA-55-8203-01A-11D-2237-01 TCGA-55-8203-01A-11D-2239-05 TCGA-55-8203-01 TCGA-55-8203-01A-11D-2237-01 26900eb0-165e-463e-84ad-51321287d2c3 TCGA-55-8203-01 26900eb0-165e-463e-84ad-51321287d2c3 TCGA-55-8203-01 26900eb0-165e-463e-84ad-51321287d2c3 TCGA-55-8203-01A-11D-2238-08 TCGA-55-8203-01 +TCGA-55-8204-01 TCGA-55-8204-01 Squamous Cluster 5 squamous-like c4 miRNA cluster 4 TCGA-55-8204 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 87 L-Upper TCGA-55-8204-F47802 TCGA-55-8204 -31818 0 515 101 Scheduled Follow-up Submission Complete Remission/Response 2013-8-28 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES NO NO Yes, History of Prior Malignancy MX N0 T2a Stage IB 8204 TUMOR FREE 88 85 Complete Remission/Response YES NO R0 Primary Tumor 01 7th NO YES NO 55 3 Lung LIVING 2011 cfa04d49-cec6-4454-b10e-8b4600485f12 TCGA-55-8204-01A-11D-2237-01 TCGA-55-8204-01A-11D-2239-05 TCGA-55-8204-01 TCGA-55-8204-01A-11D-2237-01 cfa04d49-cec6-4454-b10e-8b4600485f12 TCGA-55-8204-01 cfa04d49-cec6-4454-b10e-8b4600485f12 TCGA-55-8204-01 cfa04d49-cec6-4454-b10e-8b4600485f12 TCGA-55-8204-01A-11D-2238-08 TCGA-55-8204-01 +TCGA-55-8205-01 TCGA-55-8205-01 Squamous Cluster 6 LUAD-like c10 miRNA cluster 4 TCGA-55-8205 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung YES YES NO 76 R-Lower TCGA-55-8205-F59040 TCGA-55-8205 TCGA-55-8205-01A -28063 0 599 495 0 YES NO Scheduled Follow-up Submission Progressive Disease 2014-4-30 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 1 NO 100 YES NO Central Lung 1.1 NO Distant Metastasis YES 30 Yes, History of Prior Malignancy M0 N0 T2b Stage IIA TCGA-55-8205.7a632c9d-4215-4d85-83df-30ce645d4e0c.pdf 8205 Preoperative WITH TUMOR 73 42 Progressive Disease Convincing Imaging YES NO R0 Primary Tumor 01 0.6 2012 7th YES YES NO 55 4 Lung A LIVING 2012 1951 96b3c91a-389e-48cc-9347-ed65fa70f3de TCGA-55-8205-01A-11D-2237-01 TCGA-55-8205-01A-11D-2239-05 TCGA-55-8205-01 TCGA-55-8205-01A-11D-2237-01 96b3c91a-389e-48cc-9347-ed65fa70f3de TCGA-55-8205-01 96b3c91a-389e-48cc-9347-ed65fa70f3de TCGA-55-8205-01 96b3c91a-389e-48cc-9347-ed65fa70f3de TCGA-55-8205-01A-11D-2238-08 TCGA-55-8205-01 +TCGA-55-8206-01 TCGA-55-8206-01 BRCA-LUAD+ Cluster 5 LUAD-like c10 miRNA cluster 5 TCGA-55-8206 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 56 R-Upper TCGA-55-8206-F65698 TCGA-55-8206 -20690 0 888 98 Scheduled Follow-up Submission Complete Remission/Response 2014-9-26 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES NO NO No M0 N0 T1b Stage IA 8206 TUMOR FREE 104 84 Complete Remission/Response YES NO R0 Primary Tumor 01 7th NO YES NO 55 1 Lung LIVING 2012 e6817dfb-7634-4321-9627-ce94feb46011 TCGA-55-8206-01A-11D-2237-01 TCGA-55-8206-01A-11D-2239-05 TCGA-55-8206-01 TCGA-55-8206-01A-11D-2237-01 e6817dfb-7634-4321-9627-ce94feb46011 TCGA-55-8206-01 e6817dfb-7634-4321-9627-ce94feb46011 TCGA-55-8206-01 e6817dfb-7634-4321-9627-ce94feb46011 TCGA-55-8206-01A-11D-2238-08 TCGA-55-8206-01 +TCGA-55-8207-01 TCGA-55-8207-01 High Cluster 6 LUAD-like c10 miRNA cluster 4 TCGA-55-8207 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 73 L-Lower TCGA-55-8207-F65849 TCGA-55-8207 TCGA-55-8207-01A -26897 0 977 48 Scheduled Follow-up Submission Complete Remission/Response 2014-9-30 MALE Lung Acinar Adenocarcinoma No C34.3 8550/3 C34.3 YES 0.5 NO 0.9 NO NO Yes, History of Synchronous/Bilateral Malignancy MX N0 T2a Stage IB TCGA-55-8207.bf8af6e0-1ea5-4281-a00d-42aa138d781f.pdf 8207 TUMOR FREE 84 83 86 84 Complete Remission/Response YES NO R0 Primary Tumor 01 0.4 7th NO YES NO 55 3 Lung A LIVING 2011 7f0fe109-7153-46a8-81d7-2f132ee513f5 TCGA-55-8207-01A-11D-2237-01 TCGA-55-8207-01A-11D-2239-05 TCGA-55-8207-01 TCGA-55-8207-01A-11D-2237-01 7f0fe109-7153-46a8-81d7-2f132ee513f5 TCGA-55-8207-01 7f0fe109-7153-46a8-81d7-2f132ee513f5 TCGA-55-8207-01 7f0fe109-7153-46a8-81d7-2f132ee513f5 TCGA-55-8207-01A-11D-2238-08 TCGA-55-8207-01 +TCGA-55-8208-01 TCGA-55-8208-01 High Cluster 5 LUAD-like c10 miRNA cluster 7 TCGA-55-8208 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung YES YES 73 R-Upper TCGA-55-8208-F59045 TCGA-55-8208 536 -26716 0 674 511 50 0 Scheduled Follow-up Submission Stable Disease 2014-4-30 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 100 Peripheral Lung YES Distant Metastasis YES 50 No M0 N0 T1b Stage IA 8208 Preoperative WITH TUMOR 68 151 72 156 Complete Remission/Response Biopsy with Histologic Confirmation|Convincing Imaging YES NO R0 Primary Tumor 01 7th NO YES NO 55 2 Lung LIVING 2012 dbeac9fe-cb6a-464c-9a96-d586797b1da0 TCGA-55-8208-01A-11D-2237-01 TCGA-55-8208-01A-11D-2239-05 TCGA-55-8208-01 TCGA-55-8208-01A-11D-2237-01 dbeac9fe-cb6a-464c-9a96-d586797b1da0 TCGA-55-8208-01 dbeac9fe-cb6a-464c-9a96-d586797b1da0 TCGA-55-8208-01 dbeac9fe-cb6a-464c-9a96-d586797b1da0 TCGA-55-8208-01A-11D-2238-08 TCGA-55-8208-01 +TCGA-55-8299-01 TCGA-55-8299-01 Quiet Low purity c2 LUAD-like c10 miRNA cluster 4 TCGA-55-8299 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung NO YES NO NO 61 R-Upper TCGA-55-8299-F57915 TCGA-55-8299 -22626 469 0 216 274 Scheduled Follow-up Submission Progressive Disease 2014-3-28 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES NO Distant Metastasis YES 20 No MX N0 T1b Stage IA 8299 WITH TUMOR 75 74 Complete Remission/Response Convincing Imaging YES NO R0 Primary Tumor 01 2012 7th NO YES NO 55 4 Lung DECEASED 2012 1971 f835bdde-2b5e-4013-a8d4-0074f66c9317 TCGA-55-8299-01A-11D-2283-01 TCGA-55-8299-01A-11D-2285-05 TCGA-55-8299-01 TCGA-55-8299-01A-11D-2283-01 f835bdde-2b5e-4013-a8d4-0074f66c9317 TCGA-55-8299-01 f835bdde-2b5e-4013-a8d4-0074f66c9317 TCGA-55-8299-01 f835bdde-2b5e-4013-a8d4-0074f66c9317 TCGA-55-8299-01A-11D-2284-08 TCGA-55-8299-01 +TCGA-55-8301-01 TCGA-55-8301-01 High Cluster 5 LUAD-like c10 miRNA cluster 4 TCGA-55-8301 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung YES YES NO NO 58 R-Lower TCGA-55-8301-F56261 TCGA-55-8301 -21535 0 534 238 Scheduled Follow-up Submission Partial Remission/Response 2014-1-30 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES NO Locoregional Recurrence YES 100 No MX N0 T2a Stage IB 8301 WITH TUMOR Complete Remission/Response Convincing Imaging NO R0 Primary Tumor 01 7th NO YES NO 55 2 Lung LIVING 2012 1962 aca30642-6479-4cfb-bcac-b9b5e45c5686 TCGA-55-8301-01A-11D-2283-01 TCGA-55-8301-01A-11D-2285-05 TCGA-55-8301-01 TCGA-55-8301-01A-11D-2283-01 aca30642-6479-4cfb-bcac-b9b5e45c5686 TCGA-55-8301-01 aca30642-6479-4cfb-bcac-b9b5e45c5686 TCGA-55-8301-01 aca30642-6479-4cfb-bcac-b9b5e45c5686 TCGA-55-8301-01A-11D-2284-08 TCGA-55-8301-01 +TCGA-55-8302-01 TCGA-55-8302-01 Cluster 6 miRNA cluster 4 TCGA-55-8302 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 54 R-Lower TCGA-55-8302-F56188 TCGA-55-8302 -20011 0 478 Scheduled Follow-up Submission Complete Remission/Response 2014-1-29 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES NO NO 59 No MX N0 T2 Stage IB 8302 TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 7th NO YES NO 55 2 Lung LIVING 2012 1965 db0d3ef1-a8d7-4a5e-863e-f9e2717dee54 TCGA-55-8302-01A-11D-2322-01 TCGA-55-8302-01A-11D-2324-05 TCGA-55-8302-01 TCGA-55-8302-01A-11D-2322-01 db0d3ef1-a8d7-4a5e-863e-f9e2717dee54 TCGA-55-8302-01 db0d3ef1-a8d7-4a5e-863e-f9e2717dee54 TCGA-55-8302-01 db0d3ef1-a8d7-4a5e-863e-f9e2717dee54 TCGA-55-8302-01A-11D-2323-08 TCGA-55-8302-01 +TCGA-55-8505-01 TCGA-55-8505-01 TCGA-55-8505 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 62 R-Lower TCGA-55-8505-F47798 TCGA-55-8505 TCGA-55-8505-01A -22676 0 440 Scheduled Follow-up Submission Complete Remission/Response 2013-8-28 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 0.7 NO 1.2 NO NO No MX N2 T1a Stage IIIA TCGA-55-8505.401f1ed0-5da9-442f-ac17-6394e72e88ae.pdf 8505 TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 0.4 7th YES YES NO 55 1 Lung A LIVING 2012 865eece0-5e69-4878-b504-af3eb071273d TCGA-55-8505-01A-11D-2389-01 TCGA-55-8505-01A-11D-2398-05 TCGA-55-8505-01 TCGA-55-8505-01A-11D-2389-01 865eece0-5e69-4878-b504-af3eb071273d TCGA-55-8505-01 865eece0-5e69-4878-b504-af3eb071273d TCGA-55-8505-01 B6E226D1-F5A3-4547-9CAA-0DC89085EFC6 865eece0-5e69-4878-b504-af3eb071273d TCGA-55-8505-01A-11D-2393-08 TCGA-55-8505-01 +TCGA-55-8506-01 TCGA-55-8506-01 TCGA-55-8506 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 62 R-Upper TCGA-55-8506 TCGA-55-8506-01A -22850 0 11 2012-12-28 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.7 NO Peripheral Lung 1.1 NO No MX N0 T3 Stage IIB TCGA-55-8506.448de79c-d662-4783-a7c8-32a224ee5375.pdf 8506 R0 Primary Tumor 01 0.4 7th YES NO 55 2 Lung A LIVING 2012 1972 db1370cf-7ca5-45ed-bba6-751f28e39825 TCGA-55-8506-01A-11D-2389-01 TCGA-55-8506-01A-11D-2398-05 TCGA-55-8506-01 TCGA-55-8506-01A-11D-2389-01 db1370cf-7ca5-45ed-bba6-751f28e39825 TCGA-55-8506-01 db1370cf-7ca5-45ed-bba6-751f28e39825 TCGA-55-8506-01 D0E66396-D304-41F3-86F4-96D2CED6FFC6 db1370cf-7ca5-45ed-bba6-751f28e39825 TCGA-55-8506-01A-11D-2393-08 TCGA-55-8506-01 +TCGA-55-8507-01 TCGA-55-8507-01 TCGA-55-8507 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 53 R-Upper TCGA-55-8507-F48792 TCGA-55-8507 TCGA-55-8507-01A -19390 0 418 3 Scheduled Follow-up Submission Complete Remission/Response 2013-9-20 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.7 NO 40 Peripheral Lung 1 NO NO 120 No MX N0 T1a Stage IA TCGA-55-8507.2658f9b1-c419-42f1-944c-8148b00e13b0.pdf 8507 Other TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 0.4 7th NO YES NO 55 2 Lung A LIVING 2012 1972 758f95a1-8aca-43d0-aff2-39566606f88d TCGA-55-8507-01A-11D-2389-01 TCGA-55-8507-01A-11D-2398-05 TCGA-55-8507-01 TCGA-55-8507-01A-11D-2389-01 758f95a1-8aca-43d0-aff2-39566606f88d TCGA-55-8507-01 758f95a1-8aca-43d0-aff2-39566606f88d TCGA-55-8507-01 B44F82B6-93CE-409D-9C12-B7AB7364C200 758f95a1-8aca-43d0-aff2-39566606f88d TCGA-55-8507-01A-11D-2393-08 TCGA-55-8507-01 +TCGA-55-8508-01 TCGA-55-8508-01 TCGA-55-8508 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 60 R-Upper TCGA-55-8508-F66137 TCGA-55-8508 TCGA-55-8508-01A -22159 0 617 2 Scheduled Follow-up Submission Complete Remission/Response 2014-10-3 FEMALE Mucinous (Colloid) Carcinoma No C34.1 8480/3 C34.1 YES 0.7 NO 60 Central Lung 1 NO NO No MX N1 T2a Stage IIA TCGA-55-8508.c5d96896-7988-469a-b521-39affeab8f95.pdf 8508 Preoperative TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 0.5 7th YES YES NO 55 2 Lung A LIVING 2012 5a4f0f21-a774-46cd-a5ba-525029761d94 TCGA-55-8508-01A-11D-2389-01 TCGA-55-8508-01A-11D-2398-05 TCGA-55-8508-01 TCGA-55-8508-01A-11D-2389-01 5a4f0f21-a774-46cd-a5ba-525029761d94 TCGA-55-8508-01 5a4f0f21-a774-46cd-a5ba-525029761d94 TCGA-55-8508-01 5a4f0f21-a774-46cd-a5ba-525029761d94 TCGA-55-8508-01A-11D-2393-08 TCGA-55-8508-01 +TCGA-55-8510-01 TCGA-55-8510-01 TCGA-55-8510 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 55 R-Lower TCGA-55-8510-F57923 TCGA-55-8510 TCGA-55-8510-01A -20410 0 539 54 Scheduled Follow-up Submission Complete Remission/Response 2014-3-28 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 1 NO 1.2 NO NO No MX N0 T2a Stage IB TCGA-55-8510.54ad9f1a-326f-4cc6-991a-6717bfbaed35.pdf 8510 TUMOR FREE 90 70 98 70 Complete Remission/Response YES NO R0 Primary Tumor 01 0.4 7th NO YES NO 55 2 Lung A LIVING 2012 3088dac7-68b6-42f3-82eb-ff2bd451d7c5 TCGA-55-8510-01A-11D-2389-01 TCGA-55-8510-01A-11D-2398-05 TCGA-55-8510-01 TCGA-55-8510-01A-11D-2389-01 3088dac7-68b6-42f3-82eb-ff2bd451d7c5 TCGA-55-8510-01 3088dac7-68b6-42f3-82eb-ff2bd451d7c5 TCGA-55-8510-01 3088dac7-68b6-42f3-82eb-ff2bd451d7c5 TCGA-55-8510-01A-11D-2393-08 TCGA-55-8510-01 +TCGA-55-8511-01 TCGA-55-8511-01 TCGA-55-8511 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung NO NO 73 R-Upper TCGA-55-8511-F66028 TCGA-55-8511 -26986 0 552 460 31 2 Scheduled Follow-up Submission Progressive Disease 2014-10-1 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 70 NO YES 58 Yes, History of Prior Malignancy MX N0 T2a Stage IB 8511 Preoperative WITH TUMOR 82 53 Complete Remission/Response YES NO R0 Primary Tumor 01 7th NO YES NO 55 2 Lung LIVING 2012 1953 db0a4e20-b5ad-4034-ae70-1e3747cdaa1f TCGA-55-8511-01A-11D-2389-01 TCGA-55-8511-01A-11D-2398-05 TCGA-55-8511-01 TCGA-55-8511-01A-11D-2389-01 db0a4e20-b5ad-4034-ae70-1e3747cdaa1f TCGA-55-8511-01 db0a4e20-b5ad-4034-ae70-1e3747cdaa1f TCGA-55-8511-01 db0a4e20-b5ad-4034-ae70-1e3747cdaa1f TCGA-55-8511-01A-11D-2393-08 TCGA-55-8511-01 +TCGA-55-8512-01 TCGA-55-8512-01 TCGA-55-8512 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 41 R-Lower TCGA-55-8512-F64286 TCGA-55-8512 -15266 607 0 3 1 Scheduled Follow-up Submission Progressive Disease 2014-8-28 MALE Lung Bronchioloalveolar Carcinoma Nonmucinous No C34.3 8252/3 C34.3 YES 90 NO NO 19 No M1b N1 T1a Stage IV 8512 Preoperative WITH TUMOR Progressive Disease NO NO R0 Primary Tumor 01 7th NO YES NO 55 2 Lung DECEASED 2012 1989 e776b3c7-2afe-4f44-8596-4c0de62fd46d TCGA-55-8512-01A-11D-2389-01 TCGA-55-8512-01A-11D-2398-05 TCGA-55-8512-01 TCGA-55-8512-01A-11D-2389-01 e776b3c7-2afe-4f44-8596-4c0de62fd46d TCGA-55-8512-01 e776b3c7-2afe-4f44-8596-4c0de62fd46d TCGA-55-8512-01 e776b3c7-2afe-4f44-8596-4c0de62fd46d TCGA-55-8512-01A-11D-2393-08 TCGA-55-8512-01 +TCGA-55-8513-01 TCGA-55-8513-01 TCGA-55-8513 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung YES NO NO NO 77 L-Lower TCGA-55-8513-F64283 TCGA-55-8513 TCGA-55-8513-01A -28284 0 791 317 65 2 YES YES Scheduled Follow-up Submission Stable Disease 2014-8-28 FEMALE Mucinous (Colloid) Carcinoma No C34.30 8480/3 C34.3 YES 0.9 NO 60 1 NO Distant Metastasis YES No MX N0 T3 Stage IIB TCGA-55-8513.a93a99a9-075c-4bc4-9cf8-2d7fbc3e8d80.pdf 8513 Other WITH TUMOR 108 87 Complete Remission/Response Convincing Imaging YES NO R0 Primary Tumor 01 0.4 7th NO YES NO 55 1 Lung A LIVING 2012 518328ff-5705-456f-b71a-a194fc526653 TCGA-55-8513-01A-11D-2389-01 TCGA-55-8513-01A-11D-2398-05 TCGA-55-8513-01 TCGA-55-8513-01A-11D-2389-01 518328ff-5705-456f-b71a-a194fc526653 TCGA-55-8513-01 518328ff-5705-456f-b71a-a194fc526653 TCGA-55-8513-01 518328ff-5705-456f-b71a-a194fc526653 TCGA-55-8513-01A-11D-2393-08 TCGA-55-8513-01 +TCGA-55-8514-01 TCGA-55-8514-01 TCGA-55-8514 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 70 R-Upper TCGA-55-8514-F57917 TCGA-55-8514 -25608 0 520 90 Scheduled Follow-up Submission Complete Remission/Response 2014-3-28 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES NO NO 20 No MX N0 T2a Stage IB 8514 TUMOR FREE 114 85 Complete Remission/Response YES NO R0 Primary Tumor 01 2011 7th NO YES NO 55 4 Lung LIVING 2012 1971 bdaceebb-1720-4ed0-b4e2-e3dec1d2335b TCGA-55-8514-01A-11D-2389-01 TCGA-55-8514-01A-11D-2398-05 TCGA-55-8514-01 TCGA-55-8514-01A-11D-2389-01 bdaceebb-1720-4ed0-b4e2-e3dec1d2335b TCGA-55-8514-01 bdaceebb-1720-4ed0-b4e2-e3dec1d2335b TCGA-55-8514-01 bdaceebb-1720-4ed0-b4e2-e3dec1d2335b TCGA-55-8514-01A-11D-2393-08 TCGA-55-8514-01 +TCGA-55-8614-01 TCGA-55-8614-01 TCGA-55-8614 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 76 L-Upper TCGA-55-8614-F47843 TCGA-55-8614 TCGA-55-8614-01A -27924 0 536 113 Scheduled Follow-up Submission Complete Remission/Response 2013-8-29 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.4 NO 0.7 NO NO 40 No MX N0 T2a Stage IB TCGA-55-8614.f443d31b-ee7f-4285-9529-6f04a8dad0d5.pdf 8614 TUMOR FREE 94 Complete Remission/Response YES NO R0 Primary Tumor 01 0.3 1995 7th NO YES NO 55 3 Lung A LIVING 2011 80c995f9-48bf-49a7-82ac-27d646b93e81 TCGA-55-8614-01A-11D-2389-01 TCGA-55-8614-01A-11D-2398-05 TCGA-55-8614-01 TCGA-55-8614-01A-11D-2389-01 80c995f9-48bf-49a7-82ac-27d646b93e81 TCGA-55-8614-01 80c995f9-48bf-49a7-82ac-27d646b93e81 TCGA-55-8614-01 80c995f9-48bf-49a7-82ac-27d646b93e81 TCGA-55-8614-01A-11D-2393-08 TCGA-55-8614-01 +TCGA-55-8615-01 TCGA-55-8615-01 TCGA-55-8615 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung YES YES NO NO 67 R-Middle TCGA-55-8615-F56254 TCGA-55-8615 TCGA-55-8615-01A -24786 0 446 224 83 Scheduled Follow-up Submission Progressive Disease 2014-1-30 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.2 8140/3 C34.2 YES 0.9 NO 0.9 NO Distant Metastasis YES 67 No MX N2 T3 Stage IIIA TCGA-55-8615.37b4238a-1aea-4670-8c43-b24525b94cdd.pdf 8615 WITH TUMOR 88 Complete Remission/Response Convincing Imaging YES NO R0 Primary Tumor 01 0.6 7th YES YES NO 55 2 Lung A LIVING 2012 1966 50d1ad39-3545-422e-b8fa-440e68eeebf3 TCGA-55-8615-01A-11D-2389-01 TCGA-55-8615-01A-11D-2398-05 TCGA-55-8615-01 TCGA-55-8615-01A-11D-2389-01 50d1ad39-3545-422e-b8fa-440e68eeebf3 TCGA-55-8615-01 50d1ad39-3545-422e-b8fa-440e68eeebf3 TCGA-55-8615-01 50d1ad39-3545-422e-b8fa-440e68eeebf3 TCGA-55-8615-01A-11D-2393-08 TCGA-55-8615-01 +TCGA-55-8616-01 TCGA-55-8616-01 TCGA-55-8616 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 58 R-Upper TCGA-55-8616 TCGA-55-8616-01A -21225 0 48 0 2012-12-28 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.4 NO 0.5 NO No M0 N0 T2a Stage IB TCGA-55-8616.4506aced-56d2-4297-9a5c-40539f20be87.pdf 8616 Preoperative TUMOR FREE R0 Primary Tumor 01 0.2 1999 7th YES NO 55 4 Lung A LIVING 2012 78dd0304-d459-4d26-b0ba-39a8078c59d0 TCGA-55-8616-01A-11D-2389-01 TCGA-55-8616-01A-11D-2398-05 TCGA-55-8616-01 TCGA-55-8616-01A-11D-2389-01 78dd0304-d459-4d26-b0ba-39a8078c59d0 TCGA-55-8616-01 78dd0304-d459-4d26-b0ba-39a8078c59d0 TCGA-55-8616-01 78dd0304-d459-4d26-b0ba-39a8078c59d0 TCGA-55-8616-01A-11D-2393-08 TCGA-55-8616-01 +TCGA-55-8619-01 TCGA-55-8619-01 TCGA-55-8619 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 72 R-Lower TCGA-55-8619-F57919 TCGA-55-8619 TCGA-55-8619-01A -26616 0 416 Scheduled Follow-up Submission Complete Remission/Response 2014-3-28 FEMALE Mucinous (Colloid) Carcinoma No C34.30 8480/3 C34.3 YES 0.8 NO 90 1.2 NO NO Yes, History of Prior Malignancy MX N0 T3 Stage IIB TCGA-55-8619.dcbc1e01-c61a-4d30-b741-965c99418ecf.pdf 8619 Preoperative TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 0.6 7th NO YES NO 55 1 Lung A LIVING 2012 9d7459be-af93-4bf3-8d54-df569a16ee12 TCGA-55-8619-01A-11D-2389-01 TCGA-55-8619-01A-11D-2398-05 TCGA-55-8619-01 TCGA-55-8619-01A-11D-2389-01 9d7459be-af93-4bf3-8d54-df569a16ee12 TCGA-55-8619-01 9d7459be-af93-4bf3-8d54-df569a16ee12 TCGA-55-8619-01 9d7459be-af93-4bf3-8d54-df569a16ee12 TCGA-55-8619-01A-11D-2393-08 TCGA-55-8619-01 +TCGA-55-8620-01 TCGA-55-8620-01 TCGA-55-8620 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 60 L-Upper TCGA-55-8620-F59081 TCGA-55-8620 TCGA-55-8620-01A -22091 375 0 66 64 2 NO NO Scheduled Follow-up Submission Progressive Disease 2014-4-30 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.8 NO 70 NO Central Lung 1 NO NO 154 No M1b N1 T1a Stage IV TCGA-55-8620.d74a185a-8e07-46ca-861e-14b0012ddf22.pdf 8620 Preoperative WITH TUMOR 73 76 Progressive Disease YES YES R0 Primary Tumor 01 0.5 2012 7th NO YES NO 55 4 Lung A DECEASED 2012 1965 777c61bc-aa43-4661-a1d3-7a2f07dc055a TCGA-55-8620-01A-11D-2389-01 TCGA-55-8620-01A-11D-2398-05 TCGA-55-8620-01 TCGA-55-8620-01A-11D-2389-01 777c61bc-aa43-4661-a1d3-7a2f07dc055a TCGA-55-8620-01 777c61bc-aa43-4661-a1d3-7a2f07dc055a TCGA-55-8620-01 07DE1409-5B24-4603-B9E0-E53E42D4CEA1 777c61bc-aa43-4661-a1d3-7a2f07dc055a TCGA-55-8620-01A-11D-2393-08 TCGA-55-8620-01 +TCGA-55-8621-01 TCGA-55-8621-01 TCGA-55-8621 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 75 L-Lower TCGA-55-8621-F48791 TCGA-55-8621 TCGA-55-8621-01A -27485 0 515 1 Scheduled Follow-up Submission Complete Remission/Response 2013-9-20 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 0.6 NO 90 0.7 NO NO 30 Yes, History of Prior Malignancy MX N0 T1a Stage IA TCGA-55-8621.22990911-a16f-4607-8722-c610ed1c590b.pdf 8621 Other TUMOR FREE 112 105 110 105 Complete Remission/Response YES NO R0 Primary Tumor 01 0.6 2010 7th NO YES NO 55 4 Lung A LIVING 2012 1980 7eb83c83-31e0-435b-8866-9d2764098800 TCGA-55-8621-01A-11D-2389-01 TCGA-55-8621-01A-11D-2398-05 TCGA-55-8621-01 TCGA-55-8621-01A-11D-2389-01 7eb83c83-31e0-435b-8866-9d2764098800 TCGA-55-8621-01 7eb83c83-31e0-435b-8866-9d2764098800 TCGA-55-8621-01 7eb83c83-31e0-435b-8866-9d2764098800 TCGA-55-8621-01A-11D-2393-08 TCGA-55-8621-01 +TCGA-55-A48X-01 TCGA-55-A48X-01 TCGA-55-A48X TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung YES NO YES 63 L-Lower TCGA-55-A48X-F61500 TCGA-55-A48X TCGA-55-A48X-01A 615 -23341 111 0 689 615 79 Scheduled Follow-up Submission Complete Remission/Response 2014-6-30 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 30 NO NO New Primary Tumor YES 36 false Yes, History of Prior Malignancy M0 N1 T1b Stage IIA TCGA-55-A48X.4D06D10F-60F5-4417-BD8E-F2BBCA84BEEB.pdf A48X TUMOR FREE 57 Complete Remission/Response Biopsy with Histologic Confirmation YES NO R0 Primary Tumor 01 1999 7th YES YES NO 55 4 Lung A LIVING 2012 1963 439804ec-6110-4628-b3ea-fa807c346846 TCGA-55-A48X-01A-11D-A24C-01 TCGA-55-A48X-01A-11D-A24I-05 TCGA-55-A48X-01 TCGA-55-A48X-01A-11D-A24C-01 439804ec-6110-4628-b3ea-fa807c346846 TCGA-55-A48X-01 439804ec-6110-4628-b3ea-fa807c346846 TCGA-55-A48X-01 439804ec-6110-4628-b3ea-fa807c346846 TCGA-55-A48X-01A-11D-A24D-08 TCGA-55-A48X-01 +TCGA-55-A48Y-01 TCGA-55-A48Y-01 TCGA-55-A48Y TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 69 L-Lower TCGA-55-A48Y-F59057 TCGA-55-A48Y TCGA-55-A48Y-01A -25384 107 0 630 42 Scheduled Follow-up Submission Complete Remission/Response 2014-4-30 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 10 NO NO NO 50 false No M0 N0 T2b Stage IIA TCGA-55-A48Y.3542521A-EA16-4CD1-A61A-1FB3AE928FC9.pdf A48Y TUMOR FREE 38 Complete Remission/Response YES NO R0 Primary Tumor 01 7th YES YES NO 55 2 Lung A LIVING 2012 1962 3b576c81-9276-4177-90e9-355f641f734c TCGA-55-A48Y-01A-11D-A24C-01 TCGA-55-A48Y-01A-11D-A24I-05 TCGA-55-A48Y-01 TCGA-55-A48Y-01A-11D-A24C-01 3b576c81-9276-4177-90e9-355f641f734c TCGA-55-A48Y-01 3b576c81-9276-4177-90e9-355f641f734c TCGA-55-A48Y-01 3b576c81-9276-4177-90e9-355f641f734c TCGA-55-A48Y-01A-11D-A24D-08 TCGA-55-A48Y-01 +TCGA-55-A48Z-01 TCGA-55-A48Z-01 TCGA-55-A48Z TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung NO YES NO NO 60 R-Upper TCGA-55-A48Z-F59061 TCGA-55-A48Z TCGA-55-A48Z-01A -22056 64 0 651 536 110 2 YES Other FISH YES Scheduled Follow-up Submission 2014-4-30 FEMALE Lung Adenocarcinoma Mixed Subtype No C34.1 8255/3 C34.1 YES 70 NO 70 YES NO Central Lung NO Distant Metastasis YES 40 false No MX N3 T1a Stage IIIB TCGA-55-A48Z.74C5526C-5300-4AEA-B2BB-1B78F9B536D9.pdf A48Z Preoperative WITH TUMOR 85 87 Stable Disease Convincing Imaging YES YES R0 Primary Tumor 01 2012 7th YES YES NO 55 4 Lung A LIVING 2012 1972 6499ffb8-c649-4881-8ca1-95d84842083b TCGA-55-A48Z-01A-12D-A24O-01 TCGA-55-A48Z-01A-12D-A24U-05 TCGA-55-A48Z-01 TCGA-55-A48Z-01A-12D-A24O-01 6499ffb8-c649-4881-8ca1-95d84842083b TCGA-55-A48Z-01 6499ffb8-c649-4881-8ca1-95d84842083b TCGA-55-A48Z-01 6499ffb8-c649-4881-8ca1-95d84842083b TCGA-55-A48Z-01A-12D-A24P-08 TCGA-55-A48Z-01 +TCGA-55-A490-01 TCGA-55-A490-01 TCGA-55-A490 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 78 R-Upper TCGA-55-A490-F59076 TCGA-55-A490 -28728 99 0 48 40 1 YES FISH YES Scheduled Follow-up Submission 2014-4-30 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 80 YES YES G12C Peripheral Lung NO NO 34 No MX N0 T2b Stage IIA A490 Preoperative TUMOR FREE 60 56 YES NO R0 Primary Tumor 01 1985 7th YES YES NO 55 3 Lung DECEASED 2012 1951 abbff93f-d9f6-4db6-b769-6b4e36a7de0d TCGA-55-A490-01A-11D-A24C-01 TCGA-55-A490-01A-11D-A24I-05 TCGA-55-A490-01 TCGA-55-A490-01A-11D-A24C-01 abbff93f-d9f6-4db6-b769-6b4e36a7de0d TCGA-55-A490-01 abbff93f-d9f6-4db6-b769-6b4e36a7de0d TCGA-55-A490-01 abbff93f-d9f6-4db6-b769-6b4e36a7de0d TCGA-55-A490-01A-11D-A24D-08 TCGA-55-A490-01 +TCGA-55-A491-01 TCGA-55-A491-01 TCGA-55-A491 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 81 L-Lower TCGA-55-A491-F60134 TCGA-55-A491 TCGA-55-A491-01A -29593 31 0 626 68 2 NO NO Scheduled Follow-up Submission Complete Remission/Response 2014-5-29 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 10 NO 80 NO NO NO 45 false Yes, History of Prior Malignancy MX N0 T1b Stage IA TCGA-55-A491.EE286E94-9CDB-4E6C-A768-BB35DA870736.pdf A491 Other TUMOR FREE 73 68 72 64 Complete Remission/Response YES NO R0 Primary Tumor 01 1982 7th NO YES NO 55 3 Lung A LIVING 2012 1952 768f6ac0-d742-4dda-a695-c75070a5511a TCGA-55-A491-01A-11D-A24C-01 TCGA-55-A491-01A-11D-A24I-05 TCGA-55-A491-01 TCGA-55-A491-01A-11D-A24C-01 768f6ac0-d742-4dda-a695-c75070a5511a TCGA-55-A491-01 768f6ac0-d742-4dda-a695-c75070a5511a TCGA-55-A491-01 768f6ac0-d742-4dda-a695-c75070a5511a TCGA-55-A491-01A-11D-A24D-08 TCGA-55-A491-01 +TCGA-55-A492-01 TCGA-55-A492-01 TCGA-55-A492 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 70 R-Upper TCGA-55-A492-F60135 TCGA-55-A492 -25719 0 596 52 2 NO NO Scheduled Follow-up Submission Complete Remission/Response 2014-5-29 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 80 NO NO NO 35 Yes, History of Prior Malignancy MX N0 T1a Stage IA A492 Other TUMOR FREE 92 95 Complete Remission/Response YES NO R0 Primary Tumor 01 1995 7th NO YES NO 55 3 Lung LIVING 2012 1962 ba477731-a4c6-4e1c-b44c-1964672a777c TCGA-55-A492-01A-11D-A24C-01 TCGA-55-A492-01A-11D-A24I-05 TCGA-55-A492-01 TCGA-55-A492-01A-11D-A24C-01 ba477731-a4c6-4e1c-b44c-1964672a777c TCGA-55-A492-01 ba477731-a4c6-4e1c-b44c-1964672a777c TCGA-55-A492-01 ba477731-a4c6-4e1c-b44c-1964672a777c TCGA-55-A492-01A-11D-A24D-08 TCGA-55-A492-01 +TCGA-55-A493-01 TCGA-55-A493-01 TCGA-55-A493 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 54 R-Upper TCGA-55-A493 -20027 0 28 102 NO NO 2013-2-21 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES NO NO 53 No M0 N0 T2a Stage IB A493 TUMOR FREE 71 2 65 2 NO R0 Primary Tumor 01 7th YES NO 55 2 Lung LIVING 2012 1977 ca04916e-5edc-4481-81d0-b0cc56925005 TCGA-55-A493-01A-11D-A24C-01 TCGA-55-A493-01A-11D-A24I-05 TCGA-55-A493-01 TCGA-55-A493-01A-11D-A24C-01 ca04916e-5edc-4481-81d0-b0cc56925005 TCGA-55-A493-01 ca04916e-5edc-4481-81d0-b0cc56925005 TCGA-55-A493-01 ca04916e-5edc-4481-81d0-b0cc56925005 TCGA-55-A493-01A-11D-A24D-08 TCGA-55-A493-01 +TCGA-55-A494-01 TCGA-55-A494-01 TCGA-55-A494 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 61 R-Lower TCGA-55-A494-F59038 TCGA-55-A494 TCGA-55-A494-01A -22540 28 0 481 76 1 YES FISH YES Scheduled Follow-up Submission Complete Remission/Response 2014-4-30 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 60 NO 80 YES YES G12D Peripheral Lung NO NO 7 false No MX N0 T2a Stage IB TCGA-55-A494.6FB7C18D-27D8-4C04-B8F8-AA7EA16F8C8A.pdf A494 Preoperative TUMOR FREE 95 77 Complete Remission/Response YES NO R0 Primary Tumor 01 1980 7th NO YES NO 55 3 Lung A LIVING 2012 1967 5e532c06-5ffc-4f37-9792-2ce23146d15e TCGA-55-A494-01A-11D-A24O-01 TCGA-55-A494-01A-11D-A24U-05 TCGA-55-A494-01 TCGA-55-A494-01A-11D-A24O-01 5e532c06-5ffc-4f37-9792-2ce23146d15e TCGA-55-A494-01 5e532c06-5ffc-4f37-9792-2ce23146d15e TCGA-55-A494-01 2A3F818A-CFBA-413A-948F-95D2D0274C5A 5e532c06-5ffc-4f37-9792-2ce23146d15e TCGA-55-A494-01A-11D-A24P-08 TCGA-55-A494-01 +TCGA-55-A4DF-01 TCGA-55-A4DF-01 TCGA-55-A4DF TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung NO YES NO NO 88 R-Lower TCGA-55-A4DF-F59072 TCGA-55-A4DF -32432 614 0 47 515 82 Scheduled Follow-up Submission Progressive Disease 2014-4-30 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES NO Distant Metastasis YES 60 Yes, History of Synchronous/Bilateral Malignancy MX N0 T1b Stage IA A4DF WITH TUMOR 58 47 Complete Remission/Response Convincing Imaging YES NO R0 Primary Tumor 01 1984 7th NO YES NO 55 3 Lung DECEASED 2012 bf1fd845-aa87-49e7-8bd9-1443d6a3799c TCGA-55-A4DF-01A-11D-A24C-01 TCGA-55-A4DF-01A-11D-A24I-05 TCGA-55-A4DF-01 TCGA-55-A4DF-01A-11D-A24C-01 bf1fd845-aa87-49e7-8bd9-1443d6a3799c TCGA-55-A4DF-01 bf1fd845-aa87-49e7-8bd9-1443d6a3799c TCGA-55-A4DF-01 bf1fd845-aa87-49e7-8bd9-1443d6a3799c TCGA-55-A4DF-01A-11D-A24D-08 TCGA-55-A4DF-01 +TCGA-55-A4DG-01 TCGA-55-A4DG-01 TCGA-55-A4DG TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 71 R-Upper TCGA-55-A4DG-F59047 TCGA-55-A4DG TCGA-55-A4DG-01A -26044 229 0 608 61 Scheduled Follow-up Submission Complete Remission/Response 2014-4-30 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 50 NO NO NO 100 false No MX N0 T1b Stage IA TCGA-55-A4DG.E1EA2600-CEEE-4009-A2E7-D845153DB167.pdf A4DG TUMOR FREE 73 Complete Remission/Response YES NO R0 Primary Tumor 01 2012 7th NO YES NO 55 4 Lung A LIVING 2012 1dd50bb6-84d4-4e07-ba01-802f470b46dd TCGA-55-A4DG-01A-11D-A24C-01 TCGA-55-A4DG-01A-11D-A24I-05 TCGA-55-A4DG-01 TCGA-55-A4DG-01A-11D-A24C-01 1dd50bb6-84d4-4e07-ba01-802f470b46dd TCGA-55-A4DG-01 1dd50bb6-84d4-4e07-ba01-802f470b46dd TCGA-55-A4DG-01 1dd50bb6-84d4-4e07-ba01-802f470b46dd TCGA-55-A4DG-01A-11D-A24D-08 TCGA-55-A4DG-01 +TCGA-55-A57B-01 TCGA-55-A57B-01 TCGA-55-A57B TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 80 L-Upper TCGA-55-A57B-F60133 TCGA-55-A57B TCGA-55-A57B-01A -29452 64 0 546 77 0 NO NO Scheduled Follow-up Submission Complete Remission/Response 2014-5-29 FEMALE Lung Adenocarcinoma Mixed Subtype No C34.1 8255/3 C34.1 YES 70 NO 90 NO Peripheral Lung NO NO false No M0 N0 T1b Stage IA TCGA-55-A57B.8231F2AB-F7AC-4866-BFA0-F902E2EC18B4.pdf A57B Preoperative TUMOR FREE 99 114 Complete Remission/Response YES NO R0 Primary Tumor 01 7th NO YES NO 55 1 Lung A LIVING 2012 9c08d387-1d4f-4aee-a985-04cb01fc2b07 TCGA-55-A57B-01A-12D-A396-01 TCGA-55-A57B-01A-12D-A398-05 TCGA-55-A57B-01 TCGA-55-A57B-01A-12D-A396-01 9c08d387-1d4f-4aee-a985-04cb01fc2b07 TCGA-55-A57B-01 9c08d387-1d4f-4aee-a985-04cb01fc2b07 TCGA-55-A57B-01 9c08d387-1d4f-4aee-a985-04cb01fc2b07 TCGA-55-A57B-01 +TCGA-62-8394-01 TCGA-62-8394-01 Cluster 5 miRNA cluster 4 TCGA-62-8394 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 65 L-Lower TCGA-62-8394 TCGA-62-8394-01A -23758 139 0 NO NO 2012-7-5 FEMALE Lung Adenocarcinoma Mixed Subtype No C34.3 8255/3 C34.3 YES 0.6 NO 100 NO Central Lung 0.7 NO No M0 N2 T4 Stage IIIB TCGA-62-8394.ffcaea73-0146-4b42-aa1d-e032f6944e3d.pdf 8394 Preoperative TUMOR FREE 74 115 Complete Remission/Response YES NO R0 Primary Tumor 01 0.3 6th YES NO YES 62 1 Lung A DECEASED 2008 9713f322-bae0-47aa-88d5-e2c50a7bd687 TCGA-62-8394-01A-11D-2322-01 TCGA-62-8394-01A-11D-2324-05 TCGA-62-8394-01 TCGA-62-8394-01A-11D-2322-01 9713f322-bae0-47aa-88d5-e2c50a7bd687 TCGA-62-8394-01 9713f322-bae0-47aa-88d5-e2c50a7bd687 TCGA-62-8394-01 44C9E47E-2ED2-4F88-A818-0525053D2D7C 9713f322-bae0-47aa-88d5-e2c50a7bd687 TCGA-62-8394-01A-11D-2323-08 TCGA-62-8394-01 +TCGA-62-8395-01 TCGA-62-8395-01 Cluster 6 miRNA cluster 4 TCGA-62-8395 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung YES NO NO 80 R-Upper TCGA-62-8395-F42099 TCGA-62-8395 TCGA-62-8395-01A -29311 0 1216 395 0 YES NO Scheduled Follow-up Submission Progressive Disease 2013-5-15 FEMALE Lung Adenocarcinoma Mixed Subtype No C34.1 8255/3 C34.1 YES 0.6 NO 100 NO Central Lung 1 NO Locoregional Recurrence YES No M0 N0 T3 Stage IIB TCGA-62-8395.d30859b7-5af5-4579-854b-bab436e3ae9a.pdf 8395 Preoperative WITH TUMOR 86 130 Complete Remission/Response Convincing Imaging YES NO R0 Primary Tumor 01 0.5 6th NO NO YES 62 1 Lung A LIVING 2009 69b5d608-a290-4534-ada5-59055c352fac TCGA-62-8395-01A-11D-2322-01 TCGA-62-8395-01A-11D-2324-05 TCGA-62-8395-01 TCGA-62-8395-01A-11D-2322-01 69b5d608-a290-4534-ada5-59055c352fac TCGA-62-8395-01 69b5d608-a290-4534-ada5-59055c352fac TCGA-62-8395-01 E405D3EB-1B7B-494A-8268-7A889BEB4B7D 69b5d608-a290-4534-ada5-59055c352fac TCGA-62-8395-01A-11D-2323-08 TCGA-62-8395-01 +TCGA-62-8397-01 TCGA-62-8397-01 Cluster 5 miRNA cluster 4 TCGA-62-8397 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 70 R-Lower TCGA-62-8397-F42100 TCGA-62-8397 TCGA-62-8397-01A -25728 0 1289 0 NO NO Scheduled Follow-up Submission Complete Remission/Response 2013-5-15 FEMALE Lung Adenocarcinoma Mixed Subtype No C34.3 8255/3 C34.3 YES 0.5 NO 90 NO Peripheral Lung 0.6 NO NO No M0 N0 T3 Stage IIB TCGA-62-8397.129e57ab-653d-4b31-8777-0fdd6d01a89d.pdf 8397 Preoperative TUMOR FREE 64 86 Complete Remission/Response YES NO R0 Primary Tumor 01 0.4 6th NO NO YES 62 1 Lung A LIVING 2008 360f4431-8dc9-4bc0-a388-c88bd46766c7 TCGA-62-8397-01A-11D-2322-01 TCGA-62-8397-01A-11D-2324-05 TCGA-62-8397-01 TCGA-62-8397-01A-11D-2322-01 360f4431-8dc9-4bc0-a388-c88bd46766c7 TCGA-62-8397-01 360f4431-8dc9-4bc0-a388-c88bd46766c7 TCGA-62-8397-01 360f4431-8dc9-4bc0-a388-c88bd46766c7 TCGA-62-8397-01A-11D-2323-08 TCGA-62-8397-01 +TCGA-62-8398-01 TCGA-62-8398-01 Cluster 5 miRNA cluster 4 TCGA-62-8398 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 55 R-Lower TCGA-62-8398 TCGA-62-8398-01A -20197 444 0 NO NO 2012-7-4 MALE Lung Adenocarcinoma Mixed Subtype No C34.3 8255/3 C34.3 YES 0.6 NO 100 NO Central Lung 1 NO 20 No M0 N2 T2 Stage IIIA TCGA-62-8398.49359dce-0df1-4d52-87e8-aba44fd43363.pdf 8398 Preoperative TUMOR FREE 72 64 Complete Remission/Response YES NO R0 Primary Tumor 01 0.3 1999 6th YES NO YES 62 4 Lung A DECEASED 2007 1970 82de5dc9-2d34-4395-ae7c-430b5632ed24 TCGA-62-8398-01A-11D-2322-01 TCGA-62-8398-01A-11D-2324-05 TCGA-62-8398-01 TCGA-62-8398-01A-11D-2322-01 82de5dc9-2d34-4395-ae7c-430b5632ed24 TCGA-62-8398-01 82de5dc9-2d34-4395-ae7c-430b5632ed24 TCGA-62-8398-01 D52B4AD3-D7AE-4398-B34C-DC0FD9D3173A 82de5dc9-2d34-4395-ae7c-430b5632ed24 TCGA-62-8398-01A-11D-2323-08 TCGA-62-8398-01 +TCGA-62-8399-01 TCGA-62-8399-01 Cluster 5 miRNA cluster 4 TCGA-62-8399 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 62 L-Upper TCGA-62-8399-F52545 TCGA-62-8399 -22952 0 2696 NO NO Scheduled Follow-up Submission Complete Remission/Response 2013-12-4 MALE Lung Papillary Adenocarcinoma No C34.1 8255/3 C34.1 YES 100 NO Peripheral Lung NO NO 70 No M0 N2 T2 Stage IIIA 8399 Preoperative TUMOR FREE 48 32 Complete Remission/Response YES NO R0 Primary Tumor 01 6th NO NO YES 62 4 Lung LIVING 2006 b1235878-9ab0-4335-befc-869ffa79cfab TCGA-62-8399-01A-21D-2322-01 TCGA-62-8399-01A-21D-2324-05 TCGA-62-8399-01 TCGA-62-8399-01A-21D-2322-01 b1235878-9ab0-4335-befc-869ffa79cfab TCGA-62-8399-01 b1235878-9ab0-4335-befc-869ffa79cfab TCGA-62-8399-01 b1235878-9ab0-4335-befc-869ffa79cfab TCGA-62-8399-01A-21D-2323-08 TCGA-62-8399-01 +TCGA-62-8402-01 TCGA-62-8402-01 Cluster 5 miRNA cluster 4 TCGA-62-8402 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung YES YES NO 73 R-Upper TCGA-62-8402-F52547 TCGA-62-8402 TCGA-62-8402-01A -26934 1498 0 1445 772 0 YES Exon 19 Deletion NO Scheduled Follow-up Submission Progressive Disease 2013-12-4 FEMALE Lung Adenocarcinoma Mixed Subtype No C34.1 8255/3 C34.1 YES 0.6 NO 100 NO Peripheral Lung 0.7 NO Distant Metastasis YES No M0 N2 T2 Stage IIIA TCGA-62-8402.c5ebd021-924a-48b4-a401-b7802f7acf92.pdf 8402 Preoperative WITH TUMOR 80 134 Complete Remission/Response Convincing Imaging YES NO R0 Primary Tumor 01 0.2 6th NO NO YES 62 1 Lung A DECEASED 2008 21e0230a-8314-4d80-afca-9326c34d1299 TCGA-62-8402-01A-11D-2322-01 TCGA-62-8402-01A-11D-2324-05 TCGA-62-8402-01 TCGA-62-8402-01A-11D-2322-01 21e0230a-8314-4d80-afca-9326c34d1299 TCGA-62-8402-01 21e0230a-8314-4d80-afca-9326c34d1299 TCGA-62-8402-01 21e0230a-8314-4d80-afca-9326c34d1299 TCGA-62-8402-01A-11D-2323-08 TCGA-62-8402-01 +TCGA-62-A46O-01 TCGA-62-A46O-01 TCGA-62-A46O TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 65 R-Lower TCGA-62-A46O TCGA-62-A46O-01A -24050 2349 1454 0 NO NO 2012-10-29 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 70 NO 100 NO Central Lung YES 48 true No M0 N0 T2 Stage IB TCGA-62-A46O.C1EAC8C9-2538-4FEB-9DFF-FF9AE7A20F42.pdf A46O Preoperative WITH TUMOR 65 106 Complete Remission/Response YES NO R0 Primary Tumor 01 6th NO NO YES 62 2 Lung A DECEASED 2006 a5105fe6-6ba9-4977-a976-49d9a1b6f164 TCGA-62-A46O-01A-11D-A24C-01 TCGA-62-A46O-01A-11D-A24I-05 TCGA-62-A46O-01 TCGA-62-A46O-01A-11D-A24C-01 a5105fe6-6ba9-4977-a976-49d9a1b6f164 TCGA-62-A46O-01 a5105fe6-6ba9-4977-a976-49d9a1b6f164 TCGA-62-A46O-01 7F7753FD-B329-443F-8F4D-2C7559742EB5 a5105fe6-6ba9-4977-a976-49d9a1b6f164 TCGA-62-A46O-01A-11D-A24D-08 TCGA-62-A46O-01 +TCGA-62-A46P-01 TCGA-62-A46P-01 TCGA-62-A46P TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 65 L-Upper TCGA-62-A46P TCGA-62-A46P-01A -23993 2254 594 0 NO NO 2012-10-29 MALE Lung Adenocarcinoma Mixed Subtype No C34.1 8255/3 C34.1 YES 90 NO 100 NO Central Lung YES 40 true No M0 N0 T2 Stage IB TCGA-62-A46P.1520ADC4-F5A7-4412-B2E7-A26326EE0074.pdf A46P Preoperative TUMOR FREE 66 78 Complete Remission/Response YES NO R0 Primary Tumor 01 6th NO NO YES 62 4 Lung A DECEASED 2006 ddf657f3-c764-4003-9de5-3384931c711b TCGA-62-A46P-01A-11D-A24C-01 TCGA-62-A46P-01A-11D-A24I-05 TCGA-62-A46P-01 TCGA-62-A46P-01A-11D-A24C-01 ddf657f3-c764-4003-9de5-3384931c711b TCGA-62-A46P-01 ddf657f3-c764-4003-9de5-3384931c711b TCGA-62-A46P-01 489229C9-5E0B-43F3-BFE7-903140052B6E ddf657f3-c764-4003-9de5-3384931c711b TCGA-62-A46P-01A-11D-A24D-08 TCGA-62-A46P-01 +TCGA-62-A46R-01 TCGA-62-A46R-01 TCGA-62-A46R TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 54 L-Lower TCGA-62-A46R TCGA-62-A46R-01A -20063 2071 1725 0 NO NO 2012-10-29 FEMALE Lung Adenocarcinoma Mixed Subtype No C34.3 8255/3 C34.3 YES 100 NO 100 NO Central Lung NO 25 true No M0 N0 T2 Stage IB TCGA-62-A46R.7AF85E19-CD80-40FD-B0BE-CFFF4B252C0D.pdf A46R Preoperative TUMOR FREE 73 74 Complete Remission/Response YES NO R0 Primary Tumor 01 6th NO NO YES 62 4 Lung A DECEASED 2006 fae54004-1d4e-414e-a85e-667fc2cb89b5 TCGA-62-A46R-01A-11D-A24C-01 TCGA-62-A46R-01A-11D-A24I-05 TCGA-62-A46R-01 TCGA-62-A46R-01A-11D-A24C-01 fae54004-1d4e-414e-a85e-667fc2cb89b5 TCGA-62-A46R-01 fae54004-1d4e-414e-a85e-667fc2cb89b5 TCGA-62-A46R-01 B902BF89-CAB7-4771-A55A-7127BD5A6A70 fae54004-1d4e-414e-a85e-667fc2cb89b5 TCGA-62-A46R-01A-11D-A24D-08 TCGA-62-A46R-01 +TCGA-62-A46S-01 TCGA-62-A46S-01 TCGA-62-A46S TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 73 L-Upper TCGA-62-A46S TCGA-62-A46S-01A -26825 1936 1653 0 0 NO NO 2012-10-29 MALE Lung Papillary Adenocarcinoma No C34.1 8260/3 C34.1 YES 150 NO 100 NO Peripheral Lung YES 40 true No M0 N0 T2 Stage IB TCGA-62-A46S.56821636-8883-494F-A808-61AD827CE524.pdf A46S Preoperative WITH TUMOR 66 72 Complete Remission/Response YES NO R0 Primary Tumor 01 6th YES NO YES 62 4 Lung A DECEASED 2007 cc85d7b0-8421-4ea1-b647-92d3d0bbe550 TCGA-62-A46S-01A-11D-A24C-01 TCGA-62-A46S-01A-11D-A24I-05 TCGA-62-A46S-01 TCGA-62-A46S-01A-11D-A24C-01 cc85d7b0-8421-4ea1-b647-92d3d0bbe550 TCGA-62-A46S-01 cc85d7b0-8421-4ea1-b647-92d3d0bbe550 TCGA-62-A46S-01 DFC753AE-689E-40B7-AB75-C61B65EFE49A cc85d7b0-8421-4ea1-b647-92d3d0bbe550 TCGA-62-A46S-01A-11D-A24D-08 TCGA-62-A46S-01 +TCGA-62-A46U-01 TCGA-62-A46U-01 TCGA-62-A46U TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 71 R-Lower TCGA-62-A46U-F51441 TCGA-62-A46U TCGA-62-A46U-01A -25998 1834 0 2067 NO NO Scheduled Follow-up Submission Complete Remission/Response 2013-11-19 FEMALE Lung Adenocarcinoma Mixed Subtype No C34.3 8255/3 C34.3 YES 70 NO 100 NO Central Lung NO NO true No M0 N1 T2 Stage IIB TCGA-62-A46U.15C4143C-779A-44D7-B75F-867E5E0F7671.pdf A46U Preoperative TUMOR FREE 81 131 Complete Remission/Response YES NO R0 Primary Tumor 01 6th YES NO YES 62 1 Lung A LIVING 2007 83ca9e67-060b-45ec-9ea9-076a64ae8062 TCGA-62-A46U-01A-11D-A24C-01 TCGA-62-A46U-01A-11D-A24I-05 TCGA-62-A46U-01 TCGA-62-A46U-01A-11D-A24C-01 83ca9e67-060b-45ec-9ea9-076a64ae8062 TCGA-62-A46U-01 83ca9e67-060b-45ec-9ea9-076a64ae8062 TCGA-62-A46U-01 83ca9e67-060b-45ec-9ea9-076a64ae8062 TCGA-62-A46U-01A-11D-A24D-08 TCGA-62-A46U-01 +TCGA-62-A46V-01 TCGA-62-A46V-01 TCGA-62-A46V TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 78 L-Lower TCGA-62-A46V-F51440 TCGA-62-A46V TCGA-62-A46V-01A -28495 1751 0 2199 NO NO Scheduled Follow-up Submission Complete Remission/Response 2013-11-19 FEMALE Lung Adenocarcinoma Mixed Subtype No C34.3 8255/3 C34.3 YES 100 NO 90 NO Peripheral Lung NO NO true No M0 N0 T2 Stage IB TCGA-62-A46V.FC6490C8-996A-4FD9-B0B5-65ED9E0AE6C7.pdf A46V Preoperative TUMOR FREE 51 100 Complete Remission/Response YES NO R0 Primary Tumor 01 6th NO NO YES 62 3 Lung A LIVING 2007 fc475e1d-25de-46e4-9191-9e5ee16f0371 TCGA-62-A46V-01A-11D-A24C-01 TCGA-62-A46V-01A-11D-A24I-05 TCGA-62-A46V-01 TCGA-62-A46V-01A-11D-A24C-01 fc475e1d-25de-46e4-9191-9e5ee16f0371 TCGA-62-A46V-01 fc475e1d-25de-46e4-9191-9e5ee16f0371 TCGA-62-A46V-01 A3AEAAFD-CF26-443D-A68C-360267DAECC8 fc475e1d-25de-46e4-9191-9e5ee16f0371 TCGA-62-A46V-01A-11D-A24D-08 TCGA-62-A46V-01 +TCGA-62-A46Y-01 TCGA-62-A46Y-01 TCGA-62-A46Y TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 70 R-Lower TCGA-62-A46Y TCGA-62-A46Y-01A -25905 1608 414 0 NO NO 2012-10-30 FEMALE Lung Adenocarcinoma Mixed Subtype No C34.3 8255/3 C34.3 YES 80 NO 90 NO Peripheral Lung YES true No M0 N2 T2 Stage IIIA TCGA-62-A46Y.284FE692-BC27-4E0E-A92A-2DF64FF33405.pdf A46Y Preoperative WITH TUMOR 84 88 Complete Remission/Response YES YES R0 Primary Tumor 01 6th YES NO YES 62 1 Lung A DECEASED 2008 085abecb-d625-44e2-b699-34f9863a9b28 TCGA-62-A46Y-01A-11D-A24C-01 TCGA-62-A46Y-01A-11D-A24I-05 TCGA-62-A46Y-01 TCGA-62-A46Y-01A-11D-A24C-01 085abecb-d625-44e2-b699-34f9863a9b28 TCGA-62-A46Y-01 085abecb-d625-44e2-b699-34f9863a9b28 TCGA-62-A46Y-01 085abecb-d625-44e2-b699-34f9863a9b28 TCGA-62-A46Y-01A-11D-A24D-08 TCGA-62-A46Y-01 +TCGA-62-A470-01 TCGA-62-A470-01 TCGA-62-A470 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 84 R-Upper TCGA-62-A470 TCGA-62-A470-01A -30689 1310 1194 0 0 NO NO 2012-10-30 MALE Lung Acinar Adenocarcinoma No C34.1 8550/3 C34.1 YES 80 NO 100 NO Central Lung YES 30 true No M0 N0 T2 Stage IB TCGA-62-A470.C0136855-AF03-4065-8563-5C2B232D7070.pdf A470 Preoperative WITH TUMOR 74 111 Complete Remission/Response YES NO R0 Primary Tumor 01 6th NO NO YES 62 3 Lung A DECEASED 2009 4f8a59d0-d4e5-4015-9bec-46fccd7d139e TCGA-62-A470-01A-11D-A24C-01 TCGA-62-A470-01A-11D-A24I-05 TCGA-62-A470-01 TCGA-62-A470-01A-11D-A24C-01 4f8a59d0-d4e5-4015-9bec-46fccd7d139e TCGA-62-A470-01 4f8a59d0-d4e5-4015-9bec-46fccd7d139e TCGA-62-A470-01 4f8a59d0-d4e5-4015-9bec-46fccd7d139e TCGA-62-A470-01A-11D-A24D-08 TCGA-62-A470-01 +TCGA-62-A471-01 TCGA-62-A471-01 TCGA-62-A471 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 64 L-Upper TCGA-62-A471-F51439 TCGA-62-A471 TCGA-62-A471-01A -23689 951 0 1246 0 NO NO Scheduled Follow-up Submission Complete Remission/Response 2013-11-19 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 130 NO 100 NO Peripheral Lung NO NO 30 true No M0 N1 T2b Stage IIB TCGA-62-A471.5F2495BD-2398-4C97-8F3E-76E979F22691.pdf A471 Preoperative TUMOR FREE 75 104 Complete Remission/Response YES NO R0 Primary Tumor 01 2006 7th YES NO YES 62 4 Lung A LIVING 2010 d0979d89-4efa-4e30-8510-8aa96a7c2f3d TCGA-62-A471-01A-12D-A24C-01 TCGA-62-A471-01A-12D-A24I-05 TCGA-62-A471-01 TCGA-62-A471-01A-12D-A24C-01 d0979d89-4efa-4e30-8510-8aa96a7c2f3d TCGA-62-A471-01 d0979d89-4efa-4e30-8510-8aa96a7c2f3d TCGA-62-A471-01 5D921A12-A1EC-4265-9198-1896A5054016 d0979d89-4efa-4e30-8510-8aa96a7c2f3d TCGA-62-A471-01A-12D-A24D-08 TCGA-62-A471-01 +TCGA-62-A472-01 TCGA-62-A472-01 TCGA-62-A472 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung NO YES NO 70 R-Lower TCGA-62-A472-F51442 TCGA-62-A472 TCGA-62-A472-01A -25893 498 0 910 290 1 NO NO Scheduled Follow-up Submission Partial Remission/Response 2013-11-19 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 80 NO 80 NO Central Lung NO Locoregional Recurrence YES 60 true No M0 N0 T3 Stage IIB TCGA-62-A472.1C47AD8C-F1EB-4B7E-9633-3260EF8CEAE4.pdf A472 Preoperative WITH TUMOR 70 87 Complete Remission/Response Convincing Imaging YES NO R0 Primary Tumor 01 7th NO NO YES 62 2 Lung A LIVING 2011 17a290d7-8577-4d11-8842-86c2f48e1cac TCGA-62-A472-01A-11D-A24C-01 TCGA-62-A472-01A-11D-A24I-05 TCGA-62-A472-01 TCGA-62-A472-01A-11D-A24C-01 17a290d7-8577-4d11-8842-86c2f48e1cac TCGA-62-A472-01 17a290d7-8577-4d11-8842-86c2f48e1cac TCGA-62-A472-01 17a290d7-8577-4d11-8842-86c2f48e1cac TCGA-62-A472-01A-11D-A24D-08 TCGA-62-A472-01 +TCGA-64-1676-01 3.41 0.36 none none none none N N none none none 0.14 Squamoid none none p.C121S none none none none Adenocarcinoma, NOS Adenocarcinoma, NOS none 0 TCGA-64-1676-01 High C1-LUAD-enriched Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 4 cluster 2 mutation cluster 11 TCGA-64-1676 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 58 R-Lower TCGA-64-1676-F4366 TCGA-64-1676 TCGA-64-1676-01A -21428 0 1728 Complete Remission/Response 2010-11-15 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 0.5 NO Central Lung 1.5 NO 60 No M0 N0 T1a Stage IA TCGA-64-1676.516b08af-72b5-4b4a-b208-3c874abe63ad.pdf 1676 TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 0.3 NO NO YES 64 2 Current smoker Lung A LIVING 2005 TCGA-64-1676-01 TCGA-64-1676-01A-01D-0969-08 TCGA-64-1676-01 6447a7cf-ae7a-4896-b00f-10c357eb8c8b TCGA-64-1676-01A-01R-0946-07 TCGA-64-1676-01A-01D-0945-05 TCGA-64-1676-01 TCGA-64-1676-01A-01D-0944-01 TCGA-64-1676-01 TCGA-64-1676-01A-01D-0944-01 TCGA-64-1676-01 6447a7cf-ae7a-4896-b00f-10c357eb8c8b TCGA-64-1676-01A-21-2190-20 6447a7cf-ae7a-4896-b00f-10c357eb8c8b TCGA-64-1676-01 390c2548-0e2b-4b46-9bfb-2993a7570bc9 6447a7cf-ae7a-4896-b00f-10c357eb8c8b TCGA-64-1676-01A-01W-0928-08,TCGA-64-1676-01A-01D-0969-08 TCGA-64-1676-01 +TCGA-64-1677-01 2.68 0.32 none none none none N N none none none 0.14 Magnoid none none none none none p.E545K none Adenocarcinoma, NOS Adenocarcinoma, NOS none 0 TCGA-64-1677-01 High C1-LUAD-enriched Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 7 cluster 4 mutation cluster 2 TCGA-64-1677 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung YES YES NO NO 77 R-Lower TCGA-64-1677-F8691 TCGA-64-1677 TCGA-64-1677-01A -28482 628 0 360 2011-2-18 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.5 NO 0 1 YES 50 Yes M0 N2 T2 Stage IIIA TCGA-64-1677.31f047f0-df34-44d4-b0d1-a3b43833f560.pdf 1677 NO R0 Primary Tumor 01 0.4 YES NO YES 64 2 Current smoker Lung A DECEASED 2005 1955 TCGA-64-1677-01A-01W-0928-08 TCGA-64-1677-01A-01W-0928-08 TCGA-64-1677-01 900735b7-3870-421e-8c87-3f4e86fc8dae TCGA-64-1677-01A-01R-0946-07 TCGA-64-1677-01A-01D-0945-05 TCGA-64-1677-01 TCGA-64-1677-01A-01D-0944-01 TCGA-64-1677-01 TCGA-64-1677-01A-01D-0944-01 TCGA-64-1677-01 900735b7-3870-421e-8c87-3f4e86fc8dae TCGA-64-1677-01A-21-2190-20 900735b7-3870-421e-8c87-3f4e86fc8dae TCGA-64-1677-01 b3712c9a-2e1b-4cb2-8f49-f69cec4c5ca9 900735b7-3870-421e-8c87-3f4e86fc8dae TCGA-64-1677-01A-01W-0928-08 TCGA-64-1677-01 +TCGA-64-1678-01 3.11 0.57 none none none none N Y none none none 0.22 Magnoid none none p.K57N none none none none Adenocarcinoma, NOS Adenocarcinoma, NOS none 1 TCGA-64-1678-01 High C1-LUAD-enriched Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 6 cluster 1 mutation cluster 5 TCGA-64-1678 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 70 R-Middle TCGA-64-1678-F4371 TCGA-64-1678 TCGA-64-1678-01A -25931 0 1189 Complete Remission/Response 2010-11-15 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.8 NO 1 NO 20 No M0 N0 T2b [Discrepancy] TCGA-64-1678.5b49e9b0-c7f5-43a2-9d48-34c1537c148d.pdf 1678 TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 0.3 1990 6th YES NO YES 64 3 Current reformed smoker for > 15 years Lung A LIVING 2006 1970 TCGA-64-1678-01A-01W-0928-08 TCGA-64-1678-01A-01W-0928-08 TCGA-64-1678-01 37f38cd6-6b65-4646-8ee1-d86ccc02fa75 TCGA-64-1678-01A-01R-0946-07 TCGA-64-1678-01A-01D-0945-05 TCGA-64-1678-01 TCGA-64-1678-01A-01D-0944-01 TCGA-64-1678-01 TCGA-64-1678-01A-01D-0944-01 TCGA-64-1678-01 37f38cd6-6b65-4646-8ee1-d86ccc02fa75 TCGA-64-1678-01A-21-2190-20 37f38cd6-6b65-4646-8ee1-d86ccc02fa75 TCGA-64-1678-01 011bb13f-e0e8-4f4b-b7a5-4867bbe3b30a 37f38cd6-6b65-4646-8ee1-d86ccc02fa75 TCGA-64-1678-01A-01W-0928-08 TCGA-64-1678-01 +TCGA-64-1679-01 1.73 0.42 none none none none N N none none none 0.22 Squamoid none none none none none none none Acinar predominant Adc Acinar predominant Adc none 0 TCGA-64-1679-01 Squamous C2-Squamous-like cluster 3 Low purity c2 squamous c3 LUAD-like c10 miRNA cluster 4 cluster 2 TCGA-64-1679 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 58 R-Upper TCGA-64-1679-F66261 TCGA-64-1679 TCGA-64-1679-01A -21310 0 2488 0 Scheduled Follow-up Submission Complete Remission/Response 2014-10-7 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.5 NO NO 1 NO NO 40 No M0 N2 T1 Stage IIIA TCGA-64-1679.dd4816b8-a99f-4f95-94b1-75b011509c2d.pdf 1679 Post-Adjuvant Therapy TUMOR FREE Complete Remission/Response YES NO R0 Primary Tumor 01 0.4 6th YES NO YES 64 2 Current smoker Lung A LIVING 2007 TCGA-64-1679-01A-21D-2063-08 7c6ef5e6-8116-4a21-ae62-88a5e420bcc1 TCGA-64-1679-01A-21D-2062-01 TCGA-64-1679-01A-21D-2064-05 TCGA-64-1679-01 TCGA-64-1679-01A-21D-2062-01 7c6ef5e6-8116-4a21-ae62-88a5e420bcc1 TCGA-64-1679-01 TCGA-64-1679-01A-11-2190-20 7c6ef5e6-8116-4a21-ae62-88a5e420bcc1 TCGA-64-1679-01 112ea78d-4339-4119-bc19-7f011fee944d 7c6ef5e6-8116-4a21-ae62-88a5e420bcc1 TCGA-64-1679-01A-21D-2063-08 TCGA-64-1679-01 +TCGA-64-1680-01 3.41 0.63 none none none none N Y none none none 0.22 Bronchioid none none none none none none none Acinar predominant Adc Acinar predominant Adc Y none 1 TCGA-64-1680-01 Kirc+ C1-LUAD-enriched Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 4 cluster 2 mutation cluster 14 TCGA-64-1680 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 63 R-Middle TCGA-64-1680-F4387 TCGA-64-1680 TCGA-64-1680-01A -23267 0 1126 2010-11-16 MALE Lung Adenocarcinoma Mixed Subtype No C34.8 8255/3 C34.8 YES 0.4 NO 1.2 NO 50 No M1 N2 T2a Stage IV TCGA-64-1680.8daa91a5-773c-4c8b-ab17-b270aa75ec18.pdf 1680 TUMOR FREE Complete Remission/Response YES R0 Primary Tumor 01 0.3 1982 6th YES NO YES 64 3 Current reformed smoker for > 15 years Lung A LIVING 2007 1962 TCGA-64-1680-01 TCGA-64-1680-01A-02D-0969-08 TCGA-64-1680-01 1cade122-820d-4d68-8508-7a6c0f2b4852 TCGA-64-1680-01A-02R-0946-07 TCGA-64-1680-01A-02D-0945-05 TCGA-64-1680-01 TCGA-64-1680-01A-02D-0944-01 TCGA-64-1680-01 TCGA-64-1680-01A-02D-0944-01 TCGA-64-1680-01 1cade122-820d-4d68-8508-7a6c0f2b4852 TCGA-64-1680-01A-11-2190-20 1cade122-820d-4d68-8508-7a6c0f2b4852 TCGA-64-1680-01 9a98e01f-f8aa-4b09-856a-572743a2db89 1cade122-820d-4d68-8508-7a6c0f2b4852 TCGA-64-1680-01A-02W-0928-08,TCGA-64-1680-01A-02D-0969-08 TCGA-64-1680-01 +TCGA-64-1681-01 2.97 0.44 none none none none Y Y p.L858R none none 0.18 Bronchioid none none none none none none none Acinar predominant Adc Acinar predominant Adc none 0 TCGA-64-1681-01 BRCA-LUAD+ C1-LUAD-enriched cluster 3 Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 5 cluster 3 TCGA-64-1681 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung YES YES NO 61 R-Upper TCGA-64-1681-F20365 TCGA-64-1681 TCGA-64-1681-01A -22525 1167 0 439 YES Exon 19 Deletion Additional New Tumor Event 2011-12-21 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.9 YES 0.4 NO 0 YES NO 0.8 YES No M0 N0 T1 Stage IA TCGA-64-1681.de31291a-ced6-458b-8fb7-ad47ae581b64.pdf 1681 NO R0 Primary Tumor 01 0.4 1988 6th NO NO YES 64 3 Current reformed smoker for > 15 years Lung A DECEASED 2008 1968 TCGA-64-1681-01A-11D-2063-08 4f0fbd7c-4768-4bf2-b6f4-372f28b1953f TCGA-64-1681-01A-11D-2062-01 TCGA-64-1681-01A-11D-2064-05 TCGA-64-1681-01 TCGA-64-1681-01A-11D-2062-01 4f0fbd7c-4768-4bf2-b6f4-372f28b1953f TCGA-64-1681-01 TCGA-64-1681-01A-21-2190-20 4f0fbd7c-4768-4bf2-b6f4-372f28b1953f TCGA-64-1681-01 6fc61107-6515-4cc3-a63e-5e1fe083c3eb 4f0fbd7c-4768-4bf2-b6f4-372f28b1953f TCGA-64-1681-01A-11D-2063-08 TCGA-64-1681-01 +TCGA-64-5774-01 2.84 0.76 none none none none Y Y none none none 0.29 Magnoid none p.G12C p.G279fs none none none none Adenocarcinoma, NOS Adenocarcinoma, NOS none 0 TCGA-64-5774-01 BRCA-LUAD+ C1-LUAD-enriched cluster 3 Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 6 cluster 1 mutation cluster 12 TCGA-64-5774 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung NO NO YES 60 R-Middle TCGA-64-5774-F31478 TCGA-64-5774 TCGA-64-5774-01A -22059 0 2676 277 95 Additional New Tumor Event 2012-5-3 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.0 8140/3 C34.0 YES 0.6 NO Central Lung 1.4 Distant Metastasis YES 45 No M0 N0 T2 Stage IB TCGA-64-5774.d8d1fecd-1290-4d5a-a98b-3c29f789bde6.pdf 5774 TUMOR FREE 71 72 YES NO R0 Primary Tumor 01 0.2 2004 6th NO NO YES 64 4 Current reformed smoker for < or = 15 years Lung A LIVING 2004 1959 TCGA-64-5774-01A-01D-1625-08 TCGA-64-5774-01A-01D-1625-08 9ea59622-ed8d-48aa-aa45-665a670928a0 TCGA-64-5774-01A-01D-1624-01 TCGA-64-5774-01A-01D-1626-05 TCGA-64-5774-01 TCGA-64-5774-01A-01D-1624-01 9ea59622-ed8d-48aa-aa45-665a670928a0 TCGA-64-5774-01 TCGA-64-5774-01A-41-2191-20 9ea59622-ed8d-48aa-aa45-665a670928a0 TCGA-64-5774-01 2bb2dd1a-8bd9-45d0-9c34-9bf98476b90a 9ea59622-ed8d-48aa-aa45-665a670928a0 TCGA-64-5774-01A-01D-1625-08 TCGA-64-5774-01 +TCGA-64-5775-01 3.39 0.71 none none none none Y Y none none none 0.24 Squamoid none p.Q61L none none none none none Adenocarcinoma, NOS Adenocarcinoma, NOS none 0 TCGA-64-5775-01 Kirc+ C12-small-various cluster 1 Cluster 6 RNA cluster 2 miRNA c1uster 9 cluster 2 mutation cluster 2 TCGA-64-5775 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 71 L-Upper TCGA-64-5775-F11418 TCGA-64-5775 TCGA-64-5775-01A -26058 62 0 Progressive Disease 2011-5-2 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) Yes C34.1 8140/3 C34.1 YES 1.2 NO 0 1.3 NO 110 No M0 N0 T4 Stage IIIA TCGA-64-5775.eb576e3d-fa59-42b7-af77-416013a9bc90.pdf 5775 WITH TUMOR Progressive Disease NO R0 Primary Tumor 01 0.4 NO NO YES 64 2 Current smoker Lung A DECEASED 2005 1950 TCGA-64-5775-01A-01D-1625-08 TCGA-64-5775-01A-01D-1625-08 6cf7d085-d60c-4456-9266-5031628f687c TCGA-64-5775-01A-01D-1624-01 TCGA-64-5775-01A-01D-1626-05 TCGA-64-5775-01 TCGA-64-5775-01A-01D-1624-01 6cf7d085-d60c-4456-9266-5031628f687c TCGA-64-5775-01 6cf7d085-d60c-4456-9266-5031628f687c TCGA-64-5775-01 6cf7d085-d60c-4456-9266-5031628f687c TCGA-64-5775-01A-01D-1625-08 TCGA-64-5775-01 +TCGA-64-5778-01 3.45 0.42 none none none none Y Y none none p.G640C 0.16 Squamoid none p.G12C none none none none none Adenocarcinoma, NOS Adenocarcinoma, NOS none 0 TCGA-64-5778-01 BRCA-LUAD+ C1-LUAD-enriched cluster 3 Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 4 cluster 2 mutation cluster 2 TCGA-64-5778 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung YES NO NO NO 60 R-Upper TCGA-64-5778-F31471 TCGA-64-5778 TCGA-64-5778-01A -21927 0 1305 1168 1 Additional New Tumor Event Progressive Disease 2012-5-3 MALE Lung Bronchioloalveolar Carcinoma Nonmucinous No C34.1 8252/3 C34.1 YES 0.4 NO 0 Central Lung 1.2 NO YES 68 No M0 N0 T2 Stage IB TCGA-64-5778.36cf9846-5ec1-4d43-8b66-80a802c6b4e7.pdf 5778 Other WITH TUMOR Complete Remission/Response YES NO R0 Primary Tumor 01 0.4 2000 6th NO NO YES 64 4 Current reformed smoker for < or = 15 years Lung A LIVING 2008 1966 TCGA-64-5778-01A-01D-1625-08 TCGA-64-5778-01A-01D-1625-08 b549484e-cce0-4f6f-994c-910b458de4de TCGA-64-5778-01A-01D-1624-01 TCGA-64-5778-01A-01D-1626-05 TCGA-64-5778-01 TCGA-64-5778-01A-01D-1624-01 b549484e-cce0-4f6f-994c-910b458de4de TCGA-64-5778-01 TCGA-64-5778-01A-41-2191-20 b549484e-cce0-4f6f-994c-910b458de4de TCGA-64-5778-01 423b6125-bdf6-483c-8aad-4f0c5c2703bc b549484e-cce0-4f6f-994c-910b458de4de TCGA-64-5778-01A-01D-1625-08 TCGA-64-5778-01 +TCGA-64-5779-01 TCGA-64-5779-01 BRCA-LUAD+ C1-LUAD-enriched Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 7 mutation cluster 12 TCGA-64-5779 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung NO YES YES 61 L-Lower TCGA-64-5779-F31473 TCGA-64-5779 TCGA-64-5779-01A 797 -22305 0 864 795 100 0 Additional New Tumor Event 2012-5-3 MALE Lung Acinar Adenocarcinoma No C34.3 8550/3 C34.3 YES 1 NO Central Lung 1.3 Distant Metastasis YES 40 No M0 N2 T2 Stage IIIA TCGA-64-5779.74ed3c2e-6708-48d7-bc21-5fc04999614f.pdf 5779 Post-Adjuvant Therapy TUMOR FREE 94 100 [Discrepancy] YES YES R0 Primary Tumor 01 0.4 2009 6th YES NO YES 64 4 Lung A LIVING 2009 1969 TCGA-64-5779-01A-01D-1625-08 0f61b005-3643-4a6b-a075-bffb7320a2f3 TCGA-64-5779-01A-01D-1624-01 TCGA-64-5779-01A-01D-1626-05 TCGA-64-5779-01 TCGA-64-5779-01A-01D-1624-01 0f61b005-3643-4a6b-a075-bffb7320a2f3 TCGA-64-5779-01 TCGA-64-5779-01A-41-2191-20 0f61b005-3643-4a6b-a075-bffb7320a2f3 TCGA-64-5779-01 5e3fb226-21a1-4b99-948a-55d119066615 0f61b005-3643-4a6b-a075-bffb7320a2f3 TCGA-64-5779-01A-01D-1625-08 TCGA-64-5779-01 +TCGA-64-5781-01 1.9 0.38 none none none none N N none none none 0.19 Squamoid none none none p.Y1235H none none none Adenocarcinoma, NOS Adenocarcinoma, NOS none 0 TCGA-64-5781-01 BRCA-LUAD+ C1-LUAD-enriched cluster 2 Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 4 cluster 2 mutation cluster 1 TCGA-64-5781 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung NO NO NO YES 55 R-Upper TCGA-64-5781-F31490 TCGA-64-5781 TCGA-64-5781-01A 112 -20219 0 1559 96 73 0 Additional New Tumor Event Complete Remission/Response 2012-5-3 FEMALE Lung Adenocarcinoma Mixed Subtype No C34.1 8255/3 C34.1 YES 0.8 NO Central Lung 1 Distant Metastasis YES 25 No M0 N0 T2 Stage IB TCGA-64-5781.988a550c-800e-4ba9-9c6a-de986969753b.pdf 5781 Post-Adjuvant Therapy TUMOR FREE 61 77 Progressive Disease YES NO R0 Primary Tumor 01 0.4 2007 6th NO NO YES 64 4 Current reformed smoker for < or = 15 years Lung A LIVING 2007 1982 TCGA-64-5781-01A-01D-1625-08 TCGA-64-5781-01A-01D-1625-08 55228174-5562-47b2-a9f1-f9f5216f8c8c TCGA-64-5781-01A-01D-1624-01 TCGA-64-5781-01A-01D-1626-05 TCGA-64-5781-01 TCGA-64-5781-01A-01D-1624-01 55228174-5562-47b2-a9f1-f9f5216f8c8c TCGA-64-5781-01 TCGA-64-5781-01A-41-2191-20 55228174-5562-47b2-a9f1-f9f5216f8c8c TCGA-64-5781-01 d161ad96-a846-4f14-b954-316e4dfaffcd 55228174-5562-47b2-a9f1-f9f5216f8c8c TCGA-64-5781-01A-01D-1625-08 TCGA-64-5781-01 +TCGA-64-5815-01 TCGA-64-5815-01 Kirc+ C1-LUAD-enriched Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 4 mutation cluster 12 TCGA-64-5815 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 74 R-Upper TCGA-64-5815-F31480 TCGA-64-5815 -27280 0 866 87 1 YES Scheduled Follow-up Submission 2012-5-3 MALE Lung Adenocarcinoma Mixed Subtype No C34.1 8255/3 C34.1 YES YES Central Lung 30 No M0 N1 T2 Stage IIB 5815 Post-Adjuvant Therapy TUMOR FREE 76 89 Complete Remission/Response YES NO R0 Primary Tumor 01 1985 6th YES NO YES 64 3 Lung LIVING 2009 TCGA-64-5815-01A-01D-1625-08 a07caf79-5856-4f7d-ae48-7fa82c36cf4d TCGA-64-5815-01A-01D-1624-01 TCGA-64-5815-01A-01D-1626-05 TCGA-64-5815-01 TCGA-64-5815-01A-01D-1624-01 a07caf79-5856-4f7d-ae48-7fa82c36cf4d TCGA-64-5815-01 TCGA-64-5815-01A-41-2191-20 a07caf79-5856-4f7d-ae48-7fa82c36cf4d TCGA-64-5815-01 c1fc598f-efaa-4a42-a646-a7bac6f73085 a07caf79-5856-4f7d-ae48-7fa82c36cf4d TCGA-64-5815-01A-01D-1625-08 TCGA-64-5815-01 +TCGA-67-3770-01 TCGA-67-3770-01 BRCA-LUAD+ LUAD-like c10 miRNA cluster 7 mutation cluster 11 TCGA-67-3770 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 70 R-Upper TCGA-67-3770 TCGA-67-3770-01A -25658 0 610 NO NO 2010-12-00 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.8 NO NO Central Lung 0.9 No M0 N0 T1 Stage IA TCGA-67-3770.93f88ca0-8ac7-486f-a253-d258a0744c77.pdf 3770 TUMOR FREE R0 Primary Tumor 01 0.2 YES NO 67 3 Lung A LIVING 2009 TCGA-67-3770-01 TCGA-67-3770-01 69180b6c-8fef-4453-812d-212730a35ea7 TCGA-67-3770-01A-01R-0946-07 TCGA-67-3770-01 TCGA-67-3770-01A-01D-0944-01 TCGA-67-3770-01 TCGA-67-3770-01A-01D-0944-01 TCGA-67-3770-01 69180b6c-8fef-4453-812d-212730a35ea7 69180b6c-8fef-4453-812d-212730a35ea7 TCGA-67-3770-01 69180b6c-8fef-4453-812d-212730a35ea7 TCGA-67-3770-01A-01W-0928-08,TCGA-67-3770-01A-01D-0969-08 TCGA-67-3770-01 +TCGA-67-3771-01 2.87 0.46 none none p.E894* p.S37C N N none none none 0.19 Magnoid none none none none none none none Solid predominant Adc Solid predominant Adc none 1 TCGA-67-3771-01 High C1-LUAD-enriched OV-like c1 squamous c3 LUAD-like c10 miRNA cluster 4 cluster 4 mutation cluster 8 TCGA-67-3771 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 77 L-Upper TCGA-67-3771 TCGA-67-3771-01A -28406 0 610 NO NO 2011-1-21 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.7 NO NO Central Lung 1.1 No M0 N0 T1 Stage IA TCGA-67-3771.4bcfc5f3-136c-46b5-8e90-6be1abe3a9d8.pdf 3771 TUMOR FREE R0 Primary Tumor 01 0.7 6th YES NO 67 4 Current reformed smoker for < or = 15 years Lung A LIVING 2009 TCGA-67-3771-01 TCGA-67-3771-01A-01D-1040-01 TCGA-67-3771-01 a1022e37-586a-4c6a-a754-01709bad7a43 TCGA-67-3771-01A-01R-0946-07 TCGA-67-3771-01A-01D-0945-05 TCGA-67-3771-01 TCGA-67-3771-01A-01D-0944-01 TCGA-67-3771-01 TCGA-67-3771-01A-01D-0944-01 TCGA-67-3771-01 a1022e37-586a-4c6a-a754-01709bad7a43 TCGA-67-3771-01A-21-2190-20 a1022e37-586a-4c6a-a754-01709bad7a43 TCGA-67-3771-01 15deae70-aafb-4ace-8e1c-7d694473d742 a1022e37-586a-4c6a-a754-01709bad7a43 TCGA-67-3771-01A-01W-0928-08,TCGA-67-3771-01A-01D-1040-01 TCGA-67-3771-01 +TCGA-67-3772-01 1.89 0.43 none none none none Y Y p.L858R none none 0.22 Bronchioid none none none none none none none Acinar predominant Adc Acinar predominant Adc none 1 TCGA-67-3772-01 BRCA-LUAD+ C1-LUAD-enriched Low purity c2 LUAD-like c10 miRNA cluster 7 cluster 4 mutation cluster 14 TCGA-67-3772 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 82 R-Upper TCGA-67-3772 TCGA-67-3772-01A -29989 0 573 NO NO 2011-3-3 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.9 NO NO 0.9 No M0 N0 T2 Stage IB TCGA-67-3772.1b3a5b8e-7469-4fd6-b314-ad1fd7a2b957.pdf 3772 TUMOR FREE Primary Tumor 01 0.2 6th YES NO 67 1 Lifelong Non-smoker Lung A LIVING 2009 TCGA-67-3772-01A-01W-0928-08 TCGA-67-3772-01A-01W-0928-08 TCGA-67-3772-01 4722db5d-698c-4847-b4b7-31d4a3634f59 TCGA-67-3772-01A-01R-0946-07 TCGA-67-3772-01A-01D-0945-05 TCGA-67-3772-01 TCGA-67-3772-01A-01D-0944-01 TCGA-67-3772-01 TCGA-67-3772-01A-01D-0944-01 TCGA-67-3772-01 4722db5d-698c-4847-b4b7-31d4a3634f59 4722db5d-698c-4847-b4b7-31d4a3634f59 TCGA-67-3772-01 4722db5d-698c-4847-b4b7-31d4a3634f59 TCGA-67-3772-01A-01W-0928-08 TCGA-67-3772-01 +TCGA-67-3773-01 1.96 0.69 none none none none Y Y none none none 0.35 Bronchioid none p.G12V none none none none none Solid predominant Adc Solid predominant Adc none 0 TCGA-67-3773-01 Kirc+ C1-LUAD-enriched Cluster 6 LUAD-like c10 miRNA cluster 4 cluster 4 mutation cluster 12 TCGA-67-3773 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 84 L-Lower TCGA-67-3773 TCGA-67-3773-01A -30706 0 427 NO NO 2011-1-21 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 0.4 NO NO Central Lung 1 No M0 N0 T2 Stage IB TCGA-67-3773.e5b82f07-698e-4dff-9d33-748790e40811.pdf 3773 TUMOR FREE R0 Primary Tumor 01 0.2 6th YES NO 67 3 Current reformed smoker for > 15 years Lung A LIVING 2009 TCGA-67-3773-01 TCGA-67-3773-01A-01D-1040-01 TCGA-67-3773-01 17a5a6af-dca6-47dc-912a-7ac0c226da89 TCGA-67-3773-01A-01R-0946-07 TCGA-67-3773-01A-01D-0945-05 TCGA-67-3773-01 TCGA-67-3773-01A-01D-0944-01 TCGA-67-3773-01 TCGA-67-3773-01A-01D-0944-01 TCGA-67-3773-01 17a5a6af-dca6-47dc-912a-7ac0c226da89 17a5a6af-dca6-47dc-912a-7ac0c226da89 TCGA-67-3773-01 17a5a6af-dca6-47dc-912a-7ac0c226da89 TCGA-67-3773-01A-01D-1040-01 TCGA-67-3773-01 +TCGA-67-3774-01 1.89 0.48 none none none none Y Y none none none 0.25 Bronchioid none p.G12F none none none none none Papillary predominant Adc Papillary predominant Adc none 0 TCGA-67-3774-01 BRCA-LUAD+ C1-LUAD-enriched Cluster 5 LUAD-like c10 miRNA cluster 4 cluster 4 mutation cluster 7 TCGA-67-3774 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 73 L-Lower TCGA-67-3774 TCGA-67-3774-01A -26704 0 385 NO NO 2011-3-3 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 0.4 NO NO 0.5 No M0 N0 T2 Stage IB TCGA-67-3774.a1d72b00-7384-4a8f-b335-5beb9ae078fc.pdf 3774 TUMOR FREE RX Primary Tumor 01 0.2 6th YES NO 67 3 Current reformed smoker for > 15 years Lung A LIVING 2009 TCGA-67-3774-01 TCGA-67-3774-01A-01D-1040-01 TCGA-67-3774-01 0621fd32-18bd-4720-846b-4bf47453d296 TCGA-67-3774-01A-01R-0946-07 TCGA-67-3774-01A-01D-0945-05 TCGA-67-3774-01 TCGA-67-3774-01A-01D-0944-01 TCGA-67-3774-01 TCGA-67-3774-01A-01D-0944-01 TCGA-67-3774-01 0621fd32-18bd-4720-846b-4bf47453d296 0621fd32-18bd-4720-846b-4bf47453d296 TCGA-67-3774-01 0621fd32-18bd-4720-846b-4bf47453d296 TCGA-67-3774-01A-01W-0928-08,TCGA-67-3774-01A-01D-1040-01 TCGA-67-3774-01 +TCGA-67-4679-01 TCGA-67-4679-01 BRCA-LUAD+ C1-LUAD-enriched Cluster 6 LUAD-like c10 miRNA cluster 5 mutation cluster 7 TCGA-67-4679 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 69 R-Lower TCGA-67-4679 TCGA-67-4679-01B -25202 0 448 NO NO 2011-1-21 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 0.5 NO NO Central Lung 0.9 No M0 N0 T3 [Discrepancy] TCGA-67-4679.3528ccec-afff-4212-97aa-1d4f7af79856.pdf 4679 TUMOR FREE R0 Primary Tumor 01 0.2 YES NO 67 4 Lung B LIVING 2009 TCGA-67-4679-01B-01D-1753-08 2613a946-0689-4c1b-99f6-30cfaa0ac3f9 TCGA-67-4679-01B-01D-1752-01 TCGA-67-4679-01B-01D-1756-05 TCGA-67-4679-01 TCGA-67-4679-01B-01D-1752-01 2613a946-0689-4c1b-99f6-30cfaa0ac3f9 TCGA-67-4679-01 2613a946-0689-4c1b-99f6-30cfaa0ac3f9 TCGA-67-4679-01 2613a946-0689-4c1b-99f6-30cfaa0ac3f9 TCGA-67-4679-01B-01D-1753-08 TCGA-67-4679-01 +TCGA-67-6215-01 2.24 0.71 none Y none none none Y Y none none none 0.33 Bronchioid none none none none none none none Papillary predominant Adc Papillary predominant Adc none 0 TCGA-67-6215-01 High C1-LUAD-enriched cluster 1 Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 4 cluster 2 mutation c1uster 9 TCGA-67-6215 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 52 R-Lower TCGA-67-6215-F13585 TCGA-67-6215 TCGA-67-6215-01A -19310 0 174 2 NO NO Scheduled Follow-up Submission 2011-7-6 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 0.5 NO NO Central Lung 0.6 NO No M0 N0 T2a Stage IB TCGA-67-6215.bdaf595f-ae8e-451f-83d2-3a79ef06b2a3.pdf 6215 Adjuvant therapy TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 0.2 7th YES YES NO 67 1 Lifelong Non-smoker Lung A LIVING 2010 TCGA-67-6215-01A-11D-1753-08 TCGA-67-6215-01A-11D-1753-08 d4f590d7-626c-4c70-b170-1ad19d2ff6eb TCGA-67-6215-01A-11D-1752-01 TCGA-67-6215-01A-11D-1756-05 TCGA-67-6215-01 TCGA-67-6215-01A-11D-1752-01 d4f590d7-626c-4c70-b170-1ad19d2ff6eb TCGA-67-6215-01 TCGA-67-6215-01A-13-2191-20 d4f590d7-626c-4c70-b170-1ad19d2ff6eb TCGA-67-6215-01 72400518-bc32-4d05-9abd-9233e7cbff29 d4f590d7-626c-4c70-b170-1ad19d2ff6eb TCGA-67-6215-01A-11D-1753-08 TCGA-67-6215-01 +TCGA-67-6216-01 3.89 0.39 none Y none none none Y Y none none none 0.14 Bronchioid none none none none none none none Micropapillary predom Adc Micropapillary predom Adc none 0 TCGA-67-6216-01 Kirc+ C1-LUAD-enriched cluster 2 Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 4 cluster 4 mutation c1uster 9 TCGA-67-6216 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 57 R-Middle TCGA-67-6216-F13587 TCGA-67-6216 TCGA-67-6216-01A -20967 0 141 NO NO Scheduled Follow-up Submission 2011-7-6 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.2 8140/3 C34.2 YES 0.6 NO NO Central Lung 1.2 NO No M0 N0 T1a Stage IA TCGA-67-6216.9f6ac234-e3d8-44a9-b82d-0552e49224be.pdf 6216 TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 0.4 7th NO YES NO 67 1 Lifelong Non-smoker Lung A LIVING 2010 TCGA-67-6216-01A-11D-1753-08 TCGA-67-6216-01A-11D-1753-08 abcd4b7e-f4f0-4be5-9769-3c889a078717 TCGA-67-6216-01A-11D-1752-01 TCGA-67-6216-01A-11D-1756-05 TCGA-67-6216-01 TCGA-67-6216-01A-11D-1752-01 abcd4b7e-f4f0-4be5-9769-3c889a078717 TCGA-67-6216-01 TCGA-67-6216-01A-13-2191-20 abcd4b7e-f4f0-4be5-9769-3c889a078717 TCGA-67-6216-01 5fd7748f-8145-4251-a040-26d19aef9c87 abcd4b7e-f4f0-4be5-9769-3c889a078717 TCGA-67-6216-01A-11D-1753-08 TCGA-67-6216-01 +TCGA-67-6217-01 none none none none Y Y p.L858R none none Bronchioid none none none none none none none Acinar predominant Adc Acinar predominant Adc none 0 TCGA-67-6217-01 BRCA-LUAD+ C1-LUAD-enriched cluster 3 Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 5 cluster 3 mutation cluster 14 TCGA-67-6217 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung YES NO NO 73 L-Upper TCGA-67-6217-F13566 TCGA-67-6217 TCGA-67-6217-01A -26920 0 422 296 YES L858R RT-PCR YES Scheduled Follow-up Submission Progressive Disease 2011-7-5 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.7 NO YES NO Central Lung 1.1 YES Yes M0 N1 T2a Stage IIA TCGA-67-6217.f03e4cad-5322-4068-b986-dd98892e1c85.pdf 6217 WITH TUMOR Progressive Disease NO R0 Primary Tumor 01 0.4 1965 7th NO YES NO 67 3 Current reformed smoker for > 15 years Lung A LIVING 2010 TCGA-67-6217-01A-11D-1753-08 TCGA-67-6217-01A-11D-1753-08 5a47770e-3ebf-4390-ab03-e128fd9ac507 TCGA-67-6217-01A-11D-1752-01 TCGA-67-6217-01A-11D-1756-05 TCGA-67-6217-01 TCGA-67-6217-01A-11D-1752-01 5a47770e-3ebf-4390-ab03-e128fd9ac507 TCGA-67-6217-01 TCGA-67-6217-01A-13-2191-20 5a47770e-3ebf-4390-ab03-e128fd9ac507 TCGA-67-6217-01 e34ffd31-b15e-42f7-aa41-414b5cd519b1 5a47770e-3ebf-4390-ab03-e128fd9ac507 TCGA-67-6217-01A-11D-1753-08 TCGA-67-6217-01 +TCGA-69-7760-01 none none none none Y Y p.709_710ET>D none none Magnoid none none none none none none none Acinar predominant Adc Acinar predominant Adc none 0 TCGA-69-7760-01 Squamous C1-LUAD-enriched cluster 3 Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 5 cluster 3 TCGA-69-7760 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 73 R-Lower TCGA-69-7760-F29247 TCGA-69-7760 TCGA-69-7760-01A -26777 0 202 125 YES NO Scheduled Follow-up Submission 2012-3-13 MALE Lung Adenocarcinoma Mixed Subtype No C34.3 8255/3 C34.3 YES 0.7 NO NO Peripheral Lung 1.1 NO No M0 N0 T3 Stage IIB TCGA-69-7760.e5c9b2ce-2e5a-4127-8ee4-c6bd4ad99fa0.pdf 7760 Post-Adjuvant Therapy TUMOR FREE 91 83 YES NO Primary Tumor 01 0.3 7th YES YES NO 69 1 Lifelong Non-smoker Lung A LIVING 2011 TCGA-69-7760-01A-11D-2167-08 877fb28c-fcdd-4e75-8057-029c9ff31d26 TCGA-69-7760-01A-11D-2166-01 TCGA-69-7760-01A-11D-2168-05 TCGA-69-7760-01 TCGA-69-7760-01A-11D-2166-01 877fb28c-fcdd-4e75-8057-029c9ff31d26 TCGA-69-7760-01 TCGA-69-7760-01A-21-2192-20 877fb28c-fcdd-4e75-8057-029c9ff31d26 TCGA-69-7760-01 aea6b973-08b3-429f-bc71-0977e6a86960 877fb28c-fcdd-4e75-8057-029c9ff31d26 TCGA-69-7760-01A-11D-2167-08 TCGA-69-7760-01 +TCGA-69-7761-01 none none none none N N none none none Squamoid none none none none none none none Acinar predominant Adc Acinar predominant Adc none 0 TCGA-69-7761-01 Squamous C1-LUAD-enriched cluster 2 Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 5 cluster 3 TCGA-69-7761 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 84 L-Lower TCGA-69-7761-F29252 TCGA-69-7761 TCGA-69-7761-01A -31041 0 186 80 1 YES Other Scheduled Follow-up Submission 2012-3-13 MALE Lung Acinar Adenocarcinoma No C34.3 8550/3 C34.3 YES 0.7 NO Peripheral Lung 1.3 NO 20 No MX N0 T2a Stage IB TCGA-69-7761.1148daaf-0315-4639-92dd-f17ff727c6cc.pdf 7761 Adjuvant therapy TUMOR FREE 91 98 YES NO Primary Tumor 01 0.3 1975 7th YES NO YES 69 3 Current reformed smoker for > 15 years Lung A LIVING 2011 1955 TCGA-69-7761-01A-11D-2167-08 167ca59a-5b32-4d99-8f91-2244b723dd87 TCGA-69-7761-01A-11D-2166-01 TCGA-69-7761-01A-11D-2168-05 TCGA-69-7761-01 TCGA-69-7761-01A-11D-2166-01 167ca59a-5b32-4d99-8f91-2244b723dd87 TCGA-69-7761-01 TCGA-69-7761-01A-31-2192-20 167ca59a-5b32-4d99-8f91-2244b723dd87 TCGA-69-7761-01 63dc187d-2053-4f13-ab84-7053b9f2baa5 167ca59a-5b32-4d99-8f91-2244b723dd87 TCGA-69-7761-01A-11D-2167-08 TCGA-69-7761-01 +TCGA-69-7763-01 none none none none N N none none none Bronchioid none none none none none none none Lepidic predominant Adc Lepidic predominant Adc p.Y60fs 0 TCGA-69-7763-01 BRCA-LUAD+ C1-LUAD-enriched cluster 2 Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 5 cluster 3 TCGA-69-7763 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 69 R-Middle TCGA-69-7763-F20990 TCGA-69-7763 -25316 0 690 72 1 NO NO Scheduled Follow-up Submission 2012-1-26 MALE Lung Adenocarcinoma Mixed Subtype No C34.2 8550/3 C34.2 YES NO Peripheral Lung NO 7.5 No M0 N0 T1b Stage IA 7763 Other 93 89 YES NO Primary Tumor 01 2004 7th NO NO YES 69 4 Current reformed smoker for < or = 15 years Lung LIVING 2010 1959 TCGA-69-7763-01A-11D-2167-08 c9376fb2-9938-4516-88da-3fc03deeb6ee TCGA-69-7763-01A-11D-2166-01 TCGA-69-7763-01A-11D-2168-05 TCGA-69-7763-01 TCGA-69-7763-01A-11D-2166-01 c9376fb2-9938-4516-88da-3fc03deeb6ee TCGA-69-7763-01 TCGA-69-7763-01A-13-2192-20 c9376fb2-9938-4516-88da-3fc03deeb6ee TCGA-69-7763-01 e5fc0052-b756-4073-b7b7-b4f5d78c16ed c9376fb2-9938-4516-88da-3fc03deeb6ee TCGA-69-7763-01A-11D-2167-08 TCGA-69-7763-01 +TCGA-69-7764-01 none none none none N N none none none Bronchioid none none none none none none none Acinar predominant Adc Acinar predominant Adc none 0 TCGA-69-7764-01 BRCA-LUAD+ C1-LUAD-enriched cluster 3 Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 4 cluster 3 TCGA-69-7764 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 75 R-Upper TCGA-69-7764-F20992 TCGA-69-7764 TCGA-69-7764-01A -27693 0 414 0 YES NO Scheduled Follow-up Submission 2012-1-26 MALE Lung Adenocarcinoma Mixed Subtype No C34.1 8255/3 C34.1 YES 0.6 NO NO Peripheral Lung 0.6 NO 30 No M0 N0 T1b Stage IA TCGA-69-7764.3518ba0e-79fc-4a98-a308-ecee684e0439.pdf 7764 Other TUMOR FREE 94 106 YES NO Primary Tumor 01 0.2 1991 7th NO NO YES 69 3 Current reformed smoker for > 15 years Lung A LIVING 2010 1977 TCGA-69-7764-01A-11D-2167-08 6deb91e8-110b-444d-93c8-72cd04e4746a TCGA-69-7764-01A-11D-2166-01 TCGA-69-7764-01A-11D-2168-05 TCGA-69-7764-01 TCGA-69-7764-01A-11D-2166-01 6deb91e8-110b-444d-93c8-72cd04e4746a TCGA-69-7764-01 TCGA-69-7764-01A-13-2192-20 6deb91e8-110b-444d-93c8-72cd04e4746a TCGA-69-7764-01 f1fe363c-ae3d-4fab-bc18-d16a781851ed 6deb91e8-110b-444d-93c8-72cd04e4746a TCGA-69-7764-01A-11D-2167-08 TCGA-69-7764-01 +TCGA-69-7765-01 none p.G469V none none N Y p.Q486* none none Squamoid none none none none none none none Acinar predominant Adc Acinar predominant Adc none 0 TCGA-69-7765-01 Iq C1-LUAD-enriched cluster 1 Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 5 cluster 3 TCGA-69-7765 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 56 R-Upper TCGA-69-7765-F29244 TCGA-69-7765 -20625 0 165 45 NO Other NO Scheduled Follow-up Submission 2012-3-13 MALE Lung Adenocarcinoma Mixed Subtype No C34.1 8255/3 C34.1 YES NO Peripheral Lung NO No MX N0 T4 [Discrepancy] 7765 86 84 YES NO Primary Tumor 01 2011 7th YES YES NO 69 4 Current reformed smoker for < or = 15 years Lung LIVING 2011 1981 TCGA-69-7765-01A-11D-2167-08 a660dca3-d4cd-4d7e-93fd-6be7a622cc59 TCGA-69-7765-01A-11D-2166-01 TCGA-69-7765-01A-11D-2168-05 TCGA-69-7765-01 TCGA-69-7765-01A-11D-2166-01 a660dca3-d4cd-4d7e-93fd-6be7a622cc59 TCGA-69-7765-01 TCGA-69-7765-01A-13-2192-20 a660dca3-d4cd-4d7e-93fd-6be7a622cc59 TCGA-69-7765-01 c579c28f-8254-4e78-be5e-c673baf0f14b a660dca3-d4cd-4d7e-93fd-6be7a622cc59 TCGA-69-7765-01A-11D-2167-08 TCGA-69-7765-01 +TCGA-69-7973-01 TCGA-69-7973-01 High Cluster 5 LUAD-like c10 miRNA cluster 6 TCGA-69-7973 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung NO NO NO NO 42 R-Middle TCGA-69-7973-F30347 TCGA-69-7973 TCGA-69-7973-01A -15355 0 230 1 YES Scheduled Follow-up Submission Complete Remission/Response 2012-4-9 FEMALE Lung Adenocarcinoma Mixed Subtype No C34.2 8255/3 C34.2 YES 0.6 NO Central Lung 0.9 NO 25 No M0 N0 T2a Stage IB TCGA-69-7973.fd1b94d4-d5b9-47fe-96ad-4e3d781a638a.pdf 7973 Post-Adjuvant Therapy TUMOR FREE Complete Remission/Response NO NO Primary Tumor 01 0.5 2011 7th YES NO YES 69 4 Lung A LIVING 2011 47b76d43-afa5-4540-b129-64c997d726b4 TCGA-69-7973-01A-11D-2183-01 TCGA-69-7973-01A-11D-2185-05 TCGA-69-7973-01 TCGA-69-7973-01A-11D-2183-01 47b76d43-afa5-4540-b129-64c997d726b4 TCGA-69-7973-01 47b76d43-afa5-4540-b129-64c997d726b4 TCGA-69-7973-01 47b76d43-afa5-4540-b129-64c997d726b4 TCGA-69-7973-01A-11D-2184-08 TCGA-69-7973-01 +TCGA-69-7974-01 TCGA-69-7974-01 Kirc+ Cluster 6 LUAD-like c10 miRNA cluster 4 TCGA-69-7974 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 54 L-Upper TCGA-69-7974-F30365 TCGA-69-7974 -20021 0 184 YES Other Scheduled Follow-up Submission Progressive Disease 2012-4-9 FEMALE Lung Adenocarcinoma Mixed Subtype No C34.1 8255/3 C34.1 YES 80 Peripheral Lung NO 30 No MX N2 T2a Stage IIIA 7974 Post-Adjuvant Therapy WITH TUMOR 58 47 Progressive Disease YES YES Primary Tumor 01 2011 7th YES NO YES 69 4 Lung LIVING 2011 1981 a237a685-c274-4cc9-ae4d-64398d2ba92e TCGA-69-7974-01A-11D-2183-01 TCGA-69-7974-01A-11D-2185-05 TCGA-69-7974-01 TCGA-69-7974-01A-11D-2183-01 a237a685-c274-4cc9-ae4d-64398d2ba92e TCGA-69-7974-01 a237a685-c274-4cc9-ae4d-64398d2ba92e TCGA-69-7974-01 a237a685-c274-4cc9-ae4d-64398d2ba92e TCGA-69-7974-01A-11D-2184-08 TCGA-69-7974-01 +TCGA-69-7978-01 TCGA-69-7978-01 BRCA-LUAD+ Cluster 6 LUAD-like c10 miRNA cluster 4 TCGA-69-7978 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung NO 59 R-Upper TCGA-69-7978-F39911 TCGA-69-7978 -21785 0 134 YES Other Scheduled Follow-up Submission Stable Disease 2013-2-11 MALE Lung Adenocarcinoma Mixed Subtype No C34.1 8255/3 C34.1 YES Peripheral Lung NO NO 80 No MX N1 T2b Stage IIB 7978 [Discrepancy] 91 75 88 67 YES NO Primary Tumor 01 7th NO NO YES 69 2 Lung LIVING 2011 c2972973-dec9-4723-8fc6-af9db22e1cde TCGA-69-7978-01A-11D-2183-01 TCGA-69-7978-01A-11D-2185-05 TCGA-69-7978-01 TCGA-69-7978-01A-11D-2183-01 c2972973-dec9-4723-8fc6-af9db22e1cde TCGA-69-7978-01 c2972973-dec9-4723-8fc6-af9db22e1cde TCGA-69-7978-01 c2972973-dec9-4723-8fc6-af9db22e1cde TCGA-69-7978-01A-11D-2184-08 TCGA-69-7978-01 +TCGA-69-7979-01 TCGA-69-7979-01 High Cluster 6 LUAD-like c10 miRNA cluster 12 TCGA-69-7979 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 71 R-Upper TCGA-69-7979-F40026 TCGA-69-7979 -26180 0 408 NO NO 2014-3-19 FEMALE Lung Acinar Adenocarcinoma No C34.1 8550/3 C34.1 YES NO 28 No MX N0 T2a Stage IB 7979 71 64 70 59 YES Primary Tumor 01 7th NO YES 69 2 Lung LIVING 2011 1955 e9b4a714-487c-40e5-943d-11301e5bc54c TCGA-69-7979-01A-11D-2183-01 TCGA-69-7979-01A-11D-2185-05 TCGA-69-7979-01 TCGA-69-7979-01A-11D-2183-01 e9b4a714-487c-40e5-943d-11301e5bc54c TCGA-69-7979-01 e9b4a714-487c-40e5-943d-11301e5bc54c TCGA-69-7979-01 e9b4a714-487c-40e5-943d-11301e5bc54c TCGA-69-7979-01A-11D-2184-08 TCGA-69-7979-01 +TCGA-69-7980-01 none none p.R86L none Y Y none none p.L420M, p.L868F Bronchioid none p.G12A none none none none none 0 Acinar predominant Adc none TCGA-69-7980-01 High cluster 2 Cluster 6 LUAD-like c10 miRNA c1uster 9 cluster 2 TCGA-69-7980 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 70 R-Upper TCGA-69-7980-F57659 TCGA-69-7980 TCGA-69-7980-01A -25583 0 362 71 YES Other NO Scheduled Follow-up Submission 2014-3-19 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8550/3 C34.1 YES 1.2 NO NO 1.6 NO NO 80 No M0 N0 T1b Stage I TCGA-69-7980.a4a32cf5-43b8-4387-9873-d90f7000b134.pdf 7980 TUMOR FREE 86 92 Complete Remission/Response YES NO Primary Tumor 01 0.4 2001 7th NO YES NO 69 4 Lung A LIVING 2011 TCGA-69-7980-01A-11D-2184-08 16b48e8d-f339-45b2-8182-fe27212bc8da TCGA-69-7980-01A-11D-2183-01 TCGA-69-7980-01A-11D-2185-05 TCGA-69-7980-01 TCGA-69-7980-01A-11D-2183-01 16b48e8d-f339-45b2-8182-fe27212bc8da TCGA-69-7980-01 16b48e8d-f339-45b2-8182-fe27212bc8da TCGA-69-7980-01 16b48e8d-f339-45b2-8182-fe27212bc8da TCGA-69-7980-01A-11D-2184-08 TCGA-69-7980-01 +TCGA-69-8253-01 TCGA-69-8253-01 Iq Cluster 5 LUAD-like c10 miRNA cluster 4 TCGA-69-8253 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 59 R-Lower TCGA-69-8253-F41949 TCGA-69-8253 TCGA-69-8253-01A -21771 0 426 1 NO NO Scheduled Follow-up Submission Complete Remission/Response 2013-4-5 FEMALE Lung Adenocarcinoma Mixed Subtype No C34.3 8255/3 C34.3 YES 0.6 NO NO 1.2 NO NO 7.8 No MX N1 T1a Stage IIA TCGA-69-8253.8148140f-8b78-4c05-a2fa-59a25cc6c9d8.pdf 8253 Preoperative TUMOR FREE 87 Complete Remission/Response YES NO Primary Tumor 01 0.5 2011 7th YES YES NO 69 4 Lung A LIVING 2012 1972 2acc6f62-4829-4c3d-a813-951ec8136ae7 TCGA-69-8253-01A-11D-2283-01 TCGA-69-8253-01A-11D-2285-05 TCGA-69-8253-01 TCGA-69-8253-01A-11D-2283-01 2acc6f62-4829-4c3d-a813-951ec8136ae7 TCGA-69-8253-01 2acc6f62-4829-4c3d-a813-951ec8136ae7 TCGA-69-8253-01 2acc6f62-4829-4c3d-a813-951ec8136ae7 TCGA-69-8253-01A-11D-2284-08 TCGA-69-8253-01 +TCGA-69-8254-01 TCGA-69-8254-01 Kirc+ Cluster 6 LUAD-like c10 miRNA cluster 6 TCGA-69-8254 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 85 R-Lower TCGA-69-8254-F41950 TCGA-69-8254 TCGA-69-8254-01A -31134 0 409 0 YES Other NO Scheduled Follow-up Submission Complete Remission/Response 2013-4-5 MALE Lung Adenocarcinoma Mixed Subtype No C34.3 8255/3 C34.3 YES 0.7 NO 80 NO 1.4 NO NO 40 No T2b TCGA-69-8254.3edeafc6-1876-4547-82b2-90e18240061d.pdf 8254 Preoperative TUMOR FREE 62 Complete Remission/Response YES NO Primary Tumor 01 0.3 1989 7th NO YES NO 69 3 Lung A LIVING 2012 8fabb97c-5921-4156-98c0-86bdd642c612 TCGA-69-8254-01A-11D-2283-01 TCGA-69-8254-01A-11D-2285-05 TCGA-69-8254-01 TCGA-69-8254-01A-11D-2283-01 8fabb97c-5921-4156-98c0-86bdd642c612 TCGA-69-8254-01 8fabb97c-5921-4156-98c0-86bdd642c612 TCGA-69-8254-01 8fabb97c-5921-4156-98c0-86bdd642c612 TCGA-69-8254-01A-11D-2284-08 TCGA-69-8254-01 +TCGA-69-8255-01 TCGA-69-8255-01 Squamous Cluster 5 LAML-like c13 TCGA-69-8255 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 71 R-Upper TCGA-69-8255-F32611 TCGA-69-8255 TCGA-69-8255-01A -26289 0 129 60 YES Other NO Scheduled Follow-up Submission 2012-6-4 MALE Lung Solid Pattern Predominant Adenocarcinoma No C34.1 8230/3 C34.1 YES 0.8 NO NO 1 NO NO 40 No M0 N0 T1a Stage IA TCGA-69-8255.d807cbcd-b72d-47f5-975b-347782728e94.pdf 8255 60 57 YES NO Primary Tumor 01 0.7 7th NO YES NO 69 2 Lung A LIVING 2011 1971 ea0be0ea-2959-435e-a1c6-c5a3b4c52f51 TCGA-69-8255-01A-11D-2283-01 TCGA-69-8255-01A-11D-2285-05 TCGA-69-8255-01 TCGA-69-8255-01A-11D-2283-01 ea0be0ea-2959-435e-a1c6-c5a3b4c52f51 TCGA-69-8255-01 ea0be0ea-2959-435e-a1c6-c5a3b4c52f51 TCGA-69-8255-01 7AB70020-1031-446E-AB4B-B39C89B35DE3 ea0be0ea-2959-435e-a1c6-c5a3b4c52f51 TCGA-69-8255-01A-11D-2284-08 TCGA-69-8255-01 +TCGA-69-8453-01 TCGA-69-8453-01 Cluster 5 miRNA c1uster 9 TCGA-69-8453 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 77 R-Lower TCGA-69-8453-F58885 TCGA-69-8453 -28413 0 813 52 1 Scheduled Follow-up Submission 2014-4-25 MALE Mucinous (Colloid) Carcinoma No C34.30 8480/3 C34.3 YES Peripheral Lung NO NO 12 No MX N0 T3 Stage IIB 8453 Preoperative WITH TUMOR 87 85 86 85 Stable Disease YES NO Primary Tumor 01 1974 7th YES YES NO 69 3 Lung LIVING 2012 c58f01fe-6249-49fe-93ab-dd0f7af94df3 TCGA-69-8453-01A-12D-2322-01 TCGA-69-8453-01A-12D-2324-05 TCGA-69-8453-01 TCGA-69-8453-01A-12D-2322-01 c58f01fe-6249-49fe-93ab-dd0f7af94df3 TCGA-69-8453-01 c58f01fe-6249-49fe-93ab-dd0f7af94df3 TCGA-69-8453-01 c58f01fe-6249-49fe-93ab-dd0f7af94df3 TCGA-69-8453-01 +TCGA-69-A59K-01 TCGA-69-A59K-01 TCGA-69-A59K TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 60 R-Upper TCGA-69-A59K-F57660 TCGA-69-A59K TCGA-69-A59K-01A -22093 130 0 522 75 2 YES NO Scheduled Follow-up Submission 2014-3-19 FEMALE Lung Adenocarcinoma Mixed Subtype No C34.1 8255/3 C34.1 YES 140 NO NO NO 25 true No M0 N0 T3 Stage IIB TCGA-69-A59K.6EF9E448-6E2D-499D-8EC0-7F03B7A10FC8.pdf A59K Pre-Adjuvant Therapy TUMOR FREE 120 118 Stable Disease YES NO Primary Tumor 01 2012 7th YES YES NO 69 4 Lung A LIVING 2012 1999 0a8dbb5b-77b8-4eda-a67c-8cf842c12d53 TCGA-69-A59K-01A-11D-A25M-01 TCGA-69-A59K-01A-11D-A25R-05 TCGA-69-A59K-01 TCGA-69-A59K-01A-11D-A25M-01 0a8dbb5b-77b8-4eda-a67c-8cf842c12d53 TCGA-69-A59K-01 0a8dbb5b-77b8-4eda-a67c-8cf842c12d53 TCGA-69-A59K-01 F46C35CA-FFC7-44EA-A8F8-C1D6A53CE45C 0a8dbb5b-77b8-4eda-a67c-8cf842c12d53 TCGA-69-A59K-01A-11D-A25L-08 TCGA-69-A59K-01 +TCGA-71-6725-01 2.69 0.63 none none none none N N none none none 0.26 Bronchioid none none none none none none none Micropapillary predom Adc Micropapillary predom Adc none 0 TCGA-71-6725-01 High C1-LUAD-enriched cluster 2 Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 4 cluster 2 mutation c1uster 9 TCGA-71-6725 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung NO YES NO 48 R-Upper TCGA-71-6725-F70928 TCGA-71-6725 TCGA-71-6725-01A -17793 0 256 164 2 Scheduled Follow-up Submission Progressive Disease 2015-3-10 FEMALE Lung Papillary Adenocarcinoma No C34.1 8260/3 C34.1 YES 1 NO 60 2 NO Locoregional Recurrence YES No M0 N0 T2 Stage IB TCGA-71-6725.0d31265b-d292-4550-81cb-509a2ab9a4ce.pdf 6725 Post-Adjuvant Therapy WITH TUMOR Progressive Disease NO RX Primary Tumor 01 0.8 6th YES YES NO 71 2 Current smoker Lung A LIVING 2011 TCGA-71-6725-01A-11D-1855-08 TCGA-71-6725-01A-11D-1855-08 9680a78d-59ab-4cf0-bd92-e6ecbc640e04 TCGA-71-6725-01A-11D-1854-01 TCGA-71-6725-01A-11D-1856-05 TCGA-71-6725-01 TCGA-71-6725-01A-11D-1854-01 9680a78d-59ab-4cf0-bd92-e6ecbc640e04 TCGA-71-6725-01 TCGA-71-6725-01A-13-2191-20 9680a78d-59ab-4cf0-bd92-e6ecbc640e04 TCGA-71-6725-01 c40a352a-a90e-4015-9049-4dda961025ae 9680a78d-59ab-4cf0-bd92-e6ecbc640e04 TCGA-71-6725-01A-11D-1855-08 TCGA-71-6725-01 +TCGA-71-8520-01 TCGA-71-8520-01 TCGA-71-8520 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung NO NO NO 60 L-Upper TCGA-71-8520-F70925 TCGA-71-8520 TCGA-71-8520-01A -21921 210 0 3 179 Scheduled Follow-up Submission Progressive Disease 2015-3-10 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.7 NO 40 YES NO 0.9 NO Locoregional Recurrence YES No M0 N0 T2 Stage IB TCGA-71-8520.3ead80d6-5b6e-49ff-87a2-aed7abb8e2e7.pdf 8520 Preoperative WITH TUMOR Complete Remission/Response NO YES R0 Primary Tumor 01 0.5 7th NO YES NO 71 1 Lung A DECEASED 2011 2fe33b61-8a00-424b-b881-e2808b099022 TCGA-71-8520-01A-11D-2398-05 2fe33b61-8a00-424b-b881-e2808b099022 TCGA-71-8520-01 2fe33b61-8a00-424b-b881-e2808b099022 TCGA-71-8520-01 AB00BC04-B343-4DF6-876A-84A2199ED592 2fe33b61-8a00-424b-b881-e2808b099022 TCGA-71-8520-01A-11D-2393-08 TCGA-71-8520-01 +TCGA-73-4658-01 2.01 0.32 none none none none N N none none none 0.16 Squamoid none none none none none none none Micropapillary predom Adc Micropapillary predom Adc none 0 TCGA-73-4658-01 High C1-LUAD-enriched cluster 1 Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 5 cluster 3 mutation cluster 4 TCGA-73-4658 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 80 L-Lower TCGA-73-4658-F12975 TCGA-73-4658 TCGA-73-4658-01A -29508 1600 0 1600 NO Complete Remission/Response 2011-6-15 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 1 NO NO Central Lung 1.4 NO 25 Yes M0 N0 T2 Stage IB TCGA-73-4658.37bb6a7b-4f9e-4690-b904-4eebc3189562.pdf 4658 TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 0.3 6th NO NO YES 73 3 Current reformed smoker for > 15 years Lung A DECEASED 2004 TCGA-73-4658-01A-01D-1753-08 TCGA-73-4658-01A-01D-1753-08 8090b818-81f9-4bd6-aed2-7a721432cdc8 TCGA-73-4658-01A-01D-1752-01 TCGA-73-4658-01A-01D-1756-05 TCGA-73-4658-01 TCGA-73-4658-01A-01D-1752-01 8090b818-81f9-4bd6-aed2-7a721432cdc8 TCGA-73-4658-01 TCGA-73-4658-01A-21-2190-20 8090b818-81f9-4bd6-aed2-7a721432cdc8 TCGA-73-4658-01 8ac764a5-e8cc-4992-b647-9b07d95e7b70 8090b818-81f9-4bd6-aed2-7a721432cdc8 TCGA-73-4658-01 +TCGA-73-4658-11 2.01 0.32 none none none none N N none none none 0.16 Squamoid none none none none none none none Micropapillary predom Adc Micropapillary predom Adc none 0 TCGA-73-4658-11 C1-LUAD-enriched mutation cluster 4 TCGA-73-4658 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 80 L-Lower TCGA-73-4658-F12975 TCGA-73-4658 TCGA-73-4658-11A -29508 1600 0 1600 NO Complete Remission/Response 2011-6-15 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 0.6 NO NO Central Lung 1.1 NO 25 Yes M0 N0 T2 Stage IB 4658 TUMOR FREE Complete Remission/Response NO R0 Solid Tissue Normal 11 0.5 6th NO NO YES 73 3 Current reformed smoker for > 15 years Lung A DECEASED 2004 TCGA-73-4658-11A-01D-1756-05 +TCGA-73-4659-01 3.54 0.33 none none none none Y Y none none none 0.13 Magnoid none p.G12V none none none none none Acinar predominant Adc Acinar predominant Adc none 1 TCGA-73-4659-01 BRCA-LUAD+ C1-LUAD-enriched Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 6 cluster 1 mutation cluster 12 TCGA-73-4659 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung NO YES NO 66 R-Upper TCGA-73-4659-F42024 TCGA-73-4659 -24253 711 0 711 316 0 NO NO Scheduled Follow-up Submission Progressive Disease 2013-4-9 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.9 YES 0 NO Central Lung NO Distant Metastasis YES 12 No M0 N2 T2 Stage IIIA 4659 Other WITH TUMOR Progressive Disease Convincing Imaging NO R0 Primary Tumor 01 1986 6th NO NO YES 73 3 Current reformed smoker for > 15 years Lung DECEASED 2006 1974 TCGA-73-4659-01A-01D-1265-08 TCGA-73-4659-01A-01D-1265-08 dc1b5145-85ca-4e21-9896-2216924019bb TCGA-73-4659-01A-01D-1205-05 TCGA-73-4659-01 TCGA-73-4659-01A-01D-1204-01 TCGA-73-4659-01 TCGA-73-4659-01A-01D-1204-01 dc1b5145-85ca-4e21-9896-2216924019bb TCGA-73-4659-01A-21-2190-20 dc1b5145-85ca-4e21-9896-2216924019bb TCGA-73-4659-01 b4bf2bd5-e32e-4f30-973b-72fc8a2f426b dc1b5145-85ca-4e21-9896-2216924019bb TCGA-73-4659-01A-01D-1265-08 TCGA-73-4659-01 +TCGA-73-4659-11 3.54 0.33 none none none none Y Y none none none 0.13 Magnoid none p.G12V none none none none none Acinar predominant Adc Acinar predominant Adc none 1 TCGA-73-4659-11 C1-LUAD-enriched mutation cluster 12 TCGA-73-4659 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung NO YES NO 66 R-Upper TCGA-73-4659-F42024 TCGA-73-4659 TCGA-73-4659-11A -24253 711 0 711 316 0 NO NO Scheduled Follow-up Submission Progressive Disease 2013-4-9 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.9 YES 2.2 NO 0 NO Central Lung 2.5 NO Distant Metastasis YES 12 No M0 N2 T2 Stage IIIA 4659 Other WITH TUMOR Progressive Disease Convincing Imaging NO R0 Solid Tissue Normal 11 0.6 1986 6th NO NO YES 73 3 Current reformed smoker for > 15 years Lung A DECEASED 2006 1974 TCGA-73-4659-11A-01D-1205-05 +TCGA-73-4662-01 3 0.49 none none none none Y Y none none none 0.2 Bronchioid none p.G12C none none none none none Acinar predominant Adc Acinar predominant Adc none 0 TCGA-73-4662-01 BRCA-LUAD+ C1-LUAD-enriched Cluster 6 LUAD-like c10 miRNA cluster 4 cluster 2 mutation cluster 12 TCGA-73-4662 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 65 L-Upper TCGA-73-4662-F71029 TCGA-73-4662 -23762 0 2515 116 0 NO NO Scheduled Follow-up Submission Complete Remission/Response 2015-3-18 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 100 NO Peripheral Lung NO NO 10 No M0 N0 T1 Stage IA 4662 Preoperative TUMOR FREE 115 111 Complete Remission/Response YES NO R0 Primary Tumor 01 1972 6th NO NO YES 73 3 Current reformed smoker for > 15 years Lung LIVING 2007 1955 TCGA-73-4662-01A-01D-1265-08 TCGA-73-4662-01A-01D-1265-08 fce05b98-e717-4364-8c8d-c15759e1170a TCGA-73-4662-01A-01D-1205-05 TCGA-73-4662-01 TCGA-73-4662-01A-01D-1204-01 TCGA-73-4662-01 TCGA-73-4662-01A-01D-1204-01 fce05b98-e717-4364-8c8d-c15759e1170a fce05b98-e717-4364-8c8d-c15759e1170a TCGA-73-4662-01 fce05b98-e717-4364-8c8d-c15759e1170a TCGA-73-4662-01A-01D-1265-08 TCGA-73-4662-01 +TCGA-73-4662-11 3 0.49 none none none none Y Y none none none 0.2 Bronchioid none p.G12C none none none none none Acinar predominant Adc Acinar predominant Adc none 0 TCGA-73-4662-11 C1-LUAD-enriched mutation cluster 12 TCGA-73-4662 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 65 L-Upper TCGA-73-4662-F71029 TCGA-73-4662 TCGA-73-4662-11A -23762 0 2515 116 0 NO NO Scheduled Follow-up Submission Complete Remission/Response 2015-3-18 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 1 NO 100 NO Peripheral Lung 1.5 NO NO 10 No M0 N0 T1 Stage IA 4662 Preoperative TUMOR FREE 115 111 Complete Remission/Response YES NO R0 Solid Tissue Normal 11 0.7 1972 6th NO NO YES 73 3 Current reformed smoker for > 15 years Lung A LIVING 2007 1955 TCGA-73-4662-11A-01D-1205-05 +TCGA-73-4666-01 TCGA-73-4666-01 BRCA-LUAD+ C1-LUAD-enriched Cluster 6 LUAD-like c10 mutation cluster 2 TCGA-73-4666 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung NO YES NO YES 52 R-Upper TCGA-73-4666-F12865 TCGA-73-4666 -43 -19074 0 800 1 NO NO Complete Remission/Response 2011-6-10 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 80 NO Central Lung YES 10 No M1 N0 T1 Stage IV 4666 Post-Adjuvant Therapy TUMOR FREE Complete Remission/Response YES R0 Primary Tumor 01 2002 YES NO YES 73 4 Lung LIVING 2009 1982 TCGA-73-4666-01A-01D-1265-08 f66bb574-487a-426d-9b17-799718300e1e TCGA-73-4666-01A-01D-1205-05 TCGA-73-4666-01A-01D-1204-01 TCGA-73-4666-01 TCGA-73-4666-01A-01D-1204-01 f66bb574-487a-426d-9b17-799718300e1e f66bb574-487a-426d-9b17-799718300e1e TCGA-73-4666-01 f66bb574-487a-426d-9b17-799718300e1e TCGA-73-4666-01A-01D-1265-08 +TCGA-73-4666-11 TCGA-73-4666-11 C1-LUAD-enriched mutation cluster 2 TCGA-73-4666 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung NO YES NO YES 52 R-Upper TCGA-73-4666-F12865 TCGA-73-4666 TCGA-73-4666-11A -43 -19074 0 800 1 NO NO Complete Remission/Response 2011-6-10 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 1 NO 80 NO Central Lung 1.2 YES 10 No M1 N0 T1 Stage IV 4666 Post-Adjuvant Therapy TUMOR FREE Complete Remission/Response YES R0 Solid Tissue Normal 11 0.2 2002 YES NO YES 73 4 Lung A LIVING 2009 1982 TCGA-73-4666-11A-01D-1205-05 +TCGA-73-4668-01 TCGA-73-4668-01 High C1-LUAD-enriched Cluster 6 LUAD-like c10 mutation c1uster 10 TCGA-73-4668 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung YES YES NO NO 66 L-Upper TCGA-73-4668-F7958 TCGA-73-4668 TCGA-73-4668-01A -24255 0 467 282 0 NO NO Stable Disease 2011-1-6 FEMALE Lung Micropapillary Adenocarcinoma No C34.1 8507/3 C34.1 YES 0.3 NO 80 NO Peripheral Lung 0.6 YES 55 No M0 N1 T2 Stage IIB TCGA-73-4668.9177e909-f92c-4b50-a256-a4f840a05140.pdf 4668 Post-Adjuvant Therapy WITH TUMOR NO R0 Primary Tumor 01 0.1 2005 NO YES 73 4 Lung A LIVING 2009 1968 TCGA-73-4668-01A-01D-1265-08 297fecfd-e9b8-4882-8a55-312f2a04c3f6 TCGA-73-4668-01A-01D-1205-05 TCGA-73-4668-01A-01D-1204-01 TCGA-73-4668-01 TCGA-73-4668-01A-01D-1204-01 297fecfd-e9b8-4882-8a55-312f2a04c3f6 297fecfd-e9b8-4882-8a55-312f2a04c3f6 TCGA-73-4668-01 297fecfd-e9b8-4882-8a55-312f2a04c3f6 TCGA-73-4668-01A-01D-1265-08 +TCGA-73-4668-11 TCGA-73-4668-11 C1-LUAD-enriched mutation c1uster 10 TCGA-73-4668 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung YES YES NO NO 66 L-Upper TCGA-73-4668-F7958 TCGA-73-4668 TCGA-73-4668-11A -24255 0 467 282 0 NO NO Stable Disease 2011-1-6 FEMALE Lung Micropapillary Adenocarcinoma No C34.1 8507/3 C34.1 YES 0.5 NO 80 NO Peripheral Lung 0.8 YES 55 No M0 N1 T2 Stage IIB 4668 Post-Adjuvant Therapy WITH TUMOR NO R0 Solid Tissue Normal 11 0.2 2005 NO YES 73 4 Lung A LIVING 2009 1968 TCGA-73-4668-11A-01D-1205-05 +TCGA-73-4670-01 TCGA-73-4670-01 High C1-LUAD-enriched Cluster 6 squamous c3 LUAD-like c10 mutation cluster 11 TCGA-73-4670 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 69 L-Upper TCGA-73-4670-F12983 TCGA-73-4670 TCGA-73-4670-01A -25526 0 131 2 NO NO 2011-6-15 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 1 NO 50 NO Peripheral Lung 1.2 NO 30 No M1 N0 T2 Stage IV TCGA-73-4670.a9349f65-0980-427e-af86-1af3c747926b.pdf 4670 Adjuvant therapy WITH TUMOR Stable Disease NO R0 Primary Tumor 01 0.2 2009 YES NO YES 73 4 Lung A LIVING 2010 1979 TCGA-73-4670-01A-01D-1265-08 1671e6a6-1c3a-4ec7-b6b8-bd88f5ffcc60 TCGA-73-4670-01A-01D-1205-05 TCGA-73-4670-01A-01D-1204-01 TCGA-73-4670-01 TCGA-73-4670-01A-01D-1204-01 1671e6a6-1c3a-4ec7-b6b8-bd88f5ffcc60 TCGA-73-4670-01A-21-2190-20 1671e6a6-1c3a-4ec7-b6b8-bd88f5ffcc60 TCGA-73-4670-01 c58a6915-0ec4-4525-b15e-ad20f3f427d8 1671e6a6-1c3a-4ec7-b6b8-bd88f5ffcc60 TCGA-73-4670-01A-01D-1265-08 +TCGA-73-4670-11 TCGA-73-4670-11 C1-LUAD-enriched mutation cluster 11 TCGA-73-4670 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 69 L-Upper TCGA-73-4670-F12983 TCGA-73-4670 TCGA-73-4670-11A -25526 0 131 2 NO NO 2011-6-15 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.4 NO 50 NO Peripheral Lung 1.1 NO 30 No M1 N0 T2 Stage IV 4670 Adjuvant therapy WITH TUMOR Stable Disease NO R0 Solid Tissue Normal 11 0.2 2009 YES NO YES 73 4 Lung A LIVING 2010 1979 TCGA-73-4670-11A-01D-1205-05 +TCGA-73-4675-01 3.47 0.58 none none none none N N none none none 0.2 Magnoid none none none none none none none Micropapillary predom Adc Micropapillary predom Adc none 0 TCGA-73-4675-01 High C1-LUAD-enriched Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 6 cluster 1 mutation c1uster 9 TCGA-73-4675 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung YES NO NO 59 L-Lower TCGA-73-4675-F71055 TCGA-73-4675 TCGA-73-4675-01A -21614 922 0 40 361 69 0 NO NO Scheduled Follow-up Submission Progressive Disease 2015-3-17 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 1.1 NO NO Peripheral Lung 1.6 NO Locoregional Recurrence YES 41 No M0 N1 T3 Stage IIIA TCGA-73-4675.73be3e61-573d-43a3-a055-e86786e126f3.pdf 4675 Pre-Adjuvant Therapy TUMOR FREE 55 66 Progressive Disease Convincing Imaging YES NO RX Primary Tumor 01 0.4 2010 7th YES NO YES 73 4 Current reformed smoker for < or = 15 years Lung A DECEASED 2010 1969 TCGA-73-4675-01A-01D-1265-08 TCGA-73-4675-01A-01D-1265-08 928e4b3e-0664-4f05-b971-4c7ce6a318e4 TCGA-73-4675-01A-01D-1205-05 TCGA-73-4675-01 TCGA-73-4675-01A-01D-1204-01 TCGA-73-4675-01 TCGA-73-4675-01A-01D-1204-01 928e4b3e-0664-4f05-b971-4c7ce6a318e4 TCGA-73-4675-01A-21-2190-20 928e4b3e-0664-4f05-b971-4c7ce6a318e4 TCGA-73-4675-01 bb338195-b226-4ce4-a231-92bca76edd63 928e4b3e-0664-4f05-b971-4c7ce6a318e4 TCGA-73-4675-01A-01D-1265-08 TCGA-73-4675-01 +TCGA-73-4675-11 3.47 0.58 none none none none N N none none none 0.2 Magnoid none none none none none none none Micropapillary predom Adc Micropapillary predom Adc none 0 TCGA-73-4675-11 C1-LUAD-enriched mutation c1uster 9 TCGA-73-4675 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung YES NO NO 59 L-Lower TCGA-73-4675-F71055 TCGA-73-4675 TCGA-73-4675-11A -21614 922 0 40 361 69 0 NO NO Scheduled Follow-up Submission Progressive Disease 2015-3-17 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 0.8 NO NO Peripheral Lung 1.2 NO Locoregional Recurrence YES 41 No M0 N1 T3 Stage IIIA 4675 Pre-Adjuvant Therapy TUMOR FREE 55 66 Progressive Disease Convincing Imaging YES NO RX Solid Tissue Normal 11 0.5 2010 7th YES NO YES 73 4 Current reformed smoker for < or = 15 years Lung A DECEASED 2010 1969 TCGA-73-4675-11A-01D-1205-05 +TCGA-73-4676-01 2.57 0.52 none none none none N N none none none 0.23 Squamoid none none none none none none none Solid predominant Adc Solid predominant Adc none 0 TCGA-73-4676-01 High C1-LUAD-enriched cluster 1 Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 5 cluster 3 mutation cluster 5 TCGA-73-4676 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 45 R-Upper TCGA-73-4676-F71022 TCGA-73-4676 TCGA-73-4676-01A -16746 281 0 122 86 1 NO NO Scheduled Follow-up Submission 2015-3-18 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) Yes C34.1 8140/3 C34.1 YES 0.7 NO 70 NO Peripheral Lung 1.5 NO 48 No M0 N1 T2a Stage IIA TCGA-73-4676.d93488a2-e8a9-4775-8d8a-9622b237ba9d.pdf 4676 Preoperative WITH TUMOR 67 78 YES YES R0 Primary Tumor 01 0.3 2009 7th YES NO YES 73 4 Current reformed smoker for < or = 15 years Lung A DECEASED 2010 1977 TCGA-73-4676-01A-01D-1753-08 TCGA-73-4676-01A-01D-1753-08 c54cd39c-c7fc-4a0c-9d33-9c1f78c80871 TCGA-73-4676-01A-01D-1752-01 TCGA-73-4676-01A-01D-1756-05 TCGA-73-4676-01 TCGA-73-4676-01A-01D-1752-01 c54cd39c-c7fc-4a0c-9d33-9c1f78c80871 TCGA-73-4676-01 TCGA-73-4676-01A-21-2190-20 c54cd39c-c7fc-4a0c-9d33-9c1f78c80871 TCGA-73-4676-01 94a6f867-15a8-41a7-b9e1-5853e970678a c54cd39c-c7fc-4a0c-9d33-9c1f78c80871 TCGA-73-4676-01A-01D-1753-08 TCGA-73-4676-01 +TCGA-73-4676-11 2.57 0.52 none none none none N N none none none 0.23 Squamoid none none none none none none none Solid predominant Adc Solid predominant Adc none 0 TCGA-73-4676-11 C1-LUAD-enriched mutation cluster 5 TCGA-73-4676 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 45 R-Upper TCGA-73-4676-F71022 TCGA-73-4676 TCGA-73-4676-11A -16746 281 0 122 86 1 NO NO Scheduled Follow-up Submission 2015-3-18 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) Yes C34.1 8140/3 C34.1 YES 0.5 NO 70 NO Peripheral Lung 1.5 NO 48 No M0 N1 T2a Stage IIA 4676 Preoperative WITH TUMOR 67 78 YES YES R0 Solid Tissue Normal 11 0.2 2009 7th YES NO YES 73 4 Current reformed smoker for < or = 15 years Lung A DECEASED 2010 1977 6c12591a-55fa-4a7e-8eed-da9d698afb35 TCGA-73-4676-11A-01D-1756-05 6c12591a-55fa-4a7e-8eed-da9d698afb35 6c12591a-55fa-4a7e-8eed-da9d698afb35 6c12591a-55fa-4a7e-8eed-da9d698afb35 +TCGA-73-4677-01 TCGA-73-4677-01 BRCA-LUAD+ C1-LUAD-enriched Cluster 5 LUAD-like c10 mutation cluster 7 TCGA-73-4677 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 74 R-Upper TCGA-73-4677-F12744 TCGA-73-4677 TCGA-73-4677-01A -27381 38 0 1 NO NO 2011-6-1 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.7 NO 80 NO Peripheral Lung 0.9 NO No M0 N0 T2a [Discrepancy] TCGA-73-4677.13109adb-64f8-462a-b0c1-af0723ad9aff.pdf 4677 Adjuvant therapy WITH TUMOR Stable Disease NO R0 Primary Tumor 01 0.3 1985 NO NO YES 73 3 Lung A DECEASED 2010 TCGA-73-4677-01A-01D-1265-08 0f8cdcd1-bcf6-4591-97f1-43202071326b TCGA-73-4677-01A-01D-1205-05 TCGA-73-4677-01A-01D-1204-01 TCGA-73-4677-01 TCGA-73-4677-01A-01D-1204-01 0f8cdcd1-bcf6-4591-97f1-43202071326b 0f8cdcd1-bcf6-4591-97f1-43202071326b TCGA-73-4677-01 0f8cdcd1-bcf6-4591-97f1-43202071326b TCGA-73-4677-01A-01D-1265-08 +TCGA-73-4677-11 TCGA-73-4677-11 C1-LUAD-enriched mutation cluster 7 TCGA-73-4677 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 74 R-Upper TCGA-73-4677-F12744 TCGA-73-4677 TCGA-73-4677-11A -27381 38 0 1 NO NO 2011-6-1 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.7 NO 80 NO Peripheral Lung 1.2 NO No M0 N0 T2a [Discrepancy] 4677 Adjuvant therapy WITH TUMOR Stable Disease NO R0 Solid Tissue Normal 11 0.3 1985 NO NO YES 73 3 Lung A DECEASED 2010 TCGA-73-4677-11A-01D-1205-05 +TCGA-73-7498-01 none none none none Y Y none none none Bronchioid none p.G12C none none none none none 0 Acinar predominant Adc p.M51fs TCGA-73-7498-01 BRCA-LUAD+ C1-LUAD-enriched cluster 3 Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 5 cluster 1 TCGA-73-7498 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 58 R-Lower TCGA-73-7498-F48755 TCGA-73-7498 TCGA-73-7498-01A -21527 0 1189 74.0 0 NO NO Scheduled Follow-up Submission Complete Remission/Response 2013-9-20 FEMALE Lung Bronchioloalveolar Carcinoma Nonmucinous No C34.3 8252/3 C34.3 YES 0.6 NO 100 NO Peripheral Lung 1 NO NO 28 Yes, History of Synchronous/Bilateral Malignancy M0 N0 T1b Stage IA TCGA-73-7498.c60ca2d8-4981-406a-9b8d-8efde4976001.pdf 7498 Pre-Adjuvant Therapy TUMOR FREE 89.6 60.1 91.9 61.2 Complete Remission/Response YES NO R0 Primary Tumor 01 0.3 1997 7th YES NO YES 73 4 Lung A LIVING 2010 1969 TCGA-73-7498-01A-12D-2184-08 71772580-ecde-4cbb-a3b5-d58b50b496c5 TCGA-73-7498-01A-12D-2183-01 TCGA-73-7498-01A-12D-2185-05 TCGA-73-7498-01 TCGA-73-7498-01A-12D-2183-01 71772580-ecde-4cbb-a3b5-d58b50b496c5 TCGA-73-7498-01 TCGA-73-7498-01A-23-2192-20 71772580-ecde-4cbb-a3b5-d58b50b496c5 TCGA-73-7498-01 29736b88-08c0-4418-bfde-9f7ea3b7e8be 71772580-ecde-4cbb-a3b5-d58b50b496c5 TCGA-73-7498-01A-12D-2184-08 TCGA-73-7498-01 +TCGA-73-7499-01 none none none none N N none none none Squamoid none none none none none p.123_124MP>IA none 0 Acinar predominant Adc none TCGA-73-7499-01 High C1-LUAD-enriched cluster 2 Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 4 cluster 2 TCGA-73-7499 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung NO NO YES 81 R-Upper TCGA-73-7499-F69827 TCGA-73-7499 TCGA-73-7499-01A 1451 -29683 1531 0 519 1447 54 3 NO NO Scheduled Follow-up Submission Complete Remission/Response 2015-1-21 FEMALE Lung Adenocarcinoma Mixed Subtype No C34.1 8255/3 C34.1 YES 0.9 NO 40 NO Peripheral Lung 2.3 NO Distant Metastasis YES No M0 N0 T2a Stage IB TCGA-73-7499.8d4f6d68-7f74-4def-a235-a36a70f83ebe.pdf 7499 Other TUMOR FREE 103.7 91.5 Complete Remission/Response YES NO R0 Primary Tumor 01 0.7 7th NO NO YES 73 1 Lung A DECEASED 2010 TCGA-73-7499-01A-11D-2184-08 0d423ac2-0d64-4956-a897-d7bc6e1293c2 TCGA-73-7499-01A-11D-2183-01 TCGA-73-7499-01A-11D-2185-05 TCGA-73-7499-01 TCGA-73-7499-01A-11D-2183-01 0d423ac2-0d64-4956-a897-d7bc6e1293c2 TCGA-73-7499-01 TCGA-73-7499-01A-13-2192-20 0d423ac2-0d64-4956-a897-d7bc6e1293c2 TCGA-73-7499-01 f5f257c7-0d45-4305-a9eb-388dccb46c7a 0d423ac2-0d64-4956-a897-d7bc6e1293c2 TCGA-73-7499-01A-11D-2184-08 TCGA-73-7499-01 +TCGA-73-A9RS-01 TCGA-73-A9RS-01 TCGA-73-A9RS TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 41 R-Upper TCGA-73-A9RS-F64487 TCGA-73-A9RS TCGA-73-A9RS-01A -15162 162 340 0 305 1 YES FISH YES Scheduled Follow-up Submission Progressive Disease 2014-9-3 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8480/3 C34.1 YES 160 NO 80 YES NO Peripheral Lung NO NO 11 true No M0 N0 T3 Stage IIB TCGA-73-A9RS.7E029394-80EC-4B53-829E-8F1DA476D648.pdf A9RS Preoperative WITH TUMOR 81.9 60.2 81.5 59.6 Progressive Disease YES YES R0 Primary Tumor 01 7th NO NO YES 73 2 Lung A DECEASED 2013 1990 02bb3468-c1a4-405e-b721-68569b1b70d2 TCGA-73-A9RS-01A-11D-A40Z-01 TCGA-73-A9RS-01A-11D-A411-05 TCGA-73-A9RS-01 TCGA-73-A9RS-01A-11D-A40Z-01 02bb3468-c1a4-405e-b721-68569b1b70d2 TCGA-73-A9RS-01 02bb3468-c1a4-405e-b721-68569b1b70d2 TCGA-73-A9RS-01 53165A6D-C5C1-46A4-BA07-353BF652A1E6 02bb3468-c1a4-405e-b721-68569b1b70d2 TCGA-73-A9RS-01 +TCGA-75-5122-01 3.52 0.17 none none none none N N none none none 0.08 Squamoid none none none p.D1010_splice none none none Solid predominant Adc Solid predominant Adc none 0 TCGA-75-5122-01 High C1-LUAD-enriched cluster 2 Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 4 cluster 2 mutation c1uster 10 TCGA-75-5122 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung NO NO NO L-Upper TCGA-75-5122-F11750 TCGA-75-5122 TCGA-75-5122-01A NO NO Progressive Disease 2011-3-31 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.8 NO 0 NO Peripheral Lung 0.8 YES 20 No M0 N0 T2 Stage IB TCGA-75-5122.a664b87c-a7ef-4f18-9e4d-d37d0ccaaf70.pdf 5122 Adjuvant therapy WITH TUMOR Complete Remission/Response NO R0 Primary Tumor 01 0.5 1985 NO NO YES 75 3 Current reformed smoker for > 15 years Lung A DECEASED 2005 TCGA-75-5122-01A-01D-1753-08 TCGA-75-5122-01A-01D-1753-08 7540edef-3853-4293-bb00-41f790f27840 TCGA-75-5122-01A-01D-1752-01 TCGA-75-5122-01A-01D-1756-05 TCGA-75-5122-01 TCGA-75-5122-01A-01D-1752-01 7540edef-3853-4293-bb00-41f790f27840 TCGA-75-5122-01 TCGA-75-5122-01A-21-2190-20 7540edef-3853-4293-bb00-41f790f27840 TCGA-75-5122-01 3b21e011-4b11-4ef6-978f-391c837ccbc5 7540edef-3853-4293-bb00-41f790f27840 TCGA-75-5122-01A-01D-1753-08 TCGA-75-5122-01 +TCGA-75-5125-01 TCGA-75-5125-01 High C1-LUAD-enriched Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 4 mutation cluster 13 TCGA-75-5125 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung NO YES NO R-Upper TCGA-75-5125-F72028 TCGA-75-5125 TCGA-75-5125-01A 2027 1752 NO NO Scheduled Follow-up Submission Progressive Disease 2015-4-2 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.7 NO NO Peripheral Lung 1.6 NO YES 25 No M0 N1 T2 Stage IIB TCGA-75-5125.a0af0de5-9022-4354-8b9b-fc80e9508889.pdf 5125 Other WITH TUMOR Complete Remission/Response NO R0 Primary Tumor 01 0.4 1987 6th NO NO YES 75 3 Lung A DECEASED TCGA-75-5125-01A-01D-1753-08 dbe34afe-ea16-4faa-adab-9106a92dfde6 TCGA-75-5125-01A-01D-1752-01 TCGA-75-5125-01A-01D-1756-05 TCGA-75-5125-01 TCGA-75-5125-01A-01D-1752-01 dbe34afe-ea16-4faa-adab-9106a92dfde6 TCGA-75-5125-01 TCGA-75-5125-01A-21-2190-20 dbe34afe-ea16-4faa-adab-9106a92dfde6 TCGA-75-5125-01 8a8e4b62-7ad5-4108-a6f3-e38c47fec526 dbe34afe-ea16-4faa-adab-9106a92dfde6 TCGA-75-5125-01A-01D-1753-08 TCGA-75-5125-01 +TCGA-75-5126-01 2.01 0.27 none none none none Y Y none none none 0.13 Squamoid none p.G12C none none none none none NSCLC, favor Adeno NSCLC, favor Adeno none 0 TCGA-75-5126-01 Kirc+ C1-LUAD-enriched cluster 2 Cluster 5 LUAD-like c10 miRNA cluster 5 cluster 3 mutation cluster 12 TCGA-75-5126 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung NO NO NO L-Upper TCGA-75-5126-F11746 TCGA-75-5126 TCGA-75-5126-01A 1 NO NO Progressive Disease 2011-4-4 FEMALE Lung Papillary Adenocarcinoma No C34.1 8260/3 C34.1 YES 0.7 NO NO Peripheral Lung 1.2 YES 40 No M0 N2 T3 Stage IIIA TCGA-75-5126.ed7f326c-d2f5-46ef-bd92-ed2d0f81be26.pdf 5126 Adjuvant therapy WITH TUMOR Partial Remission/Response NO R2 Primary Tumor 01 0.2 2007 NO NO YES 75 4 Current reformed smoker for < or = 15 years Lung A LIVING 2007 TCGA-75-5126-01A-01D-1753-08 TCGA-75-5126-01A-01D-1753-08 6047b848-8fe8-4aab-81a7-2df3f31f7392 TCGA-75-5126-01A-01D-1752-01 TCGA-75-5126-01A-01D-1756-05 TCGA-75-5126-01 TCGA-75-5126-01A-01D-1752-01 6047b848-8fe8-4aab-81a7-2df3f31f7392 TCGA-75-5126-01 6047b848-8fe8-4aab-81a7-2df3f31f7392 TCGA-75-5126-01 6047b848-8fe8-4aab-81a7-2df3f31f7392 TCGA-75-5126-01A-01D-1753-08 TCGA-75-5126-01 +TCGA-75-5146-01 1.8 0.57 none p.G469V none none N Y none none none 0.3 Bronchioid none none none none none none none Acinar predominant Adc Acinar predominant Adc p.W239C 0 TCGA-75-5146-01 Squamous C1-LUAD-enriched cluster 3 Cluster 5 LUAD-like c10 miRNA cluster 5 cluster 3 mutation cluster 8 TCGA-75-5146 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung YES NO R-Lower TCGA-75-5146-F72030 TCGA-75-5146 2368 1773 NO NO Scheduled Follow-up Submission 2015-4-2 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8252/3 C34.3 YES NO Peripheral Lung NO New Primary Tumor YES No M0 N0 T2 Stage IB 5146 Other TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 1987 6th NO NO YES 75 3 Current reformed smoker for > 15 years Lung LIVING TCGA-75-5146-01A-01D-1625-08 TCGA-75-5146-01A-01D-1625-08 aa7b5f63-ac8e-45bf-80e9-be4a576426a5 TCGA-75-5146-01A-01D-1624-01 TCGA-75-5146-01A-01D-1626-05 TCGA-75-5146-01 TCGA-75-5146-01A-01D-1624-01 aa7b5f63-ac8e-45bf-80e9-be4a576426a5 TCGA-75-5146-01 aa7b5f63-ac8e-45bf-80e9-be4a576426a5 TCGA-75-5146-01 aa7b5f63-ac8e-45bf-80e9-be4a576426a5 TCGA-75-5146-01A-01D-1625-08 TCGA-75-5146-01 +TCGA-75-5147-01 3.27 0.4 none none none none N N none none none 0.16 Squamoid none none none none none none none Acinar predominant Adc Acinar predominant Adc none 0 TCGA-75-5147-01 BRCA-LUAD+ C1-LUAD-enriched cluster 3 Cluster 5 LUAD-like c10 miRNA cluster 5 cluster 3 mutation cluster 5 TCGA-75-5147 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung R-Upper TCGA-75-5147-F72031 TCGA-75-5147 1333 NO NO Scheduled Follow-up Submission Complete Remission/Response 2015-4-2 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8252/3 C34.1 YES NO Peripheral Lung NO NO No M0 N0 T2 Stage IB 5147 Other TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 6th NO NO YES 75 1 Lifelong Non-smoker Lung LIVING TCGA-75-5147-01A-01D-1625-08 TCGA-75-5147-01A-01D-1625-08 dea6072e-021d-4984-87ba-2c624e07fa18 TCGA-75-5147-01A-01D-1624-01 TCGA-75-5147-01A-01D-1626-05 TCGA-75-5147-01 TCGA-75-5147-01A-01D-1624-01 dea6072e-021d-4984-87ba-2c624e07fa18 TCGA-75-5147-01 dea6072e-021d-4984-87ba-2c624e07fa18 TCGA-75-5147-01 dea6072e-021d-4984-87ba-2c624e07fa18 TCGA-75-5147-01A-01D-1625-08 TCGA-75-5147-01 +TCGA-75-6203-01 2.21 0.26 none none none none N Y none none none 0.13 Bronchioid none none none none none none none Invasive mucinous Invasive mucinous Y - unknown binding partner none 0 TCGA-75-6203-01 Kirc+ C1-LUAD-enriched cluster 3 Low purity c2 squamous c3 LUAD-like c10 miRNA cluster 5 cluster 3 mutation c1uster 9 TCGA-75-6203 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung L-Lower TCGA-75-6203-F15862 TCGA-75-6203 Complete Remission/Response 2011-8-15 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES No M0 N2 T2 Stage IIIA 6203 TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 6th YES NO YES 75 1 Lifelong Non-smoker Lung LIVING 2008 TCGA-75-6203-01A-11D-1753-08 TCGA-75-6203-01A-11D-1753-08 ccf84703-a5c7-4995-a1c2-b3e4e15d99b7 TCGA-75-6203-01A-11D-1752-01 TCGA-75-6203-01A-11D-1756-05 TCGA-75-6203-01 TCGA-75-6203-01A-11D-1752-01 ccf84703-a5c7-4995-a1c2-b3e4e15d99b7 TCGA-75-6203-01 TCGA-75-6203-01A-13-2191-20 ccf84703-a5c7-4995-a1c2-b3e4e15d99b7 TCGA-75-6203-01 b8ce0a35-56d2-4294-881d-63f96342f51b ccf84703-a5c7-4995-a1c2-b3e4e15d99b7 TCGA-75-6203-01A-11D-1753-08 TCGA-75-6203-01 +TCGA-75-6205-01 none none none none N N none none none Squamoid none none none p.Y1003* none none none Solid predominant Adc Solid predominant Adc none 0 TCGA-75-6205-01 Squamous C1-LUAD-enriched cluster 2 Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 5 cluster 3 mutation c1uster 9 TCGA-75-6205 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung NO NO NO NO L-Upper TCGA-75-6205-F15083 TCGA-75-6205 TCGA-75-6205-01A 2011-7-21 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.5 NO Peripheral Lung 0.7 YES No M0 N0 T2a Stage IB TCGA-75-6205.50af99e1-fe4a-4d65-86c0-59fd699433e3.pdf 6205 Adjuvant therapy WITH TUMOR Complete Remission/Response NO R0 Primary Tumor 01 0.3 7th NO NO YES 75 1 Lifelong Non-smoker Lung A DECEASED 2006 TCGA-75-6205-01A-11D-1753-08 TCGA-75-6205-01A-11D-1753-08 2e8a5454-24d7-4059-ac17-595dcfccaf0b TCGA-75-6205-01A-11D-1752-01 TCGA-75-6205-01A-11D-1756-05 TCGA-75-6205-01 TCGA-75-6205-01A-11D-1752-01 2e8a5454-24d7-4059-ac17-595dcfccaf0b TCGA-75-6205-01 TCGA-75-6205-01A-13-2191-20 2e8a5454-24d7-4059-ac17-595dcfccaf0b TCGA-75-6205-01 d5765a3d-3aa3-4076-ac67-bb67763af157 2e8a5454-24d7-4059-ac17-595dcfccaf0b TCGA-75-6205-01A-11D-1753-08 TCGA-75-6205-01 +TCGA-75-6206-01 TCGA-75-6206-01 BRCA-LUAD+ C1-LUAD-enriched squamous c3 LUAD-like c10 miRNA cluster 5 mutation cluster 12 TCGA-75-6206 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung R-Upper TCGA-75-6206-F72036 TCGA-75-6206 TCGA-75-6206-01A 2590 Scheduled Follow-up Submission Complete Remission/Response 2015-4-2 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.6 NO Peripheral Lung 0.7 NO NO 20 No M0 N0 T2 Stage IB TCGA-75-6206.ad913d82-cb95-477f-8eeb-dba23f5c85c8.pdf 6206 TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 0.3 1962 6th NO NO YES 75 3 Lung A LIVING TCGA-75-6206-01A-11D-1753-08 b74b611d-7090-4beb-ae34-13086884a7e3 TCGA-75-6206-01A-11D-1752-01 TCGA-75-6206-01A-11D-1756-05 TCGA-75-6206-01 TCGA-75-6206-01A-11D-1752-01 b74b611d-7090-4beb-ae34-13086884a7e3 TCGA-75-6206-01 TCGA-75-6206-01A-13-2191-20 b74b611d-7090-4beb-ae34-13086884a7e3 TCGA-75-6206-01 40123d1f-93e7-4182-a279-66c8cbb2d6c3 b74b611d-7090-4beb-ae34-13086884a7e3 TCGA-75-6206-01A-11D-1753-08 TCGA-75-6206-01 +TCGA-75-6207-01 1.94 0.64 none none none none Y Y p.ELREA746del none none 0.33 Squamoid none none none none none none none Solid predominant Adc Solid predominant Adc none 0 TCGA-75-6207-01 Squamous C1-LUAD-enriched cluster 1 Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 4 cluster 2 mutation cluster 8 TCGA-75-6207 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung NO NO R-Upper TCGA-75-6207-F15092 TCGA-75-6207 TCGA-75-6207-01A 2011-7-21 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.9 YES 0.4 NO Peripheral Lung 1 10 No M0 N2 T2 Stage IIIA TCGA-75-6207.46e1c8e2-5603-41c4-8b84-552ba6537ff1.pdf 6207 Complete Remission/Response NO R0 Primary Tumor 01 0.2 1972 6th NO NO YES 75 3 Current reformed smoker for > 15 years Lung A DECEASED 2007 TCGA-75-6207-01A-11D-1753-08 TCGA-75-6207-01A-11D-1753-08 4b57bac2-6b38-435f-b935-8eb6a3369d1c TCGA-75-6207-01A-11D-1752-01 TCGA-75-6207-01A-11D-1756-05 TCGA-75-6207-01 TCGA-75-6207-01A-11D-1752-01 4b57bac2-6b38-435f-b935-8eb6a3369d1c TCGA-75-6207-01 TCGA-75-6207-01A-13-2191-20 4b57bac2-6b38-435f-b935-8eb6a3369d1c TCGA-75-6207-01 6ba7b19d-fe29-467f-ba50-78ac47ad8a4d 4b57bac2-6b38-435f-b935-8eb6a3369d1c TCGA-75-6207-01A-11D-1753-08 TCGA-75-6207-01 +TCGA-75-6211-01 3.1 0.39 none none none none N N none none none 0.16 Magnoid none none p.F53L none none none none Solid predominant Adc Solid predominant Adc none 0 TCGA-75-6211-01 High C1-LUAD-enriched cluster 2 Cluster 6 squamous c3 LUAD-like c10 miRNA c1uster 10 cluster 5 mutation cluster 11 TCGA-75-6211 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung NO YES NO Bronchial TCGA-75-6211-F15095 TCGA-75-6211 TCGA-75-6211-01A Progressive Disease 2011-7-21 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.9 YES 0.6 NO 0.8 YES 34 No M0 N0 T2 Stage IB TCGA-75-6211.7dff638f-e4c9-495b-95a0-00bb2a753378.pdf 6211 Adjuvant therapy WITH TUMOR Complete Remission/Response NO R0 Primary Tumor 01 0.4 6th NO NO YES 75 2 Current smoker Lung A DECEASED 2009 TCGA-75-6211-01A-11D-1753-08 TCGA-75-6211-01A-11D-1753-08 9a28482f-36a7-490f-9d22-a69f82fbfc05 TCGA-75-6211-01A-11D-1752-01 TCGA-75-6211-01A-11D-1756-05 TCGA-75-6211-01 TCGA-75-6211-01A-11D-1752-01 9a28482f-36a7-490f-9d22-a69f82fbfc05 TCGA-75-6211-01 TCGA-75-6211-01A-13-2191-20 9a28482f-36a7-490f-9d22-a69f82fbfc05 TCGA-75-6211-01 7510fd86-91a5-47ed-88bc-64b774eebc6c 9a28482f-36a7-490f-9d22-a69f82fbfc05 TCGA-75-6211-01A-11D-1753-08 TCGA-75-6211-01 +TCGA-75-6212-01 2.76 0.41 none none none none Y Y p.ELR746del none none 0.18 Bronchioid none none none none none none none Papillary predominant Adc Papillary predominant Adc none 0 TCGA-75-6212-01 Kirc+ C1-LUAD-enriched cluster 3 KIRC-like c17 squamous c3 LUAD-like c10 miRNA cluster 7 cluster 4 mutation cluster 14 TCGA-75-6212 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung YES NO L-Lower TCGA-75-6212-F72037 TCGA-75-6212 TCGA-75-6212-01A 1516 1340 0 Scheduled Follow-up Submission Progressive Disease 2015-4-2 FEMALE Lung Micropapillary Adenocarcinoma No C34.3 8507/3 C34.3 YES 0.8 NO Peripheral Lung 2.5 NO New Primary Tumor YES No M0 N1 T2 Stage IIB TCGA-75-6212.6749d901-d37c-4ef9-b0a0-0ee0ee1d7f0e.pdf 6212 Post-Adjuvant Therapy WITH TUMOR Complete Remission/Response NO R0 Primary Tumor 01 0.2 6th YES NO YES 75 1 Lifelong Non-smoker Lung A DECEASED TCGA-75-6212-01A-11D-1753-08 TCGA-75-6212-01A-11D-1753-08 69d106c0-b3e7-4918-a442-d142dce3adab TCGA-75-6212-01A-11D-1752-01 TCGA-75-6212-01A-11D-1756-05 TCGA-75-6212-01 TCGA-75-6212-01A-11D-1752-01 69d106c0-b3e7-4918-a442-d142dce3adab TCGA-75-6212-01 TCGA-75-6212-01A-13-2191-20 69d106c0-b3e7-4918-a442-d142dce3adab TCGA-75-6212-01 5383ef0c-7d86-4025-93f5-71098359a488 69d106c0-b3e7-4918-a442-d142dce3adab TCGA-75-6212-01A-11D-1753-08 TCGA-75-6212-01 +TCGA-75-6214-01 none none none p.E55K N N none none none Magnoid none none none none none p.E545K p.M82V Solid predominant Adc Solid predominant Adc none 0 TCGA-75-6214-01 COAD-READ C2-Squamous-like cluster 3 Cluster 5 squamous c3 squamous-like c4 miRNA cluster 11 cluster 5 TCGA-75-6214 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung NO YES YES R-Upper TCGA-75-6214-F72038 TCGA-75-6214 TCGA-75-6214-01A 524 1115 419 0 Scheduled Follow-up Submission Progressive Disease 2015-4-2 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.8 NO Peripheral Lung 1.9 NO Distant Metastasis YES 40 No M0 N2 T2 Stage IIIA TCGA-75-6214.e3473dc5-927a-466f-ac60-0ac0771a8b1f.pdf 6214 Post-Adjuvant Therapy WITH TUMOR Complete Remission/Response NO R0 Primary Tumor 01 0.2 6th NO NO YES 75 2 Current smoker Lung A DECEASED 1970 TCGA-75-6214-01A-41D-1945-08 f398c31b-c947-4ba7-84c0-6d3b36daaf3f TCGA-75-6214-01A-41D-1943-01 TCGA-75-6214-01A-41D-1947-05 TCGA-75-6214-01 TCGA-75-6214-01A-41D-1943-01 f398c31b-c947-4ba7-84c0-6d3b36daaf3f TCGA-75-6214-01 TCGA-75-6214-01A-23-2192-20 f398c31b-c947-4ba7-84c0-6d3b36daaf3f TCGA-75-6214-01 85c494c4-bc37-424f-bae2-c374c44b8da9 f398c31b-c947-4ba7-84c0-6d3b36daaf3f TCGA-75-6214-01A-41D-1945-08 TCGA-75-6214-01 +TCGA-75-7025-01 3.66 0.34 none none none none Y Y p.ELREA746del none none 0.13 Bronchioid none none none none none none none Acinar predominant Adc Acinar predominant Adc none 0 TCGA-75-7025-01 BRCA-LUAD+ cluster 3 Cluster 5 LUAD-like c10 miRNA c1uster 9 cluster 4 TCGA-75-7025 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung YES NO YES YES L-Lower TCGA-75-7025-F72041 TCGA-75-7025 TCGA-75-7025-01A 1481 2092 3305 1481 0 Scheduled Follow-up Submission Complete Remission/Response 2015-4-2 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.5 NO Peripheral Lung 0.6 NO Locoregional Recurrence|Distant Metastasis YES No M0 N0 T2 Stage IB TCGA-75-7025.6d05110b-1a5f-4002-b140-00a36c5c102b.pdf 7025 Preoperative TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 0.2 1986 6th NO NO YES 75 3 Current reformed smoker for > 15 years Lung A LIVING 1967 TCGA-75-7025-01A-12D-1945-08 8966f44c-9452-4e21-9fad-142ea03c9bff TCGA-75-7025-01A-12D-1943-01 TCGA-75-7025-01A-12D-1947-05 TCGA-75-7025-01 TCGA-75-7025-01A-12D-1943-01 8966f44c-9452-4e21-9fad-142ea03c9bff TCGA-75-7025-01 8966f44c-9452-4e21-9fad-142ea03c9bff TCGA-75-7025-01 8966f44c-9452-4e21-9fad-142ea03c9bff TCGA-75-7025-01A-12D-1945-08 TCGA-75-7025-01 +TCGA-75-7027-01 3.09 0.62 none none none none Y Y none none none 0.23 Magnoid none p.G12V none none none none none Solid predominant Adc Solid predominant Adc none 0 TCGA-75-7027-01 BRCA-LUAD+ C1-LUAD-enriched cluster 3 Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 4 cluster 1 TCGA-75-7027 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung YES YES NO L-Lower TCGA-75-7027-F72040 TCGA-75-7027 TCGA-75-7027-01A 3059 2949 0 Scheduled Follow-up Submission 2015-4-2 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 0.7 NO Peripheral Lung 1.4 NO Locoregional Recurrence YES 50 No M0 N0 T2 Stage IB TCGA-75-7027.04803f1d-6cb8-44ec-b4f1-11f1308dc840.pdf 7027 Preoperative TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 0.7 6th NO NO YES 75 2 Current smoker Lung A LIVING 1956 TCGA-75-7027-01A-11D-1945-08 ef16aead-4eec-4c97-a393-dc7a54ce5264 TCGA-75-7027-01A-11D-1943-01 TCGA-75-7027-01A-11D-1947-05 TCGA-75-7027-01 TCGA-75-7027-01A-11D-1943-01 ef16aead-4eec-4c97-a393-dc7a54ce5264 TCGA-75-7027-01 TCGA-75-7027-01A-13-2191-20 ef16aead-4eec-4c97-a393-dc7a54ce5264 TCGA-75-7027-01 5f83ce7b-d3b2-4053-8d30-753fd9820a93 ef16aead-4eec-4c97-a393-dc7a54ce5264 TCGA-75-7027-01A-11D-1945-08 TCGA-75-7027-01 +TCGA-75-7030-01 2.01 0.17 none none none none Y Y none none none 0.08 Bronchioid none p.G12D none none none none none Papillary predominant Adc Papillary predominant Adc none 0 TCGA-75-7030-01 Quiet C1-LUAD-enriched cluster 3 Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 4 cluster 4 TCGA-75-7030 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung NO NO NO NO R-Lower TCGA-75-7030-F15878 TCGA-75-7030 TCGA-75-7030-01A 0 Complete Remission/Response 2011-8-16 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 0.6 NO Peripheral Lung 0.6 NO No M0 N0 T3 Stage IIB TCGA-75-7030.34fb09ff-9b3b-4197-8fb7-91fe66981ac2.pdf 7030 Post-Adjuvant Therapy TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 0.5 6th YES NO YES 75 1 Lifelong Non-smoker Lung A LIVING 2007 TCGA-75-7030-01A-11D-1945-08 aa1dfe29-6e97-4b20-b439-1d06455dfc56 TCGA-75-7030-01A-11D-1943-01 TCGA-75-7030-01A-11D-1947-05 TCGA-75-7030-01 TCGA-75-7030-01A-11D-1943-01 aa1dfe29-6e97-4b20-b439-1d06455dfc56 TCGA-75-7030-01 TCGA-75-7030-01A-13-2191-20 aa1dfe29-6e97-4b20-b439-1d06455dfc56 TCGA-75-7030-01 7b85c15a-ee62-464b-a28c-03499ea5d340 aa1dfe29-6e97-4b20-b439-1d06455dfc56 TCGA-75-7030-01A-11D-1945-08 TCGA-75-7030-01 +TCGA-75-7031-01 4.01 0.48 none none none none N N none none none 0.16 Magnoid none none none none none none none Acinar predominant Adc Acinar predominant Adc p.W239C 0 TCGA-75-7031-01 High C4-BRCA/Basal cluster 3 Low purity c2 BRCA basal-like c6 LUAD-like c10 miRNA cluster 4 cluster 1 TCGA-75-7031 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung NO NO NO NO R-Upper TCGA-75-7031-F15880 TCGA-75-7031 TCGA-75-7031-01A 0 2011-8-16 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.6 NO Peripheral Lung 0.9 NO 5 No M0 N0 T2 Stage IB TCGA-75-7031.0f516d64-bec9-42ff-9432-d626193c3dd2.pdf 7031 Preoperative TUMOR FREE NO R0 Primary Tumor 01 0.3 1975 6th NO NO YES 75 3 Current reformed smoker for > 15 years Lung A LIVING 2008 1965 TCGA-75-7031-01A-11D-1945-08 66b0fb5a-0587-4d01-8960-29c19c0b0b20 TCGA-75-7031-01A-11D-1943-01 TCGA-75-7031-01A-11D-1947-05 TCGA-75-7031-01 TCGA-75-7031-01A-11D-1943-01 66b0fb5a-0587-4d01-8960-29c19c0b0b20 TCGA-75-7031-01 TCGA-75-7031-01A-13-2192-20 66b0fb5a-0587-4d01-8960-29c19c0b0b20 TCGA-75-7031-01 1ae37e42-5c58-4388-89da-a30726493ed1 66b0fb5a-0587-4d01-8960-29c19c0b0b20 TCGA-75-7031-01A-11D-1945-08 TCGA-75-7031-01 +TCGA-78-7143-01 none none none none N N none none none Bronchioid none none none p.D963_splice none none none Adenocarcinoma, NOS Adenocarcinoma, NOS none 0 TCGA-78-7143-01 High C1-LUAD-enriched cluster 2 Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 5 cluster 3 TCGA-78-7143 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung NO NO NO NO 62 L-Upper TCGA-78-7143-F16669 TCGA-78-7143 TCGA-78-7143-01A -22673 4961 0 4608 0 NO NO Additional New Tumor Event 2011-9-23 FEMALE Lung Bronchioloalveolar Carcinoma Nonmucinous No C34.1 8252/3 C34.1 YES 1 NO NO Central Lung 1.1 YES No M0 N0 T2 Stage IB TCGA-78-7143.083bd90a-b596-4a8b-84f5-97ca17cee7fa.pdf 7143 Preoperative TUMOR FREE R0 Primary Tumor 01 0.7 6th NO YES 78 1 Lifelong Non-smoker Lung A DECEASED 1992 TCGA-78-7143-01A-11D-2036-08 274a99f3-1b61-48f3-afab-11088c63f488 TCGA-78-7143-01A-11D-2035-01 TCGA-78-7143-01A-11D-2037-05 TCGA-78-7143-01 TCGA-78-7143-01A-11D-2035-01 274a99f3-1b61-48f3-afab-11088c63f488 TCGA-78-7143-01 TCGA-78-7143-01A-13-2192-20 274a99f3-1b61-48f3-afab-11088c63f488 TCGA-78-7143-01 de7019fd-493c-4c57-a720-3b20049d5e82 274a99f3-1b61-48f3-afab-11088c63f488 TCGA-78-7143-01 +TCGA-78-7145-01 2.04 0.78 none none none none Y Y none none none 0.38 Squamoid none p.G12Y none none none none none Micropapillary predom Adc Micropapillary predom Adc none 0 TCGA-78-7145-01 High C1-LUAD-enriched cluster 2 Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 4 cluster 2 TCGA-78-7145 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung YES YES NO NO 52 R-Middle TCGA-78-7145-F16671 TCGA-78-7145 TCGA-78-7145-01A -19080 826 0 422 1 NO NO Scheduled Follow-up Submission Progressive Disease 2011-9-23 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.2 8140/3 C34.2 YES 1 NO NO Peripheral Lung 1.4 YES 25 No M1 N1 T4 Stage IV TCGA-78-7145.b9516a4e-5bc3-47f6-8ca3-f1e5abf71b34.pdf 7145 Preoperative WITH TUMOR NO R1 Primary Tumor 01 0.6 1998 6th YES NO YES 78 4 Current reformed smoker for < or = 15 years Lung A DECEASED 2000 1973 TCGA-78-7145-01A-11D-2036-08 29f0cffb-22a7-40a7-964d-9b84d7c5b442 TCGA-78-7145-01A-11D-2035-01 TCGA-78-7145-01A-11D-2037-05 TCGA-78-7145-01 TCGA-78-7145-01A-11D-2035-01 29f0cffb-22a7-40a7-964d-9b84d7c5b442 TCGA-78-7145-01 TCGA-78-7145-01A-13-2192-20 29f0cffb-22a7-40a7-964d-9b84d7c5b442 TCGA-78-7145-01 470c8ea8-5563-4fa6-8ae2-e44d589a0de2 29f0cffb-22a7-40a7-964d-9b84d7c5b442 TCGA-78-7145-01A-11D-2036-08 TCGA-78-7145-01 +TCGA-78-7146-01 TCGA-78-7146-01 High C1-LUAD-enriched Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 4 TCGA-78-7146 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 71 L-Lower TCGA-78-7146-F16969 TCGA-78-7146 TCGA-78-7146-01A -26272 173 0 1 NO NO Scheduled Follow-up Submission 2011-9-28 FEMALE Lung Adenocarcinoma Mixed Subtype No C34.3 8255/3 C34.3 YES 0.8 NO NO Peripheral Lung 0.8 6 No M0 N2 T2 Stage IIIA TCGA-78-7146.3ff87253-3d93-4283-8052-499cd0edea85.pdf 7146 Preoperative NO R0 Primary Tumor 01 0.6 1998 6th NO NO YES 78 4 Lung A DECEASED 1999 1988 6a45204a-96c6-4617-a4cc-27f71c05170b TCGA-78-7146-01A-11D-2035-01 TCGA-78-7146-01A-11D-2037-05 TCGA-78-7146-01 TCGA-78-7146-01A-11D-2035-01 6a45204a-96c6-4617-a4cc-27f71c05170b TCGA-78-7146-01 TCGA-78-7146-01A-13-2192-20 6a45204a-96c6-4617-a4cc-27f71c05170b TCGA-78-7146-01 067d2d3a-828e-426a-87bf-86018e3bc83b 6a45204a-96c6-4617-a4cc-27f71c05170b TCGA-78-7146-01A-11D-2036-08 TCGA-78-7146-01 +TCGA-78-7147-01 1.9 0.77 none none none none Y Y p.L387M, p.L861Q, p.D1083fs none none 0.4 Bronchioid none none none none none none none Acinar predominant Adc Acinar predominant Adc none 0 TCGA-78-7147-01 BRCA-LUAD+ C1-LUAD-enriched cluster 1 Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 4 cluster 3 TCGA-78-7147 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung NO NO NO NO 67 R-Upper TCGA-78-7147-F16971 TCGA-78-7147 TCGA-78-7147-01A -24809 586 0 578 1 NO NO Scheduled Follow-up Submission Progressive Disease 2011-9-28 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.8 NO NO Peripheral Lung 0.9 YES 50 No M0 N1 T2 Stage IIB TCGA-78-7147.0f5ad63e-a072-4f02-8f88-1d75fabd3a4b.pdf 7147 Preoperative WITH TUMOR NO R0 Primary Tumor 01 0.8 6th NO NO YES 78 2 Current smoker Lung A DECEASED 2001 1950 TCGA-78-7147-01A-11D-2036-08 8c957960-d5a3-4d07-a3aa-6c13b16fff0e TCGA-78-7147-01A-11D-2035-01 TCGA-78-7147-01A-11D-2037-05 TCGA-78-7147-01 TCGA-78-7147-01A-11D-2035-01 8c957960-d5a3-4d07-a3aa-6c13b16fff0e TCGA-78-7147-01 TCGA-78-7147-01A-13-2192-20 8c957960-d5a3-4d07-a3aa-6c13b16fff0e TCGA-78-7147-01 86f70a35-27ae-46fe-bae0-152228134cd1 8c957960-d5a3-4d07-a3aa-6c13b16fff0e TCGA-78-7147-01A-11D-2036-08 TCGA-78-7147-01 +TCGA-78-7148-01 none none none none Y Y none none p.R1304L Magnoid none p.G12C none none none none none Acinar predominant Adc Acinar predominant Adc p.E265fs 0 TCGA-78-7148-01 BRCA-LUAD+ C1-LUAD-enriched cluster 3 Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 4 cluster 2 TCGA-78-7148 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung NO YES 71 L-Upper TCGA-78-7148-F17170 TCGA-78-7148 TCGA-78-7148-01A 182 -25990 626 0 182 0 NO NO Scheduled Follow-up Submission 2011-10-4 MALE Lung Adenocarcinoma Mixed Subtype No C34.1 8255/3 C34.1 YES 0.8 NO NO Peripheral Lung 0.9 YES 57 No M0 N1 T2 Stage IIB TCGA-78-7148.5c97d03f-3dfc-4876-ab9e-ad2f4606d62b.pdf 7148 Preoperative NO R0 Primary Tumor 01 0.6 6th NO NO YES 78 2 Current smoker Lung A DECEASED 2001 1944 TCGA-78-7148-01A-11D-2036-08 614ad2cf-7744-4ce1-b684-b6a57827e8c8 TCGA-78-7148-01A-11D-2035-01 TCGA-78-7148-01A-11D-2037-05 TCGA-78-7148-01 TCGA-78-7148-01A-11D-2035-01 614ad2cf-7744-4ce1-b684-b6a57827e8c8 TCGA-78-7148-01 TCGA-78-7148-01A-13-2192-20 614ad2cf-7744-4ce1-b684-b6a57827e8c8 TCGA-78-7148-01 3c3ea12a-d4d9-48b5-a19e-552c41a626c4 614ad2cf-7744-4ce1-b684-b6a57827e8c8 TCGA-78-7148-01A-11D-2036-08 TCGA-78-7148-01 +TCGA-78-7149-01 1.89 0.74 none none none none N N none none none 0.39 Magnoid none none none p.P1322H none none none Papillary predominant Adc Papillary predominant Adc none 0 TCGA-78-7149-01 BRCA-LUAD+ C1-LUAD-enriched cluster 3 Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 5 cluster 3 TCGA-78-7149 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 71 R-Lower TCGA-78-7149-F46148 TCGA-78-7149 TCGA-78-7149-01A -26285 0 3940 1 NO NO Scheduled Follow-up Submission 2013-8-23 MALE Lung Adenocarcinoma Mixed Subtype No C34.3 8255/3 C34.3 YES 0.9 NO NO Central Lung 1 NO 115 No M0 N0 T4 Stage IIIB TCGA-78-7149.2211dcab-03dd-493c-9131-684a9accea7a.pdf 7149 Preoperative Complete Remission/Response NO NO R0 Primary Tumor 01 0.5 6th NO NO YES 78 2 Current smoker Lung A LIVING 2002 1950 TCGA-78-7149-01A-11D-2036-08 02e43817-47d3-4436-bcfa-37dd510eec4c TCGA-78-7149-01A-11D-2035-01 TCGA-78-7149-01A-11D-2037-05 TCGA-78-7149-01 TCGA-78-7149-01A-11D-2035-01 02e43817-47d3-4436-bcfa-37dd510eec4c TCGA-78-7149-01 TCGA-78-7149-01A-13-2192-20 02e43817-47d3-4436-bcfa-37dd510eec4c TCGA-78-7149-01 71dc1546-3861-4b65-9151-152972f6872e 02e43817-47d3-4436-bcfa-37dd510eec4c TCGA-78-7149-01A-11D-2036-08 TCGA-78-7149-01 +TCGA-78-7150-01 3 0.46 none none none none N N none none none 0.19 Magnoid none none none none none none none Solid predominant Adc Solid predominant Adc none 0 TCGA-78-7150-01 Squamous C1-LUAD-enriched cluster 3 Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 4 cluster 2 TCGA-78-7150 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung YES YES NO YES 59 L-Lower TCGA-78-7150-F16962 TCGA-78-7150 TCGA-78-7150-01A 164 -21891 666 0 139 0 NO NO Scheduled Follow-up Submission 2011-9-28 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 0.8 NO NO Central Lung 0.9 YES 37 No M0 N1 T2 Stage IIB TCGA-78-7150.99bec792-e05e-49fd-8601-5f51e876e614.pdf 7150 Preoperative WITH TUMOR NO R0 Primary Tumor 01 0.6 2000 6th NO NO YES 78 4 Current reformed smoker for < or = 15 years Lung A DECEASED 2002 1963 TCGA-78-7150-01A-21D-2036-08 fb59e5ad-650a-4620-af05-9e8cb6c402ea TCGA-78-7150-01A-21D-2035-01 TCGA-78-7150-01A-21D-2037-05 TCGA-78-7150-01 TCGA-78-7150-01A-21D-2035-01 fb59e5ad-650a-4620-af05-9e8cb6c402ea TCGA-78-7150-01 TCGA-78-7150-01A-23-2192-20 fb59e5ad-650a-4620-af05-9e8cb6c402ea TCGA-78-7150-01 67bbd18a-fc5c-472d-9203-cf91078210d5 fb59e5ad-650a-4620-af05-9e8cb6c402ea TCGA-78-7150-01A-21D-2036-08 TCGA-78-7150-01 +TCGA-78-7152-01 1.99 0.56 none none none none N N none none none 0.28 Bronchioid none none none none none none none Acinar predominant Adc Acinar predominant Adc p.I29fs 0 TCGA-78-7152-01 Kirc+ C1-LUAD-enriched cluster 1 Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 5 cluster 3 TCGA-78-7152 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung NO YES NO 65 R-Upper TCGA-78-7152-F46144 TCGA-78-7152 TCGA-78-7152-01A -23782 1215 0 1202 1202 1 NO NO Scheduled Follow-up Submission Progressive Disease 2013-8-4 MALE Lung Adenocarcinoma Mixed Subtype No C34.1 8255/3 C34.1 YES 0.7 NO NO Peripheral Lung 0.9 NO Distant Metastasis YES 40 No M0 N0 T2 Stage IB TCGA-78-7152.4ee9aa80-a04b-4220-8657-0b05af9da97c.pdf 7152 Preoperative WITH TUMOR Complete Remission/Response Biopsy with Histologic Confirmation|Convincing Imaging NO NO R0 Primary Tumor 01 0.7 1999 6th NO NO YES 78 4 Current reformed smoker for < or = 15 years Lung A DECEASED 2003 1959 TCGA-78-7152-01A-11D-2036-08 5a775e87-c4e5-4875-bc64-e2e2a59376e8 TCGA-78-7152-01A-11D-2035-01 TCGA-78-7152-01A-11D-2037-05 TCGA-78-7152-01 TCGA-78-7152-01A-11D-2035-01 5a775e87-c4e5-4875-bc64-e2e2a59376e8 TCGA-78-7152-01 TCGA-78-7152-01A-13-2192-20 5a775e87-c4e5-4875-bc64-e2e2a59376e8 TCGA-78-7152-01 fd44c328-915d-40a6-a1de-3ac0b666cca9 5a775e87-c4e5-4875-bc64-e2e2a59376e8 TCGA-78-7152-01A-11D-2036-08 TCGA-78-7152-01 +TCGA-78-7153-01 2.12 0.74 none p.G466A p.IVVD429del p.S33N N Y none none none 0.35 Magnoid none none none none none p.Q296E none Papillary predominant Adc Papillary predominant Adc none 0 TCGA-78-7153-01 Iq C1-LUAD-enriched cluster 1 Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 5 cluster 3 TCGA-78-7153 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 65 R-Upper TCGA-78-7153-F46077 TCGA-78-7153 -23922 0 3635 0 NO NO Scheduled Follow-up Submission 2013-8-23 FEMALE Lung Adenocarcinoma Mixed Subtype No C34.8 8255/3 C34.8 YES NO Peripheral Lung NO 20 No M0 N0 T2 Stage IB 7153 Preoperative Complete Remission/Response NO NO R0 Primary Tumor 01 1988 6th NO NO YES 78 4 Current reformed smoker for < or = 15 years Lung LIVING 2003 1948 TCGA-78-7153-01A-11D-2036-08 e1bbe3cc-e58e-45d6-82a7-57e8d202e7e6 TCGA-78-7153-01A-11D-2035-01 TCGA-78-7153-01A-11D-2037-05 TCGA-78-7153-01 TCGA-78-7153-01A-11D-2035-01 e1bbe3cc-e58e-45d6-82a7-57e8d202e7e6 TCGA-78-7153-01 TCGA-78-7153-01A-13-2192-20 e1bbe3cc-e58e-45d6-82a7-57e8d202e7e6 TCGA-78-7153-01 bbd8169d-89fa-476d-b097-eeedd8a977e8 e1bbe3cc-e58e-45d6-82a7-57e8d202e7e6 TCGA-78-7153-01A-11D-2036-08 TCGA-78-7153-01 +TCGA-78-7154-01 2.17 0.68 none none none none N N none none none 0.32 Magnoid none none none none none none none Papillary predominant Adc Papillary predominant Adc none 0 TCGA-78-7154-01 High C1-LUAD-enriched cluster 1 Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 4 cluster 5 TCGA-78-7154 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 72 L-Upper TCGA-78-7154-F16951 TCGA-78-7154 -26481 593 0 1 NO NO Scheduled Follow-up Submission 2011-9-28 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES NO Peripheral Lung 112.5 No M0 N2 T3 Stage IIIA 7154 Preoperative R0 Primary Tumor 01 1993 6th NO YES 78 4 Current reformed smoker for < or = 15 years Lung DECEASED 2003 1948 TCGA-78-7154-01A-11D-2036-08 dbe8b05d-9b51-4d93-9e04-9609a5dd4cb8 TCGA-78-7154-01A-11D-2035-01 TCGA-78-7154-01A-11D-2037-05 TCGA-78-7154-01 TCGA-78-7154-01A-11D-2035-01 dbe8b05d-9b51-4d93-9e04-9609a5dd4cb8 TCGA-78-7154-01 TCGA-78-7154-01A-13-2192-20 dbe8b05d-9b51-4d93-9e04-9609a5dd4cb8 TCGA-78-7154-01 d4d06599-d87f-4cf3-bb74-288516ccedee dbe8b05d-9b51-4d93-9e04-9609a5dd4cb8 TCGA-78-7154-01A-11D-2036-08 TCGA-78-7154-01 +TCGA-78-7155-01 2.53 0.81 none none none none N N p.Q432H, p.K754I, p.G901V none none 0.33 Squamoid none none none none none none none Solid predominant Adc Solid predominant Adc none 0 TCGA-78-7155-01 High C1-LUAD-enriched cluster 3 Cluster 5 squamous c3 RNA cluster 14 miRNA cluster 12 cluster 5 TCGA-78-7155 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung YES YES NO NO 68 L-Upper TCGA-78-7155-F16958 TCGA-78-7155 TCGA-78-7155-01A -24863 1171 0 209 0 NO NO Scheduled Follow-up Submission Progressive Disease 2011-9-28 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.7 NO NO Peripheral Lung 0.9 YES 48 No M0 N0 T2 Stage IB TCGA-78-7155.0a07b1a2-095d-4da1-ba4f-112169b62971.pdf 7155 Preoperative R0 Primary Tumor 01 0.7 2005 6th NO YES 78 4 Current reformed smoker for < or = 15 years Lung A DECEASED 2005 1957 TCGA-78-7155-01A-11D-2036-08 ddb17f24-f233-40dc-bbbd-731e50d4fce4 TCGA-78-7155-01A-11D-2035-01 TCGA-78-7155-01A-11D-2037-05 TCGA-78-7155-01 TCGA-78-7155-01A-11D-2035-01 ddb17f24-f233-40dc-bbbd-731e50d4fce4 TCGA-78-7155-01 TCGA-78-7155-01A-13-2192-20 ddb17f24-f233-40dc-bbbd-731e50d4fce4 TCGA-78-7155-01 815f2443-e1d3-43e0-ac43-6fab6279696c ddb17f24-f233-40dc-bbbd-731e50d4fce4 TCGA-78-7155-01A-11D-2036-08 TCGA-78-7155-01 +TCGA-78-7156-01 1.98 0.8 none none none none N N none none none 0.4 Magnoid none none none none none none none Papillary predominant Adc Papillary predominant Adc p.G279fs 0 TCGA-78-7156-01 BRCA-LUAD+ C1-LUAD-enriched cluster 3 Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 5 cluster 3 TCGA-78-7156 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 62 TCGA-78-7156-F16982 TCGA-78-7156 TCGA-78-7156-01A -22720 976 0 1 NO NO Scheduled Follow-up Submission 2011-9-29 MALE Lung Adenocarcinoma Mixed Subtype No C34.9 8255/3 C34.9 YES 0.7 NO NO Peripheral Lung 1.1 84 No M1 N1 T4 Stage IV TCGA-78-7156.28b28933-7e87-4a7b-a17b-170e494d1a30.pdf 7156 Preoperative NO R0 Primary Tumor 01 0.6 1989 6th NO NO YES 78 3 Current reformed smoker for > 15 years Lung A DECEASED 2006 1961 TCGA-78-7156-01A-11D-2036-08 e6aecb65-29f2-48de-a8a0-55b25fbafef1 TCGA-78-7156-01A-11D-2035-01 TCGA-78-7156-01A-11D-2037-05 TCGA-78-7156-01 TCGA-78-7156-01A-11D-2035-01 e6aecb65-29f2-48de-a8a0-55b25fbafef1 TCGA-78-7156-01 TCGA-78-7156-01A-13-2192-20 e6aecb65-29f2-48de-a8a0-55b25fbafef1 TCGA-78-7156-01 45d51359-305c-4ee3-b02d-b88154ee3e47 e6aecb65-29f2-48de-a8a0-55b25fbafef1 TCGA-78-7156-01A-11D-2036-08 TCGA-78-7156-01 +TCGA-78-7158-01 2.09 0.92 none none none p.S37F N N p.L907M none none 0.44 Bronchioid none none none none none none none Micropapillary predom Adc Micropapillary predom Adc none 0 TCGA-78-7158-01 BRCA-LUAD+ C1-LUAD-enriched cluster 1 Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 3 cluster 1 TCGA-78-7158 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung NO NO 59 L-Lower TCGA-78-7158-F16166 TCGA-78-7158 TCGA-78-7158-01A -21742 179 0 132 1 NO NO Scheduled Follow-up Submission 2011-9-15 FEMALE Lung Adenocarcinoma Mixed Subtype No C34.3 8255/3 C34.3 YES 0.9 NO NO Peripheral Lung 1.1 YES 14 No M0 N2 T4 Stage IIIB TCGA-78-7158.1ac638bd-3da2-472d-90bf-1e100bfcdb19.pdf 7158 Preoperative WITH TUMOR Progressive Disease NO R1 Primary Tumor 01 0.5 2005 6th YES NO YES 78 4 Current reformed smoker for < or = 15 years Lung A DECEASED 2007 1963 TCGA-78-7158-01A-11D-2036-08 cc748956-075e-4433-9640-274ee42bdba8 TCGA-78-7158-01A-11D-2035-01 TCGA-78-7158-01A-11D-2037-05 TCGA-78-7158-01 TCGA-78-7158-01A-11D-2035-01 cc748956-075e-4433-9640-274ee42bdba8 TCGA-78-7158-01 TCGA-78-7158-01A-13-2192-20 cc748956-075e-4433-9640-274ee42bdba8 TCGA-78-7158-01 85bf5bc8-7e43-4cb3-a654-152c901477ea cc748956-075e-4433-9640-274ee42bdba8 TCGA-78-7158-01A-11D-2036-08 TCGA-78-7158-01 +TCGA-78-7159-01 2.13 0.71 none none none none N N none none none 0.34 Magnoid none none none none none none none Acinar predominant Adc Acinar predominant Adc p.N259fs 0 TCGA-78-7159-01 High C1-LUAD-enriched cluster 2 Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 6 cluster 1 TCGA-78-7159 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 60 L-Upper TCGA-78-7159-F46103 TCGA-78-7159 TCGA-78-7159-01A -22261 0 1974 1 NO NO Scheduled Follow-up Submission 2013-8-4 FEMALE Lung Adenocarcinoma Mixed Subtype No C34.1 8255/3 C34.1 YES 1 NO NO Peripheral Lung 1.1 NO 21 No M0 NX T1 Stage IA TCGA-78-7159.abb2f0e8-b167-4ffb-a52d-2116d4a919c6.pdf 7159 Preoperative Complete Remission/Response NO R0 Primary Tumor 01 0.7 2007 6th NO NO YES 78 4 Current smoker Lung A LIVING 2008 1965 TCGA-78-7159-01A-11D-2036-08 cc6ff65b-c9fe-4992-971c-3c9a61caeec1 TCGA-78-7159-01A-11D-2035-01 TCGA-78-7159-01A-11D-2037-05 TCGA-78-7159-01 TCGA-78-7159-01A-11D-2035-01 cc6ff65b-c9fe-4992-971c-3c9a61caeec1 TCGA-78-7159-01 TCGA-78-7159-01A-13-2192-20 cc6ff65b-c9fe-4992-971c-3c9a61caeec1 TCGA-78-7159-01 9cd6f033-15cc-4a73-97d9-38bc5c99fdd7 cc6ff65b-c9fe-4992-971c-3c9a61caeec1 TCGA-78-7159-01A-11D-2036-08 TCGA-78-7159-01 +TCGA-78-7160-01 3.23 0.17 none none none none Y Y none none p.P1240H 0.08 Magnoid none p.G12D none none none none none Micropapillary predom Adc Micropapillary predom Adc p.M51fs 0 TCGA-78-7160-01 Squamous C1-LUAD-enriched cluster 3 Low purity c2 squamous c3 LUAD-like c10 miRNA cluster 5 cluster 3 TCGA-78-7160 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 61 R-Lower TCGA-78-7160-F46139 TCGA-78-7160 -22385 697 0 678 1 NO NO Scheduled Follow-up Submission 2013-8-4 MALE Lung Adenocarcinoma Mixed Subtype No C34.3 8255/3 C34.3 YES NO Central Lung NO 43.8 No M1 N2 T4 Stage IV 7160 Preoperative Complete Remission/Response NO NO R0 Primary Tumor 01 1998 6th YES NO YES 78 4 Current reformed smoker for < or = 15 years Lung DECEASED 2008 1963 TCGA-78-7160-01A-11D-2036-08 d41fd6e3-f45d-40df-86bc-7fb9d2e3cdd3 TCGA-78-7160-01A-11D-2035-01 TCGA-78-7160-01A-11D-2037-05 TCGA-78-7160-01 TCGA-78-7160-01A-11D-2035-01 d41fd6e3-f45d-40df-86bc-7fb9d2e3cdd3 TCGA-78-7160-01 TCGA-78-7160-01A-13-2192-20 d41fd6e3-f45d-40df-86bc-7fb9d2e3cdd3 TCGA-78-7160-01 d370d747-9c80-4bba-af93-4aa5db7c587c d41fd6e3-f45d-40df-86bc-7fb9d2e3cdd3 TCGA-78-7160-01A-11D-2036-08 TCGA-78-7160-01 +TCGA-78-7161-01 none none none none Y Y none none none Magnoid none p.G12V none none none none none Acinar predominant Adc Acinar predominant Adc p.G155_splice 0 TCGA-78-7161-01 High C1-LUAD-enriched cluster 1 Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 6 cluster 1 TCGA-78-7161 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung NO 69 L-Upper TCGA-78-7161-F46153 TCGA-78-7161 TCGA-78-7161-01A -25294 291 0 215 162 1 YES NO Scheduled Follow-up Submission Progressive Disease 2013-8-23 FEMALE Lung Adenocarcinoma Mixed Subtype No C34.1 8255/3 C34.1 YES 0.6 NO NO Peripheral Lung 1 NO Locoregional Recurrence YES 27.8 No M0 N0 T3 Stage IIB TCGA-78-7161.0a86e747-a5e2-4d91-8ebd-6ef80e11cbc8.pdf 7161 Preoperative WITH TUMOR Progressive Disease Biopsy with Histologic Confirmation NO NO R1 Primary Tumor 01 0.5 1998 7th YES NO YES 78 4 Current reformed smoker for < or = 15 years Lung A DECEASED 2011 1961 TCGA-78-7161-01A-11D-2036-08 3bc1fe5d-5eff-46f2-adf6-e6bc8b7e8f90 TCGA-78-7161-01A-11D-2035-01 TCGA-78-7161-01A-11D-2037-05 TCGA-78-7161-01 TCGA-78-7161-01A-11D-2035-01 3bc1fe5d-5eff-46f2-adf6-e6bc8b7e8f90 TCGA-78-7161-01 TCGA-78-7161-01A-13-2192-20 3bc1fe5d-5eff-46f2-adf6-e6bc8b7e8f90 TCGA-78-7161-01 7dfad617-4921-46ff-9151-2b34915859e7 3bc1fe5d-5eff-46f2-adf6-e6bc8b7e8f90 TCGA-78-7161-01A-11D-2036-08 TCGA-78-7161-01 +TCGA-78-7162-01 none none none none N N none none none Bronchioid none none none none none none none Adenocarcinoma, NOS Adenocarcinoma, NOS none 0 TCGA-78-7162-01 BRCA-LUAD+ C1-LUAD-enriched cluster 3 Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 5 cluster 3 TCGA-78-7162 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung YES NO NO NO 75 L-Upper TCGA-78-7162-F17127 TCGA-78-7162 TCGA-78-7162-01A -27593 3169 0 2740 0 NO NO Additional New Tumor Event 2011-10-3 MALE Lung Adenocarcinoma Mixed Subtype No C34.1 8255/3 C34.1 YES 0.6 NO NO Peripheral Lung 0.7 YES 12 No M0 N0 T1 Stage IA TCGA-78-7162.41e3d123-0a90-43e4-80b7-7be47de9fd16.pdf 7162 Preoperative NO R0 Primary Tumor 01 0.5 6th NO NO YES 78 2 Current smoker Lung A DECEASED 1991 1940 TCGA-78-7162-01A-21D-2063-08 01a75809-bb4e-42f3-a3ca-25e4d1ca37a3 TCGA-78-7162-01A-21D-2062-01 TCGA-78-7162-01A-21D-2064-05 TCGA-78-7162-01 TCGA-78-7162-01A-21D-2062-01 01a75809-bb4e-42f3-a3ca-25e4d1ca37a3 TCGA-78-7162-01 TCGA-78-7162-01A-23-2192-20 01a75809-bb4e-42f3-a3ca-25e4d1ca37a3 TCGA-78-7162-01 78e8850d-ff5b-4199-b9ac-f098ddf67561 01a75809-bb4e-42f3-a3ca-25e4d1ca37a3 TCGA-78-7162-01A-21D-2063-08 TCGA-78-7162-01 +TCGA-78-7163-01 2.56 0.7 none Y none none none Y Y none none none 0.29 Bronchioid none none none none none none none Invasive mucinous Invasive mucinous none 0 TCGA-78-7163-01 Kirc+ C1-LUAD-enriched cluster 3 Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 4 cluster 1 TCGA-78-7163 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 60 R-Lower TCGA-78-7163-F46140 TCGA-78-7163 TCGA-78-7163-01A -22002 0 7248 1 NO NO Scheduled Follow-up Submission 2013-8-4 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 0.7 NO NO Peripheral Lung 1.2 NO 41 No M0 N0 T2 Stage IB TCGA-78-7163.40948ca8-3075-47ef-a679-94ea5dc29a08.pdf 7163 Preoperative TUMOR FREE Complete Remission/Response NO NO R0 Primary Tumor 01 0.4 1991 6th NO NO YES 78 4 Current reformed smoker for < or = 15 years Lung A LIVING 1992 1950 TCGA-78-7163-01A-12D-2063-08 5deb51ff-a271-4fc4-90b6-3bdb0c508967 TCGA-78-7163-01A-12D-2062-01 TCGA-78-7163-01A-12D-2064-05 TCGA-78-7163-01 TCGA-78-7163-01A-12D-2062-01 5deb51ff-a271-4fc4-90b6-3bdb0c508967 TCGA-78-7163-01 TCGA-78-7163-01A-23-2192-20 5deb51ff-a271-4fc4-90b6-3bdb0c508967 TCGA-78-7163-01 1a4d9a2b-2eaf-4e8e-a463-2a9060163096 5deb51ff-a271-4fc4-90b6-3bdb0c508967 TCGA-78-7163-01A-12D-2063-08 TCGA-78-7163-01 +TCGA-78-7163-11 2.56 0.7 none Y none none none Y Y none none none 0.29 Bronchioid none none none none none none none Invasive mucinous Invasive mucinous none 0 TCGA-78-7163-11 C1-LUAD-enriched TCGA-78-7163 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 60 R-Lower TCGA-78-7163-F46140 TCGA-78-7163 -22002 0 7248 1 NO NO Scheduled Follow-up Submission 2013-8-4 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES NO Peripheral Lung NO 41 No M0 N0 T2 Stage IB 7163 Preoperative TUMOR FREE Complete Remission/Response NO NO R0 Solid Tissue Normal 11 1991 6th NO NO YES 78 4 Current reformed smoker for < or = 15 years Lung LIVING 1992 1950 TCGA-78-7163-11 TCGA-78-7163-11 +TCGA-78-7166-01 2.04 0.63 none none none none Y Y none none none 0.31 Magnoid none p.G12C none none none none none Invasive mucinous Invasive mucinous p.G56V, p.K78E 0 TCGA-78-7166-01 Iq C1-LUAD-enriched cluster 3 Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 4 cluster 2 TCGA-78-7166 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung NO NO 84 L-Lower TCGA-78-7166-F16954 TCGA-78-7166 TCGA-78-7166-01A -30869 258 0 2 NO NO Scheduled Follow-up Submission 2011-9-28 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 0.6 NO NO Central Lung 0.9 NO 38 Yes M0 N1 T2 Stage IIB TCGA-78-7166.e2ddc3ba-8151-4f3e-9219-cd3147ea5029.pdf 7166 Preoperative YES R0 Primary Tumor 01 0.4 1972 6th NO NO YES 78 3 Current reformed smoker for > 15 years Lung A DECEASED 2002 1934 TCGA-78-7166-01A-12D-2063-08 3d86f6ec-741c-4da5-836e-28b029b32706 TCGA-78-7166-01A-12D-2062-01 TCGA-78-7166-01A-12D-2064-05 TCGA-78-7166-01 TCGA-78-7166-01A-12D-2062-01 3d86f6ec-741c-4da5-836e-28b029b32706 TCGA-78-7166-01 TCGA-78-7166-01A-23-2192-20 3d86f6ec-741c-4da5-836e-28b029b32706 TCGA-78-7166-01 bbde7e4b-5d2e-4fa1-8548-7b4f87d96cfb 3d86f6ec-741c-4da5-836e-28b029b32706 TCGA-78-7166-01A-12D-2063-08 TCGA-78-7166-01 +TCGA-78-7167-01 none none none none Y Y none none none Magnoid none p.G12F none none none none none Lepidic predominant Adc Lepidic predominant Adc p.R331fs 0 TCGA-78-7167-01 BRCA-LUAD+ C1-LUAD-enriched cluster 3 Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 6 cluster 1 TCGA-78-7167 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung NO NO NO NO 77 TCGA-78-7167-F17172 TCGA-78-7167 TCGA-78-7167-01A -28295 2681 0 726 1 NO NO Scheduled Follow-up Submission Progressive Disease 2011-10-4 MALE Lung Papillary Adenocarcinoma No C34.9 8260/3 C34.9 YES 0.6 NO NO Peripheral Lung 0.7 YES 64 No M1 N0 T2 Stage IV TCGA-78-7167.a164a9ae-8f90-4deb-83ce-8f111897e5d6.pdf 7167 Preoperative WITH TUMOR NO R0 Primary Tumor 01 0.6 6th NO NO YES 78 2 Current smoker Lung A DECEASED 2002 1937 TCGA-78-7167-01A-11D-2063-08 30642287-a06f-46e0-8e37-839935a2d3dc TCGA-78-7167-01A-11D-2062-01 TCGA-78-7167-01A-11D-2064-05 TCGA-78-7167-01 TCGA-78-7167-01A-11D-2062-01 30642287-a06f-46e0-8e37-839935a2d3dc TCGA-78-7167-01 TCGA-78-7167-01A-13-2192-20 30642287-a06f-46e0-8e37-839935a2d3dc TCGA-78-7167-01 07fd6c8a-3e19-45c8-9a15-b46cb4365d43 30642287-a06f-46e0-8e37-839935a2d3dc TCGA-78-7167-01A-11D-2063-08 TCGA-78-7167-01 +TCGA-78-7220-01 TCGA-78-7220-01 High Cluster 5 LUAD-like c10 miRNA cluster 4 TCGA-78-7220 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung NO YES NO NO 53 L-Upper TCGA-78-7220-F19298 TCGA-78-7220 -19480 807 0 531 0 NO NO Scheduled Follow-up Submission 2011-12-8 FEMALE Lung Adenocarcinoma Mixed Subtype No C34.1 8255/3 C34.1 YES NO Peripheral Lung YES 35 No M0 N2 T2 Stage IIIA 7220 Preoperative WITH TUMOR YES R0 Primary Tumor 01 6th NO NO YES 78 2 Lung DECEASED 2000 1965 aa29c7b0-8641-4a59-8b17-c007b3cb8726 TCGA-78-7220-01A-11D-2035-01 TCGA-78-7220-01A-11D-2037-05 TCGA-78-7220-01 TCGA-78-7220-01A-11D-2035-01 aa29c7b0-8641-4a59-8b17-c007b3cb8726 TCGA-78-7220-01 aa29c7b0-8641-4a59-8b17-c007b3cb8726 TCGA-78-7220-01 aa29c7b0-8641-4a59-8b17-c007b3cb8726 TCGA-78-7220-01A-11D-2036-08 TCGA-78-7220-01 +TCGA-78-7535-01 1.53 0.75 none none none none N N none none none 0.46 Squamoid none none none none none none none Solid predominant Adc Solid predominant Adc p.L245_splice 0 TCGA-78-7535-01 BRCA-LUAD+ C1-LUAD-enriched cluster 1 Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 4 cluster 2 TCGA-78-7535 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung NO NO NO YES 45 L-Upper TCGA-78-7535-F20633 TCGA-78-7535 TCGA-78-7535-01A 809 -16571 949 0 809 0 NO NO Scheduled Follow-up Submission Progressive Disease 2012-1-19 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 1 NO NO 1.2 YES 35 No M0 N0 T2 Stage IB TCGA-78-7535.217e5c9a-950f-46c0-a022-5ece5205d9d4.pdf 7535 Preoperative WITH TUMOR Stable Disease NO R0 Primary Tumor 01 0.6 6th YES NO YES 78 2 Current smoker Lung A DECEASED 2000 1972 TCGA-78-7535-01A-11D-2063-08 2cbd77bd-dece-4177-ace2-98d9d545b575 TCGA-78-7535-01A-11D-2062-01 TCGA-78-7535-01A-11D-2064-05 TCGA-78-7535-01 TCGA-78-7535-01A-11D-2062-01 2cbd77bd-dece-4177-ace2-98d9d545b575 TCGA-78-7535-01 TCGA-78-7535-01A-13-2192-20 2cbd77bd-dece-4177-ace2-98d9d545b575 TCGA-78-7535-01 ff5b1536-6edf-4479-b3f2-50d59414eae6 2cbd77bd-dece-4177-ace2-98d9d545b575 TCGA-78-7535-01A-11D-2063-08 TCGA-78-7535-01 +TCGA-78-7536-01 3.07 0.78 none none none none N N none none none 0.28 Magnoid none none none none none none p.E313* Solid predominant Adc Solid predominant Adc p.G279fs 0 TCGA-78-7536-01 High C1-LUAD-enriched cluster 3 Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 4 cluster 1 TCGA-78-7536 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung NO NO NO NO 69 R-Upper TCGA-78-7536-F20631 TCGA-78-7536 TCGA-78-7536-01A -25558 244 0 231 0 NO NO Scheduled Follow-up Submission Progressive Disease 2012-1-19 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.7 NO NO 1.1 YES 44 No M0 N2 T2 Stage IIIA TCGA-78-7536.543b5396-e92f-436e-93c5-1324b9171598.pdf 7536 Preoperative WITH TUMOR Progressive Disease YES R0 Primary Tumor 01 0.6 1993 6th NO NO YES 78 4 Current reformed smoker for < or = 15 years Lung A DECEASED 2001 1949 TCGA-78-7536-01A-11D-2063-08 9334a61d-eb4f-4504-9f4d-b9d55a8733de TCGA-78-7536-01A-11D-2062-01 TCGA-78-7536-01A-11D-2064-05 TCGA-78-7536-01 TCGA-78-7536-01A-11D-2062-01 9334a61d-eb4f-4504-9f4d-b9d55a8733de TCGA-78-7536-01 TCGA-78-7536-01A-13-2192-20 9334a61d-eb4f-4504-9f4d-b9d55a8733de TCGA-78-7536-01 a35de618-0eec-4f5b-afbc-7111491df9b8 9334a61d-eb4f-4504-9f4d-b9d55a8733de TCGA-78-7536-01A-11D-2063-08 TCGA-78-7536-01 +TCGA-78-7537-01 2.08 0.74 none p.G466V none none N Y none none none 0.36 Bronchioid none none none none none none none Papillary predominant Adc Papillary predominant Adc p.K175fs 0 TCGA-78-7537-01 Iq C1-LUAD-enriched cluster 2 Cluster 6 squamous c3 LUAD-like c10 miRNA c1uster 9 cluster 4 TCGA-78-7537 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 72 R-Upper TCGA-78-7537-F20455 TCGA-78-7537 -26610 1622 0 1 NO NO Scheduled Follow-up Submission 2012-1-13 MALE Lung Adenocarcinoma Mixed Subtype No C34.1 8255/3 C34.1 YES NO 20 No M0 N0 T2 Stage IB 7537 Preoperative NO R0 Primary Tumor 01 1984 6th NO YES NO 78 3 Current reformed smoker for > 15 years Lung DECEASED 2002 1944 TCGA-78-7537-01A-11D-2063-08 a91960e0-f237-419e-aa57-f90ceb12fcde TCGA-78-7537-01A-11D-2062-01 TCGA-78-7537-01A-11D-2064-05 TCGA-78-7537-01 TCGA-78-7537-01A-11D-2062-01 a91960e0-f237-419e-aa57-f90ceb12fcde TCGA-78-7537-01 TCGA-78-7537-01A-13-2192-20 a91960e0-f237-419e-aa57-f90ceb12fcde TCGA-78-7537-01 d853bbc6-ad3a-4e47-8387-91d27e06d8bc a91960e0-f237-419e-aa57-f90ceb12fcde TCGA-78-7537-01A-11D-2063-08 TCGA-78-7537-01 +TCGA-78-7539-01 2.1 0.69 none none none none Y Y none none none 0.33 Bronchioid none p.G12C none none none none none Papillary predominant Adc Papillary predominant Adc none 0 TCGA-78-7539-01 High C1-LUAD-enriched cluster 2 Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 4 cluster 2 TCGA-78-7539 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung YES YES 75 R-Upper TCGA-78-7539-F46143 TCGA-78-7539 TCGA-78-7539-01A 688 -27445 0 791 688 1 NO NO Scheduled Follow-up Submission 2013-8-4 FEMALE Lung Adenocarcinoma Mixed Subtype No C34.1 8255/3 C34.1 YES 0.8 NO NO 0.9 NO Distant Metastasis YES 2.2 No M0 N0 T2b Stage IIA TCGA-78-7539.686bc9a9-71b6-4c27-a76d-4ca9713fbdbe.pdf 7539 Preoperative Complete Remission/Response Biopsy with Histologic Confirmation NO NO R0 Primary Tumor 01 0.7 1981 7th YES NO YES 78 3 Current smoker Lung A LIVING 2011 1953 TCGA-78-7539-01A-11D-2063-08 479528a6-12ed-4e7b-8ca6-cf9fe6baa6de TCGA-78-7539-01A-11D-2062-01 TCGA-78-7539-01A-11D-2064-05 TCGA-78-7539-01 TCGA-78-7539-01A-11D-2062-01 479528a6-12ed-4e7b-8ca6-cf9fe6baa6de TCGA-78-7539-01 TCGA-78-7539-01A-13-2192-20 479528a6-12ed-4e7b-8ca6-cf9fe6baa6de TCGA-78-7539-01 d9129bfe-b2b1-4c6c-bf9a-249921abce2b 479528a6-12ed-4e7b-8ca6-cf9fe6baa6de TCGA-78-7539-01A-11D-2063-08 TCGA-78-7539-01 +TCGA-78-7540-01 2.02 0.58 none none none none Y Y none none none 0.29 Bronchioid none p.G12V none none none none none Invasive mucinous Invasive mucinous none 0 TCGA-78-7540-01 GBM C1-LUAD-enriched cluster 1 Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 5 cluster 3 TCGA-78-7540 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 66 L-Lower TCGA-78-7540-F46104 TCGA-78-7540 TCGA-78-7540-01A -24440 1197 0 881 0 NO NO Scheduled Follow-up Submission 2013-8-2 FEMALE Lung Bronchioloalveolar Carcinoma Mucinous No C34.3 8253/3 C34.3 YES 0.8 NO NO 1.3 NO No M0 N0 T2 Stage IB TCGA-78-7540.95cad21d-0a35-4ac7-9163-f5b7bb21e18d.pdf 7540 Preoperative Complete Remission/Response R0 Primary Tumor 01 0.5 6th NO YES 78 1 Lifelong Non-smoker Lung A DECEASED 1999 TCGA-78-7540-01A-11D-2063-08 193873d4-f0ad-4e8d-918b-9beb83965483 TCGA-78-7540-01A-11D-2062-01 TCGA-78-7540-01A-11D-2064-05 TCGA-78-7540-01 TCGA-78-7540-01A-11D-2062-01 193873d4-f0ad-4e8d-918b-9beb83965483 TCGA-78-7540-01 TCGA-78-7540-01A-13-2192-20 193873d4-f0ad-4e8d-918b-9beb83965483 TCGA-78-7540-01 9e24367f-3036-45d3-85fe-46808f92fe25 193873d4-f0ad-4e8d-918b-9beb83965483 TCGA-78-7540-01A-11D-2063-08 TCGA-78-7540-01 +TCGA-78-7540-11 2.02 0.58 none none none none Y Y none none none 0.29 Bronchioid none p.G12V none none none none none Invasive mucinous Invasive mucinous none 0 TCGA-78-7540-11 C1-LUAD-enriched TCGA-78-7540 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 66 L-Lower TCGA-78-7540-F46104 TCGA-78-7540 -24440 1197 0 881 0 NO NO Scheduled Follow-up Submission 2013-8-2 FEMALE Lung Bronchioloalveolar Carcinoma Mucinous No C34.3 8253/3 C34.3 YES NO NO No M0 N0 T2 Stage IB 7540 Preoperative Complete Remission/Response R0 Solid Tissue Normal 11 6th NO YES 78 1 Lifelong Non-smoker Lung DECEASED 1999 TCGA-78-7540-11 TCGA-78-7540-11 +TCGA-78-7542-01 3.49 0.44 none none none none N N none none none 0.17 Squamoid none none none none none none none Solid predominant Adc Solid predominant Adc none 0 TCGA-78-7542-01 High C2-Squamous-like cluster 2 Cluster 6 squamous c3 squamous-like c4 miRNA c1uster 9 cluster 3 TCGA-78-7542 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 56 R-Upper TCGA-78-7542-F20456 TCGA-78-7542 -20763 321 0 0 NO NO Scheduled Follow-up Submission 2012-1-13 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES NO 60 No M0 N0 T2 Stage IB 7542 Preoperative R0 Primary Tumor 01 6th NO YES 78 2 Current smoker Lung DECEASED 1993 1952 TCGA-78-7542-01A-21D-2063-08 ff74b4c6-e938-4a40-ab1a-84525349a62e TCGA-78-7542-01A-21D-2062-01 TCGA-78-7542-01A-21D-2064-05 TCGA-78-7542-01 TCGA-78-7542-01A-21D-2062-01 ff74b4c6-e938-4a40-ab1a-84525349a62e TCGA-78-7542-01 TCGA-78-7542-01A-23-2192-20 ff74b4c6-e938-4a40-ab1a-84525349a62e TCGA-78-7542-01 ed42ee40-c1b5-4241-98ca-ed13a0bf8861 ff74b4c6-e938-4a40-ab1a-84525349a62e TCGA-78-7542-01A-21D-2063-08 TCGA-78-7542-01 +TCGA-78-7633-01 2.19 0.75 none p.G469L none none N Y none none none 0.35 Magnoid none none none none none none none Papillary predominant Adc Papillary predominant Adc none 0 TCGA-78-7633-01 Iq C1-LUAD-enriched cluster 3 Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 5 cluster 3 TCGA-78-7633 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 67 L-Upper TCGA-78-7633-F46157 TCGA-78-7633 TCGA-78-7633-01A -24713 1528 0 994 1450 57 0 NO NO Scheduled Follow-up Submission Progressive Disease 2013-8-29 MALE Lung Adenocarcinoma Mixed Subtype No C34.1 8255/3 C34.1 YES 0.9 NO NO 1 NO Locoregional Recurrence YES 94 Yes M0 N0 T2 Stage IB TCGA-78-7633.b1031a29-f3af-4f4f-a3d2-1be59c524222.pdf 7633 Preoperative WITH TUMOR 100 Complete Remission/Response Biopsy with Histologic Confirmation YES R0 Primary Tumor 01 0.5 2002 6th NO YES 78 4 Current reformed smoker for < or = 15 years Lung A DECEASED 2009 1955 TCGA-78-7633-01A-11D-2063-08 006eb1bc-b058-49b9-8c2d-3c50f2427d95 TCGA-78-7633-01A-11D-2062-01 TCGA-78-7633-01A-11D-2064-05 TCGA-78-7633-01 TCGA-78-7633-01A-11D-2062-01 006eb1bc-b058-49b9-8c2d-3c50f2427d95 TCGA-78-7633-01 TCGA-78-7633-01A-13-2192-20 006eb1bc-b058-49b9-8c2d-3c50f2427d95 TCGA-78-7633-01 46727f4d-0ce9-401f-ac87-531f1ea3dc11 006eb1bc-b058-49b9-8c2d-3c50f2427d95 TCGA-78-7633-01A-11D-2063-08 TCGA-78-7633-01 +TCGA-78-8640-01 TCGA-78-8640-01 TCGA-78-8640 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 59 L-Upper TCGA-78-8640-F70500 TCGA-78-8640 TCGA-78-8640-01A -21832 0 7062 0 NO NO Scheduled Follow-up Submission 2015-3-25 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.7 NO NO Peripheral Lung 0.8 NO NO 45 No M0 N1 T1 Stage IIA TCGA-78-8640.b39fa23e-bac4-49c9-919b-6e6d4cb8d90d.pdf 8640 Preoperative TUMOR FREE 73 66 Complete Remission/Response YES NO R0 Primary Tumor 01 0.3 6th NO NO YES 78 2 Lung A LIVING 1994 1949 5cb476d8-eae8-453c-8157-fdb71b4d5efa TCGA-78-8640-01A-11D-2389-01 TCGA-78-8640-01A-11D-2398-05 TCGA-78-8640-01 TCGA-78-8640-01A-11D-2389-01 5cb476d8-eae8-453c-8157-fdb71b4d5efa TCGA-78-8640-01 5cb476d8-eae8-453c-8157-fdb71b4d5efa TCGA-78-8640-01 5cb476d8-eae8-453c-8157-fdb71b4d5efa TCGA-78-8640-01A-11D-2393-08 TCGA-78-8640-01 +TCGA-78-8648-01 TCGA-78-8648-01 TCGA-78-8648 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 58 R-Upper TCGA-78-8648 TCGA-78-8648-01A -21443 1209 0 69 2 NO NO 2012-10-23 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.8 NO NO Peripheral Lung 1.2 YES 45 No M0 N0 T3 Stage IIB TCGA-78-8648.a439594e-b536-4bd3-a77a-fb50304de9a2.pdf 8648 Preoperative 83 70 YES NO R0 Primary Tumor 01 0.4 6th NO NO YES 78 2 Lung A DECEASED 2002 1971 42ab0bc6-16cb-43e4-9729-9b947f2e6432 TCGA-78-8648-01A-11D-2389-01 TCGA-78-8648-01A-11D-2398-05 TCGA-78-8648-01 TCGA-78-8648-01A-11D-2389-01 42ab0bc6-16cb-43e4-9729-9b947f2e6432 TCGA-78-8648-01 42ab0bc6-16cb-43e4-9729-9b947f2e6432 TCGA-78-8648-01 42ab0bc6-16cb-43e4-9729-9b947f2e6432 TCGA-78-8648-01A-11D-2393-08 TCGA-78-8648-01 +TCGA-78-8655-01 TCGA-78-8655-01 TCGA-78-8655 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 77 L-Lower TCGA-78-8655-F46154 TCGA-78-8655 -28379 0 2360 93 0 NO NO Scheduled Follow-up Submission 2013-8-28 FEMALE Lung Adenocarcinoma Mixed Subtype No C34.3 8255/3 C34.3 YES NO Peripheral Lung YES 10 No M0 N0 T1 Stage IA 8655 Preoperative 70 128 Complete Remission/Response YES NO R0 Primary Tumor 01 2001 6th NO NO YES 78 4 Lung LIVING 2003 1981 a0e0a895-ce81-44a6-a21e-453e727acdbb TCGA-78-8655-01A-11D-2389-01 TCGA-78-8655-01A-11D-2398-05 TCGA-78-8655-01 TCGA-78-8655-01A-11D-2389-01 a0e0a895-ce81-44a6-a21e-453e727acdbb TCGA-78-8655-01 a0e0a895-ce81-44a6-a21e-453e727acdbb TCGA-78-8655-01 a0e0a895-ce81-44a6-a21e-453e727acdbb TCGA-78-8655-01A-11D-2393-08 TCGA-78-8655-01 +TCGA-78-8660-01 TCGA-78-8660-01 TCGA-78-8660 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 69 R-Lower TCGA-78-8660 TCGA-78-8660-01A -25422 321 0 87 1 NO NO 2012-10-23 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 0.8 NO NO Peripheral Lung 1.1 YES 11 Yes, History of Prior Malignancy M0 N1 T2 Stage IIB TCGA-78-8660.2c53d65a-d792-41bc-a6c3-cd2d079a5386.pdf 8660 Preoperative WITH TUMOR 72 108 YES YES R0 Primary Tumor 01 0.5 2005 6th NO NO YES 78 4 Lung A DECEASED 2005 1954 664ffa40-4508-40ae-9505-84a10136b362 TCGA-78-8660-01A-11D-2389-01 TCGA-78-8660-01A-11D-2398-05 TCGA-78-8660-01 TCGA-78-8660-01A-11D-2389-01 664ffa40-4508-40ae-9505-84a10136b362 TCGA-78-8660-01 664ffa40-4508-40ae-9505-84a10136b362 TCGA-78-8660-01 664ffa40-4508-40ae-9505-84a10136b362 TCGA-78-8660-01A-11D-2393-08 TCGA-78-8660-01 +TCGA-78-8662-01 TCGA-78-8662-01 TCGA-78-8662 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 53 R-Upper TCGA-78-8662 TCGA-78-8662-01A -19563 3361 0 76 0 NO NO 2012-10-23 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES NO NO Peripheral Lung YES 45 No M0 N0 T2 Stage IB TCGA-78-8662.fb1023d3-d221-4dbb-80f9-0c3dd7b0750f.pdf 8662 Preoperative 64 96 Complete Remission/Response YES NO R0 Primary Tumor 01 6th NO NO YES 78 2 Lung A DECEASED 2000 1964 4c893780-d86b-4b01-a423-ca099e4fc007 TCGA-78-8662-01A-11D-2389-01 TCGA-78-8662-01A-11D-2398-05 TCGA-78-8662-01 TCGA-78-8662-01A-11D-2389-01 4c893780-d86b-4b01-a423-ca099e4fc007 TCGA-78-8662-01 4c893780-d86b-4b01-a423-ca099e4fc007 TCGA-78-8662-01 A93B8E14-B557-46DC-B1D5-7BD46458C569 4c893780-d86b-4b01-a423-ca099e4fc007 TCGA-78-8662-01A-11D-2393-08 TCGA-78-8662-01 +TCGA-80-5607-01 2.02 0.49 none p.V600E none none N Y none none none 0.24 Bronchioid none none none none none p.E545K none Acinar predominant Adc Acinar predominant Adc none 0 TCGA-80-5607-01 Kirc+ C1-LUAD-enriched cluster 1 Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 4 cluster 4 TCGA-80-5607 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung NO NO NO NO L-Upper TCGA-80-5607-F15867 TCGA-80-5607 TCGA-80-5607-01A 1 2011-8-15 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.8 NO Peripheral Lung 1.4 YES 15 Yes M0 N1 T2 Stage IIB TCGA-80-5607.6c775590-55a2-4e85-b511-afd2fa76cabc.pdf 5607 Preoperative WITH TUMOR NO R0 Primary Tumor 01 0.6 1985 6th NO NO YES 80 3 Current reformed smoker for > 15 years Lung A LIVING 2007 1965 TCGA-80-5607-01A-31D-1945-08 0ddf256d-70a4-4dfc-ade0-1f51a4c115a3 TCGA-80-5607-01A-31D-1943-01 TCGA-80-5607-01A-31D-1947-05 TCGA-80-5607-01 TCGA-80-5607-01A-31D-1943-01 0ddf256d-70a4-4dfc-ade0-1f51a4c115a3 TCGA-80-5607-01 TCGA-80-5607-01A-11-2190-20 0ddf256d-70a4-4dfc-ade0-1f51a4c115a3 TCGA-80-5607-01 aa426968-088a-443a-862c-171fdc182ca9 0ddf256d-70a4-4dfc-ade0-1f51a4c115a3 TCGA-80-5607-01A-31D-1945-08 TCGA-80-5607-01 +TCGA-80-5608-01 3.11 0.48 none none none none Y Y none none p.H1303Q 0.19 Magnoid none p.G12A none none none none none Acinar predominant Adc Acinar predominant Adc p.K62* 0 TCGA-80-5608-01 High C1-LUAD-enriched cluster 2 Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 6 cluster 1 TCGA-80-5608 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung R-Upper TCGA-80-5608-F72033 TCGA-80-5608 TCGA-80-5608-01A 2832 1 Scheduled Follow-up Submission 2015-4-2 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.7 NO Peripheral Lung 1.2 NO NO 26 No M0 N0 T1 Stage IA TCGA-80-5608.a4f3469b-1aae-424f-9135-7e6bfcc08d03.pdf 5608 Preoperative TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 0.5 6th NO NO YES 80 2 Current smoker Lung A LIVING 1972 TCGA-80-5608-01A-31D-1945-08 b93762e1-ee51-4768-8343-f49e241fd397 TCGA-80-5608-01A-31D-1943-01 TCGA-80-5608-01A-31D-1947-05 TCGA-80-5608-01 TCGA-80-5608-01A-31D-1943-01 b93762e1-ee51-4768-8343-f49e241fd397 TCGA-80-5608-01 TCGA-80-5608-01A-11-2190-20 b93762e1-ee51-4768-8343-f49e241fd397 TCGA-80-5608-01 1e6ecda8-bdc5-4133-adf1-99b849623c7e b93762e1-ee51-4768-8343-f49e241fd397 TCGA-80-5608-01A-31D-1945-08 TCGA-80-5608-01 +TCGA-80-5611-01 TCGA-80-5611-01 BRCA-LUAD+ C1-LUAD-enriched Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 4 mutation c1uster 9 TCGA-80-5611 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung L-Upper TCGA-80-5611-F72034 TCGA-80-5611 TCGA-80-5611-01A 2595 0 Scheduled Follow-up Submission 2015-4-2 MALE Lung Solid Pattern Predominant Adenocarcinoma No C34.1 8230/3 C34.1 YES 0.8 NO Peripheral Lung 1.2 NO NO 60 Yes M0 N0 T2 Stage IB TCGA-80-5611.42e15634-a742-4e7c-a795-e5fe6fd7b9aa.pdf 5611 Preoperative TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 0.6 2008 6th NO NO YES 80 4 Lung A LIVING TCGA-80-5611-01A-01D-1625-08 7f12f566-ca68-4528-b704-b3ef4cb9ba09 TCGA-80-5611-01A-01D-1624-01 TCGA-80-5611-01A-01D-1626-05 TCGA-80-5611-01 TCGA-80-5611-01A-01D-1624-01 7f12f566-ca68-4528-b704-b3ef4cb9ba09 TCGA-80-5611-01 TCGA-80-5611-01A-31-2191-20 7f12f566-ca68-4528-b704-b3ef4cb9ba09 TCGA-80-5611-01 0829a330-1be5-44b1-80ac-2a426e24bac3 7f12f566-ca68-4528-b704-b3ef4cb9ba09 TCGA-80-5611-01A-01D-1625-08 TCGA-80-5611-01 +TCGA-83-5908-01 TCGA-83-5908-01 Squamous C1-LUAD-enriched Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 4 TCGA-83-5908 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung NO NO NO NO 59 L-Upper TCGA-83-5908-F12196 TCGA-83-5908 TCGA-83-5908-01A -21760 0 824 1 NO NO Stable Disease 2011-5-25 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 1 NO 90 NO 1.9 NO 69 No M0 N0 T1 Stage IA TCGA-83-5908.bf81e5a3-26db-4476-b553-38d4f6897309.pdf 5908 Other TUMOR FREE Stable Disease NO R0 Primary Tumor 01 0.6 2007 6th NO YES NO 83 4 Lung A LIVING 2009 1962 772f9a82-9a03-4bf0-b7ce-877b15e3d017 TCGA-83-5908-01A-21D-2283-01 TCGA-83-5908-01A-21D-2285-05 TCGA-83-5908-01 TCGA-83-5908-01A-21D-2283-01 772f9a82-9a03-4bf0-b7ce-877b15e3d017 TCGA-83-5908-01 TCGA-83-5908-01A-31-2191-20 772f9a82-9a03-4bf0-b7ce-877b15e3d017 TCGA-83-5908-01 bd5509b4-f8fb-4e68-a735-c42b23cdbbf8 772f9a82-9a03-4bf0-b7ce-877b15e3d017 TCGA-83-5908-01A-21D-2284-08 TCGA-83-5908-01 +TCGA-86-6562-01 3.43 0.45 none none none none N Y none p.776_776G>VC none 0.17 Squamoid none none none none none none none Micropapillary predom Adc Micropapillary predom Adc none 0 TCGA-86-6562-01 High C1-LUAD-enriched cluster 2 Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 4 cluster 5 mutation c1uster 9 TCGA-86-6562 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung NO NO NO 52 R-Upper TCGA-86-6562-F29765 TCGA-86-6562 TCGA-86-6562-01A -19301 376 0 0 274 Scheduled Follow-up Submission Progressive Disease 2012-3-28 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 1.4 NO 0 NO Central Lung 1.9 YES No M0 N1 T2a Stage IIA TCGA-86-6562.b0e49ac9-6b9c-4e70-a4a9-10e0686e61aa.pdf 6562 WITH TUMOR Progressive Disease NO NO R0 Primary Tumor 01 0.4 7th YES YES NO 86 1 Lifelong Non-smoker Lung A DECEASED 2011 TCGA-86-6562-01A-11D-1753-08 TCGA-86-6562-01A-11D-1753-08 a0c2dedc-803a-4097-8225-653262fbf394 TCGA-86-6562-01A-11D-1752-01 TCGA-86-6562-01A-11D-1756-05 TCGA-86-6562-01 TCGA-86-6562-01A-11D-1752-01 a0c2dedc-803a-4097-8225-653262fbf394 TCGA-86-6562-01 TCGA-86-6562-01A-13-2191-20 a0c2dedc-803a-4097-8225-653262fbf394 TCGA-86-6562-01 1534f1f0-bd71-43e0-8185-ec0809746d2f a0c2dedc-803a-4097-8225-653262fbf394 TCGA-86-6562-01A-11D-1753-08 TCGA-86-6562-01 +TCGA-86-6851-01 3.34 0.32 none none none none N N none none none 0.13 Squamoid none none none none none none none Acinar predominant Adc Acinar predominant Adc none 0 TCGA-86-6851-01 Squamous C1-LUAD-enriched cluster 2 Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 7 cluster 4 TCGA-86-6851 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 73 L-Upper TCGA-86-6851-F53594 TCGA-86-6851 TCGA-86-6851-01A -26808 0 179 0 Scheduled Follow-up Submission Complete Remission/Response 2013-12-12 FEMALE Lung Adenocarcinoma Mixed Subtype No C34.1 8255/3 C34.1 YES 0.7 NO 100 1 YES NO 52 No M0 N1 T1b Stage IIA TCGA-86-6851.519253c3-7e47-4c66-9149-65e622f1ba29.pdf 6851 Post-Adjuvant Therapy TUMOR FREE Complete Remission/Response NO NO Primary Tumor 01 0.4 7th NO YES NO 86 2 Current smoker Lung A LIVING 2011 1959 TCGA-86-6851-01A-11D-1945-08 9214caa3-2ad2-41ff-ab77-cf22c4ccce97 TCGA-86-6851-01A-11D-1943-01 TCGA-86-6851-01A-11D-1947-05 TCGA-86-6851-01 TCGA-86-6851-01A-11D-1943-01 9214caa3-2ad2-41ff-ab77-cf22c4ccce97 TCGA-86-6851-01 TCGA-86-6851-01A-13-2191-20 9214caa3-2ad2-41ff-ab77-cf22c4ccce97 TCGA-86-6851-01 be82da85-37a8-4c75-9cf7-ef9ec0acddba 9214caa3-2ad2-41ff-ab77-cf22c4ccce97 TCGA-86-6851-01A-11D-1945-08 TCGA-86-6851-01 +TCGA-86-7701-01 TCGA-86-7701-01 BRCA-LUAD+ C1-LUAD-enriched Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 6 TCGA-86-7701 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung YES YES NO 66 R-Upper TCGA-86-7701-F58406 TCGA-86-7701 TCGA-86-7701-01A -24209 0 947 900 2 Scheduled Follow-up Submission Progressive Disease 2014-4-9 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 1.7 NO 80 Peripheral Lung 1.8 NO Distant Metastasis YES No M1 N0 T2 Stage IV TCGA-86-7701.711a97e9-ac1d-4f62-b488-a3eb8370841e.pdf 7701 Post-Adjuvant Therapy WITH TUMOR Complete Remission/Response NO NO R0 Primary Tumor 01 0.2 7th YES YES NO 86 1 Lung A LIVING 2011 7524ebc8-c57e-44d5-9a4e-b5ccce93bf55 TCGA-86-7701-01A-11D-2166-01 TCGA-86-7701-01A-11D-2168-05 TCGA-86-7701-01 TCGA-86-7701-01A-11D-2166-01 7524ebc8-c57e-44d5-9a4e-b5ccce93bf55 TCGA-86-7701-01 TCGA-86-7701-01A-13-2192-20 7524ebc8-c57e-44d5-9a4e-b5ccce93bf55 TCGA-86-7701-01 e2450111-6105-461c-bf1f-70106b4eb4e5 7524ebc8-c57e-44d5-9a4e-b5ccce93bf55 TCGA-86-7701-01A-11D-2167-08 TCGA-86-7701-01 +TCGA-86-7711-01 TCGA-86-7711-01 High C1-LUAD-enriched Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 4 TCGA-86-7711 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 70 R-Lower TCGA-86-7711-F41203 TCGA-86-7711 TCGA-86-7711-01A -25719 1046 0 27 2 Scheduled Follow-up Submission Progressive Disease 2013-3-13 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 1.5 NO 80 NO Peripheral Lung 1.8 NO NO 50 No M0 N1 T2a Stage IIA TCGA-86-7711.5a85d8a6-3533-4ac8-9fc9-437a81b436d6.pdf 7711 WITH TUMOR Progressive Disease NO NO R0 Primary Tumor 01 0.4 7th YES YES NO 86 2 Lung A DECEASED 2011 1960 597e959c-bab8-4234-b57b-1b8413de7955 TCGA-86-7711-01A-11D-2062-01 TCGA-86-7711-01A-11D-2064-05 TCGA-86-7711-01 TCGA-86-7711-01A-11D-2062-01 597e959c-bab8-4234-b57b-1b8413de7955 TCGA-86-7711-01 TCGA-86-7711-01A-13-2192-20 597e959c-bab8-4234-b57b-1b8413de7955 TCGA-86-7711-01 12e8ae79-b62d-4a85-a4f9-30fadb5e0dc0 597e959c-bab8-4234-b57b-1b8413de7955 TCGA-86-7711-01A-11D-2063-08 TCGA-86-7711-01 +TCGA-86-7711-11 TCGA-86-7711-11 C1-LUAD-enriched TCGA-86-7711 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 70 R-Lower TCGA-86-7711-F41203 TCGA-86-7711 -25719 1046 0 27 2 Scheduled Follow-up Submission Progressive Disease 2013-3-13 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 80 NO Peripheral Lung NO NO 50 No M0 N1 T2a Stage IIA 7711 WITH TUMOR Progressive Disease NO NO R0 Solid Tissue Normal 11 7th YES YES NO 86 2 Lung DECEASED 2011 1960 TCGA-86-7711-11 TCGA-86-7711-11 +TCGA-86-7713-01 2.14 0.79 none none none none Y Y none none none 0.37 Magnoid none p.G12C none none none none none Micropapillary predom Adc Micropapillary predom Adc p.L245F 0 TCGA-86-7713-01 BRCA-LUAD+ C1-LUAD-enriched cluster 3 Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 4 cluster 2 TCGA-86-7713 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 70 R-Middle TCGA-86-7713-F63513 TCGA-86-7713 TCGA-86-7713-01A -25791 0 1157 0 Scheduled Follow-up Submission Complete Remission/Response 2014-8-12 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.2 8140/3 C34.2 YES 1.2 NO 100 NO Peripheral Lung 3 NO NO No M0 N0 T2b Stage IIA TCGA-86-7713.0ec59eb0-0640-4d6b-b191-76bad8bb38d8.pdf 7713 Post-Adjuvant Therapy TUMOR FREE Complete Remission/Response NO NO R0 Primary Tumor 01 0.5 7th YES YES NO 86 1 Lifelong Non-smoker Lung A LIVING 2011 TCGA-86-7713-01A-11D-2063-08 2d1f10dd-a834-4c64-919c-2d9eea15c37a TCGA-86-7713-01A-11D-2062-01 TCGA-86-7713-01A-11D-2064-05 TCGA-86-7713-01 TCGA-86-7713-01A-11D-2062-01 2d1f10dd-a834-4c64-919c-2d9eea15c37a TCGA-86-7713-01 TCGA-86-7713-01A-13-2192-20 2d1f10dd-a834-4c64-919c-2d9eea15c37a TCGA-86-7713-01 3aed5efc-311a-4163-a44d-6f2972340d19 2d1f10dd-a834-4c64-919c-2d9eea15c37a TCGA-86-7713-01A-11D-2063-08 TCGA-86-7713-01 +TCGA-86-7713-11 2.14 0.79 none none none none Y Y none none none 0.37 Magnoid none p.G12C none none none none none Micropapillary predom Adc Micropapillary predom Adc p.L245F 0 TCGA-86-7713-11 C1-LUAD-enriched TCGA-86-7713 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 70 R-Middle TCGA-86-7713-F63513 TCGA-86-7713 -25791 0 1157 0 Scheduled Follow-up Submission Complete Remission/Response 2014-8-12 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.2 8140/3 C34.2 YES 100 NO Peripheral Lung NO NO No M0 N0 T2b Stage IIA 7713 Post-Adjuvant Therapy TUMOR FREE Complete Remission/Response NO NO R0 Solid Tissue Normal 11 7th YES YES NO 86 1 Lifelong Non-smoker Lung LIVING 2011 TCGA-86-7713-11 TCGA-86-7713-11 +TCGA-86-7714-01 none p.V600E none none N Y none none none Bronchioid none none none none none p.E726K none Lepidic predominant Adc Lepidic predominant Adc none 0 TCGA-86-7714-01 Kirc+ cluster 2 Cluster 6 LUAD-like c10 miRNA cluster 5 cluster 3 TCGA-86-7714 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 61 R-Lower TCGA-86-7714-F53595 TCGA-86-7714 -22619 625 0 0 0 NO Scheduled Follow-up Submission Progressive Disease 2013-12-12 FEMALE Lung Adenocarcinoma Mixed Subtype No C34.3 8255/3 C34.3 YES 0 NO Peripheral Lung NO NO 43 No M0 N2 T1b Stage IIIA 7714 Post-Adjuvant Therapy WITH TUMOR Stable Disease NO NO R0 Primary Tumor 01 7th NO YES NO 86 2 Current smoker Lung DECEASED 2011 1968 TCGA-86-7714-01A-12D-2167-08 a6af2ef5-6774-422c-99d1-826a686334d0 TCGA-86-7714-01A-12D-2166-01 TCGA-86-7714-01A-12D-2168-05 TCGA-86-7714-01 TCGA-86-7714-01A-12D-2166-01 a6af2ef5-6774-422c-99d1-826a686334d0 TCGA-86-7714-01 a6af2ef5-6774-422c-99d1-826a686334d0 TCGA-86-7714-01 a6af2ef5-6774-422c-99d1-826a686334d0 TCGA-86-7714-01A-12D-2167-08 TCGA-86-7714-01 +TCGA-86-7953-01 TCGA-86-7953-01 BRCA-LUAD+ C1-LUAD-enriched Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 4 TCGA-86-7953 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 69 L-Upper TCGA-86-7953-F66262 TCGA-86-7953 TCGA-86-7953-01A -25315 0 997 1 NO Scheduled Follow-up Submission Complete Remission/Response 2014-10-7 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8250/3 C34.1 YES 1.2 NO 90 Peripheral Lung 3 NO NO No M0 N0 T1b Stage IA TCGA-86-7953.1af715d0-9b4b-444f-b93e-53478cde8e58.pdf 7953 Preoperative TUMOR FREE Complete Remission/Response NO NO RX Primary Tumor 01 0.2 7th NO YES NO 86 1 Lung A LIVING 2011 90865a55-659d-409f-a865-bae9e46c4a7c TCGA-86-7953-01A-11D-2183-01 TCGA-86-7953-01A-11D-2185-05 TCGA-86-7953-01 TCGA-86-7953-01A-11D-2183-01 90865a55-659d-409f-a865-bae9e46c4a7c TCGA-86-7953-01 TCGA-86-7953-01A-13-2192-20 90865a55-659d-409f-a865-bae9e46c4a7c TCGA-86-7953-01 2b5c0a28-53db-48a3-8f06-2878f99f42b3 90865a55-659d-409f-a865-bae9e46c4a7c TCGA-86-7953-01A-11D-2184-08 TCGA-86-7953-01 +TCGA-86-7954-01 TCGA-86-7954-01 High C1-LUAD-enriched Cluster 5 squamous c3 LUAD-like c10 miRNA c1uster 10 TCGA-86-7954 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 68 R-Lower TCGA-86-7954-F57948 TCGA-86-7954 TCGA-86-7954-01A -25062 0 605 0 NO Scheduled Follow-up Submission Complete Remission/Response 2014-3-28 FEMALE Lung Bronchioloalveolar Carcinoma Nonmucinous No C34.3 8250/3 C34.3 YES 1 NO 100 NO Peripheral Lung 1.1 NO NO 8 No M0 N0 T2 Stage IB TCGA-86-7954.6a0c9a64-8c57-412a-8b3c-efb8e0b184ea.pdf 7954 Post-Adjuvant Therapy TUMOR FREE Complete Remission/Response NO NO R0 Primary Tumor 01 0.3 1971 7th YES YES NO 86 3 Lung A LIVING 2011 1963 f84c748d-1296-44aa-b7b1-0795939a88fe TCGA-86-7954-01A-11D-2183-01 TCGA-86-7954-01A-11D-2185-05 TCGA-86-7954-01 TCGA-86-7954-01A-11D-2183-01 f84c748d-1296-44aa-b7b1-0795939a88fe TCGA-86-7954-01 TCGA-86-7954-01A-13-2192-20 f84c748d-1296-44aa-b7b1-0795939a88fe TCGA-86-7954-01 478cc583-9ef7-409b-9cda-4d1f64f447a4 f84c748d-1296-44aa-b7b1-0795939a88fe TCGA-86-7954-01A-11D-2184-08 TCGA-86-7954-01 +TCGA-86-7955-01 TCGA-86-7955-01 High C1-LUAD-enriched Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 4 TCGA-86-7955 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung YES YES NO 62 R-Lower TCGA-86-7955-F63517 TCGA-86-7955 TCGA-86-7955-01A -22772 0 1072 820 0 NO Scheduled Follow-up Submission Complete Remission/Response 2014-8-12 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 1.5 NO 100 NO Peripheral Lung 2.1 NO Locoregional Recurrence YES No M0 N0 T2a Stage IB TCGA-86-7955.d6a25f15-9117-43b7-bbd4-132914a24d16.pdf 7955 Post-Adjuvant Therapy TUMOR FREE Complete Remission/Response NO YES RX Primary Tumor 01 0.4 7th YES YES NO 86 1 Lung A LIVING 2011 937a163b-b469-46a0-87b8-6d7c7e6105d7 TCGA-86-7955-01A-11D-2183-01 TCGA-86-7955-01A-11D-2185-05 TCGA-86-7955-01 TCGA-86-7955-01A-11D-2183-01 937a163b-b469-46a0-87b8-6d7c7e6105d7 TCGA-86-7955-01 TCGA-86-7955-01A-21-2192-20 937a163b-b469-46a0-87b8-6d7c7e6105d7 TCGA-86-7955-01 a7ef7d69-1adb-4014-82ef-d078c1121456 937a163b-b469-46a0-87b8-6d7c7e6105d7 TCGA-86-7955-01A-11D-2184-08 TCGA-86-7955-01 +TCGA-86-8054-01 TCGA-86-8054-01 BRCA-LUAD+ Cluster 5 LUAD-like c10 miRNA cluster 6 TCGA-86-8054 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 61 R-Upper TCGA-86-8054-F65792 TCGA-86-8054 TCGA-86-8054-01A -22584 0 1148 2 NO NO Scheduled Follow-up Submission Complete Remission/Response 2014-9-30 MALE Lung Acinar Adenocarcinoma No C34.1 8550/3 C34.1 YES 1.1 NO 80 NO Central Lung 1.7 NO NO 9 No M0 N1 T2b Stage IIB TCGA-86-8054.a47b8835-2314-4631-b55d-f99af91ad5e7.pdf 8054 Preoperative TUMOR FREE Complete Remission/Response NO NO R0 Primary Tumor 01 0.4 7th YES YES NO 86 2 Lung A LIVING 2011 1994 ed7e5789-ce06-4213-beda-f0892b103ce4 TCGA-86-8054-01A-11D-2237-01 TCGA-86-8054-01A-11D-2239-05 TCGA-86-8054-01 TCGA-86-8054-01A-11D-2237-01 ed7e5789-ce06-4213-beda-f0892b103ce4 TCGA-86-8054-01 ed7e5789-ce06-4213-beda-f0892b103ce4 TCGA-86-8054-01 12254A12-4508-4B07-A365-E1D133723141 ed7e5789-ce06-4213-beda-f0892b103ce4 TCGA-86-8054-01A-11D-2238-08 TCGA-86-8054-01 +TCGA-86-8055-01 TCGA-86-8055-01 BRCA-LUAD+ Cluster 5 LUAD-like c10 miRNA c1uster 9 TCGA-86-8055 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung NO 79 L-Upper TCGA-86-8055-F40636 TCGA-86-8055 TCGA-86-8055-01A -29124 124 0 10 2 NO Scheduled Follow-up Submission Complete Remission/Response 2013-2-26 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 1.3 NO 80 NO Peripheral Lung 3.2 NO NO 60 No M0 N1 T2a Stage IIA TCGA-86-8055.b0f478a2-7696-4fc2-bdc9-839142556b6f.pdf 8055 Preoperative TUMOR FREE Complete Remission/Response NO NO R0 Primary Tumor 01 0.4 7th NO YES NO 86 2 Lung A DECEASED 2011 1955 b0b8fd4b-d725-417b-b17b-4cb6a7136459 TCGA-86-8055-01A-11D-2237-01 TCGA-86-8055-01A-11D-2239-05 TCGA-86-8055-01 TCGA-86-8055-01A-11D-2237-01 b0b8fd4b-d725-417b-b17b-4cb6a7136459 TCGA-86-8055-01 b0b8fd4b-d725-417b-b17b-4cb6a7136459 TCGA-86-8055-01 D64A8265-A17C-4EB4-B35B-F050A7BA32A5 b0b8fd4b-d725-417b-b17b-4cb6a7136459 TCGA-86-8055-01A-11D-2238-08 TCGA-86-8055-01 +TCGA-86-8056-01 TCGA-86-8056-01 BRCA-LUAD+ Cluster 6 LUAD-like c10 miRNA cluster 4 TCGA-86-8056 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 63 Other (please specify) Right upper, lower TCGA-86-8056-F57951 TCGA-86-8056 TCGA-86-8056-01A -23369 0 139 0 NO NO Scheduled Follow-up Submission 2014-3-28 FEMALE Lung Adenocarcinoma Mixed Subtype No C34.1 8255/3 C34.1 YES 1.1 NO 100 NO Peripheral Lung 1.4 YES NO 36 No M0 N0 T4 Stage IIIA TCGA-86-8056.b372fd6d-8c36-4642-b660-d353efb0bd89.pdf 8056 Preoperative TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 0.4 1975 7th YES NO 86 3 Lung A LIVING 2011 1963 8684c13a-9445-45a8-b37f-ce2b04b218bf TCGA-86-8056-01A-11D-2237-01 TCGA-86-8056-01A-11D-2239-05 TCGA-86-8056-01 TCGA-86-8056-01A-11D-2237-01 8684c13a-9445-45a8-b37f-ce2b04b218bf TCGA-86-8056-01 8684c13a-9445-45a8-b37f-ce2b04b218bf TCGA-86-8056-01 EC2B7FF4-EB02-4503-9320-7438E8ECA695 8684c13a-9445-45a8-b37f-ce2b04b218bf TCGA-86-8056-01A-11D-2238-08 TCGA-86-8056-01 +TCGA-86-8073-01 TCGA-86-8073-01 High Cluster 6 LUAD-like c10 miRNA c1uster 9 TCGA-86-8073 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 58 L-Upper TCGA-86-8073-F66082 TCGA-86-8073 TCGA-86-8073-01A -21214 0 740 0 NO NO Scheduled Follow-up Submission Complete Remission/Response 2014-10-2 MALE Lung Bronchioloalveolar Carcinoma Nonmucinous No C34.1 8250/3 C34.1 YES 1.5 NO 100 NO Peripheral Lung 1.8 NO NO 40 No M0 N0 T2a Stage IB TCGA-86-8073.2ae8592b-aa83-476a-b77f-dc53e8eb802b.pdf 8073 Other TUMOR FREE Complete Remission/Response NO NO R0 Primary Tumor 01 0.4 7th NO YES NO 86 2 Lung A LIVING 2011 1970 97c75ab2-4b91-4c26-992e-ed1252805aac TCGA-86-8073-01A-11D-2237-01 TCGA-86-8073-01A-11D-2239-05 TCGA-86-8073-01 TCGA-86-8073-01A-11D-2237-01 97c75ab2-4b91-4c26-992e-ed1252805aac TCGA-86-8073-01 97c75ab2-4b91-4c26-992e-ed1252805aac TCGA-86-8073-01 9DE79452-B65C-4691-ACE1-291B310376FC 97c75ab2-4b91-4c26-992e-ed1252805aac TCGA-86-8073-01A-11D-2238-08 TCGA-86-8073-01 +TCGA-86-8074-01 TCGA-86-8074-01 BRCA-LUAD+ Cluster 6 LUAD-like c10 miRNA cluster 4 TCGA-86-8074 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 62 L-Lower TCGA-86-8074-F41667 TCGA-86-8074 TCGA-86-8074-01A -22862 0 24 2 NO NO Scheduled Follow-up Submission 2013-3-26 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8260/3 C34.3 YES 1.3 NO 80 NO Peripheral Lung 2.3 YES 40 No M0 N1 T1b Stage IIA TCGA-86-8074.a1e9569b-0254-4be6-adb2-3a842e23613f.pdf 8074 TUMOR FREE NO R0 Primary Tumor 01 0.3 7th YES NO 86 2 Lung A LIVING 2011 1970 13549fc9-6145-4853-88a6-39c78cb3ab0a TCGA-86-8074-01A-11D-2237-01 TCGA-86-8074-01A-11D-2239-05 TCGA-86-8074-01 TCGA-86-8074-01A-11D-2237-01 13549fc9-6145-4853-88a6-39c78cb3ab0a TCGA-86-8074-01 13549fc9-6145-4853-88a6-39c78cb3ab0a TCGA-86-8074-01 39CEF057-7CC2-48A2-835F-9BEED0BB5265 13549fc9-6145-4853-88a6-39c78cb3ab0a TCGA-86-8074-01A-11D-2238-08 TCGA-86-8074-01 +TCGA-86-8075-01 TCGA-86-8075-01 BRCA-LUAD+ Cluster 5 LUAD-like c10 miRNA cluster 4 TCGA-86-8075 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 66 L-Upper TCGA-86-8075-F63521 TCGA-86-8075 TCGA-86-8075-01A -24402 694 0 43 1 NO NO Scheduled Follow-up Submission Complete Remission/Response 2014-8-12 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 1.6 NO 90 NO Peripheral Lung 1.8 NO NO No M0 N0 T2 Stage IB TCGA-86-8075.7988f9a9-584e-4ce9-b12c-f3e289af1d6d.pdf 8075 Preoperative TUMOR FREE Complete Remission/Response NO NO R0 Primary Tumor 01 0.4 7th NO YES NO 86 1 Lung A DECEASED 2011 fa3d0703-ce5e-49a9-96a6-0777f8e81cd3 TCGA-86-8075-01A-11D-2237-01 TCGA-86-8075-01A-11D-2239-05 TCGA-86-8075-01 TCGA-86-8075-01A-11D-2237-01 fa3d0703-ce5e-49a9-96a6-0777f8e81cd3 TCGA-86-8075-01 fa3d0703-ce5e-49a9-96a6-0777f8e81cd3 TCGA-86-8075-01 2CC15F30-6AD7-4295-A3AE-B1B4F2851F76 fa3d0703-ce5e-49a9-96a6-0777f8e81cd3 TCGA-86-8075-01A-11D-2238-08 TCGA-86-8075-01 +TCGA-86-8076-01 TCGA-86-8076-01 Iq Cluster 5 LUAD-like c10 miRNA c1uster 9 TCGA-86-8076 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 42 R-Upper TCGA-86-8076-F63522 TCGA-86-8076 TCGA-86-8076-01A -15605 0 993 0 NO NO Scheduled Follow-up Submission Complete Remission/Response 2014-8-12 MALE Lung Papillary Adenocarcinoma No C34.1 8260/3 C34.1 YES 1.2 NO 100 NO Peripheral Lung 1.7 NO NO No M0 N0 T1 Stage IA TCGA-86-8076.c282d817-b99a-4bda-8073-9de1cac074f9.pdf 8076 Post-Adjuvant Therapy TUMOR FREE Complete Remission/Response NO NO R0 Primary Tumor 01 0.4 7th YES YES NO 86 1 Lung A LIVING 2011 c9cf5f5f-30de-4062-99c3-dcb9cfd55870 TCGA-86-8076-01A-31D-2237-01 TCGA-86-8076-01A-31D-2239-05 TCGA-86-8076-01 TCGA-86-8076-01A-31D-2237-01 c9cf5f5f-30de-4062-99c3-dcb9cfd55870 TCGA-86-8076-01 c9cf5f5f-30de-4062-99c3-dcb9cfd55870 TCGA-86-8076-01 45139A07-3CD0-4EC6-AE37-442BDA160BFE c9cf5f5f-30de-4062-99c3-dcb9cfd55870 TCGA-86-8076-01A-31D-2238-08 TCGA-86-8076-01 +TCGA-86-8278-01 TCGA-86-8278-01 Kirc+ Cluster 6 miRNA c1uster 9 TCGA-86-8278 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 63 L-Lower TCGA-86-8278-F59732 TCGA-86-8278 TCGA-86-8278-01A -23117 0 944 1 Scheduled Follow-up Submission Stable Disease 2014-5-20 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.30 8480/3 C34.3 YES 1.2 NO 90 NO Peripheral Lung 2 NO NO No M0 N1 T2 Stage IIB TCGA-86-8278.75c05d77-d3b7-4cd1-9e6f-d8a18fc23f6c.pdf 8278 Preoperative WITH TUMOR Complete Remission/Response NO R0 Primary Tumor 01 0.3 7th NO YES NO 86 1 Lung A LIVING 2011 8719f9af-0876-4ec6-a4dc-4178ad964349 TCGA-86-8278-01A-11D-2283-01 TCGA-86-8278-01A-11D-2285-05 TCGA-86-8278-01 TCGA-86-8278-01A-11D-2283-01 8719f9af-0876-4ec6-a4dc-4178ad964349 TCGA-86-8278-01 8719f9af-0876-4ec6-a4dc-4178ad964349 TCGA-86-8278-01 23B1CC79-FF71-43C3-9903-CA3C6202D1DC 8719f9af-0876-4ec6-a4dc-4178ad964349 TCGA-86-8278-01A-11D-2284-08 TCGA-86-8278-01 +TCGA-86-8279-01 TCGA-86-8279-01 High Cluster 5 LUAD-like c10 miRNA cluster 4 TCGA-86-8279 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 46 R-Upper TCGA-86-8279-F59731 TCGA-86-8279 TCGA-86-8279-01A -17032 0 949 1 Scheduled Follow-up Submission Complete Remission/Response 2014-5-20 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 1.5 NO 90 NO Peripheral Lung 1.8 NO NO No M0 N1 T2a Stage IIA TCGA-86-8279.e7e4b4fd-f47d-4aab-826c-0ef1f620a739.pdf 8279 Preoperative TUMOR FREE Complete Remission/Response NO YES R0 Primary Tumor 01 0.3 7th YES YES NO 86 1 Lung A LIVING 2011 87e51ccb-9ded-43c6-bb1a-a8a85d2d9fa6 TCGA-86-8279-01A-11D-2283-01 TCGA-86-8279-01A-11D-2285-05 TCGA-86-8279-01 TCGA-86-8279-01A-11D-2283-01 87e51ccb-9ded-43c6-bb1a-a8a85d2d9fa6 TCGA-86-8279-01 87e51ccb-9ded-43c6-bb1a-a8a85d2d9fa6 TCGA-86-8279-01 55B45160-BCC0-4545-A462-9D452A192EAB 87e51ccb-9ded-43c6-bb1a-a8a85d2d9fa6 TCGA-86-8279-01A-11D-2284-08 TCGA-86-8279-01 +TCGA-86-8280-01 TCGA-86-8280-01 BRCA-LUAD+ Cluster 5 LUAD-like c10 miRNA cluster 7 TCGA-86-8280 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 54 L-Lower TCGA-86-8280-F66079 TCGA-86-8280 TCGA-86-8280-01A -19977 0 701 0 Scheduled Follow-up Submission Complete Remission/Response 2014-10-2 FEMALE Lung Bronchioloalveolar Carcinoma Nonmucinous No C34.3 8252/3 C34.3 YES 1.4 NO 100 NO Peripheral Lung 2.8 NO NO No M0 N0 T2b Stage IIA TCGA-86-8280.49459cae-eee4-4e46-a8fc-efbeb6cb1f5d.pdf 8280 Other TUMOR FREE Complete Remission/Response NO NO R0 Primary Tumor 01 0.4 7th YES YES NO 86 1 Lung A LIVING 2011 974f4223-c166-4ea2-a061-25e3f4b415e7 TCGA-86-8280-01A-11D-2283-01 TCGA-86-8280-01A-11D-2285-05 TCGA-86-8280-01 TCGA-86-8280-01A-11D-2283-01 974f4223-c166-4ea2-a061-25e3f4b415e7 TCGA-86-8280-01 974f4223-c166-4ea2-a061-25e3f4b415e7 TCGA-86-8280-01 9F0028D2-E480-470D-B5A5-01A5754BB4ED 974f4223-c166-4ea2-a061-25e3f4b415e7 TCGA-86-8280-01A-11D-2284-08 TCGA-86-8280-01 +TCGA-86-8281-01 TCGA-86-8281-01 BRCA-LUAD+ Cluster 5 LUAD-like c10 miRNA cluster 4 TCGA-86-8281 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 75 R-Lower TCGA-86-8281-F57953 TCGA-86-8281 TCGA-86-8281-01A -27409 0 0 0 Scheduled Follow-up Submission 2014-4-21 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 0.6 NO 100 NO Peripheral Lung 1.6 YES NO 30 No M0 NX T1 Stage IA TCGA-86-8281.775debd9-a338-412e-86da-5c132df883c1.pdf 8281 Preoperative TUMOR FREE Complete Remission/Response NO Primary Tumor 01 0.4 1985 7th YES NO 86 3 Lung A LIVING 2011 1955 f9e17a94-37a3-4bac-bbfe-0128fc3a644b TCGA-86-8281-01A-11D-2283-01 TCGA-86-8281-01A-11D-2285-05 TCGA-86-8281-01 TCGA-86-8281-01A-11D-2283-01 f9e17a94-37a3-4bac-bbfe-0128fc3a644b TCGA-86-8281-01 f9e17a94-37a3-4bac-bbfe-0128fc3a644b TCGA-86-8281-01 D255BC28-A2F1-4B69-9447-749D5BCD7288 f9e17a94-37a3-4bac-bbfe-0128fc3a644b TCGA-86-8281-01A-11D-2284-08 TCGA-86-8281-01 +TCGA-86-8358-01 TCGA-86-8358-01 Cluster 6 miRNA cluster 6 TCGA-86-8358 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 44 R-Upper TCGA-86-8358-F58410 TCGA-86-8358 TCGA-86-8358-01A -16409 0 653 0 Scheduled Follow-up Submission Complete Remission/Response 2014-4-9 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 1.4 NO 100 NO Peripheral Lung 1.7 NO NO 20 No M0 N0 T2a Stage IB TCGA-86-8358.bdfc4ca3-ce4f-4206-b3ff-3733df596e9d.pdf 8358 Other TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 0.5 7th NO YES NO 86 2 Lung A LIVING 2012 1992 6addf668-7b4d-4e3d-9086-b95818648be2 TCGA-86-8358-01A-11D-2322-01 TCGA-86-8358-01A-11D-2324-05 TCGA-86-8358-01 TCGA-86-8358-01A-11D-2322-01 6addf668-7b4d-4e3d-9086-b95818648be2 TCGA-86-8358-01 6addf668-7b4d-4e3d-9086-b95818648be2 TCGA-86-8358-01 4FAE672F-FA96-42B1-9A49-ADA69B980562 6addf668-7b4d-4e3d-9086-b95818648be2 TCGA-86-8358-01A-11D-2323-08 TCGA-86-8358-01 +TCGA-86-8359-01 TCGA-86-8359-01 Cluster 5 miRNA cluster 4 TCGA-86-8359 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 52 L-Lower TCGA-86-8359-F43296 TCGA-86-8359 TCGA-86-8359-01A -19088 444 0 26 4 Scheduled Follow-up Submission 2013-5-16 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 2 NO 20 Peripheral Lung 2.5 NO 36 No M0 N2 T3 Stage IIIA TCGA-86-8359.7525adb2-550a-4d65-beed-5fb0fef0b36d.pdf 8359 Post-Adjuvant Therapy TUMOR FREE NO R0 Primary Tumor 01 0.5 7th YES NO 86 2 Lung A DECEASED 2012 1982 1ed6d4b1-0a36-4515-9475-709ad876ffa9 TCGA-86-8359-01A-11D-2322-01 TCGA-86-8359-01A-11D-2324-05 TCGA-86-8359-01 TCGA-86-8359-01A-11D-2322-01 1ed6d4b1-0a36-4515-9475-709ad876ffa9 TCGA-86-8359-01 1ed6d4b1-0a36-4515-9475-709ad876ffa9 TCGA-86-8359-01 F28DE85D-791C-4A84-A056-647DACAE5046 1ed6d4b1-0a36-4515-9475-709ad876ffa9 TCGA-86-8359-01A-11D-2323-08 TCGA-86-8359-01 +TCGA-86-8585-01 TCGA-86-8585-01 TCGA-86-8585 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 57 L-Upper TCGA-86-8585-F46400 TCGA-86-8585 TCGA-86-8585-01A -20918 0 353 NO Scheduled Follow-up Submission Complete Remission/Response 2013-9-19 MALE Lung Solid Pattern Predominant Adenocarcinoma No C34.1 8230/3 C34.1 YES 2 NO NO Peripheral Lung 2.2 YES NO No M0 N0 T2a Stage IB TCGA-86-8585.6c3d5577-390c-4a80-8c02-dee4901c2a16.pdf 8585 TUMOR FREE Complete Remission/Response NO NO R0 Primary Tumor 01 0.4 7th NO YES NO 86 1 Lung A LIVING 2012 5642f9d8-a84b-4ab6-b841-910ac4010e16 TCGA-86-8585-01A-11D-2389-01 TCGA-86-8585-01A-11D-2398-05 TCGA-86-8585-01 TCGA-86-8585-01A-11D-2389-01 5642f9d8-a84b-4ab6-b841-910ac4010e16 TCGA-86-8585-01 5642f9d8-a84b-4ab6-b841-910ac4010e16 TCGA-86-8585-01 9493BA2A-E810-46D1-B99D-7EA76B68BCDB 5642f9d8-a84b-4ab6-b841-910ac4010e16 TCGA-86-8585-01A-11D-2393-08 TCGA-86-8585-01 +TCGA-86-8668-01 TCGA-86-8668-01 TCGA-86-8668 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 61 L-Lower TCGA-86-8668-F66084 TCGA-86-8668 TCGA-86-8668-01A -22383 0 423 0 Scheduled Follow-up Submission Complete Remission/Response 2014-10-2 FEMALE Lung Bronchioloalveolar Carcinoma Mucinous No C34.3 8253/3 C34.3 YES 1.6 NO 100 NO Peripheral Lung 2 NO NO No M0 N0 T1b Stage IA TCGA-86-8668.be6c4ce2-4c88-41a7-bff6-e5bb157ad3ad.pdf 8668 Other TUMOR FREE Complete Remission/Response NO NO R0 Primary Tumor 01 0.5 7th NO YES NO 86 1 Lung A LIVING 2012 ae6e4491-f510-41b0-9279-d4887504a637 TCGA-86-8668-01A-11D-2389-01 TCGA-86-8668-01A-11D-2398-05 TCGA-86-8668-01 TCGA-86-8668-01A-11D-2389-01 ae6e4491-f510-41b0-9279-d4887504a637 TCGA-86-8668-01 ae6e4491-f510-41b0-9279-d4887504a637 TCGA-86-8668-01 DDD67F62-BE18-4F27-A2E1-41782D30BC7B ae6e4491-f510-41b0-9279-d4887504a637 TCGA-86-8668-01A-11D-2393-08 TCGA-86-8668-01 +TCGA-86-8669-01 TCGA-86-8669-01 TCGA-86-8669 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung YES NO NO 64 R-Upper TCGA-86-8669-F66085 TCGA-86-8669 TCGA-86-8669-01A -23443 0 938 849 0 Scheduled Follow-up Submission Complete Remission/Response 2014-10-15 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 1.5 NO 100 NO Peripheral Lung 2.2 NO Distant Metastasis YES 47 No M0 N0 T1b Stage IA TCGA-86-8669.6c8d6319-a235-4757-be34-79286a8da60f.pdf 8669 Preoperative TUMOR FREE Complete Remission/Response Convincing Imaging NO NO R0 Primary Tumor 01 0.4 7th NO YES NO 86 2 Lung A LIVING 2012 1965 b363949d-cc43-4480-8afd-9f4693fe43cc TCGA-86-8669-01A-11D-2389-01 TCGA-86-8669-01A-11D-2398-05 TCGA-86-8669-01 TCGA-86-8669-01A-11D-2389-01 b363949d-cc43-4480-8afd-9f4693fe43cc TCGA-86-8669-01 b363949d-cc43-4480-8afd-9f4693fe43cc TCGA-86-8669-01 5B0FD5E1-D603-431F-A843-EEDDD0B0488C b363949d-cc43-4480-8afd-9f4693fe43cc TCGA-86-8669-01A-11D-2393-08 TCGA-86-8669-01 +TCGA-86-8671-01 TCGA-86-8671-01 TCGA-86-8671 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 72 R-Upper TCGA-86-8671-F66089 TCGA-86-8671 TCGA-86-8671-01A -26448 0 839 0 Scheduled Follow-up Submission Complete Remission/Response 2014-10-2 FEMALE Lung Papillary Adenocarcinoma No C34.1 8260/3 C34.1 YES 0.8 NO 100 Peripheral Lung 0.9 NO NO No M0 N1 T2b Stage IIB TCGA-86-8671.94c08fb3-35a3-494e-90ee-b8df1d8cf34f.pdf 8671 Other TUMOR FREE Complete Remission/Response NO NO R0 Primary Tumor 01 0.4 7th YES YES NO 86 1 Lung A LIVING 2012 00c7a308-6add-457c-9003-784d4e65c318 TCGA-86-8671-01A-11D-2389-01 TCGA-86-8671-01A-11D-2398-05 TCGA-86-8671-01 TCGA-86-8671-01A-11D-2389-01 00c7a308-6add-457c-9003-784d4e65c318 TCGA-86-8671-01 00c7a308-6add-457c-9003-784d4e65c318 TCGA-86-8671-01 AEE7F089-32C7-436C-9F88-A6E8E7379A13 00c7a308-6add-457c-9003-784d4e65c318 TCGA-86-8671-01A-11D-2393-08 TCGA-86-8671-01 +TCGA-86-8672-01 TCGA-86-8672-01 TCGA-86-8672 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 59 R-Upper TCGA-86-8672-F46401 TCGA-86-8672 TCGA-86-8672-01A -21682 19 0 15 Scheduled Follow-up Submission 2013-8-7 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 1.7 NO NO Central Lung 2.2 NO NO No M0 N0 T3 Stage IIB TCGA-86-8672.df3d9fe7-a56c-4100-9fdb-9fe3e7b11b2a.pdf 8672 TUMOR FREE Complete Remission/Response NO NO R0 Primary Tumor 01 0.4 7th NO YES NO 86 1 Lung A DECEASED 2012 764bce37-06d7-41e7-83d9-ce803dabd5f0 TCGA-86-8672-01A-21D-2389-01 TCGA-86-8672-01A-21D-2398-05 TCGA-86-8672-01 TCGA-86-8672-01A-21D-2389-01 764bce37-06d7-41e7-83d9-ce803dabd5f0 TCGA-86-8672-01 764bce37-06d7-41e7-83d9-ce803dabd5f0 TCGA-86-8672-01 764bce37-06d7-41e7-83d9-ce803dabd5f0 TCGA-86-8672-01A-21D-2393-08 TCGA-86-8672-01 +TCGA-86-8673-01 TCGA-86-8673-01 TCGA-86-8673 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung NO NO YES 61 L-Upper TCGA-86-8673-F59092 TCGA-86-8673 TCGA-86-8673-01A 639 -22571 0 862 636 Scheduled Follow-up Submission Complete Remission/Response 2014-4-30 MALE Lung Bronchioloalveolar Carcinoma Nonmucinous No C34.1 8252/3 C34.1 YES 1.8 NO 2.9 NO Locoregional Recurrence YES 54 No M0 N0 T2 Stage IB TCGA-86-8673.0e5c5229-2b1d-45d6-8fae-02a32fb84988.pdf 8673 TUMOR FREE Complete Remission/Response NO NO R0 Primary Tumor 01 0.5 7th NO YES NO 86 2 Lung A LIVING 2011 1968 ab39e99f-8967-4068-b1e2-49e1fe2298ff TCGA-86-8673-01A-11D-2389-01 TCGA-86-8673-01A-11D-2398-05 TCGA-86-8673-01 TCGA-86-8673-01A-11D-2389-01 ab39e99f-8967-4068-b1e2-49e1fe2298ff TCGA-86-8673-01 ab39e99f-8967-4068-b1e2-49e1fe2298ff TCGA-86-8673-01 E813BA5F-3E01-4FD6-AFA0-DECE1B2B3E83 ab39e99f-8967-4068-b1e2-49e1fe2298ff TCGA-86-8673-01A-11D-2393-08 TCGA-86-8673-01 +TCGA-86-8674-01 TCGA-86-8674-01 TCGA-86-8674 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 50 R-Middle TCGA-86-8674-F59096 TCGA-86-8674 TCGA-86-8674-01A -18479 0 806 Scheduled Follow-up Submission Complete Remission/Response 2014-4-30 MALE Lung Papillary Adenocarcinoma No C34.2 8260/3 C34.2 YES 1.5 NO Peripheral Lung 2.5 NO NO 37.5 No M0 N1 T2a Stage IIA TCGA-86-8674.463cd118-45ef-4e2f-aca3-39ce953dcb09.pdf 8674 TUMOR FREE Complete Remission/Response NO NO R0 Primary Tumor 01 0.5 2012 7th YES YES NO 86 4 Lung A LIVING 2012 1982 81be01d3-ad98-495f-910c-c33a7b100b53 TCGA-86-8674-01A-21D-2389-01 TCGA-86-8674-01A-21D-2398-05 TCGA-86-8674-01 TCGA-86-8674-01A-21D-2389-01 81be01d3-ad98-495f-910c-c33a7b100b53 TCGA-86-8674-01 81be01d3-ad98-495f-910c-c33a7b100b53 TCGA-86-8674-01 81be01d3-ad98-495f-910c-c33a7b100b53 TCGA-86-8674-01A-21D-2393-08 TCGA-86-8674-01 +TCGA-86-A456-01 TCGA-86-A456-01 TCGA-86-A456 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 78 L-Upper TCGA-86-A456-F67789 TCGA-86-A456 TCGA-86-A456-01A -28533 90 0 896 Scheduled Follow-up Submission Complete Remission/Response 2014-11-11 FEMALE Lung Papillary Adenocarcinoma No C34.1 8260/3 C34.1 YES 580 NO 80 Peripheral Lung NO NO true No M0 N0 T1a Stage IA TCGA-86-A456.56606792-5083-4F1E-ABEF-711BACF546E6.pdf A456 Post-Adjuvant Therapy TUMOR FREE Complete Remission/Response NO NO R0 Primary Tumor 01 2009 7th YES NO 86 4 Lung A LIVING 2012 1974 46749725-ef75-479b-9af9-1cb898682e1c TCGA-86-A456-01A-11D-A24C-01 TCGA-86-A456-01A-11D-A24I-05 TCGA-86-A456-01 TCGA-86-A456-01A-11D-A24C-01 46749725-ef75-479b-9af9-1cb898682e1c TCGA-86-A456-01 46749725-ef75-479b-9af9-1cb898682e1c TCGA-86-A456-01 A75F6121-F3AB-4794-923B-9F2B4AFA0395 46749725-ef75-479b-9af9-1cb898682e1c TCGA-86-A456-01A-11D-A24D-08 TCGA-86-A456-01 +TCGA-86-A4D0-01 TCGA-86-A4D0-01 TCGA-86-A4D0 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 48 R-Upper TCGA-86-A4D0-F52852 TCGA-86-A4D0 TCGA-86-A4D0-01A -17607 133 116 0 30 1 NO NO Scheduled Follow-up Submission Complete Remission/Response 2013-12-6 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 920 NO 90 NO NO NO true No M0 N0 T2b Stage IIA TCGA-86-A4D0.80C129A3-A5B6-4B1C-9979-44A307867744.pdf A4D0 Preoperative TUMOR FREE Complete Remission/Response NO NO R0 Primary Tumor 01 7th YES YES NO 86 2 Lung A DECEASED 2012 1983 ae82fe73-dc4c-403b-af98-1d01ad87e732 TCGA-86-A4D0-01A-11D-A24C-01 TCGA-86-A4D0-01A-11D-A24I-05 TCGA-86-A4D0-01 TCGA-86-A4D0-01A-11D-A24C-01 ae82fe73-dc4c-403b-af98-1d01ad87e732 TCGA-86-A4D0-01 ae82fe73-dc4c-403b-af98-1d01ad87e732 TCGA-86-A4D0-01 11425CD6-20A7-424C-8B84-C3BE4E5CA3A3 ae82fe73-dc4c-403b-af98-1d01ad87e732 TCGA-86-A4D0-01 +TCGA-86-A4JF-01 TCGA-86-A4JF-01 TCGA-86-A4JF TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 56 R-Upper TCGA-86-A4JF-F70857 TCGA-86-A4JF TCGA-86-A4JF-01A -20491 140 737 0 0 4 NO NO Scheduled Follow-up Submission Progressive Disease 2015-3-10 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 940 NO 20 NO Central Lung NO NO true No M0 N0 T3 Stage IIB TCGA-86-A4JF.5D7BD5E2-4575-4169-B07F-DBF4C2307A13.pdf A4JF Post-Adjuvant Therapy WITH TUMOR Complete Remission/Response NO NO R0 Primary Tumor 01 2012 7th YES YES NO 86 4 Lung A DECEASED 2012 b30fef8e-9736-4f6d-9547-cfd9163ebbb9 TCGA-86-A4JF-01A-11D-A24O-01 TCGA-86-A4JF-01A-11D-A24U-05 TCGA-86-A4JF-01 TCGA-86-A4JF-01A-11D-A24O-01 b30fef8e-9736-4f6d-9547-cfd9163ebbb9 TCGA-86-A4JF-01 b30fef8e-9736-4f6d-9547-cfd9163ebbb9 TCGA-86-A4JF-01 5F5878C1-9358-4021-8CAA-67BDED439B59 b30fef8e-9736-4f6d-9547-cfd9163ebbb9 TCGA-86-A4JF-01A-11D-A24P-08 TCGA-86-A4JF-01 +TCGA-86-A4P7-01 TCGA-86-A4P7-01 TCGA-86-A4P7 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 63 L-Lower TCGA-86-A4P7-F66092 TCGA-86-A4P7 TCGA-86-A4P7-01A -23330 220 0 415 0 NO NO Scheduled Follow-up Submission Complete Remission/Response 2014-10-2 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 350 NO 100 NO Peripheral Lung NO NO true No M0 N0 T2a Stage IB TCGA-86-A4P7.E6FEB175-8903-47D5-BBD4-3BF2E95C3B15.pdf A4P7 Other TUMOR FREE Complete Remission/Response NO NO R0 Primary Tumor 01 7th NO YES NO 86 1 Lung A LIVING 2012 3a401a11-c977-45b6-9900-87c6adb7dc09 TCGA-86-A4P7-01A-11D-A24O-01 TCGA-86-A4P7-01A-11D-A24U-05 TCGA-86-A4P7-01 TCGA-86-A4P7-01A-11D-A24O-01 3a401a11-c977-45b6-9900-87c6adb7dc09 TCGA-86-A4P7-01 3a401a11-c977-45b6-9900-87c6adb7dc09 TCGA-86-A4P7-01 6EC60F08-C9CA-41DA-A6F0-E40A02482619 3a401a11-c977-45b6-9900-87c6adb7dc09 TCGA-86-A4P7-01A-11D-A24P-08 TCGA-86-A4P7-01 +TCGA-86-A4P8-01 TCGA-86-A4P8-01 TCGA-86-A4P8 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 59 R-Lower TCGA-86-A4P8-F65331 TCGA-86-A4P8 TCGA-86-A4P8-01A -21738 98 0 805 85 0 YES FISH YES Scheduled Follow-up Submission Complete Remission/Response 2014-9-22 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 360 NO NO NO NO true No MX N2 T1b Stage IIIA TCGA-86-A4P8.72828D6C-9995-42E2-ABE7-D4BA29B8A987.pdf A4P8 Post-Adjuvant Therapy TUMOR FREE 78 89 74 84 Complete Remission/Response YES YES Primary Tumor 01 7th YES YES NO 86 1 Lung A LIVING 2012 fe82fe98-0116-4657-acb0-36b2093fb639 TCGA-86-A4P8-01A-11D-A24O-01 TCGA-86-A4P8-01A-11D-A24U-05 TCGA-86-A4P8-01 TCGA-86-A4P8-01A-11D-A24O-01 fe82fe98-0116-4657-acb0-36b2093fb639 TCGA-86-A4P8-01 fe82fe98-0116-4657-acb0-36b2093fb639 TCGA-86-A4P8-01 6796D8BC-0520-49A2-8650-782E9EC339CB fe82fe98-0116-4657-acb0-36b2093fb639 TCGA-86-A4P8-01A-11D-A24P-08 TCGA-86-A4P8-01 +TCGA-91-6828-01 none none none none Y Y none none none Magnoid none p.G12V none none none none none Acinar predominant Adc Acinar predominant Adc none 0 TCGA-91-6828-01 High C1-LUAD-enriched cluster 1 Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 6 cluster 1 mutation cluster 12 TCGA-91-6828 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 70 L-Lower TCGA-91-6828-F21014 TCGA-91-6828 TCGA-91-6828-01A -25870 0 323 71 2 Scheduled Follow-up Submission 2012-5-8 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 0.8 NO NO 1.5 NO No M0 N0 T1a Stage IA TCGA-91-6828.8b494f5f-5e6f-43bb-8748-0cb2d36eab37.pdf 6828 Preoperative TUMOR FREE 81 Complete Remission/Response YES NO R0 Primary Tumor 01 0.4 1993 7th NO YES NO 91 3 Current reformed smoker for > 15 years Lung A LIVING 2011 TCGA-91-6828-01A-11D-1855-08 TCGA-91-6828-01A-11D-1855-08 e3958992-3206-4cdd-8bc9-38fd43853800 TCGA-91-6828-01A-11D-1854-01 TCGA-91-6828-01A-11D-1856-05 TCGA-91-6828-01 TCGA-91-6828-01A-11D-1854-01 e3958992-3206-4cdd-8bc9-38fd43853800 TCGA-91-6828-01 TCGA-91-6828-01A-13-2191-20 e3958992-3206-4cdd-8bc9-38fd43853800 TCGA-91-6828-01 868a423e-7b37-44b0-af6a-7331066e88d3 e3958992-3206-4cdd-8bc9-38fd43853800 TCGA-91-6828-01A-11D-1855-08 TCGA-91-6828-01 +TCGA-91-6828-11 none none none none Y Y none none none Magnoid none p.G12V none none none none none Acinar predominant Adc Acinar predominant Adc none 0 TCGA-91-6828-11 C1-LUAD-enriched mutation cluster 12 TCGA-91-6828 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 70 L-Lower TCGA-91-6828-F21014 TCGA-91-6828 TCGA-91-6828-11A -25870 0 323 71 2 Scheduled Follow-up Submission 2012-5-8 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 0.9 NO NO 1.4 NO No M0 N0 T1a Stage IA 6828 Preoperative TUMOR FREE 81 Complete Remission/Response YES NO R0 Solid Tissue Normal 11 0.3 1993 7th NO YES NO 91 3 Current reformed smoker for > 15 years Lung A LIVING 2011 e7e90370-f414-4668-910c-c556613be671 e7e90370-f414-4668-910c-c556613be671 e7e90370-f414-4668-910c-c556613be671 e7e90370-f414-4668-910c-c556613be671 +TCGA-91-6829-01 2.78 0.48 none none none none N N none none none 0.2 Squamoid none none none none none none none Acinar predominant Adc Acinar predominant Adc none 0 TCGA-91-6829-01 High C1-LUAD-enriched cluster 2 Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 5 cluster 3 mutation cluster 8 TCGA-91-6829 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 78 R-Lower TCGA-91-6829-F32591 TCGA-91-6829 TCGA-91-6829-01A -28841 1258 0 3 Scheduled Follow-up Submission Progressive Disease 2012-6-4 MALE Lung Bronchioloalveolar Carcinoma Nonmucinous No C34.3 8252/3 C34.3 YES 0.5 NO 0 NO 0.9 NO NO 94.5 No MX N0 T2 Stage IB TCGA-91-6829.d21d20d3-a384-417a-aa95-11f4b6930af0.pdf 6829 Other TUMOR FREE Progressive Disease NO R0 Primary Tumor 01 0.4 2003 5th NO NO YES 91 4 Current reformed smoker for < or = 15 years Lung A DECEASED 2001 1940 TCGA-91-6829-01A-21D-1855-08 TCGA-91-6829-01A-21D-1855-08 b4e31dbe-0923-401e-a664-e779914254b8 TCGA-91-6829-01A-21D-1854-01 TCGA-91-6829-01A-21D-1856-05 TCGA-91-6829-01 TCGA-91-6829-01A-21D-1854-01 b4e31dbe-0923-401e-a664-e779914254b8 TCGA-91-6829-01 TCGA-91-6829-01A-23-2191-20 b4e31dbe-0923-401e-a664-e779914254b8 TCGA-91-6829-01 36a9dbe9-dfd6-41d7-9f76-04dcf1c93755 b4e31dbe-0923-401e-a664-e779914254b8 TCGA-91-6829-01A-21D-1855-08 TCGA-91-6829-01 +TCGA-91-6829-11 2.78 0.48 none none none none N N none none none 0.2 Squamoid none none none none none none none Acinar predominant Adc Acinar predominant Adc none 0 TCGA-91-6829-11 C1-LUAD-enriched mutation cluster 8 TCGA-91-6829 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 78 R-Lower TCGA-91-6829-F32591 TCGA-91-6829 TCGA-91-6829-11A -28841 1258 0 3 Scheduled Follow-up Submission Progressive Disease 2012-6-4 MALE Lung Bronchioloalveolar Carcinoma Nonmucinous No C34.3 8252/3 C34.3 YES 0.8 NO 0 NO 1.1 NO NO 94.5 No MX N0 T2 Stage IB 6829 Other TUMOR FREE Progressive Disease NO R0 Solid Tissue Normal 11 0.4 2003 5th NO NO YES 91 4 Current reformed smoker for < or = 15 years Lung A DECEASED 2001 1940 d3b983d1-2665-4cdd-893e-4f120dc43346 d3b983d1-2665-4cdd-893e-4f120dc43346 d3b983d1-2665-4cdd-893e-4f120dc43346 d3b983d1-2665-4cdd-893e-4f120dc43346 +TCGA-91-6830-01 TCGA-91-6830-01 Squamous C1-LUAD-enriched Low purity c2 squamous c3 LUAD-like c10 miRNA c1uster 9 TCGA-91-6830 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung NO YES YES 65 L-Upper TCGA-91-6830-F32595 TCGA-91-6830 18 -23922 0 60 18 Scheduled Follow-up Submission 2012-6-4 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES NO YES Distant Metastasis YES 12 No MX N1 T1 Stage IIA 6830 WITH TUMOR Biopsy with Histologic Confirmation NO Primary Tumor 01 2002 5th NO NO YES 91 4 Lung LIVING 2002 1990 f61ba831-745d-468c-a3b0-0229000926f5 TCGA-91-6830-01A-11D-1943-01 TCGA-91-6830-01A-11D-1947-05 TCGA-91-6830-01 TCGA-91-6830-01A-11D-1943-01 f61ba831-745d-468c-a3b0-0229000926f5 TCGA-91-6830-01 TCGA-91-6830-01A-13-2191-20 f61ba831-745d-468c-a3b0-0229000926f5 TCGA-91-6830-01 a05658f0-5ddb-449d-b36a-383e17b9b95b f61ba831-745d-468c-a3b0-0229000926f5 TCGA-91-6830-01A-11D-1945-08 TCGA-91-6830-01 +TCGA-91-6831-01 TCGA-91-6831-01 High C1-LUAD-enriched Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 4 mutation cluster 2 TCGA-91-6831 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 66 R-Middle TCGA-91-6831-F32636 TCGA-91-6831 TCGA-91-6831-01A -24436 0 310 Scheduled Follow-up Submission Complete Remission/Response 2012-6-5 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.2 8140/3 C34.2 YES 0.6 NO NO 0.6 YES NO No MX N0 T2 Stage IB TCGA-91-6831.21f30ab4-751e-4ef5-bffa-75d5086ea1cb.pdf 6831 TUMOR FREE Complete Remission/Response NO NO Primary Tumor 01 0.4 5th NO NO YES 91 2 Lung A LIVING 2001 TCGA-91-6831-01A-11D-1855-08 860fa33f-75d9-480d-92e7-2a5a45b35433 TCGA-91-6831-01A-11D-1854-01 TCGA-91-6831-01A-11D-1856-05 TCGA-91-6831-01 TCGA-91-6831-01A-11D-1854-01 860fa33f-75d9-480d-92e7-2a5a45b35433 TCGA-91-6831-01 TCGA-91-6831-01A-13-2191-20 860fa33f-75d9-480d-92e7-2a5a45b35433 TCGA-91-6831-01 71cf2558-e5c1-4a83-bdec-6c3d8b3de2c1 860fa33f-75d9-480d-92e7-2a5a45b35433 TCGA-91-6831-01A-11D-1855-08 TCGA-91-6831-01 +TCGA-91-6831-11 TCGA-91-6831-11 C1-LUAD-enriched mutation cluster 2 TCGA-91-6831 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 66 R-Middle TCGA-91-6831-F32636 TCGA-91-6831 TCGA-91-6831-11A -24436 0 310 Scheduled Follow-up Submission Complete Remission/Response 2012-6-5 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.2 8140/3 C34.2 YES 0.6 NO NO 1.3 YES NO No MX N0 T2 Stage IB 6831 TUMOR FREE Complete Remission/Response NO NO Solid Tissue Normal 11 0.4 5th NO NO YES 91 2 Lung A LIVING 2001 292dfcd4-8c49-4348-9622-87b52f593ac3 292dfcd4-8c49-4348-9622-87b52f593ac3 292dfcd4-8c49-4348-9622-87b52f593ac3 292dfcd4-8c49-4348-9622-87b52f593ac3 +TCGA-91-6835-01 none none none none Y Y p.L858R none none Squamoid none none none none none none none Solid predominant Adc Solid predominant Adc none 0 TCGA-91-6835-01 High C1-LUAD-enriched cluster 3 Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 4 cluster 2 mutation cluster 14 TCGA-91-6835 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 81 R-Lower TCGA-91-6835-F32643 TCGA-91-6835 TCGA-91-6835-01A -29887 0 79 78 NO Scheduled Follow-up Submission Complete Remission/Response 2012-6-5 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 0.5 NO NO 1.1 YES NO 25 No M0 N0 T1 Stage IA TCGA-91-6835.bb4510c1-addd-42a3-9439-dfc7e43078d3.pdf 6835 TUMOR FREE 91 75 Complete Remission/Response YES NO R0 Primary Tumor 01 0.4 1976 7th NO NO YES 91 3 Current reformed smoker for > 15 years Lung A LIVING 2010 TCGA-91-6835-01A-11D-1855-08 TCGA-91-6835-01A-11D-1855-08 4502921a-1650-4721-b814-c9435fe6042d TCGA-91-6835-01A-11D-1854-01 TCGA-91-6835-01A-11D-1856-05 TCGA-91-6835-01 TCGA-91-6835-01A-11D-1854-01 4502921a-1650-4721-b814-c9435fe6042d TCGA-91-6835-01 TCGA-91-6835-01A-13-2191-20 4502921a-1650-4721-b814-c9435fe6042d TCGA-91-6835-01 9fc7b7be-5f60-4b40-adc9-b54df34d01cd 4502921a-1650-4721-b814-c9435fe6042d TCGA-91-6835-01A-11D-1855-08 TCGA-91-6835-01 +TCGA-91-6835-11 none none none none Y Y p.L858R none none Squamoid none none none none none none none Solid predominant Adc Solid predominant Adc none 0 TCGA-91-6835-11 C1-LUAD-enriched mutation cluster 14 TCGA-91-6835 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 81 R-Lower TCGA-91-6835-F32643 TCGA-91-6835 TCGA-91-6835-11A -29887 0 79 78 NO Scheduled Follow-up Submission Complete Remission/Response 2012-6-5 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 0.5 NO NO 1.5 YES NO 25 No M0 N0 T1 Stage IA 6835 TUMOR FREE 91 75 Complete Remission/Response YES NO R0 Solid Tissue Normal 11 0.4 1976 7th NO NO YES 91 3 Current reformed smoker for > 15 years Lung A LIVING 2010 183b2543-2665-403a-a8c0-7ae668082f2d 183b2543-2665-403a-a8c0-7ae668082f2d TCGA-91-6835-11 183b2543-2665-403a-a8c0-7ae668082f2d 183b2543-2665-403a-a8c0-7ae668082f2d TCGA-91-6835-11 +TCGA-91-6836-01 TCGA-91-6836-01 High C1-LUAD-enriched Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 4 mutation cluster 11 TCGA-91-6836 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 52 R-Upper TCGA-91-6836-F32646 TCGA-91-6836 TCGA-91-6836-01A -19216 0 417 97 NO Scheduled Follow-up Submission Complete Remission/Response 2012-6-5 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.6 NO NO 0.9 NO NO 50 Yes MX N0 T2 Stage IB TCGA-91-6836.89441c7c-1e09-4b73-8cc3-27cba26f3bd3.pdf 6836 TUMOR FREE 101 109 108 Complete Remission/Response YES NO Primary Tumor 01 0.4 7th NO NO YES 91 2 Lung A LIVING 2010 1973 TCGA-91-6836-01A-21D-1855-08 8ccc7a37-a9a4-4d77-9126-c8513c20bb29 TCGA-91-6836-01A-21D-1854-01 TCGA-91-6836-01A-21D-1856-05 TCGA-91-6836-01 TCGA-91-6836-01A-21D-1854-01 8ccc7a37-a9a4-4d77-9126-c8513c20bb29 TCGA-91-6836-01 TCGA-91-6836-01A-23-2191-20 8ccc7a37-a9a4-4d77-9126-c8513c20bb29 TCGA-91-6836-01 8534a1e1-144d-4978-b452-dffe629915fa 8ccc7a37-a9a4-4d77-9126-c8513c20bb29 TCGA-91-6836-01A-21D-1855-08 TCGA-91-6836-01 +TCGA-91-6836-11 TCGA-91-6836-11 C1-LUAD-enriched mutation cluster 11 TCGA-91-6836 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 52 R-Upper TCGA-91-6836-F32646 TCGA-91-6836 -19216 0 417 97 NO Scheduled Follow-up Submission Complete Remission/Response 2012-6-5 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES NO NO NO 50 Yes MX N0 T2 Stage IB 6836 TUMOR FREE 101 109 108 Complete Remission/Response YES NO Solid Tissue Normal 11 7th NO NO YES 91 2 Lung LIVING 2010 1973 de68950c-3885-4bfe-b23e-2d218787ca15 de68950c-3885-4bfe-b23e-2d218787ca15 TCGA-91-6836-11 de68950c-3885-4bfe-b23e-2d218787ca15 de68950c-3885-4bfe-b23e-2d218787ca15 TCGA-91-6836-11 +TCGA-91-6840-01 2.83 0.62 none none none none N N none none none 0.25 Magnoid none none none none none none none Solid predominant Adc Solid predominant Adc none 0 TCGA-91-6840-01 High C1-LUAD-enriched cluster 3 Low purity c2 squamous c3 LUAD-like c10 miRNA cluster 2 cluster 5 TCGA-91-6840 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 59 R-Upper TCGA-91-6840-F21664 TCGA-91-6840 TCGA-91-6840-01A -21854 0 372 Scheduled Follow-up Submission 2012-5-8 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.5 NO NO 0.7 NO 50 No M0 N0 T1b Stage IA TCGA-91-6840.2f5322c3-f57f-4252-8e17-e5a964e81793.pdf 6840 TUMOR FREE Complete Remission/Response NO NO R0 Primary Tumor 01 0.4 1996 7th NO YES NO 91 3 Current reformed smoker for > 15 years Lung A LIVING 2011 1971 TCGA-91-6840-01A-11D-1945-08 64f425a9-2260-4cd3-8ddd-c43ac410b1a4 TCGA-91-6840-01A-11D-1943-01 TCGA-91-6840-01A-11D-1947-05 TCGA-91-6840-01 TCGA-91-6840-01A-11D-1943-01 64f425a9-2260-4cd3-8ddd-c43ac410b1a4 TCGA-91-6840-01 TCGA-91-6840-01A-13-2191-20 64f425a9-2260-4cd3-8ddd-c43ac410b1a4 TCGA-91-6840-01 461b2f41-f117-4d06-93b3-5654fb4af5fa 64f425a9-2260-4cd3-8ddd-c43ac410b1a4 TCGA-91-6840-01A-11D-1945-08 TCGA-91-6840-01 +TCGA-91-6847-01 3.86 0.86 none none none none Y Y p.L861Q none none 0.24 Squamoid none none none p.Y321H none none none Acinar predominant Adc Acinar predominant Adc none 0 TCGA-91-6847-01 BRCA-LUAD+ C1-LUAD-enriched cluster 2 Cluster 6 squamous c3 RNA cluster 14 miRNA cluster 12 cluster 5 TCGA-91-6847 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung NO YES NO 62 R-Lower TCGA-91-6847-F32637 TCGA-91-6847 TCGA-91-6847-01A -22862 0 842 772 Scheduled Follow-up Submission Stable Disease 2012-6-5 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 0.4 NO NO 1.1 YES Distant Metastasis YES No MX N0 T2 Stage IB TCGA-91-6847.4e40d97c-ca3c-41ec-b5c5-eb2f85ee29b3.pdf 6847 WITH TUMOR Progressive Disease Convincing Imaging YES Primary Tumor 01 0.3 1967 5th NO NO YES 91 3 Current reformed smoker for > 15 years Lung A LIVING 2002 TCGA-91-6847-01A-11D-1945-08 0c96bb0f-11f1-421c-b2c5-55458ba95d97 TCGA-91-6847-01A-11D-1943-01 TCGA-91-6847-01A-11D-1947-05 TCGA-91-6847-01 TCGA-91-6847-01A-11D-1943-01 0c96bb0f-11f1-421c-b2c5-55458ba95d97 TCGA-91-6847-01 TCGA-91-6847-01A-13-2191-20 0c96bb0f-11f1-421c-b2c5-55458ba95d97 TCGA-91-6847-01 c9e583e9-c014-4508-acdc-11a8b46c6034 0c96bb0f-11f1-421c-b2c5-55458ba95d97 TCGA-91-6847-01A-11D-1945-08 TCGA-91-6847-01 +TCGA-91-6847-11 3.86 0.86 none none none none Y Y p.L861Q none none 0.24 Squamoid none none none p.Y321H none none none Acinar predominant Adc Acinar predominant Adc none 0 TCGA-91-6847-11 C1-LUAD-enriched TCGA-91-6847 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung NO YES NO 62 R-Lower TCGA-91-6847-F32637 TCGA-91-6847 TCGA-91-6847-11A -22862 0 842 772 Scheduled Follow-up Submission Stable Disease 2012-6-5 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 0.5 NO NO 1.2 YES Distant Metastasis YES No MX N0 T2 Stage IB 6847 WITH TUMOR Progressive Disease Convincing Imaging YES Solid Tissue Normal 11 0.3 1967 5th NO NO YES 91 3 Current reformed smoker for > 15 years Lung A LIVING 2002 32f582db-018c-4134-9998-79138bf301f2 32f582db-018c-4134-9998-79138bf301f2 32f582db-018c-4134-9998-79138bf301f2 32f582db-018c-4134-9998-79138bf301f2 +TCGA-91-6848-01 TCGA-91-6848-01 BRCA-LUAD+ C12-small-various BRCA CIMP c7 squamous c3 RNA cluster 2 miRNA c1uster 9 TCGA-91-6848 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 59 L-Upper TCGA-91-6848-F32641 TCGA-91-6848 TCGA-91-6848-01A -21829 0 224 Scheduled Follow-up Submission Complete Remission/Response 2012-6-5 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.8 NO YES NO 1.1 YES NO No MX N2 T2 Stage IIIA TCGA-91-6848.a790e051-b741-4913-aff6-5a48c9e8e8cd.pdf 6848 TUMOR FREE Complete Remission/Response NO Primary Tumor 01 0.6 2007 6th YES NO YES 91 4 Lung A LIVING 2009 0cfbefba-24ff-474b-8bfa-b44a1f71b48c TCGA-91-6848-01A-11D-1943-01 TCGA-91-6848-01A-11D-1947-05 TCGA-91-6848-01 TCGA-91-6848-01A-11D-1943-01 0cfbefba-24ff-474b-8bfa-b44a1f71b48c TCGA-91-6848-01 TCGA-91-6848-01A-13-2191-20 0cfbefba-24ff-474b-8bfa-b44a1f71b48c TCGA-91-6848-01 46b0370f-a666-4cce-a746-8701a344a36e 0cfbefba-24ff-474b-8bfa-b44a1f71b48c TCGA-91-6848-01A-11D-1945-08 TCGA-91-6848-01 +TCGA-91-6849-01 1.93 0.6 none none none none Y Y none none p.G240* 0.31 Bronchioid none p.G12C none none none none none Acinar predominant Adc Acinar predominant Adc p.G288_splice 0 TCGA-91-6849-01 BRCA-LUAD+ C1-LUAD-enriched cluster 2 Cluster 6 squamous c3 LUAD-like c10 miRNA c1uster 9 cluster 4 TCGA-91-6849 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 75 L-Upper TCGA-91-6849-F32642 TCGA-91-6849 TCGA-91-6849-01A -27676 0 35 66 YES Scheduled Follow-up Submission 2012-6-5 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.5 NO 90 NO 1.5 YES 30 No MX N2 T2 Stage IIIA TCGA-91-6849.910d922e-8180-48ba-9e13-0f177dc71b2d.pdf 6849 Preoperative 75 86 76 88 YES Primary Tumor 01 0.4 1976 6th NO YES 91 3 Current reformed smoker for > 15 years Lung A LIVING 2009 1946 TCGA-91-6849-01A-11D-1945-08 821a5315-e4a2-4005-b5fc-572b32a2386a TCGA-91-6849-01A-11D-1943-01 TCGA-91-6849-01A-11D-1947-05 TCGA-91-6849-01 TCGA-91-6849-01A-11D-1943-01 821a5315-e4a2-4005-b5fc-572b32a2386a TCGA-91-6849-01 TCGA-91-6849-01A-13-2191-20 821a5315-e4a2-4005-b5fc-572b32a2386a TCGA-91-6849-01 0f7b0379-6a78-482e-909f-c85766abcb9d 821a5315-e4a2-4005-b5fc-572b32a2386a TCGA-91-6849-01A-11D-1945-08 TCGA-91-6849-01 +TCGA-91-6849-11 1.93 0.6 none none none none Y Y none none p.G240* 0.31 Bronchioid none p.G12C none none none none none Acinar predominant Adc Acinar predominant Adc p.G288_splice 0 TCGA-91-6849-11 C1-LUAD-enriched TCGA-91-6849 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 75 L-Upper TCGA-91-6849-F32642 TCGA-91-6849 TCGA-91-6849-11A -27676 0 35 66 YES Scheduled Follow-up Submission 2012-6-5 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.6 NO 90 NO 0.7 YES 30 No MX N2 T2 Stage IIIA 6849 Preoperative 75 86 76 88 YES Solid Tissue Normal 11 0.6 1976 6th NO YES 91 3 Current reformed smoker for > 15 years Lung A LIVING 2009 1946 9aec6b23-f6a0-4400-b72c-d7c3d16293f4 9aec6b23-f6a0-4400-b72c-d7c3d16293f4 9aec6b23-f6a0-4400-b72c-d7c3d16293f4 9aec6b23-f6a0-4400-b72c-d7c3d16293f4 +TCGA-91-7771-01 none none none none N N none none p.R47G Bronchioid none none none none none none none Solid predominant Adc Solid predominant Adc none 0 TCGA-91-7771-01 High C1-LUAD-enriched cluster 2 Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 5 cluster 3 TCGA-91-7771 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 62 R-Upper TCGA-91-7771-F37916 TCGA-91-7771 TCGA-91-7771-01A -22926 0 492 NO Scheduled Follow-up Submission Complete Remission/Response 2012-12-6 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.9 NO NO 3 NO NO 75 Yes MX N0 T3 Stage IIB TCGA-91-7771.a8247167-a991-441b-b60a-9f69f4c5d9da.pdf 7771 TUMOR FREE Complete Remission/Response NO NO Primary Tumor 01 0.6 2011 7th YES YES NO 91 4 Current reformed smoker for < or = 15 years Lung A LIVING 2011 TCGA-91-7771-01A-11D-2167-08 6f2e3098-e76b-411f-9d8e-cd8594ed1175 TCGA-91-7771-01A-11D-2166-01 TCGA-91-7771-01A-11D-2168-05 TCGA-91-7771-01 TCGA-91-7771-01A-11D-2166-01 6f2e3098-e76b-411f-9d8e-cd8594ed1175 TCGA-91-7771-01 TCGA-91-7771-01A-13-2192-20 6f2e3098-e76b-411f-9d8e-cd8594ed1175 TCGA-91-7771-01 6a99d37c-55d6-4316-9280-f852f974a786 6f2e3098-e76b-411f-9d8e-cd8594ed1175 TCGA-91-7771-01A-11D-2167-08 TCGA-91-7771-01 +TCGA-91-8496-01 TCGA-91-8496-01 TCGA-91-8496 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 63 L-Lower TCGA-91-8496-F45467 TCGA-91-8496 TCGA-91-8496-01A -23358 0 505 0 NO NO Scheduled Follow-up Submission Complete Remission/Response 2013-7-15 FEMALE Lung Bronchioloalveolar Carcinoma Nonmucinous No C34.3 8252/3 C34.3 YES 0.4 NO NO 2 NO NO No MX NX T2a Stage IB TCGA-91-8496.d513e826-62f5-4e2d-95ef-7b48fea0643a.pdf 8496 Preoperative TUMOR FREE Complete Remission/Response NO NO Primary Tumor 01 0.3 7th NO YES NO 91 1 Lung A LIVING 2011 0a85f2bd-d169-44e4-bde3-c92ff92ddc94 TCGA-91-8496-01A-11D-2389-01 TCGA-91-8496-01A-11D-2398-05 TCGA-91-8496-01 TCGA-91-8496-01A-11D-2389-01 0a85f2bd-d169-44e4-bde3-c92ff92ddc94 TCGA-91-8496-01 0a85f2bd-d169-44e4-bde3-c92ff92ddc94 TCGA-91-8496-01 DBDBC88F-6B74-4A76-B4F5-2307572A8633 0a85f2bd-d169-44e4-bde3-c92ff92ddc94 TCGA-91-8496-01A-11D-2393-08 TCGA-91-8496-01 +TCGA-91-8497-01 TCGA-91-8497-01 TCGA-91-8497 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 75 R-Upper TCGA-91-8497-F58334 TCGA-91-8497 TCGA-91-8497-01A -27632 434 0 174 Scheduled Follow-up Submission Complete Remission/Response 2014-4-7 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.7 NO NO 1.8 NO NO No MX N0 T1a Stage IA TCGA-91-8497.e393a314-6d4d-41f4-a9d3-7d67ab25713b.pdf 8497 TUMOR FREE Complete Remission/Response NO NO Primary Tumor 01 0.4 7th NO YES NO 91 1 Lung A DECEASED 2012 f5c78889-7c7f-4b88-8660-6560b49b7be4 TCGA-91-8497-01A-11D-2389-01 TCGA-91-8497-01A-11D-2398-05 TCGA-91-8497-01 TCGA-91-8497-01A-11D-2389-01 f5c78889-7c7f-4b88-8660-6560b49b7be4 TCGA-91-8497-01 f5c78889-7c7f-4b88-8660-6560b49b7be4 TCGA-91-8497-01 DE5D87CD-E176-49F0-8401-CF364136CEF5 f5c78889-7c7f-4b88-8660-6560b49b7be4 TCGA-91-8497-01A-11D-2393-08 TCGA-91-8497-01 +TCGA-91-8499-01 TCGA-91-8499-01 TCGA-91-8499 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 76 L-Lower TCGA-91-8499-F37976 TCGA-91-8499 TCGA-91-8499-01A -27853 0 36 YES Scheduled Follow-up Submission 2012-12-7 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 0.6 NO NO 1.2 YES NO 90 No MX N0 T1b Stage IA TCGA-91-8499.99ab423d-db99-4ef1-bf1f-a8dddb94e788.pdf 8499 49 YES NO Primary Tumor 01 0.4 7th NO YES NO 91 2 Lung A LIVING 2011 1945 9cf68c53-c1a5-4102-aeba-a2083335954e TCGA-91-8499-01A-11D-2389-01 TCGA-91-8499-01A-11D-2398-05 TCGA-91-8499-01 TCGA-91-8499-01A-11D-2389-01 9cf68c53-c1a5-4102-aeba-a2083335954e TCGA-91-8499-01 9cf68c53-c1a5-4102-aeba-a2083335954e TCGA-91-8499-01 552D8E51-111D-471C-90B4-3E6E9B1D1BFE 9cf68c53-c1a5-4102-aeba-a2083335954e TCGA-91-8499-01A-11D-2393-08 TCGA-91-8499-01 +TCGA-91-A4BC-01 TCGA-91-A4BC-01 TCGA-91-A4BC TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 59 R-Upper TCGA-91-A4BC-F45192 TCGA-91-A4BC TCGA-91-A4BC-01A -21565 225 0 44 44 NO Scheduled Follow-up Submission 2013-7-10 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 280 NO NO YES 30 false Yes, History of Synchronous/Bilateral Malignancy MX N0 T2b Stage IIA TCGA-91-A4BC.6C586925-8FAC-4A75-8A67-574B24B9D0BA.pdf A4BC 69 YES Primary Tumor 01 2001 7th YES NO 91 4 Lung A LIVING 2012 1976 439820e6-1011-461e-8002-5af1470a7827 TCGA-91-A4BC-01A-11D-A24C-01 TCGA-91-A4BC-01A-11D-A24I-05 TCGA-91-A4BC-01 TCGA-91-A4BC-01A-11D-A24C-01 439820e6-1011-461e-8002-5af1470a7827 TCGA-91-A4BC-01 439820e6-1011-461e-8002-5af1470a7827 TCGA-91-A4BC-01 333255BF-9870-4B6A-999B-6B7AD02954DD 439820e6-1011-461e-8002-5af1470a7827 TCGA-91-A4BC-01A-11D-A24D-08 TCGA-91-A4BC-01 +TCGA-91-A4BD-01 TCGA-91-A4BD-01 TCGA-91-A4BD TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 78 L-Lower TCGA-91-A4BD-F58335 TCGA-91-A4BD TCGA-91-A4BD-01A -28544 162 0 603 94 1 NO Scheduled Follow-up Submission Complete Remission/Response 2014-4-7 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 220 NO NO NO NO false No MX N1 T1b Stage IIA TCGA-91-A4BD.5767AA19-6B73-4FC8-BC3E-930044E249A3.pdf A4BD Other TUMOR FREE 70 92 Complete Remission/Response YES NO RX Primary Tumor 01 1981 7th NO YES NO 91 3 Lung A LIVING 2012 883fcc6f-4ef3-4c93-872a-a096b87bd85b TCGA-91-A4BD-01A-11D-A24C-01 TCGA-91-A4BD-01A-11D-A24I-05 TCGA-91-A4BD-01 TCGA-91-A4BD-01A-11D-A24C-01 883fcc6f-4ef3-4c93-872a-a096b87bd85b TCGA-91-A4BD-01 883fcc6f-4ef3-4c93-872a-a096b87bd85b TCGA-91-A4BD-01 0AB8A055-9D78-4772-8086-652384CBEE0D 883fcc6f-4ef3-4c93-872a-a096b87bd85b TCGA-91-A4BD-01A-11D-A24D-08 TCGA-91-A4BD-01 +TCGA-93-7347-01 none none none none Y Y none none none Bronchioid none p.G12C none none none none none Acinar predominant Adc Acinar predominant Adc none 0 TCGA-93-7347-01 Kirc+ cluster 3 Cluster 5 LUAD-like c10 miRNA cluster 4 cluster 4 TCGA-93-7347 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 76 R-Upper TCGA-93-7347-F43155 TCGA-93-7347 TCGA-93-7347-01A -27949 0 683 70 NO NO Scheduled Follow-up Submission 2013-5-14 FEMALE Lung Adenocarcinoma Mixed Subtype No C34.1 8255/3 C34.1 YES 1 NO NO Central Lung 1 NO NO 11 No MX N0 T1a Stage IA TCGA-93-7347.a89ef8ab-8af7-4906-844e-eb216316f584.pdf 7347 TUMOR FREE 61 84 62 84 Complete Remission/Response YES NO R0 Primary Tumor 01 0.2 1967 7th NO YES NO 93 3 Current reformed smoker for > 15 years Lung A LIVING 2011 1952 TCGA-93-7347-01A-11D-2184-08 2cb8a95d-20c3-4623-9b4d-b06b2a494b18 TCGA-93-7347-01A-11D-2183-01 TCGA-93-7347-01A-11D-2185-05 TCGA-93-7347-01 TCGA-93-7347-01A-11D-2183-01 2cb8a95d-20c3-4623-9b4d-b06b2a494b18 TCGA-93-7347-01 2cb8a95d-20c3-4623-9b4d-b06b2a494b18 TCGA-93-7347-01 2cb8a95d-20c3-4623-9b4d-b06b2a494b18 TCGA-93-7347-01A-11D-2184-08 TCGA-93-7347-01 +TCGA-93-7348-01 1.76 0.35 none none none none N N none none none 0.18 Bronchioid none none none p.D1010_splice none p.E542K none Acinar predominant Adc Acinar predominant Adc none 0 TCGA-93-7348-01 BRCA-LUAD+ C1-LUAD-enriched cluster 3 Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 5 cluster 3 TCGA-93-7348 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 75 R-Upper TCGA-93-7348-F43154 TCGA-93-7348 TCGA-93-7348-01A -27456 0 531 0 NO NO Scheduled Follow-up Submission 2013-5-14 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 1.2 NO 100 NO Central Lung 1.5 NO NO 42 No MX N0 T1a Stage IA TCGA-93-7348.2ad907ad-1005-4e89-91b8-d09a173bcd4d.pdf 7348 Preoperative TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 0.4 1999 7th NO YES NO 93 4 Current reformed smoker for < or = 15 years Lung A LIVING 2011 1957 TCGA-93-7348-01A-21D-2036-08 6d1614e8-67cb-4551-a447-ae3b94990d70 TCGA-93-7348-01A-21D-2035-01 TCGA-93-7348-01A-21D-2037-05 TCGA-93-7348-01 TCGA-93-7348-01A-21D-2035-01 6d1614e8-67cb-4551-a447-ae3b94990d70 TCGA-93-7348-01 TCGA-93-7348-01A-23-2192-20 6d1614e8-67cb-4551-a447-ae3b94990d70 TCGA-93-7348-01 048615c7-c08c-4199-b394-c59160337d67 6d1614e8-67cb-4551-a447-ae3b94990d70 TCGA-93-7348-01A-21D-2036-08 TCGA-93-7348-01 +TCGA-93-7348-11 1.76 0.35 none none none none N N none none none 0.18 Bronchioid none none none p.D1010_splice none p.E542K none Acinar predominant Adc Acinar predominant Adc none 0 TCGA-93-7348-11 C1-LUAD-enriched TCGA-93-7348 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 75 R-Upper TCGA-93-7348-F43154 TCGA-93-7348 -27456 0 531 0 NO NO Scheduled Follow-up Submission 2013-5-14 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 100 NO Central Lung NO NO 42 No MX N0 T1a Stage IA 7348 Preoperative TUMOR FREE Complete Remission/Response NO R0 Solid Tissue Normal 11 1999 7th NO YES NO 93 4 Current reformed smoker for < or = 15 years Lung LIVING 2011 1957 TCGA-93-7348-11 TCGA-93-7348-11 +TCGA-93-8067-01 TCGA-93-8067-01 High Cluster 6 LUAD-like c10 miRNA c1uster 9 TCGA-93-8067 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 77 L-Lower TCGA-93-8067-F32193 TCGA-93-8067 -28453 0 186 47 2 NO NO Scheduled Follow-up Submission Complete Remission/Response 2012-5-18 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 80 NO Peripheral Lung NO NO 20 Yes, History of Prior Malignancy MX N0 T2a Stage IB 8067 Preoperative TUMOR FREE 94 103 89 94 Complete Remission/Response YES NO RX FFPE Scrolls 01 2001 7th NO YES NO 93 4 Lung LIVING 2011 1961 bf359688-8652-4266-b4fd-e2f8f2782a97 TCGA-93-8067-01A-11D-2283-01 TCGA-93-8067-01A-11D-2285-05 TCGA-93-8067-01 TCGA-93-8067-01A-11D-2283-01 bf359688-8652-4266-b4fd-e2f8f2782a97 TCGA-93-8067-01 bf359688-8652-4266-b4fd-e2f8f2782a97 TCGA-93-8067-01 bf359688-8652-4266-b4fd-e2f8f2782a97 TCGA-93-8067-01A-11D-2284-08 TCGA-93-8067-01 +TCGA-93-A4JN-01 TCGA-93-A4JN-01 TCGA-93-A4JN TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 71 L-Upper TCGA-93-A4JN-F56980 TCGA-93-A4JN TCGA-93-A4JN-01A -26273 209 0 718 1 YES FISH YES Scheduled Follow-up Submission Stable Disease 2014-2-27 MALE Lung Acinar Adenocarcinoma No C34.1 8550/3 C34.1 YES 330 NO 90 YES NO NO NO 40 true No M1a N0 T2a Stage IV TCGA-93-A4JN.BA9DB454-6107-4F98-8646-89129230D602.pdf A4JN Preoperative WITH TUMOR Stable Disease NO NO RX Primary Tumor 01 1991 7th YES YES NO 93 3 Lung A LIVING 2012 1971 b31f6ff5-bd06-43d7-966e-426b787222e8 TCGA-93-A4JN-01A-11D-A24O-01 TCGA-93-A4JN-01A-11D-A24U-05 TCGA-93-A4JN-01 TCGA-93-A4JN-01A-11D-A24O-01 b31f6ff5-bd06-43d7-966e-426b787222e8 TCGA-93-A4JN-01 b31f6ff5-bd06-43d7-966e-426b787222e8 TCGA-93-A4JN-01 ACA6A642-9885-4013-BB03-09ABD1DF957E b31f6ff5-bd06-43d7-966e-426b787222e8 TCGA-93-A4JN-01A-11D-A24P-08 TCGA-93-A4JN-01 +TCGA-93-A4JO-01 TCGA-93-A4JO-01 TCGA-93-A4JO TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 70 R-Lower TCGA-93-A4JO TCGA-93-A4JO-01A -25898 230 33 0 81 1 NO NO 2014-2-27 MALE Lung Adenocarcinoma Mixed Subtype No C34.3 8255/3 C34.3 YES 390 NO 90 NO NO 50 true No MX N0 T1a Stage IA TCGA-93-A4JO.54D7BAFD-D766-4EE6-A769-F57A858B5F44.pdf A4JO Preoperative TUMOR FREE 126 97 125 98 YES NO RX Primary Tumor 01 2006 7th NO YES NO 93 4 Lung A DECEASED 2012 1956 993626ac-469c-4d9d-8278-63fda45598c0 TCGA-93-A4JO-01A-21D-A24O-01 TCGA-93-A4JO-01A-21D-A24U-05 TCGA-93-A4JO-01 TCGA-93-A4JO-01A-21D-A24O-01 993626ac-469c-4d9d-8278-63fda45598c0 TCGA-93-A4JO-01 993626ac-469c-4d9d-8278-63fda45598c0 TCGA-93-A4JO-01 63D18EA0-CC63-461C-809B-D583F4632D86 993626ac-469c-4d9d-8278-63fda45598c0 TCGA-93-A4JO-01A-21D-A24P-08 TCGA-93-A4JO-01 +TCGA-93-A4JP-01 TCGA-93-A4JP-01 TCGA-93-A4JP TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung YES YES NO 64 R-Lower TCGA-93-A4JP-F56970 TCGA-93-A4JP TCGA-93-A4JP-01A -23620 72 0 578 497 1 YES L861Q NO Scheduled Follow-up Submission Progressive Disease 2014-2-28 MALE Lung Papillary Adenocarcinoma No C34.3 8260/3 C34.3 YES 450 NO NO NO Distant Metastasis YES true No M1b NX TX Stage IV TCGA-93-A4JP.3AFDF9A9-8D19-4060-86E0-B24AE8C83A82.pdf A4JP Post-Adjuvant Therapy WITH TUMOR Partial Remission/Response Convincing Imaging NO NO RX Primary Tumor 01 7th YES YES NO 93 1 Lung A LIVING 2012 51705e9c-8423-4eb8-8839-09206d4d115b TCGA-93-A4JP-01A-11D-A24O-01 TCGA-93-A4JP-01A-11D-A24U-05 TCGA-93-A4JP-01 TCGA-93-A4JP-01A-11D-A24O-01 51705e9c-8423-4eb8-8839-09206d4d115b TCGA-93-A4JP-01 51705e9c-8423-4eb8-8839-09206d4d115b TCGA-93-A4JP-01 F636C8C6-1BE2-4C2F-8557-6E507284657A 51705e9c-8423-4eb8-8839-09206d4d115b TCGA-93-A4JP-01A-11D-A24P-08 TCGA-93-A4JP-01 +TCGA-93-A4JQ-01 TCGA-93-A4JQ-01 TCGA-93-A4JQ TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 49 R-Upper TCGA-93-A4JQ-F57022 TCGA-93-A4JQ TCGA-93-A4JQ-01A -17951 57 0 526 83 0 NO NO Scheduled Follow-up Submission Complete Remission/Response 2014-2-28 MALE Lung Acinar Adenocarcinoma No C34.1 8550/3 C34.1 YES 290 NO NO NO NO true Yes, History of Prior Malignancy MX N0 T1b Stage IA TCGA-93-A4JQ.B9CE532C-BACD-4123-B560-6671CABC5132.pdf A4JQ Preoperative TUMOR FREE 97 100 94 93 Complete Remission/Response YES NO RX Primary Tumor 01 1993 7th NO YES NO 93 3 Lung A LIVING 2012 1973 7c22c18e-b357-4f5d-a3c0-d947d9b95c15 TCGA-93-A4JQ-01A-11D-A24O-01 TCGA-93-A4JQ-01A-11D-A24U-05 TCGA-93-A4JQ-01 TCGA-93-A4JQ-01A-11D-A24O-01 7c22c18e-b357-4f5d-a3c0-d947d9b95c15 TCGA-93-A4JQ-01 7c22c18e-b357-4f5d-a3c0-d947d9b95c15 TCGA-93-A4JQ-01 85A3C8F3-775D-4804-B703-8B0B7FF963B1 7c22c18e-b357-4f5d-a3c0-d947d9b95c15 TCGA-93-A4JQ-01A-11D-A24P-08 TCGA-93-A4JQ-01 +TCGA-95-7039-01 5.71 0.42 none p.D565_splice none none N N p.S921R none none 0.12 Squamoid none p.D33E none none none none none Micropapillary predom Adc Micropapillary predom Adc none 0 TCGA-95-7039-01 High C1-LUAD-enriched cluster 1 Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 4 cluster 2 TCGA-95-7039 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung NO NO NO 54 R-Upper TCGA-95-7039-F67192 TCGA-95-7039 TCGA-95-7039-01A -19981 0 1272 1258 1 Additional New Tumor Event Progressive Disease 2014-10-31 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.8 NO 0.8 NO Locoregional Recurrence YES 34 No MX N0 T3 Stage IIB TCGA-95-7039.8bb3ec39-1368-448f-8f75-36bac5f19f02.pdf 7039 Preoperative WITH TUMOR Complete Remission/Response Biopsy with Histologic Confirmation|Convincing Imaging|Positive Biomarker(s) NO Primary Tumor 01 0.2 7th NO YES NO 95 2 Current smoker Lung A LIVING 2011 TCGA-95-7039-01A-11D-1945-08 a017b3e8-6e27-4f0c-aff2-166b73743991 TCGA-95-7039-01A-11D-1943-01 TCGA-95-7039-01A-11D-1947-05 TCGA-95-7039-01 TCGA-95-7039-01A-11D-1943-01 a017b3e8-6e27-4f0c-aff2-166b73743991 TCGA-95-7039-01 TCGA-95-7039-01A-13-2192-20 a017b3e8-6e27-4f0c-aff2-166b73743991 TCGA-95-7039-01 89356e0b-28f3-4115-9a1a-ba5788b848b8 a017b3e8-6e27-4f0c-aff2-166b73743991 TCGA-95-7039-01A-11D-1945-08 TCGA-95-7039-01 +TCGA-95-7043-01 3.72 0.77 none none none none N N none none none 0.23 Magnoid none none none none none none none Adenocarcinoma, NOS Adenocarcinoma, NOS none 0 TCGA-95-7043-01 Squamous C1-LUAD-enriched cluster 3 Cluster 6 BRCA basal-like c6 LUAD-like c10 miRNA c1uster 10 cluster 5 TCGA-95-7043 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 63 R-Upper TCGA-95-7043-F67188 TCGA-95-7043 TCGA-95-7043-01A -23165 503 0 2 Scheduled Follow-up Submission Progressive Disease 2014-10-31 FEMALE Lung Adenocarcinoma Mixed Subtype No C34.1 8255/3 C34.1 YES 0.6 NO 0.6 NO 40 Yes MX N0 T1a Stage IA TCGA-95-7043.a30ed7ec-19a9-4d15-b405-86132271a652.pdf 7043 WITH TUMOR Complete Remission/Response NO Primary Tumor 01 0.1 2003 7th YES YES NO 95 4 Current reformed smoker for > 15 years Lung A DECEASED 2011 1964 TCGA-95-7043-01A-11D-1945-08 8a8e816b-8067-4ffe-ac37-f3ac2e0a29c4 TCGA-95-7043-01A-11D-1943-01 TCGA-95-7043-01A-11D-1947-05 TCGA-95-7043-01 TCGA-95-7043-01A-11D-1943-01 8a8e816b-8067-4ffe-ac37-f3ac2e0a29c4 TCGA-95-7043-01 TCGA-95-7043-01A-13-2192-20 8a8e816b-8067-4ffe-ac37-f3ac2e0a29c4 TCGA-95-7043-01 e4b22dc8-a344-4b20-a743-9af3e4308605 8a8e816b-8067-4ffe-ac37-f3ac2e0a29c4 TCGA-95-7043-01A-11D-1945-08 TCGA-95-7043-01 +TCGA-95-7562-01 TCGA-95-7562-01 BRCA-LUAD+ Cluster 6 LUAD-like c10 miRNA cluster 12 TCGA-95-7562 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 71 R-Lower TCGA-95-7562-F32832 TCGA-95-7562 -26000 87 0 57 1 Scheduled Follow-up Submission 2012-6-13 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES NO NO 10 Yes, History of Prior Malignancy M0 N1 T2a Stage IIA 7562 Post-Adjuvant Therapy TUMOR FREE 72 90 76 80 YES NO RX Primary Tumor 01 1983 7th YES YES NO 95 3 Lung DECEASED 2011 1973 c2842301-c4ec-41c6-96f7-53701541d93c TCGA-95-7562-01A-11D-2237-01 TCGA-95-7562-01A-11D-2239-05 TCGA-95-7562-01 TCGA-95-7562-01A-11D-2237-01 c2842301-c4ec-41c6-96f7-53701541d93c TCGA-95-7562-01 c2842301-c4ec-41c6-96f7-53701541d93c TCGA-95-7562-01 c2842301-c4ec-41c6-96f7-53701541d93c TCGA-95-7562-01A-11D-2238-08 TCGA-95-7562-01 +TCGA-95-7567-01 2.66 0.53 none none none none Y Y none p.R1230fs p.A888T 0.23 Squamoid none p.G12V none none none none none Adenocarcinoma, NOS Adenocarcinoma, NOS none 0 TCGA-95-7567-01 High C1-LUAD-enriched cluster 1 Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 4 cluster 2 TCGA-95-7567 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 61 R-Upper TCGA-95-7567-F40935 TCGA-95-7567 TCGA-95-7567-01A -22437 0 568 0 Scheduled Follow-up Submission Complete Remission/Response 2013-3-6 MALE Lung Adenocarcinoma Mixed Subtype No C34.1 8255/3 C34.1 YES 0.7 NO 100 1 NO NO No M0 N1 T2b Stage IIB TCGA-95-7567.7b2574cb-ff02-4e3e-b64b-9d0265ef9335.pdf 7567 Post-Adjuvant Therapy TUMOR FREE Stable Disease NO NO Primary Tumor 01 0.2 2011 7th YES YES NO 95 4 Current reformed smoker for > 15 years Lung A LIVING 2011 1970 TCGA-95-7567-01A-11D-2063-08 84c8990e-7656-4c48-8e5a-b03e2013013d TCGA-95-7567-01A-11D-2062-01 TCGA-95-7567-01A-11D-2064-05 TCGA-95-7567-01 TCGA-95-7567-01A-11D-2062-01 84c8990e-7656-4c48-8e5a-b03e2013013d TCGA-95-7567-01 TCGA-95-7567-01A-13-2192-20 84c8990e-7656-4c48-8e5a-b03e2013013d TCGA-95-7567-01 b1812676-0dc7-4038-937b-1e11d9f3a8eb 84c8990e-7656-4c48-8e5a-b03e2013013d TCGA-95-7567-01A-11D-2063-08 TCGA-95-7567-01 +TCGA-95-7944-01 TCGA-95-7944-01 GBM C1-LUAD-enriched Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 4 TCGA-95-7944 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 71 L-Lower TCGA-95-7944-F40938 TCGA-95-7944 TCGA-95-7944-01A -26003 0 377 60 Scheduled Follow-up Submission Complete Remission/Response 2013-3-7 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 0.7 NO 1.3 NO NO 50 No M0 N0 T1a Stage IA TCGA-95-7944.567e989f-6896-4faf-84bb-8ef786461228.pdf 7944 TUMOR FREE 87 86 Stable Disease YES NO R0 Primary Tumor 01 0.2 7th NO YES NO 95 2 Lung A LIVING 2011 1961 f842dd09-8bea-47d4-8489-a9ac06ca5172 TCGA-95-7944-01A-11D-2183-01 TCGA-95-7944-01A-11D-2185-05 TCGA-95-7944-01 TCGA-95-7944-01A-11D-2183-01 f842dd09-8bea-47d4-8489-a9ac06ca5172 TCGA-95-7944-01 TCGA-95-7944-01A-12-2192-20 f842dd09-8bea-47d4-8489-a9ac06ca5172 TCGA-95-7944-01 4e9e76ae-0854-4d55-8ac1-1e156220d369 f842dd09-8bea-47d4-8489-a9ac06ca5172 TCGA-95-7944-01A-11D-2184-08 TCGA-95-7944-01 +TCGA-95-7947-01 none none none none N N p.I91V, p.R1052I none none Squamoid none none none none none p.E453Q none 0 Acinar predominant Adc none TCGA-95-7947-01 High C1-LUAD-enriched cluster 3 Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 4 cluster 4 TCGA-95-7947 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 67 L-Upper TCGA-95-7947-F40940 TCGA-95-7947 TCGA-95-7947-01A -24752 0 477 Scheduled Follow-up Submission Complete Remission/Response 2013-3-7 MALE Lung Adenocarcinoma Mixed Subtype No C34.1 8255/3 C34.1 YES 0.6 NO 1.2 NO NO 100 Yes M0 N0 T1a Stage IA TCGA-95-7947.003c68cb-72ea-44c9-80e3-f62224ab3ee2.pdf 7947 TUMOR FREE 37 37 Complete Remission/Response YES NO R0 Primary Tumor 01 0.3 2006 7th NO YES NO 95 4 Lung A LIVING 2011 1956 TCGA-95-7947-01A-11D-2184-08 5893078d-d8cd-4c74-b0e2-d412e367710b TCGA-95-7947-01A-11D-2183-01 TCGA-95-7947-01A-11D-2185-05 TCGA-95-7947-01 TCGA-95-7947-01A-11D-2183-01 5893078d-d8cd-4c74-b0e2-d412e367710b TCGA-95-7947-01 TCGA-95-7947-01A-13-2192-20 5893078d-d8cd-4c74-b0e2-d412e367710b TCGA-95-7947-01 394b67ed-76b7-4d7a-9d58-bf5a790b05d4 5893078d-d8cd-4c74-b0e2-d412e367710b TCGA-95-7947-01A-11D-2184-08 TCGA-95-7947-01 +TCGA-95-7948-01 none none none none N N none none none Squamoid none none none none none p.E545K none 0 Micropapillary predom Adc none TCGA-95-7948-01 Squamous C1-LUAD-enriched cluster 2 Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 12 cluster 5 TCGA-95-7948 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 42 R-Lower TCGA-95-7948-F40945 TCGA-95-7948 TCGA-95-7948-01A -15363 0 476 87 Scheduled Follow-up Submission Complete Remission/Response 2013-3-7 FEMALE Lung Adenocarcinoma Mixed Subtype No C34.3 8255/3 C34.3 YES 0.7 NO 1.3 NO NO .15 Yes M0 N0 T2a Stage IB TCGA-95-7948.1cee5f67-bdcc-41cb-8764-5e0d8e09ed61.pdf 7948 TUMOR FREE 79 72 Complete Remission/Response YES NO R0 Primary Tumor 01 0.3 1995 7th NO YES NO 95 3 Lung A LIVING 2011 1993 TCGA-95-7948-01A-11D-2184-08 a5e6acbf-7027-4837-85d7-aacfe707900d TCGA-95-7948-01A-11D-2183-01 TCGA-95-7948-01A-11D-2185-05 TCGA-95-7948-01 TCGA-95-7948-01A-11D-2183-01 a5e6acbf-7027-4837-85d7-aacfe707900d TCGA-95-7948-01 TCGA-95-7948-01A-13-2192-20 a5e6acbf-7027-4837-85d7-aacfe707900d TCGA-95-7948-01 32138cac-7e19-47d7-9a9a-c7270643ea2f a5e6acbf-7027-4837-85d7-aacfe707900d TCGA-95-7948-01A-11D-2184-08 TCGA-95-7948-01 +TCGA-95-8039-01 TCGA-95-8039-01 BRCA-LUAD+ Cluster 6 LUAD-like c10 miRNA cluster 4 TCGA-95-8039 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung YES YES NO 72 R-Upper TCGA-95-8039-F61691 TCGA-95-8039 TCGA-95-8039-01A -26317 0 830 228 98 0 Scheduled Follow-up Submission Complete Remission/Response 2014-7-3 MALE Lung Acinar Adenocarcinoma No C34.1 8550/3 C34.1 YES 0.5 NO 0.9 NO Locoregional Recurrence YES No MX N0 T1 Stage IA TCGA-95-8039.2bc3d5a2-7341-44a1-a625-fbfdef9bba6c.pdf 8039 Post-Adjuvant Therapy TUMOR FREE 70 2.54 67 2.40 Complete Remission/Response Biopsy with Histologic Confirmation|Convincing Imaging YES NO RX Primary Tumor 01 0.4 7th NO YES NO 95 1 Lung A LIVING 2012 8deed508-4b81-4573-afc1-a3da5ca52c60 TCGA-95-8039-01A-11D-2237-01 TCGA-95-8039-01A-11D-2239-05 TCGA-95-8039-01 TCGA-95-8039-01A-11D-2237-01 8deed508-4b81-4573-afc1-a3da5ca52c60 TCGA-95-8039-01 8deed508-4b81-4573-afc1-a3da5ca52c60 TCGA-95-8039-01 8deed508-4b81-4573-afc1-a3da5ca52c60 TCGA-95-8039-01A-11D-2238-08 TCGA-95-8039-01 +TCGA-95-8494-01 TCGA-95-8494-01 Cluster 6 miRNA cluster 4 TCGA-95-8494 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 67 R-Middle TCGA-95-8494-F58476 TCGA-95-8494 -24773 0 84 NO NO Scheduled Follow-up Submission 2014-4-10 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.2 8140/3 C34.2 YES NO YES NO No M0 N1 T2a Stage IIA 8494 Complete Remission/Response NO NO Primary Tumor 01 7th NO YES NO 95 5 Lung LIVING 2012 af100535-eaf2-49a6-b4bb-5a2b85a2d2c9 TCGA-95-8494-01A-11D-2322-01 TCGA-95-8494-01A-11D-2324-05 TCGA-95-8494-01 TCGA-95-8494-01A-11D-2322-01 af100535-eaf2-49a6-b4bb-5a2b85a2d2c9 TCGA-95-8494-01 af100535-eaf2-49a6-b4bb-5a2b85a2d2c9 TCGA-95-8494-01 af100535-eaf2-49a6-b4bb-5a2b85a2d2c9 TCGA-95-8494-01A-11D-2323-08 TCGA-95-8494-01 +TCGA-95-A4VK-01 TCGA-95-A4VK-01 TCGA-95-A4VK TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung NO YES NO 74 R-Upper TCGA-95-A4VK-F58477 TCGA-95-A4VK TCGA-95-A4VK-01A -27040 155 0 651 496 81 1 YES NO Scheduled Follow-up Submission Stable Disease 2014-4-10 FEMALE Lung Adenocarcinoma Mixed Subtype No C34.1 8255/3 C34.1 YES 140 NO NO NO Distant Metastasis YES 45 true Yes, History of Prior Malignancy M0 N2 T2b Stage IIIA TCGA-95-A4VK.0B713E19-EE67-4C3B-8319-4C69019C00D0.pdf A4VK Post-Adjuvant Therapy WITH TUMOR 72 99 67 99 Stable Disease Convincing Imaging YES YES RX Primary Tumor 01 1986 7th YES YES NO 95 3 Lung A LIVING 2012 1956 f1a2ff30-bc18-4a82-b1a6-69f4b827fddd TCGA-95-A4VK-01A-11D-A25M-01 TCGA-95-A4VK-01A-11D-A25R-05 TCGA-95-A4VK-01 TCGA-95-A4VK-01A-11D-A25M-01 f1a2ff30-bc18-4a82-b1a6-69f4b827fddd TCGA-95-A4VK-01 f1a2ff30-bc18-4a82-b1a6-69f4b827fddd TCGA-95-A4VK-01 C1C311E9-B955-4217-BA53-CF6C58126835 f1a2ff30-bc18-4a82-b1a6-69f4b827fddd TCGA-95-A4VK-01A-11D-A25L-08 TCGA-95-A4VK-01 +TCGA-95-A4VN-01 TCGA-95-A4VN-01 TCGA-95-A4VN TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 62 R-Lower TCGA-95-A4VN-F58501 TCGA-95-A4VN TCGA-95-A4VN-01A -22927 23 0 553 50 1 YES NO Scheduled Follow-up Submission Stable Disease 2014-4-11 FEMALE Lung Solid Pattern Predominant Adenocarcinoma No C34.3 8140/3 C34.3 YES 150 NO NO NO NO 42 true Yes, History of Prior Malignancy M0 N1 T2a Stage IIA TCGA-95-A4VN.D348711A-FD65-4771-A604-D761C96F5C48.pdf A4VN Pre-Adjuvant Therapy TUMOR FREE 65 67 60 58 Stable Disease YES NO R0 Primary Tumor 01 2007 7th NO YES NO 95 4 Lung A LIVING 2012 1965 dd53f806-9971-4f03-960c-7753d6b29904 TCGA-95-A4VN-01A-11D-A25M-01 TCGA-95-A4VN-01A-11D-A25R-05 TCGA-95-A4VN-01 TCGA-95-A4VN-01A-11D-A25M-01 dd53f806-9971-4f03-960c-7753d6b29904 TCGA-95-A4VN-01 dd53f806-9971-4f03-960c-7753d6b29904 TCGA-95-A4VN-01 001668FF-E11D-415F-981E-E67389912B4E dd53f806-9971-4f03-960c-7753d6b29904 TCGA-95-A4VN-01A-11D-A25L-08 TCGA-95-A4VN-01 +TCGA-95-A4VP-01 TCGA-95-A4VP-01 TCGA-95-A4VP TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung NO YES NO 66 L-Lower TCGA-95-A4VP-F58502 TCGA-95-A4VP TCGA-95-A4VP-01A -24130 68 0 605 216 1 NO NO Scheduled Follow-up Submission Stable Disease 2014-4-11 FEMALE Lung Acinar Adenocarcinoma No C34.3 8550/3 C34.3 YES 640 NO NO NO Distant Metastasis YES 20 true No M0 N2 T2b Stage IIIA TCGA-95-A4VP.8892002E-D9B2-47FA-9540-A19E4A35B6C7.pdf A4VP Post-Adjuvant Therapy WITH TUMOR Stable Disease Biopsy with Histologic Confirmation|Convincing Imaging NO NO Primary Tumor 01 2012 7th YES YES NO 95 4 Lung A LIVING 2012 1972 680579c1-690f-444a-9b6e-f76f5cdd1ae8 TCGA-95-A4VP-01A-21D-A25M-01 TCGA-95-A4VP-01A-21D-A25R-05 TCGA-95-A4VP-01 TCGA-95-A4VP-01A-21D-A25M-01 680579c1-690f-444a-9b6e-f76f5cdd1ae8 TCGA-95-A4VP-01 680579c1-690f-444a-9b6e-f76f5cdd1ae8 TCGA-95-A4VP-01 155C7377-148B-47D4-8BC7-3DFA092A6CB7 680579c1-690f-444a-9b6e-f76f5cdd1ae8 TCGA-95-A4VP-01A-21D-A25L-08 TCGA-95-A4VP-01 +TCGA-97-7546-01 1.8 0.57 none none none none N N none none none 0.3 Bronchioid none none none none none none none Lepidic predominant Adc Lepidic predominant Adc none 0 TCGA-97-7546-01 BRCA-LUAD+ C1-LUAD-enriched cluster 3 Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 5 cluster 3 TCGA-97-7546 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung YES YES 76 L-Upper TCGA-97-7546-F31995 TCGA-97-7546 TCGA-97-7546-01A -27913 0 1285 1255 60 Additional New Tumor Event 2012-5-15 FEMALE Lung Acinar Adenocarcinoma No C34.1 8550/3 C34.1 YES 0.6 NO 1.2 NO New Primary Tumor YES 25 No MX N0 T1 Stage IA TCGA-97-7546.6d3d1827-e313-45ab-a388-406a3b26b427.pdf 7546 WITH TUMOR 96 84 100 85 Progressive Disease Convincing Imaging YES YES R0 Primary Tumor 01 0.6 1983 6th YES NO YES 97 3 Current reformed smoker for > 15 years Lung A LIVING 2008 1963 TCGA-97-7546-01A-11D-2036-08 46ba6b5d-e758-4c4d-bbbf-8ec31fdd24e7 TCGA-97-7546-01A-11D-2035-01 TCGA-97-7546-01A-11D-2037-05 TCGA-97-7546-01 TCGA-97-7546-01A-11D-2035-01 46ba6b5d-e758-4c4d-bbbf-8ec31fdd24e7 TCGA-97-7546-01 TCGA-97-7546-01A-13-2192-20 46ba6b5d-e758-4c4d-bbbf-8ec31fdd24e7 TCGA-97-7546-01 936aa67d-90fe-464a-876e-74c37cd2d9bb 46ba6b5d-e758-4c4d-bbbf-8ec31fdd24e7 TCGA-97-7546-01A-11D-2036-08 TCGA-97-7546-01 +TCGA-97-7547-01 TCGA-97-7547-01 Iq Cluster 5 LUAD-like c10 miRNA cluster 5 TCGA-97-7547 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung YES NO YES 67 R-Upper TCGA-97-7547-F37177 TCGA-97-7547 TCGA-97-7547-01A 1894 -24737 0 1965 1147 94 Scheduled Follow-up Submission Progressive Disease 2012-11-29 FEMALE Lung Papillary Adenocarcinoma No C34.1 8260/3 C34.1 YES 0.2 NO 0.7 NO Locoregional Recurrence YES 30 No MX N0 T2 Stage IB TCGA-97-7547.4a96b27c-c641-4db1-abb2-d2f5ec4a404d.pdf 7547 WITH TUMOR 83 101 82 106 Progressive Disease Biopsy with Histologic Confirmation YES NO Primary Tumor 01 0.1 1986 6th YES NO YES 97 3 Lung A LIVING 2007 2680c851-cb71-4c87-a789-6448b1f66faf TCGA-97-7547-01A-11D-2035-01 TCGA-97-7547-01A-11D-2037-05 TCGA-97-7547-01 TCGA-97-7547-01A-11D-2035-01 2680c851-cb71-4c87-a789-6448b1f66faf TCGA-97-7547-01 2680c851-cb71-4c87-a789-6448b1f66faf TCGA-97-7547-01 2680c851-cb71-4c87-a789-6448b1f66faf TCGA-97-7547-01A-11D-2036-08 TCGA-97-7547-01 +TCGA-97-7552-01 1.95 0.18 none none none none N N none none none 0.09 Bronchioid none none none none none none none Invasive mucinous Invasive mucinous none 0 TCGA-97-7552-01 Kirc+ C1-LUAD-enriched cluster 2 Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 5 cluster 3 TCGA-97-7552 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung NO NO 70 L-Lower TCGA-97-7552-F37174 TCGA-97-7552 -25578 0 1932 798 Scheduled Follow-up Submission Complete Remission/Response 2012-11-29 MALE Lung Bronchioloalveolar Carcinoma Mucinous No C34.3 8253/3 C34.3 YES NO New Primary Tumor YES 40 No MX N0 T2 Stage IB 7552 TUMOR FREE 82 81 Stable Disease YES NO Primary Tumor 01 1985 6th NO NO YES 97 3 Current reformed smoker for > 15 years Lung LIVING 2007 TCGA-97-7552-01A-11D-2036-08 a8873600-a0a6-4880-b933-2cbcfb274233 TCGA-97-7552-01A-11D-2035-01 TCGA-97-7552-01A-11D-2037-05 TCGA-97-7552-01 TCGA-97-7552-01A-11D-2035-01 a8873600-a0a6-4880-b933-2cbcfb274233 TCGA-97-7552-01 TCGA-97-7552-01A-13-2192-20 a8873600-a0a6-4880-b933-2cbcfb274233 TCGA-97-7552-01 ae55fdf1-f35a-4930-a339-0c51f52b791a a8873600-a0a6-4880-b933-2cbcfb274233 TCGA-97-7552-01A-11D-2036-08 TCGA-97-7552-01 +TCGA-97-7553-01 1.47 0.3 none none none none N N none none none 0.16 Bronchioid none none none none none none none Acinar predominant Adc Acinar predominant Adc none 0 TCGA-97-7553-01 High C1-LUAD-enriched cluster 3 Low purity c2 squamous c3 LUAD-like c10 miRNA cluster 5 cluster 3 TCGA-97-7553 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 58 L-Lower TCGA-97-7553-F31865 TCGA-97-7553 TCGA-97-7553-01A -21518 0 1870 64 Scheduled Follow-up Submission 2012-5-14 FEMALE Lung Bronchioloalveolar Carcinoma Nonmucinous No C34.3 8252/3 C34.3 YES 1 NO Central Lung 1.5 NO NO 20 No MX N0 T1 Stage IA TCGA-97-7553.85eedad8-21be-4b10-910b-5b71802ae52f.pdf 7553 TUMOR FREE 70 99 70 99 Complete Remission/Response YES NO Primary Tumor 01 0.4 6th NO NO YES 97 2 Current smoker Lung A LIVING 2007 1967 TCGA-97-7553-01A-21D-2036-08 4af52410-54ab-4307-96a0-b80579d18e0b TCGA-97-7553-01A-21D-2035-01 TCGA-97-7553-01A-21D-2037-05 TCGA-97-7553-01 TCGA-97-7553-01A-21D-2035-01 4af52410-54ab-4307-96a0-b80579d18e0b TCGA-97-7553-01 TCGA-97-7553-01A-23-2192-20 4af52410-54ab-4307-96a0-b80579d18e0b TCGA-97-7553-01 45376060-6ebe-467c-ac0c-af4b2f3a9670 4af52410-54ab-4307-96a0-b80579d18e0b TCGA-97-7553-01A-21D-2036-08 TCGA-97-7553-01 +TCGA-97-7554-01 2.28 0.49 none none none none Y Y none none none 0.23 Squamoid none p.G12V none none none none none Acinar predominant Adc Acinar predominant Adc none 0 TCGA-97-7554-01 BRCA-LUAD+ C1-LUAD-enriched cluster 1 Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 4 cluster 2 TCGA-97-7554 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 83 L-Lower TCGA-97-7554-F20552 TCGA-97-7554 -30327 0 775 53 1 Scheduled Follow-up Submission 2012-1-17 FEMALE Lung Papillary Adenocarcinoma No C34.3 8260/3 C34.3 YES YES YES G12V NO 30 No M0 N2 T2a Stage IIIA 7554 Post-Adjuvant Therapy TUMOR FREE 75 75 76 68 Complete Remission/Response YES NO R0 Primary Tumor 01 1983 7th YES NO YES 97 3 Current reformed smoker for > 15 years Lung LIVING 2010 1945 TCGA-97-7554-01A-11D-2036-08 db278ebc-bf83-43c0-8a60-a863786ea973 TCGA-97-7554-01A-11D-2035-01 TCGA-97-7554-01A-11D-2037-05 TCGA-97-7554-01 TCGA-97-7554-01A-11D-2035-01 db278ebc-bf83-43c0-8a60-a863786ea973 TCGA-97-7554-01 TCGA-97-7554-01A-13-2192-20 db278ebc-bf83-43c0-8a60-a863786ea973 TCGA-97-7554-01 b2825831-dc98-4443-9963-3f8399f86ea9 db278ebc-bf83-43c0-8a60-a863786ea973 TCGA-97-7554-01A-11D-2036-08 TCGA-97-7554-01 +TCGA-97-7937-01 none none p.C401F none N N none none none Squamoid none none none none none none none Acinar predominant Adc Acinar predominant Adc none 0 TCGA-97-7937-01 High C1-LUAD-enriched cluster 1 Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 5 cluster 3 TCGA-97-7937 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung NO 65 L-Upper TCGA-97-7937-F33767 TCGA-97-7937 TCGA-97-7937-01A -23919 0 564 89 0 YES FISH YES Scheduled Follow-up Submission 2012-9-12 MALE Lung Micropapillary Adenocarcinoma No C34.1 8507/3 C34.1 YES 1.1 NO YES NO 1.1 NO NO 35 No MX N0 T2a Stage IB TCGA-97-7937.c52adb5c-9ab3-475b-b21c-c817ea5209f2.pdf 7937 Preoperative TUMOR FREE 77 120 Stable Disease YES NO Primary Tumor 01 0.5 1994 7th NO YES NO 97 3 Current reformed smoker for > 15 years Lung A LIVING 2011 TCGA-97-7937-01A-11D-2167-08 4b847934-8dcb-451a-a0f1-a5f59bbd33db TCGA-97-7937-01A-11D-2166-01 TCGA-97-7937-01A-11D-2168-05 TCGA-97-7937-01 TCGA-97-7937-01A-11D-2166-01 4b847934-8dcb-451a-a0f1-a5f59bbd33db TCGA-97-7937-01 TCGA-97-7937-01A-13-2192-20 4b847934-8dcb-451a-a0f1-a5f59bbd33db TCGA-97-7937-01 c239f617-19b3-4f8e-933e-492103f7ee83 4b847934-8dcb-451a-a0f1-a5f59bbd33db TCGA-97-7937-01A-11D-2167-08 TCGA-97-7937-01 +TCGA-97-7938-01 none none none none Y Y none none none Bronchioid none p.G12C none none none none none Lepidic predominant Adc Lepidic predominant Adc none 0 TCGA-97-7938-01 BRCA-LUAD+ C1-LUAD-enriched cluster 3 Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 5 cluster 3 TCGA-97-7938 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 76 R-Upper TCGA-97-7938-F57460 TCGA-97-7938 TCGA-97-7938-01A -27980 18 0 53 YES NO Scheduled Follow-up Submission Complete Remission/Response 2014-3-11 FEMALE Lung Bronchioloalveolar Carcinoma Nonmucinous No C34.1 8252/3 C34.1 YES 0.8 NO YES YES G12C 1.2 NO NO 40 No MX N0 T1a Stage IA TCGA-97-7938.c1b81542-c8ad-43d1-a963-1584868e7fe7.pdf 7938 TUMOR FREE 59 54 58 50 Complete Remission/Response YES NO R0 Primary Tumor 01 0.2 1996 7th NO YES NO 97 3 Current reformed smoker for > 15 years Lung A DECEASED 2011 TCGA-97-7938-01A-11D-2167-08 3163dcdb-7a0f-428d-94be-9fc140cca0ca TCGA-97-7938-01A-11D-2166-01 TCGA-97-7938-01A-11D-2168-05 TCGA-97-7938-01 TCGA-97-7938-01A-11D-2166-01 3163dcdb-7a0f-428d-94be-9fc140cca0ca TCGA-97-7938-01 TCGA-97-7938-01A-13-2192-20 3163dcdb-7a0f-428d-94be-9fc140cca0ca TCGA-97-7938-01 4bfded3e-651d-476f-a780-b8345171b8cc 3163dcdb-7a0f-428d-94be-9fc140cca0ca TCGA-97-7938-01A-11D-2167-08 TCGA-97-7938-01 +TCGA-97-7941-01 none none none none Y Y none none none Bronchioid none p.G12A none none none none none Acinar predominant Adc Acinar predominant Adc none 0 TCGA-97-7941-01 Kirc+ C1-LUAD-enriched cluster 3 Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 14 cluster 4 TCGA-97-7941 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 72 L-Upper TCGA-97-7941-F33765 TCGA-97-7941 TCGA-97-7941-01A -26298 0 484 57 0 YES NO Scheduled Follow-up Submission 2012-8-13 FEMALE Lung Acinar Adenocarcinoma No C34.1 8550/3 C34.1 YES 1 NO YES YES G12A 1.3 NO NO 22.5 No MX N0 T1b Stage IA TCGA-97-7941.f95131f4-d721-441f-86ee-d9981befc2a7.pdf 7941 Preoperative TUMOR FREE 81 98 94 97 Complete Remission/Response YES NO R0 Primary Tumor 01 0.2 1985 7th NO YES NO 97 3 Current reformed smoker for > 15 years Lung A LIVING 2011 1960 TCGA-97-7941-01A-11D-2184-08 8f52d9f9-9077-4203-ac3a-d64b6589b536 TCGA-97-7941-01A-11D-2183-01 TCGA-97-7941-01A-11D-2185-05 TCGA-97-7941-01 TCGA-97-7941-01A-11D-2183-01 8f52d9f9-9077-4203-ac3a-d64b6589b536 TCGA-97-7941-01 TCGA-97-7941-01A-13-2192-20 8f52d9f9-9077-4203-ac3a-d64b6589b536 TCGA-97-7941-01 803df9cc-873d-4ea2-8895-3090f505e2fd 8f52d9f9-9077-4203-ac3a-d64b6589b536 TCGA-97-7941-01A-11D-2184-08 TCGA-97-7941-01 +TCGA-97-8171-01 TCGA-97-8171-01 BRCA-LUAD+ Cluster 5 LUAD-like c10 miRNA cluster 7 TCGA-97-8171 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung YES NO YES 81 Other (please specify) RUL and RML TCGA-97-8171-F44232 TCGA-97-8171 TCGA-97-8171-01A 441 -29627 0 568 441 110 1 YES Exon 19 Deletion NO Scheduled Follow-up Submission Progressive Disease 2013-6-19 MALE Lung Papillary Adenocarcinoma No C34.8 8260/3 C34.8 YES 0.8 NO YES NO 1.9 NO Distant Metastasis YES 65 No M1a N2 T2a Stage IV TCGA-97-8171.71aa5cff-eda0-47d0-97d8-caf4c02f5626.pdf 8171 Preoperative WITH TUMOR 55 104 55 99 Progressive Disease Biopsy with Histologic Confirmation YES NO Primary Tumor 01 0.5 7th YES YES NO 97 2 Lung A LIVING 2011 1946 8dedea58-fb63-44cc-860c-56e66b52d11b TCGA-97-8171-01A-11D-2283-01 TCGA-97-8171-01A-11D-2285-05 TCGA-97-8171-01 TCGA-97-8171-01A-11D-2283-01 8dedea58-fb63-44cc-860c-56e66b52d11b TCGA-97-8171-01 8dedea58-fb63-44cc-860c-56e66b52d11b TCGA-97-8171-01 8dedea58-fb63-44cc-860c-56e66b52d11b TCGA-97-8171-01A-11D-2284-08 TCGA-97-8171-01 +TCGA-97-8172-01 TCGA-97-8172-01 Kirc+ Cluster 6 LUAD-like c10 miRNA c1uster 9 TCGA-97-8172 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 75 R-Upper TCGA-97-8172-F44230 TCGA-97-8172 TCGA-97-8172-01A -27416 0 545 64.98 1 YES NO Scheduled Follow-up Submission Complete Remission/Response 2013-6-19 FEMALE Lung Acinar Adenocarcinoma No C34.1 8550/3 C34.1 YES 1.2 NO YES YES G12V 1.7 NO NO 20 Yes, History of Prior Malignancy M0 N0 T2a Stage IB TCGA-97-8172.ef65fdd5-820a-4029-a667-56b5200276a7.pdf 8172 Preoperative TUMOR FREE 105.10 107.25 93.27 104.64 Complete Remission/Response YES NO Primary Tumor 01 0.5 1981 7th NO YES NO 97 3 Lung A LIVING 2011 1961 9b1118f0-743f-4186-b6cb-571ddb72bc74 TCGA-97-8172-01A-11D-2283-01 TCGA-97-8172-01A-11D-2285-05 TCGA-97-8172-01 TCGA-97-8172-01A-11D-2283-01 9b1118f0-743f-4186-b6cb-571ddb72bc74 TCGA-97-8172-01 9b1118f0-743f-4186-b6cb-571ddb72bc74 TCGA-97-8172-01 9b1118f0-743f-4186-b6cb-571ddb72bc74 TCGA-97-8172-01A-11D-2284-08 TCGA-97-8172-01 +TCGA-97-8174-01 TCGA-97-8174-01 BRCA-LUAD+ Cluster 5 LUAD-like c10 miRNA c1uster 9 TCGA-97-8174 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 67 R-Upper TCGA-97-8174 TCGA-97-8174-01A -24725 164 0 90 0 YES FISH YES 2012-6-13 MALE Lung Papillary Adenocarcinoma No C34.1 8260/3 C34.1 YES 1.5 NO YES NO 1.5 NO 40 No M0 N0 T2b Stage IIA TCGA-97-8174.f71782a0-0d9f-486e-9e17-cd5ff92d44d7.pdf 8174 Preoperative 86 99 81 91 YES NO Primary Tumor 01 0.5 1985 7th YES YES NO 97 3 Lung A DECEASED 2011 1965 076c0fa3-ca40-4362-9ba4-5d31fc27af41 TCGA-97-8174-01A-11D-2283-01 TCGA-97-8174-01A-11D-2285-05 TCGA-97-8174-01 TCGA-97-8174-01A-11D-2283-01 076c0fa3-ca40-4362-9ba4-5d31fc27af41 TCGA-97-8174-01 076c0fa3-ca40-4362-9ba4-5d31fc27af41 TCGA-97-8174-01 076c0fa3-ca40-4362-9ba4-5d31fc27af41 TCGA-97-8174-01A-11D-2284-08 TCGA-97-8174-01 +TCGA-97-8175-01 TCGA-97-8175-01 GBM Cluster 6 LUAD-like c10 miRNA cluster 4 TCGA-97-8175 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung YES YES YES 55 L-Upper TCGA-97-8175-F44234 TCGA-97-8175 TCGA-97-8175-01A 294 -20206 0 551 294 YES FISH YES Scheduled Follow-up Submission Complete Remission/Response 2013-6-19 FEMALE Lung Solid Pattern Predominant Adenocarcinoma No C34.1 8230/3 C34.1 YES 1 NO YES NO Peripheral Lung 2 NO Locoregional Recurrence YES No M0 N0 T2a Stage IB TCGA-97-8175.19c71bba-794d-4245-bbd8-536740912c9f.pdf 8175 TUMOR FREE Complete Remission/Response Biopsy with Histologic Confirmation NO NO Primary Tumor 01 0.4 1981 7th NO YES NO 97 3 Lung A LIVING 2011 708e83be-4726-4eb6-a72c-ad855942551c TCGA-97-8175-01A-11D-2283-01 TCGA-97-8175-01A-11D-2285-05 TCGA-97-8175-01 TCGA-97-8175-01A-11D-2283-01 708e83be-4726-4eb6-a72c-ad855942551c TCGA-97-8175-01 708e83be-4726-4eb6-a72c-ad855942551c TCGA-97-8175-01 708e83be-4726-4eb6-a72c-ad855942551c TCGA-97-8175-01A-11D-2284-08 TCGA-97-8175-01 +TCGA-97-8176-01 TCGA-97-8176-01 TCGA-97-8176 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 63 R-Lower TCGA-97-8176-F49542 TCGA-97-8176 -23170 468 0 252 61 0 YES NO Scheduled Follow-up Submission Progressive Disease 2013-10-11 MALE Lung Acinar Adenocarcinoma No C34.3 8550/3 C34.3 YES YES YES G12S NO NO 40 No M0 N1 T3 Stage IIIA 8176 Preoperative TUMOR FREE 68 104 67 100 Stable Disease YES YES R0 Primary Tumor 01 2011 7th YES YES NO 97 4 Lung DECEASED 2012 1971 a49c5cb5-9a31-456d-b55d-904081633729 TCGA-97-8176-01A-11D-2389-01 TCGA-97-8176-01A-11D-2398-05 TCGA-97-8176-01 TCGA-97-8176-01A-11D-2389-01 a49c5cb5-9a31-456d-b55d-904081633729 TCGA-97-8176-01 a49c5cb5-9a31-456d-b55d-904081633729 TCGA-97-8176-01 a49c5cb5-9a31-456d-b55d-904081633729 TCGA-97-8176-01A-11D-2393-08 TCGA-97-8176-01 +TCGA-97-8177-01 TCGA-97-8177-01 Kirc+ Cluster 5 LUAD-like c10 miRNA cluster 4 TCGA-97-8177 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 59 L-Lower TCGA-97-8177-F44243 TCGA-97-8177 TCGA-97-8177-01A -21648 0 499 97 0 YES L858R NO Scheduled Follow-up Submission Complete Remission/Response 2013-6-19 FEMALE Lung Adenocarcinoma Mixed Subtype No C34.3 8255/3 C34.3 YES 1.7 NO YES NO 2.4 NO NO No M0 N0 T2a Stage IB TCGA-97-8177.addbe4e2-114d-4e38-aa21-c3e9695da8fa.pdf 8177 Preoperative TUMOR FREE 82 109 80 106 Complete Remission/Response YES NO Primary Tumor 01 0.3 7th YES YES NO 97 1 Lung A LIVING 2012 61e0c561-bf01-400c-843a-7c63e5a74b9f TCGA-97-8177-01A-11D-2283-01 TCGA-97-8177-01A-11D-2285-05 TCGA-97-8177-01 TCGA-97-8177-01A-11D-2283-01 61e0c561-bf01-400c-843a-7c63e5a74b9f TCGA-97-8177-01 61e0c561-bf01-400c-843a-7c63e5a74b9f TCGA-97-8177-01 61e0c561-bf01-400c-843a-7c63e5a74b9f TCGA-97-8177-01A-11D-2284-08 TCGA-97-8177-01 +TCGA-97-8179-01 TCGA-97-8179-01 High Cluster 6 LUAD-like c10 miRNA cluster 4 TCGA-97-8179 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 72 R-Upper TCGA-97-8179-F44247 TCGA-97-8179 TCGA-97-8179-01A -26305 0 435 73 0 YES FISH YES Scheduled Follow-up Submission Complete Remission/Response 2013-6-19 MALE Lung Acinar Adenocarcinoma No C34.1 8550/3 C34.1 YES 0.6 NO YES NO 0.8 NO NO 60 No M0 N0 T1a Stage IA TCGA-97-8179.8ed138ef-c9fe-45dd-870a-a438f6f22214.pdf 8179 Preoperative TUMOR FREE 91 95 86 90 Complete Remission/Response YES NO Primary Tumor 01 0.2 1988 7th NO YES NO 97 3 Lung A LIVING 2012 1958 1a331a89-0666-49c2-8f5c-915568d8cb31 TCGA-97-8179-01A-11D-2283-01 TCGA-97-8179-01A-11D-2285-05 TCGA-97-8179-01 TCGA-97-8179-01A-11D-2283-01 1a331a89-0666-49c2-8f5c-915568d8cb31 TCGA-97-8179-01 1a331a89-0666-49c2-8f5c-915568d8cb31 TCGA-97-8179-01 C33AD4AF-80A5-4078-883D-CE6D93BA29C6 1a331a89-0666-49c2-8f5c-915568d8cb31 TCGA-97-8179-01A-11D-2284-08 TCGA-97-8179-01 +TCGA-97-8547-01 TCGA-97-8547-01 TCGA-97-8547 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 78 R-Lower TCGA-97-8547-F49559 TCGA-97-8547 -28801 0 657 87 YES Exon 19 Deletion NO Scheduled Follow-up Submission Complete Remission/Response 2013-10-3 FEMALE Lung Adenocarcinoma Mixed Subtype No C34.3 8550/3 C34.3 YES YES NO NO NO No MX N2 T2a Stage IIIA 8547 TUMOR FREE 136 Complete Remission/Response YES NO Primary Tumor 01 7th YES YES NO 97 1 Lung LIVING 2012 c11b849f-04dd-4599-8073-e2431bd68dd1 TCGA-97-8547-01A-11D-2389-01 TCGA-97-8547-01A-11D-2398-05 TCGA-97-8547-01 TCGA-97-8547-01A-11D-2389-01 c11b849f-04dd-4599-8073-e2431bd68dd1 TCGA-97-8547-01 c11b849f-04dd-4599-8073-e2431bd68dd1 TCGA-97-8547-01 c11b849f-04dd-4599-8073-e2431bd68dd1 TCGA-97-8547-01A-11D-2393-08 TCGA-97-8547-01 +TCGA-97-8552-01 TCGA-97-8552-01 TCGA-97-8552 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 55 L-Lower TCGA-97-8552-F49557 TCGA-97-8552 TCGA-97-8552-01A -20331 0 626 75 0 YES Exon 19 Deletion NO Scheduled Follow-up Submission Complete Remission/Response 2013-10-3 FEMALE Lung Bronchioloalveolar Carcinoma Nonmucinous No C34.3 8252/3 C34.3 YES 1.1 NO YES NO 1.6 NO NO No MX N0 T1a Stage I TCGA-97-8552.0bfe6dee-7584-4803-be3e-5201cd5ad412.pdf 8552 Other TUMOR FREE 77 95 Complete Remission/Response YES NO Primary Tumor 01 0.4 7th NO YES NO 97 1 Lung A LIVING 2012 7d16518c-7da4-4b50-ae77-a708eccf5db0 TCGA-97-8552-01A-11D-2389-01 TCGA-97-8552-01A-11D-2398-05 TCGA-97-8552-01 TCGA-97-8552-01A-11D-2389-01 7d16518c-7da4-4b50-ae77-a708eccf5db0 TCGA-97-8552-01 7d16518c-7da4-4b50-ae77-a708eccf5db0 TCGA-97-8552-01 7d16518c-7da4-4b50-ae77-a708eccf5db0 TCGA-97-8552-01A-11D-2393-08 TCGA-97-8552-01 +TCGA-97-A4LX-01 TCGA-97-A4LX-01 TCGA-97-A4LX TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 81 Other (please specify) Lingula TCGA-97-A4LX-F57384 TCGA-97-A4LX TCGA-97-A4LX-01A -29915 127 0 614 61 0 NO NO Scheduled Follow-up Submission Complete Remission/Response 2014-3-10 MALE Lung Adenocarcinoma Mixed Subtype No C34.1 8255/3 C34.1 YES 50 NO YES YES G12A NO NO 120 true Yes, History of Synchronous/Bilateral Malignancy M0 N0 T2a Stage IB TCGA-97-A4LX.1D7E3689-7B7F-4916-BCD9-04C5A98F09DE.pdf A4LX Other TUMOR FREE 96 90 91 91 Complete Remission/Response YES NO Primary Tumor 01 1985 7th NO YES NO 97 3 Lung A LIVING 2012 1945 7d313d92-13f0-49f2-bff6-20e4fdd09337 TCGA-97-A4LX-01A-11D-A24O-01 TCGA-97-A4LX-01A-11D-A24U-05 TCGA-97-A4LX-01 TCGA-97-A4LX-01A-11D-A24O-01 7d313d92-13f0-49f2-bff6-20e4fdd09337 TCGA-97-A4LX-01 7d313d92-13f0-49f2-bff6-20e4fdd09337 TCGA-97-A4LX-01 7d313d92-13f0-49f2-bff6-20e4fdd09337 TCGA-97-A4LX-01A-11D-A24P-08 TCGA-97-A4LX-01 +TCGA-97-A4M0-01 TCGA-97-A4M0-01 TCGA-97-A4M0 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 60 R-Upper TCGA-97-A4M0-F57385 TCGA-97-A4M0 TCGA-97-A4M0-01A -22206 136 0 652 0 NO NO Scheduled Follow-up Submission Complete Remission/Response 2014-3-10 FEMALE Lung Adenocarcinoma Mixed Subtype No C34.1 8255/3 C34.1 YES 150 NO YES YES G12C NO NO 34 true No M0 N0 T2a Stage IB TCGA-97-A4M0.0ACA9251-2F21-49E1-9E56-4D7359EF614F.pdf A4M0 Other TUMOR FREE 90 97 Complete Remission/Response YES NO Primary Tumor 01 2004 7th NO YES NO 97 4 Lung A LIVING 2012 1970 91128d24-c61a-47cf-938b-00ff80e4d0e7 TCGA-97-A4M0-01A-11D-A24O-01 TCGA-97-A4M0-01A-11D-A24U-05 TCGA-97-A4M0-01 TCGA-97-A4M0-01A-11D-A24O-01 91128d24-c61a-47cf-938b-00ff80e4d0e7 TCGA-97-A4M0-01 91128d24-c61a-47cf-938b-00ff80e4d0e7 TCGA-97-A4M0-01 321ABB1E-B7E7-4CA9-B1AC-6364EBEE1CE0 91128d24-c61a-47cf-938b-00ff80e4d0e7 TCGA-97-A4M0-01A-11D-A24P-08 TCGA-97-A4M0-01 +TCGA-97-A4M1-01 TCGA-97-A4M1-01 TCGA-97-A4M1 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 52 R-Upper TCGA-97-A4M1-F57386 TCGA-97-A4M1 -19272 0 601 111 0 NO NO Scheduled Follow-up Submission Complete Remission/Response 2014-3-10 FEMALE Lung Adenocarcinoma Mixed Subtype No C34.1 8255/3 C34.1 YES NO NO NO 3 No M0 N0 T1a Stage IA A4M1 Other TUMOR FREE 92 105 87 100 Complete Remission/Response YES NO Primary Tumor 01 1975 7th NO YES NO 97 3 Lung LIVING 2012 1972 da823ce3-fb4c-4626-824d-deef668836cf TCGA-97-A4M1-01A-11D-A24O-01 TCGA-97-A4M1-01A-11D-A24U-05 TCGA-97-A4M1-01 TCGA-97-A4M1-01A-11D-A24O-01 da823ce3-fb4c-4626-824d-deef668836cf TCGA-97-A4M1-01 da823ce3-fb4c-4626-824d-deef668836cf TCGA-97-A4M1-01 da823ce3-fb4c-4626-824d-deef668836cf TCGA-97-A4M1-01A-11D-A24P-08 TCGA-97-A4M1-01 +TCGA-97-A4M2-01 TCGA-97-A4M2-01 TCGA-97-A4M2 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 66 R-Middle TCGA-97-A4M2-F57453 TCGA-97-A4M2 TCGA-97-A4M2-01A -24313 93 0 624 91 1 NO NO Scheduled Follow-up Submission Complete Remission/Response 2014-3-12 MALE Lung Adenocarcinoma Mixed Subtype No C34.2 8255/3 C34.2 YES 180 NO YES NO NO NO 100 true Yes, History of Prior Malignancy M0 N0 T1a Stage IA TCGA-97-A4M2.0D5976EC-5D41-44A2-AC0A-CBE90F2A908E.pdf A4M2 Preoperative TUMOR FREE 89 103 96 102 Complete Remission/Response YES NO R0 Primary Tumor 01 7th NO YES NO 97 2 Lung A LIVING 2012 1972 dc3f6cbd-8bf0-4b8e-bce8-eada0768499d TCGA-97-A4M2-01A-12D-A24O-01 TCGA-97-A4M2-01A-12D-A24U-05 TCGA-97-A4M2-01 TCGA-97-A4M2-01A-12D-A24O-01 dc3f6cbd-8bf0-4b8e-bce8-eada0768499d TCGA-97-A4M2-01 dc3f6cbd-8bf0-4b8e-bce8-eada0768499d TCGA-97-A4M2-01 8BF45AB6-A183-4187-9AE7-82E2C9DD83CA dc3f6cbd-8bf0-4b8e-bce8-eada0768499d TCGA-97-A4M2-01A-12D-A24P-08 TCGA-97-A4M2-01 +TCGA-97-A4M3-01 TCGA-97-A4M3-01 TCGA-97-A4M3 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung NO NO 69 R-Upper TCGA-97-A4M3-F57436 TCGA-97-A4M3 -25384 0 540 54 106 1 NO NO Scheduled Follow-up Submission Complete Remission/Response 2014-3-11 FEMALE Lung Adenocarcinoma Mixed Subtype No C34.1 8255/3 C34.1 YES YES NO NO New Primary Tumor YES 37.5 Yes, History of Prior Malignancy M0 N0 T1b Stage IA A4M3 Other TUMOR FREE 69 73 61 61 Complete Remission/Response Biopsy with Histologic Confirmation YES NO Primary Tumor 01 1984 7th NO YES NO 97 3 Lung LIVING 2012 1959 cb8f5c13-0ae8-4ec2-9249-3322ff220fff TCGA-97-A4M3-01A-11D-A24O-01 TCGA-97-A4M3-01A-11D-A24U-05 TCGA-97-A4M3-01 TCGA-97-A4M3-01A-11D-A24O-01 cb8f5c13-0ae8-4ec2-9249-3322ff220fff TCGA-97-A4M3-01 cb8f5c13-0ae8-4ec2-9249-3322ff220fff TCGA-97-A4M3-01 cb8f5c13-0ae8-4ec2-9249-3322ff220fff TCGA-97-A4M3-01A-11D-A24P-08 TCGA-97-A4M3-01 +TCGA-97-A4M5-01 TCGA-97-A4M5-01 TCGA-97-A4M5 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 83 R-Upper TCGA-97-A4M5-F57443 TCGA-97-A4M5 TCGA-97-A4M5-01A -30665 104 0 634 51 NO NO Scheduled Follow-up Submission Complete Remission/Response 2014-3-12 MALE Lung Adenocarcinoma Mixed Subtype No C34.1 8255/3 C34.1 YES 200 NO YES YES G12C NO NO 6 true No M0 N0 T1b Stage IA TCGA-97-A4M5.BD386F47-1CDC-46D5-A14D-F7D27F70982F.pdf A4M5 TUMOR FREE 84 94 85 98 Complete Remission/Response YES NO Primary Tumor 01 1982 7th NO YES NO 97 3 Lung A LIVING 2012 1952 a9b0abf6-d818-4aa0-a1bc-3e3c1cf2ff59 TCGA-97-A4M5-01A-11D-A24O-01 TCGA-97-A4M5-01A-11D-A24U-05 TCGA-97-A4M5-01 TCGA-97-A4M5-01A-11D-A24O-01 a9b0abf6-d818-4aa0-a1bc-3e3c1cf2ff59 TCGA-97-A4M5-01 a9b0abf6-d818-4aa0-a1bc-3e3c1cf2ff59 TCGA-97-A4M5-01 D9F235CC-55EF-4AC4-98B3-B69F92DCE4CB a9b0abf6-d818-4aa0-a1bc-3e3c1cf2ff59 TCGA-97-A4M5-01A-11D-A24P-08 TCGA-97-A4M5-01 +TCGA-97-A4M6-01 TCGA-97-A4M6-01 TCGA-97-A4M6 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 45 R-Lower TCGA-97-A4M6-F57434 TCGA-97-A4M6 TCGA-97-A4M6-01A -16764 115 0 568 92 0 YES Exon 19 Deletion NO Scheduled Follow-up Submission Complete Remission/Response 2014-3-11 FEMALE Lung Adenocarcinoma Mixed Subtype No C34.3 8255/3 C34.3 YES 180 NO YES NO NO NO true No M0 N0 T1a Stage IA TCGA-97-A4M6.E697A53A-C377-4BC8-8D3F-79562DFF6F0A.pdf A4M6 Other TUMOR FREE 95 116 95 110 Complete Remission/Response YES NO Primary Tumor 01 7th NO YES NO 97 1 Lung A LIVING 2012 39408ce7-3fca-4e7e-8016-e8586b7bafad TCGA-97-A4M6-01A-11D-A24O-01 TCGA-97-A4M6-01A-11D-A24U-05 TCGA-97-A4M6-01 TCGA-97-A4M6-01A-11D-A24O-01 39408ce7-3fca-4e7e-8016-e8586b7bafad TCGA-97-A4M6-01 39408ce7-3fca-4e7e-8016-e8586b7bafad TCGA-97-A4M6-01 182BCA7C-1999-4ACE-A36C-DF0C597D67FE 39408ce7-3fca-4e7e-8016-e8586b7bafad TCGA-97-A4M6-01A-11D-A24P-08 TCGA-97-A4M6-01 +TCGA-97-A4M7-01 TCGA-97-A4M7-01 TCGA-97-A4M7 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 74 R-Middle TCGA-97-A4M7-F57383 TCGA-97-A4M7 TCGA-97-A4M7-01A -27062 132 0 629 99 0 YES L858R NO Scheduled Follow-up Submission Complete Remission/Response 2014-3-10 MALE Lung Adenocarcinoma Mixed Subtype No C34.2 8255/3 C34.2 YES 160 NO YES NO NO NO 40 true Yes, History of Synchronous/Bilateral Malignancy M0 N0 T1b Stage IA TCGA-97-A4M7.6E901848-BA21-4D4A-9CB5-0A5786D2843B.pdf A4M7 Other TUMOR FREE 82 101 74 91 Complete Remission/Response YES NO R0 Primary Tumor 01 1978 7th NO YES NO 97 3 Lung A LIVING 2012 1958 038898c8-e2f3-4bd9-9b8e-da45b86ea2ea TCGA-97-A4M7-01A-11D-A24O-01 TCGA-97-A4M7-01A-11D-A24U-05 TCGA-97-A4M7-01 TCGA-97-A4M7-01A-11D-A24O-01 038898c8-e2f3-4bd9-9b8e-da45b86ea2ea TCGA-97-A4M7-01 038898c8-e2f3-4bd9-9b8e-da45b86ea2ea TCGA-97-A4M7-01 8AEEDABD-261B-43F1-B68E-0CE7B0F3E74A 038898c8-e2f3-4bd9-9b8e-da45b86ea2ea TCGA-97-A4M7-01A-11D-A24P-08 TCGA-97-A4M7-01 +TCGA-99-7458-01 1.79 0.36 none none none none Y Y none none none 0.19 Bronchioid none p.G12R none none none none none Micropapillary predom Adc Micropapillary predom Adc none 0 TCGA-99-7458-01 BRCA-LUAD+ C1-LUAD-enriched cluster 2 Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 5 cluster 3 TCGA-99-7458 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 74 R-Lower TCGA-99-7458-F40777 TCGA-99-7458 TCGA-99-7458-01A -27359 0 747 1 YES RT-PCR YES Scheduled Follow-up Submission Stable Disease 2013-4-17 FEMALE Lung Bronchioloalveolar Carcinoma Nonmucinous No C34.3 8252/3 C34.3 YES 0.7 NO 90 YES YES G12A 1.2 NO NO 52 No M0 N0 T4 Stage IIIA TCGA-99-7458.d17d08c5-429b-413f-8ed6-984bc2021392.pdf 7458 Preoperative WITH TUMOR Stable Disease NO R0 Primary Tumor 01 0.7 2010 7th YES NO YES 99 4 Current reformed smoker for < or = 15 years Lung A LIVING 2010 1958 TCGA-99-7458-01A-11D-2036-08 38574f35-5845-4a7d-8657-da3d8757a0eb TCGA-99-7458-01A-11D-2035-01 TCGA-99-7458-01A-11D-2037-05 TCGA-99-7458-01 TCGA-99-7458-01A-11D-2035-01 38574f35-5845-4a7d-8657-da3d8757a0eb TCGA-99-7458-01 TCGA-99-7458-01A-13-2192-20 38574f35-5845-4a7d-8657-da3d8757a0eb TCGA-99-7458-01 603528a1-05bf-43b5-a90b-1b8266f2a925 38574f35-5845-4a7d-8657-da3d8757a0eb TCGA-99-7458-01A-11D-2036-08 TCGA-99-7458-01 +TCGA-99-8025-01 TCGA-99-8025-01 High Cluster 6 LUAD-like c10 miRNA cluster 4 TCGA-99-8025 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 72 R-Upper TCGA-99-8025-F57698 TCGA-99-8025 TCGA-99-8025-01A -26634 0 1060 87 1 YES YES Scheduled Follow-up Submission Complete Remission/Response 2014-5-23 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.8 NO YES NO Central Lung 1.2 NO NO 20 No M0 N2 T3 Stage IIIA TCGA-99-8025.42373413-46df-4837-a01f-2659d92888cd.pdf 8025 Preoperative TUMOR FREE 111 Complete Remission/Response YES NO R0 Primary Tumor 01 0.4 1998 7th YES NO YES 99 4 Lung A LIVING 2010 1958 36c6906f-7f3e-4bb4-9813-246dc7669fc6 TCGA-99-8025-01A-11D-2237-01 TCGA-99-8025-01A-11D-2239-05 TCGA-99-8025-01 TCGA-99-8025-01A-11D-2237-01 36c6906f-7f3e-4bb4-9813-246dc7669fc6 TCGA-99-8025-01 36c6906f-7f3e-4bb4-9813-246dc7669fc6 TCGA-99-8025-01 36c6906f-7f3e-4bb4-9813-246dc7669fc6 TCGA-99-8025-01A-11D-2238-08 TCGA-99-8025-01 +TCGA-99-8028-01 TCGA-99-8028-01 Kirc+ Cluster 5 LUAD-like c10 miRNA c1uster 9 TCGA-99-8028 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 50 L-Upper TCGA-99-8028-F57699 TCGA-99-8028 TCGA-99-8028-01A -18542 0 1118 71 0 YES RT-PCR YES Scheduled Follow-up Submission Complete Remission/Response 2014-4-17 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.6 NO YES YES G12C 1.3 NO NO 30 No M0 N0 T1a Stage IA TCGA-99-8028.c5b3fd4e-8e81-4b8f-b38d-e2a6bbded1ee.pdf 8028 Preoperative TUMOR FREE 91 98 91 94 Complete Remission/Response YES NO R0 Primary Tumor 01 0.5 2011 7th NO NO YES 99 4 Lung A LIVING 2011 1981 e4ac001e-f87e-4c46-8e0e-cee8a4f80965 TCGA-99-8028-01A-11D-2237-01 TCGA-99-8028-01A-11D-2239-05 TCGA-99-8028-01 TCGA-99-8028-01A-11D-2237-01 e4ac001e-f87e-4c46-8e0e-cee8a4f80965 TCGA-99-8028-01 e4ac001e-f87e-4c46-8e0e-cee8a4f80965 TCGA-99-8028-01 990284E7-6075-4B31-AABB-499539FCBBDF e4ac001e-f87e-4c46-8e0e-cee8a4f80965 TCGA-99-8028-01A-11D-2238-08 TCGA-99-8028-01 +TCGA-99-8032-01 TCGA-99-8032-01 BRCA-LUAD+ Cluster 5 LUAD-like c10 miRNA cluster 6 TCGA-99-8032 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 61 R-Upper TCGA-99-8032 TCGA-99-8032-01A -22635 0 44 54 0 YES NO 2012-6-15 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.7 NO YES YES G12C 1.3 90 No M0 N0 T1a Stage IA TCGA-99-8032.376597ef-e750-4f66-b744-2b042c0df836.pdf 8032 Preoperative TUMOR FREE 55 59 Complete Remission/Response YES NO R0 Primary Tumor 01 0.5 7th NO YES NO 99 2 Lung A LIVING 2011 1966 179cc9f5-4583-4c7c-945b-a2754234716f TCGA-99-8032-01A-11D-2237-01 TCGA-99-8032-01A-11D-2239-05 TCGA-99-8032-01 TCGA-99-8032-01A-11D-2237-01 179cc9f5-4583-4c7c-945b-a2754234716f TCGA-99-8032-01 179cc9f5-4583-4c7c-945b-a2754234716f TCGA-99-8032-01 179cc9f5-4583-4c7c-945b-a2754234716f TCGA-99-8032-01A-11D-2238-08 TCGA-99-8032-01 +TCGA-99-8033-01 TCGA-99-8033-01 High Cluster 5 LUAD-like c10 miRNA cluster 4 TCGA-99-8033 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 74 R-Upper TCGA-99-8033-F58623 TCGA-99-8033 TCGA-99-8033-01A -27342 656 0 170 2 YES NO Scheduled Follow-up Submission 2015-3-30 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.6 NO YES NO Peripheral Lung 0.6 NO NO No M1 NX TX Stage IV TCGA-99-8033.a7f10fd8-ab32-4adb-94a9-31632e286b11.pdf 8033 Post-Adjuvant Therapy WITH TUMOR Progressive Disease NO YES R0 Primary Tumor 01 0.5 7th YES YES NO 99 1 Lung A DECEASED 2011 1fd32c7c-73dd-4c17-a0ac-7b33f610976e TCGA-99-8033-01A-11D-2237-01 TCGA-99-8033-01A-11D-2239-05 TCGA-99-8033-01 TCGA-99-8033-01A-11D-2237-01 1fd32c7c-73dd-4c17-a0ac-7b33f610976e TCGA-99-8033-01 1fd32c7c-73dd-4c17-a0ac-7b33f610976e TCGA-99-8033-01 1fd32c7c-73dd-4c17-a0ac-7b33f610976e TCGA-99-8033-01A-11D-2238-08 TCGA-99-8033-01 +TCGA-99-AA5R-01 TCGA-99-AA5R-01 TCGA-99-AA5R TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 70 L-Lower TCGA-99-AA5R-F69298 TCGA-99-AA5R TCGA-99-AA5R-01A -25778 323 0 658 47 1 YES IHC YES Scheduled Follow-up Submission 2014-12-31 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 90 NO YES YES G12C NO NO 46 true No M0 N0 T1a Stage IA TCGA-99-AA5R.5541B103-6FD2-4767-B914-8A5B58E86D0A.pdf AA5R Preoperative TUMOR FREE 65 64 Complete Remission/Response YES NO R0 Primary Tumor 01 7th NO YES NO 99 2 Lung A LIVING 2013 1967 07f7b453-5716-466f-affd-74a24c4d5c53 TCGA-99-AA5R-01A-11D-A396-01 TCGA-99-AA5R-01A-11D-A398-05 TCGA-99-AA5R-01 TCGA-99-AA5R-01A-11D-A396-01 07f7b453-5716-466f-affd-74a24c4d5c53 TCGA-99-AA5R-01 07f7b453-5716-466f-affd-74a24c4d5c53 TCGA-99-AA5R-01 07f7b453-5716-466f-affd-74a24c4d5c53 TCGA-99-AA5R-01 +TCGA-J2-8192-01 TCGA-J2-8192-01 Kirc+ Cluster 5 LUAD-like c10 miRNA cluster 4 TCGA-J2-8192 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung YES NO NO NO 65 L-Upper TCGA-J2-8192-F55390 TCGA-J2-8192 TCGA-J2-8192-01A -23892 0 739 482 112 YES Exon 19 Deletion NO Scheduled Follow-up Submission 2014-2-18 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.7 NO YES NO 1 NO Locoregional Recurrence YES Yes, History of Prior Malignancy MX N1 T2a Stage IIA TCGA-J2-8192.ab6bb598-f1a2-4691-90c4-e8d63dea8772.pdf 8192 TUMOR FREE 100 89 97 77 Progressive Disease Biopsy with Histologic Confirmation YES NO Primary Tumor 01 0.3 7th YES YES NO J2 1 Lung A LIVING 2011 54e59fdb-a377-4f69-84aa-8aa21312d270 TCGA-J2-8192-01A-11D-2237-01 TCGA-J2-8192-01A-11D-2239-05 TCGA-J2-8192-01 TCGA-J2-8192-01A-11D-2237-01 54e59fdb-a377-4f69-84aa-8aa21312d270 TCGA-J2-8192-01 54e59fdb-a377-4f69-84aa-8aa21312d270 TCGA-J2-8192-01 7C2B57F4-354C-48E0-98D4-98686E0F435D 54e59fdb-a377-4f69-84aa-8aa21312d270 TCGA-J2-8192-01A-11D-2238-08 TCGA-J2-8192-01 +TCGA-J2-8194-01 TCGA-J2-8194-01 BRCA-LUAD+ Cluster 5 LUAD-like c10 miRNA cluster 4 TCGA-J2-8194 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung YES NO NO YES 69 R-Lower TCGA-J2-8194-F55317 TCGA-J2-8194 TCGA-J2-8194-01A 518 -25441 0 724 470 59 Scheduled Follow-up Submission Partial Remission/Response 2014-1-3 FEMALE Lung Adenocarcinoma Mixed Subtype No C34.3 8255/3 C34.3 YES 0.6 NO 0.8 NO Distant Metastasis YES 20 Yes, History of Prior Malignancy MX N0 T3 Stage IIB TCGA-J2-8194.9604f23f-f09c-480e-828f-5760b5fcdae4.pdf 8194 WITH TUMOR 2.04 83 2.04 83 Progressive Disease Biopsy with Histologic Confirmation|Convincing Imaging YES YES Primary Tumor 01 0.4 1982 7th YES YES NO J2 3 Lung A LIVING 2011 1956 c0639498-dcbb-432b-816a-1aa025c5ad60 TCGA-J2-8194-01A-11D-2237-01 TCGA-J2-8194-01A-11D-2239-05 TCGA-J2-8194-01 TCGA-J2-8194-01A-11D-2237-01 c0639498-dcbb-432b-816a-1aa025c5ad60 TCGA-J2-8194-01 c0639498-dcbb-432b-816a-1aa025c5ad60 TCGA-J2-8194-01 8A3CA32A-7352-4CD6-9B49-F0D1C13B27E7 c0639498-dcbb-432b-816a-1aa025c5ad60 TCGA-J2-8194-01A-11D-2238-08 TCGA-J2-8194-01 +TCGA-J2-A4AD-01 TCGA-J2-A4AD-01 TCGA-J2-A4AD TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung NO NO 61 L-Upper TCGA-J2-A4AD-F55524 TCGA-J2-A4AD TCGA-J2-A4AD-01A -22414 178 550 0 287 524 NO NO Scheduled Follow-up Submission 2014-1-8 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 110 NO NO NO Locoregional Recurrence|Distant Metastasis YES 120 true No MX N0 T1a Stage IA TCGA-J2-A4AD.C7D2CA13-F82C-4B95-9161-E9D8C8D958E0.pdf A4AD WITH TUMOR 1.95 Convincing Imaging YES NO RX Primary Tumor 01 7th NO YES NO J2 2 Lung A DECEASED 2012 1970 2d6005de-b9ad-48ab-bfc9-60995838a002 TCGA-J2-A4AD-01A-11D-A24C-01 TCGA-J2-A4AD-01A-11D-A24I-05 TCGA-J2-A4AD-01 TCGA-J2-A4AD-01A-11D-A24C-01 2d6005de-b9ad-48ab-bfc9-60995838a002 TCGA-J2-A4AD-01 2d6005de-b9ad-48ab-bfc9-60995838a002 TCGA-J2-A4AD-01 ABFCA382-3B85-4597-B9A4-ECC64E6894EA 2d6005de-b9ad-48ab-bfc9-60995838a002 TCGA-J2-A4AD-01A-11D-A24D-08 TCGA-J2-A4AD-01 +TCGA-J2-A4AE-01 TCGA-J2-A4AE-01 TCGA-J2-A4AE TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 77 L-Upper TCGA-J2-A4AE-F70639 TCGA-J2-A4AE TCGA-J2-A4AE-01A -28163 177 0 1079 89 NO NO Scheduled Follow-up Submission Complete Remission/Response 2015-2-27 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 90 NO NO NO NO true No MX N0 T1a Stage IA TCGA-J2-A4AE.DF9C8900-3277-481F-82BD-335744EABD7A.pdf A4AE TUMOR FREE 0.72 92 Complete Remission/Response YES NO R0 Primary Tumor 01 7th NO YES NO J2 1 Lung A LIVING 2012 25b7445f-2f62-4303-b983-cdde19c12256 TCGA-J2-A4AE-01A-21D-A24C-01 TCGA-J2-A4AE-01A-21D-A24I-05 TCGA-J2-A4AE-01 TCGA-J2-A4AE-01A-21D-A24C-01 25b7445f-2f62-4303-b983-cdde19c12256 TCGA-J2-A4AE-01 25b7445f-2f62-4303-b983-cdde19c12256 TCGA-J2-A4AE-01 25b7445f-2f62-4303-b983-cdde19c12256 TCGA-J2-A4AE-01A-21D-A24D-08 TCGA-J2-A4AE-01 +TCGA-J2-A4AG-01 TCGA-J2-A4AG-01 TCGA-J2-A4AG TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 66 L-Upper TCGA-J2-A4AG-F70848 TCGA-J2-A4AG TCGA-J2-A4AG-01A -24224 129 0 988 NO NO Scheduled Follow-up Submission Complete Remission/Response 2015-3-10 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 280 NO NO NO NO 25 true No MX N0 T1b Stage IA TCGA-J2-A4AG.E56191DA-873E-4506-8591-A6989706F8CB.pdf A4AG TUMOR FREE Complete Remission/Response NO NO R0 Primary Tumor 01 1981 7th NO YES NO J2 3 Lung A LIVING 2012 1956 34c74991-850e-4794-9603-a7212905e13b TCGA-J2-A4AG-01A-11D-A24C-01 TCGA-J2-A4AG-01A-11D-A24I-05 TCGA-J2-A4AG-01 TCGA-J2-A4AG-01A-11D-A24C-01 34c74991-850e-4794-9603-a7212905e13b TCGA-J2-A4AG-01 34c74991-850e-4794-9603-a7212905e13b TCGA-J2-A4AG-01 EBC840C6-D38B-46E7-A2DA-98BF4D76EECF 34c74991-850e-4794-9603-a7212905e13b TCGA-J2-A4AG-01A-11D-A24D-08 TCGA-J2-A4AG-01 +TCGA-L4-A4E5-01 TCGA-L4-A4E5-01 TCGA-L4-A4E5 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 48 L-Upper TCGA-L4-A4E5-F49031 TCGA-L4-A4E5 TCGA-L4-A4E5-01A -17680 227 0 578 93 1 NO NO Scheduled Follow-up Submission Complete Remission/Response 2013-9-25 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 160 NO NO Central Lung NO NO 33 true No M0 N0 T1 Stage I TCGA-L4-A4E5.22CFA28A-0CE4-4806-97B0-32635D6DCE3F.pdf A4E5 Other TUMOR FREE 94 82 94 82 Complete Remission/Response YES NO R0 Primary Tumor 01 2012 7th NO NO YES L4 4 Lung A LIVING 2012 1979 00481f66-1aad-4885-9162-bf802b1ed7f5 TCGA-L4-A4E5-01A-11D-A24O-01 TCGA-L4-A4E5-01A-11D-A24U-05 TCGA-L4-A4E5-01 TCGA-L4-A4E5-01A-11D-A24O-01 00481f66-1aad-4885-9162-bf802b1ed7f5 TCGA-L4-A4E5-01 00481f66-1aad-4885-9162-bf802b1ed7f5 TCGA-L4-A4E5-01 331399DA-7E57-4B25-9877-30C156C27CCA 00481f66-1aad-4885-9162-bf802b1ed7f5 TCGA-L4-A4E5-01A-11D-A24P-08 TCGA-L4-A4E5-01 +TCGA-L4-A4E6-01 TCGA-L4-A4E6-01 TCGA-L4-A4E6 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 67 R-Upper TCGA-L4-A4E6-F51277 TCGA-L4-A4E6 TCGA-L4-A4E6-01A -24631 22 0 435 98 NO NO Scheduled Follow-up Submission Complete Remission/Response 2013-11-14 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 210 NO NO Peripheral Lung NO NO 30 true No M0 N0 T1 Stage IA TCGA-L4-A4E6.A6FC7AD1-BE0E-4B6C-A71C-CBDC7CD58968.pdf A4E6 TUMOR FREE 82 85 84 69 Complete Remission/Response YES NO R0 Primary Tumor 01 1984 7th NO NO YES L4 3 Lung A LIVING 2012 1954 ff0e31ac-ee03-495a-97e0-a5283fd1c3ae TCGA-L4-A4E6-01A-11D-A24C-01 TCGA-L4-A4E6-01A-11D-A24I-05 TCGA-L4-A4E6-01 TCGA-L4-A4E6-01A-11D-A24C-01 ff0e31ac-ee03-495a-97e0-a5283fd1c3ae TCGA-L4-A4E6-01 ff0e31ac-ee03-495a-97e0-a5283fd1c3ae TCGA-L4-A4E6-01 22C2601E-1B91-4320-8DA2-0605B8E2680C ff0e31ac-ee03-495a-97e0-a5283fd1c3ae TCGA-L4-A4E6-01A-11D-A24D-08 TCGA-L4-A4E6-01 +TCGA-L9-A443-01 TCGA-L9-A443-01 TCGA-L9-A443 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 63 L-Lower TCGA-L9-A443-F46410 TCGA-L9-A443 TCGA-L9-A443-01A -23062 50 193 0 116 61 1 NO NO Scheduled Follow-up Submission 2013-8-7 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 230 NO NO Central Lung NO NO 90 false Yes, History of Prior Malignancy MX N0 T1a Stage IA TCGA-L9-A443.4D3DD711-7FC9-4CC8-B297-48036F42DCE7.pdf A443 Preoperative TUMOR FREE 74 69 Complete Remission/Response YES NO R0 Primary Tumor 01 2005 7th NO YES NO L9 4 Lung A DECEASED 2012 1960 12922017-4f50-4d3d-9bf9-8d9bf7a3b8d4 TCGA-L9-A443-01A-12D-A24C-01 TCGA-L9-A443-01A-12D-A24I-05 TCGA-L9-A443-01 TCGA-L9-A443-01A-12D-A24C-01 12922017-4f50-4d3d-9bf9-8d9bf7a3b8d4 TCGA-L9-A443-01 12922017-4f50-4d3d-9bf9-8d9bf7a3b8d4 TCGA-L9-A443-01 B966DC18-9A95-46B3-AB90-841345077266 12922017-4f50-4d3d-9bf9-8d9bf7a3b8d4 TCGA-L9-A443-01A-12D-A24D-08 TCGA-L9-A443-01 +TCGA-L9-A444-01 TCGA-L9-A444-01 TCGA-L9-A444 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 60 R-Upper TCGA-L9-A444-F46270 TCGA-L9-A444 TCGA-L9-A444-01A -22202 8 0 307 57 0 NO NO Scheduled Follow-up Submission Complete Remission/Response 2013-8-5 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 150 NO NO Central Lung NO NO 10 false Yes, History of Prior Malignancy MX N0 T1a Stage IA TCGA-L9-A444.7356DDFB-ADA7-4809-85EC-1C6D51D5B32D.pdf A444 Preoperative TUMOR FREE 62 54 58 49 Complete Remission/Response YES NO R0 Primary Tumor 01 7th NO YES NO L9 2 Lung A LIVING 2012 1972 a3b81644-c1b8-4d12-b6f8-6160533758cc TCGA-L9-A444-01A-21D-A24C-01 TCGA-L9-A444-01A-21D-A24I-05 TCGA-L9-A444-01 TCGA-L9-A444-01A-21D-A24C-01 a3b81644-c1b8-4d12-b6f8-6160533758cc TCGA-L9-A444-01 a3b81644-c1b8-4d12-b6f8-6160533758cc TCGA-L9-A444-01 DE878A76-48F1-498B-B170-8472576EEF51 a3b81644-c1b8-4d12-b6f8-6160533758cc TCGA-L9-A444-01A-21D-A24D-08 TCGA-L9-A444-01 +TCGA-L9-A50W-01 TCGA-L9-A50W-01 TCGA-L9-A50W TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung NO NO NO NO 75 L-Lower TCGA-L9-A50W-F50396 TCGA-L9-A50W TCGA-L9-A50W-01A -27414 205 442 0 266 389 0 YES T790M FISH YES Scheduled Follow-up Submission Progressive Disease 2013-10-23 MALE Lung Adenocarcinoma Mixed Subtype No C34.3 8255/3 C34.3 YES 240 NO NO NO Distant Metastasis YES 19 false No MX N1 T1b Stage IIA TCGA-L9-A50W.ADB0E9E3-62E7-4461-9254-14DC15DCB877.pdf A50W Preoperative WITH TUMOR 103 81 Stable Disease Biopsy with Histologic Confirmation|Convincing Imaging YES NO R0 Primary Tumor 01 1986 7th NO YES NO L9 3 Lung A DECEASED 2012 1967 717093f1-916b-4d01-a74c-18af938563c0 TCGA-L9-A50W-01A-12D-A396-01 TCGA-L9-A50W-01A-12D-A398-05 TCGA-L9-A50W-01 TCGA-L9-A50W-01A-12D-A396-01 717093f1-916b-4d01-a74c-18af938563c0 TCGA-L9-A50W-01 717093f1-916b-4d01-a74c-18af938563c0 TCGA-L9-A50W-01 BABAEBD1-66FA-47EB-B655-5122162A0ECA 717093f1-916b-4d01-a74c-18af938563c0 TCGA-L9-A50W-01 +TCGA-L9-A5IP-01 TCGA-L9-A5IP-01 TCGA-L9-A5IP TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 40 R-Upper TCGA-L9-A5IP TCGA-L9-A5IP-01A -14681 94 58 0 YES FISH YES 2013-5-14 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 140 NO NO YES false No M1b N2 T3 Stage IV TCGA-L9-A5IP.0C79A75F-E3B3-4984-8406-2532E4A68D96.pdf A5IP WITH TUMOR Progressive Disease NO NO R1 Primary Tumor 01 2012 7th NO YES NO L9 4 Lung A DECEASED 2012 07cf4544-6ba1-4535-8bf5-18d5bf9e4123 TCGA-L9-A5IP-01A-21D-A396-01 TCGA-L9-A5IP-01A-21D-A398-05 TCGA-L9-A5IP-01 TCGA-L9-A5IP-01A-21D-A396-01 07cf4544-6ba1-4535-8bf5-18d5bf9e4123 TCGA-L9-A5IP-01 07cf4544-6ba1-4535-8bf5-18d5bf9e4123 TCGA-L9-A5IP-01 F7F211F5-D699-415B-87F2-15ED8BA97EE0 07cf4544-6ba1-4535-8bf5-18d5bf9e4123 TCGA-L9-A5IP-01 +TCGA-L9-A743-01 TCGA-L9-A743-01 TCGA-L9-A743 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 56 L-Upper TCGA-L9-A743-F66554 TCGA-L9-A743 TCGA-L9-A743-01A -20780 97 0 664 45 0 NO NO Scheduled Follow-up Submission Complete Remission/Response 2014-10-20 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 520 NO NO Central Lung NO NO 40.5 false Yes, History of Prior Malignancy M0 N1 T2a Stage IIA TCGA-L9-A743.58EBD3CE-DB70-4A6C-A267-AEC8E50B6BD3.pdf A743 Preoperative TUMOR FREE 81 78 85 88 Complete Remission/Response YES NO R0 Primary Tumor 01 7th YES YES NO L9 2 Lung A LIVING 2013 1986 a16a9fdf-3aa3-431b-a680-082e1bde6aab TCGA-L9-A743-01A-43D-A396-01 TCGA-L9-A743-01A-43D-A398-05 TCGA-L9-A743-01 TCGA-L9-A743-01A-43D-A396-01 a16a9fdf-3aa3-431b-a680-082e1bde6aab TCGA-L9-A743-01 a16a9fdf-3aa3-431b-a680-082e1bde6aab TCGA-L9-A743-01 4341B69A-5F22-40E4-B8E5-014FE0D1B8F9 a16a9fdf-3aa3-431b-a680-082e1bde6aab TCGA-L9-A743-01 +TCGA-L9-A7SV-01 TCGA-L9-A7SV-01 TCGA-L9-A7SV TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 69 L-Lower TCGA-L9-A7SV-F65116 TCGA-L9-A7SV TCGA-L9-A7SV-01A -25298 42 0 565 55 0 NO NO Scheduled Follow-up Submission Complete Remission/Response 2014-9-18 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 220 NO NO NO NO 93 false No M0 N1 T2a Stage IIA TCGA-L9-A7SV.C6014F3D-A7C4-455E-9DC8-A59244C81DF7.pdf A7SV Preoperative TUMOR FREE 40 45 38 40 Complete Remission/Response YES NO R0 Primary Tumor 01 1990 7th YES YES NO L9 3 Lung A LIVING 2013 1959 52592aa6-979e-4671-bc5a-4c6d31c3e8e1 TCGA-L9-A7SV-01A-11D-A396-01 TCGA-L9-A7SV-01A-11D-A398-05 TCGA-L9-A7SV-01 TCGA-L9-A7SV-01A-11D-A396-01 52592aa6-979e-4671-bc5a-4c6d31c3e8e1 TCGA-L9-A7SV-01 52592aa6-979e-4671-bc5a-4c6d31c3e8e1 TCGA-L9-A7SV-01 1C560CC9-A5FC-4E86-AF64-38C40110783A 52592aa6-979e-4671-bc5a-4c6d31c3e8e1 TCGA-L9-A7SV-01 +TCGA-L9-A8F4-01 TCGA-L9-A8F4-01 TCGA-L9-A8F4 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 64 L-Upper TCGA-L9-A8F4-F64972 TCGA-L9-A8F4 TCGA-L9-A8F4-01A -23617 93 0 476 35 0 NO NO Scheduled Follow-up Submission 2014-9-16 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 190 NO NO NO NO 14 false No MX N0 T2a Stage IB TCGA-L9-A8F4.FB592A19-E23C-465D-AEF4-55B9BBF7D486.pdf A8F4 Preoperative TUMOR FREE 48 54 45 53 YES YES R0 Primary Tumor 01 7th NO YES NO L9 2 Lung A LIVING 2013 1973 8fa61a97-acaa-4d5d-bc19-b1767afa356a TCGA-L9-A8F4-01A-11D-A396-01 TCGA-L9-A8F4-01A-11D-A398-05 TCGA-L9-A8F4-01 TCGA-L9-A8F4-01A-11D-A396-01 8fa61a97-acaa-4d5d-bc19-b1767afa356a TCGA-L9-A8F4-01 8fa61a97-acaa-4d5d-bc19-b1767afa356a TCGA-L9-A8F4-01 89418185-FE92-4730-99DA-DC68D7B4644E 8fa61a97-acaa-4d5d-bc19-b1767afa356a TCGA-L9-A8F4-01 +TCGA-MN-A4N1-01 TCGA-MN-A4N1-01 TCGA-MN-A4N1 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 60 R-Upper TCGA-MN-A4N1-F56662 TCGA-MN-A4N1 TCGA-MN-A4N1-01A -21939 330 0 827 55 0 YES IHC YES Scheduled Follow-up Submission Complete Remission/Response 2014-2-17 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 140 NO 100 NO NO NO true Yes, History of Prior Malignancy M0 N1 T2a Stage IIA TCGA-MN-A4N1.F6E1C257-EE3E-4564-8DE9-445C60D78AB8.pdf A4N1 Preoperative TUMOR FREE 74 117 Complete Remission/Response YES NO R0 Primary Tumor 01 7th NO NO YES MN 2 Lung A LIVING 2011 1967 38843819-bf57-4c30-ae2f-408653860739 TCGA-MN-A4N1-01A-11D-A24O-01 TCGA-MN-A4N1-01A-11D-A24U-05 TCGA-MN-A4N1-01 TCGA-MN-A4N1-01A-11D-A24O-01 38843819-bf57-4c30-ae2f-408653860739 TCGA-MN-A4N1-01 38843819-bf57-4c30-ae2f-408653860739 TCGA-MN-A4N1-01 0A23E69F-43EC-4242-BD62-E04899F8C238 38843819-bf57-4c30-ae2f-408653860739 TCGA-MN-A4N1-01A-11D-A24P-08 TCGA-MN-A4N1-01 +TCGA-MN-A4N4-01 TCGA-MN-A4N4-01 TCGA-MN-A4N4 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 57 L-Upper TCGA-MN-A4N4-F56667 TCGA-MN-A4N4 TCGA-MN-A4N4-01A -20888 664 0 1175 1 NO NO Scheduled Follow-up Submission Complete Remission/Response 2014-2-17 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 120 NO 100 NO NO NO true No M0 N0 T1b Stage IA TCGA-MN-A4N4.4D754ACD-90C1-4268-8E84-6A8A647A29C5.pdf A4N4 Preoperative TUMOR FREE 75 82 70 77 Complete Remission/Response YES NO R0 Primary Tumor 01 7th NO NO YES MN 2 Lung A LIVING 2010 1980 0d7719a9-58ac-4c27-99d3-0a6321c03ef6 TCGA-MN-A4N4-01A-12D-A24O-01 TCGA-MN-A4N4-01A-12D-A24U-05 TCGA-MN-A4N4-01 TCGA-MN-A4N4-01A-12D-A24O-01 0d7719a9-58ac-4c27-99d3-0a6321c03ef6 TCGA-MN-A4N4-01 0d7719a9-58ac-4c27-99d3-0a6321c03ef6 TCGA-MN-A4N4-01 28498EC3-F478-474D-B361-75EC6D6F9FA4 0d7719a9-58ac-4c27-99d3-0a6321c03ef6 TCGA-MN-A4N4-01A-12D-A24P-08 TCGA-MN-A4N4-01 +TCGA-MN-A4N5-01 TCGA-MN-A4N5-01 TCGA-MN-A4N5 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 63 L-Upper TCGA-MN-A4N5-F56665 TCGA-MN-A4N5 TCGA-MN-A4N5-01A -23257 408 0 84 82 0 YES IHC YES Scheduled Follow-up Submission 2014-2-17 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 80 NO 100 NO YES NO true No M0 N0 T1a Stage IA TCGA-MN-A4N5.3F2359D8-9958-485B-B00F-BD8ADD34FB1E.pdf A4N5 Preoperative TUMOR FREE 77 105 Complete Remission/Response YES NO R0 Primary Tumor 01 2011 7th NO NO YES MN 4 Lung A LIVING 2011 1971 6b636016-1b27-4977-8632-85ce773f7db9 TCGA-MN-A4N5-01A-11D-A24O-01 TCGA-MN-A4N5-01A-11D-A24U-05 TCGA-MN-A4N5-01 TCGA-MN-A4N5-01A-11D-A24O-01 6b636016-1b27-4977-8632-85ce773f7db9 TCGA-MN-A4N5-01 6b636016-1b27-4977-8632-85ce773f7db9 TCGA-MN-A4N5-01 6b636016-1b27-4977-8632-85ce773f7db9 TCGA-MN-A4N5-01A-11D-A24P-08 TCGA-MN-A4N5-01 +TCGA-MP-A4SV-01 TCGA-MP-A4SV-01 TCGA-MP-A4SV TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 67 L-Lower TCGA-MP-A4SV TCGA-MP-A4SV-01A -24516 3964 2620 0 48 NO NO 2013-4-2 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 160 NO NO 110 true No M0 N0 T2 Stage IB TCGA-MP-A4SV.8E809652-9783-4B7A-B92D-8C393A2940AB.pdf A4SV 78 62 Complete Remission/Response YES NO R0 Primary Tumor 01 5th NO NO YES MP 2 Lung A DECEASED 2001 1946 27a878b3-d7eb-49e3-9e1f-a12fcc33d67d TCGA-MP-A4SV-01A-11D-A24O-01 TCGA-MP-A4SV-01A-11D-A24U-05 TCGA-MP-A4SV-01 TCGA-MP-A4SV-01A-11D-A24O-01 27a878b3-d7eb-49e3-9e1f-a12fcc33d67d TCGA-MP-A4SV-01 27a878b3-d7eb-49e3-9e1f-a12fcc33d67d TCGA-MP-A4SV-01 AC6EC310-4C35-49E9-8817-C070C136A907 27a878b3-d7eb-49e3-9e1f-a12fcc33d67d TCGA-MP-A4SV-01A-11D-A24P-08 TCGA-MP-A4SV-01 +TCGA-MP-A4SW-01 TCGA-MP-A4SW-01 TCGA-MP-A4SW TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 53 L-Upper TCGA-MP-A4SW TCGA-MP-A4SW-01A -19640 3723 1778 0 102 NO NO 2013-4-2 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 130 NO NO 15 true No M0 N1 T2 Stage IIB TCGA-MP-A4SW.2A3C5E05-A4B8-4C01-B61D-3C46E9614707.pdf A4SW 101 90 Complete Remission/Response YES NO R0 Primary Tumor 01 1982 5th NO NO YES MP 3 Lung A DECEASED 2002 1967 f7301b53-0d6b-47ea-a7c4-6191ed59d3cb TCGA-MP-A4SW-01A-21D-A24O-01 TCGA-MP-A4SW-01A-21D-A24U-05 TCGA-MP-A4SW-01 TCGA-MP-A4SW-01A-21D-A24O-01 f7301b53-0d6b-47ea-a7c4-6191ed59d3cb TCGA-MP-A4SW-01 f7301b53-0d6b-47ea-a7c4-6191ed59d3cb TCGA-MP-A4SW-01 CDD79E0C-6487-421E-9543-1307A0C8DAD7 f7301b53-0d6b-47ea-a7c4-6191ed59d3cb TCGA-MP-A4SW-01A-21D-A24P-08 TCGA-MP-A4SW-01 +TCGA-MP-A4SY-01 TCGA-MP-A4SY-01 TCGA-MP-A4SY TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 61 R-Lower TCGA-MP-A4SY TCGA-MP-A4SY-01A -22448 3620 1501 0 73 0 NO NO 2013-4-2 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 130 NO NO Central Lung YES 40 true No M0 N1 T2 Stage IIB TCGA-MP-A4SY.C7A34958-C69B-4EDC-A4D6-503F52BA5330.pdf A4SY Pre-Adjuvant Therapy TUMOR FREE 74 54 Complete Remission/Response YES NO R0 Primary Tumor 01 2002 5th NO NO YES MP 4 Lung A DECEASED 2002 b695df40-ae14-490c-9d67-acda17494a35 TCGA-MP-A4SY-01A-21D-A24O-01 TCGA-MP-A4SY-01A-21D-A24U-05 TCGA-MP-A4SY-01 TCGA-MP-A4SY-01A-21D-A24O-01 b695df40-ae14-490c-9d67-acda17494a35 TCGA-MP-A4SY-01 b695df40-ae14-490c-9d67-acda17494a35 TCGA-MP-A4SY-01 811635C2-6BBD-4E84-A80A-10B3A9AA4864 b695df40-ae14-490c-9d67-acda17494a35 TCGA-MP-A4SY-01A-21D-A24P-08 TCGA-MP-A4SY-01 +TCGA-MP-A4T2-01 TCGA-MP-A4T2-01 TCGA-MP-A4T2 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung NO YES NO NO 71 L-Lower TCGA-MP-A4T2-F41327 TCGA-MP-A4T2 TCGA-MP-A4T2-01A -26010 3237 1136 0 1110 46 NO NO Additional New Tumor Event Progressive Disease 2013-3-14 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 240 NO NO NO Locoregional Recurrence|Distant Metastasis YES 75 true No M0 N0 T1 Stage IA TCGA-MP-A4T2.EC30FFC5-3C51-49E7-8996-18D9BCFC8552.pdf A4T2 WITH TUMOR 51 31 Complete Remission/Response Biopsy with Histologic Confirmation YES NO R0 Primary Tumor 01 2001 6th NO NO YES MP 4 Lung A DECEASED 2003 1951 TCGA-MP-A4T2-01A-11D-A24O-01 TCGA-MP-A4T2-01A-11D-A24U-05 TCGA-MP-A4T2-01A-11D-A24O-01 TCGA-MP-A4T2-01 BC635972-7BD2-4AC0-9025-A9EE61F23022 TCGA-MP-A4T2-01A-11D-A24P-08 TCGA-MP-A4T2-01 +TCGA-MP-A4T4-01 TCGA-MP-A4T4-01 TCGA-MP-A4T4 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 68 R-Lower TCGA-MP-A4T4 TCGA-MP-A4T4-01A -25052 2982 2617 0 53 0 NO NO 2013-4-2 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 440 NO NO 50 true No M0 N1 T2 Stage IIB TCGA-MP-A4T4.30003377-8D42-4189-BCCA-C04AB0669EBC.pdf A4T4 Preoperative 110 113 Complete Remission/Response YES NO R0 Primary Tumor 01 6th NO NO YES MP 2 Lung A DECEASED 2004 1954 fd1831a1-568b-4292-8d70-1450c392825f TCGA-MP-A4T4-01A-11D-A25M-01 TCGA-MP-A4T4-01A-11D-A25R-05 TCGA-MP-A4T4-01 TCGA-MP-A4T4-01A-11D-A25M-01 fd1831a1-568b-4292-8d70-1450c392825f TCGA-MP-A4T4-01 fd1831a1-568b-4292-8d70-1450c392825f TCGA-MP-A4T4-01 76113143-7458-4B3D-A466-4648AD6ADC27 fd1831a1-568b-4292-8d70-1450c392825f TCGA-MP-A4T4-01A-11D-A25L-08 TCGA-MP-A4T4-01 +TCGA-MP-A4T6-01 TCGA-MP-A4T6-01 TCGA-MP-A4T6 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 76 L-Lower TCGA-MP-A4T6 TCGA-MP-A4T6-01A -27993 2778 1790 0 63 NO NO 2013-4-2 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 220 NO NO Peripheral Lung NO 50 true No MX N2 T1 Stage IIIA TCGA-MP-A4T6.2FAB9F3E-DD9B-45AF-9160-D23ECCA95A2D.pdf A4T6 TUMOR FREE 79 77 Complete Remission/Response YES NO R0 Primary Tumor 01 1989 6th NO NO YES MP 3 Lung A DECEASED 2005 225d40a7-eb72-4ee2-8a58-293a05df95e8 TCGA-MP-A4T6-01A-32D-A25M-01 TCGA-MP-A4T6-01A-32D-A25R-05 TCGA-MP-A4T6-01 TCGA-MP-A4T6-01A-32D-A25M-01 225d40a7-eb72-4ee2-8a58-293a05df95e8 TCGA-MP-A4T6-01 225d40a7-eb72-4ee2-8a58-293a05df95e8 TCGA-MP-A4T6-01 BF6C9558-7E31-40ED-A449-4DAD978060BD 225d40a7-eb72-4ee2-8a58-293a05df95e8 TCGA-MP-A4T6-01A-32D-A25L-08 TCGA-MP-A4T6-01 +TCGA-MP-A4T7-01 TCGA-MP-A4T7-01 TCGA-MP-A4T7 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 75 R-Lower TCGA-MP-A4T7 TCGA-MP-A4T7-01A -27603 2710 167 0 57 NO NO 2013-4-2 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 280 NO NO 50 true No M1 N0 T2 Stage IV TCGA-MP-A4T7.D973F9E7-74DB-4880-B8F0-03E3887BDC36.pdf A4T7 91 87 YES NO R0 Primary Tumor 01 2004 6th NO NO YES MP 4 Lung A DECEASED 2005 1954 fc674e5c-f387-421e-9dc8-04272b876858 TCGA-MP-A4T7-01A-11D-A24O-01 TCGA-MP-A4T7-01A-11D-A24U-05 TCGA-MP-A4T7-01 TCGA-MP-A4T7-01A-11D-A24O-01 fc674e5c-f387-421e-9dc8-04272b876858 TCGA-MP-A4T7-01 fc674e5c-f387-421e-9dc8-04272b876858 TCGA-MP-A4T7-01 6BD8942F-05C6-4894-8469-A0DAF99D724E fc674e5c-f387-421e-9dc8-04272b876858 TCGA-MP-A4T7-01A-11D-A24P-08 TCGA-MP-A4T7-01 +TCGA-MP-A4T8-01 TCGA-MP-A4T8-01 TCGA-MP-A4T8 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 68 L-Upper TCGA-MP-A4T8 TCGA-MP-A4T8-01A -25069 2352 161 0 102 1 NO NO 2013-4-2 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 130 NO NO 25 true Yes, History of Prior Malignancy M0 N2 T2 Stage IIIA TCGA-MP-A4T8.11D12F13-E03D-43D1-B0B1-AD9168960EE0.pdf A4T8 Pre-Adjuvant Therapy 72 60 YES NO R0 Primary Tumor 01 1972 6th YES NO YES MP 3 Lung A DECEASED 2006 1957 2ea1224b-66aa-48a4-a605-4d1262e84303 TCGA-MP-A4T8-01A-11D-A24O-01 TCGA-MP-A4T8-01A-11D-A24U-05 TCGA-MP-A4T8-01 TCGA-MP-A4T8-01A-11D-A24O-01 2ea1224b-66aa-48a4-a605-4d1262e84303 TCGA-MP-A4T8-01 2ea1224b-66aa-48a4-a605-4d1262e84303 TCGA-MP-A4T8-01 CF31121E-7B77-4290-883A-84590F96E6D8 2ea1224b-66aa-48a4-a605-4d1262e84303 TCGA-MP-A4T8-01A-11D-A24P-08 TCGA-MP-A4T8-01 +TCGA-MP-A4T9-01 TCGA-MP-A4T9-01 TCGA-MP-A4T9 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung NO NO YES 54 L-Upper TCGA-MP-A4T9-F41357 TCGA-MP-A4T9 TCGA-MP-A4T9-01A 1255 -19767 2332 1265 0 1248 106 NO NO Additional New Tumor Event Progressive Disease 2013-3-15 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 230 NO NO NO Locoregional Recurrence YES 24 true No MX N2 T2 Stage IIIA TCGA-MP-A4T9.FE06303C-736B-43C5-B692-FECA9A173EF6.pdf A4T9 WITH TUMOR 105 99 Complete Remission/Response Biopsy with Histologic Confirmation YES YES RX Primary Tumor 01 2004 6th YES NO YES MP 4 Lung A DECEASED 2006 1980 da2c0992-74c0-4380-8c6c-c9ffa73767f6 TCGA-MP-A4T9-01A-11D-A24O-01 TCGA-MP-A4T9-01A-11D-A24U-05 TCGA-MP-A4T9-01 TCGA-MP-A4T9-01A-11D-A24O-01 da2c0992-74c0-4380-8c6c-c9ffa73767f6 TCGA-MP-A4T9-01 da2c0992-74c0-4380-8c6c-c9ffa73767f6 TCGA-MP-A4T9-01 894C5741-75C4-439A-B4C6-C4D00C369FA3 da2c0992-74c0-4380-8c6c-c9ffa73767f6 TCGA-MP-A4T9-01A-11D-A24P-08 TCGA-MP-A4T9-01 +TCGA-MP-A4TA-01 TCGA-MP-A4TA-01 TCGA-MP-A4TA TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 75 R-Upper TCGA-MP-A4TA TCGA-MP-A4TA-01A -27513 2159 950 0 46 1 NO NO 2013-4-2 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 120 NO NO Peripheral Lung YES 55 true Yes, History of Prior Malignancy M0 N0 T1 Stage IA TCGA-MP-A4TA.B8573F06-EEC4-49A8-943E-7F2EFF3AFBEE.pdf A4TA Pre-Adjuvant Therapy WITH TUMOR 74 65 Complete Remission/Response YES NO R0 Primary Tumor 01 2006 6th NO NO YES MP 4 Lung A DECEASED 2006 1951 38534c34-666f-4319-86b8-8243ab76cb40 TCGA-MP-A4TA-01A-21D-A24O-01 TCGA-MP-A4TA-01A-21D-A24U-05 TCGA-MP-A4TA-01 TCGA-MP-A4TA-01A-21D-A24O-01 38534c34-666f-4319-86b8-8243ab76cb40 TCGA-MP-A4TA-01 38534c34-666f-4319-86b8-8243ab76cb40 TCGA-MP-A4TA-01 A1C04D1A-3D2B-429C-9112-30753164138D 38534c34-666f-4319-86b8-8243ab76cb40 TCGA-MP-A4TA-01A-21D-A24P-08 TCGA-MP-A4TA-01 +TCGA-MP-A4TC-01 TCGA-MP-A4TC-01 TCGA-MP-A4TC TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 77 R-Middle TCGA-MP-A4TC TCGA-MP-A4TC-01A -28471 1604 74 0 68 NO NO 2013-4-2 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.2 8140/3 C34.2 YES 230 NO NO NO 125 true Yes, History of Prior Malignancy M0 N2 T1 Stage IIIA TCGA-MP-A4TC.556F6F07-52C6-4FFA-AB6B-46FD9614EB0C.pdf A4TC TUMOR FREE 76 83 Complete Remission/Response YES NO R0 Primary Tumor 01 1976 6th YES NO YES MP 3 Lung A DECEASED 2008 1944 f2510b83-536a-4d29-bca7-ff3ca3ca9e44 TCGA-MP-A4TC-01A-11D-A24O-01 TCGA-MP-A4TC-01A-11D-A24U-05 TCGA-MP-A4TC-01 TCGA-MP-A4TC-01A-11D-A24O-01 f2510b83-536a-4d29-bca7-ff3ca3ca9e44 TCGA-MP-A4TC-01 f2510b83-536a-4d29-bca7-ff3ca3ca9e44 TCGA-MP-A4TC-01 C78DED8D-D70D-4874-8EA7-BD5D882DC36D f2510b83-536a-4d29-bca7-ff3ca3ca9e44 TCGA-MP-A4TC-01A-11D-A24P-08 TCGA-MP-A4TC-01 +TCGA-MP-A4TD-01 TCGA-MP-A4TD-01 TCGA-MP-A4TD TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 71 L-Lower TCGA-MP-A4TD TCGA-MP-A4TD-01A -25983 1471 307 0 61 0 NO NO 2013-5-8 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 230 NO NO Peripheral Lung YES 20 true Yes, History of Prior Malignancy M0 N2 T2 Stage IIIA TCGA-MP-A4TD.12D870FD-E7C7-470B-9303-63495911A5FE.pdf A4TD Post-Adjuvant Therapy 92 93 Complete Remission/Response YES NO RX Primary Tumor 01 1990 6th YES NO YES MP 3 Lung A DECEASED 2008 53aaf8ed-546d-493a-bde3-bead91b7691f TCGA-MP-A4TD-01A-32D-A25M-01 TCGA-MP-A4TD-01A-32D-A25R-05 TCGA-MP-A4TD-01 TCGA-MP-A4TD-01A-32D-A25M-01 53aaf8ed-546d-493a-bde3-bead91b7691f TCGA-MP-A4TD-01 53aaf8ed-546d-493a-bde3-bead91b7691f TCGA-MP-A4TD-01 66E4093D-2BEA-4887-A720-36CA6476AC2F 53aaf8ed-546d-493a-bde3-bead91b7691f TCGA-MP-A4TD-01A-32D-A25L-08 TCGA-MP-A4TD-01 +TCGA-MP-A4TE-01 TCGA-MP-A4TE-01 TCGA-MP-A4TE TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung NO 56 L-Lower TCGA-MP-A4TE-F41405 TCGA-MP-A4TE TCGA-MP-A4TE-01A -20627 1009 896 0 845 NO NO Additional New Tumor Event 2013-3-18 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 270 NO YES YES G12C Peripheral Lung NO Distant Metastasis YES 40 true No MX N0 T2b Stage IIA TCGA-MP-A4TE.3AC0F53B-A612-484B-9589-699F583F4F1D.pdf A4TE WITH TUMOR Complete Remission/Response Convincing Imaging NO NO RX Primary Tumor 01 2010 7th NO NO YES MP 4 Lung A DECEASED 2010 1970 686d6738-e29a-4039-8d97-b2f25b87a795 TCGA-MP-A4TE-01A-22D-A25M-01 TCGA-MP-A4TE-01A-22D-A25R-05 TCGA-MP-A4TE-01 TCGA-MP-A4TE-01A-22D-A25M-01 686d6738-e29a-4039-8d97-b2f25b87a795 TCGA-MP-A4TE-01 686d6738-e29a-4039-8d97-b2f25b87a795 TCGA-MP-A4TE-01 C0561CFD-92CF-467B-B6E5-7A0CF1BC21D9 686d6738-e29a-4039-8d97-b2f25b87a795 TCGA-MP-A4TE-01A-22D-A25L-08 TCGA-MP-A4TE-01 +TCGA-MP-A4TF-01 TCGA-MP-A4TF-01 TCGA-MP-A4TF TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 58 R-Upper TCGA-MP-A4TF TCGA-MP-A4TF-01A -21387 784 336 0 77 NO NO 2013-4-2 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 240 NO NO Peripheral Lung YES 40 true No M0 N0 T2b Stage IIA TCGA-MP-A4TF.04511D30-B6E2-46F1-93B9-033B78257F1F.pdf A4TF WITH TUMOR 108 109 Partial Remission/Response YES NO R0 Primary Tumor 01 2010 7th YES NO YES MP 4 Lung A DECEASED 2010 1970 6028a290-48e8-400f-9ab6-39beda6051cd TCGA-MP-A4TF-01A-11D-A25M-01 TCGA-MP-A4TF-01A-11D-A25R-05 TCGA-MP-A4TF-01 TCGA-MP-A4TF-01A-11D-A25M-01 6028a290-48e8-400f-9ab6-39beda6051cd TCGA-MP-A4TF-01 6028a290-48e8-400f-9ab6-39beda6051cd TCGA-MP-A4TF-01 33FA8A68-0877-4CC0-9B60-B34FACACF3B5 6028a290-48e8-400f-9ab6-39beda6051cd TCGA-MP-A4TF-01A-11D-A25L-08 TCGA-MP-A4TF-01 +TCGA-MP-A4TH-01 TCGA-MP-A4TH-01 TCGA-MP-A4TH TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 70 L-Lower TCGA-MP-A4TH-F69949 TCGA-MP-A4TH TCGA-MP-A4TH-01A -25759 78 0 741 73 NO NO Scheduled Follow-up Submission Complete Remission/Response 2015-1-22 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 200 NO NO Peripheral Lung NO NO 20 true No M0 N0 T1a Stage IA TCGA-MP-A4TH.842ADC9F-9FEE-49DC-A95D-37FCBF8FB764.pdf A4TH TUMOR FREE 117 115 110 115 Complete Remission/Response YES NO R0 Primary Tumor 01 1982 7th NO YES NO MP 3 Lung A LIVING 2012 1962 9b4f4156-947b-4c34-9153-021bc670a093 TCGA-MP-A4TH-01A-31D-A25M-01 TCGA-MP-A4TH-01A-31D-A25R-05 TCGA-MP-A4TH-01 TCGA-MP-A4TH-01A-31D-A25M-01 9b4f4156-947b-4c34-9153-021bc670a093 TCGA-MP-A4TH-01 9b4f4156-947b-4c34-9153-021bc670a093 TCGA-MP-A4TH-01 456D68F5-BBCD-4CBF-A42E-60A5205432EF 9b4f4156-947b-4c34-9153-021bc670a093 TCGA-MP-A4TH-01A-31D-A25L-08 TCGA-MP-A4TH-01 +TCGA-MP-A4TI-01 TCGA-MP-A4TI-01 TCGA-MP-A4TI TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 72 R-Lower TCGA-MP-A4TI TCGA-MP-A4TI-01A -26565 780 429 0 YES NO 2013-4-2 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 200 NO YES YES G12C YES 35 true No M0 N1 T2a Stage IIA TCGA-MP-A4TI.FE74F98E-3131-4F7F-9899-AF5259B3A8C5.pdf A4TI WITH TUMOR NO R0 Primary Tumor 01 1990 7th NO YES MP 3 Lung A DECEASED 2010 1955 a117b181-a01e-49a7-a82b-13f4a385dd45 TCGA-MP-A4TI-01A-21D-A24O-01 TCGA-MP-A4TI-01A-21D-A24U-05 TCGA-MP-A4TI-01 TCGA-MP-A4TI-01A-21D-A24O-01 a117b181-a01e-49a7-a82b-13f4a385dd45 TCGA-MP-A4TI-01 a117b181-a01e-49a7-a82b-13f4a385dd45 TCGA-MP-A4TI-01 64296FB2-BF3D-4DB2-8216-C6F47D1FDC13 a117b181-a01e-49a7-a82b-13f4a385dd45 TCGA-MP-A4TI-01A-21D-A24P-08 TCGA-MP-A4TI-01 +TCGA-MP-A4TJ-01 TCGA-MP-A4TJ-01 TCGA-MP-A4TJ TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 62 R-Upper TCGA-MP-A4TJ TCGA-MP-A4TJ-01A -22875 2204 339 0 29 NO NO 2013-4-2 FEMALE Lung Signet Ring Adenocarcinoma No C34.1 8490/3 C34.1 YES 270 NO NO Central Lung true No M0 N0 T1 Stage IA TCGA-MP-A4TJ.23EC6DA5-7109-4E11-B2BC-F1EDC7DF0ED3.pdf A4TJ 30.1 36 29.7 27 Complete Remission/Response YES NO R0 Primary Tumor 01 6th NO NO YES MP 2 Lung A DECEASED 2006 eaf5ff83-0419-4f44-bec0-93f8517a56c9 TCGA-MP-A4TJ-01A-51D-A25M-01 TCGA-MP-A4TJ-01A-51D-A25R-05 TCGA-MP-A4TJ-01 TCGA-MP-A4TJ-01A-51D-A25M-01 eaf5ff83-0419-4f44-bec0-93f8517a56c9 TCGA-MP-A4TJ-01 eaf5ff83-0419-4f44-bec0-93f8517a56c9 TCGA-MP-A4TJ-01 1E357A4A-08C6-48E0-A9B5-B63A8B8EF339 eaf5ff83-0419-4f44-bec0-93f8517a56c9 TCGA-MP-A4TJ-01 +TCGA-MP-A4TK-01 TCGA-MP-A4TK-01 TCGA-MP-A4TK TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung YES YES NO 56 R-Lower TCGA-MP-A4TK-F41426 TCGA-MP-A4TK TCGA-MP-A4TK-01A -20581 3744 582 0 545 88 NO NO Additional New Tumor Event Progressive Disease 2013-3-18 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 170 NO NO NO Distant Metastasis YES 28 true No MX N1 T2 Stage IIB TCGA-MP-A4TK.D590727D-0D9F-4986-A41F-A5031C432967.pdf A4TK WITH TUMOR 64 57 Complete Remission/Response Convincing Imaging YES NO R0 Primary Tumor 01 1999 5th NO NO YES MP 4 Lung A DECEASED 2002 1971 704d2001-9501-4426-b751-af5fc74a6378 TCGA-MP-A4TK-01A-11D-A24O-01 TCGA-MP-A4TK-01A-11D-A24U-05 TCGA-MP-A4TK-01 TCGA-MP-A4TK-01A-11D-A24O-01 704d2001-9501-4426-b751-af5fc74a6378 TCGA-MP-A4TK-01 704d2001-9501-4426-b751-af5fc74a6378 TCGA-MP-A4TK-01 DED08840-92E6-4E29-A007-5D97A06CC224 704d2001-9501-4426-b751-af5fc74a6378 TCGA-MP-A4TK-01A-11D-A24P-08 TCGA-MP-A4TK-01 +TCGA-MP-A5C7-01 TCGA-MP-A5C7-01 TCGA-MP-A5C7 TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 76 L-Upper TCGA-MP-A5C7-F67079 TCGA-MP-A5C7 TCGA-MP-A5C7-01A -28015 1555 0 2248 105 1 NO NO Scheduled Follow-up Submission Complete Remission/Response 2014-10-30 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 170 NO NO Central Lung NO NO 15 true No M0 N0 T2 Stage IB TCGA-MP-A5C7.656F0756-05CC-437B-98D4-C2AED4B77DAB.pdf A5C7 Other TUMOR FREE 93 89 Complete Remission/Response YES NO R0 Primary Tumor 01 1968 6th NO NO YES MP 3 Lung A LIVING 2008 1953 d793a609-add1-4029-87fe-1e5c8cf0e173 TCGA-MP-A5C7-01A-11D-A25M-01 TCGA-MP-A5C7-01A-11D-A25R-05 TCGA-MP-A5C7-01 TCGA-MP-A5C7-01A-11D-A25M-01 d793a609-add1-4029-87fe-1e5c8cf0e173 TCGA-MP-A5C7-01 d793a609-add1-4029-87fe-1e5c8cf0e173 TCGA-MP-A5C7-01 CA388905-28E3-4183-ACB6-C462B736BEBE d793a609-add1-4029-87fe-1e5c8cf0e173 TCGA-MP-A5C7-01A-11D-A25L-08 TCGA-MP-A5C7-01 +TCGA-NJ-A4YF-01 TCGA-NJ-A4YF-01 TCGA-NJ-A4YF TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 50 R-Upper TCGA-NJ-A4YF-F50858 TCGA-NJ-A4YF TCGA-NJ-A4YF-01A -18584 1819 0 2161 77.5 NO NO Scheduled Follow-up Submission Stable Disease 2013-11-1 FEMALE Lung Adenocarcinoma Mixed Subtype No C34.1 8255/3 C34.1 YES 90 NO NO NO NO 30 true No M0 N0 T1 Stage IA TCGA-NJ-A4YF.1C272E41-4BE4-4E8A-BD33-A5EC5C33149C.pdf A4YF TUMOR FREE 95.1 83.9 96 80.7 Stable Disease YES NO Primary Tumor 01 6th NO NO YES NJ 3 Lung A LIVING 2007 dc1f01da-cff9-4b61-b743-0452e023e2a1 TCGA-NJ-A4YF-01A-12D-A25M-01 TCGA-NJ-A4YF-01A-12D-A25R-05 TCGA-NJ-A4YF-01 TCGA-NJ-A4YF-01A-12D-A25M-01 dc1f01da-cff9-4b61-b743-0452e023e2a1 TCGA-NJ-A4YF-01 dc1f01da-cff9-4b61-b743-0452e023e2a1 TCGA-NJ-A4YF-01 4811C6C9-CAC7-403C-8C32-AE289B407C86 dc1f01da-cff9-4b61-b743-0452e023e2a1 TCGA-NJ-A4YF-01A-12D-A25L-08 TCGA-NJ-A4YF-01 +TCGA-NJ-A4YG-01 TCGA-NJ-A4YG-01 TCGA-NJ-A4YG TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 65 L-Upper TCGA-NJ-A4YG-F70643 TCGA-NJ-A4YG TCGA-NJ-A4YG-01A -23812 1691 0 2261 Scheduled Follow-up Submission Stable Disease 2015-2-27 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8255/3 C34.1 YES 280 NO NO NO 104 true No M0 N0 T2 Stage IB TCGA-NJ-A4YG.6A90E23E-9E8F-4282-837C-120E3AE994D7.pdf A4YG TUMOR FREE Stable Disease NO NO Primary Tumor 01 2007 6th NO NO YES NJ 4 Lung A LIVING 2008 1955 b7989e5f-032a-478c-a882-b4db35bdd42c TCGA-NJ-A4YG-01A-22D-A25M-01 TCGA-NJ-A4YG-01A-22D-A25R-05 TCGA-NJ-A4YG-01 TCGA-NJ-A4YG-01A-22D-A25M-01 b7989e5f-032a-478c-a882-b4db35bdd42c TCGA-NJ-A4YG-01 b7989e5f-032a-478c-a882-b4db35bdd42c TCGA-NJ-A4YG-01 D0BD3C4F-37E1-4168-8AD9-409263FEA49D b7989e5f-032a-478c-a882-b4db35bdd42c TCGA-NJ-A4YG-01A-22D-A25L-08 TCGA-NJ-A4YG-01 +TCGA-NJ-A4YI-01 TCGA-NJ-A4YI-01 TCGA-NJ-A4YI TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 87 R-Upper TCGA-NJ-A4YI-F50887 TCGA-NJ-A4YI TCGA-NJ-A4YI-01A -31867 1385 4 0 52 Scheduled Follow-up Submission Stable Disease 2013-11-1 FEMALE Lung Papillary Adenocarcinoma No C34.1 8550/3 C34.1 YES 200 NO NO NO 3 true No M0 N2 T2 Stage IIIA TCGA-NJ-A4YI.DEFC8FAD-A129-40CA-B0CF-E3773377D8A6.pdf A4YI 94 89 YES NO Primary Tumor 01 1976 6th NO NO YES NJ 3 Lung A DECEASED 2009 1936 628fb2b6-09b2-4460-8815-fda9b89ac0c2 TCGA-NJ-A4YI-01A-11D-A25M-01 TCGA-NJ-A4YI-01A-11D-A25R-05 TCGA-NJ-A4YI-01 TCGA-NJ-A4YI-01A-11D-A25M-01 628fb2b6-09b2-4460-8815-fda9b89ac0c2 TCGA-NJ-A4YI-01 628fb2b6-09b2-4460-8815-fda9b89ac0c2 TCGA-NJ-A4YI-01 82422992-2C68-4B57-BAF5-B4AC14ED6347 628fb2b6-09b2-4460-8815-fda9b89ac0c2 TCGA-NJ-A4YI-01A-11D-A25L-08 TCGA-NJ-A4YI-01 +TCGA-NJ-A4YP-01 TCGA-NJ-A4YP-01 TCGA-NJ-A4YP TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 52 R-Lower TCGA-NJ-A4YP-F50888 TCGA-NJ-A4YP TCGA-NJ-A4YP-01A -19106 615 0 50 NO NO Scheduled Follow-up Submission Stable Disease 2013-11-1 MALE Lung Papillary Adenocarcinoma No C34.3 8255/3 C34.3 YES 70 NO NO YES NO 60 true No M0 N0 T2a Stage IB TCGA-NJ-A4YP.13552F62-0795-453F-A597-54B3214C6F24.pdf A4YP TUMOR FREE Stable Disease NO NO Primary Tumor 01 7th NO NJ 5 Lung A LIVING 2011 364051c3-87fd-4f4a-b2ae-8cc6cf883407 TCGA-NJ-A4YP-01A-11D-A25M-01 TCGA-NJ-A4YP-01A-11D-A25R-05 TCGA-NJ-A4YP-01 TCGA-NJ-A4YP-01A-11D-A25M-01 364051c3-87fd-4f4a-b2ae-8cc6cf883407 TCGA-NJ-A4YP-01 364051c3-87fd-4f4a-b2ae-8cc6cf883407 TCGA-NJ-A4YP-01 364051c3-87fd-4f4a-b2ae-8cc6cf883407 TCGA-NJ-A4YP-01A-11D-A25L-08 TCGA-NJ-A4YP-01 +TCGA-NJ-A4YQ-01 TCGA-NJ-A4YQ-01 TCGA-NJ-A4YQ TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 69 L-Upper TCGA-NJ-A4YQ-F70646 TCGA-NJ-A4YQ TCGA-NJ-A4YQ-01A -25427 592 0 1432 NO NO Scheduled Follow-up Submission Stable Disease 2015-2-27 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8255/3 C34.1 YES 80 NO NO NO NO 40 true No M0 N0 T1b Stage IA TCGA-NJ-A4YQ.232A989B-38EA-4BAC-8B08-075913ADA7EF.pdf A4YQ TUMOR FREE Stable Disease NO NO RX Primary Tumor 01 2011 7th NO NJ 4 Lung A LIVING 2011 72cad61d-c9cf-4507-b79a-9ecf459a119d TCGA-NJ-A4YQ-01A-11D-A25M-01 TCGA-NJ-A4YQ-01A-11D-A25R-05 TCGA-NJ-A4YQ-01 TCGA-NJ-A4YQ-01A-11D-A25M-01 72cad61d-c9cf-4507-b79a-9ecf459a119d TCGA-NJ-A4YQ-01 72cad61d-c9cf-4507-b79a-9ecf459a119d TCGA-NJ-A4YQ-01 72cad61d-c9cf-4507-b79a-9ecf459a119d TCGA-NJ-A4YQ-01A-11D-A25L-08 TCGA-NJ-A4YQ-01 +TCGA-NJ-A55A-01 TCGA-NJ-A55A-01 TCGA-NJ-A55A TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 76 R-Lower TCGA-NJ-A55A-F70649 TCGA-NJ-A55A TCGA-NJ-A55A-01A -28022 1199 0 15 NO NO Scheduled Follow-up Submission Stable Disease 2015-2-27 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8550/3 C34.3 YES 160 NO NO YES NO 25 true No M0 N0 T2 Stage IB TCGA-NJ-A55A.9D29FA79-BE75-4FA6-933E-4185C0B5D03C.pdf A55A TUMOR FREE Stable Disease NO NO Primary Tumor 01 1983 6th NO NJ 3 Lung A LIVING 2009 b964538d-a322-4632-8b32-b64b9ee66244 TCGA-NJ-A55A-01A-11D-A25M-01 TCGA-NJ-A55A-01A-11D-A25R-05 TCGA-NJ-A55A-01 TCGA-NJ-A55A-01A-11D-A25M-01 b964538d-a322-4632-8b32-b64b9ee66244 TCGA-NJ-A55A-01 b964538d-a322-4632-8b32-b64b9ee66244 TCGA-NJ-A55A-01 F67248A2-11AB-4A41-B702-7ED39A01B760 b964538d-a322-4632-8b32-b64b9ee66244 TCGA-NJ-A55A-01A-11D-A25L-08 TCGA-NJ-A55A-01 +TCGA-NJ-A55O-01 TCGA-NJ-A55O-01 TCGA-NJ-A55O TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 56 R-Upper TCGA-NJ-A55O-F50898 TCGA-NJ-A55O TCGA-NJ-A55O-01A -20628 428 0 13 NO NO Scheduled Follow-up Submission Stable Disease 2013-11-1 FEMALE Mucinous (Colloid) Carcinoma No C34.1 8480/3 C34.1 YES 150 NO NO YES NO 30 true No M0 N1 T1b Stage IIA TCGA-NJ-A55O.FBB218E1-EB67-4C9D-8149-EE276C1E9BCE.pdf A55O TUMOR FREE Stable Disease NO NO Primary Tumor 01 2000 7th NO NJ 4 Lung A LIVING 2011 a5c91562-e870-451a-8255-9620fa5f8977 TCGA-NJ-A55O-01A-11D-A25M-01 TCGA-NJ-A55O-01A-11D-A25R-05 TCGA-NJ-A55O-01 TCGA-NJ-A55O-01A-11D-A25M-01 a5c91562-e870-451a-8255-9620fa5f8977 TCGA-NJ-A55O-01 a5c91562-e870-451a-8255-9620fa5f8977 TCGA-NJ-A55O-01 07F8E95D-8A94-40E0-924F-2EEF25702F78 a5c91562-e870-451a-8255-9620fa5f8977 TCGA-NJ-A55O-01A-11D-A25L-08 TCGA-NJ-A55O-01 +TCGA-NJ-A55R-01 TCGA-NJ-A55R-01 TCGA-NJ-A55R TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 67 L-Upper TCGA-NJ-A55R-F70652 TCGA-NJ-A55R TCGA-NJ-A55R-01A -24738 499 0 603 NO NO Scheduled Follow-up Submission Stable Disease 2015-2-27 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8230/3 C34.1 YES 200 NO NO YES NO 5 true No MX N0 T1b Stage IA TCGA-NJ-A55R.726A5F6E-4592-49AA-976F-556CABABDD3D.pdf A55R TUMOR FREE Stable Disease NO NO Primary Tumor 01 1986 7th NO NJ 3 Lung A LIVING 2011 71937412-13b3-4584-8b61-8a83e762e2d7 TCGA-NJ-A55R-01A-11D-A25M-01 TCGA-NJ-A55R-01A-11D-A25R-05 TCGA-NJ-A55R-01 TCGA-NJ-A55R-01A-11D-A25M-01 71937412-13b3-4584-8b61-8a83e762e2d7 TCGA-NJ-A55R-01 71937412-13b3-4584-8b61-8a83e762e2d7 TCGA-NJ-A55R-01 7F27BC0A-2F99-435F-8717-B9976FB4C9DA 71937412-13b3-4584-8b61-8a83e762e2d7 TCGA-NJ-A55R-01A-11D-A25L-08 TCGA-NJ-A55R-01 +TCGA-NJ-A7XG-01 TCGA-NJ-A7XG-01 TCGA-NJ-A7XG TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 49 L-Upper TCGA-NJ-A7XG-F71390 TCGA-NJ-A7XG TCGA-NJ-A7XG-01A -18127 72 0 617 YES Other Scheduled Follow-up Submission Stable Disease 2015-3-25 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 140 NO YES NO NO NO true No M0 N1 T4 Stage IIIA TCGA-NJ-A7XG.8EFDF414-12F3-4DF8-BB21-9E8876B727E8.pdf A7XG WITH TUMOR Stable Disease NO NO Primary Tumor 01 7th YES NJ 3 Lung A LIVING 2013 885e59fd-b9e5-4c5a-85cc-c979232b1e77 TCGA-NJ-A7XG-01A-12D-A396-01 TCGA-NJ-A7XG-01A-12D-A398-05 TCGA-NJ-A7XG-01 TCGA-NJ-A7XG-01A-12D-A396-01 885e59fd-b9e5-4c5a-85cc-c979232b1e77 TCGA-NJ-A7XG-01 885e59fd-b9e5-4c5a-85cc-c979232b1e77 TCGA-NJ-A7XG-01 9D10E64C-AC93-44A9-A81D-B6D307824D95 885e59fd-b9e5-4c5a-85cc-c979232b1e77 TCGA-NJ-A7XG-01 +TCGA-O1-A52J-01 TCGA-O1-A52J-01 TCGA-O1-A52J TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 74 L-Lower TCGA-O1-A52J TCGA-O1-A52J-01A -27223 2000 1798 0 1 NO NO 2013-4-11 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 50 NO NO YES 45 true No MX N0 T1 Stage IA TCGA-O1-A52J.E5C54019-F404-4F8D-847A-80CF65F65E19.pdf A52J WITH TUMOR NO NO Primary Tumor 01 1980 6th NO NO YES O1 3 Lung A DECEASED 2007 1950 ca467949-9170-4c3f-8e67-5b7762d31d4a TCGA-O1-A52J-01A-11D-A25M-01 TCGA-O1-A52J-01A-11D-A25R-05 TCGA-O1-A52J-01 TCGA-O1-A52J-01A-11D-A25M-01 ca467949-9170-4c3f-8e67-5b7762d31d4a TCGA-O1-A52J-01 ca467949-9170-4c3f-8e67-5b7762d31d4a TCGA-O1-A52J-01 7CA1E6EE-521F-46AF-83F6-D9B12FD1C567 ca467949-9170-4c3f-8e67-5b7762d31d4a TCGA-O1-A52J-01A-11D-A25L-08 TCGA-O1-A52J-01 +TCGA-S2-AA1A-01 TCGA-S2-AA1A-01 TCGA-S2-AA1A TCGA Lung Adenocarcinoma (LUAD) lung adenocarcinoma Lung 68 R-Upper TCGA-S2-AA1A-F67520 TCGA-S2-AA1A TCGA-S2-AA1A-01A -24903 95 0 513 65 NO NO Scheduled Follow-up Submission Complete Remission/Response 2014-11-7 FEMALE Lung Bronchioloalveolar Carcinoma Mucinous No C34.1 8253/3 C34.1 YES 170 NO NO NO NO 95 true No M0 N0 T1b Stage IA TCGA-S2-AA1A.83A6F838-3F30-411F-9982-B8985C7FA52E.pdf AA1A TUMOR FREE 83 2.16 79 2.01 Complete Remission/Response YES NO R0 Primary Tumor 01 1995 7th NO YES NO S2 3 Lung A LIVING 2013 1957 b129c3f7-a2ff-40ba-91b0-a9c96f1e2b00 TCGA-S2-AA1A-01A-12D-A396-01 TCGA-S2-AA1A-01A-12D-A398-05 TCGA-S2-AA1A-01 TCGA-S2-AA1A-01A-12D-A396-01 b129c3f7-a2ff-40ba-91b0-a9c96f1e2b00 TCGA-S2-AA1A-01 b129c3f7-a2ff-40ba-91b0-a9c96f1e2b00 TCGA-S2-AA1A-01 76952263-FC42-4F1C-AB20-02FBA6F877EA b129c3f7-a2ff-40ba-91b0-a9c96f1e2b00 TCGA-S2-AA1A-01 diff --git a/input/TCGA/TCGA_Lung_Cancer_(LUNG)/TCGA.LUNG.sampleMap_HiSeqV2_PANCAN.gz b/input/TCGA/TCGA_Lung_Cancer_(LUNG)/TCGA.LUNG.sampleMap_HiSeqV2_PANCAN.gz new file mode 100644 index 0000000000000000000000000000000000000000..971ad99478839c56e9b545943890eb4c208b308f --- /dev/null +++ b/input/TCGA/TCGA_Lung_Cancer_(LUNG)/TCGA.LUNG.sampleMap_HiSeqV2_PANCAN.gz @@ -0,0 +1,3 @@ +version https://git-lfs.github.com/spec/v1 +oid sha256:63734966640c185116c42ebb9d67889724a32dd6ad707bcdaf4d860d17097f73 +size 78667981 diff --git a/input/TCGA/TCGA_Lung_Cancer_(LUNG)/TCGA.LUNG.sampleMap_LUNG_clinicalMatrix b/input/TCGA/TCGA_Lung_Cancer_(LUNG)/TCGA.LUNG.sampleMap_LUNG_clinicalMatrix new file mode 100644 index 0000000000000000000000000000000000000000..f3e13c0494d57812d45e32f4a57e9a3e6e2e3e5b --- /dev/null +++ b/input/TCGA/TCGA_Lung_Cancer_(LUNG)/TCGA.LUNG.sampleMap_LUNG_clinicalMatrix @@ -0,0 +1,1300 @@ +sampleID ABSOLUTE_Ploidy ABSOLUTE_Purity AKT1 ALK_translocation BRAF CBL CTNNB1 Canonical_mut_in_KRAS_EGFR_ALK Cnncl_mt_n_KRAS_EGFR_ALK_RET_ROS1_BRAF_ERBB2_HRAS_NRAS_AKT1_MAP2 EGFR ERBB2 ERBB4 Estimated_allele_fraction_of_a_clonal_varnt_prsnt_t_1_cpy_pr_cll Expression_Subtype HRAS KRAS MAP2K1 MET NRAS PIK3CA PTPN11 Pathology Pathology_Updated RET_translocation ROS1_translocation STK11 WGS_as_of_20120731_0_no_1_yes _INTEGRATION _PANCAN_CNA_PANCAN_K8 _PANCAN_Cluster_Cluster_PANCAN _PANCAN_DNAMethyl_PANCAN _PANCAN_RPPA_PANCAN_K8 _PANCAN_UNC_RNAseq_PANCAN_K16 _PANCAN_miRNA_PANCAN _PANCAN_mutation_PANCAN _PATIENT _cohort _primary_disease _primary_site additional_pharmaceutical_therapy additional_radiation_therapy additional_surgery_locoregional_procedure additional_surgery_metastatic_procedure age_at_initial_pathologic_diagnosis anatomic_neoplasm_subdivision anatomic_neoplasm_subdivision_other bcr_followup_barcode bcr_patient_barcode bcr_sample_barcode days_to_additional_surgery_locoregional_procedure days_to_additional_surgery_metastatic_procedure days_to_birth days_to_collection days_to_death days_to_initial_pathologic_diagnosis days_to_last_followup days_to_new_tumor_event_after_initial_treatment disease_code dlco_predictive_percent eastern_cancer_oncology_group egfr_mutation_performed egfr_mutation_result eml4_alk_translocation_method eml4_alk_translocation_performed followup_case_report_form_submission_reason followup_treatment_success form_completion_date gender histological_type history_of_neoadjuvant_treatment icd_10 icd_o_3_histology icd_o_3_site informed_consent_verified initial_weight intermediate_dimension is_ffpe karnofsky_performance_score kras_gene_analysis_performed kras_mutation_found kras_mutation_result location_in_lung_parenchyma longest_dimension lost_follow_up new_neoplasm_event_type new_tumor_event_after_initial_treatment number_pack_years_smoked oct_embedded other_dx pathologic_M pathologic_N pathologic_T pathologic_stage pathology_report_file_name patient_id performance_status_scale_timing person_neoplasm_cancer_status post_bronchodilator_fev1_fvc_percent post_bronchodilator_fev1_percent pre_bronchodilator_fev1_fvc_percent pre_bronchodilator_fev1_percent primary_therapy_outcome_success progression_determined_by project_code pulmonary_function_test_performed radiation_therapy residual_tumor sample_type sample_type_id shortest_dimension stopped_smoking_year system_version targeted_molecular_therapy tissue_prospective_collection_indicator tissue_retrospective_collection_indicator tissue_source_site tobacco_smoking_history tobacco_smoking_history_indicator tumor_tissue_site vial_number vital_status year_of_initial_pathologic_diagnosis year_of_tobacco_smoking_onset _GENOMIC_ID_TCGA_LUNG_exp_HiSeqV2_exon _GENOMIC_ID_TCGA_LUNG_hMethyl27 _GENOMIC_ID_TCGA_LUNG_mutation _GENOMIC_ID_TCGA_LUNG_exp_HiSeqV2_PANCAN _GENOMIC_ID_TCGA_LUNG_hMethyl450 _GENOMIC_ID_TCGA_LUNG_gistic2thd _GENOMIC_ID_TCGA_LUNG_G4502A_07_3 _GENOMIC_ID_TCGA_LUNG_exp_HiSeqV2 _GENOMIC_ID_TCGA_LUNG_gistic2 _GENOMIC_ID_TCGA_LUNG_RPPA_RBN +TCGA-05-4244-01 TCGA-05-4244-01 High C1-LUAD-enriched Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 4 mutation cluster 12 TCGA-05-4244 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 70 R-Lower TCGA-05-4244 TCGA-05-4244-01A -25752 0 0 2010-7-22 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 0.9 NO Peripheral Lung 1.1 38 No M1 N2 T2 Stage IV TCGA-05-4244.3a844132-f813-4d8e-8f7d-dbae0b23d7fd.pdf 4244 TUMOR FREE RX Primary Tumor 01 0.3 6th NO YES 05 4 Lung A LIVING 2009 e6a101b9-61f9-4ed1-a59f-d9db3fdb4555 TCGA-05-4244-01A-01D-1104-05 TCGA-05-4244-01A-01D-1105-08 e6a101b9-61f9-4ed1-a59f-d9db3fdb4555 TCGA-05-4244-01A-01D-1877-01 TCGA-05-4244-01A-01R-1107-07 e6a101b9-61f9-4ed1-a59f-d9db3fdb4555 TCGA-05-4244-01A-01D-1877-01 TCGA-05-4244-01A-21-2190-20 +TCGA-05-4249-01 3.77 0.46 none p.A762E none none Y Y none none none 0.16 Bronchioid none p.G12C none none none p.E545K none Papillary predominant Adc Papillary predominant Adc none 0 TCGA-05-4249-01 BRCA-LUAD+ C1-LUAD-enriched Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 4 mutation cluster 1 TCGA-05-4249 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 67 R-Lower TCGA-05-4249-F36327 TCGA-05-4249 TCGA-05-4249-01A -24532 0 1523 Scheduled Follow-up Submission Complete Remission/Response 2012-10-29 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 0.8 NO Peripheral Lung 1.4 NO NO 52 No M0 N0 T2 Stage IB TCGA-05-4249.7e920317-d5c2-4160-9e2b-ef0101eb5a23.pdf 4249 TUMOR FREE NO R0 Primary Tumor 01 0.4 6th NO NO YES 05 3 Current reformed smoker for > 15 years Lung A LIVING 2007 d1a8d88d-1708-4959-9695-6f2e67853bd5 TCGA-05-4249-01A-01D-1104-05 TCGA-05-4249-01A-01D-1105-08 d1a8d88d-1708-4959-9695-6f2e67853bd5 TCGA-05-4249-01A-01D-1877-01 TCGA-05-4249-01A-01R-1107-07 d1a8d88d-1708-4959-9695-6f2e67853bd5 TCGA-05-4249-01A-01D-1877-01 TCGA-05-4249-01A-21-2190-20 +TCGA-05-4250-01 TCGA-05-4250-01 High C1-LUAD-enriched Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 4 mutation cluster 12 TCGA-05-4250 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 79 R-Lower TCGA-05-4250 TCGA-05-4250-01A -29068 121 0 2010-7-22 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 0.7 NO 1.2 47 No M0 N1 T3 Stage IIIA TCGA-05-4250.5574f2f8-f247-40e6-a285-7793edcf5358.pdf 4250 R2 Primary Tumor 01 0.3 6th NO YES 05 4 Lung A DECEASED 2007 bba9333a-09f7-4585-b22e-e4ae4049f7da TCGA-05-4250-01A-01D-1104-05 TCGA-05-4250-01A-01D-1105-08 bba9333a-09f7-4585-b22e-e4ae4049f7da TCGA-05-4250-01A-01D-1877-01 TCGA-05-4250-01A-01R-1107-07 bba9333a-09f7-4585-b22e-e4ae4049f7da TCGA-05-4250-01A-01D-1877-01 TCGA-05-4250-01A-21-2190-20 +TCGA-05-4382-01 none p.L613F none none N N p.R222L, p.E545Q none p.D922E Squamoid none none none none none none none Solid predominant Adc Solid predominant Adc none 0 TCGA-05-4382-01 High C1-LUAD-enriched Cluster 5 LUAD-like c10 miRNA cluster 4 mutation cluster 11 TCGA-05-4382 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung YES 68 L-Upper TCGA-05-4382-F36329 TCGA-05-4382 TCGA-05-4382-01A -24868 0 607 334 Scheduled Follow-up Submission Complete Remission/Response 2012-10-29 MALE Lung Adenocarcinoma Mixed Subtype No C34.1 8255/3 C34.1 YES 0.8 NO 0.9 NO Distant Metastasis YES 62 Yes M0 N0 T2 Stage IB TCGA-05-4382.952c0f32-1472-49e1-8334-b0f1de4ac921.pdf 4382 TUMOR FREE Complete Remission/Response YES R0 Primary Tumor 01 0.3 6th NO NO YES 05 4 Current reformed smoker for < or = 15 years Lung A LIVING 2009 e4177b01-6898-4bb7-b38d-0c09f85c5668 TCGA-05-4382-01A-01D-1205-05 TCGA-05-4382-01A-01D-1265-08 e4177b01-6898-4bb7-b38d-0c09f85c5668 TCGA-05-4382-01A-01D-1204-01 e4177b01-6898-4bb7-b38d-0c09f85c5668 TCGA-05-4382-01A-01D-1204-01 +TCGA-05-4384-01 2.04 0.48 none none none p.F777S N N none p.S633_splice none 0.24 Bronchioid none none none none none none none Papillary predominant Adc Papillary predominant Adc none 0 TCGA-05-4384-01 Iq C1-LUAD-enriched Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 5 mutation cluster 5 TCGA-05-4384 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung YES 66 R-Lower TCGA-05-4384-F36330 TCGA-05-4384 TCGA-05-4384-01A -24411 0 426 183 Scheduled Follow-up Submission Progressive Disease 2012-10-29 MALE Lung Adenocarcinoma Mixed Subtype No C34.3 8255/3 C34.3 YES 0.8 NO 0.8 NO Distant Metastasis YES 20 Yes M0 N2 T2 Stage IIIA TCGA-05-4384.b70e95c5-2e6c-4409-8bbd-80e03e302b4c.pdf 4384 WITH TUMOR Progressive Disease YES RX Primary Tumor 01 0.4 1987 6th YES NO YES 05 3 Current reformed smoker for > 15 years Lung A LIVING 2009 1963 7d6cf896-b04a-431a-a192-aaf540eeaf77 TCGA-05-4384-01A-01D-1753-08 7d6cf896-b04a-431a-a192-aaf540eeaf77 TCGA-05-4384-01A-01D-1756-05 TCGA-05-4384-01A-01D-1752-01 7d6cf896-b04a-431a-a192-aaf540eeaf77 TCGA-05-4384-01A-01D-1752-01 TCGA-05-4384-01A-21-2190-20 +TCGA-05-4389-01 3.29 0.48 none p.G469V none p.T41A N Y none none none 0.18 Magnoid none none none none none none none Solid predominant Adc Solid predominant Adc none 1 TCGA-05-4389-01 High C1-LUAD-enriched Cluster 5 LUAD-like c10 miRNA cluster 4 mutation c1uster 9 TCGA-05-4389 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 70 R-Upper TCGA-05-4389-F36455 TCGA-05-4389 TCGA-05-4389-01A -25660 0 1369 Scheduled Follow-up Submission Complete Remission/Response 2012-10-31 MALE Lung Adenocarcinoma Mixed Subtype No C34.1 8255/3 C34.1 YES 0.9 NO 1.3 NO NO 43 No M0 N0 T1 Stage IA TCGA-05-4389.924f5877-07dc-48dc-b920-c59ba743498e.pdf 4389 TUMOR FREE NO R0 Primary Tumor 01 0.3 5th NO NO YES 05 3 Current reformed smoker for > 15 years Lung A LIVING 2005 a588764f-f972-4d3a-b8f8-d0209fc7d2a1 TCGA-05-4389-01A-01D-1205-05 TCGA-05-4389-01A-01D-1265-08 a588764f-f972-4d3a-b8f8-d0209fc7d2a1 TCGA-05-4389-01A-01D-1204-01 a588764f-f972-4d3a-b8f8-d0209fc7d2a1 TCGA-05-4389-01A-01D-1204-01 +TCGA-05-4390-01 3.99 0.57 none none none none Y Y none none none 0.18 Magnoid none p.G12V none none none none none Acinar predominant Adc Acinar predominant Adc none 0 TCGA-05-4390-01 COAD-READ C1-LUAD-enriched Cluster 6 LUAD-like c10 miRNA cluster 6 mutation cluster 12 TCGA-05-4390 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 58 R-Upper TCGA-05-4390-F36456 TCGA-05-4390 TCGA-05-4390-01A -21430 0 1126 395 Scheduled Follow-up Submission Complete Remission/Response 2012-10-31 FEMALE Lung Adenocarcinoma Mixed Subtype No C34.1 8255/3 C34.1 YES 0.9 NO 1.8 NO YES 15 No M0 N0 T2 Stage IB TCGA-05-4390.2e3faad1-3a5e-4efb-96ea-8c44839fec6e.pdf 4390 TUMOR FREE Progressive Disease NO R0 Primary Tumor 01 0.3 1996 5th YES NO YES 05 4 Current reformed smoker for < or = 15 years Lung A LIVING 2005 1966 6b6d7855-8621-45f8-98c9-5ad5b924b15e TCGA-05-4390-01A-02D-1753-08 6b6d7855-8621-45f8-98c9-5ad5b924b15e TCGA-05-4390-01A-02D-1756-05 TCGA-05-4390-01A-02D-1752-01 6b6d7855-8621-45f8-98c9-5ad5b924b15e TCGA-05-4390-01A-02D-1752-01 +TCGA-05-4395-01 3.24 0.61 none none none none Y Y none none none 0.22 Squamoid none p.G12V none none none none none Solid predominant Adc Solid predominant Adc p.G56W 0 TCGA-05-4395-01 BRCA-LUAD+ C1-LUAD-enriched Cluster 6 LUAD-like c10 miRNA cluster 4 mutation cluster 2 TCGA-05-4395 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 76 L-Upper TCGA-05-4395 TCGA-05-4395-01A -27971 0 0 2010-7-22 MALE Lung Adenocarcinoma Mixed Subtype No C34.1 8255/3 C34.1 YES 0.4 NO 1 No M0 N2 T4 Stage IIIB TCGA-05-4395.601b48ca-e99c-4d4b-854e-4aa923b63237.pdf 4395 TUMOR FREE R0 Primary Tumor 01 0.4 1983 5th NO YES 05 3 Lifelong Non-smoker Lung A DECEASED 2006 3ae6f6d4-ae90-4572-9bd5-ed8700570b96 TCGA-05-4395-01A-01D-1205-05 TCGA-05-4395-01A-01D-1265-08 3ae6f6d4-ae90-4572-9bd5-ed8700570b96 TCGA-05-4395-01A-01D-1204-01 3ae6f6d4-ae90-4572-9bd5-ed8700570b96 TCGA-05-4395-01A-01D-1204-01 +TCGA-05-4396-01 1.86 0.74 none none none none N N none none none 0.39 Magnoid none none none none none none none Papillary predominant Adc Papillary predominant Adc none 0 TCGA-05-4396-01 Squamous C1-LUAD-enriched Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 6 mutation cluster 11 TCGA-05-4396 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 76 R-Lower TCGA-05-4396 TCGA-05-4396-01A -28094 303 0 2010-7-22 MALE Lung Adenocarcinoma Mixed Subtype No C34.3 8255/3 C34.3 YES 0.9 NO 1.6 19 Yes M0 N1 T4 Stage IIIB TCGA-05-4396.96f3b48a-c5c4-40c3-a3d1-64477499c6e6.pdf 4396 R0 Primary Tumor 01 0.5 1984 5th NO YES 05 3 Current reformed smoker for > 15 years Lung A DECEASED 2006 1947 82b154a5-b4d5-4737-8f79-10d252741963 TCGA-05-4396-01A-21D-1855-08 82b154a5-b4d5-4737-8f79-10d252741963 TCGA-05-4396-01A-21D-1856-05 TCGA-05-4396-01A-21D-1854-01 82b154a5-b4d5-4737-8f79-10d252741963 TCGA-05-4396-01A-21D-1854-01 TCGA-05-4396-01A-22-2190-20 +TCGA-05-4397-01 TCGA-05-4397-01 Squamous C1-LUAD-enriched Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 7 mutation cluster 8 TCGA-05-4397 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 65 R-Middle TCGA-05-4397 TCGA-05-4397-01A -23833 731 0 2010-7-22 MALE Lung Adenocarcinoma Mixed Subtype No C34.2 8255/3 C34.2 YES 0.9 NO 0.9 45 No M0 N1 T2 Stage IIB TCGA-05-4397.e3f87d2c-61b5-435a-a095-318d2bf58bb3.pdf 4397 R0 Primary Tumor 01 0.5 5th NO YES 05 2 Lung A DECEASED 2006 e8fb125c-3249-44f4-9bc7-5cd086011d89 TCGA-05-4397-01A-01D-1205-05 TCGA-05-4397-01A-01D-1265-08 e8fb125c-3249-44f4-9bc7-5cd086011d89 TCGA-05-4397-01A-01D-1204-01 e8fb125c-3249-44f4-9bc7-5cd086011d89 TCGA-05-4397-01A-01D-1204-01 TCGA-05-4397-01A-21-2190-20 +TCGA-05-4398-01 4.86 0.33 none none none none N N none none none 0.11 Squamoid none none none none none none none Solid predominant Adc Solid predominant Adc none 1 TCGA-05-4398-01 Squamous C1-LUAD-enriched Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 4 mutation cluster 2 TCGA-05-4398 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 47 R-Upper TCGA-05-4398-F36462 TCGA-05-4398 TCGA-05-4398-01A -17471 0 1431 Scheduled Follow-up Submission Complete Remission/Response 2012-10-31 FEMALE Lung Adenocarcinoma Mixed Subtype No C34.1 8255/3 C34.1 YES 0.9 NO 1.5 NO NO 72 No M0 N3 T4 Stage IIIB TCGA-05-4398.37d9ee69-f24e-4dda-a283-078243db1fa8.pdf 4398 TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 0.4 5th YES NO YES 05 2 Current smoker Lung A LIVING 2006 8835ae28-831e-49da-a046-a1a43b626a4e TCGA-05-4398-01A-01D-1205-05 TCGA-05-4398-01A-01D-1265-08 8835ae28-831e-49da-a046-a1a43b626a4e TCGA-05-4398-01A-01D-1204-01 8835ae28-831e-49da-a046-a1a43b626a4e TCGA-05-4398-01A-01D-1204-01 TCGA-05-4398-01A-21-2190-20 +TCGA-05-4402-01 3.24 0.44 none none none none Y Y p.TSPKANKE751del none none 0.17 Bronchioid none none none none none none none Acinar predominant Adc Acinar predominant Adc none 0 TCGA-05-4402-01 BRCA-LUAD+ C1-LUAD-enriched Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 4 mutation cluster 8 TCGA-05-4402 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 57 R-Lower TCGA-05-4402-F36466 TCGA-05-4402 TCGA-05-4402-01A -20819 244 0 Scheduled Follow-up Submission Complete Remission/Response 2012-10-31 FEMALE Lung Adenocarcinoma Mixed Subtype No C34.3 8255/3 C34.3 YES 0.6 NO 1.6 NO NO Yes M1 NX T2 Stage IV TCGA-05-4402.8099c860-5c8d-4200-8c8f-07f9e1b71780.pdf 4402 TUMOR FREE Complete Remission/Response NO R2 Primary Tumor 01 0.2 6th YES NO YES 05 1 Lifelong Non-smoker Lung A DECEASED 2007 86973b83-4077-414a-ad8d-dbf32b6707d1 TCGA-05-4402-01A-01D-1205-05 TCGA-05-4402-01A-01D-1265-08 86973b83-4077-414a-ad8d-dbf32b6707d1 TCGA-05-4402-01A-01D-1204-01 86973b83-4077-414a-ad8d-dbf32b6707d1 TCGA-05-4402-01A-01D-1204-01 TCGA-05-4402-01A-21-2190-20 +TCGA-05-4403-01 2.06 0.46 none none none none Y Y none none none 0.23 Bronchioid none p.G12C none p.H476Y none none none Invasive mucinous Invasive mucinous none 0 TCGA-05-4403-01 Kirc+ C1-LUAD-enriched Cluster 6 LUAD-like c10 miRNA cluster 8 mutation cluster 12 TCGA-05-4403 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 76 R-Upper TCGA-05-4403 TCGA-05-4403-01A -27881 0 578 2010-7-22 MALE Lung Adenocarcinoma Mixed Subtype No C34.1 8255/3 C34.1 YES 1 NO 1.5 No M0 N0 T2 Stage IB TCGA-05-4403.96181bb6-7944-4674-83ba-5268ef8b10a5.pdf 4403 R0 Primary Tumor 01 0.4 1975 5th NO YES 05 3 Current reformed smoker for > 15 years Lung A LIVING 2006 89059faf-e38c-49d0-890e-47c455f19dc7 TCGA-05-4403-01A-01D-1205-05 TCGA-05-4403-01A-01D-1265-08 89059faf-e38c-49d0-890e-47c455f19dc7 TCGA-05-4403-01A-01D-1204-01 89059faf-e38c-49d0-890e-47c455f19dc7 TCGA-05-4403-01A-01D-1204-01 +TCGA-05-4405-01 3.34 0.38 none none none none N N none none none 0.15 Bronchioid none none none none none none none Acinar predominant Adc Acinar predominant Adc none 0 TCGA-05-4405-01 High C1-LUAD-enriched Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 4 mutation cluster 2 TCGA-05-4405 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 74 R-Lower TCGA-05-4405-F36494 TCGA-05-4405 TCGA-05-4405-01A -27241 0 610 Scheduled Follow-up Submission Complete Remission/Response 2012-10-31 FEMALE Lung Adenocarcinoma Mixed Subtype No C34.3 8255/3 C34.3 YES 0.7 NO 0.9 NO NO 65 Yes M0 N0 T2 Stage IB TCGA-05-4405.AB2C32B2-3CB1-4977-8C79-7B19F9022DFB.pdf 4405 TUMOR FREE NO R0 Primary Tumor 01 0.3 1994 5th NO NO YES 05 4 Current reformed smoker for < or = 15 years Lung A LIVING 2006 1951 a1510fc9-aff1-4cc2-8d8e-9aafce9319f7 TCGA-05-4405-01A-21D-1855-08 a1510fc9-aff1-4cc2-8d8e-9aafce9319f7 TCGA-05-4405-01A-21D-1856-05 TCGA-05-4405-01A-21D-1854-01 a1510fc9-aff1-4cc2-8d8e-9aafce9319f7 TCGA-05-4405-01A-21D-1854-01 TCGA-05-4405-01A-22-2190-20 +TCGA-05-4410-01 none p.G466V none none N Y p.R377S none none Bronchioid none none none none none none none Micropapillary predom Adc Micropapillary predom Adc none 0 TCGA-05-4410-01 High C1-LUAD-enriched Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 4 mutation cluster 11 TCGA-05-4410 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 62 L-Upper TCGA-05-4410 TCGA-05-4410-01A -22888 0 0 2010-7-22 MALE Lung Adenocarcinoma Mixed Subtype No C34.1 8255/3 C34.1 YES 0.8 NO 1 98 Yes M0 N0 T2 Stage IB TCGA-05-4410.13c40632-79e2-485c-9ef2-da6d075b054c.pdf 4410 RX Primary Tumor 01 0.4 2007 6th NO YES 05 4 Current reformed smoker for < or = 15 years Lung A LIVING 2007 1958 149e2d5d-3d6c-410e-b435-7e37b3f96661 TCGA-05-4410-01A-21D-1855-08 149e2d5d-3d6c-410e-b435-7e37b3f96661 TCGA-05-4410-01A-21D-1856-05 TCGA-05-4410-01A-21D-1854-01 149e2d5d-3d6c-410e-b435-7e37b3f96661 TCGA-05-4410-01A-21D-1854-01 TCGA-05-4410-01A-22-2190-20 +TCGA-05-4415-01 3.65 0.65 none none none none Y Y none none none 0.21 Magnoid none p.G12C none none none none none Micropapillary predom Adc Micropapillary predom Adc p.G227fs 0 TCGA-05-4415-01 GBM C1-LUAD-enriched Cluster 5 LUAD-like c10 miRNA cluster 4 mutation cluster 12 TCGA-05-4415 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 57 L-Lower TCGA-05-4415-F36499 TCGA-05-4415 TCGA-05-4415-01A -20880 91 0 60 Scheduled Follow-up Submission Progressive Disease 2012-10-31 MALE Lung Adenocarcinoma Mixed Subtype No C34.3 8255/3 C34.3 YES 1 NO 1.1 NO YES 29 No M0 N2 T4 Stage IIIB TCGA-05-4415.e8871f29-3623-4975-be19-bda98dbbc33b.pdf 4415 WITH TUMOR Progressive Disease NO R0 Primary Tumor 01 0.4 2007 6th NO NO YES 05 4 Current reformed smoker for < or = 15 years Lung A DECEASED 2008 1997 7f9f381e-edb1-4a5e-b5f7-c31b2a769912 TCGA-05-4415-01A-22D-1855-08 7f9f381e-edb1-4a5e-b5f7-c31b2a769912 TCGA-05-4415-01A-22D-1856-05 TCGA-05-4415-01A-22D-1854-01 7f9f381e-edb1-4a5e-b5f7-c31b2a769912 TCGA-05-4415-01A-22D-1854-01 +TCGA-05-4417-01 2.96 0.39 none none none none Y Y none none none 0.16 Magnoid none p.G12C none none none none none Solid predominant Adc Solid predominant Adc p.H168R 0 TCGA-05-4417-01 BRCA-LUAD+ C1-LUAD-enriched Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 4 mutation cluster 12 TCGA-05-4417 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 51 R-Upper TCGA-05-4417-F36502 TCGA-05-4417 TCGA-05-4417-01A -18780 0 455 Scheduled Follow-up Submission Partial Remission/Response 2012-10-31 FEMALE Lung Adenocarcinoma Mixed Subtype No C34.1 8255/3 C34.1 YES 0.8 NO 1.4 NO NO 56 No M0 N0 T2 Stage IB TCGA-05-4417.0b795830-d3bf-4a94-8355-b76a5f4469a5.pdf 4417 TUMOR FREE Partial Remission/Response NO R0 Primary Tumor 01 0.3 2008 6th NO NO YES 05 4 Current reformed smoker for < or = 15 years Lung A LIVING 2008 1971 c5c76768-3b14-4d6e-9455-13783631d796 TCGA-05-4417-01A-22D-1855-08 c5c76768-3b14-4d6e-9455-13783631d796 TCGA-05-4417-01A-22D-1856-05 TCGA-05-4417-01A-22D-1854-01 c5c76768-3b14-4d6e-9455-13783631d796 TCGA-05-4417-01A-22D-1854-01 TCGA-05-4417-01A-23-2190-20 +TCGA-05-4418-01 2.01 0.53 none none none none Y Y none none none 0.26 Magnoid none p.G12C none none none none none Solid predominant Adc Solid predominant Adc none 0 TCGA-05-4418-01 BRCA-LUAD+ C1-LUAD-enriched Cluster 5 squamous c3 LUAD-like c10 miRNA c1uster 9 mutation cluster 12 TCGA-05-4418 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 69 L-Lower TCGA-05-4418 TCGA-05-4418-01A -25417 274 0 2010-7-22 MALE Lung Adenocarcinoma Mixed Subtype No C34.3 8255/3 C34.3 YES 1 NO 1.2 25 Yes M0 N2 T3 Stage IIIA TCGA-05-4418.4d77e536-98f2-4e34-9e76-adb4bc79bf5e.pdf 4418 R0 Primary Tumor 01 0.4 6th NO YES 05 2 Current smoker Lung A DECEASED 2008 271766c9-819e-4555-89d7-dc7a52203386 TCGA-05-4418-01A-01D-1205-05 TCGA-05-4418-01A-01D-1265-08 271766c9-819e-4555-89d7-dc7a52203386 TCGA-05-4418-01A-01D-1204-01 271766c9-819e-4555-89d7-dc7a52203386 TCGA-05-4418-01A-01D-1204-01 TCGA-05-4418-01A-21-2190-20 +TCGA-05-4420-01 3.53 0.6 none none none none N Y none none none 0.21 Magnoid p.Q61L none none none none none none Invasive mucinous Invasive mucinous none 1 TCGA-05-4420-01 High C1-LUAD-enriched Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 6 mutation cluster 3 TCGA-05-4420 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 41 R-Lower TCGA-05-4420-F36531 TCGA-05-4420 TCGA-05-4420-01A -15159 0 912 Scheduled Follow-up Submission Complete Remission/Response 2012-11-1 MALE Lung Adenocarcinoma Mixed Subtype No C34.3 8255/3 C34.3 YES 0.8 NO 0.8 NO NO 38 No M0 N0 T2 Stage IB TCGA-05-4420.682a1fdc-41dd-441b-831c-fe3cf834638e.pdf 4420 TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 0.3 6th NO NO YES 05 2 Current smoker Lung A LIVING 2008 89dda3b6-2905-4577-9b74-965fb7f77c98 TCGA-05-4420-01A-01D-1205-05 TCGA-05-4420-01A-01D-1265-08 89dda3b6-2905-4577-9b74-965fb7f77c98 TCGA-05-4420-01A-01D-1204-01 89dda3b6-2905-4577-9b74-965fb7f77c98 TCGA-05-4420-01A-01D-1204-01 TCGA-05-4420-01A-21-2190-20 +TCGA-05-4422-01 2.09 0.63 none none none p.S37F N N none none none 0.31 Magnoid none none none none none none none Acinar predominant Adc Acinar predominant Adc p.G251V 1 TCGA-05-4422-01 COAD-READ C1-LUAD-enriched Low purity c2 squamous c3 LUAD-like c10 miRNA cluster 7 mutation c1uster 9 TCGA-05-4422 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 68 L-Lower TCGA-05-4422 TCGA-05-4422-01A -24837 0 365 2010-7-22 MALE Lung Adenocarcinoma Mixed Subtype No C34.3 8255/3 C34.3 YES 0.8 NO 1.5 147 No M0 N0 T2 Stage IB TCGA-05-4422.b51045ca-f7ae-459f-90b7-631683d84e0f.pdf 4422 R0 Primary Tumor 01 0.4 6th NO YES 05 4 Current reformed smoker for < or = 15 years Lung A LIVING 2008 2662f59e-0959-4fbf-a8bf-6ad639e44005 TCGA-05-4422-01A-01D-1205-05 TCGA-05-4422-01A-01D-1265-08 2662f59e-0959-4fbf-a8bf-6ad639e44005 TCGA-05-4422-01A-01D-1204-01 2662f59e-0959-4fbf-a8bf-6ad639e44005 TCGA-05-4422-01A-01D-1204-01 TCGA-05-4422-01A-21-2190-20 +TCGA-05-4424-01 none none none none N N none none none Bronchioid none none none none none none none Acinar predominant Adc Acinar predominant Adc none 0 TCGA-05-4424-01 High C1-LUAD-enriched Low purity c2 LUAD-like c10 miRNA cluster 5 mutation cluster 2 TCGA-05-4424 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung YES 70 R-Upper TCGA-05-4424-F36536 TCGA-05-4424 TCGA-05-4424-01A -25689 0 913 153 Scheduled Follow-up Submission Partial Remission/Response 2012-11-1 MALE Lung Adenocarcinoma Mixed Subtype No C34.1 8255/3 C34.1 YES 0.8 NO 1.1 NO Distant Metastasis YES 50 No M0 N0 T3 Stage IIB TCGA-05-4424.da7dff31-acbb-4d15-b607-e3c0a4fa5901.pdf 4424 WITH TUMOR Progressive Disease YES R1 Primary Tumor 01 0.4 2007 6th YES NO YES 05 4 Current reformed smoker for < or = 15 years Lung A LIVING 2008 1957 c4da944d-4055-493e-bb87-7ccd1e5d1a87 TCGA-05-4424-01A-22D-1855-08 c4da944d-4055-493e-bb87-7ccd1e5d1a87 TCGA-05-4424-01A-22D-1856-05 TCGA-05-4424-01A-22D-1854-01 c4da944d-4055-493e-bb87-7ccd1e5d1a87 TCGA-05-4424-01A-22D-1854-01 +TCGA-05-4425-01 1.96 0.61 none none none p.S45F N N none none none 0.31 Squamoid none none none none none none none Papillary predominant Adc Papillary predominant Adc none 0 TCGA-05-4425-01 Kirc+ C1-LUAD-enriched Cluster 6 LUAD-like c10 miRNA cluster 4 mutation c1uster 9 TCGA-05-4425 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 70 R-Middle TCGA-05-4425 TCGA-05-4425-01A -25902 0 669 2010-7-22 FEMALE Lung Adenocarcinoma Mixed Subtype No C34.2 8255/3 C34.2 YES 1 NO 1.1 28 No M1 N0 T2 Stage IV TCGA-05-4425.adafa26d-044f-4b01-804a-5066ee20ceb6.pdf 4425 R1 Primary Tumor 01 0.3 6th NO YES 05 3 Current reformed smoker for > 15 years Lung A LIVING 2008 ac9dd948-4352-4869-85a1-639151a4bffb TCGA-05-4425-01A-01D-1753-08 ac9dd948-4352-4869-85a1-639151a4bffb TCGA-05-4425-01A-01D-1756-05 TCGA-05-4425-01A-01D-1752-01 ac9dd948-4352-4869-85a1-639151a4bffb TCGA-05-4425-01A-01D-1752-01 +TCGA-05-4426-01 1.99 0.71 none none none none N Y none none none 0.36 Squamoid none none none none none none none Solid predominant Adc Solid predominant Adc Y none 0 TCGA-05-4426-01 Kirc+ C1-LUAD-enriched Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 4 mutation cluster 5 TCGA-05-4426 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 71 L-Lower TCGA-05-4426-F36562 TCGA-05-4426 TCGA-05-4426-01A -26084 0 791 457 Scheduled Follow-up Submission Complete Remission/Response 2012-11-2 MALE Lung Adenocarcinoma Mixed Subtype No C34.3 8255/3 C34.3 YES 0.9 NO 1.5 NO YES 20 No M0 N0 T2 Stage IB TCGA-05-4426.0c54267d-6868-4aa3-a2a3-6c2eb309f6a7.pdf 4426 TUMOR FREE Complete Remission/Response R0 Primary Tumor 01 0.5 6th NO YES 05 3 Current reformed smoker for > 15 years Lung A LIVING 2008 b2aba2a6-3b30-41bb-a4cc-74f36b60a114 TCGA-05-4426-01A-01D-1205-05 TCGA-05-4426-01A-01D-1265-08 b2aba2a6-3b30-41bb-a4cc-74f36b60a114 TCGA-05-4426-01A-01D-1204-01 b2aba2a6-3b30-41bb-a4cc-74f36b60a114 TCGA-05-4426-01A-01D-1204-01 TCGA-05-4426-01A-21-2190-20 +TCGA-05-4427-01 TCGA-05-4427-01 BRCA-LUAD+ C1-LUAD-enriched Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 4 mutation cluster 11 TCGA-05-4427 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 65 L-Upper TCGA-05-4427-F36564 TCGA-05-4427 TCGA-05-4427-01A -23893 0 791 Scheduled Follow-up Submission Complete Remission/Response 2012-11-2 FEMALE Lung Adenocarcinoma Mixed Subtype No C34.1 8255/3 C34.1 YES 0.6 NO 1.7 NO NO 8 Yes M0 N1 T2 Stage IIB TCGA-05-4427.06c7cdb1-5048-4c75-9002-090997275eff.pdf 4427 TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 0.3 2008 6th YES NO YES 05 4 Lung A LIVING 2008 1993 fd4a3155-ca05-464c-b8d9-816103de489d TCGA-05-4427-01A-21D-1855-08 fd4a3155-ca05-464c-b8d9-816103de489d TCGA-05-4427-01A-21D-1856-05 TCGA-05-4427-01A-21D-1854-01 fd4a3155-ca05-464c-b8d9-816103de489d TCGA-05-4427-01A-21D-1854-01 TCGA-05-4427-01A-22-2190-20 +TCGA-05-4430-01 3.44 0.2 none none none none N N none none none 0.09 Bronchioid none none none none none none none Solid predominant Adc Solid predominant Adc none 0 TCGA-05-4430-01 High C1-LUAD-enriched Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 4 mutation cluster 2 TCGA-05-4430 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 59 L-Lower TCGA-05-4430-F36427 TCGA-05-4430 TCGA-05-4430-01A -21884 0 761 Scheduled Follow-up Submission Complete Remission/Response 2012-10-30 FEMALE Lung Adenocarcinoma Mixed Subtype No C34.3 8255/3 C34.3 YES 0.8 NO 0.9 NO NO 80 No M0 N0 T2 Stage IB TCGA-05-4430.0c8a524e-3241-4cde-8d22-1330aaf8c603.pdf 4430 TUMOR FREE R0 Primary Tumor 01 0.4 6th NO YES 05 4 Current reformed smoker for < or = 15 years Lung A LIVING 2008 bda96534-9900-4f6f-ab17-a09f52dfada4 TCGA-05-4430-01A-02D-1205-05 TCGA-05-4430-01A-02D-1265-08 bda96534-9900-4f6f-ab17-a09f52dfada4 TCGA-05-4430-01A-02D-1204-01 bda96534-9900-4f6f-ab17-a09f52dfada4 TCGA-05-4430-01A-02D-1204-01 TCGA-05-4430-01A-11-2190-20 +TCGA-05-4432-01 3.33 0.37 none none none none N N none none p.P1206L 0.15 Magnoid none none none none none none none Solid predominant Adc Solid predominant Adc p.137_138QE>H* 1 TCGA-05-4432-01 High C1-LUAD-enriched Low purity c2 LUAD-like c10 miRNA cluster 7 mutation cluster 2 TCGA-05-4432 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 66 R-Upper TCGA-05-4432-F36424 TCGA-05-4432 TCGA-05-4432-01A -24350 0 761 Scheduled Follow-up Submission Complete Remission/Response 2012-10-30 MALE Lung Adenocarcinoma Mixed Subtype No C34.1 8255/3 C34.1 YES 0.7 NO 1 NO NO 58 No M0 N1 T2 Stage IIB TCGA-05-4432.f99933b1-6f7b-4e5e-87a4-4f902d031c76.pdf 4432 TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 0.3 6th YES NO YES 05 2 Current smoker Lung A LIVING 2008 31769d4d-64f5-4a2b-b8da-d5b2252badb3 TCGA-05-4432-01A-01D-1205-05 TCGA-05-4432-01A-01D-1265-08 31769d4d-64f5-4a2b-b8da-d5b2252badb3 TCGA-05-4432-01A-01D-1204-01 31769d4d-64f5-4a2b-b8da-d5b2252badb3 TCGA-05-4432-01A-01D-1204-01 +TCGA-05-4433-01 1.9 0.61 none none none none Y Y none none none 0.31 Bronchioid none p.G12V none none none none none Invasive mucinous Invasive mucinous none 0 TCGA-05-4433-01 Squamous C1-LUAD-enriched Cluster 5 LUAD-like c10 miRNA cluster 4 mutation cluster 2 TCGA-05-4433 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 82 L-Lower TCGA-05-4433-F36530 TCGA-05-4433 TCGA-05-4433-01A -30194 0 730 Scheduled Follow-up Submission Complete Remission/Response 2012-11-1 MALE Lung Adenocarcinoma Mixed Subtype No C34.3 8255/3 C34.3 YES 1 NO 1.1 NO NO 1 No M0 N0 T2 Stage IB TCGA-05-4433.eeae318d-a517-48b6-9a21-5c72dc4bd510.pdf 4433 TUMOR FREE R0 Primary Tumor 01 0.3 1948 6th NO YES 05 3 Current reformed smoker for > 15 years Lung A LIVING 2008 1946 013f7a4f-eec9-4ba8-8473-6515cdc9be68 TCGA-05-4433-01A-22D-1855-08 013f7a4f-eec9-4ba8-8473-6515cdc9be68 TCGA-05-4433-01A-22D-1856-05 TCGA-05-4433-01A-22D-1854-01 013f7a4f-eec9-4ba8-8473-6515cdc9be68 TCGA-05-4433-01A-22D-1854-01 +TCGA-05-4434-01 TCGA-05-4434-01 Kirc+ C1-LUAD-enriched Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 4 mutation c1uster 9 TCGA-05-4434 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 67 R-Lower TCGA-05-4434 TCGA-05-4434-01A -24472 457 0 2010-7-22 FEMALE Lung Adenocarcinoma Mixed Subtype No C34.3 8255/3 C34.3 YES 0.8 NO 1.3 15 Yes M1 N1 T4 Stage IV TCGA-05-4434.0e9e74b2-7fd5-47b0-adf5-83c83b0c2d3d.pdf 4434 R2 Primary Tumor 01 0.3 6th NO YES 05 2 Lung A DECEASED 2008 49511397-f9b7-4946-98b7-d26f9a2ec0c2 TCGA-05-4434-01A-01D-1205-05 TCGA-05-4434-01A-01D-1265-08 49511397-f9b7-4946-98b7-d26f9a2ec0c2 TCGA-05-4434-01A-01D-1204-01 49511397-f9b7-4946-98b7-d26f9a2ec0c2 TCGA-05-4434-01A-01D-1204-01 TCGA-05-4434-01A-21-2190-20 +TCGA-05-5420-01 1.83 0.25 none none none none N N none none none 0.13 Squamoid none none none none none none none Solid predominant Adc Solid predominant Adc none 0 TCGA-05-5420-01 High C1-LUAD-enriched Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 4 mutation c1uster 9 TCGA-05-5420 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 67 L-Upper TCGA-05-5420-F36422 TCGA-05-5420 TCGA-05-5420-01A -24472 0 457 245 Scheduled Follow-up Submission Progressive Disease 2012-10-30 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.9 YES 0.9 NO 1 NO YES 40 Yes M0 N2 T2 Stage IIIA TCGA-05-5420.0777F8E7-46DF-4C9C-8CE9-B9B6E36DBAF5.pdf 5420 WITH TUMOR Progressive Disease R0 Primary Tumor 01 0.3 2001 6th NO YES 05 4 Current reformed smoker for < or = 15 years Lung A LIVING 2008 1961 8d78dad5-81bc-41d5-83db-10bec2cf114e TCGA-05-5420-01A-01D-1625-08 8d78dad5-81bc-41d5-83db-10bec2cf114e TCGA-05-5420-01A-01D-1626-05 TCGA-05-5420-01A-01D-1624-01 8d78dad5-81bc-41d5-83db-10bec2cf114e TCGA-05-5420-01A-01D-1624-01 TCGA-05-5420-01A-21-2190-20 +TCGA-05-5420-11 1.83 0.25 none none none none N N none none none 0.13 Squamoid none none none none none none none Solid predominant Adc Solid predominant Adc none 0 TCGA-05-5420-11 C1-LUAD-enriched mutation c1uster 9 TCGA-05-5420 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 67 L-Upper TCGA-05-5420-F36422 TCGA-05-5420 TCGA-05-5420-11A -24472 0 457 245 Scheduled Follow-up Submission Progressive Disease 2012-10-30 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.9 YES 0.9 NO 0.9 NO YES 40 Yes M0 N2 T2 Stage IIIA 5420 WITH TUMOR Progressive Disease R0 Solid Tissue Normal 11 0.9 2001 6th NO YES 05 4 Current reformed smoker for < or = 15 years Lung A LIVING 2008 1961 TCGA-05-5420-11A-01D-1626-05 +TCGA-05-5423-01 2.36 0.6 none none none none Y Y p.L833F, p.L861Q none none 0.27 Bronchioid none none none none none none none Acinar predominant Adc Acinar predominant Adc none 0 TCGA-05-5423-01 High C1-LUAD-enriched Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 4 mutation cluster 8 TCGA-05-5423 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 65 L-Upper TCGA-05-5423 TCGA-05-5423-01A -23863 0 151 2011-3-22 MALE Lung Adenocarcinoma Mixed Subtype No C34.9 8255/3 C34.9 YES 0.8 NO 1.4 72 No M0 N1 T2 Stage IIB TCGA-05-5423.37823CCB-824B-4761-A520-A9F2C8D457EF.pdf 5423 TUMOR FREE R0 Primary Tumor 01 0.3 1980 6th NO YES 05 3 Current reformed smoker for > 15 years Lung A LIVING 2006 1956 44d80508-53d8-4ba3-b263-8c31e4b58096 TCGA-05-5423-01A-01D-1625-08 44d80508-53d8-4ba3-b263-8c31e4b58096 TCGA-05-5423-01A-01D-1626-05 TCGA-05-5423-01A-01D-1624-01 44d80508-53d8-4ba3-b263-8c31e4b58096 TCGA-05-5423-01A-01D-1624-01 TCGA-05-5423-01A-21-2190-20 +TCGA-05-5425-01 TCGA-05-5425-01 High C1-LUAD-enriched Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 4 mutation c1uster 9 TCGA-05-5425 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 68 R-Upper TCGA-05-5425-F36403 TCGA-05-5425 TCGA-05-5425-01A -25020 0 882 486 Scheduled Follow-up Submission Progressive Disease 2012-10-30 MALE Lung Adenocarcinoma Mixed Subtype No C34.9 8255/3 C34.9 YES 0.9 NO 1.2 NO YES 40 No M0 N1 T2b Stage IIB TCGA-05-5425.6367B293-BF9C-4651-9B73-7B9D1764948D.pdf 5425 WITH TUMOR YES R0 Primary Tumor 01 0.4 1985 7th YES NO YES 05 3 Lung A LIVING 2009 1965 46b786be-8c30-4025-aa29-708c76bb4bcf TCGA-05-5425-01A-02D-1625-08 46b786be-8c30-4025-aa29-708c76bb4bcf TCGA-05-5425-01A-02D-1626-05 TCGA-05-5425-01A-02D-1624-01 46b786be-8c30-4025-aa29-708c76bb4bcf TCGA-05-5425-01A-02D-1624-01 TCGA-05-5425-01A-11-2190-20 +TCGA-05-5428-01 3.37 0.63 none p.D594N none none N Y none none none 0.22 Squamoid none none none none none none none Solid predominant Adc Solid predominant Adc none 0 TCGA-05-5428-01 BRCA-LUAD+ C1-LUAD-enriched Cluster 6 LUAD-like c10 miRNA cluster 4 mutation cluster 8 TCGA-05-5428 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 57 R-Upper TCGA-05-5428-F36401 TCGA-05-5428 TCGA-05-5428-01A -21061 0 670 Scheduled Follow-up Submission Complete Remission/Response 2012-10-30 MALE Lung Adenocarcinoma Mixed Subtype No C34.9 8255/3 C34.9 YES 0.8 NO 1 NO NO 30 No M0 N1 T1b Stage IIA TCGA-05-5428.E5422AE1-E0E5-470E-A6E2-E66BF61B157B.pdf 5428 TUMOR FREE Complete Remission/Response YES R0 Primary Tumor 01 0.2 1993 7th YES NO YES 05 3 Current reformed smoker for > 15 years Lung A LIVING 2010 1969 7dfdb65a-8f75-4223-8e5c-bb13f1d8eb3b TCGA-05-5428-01A-01D-1625-08 7dfdb65a-8f75-4223-8e5c-bb13f1d8eb3b TCGA-05-5428-01A-01D-1626-05 TCGA-05-5428-01A-01D-1624-01 7dfdb65a-8f75-4223-8e5c-bb13f1d8eb3b TCGA-05-5428-01A-01D-1624-01 +TCGA-05-5429-01 2.07 0.47 none none none none N N none none none 0.23 Magnoid none none none none none none none Acinar predominant Adc Acinar predominant Adc none 0 TCGA-05-5429-01 Iq C1-LUAD-enriched Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 8 mutation c1uster 9 TCGA-05-5429 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 60 L-Upper TCGA-05-5429-F36396 TCGA-05-5429 TCGA-05-5429-01A -22066 275 0 30 Scheduled Follow-up Submission 2012-10-30 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.9 YES 0.9 NO 1 NO No M0 N2 T3 Stage IIIA TCGA-05-5429.087C433B-9B20-439A-932C-4C852341A052.pdf 5429 TUMOR FREE R0 Primary Tumor 01 0.3 7th NO YES 05 1 Lifelong Non-smoker Lung A DECEASED 2010 33f213fa-6fa4-48ed-bd7e-a63ed8c3a8da TCGA-05-5429-01A-01D-1625-08 33f213fa-6fa4-48ed-bd7e-a63ed8c3a8da TCGA-05-5429-01A-01D-1626-05 TCGA-05-5429-01A-01D-1624-01 33f213fa-6fa4-48ed-bd7e-a63ed8c3a8da TCGA-05-5429-01A-01D-1624-01 TCGA-05-5429-01A-21-2190-20 +TCGA-05-5715-01 1.82 0.74 none none none none N Y none p.774_775insAYVM none 0.4 Bronchioid none none none none none none none Micropapillary predom Adc Micropapillary predom Adc none 0 TCGA-05-5715-01 BRCA-LUAD+ C1-LUAD-enriched Cluster 6 KIRC-like c1 LUAD-like c10 miRNA c1uster 10 mutation c1uster 10 TCGA-05-5715 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 69 L-Upper TCGA-05-5715 TCGA-05-5715-01A -25383 0 62 2011-3-22 FEMALE Lung Adenocarcinoma Mixed Subtype No C34.1 8255/3 C34.1 YES 0.6 NO 0.9 No M0 N0 T2a Stage IB TCGA-05-5715.b764fced-b638-48c6-82a6-4d3663bb2168.pdf 5715 TUMOR FREE R0 Primary Tumor 01 0.6 7th NO YES 05 1 Lifelong Non-smoker Lung A LIVING 2010 a9c81a18-bc29-4fac-83b2-bbd8047599bd TCGA-05-5715-01A-01D-1625-08 a9c81a18-bc29-4fac-83b2-bbd8047599bd TCGA-05-5715-01A-01D-1626-05 TCGA-05-5715-01A-01D-1624-01 a9c81a18-bc29-4fac-83b2-bbd8047599bd TCGA-05-5715-01A-01D-1624-01 TCGA-05-5715-01A-41-2191-20 +TCGA-17-Z000-01 TCGA-17-Z000-01 Cluster 5 mutation c1uster 9 TCGA-17-Z000 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung TCGA-17-Z000-01A-01D-0752-05 TCGA-17-Z000-01A-01W-0746-08 +TCGA-17-Z001-01 TCGA-17-Z001-01 Cluster 5 mutation cluster 8 TCGA-17-Z001 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung TCGA-17-Z001-01A-01D-0752-05 TCGA-17-Z001-01A-01W-0746-08 +TCGA-17-Z002-01 TCGA-17-Z002-01 Cluster 6 TCGA-17-Z002 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung TCGA-17-Z002-01A-01D-0752-05 +TCGA-17-Z003-01 TCGA-17-Z003-01 Cluster 5 mutation cluster 5 TCGA-17-Z003 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung TCGA-17-Z003-01A-01D-0752-05 TCGA-17-Z003-01A-01W-0746-08 +TCGA-17-Z004-01 TCGA-17-Z004-01 Low purity c2 mutation c1uster 9 TCGA-17-Z004 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung TCGA-17-Z004-01A-01D-0752-05 TCGA-17-Z004-01A-01W-0746-08 +TCGA-17-Z005-01 TCGA-17-Z005-01 Cluster 6 mutation cluster 5 TCGA-17-Z005 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung TCGA-17-Z005-01A-01D-0752-05 TCGA-17-Z005-01A-01W-0746-08 +TCGA-17-Z006-01 TCGA-17-Z006-01 Cluster 5 TCGA-17-Z006 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung TCGA-17-Z006-01A-01D-0752-05 +TCGA-17-Z007-01 TCGA-17-Z007-01 COADREAD non-CIMP c11 mutation cluster 5 TCGA-17-Z007 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung TCGA-17-Z007-01A-01D-0752-05 TCGA-17-Z007-01A-01W-0746-08 +TCGA-17-Z008-01 TCGA-17-Z008-01 Cluster 5 mutation cluster 7 TCGA-17-Z008 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung TCGA-17-Z008-01A-01D-0752-05 TCGA-17-Z008-01A-01W-0746-08 +TCGA-17-Z009-01 TCGA-17-Z009-01 Low purity c2 mutation cluster 14 TCGA-17-Z009 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung TCGA-17-Z009-01A-01D-0752-05 TCGA-17-Z009-01A-01W-0746-08 +TCGA-17-Z010-01 TCGA-17-Z010-01 Cluster 6 mutation cluster 7 TCGA-17-Z010 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung TCGA-17-Z010-01A-01D-0752-05 TCGA-17-Z010-01A-01W-0746-08 +TCGA-17-Z011-01 TCGA-17-Z011-01 Cluster 5 mutation c1uster 9 TCGA-17-Z011 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung TCGA-17-Z011-01A-01D-0752-05 TCGA-17-Z011-01A-01W-0746-08 +TCGA-17-Z012-01 TCGA-17-Z012-01 Cluster 5 mutation cluster 5 TCGA-17-Z012 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung TCGA-17-Z012-01A-01D-0752-05 TCGA-17-Z012-01A-01W-0746-08 +TCGA-17-Z013-01 TCGA-17-Z013-01 Cluster 5 mutation c1uster 9 TCGA-17-Z013 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung TCGA-17-Z013-01A-01D-0752-05 TCGA-17-Z013-01A-01W-0746-08 +TCGA-17-Z014-01 TCGA-17-Z014-01 Cluster 6 mutation cluster 12 TCGA-17-Z014 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung TCGA-17-Z014-01A-01D-0752-05 TCGA-17-Z014-01A-01W-0746-08 +TCGA-17-Z015-01 TCGA-17-Z015-01 Cluster 6 mutation cluster 8 TCGA-17-Z015 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung TCGA-17-Z015-01A-01D-0752-05 TCGA-17-Z015-01A-01W-0746-08 +TCGA-17-Z016-01 TCGA-17-Z016-01 Cluster 5 mutation cluster 12 TCGA-17-Z016 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung TCGA-17-Z016-01A-01D-0752-05 TCGA-17-Z016-01A-01W-0746-08 +TCGA-17-Z017-01 TCGA-17-Z017-01 Cluster 6 mutation cluster 2 TCGA-17-Z017 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung TCGA-17-Z017-01A-01D-0752-05 TCGA-17-Z017-01A-01W-0746-08 +TCGA-17-Z018-01 TCGA-17-Z018-01 Cluster 5 mutation cluster 6 TCGA-17-Z018 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung TCGA-17-Z018-01A-01D-0752-05 TCGA-17-Z018-01A-01W-0746-08 +TCGA-17-Z019-01 TCGA-17-Z019-01 Cluster 5 TCGA-17-Z019 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung TCGA-17-Z019-01A-01D-0752-05 +TCGA-17-Z020-01 TCGA-17-Z020-01 Cluster 5 mutation cluster 2 TCGA-17-Z020 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung TCGA-17-Z020-01A-01D-0752-05 TCGA-17-Z020-01A-01W-0746-08 +TCGA-17-Z021-01 TCGA-17-Z021-01 Cluster 5 mutation cluster 5 TCGA-17-Z021 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung TCGA-17-Z021-01A-01D-0752-05 TCGA-17-Z021-01A-01W-0746-08 +TCGA-17-Z022-01 TCGA-17-Z022-01 Cluster 5 mutation cluster 11 TCGA-17-Z022 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung TCGA-17-Z022-01A-01D-0752-05 TCGA-17-Z022-01A-01W-0746-08 +TCGA-17-Z023-01 TCGA-17-Z023-01 Low purity c2 mutation cluster 2 TCGA-17-Z023 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung TCGA-17-Z023-01A-01D-0752-05 TCGA-17-Z023-01A-01W-0746-08 +TCGA-17-Z024-01 TCGA-17-Z024-01 Cluster 5 TCGA-17-Z024 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung TCGA-17-Z024-01A-01D-0752-05 +TCGA-17-Z025-01 TCGA-17-Z025-01 Cluster 6 mutation cluster 12 TCGA-17-Z025 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung TCGA-17-Z025-01A-01D-0752-05 TCGA-17-Z025-01A-01W-0746-08 +TCGA-17-Z026-01 TCGA-17-Z026-01 Cluster 5 mutation cluster 11 TCGA-17-Z026 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung TCGA-17-Z026-01A-01D-0752-05 TCGA-17-Z026-01A-01W-0746-08 +TCGA-17-Z027-01 TCGA-17-Z027-01 Cluster 5 mutation cluster 8 TCGA-17-Z027 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung TCGA-17-Z027-01A-01D-0752-05 TCGA-17-Z027-01A-01W-0746-08 +TCGA-17-Z028-01 TCGA-17-Z028-01 Cluster 5 mutation cluster 8 TCGA-17-Z028 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung TCGA-17-Z028-01A-01D-0752-05 TCGA-17-Z028-01A-01W-0746-08 +TCGA-17-Z029-01 TCGA-17-Z029-01 Low purity c2 TCGA-17-Z029 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung TCGA-17-Z029-01A-01D-0752-05 +TCGA-17-Z030-01 TCGA-17-Z030-01 Cluster 5 mutation cluster 11 TCGA-17-Z030 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung TCGA-17-Z030-01A-01D-0752-05 TCGA-17-Z030-01A-01W-0746-08 +TCGA-17-Z031-01 TCGA-17-Z031-01 Cluster 6 mutation cluster 11 TCGA-17-Z031 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung TCGA-17-Z031-01A-01D-0752-05 TCGA-17-Z031-01A-01W-0746-08 +TCGA-17-Z032-01 TCGA-17-Z032-01 Cluster 5 mutation cluster 14 TCGA-17-Z032 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung TCGA-17-Z032-01A-01D-0752-05 TCGA-17-Z032-01A-01W-0746-08 +TCGA-17-Z033-01 TCGA-17-Z033-01 Cluster 6 mutation cluster 12 TCGA-17-Z033 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung TCGA-17-Z033-01A-01D-0752-05 TCGA-17-Z033-01A-01W-0746-08 +TCGA-17-Z034-01 TCGA-17-Z034-01 Low purity c2 TCGA-17-Z034 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung TCGA-17-Z034-01A-01D-0752-05 +TCGA-17-Z035-01 TCGA-17-Z035-01 Cluster 5 mutation cluster 8 TCGA-17-Z035 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung TCGA-17-Z035-01A-01D-0752-05 TCGA-17-Z035-01A-01W-0746-08 +TCGA-17-Z036-01 TCGA-17-Z036-01 Cluster 5 mutation cluster 12 TCGA-17-Z036 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung TCGA-17-Z036-01A-01D-0752-05 TCGA-17-Z036-01A-01W-0746-08 +TCGA-17-Z037-01 TCGA-17-Z037-01 COADREAD non-CIMP c11 mutation cluster 2 TCGA-17-Z037 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung TCGA-17-Z037-01A-01D-0752-05 TCGA-17-Z037-01A-01W-0746-08 +TCGA-17-Z038-01 TCGA-17-Z038-01 Cluster 5 mutation c1uster 9 TCGA-17-Z038 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung TCGA-17-Z038-01A-01D-0752-05 TCGA-17-Z038-01A-01W-0746-08 +TCGA-17-Z039-01 TCGA-17-Z039-01 Low purity c2 mutation c1uster 9 TCGA-17-Z039 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung TCGA-17-Z039-01A-01D-0752-05 TCGA-17-Z039-01A-01W-0746-08 +TCGA-17-Z040-01 TCGA-17-Z040-01 Cluster 5 mutation c1uster 9 TCGA-17-Z040 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung TCGA-17-Z040-01A-01D-0752-05 TCGA-17-Z040-01A-01W-0746-08 +TCGA-17-Z041-01 TCGA-17-Z041-01 Cluster 5 mutation c1uster 9 TCGA-17-Z041 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung TCGA-17-Z041-01A-01D-0752-05 TCGA-17-Z041-01A-01W-0746-08 +TCGA-17-Z042-01 TCGA-17-Z042-01 Cluster 6 mutation cluster 11 TCGA-17-Z042 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung TCGA-17-Z042-01A-01D-0752-05 TCGA-17-Z042-01A-01W-0746-08 +TCGA-17-Z043-01 TCGA-17-Z043-01 Cluster 5 mutation cluster 5 TCGA-17-Z043 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung TCGA-17-Z043-01A-01D-0752-05 TCGA-17-Z043-01A-01W-0746-08 +TCGA-17-Z044-01 TCGA-17-Z044-01 Cluster 5 mutation cluster 8 TCGA-17-Z044 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung TCGA-17-Z044-01A-01D-0752-05 TCGA-17-Z044-01A-01W-0746-08 +TCGA-17-Z045-01 TCGA-17-Z045-01 Cluster 5 mutation cluster 2 TCGA-17-Z045 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung TCGA-17-Z045-01A-01D-0752-05 TCGA-17-Z045-01A-01W-0746-08 +TCGA-17-Z046-01 TCGA-17-Z046-01 Cluster 6 mutation cluster 11 TCGA-17-Z046 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung TCGA-17-Z046-01A-01D-0752-05 TCGA-17-Z046-01A-01W-0746-08 +TCGA-17-Z047-01 TCGA-17-Z047-01 Cluster 5 mutation cluster 8 TCGA-17-Z047 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung TCGA-17-Z047-01A-01D-0752-05 TCGA-17-Z047-01A-01W-0747-08 +TCGA-17-Z048-01 TCGA-17-Z048-01 Cluster 5 mutation cluster 14 TCGA-17-Z048 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung TCGA-17-Z048-01A-01D-0752-05 TCGA-17-Z048-01A-01W-0746-08 +TCGA-17-Z049-01 TCGA-17-Z049-01 Cluster 5 mutation cluster 2 TCGA-17-Z049 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung TCGA-17-Z049-01A-01D-0752-05 TCGA-17-Z049-01A-01W-0746-08 +TCGA-17-Z050-01 TCGA-17-Z050-01 Cluster 6 mutation cluster 7 TCGA-17-Z050 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung TCGA-17-Z050-01A-01D-0752-05 TCGA-17-Z050-01A-01W-0747-08 +TCGA-17-Z051-01 TCGA-17-Z051-01 Cluster 5 mutation c1uster 9 TCGA-17-Z051 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung TCGA-17-Z051-01A-01D-0752-05 TCGA-17-Z051-01A-01W-0747-08 +TCGA-17-Z052-01 TCGA-17-Z052-01 Low purity c2 mutation cluster 5 TCGA-17-Z052 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung TCGA-17-Z052-01A-01D-0752-05 TCGA-17-Z052-01A-01W-0747-08 +TCGA-17-Z053-01 TCGA-17-Z053-01 Cluster 13 (HNSC-LUSC) mutation cluster 2 TCGA-17-Z053 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung TCGA-17-Z053-01A-01D-0752-05 TCGA-17-Z053-01A-01W-0747-08 +TCGA-17-Z054-01 TCGA-17-Z054-01 Cluster 5 mutation c1uster 9 TCGA-17-Z054 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung TCGA-17-Z054-01A-01D-0752-05 TCGA-17-Z054-01A-01W-0747-08 +TCGA-17-Z055-01 TCGA-17-Z055-01 mutation cluster 2 TCGA-17-Z055 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung TCGA-17-Z055-01A-01W-0747-08 +TCGA-17-Z056-01 TCGA-17-Z056-01 Cluster 5 mutation cluster 8 TCGA-17-Z056 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung TCGA-17-Z056-01A-01D-0752-05 TCGA-17-Z056-01A-01W-0747-08 +TCGA-17-Z057-01 TCGA-17-Z057-01 mutation cluster 5 TCGA-17-Z057 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung TCGA-17-Z057-01A-01W-0747-08 +TCGA-17-Z058-01 TCGA-17-Z058-01 Cluster 5 mutation cluster 12 TCGA-17-Z058 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung TCGA-17-Z058-01A-01D-0752-05 TCGA-17-Z058-01A-01W-0747-08 +TCGA-17-Z059-01 TCGA-17-Z059-01 Cluster 6 mutation c1uster 9 TCGA-17-Z059 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung TCGA-17-Z059-01A-01D-0752-05 TCGA-17-Z059-01A-01W-0747-08 +TCGA-17-Z060-01 TCGA-17-Z060-01 Cluster 5 mutation cluster 12 TCGA-17-Z060 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung TCGA-17-Z060-01A-01D-0752-05 TCGA-17-Z060-01A-01W-0747-08 +TCGA-17-Z061-01 TCGA-17-Z061-01 Cluster 5 mutation cluster 13 TCGA-17-Z061 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung TCGA-17-Z061-01A-01D-0752-05 TCGA-17-Z061-01A-01W-0747-08 +TCGA-17-Z062-01 TCGA-17-Z062-01 Cluster 5 mutation cluster 11 TCGA-17-Z062 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung TCGA-17-Z062-01A-01D-0752-05 TCGA-17-Z062-01A-01W-0747-08 +TCGA-18-3406-01 TCGA-18-3406-01 Squamous C2-Squamous-like Cluster 13 (HNSC-LUSC) squamous-like c4 miRNA cluster 11 mutation cluster 5 TCGA-18-3406 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung NO NO NO 67 L-Upper TCGA-18-3406-F69068 TCGA-18-3406 TCGA-18-3406-01A -24477 371 0 357 Scheduled Follow-up Submission 2014-12-29 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.5 NO 0 0.8 NO Locoregional Recurrence YES 200 Yes M0 N0 T1 Stage IA TCGA-18-3406.a0eef850-7543-4f82-8e46-3d81e203412d.pdf 3406 WITH TUMOR Progressive Disease Convincing Imaging NO R0 Primary Tumor 01 0.3 NO NO YES 18 4 Lung A DECEASED 2003 1951 99516b1e-9ee2-48d9-90e4-e78370eccef6 TCGA-18-3406-01A-01D-0979-05 TCGA-18-3406-01A-01D-0983-08 99516b1e-9ee2-48d9-90e4-e78370eccef6 TCGA-18-3406-01A-01D-0978-01 TCGA-18-3406-01A-01R-0980-07 99516b1e-9ee2-48d9-90e4-e78370eccef6 TCGA-18-3406-01A-01D-0978-01 +TCGA-18-3406-11 TCGA-18-3406-11 C2-Squamous-like mutation cluster 5 TCGA-18-3406 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung NO NO NO 67 L-Upper TCGA-18-3406-F69068 TCGA-18-3406 TCGA-18-3406-11A -24477 371 0 357 Scheduled Follow-up Submission 2014-12-29 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.4 NO 0 0.8 NO Locoregional Recurrence YES 200 Yes M0 N0 T1 Stage IA 3406 WITH TUMOR Progressive Disease Convincing Imaging NO R0 Solid Tissue Normal 11 0.2 NO NO YES 18 4 Lung A DECEASED 2003 1951 TCGA-18-3406-11A-01D-0979-05 +TCGA-18-3407-01 TCGA-18-3407-01 High C2-Squamous-like Cluster 14 (HNSC) squamous-like c4 miRNA cluster 4 mutation cluster 2 TCGA-18-3407 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 72 L-Upper TCGA-18-3407-F69081 TCGA-18-3407 TCGA-18-3407-01A -26615 136 0 Scheduled Follow-up Submission 2014-12-29 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.5 NO 0 0.5 NO NO 40 Yes M0 N0 T2 Stage IB TCGA-18-3407.c9b161d4-e3e2-43a9-8997-195db2fcc1d7.pdf 3407 TUMOR FREE NO R0 Primary Tumor 01 0.2 1988 NO NO YES 18 3 Lung A DECEASED 2003 0aea71d4-f403-474a-91d3-f9b0929c0acf TCGA-18-3407-01A-01D-0979-05 TCGA-18-3407-01A-01D-0983-08 0aea71d4-f403-474a-91d3-f9b0929c0acf TCGA-18-3407-01A-01D-1969-01 TCGA-18-3407-01A-01R-0980-07 0aea71d4-f403-474a-91d3-f9b0929c0acf TCGA-18-3407-01A-01D-1969-01 +TCGA-18-3407-11 TCGA-18-3407-11 C2-Squamous-like mutation cluster 2 TCGA-18-3407 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 72 L-Upper TCGA-18-3407-F69081 TCGA-18-3407 TCGA-18-3407-11A -26615 136 0 Scheduled Follow-up Submission 2014-12-29 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.7 NO 0 0.9 NO NO 40 Yes M0 N0 T2 Stage IB 3407 TUMOR FREE NO R0 Solid Tissue Normal 11 0.4 1988 NO NO YES 18 3 Lung A DECEASED 2003 TCGA-18-3407-11A-01D-0979-05 +TCGA-18-3408-01 TCGA-18-3408-01 Squamous C2-Squamous-like Cluster 13 (HNSC-LUSC) squamous-like c4 miRNA cluster 11 mutation cluster 5 TCGA-18-3408 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung NO YES NO 77 R-Lower TCGA-18-3408-F67568 TCGA-18-3408 TCGA-18-3408-01A -28171 2304 0 2099 1793 Scheduled Follow-up Submission Progressive Disease 2014-11-14 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.4 NO 0 0.5 NO Locoregional Recurrence YES 30 No M0 N0 T2 Stage IB TCGA-18-3408.ef586d16-0c67-42db-9d31-86df9476d49d.pdf 3408 WITH TUMOR Biopsy with Histologic Confirmation NO R0 Primary Tumor 01 0.3 2004 NO NO YES 18 4 Lung A DECEASED 2004 43672213-eb65-4206-bc57-56587b08259f TCGA-18-3408-01A-01D-0979-05 TCGA-18-3408-01A-01D-0983-08 43672213-eb65-4206-bc57-56587b08259f TCGA-18-3408-01A-01D-0978-01 TCGA-18-3408-01A-01R-0980-07 43672213-eb65-4206-bc57-56587b08259f TCGA-18-3408-01A-01D-0978-01 +TCGA-18-3408-11 TCGA-18-3408-11 C2-Squamous-like mutation cluster 5 TCGA-18-3408 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung NO YES NO 77 R-Lower TCGA-18-3408-F67568 TCGA-18-3408 TCGA-18-3408-11A -28171 2304 0 2099 1793 Scheduled Follow-up Submission Progressive Disease 2014-11-14 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.5 NO 0 0.5 NO Locoregional Recurrence YES 30 No M0 N0 T2 Stage IB 3408 WITH TUMOR Biopsy with Histologic Confirmation NO R0 Solid Tissue Normal 11 0.5 2004 NO NO YES 18 4 Lung A DECEASED 2004 TCGA-18-3408-11A-01D-0979-05 +TCGA-18-3409-01 TCGA-18-3409-01 COAD-READ C2-Squamous-like Cluster 5 squamous-like c4 mutation cluster 11 TCGA-18-3409 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung YES YES 74 L-Upper TCGA-18-3409-F72297 TCGA-18-3409 TCGA-18-3409-01A -27154 0 3747 2291 Additional New Tumor Event Complete Remission/Response 2015-5-6 MALE Lung Basaloid Squamous Cell Carcinoma No C34.1 8083/3 C34.1 YES 0.4 NO 0.9 NO New Primary Tumor YES 20 Yes M0 N0 T1 Stage IA TCGA-18-3409.978339c6-aea3-4ac1-87db-40388a3adf39.pdf 3409 TUMOR FREE Complete Remission/Response NO NO R0 Primary Tumor 01 0.2 1974 6th NO NO YES 18 3 Lung A LIVING 2004 c26af662-dd33-4073-bd97-1f79da7bfa43 TCGA-18-3409-01A-01D-0979-05 TCGA-18-3409-01A-01D-0983-08 c26af662-dd33-4073-bd97-1f79da7bfa43 TCGA-18-3409-01A-01D-0978-01 TCGA-18-3409-01A-01R-0980-07 c26af662-dd33-4073-bd97-1f79da7bfa43 TCGA-18-3409-01A-01D-0978-01 +TCGA-18-3409-11 TCGA-18-3409-11 C2-Squamous-like mutation cluster 11 TCGA-18-3409 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung YES YES 74 L-Upper TCGA-18-3409-F72297 TCGA-18-3409 TCGA-18-3409-11A -27154 0 3747 2291 Additional New Tumor Event Complete Remission/Response 2015-5-6 MALE Lung Basaloid Squamous Cell Carcinoma No C34.1 8083/3 C34.1 YES 0.4 NO 0.8 NO New Primary Tumor YES 20 Yes M0 N0 T1 Stage IA 3409 TUMOR FREE Complete Remission/Response NO NO R0 Solid Tissue Normal 11 0.2 1974 6th NO NO YES 18 3 Lung A LIVING 2004 TCGA-18-3409-11A-01D-0979-05 +TCGA-18-3410-01 TCGA-18-3410-01 Squamous C2-Squamous-like Cluster 5 squamous-like c4 miRNA cluster 12 mutation cluster 2 TCGA-18-3410 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 81 R-Lower TCGA-18-3410-F69095 TCGA-18-3410 TCGA-18-3410-01A -29827 146 0 Scheduled Follow-up Submission 2014-12-29 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.4 NO 0 Peripheral Lung 0.5 NO NO Yes M0 N0 T3 Stage IIB TCGA-18-3410.956030d1-c74c-4bb6-93d9-04eb5c786905.pdf 3410 TUMOR FREE NO R0 Primary Tumor 01 0.3 NO NO YES 18 3 Lung A DECEASED 2004 388eaf67-9d6d-4b9a-b404-a4ce171fbd18 TCGA-18-3410-01A-01D-0979-05 TCGA-18-3410-01A-01D-0983-08 388eaf67-9d6d-4b9a-b404-a4ce171fbd18 TCGA-18-3410-01A-01D-1969-01 TCGA-18-3410-01A-01R-0980-07 388eaf67-9d6d-4b9a-b404-a4ce171fbd18 TCGA-18-3410-01A-01D-1969-01 +TCGA-18-3410-11 TCGA-18-3410-11 C2-Squamous-like mutation cluster 2 TCGA-18-3410 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 81 R-Lower TCGA-18-3410-F69095 TCGA-18-3410 TCGA-18-3410-11A -29827 146 0 Scheduled Follow-up Submission 2014-12-29 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.5 NO 0 Peripheral Lung 0.7 NO NO Yes M0 N0 T3 Stage IIB 3410 TUMOR FREE NO R0 Solid Tissue Normal 11 0.5 NO NO YES 18 3 Lung A DECEASED 2004 TCGA-18-3410-11A-01D-0979-05 +TCGA-18-3411-01 TCGA-18-3411-01 High C2-Squamous-like Cluster 13 (HNSC-LUSC) squamous-like c4 miRNA cluster 4 mutation cluster 13 TCGA-18-3411 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 63 R-Upper TCGA-18-3411-F68326 TCGA-18-3411 TCGA-18-3411-01A -23370 0 3576 Scheduled Follow-up Submission 2014-11-14 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.5 NO 0.6 NO 50 No M0 N2 T2 Stage IIIA TCGA-18-3411.03efa03c-f8f9-43c3-9244-265bc02cbb5c.pdf 3411 TUMOR FREE YES R0 Primary Tumor 01 0.5 YES NO YES 18 2 Lung A LIVING 2005 bc493a57-6821-4607-a841-5ffc39391910 TCGA-18-3411-01A-01D-0979-05 TCGA-18-3411-01A-01D-0983-08 bc493a57-6821-4607-a841-5ffc39391910 TCGA-18-3411-01A-01D-1969-01 TCGA-18-3411-01A-01R-0980-07 bc493a57-6821-4607-a841-5ffc39391910 TCGA-18-3411-01A-01D-1969-01 +TCGA-18-3411-11 TCGA-18-3411-11 C2-Squamous-like mutation cluster 13 TCGA-18-3411 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 63 R-Upper TCGA-18-3411-F68326 TCGA-18-3411 TCGA-18-3411-11A -23370 0 3576 Scheduled Follow-up Submission 2014-11-14 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.5 NO 0.9 NO 50 No M0 N2 T2 Stage IIIA 3411 TUMOR FREE YES R0 Solid Tissue Normal 11 0.3 YES NO YES 18 2 Lung A LIVING 2005 TCGA-18-3411-11A-01D-0979-05 +TCGA-18-3412-01 TCGA-18-3412-01 Squamous C2-Squamous-like Cluster 13 (HNSC-LUSC) squamous-like c4 miRNA cluster 11 mutation c1uster 9 TCGA-18-3412 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung YES NO NO NO 52 L-Lower TCGA-18-3412-F69101 TCGA-18-3412 TCGA-18-3412-01A -19025 345 0 273 Scheduled Follow-up Submission Progressive Disease 2014-12-29 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.5 NO 0 Central Lung 0.6 NO Distant Metastasis YES 25 No M0 N0 T2 Stage IB TCGA-18-3412.cae58929-ecc1-4c4a-8df6-cf48a32785ee.pdf 3412 WITH TUMOR Progressive Disease Convincing Imaging NO R0 Primary Tumor 01 0.3 1995 YES NO YES 18 4 Lung A DECEASED 2005 8539f984-feb7-4b21-ac81-1ae2b403b845 TCGA-18-3412-01A-01D-0979-05 TCGA-18-3412-01A-01D-0983-08 8539f984-feb7-4b21-ac81-1ae2b403b845 TCGA-18-3412-01A-01D-0978-01 TCGA-18-3412-01A-01R-0980-07 8539f984-feb7-4b21-ac81-1ae2b403b845 TCGA-18-3412-01A-01D-0978-01 +TCGA-18-3412-11 TCGA-18-3412-11 C2-Squamous-like mutation c1uster 9 TCGA-18-3412 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung YES NO NO NO 52 L-Lower TCGA-18-3412-F69101 TCGA-18-3412 TCGA-18-3412-11A -19025 345 0 273 Scheduled Follow-up Submission Progressive Disease 2014-12-29 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.5 NO 0 Central Lung 0.7 NO Distant Metastasis YES 25 No M0 N0 T2 Stage IB 3412 WITH TUMOR Progressive Disease Convincing Imaging NO R0 Solid Tissue Normal 11 0.5 1995 YES NO YES 18 4 Lung A DECEASED 2005 TCGA-18-3412-11A-01D-0979-05 +TCGA-18-3414-01 TCGA-18-3414-01 Squamous C2-Squamous-like Cluster 5 squamous-like c4 miRNA cluster 4 mutation cluster 8 TCGA-18-3414 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 73 R-Lower TCGA-18-3414-F69131 TCGA-18-3414 TCGA-18-3414-01A -26938 716 0 Scheduled Follow-up Submission 2014-12-29 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.5 NO 0 0.7 NO NO 25 No M1 N1 T4 Stage IV TCGA-18-3414.f0bd5a6e-4ebf-4859-b139-80fbb3a54daf.pdf 3414 TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 0.4 1997 NO NO YES 18 4 Lung A DECEASED 2005 fddbc301-c80e-4ecd-b347-21783f885157 TCGA-18-3414-01A-01D-0979-05 TCGA-18-3414-01A-01D-0983-08 fddbc301-c80e-4ecd-b347-21783f885157 TCGA-18-3414-01A-01D-0978-01 TCGA-18-3414-01A-01R-0980-07 fddbc301-c80e-4ecd-b347-21783f885157 TCGA-18-3414-01A-01D-0978-01 +TCGA-18-3414-11 TCGA-18-3414-11 C2-Squamous-like mutation cluster 8 TCGA-18-3414 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 73 R-Lower TCGA-18-3414-F69131 TCGA-18-3414 TCGA-18-3414-11A -26938 716 0 Scheduled Follow-up Submission 2014-12-29 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.5 NO 0 0.7 NO NO 25 No M1 N1 T4 Stage IV 3414 TUMOR FREE Complete Remission/Response NO R0 Solid Tissue Normal 11 0.5 1997 NO NO YES 18 4 Lung A DECEASED 2005 TCGA-18-3414-11A-01D-0979-05 +TCGA-18-3415-01 TCGA-18-3415-01 Squamous C2-Squamous-like Cluster 13 (HNSC-LUSC) squamous-like c4 miRNA cluster 11 mutation cluster 5 TCGA-18-3415 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 77 R-Upper TCGA-18-3415-F67627 TCGA-18-3415 TCGA-18-3415-01A -28430 2803 0 1810 Scheduled Follow-up Submission 2014-11-7 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.5 NO 0.8 NO NO 30 No M0 N0 T2 Stage IB TCGA-18-3415.a37738c0-91cf-4e7e-b16c-3737a61bea72.pdf 3415 TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 0.2 1975 YES NO YES 18 3 Lung A DECEASED 2006 539545e6-7309-4431-85bf-101159542bdb TCGA-18-3415-01A-01D-0979-05 TCGA-18-3415-01A-01D-0983-08 539545e6-7309-4431-85bf-101159542bdb TCGA-18-3415-01A-01D-0978-01 TCGA-18-3415-01A-01R-0980-07 539545e6-7309-4431-85bf-101159542bdb TCGA-18-3415-01A-01D-0978-01 +TCGA-18-3415-11 TCGA-18-3415-11 C2-Squamous-like mutation cluster 5 TCGA-18-3415 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 77 R-Upper TCGA-18-3415-F67627 TCGA-18-3415 TCGA-18-3415-11A -28430 2803 0 1810 Scheduled Follow-up Submission 2014-11-7 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.5 NO 1 NO NO 30 No M0 N0 T2 Stage IB 3415 TUMOR FREE Complete Remission/Response NO R0 Solid Tissue Normal 11 0.3 1975 YES NO YES 18 3 Lung A DECEASED 2006 TCGA-18-3415-11A-01D-0979-05 +TCGA-18-3416-01 TCGA-18-3416-01 High C2-Squamous-like Cluster 14 (HNSC) squamous-like c4 miRNA cluster 4 mutation cluster 2 TCGA-18-3416 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 83 L-Upper TCGA-18-3416-F67641 TCGA-18-3416 TCGA-18-3416-01A -30435 973 0 956 940 Scheduled Follow-up Submission Progressive Disease 2014-11-7 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.5 NO 0.5 NO Distant Metastasis YES 40 Yes M0 N1 T2 Stage IIB TCGA-18-3416.d313ac3e-6ce5-411c-b014-8b88c7b7198b.pdf 3416 WITH TUMOR Complete Remission/Response Biopsy with Histologic Confirmation NO R0 Primary Tumor 01 0.4 NO NO YES 18 3 Lung A DECEASED 2006 c5532e8c-8632-4e7a-8143-e062af4b1d60 TCGA-18-3416-01A-01D-0979-05 TCGA-18-3416-01A-01D-0983-08 c5532e8c-8632-4e7a-8143-e062af4b1d60 TCGA-18-3416-01A-01D-0978-01 TCGA-18-3416-01A-01R-0980-07 c5532e8c-8632-4e7a-8143-e062af4b1d60 TCGA-18-3416-01A-01D-0978-01 +TCGA-18-3416-11 TCGA-18-3416-11 C2-Squamous-like mutation cluster 2 TCGA-18-3416 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 83 L-Upper TCGA-18-3416-F67641 TCGA-18-3416 TCGA-18-3416-11A -30435 973 0 956 940 Scheduled Follow-up Submission Progressive Disease 2014-11-7 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.6 NO 0.8 NO Distant Metastasis YES 40 Yes M0 N1 T2 Stage IIB 3416 WITH TUMOR Complete Remission/Response Biopsy with Histologic Confirmation NO R0 Solid Tissue Normal 11 0.2 NO NO YES 18 3 Lung A DECEASED 2006 TCGA-18-3416-11A-01D-0979-05 +TCGA-18-3417-01 TCGA-18-3417-01 High C2-Squamous-like Cluster 14 (HNSC) squamous-like c4 miRNA cluster 4 mutation cluster 6 TCGA-18-3417 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 65 R-Upper TCGA-18-3417-F67643 TCGA-18-3417 TCGA-18-3417-01A -24019 1097 0 758 Scheduled Follow-up Submission 2014-11-7 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.9 8070/3 C34.9 YES 0.4 NO 0.8 NO 25 No M1 N1 T2 Stage IV TCGA-18-3417.71b38c75-44cf-4f27-90c2-04caee0d55a6.pdf 3417 TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 0.3 1989 YES NO YES 18 3 Lung A DECEASED 2006 1963 608a1e43-d38c-498f-99d8-e5539d43b636 TCGA-18-3417-01A-01D-1441-08 608a1e43-d38c-498f-99d8-e5539d43b636 TCGA-18-3417-01A-01D-1440-05 TCGA-18-3417-01A-01D-1439-01 TCGA-18-3417-01A-01R-1443-07 608a1e43-d38c-498f-99d8-e5539d43b636 TCGA-18-3417-01A-01D-1439-01 +TCGA-18-3417-11 TCGA-18-3417-11 C2-Squamous-like mutation cluster 6 TCGA-18-3417 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 65 R-Upper TCGA-18-3417-F67643 TCGA-18-3417 TCGA-18-3417-11A -24019 1097 0 758 Scheduled Follow-up Submission 2014-11-7 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.9 8070/3 C34.9 YES 0.5 NO 0.5 NO 25 No M1 N1 T2 Stage IV 3417 TUMOR FREE Complete Remission/Response NO R0 Solid Tissue Normal 11 0.5 1989 YES NO YES 18 3 Lung A DECEASED 2006 1963 TCGA-18-3417-11A-01D-1440-05 +TCGA-18-3419-01 TCGA-18-3419-01 Squamous C2-Squamous-like Cluster 13 (HNSC-LUSC) squamous-like c4 miRNA cluster 11 mutation cluster 13 TCGA-18-3419 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 73 L-Lower TCGA-18-3419-F68328 TCGA-18-3419 TCGA-18-3419-01A -26813 0 2811 Scheduled Follow-up Submission 2014-11-14 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.6 NO 0.9 NO NO 50 No M0 N1 T2 Stage IIB TCGA-18-3419.be697b2e-96c7-401c-935b-5046a939f6af.pdf 3419 TUMOR FREE Complete Remission/Response R0 Primary Tumor 01 0.2 2002 NO YES 18 4 Lung A LIVING 2007 74c7652b-fa92-4fda-b52c-1b122d5a6462 TCGA-18-3419-01A-01D-0979-05 TCGA-18-3419-01A-01D-0983-08 74c7652b-fa92-4fda-b52c-1b122d5a6462 TCGA-18-3419-01A-01D-0978-01 TCGA-18-3419-01A-01R-0980-07 74c7652b-fa92-4fda-b52c-1b122d5a6462 TCGA-18-3419-01A-01D-0978-01 +TCGA-18-3419-11 TCGA-18-3419-11 C2-Squamous-like mutation cluster 13 TCGA-18-3419 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 73 L-Lower TCGA-18-3419-F68328 TCGA-18-3419 TCGA-18-3419-11A -26813 0 2811 Scheduled Follow-up Submission 2014-11-14 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.3 NO 0.4 NO NO 50 No M0 N1 T2 Stage IIB 3419 TUMOR FREE Complete Remission/Response R0 Solid Tissue Normal 11 0.1 2002 NO YES 18 4 Lung A LIVING 2007 TCGA-18-3419-11A-01D-0979-05 +TCGA-18-3421-01 TCGA-18-3421-01 High C2-Squamous-like Cluster 14 (HNSC) squamous-like c4 miRNA cluster 4 mutation cluster 13 TCGA-18-3421 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 65 R-Lower TCGA-18-3421-F67656 TCGA-18-3421 TCGA-18-3421-01A -23972 0 2645 Scheduled Follow-up Submission Complete Remission/Response 2014-11-7 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.8 NO 1 NO NO 40 No M0 N0 T2 Stage IB TCGA-18-3421.7640a498-7b8b-4e83-959d-c87e6753e12c.pdf 3421 TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 0.3 2007 NO NO YES 18 4 Lung A LIVING 2007 d0819fd7-9468-4da3-aade-ccf24cf3989d TCGA-18-3421-01A-01D-0979-05 TCGA-18-3421-01A-01D-0983-08 d0819fd7-9468-4da3-aade-ccf24cf3989d TCGA-18-3421-01A-01D-0978-01 TCGA-18-3421-01A-01R-0980-07 d0819fd7-9468-4da3-aade-ccf24cf3989d TCGA-18-3421-01A-01D-0978-01 +TCGA-18-3421-11 TCGA-18-3421-11 C2-Squamous-like mutation cluster 13 TCGA-18-3421 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 65 R-Lower TCGA-18-3421-F67656 TCGA-18-3421 TCGA-18-3421-11A -23972 0 2645 Scheduled Follow-up Submission Complete Remission/Response 2014-11-7 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.5 NO 1 NO NO 40 No M0 N0 T2 Stage IB 3421 TUMOR FREE Complete Remission/Response NO R0 Solid Tissue Normal 11 0.3 2007 NO NO YES 18 4 Lung A LIVING 2007 TCGA-18-3421-11A-01D-0979-05 +TCGA-18-4083-01 TCGA-18-4083-01 Squamous C2-Squamous-like Cluster 13 (HNSC-LUSC) squamous-like c4 mutation cluster 5 TCGA-18-4083 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 63 L-Lower TCGA-18-4083-F69111 TCGA-18-4083 TCGA-18-4083-01A -23125 188 0 Scheduled Follow-up Submission 2014-12-29 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.4 NO 0 0.5 NO 45 Yes M0 N1 T2 Stage IIB TCGA-18-4083.17a6525d-91d1-4cf5-b718-ea4c5e133a64.pdf 4083 TUMOR FREE NO R0 Primary Tumor 01 0.3 YES NO YES 18 2 Lung A DECEASED 2005 984b427f-6831-4ce5-8135-d25c0a2e62d2 TCGA-18-4083-01A-01D-1096-05 TCGA-18-4083-01A-01D-1352-08 984b427f-6831-4ce5-8135-d25c0a2e62d2 TCGA-18-4083-01A-01D-1097-01 TCGA-18-4083-01A-01R-1100-07 984b427f-6831-4ce5-8135-d25c0a2e62d2 TCGA-18-4083-01A-01D-1097-01 +TCGA-18-4086-01 TCGA-18-4086-01 Squamous C2-Squamous-like Cluster 5 squamous-like c4 miRNA cluster 7 mutation cluster 5 TCGA-18-4086 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 64 R-Lower TCGA-18-4086 TCGA-18-4086-01A -23731 85 0 2011-4-4 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.5 NO 0.8 30 No M0 N0 T2 Stage IB TCGA-18-4086.f83c1343-f2dc-4602-a34c-3a259edfb343.pdf 4086 TUMOR FREE R0 Primary Tumor 01 0.3 2001 NO YES 18 4 Lung A DECEASED 2009 95eea5e6-b72a-4dc6-a285-1c79bcf99465 TCGA-18-4086-01A-01D-1096-05 TCGA-18-4086-01A-01D-1352-08 95eea5e6-b72a-4dc6-a285-1c79bcf99465 TCGA-18-4086-01A-01D-1097-01 TCGA-18-4086-01A-01R-1100-07 95eea5e6-b72a-4dc6-a285-1c79bcf99465 TCGA-18-4086-01A-01D-1097-01 +TCGA-18-4721-01 TCGA-18-4721-01 Squamous C2-Squamous-like Cluster 13 (HNSC-LUSC) squamous c3 squamous-like c4 miRNA cluster 7 mutation c1uster 9 TCGA-18-4721 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 74 L-Lower TCGA-18-4721-F68325 TCGA-18-4721 TCGA-18-4721-01A -27076 0 4694 Scheduled Follow-up Submission 2014-11-14 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.8 NO 1 NO No M0 N0 T1 Stage IA TCGA-18-4721.107fcb94-0216-4e11-90e0-31f2bdc044fb.pdf 4721 TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 0.3 2001 NO NO YES 18 4 Lung A LIVING 2002 7bd328df-04eb-4500-b52e-59c8dba766a3 TCGA-18-4721-01A-01D-1441-08 7bd328df-04eb-4500-b52e-59c8dba766a3 TCGA-18-4721-01A-01D-1440-05 TCGA-18-4721-01A-01D-1439-01 7bd328df-04eb-4500-b52e-59c8dba766a3 TCGA-18-4721-01A-01D-1439-01 TCGA-18-4721-01A-21-2193-20 +TCGA-18-4721-11 TCGA-18-4721-11 C2-Squamous-like mutation c1uster 9 TCGA-18-4721 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 74 L-Lower TCGA-18-4721-F68325 TCGA-18-4721 TCGA-18-4721-11A -27076 0 4694 Scheduled Follow-up Submission 2014-11-14 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.4 NO 1 NO No M0 N0 T1 Stage IA 4721 TUMOR FREE Complete Remission/Response NO R0 Solid Tissue Normal 11 0.4 2001 NO NO YES 18 4 Lung A LIVING 2002 TCGA-18-4721-11A-01D-1440-05 +TCGA-18-5592-01 TCGA-18-5592-01 Squamous C2-Squamous-like Cluster 13 (HNSC-LUSC) squamous c3 squamous-like c4 mutation cluster 2 TCGA-18-5592 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 57 L-Upper TCGA-18-5592-F68323 TCGA-18-5592 TCGA-18-5592-01A -21020 0 1519 Scheduled Follow-up Submission 2014-11-14 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.5 NO 1.1 NO 40 No M0 N0 T3 Stage IIB TCGA-18-5592.fe921521-1681-4f88-bcda-b216cea7981a.pdf 5592 TUMOR FREE YES R0 Primary Tumor 01 0.4 YES NO YES 18 3 Lung A LIVING 2010 b1300b0f-5051-4e52-b1ff-5291f6653f0b TCGA-18-5592-01A-01D-1632-08 b1300b0f-5051-4e52-b1ff-5291f6653f0b TCGA-18-5592-01A-01D-1633-05 TCGA-18-5592-01A-01D-1631-01 b1300b0f-5051-4e52-b1ff-5291f6653f0b TCGA-18-5592-01A-01D-1631-01 TCGA-18-5592-01A-21-2194-20 +TCGA-18-5592-11 TCGA-18-5592-11 C2-Squamous-like mutation cluster 2 TCGA-18-5592 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 57 L-Upper TCGA-18-5592-F68323 TCGA-18-5592 TCGA-18-5592-11A -21020 0 1519 Scheduled Follow-up Submission 2014-11-14 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.6 NO 0.6 NO 40 No M0 N0 T3 Stage IIB 5592 TUMOR FREE YES R0 Solid Tissue Normal 11 0.3 YES NO YES 18 3 Lung A LIVING 2010 TCGA-18-5592-11A-11D-1633-05 +TCGA-18-5595-01 TCGA-18-5595-01 Kirc+ C2-Squamous-like Cluster 14 (HNSC) squamous c3 squamous-like c4 mutation cluster 4 TCGA-18-5595 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 50 R-Lower TCGA-18-5595 TCGA-18-5595-01A -18611 827 0 2011-4-27 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.6 NO 0.8 Yes M0 N0 T2 Stage IB TCGA-18-5595.3ca67814-08d3-4146-985d-b6608b3a7fe6.pdf 5595 R0 Primary Tumor 01 0.3 NO YES 18 1 Lung A DECEASED 2008 aace0b09-d6bd-4ebd-a694-c838e8724bd3 TCGA-18-5595-01A-01D-1632-08 aace0b09-d6bd-4ebd-a694-c838e8724bd3 TCGA-18-5595-01A-01D-1633-05 TCGA-18-5595-01A-01D-1631-01 aace0b09-d6bd-4ebd-a694-c838e8724bd3 TCGA-18-5595-01A-01D-1631-01 TCGA-18-5595-01A-21-2194-20 +TCGA-18-5595-11 TCGA-18-5595-11 C2-Squamous-like mutation cluster 4 TCGA-18-5595 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 50 R-Lower TCGA-18-5595 TCGA-18-5595-11A -18611 827 0 2011-4-27 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.5 NO 0.6 Yes M0 N0 T2 Stage IB 5595 R0 Solid Tissue Normal 11 0.3 NO YES 18 1 Lung A DECEASED 2008 TCGA-18-5595-11A-01D-1633-05 +TCGA-21-1070-01 TCGA-21-1070-01 High C2-Squamous-like Low purity c2 squamous c3 squamous-like c4 mutation c1uster 9 TCGA-21-1070 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung NO NO NO NO 60 L-Upper TCGA-21-1070-F4163 TCGA-21-1070 TCGA-21-1070-01A -22273 0 3636 2010-2-24 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 1 NO 1.2 NO 15 Yes M0 N0 T3 Stage IIIA TCGA-21-1070.32e48ff2-1c64-46c0-a1ff-eb77f4ad21b5.pdf 1070 TUMOR FREE NO R0 Primary Tumor 01 0.8 1992 NO NO YES 21 4 Lung A LIVING 2000 3a86e548-34d7-4677-9265-8ddd0e4ca4da TCGA-21-1070-01A-01D-0689-05 TCGA-21-1070-01A-01D-1521-08 3a86e548-34d7-4677-9265-8ddd0e4ca4da TCGA-21-1070-01A-01D-0685-01 TCGA-21-1070-01A-01R-0692-07 3a86e548-34d7-4677-9265-8ddd0e4ca4da TCGA-21-1070-01A-01D-0685-01 TCGA-21-1070-01A-21-2193-20 +TCGA-21-1071-01 TCGA-21-1071-01 Squamous C2-Squamous-like Cluster 13 (HNSC-LUSC) squamous c3 squamous-like c4 mutation cluster 4 TCGA-21-1071 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung YES YES NO NO 67 R-Upper TCGA-21-1071-F4146 TCGA-21-1071 TCGA-21-1071-01A -24515 1426 0 1426 993 2010-2-23 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 1 NO 1.2 YES 90 No M0 N0 T2 Stage IB TCGA-21-1071.7e0fc9aa-af71-4605-a396-3edf6b1870f4.pdf 1071 WITH TUMOR NO R0 Primary Tumor 01 0.3 NO NO YES 21 2 Lung A DECEASED 2001 6b56c843-4716-4118-8312-c86c3218d02a TCGA-21-1071-01A-01D-0689-05 TCGA-21-1071-01A-01D-1521-08 6b56c843-4716-4118-8312-c86c3218d02a TCGA-21-1071-01A-01D-0685-01 TCGA-21-1071-01A-01R-0692-07 6b56c843-4716-4118-8312-c86c3218d02a TCGA-21-1071-01A-01D-0685-01 TCGA-21-1071-01A-21-2193-20 +TCGA-21-1072-01 TCGA-21-1072-01 Squamous C2-Squamous-like BRCA CIMP c7 squamous c3 squamous-like c4 miRNA cluster 4 TCGA-21-1072 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 75 R-Upper TCGA-21-1072-F4150 TCGA-21-1072 TCGA-21-1072-01A -27397 0 3016 2010-2-23 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.9 8070/3 C34.9 YES 1.3 NO 1.6 NO No M0 N0 T2 Stage IB TCGA-21-1072.f035b8f2-1c3e-49b4-8ff5-101af46db322.pdf 1072 TUMOR FREE NO R0 Primary Tumor 01 0.4 NO NO YES 21 3 Lung A LIVING 2001 adf7cabd-e763-4adf-923f-9f47fa86ea7a TCGA-21-1072-01A-01D-0689-05 adf7cabd-e763-4adf-923f-9f47fa86ea7a TCGA-21-1072-01A-01D-0685-01 TCGA-21-1072-01A-01R-0692-07 adf7cabd-e763-4adf-923f-9f47fa86ea7a TCGA-21-1072-01A-01D-0685-01 TCGA-21-1072-01A-21-2193-20 +TCGA-21-1075-01 TCGA-21-1075-01 Squamous C2-Squamous-like Cluster 13 (HNSC-LUSC) squamous c3 squamous-like c4 miRNA cluster 12 TCGA-21-1075 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung NO NO NO NO 57 L-Lower TCGA-21-1075-F4151 TCGA-21-1075 TCGA-21-1075-01A -21093 0 2134 2010-3-3 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.8 NO 1 NO 74 No M0 N1 T2 Stage IIB TCGA-21-1075.8b3a07b0-b34e-4d70-b8be-7bb6bb30395a.pdf 1075 TUMOR FREE NO R0 Primary Tumor 01 0.8 NO NO YES 21 2 Lung A LIVING 2002 76ad7c60-3911-478f-bb99-2161769fa380 TCGA-21-1075-01A-01D-0689-05 76ad7c60-3911-478f-bb99-2161769fa380 TCGA-21-1075-01A-01D-0685-01 TCGA-21-1075-01A-01R-0692-07 76ad7c60-3911-478f-bb99-2161769fa380 TCGA-21-1075-01A-01D-0685-01 TCGA-21-1075-01A-21-2193-20 +TCGA-21-1076-01 TCGA-21-1076-01 BRCA-LUAD+ C2-Squamous-like Cluster 5 squamous c3 squamous-like c4 miRNA cluster 11 mutation cluster 2 TCGA-21-1076 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung NO NO NO NO 54 L-Lower TCGA-21-1076-F4153 TCGA-21-1076 TCGA-21-1076-01A -19863 0 1852 1575 2010-3-3 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.8 NO 1 YES 35 No M0 N0 T2 Stage IB TCGA-21-1076.990cc93f-4af3-4af5-8cd7-0bb81133e1be.pdf 1076 TUMOR FREE NO R0 Primary Tumor 01 0.6 1994 NO NO YES 21 4 Lung A LIVING 2005 db2c54e8-2023-49de-a116-7bec77297dee,0e4155e3-ff27-48f0-bc7d-c63b7c93d199 TCGA-21-1076-01A-01D-0689-05,TCGA-21-1076-01A-02D-0689-05 TCGA-21-1076-01A-02D-1521-08 db2c54e8-2023-49de-a116-7bec77297dee,0e4155e3-ff27-48f0-bc7d-c63b7c93d199 TCGA-21-1076-01A-02D-0685-01 TCGA-21-1076-01A-02R-0692-07,TCGA-21-1076-01A-01R-0692-07 db2c54e8-2023-49de-a116-7bec77297dee,0e4155e3-ff27-48f0-bc7d-c63b7c93d199 TCGA-21-1076-01A-02D-0685-01 TCGA-21-1076-01A-41-2193-20 +TCGA-21-1077-01 TCGA-21-1077-01 High C2-Squamous-like Cluster 13 (HNSC-LUSC) squamous-like c4 miRNA cluster 7 mutation cluster 12 TCGA-21-1077 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung NO NO NO NO 64 R-Upper TCGA-21-1077-F4164 TCGA-21-1077 TCGA-21-1077-01A -23523 1058 0 1058 644 2010-3-3 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.6 NO 0.9 YES 56 Yes M0 N1 T2 Stage IIB TCGA-21-1077.9313f5a4-32ef-4a20-890f-d437c24e2f8a.pdf 1077 WITH TUMOR NO R0 Primary Tumor 01 0.4 1996 NO NO YES 21 4 Lung A DECEASED 2006 a80c9de4-3d81-4b05-a26a-285e9bbbfafa TCGA-21-1077-01A-01D-0689-05 TCGA-21-1077-01A-01D-1521-08 a80c9de4-3d81-4b05-a26a-285e9bbbfafa TCGA-21-1077-01A-01D-0685-01 TCGA-21-1077-01A-01R-0692-07 a80c9de4-3d81-4b05-a26a-285e9bbbfafa TCGA-21-1077-01A-01D-0685-01 +TCGA-21-1078-01 TCGA-21-1078-01 COAD-READ C8-BLCA Cluster 5 squamous c3 BLCA nonsquamous-like c1 miRNA cluster 11 mutation cluster 1 TCGA-21-1078 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung NO NO NO NO 77 R-Lower TCGA-21-1078-F4165 TCGA-21-1078 TCGA-21-1078-01A -28125 474 0 469 257 2010-5-4 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 1 NO 2 YES 9 Yes M0 N0 T2 Stage IB TCGA-21-1078.8366df03-5b00-4476-9fd2-3bf80d53dc6e.pdf 1078 WITH TUMOR NO R0 Primary Tumor 01 0.8 2006 NO NO YES 21 4 Lung A DECEASED 2006 1947 320810be-bd11-40c7-9eee-7496f7564599 TCGA-21-1078-01A-01D-0689-05 TCGA-21-1078-01A-01D-1521-08 320810be-bd11-40c7-9eee-7496f7564599 TCGA-21-1078-01A-01D-0685-01 TCGA-21-1078-01A-01R-0692-07 320810be-bd11-40c7-9eee-7496f7564599 TCGA-21-1078-01A-01D-0685-01 TCGA-21-1078-01A-21-2193-20 +TCGA-21-1079-01 TCGA-21-1079-01 Squamous C2-Squamous-like Cluster 14 (HNSC) squamous c3 squamous-like c4 miRNA cluster 4 TCGA-21-1079 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung NO NO NO NO 71 L-Upper TCGA-21-1079-F4154 TCGA-21-1079 TCGA-21-1079-01A -26176 965 0 965 317 2010-2-23 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 1 NO 2 YES 80 No M0 N0 T3 Stage IIIA TCGA-21-1079.ddcba444-a2bd-48cc-a035-553126bca0c6.pdf 1079 WITH TUMOR NO R0 Primary Tumor 01 0.8 1980 NO NO YES 21 3 Lung A DECEASED 1995 f66b0cd6-fc69-4d6e-8c07-e5dc10c6628b TCGA-21-1079-01A-01D-0689-05 f66b0cd6-fc69-4d6e-8c07-e5dc10c6628b TCGA-21-1079-01A-01D-0685-01 TCGA-21-1079-01A-01R-0692-07 f66b0cd6-fc69-4d6e-8c07-e5dc10c6628b TCGA-21-1079-01A-01D-0685-01 TCGA-21-1079-01A-21-2193-20 +TCGA-21-1080-01 TCGA-21-1080-01 Squamous C2-Squamous-like Cluster 13 (HNSC-LUSC) squamous c3 squamous-like c4 miRNA cluster 4 TCGA-21-1080 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung NO NO NO NO 66 L-Lower TCGA-21-1080-F4157 TCGA-21-1080 TCGA-21-1080-01A -24253 0 3724 2010-2-23 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 1 NO 2 NO 100 No M0 N0 T2 Stage IB TCGA-21-1080.c5e7cfa9-2ee0-455f-80d2-e5ecc721d1ec.pdf 1080 TUMOR FREE NO R0 Primary Tumor 01 0.4 1991 NO NO YES 21 4 Lung A LIVING 1996 263780bc-cbb0-426e-9c0c-cef110a83b51 TCGA-21-1080-01A-01D-0689-05 263780bc-cbb0-426e-9c0c-cef110a83b51 TCGA-21-1080-01A-01D-0685-01 TCGA-21-1080-01A-01R-0692-07 263780bc-cbb0-426e-9c0c-cef110a83b51 TCGA-21-1080-01A-01D-0685-01 TCGA-21-1080-01A-21-2193-20 +TCGA-21-1081-01 TCGA-21-1081-01 High C2-Squamous-like Cluster 5 squamous c3 squamous-like c4 mutation c1uster 9 TCGA-21-1081 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung NO NO NO NO 69 L-Lower TCGA-21-1081-F4160 TCGA-21-1081 TCGA-21-1081-01A -25440 284 0 284 2010-2-12 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 1.5 NO 0 2.2 NO 45 No M0 N1 T2 Stage IIB TCGA-21-1081.b7eb9e52-9c41-4398-9cfb-7832a6183258.pdf 1081 WITH TUMOR YES R0 Primary Tumor 01 0.8 1992 NO NO YES 21 4 Lung A DECEASED 1996 89aaa481-724a-44d3-a4f2-d1a058563b03 TCGA-21-1081-01A-01D-0689-05 TCGA-21-1081-01A-01D-1521-08 89aaa481-724a-44d3-a4f2-d1a058563b03 TCGA-21-1081-01A-01D-0685-01 TCGA-21-1081-01A-01R-0692-07 89aaa481-724a-44d3-a4f2-d1a058563b03 TCGA-21-1081-01A-01D-0685-01 TCGA-21-1081-01A-21-2193-20 +TCGA-21-1082-01 TCGA-21-1082-01 Squamous C2-Squamous-like Cluster 5 squamous c3 squamous-like c4 TCGA-21-1082 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung NO NO NO NO 61 L-Lower TCGA-21-1082-F4161 TCGA-21-1082 TCGA-21-1082-01A -22492 0 3644 2010-2-12 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 1 NO 1.3 NO No M0 N0 T2 Stage IB TCGA-21-1082.c5b2ca19-e38d-41f2-9530-65a610990954.pdf 1082 TUMOR FREE NO R0 Primary Tumor 01 0.3 NO NO YES 21 Lung A LIVING 1997 fca05afb-d892-431c-a19a-e0c8c6e283eb TCGA-21-1082-01A-01D-0689-05 fca05afb-d892-431c-a19a-e0c8c6e283eb TCGA-21-1082-01A-01D-0685-01 TCGA-21-1082-01A-01R-0692-07 fca05afb-d892-431c-a19a-e0c8c6e283eb TCGA-21-1082-01A-01D-0685-01 TCGA-21-1082-01A-21-2193-20 +TCGA-21-1083-01 TCGA-21-1083-01 High C1-LUAD-enriched OV-like c1 squamous c3 RNA cluster 12 miRNA cluster 4 TCGA-21-1083 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung NO NO NO NO 75 L-Upper TCGA-21-1083-F4166 TCGA-21-1083 TCGA-21-1083-01A -27708 1315 0 267 2010-2-12 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.8 NO 1.5 NO 240 Yes M0 N0 T1 Stage IA TCGA-21-1083.568a237a-00c3-4160-a471-3ed3623ca233.pdf 1083 TUMOR FREE NO R0 Primary Tumor 01 0.6 NO NO YES 21 2 Lung A DECEASED 1997 86452157-2294-4029-a61d-6702a7889b7e TCGA-21-1083-01A-01D-0689-05 86452157-2294-4029-a61d-6702a7889b7e TCGA-21-1083-01A-01D-0685-01 TCGA-21-1083-01A-01R-0692-07 86452157-2294-4029-a61d-6702a7889b7e TCGA-21-1083-01A-01D-0685-01 TCGA-21-1083-01A-21-2193-20 +TCGA-21-5782-01 TCGA-21-5782-01 Squamous C2-Squamous-like Cluster 5 squamous c3 squamous-like c4 mutation cluster 11 TCGA-21-5782 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 68 L-Lower TCGA-21-5782-F11448 TCGA-21-5782 TCGA-21-5782-01A -24969 962 0 962 2011-5-2 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.9 NO 0 1.3 NO 48 No M0 N0 T2 Stage IB TCGA-21-5782.644e67c4-61cd-40f8-b2cb-287b8a868eb4.pdf 5782 Complete Remission/Response NO R0 Primary Tumor 01 0.3 2004 NO NO YES 21 4 Lung A DECEASED 2004 1953 6ccc37a2-f073-4050-bfcd-de106d86236b TCGA-21-5782-01A-01D-1632-08 6ccc37a2-f073-4050-bfcd-de106d86236b TCGA-21-5782-01A-01D-1633-05 TCGA-21-5782-01A-01D-1631-01 6ccc37a2-f073-4050-bfcd-de106d86236b TCGA-21-5782-01A-01D-1631-01 TCGA-21-5782-01A-21-2194-20 +TCGA-21-5783-01 TCGA-21-5783-01 Squamous Cluster 5 squamous-like c4 miRNA cluster 4 TCGA-21-5783 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 76 L-Upper TCGA-21-5783-F30661 TCGA-21-5783 TCGA-21-5783-01A -27904 2680 0 NO NO Scheduled Follow-up Submission 2012-3-12 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 1 NO 0 NO Peripheral Lung 1 No M0 N0 T2 Stage IB TCGA-21-5783.83eb92fc-a1f0-4fea-a7c4-3254e98735af.pdf 5783 83 YES NO R0 Primary Tumor 01 0.4 1974 6th NO NO YES 21 3 Lung A DECEASED 2004 4220f308-b671-4bf8-bf9c-5884a66e9797 4220f308-b671-4bf8-bf9c-5884a66e9797 TCGA-21-5783-01A-41D-2185-05 TCGA-21-5783-01A-41D-2183-01 4220f308-b671-4bf8-bf9c-5884a66e9797 TCGA-21-5783-01A-41D-2183-01 +TCGA-21-5784-01 TCGA-21-5784-01 High C2-Squamous-like Cluster 5 squamous c3 squamous-like c4 miRNA cluster 7 mutation cluster 2 TCGA-21-5784 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung NO NO 80 R-Upper TCGA-21-5784-F31486 TCGA-21-5784 TCGA-21-5784-01A -29362 0 1268 69 Scheduled Follow-up Submission Complete Remission/Response 2012-5-3 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 1 NO Central Lung 1 NO 14 No M0 N0 T2 Stage IB TCGA-21-5784.5d154faf-bb6e-4237-80cf-9d02e2127adb.pdf 5784 TUMOR FREE 74 80 Complete Remission/Response YES NO R0 Primary Tumor 01 0.4 1978 6th NO NO YES 21 3 Lung A LIVING 2008 c541f28a-299d-4c21-9329-4922e204e2ab TCGA-21-5784-01A-01D-1632-08 c541f28a-299d-4c21-9329-4922e204e2ab TCGA-21-5784-01A-01D-1633-05 TCGA-21-5784-01A-01D-1631-01 c541f28a-299d-4c21-9329-4922e204e2ab TCGA-21-5784-01A-01D-1631-01 TCGA-21-5784-01A-21-2194-20 +TCGA-21-5786-01 TCGA-21-5786-01 High C2-Squamous-like Cluster 5 squamous c3 squamous-like c4 miRNA cluster 7 mutation cluster 2 TCGA-21-5786 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung NO NO YES NO 64 R-Upper TCGA-21-5786-F31485 TCGA-21-5786 TCGA-21-5786-01A 838 -23649 0 1032 817 71 Additional New Tumor Event Complete Remission/Response 2012-5-3 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 1 NO Central Lung 1 Locoregional Recurrence YES 75 No M0 N0 T2 Stage IB TCGA-21-5786.7c63d47f-0a73-415c-b4e5-d5c70886709e.pdf 5786 TUMOR FREE 76 76 Complete Remission/Response YES NO R0 Primary Tumor 01 0.3 6th NO NO YES 21 2 Lung A LIVING 2009 1959 b8bcd42e-f1bc-4c93-8dac-933d94d33a0d TCGA-21-5786-01A-01D-1632-08 b8bcd42e-f1bc-4c93-8dac-933d94d33a0d TCGA-21-5786-01A-01D-1633-05 TCGA-21-5786-01A-01D-1631-01 b8bcd42e-f1bc-4c93-8dac-933d94d33a0d TCGA-21-5786-01A-01D-1631-01 TCGA-21-5786-01A-21-2194-20 +TCGA-21-5787-01 TCGA-21-5787-01 High C1-LUAD-enriched Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 11 mutation cluster 5 TCGA-21-5787 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung NO YES NO NO 65 L-Upper TCGA-21-5787-F11443 TCGA-21-5787 TCGA-21-5787-01A -24071 329 0 329 103 Progressive Disease 2011-5-3 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 1 NO 0 1.1 YES 100 No M0 N2 T2 Stage IIIA TCGA-21-5787.fe205444-57af-48ab-8e50-ea8c4a42eb07.pdf 5787 WITH TUMOR Progressive Disease YES R0 Primary Tumor 01 0.2 2009 NO NO YES 21 4 Lung A DECEASED 2009 1956 b45df1ad-f756-4ec6-ae76-264dd51fae7e TCGA-21-5787-01A-01D-1632-08 b45df1ad-f756-4ec6-ae76-264dd51fae7e TCGA-21-5787-01A-01D-1633-05 TCGA-21-5787-01A-01D-1631-01 b45df1ad-f756-4ec6-ae76-264dd51fae7e TCGA-21-5787-01A-01D-1631-01 TCGA-21-5787-01A-21-2194-20 +TCGA-21-A5DI-01 TCGA-21-A5DI-01 TCGA-21-A5DI TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 77 R-Lower TCGA-21-A5DI-F66358 TCGA-21-A5DI TCGA-21-A5DI-01A -28374 2379 0 979 Scheduled Follow-up Submission 2014-10-13 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 220 NO YES NO true Yes, History of Prior Malignancy M0 N0 T1b Stage IA TCGA-21-A5DI.54DCDFE6-FF29-4549-ACB2-420165FF391B.pdf A5DI TUMOR FREE Complete Remission/Response NO NO R0 Primary Tumor 01 6th NO NO YES 21 3 Lung A LIVING 2006 3a7a9459-d88c-4d0b-b32f-1623deba6cea 3a7a9459-d88c-4d0b-b32f-1623deba6cea TCGA-21-A5DI-01A-31D-A26N-05 TCGA-21-A5DI-01A-31D-A26L-01 3a7a9459-d88c-4d0b-b32f-1623deba6cea TCGA-21-A5DI-01A-31D-A26L-01 +TCGA-22-0940-01 TCGA-22-0940-01 BRCA-LUAD+ C2-Squamous-like Cluster 13 (HNSC-LUSC) squamous c3 squamous-like c4 miRNA cluster 4 TCGA-22-0940 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung NO YES 71 L-Lower TCGA-22-0940-F4132 TCGA-22-0940 TCGA-22-0940-01A -26272 669 0 608 NO NO 2010-2-3 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.9 8070/3 C34.9 YES 0.8 NO NO Peripheral Lung 1 25 No M0 N1 T1 Stage IIA TCGA-22-0940.4F7F45DC-0B14-4B61-AB61-F07030604AE9.pdf 0940 WITH TUMOR NO R0 Primary Tumor 01 0.4 1972 NO NO YES 22 3 Lung A DECEASED 2000 1948 c322339f-28e6-480d-8cc3-5d63b07e66d0 TCGA-22-0940-01A-01D-0689-05 c322339f-28e6-480d-8cc3-5d63b07e66d0 TCGA-22-0940-01A-01D-0685-01 TCGA-22-0940-01A-01R-0692-07 c322339f-28e6-480d-8cc3-5d63b07e66d0 TCGA-22-0940-01A-01D-0685-01 TCGA-22-0940-01A-21-2193-20 +TCGA-22-0944-01 TCGA-22-0944-01 Squamous C2-Squamous-like Cluster 5 squamous-like c4 miRNA cluster 4 mutation cluster 13 TCGA-22-0944 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 61 L-Upper TCGA-22-0944-F4097 TCGA-22-0944 TCGA-22-0944-01A -22329 223 0 223 NO NO 2010-2-12 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.9 8070/3 C34.9 YES 0.6 NO NO 0.6 NO 38 No M0 N0 T2 Stage IB TCGA-22-0944.A4E962A1-69D2-4D46-977B-DCDE3E696772.pdf 0944 TUMOR FREE R0 Primary Tumor 01 0.2 NO YES 22 2 Lung A DECEASED 2000 1970 c806fc33-7a1d-44a8-b67b-7f74363c3f01 TCGA-22-0944-01A-01D-0689-05 TCGA-22-0944-01A-01D-1521-08 c806fc33-7a1d-44a8-b67b-7f74363c3f01 TCGA-22-0944-01A-01D-0685-01 TCGA-22-0944-01A-01R-0692-07 c806fc33-7a1d-44a8-b67b-7f74363c3f01 TCGA-22-0944-01A-01D-0685-01 +TCGA-22-1000-01 TCGA-22-1000-01 Kirc+ Low purity c2 squamous c3 TCGA-22-1000 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung NO YES 76 R-Lower TCGA-22-1000-F4167 TCGA-22-1000 TCGA-22-1000-01A -27901 454 0 263 NO NO 2010-2-12 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.9 8070/3 C34.9 YES 0.4 NO NO Central Lung 1 YES 40 Yes M0 N0 T2 Stage IB TCGA-22-1000.B57BD00D-1719-4DB1-9CFE-14CD5E63D561.pdf 1000 WITH TUMOR Complete Remission/Response NO R0 Primary Tumor 01 0.3 1990 7th NO NO YES 22 4 Lung A DECEASED 2000 1945 62710cd0-82b4-4746-ad7c-b320d933a542 TCGA-22-1000-01A-01D-0689-05 62710cd0-82b4-4746-ad7c-b320d933a542 TCGA-22-1000-01A-01D-0685-01 TCGA-22-1000-01A-01R-0692-07 62710cd0-82b4-4746-ad7c-b320d933a542 TCGA-22-1000-01A-01D-0685-01 TCGA-22-1000-01A-21-2193-20 +TCGA-22-1002-01 TCGA-22-1002-01 Squamous C2-Squamous-like Cluster 5 squamous-like c4 mutation cluster 4 TCGA-22-1002 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 69 R-Middle TCGA-22-1002-F4135 TCGA-22-1002 TCGA-22-1002-01A -25359 131 0 131 NO NO 2010-5-12 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.9 8070/3 C34.9 YES 0.5 NO NO 0.8 NO 85 No M0 N0 T1 Stage IA TCGA-22-1002.D486319E-ED8A-4F0A-BAEC-219B56AAF33E.pdf 1002 TUMOR FREE NO R0 Primary Tumor 01 0.2 2001 NO NO YES 22 4 Lung A DECEASED 2001 1952 32fa734c-e551-45fb-818a-9452d0c6557e TCGA-22-1002-01A-01D-0689-05 TCGA-22-1002-01A-01D-1521-08 32fa734c-e551-45fb-818a-9452d0c6557e TCGA-22-1002-01A-01D-0685-01 TCGA-22-1002-01A-01R-0692-07 32fa734c-e551-45fb-818a-9452d0c6557e TCGA-22-1002-01A-01D-0685-01 +TCGA-22-1005-01 TCGA-22-1005-01 Kirc+ Low purity c2 TCGA-22-1005 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung NO NO 63 R-Upper TCGA-22-1005-F4137 TCGA-22-1005 TCGA-22-1005-01A -23322 1953 0 1953 NO NO 2010-2-12 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.9 8070/3 C34.9 YES 0.3 NO NO 0.6 NO 40 No M0 N0 T1 Stage IA TCGA-22-1005.A7E8C61B-6800-485E-A603-0220183BD6E9.pdf 1005 TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 0.2 1997 NO YES NO 22 4 Lung A DECEASED 2001 1952 e049e194-d224-41cf-99b6-a4e7490674f9 TCGA-22-1005-01A-01D-0689-05 e049e194-d224-41cf-99b6-a4e7490674f9 TCGA-22-1005-01A-01D-0685-01 TCGA-22-1005-01A-01R-0692-07 e049e194-d224-41cf-99b6-a4e7490674f9 TCGA-22-1005-01A-01D-0685-01 +TCGA-22-1011-01 TCGA-22-1011-01 Squamous C2-Squamous-like Low purity c2 squamous c3 squamous-like c4 miRNA cluster 7 mutation cluster 13 TCGA-22-1011 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung NO NO 73 R-Upper TCGA-22-1011-F4138 TCGA-22-1011 TCGA-22-1011-01A -26732 53 0 53 NO NO 2010-2-15 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.9 8070/3 C34.9 YES 0.4 NO NO 1 NO 83 No M0 N0 T2 Stage IB TCGA-22-1011.5B20E854-19A2-422A-8ED2-9339845AB6CE.pdf 1011 TUMOR FREE NO R0 Primary Tumor 01 0.4 NO NO YES 22 2 Lung A DECEASED 2001 1946 fe3a32fe-6338-43d3-b134-39fab3447f42 TCGA-22-1011-01A-01D-0689-05 TCGA-22-1011-01A-01D-1521-08 fe3a32fe-6338-43d3-b134-39fab3447f42 TCGA-22-1011-01A-01D-0685-01 TCGA-22-1011-01A-01R-0692-07 fe3a32fe-6338-43d3-b134-39fab3447f42 TCGA-22-1011-01A-01D-0685-01 TCGA-22-1011-01A-31-2193-20 +TCGA-22-1012-01 TCGA-22-1012-01 Squamous C2-Squamous-like Cluster 5 squamous-like c4 miRNA cluster 11 mutation cluster 5 TCGA-22-1012 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 80 R-Lower TCGA-22-1012-F4141 TCGA-22-1012 TCGA-22-1012-01A -29273 429 0 NO NO 2010-2-15 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.9 8070/3 C34.9 YES 0.4 NO NO 0.6 NO 60 No M0 N0 T2 Stage IB TCGA-22-1012.442C89DF-A3F3-44DD-960E-F4B26281D9AE.pdf 1012 TUMOR FREE Complete Remission/Response R0 Primary Tumor 01 0.2 2001 NO YES 22 4 Lung A DECEASED 2001 1940 de4a60ba-a4a6-4ff8-8768-4c47e3926eb3 TCGA-22-1012-01A-01D-0689-05 TCGA-22-1012-01A-01D-1521-08 de4a60ba-a4a6-4ff8-8768-4c47e3926eb3 TCGA-22-1012-01A-01D-0685-01 TCGA-22-1012-01A-01R-0692-07 de4a60ba-a4a6-4ff8-8768-4c47e3926eb3 TCGA-22-1012-01A-01D-0685-01 +TCGA-22-1016-01 TCGA-22-1016-01 High C2-Squamous-like Cluster 5 squamous-like c4 mutation cluster 13 TCGA-22-1016 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung NO NO 65 R-Upper TCGA-22-1016-F4144 TCGA-22-1016 TCGA-22-1016-01A -24078 822 0 802 NO NO 2010-2-15 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.9 8070/3 C34.9 YES 0.6 NO NO 1 NO 40 No M0 N0 T2 Stage IB TCGA-22-1016.DDA12CCE-0C66-4E29-9B36-BC4E24CFEC7B.pdf 1016 TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 0.1 1984 NO NO YES 22 3 Lung A DECEASED 2001 1954 10e6a64d-2d89-444f-ad6f-d4fde86d8a8a TCGA-22-1016-01A-01D-0689-05 TCGA-22-1016-01A-01D-1521-08 10e6a64d-2d89-444f-ad6f-d4fde86d8a8a TCGA-22-1016-01A-01D-0685-01 TCGA-22-1016-01A-01R-0692-07 10e6a64d-2d89-444f-ad6f-d4fde86d8a8a TCGA-22-1016-01A-01D-0685-01 +TCGA-22-1017-01 TCGA-22-1017-01 High Cluster 6 LUAD-like c10 TCGA-22-1017 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung YES YES NO YES 62 L-Upper TCGA-22-1017-F58939 TCGA-22-1017 TCGA-22-1017-01A 1022 -22880 1485 0 904 60 1 NO NO Scheduled Follow-up Submission Progressive Disease 2014-4-29 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) Yes C34.9 8070/3 C34.9 YES 0.4 NO 0 NO Central Lung 0.7 NO Locoregional Recurrence|Distant Metastasis YES Yes M0 N0 T1 Stage IA TCGA-22-1017.0C5101D2-339B-4B6B-B128-FAE9EF206C6B.pdf 1017 Preoperative WITH TUMOR 68 75 61 58 Complete Remission/Response Convincing Imaging YES NO R0 Primary Tumor 01 0.3 1999 5th NO NO YES 22 4 Lung A DECEASED 1999 1959 cf12415f-4487-4e0d-9c9b-2239f7c83599 TCGA-22-1017-01A-01D-0689-05 cf12415f-4487-4e0d-9c9b-2239f7c83599 TCGA-22-1017-01A-01D-0685-01 TCGA-22-1017-01A-01R-0692-07 cf12415f-4487-4e0d-9c9b-2239f7c83599 TCGA-22-1017-01A-01D-0685-01 +TCGA-22-4591-01 TCGA-22-4591-01 High C2-Squamous-like Cluster 5 squamous c3 squamous-like c4 miRNA cluster 12 mutation cluster 12 TCGA-22-4591 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung YES NO NO NO 80 R-Lower TCGA-22-4591-F5692 TCGA-22-4591 TCGA-22-4591-01A -29250 623 0 623 443 NO NO Progressive Disease 2010-11-29 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.9 NO 0 NO Peripheral Lung 1.1 YES No M0 N2 T3 Stage IIIA TCGA-22-4591.97a5b9f1-ac4b-4744-abd9-03ccf04d1892.pdf 4591 Other WITH TUMOR Partial Remission/Response NO R0 Primary Tumor 01 0.4 NO NO YES 22 2 Lung A DECEASED 2001 1933 4e2f417c-e1db-4d99-b999-d3aab967c244 TCGA-22-4591-01A-01D-1198-05 TCGA-22-4591-01A-01D-1267-08 4e2f417c-e1db-4d99-b999-d3aab967c244 TCGA-22-4591-01A-01D-1195-01 TCGA-22-4591-01A-01R-1201-07 4e2f417c-e1db-4d99-b999-d3aab967c244 TCGA-22-4591-01A-01D-1195-01 TCGA-22-4591-01A-21-2193-20 +TCGA-22-4593-01 TCGA-22-4593-01 BRCA-LUAD+ C2-Squamous-like Cluster 13 (HNSC-LUSC) squamous-like c4 miRNA cluster 4 mutation cluster 5 TCGA-22-4593 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 77 R-Lower TCGA-22-4593-F14642 TCGA-22-4593 TCGA-22-4593-01A -28385 1067 0 1067 NO NO Scheduled Follow-up Submission 2011-8-5 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.8 NO 0 NO Central Lung 0.8 NO 30 No M0 N0 T2b Stage IIA TCGA-22-4593.d20d26e3-da2c-4456-894d-6f08d62856ea.pdf 4593 TUMOR FREE NO R0 Primary Tumor 01 0.2 2002 7th NO NO YES 22 4 Lung A DECEASED 2002 1942 88d40fcc-c30a-437f-b514-ef0a60f8836e TCGA-22-4593-01A-21D-1817-08 88d40fcc-c30a-437f-b514-ef0a60f8836e TCGA-22-4593-01A-21D-1818-05 TCGA-22-4593-01A-21D-1816-01 88d40fcc-c30a-437f-b514-ef0a60f8836e TCGA-22-4593-01A-21D-1816-01 +TCGA-22-4593-11 TCGA-22-4593-11 C2-Squamous-like mutation cluster 5 TCGA-22-4593 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 77 R-Lower TCGA-22-4593-F14642 TCGA-22-4593 TCGA-22-4593-11A -28385 1067 0 1067 NO NO Scheduled Follow-up Submission 2011-8-5 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.7 NO 0 NO Central Lung 0.9 NO 30 No M0 N0 T2b Stage IIA 4593 TUMOR FREE NO R0 Solid Tissue Normal 11 0.2 2002 7th NO NO YES 22 4 Lung A DECEASED 2002 1942 731aca7f-57bb-438d-927b-1be5adcdcf0e 731aca7f-57bb-438d-927b-1be5adcdcf0e 731aca7f-57bb-438d-927b-1be5adcdcf0e +TCGA-22-4594-01 TCGA-22-4594-01 High Cluster 5 LUAD-like c10 miRNA cluster 7 TCGA-22-4594 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 60 L-Upper TCGA-22-4594-F7386 TCGA-22-4594 TCGA-22-4594-01A -22115 1470 0 1470 NO NO 2010-11-29 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.5 NO 0 NO Peripheral Lung 1.3 40 No M0 N2 T3 Stage IIIA TCGA-22-4594.fc15b2ea-bead-452d-9857-7380ff2ed628.pdf 4594 R0 Primary Tumor 01 0.3 NO YES 22 4 Lung A DECEASED 2002 1cdc026e-58bc-424d-9cf4-6c6701e081ad TCGA-22-4594-01A-01D-1198-05 1cdc026e-58bc-424d-9cf4-6c6701e081ad TCGA-22-4594-01A-01D-1195-01 TCGA-22-4594-01A-01R-1201-07 1cdc026e-58bc-424d-9cf4-6c6701e081ad TCGA-22-4594-01A-01D-1195-01 +TCGA-22-4595-01 TCGA-22-4595-01 High C2-Squamous-like Cluster 5 squamous-like c4 miRNA cluster 11 mutation cluster 13 TCGA-22-4595 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung YES NO NO NO 57 L-Lower TCGA-22-4595-F7413 TCGA-22-4595 TCGA-22-4595-01A -21146 734 0 734 584 1 NO NO Progressive Disease 2011-2-9 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.5 NO 0 NO 1 YES 37 No N2 T3 Stage IIIA TCGA-22-4595.797ad94e-b3d2-44a4-8412-d8361a58bcd5.pdf 4595 Adjuvant therapy WITH TUMOR R0 Primary Tumor 01 0.2 NO YES 22 2 Lung A DECEASED 2002 66323357-708a-4b9e-b716-c8e7b24385d1 TCGA-22-4595-01A-01D-1198-05 TCGA-22-4595-01A-01D-1267-08 66323357-708a-4b9e-b716-c8e7b24385d1 TCGA-22-4595-01A-01D-1195-01 TCGA-22-4595-01A-01R-1201-07 66323357-708a-4b9e-b716-c8e7b24385d1 TCGA-22-4595-01A-01D-1195-01 +TCGA-22-4596-01 TCGA-22-4596-01 BRCA-LUAD+ C1-LUAD-enriched Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 4 TCGA-22-4596 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung NO NO 69 L-Upper TCGA-22-4596-F5730 TCGA-22-4596 TCGA-22-4596-01A -25448 17 0 17 NO NO 2010-11-30 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 1 NO 0 NO 1.4 NO 40 No M0 N0 T1b Stage IB TCGA-22-4596.fd87facc-8690-4f1a-bf75-1e6d2c1e8882.pdf 4596 Other TUMOR FREE NO R0 Primary Tumor 01 0.3 2002 NO NO YES 22 4 Lung A DECEASED 2002 1962 cb61137c-aa73-433e-b7a8-f3e8b161a532 TCGA-22-4596-01A-01D-1198-05 cb61137c-aa73-433e-b7a8-f3e8b161a532 TCGA-22-4596-01A-01D-1195-01 TCGA-22-4596-01A-01R-1201-07 cb61137c-aa73-433e-b7a8-f3e8b161a532 TCGA-22-4596-01A-01D-1195-01 TCGA-22-4596-01A-21-2194-20 +TCGA-22-4599-01 TCGA-22-4599-01 Squamous C2-Squamous-like Cluster 13 (HNSC-LUSC) squamous-like c4 mutation cluster 5 TCGA-22-4599 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 73 TCGA-22-4599-F7558 TCGA-22-4599 TCGA-22-4599-01A -26925 1161 0 1161 NO NO 2010-11-30 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.8 8070/3 C34.8 YES 0.6 NO 0 NO Central Lung 1.1 25 No M0 N0 T2a Stage IB TCGA-22-4599.39e30903-77e8-47ed-9f00-64d4225f996d.pdf 4599 R0 Primary Tumor 01 0.1 NO YES 22 2 Lung A DECEASED 2002 fb4a4126-ddff-4e71-b4d8-394ac8f03654 TCGA-22-4599-01A-01D-1441-08 fb4a4126-ddff-4e71-b4d8-394ac8f03654 TCGA-22-4599-01A-01D-1440-05 TCGA-22-4599-01A-01D-1439-01 TCGA-22-4599-01A-01R-1443-07 fb4a4126-ddff-4e71-b4d8-394ac8f03654 TCGA-22-4599-01A-01D-1439-01 +TCGA-22-4599-11 TCGA-22-4599-11 C2-Squamous-like mutation cluster 5 TCGA-22-4599 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 73 TCGA-22-4599-F7558 TCGA-22-4599 TCGA-22-4599-11A -26925 1161 0 1161 NO NO 2010-11-30 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.8 8070/3 C34.8 YES 0.7 NO 0 NO Central Lung 1.5 25 No M0 N0 T2a Stage IB 4599 R0 Solid Tissue Normal 11 0.2 NO YES 22 2 Lung A DECEASED 2002 TCGA-22-4599-11A-01D-1440-05 +TCGA-22-4601-01 TCGA-22-4601-01 Squamous C2-Squamous-like Cluster 13 (HNSC-LUSC) squamous-like c4 miRNA cluster 11 mutation cluster 11 TCGA-22-4601 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung NO NO NO 73 R-Upper TCGA-22-4601-F7567 TCGA-22-4601 TCGA-22-4601-01A -26937 1057 0 1057 525 NO NO 2010-11-30 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.4 NO 0 NO 0.7 YES 60 No M0 N0 T4 Stage IIIA TCGA-22-4601.1de412fd-daf8-4125-9eff-98e902a6c377.pdf 4601 WITH TUMOR R0 Primary Tumor 01 0.2 NO NO YES 22 2 Lung A DECEASED 2003 e4e94ad0-a63b-43c1-928a-aa0333e72bed TCGA-22-4601-01A-01D-1441-08 e4e94ad0-a63b-43c1-928a-aa0333e72bed TCGA-22-4601-01A-01D-1440-05 TCGA-22-4601-01A-01D-1969-01 TCGA-22-4601-01A-01R-1443-07 e4e94ad0-a63b-43c1-928a-aa0333e72bed TCGA-22-4601-01A-01D-1969-01 +TCGA-22-4601-11 TCGA-22-4601-11 C2-Squamous-like mutation cluster 11 TCGA-22-4601 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung NO NO NO 73 R-Upper TCGA-22-4601-F7567 TCGA-22-4601 TCGA-22-4601-11A -26937 1057 0 1057 525 NO NO 2010-11-30 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.8 NO 0 NO 0.8 YES 60 No M0 N0 T4 Stage IIIA 4601 WITH TUMOR R0 Solid Tissue Normal 11 0.2 NO NO YES 22 2 Lung A DECEASED 2003 TCGA-22-4601-11A-01D-1440-05 +TCGA-22-4604-01 TCGA-22-4604-01 Squamous C2-Squamous-like Cluster 13 (HNSC-LUSC) squamous-like c4 miRNA cluster 4 mutation cluster 3 TCGA-22-4604 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung NO YES NO NO 73 L-Upper TCGA-22-4604-F7520 TCGA-22-4604 TCGA-22-4604-01A -26952 399 0 306 0 NO NO Progressive Disease 2010-11-30 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.5 NO 0 NO Central Lung 1.5 YES 50 No M0 N1 T2a Stage IIA TCGA-22-4604.a66769a0-8ad7-4912-8eee-ec76d5aef626.pdf 4604 Adjuvant therapy WITH TUMOR NO R0 Primary Tumor 01 0.2 YES NO YES 22 2 Lung A DECEASED 2003 017e0cba-13b0-457a-80bb-8d6090506cc9 TCGA-22-4604-01A-01D-1198-05 TCGA-22-4604-01A-01D-1267-08 017e0cba-13b0-457a-80bb-8d6090506cc9 TCGA-22-4604-01A-01D-1195-01 TCGA-22-4604-01A-01R-1201-07 017e0cba-13b0-457a-80bb-8d6090506cc9 TCGA-22-4604-01A-01D-1195-01 +TCGA-22-4605-01 TCGA-22-4605-01 Squamous C2-Squamous-like Cluster 5 squamous c3 squamous-like c4 miRNA cluster 11 TCGA-22-4605 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 78 R-Upper TCGA-22-4605-F20533 TCGA-22-4605 TCGA-22-4605-01A -28623 974 0 58 NO NO Scheduled Follow-up Submission 2012-1-16 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.10 8072/3 C34.1 YES 0.8 NO NO 1.3 NO 75 No M0 N0 T2 Stage IB TCGA-22-4605.6d8491df-72b3-46f8-96b4-016d8662eb15.pdf 4605 TUMOR FREE 81 80 Complete Remission/Response YES YES R0 Primary Tumor 01 0.2 1996 6th NO NO YES 22 4 Lung A DECEASED 2003 1946 f5255c17-4a9e-4532-88b1-880f3e933579 f5255c17-4a9e-4532-88b1-880f3e933579 TCGA-22-4605-01A-21D-2123-05 TCGA-22-4605-01A-21D-2121-01 f5255c17-4a9e-4532-88b1-880f3e933579 TCGA-22-4605-01A-21D-2121-01 TCGA-22-4605-01A-11-2193-20 +TCGA-22-4607-01 TCGA-22-4607-01 Squamous C2-Squamous-like Cluster 5 squamous c3 squamous-like c4 miRNA cluster 4 mutation cluster 3 TCGA-22-4607 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 75 R-Lower TCGA-22-4607-F7550 TCGA-22-4607 TCGA-22-4607-01A -27601 587 0 587 3 NO NO 2010-11-30 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.8 NO NO Peripheral Lung 1.1 NO 20 No M0 N0 T2a Stage IB TCGA-22-4607.261ab183-8f0c-4288-9bdb-53fd2754da31.pdf 4607 Other TUMOR FREE NO R0 Primary Tumor 01 0.4 1968 NO NO YES 22 3 Lung A DECEASED 2003 1948 4972964a-475f-4611-ab72-22543d9aa6fb TCGA-22-4607-01A-01D-1198-05 TCGA-22-4607-01A-01D-1267-08 4972964a-475f-4611-ab72-22543d9aa6fb TCGA-22-4607-01A-01D-1195-01 TCGA-22-4607-01A-01R-1201-07 4972964a-475f-4611-ab72-22543d9aa6fb TCGA-22-4607-01A-01D-1195-01 TCGA-22-4607-01A-21-2194-20 +TCGA-22-4609-01 TCGA-22-4609-01 Squamous Cluster 5 squamous c3 miRNA cluster 11 TCGA-22-4609 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 81 R-Upper TCGA-22-4609-F20535 TCGA-22-4609 TCGA-22-4609-01A -29844 291 0 58 NO NO Scheduled Follow-up Submission 2012-1-16 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.9 NO NO 1 NO 77 No M0 N0 T1 Stage IA TCGA-22-4609.eb0d58da-99c4-4b6a-b226-5f758aa59f6c.pdf 4609 TUMOR FREE 81 58 Complete Remission/Response YES NO R0 Primary Tumor 01 0.4 6th NO NO YES 22 2 Lung A DECEASED 2003 f6c0f677-2bd8-4406-8d44-f0d2d1c02763 f6c0f677-2bd8-4406-8d44-f0d2d1c02763 TCGA-22-4609-01A-21D-2123-05 TCGA-22-4609-01A-21D-2121-01 f6c0f677-2bd8-4406-8d44-f0d2d1c02763 TCGA-22-4609-01A-21D-2121-01 TCGA-22-4609-01A-11-2193-20 +TCGA-22-4609-11 TCGA-22-4609-11 TCGA-22-4609 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 81 R-Upper TCGA-22-4609-F20535 TCGA-22-4609 TCGA-22-4609-11A -29844 291 0 58 NO NO Scheduled Follow-up Submission 2012-1-16 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.8 NO NO 1.6 NO 77 No M0 N0 T1 Stage IA 4609 TUMOR FREE 81 58 Complete Remission/Response YES NO R0 Solid Tissue Normal 11 0.1 6th NO NO YES 22 2 Lung A DECEASED 2003 e35ae11f-244b-42bf-b506-1dc1f612b414 e35ae11f-244b-42bf-b506-1dc1f612b414 e35ae11f-244b-42bf-b506-1dc1f612b414 +TCGA-22-4613-01 TCGA-22-4613-01 Squamous C2-Squamous-like Cluster 13 (HNSC-LUSC) squamous-like c4 miRNA cluster 7 mutation cluster 3 TCGA-22-4613 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 73 L-Upper TCGA-22-4613-F7570 TCGA-22-4613 TCGA-22-4613-01A -26722 358 0 358 NO NO 2010-11-30 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.8 NO 0 NO 1.1 30 No M0 N0 T1b Stage IA TCGA-22-4613.bbb6127c-7368-415d-b984-65e21e23c03a.pdf 4613 NO R0 Primary Tumor 01 0.3 1988 NO NO YES 22 3 Lung A DECEASED 2004 1958 82586a59-47ac-4dba-b460-87e968a9d658 TCGA-22-4613-01A-01D-1441-08 82586a59-47ac-4dba-b460-87e968a9d658 TCGA-22-4613-01A-01D-1440-05 TCGA-22-4613-01A-01D-1439-01 TCGA-22-4613-01A-01R-1443-07 82586a59-47ac-4dba-b460-87e968a9d658 TCGA-22-4613-01A-01D-1439-01 +TCGA-22-4613-11 TCGA-22-4613-11 C2-Squamous-like mutation cluster 3 TCGA-22-4613 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 73 L-Upper TCGA-22-4613-F7570 TCGA-22-4613 TCGA-22-4613-11A -26722 358 0 358 NO NO 2010-11-30 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.9 NO 0 NO 1.1 30 No M0 N0 T1b Stage IA 4613 NO R0 Solid Tissue Normal 11 0.3 1988 NO NO YES 22 3 Lung A DECEASED 2004 1958 TCGA-22-4613-11A-01D-1440-05 +TCGA-22-5471-01 TCGA-22-5471-01 High C2-Squamous-like Cluster 13 (HNSC-LUSC) squamous c3 squamous-like c4 miRNA cluster 4 mutation cluster 13 TCGA-22-5471 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 75 L-Lower TCGA-22-5471-F69952 TCGA-22-5471 TCGA-22-5471-01A -27749 0 1845 1 NO NO Scheduled Follow-up Submission 2015-1-22 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.5 NO NO 0.9 YES 50 Yes M0 N0 T2 Stage IB TCGA-22-5471.139e042e-6971-4840-97b1-a54988346967.pdf 5471 Pre-Adjuvant Therapy Complete Remission/Response YES R2 Primary Tumor 01 0.4 2005 6th NO NO YES 22 4 Lung A LIVING 2005 c7372404-46b6-415c-8084-2dac0e7f3cee TCGA-22-5471-01A-01D-1632-08 c7372404-46b6-415c-8084-2dac0e7f3cee TCGA-22-5471-01A-01D-1633-05 TCGA-22-5471-01A-01D-1631-01 c7372404-46b6-415c-8084-2dac0e7f3cee TCGA-22-5471-01A-01D-1631-01 TCGA-22-5471-01A-21-2194-20 +TCGA-22-5471-11 TCGA-22-5471-11 C2-Squamous-like mutation cluster 13 TCGA-22-5471 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 75 L-Lower TCGA-22-5471-F69952 TCGA-22-5471 TCGA-22-5471-11A -27749 0 1845 1 NO NO Scheduled Follow-up Submission 2015-1-22 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.8 NO NO 1.5 YES 50 Yes M0 N0 T2 Stage IB 5471 Pre-Adjuvant Therapy Complete Remission/Response YES R2 Solid Tissue Normal 11 0.4 2005 6th NO NO YES 22 4 Lung A LIVING 2005 aac4936d-3550-4acd-8fd4-1b1951242d80 aac4936d-3550-4acd-8fd4-1b1951242d80 TCGA-22-5471-11A-01D-1633-05 aac4936d-3550-4acd-8fd4-1b1951242d80 +TCGA-22-5472-01 TCGA-22-5472-01 Kirc+ C2-Squamous-like Cluster 13 (HNSC-LUSC) squamous c3 squamous-like c4 miRNA cluster 11 mutation cluster 12 TCGA-22-5472 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung YES YES NO NO 67 R-Lower TCGA-22-5472-F11156 TCGA-22-5472 TCGA-22-5472-01A -24482 1975 0 1975 902 NO NO Progressive Disease 2011-5-4 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.8 NO 0 NO 1.2 YES 35 Yes M0 N0 T2a Stage IB TCGA-22-5472.a882eb26-0b08-463e-9700-4396fce9e8fd.pdf 5472 TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 0.3 1999 NO NO YES 22 4 Lung A DECEASED 2005 1964 17d5f5c9-ed12-4dd7-810e-601b7545b47f TCGA-22-5472-01A-01D-1632-08 17d5f5c9-ed12-4dd7-810e-601b7545b47f TCGA-22-5472-01A-01D-1633-05 TCGA-22-5472-01A-01D-1631-01 17d5f5c9-ed12-4dd7-810e-601b7545b47f TCGA-22-5472-01A-01D-1631-01 TCGA-22-5472-01A-21-2194-20 +TCGA-22-5472-11 TCGA-22-5472-11 C2-Squamous-like mutation cluster 12 TCGA-22-5472 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung YES YES NO NO 67 R-Lower TCGA-22-5472-F11156 TCGA-22-5472 TCGA-22-5472-11A -24482 1975 0 1975 902 NO NO Progressive Disease 2011-5-4 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 1 NO 0 NO 1.3 YES 35 Yes M0 N0 T2a Stage IB 5472 TUMOR FREE Complete Remission/Response NO R0 Solid Tissue Normal 11 0.5 1999 NO NO YES 22 4 Lung A DECEASED 2005 1964 a835eee9-b865-4e53-9b33-3db9fbcee18e a835eee9-b865-4e53-9b33-3db9fbcee18e TCGA-22-5472-11A-11D-1633-05 a835eee9-b865-4e53-9b33-3db9fbcee18e +TCGA-22-5473-01 TCGA-22-5473-01 Squamous C2-Squamous-like Cluster 13 (HNSC-LUSC) squamous c3 squamous-like c4 mutation cluster 2 TCGA-22-5473 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung NO NO YES 78 [Discrepancy] TCGA-22-5473-F11133 TCGA-22-5473 TCGA-22-5473-01A 1658 -28826 1933 0 1655 NO NO [Discrepancy] 2011-5-3 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 1 NO 0 NO 1.1 YES 45 No M0 N0 T3 [Discrepancy] TCGA-22-5473.12973d4a-4c25-43dc-920b-d32407d45461.pdf 5473 TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 0.5 1987 YES NO YES 22 3 Lung A DECEASED 2005 1942 5c8d386c-5879-4b83-a899-4e731ae08d92 TCGA-22-5473-01A-01D-1632-08 5c8d386c-5879-4b83-a899-4e731ae08d92 TCGA-22-5473-01A-01D-1633-05 TCGA-22-5473-01A-01D-1631-01 5c8d386c-5879-4b83-a899-4e731ae08d92 TCGA-22-5473-01A-01D-1631-01 TCGA-22-5473-01A-21-2194-20 +TCGA-22-5473-11 TCGA-22-5473-11 C2-Squamous-like mutation cluster 2 TCGA-22-5473 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung NO NO YES 78 [Discrepancy] TCGA-22-5473-F11133 TCGA-22-5473 TCGA-22-5473-11A 1658 -28826 1933 0 1655 NO NO [Discrepancy] 2011-5-3 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 1 NO 0 NO 1.3 YES 45 No M0 N0 T3 [Discrepancy] 5473 TUMOR FREE Complete Remission/Response NO R0 Solid Tissue Normal 11 0.3 1987 YES NO YES 22 3 Lung A DECEASED 2005 1942 TCGA-22-5473-11A-11D-1633-05 +TCGA-22-5474-01 TCGA-22-5474-01 Squamous C2-Squamous-like Cluster 13 (HNSC-LUSC) squamous c3 squamous-like c4 mutation cluster 5 TCGA-22-5474 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 74 L-Upper TCGA-22-5474-F11210 TCGA-22-5474 TCGA-22-5474-01A -27271 445 0 445 NO NO 2011-5-4 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 1 NO 0 NO 1 NO 50 No M0 N0 T2a Stage IB TCGA-22-5474.e0bf9b86-3d7e-4a37-9545-b74dd999e128.pdf 5474 TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 0.3 1994 NO NO YES 22 4 Lung A DECEASED 2005 1944 0242dfba-2ab3-457e-b905-82dc83348e11 TCGA-22-5474-01A-01D-1632-08 0242dfba-2ab3-457e-b905-82dc83348e11 TCGA-22-5474-01A-01D-1633-05 TCGA-22-5474-01A-01D-1631-01 0242dfba-2ab3-457e-b905-82dc83348e11 TCGA-22-5474-01A-01D-1631-01 TCGA-22-5474-01A-21-2194-20 +TCGA-22-5474-11 TCGA-22-5474-11 C2-Squamous-like mutation cluster 5 TCGA-22-5474 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 74 L-Upper TCGA-22-5474-F11210 TCGA-22-5474 TCGA-22-5474-11A -27271 445 0 445 NO NO 2011-5-4 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 1 NO 0 NO 1 NO 50 No M0 N0 T2a Stage IB 5474 TUMOR FREE Complete Remission/Response NO R0 Solid Tissue Normal 11 0.3 1994 NO NO YES 22 4 Lung A DECEASED 2005 1944 TCGA-22-5474-11A-01D-1633-05 +TCGA-22-5477-01 TCGA-22-5477-01 High C2-Squamous-like Cluster 13 (HNSC-LUSC) squamous c3 squamous-like c4 mutation cluster 5 TCGA-22-5477 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung NO NO 65 R-Lower TCGA-22-5477-F11237 TCGA-22-5477 TCGA-22-5477-01A -24055 1346 0 1346 511 NO NO Progressive Disease 2011-5-4 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.8 NO 0 NO 1.4 YES 100 No M0 N0 T1 Stage IA TCGA-22-5477.9dcdc788-4ebd-4376-ab97-b0602a684b90.pdf 5477 Complete Remission/Response NO R0 Primary Tumor 01 0.3 NO NO YES 22 2 Lung A DECEASED 2004 b6cbe950-44d8-4da9-ba79-116f25015278 TCGA-22-5477-01A-01D-1632-08 b6cbe950-44d8-4da9-ba79-116f25015278 TCGA-22-5477-01A-01D-1633-05 TCGA-22-5477-01A-01D-1631-01 b6cbe950-44d8-4da9-ba79-116f25015278 TCGA-22-5477-01A-01D-1631-01 TCGA-22-5477-01A-21-2194-20 +TCGA-22-5477-11 TCGA-22-5477-11 C2-Squamous-like mutation cluster 5 TCGA-22-5477 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung NO NO 65 R-Lower TCGA-22-5477-F11237 TCGA-22-5477 TCGA-22-5477-11A -24055 1346 0 1346 511 NO NO Progressive Disease 2011-5-4 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.7 NO 0 NO 1.2 YES 100 No M0 N0 T1 Stage IA 5477 Complete Remission/Response NO R0 Solid Tissue Normal 11 0.4 NO NO YES 22 2 Lung A DECEASED 2004 TCGA-22-5477-11A-11D-1633-05 +TCGA-22-5478-01 TCGA-22-5478-01 BRCA-LUAD+ C1-LUAD-enriched Cluster 5 squamous c3 squamous-like c4 miRNA cluster 12 mutation cluster 5 TCGA-22-5478 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 79 R-Lower TCGA-22-5478-F11287 TCGA-22-5478 TCGA-22-5478-01A -28978 24 0 24 NO NO 2011-5-6 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.5 NO 0 NO Peripheral Lung 1.1 NO No M0 N0 T2a Stage IB TCGA-22-5478.912bf8ba-d6bb-4643-a5dd-3449c86ceec3.pdf 5478 TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 0.3 1994 NO NO YES 22 4 Lung A DECEASED 2004 c68cacc1-3783-494b-aced-e06cea977a4f TCGA-22-5478-01A-01D-1632-08 c68cacc1-3783-494b-aced-e06cea977a4f TCGA-22-5478-01A-01D-1633-05 TCGA-22-5478-01A-01D-1631-01 c68cacc1-3783-494b-aced-e06cea977a4f TCGA-22-5478-01A-01D-1631-01 TCGA-22-5478-01A-21-2194-20 +TCGA-22-5478-11 TCGA-22-5478-11 C1-LUAD-enriched mutation cluster 5 TCGA-22-5478 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 79 R-Lower TCGA-22-5478-F11287 TCGA-22-5478 TCGA-22-5478-11A -28978 24 0 24 NO NO 2011-5-6 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.7 NO 0 NO Peripheral Lung 1 NO No M0 N0 T2a Stage IB 5478 TUMOR FREE Complete Remission/Response NO R0 Solid Tissue Normal 11 0.2 1994 NO NO YES 22 4 Lung A DECEASED 2004 6a39f9d6-adbb-478f-a59e-93a8bafb4604 6a39f9d6-adbb-478f-a59e-93a8bafb4604 TCGA-22-5478-11A-11D-1633-05 6a39f9d6-adbb-478f-a59e-93a8bafb4604 +TCGA-22-5479-01 TCGA-22-5479-01 Squamous C2-Squamous-like Cluster 13 (HNSC-LUSC) squamous c3 squamous-like c4 miRNA cluster 7 TCGA-22-5479 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 64 L-Lower TCGA-22-5479-F69951 TCGA-22-5479 TCGA-22-5479-01A -23563 2625 0 1651 1 NO NO Scheduled Follow-up Submission 2015-1-22 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.6 NO NO Peripheral Lung 1.1 NO 35 No M0 N0 T2 Stage IB TCGA-22-5479.63ec0c23-5ffc-4c19-a40b-a314c1c91d36.pdf 5479 Pre-Adjuvant Therapy NO R0 Primary Tumor 01 0.3 2001 6th YES NO YES 22 4 Lung A DECEASED 2004 1966 d7086de7-6fd7-4709-b390-90f106977829 d7086de7-6fd7-4709-b390-90f106977829 TCGA-22-5479-01A-31D-1947-05 TCGA-22-5479-01A-31D-1943-01 d7086de7-6fd7-4709-b390-90f106977829 TCGA-22-5479-01A-31D-1943-01 TCGA-22-5479-01A-11-2194-20 +TCGA-22-5480-01 TCGA-22-5480-01 High C2-Squamous-like Cluster 13 (HNSC-LUSC) squamous c3 squamous-like c4 miRNA cluster 7 mutation cluster 13 TCGA-22-5480 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung YES YES NO 66 L-Upper TCGA-22-5480-F11296 TCGA-22-5480 TCGA-22-5480-01A -24245 2170 0 2170 1779 2 NO NO Progressive Disease 2011-5-6 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.6 NO 0 NO Central Lung 1.5 YES 50 No M0 N0 T1b Stage IA TCGA-22-5480.62c5d0aa-1dbd-456a-b16f-cb233be02a88.pdf 5480 Post-Adjuvant Therapy WITH TUMOR Complete Remission/Response NO R0 Primary Tumor 01 0.3 2002 NO NO YES 22 4 Lung A DECEASED 2002 1952 2d8e77a9-f69e-4c27-acaa-1ae73dbc5997 TCGA-22-5480-01A-01D-1632-08 2d8e77a9-f69e-4c27-acaa-1ae73dbc5997 TCGA-22-5480-01A-01D-1633-05 TCGA-22-5480-01A-01D-1631-01 2d8e77a9-f69e-4c27-acaa-1ae73dbc5997 TCGA-22-5480-01A-01D-1631-01 TCGA-22-5480-01A-21-2194-20 +TCGA-22-5480-11 TCGA-22-5480-11 C2-Squamous-like mutation cluster 13 TCGA-22-5480 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung YES YES NO 66 L-Upper TCGA-22-5480-F11296 TCGA-22-5480 TCGA-22-5480-11A -24245 2170 0 2170 1779 2 NO NO Progressive Disease 2011-5-6 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.8 NO 0 NO Central Lung 0.9 YES 50 No M0 N0 T1b Stage IA 5480 Post-Adjuvant Therapy WITH TUMOR Complete Remission/Response NO R0 Solid Tissue Normal 11 0.2 2002 NO NO YES 22 4 Lung A DECEASED 2002 1952 TCGA-22-5480-11A-01D-1633-05 +TCGA-22-5481-01 TCGA-22-5481-01 High Cluster 5 RNA cluster 12 miRNA cluster 12 TCGA-22-5481 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung YES 72 L-Lower TCGA-22-5481-F17912 TCGA-22-5481 TCGA-22-5481-01A 366 -26419 2409 0 346 NO NO Scheduled Follow-up Submission 2011-10-27 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.8 NO NO 1 YES 75 No M0 N1 T2 Stage IIB TCGA-22-5481.71745674-14e0-47ac-b16c-95a18980a37d.pdf 5481 Complete Remission/Response NO R0 Primary Tumor 01 0.3 2002 5th NO NO YES 22 4 Lung A DECEASED 2002 1952 921b83c7-9731-4b26-9a91-f84347e36d5b 921b83c7-9731-4b26-9a91-f84347e36d5b TCGA-22-5481-01A-31D-1947-05 TCGA-22-5481-01A-31D-1943-01 921b83c7-9731-4b26-9a91-f84347e36d5b TCGA-22-5481-01A-31D-1943-01 +TCGA-22-5481-11 TCGA-22-5481-11 TCGA-22-5481 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung YES 72 L-Lower TCGA-22-5481-F17912 TCGA-22-5481 TCGA-22-5481-11A 366 -26419 2409 0 346 NO NO Scheduled Follow-up Submission 2011-10-27 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 1 NO NO 1 YES 75 No M0 N1 T2 Stage IIB 5481 Complete Remission/Response NO R0 Solid Tissue Normal 11 0.3 2002 5th NO NO YES 22 4 Lung A DECEASED 2002 1952 02107e86-44c9-42bd-9a46-2a98e54bd54c 02107e86-44c9-42bd-9a46-2a98e54bd54c 02107e86-44c9-42bd-9a46-2a98e54bd54c +TCGA-22-5482-01 TCGA-22-5482-01 Squamous C2-Squamous-like Cluster 13 (HNSC-LUSC) squamous c3 squamous-like c4 miRNA cluster 11 mutation cluster 8 TCGA-22-5482 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 81 L-Upper TCGA-22-5482-F11304 TCGA-22-5482 TCGA-22-5482-01A -29657 357 0 357 NO NO 2011-5-6 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 1 NO 0 NO 1.2 NO 60 No M0 N0 T2a Stage IB TCGA-22-5482.b98aff53-a7e3-4bf9-b0b3-608f20940ac3.pdf 5482 TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 0.5 2004 NO NO YES 22 4 Lung A DECEASED 2005 1944 71a18be8-ea00-4006-81cd-7ce875f67077 TCGA-22-5482-01A-01D-1632-08 71a18be8-ea00-4006-81cd-7ce875f67077 TCGA-22-5482-01A-01D-1633-05 TCGA-22-5482-01A-01D-1631-01 71a18be8-ea00-4006-81cd-7ce875f67077 TCGA-22-5482-01A-01D-1631-01 TCGA-22-5482-01A-21-2194-20 +TCGA-22-5482-11 TCGA-22-5482-11 C2-Squamous-like mutation cluster 8 TCGA-22-5482 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 81 L-Upper TCGA-22-5482-F11304 TCGA-22-5482 TCGA-22-5482-11A -29657 357 0 357 NO NO 2011-5-6 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 1 NO 0 NO 1.3 NO 60 No M0 N0 T2a Stage IB 5482 TUMOR FREE Complete Remission/Response NO R0 Solid Tissue Normal 11 0.5 2004 NO NO YES 22 4 Lung A DECEASED 2005 1944 eba3191c-d7bd-4af7-811e-8902edb70355 eba3191c-d7bd-4af7-811e-8902edb70355 TCGA-22-5482-11A-01D-1633-05 eba3191c-d7bd-4af7-811e-8902edb70355 +TCGA-22-5483-01 TCGA-22-5483-01 Squamous C2-Squamous-like Cluster 13 (HNSC-LUSC) squamous c3 RNA cluster 3 miRNA cluster 12 TCGA-22-5483 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung NO NO NO 74 R-Upper TCGA-22-5483-F11477 TCGA-22-5483 TCGA-22-5483-01A -27109 573 0 573 568 NO NO Progressive Disease 2011-5-10 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.5 NO 0 NO 1.9 YES 50 No M0 N1 T1a Stage IIA TCGA-22-5483.45ffb097-f0d9-4850-895e-ce7ebef84502.pdf 5483 WITH TUMOR Complete Remission/Response NO R0 Primary Tumor 01 0.2 2004 YES NO YES 22 4 Lung A DECEASED 2005 bfff9773-9089-4b7e-9470-f0ddcabae065 bfff9773-9089-4b7e-9470-f0ddcabae065 TCGA-22-5483-01A-01D-1818-05 TCGA-22-5483-01A-01D-1816-01 bfff9773-9089-4b7e-9470-f0ddcabae065 TCGA-22-5483-01A-01D-1816-01 TCGA-22-5483-01A-21-2194-20 +TCGA-22-5483-11 TCGA-22-5483-11 C2-Squamous-like TCGA-22-5483 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung NO NO NO 74 R-Upper TCGA-22-5483-F11477 TCGA-22-5483 TCGA-22-5483-11A -27109 573 0 573 568 NO NO Progressive Disease 2011-5-10 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 1 NO 0 NO 1.3 YES 50 No M0 N1 T1a Stage IIA 5483 WITH TUMOR Complete Remission/Response NO R0 Solid Tissue Normal 11 0.3 2004 YES NO YES 22 4 Lung A DECEASED 2005 be550442-9380-47cb-b03f-14b84b0db775 be550442-9380-47cb-b03f-14b84b0db775 be550442-9380-47cb-b03f-14b84b0db775 +TCGA-22-5485-01 TCGA-22-5485-01 High C2-Squamous-like Cluster 13 (HNSC-LUSC) squamous c3 squamous-like c4 miRNA cluster 12 mutation cluster 5 TCGA-22-5485 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung NO NO 58 R-Upper TCGA-22-5485-F11483 TCGA-22-5485 TCGA-22-5485-01A -21488 916 0 916 840 NO NO Progressive Disease 2011-5-10 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.7 NO 0 NO 1.2 YES 60 No M0 N0 T1a Stage IA TCGA-22-5485.1a1abb9b-fe80-4a56-a276-94135fcedf4b.pdf 5485 WITH TUMOR Complete Remission/Response NO R0 Primary Tumor 01 0.2 NO NO YES 22 2 Lung A DECEASED 2001 0e17aa25-2993-4ea1-bbee-d600d8c0bf89 TCGA-22-5485-01A-01D-1632-08 0e17aa25-2993-4ea1-bbee-d600d8c0bf89 TCGA-22-5485-01A-01D-1633-05 TCGA-22-5485-01A-01D-1631-01 0e17aa25-2993-4ea1-bbee-d600d8c0bf89 TCGA-22-5485-01A-01D-1631-01 TCGA-22-5485-01A-21-2194-20 +TCGA-22-5485-11 TCGA-22-5485-11 C2-Squamous-like mutation cluster 5 TCGA-22-5485 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung NO NO 58 R-Upper TCGA-22-5485-F11483 TCGA-22-5485 TCGA-22-5485-11A -21488 916 0 916 840 NO NO Progressive Disease 2011-5-10 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 1 NO 0 NO 1.1 YES 60 No M0 N0 T1a Stage IA 5485 WITH TUMOR Complete Remission/Response NO R0 Solid Tissue Normal 11 0.3 NO NO YES 22 2 Lung A DECEASED 2001 TCGA-22-5485-11A-01D-1633-05 +TCGA-22-5489-01 TCGA-22-5489-01 High C2-Squamous-like Cluster 13 (HNSC-LUSC) squamous c3 squamous-like c4 miRNA cluster 7 mutation cluster 2 TCGA-22-5489 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung YES NO NO NO 64 L-Upper TCGA-22-5489-F11536 TCGA-22-5489 TCGA-22-5489-01A -23618 1912 0 1912 730 1 NO NO Progressive Disease 2011-5-11 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.8 NO 0 NO 1.6 YES 70 No M0 N0 T1b Stage IA TCGA-22-5489.c83cbd0b-f2e0-42df-b68e-4ca20dfbce00.pdf 5489 Other WITH TUMOR Complete Remission/Response NO R0 Primary Tumor 01 0.2 2003 NO NO YES 22 4 Lung A DECEASED 2003 142496ba-0118-475e-9169-a201e98e11b5 TCGA-22-5489-01A-01D-1632-08 142496ba-0118-475e-9169-a201e98e11b5 TCGA-22-5489-01A-01D-1633-05 TCGA-22-5489-01A-01D-1631-01 142496ba-0118-475e-9169-a201e98e11b5 TCGA-22-5489-01A-01D-1631-01 TCGA-22-5489-01A-21-2194-20 +TCGA-22-5489-11 TCGA-22-5489-11 C2-Squamous-like mutation cluster 2 TCGA-22-5489 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung YES NO NO NO 64 L-Upper TCGA-22-5489-F11536 TCGA-22-5489 TCGA-22-5489-11A -23618 1912 0 1912 730 1 NO NO Progressive Disease 2011-5-11 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.6 NO 0 NO 0.8 YES 70 No M0 N0 T1b Stage IA 5489 Other WITH TUMOR Complete Remission/Response NO R0 Solid Tissue Normal 11 0.2 2003 NO NO YES 22 4 Lung A DECEASED 2003 5f4c103d-fd38-45c5-b2e6-da62eb63da6a 5f4c103d-fd38-45c5-b2e6-da62eb63da6a TCGA-22-5489-11A-01D-1633-05 5f4c103d-fd38-45c5-b2e6-da62eb63da6a +TCGA-22-5491-01 TCGA-22-5491-01 Squamous C2-Squamous-like Cluster 13 (HNSC-LUSC) squamous c3 squamous-like c4 mutation cluster 3 TCGA-22-5491 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 74 L-Lower TCGA-22-5491-F11545 TCGA-22-5491 TCGA-22-5491-01A -27145 1713 0 1713 NO NO 2011-5-11 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.7 NO 0 NO 0.8 57 No M0 N0 T1a Stage IA TCGA-22-5491.187ab883-e568-47db-a048-c39c4e9d0f29.pdf 5491 R0 Primary Tumor 01 0.2 NO YES 22 2 Lung A DECEASED 2003 8ecb75cd-cf31-4cc8-a2eb-01d1346791e9 TCGA-22-5491-01A-01D-1632-08 8ecb75cd-cf31-4cc8-a2eb-01d1346791e9 TCGA-22-5491-01A-01D-1633-05 TCGA-22-5491-01A-01D-1631-01 8ecb75cd-cf31-4cc8-a2eb-01d1346791e9 TCGA-22-5491-01A-01D-1631-01 TCGA-22-5491-01A-21-2194-20 +TCGA-22-5491-11 TCGA-22-5491-11 C2-Squamous-like mutation cluster 3 TCGA-22-5491 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 74 L-Lower TCGA-22-5491-F11545 TCGA-22-5491 TCGA-22-5491-11A -27145 1713 0 1713 NO NO 2011-5-11 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.5 NO 0 NO 1.2 57 No M0 N0 T1a Stage IA 5491 R0 Solid Tissue Normal 11 0.2 NO YES 22 2 Lung A DECEASED 2003 c06339ee-3381-47f0-bf81-9310acfd78b3 c06339ee-3381-47f0-bf81-9310acfd78b3 TCGA-22-5491-11A-01D-1633-05 c06339ee-3381-47f0-bf81-9310acfd78b3 +TCGA-22-5492-01 TCGA-22-5492-01 Squamous C2-Squamous-like Cluster 5 squamous c3 squamous-like c4 mutation cluster 8 TCGA-22-5492 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 73 L-Upper TCGA-22-5492-F11552 TCGA-22-5492 TCGA-22-5492-01A -26838 506 0 506 NO NO 2011-5-11 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 1 NO 0 NO 1.8 50 No M0 N2 T2a Stage IIIA TCGA-22-5492.d3432f86-2b6a-4c4b-81e5-827f8e5e918c.pdf 5492 R0 Primary Tumor 01 0.2 2003 NO NO YES 22 4 Lung A DECEASED 2003 1953 8dc89366-a78f-4e41-983f-13dfbbe782a2 TCGA-22-5492-01A-01D-1632-08 8dc89366-a78f-4e41-983f-13dfbbe782a2 TCGA-22-5492-01A-01D-1633-05 TCGA-22-5492-01A-01D-1631-01 8dc89366-a78f-4e41-983f-13dfbbe782a2 TCGA-22-5492-01A-01D-1631-01 TCGA-22-5492-01A-21-2194-20 +TCGA-22-5492-11 TCGA-22-5492-11 C2-Squamous-like mutation cluster 8 TCGA-22-5492 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 73 L-Upper TCGA-22-5492-F11552 TCGA-22-5492 TCGA-22-5492-11A -26838 506 0 506 NO NO 2011-5-11 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.9 NO 0 NO 1.1 50 No M0 N2 T2a Stage IIIA 5492 R0 Solid Tissue Normal 11 0.3 2003 NO NO YES 22 4 Lung A DECEASED 2003 1953 TCGA-22-5492-11A-01D-1633-05 +TCGA-22-A5C4-01 TCGA-22-A5C4-01 TCGA-22-A5C4 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 70 R-Lower TCGA-22-A5C4-F63882 TCGA-22-A5C4 TCGA-22-A5C4-01A -25629 49 0 671 74 1 NO NO Scheduled Follow-up Submission Complete Remission/Response 2014-8-20 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 290 NO NO Central Lung NO NO 80 true Yes, History of Prior Malignancy M0 N0 T2b Stage IIA TCGA-22-A5C4.4B2F6A48-A414-45A6-A729-4BBA1EF29021.pdf A5C4 Other TUMOR FREE 82 73 Complete Remission/Response YES NO R0 Primary Tumor 01 2012 7th NO NO YES 22 4 Lung A LIVING 2012 1960 4548b282-a56a-4e93-989f-5e093122aa6d 4548b282-a56a-4e93-989f-5e093122aa6d TCGA-22-A5C4-01A-12D-A27L-05 TCGA-22-A5C4-01A-12D-A27J-01 4548b282-a56a-4e93-989f-5e093122aa6d TCGA-22-A5C4-01A-12D-A27J-01 +TCGA-33-4532-01 TCGA-33-4532-01 High C2-Squamous-like Cluster 5 squamous c3 squamous-like c4 miRNA cluster 11 mutation cluster 8 TCGA-33-4532 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 68 R-Lower TCGA-33-4532-F71134 TCGA-33-4532 TCGA-33-4532-01A -25169 3924 0 2524 27 1 Scheduled Follow-up Submission Complete Remission/Response 2015-3-18 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 1 NO 2 NO NO 53 Yes M0 N0 T2 Stage IB TCGA-33-4532.6ec80633-f41f-4a9d-abfe-b1c72f9f9d10.pdf 4532 TUMOR FREE 76 3 78 3 Complete Remission/Response YES NO R0 Primary Tumor 01 0.3 5th NO NO YES 33 2 Lung A DECEASED 2001 fa7be44d-ec78-4bbe-b5af-38e0744f14a9 TCGA-33-4532-01A-01D-1198-05 TCGA-33-4532-01A-01D-1267-08 fa7be44d-ec78-4bbe-b5af-38e0744f14a9 TCGA-33-4532-01A-01D-1195-01 TCGA-33-4532-01A-01R-1201-07 fa7be44d-ec78-4bbe-b5af-38e0744f14a9 TCGA-33-4532-01A-01D-1195-01 TCGA-33-4532-01A-21-2193-20 +TCGA-33-4533-01 TCGA-33-4533-01 Squamous C10-GBM Cluster 5 GBM-like c6 miRNA c1uster 9 mutation cluster 5 TCGA-33-4533 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 76 L-Upper TCGA-33-4533-F58821 TCGA-33-4533 TCGA-33-4533-01A -28001 0 4068 11 1 Scheduled Follow-up Submission 2014-4-24 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.9 8070/3 C34.9 YES 1.3 NO 90 1.5 NO NO 50 Yes M0 N0 T2 Stage IB TCGA-33-4533.1791e931-cced-44e6-b530-21bba650cc8c.pdf 4533 Preoperative TUMOR FREE 63 1 63 1 Complete Remission/Response YES NO R0 Primary Tumor 01 0.2 1990 5th NO NO YES 33 4 Lung A LIVING 2001 1940 73c2db42-5c8b-4b21-a1a5-ad3b106f2b13 TCGA-33-4533-01A-01D-1198-05 TCGA-33-4533-01A-01D-1267-08 73c2db42-5c8b-4b21-a1a5-ad3b106f2b13 TCGA-33-4533-01A-01D-1195-01 TCGA-33-4533-01A-01R-1201-07 73c2db42-5c8b-4b21-a1a5-ad3b106f2b13 TCGA-33-4533-01A-01D-1195-01 +TCGA-33-4538-01 TCGA-33-4538-01 High C2-Squamous-like Cluster 13 (HNSC-LUSC) squamous-like c4 miRNA cluster 7 mutation cluster 2 TCGA-33-4538 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 66 L-Upper TCGA-33-4538-F58812 TCGA-33-4538 TCGA-33-4538-01A -24174 2979 0 20 1 Scheduled Follow-up Submission 2014-4-24 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) Yes C34.1 8070/3 C34.1 YES 0.6 NO 90 0.9 NO 51 No M0 N2 T2 Stage IIIA TCGA-33-4538.fcc5edd0-a274-49b7-83c8-ea8de74b9571.pdf 4538 Preoperative 3 2 Complete Remission/Response YES NO RX Primary Tumor 01 0.1 6th YES NO YES 33 2 Lung A DECEASED 2002 867b4c4f-b1d3-4702-80ff-74ba4e169e3b TCGA-33-4538-01A-01D-1198-05 TCGA-33-4538-01A-01D-1267-08 867b4c4f-b1d3-4702-80ff-74ba4e169e3b TCGA-33-4538-01A-01D-1195-01 TCGA-33-4538-01A-01R-1201-07 867b4c4f-b1d3-4702-80ff-74ba4e169e3b TCGA-33-4538-01A-01D-1195-01 +TCGA-33-4547-01 TCGA-33-4547-01 Squamous C2-Squamous-like Cluster 5 squamous c3 squamous-like c4 miRNA cluster 4 mutation cluster 3 TCGA-33-4547 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 68 R-Upper TCGA-33-4547-F58819 TCGA-33-4547 TCGA-33-4547-01A -25056 0 2419 0 Scheduled Follow-up Submission 2014-4-24 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 1.3 NO 100 NO 1.7 NO NO 40 No M0 N0 T2 Stage IB TCGA-33-4547.c2a8e692-5b5a-4a56-85e9-165e523a341c.pdf 4547 Other TUMOR FREE 62 Complete Remission/Response YES NO R0 Primary Tumor 01 0.4 1970 6th NO NO YES 33 3 Lung A LIVING 2007 1950 f31fd0a1-b600-42bc-a6fa-689c05a581ce TCGA-33-4547-01A-01D-1198-05 TCGA-33-4547-01A-01D-1267-08 f31fd0a1-b600-42bc-a6fa-689c05a581ce TCGA-33-4547-01A-01D-1195-01 TCGA-33-4547-01A-01R-1201-07 f31fd0a1-b600-42bc-a6fa-689c05a581ce TCGA-33-4547-01A-01D-1195-01 TCGA-33-4547-01A-21-2193-20 +TCGA-33-4566-01 TCGA-33-4566-01 High C1-LUAD-enriched Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 4 mutation cluster 11 TCGA-33-4566 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 40 R-Upper TCGA-33-4566-F58817 TCGA-33-4566 TCGA-33-4566-01A -14643 5287 0 23 1 Scheduled Follow-up Submission 2014-4-24 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.9 NO 1.5 NO 20 No M0 N0 T2 Stage IB TCGA-33-4566.cd1a9ba4-3ccf-4f10-b512-a76baa9d8d44.pdf 4566 Other 77 4 YES R0 Primary Tumor 01 0.3 4th NO YES 33 2 Lung A DECEASED 1996 9c14d16a-7e54-492c-bc10-055d69b5dd80 TCGA-33-4566-01A-01D-1441-08 9c14d16a-7e54-492c-bc10-055d69b5dd80 TCGA-33-4566-01A-01D-1440-05 TCGA-33-4566-01A-01D-1439-01 TCGA-33-4566-01A-01R-1443-07 9c14d16a-7e54-492c-bc10-055d69b5dd80 TCGA-33-4566-01A-01D-1439-01 TCGA-33-4566-01A-21-2193-20 +TCGA-33-4566-11 TCGA-33-4566-11 C1-LUAD-enriched mutation cluster 11 TCGA-33-4566 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 40 R-Upper TCGA-33-4566-F58817 TCGA-33-4566 TCGA-33-4566-11A -14643 5287 0 23 1 Scheduled Follow-up Submission 2014-4-24 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 1 NO 1.8 NO 20 No M0 N0 T2 Stage IB 4566 Other 77 4 YES R0 Solid Tissue Normal 11 0.2 4th NO YES 33 2 Lung A DECEASED 1996 TCGA-33-4566-11A-01D-1440-05 +TCGA-33-4579-01 TCGA-33-4579-01 TCGA-33-4579 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung TCGA-33-4579-01A 0.7 NO 1 TCGA-33-4579.5c0b7635-ab69-45d6-8ee4-71aeab582594.pdf Primary Tumor 01 0.3 A 3cc08419-e5dd-4dc9-ad6d-d9bac7dfac34 3cc08419-e5dd-4dc9-ad6d-d9bac7dfac34 TCGA-33-4579-01A-01D-1440-05 TCGA-33-4579-01A-01R-1443-07 3cc08419-e5dd-4dc9-ad6d-d9bac7dfac34 +TCGA-33-4579-11 TCGA-33-4579-11 TCGA-33-4579 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung TCGA-33-4579-11A 0.5 NO 1.6 Solid Tissue Normal 11 0.3 A TCGA-33-4579-11A-01D-1440-05 +TCGA-33-4582-01 TCGA-33-4582-01 High C2-Squamous-like Cluster 5 squamous c3 squamous-like c4 miRNA cluster 4 mutation cluster 13 TCGA-33-4582 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung NO NO NO NO 55 L-Lower TCGA-33-4582-F58815 TCGA-33-4582 TCGA-33-4582-01A -20402 3149 0 2923 25 2 Scheduled Follow-up Submission Progressive Disease 2014-4-24 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 1 NO 60 1.1 NO Locoregional Recurrence YES 86 No M0 N0 T1 Stage IA TCGA-33-4582.3c5a7297-2aad-496b-a552-c570cbee49b0.pdf 4582 Post-Adjuvant Therapy WITH TUMOR 37 1 Complete Remission/Response Convincing Imaging YES YES R0 Primary Tumor 01 0.2 5th YES 33 2 Lung A DECEASED 2000 1966 c192c13f-7bc1-479f-b2e4-ba64b46b0d68 TCGA-33-4582-01A-01D-1441-08 c192c13f-7bc1-479f-b2e4-ba64b46b0d68 TCGA-33-4582-01A-01D-1440-05 TCGA-33-4582-01A-01D-1439-01 TCGA-33-4582-01A-01R-1443-07 c192c13f-7bc1-479f-b2e4-ba64b46b0d68 TCGA-33-4582-01A-01D-1439-01 TCGA-33-4582-01A-21-2193-20 +TCGA-33-4582-11 TCGA-33-4582-11 C2-Squamous-like mutation cluster 13 TCGA-33-4582 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung NO NO NO NO 55 L-Lower TCGA-33-4582-F58815 TCGA-33-4582 TCGA-33-4582-11A -20402 3149 0 2923 25 2 Scheduled Follow-up Submission Progressive Disease 2014-4-24 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.9 NO 60 1.1 NO Locoregional Recurrence YES 86 No M0 N0 T1 Stage IA 4582 Post-Adjuvant Therapy WITH TUMOR 37 1 Complete Remission/Response Convincing Imaging YES YES R0 Solid Tissue Normal 11 0.4 5th YES 33 2 Lung A DECEASED 2000 1966 TCGA-33-4582-11A-01D-1440-05 +TCGA-33-4583-01 TCGA-33-4583-01 BRCA-LUAD+ C2-Squamous-like Cluster 13 (HNSC-LUSC) squamous-like c4 miRNA cluster 11 mutation cluster 2 TCGA-33-4583 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 73 L-Lower TCGA-33-4583-F58820 TCGA-33-4583 TCGA-33-4583-01A -26799 4601 0 4299 29 1 Scheduled Follow-up Submission 2014-4-24 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 1 NO 90 1 NO NO 46 No M0 N0 T1 Stage IA TCGA-33-4583.535235c0-4540-4638-b799-b7dfd082f5b8.pdf 4583 Other TUMOR FREE 73 3 Complete Remission/Response YES NO R0 Primary Tumor 01 0.3 1987 5th NO 33 4 Lung A DECEASED 1999 1941 4865a07c-0af4-4cdd-b55f-ec11670d6e29 TCGA-33-4583-01A-01D-1441-08 4865a07c-0af4-4cdd-b55f-ec11670d6e29 TCGA-33-4583-01A-01D-1440-05 TCGA-33-4583-01A-01D-1439-01 4865a07c-0af4-4cdd-b55f-ec11670d6e29 TCGA-33-4583-01A-01D-1439-01 +TCGA-33-4583-11 TCGA-33-4583-11 C2-Squamous-like mutation cluster 2 TCGA-33-4583 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 73 L-Lower TCGA-33-4583-F58820 TCGA-33-4583 TCGA-33-4583-11A -26799 4601 0 4299 29 1 Scheduled Follow-up Submission 2014-4-24 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 1.1 NO 90 1.2 NO NO 46 No M0 N0 T1 Stage IA 4583 Other TUMOR FREE 73 3 Complete Remission/Response YES NO R0 Solid Tissue Normal 11 0.4 1987 5th NO 33 4 Lung A DECEASED 1999 1941 TCGA-33-4583-11A-01D-1440-05 +TCGA-33-4586-01 TCGA-33-4586-01 High C2-Squamous-like Cluster 13 (HNSC-LUSC) squamous c3 squamous-like c4 miRNA cluster 4 mutation cluster 5 TCGA-33-4586 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung YES YES NO 57 L-Lower TCGA-33-4586-F58818 TCGA-33-4586 TCGA-33-4586-01A -21148 428 0 169 37 1 Scheduled Follow-up Submission Progressive Disease 2014-4-24 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.9 NO 80 1.5 NO Locoregional Recurrence YES 108 No M0 N2 T2 Stage IIIA TCGA-33-4586.7fbf4e5b-0ea6-4630-b35f-9af85414be08.pdf 4586 Post-Adjuvant Therapy 69 2 70 2 Complete Remission/Response Convincing Imaging YES YES Primary Tumor 01 0.3 2004 6th YES 33 4 Lung A DECEASED 2007 1961 80444ef3-0ac2-45fc-b0c5-237cd8bb8fc0 TCGA-33-4586-01A-01D-1441-08 80444ef3-0ac2-45fc-b0c5-237cd8bb8fc0 TCGA-33-4586-01A-01D-1440-05 TCGA-33-4586-01A-01D-1439-01 80444ef3-0ac2-45fc-b0c5-237cd8bb8fc0 TCGA-33-4586-01A-01D-1439-01 TCGA-33-4586-01A-21-2193-20 +TCGA-33-4586-11 TCGA-33-4586-11 C2-Squamous-like mutation cluster 5 TCGA-33-4586 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung YES YES NO 57 L-Lower TCGA-33-4586-F58818 TCGA-33-4586 TCGA-33-4586-11A -21148 428 0 169 37 1 Scheduled Follow-up Submission Progressive Disease 2014-4-24 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 1 NO 80 1 NO Locoregional Recurrence YES 108 No M0 N2 T2 Stage IIIA 4586 Post-Adjuvant Therapy 69 2 70 2 Complete Remission/Response Convincing Imaging YES YES Solid Tissue Normal 11 0.3 2004 6th YES 33 4 Lung A DECEASED 2007 1961 TCGA-33-4586-11A-01D-1440-05 +TCGA-33-4587-01 TCGA-33-4587-01 Squamous OV-like c1 RNA cluster 12 miRNA cluster 6 TCGA-33-4587 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 63 R-Middle TCGA-33-4587-F22037 TCGA-33-4587 TCGA-33-4587-01A -23062 1656 0 111 Scheduled Follow-up Submission Stable Disease 2012-2-23 FEMALE Lung Small Cell Squamous Cell Carcinoma No C34.2 8073/3 C34.2 YES 0.7 NO NO 1 NO No MX N0 T2 Stage IB TCGA-33-4587.6e5b11a3-0414-4af4-8cd2-0e80c02b8bcf.pdf 4587 WITH TUMOR 91 73 76 75 Progressive Disease YES NO R0 Primary Tumor 01 0.3 2003 6th YES NO YES 33 4 Lung A DECEASED 2003 1970 56dc0212-f15b-4a18-81db-7b8268106162 56dc0212-f15b-4a18-81db-7b8268106162 TCGA-33-4587-01A-11D-2123-05 TCGA-33-4587-01A-11D-2121-01 56dc0212-f15b-4a18-81db-7b8268106162 TCGA-33-4587-01A-11D-2121-01 +TCGA-33-4587-11 TCGA-33-4587-11 TCGA-33-4587 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 63 R-Middle TCGA-33-4587-F22037 TCGA-33-4587 TCGA-33-4587-11A -23062 1656 0 111 Scheduled Follow-up Submission Stable Disease 2012-2-23 FEMALE Lung Small Cell Squamous Cell Carcinoma No C34.2 8073/3 C34.2 YES 1.1 NO NO 1.9 NO No MX N0 T2 Stage IB 4587 WITH TUMOR 91 73 76 75 Progressive Disease YES NO R0 Solid Tissue Normal 11 0.3 2003 6th YES NO YES 33 4 Lung A DECEASED 2003 1970 3e8b3913-495f-488c-872c-9ab46b85c301 3e8b3913-495f-488c-872c-9ab46b85c301 3e8b3913-495f-488c-872c-9ab46b85c301 +TCGA-33-4589-01 TCGA-33-4589-01 Squamous Cluster 14 (HNSC) squamous c3 miRNA cluster 11 TCGA-33-4589 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 62 R-Lower TCGA-33-4589-F58813 TCGA-33-4589 TCGA-33-4589-01A -22754 47 0 1 Scheduled Follow-up Submission 2014-4-24 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.9 8070/3 C34.9 YES 0.6 NO 80 1.4 NO NO 45 Yes M0 N1 T2 Stage IIB TCGA-33-4589.f77f14e6-c17d-4908-a5e3-77d1e11f26c9.pdf 4589 Preoperative TUMOR FREE Complete Remission/Response NO NO Primary Tumor 01 0.3 3rd NO 33 2 Lung A DECEASED 1992 1948 5a6bed81-2364-4681-b659-af68a1028512 5a6bed81-2364-4681-b659-af68a1028512 TCGA-33-4589-01A-01D-1440-05 TCGA-33-4589-01A-01D-1439-01 TCGA-33-4589-01A-01R-1443-07 5a6bed81-2364-4681-b659-af68a1028512 TCGA-33-4589-01A-01D-1439-01 TCGA-33-4589-01A-21-2193-20 +TCGA-33-4589-11 TCGA-33-4589-11 TCGA-33-4589 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 62 R-Lower TCGA-33-4589-F58813 TCGA-33-4589 TCGA-33-4589-11A -22754 47 0 1 Scheduled Follow-up Submission 2014-4-24 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.9 8070/3 C34.9 YES 0.6 NO 80 1.5 NO NO 45 Yes M0 N1 T2 Stage IIB 4589 Preoperative TUMOR FREE Complete Remission/Response NO NO Solid Tissue Normal 11 0.4 3rd NO 33 2 Lung A DECEASED 1992 1948 TCGA-33-4589-11A-01D-1440-05 +TCGA-33-6737-01 TCGA-33-6737-01 High C1-LUAD-enriched Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 4 mutation cluster 13 TCGA-33-6737 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 71 R-Upper TCGA-33-6737-F16690 TCGA-33-6737 TCGA-33-6737-01A -26033 601 0 Scheduled Follow-up Submission 2011-9-23 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.4 NO 2 NO 20 Yes M0 N2 T2 Stage IIIA TCGA-33-6737.d8a5d5d4-48a9-4b5a-bf57-ff32e7302d74.pdf 6737 WITH TUMOR Progressive Disease NO Primary Tumor 01 0.3 6th YES NO YES 33 4 Lung A DECEASED 2008 38dbab79-7aeb-4153-b3ce-8feeb36b48e5 TCGA-33-6737-01A-11D-1817-08 38dbab79-7aeb-4153-b3ce-8feeb36b48e5 TCGA-33-6737-01A-11D-1818-05 TCGA-33-6737-01A-11D-1816-01 38dbab79-7aeb-4153-b3ce-8feeb36b48e5 TCGA-33-6737-01A-11D-1816-01 TCGA-33-6737-01A-13-2194-20 +TCGA-33-6737-11 TCGA-33-6737-11 C1-LUAD-enriched mutation cluster 13 TCGA-33-6737 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 71 R-Upper TCGA-33-6737-F16690 TCGA-33-6737 TCGA-33-6737-11A -26033 601 0 Scheduled Follow-up Submission 2011-9-23 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.7 NO 0.9 NO 20 Yes M0 N2 T2 Stage IIIA 6737 WITH TUMOR Progressive Disease NO Solid Tissue Normal 11 0.3 6th YES NO YES 33 4 Lung A DECEASED 2008 d7ff5d57-d610-4ea9-a849-b974736121fa d7ff5d57-d610-4ea9-a849-b974736121fa d7ff5d57-d610-4ea9-a849-b974736121fa +TCGA-33-6738-01 TCGA-33-6738-01 Squamous C2-Squamous-like BRCA CIMP c7 squamous c3 squamous-like c4 miRNA c1uster 9 TCGA-33-6738 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 80 L-Upper TCGA-33-6738-F71135 TCGA-33-6738 TCGA-33-6738-01A -29368 0 1927 0 Scheduled Follow-up Submission Complete Remission/Response 2015-3-18 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.8 NO 100 1 NO NO 50 No MX N2 T1 Stage IIIA TCGA-33-6738.ba07bb38-7742-4129-bdf2-f76ce3378b6f.pdf 6738 TUMOR FREE Complete Remission/Response NO NO Primary Tumor 01 0.3 6th YES NO YES 33 4 Lung A LIVING 2009 f62b601a-a8a2-4179-be5b-6b9548da05c2 f62b601a-a8a2-4179-be5b-6b9548da05c2 TCGA-33-6738-01A-11D-1947-05 TCGA-33-6738-01A-11D-1943-01 f62b601a-a8a2-4179-be5b-6b9548da05c2 TCGA-33-6738-01A-11D-1943-01 TCGA-33-6738-01A-13-2194-20 +TCGA-33-A4WN-01 TCGA-33-A4WN-01 TCGA-33-A4WN TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 60 R-Upper TCGA-33-A4WN-F58488 TCGA-33-A4WN TCGA-33-A4WN-01A -22268 327 143 0 4 Scheduled Follow-up Submission Complete Remission/Response 2014-4-11 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 350 NO 20 NO NO 60 true No MX N0 T2a Stage IB TCGA-33-A4WN.D4BD5AF3-DDC8-4724-A9E7-F54F5BDB9826.pdf A4WN Other TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 7th YES NO 33 2 Lung A DECEASED 2011 1970 ac66c676-f950-4565-82ac-a9d98adbcde9 ac66c676-f950-4565-82ac-a9d98adbcde9 TCGA-33-A4WN-01A-11D-A25R-05 TCGA-33-A4WN-01A-11D-A25M-01 ac66c676-f950-4565-82ac-a9d98adbcde9 TCGA-33-A4WN-01A-11D-A25M-01 +TCGA-33-A5GW-01 TCGA-33-A5GW-01 TCGA-33-A5GW TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 67 R-Lower TCGA-33-A5GW-F58489 TCGA-33-A5GW TCGA-33-A5GW-01A -24586 301 9 0 9 4 Scheduled Follow-up Submission Complete Remission/Response 2014-4-11 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 50 NO 20 NO NO 50 true No MX N1 T1a Stage IIA TCGA-33-A5GW.67D1EB63-96A5-41C4-B324-0C8321F3B064.pdf A5GW Other TUMOR FREE 90.9 84.9 Complete Remission/Response YES NO R0 Primary Tumor 01 2008 7th NO YES NO 33 4 Lung A DECEASED 2012 425af988-b4b8-4476-ba67-8fc7148f4452 425af988-b4b8-4476-ba67-8fc7148f4452 TCGA-33-A5GW-01A-11D-A27L-05 TCGA-33-A5GW-01A-11D-A27J-01 425af988-b4b8-4476-ba67-8fc7148f4452 TCGA-33-A5GW-01A-11D-A27J-01 +TCGA-33-AAS8-01 TCGA-33-AAS8-01 TCGA-33-AAS8 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 59 R-Upper TCGA-33-AAS8 TCGA-33-AAS8-01A -21675 5727 1114 0 1 2014-6-13 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 90 NO 90 NO 60 true No MX N0 T1 Stage IA TCGA-33-AAS8.637118ED-26C4-4AEF-B4C9-D06C10F98F59.pdf AAS8 Preoperative TUMOR FREE Complete Remission/Response NO NO R0 Primary Tumor 01 1991 5th YES NO YES 33 4 Lung A DECEASED 1998 1971 c86cac86-41e9-453c-9de5-83d506990256 c86cac86-41e9-453c-9de5-83d506990256 TCGA-33-AAS8-01A-11D-A408-05 TCGA-33-AAS8-01A-11D-A400-01 c86cac86-41e9-453c-9de5-83d506990256 TCGA-33-AAS8-01A-11D-A400-01 +TCGA-33-AASB-01 TCGA-33-AASB-01 TCGA-33-AASB TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 66 L-Upper TCGA-33-AASB TCGA-33-AASB-01A -24183 4286 211 0 84.6 1 2014-6-13 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 150 NO 90 YES 40 true No MX N0 T2 Stage IB TCGA-33-AASB.DF569855-8AF0-4930-97CC-8A65CA697106.pdf AASB Preoperative WITH TUMOR 62.1 103.1 64.6 107.2 Progressive Disease YES NO R0 Primary Tumor 01 5th YES NO YES 33 2 Lung A DECEASED 2002 1962 81fd0745-ced7-4eab-adeb-0588634e1fae 81fd0745-ced7-4eab-adeb-0588634e1fae TCGA-33-AASB-01A-11D-A408-05 TCGA-33-AASB-01A-11D-A400-01 81fd0745-ced7-4eab-adeb-0588634e1fae TCGA-33-AASB-01A-11D-A400-01 +TCGA-33-AASD-01 TCGA-33-AASD-01 TCGA-33-AASD TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 83 R-Lower TCGA-33-AASD TCGA-33-AASD-01A -30623 4641 3376 0 38.1 1 2014-6-13 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 120 NO 80 YES 84 true No MX N0 T1 Stage IA TCGA-33-AASD.00E9AF99-0DD2-447D-90F3-7F068E6C3E55.pdf AASD Preoperative WITH TUMOR 66.9 82.4 77.4 95.3 Progressive Disease YES NO R0 Primary Tumor 01 5th NO NO YES 33 2 Lung A DECEASED 2001 1950 95e1065f-3bd1-4249-b896-e8835c856582 95e1065f-3bd1-4249-b896-e8835c856582 TCGA-33-AASD-01A-11D-A408-05 TCGA-33-AASD-01A-11D-A400-01 95e1065f-3bd1-4249-b896-e8835c856582 TCGA-33-AASD-01A-11D-A400-01 +TCGA-33-AASI-01 TCGA-33-AASI-01 TCGA-33-AASI TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 65 L-Lower TCGA-33-AASI TCGA-33-AASI-01A -23965 2032 1344 0 1 2014-6-13 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 220 NO 90 NO 60 true No MX N1 T2 Stage IIB TCGA-33-AASI.A04F5C2E-6BDB-425D-9A4B-B5FDE0BC0EE9.pdf AASI Preoperative WITH TUMOR Stable Disease NO YES RX Primary Tumor 01 6th YES NO YES 33 4 Lung A DECEASED 2008 7dedcae7-dff0-4df0-9075-f368be9cb60b 7dedcae7-dff0-4df0-9075-f368be9cb60b TCGA-33-AASI-01A-22D-A408-05 TCGA-33-AASI-01A-22D-A400-01 7dedcae7-dff0-4df0-9075-f368be9cb60b TCGA-33-AASI-01A-22D-A400-01 +TCGA-33-AASJ-01 TCGA-33-AASJ-01 TCGA-33-AASJ TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 60 R-Lower TCGA-33-AASJ TCGA-33-AASJ-01A -22179 5439 3600 0 80.9 1 2014-6-13 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 150 NO 90 YES true No MX N0 T2 Stage IB TCGA-33-AASJ.B6B6F820-32C4-4D60-9EC5-458F4D3676D8.pdf AASJ Preoperative WITH TUMOR 49.6 37.5 79.4 60.0 Complete Remission/Response YES NO R0 Primary Tumor 01 1991 5th NO NO YES 33 4 Lung A DECEASED 1999 1983 57162746-b63a-4560-aea4-a933e0051c63 57162746-b63a-4560-aea4-a933e0051c63 TCGA-33-AASJ-01A-11D-A408-05 TCGA-33-AASJ-01A-11D-A400-01 57162746-b63a-4560-aea4-a933e0051c63 TCGA-33-AASJ-01A-11D-A400-01 +TCGA-33-AASL-01 TCGA-33-AASL-01 TCGA-33-AASL TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 57 R-Upper TCGA-33-AASL TCGA-33-AASL-01A -20940 4936 826 0 59.6 2 2014-6-13 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 80 NO 90 YES 60 true No MX N0 T1 Stage IA TCGA-33-AASL.BA440A37-33C3-4154-9015-2EA006E50E0C.pdf AASL Preoperative WITH TUMOR 71.2 56.2 80.0 63.1 Progressive Disease YES NO R0 Primary Tumor 01 5th NO NO YES 33 2 Lung A DECEASED 2000 b9b42bfa-2222-4d21-a163-02f767c4db38 b9b42bfa-2222-4d21-a163-02f767c4db38 TCGA-33-AASL-01A-11D-A408-05 TCGA-33-AASL-01A-11D-A400-01 b9b42bfa-2222-4d21-a163-02f767c4db38 TCGA-33-AASL-01A-11D-A400-01 +TCGA-34-2596-01 TCGA-34-2596-01 High C2-Squamous-like Cluster 13 (HNSC-LUSC) squamous c3 squamous-like c4 miRNA cluster 4 mutation cluster 5 TCGA-34-2596 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung NO NO NO NO 70 Bronchial TCGA-34-2596-F5309 TCGA-34-2596 TCGA-34-2596-01A -25574 80 0 80 2010-8-26 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.9 8070/3 C34.9 YES 1.2 NO 1.8 NO 60 No M0 N1 T2 Stage IIB TCGA-34-2596.03af2ab8-fad5-49f6-94d7-8faaec71b63f.pdf 2596 TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 0.4 1974 NO NO YES 34 3 Lung A DECEASED 2004 3647c517-acfa-439c-85a2-e03a305b8ce1 TCGA-34-2596-01A-01D-0848-05 TCGA-34-2596-01A-01D-1522-08 3647c517-acfa-439c-85a2-e03a305b8ce1 TCGA-34-2596-01A-01D-0844-01 TCGA-34-2596-01A-01R-0851-07 3647c517-acfa-439c-85a2-e03a305b8ce1 TCGA-34-2596-01A-01D-0844-01 TCGA-34-2596-01A-21-2193-20 +TCGA-34-2600-01 TCGA-34-2600-01 Squamous C2-Squamous-like Cluster 5 squamous-like c4 miRNA cluster 11 mutation cluster 8 TCGA-34-2600 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 76 R-Lower TCGA-34-2600-F19851 TCGA-34-2600 TCGA-34-2600-01A -28072 1874 0 1874 Scheduled Follow-up Submission 2011-12-29 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.5 NO Central Lung 1.1 NO 50 No M0 N0 T1 Stage IA TCGA-34-2600.cfe4e419-1c0d-4a22-8a6a-968aaacbf935.pdf 2600 TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 0.2 1997 NO NO YES 34 4 Lung A DECEASED 2000 e1d11ec9-09e9-4cbb-b3a6-6724f4379cc7 TCGA-34-2600-01A-01D-0848-05 TCGA-34-2600-01A-01D-1522-08 e1d11ec9-09e9-4cbb-b3a6-6724f4379cc7 TCGA-34-2600-01A-01D-0844-01 TCGA-34-2600-01A-01R-0851-07 e1d11ec9-09e9-4cbb-b3a6-6724f4379cc7 TCGA-34-2600-01A-01D-0844-01 +TCGA-34-2604-01 TCGA-34-2604-01 Squamous Cluster 5 squamous c3 miRNA cluster 4 TCGA-34-2604 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 81 L-Lower TCGA-34-2604-F4217 TCGA-34-2604 TCGA-34-2604-01A -29827 958 0 958 NO NO 2010-11-4 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.7 NO NO 2 NO 132 Yes M0 N0 T2 Stage IB TCGA-34-2604.8a9824bd-7b50-4ad8-bd84-dfa29a88d6b2.pdf 2604 TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 0.5 NO NO YES 34 2 Lung A DECEASED 1999 1933 TCGA-34-2604-01A-01D-0848-05 TCGA-34-2604-01A-01D-0844-01 TCGA-34-2604-01A-01R-0851-07 TCGA-34-2604-01A-01D-0844-01 TCGA-34-2604-01A-21-2193-20 +TCGA-34-2605-01 TCGA-34-2605-01 High Cluster 13 (HNSC-LUSC) squamous c3 miRNA cluster 4 TCGA-34-2605 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung NO NO 76 R-Upper TCGA-34-2605-F4240 TCGA-34-2605 TCGA-34-2605-01A -27833 881 0 881 844 3 NO NO 2010-11-4 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.7 NO NO 2 YES 60 Yes M0 N1 T4 Stage IIIB TCGA-34-2605.53291789-2743-4446-b859-aa65568586a7.pdf 2605 Post-Adjuvant Therapy WITH TUMOR Complete Remission/Response NO R0 Primary Tumor 01 0.4 2006 YES NO YES 34 4 Lung A DECEASED 2006 1946 TCGA-34-2605-01A-01D-0848-05 TCGA-34-2605-01A-01D-0844-01 TCGA-34-2605-01A-01R-0851-07 TCGA-34-2605-01A-01D-0844-01 TCGA-34-2605-01A-21-2193-20 +TCGA-34-2608-01 TCGA-34-2608-01 Squamous C2-Squamous-like Low purity c2 squamous c3 squamous-like c4 miRNA cluster 4 mutation cluster 5 TCGA-34-2608 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung NO NO NO NO 84 L-Upper TCGA-34-2608-F5308 TCGA-34-2608 TCGA-34-2608-01A -30958 1000 0 1000 2010-8-26 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.7 NO 1.9 NO 60 No M0 N0 T2 Stage IB TCGA-34-2608.18c043ab-df83-40bf-bafc-e33aed1ebdea.pdf 2608 TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 0.6 1959 NO NO YES 34 3 Lung A DECEASED 1999 ea2e88e9-53f1-4fcd-b7b8-924ec8ed0aaa TCGA-34-2608-01A-02D-0848-05 TCGA-34-2608-01A-02D-1522-08 ea2e88e9-53f1-4fcd-b7b8-924ec8ed0aaa TCGA-34-2608-01A-02D-0844-01 TCGA-34-2608-01A-02R-0851-07 ea2e88e9-53f1-4fcd-b7b8-924ec8ed0aaa TCGA-34-2608-01A-02D-0844-01 TCGA-34-2608-01A-11-2193-20 +TCGA-34-2609-01 TCGA-34-2609-01 High Cluster 13 (HNSC-LUSC) squamous c3 miRNA cluster 7 TCGA-34-2609 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung YES NO NO NO 81 R-Lower TCGA-34-2609-F4225 TCGA-34-2609 TCGA-34-2609-01A -29871 951 0 951 898 NO NO Progressive Disease 2010-11-4 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.4 NO NO 2 YES 60 Yes M0 N1 T2 Stage IIB TCGA-34-2609.8101c165-87f1-4edc-9756-163156377cab.pdf 2609 WITH TUMOR Complete Remission/Response NO R0 Primary Tumor 01 0.3 2004 YES NO YES 34 4 Lung A DECEASED 2004 1941 TCGA-34-2609-01A-01D-0848-05 TCGA-34-2609-01A-01D-0844-01 TCGA-34-2609-01A-01R-0851-07 TCGA-34-2609-01A-01D-0844-01 TCGA-34-2609-01A-21-2193-20 +TCGA-34-5231-01 TCGA-34-5231-01 Squamous C2-Squamous-like Cluster 13 (HNSC-LUSC) squamous c3 squamous-like c4 miRNA cluster 12 mutation cluster 12 TCGA-34-5231 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung NO NO NO 72 R-Upper TCGA-34-5231-F32187 TCGA-34-5231 TCGA-34-5231-01A -26525 1984 0 1528 YES Scheduled Follow-up Submission Stable Disease 2012-5-18 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 1 NO 1.5 NO NO 50 No M0 N0 T1 Stage IA TCGA-34-5231.f86f0624-ede3-4128-80c7-35d5f1d65fc4.pdf 5231 TUMOR FREE Stable Disease NO Primary Tumor 01 0.3 6th NO NO YES 34 3 Lung A DECEASED 2006 cdae461e-021e-4e59-ac04-d640d29d29dc TCGA-34-5231-01A-21D-1817-08 cdae461e-021e-4e59-ac04-d640d29d29dc TCGA-34-5231-01A-21D-1818-05 TCGA-34-5231-01A-21D-1816-01 cdae461e-021e-4e59-ac04-d640d29d29dc TCGA-34-5231-01A-21D-1816-01 TCGA-34-5231-01A-22-2194-20 +TCGA-34-5232-01 TCGA-34-5232-01 Squamous C2-Squamous-like Cluster 13 (HNSC-LUSC) squamous c3 squamous-like c4 miRNA cluster 11 mutation cluster 3 TCGA-34-5232 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 75 L-Upper TCGA-34-5232-F70378 TCGA-34-5232 TCGA-34-5232-01A -27633 0 2471 YES Scheduled Follow-up Submission Complete Remission/Response 2015-2-10 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 1 NO 1.5 NO NO No M0 N1 T1 Stage IIA TCGA-34-5232.5b40bf87-de4d-4010-934f-b117f286562f.pdf 5232 TUMOR FREE Complete Remission/Response NO NO Primary Tumor 01 0.4 6th NO NO YES 34 Lung A LIVING 2006 f1d662e9-e8dc-47d4-b350-c41798ad4584 TCGA-34-5232-01A-21D-1817-08 f1d662e9-e8dc-47d4-b350-c41798ad4584 TCGA-34-5232-01A-21D-1818-05 TCGA-34-5232-01A-21D-1816-01 f1d662e9-e8dc-47d4-b350-c41798ad4584 TCGA-34-5232-01A-21D-1816-01 TCGA-34-5232-01A-22-2194-20 +TCGA-34-5234-01 TCGA-34-5234-01 COAD-READ C1-LUAD-enriched Low purity c2 squamous c3 squamous-like c4 miRNA cluster 7 mutation cluster 14 TCGA-34-5234 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 71 L-Upper TCGA-34-5234-F70379 TCGA-34-5234 TCGA-34-5234-01A -26072 0 2271 NO Scheduled Follow-up Submission Complete Remission/Response 2015-2-10 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.7 NO 90 NO Central Lung 1.5 NO NO 40 No M0 N0 T1 Stage IA TCGA-34-5234.ecde2410-dc20-4f6d-9215-4bf5452d530c.pdf 5234 TUMOR FREE Complete Remission/Response NO NO R0 Primary Tumor 01 0.3 2000 6th NO NO YES 34 4 Lung A LIVING 2007 1960 523d5f7e-4980-4f87-be5d-3a81bb6f8314 TCGA-34-5234-01A-01D-1632-08 523d5f7e-4980-4f87-be5d-3a81bb6f8314 TCGA-34-5234-01A-01D-1633-05 TCGA-34-5234-01A-01D-1631-01 523d5f7e-4980-4f87-be5d-3a81bb6f8314 TCGA-34-5234-01A-01D-1631-01 TCGA-34-5234-01A-21-2194-20 +TCGA-34-5236-01 TCGA-34-5236-01 Squamous C2-Squamous-like Cluster 13 (HNSC-LUSC) squamous c3 squamous-like c4 miRNA cluster 5 mutation cluster 5 TCGA-34-5236 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung YES YES NO 60 L-Upper TCGA-34-5236-F32198 TCGA-34-5236 TCGA-34-5236-01A -21935 276 0 113 YES Scheduled Follow-up Submission Progressive Disease 2012-5-18 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.7 NO 2.1 NO Locoregional Recurrence YES No M0 N0 T3 Stage IIB TCGA-34-5236.8aadcd05-f598-4c12-87eb-6769bbf24b51.pdf 5236 WITH TUMOR Progressive Disease Convincing Imaging NO Primary Tumor 01 0.2 6th NO NO YES 34 Lung A DECEASED 2007 e6333a68-bb60-4450-af13-2a22a2335e03 TCGA-34-5236-01A-21D-1817-08 e6333a68-bb60-4450-af13-2a22a2335e03 TCGA-34-5236-01A-21D-1818-05 TCGA-34-5236-01A-21D-1816-01 e6333a68-bb60-4450-af13-2a22a2335e03 TCGA-34-5236-01A-21D-1816-01 TCGA-34-5236-01A-22-2194-20 +TCGA-34-5239-01 TCGA-34-5239-01 BRCA-LUAD+ C2-Squamous-like Cluster 14 (HNSC) squamous c3 squamous-like c4 miRNA cluster 5 mutation cluster 8 TCGA-34-5239 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung YES NO NO 75 L-Upper TCGA-34-5239-F70380 TCGA-34-5239 TCGA-34-5239-01A -27528 0 1834 1530 YES YES Scheduled Follow-up Submission Progressive Disease 2015-2-10 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 1 NO 1.1 NO Distant Metastasis YES No M0 N0 T4 Stage IIIA TCGA-34-5239.63c38b6b-14d2-4a12-bd73-957ac5207fee.pdf 5239 WITH TUMOR Complete Remission/Response NO NO Primary Tumor 01 0.3 7th NO NO YES 34 Lung A LIVING 2010 ca366b19-d82e-4e65-9fde-f3be38fbe038 TCGA-34-5239-01A-21D-1817-08 ca366b19-d82e-4e65-9fde-f3be38fbe038 TCGA-34-5239-01A-21D-1818-05 TCGA-34-5239-01A-21D-1816-01 ca366b19-d82e-4e65-9fde-f3be38fbe038 TCGA-34-5239-01A-21D-1816-01 TCGA-34-5239-01A-22-2194-20 +TCGA-34-5240-01 TCGA-34-5240-01 High C2-Squamous-like Cluster 13 (HNSC-LUSC) squamous-like c4 miRNA cluster 4 mutation cluster 3 TCGA-34-5240 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 73 L-Upper TCGA-34-5240-F70373 TCGA-34-5240 TCGA-34-5240-01A -26735 0 1541 NO NO Scheduled Follow-up Submission Complete Remission/Response 2015-2-10 FEMALE Lung Basaloid Squamous Cell Carcinoma No C34.1 8083/3 C34.1 YES 0.6 NO NO Central Lung 1.2 NO NO 56 No M0 N1 T2 Stage IIB TCGA-34-5240.060ba86b-73eb-4636-b706-d813bee1dd5c.pdf 5240 TUMOR FREE Complete Remission/Response NO NO Primary Tumor 01 0.2 6th YES NO YES 34 2 Lung A LIVING 2009 1953 d3642776-8fd7-4cdd-b94a-1d558b5ac69d TCGA-34-5240-01A-01D-1441-08 d3642776-8fd7-4cdd-b94a-1d558b5ac69d TCGA-34-5240-01A-01D-1440-05 TCGA-34-5240-01A-01D-1439-01 TCGA-34-5240-01A-01R-1443-07 d3642776-8fd7-4cdd-b94a-1d558b5ac69d TCGA-34-5240-01A-01D-1439-01 +TCGA-34-5241-01 TCGA-34-5241-01 Squamous C2-Squamous-like Cluster 5 squamous c3 squamous-like c4 miRNA cluster 4 mutation c1uster 9 TCGA-34-5241 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung NO NO NO 79 R-Lower TCGA-34-5241-F32205 TCGA-34-5241 TCGA-34-5241-01A -29098 515 0 428 NO Scheduled Follow-up Submission Complete Remission/Response 2012-5-18 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 1 NO NO NO 1.5 NO NO 25 No M0 N0 T2 Stage IB TCGA-34-5241.9d9a1bba-2489-40b3-bad8-950bc742862d.pdf 5241 TUMOR FREE Stable Disease NO Primary Tumor 01 0.3 1979 NO NO YES 34 3 Lung A DECEASED 2009 1954 e778c0a5-1f5b-4e94-9779-2f7386586ff1 TCGA-34-5241-01A-01D-1441-08 e778c0a5-1f5b-4e94-9779-2f7386586ff1 TCGA-34-5241-01A-01D-1440-05 TCGA-34-5241-01A-01D-1439-01 TCGA-34-5241-01A-01R-1443-07 e778c0a5-1f5b-4e94-9779-2f7386586ff1 TCGA-34-5241-01A-01D-1439-01 TCGA-34-5241-01A-21-2194-20 +TCGA-34-5927-01 TCGA-34-5927-01 Squamous C2-Squamous-like Cluster 5 squamous c3 squamous-like c4 miRNA cluster 12 mutation cluster 2 TCGA-34-5927 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 70 R-Lower TCGA-34-5927-F70383 TCGA-34-5927 TCGA-34-5927-01A -25857 0 1361 Scheduled Follow-up Submission 2015-2-10 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.7 NO 1 NO NO No M0 N0 T1 Stage IA TCGA-34-5927.581a7cc6-ceab-4ba3-baec-fd675fd87732.pdf 5927 TUMOR FREE NO NO Primary Tumor 01 0.4 NO NO YES 34 Lung A LIVING 2009 a67dbc0f-e3b6-4043-8512-8cfb675ddd99 TCGA-34-5927-01A-11D-1817-08 a67dbc0f-e3b6-4043-8512-8cfb675ddd99 TCGA-34-5927-01A-11D-1818-05 TCGA-34-5927-01A-11D-1816-01 a67dbc0f-e3b6-4043-8512-8cfb675ddd99 TCGA-34-5927-01A-11D-1816-01 TCGA-34-5927-01A-13-2194-20 +TCGA-34-5928-01 TCGA-34-5928-01 High C2-Squamous-like Cluster 5 squamous c3 squamous-like c4 miRNA cluster 5 mutation cluster 2 TCGA-34-5928 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 83 L-Lower TCGA-34-5928-F70385 TCGA-34-5928 TCGA-34-5928-01A -30334 0 1196 Scheduled Follow-up Submission Complete Remission/Response 2015-2-10 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.6 NO 1 NO NO 40 No M0 N1 T2 Stage IIB TCGA-34-5928.0880181a-6d0e-4b59-82b3-46a4f44f49b6.pdf 5928 TUMOR FREE Complete Remission/Response NO NO Primary Tumor 01 0.3 1993 7th NO NO YES 34 3 Lung A LIVING 2010 b9db5c2a-c5dd-4e58-905f-fefccd469f1f TCGA-34-5928-01A-11D-1817-08 b9db5c2a-c5dd-4e58-905f-fefccd469f1f TCGA-34-5928-01A-11D-1818-05 TCGA-34-5928-01A-11D-1816-01 b9db5c2a-c5dd-4e58-905f-fefccd469f1f TCGA-34-5928-01A-11D-1816-01 TCGA-34-5928-01A-13-2194-20 +TCGA-34-5929-01 TCGA-34-5929-01 Squamous C2-Squamous-like Cluster 5 squamous c3 squamous-like c4 miRNA cluster 12 mutation cluster 5 TCGA-34-5929 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung NO NO NO 78 L-Upper TCGA-34-5929-F32179 TCGA-34-5929 TCGA-34-5929-01A -28844 151 0 YES YES Scheduled Follow-up Submission Stable Disease 2012-5-18 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 1 NO 1.5 NO NO 40 No M0 N0 T2 Stage IB TCGA-34-5929.9fcfe85f-c7ed-4c1f-b21a-dae956cf8616.pdf 5929 TUMOR FREE Stable Disease NO Primary Tumor 01 0.4 1985 7th NO NO YES 34 3 Lung A DECEASED 2010 4686dc73-c481-4e93-977c-980887726234 TCGA-34-5929-01A-11D-1817-08 4686dc73-c481-4e93-977c-980887726234 TCGA-34-5929-01A-11D-1818-05 TCGA-34-5929-01A-11D-1816-01 4686dc73-c481-4e93-977c-980887726234 TCGA-34-5929-01A-11D-1816-01 TCGA-34-5929-01A-13-2194-20 +TCGA-34-5929-11 TCGA-34-5929-11 C2-Squamous-like mutation cluster 5 TCGA-34-5929 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung NO NO NO 78 L-Upper TCGA-34-5929-F32179 TCGA-34-5929 TCGA-34-5929-11A -28844 151 0 YES YES Scheduled Follow-up Submission Stable Disease 2012-5-18 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 1.2 NO 1.7 NO NO 40 No M0 N0 T2 Stage IB 5929 TUMOR FREE Stable Disease NO Solid Tissue Normal 11 0.2 1985 7th NO NO YES 34 3 Lung A DECEASED 2010 TCGA-34-5929-11A-01D-1818-05 +TCGA-34-7107-01 TCGA-34-7107-01 High C2-Squamous-like Cluster 5 squamous c3 squamous-like c4 miRNA c1uster 9 TCGA-34-7107 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 70 R-Lower TCGA-34-7107 TCGA-34-7107-01A -25677 34 0 2012-1-11 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 1 NO 1.1 No M0 N0 T2a Stage II TCGA-34-7107.e944ec22-44f1-4a7c-a06c-50e0d2d167a9.pdf 7107 Primary Tumor 01 0.2 7th NO YES 34 4 Lung A DECEASED 2011 7db69d77-75ce-4f75-9e95-7205c55e5e6d 7db69d77-75ce-4f75-9e95-7205c55e5e6d TCGA-34-7107-01A-11D-1947-05 TCGA-34-7107-01A-11D-1943-01 7db69d77-75ce-4f75-9e95-7205c55e5e6d TCGA-34-7107-01A-11D-1943-01 TCGA-34-7107-01A-13-2194-20 +TCGA-34-7107-11 TCGA-34-7107-11 C2-Squamous-like TCGA-34-7107 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 70 R-Lower TCGA-34-7107 TCGA-34-7107-11A -25677 34 0 2012-1-11 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.6 NO 0.7 No M0 N0 T2a Stage II 7107 Solid Tissue Normal 11 0.4 7th NO YES 34 4 Lung A DECEASED 2011 ee465ac7-c842-4337-8bd4-58fb49fce9bb ee465ac7-c842-4337-8bd4-58fb49fce9bb ee465ac7-c842-4337-8bd4-58fb49fce9bb +TCGA-34-8454-01 TCGA-34-8454-01 Cluster 5 miRNA cluster 4 TCGA-34-8454 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 62 R-Lower TCGA-34-8454-F70386 TCGA-34-8454 TCGA-34-8454-01A -22913 0 1180 Scheduled Follow-up Submission Complete Remission/Response 2015-2-10 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.9 NO 0.9 NO NO 90 No M0 N1 T3 Stage IIIA TCGA-34-8454.5a59ce20-3e53-4370-b09d-40d784c679e7.pdf 8454 TUMOR FREE Complete Remission/Response NO NO R0 Primary Tumor 01 0.2 7th YES YES NO 34 4 Lung A LIVING 2011 71b1bdd1-2a00-4fd9-a229-cbc5d535af03 71b1bdd1-2a00-4fd9-a229-cbc5d535af03 TCGA-34-8454-01A-11D-2324-05 TCGA-34-8454-01A-11D-2322-01 71b1bdd1-2a00-4fd9-a229-cbc5d535af03 TCGA-34-8454-01A-11D-2322-01 +TCGA-34-8454-11 TCGA-34-8454-11 TCGA-34-8454 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 62 R-Lower TCGA-34-8454-F70386 TCGA-34-8454 TCGA-34-8454-11A -22913 0 1180 Scheduled Follow-up Submission Complete Remission/Response 2015-2-10 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 1.1 NO 1.2 NO NO 90 No M0 N1 T3 Stage IIIA 8454 TUMOR FREE Complete Remission/Response NO NO R0 Solid Tissue Normal 11 0.3 7th YES YES NO 34 4 Lung A LIVING 2011 b193b90e-f4e8-4a3d-bfd5-2a805fb33735 b193b90e-f4e8-4a3d-bfd5-2a805fb33735 b193b90e-f4e8-4a3d-bfd5-2a805fb33735 +TCGA-34-8455-01 TCGA-34-8455-01 Cluster 5 miRNA cluster 4 TCGA-34-8455 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung NO NO 67 L-Upper TCGA-34-8455-F69235 TCGA-34-8455 TCGA-34-8455-01A -24624 123 0 Scheduled Follow-up Submission Progressive Disease 2014-12-30 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 1.2 NO 1.5 NO YES 50 No M1a N0 T4 Stage IV TCGA-34-8455.85247b02-2995-4cc7-9238-387bda38dcee.pdf 8455 WITH TUMOR Progressive Disease NO NO R0 Primary Tumor 01 0.3 7th NO YES NO 34 4 Lung A DECEASED 2011 24531d9f-822b-4eb8-add6-79fa27816a4b 24531d9f-822b-4eb8-add6-79fa27816a4b TCGA-34-8455-01A-11D-2324-05 TCGA-34-8455-01A-11D-2322-01 24531d9f-822b-4eb8-add6-79fa27816a4b TCGA-34-8455-01A-11D-2322-01 +TCGA-34-8456-01 TCGA-34-8456-01 Cluster 5 miRNA cluster 11 TCGA-34-8456 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 71 R-Lower TCGA-34-8456-F69237 TCGA-34-8456 TCGA-34-8456-01A -26183 0 804 Scheduled Follow-up Submission 2014-12-30 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.7 NO 1.1 NO NO 20 No M0 N1 T2a Stage IIA TCGA-34-8456.650c7ad8-13aa-487b-922d-373e4e556054.pdf 8456 TUMOR FREE Complete Remission/Response NO NO R0 Primary Tumor 01 0.2 7th NO YES NO 34 5 Lung A LIVING 2011 c3ed3530-0c9c-497e-bf90-88df981d475a c3ed3530-0c9c-497e-bf90-88df981d475a TCGA-34-8456-01A-21D-2324-05 TCGA-34-8456-01A-21D-2322-01 c3ed3530-0c9c-497e-bf90-88df981d475a TCGA-34-8456-01A-21D-2322-01 +TCGA-34-A5IX-01 TCGA-34-A5IX-01 TCGA-34-A5IX TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 80 R-Lower TCGA-34-A5IX-F69241 TCGA-34-A5IX TCGA-34-A5IX-01A -29391 288 0 1031 Scheduled Follow-up Submission 2014-12-30 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 210 NO NO NO true No M0 N0 T3 Stage IIB TCGA-34-A5IX.7DFC893F-4AA7-4885-B2D3-AF0203ED536A.pdf A5IX TUMOR FREE Complete Remission/Response NO NO Primary Tumor 01 2008 7th NO YES NO 34 4 Lung A LIVING 2012 1b4f8b52-3d0b-4ba4-b1b8-be045cd67f86 1b4f8b52-3d0b-4ba4-b1b8-be045cd67f86 TCGA-34-A5IX-01A-12D-A27L-05 TCGA-34-A5IX-01A-12D-A27J-01 1b4f8b52-3d0b-4ba4-b1b8-be045cd67f86 TCGA-34-A5IX-01A-12D-A27J-01 +TCGA-35-3615-01 2.07 0.68 none none none none Y Y none none none 0.33 Magnoid none p.G12C none none none none none Lepidic predominant Adc Lepidic predominant Adc p.L245_splice 0 TCGA-35-3615-01 Iq C1-LUAD-enriched Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 7 mutation cluster 12 TCGA-35-3615 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 57 R-Upper TCGA-35-3615-F68919 TCGA-35-3615 -21076 0 14 NO NO Scheduled Follow-up Submission 2015-8-24 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES NO Peripheral Lung YES No M0 N0 T2 Stage IB 3615 TUMOR FREE R0 Primary Tumor 01 NO YES 35 1 Lifelong Non-smoker Lung LIVING 2007 c3fb15e3-4fca-413f-86e8-24cb073ef3f1 TCGA-35-3615-01A-01D-0945-05 TCGA-35-3615-01 c3fb15e3-4fca-413f-86e8-24cb073ef3f1 TCGA-35-3615-01A-01D-0944-01 TCGA-35-3615-01A-01R-0946-07 c3fb15e3-4fca-413f-86e8-24cb073ef3f1 TCGA-35-3615-01A-01D-0944-01 TCGA-35-3615-01A-21-2190-20 +TCGA-35-3621-01 TCGA-35-3621-01 TCGA-35-3621 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung TCGA-35-3621-01A 0.4 NO 0.8 Primary Tumor 01 0.3 A TCGA-35-3621-01A-01D-1104-05 TCGA-35-3621-01A-01D-0969-08 TCGA-35-3621-01A-01R-1107-07 +TCGA-35-4122-01 TCGA-35-4122-01 High C1-LUAD-enriched Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 4 mutation cluster 5 TCGA-35-4122 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 69 L-Upper TCGA-35-4122-F68915 TCGA-35-4122 TCGA-35-4122-01A -25491 0 225 1 NO NO Scheduled Follow-up Submission 2014-12-23 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.7 NO 80 NO Peripheral Lung 1 YES 45 No M0 N0 T1 Stage IA TCGA-35-4122.a970d363-3ea8-4f28-a3a5-81c28dcb799f.pdf 4122 Preoperative TUMOR FREE YES R0 Primary Tumor 01 0.5 2010 7th NO YES 35 4 Lung A LIVING 2010 1965 9d983613-1588-48a2-a515-7afae7aafc92 TCGA-35-4122-01A-01D-1104-05 TCGA-35-4122-01A-01D-1105-08 9d983613-1588-48a2-a515-7afae7aafc92 TCGA-35-4122-01A-01D-1877-01 TCGA-35-4122-01A-01R-1107-07 9d983613-1588-48a2-a515-7afae7aafc92 TCGA-35-4122-01A-01D-1877-01 TCGA-35-4122-01A-21-2190-20 +TCGA-35-4123-01 TCGA-35-4123-01 Squamous C1-LUAD-enriched Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 4 mutation cluster 3 TCGA-35-4123 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 38 R-Upper TCGA-35-4123-F68918 TCGA-35-4123 TCGA-35-4123-01A -14064 0 182 1 NO NO Scheduled Follow-up Submission 2014-12-23 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.4 NO 90 NO Peripheral Lung 0.9 YES 20 No M0 N0 T1 Stage IA TCGA-35-4123.7f74ee3b-0ecf-468d-9280-d30686d67d3a.pdf 4123 Preoperative TUMOR FREE YES R0 Primary Tumor 01 0.3 2010 7th NO YES 35 4 Lung A LIVING 2010 1990 2ef846b1-a0f9-412e-a72e-6dab6543d41f TCGA-35-4123-01A-01D-1104-05 TCGA-35-4123-01A-01D-1105-08 2ef846b1-a0f9-412e-a72e-6dab6543d41f TCGA-35-4123-01A-01D-1877-01 TCGA-35-4123-01A-01R-1107-07 2ef846b1-a0f9-412e-a72e-6dab6543d41f TCGA-35-4123-01A-01D-1877-01 TCGA-35-4123-01A-21-2190-20 +TCGA-35-5375-01 TCGA-35-5375-01 High C2-Squamous-like BRCA CIMP c7 squamous c3 squamous-like c4 miRNA cluster 12 mutation cluster 11 TCGA-35-5375 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 61 L-Upper TCGA-35-5375-F68920 TCGA-35-5375 TCGA-35-5375-01A -22628 0 264 1 Scheduled Follow-up Submission 2015-8-24 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 1 NO 90 Peripheral Lung 1.3 YES 35 No M0 N2 T2 Stage IIIA TCGA-35-5375.a93477c8-5ebe-436b-978a-61b573f65471.pdf 5375 Post-Adjuvant Therapy TUMOR FREE R0 Primary Tumor 01 0.3 2006 NO YES 35 4 Lung A LIVING 2010 1971 ab215c47-4678-4ca9-8cd3-ac6e3e804c05 TCGA-35-5375-01A-01D-1625-08 ab215c47-4678-4ca9-8cd3-ac6e3e804c05 TCGA-35-5375-01A-01D-1626-05 TCGA-35-5375-01A-01D-1624-01 ab215c47-4678-4ca9-8cd3-ac6e3e804c05 TCGA-35-5375-01A-01D-1624-01 TCGA-35-5375-01A-21-2190-20 +TCGA-37-3783-01 TCGA-37-3783-01 High C2-Squamous-like Cluster 14 (HNSC) squamous-like c4 mutation cluster 3 TCGA-37-3783 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 51 L-Upper TCGA-37-3783-F68931 TCGA-37-3783 TCGA-37-3783-01A -18728 0 122 NO NO Scheduled Follow-up Submission 2014-12-23 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.5 NO NO Central Lung 0.5 YES No M0 N2 T3 Stage IIIA TCGA-37-3783.b3f279c3-f3a4-45a3-a711-b61873a3ca0a.pdf 3783 TUMOR FREE YES R0 Primary Tumor 01 0.4 7th NO YES 37 Lung A LIVING 2006 4becf4e5-085b-442e-9b06-e2472c0dc239 TCGA-37-3783-01A-01D-1198-05 TCGA-37-3783-01A-01D-1267-08 4becf4e5-085b-442e-9b06-e2472c0dc239 TCGA-37-3783-01A-01D-1195-01 TCGA-37-3783-01A-01R-1201-07 4becf4e5-085b-442e-9b06-e2472c0dc239 TCGA-37-3783-01A-01D-1195-01 +TCGA-37-3789-01 TCGA-37-3789-01 Squamous C2-Squamous-like Cluster 13 (HNSC-LUSC) squamous c3 squamous-like c4 miRNA cluster 11 mutation cluster 13 TCGA-37-3789 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 65 L-Upper TCGA-37-3789-F68932 TCGA-37-3789 TCGA-37-3789-01A -23782 0 13 NO NO Scheduled Follow-up Submission 2014-12-23 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.5 NO NO Central Lung 1 YES No N0 T2 Stage IB TCGA-37-3789.9051358f-5b74-4f6c-b7f2-fc83e8f43306.pdf 3789 TUMOR FREE YES R0 Primary Tumor 01 0.3 7th NO YES 37 1 Lung A LIVING 2006 d23adf22-4453-4144-9a70-2c60bad34d97 TCGA-37-3789-01A-01D-0979-05 TCGA-37-3789-01A-01D-0983-08 d23adf22-4453-4144-9a70-2c60bad34d97 TCGA-37-3789-01A-01D-0978-01 TCGA-37-3789-01A-01R-0980-07 d23adf22-4453-4144-9a70-2c60bad34d97 TCGA-37-3789-01A-01D-0978-01 TCGA-37-3789-01A-21-2193-20 +TCGA-37-3792-01 TCGA-37-3792-01 High C1-LUAD-enriched Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 4 TCGA-37-3792 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 69 R-Upper TCGA-37-3792-F68933 TCGA-37-3792 TCGA-37-3792-01A -25502 0 12 NO NO Scheduled Follow-up Submission 2014-12-23 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.5 NO NO Central Lung 1.2 YES No M0 N0 T2 Stage IB TCGA-37-3792.d3661994-55f7-48d5-b27e-2bd64d13f4f6.pdf 3792 TUMOR FREE YES R0 Primary Tumor 01 0.3 7th NO YES 37 1 Lung A LIVING 2006 f2956875-df61-4a7a-97dd-dd5d5a8f1d7a TCGA-37-3792-01A-01D-0979-05 f2956875-df61-4a7a-97dd-dd5d5a8f1d7a TCGA-37-3792-01A-01D-1969-01 TCGA-37-3792-01A-01R-0980-07 f2956875-df61-4a7a-97dd-dd5d5a8f1d7a TCGA-37-3792-01A-01D-1969-01 TCGA-37-3792-01A-21-2193-20 +TCGA-37-4129-01 TCGA-37-4129-01 Squamous C10-GBM Low purity c2 squamous c3 GBM-like c6 TCGA-37-4129 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung NO NO 52 R-Middle TCGA-37-4129-F68926 TCGA-37-4129 TCGA-37-4129-01A -19154 0 242 1 NO NO Scheduled Follow-up Submission Complete Remission/Response 2014-12-23 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.2 8070/3 C34.2 YES 0.9 NO 90 NO Central Lung 0.9 NO NO 30 No M0 N0 T1b Stage IA TCGA-37-4129.609db8ab-d13d-46ec-a247-a638da93e35b.pdf 4129 Preoperative TUMOR FREE Complete Remission/Response YES NO R0 Primary Tumor 01 0.3 2010 7th NO NO YES 37 4 Lung A LIVING 2010 1980 26283541-2370-40ca-8687-e46b6cee1bc5 TCGA-37-4129-01A-01D-1096-05 26283541-2370-40ca-8687-e46b6cee1bc5 TCGA-37-4129-01A-01D-1969-01 TCGA-37-4129-01A-01R-1100-07 26283541-2370-40ca-8687-e46b6cee1bc5 TCGA-37-4129-01A-01D-1969-01 TCGA-37-4129-01A-21-2193-20 +TCGA-37-4130-01 TCGA-37-4130-01 High Cluster 5 LAML-like c13 miRNA cluster 7 TCGA-37-4130 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 56 R-Upper TCGA-37-4130-F68927 TCGA-37-4130 TCGA-37-4130-01A -20652 0 247 1 NO NO Scheduled Follow-up Submission 2014-12-23 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.5 NO 90 NO Central Lung 1 YES 25 No M0 N0 T1b Stage IA TCGA-37-4130.ed6702d0-e9b6-4258-adde-a07b7ba681e6.pdf 4130 Preoperative TUMOR FREE YES R0 Primary Tumor 01 0.3 2010 7th NO YES 37 4 Lung A LIVING 2010 1985 3f0ad86f-9713-4d26-a2b4-87a2204855fe TCGA-37-4130-01A-01D-1096-05 3f0ad86f-9713-4d26-a2b4-87a2204855fe TCGA-37-4130-01A-01D-1969-01 TCGA-37-4130-01A-01R-1100-07 3f0ad86f-9713-4d26-a2b4-87a2204855fe TCGA-37-4130-01A-01D-1969-01 +TCGA-37-4132-01 TCGA-37-4132-01 Squamous Low purity c2 RNA cluster 3 TCGA-37-4132 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 61 L-Lower TCGA-37-4132-F68928 TCGA-37-4132 TCGA-37-4132-01A -22520 0 227 2 NO NO Scheduled Follow-up Submission 2014-12-23 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.6 NO 50 NO Peripheral Lung 0.8 NO No M1 N0 T2 Stage IV TCGA-37-4132.1428fb74-8aab-487b-ace9-79bbe01de096.pdf 4132 Post-Adjuvant Therapy TUMOR FREE Complete Remission/Response YES NO R0 Primary Tumor 01 0.2 7th NO NO YES 37 1 Lung A LIVING 2010 967fb40b-bea9-40fd-bab1-7c524e12ac0d TCGA-37-4132-01A-01D-1096-05 967fb40b-bea9-40fd-bab1-7c524e12ac0d TCGA-37-4132-01A-01D-1969-01 TCGA-37-4132-01A-01R-1100-07 967fb40b-bea9-40fd-bab1-7c524e12ac0d TCGA-37-4132-01A-01D-1969-01 +TCGA-37-4133-01 TCGA-37-4133-01 High C2-Squamous-like Cluster 13 (HNSC-LUSC) squamous c3 squamous-like c4 miRNA cluster 4 mutation cluster 5 TCGA-37-4133 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 63 R-Lower TCGA-37-4133-F68929 TCGA-37-4133 TCGA-37-4133-01A -23083 0 238 2 NO NO Scheduled Follow-up Submission 2014-12-23 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.9 8070/3 C34.9 YES 0.7 NO 50 NO Peripheral Lung 1.8 YES 40 No M0 N0 T4 Stage IIIA TCGA-37-4133.7f0f7712-3db1-4f55-aa5d-724e58d5fb90.pdf 4133 Post-Adjuvant Therapy TUMOR FREE YES R0 Primary Tumor 01 0.4 2010 7th NO YES 37 4 Lung A LIVING 2010 1970 9ca70bc7-d228-46cb-afb5-ccb7c5e04770 TCGA-37-4133-01A-01D-1096-05 TCGA-37-4133-01A-01D-1352-08 9ca70bc7-d228-46cb-afb5-ccb7c5e04770 TCGA-37-4133-01A-01D-1097-01 TCGA-37-4133-01A-01R-1100-07 9ca70bc7-d228-46cb-afb5-ccb7c5e04770 TCGA-37-4133-01A-01D-1097-01 TCGA-37-4133-01A-21-2193-20 +TCGA-37-4135-01 TCGA-37-4135-01 High C1-LUAD-enriched Cluster 5 squamous c3 RNA cluster 12 miRNA cluster 12 mutation cluster 2 TCGA-37-4135 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 68 R-Lower TCGA-37-4135-F68930 TCGA-37-4135 TCGA-37-4135-01A -25041 0 207 1 NO NO Scheduled Follow-up Submission 2014-12-23 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 1 NO 80 NO Peripheral Lung 1 YES 45 No M0 N0 T2a Stage IB TCGA-37-4135.27fd3de4-a7da-4dc1-a135-637bcb4b7316.pdf 4135 Other TUMOR FREE YES R0 Primary Tumor 01 0.4 2010 7th NO YES 37 4 Lung A LIVING 2010 1965 2adbe625-d7cc-45a9-b00b-e5e439e52deb TCGA-37-4135-01A-01D-1096-05 TCGA-37-4135-01A-01D-1352-08 2adbe625-d7cc-45a9-b00b-e5e439e52deb TCGA-37-4135-01A-01D-1969-01 TCGA-37-4135-01A-01R-1100-07 2adbe625-d7cc-45a9-b00b-e5e439e52deb TCGA-37-4135-01A-01D-1969-01 TCGA-37-4135-01A-21-2193-20 +TCGA-37-4141-01 TCGA-37-4141-01 High C1-LUAD-enriched Cluster 5 squamous c3 RNA cluster 3 miRNA cluster 7 mutation cluster 2 TCGA-37-4141 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 65 R-Upper TCGA-37-4141-F68934 TCGA-37-4141 TCGA-37-4141-01A -24048 0 12 NO NO Scheduled Follow-up Submission 2014-12-23 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.6 NO NO Peripheral Lung 1.3 YES No M0 N0 T1b Stage IA TCGA-37-4141.6cf75b07-d6a7-4b78-af73-e37c3a0581f8.pdf 4141 TUMOR FREE YES R0 Primary Tumor 01 0.3 7th NO YES 37 1 Lung A LIVING 2010 2c6ccb67-23b3-4e1c-9136-30f373c7e40c TCGA-37-4141-01A-02D-1096-05 TCGA-37-4141-01A-02D-1352-08 2c6ccb67-23b3-4e1c-9136-30f373c7e40c TCGA-37-4141-01A-02D-1969-01 TCGA-37-4141-01A-02R-1100-07 2c6ccb67-23b3-4e1c-9136-30f373c7e40c TCGA-37-4141-01A-02D-1969-01 TCGA-37-4141-01A-11-2193-20 +TCGA-37-5819-01 TCGA-37-5819-01 Squamous C1-LUAD-enriched Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 6 mutation cluster 2 TCGA-37-5819 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 64 R-Upper TCGA-37-5819-F68935 TCGA-37-5819 TCGA-37-5819-01A -23726 0 103 1 Scheduled Follow-up Submission 2014-12-23 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.9 NO 90 Peripheral Lung 1.2 YES 45 No M0 N2 T2 Stage IIIA TCGA-37-5819.8c9b5277-0cbf-4ba1-bda0-2c84bdadc9bd.pdf 5819 Post-Adjuvant Therapy TUMOR FREE YES R0 Primary Tumor 01 0.6 2010 7th NO YES 37 4 Lung A LIVING 2010 1965 21b53e5f-a306-46b8-a3a1-daf24a69264b TCGA-37-5819-01A-01D-1632-08 21b53e5f-a306-46b8-a3a1-daf24a69264b TCGA-37-5819-01A-01D-1633-05 TCGA-37-5819-01A-01D-1631-01 21b53e5f-a306-46b8-a3a1-daf24a69264b TCGA-37-5819-01A-01D-1631-01 TCGA-37-5819-01A-21-2194-20 +TCGA-37-A5EL-01 TCGA-37-A5EL-01 TCGA-37-A5EL TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung NO NO NO NO 53 L-Upper TCGA-37-A5EL-F68921 TCGA-37-A5EL TCGA-37-A5EL-01A -19371 524 1143 0 454 946 Scheduled Follow-up Submission 2014-12-23 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 140 NO Central Lung NO Distant Metastasis YES true No M0 N0 T3 Stage IIB TCGA-37-A5EL.EAE31B82-48BE-4659-B32B-BC59A30D97DC.pdf A5EL WITH TUMOR Partial Remission/Response NO YES Primary Tumor 01 7th YES YES NO 37 Lung A DECEASED 2011 cf34ea0c-75f2-485b-aab0-e06694d69171 cf34ea0c-75f2-485b-aab0-e06694d69171 TCGA-37-A5EL-01A-11D-A26N-05 TCGA-37-A5EL-01A-11D-A26L-01 cf34ea0c-75f2-485b-aab0-e06694d69171 TCGA-37-A5EL-01A-11D-A26L-01 +TCGA-37-A5EM-01 TCGA-37-A5EM-01 TCGA-37-A5EM TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 49 L-Upper TCGA-37-A5EM-F68923 TCGA-37-A5EM TCGA-37-A5EM-01A -18011 492 0 867 Scheduled Follow-up Submission Complete Remission/Response 2014-12-23 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 220 NO Central Lung NO NO true No M0 N0 T2 Stage II TCGA-37-A5EM.5D9E8908-FE51-46B4-917C-4A0F6FAA3E38.pdf A5EM TUMOR FREE Complete Remission/Response NO NO Primary Tumor 01 7th NO YES NO 37 Lung A LIVING 2011 cad49182-6517-442a-af4a-962e110826f9 cad49182-6517-442a-af4a-962e110826f9 TCGA-37-A5EM-01A-21D-A27L-05 cad49182-6517-442a-af4a-962e110826f9 +TCGA-37-A5EN-01 TCGA-37-A5EN-01 TCGA-37-A5EN TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 59 R-Middle TCGA-37-A5EN-F68924 TCGA-37-A5EN TCGA-37-A5EN-01A -21600 376 0 660 Scheduled Follow-up Submission Complete Remission/Response 2014-12-23 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.2 8070/3 C34.2 YES 160 NO Central Lung NO NO true No M0 N2 T4 Stage IIIB TCGA-37-A5EN.CABD8B0D-315A-4134-BC68-E7ADD3A7CB39.pdf A5EN TUMOR FREE Complete Remission/Response NO NO Primary Tumor 01 7th NO YES NO 37 Lung A LIVING 2011 72c7d42b-8821-4702-8e55-081f3de759dc 72c7d42b-8821-4702-8e55-081f3de759dc TCGA-37-A5EN-01A-21D-A26N-05 TCGA-37-A5EN-01A-21D-A26L-01 72c7d42b-8821-4702-8e55-081f3de759dc TCGA-37-A5EN-01A-21D-A26L-01 +TCGA-38-4625-01 TCGA-38-4625-01 Squamous C1-LUAD-enriched Cluster 6 squamous c3 LUAD-like c10 miRNA c1uster 9 mutation cluster 13 TCGA-38-4625 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 66 R-Upper TCGA-38-4625-F33407 TCGA-38-4625 TCGA-38-4625-01A -24241 0 2973 68 NO NO Scheduled Follow-up Submission Complete Remission/Response 2012-7-26 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.6 NO NO Peripheral Lung 0.7 YES 50 No M0 N0 T2a Stage IB TCGA-38-4625.ede2780e-09fd-43ad-a29b-6ca1667d2965.pdf 4625 66 66 68 64 YES R0 Primary Tumor 01 0.5 5th NO YES 38 2 Lung A LIVING 2002 1952 bc6c762f-727f-43c8-a4bc-4c41351c7f13 TCGA-38-4625-01A-01D-1205-05 TCGA-38-4625-01A-01D-1553-08 bc6c762f-727f-43c8-a4bc-4c41351c7f13 TCGA-38-4625-01A-01D-1204-01 bc6c762f-727f-43c8-a4bc-4c41351c7f13 TCGA-38-4625-01A-01D-1204-01 TCGA-38-4625-01A-21-2190-20 +TCGA-38-4625-11 TCGA-38-4625-11 C1-LUAD-enriched mutation cluster 13 TCGA-38-4625 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 66 R-Upper TCGA-38-4625-F33407 TCGA-38-4625 TCGA-38-4625-11A -24241 0 2973 68 NO NO Scheduled Follow-up Submission Complete Remission/Response 2012-7-26 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.6 NO NO Peripheral Lung 0.9 YES 50 No M0 N0 T2a Stage IB 4625 66 66 68 64 YES R0 Solid Tissue Normal 11 0.2 5th NO YES 38 2 Lung A LIVING 2002 1952 cc556dfb-6bd4-4d53-a33b-6dae9407d7c4 cc556dfb-6bd4-4d53-a33b-6dae9407d7c4 cc556dfb-6bd4-4d53-a33b-6dae9407d7c4 +TCGA-38-4626-01 none none none none Y Y none none none Bronchioid none p.G12V none none none none none Solid predominant Adc Solid predominant Adc none 0 TCGA-38-4626-01 BRCA-LUAD+ C1-LUAD-enriched Cluster 5 squamous c3 LUAD-like c10 miRNA c1uster 9 mutation cluster 12 TCGA-38-4626 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung NO NO NO 57 L-Upper TCGA-38-4626-F33409 TCGA-38-4626 TCGA-38-4626-01A -20903 0 3674 2518 57 Scheduled Follow-up Submission Complete Remission/Response 2012-7-26 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.9 NO Central Lung 1 NO New Primary Tumor YES 40 No M0 N0 T2b [Discrepancy] TCGA-38-4626.9ac3c8f7-8399-46b1-9f2c-4e994faf88a3.pdf 4626 TUMOR FREE 68 85 71 85 Complete Remission/Response YES NO R0 Primary Tumor 01 0.5 6th NO NO YES 38 2 Current smoker Lung A LIVING 2003 1962 abc25621-f98e-4bce-968b-df64793b2daf TCGA-38-4626-01A-01D-1205-05 TCGA-38-4626-01A-01D-1553-08 abc25621-f98e-4bce-968b-df64793b2daf TCGA-38-4626-01A-01D-1204-01 abc25621-f98e-4bce-968b-df64793b2daf TCGA-38-4626-01A-01D-1204-01 TCGA-38-4626-01A-21-2190-20 +TCGA-38-4626-11 none none none none Y Y none none none Bronchioid none p.G12V none none none none none Solid predominant Adc Solid predominant Adc none 0 TCGA-38-4626-11 C1-LUAD-enriched mutation cluster 12 TCGA-38-4626 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung NO NO NO 57 L-Upper TCGA-38-4626-F33409 TCGA-38-4626 TCGA-38-4626-11A -20903 0 3674 2518 57 Scheduled Follow-up Submission Complete Remission/Response 2012-7-26 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.6 NO Central Lung 0.6 NO New Primary Tumor YES 40 No M0 N0 T2b [Discrepancy] 4626 TUMOR FREE 68 85 71 85 Complete Remission/Response YES NO R0 Solid Tissue Normal 11 0.3 6th NO NO YES 38 2 Current smoker Lung A LIVING 2003 1962 aad6bc48-5020-41e4-a2d0-f994c08170a9 aad6bc48-5020-41e4-a2d0-f994c08170a9 aad6bc48-5020-41e4-a2d0-f994c08170a9 +TCGA-38-4627-01 none none none none Y Y p.L62R, p.L858R none none Squamoid none none none none none none none Acinar predominant Adc Acinar predominant Adc none 0 TCGA-38-4627-01 Quiet C1-LUAD-enriched Cluster 5 squamous c3 LUAD-like c10 miRNA c1uster 9 mutation cluster 14 TCGA-38-4627 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 64 R-Upper TCGA-38-4627-F4508 TCGA-38-4627 TCGA-38-4627-01A -23510 1147 0 2010-12-8 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.7 NO Central Lung 1.4 No M0 N1 T1b Stage IIA TCGA-38-4627.255a7ca7-4aa4-4014-884c-33c331af765d.pdf 4627 Complete Remission/Response NO R0 Primary Tumor 01 0.3 NO NO YES 38 4 Current reformed smoker for < or = 15 years Lung A DECEASED 2003 ca296fb4-2d1e-4ce9-acc8-81bd4cd11e58 TCGA-38-4627-01A-01D-1205-05 TCGA-38-4627-01A-01D-1553-08 ca296fb4-2d1e-4ce9-acc8-81bd4cd11e58 TCGA-38-4627-01A-01D-1549-01 ca296fb4-2d1e-4ce9-acc8-81bd4cd11e58 TCGA-38-4627-01A-01D-1549-01 TCGA-38-4627-01A-21-2190-20 +TCGA-38-4627-11 none none none none Y Y p.L62R, p.L858R none none Squamoid none none none none none none none Acinar predominant Adc Acinar predominant Adc none 0 TCGA-38-4627-11 C1-LUAD-enriched mutation cluster 14 TCGA-38-4627 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 64 R-Upper TCGA-38-4627-F4508 TCGA-38-4627 TCGA-38-4627-11A -23510 1147 0 2010-12-8 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.8 NO Central Lung 1 No M0 N1 T1b Stage IIA 4627 Complete Remission/Response NO R0 Solid Tissue Normal 11 0.1 NO NO YES 38 4 Current reformed smoker for < or = 15 years Lung A DECEASED 2003 90a1abbc-6287-48f9-a669-10033380c9db 90a1abbc-6287-48f9-a669-10033380c9db 90a1abbc-6287-48f9-a669-10033380c9db +TCGA-38-4628-01 5.05 0.5 none none none none Y Y p.ELREA746del none none 0.14 Squamoid none none none none none none none Acinar predominant Adc Acinar predominant Adc none 1 TCGA-38-4628-01 High C1-LUAD-enriched Cluster 6 LUAD-like c10 miRNA cluster 4 mutation cluster 14 TCGA-38-4628 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung YES NO NO YES 65 R-Upper TCGA-38-4628-F4676 TCGA-38-4628 TCGA-38-4628-01A 1118 -24057 1492 0 1083 72 NO NO Stable Disease 2010-12-9 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.5 NO NO Central Lung 0.8 YES No M0 N1 T2 Stage IIB TCGA-38-4628.0a4269d2-d168-4750-ab8c-3c27907c45ef.pdf 4628 WITH TUMOR 78 85 74 86 Complete Remission/Response YES NO R0 Primary Tumor 01 0.2 5th NO NO YES 38 1 Lifelong Non-smoker Lung A DECEASED 2002 20c29e50-f961-465c-aa22-12e9ab187e71 TCGA-38-4628-01A-01D-1205-05 TCGA-38-4628-01A-01D-1265-08 20c29e50-f961-465c-aa22-12e9ab187e71 TCGA-38-4628-01A-01D-1204-01 20c29e50-f961-465c-aa22-12e9ab187e71 TCGA-38-4628-01A-01D-1204-01 +TCGA-38-4628-11 5.05 0.5 none none none none Y Y p.ELREA746del none none 0.14 Squamoid none none none none none none none Acinar predominant Adc Acinar predominant Adc none 1 TCGA-38-4628-11 C1-LUAD-enriched mutation cluster 14 TCGA-38-4628 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung YES NO NO YES 65 R-Upper TCGA-38-4628-F4676 TCGA-38-4628 TCGA-38-4628-11A 1118 -24057 1492 0 1083 72 NO NO Stable Disease 2010-12-9 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.9 NO NO Central Lung 1 YES No M0 N1 T2 Stage IIB 4628 WITH TUMOR 78 85 74 86 Complete Remission/Response YES NO R0 Solid Tissue Normal 11 0.4 5th NO NO YES 38 1 Lifelong Non-smoker Lung A DECEASED 2002 TCGA-38-4628-11A-01D-1205-05 +TCGA-38-4629-01 TCGA-38-4629-01 High C1-LUAD-enriched Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 4 mutation cluster 11 TCGA-38-4629 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung NO NO NO NO 68 R-Upper TCGA-38-4629-F4887 TCGA-38-4629 TCGA-38-4629-01A -25104 864 0 379 NO NO 2010-12-14 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 1 NO NO Peripheral Lung 1.3 YES 100 Yes M0 N0 T3 Stage IIB TCGA-38-4629.9546e974-686d-4d97-b5bd-771972cb4b82.pdf 4629 WITH TUMOR Complete Remission/Response NO R0 Primary Tumor 01 0.2 2003 NO NO YES 38 4 Lung A DECEASED 2003 6ed236e4-faf1-4d23-bccd-341688b034c3 TCGA-38-4629-01A-02D-1205-05 TCGA-38-4629-01A-02D-1265-08 6ed236e4-faf1-4d23-bccd-341688b034c3 TCGA-38-4629-01A-02D-1204-01 6ed236e4-faf1-4d23-bccd-341688b034c3 TCGA-38-4629-01A-02D-1204-01 TCGA-38-4629-01A-11-2190-20 +TCGA-38-4629-11 TCGA-38-4629-11 C1-LUAD-enriched mutation cluster 11 TCGA-38-4629 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung NO NO NO NO 68 R-Upper TCGA-38-4629-F4887 TCGA-38-4629 TCGA-38-4629-11A -25104 864 0 379 NO NO 2010-12-14 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.6 NO NO Peripheral Lung 1 YES 100 Yes M0 N0 T3 Stage IIB 4629 WITH TUMOR Complete Remission/Response NO R0 Solid Tissue Normal 11 0.1 2003 NO NO YES 38 4 Lung A DECEASED 2003 TCGA-38-4629-11A-01D-1205-05 +TCGA-38-4630-01 TCGA-38-4630-01 High C6-UCEC UCEC Serous c4 UCEC-like c11 miRNA c1uster 10 mutation cluster 5 TCGA-38-4630 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung NO YES NO NO 75 R-Upper TCGA-38-4630-F4972 TCGA-38-4630 TCGA-38-4630-01A -27667 1073 0 836 NO NO Stable Disease 2010-12-16 FEMALE Lung Papillary Adenocarcinoma No C34.1 8260/3 C34.1 YES 0.8 NO NO Peripheral Lung 1.6 YES Yes M0 N0 T2 Stage IB TCGA-38-4630.63d133eb-0aa7-4c76-bf48-b9206df8975f.pdf 4630 WITH TUMOR Complete Remission/Response NO NO R1 Primary Tumor 01 0.3 6th NO NO YES 38 1 Lung A DECEASED 2000 09a88dca-7503-4fcb-b42a-ac5af9fdbca7 TCGA-38-4630-01A-01D-1205-05 TCGA-38-4630-01A-01D-1265-08 09a88dca-7503-4fcb-b42a-ac5af9fdbca7 TCGA-38-4630-01A-01D-1204-01 09a88dca-7503-4fcb-b42a-ac5af9fdbca7 TCGA-38-4630-01A-01D-1204-01 +TCGA-38-4630-11 TCGA-38-4630-11 C6-UCEC mutation cluster 5 TCGA-38-4630 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung NO YES NO NO 75 R-Upper TCGA-38-4630-F4972 TCGA-38-4630 TCGA-38-4630-11A -27667 1073 0 836 NO NO Stable Disease 2010-12-16 FEMALE Lung Papillary Adenocarcinoma No C34.1 8260/3 C34.1 YES 0.7 NO NO Peripheral Lung 1.2 YES Yes M0 N0 T2 Stage IB 4630 WITH TUMOR Complete Remission/Response NO NO R1 Solid Tissue Normal 11 0.2 6th NO NO YES 38 1 Lung A DECEASED 2000 TCGA-38-4630-11A-01D-1205-05 +TCGA-38-4631-01 none none none none N N none none p.P610T Magnoid none none none none none none none NSCLC, favor Adeno NSCLC, favor Adeno none 0 TCGA-38-4631-01 BRCA-LUAD+ C1-LUAD-enriched Cluster 5 LUAD-like c10 miRNA cluster 5 mutation cluster 5 TCGA-38-4631 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung NO YES NO NO 72 L-Upper TCGA-38-4631-F4892 TCGA-38-4631 TCGA-38-4631-01A -26538 354 0 NO NO 2010-12-14 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.4 NO NO Peripheral Lung 0.7 YES 40 Yes M0 N0 T2 Stage IB TCGA-38-4631.fe8cedaf-e5d1-4836-b6d7-6f21e5e8cd53.pdf 4631 WITH TUMOR Progressive Disease NO R0 Primary Tumor 01 0.4 NO NO YES 38 4 Current reformed smoker for < or = 15 years Lung A DECEASED 1997 c436fa86-ae7e-490e-a52c-5004a8643b50 TCGA-38-4631-01A-01D-1753-08 c436fa86-ae7e-490e-a52c-5004a8643b50 TCGA-38-4631-01A-01D-1756-05 TCGA-38-4631-01A-01D-1752-01 c436fa86-ae7e-490e-a52c-5004a8643b50 TCGA-38-4631-01A-01D-1752-01 +TCGA-38-4631-11 none none none none N N none none p.P610T Magnoid none none none none none none none NSCLC, favor Adeno NSCLC, favor Adeno none 0 TCGA-38-4631-11 C1-LUAD-enriched mutation cluster 5 TCGA-38-4631 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung NO YES NO NO 72 L-Upper TCGA-38-4631-F4892 TCGA-38-4631 TCGA-38-4631-11A -26538 354 0 NO NO 2010-12-14 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.6 NO NO Peripheral Lung 1.1 YES 40 Yes M0 N0 T2 Stage IB 4631 WITH TUMOR Progressive Disease NO R0 Solid Tissue Normal 11 0.3 NO NO YES 38 4 Current reformed smoker for < or = 15 years Lung A DECEASED 1997 TCGA-38-4631-11A-01D-1756-05 +TCGA-38-4632-01 none none none none N Y none none none Squamoid none none none none p.Q61L none none Solid predominant Adc Solid predominant Adc none 0 TCGA-38-4632-01 High C1-LUAD-enriched Cluster 6 LUAD-like c10 miRNA cluster 4 mutation cluster 11 TCGA-38-4632 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung YES YES NO NO 42 L-Upper TCGA-38-4632-F4842 TCGA-38-4632 TCGA-38-4632-01A -15418 1357 0 925 NO NO Progressive Disease 2010-12-13 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.7 NO NO Peripheral Lung 0.8 YES 10 No M1 N1 T2 Stage IV TCGA-38-4632.8a178633-5c59-47fe-b1ce-c15e03c66198.pdf 4632 WITH TUMOR Complete Remission/Response NO NO R0 Primary Tumor 01 0.3 1991 5th NO NO YES 38 4 Current reformed smoker for < or = 15 years Lung A DECEASED 1998 b3cb327b-b0d4-478f-8dac-75abdb6365eb TCGA-38-4632-01A-01D-1753-08 b3cb327b-b0d4-478f-8dac-75abdb6365eb TCGA-38-4632-01A-01D-1756-05 TCGA-38-4632-01A-01D-1752-01 b3cb327b-b0d4-478f-8dac-75abdb6365eb TCGA-38-4632-01A-01D-1752-01 +TCGA-38-4632-11 none none none none N Y none none none Squamoid none none none none p.Q61L none none Solid predominant Adc Solid predominant Adc none 0 TCGA-38-4632-11 C1-LUAD-enriched mutation cluster 11 TCGA-38-4632 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung YES YES NO NO 42 L-Upper TCGA-38-4632-F4842 TCGA-38-4632 TCGA-38-4632-11A -15418 1357 0 925 NO NO Progressive Disease 2010-12-13 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 1 NO NO Peripheral Lung 1.6 YES 10 No M1 N1 T2 Stage IV 4632 WITH TUMOR Complete Remission/Response NO NO R0 Solid Tissue Normal 11 0.4 1991 5th NO NO YES 38 4 Current reformed smoker for < or = 15 years Lung A DECEASED 1998 190cca34-43f6-4d87-93fc-e36220f1782f 190cca34-43f6-4d87-93fc-e36220f1782f TCGA-38-4632-11A-01D-1756-05 190cca34-43f6-4d87-93fc-e36220f1782f +TCGA-38-6178-01 3.91 0.33 none none none none Y Y p.ELREA746del none none 0.13 Bronchioid none none none none none none none Acinar predominant Adc Acinar predominant Adc none 0 TCGA-38-6178-01 BRCA-LUAD+ C1-LUAD-enriched Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 5 mutation cluster 8 TCGA-38-6178 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 70 L-Upper TCGA-38-6178-F22078 TCGA-38-6178 TCGA-38-6178-01A -25593 0 448 YES Exon 19 Deletion NO Scheduled Follow-up Submission 2012-2-23 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.6 NO YES NO Central Lung 1.5 NO Yes N2 T2b Stage IIIA TCGA-38-6178.c2b33805-c417-4d5b-97ff-ec0d93afee8c.pdf 6178 WITH TUMOR Stable Disease NO R1 Primary Tumor 01 0.3 YES YES NO 38 1 Lifelong Non-smoker Lung A LIVING 2010 b73f5912-d163-4812-995c-0a273f543af1 TCGA-38-6178-01A-11D-1753-08 b73f5912-d163-4812-995c-0a273f543af1 TCGA-38-6178-01A-11D-1756-05 TCGA-38-6178-01A-11D-1752-01 b73f5912-d163-4812-995c-0a273f543af1 TCGA-38-6178-01A-11D-1752-01 TCGA-38-6178-01A-13-2191-20 +TCGA-38-7271-01 TCGA-38-7271-01 Iq Cluster 5 LUAD-like c10 miRNA cluster 5 TCGA-38-7271 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung NO YES NO NO 72 R-Upper TCGA-38-7271-F18312 TCGA-38-7271 TCGA-38-7271-01A -26440 800 0 633 76 NO NO Additional New Tumor Event Progressive Disease 2011-11-10 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.8 NO NO 1.1 YES 25 Yes M0 N0 T1 Stage IA TCGA-38-7271.7eb95f4d-3fb0-4312-89d1-4d5ec9f4f677.pdf 7271 WITH TUMOR 46 45 43 40 YES R0 Primary Tumor 01 0.5 1999 6th NO YES 38 4 Lung A DECEASED 2006 1971 8d895d3d-9598-459b-813e-3fc84dd3efe8 8d895d3d-9598-459b-813e-3fc84dd3efe8 TCGA-38-7271-01A-11D-2037-05 TCGA-38-7271-01A-11D-2035-01 8d895d3d-9598-459b-813e-3fc84dd3efe8 TCGA-38-7271-01A-11D-2035-01 +TCGA-38-A44F-01 TCGA-38-A44F-01 TCGA-38-A44F TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 80 R-Upper TCGA-38-A44F-F47557 TCGA-38-A44F TCGA-38-A44F-01A -29534 127 0 133 35 NO FISH YES Scheduled Follow-up Submission 2013-8-26 MALE Lung Adenocarcinoma Mixed Subtype No C34.1 8550/3 C34.1 YES 580 NO NO Peripheral Lung YES NO 12 false No M0 N0 T2a Stage IB TCGA-38-A44F.FC3ACA4F-AA49-47F4-9BA3-7B18C56F64AD.pdf A44F TUMOR FREE 71 72 52 Complete Remission/Response YES NO R0 Primary Tumor 01 1977 7th NO YES NO 38 3 Lung A LIVING 2012 1965 c8762ae1-49de-496d-a00f-4cde20bbd3af c8762ae1-49de-496d-a00f-4cde20bbd3af TCGA-38-A44F-01A-11D-A24I-05 TCGA-38-A44F-01A-11D-A24C-01 c8762ae1-49de-496d-a00f-4cde20bbd3af TCGA-38-A44F-01A-11D-A24C-01 +TCGA-39-5011-01 TCGA-39-5011-01 High C1-LUAD-enriched Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 4 TCGA-39-5011 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 70 R-Lower TCGA-39-5011-F45652 TCGA-39-5011 TCGA-39-5011-01A -25788 0 4053 75 NO NO Scheduled Follow-up Submission 2013-7-18 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.9 8070/3 C34.9 YES 1.4 NO NO Peripheral Lung 2.1 NO NO 45 No M0 N0 T1b Stage IA TCGA-39-5011.6d1ee212-f843-4e78-908a-4cfd5f01a0a8.pdf 5011 TUMOR FREE 72 66 63 Complete Remission/Response YES NO R0 Primary Tumor 01 0.4 1995 6th NO NO YES 39 4 Lung A LIVING 2002 04b90b6a-445b-4d52-bed6-32b574e0a2ed 04b90b6a-445b-4d52-bed6-32b574e0a2ed TCGA-39-5011-01A-01D-1440-05 TCGA-39-5011-01A-01D-1439-01 TCGA-39-5011-01A-01R-1443-07 04b90b6a-445b-4d52-bed6-32b574e0a2ed TCGA-39-5011-01A-01D-1439-01 TCGA-39-5011-01A-21-2194-20 +TCGA-39-5011-11 TCGA-39-5011-11 C1-LUAD-enriched TCGA-39-5011 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 70 R-Lower TCGA-39-5011-F45652 TCGA-39-5011 TCGA-39-5011-11A -25788 0 4053 75 NO NO Scheduled Follow-up Submission 2013-7-18 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.9 8070/3 C34.9 YES 1.6 NO NO Peripheral Lung 1.8 NO NO 45 No M0 N0 T1b Stage IA 5011 TUMOR FREE 72 66 63 Complete Remission/Response YES NO R0 Solid Tissue Normal 11 0.4 1995 6th NO NO YES 39 4 Lung A LIVING 2002 TCGA-39-5011-11A-01D-1440-05 +TCGA-39-5016-01 TCGA-39-5016-01 BRCA-LUAD+ C2-Squamous-like Cluster 13 (HNSC-LUSC) BRCA basal-like c6 squamous-like c4 mutation cluster 13 TCGA-39-5016 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 44 R-Lower TCGA-39-5016-F45653 TCGA-39-5016 TCGA-39-5016-01A -16306 0 3850 98 NO NO Scheduled Follow-up Submission 2013-7-18 MALE Lung Basaloid Squamous Cell Carcinoma No C34.3 8083/3 C34.3 YES 1.2 NO NO Central Lung 1.3 NO NO 40 No M0 N1 T2a Stage IIA TCGA-39-5016.7b50ffbc-010e-415b-8d85-b5639801e287.pdf 5016 TUMOR FREE 73 75 73 77 Complete Remission/Response YES NO R0 Primary Tumor 01 0.3 2003 6th NO NO YES 39 4 Lung A LIVING 2003 3379dfb4-e4f0-492f-bdcd-0f76d3b94b0d TCGA-39-5016-01A-01D-1441-08 3379dfb4-e4f0-492f-bdcd-0f76d3b94b0d TCGA-39-5016-01A-01D-1440-05 TCGA-39-5016-01A-01D-1439-01 TCGA-39-5016-01A-01R-1443-07 3379dfb4-e4f0-492f-bdcd-0f76d3b94b0d TCGA-39-5016-01A-01D-1439-01 TCGA-39-5016-01A-21-2194-20 +TCGA-39-5016-11 TCGA-39-5016-11 C2-Squamous-like mutation cluster 13 TCGA-39-5016 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 44 R-Lower TCGA-39-5016-F45653 TCGA-39-5016 TCGA-39-5016-11A -16306 0 3850 98 NO NO Scheduled Follow-up Submission 2013-7-18 MALE Lung Basaloid Squamous Cell Carcinoma No C34.3 8083/3 C34.3 YES 1.6 NO NO Central Lung 1.7 NO NO 40 No M0 N1 T2a Stage IIA 5016 TUMOR FREE 73 75 73 77 Complete Remission/Response YES NO R0 Solid Tissue Normal 11 0.3 2003 6th NO NO YES 39 4 Lung A LIVING 2003 TCGA-39-5016-11A-01D-1440-05 +TCGA-39-5019-01 TCGA-39-5019-01 High C2-Squamous-like Cluster 13 (HNSC-LUSC) squamous c3 squamous-like c4 miRNA cluster 5 mutation cluster 5 TCGA-39-5019 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 70 R-Upper TCGA-39-5019-F45654 TCGA-39-5019 TCGA-39-5019-01A -25756 0 3387 96 NO NO Scheduled Follow-up Submission 2013-7-18 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 1.2 NO NO Peripheral Lung 1.8 NO NO 30 No M0 N0 T2a Stage IB TCGA-39-5019.6cd83aca-c74c-49a4-8115-324e7c359cc9.pdf 5019 TUMOR FREE 72 62 76 57 Complete Remission/Response YES NO R0 Primary Tumor 01 0.4 7th NO NO YES 39 3 Lung A LIVING 2004 a3196a69-230e-4dfe-ba2d-d8c5a8310d29 TCGA-39-5019-01A-01D-1817-08 a3196a69-230e-4dfe-ba2d-d8c5a8310d29 TCGA-39-5019-01A-01D-1818-05 TCGA-39-5019-01A-01D-1816-01 a3196a69-230e-4dfe-ba2d-d8c5a8310d29 TCGA-39-5019-01A-01D-1816-01 TCGA-39-5019-01A-21-2194-20 +TCGA-39-5019-11 TCGA-39-5019-11 C2-Squamous-like mutation cluster 5 TCGA-39-5019 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 70 R-Upper TCGA-39-5019-F45654 TCGA-39-5019 TCGA-39-5019-11A -25756 0 3387 96 NO NO Scheduled Follow-up Submission 2013-7-18 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 1.3 NO NO Peripheral Lung 1.5 NO NO 30 No M0 N0 T2a Stage IB 5019 TUMOR FREE 72 62 76 57 Complete Remission/Response YES NO R0 Solid Tissue Normal 11 0.3 7th NO NO YES 39 3 Lung A LIVING 2004 TCGA-39-5019-11A-01D-1818-05 +TCGA-39-5021-01 TCGA-39-5021-01 High C2-Squamous-like Cluster 5 squamous c3 squamous-like c4 miRNA cluster 7 mutation cluster 5 TCGA-39-5021 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung YES NO NO NO 70 L-Upper TCGA-39-5021-F8453 TCGA-39-5021 TCGA-39-5021-01A -25895 2086 0 2057 1875 NO NO Progressive Disease 2010-12-4 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 1.6 NO NO NO Central Lung 1.8 YES 114 No M0 N0 T2a Stage IB TCGA-39-5021.84d7dc8e-29cd-4adc-93ea-cda77cf855b4.pdf 5021 WITH TUMOR Complete Remission/Response NO R0 Primary Tumor 01 0.4 2004 NO NO YES 39 4 Lung A DECEASED 2004 1947 05e29bda-269a-4b56-b179-8b56867c036e TCGA-39-5021-01A-01D-1441-08 05e29bda-269a-4b56-b179-8b56867c036e TCGA-39-5021-01A-01D-1440-05 TCGA-39-5021-01A-01D-1439-01 TCGA-39-5021-01A-01R-1443-07 05e29bda-269a-4b56-b179-8b56867c036e TCGA-39-5021-01A-01D-1439-01 TCGA-39-5021-01A-21-2194-20 +TCGA-39-5021-11 TCGA-39-5021-11 C2-Squamous-like mutation cluster 5 TCGA-39-5021 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung YES NO NO NO 70 L-Upper TCGA-39-5021-F8453 TCGA-39-5021 TCGA-39-5021-11A -25895 2086 0 2057 1875 NO NO Progressive Disease 2010-12-4 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 1.7 NO NO NO Central Lung 2 YES 114 No M0 N0 T2a Stage IB 5021 WITH TUMOR Complete Remission/Response NO R0 Solid Tissue Normal 11 0.2 2004 NO NO YES 39 4 Lung A DECEASED 2004 1947 TCGA-39-5021-11A-01D-1440-05 +TCGA-39-5022-01 TCGA-39-5022-01 Squamous C2-Squamous-like Cluster 5 squamous c3 miRNA cluster 5 mutation cluster 12 TCGA-39-5022 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung YES YES 76 R-Upper TCGA-39-5022-F17149 TCGA-39-5022 TCGA-39-5022-01A 1448 -27856 1679 0 1448 NO NO Scheduled Follow-up Submission 2011-9-19 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 1.2 NO NO Peripheral Lung 1.4 YES 35 No M0 N0 T2a Stage IB TCGA-39-5022.76f4d72a-526a-4b52-ba4d-067a81281984.pdf 5022 TUMOR FREE NO R0 Primary Tumor 01 0.4 2005 7th NO NO YES 39 4 Lung A DECEASED 2005 1996 db85a3d4-61c8-4b3d-8d5e-f49fc9638cbb TCGA-39-5022-01A-21D-1817-08 db85a3d4-61c8-4b3d-8d5e-f49fc9638cbb TCGA-39-5022-01A-21D-1818-05 TCGA-39-5022-01A-21D-1816-01 db85a3d4-61c8-4b3d-8d5e-f49fc9638cbb TCGA-39-5022-01A-21D-1816-01 TCGA-39-5022-01A-22-2194-20 +TCGA-39-5024-01 TCGA-39-5024-01 High C2-Squamous-like Cluster 5 squamous c3 squamous-like c4 miRNA cluster 4 mutation cluster 5 TCGA-39-5024 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 65 Bronchial TCGA-39-5024-F45655 TCGA-39-5024 TCGA-39-5024-01A -23975 0 2510 81 NO NO Scheduled Follow-up Submission 2013-7-18 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.9 8070/3 C34.9 YES 1.5 NO NO Central Lung 1.7 NO NO 40 No M0 N2 T2a Stage IIIA TCGA-39-5024.ec84ade8-8988-4735-be04-97a52b8b8033.pdf 5024 TUMOR FREE 96 87 91 88 Complete Remission/Response YES NO R0 Primary Tumor 01 0.4 2005 7th YES NO YES 39 4 Lung A LIVING 2005 1964 e4d0c9ca-ecf9-4ded-a572-3c4cc9ce955a TCGA-39-5024-01A-21D-1817-08 e4d0c9ca-ecf9-4ded-a572-3c4cc9ce955a TCGA-39-5024-01A-21D-1818-05 TCGA-39-5024-01A-21D-1816-01 e4d0c9ca-ecf9-4ded-a572-3c4cc9ce955a TCGA-39-5024-01A-21D-1816-01 TCGA-39-5024-01A-22-2194-20 +TCGA-39-5027-01 TCGA-39-5027-01 Squamous C2-Squamous-like Cluster 13 (HNSC-LUSC) squamous c3 squamous-like c4 miRNA cluster 12 mutation cluster 5 TCGA-39-5027 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 73 R-Lower TCGA-39-5027-F45656 TCGA-39-5027 TCGA-39-5027-01A -26714 0 3108 3081 79 2 NO NO Scheduled Follow-up Submission 2013-7-18 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 1.3 NO NO Peripheral Lung 1.8 NO New Primary Tumor YES 40 No M0 N0 T2a Stage IB TCGA-39-5027.02693e05-2498-437a-9c26-7de09702c5ee.pdf 5027 Other WITH TUMOR 82 63 78 55 Complete Remission/Response Biopsy with Histologic Confirmation YES NO R0 Primary Tumor 01 0.4 2002 7th NO NO YES 39 4 Lung A LIVING 2006 1946 94f47d71-e3ad-44ad-8ddd-370db58ff67d TCGA-39-5027-01A-21D-1817-08 94f47d71-e3ad-44ad-8ddd-370db58ff67d TCGA-39-5027-01A-21D-1818-05 TCGA-39-5027-01A-21D-1816-01 94f47d71-e3ad-44ad-8ddd-370db58ff67d TCGA-39-5027-01A-21D-1816-01 TCGA-39-5027-01A-22-2194-20 +TCGA-39-5028-01 TCGA-39-5028-01 Squamous C2-Squamous-like Cluster 5 squamous c3 squamous-like c4 miRNA cluster 7 mutation cluster 13 TCGA-39-5028 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung NO NO 75 R-Upper TCGA-39-5028-F8459 TCGA-39-5028 TCGA-39-5028-01A -27707 52 0 52 NO NO 2010-12-4 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 1.5 NO NO NO Central Lung 1.9 NO 30 No M0 N1 T4 Stage IIIA TCGA-39-5028.3e8d3fab-2418-4860-8119-a011528f2f06.pdf 5028 NO R0 Primary Tumor 01 0.4 1981 NO NO YES 39 3 Lung A DECEASED 2006 1946 fecc45b4-3293-4a47-837b-74e42c6cbf0f TCGA-39-5028-01A-01D-1441-08 fecc45b4-3293-4a47-837b-74e42c6cbf0f TCGA-39-5028-01A-01D-1440-05 TCGA-39-5028-01A-01D-1439-01 fecc45b4-3293-4a47-837b-74e42c6cbf0f TCGA-39-5028-01A-01D-1439-01 TCGA-39-5028-01A-21-2194-20 +TCGA-39-5028-11 TCGA-39-5028-11 C2-Squamous-like mutation cluster 13 TCGA-39-5028 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung NO NO 75 R-Upper TCGA-39-5028-F8459 TCGA-39-5028 TCGA-39-5028-11A -27707 52 0 52 NO NO 2010-12-4 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.8 NO NO NO Central Lung 1.6 NO 30 No M0 N1 T4 Stage IIIA 5028 NO R0 Solid Tissue Normal 11 0.4 1981 NO NO YES 39 3 Lung A DECEASED 2006 1946 TCGA-39-5028-11A-01D-1440-05 +TCGA-39-5029-01 TCGA-39-5029-01 High C2-Squamous-like Cluster 13 (HNSC-LUSC) squamous c3 squamous-like c4 miRNA cluster 4 mutation cluster 5 TCGA-39-5029 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung YES YES NO YES 67 L-Lower TCGA-39-5029-F8462 TCGA-39-5029 TCGA-39-5029-01A 612 -24713 740 0 491 NO NO Stable Disease 2010-12-4 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 1.6 NO NO [Discrepancy] Central Lung 2 YES 192 No M0 N2 T1b Stage IIIA TCGA-39-5029.61c4772e-24ff-4b25-94d2-2d8e64c4753a.pdf 5029 WITH TUMOR Stable Disease NO R0 Primary Tumor 01 0.3 2006 YES NO YES 39 4 Lung A DECEASED 2006 1958 d424d3e3-9055-4d6a-a7ce-debbd3537fcd TCGA-39-5029-01A-01D-1441-08 d424d3e3-9055-4d6a-a7ce-debbd3537fcd TCGA-39-5029-01A-01D-1440-05 TCGA-39-5029-01A-01D-1439-01 TCGA-39-5029-01A-01R-1443-07 d424d3e3-9055-4d6a-a7ce-debbd3537fcd TCGA-39-5029-01A-01D-1439-01 TCGA-39-5029-01A-21-2194-20 +TCGA-39-5029-11 TCGA-39-5029-11 C2-Squamous-like mutation cluster 5 TCGA-39-5029 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung YES YES NO YES 67 L-Lower TCGA-39-5029-F8462 TCGA-39-5029 TCGA-39-5029-11A 612 -24713 740 0 491 NO NO Stable Disease 2010-12-4 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 1.6 NO NO [Discrepancy] Central Lung 1.7 YES 192 No M0 N2 T1b Stage IIIA 5029 WITH TUMOR Stable Disease NO R0 Solid Tissue Normal 11 0.4 2006 YES NO YES 39 4 Lung A DECEASED 2006 1958 TCGA-39-5029-11A-01D-1440-05 +TCGA-39-5030-01 TCGA-39-5030-01 Squamous C2-Squamous-like Cluster 5 squamous c3 squamous-like c4 miRNA cluster 7 mutation cluster 14 TCGA-39-5030 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung NO NO 81 L-Lower TCGA-39-5030-F8486 TCGA-39-5030 TCGA-39-5030-01A -29893 59 0 59 NO NO Complete Remission/Response 2010-12-4 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 1.4 NO NO NO Peripheral Lung 2 NO 08 No M0 N2 T2a Stage IIIA TCGA-39-5030.ae1b3081-2545-4236-94b3-2d474b021363.pdf 5030 Complete Remission/Response NO R0 Primary Tumor 01 0.4 1971 NO NO YES 39 3 Lung A DECEASED 2006 1960 87af5ba8-6e7d-4177-82d2-57b7268d6018 TCGA-39-5030-01A-01D-1441-08 87af5ba8-6e7d-4177-82d2-57b7268d6018 TCGA-39-5030-01A-01D-1440-05 TCGA-39-5030-01A-01D-1439-01 TCGA-39-5030-01A-01R-1443-07 87af5ba8-6e7d-4177-82d2-57b7268d6018 TCGA-39-5030-01A-01D-1439-01 TCGA-39-5030-01A-21-2194-20 +TCGA-39-5030-11 TCGA-39-5030-11 C2-Squamous-like mutation cluster 14 TCGA-39-5030 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung NO NO 81 L-Lower TCGA-39-5030-F8486 TCGA-39-5030 TCGA-39-5030-11A -29893 59 0 59 NO NO Complete Remission/Response 2010-12-4 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 1.7 NO NO NO Peripheral Lung 2.3 NO 08 No M0 N2 T2a Stage IIIA 5030 Complete Remission/Response NO R0 Solid Tissue Normal 11 0.4 1971 NO NO YES 39 3 Lung A DECEASED 2006 1960 TCGA-39-5030-11A-01D-1440-05 +TCGA-39-5031-01 TCGA-39-5031-01 Squamous C2-Squamous-like Cluster 5 squamous c3 squamous-like c4 miRNA cluster 7 mutation cluster 2 TCGA-39-5031 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 76 L-Upper TCGA-39-5031-F45657 TCGA-39-5031 TCGA-39-5031-01A -28106 1841 0 833 58 NO NO Scheduled Follow-up Submission 2013-7-18 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 1 NO NO Peripheral Lung 1.9 NO NO 60 No M0 N0 T1a Stage IA TCGA-39-5031.45179ec8-08fe-4e6c-b5b3-e2ef7711b710.pdf 5031 TUMOR FREE 89 79 85 76 Complete Remission/Response YES NO R0 Primary Tumor 01 0.3 1997 6th NO NO YES 39 4 Lung A DECEASED 2007 1946 3ab5fa89-ae39-40a2-92ac-d1721cea9f7e TCGA-39-5031-01A-01D-1441-08 3ab5fa89-ae39-40a2-92ac-d1721cea9f7e TCGA-39-5031-01A-01D-1440-05 TCGA-39-5031-01A-01D-1439-01 3ab5fa89-ae39-40a2-92ac-d1721cea9f7e TCGA-39-5031-01A-01D-1439-01 TCGA-39-5031-01A-21-2194-20 +TCGA-39-5031-11 TCGA-39-5031-11 C2-Squamous-like mutation cluster 2 TCGA-39-5031 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 76 L-Upper TCGA-39-5031-F45657 TCGA-39-5031 TCGA-39-5031-11A -28106 1841 0 833 58 NO NO Scheduled Follow-up Submission 2013-7-18 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 1.5 NO NO Peripheral Lung 1.6 NO NO 60 No M0 N0 T1a Stage IA 5031 TUMOR FREE 89 79 85 76 Complete Remission/Response YES NO R0 Solid Tissue Normal 11 0.2 1997 6th NO NO YES 39 4 Lung A DECEASED 2007 1946 TCGA-39-5031-11A-01D-1440-05 +TCGA-39-5034-01 TCGA-39-5034-01 High C1-LUAD-enriched Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 7 TCGA-39-5034 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung NO NO NO NO 73 R-Upper TCGA-39-5034-F8491 TCGA-39-5034 TCGA-39-5034-01A -26682 1107 0 1107 352 YES NO Progressive Disease 2010-12-6 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 1.5 NO YES NO Peripheral Lung 1.6 YES 084 No M0 N0 T3 Stage IIB TCGA-39-5034.8d0c1256-1e5c-4db3-961d-15a4e1329224.pdf 5034 Complete Remission/Response NO R0 Primary Tumor 01 0.2 2007 NO NO YES 39 4 Lung A DECEASED 2007 1950 ea64d44e-32d1-40f6-b49f-e019401a76d5 ea64d44e-32d1-40f6-b49f-e019401a76d5 TCGA-39-5034-01A-01D-1440-05 TCGA-39-5034-01A-01D-1439-01 TCGA-39-5034-01A-01R-1443-07 ea64d44e-32d1-40f6-b49f-e019401a76d5 TCGA-39-5034-01A-01D-1439-01 TCGA-39-5034-01A-21-2194-20 +TCGA-39-5034-11 TCGA-39-5034-11 C1-LUAD-enriched TCGA-39-5034 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung NO NO NO NO 73 R-Upper TCGA-39-5034-F8491 TCGA-39-5034 TCGA-39-5034-11A -26682 1107 0 1107 352 YES NO Progressive Disease 2010-12-6 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 2 NO YES NO Peripheral Lung 2.3 YES 084 No M0 N0 T3 Stage IIB 5034 Complete Remission/Response NO R0 Solid Tissue Normal 11 0.4 2007 NO NO YES 39 4 Lung A DECEASED 2007 1950 TCGA-39-5034-11A-01D-1440-05 +TCGA-39-5035-01 TCGA-39-5035-01 Squamous C2-Squamous-like Cluster 13 (HNSC-LUSC) squamous c3 squamous-like c4 miRNA cluster 7 mutation cluster 5 TCGA-39-5035 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 72 R-Lower TCGA-39-5035-F45658 TCGA-39-5035 TCGA-39-5035-01A -26383 0 2080 39 NO NO Scheduled Follow-up Submission 2013-7-18 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 1.5 NO NO Central Lung 1.8 NO NO 47 No M0 N0 T1b Stage IA TCGA-39-5035.65d294e9-bdde-476e-8b45-dcee87915a69.pdf 5035 TUMOR FREE 67 71 63 68 Complete Remission/Response YES NO R0 Primary Tumor 01 0.4 1997 6th NO NO YES 39 4 Lung A LIVING 2007 1950 2f3702b6-bd6e-4863-8b81-e7d3850a9017 TCGA-39-5035-01A-01D-1441-08 2f3702b6-bd6e-4863-8b81-e7d3850a9017 TCGA-39-5035-01A-01D-1440-05 TCGA-39-5035-01A-01D-1439-01 TCGA-39-5035-01A-01R-1443-07 2f3702b6-bd6e-4863-8b81-e7d3850a9017 TCGA-39-5035-01A-01D-1439-01 TCGA-39-5035-01A-21-2194-20 +TCGA-39-5035-11 TCGA-39-5035-11 C2-Squamous-like mutation cluster 5 TCGA-39-5035 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 72 R-Lower TCGA-39-5035-F45658 TCGA-39-5035 TCGA-39-5035-11A -26383 0 2080 39 NO NO Scheduled Follow-up Submission 2013-7-18 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 1.3 NO NO Central Lung 1.7 NO NO 47 No M0 N0 T1b Stage IA 5035 TUMOR FREE 67 71 63 68 Complete Remission/Response YES NO R0 Solid Tissue Normal 11 0.4 1997 6th NO NO YES 39 4 Lung A LIVING 2007 1950 TCGA-39-5035-11A-01D-1440-05 +TCGA-39-5036-01 TCGA-39-5036-01 Squamous C2-Squamous-like Cluster 13 (HNSC-LUSC) squamous-like c4 miRNA cluster 11 mutation cluster 5 TCGA-39-5036 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 73 L-Upper TCGA-39-5036-F45659 TCGA-39-5036 TCGA-39-5036-01A -26963 0 2165 71 NO NO Scheduled Follow-up Submission 2013-7-18 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.9 NO NO Peripheral Lung 1.5 NO NO 63 No M0 N0 T2 Stage IB TCGA-39-5036.b5f0955a-6175-4c71-ab34-639f8ac6d69a.pdf 5036 TUMOR FREE 49 62 53 61 Complete Remission/Response YES NO R0 Primary Tumor 01 0.1 2000 6th NO NO YES 39 4 Lung A LIVING 2007 1957 cd60c90b-bd9a-4494-ad73-993664b12f33 TCGA-39-5036-01A-01D-1441-08 cd60c90b-bd9a-4494-ad73-993664b12f33 TCGA-39-5036-01A-01D-1440-05 TCGA-39-5036-01A-01D-1439-01 TCGA-39-5036-01A-01R-1443-07 cd60c90b-bd9a-4494-ad73-993664b12f33 TCGA-39-5036-01A-01D-1439-01 +TCGA-39-5036-11 TCGA-39-5036-11 C2-Squamous-like mutation cluster 5 TCGA-39-5036 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 73 L-Upper TCGA-39-5036-F45659 TCGA-39-5036 TCGA-39-5036-11A -26963 0 2165 71 NO NO Scheduled Follow-up Submission 2013-7-18 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 1.7 NO NO Peripheral Lung 1.7 NO NO 63 No M0 N0 T2 Stage IB 5036 TUMOR FREE 49 62 53 61 Complete Remission/Response YES NO R0 Solid Tissue Normal 11 0.2 2000 6th NO NO YES 39 4 Lung A LIVING 2007 1957 TCGA-39-5036-11A-01D-1440-05 +TCGA-39-5037-01 TCGA-39-5037-01 Squamous C2-Squamous-like Cluster 13 (HNSC-LUSC) squamous c3 squamous-like c4 miRNA cluster 11 mutation cluster 5 TCGA-39-5037 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 65 L-Lower TCGA-39-5037-F45660 TCGA-39-5037 TCGA-39-5037-01A -23868 0 1690 79 NO NO Scheduled Follow-up Submission 2013-7-18 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 1 NO NO Central Lung 1.3 NO NO 26 No M0 N1 T1b Stage IIA TCGA-39-5037.7a100e58-1e99-48b4-9db1-0228aaf4bb71.pdf 5037 TUMOR FREE 56 60 61 56 Complete Remission/Response YES NO R0 Primary Tumor 01 0.4 6th NO NO YES 39 2 Lung A LIVING 2007 1969 f5debd70-0db6-42d6-8894-fd65c9f4c66e TCGA-39-5037-01A-01D-1441-08 f5debd70-0db6-42d6-8894-fd65c9f4c66e TCGA-39-5037-01A-01D-1440-05 TCGA-39-5037-01A-01D-1439-01 TCGA-39-5037-01A-01R-1443-07 f5debd70-0db6-42d6-8894-fd65c9f4c66e TCGA-39-5037-01A-01D-1439-01 TCGA-39-5037-01A-21-2194-20 +TCGA-39-5037-11 TCGA-39-5037-11 C2-Squamous-like mutation cluster 5 TCGA-39-5037 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 65 L-Lower TCGA-39-5037-F45660 TCGA-39-5037 TCGA-39-5037-11A -23868 0 1690 79 NO NO Scheduled Follow-up Submission 2013-7-18 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 1.5 NO NO Central Lung 1.6 NO NO 26 No M0 N1 T1b Stage IIA 5037 TUMOR FREE 56 60 61 56 Complete Remission/Response YES NO R0 Solid Tissue Normal 11 0.4 6th NO NO YES 39 2 Lung A LIVING 2007 1969 TCGA-39-5037-11A-01D-1440-05 +TCGA-39-5039-01 TCGA-39-5039-01 High C2-Squamous-like Low purity c2 squamous-like c4 miRNA c1uster 9 mutation c1uster 9 TCGA-39-5039 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung NO NO NO NO 76 R-Upper TCGA-39-5039-F8512 TCGA-39-5039 TCGA-39-5039-01A -27781 544 0 544 NO NO Complete Remission/Response 2010-12-6 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 1.2 NO NO NO Central Lung 2 NO 64 Yes M0 N0 T2b Stage IIA TCGA-39-5039.10fd2687-7713-4435-9fcc-0cd6f9a430e1.pdf 5039 TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 0.1 1983 NO NO YES 39 3 Lung A DECEASED 2008 1949 ae96337f-1b6e-41e6-8045-35f4adec76f4 TCGA-39-5039-01A-01D-1441-08 ae96337f-1b6e-41e6-8045-35f4adec76f4 TCGA-39-5039-01A-01D-1440-05 TCGA-39-5039-01A-01D-1439-01 ae96337f-1b6e-41e6-8045-35f4adec76f4 TCGA-39-5039-01A-01D-1439-01 +TCGA-39-5039-11 TCGA-39-5039-11 C2-Squamous-like mutation c1uster 9 TCGA-39-5039 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung NO NO NO NO 76 R-Upper TCGA-39-5039-F8512 TCGA-39-5039 TCGA-39-5039-11A -27781 544 0 544 NO NO Complete Remission/Response 2010-12-6 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 1.4 NO NO NO Central Lung 1.5 NO 64 Yes M0 N0 T2b Stage IIA 5039 TUMOR FREE Complete Remission/Response NO R0 Solid Tissue Normal 11 0.2 1983 NO NO YES 39 3 Lung A DECEASED 2008 1949 TCGA-39-5039-11A-01D-1440-05 +TCGA-39-5040-01 TCGA-39-5040-01 High BRCA CIMP c7 squamous c3 miRNA c1uster 9 TCGA-39-5040 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung YES NO NO 59 L-Upper TCGA-39-5040-F29963 TCGA-39-5040 TCGA-39-5040-01A -21790 519 0 442 80 NO NO Progressive Disease 2012-3-5 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 1.5 NO 80 NO Peripheral Lung 1.5 YES 60 No M0 N2 T2a Stage IIIA TCGA-39-5040.6bef6712-0d27-4032-9f72-3c9f13901223.pdf 5040 Post-Adjuvant Therapy WITH TUMOR 93 97 Stable Disease YES YES R0 Primary Tumor 01 0.4 2005 7th YES NO YES 39 4 Lung A DECEASED 2008 1964 48b4302e-03cd-4f73-ab52-fb8dc22a10d4 48b4302e-03cd-4f73-ab52-fb8dc22a10d4 TCGA-39-5040-01A-21D-2123-05 TCGA-39-5040-01A-21D-2121-01 48b4302e-03cd-4f73-ab52-fb8dc22a10d4 TCGA-39-5040-01A-21D-2121-01 TCGA-39-5040-01A-11-2194-20 +TCGA-39-5040-11 TCGA-39-5040-11 TCGA-39-5040 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung YES NO NO 59 L-Upper TCGA-39-5040-F29963 TCGA-39-5040 TCGA-39-5040-11A -21790 519 0 442 80 NO NO Progressive Disease 2012-3-5 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 1 NO 80 NO Peripheral Lung 1.7 YES 60 No M0 N2 T2a Stage IIIA 5040 Post-Adjuvant Therapy WITH TUMOR 93 97 Stable Disease YES YES R0 Solid Tissue Normal 11 0.3 2005 7th YES NO YES 39 4 Lung A DECEASED 2008 1964 3b3b0303-49cd-47b5-83b9-5192fe6a6e58 3b3b0303-49cd-47b5-83b9-5192fe6a6e58 3b3b0303-49cd-47b5-83b9-5192fe6a6e58 +TCGA-43-2576-01 TCGA-43-2576-01 Squamous miRNA cluster 4 TCGA-43-2576 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 62 L-Upper TCGA-43-2576-F39331 TCGA-43-2576 TCGA-43-2576-01A -22805 0 1223 72 Scheduled Follow-up Submission Complete Remission/Response 2013-1-17 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.6 NO 90 NO 1.2 NO NO 20 No M0 N2 T2 Stage IIIA TCGA-43-2576.15a1f3eb-1b46-45c4-85f8-0d52710986b3.pdf 2576 Pre-Adjuvant Therapy TUMOR FREE 79 75 70 69 Complete Remission/Response YES YES R0 Primary Tumor 01 0.4 2004 6th YES YES NO 43 4 Lung A LIVING 2009 1969 ac4077ca-1cc5-4df5-b621-94e2cb8ecd0f ac4077ca-1cc5-4df5-b621-94e2cb8ecd0f TCGA-43-2576-01A-01D-0844-01 TCGA-43-2576-01A-01R-0851-07 ac4077ca-1cc5-4df5-b621-94e2cb8ecd0f TCGA-43-2576-01A-01D-0844-01 +TCGA-43-2578-01 TCGA-43-2578-01 High C1-LUAD-enriched Cluster 5 squamous c3 RNA cluster 3 miRNA cluster 12 mutation cluster 4 TCGA-43-2578 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 59 L-Upper TCGA-43-2578-F13290 TCGA-43-2578 TCGA-43-2578-01A -21747 684 0 684 0 Complete Remission/Response 2011-6-23 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.7 NO NO 0.8 NO 64 Yes M0 N0 T1 Stage IA TCGA-43-2578.ebd86e31-d68f-404b-ad7d-bdfbee556f3b.pdf 2578 Preoperative TUMOR FREE 60 45 63 42 Complete Remission/Response YES NO R0 Primary Tumor 01 0.7 2000 6th NO YES NO 43 4 Lung A DECEASED 2009 1968 c7b94923-c28a-449e-962c-40d56a1b2e61 TCGA-43-2578-01A-01D-0848-05 TCGA-43-2578-01A-01D-1522-08 c7b94923-c28a-449e-962c-40d56a1b2e61 TCGA-43-2578-01A-01D-1969-01 TCGA-43-2578-01A-01R-0851-07 c7b94923-c28a-449e-962c-40d56a1b2e61 TCGA-43-2578-01A-01D-1969-01 TCGA-43-2578-01A-21-2193-20 +TCGA-43-2581-01 TCGA-43-2581-01 High C1-LUAD-enriched Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 4 TCGA-43-2581 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 47 R-Upper TCGA-43-2581-F39082 TCGA-43-2581 TCGA-43-2581-01A -17447 0 1176 50 1 Scheduled Follow-up Submission Complete Remission/Response 2013-1-11 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.7 NO NO 1.3 NO NO 30 No M0 N1 T3 Stage IIIA TCGA-43-2581.eb835b34-3938-4ace-9c89-11ebefb85da2.pdf 2581 Pre-Adjuvant Therapy TUMOR FREE 50 44 41 38 Complete Remission/Response YES NO R0 Primary Tumor 01 0.4 6th YES YES NO 43 2 Lung A LIVING 2009 1979 9471e29a-1dcc-4de4-a213-15765427e8e5 TCGA-43-2581-01A-01D-0848-05 9471e29a-1dcc-4de4-a213-15765427e8e5 TCGA-43-2581-01A-01D-0844-01 TCGA-43-2581-01A-01R-0851-07 9471e29a-1dcc-4de4-a213-15765427e8e5 TCGA-43-2581-01A-01D-0844-01 TCGA-43-2581-01A-21-2193-20 +TCGA-43-3394-01 TCGA-43-3394-01 Squamous C2-Squamous-like Cluster 5 squamous c3 squamous-like c4 miRNA cluster 4 mutation cluster 5 TCGA-43-3394 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 52 L-Lower TCGA-43-3394-F38662 TCGA-43-3394 TCGA-43-3394-01A -19310 1190 0 352 81 0 Scheduled Follow-up Submission 2012-12-19 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.9 NO NO 0.9 NO NO 15 No M0 N0 T2a Stage IB TCGA-43-3394.ab2c3289-581e-4bb2-a41f-418b057ef54b.pdf 3394 Other WITH TUMOR 60 50 60 36 Complete Remission/Response YES NO R0 Primary Tumor 01 0.6 6th YES YES NO 43 2 Lung A DECEASED 2009 1979 27e89ada-fc8b-484f-8570-c26af5434438 TCGA-43-3394-01A-01D-0979-05 TCGA-43-3394-01A-01D-0983-08 27e89ada-fc8b-484f-8570-c26af5434438 TCGA-43-3394-01A-01D-1549-01 TCGA-43-3394-01A-01R-0980-07 27e89ada-fc8b-484f-8570-c26af5434438 TCGA-43-3394-01A-01D-1549-01 TCGA-43-3394-01A-21-2193-20 +TCGA-43-3394-11 TCGA-43-3394-11 C2-Squamous-like mutation cluster 5 TCGA-43-3394 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 52 L-Lower TCGA-43-3394-F38662 TCGA-43-3394 TCGA-43-3394-11A -19310 1190 0 352 81 0 Scheduled Follow-up Submission 2012-12-19 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.8 NO NO 4.4 NO NO 15 No M0 N0 T2a Stage IB 3394 Other WITH TUMOR 60 50 60 36 Complete Remission/Response YES NO R0 Solid Tissue Normal 11 0.8 6th YES YES NO 43 2 Lung A DECEASED 2009 1979 d5da6fea-e0ee-4da5-8f4a-45d850fead0c d5da6fea-e0ee-4da5-8f4a-45d850fead0c TCGA-43-3394-11A-01D-1551-05 d5da6fea-e0ee-4da5-8f4a-45d850fead0c +TCGA-43-3920-01 TCGA-43-3920-01 High C2-Squamous-like Cluster 5 squamous-like c4 miRNA cluster 7 mutation cluster 5 TCGA-43-3920 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 71 R-Upper TCGA-43-3920-F39254 TCGA-43-3920 TCGA-43-3920-01A -26059 0 1007 50 Scheduled Follow-up Submission Complete Remission/Response 2013-1-16 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.7 NO NO 1.3 NO NO 50 No M0 N0 T2 Stage IB TCGA-43-3920.93f563a8-23e6-4a60-a7ca-b51ab176f978.pdf 3920 TUMOR FREE 97 77 95 78 Complete Remission/Response YES NO R0 Primary Tumor 01 0.3 2009 7th NO YES NO 43 4 Lung A LIVING 2009 1959 185c6574-0d29-4078-9198-ed4f427331bd TCGA-43-3920-01A-01D-0979-05 TCGA-43-3920-01A-01D-0983-08 185c6574-0d29-4078-9198-ed4f427331bd TCGA-43-3920-01A-01D-1549-01 TCGA-43-3920-01A-01R-0980-07 185c6574-0d29-4078-9198-ed4f427331bd TCGA-43-3920-01A-01D-1549-01 +TCGA-43-3920-11 TCGA-43-3920-11 C2-Squamous-like mutation cluster 5 TCGA-43-3920 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 71 R-Upper TCGA-43-3920-F39254 TCGA-43-3920 TCGA-43-3920-11B -26059 0 1007 50 Scheduled Follow-up Submission Complete Remission/Response 2013-1-16 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.8 NO NO 2 NO NO 50 No M0 N0 T2 Stage IB 3920 TUMOR FREE 97 77 95 78 Complete Remission/Response YES NO R0 Solid Tissue Normal 11 0.8 2009 7th NO YES NO 43 4 Lung B LIVING 2009 1959 TCGA-43-3920-11B-01D-1551-05 +TCGA-43-5668-01 TCGA-43-5668-01 High C1-LUAD-enriched Cluster 6 squamous c3 RNA cluster 5 miRNA cluster 2 mutation cluster 11 TCGA-43-5668 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung YES NO NO NO 78 R-Upper TCGA-43-5668-F31287 TCGA-43-5668 TCGA-43-5668-01A -28635 559 0 258 470 61 1 Additional New Tumor Event Progressive Disease 2012-4-26 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.6 NO 1.3 YES 20 Yes M0 N1 T1b Stage IIA TCGA-43-5668.e41d4d1f-8334-42c6-8759-ad5366a11c93.pdf 5668 Pre-Adjuvant Therapy WITH TUMOR 89 83 84 74 Progressive Disease YES NO Primary Tumor 01 0.4 1983 7th YES YES NO 43 3 Lung A DECEASED 2010 3cb7b861-6dba-4d54-bc04-c63a238e394e TCGA-43-5668-01A-01D-1632-08 3cb7b861-6dba-4d54-bc04-c63a238e394e TCGA-43-5668-01A-01D-1633-05 TCGA-43-5668-01A-01D-1631-01 3cb7b861-6dba-4d54-bc04-c63a238e394e TCGA-43-5668-01A-01D-1631-01 TCGA-43-5668-01A-21-2194-20 +TCGA-43-5668-11 TCGA-43-5668-11 C1-LUAD-enriched mutation cluster 11 TCGA-43-5668 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung YES NO NO NO 78 R-Upper TCGA-43-5668-F31287 TCGA-43-5668 TCGA-43-5668-11A -28635 559 0 258 470 61 1 Additional New Tumor Event Progressive Disease 2012-4-26 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.9 NO 1.1 YES 20 Yes M0 N1 T1b Stage IIA 5668 Pre-Adjuvant Therapy WITH TUMOR 89 83 84 74 Progressive Disease YES NO Solid Tissue Normal 11 0.9 1983 7th YES YES NO 43 3 Lung A DECEASED 2010 TCGA-43-5668-11A-01D-1633-05 +TCGA-43-5670-01 TCGA-43-5670-01 High Cluster 5 squamous c3 miRNA cluster 11 TCGA-43-5670 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung NO 70 L-Lower TCGA-43-5670-F40410 TCGA-43-5670 TCGA-43-5670-01A -25652 0 849 53 0 Scheduled Follow-up Submission Complete Remission/Response 2013-2-19 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 1 NO 1.3 NO NO 30 No M0 N0 T2b Stage IIA TCGA-43-5670.ca16f05f-5198-405b-91e4-cde6119a75bb.pdf 5670 Post-Adjuvant Therapy TUMOR FREE 98 108 92 100 Complete Remission/Response YES NO Primary Tumor 01 0.3 1980 7th YES YES NO 43 3 Lung A LIVING 2010 1970 8e49dba6-1d3d-4e60-aba7-a093fe5bbd41 8e49dba6-1d3d-4e60-aba7-a093fe5bbd41 TCGA-43-5670-01A-21D-2123-05 TCGA-43-5670-01A-21D-2121-01 8e49dba6-1d3d-4e60-aba7-a093fe5bbd41 TCGA-43-5670-01A-21D-2121-01 TCGA-43-5670-01A-11-2194-20 +TCGA-43-5670-11 TCGA-43-5670-11 TCGA-43-5670 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung NO 70 L-Lower TCGA-43-5670-F40410 TCGA-43-5670 TCGA-43-5670-11A -25652 0 849 53 0 Scheduled Follow-up Submission Complete Remission/Response 2013-2-19 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.9 NO 1.8 NO NO 30 No M0 N0 T2b Stage IIA 5670 Post-Adjuvant Therapy TUMOR FREE 98 108 92 100 Complete Remission/Response YES NO Solid Tissue Normal 11 0.7 1980 7th YES YES NO 43 3 Lung A LIVING 2010 1970 b0b31be8-d2f5-4543-90c4-52d88e1bff94 b0b31be8-d2f5-4543-90c4-52d88e1bff94 b0b31be8-d2f5-4543-90c4-52d88e1bff94 +TCGA-43-6143-01 TCGA-43-6143-01 Squamous C1-LUAD-enriched Cluster 5 squamous c3 RNA cluster 12 miRNA cluster 13 mutation cluster 2 TCGA-43-6143 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung NO 70 R-Lower TCGA-43-6143-F38926 TCGA-43-6143 TCGA-43-6143-01A -25820 0 699 40 1 Scheduled Follow-up Submission Complete Remission/Response 2013-1-4 MALE Lung Basaloid Squamous Cell Carcinoma No C34.3 8083/3 C34.3 YES 0.8 NO 80 1.6 NO NO 114 No M0 N0 T2 Stage IB TCGA-43-6143.0a88e8ad-53bb-4450-8131-f7ac7c79960a.pdf 6143 Other TUMOR FREE 77 50 78 45 Complete Remission/Response YES NO RX Primary Tumor 01 0.8 2010 7th YES YES NO 43 4 Lung A LIVING 2010 1953 0896ba53-2761-4378-9042-de4895b173ac TCGA-43-6143-01A-11D-1817-08 0896ba53-2761-4378-9042-de4895b173ac TCGA-43-6143-01A-11D-1818-05 TCGA-43-6143-01A-11D-1816-01 0896ba53-2761-4378-9042-de4895b173ac TCGA-43-6143-01A-11D-1816-01 TCGA-43-6143-01A-13-2194-20 +TCGA-43-6143-11 TCGA-43-6143-11 C1-LUAD-enriched mutation cluster 2 TCGA-43-6143 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung NO 70 R-Lower TCGA-43-6143-F38926 TCGA-43-6143 TCGA-43-6143-11A -25820 0 699 40 1 Scheduled Follow-up Submission Complete Remission/Response 2013-1-4 MALE Lung Basaloid Squamous Cell Carcinoma No C34.3 8083/3 C34.3 YES 1 NO 80 2.2 NO NO 114 No M0 N0 T2 Stage IB 6143 Other TUMOR FREE 77 50 78 45 Complete Remission/Response YES NO RX Solid Tissue Normal 11 1 2010 7th YES YES NO 43 4 Lung A LIVING 2010 1953 80fbe4ac-7a80-4b89-8fce-3caddfafee64 80fbe4ac-7a80-4b89-8fce-3caddfafee64 80fbe4ac-7a80-4b89-8fce-3caddfafee64 +TCGA-43-6647-01 TCGA-43-6647-01 Squamous C2-Squamous-like Cluster 5 squamous-like c4 miRNA cluster 5 mutation c1uster 10 TCGA-43-6647 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 69 R-Lower TCGA-43-6647-F39010 TCGA-43-6647 TCGA-43-6647-01A -25378 0 757 0 Scheduled Follow-up Submission Complete Remission/Response 2013-1-8 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 1 NO 100 1 NO NO 36 No MX N1 T2b Stage IIB TCGA-43-6647.c4fee0a5-5591-4466-8f65-d2e0bf29f990.pdf 6647 Post-Adjuvant Therapy TUMOR FREE 76 Complete Remission/Response YES NO RX Primary Tumor 01 0.5 1995 7th YES YES NO 43 4 Lung A LIVING 2010 1959 bd265674-2868-40d9-9d1a-72f4baf887f0 TCGA-43-6647-01A-11D-1817-08 bd265674-2868-40d9-9d1a-72f4baf887f0 TCGA-43-6647-01A-11D-1818-05 TCGA-43-6647-01A-11D-1816-01 bd265674-2868-40d9-9d1a-72f4baf887f0 TCGA-43-6647-01A-11D-1816-01 +TCGA-43-6647-11 TCGA-43-6647-11 C2-Squamous-like mutation c1uster 10 TCGA-43-6647 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 69 R-Lower TCGA-43-6647-F39010 TCGA-43-6647 TCGA-43-6647-11A -25378 0 757 0 Scheduled Follow-up Submission Complete Remission/Response 2013-1-8 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 1 NO 100 2.5 NO NO 36 No MX N1 T2b Stage IIB 6647 Post-Adjuvant Therapy TUMOR FREE 76 Complete Remission/Response YES NO RX Solid Tissue Normal 11 1 1995 7th YES YES NO 43 4 Lung A LIVING 2010 1959 d3ffdd2d-b156-4e82-92ab-37c9e48a736b d3ffdd2d-b156-4e82-92ab-37c9e48a736b d3ffdd2d-b156-4e82-92ab-37c9e48a736b +TCGA-43-6770-01 TCGA-43-6770-01 High C2-Squamous-like Cluster 5 squamous c3 squamous-like c4 miRNA cluster 12 mutation cluster 2 TCGA-43-6770 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 59 L-Upper TCGA-43-6770-F39906 TCGA-43-6770 TCGA-43-6770-01A -21683 0 653 59 Scheduled Follow-up Submission Complete Remission/Response 2013-2-5 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.7 NO 90 2 NO NO 34 No MX N0 T2a Stage IB TCGA-43-6770.cacfd9dd-aad5-48d8-9ecc-3db108bff2f8.pdf 6770 Other TUMOR FREE 96 93 99 97 Complete Remission/Response YES NO RX Primary Tumor 01 0.4 7th YES YES NO 43 2 Lung A LIVING 2011 1977 6322257f-c99b-4562-95fb-1b26651bc876 TCGA-43-6770-01A-11D-1817-08 6322257f-c99b-4562-95fb-1b26651bc876 TCGA-43-6770-01A-11D-1818-05 TCGA-43-6770-01A-11D-1816-01 6322257f-c99b-4562-95fb-1b26651bc876 TCGA-43-6770-01A-11D-1816-01 TCGA-43-6770-01A-13-2195-20 +TCGA-43-6771-01 TCGA-43-6771-01 Squamous C2-Squamous-like Cluster 6 squamous c3 squamous-like c4 miRNA cluster 11 mutation c1uster 9 TCGA-43-6771 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung NO 85 L-Upper TCGA-43-6771-F15614 TCGA-43-6771 TCGA-43-6771-01A -31052 166 0 154 101 Scheduled Follow-up Submission 2011-8-26 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.8 NO 1 YES 40 No MX N0 T2 Stage IB TCGA-43-6771.09fbd8e1-9f86-47c1-abea-fd8e96366908.pdf 6771 WITH TUMOR 121 109 117 104 Progressive Disease YES NO RX Primary Tumor 01 0.7 1976 6th NO NO YES 43 3 Lung A DECEASED 2006 1936 b936c3f0-795b-4128-bca0-b797b3d86f8d TCGA-43-6771-01A-11D-1817-08 b936c3f0-795b-4128-bca0-b797b3d86f8d TCGA-43-6771-01A-11D-1818-05 TCGA-43-6771-01A-11D-1816-01 b936c3f0-795b-4128-bca0-b797b3d86f8d TCGA-43-6771-01A-11D-1816-01 TCGA-43-6771-01A-13-2195-20 +TCGA-43-6771-11 TCGA-43-6771-11 C2-Squamous-like mutation c1uster 9 TCGA-43-6771 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung NO 85 L-Upper TCGA-43-6771-F15614 TCGA-43-6771 TCGA-43-6771-11A -31052 166 0 154 101 Scheduled Follow-up Submission 2011-8-26 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.8 NO 0.8 YES 40 No MX N0 T2 Stage IB 6771 WITH TUMOR 121 109 117 104 Progressive Disease YES NO RX Solid Tissue Normal 11 0.8 1976 6th NO NO YES 43 3 Lung A DECEASED 2006 1936 79b04aa9-2ebd-4891-8fe4-ea635dbafa2f 79b04aa9-2ebd-4891-8fe4-ea635dbafa2f TCGA-43-6771-11A-01D-1818-05 79b04aa9-2ebd-4891-8fe4-ea635dbafa2f +TCGA-43-6773-01 TCGA-43-6773-01 Quiet Low purity c2 miRNA cluster 7 TCGA-43-6773 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 76 R-Lower TCGA-43-6773-F17411 TCGA-43-6773 TCGA-43-6773-01A -28036 116 0 84 Scheduled Follow-up Submission 2011-10-12 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.2 8070/3 C34.2 YES 0.8 NO 1.3 No MX N1 T2 Stage IIB TCGA-43-6773.b09e0471-a726-41b4-90ed-b9e1e062896d.pdf 6773 TUMOR FREE 70 65 YES NO Primary Tumor 01 0.8 1988 6th NO NO YES 43 3 Lung A DECEASED 2008 25361c46-91f3-4b7b-80e0-ef8576ce00c1 25361c46-91f3-4b7b-80e0-ef8576ce00c1 TCGA-43-6773-01A-41D-1947-05 TCGA-43-6773-01A-41D-1943-01 25361c46-91f3-4b7b-80e0-ef8576ce00c1 TCGA-43-6773-01A-41D-1943-01 +TCGA-43-6773-11 TCGA-43-6773-11 TCGA-43-6773 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 76 R-Lower TCGA-43-6773-F17411 TCGA-43-6773 TCGA-43-6773-11A -28036 116 0 84 Scheduled Follow-up Submission 2011-10-12 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.2 8070/3 C34.2 YES 0.9 NO 1.2 No MX N1 T2 Stage IIB 6773 TUMOR FREE 70 65 YES NO Solid Tissue Normal 11 0.9 1988 6th NO NO YES 43 3 Lung A DECEASED 2008 2c3b36e7-3761-433c-976e-30aed0a82819 2c3b36e7-3761-433c-976e-30aed0a82819 2c3b36e7-3761-433c-976e-30aed0a82819 +TCGA-43-7656-01 TCGA-43-7656-01 Squamous C2-Squamous-like Low purity c2 squamous c3 RNA cluster 12 miRNA cluster 4 TCGA-43-7656 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 71 R-Lower TCGA-43-7656-F39647 TCGA-43-7656 TCGA-43-7656-01A -25991 0 596 67 0 Scheduled Follow-up Submission 2013-1-28 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.5 NO NO 1 NO NO 45 No MX N0 T1b Stage IA TCGA-43-7656.57b4e426-72c1-43ba-b8f1-d17ce36e6478.pdf 7656 Other TUMOR FREE 75 62 73 60 Complete Remission/Response NO Primary Tumor 01 0.4 7th NO YES NO 43 4 Lung A LIVING 2011 1956 f7106ef9-450f-4952-8b64-c5d31317ae66 f7106ef9-450f-4952-8b64-c5d31317ae66 TCGA-43-7656-01A-11D-2123-05 TCGA-43-7656-01A-11D-2121-01 f7106ef9-450f-4952-8b64-c5d31317ae66 TCGA-43-7656-01A-11D-2121-01 TCGA-43-7656-01A-13-2195-20 +TCGA-43-7657-01 TCGA-43-7657-01 Squamous Low purity c2 miRNA cluster 4 TCGA-43-7657 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 68 R-Upper TCGA-43-7657-F34027 TCGA-43-7657 TCGA-43-7657-01A -25042 0 236 64 0 Scheduled Follow-up Submission Complete Remission/Response 2012-7-25 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.7 NO NO 1 NO NO 45 Yes MX N0 T1 Stage IA TCGA-43-7657.24615ceb-b7aa-472d-9dc0-7af1fdf9f8c8.pdf 7657 Preoperative TUMOR FREE 95 103 90 91 Complete Remission/Response YES NO Primary Tumor 01 0.5 2002 7th NO YES NO 43 4 Lung A LIVING 2011 1957 56b4ee76-fe71-41fd-bb02-01cb4fcf5e38 56b4ee76-fe71-41fd-bb02-01cb4fcf5e38 TCGA-43-7657-01A-31D-2123-05 TCGA-43-7657-01A-31D-2121-01 56b4ee76-fe71-41fd-bb02-01cb4fcf5e38 TCGA-43-7657-01A-31D-2121-01 +TCGA-43-7657-11 TCGA-43-7657-11 TCGA-43-7657 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 68 R-Upper TCGA-43-7657-F34027 TCGA-43-7657 TCGA-43-7657-11A -25042 0 236 64 0 Scheduled Follow-up Submission Complete Remission/Response 2012-7-25 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 1 NO NO 1.4 NO NO 45 Yes MX N0 T1 Stage IA 7657 Preoperative TUMOR FREE 95 103 90 91 Complete Remission/Response YES NO Solid Tissue Normal 11 0.7 2002 7th NO YES NO 43 4 Lung A LIVING 2011 1957 148d34df-aec2-42bf-8e36-b91a68959606 148d34df-aec2-42bf-8e36-b91a68959606 148d34df-aec2-42bf-8e36-b91a68959606 +TCGA-43-7658-01 TCGA-43-7658-01 High Cluster 5 squamous c3 miRNA cluster 1 TCGA-43-7658 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung NO YES NO 75 R-Upper TCGA-43-7658-F39387 TCGA-43-7658 TCGA-43-7658-01A -27734 2378 0 2023 2305 0 Additional New Tumor Event Progressive Disease 2013-1-22 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.6 NO 50 0.8 NO Distant Metastasis|New Primary Tumor YES 12 Yes M0 N0 T1 Stage IA TCGA-43-7658.0c0d2eb2-af28-40f9-a4a3-067c1bc78cc6.pdf 7658 Other WITH TUMOR Complete Remission/Response Biopsy with Histologic Confirmation|Convincing Imaging YES NO Primary Tumor 01 0.1 1995 6th NO NO YES 43 4 Lung A DECEASED 2006 1970 c859b0e7-c582-41af-83d7-83ac07f53d13 c859b0e7-c582-41af-83d7-83ac07f53d13 TCGA-43-7658-01A-11D-2123-05 TCGA-43-7658-01A-11D-2121-01 c859b0e7-c582-41af-83d7-83ac07f53d13 TCGA-43-7658-01A-11D-2121-01 TCGA-43-7658-01A-13-2195-20 +TCGA-43-7658-11 TCGA-43-7658-11 TCGA-43-7658 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung NO YES NO 75 R-Upper TCGA-43-7658-F39387 TCGA-43-7658 TCGA-43-7658-11A -27734 2378 0 2023 2305 0 Additional New Tumor Event Progressive Disease 2013-1-22 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.9 NO 50 0.9 NO Distant Metastasis|New Primary Tumor YES 12 Yes M0 N0 T1 Stage IA 7658 Other WITH TUMOR Complete Remission/Response Biopsy with Histologic Confirmation|Convincing Imaging YES NO Solid Tissue Normal 11 0.8 1995 6th NO NO YES 43 4 Lung A DECEASED 2006 1970 e22f0063-e7ec-4f86-b937-2fcd7797c103 e22f0063-e7ec-4f86-b937-2fcd7797c103 e22f0063-e7ec-4f86-b937-2fcd7797c103 +TCGA-43-8115-01 TCGA-43-8115-01 Squamous Cluster 5 miRNA cluster 4 TCGA-43-8115 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung NO NO NO 72 L-Lower TCGA-43-8115-F37153 TCGA-43-8115 TCGA-43-8115-01A -26406 0 407 1 Scheduled Follow-up Submission Stable Disease 2012-11-28 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.7 NO 1.5 NO NO 55.83 No MX N1 T2a Stage IIA TCGA-43-8115.a18f4ec6-0500-4e01-98ff-e30faa481fa4.pdf 8115 Post-Adjuvant Therapy TUMOR FREE 66 54 Stable Disease YES NO R0 Primary Tumor 01 0.7 2011 7th YES YES NO 43 4 Lung A LIVING 2011 1955 3e1695a2-9716-466c-89a8-91a3c996cdbe 3e1695a2-9716-466c-89a8-91a3c996cdbe TCGA-43-8115-01A-11D-2245-05 TCGA-43-8115-01A-11D-2243-01 3e1695a2-9716-466c-89a8-91a3c996cdbe TCGA-43-8115-01A-11D-2243-01 +TCGA-43-8116-01 TCGA-43-8116-01 Squamous Cluster 13 (HNSC-LUSC) miRNA cluster 4 TCGA-43-8116 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 73 L-Upper TCGA-43-8116-F36263 TCGA-43-8116 TCGA-43-8116-01A -26790 0 358 55 1 Scheduled Follow-up Submission 2012-10-25 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.8 NO 1.4 NO NO 35 No M0 N0 T1b Stage IA TCGA-43-8116.2038982b-7cfc-4a88-846f-f44f7e8ff78a.pdf 8116 Preoperative TUMOR FREE 102 99 102 94 Complete Remission/Response YES NO Primary Tumor 01 0.6 7th NO YES NO 43 2 Lung A LIVING 2011 1959 570cec62-e184-4e9b-a7fe-93f8615b2271 570cec62-e184-4e9b-a7fe-93f8615b2271 TCGA-43-8116-01A-11D-2245-05 TCGA-43-8116-01A-11D-2243-01 570cec62-e184-4e9b-a7fe-93f8615b2271 TCGA-43-8116-01A-11D-2243-01 +TCGA-43-8118-01 TCGA-43-8118-01 TCGA-43-8118 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 55 R-Upper TCGA-43-8118-F36773 TCGA-43-8118 TCGA-43-8118-01A -20224 89 0 50 1 NO NO 2012-11-13 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.7 NO NO 1 NO NO 20 Yes, History of Synchronous/Bilateral Malignancy M0 N0 T1b Stage IA TCGA-43-8118.52C7F12F-DA4C-4784-9B71-9EB385F25077.pdf 8118 Pre-Adjuvant Therapy 92 73 88 66 YES NO Primary Tumor 01 0.5 7th YES YES NO 43 2 Lung A DECEASED 2011 1971 8cebbeaa-9421-4012-becb-10de3f135a3e 8cebbeaa-9421-4012-becb-10de3f135a3e TCGA-43-8118-01A-11D-2398-05 TCGA-43-8118-01A-11D-2391-01 8cebbeaa-9421-4012-becb-10de3f135a3e TCGA-43-8118-01A-11D-2391-01 +TCGA-43-A474-01 TCGA-43-A474-01 TCGA-43-A474 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 66 L-Upper TCGA-43-A474-F39908 TCGA-43-A474 TCGA-43-A474-01A -24286 214 0 353 73 Scheduled Follow-up Submission Complete Remission/Response 2013-2-5 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 230 NO 90 NO NO 47 false Yes, History of Prior Malignancy M0 N0 T2b Stage IIA TCGA-43-A474.31549DED-DB58-4FA2-A598-29B34B12AF4E.pdf A474 Post-Adjuvant Therapy TUMOR FREE 83 82 79 66 Complete Remission/Response YES NO R0 Primary Tumor 01 2012 7th YES YES NO 43 4 Lung A LIVING 2012 1965 7533fbaf-dbbd-4778-b213-741229a58f4c 7533fbaf-dbbd-4778-b213-741229a58f4c TCGA-43-A474-01A-11D-A24I-05 TCGA-43-A474-01A-11D-A24C-01 7533fbaf-dbbd-4778-b213-741229a58f4c TCGA-43-A474-01A-11D-A24C-01 +TCGA-43-A475-01 TCGA-43-A475-01 TCGA-43-A475 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 67 R-Upper TCGA-43-A475-F41130 TCGA-43-A475 TCGA-43-A475-01A -24680 148 0 296 53 0 Scheduled Follow-up Submission 2013-3-12 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 320 NO 80 NO NO 100 false No M0 N0 T3 Stage IIB TCGA-43-A475.24B44F94-4883-492D-A373-626D240014A5.pdf A475 Other TUMOR FREE 77 71 77 67 Complete Remission/Response YES YES R1 Primary Tumor 01 2008 7th YES YES NO 43 4 Lung A LIVING 2012 1958 72a23d60-178c-4cd2-9204-c00aebc935b6 72a23d60-178c-4cd2-9204-c00aebc935b6 TCGA-43-A475-01A-11D-A24I-05 TCGA-43-A475-01A-11D-A24C-01 72a23d60-178c-4cd2-9204-c00aebc935b6 TCGA-43-A475-01A-11D-A24C-01 +TCGA-43-A56U-01 TCGA-43-A56U-01 TCGA-43-A56U TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 76 L-Upper TCGA-43-A56U-F51576 TCGA-43-A56U TCGA-43-A56U-01A -27847 76 0 432 75 0 Scheduled Follow-up Submission Complete Remission/Response 2013-11-20 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 70 NO NO NO 20.5 false No MX N0 T1b Stage IA TCGA-43-A56U.51B3C5AA-AF58-4976-AFE0-0E6BEAA3D6B6.pdf A56U Preoperative TUMOR FREE 96 89 92 85 Complete Remission/Response YES NO R0 Primary Tumor 01 2012 7th NO YES NO 43 4 Lung A LIVING 2012 1971 b9af6223-4001-41ad-adc1-be15c76d8150 b9af6223-4001-41ad-adc1-be15c76d8150 TCGA-43-A56U-01A-11D-A26N-05 TCGA-43-A56U-01A-11D-A26L-01 b9af6223-4001-41ad-adc1-be15c76d8150 TCGA-43-A56U-01A-11D-A26L-01 +TCGA-43-A56V-01 TCGA-43-A56V-01 TCGA-43-A56V TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung NO NO NO NO 61 R-Middle TCGA-43-A56V-F51041 TCGA-43-A56V TCGA-43-A56V-01A -22475 27 0 366 355 58 Scheduled Follow-up Submission Progressive Disease 2013-11-6 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.2 8070/3 C34.2 YES 280 NO 70 NO Locoregional Recurrence|Distant Metastasis YES 48 false Yes, History of Synchronous/Bilateral Malignancy M0 N2 T2a Stage IIIA TCGA-43-A56V.716CE78F-14FC-43DE-96F9-A12874CA9648.pdf A56V Other WITH TUMOR 97 76 97 78 Complete Remission/Response Convincing Imaging YES NO Primary Tumor 01 1999 7th YES YES NO 43 4 Lung A LIVING 2012 1967 165b9f2f-04c6-44d0-a4ac-069ad04e4e42 165b9f2f-04c6-44d0-a4ac-069ad04e4e42 TCGA-43-A56V-01A-11D-A26N-05 TCGA-43-A56V-01A-11D-A26L-01 165b9f2f-04c6-44d0-a4ac-069ad04e4e42 TCGA-43-A56V-01A-11D-A26L-01 +TCGA-44-2655-01 2.05 0.3 none none none none N N none none none 0.15 Bronchioid none none none none none none none Acinar predominant Adc Acinar predominant Adc none 0 TCGA-44-2655-01 Iq C1-LUAD-enriched Cluster 5 LUAD-like c10 miRNA cluster 5 mutation c1uster 9 TCGA-44-2655 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung NO NO NO NO 65 R-Upper TCGA-44-2655-F39289 TCGA-44-2655 TCGA-44-2655-01A -23854 0 1324 1009 73 0 Scheduled Follow-up Submission Complete Remission/Response 2013-1-16 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.5 NO NO 0.5 NO New Primary Tumor YES 30 Yes M0 N0 T1 Stage IA TCGA-44-2655.ebae1e0e-18fb-48c8-b2f3-282dab7352d4.pdf 2655 Pre-Adjuvant Therapy TUMOR FREE 100 91 Complete Remission/Response YES NO R0 Primary Tumor 01 0.3 1988 6th NO YES NO 44 3 Current reformed smoker for > 15 years Lung A LIVING 2009 1958 785a76b0-7ae7-44ed-a8a6-519fe6e15f04 TCGA-44-2655-01A-01D-0945-05 TCGA-44-2655-01 785a76b0-7ae7-44ed-a8a6-519fe6e15f04 TCGA-44-2655-01A-01D-0944-01 TCGA-44-2655-01A-01R-0946-07 785a76b0-7ae7-44ed-a8a6-519fe6e15f04 TCGA-44-2655-01A-01D-0944-01 +TCGA-44-2655-11 2.05 0.3 none none none none N N none none none 0.15 Bronchioid none none none none none none none Acinar predominant Adc Acinar predominant Adc none 0 TCGA-44-2655-11 C1-LUAD-enriched mutation c1uster 9 TCGA-44-2655 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung NO NO NO NO 65 R-Upper TCGA-44-2655-F39289 TCGA-44-2655 TCGA-44-2655-11A -23854 0 1324 1009 73 0 Scheduled Follow-up Submission Complete Remission/Response 2013-1-16 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.6 NO NO 1 NO New Primary Tumor YES 30 Yes M0 N0 T1 Stage IA 2655 Pre-Adjuvant Therapy TUMOR FREE 100 91 Complete Remission/Response YES NO R0 Solid Tissue Normal 11 0.4 1988 6th NO YES NO 44 3 Current reformed smoker for > 15 years Lung A LIVING 2009 1958 e218db14-8225-450d-92b1-865d46ab59bf e218db14-8225-450d-92b1-865d46ab59bf TCGA-44-2655-11A-01D-1551-05 e218db14-8225-450d-92b1-865d46ab59bf +TCGA-44-2656-01 3.14 0.31 none none none none N Y none p.S310F none 0.13 Squamoid none none none none none none none Solid predominant Adc Solid predominant Adc none 0 TCGA-44-2656-01 BRCA-LUAD+ C1-LUAD-enriched Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 4 mutation cluster 11 TCGA-44-2656 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung YES YES 59 R-Upper TCGA-44-2656-F39934 TCGA-44-2656 TCGA-44-2656-01A -21766 0 1429 568 FPPP 72 0 Scheduled Follow-up Submission Complete Remission/Response 2013-2-6 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 50 0.8 NO NO 0.8 NO New Primary Tumor YES 23 No M0 N0 T2 Stage IB TCGA-44-2656.3c7e7f0d-f1b6-42cf-895e-df6cc52f4c2a.pdf 2656 Pre-Adjuvant Therapy TUMOR FREE 86 84 86 79 Complete Remission/Response Biopsy with Histologic Confirmation TCGA YES NO Primary Tumor 01 0.4 2009 6th NO YES NO 44 4 Current reformed smoker for < or = 15 years Lung A LIVING 2009 1994 7b9dc578-8869-4322-a705-bfb9942d9b65 TCGA-44-2656-01A-02D-0945-05 TCGA-44-2656-01 7b9dc578-8869-4322-a705-bfb9942d9b65 TCGA-44-2656-01A-02D-A276-05,TCGA-44-2656-01B-06D-A276-05 TCGA-44-2656-01A-02D-A273-01 TCGA-44-2656-01A-02R-0946-07 7b9dc578-8869-4322-a705-bfb9942d9b65 TCGA-44-2656-01A-02D-A273-01 TCGA-44-2656-01A-11-2190-20 +TCGA-44-2656-11 3.14 0.31 none none none none N Y none p.S310F none 0.13 Squamoid none none none none none none none Solid predominant Adc Solid predominant Adc none 0 TCGA-44-2656-11 C1-LUAD-enriched mutation cluster 11 TCGA-44-2656 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung YES YES 59 R-Upper TCGA-44-2656-F39934 TCGA-44-2656 TCGA-44-2656-11A -21766 0 1429 568 FPPP 72 0 Scheduled Follow-up Submission Complete Remission/Response 2013-2-6 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 530 0.9 NO NO 2 NO New Primary Tumor YES 23 No M0 N0 T2 Stage IB 2656 Pre-Adjuvant Therapy TUMOR FREE 86 84 86 79 Complete Remission/Response Biopsy with Histologic Confirmation TCGA YES NO Solid Tissue Normal 11 0.9 2009 6th NO YES NO 44 4 Current reformed smoker for < or = 15 years Lung A LIVING 2009 1994 TCGA-44-2656-11A-01D-1551-05 +TCGA-44-2657-01 1.74 0.33 none none none none N N none none none 0.17 Bronchioid none none none p.N315S none none none Acinar predominant Adc Acinar predominant Adc none 0 TCGA-44-2657-01 BRCA-LUAD+ C1-LUAD-enriched Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 7 mutation c1uster 10 TCGA-44-2657 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 74 L-Upper TCGA-44-2657-F39296 TCGA-44-2657 TCGA-44-2657-01A -27298 0 1351 96 0 Scheduled Follow-up Submission Complete Remission/Response 2013-1-16 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.6 NO NO 1 NO NO 25 No M0 NX T2 Stage IB TCGA-44-2657.d31fa48b-949c-48b7-bc78-6954ede98172.pdf 2657 Pre-Adjuvant Therapy TUMOR FREE 87 147 78 120 Complete Remission/Response YES NO R0 Primary Tumor 01 0.3 2006 6th NO YES NO 44 4 Current reformed smoker for < or = 15 years Lung A LIVING 2009 1959 e1a6b655-0a09-4a79-b86b-8ff65b2bbceb TCGA-44-2657-01A-01D-1104-05 TCGA-44-2657-01A-01D-1105-08 e1a6b655-0a09-4a79-b86b-8ff65b2bbceb TCGA-44-2657-01A-01D-1877-01 TCGA-44-2657-01A-01R-1107-07 e1a6b655-0a09-4a79-b86b-8ff65b2bbceb TCGA-44-2657-01A-01D-1877-01 TCGA-44-2657-01A-21-2190-20 +TCGA-44-2657-11 1.74 0.33 none none none none N N none none none 0.17 Bronchioid none none none p.N315S none none none Acinar predominant Adc Acinar predominant Adc none 0 TCGA-44-2657-11 C1-LUAD-enriched mutation c1uster 10 TCGA-44-2657 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 74 L-Upper TCGA-44-2657-F39296 TCGA-44-2657 TCGA-44-2657-11A -27298 0 1351 96 0 Scheduled Follow-up Submission Complete Remission/Response 2013-1-16 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.6 NO NO 1.6 NO NO 25 No M0 NX T2 Stage IB 2657 Pre-Adjuvant Therapy TUMOR FREE 87 147 78 120 Complete Remission/Response YES NO R0 Solid Tissue Normal 11 0.5 2006 6th NO YES NO 44 4 Current reformed smoker for < or = 15 years Lung A LIVING 2009 1959 ca16fef9-9795-4a33-899f-9bf111ee093e ca16fef9-9795-4a33-899f-9bf111ee093e ca16fef9-9795-4a33-899f-9bf111ee093e +TCGA-44-2659-01 3.6 0.41 none none none none N N none none none 0.15 Bronchioid none none none none none none none Solid predominant Adc Solid predominant Adc none 1 TCGA-44-2659-01 BRCA-LUAD+ LUAD-like c10 miRNA cluster 7 mutation cluster 5 TCGA-44-2659 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 65 [Discrepancy] TCGA-44-2659-F40300 TCGA-44-2659 TCGA-44-2659-01A -23808 0 1367 67 1 Scheduled Follow-up Submission Complete Remission/Response 2013-2-15 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 0.8 NO NO 1.3 NO NO 57 No M0 N1 T1 Stage IIB TCGA-44-2659.9015ab9c-ad9f-44f1-af94-3c7bf34f12fd.pdf 2659 Other TUMOR FREE 87 73 77 64 Complete Remission/Response YES NO R0 Primary Tumor 01 0.3 2003 6th YES YES NO 44 4 Current reformed smoker for < or = 15 years Lung A LIVING 2009 1965 6f748364-2a6a-4fd4-af87-3de643719577 TCGA-44-2659-01 6f748364-2a6a-4fd4-af87-3de643719577 TCGA-44-2659-01A-01D-0944-01 TCGA-44-2659-01A-01R-0946-07 6f748364-2a6a-4fd4-af87-3de643719577 TCGA-44-2659-01A-01D-0944-01 +TCGA-44-2659-11 3.6 0.41 none none none none N N none none none 0.15 Bronchioid none none none none none none none Solid predominant Adc Solid predominant Adc none 1 TCGA-44-2659-11 mutation cluster 5 TCGA-44-2659 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 65 [Discrepancy] TCGA-44-2659-F40300 TCGA-44-2659 TCGA-44-2659-11A -23808 0 1367 67 1 Scheduled Follow-up Submission Complete Remission/Response 2013-2-15 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 0.9 NO NO 1.5 NO NO 57 No M0 N1 T1 Stage IIB 2659 Other TUMOR FREE 87 73 77 64 Complete Remission/Response YES NO R0 Solid Tissue Normal 11 0.7 2003 6th YES YES NO 44 4 Current reformed smoker for < or = 15 years Lung A LIVING 2009 1965 TCGA-44-2659-11A-01D-1551-05 +TCGA-44-2661-01 1.86 0.27 none none none none Y Y p.ELREA746del none none 0.14 Bronchioid none none none none none none none Acinar predominant Adc Acinar predominant Adc none 0 TCGA-44-2661-01 Kirc+ C1-LUAD-enriched Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 4 mutation cluster 14 TCGA-44-2661 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 69 L-Upper TCGA-44-2661-F41293 TCGA-44-2661 TCGA-44-2661-01A -25313 0 1159 1 Scheduled Follow-up Submission Complete Remission/Response 2013-3-14 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.7 NO NO 1.5 NO NO Yes M0 N0 T1 Stage IA TCGA-44-2661.17e596f5-74fe-46cc-bee2-fa1355b01721.pdf 2661 Pre-Adjuvant Therapy TUMOR FREE Complete Remission/Response YES NO R0 Primary Tumor 01 0.4 6th NO YES NO 44 1 Lifelong Non-smoker Lung A LIVING 2009 847f00ce-5f09-4e12-90c5-ebdf7612d707 TCGA-44-2661-01A-01D-1104-05 TCGA-44-2661-01A-01D-1105-08 847f00ce-5f09-4e12-90c5-ebdf7612d707 TCGA-44-2661-01A-01D-1877-01 TCGA-44-2661-01A-01R-1107-07 847f00ce-5f09-4e12-90c5-ebdf7612d707 TCGA-44-2661-01A-01D-1877-01 TCGA-44-2661-01A-21-2190-20 +TCGA-44-2661-11 1.86 0.27 none none none none Y Y p.ELREA746del none none 0.14 Bronchioid none none none none none none none Acinar predominant Adc Acinar predominant Adc none 0 TCGA-44-2661-11 C1-LUAD-enriched mutation cluster 14 TCGA-44-2661 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 69 L-Upper TCGA-44-2661-F41293 TCGA-44-2661 TCGA-44-2661-11A -25313 0 1159 1 Scheduled Follow-up Submission Complete Remission/Response 2013-3-14 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.9 NO NO 1.3 NO NO Yes M0 N0 T1 Stage IA 2661 Pre-Adjuvant Therapy TUMOR FREE Complete Remission/Response YES NO R0 Solid Tissue Normal 11 0.4 6th NO YES NO 44 1 Lifelong Non-smoker Lung A LIVING 2009 90b503db-13ca-4257-bda3-31d4e7bc69b4 90b503db-13ca-4257-bda3-31d4e7bc69b4 90b503db-13ca-4257-bda3-31d4e7bc69b4 +TCGA-44-2662-01 3.33 0.25 none p.N581S none none N N none none none 0.11 Squamoid none none none none none none none Solid predominant Adc Solid predominant Adc none 0 TCGA-44-2662-01 BRCA-LUAD+ C1-LUAD-enriched Cluster 5 LUAD-like c10 miRNA cluster 4 mutation cluster 2 TCGA-44-2662 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung NO 65 R-Upper TCGA-44-2662-F39415 TCGA-44-2662 TCGA-44-2662-01A -24014 0 1280 FPPP 78 Scheduled Follow-up Submission Complete Remission/Response 2013-1-22 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.9 NO NO 1 NO NO 56 Yes M0 N0 T2 Stage IB TCGA-44-2662.76bab538-e95a-48a6-9f83-36b9a472252b.pdf 2662 TUMOR FREE 94 73 88 67 Progressive Disease TCGA YES NO R0 Primary Tumor 01 0.2 1984 6th YES YES NO 44 3 Current reformed smoker for > 15 years Lung A LIVING 2009 1956 5ec48286-3f47-49eb-83ba-a1169f734bba TCGA-44-2662-01A-01D-0945-05 TCGA-44-2662-01 5ec48286-3f47-49eb-83ba-a1169f734bba TCGA-44-2662-01A-01D-A273-01 TCGA-44-2662-01A-01R-0946-07 5ec48286-3f47-49eb-83ba-a1169f734bba TCGA-44-2662-01A-01D-A273-01 +TCGA-44-2662-11 3.33 0.25 none p.N581S none none N N none none none 0.11 Squamoid none none none none none none none Solid predominant Adc Solid predominant Adc none 0 TCGA-44-2662-11 C1-LUAD-enriched mutation cluster 2 TCGA-44-2662 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung NO 65 R-Upper TCGA-44-2662-F39415 TCGA-44-2662 TCGA-44-2662-11A -24014 0 1280 FPPP 78 Scheduled Follow-up Submission Complete Remission/Response 2013-1-22 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.8 NO NO 1 NO NO 56 Yes M0 N0 T2 Stage IB 2662 TUMOR FREE 94 73 88 67 Progressive Disease TCGA YES NO R0 Solid Tissue Normal 11 0.4 1984 6th YES YES NO 44 3 Current reformed smoker for > 15 years Lung A LIVING 2009 1956 b548a64b-0275-4beb-9b67-ce8bad3ccd63 b548a64b-0275-4beb-9b67-ce8bad3ccd63 TCGA-44-2662-11A-01D-1551-05 b548a64b-0275-4beb-9b67-ce8bad3ccd63 +TCGA-44-2664-01 TCGA-44-2664-01 squamous c3 TCGA-44-2664 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung NO YES NO 66 R-Lower TCGA-44-2664-F34138 TCGA-44-2664 TCGA-44-2664-01A -24468 0 1251 832 74 2 Additional New Tumor Event Complete Remission/Response 2012-7-30 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 0.6 NO NO 1 NO Locoregional Recurrence YES 23 No M0 N0 T1 Stage IA TCGA-44-2664.8ac6aec3-d709-411f-9233-f264bac80972.pdf 2664 Other TUMOR FREE 109 113 Complete Remission/Response Convincing Imaging YES NO R0 Primary Tumor 01 0.4 6th NO YES NO 44 2 Lung A LIVING 2009 1964 TCGA-44-2664-01A-21-2190-20 +TCGA-44-2665-01 2.12 0.44 none none none none N Y none none none 0.21 Squamoid none none none none none none none Solid predominant Adc Solid predominant Adc Y none 1 TCGA-44-2665-01 Iq C1-LUAD-enriched Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 4 mutation c1uster 9 TCGA-44-2665 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 55 R-Upper TCGA-44-2665-F40281 TCGA-44-2665 TCGA-44-2665-01A -20349 0 1301 FPPP 71 0 Scheduled Follow-up Submission Complete Remission/Response 2013-2-15 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.6 NO NO 1.1 NO NO No M0 N1 T2 Stage IIB TCGA-44-2665.262e300a-7b16-4f2b-80bf-29decfe84d33.pdf 2665 Other TUMOR FREE 79 105 79 114 Stable Disease TCGA YES NO R0 Primary Tumor 01 0.3 6th YES YES NO 44 1 Lifelong Non-smoker Lung A LIVING 2009 9a6962a2-0a32-44d5-a2bf-c28c5f1a9cd0 TCGA-44-2665-01A-01D-0945-05 TCGA-44-2665-01 9a6962a2-0a32-44d5-a2bf-c28c5f1a9cd0 TCGA-44-2665-01B-06D-A276-05,TCGA-44-2665-01A-01D-A276-05 TCGA-44-2665-01A-01D-A273-01 TCGA-44-2665-01A-01R-0946-07 9a6962a2-0a32-44d5-a2bf-c28c5f1a9cd0 TCGA-44-2665-01A-01D-A273-01 TCGA-44-2665-01A-21-2190-20 +TCGA-44-2665-11 2.12 0.44 none none none none N Y none none none 0.21 Squamoid none none none none none none none Solid predominant Adc Solid predominant Adc Y none 1 TCGA-44-2665-11 C1-LUAD-enriched mutation c1uster 9 TCGA-44-2665 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 55 R-Upper TCGA-44-2665-F40281 TCGA-44-2665 TCGA-44-2665-11A -20349 0 1301 FPPP 71 0 Scheduled Follow-up Submission Complete Remission/Response 2013-2-15 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.8 NO NO 1.9 NO NO No M0 N1 T2 Stage IIB 2665 Other TUMOR FREE 79 105 79 114 Stable Disease TCGA YES NO R0 Solid Tissue Normal 11 0.6 6th YES YES NO 44 1 Lifelong Non-smoker Lung A LIVING 2009 756942cf-3ba1-456e-8086-57f710247b8e 756942cf-3ba1-456e-8086-57f710247b8e TCGA-44-2665-11A-01D-1551-05 756942cf-3ba1-456e-8086-57f710247b8e +TCGA-44-2666-01 1.94 0.58 none p.V600E none none N Y none none none 0.3 Bronchioid none none none none none none none Papillary predominant Adc Papillary predominant Adc none 1 TCGA-44-2666-01 Kirc+ C1-LUAD-enriched Cluster 6 LUAD-like c10 miRNA cluster 5 mutation cluster 5 TCGA-44-2666 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung NO NO NO NO 43 R-Upper TCGA-44-2666-F5304 TCGA-44-2666 -15970 97 0 97 FPPP 66 2010-10-12 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES NO NO 30 No M0 N0 T2 Stage IB 2666 WITH TUMOR 86 87 TCGA YES NO R0 Primary Tumor 01 6th NO YES NO 44 2 Current smoker Lung DECEASED 2009 1979 bfad522f-6130-424d-8497-99cac9714966 TCGA-44-2666-01A-01D-0945-05 TCGA-44-2666-01 bfad522f-6130-424d-8497-99cac9714966 TCGA-44-2666-01B-02D-A276-05,TCGA-44-2666-01A-01D-A276-05 TCGA-44-2666-01A-01D-A273-01 TCGA-44-2666-01A-01R-0946-07 bfad522f-6130-424d-8497-99cac9714966 TCGA-44-2666-01A-01D-A273-01 +TCGA-44-2668-01 TCGA-44-2668-01 High C1-LUAD-enriched Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 4 mutation cluster 2 TCGA-44-2668 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung YES YES NO 51 R-Upper TCGA-44-2668-F18688 TCGA-44-2668 TCGA-44-2668-01A 453 -18856 761 0 246 433 FPPP 53 0 Additional New Tumor Event Progressive Disease 2011-11-22 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 1 NO NO 1.2 YES 60 No M0 N0 T2 Stage IB TCGA-44-2668.d5ebaec8-79c6-493b-ae2a-bbc96e6e5ddc.pdf 2668 Other WITH TUMOR 104 82 TCGA YES R0 Primary Tumor 01 0.3 2009 6th YES NO 44 4 Lung A DECEASED 2009 1979 4c5c1c05-b9d1-4073-9d91-5c4e552928ae TCGA-44-2668-01A-01D-0945-05 TCGA-44-2668-01 4c5c1c05-b9d1-4073-9d91-5c4e552928ae TCGA-44-2668-01B-02D-A276-05,TCGA-44-2668-01A-01D-A276-05 TCGA-44-2668-01A-01D-A273-01 TCGA-44-2668-01A-01R-0946-07 4c5c1c05-b9d1-4073-9d91-5c4e552928ae TCGA-44-2668-01A-01D-A273-01 TCGA-44-2668-01A-21-2190-20 +TCGA-44-2668-11 TCGA-44-2668-11 C1-LUAD-enriched mutation cluster 2 TCGA-44-2668 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung YES YES NO 51 R-Upper TCGA-44-2668-F18688 TCGA-44-2668 TCGA-44-2668-11A 453 -18856 761 0 246 433 FPPP 53 0 Additional New Tumor Event Progressive Disease 2011-11-22 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 1 NO NO 1.5 YES 60 No M0 N0 T2 Stage IB 2668 Other WITH TUMOR 104 82 TCGA YES R0 Solid Tissue Normal 11 0.5 2009 6th YES NO 44 4 Lung A DECEASED 2009 1979 2170c29a-1256-45eb-b08e-e1192dad3560 2170c29a-1256-45eb-b08e-e1192dad3560 TCGA-44-2668-11A-01D-1551-05 2170c29a-1256-45eb-b08e-e1192dad3560 +TCGA-44-3396-01 none none none none N N none none none Squamoid none none none none none none none Solid predominant Adc Solid predominant Adc none 0 TCGA-44-3396-01 Kirc+ C1-LUAD-enriched Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 7 mutation cluster 5 TCGA-44-3396 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 74 [Discrepancy] TCGA-44-3396-F39080 TCGA-44-3396 TCGA-44-3396-01A -27073 0 1130 48 1 Scheduled Follow-up Submission Complete Remission/Response 2013-1-11 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 1 NO 80 NO 1.3 NO NO 50 No M0 N2 T2 Stage IIIA TCGA-44-3396.6a7ec9e8-ea86-4c3b-9d0e-9564e41311b5.pdf 3396 Other TUMOR FREE 98 89 Complete Remission/Response YES NO R0 Primary Tumor 01 0.4 7th YES YES NO 44 2 Current smoker Lung A LIVING 2009 1959 8b0a1ab6-e7ea-45f9-9e3a-bd98b3f59972 TCGA-44-3396-01A-01D-1205-05 TCGA-44-3396-01A-01D-1265-08 8b0a1ab6-e7ea-45f9-9e3a-bd98b3f59972 TCGA-44-3396-01A-01D-1204-01 8b0a1ab6-e7ea-45f9-9e3a-bd98b3f59972 TCGA-44-3396-01A-01D-1204-01 TCGA-44-3396-01A-31-2190-20 +TCGA-44-3396-11 none none none none N N none none none Squamoid none none none none none none none Solid predominant Adc Solid predominant Adc none 0 TCGA-44-3396-11 C1-LUAD-enriched mutation cluster 5 TCGA-44-3396 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 74 [Discrepancy] TCGA-44-3396-F39080 TCGA-44-3396 TCGA-44-3396-11A -27073 0 1130 48 1 Scheduled Follow-up Submission Complete Remission/Response 2013-1-11 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 1 NO 80 NO 2.5 NO NO 50 No M0 N2 T2 Stage IIIA 3396 Other TUMOR FREE 98 89 Complete Remission/Response YES NO R0 Solid Tissue Normal 11 0.9 7th YES YES NO 44 2 Current smoker Lung A LIVING 2009 1959 f879b84d-a2e7-4189-bcf6-9286b52e19dd f879b84d-a2e7-4189-bcf6-9286b52e19dd f879b84d-a2e7-4189-bcf6-9286b52e19dd +TCGA-44-3398-01 TCGA-44-3398-01 Kirc+ C1-LUAD-enriched Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 4 mutation c1uster 9 TCGA-44-3398 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 77 R-Lower TCGA-44-3398-F38762 TCGA-44-3398 TCGA-44-3398-01A -28392 0 1163 60 Scheduled Follow-up Submission Complete Remission/Response 2012-12-21 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 0.9 NO NO 1.7 NO NO 60 No M0 N0 T1b Stage IA TCGA-44-3398.7dc9c668-3304-47d8-9c33-5b72352672db.pdf 3398 TUMOR FREE 89 96 84 87 Complete Remission/Response YES NO R0 Primary Tumor 01 0.5 2009 6th NO YES NO 44 4 Lung A LIVING 2009 1959 c63e6cf3-936d-4d14-ab87-11aa4ef51242 TCGA-44-3398-01A-01D-1104-05 TCGA-44-3398-01A-01D-1105-08 c63e6cf3-936d-4d14-ab87-11aa4ef51242 TCGA-44-3398-01A-01D-1877-01 TCGA-44-3398-01A-01R-1107-07 c63e6cf3-936d-4d14-ab87-11aa4ef51242 TCGA-44-3398-01A-01D-1877-01 TCGA-44-3398-01A-31-2190-20 +TCGA-44-3398-11 TCGA-44-3398-11 C1-LUAD-enriched mutation c1uster 9 TCGA-44-3398 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 77 R-Lower TCGA-44-3398-F38762 TCGA-44-3398 TCGA-44-3398-11B -28392 0 1163 60 Scheduled Follow-up Submission Complete Remission/Response 2012-12-21 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 0.8 NO NO 1.8 NO NO 60 No M0 N0 T1b Stage IA 3398 TUMOR FREE 89 96 84 87 Complete Remission/Response YES NO R0 Solid Tissue Normal 11 0.8 2009 6th NO YES NO 44 4 Lung B LIVING 2009 1959 453cdfcc-52a8-4ab0-80ac-ce1dc1bc1bf8 453cdfcc-52a8-4ab0-80ac-ce1dc1bc1bf8 453cdfcc-52a8-4ab0-80ac-ce1dc1bc1bf8 +TCGA-44-3917-01 TCGA-44-3917-01 squamous c3 TCGA-44-3917 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 33 R-Upper TCGA-44-3917-F38799 TCGA-44-3917 TCGA-44-3917-01A -12179 0 1183 FPPP 83 Scheduled Follow-up Submission Complete Remission/Response 2012-12-24 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.6 NO 100 NO 1.2 NO NO 16 No M0 N0 T2 Stage IB TCGA-44-3917.240f6268-ffef-488e-855d-9c39e3969c65.pdf 3917 Post-Adjuvant Therapy TUMOR FREE 87 106 Complete Remission/Response TCGA YES NO R0 Primary Tumor 01 0.2 6th NO YES NO 44 2 Lung A LIVING 2009 1993 TCGA-44-3917-01B-02D-A276-05,TCGA-44-3917-01A-01D-A276-05 TCGA-44-3917-01A-01D-A273-01 TCGA-44-3917-01A-01D-A273-01 TCGA-44-3917-01A-21-2190-20 +TCGA-44-3918-01 TCGA-44-3918-01 High C1-LUAD-enriched Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 4 mutation cluster 11 TCGA-44-3918 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung YES YES NO 60 L-Upper TCGA-44-3918-F38999 TCGA-44-3918 TCGA-44-3918-01A -22236 0 1036 511 FPPP 76 Scheduled Follow-up Submission Stable Disease 2013-1-10 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 280 0.8 NO 90 NO 2 NO Locoregional Recurrence YES 20 No M0 N0 T1 Stage IA TCGA-44-3918.da381e6d-f69d-424f-ab84-5c300ca19435.pdf 3918 Other WITH TUMOR 103 104 Complete Remission/Response Biopsy with Histologic Confirmation|Convincing Imaging TCGA YES NO R0 Primary Tumor 01 0.8 1994 6th NO YES NO 44 3 Lung A LIVING 2010 1974 d9f5e680-b72e-4a64-942b-191154d8012a TCGA-44-3918-01A-01D-1104-05 TCGA-44-3918-01A-01D-1105-08 d9f5e680-b72e-4a64-942b-191154d8012a TCGA-44-3918-01B-02D-A276-05,TCGA-44-3918-01A-01D-A276-05 TCGA-44-3918-01A-01D-A273-01 TCGA-44-3918-01A-01R-1107-07 d9f5e680-b72e-4a64-942b-191154d8012a TCGA-44-3918-01A-01D-A273-01 TCGA-44-3918-01A-21-2190-20 +TCGA-44-3918-11 TCGA-44-3918-11 C1-LUAD-enriched mutation cluster 11 TCGA-44-3918 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung YES YES NO 60 L-Upper TCGA-44-3918-F38999 TCGA-44-3918 TCGA-44-3918-11A -22236 0 1036 511 FPPP 76 Scheduled Follow-up Submission Stable Disease 2013-1-10 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 600 0.8 NO 90 NO 2 NO Locoregional Recurrence YES 20 No M0 N0 T1 Stage IA 3918 Other WITH TUMOR 103 104 Complete Remission/Response Biopsy with Histologic Confirmation|Convincing Imaging TCGA YES NO R0 Solid Tissue Normal 11 0.8 1994 6th NO YES NO 44 3 Lung A LIVING 2010 1974 TCGA-44-3918-11A-01D-1104-05 +TCGA-44-3919-01 1.94 0.49 none none none none N Y none p.774_775insAYVM none 0.25 Bronchioid none none none none none none none Solid predominant Adc Solid predominant Adc none 0 TCGA-44-3919-01 High C1-LUAD-enriched Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 4 mutation c1uster 9 TCGA-44-3919 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung NO YES NO NO 71 R-Upper TCGA-44-3919-F38530 TCGA-44-3919 -26081 1026 0 190 984 103 2 Additional New Tumor Event 2012-12-19 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES NO NO Distant Metastasis YES No M0 N0 T1 Stage IA 3919 Other WITH TUMOR 99 100 Complete Remission/Response Convincing Imaging YES NO R0 Primary Tumor 01 7th NO YES NO 44 1 Lifelong Non-smoker Lung DECEASED 2010 fa3183f2-b71c-4837-8b1e-5e29336caf62 TCGA-44-3919-01A-02D-1104-05 TCGA-44-3919-01 fa3183f2-b71c-4837-8b1e-5e29336caf62 TCGA-44-3919-01A-02D-1877-01 TCGA-44-3919-01A-02R-1107-07 fa3183f2-b71c-4837-8b1e-5e29336caf62 TCGA-44-3919-01A-02D-1877-01 TCGA-44-3919-01A-11-2190-20 +TCGA-44-3919-11 1.94 0.49 none none none none N Y none p.774_775insAYVM none 0.25 Bronchioid none none none none none none none Solid predominant Adc Solid predominant Adc none 0 TCGA-44-3919-11 C1-LUAD-enriched mutation c1uster 9 TCGA-44-3919 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung NO YES NO NO 71 R-Upper TCGA-44-3919-F38530 TCGA-44-3919 TCGA-44-3919-11A -26081 1026 0 190 984 103 2 Additional New Tumor Event 2012-12-19 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.7 NO NO 1.3 NO Distant Metastasis YES No M0 N0 T1 Stage IA 3919 Other WITH TUMOR 99 100 Complete Remission/Response Convincing Imaging YES NO R0 Solid Tissue Normal 11 0.4 7th NO YES NO 44 1 Lifelong Non-smoker Lung A DECEASED 2010 TCGA-44-3919-11A-01D-1104-05 +TCGA-44-4112-01 2.13 0.56 none none none p.G367V N N none none p.C304F 0.27 Squamoid none none none none none none none Solid predominant Adc Solid predominant Adc none 0 TCGA-44-4112-01 BRCA-LUAD+ C1-LUAD-enriched Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 4 mutation cluster 12 TCGA-44-4112 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung NO 60 R-Upper TCGA-44-4112-F32266 TCGA-44-4112 TCGA-44-4112-01A -22106 808 0 141 FPPP 2012-5-22 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 220 1 NO NO 2 NO 30 No M0 N0 T2a Stage IB TCGA-44-4112.9f214c90-f9a8-458c-8a53-ca8e8b09a2b2.pdf 4112 WITH TUMOR TCGA YES R0 Primary Tumor 01 0.4 1992 6th YES NO 44 3 Current reformed smoker for > 15 years Lung A DECEASED 2010 1972 220d4f21-012b-4e06-aabf-a32d23f28a78 TCGA-44-4112-01A-01D-1104-05 TCGA-44-4112-01 220d4f21-012b-4e06-aabf-a32d23f28a78 TCGA-44-4112-01B-06D-A276-05,TCGA-44-4112-01A-01D-A276-05 TCGA-44-4112-01A-01D-A273-01 TCGA-44-4112-01A-01R-1107-07 220d4f21-012b-4e06-aabf-a32d23f28a78 TCGA-44-4112-01A-01D-A273-01 TCGA-44-4112-01A-21-2190-20 +TCGA-44-4112-11 2.13 0.56 none none none p.G367V N N none none p.C304F 0.27 Squamoid none none none none none none none Solid predominant Adc Solid predominant Adc none 0 TCGA-44-4112-11 C1-LUAD-enriched mutation cluster 12 TCGA-44-4112 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung NO 60 R-Upper TCGA-44-4112-F32266 TCGA-44-4112 TCGA-44-4112-11A -22106 808 0 141 FPPP 2012-5-22 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 520 1 NO NO 1.5 NO 30 No M0 N0 T2a Stage IB 4112 WITH TUMOR TCGA YES R0 Solid Tissue Normal 11 0.4 1992 6th YES NO 44 3 Current reformed smoker for > 15 years Lung A DECEASED 2010 1972 TCGA-44-4112-11A-01D-1104-05 +TCGA-44-5643-01 TCGA-44-5643-01 Squamous C2-Squamous-like Cluster 13 (HNSC-LUSC) BRCA basal-like c6 squamous-like c4 miRNA cluster 11 mutation cluster 3 TCGA-44-5643 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung NO 53 R-Lower TCGA-44-5643-F39742 TCGA-44-5643 TCGA-44-5643-01A -19426 0 1013 75 1 Scheduled Follow-up Submission Complete Remission/Response 2013-2-25 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 0.8 NO 1.2 NO NO 20 No M0 N2 T2b Stage IIIA TCGA-44-5643.3117a24b-6125-47a8-a05b-4ada99e68dfa.pdf 5643 Other TUMOR FREE 92 66 YES Primary Tumor 01 0.8 7th YES NO 44 2 Lung A LIVING 2010 a8ef928f-7321-4355-b136-cec50ebd9481 TCGA-44-5643-01A-01D-1625-08 a8ef928f-7321-4355-b136-cec50ebd9481 TCGA-44-5643-01A-01D-1626-05 TCGA-44-5643-01A-01D-1624-01 a8ef928f-7321-4355-b136-cec50ebd9481 TCGA-44-5643-01A-01D-1624-01 TCGA-44-5643-01A-41-2191-20 +TCGA-44-5643-11 TCGA-44-5643-11 C2-Squamous-like mutation cluster 3 TCGA-44-5643 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung NO 53 R-Lower TCGA-44-5643-F39742 TCGA-44-5643 TCGA-44-5643-11A -19426 0 1013 75 1 Scheduled Follow-up Submission Complete Remission/Response 2013-2-25 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 0.9 NO 1.9 NO NO 20 No M0 N2 T2b Stage IIIA 5643 Other TUMOR FREE 92 66 YES Solid Tissue Normal 11 0.7 7th YES NO 44 2 Lung A LIVING 2010 TCGA-44-5643-11A-01D-1626-05 +TCGA-44-5644-01 TCGA-44-5644-01 High C1-LUAD-enriched Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 6 TCGA-44-5644 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung NO 51 R-Lower TCGA-44-5644-F38817 TCGA-44-5644 TCGA-44-5644-01A -18644 0 863 61 Scheduled Follow-up Submission Complete Remission/Response 2012-12-26 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 1 NO 1 NO NO 17.5 No N0 T2a Stage IB TCGA-44-5644.041e212a-2fdd-42af-9326-9fb5fef07126.pdf 5644 TUMOR FREE 103 59 Complete Remission/Response YES NO Primary Tumor 01 0.2 7th NO YES NO 44 2 Lung A LIVING 2010 1975 44205bf0-b593-4c0d-9aeb-4e604314e10f 44205bf0-b593-4c0d-9aeb-4e604314e10f TCGA-44-5644-01A-21D-2037-05 TCGA-44-5644-01A-21D-2035-01 44205bf0-b593-4c0d-9aeb-4e604314e10f TCGA-44-5644-01A-21D-2035-01 TCGA-44-5644-01A-41-2191-20 +TCGA-44-5645-01 2.38 0.54 none none none none N N none none none 0.24 Bronchioid none none none none none p.H1047R none Lepidic predominant Adc Lepidic predominant Adc none 0 TCGA-44-5645-01 Iq C1-LUAD-enriched Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 5 mutation cluster 3 TCGA-44-5645 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung NO 61 L-Upper TCGA-44-5645-F38800 TCGA-44-5645 TCGA-44-5645-01A -22471 0 852 FPPP 82 Scheduled Follow-up Submission Complete Remission/Response 2012-12-24 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 140 0.6 NO 1.3 NO NO 5 No NX T1 Stage IA TCGA-44-5645.8904f1ec-527d-4f2e-a112-157d31ec9b3d.pdf 5645 TUMOR FREE 90 100 Complete Remission/Response TCGA YES NO Primary Tumor 01 0.4 1973 7th NO YES NO 44 3 Current reformed smoker for > 15 years Lung A LIVING 2010 1963 b4bbc93a-5460-476d-a663-61299fddfab2 TCGA-44-5645-01A-01D-1625-08 b4bbc93a-5460-476d-a663-61299fddfab2 TCGA-44-5645-01B-04D-A276-05,TCGA-44-5645-01A-01D-A276-05,TCGA-44-5645-01A-01D-1626-05 TCGA-44-5645-01A-01D-A273-01 b4bbc93a-5460-476d-a663-61299fddfab2 TCGA-44-5645-01A-01D-A273-01 TCGA-44-5645-01A-41-2191-20 +TCGA-44-5645-11 2.38 0.54 none none none none N N none none none 0.24 Bronchioid none none none none none p.H1047R none Lepidic predominant Adc Lepidic predominant Adc none 0 TCGA-44-5645-11 C1-LUAD-enriched mutation cluster 3 TCGA-44-5645 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung NO 61 L-Upper TCGA-44-5645-F38800 TCGA-44-5645 TCGA-44-5645-11A -22471 0 852 FPPP 82 Scheduled Follow-up Submission Complete Remission/Response 2012-12-24 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 860 1 NO 2.4 NO NO 5 No NX T1 Stage IA 5645 TUMOR FREE 90 100 Complete Remission/Response TCGA YES NO Solid Tissue Normal 11 0.8 1973 7th NO YES NO 44 3 Current reformed smoker for > 15 years Lung A LIVING 2010 1963 cafb7a81-9e7a-49c0-8a55-96cb32ad273e cafb7a81-9e7a-49c0-8a55-96cb32ad273e TCGA-44-5645-11A-01D-1626-05 cafb7a81-9e7a-49c0-8a55-96cb32ad273e +TCGA-44-6144-01 TCGA-44-6144-01 BRCA-LUAD+ C1-LUAD-enriched Cluster 5 squamous c3 miRNA cluster 5 mutation cluster 2 TCGA-44-6144 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung YES NO NO NO 58 R-Upper TCGA-44-6144-F39034 TCGA-44-6144 TCGA-44-6144-01A -21283 0 723 399 82 0 Scheduled Follow-up Submission Progressive Disease 2013-1-9 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.6 NO 70 0.9 NO Locoregional Recurrence|Distant Metastasis YES 67.5 No M0 N0 T1a Stage IA TCGA-44-6144.1dfaf7f2-8902-403c-b903-dc59c8156d17.pdf 6144 Other WITH TUMOR 97 77 87 63 Complete Remission/Response Biopsy with Histologic Confirmation|Convincing Imaging YES NO RX Primary Tumor 01 0.4 7th NO YES NO 44 2 Lung A LIVING 2011 1968 TCGA-44-6144-01A-11D-1753-08 TCGA-44-6144-01A-11D-1756-05 TCGA-44-6144-01A-11D-1752-01 TCGA-44-6144-01A-11D-1752-01 TCGA-44-6144-01A-13-2191-20 +TCGA-44-6144-11 TCGA-44-6144-11 C1-LUAD-enriched mutation cluster 2 TCGA-44-6144 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung YES NO NO NO 58 R-Upper TCGA-44-6144-F39034 TCGA-44-6144 TCGA-44-6144-11A -21283 0 723 399 82 0 Scheduled Follow-up Submission Progressive Disease 2013-1-9 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.9 NO 70 2 NO Locoregional Recurrence|Distant Metastasis YES 67.5 No M0 N0 T1a Stage IA 6144 Other WITH TUMOR 97 77 87 63 Complete Remission/Response Biopsy with Histologic Confirmation|Convincing Imaging YES NO RX Solid Tissue Normal 11 0.9 7th NO YES NO 44 2 Lung A LIVING 2011 1968 e9c07b6c-0a18-44ff-90cd-d39ae6c47fd6 e9c07b6c-0a18-44ff-90cd-d39ae6c47fd6 TCGA-44-6144-11A-01D-1756-05 e9c07b6c-0a18-44ff-90cd-d39ae6c47fd6 +TCGA-44-6145-01 1.66 0.31 none none none none Y Y none none none 0.16 Squamoid none p.G12V none none none none none Solid predominant Adc Solid predominant Adc none 0 TCGA-44-6145-01 High C1-LUAD-enriched Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 4 mutation cluster 11 TCGA-44-6145 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 62 R-Upper TCGA-44-6145-F38802 TCGA-44-6145 TCGA-44-6145-01A -22745 0 595 73 0 Scheduled Follow-up Submission Complete Remission/Response 2012-12-24 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 1 NO NO NO 1.5 NO NO 75 No M0 N0 T1 Stage IA TCGA-44-6145.57537882-084b-4082-bcf0-f7d297a877e6.pdf 6145 Preoperative TUMOR FREE 91 90 77 71 Complete Remission/Response YES NO Primary Tumor 01 0.5 1999 7th NO YES NO 44 4 Current reformed smoker for < or = 15 years Lung A LIVING 2011 1963 2d452408-9d25-49e1-81db-542021eb28cb TCGA-44-6145-01A-11D-1753-08 2d452408-9d25-49e1-81db-542021eb28cb TCGA-44-6145-01A-11D-1756-05 TCGA-44-6145-01A-11D-1752-01 2d452408-9d25-49e1-81db-542021eb28cb TCGA-44-6145-01A-11D-1752-01 TCGA-44-6145-01A-13-2191-20 +TCGA-44-6145-11 1.66 0.31 none none none none Y Y none none none 0.16 Squamoid none p.G12V none none none none none Solid predominant Adc Solid predominant Adc none 0 TCGA-44-6145-11 C1-LUAD-enriched mutation cluster 11 TCGA-44-6145 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 62 R-Upper TCGA-44-6145-F38802 TCGA-44-6145 TCGA-44-6145-11A -22745 0 595 73 0 Scheduled Follow-up Submission Complete Remission/Response 2012-12-24 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 1 NO NO NO 2 NO NO 75 No M0 N0 T1 Stage IA 6145 Preoperative TUMOR FREE 91 90 77 71 Complete Remission/Response YES NO Solid Tissue Normal 11 1 1999 7th NO YES NO 44 4 Current reformed smoker for < or = 15 years Lung A LIVING 2011 1963 3b3948f2-e93e-4d89-8611-3cde3b962193 3b3948f2-e93e-4d89-8611-3cde3b962193 TCGA-44-6145-11A-01D-1756-05 3b3948f2-e93e-4d89-8611-3cde3b962193 +TCGA-44-6146-01 1.87 0.74 none none none none Y Y none none none 0.39 Bronchioid none p.G12V none none none none none Invasive mucinous Invasive mucinous none 0 TCGA-44-6146-01 BRCA-LUAD+ C1-LUAD-enriched Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 6 mutation cluster 12 TCGA-44-6146 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung YES NO NO 64 L-Lower TCGA-44-6146-F34551 TCGA-44-6146 TCGA-44-6146-01A -23378 0 728 631 FPPP 76 0 Additional New Tumor Event 2012-8-22 MALE Lung Mucinous Adenocarcinoma No C34.30 8480/3 C34.3 YES 420 0.8 NO 2 NO Locoregional Recurrence YES 15 Yes M0 N0 T3 Stage IIB TCGA-44-6146.51a479ab-4c21-4189-a682-e6976d509ed3.pdf 6146 Other TUMOR FREE 95 94 88 87 Convincing Imaging TCGA YES Primary Tumor 01 0.8 1980 7th YES NO 44 3 Current reformed smoker for > 15 years Lung A LIVING 2010 c18d4714-5af9-4370-8b6d-f86b0c43b285 TCGA-44-6146-01A-11D-1753-08 c18d4714-5af9-4370-8b6d-f86b0c43b285 TCGA-44-6146-01A-11D-1756-05,TCGA-44-6146-01A-11D-A276-05,TCGA-44-6146-01B-04D-A276-05 TCGA-44-6146-01A-11D-A273-01 c18d4714-5af9-4370-8b6d-f86b0c43b285 TCGA-44-6146-01A-11D-A273-01 TCGA-44-6146-01A-13-2191-20 +TCGA-44-6146-11 1.87 0.74 none none none none Y Y none none none 0.39 Bronchioid none p.G12V none none none none none Invasive mucinous Invasive mucinous none 0 TCGA-44-6146-11 C1-LUAD-enriched mutation cluster 12 TCGA-44-6146 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung YES NO NO 64 L-Lower TCGA-44-6146-F34551 TCGA-44-6146 TCGA-44-6146-11A -23378 0 728 631 FPPP 76 0 Additional New Tumor Event 2012-8-22 MALE Lung Mucinous Adenocarcinoma No C34.30 8480/3 C34.3 YES 400 0.9 NO 1.5 NO Locoregional Recurrence YES 15 Yes M0 N0 T3 Stage IIB 6146 Other TUMOR FREE 95 94 88 87 Convincing Imaging TCGA YES Solid Tissue Normal 11 0.9 1980 7th YES NO 44 3 Current reformed smoker for > 15 years Lung A LIVING 2010 488285fc-5482-46b7-b97e-2f5e7330311a 488285fc-5482-46b7-b97e-2f5e7330311a TCGA-44-6146-11A-01D-1756-05 488285fc-5482-46b7-b97e-2f5e7330311a +TCGA-44-6147-01 2.19 0.36 none none none none Y Y p.S768I, p.V769L none none 0.17 Bronchioid none none none none none none none Acinar predominant Adc Acinar predominant Adc none 0 TCGA-44-6147-01 High C1-LUAD-enriched Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 5 mutation cluster 8 TCGA-44-6147 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung NO NO NO 67 R-Upper TCGA-44-6147-F38947 TCGA-44-6147 TCGA-44-6147-01A -24631 0 845 FPPP 68 Scheduled Follow-up Submission Complete Remission/Response 2013-1-4 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 80 0.8 NO 80 1 NO NO Yes M0 NX T1b Stage IA TCGA-44-6147.06f76ecf-14db-4228-b413-f6b4e187a1e4.pdf 6147 Other TUMOR FREE 105 97 Complete Remission/Response TCGA YES NO Primary Tumor 01 0.6 1980 7th NO YES NO 44 3 Current reformed smoker for > 15 years Lung A LIVING 2010 1976 29af0307-5d76-462d-beee-18e8c4f179b8 TCGA-44-6147-01A-11D-1753-08 29af0307-5d76-462d-beee-18e8c4f179b8 TCGA-44-6147-01A-11D-1756-05,TCGA-44-6147-01B-06D-A276-05,TCGA-44-6147-01A-11D-A276-05 TCGA-44-6147-01A-11D-A273-01 29af0307-5d76-462d-beee-18e8c4f179b8 TCGA-44-6147-01A-11D-A273-01 TCGA-44-6147-01A-13-2191-20 +TCGA-44-6147-11 2.19 0.36 none none none none Y Y p.S768I, p.V769L none none 0.17 Bronchioid none none none none none none none Acinar predominant Adc Acinar predominant Adc none 0 TCGA-44-6147-11 C1-LUAD-enriched mutation cluster 8 TCGA-44-6147 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung NO NO NO 67 R-Upper TCGA-44-6147-F38947 TCGA-44-6147 TCGA-44-6147-11A -24631 0 845 FPPP 68 Scheduled Follow-up Submission Complete Remission/Response 2013-1-4 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 720 1 NO 80 2.2 NO NO Yes M0 NX T1b Stage IA 6147 Other TUMOR FREE 105 97 Complete Remission/Response TCGA YES NO Solid Tissue Normal 11 1 1980 7th NO YES NO 44 3 Current reformed smoker for > 15 years Lung A LIVING 2010 1976 2f16ddcc-8a98-4734-9878-645ff102fb14 2f16ddcc-8a98-4734-9878-645ff102fb14 TCGA-44-6147-11A-01D-1756-05 2f16ddcc-8a98-4734-9878-645ff102fb14 +TCGA-44-6148-01 TCGA-44-6148-01 Kirc+ C1-LUAD-enriched Low purity c2 squamous c3 LUAD-like c10 mutation c1uster 9 TCGA-44-6148 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung NO 60 L-Lower TCGA-44-6148-F38967 TCGA-44-6148 TCGA-44-6148-01A -22138 0 704 1 Scheduled Follow-up Submission Complete Remission/Response 2013-1-7 MALE Lung Mucinous Adenocarcinoma No C34.30 8480/3 C34.3 YES 0.8 NO NO NO 1.5 NO NO 60 No M0 N0 T1b Stage IA TCGA-44-6148.5407ff6d-a042-47db-998b-60e6f15109ab.pdf 6148 Preoperative TUMOR FREE 110 77 98 74 Complete Remission/Response YES NO RX Primary Tumor 01 0.4 1994 7th NO YES NO 44 3 Lung A LIVING 2011 1963 472518f5-c62b-4e50-9ea9-077a44a8f117 TCGA-44-6148-01A-11D-1753-08 472518f5-c62b-4e50-9ea9-077a44a8f117 TCGA-44-6148-01A-11D-1756-05 TCGA-44-6148-01A-11D-1752-01 472518f5-c62b-4e50-9ea9-077a44a8f117 TCGA-44-6148-01A-11D-1752-01 TCGA-44-6148-01A-13-2191-20 +TCGA-44-6148-11 TCGA-44-6148-11 C1-LUAD-enriched mutation c1uster 9 TCGA-44-6148 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung NO 60 L-Lower TCGA-44-6148-F38967 TCGA-44-6148 TCGA-44-6148-11A -22138 0 704 1 Scheduled Follow-up Submission Complete Remission/Response 2013-1-7 MALE Lung Mucinous Adenocarcinoma No C34.30 8480/3 C34.3 YES 0.9 NO NO NO 2.3 NO NO 60 No M0 N0 T1b Stage IA 6148 Preoperative TUMOR FREE 110 77 98 74 Complete Remission/Response YES NO RX Solid Tissue Normal 11 0.9 1994 7th NO YES NO 44 3 Lung A LIVING 2011 1963 0391cb59-6ceb-4d9a-be02-5d68b4ddafc3 0391cb59-6ceb-4d9a-be02-5d68b4ddafc3 TCGA-44-6148-11A-01D-1756-05 0391cb59-6ceb-4d9a-be02-5d68b4ddafc3 +TCGA-44-6774-01 2.13 0.36 none p.N581S none none N N none none none 0.18 Squamoid none none none none none none none Acinar predominant Adc Acinar predominant Adc none 0 TCGA-44-6774-01 High C1-LUAD-enriched Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 5 mutation cluster 13 TCGA-44-6774 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung NO 56 L-Lower TCGA-44-6774-F39646 TCGA-44-6774 TCGA-44-6774-01A -20462 0 658 101 1 Scheduled Follow-up Submission Complete Remission/Response 2013-1-28 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 1 NO 1.5 NO NO 20 No M0 N2 T1 Stage IIIA TCGA-44-6774.f9587269-4f32-497a-a95a-42d505af2434.pdf 6774 Other TUMOR FREE 84 96 Complete Remission/Response YES YES Primary Tumor 01 0.3 7th YES YES NO 44 2 Current smoker Lung A LIVING 2011 1971 7d27cfbf-870f-45e8-80a9-7e3848f414dc TCGA-44-6774-01A-21D-1855-08 7d27cfbf-870f-45e8-80a9-7e3848f414dc TCGA-44-6774-01A-21D-1856-05 TCGA-44-6774-01A-21D-1854-01 7d27cfbf-870f-45e8-80a9-7e3848f414dc TCGA-44-6774-01A-21D-1854-01 TCGA-44-6774-01A-23-2191-20 +TCGA-44-6775-01 2.24 0.38 none none none none N N none none none 0.18 Squamoid none none none exon 14 skipping by RSeq none none none Acinar predominant Adc Acinar predominant Adc none 0 TCGA-44-6775-01 BRCA-LUAD+ C1-LUAD-enriched Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 4 mutation cluster 13 TCGA-44-6775 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung NO NO NO 72 R-Upper TCGA-44-6775-F40408 TCGA-44-6775 TCGA-44-6775-01A -26415 0 705 684 FPPP 66 Scheduled Follow-up Submission Progressive Disease 2013-2-19 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 70 1.1 NO 100 1.1 NO Locoregional Recurrence YES 25 No MX N0 T2a Stage IB TCGA-44-6775.cd641541-f607-49de-8f57-fa54b0561721.pdf 6775 Other WITH TUMOR 89 72 84 68 Complete Remission/Response Convincing Imaging TCGA YES NO RX Primary Tumor 01 0.2 2005 7th NO YES NO 44 4 Current reformed smoker for < or = 15 years Lung A LIVING 2011 1955 6a4b7295-a738-4d4a-a264-72fba462e60c TCGA-44-6775-01A-11D-1855-08 6a4b7295-a738-4d4a-a264-72fba462e60c TCGA-44-6775-01A-11D-1856-05,TCGA-44-6775-01A-11D-A276-05,TCGA-44-6775-01C-02D-A276-05 TCGA-44-6775-01A-11D-A273-01 6a4b7295-a738-4d4a-a264-72fba462e60c TCGA-44-6775-01A-11D-A273-01 TCGA-44-6775-01A-13-2191-20 +TCGA-44-6776-01 1.95 0.64 none none none none Y Y none none none 0.33 Bronchioid none p.G12D none none none none none Papillary predominant Adc Papillary predominant Adc p.Q220* 0 TCGA-44-6776-01 BRCA-LUAD+ C1-LUAD-enriched Cluster 5 squamous c3 LUAD-like c10 miRNA c1uster 9 mutation cluster 7 TCGA-44-6776 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung NO 60 R-Upper TCGA-44-6776-F39378 TCGA-44-6776 TCGA-44-6776-01A -22150 0 2616 80 Scheduled Follow-up Submission Complete Remission/Response 2013-1-21 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.7 NO 1.5 NO NO 45 Yes MX N0 T1 Stage IA TCGA-44-6776.b28e19bf-f05d-46a6-85b8-2319be9fcb22.pdf 6776 TUMOR FREE 85 82 95 74 Complete Remission/Response YES NO Primary Tumor 01 0.5 2005 6th NO NO YES 44 4 Current reformed smoker for < or = 15 years Lung A LIVING 2005 1960 aae03245-71cc-4081-87b6-925f96bee9ef TCGA-44-6776-01A-11D-1855-08 aae03245-71cc-4081-87b6-925f96bee9ef TCGA-44-6776-01A-11D-1856-05 TCGA-44-6776-01A-11D-1854-01 aae03245-71cc-4081-87b6-925f96bee9ef TCGA-44-6776-01A-11D-1854-01 TCGA-44-6776-01A-13-2191-20 +TCGA-44-6776-11 1.95 0.64 none none none none Y Y none none none 0.33 Bronchioid none p.G12D none none none none none Papillary predominant Adc Papillary predominant Adc p.Q220* 0 TCGA-44-6776-11 C1-LUAD-enriched mutation cluster 7 TCGA-44-6776 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung NO 60 R-Upper TCGA-44-6776-F39378 TCGA-44-6776 TCGA-44-6776-11A -22150 0 2616 80 Scheduled Follow-up Submission Complete Remission/Response 2013-1-21 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.9 NO 1.2 NO NO 45 Yes MX N0 T1 Stage IA 6776 TUMOR FREE 85 82 95 74 Complete Remission/Response YES NO Solid Tissue Normal 11 0.9 2005 6th NO NO YES 44 4 Current reformed smoker for < or = 15 years Lung A LIVING 2005 1960 d3402ac8-0188-4fb8-8054-ba3145120952 d3402ac8-0188-4fb8-8054-ba3145120952 d3402ac8-0188-4fb8-8054-ba3145120952 +TCGA-44-6777-01 1.91 0.34 none none none none Y Y none none p.D335Y 0.17 Squamoid none p.G12C none none none none none Solid predominant Adc Solid predominant Adc none 0 TCGA-44-6777-01 High C1-LUAD-enriched Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 4 mutation cluster 2 TCGA-44-6777 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 85 L-Upper TCGA-44-6777-F15694 TCGA-44-6777 TCGA-44-6777-01A -31234 987 0 178 3 Scheduled Follow-up Submission 2011-8-30 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 1 NO 1.8 NO 64 No MX NX T2 Stage IB TCGA-44-6777.600a1078-21f2-4267-9d3c-03f292fa6a32.pdf 6777 Post-Adjuvant Therapy TUMOR FREE 77 71 68 62 Complete Remission/Response YES YES Primary Tumor 01 0.4 2006 6th NO NO YES 44 4 Current reformed smoker for < or = 15 years Lung A DECEASED 2006 1942 25f0eee1-8f38-4e75-accf-7e7bb686405c TCGA-44-6777-01A-11D-1855-08 25f0eee1-8f38-4e75-accf-7e7bb686405c TCGA-44-6777-01A-11D-1856-05 TCGA-44-6777-01A-11D-1854-01 25f0eee1-8f38-4e75-accf-7e7bb686405c TCGA-44-6777-01A-11D-1854-01 TCGA-44-6777-01A-13-2191-20 +TCGA-44-6777-11 1.91 0.34 none none none none Y Y none none p.D335Y 0.17 Squamoid none p.G12C none none none none none Solid predominant Adc Solid predominant Adc none 0 TCGA-44-6777-11 C1-LUAD-enriched mutation cluster 2 TCGA-44-6777 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 85 L-Upper TCGA-44-6777-F15694 TCGA-44-6777 TCGA-44-6777-11A -31234 987 0 178 3 Scheduled Follow-up Submission 2011-8-30 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.6 NO 1 NO 64 No MX NX T2 Stage IB 6777 Post-Adjuvant Therapy TUMOR FREE 77 71 68 62 Complete Remission/Response YES YES Solid Tissue Normal 11 0.4 2006 6th NO NO YES 44 4 Current reformed smoker for < or = 15 years Lung A DECEASED 2006 1942 f3bb69da-304f-462d-b020-f479a866381e f3bb69da-304f-462d-b020-f479a866381e f3bb69da-304f-462d-b020-f479a866381e +TCGA-44-6778-01 TCGA-44-6778-01 High C1-LUAD-enriched Low purity c2 squamous c3 LUAD-like c10 miRNA cluster 6 mutation cluster 2 TCGA-44-6778 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 59 [Discrepancy] TCGA-44-6778-F39376 TCGA-44-6778 TCGA-44-6778-01A -21725 0 1864 53 Scheduled Follow-up Submission Complete Remission/Response 2013-1-21 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.9 YES 0.9 NO 1 NO NO 15 No MX N0 T1 Stage IA TCGA-44-6778.b1f41c0e-a2a1-4945-85b3-a2ef6a994cbe.pdf 6778 TUMOR FREE 90 74 Complete Remission/Response YES NO Primary Tumor 01 0.8 2004 6th NO NO YES 44 4 Lung A LIVING 2007 1974 ee90d7cd-4ac9-4be0-b9a8-49329890f69d TCGA-44-6778-01A-11D-1855-08 ee90d7cd-4ac9-4be0-b9a8-49329890f69d TCGA-44-6778-01A-11D-1856-05 TCGA-44-6778-01A-11D-1854-01 ee90d7cd-4ac9-4be0-b9a8-49329890f69d TCGA-44-6778-01A-11D-1854-01 TCGA-44-6778-01A-13-2191-20 +TCGA-44-6778-11 TCGA-44-6778-11 C1-LUAD-enriched mutation cluster 2 TCGA-44-6778 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 59 [Discrepancy] TCGA-44-6778-F39376 TCGA-44-6778 TCGA-44-6778-11A -21725 0 1864 53 Scheduled Follow-up Submission Complete Remission/Response 2013-1-21 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.9 YES 0.9 NO 0.9 NO NO 15 No MX N0 T1 Stage IA 6778 TUMOR FREE 90 74 Complete Remission/Response YES NO Solid Tissue Normal 11 0.9 2004 6th NO NO YES 44 4 Lung A LIVING 2007 1974 a89e4f9e-0dfe-449d-a215-6c770cc5ea55 a89e4f9e-0dfe-449d-a215-6c770cc5ea55 TCGA-44-6778-11A-01D-1856-05 a89e4f9e-0dfe-449d-a215-6c770cc5ea55 +TCGA-44-6779-01 3.12 0.43 none none none none N N none none none 0.17 Squamoid none none none none none none none Solid predominant Adc Solid predominant Adc p.K235* 0 TCGA-44-6779-01 High C1-LUAD-enriched Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 4 mutation cluster 8 TCGA-44-6779 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung YES NO NO 50 [Discrepancy] TCGA-44-6779-F15758 TCGA-44-6779 TCGA-44-6779-01A -18469 500 0 232 44 Scheduled Follow-up Submission 2011-9-12 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.9 YES 0.7 NO 1 YES 15 No MX N1 T2 Stage IIB TCGA-44-6779.7f7b5635-2f0e-4f0e-b56a-5c19cfe0593c.pdf 6779 WITH TUMOR 83 48 83 49 Progressive Disease YES NO Primary Tumor 01 0.5 2008 6th YES NO YES 44 4 Current reformed smoker for < or = 15 years Lung A DECEASED 2008 1978 57f72fed-dcb9-4bba-8810-30c254f4635c TCGA-44-6779-01A-11D-1855-08 57f72fed-dcb9-4bba-8810-30c254f4635c TCGA-44-6779-01A-11D-1856-05 TCGA-44-6779-01A-11D-1854-01 57f72fed-dcb9-4bba-8810-30c254f4635c TCGA-44-6779-01A-11D-1854-01 TCGA-44-6779-01A-13-2191-20 +TCGA-44-7659-01 2.09 0.59 none none none none Y Y none none none 0.29 Bronchioid none p.G12C none none none none none Acinar predominant Adc Acinar predominant Adc none 0 TCGA-44-7659-01 Iq C1-LUAD-enriched Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 5 TCGA-44-7659 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung NO 70 L-Upper TCGA-44-7659-F39654 TCGA-44-7659 TCGA-44-7659-01A -25730 0 691 43 Scheduled Follow-up Submission Complete Remission/Response 2013-1-29 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.8 NO NO 1.2 NO NO 40 No MX N0 T1b Stage IA TCGA-44-7659.ca4281d7-0cd7-4ebc-8050-9dd81fbbefbc.pdf 7659 TUMOR FREE 60 47 55 42 Complete Remission/Response YES NO Primary Tumor 01 0.4 7th NO YES NO 44 2 Current smoker Lung A LIVING 2010 1989 e01db349-84f5-4e73-a356-3460d3267f03 e01db349-84f5-4e73-a356-3460d3267f03 TCGA-44-7659-01A-11D-2064-05 TCGA-44-7659-01A-11D-2062-01 e01db349-84f5-4e73-a356-3460d3267f03 TCGA-44-7659-01A-11D-2062-01 TCGA-44-7659-01A-13-2192-20 +TCGA-44-7660-01 TCGA-44-7660-01 Squamous C2-Squamous-like OV-like c1 squamous c3 squamous-like c4 miRNA cluster 4 TCGA-44-7660 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung NO 72 R-Upper TCGA-44-7660-F40409 TCGA-44-7660 TCGA-44-7660-01A -26594 0 592 80 1 Scheduled Follow-up Submission Stable Disease 2013-2-19 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.7 NO 70 NO 1 NO NO 124 No MX N0 T2 Stage IB TCGA-44-7660.8087d940-503c-4492-879f-042b3d037fd7.pdf 7660 Other WITH TUMOR 95 94 92 83 Progressive Disease YES NO Primary Tumor 01 0.7 7th YES YES NO 44 2 Lung A LIVING 2011 1949 bbf1f651-44f0-42c9-a519-64f3d47b42dc bbf1f651-44f0-42c9-a519-64f3d47b42dc TCGA-44-7660-01A-11D-2064-05 TCGA-44-7660-01A-11D-2062-01 bbf1f651-44f0-42c9-a519-64f3d47b42dc TCGA-44-7660-01A-11D-2062-01 TCGA-44-7660-01A-13-2192-20 +TCGA-44-7661-01 TCGA-44-7661-01 Kirc+ C1-LUAD-enriched Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 5 TCGA-44-7661 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung YES YES NO NO 69 R-Lower TCGA-44-7661-F39321 TCGA-44-7661 TCGA-44-7661-01A -25483 557 0 153 335 0 YES YES Scheduled Follow-up Submission Progressive Disease 2013-1-17 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 0.8 NO Peripheral Lung 1.4 NO Locoregional Recurrence YES 22 Yes M0 N0 T2a Stage IB TCGA-44-7661.c21444e4-547b-4114-91c5-9852418e3e6b.pdf 7661 Preoperative WITH TUMOR 95 81 92 68 Complete Remission/Response Convincing Imaging YES NO Primary Tumor 01 0.7 1976 7th NO YES NO 44 3 Lung A DECEASED 2011 1961 d037d7f2-3277-4dc3-954b-503f906bc467 d037d7f2-3277-4dc3-954b-503f906bc467 TCGA-44-7661-01A-11D-2064-05 TCGA-44-7661-01A-11D-2062-01 d037d7f2-3277-4dc3-954b-503f906bc467 TCGA-44-7661-01A-11D-2062-01 TCGA-44-7661-01A-13-2192-20 +TCGA-44-7662-01 2.9 0.33 none none none none N N none none p.A828D 0.14 Squamoid none none none none none none none Solid predominant Adc Solid predominant Adc none 0 TCGA-44-7662-01 High C1-LUAD-enriched Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 4 TCGA-44-7662 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 61 L-Upper TCGA-44-7662-F34016 TCGA-44-7662 TCGA-44-7662-01A -22543 0 218 57 Scheduled Follow-up Submission Complete Remission/Response 2012-7-25 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.7 NO NO 1 NO NO 50 No MX N0 T2a Stage IB TCGA-44-7662.7b34e153-7bc5-4ba6-8445-bac63ca2dcc6.pdf 7662 TUMOR FREE 66 68 68 60 Complete Remission/Response YES NO Primary Tumor 01 0.3 7th NO YES NO 44 2 Current smoker Lung A LIVING 2011 1961 0216208c-fbbd-4370-93dd-19fbb7703568 0216208c-fbbd-4370-93dd-19fbb7703568 TCGA-44-7662-01A-11D-2064-05 TCGA-44-7662-01A-11D-2062-01 0216208c-fbbd-4370-93dd-19fbb7703568 TCGA-44-7662-01A-11D-2062-01 TCGA-44-7662-01A-13-2192-20 +TCGA-44-7667-01 TCGA-44-7667-01 High C1-LUAD-enriched Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 6 TCGA-44-7667 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 49 R-Lower TCGA-44-7667-F39968 TCGA-44-7667 TCGA-44-7667-01A -18062 0 1097 50 Scheduled Follow-up Submission Complete Remission/Response 2013-2-7 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 0.8 NO NO 1.7 NO NO 50 No MX N0 T3 Stage IIB TCGA-44-7667.9722e13c-6ac6-415b-a84f-997d301cea49.pdf 7667 TUMOR FREE 104 74 Complete Remission/Response YES NO Primary Tumor 01 0.5 6th NO YES NO 44 2 Lung A LIVING 2009 1974 7dcc9d07-9af9-405e-b75a-c0e7ffdff5c0 7dcc9d07-9af9-405e-b75a-c0e7ffdff5c0 TCGA-44-7667-01A-31D-2064-05 TCGA-44-7667-01A-31D-2062-01 7dcc9d07-9af9-405e-b75a-c0e7ffdff5c0 TCGA-44-7667-01A-31D-2062-01 TCGA-44-7667-01A-23-2192-20 +TCGA-44-7669-01 TCGA-44-7669-01 GBM C1-LUAD-enriched Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 6 TCGA-44-7669 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung YES YES NO NO 59 R-Upper TCGA-44-7669-F20505 TCGA-44-7669 TCGA-44-7669-01A -21893 574 0 525 52 Additional New Tumor Event Progressive Disease 2012-1-16 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.9 NO NO 1.8 YES 20 No MX N1 T1b Stage IIA TCGA-44-7669.4b112ed4-a999-467d-aace-8bc2c13db1cb.pdf 7669 WITH TUMOR 84 80 80 73 YES Primary Tumor 01 0.7 7th YES NO 44 2 Lung A DECEASED 2010 1970 109f2b77-1742-4afa-bcba-b763746fe080 109f2b77-1742-4afa-bcba-b763746fe080 TCGA-44-7669-01A-21D-2064-05 TCGA-44-7669-01A-21D-2062-01 109f2b77-1742-4afa-bcba-b763746fe080 TCGA-44-7669-01A-21D-2062-01 TCGA-44-7669-01A-23-2192-20 +TCGA-44-7670-01 2.76 0.68 none none none none N N none none p.R866K 0.27 Magnoid none none none none none p.E600K none Lepidic predominant Adc Lepidic predominant Adc none 0 TCGA-44-7670-01 High C1-LUAD-enriched Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 5 TCGA-44-7670 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung NO 47 L-Upper TCGA-44-7670-F39052 TCGA-44-7670 TCGA-44-7670-01A -17392 0 882 50 Scheduled Follow-up Submission Complete Remission/Response 2013-1-9 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.8 NO 1.5 NO NO 30 Yes M0 N1 T1b Stage IIA TCGA-44-7670.b93c87ac-5344-408e-a0e1-763b998a55b7.pdf 7670 TUMOR FREE 90 82 86 80 Complete Remission/Response YES NO Primary Tumor 01 0.7 7th YES YES NO 44 2 Current smoker Lung A LIVING 2010 1980 0b8ef0be-c6fb-4ca9-9da0-f97dd22767bf 0b8ef0be-c6fb-4ca9-9da0-f97dd22767bf TCGA-44-7670-01A-11D-2064-05 TCGA-44-7670-01A-11D-2062-01 0b8ef0be-c6fb-4ca9-9da0-f97dd22767bf TCGA-44-7670-01A-11D-2062-01 TCGA-44-7670-01A-11-2192-20 +TCGA-44-7671-01 3.03 0.67 none none none none Y Y none none none 0.25 Magnoid none p.G12C none p.T660R none none none Acinar predominant Adc Acinar predominant Adc p.K262* 0 TCGA-44-7671-01 BRCA-LUAD+ C1-LUAD-enriched Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 5 TCGA-44-7671 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung NO NO 64 TCGA-44-7671-F38982 TCGA-44-7671 TCGA-44-7671-01A -23538 0 889 883 65 Scheduled Follow-up Submission 2013-1-8 MALE Lung Adenocarcinoma Mixed Subtype No C34.2 8255/3 C34.2 YES 0.6 NO 1 NO Locoregional Recurrence YES Yes M0 N0 T2a Stage IB TCGA-44-7671.bececab6-d442-4261-ab28-f4742e3828ce.pdf 7671 WITH TUMOR 103 82 97 76 Complete Remission/Response Convincing Imaging YES NO Primary Tumor 01 0.3 1995 7th NO YES NO 44 3 Current reformed smoker for > 15 years Lung A LIVING 2010 b294ae61-dd94-40a4-8cda-1001658d986f b294ae61-dd94-40a4-8cda-1001658d986f TCGA-44-7671-01A-11D-2064-05 TCGA-44-7671-01A-11D-2062-01 b294ae61-dd94-40a4-8cda-1001658d986f TCGA-44-7671-01A-11D-2062-01 TCGA-44-7671-01A-21-2192-20 +TCGA-44-7672-01 2.88 0.19 none none none none Y Y none none none 0.09 Squamoid none p.G12A none none none none none Solid predominant Adc Solid predominant Adc none 0 TCGA-44-7672-01 High C1-LUAD-enriched Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 4 TCGA-44-7672 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 52 L-Upper TCGA-44-7672-F39074 TCGA-44-7672 TCGA-44-7672-01A -19200 0 719 82 Scheduled Follow-up Submission Complete Remission/Response 2013-1-10 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.9 NO 1.5 NO NO 20 No M0 N0 T1b Stage IA TCGA-44-7672.65857640-a645-4830-897c-3deafb4ac36f.pdf 7672 TUMOR FREE 90 105 Complete Remission/Response YES NO Primary Tumor 01 0.8 7th NO YES NO 44 2 Current smoker Lung A LIVING 2010 1980 e0c25421-eda1-4204-8d86-37613a005180 e0c25421-eda1-4204-8d86-37613a005180 TCGA-44-7672-01A-11D-2064-05 TCGA-44-7672-01A-11D-2062-01 e0c25421-eda1-4204-8d86-37613a005180 TCGA-44-7672-01A-11D-2062-01 TCGA-44-7672-01A-21-2192-20 +TCGA-44-8117-01 TCGA-44-8117-01 High Cluster 6 LUAD-like c10 miRNA cluster 4 TCGA-44-8117 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 54 R-Upper TCGA-44-8117-F36070 TCGA-44-8117 TCGA-44-8117-01A -19855 0 385 86 1 Scheduled Follow-up Submission Complete Remission/Response 2012-10-18 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.7 NO 1.1 NO NO 54 No M0 N0 T2a Stage IB TCGA-44-8117.af49cbe4-eb8a-46df-bd70-4023acee6ae1.pdf 8117 Post-Adjuvant Therapy TUMOR FREE 88 65 83 60 Complete Remission/Response YES NO Primary Tumor 01 0.4 2011 7th YES YES NO 44 4 Lung A LIVING 2011 1975 4bd54818-dbda-44f7-837e-0235716712d9 4bd54818-dbda-44f7-837e-0235716712d9 TCGA-44-8117-01A-11D-2239-05 TCGA-44-8117-01A-11D-2237-01 4bd54818-dbda-44f7-837e-0235716712d9 TCGA-44-8117-01A-11D-2237-01 +TCGA-44-8119-01 TCGA-44-8119-01 High Cluster 5 LUAD-like c10 miRNA cluster 4 TCGA-44-8119 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung NO 73 R-Upper TCGA-44-8119-F38976 TCGA-44-8119 TCGA-44-8119-01A -27003 0 285 40 0 Scheduled Follow-up Submission Complete Remission/Response 2013-1-8 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 1 NO 2.6 NO NO 50 Yes, History of Prior Malignancy M0 N0 T3 Stage IIB TCGA-44-8119.c40ea4c8-8cbe-4a44-96d4-ae524a916449.pdf 8119 Preoperative TUMOR FREE 74 59 73 55 Complete Remission/Response YES NO Primary Tumor 01 1 7th NO YES NO 44 2 Lung A LIVING 2012 1961 b524809c-72a5-4e46-a3d9-7a838fbc4f02 b524809c-72a5-4e46-a3d9-7a838fbc4f02 TCGA-44-8119-01A-11D-2239-05 TCGA-44-8119-01A-11D-2237-01 b524809c-72a5-4e46-a3d9-7a838fbc4f02 TCGA-44-8119-01A-11D-2237-01 +TCGA-44-8120-01 TCGA-44-8120-01 Squamous Cluster 6 LUAD-like c10 miRNA cluster 4 TCGA-44-8120 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 58 R-Upper TCGA-44-8120-F36757 TCGA-44-8120 TCGA-44-8120-01A -21188 0 260 0 Scheduled Follow-up Submission Complete Remission/Response 2012-11-13 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.9 NO 1 NO NO 30 No M0 N0 T2a Stage IB TCGA-44-8120.6996d5eb-bdfd-4b9b-9517-40c28e439834.pdf 8120 Preoperative TUMOR FREE 100 101 98 97 Complete Remission/Response YES NO Primary Tumor 01 0.4 7th NO YES NO 44 5 Lung A LIVING 2011 1981 8af91e43-8345-432a-a758-1ce8aa55c664 8af91e43-8345-432a-a758-1ce8aa55c664 TCGA-44-8120-01A-11D-2239-05 TCGA-44-8120-01A-11D-2237-01 8af91e43-8345-432a-a758-1ce8aa55c664 TCGA-44-8120-01A-11D-2237-01 +TCGA-44-A479-01 TCGA-44-A479-01 TCGA-44-A479 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung NO NO YES NO 73 R-Upper TCGA-44-A479-F45874 TCGA-44-A479 TCGA-44-A479-01A 437 -27024 193 0 486 437 60 0 YES NO Additional New Tumor Event Complete Remission/Response 2013-8-12 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 280 NO NO NO New Primary Tumor YES 40 false No MX N0 T2 Stage IB TCGA-44-A479.FFCFD93C-1D69-4DF8-9E1B-E2A4EEA66613.pdf A479 Preoperative TUMOR FREE 115 102 Complete Remission/Response YES NO R0 Primary Tumor 01 2002 7th NO YES NO 44 4 Lung A LIVING 2012 1962 9de618ee-04ff-49da-830a-f82eff981616 9de618ee-04ff-49da-830a-f82eff981616 TCGA-44-A479-01A-31D-A24I-05 TCGA-44-A479-01A-31D-A24C-01 9de618ee-04ff-49da-830a-f82eff981616 TCGA-44-A479-01A-31D-A24C-01 +TCGA-44-A47A-01 TCGA-44-A47A-01 TCGA-44-A47A TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung NO YES NO NO 78 R-Upper TCGA-44-A47A-F46609 TCGA-44-A47A TCGA-44-A47A-01A -28782 117 0 466 397 1 NO NO Additional New Tumor Event 2013-8-12 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 290 NO NO NO Distant Metastasis YES 80 false No MX N0 T2a Stage IB TCGA-44-A47A.3F92B4C0-ED5F-486D-A751-730136B1D9A8.pdf A47A Preoperative WITH TUMOR Complete Remission/Response Convincing Imaging NO NO R0 Primary Tumor 01 2010 7th NO YES NO 44 4 Lung A LIVING 2012 1970 99268491-1400-4982-8aa4-7b8c3c815727 99268491-1400-4982-8aa4-7b8c3c815727 TCGA-44-A47A-01A-21D-A24I-05 TCGA-44-A47A-01A-21D-A24C-01 99268491-1400-4982-8aa4-7b8c3c815727 TCGA-44-A47A-01A-21D-A24C-01 +TCGA-44-A47B-01 TCGA-44-A47B-01 TCGA-44-A47B TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 79 R-Upper TCGA-44-A47B-F41746 TCGA-44-A47B TCGA-44-A47B-01A -28869 118 0 287 73 0 NO NO Scheduled Follow-up Submission Complete Remission/Response 2013-3-27 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 80 NO NO NO NO 4.5 false No M0 N0 T2a Stage IB TCGA-44-A47B.A835F045-77B3-4EBD-8883-D24E244535FC.pdf A47B Preoperative TUMOR FREE 102 96 98 96 Complete Remission/Response YES NO R0 Primary Tumor 01 1965 7th NO YES NO 44 3 Lung A LIVING 2012 1956 ec29675b-7379-44ee-981b-458fe9aca616 ec29675b-7379-44ee-981b-458fe9aca616 TCGA-44-A47B-01A-11D-A24I-05 TCGA-44-A47B-01A-11D-A24C-01 ec29675b-7379-44ee-981b-458fe9aca616 TCGA-44-A47B-01A-11D-A24C-01 +TCGA-44-A47F-01 TCGA-44-A47F-01 TCGA-44-A47F TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 74 L-Upper TCGA-44-A47F-F41750 TCGA-44-A47F TCGA-44-A47F-01A -27122 169 0 337 0 Scheduled Follow-up Submission Complete Remission/Response 2013-3-27 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 370 NO 90 NO NO 20 false Yes, History of Prior Malignancy M0 N1 T2b Stage IIB TCGA-44-A47F.FC0E596B-733C-4532-AF0D-94B4A4ECB90C.pdf A47F Post-Adjuvant Therapy TUMOR FREE 127 84 122 81 Complete Remission/Response YES NO Primary Tumor 01 1987 7th YES YES NO 44 3 Lung A LIVING 2012 1955 TCGA-44-A47F-01A-11D-A24I-05 TCGA-44-A47F-01A-11D-A24C-01 TCGA-44-A47F-01A-11D-A24C-01 +TCGA-44-A47G-01 TCGA-44-A47G-01 TCGA-44-A47G TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 73 R-Upper TCGA-44-A47G-F49023 TCGA-44-A47G TCGA-44-A47G-01A -26800 71 0 351 85 0 NO NO Scheduled Follow-up Submission Complete Remission/Response 2013-9-25 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 170 NO NO NO NO 28 false No M0 N0 T1 Stage IA TCGA-44-A47G.103CEC27-11AE-4E7F-88F4-530A94CB5278.pdf A47G Preoperative TUMOR FREE 113 100 Complete Remission/Response YES NO R0 Primary Tumor 01 2012 7th NO YES NO 44 4 Lung A LIVING 2012 1956 64f41383-d668-489a-9fe7-f00235015442 64f41383-d668-489a-9fe7-f00235015442 TCGA-44-A47G-01A-21D-A24I-05 TCGA-44-A47G-01A-21D-A24C-01 64f41383-d668-489a-9fe7-f00235015442 TCGA-44-A47G-01A-21D-A24C-01 +TCGA-44-A4SS-01 TCGA-44-A4SS-01 TCGA-44-A4SS TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 73 L-Upper TCGA-44-A4SS-F49165 TCGA-44-A4SS TCGA-44-A4SS-01A -26991 86 0 415 54 0 Scheduled Follow-up Submission Complete Remission/Response 2013-9-26 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 200 NO NO NO 90 false No M0 N0 T1b Stage IA TCGA-44-A4SS.12F30C5F-91F0-4ECD-A073-74CDEA147097.pdf A4SS Preoperative TUMOR FREE 88 71 86 69 Complete Remission/Response YES NO Primary Tumor 01 2012 7th NO YES NO 44 4 Lung A LIVING 2012 1952 89b3869c-aacb-4882-8aa0-4d9058cf5625 89b3869c-aacb-4882-8aa0-4d9058cf5625 TCGA-44-A4SS-01A-11D-A24U-05 TCGA-44-A4SS-01A-11D-A24O-01 89b3869c-aacb-4882-8aa0-4d9058cf5625 TCGA-44-A4SS-01A-11D-A24O-01 +TCGA-44-A4SU-01 TCGA-44-A4SU-01 TCGA-44-A4SU TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung NO NO NO 67 R-Lower TCGA-44-A4SU-F49438 TCGA-44-A4SU TCGA-44-A4SU-01A -24820 55 409 0 76 260 74 3 Scheduled Follow-up Submission Progressive Disease 2013-10-3 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 140 NO NO Locoregional Recurrence YES 50 false No MX N0 T1a Stage IA TCGA-44-A4SU.14019D02-C4EC-4EA7-8AEB-255A14EB8D07.pdf A4SU Other WITH TUMOR 100 95 100 88 Complete Remission/Response Biopsy with Histologic Confirmation|Convincing Imaging YES NO R0 Primary Tumor 01 2011 7th NO YES NO 44 4 Lung A DECEASED 2012 1961 5f83fb8f-01d8-4deb-89d1-2fe9fb69255e 5f83fb8f-01d8-4deb-89d1-2fe9fb69255e TCGA-44-A4SU-01A-11D-A24U-05 TCGA-44-A4SU-01A-11D-A24O-01 5f83fb8f-01d8-4deb-89d1-2fe9fb69255e TCGA-44-A4SU-01A-11D-A24O-01 +TCGA-46-3765-01 TCGA-46-3765-01 Squamous C2-Squamous-like Cluster 13 (HNSC-LUSC) squamous-like c4 miRNA cluster 7 mutation cluster 6 TCGA-46-3765 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 59 R-Upper TCGA-46-3765-F43470 TCGA-46-3765 TCGA-46-3765-01A -21762 0 405 NO NO Scheduled Follow-up Submission Complete Remission/Response 2015-9-17 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.5 NO NO Central Lung 0.8 NO NO No M0 N0 T1 Stage IA TCGA-46-3765.70f74440-e1da-4d78-9b0d-633342c3b4c3.pdf 3765 TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 0.3 NO YES NO 46 2 Lung A LIVING 2009 f4b89ed8-5cd7-4b62-b427-ba408a24a60f TCGA-46-3765-01A-01D-0979-05 TCGA-46-3765-01A-01D-0983-08 f4b89ed8-5cd7-4b62-b427-ba408a24a60f TCGA-46-3765-01A-01D-0978-01 TCGA-46-3765-01A-01R-0980-07 f4b89ed8-5cd7-4b62-b427-ba408a24a60f TCGA-46-3765-01A-01D-0978-01 +TCGA-46-3766-01 TCGA-46-3766-01 Squamous C2-Squamous-like Cluster 5 squamous-like c4 miRNA cluster 4 mutation c1uster 9 TCGA-46-3766 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 62 R-Lower TCGA-46-3766-F43472 TCGA-46-3766 TCGA-46-3766-01A -22707 0 370 NO NO Scheduled Follow-up Submission Complete Remission/Response 2015-9-17 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.5 NO NO Central Lung 0.8 NO NO No M0 N0 T1 Stage IA TCGA-46-3766.188fd38f-839c-49ec-b8e6-41655c2a8479.pdf 3766 TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 0.1 NO YES NO 46 4 Lung A LIVING 2009 9718e096-a9bc-42fc-af97-1624c4ba6a9b TCGA-46-3766-01A-01D-0979-05 TCGA-46-3766-01A-01D-0983-08 9718e096-a9bc-42fc-af97-1624c4ba6a9b TCGA-46-3766-01A-01D-0978-01 TCGA-46-3766-01A-01R-0980-07 9718e096-a9bc-42fc-af97-1624c4ba6a9b TCGA-46-3766-01A-01D-0978-01 +TCGA-46-3767-01 TCGA-46-3767-01 Kirc+ C2-Squamous-like Cluster 5 squamous-like c4 miRNA cluster 4 mutation cluster 2 TCGA-46-3767 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 76 L-Lower TCGA-46-3767-F43441 TCGA-46-3767 TCGA-46-3767-01A -27912 0 388 NO NO Scheduled Follow-up Submission Complete Remission/Response 2015-9-17 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.8 NO NO Central Lung 0.8 NO NO No M0 N0 T1a Stage IA TCGA-46-3767.8e91ee2e-da06-49fe-aa5e-4faca1240a25.pdf 3767 TUMOR FREE Complete Remission/Response R0 Primary Tumor 01 0.1 YES NO 46 3 Lung A LIVING 2009 566b24cb-eb71-4b13-a0bd-9d3bb6d8f475 TCGA-46-3767-01A-01D-0979-05 TCGA-46-3767-01A-01D-0983-08 566b24cb-eb71-4b13-a0bd-9d3bb6d8f475 TCGA-46-3767-01A-01D-0978-01 TCGA-46-3767-01A-01R-0980-07 566b24cb-eb71-4b13-a0bd-9d3bb6d8f475 TCGA-46-3767-01A-01D-0978-01 +TCGA-46-3768-01 TCGA-46-3768-01 Squamous C2-Squamous-like Cluster 13 (HNSC-LUSC) squamous-like c4 miRNA cluster 4 mutation cluster 13 TCGA-46-3768 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 58 L-Upper TCGA-46-3768-F43464 TCGA-46-3768 TCGA-46-3768-01A -21307 299 0 1 NO NO Scheduled Follow-up Submission Complete Remission/Response 2015-9-17 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.6 NO NO Central Lung 0.7 YES NO No M0 N1 T3 Stage IIIA TCGA-46-3768.83e30a4b-4df4-41d8-aa7c-7ae95be3b9fb.pdf 3768 Post-Adjuvant Therapy TUMOR FREE Complete Remission/Response YES R0 Primary Tumor 01 0.3 YES YES NO 46 4 Lung A DECEASED 2010 e52ba522-f5b9-4f9c-b03c-7d317ca7a30e TCGA-46-3768-01A-01D-0979-05 TCGA-46-3768-01A-01D-0983-08 e52ba522-f5b9-4f9c-b03c-7d317ca7a30e TCGA-46-3768-01A-01D-0978-01 TCGA-46-3768-01A-01R-0980-07 e52ba522-f5b9-4f9c-b03c-7d317ca7a30e TCGA-46-3768-01A-01D-0978-01 +TCGA-46-3769-01 TCGA-46-3769-01 High C1-LUAD-enriched Cluster 6 LUAD-like c10 miRNA cluster 4 mutation cluster 11 TCGA-46-3769 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 57 R-Upper TCGA-46-3769-F9102 TCGA-46-3769 TCGA-46-3769-01A -20941 0 135 YES NO Complete Remission/Response 2013-5-21 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.8 NO NO Central Lung 0.9 NO No M0 N0 T4 [Discrepancy] TCGA-46-3769.edd4e055-6670-43a8-ba91-0b4ac766abfd.pdf 3769 TUMOR FREE Complete Remission/Response YES R1 Primary Tumor 01 0.2 YES YES NO 46 4 Lung A LIVING 2009 6606d696-1211-43ad-b7b0-43b183af7faa TCGA-46-3769-01A-01D-0979-05 TCGA-46-3769-01A-01D-0983-08 6606d696-1211-43ad-b7b0-43b183af7faa TCGA-46-3769-01A-01D-0978-01 TCGA-46-3769-01A-01R-0980-07 6606d696-1211-43ad-b7b0-43b183af7faa TCGA-46-3769-01A-01D-0978-01 +TCGA-46-6025-01 TCGA-46-6025-01 High C2-Squamous-like Cluster 13 (HNSC-LUSC) squamous c3 squamous-like c4 miRNA cluster 4 mutation cluster 5 TCGA-46-6025 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 71 R-Lower TCGA-46-6025-F13454 TCGA-46-6025 TCGA-46-6025-01A -26168 0 324 1 NO NO Scheduled Follow-up Submission 2011-6-28 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.8 NO NO Central Lung 1 NO No M0 N1 T2b Stage IIB TCGA-46-6025.1664466d-20af-4e97-b5e1-a013803f5e6a.pdf 6025 Post-Adjuvant Therapy TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 0.3 2010 YES YES NO 46 4 Lung A LIVING 2010 ba725298-74f8-4ff3-a28b-1e4a92331f07 TCGA-46-6025-01A-11D-1817-08 ba725298-74f8-4ff3-a28b-1e4a92331f07 TCGA-46-6025-01A-11D-1818-05 TCGA-46-6025-01A-11D-1816-01 ba725298-74f8-4ff3-a28b-1e4a92331f07 TCGA-46-6025-01A-11D-1816-01 TCGA-46-6025-01A-13-2194-20 +TCGA-46-6026-01 TCGA-46-6026-01 High C2-Squamous-like Cluster 13 (HNSC-LUSC) squamous c3 squamous-like c4 miRNA cluster 5 mutation cluster 5 TCGA-46-6026 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung NO NO NO NO 81 R-Lower TCGA-46-6026-F13515 TCGA-46-6026 TCGA-46-6026-01A -29890 0 423 3 NO NO Scheduled Follow-up Submission 2011-6-30 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.9 NO NO Central Lung 1 NO No M0 N1 T2a Stage IIB TCGA-46-6026.ad6737a0-c741-40d5-9548-34b0fc17f542.pdf 6026 Post-Adjuvant Therapy TUMOR FREE Complete Remission/Response YES R2 Primary Tumor 01 0.2 1985 YES YES NO 46 3 Lung A LIVING 2010 3361fa31-f545-4a50-912e-3bab98eb7930 TCGA-46-6026-01A-11D-1817-08 3361fa31-f545-4a50-912e-3bab98eb7930 TCGA-46-6026-01A-11D-1818-05 TCGA-46-6026-01A-11D-1816-01 3361fa31-f545-4a50-912e-3bab98eb7930 TCGA-46-6026-01A-11D-1816-01 TCGA-46-6026-01A-13-2194-20 +TCGA-49-4486-01 2.1 0.72 none none none none N N none none none 0.35 Bronchioid none none none none none none none Lepidic predominant Adc Lepidic predominant Adc p.N181I 1 TCGA-49-4486-01 Iq C1-LUAD-enriched Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 7 mutation cluster 5 TCGA-49-4486 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung NO NO NO NO 72 R-Lower TCGA-49-4486-F58843 TCGA-49-4486 TCGA-49-4486-01A -26415 2318 0 2045 2 Scheduled Follow-up Submission Progressive Disease 2014-4-25 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 0.6 NO 60 1.6 NO Distant Metastasis YES 17.5 No M0 N0 T1 Stage IA TCGA-49-4486.30b3b92c-c810-4cf8-8342-f6e9d87bacfe.pdf 4486 Other WITH TUMOR 69 96 77 108 Complete Remission/Response Convincing Imaging YES NO R0 Primary Tumor 01 0.6 1967 3rd NO NO YES 49 3 Current reformed smoker for > 15 years Lung A DECEASED 1992 1932 0c0cfdfb-107b-4a20-bfda-7922453c041e TCGA-49-4486-01A-01D-1205-05 TCGA-49-4486-01A-01D-1265-08 0c0cfdfb-107b-4a20-bfda-7922453c041e TCGA-49-4486-01A-01D-1204-01 0c0cfdfb-107b-4a20-bfda-7922453c041e TCGA-49-4486-01A-01D-1204-01 TCGA-49-4486-01A-21-2190-20 +TCGA-49-4486-11 2.1 0.72 none none none none N N none none none 0.35 Bronchioid none none none none none none none Lepidic predominant Adc Lepidic predominant Adc p.N181I 1 TCGA-49-4486-11 C1-LUAD-enriched mutation cluster 5 TCGA-49-4486 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung NO NO NO NO 72 R-Lower TCGA-49-4486-F58843 TCGA-49-4486 TCGA-49-4486-11A -26415 2318 0 2045 2 Scheduled Follow-up Submission Progressive Disease 2014-4-25 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 0.7 NO 60 1 NO Distant Metastasis YES 17.5 No M0 N0 T1 Stage IA 4486 Other WITH TUMOR 69 96 77 108 Complete Remission/Response Convincing Imaging YES NO R0 Solid Tissue Normal 11 0.2 1967 3rd NO NO YES 49 3 Current reformed smoker for > 15 years Lung A DECEASED 1992 1932 TCGA-49-4486-11A-01D-1205-05 +TCGA-49-4487-01 none none none none N N none none none Squamoid none none none none none none none Adenocarcinoma, NOS Adenocarcinoma, NOS p.E70* 0 TCGA-49-4487-01 High C1-LUAD-enriched Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 4 mutation cluster 11 TCGA-49-4487 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung NO YES YES YES 72 L-Upper TCGA-49-4487-F14693 TCGA-49-4487 TCGA-49-4487-01A 697 712 -26583 855 0 697 Scheduled Follow-up Submission Progressive Disease 2011-8-9 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.7 NO 0.9 YES 40 No M0 N0 T1 Stage IA TCGA-49-4487.c67031fc-f601-4bd2-b8fd-429a0664cc65.pdf 4487 WITH TUMOR Complete Remission/Response YES R0 Primary Tumor 01 0.3 3rd NO NO YES 49 4 Current reformed smoker for < or = 15 years Lung A DECEASED 1992 3cc3fe41-c7e8-4dcf-99a0-a488f7763e93 TCGA-49-4487-01A-21D-1855-08 3cc3fe41-c7e8-4dcf-99a0-a488f7763e93 TCGA-49-4487-01A-21D-1856-05 TCGA-49-4487-01A-21D-1854-01 3cc3fe41-c7e8-4dcf-99a0-a488f7763e93 TCGA-49-4487-01A-21D-1854-01 TCGA-49-4487-01A-22-2190-20 +TCGA-49-4488-01 none none none none N N none none none Squamoid none none none none none none none Papillary predominant Adc Papillary predominant Adc none 0 TCGA-49-4488-01 BRCA-LUAD+ C1-LUAD-enriched Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 12 mutation c1uster 10 TCGA-49-4488 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung NO YES 74 L-Lower TCGA-49-4488-F14699 TCGA-49-4488 TCGA-49-4488-01A 690 -27332 869 0 634 Scheduled Follow-up Submission 2011-8-9 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 0.8 NO 2 YES No MX N0 T1 Stage IA TCGA-49-4488.1aae91ef-85c6-49f4-a76a-3f09d5cabcb5.pdf 4488 NO R0 Primary Tumor 01 0.4 1964 3rd NO NO YES 49 3 Current reformed smoker for > 15 years Lung A DECEASED 1992 94a591be-8b32-4680-b2ad-fc856f3f0c8e TCGA-49-4488-01A-01D-1753-08 94a591be-8b32-4680-b2ad-fc856f3f0c8e TCGA-49-4488-01A-01D-1756-05 TCGA-49-4488-01A-01D-1752-01 94a591be-8b32-4680-b2ad-fc856f3f0c8e TCGA-49-4488-01A-01D-1752-01 TCGA-49-4488-01A-21-2190-20 +TCGA-49-4488-11 none none none none N N none none none Squamoid none none none none none none none Papillary predominant Adc Papillary predominant Adc none 0 TCGA-49-4488-11 C1-LUAD-enriched mutation c1uster 10 TCGA-49-4488 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung NO YES 74 L-Lower TCGA-49-4488-F14699 TCGA-49-4488 TCGA-49-4488-11A 690 -27332 869 0 634 Scheduled Follow-up Submission 2011-8-9 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 0.8 NO 1 YES No MX N0 T1 Stage IA 4488 NO R0 Solid Tissue Normal 11 0.4 1964 3rd NO NO YES 49 3 Current reformed smoker for > 15 years Lung A DECEASED 1992 TCGA-49-4488-11A-01D-1756-05 +TCGA-49-4490-01 none none none none Y Y p.L858R none none Bronchioid none none none none none none none Micropapillary predom Adc Micropapillary predom Adc none 0 TCGA-49-4490-01 BRCA-LUAD+ C1-LUAD-enriched Cluster 5 LUAD-like c10 miRNA cluster 4 mutation cluster 8 TCGA-49-4490 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 45 L-Upper TCGA-49-4490-F14703 TCGA-49-4490 TCGA-49-4490-01A -16634 385 0 Scheduled Follow-up Submission 2011-8-9 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.5 NO 0.5 NO 5 No M0 N2 T3 Stage IIIA TCGA-49-4490.d6ec6f67-0c16-4396-be41-aaa6868a6106.pdf 4490 WITH TUMOR YES Primary Tumor 01 0.5 4th YES NO YES 49 3 Current reformed smoker for > 15 years Lung A DECEASED 1993 5e45c9ab-f5fe-497b-b919-72b0d8dec83d TCGA-49-4490-01A-21D-1855-08 5e45c9ab-f5fe-497b-b919-72b0d8dec83d TCGA-49-4490-01A-21D-1856-05 TCGA-49-4490-01A-21D-1854-01 5e45c9ab-f5fe-497b-b919-72b0d8dec83d TCGA-49-4490-01A-21D-1854-01 +TCGA-49-4490-11 none none none none Y Y p.L858R none none Bronchioid none none none none none none none Micropapillary predom Adc Micropapillary predom Adc none 0 TCGA-49-4490-11 C1-LUAD-enriched mutation cluster 8 TCGA-49-4490 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 45 L-Upper TCGA-49-4490-F14703 TCGA-49-4490 TCGA-49-4490-11A -16634 385 0 Scheduled Follow-up Submission 2011-8-9 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.9 NO 1.9 NO 5 No M0 N2 T3 Stage IIIA 4490 WITH TUMOR YES Solid Tissue Normal 11 0.6 4th YES NO YES 49 3 Current reformed smoker for > 15 years Lung A DECEASED 1993 d0e9dd65-ec79-4eee-802a-3f5438168136 d0e9dd65-ec79-4eee-802a-3f5438168136 d0e9dd65-ec79-4eee-802a-3f5438168136 +TCGA-49-4494-01 4.06 0.3 none none none none Y Y p.T790M, p.L858R none none 0.11 Magnoid none none none none none none none Acinar predominant Adc Acinar predominant Adc none 0 TCGA-49-4494-01 BRCA-LUAD+ C1-LUAD-enriched Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 4 mutation cluster 7 TCGA-49-4494 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 77 L-Upper TCGA-49-4494-F58840 TCGA-49-4494 TCGA-49-4494-01A -28387 1081 0 1 Scheduled Follow-up Submission 2014-4-25 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 1 NO 90 2.5 NO 50 No M0 N2 T3 Stage IIIA TCGA-49-4494.178a8648-f3cd-46ae-b90a-a45d6715c889.pdf 4494 Preoperative WITH TUMOR Complete Remission/Response NO R0 Primary Tumor 01 0.4 1955 4th NO YES 49 3 Current reformed smoker for > 15 years Lung A DECEASED 1995 1930 f338175a-fa1e-4b98-91e2-f4f0ee349e8e TCGA-49-4494-01A-01D-1205-05 TCGA-49-4494-01A-01D-1265-08 f338175a-fa1e-4b98-91e2-f4f0ee349e8e TCGA-49-4494-01A-01D-1204-01 f338175a-fa1e-4b98-91e2-f4f0ee349e8e TCGA-49-4494-01A-01D-1204-01 TCGA-49-4494-01A-21-2190-20 +TCGA-49-4494-11 4.06 0.3 none none none none Y Y p.T790M, p.L858R none none 0.11 Magnoid none none none none none none none Acinar predominant Adc Acinar predominant Adc none 0 TCGA-49-4494-11 C1-LUAD-enriched mutation cluster 7 TCGA-49-4494 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 77 L-Upper TCGA-49-4494-F58840 TCGA-49-4494 TCGA-49-4494-11A -28387 1081 0 1 Scheduled Follow-up Submission 2014-4-25 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.9 NO 90 0.9 NO 50 No M0 N2 T3 Stage IIIA 4494 Preoperative WITH TUMOR Complete Remission/Response NO R0 Solid Tissue Normal 11 0.4 1955 4th NO YES 49 3 Current reformed smoker for > 15 years Lung A DECEASED 1995 1930 TCGA-49-4494-11A-01D-1205-05 +TCGA-49-4501-01 2.85 0.43 none none none none Y Y p.ELREA746del none none 0.18 Bronchioid none none none none none none none Acinar predominant Adc Acinar predominant Adc none 0 TCGA-49-4501-01 BRCA-LUAD+ C1-LUAD-enriched Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 4 mutation cluster 14 TCGA-49-4501 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung YES NO NO 67 R-Upper TCGA-49-4501-F7014 TCGA-49-4501 TCGA-49-4501-01A -24817 1421 0 545 1 Progressive Disease 2011-2-2 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.6 NO 1.2 YES Yes M0 N0 T2 Stage IB TCGA-49-4501.da1bf563-9ad3-49cf-a68a-44af8ed41684.pdf 4501 Other WITH TUMOR Complete Remission/Response NO R0 Primary Tumor 01 0.3 NO NO YES 49 1 Lifelong Non-smoker Lung A DECEASED 1996 f118c45b-544d-45eb-8acd-a4c8cfcab3fd TCGA-49-4501-01A-01D-1205-05 TCGA-49-4501-01A-01D-1265-08 f118c45b-544d-45eb-8acd-a4c8cfcab3fd TCGA-49-4501-01A-01D-1204-01 f118c45b-544d-45eb-8acd-a4c8cfcab3fd TCGA-49-4501-01A-01D-1204-01 TCGA-49-4501-01A-21-2190-20 +TCGA-49-4501-11 2.85 0.43 none none none none Y Y p.ELREA746del none none 0.18 Bronchioid none none none none none none none Acinar predominant Adc Acinar predominant Adc none 0 TCGA-49-4501-11 C1-LUAD-enriched mutation cluster 14 TCGA-49-4501 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung YES NO NO 67 R-Upper TCGA-49-4501-F7014 TCGA-49-4501 TCGA-49-4501-11A -24817 1421 0 545 1 Progressive Disease 2011-2-2 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.9 NO 1.2 YES Yes M0 N0 T2 Stage IB 4501 Other WITH TUMOR Complete Remission/Response NO R0 Solid Tissue Normal 11 0.5 NO NO YES 49 1 Lifelong Non-smoker Lung A DECEASED 1996 TCGA-49-4501-11A-01D-1205-05 +TCGA-49-4505-01 none none none none Y Y none none none Bronchioid none p.G12C none none none none none Micropapillary predom Adc Micropapillary predom Adc none 0 TCGA-49-4505-01 BRCA-LUAD+ C1-LUAD-enriched Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 4 mutation cluster 11 TCGA-49-4505 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 61 R-Lower TCGA-49-4505-F58844 TCGA-49-4505 TCGA-49-4505-01A -22628 428 0 417 1 Scheduled Follow-up Submission 2014-4-25 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 0.7 NO 80 1.5 NO Distant Metastasis|New Primary Tumor YES 74 No M0 N1 T2 Stage IIB TCGA-49-4505.1733d182-08f0-4426-9227-9f008893ac14.pdf 4505 Preoperative WITH TUMOR Complete Remission/Response Convincing Imaging NO NO R0 Primary Tumor 01 0.3 1986 4th NO NO YES 49 4 Current reformed smoker for < or = 15 years Lung A DECEASED 1996 1949 cb06be5e-7c1d-49a4-9818-e1cbc52de9b6 TCGA-49-4505-01A-01D-1205-05 TCGA-49-4505-01A-01D-1265-08 cb06be5e-7c1d-49a4-9818-e1cbc52de9b6 TCGA-49-4505-01A-01D-1204-01 cb06be5e-7c1d-49a4-9818-e1cbc52de9b6 TCGA-49-4505-01A-01D-1204-01 TCGA-49-4505-01A-21-2190-20 +TCGA-49-4505-11 none none none none Y Y none none none Bronchioid none p.G12C none none none none none Micropapillary predom Adc Micropapillary predom Adc none 0 TCGA-49-4505-11 C1-LUAD-enriched mutation cluster 11 TCGA-49-4505 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 61 R-Lower TCGA-49-4505-F58844 TCGA-49-4505 TCGA-49-4505-11A -22628 428 0 417 1 Scheduled Follow-up Submission 2014-4-25 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 1.1 NO 80 1.3 NO Distant Metastasis|New Primary Tumor YES 74 No M0 N1 T2 Stage IIB 4505 Preoperative WITH TUMOR Complete Remission/Response Convincing Imaging NO NO R0 Solid Tissue Normal 11 0.4 1986 4th NO NO YES 49 4 Current reformed smoker for < or = 15 years Lung A DECEASED 1996 1949 TCGA-49-4505-11A-01D-1205-05 +TCGA-49-4506-01 2.69 0.25 none none none none N N none none none 0.12 Magnoid none none none none none none none Micropapillary predom Adc Micropapillary predom Adc none 0 TCGA-49-4506-01 BRCA-LUAD+ C1-LUAD-enriched Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 4 mutation c1uster 9 TCGA-49-4506 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung NO NO NO 68 L-Upper TCGA-49-4506-F58841 TCGA-49-4506 TCGA-49-4506-01A -25132 999 0 692 2 Scheduled Follow-up Submission Progressive Disease 2014-4-25 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.4 NO 70 Peripheral Lung 0.8 NO Locoregional Recurrence YES 100 No M0 N1 T2 Stage IIB TCGA-49-4506.09fb40cf-afb5-4dd5-a1b6-6261ef27b65e.pdf 4506 Post-Adjuvant Therapy TUMOR FREE Complete Remission/Response Convincing Imaging NO YES R1 Primary Tumor 01 0.3 4th YES NO YES 49 2 Current smoker Lung A DECEASED 1997 7ce14f35-6404-4adc-8929-4d5cd3c85697 TCGA-49-4506-01A-01D-1205-05 TCGA-49-4506-01A-01D-1265-08 7ce14f35-6404-4adc-8929-4d5cd3c85697 TCGA-49-4506-01A-01D-1204-01 7ce14f35-6404-4adc-8929-4d5cd3c85697 TCGA-49-4506-01A-01D-1204-01 TCGA-49-4506-01A-21-2190-20 +TCGA-49-4506-11 2.69 0.25 none none none none N N none none none 0.12 Magnoid none none none none none none none Micropapillary predom Adc Micropapillary predom Adc none 0 TCGA-49-4506-11 C1-LUAD-enriched mutation c1uster 9 TCGA-49-4506 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung NO NO NO 68 L-Upper TCGA-49-4506-F58841 TCGA-49-4506 TCGA-49-4506-11A -25132 999 0 692 2 Scheduled Follow-up Submission Progressive Disease 2014-4-25 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.6 NO 70 Peripheral Lung 2.4 NO Locoregional Recurrence YES 100 No M0 N1 T2 Stage IIB 4506 Post-Adjuvant Therapy TUMOR FREE Complete Remission/Response Convincing Imaging NO YES R1 Solid Tissue Normal 11 0.5 4th YES NO YES 49 2 Current smoker Lung A DECEASED 1997 TCGA-49-4506-11A-01D-1205-05 +TCGA-49-4507-01 2.7 0.35 none none none none N N none none none 0.16 Squamoid none none none none none none none Solid predominant Adc Solid predominant Adc p.D176A 0 TCGA-49-4507-01 High C1-LUAD-enriched Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 4 mutation c1uster 9 TCGA-49-4507 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung YES NO NO NO 73 R-Middle TCGA-49-4507-F7007 TCGA-49-4507 TCGA-49-4507-01A -26851 268 0 158 1 Progressive Disease 2011-2-2 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.0 8140/3 C34.0 YES 0.7 NO 1 YES 78 No M0 N1 T3 Stage IIIA TCGA-49-4507.e37717f8-8175-4f30-a817-ae365097804a.pdf 4507 Preoperative WITH TUMOR Progressive Disease YES R0 Primary Tumor 01 0.3 1991 YES NO YES 49 4 Current reformed smoker for < or = 15 years Lung A DECEASED 1997 15f243f1-05de-4750-9826-d80ddc97d739 TCGA-49-4507-01A-01D-1205-05 TCGA-49-4507-01A-01D-1265-08 15f243f1-05de-4750-9826-d80ddc97d739 TCGA-49-4507-01A-01D-1204-01 15f243f1-05de-4750-9826-d80ddc97d739 TCGA-49-4507-01A-01D-1204-01 TCGA-49-4507-01A-21-2190-20 +TCGA-49-4507-11 2.7 0.35 none none none none N N none none none 0.16 Squamoid none none none none none none none Solid predominant Adc Solid predominant Adc p.D176A 0 TCGA-49-4507-11 C1-LUAD-enriched mutation c1uster 9 TCGA-49-4507 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung YES NO NO NO 73 R-Middle TCGA-49-4507-F7007 TCGA-49-4507 TCGA-49-4507-11A -26851 268 0 158 1 Progressive Disease 2011-2-2 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.0 8140/3 C34.0 YES 1.1 NO 1.4 YES 78 No M0 N1 T3 Stage IIIA 4507 Preoperative WITH TUMOR Progressive Disease YES R0 Solid Tissue Normal 11 0.3 1991 YES NO YES 49 4 Current reformed smoker for < or = 15 years Lung A DECEASED 1997 TCGA-49-4507-11A-01D-1205-05 +TCGA-49-4510-01 3.39 0.63 none none none none Y Y none none none 0.22 Bronchioid none p.G12D none none none none none Papillary predominant Adc Papillary predominant Adc none 1 TCGA-49-4510-01 High C1-LUAD-enriched Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 7 mutation cluster 12 TCGA-49-4510 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung YES NO NO NO 51 L-Upper TCGA-49-4510-F58842 TCGA-49-4510 TCGA-49-4510-01A -18762 896 0 502 1 Scheduled Follow-up Submission Stable Disease 2014-4-25 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.7 NO 80 0.9 NO Distant Metastasis YES 55.5 No M0 N1 T2 Stage IIB TCGA-49-4510.de27239d-52ae-4979-979f-51e1ce7a43e8.pdf 4510 Post-Adjuvant Therapy WITH TUMOR Stable Disease Convincing Imaging NO YES R0 Primary Tumor 01 0.3 5th YES NO YES 49 2 Current smoker Lung A DECEASED 2001 3739f699-5aef-4152-a918-36dc138c432e TCGA-49-4510-01A-01D-1205-05 TCGA-49-4510-01A-01D-1265-08 3739f699-5aef-4152-a918-36dc138c432e TCGA-49-4510-01A-01D-1204-01 3739f699-5aef-4152-a918-36dc138c432e TCGA-49-4510-01A-01D-1204-01 TCGA-49-4510-01A-21-2190-20 +TCGA-49-4510-11 3.39 0.63 none none none none Y Y none none none 0.22 Bronchioid none p.G12D none none none none none Papillary predominant Adc Papillary predominant Adc none 1 TCGA-49-4510-11 C1-LUAD-enriched mutation cluster 12 TCGA-49-4510 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung YES NO NO NO 51 L-Upper TCGA-49-4510-F58842 TCGA-49-4510 TCGA-49-4510-11A -18762 896 0 502 1 Scheduled Follow-up Submission Stable Disease 2014-4-25 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 1 NO 80 1.3 NO Distant Metastasis YES 55.5 No M0 N1 T2 Stage IIB 4510 Post-Adjuvant Therapy WITH TUMOR Stable Disease Convincing Imaging NO YES R0 Solid Tissue Normal 11 0.4 5th YES NO YES 49 2 Current smoker Lung A DECEASED 2001 TCGA-49-4510-11A-01D-1205-05 +TCGA-49-4512-01 2.43 0.48 none none none none N N none none none 0.22 Bronchioid none none none none none none none Micropapillary predom Adc Micropapillary predom Adc none 0 TCGA-49-4512-01 High C1-LUAD-enriched Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 4 mutation c1uster 9 TCGA-49-4512 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 69 R-Middle TCGA-49-4512-F14815 TCGA-49-4512 TCGA-49-4512-01A -25502 905 0 157 Scheduled Follow-up Submission 2011-8-10 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.2 8140/3 C34.2 YES 0.8 NO 2.2 NO No MX N2 T2 Stage IIIA TCGA-49-4512.dddbac81-a9e3-42a8-ab35-6d506c58413a.pdf 4512 WITH TUMOR Progressive Disease NO R1 Primary Tumor 01 0.3 6th YES NO YES 49 1 Lifelong Non-smoker Lung A DECEASED 2007 c1796b57-c5e4-45dd-931d-bf533dcb9e1a TCGA-49-4512-01A-21D-1855-08 c1796b57-c5e4-45dd-931d-bf533dcb9e1a TCGA-49-4512-01A-21D-1856-05 TCGA-49-4512-01A-21D-1854-01 c1796b57-c5e4-45dd-931d-bf533dcb9e1a TCGA-49-4512-01A-21D-1854-01 TCGA-49-4512-01A-22-2190-20 +TCGA-49-4512-11 2.43 0.48 none none none none N N none none none 0.22 Bronchioid none none none none none none none Micropapillary predom Adc Micropapillary predom Adc none 0 TCGA-49-4512-11 C1-LUAD-enriched mutation c1uster 9 TCGA-49-4512 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 69 R-Middle TCGA-49-4512-F14815 TCGA-49-4512 TCGA-49-4512-11A -25502 905 0 157 Scheduled Follow-up Submission 2011-8-10 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.2 8140/3 C34.2 YES 0.7 NO 1 NO No MX N2 T2 Stage IIIA 4512 WITH TUMOR Progressive Disease NO R1 Solid Tissue Normal 11 0.3 6th YES NO YES 49 1 Lifelong Non-smoker Lung A DECEASED 2007 a137e804-ed82-4ad8-b25e-f9dcb71331bb a137e804-ed82-4ad8-b25e-f9dcb71331bb a137e804-ed82-4ad8-b25e-f9dcb71331bb +TCGA-49-4514-01 1.79 0.34 none none none none N N none none none 0.18 Magnoid none none none none none none none Papillary predominant Adc Papillary predominant Adc none 0 TCGA-49-4514-01 High C1-LUAD-enriched Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 4 mutation cluster 2 TCGA-49-4514 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 79 L-Upper TCGA-49-4514-F14817 TCGA-49-4514 TCGA-49-4514-01A -28908 0 1700 Scheduled Follow-up Submission 2011-8-10 FEMALE Lung Papillary Adenocarcinoma No C34.1 8260/3 C34.1 YES 0.8 NO 1.4 NO 65 No M0 N0 T1 Stage IA TCGA-49-4514.1d1c3125-05a9-4939-a296-f98d8f977ab7.pdf 4514 TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 0.4 6th NO NO YES 49 3 Current reformed smoker for > 15 years Lung A LIVING 2007 4b05bcbb-08b4-4cf5-bd31-798490e00f94 TCGA-49-4514-01A-21D-1855-08 4b05bcbb-08b4-4cf5-bd31-798490e00f94 TCGA-49-4514-01A-21D-1856-05 TCGA-49-4514-01A-21D-1854-01 4b05bcbb-08b4-4cf5-bd31-798490e00f94 TCGA-49-4514-01A-21D-1854-01 TCGA-49-4514-01A-22-2190-20 +TCGA-49-6742-01 3.59 0.49 none none none none N N none none none 0.18 Magnoid none none none none none none none Acinar predominant Adc Acinar predominant Adc none 0 TCGA-49-6742-01 High C1-LUAD-enriched Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 5 mutation cluster 12 TCGA-49-6742 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung YES NO NO YES 70 L-Upper TCGA-49-6742-F70579 TCGA-49-6742 TCGA-49-6742-01A 214 -25839 488 0 1678 214 3 Scheduled Follow-up Submission Progressive Disease 2015-2-25 MALE Mucinous (Colloid) Carcinoma No C34.1 8480/3 C34.1 YES 0.8 NO 40 YES NO 2.1 NO Distant Metastasis YES 10 Yes M0 N1 T2a Stage IIA TCGA-49-6742.d9853b55-fd00-4a20-8181-5f4dad297724.pdf 6742 Post-Adjuvant Therapy WITH TUMOR Progressive Disease NO R0 Primary Tumor 01 0.4 7th YES NO YES 49 3 Current reformed smoker for > 15 years Lung A DECEASED 2010 6e3df59e-5d52-4ced-b9dd-785df1952339 TCGA-49-6742-01A-11D-1855-08 6e3df59e-5d52-4ced-b9dd-785df1952339 TCGA-49-6742-01A-11D-1856-05 TCGA-49-6742-01A-11D-1854-01 6e3df59e-5d52-4ced-b9dd-785df1952339 TCGA-49-6742-01A-11D-1854-01 TCGA-49-6742-01A-13-2191-20 +TCGA-49-6742-11 3.59 0.49 none none none none N N none none none 0.18 Magnoid none none none none none none none Acinar predominant Adc Acinar predominant Adc none 0 TCGA-49-6742-11 C1-LUAD-enriched mutation cluster 12 TCGA-49-6742 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung YES NO NO YES 70 L-Upper TCGA-49-6742-F70579 TCGA-49-6742 TCGA-49-6742-11A 214 -25839 488 0 1678 214 3 Scheduled Follow-up Submission Progressive Disease 2015-2-25 MALE Mucinous (Colloid) Carcinoma No C34.1 8480/3 C34.1 YES 0.7 NO 40 YES NO 1 NO Distant Metastasis YES 10 Yes M0 N1 T2a Stage IIA 6742 Post-Adjuvant Therapy WITH TUMOR Progressive Disease NO R0 Solid Tissue Normal 11 0.4 7th YES NO YES 49 3 Current reformed smoker for > 15 years Lung A DECEASED 2010 98056d94-9c31-4cf7-9b0f-5ebe06be01bd 98056d94-9c31-4cf7-9b0f-5ebe06be01bd 98056d94-9c31-4cf7-9b0f-5ebe06be01bd +TCGA-49-6743-01 TCGA-49-6743-01 Squamous C1-LUAD-enriched Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 4 mutation cluster 6 TCGA-49-6743 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 81 R-Upper TCGA-49-6743-F71136 TCGA-49-6743 TCGA-49-6743-01A -29807 0 1621 Scheduled Follow-up Submission Complete Remission/Response 2015-3-18 FEMALE Lung Clear Cell Adenocarcinoma No C34.1 8310/3 C34.1 YES 0.4 NO 100 1.2 NO NO 50 No MX N2 T1 Stage IIIA TCGA-49-6743.bc777cb6-8409-4a25-a22a-a398c28ef065.pdf 6743 TUMOR FREE Complete Remission/Response NO Primary Tumor 01 0.4 7th YES NO YES 49 4 Lung A LIVING 2010 93f3f561-056a-4036-afcf-4662b45e6965 TCGA-49-6743-01A-11D-1855-08 93f3f561-056a-4036-afcf-4662b45e6965 TCGA-49-6743-01A-11D-1856-05 TCGA-49-6743-01A-11D-1854-01 93f3f561-056a-4036-afcf-4662b45e6965 TCGA-49-6743-01A-11D-1854-01 TCGA-49-6743-01A-13-2191-20 +TCGA-49-6743-11 TCGA-49-6743-11 C1-LUAD-enriched mutation cluster 6 TCGA-49-6743 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 81 R-Upper TCGA-49-6743-F71136 TCGA-49-6743 TCGA-49-6743-11A -29807 0 1621 Scheduled Follow-up Submission Complete Remission/Response 2015-3-18 FEMALE Lung Clear Cell Adenocarcinoma No C34.1 8310/3 C34.1 YES 0.4 NO 100 1.5 NO NO 50 No MX N2 T1 Stage IIIA 6743 TUMOR FREE Complete Remission/Response NO Solid Tissue Normal 11 0.3 7th YES NO YES 49 4 Lung A LIVING 2010 6eb0d705-8faf-476a-8062-afb1f927db99 6eb0d705-8faf-476a-8062-afb1f927db99 6eb0d705-8faf-476a-8062-afb1f927db99 +TCGA-49-6744-01 none none none none N N none none none Bronchioid none none none none none none none Papillary predominant Adc Papillary predominant Adc none 0 TCGA-49-6744-01 BRCA-LUAD+ C1-LUAD-enriched Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 4 mutation cluster 12 TCGA-49-6744 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung NO NO 64 L-Upper TCGA-49-6744-F70580 TCGA-49-6744 TCGA-49-6744-01A -23484 0 1683 1 Scheduled Follow-up Submission Complete Remission/Response 2015-2-25 FEMALE Lung Adenocarcinoma Mixed Subtype No C34.1 8255/3 C34.1 YES 0.5 NO 90 YES YES 2.1 NO NO 20 No MX N1 T2a Stage IIA TCGA-49-6744.9a6d2cc6-3d78-42ec-b747-74bb6e96d22b.pdf 6744 Post-Adjuvant Therapy TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 0.5 7th YES NO YES 49 4 Current reformed smoker for < or = 15 years Lung A LIVING 2010 d4b90c1d-0d33-4845-bec2-ceedcace2dcb TCGA-49-6744-01A-11D-1855-08 d4b90c1d-0d33-4845-bec2-ceedcace2dcb TCGA-49-6744-01A-11D-1856-05 TCGA-49-6744-01A-11D-1854-01 d4b90c1d-0d33-4845-bec2-ceedcace2dcb TCGA-49-6744-01A-11D-1854-01 TCGA-49-6744-01A-13-2191-20 +TCGA-49-6744-11 none none none none N N none none none Bronchioid none none none none none none none Papillary predominant Adc Papillary predominant Adc none 0 TCGA-49-6744-11 C1-LUAD-enriched mutation cluster 12 TCGA-49-6744 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung NO NO 64 L-Upper TCGA-49-6744-F70580 TCGA-49-6744 TCGA-49-6744-11A -23484 0 1683 1 Scheduled Follow-up Submission Complete Remission/Response 2015-2-25 FEMALE Lung Adenocarcinoma Mixed Subtype No C34.1 8255/3 C34.1 YES 0.9 NO 90 YES YES 1 NO NO 20 No MX N1 T2a Stage IIA 6744 Post-Adjuvant Therapy TUMOR FREE Complete Remission/Response NO R0 Solid Tissue Normal 11 0.4 7th YES NO YES 49 4 Current reformed smoker for < or = 15 years Lung A LIVING 2010 6abcb12e-73c2-491e-b9f3-4f61f8a4e854 6abcb12e-73c2-491e-b9f3-4f61f8a4e854 6abcb12e-73c2-491e-b9f3-4f61f8a4e854 +TCGA-49-6745-01 2.16 0.34 none none none none N N none none none 0.17 Squamoid none none none p.D1010_splice none none none Micropapillary predom Adc Micropapillary predom Adc none 0 TCGA-49-6745-01 BRCA-LUAD+ C1-LUAD-enriched Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 4 mutation c1uster 9 TCGA-49-6745 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 82 L-Upper TCGA-49-6745-F15015 TCGA-49-6745 TCGA-49-6745-01A -30133 0 522 YES Scheduled Follow-up Submission 2011-8-11 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8260/3 C34.1 YES 0.7 NO YES NO 1.1 NO 20 Yes M0 N2 T2a Stage IIIA TCGA-49-6745.e291ad97-8658-435d-ae71-f0eb80bbb816.pdf 6745 TUMOR FREE NO Primary Tumor 01 0.3 7th YES NO YES 49 4 Current reformed smoker for < or = 15 years Lung A LIVING 2011 5969b621-a81e-42aa-ac40-4849df285060 TCGA-49-6745-01A-11D-1855-08 5969b621-a81e-42aa-ac40-4849df285060 TCGA-49-6745-01A-11D-1856-05 TCGA-49-6745-01A-11D-1854-01 5969b621-a81e-42aa-ac40-4849df285060 TCGA-49-6745-01A-11D-1854-01 TCGA-49-6745-01A-13-2191-20 +TCGA-49-6745-11 2.16 0.34 none none none none N N none none none 0.17 Squamoid none none none p.D1010_splice none none none Micropapillary predom Adc Micropapillary predom Adc none 0 TCGA-49-6745-11 C1-LUAD-enriched mutation c1uster 9 TCGA-49-6745 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 82 L-Upper TCGA-49-6745-F15015 TCGA-49-6745 TCGA-49-6745-11A -30133 0 522 YES Scheduled Follow-up Submission 2011-8-11 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8260/3 C34.1 YES 0.7 NO YES NO 2.5 NO 20 Yes M0 N2 T2a Stage IIIA 6745 TUMOR FREE NO Solid Tissue Normal 11 0.4 7th YES NO YES 49 4 Current reformed smoker for < or = 15 years Lung A LIVING 2011 1b4bb160-191b-4796-8759-339b11fe386d 1b4bb160-191b-4796-8759-339b11fe386d TCGA-49-6745-11A-01D-1856-05 1b4bb160-191b-4796-8759-339b11fe386d +TCGA-49-6761-01 3.13 0.29 none none none none Y Y none none none 0.12 Squamoid none p.G12D none p.S441C none none none Solid predominant Adc Solid predominant Adc none 0 TCGA-49-6761-01 BRCA-LUAD+ C1-LUAD-enriched Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 4 TCGA-49-6761 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung NO NO 68 R-Upper TCGA-49-6761-F22056 TCGA-49-6761 TCGA-49-6761-01A -24849 0 354 1 Scheduled Follow-up Submission 2012-2-23 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.7 NO 2.3 NO 50 Yes MX N2 T1 Stage IIIA TCGA-49-6761.73669cba-81ee-4215-a938-32556c5a211a.pdf 6761 TUMOR FREE 64 56 64 52 Complete Remission/Response YES NO R0 Primary Tumor 01 0.4 6th NO NO YES 49 4 Current reformed smoker for < or = 15 years Lung A LIVING 2009 ed630d55-aca9-4b8e-9128-f89177733bd5 ed630d55-aca9-4b8e-9128-f89177733bd5 TCGA-49-6761-01A-31D-1947-05 TCGA-49-6761-01A-31D-1943-01 ed630d55-aca9-4b8e-9128-f89177733bd5 TCGA-49-6761-01A-31D-1943-01 TCGA-49-6761-01A-13-2191-20 +TCGA-49-6761-11 3.13 0.29 none none none none Y Y none none none 0.12 Squamoid none p.G12D none p.S441C none none none Solid predominant Adc Solid predominant Adc none 0 TCGA-49-6761-11 C1-LUAD-enriched TCGA-49-6761 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung NO NO 68 R-Upper TCGA-49-6761-F22056 TCGA-49-6761 TCGA-49-6761-11A -24849 0 354 1 Scheduled Follow-up Submission 2012-2-23 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.6 NO 1.4 NO 50 Yes MX N2 T1 Stage IIIA 6761 TUMOR FREE 64 56 64 52 Complete Remission/Response YES NO R0 Solid Tissue Normal 11 0.4 6th NO NO YES 49 4 Current reformed smoker for < or = 15 years Lung A LIVING 2009 0ab304f8-0976-4637-8955-199e1782ab16 0ab304f8-0976-4637-8955-199e1782ab16 0ab304f8-0976-4637-8955-199e1782ab16 +TCGA-49-6767-01 3.32 0.43 none none none none N N none none p.P645T 0.17 Squamoid none none none none none none none Adenocarcinoma, NOS Adenocarcinoma, NOS none 0 TCGA-49-6767-01 High C1-LUAD-enriched Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 4 mutation cluster 8 TCGA-49-6767 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 46 R-Middle TCGA-49-6767-F58822 TCGA-49-6767 TCGA-49-6767-01A -17108 0 677 Scheduled Follow-up Submission 2014-4-24 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.2 8140/3 C34.2 YES 0.5 NO 1.5 NO 30 No MX N0 T3 Stage IIB TCGA-49-6767.8e8171dc-1baa-4b81-8e05-e15714135c1f.pdf 6767 TUMOR FREE NO R0 Primary Tumor 01 0.4 7th NO YES 49 2 Current smoker Lung A LIVING 2010 6a1b9b24-7377-4807-a876-282f9d948473 TCGA-49-6767-01A-11D-1855-08 6a1b9b24-7377-4807-a876-282f9d948473 TCGA-49-6767-01A-11D-1856-05 TCGA-49-6767-01A-11D-1854-01 6a1b9b24-7377-4807-a876-282f9d948473 TCGA-49-6767-01A-11D-1854-01 TCGA-49-6767-01A-13-2191-20 +TCGA-49-AAQV-01 TCGA-49-AAQV-01 TCGA-49-AAQV TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 63 L-Lower TCGA-49-AAQV TCGA-49-AAQV-01A -23370 717 677 0 95.5 1 YES Exon 19 Deletion FISH YES 2014-6-13 FEMALE Lung Adenocarcinoma Mixed Subtype No C34.3 8255/3 C34.3 YES 160 NO 90 YES true No MX N1 T1 Stage II TCGA-49-AAQV.4FE4DC74-AF70-4F6C-B290-561808DD7FAE.pdf AAQV Preoperative TUMOR FREE 77.29 81.7 78.80 83.3 Complete Remission/Response YES NO R0 Primary Tumor 01 7th NO NO YES 49 1 Lung A DECEASED 2012 a32fcc87-5473-43d5-9e4b-bad78719156c a32fcc87-5473-43d5-9e4b-bad78719156c TCGA-49-AAQV-01A-11D-A398-05 TCGA-49-AAQV-01A-11D-A396-01 a32fcc87-5473-43d5-9e4b-bad78719156c TCGA-49-AAQV-01A-11D-A396-01 +TCGA-49-AAR0-01 TCGA-49-AAR0-01 TCGA-49-AAR0 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 57 R-Upper TCGA-49-AAR0-F71576 TCGA-49-AAR0 TCGA-49-AAR0-01A -20932 4298 0 4765 107 1 Scheduled Follow-up Submission Complete Remission/Response 2015-4-10 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 200 NO 90 NO NO 37 true Yes, History of Prior Malignancy MX N0 T1 Stage IA TCGA-49-AAR0.FCCE5D5B-6AB6-441F-9FBF-65B23060C95B.pdf AAR0 Preoperative TUMOR FREE 80 62.5 58.6 85.4 Complete Remission/Response YES NO R0 Primary Tumor 01 5th NO NO YES 49 2 Lung A LIVING 2002 a90eef12-777c-4a46-b90e-1385807269f8 a90eef12-777c-4a46-b90e-1385807269f8 TCGA-49-AAR0-01A-21D-A398-05 TCGA-49-AAR0-01A-21D-A396-01 a90eef12-777c-4a46-b90e-1385807269f8 TCGA-49-AAR0-01A-21D-A396-01 +TCGA-49-AAR2-01 TCGA-49-AAR2-01 TCGA-49-AAR2 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 64 R-Lower TCGA-49-AAR2-F72094 TCGA-49-AAR2 TCGA-49-AAR2-01A -23479 1778 0 2224 105.8 1 Scheduled Follow-up Submission Complete Remission/Response 2015-4-10 MALE Lung Acinar Adenocarcinoma No C34.3 8550/3 C34.3 YES 130 NO 90 NO NO true No MX N0 T2 Stage IB TCGA-49-AAR2.70CAA6C7-B5DB-449A-A151-EED87511DEE5.pdf AAR2 Preoperative TUMOR FREE 78.2 79.5 78.6 80 Complete Remission/Response YES NO R0 Primary Tumor 01 2006 6th YES NO YES 49 4 Lung A LIVING 2009 1c03d9f5-e222-48b2-afeb-dfdeeff246b0 1c03d9f5-e222-48b2-afeb-dfdeeff246b0 TCGA-49-AAR2-01A-11D-A398-05 TCGA-49-AAR2-01A-11D-A396-01 1c03d9f5-e222-48b2-afeb-dfdeeff246b0 TCGA-49-AAR2-01A-11D-A396-01 +TCGA-49-AAR3-01 TCGA-49-AAR3-01 TCGA-49-AAR3 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 69 R-Upper TCGA-49-AAR3-F70567 TCGA-49-AAR3 TCGA-49-AAR3-01A -25469 1927 0 1893 0 Scheduled Follow-up Submission Complete Remission/Response 2015-2-25 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 140 NO 100 NO NO true No MX N1 T2 Stage IIB TCGA-49-AAR3.75D3436D-1CF9-4DC9-97EE-B93E2D6A3049.pdf AAR3 Post-Adjuvant Therapy TUMOR FREE Complete Remission/Response NO NO R0 Primary Tumor 01 6th YES NO YES 49 Lung A LIVING 2008 5c7d1e9d-56b8-4e54-a573-f7bd91f2afee 5c7d1e9d-56b8-4e54-a573-f7bd91f2afee TCGA-49-AAR3-01A-11D-A411-05 TCGA-49-AAR3-01A-11D-A40Z-01 5c7d1e9d-56b8-4e54-a573-f7bd91f2afee TCGA-49-AAR3-01A-11D-A40Z-01 +TCGA-49-AAR4-01 TCGA-49-AAR4-01 TCGA-49-AAR4 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 51 L-Upper TCGA-49-AAR4 TCGA-49-AAR4-01A -18939 2842 879 0 109.4 1 2014-6-18 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 200 NO 80 NO 35 true No MX N2 T2 Stage IIIA TCGA-49-AAR4.8982CE18-FA5A-4882-AAC4-F2AC6ED60C49.pdf AAR4 Preoperative WITH TUMOR 79.0 97.5 81.2 100.2 Stable Disease YES YES R0 Primary Tumor 01 6th YES NO YES 49 2 Lung A DECEASED 2006 653f5c38-8795-4ed9-8c4a-aaf5597eee8c 653f5c38-8795-4ed9-8c4a-aaf5597eee8c TCGA-49-AAR4-01A-12D-A411-05 TCGA-49-AAR4-01A-12D-A40Z-01 653f5c38-8795-4ed9-8c4a-aaf5597eee8c TCGA-49-AAR4-01A-12D-A40Z-01 +TCGA-49-AAR9-01 TCGA-49-AAR9-01 TCGA-49-AAR9 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 61 Other (please specify) ALL 3 LOBES OF RT Lung TCGA-49-AAR9 TCGA-49-AAR9-01A -22510 5308 260 0 1 2014-6-18 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.9 YES 260 NO 80 NO true No MX N0 T3 Stage IIB TCGA-49-AAR9.F2AB65ED-823F-446C-92CB-5F9DAB58D37A.pdf AAR9 Preoperative WITH TUMOR Progressive Disease NO NO R0 Primary Tumor 01 5th NO NO YES 49 2 Lung A DECEASED 1999 c3a5aa9d-5b4d-4c3a-9e4c-656f174e2a6e c3a5aa9d-5b4d-4c3a-9e4c-656f174e2a6e TCGA-49-AAR9-01A-21D-A411-05 TCGA-49-AAR9-01A-21D-A40Z-01 c3a5aa9d-5b4d-4c3a-9e4c-656f174e2a6e TCGA-49-AAR9-01A-21D-A40Z-01 +TCGA-49-AARE-01 TCGA-49-AARE-01 TCGA-49-AARE TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 51 R-Upper TCGA-49-AARE TCGA-49-AARE-01A -18893 5455 1229 0 107.2 1 2014-6-19 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 180 NO 90 YES 15 true No MX N0 T1 Stage IA TCGA-49-AARE.D15D2040-F72D-4913-92FC-54741F573151.pdf AARE Other WITH TUMOR 55.2 41.7 81 61.2 Complete Remission/Response YES NO R0 Primary Tumor 01 1995 5th NO NO YES 49 4 Lung A DECEASED 1999 1980 fb2e021f-ebae-4f7a-a072-d14046a20ce6 fb2e021f-ebae-4f7a-a072-d14046a20ce6 TCGA-49-AARE-01A-11D-A411-05 TCGA-49-AARE-01A-11D-A40Z-01 fb2e021f-ebae-4f7a-a072-d14046a20ce6 TCGA-49-AARE-01A-11D-A40Z-01 +TCGA-49-AARN-01 TCGA-49-AARN-01 TCGA-49-AARN TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 56 R-Lower TCGA-49-AARN TCGA-49-AARN-01A -20605 4882 1135 0 110.6 1 2014-6-19 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 210 NO 90 true Yes, History of Synchronous/Bilateral Malignancy MX N0 T1 Stage IA TCGA-49-AARN.19256999-CAE3-4D04-AA1C-758B4E80BCD1.pdf AARN Preoperative 85.9 101.1 80.2 94.4 Complete Remission/Response YES NO R0 Primary Tumor 01 5th NO NO YES 49 5 Lung A DECEASED 2000 b58ffa95-5a94-4b18-b149-8a0095c53bb8 b58ffa95-5a94-4b18-b149-8a0095c53bb8 TCGA-49-AARN-01A-21D-A411-05 TCGA-49-AARN-01A-21D-A40Z-01 b58ffa95-5a94-4b18-b149-8a0095c53bb8 TCGA-49-AARN-01A-21D-A40Z-01 +TCGA-49-AARO-01 TCGA-49-AARO-01 TCGA-49-AARO TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung YES NO NO 39 L-Upper TCGA-49-AARO-F70571 TCGA-49-AARO TCGA-49-AARO-01A -14527 3838 0 3759 3521 103.3 3 Scheduled Follow-up Submission Stable Disease 2015-2-25 FEMALE Lung Papillary Adenocarcinoma No C34.1 8260/3 C34.1 YES 170 NO 40 NO Locoregional Recurrence YES true No MX N0 T1a Stage IA TCGA-49-AARO.5E71C822-2014-431A-B050-102C4A845321.pdf AARO Post-Adjuvant Therapy WITH TUMOR 84.4 83.9 83.6 83.0 Complete Remission/Response Convincing Imaging YES YES R0 Primary Tumor 01 6th YES NO YES 49 2 Lung A LIVING 2003 51122947-fc8a-4285-b83a-4d5eabbe7c87 51122947-fc8a-4285-b83a-4d5eabbe7c87 TCGA-49-AARO-01A-12D-A411-05 TCGA-49-AARO-01A-12D-A40Z-01 51122947-fc8a-4285-b83a-4d5eabbe7c87 TCGA-49-AARO-01A-12D-A40Z-01 +TCGA-49-AARQ-01 TCGA-49-AARQ-01 TCGA-49-AARQ TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 41 R-Upper TCGA-49-AARQ-F72093 TCGA-49-AARQ TCGA-49-AARQ-01A -15065 6271 0 6732 99.9 1 Scheduled Follow-up Submission Complete Remission/Response 2015-4-10 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 60 NO 90 NO NO 60 true No MX N0 T2 Stage I TCGA-49-AARQ.9A745E52-5B6D-4209-9A05-E30D8CE40A3E.pdf AARQ Preoperative TUMOR FREE 56.8 56.1 83.2 82.2 Complete Remission/Response YES NO R0 Primary Tumor 01 2007 4th NO NO YES 49 4 Lung A LIVING 1996 1ec3463c-c56d-4b93-9873-1e7b9d2d4fc4 1ec3463c-c56d-4b93-9873-1e7b9d2d4fc4 TCGA-49-AARQ-01A-11D-A411-05 TCGA-49-AARQ-01A-11D-A40Z-01 1ec3463c-c56d-4b93-9873-1e7b9d2d4fc4 TCGA-49-AARQ-01A-11D-A40Z-01 +TCGA-49-AARR-01 TCGA-49-AARR-01 TCGA-49-AARR TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung NO NO NO 68 L-Upper TCGA-49-AARR-F70574 TCGA-49-AARR TCGA-49-AARR-01A -24942 4634 0 4992 4812 103.5 1 Scheduled Follow-up Submission Stable Disease 2015-2-25 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 170 NO 80 NO Locoregional Recurrence YES true No MX N0 T1 Stage IA TCGA-49-AARR.55998E02-5285-4E6F-8BB8-7DB57F18C0D2.pdf AARR Preoperative WITH TUMOR 76.3 78.8 77.8 80.3 Complete Remission/Response Convincing Imaging YES NO R0 Primary Tumor 01 1987 5th NO NO YES 49 3 Lung A LIVING 2001 367f7d8f-d11e-4cec-8df8-ab4e23e1ed0c 367f7d8f-d11e-4cec-8df8-ab4e23e1ed0c TCGA-49-AARR-01A-11D-A411-05 TCGA-49-AARR-01A-11D-A40Z-01 367f7d8f-d11e-4cec-8df8-ab4e23e1ed0c TCGA-49-AARR-01A-11D-A40Z-01 +TCGA-4B-A93V-01 TCGA-4B-A93V-01 TCGA-4B-A93V TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung NO YES NO NO 52 R-Lower TCGA-4B-A93V-F67919 TCGA-4B-A93V TCGA-4B-A93V-01A -19035 84 300 0 254 251 0 Additional New Tumor Event Progressive Disease 2014-11-12 FEMALE Lung Adenocarcinoma Mixed Subtype No C34.3 8140/3 C34.3 YES 400 NO 0 Peripheral Lung YES Distant Metastasis YES 30 true No M0 N0 T1b Stage IA TCGA-4B-A93V.3723B92A-EFB6-4239-9D26-B88AF56252CE.pdf A93V Post-Adjuvant Therapy WITH TUMOR Progressive Disease Convincing Imaging NO YES R0 Primary Tumor 01 2013 7th NO YES NO 4B 4 Lung A DECEASED 2013 1984 924c4803-0337-4423-ab6c-7aa43a5f7874 924c4803-0337-4423-ab6c-7aa43a5f7874 TCGA-4B-A93V-01A-11D-A398-05 TCGA-4B-A93V-01A-11D-A396-01 924c4803-0337-4423-ab6c-7aa43a5f7874 TCGA-4B-A93V-01A-11D-A396-01 +TCGA-50-5044-01 2.03 0.21 none p.D594H none none N Y none none none 0.1 Squamoid none none none none none p.E542K none Adenocarcinoma, NOS Adenocarcinoma, NOS none 0 TCGA-50-5044-01 Iq C1-LUAD-enriched Cluster 5 KIRC-like c1 LUAD-like c10 miRNA cluster 4 mutation cluster 14 TCGA-50-5044 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung YES YES NO NO 72 R-Lower TCGA-50-5044-F31976 TCGA-50-5044 TCGA-50-5044-01A -26567 624 0 483 Scheduled Follow-up Submission Progressive Disease 2012-5-14 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 0.9 NO 1.4 NO Distant Metastasis YES No M0 N1 T4 Stage IIIB TCGA-50-5044.40500921-fe3e-4fc0-a768-0062c488a832.pdf 5044 WITH TUMOR Progressive Disease Convincing Imaging YES Primary Tumor 01 0.4 5th NO NO YES 50 Lung A DECEASED 2002 dac01b76-c2a3-4041-b704-97f1afc2c4d3 TCGA-50-5044-01A-21D-1855-08 dac01b76-c2a3-4041-b704-97f1afc2c4d3 TCGA-50-5044-01A-21D-1856-05 TCGA-50-5044-01A-21D-1854-01 dac01b76-c2a3-4041-b704-97f1afc2c4d3 TCGA-50-5044-01A-21D-1854-01 TCGA-50-5044-01A-31-2190-20 +TCGA-50-5045-01 TCGA-50-5045-01 BRCA-LUAD+ C1-LUAD-enriched Cluster 5 squamous c3 miRNA cluster 4 mutation cluster 5 TCGA-50-5045 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung YES YES NO 57 R-Lower TCGA-50-5045-F32015 TCGA-50-5045 TCGA-50-5045-01A -20961 2174 0 1433 Scheduled Follow-up Submission Progressive Disease 2012-5-15 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 1.5 NO 1.8 NO Locoregional Recurrence YES No M0 N1 T2 [Discrepancy] TCGA-50-5045.1d5c2f0f-4203-4db9-b63c-b6d80d04207e.pdf 5045 WITH TUMOR Progressive Disease Biopsy with Histologic Confirmation YES Primary Tumor 01 0.4 6th NO YES 50 Lung A DECEASED 2004 7a4e94fa-09fb-4483-8816-f3ff2f1b2a6f TCGA-50-5045-01A-01D-1625-08 7a4e94fa-09fb-4483-8816-f3ff2f1b2a6f TCGA-50-5045-01A-01D-1626-05 TCGA-50-5045-01A-01D-1624-01 7a4e94fa-09fb-4483-8816-f3ff2f1b2a6f TCGA-50-5045-01A-01D-1624-01 TCGA-50-5045-01A-31-2190-20 +TCGA-50-5049-01 none none none none N N none none p.Q1126* Squamoid none none none none none none p.D551N Acinar predominant Adc Acinar predominant Adc none 0 TCGA-50-5049-01 High C1-LUAD-enriched Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 4 mutation cluster 11 TCGA-50-5049 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung NO YES NO 70 R-Upper TCGA-50-5049-F70448 TCGA-50-5049 TCGA-50-5049-01A -25577 0 3094 2544 YES Scheduled Follow-up Submission 2015-2-16 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 1.5 NO YES NO 2 NO Locoregional Recurrence YES No M0 N0 T2 Stage IA TCGA-50-5049.3d60a219-3c2c-4e2a-ab29-5d61cd31478b.pdf 5049 WITH TUMOR Progressive Disease Convincing Imaging NO YES Primary Tumor 01 0.3 6th NO NO YES 50 Lung A LIVING 2006 299d2ad8-b54d-4ddb-b6c5-b80d8baf39f2 TCGA-50-5049-01A-01D-1625-08 299d2ad8-b54d-4ddb-b6c5-b80d8baf39f2 TCGA-50-5049-01A-01D-1626-05 TCGA-50-5049-01A-01D-1624-01 299d2ad8-b54d-4ddb-b6c5-b80d8baf39f2 TCGA-50-5049-01A-01D-1624-01 TCGA-50-5049-01A-21-2190-20 +TCGA-50-5051-01 2.99 0.59 none none none none Y Y none none none 0.23 Magnoid none p.G12C none none none none none Adenocarcinoma, NOS Adenocarcinoma, NOS none 0 TCGA-50-5051-01 High C1-LUAD-enriched Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 4 mutation cluster 12 TCGA-50-5051 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung NO NO NO NO 42 L-Upper TCGA-50-5051-F32019 TCGA-50-5051 TCGA-50-5051-01A -15585 478 0 455 184 YES Scheduled Follow-up Submission Progressive Disease 2012-5-15 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 1 NO YES YES Other 1.2 NO Distant Metastasis YES 30 No M0 N2 T2 Stage IIIA TCGA-50-5051.ff5f5187-c4da-482c-b6fe-cbde5c820a80.pdf 5051 WITH TUMOR Progressive Disease Convincing Imaging YES R0 Primary Tumor 01 0.4 2006 6th YES NO YES 50 4 Current reformed smoker for < or = 15 years Lung A DECEASED 2007 ebbb3b0d-c092-4af4-919a-25fcb49eac69 TCGA-50-5051-01A-21D-1855-08 ebbb3b0d-c092-4af4-919a-25fcb49eac69 TCGA-50-5051-01A-21D-1856-05 TCGA-50-5051-01A-21D-1854-01 ebbb3b0d-c092-4af4-919a-25fcb49eac69 TCGA-50-5051-01A-21D-1854-01 TCGA-50-5051-01A-22-2190-20 +TCGA-50-5055-01 none none none none N N none none none Bronchioid none none none none none none none Acinar predominant Adc Acinar predominant Adc none 0 TCGA-50-5055-01 GBM C10-GBM Low purity c2 LUAD-like c10 miRNA cluster 5 mutation c1uster 9 TCGA-50-5055 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung YES YES YES NO 79 L-Lower TCGA-50-5055-F32023 TCGA-50-5055 TCGA-50-5055-01A 792 -28988 1830 0 785 771 YES Scheduled Follow-up Submission Progressive Disease 2012-5-15 FEMALE Lung Adenocarcinoma Mixed Subtype No C34.3 8255/3 C34.3 YES 1.5 NO YES NO 1.9 NO Locoregional Recurrence|Distant Metastasis YES No M0 N1 T1 Stage IIA TCGA-50-5055.847a0c64-cd3e-4a99-a6f7-b4ba1636ada1.pdf 5055 WITH TUMOR Stable Disease Biopsy with Histologic Confirmation|Convincing Imaging NO R0 Primary Tumor 01 0.1 6th NO NO YES 50 Lung A DECEASED 2008 15be34fa-d099-42d0-98ca-e66c83a16790 TCGA-50-5055-01A-01D-1625-08 15be34fa-d099-42d0-98ca-e66c83a16790 TCGA-50-5055-01A-01D-1626-05 TCGA-50-5055-01A-01D-1624-01 15be34fa-d099-42d0-98ca-e66c83a16790 TCGA-50-5055-01A-01D-1624-01 +TCGA-50-5066-01 TCGA-50-5066-01 BRCA-LUAD+ C1-LUAD-enriched Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 4 mutation cluster 13 TCGA-50-5066 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 72 R-Upper TCGA-50-5066-F70450 TCGA-50-5066 TCGA-50-5066-01A -26385 0 1442 YES YES Scheduled Follow-up Submission Complete Remission/Response 2015-2-16 MALE Lung Adenocarcinoma Mixed Subtype No C34.1 8255/3 C34.1 YES 1 NO YES NO 1.5 NO NO No M0 N0 T2 Stage IB TCGA-50-5066.E00CB449-F980-4829-A006-32706F041E94.pdf 5066 TUMOR FREE Complete Remission/Response NO NO R0 Primary Tumor 01 0.2 6th YES NO YES 50 1 Lung A LIVING 2009 554a301f-fbc8-41f2-96e9-5da2ee943727 TCGA-50-5066-01A-01D-1625-08 554a301f-fbc8-41f2-96e9-5da2ee943727 TCGA-50-5066-01A-01D-1626-05 TCGA-50-5066-01A-01D-1624-01 554a301f-fbc8-41f2-96e9-5da2ee943727 TCGA-50-5066-01A-01D-1624-01 TCGA-50-5066-01A-21-2190-20 +TCGA-50-5066-02 TCGA-50-5066-02 C1-LUAD-enriched Cluster 5 LUAD-like c10 miRNA cluster 5 mutation cluster 13 TCGA-50-5066 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 72 R-Upper TCGA-50-5066-F70450 TCGA-50-5066 TCGA-50-5066-02A -26385 0 1442 YES YES Scheduled Follow-up Submission Complete Remission/Response 2015-2-16 MALE Lung Adenocarcinoma Mixed Subtype No C34.1 8255/3 C34.1 YES 1.3 NO YES NO 1.5 NO NO No M0 N0 T2 Stage IB TCGA-50-5066.BB1E3DC0-FEAA-463D-910F-E0DBCA0F3F0E.pdf 5066 TUMOR FREE Complete Remission/Response NO NO R0 Recurrent Tumor 02 0.3 6th YES NO YES 50 1 Lung A LIVING 2009 f274e34b-e111-47e0-8fff-5c338d387d76 f274e34b-e111-47e0-8fff-5c338d387d76 TCGA-50-5066-02A-11D-2087-05 f274e34b-e111-47e0-8fff-5c338d387d76 +TCGA-50-5068-01 1.62 0.38 none none none none N N none none none 0.2 Squamoid none none none none none none none Acinar predominant Adc Acinar predominant Adc none 0 TCGA-50-5068-01 High C1-LUAD-enriched Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 4 mutation cluster 5 TCGA-50-5068 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung YES NO YES NO 59 R-Lower TCGA-50-5068-F32057 TCGA-50-5068 TCGA-50-5068-01A 686 -21728 1499 0 1499 686 Scheduled Follow-up Submission Progressive Disease 2012-5-16 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 1.3 NO 1.4 NO Distant Metastasis YES No MX N1 T2 Stage IIB TCGA-50-5068.d8025f22-0b42-4204-bc58-56fc727c71ac.pdf 5068 WITH TUMOR Progressive Disease Biopsy with Histologic Confirmation|Convincing Imaging NO Primary Tumor 01 0.3 6th YES NO YES 50 Lung A DECEASED 2003 10c6a96f-b119-43a8-8dfa-9af13bce53b9 TCGA-50-5068-01A-01D-1625-08 10c6a96f-b119-43a8-8dfa-9af13bce53b9 TCGA-50-5068-01A-01D-1626-05 TCGA-50-5068-01A-01D-1624-01 10c6a96f-b119-43a8-8dfa-9af13bce53b9 TCGA-50-5068-01A-01D-1624-01 TCGA-50-5068-01A-21-2190-20 +TCGA-50-5072-01 2.1 0.45 none none none none N N none none none 0.22 Magnoid none none none none none none none Solid predominant Adc Solid predominant Adc p.K97_splice 0 TCGA-50-5072-01 High C1-LUAD-enriched Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 5 mutation c1uster 9 TCGA-50-5072 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung NO YES NO 74 L-Upper TCGA-50-5072-F32059 TCGA-50-5072 TCGA-50-5072-01A -27036 250 0 246 213 YES YES Scheduled Follow-up Submission Progressive Disease 2012-5-16 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) Yes C34.1 8140/3 C34.1 YES 0.9 NO YES 1.2 NO Distant Metastasis YES 15 No M0 N2 T2 Stage IIIA TCGA-50-5072.0e998d45-ba74-4a11-8a14-e394299c9bba.pdf 5072 WITH TUMOR Progressive Disease Convincing Imaging NO YES Primary Tumor 01 0.3 1974 6th YES NO YES 50 3 Current reformed smoker for > 15 years Lung A DECEASED 2009 d27e254c-1ccb-4b13-97f3-48d1e427d130 TCGA-50-5072-01A-21D-1855-08 d27e254c-1ccb-4b13-97f3-48d1e427d130 TCGA-50-5072-01A-21D-1856-05 TCGA-50-5072-01A-21D-1854-01 d27e254c-1ccb-4b13-97f3-48d1e427d130 TCGA-50-5072-01A-21D-1854-01 TCGA-50-5072-01A-22-2190-20 +TCGA-50-5930-01 TCGA-50-5930-01 BRCA-LUAD+ C1-LUAD-enriched Cluster 5 squamous c3 miRNA cluster 4 mutation c1uster 9 TCGA-50-5930 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung NO YES NO 47 [Discrepancy] TCGA-50-5930-F32064 TCGA-50-5930 TCGA-50-5930-01A -17238 282 0 177 Scheduled Follow-up Submission Progressive Disease 2012-5-16 MALE Lung Adenocarcinoma Mixed Subtype No C34.3 8255/3 C34.3 YES 1 NO 1.2 NO Distant Metastasis YES No M0 N2 T2 Stage IIIA TCGA-50-5930.ebb21844-9982-40da-972b-6f52941c5c4b.pdf 5930 WITH TUMOR Progressive Disease Convincing Imaging YES Primary Tumor 01 0.4 5th YES NO YES 50 Lung A DECEASED 2001 ea55c131-97f8-49cc-a445-87523ce1f075 TCGA-50-5930-01A-11D-1753-08 ea55c131-97f8-49cc-a445-87523ce1f075 TCGA-50-5930-01A-11D-1756-05 TCGA-50-5930-01A-11D-1752-01 ea55c131-97f8-49cc-a445-87523ce1f075 TCGA-50-5930-01A-11D-1752-01 TCGA-50-5930-01A-31-2191-20 +TCGA-50-5930-11 TCGA-50-5930-11 C1-LUAD-enriched mutation c1uster 9 TCGA-50-5930 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung NO YES NO 47 [Discrepancy] TCGA-50-5930-F32064 TCGA-50-5930 TCGA-50-5930-11A -17238 282 0 177 Scheduled Follow-up Submission Progressive Disease 2012-5-16 MALE Lung Adenocarcinoma Mixed Subtype No C34.3 8255/3 C34.3 YES 1.2 NO 1.9 NO Distant Metastasis YES No M0 N2 T2 Stage IIIA 5930 WITH TUMOR Progressive Disease Convincing Imaging YES Solid Tissue Normal 11 0.2 5th YES NO YES 50 Lung A DECEASED 2001 c019f320-2e0e-4f00-a393-2e5717d64cc0 c019f320-2e0e-4f00-a393-2e5717d64cc0 TCGA-50-5930-11A-01D-1756-05 c019f320-2e0e-4f00-a393-2e5717d64cc0 +TCGA-50-5931-01 3.68 0.76 none none none none N N none none none 0.23 Magnoid none none none none none none none Solid predominant Adc Solid predominant Adc none 0 TCGA-50-5931-01 Squamous C1-LUAD-enriched Cluster 5 squamous c3 RNA cluster 12 miRNA cluster 5 mutation cluster 2 TCGA-50-5931 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung NO NO NO 75 L-Upper TCGA-50-5931-F32067 TCGA-50-5931 TCGA-50-5931-01A -27733 434 0 267 425 Scheduled Follow-up Submission Progressive Disease 2012-5-16 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 1 NO Central Lung 1.7 NO Distant Metastasis YES 40 No M0 N0 T2 Stage IB TCGA-50-5931.396c0f5f-1b86-4aa9-88ef-ca9220f4ccf3.pdf 5931 WITH TUMOR Progressive Disease Convincing Imaging NO R0 Primary Tumor 01 0.3 5th NO NO YES 50 4 Lung A DECEASED 2001 e2a7336c-5262-433a-ad52-8834eaee2e1e TCGA-50-5931-01A-11D-1753-08 e2a7336c-5262-433a-ad52-8834eaee2e1e TCGA-50-5931-01A-11D-1756-05 TCGA-50-5931-01A-11D-1752-01 e2a7336c-5262-433a-ad52-8834eaee2e1e TCGA-50-5931-01A-11D-1752-01 TCGA-50-5931-01A-31-2191-20 +TCGA-50-5931-11 3.68 0.76 none none none none N N none none none 0.23 Magnoid none none none none none none none Solid predominant Adc Solid predominant Adc none 0 TCGA-50-5931-11 C1-LUAD-enriched mutation cluster 2 TCGA-50-5931 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung NO NO NO 75 L-Upper TCGA-50-5931-F32067 TCGA-50-5931 TCGA-50-5931-11A -27733 434 0 267 425 Scheduled Follow-up Submission Progressive Disease 2012-5-16 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 1 NO Central Lung 1.2 NO Distant Metastasis YES 40 No M0 N0 T2 Stage IB 5931 WITH TUMOR Progressive Disease Convincing Imaging NO R0 Solid Tissue Normal 11 0.3 5th NO NO YES 50 4 Lung A DECEASED 2001 4cc61cbe-fa79-499b-9fd5-9b454030154c 4cc61cbe-fa79-499b-9fd5-9b454030154c TCGA-50-5931-11A-01D-1756-05 4cc61cbe-fa79-499b-9fd5-9b454030154c +TCGA-50-5932-01 1.8 0.85 none none none none Y Y none none none 0.46 Magnoid none p.G12C none none none none none Papillary predominant Adc Papillary predominant Adc p.N181Y 0 TCGA-50-5932-01 BRCA-LUAD+ C1-LUAD-enriched Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 4 mutation cluster 12 TCGA-50-5932 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung YES NO NO NO 75 R-Upper TCGA-50-5932-F32080 TCGA-50-5932 TCGA-50-5932-01A -27454 1235 0 1091 1090 Scheduled Follow-up Submission Progressive Disease 2012-5-16 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 1.3 NO Central Lung 1.4 NO Locoregional Recurrence YES Yes M0 N1 T2 Stage IIB TCGA-50-5932.d7713068-4d83-4242-bae2-8035c1ba9b8d.pdf 5932 WITH TUMOR Progressive Disease Biopsy with Histologic Confirmation|Convincing Imaging NO Primary Tumor 01 0.5 5th NO NO YES 50 Lung A DECEASED 2001 80032260-febc-4069-9897-e36cf1118e68 TCGA-50-5932-01A-11D-1753-08 80032260-febc-4069-9897-e36cf1118e68 TCGA-50-5932-01A-11D-1756-05 TCGA-50-5932-01A-11D-1752-01 80032260-febc-4069-9897-e36cf1118e68 TCGA-50-5932-01A-11D-1752-01 TCGA-50-5932-01A-31-2191-20 +TCGA-50-5932-11 1.8 0.85 none none none none Y Y none none none 0.46 Magnoid none p.G12C none none none none none Papillary predominant Adc Papillary predominant Adc p.N181Y 0 TCGA-50-5932-11 C1-LUAD-enriched mutation cluster 12 TCGA-50-5932 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung YES NO NO NO 75 R-Upper TCGA-50-5932-F32080 TCGA-50-5932 TCGA-50-5932-11A -27454 1235 0 1091 1090 Scheduled Follow-up Submission Progressive Disease 2012-5-16 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 1.3 NO Central Lung 2.2 NO Locoregional Recurrence YES Yes M0 N1 T2 Stage IIB 5932 WITH TUMOR Progressive Disease Biopsy with Histologic Confirmation|Convincing Imaging NO Solid Tissue Normal 11 0.5 5th NO NO YES 50 Lung A DECEASED 2001 7284cc3a-d5a1-42b1-8b1a-89665c4bc35f 7284cc3a-d5a1-42b1-8b1a-89665c4bc35f TCGA-50-5932-11A-01D-1756-05 7284cc3a-d5a1-42b1-8b1a-89665c4bc35f +TCGA-50-5933-01 2.78 0.3 none none none none N N none none none 0.13 Squamoid none none none p.C98F none none none Solid predominant Adc Solid predominant Adc none 0 TCGA-50-5933-01 High C1-LUAD-enriched Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 5 mutation cluster 11 TCGA-50-5933 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 72 L-Lower TCGA-50-5933-F32104 TCGA-50-5933 TCGA-50-5933-01A -26377 2393 0 2370 Scheduled Follow-up Submission Complete Remission/Response 2012-5-17 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 1 NO Central Lung 1.7 NO NO No M0 N2 T4 Stage IIIB TCGA-50-5933.68d471f3-43c0-44cf-97ce-003ff111c35c.pdf 5933 TUMOR FREE Complete Remission/Response YES Primary Tumor 01 0.5 5th YES NO YES 50 Lung A DECEASED 2001 51eae0de-8f16-4093-b42e-5c34c4768459 TCGA-50-5933-01A-11D-1753-08 51eae0de-8f16-4093-b42e-5c34c4768459 TCGA-50-5933-01A-11D-1756-05 TCGA-50-5933-01A-11D-1752-01 51eae0de-8f16-4093-b42e-5c34c4768459 TCGA-50-5933-01A-11D-1752-01 TCGA-50-5933-01A-31-2191-20 +TCGA-50-5933-11 2.78 0.3 none none none none N N none none none 0.13 Squamoid none none none p.C98F none none none Solid predominant Adc Solid predominant Adc none 0 TCGA-50-5933-11 C1-LUAD-enriched mutation cluster 11 TCGA-50-5933 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 72 L-Lower TCGA-50-5933-F32104 TCGA-50-5933 TCGA-50-5933-11A -26377 2393 0 2370 Scheduled Follow-up Submission Complete Remission/Response 2012-5-17 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 1.1 NO Central Lung 1.5 NO NO No M0 N2 T4 Stage IIIB 5933 TUMOR FREE Complete Remission/Response YES Solid Tissue Normal 11 0.3 5th YES NO YES 50 Lung A DECEASED 2001 af24ffd8-4d43-4f7a-ae49-590814d00f39 af24ffd8-4d43-4f7a-ae49-590814d00f39 TCGA-50-5933-11A-01D-1756-05 af24ffd8-4d43-4f7a-ae49-590814d00f39 +TCGA-50-5935-01 3.08 0.58 none none none none N N none none none 0.22 Bronchioid none none none none none none none Acinar predominant Adc Acinar predominant Adc none 0 TCGA-50-5935-01 BRCA-LUAD+ C1-LUAD-enriched Cluster 6 LUAD-like c10 miRNA cluster 4 mutation cluster 12 TCGA-50-5935 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung NO 86 L-Upper TCGA-50-5935-F32108 TCGA-50-5935 TCGA-50-5935-01A -31610 653 0 653 YES Other Scheduled Follow-up Submission Complete Remission/Response 2012-5-17 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.8 NO YES YES 1.4 NO NO Yes M0 N0 T1 Stage IA TCGA-50-5935.b6f8e549-cb8e-4e6d-8cfe-2df2b1d57646.pdf 5935 TUMOR FREE Complete Remission/Response YES Primary Tumor 01 0.5 6th NO NO YES 50 Lung A DECEASED 2006 bf999d4c-d1e6-4e8b-8aa3-becb7b734037 TCGA-50-5935-01A-11D-1753-08 bf999d4c-d1e6-4e8b-8aa3-becb7b734037 TCGA-50-5935-01A-11D-1756-05 TCGA-50-5935-01A-11D-1752-01 bf999d4c-d1e6-4e8b-8aa3-becb7b734037 TCGA-50-5935-01A-11D-1752-01 +TCGA-50-5935-11 3.08 0.58 none none none none N N none none none 0.22 Bronchioid none none none none none none none Acinar predominant Adc Acinar predominant Adc none 0 TCGA-50-5935-11 C1-LUAD-enriched mutation cluster 12 TCGA-50-5935 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung NO 86 L-Upper TCGA-50-5935-F32108 TCGA-50-5935 TCGA-50-5935-11A -31610 653 0 653 YES Other Scheduled Follow-up Submission Complete Remission/Response 2012-5-17 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 1.1 NO YES YES 1.5 NO NO Yes M0 N0 T1 Stage IA 5935 TUMOR FREE Complete Remission/Response YES Solid Tissue Normal 11 0.3 6th NO NO YES 50 Lung A DECEASED 2006 c6722ce9-8824-4721-9e95-96e9b0b09066 c6722ce9-8824-4721-9e95-96e9b0b09066 TCGA-50-5935-11A-01D-1756-05 c6722ce9-8824-4721-9e95-96e9b0b09066 +TCGA-50-5936-01 3.25 0.43 none none none none N N none none none 0.17 Magnoid none none none none none none none Acinar predominant Adc Acinar predominant Adc none 0 TCGA-50-5936-01 Squamous C1-LUAD-enriched Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 4 mutation cluster 12 TCGA-50-5936 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung YES NO YES NO 58 R-Lower TCGA-50-5936-F32110 TCGA-50-5936 TCGA-50-5936-01A 177 -21238 257 0 150 YES Scheduled Follow-up Submission Progressive Disease 2012-5-17 MALE Mucinous (Colloid) Carcinoma No C34.30 8480/3 C34.3 YES 0.8 NO YES YES G12C 0.9 NO YES No M0 N2 T2 Stage IIIA TCGA-50-5936.8d30d2aa-bef2-4329-944b-99ad5c9d8fc6.pdf 5936 WITH TUMOR Progressive Disease Biopsy with Histologic Confirmation|Convincing Imaging NO Primary Tumor 01 0.3 6th NO NO YES 50 Lung A DECEASED 2007 3bb181ee-960f-488b-b04b-c2acb7cfb127 TCGA-50-5936-01A-11D-1625-08 3bb181ee-960f-488b-b04b-c2acb7cfb127 TCGA-50-5936-01A-11D-1626-05 TCGA-50-5936-01A-11D-1624-01 3bb181ee-960f-488b-b04b-c2acb7cfb127 TCGA-50-5936-01A-11D-1624-01 TCGA-50-5936-01A-31-2191-20 +TCGA-50-5936-11 3.25 0.43 none none none none N N none none none 0.17 Magnoid none none none none none none none Acinar predominant Adc Acinar predominant Adc none 0 TCGA-50-5936-11 C1-LUAD-enriched mutation cluster 12 TCGA-50-5936 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung YES NO YES NO 58 R-Lower TCGA-50-5936-F32110 TCGA-50-5936 TCGA-50-5936-11A 177 -21238 257 0 150 YES Scheduled Follow-up Submission Progressive Disease 2012-5-17 MALE Mucinous (Colloid) Carcinoma No C34.30 8480/3 C34.3 YES 1.4 NO YES YES G12C 2.2 NO YES No M0 N2 T2 Stage IIIA 5936 WITH TUMOR Progressive Disease Biopsy with Histologic Confirmation|Convincing Imaging NO Solid Tissue Normal 11 0.1 6th NO NO YES 50 Lung A DECEASED 2007 81e8d16b-1a9b-4156-a438-07d89807f652 81e8d16b-1a9b-4156-a438-07d89807f652 TCGA-50-5936-11A-01D-1626-05 81e8d16b-1a9b-4156-a438-07d89807f652 +TCGA-50-5939-01 1.72 0.33 none none none none N N none none none 0.17 Squamoid none none none none none none none Solid predominant Adc Solid predominant Adc none 0 TCGA-50-5939-01 Squamous C1-LUAD-enriched Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 4 mutation cluster 5 TCGA-50-5939 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 85 R-Upper TCGA-50-5939-F32124 TCGA-50-5939 TCGA-50-5939-01A -31236 460 0 Scheduled Follow-up Submission Complete Remission/Response 2012-5-17 MALE Lung Adenocarcinoma Mixed Subtype No C34.1 8255/3 C34.1 YES 0.8 NO 1.2 NO 15 No M0 N0 T2 Stage IB TCGA-50-5939.b8f00ba8-722f-4df1-bfcd-2ccfe6583abd.pdf 5939 TUMOR FREE Complete Remission/Response NO Primary Tumor 01 0.4 1968 6th NO NO YES 50 3 Current reformed smoker for > 15 years Lung A DECEASED 2008 3cafb1e5-9de0-4ced-8b87-d2299a207b97 TCGA-50-5939-01A-11D-1625-08 3cafb1e5-9de0-4ced-8b87-d2299a207b97 TCGA-50-5939-01A-11D-1626-05 TCGA-50-5939-01A-11D-1624-01 3cafb1e5-9de0-4ced-8b87-d2299a207b97 TCGA-50-5939-01A-11D-1624-01 TCGA-50-5939-01A-31-2191-20 +TCGA-50-5939-11 1.72 0.33 none none none none N N none none none 0.17 Squamoid none none none none none none none Solid predominant Adc Solid predominant Adc none 0 TCGA-50-5939-11 C1-LUAD-enriched mutation cluster 5 TCGA-50-5939 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 85 R-Upper TCGA-50-5939-F32124 TCGA-50-5939 TCGA-50-5939-11A -31236 460 0 Scheduled Follow-up Submission Complete Remission/Response 2012-5-17 MALE Lung Adenocarcinoma Mixed Subtype No C34.1 8255/3 C34.1 YES 2 NO 2.5 NO 15 No M0 N0 T2 Stage IB 5939 TUMOR FREE Complete Remission/Response NO Solid Tissue Normal 11 0.2 1968 6th NO NO YES 50 3 Current reformed smoker for > 15 years Lung A DECEASED 2008 0569af63-9a1d-4f03-9a67-1269c7973677 0569af63-9a1d-4f03-9a67-1269c7973677 TCGA-50-5939-11A-01D-1626-05 0569af63-9a1d-4f03-9a67-1269c7973677 +TCGA-50-5941-01 none p.G327_splice none none Y Y none none none Squamoid none p.G12A none none none none none Adenocarcinoma, NOS Adenocarcinoma, NOS none 0 TCGA-50-5941-01 High C1-LUAD-enriched Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 4 mutation cluster 2 TCGA-50-5941 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 55 R-Upper TCGA-50-5941-F70451 TCGA-50-5941 TCGA-50-5941-01A -20350 0 1474 Scheduled Follow-up Submission Complete Remission/Response 2015-2-16 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 1 NO 1 NO NO 25 No M0 N2 T2a Stage IIIA TCGA-50-5941.d49e610e-998f-4c6e-bb3d-b9c3a4221544.pdf 5941 TUMOR FREE Complete Remission/Response NO NO Primary Tumor 01 0.3 7th YES NO YES 50 2 Current smoker Lung A LIVING 2010 84138ee7-b120-4201-95b1-ccdc1c82ebda TCGA-50-5941-01A-11D-1753-08 84138ee7-b120-4201-95b1-ccdc1c82ebda TCGA-50-5941-01A-11D-1756-05 TCGA-50-5941-01A-11D-1752-01 84138ee7-b120-4201-95b1-ccdc1c82ebda TCGA-50-5941-01A-11D-1752-01 TCGA-50-5941-01A-31-2191-20 +TCGA-50-5942-01 1.95 0.7 none p.V600E none none N Y none none none 0.36 Bronchioid none none none none none none none Lepidic predominant Adc Lepidic predominant Adc none 0 TCGA-50-5942-01 Kirc+ C1-LUAD-enriched Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 5 mutation c1uster 9 TCGA-50-5942 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung NO YES 67 R-Upper TCGA-50-5942-F70452 TCGA-50-5942 TCGA-50-5942-01A -24781 0 1847 1378 Scheduled Follow-up Submission 2015-2-16 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.7 NO 1 NO Locoregional Recurrence YES 30 No M0 N0 T1 Stage IA TCGA-50-5942.915634e0-d38b-4a37-b96f-b9ac10507179.pdf 5942 WITH TUMOR Stable Disease Convincing Imaging NO YES R0 Primary Tumor 01 0.3 2009 7th NO NO YES 50 4 Current reformed smoker for < or = 15 years Lung A LIVING 2009 43a90c23-bff9-45ae-a5b5-c65f343d1cdc TCGA-50-5942-01A-21D-1753-08 43a90c23-bff9-45ae-a5b5-c65f343d1cdc TCGA-50-5942-01A-21D-1756-05 TCGA-50-5942-01A-21D-1752-01 43a90c23-bff9-45ae-a5b5-c65f343d1cdc TCGA-50-5942-01A-21D-1752-01 TCGA-50-5942-01A-31-2191-20 +TCGA-50-5944-01 3.32 0.57 none none none none Y Y p.L858R none none 0.21 Bronchioid none none none none none none none Lepidic predominant Adc Lepidic predominant Adc none 0 TCGA-50-5944-01 High C1-LUAD-enriched Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 5 mutation cluster 8 TCGA-50-5944 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 69 R-Upper TCGA-50-5944-F70454 TCGA-50-5944 TCGA-50-5944-01A -25440 0 1750 Scheduled Follow-up Submission Complete Remission/Response 2015-2-16 FEMALE Lung Acinar Adenocarcinoma No C34.1 8550/3 C34.1 YES 0.6 NO 0.6 NO NO No M0 N0 T1 Stage IA TCGA-50-5944.a3ad8013-b778-4fd0-9a5f-a516d6ff5a3e.pdf 5944 TUMOR FREE Complete Remission/Response NO NO R0 Primary Tumor 01 0.2 7th NO NO YES 50 Lung A LIVING 2010 c1859475-12fd-47f6-887d-136d334399cd TCGA-50-5944-01A-11D-1753-08 c1859475-12fd-47f6-887d-136d334399cd TCGA-50-5944-01A-11D-1756-05 TCGA-50-5944-01A-11D-1752-01 c1859475-12fd-47f6-887d-136d334399cd TCGA-50-5944-01A-11D-1752-01 TCGA-50-5944-01A-13-2191-20 +TCGA-50-5946-01 TCGA-50-5946-01 High C1-LUAD-enriched Cluster 5 squamous c3 LUAD-like c10 mutation cluster 5 TCGA-50-5946 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung NO NO NO 62 R-Upper TCGA-50-5946-F70455 TCGA-50-5946 TCGA-50-5946-01A -22852 0 1617 811 Progressive Disease 2015-2-16 MALE Lung Adenocarcinoma Mixed Subtype No C34.1 8255/3 C34.1 YES 1.2 NO 1.5 NO Distant Metastasis YES No MX N0 T1 Stage IA TCGA-50-5946.E0329D21-475F-4C7D-9703-8297FF21B39F.pdf 5946 WITH TUMOR Progressive Disease Convincing Imaging NO NO Primary Tumor 01 0.3 2009 NO NO YES 50 4 Lung A LIVING 2010 8a5cfa5b-2dab-4775-ae08-3d7e0b36e93f TCGA-50-5946-01A-11D-1753-08 8a5cfa5b-2dab-4775-ae08-3d7e0b36e93f TCGA-50-5946-01A-11D-1756-05 TCGA-50-5946-01A-11D-1752-01 8a5cfa5b-2dab-4775-ae08-3d7e0b36e93f TCGA-50-5946-01A-11D-1752-01 TCGA-50-5946-01A-13-2191-20 +TCGA-50-5946-02 TCGA-50-5946-02 C1-LUAD-enriched Cluster 5 LUAD-like c10 miRNA cluster 5 mutation cluster 5 TCGA-50-5946 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung NO NO NO 62 R-Upper TCGA-50-5946-F70455 TCGA-50-5946 TCGA-50-5946-02A -22852 0 1617 811 Progressive Disease 2015-2-16 MALE Lung Adenocarcinoma Mixed Subtype No C34.1 8255/3 C34.1 YES 0.4 NO 1.9 NO Distant Metastasis YES No MX N0 T1 Stage IA TCGA-50-5946.E0329D21-475F-4C7D-9703-8297FF21B39F.pdf 5946 WITH TUMOR Progressive Disease Convincing Imaging NO NO Recurrent Tumor 02 0.2 2009 NO NO YES 50 4 Lung A LIVING 2010 0bfc47d8-bd48-49e9-8d37-6a418d049aef 0bfc47d8-bd48-49e9-8d37-6a418d049aef TCGA-50-5946-02A-11D-2087-05 0bfc47d8-bd48-49e9-8d37-6a418d049aef +TCGA-50-6590-01 TCGA-50-6590-01 BRCA-LUAD+ C1-LUAD-enriched Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 4 mutation cluster 11 TCGA-50-6590 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 72 R-Upper TCGA-50-6590-F43827 TCGA-50-6590 TCGA-50-6590-01A -26444 1288 0 YES Scheduled Follow-up Submission Complete Remission/Response 2013-6-4 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 1 NO 1.6 NO NO 50 No M0 N0 T2 Stage IB TCGA-50-6590.13192955-ae90-4708-8f85-3b4e35781345.pdf 6590 TUMOR FREE Complete Remission/Response NO Primary Tumor 01 0.3 2002 6th YES NO YES 50 4 Lung A DECEASED 2005 12fdf681-a6f5-4dfe-b556-d7e7f7e4d58a TCGA-50-6590-01A-12D-1855-08 12fdf681-a6f5-4dfe-b556-d7e7f7e4d58a TCGA-50-6590-01A-12D-1856-05 TCGA-50-6590-01A-12D-1854-01 12fdf681-a6f5-4dfe-b556-d7e7f7e4d58a TCGA-50-6590-01A-12D-1854-01 TCGA-50-6590-01A-23-2191-20 +TCGA-50-6591-01 TCGA-50-6591-01 BRCA-LUAD+ C1-LUAD-enriched Cluster 5 squamous c3 GBM-like c6 miRNA cluster 13 mutation cluster 8 TCGA-50-6591 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 63 L-Lower TCGA-50-6591-F43833 TCGA-50-6591 TCGA-50-6591-01A -23067 119 0 Scheduled Follow-up Submission Progressive Disease 2013-6-4 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 0.8 NO 0.9 NO NO No M1 N0 T2 Stage IV TCGA-50-6591.d1bb9feb-2cd4-40fd-a4d6-300d16b29d51.pdf 6591 WITH TUMOR Progressive Disease NO Primary Tumor 01 0.7 6th NO NO YES 50 1 Lung A DECEASED 2007 92321ab5-8c77-4208-9daf-e6fcb01cc7a1 TCGA-50-6591-01A-11D-1753-08 92321ab5-8c77-4208-9daf-e6fcb01cc7a1 TCGA-50-6591-01A-11D-1756-05 TCGA-50-6591-01A-11D-1752-01 92321ab5-8c77-4208-9daf-e6fcb01cc7a1 TCGA-50-6591-01A-11D-1752-01 TCGA-50-6591-01A-13-2191-20 +TCGA-50-6591-11 TCGA-50-6591-11 C1-LUAD-enriched mutation cluster 8 TCGA-50-6591 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 63 L-Lower TCGA-50-6591-F43833 TCGA-50-6591 TCGA-50-6591-11A -23067 119 0 Scheduled Follow-up Submission Progressive Disease 2013-6-4 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 1.1 NO 1.8 NO NO No M1 N0 T2 Stage IV 6591 WITH TUMOR Progressive Disease NO Solid Tissue Normal 11 0.4 6th NO NO YES 50 1 Lung A DECEASED 2007 TCGA-50-6591-11A-01D-1756-05 +TCGA-50-6592-01 TCGA-50-6592-01 High C1-LUAD-enriched Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 4 mutation cluster 3 TCGA-50-6592 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 71 L-Lower TCGA-50-6592-F43835 TCGA-50-6592 TCGA-50-6592-01A -26191 777 0 Scheduled Follow-up Submission Progressive Disease 2013-6-4 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 1 NO 2 NO NO No M0 N0 T2 Stage IB TCGA-50-6592.9a5098a9-7600-4b77-9b16-d6c274affd77.pdf 6592 WITH TUMOR Progressive Disease YES Primary Tumor 01 0.3 6th NO NO YES 50 4 Lung A DECEASED 2007 444662df-ae9b-4fec-9afc-df392ba3a88d TCGA-50-6592-01A-11D-1753-08 444662df-ae9b-4fec-9afc-df392ba3a88d TCGA-50-6592-01A-11D-1756-05 TCGA-50-6592-01A-11D-1752-01 444662df-ae9b-4fec-9afc-df392ba3a88d TCGA-50-6592-01A-11D-1752-01 TCGA-50-6592-01A-13-2191-20 +TCGA-50-6592-11 TCGA-50-6592-11 C1-LUAD-enriched mutation cluster 3 TCGA-50-6592 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 71 L-Lower TCGA-50-6592-F43835 TCGA-50-6592 TCGA-50-6592-11A -26191 777 0 Scheduled Follow-up Submission Progressive Disease 2013-6-4 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 1.5 NO 2 NO NO No M0 N0 T2 Stage IB 6592 WITH TUMOR Progressive Disease YES Solid Tissue Normal 11 0.1 6th NO NO YES 50 4 Lung A DECEASED 2007 TCGA-50-6592-11A-01D-1756-05 +TCGA-50-6593-01 2.9 0.31 none none none none N N none none none 0.14 Squamoid none none none none none none none Acinar predominant Adc Acinar predominant Adc none 0 TCGA-50-6593-01 High C1-LUAD-enriched Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 5 mutation cluster 13 TCGA-50-6593 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung NO NO NO 49 R-Upper TCGA-50-6593-F43840 TCGA-50-6593 TCGA-50-6593-01A -18152 336 0 266 YES YES Scheduled Follow-up Submission Progressive Disease 2013-6-13 FEMALE Lung Adenocarcinoma Mixed Subtype No C34.1 8255/3 C34.1 YES 1 NO YES NO 1.4 NO Distant Metastasis YES No M0 N2 T1 Stage IIIA TCGA-50-6593.61906551-b954-4723-bb64-33bd88cc57f6.pdf 6593 WITH TUMOR Progressive Disease Convincing Imaging NO YES R0 Primary Tumor 01 0.3 6th NO NO YES 50 4 Current reformed smoker for < or = 15 years Lung A DECEASED 2008 ace0aace-27ba-42a6-8d6b-3c29095ccbe5 TCGA-50-6593-01A-11D-1753-08 ace0aace-27ba-42a6-8d6b-3c29095ccbe5 TCGA-50-6593-01A-11D-1756-05 TCGA-50-6593-01A-11D-1752-01 ace0aace-27ba-42a6-8d6b-3c29095ccbe5 TCGA-50-6593-01A-11D-1752-01 TCGA-50-6593-01A-13-2191-20 +TCGA-50-6593-11 2.9 0.31 none none none none N N none none none 0.14 Squamoid none none none none none none none Acinar predominant Adc Acinar predominant Adc none 0 TCGA-50-6593-11 C1-LUAD-enriched mutation cluster 13 TCGA-50-6593 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung NO NO NO 49 R-Upper TCGA-50-6593-F43840 TCGA-50-6593 TCGA-50-6593-11A -18152 336 0 266 YES YES Scheduled Follow-up Submission Progressive Disease 2013-6-13 FEMALE Lung Adenocarcinoma Mixed Subtype No C34.1 8255/3 C34.1 YES 0.6 NO YES NO 1.5 NO Distant Metastasis YES No M0 N2 T1 Stage IIIA 6593 WITH TUMOR Progressive Disease Convincing Imaging NO YES R0 Solid Tissue Normal 11 0.4 6th NO NO YES 50 4 Current reformed smoker for < or = 15 years Lung A DECEASED 2008 TCGA-50-6593-11A-01D-1756-05 +TCGA-50-6594-01 TCGA-50-6594-01 BRCA-LUAD+ C1-LUAD-enriched Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 4 mutation cluster 2 TCGA-50-6594 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung NO YES NO 79 L-Upper TCGA-50-6594-F44032 TCGA-50-6594 TCGA-50-6594-01A -28924 370 0 285 YES Scheduled Follow-up Submission Progressive Disease 2013-6-13 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 1 NO NO 1.5 NO Distant Metastasis YES No M0 N2 T3 Stage IIIA TCGA-50-6594.f0ca0fa2-8143-4d83-a82b-188c044d7071.pdf 6594 WITH TUMOR Progressive Disease Convincing Imaging NO Primary Tumor 01 0.3 1998 6th NO NO YES 50 4 Lung A DECEASED 2009 7326b41e-46e0-47fb-895d-43ef08c91b97 TCGA-50-6594-01A-11D-1753-08 7326b41e-46e0-47fb-895d-43ef08c91b97 TCGA-50-6594-01A-11D-1756-05 TCGA-50-6594-01A-11D-1752-01 7326b41e-46e0-47fb-895d-43ef08c91b97 TCGA-50-6594-01A-11D-1752-01 TCGA-50-6594-01A-13-2191-20 +TCGA-50-6594-11 TCGA-50-6594-11 C1-LUAD-enriched mutation cluster 2 TCGA-50-6594 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung NO YES NO 79 L-Upper TCGA-50-6594-F44032 TCGA-50-6594 TCGA-50-6594-11A -28924 370 0 285 YES Scheduled Follow-up Submission Progressive Disease 2013-6-13 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 1 NO NO 1.5 NO Distant Metastasis YES No M0 N2 T3 Stage IIIA 6594 WITH TUMOR Progressive Disease Convincing Imaging NO Solid Tissue Normal 11 0.4 1998 6th NO NO YES 50 4 Lung A DECEASED 2009 TCGA-50-6594-11A-01D-1756-05 +TCGA-50-6595-01 none none none none Y Y p.G719A, p.S768I none none Squamoid none none none none none none none NSCLC, favor Adeno NSCLC, favor Adeno none 0 TCGA-50-6595-01 BRCA-LUAD+ C1-LUAD-enriched Cluster 5 squamous c3 squamous-like c4 miRNA cluster 4 mutation cluster 8 TCGA-50-6595 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung NO NO NO YES 74 R-Upper TCGA-50-6595-F44127 TCGA-50-6595 TCGA-50-6595-01A 187 -27197 189 0 182 YES YES Scheduled Follow-up Submission Progressive Disease 2013-6-13 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.8 NO YES 1.7 NO Distant Metastasis YES No M0 N2 T2 Stage IIIA TCGA-50-6595.13f36f42-a0d4-4cf3-b8ea-8cdeff292a91.pdf 6595 WITH TUMOR Progressive Disease Biopsy with Histologic Confirmation NO YES Primary Tumor 01 0.3 1979 6th YES NO YES 50 3 Current reformed smoker for > 15 years Lung A DECEASED 2009 cb72fb22-d492-432c-8188-82fce70c071c TCGA-50-6595-01A-12D-1855-08 cb72fb22-d492-432c-8188-82fce70c071c TCGA-50-6595-01A-12D-1856-05 TCGA-50-6595-01A-12D-1854-01 cb72fb22-d492-432c-8188-82fce70c071c TCGA-50-6595-01A-12D-1854-01 TCGA-50-6595-01A-23-2191-20 +TCGA-50-6595-11 none none none none Y Y p.G719A, p.S768I none none Squamoid none none none none none none none NSCLC, favor Adeno NSCLC, favor Adeno none 0 TCGA-50-6595-11 C1-LUAD-enriched mutation cluster 8 TCGA-50-6595 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung NO NO NO YES 74 R-Upper TCGA-50-6595-F44127 TCGA-50-6595 TCGA-50-6595-11A 187 -27197 189 0 182 YES YES Scheduled Follow-up Submission Progressive Disease 2013-6-13 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 1.1 NO YES 1.7 NO Distant Metastasis YES No M0 N2 T2 Stage IIIA 6595 WITH TUMOR Progressive Disease Biopsy with Histologic Confirmation NO YES Solid Tissue Normal 11 0.1 1979 6th YES NO YES 50 3 Current reformed smoker for > 15 years Lung A DECEASED 2009 44ffccc3-f2ba-4c7a-bc88-afbf93f63102 44ffccc3-f2ba-4c7a-bc88-afbf93f63102 44ffccc3-f2ba-4c7a-bc88-afbf93f63102 +TCGA-50-6597-01 none none none none N N none none none Bronchioid none none none p.D1010_splice none none none Lepidic predominant Adc Lepidic predominant Adc none 0 TCGA-50-6597-01 High C1-LUAD-enriched Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 4 mutation c1uster 9 TCGA-50-6597 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 79 R-Lower TCGA-50-6597-F44134 TCGA-50-6597 TCGA-50-6597-01A -29195 1268 0 1015 YES Scheduled Follow-up Submission Complete Remission/Response 2013-6-13 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 0.9 NO YES NO 2 NO NO No M0 N0 T2 Stage IB TCGA-50-6597.6ba1ee6a-b37e-4f8d-9435-3d69ad1dbfdd.pdf 6597 TUMOR FREE Partial Remission/Response NO NO R0 Primary Tumor 01 0.1 6th NO NO YES 50 1 Lifelong Non-smoker Lung A DECEASED 2007 ce74929b-eae4-4e87-9a60-90230e28dadd TCGA-50-6597-01A-11D-1855-08 ce74929b-eae4-4e87-9a60-90230e28dadd TCGA-50-6597-01A-11D-1856-05 TCGA-50-6597-01A-11D-1854-01 ce74929b-eae4-4e87-9a60-90230e28dadd TCGA-50-6597-01A-11D-1854-01 TCGA-50-6597-01A-23-2191-20 +TCGA-50-6673-01 3.77 0.35 none none none none Y Y p.773_774insH none none 0.13 Bronchioid none none none none none none none Papillary predominant Adc Papillary predominant Adc none 0 TCGA-50-6673-01 Squamous C1-LUAD-enriched Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 7 TCGA-50-6673 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 84 R-Upper TCGA-50-6673-F44135 TCGA-50-6673 TCGA-50-6673-01A -30689 22 0 Scheduled Follow-up Submission 2013-6-13 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 1 NO 1.1 NO NO No M0 N0 T1 Stage I TCGA-50-6673.e2a03d91-afb5-4c25-99ae-e339660d7e2c.pdf 6673 YES R0 Primary Tumor 01 0.3 6th NO NO YES 50 1 Lifelong Non-smoker Lung A DECEASED 2004 5655a240-2ed7-469e-af17-9997547ea119 5655a240-2ed7-469e-af17-9997547ea119 TCGA-50-6673-01A-11D-1947-05 TCGA-50-6673-01A-11D-1943-01 5655a240-2ed7-469e-af17-9997547ea119 TCGA-50-6673-01A-11D-1943-01 TCGA-50-6673-01A-13-2191-20 +TCGA-50-7109-01 2.91 0.45 none none none none N N none none none 0.19 Magnoid none none none none none none none Solid predominant Adc Solid predominant Adc p.D194Y 0 TCGA-50-7109-01 High C1-LUAD-enriched Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 4 TCGA-50-7109 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung NO NO NO NO 60 R-Lower TCGA-50-7109-F44136 TCGA-50-7109 TCGA-50-7109-01A -21979 308 0 255 15 Scheduled Follow-up Submission Progressive Disease 2013-6-13 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 0.9 NO 1.3 NO Distant Metastasis YES 120 No M0 N0 T1 Stage IA TCGA-50-7109.a34c2391-f021-4b46-a4e9-8d9b7ee31402.pdf 7109 WITH TUMOR Progressive Disease Convincing Imaging NO NO Primary Tumor 01 0.2 7th NO NO YES 50 2 Current smoker Lung A DECEASED 2011 330a29fe-e4ec-458b-8d1f-05f147ac98d9 330a29fe-e4ec-458b-8d1f-05f147ac98d9 TCGA-50-7109-01A-11D-2037-05 TCGA-50-7109-01A-11D-2035-01 330a29fe-e4ec-458b-8d1f-05f147ac98d9 TCGA-50-7109-01A-11D-2035-01 TCGA-50-7109-01A-13-2192-20 +TCGA-50-8457-01 TCGA-50-8457-01 Cluster 5 miRNA cluster 4 TCGA-50-8457 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 63 R-Upper TCGA-50-8457-F70409 TCGA-50-8457 TCGA-50-8457-01A -23055 0 1125 YES FISH YES Scheduled Follow-up Submission Complete Remission/Response 2015-2-11 FEMALE Lung Adenocarcinoma Mixed Subtype No C34.1 8255/3 C34.1 YES 0.9 NO YES YES G12A 1.2 NO NO 30 No M0 N0 T1a Stage IA TCGA-50-8457.21529b79-5b5b-46e6-8deb-e4e6460a4695.pdf 8457 TUMOR FREE Complete Remission/Response NO NO Primary Tumor 01 0.3 1997 7th NO YES NO 50 4 Lung A LIVING 2011 9475bf3a-ae1b-482c-88d8-3f0c90ff18f6 9475bf3a-ae1b-482c-88d8-3f0c90ff18f6 TCGA-50-8457-01A-11D-2324-05 TCGA-50-8457-01A-11D-2322-01 9475bf3a-ae1b-482c-88d8-3f0c90ff18f6 TCGA-50-8457-01A-11D-2322-01 +TCGA-50-8459-01 TCGA-50-8459-01 Cluster 5 miRNA cluster 4 TCGA-50-8459 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 68 R-Lower TCGA-50-8459-F70410 TCGA-50-8459 TCGA-50-8459-01A -24859 0 1119 70 YES Scheduled Follow-up Submission Progressive Disease 2015-2-11 MALE Mucinous (Colloid) Carcinoma No C34.30 8480/3 C34.3 YES 0.7 NO YES YES G12C 1.2 NO NO 10 No M0 N0 T3 Stage IIB TCGA-50-8459.be87241c-fcb4-416f-a8a4-74b09033ca0b.pdf 8459 WITH TUMOR 70 72 Progressive Disease YES NO Primary Tumor 01 0.3 7th YES YES NO 50 2 Lung A LIVING 2012 defb83d5-ba61-435f-a8bf-98daaa1c546f defb83d5-ba61-435f-a8bf-98daaa1c546f TCGA-50-8459-01A-11D-2324-05 TCGA-50-8459-01A-11D-2322-01 defb83d5-ba61-435f-a8bf-98daaa1c546f TCGA-50-8459-01A-11D-2322-01 +TCGA-50-8460-01 TCGA-50-8460-01 Cluster 5 miRNA cluster 4 TCGA-50-8460 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 74 R-Upper TCGA-50-8460-F69335 TCGA-50-8460 TCGA-50-8460-01A -27270 0 829 YES Scheduled Follow-up Submission Complete Remission/Response 2015-1-5 MALE Lung Papillary Adenocarcinoma No C34.1 8260/3 C34.1 YES 0.9 NO YES NO 1.3 NO NO No M0 N0 T1a Stage IA TCGA-50-8460.fc79e8c5-c79b-46d3-ab41-03399a68999a.pdf 8460 TUMOR FREE Complete Remission/Response NO YES R0 Primary Tumor 01 0.3 7th NO YES NO 50 Lung A LIVING 2012 42a4a133-ec9d-4f5a-8b95-be83cbddb148 42a4a133-ec9d-4f5a-8b95-be83cbddb148 TCGA-50-8460-01A-11D-2324-05 TCGA-50-8460-01A-11D-2322-01 42a4a133-ec9d-4f5a-8b95-be83cbddb148 TCGA-50-8460-01A-11D-2322-01 +TCGA-51-4079-01 TCGA-51-4079-01 Squamous C2-Squamous-like Cluster 13 (HNSC-LUSC) squamous-like c4 miRNA cluster 4 mutation cluster 3 TCGA-51-4079 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 73 R-Upper TCGA-51-4079-F4465 TCGA-51-4079 TCGA-51-4079-01A -26899 12 0 NO NO 2010-12-7 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.4 NO NO Central Lung 0.8 NO 25 No N0 T2 Stage IB TCGA-51-4079.8bc3980d-0a81-419b-8383-400c03be01f0.pdf 4079 NO R0 Primary Tumor 01 0.2 2007 6th NO NO YES 51 4 Lung A DECEASED 2009 ca290d55-534f-47d9-a65a-1ba12dbaa233 TCGA-51-4079-01A-01D-1096-05 TCGA-51-4079-01A-01D-1458-08 ca290d55-534f-47d9-a65a-1ba12dbaa233 TCGA-51-4079-01A-01D-1097-01 TCGA-51-4079-01A-01R-1100-07 ca290d55-534f-47d9-a65a-1ba12dbaa233 TCGA-51-4079-01A-01D-1097-01 +TCGA-51-4079-11 TCGA-51-4079-11 C2-Squamous-like mutation cluster 3 TCGA-51-4079 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 73 R-Upper TCGA-51-4079-F4465 TCGA-51-4079 TCGA-51-4079-11A -26899 12 0 NO NO 2010-12-7 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.6 NO NO Central Lung 0.9 NO 25 No N0 T2 Stage IB 4079 NO R0 Solid Tissue Normal 11 0.2 2007 6th NO NO YES 51 4 Lung A DECEASED 2009 e21484e9-d9c3-463f-89bd-82f09cc2579a e21484e9-d9c3-463f-89bd-82f09cc2579a e21484e9-d9c3-463f-89bd-82f09cc2579a +TCGA-51-4080-01 TCGA-51-4080-01 Squamous C2-Squamous-like Cluster 13 (HNSC-LUSC) squamous-like c4 miRNA cluster 11 mutation cluster 13 TCGA-51-4080 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 65 R-Upper TCGA-51-4080-F4490 TCGA-51-4080 TCGA-51-4080-01A -24054 12 0 NO NO 2010-12-7 MALE Lung Basaloid Squamous Cell Carcinoma No C34.1 8083/3 C34.1 YES 0.6 NO NO Central Lung 1.3 NO No N1 T4 Stage IIIB TCGA-51-4080.4142077f-f67b-46f9-9302-18ba26e15e27.pdf 4080 TUMOR FREE NO R0 Primary Tumor 01 0.3 2005 NO NO YES 51 4 Lung A DECEASED 2009 6e6c90e7-2f98-4880-9e6e-d85966baa663 TCGA-51-4080-01A-01D-1096-05 TCGA-51-4080-01A-01D-1458-08 6e6c90e7-2f98-4880-9e6e-d85966baa663 TCGA-51-4080-01A-01D-1969-01 TCGA-51-4080-01A-01R-1100-07 6e6c90e7-2f98-4880-9e6e-d85966baa663 TCGA-51-4080-01A-01D-1969-01 +TCGA-51-4080-11 TCGA-51-4080-11 C2-Squamous-like mutation cluster 13 TCGA-51-4080 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 65 R-Upper TCGA-51-4080-F4490 TCGA-51-4080 TCGA-51-4080-11A -24054 12 0 NO NO 2010-12-7 MALE Lung Basaloid Squamous Cell Carcinoma No C34.1 8083/3 C34.1 YES 0.4 NO NO Central Lung 0.8 NO No N1 T4 Stage IIIB 4080 TUMOR FREE NO R0 Solid Tissue Normal 11 0.2 2005 NO NO YES 51 4 Lung A DECEASED 2009 80ee8813-997d-48b9-9853-520080e22e05 80ee8813-997d-48b9-9853-520080e22e05 80ee8813-997d-48b9-9853-520080e22e05 +TCGA-51-4081-01 TCGA-51-4081-01 Squamous C2-Squamous-like Cluster 13 (HNSC-LUSC) squamous-like c4 miRNA cluster 11 mutation cluster 5 TCGA-51-4081 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 55 R-Upper TCGA-51-4081-F30894 TCGA-51-4081 TCGA-51-4081-01A -20261 0 911 NO NO Scheduled Follow-up Submission Complete Remission/Response 2012-4-18 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.3 NO NO Central Lung 1 NO 80 No M0 N1 T2a Stage IIB TCGA-51-4081.0bf5aacf-58ab-45dd-b257-2d56045b9877.pdf 4081 TUMOR FREE R0 Primary Tumor 01 0.3 YES NO YES 51 2 Lung A LIVING 2009 25c74ec3-c453-4ccb-94d1-a38bfc4aa0b2 TCGA-51-4081-01A-01D-1096-05 TCGA-51-4081-01A-01D-1458-08 25c74ec3-c453-4ccb-94d1-a38bfc4aa0b2 TCGA-51-4081-01A-01D-1097-01 TCGA-51-4081-01A-01R-1100-07 25c74ec3-c453-4ccb-94d1-a38bfc4aa0b2 TCGA-51-4081-01A-01D-1097-01 +TCGA-51-4081-11 TCGA-51-4081-11 C2-Squamous-like mutation cluster 5 TCGA-51-4081 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 55 R-Upper TCGA-51-4081-F30894 TCGA-51-4081 TCGA-51-4081-11A -20261 0 911 NO NO Scheduled Follow-up Submission Complete Remission/Response 2012-4-18 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.9 NO NO Central Lung 1 NO 80 No M0 N1 T2a Stage IIB 4081 TUMOR FREE R0 Solid Tissue Normal 11 0.4 YES NO YES 51 2 Lung A LIVING 2009 47bb130b-c5cc-40ba-b72f-7d337080c62f 47bb130b-c5cc-40ba-b72f-7d337080c62f 47bb130b-c5cc-40ba-b72f-7d337080c62f +TCGA-51-6867-01 TCGA-51-6867-01 Squamous C2-Squamous-like Cluster 13 (HNSC-LUSC) squamous c3 squamous-like c4 miRNA cluster 4 TCGA-51-6867 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung NO NO NO NO 72 R-Upper TCGA-51-6867-F17331 TCGA-51-6867 TCGA-51-6867-01A -26523 1856 0 788 NO Additional New Tumor Event Stable Disease 2011-10-10 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.6 NO NO Peripheral Lung 0.8 YES 40 Yes M0 N0 T1 Stage I TCGA-51-6867.6eb25b3d-1446-47f3-b52e-e97157f4832f.pdf 6867 WITH TUMOR Complete Remission/Response NO R0 Primary Tumor 01 0.4 2002 6th NO NO YES 51 4 Lung A DECEASED 2003 67406266-5f84-4a8a-90a0-8655bece5a69 67406266-5f84-4a8a-90a0-8655bece5a69 TCGA-51-6867-01A-11D-2043-05 67406266-5f84-4a8a-90a0-8655bece5a69 TCGA-51-6867-01A-13-2194-20 +TCGA-52-7622-01 TCGA-52-7622-01 Squamous Cluster 13 (HNSC-LUSC) miRNA c1uster 9 TCGA-52-7622 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 62 R-Lower TCGA-52-7622-F28782 TCGA-52-7622 TCGA-52-7622-01A -22807 0 862 88 1 NO NO Scheduled Follow-up Submission 2013-1-4 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES NO 90 NO Central Lung NO 22 No M0 N0 T1a Stage IA TCGA-52-7622.a710001f-dffd-4277-9ff5-e380d6ec827d.pdf 7622 Post-Adjuvant Therapy TUMOR FREE 69 91 67 90 Complete Remission/Response YES NO R0 Primary Tumor 01 2010 7th YES NO YES 52 4 Lung A LIVING 2010 1965 dcfd52b5-c7d6-44e3-8137-405cf0fff780 dcfd52b5-c7d6-44e3-8137-405cf0fff780 TCGA-52-7622-01A-11D-2123-05 TCGA-52-7622-01A-11D-2121-01 dcfd52b5-c7d6-44e3-8137-405cf0fff780 TCGA-52-7622-01A-11D-2121-01 +TCGA-52-7809-01 TCGA-52-7809-01 High Cluster 5 miRNA c1uster 9 TCGA-52-7809 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 74 R-Upper TCGA-52-7809-F39788 TCGA-52-7809 TCGA-52-7809-01A -27233 166 0 NO NO Scheduled Follow-up Submission 2013-2-1 MALE Lung Basaloid Squamous Cell Carcinoma No C34.1 8083/3 C34.1 YES 0.7 NO 0 NO Peripheral Lung 1.2 NO 60 No M0 N0 T2 Stage IB TCGA-52-7809.83c514c4-6d90-4ff0-bda1-5615aa769bbd.pdf 7809 WITH TUMOR Progressive Disease NO R0 Primary Tumor 01 0.3 6th NO YES 52 2 Lung A DECEASED 2009 1948 9383278e-22a7-4ea3-8700-988b1c9d8fd9 9383278e-22a7-4ea3-8700-988b1c9d8fd9 TCGA-52-7809-01A-21D-2123-05 TCGA-52-7809-01A-21D-2121-01 9383278e-22a7-4ea3-8700-988b1c9d8fd9 TCGA-52-7809-01A-21D-2121-01 +TCGA-52-7810-01 TCGA-52-7810-01 Squamous Cluster 5 squamous c3 miRNA cluster 4 TCGA-52-7810 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 60 R-Upper TCGA-52-7810-F39789 TCGA-52-7810 TCGA-52-7810-01A -22241 0 923 0 NO NO Scheduled Follow-up Submission 2013-2-1 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.8 8070/3 C34.8 YES 0.7 NO 90 NO 0.8 NO NO 20 No M0 N0 T3 Stage IIB TCGA-52-7810.2da4232b-8a69-480f-a5f1-671cc7ed5213.pdf 7810 Pre-Adjuvant Therapy TUMOR FREE Complete Remission/Response NO YES Primary Tumor 01 0.4 1990 6th YES NO YES 52 3 Lung A LIVING 2008 1970 eefac675-8386-4ffe-a18a-8763f90b2056 eefac675-8386-4ffe-a18a-8763f90b2056 TCGA-52-7810-01A-11D-2123-05 TCGA-52-7810-01A-11D-2121-01 eefac675-8386-4ffe-a18a-8763f90b2056 TCGA-52-7810-01A-11D-2121-01 TCGA-52-7810-01A-13-2195-20 +TCGA-52-7811-01 TCGA-52-7811-01 Squamous Cluster 5 squamous c3 miRNA cluster 4 TCGA-52-7811 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung NO NO NO 67 L-Lower TCGA-52-7811-F39790 TCGA-52-7811 TCGA-52-7811-01A -24782 266 0 153 84 0 NO NO Scheduled Follow-up Submission Progressive Disease 2013-2-1 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.9 NO 0 NO 1.1 NO Distant Metastasis YES 50 No M0 N0 T2 Stage IB TCGA-52-7811.69e3e936-4a9d-4ab9-8402-2ee313244b7c.pdf 7811 Pre-Adjuvant Therapy WITH TUMOR 66 90 66 90 Progressive Disease Biopsy with Histologic Confirmation YES NO R0 Primary Tumor 01 0.4 6th NO NO YES 52 2 Lung A DECEASED 2009 1958 3f4f3e8c-af8c-405e-8fd4-c971f394e35f 3f4f3e8c-af8c-405e-8fd4-c971f394e35f TCGA-52-7811-01A-11D-2123-05 TCGA-52-7811-01A-11D-2121-01 3f4f3e8c-af8c-405e-8fd4-c971f394e35f TCGA-52-7811-01A-11D-2121-01 TCGA-52-7811-01A-13-2195-20 +TCGA-52-7812-01 TCGA-52-7812-01 High Cluster 6 squamous c3 miRNA cluster 4 TCGA-52-7812 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung YES NO NO YES 68 L-Upper TCGA-52-7812-F39282 TCGA-52-7812 TCGA-52-7812-01A -24887 835 0 791 1 NO NO Scheduled Follow-up Submission Progressive Disease 2013-1-30 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.9 8070/3 C34.9 YES 0.6 NO 0 NO Central Lung 1.1 NO Distant Metastasis YES 30 No M0 N2 T2 [Discrepancy] TCGA-52-7812.c7bb38e8-f472-437c-9d6e-7cfb6a5785b4.pdf 7812 Preoperative WITH TUMOR Progressive Disease Biopsy with Histologic Confirmation NO YES R0 Primary Tumor 01 0.4 1997 6th YES NO YES 52 4 Lung A DECEASED 2009 1967 2afa4dfe-6d9b-46b1-89bd-235c7b5cbebf 2afa4dfe-6d9b-46b1-89bd-235c7b5cbebf TCGA-52-7812-01A-11D-2123-05 TCGA-52-7812-01A-11D-2121-01 2afa4dfe-6d9b-46b1-89bd-235c7b5cbebf TCGA-52-7812-01A-11D-2121-01 TCGA-52-7812-01A-13-2195-20 +TCGA-53-7624-01 TCGA-53-7624-01 High C8-BLCA Cluster 5 squamous c3 BLCA nonsquamous-like c1 miRNA cluster 4 TCGA-53-7624 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung YES YES YES 40 R-Upper TCGA-53-7624-F39722 TCGA-53-7624 TCGA-53-7624-01A 593 -14794 1043 0 400 0 NO NO Scheduled Follow-up Submission Progressive Disease 2013-1-31 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES NO 0 NO Peripheral Lung NO Distant Metastasis YES 50 No M1 N0 T2 Stage IV TCGA-53-7624.b108a209-518b-4271-a90c-7f3857044581.pdf 7624 Post-Adjuvant Therapy WITH TUMOR Progressive Disease Biopsy with Histologic Confirmation NO R0 Primary Tumor 01 6th YES NO YES 53 2 Lung A DECEASED 2008 1986 50d03646-1082-4ae3-9853-f5295006f11a 50d03646-1082-4ae3-9853-f5295006f11a TCGA-53-7624-01A-11D-2064-05 TCGA-53-7624-01A-11D-2062-01 50d03646-1082-4ae3-9853-f5295006f11a TCGA-53-7624-01A-11D-2062-01 TCGA-53-7624-01A-13-2192-20 +TCGA-53-7626-01 3.58 0.26 none none none none N N none none p.C589F 0.11 Bronchioid none none none none none none none Adenocarcinoma, NOS Adenocarcinoma, NOS none 0 TCGA-53-7626-01 BRCA-LUAD+ C1-LUAD-enriched Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 4 TCGA-53-7626 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung NO NO NO 76 R-Upper TCGA-53-7626-F38969 TCGA-53-7626 TCGA-53-7626-01A -28024 929 0 865 0 NO NO Scheduled Follow-up Submission Progressive Disease 2013-1-15 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES NO NO Peripheral Lung NO Locoregional Recurrence YES 35 No M0 N1 T1 Stage IIA TCGA-53-7626.23a82f88-d450-4546-88e0-c26cf8de267e.pdf 7626 Post-Adjuvant Therapy WITH TUMOR Progressive Disease Biopsy with Histologic Confirmation NO R0 Primary Tumor 01 2006 6th YES NO YES 53 4 Current reformed smoker for < or = 15 years Lung A DECEASED 2008 1971 f3196cf4-2cda-4377-9089-e29434cbd4d4 f3196cf4-2cda-4377-9089-e29434cbd4d4 TCGA-53-7626-01A-12D-2064-05 TCGA-53-7626-01A-12D-2062-01 f3196cf4-2cda-4377-9089-e29434cbd4d4 TCGA-53-7626-01A-12D-2062-01 TCGA-53-7626-01A-23-2192-20 +TCGA-53-7813-01 none none none none Y Y none none none Magnoid none p.G12A none none none none none p.Y60fs TCGA-53-7813-01 BRCA-LUAD+ C1-LUAD-enriched Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 6 TCGA-53-7813 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 51 R-Upper TCGA-53-7813-F39281 TCGA-53-7813 TCGA-53-7813-01A -18875 0 424 88 1 NO NO Scheduled Follow-up Submission 2013-1-31 FEMALE Lung Bronchioloalveolar Carcinoma Nonmucinous No C34.1 8252/3 C34.1 YES 0.6 NO NO 0.8 YES 35 No M0 N0 T4 Stage IIIB TCGA-53-7813.bda037b7-ac21-42c0-95c1-c546f0ace670.pdf 7813 Pre-Adjuvant Therapy TUMOR FREE 69 91 67 90 Progressive Disease YES NO Primary Tumor 01 0.4 2008 6th YES NO YES 53 4 Lung A LIVING 2008 1973 f8d65338-5f5e-4cf5-a119-25faf54453d4 f8d65338-5f5e-4cf5-a119-25faf54453d4 TCGA-53-7813-01A-11D-2168-05 TCGA-53-7813-01A-11D-2166-01 f8d65338-5f5e-4cf5-a119-25faf54453d4 TCGA-53-7813-01A-11D-2166-01 TCGA-53-7813-01A-13-2192-20 +TCGA-53-A4EZ-01 TCGA-53-A4EZ-01 TCGA-53-A4EZ TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 63 L-Upper TCGA-53-A4EZ-F61081 TCGA-53-A4EZ TCGA-53-A4EZ-01A -23201 163 0 1071 86 1 YES FISH YES Scheduled Follow-up Submission Complete Remission/Response 2015-3-19 MALE Lung Acinar Adenocarcinoma No C34.1 8550/3 C34.1 YES 120 NO 80 YES NO Peripheral Lung NO NO 40 true No MX N1 T2a Stage IIA TCGA-53-A4EZ.E4CB6C1D-9774-47BE-989E-F9CD05D9EED8.pdf A4EZ Post-Adjuvant Therapy TUMOR FREE 73 75 73 76 Stable Disease YES YES RX Primary Tumor 01 1996 7th YES YES NO 53 3 Lung A LIVING 2012 1956 465ce132-c1f4-490f-b1f1-46300fde4441 465ce132-c1f4-490f-b1f1-46300fde4441 TCGA-53-A4EZ-01A-12D-A24U-05 TCGA-53-A4EZ-01A-12D-A24O-01 465ce132-c1f4-490f-b1f1-46300fde4441 TCGA-53-A4EZ-01A-12D-A24O-01 +TCGA-55-1592-01 3.24 0.49 none none none none N N none none none 0.19 Bronchioid none none none none none none none Adenocarcinoma, NOS Adenocarcinoma, NOS none 0 TCGA-55-1592-01 High C1-LUAD-enriched Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 4 mutation cluster 11 TCGA-55-1592 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung NO NO NO NO 65 L-Upper TCGA-55-1592-F9167 TCGA-55-1592 701 0 452 Progressive Disease 2011-3-15 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES YES Yes M0 N0 T2 Stage IA 1592 WITH TUMOR Complete Remission/Response NO R0 Primary Tumor 01 1997 NO NO YES 55 4 Current reformed smoker for < or = 15 years Lung DECEASED 2005 1957 f215665e-3c8d-4746-a18a-859ac95b2fdb TCGA-55-1592-01A-01D-0945-05 TCGA-55-1592-01 f215665e-3c8d-4746-a18a-859ac95b2fdb TCGA-55-1592-01A-01D-0944-01 TCGA-55-1592-01A-01R-0946-07 f215665e-3c8d-4746-a18a-859ac95b2fdb TCGA-55-1592-01A-01D-0944-01 TCGA-55-1592-01A-21-2190-20 +TCGA-55-1592-11 3.24 0.49 none none none none N N none none none 0.19 Bronchioid none none none none none none none Adenocarcinoma, NOS Adenocarcinoma, NOS none 0 TCGA-55-1592-11 C1-LUAD-enriched mutation cluster 11 TCGA-55-1592 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung NO NO NO NO 65 L-Upper TCGA-55-1592-F9167 TCGA-55-1592 TCGA-55-1592-11A 701 0 452 Progressive Disease 2011-3-15 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.4 NO 1 YES Yes M0 N0 T2 Stage IA 1592 WITH TUMOR Complete Remission/Response NO R0 Solid Tissue Normal 11 0.2 1997 NO NO YES 55 4 Current reformed smoker for < or = 15 years Lung A DECEASED 2005 1957 TCGA-55-1592-11A-01D-0945-05 +TCGA-55-1594-01 3.28 0.54 none none none none N N none none none 0.2 Magnoid none none none none none none none Solid predominant Adc Solid predominant Adc none 1 TCGA-55-1594-01 High C1-LUAD-enriched Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 6 mutation cluster 5 TCGA-55-1594 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 68 R-Lower TCGA-55-1594 TCGA-55-1594-01A -25008 0 1178 2010-9-14 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 0.5 NO 2 No M0 N2 T2 Stage IIIA TCGA-55-1594.bdbfef54-ca5a-4b4f-809d-4de379232a8a.pdf 1594 TUMOR FREE R0 Primary Tumor 01 0.2 NO YES 55 2 Current smoker Lung A LIVING 2005 1965 63b6924e-921f-4fac-9866-dd97e996d7ac TCGA-55-1594-01A-01D-0945-05 TCGA-55-1594-01 63b6924e-921f-4fac-9866-dd97e996d7ac TCGA-55-1594-01A-01D-0944-01 TCGA-55-1594-01A-01R-0946-07 63b6924e-921f-4fac-9866-dd97e996d7ac TCGA-55-1594-01A-01D-0944-01 TCGA-55-1594-01A-21-2190-20 +TCGA-55-1594-11 3.28 0.54 none none none none N N none none none 0.2 Magnoid none none none none none none none Solid predominant Adc Solid predominant Adc none 1 TCGA-55-1594-11 C1-LUAD-enriched mutation cluster 5 TCGA-55-1594 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 68 R-Lower TCGA-55-1594 TCGA-55-1594-11A -25008 0 1178 2010-9-14 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 1 NO 3 No M0 N2 T2 Stage IIIA 1594 TUMOR FREE R0 Solid Tissue Normal 11 0.6 NO YES 55 2 Current smoker Lung A LIVING 2005 1965 TCGA-55-1594-11A-01D-0945-05 +TCGA-55-1595-01 TCGA-55-1595-01 High C1-LUAD-enriched Cluster 6 LUAD-like c10 miRNA cluster 4 mutation cluster 12 TCGA-55-1595 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 74 L-Lower TCGA-55-1595-F9159 TCGA-55-1595 TCGA-55-1595-01A 0 1479 2011-3-15 FEMALE Lung Clear Cell Adenocarcinoma No C34.3 8310/3 C34.3 YES 0.5 NO 0.5 NO Yes M0 N0 T1 Stage IA TCGA-55-1595.b4ec8fa3-74b6-4656-bd2e-6fe5ba0af7d8.pdf 1595 TUMOR FREE Complete Remission/Response NO Primary Tumor 01 0.2 1993 6th NO 55 4 Lung A LIVING 2004 1964 e7db32c0-8d04-4ab7-9c64-c4590d62539b TCGA-55-1595-01A-01D-0945-05 TCGA-55-1595-01A-01D-0969-08 e7db32c0-8d04-4ab7-9c64-c4590d62539b TCGA-55-1595-01A-01D-0944-01 TCGA-55-1595-01A-01R-0946-07 e7db32c0-8d04-4ab7-9c64-c4590d62539b TCGA-55-1595-01A-01D-0944-01 +TCGA-55-1595-11 TCGA-55-1595-11 C1-LUAD-enriched mutation cluster 12 TCGA-55-1595 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 74 L-Lower TCGA-55-1595-F9159 TCGA-55-1595 TCGA-55-1595-11A 0 1479 2011-3-15 FEMALE Lung Clear Cell Adenocarcinoma No C34.3 8310/3 C34.3 YES 0.4 NO 0.4 NO Yes M0 N0 T1 Stage IA 1595 TUMOR FREE Complete Remission/Response NO Solid Tissue Normal 11 0.4 1993 6th NO 55 4 Lung A LIVING 2004 1964 TCGA-55-1595-11A-01D-0945-05 +TCGA-55-1596-01 3.45 0.62 none none none none N N none none none 0.21 Magnoid none none none none none none none Solid predominant Adc Solid predominant Adc p.S216F, p.G242W 1 TCGA-55-1596-01 Squamous C1-LUAD-enriched Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 4 mutation cluster 5 TCGA-55-1596 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 55 R-Upper TCGA-55-1596-F40544 TCGA-55-1596 TCGA-55-1596-01A -20381 0 2065 Scheduled Follow-up Submission Complete Remission/Response 2013-2-22 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.6 NO 0.9 NO NO 50 No M0 N1 T2 Stage IIB TCGA-55-1596.200ccd8b-b3dc-4e3f-8c1e-ed9fa31ae9da.pdf 1596 TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 0.4 6th YES NO YES 55 2 Current smoker Lung A LIVING 2004 1979 8b2f9a82-4c0d-496b-a46c-15d20d069e11 TCGA-55-1596-01A-01D-0945-05 TCGA-55-1596-01 8b2f9a82-4c0d-496b-a46c-15d20d069e11 TCGA-55-1596-01A-01D-0944-01 TCGA-55-1596-01A-01R-0946-07 8b2f9a82-4c0d-496b-a46c-15d20d069e11 TCGA-55-1596-01A-01D-0944-01 TCGA-55-1596-01A-21-2190-20 +TCGA-55-1596-11 3.45 0.62 none none none none N N none none none 0.21 Magnoid none none none none none none none Solid predominant Adc Solid predominant Adc p.S216F, p.G242W 1 TCGA-55-1596-11 C1-LUAD-enriched mutation cluster 5 TCGA-55-1596 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 55 R-Upper TCGA-55-1596-F40544 TCGA-55-1596 TCGA-55-1596-11A -20381 0 2065 Scheduled Follow-up Submission Complete Remission/Response 2013-2-22 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.5 NO 1 NO NO 50 No M0 N1 T2 Stage IIB 1596 TUMOR FREE Complete Remission/Response NO R0 Solid Tissue Normal 11 0.2 6th YES NO YES 55 2 Current smoker Lung A LIVING 2004 1979 TCGA-55-1596-11A-01D-0945-05 +TCGA-55-5899-01 TCGA-55-5899-01 Squamous C1-LUAD-enriched Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 6 mutation cluster 3 TCGA-55-5899 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 58 R-Upper TCGA-55-5899-F43194 TCGA-55-5899 TCGA-55-5899-01A 0 930 0 Scheduled Follow-up Submission Complete Remission/Response 2013-5-15 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.6 NO 100 1 NO NO No M0 N1 T1a [Discrepancy] TCGA-55-5899.8fcdc599-a63e-4774-a58d-8b1b19d13980.pdf 5899 Post-Adjuvant Therapy TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 0.3 7th YES NO YES 55 2 Lung A LIVING 2010 1985 f51ff2e2-bc0a-4cdd-b008-933a8f7fa8fc TCGA-55-5899-01A-11D-1625-08 f51ff2e2-bc0a-4cdd-b008-933a8f7fa8fc TCGA-55-5899-01A-11D-1626-05 TCGA-55-5899-01A-11D-1624-01 f51ff2e2-bc0a-4cdd-b008-933a8f7fa8fc TCGA-55-5899-01A-11D-1624-01 TCGA-55-5899-01A-21-2190-20 +TCGA-55-6543-01 2.29 0.65 none none none none N Y none none none 0.3 Bronchioid none none none none none none none Acinar predominant Adc Acinar predominant Adc Y none 0 TCGA-55-6543-01 Kirc+ C1-LUAD-enriched Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 5 mutation c1uster 9 TCGA-55-6543 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 60 R-Upper TCGA-55-6543-F46659 TCGA-55-6543 TCGA-55-6543-01A 0 435 Scheduled Follow-up Submission Complete Remission/Response 2013-8-13 FEMALE Lung Bronchioloalveolar Carcinoma Mucinous No C34.1 8253/3 C34.1 YES 0.4 NO Peripheral Lung 1 NO NO 60 No MX N0 T1b Stage IA TCGA-55-6543.b1b81957-278c-4c30-af49-821ab7e0429c.pdf 6543 TUMOR FREE Complete Remission/Response NO Primary Tumor 01 0.4 2004 7th NO NO YES 55 4 Current reformed smoker for < or = 15 years Lung A LIVING 2010 991a6ea6-32cf-479b-87a6-cc930baeddfa TCGA-55-6543-01A-11D-1753-08 991a6ea6-32cf-479b-87a6-cc930baeddfa TCGA-55-6543-01A-11D-1756-05 TCGA-55-6543-01A-11D-1752-01 991a6ea6-32cf-479b-87a6-cc930baeddfa TCGA-55-6543-01A-11D-1752-01 TCGA-55-6543-01A-13-2191-20 +TCGA-55-6642-01 2.66 0.36 none none none none Y Y none none none 0.16 Magnoid none p.G12V none none none none none Micropapillary predom Adc Micropapillary predom Adc none 0 TCGA-55-6642-01 Squamous C1-LUAD-enriched Cluster 5 LUAD-like c10 miRNA cluster 4 mutation cluster 12 TCGA-55-6642 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 63 R-Lower TCGA-55-6642-F45614 TCGA-55-6642 TCGA-55-6642-01A -23107 0 2449 Scheduled Follow-up Submission Complete Remission/Response 2013-7-17 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 0.9 NO 1 NO NO No MX N0 T2 Stage IB TCGA-55-6642.5d390c9f-0f12-4ed2-a7ec-d9e7c8f05320.pdf 6642 TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 0.4 6th NO NO YES 55 2 Current smoker Lung A LIVING 2006 1961 891aefa4-e7f1-482f-a2f5-b2d5c7d9e179 TCGA-55-6642-01A-11D-1855-08 891aefa4-e7f1-482f-a2f5-b2d5c7d9e179 TCGA-55-6642-01A-11D-1856-05 TCGA-55-6642-01A-11D-1854-01 891aefa4-e7f1-482f-a2f5-b2d5c7d9e179 TCGA-55-6642-01A-11D-1854-01 +TCGA-55-6712-01 3.31 0.29 none none none none N N none none none 0.12 Squamoid none none none p.E1314G none none none Adenocarcinoma, NOS Adenocarcinoma, NOS none 0 TCGA-55-6712-01 High C1-LUAD-enriched Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 4 mutation cluster 5 TCGA-55-6712 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 71 L-Upper TCGA-55-6712-F46639 TCGA-55-6712 TCGA-55-6712-01A 171 0 24 Scheduled Follow-up Submission Progressive Disease 2013-8-13 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.8 NO 0.9 NO NO No MX N1 T2a Stage IIA TCGA-55-6712.156f5763-3bc6-47a8-b579-6d767fa3fd00.pdf 6712 WITH TUMOR Progressive Disease NO R1 Primary Tumor 01 0.4 2003 7th YES NO YES 55 4 Current reformed smoker for < or = 15 years Lung A DECEASED 2010 1970 f5a01f2f-247a-42a0-a713-ba6f8bb8d03e TCGA-55-6712-01A-11D-1855-08 f5a01f2f-247a-42a0-a713-ba6f8bb8d03e TCGA-55-6712-01A-11D-1856-05 TCGA-55-6712-01A-11D-1854-01 f5a01f2f-247a-42a0-a713-ba6f8bb8d03e TCGA-55-6712-01A-11D-1854-01 TCGA-55-6712-01A-13-2191-20 +TCGA-55-6968-01 TCGA-55-6968-01 Squamous Cluster 5 LUAD-like c10 miRNA cluster 6 TCGA-55-6968 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 61 R-Lower TCGA-55-6968-F56247 TCGA-55-6968 TCGA-55-6968-01A -22344 1293 0 Scheduled Follow-up Submission Stable Disease 2014-1-30 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 0.4 NO 0.7 NO NO No M1 N0 T1 Stage IV TCGA-55-6968.87f5cbe6-cce1-4a8c-8189-c6feabd3b4bb.pdf 6968 WITH TUMOR Stable Disease YES Primary Tumor 01 0.2 6th YES NO YES 55 2 Lung A DECEASED 2004 09fba9fa-29d2-41a1-b3aa-4bfd97be3fc8 09fba9fa-29d2-41a1-b3aa-4bfd97be3fc8 TCGA-55-6968-01A-11D-1947-05 TCGA-55-6968-01A-11D-1943-01 09fba9fa-29d2-41a1-b3aa-4bfd97be3fc8 TCGA-55-6968-01A-11D-1943-01 +TCGA-55-6968-11 TCGA-55-6968-11 TCGA-55-6968 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 61 R-Lower TCGA-55-6968-F56247 TCGA-55-6968 TCGA-55-6968-11A -22344 1293 0 Scheduled Follow-up Submission Stable Disease 2014-1-30 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 0.9 NO 0.9 NO NO No M1 N0 T1 Stage IV 6968 WITH TUMOR Stable Disease YES Solid Tissue Normal 11 0.3 6th YES NO YES 55 2 Lung A DECEASED 2004 372ec0c3-ab4c-421b-acc4-6fecf473d2fb 372ec0c3-ab4c-421b-acc4-6fecf473d2fb 372ec0c3-ab4c-421b-acc4-6fecf473d2fb +TCGA-55-6969-01 TCGA-55-6969-01 High C1-LUAD-enriched Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 7 TCGA-55-6969 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 52 L-Upper TCGA-55-6969 TCGA-55-6969-01A -19270 0 1239 NO NO 2011-7-25 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.5 NO NO 0.9 No M0 N0 T2 Stage IB TCGA-55-6969.96b7d4c4-6513-4249-a6d5-b5cf0bf49ab4.pdf 6969 TUMOR FREE Primary Tumor 01 0.3 2004 6th NO YES 55 4 Lung A LIVING 2004 a4c1e9e8-a335-47b0-afc6-c2b490da4e58 a4c1e9e8-a335-47b0-afc6-c2b490da4e58 TCGA-55-6969-01A-11D-1947-05 TCGA-55-6969-01A-11D-1943-01 a4c1e9e8-a335-47b0-afc6-c2b490da4e58 TCGA-55-6969-01A-11D-1943-01 TCGA-55-6969-01A-13-2191-20 +TCGA-55-6969-11 TCGA-55-6969-11 C1-LUAD-enriched TCGA-55-6969 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 52 L-Upper TCGA-55-6969 TCGA-55-6969-11A -19270 0 1239 NO NO 2011-7-25 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.7 NO NO 0.9 No M0 N0 T2 Stage IB 6969 TUMOR FREE Solid Tissue Normal 11 0.5 2004 6th NO YES 55 4 Lung A LIVING 2004 7921e917-f743-4813-8fcf-2145dce93c37 7921e917-f743-4813-8fcf-2145dce93c37 7921e917-f743-4813-8fcf-2145dce93c37 +TCGA-55-6970-01 1.39 0.56 none none none none Y Y none none none 0.34 Magnoid none p.G12V none none none none none Papillary predominant Adc Papillary predominant Adc p.T250fs 0 TCGA-55-6970-01 High C1-LUAD-enriched Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 4 TCGA-55-6970 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung NO NO NO 67 R-Upper TCGA-55-6970-F57904 TCGA-55-6970 TCGA-55-6970-01A -24773 464 0 457 NO NO Scheduled Follow-up Submission Progressive Disease 2014-3-28 FEMALE Lung Papillary Adenocarcinoma No C34.1 8260/3 C34.1 YES 0.8 NO NO 1.1 NO Locoregional Recurrence YES No MX N2 T2 Stage IIIA TCGA-55-6970.1662fe4b-da42-444a-b7fa-4990d9e8aa9d.pdf 6970 WITH TUMOR Stable Disease Convincing Imaging YES R1 Primary Tumor 01 0.4 6th YES NO YES 55 4 Current reformed smoker for < or = 15 years Lung A DECEASED 2004 4f5215c3-7763-49f8-afe7-b3ce3474afe2 4f5215c3-7763-49f8-afe7-b3ce3474afe2 TCGA-55-6970-01A-11D-1947-05 TCGA-55-6970-01A-11D-1943-01 4f5215c3-7763-49f8-afe7-b3ce3474afe2 TCGA-55-6970-01A-11D-1943-01 TCGA-55-6970-01A-13-2191-20 +TCGA-55-6970-11 1.39 0.56 none none none none Y Y none none none 0.34 Magnoid none p.G12V none none none none none Papillary predominant Adc Papillary predominant Adc p.T250fs 0 TCGA-55-6970-11 C1-LUAD-enriched TCGA-55-6970 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung NO NO NO 67 R-Upper TCGA-55-6970-F57904 TCGA-55-6970 TCGA-55-6970-11A -24773 464 0 457 NO NO Scheduled Follow-up Submission Progressive Disease 2014-3-28 FEMALE Lung Papillary Adenocarcinoma No C34.1 8260/3 C34.1 YES 0.4 NO NO 0.8 NO Locoregional Recurrence YES No MX N2 T2 Stage IIIA 6970 WITH TUMOR Stable Disease Convincing Imaging YES R1 Solid Tissue Normal 11 0.4 6th YES NO YES 55 4 Current reformed smoker for < or = 15 years Lung A DECEASED 2004 fc4df3f7-2c4b-4a4d-9e5d-faac9e84fde8 fc4df3f7-2c4b-4a4d-9e5d-faac9e84fde8 fc4df3f7-2c4b-4a4d-9e5d-faac9e84fde8 +TCGA-55-6971-01 3.34 0.22 none none none none N N none none none 0.1 Magnoid none none none none none none none Acinar predominant Adc Acinar predominant Adc p.G251F 0 TCGA-55-6971-01 BRCA-LUAD+ C1-LUAD-enriched Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 4 TCGA-55-6971 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 59 L-Lower TCGA-55-6971-F56190 TCGA-55-6971 TCGA-55-6971-01A -21734 0 1400 NO NO Scheduled Follow-up Submission Complete Remission/Response 2014-1-29 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 0.5 NO NO 1.1 NO NO 60 No MX N0 T2 Stage IB TCGA-55-6971.c270e56a-dfc6-41a5-9cfc-3c302c4ccc13.pdf 6971 TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 0.2 2010 7th NO NO YES 55 4 Current reformed smoker for < or = 15 years Lung A LIVING 2010 1970 50b1d328-57c8-44ab-9c1a-a2bdbc40c6a4 50b1d328-57c8-44ab-9c1a-a2bdbc40c6a4 TCGA-55-6971-01A-11D-1947-05 TCGA-55-6971-01A-11D-1943-01 50b1d328-57c8-44ab-9c1a-a2bdbc40c6a4 TCGA-55-6971-01A-11D-1943-01 TCGA-55-6971-01A-13-2191-20 +TCGA-55-6971-11 3.34 0.22 none none none none N N none none none 0.1 Magnoid none none none none none none none Acinar predominant Adc Acinar predominant Adc p.G251F 0 TCGA-55-6971-11 C1-LUAD-enriched TCGA-55-6971 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 59 L-Lower TCGA-55-6971-F56190 TCGA-55-6971 TCGA-55-6971-11A -21734 0 1400 NO NO Scheduled Follow-up Submission Complete Remission/Response 2014-1-29 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 0.5 NO NO 1 NO NO 60 No MX N0 T2 Stage IB 6971 TUMOR FREE Complete Remission/Response NO R0 Solid Tissue Normal 11 0.4 2010 7th NO NO YES 55 4 Current reformed smoker for < or = 15 years Lung A LIVING 2010 1970 0b78c265-393c-4e3a-a53e-3ba76556c506 0b78c265-393c-4e3a-a53e-3ba76556c506 0b78c265-393c-4e3a-a53e-3ba76556c506 +TCGA-55-6972-01 none none none none N N none none none Magnoid none none none none none none none Acinar predominant Adc Acinar predominant Adc none 0 TCGA-55-6972-01 High Low purity c2 LUAD-like c10 miRNA cluster 7 TCGA-55-6972 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 72 R-Upper TCGA-55-6972-F56187 TCGA-55-6972 TCGA-55-6972-01A -26625 1632 0 1475 NO NO Scheduled Follow-up Submission Complete Remission/Response 2014-1-29 MALE Lung Papillary Adenocarcinoma No C34.1 8260/3 C34.1 YES 0.4 NO NO 0.6 NO NO No M0 N0 T2 Stage IB TCGA-55-6972.7d2c5e22-45d5-404c-97c5-5523ea656d75.pdf 6972 TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 0.2 6th NO NO YES 55 2 Current smoker Lung A DECEASED 2005 13e20aec-d506-4fa0-a6e1-121e76dcedc4 13e20aec-d506-4fa0-a6e1-121e76dcedc4 TCGA-55-6972-01A-11D-1947-05 TCGA-55-6972-01A-11D-1943-01 13e20aec-d506-4fa0-a6e1-121e76dcedc4 TCGA-55-6972-01A-11D-1943-01 +TCGA-55-6972-11 none none none none N N none none none Magnoid none none none none none none none Acinar predominant Adc Acinar predominant Adc none 0 TCGA-55-6972-11 TCGA-55-6972 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 72 R-Upper TCGA-55-6972-F56187 TCGA-55-6972 TCGA-55-6972-11A -26625 1632 0 1475 NO NO Scheduled Follow-up Submission Complete Remission/Response 2014-1-29 MALE Lung Papillary Adenocarcinoma No C34.1 8260/3 C34.1 YES 0.7 NO NO 0.7 NO NO No M0 N0 T2 Stage IB 6972 TUMOR FREE Complete Remission/Response NO R0 Solid Tissue Normal 11 0.4 6th NO NO YES 55 2 Current smoker Lung A DECEASED 2005 e448d6d2-be85-4164-be3f-fd7e5a0c53ec e448d6d2-be85-4164-be3f-fd7e5a0c53ec e448d6d2-be85-4164-be3f-fd7e5a0c53ec +TCGA-55-6975-01 TCGA-55-6975-01 Squamous Cluster 5 LUAD-like c10 TCGA-55-6975 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 61 L-Lower TCGA-55-6975-F45635 TCGA-55-6975 TCGA-55-6975-01A 118 0 NO NO Scheduled Follow-up Submission Progressive Disease 2013-7-17 MALE Lung Adenocarcinoma Mixed Subtype No C34.3 8255/3 C34.3 YES 0.2 NO NO 0.2 NO NO No M0 N1 T2 Stage IIB TCGA-55-6975.7c03cf6a-c871-4c53-af4d-cb931f6d8b72.pdf 6975 WITH TUMOR Progressive Disease NO Primary Tumor 01 0.1 2004 6th NO NO YES 55 4 Lung A DECEASED 2004 7ee4963f-9682-46b1-8946-4c726fd81c39 7ee4963f-9682-46b1-8946-4c726fd81c39 TCGA-55-6975-01A-11D-1947-05 TCGA-55-6975-01A-11D-1943-01 7ee4963f-9682-46b1-8946-4c726fd81c39 TCGA-55-6975-01A-11D-1943-01 +TCGA-55-6975-11 TCGA-55-6975-11 TCGA-55-6975 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 61 L-Lower TCGA-55-6975-F45635 TCGA-55-6975 TCGA-55-6975-11A 118 0 NO NO Scheduled Follow-up Submission Progressive Disease 2013-7-17 MALE Lung Adenocarcinoma Mixed Subtype No C34.3 8255/3 C34.3 YES 0.9 NO NO 0.9 NO NO No M0 N1 T2 Stage IIB 6975 WITH TUMOR Progressive Disease NO Solid Tissue Normal 11 0.8 2004 6th NO NO YES 55 4 Lung A DECEASED 2004 9ae0702d-672e-44c0-b548-25e11c198887 9ae0702d-672e-44c0-b548-25e11c198887 9ae0702d-672e-44c0-b548-25e11c198887 +TCGA-55-6978-01 none none none none N N none none none Squamoid none none none none none none none NSCLC, favor Adeno NSCLC, favor Adeno none 0 TCGA-55-6978-01 Squamous C1-LUAD-enriched Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 4 TCGA-55-6978 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung NO YES NO NO 81 R-Middle TCGA-55-6978-F45607 TCGA-55-6978 TCGA-55-6978-01A 176 0 42 NO NO Scheduled Follow-up Submission Progressive Disease 2013-7-17 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.2 8140/3 C34.2 YES 0.6 NO NO 0.7 NO YES Yes MX N0 T2b Stage IIA TCGA-55-6978.3e3c1e82-ee09-4eeb-873a-9b6580274f97.pdf 6978 WITH TUMOR Progressive Disease NO Primary Tumor 01 0.2 7th NO NO YES 55 1 Lifelong Non-smoker Lung A DECEASED 2010 7a25f591-c475-4bc4-a0ad-85f41e072608 7a25f591-c475-4bc4-a0ad-85f41e072608 TCGA-55-6978-01A-11D-1947-05 TCGA-55-6978-01A-11D-1943-01 7a25f591-c475-4bc4-a0ad-85f41e072608 TCGA-55-6978-01A-11D-1943-01 TCGA-55-6978-01A-13-2191-20 +TCGA-55-6978-11 none none none none N N none none none Squamoid none none none none none none none NSCLC, favor Adeno NSCLC, favor Adeno none 0 TCGA-55-6978-11 C1-LUAD-enriched TCGA-55-6978 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung NO YES NO NO 81 R-Middle TCGA-55-6978-F45607 TCGA-55-6978 TCGA-55-6978-11A 176 0 42 NO NO Scheduled Follow-up Submission Progressive Disease 2013-7-17 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.2 8140/3 C34.2 YES 0.7 NO NO 1.1 NO YES Yes MX N0 T2b Stage IIA 6978 WITH TUMOR Progressive Disease NO Solid Tissue Normal 11 0.5 7th NO NO YES 55 1 Lifelong Non-smoker Lung A DECEASED 2010 b3b1d4f3-1511-40a5-bf62-0ddf0893eac5 b3b1d4f3-1511-40a5-bf62-0ddf0893eac5 b3b1d4f3-1511-40a5-bf62-0ddf0893eac5 +TCGA-55-6979-01 3.35 0.18 none p.P367R none none N N none none none 0.08 Squamoid none none none none none none none Solid predominant Adc Solid predominant Adc none 0 TCGA-55-6979-01 High C1-LUAD-enriched Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 7 TCGA-55-6979 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung YES YES NO 59 L-Upper TCGA-55-6979-F37057 TCGA-55-6979 TCGA-55-6979-01A -21780 237 0 195 NO NO Scheduled Follow-up Submission Progressive Disease 2013-2-22 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.7 NO NO 1 NO Distant Metastasis YES Yes M0 N1 T2 Stage IIB TCGA-55-6979.c7896f40-c1a5-4e4c-bfea-7e80c94c66ad.pdf 6979 WITH TUMOR Progressive Disease Convincing Imaging NO Primary Tumor 01 0.4 6th YES NO YES 55 3 Current reformed smoker for > 15 years Lung A DECEASED 2006 a7a6d133-a7d0-44ea-bac5-3a8b7ddd9cd8 a7a6d133-a7d0-44ea-bac5-3a8b7ddd9cd8 TCGA-55-6979-01A-11D-1947-05 TCGA-55-6979-01A-11D-1943-01 a7a6d133-a7d0-44ea-bac5-3a8b7ddd9cd8 TCGA-55-6979-01A-11D-1943-01 TCGA-55-6979-01A-13-2191-20 +TCGA-55-6979-11 3.35 0.18 none p.P367R none none N N none none none 0.08 Squamoid none none none none none none none Solid predominant Adc Solid predominant Adc none 0 TCGA-55-6979-11 C1-LUAD-enriched TCGA-55-6979 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung YES YES NO 59 L-Upper TCGA-55-6979-F37057 TCGA-55-6979 TCGA-55-6979-11A -21780 237 0 195 NO NO Scheduled Follow-up Submission Progressive Disease 2013-2-22 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.5 NO NO 1 NO Distant Metastasis YES Yes M0 N1 T2 Stage IIB 6979 WITH TUMOR Progressive Disease Convincing Imaging NO Solid Tissue Normal 11 0.1 6th YES NO YES 55 3 Current reformed smoker for > 15 years Lung A DECEASED 2006 3d563365-c563-4fba-b67b-8aad1af89eab 3d563365-c563-4fba-b67b-8aad1af89eab 3d563365-c563-4fba-b67b-8aad1af89eab +TCGA-55-6980-01 2.15 0.3 none none none none Y Y p.709_710ET>D none none 0.15 Bronchioid none none none none none none none Other see comment Acinar predominant Adc none 0 TCGA-55-6980-01 High Cluster 5 LUAD-like c10 miRNA cluster 4 TCGA-55-6980 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 56 R-Lower TCGA-55-6980-F46642 TCGA-55-6980 TCGA-55-6980-01A 0 2109 NO NO Scheduled Follow-up Submission Complete Remission/Response 2013-8-13 MALE Lung Bronchioloalveolar Carcinoma Nonmucinous No C34.3 8252/3 C34.3 YES 0.3 NO NO 0.7 NO NO No M0 N0 T1 Stage IA TCGA-55-6980.e73aad2d-83d3-46b2-b2e9-cc93c5fbd670.pdf 6980 TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 0.1 6th NO NO YES 55 1 Lifelong Non-smoker Lung A LIVING 2006 5eae1d0f-5ca1-499b-963f-2fce4807ccc6 5eae1d0f-5ca1-499b-963f-2fce4807ccc6 TCGA-55-6980-01A-11D-1947-05 TCGA-55-6980-01A-11D-1943-01 5eae1d0f-5ca1-499b-963f-2fce4807ccc6 TCGA-55-6980-01A-11D-1943-01 +TCGA-55-6980-11 2.15 0.3 none none none none Y Y p.709_710ET>D none none 0.15 Bronchioid none none none none none none none Other see comment Acinar predominant Adc none 0 TCGA-55-6980-11 TCGA-55-6980 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 56 R-Lower TCGA-55-6980-F46642 TCGA-55-6980 TCGA-55-6980-11A 0 2109 NO NO Scheduled Follow-up Submission Complete Remission/Response 2013-8-13 MALE Lung Bronchioloalveolar Carcinoma Nonmucinous No C34.3 8252/3 C34.3 YES 0.9 NO NO 1 NO NO No M0 N0 T1 Stage IA 6980 TUMOR FREE Complete Remission/Response NO R0 Solid Tissue Normal 11 0.2 6th NO NO YES 55 1 Lifelong Non-smoker Lung A LIVING 2006 cdc81d17-1d85-42e5-a3ec-f458e6ab83f6 cdc81d17-1d85-42e5-a3ec-f458e6ab83f6 cdc81d17-1d85-42e5-a3ec-f458e6ab83f6 +TCGA-55-6981-01 3.42 0.27 none none none none Y Y p.LREAT747del none none 0.11 Squamoid none none none none none none none Solid predominant Adc Solid predominant Adc none 0 TCGA-55-6981-01 BRCA-LUAD+ C1-LUAD-enriched Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 4 TCGA-55-6981 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 53 L-Upper TCGA-55-6981-F56243 TCGA-55-6981 TCGA-55-6981-01A -19497 1379 0 NO NO Scheduled Follow-up Submission Complete Remission/Response 2014-1-30 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.6 NO NO 0.8 NO NO No M0 N2 T1 Stage IIIA TCGA-55-6981.84738cad-3b17-456c-a9a0-21f6e044a688.pdf 6981 TUMOR FREE Complete Remission/Response YES R0 Primary Tumor 01 0.4 6th YES NO YES 55 3 Current reformed smoker for > 15 years Lung A DECEASED 2005 af2f26d9-617a-42f3-a083-352d5e576460 af2f26d9-617a-42f3-a083-352d5e576460 TCGA-55-6981-01A-11D-1947-05 TCGA-55-6981-01A-11D-1943-01 af2f26d9-617a-42f3-a083-352d5e576460 TCGA-55-6981-01A-11D-1943-01 TCGA-55-6981-01A-13-2191-20 +TCGA-55-6981-11 3.42 0.27 none none none none Y Y p.LREAT747del none none 0.11 Squamoid none none none none none none none Solid predominant Adc Solid predominant Adc none 0 TCGA-55-6981-11 C1-LUAD-enriched TCGA-55-6981 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 53 L-Upper TCGA-55-6981-F56243 TCGA-55-6981 TCGA-55-6981-11A -19497 1379 0 NO NO Scheduled Follow-up Submission Complete Remission/Response 2014-1-30 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.8 NO NO 1.1 NO NO No M0 N2 T1 Stage IIIA 6981 TUMOR FREE Complete Remission/Response YES R0 Solid Tissue Normal 11 0.4 6th YES NO YES 55 3 Current reformed smoker for > 15 years Lung A DECEASED 2005 988e9e29-398e-45af-a4da-b6e7d119b776 988e9e29-398e-45af-a4da-b6e7d119b776 988e9e29-398e-45af-a4da-b6e7d119b776 +TCGA-55-6982-01 2.7 0.25 none none none none N N none none none 0.11 Squamoid none none none p.D1010_splice none none none Solid predominant Adc Solid predominant Adc none 0 TCGA-55-6982-01 BRCA-LUAD+ C1-LUAD-enriched Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 4 TCGA-55-6982 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung YES YES NO YES 79 R-Lower TCGA-55-6982-F46626 TCGA-55-6982 TCGA-55-6982-01A 183 995 0 183 NO NO Scheduled Follow-up Submission Progressive Disease 2013-8-13 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 0.3 NO NO 0.5 NO Distant Metastasis YES No M0 N1 T2 Stage IIB TCGA-55-6982.54e65072-9bea-41d0-b976-5f5723379c51.pdf 6982 WITH TUMOR Progressive Disease Convincing Imaging NO Primary Tumor 01 0.1 6th NO NO YES 55 1 Lifelong Non-smoker Lung A DECEASED 2004 681fbd5b-5bff-434d-8ff4-d995fc517e93 681fbd5b-5bff-434d-8ff4-d995fc517e93 TCGA-55-6982-01A-11D-1947-05 TCGA-55-6982-01A-11D-1943-01 681fbd5b-5bff-434d-8ff4-d995fc517e93 TCGA-55-6982-01A-11D-1943-01 TCGA-55-6982-01A-13-2191-20 +TCGA-55-6982-11 2.7 0.25 none none none none N N none none none 0.11 Squamoid none none none p.D1010_splice none none none Solid predominant Adc Solid predominant Adc none 0 TCGA-55-6982-11 C1-LUAD-enriched TCGA-55-6982 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung YES YES NO YES 79 R-Lower TCGA-55-6982-F46626 TCGA-55-6982 TCGA-55-6982-11A 183 995 0 183 NO NO Scheduled Follow-up Submission Progressive Disease 2013-8-13 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 0.7 NO NO 0.8 NO Distant Metastasis YES No M0 N1 T2 Stage IIB 6982 WITH TUMOR Progressive Disease Convincing Imaging NO Solid Tissue Normal 11 0.5 6th NO NO YES 55 1 Lifelong Non-smoker Lung A DECEASED 2004 2b7e9552-e34f-4c68-96af-1c01a605df60 2b7e9552-e34f-4c68-96af-1c01a605df60 2b7e9552-e34f-4c68-96af-1c01a605df60 +TCGA-55-6983-01 none none none none Y Y none none none Magnoid none p.G12C none none none none none Colloid adenoca Colloid adenoca p.R75fs 0 TCGA-55-6983-01 Iq Cluster 6 LUAD-like c10 miRNA cluster 6 TCGA-55-6983 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 81 L-Lower TCGA-55-6983-F47805 TCGA-55-6983 TCGA-55-6983-01A 0 2823 NO NO Scheduled Follow-up Submission Complete Remission/Response 2013-8-28 MALE Mucinous (Colloid) Carcinoma No C34.30 8480/3 C34.3 YES 0.3 NO NO 0.5 NO NO 60 No M0 N1 T2 Stage IIB TCGA-55-6983.5428a18c-8db6-4dbc-bec0-b55658f3302b.pdf 6983 TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 0.2 6th YES NO YES 55 4 Current reformed smoker for < or = 15 years Lung A LIVING 2005 3f4a27fd-378a-4d74-91c1-eda773c26b79 3f4a27fd-378a-4d74-91c1-eda773c26b79 TCGA-55-6983-01A-11D-1947-05 TCGA-55-6983-01A-11D-1943-01 3f4a27fd-378a-4d74-91c1-eda773c26b79 TCGA-55-6983-01A-11D-1943-01 +TCGA-55-6983-11 none none none none Y Y none none none Magnoid none p.G12C none none none none none Colloid adenoca Colloid adenoca p.R75fs 0 TCGA-55-6983-11 TCGA-55-6983 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 81 L-Lower TCGA-55-6983-F47805 TCGA-55-6983 TCGA-55-6983-11A 0 2823 NO NO Scheduled Follow-up Submission Complete Remission/Response 2013-8-28 MALE Mucinous (Colloid) Carcinoma No C34.30 8480/3 C34.3 YES 0.9 NO NO 1.1 NO NO 60 No M0 N1 T2 Stage IIB 6983 TUMOR FREE Complete Remission/Response NO R0 Solid Tissue Normal 11 0.4 6th YES NO YES 55 4 Current reformed smoker for < or = 15 years Lung A LIVING 2005 97a84c2b-7832-479c-8d01-a9ff610e7bf4 97a84c2b-7832-479c-8d01-a9ff610e7bf4 97a84c2b-7832-479c-8d01-a9ff610e7bf4 +TCGA-55-6984-01 TCGA-55-6984-01 BRCA-LUAD+ BRCA non-CIMP c9 LUAD-like c10 miRNA cluster 4 TCGA-55-6984 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung YES NO NO NO 71 L-Lower TCGA-55-6984-F45632 TCGA-55-6984 TCGA-55-6984-01A 760 0 724 NO NO Scheduled Follow-up Submission Progressive Disease 2013-7-17 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 0.4 NO NO 0.6 NO YES No M0 N1 T2 Stage IIB TCGA-55-6984.361307d6-aebb-446b-b06f-41c71deab5d2.pdf 6984 WITH TUMOR Complete Remission/Response NO Primary Tumor 01 0.2 6th YES NO YES 55 Lung A DECEASED 2006 bf920e10-514e-4623-b92e-c83a3e32485f bf920e10-514e-4623-b92e-c83a3e32485f TCGA-55-6984-01A-11D-1947-05 TCGA-55-6984-01A-11D-1943-01 bf920e10-514e-4623-b92e-c83a3e32485f TCGA-55-6984-01A-11D-1943-01 +TCGA-55-6984-11 TCGA-55-6984-11 TCGA-55-6984 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung YES NO NO NO 71 L-Lower TCGA-55-6984-F45632 TCGA-55-6984 TCGA-55-6984-11A 760 0 724 NO NO Scheduled Follow-up Submission Progressive Disease 2013-7-17 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 0.6 NO NO 1 NO YES No M0 N1 T2 Stage IIB 6984 WITH TUMOR Complete Remission/Response NO Solid Tissue Normal 11 0.4 6th YES NO YES 55 Lung A DECEASED 2006 d777ced1-c519-4281-b0c0-9e9188303e87 d777ced1-c519-4281-b0c0-9e9188303e87 d777ced1-c519-4281-b0c0-9e9188303e87 +TCGA-55-6985-01 none none none none N N none none none Squamoid none none none none none none none Acinar predominant Adc Acinar predominant Adc none 0 TCGA-55-6985-01 Squamous Cluster 6 LUAD-like c10 miRNA cluster 4 TCGA-55-6985 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 58 L-Upper TCGA-55-6985-F37056 TCGA-55-6985 TCGA-55-6985-01A -21381 0 1233 NO NO Scheduled Follow-up Submission 2013-2-22 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.1 NO NO 0.2 YES NO 50 No MX N0 T2 Stage IB TCGA-55-6985.c6fc0473-b67a-47f1-81f2-ecc0cbc9cc5f.pdf 6985 TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 0.1 2004 6th NO NO YES 55 4 Current reformed smoker for < or = 15 years Lung A LIVING 2004 fc852193-d692-4a36-83bd-30f49df5f973 fc852193-d692-4a36-83bd-30f49df5f973 TCGA-55-6985-01A-11D-1947-05 TCGA-55-6985-01A-11D-1943-01 fc852193-d692-4a36-83bd-30f49df5f973 TCGA-55-6985-01A-11D-1943-01 +TCGA-55-6985-11 none none none none N N none none none Squamoid none none none none none none none Acinar predominant Adc Acinar predominant Adc none 0 TCGA-55-6985-11 TCGA-55-6985 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 58 L-Upper TCGA-55-6985-F37056 TCGA-55-6985 TCGA-55-6985-11A -21381 0 1233 NO NO Scheduled Follow-up Submission 2013-2-22 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.9 NO NO 1.2 YES NO 50 No MX N0 T2 Stage IB 6985 TUMOR FREE Complete Remission/Response NO R0 Solid Tissue Normal 11 0.4 2004 6th NO NO YES 55 4 Current reformed smoker for < or = 15 years Lung A LIVING 2004 6cc31d25-1d4e-4f17-9321-2474befc3232 6cc31d25-1d4e-4f17-9321-2474befc3232 6cc31d25-1d4e-4f17-9321-2474befc3232 +TCGA-55-6986-01 1.96 0.39 none none none none N Y none none none 0.2 Bronchioid none none none none none none none Micropapillary predom Adc Micropapillary predom Adc Y none 0 TCGA-55-6986-01 Kirc+ Cluster 6 LUAD-like c10 miRNA c1uster 9 TCGA-55-6986 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 74 R-Lower TCGA-55-6986-F45606 TCGA-55-6986 TCGA-55-6986-01A 0 3261 NO NO Scheduled Follow-up Submission Complete Remission/Response 2013-7-17 FEMALE Lung Bronchioloalveolar Carcinoma Nonmucinous No C34.3 8252/3 C34.3 YES 0.4 NO NO 0.5 NO NO No M0 N0 T2 Stage IB TCGA-55-6986.bc8c1075-8f74-42da-bc09-80b4152b160f.pdf 6986 TUMOR FREE Complete Remission/Response NO Primary Tumor 01 0.1 6th NO NO YES 55 1 Lifelong Non-smoker Lung A LIVING 2004 c2711074-5019-4c8f-a5d7-7bf4654f5647 c2711074-5019-4c8f-a5d7-7bf4654f5647 TCGA-55-6986-01A-11D-1947-05 TCGA-55-6986-01A-11D-1943-01 c2711074-5019-4c8f-a5d7-7bf4654f5647 TCGA-55-6986-01A-11D-1943-01 +TCGA-55-6986-11 1.96 0.39 none none none none N Y none none none 0.2 Bronchioid none none none none none none none Micropapillary predom Adc Micropapillary predom Adc Y none 0 TCGA-55-6986-11 TCGA-55-6986 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 74 R-Lower TCGA-55-6986-F45606 TCGA-55-6986 TCGA-55-6986-11A 0 3261 NO NO Scheduled Follow-up Submission Complete Remission/Response 2013-7-17 FEMALE Lung Bronchioloalveolar Carcinoma Nonmucinous No C34.3 8252/3 C34.3 YES 0.6 NO NO 0.7 NO NO No M0 N0 T2 Stage IB 6986 TUMOR FREE Complete Remission/Response NO Solid Tissue Normal 11 0.5 6th NO NO YES 55 1 Lifelong Non-smoker Lung A LIVING 2004 e1adae95-dfa9-4279-8fc1-2f899f432360 e1adae95-dfa9-4279-8fc1-2f899f432360 e1adae95-dfa9-4279-8fc1-2f899f432360 +TCGA-55-6987-01 TCGA-55-6987-01 High Cluster 5 LUAD-like c10 miRNA cluster 7 TCGA-55-6987 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 77 L-Lower TCGA-55-6987-F47803 TCGA-55-6987 TCGA-55-6987-01A -28382 0 2137 NO NO Scheduled Follow-up Submission Complete Remission/Response 2013-8-28 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 0.1 NO NO 0.2 NO NO No M0 N0 T1 Stage IA TCGA-55-6987.345eb11f-9520-4463-8a84-07aeb26ce559.pdf 6987 TUMOR FREE Complete Remission/Response NO Primary Tumor 01 0.1 2006 6th NO NO YES 55 4 Lung A LIVING 2006 779acc52-4279-4249-b993-88ed032ccefa 779acc52-4279-4249-b993-88ed032ccefa TCGA-55-6987-01A-11D-1947-05 TCGA-55-6987-01A-11D-1943-01 779acc52-4279-4249-b993-88ed032ccefa TCGA-55-6987-01A-11D-1943-01 +TCGA-55-7227-01 TCGA-55-7227-01 Kirc+ Cluster 6 LUAD-like c10 miRNA cluster 4 TCGA-55-7227 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung YES NO NO 77 R-Lower TCGA-55-7227-F65704 TCGA-55-7227 TCGA-55-7227-01A -28458 952 0 53 255 Scheduled Follow-up Submission Progressive Disease 2014-9-26 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 0.3 NO 0.5 NO Locoregional Recurrence YES No MX N1 T3 Stage IIIA TCGA-55-7227.7910979d-a635-4ef5-ab00-84df0455df66.pdf 7227 WITH TUMOR Complete Remission/Response Convincing Imaging NO R0 Primary Tumor 01 0.1 1993 7th NO YES NO 55 3 Lung A DECEASED 2011 1953 987c7eea-648f-4feb-8239-0b9151a74331 987c7eea-648f-4feb-8239-0b9151a74331 TCGA-55-7227-01A-11D-2037-05 987c7eea-648f-4feb-8239-0b9151a74331 +TCGA-55-7281-01 1.85 0.59 none none none none Y Y none none none 0.31 Bronchioid none p.G12C none none none none none Acinar predominant Adc Acinar predominant Adc none 0 TCGA-55-7281-01 BRCA-LUAD+ Cluster 6 LUAD-like c10 miRNA cluster 4 TCGA-55-7281 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung YES YES NO NO 70 R-Middle TCGA-55-7281-F47807 TCGA-55-7281 TCGA-55-7281-01A -25870 0 872 339 Scheduled Follow-up Submission Partial Remission/Response 2013-8-28 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.2 8140/3 C34.2 YES 0.2 NO NO 0.3 NO Distant Metastasis YES 20 No M0 N0 T1b Stage IA TCGA-55-7281.8c99c857-2ab0-4481-ab5d-8ed971968620.pdf 7281 WITH TUMOR Complete Remission/Response Convincing Imaging NO R0 Primary Tumor 01 0.1 7th NO YES NO 55 4 Current reformed smoker for < or = 15 years Lung A LIVING 2011 b4a82c9e-4b14-42ed-8d33-6494ec475827 b4a82c9e-4b14-42ed-8d33-6494ec475827 TCGA-55-7281-01A-11D-2037-05 TCGA-55-7281-01A-11D-2035-01 b4a82c9e-4b14-42ed-8d33-6494ec475827 TCGA-55-7281-01A-11D-2035-01 +TCGA-55-7283-01 p.D323Y none none none Y Y none none none Bronchioid none p.G12S none none none none none Adenocarcinoma, NOS Adenocarcinoma, NOS none 0 TCGA-55-7283-01 BRCA-LUAD+ Cluster 6 LUAD-like c10 miRNA cluster 5 TCGA-55-7283 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 76 R-Upper TCGA-55-7283-F46988 TCGA-55-7283 TCGA-55-7283-01A -27946 0 609 64 0 NO NO Scheduled Follow-up Submission Partial Remission/Response 2013-8-21 FEMALE Lung Bronchioloalveolar Carcinoma Nonmucinous No C34.1 8252/3 C34.1 YES 0.1 NO 100 NO Central Lung 0.1 NO NO 5 No MX N2 T3 Stage IIIA TCGA-55-7283.39929fe3-b87c-413c-8613-f5a15b407b28.pdf 7283 Preoperative WITH TUMOR 105 82 Partial Remission/Response YES NO Primary Tumor 01 0.1 1961 7th YES YES NO 55 3 Current reformed smoker for > 15 years Lung A LIVING 2011 1950 91449ec2-a03f-4cc8-8738-4819564d9dae 91449ec2-a03f-4cc8-8738-4819564d9dae TCGA-55-7283-01A-11D-2037-05 TCGA-55-7283-01A-11D-2035-01 91449ec2-a03f-4cc8-8738-4819564d9dae TCGA-55-7283-01A-11D-2035-01 +TCGA-55-7284-01 TCGA-55-7284-01 Iq Cluster 5 LUAD-like c10 miRNA cluster 4 TCGA-55-7284 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung NO NO NO NO 74 R-Lower TCGA-55-7284-F61486 TCGA-55-7284 TCGA-55-7284-01B -27087 243 0 121 231 89 Scheduled Follow-up Submission Progressive Disease 2014-6-30 MALE Lung Bronchioloalveolar Carcinoma Nonmucinous No C34.8 8252/3 C34.8 YES 0.5 NO 0.9 NO Distant Metastasis YES Yes, History of Synchronous/Bilateral Malignancy MX N0 T3 Stage IIB TCGA-55-7284.ca201579-79b6-4a03-a982-9f43bf16471b.pdf 7284 WITH TUMOR 102 70 108 74 Complete Remission/Response Convincing Imaging YES NO R0 Primary Tumor 01 0.3 7th NO YES NO 55 3 Lung B DECEASED 2011 43d4cf00-5ed1-4f50-a2a4-31ee7c387eb9 43d4cf00-5ed1-4f50-a2a4-31ee7c387eb9 TCGA-55-7284-01B-11D-2239-05 TCGA-55-7284-01B-11D-2237-01 43d4cf00-5ed1-4f50-a2a4-31ee7c387eb9 TCGA-55-7284-01B-11D-2237-01 +TCGA-55-7570-01 TCGA-55-7570-01 Squamous Cluster 5 RNA cluster 3 miRNA cluster 4 TCGA-55-7570 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 60 R-Upper TCGA-55-7570-F56185 TCGA-55-7570 TCGA-55-7570-01A -22218 0 824 Scheduled Follow-up Submission Complete Remission/Response 2014-1-29 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.2 NO 0.3 NO NO No MX N0 T1a Stage IA TCGA-55-7570.95cb32d6-2999-44eb-a93f-31aa65a6c51c.pdf 7570 TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 0.2 7th NO YES NO 55 2 Lung A LIVING 2011 1971 56982118-0f10-47b2-af05-18b037c73f22 56982118-0f10-47b2-af05-18b037c73f22 TCGA-55-7570-01A-11D-2037-05 TCGA-55-7570-01A-11D-2035-01 56982118-0f10-47b2-af05-18b037c73f22 TCGA-55-7570-01A-11D-2035-01 +TCGA-55-7573-01 3.2 0.33 none none none none Y Y p.K754E, p.ELR746del none none 0.14 Bronchioid none none none none none none none Acinar predominant Adc Acinar predominant Adc none 0 TCGA-55-7573-01 Iq C1-LUAD-enriched Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 5 TCGA-55-7573 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 72 R-Upper TCGA-55-7573-F46657 TCGA-55-7573 TCGA-55-7573-01A -26302 0 487 51 1 NO NO Scheduled Follow-up Submission Complete Remission/Response 2013-8-13 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.7 NO 90 NO Central Lung 0.9 NO NO Yes MX N0 T1b Stage IA TCGA-55-7573.3eda2065-31da-49d1-8974-9d004ed26113.pdf 7573 Preoperative TUMOR FREE 119 134 115 130 Complete Remission/Response YES NO Primary Tumor 01 0.2 1983 7th NO YES NO 55 3 Current reformed smoker for > 15 years Lung A LIVING 2011 f9faf081-c497-44a3-9df1-da2be95e41d0 f9faf081-c497-44a3-9df1-da2be95e41d0 TCGA-55-7573-01A-11D-2037-05 TCGA-55-7573-01A-11D-2035-01 f9faf081-c497-44a3-9df1-da2be95e41d0 TCGA-55-7573-01A-11D-2035-01 TCGA-55-7573-01A-11-2192-20 +TCGA-55-7574-01 2.12 0.16 none none none none N N none none none 0.08 Bronchioid none none none none none p.R87T none Solid predominant Adc Solid predominant Adc p.K97_splice 0 TCGA-55-7574-01 Squamous C1-LUAD-enriched Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 5 TCGA-55-7574 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung YES YES NO NO 64 R-Upper TCGA-55-7574-F64279 TCGA-55-7574 TCGA-55-7574-01A -23703 995 0 95 478 3 Scheduled Follow-up Submission Progressive Disease 2014-8-28 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.7 NO 50 NO 0.9 NO Distant Metastasis YES 2 No M0 N0 T2a Stage IB TCGA-55-7574.7bf6ed4b-a0da-4bcd-ba62-211d2d2a86e7.pdf 7574 Post-Adjuvant Therapy WITH TUMOR Complete Remission/Response Convincing Imaging YES R1 Primary Tumor 01 0.4 2011 7th YES YES NO 55 4 Current reformed smoker for < or = 15 years Lung A DECEASED 2011 1971 bbf4c600-a4c5-4ad6-8842-d90639aab690 bbf4c600-a4c5-4ad6-8842-d90639aab690 TCGA-55-7574-01A-11D-2037-05 TCGA-55-7574-01A-11D-2035-01 bbf4c600-a4c5-4ad6-8842-d90639aab690 TCGA-55-7574-01A-11D-2035-01 TCGA-55-7574-01A-11-2192-20 +TCGA-55-7576-01 2.86 0.47 none none none none Y Y none none none 0.2 Squamoid none p.G12S none none none none none Acinar predominant Adc Acinar predominant Adc none 0 TCGA-55-7576-01 Squamous Cluster 6 LUAD-like c10 miRNA cluster 4 TCGA-55-7576 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 54 R-Upper TCGA-55-7576-F45603 TCGA-55-7576 TCGA-55-7576-01A -19917 0 670 Scheduled Follow-up Submission Complete Remission/Response 2013-7-17 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.5 NO 0.5 NO NO No M0 N0 T2a Stage IB TCGA-55-7576.feac18c2-ce79-4092-ad5a-98143981a24e.pdf 7576 TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 0.2 7th YES YES NO 55 2 Current smoker Lung A LIVING 2011 1972 829b31ba-7ab2-475e-bad9-1d1a9b6ab13f 829b31ba-7ab2-475e-bad9-1d1a9b6ab13f TCGA-55-7576-01A-11D-2064-05 TCGA-55-7576-01A-11D-2062-01 829b31ba-7ab2-475e-bad9-1d1a9b6ab13f TCGA-55-7576-01A-11D-2062-01 +TCGA-55-7724-01 p.E17K none none none N Y none none none Squamoid none none none none none p.E542K none Solid predominant Adc Solid predominant Adc none TCGA-55-7724-01 Squamous Cluster 5 squamous-like c4 miRNA cluster 5 TCGA-55-7724 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 76 L-Upper TCGA-55-7724-F56186 TCGA-55-7724 TCGA-55-7724-01A -27891 0 705 49 Scheduled Follow-up Submission Complete Remission/Response 2014-1-29 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.4 NO 0.7 NO NO 50 Yes MX N0 T2a Stage IB TCGA-55-7724.2d61169f-eaf9-4a67-afef-0dd4c2ffe0c5.pdf 7724 TUMOR FREE 36 33 Complete Remission/Response YES NO R0 Primary Tumor 01 0.2 2008 7th NO YES NO 55 4 Lung A LIVING 2011 1958 4be7594c-c6ff-47c3-bb57-22ba6489b0f4 4be7594c-c6ff-47c3-bb57-22ba6489b0f4 TCGA-55-7724-01A-11D-2168-05 TCGA-55-7724-01A-11D-2166-01 4be7594c-c6ff-47c3-bb57-22ba6489b0f4 TCGA-55-7724-01A-11D-2166-01 +TCGA-55-7725-01 none none none none Y Y none none none Bronchioid none p.G12V none none none none none Acinar predominant Adc Acinar predominant Adc none 0 TCGA-55-7725-01 Kirc+ Cluster 5 LUAD-like c10 miRNA cluster 5 TCGA-55-7725 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 68 R-Lower TCGA-55-7725-F46647 TCGA-55-7725 TCGA-55-7725-01A -24848 0 442 0 NO NO Scheduled Follow-up Submission Complete Remission/Response 2013-8-13 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 0.4 NO 100 NO Central Lung 0.5 NO NO 16 Yes MX N0 T1a Stage IA TCGA-55-7725.e25ffd17-6064-4eef-acd4-5e26475cd842.pdf 7725 Post-Adjuvant Therapy TUMOR FREE 88 64 89 61 Complete Remission/Response YES NO R0 Primary Tumor 01 0.2 1994 7th NO YES NO 55 3 Current reformed smoker for > 15 years Lung A LIVING 2011 1963 8b1695b3-8abd-4bfc-98e4-7d0ad20a5acc 8b1695b3-8abd-4bfc-98e4-7d0ad20a5acc TCGA-55-7725-01A-11D-2168-05 TCGA-55-7725-01A-11D-2166-01 8b1695b3-8abd-4bfc-98e4-7d0ad20a5acc TCGA-55-7725-01A-11D-2166-01 +TCGA-55-7726-01 none none none none Y Y none none none Squamoid none p.G12C none none none none none none TCGA-55-7726-01 BRCA-LUAD+ Cluster 5 squamous-like c4 miRNA cluster 5 TCGA-55-7726 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 72 L-Lower TCGA-55-7726-F47844 TCGA-55-7726 TCGA-55-7726-01A -26451 0 652 72 Scheduled Follow-up Submission Complete Remission/Response 2013-8-29 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 0.3 NO 0.6 NO NO 30 Yes MX N0 T1b Stage IA TCGA-55-7726.094c672b-f6c7-4250-bb17-4d23a48b81c7.pdf 7726 TUMOR FREE 59 61 55 49 Complete Remission/Response YES NO R0 Primary Tumor 01 0.2 1979 7th NO YES NO 55 3 Lung A LIVING 2011 1955 b2d849d8-f837-43e4-b06c-051f041172ae b2d849d8-f837-43e4-b06c-051f041172ae TCGA-55-7726-01A-11D-2168-05 TCGA-55-7726-01A-11D-2166-01 b2d849d8-f837-43e4-b06c-051f041172ae TCGA-55-7726-01A-11D-2166-01 +TCGA-55-7727-01 none none none none N N none none none Magnoid none none none none none none none Micropapillary predom Adc Micropapillary predom Adc none 0 TCGA-55-7727-01 BRCA-LUAD+ Cluster 6 LUAD-like c10 miRNA cluster 4 TCGA-55-7727 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 70 L-Upper TCGA-55-7727-F66030 TCGA-55-7727 TCGA-55-7727-01A -25929 0 119 86 Scheduled Follow-up Submission Complete Remission/Response 2014-10-1 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.3 NO 0.6 YES NO No MX N2 T1a Stage IIIA TCGA-55-7727.1e6155d1-e9eb-447d-951e-3b81f6d41156.pdf 7727 TUMOR FREE 48 73 49 74 Complete Remission/Response YES NO R0 Primary Tumor 01 0.2 7th YES YES NO 55 2 Current smoker Lung A LIVING 2011 d4349207-30b1-44ad-b460-14db8ea58cc4 d4349207-30b1-44ad-b460-14db8ea58cc4 TCGA-55-7727-01A-11D-2168-05 TCGA-55-7727-01A-11D-2166-01 d4349207-30b1-44ad-b460-14db8ea58cc4 TCGA-55-7727-01A-11D-2166-01 +TCGA-55-7728-01 none none none none Y Y none none p.H841Q Bronchioid none p.G12V none none none none none Invasive mucinous Invasive mucinous none 0 TCGA-55-7728-01 Kirc+ C1-LUAD-enriched Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 4 TCGA-55-7728 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 64 L-Upper TCGA-55-7728-F47841 TCGA-55-7728 TCGA-55-7728-01A -23505 0 704 64 NO NO Scheduled Follow-up Submission Complete Remission/Response 2013-8-29 FEMALE Mucinous (Colloid) Carcinoma No C34.1 8480/3 C34.1 YES 0.8 NO NO 1 NO NO 30 No MX N0 T2a Stage IB TCGA-55-7728.d12721b3-53dc-47e8-a9c2-03343ec7a4bb.pdf 7728 TUMOR FREE 74 67 Complete Remission/Response YES NO R0 Primary Tumor 01 0.5 1996 7th NO YES NO 55 4 Current reformed smoker for < or = 15 years Lung A LIVING 2011 1980 d54aa159-e398-4fd4-bd2c-a437e7766582 d54aa159-e398-4fd4-bd2c-a437e7766582 TCGA-55-7728-01A-11D-2185-05 TCGA-55-7728-01A-11D-2183-01 d54aa159-e398-4fd4-bd2c-a437e7766582 TCGA-55-7728-01A-11D-2183-01 TCGA-55-7728-01A-13-2192-20 +TCGA-55-7815-01 none none none none Y Y none none none Magnoid none p.G12V none none none none none none TCGA-55-7815-01 BRCA-LUAD+ C1-LUAD-enriched Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 4 TCGA-55-7815 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung YES YES NO NO 76 R-Lower TCGA-55-7815-F61497 TCGA-55-7815 TCGA-55-7815-01A -28119 0 773 592 59 Additional New Tumor Event Progressive Disease 2014-6-30 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 0.7 NO 0.7 NO Distant Metastasis YES No MX N0 T2a Stage IB TCGA-55-7815.4caba554-2bb8-4158-af8a-9690d4d5f73c.pdf 7815 WITH TUMOR 76 72 Complete Remission/Response YES NO R0 Primary Tumor 01 0.4 7th NO YES NO 55 1 Lung A LIVING 2011 ea6af137-a116-4a32-9436-a9470abb3b10 ea6af137-a116-4a32-9436-a9470abb3b10 TCGA-55-7815-01A-11D-2168-05 TCGA-55-7815-01A-11D-2166-01 ea6af137-a116-4a32-9436-a9470abb3b10 TCGA-55-7815-01A-11D-2166-01 TCGA-55-7815-01A-13-2192-20 +TCGA-55-7816-01 TCGA-55-7816-01 Low purity c2 miRNA cluster 5 TCGA-55-7816 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 49 R-Upper TCGA-55-7816-F60131 TCGA-55-7816 TCGA-55-7816-01A -18170 468 0 44 Scheduled Follow-up Submission Progressive Disease 2014-5-29 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.3 NO 0.3 NO NO No MX NX TX Stage IV TCGA-55-7816.ca0d6f7a-fee3-49c5-8239-8a2583cecdd1.pdf 7816 WITH TUMOR Progressive Disease NO NO Primary Tumor 01 0.2 7th NO YES NO 55 1 Lung A DECEASED 2011 94beac77-4ba2-4465-9f42-813e7de4df3e 94beac77-4ba2-4465-9f42-813e7de4df3e TCGA-55-7816-01A-11D-2168-05 94beac77-4ba2-4465-9f42-813e7de4df3e +TCGA-55-7903-01 none p.R146W, p.V600E none none N Y none none none Squamoid none none none none none none none Solid predominant Adc Solid predominant Adc none 0 TCGA-55-7903-01 BRCA-LUAD+ Cluster 6 LUAD-like c10 miRNA cluster 4 TCGA-55-7903 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 64 R-Lower TCGA-55-7903-F47840 TCGA-55-7903 TCGA-55-7903-01A -23509 0 567 83 NO NO Scheduled Follow-up Submission Complete Remission/Response 2013-8-29 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 0.2 NO NO 0.5 NO NO 40 No MX N0 T1b Stage IA TCGA-55-7903.f044afa0-43c8-4047-a6bf-d46bfb42433c.pdf 7903 TUMOR FREE 63 66 Complete Remission/Response YES NO R0 Primary Tumor 01 0.2 7th NO YES NO 55 2 Current smoker Lung A LIVING 2011 514e90fa-113f-48d7-9166-41096e0ad209 514e90fa-113f-48d7-9166-41096e0ad209 TCGA-55-7903-01A-11D-2168-05 TCGA-55-7903-01A-11D-2166-01 514e90fa-113f-48d7-9166-41096e0ad209 TCGA-55-7903-01A-11D-2166-01 +TCGA-55-7907-01 none none none none Y Y none none p.L805V Squamoid none p.G12C none none none none none Micropapillary predom Adc Micropapillary predom Adc none 0 TCGA-55-7907-01 High Cluster 6 LUAD-like c10 miRNA cluster 5 TCGA-55-7907 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung NO NO NO 77 L-Upper TCGA-55-7907-F60132 TCGA-55-7907 TCGA-55-7907-01A -28201 343 0 16 294 75 Scheduled Follow-up Submission Progressive Disease 2014-5-29 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.3 NO 0.3 NO Distant Metastasis YES 80 No MX N1 T2a Stage IIA TCGA-55-7907.233ef961-8050-47e5-bb53-260a7de4174d.pdf 7907 WITH TUMOR 80 87 75 76 Complete Remission/Response Convincing Imaging YES NO R0 Primary Tumor 01 0.1 1994 7th NO YES NO 55 3 Current reformed smoker for > 15 years Lung A DECEASED 2011 1954 0168f22b-6d11-4492-9aea-5ffa451bff3e 0168f22b-6d11-4492-9aea-5ffa451bff3e TCGA-55-7907-01A-11D-2168-05 TCGA-55-7907-01A-11D-2166-01 0168f22b-6d11-4492-9aea-5ffa451bff3e TCGA-55-7907-01A-11D-2166-01 +TCGA-55-7910-01 TCGA-55-7910-01 High C1-LUAD-enriched Low purity c2 squamous c3 LUAD-like c10 miRNA cluster 5 TCGA-55-7910 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung NO YES 50 L-Lower TCGA-55-7910-F66140 TCGA-55-7910 TCGA-55-7910-01A -18289 0 1040 1018 44 1 Scheduled Follow-up Submission 2014-10-3 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 0.6 NO 80 Peripheral Lung 0.9 NO YES 15 No M0 N0 T2b Stage IIA TCGA-55-7910.c205abda-dfe0-43b1-a265-4c41125216fe.pdf 7910 Preoperative WITH TUMOR 91 91 97 86 Complete Remission/Response YES NO R0 Primary Tumor 01 0.5 2011 7th YES YES NO 55 4 Lung A LIVING 2011 1996 4ff760c4-074e-4876-b63f-71098942c780 4ff760c4-074e-4876-b63f-71098942c780 TCGA-55-7910-01A-11D-2168-05 TCGA-55-7910-01A-11D-2166-01 4ff760c4-074e-4876-b63f-71098942c780 TCGA-55-7910-01A-11D-2166-01 TCGA-55-7910-01A-13-2192-20 +TCGA-55-7911-01 none none none none Y Y none none none Squamoid none p.G12V, p.K88* none none none none none Solid predominant Adc Solid predominant Adc none 0 TCGA-55-7911-01 BRCA-LUAD+ C1-LUAD-enriched Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 4 TCGA-55-7911 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung NO YES NO NO 70 R-Middle TCGA-55-7911-F48785 TCGA-55-7911 TCGA-55-7911-01A -25746 0 537 515 NO NO Scheduled Follow-up Submission Complete Remission/Response 2013-9-20 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.2 8140/3 C34.2 YES 0.5 NO NO 0.8 NO New Primary Tumor YES 96 No MX N0 T1a Stage IA TCGA-55-7911.0c8ea3a9-23b7-4c43-8972-3660048b8537.pdf 7911 TUMOR FREE 86 64 Complete Remission/Response YES NO R0 Primary Tumor 01 0.4 1981 7th NO YES NO 55 3 Current reformed smoker for > 15 years Lung A LIVING 2011 1959 9142e848-c5cb-41c1-b80f-5f7674f9a1cb 9142e848-c5cb-41c1-b80f-5f7674f9a1cb TCGA-55-7911-01A-11D-2168-05 TCGA-55-7911-01A-11D-2166-01 9142e848-c5cb-41c1-b80f-5f7674f9a1cb TCGA-55-7911-01A-11D-2166-01 TCGA-55-7911-01A-13-2192-20 +TCGA-55-7913-01 TCGA-55-7913-01 BRCA-LUAD+ Cluster 5 LUAD-like c10 miRNA cluster 6 TCGA-55-7913 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung NO YES NO 61 L-Lower TCGA-55-7913-F57911 TCGA-55-7913 TCGA-55-7913-01B -22326 561 0 62 480 1 YES FISH YES Scheduled Follow-up Submission Progressive Disease 2014-3-28 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 0.4 NO 90 YES NO Central Lung 0.7 NO Distant Metastasis YES 40 No MX N0 T1b Stage IA TCGA-55-7913.7ce361fa-ad56-4e0e-95e3-ea977a513e98.pdf 7913 Preoperative WITH TUMOR Complete Remission/Response Convincing Imaging NO R0 Primary Tumor 01 0.2 7th NO YES NO 55 2 Lung B DECEASED 2011 1971 168efb85-ed48-4e77-ba13-90674218c506 168efb85-ed48-4e77-ba13-90674218c506 TCGA-55-7913-01B-11D-2239-05 TCGA-55-7913-01B-11D-2237-01 168efb85-ed48-4e77-ba13-90674218c506 TCGA-55-7913-01B-11D-2237-01 +TCGA-55-7914-01 none none none none Y Y none none none Bronchioid none p.G12C none none none none none Acinar predominant Adc Acinar predominant Adc none 0 TCGA-55-7914-01 Squamous Cluster 6 LUAD-like c10 miRNA cluster 5 TCGA-55-7914 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 71 R-Upper TCGA-55-7914-F59091 TCGA-55-7914 TCGA-55-7914-01A -26105 187 0 3 56 1 YES FISH YES Scheduled Follow-up Submission Progressive Disease 2014-4-30 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.2 NO 80 YES YES G12C Central Lung 0.4 NO NO 5 Yes MX N1 T1b Stage IIA TCGA-55-7914.eaabadac-ea5e-47c3-9db7-d2c0c77b7b68.pdf 7914 Preoperative WITH TUMOR 88 73 Progressive Disease YES NO R0 Primary Tumor 01 0.2 7th YES YES NO 55 2 Current smoker Lung A DECEASED 2011 1990 5bfe179e-eae2-4d2a-9f2a-b4af4602a2b5 5bfe179e-eae2-4d2a-9f2a-b4af4602a2b5 TCGA-55-7914-01A-11D-2168-05 TCGA-55-7914-01A-11D-2166-01 5bfe179e-eae2-4d2a-9f2a-b4af4602a2b5 TCGA-55-7914-01A-11D-2166-01 +TCGA-55-7994-01 TCGA-55-7994-01 Squamous Cluster 6 LUAD-like c10 miRNA cluster 4 TCGA-55-7994 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 81 R-Upper TCGA-55-7994-F47823 TCGA-55-7994 TCGA-55-7994-01A -29858 0 603 NO NO Scheduled Follow-up Submission Complete Remission/Response 2013-8-28 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.8 NO NO 1 NO NO 28 No MX N0 T3 Stage IIB TCGA-55-7994.8454b0fe-a466-43b7-843f-16db8b4c43cd.pdf 7994 TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 0.4 7th YES YES NO 55 2 Lung A LIVING 2011 c857b341-4021-48e6-a9e7-fff0525cdb96 c857b341-4021-48e6-a9e7-fff0525cdb96 TCGA-55-7994-01A-11D-2185-05 TCGA-55-7994-01A-11D-2183-01 c857b341-4021-48e6-a9e7-fff0525cdb96 TCGA-55-7994-01A-11D-2183-01 +TCGA-55-7995-01 TCGA-55-7995-01 High BRCA basal-like c8 LUAD-like c10 miRNA cluster 4 TCGA-55-7995 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung YES YES NO 73 L-Upper TCGA-55-7995-F65700 TCGA-55-7995 TCGA-55-7995-01A -26837 0 889 468 51 1 NO NO Scheduled Follow-up Submission Complete Remission/Response 2014-9-26 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.7 NO 80 Peripheral Lung 0.8 NO Locoregional Recurrence YES 60 No M0 N0 T1b Stage IA TCGA-55-7995.3f3f4bdf-75f6-4b5b-988e-cebc4f098cbd.pdf 7995 Post-Adjuvant Therapy TUMOR FREE 71 77 Complete Remission/Response Convincing Imaging YES NO R0 Primary Tumor 01 0.2 2002 7th NO YES NO 55 4 Lung A LIVING 2012 956590e9-4962-497b-a59f-81ee0a1c0caf 956590e9-4962-497b-a59f-81ee0a1c0caf TCGA-55-7995-01A-11D-2185-05 TCGA-55-7995-01A-11D-2183-01 956590e9-4962-497b-a59f-81ee0a1c0caf TCGA-55-7995-01A-11D-2183-01 +TCGA-55-8085-01 TCGA-55-8085-01 BRCA-LUAD+ Cluster 5 LUAD-like c10 miRNA cluster 7 TCGA-55-8085 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 64 L-Lower TCGA-55-8085-F65697 TCGA-55-8085 TCGA-55-8085-01A -23596 0 904 51 1 Scheduled Follow-up Submission Complete Remission/Response 2014-9-26 MALE Lung Papillary Adenocarcinoma No C34.3 8260/3 C34.3 YES 0.5 NO 0.7 NO NO No M0 N0 T1b Stage IA TCGA-55-8085.16f4298e-d5f3-4503-bdad-a15531c3635c.pdf 8085 TUMOR FREE 46 45 39 35 Complete Remission/Response YES NO R0 Primary Tumor 01 0.3 7th NO YES NO 55 2 Lung A LIVING 2011 04104d50-dcf7-4e77-9038-8fed73db6a12 04104d50-dcf7-4e77-9038-8fed73db6a12 TCGA-55-8085-01A-11D-2239-05 TCGA-55-8085-01A-11D-2237-01 04104d50-dcf7-4e77-9038-8fed73db6a12 TCGA-55-8085-01A-11D-2237-01 +TCGA-55-8087-01 TCGA-55-8087-01 Iq Cluster 5 LUAD-like c10 miRNA c1uster 9 TCGA-55-8087 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 59 R-Upper TCGA-55-8087-F47822 TCGA-55-8087 TCGA-55-8087-01A -21655 0 462 142 NO NO Scheduled Follow-up Submission Complete Remission/Response 2013-8-28 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.8 NO NO 0.9 NO NO No MX N0 T2a Stage IB TCGA-55-8087.a2478c36-05ee-4b55-9293-5cce65217c94.pdf 8087 TUMOR FREE 126 Complete Remission/Response YES NO R0 Primary Tumor 01 0.7 7th NO YES NO 55 1 Lung A LIVING 2011 ce03cab8-df0a-433b-bc39-96203ab061a1 ce03cab8-df0a-433b-bc39-96203ab061a1 TCGA-55-8087-01A-11D-2239-05 TCGA-55-8087-01A-11D-2237-01 ce03cab8-df0a-433b-bc39-96203ab061a1 TCGA-55-8087-01A-11D-2237-01 +TCGA-55-8089-01 TCGA-55-8089-01 High Cluster 6 LUAD-like c10 miRNA cluster 4 TCGA-55-8089 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 56 R-Upper TCGA-55-8089-F59075 TCGA-55-8089 TCGA-55-8089-01A -20576 702 0 100 90 0 YES YES Scheduled Follow-up Submission Complete Remission/Response 2014-4-30 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.2 NO 100 YES NO Peripheral Lung 0.2 NO NO 97 No M0 N0 T1a Stage IA TCGA-55-8089.af442cea-76df-4233-b3d6-134b1e91c607.pdf 8089 Preoperative TUMOR FREE 85 70 Complete Remission/Response YES NO R0 Primary Tumor 01 0.1 7th NO YES NO 55 2 Lung A DECEASED 2011 1973 671a4dd5-cb2a-4d9b-aec7-c5963d50f2ab 671a4dd5-cb2a-4d9b-aec7-c5963d50f2ab TCGA-55-8089-01A-11D-2239-05 TCGA-55-8089-01A-11D-2237-01 671a4dd5-cb2a-4d9b-aec7-c5963d50f2ab TCGA-55-8089-01A-11D-2237-01 +TCGA-55-8090-01 TCGA-55-8090-01 BRCA-LUAD+ Cluster 6 LUAD-like c10 miRNA c1uster 9 TCGA-55-8090 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung NO NO NO 80 R-Lower TCGA-55-8090-F56189 TCGA-55-8090 TCGA-55-8090-01A -29235 598 0 6 548 58 Scheduled Follow-up Submission Progressive Disease 2014-1-29 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 0.4 NO 1 NO Distant Metastasis YES Yes, History of Synchronous/Bilateral Malignancy M0 N0 T1a Stage IA TCGA-55-8090.8f75f207-fe12-44ba-86b2-444ab5578d45.pdf 8090 WITH TUMOR 4 6 103 83 Complete Remission/Response Convincing Imaging YES NO R0 Primary Tumor 01 0.2 7th NO YES NO 55 2 Lung A DECEASED 2011 5877248b-dff8-494d-a5c1-7721072ec225 5877248b-dff8-494d-a5c1-7721072ec225 TCGA-55-8090-01A-11D-2239-05 TCGA-55-8090-01A-11D-2237-01 5877248b-dff8-494d-a5c1-7721072ec225 TCGA-55-8090-01A-11D-2237-01 +TCGA-55-8091-01 TCGA-55-8091-01 Kirc+ Cluster 5 LUAD-like c10 miRNA c1uster 9 TCGA-55-8091 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 74 R-Lower TCGA-55-8091-F47820 TCGA-55-8091 TCGA-55-8091-01A -27385 0 600 65 NO NO Scheduled Follow-up Submission Complete Remission/Response 2013-8-28 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 0.8 NO NO 1.1 NO NO Yes, History of Prior Malignancy MX N0 T2 Stage IB TCGA-55-8091.33902b19-5be6-47ff-81a7-b945ae674a2f.pdf 8091 TUMOR FREE 79 82 Complete Remission/Response YES NO R0 Primary Tumor 01 0.6 1985 7th NO YES NO 55 3 Lung A LIVING 2011 40adb8fd-ac1d-4f5d-98a4-3bb5256626c4 40adb8fd-ac1d-4f5d-98a4-3bb5256626c4 TCGA-55-8091-01A-11D-2239-05 TCGA-55-8091-01A-11D-2237-01 40adb8fd-ac1d-4f5d-98a4-3bb5256626c4 TCGA-55-8091-01A-11D-2237-01 +TCGA-55-8092-01 TCGA-55-8092-01 High Cluster 6 LUAD-like c10 miRNA cluster 7 TCGA-55-8092 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung NO NO NO 75 R-Upper TCGA-55-8092-F46643 TCGA-55-8092 TCGA-55-8092-01A -27597 154 0 26 127 19 Scheduled Follow-up Submission Progressive Disease 2013-8-13 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.5 NO 0.7 NO Locoregional Recurrence YES 40 No MX N0 T3 Stage IIB TCGA-55-8092.c21d060b-3f55-4a82-85df-38814c7a37e7.pdf 8092 WITH TUMOR 2 19 66 68 Complete Remission/Response Convincing Imaging YES NO R0 Primary Tumor 01 0.5 2012 7th NO YES NO 55 4 Lung A DECEASED 2012 1972 add23090-21e1-4cc2-a833-539b1db1e05f add23090-21e1-4cc2-a833-539b1db1e05f TCGA-55-8092-01A-11D-2239-05 TCGA-55-8092-01A-11D-2237-01 add23090-21e1-4cc2-a833-539b1db1e05f TCGA-55-8092-01A-11D-2237-01 +TCGA-55-8094-01 TCGA-55-8094-01 High Cluster 5 LUAD-like c10 miRNA cluster 6 TCGA-55-8094 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 51 L-Upper TCGA-55-8094-F66029 TCGA-55-8094 TCGA-55-8094-01A -18903 0 541 YES FISH YES Scheduled Follow-up Submission Partial Remission/Response 2014-10-1 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.5 NO NO Peripheral Lung 0.7 NO NO 70 No M1b N0 T2b Stage IV TCGA-55-8094.807ba9c2-925a-4fda-a1a4-a6e856be0bb3.pdf 8094 WITH TUMOR Progressive Disease YES R0 Primary Tumor 01 0.2 2011 7th YES YES NO 55 4 Lung A LIVING 2012 1976 b08923df-9b70-48eb-bc2b-023d1e1b0eeb b08923df-9b70-48eb-bc2b-023d1e1b0eeb TCGA-55-8094-01A-11D-2239-05 TCGA-55-8094-01A-11D-2237-01 b08923df-9b70-48eb-bc2b-023d1e1b0eeb TCGA-55-8094-01A-11D-2237-01 +TCGA-55-8096-01 TCGA-55-8096-01 High Low purity c2 LUAD-like c10 miRNA cluster 4 TCGA-55-8096 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung NO YES NO 67 L-Upper TCGA-55-8096-F59097 TCGA-55-8096 TCGA-55-8096-01A -24684 719 0 47 566 2 NO NO Scheduled Follow-up Submission Progressive Disease 2014-4-30 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.9 NO 70 NO Central Lung 0.9 NO Distant Metastasis YES 104 No MX N0 T2a Stage IB TCGA-55-8096.d27900ae-8cf6-4d92-84e8-5247df7d46b4.pdf 8096 Preoperative WITH TUMOR 77 55 Complete Remission/Response Convincing Imaging YES NO Primary Tumor 01 0.4 7th NO YES NO 55 2 Lung A DECEASED 2011 1959 22366c3f-bf63-421e-b086-0ffb87945bf9 22366c3f-bf63-421e-b086-0ffb87945bf9 TCGA-55-8096-01A-11D-2239-05 TCGA-55-8096-01A-11D-2237-01 22366c3f-bf63-421e-b086-0ffb87945bf9 TCGA-55-8096-01A-11D-2237-01 +TCGA-55-8097-01 TCGA-55-8097-01 COAD-READ Cluster 5 LUAD-like c10 miRNA cluster 4 TCGA-55-8097 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 60 R-Upper TCGA-55-8097-F47821 TCGA-55-8097 TCGA-55-8097-01A -22260 0 476 74 NO NO Scheduled Follow-up Submission Complete Remission/Response 2013-8-28 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.4 NO NO 0.5 NO NO 35 No MX N0 T1a Stage IA TCGA-55-8097.3e2989f4-213d-4f64-be03-9b967f1fcc08.pdf 8097 TUMOR FREE 87 79 Complete Remission/Response YES NO R0 Primary Tumor 01 0.1 2008 7th NO YES NO 55 4 Lung A LIVING 2012 1973 6191a9e8-7ed1-49d0-b582-e38b29c61649 6191a9e8-7ed1-49d0-b582-e38b29c61649 TCGA-55-8097-01A-11D-2239-05 TCGA-55-8097-01A-11D-2237-01 6191a9e8-7ed1-49d0-b582-e38b29c61649 TCGA-55-8097-01A-11D-2237-01 +TCGA-55-8203-01 TCGA-55-8203-01 BRCA-LUAD+ Cluster 6 LUAD-like c10 miRNA cluster 6 TCGA-55-8203 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 69 R-Lower TCGA-55-8203-F47819 TCGA-55-8203 TCGA-55-8203-01A -25477 0 547 39 NO NO Scheduled Follow-up Submission Complete Remission/Response 2013-8-28 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 0.3 NO NO 0.4 NO NO 50 Yes, History of Prior Malignancy M0 N0 T1b Stage IA TCGA-55-8203.079475a1-b61d-4cb3-b1e1-a5a890d3073b.pdf 8203 TUMOR FREE 50 48 52 49 Complete Remission/Response YES NO R0 Primary Tumor 01 0.2 7th NO YES NO 55 2 Lung A LIVING 2011 26900eb0-165e-463e-84ad-51321287d2c3 26900eb0-165e-463e-84ad-51321287d2c3 TCGA-55-8203-01A-11D-2239-05 TCGA-55-8203-01A-11D-2237-01 26900eb0-165e-463e-84ad-51321287d2c3 TCGA-55-8203-01A-11D-2237-01 +TCGA-55-8204-01 TCGA-55-8204-01 Squamous Cluster 5 squamous-like c4 miRNA cluster 4 TCGA-55-8204 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 87 L-Upper TCGA-55-8204-F47802 TCGA-55-8204 TCGA-55-8204-01A -31818 0 515 101 Scheduled Follow-up Submission Complete Remission/Response 2013-8-28 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.2 NO 0.2 NO NO Yes, History of Prior Malignancy MX N0 T2a Stage IB TCGA-55-8204.e3a193f9-f815-4bd4-b5f5-0329d7d6e845.pdf 8204 TUMOR FREE 88 85 Complete Remission/Response YES NO R0 Primary Tumor 01 0.2 7th NO YES NO 55 3 Lung A LIVING 2011 cfa04d49-cec6-4454-b10e-8b4600485f12 cfa04d49-cec6-4454-b10e-8b4600485f12 TCGA-55-8204-01A-11D-2239-05 TCGA-55-8204-01A-11D-2237-01 cfa04d49-cec6-4454-b10e-8b4600485f12 TCGA-55-8204-01A-11D-2237-01 +TCGA-55-8205-01 TCGA-55-8205-01 Squamous Cluster 6 LUAD-like c10 miRNA cluster 4 TCGA-55-8205 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung YES YES NO 76 R-Lower TCGA-55-8205-F59040 TCGA-55-8205 TCGA-55-8205-01A -28063 0 599 495 0 YES NO Scheduled Follow-up Submission Progressive Disease 2014-4-30 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 1 NO 100 YES NO Central Lung 1.1 NO Distant Metastasis YES 30 Yes, History of Prior Malignancy M0 N0 T2b Stage IIA TCGA-55-8205.7a632c9d-4215-4d85-83df-30ce645d4e0c.pdf 8205 Preoperative WITH TUMOR 73 42 Progressive Disease Convincing Imaging YES NO R0 Primary Tumor 01 0.6 2012 7th YES YES NO 55 4 Lung A LIVING 2012 1951 96b3c91a-389e-48cc-9347-ed65fa70f3de 96b3c91a-389e-48cc-9347-ed65fa70f3de TCGA-55-8205-01A-11D-2239-05 TCGA-55-8205-01A-11D-2237-01 96b3c91a-389e-48cc-9347-ed65fa70f3de TCGA-55-8205-01A-11D-2237-01 +TCGA-55-8206-01 TCGA-55-8206-01 BRCA-LUAD+ Cluster 5 LUAD-like c10 miRNA cluster 5 TCGA-55-8206 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 56 R-Upper TCGA-55-8206-F65698 TCGA-55-8206 TCGA-55-8206-01A -20690 0 888 98 Scheduled Follow-up Submission Complete Remission/Response 2014-9-26 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.8 NO 0.9 NO NO No M0 N0 T1b Stage IA TCGA-55-8206.6a62aeff-3381-4ae5-8bb5-789542f8ce3c.pdf 8206 TUMOR FREE 104 84 Complete Remission/Response YES NO R0 Primary Tumor 01 0.5 7th NO YES NO 55 1 Lung A LIVING 2012 e6817dfb-7634-4321-9627-ce94feb46011 e6817dfb-7634-4321-9627-ce94feb46011 TCGA-55-8206-01A-11D-2239-05 TCGA-55-8206-01A-11D-2237-01 e6817dfb-7634-4321-9627-ce94feb46011 TCGA-55-8206-01A-11D-2237-01 +TCGA-55-8207-01 TCGA-55-8207-01 High Cluster 6 LUAD-like c10 miRNA cluster 4 TCGA-55-8207 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 73 L-Lower TCGA-55-8207-F65849 TCGA-55-8207 TCGA-55-8207-01A -26897 0 977 48 Scheduled Follow-up Submission Complete Remission/Response 2014-9-30 MALE Lung Acinar Adenocarcinoma No C34.3 8550/3 C34.3 YES 0.5 NO 0.9 NO NO Yes, History of Synchronous/Bilateral Malignancy MX N0 T2a Stage IB TCGA-55-8207.bf8af6e0-1ea5-4281-a00d-42aa138d781f.pdf 8207 TUMOR FREE 84 83 86 84 Complete Remission/Response YES NO R0 Primary Tumor 01 0.4 7th NO YES NO 55 3 Lung A LIVING 2011 7f0fe109-7153-46a8-81d7-2f132ee513f5 7f0fe109-7153-46a8-81d7-2f132ee513f5 TCGA-55-8207-01A-11D-2239-05 TCGA-55-8207-01A-11D-2237-01 7f0fe109-7153-46a8-81d7-2f132ee513f5 TCGA-55-8207-01A-11D-2237-01 +TCGA-55-8208-01 TCGA-55-8208-01 High Cluster 5 LUAD-like c10 miRNA cluster 7 TCGA-55-8208 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung YES YES 73 R-Upper TCGA-55-8208-F59045 TCGA-55-8208 TCGA-55-8208-01A 536 -26716 0 674 511 50 0 Scheduled Follow-up Submission Stable Disease 2014-4-30 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.6 NO 100 Peripheral Lung 1.4 YES Distant Metastasis YES 50 No M0 N0 T1b Stage IA TCGA-55-8208.9e4cf1b8-6628-4791-aa3c-2d7c42b3936b.pdf 8208 Preoperative WITH TUMOR 68 151 72 156 Complete Remission/Response Biopsy with Histologic Confirmation|Convincing Imaging YES NO R0 Primary Tumor 01 0.3 7th NO YES NO 55 2 Lung A LIVING 2012 dbeac9fe-cb6a-464c-9a96-d586797b1da0 dbeac9fe-cb6a-464c-9a96-d586797b1da0 TCGA-55-8208-01A-11D-2239-05 TCGA-55-8208-01A-11D-2237-01 dbeac9fe-cb6a-464c-9a96-d586797b1da0 TCGA-55-8208-01A-11D-2237-01 +TCGA-55-8299-01 TCGA-55-8299-01 Quiet Low purity c2 LUAD-like c10 miRNA cluster 4 TCGA-55-8299 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung NO YES NO NO 61 R-Upper TCGA-55-8299-F57915 TCGA-55-8299 TCGA-55-8299-01A -22626 469 0 216 274 Scheduled Follow-up Submission Progressive Disease 2014-3-28 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.3 NO 0.3 NO Distant Metastasis YES 20 No MX N0 T1b Stage IA TCGA-55-8299.a63e89aa-463d-4a53-9176-b4fd917e6416.pdf 8299 WITH TUMOR 75 74 Complete Remission/Response Convincing Imaging YES NO R0 Primary Tumor 01 0.1 2012 7th NO YES NO 55 4 Lung A DECEASED 2012 1971 f835bdde-2b5e-4013-a8d4-0074f66c9317 f835bdde-2b5e-4013-a8d4-0074f66c9317 TCGA-55-8299-01A-11D-2285-05 TCGA-55-8299-01A-11D-2283-01 f835bdde-2b5e-4013-a8d4-0074f66c9317 TCGA-55-8299-01A-11D-2283-01 +TCGA-55-8301-01 TCGA-55-8301-01 High Cluster 5 LUAD-like c10 miRNA cluster 4 TCGA-55-8301 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung YES YES NO NO 58 R-Lower TCGA-55-8301-F56261 TCGA-55-8301 TCGA-55-8301-01A -21535 0 534 238 Scheduled Follow-up Submission Partial Remission/Response 2014-1-30 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 0.3 NO 0.4 NO Locoregional Recurrence YES 100 No MX N0 T2a Stage IB TCGA-55-8301.55b2132a-ec1c-47a7-b91b-65f48c45fcb5.pdf 8301 WITH TUMOR Complete Remission/Response Convincing Imaging NO R0 Primary Tumor 01 0.1 7th NO YES NO 55 2 Lung A LIVING 2012 1962 aca30642-6479-4cfb-bcac-b9b5e45c5686 aca30642-6479-4cfb-bcac-b9b5e45c5686 TCGA-55-8301-01A-11D-2285-05 TCGA-55-8301-01A-11D-2283-01 aca30642-6479-4cfb-bcac-b9b5e45c5686 TCGA-55-8301-01A-11D-2283-01 +TCGA-55-8302-01 TCGA-55-8302-01 Cluster 6 miRNA cluster 4 TCGA-55-8302 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 54 R-Lower TCGA-55-8302-F56188 TCGA-55-8302 TCGA-55-8302-01A -20011 0 478 Scheduled Follow-up Submission Complete Remission/Response 2014-1-29 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 0.3 NO 0.3 NO NO 59 No MX N0 T2 Stage IB TCGA-55-8302.aa106e5a-b9b9-4f54-b902-120e8a3eb689.pdf 8302 TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 0.2 7th NO YES NO 55 2 Lung A LIVING 2012 1965 db0d3ef1-a8d7-4a5e-863e-f9e2717dee54 db0d3ef1-a8d7-4a5e-863e-f9e2717dee54 TCGA-55-8302-01A-11D-2324-05 TCGA-55-8302-01A-11D-2322-01 db0d3ef1-a8d7-4a5e-863e-f9e2717dee54 TCGA-55-8302-01A-11D-2322-01 +TCGA-55-8505-01 TCGA-55-8505-01 TCGA-55-8505 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 62 R-Lower TCGA-55-8505-F47798 TCGA-55-8505 TCGA-55-8505-01A -22676 0 440 Scheduled Follow-up Submission Complete Remission/Response 2013-8-28 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 0.7 NO 1.2 NO NO No MX N2 T1a Stage IIIA TCGA-55-8505.401f1ed0-5da9-442f-ac17-6394e72e88ae.pdf 8505 TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 0.4 7th YES YES NO 55 1 Lung A LIVING 2012 865eece0-5e69-4878-b504-af3eb071273d 865eece0-5e69-4878-b504-af3eb071273d TCGA-55-8505-01A-11D-2398-05 TCGA-55-8505-01A-11D-2389-01 865eece0-5e69-4878-b504-af3eb071273d TCGA-55-8505-01A-11D-2389-01 +TCGA-55-8506-01 TCGA-55-8506-01 TCGA-55-8506 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 62 R-Upper TCGA-55-8506 TCGA-55-8506-01A -22850 0 11 2012-12-28 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.7 NO Peripheral Lung 1.1 NO No MX N0 T3 Stage IIB TCGA-55-8506.448de79c-d662-4783-a7c8-32a224ee5375.pdf 8506 R0 Primary Tumor 01 0.4 7th YES NO 55 2 Lung A LIVING 2012 1972 db1370cf-7ca5-45ed-bba6-751f28e39825 db1370cf-7ca5-45ed-bba6-751f28e39825 TCGA-55-8506-01A-11D-2398-05 TCGA-55-8506-01A-11D-2389-01 db1370cf-7ca5-45ed-bba6-751f28e39825 TCGA-55-8506-01A-11D-2389-01 +TCGA-55-8507-01 TCGA-55-8507-01 TCGA-55-8507 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 53 R-Upper TCGA-55-8507-F48792 TCGA-55-8507 TCGA-55-8507-01A -19390 0 418 3 Scheduled Follow-up Submission Complete Remission/Response 2013-9-20 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.7 NO 40 Peripheral Lung 1 NO NO 120 No MX N0 T1a Stage IA TCGA-55-8507.2658f9b1-c419-42f1-944c-8148b00e13b0.pdf 8507 Other TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 0.4 7th NO YES NO 55 2 Lung A LIVING 2012 1972 758f95a1-8aca-43d0-aff2-39566606f88d 758f95a1-8aca-43d0-aff2-39566606f88d TCGA-55-8507-01A-11D-2398-05 TCGA-55-8507-01A-11D-2389-01 758f95a1-8aca-43d0-aff2-39566606f88d TCGA-55-8507-01A-11D-2389-01 +TCGA-55-8508-01 TCGA-55-8508-01 TCGA-55-8508 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 60 R-Upper TCGA-55-8508-F66137 TCGA-55-8508 TCGA-55-8508-01A -22159 0 617 2 Scheduled Follow-up Submission Complete Remission/Response 2014-10-3 FEMALE Mucinous (Colloid) Carcinoma No C34.1 8480/3 C34.1 YES 0.7 NO 60 Central Lung 1 NO NO No MX N1 T2a Stage IIA TCGA-55-8508.c5d96896-7988-469a-b521-39affeab8f95.pdf 8508 Preoperative TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 0.5 7th YES YES NO 55 2 Lung A LIVING 2012 5a4f0f21-a774-46cd-a5ba-525029761d94 5a4f0f21-a774-46cd-a5ba-525029761d94 TCGA-55-8508-01A-11D-2398-05 TCGA-55-8508-01A-11D-2389-01 5a4f0f21-a774-46cd-a5ba-525029761d94 TCGA-55-8508-01A-11D-2389-01 +TCGA-55-8510-01 TCGA-55-8510-01 TCGA-55-8510 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 55 R-Lower TCGA-55-8510-F57923 TCGA-55-8510 TCGA-55-8510-01A -20410 0 539 54 Scheduled Follow-up Submission Complete Remission/Response 2014-3-28 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 1 NO 1.2 NO NO No MX N0 T2a Stage IB TCGA-55-8510.54ad9f1a-326f-4cc6-991a-6717bfbaed35.pdf 8510 TUMOR FREE 90 70 98 70 Complete Remission/Response YES NO R0 Primary Tumor 01 0.4 7th NO YES NO 55 2 Lung A LIVING 2012 3088dac7-68b6-42f3-82eb-ff2bd451d7c5 3088dac7-68b6-42f3-82eb-ff2bd451d7c5 TCGA-55-8510-01A-11D-2398-05 TCGA-55-8510-01A-11D-2389-01 3088dac7-68b6-42f3-82eb-ff2bd451d7c5 TCGA-55-8510-01A-11D-2389-01 +TCGA-55-8511-01 TCGA-55-8511-01 TCGA-55-8511 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung NO NO 73 R-Upper TCGA-55-8511-F66028 TCGA-55-8511 TCGA-55-8511-01A -26986 0 552 460 31 2 Scheduled Follow-up Submission Progressive Disease 2014-10-1 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.7 NO 70 1.1 NO YES 58 Yes, History of Prior Malignancy MX N0 T2a Stage IB TCGA-55-8511.b44d3138-fbf3-4b0b-a082-606070f1c6b9.pdf 8511 Preoperative WITH TUMOR 82 53 Complete Remission/Response YES NO R0 Primary Tumor 01 0.5 7th NO YES NO 55 2 Lung A LIVING 2012 1953 db0a4e20-b5ad-4034-ae70-1e3747cdaa1f db0a4e20-b5ad-4034-ae70-1e3747cdaa1f TCGA-55-8511-01A-11D-2398-05 TCGA-55-8511-01A-11D-2389-01 db0a4e20-b5ad-4034-ae70-1e3747cdaa1f TCGA-55-8511-01A-11D-2389-01 +TCGA-55-8512-01 TCGA-55-8512-01 TCGA-55-8512 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 41 R-Lower TCGA-55-8512-F64286 TCGA-55-8512 TCGA-55-8512-01A -15266 607 0 3 1 Scheduled Follow-up Submission Progressive Disease 2014-8-28 MALE Lung Bronchioloalveolar Carcinoma Nonmucinous No C34.3 8252/3 C34.3 YES 1 NO 90 1 NO NO 19 No M1b N1 T1a Stage IV TCGA-55-8512.5146c0eb-7bbb-4160-a52f-c0d0ee34ff83.pdf 8512 Preoperative WITH TUMOR Progressive Disease NO NO R0 Primary Tumor 01 0.4 7th NO YES NO 55 2 Lung A DECEASED 2012 1989 e776b3c7-2afe-4f44-8596-4c0de62fd46d e776b3c7-2afe-4f44-8596-4c0de62fd46d TCGA-55-8512-01A-11D-2398-05 TCGA-55-8512-01A-11D-2389-01 e776b3c7-2afe-4f44-8596-4c0de62fd46d TCGA-55-8512-01A-11D-2389-01 +TCGA-55-8513-01 TCGA-55-8513-01 TCGA-55-8513 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung YES NO NO NO 77 L-Lower TCGA-55-8513-F64283 TCGA-55-8513 TCGA-55-8513-01A -28284 0 791 317 65 2 YES YES Scheduled Follow-up Submission Stable Disease 2014-8-28 FEMALE Mucinous (Colloid) Carcinoma No C34.30 8480/3 C34.3 YES 0.9 NO 60 1 NO Distant Metastasis YES No MX N0 T3 Stage IIB TCGA-55-8513.a93a99a9-075c-4bc4-9cf8-2d7fbc3e8d80.pdf 8513 Other WITH TUMOR 108 87 Complete Remission/Response Convincing Imaging YES NO R0 Primary Tumor 01 0.4 7th NO YES NO 55 1 Lung A LIVING 2012 518328ff-5705-456f-b71a-a194fc526653 518328ff-5705-456f-b71a-a194fc526653 TCGA-55-8513-01A-11D-2398-05 TCGA-55-8513-01A-11D-2389-01 518328ff-5705-456f-b71a-a194fc526653 TCGA-55-8513-01A-11D-2389-01 +TCGA-55-8514-01 TCGA-55-8514-01 TCGA-55-8514 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 70 R-Upper TCGA-55-8514-F57917 TCGA-55-8514 TCGA-55-8514-01A -25608 0 520 90 Scheduled Follow-up Submission Complete Remission/Response 2014-3-28 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.4 NO 0.5 NO NO 20 No MX N0 T2a Stage IB TCGA-55-8514.c2df4f99-8079-4900-98eb-b9117ef05467.pdf 8514 TUMOR FREE 114 85 Complete Remission/Response YES NO R0 Primary Tumor 01 0.3 2011 7th NO YES NO 55 4 Lung A LIVING 2012 1971 bdaceebb-1720-4ed0-b4e2-e3dec1d2335b bdaceebb-1720-4ed0-b4e2-e3dec1d2335b TCGA-55-8514-01A-11D-2398-05 TCGA-55-8514-01A-11D-2389-01 bdaceebb-1720-4ed0-b4e2-e3dec1d2335b TCGA-55-8514-01A-11D-2389-01 +TCGA-55-8614-01 TCGA-55-8614-01 TCGA-55-8614 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 76 L-Upper TCGA-55-8614-F47843 TCGA-55-8614 TCGA-55-8614-01A -27924 0 536 113 Scheduled Follow-up Submission Complete Remission/Response 2013-8-29 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.4 NO 0.7 NO NO 40 No MX N0 T2a Stage IB TCGA-55-8614.f443d31b-ee7f-4285-9529-6f04a8dad0d5.pdf 8614 TUMOR FREE 94 Complete Remission/Response YES NO R0 Primary Tumor 01 0.3 1995 7th NO YES NO 55 3 Lung A LIVING 2011 80c995f9-48bf-49a7-82ac-27d646b93e81 80c995f9-48bf-49a7-82ac-27d646b93e81 TCGA-55-8614-01A-11D-2398-05 TCGA-55-8614-01A-11D-2389-01 80c995f9-48bf-49a7-82ac-27d646b93e81 TCGA-55-8614-01A-11D-2389-01 +TCGA-55-8615-01 TCGA-55-8615-01 TCGA-55-8615 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung YES YES NO NO 67 R-Middle TCGA-55-8615-F56254 TCGA-55-8615 TCGA-55-8615-01A -24786 0 446 224 83 Scheduled Follow-up Submission Progressive Disease 2014-1-30 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.2 8140/3 C34.2 YES 0.9 NO 0.9 NO Distant Metastasis YES 67 No MX N2 T3 Stage IIIA TCGA-55-8615.37b4238a-1aea-4670-8c43-b24525b94cdd.pdf 8615 WITH TUMOR 88 Complete Remission/Response Convincing Imaging YES NO R0 Primary Tumor 01 0.6 7th YES YES NO 55 2 Lung A LIVING 2012 1966 50d1ad39-3545-422e-b8fa-440e68eeebf3 50d1ad39-3545-422e-b8fa-440e68eeebf3 TCGA-55-8615-01A-11D-2398-05 TCGA-55-8615-01A-11D-2389-01 50d1ad39-3545-422e-b8fa-440e68eeebf3 TCGA-55-8615-01A-11D-2389-01 +TCGA-55-8616-01 TCGA-55-8616-01 TCGA-55-8616 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 58 R-Upper TCGA-55-8616 TCGA-55-8616-01A -21225 0 48 0 2012-12-28 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.4 NO 0.5 NO No M0 N0 T2a Stage IB TCGA-55-8616.4506aced-56d2-4297-9a5c-40539f20be87.pdf 8616 Preoperative TUMOR FREE R0 Primary Tumor 01 0.2 1999 7th YES NO 55 4 Lung A LIVING 2012 78dd0304-d459-4d26-b0ba-39a8078c59d0 78dd0304-d459-4d26-b0ba-39a8078c59d0 TCGA-55-8616-01A-11D-2398-05 TCGA-55-8616-01A-11D-2389-01 78dd0304-d459-4d26-b0ba-39a8078c59d0 TCGA-55-8616-01A-11D-2389-01 +TCGA-55-8619-01 TCGA-55-8619-01 TCGA-55-8619 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 72 R-Lower TCGA-55-8619-F57919 TCGA-55-8619 TCGA-55-8619-01A -26616 0 416 Scheduled Follow-up Submission Complete Remission/Response 2014-3-28 FEMALE Mucinous (Colloid) Carcinoma No C34.30 8480/3 C34.3 YES 0.8 NO 90 1.2 NO NO Yes, History of Prior Malignancy MX N0 T3 Stage IIB TCGA-55-8619.dcbc1e01-c61a-4d30-b741-965c99418ecf.pdf 8619 Preoperative TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 0.6 7th NO YES NO 55 1 Lung A LIVING 2012 9d7459be-af93-4bf3-8d54-df569a16ee12 9d7459be-af93-4bf3-8d54-df569a16ee12 TCGA-55-8619-01A-11D-2398-05 TCGA-55-8619-01A-11D-2389-01 9d7459be-af93-4bf3-8d54-df569a16ee12 TCGA-55-8619-01A-11D-2389-01 +TCGA-55-8620-01 TCGA-55-8620-01 TCGA-55-8620 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 60 L-Upper TCGA-55-8620-F59081 TCGA-55-8620 TCGA-55-8620-01A -22091 375 0 66 64 2 NO NO Scheduled Follow-up Submission Progressive Disease 2014-4-30 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.8 NO 70 NO Central Lung 1 NO NO 154 No M1b N1 T1a Stage IV TCGA-55-8620.d74a185a-8e07-46ca-861e-14b0012ddf22.pdf 8620 Preoperative WITH TUMOR 73 76 Progressive Disease YES YES R0 Primary Tumor 01 0.5 2012 7th NO YES NO 55 4 Lung A DECEASED 2012 1965 777c61bc-aa43-4661-a1d3-7a2f07dc055a 777c61bc-aa43-4661-a1d3-7a2f07dc055a TCGA-55-8620-01A-11D-2398-05 TCGA-55-8620-01A-11D-2389-01 777c61bc-aa43-4661-a1d3-7a2f07dc055a TCGA-55-8620-01A-11D-2389-01 +TCGA-55-8621-01 TCGA-55-8621-01 TCGA-55-8621 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 75 L-Lower TCGA-55-8621-F48791 TCGA-55-8621 TCGA-55-8621-01A -27485 0 515 1 Scheduled Follow-up Submission Complete Remission/Response 2013-9-20 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 0.6 NO 90 0.7 NO NO 30 Yes, History of Prior Malignancy MX N0 T1a Stage IA TCGA-55-8621.22990911-a16f-4607-8722-c610ed1c590b.pdf 8621 Other TUMOR FREE 112 105 110 105 Complete Remission/Response YES NO R0 Primary Tumor 01 0.6 2010 7th NO YES NO 55 4 Lung A LIVING 2012 1980 7eb83c83-31e0-435b-8866-9d2764098800 7eb83c83-31e0-435b-8866-9d2764098800 TCGA-55-8621-01A-11D-2398-05 TCGA-55-8621-01A-11D-2389-01 7eb83c83-31e0-435b-8866-9d2764098800 TCGA-55-8621-01A-11D-2389-01 +TCGA-55-A48X-01 TCGA-55-A48X-01 TCGA-55-A48X TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung YES NO YES 63 L-Lower TCGA-55-A48X-F61500 TCGA-55-A48X TCGA-55-A48X-01A 615 -23341 111 0 689 615 79 Scheduled Follow-up Submission Complete Remission/Response 2014-6-30 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 30 NO NO New Primary Tumor YES 36 false Yes, History of Prior Malignancy M0 N1 T1b Stage IIA TCGA-55-A48X.4D06D10F-60F5-4417-BD8E-F2BBCA84BEEB.pdf A48X TUMOR FREE 57 Complete Remission/Response Biopsy with Histologic Confirmation YES NO R0 Primary Tumor 01 1999 7th YES YES NO 55 4 Lung A LIVING 2012 1963 439804ec-6110-4628-b3ea-fa807c346846 439804ec-6110-4628-b3ea-fa807c346846 TCGA-55-A48X-01A-11D-A24I-05 TCGA-55-A48X-01A-11D-A24C-01 439804ec-6110-4628-b3ea-fa807c346846 TCGA-55-A48X-01A-11D-A24C-01 +TCGA-55-A48Y-01 TCGA-55-A48Y-01 TCGA-55-A48Y TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 69 L-Lower TCGA-55-A48Y-F59057 TCGA-55-A48Y TCGA-55-A48Y-01A -25384 107 0 630 42 Scheduled Follow-up Submission Complete Remission/Response 2014-4-30 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 10 NO NO NO 50 false No M0 N0 T2b Stage IIA TCGA-55-A48Y.3542521A-EA16-4CD1-A61A-1FB3AE928FC9.pdf A48Y TUMOR FREE 38 Complete Remission/Response YES NO R0 Primary Tumor 01 7th YES YES NO 55 2 Lung A LIVING 2012 1962 3b576c81-9276-4177-90e9-355f641f734c 3b576c81-9276-4177-90e9-355f641f734c TCGA-55-A48Y-01A-11D-A24I-05 TCGA-55-A48Y-01A-11D-A24C-01 3b576c81-9276-4177-90e9-355f641f734c TCGA-55-A48Y-01A-11D-A24C-01 +TCGA-55-A48Z-01 TCGA-55-A48Z-01 TCGA-55-A48Z TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung NO YES NO NO 60 R-Upper TCGA-55-A48Z-F59061 TCGA-55-A48Z TCGA-55-A48Z-01A -22056 64 0 651 536 110 2 YES Other FISH YES Scheduled Follow-up Submission 2014-4-30 FEMALE Lung Adenocarcinoma Mixed Subtype No C34.1 8255/3 C34.1 YES 70 NO 70 YES NO Central Lung NO Distant Metastasis YES 40 false No MX N3 T1a Stage IIIB TCGA-55-A48Z.74C5526C-5300-4AEA-B2BB-1B78F9B536D9.pdf A48Z Preoperative WITH TUMOR 85 87 Stable Disease Convincing Imaging YES YES R0 Primary Tumor 01 2012 7th YES YES NO 55 4 Lung A LIVING 2012 1972 6499ffb8-c649-4881-8ca1-95d84842083b 6499ffb8-c649-4881-8ca1-95d84842083b TCGA-55-A48Z-01A-12D-A24U-05 TCGA-55-A48Z-01A-12D-A24O-01 6499ffb8-c649-4881-8ca1-95d84842083b TCGA-55-A48Z-01A-12D-A24O-01 +TCGA-55-A490-01 TCGA-55-A490-01 TCGA-55-A490 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 78 R-Upper TCGA-55-A490-F59076 TCGA-55-A490 TCGA-55-A490-01A -28728 77 99 0 48 40 1 YES FISH YES Scheduled Follow-up Submission 2014-4-30 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 10 NO 80 YES YES G12C Peripheral Lung NO NO 34 false No MX N0 T2b Stage IIA TCGA-55-A490.4A4BD086-ACA6-4E14-8BC0-4D2393FAD456.pdf A490 Preoperative TUMOR FREE 60 56 YES NO R0 Primary Tumor 01 1985 7th YES YES NO 55 3 Lung A DECEASED 2012 1951 abbff93f-d9f6-4db6-b769-6b4e36a7de0d abbff93f-d9f6-4db6-b769-6b4e36a7de0d TCGA-55-A490-01A-11D-A24I-05 TCGA-55-A490-01A-11D-A24C-01 abbff93f-d9f6-4db6-b769-6b4e36a7de0d TCGA-55-A490-01A-11D-A24C-01 +TCGA-55-A491-01 TCGA-55-A491-01 TCGA-55-A491 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 81 L-Lower TCGA-55-A491-F60134 TCGA-55-A491 TCGA-55-A491-01A -29593 31 0 626 68 2 NO NO Scheduled Follow-up Submission Complete Remission/Response 2014-5-29 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 10 NO 80 NO NO NO 45 false Yes, History of Prior Malignancy MX N0 T1b Stage IA TCGA-55-A491.EE286E94-9CDB-4E6C-A768-BB35DA870736.pdf A491 Other TUMOR FREE 73 68 72 64 Complete Remission/Response YES NO R0 Primary Tumor 01 1982 7th NO YES NO 55 3 Lung A LIVING 2012 1952 768f6ac0-d742-4dda-a695-c75070a5511a 768f6ac0-d742-4dda-a695-c75070a5511a TCGA-55-A491-01A-11D-A24I-05 TCGA-55-A491-01A-11D-A24C-01 768f6ac0-d742-4dda-a695-c75070a5511a TCGA-55-A491-01A-11D-A24C-01 +TCGA-55-A492-01 TCGA-55-A492-01 TCGA-55-A492 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 70 R-Upper TCGA-55-A492-F60135 TCGA-55-A492 TCGA-55-A492-01A -25719 31 0 596 52 2 NO NO Scheduled Follow-up Submission Complete Remission/Response 2014-5-29 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 50 NO 80 NO NO NO 35 false Yes, History of Prior Malignancy MX N0 T1a Stage IA TCGA-55-A492.41F07E95-2D84-47CB-B78D-8F03D9C3D80E.pdf A492 Other TUMOR FREE 92 95 Complete Remission/Response YES NO R0 Primary Tumor 01 1995 7th NO YES NO 55 3 Lung A LIVING 2012 1962 ba477731-a4c6-4e1c-b44c-1964672a777c ba477731-a4c6-4e1c-b44c-1964672a777c TCGA-55-A492-01A-11D-A24I-05 TCGA-55-A492-01A-11D-A24C-01 ba477731-a4c6-4e1c-b44c-1964672a777c TCGA-55-A492-01A-11D-A24C-01 +TCGA-55-A493-01 TCGA-55-A493-01 TCGA-55-A493 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 54 R-Upper TCGA-55-A493 TCGA-55-A493-01A -20027 77 0 28 102 NO NO 2013-2-21 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 70 NO NO NO 53 false No M0 N0 T2a Stage IB TCGA-55-A493.B22D9414-01C4-4042-97E5-3C8B2DF9AD97.pdf A493 TUMOR FREE 71 2 65 2 NO R0 Primary Tumor 01 7th YES NO 55 2 Lung A LIVING 2012 1977 ca04916e-5edc-4481-81d0-b0cc56925005 ca04916e-5edc-4481-81d0-b0cc56925005 TCGA-55-A493-01A-11D-A24I-05 TCGA-55-A493-01A-11D-A24C-01 ca04916e-5edc-4481-81d0-b0cc56925005 TCGA-55-A493-01A-11D-A24C-01 +TCGA-55-A494-01 TCGA-55-A494-01 TCGA-55-A494 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 61 R-Lower TCGA-55-A494-F59038 TCGA-55-A494 TCGA-55-A494-01A -22540 28 0 481 76 1 YES FISH YES Scheduled Follow-up Submission Complete Remission/Response 2014-4-30 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 60 NO 80 YES YES G12D Peripheral Lung NO NO 7 false No MX N0 T2a Stage IB TCGA-55-A494.6FB7C18D-27D8-4C04-B8F8-AA7EA16F8C8A.pdf A494 Preoperative TUMOR FREE 95 77 Complete Remission/Response YES NO R0 Primary Tumor 01 1980 7th NO YES NO 55 3 Lung A LIVING 2012 1967 5e532c06-5ffc-4f37-9792-2ce23146d15e 5e532c06-5ffc-4f37-9792-2ce23146d15e TCGA-55-A494-01A-11D-A24U-05 TCGA-55-A494-01A-11D-A24O-01 5e532c06-5ffc-4f37-9792-2ce23146d15e TCGA-55-A494-01A-11D-A24O-01 +TCGA-55-A4DF-01 TCGA-55-A4DF-01 TCGA-55-A4DF TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung NO YES NO NO 88 R-Lower TCGA-55-A4DF-F59072 TCGA-55-A4DF TCGA-55-A4DF-01A -32432 113 614 0 47 515 82 Scheduled Follow-up Submission Progressive Disease 2014-4-30 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 60 NO NO Distant Metastasis YES 60 false Yes, History of Synchronous/Bilateral Malignancy MX N0 T1b Stage IA TCGA-55-A4DF.25E84F93-E9AF-4A09-B3A9-86C5AC80BD4A.pdf A4DF WITH TUMOR 58 47 Complete Remission/Response Convincing Imaging YES NO R0 Primary Tumor 01 1984 7th NO YES NO 55 3 Lung A DECEASED 2012 bf1fd845-aa87-49e7-8bd9-1443d6a3799c bf1fd845-aa87-49e7-8bd9-1443d6a3799c TCGA-55-A4DF-01A-11D-A24I-05 TCGA-55-A4DF-01A-11D-A24C-01 bf1fd845-aa87-49e7-8bd9-1443d6a3799c TCGA-55-A4DF-01A-11D-A24C-01 +TCGA-55-A4DG-01 TCGA-55-A4DG-01 TCGA-55-A4DG TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 71 R-Upper TCGA-55-A4DG-F59047 TCGA-55-A4DG TCGA-55-A4DG-01A -26044 229 0 608 61 Scheduled Follow-up Submission Complete Remission/Response 2014-4-30 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 50 NO NO NO 100 false No MX N0 T1b Stage IA TCGA-55-A4DG.E1EA2600-CEEE-4009-A2E7-D845153DB167.pdf A4DG TUMOR FREE 73 Complete Remission/Response YES NO R0 Primary Tumor 01 2012 7th NO YES NO 55 4 Lung A LIVING 2012 1dd50bb6-84d4-4e07-ba01-802f470b46dd 1dd50bb6-84d4-4e07-ba01-802f470b46dd TCGA-55-A4DG-01A-11D-A24I-05 TCGA-55-A4DG-01A-11D-A24C-01 1dd50bb6-84d4-4e07-ba01-802f470b46dd TCGA-55-A4DG-01A-11D-A24C-01 +TCGA-55-A57B-01 TCGA-55-A57B-01 TCGA-55-A57B TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 80 L-Upper TCGA-55-A57B-F60133 TCGA-55-A57B TCGA-55-A57B-01A -29452 64 0 546 77 0 NO NO Scheduled Follow-up Submission Complete Remission/Response 2014-5-29 FEMALE Lung Adenocarcinoma Mixed Subtype No C34.1 8255/3 C34.1 YES 70 NO 90 NO Peripheral Lung NO NO false No M0 N0 T1b Stage IA TCGA-55-A57B.8231F2AB-F7AC-4866-BFA0-F902E2EC18B4.pdf A57B Preoperative TUMOR FREE 99 114 Complete Remission/Response YES NO R0 Primary Tumor 01 7th NO YES NO 55 1 Lung A LIVING 2012 9c08d387-1d4f-4aee-a985-04cb01fc2b07 9c08d387-1d4f-4aee-a985-04cb01fc2b07 TCGA-55-A57B-01A-12D-A398-05 TCGA-55-A57B-01A-12D-A396-01 9c08d387-1d4f-4aee-a985-04cb01fc2b07 TCGA-55-A57B-01A-12D-A396-01 +TCGA-56-1622-01 TCGA-56-1622-01 High C2-Squamous-like Cluster 5 squamous-like c4 miRNA cluster 4 mutation cluster 13 TCGA-56-1622 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 58 R-Lower TCGA-56-1622-F4096 TCGA-56-1622 TCGA-56-1622-01A -21371 881 0 2010-2-3 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.6 NO 0.9 NO 86 No M0 N0 T2 Stage IB TCGA-56-1622.8b6c2041-dff4-4ce6-bbd1-683736983803.pdf 1622 WITH TUMOR Complete Remission/Response NO R0 Primary Tumor 01 0.4 2006 NO YES NO 56 4 Lung A DECEASED 2007 1962 e912b601-aff4-49e1-924f-44d242699608 TCGA-56-1622-01A-01D-0689-05 TCGA-56-1622-01A-01D-1521-08 e912b601-aff4-49e1-924f-44d242699608 TCGA-56-1622-01A-01D-0685-01 TCGA-56-1622-01A-01R-0692-07 e912b601-aff4-49e1-924f-44d242699608 TCGA-56-1622-01A-01D-0685-01 +TCGA-56-5897-01 TCGA-56-5897-01 Squamous C2-Squamous-like Low purity c2 squamous c3 squamous-like c4 mutation cluster 5 TCGA-56-5897 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 74 R-Upper TCGA-56-5897-F43197 TCGA-56-5897 TCGA-56-5897-01A -27118 0 378 Scheduled Follow-up Submission Complete Remission/Response 2013-5-15 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.4 NO 0.6 NO NO No MX N0 T1b Stage IA TCGA-56-5897.8efc19c8-ab28-4ff9-a2c6-4caefe60d0f2.pdf 5897 TUMOR FREE Complete Remission/Response NO Primary Tumor 01 0.2 1983 7th NO NO YES 56 3 Lung A LIVING 2010 31137a90-0e02-4c48-80c1-14c882eff26f TCGA-56-5897-01A-11D-1632-08 31137a90-0e02-4c48-80c1-14c882eff26f TCGA-56-5897-01A-11D-1633-05 TCGA-56-5897-01A-11D-1631-01 31137a90-0e02-4c48-80c1-14c882eff26f TCGA-56-5897-01A-11D-1631-01 TCGA-56-5897-01A-12-2194-20 +TCGA-56-5898-01 TCGA-56-5898-01 Squamous C2-Squamous-like Cluster 13 (HNSC-LUSC) squamous c3 squamous-like c4 mutation cluster 8 TCGA-56-5898 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 69 R-Upper TCGA-56-5898-F43198 TCGA-56-5898 TCGA-56-5898-01A -25441 0 555 Scheduled Follow-up Submission Complete Remission/Response 2013-5-15 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.6 NO 0.8 NO NO No M0 N0 T1b Stage IA TCGA-56-5898.04ca3e3e-ca70-4616-b7ba-8d48d88007bd.pdf 5898 TUMOR FREE Complete Remission/Response NO NO R0 Primary Tumor 01 0.3 7th NO NO YES 56 2 Lung A LIVING 2010 1955 2589ea8d-6306-4460-999f-c87a4b005420 TCGA-56-5898-01A-11D-1632-08 2589ea8d-6306-4460-999f-c87a4b005420 TCGA-56-5898-01A-11D-1633-05 TCGA-56-5898-01A-11D-1631-01 2589ea8d-6306-4460-999f-c87a4b005420 TCGA-56-5898-01A-11D-1631-01 TCGA-56-5898-01A-12-2194-20 +TCGA-56-6545-01 TCGA-56-6545-01 High C2-Squamous-like Cluster 5 squamous c3 squamous-like c4 miRNA cluster 5 mutation cluster 13 TCGA-56-6545 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 77 R-Upper TCGA-56-6545-F46625 TCGA-56-6545 TCGA-56-6545-01A -28400 0 666 Scheduled Follow-up Submission Complete Remission/Response 2013-8-13 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.8 NO 1 NO NO No M0 N0 T2a Stage IB TCGA-56-6545.526beb21-7ffd-4d23-a870-47fcc5ec6b73.pdf 6545 TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 0.3 1996 7th NO YES NO 56 4 Lung A LIVING 2010 1952 2e6e7411-9875-418e-97a7-8fd61866d5a6 TCGA-56-6545-01A-11D-1817-08 2e6e7411-9875-418e-97a7-8fd61866d5a6 TCGA-56-6545-01A-11D-1818-05 TCGA-56-6545-01A-11D-1816-01 2e6e7411-9875-418e-97a7-8fd61866d5a6 TCGA-56-6545-01A-11D-1816-01 TCGA-56-6545-01A-13-2194-20 +TCGA-56-6546-01 TCGA-56-6546-01 High C1-LUAD-enriched Cluster 5 squamous c3 RNA cluster 2 miRNA cluster 5 mutation cluster 13 TCGA-56-6546 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 67 R-Upper TCGA-56-6546-F45631 TCGA-56-6546 TCGA-56-6546-01A -24594 [Discrepancy] 0 [Discrepancy] Scheduled Follow-up Submission 2013-7-17 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.7 NO 0.9 NO NO No MX N0 T2b Stage IIA TCGA-56-6546.6bf4b1cb-22c2-45ec-b45f-9ccf5db582fe.pdf 6546 TUMOR FREE YES NO Primary Tumor 01 0.4 2011 7th NO YES NO 56 4 Lung A DECEASED 2011 1954 8578f1c0-bec8-467e-9426-b2f18071eca8 TCGA-56-6546-01A-11D-1817-08 8578f1c0-bec8-467e-9426-b2f18071eca8 TCGA-56-6546-01A-11D-1818-05 TCGA-56-6546-01A-11D-1816-01 8578f1c0-bec8-467e-9426-b2f18071eca8 TCGA-56-6546-01A-11D-1816-01 TCGA-56-6546-01A-13-2194-20 +TCGA-56-7221-01 TCGA-56-7221-01 Squamous C2-Squamous-like Cluster 5 squamous c3 squamous-like c4 miRNA cluster 11 TCGA-56-7221 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 79 R-Lower TCGA-56-7221-F47791 TCGA-56-7221 TCGA-56-7221-01A -28873 0 608 Scheduled Follow-up Submission Complete Remission/Response 2013-8-28 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.7 NO 0.8 NO NO 25 Yes M0 N0 T2 Stage IB TCGA-56-7221.9c136f18-c53c-45f8-b20f-850086ee0f55.pdf 7221 TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 0.2 1982 7th NO YES NO 56 3 Lung A LIVING 2011 6d9dfd56-1006-46b7-89c0-efba05fe13e3 6d9dfd56-1006-46b7-89c0-efba05fe13e3 TCGA-56-7221-01A-11D-2043-05 TCGA-56-7221-01A-11D-2041-01 6d9dfd56-1006-46b7-89c0-efba05fe13e3 TCGA-56-7221-01A-11D-2041-01 TCGA-56-7221-01A-13-2195-20 +TCGA-56-7222-01 TCGA-56-7222-01 Squamous C2-Squamous-like Cluster 13 (HNSC-LUSC) squamous c3 squamous-like c4 miRNA cluster 4 TCGA-56-7222 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung YES NO NO NO 60 R-Upper TCGA-56-7222-F47055 TCGA-56-7222 TCGA-56-7222-01A -22097 562 0 13 427 62 3 NO NO Scheduled Follow-up Submission Progressive Disease 2013-8-21 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 1.3 NO 70 NO Central Lung 1.4 NO YES 23 No M0 N0 T2a Stage IB TCGA-56-7222.46f2eec5-0507-4d1b-83a5-2206d68e635d.pdf 7222 Preoperative WITH TUMOR 97 64 95 58 Complete Remission/Response YES NO Primary Tumor 01 0.2 7th YES YES NO 56 2 Lung A DECEASED 2011 1963 13daa1a0-a236-474e-b621-eb131be34af1 13daa1a0-a236-474e-b621-eb131be34af1 TCGA-56-7222-01A-11D-2043-05 TCGA-56-7222-01A-11D-2041-01 13daa1a0-a236-474e-b621-eb131be34af1 TCGA-56-7222-01A-11D-2041-01 TCGA-56-7222-01A-13-2195-20 +TCGA-56-7222-11 TCGA-56-7222-11 C2-Squamous-like TCGA-56-7222 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung YES NO NO NO 60 R-Upper TCGA-56-7222-F47055 TCGA-56-7222 TCGA-56-7222-11A -22097 562 0 13 427 62 3 NO NO Scheduled Follow-up Submission Progressive Disease 2013-8-21 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 1 NO 70 NO Central Lung 1.3 NO YES 23 No M0 N0 T2a Stage IB 7222 Preoperative WITH TUMOR 97 64 95 58 Complete Remission/Response YES NO Solid Tissue Normal 11 0.3 7th YES YES NO 56 2 Lung A DECEASED 2011 1963 0241c7d8-a820-421e-821e-291d4575a121 0241c7d8-a820-421e-821e-291d4575a121 0241c7d8-a820-421e-821e-291d4575a121 +TCGA-56-7223-01 TCGA-56-7223-01 BRCA-LUAD+ Cluster 13 (HNSC-LUSC) RNA cluster 3 miRNA cluster 12 TCGA-56-7223 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung YES NO NO 66 R-Lower TCGA-56-7223-F65844 TCGA-56-7223 TCGA-56-7223-01A -24288 442 0 30 132 Scheduled Follow-up Submission Progressive Disease 2014-9-30 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.8 8070/3 C34.8 YES 0.2 NO 0.5 NO Locoregional Recurrence YES No MX N1 T3 Stage IIIA TCGA-56-7223.58b457c7-7273-4cc2-8eb9-5d14c01ebb45.pdf 7223 WITH TUMOR Progressive Disease Convincing Imaging NO R0 Primary Tumor 01 0.1 2011 7th NO YES NO 56 4 Lung A DECEASED 2011 659acaaf-d086-4066-8d30-7e33de4b8825 659acaaf-d086-4066-8d30-7e33de4b8825 TCGA-56-7223-01A-11D-2043-05 TCGA-56-7223-01A-11D-2041-01 659acaaf-d086-4066-8d30-7e33de4b8825 TCGA-56-7223-01A-11D-2041-01 +TCGA-56-7579-01 TCGA-56-7579-01 Squamous Cluster 13 (HNSC-LUSC) squamous-like c4 miRNA cluster 11 TCGA-56-7579 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung YES NO 61 L-Upper TCGA-56-7579-F60112 TCGA-56-7579 TCGA-56-7579-01A -22632 951 0 44 149 Scheduled Follow-up Submission Progressive Disease 2014-5-29 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.2 NO 0.3 NO Locoregional Recurrence YES 2 No M0 N1 T3 Stage IIIA TCGA-56-7579.fd7a1de0-aa43-4d5a-b1e4-67473689bd58.pdf 7579 WITH TUMOR Progressive Disease Convincing Imaging YES R0 Primary Tumor 01 0.2 2003 7th YES YES NO 56 4 Lung A DECEASED 2011 1986 e28b7dfd-d7ba-4645-bf2e-f4a5aa3873f7 e28b7dfd-d7ba-4645-bf2e-f4a5aa3873f7 TCGA-56-7579-01A-11D-2043-05 TCGA-56-7579-01A-11D-2041-01 e28b7dfd-d7ba-4645-bf2e-f4a5aa3873f7 TCGA-56-7579-01A-11D-2041-01 +TCGA-56-7579-11 TCGA-56-7579-11 TCGA-56-7579 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung YES NO 61 L-Upper TCGA-56-7579-F60112 TCGA-56-7579 TCGA-56-7579-11A -22632 951 0 44 149 Scheduled Follow-up Submission Progressive Disease 2014-5-29 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.9 NO 1 NO Locoregional Recurrence YES 2 No M0 N1 T3 Stage IIIA 7579 WITH TUMOR Progressive Disease Convincing Imaging YES R0 Solid Tissue Normal 11 0.3 2003 7th YES YES NO 56 4 Lung A DECEASED 2011 1986 f98e6150-605d-4d37-9add-b6da6eb19928 f98e6150-605d-4d37-9add-b6da6eb19928 f98e6150-605d-4d37-9add-b6da6eb19928 +TCGA-56-7580-01 TCGA-56-7580-01 Squamous Cluster 5 squamous-like c4 miRNA c1uster 9 TCGA-56-7580 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 84 L-Lower TCGA-56-7580-F56184 TCGA-56-7580 TCGA-56-7580-01A -30740 0 925 Scheduled Follow-up Submission Complete Remission/Response 2014-1-29 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.1 NO 0.3 NO NO No M0 N0 T2a Stage IB TCGA-56-7580.b1697486-2a16-4466-8f2f-7f2cb7676563.pdf 7580 TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 0.1 1985 7th NO YES NO 56 3 Lung A LIVING 2011 1947 cd804abb-1eb2-462b-bbe1-045e3f29569f cd804abb-1eb2-462b-bbe1-045e3f29569f TCGA-56-7580-01A-11D-2043-05 TCGA-56-7580-01A-11D-2041-01 cd804abb-1eb2-462b-bbe1-045e3f29569f TCGA-56-7580-01A-11D-2041-01 +TCGA-56-7580-11 TCGA-56-7580-11 TCGA-56-7580 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 84 L-Lower TCGA-56-7580-F56184 TCGA-56-7580 TCGA-56-7580-11A -30740 0 925 Scheduled Follow-up Submission Complete Remission/Response 2014-1-29 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 1 NO 1.1 NO NO No M0 N0 T2a Stage IB 7580 TUMOR FREE Complete Remission/Response NO R0 Solid Tissue Normal 11 0.5 1985 7th NO YES NO 56 3 Lung A LIVING 2011 1947 0ddf6059-1ce0-4bac-bea9-8106a4dc764e 0ddf6059-1ce0-4bac-bea9-8106a4dc764e 0ddf6059-1ce0-4bac-bea9-8106a4dc764e +TCGA-56-7582-01 TCGA-56-7582-01 Squamous Cluster 13 (HNSC-LUSC) squamous-like c4 miRNA cluster 4 TCGA-56-7582 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 83 R-Lower TCGA-56-7582-F57031 TCGA-56-7582 TCGA-56-7582-01A -30678 0 601 Scheduled Follow-up Submission Complete Remission/Response 2014-2-28 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.2 NO 100 0.5 NO NO No M0 N0 T2a Stage IB TCGA-56-7582.f7a77662-4bab-47e4-8768-4d9e62891531.pdf 7582 Post-Adjuvant Therapy TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 0.2 1995 7th NO YES NO 56 3 Lung A LIVING 2011 78ed13d4-1578-46b8-81fa-b4395643691d 78ed13d4-1578-46b8-81fa-b4395643691d TCGA-56-7582-01A-11D-2043-05 TCGA-56-7582-01A-11D-2041-01 78ed13d4-1578-46b8-81fa-b4395643691d TCGA-56-7582-01A-11D-2041-01 +TCGA-56-7582-11 TCGA-56-7582-11 TCGA-56-7582 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 83 R-Lower TCGA-56-7582-F57031 TCGA-56-7582 TCGA-56-7582-11A -30678 0 601 Scheduled Follow-up Submission Complete Remission/Response 2014-2-28 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.4 NO 100 0.6 NO NO No M0 N0 T2a Stage IB 7582 Post-Adjuvant Therapy TUMOR FREE Complete Remission/Response NO R0 Solid Tissue Normal 11 0.2 1995 7th NO YES NO 56 3 Lung A LIVING 2011 670b4f33-2935-45c1-99b1-57660da763bb 670b4f33-2935-45c1-99b1-57660da763bb 670b4f33-2935-45c1-99b1-57660da763bb +TCGA-56-7730-01 TCGA-56-7730-01 Squamous Cluster 13 (HNSC-LUSC) squamous c3 miRNA cluster 11 TCGA-56-7730 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 73 R-Upper TCGA-56-7730-F64295 TCGA-56-7730 TCGA-56-7730-01A -26699 198 0 6 59 Scheduled Follow-up Submission Progressive Disease 2014-8-28 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.4 NO NO Peripheral Lung 1 NO NO No M0 N0 T2b Stage IIA TCGA-56-7730.a8561dcf-b71e-4f28-a8bb-f0ce96066934.pdf 7730 WITH TUMOR 76 72 Progressive Disease YES YES R1 Primary Tumor 01 0.2 7th YES YES NO 56 2 Lung A DECEASED 2011 a632cbdb-7a01-42e2-8118-20103917cc8e a632cbdb-7a01-42e2-8118-20103917cc8e TCGA-56-7730-01A-11D-2123-05 TCGA-56-7730-01A-11D-2121-01 a632cbdb-7a01-42e2-8118-20103917cc8e TCGA-56-7730-01A-11D-2121-01 TCGA-56-7730-01A-13-2195-20 +TCGA-56-7730-11 TCGA-56-7730-11 TCGA-56-7730 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 73 R-Upper TCGA-56-7730-F64295 TCGA-56-7730 TCGA-56-7730-11A -26699 198 0 6 59 Scheduled Follow-up Submission Progressive Disease 2014-8-28 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.7 NO NO Peripheral Lung 0.8 NO NO No M0 N0 T2b Stage IIA 7730 WITH TUMOR 76 72 Progressive Disease YES YES R1 Solid Tissue Normal 11 0.5 7th YES YES NO 56 2 Lung A DECEASED 2011 dc660b3d-255f-4239-8368-b21149caa61c dc660b3d-255f-4239-8368-b21149caa61c dc660b3d-255f-4239-8368-b21149caa61c +TCGA-56-7731-01 TCGA-56-7731-01 Squamous Cluster 5 miRNA c1uster 9 TCGA-56-7731 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 66 R-Upper TCGA-56-7731-F56183 TCGA-56-7731 TCGA-56-7731-01A -24441 3 0 0 59 Scheduled Follow-up Submission 2014-1-29 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.3 NO 0.3 NO NO 100 No MX N0 T2a Stage IB TCGA-56-7731.afdaabb6-b65a-44b9-867f-b22c405df456.pdf 7731 TUMOR FREE 71 67 71 64 YES NO Primary Tumor 01 0.1 2011 7th NO YES NO 56 4 Lung A DECEASED 2011 1961 3f846f2e-41c5-4ce9-bccb-8142cbc76525 3f846f2e-41c5-4ce9-bccb-8142cbc76525 TCGA-56-7731-01A-11D-2123-05 TCGA-56-7731-01A-11D-2121-01 3f846f2e-41c5-4ce9-bccb-8142cbc76525 TCGA-56-7731-01A-11D-2121-01 +TCGA-56-7731-11 TCGA-56-7731-11 TCGA-56-7731 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 66 R-Upper TCGA-56-7731-F56183 TCGA-56-7731 TCGA-56-7731-11A -24441 3 0 0 59 Scheduled Follow-up Submission 2014-1-29 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.7 NO 0.7 NO NO 100 No MX N0 T2a Stage IB 7731 TUMOR FREE 71 67 71 64 YES NO Solid Tissue Normal 11 0.3 2011 7th NO YES NO 56 4 Lung A DECEASED 2011 1961 2952091b-1093-44b4-aa09-8aeefb609365 2952091b-1093-44b4-aa09-8aeefb609365 2952091b-1093-44b4-aa09-8aeefb609365 +TCGA-56-7822-01 TCGA-56-7822-01 Squamous Cluster 5 squamous-like c4 miRNA cluster 11 TCGA-56-7822 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung YES YES NO NO 75 R-Upper TCGA-56-7822-F66152 TCGA-56-7822 TCGA-56-7822-01A -27755 532 0 1 301 42 1 Scheduled Follow-up Submission Progressive Disease 2014-10-3 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.3 NO 80 0.4 NO YES 60 No M0 N1 T2b Stage IIB TCGA-56-7822.53197469-7424-4f46-b67c-b16364e8df79.pdf 7822 Preoperative WITH TUMOR 91 86 93 91 YES R0 Primary Tumor 01 0.2 2011 7th YES NO 56 4 Lung A DECEASED 2011 765af249-7e13-4b85-815d-081801889982 765af249-7e13-4b85-815d-081801889982 TCGA-56-7822-01A-11D-2123-05 TCGA-56-7822-01A-11D-2121-01 765af249-7e13-4b85-815d-081801889982 TCGA-56-7822-01A-11D-2121-01 +TCGA-56-7823-01 TCGA-56-7823-01 Squamous Cluster 13 (HNSC-LUSC) miRNA cluster 11 TCGA-56-7823 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 58 R-Upper TCGA-56-7823-F60128 TCGA-56-7823 TCGA-56-7823-01B -21344 0 1011 43 1 Scheduled Follow-up Submission Complete Remission/Response 2014-5-29 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.2 NO 90 NO 0.2 NO NO 80 No M0 N1 T1b Stage IIA TCGA-56-7823.6b37394d-c1fa-4e01-86c7-4aa00588eba9.pdf 7823 Other TUMOR FREE 69 76 78 73 Complete Remission/Response YES NO Primary Tumor 01 0.2 2008 7th YES YES NO 56 4 Lung B LIVING 2011 1968 f3c5b879-2ca4-4d16-972b-6ed8f82b97a1 f3c5b879-2ca4-4d16-972b-6ed8f82b97a1 TCGA-56-7823-01B-11D-2245-05 TCGA-56-7823-01B-11D-2243-01 f3c5b879-2ca4-4d16-972b-6ed8f82b97a1 TCGA-56-7823-01B-11D-2243-01 +TCGA-56-7823-11 TCGA-56-7823-11 TCGA-56-7823 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 58 R-Upper TCGA-56-7823-F60128 TCGA-56-7823 TCGA-56-7823-11A -21344 0 1011 43 1 Scheduled Follow-up Submission Complete Remission/Response 2014-5-29 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.3 NO 90 NO 0.3 NO NO 80 No M0 N1 T1b Stage IIA 7823 Other TUMOR FREE 69 76 78 73 Complete Remission/Response YES NO Solid Tissue Normal 11 0.3 2008 7th YES YES NO 56 4 Lung A LIVING 2011 1968 3a627bd6-6f7e-4dca-a480-71eeb76e03b0 3a627bd6-6f7e-4dca-a480-71eeb76e03b0 3a627bd6-6f7e-4dca-a480-71eeb76e03b0 +TCGA-56-8082-01 TCGA-56-8082-01 High Cluster 5 miRNA cluster 11 TCGA-56-8082 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 80 R-Lower TCGA-56-8082-F47790 TCGA-56-8082 TCGA-56-8082-01A -29440 0 455 1 Scheduled Follow-up Submission Complete Remission/Response 2013-8-28 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.8 NO 0.9 NO NO No MX N0 T2b Stage IIA TCGA-56-8082.0dba1129-8d66-465d-9ab7-6b42515442f0.pdf 8082 Other TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 0.5 7th NO YES NO 56 3 Lung A LIVING 2011 4ec591d8-c168-4541-a685-f009d0c3da38 4ec591d8-c168-4541-a685-f009d0c3da38 TCGA-56-8082-01A-11D-2245-05 TCGA-56-8082-01A-11D-2243-01 4ec591d8-c168-4541-a685-f009d0c3da38 TCGA-56-8082-01A-11D-2243-01 +TCGA-56-8082-11 TCGA-56-8082-11 TCGA-56-8082 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 80 R-Lower TCGA-56-8082-F47790 TCGA-56-8082 TCGA-56-8082-11A -29440 0 455 1 Scheduled Follow-up Submission Complete Remission/Response 2013-8-28 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.6 NO 1 NO NO No MX N0 T2b Stage IIA 8082 Other TUMOR FREE Complete Remission/Response NO R0 Solid Tissue Normal 11 0.3 7th NO YES NO 56 3 Lung A LIVING 2011 089dccc0-b701-4b4e-ae11-82ec54b42c39 089dccc0-b701-4b4e-ae11-82ec54b42c39 089dccc0-b701-4b4e-ae11-82ec54b42c39 +TCGA-56-8083-01 TCGA-56-8083-01 Squamous Cluster 5 miRNA c1uster 9 TCGA-56-8083 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 56 L-Upper TCGA-56-8083-F65848 TCGA-56-8083 TCGA-56-8083-01A -20696 0 150 95 Scheduled Follow-up Submission 2014-9-30 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.8 NO 1 YES NO 30 No MX N0 T2a Stage IB TCGA-56-8083.9ec3009b-f666-48bc-acd6-ac15ff81eb44.pdf 8083 TUMOR FREE 109 83 YES R0 Primary Tumor 01 0.4 2000 7th YES NO 56 4 Lung A LIVING 2011 06460d4f-a32d-4e68-a02b-e047d491c3a5 06460d4f-a32d-4e68-a02b-e047d491c3a5 TCGA-56-8083-01A-11D-2245-05 TCGA-56-8083-01A-11D-2243-01 06460d4f-a32d-4e68-a02b-e047d491c3a5 TCGA-56-8083-01A-11D-2243-01 +TCGA-56-8083-11 TCGA-56-8083-11 TCGA-56-8083 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 56 L-Upper TCGA-56-8083-F65848 TCGA-56-8083 TCGA-56-8083-11A -20696 0 150 95 Scheduled Follow-up Submission 2014-9-30 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.5 NO 0.7 YES NO 30 No MX N0 T2a Stage IB 8083 TUMOR FREE 109 83 YES R0 Solid Tissue Normal 11 0.5 2000 7th YES NO 56 4 Lung A LIVING 2011 cabf7b00-4cb0-4873-a632-a5ffc72df2c8 cabf7b00-4cb0-4873-a632-a5ffc72df2c8 cabf7b00-4cb0-4873-a632-a5ffc72df2c8 +TCGA-56-8201-01 TCGA-56-8201-01 Squamous Cluster 14 (HNSC) miRNA cluster 4 TCGA-56-8201 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 74 R-Upper TCGA-56-8201-F65845 TCGA-56-8201 TCGA-56-8201-01A -27211 397 0 28 Scheduled Follow-up Submission Progressive Disease 2014-9-30 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.4 NO 0.7 NO YES Yes, History of Prior Malignancy MX N0 T3 Stage IIB TCGA-56-8201.8990e058-ecf1-4387-8cb5-96ebef082cac.pdf 8201 WITH TUMOR NO R0 Primary Tumor 01 0.3 7th NO YES NO 56 4 Lung A DECEASED 2011 24cbacbe-2de9-40b6-beea-d285eaf4c8b0 24cbacbe-2de9-40b6-beea-d285eaf4c8b0 TCGA-56-8201-01A-11D-2245-05 TCGA-56-8201-01A-11D-2243-01 24cbacbe-2de9-40b6-beea-d285eaf4c8b0 TCGA-56-8201-01A-11D-2243-01 +TCGA-56-8201-11 TCGA-56-8201-11 TCGA-56-8201 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 74 R-Upper TCGA-56-8201-F65845 TCGA-56-8201 TCGA-56-8201-11A -27211 397 0 28 Scheduled Follow-up Submission Progressive Disease 2014-9-30 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.5 NO 0.8 NO YES Yes, History of Prior Malignancy MX N0 T3 Stage IIB 8201 WITH TUMOR NO R0 Solid Tissue Normal 11 0.5 7th NO YES NO 56 4 Lung A DECEASED 2011 eb47358f-9627-4d58-9397-b4e80a28f85c eb47358f-9627-4d58-9397-b4e80a28f85c eb47358f-9627-4d58-9397-b4e80a28f85c +TCGA-56-8304-01 TCGA-56-8304-01 Cluster 5 miRNA cluster 7 TCGA-56-8304 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 73 R-Upper TCGA-56-8304-F61479 TCGA-56-8304 TCGA-56-8304-01A -26803 0 106 Scheduled Follow-up Submission 2014-6-30 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.3 NO 0.4 YES NO 58 No MX N0 T1b Stage IA TCGA-56-8304.7376adfa-7f9a-4f1d-b878-b3fc105009ac.pdf 8304 TUMOR FREE Complete Remission/Response R0 Primary Tumor 01 0.2 7th YES NO 56 2 Lung A LIVING 2011 1953 d5af268a-0e5d-4115-a44e-866997aff778 d5af268a-0e5d-4115-a44e-866997aff778 TCGA-56-8304-01A-11D-2324-05 TCGA-56-8304-01A-11D-2322-01 d5af268a-0e5d-4115-a44e-866997aff778 TCGA-56-8304-01A-11D-2322-01 +TCGA-56-8305-01 TCGA-56-8305-01 Squamous Cluster 13 (HNSC-LUSC) miRNA cluster 11 TCGA-56-8305 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 72 R-Upper TCGA-56-8305 TCGA-56-8305-01A -26428 0 105 49 2012-9-28 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.4 NO 0.4 NO 100 Yes, History of Prior Malignancy M0 N0 T2a Stage IB TCGA-56-8305.d9665618-8c24-4c18-9449-7695df876a2d.pdf 8305 TUMOR FREE 56 70 55 63 Complete Remission/Response YES R0 Primary Tumor 01 0.3 1996 7th YES NO 56 3 Lung A LIVING 2011 1946 0956217d-5f82-40be-8165-d7bb64135f23 0956217d-5f82-40be-8165-d7bb64135f23 TCGA-56-8305-01A-11D-2294-05 TCGA-56-8305-01A-11D-2292-01 0956217d-5f82-40be-8165-d7bb64135f23 TCGA-56-8305-01A-11D-2292-01 +TCGA-56-8307-01 TCGA-56-8307-01 Squamous Cluster 5 miRNA cluster 12 TCGA-56-8307 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 55 R-Lower TCGA-56-8307-F66144 TCGA-56-8307 TCGA-56-8307-01A -20411 0 818 51 Scheduled Follow-up Submission Complete Remission/Response 2014-10-3 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.8 NO 1 NO NO 35 No M0 N0 T3 Stage IIB TCGA-56-8307.dd8a238f-f909-4b35-b6e5-b4b9d404d424.pdf 8307 TUMOR FREE 85 69 Complete Remission/Response YES NO R0 Primary Tumor 01 0.3 7th NO YES NO 56 2 Lung A LIVING 2012 1977 f43b8267-4311-41ef-bd2f-92ac8f336e86 f43b8267-4311-41ef-bd2f-92ac8f336e86 TCGA-56-8307-01A-11D-2294-05 TCGA-56-8307-01A-11D-2292-01 f43b8267-4311-41ef-bd2f-92ac8f336e86 TCGA-56-8307-01A-11D-2292-01 +TCGA-56-8308-01 TCGA-56-8308-01 Squamous Cluster 13 (HNSC-LUSC) miRNA cluster 4 TCGA-56-8308 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 79 L-Upper TCGA-56-8308-F57935 TCGA-56-8308 TCGA-56-8308-01A -29139 0 517 42 Scheduled Follow-up Submission Stable Disease 2014-3-28 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.2 NO 80 0.3 NO NO 63 Yes, History of Prior Malignancy MX N0 T3 Stage IIB TCGA-56-8308.2bdd49ae-3401-416b-8069-4e375c759287.pdf 8308 Post-Adjuvant Therapy WITH TUMOR 84 88 81 81 Stable Disease YES YES R1 Primary Tumor 01 0.1 1992 7th YES YES NO 56 3 Lung A LIVING 2012 1967 e58c5f71-33ca-4443-890e-49b85916f080 e58c5f71-33ca-4443-890e-49b85916f080 TCGA-56-8308-01A-11D-2294-05 TCGA-56-8308-01A-11D-2292-01 e58c5f71-33ca-4443-890e-49b85916f080 TCGA-56-8308-01A-11D-2292-01 +TCGA-56-8309-01 TCGA-56-8309-01 Squamous Cluster 5 miRNA cluster 4 TCGA-56-8309 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 66 R-Lower TCGA-56-8309-F59049 TCGA-56-8309 TCGA-56-8309-01A -24382 0 428 Scheduled Follow-up Submission Complete Remission/Response 2014-4-30 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.7 NO 1 NO NO 50 No MX N0 T1b Stage IA TCGA-56-8309.a01bec0a-8ecc-40cd-9b25-885f31390ed8.pdf 8309 TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 0.4 7th NO YES NO 56 2 Lung A LIVING 2012 cee82dd8-a3d1-448c-814d-b9481a30fb38 cee82dd8-a3d1-448c-814d-b9481a30fb38 TCGA-56-8309-01A-11D-2294-05 TCGA-56-8309-01A-11D-2292-01 cee82dd8-a3d1-448c-814d-b9481a30fb38 TCGA-56-8309-01A-11D-2292-01 +TCGA-56-8309-11 TCGA-56-8309-11 TCGA-56-8309 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 66 R-Lower TCGA-56-8309-F59049 TCGA-56-8309 TCGA-56-8309-11A -24382 0 428 Scheduled Follow-up Submission Complete Remission/Response 2014-4-30 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.4 NO 0.5 NO NO 50 No MX N0 T1b Stage IA 8309 TUMOR FREE Complete Remission/Response NO R0 Solid Tissue Normal 11 0.4 7th NO YES NO 56 2 Lung A LIVING 2012 b87b2d94-2d62-4892-85b4-8ee7a566294c b87b2d94-2d62-4892-85b4-8ee7a566294c b87b2d94-2d62-4892-85b4-8ee7a566294c +TCGA-56-8503-01 TCGA-56-8503-01 TCGA-56-8503 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 76 R-Lower TCGA-56-8503 TCGA-56-8503-01A -28095 0 41 2012-12-28 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.5 NO Peripheral Lung 0.5 NO 91 No M0 N0 T3 Stage IIB TCGA-56-8503.c30ec092-366c-4552-876f-9c69502dee3e.pdf 8503 TUMOR FREE R0 Primary Tumor 01 0.3 7th YES NO 56 2 Lung A LIVING 2012 1951 bbbac47c-0764-4bdb-857d-bd218e9d76ca bbbac47c-0764-4bdb-857d-bd218e9d76ca TCGA-56-8503-01A-11D-2398-05 TCGA-56-8503-01A-11D-2391-01 bbbac47c-0764-4bdb-857d-bd218e9d76ca TCGA-56-8503-01A-11D-2391-01 +TCGA-56-8504-01 TCGA-56-8504-01 TCGA-56-8504 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 74 L-Upper TCGA-56-8504-F64288 TCGA-56-8504 TCGA-56-8504-01A -27210 0 510 1 Scheduled Follow-up Submission Complete Remission/Response 2014-8-28 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.9 NO 90 0.9 NO NO Yes, History of Prior Malignancy MX N0 T2a Stage IB TCGA-56-8504.bd602ed5-b728-4e7f-8022-cb7d0064c863.pdf 8504 Other TUMOR FREE 82 65 80 65 Complete Remission/Response YES NO R0 Primary Tumor 01 0.5 2008 7th NO YES NO 56 4 Lung A LIVING 2012 3e456d4d-3c85-464d-a5e3-f837c6145abf 3e456d4d-3c85-464d-a5e3-f837c6145abf TCGA-56-8504-01A-11D-2398-05 TCGA-56-8504-01A-11D-2391-01 3e456d4d-3c85-464d-a5e3-f837c6145abf TCGA-56-8504-01A-11D-2391-01 +TCGA-56-8622-01 TCGA-56-8622-01 TCGA-56-8622 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 68 R-Lower TCGA-56-8622 TCGA-56-8622-01A -24861 0 55 2012-12-28 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.3 NO 0.5 NO 40 No M0 N0 T2a Stage IB TCGA-56-8622.4366e2bc-8ded-4969-a3bd-18af96de43a6.pdf 8622 TUMOR FREE R0 Primary Tumor 01 0.2 2004 7th YES NO 56 3 Lung A LIVING 2012 1984 f48f08fe-9fa5-4eea-85b1-6fa691515349 f48f08fe-9fa5-4eea-85b1-6fa691515349 TCGA-56-8622-01A-11D-2398-05 TCGA-56-8622-01A-11D-2391-01 f48f08fe-9fa5-4eea-85b1-6fa691515349 TCGA-56-8622-01A-11D-2391-01 +TCGA-56-8623-01 TCGA-56-8623-01 TCGA-56-8623 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung NO NO YES 71 R-Upper TCGA-56-8623-F66147 TCGA-56-8623 TCGA-56-8623-01A 680 -26231 692 0 6 645 0 Scheduled Follow-up Submission Complete Remission/Response 2014-10-3 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.9 NO 90 Peripheral Lung 1.1 NO New Primary Tumor YES 45 No MX N0 T2a Stage IB TCGA-56-8623.8d223b19-5ef0-4e25-814e-97cfe32aea3b.pdf 8623 Preoperative TUMOR FREE Complete Remission/Response Biopsy with Histologic Confirmation NO R0 Primary Tumor 01 0.7 7th NO YES NO 56 2 Lung A DECEASED 2012 265c0257-54b6-4b79-8c9a-d56ca8bbdb48 265c0257-54b6-4b79-8c9a-d56ca8bbdb48 TCGA-56-8623-01A-11D-2398-05 TCGA-56-8623-01A-11D-2391-01 265c0257-54b6-4b79-8c9a-d56ca8bbdb48 TCGA-56-8623-01A-11D-2391-01 +TCGA-56-8623-11 TCGA-56-8623-11 TCGA-56-8623 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung NO NO YES 71 R-Upper TCGA-56-8623-F66147 TCGA-56-8623 TCGA-56-8623-11A 680 -26231 692 0 6 645 0 Scheduled Follow-up Submission Complete Remission/Response 2014-10-3 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.8 NO 90 Peripheral Lung 1.1 NO New Primary Tumor YES 45 No MX N0 T2a Stage IB 8623 Preoperative TUMOR FREE Complete Remission/Response Biopsy with Histologic Confirmation NO R0 Solid Tissue Normal 11 0.2 7th NO YES NO 56 2 Lung A DECEASED 2012 9fe04d07-57ba-434f-8254-184fe00ab23e 9fe04d07-57ba-434f-8254-184fe00ab23e 9fe04d07-57ba-434f-8254-184fe00ab23e +TCGA-56-8624-01 TCGA-56-8624-01 TCGA-56-8624 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 84 R-Lower TCGA-56-8624-F47792 TCGA-56-8624 TCGA-56-8624-01A -30798 0 420 84 YES YES Scheduled Follow-up Submission Complete Remission/Response 2013-8-28 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.8 NO 1.2 NO NO 20 No MX N0 T3 Stage IIB TCGA-56-8624.0c8899e7-79f4-46b1-9184-259f8315ef52.pdf 8624 TUMOR FREE 87 Complete Remission/Response YES NO R0 Primary Tumor 01 0.6 1952 7th YES YES NO 56 3 Lung A LIVING 2012 02da99c7-0a26-4857-9733-42e02c46cbe7 02da99c7-0a26-4857-9733-42e02c46cbe7 TCGA-56-8624-01A-11D-2398-05 TCGA-56-8624-01A-11D-2391-01 02da99c7-0a26-4857-9733-42e02c46cbe7 TCGA-56-8624-01A-11D-2391-01 +TCGA-56-8625-01 TCGA-56-8625-01 TCGA-56-8625 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung NO NO NO NO 66 R-Lower TCGA-56-8625-F59027 TCGA-56-8625 TCGA-56-8625-01A -24188 315 0 63 272 31 Scheduled Follow-up Submission Progressive Disease 2014-4-30 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.8 NO Peripheral Lung 1 NO Distant Metastasis YES No MX N1 T3 Stage IIIA TCGA-56-8625.9be086c9-059b-41cb-8a87-57ce75bc0950.pdf 8625 WITH TUMOR 58 52 61 48 Progressive Disease Convincing Imaging YES NO RX Primary Tumor 01 0.6 7th YES YES NO 56 2 Lung A DECEASED 2012 fed19371-74a4-414f-84a7-495d1ad86c6d fed19371-74a4-414f-84a7-495d1ad86c6d TCGA-56-8625-01A-11D-2398-05 TCGA-56-8625-01A-11D-2391-01 fed19371-74a4-414f-84a7-495d1ad86c6d TCGA-56-8625-01A-11D-2391-01 +TCGA-56-8626-01 TCGA-56-8626-01 TCGA-56-8626 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 59 L-Upper TCGA-56-8626-F57930 TCGA-56-8626 TCGA-56-8626-01A -21908 302 0 17 Scheduled Follow-up Submission 2014-3-28 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.4 NO 0.8 NO NO 50 No MX N0 T1a Stage IA TCGA-56-8626.7a75cbd1-a056-4677-a63b-43aab3bb1379.pdf 8626 TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 0.3 7th NO YES NO 56 2 Lung A DECEASED 2012 1962 f9cc97c0-af9a-4d77-b68e-fcfe9ca9d238 f9cc97c0-af9a-4d77-b68e-fcfe9ca9d238 TCGA-56-8626-01A-11D-2398-05 TCGA-56-8626-01A-11D-2391-01 f9cc97c0-af9a-4d77-b68e-fcfe9ca9d238 TCGA-56-8626-01A-11D-2391-01 +TCGA-56-8628-01 TCGA-56-8628-01 TCGA-56-8628 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 78 R-Upper TCGA-56-8628-F64290 TCGA-56-8628 TCGA-56-8628-01A -28805 0 616 3 Scheduled Follow-up Submission Complete Remission/Response 2014-8-28 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.6 NO 70 0.9 NO NO No MX N0 T1b Stage IA TCGA-56-8628.e7266b19-b7fc-499b-9429-ba6afca960ea.pdf 8628 Other TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 0.3 2007 7th NO YES NO 56 4 Lung A LIVING 2012 ac7e54d7-3886-4da3-a569-dd59fe479dea ac7e54d7-3886-4da3-a569-dd59fe479dea TCGA-56-8628-01A-11D-2398-05 TCGA-56-8628-01A-11D-2391-01 ac7e54d7-3886-4da3-a569-dd59fe479dea TCGA-56-8628-01A-11D-2391-01 +TCGA-56-8629-01 TCGA-56-8629-01 TCGA-56-8629 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 63 L-Lower TCGA-56-8629-F57032 TCGA-56-8629 TCGA-56-8629-01A -23346 0 481 1 NO NO Scheduled Follow-up Submission Complete Remission/Response 2014-2-28 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.8 NO 80 NO 1.1 NO NO 66 No MX N0 T2b Stage IIA TCGA-56-8629.673bcff6-ef66-481f-baba-50c86f18d551.pdf 8629 Preoperative TUMOR FREE 98 51 Complete Remission/Response YES NO R0 Primary Tumor 01 0.3 2001 7th YES YES NO 56 4 Lung A LIVING 2012 1968 55d51796-c9c2-425b-8c94-bbd7475bc690 55d51796-c9c2-425b-8c94-bbd7475bc690 TCGA-56-8629-01A-11D-2398-05 TCGA-56-8629-01A-11D-2391-01 55d51796-c9c2-425b-8c94-bbd7475bc690 TCGA-56-8629-01A-11D-2391-01 +TCGA-56-A49D-01 TCGA-56-A49D-01 TCGA-56-A49D TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 67 L-Upper TCGA-56-A49D-F66146 TCGA-56-A49D TCGA-56-A49D-01A -24745 76 0 637 64 Scheduled Follow-up Submission Complete Remission/Response 2014-10-3 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 40 NO Central Lung NO NO 53 false No MX N2 T2a Stage IIIA TCGA-56-A49D.C80AAD15-0A9A-4A15-B757-1292352964FE.pdf A49D TUMOR FREE 70 72 Complete Remission/Response YES NO R0 Primary Tumor 01 2005 7th NO YES NO 56 4 Lung A LIVING 2012 1953 c9eb7517-0b47-407c-abaa-abae989044fd c9eb7517-0b47-407c-abaa-abae989044fd TCGA-56-A49D-01A-11D-A24I-05 TCGA-56-A49D-01A-11D-A24C-01 c9eb7517-0b47-407c-abaa-abae989044fd TCGA-56-A49D-01A-11D-A24C-01 +TCGA-56-A4BW-01 TCGA-56-A4BW-01 TCGA-56-A4BW TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 55 L-Upper TCGA-56-A4BW-F66149 TCGA-56-A4BW TCGA-56-A4BW-01A -20301 128 0 585 0 Scheduled Follow-up Submission Complete Remission/Response 2014-10-3 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 70 NO 90 Central Lung NO NO 120 false No M0 N1 T2a Stage IIA TCGA-56-A4BW.8CC4BF2C-0E0E-4724-BC6C-6E317E0C5C5F.pdf A4BW Preoperative TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 1999 7th YES YES NO 56 4 Lung A LIVING 2012 1969 aa07fad1-0896-44c3-b8f8-289ac06d2d79 aa07fad1-0896-44c3-b8f8-289ac06d2d79 TCGA-56-A4BW-01A-11D-A24I-05 TCGA-56-A4BW-01A-11D-A24C-01 aa07fad1-0896-44c3-b8f8-289ac06d2d79 TCGA-56-A4BW-01A-11D-A24C-01 +TCGA-56-A4BX-01 TCGA-56-A4BX-01 TCGA-56-A4BX TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 70 R-Lower TCGA-56-A4BX-F60125 TCGA-56-A4BX TCGA-56-A4BX-01A -25745 89 0 405 53 2 NO NO Scheduled Follow-up Submission Complete Remission/Response 2014-5-29 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 80 NO 70 NO Central Lung NO NO 83 false No MX N0 T2b Stage IIA TCGA-56-A4BX.921CAB89-9289-4C98-9746-4BFB3569E338.pdf A4BX Preoperative TUMOR FREE 91 85 89 79 Complete Remission/Response YES NO R0 Primary Tumor 01 2012 7th YES YES NO 56 4 Lung A LIVING 2012 1957 35434208-98c0-4f0d-a487-03fec50b33df 35434208-98c0-4f0d-a487-03fec50b33df TCGA-56-A4BX-01A-11D-A24I-05 TCGA-56-A4BX-01A-11D-A24C-01 35434208-98c0-4f0d-a487-03fec50b33df TCGA-56-A4BX-01A-11D-A24C-01 +TCGA-56-A4BY-01 TCGA-56-A4BY-01 TCGA-56-A4BY TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 66 L-Upper TCGA-56-A4BY-F59033 TCGA-56-A4BY TCGA-56-A4BY-01A -24445 67 543 0 31 16 2 NO NO Scheduled Follow-up Submission Complete Remission/Response 2014-4-30 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8071/3 C34.1 YES 50 NO 80 NO Central Lung NO NO 65 false Yes, History of Prior Malignancy MX N0 T2a Stage IB TCGA-56-A4BY.62DC00DE-B06C-4A85-A1DB-3B6498D617C1.pdf A4BY Preoperative WITH TUMOR 71 44 Complete Remission/Response YES YES RX Primary Tumor 01 2004 7th NO YES NO 56 4 Lung A DECEASED 2012 1961 3eec1382-92cb-44c8-b45d-38eda989e956 3eec1382-92cb-44c8-b45d-38eda989e956 TCGA-56-A4BY-01A-11D-A24I-05 TCGA-56-A4BY-01A-11D-A24C-01 3eec1382-92cb-44c8-b45d-38eda989e956 TCGA-56-A4BY-01A-11D-A24C-01 +TCGA-56-A4ZJ-01 TCGA-56-A4ZJ-01 TCGA-56-A4ZJ TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 75 R-Lower TCGA-56-A4ZJ-F59037 TCGA-56-A4ZJ TCGA-56-A4ZJ-01A -27516 108 0 640 48 Scheduled Follow-up Submission Complete Remission/Response 2014-4-30 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8072/3 C34.3 YES 70 NO NO NO 100 false Yes, History of Prior Malignancy M0 N0 T1a Stage IA TCGA-56-A4ZJ.94A1F143-A043-4277-8DD7-E248DF53C1C0.pdf A4ZJ TUMOR FREE 75 118 77 115 Complete Remission/Response YES NO R0 Primary Tumor 01 2002 7th NO YES NO 56 4 Lung A LIVING 2012 d57e41d2-e98e-4a24-b1cf-bfca3cb5e255 d57e41d2-e98e-4a24-b1cf-bfca3cb5e255 TCGA-56-A4ZJ-01A-11D-A25R-05 TCGA-56-A4ZJ-01A-11D-A25M-01 d57e41d2-e98e-4a24-b1cf-bfca3cb5e255 TCGA-56-A4ZJ-01A-11D-A25M-01 +TCGA-56-A4ZK-01 TCGA-56-A4ZK-01 TCGA-56-A4ZK TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 76 R-Lower TCGA-56-A4ZK-F59036 TCGA-56-A4ZK TCGA-56-A4ZK-01A -28039 54 0 570 1 NO NO Scheduled Follow-up Submission Complete Remission/Response 2014-4-30 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 30 NO 90 NO Central Lung NO NO false No M0 N0 T2 Stage IB TCGA-56-A4ZK.3F2B148C-7611-4F00-9483-B05A1CFD9EEF.pdf A4ZK Preoperative TUMOR FREE Complete Remission/Response NO R1 Primary Tumor 01 2007 7th NO YES NO 56 4 Lung A LIVING 2012 1955 9cf2d1c9-90c2-46a5-bdf2-ff27745b7808 9cf2d1c9-90c2-46a5-bdf2-ff27745b7808 TCGA-56-A4ZK-01A-11D-A25R-05 TCGA-56-A4ZK-01A-11D-A25M-01 9cf2d1c9-90c2-46a5-bdf2-ff27745b7808 TCGA-56-A4ZK-01A-11D-A25M-01 +TCGA-56-A5DR-01 TCGA-56-A5DR-01 TCGA-56-A5DR TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 81 L-Upper TCGA-56-A5DR-F61481 TCGA-56-A5DR TCGA-56-A5DR-01A -29828 66 0 4 64 NO NO Scheduled Follow-up Submission Complete Remission/Response 2014-6-30 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 80 NO NO YES NO false Yes, History of Prior Malignancy MX N0 T1a Stage IA TCGA-56-A5DR.569C859A-67CF-4501-B0E3-66715FD193FA.pdf A5DR TUMOR FREE 52 70 Complete Remission/Response YES NO R0 Primary Tumor 01 7th NO YES NO 56 1 Lung A LIVING 2012 eaf753de-dd57-49bf-b0ad-ffc019fdbef3 eaf753de-dd57-49bf-b0ad-ffc019fdbef3 TCGA-56-A5DR-01A-11D-A27L-05 TCGA-56-A5DR-01A-11D-A27J-01 eaf753de-dd57-49bf-b0ad-ffc019fdbef3 TCGA-56-A5DR-01A-11D-A27J-01 +TCGA-56-A5DS-01 TCGA-56-A5DS-01 TCGA-56-A5DS TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 72 R-Lower TCGA-56-A5DS-F61483 TCGA-56-A5DS TCGA-56-A5DS-01A -26355 70 0 8 NO NO Scheduled Follow-up Submission Complete Remission/Response 2014-6-30 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 100 NO NO YES NO 50 false No MX N0 T2a Stage IB TCGA-56-A5DS.17B3CEDD-13C1-4E7A-8FE9-6710C61B1EE6.pdf A5DS TUMOR FREE Complete Remission/Response YES R0 Primary Tumor 01 7th YES NO 56 2 Lung A LIVING 2012 1962 165b20b1-cf41-442d-b08c-03bda738830a 165b20b1-cf41-442d-b08c-03bda738830a TCGA-56-A5DS-01A-11D-A27L-05 TCGA-56-A5DS-01A-11D-A27J-01 165b20b1-cf41-442d-b08c-03bda738830a TCGA-56-A5DS-01A-11D-A27J-01 +TCGA-56-A62T-01 TCGA-56-A62T-01 TCGA-56-A62T TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 78 L-Upper TCGA-56-A62T-F66644 TCGA-56-A62T TCGA-56-A62T-01A -28522 41 0 440 64 1 NO NO Scheduled Follow-up Submission Complete Remission/Response 2014-10-21 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 40 NO 90 NO Central Lung NO NO 102 false No MX N0 T2b Stage IIA TCGA-56-A62T.8A436D40-6B36-4A34-B589-BFCCCE228F5C.pdf A62T Preoperative TUMOR FREE 98 66 Complete Remission/Response YES YES R1 Primary Tumor 01 7th YES YES NO 56 2 Lung A LIVING 2013 1962 78bff220-61fb-4bcf-9520-6c8f287cdf0e 78bff220-61fb-4bcf-9520-6c8f287cdf0e TCGA-56-A62T-01A-11D-A408-05 TCGA-56-A62T-01A-11D-A400-01 78bff220-61fb-4bcf-9520-6c8f287cdf0e TCGA-56-A62T-01A-11D-A400-01 +TCGA-58-8386-01 TCGA-58-8386-01 Squamous Cluster 13 (HNSC-LUSC) miRNA cluster 4 TCGA-58-8386 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 75 R-Upper TCGA-58-8386 TCGA-58-8386-01A -27455 1 0 NO NO 2012-7-4 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.6 NO 90 NO Central Lung 0.8 NO 65 No M1 NX T3 Stage IV TCGA-58-8386.f239ea75-1ebb-48ac-ab2a-10669e72a24d.pdf 8386 Preoperative TUMOR FREE 55 85 Complete Remission/Response YES NO R0 Primary Tumor 01 0.5 6th NO NO YES 58 2 Lung A DECEASED 2008 6e1fbe8d-8e83-4424-87e9-6e38313215d3 6e1fbe8d-8e83-4424-87e9-6e38313215d3 TCGA-58-8386-01A-11D-2294-05 TCGA-58-8386-01A-11D-2292-01 6e1fbe8d-8e83-4424-87e9-6e38313215d3 TCGA-58-8386-01A-11D-2292-01 +TCGA-58-8386-11 TCGA-58-8386-11 TCGA-58-8386 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 75 R-Upper TCGA-58-8386 TCGA-58-8386-11A -27455 1 0 NO NO 2012-7-4 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.6 NO 90 NO Central Lung 0.6 NO 65 No M1 NX T3 Stage IV 8386 Preoperative TUMOR FREE 55 85 Complete Remission/Response YES NO R0 Solid Tissue Normal 11 0.5 6th NO NO YES 58 2 Lung A DECEASED 2008 153e5c1e-46ba-460f-a966-c3bb10dc490d 153e5c1e-46ba-460f-a966-c3bb10dc490d 153e5c1e-46ba-460f-a966-c3bb10dc490d +TCGA-58-8387-01 TCGA-58-8387-01 Squamous Cluster 5 miRNA cluster 4 TCGA-58-8387 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 60 R-Lower TCGA-58-8387 TCGA-58-8387-01A -21952 403 0 0 NO NO 2012-7-4 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.4 NO 90 NO Peripheral Lung 0.5 NO 40 No M0 N0 T2b Stage IIA TCGA-58-8387.f60b853b-5d1d-47cc-a961-db2da5aa837b.pdf 8387 Preoperative TUMOR FREE 74 74 Complete Remission/Response YES NO R0 Primary Tumor 01 0.2 2010 7th YES NO YES 58 4 Lung A DECEASED 2010 40c82f91-98b7-4c3f-8885-3ea4e383e7be 40c82f91-98b7-4c3f-8885-3ea4e383e7be TCGA-58-8387-01A-11D-2294-05 TCGA-58-8387-01A-11D-2292-01 40c82f91-98b7-4c3f-8885-3ea4e383e7be TCGA-58-8387-01A-11D-2292-01 +TCGA-58-8388-01 TCGA-58-8388-01 Cluster 5 miRNA cluster 14 TCGA-58-8388 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 60 L-Upper TCGA-58-8388-F42095 TCGA-58-8388 TCGA-58-8388-01A -21949 412 0 378 0 NO NO Scheduled Follow-up Submission Complete Remission/Response 2013-5-15 MALE Lung Basaloid Squamous Cell Carcinoma No C34.1 8083/3 C34.1 YES 0.8 NO 90 NO Peripheral Lung 1 NO NO 80 No M0 N0 T2a Stage IB TCGA-58-8388.e7a3f2b5-cc34-47e1-8a36-a552b3150847.pdf 8388 Preoperative TUMOR FREE 65 71 Complete Remission/Response YES NO R0 Primary Tumor 01 0.5 7th NO NO YES 58 2 Lung A DECEASED 2010 68623699-7543-425b-93a1-e0947e3b897e 68623699-7543-425b-93a1-e0947e3b897e TCGA-58-8388-01A-11D-2324-05 TCGA-58-8388-01A-11D-2322-01 68623699-7543-425b-93a1-e0947e3b897e TCGA-58-8388-01A-11D-2322-01 +TCGA-58-8390-01 TCGA-58-8390-01 Cluster 5 miRNA cluster 4 TCGA-58-8390 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 70 R-Lower TCGA-58-8390-F42096 TCGA-58-8390 TCGA-58-8390-01A -25827 0 911 0 NO NO Scheduled Follow-up Submission Complete Remission/Response 2013-5-15 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.5 NO 90 NO Central Lung 1.7 NO NO 120 No M0 N0 T2b Stage IIA TCGA-58-8390.9c901bb6-5752-4c8a-88f4-689b8cde19ab.pdf 8390 Preoperative TUMOR FREE 72 64 Complete Remission/Response YES NO R0 Primary Tumor 01 0.3 1998 7th NO NO YES 58 4 Lung A LIVING 2010 f8789ef6-b073-463f-be80-1fe462adeee7 f8789ef6-b073-463f-be80-1fe462adeee7 TCGA-58-8390-01A-11D-2324-05 TCGA-58-8390-01A-11D-2322-01 f8789ef6-b073-463f-be80-1fe462adeee7 TCGA-58-8390-01A-11D-2322-01 +TCGA-58-8391-01 TCGA-58-8391-01 Cluster 13 (HNSC-LUSC) miRNA cluster 4 TCGA-58-8391 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung NO 57 Bronchial TCGA-58-8391-F42097 TCGA-58-8391 TCGA-58-8391-01A -21102 0 2167 2033 NO NO Scheduled Follow-up Submission Progressive Disease 2013-5-15 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.9 8070/3 C34.9 YES 0.4 NO 100 NO Central Lung 0.7 NO Distant Metastasis|New Primary Tumor YES 30 No M0 N2 T2 Stage IIIA TCGA-58-8391.aca4cc6c-a56b-4936-b459-b4c48892924a.pdf 8391 Preoperative WITH TUMOR 74 75 Complete Remission/Response Convincing Imaging YES YES R0 Primary Tumor 01 0.4 6th YES NO YES 58 2 Lung A LIVING 2006 9bb5155e-25b8-41b7-a424-8aeb81853366 9bb5155e-25b8-41b7-a424-8aeb81853366 TCGA-58-8391-01A-11D-2324-05 TCGA-58-8391-01A-11D-2322-01 9bb5155e-25b8-41b7-a424-8aeb81853366 TCGA-58-8391-01A-11D-2322-01 +TCGA-58-8392-01 TCGA-58-8392-01 Cluster 13 (HNSC-LUSC) miRNA cluster 11 TCGA-58-8392 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 70 L-Upper TCGA-58-8392 TCGA-58-8392-01A -25710 501 0 1 YES L858R NO 2012-7-4 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.6 NO 70 NO Peripheral Lung 0.7 YES 80 No M0 N0 T2a Stage IB TCGA-58-8392.d98ba859-91e2-4de1-bb61-b925d77e33de.pdf 8392 Preoperative WITH TUMOR 33 31 Complete Remission/Response YES NO R0 Primary Tumor 01 0.4 7th NO NO YES 58 2 Lung A DECEASED 2010 4a3692a0-d9de-4cd3-9c4a-bbb087aa67c3 4a3692a0-d9de-4cd3-9c4a-bbb087aa67c3 TCGA-58-8392-01A-11D-2324-05 TCGA-58-8392-01A-11D-2322-01 4a3692a0-d9de-4cd3-9c4a-bbb087aa67c3 TCGA-58-8392-01A-11D-2322-01 +TCGA-58-8393-01 TCGA-58-8393-01 Cluster 13 (HNSC-LUSC) miRNA cluster 4 TCGA-58-8393 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 68 R-Lower TCGA-58-8393-F42098 TCGA-58-8393 TCGA-58-8393-01A -25132 0 1058 0 NO NO Scheduled Follow-up Submission Complete Remission/Response 2013-5-15 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.7 NO 100 NO Central Lung 0.9 NO NO 7 No M0 N0 T2a Stage IB TCGA-58-8393.bbc15d06-72ec-47e4-a65b-e3f7934ab41b.pdf 8393 Preoperative TUMOR FREE 72 115 Complete Remission/Response YES NO R0 Primary Tumor 01 0.4 7th NO NO YES 58 2 Lung A LIVING 2010 bc95bdc7-553c-4b87-b546-899d8bd3fc41 bc95bdc7-553c-4b87-b546-899d8bd3fc41 TCGA-58-8393-01A-11D-2324-05 TCGA-58-8393-01A-11D-2322-01 bc95bdc7-553c-4b87-b546-899d8bd3fc41 TCGA-58-8393-01A-11D-2322-01 +TCGA-58-A46J-01 TCGA-58-A46J-01 TCGA-58-A46J TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 64 R-Upper TCGA-58-A46J-F51444 TCGA-58-A46J TCGA-58-A46J-01A -23653 2176 0 2589 NO NO Scheduled Follow-up Submission Complete Remission/Response 2013-11-19 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 130 NO 80 NO Central Lung NO NO true No M0 N1 T2 Stage IIB TCGA-58-A46J.18E403FA-639F-4E53-820B-0A756A039C73.pdf A46J Preoperative TUMOR FREE 79 48 Complete Remission/Response YES NO R0 Primary Tumor 01 6th YES NO YES 58 2 Lung A LIVING 2006 52925e7c-35c6-405c-982d-28a8a5ce1201 52925e7c-35c6-405c-982d-28a8a5ce1201 TCGA-58-A46J-01A-11D-A24I-05 TCGA-58-A46J-01A-11D-A24C-01 52925e7c-35c6-405c-982d-28a8a5ce1201 TCGA-58-A46J-01A-11D-A24C-01 +TCGA-58-A46K-01 TCGA-58-A46K-01 TCGA-58-A46K TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 59 R-Lower TCGA-58-A46K TCGA-58-A46K-01A -21867 1491 1045 0 0 NO NO 2012-10-29 MALE Lung Basaloid Squamous Cell Carcinoma No C34.3 8083/3 C34.3 YES 90 NO 100 NO Peripheral Lung YES 10 true No M0 N2 T2 Stage IIIA TCGA-58-A46K.526A34E6-B8D1-4A05-B6E9-1CDDA281BD7A.pdf A46K Preoperative WITH TUMOR 70 82 Complete Remission/Response YES YES R0 Primary Tumor 01 2005 6th YES NO YES 58 4 Lung A DECEASED 2008 3c6a4510-fc3e-4b40-9d15-2ccbce48dca2 3c6a4510-fc3e-4b40-9d15-2ccbce48dca2 TCGA-58-A46K-01A-11D-A24I-05 TCGA-58-A46K-01A-11D-A24C-01 3c6a4510-fc3e-4b40-9d15-2ccbce48dca2 TCGA-58-A46K-01A-11D-A24C-01 +TCGA-58-A46L-01 TCGA-58-A46L-01 TCGA-58-A46L TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 73 R-Upper TCGA-58-A46L-F51445 TCGA-58-A46L TCGA-58-A46L-01A -26685 1426 0 1723 0 NO NO Scheduled Follow-up Submission Complete Remission/Response 2013-11-19 MALE Lung Basaloid Squamous Cell Carcinoma No C34.1 8083/3 C34.1 YES 110 NO 100 NO Central Lung NO NO true No M0 N2 T2 Stage IIIA TCGA-58-A46L.56894615-979E-4A89-B6D4-F6639C0188FE.pdf A46L Preoperative TUMOR FREE 50 61 Complete Remission/Response YES NO R0 Primary Tumor 01 6th YES NO YES 58 5 Lung A LIVING 2008 9aa74fcf-9845-4708-a09b-a17aa4b9e94a 9aa74fcf-9845-4708-a09b-a17aa4b9e94a TCGA-58-A46L-01A-11D-A24I-05 TCGA-58-A46L-01A-11D-A24C-01 9aa74fcf-9845-4708-a09b-a17aa4b9e94a TCGA-58-A46L-01A-11D-A24C-01 +TCGA-58-A46M-01 TCGA-58-A46M-01 TCGA-58-A46M TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 61 L-Lower TCGA-58-A46M-F51443 TCGA-58-A46M TCGA-58-A46M-01A -22592 686 0 1072 0 NO NO Scheduled Follow-up Submission Complete Remission/Response 2013-11-19 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 100 NO 100 NO Central Lung NO NO true No M0 N1 T2b Stage IIB TCGA-58-A46M.29B1DF65-6310-4E01-9CBF-7678678A7D38.pdf A46M Preoperative TUMOR FREE 41 0 Complete Remission/Response YES NO R0 Primary Tumor 01 7th NO NO YES 58 2 Lung A LIVING 2010 f5b03cae-1e62-46aa-9c0b-a2fb62948aed f5b03cae-1e62-46aa-9c0b-a2fb62948aed TCGA-58-A46M-01A-11D-A24I-05 TCGA-58-A46M-01A-11D-A24C-01 f5b03cae-1e62-46aa-9c0b-a2fb62948aed TCGA-58-A46M-01A-11D-A24C-01 +TCGA-58-A46N-01 TCGA-58-A46N-01 TCGA-58-A46N TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung NO YES NO 52 R-Lower TCGA-58-A46N-F51446 TCGA-58-A46N TCGA-58-A46N-01A -19050 566 0 910 630 0 NO NO Scheduled Follow-up Submission Partial Remission/Response 2013-11-19 MALE Lung Basaloid Squamous Cell Carcinoma No C34.3 8083/3 C34.3 YES 100 NO 90 NO Central Lung NO Locoregional Recurrence YES 50 true No M0 N0 T2a Stage IB TCGA-58-A46N.95A2F9CB-DFB3-441E-9F24-467D9AB343F9.pdf A46N Preoperative WITH TUMOR 58 63 Complete Remission/Response Convincing Imaging YES NO R0 Primary Tumor 01 7th NO NO YES 58 2 Lung A LIVING 2011 14053697-8879-40ef-ad7d-9840ebae105a 14053697-8879-40ef-ad7d-9840ebae105a TCGA-58-A46N-01A-11D-A24I-05 TCGA-58-A46N-01A-11D-A24C-01 14053697-8879-40ef-ad7d-9840ebae105a TCGA-58-A46N-01A-11D-A24C-01 +TCGA-60-2695-01 TCGA-60-2695-01 High C1-LUAD-enriched Cluster 5 squamous c3 RNA cluster 12 miRNA c1uster 10 TCGA-60-2695 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung NO NO 74 L-Upper TCGA-60-2695-F5377 TCGA-60-2695 TCGA-60-2695-01A -27211 0 642 NO NO 2010-7-15 FEMALE Lung Basaloid Squamous Cell Carcinoma No C34.1 8083/3 C34.1 YES 0.8 NO NO 1 NO 64 No M0 N0 T2 Stage IB TCGA-60-2695.ee5f477a-e6f4-4c37-8ee1-f9dc269aef9b.pdf 2695 TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 0.4 1983 NO NO YES 60 3 Lung A LIVING 2009 1951 9359bed2-0958-4cba-954e-3d548320e12e TCGA-60-2695-01A-01D-0848-05 9359bed2-0958-4cba-954e-3d548320e12e TCGA-60-2695-01A-01D-0844-01 TCGA-60-2695-01A-01R-0851-07 9359bed2-0958-4cba-954e-3d548320e12e TCGA-60-2695-01A-01D-0844-01 TCGA-60-2695-01A-21-2193-20 +TCGA-60-2696-01 TCGA-60-2696-01 Squamous C2-Squamous-like Cluster 5 squamous c3 squamous-like c4 miRNA cluster 4 TCGA-60-2696 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung NO NO 76 L-Upper TCGA-60-2696-F5373 TCGA-60-2696 TCGA-60-2696-01A -27991 109 0 109 NO NO 2010-7-15 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) Yes C34.1 8070/3 C34.1 YES 0.6 NO 0 NO Central Lung 1 NO 15 Yes M0 N0 T2 Stage IIA TCGA-60-2696.afe56cab-1fd2-4503-899b-cbfeb79ee7a0.pdf 2696 NO RX Primary Tumor 01 0.5 1985 NO NO YES 60 3 Lung A DECEASED 2009 1955 ff913d7b-73f5-4987-97f9-294463272f82 TCGA-60-2696-01A-01D-0848-05 ff913d7b-73f5-4987-97f9-294463272f82 TCGA-60-2696-01A-01D-0844-01 TCGA-60-2696-01A-01R-0851-07 ff913d7b-73f5-4987-97f9-294463272f82 TCGA-60-2696-01A-01D-0844-01 TCGA-60-2696-01A-21-2193-20 +TCGA-60-2697-01 TCGA-60-2697-01 Kirc+ Low purity c2 squamous c3 miRNA c1uster 9 TCGA-60-2697 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung YES YES NO 41 R-Middle TCGA-60-2697-F20962 TCGA-60-2697 TCGA-60-2697-01A -14984 372 0 200 NO NO Scheduled Follow-up Submission Progressive Disease 2012-1-18 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) Yes C34.9 8070/3 C34.9 YES 0.7 NO NO 1.5 YES No M0 N2 T2 Stage IIA TCGA-60-2697.a5d927b3-eb14-4127-a74f-5a53eb3cf536.pdf 2697 WITH TUMOR Complete Remission/Response NO RX Primary Tumor 01 0.3 3rd NO NO YES 60 Lung A DECEASED 1992 a4367d0e-d5a3-4865-8c58-4ef4c5493465 a4367d0e-d5a3-4865-8c58-4ef4c5493465 TCGA-60-2697-01A-11D-2123-05 TCGA-60-2697-01A-11D-2121-01 a4367d0e-d5a3-4865-8c58-4ef4c5493465 TCGA-60-2697-01A-11D-2121-01 TCGA-60-2697-01A-21-2193-20 +TCGA-60-2698-01 TCGA-60-2698-01 High C2-Squamous-like Cluster 5 squamous c3 squamous-like c4 miRNA cluster 4 mutation cluster 8 TCGA-60-2698 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung YES YES 62 R-Lower TCGA-60-2698-F5379 TCGA-60-2698 TCGA-60-2698-01A -22800 311 0 114 NO NO Progressive Disease 2010-7-26 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 1.5 NO 0 NO 1.7 YES No M0 N1 T2 Stage IIB TCGA-60-2698.fd7aab4d-f043-48e5-af10-789c56debc41.pdf 2698 WITH TUMOR NO RX Primary Tumor 01 0.5 1993 NO NO YES 60 4 Lung A DECEASED 1993 cf406671-32e5-46c6-8e55-ac696c5d9bc9 TCGA-60-2698-01A-01D-0848-05 TCGA-60-2698-01A-01D-1522-08 cf406671-32e5-46c6-8e55-ac696c5d9bc9 TCGA-60-2698-01A-01D-0844-01 TCGA-60-2698-01A-01R-0851-07 cf406671-32e5-46c6-8e55-ac696c5d9bc9 TCGA-60-2698-01A-01D-0844-01 TCGA-60-2698-01A-21-2193-20 +TCGA-60-2703-01 TCGA-60-2703-01 Squamous C2-Squamous-like Cluster 5 squamous c3 squamous-like c4 miRNA cluster 4 TCGA-60-2703 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung NO NO YES YES 73 R-Lower TCGA-60-2703-F19864 TCGA-60-2703 TCGA-60-2703-01A 1757 2215 -27003 2945 0 1757 0 NO Scheduled Follow-up Submission Progressive Disease 2011-12-21 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.9 8070/3 C34.9 YES 0.5 NO NO Peripheral Lung 0.6 YES 50 No M0 N1 T2 Stage IIB TCGA-60-2703.880fe05a-3a40-430e-8254-1a0becdfc462.pdf 2703 Adjuvant therapy Complete Remission/Response NO R0 Primary Tumor 01 0.5 2000 5th NO NO YES 60 4 Lung A DECEASED 2002 1950 4228ef47-cd33-4bec-aa70-7a0cbe88de80 4228ef47-cd33-4bec-aa70-7a0cbe88de80 TCGA-60-2703-01A-11D-2043-05 TCGA-60-2703-01A-11D-2041-01 4228ef47-cd33-4bec-aa70-7a0cbe88de80 TCGA-60-2703-01A-11D-2041-01 TCGA-60-2703-01A-21-2193-20 +TCGA-60-2704-01 TCGA-60-2704-01 High C2-Squamous-like Cluster 5 squamous c3 squamous-like c4 miRNA cluster 4 TCGA-60-2704 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung YES YES NO NO 73 R-Upper TCGA-60-2704-F20241 TCGA-60-2704 TCGA-60-2704-01A -26927 1154 0 1045 0 NO NO Scheduled Follow-up Submission 2012-1-9 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 1.5 NO NO Central Lung 2.5 YES 60 No M0 N1 T2 Stage IIB TCGA-60-2704.5fc80d98-89c6-4bb4-bbf7-639f1d2c5647.pdf 2704 Post-Adjuvant Therapy WITH TUMOR NO R0 Primary Tumor 01 0.5 6th NO NO YES 60 2 Lung A DECEASED 2003 1943 790c2e10-c79a-412d-9a24-d571652ff80e 790c2e10-c79a-412d-9a24-d571652ff80e TCGA-60-2704-01A-11D-2043-05 TCGA-60-2704-01A-11D-2041-01 790c2e10-c79a-412d-9a24-d571652ff80e TCGA-60-2704-01A-11D-2041-01 TCGA-60-2704-01A-21-2193-20 +TCGA-60-2706-01 TCGA-60-2706-01 Squamous C1-LUAD-enriched Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 4 TCGA-60-2706 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 58 R-Upper TCGA-60-2706-F13011 TCGA-60-2706 TCGA-60-2706-01A -21477 0 2820 0 NO NO Complete Remission/Response 2011-6-16 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.9 8070/3 C34.9 YES 0.4 NO 100 NO 1 NO 51 No M0 N0 T1 Stage IA TCGA-60-2706.94622916-d2d7-44da-8013-437e4370dc96.pdf 2706 Post-Adjuvant Therapy TUMOR FREE Complete Remission/Response NO Primary Tumor 01 0.4 NO NO YES 60 2 Lung A LIVING 2003 1958 134503af-e10e-41f4-97a4-c1261144b36a TCGA-60-2706-01A-01D-0848-05 134503af-e10e-41f4-97a4-c1261144b36a TCGA-60-2706-01A-01D-0844-01 TCGA-60-2706-01A-01R-0851-07 134503af-e10e-41f4-97a4-c1261144b36a TCGA-60-2706-01A-01D-0844-01 TCGA-60-2706-01A-21-2193-20 +TCGA-60-2707-01 TCGA-60-2707-01 Squamous C2-Squamous-like Cluster 13 (HNSC-LUSC) squamous-like c4 mutation cluster 8 TCGA-60-2707 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung YES NO 70 L-Upper TCGA-60-2707-F5391 TCGA-60-2707 TCGA-60-2707-01A -25758 667 0 661 579 NO NO 2010-7-16 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 1 NO NO Peripheral Lung 1.5 YES 49 No M0 N0 T2 Stage IB TCGA-60-2707.c3e54948-6849-4bac-b04b-3e1a196e866b.pdf 2707 WITH TUMOR Complete Remission/Response NO RX Primary Tumor 01 0.4 1983 NO NO YES 60 3 Lung A DECEASED 2003 1950 2c299eb8-f688-487f-b0d8-9b2bd297193b TCGA-60-2707-01A-01D-0848-05 TCGA-60-2707-01A-01D-1522-08 2c299eb8-f688-487f-b0d8-9b2bd297193b TCGA-60-2707-01A-01D-0844-01 TCGA-60-2707-01A-01R-0851-07 2c299eb8-f688-487f-b0d8-9b2bd297193b TCGA-60-2707-01A-01D-0844-01 +TCGA-60-2708-01 TCGA-60-2708-01 High C2-Squamous-like Cluster 13 (HNSC-LUSC) squamous c3 squamous-like c4 miRNA cluster 4 mutation cluster 8 TCGA-60-2708 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung NO NO 64 L-Lower TCGA-60-2708-F5393 TCGA-60-2708 TCGA-60-2708-01A -23691 0 2447 NO NO 2010-7-16 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.5 NO NO Central Lung 1.4 NO 20 No M0 N1 T2 Stage IIB TCGA-60-2708.7f0ed176-146a-4ea2-8f39-36d402d74757.pdf 2708 TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 0.5 2003 YES NO YES 60 4 Lung A LIVING 2004 1963 55aa5a0a-1fb8-4420-bcee-cf281b36fdab TCGA-60-2708-01A-01D-0848-05 TCGA-60-2708-01A-01D-1522-08 55aa5a0a-1fb8-4420-bcee-cf281b36fdab TCGA-60-2708-01A-01D-0844-01 TCGA-60-2708-01A-01R-0851-07 55aa5a0a-1fb8-4420-bcee-cf281b36fdab TCGA-60-2708-01A-01D-0844-01 TCGA-60-2708-01A-21-2193-20 +TCGA-60-2709-01 TCGA-60-2709-01 Squamous C2-Squamous-like Cluster 5 squamous c3 squamous-like c4 miRNA cluster 4 mutation cluster 12 TCGA-60-2709 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 69 L-Upper TCGA-60-2709-F14659 TCGA-60-2709 TCGA-60-2709-01A -25453 0 1505 NO NO Scheduled Follow-up Submission Complete Remission/Response 2011-8-4 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 1 NO NO Peripheral Lung 2 NO 157.5 No MX N0 T2 Stage IB TCGA-60-2709.f1e99e51-52e3-4f5d-b483-3c1b1eadd977.pdf 2709 TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 0.4 6th NO NO YES 60 2 Lung A LIVING 2004 1959 87fc2c1d-3072-40fb-bc36-5b7a5604d4d7 TCGA-60-2709-01A-21D-1817-08 87fc2c1d-3072-40fb-bc36-5b7a5604d4d7 TCGA-60-2709-01A-21D-1818-05 TCGA-60-2709-01A-21D-1816-01 87fc2c1d-3072-40fb-bc36-5b7a5604d4d7 TCGA-60-2709-01A-21D-1816-01 TCGA-60-2709-01A-22-2193-20 +TCGA-60-2709-11 TCGA-60-2709-11 C2-Squamous-like mutation cluster 12 TCGA-60-2709 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 69 L-Upper TCGA-60-2709-F14659 TCGA-60-2709 TCGA-60-2709-11A -25453 0 1505 NO NO Scheduled Follow-up Submission Complete Remission/Response 2011-8-4 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.7 NO NO Peripheral Lung 1.5 NO 157.5 No MX N0 T2 Stage IB 2709 TUMOR FREE Complete Remission/Response NO R0 Solid Tissue Normal 11 0.5 6th NO NO YES 60 2 Lung A LIVING 2004 1959 aacc0084-c133-4dc9-80af-a3f6b74618d9 aacc0084-c133-4dc9-80af-a3f6b74618d9 aacc0084-c133-4dc9-80af-a3f6b74618d9 +TCGA-60-2710-01 TCGA-60-2710-01 Squamous C2-Squamous-like Cluster 13 (HNSC-LUSC) squamous c3 squamous-like c4 miRNA cluster 7 mutation cluster 8 TCGA-60-2710 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 67 L-Upper TCGA-60-2710-F13275 TCGA-60-2710 TCGA-60-2710-01A -24669 0 2024 61 1 NO NO Complete Remission/Response 2011-6-16 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) Yes C34.1 8070/3 C34.1 YES 0.6 NO 80 NO Peripheral Lung 1.5 NO 63 No M0 N1 T1 Stage IIA TCGA-60-2710.da7da3b9-53af-4b12-be95-07dfc7be8458.pdf 2710 Post-Adjuvant Therapy TUMOR FREE 67 61 Complete Remission/Response YES NO Primary Tumor 01 0.5 2005 6th YES NO YES 60 4 Lung A LIVING 2005 1963 cdcd386e-cbf8-474e-a79e-666fffcadcd0 TCGA-60-2710-01A-01D-0848-05 TCGA-60-2710-01A-01D-1522-08 cdcd386e-cbf8-474e-a79e-666fffcadcd0 TCGA-60-2710-01A-01D-1969-01 TCGA-60-2710-01A-01R-0851-07 cdcd386e-cbf8-474e-a79e-666fffcadcd0 TCGA-60-2710-01A-01D-1969-01 TCGA-60-2710-01A-21-2193-20 +TCGA-60-2711-01 TCGA-60-2711-01 Squamous C2-Squamous-like Cluster 13 (HNSC-LUSC) squamous c3 squamous-like c4 miRNA cluster 7 mutation cluster 5 TCGA-60-2711 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 64 R-Lower TCGA-60-2711-F13356 TCGA-60-2711 TCGA-60-2711-01A -23651 0 1260 0 NO NO Complete Remission/Response 2011-6-16 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.9 8070/3 C34.9 YES 0.9 NO 90 NO Peripheral Lung 1.3 NO 39 Yes M0 N0 T2 Stage IB TCGA-60-2711.efc8dedf-808c-4872-87a0-4249493f59b3.pdf 2711 Post-Adjuvant Therapy TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 0.3 2008 NO NO YES 60 4 Lung A LIVING 2007 1969 7e152b9b-7115-4800-864e-e8162d617661 TCGA-60-2711-01A-01D-0848-05 TCGA-60-2711-01A-01D-1522-08 7e152b9b-7115-4800-864e-e8162d617661 TCGA-60-2711-01A-01D-0844-01 TCGA-60-2711-01A-01R-0851-07 7e152b9b-7115-4800-864e-e8162d617661 TCGA-60-2711-01A-01D-0844-01 TCGA-60-2711-01A-21-2193-20 +TCGA-60-2712-01 TCGA-60-2712-01 Squamous C2-Squamous-like Cluster 5 squamous c3 squamous-like c4 miRNA cluster 7 mutation c1uster 9 TCGA-60-2712 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung NO NO 79 L-Upper TCGA-60-2712-F5398 TCGA-60-2712 TCGA-60-2712-01A -29131 274 0 274 NO NO 2010-7-16 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.9 NO 0 NO Central Lung 0.9 NO 10 Yes M0 N1 T2 Stage IIB TCGA-60-2712.dc936761-8bc0-4f4d-ba51-d6c9c0009c3b.pdf 2712 Complete Remission/Response NO R0 Primary Tumor 01 0.5 1979 NO NO YES 60 3 Lung A DECEASED 2006 1959 02311dd2-115e-452f-a5de-b3230a51d7f2 TCGA-60-2712-01A-01D-0848-05 TCGA-60-2712-01A-01D-1522-08 02311dd2-115e-452f-a5de-b3230a51d7f2 TCGA-60-2712-01A-01D-0844-01 TCGA-60-2712-01A-01R-0851-07 02311dd2-115e-452f-a5de-b3230a51d7f2 TCGA-60-2712-01A-01D-0844-01 TCGA-60-2712-01A-21-2193-20 +TCGA-60-2713-01 TCGA-60-2713-01 Squamous C2-Squamous-like Low purity c2 squamous c3 squamous-like c4 miRNA cluster 4 mutation cluster 2 TCGA-60-2713 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung YES NO YES NO 64 R-Lower TCGA-60-2713-F13270 TCGA-60-2713 TCGA-60-2713-01A 1433 -23630 0 1731 1433 1 NO NO 2011-6-16 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.8 NO 70 NO 0.9 YES 110 No M0 N0 T2 Stage IB TCGA-60-2713.55688ea3-81a1-45bc-92c6-431f7a53a734.pdf 2713 Post-Adjuvant Therapy Partial Remission/Response NO R0 Primary Tumor 01 0.4 NO NO YES 60 2 Lung A LIVING 2006 1955 4d65f6a2-ba96-4ef3-9a47-13808922e76a TCGA-60-2713-01A-01D-0848-05 TCGA-60-2713-01A-01D-1522-08 4d65f6a2-ba96-4ef3-9a47-13808922e76a TCGA-60-2713-01A-01D-0844-01 TCGA-60-2713-01A-01R-0851-07 4d65f6a2-ba96-4ef3-9a47-13808922e76a TCGA-60-2713-01A-01D-0844-01 TCGA-60-2713-01A-21-2193-20 +TCGA-60-2714-01 TCGA-60-2714-01 High C1-LUAD-enriched Cluster 6 squamous c3 LUAD-like c10 miRNA c1uster 9 TCGA-60-2714 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 66 R-Upper TCGA-60-2714-F13259 TCGA-60-2714 TCGA-60-2714-01A -24169 0 1531 47 0 NO NO Complete Remission/Response 2011-6-16 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) Yes C34.9 8070/3 C34.9 YES 0.7 NO 100 NO Peripheral Lung 0.7 NO 90 No M0 N1 T2 Stage IIB TCGA-60-2714.8c5c0056-9ae8-42e2-8a8f-cdf2f7bbbaa6.pdf 2714 Adjuvant therapy TUMOR FREE 73 81 Complete Remission/Response YES NO R0 Primary Tumor 01 0.3 2005 6th YES NO YES 60 4 Lung A LIVING 2006 1960 92157a18-814f-41b7-9c7f-7bdd1f76e464 TCGA-60-2714-01A-01D-0848-05 92157a18-814f-41b7-9c7f-7bdd1f76e464 TCGA-60-2714-01A-01D-0844-01 TCGA-60-2714-01A-01R-0851-07 92157a18-814f-41b7-9c7f-7bdd1f76e464 TCGA-60-2714-01A-01D-0844-01 TCGA-60-2714-01A-21-2193-20 +TCGA-60-2715-01 TCGA-60-2715-01 High C2-Squamous-like Low purity c2 squamous-like c4 mutation c1uster 9 TCGA-60-2715 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 51 L-Upper TCGA-60-2715-F12843 TCGA-60-2715 TCGA-60-2715-01A -18990 1075 0 134 1 NO NO Progressive Disease 2011-6-9 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.4 NO 80 NO 0.5 NO 25 Yes M0 N0 T1 Stage IA TCGA-60-2715.3378cd9a-00ea-42f9-9884-a72a54f1dd32.pdf 2715 Adjuvant therapy WITH TUMOR 61 86 Progressive Disease YES YES RX Primary Tumor 01 0.3 2006 6th YES NO YES 60 4 Lung A DECEASED 2008 1983 0929665a-9dba-4744-ab13-fd483ff70c3a TCGA-60-2715-01A-01D-0848-05 TCGA-60-2715-01A-01D-1522-08 0929665a-9dba-4744-ab13-fd483ff70c3a TCGA-60-2715-01A-01D-0844-01 TCGA-60-2715-01A-01R-0851-07 0929665a-9dba-4744-ab13-fd483ff70c3a TCGA-60-2715-01A-01D-0844-01 +TCGA-60-2716-01 TCGA-60-2716-01 Quiet C2-Squamous-like Low purity c2 COADREAD-like c7 squamous-like c4 miRNA cluster 11 TCGA-60-2716 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 39 L-Upper TCGA-60-2716-F13256 TCGA-60-2716 TCGA-60-2716-01A -14345 0 1475 0 NO NO [Discrepancy] 2011-6-17 MALE Lung Papillary Squamous Cell Caricnoma No C34.9 8070/3 C34.9 YES 0.7 NO 90 NO Central Lung 1 NO No M0 N1 T2 Stage IIB TCGA-60-2716.de896266-23c5-469b-a219-bb523657b822.pdf 2716 Post-Adjuvant Therapy TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 0.3 YES NO YES 60 1 Lung A LIVING 2007 0b16749a-54a1-47f0-9534-4c3428fc7504 TCGA-60-2716-01A-01D-0848-05 0b16749a-54a1-47f0-9534-4c3428fc7504 TCGA-60-2716-01A-01D-0844-01 TCGA-60-2716-01A-01R-0851-07 0b16749a-54a1-47f0-9534-4c3428fc7504 TCGA-60-2716-01A-01D-0844-01 TCGA-60-2716-01A-21-2193-20 +TCGA-60-2719-01 TCGA-60-2719-01 Squamous C2-Squamous-like Cluster 5 squamous c3 squamous-like c4 miRNA cluster 12 mutation cluster 13 TCGA-60-2719 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 83 R-Upper TCGA-60-2719-F13255 TCGA-60-2719 TCGA-60-2719-01A -30379 0 1297 2 NO NO Complete Remission/Response 2011-6-17 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.9 8070/3 C34.9 YES 1 NO 60 NO Central Lung 1.2 NO 7 No M0 N0 T1 Stage IB TCGA-60-2719.1843b1c7-9197-4595-ad5d-862e0f1ec3f8.pdf 2719 Post-Adjuvant Therapy TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 0.3 1978 NO NO YES 60 3 Lung A LIVING 2007 1950 b5e61a38-2067-473e-8eb3-0d8c259b7e67 TCGA-60-2719-01A-01D-0848-05 TCGA-60-2719-01A-01D-1522-08 b5e61a38-2067-473e-8eb3-0d8c259b7e67 TCGA-60-2719-01A-01D-0844-01 TCGA-60-2719-01A-01R-0851-07 b5e61a38-2067-473e-8eb3-0d8c259b7e67 TCGA-60-2719-01A-01D-0844-01 TCGA-60-2719-01A-21-2193-20 +TCGA-60-2720-01 TCGA-60-2720-01 Squamous C2-Squamous-like Cluster 5 squamous c3 squamous-like c4 miRNA cluster 4 mutation cluster 8 TCGA-60-2720 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung NO NO 60 R-Lower TCGA-60-2720-F8616 TCGA-60-2720 TCGA-60-2720-01A -22238 0 97 NO NO 2010-7-19 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.6 NO NO Central Lung 1.2 110 No M0 N0 T2 Stage IB TCGA-60-2720.02b1ae97-4962-46c8-9672-0597bdc85705.pdf 2720 TUMOR FREE R0 Primary Tumor 01 0.2 2007 YES NO YES 60 4 Lung A LIVING 2007 1967 590b397c-38e0-4d77-9c7c-0d6cde2e5757 TCGA-60-2720-01A-01D-0848-05 TCGA-60-2720-01A-01D-1522-08 590b397c-38e0-4d77-9c7c-0d6cde2e5757 TCGA-60-2720-01A-01D-1969-01 TCGA-60-2720-01A-01R-0851-07 590b397c-38e0-4d77-9c7c-0d6cde2e5757 TCGA-60-2720-01A-01D-1969-01 TCGA-60-2720-01A-21-2193-20 +TCGA-60-2721-01 TCGA-60-2721-01 Squamous C2-Squamous-like Cluster 5 squamous c3 squamous-like c4 miRNA cluster 11 mutation cluster 5 TCGA-60-2721 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung NO NO 73 R-Upper TCGA-60-2721-F5407 TCGA-60-2721 TCGA-60-2721-01A -27007 0 983 1 NO NO 2010-7-20 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 1 NO 70 NO Central Lung 1.2 NO 93 Yes M0 N0 T2 Stage IB TCGA-60-2721.1447d27e-c268-4bc6-8919-b13878f8e862.pdf 2721 Post-Adjuvant Therapy TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 0.4 2008 NO NO YES 60 4 Lung A LIVING 2008 1946 ac70793d-cc2c-48c8-a6f7-12b4c319364a TCGA-60-2721-01A-01D-0848-05 TCGA-60-2721-01A-01D-1522-08 ac70793d-cc2c-48c8-a6f7-12b4c319364a TCGA-60-2721-01A-01D-0844-01 TCGA-60-2721-01A-01R-0851-07 ac70793d-cc2c-48c8-a6f7-12b4c319364a TCGA-60-2721-01A-01D-0844-01 TCGA-60-2721-01A-21-2193-20 +TCGA-60-2722-01 TCGA-60-2722-01 BRCA-LUAD+ C2-Squamous-like BRCA CIMP c7 squamous-like c4 miRNA cluster 11 mutation cluster 5 TCGA-60-2722 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung YES [Discrepancy] NO 66 R-Upper TCGA-60-2722-F5408 TCGA-60-2722 TCGA-60-2722-01A -24267 0 908 851 NO NO 2010-7-20 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.5 NO NO Central Lung 0.6 YES 90 No M0 N1 T2 Stage IIB TCGA-60-2722.1695c98e-f870-4a29-8987-acb46860b525.pdf 2722 TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 0.4 2008 YES NO YES 60 4 Lung A LIVING 2008 afac7352-d5be-4b87-baf0-0d22e761872b TCGA-60-2722-01A-01D-0848-05 TCGA-60-2722-01A-01D-1522-08 afac7352-d5be-4b87-baf0-0d22e761872b TCGA-60-2722-01A-01D-0844-01 TCGA-60-2722-01A-01R-0851-07 afac7352-d5be-4b87-baf0-0d22e761872b TCGA-60-2722-01A-01D-0844-01 +TCGA-60-2723-01 TCGA-60-2723-01 High C2-Squamous-like Cluster 13 (HNSC-LUSC) squamous-like c4 miRNA cluster 4 mutation cluster 8 TCGA-60-2723 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 74 R-Middle TCGA-60-2723-F13248 TCGA-60-2723 TCGA-60-2723-01A -27225 0 1092 2 NO NO Complete Remission/Response 2011-6-17 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.9 8070/3 C34.9 YES 0.4 NO 60 NO Peripheral Lung 1.2 NO 58 No M0 N0 T2 Stage IB TCGA-60-2723.681ea3dd-7685-4dc2-aa6c-73de2ae4cc60.pdf 2723 Post-Adjuvant Therapy TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 0.3 2008 NO NO YES 60 4 Lung A LIVING 2008 1949 1eb4fd74-0fa3-4ec9-8fc4-aa5d26a5f690 TCGA-60-2723-01A-01D-0848-05 TCGA-60-2723-01A-01D-1522-08 1eb4fd74-0fa3-4ec9-8fc4-aa5d26a5f690 TCGA-60-2723-01A-01D-0844-01 TCGA-60-2723-01A-01R-0851-07 1eb4fd74-0fa3-4ec9-8fc4-aa5d26a5f690 TCGA-60-2723-01A-01D-0844-01 +TCGA-60-2724-01 TCGA-60-2724-01 Squamous C2-Squamous-like Cluster 5 squamous c3 squamous-like c4 miRNA c1uster 9 mutation cluster 2 TCGA-60-2724 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 47 Bronchial TCGA-60-2724-F5411 TCGA-60-2724 TCGA-60-2724-01A -17462 0 717 NO NO 2010-7-20 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.9 8070/3 C34.9 YES 0.9 NO NO 1.5 NO 60 No M0 N1 T3 Stage IIIA TCGA-60-2724.7a4d6104-67c3-4cbc-ab20-34babe747aba.pdf 2724 TUMOR FREE NO R0 Primary Tumor 01 0.4 2006 YES NO YES 60 4 Lung A LIVING 2008 1976 c3c18dde-e425-48c9-a6d6-6d55c31147f3 TCGA-60-2724-01A-01D-0848-05 TCGA-60-2724-01A-01D-1522-08 c3c18dde-e425-48c9-a6d6-6d55c31147f3 TCGA-60-2724-01A-01D-0844-01 TCGA-60-2724-01A-01R-0851-07 c3c18dde-e425-48c9-a6d6-6d55c31147f3 TCGA-60-2724-01A-01D-0844-01 TCGA-60-2724-01A-21-2193-20 +TCGA-60-2725-01 TCGA-60-2725-01 Kirc+ C2-Squamous-like Cluster 5 squamous c3 squamous-like c4 miRNA c1uster 9 mutation c1uster 9 TCGA-60-2725 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 74 L-Upper TCGA-60-2725-F12454 TCGA-60-2725 TCGA-60-2725-01A -27073 0 816 0 NO NO Complete Remission/Response 2011-6-2 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.6 NO 90 NO Central Lung 1.2 NO 56 No M0 N0 T2 Stage IB TCGA-60-2725.86e5a074-bb1a-426e-987d-fc91ffd0ef21.pdf 2725 Post-Adjuvant Therapy TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 0.3 1978 NO NO YES 60 3 Lung A LIVING 2009 1950 d540849d-46de-4d86-b93e-c4eb220d9dd1 TCGA-60-2725-01A-01D-1198-05 TCGA-60-2725-01A-01D-1267-08 d540849d-46de-4d86-b93e-c4eb220d9dd1 TCGA-60-2725-01A-01D-1195-01 TCGA-60-2725-01A-01R-1201-07 d540849d-46de-4d86-b93e-c4eb220d9dd1 TCGA-60-2725-01A-01D-1195-01 TCGA-60-2725-01A-21-2193-20 +TCGA-60-2726-01 TCGA-60-2726-01 High C2-Squamous-like Cluster 5 squamous c3 squamous-like c4 mutation cluster 4 TCGA-60-2726 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung NO NO 56 R-Middle TCGA-60-2726-F5413 TCGA-60-2726 TCGA-60-2726-01A -20618 358 0 358 NO NO 2010-7-20 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.2 8070/3 C34.2 YES 0.8 NO 0 NO Central Lung 1 NO 42 No M0 N1 T2 Stage IIA TCGA-60-2726.ef1d119f-abc8-4adf-bc23-53141a65cfff.pdf 2726 TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 0.3 2009 NO NO YES 60 4 Lung A DECEASED 2009 1967 7642842f-8f88-4ac5-a393-ec2d37655033 TCGA-60-2726-01A-01D-0848-05 TCGA-60-2726-01A-01D-1522-08 7642842f-8f88-4ac5-a393-ec2d37655033 TCGA-60-2726-01A-01D-0844-01 TCGA-60-2726-01A-01R-0851-07 7642842f-8f88-4ac5-a393-ec2d37655033 TCGA-60-2726-01A-01D-0844-01 TCGA-60-2726-01A-21-2193-20 +TCGA-62-8394-01 TCGA-62-8394-01 Cluster 5 miRNA cluster 4 TCGA-62-8394 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 65 L-Lower TCGA-62-8394 TCGA-62-8394-01A -23758 139 0 NO NO 2012-7-5 FEMALE Lung Adenocarcinoma Mixed Subtype No C34.3 8255/3 C34.3 YES 0.6 NO 100 NO Central Lung 0.7 NO No M0 N2 T4 Stage IIIB TCGA-62-8394.ffcaea73-0146-4b42-aa1d-e032f6944e3d.pdf 8394 Preoperative TUMOR FREE 74 115 Complete Remission/Response YES NO R0 Primary Tumor 01 0.3 6th YES NO YES 62 1 Lung A DECEASED 2008 9713f322-bae0-47aa-88d5-e2c50a7bd687 9713f322-bae0-47aa-88d5-e2c50a7bd687 TCGA-62-8394-01A-11D-2324-05 TCGA-62-8394-01A-11D-2322-01 9713f322-bae0-47aa-88d5-e2c50a7bd687 TCGA-62-8394-01A-11D-2322-01 +TCGA-62-8395-01 TCGA-62-8395-01 Cluster 6 miRNA cluster 4 TCGA-62-8395 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung YES NO NO 80 R-Upper TCGA-62-8395-F42099 TCGA-62-8395 TCGA-62-8395-01A -29311 0 1216 395 0 YES NO Scheduled Follow-up Submission Progressive Disease 2013-5-15 FEMALE Lung Adenocarcinoma Mixed Subtype No C34.1 8255/3 C34.1 YES 0.6 NO 100 NO Central Lung 1 NO Locoregional Recurrence YES No M0 N0 T3 Stage IIB TCGA-62-8395.d30859b7-5af5-4579-854b-bab436e3ae9a.pdf 8395 Preoperative WITH TUMOR 86 130 Complete Remission/Response Convincing Imaging YES NO R0 Primary Tumor 01 0.5 6th NO NO YES 62 1 Lung A LIVING 2009 69b5d608-a290-4534-ada5-59055c352fac 69b5d608-a290-4534-ada5-59055c352fac TCGA-62-8395-01A-11D-2324-05 TCGA-62-8395-01A-11D-2322-01 69b5d608-a290-4534-ada5-59055c352fac TCGA-62-8395-01A-11D-2322-01 +TCGA-62-8397-01 TCGA-62-8397-01 Cluster 5 miRNA cluster 4 TCGA-62-8397 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 70 R-Lower TCGA-62-8397-F42100 TCGA-62-8397 TCGA-62-8397-01A -25728 0 1289 0 NO NO Scheduled Follow-up Submission Complete Remission/Response 2013-5-15 FEMALE Lung Adenocarcinoma Mixed Subtype No C34.3 8255/3 C34.3 YES 0.5 NO 90 NO Peripheral Lung 0.6 NO NO No M0 N0 T3 Stage IIB TCGA-62-8397.129e57ab-653d-4b31-8777-0fdd6d01a89d.pdf 8397 Preoperative TUMOR FREE 64 86 Complete Remission/Response YES NO R0 Primary Tumor 01 0.4 6th NO NO YES 62 1 Lung A LIVING 2008 360f4431-8dc9-4bc0-a388-c88bd46766c7 360f4431-8dc9-4bc0-a388-c88bd46766c7 TCGA-62-8397-01A-11D-2324-05 TCGA-62-8397-01A-11D-2322-01 360f4431-8dc9-4bc0-a388-c88bd46766c7 TCGA-62-8397-01A-11D-2322-01 +TCGA-62-8398-01 TCGA-62-8398-01 Cluster 5 miRNA cluster 4 TCGA-62-8398 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 55 R-Lower TCGA-62-8398 TCGA-62-8398-01A -20197 444 0 NO NO 2012-7-4 MALE Lung Adenocarcinoma Mixed Subtype No C34.3 8255/3 C34.3 YES 0.6 NO 100 NO Central Lung 1 NO 20 No M0 N2 T2 Stage IIIA TCGA-62-8398.49359dce-0df1-4d52-87e8-aba44fd43363.pdf 8398 Preoperative TUMOR FREE 72 64 Complete Remission/Response YES NO R0 Primary Tumor 01 0.3 1999 6th YES NO YES 62 4 Lung A DECEASED 2007 1970 82de5dc9-2d34-4395-ae7c-430b5632ed24 82de5dc9-2d34-4395-ae7c-430b5632ed24 TCGA-62-8398-01A-11D-2324-05 TCGA-62-8398-01A-11D-2322-01 82de5dc9-2d34-4395-ae7c-430b5632ed24 TCGA-62-8398-01A-11D-2322-01 +TCGA-62-8399-01 TCGA-62-8399-01 Cluster 5 miRNA cluster 4 TCGA-62-8399 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 62 L-Upper TCGA-62-8399-F52545 TCGA-62-8399 TCGA-62-8399-01A -22952 0 2696 NO NO Scheduled Follow-up Submission Complete Remission/Response 2013-12-4 MALE Lung Papillary Adenocarcinoma No C34.1 8255/3 C34.1 YES 0.6 NO 100 NO Peripheral Lung 1 NO NO 70 No M0 N2 T2 Stage IIIA TCGA-62-8399.10c88394-5444-48a1-be79-56733264d087.pdf 8399 Preoperative TUMOR FREE 48 32 Complete Remission/Response YES NO R0 Primary Tumor 01 0.3 6th NO NO YES 62 4 Lung A LIVING 2006 b1235878-9ab0-4335-befc-869ffa79cfab b1235878-9ab0-4335-befc-869ffa79cfab TCGA-62-8399-01A-21D-2324-05 TCGA-62-8399-01A-21D-2322-01 b1235878-9ab0-4335-befc-869ffa79cfab TCGA-62-8399-01A-21D-2322-01 +TCGA-62-8402-01 TCGA-62-8402-01 Cluster 5 miRNA cluster 4 TCGA-62-8402 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung YES YES NO 73 R-Upper TCGA-62-8402-F52547 TCGA-62-8402 TCGA-62-8402-01A -26934 1498 0 1445 772 0 YES Exon 19 Deletion NO Scheduled Follow-up Submission Progressive Disease 2013-12-4 FEMALE Lung Adenocarcinoma Mixed Subtype No C34.1 8255/3 C34.1 YES 0.6 NO 100 NO Peripheral Lung 0.7 NO Distant Metastasis YES No M0 N2 T2 Stage IIIA TCGA-62-8402.c5ebd021-924a-48b4-a401-b7802f7acf92.pdf 8402 Preoperative WITH TUMOR 80 134 Complete Remission/Response Convincing Imaging YES NO R0 Primary Tumor 01 0.2 6th NO NO YES 62 1 Lung A DECEASED 2008 21e0230a-8314-4d80-afca-9326c34d1299 21e0230a-8314-4d80-afca-9326c34d1299 TCGA-62-8402-01A-11D-2324-05 TCGA-62-8402-01A-11D-2322-01 21e0230a-8314-4d80-afca-9326c34d1299 TCGA-62-8402-01A-11D-2322-01 +TCGA-62-A46O-01 TCGA-62-A46O-01 TCGA-62-A46O TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 65 R-Lower TCGA-62-A46O TCGA-62-A46O-01A -24050 2349 1454 0 NO NO 2012-10-29 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 70 NO 100 NO Central Lung YES 48 true No M0 N0 T2 Stage IB TCGA-62-A46O.C1EAC8C9-2538-4FEB-9DFF-FF9AE7A20F42.pdf A46O Preoperative WITH TUMOR 65 106 Complete Remission/Response YES NO R0 Primary Tumor 01 6th NO NO YES 62 2 Lung A DECEASED 2006 a5105fe6-6ba9-4977-a976-49d9a1b6f164 a5105fe6-6ba9-4977-a976-49d9a1b6f164 TCGA-62-A46O-01A-11D-A24I-05 TCGA-62-A46O-01A-11D-A24C-01 a5105fe6-6ba9-4977-a976-49d9a1b6f164 TCGA-62-A46O-01A-11D-A24C-01 +TCGA-62-A46P-01 TCGA-62-A46P-01 TCGA-62-A46P TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 65 L-Upper TCGA-62-A46P TCGA-62-A46P-01A -23993 2254 594 0 NO NO 2012-10-29 MALE Lung Adenocarcinoma Mixed Subtype No C34.1 8255/3 C34.1 YES 90 NO 100 NO Central Lung YES 40 true No M0 N0 T2 Stage IB TCGA-62-A46P.1520ADC4-F5A7-4412-B2E7-A26326EE0074.pdf A46P Preoperative TUMOR FREE 66 78 Complete Remission/Response YES NO R0 Primary Tumor 01 6th NO NO YES 62 4 Lung A DECEASED 2006 ddf657f3-c764-4003-9de5-3384931c711b ddf657f3-c764-4003-9de5-3384931c711b TCGA-62-A46P-01A-11D-A24I-05 TCGA-62-A46P-01A-11D-A24C-01 ddf657f3-c764-4003-9de5-3384931c711b TCGA-62-A46P-01A-11D-A24C-01 +TCGA-62-A46R-01 TCGA-62-A46R-01 TCGA-62-A46R TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 54 L-Lower TCGA-62-A46R TCGA-62-A46R-01A -20063 2071 1725 0 NO NO 2012-10-29 FEMALE Lung Adenocarcinoma Mixed Subtype No C34.3 8255/3 C34.3 YES 100 NO 100 NO Central Lung NO 25 true No M0 N0 T2 Stage IB TCGA-62-A46R.7AF85E19-CD80-40FD-B0BE-CFFF4B252C0D.pdf A46R Preoperative TUMOR FREE 73 74 Complete Remission/Response YES NO R0 Primary Tumor 01 6th NO NO YES 62 4 Lung A DECEASED 2006 fae54004-1d4e-414e-a85e-667fc2cb89b5 fae54004-1d4e-414e-a85e-667fc2cb89b5 TCGA-62-A46R-01A-11D-A24I-05 TCGA-62-A46R-01A-11D-A24C-01 fae54004-1d4e-414e-a85e-667fc2cb89b5 TCGA-62-A46R-01A-11D-A24C-01 +TCGA-62-A46S-01 TCGA-62-A46S-01 TCGA-62-A46S TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 73 L-Upper TCGA-62-A46S TCGA-62-A46S-01A -26825 1936 1653 0 0 NO NO 2012-10-29 MALE Lung Papillary Adenocarcinoma No C34.1 8260/3 C34.1 YES 150 NO 100 NO Peripheral Lung YES 40 true No M0 N0 T2 Stage IB TCGA-62-A46S.56821636-8883-494F-A808-61AD827CE524.pdf A46S Preoperative WITH TUMOR 66 72 Complete Remission/Response YES NO R0 Primary Tumor 01 6th YES NO YES 62 4 Lung A DECEASED 2007 cc85d7b0-8421-4ea1-b647-92d3d0bbe550 cc85d7b0-8421-4ea1-b647-92d3d0bbe550 TCGA-62-A46S-01A-11D-A24I-05 TCGA-62-A46S-01A-11D-A24C-01 cc85d7b0-8421-4ea1-b647-92d3d0bbe550 TCGA-62-A46S-01A-11D-A24C-01 +TCGA-62-A46U-01 TCGA-62-A46U-01 TCGA-62-A46U TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 71 R-Lower TCGA-62-A46U-F51441 TCGA-62-A46U TCGA-62-A46U-01A -25998 1834 0 2067 NO NO Scheduled Follow-up Submission Complete Remission/Response 2013-11-19 FEMALE Lung Adenocarcinoma Mixed Subtype No C34.3 8255/3 C34.3 YES 70 NO 100 NO Central Lung NO NO true No M0 N1 T2 Stage IIB TCGA-62-A46U.15C4143C-779A-44D7-B75F-867E5E0F7671.pdf A46U Preoperative TUMOR FREE 81 131 Complete Remission/Response YES NO R0 Primary Tumor 01 6th YES NO YES 62 1 Lung A LIVING 2007 83ca9e67-060b-45ec-9ea9-076a64ae8062 83ca9e67-060b-45ec-9ea9-076a64ae8062 TCGA-62-A46U-01A-11D-A24I-05 TCGA-62-A46U-01A-11D-A24C-01 83ca9e67-060b-45ec-9ea9-076a64ae8062 TCGA-62-A46U-01A-11D-A24C-01 +TCGA-62-A46V-01 TCGA-62-A46V-01 TCGA-62-A46V TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 78 L-Lower TCGA-62-A46V-F51440 TCGA-62-A46V TCGA-62-A46V-01A -28495 1751 0 2199 NO NO Scheduled Follow-up Submission Complete Remission/Response 2013-11-19 FEMALE Lung Adenocarcinoma Mixed Subtype No C34.3 8255/3 C34.3 YES 100 NO 90 NO Peripheral Lung NO NO true No M0 N0 T2 Stage IB TCGA-62-A46V.FC6490C8-996A-4FD9-B0B5-65ED9E0AE6C7.pdf A46V Preoperative TUMOR FREE 51 100 Complete Remission/Response YES NO R0 Primary Tumor 01 6th NO NO YES 62 3 Lung A LIVING 2007 fc475e1d-25de-46e4-9191-9e5ee16f0371 fc475e1d-25de-46e4-9191-9e5ee16f0371 TCGA-62-A46V-01A-11D-A24I-05 TCGA-62-A46V-01A-11D-A24C-01 fc475e1d-25de-46e4-9191-9e5ee16f0371 TCGA-62-A46V-01A-11D-A24C-01 +TCGA-62-A46Y-01 TCGA-62-A46Y-01 TCGA-62-A46Y TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 70 R-Lower TCGA-62-A46Y TCGA-62-A46Y-01A -25905 1608 414 0 NO NO 2012-10-30 FEMALE Lung Adenocarcinoma Mixed Subtype No C34.3 8255/3 C34.3 YES 80 NO 90 NO Peripheral Lung YES true No M0 N2 T2 Stage IIIA TCGA-62-A46Y.284FE692-BC27-4E0E-A92A-2DF64FF33405.pdf A46Y Preoperative WITH TUMOR 84 88 Complete Remission/Response YES YES R0 Primary Tumor 01 6th YES NO YES 62 1 Lung A DECEASED 2008 085abecb-d625-44e2-b699-34f9863a9b28 085abecb-d625-44e2-b699-34f9863a9b28 TCGA-62-A46Y-01A-11D-A24I-05 TCGA-62-A46Y-01A-11D-A24C-01 085abecb-d625-44e2-b699-34f9863a9b28 TCGA-62-A46Y-01A-11D-A24C-01 +TCGA-62-A470-01 TCGA-62-A470-01 TCGA-62-A470 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 84 R-Upper TCGA-62-A470 TCGA-62-A470-01A -30689 1310 1194 0 0 NO NO 2012-10-30 MALE Lung Acinar Adenocarcinoma No C34.1 8550/3 C34.1 YES 80 NO 100 NO Central Lung YES 30 true No M0 N0 T2 Stage IB TCGA-62-A470.C0136855-AF03-4065-8563-5C2B232D7070.pdf A470 Preoperative WITH TUMOR 74 111 Complete Remission/Response YES NO R0 Primary Tumor 01 6th NO NO YES 62 3 Lung A DECEASED 2009 4f8a59d0-d4e5-4015-9bec-46fccd7d139e 4f8a59d0-d4e5-4015-9bec-46fccd7d139e TCGA-62-A470-01A-11D-A24I-05 TCGA-62-A470-01A-11D-A24C-01 4f8a59d0-d4e5-4015-9bec-46fccd7d139e TCGA-62-A470-01A-11D-A24C-01 +TCGA-62-A471-01 TCGA-62-A471-01 TCGA-62-A471 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 64 L-Upper TCGA-62-A471-F51439 TCGA-62-A471 TCGA-62-A471-01A -23689 951 0 1246 0 NO NO Scheduled Follow-up Submission Complete Remission/Response 2013-11-19 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 130 NO 100 NO Peripheral Lung NO NO 30 true No M0 N1 T2b Stage IIB TCGA-62-A471.5F2495BD-2398-4C97-8F3E-76E979F22691.pdf A471 Preoperative TUMOR FREE 75 104 Complete Remission/Response YES NO R0 Primary Tumor 01 2006 7th YES NO YES 62 4 Lung A LIVING 2010 d0979d89-4efa-4e30-8510-8aa96a7c2f3d d0979d89-4efa-4e30-8510-8aa96a7c2f3d TCGA-62-A471-01A-12D-A24I-05 TCGA-62-A471-01A-12D-A24C-01 d0979d89-4efa-4e30-8510-8aa96a7c2f3d TCGA-62-A471-01A-12D-A24C-01 +TCGA-62-A472-01 TCGA-62-A472-01 TCGA-62-A472 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung NO YES NO 70 R-Lower TCGA-62-A472-F51442 TCGA-62-A472 TCGA-62-A472-01A -25893 498 0 910 290 1 NO NO Scheduled Follow-up Submission Partial Remission/Response 2013-11-19 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 80 NO 80 NO Central Lung NO Locoregional Recurrence YES 60 true No M0 N0 T3 Stage IIB TCGA-62-A472.1C47AD8C-F1EB-4B7E-9633-3260EF8CEAE4.pdf A472 Preoperative WITH TUMOR 70 87 Complete Remission/Response Convincing Imaging YES NO R0 Primary Tumor 01 7th NO NO YES 62 2 Lung A LIVING 2011 17a290d7-8577-4d11-8842-86c2f48e1cac 17a290d7-8577-4d11-8842-86c2f48e1cac TCGA-62-A472-01A-11D-A24I-05 TCGA-62-A472-01A-11D-A24C-01 17a290d7-8577-4d11-8842-86c2f48e1cac TCGA-62-A472-01A-11D-A24C-01 +TCGA-63-5128-01 TCGA-63-5128-01 Squamous C2-Squamous-like Cluster 13 (HNSC-LUSC) squamous c3 squamous-like c4 miRNA cluster 11 mutation cluster 8 TCGA-63-5128 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung NO NO NO L-Upper TCGA-63-5128-F11740 TCGA-63-5128 TCGA-63-5128-01A NO NO Progressive Disease 2011-4-4 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.8 NO NO 1.1 YES No M0 N0 T2 Stage IB TCGA-63-5128.0883f7aa-5aa8-45d8-89b2-6279d2088c72.pdf 5128 Adjuvant therapy WITH TUMOR 60 Complete Remission/Response NO R0 Primary Tumor 01 0.4 2002 6th NO NO YES 63 4 Lung A DECEASED 2007 4609abbc-9257-40f5-aaa3-176ab36ddd51 TCGA-63-5128-01A-01D-1441-08 4609abbc-9257-40f5-aaa3-176ab36ddd51 TCGA-63-5128-01A-01D-1440-05 TCGA-63-5128-01A-01D-1439-01 TCGA-63-5128-01A-01R-1443-07 4609abbc-9257-40f5-aaa3-176ab36ddd51 TCGA-63-5128-01A-01D-1439-01 TCGA-63-5128-01A-21-2194-20 +TCGA-63-5131-01 TCGA-63-5131-01 Squamous C2-Squamous-like Cluster 5 squamous c3 squamous-like c4 miRNA cluster 4 mutation cluster 5 TCGA-63-5131 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung R-Lower TCGA-63-5131-F11737 TCGA-63-5131 TCGA-63-5131-01A NO NO Complete Remission/Response 2011-4-6 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.9 8070/3 C34.9 YES 0.6 NO 0 NO Central Lung 1.2 NO 50 No M0 N1 T2 Stage IIB TCGA-63-5131.de9fb170-d3d9-4642-a3d3-60639889df2d.pdf 5131 TUMOR FREE 60 Complete Remission/Response YES NO R0 Primary Tumor 01 0.6 2001 6th NO NO YES 63 4 Lung A DECEASED 2008 d998fb64-f09e-462e-b7c4-d2e63e56a553 TCGA-63-5131-01A-01D-1441-08 d998fb64-f09e-462e-b7c4-d2e63e56a553 TCGA-63-5131-01A-01D-1440-05 TCGA-63-5131-01A-01D-1439-01 TCGA-63-5131-01A-01R-1443-07 d998fb64-f09e-462e-b7c4-d2e63e56a553 TCGA-63-5131-01A-01D-1439-01 TCGA-63-5131-01A-21-2194-20 +TCGA-63-6202-01 TCGA-63-6202-01 High C1-LUAD-enriched Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 4 mutation cluster 2 TCGA-63-6202 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung R-Upper TCGA-63-6202-F48025 TCGA-63-6202 TCGA-63-6202-01A 1602 1 Scheduled Follow-up Submission Complete Remission/Response 2013-9-4 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.5 NO Central Lung 1 NO NO 35 No M0 N0 T2 Stage IIA TCGA-63-6202.b8730165-2c60-469b-ae9a-f630fd97016a.pdf 6202 Preoperative TUMOR FREE Complete Remission/Response YES NO R0 Primary Tumor 01 0.4 2008 6th NO NO YES 63 4 Lung A LIVING 2008 1973 a82887c2-9f01-41c0-8c74-2063aaf97261 TCGA-63-6202-01A-11D-1817-08 a82887c2-9f01-41c0-8c74-2063aaf97261 TCGA-63-6202-01A-11D-1818-05 TCGA-63-6202-01A-11D-1816-01 a82887c2-9f01-41c0-8c74-2063aaf97261 TCGA-63-6202-01A-11D-1816-01 TCGA-63-6202-01A-13-2194-20 +TCGA-63-7020-01 TCGA-63-7020-01 High C2-Squamous-like Cluster 5 squamous c3 squamous-like c4 miRNA cluster 4 TCGA-63-7020 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung R-Upper TCGA-63-7020-F48027 TCGA-63-7020 TCGA-63-7020-01A 2133 93 1 Scheduled Follow-up Submission Complete Remission/Response 2013-9-4 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.5 NO Peripheral Lung 0.8 NO NO 50 No M0 N0 T1 Stage IA TCGA-63-7020.16835e39-755e-4959-9014-7946bb7fed2d.pdf 7020 Other TUMOR FREE Complete Remission/Response YES NO R0 Primary Tumor 01 0.4 2010 6th NO NO YES 63 4 Lung A LIVING 2007 1957 5f76cbbf-fb21-4ec7-8ff3-5f7baf16488d 5f76cbbf-fb21-4ec7-8ff3-5f7baf16488d TCGA-63-7020-01A-11D-1947-05 TCGA-63-7020-01A-11D-1943-01 5f76cbbf-fb21-4ec7-8ff3-5f7baf16488d TCGA-63-7020-01A-11D-1943-01 TCGA-63-7020-01A-13-2194-20 +TCGA-63-7021-01 TCGA-63-7021-01 Squamous C2-Squamous-like Low purity c2 squamous c3 squamous-like c4 miRNA cluster 11 TCGA-63-7021 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung NO NO L-Upper TCGA-63-7021-F48028 TCGA-63-7021 TCGA-63-7021-01A 2142 1503 62 0 Scheduled Follow-up Submission Complete Remission/Response 2013-9-4 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.4 NO Peripheral Lung 0.7 NO New Primary Tumor YES 21 No M0 N0 T1 Stage IA TCGA-63-7021.c5d87b3e-b93b-4a74-aee0-966187b1999e.pdf 7021 Other TUMOR FREE Complete Remission/Response YES NO R0 Primary Tumor 01 0.3 2007 6th NO NO YES 63 4 Lung A LIVING 2007 1955 18278118-50d2-4f87-9892-54d40d81391c 18278118-50d2-4f87-9892-54d40d81391c TCGA-63-7021-01A-11D-1947-05 TCGA-63-7021-01A-11D-1943-01 18278118-50d2-4f87-9892-54d40d81391c TCGA-63-7021-01A-11D-1943-01 TCGA-63-7021-01A-13-2194-20 +TCGA-63-7022-01 TCGA-63-7022-01 High C2-Squamous-like Low purity c2 squamous c3 squamous-like c4 miRNA cluster 7 TCGA-63-7022 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung L-Upper TCGA-63-7022-F48029 TCGA-63-7022 TCGA-63-7022-01A 2073 0 Scheduled Follow-up Submission Complete Remission/Response 2013-9-4 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.5 NO Peripheral Lung 0.9 NO NO 30 No M0 N0 T1 Stage IA TCGA-63-7022.ae7a8f69-0082-4dbe-839b-e16b5875c6e4.pdf 7022 Other TUMOR FREE Complete Remission/Response YES NO R0 Primary Tumor 01 0.4 2007 6th NO NO YES 63 4 Lung A LIVING 2007 1947 df4110b6-3360-4c78-bb4f-89ae7cffba0c df4110b6-3360-4c78-bb4f-89ae7cffba0c TCGA-63-7022-01A-11D-1947-05 TCGA-63-7022-01A-11D-1943-01 df4110b6-3360-4c78-bb4f-89ae7cffba0c TCGA-63-7022-01A-11D-1943-01 TCGA-63-7022-01A-13-2194-20 +TCGA-63-7023-01 TCGA-63-7023-01 Squamous C2-Squamous-like Cluster 5 squamous c3 squamous-like c4 TCGA-63-7023 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung L-Lower TCGA-63-7023-F48030 TCGA-63-7023 TCGA-63-7023-01A 1682 70 1 Scheduled Follow-up Submission Complete Remission/Response 2013-9-4 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.8 NO Central Lung 1 NO NO 55 No M0 N1 T1 Stage IIA TCGA-63-7023.ed241575-c4e4-44c8-9692-428b82be431d.pdf 7023 Other TUMOR FREE 87 Complete Remission/Response YES YES R0 Primary Tumor 01 0.5 2008 6th YES NO YES 63 4 Lung A LIVING 2008 1952 8322db3e-e34c-469a-becd-a29ce4676473 8322db3e-e34c-469a-becd-a29ce4676473 TCGA-63-7023-01A-11D-1947-05 TCGA-63-7023-01A-11D-1943-01 8322db3e-e34c-469a-becd-a29ce4676473 TCGA-63-7023-01A-11D-1943-01 TCGA-63-7023-01A-13-2194-20 +TCGA-63-A5M9-01 TCGA-63-A5M9-01 TCGA-63-A5M9 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung L-Lower TCGA-63-A5M9-F64766 TCGA-63-A5M9 TCGA-63-A5M9-01A 0 Scheduled Follow-up Submission 2014-9-11 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 40 NO YES 25 false M0 N1 T2 Stage IIB TCGA-63-A5M9.4125B48F-3D99-41B5-951A-6A7AF253DF1E.pdf A5M9 RX Primary Tumor 01 2010 6th NO YES 63 4 Lung A LIVING 9e35f111-e7b9-4238-bbfb-88a74d51f1b4 9e35f111-e7b9-4238-bbfb-88a74d51f1b4 TCGA-63-A5M9-01A-11D-A26N-05 TCGA-63-A5M9-01A-11D-A26L-01 9e35f111-e7b9-4238-bbfb-88a74d51f1b4 TCGA-63-A5M9-01A-11D-A26L-01 +TCGA-63-A5MB-01 TCGA-63-A5MB-01 TCGA-63-A5MB TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 62 L-Upper TCGA-63-A5MB-F64768 TCGA-63-A5MB TCGA-63-A5MB-01A -22930 3123 NO NO Scheduled Follow-up Submission Complete Remission/Response 2014-9-11 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 210 NO NO NO NO 25 false No M0 N0 T2 Stage IB TCGA-63-A5MB.D830087F-913A-4E59-9EC4-A230E613B0DF.pdf A5MB TUMOR FREE Complete Remission/Response NO NO R0 Primary Tumor 01 1995 6th YES NO YES 63 3 Lung A LIVING 79fd09d5-1323-4370-b6fb-b8c01d9db6e9 79fd09d5-1323-4370-b6fb-b8c01d9db6e9 TCGA-63-A5MB-01A-11D-A26N-05 TCGA-63-A5MB-01A-11D-A26L-01 79fd09d5-1323-4370-b6fb-b8c01d9db6e9 TCGA-63-A5MB-01A-11D-A26L-01 +TCGA-63-A5MG-01 TCGA-63-A5MG-01 TCGA-63-A5MG TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 68 L-Lower TCGA-63-A5MG-F64777 TCGA-63-A5MG TCGA-63-A5MG-01A -24957 2148 NO Scheduled Follow-up Submission Complete Remission/Response 2014-9-11 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 120 NO NO NO NO false No M0 N0 T2 Stage IB TCGA-63-A5MG.5D9D3CB6-1FE3-4DAE-8C36-C94D802E430F.pdf A5MG TUMOR FREE Complete Remission/Response NO NO R0 Primary Tumor 01 1990 6th NO NO YES 63 3 Lung A LIVING 1cd8c21c-72a5-40df-9b65-3006bebdfa86 1cd8c21c-72a5-40df-9b65-3006bebdfa86 TCGA-63-A5MG-01A-12D-A27L-05 TCGA-63-A5MG-01A-12D-A27J-01 1cd8c21c-72a5-40df-9b65-3006bebdfa86 TCGA-63-A5MG-01A-12D-A27J-01 +TCGA-63-A5MH-01 TCGA-63-A5MH-01 TCGA-63-A5MH TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 68 L-Lower TCGA-63-A5MH-F64779 TCGA-63-A5MH TCGA-63-A5MH-01A -25159 2026 NO NO Scheduled Follow-up Submission Complete Remission/Response 2014-9-11 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 80 NO NO NO NO 35 false Yes, History of Synchronous/Bilateral Malignancy M0 N0 T1 Stage IA TCGA-63-A5MH.E96A18CD-781D-49AD-BE80-91B42A3C6868.pdf A5MH TUMOR FREE Complete Remission/Response NO NO R0 Primary Tumor 01 6th NO NO YES 63 5 Lung A LIVING 76e9e0bd-c2d9-4659-b71e-c913094adc93 76e9e0bd-c2d9-4659-b71e-c913094adc93 TCGA-63-A5MH-01A-12D-A27L-05 TCGA-63-A5MH-01A-12D-A27J-01 76e9e0bd-c2d9-4659-b71e-c913094adc93 TCGA-63-A5MH-01A-12D-A27J-01 +TCGA-63-A5MI-01 TCGA-63-A5MI-01 TCGA-63-A5MI TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 65 Bronchial TCGA-63-A5MI-F64782 TCGA-63-A5MI TCGA-63-A5MI-01A -24040 1784 NO NO Scheduled Follow-up Submission Complete Remission/Response 2014-9-11 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 230 NO NO Peripheral Lung NO NO 50 false No M0 N2 T2 Stage IIIA TCGA-63-A5MI.2B06F8A1-CAA2-4796-9FE0-DD46866654FB.pdf A5MI TUMOR FREE Complete Remission/Response YES NO R0 Primary Tumor 01 2008 6th YES NO YES 63 4 Lung A LIVING 56947d0d-2959-4746-9955-e085fd9afc32 56947d0d-2959-4746-9955-e085fd9afc32 TCGA-63-A5MI-01A-12D-A27L-05 TCGA-63-A5MI-01A-12D-A27J-01 56947d0d-2959-4746-9955-e085fd9afc32 TCGA-63-A5MI-01A-12D-A27J-01 +TCGA-63-A5MJ-01 TCGA-63-A5MJ-01 TCGA-63-A5MJ TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 54 Other (please specify) Left lung, main bronchus TCGA-63-A5MJ-F64785 TCGA-63-A5MJ TCGA-63-A5MJ-01A -20018 1824 NO NO Scheduled Follow-up Submission Complete Remission/Response 2014-9-11 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.9 8070/3 C34.9 YES 90 NO NO NO NO false No M0 N1 T2 Stage IIB TCGA-63-A5MJ.3F93AE77-BCC1-45CE-B5BC-1ED86C002A88.pdf A5MJ TUMOR FREE Complete Remission/Response YES NO R0 Primary Tumor 01 6th YES NO YES 63 2 Lung A LIVING 1989 518b950c-2097-407c-afa5-a4779cb221aa 518b950c-2097-407c-afa5-a4779cb221aa TCGA-63-A5MJ-01A-11D-A27L-05 TCGA-63-A5MJ-01A-11D-A27J-01 518b950c-2097-407c-afa5-a4779cb221aa TCGA-63-A5MJ-01A-11D-A27J-01 +TCGA-63-A5ML-01 TCGA-63-A5ML-01 TCGA-63-A5ML TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 68 R-Lower TCGA-63-A5ML-F64786 TCGA-63-A5ML TCGA-63-A5ML-01A -24947 1386 NO NO Scheduled Follow-up Submission Complete Remission/Response 2014-9-11 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 280 NO NO NO NO 60 false No M0 N0 T2 Stage IB TCGA-63-A5ML.F595F7AB-559C-4FEF-A49A-E7B7DB8E9352.pdf A5ML TUMOR FREE Complete Remission/Response YES NO R0 Primary Tumor 01 2009 6th YES NO YES 63 4 Lung A LIVING f8dc8adc-22a6-4b4d-afd7-53a7c766c8cf f8dc8adc-22a6-4b4d-afd7-53a7c766c8cf TCGA-63-A5ML-01A-31D-A27L-05 TCGA-63-A5ML-01A-31D-A27J-01 f8dc8adc-22a6-4b4d-afd7-53a7c766c8cf TCGA-63-A5ML-01A-31D-A27J-01 +TCGA-63-A5MM-01 TCGA-63-A5MM-01 TCGA-63-A5MM TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung NO YES NO NO 69 Bronchial TCGA-63-A5MM-F64990 TCGA-63-A5MM TCGA-63-A5MM-01A -25348 456 218 88 NO NO Scheduled Follow-up Submission Progressive Disease 2014-9-17 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.8 8070/3 C34.8 YES 230 NO NO NO YES 30 false No M0 N1 T2 Stage IIB TCGA-63-A5MM.5174B6E7-5492-4E02-99D2-CD23D456E7F0.pdf A5MM WITH TUMOR 79 Complete Remission/Response YES NO R0 Primary Tumor 01 1989 6th YES NO YES 63 3 Lung A DECEASED 87f18dcb-093e-4dac-91e1-73183fc6a0d9 87f18dcb-093e-4dac-91e1-73183fc6a0d9 TCGA-63-A5MM-01A-11D-A26N-05 TCGA-63-A5MM-01A-11D-A26L-01 87f18dcb-093e-4dac-91e1-73183fc6a0d9 TCGA-63-A5MM-01A-11D-A26L-01 +TCGA-63-A5MN-01 TCGA-63-A5MN-01 TCGA-63-A5MN TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung NO NO NO NO 78 R-Upper TCGA-63-A5MN-F64991 TCGA-63-A5MN TCGA-63-A5MN-01A -28677 345 320 103 NO NO Scheduled Follow-up Submission Progressive Disease 2014-9-17 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 490 NO NO NO YES false No M0 N0 T3 Stage IIB TCGA-63-A5MN.DE0BDA98-3AB9-4CED-AB54-81226E239786.pdf A5MN WITH TUMOR 87 Complete Remission/Response YES YES R1 Primary Tumor 01 6th NO NO YES 63 1 Lung A DECEASED 6c120b12-014b-4722-9b9d-b37de6d3d8c0 6c120b12-014b-4722-9b9d-b37de6d3d8c0 TCGA-63-A5MN-01A-22D-A27L-05 TCGA-63-A5MN-01A-22D-A27J-01 6c120b12-014b-4722-9b9d-b37de6d3d8c0 TCGA-63-A5MN-01A-22D-A27J-01 +TCGA-63-A5MP-01 TCGA-63-A5MP-01 TCGA-63-A5MP TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 56 R-Lower TCGA-63-A5MP TCGA-63-A5MP-01A -20818 769 66 0 NO NO 2013-9-24 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 150 NO NO Central Lung YES 41 false No M0 N1 T2 Stage IIB TCGA-63-A5MP.FCF08990-AEB1-437F-A6A5-29DC710B49B5.pdf A5MP Preoperative WITH TUMOR 62 Complete Remission/Response YES YES R0 Primary Tumor 01 1997 6th YES NO YES 63 4 Lung A LIVING 1956 e421b4a8-d6e0-4c30-adc2-1311d04f7696 e421b4a8-d6e0-4c30-adc2-1311d04f7696 TCGA-63-A5MP-01A-11D-A26N-05 TCGA-63-A5MP-01A-11D-A26L-01 e421b4a8-d6e0-4c30-adc2-1311d04f7696 TCGA-63-A5MP-01A-11D-A26L-01 +TCGA-63-A5MR-01 TCGA-63-A5MR-01 TCGA-63-A5MR TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 70 L-Upper TCGA-63-A5MR-F65002 TCGA-63-A5MR TCGA-63-A5MR-01A -25879 2716 61 1 NO NO Scheduled Follow-up Submission 2014-9-17 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 310 NO NO Peripheral Lung NO NO 120 false No M0 N0 T2 Stage IB TCGA-63-A5MR.F33B0128-A333-4E13-9403-93F01C2EFB77.pdf A5MR Other TUMOR FREE 60 56 Complete Remission/Response YES NO R0 Primary Tumor 01 1997 6th NO NO YES 63 4 Lung A LIVING 1957 0bb6e848-b69a-465d-9039-1aa75d98815f 0bb6e848-b69a-465d-9039-1aa75d98815f TCGA-63-A5MR-01A-31D-A27L-05 TCGA-63-A5MR-01A-31D-A27J-01 0bb6e848-b69a-465d-9039-1aa75d98815f TCGA-63-A5MR-01A-31D-A27J-01 +TCGA-63-A5MS-01 TCGA-63-A5MS-01 TCGA-63-A5MS TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 78 L-Upper TCGA-63-A5MS-F65006 TCGA-63-A5MS TCGA-63-A5MS-01A -28827 2381 83 1 NO NO Scheduled Follow-up Submission 2014-9-17 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 130 NO NO Central Lung NO NO 6 false No M0 N0 T2 Stage IB TCGA-63-A5MS.931632DA-991E-455F-9C4B-51C787880EE7.pdf A5MS Other TUMOR FREE 94 Complete Remission/Response YES NO R0 Primary Tumor 01 6th NO NO YES 63 3 Lung A LIVING 920292b7-e792-4e3e-89f9-aa0c764aef74 920292b7-e792-4e3e-89f9-aa0c764aef74 TCGA-63-A5MS-01A-11D-A26N-05 TCGA-63-A5MS-01A-11D-A26L-01 920292b7-e792-4e3e-89f9-aa0c764aef74 TCGA-63-A5MS-01A-11D-A26L-01 +TCGA-63-A5MT-01 TCGA-63-A5MT-01 TCGA-63-A5MT TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 74 R-Upper TCGA-63-A5MT TCGA-63-A5MT-01A -27263 498 68 1 NO NO 2013-9-24 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 270 NO NO Peripheral Lung YES 100 false No M0 N0 T3 Stage IIB TCGA-63-A5MT.81E6FD63-4E66-426B-9221-853906532726.pdf A5MT Preoperative WITH TUMOR 86 Complete Remission/Response YES NO R0 Primary Tumor 01 2011 7th YES NO YES 63 4 Lung A LIVING 1961 6309a039-6d4a-4757-8c05-043b17010104 6309a039-6d4a-4757-8c05-043b17010104 TCGA-63-A5MT-01A-21D-A26N-05 TCGA-63-A5MT-01A-21D-A26L-01 6309a039-6d4a-4757-8c05-043b17010104 TCGA-63-A5MT-01A-21D-A26L-01 +TCGA-63-A5MU-01 TCGA-63-A5MU-01 TCGA-63-A5MU TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 48 R-Lower TCGA-63-A5MU-F65013 TCGA-63-A5MU TCGA-63-A5MU-01A -17801 [Discrepancy] 64 0 NO NO Scheduled Follow-up Submission 2014-9-17 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 280 NO 0 NO Central Lung NO NO 15 false No M0 N1 T2b Stage IIB TCGA-63-A5MU.AE73DEFC-421B-4F5D-8882-E15FC4483FF1.pdf A5MU Other WITH TUMOR 69 81 Complete Remission/Response YES NO R0 Primary Tumor 01 2011 7th YES NO YES 63 4 Lung A DECEASED 1981 fe0ee6d5-c68d-40ab-8892-678df4554aa6 fe0ee6d5-c68d-40ab-8892-678df4554aa6 TCGA-63-A5MU-01A-11D-A26N-05 TCGA-63-A5MU-01A-11D-A26L-01 fe0ee6d5-c68d-40ab-8892-678df4554aa6 TCGA-63-A5MU-01A-11D-A26L-01 +TCGA-63-A5MV-01 TCGA-63-A5MV-01 TCGA-63-A5MV TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 69 R-Lower TCGA-63-A5MV-F65014 TCGA-63-A5MV TCGA-63-A5MV-01A -25505 1100 60 0 NO NO Scheduled Follow-up Submission 2014-9-17 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 250 NO NO Peripheral Lung NO NO 50 false No M0 N0 T2b Stage IIA TCGA-63-A5MV.494B2443-C3FD-43A0-A735-29D9D801C9D1.pdf A5MV Other TUMOR FREE 71 64 66 55 Complete Remission/Response YES NO R0 Primary Tumor 01 2011 7th YES NO YES 63 4 Lung A LIVING 1961 34b3ffb2-9fd1-4521-856a-f465f537804b 34b3ffb2-9fd1-4521-856a-f465f537804b TCGA-63-A5MV-01A-21D-A26N-05 TCGA-63-A5MV-01A-21D-A26L-01 34b3ffb2-9fd1-4521-856a-f465f537804b TCGA-63-A5MV-01A-21D-A26L-01 +TCGA-63-A5MW-01 TCGA-63-A5MW-01 TCGA-63-A5MW TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 76 R-Upper TCGA-63-A5MW-F65023 TCGA-63-A5MW TCGA-63-A5MW-01A -27892 1639 41 0 Scheduled Follow-up Submission Complete Remission/Response 2014-9-17 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 70 NO Peripheral Lung NO NO 60 false No M0 N0 T2 Stage IB TCGA-63-A5MW.5D901376-7A8B-4171-A2B2-8449F24252CC.pdf A5MW Other TUMOR FREE 58 59 Complete Remission/Response YES NO R0 Primary Tumor 01 6th NO NO YES 63 4 Lung A LIVING 4daf4ef1-7b4e-4580-ba4c-1f8e81d8b250 4daf4ef1-7b4e-4580-ba4c-1f8e81d8b250 TCGA-63-A5MW-01A-11D-A26N-05 TCGA-63-A5MW-01A-11D-A26L-01 4daf4ef1-7b4e-4580-ba4c-1f8e81d8b250 TCGA-63-A5MW-01A-11D-A26L-01 +TCGA-63-A5MY-01 TCGA-63-A5MY-01 TCGA-63-A5MY TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 63 L-Lower TCGA-63-A5MY-F65025 TCGA-63-A5MY TCGA-63-A5MY-01A -23276 1052 52 Scheduled Follow-up Submission Complete Remission/Response 2014-9-17 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 90 NO NO NO 40 false No M0 N0 T1b Stage IA TCGA-63-A5MY.E2D395F8-F5F6-4870-86D7-F55288204F65.pdf A5MY TUMOR FREE 69 67 69 67 Complete Remission/Response YES NO R0 Primary Tumor 01 2010 7th NO NO YES 63 4 Lung A LIVING 1966 621db48c-a6ba-4cd6-8c58-24a87d4b44b4 621db48c-a6ba-4cd6-8c58-24a87d4b44b4 TCGA-63-A5MY-01A-11D-A26N-05 TCGA-63-A5MY-01A-11D-A26L-01 621db48c-a6ba-4cd6-8c58-24a87d4b44b4 TCGA-63-A5MY-01A-11D-A26L-01 +TCGA-64-1676-01 3.41 0.36 none none none none N N none none none 0.14 Squamoid none none p.C121S none none none none Adenocarcinoma, NOS Adenocarcinoma, NOS none 0 TCGA-64-1676-01 High C1-LUAD-enriched Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 4 mutation cluster 11 TCGA-64-1676 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 58 R-Lower TCGA-64-1676-F4366 TCGA-64-1676 TCGA-64-1676-01A -21428 0 1728 Complete Remission/Response 2010-11-15 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 0.5 NO Central Lung 1.5 NO 60 No M0 N0 T1a Stage IA TCGA-64-1676.516b08af-72b5-4b4a-b208-3c874abe63ad.pdf 1676 TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 0.3 NO NO YES 64 2 Current smoker Lung A LIVING 2005 6447a7cf-ae7a-4896-b00f-10c357eb8c8b TCGA-64-1676-01A-01D-0945-05 TCGA-64-1676-01 6447a7cf-ae7a-4896-b00f-10c357eb8c8b TCGA-64-1676-01A-01D-0944-01 TCGA-64-1676-01A-01R-0946-07 6447a7cf-ae7a-4896-b00f-10c357eb8c8b TCGA-64-1676-01A-01D-0944-01 TCGA-64-1676-01A-21-2190-20 +TCGA-64-1677-01 2.68 0.32 none none none none N N none none none 0.14 Magnoid none none none none none p.E545K none Adenocarcinoma, NOS Adenocarcinoma, NOS none 0 TCGA-64-1677-01 High C1-LUAD-enriched Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 7 mutation cluster 2 TCGA-64-1677 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung YES YES NO NO 77 R-Lower TCGA-64-1677-F8691 TCGA-64-1677 TCGA-64-1677-01A -28482 628 0 360 2011-2-18 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.5 NO 0 1 YES 50 Yes M0 N2 T2 Stage IIIA TCGA-64-1677.31f047f0-df34-44d4-b0d1-a3b43833f560.pdf 1677 NO R0 Primary Tumor 01 0.4 YES NO YES 64 2 Current smoker Lung A DECEASED 2005 1955 900735b7-3870-421e-8c87-3f4e86fc8dae TCGA-64-1677-01A-01D-0945-05 TCGA-64-1677-01A-01W-0928-08 900735b7-3870-421e-8c87-3f4e86fc8dae TCGA-64-1677-01A-01D-0944-01 TCGA-64-1677-01A-01R-0946-07 900735b7-3870-421e-8c87-3f4e86fc8dae TCGA-64-1677-01A-01D-0944-01 TCGA-64-1677-01A-21-2190-20 +TCGA-64-1678-01 3.11 0.57 none none none none N Y none none none 0.22 Magnoid none none p.K57N none none none none Adenocarcinoma, NOS Adenocarcinoma, NOS none 1 TCGA-64-1678-01 High C1-LUAD-enriched Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 6 mutation cluster 5 TCGA-64-1678 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 70 R-Middle TCGA-64-1678-F4371 TCGA-64-1678 TCGA-64-1678-01A -25931 0 1189 Complete Remission/Response 2010-11-15 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.8 NO 1 NO 20 No M0 N0 T2b [Discrepancy] TCGA-64-1678.5b49e9b0-c7f5-43a2-9d48-34c1537c148d.pdf 1678 TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 0.3 1990 6th YES NO YES 64 3 Current reformed smoker for > 15 years Lung A LIVING 2006 1970 37f38cd6-6b65-4646-8ee1-d86ccc02fa75 TCGA-64-1678-01A-01D-0945-05 TCGA-64-1678-01A-01W-0928-08 37f38cd6-6b65-4646-8ee1-d86ccc02fa75 TCGA-64-1678-01A-01D-0944-01 TCGA-64-1678-01A-01R-0946-07 37f38cd6-6b65-4646-8ee1-d86ccc02fa75 TCGA-64-1678-01A-01D-0944-01 TCGA-64-1678-01A-21-2190-20 +TCGA-64-1679-01 1.73 0.42 none none none none N N none none none 0.22 Squamoid none none none none none none none Acinar predominant Adc Acinar predominant Adc none 0 TCGA-64-1679-01 Squamous C2-Squamous-like Low purity c2 squamous c3 LUAD-like c10 miRNA cluster 4 TCGA-64-1679 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 58 R-Upper TCGA-64-1679-F66261 TCGA-64-1679 TCGA-64-1679-01A -21310 0 2488 0 Scheduled Follow-up Submission Complete Remission/Response 2014-10-7 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.5 NO NO 1 NO NO 40 No M0 N2 T1 Stage IIIA TCGA-64-1679.dd4816b8-a99f-4f95-94b1-75b011509c2d.pdf 1679 Post-Adjuvant Therapy TUMOR FREE Complete Remission/Response YES NO R0 Primary Tumor 01 0.4 6th YES NO YES 64 2 Current smoker Lung A LIVING 2007 7c6ef5e6-8116-4a21-ae62-88a5e420bcc1 7c6ef5e6-8116-4a21-ae62-88a5e420bcc1 TCGA-64-1679-01A-21D-2064-05 TCGA-64-1679-01A-21D-2062-01 7c6ef5e6-8116-4a21-ae62-88a5e420bcc1 TCGA-64-1679-01A-21D-2062-01 TCGA-64-1679-01A-11-2190-20 +TCGA-64-1680-01 3.41 0.63 none none none none N Y none none none 0.22 Bronchioid none none none none none none none Acinar predominant Adc Acinar predominant Adc Y none 1 TCGA-64-1680-01 Kirc+ C1-LUAD-enriched Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 4 mutation cluster 14 TCGA-64-1680 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 63 R-Middle TCGA-64-1680-F4387 TCGA-64-1680 TCGA-64-1680-01A -23267 0 1126 2010-11-16 MALE Lung Adenocarcinoma Mixed Subtype No C34.8 8255/3 C34.8 YES 0.4 NO 1.2 NO 50 No M1 N2 T2a Stage IV TCGA-64-1680.8daa91a5-773c-4c8b-ab17-b270aa75ec18.pdf 1680 TUMOR FREE Complete Remission/Response YES R0 Primary Tumor 01 0.3 1982 6th YES NO YES 64 3 Current reformed smoker for > 15 years Lung A LIVING 2007 1962 1cade122-820d-4d68-8508-7a6c0f2b4852 TCGA-64-1680-01A-02D-0945-05 TCGA-64-1680-01 1cade122-820d-4d68-8508-7a6c0f2b4852 TCGA-64-1680-01A-02D-0944-01 TCGA-64-1680-01A-02R-0946-07 1cade122-820d-4d68-8508-7a6c0f2b4852 TCGA-64-1680-01A-02D-0944-01 TCGA-64-1680-01A-11-2190-20 +TCGA-64-1681-01 2.97 0.44 none none none none Y Y p.L858R none none 0.18 Bronchioid none none none none none none none Acinar predominant Adc Acinar predominant Adc none 0 TCGA-64-1681-01 BRCA-LUAD+ C1-LUAD-enriched Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 5 TCGA-64-1681 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung YES YES NO 61 R-Upper TCGA-64-1681-F20365 TCGA-64-1681 TCGA-64-1681-01A -22525 1167 0 439 YES Exon 19 Deletion Additional New Tumor Event 2011-12-21 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.9 YES 0.4 NO 0 YES NO 0.8 YES No M0 N0 T1 Stage IA TCGA-64-1681.de31291a-ced6-458b-8fb7-ad47ae581b64.pdf 1681 NO R0 Primary Tumor 01 0.4 1988 6th NO NO YES 64 3 Current reformed smoker for > 15 years Lung A DECEASED 2008 1968 4f0fbd7c-4768-4bf2-b6f4-372f28b1953f 4f0fbd7c-4768-4bf2-b6f4-372f28b1953f TCGA-64-1681-01A-11D-2064-05 TCGA-64-1681-01A-11D-2062-01 4f0fbd7c-4768-4bf2-b6f4-372f28b1953f TCGA-64-1681-01A-11D-2062-01 TCGA-64-1681-01A-21-2190-20 +TCGA-64-5774-01 2.84 0.76 none none none none Y Y none none none 0.29 Magnoid none p.G12C p.G279fs none none none none Adenocarcinoma, NOS Adenocarcinoma, NOS none 0 TCGA-64-5774-01 BRCA-LUAD+ C1-LUAD-enriched Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 6 mutation cluster 12 TCGA-64-5774 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung NO NO YES 60 R-Middle TCGA-64-5774-F31478 TCGA-64-5774 TCGA-64-5774-01A -22059 0 2676 277 95 Additional New Tumor Event 2012-5-3 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.0 8140/3 C34.0 YES 0.6 NO Central Lung 1.4 Distant Metastasis YES 45 No M0 N0 T2 Stage IB TCGA-64-5774.d8d1fecd-1290-4d5a-a98b-3c29f789bde6.pdf 5774 TUMOR FREE 71 72 YES NO R0 Primary Tumor 01 0.2 2004 6th NO NO YES 64 4 Current reformed smoker for < or = 15 years Lung A LIVING 2004 1959 9ea59622-ed8d-48aa-aa45-665a670928a0 TCGA-64-5774-01A-01D-1625-08 9ea59622-ed8d-48aa-aa45-665a670928a0 TCGA-64-5774-01A-01D-1626-05 TCGA-64-5774-01A-01D-1624-01 9ea59622-ed8d-48aa-aa45-665a670928a0 TCGA-64-5774-01A-01D-1624-01 TCGA-64-5774-01A-41-2191-20 +TCGA-64-5775-01 3.39 0.71 none none none none Y Y none none none 0.24 Squamoid none p.Q61L none none none none none Adenocarcinoma, NOS Adenocarcinoma, NOS none 0 TCGA-64-5775-01 Kirc+ C12-small-various Cluster 6 RNA cluster 2 miRNA c1uster 9 mutation cluster 2 TCGA-64-5775 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 71 L-Upper TCGA-64-5775-F11418 TCGA-64-5775 TCGA-64-5775-01A -26058 62 0 Progressive Disease 2011-5-2 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) Yes C34.1 8140/3 C34.1 YES 1.2 NO 0 1.3 NO 110 No M0 N0 T4 Stage IIIA TCGA-64-5775.eb576e3d-fa59-42b7-af77-416013a9bc90.pdf 5775 WITH TUMOR Progressive Disease NO R0 Primary Tumor 01 0.4 NO NO YES 64 2 Current smoker Lung A DECEASED 2005 1950 6cf7d085-d60c-4456-9266-5031628f687c TCGA-64-5775-01A-01D-1625-08 6cf7d085-d60c-4456-9266-5031628f687c TCGA-64-5775-01A-01D-1626-05 TCGA-64-5775-01A-01D-1624-01 6cf7d085-d60c-4456-9266-5031628f687c TCGA-64-5775-01A-01D-1624-01 +TCGA-64-5778-01 3.45 0.42 none none none none Y Y none none p.G640C 0.16 Squamoid none p.G12C none none none none none Adenocarcinoma, NOS Adenocarcinoma, NOS none 0 TCGA-64-5778-01 BRCA-LUAD+ C1-LUAD-enriched Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 4 mutation cluster 2 TCGA-64-5778 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung YES NO NO NO 60 R-Upper TCGA-64-5778-F31471 TCGA-64-5778 TCGA-64-5778-01A -21927 0 1305 1168 1 Additional New Tumor Event Progressive Disease 2012-5-3 MALE Lung Bronchioloalveolar Carcinoma Nonmucinous No C34.1 8252/3 C34.1 YES 0.4 NO 0 Central Lung 1.2 NO YES 68 No M0 N0 T2 Stage IB TCGA-64-5778.36cf9846-5ec1-4d43-8b66-80a802c6b4e7.pdf 5778 Other WITH TUMOR Complete Remission/Response YES NO R0 Primary Tumor 01 0.4 2000 6th NO NO YES 64 4 Current reformed smoker for < or = 15 years Lung A LIVING 2008 1966 b549484e-cce0-4f6f-994c-910b458de4de TCGA-64-5778-01A-01D-1625-08 b549484e-cce0-4f6f-994c-910b458de4de TCGA-64-5778-01A-01D-1626-05 TCGA-64-5778-01A-01D-1624-01 b549484e-cce0-4f6f-994c-910b458de4de TCGA-64-5778-01A-01D-1624-01 TCGA-64-5778-01A-41-2191-20 +TCGA-64-5779-01 TCGA-64-5779-01 BRCA-LUAD+ C1-LUAD-enriched Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 7 mutation cluster 12 TCGA-64-5779 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung NO YES YES 61 L-Lower TCGA-64-5779-F31473 TCGA-64-5779 TCGA-64-5779-01A 797 -22305 0 864 795 100 0 Additional New Tumor Event 2012-5-3 MALE Lung Acinar Adenocarcinoma No C34.3 8550/3 C34.3 YES 1 NO Central Lung 1.3 Distant Metastasis YES 40 No M0 N2 T2 Stage IIIA TCGA-64-5779.74ed3c2e-6708-48d7-bc21-5fc04999614f.pdf 5779 Post-Adjuvant Therapy TUMOR FREE 94 100 [Discrepancy] YES YES R0 Primary Tumor 01 0.4 2009 6th YES NO YES 64 4 Lung A LIVING 2009 1969 0f61b005-3643-4a6b-a075-bffb7320a2f3 TCGA-64-5779-01A-01D-1625-08 0f61b005-3643-4a6b-a075-bffb7320a2f3 TCGA-64-5779-01A-01D-1626-05 TCGA-64-5779-01A-01D-1624-01 0f61b005-3643-4a6b-a075-bffb7320a2f3 TCGA-64-5779-01A-01D-1624-01 TCGA-64-5779-01A-41-2191-20 +TCGA-64-5781-01 1.9 0.38 none none none none N N none none none 0.19 Squamoid none none none p.Y1235H none none none Adenocarcinoma, NOS Adenocarcinoma, NOS none 0 TCGA-64-5781-01 BRCA-LUAD+ C1-LUAD-enriched Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 4 mutation cluster 1 TCGA-64-5781 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung NO NO NO YES 55 R-Upper TCGA-64-5781-F31490 TCGA-64-5781 TCGA-64-5781-01A 112 -20219 0 1559 96 73 0 Additional New Tumor Event Complete Remission/Response 2012-5-3 FEMALE Lung Adenocarcinoma Mixed Subtype No C34.1 8255/3 C34.1 YES 0.8 NO Central Lung 1 Distant Metastasis YES 25 No M0 N0 T2 Stage IB TCGA-64-5781.988a550c-800e-4ba9-9c6a-de986969753b.pdf 5781 Post-Adjuvant Therapy TUMOR FREE 61 77 Progressive Disease YES NO R0 Primary Tumor 01 0.4 2007 6th NO NO YES 64 4 Current reformed smoker for < or = 15 years Lung A LIVING 2007 1982 55228174-5562-47b2-a9f1-f9f5216f8c8c TCGA-64-5781-01A-01D-1625-08 55228174-5562-47b2-a9f1-f9f5216f8c8c TCGA-64-5781-01A-01D-1626-05 TCGA-64-5781-01A-01D-1624-01 55228174-5562-47b2-a9f1-f9f5216f8c8c TCGA-64-5781-01A-01D-1624-01 TCGA-64-5781-01A-41-2191-20 +TCGA-64-5815-01 TCGA-64-5815-01 Kirc+ C1-LUAD-enriched Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 4 mutation cluster 12 TCGA-64-5815 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 74 R-Upper TCGA-64-5815-F31480 TCGA-64-5815 TCGA-64-5815-01A -27280 0 866 87 1 YES Scheduled Follow-up Submission 2012-5-3 MALE Lung Adenocarcinoma Mixed Subtype No C34.1 8255/3 C34.1 YES 0.8 NO YES Central Lung 0.8 30 No M0 N1 T2 Stage IIB TCGA-64-5815.d7bef7c7-2687-4d23-96b2-8dd1f5305997.pdf 5815 Post-Adjuvant Therapy TUMOR FREE 76 89 Complete Remission/Response YES NO R0 Primary Tumor 01 0.2 1985 6th YES NO YES 64 3 Lung A LIVING 2009 a07caf79-5856-4f7d-ae48-7fa82c36cf4d TCGA-64-5815-01A-01D-1625-08 a07caf79-5856-4f7d-ae48-7fa82c36cf4d TCGA-64-5815-01A-01D-1626-05 TCGA-64-5815-01A-01D-1624-01 a07caf79-5856-4f7d-ae48-7fa82c36cf4d TCGA-64-5815-01A-01D-1624-01 TCGA-64-5815-01A-41-2191-20 +TCGA-66-2727-01 TCGA-66-2727-01 Squamous C2-Squamous-like Cluster 13 (HNSC-LUSC) squamous c3 squamous-like c4 miRNA cluster 4 mutation cluster 8 TCGA-66-2727 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 55 L-Lower TCGA-66-2727 TCGA-66-2727-01A -20150 516 0 2011-3-7 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.8 NO 1 56 No M0 N0 T2 Stage IB TCGA-66-2727.97328404-08ac-4c35-b15c-79485d60c892.pdf 2727 R0 Primary Tumor 01 0.6 2004 5th NO YES 66 4 Lung A DECEASED 2004 1967 bec47a82-4a30-4206-bb40-f7674028db1d TCGA-66-2727-01A-01D-0979-05 TCGA-66-2727-01A-01D-0983-08 bec47a82-4a30-4206-bb40-f7674028db1d TCGA-66-2727-01A-01D-0978-01 TCGA-66-2727-01A-01R-0980-07 bec47a82-4a30-4206-bb40-f7674028db1d TCGA-66-2727-01A-01D-0978-01 TCGA-66-2727-01A-21-2193-20 +TCGA-66-2727-11 TCGA-66-2727-11 C2-Squamous-like mutation cluster 8 TCGA-66-2727 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 55 L-Lower TCGA-66-2727 TCGA-66-2727-11A -20150 516 0 2011-3-7 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.6 NO 0.6 56 No M0 N0 T2 Stage IB 2727 R0 Solid Tissue Normal 11 0.3 2004 5th NO YES 66 4 Lung A DECEASED 2004 1967 TCGA-66-2727-11A-01D-0979-05 +TCGA-66-2734-01 TCGA-66-2734-01 Squamous C2-Squamous-like Cluster 5 squamous-like c4 miRNA cluster 4 mutation cluster 13 TCGA-66-2734 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 62 L-Lower TCGA-66-2734-F36597 TCGA-66-2734 TCGA-66-2734-01A -22919 0 1311 Scheduled Follow-up Submission Complete Remission/Response 2012-11-6 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.7 NO 1 NO NO 40 No M0 N0 T2 Stage IB TCGA-66-2734.5cda5b60-06f5-411c-805f-0ec3ee89de67.pdf 2734 TUMOR FREE NO R0 Primary Tumor 01 0.5 2005 5th NO NO YES 66 4 Lung A LIVING 2005 1965 eb104ebb-be06-4f91-be68-d3b4ef649d2a TCGA-66-2734-01A-01D-0979-05 TCGA-66-2734-01A-01D-0983-08 eb104ebb-be06-4f91-be68-d3b4ef649d2a TCGA-66-2734-01A-01D-0978-01 TCGA-66-2734-01A-01R-0980-07 eb104ebb-be06-4f91-be68-d3b4ef649d2a TCGA-66-2734-01A-01D-0978-01 +TCGA-66-2734-11 TCGA-66-2734-11 C2-Squamous-like mutation cluster 13 TCGA-66-2734 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 62 L-Lower TCGA-66-2734-F36597 TCGA-66-2734 TCGA-66-2734-11A -22919 0 1311 Scheduled Follow-up Submission Complete Remission/Response 2012-11-6 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.5 NO 0.6 NO NO 40 No M0 N0 T2 Stage IB 2734 TUMOR FREE NO R0 Solid Tissue Normal 11 0.3 2005 5th NO NO YES 66 4 Lung A LIVING 2005 1965 TCGA-66-2734-11A-01D-0979-05 +TCGA-66-2737-01 TCGA-66-2737-01 High C2-Squamous-like Cluster 5 squamous c3 squamous-like c4 miRNA cluster 4 TCGA-66-2737 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 72 R-Middle TCGA-66-2737 TCGA-66-2737-01A -26390 0 61 2011-3-7 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.2 8070/3 C34.2 YES 1 NO 1 40 No M0 N1 T2 Stage IIB TCGA-66-2737.81cc3e56-576f-4285-906c-75290f9ae4b0.pdf 2737 TUMOR FREE R0 Primary Tumor 01 0.5 1969 5th NO YES 66 3 Lung A LIVING 2005 1949 b00d66ea-f8e2-4f18-8df8-e6248d929373 TCGA-66-2737-01A-01D-0979-05 b00d66ea-f8e2-4f18-8df8-e6248d929373 TCGA-66-2737-01A-01D-0978-01 TCGA-66-2737-01A-01R-0980-07 b00d66ea-f8e2-4f18-8df8-e6248d929373 TCGA-66-2737-01A-01D-0978-01 TCGA-66-2737-01A-41-2193-20 +TCGA-66-2737-11 TCGA-66-2737-11 C2-Squamous-like TCGA-66-2737 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 72 R-Middle TCGA-66-2737 TCGA-66-2737-11A -26390 0 61 2011-3-7 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.2 8070/3 C34.2 YES 0.7 NO 0.8 40 No M0 N1 T2 Stage IIB 2737 TUMOR FREE R0 Solid Tissue Normal 11 0.3 1969 5th NO YES 66 3 Lung A LIVING 2005 1949 TCGA-66-2737-11A-01D-0979-05 +TCGA-66-2742-01 TCGA-66-2742-01 High C2-Squamous-like Cluster 13 (HNSC-LUSC) squamous-like c4 miRNA cluster 4 mutation cluster 8 TCGA-66-2742 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 70 R-Upper TCGA-66-2742-F36598 TCGA-66-2742 TCGA-66-2742-01A -25688 0 641 Scheduled Follow-up Submission Complete Remission/Response 2012-11-6 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.7 NO 1.2 NO NO 44 No M1 N1 T2 Stage IV TCGA-66-2742.07c5c025-c1cd-486e-b510-ebc19d3e53d0.pdf 2742 TUMOR FREE NO R0 Primary Tumor 01 0.6 1991 5th NO NO YES 66 3 Lung A LIVING 2006 1956 002e2fae-9e30-4800-b23e-8f23bd16ad56 TCGA-66-2742-01A-01D-0979-05 TCGA-66-2742-01A-01D-0983-08 002e2fae-9e30-4800-b23e-8f23bd16ad56 TCGA-66-2742-01A-01D-0978-01 TCGA-66-2742-01A-01R-0980-07 002e2fae-9e30-4800-b23e-8f23bd16ad56 TCGA-66-2742-01A-01D-0978-01 +TCGA-66-2742-11 TCGA-66-2742-11 C2-Squamous-like mutation cluster 8 TCGA-66-2742 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 70 R-Upper TCGA-66-2742-F36598 TCGA-66-2742 TCGA-66-2742-11A -25688 0 641 Scheduled Follow-up Submission Complete Remission/Response 2012-11-6 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.9 NO 1.2 NO NO 44 No M1 N1 T2 Stage IV 2742 TUMOR FREE NO R0 Solid Tissue Normal 11 0.5 1991 5th NO NO YES 66 3 Lung A LIVING 2006 1956 TCGA-66-2742-11A-01D-0979-05 +TCGA-66-2744-01 TCGA-66-2744-01 Kirc+ C2-Squamous-like Cluster 5 squamous-like c4 miRNA cluster 5 mutation cluster 2 TCGA-66-2744 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 71 R-Lower TCGA-66-2744 TCGA-66-2744-01A -26084 0 30 2011-3-7 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.6 NO 0.6 63 No M0 N1 T2 Stage IIB TCGA-66-2744.75ad62a3-0cf4-45ef-a1cf-4c710a3368d3.pdf 2744 TUMOR FREE R0 Primary Tumor 01 0.3 2006 5th NO YES 66 4 Lung A LIVING 2006 1956 2a016a06-5097-49b5-85b2-8ea5291fed23 TCGA-66-2744-01A-01D-0979-05 TCGA-66-2744-01A-01D-0983-08 2a016a06-5097-49b5-85b2-8ea5291fed23 TCGA-66-2744-01A-01D-1969-01 TCGA-66-2744-01A-01R-0980-07 2a016a06-5097-49b5-85b2-8ea5291fed23 TCGA-66-2744-01A-01D-1969-01 +TCGA-66-2744-11 TCGA-66-2744-11 C2-Squamous-like mutation cluster 2 TCGA-66-2744 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 71 R-Lower TCGA-66-2744 TCGA-66-2744-11A -26084 0 30 2011-3-7 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.8 NO 0.9 63 No M0 N1 T2 Stage IIB 2744 TUMOR FREE R0 Solid Tissue Normal 11 0.3 2006 5th NO YES 66 4 Lung A LIVING 2006 1956 TCGA-66-2744-11A-01D-0979-05 +TCGA-66-2753-01 TCGA-66-2753-01 Squamous Cluster 13 (HNSC-LUSC) squamous-like c4 miRNA cluster 7 TCGA-66-2753 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 69 L-Lower TCGA-66-2753 TCGA-66-2753-01A -25506 0 31 2011-3-7 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.7 NO 0.9 162 No M0 N0 T2 Stage IB TCGA-66-2753.e430d6d9-d03a-437b-9045-18ea0de16574.pdf 2753 TUMOR FREE R0 Primary Tumor 01 0.5 2007 5th NO YES 66 4 Lung A LIVING 2007 1953 a10bc546-eb5d-4022-8f77-ea993db1a9d3 TCGA-66-2753-01A-01D-0979-05 a10bc546-eb5d-4022-8f77-ea993db1a9d3 TCGA-66-2753-01A-01D-0978-01 TCGA-66-2753-01A-01R-0980-07 a10bc546-eb5d-4022-8f77-ea993db1a9d3 TCGA-66-2753-01A-01D-0978-01 +TCGA-66-2753-11 TCGA-66-2753-11 TCGA-66-2753 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 69 L-Lower TCGA-66-2753 TCGA-66-2753-11A -25506 0 31 2011-3-7 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 1 NO 2 162 No M0 N0 T2 Stage IB 2753 TUMOR FREE R0 Solid Tissue Normal 11 0.4 2007 5th NO YES 66 4 Lung A LIVING 2007 1953 TCGA-66-2753-11A-01D-0979-05 +TCGA-66-2754-01 TCGA-66-2754-01 Squamous C1-LUAD-enriched Cluster 5 LUAD-like c10 miRNA cluster 6 mutation cluster 2 TCGA-66-2754 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 67 R-Upper TCGA-66-2754 TCGA-66-2754-01A -24471 0 61 2011-3-7 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.7 NO 0.7 40 No M0 N2 T2 Stage IIIA TCGA-66-2754.d291f110-97b0-4ef7-b9ef-552e445e8378.pdf 2754 TUMOR FREE R0 Primary Tumor 01 0.2 2007 6th NO YES 66 4 Lung A LIVING 2007 1967 98fef165-d1ea-40e8-9bc5-5e8e70b7aaa5 TCGA-66-2754-01A-01D-0979-05 TCGA-66-2754-01A-01D-0983-08 98fef165-d1ea-40e8-9bc5-5e8e70b7aaa5 TCGA-66-2754-01A-01D-0978-01 TCGA-66-2754-01A-01R-0980-07 98fef165-d1ea-40e8-9bc5-5e8e70b7aaa5 TCGA-66-2754-01A-01D-0978-01 +TCGA-66-2754-11 TCGA-66-2754-11 C1-LUAD-enriched mutation cluster 2 TCGA-66-2754 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 67 R-Upper TCGA-66-2754 TCGA-66-2754-11A -24471 0 61 2011-3-7 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.9 NO 0.9 40 No M0 N2 T2 Stage IIIA 2754 TUMOR FREE R0 Solid Tissue Normal 11 0.5 2007 6th NO YES 66 4 Lung A LIVING 2007 1967 TCGA-66-2754-11A-01D-0979-05 +TCGA-66-2755-01 TCGA-66-2755-01 Squamous C2-Squamous-like Cluster 5 squamous-like c4 miRNA cluster 4 mutation cluster 3 TCGA-66-2755 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 63 R-Upper TCGA-66-2755 TCGA-66-2755-01A -23348 0 28 2011-3-7 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.6 NO 0.6 20 No M0 N0 T2 Stage IB TCGA-66-2755.bbae44d1-526f-4dad-9224-cf2dc56d0852.pdf 2755 TUMOR FREE R0 Primary Tumor 01 0.6 1990 5th NO YES 66 3 Lung A LIVING 2007 1970 8c547100-3fac-4519-91e9-7976a49ec9c3 TCGA-66-2755-01A-01D-0848-05 TCGA-66-2755-01A-01D-1522-08 8c547100-3fac-4519-91e9-7976a49ec9c3 TCGA-66-2755-01A-01D-0844-01 TCGA-66-2755-01A-01R-0851-07 8c547100-3fac-4519-91e9-7976a49ec9c3 TCGA-66-2755-01A-01D-0844-01 +TCGA-66-2756-01 TCGA-66-2756-01 High C1-LUAD-enriched Cluster 5 LUAD-like c10 mutation cluster 11 TCGA-66-2756 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 68 L-Upper TCGA-66-2756 TCGA-66-2756-01A -24929 0 30 2011-3-7 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 1 NO 1.2 No M0 N0 T4 Stage IIIB TCGA-66-2756.1ac41670-2aaf-428f-b8b5-d257951e6f5f.pdf 2756 TUMOR FREE R0 Primary Tumor 01 0.4 2002 6th NO YES 66 4 Lung A LIVING 2007 1962 77981a9c-ea15-47bb-bd1a-6600cdc50f09 TCGA-66-2756-01A-01D-0848-05 TCGA-66-2756-01A-01D-1522-08 77981a9c-ea15-47bb-bd1a-6600cdc50f09 TCGA-66-2756-01A-01D-0844-01 TCGA-66-2756-01A-01R-0851-07 77981a9c-ea15-47bb-bd1a-6600cdc50f09 TCGA-66-2756-01A-01D-0844-01 +TCGA-66-2757-01 TCGA-66-2757-01 High C1-LUAD-enriched Cluster 5 RNA cluster 12 mutation cluster 13 TCGA-66-2757 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 65 L-Upper TCGA-66-2757-F36596 TCGA-66-2757 TCGA-66-2757-01A -24014 1338 0 30 912 Scheduled Follow-up Submission Progressive Disease 2012-11-20 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.4 NO 1 NO YES 72 No M0 N0 T1 Stage IA TCGA-66-2757.b44205a6-8c17-4b6b-bb91-ec1ad1be0b3f.pdf 2757 WITH TUMOR YES R0 Primary Tumor 01 0.3 2007 6th YES NO YES 66 4 Lung A DECEASED 2007 1959 384dced4-1686-4f9d-bdd7-c5c54ca92bf8 TCGA-66-2757-01A-01D-0848-05 TCGA-66-2757-01A-01D-1522-08 384dced4-1686-4f9d-bdd7-c5c54ca92bf8 TCGA-66-2757-01A-01D-0844-01 TCGA-66-2757-01A-01R-0851-07 384dced4-1686-4f9d-bdd7-c5c54ca92bf8 TCGA-66-2757-01A-01D-0844-01 +TCGA-66-2758-01 TCGA-66-2758-01 High C2-Squamous-like Cluster 13 (HNSC-LUSC) squamous c3 squamous-like c4 miRNA cluster 12 mutation cluster 3 TCGA-66-2758 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 71 L-Upper TCGA-66-2758-F36608 TCGA-66-2758 TCGA-66-2758-01A -26209 0 639 Scheduled Follow-up Submission Complete Remission/Response 2012-11-6 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.7 NO 1 NO NO 56 No M0 N0 T2 Stage IB TCGA-66-2758.c35772e8-176c-4572-80bd-e4ea7bd0684d.pdf 2758 TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 0.7 2007 5th YES NO YES 66 4 Lung A LIVING 2007 1951 a26c6cd1-144d-433a-b499-848ae93374c1 TCGA-66-2758-01A-02D-0848-05 TCGA-66-2758-01A-02D-1522-08 a26c6cd1-144d-433a-b499-848ae93374c1 TCGA-66-2758-01A-02D-1969-01 TCGA-66-2758-01A-02R-0851-07 a26c6cd1-144d-433a-b499-848ae93374c1 TCGA-66-2758-01A-02D-1969-01 TCGA-66-2758-01A-11-2193-20 +TCGA-66-2759-01 TCGA-66-2759-01 Squamous C2-Squamous-like Cluster 13 (HNSC-LUSC) squamous-like c4 miRNA cluster 4 mutation cluster 8 TCGA-66-2759 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 66 L-Lower TCGA-66-2759-F36687 TCGA-66-2759 TCGA-66-2759-01A -24287 0 762 Scheduled Follow-up Submission Complete Remission/Response 2012-11-12 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.8 NO 1 NO NO 16 No M0 N2 T2 Stage IIIA TCGA-66-2759.adc593c7-44fc-4059-a161-a80b267db72a.pdf 2759 TUMOR FREE Complete Remission/Response YES R0 Primary Tumor 01 0.4 1990 5th YES NO YES 66 3 Lung A LIVING 2007 1959 adfbf8b6-405d-4887-b363-d130e20b70ef TCGA-66-2759-01A-01D-0848-05 TCGA-66-2759-01A-01D-1522-08 adfbf8b6-405d-4887-b363-d130e20b70ef TCGA-66-2759-01A-01D-1969-01 TCGA-66-2759-01A-01R-0851-07 adfbf8b6-405d-4887-b363-d130e20b70ef TCGA-66-2759-01A-01D-1969-01 +TCGA-66-2763-01 TCGA-66-2763-01 Squamous C2-Squamous-like Cluster 13 (HNSC-LUSC) squamous-like c4 miRNA cluster 11 mutation cluster 11 TCGA-66-2763 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 63 L-Upper TCGA-66-2763 TCGA-66-2763-01A -23315 0 30 2011-3-7 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.6 NO 1.5 40 No M0 N0 T2 Stage IB TCGA-66-2763.109e31cb-1414-4d8c-89da-c3b3eccf20a0.pdf 2763 TUMOR FREE R0 Primary Tumor 01 0.6 2007 6th NO YES 66 4 Lung A LIVING 2007 1967 f1c8f94b-6397-4756-abf6-42a5e9e5c76e TCGA-66-2763-01A-01D-0848-05 TCGA-66-2763-01A-01D-1522-08 f1c8f94b-6397-4756-abf6-42a5e9e5c76e TCGA-66-2763-01A-01D-0844-01 TCGA-66-2763-01A-01R-0851-07 f1c8f94b-6397-4756-abf6-42a5e9e5c76e TCGA-66-2763-01A-01D-0844-01 +TCGA-66-2765-01 TCGA-66-2765-01 Squamous C2-Squamous-like Cluster 5 squamous-like c4 miRNA cluster 4 mutation cluster 5 TCGA-66-2765 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 64 L-Lower TCGA-66-2765 TCGA-66-2765-01A -23465 0 61 2011-3-7 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.5 NO 1.3 108 No M0 N0 T2 Stage IB TCGA-66-2765.89c0d8ed-b798-4684-8c7f-1ef75968df1b.pdf 2765 TUMOR FREE R0 Primary Tumor 01 0.2 2007 6th NO YES 66 4 Lung A LIVING 2007 1953 02497ea4-eb86-4154-a7a2-63b4baaebc97 TCGA-66-2765-01A-01D-0848-05 TCGA-66-2765-01A-01D-1522-08 02497ea4-eb86-4154-a7a2-63b4baaebc97 TCGA-66-2765-01A-01D-0844-01 TCGA-66-2765-01A-01R-0851-07 02497ea4-eb86-4154-a7a2-63b4baaebc97 TCGA-66-2765-01A-01D-0844-01 +TCGA-66-2766-01 TCGA-66-2766-01 High C2-Squamous-like Cluster 13 (HNSC-LUSC) squamous c3 squamous-like c4 miRNA cluster 4 mutation cluster 3 TCGA-66-2766 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 54 L-Upper TCGA-66-2766 TCGA-66-2766-01A -19814 0 31 2011-3-7 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.7 NO 2 80 No M0 N2 T2 Stage IIIA TCGA-66-2766.d210f986-d5a2-4490-87a4-e14564a6d0ff.pdf 2766 TUMOR FREE R0 Primary Tumor 01 0.5 2007 6th NO YES 66 4 Lung A LIVING 2007 1967 9a76d668-932a-47cd-a8c0-5840641e1aea TCGA-66-2766-01A-01D-0848-05 TCGA-66-2766-01A-01D-1522-08 9a76d668-932a-47cd-a8c0-5840641e1aea TCGA-66-2766-01A-01D-0844-01 TCGA-66-2766-01A-01R-0851-07 9a76d668-932a-47cd-a8c0-5840641e1aea TCGA-66-2766-01A-01D-0844-01 TCGA-66-2766-01A-21-2193-20 +TCGA-66-2767-01 TCGA-66-2767-01 Squamous C2-Squamous-like Cluster 13 (HNSC-LUSC) squamous c3 squamous-like c4 miRNA cluster 7 mutation cluster 11 TCGA-66-2767 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 62 R-Lower TCGA-66-2767 TCGA-66-2767-01A -22888 0 61 2011-3-7 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.8 NO 0.8 43 No M0 N3 T2 Stage IIIB TCGA-66-2767.bc27c9ee-26e1-4362-b03d-4e2c08ed6111.pdf 2767 TUMOR FREE R0 Primary Tumor 01 0.2 2007 6th NO YES 66 4 Lung A LIVING 2007 1964 f54e8f7c-75c2-4566-8696-06e5ac1b8a0d TCGA-66-2767-01A-01D-0848-05 TCGA-66-2767-01A-01D-1522-08 f54e8f7c-75c2-4566-8696-06e5ac1b8a0d TCGA-66-2767-01A-01D-0844-01 TCGA-66-2767-01A-01R-0851-07 f54e8f7c-75c2-4566-8696-06e5ac1b8a0d TCGA-66-2767-01A-01D-0844-01 TCGA-66-2767-01A-21-2193-20 +TCGA-66-2768-01 TCGA-66-2768-01 Squamous C2-Squamous-like Cluster 13 (HNSC-LUSC) squamous c3 squamous-like c4 miRNA cluster 11 mutation cluster 13 TCGA-66-2768 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 57 L-Lower TCGA-66-2768 TCGA-66-2768-01A -20970 0 61 2011-3-7 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.7 NO 1.1 No M0 N1 T2 Stage IIB TCGA-66-2768.ebd0c8a9-a96a-4e09-8498-3476d1faf292.pdf 2768 TUMOR FREE R0 Primary Tumor 01 0.3 6th NO YES 66 2 Lung A LIVING 2007 97454c59-eed0-470f-a234-ff8b25b4b8a6 TCGA-66-2768-01A-01D-0848-05 TCGA-66-2768-01A-01D-1522-08 97454c59-eed0-470f-a234-ff8b25b4b8a6 TCGA-66-2768-01A-01D-0844-01 TCGA-66-2768-01A-01R-0851-07 97454c59-eed0-470f-a234-ff8b25b4b8a6 TCGA-66-2768-01A-01D-0844-01 TCGA-66-2768-01A-21-2193-20 +TCGA-66-2769-01 TCGA-66-2769-01 Squamous C2-Squamous-like Cluster 5 squamous c3 squamous-like c4 TCGA-66-2769 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 75 L-Upper TCGA-66-2769 TCGA-66-2769-01A -27515 215 0 2011-3-7 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.9 NO 1 33 No M0 N0 T4 Stage IIIB TCGA-66-2769.3a61e4a8-b574-49a2-bea4-5479a1efb1f4.pdf 2769 R1 Primary Tumor 01 0.3 1980 6th NO YES 66 3 Lung A DECEASED 2007 1947 41ab6249-4301-4c67-9b1f-83c295536b13 TCGA-66-2769-01A-02D-0848-05 41ab6249-4301-4c67-9b1f-83c295536b13 TCGA-66-2769-01A-02D-0844-01 TCGA-66-2769-01A-02R-0851-07 41ab6249-4301-4c67-9b1f-83c295536b13 TCGA-66-2769-01A-02D-0844-01 TCGA-66-2769-01A-11-2193-20 +TCGA-66-2770-01 TCGA-66-2770-01 Squamous C2-Squamous-like Cluster 5 squamous c3 squamous-like c4 miRNA cluster 7 mutation cluster 5 TCGA-66-2770 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 79 R-Lower TCGA-66-2770 TCGA-66-2770-01A -28945 0 700 2011-3-7 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.9 NO 1.3 25 No M0 N0 T2 Stage IB TCGA-66-2770.495898f2-833b-4db0-9fac-680970795f2e.pdf 2770 R0 Primary Tumor 01 0.3 1967 6th NO YES 66 3 Lung A LIVING 2007 1942 8c1c733a-abed-468f-b4d0-d1ac34ba6d8b TCGA-66-2770-01A-01D-0848-05 TCGA-66-2770-01A-01D-1522-08 8c1c733a-abed-468f-b4d0-d1ac34ba6d8b TCGA-66-2770-01A-01D-0844-01 TCGA-66-2770-01A-01R-0851-07 8c1c733a-abed-468f-b4d0-d1ac34ba6d8b TCGA-66-2770-01A-01D-0844-01 TCGA-66-2770-01A-21-2193-20 +TCGA-66-2771-01 TCGA-66-2771-01 Squamous C2-Squamous-like Low purity c2 squamous-like c4 miRNA cluster 7 mutation cluster 12 TCGA-66-2771 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 60 R-Upper TCGA-66-2771-F36692 TCGA-66-2771 TCGA-66-2771-01A -22219 0 578 Scheduled Follow-up Submission Complete Remission/Response 2012-11-12 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.7 NO 0.9 NO NO 70 No M0 N1 T2 Stage IIB TCGA-66-2771.e09c6c36-88a1-4f23-8611-241130866096.pdf 2771 TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 0.2 2006 6th YES NO YES 66 4 Lung A LIVING 2007 1971 91102ced-5e0a-427b-8640-4dfddf2004a7 TCGA-66-2771-01A-01D-0979-05 TCGA-66-2771-01A-01D-0983-08 91102ced-5e0a-427b-8640-4dfddf2004a7 TCGA-66-2771-01A-01D-0978-01 TCGA-66-2771-01A-01R-0980-07 91102ced-5e0a-427b-8640-4dfddf2004a7 TCGA-66-2771-01A-01D-0978-01 +TCGA-66-2771-11 TCGA-66-2771-11 C2-Squamous-like mutation cluster 12 TCGA-66-2771 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 60 R-Upper TCGA-66-2771-F36692 TCGA-66-2771 TCGA-66-2771-11A -22219 0 578 Scheduled Follow-up Submission Complete Remission/Response 2012-11-12 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.7 NO 0.8 NO NO 70 No M0 N1 T2 Stage IIB 2771 TUMOR FREE Complete Remission/Response NO R0 Solid Tissue Normal 11 0.4 2006 6th YES NO YES 66 4 Lung A LIVING 2007 1971 TCGA-66-2771-11A-01D-0979-05 +TCGA-66-2773-01 TCGA-66-2773-01 Squamous C2-Squamous-like Cluster 13 (HNSC-LUSC) squamous c3 squamous-like c4 mutation cluster 4 TCGA-66-2773 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 69 L-Lower TCGA-66-2773 TCGA-66-2773-01A -25355 92 0 2011-3-7 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 1 NO 1.2 58 No M0 N0 T2 Stage IB TCGA-66-2773.406db03f-3258-48b3-b0de-b7388d63a559.pdf 2773 TUMOR FREE R0 Primary Tumor 01 0.4 1969 6th NO YES 66 3 Lung A DECEASED 2007 1946 b8152ff5-e2f1-44a5-8173-c6c75ec3a79c TCGA-66-2773-01A-01D-1198-05 TCGA-66-2773-01A-01D-1267-08 b8152ff5-e2f1-44a5-8173-c6c75ec3a79c TCGA-66-2773-01A-01D-1195-01 TCGA-66-2773-01A-01R-1201-07 b8152ff5-e2f1-44a5-8173-c6c75ec3a79c TCGA-66-2773-01A-01D-1195-01 TCGA-66-2773-01A-21-2193-20 +TCGA-66-2777-01 TCGA-66-2777-01 BRCA-LUAD+ C2-Squamous-like OV-like c1 squamous c3 squamous-like c4 miRNA cluster 4 mutation cluster 11 TCGA-66-2777 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 71 R-Middle TCGA-66-2777 TCGA-66-2777-01A -26085 0 61 2011-3-7 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.2 8070/3 C34.2 YES 0.8 NO 1 12 No M0 N0 T2 Stage IB TCGA-66-2777.32548c06-21b0-4a9c-a8b4-ead02948d323.pdf 2777 TUMOR FREE R0 Primary Tumor 01 0.3 2007 6th NO YES 66 4 Lung A LIVING 2007 1972 030f341f-bf04-4bc1-9572-721160a2ec28 TCGA-66-2777-01A-01D-1198-05 TCGA-66-2777-01A-01D-1267-08 030f341f-bf04-4bc1-9572-721160a2ec28 TCGA-66-2777-01A-01D-1195-01 TCGA-66-2777-01A-01R-1201-07 030f341f-bf04-4bc1-9572-721160a2ec28 TCGA-66-2777-01A-01D-1195-01 TCGA-66-2777-01A-21-2193-20 +TCGA-66-2778-01 TCGA-66-2778-01 Squamous C2-Squamous-like Cluster 5 squamous c3 squamous-like c4 mutation c1uster 10 TCGA-66-2778 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 68 L-Lower TCGA-66-2778-F36696 TCGA-66-2778 TCGA-66-2778-01A -25080 0 578 Scheduled Follow-up Submission Complete Remission/Response 2012-11-12 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.6 NO 0.6 NO NO 37 No M0 N3 T2 Stage IIIB TCGA-66-2778.b4ddc4fa-5416-4a8b-8187-b328dbc0b946.pdf 2778 TUMOR FREE Complete Remission/Response YES R2 Primary Tumor 01 0.5 1995 6th YES NO YES 66 4 Lung A LIVING 2007 1958 30fd754a-0625-4435-877d-7dfaee227f8b TCGA-66-2778-01A-02D-0848-05 TCGA-66-2778-01A-02D-1522-08 30fd754a-0625-4435-877d-7dfaee227f8b TCGA-66-2778-01A-02D-0844-01 TCGA-66-2778-01A-02R-0851-07 30fd754a-0625-4435-877d-7dfaee227f8b TCGA-66-2778-01A-02D-0844-01 TCGA-66-2778-01A-11-2193-20 +TCGA-66-2780-01 TCGA-66-2780-01 Squamous C2-Squamous-like Cluster 5 squamous-like c4 miRNA cluster 4 mutation c1uster 10 TCGA-66-2780 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 65 L-Upper TCGA-66-2780 TCGA-66-2780-01A -23955 366 0 2011-3-7 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.6 NO 1.2 28 No M0 N0 T2 Stage IB TCGA-66-2780.56ff78fe-0830-483a-a8b9-72a62f80e101.pdf 2780 R0 Primary Tumor 01 0.2 1970 6th NO YES 66 3 Lung A DECEASED 2007 1956 518e09a8-84da-4247-b2f5-2c32e07ea046 TCGA-66-2780-01A-01D-0848-05 TCGA-66-2780-01A-01D-1522-08 518e09a8-84da-4247-b2f5-2c32e07ea046 TCGA-66-2780-01A-01D-0844-01 TCGA-66-2780-01A-01R-0851-07 518e09a8-84da-4247-b2f5-2c32e07ea046 TCGA-66-2780-01A-01D-0844-01 +TCGA-66-2781-01 TCGA-66-2781-01 Squamous C2-Squamous-like Low purity c2 squamous c3 squamous-like c4 miRNA cluster 4 mutation c1uster 9 TCGA-66-2781 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 67 L-Upper TCGA-66-2781 TCGA-66-2781-01A -24471 0 121 2011-3-7 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.6 NO 1 80 No M0 N0 T2 Stage IB TCGA-66-2781.4227efe2-597d-4d53-91f5-73c3fa32f6f5.pdf 2781 TUMOR FREE R0 Primary Tumor 01 0.4 2007 6th NO YES 66 4 Lung A LIVING 2007 1954 87ef65df-919a-4c65-87db-364380aec736 TCGA-66-2781-01A-01D-0848-05 TCGA-66-2781-01A-01D-1522-08 87ef65df-919a-4c65-87db-364380aec736 TCGA-66-2781-01A-01D-0844-01 TCGA-66-2781-01A-01R-0851-07 87ef65df-919a-4c65-87db-364380aec736 TCGA-66-2781-01A-01D-0844-01 TCGA-66-2781-01A-21-2193-20 +TCGA-66-2782-01 TCGA-66-2782-01 Squamous C2-Squamous-like Cluster 5 squamous c3 squamous-like c4 miRNA cluster 4 mutation cluster 5 TCGA-66-2782 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung YES NO 71 R-Upper TCGA-66-2782-F37032 TCGA-66-2782 TCGA-66-2782-01A -26237 365 0 304 Scheduled Follow-up Submission Progressive Disease 2012-11-21 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 1 NO 3.3 NO YES 50 No M0 N0 T3 Stage IIB TCGA-66-2782.bdae0797-b3e2-47fd-b95b-20d4510277b8.pdf 2782 WITH TUMOR Progressive Disease NO R0 Primary Tumor 01 0.5 2004 5th YES NO YES 66 4 Lung A DECEASED 2004 1954 f20dc5d8-5ad0-46ce-b5d7-02f3f2e8c27a TCGA-66-2782-01A-01D-0848-05 TCGA-66-2782-01A-01D-1522-08 f20dc5d8-5ad0-46ce-b5d7-02f3f2e8c27a TCGA-66-2782-01A-01D-0844-01 TCGA-66-2782-01A-01R-0851-07 f20dc5d8-5ad0-46ce-b5d7-02f3f2e8c27a TCGA-66-2782-01A-01D-0844-01 TCGA-66-2782-01A-21-2193-20 +TCGA-66-2783-01 TCGA-66-2783-01 Squamous C2-Squamous-like Cluster 13 (HNSC-LUSC) squamous c3 squamous-like c4 miRNA cluster 7 mutation cluster 5 TCGA-66-2783 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 67 L-Lower TCGA-66-2783-F37019 TCGA-66-2783 TCGA-66-2783-01A -24686 0 759 Complete Remission/Response 2012-11-20 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.9 NO 1 NO 65 No M0 N3 T2 Stage IIIB TCGA-66-2783.15cde679-e737-4f03-ae8b-ce80908fea17.pdf 2783 TUMOR FREE Complete Remission/Response YES R2 Primary Tumor 01 0.5 2003 6th YES NO YES 66 4 Lung A LIVING 2008 1960 bb854114-88f2-467c-a3f8-ce8f5ee4cdb9 TCGA-66-2783-01A-01D-1198-05 TCGA-66-2783-01A-01D-1267-08 bb854114-88f2-467c-a3f8-ce8f5ee4cdb9 TCGA-66-2783-01A-01D-1195-01 TCGA-66-2783-01A-01R-1201-07 bb854114-88f2-467c-a3f8-ce8f5ee4cdb9 TCGA-66-2783-01A-01D-1195-01 TCGA-66-2783-01A-21-2193-20 +TCGA-66-2785-01 TCGA-66-2785-01 High C4-BRCA/Basal Cluster 5 squamous c3 BRCA basal-like c8 miRNA cluster 11 mutation cluster 11 TCGA-66-2785 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 65 L-Upper TCGA-66-2785 TCGA-66-2785-01A -23772 0 60 2011-3-7 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.5 NO 1.4 70 No M0 N0 T2 Stage IB TCGA-66-2785.92f38512-f7c8-462c-b7f4-018648ad4f56.pdf 2785 TUMOR FREE R0 Primary Tumor 01 0.5 2008 6th NO YES 66 4 Lung A LIVING 2008 9083747c-9d2d-431f-ace5-3e55795e18af TCGA-66-2785-01A-01D-0848-05 TCGA-66-2785-01A-01D-1522-08 9083747c-9d2d-431f-ace5-3e55795e18af TCGA-66-2785-01A-01D-0844-01 TCGA-66-2785-01A-01R-0851-07 9083747c-9d2d-431f-ace5-3e55795e18af TCGA-66-2785-01A-01D-0844-01 TCGA-66-2785-01A-21-2193-20 +TCGA-66-2786-01 TCGA-66-2786-01 Squamous C2-Squamous-like Cluster 5 squamous-like c4 miRNA cluster 4 mutation cluster 5 TCGA-66-2786 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 68 R-Upper TCGA-66-2786-F37034 TCGA-66-2786 TCGA-66-2786-01A -25051 0 790 Scheduled Follow-up Submission Complete Remission/Response 2012-11-21 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.7 NO 0.9 NO NO 74 No M0 N0 T1 Stage IA TCGA-66-2786.1f8077d2-efa8-4e09-b4a2-e848c3723278.pdf 2786 TUMOR FREE NO R0 Primary Tumor 01 0.3 2007 5th NO NO YES 66 4 Lung A LIVING 2008 1959 1190c768-24c0-4762-8701-dea5d35e8fe1 TCGA-66-2786-01A-01D-0848-05 TCGA-66-2786-01A-01D-1522-08 1190c768-24c0-4762-8701-dea5d35e8fe1 TCGA-66-2786-01A-01D-0844-01 TCGA-66-2786-01A-01R-0851-07 1190c768-24c0-4762-8701-dea5d35e8fe1 TCGA-66-2786-01A-01D-0844-01 +TCGA-66-2787-01 TCGA-66-2787-01 Squamous C2-Squamous-like Cluster 13 (HNSC-LUSC) squamous-like c4 miRNA cluster 4 mutation cluster 11 TCGA-66-2787 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 57 R-Upper TCGA-66-2787-F37035 TCGA-66-2787 TCGA-66-2787-01A -21124 0 1217 Scheduled Follow-up Submission Complete Remission/Response 2012-11-21 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.4 NO 1.4 NO NO 40 No M0 N0 T1 Stage IA TCGA-66-2787.aa241183-bb71-4b0c-8d00-e10ec86145e1.pdf 2787 TUMOR FREE NO R0 Primary Tumor 01 0.2 2004 6th NO NO YES 66 4 Lung A LIVING 2004 1964 a7e57e13-7e54-4839-9b94-0c7d3dda0489 TCGA-66-2787-01A-01D-0979-05 TCGA-66-2787-01A-01D-0983-08 a7e57e13-7e54-4839-9b94-0c7d3dda0489 TCGA-66-2787-01A-01D-0978-01 TCGA-66-2787-01A-01R-0980-07 a7e57e13-7e54-4839-9b94-0c7d3dda0489 TCGA-66-2787-01A-01D-0978-01 +TCGA-66-2787-11 TCGA-66-2787-11 C2-Squamous-like mutation cluster 11 TCGA-66-2787 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 57 R-Upper TCGA-66-2787-F37035 TCGA-66-2787 TCGA-66-2787-11A -21124 0 1217 Scheduled Follow-up Submission Complete Remission/Response 2012-11-21 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.8 NO 1 NO NO 40 No M0 N0 T1 Stage IA 2787 TUMOR FREE NO R0 Solid Tissue Normal 11 0.3 2004 6th NO NO YES 66 4 Lung A LIVING 2004 1964 TCGA-66-2787-11A-01D-0979-05 +TCGA-66-2788-01 TCGA-66-2788-01 High C2-Squamous-like Low purity c2 squamous c3 squamous-like c4 miRNA cluster 7 mutation cluster 5 TCGA-66-2788 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 56 L-Lower TCGA-66-2788-F37036 TCGA-66-2788 TCGA-66-2788-01A -20637 0 699 Scheduled Follow-up Submission Complete Remission/Response 2012-11-21 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.9 NO 0.9 NO NO 80 No M0 N0 T2 Stage IB TCGA-66-2788.8ec97dec-6e60-43c6-97c6-c164f28e3639.pdf 2788 TUMOR FREE NO R0 Primary Tumor 01 0.4 2008 6th NO NO YES 66 4 Lung A LIVING 2008 1968 700121ee-a711-4ccc-9250-e2b299d0f46e TCGA-66-2788-01A-01D-0979-05 TCGA-66-2788-01A-01D-0983-08 700121ee-a711-4ccc-9250-e2b299d0f46e TCGA-66-2788-01A-01D-0978-01 TCGA-66-2788-01A-01R-0980-07 700121ee-a711-4ccc-9250-e2b299d0f46e TCGA-66-2788-01A-01D-0978-01 TCGA-66-2788-01A-21-2193-20 +TCGA-66-2788-11 TCGA-66-2788-11 C2-Squamous-like mutation cluster 5 TCGA-66-2788 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 56 L-Lower TCGA-66-2788-F37036 TCGA-66-2788 TCGA-66-2788-11A -20637 0 699 Scheduled Follow-up Submission Complete Remission/Response 2012-11-21 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.8 NO 1 NO NO 80 No M0 N0 T2 Stage IB 2788 TUMOR FREE NO R0 Solid Tissue Normal 11 0.6 2008 6th NO NO YES 66 4 Lung A LIVING 2008 1968 TCGA-66-2788-11A-01D-0979-05 +TCGA-66-2789-01 TCGA-66-2789-01 Squamous C2-Squamous-like Cluster 13 (HNSC-LUSC) squamous-like c4 miRNA cluster 4 mutation cluster 12 TCGA-66-2789 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 73 L-Lower TCGA-66-2789 TCGA-66-2789-01A -26753 123 0 2011-3-7 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.8 NO 1.5 40 No M0 N3 T1 Stage IIIB TCGA-66-2789.50601de1-9156-4793-9cdc-b140bb932cc0.pdf 2789 TUMOR FREE R0 Primary Tumor 01 0.2 1995 6th NO YES 66 4 Lung A DECEASED 2008 1955 4c91a673-ed50-41b5-8261-50c9b8716aa2 TCGA-66-2789-01A-01D-0979-05 TCGA-66-2789-01A-01D-0983-08 4c91a673-ed50-41b5-8261-50c9b8716aa2 TCGA-66-2789-01A-01D-0978-01 TCGA-66-2789-01A-01R-0980-07 4c91a673-ed50-41b5-8261-50c9b8716aa2 TCGA-66-2789-01A-01D-0978-01 +TCGA-66-2789-11 TCGA-66-2789-11 C2-Squamous-like mutation cluster 12 TCGA-66-2789 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 73 L-Lower TCGA-66-2789 TCGA-66-2789-11A -26753 123 0 2011-3-7 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.9 NO 1 40 No M0 N3 T1 Stage IIIB 2789 TUMOR FREE R0 Solid Tissue Normal 11 0.3 1995 6th NO YES 66 4 Lung A DECEASED 2008 1955 TCGA-66-2789-11A-01D-0979-05 +TCGA-66-2790-01 TCGA-66-2790-01 Squamous C2-Squamous-like Cluster 13 (HNSC-LUSC) squamous c3 squamous-like c4 miRNA cluster 4 TCGA-66-2790 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung NO NO 72 L-Upper TCGA-66-2790-F37037 TCGA-66-2790 TCGA-66-2790-01A -26420 0 699 699 Scheduled Follow-up Submission Progressive Disease 2012-11-21 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.5 NO 1.3 NO YES 57 No M0 N1 T2 Stage IIB TCGA-66-2790.7e17dc53-b237-46db-b6d6-86b7eeb51bab.pdf 2790 WITH TUMOR Progressive Disease NO R0 Primary Tumor 01 0.3 2008 6th YES NO YES 66 4 Lung A LIVING 2008 1951 37396d97-dda9-4ee3-a477-8281d8baf948 TCGA-66-2790-01A-01D-0979-05 37396d97-dda9-4ee3-a477-8281d8baf948 TCGA-66-2790-01A-01D-0978-01 TCGA-66-2790-01A-01R-0980-07 37396d97-dda9-4ee3-a477-8281d8baf948 TCGA-66-2790-01A-01D-0978-01 TCGA-66-2790-01A-21-2193-20 +TCGA-66-2790-11 TCGA-66-2790-11 C2-Squamous-like TCGA-66-2790 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung NO NO 72 L-Upper TCGA-66-2790-F37037 TCGA-66-2790 TCGA-66-2790-11A -26420 0 699 699 Scheduled Follow-up Submission Progressive Disease 2012-11-21 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 1 NO 1.3 NO YES 57 No M0 N1 T2 Stage IIB 2790 WITH TUMOR Progressive Disease NO R0 Solid Tissue Normal 11 0.3 2008 6th YES NO YES 66 4 Lung A LIVING 2008 1951 TCGA-66-2790-11A-01D-0979-05 +TCGA-66-2791-01 TCGA-66-2791-01 Squamous C2-Squamous-like Cluster 13 (HNSC-LUSC) squamous c3 squamous-like c4 miRNA cluster 4 mutation cluster 13 TCGA-66-2791 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 66 R-Lower TCGA-66-2791 TCGA-66-2791-01A -24138 153 0 2011-3-7 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.8 NO 1 25 No M0 N3 T2 Stage IIIB TCGA-66-2791.402c71d9-26d5-4e94-82a6-6ae5ea39a391.pdf 2791 R1 Primary Tumor 01 0.2 2002 6th NO YES 66 4 Lung A DECEASED 2008 1977 95d2741d-894f-447e-9010-844f1d8a6572 TCGA-66-2791-01A-01D-0979-05 TCGA-66-2791-01A-01D-0983-08 95d2741d-894f-447e-9010-844f1d8a6572 TCGA-66-2791-01A-01D-1969-01 TCGA-66-2791-01A-01R-0980-07 95d2741d-894f-447e-9010-844f1d8a6572 TCGA-66-2791-01A-01D-1969-01 TCGA-66-2791-01A-21-2193-20 +TCGA-66-2791-11 TCGA-66-2791-11 C2-Squamous-like mutation cluster 13 TCGA-66-2791 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 66 R-Lower TCGA-66-2791 TCGA-66-2791-11A -24138 153 0 2011-3-7 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.8 NO 1 25 No M0 N3 T2 Stage IIIB 2791 R1 Solid Tissue Normal 11 0.5 2002 6th NO YES 66 4 Lung A DECEASED 2008 1977 TCGA-66-2791-11A-01D-0979-05 +TCGA-66-2792-01 TCGA-66-2792-01 Squamous C2-Squamous-like Cluster 13 (HNSC-LUSC) squamous-like c4 miRNA cluster 4 mutation cluster 8 TCGA-66-2792 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 58 L-Lower TCGA-66-2792-F37042 TCGA-66-2792 TCGA-66-2792-01A -21428 0 913 Scheduled Follow-up Submission Complete Remission/Response 2012-11-21 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.5 NO 1 NO NO 10 No M0 N1 T2 Stage IIB TCGA-66-2792.c4e1fcb9-cf6d-434e-a38d-57ed9579b588.pdf 2792 TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 0.3 2008 6th YES NO YES 66 4 Lung A LIVING 2008 1968 cb96190b-51ec-4380-ab8a-a3b33d3ef4d2 TCGA-66-2792-01A-01D-0979-05 TCGA-66-2792-01A-01D-0983-08 cb96190b-51ec-4380-ab8a-a3b33d3ef4d2 TCGA-66-2792-01A-01D-0978-01 TCGA-66-2792-01A-01R-0980-07 cb96190b-51ec-4380-ab8a-a3b33d3ef4d2 TCGA-66-2792-01A-01D-0978-01 +TCGA-66-2792-11 TCGA-66-2792-11 C2-Squamous-like mutation cluster 8 TCGA-66-2792 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 58 L-Lower TCGA-66-2792-F37042 TCGA-66-2792 TCGA-66-2792-11A -21428 0 913 Scheduled Follow-up Submission Complete Remission/Response 2012-11-21 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.8 NO 0.8 NO NO 10 No M0 N1 T2 Stage IIB 2792 TUMOR FREE Complete Remission/Response NO R0 Solid Tissue Normal 11 0.8 2008 6th YES NO YES 66 4 Lung A LIVING 2008 1968 TCGA-66-2792-11A-01D-0979-05 +TCGA-66-2793-01 TCGA-66-2793-01 High C2-Squamous-like Cluster 5 squamous-like c4 miRNA cluster 12 mutation cluster 13 TCGA-66-2793 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 68 R-Middle TCGA-66-2793 TCGA-66-2793-01A -25111 306 0 2011-3-7 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.2 8070/3 C34.2 YES 0.5 NO 0.9 112 No M0 N1 T4 Stage IIIB TCGA-66-2793.c2a1ad10-926c-4bab-9a34-467b3496a453.pdf 2793 TUMOR FREE R0 Primary Tumor 01 0.4 2008 6th NO YES 66 4 Lung A DECEASED 2008 1952 df7bc5ee-3423-495a-bc08-c0053e1640ad TCGA-66-2793-01A-01D-1198-05 TCGA-66-2793-01A-01D-1267-08 df7bc5ee-3423-495a-bc08-c0053e1640ad TCGA-66-2793-01A-01D-1195-01 TCGA-66-2793-01A-01R-1201-07 df7bc5ee-3423-495a-bc08-c0053e1640ad TCGA-66-2793-01A-01D-1195-01 +TCGA-66-2794-01 TCGA-66-2794-01 Squamous C2-Squamous-like Cluster 13 (HNSC-LUSC) squamous c3 squamous-like c4 miRNA cluster 4 mutation cluster 5 TCGA-66-2794 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 64 L-Upper TCGA-66-2794-F37017 TCGA-66-2794 TCGA-66-2794-01A -23710 0 1645 Complete Remission/Response 2012-11-20 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 1 NO 1.2 NO 100 No M0 N2 T4 Stage IIIB TCGA-66-2794.b0788a69-3dd0-42d6-8564-958a0108654b.pdf 2794 TUMOR FREE Complete Remission/Response YES R0 Primary Tumor 01 0.3 1993 6th NO NO YES 66 4 Lung A LIVING 2006 1957 70235f1f-1376-4326-99d0-e413fab24662 TCGA-66-2794-01A-01D-1198-05 TCGA-66-2794-01A-01D-1267-08 70235f1f-1376-4326-99d0-e413fab24662 TCGA-66-2794-01A-01D-1195-01 TCGA-66-2794-01A-01R-1201-07 70235f1f-1376-4326-99d0-e413fab24662 TCGA-66-2794-01A-01D-1195-01 TCGA-66-2794-01A-21-2193-20 +TCGA-66-2795-01 TCGA-66-2795-01 Squamous C2-Squamous-like Cluster 13 (HNSC-LUSC) squamous c3 squamous-like c4 miRNA cluster 4 mutation cluster 8 TCGA-66-2795 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 68 L-Upper TCGA-66-2795 TCGA-66-2795-01A -24897 0 122 2011-3-7 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 1 NO 1 86 No M0 N1 T4 Stage IIIB TCGA-66-2795.7993de3e-afeb-4eaf-96fa-4efbb5167130.pdf 2795 TUMOR FREE R0 Primary Tumor 01 0.3 2008 6th NO YES 66 4 Lung A LIVING 2008 1965 ae8b243b-3190-47e5-af8f-3ff76a403516 TCGA-66-2795-01A-02D-0979-05 TCGA-66-2795-01A-02D-0983-08 ae8b243b-3190-47e5-af8f-3ff76a403516 TCGA-66-2795-01A-02D-0978-01 TCGA-66-2795-01A-02R-0980-07 ae8b243b-3190-47e5-af8f-3ff76a403516 TCGA-66-2795-01A-02D-0978-01 TCGA-66-2795-01A-11-2193-20 +TCGA-66-2795-11 TCGA-66-2795-11 C2-Squamous-like mutation cluster 8 TCGA-66-2795 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 68 L-Upper TCGA-66-2795 TCGA-66-2795-11A -24897 0 122 2011-3-7 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.8 NO 1.2 86 No M0 N1 T4 Stage IIIB 2795 TUMOR FREE R0 Solid Tissue Normal 11 0.8 2008 6th NO YES 66 4 Lung A LIVING 2008 1965 TCGA-66-2795-11A-01D-0979-05 +TCGA-66-2800-01 TCGA-66-2800-01 Squamous C2-Squamous-like Cluster 13 (HNSC-LUSC) squamous c3 squamous-like c4 miRNA c1uster 9 mutation cluster 5 TCGA-66-2800 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 70 R-Upper TCGA-66-2800-F37048 TCGA-66-2800 TCGA-66-2800-01A -25810 0 1492 Scheduled Follow-up Submission Complete Remission/Response 2012-11-21 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 1 NO 2 NO NO 75 No M0 N0 T4 Stage IIIB TCGA-66-2800.06d8266a-1fc8-4082-8a06-178dc57639c6.pdf 2800 TUMOR FREE NO R0 Primary Tumor 01 0.6 2000 5th NO NO YES 66 4 Lung A LIVING 2004 1950 e24747be-f71a-488a-84bb-5872711cc40e TCGA-66-2800-01A-01D-1198-05 TCGA-66-2800-01A-01D-1267-08 e24747be-f71a-488a-84bb-5872711cc40e TCGA-66-2800-01A-01D-1195-01 TCGA-66-2800-01A-01R-1201-07 e24747be-f71a-488a-84bb-5872711cc40e TCGA-66-2800-01A-01D-1195-01 TCGA-66-2800-01A-21-2193-20 +TCGA-67-3770-01 TCGA-67-3770-01 BRCA-LUAD+ LUAD-like c10 miRNA cluster 7 mutation cluster 11 TCGA-67-3770 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 70 R-Upper TCGA-67-3770 TCGA-67-3770-01A -25658 0 610 NO NO 2010-12-00 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.8 NO NO Central Lung 0.9 No M0 N0 T1 Stage IA TCGA-67-3770.93f88ca0-8ac7-486f-a253-d258a0744c77.pdf 3770 TUMOR FREE R0 Primary Tumor 01 0.2 YES NO 67 3 Lung A LIVING 2009 69180b6c-8fef-4453-812d-212730a35ea7 TCGA-67-3770-01 69180b6c-8fef-4453-812d-212730a35ea7 TCGA-67-3770-01A-01D-0944-01 TCGA-67-3770-01A-01R-0946-07 69180b6c-8fef-4453-812d-212730a35ea7 TCGA-67-3770-01A-01D-0944-01 +TCGA-67-3771-01 2.87 0.46 none none p.E894* p.S37C N N none none none 0.19 Magnoid none none none none none none none Solid predominant Adc Solid predominant Adc none 1 TCGA-67-3771-01 High C1-LUAD-enriched OV-like c1 squamous c3 LUAD-like c10 miRNA cluster 4 mutation cluster 8 TCGA-67-3771 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 77 L-Upper TCGA-67-3771 -28406 0 610 NO NO 2011-1-21 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES NO Central Lung No M0 N0 T1 Stage IA 3771 TUMOR FREE R0 Primary Tumor 01 6th YES NO 67 4 Current reformed smoker for < or = 15 years Lung LIVING 2009 a1022e37-586a-4c6a-a754-01709bad7a43 TCGA-67-3771-01A-01D-0945-05 TCGA-67-3771-01 a1022e37-586a-4c6a-a754-01709bad7a43 TCGA-67-3771-01A-01D-0944-01 TCGA-67-3771-01A-01R-0946-07 a1022e37-586a-4c6a-a754-01709bad7a43 TCGA-67-3771-01A-01D-0944-01 TCGA-67-3771-01A-21-2190-20 +TCGA-67-3772-01 1.89 0.43 none none none none Y Y p.L858R none none 0.22 Bronchioid none none none none none none none Acinar predominant Adc Acinar predominant Adc none 1 TCGA-67-3772-01 BRCA-LUAD+ C1-LUAD-enriched Low purity c2 LUAD-like c10 miRNA cluster 7 mutation cluster 14 TCGA-67-3772 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 82 R-Upper TCGA-67-3772 TCGA-67-3772-01A -29989 0 573 NO NO 2011-3-3 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.9 NO NO 0.9 No M0 N0 T2 Stage IB TCGA-67-3772.1b3a5b8e-7469-4fd6-b314-ad1fd7a2b957.pdf 3772 TUMOR FREE Primary Tumor 01 0.2 6th YES NO 67 1 Lifelong Non-smoker Lung A LIVING 2009 4722db5d-698c-4847-b4b7-31d4a3634f59 TCGA-67-3772-01A-01D-0945-05 TCGA-67-3772-01A-01W-0928-08 4722db5d-698c-4847-b4b7-31d4a3634f59 TCGA-67-3772-01A-01D-0944-01 TCGA-67-3772-01A-01R-0946-07 4722db5d-698c-4847-b4b7-31d4a3634f59 TCGA-67-3772-01A-01D-0944-01 +TCGA-67-3773-01 1.96 0.69 none none none none Y Y none none none 0.35 Bronchioid none p.G12V none none none none none Solid predominant Adc Solid predominant Adc none 0 TCGA-67-3773-01 Kirc+ C1-LUAD-enriched Cluster 6 LUAD-like c10 miRNA cluster 4 mutation cluster 12 TCGA-67-3773 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 84 L-Lower TCGA-67-3773 TCGA-67-3773-01A -30706 0 427 NO NO 2011-1-21 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 0.4 NO NO Central Lung 1 No M0 N0 T2 Stage IB TCGA-67-3773.e5b82f07-698e-4dff-9d33-748790e40811.pdf 3773 TUMOR FREE R0 Primary Tumor 01 0.2 6th YES NO 67 3 Current reformed smoker for > 15 years Lung A LIVING 2009 17a5a6af-dca6-47dc-912a-7ac0c226da89 TCGA-67-3773-01A-01D-0945-05 TCGA-67-3773-01 17a5a6af-dca6-47dc-912a-7ac0c226da89 TCGA-67-3773-01A-01D-0944-01 TCGA-67-3773-01A-01R-0946-07 17a5a6af-dca6-47dc-912a-7ac0c226da89 TCGA-67-3773-01A-01D-0944-01 +TCGA-67-3774-01 1.89 0.48 none none none none Y Y none none none 0.25 Bronchioid none p.G12F none none none none none Papillary predominant Adc Papillary predominant Adc none 0 TCGA-67-3774-01 BRCA-LUAD+ C1-LUAD-enriched Cluster 5 LUAD-like c10 miRNA cluster 4 mutation cluster 7 TCGA-67-3774 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 73 L-Lower TCGA-67-3774 TCGA-67-3774-01A -26704 0 385 NO NO 2011-3-3 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 0.4 NO NO 0.5 No M0 N0 T2 Stage IB TCGA-67-3774.a1d72b00-7384-4a8f-b335-5beb9ae078fc.pdf 3774 TUMOR FREE RX Primary Tumor 01 0.2 6th YES NO 67 3 Current reformed smoker for > 15 years Lung A LIVING 2009 0621fd32-18bd-4720-846b-4bf47453d296 TCGA-67-3774-01A-01D-0945-05 TCGA-67-3774-01 0621fd32-18bd-4720-846b-4bf47453d296 TCGA-67-3774-01A-01D-0944-01 TCGA-67-3774-01A-01R-0946-07 0621fd32-18bd-4720-846b-4bf47453d296 TCGA-67-3774-01A-01D-0944-01 +TCGA-67-4679-01 TCGA-67-4679-01 BRCA-LUAD+ C1-LUAD-enriched Cluster 6 LUAD-like c10 miRNA cluster 5 mutation cluster 7 TCGA-67-4679 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 69 R-Lower TCGA-67-4679 TCGA-67-4679-01B -25202 0 448 NO NO 2011-1-21 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 0.5 NO NO Central Lung 0.9 No M0 N0 T3 [Discrepancy] TCGA-67-4679.3528ccec-afff-4212-97aa-1d4f7af79856.pdf 4679 TUMOR FREE R0 Primary Tumor 01 0.2 YES NO 67 4 Lung B LIVING 2009 2613a946-0689-4c1b-99f6-30cfaa0ac3f9 TCGA-67-4679-01B-01D-1753-08 2613a946-0689-4c1b-99f6-30cfaa0ac3f9 TCGA-67-4679-01B-01D-1756-05 TCGA-67-4679-01B-01D-1752-01 2613a946-0689-4c1b-99f6-30cfaa0ac3f9 TCGA-67-4679-01B-01D-1752-01 +TCGA-67-6215-01 2.24 0.71 none Y none none none Y Y none none none 0.33 Bronchioid none none none none none none none Papillary predominant Adc Papillary predominant Adc none 0 TCGA-67-6215-01 High C1-LUAD-enriched Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 4 mutation c1uster 9 TCGA-67-6215 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 52 R-Lower TCGA-67-6215-F13585 TCGA-67-6215 TCGA-67-6215-01A -19310 0 174 2 NO NO Scheduled Follow-up Submission 2011-7-6 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 0.5 NO NO Central Lung 0.6 NO No M0 N0 T2a Stage IB TCGA-67-6215.bdaf595f-ae8e-451f-83d2-3a79ef06b2a3.pdf 6215 Adjuvant therapy TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 0.2 7th YES YES NO 67 1 Lifelong Non-smoker Lung A LIVING 2010 d4f590d7-626c-4c70-b170-1ad19d2ff6eb TCGA-67-6215-01A-11D-1753-08 d4f590d7-626c-4c70-b170-1ad19d2ff6eb TCGA-67-6215-01A-11D-1756-05 TCGA-67-6215-01A-11D-1752-01 d4f590d7-626c-4c70-b170-1ad19d2ff6eb TCGA-67-6215-01A-11D-1752-01 TCGA-67-6215-01A-13-2191-20 +TCGA-67-6216-01 3.89 0.39 none Y none none none Y Y none none none 0.14 Bronchioid none none none none none none none Micropapillary predom Adc Micropapillary predom Adc none 0 TCGA-67-6216-01 Kirc+ C1-LUAD-enriched Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 4 mutation c1uster 9 TCGA-67-6216 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 57 R-Middle TCGA-67-6216-F13587 TCGA-67-6216 TCGA-67-6216-01A -20967 0 141 NO NO Scheduled Follow-up Submission 2011-7-6 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.2 8140/3 C34.2 YES 0.6 NO NO Central Lung 1.2 NO No M0 N0 T1a Stage IA TCGA-67-6216.9f6ac234-e3d8-44a9-b82d-0552e49224be.pdf 6216 TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 0.4 7th NO YES NO 67 1 Lifelong Non-smoker Lung A LIVING 2010 abcd4b7e-f4f0-4be5-9769-3c889a078717 TCGA-67-6216-01A-11D-1753-08 abcd4b7e-f4f0-4be5-9769-3c889a078717 TCGA-67-6216-01A-11D-1756-05 TCGA-67-6216-01A-11D-1752-01 abcd4b7e-f4f0-4be5-9769-3c889a078717 TCGA-67-6216-01A-11D-1752-01 TCGA-67-6216-01A-13-2191-20 +TCGA-67-6217-01 none none none none Y Y p.L858R none none Bronchioid none none none none none none none Acinar predominant Adc Acinar predominant Adc none 0 TCGA-67-6217-01 BRCA-LUAD+ C1-LUAD-enriched Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 5 mutation cluster 14 TCGA-67-6217 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung YES NO NO 73 L-Upper TCGA-67-6217-F13566 TCGA-67-6217 TCGA-67-6217-01A -26920 0 422 296 YES L858R RT-PCR YES Scheduled Follow-up Submission Progressive Disease 2011-7-5 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.7 NO YES NO Central Lung 1.1 YES Yes M0 N1 T2a Stage IIA TCGA-67-6217.f03e4cad-5322-4068-b986-dd98892e1c85.pdf 6217 WITH TUMOR Progressive Disease NO R0 Primary Tumor 01 0.4 1965 7th NO YES NO 67 3 Current reformed smoker for > 15 years Lung A LIVING 2010 5a47770e-3ebf-4390-ab03-e128fd9ac507 TCGA-67-6217-01A-11D-1753-08 5a47770e-3ebf-4390-ab03-e128fd9ac507 TCGA-67-6217-01A-11D-1756-05 TCGA-67-6217-01A-11D-1752-01 5a47770e-3ebf-4390-ab03-e128fd9ac507 TCGA-67-6217-01A-11D-1752-01 TCGA-67-6217-01A-13-2191-20 +TCGA-68-7755-01 TCGA-68-7755-01 Squamous Cluster 13 (HNSC-LUSC) miRNA cluster 4 TCGA-68-7755 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung NO NO 60 R-Lower TCGA-68-7755-F20819 TCGA-68-7755 TCGA-68-7755-01A -21936 0 83 NO NO Scheduled Follow-up Submission 2012-1-23 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.6 NO NO Peripheral Lung 0.7 NO 78 No M0 N1 T1b Stage IIA TCGA-68-7755.472f285d-d573-47af-95c7-9c4b45fbae40.pdf 7755 TUMOR FREE NO Primary Tumor 01 0.2 1999 7th YES YES NO 68 4 Lung A LIVING 2011 1973 990bafa2-fdcf-4e80-aeb3-702157438626 990bafa2-fdcf-4e80-aeb3-702157438626 TCGA-68-7755-01A-11D-2123-05 TCGA-68-7755-01A-11D-2121-01 990bafa2-fdcf-4e80-aeb3-702157438626 TCGA-68-7755-01A-11D-2121-01 +TCGA-68-7756-01 TCGA-68-7756-01 Squamous Cluster 5 squamous c3 miRNA cluster 4 TCGA-68-7756 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung NO NO 84 L-Upper TCGA-68-7756-F20861 TCGA-68-7756 TCGA-68-7756-01A -30763 0 202 96 YES NO Scheduled Follow-up Submission 2012-1-24 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.7 NO NO Peripheral Lung 0.9 NO 20 No MX N1 T4 Stage IIIA TCGA-68-7756.c358874d-3ef7-4361-aaae-058b405619f4.pdf 7756 85 89 87 84 YES YES Primary Tumor 01 0.2 1971 7th YES YES NO 68 3 Lung A LIVING 2011 f8243dda-830f-4c7e-bde2-20bad21725d0 f8243dda-830f-4c7e-bde2-20bad21725d0 TCGA-68-7756-01A-11D-2123-05 TCGA-68-7756-01A-11D-2121-01 f8243dda-830f-4c7e-bde2-20bad21725d0 TCGA-68-7756-01A-11D-2121-01 TCGA-68-7756-01A-13-2195-20 +TCGA-68-7757-01 TCGA-68-7757-01 Squamous Cluster 5 miRNA cluster 4 TCGA-68-7757 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung NO NO 74 L-Upper TCGA-68-7757-F32558 TCGA-68-7757 TCGA-68-7757-01B -27272 0 211 71 0 NO NO Scheduled Follow-up Submission 2012-6-1 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.8 NO NO 0.8 YES NO 25 No MX N0 T1b Stage IA TCGA-68-7757.87fd1307-e3eb-45da-b0ec-2e3cb95e06d5.pdf 7757 Preoperative 83 86 81 85 YES NO Primary Tumor 01 0.5 2010 7th NO NO YES 68 4 Lung B LIVING 2011 1960 bea8760d-cd7c-4d02-8032-cf32505fda56 bea8760d-cd7c-4d02-8032-cf32505fda56 TCGA-68-7757-01B-11D-2294-05 TCGA-68-7757-01B-11D-2292-01 bea8760d-cd7c-4d02-8032-cf32505fda56 TCGA-68-7757-01B-11D-2292-01 +TCGA-68-8250-01 TCGA-68-8250-01 High Cluster 5 miRNA c1uster 9 TCGA-68-8250 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 66 R-Upper TCGA-68-8250-F32333 TCGA-68-8250 TCGA-68-8250-01A -24118 0 244 68 NO Scheduled Follow-up Submission 2012-5-23 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.4 NO 1.1 NO NO 50 Yes, History of Synchronous/Bilateral Malignancy MX N0 T1a Stage IA TCGA-68-8250.db0359b7-58b4-456f-a905-c8dc2b3ea8a4.pdf 8250 TUMOR FREE 88 YES NO Primary Tumor 01 0.3 2011 7th NO NO YES 68 4 Lung A LIVING 2011 2bdb8f96-2194-4541-bf8b-2798fb197a7c 2bdb8f96-2194-4541-bf8b-2798fb197a7c TCGA-68-8250-01A-11D-2294-05 TCGA-68-8250-01A-11D-2292-01 2bdb8f96-2194-4541-bf8b-2798fb197a7c TCGA-68-8250-01A-11D-2292-01 +TCGA-68-8251-01 TCGA-68-8251-01 Squamous Cluster 13 (HNSC-LUSC) miRNA cluster 4 TCGA-68-8251 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 78 L-Upper TCGA-68-8251-F41951 TCGA-68-8251 TCGA-68-8251-01A -28739 0 406 75 0 Scheduled Follow-up Submission Stable Disease 2013-4-5 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.6 NO 1.2 NO NO 52 No M0 N0 T2a Stage IB TCGA-68-8251.ca919e01-66e2-4307-b0ef-2dda4c1ca840.pdf 8251 Preoperative TUMOR FREE 99 91 Stable Disease YES NO Primary Tumor 01 0.4 1979 7th YES NO YES 68 3 Lung A LIVING 2012 1944 9ceb9e31-6495-4ae8-8c41-58fe981f9ac7 9ceb9e31-6495-4ae8-8c41-58fe981f9ac7 TCGA-68-8251-01A-11D-2294-05 TCGA-68-8251-01A-11D-2292-01 9ceb9e31-6495-4ae8-8c41-58fe981f9ac7 TCGA-68-8251-01A-11D-2292-01 +TCGA-68-A59I-01 TCGA-68-A59I-01 TCGA-68-A59I TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung YES YES 73 L-Lower TCGA-68-A59I-F57691 TCGA-68-A59I TCGA-68-A59I-01A -26839 36 0 428 159 Scheduled Follow-up Submission 2014-3-20 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 220 NO NO New Primary Tumor YES 50 true No M0 N1 T3 Stage IIIA TCGA-68-A59I.B0897B1D-F870-489E-9D9C-C670982BB3E0.pdf A59I WITH TUMOR 101 66.09 Stable Disease Convincing Imaging YES YES Primary Tumor 01 2012 7th YES YES NO 68 4 Lung A LIVING 2012 1962 04082349-5790-405a-9bbb-13d745fd4c05 04082349-5790-405a-9bbb-13d745fd4c05 TCGA-68-A59I-01A-11D-A26N-05 TCGA-68-A59I-01A-11D-A26L-01 04082349-5790-405a-9bbb-13d745fd4c05 TCGA-68-A59I-01A-11D-A26L-01 +TCGA-68-A59J-01 TCGA-68-A59J-01 TCGA-68-A59J TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 74 R-Lower TCGA-68-A59J-F57690 TCGA-68-A59J TCGA-68-A59J-01A -27031 20 0 409 Scheduled Follow-up Submission 2014-3-20 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 240 NO NO NO 45 true No MX N0 T2a Stage IB TCGA-68-A59J.629F9E80-0846-48A6-A872-5250D66BD0F7.pdf A59J TUMOR FREE 67 62 Complete Remission/Response YES NO R0 Primary Tumor 01 2007 7th NO YES NO 68 4 Lung A LIVING 2012 1962 ba2a4e28-8085-4721-a72c-2f26b49b6776 ba2a4e28-8085-4721-a72c-2f26b49b6776 TCGA-68-A59J-01A-21D-A26N-05 TCGA-68-A59J-01A-21D-A26L-01 ba2a4e28-8085-4721-a72c-2f26b49b6776 TCGA-68-A59J-01A-21D-A26L-01 +TCGA-69-7760-01 none none none none Y Y p.709_710ET>D none none Magnoid none none none none none none none Acinar predominant Adc Acinar predominant Adc none 0 TCGA-69-7760-01 Squamous C1-LUAD-enriched Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 5 TCGA-69-7760 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 73 R-Lower TCGA-69-7760-F29247 TCGA-69-7760 TCGA-69-7760-01A -26777 0 202 125 YES NO Scheduled Follow-up Submission 2012-3-13 MALE Lung Adenocarcinoma Mixed Subtype No C34.3 8255/3 C34.3 YES 0.7 NO NO Peripheral Lung 1.1 NO No M0 N0 T3 Stage IIB TCGA-69-7760.e5c9b2ce-2e5a-4127-8ee4-c6bd4ad99fa0.pdf 7760 Post-Adjuvant Therapy TUMOR FREE 91 83 YES NO Primary Tumor 01 0.3 7th YES YES NO 69 1 Lifelong Non-smoker Lung A LIVING 2011 877fb28c-fcdd-4e75-8057-029c9ff31d26 877fb28c-fcdd-4e75-8057-029c9ff31d26 TCGA-69-7760-01A-11D-2168-05 TCGA-69-7760-01A-11D-2166-01 877fb28c-fcdd-4e75-8057-029c9ff31d26 TCGA-69-7760-01A-11D-2166-01 TCGA-69-7760-01A-21-2192-20 +TCGA-69-7761-01 none none none none N N none none none Squamoid none none none none none none none Acinar predominant Adc Acinar predominant Adc none 0 TCGA-69-7761-01 Squamous C1-LUAD-enriched Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 5 TCGA-69-7761 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 84 L-Lower TCGA-69-7761-F29252 TCGA-69-7761 TCGA-69-7761-01A -31041 0 186 80 1 YES Other Scheduled Follow-up Submission 2012-3-13 MALE Lung Acinar Adenocarcinoma No C34.3 8550/3 C34.3 YES 0.7 NO Peripheral Lung 1.3 NO 20 No MX N0 T2a Stage IB TCGA-69-7761.1148daaf-0315-4639-92dd-f17ff727c6cc.pdf 7761 Adjuvant therapy TUMOR FREE 91 98 YES NO Primary Tumor 01 0.3 1975 7th YES NO YES 69 3 Current reformed smoker for > 15 years Lung A LIVING 2011 1955 167ca59a-5b32-4d99-8f91-2244b723dd87 167ca59a-5b32-4d99-8f91-2244b723dd87 TCGA-69-7761-01A-11D-2168-05 TCGA-69-7761-01A-11D-2166-01 167ca59a-5b32-4d99-8f91-2244b723dd87 TCGA-69-7761-01A-11D-2166-01 TCGA-69-7761-01A-31-2192-20 +TCGA-69-7763-01 none none none none N N none none none Bronchioid none none none none none none none Lepidic predominant Adc Lepidic predominant Adc p.Y60fs 0 TCGA-69-7763-01 BRCA-LUAD+ C1-LUAD-enriched Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 5 TCGA-69-7763 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 69 R-Middle TCGA-69-7763-F20990 TCGA-69-7763 TCGA-69-7763-01A -25316 0 690 72 1 NO NO Scheduled Follow-up Submission 2012-1-26 MALE Lung Adenocarcinoma Mixed Subtype No C34.2 8550/3 C34.2 YES 0.5 NO NO Peripheral Lung 0.9 NO 7.5 No M0 N0 T1b Stage IA TCGA-69-7763.c1af94b6-becb-493d-bfac-2367f2e69490.pdf 7763 Other 93 89 YES NO Primary Tumor 01 0.3 2004 7th NO NO YES 69 4 Current reformed smoker for < or = 15 years Lung A LIVING 2010 1959 c9376fb2-9938-4516-88da-3fc03deeb6ee c9376fb2-9938-4516-88da-3fc03deeb6ee TCGA-69-7763-01A-11D-2168-05 TCGA-69-7763-01A-11D-2166-01 c9376fb2-9938-4516-88da-3fc03deeb6ee TCGA-69-7763-01A-11D-2166-01 TCGA-69-7763-01A-13-2192-20 +TCGA-69-7764-01 none none none none N N none none none Bronchioid none none none none none none none Acinar predominant Adc Acinar predominant Adc none 0 TCGA-69-7764-01 BRCA-LUAD+ C1-LUAD-enriched Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 4 TCGA-69-7764 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 75 R-Upper TCGA-69-7764-F20992 TCGA-69-7764 TCGA-69-7764-01A -27693 0 414 0 YES NO Scheduled Follow-up Submission 2012-1-26 MALE Lung Adenocarcinoma Mixed Subtype No C34.1 8255/3 C34.1 YES 0.6 NO NO Peripheral Lung 0.6 NO 30 No M0 N0 T1b Stage IA TCGA-69-7764.3518ba0e-79fc-4a98-a308-ecee684e0439.pdf 7764 Other TUMOR FREE 94 106 YES NO Primary Tumor 01 0.2 1991 7th NO NO YES 69 3 Current reformed smoker for > 15 years Lung A LIVING 2010 1977 6deb91e8-110b-444d-93c8-72cd04e4746a 6deb91e8-110b-444d-93c8-72cd04e4746a TCGA-69-7764-01A-11D-2168-05 TCGA-69-7764-01A-11D-2166-01 6deb91e8-110b-444d-93c8-72cd04e4746a TCGA-69-7764-01A-11D-2166-01 TCGA-69-7764-01A-13-2192-20 +TCGA-69-7765-01 none p.G469V none none N Y p.Q486* none none Squamoid none none none none none none none Acinar predominant Adc Acinar predominant Adc none 0 TCGA-69-7765-01 Iq C1-LUAD-enriched Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 5 TCGA-69-7765 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 56 R-Upper TCGA-69-7765-F29244 TCGA-69-7765 TCGA-69-7765-01A -20625 0 165 45 NO Other NO Scheduled Follow-up Submission 2012-3-13 MALE Lung Adenocarcinoma Mixed Subtype No C34.1 8255/3 C34.1 YES 1 NO NO Peripheral Lung 1 NO No MX N0 T4 [Discrepancy] TCGA-69-7765.89d3bed4-3090-463f-ac00-c2de1abaabb2.pdf 7765 86 84 YES NO Primary Tumor 01 0.3 2011 7th YES YES NO 69 4 Current reformed smoker for < or = 15 years Lung A LIVING 2011 1981 a660dca3-d4cd-4d7e-93fd-6be7a622cc59 a660dca3-d4cd-4d7e-93fd-6be7a622cc59 TCGA-69-7765-01A-11D-2168-05 TCGA-69-7765-01A-11D-2166-01 a660dca3-d4cd-4d7e-93fd-6be7a622cc59 TCGA-69-7765-01A-11D-2166-01 TCGA-69-7765-01A-13-2192-20 +TCGA-69-7973-01 TCGA-69-7973-01 High Cluster 5 LUAD-like c10 miRNA cluster 6 TCGA-69-7973 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung NO NO NO NO 42 R-Middle TCGA-69-7973-F30347 TCGA-69-7973 TCGA-69-7973-01A -15355 0 230 1 YES Scheduled Follow-up Submission Complete Remission/Response 2012-4-9 FEMALE Lung Adenocarcinoma Mixed Subtype No C34.2 8255/3 C34.2 YES 0.6 NO Central Lung 0.9 NO 25 No M0 N0 T2a Stage IB TCGA-69-7973.fd1b94d4-d5b9-47fe-96ad-4e3d781a638a.pdf 7973 Post-Adjuvant Therapy TUMOR FREE Complete Remission/Response NO NO Primary Tumor 01 0.5 2011 7th YES NO YES 69 4 Lung A LIVING 2011 47b76d43-afa5-4540-b129-64c997d726b4 47b76d43-afa5-4540-b129-64c997d726b4 TCGA-69-7973-01A-11D-2185-05 TCGA-69-7973-01A-11D-2183-01 47b76d43-afa5-4540-b129-64c997d726b4 TCGA-69-7973-01A-11D-2183-01 +TCGA-69-7974-01 TCGA-69-7974-01 Kirc+ Cluster 6 LUAD-like c10 miRNA cluster 4 TCGA-69-7974 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 54 L-Upper TCGA-69-7974-F30365 TCGA-69-7974 TCGA-69-7974-01A -20021 0 184 YES Other Scheduled Follow-up Submission Progressive Disease 2012-4-9 FEMALE Lung Adenocarcinoma Mixed Subtype No C34.1 8255/3 C34.1 YES 0.6 NO 80 Peripheral Lung 0.8 NO 30 No MX N2 T2a Stage IIIA TCGA-69-7974.f2c5dd0c-88d1-4c68-abd0-c5ee5fbade8b.pdf 7974 Post-Adjuvant Therapy WITH TUMOR 58 47 Progressive Disease YES YES Primary Tumor 01 0.4 2011 7th YES NO YES 69 4 Lung A LIVING 2011 1981 a237a685-c274-4cc9-ae4d-64398d2ba92e a237a685-c274-4cc9-ae4d-64398d2ba92e TCGA-69-7974-01A-11D-2185-05 TCGA-69-7974-01A-11D-2183-01 a237a685-c274-4cc9-ae4d-64398d2ba92e TCGA-69-7974-01A-11D-2183-01 +TCGA-69-7978-01 TCGA-69-7978-01 BRCA-LUAD+ Cluster 6 LUAD-like c10 miRNA cluster 4 TCGA-69-7978 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung NO 59 R-Upper TCGA-69-7978-F39911 TCGA-69-7978 TCGA-69-7978-01A -21785 0 134 YES Other Scheduled Follow-up Submission Stable Disease 2013-2-11 MALE Lung Adenocarcinoma Mixed Subtype No C34.1 8255/3 C34.1 YES 0.8 NO Peripheral Lung 1 NO NO 80 No MX N1 T2b Stage IIB TCGA-69-7978.f832fcc5-67a6-472c-9a50-081084bc029c.pdf 7978 [Discrepancy] 91 75 88 67 YES NO Primary Tumor 01 0.3 7th NO NO YES 69 2 Lung A LIVING 2011 c2972973-dec9-4723-8fc6-af9db22e1cde c2972973-dec9-4723-8fc6-af9db22e1cde TCGA-69-7978-01A-11D-2185-05 TCGA-69-7978-01A-11D-2183-01 c2972973-dec9-4723-8fc6-af9db22e1cde TCGA-69-7978-01A-11D-2183-01 +TCGA-69-7979-01 TCGA-69-7979-01 High Cluster 6 LUAD-like c10 miRNA cluster 12 TCGA-69-7979 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 71 R-Upper TCGA-69-7979-F40026 TCGA-69-7979 TCGA-69-7979-01A -26180 0 408 NO NO 2014-3-19 FEMALE Lung Acinar Adenocarcinoma No C34.1 8550/3 C34.1 YES 0.6 NO NO 0.9 28 No MX N0 T2a Stage IB TCGA-69-7979.98f68d62-141d-4f50-9987-6e13d35195d2.pdf 7979 71 64 70 59 YES Primary Tumor 01 0.5 7th NO YES 69 2 Lung A LIVING 2011 1955 e9b4a714-487c-40e5-943d-11301e5bc54c e9b4a714-487c-40e5-943d-11301e5bc54c TCGA-69-7979-01A-11D-2185-05 TCGA-69-7979-01A-11D-2183-01 e9b4a714-487c-40e5-943d-11301e5bc54c TCGA-69-7979-01A-11D-2183-01 +TCGA-69-7980-01 none none p.R86L none Y Y none none p.L420M, p.L868F Bronchioid none p.G12A none none none none none 0 Acinar predominant Adc none TCGA-69-7980-01 High Cluster 6 LUAD-like c10 miRNA c1uster 9 TCGA-69-7980 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 70 R-Upper TCGA-69-7980-F57659 TCGA-69-7980 TCGA-69-7980-01A -25583 0 362 71 YES Other NO Scheduled Follow-up Submission 2014-3-19 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8550/3 C34.1 YES 1.2 NO NO 1.6 NO NO 80 No M0 N0 T1b Stage I TCGA-69-7980.a4a32cf5-43b8-4387-9873-d90f7000b134.pdf 7980 TUMOR FREE 86 92 Complete Remission/Response YES NO Primary Tumor 01 0.4 2001 7th NO YES NO 69 4 Lung A LIVING 2011 16b48e8d-f339-45b2-8182-fe27212bc8da 16b48e8d-f339-45b2-8182-fe27212bc8da TCGA-69-7980-01A-11D-2185-05 TCGA-69-7980-01A-11D-2183-01 16b48e8d-f339-45b2-8182-fe27212bc8da TCGA-69-7980-01A-11D-2183-01 +TCGA-69-8253-01 TCGA-69-8253-01 Iq Cluster 5 LUAD-like c10 miRNA cluster 4 TCGA-69-8253 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 59 R-Lower TCGA-69-8253-F41949 TCGA-69-8253 TCGA-69-8253-01A -21771 0 426 1 NO NO Scheduled Follow-up Submission Complete Remission/Response 2013-4-5 FEMALE Lung Adenocarcinoma Mixed Subtype No C34.3 8255/3 C34.3 YES 0.6 NO NO 1.2 NO NO 7.8 No MX N1 T1a Stage IIA TCGA-69-8253.8148140f-8b78-4c05-a2fa-59a25cc6c9d8.pdf 8253 Preoperative TUMOR FREE 87 Complete Remission/Response YES NO Primary Tumor 01 0.5 2011 7th YES YES NO 69 4 Lung A LIVING 2012 1972 2acc6f62-4829-4c3d-a813-951ec8136ae7 2acc6f62-4829-4c3d-a813-951ec8136ae7 TCGA-69-8253-01A-11D-2285-05 TCGA-69-8253-01A-11D-2283-01 2acc6f62-4829-4c3d-a813-951ec8136ae7 TCGA-69-8253-01A-11D-2283-01 +TCGA-69-8254-01 TCGA-69-8254-01 Kirc+ Cluster 6 LUAD-like c10 miRNA cluster 6 TCGA-69-8254 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 85 R-Lower TCGA-69-8254-F41950 TCGA-69-8254 TCGA-69-8254-01A -31134 0 409 0 YES Other NO Scheduled Follow-up Submission Complete Remission/Response 2013-4-5 MALE Lung Adenocarcinoma Mixed Subtype No C34.3 8255/3 C34.3 YES 0.7 NO 80 NO 1.4 NO NO 40 No T2b TCGA-69-8254.3edeafc6-1876-4547-82b2-90e18240061d.pdf 8254 Preoperative TUMOR FREE 62 Complete Remission/Response YES NO Primary Tumor 01 0.3 1989 7th NO YES NO 69 3 Lung A LIVING 2012 8fabb97c-5921-4156-98c0-86bdd642c612 8fabb97c-5921-4156-98c0-86bdd642c612 TCGA-69-8254-01A-11D-2285-05 TCGA-69-8254-01A-11D-2283-01 8fabb97c-5921-4156-98c0-86bdd642c612 TCGA-69-8254-01A-11D-2283-01 +TCGA-69-8255-01 TCGA-69-8255-01 Squamous Cluster 5 LAML-like c13 TCGA-69-8255 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 71 R-Upper TCGA-69-8255-F32611 TCGA-69-8255 TCGA-69-8255-01A -26289 0 129 60 YES Other NO Scheduled Follow-up Submission 2012-6-4 MALE Lung Solid Pattern Predominant Adenocarcinoma No C34.1 8230/3 C34.1 YES 0.8 NO NO 1 NO NO 40 No M0 N0 T1a Stage IA TCGA-69-8255.d807cbcd-b72d-47f5-975b-347782728e94.pdf 8255 60 57 YES NO Primary Tumor 01 0.7 7th NO YES NO 69 2 Lung A LIVING 2011 1971 ea0be0ea-2959-435e-a1c6-c5a3b4c52f51 ea0be0ea-2959-435e-a1c6-c5a3b4c52f51 TCGA-69-8255-01A-11D-2285-05 TCGA-69-8255-01A-11D-2283-01 ea0be0ea-2959-435e-a1c6-c5a3b4c52f51 TCGA-69-8255-01A-11D-2283-01 +TCGA-69-8453-01 TCGA-69-8453-01 Cluster 5 miRNA c1uster 9 TCGA-69-8453 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 77 R-Lower TCGA-69-8453-F58885 TCGA-69-8453 TCGA-69-8453-01A -28413 0 813 52 1 Scheduled Follow-up Submission 2014-4-25 MALE Mucinous (Colloid) Carcinoma No C34.30 8480/3 C34.3 YES 0.4 NO Peripheral Lung 0.6 NO NO 12 No MX N0 T3 Stage IIB TCGA-69-8453.3f4d0319-89c9-4256-b43c-c0b1514c4380.pdf 8453 Preoperative WITH TUMOR 87 85 86 85 Stable Disease YES NO Primary Tumor 01 0.3 1974 7th YES YES NO 69 3 Lung A LIVING 2012 c58f01fe-6249-49fe-93ab-dd0f7af94df3 c58f01fe-6249-49fe-93ab-dd0f7af94df3 TCGA-69-8453-01A-12D-2324-05 TCGA-69-8453-01A-12D-2322-01 c58f01fe-6249-49fe-93ab-dd0f7af94df3 TCGA-69-8453-01A-12D-2322-01 +TCGA-69-A59K-01 TCGA-69-A59K-01 TCGA-69-A59K TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 60 R-Upper TCGA-69-A59K-F57660 TCGA-69-A59K TCGA-69-A59K-01A -22093 130 0 522 75 2 YES NO Scheduled Follow-up Submission 2014-3-19 FEMALE Lung Adenocarcinoma Mixed Subtype No C34.1 8255/3 C34.1 YES 140 NO NO NO 25 true No M0 N0 T3 Stage IIB TCGA-69-A59K.6EF9E448-6E2D-499D-8EC0-7F03B7A10FC8.pdf A59K Pre-Adjuvant Therapy TUMOR FREE 120 118 Stable Disease YES NO Primary Tumor 01 2012 7th YES YES NO 69 4 Lung A LIVING 2012 1999 0a8dbb5b-77b8-4eda-a67c-8cf842c12d53 0a8dbb5b-77b8-4eda-a67c-8cf842c12d53 TCGA-69-A59K-01A-11D-A25R-05 TCGA-69-A59K-01A-11D-A25M-01 0a8dbb5b-77b8-4eda-a67c-8cf842c12d53 TCGA-69-A59K-01A-11D-A25M-01 +TCGA-6A-AB49-01 TCGA-6A-AB49-01 TCGA-6A-AB49 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 73 L-Lower TCGA-6A-AB49-F66619 TCGA-6A-AB49 TCGA-6A-AB49-01A 1691 [Discrepancy] 0 Scheduled Follow-up Submission Complete Remission/Response 2014-10-21 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 80 NO 0 Central Lung NO NO 50 false No MX N0 T2 Stage IB TCGA-6A-AB49.2424B47C-B6A9-449C-86C3-1B8C2604FA8F.pdf AB49 Other TUMOR FREE 70 71 72 70 Complete Remission/Response YES NO RX Primary Tumor 01 6th NO NO YES 6A 3 Lung A DECEASED 2009 1969 4f64d057-a632-4a38-a9fe-977a194bcd34 4f64d057-a632-4a38-a9fe-977a194bcd34 TCGA-6A-AB49-01A-12D-A408-05 TCGA-6A-AB49-01A-12D-A400-01 4f64d057-a632-4a38-a9fe-977a194bcd34 TCGA-6A-AB49-01A-12D-A400-01 +TCGA-70-6722-01 TCGA-70-6722-01 Squamous C2-Squamous-like Cluster 5 squamous c3 squamous-like c4 miRNA cluster 5 mutation cluster 6 TCGA-70-6722 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung NO NO NO 47 R-Upper TCGA-70-6722-F70936 TCGA-70-6722 TCGA-70-6722-01A -17328 0 367 293 2 Scheduled Follow-up Submission Progressive Disease 2015-3-10 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.6 NO 20 2.2 NO Locoregional Recurrence YES No M0 N1 T3 Stage IIIA TCGA-70-6722.09915ca9-3880-4aa5-aab2-3762bf1d162c.pdf 6722 Post-Adjuvant Therapy WITH TUMOR Progressive Disease YES RX Primary Tumor 01 0.6 6th NO YES NO 70 1 Lung A LIVING 2010 c4298e1d-a255-4c7d-af91-48868b8a72ea TCGA-70-6722-01A-11D-1817-08 c4298e1d-a255-4c7d-af91-48868b8a72ea TCGA-70-6722-01A-11D-1818-05 TCGA-70-6722-01A-11D-1816-01 c4298e1d-a255-4c7d-af91-48868b8a72ea TCGA-70-6722-01A-11D-1816-01 TCGA-70-6722-01A-13-2194-20 +TCGA-70-6723-01 TCGA-70-6723-01 Squamous C2-Squamous-like Cluster 13 (HNSC-LUSC) squamous c3 squamous-like c4 miRNA cluster 12 mutation cluster 5 TCGA-70-6723 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung NO NO NO 65 R-Upper TCGA-70-6723-F70934 TCGA-70-6723 TCGA-70-6723-01A -24035 0 375 312 2 Scheduled Follow-up Submission Progressive Disease 2015-3-10 MALE Lung Papillary Squamous Cell Caricnoma No C34.1 8052/3 C34.1 YES 1 NO 40 1.5 NO Locoregional Recurrence YES No M0 N0 T3 Stage IIA TCGA-70-6723.09544798-db0a-443e-8f57-ca404db4f4ef.pdf 6723 Post-Adjuvant Therapy WITH TUMOR Progressive Disease YES RX Primary Tumor 01 0.8 6th NO YES NO 70 1 Lung A LIVING 2010 88ef1c54-2210-429c-9cc4-6c12e6ee9d61 TCGA-70-6723-01A-11D-1817-08 88ef1c54-2210-429c-9cc4-6c12e6ee9d61 TCGA-70-6723-01A-11D-1818-05 TCGA-70-6723-01A-11D-1816-01 88ef1c54-2210-429c-9cc4-6c12e6ee9d61 TCGA-70-6723-01A-11D-1816-01 TCGA-70-6723-01A-13-2194-20 +TCGA-71-6725-01 2.69 0.63 none none none none N N none none none 0.26 Bronchioid none none none none none none none Micropapillary predom Adc Micropapillary predom Adc none 0 TCGA-71-6725-01 High C1-LUAD-enriched Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 4 mutation c1uster 9 TCGA-71-6725 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung NO YES NO 48 R-Upper TCGA-71-6725-F70928 TCGA-71-6725 TCGA-71-6725-01A -17793 0 256 164 2 Scheduled Follow-up Submission Progressive Disease 2015-3-10 FEMALE Lung Papillary Adenocarcinoma No C34.1 8260/3 C34.1 YES 1 NO 60 2 NO Locoregional Recurrence YES No M0 N0 T2 Stage IB TCGA-71-6725.0d31265b-d292-4550-81cb-509a2ab9a4ce.pdf 6725 Post-Adjuvant Therapy WITH TUMOR Progressive Disease NO RX Primary Tumor 01 0.8 6th YES YES NO 71 2 Current smoker Lung A LIVING 2011 9680a78d-59ab-4cf0-bd92-e6ecbc640e04 TCGA-71-6725-01A-11D-1855-08 9680a78d-59ab-4cf0-bd92-e6ecbc640e04 TCGA-71-6725-01A-11D-1856-05 TCGA-71-6725-01A-11D-1854-01 9680a78d-59ab-4cf0-bd92-e6ecbc640e04 TCGA-71-6725-01A-11D-1854-01 TCGA-71-6725-01A-13-2191-20 +TCGA-71-8520-01 TCGA-71-8520-01 TCGA-71-8520 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung NO NO NO 60 L-Upper TCGA-71-8520-F70925 TCGA-71-8520 TCGA-71-8520-01A -21921 210 0 3 179 Scheduled Follow-up Submission Progressive Disease 2015-3-10 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.7 NO 40 YES NO 0.9 NO Locoregional Recurrence YES No M0 N0 T2 Stage IB TCGA-71-8520.3ead80d6-5b6e-49ff-87a2-aed7abb8e2e7.pdf 8520 Preoperative WITH TUMOR Complete Remission/Response NO YES R0 Primary Tumor 01 0.5 7th NO YES NO 71 1 Lung A DECEASED 2011 2fe33b61-8a00-424b-b881-e2808b099022 2fe33b61-8a00-424b-b881-e2808b099022 TCGA-71-8520-01A-11D-2398-05 2fe33b61-8a00-424b-b881-e2808b099022 +TCGA-73-4658-01 2.01 0.32 none none none none N N none none none 0.16 Squamoid none none none none none none none Micropapillary predom Adc Micropapillary predom Adc none 0 TCGA-73-4658-01 High C1-LUAD-enriched Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 5 mutation cluster 4 TCGA-73-4658 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 80 L-Lower TCGA-73-4658-F12975 TCGA-73-4658 TCGA-73-4658-01A -29508 1600 0 1600 NO Complete Remission/Response 2011-6-15 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 1 NO NO Central Lung 1.4 NO 25 Yes M0 N0 T2 Stage IB TCGA-73-4658.37bb6a7b-4f9e-4690-b904-4eebc3189562.pdf 4658 TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 0.3 6th NO NO YES 73 3 Current reformed smoker for > 15 years Lung A DECEASED 2004 8090b818-81f9-4bd6-aed2-7a721432cdc8 TCGA-73-4658-01A-01D-1753-08 8090b818-81f9-4bd6-aed2-7a721432cdc8 TCGA-73-4658-01A-01D-1756-05 TCGA-73-4658-01A-01D-1752-01 8090b818-81f9-4bd6-aed2-7a721432cdc8 TCGA-73-4658-01A-01D-1752-01 TCGA-73-4658-01A-21-2190-20 +TCGA-73-4658-11 2.01 0.32 none none none none N N none none none 0.16 Squamoid none none none none none none none Micropapillary predom Adc Micropapillary predom Adc none 0 TCGA-73-4658-11 C1-LUAD-enriched mutation cluster 4 TCGA-73-4658 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 80 L-Lower TCGA-73-4658-F12975 TCGA-73-4658 TCGA-73-4658-11A -29508 1600 0 1600 NO Complete Remission/Response 2011-6-15 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 0.6 NO NO Central Lung 1.1 NO 25 Yes M0 N0 T2 Stage IB 4658 TUMOR FREE Complete Remission/Response NO R0 Solid Tissue Normal 11 0.5 6th NO NO YES 73 3 Current reformed smoker for > 15 years Lung A DECEASED 2004 TCGA-73-4658-11A-01D-1756-05 +TCGA-73-4659-01 3.54 0.33 none none none none Y Y none none none 0.13 Magnoid none p.G12V none none none none none Acinar predominant Adc Acinar predominant Adc none 1 TCGA-73-4659-01 BRCA-LUAD+ C1-LUAD-enriched Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 6 mutation cluster 12 TCGA-73-4659 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung NO YES NO 66 R-Upper TCGA-73-4659-F42024 TCGA-73-4659 TCGA-73-4659-01A -24253 711 0 711 316 0 NO NO Scheduled Follow-up Submission Progressive Disease 2013-4-9 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.9 YES 1 NO 0 NO Central Lung 1.2 NO Distant Metastasis YES 12 No M0 N2 T2 Stage IIIA TCGA-73-4659.a6f30521-a0d2-4871-8b9f-a338f15ce8e8.pdf 4659 Other WITH TUMOR Progressive Disease Convincing Imaging NO R0 Primary Tumor 01 0.4 1986 6th NO NO YES 73 3 Current reformed smoker for > 15 years Lung A DECEASED 2006 1974 dc1b5145-85ca-4e21-9896-2216924019bb TCGA-73-4659-01A-01D-1205-05 TCGA-73-4659-01A-01D-1265-08 dc1b5145-85ca-4e21-9896-2216924019bb TCGA-73-4659-01A-01D-1204-01 dc1b5145-85ca-4e21-9896-2216924019bb TCGA-73-4659-01A-01D-1204-01 TCGA-73-4659-01A-21-2190-20 +TCGA-73-4659-11 3.54 0.33 none none none none Y Y none none none 0.13 Magnoid none p.G12V none none none none none Acinar predominant Adc Acinar predominant Adc none 1 TCGA-73-4659-11 C1-LUAD-enriched mutation cluster 12 TCGA-73-4659 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung NO YES NO 66 R-Upper TCGA-73-4659-F42024 TCGA-73-4659 TCGA-73-4659-11A -24253 711 0 711 316 0 NO NO Scheduled Follow-up Submission Progressive Disease 2013-4-9 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.9 YES 2.2 NO 0 NO Central Lung 2.5 NO Distant Metastasis YES 12 No M0 N2 T2 Stage IIIA 4659 Other WITH TUMOR Progressive Disease Convincing Imaging NO R0 Solid Tissue Normal 11 0.6 1986 6th NO NO YES 73 3 Current reformed smoker for > 15 years Lung A DECEASED 2006 1974 TCGA-73-4659-11A-01D-1205-05 +TCGA-73-4662-01 3 0.49 none none none none Y Y none none none 0.2 Bronchioid none p.G12C none none none none none Acinar predominant Adc Acinar predominant Adc none 0 TCGA-73-4662-01 BRCA-LUAD+ C1-LUAD-enriched Cluster 6 LUAD-like c10 miRNA cluster 4 mutation cluster 12 TCGA-73-4662 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 65 L-Upper TCGA-73-4662-F71029 TCGA-73-4662 TCGA-73-4662-01A -23762 0 2515 116 0 NO NO Scheduled Follow-up Submission Complete Remission/Response 2015-3-18 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.5 NO 100 NO Peripheral Lung 0.8 NO NO 10 No M0 N0 T1 Stage IA TCGA-73-4662.5dd8c28f-e814-4a29-a3cd-b3524fa41941.pdf 4662 Preoperative TUMOR FREE 115 111 Complete Remission/Response YES NO R0 Primary Tumor 01 0.3 1972 6th NO NO YES 73 3 Current reformed smoker for > 15 years Lung A LIVING 2007 1955 fce05b98-e717-4364-8c8d-c15759e1170a TCGA-73-4662-01A-01D-1205-05 TCGA-73-4662-01A-01D-1265-08 fce05b98-e717-4364-8c8d-c15759e1170a TCGA-73-4662-01A-01D-1204-01 fce05b98-e717-4364-8c8d-c15759e1170a TCGA-73-4662-01A-01D-1204-01 +TCGA-73-4662-11 3 0.49 none none none none Y Y none none none 0.2 Bronchioid none p.G12C none none none none none Acinar predominant Adc Acinar predominant Adc none 0 TCGA-73-4662-11 C1-LUAD-enriched mutation cluster 12 TCGA-73-4662 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 65 L-Upper TCGA-73-4662-F71029 TCGA-73-4662 TCGA-73-4662-11A -23762 0 2515 116 0 NO NO Scheduled Follow-up Submission Complete Remission/Response 2015-3-18 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 1 NO 100 NO Peripheral Lung 1.5 NO NO 10 No M0 N0 T1 Stage IA 4662 Preoperative TUMOR FREE 115 111 Complete Remission/Response YES NO R0 Solid Tissue Normal 11 0.7 1972 6th NO NO YES 73 3 Current reformed smoker for > 15 years Lung A LIVING 2007 1955 TCGA-73-4662-11A-01D-1205-05 +TCGA-73-4666-01 TCGA-73-4666-01 BRCA-LUAD+ C1-LUAD-enriched Cluster 6 LUAD-like c10 mutation cluster 2 TCGA-73-4666 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung NO YES NO YES 52 R-Upper TCGA-73-4666-F12865 TCGA-73-4666 TCGA-73-4666-01A -43 -19074 0 800 1 NO NO Complete Remission/Response 2011-6-10 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.6 NO 80 NO Central Lung 0.7 YES 10 No M1 N0 T1 Stage IV TCGA-73-4666.4ab3bc9e-68ae-4c85-9a2a-11ead25ee142.pdf 4666 Post-Adjuvant Therapy TUMOR FREE Complete Remission/Response YES R0 Primary Tumor 01 0.3 2002 YES NO YES 73 4 Lung A LIVING 2009 1982 f66bb574-487a-426d-9b17-799718300e1e TCGA-73-4666-01A-01D-1205-05 TCGA-73-4666-01A-01D-1265-08 f66bb574-487a-426d-9b17-799718300e1e TCGA-73-4666-01A-01D-1204-01 f66bb574-487a-426d-9b17-799718300e1e TCGA-73-4666-01A-01D-1204-01 +TCGA-73-4666-11 TCGA-73-4666-11 C1-LUAD-enriched mutation cluster 2 TCGA-73-4666 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung NO YES NO YES 52 R-Upper TCGA-73-4666-F12865 TCGA-73-4666 TCGA-73-4666-11A -43 -19074 0 800 1 NO NO Complete Remission/Response 2011-6-10 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 1 NO 80 NO Central Lung 1.2 YES 10 No M1 N0 T1 Stage IV 4666 Post-Adjuvant Therapy TUMOR FREE Complete Remission/Response YES R0 Solid Tissue Normal 11 0.2 2002 YES NO YES 73 4 Lung A LIVING 2009 1982 TCGA-73-4666-11A-01D-1205-05 +TCGA-73-4668-01 TCGA-73-4668-01 High C1-LUAD-enriched Cluster 6 LUAD-like c10 mutation c1uster 10 TCGA-73-4668 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung YES YES NO NO 66 L-Upper TCGA-73-4668-F7958 TCGA-73-4668 TCGA-73-4668-01A -24255 0 467 282 0 NO NO Stable Disease 2011-1-6 FEMALE Lung Micropapillary Adenocarcinoma No C34.1 8507/3 C34.1 YES 0.3 NO 80 NO Peripheral Lung 0.6 YES 55 No M0 N1 T2 Stage IIB TCGA-73-4668.9177e909-f92c-4b50-a256-a4f840a05140.pdf 4668 Post-Adjuvant Therapy WITH TUMOR NO R0 Primary Tumor 01 0.1 2005 NO YES 73 4 Lung A LIVING 2009 1968 297fecfd-e9b8-4882-8a55-312f2a04c3f6 TCGA-73-4668-01A-01D-1205-05 TCGA-73-4668-01A-01D-1265-08 297fecfd-e9b8-4882-8a55-312f2a04c3f6 TCGA-73-4668-01A-01D-1204-01 297fecfd-e9b8-4882-8a55-312f2a04c3f6 TCGA-73-4668-01A-01D-1204-01 +TCGA-73-4668-11 TCGA-73-4668-11 C1-LUAD-enriched mutation c1uster 10 TCGA-73-4668 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung YES YES NO NO 66 L-Upper TCGA-73-4668-F7958 TCGA-73-4668 TCGA-73-4668-11A -24255 0 467 282 0 NO NO Stable Disease 2011-1-6 FEMALE Lung Micropapillary Adenocarcinoma No C34.1 8507/3 C34.1 YES 0.5 NO 80 NO Peripheral Lung 0.8 YES 55 No M0 N1 T2 Stage IIB 4668 Post-Adjuvant Therapy WITH TUMOR NO R0 Solid Tissue Normal 11 0.2 2005 NO YES 73 4 Lung A LIVING 2009 1968 TCGA-73-4668-11A-01D-1205-05 +TCGA-73-4670-01 TCGA-73-4670-01 High C1-LUAD-enriched Cluster 6 squamous c3 LUAD-like c10 mutation cluster 11 TCGA-73-4670 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 69 L-Upper TCGA-73-4670-F12983 TCGA-73-4670 TCGA-73-4670-01A -25526 0 131 2 NO NO 2011-6-15 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 1 NO 50 NO Peripheral Lung 1.2 NO 30 No M1 N0 T2 Stage IV TCGA-73-4670.a9349f65-0980-427e-af86-1af3c747926b.pdf 4670 Adjuvant therapy WITH TUMOR Stable Disease NO R0 Primary Tumor 01 0.2 2009 YES NO YES 73 4 Lung A LIVING 2010 1979 1671e6a6-1c3a-4ec7-b6b8-bd88f5ffcc60 TCGA-73-4670-01A-01D-1205-05 TCGA-73-4670-01A-01D-1265-08 1671e6a6-1c3a-4ec7-b6b8-bd88f5ffcc60 TCGA-73-4670-01A-01D-1204-01 1671e6a6-1c3a-4ec7-b6b8-bd88f5ffcc60 TCGA-73-4670-01A-01D-1204-01 TCGA-73-4670-01A-21-2190-20 +TCGA-73-4670-11 TCGA-73-4670-11 C1-LUAD-enriched mutation cluster 11 TCGA-73-4670 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 69 L-Upper TCGA-73-4670-F12983 TCGA-73-4670 TCGA-73-4670-11A -25526 0 131 2 NO NO 2011-6-15 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.4 NO 50 NO Peripheral Lung 1.1 NO 30 No M1 N0 T2 Stage IV 4670 Adjuvant therapy WITH TUMOR Stable Disease NO R0 Solid Tissue Normal 11 0.2 2009 YES NO YES 73 4 Lung A LIVING 2010 1979 TCGA-73-4670-11A-01D-1205-05 +TCGA-73-4675-01 3.47 0.58 none none none none N N none none none 0.2 Magnoid none none none none none none none Micropapillary predom Adc Micropapillary predom Adc none 0 TCGA-73-4675-01 High C1-LUAD-enriched Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 6 mutation c1uster 9 TCGA-73-4675 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung YES NO NO 59 L-Lower TCGA-73-4675-F71055 TCGA-73-4675 TCGA-73-4675-01A -21614 922 0 40 361 69 0 NO NO Scheduled Follow-up Submission Progressive Disease 2015-3-17 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 1.1 NO NO Peripheral Lung 1.6 NO Locoregional Recurrence YES 41 No M0 N1 T3 Stage IIIA TCGA-73-4675.73be3e61-573d-43a3-a055-e86786e126f3.pdf 4675 Pre-Adjuvant Therapy TUMOR FREE 55 66 Progressive Disease Convincing Imaging YES NO RX Primary Tumor 01 0.4 2010 7th YES NO YES 73 4 Current reformed smoker for < or = 15 years Lung A DECEASED 2010 1969 928e4b3e-0664-4f05-b971-4c7ce6a318e4 TCGA-73-4675-01A-01D-1205-05 TCGA-73-4675-01A-01D-1265-08 928e4b3e-0664-4f05-b971-4c7ce6a318e4 TCGA-73-4675-01A-01D-1204-01 928e4b3e-0664-4f05-b971-4c7ce6a318e4 TCGA-73-4675-01A-01D-1204-01 TCGA-73-4675-01A-21-2190-20 +TCGA-73-4675-11 3.47 0.58 none none none none N N none none none 0.2 Magnoid none none none none none none none Micropapillary predom Adc Micropapillary predom Adc none 0 TCGA-73-4675-11 C1-LUAD-enriched mutation c1uster 9 TCGA-73-4675 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung YES NO NO 59 L-Lower TCGA-73-4675-F71055 TCGA-73-4675 TCGA-73-4675-11A -21614 922 0 40 361 69 0 NO NO Scheduled Follow-up Submission Progressive Disease 2015-3-17 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 0.8 NO NO Peripheral Lung 1.2 NO Locoregional Recurrence YES 41 No M0 N1 T3 Stage IIIA 4675 Pre-Adjuvant Therapy TUMOR FREE 55 66 Progressive Disease Convincing Imaging YES NO RX Solid Tissue Normal 11 0.5 2010 7th YES NO YES 73 4 Current reformed smoker for < or = 15 years Lung A DECEASED 2010 1969 TCGA-73-4675-11A-01D-1205-05 +TCGA-73-4676-01 2.57 0.52 none none none none N N none none none 0.23 Squamoid none none none none none none none Solid predominant Adc Solid predominant Adc none 0 TCGA-73-4676-01 High C1-LUAD-enriched Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 5 mutation cluster 5 TCGA-73-4676 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 45 R-Upper TCGA-73-4676-F71022 TCGA-73-4676 TCGA-73-4676-01A -16746 281 0 122 86 1 NO NO Scheduled Follow-up Submission 2015-3-18 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) Yes C34.1 8140/3 C34.1 YES 0.7 NO 70 NO Peripheral Lung 1.5 NO 48 No M0 N1 T2a Stage IIA TCGA-73-4676.d93488a2-e8a9-4775-8d8a-9622b237ba9d.pdf 4676 Preoperative WITH TUMOR 67 78 YES YES R0 Primary Tumor 01 0.3 2009 7th YES NO YES 73 4 Current reformed smoker for < or = 15 years Lung A DECEASED 2010 1977 c54cd39c-c7fc-4a0c-9d33-9c1f78c80871 TCGA-73-4676-01A-01D-1753-08 c54cd39c-c7fc-4a0c-9d33-9c1f78c80871 TCGA-73-4676-01A-01D-1756-05 TCGA-73-4676-01A-01D-1752-01 c54cd39c-c7fc-4a0c-9d33-9c1f78c80871 TCGA-73-4676-01A-01D-1752-01 TCGA-73-4676-01A-21-2190-20 +TCGA-73-4676-11 2.57 0.52 none none none none N N none none none 0.23 Squamoid none none none none none none none Solid predominant Adc Solid predominant Adc none 0 TCGA-73-4676-11 C1-LUAD-enriched mutation cluster 5 TCGA-73-4676 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 45 R-Upper TCGA-73-4676-F71022 TCGA-73-4676 TCGA-73-4676-11A -16746 281 0 122 86 1 NO NO Scheduled Follow-up Submission 2015-3-18 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) Yes C34.1 8140/3 C34.1 YES 0.5 NO 70 NO Peripheral Lung 1.5 NO 48 No M0 N1 T2a Stage IIA 4676 Preoperative WITH TUMOR 67 78 YES YES R0 Solid Tissue Normal 11 0.2 2009 7th YES NO YES 73 4 Current reformed smoker for < or = 15 years Lung A DECEASED 2010 1977 6c12591a-55fa-4a7e-8eed-da9d698afb35 6c12591a-55fa-4a7e-8eed-da9d698afb35 TCGA-73-4676-11A-01D-1756-05 6c12591a-55fa-4a7e-8eed-da9d698afb35 +TCGA-73-4677-01 TCGA-73-4677-01 BRCA-LUAD+ C1-LUAD-enriched Cluster 5 LUAD-like c10 mutation cluster 7 TCGA-73-4677 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 74 R-Upper TCGA-73-4677-F12744 TCGA-73-4677 TCGA-73-4677-01A -27381 38 0 1 NO NO 2011-6-1 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.7 NO 80 NO Peripheral Lung 0.9 NO No M0 N0 T2a [Discrepancy] TCGA-73-4677.13109adb-64f8-462a-b0c1-af0723ad9aff.pdf 4677 Adjuvant therapy WITH TUMOR Stable Disease NO R0 Primary Tumor 01 0.3 1985 NO NO YES 73 3 Lung A DECEASED 2010 0f8cdcd1-bcf6-4591-97f1-43202071326b TCGA-73-4677-01A-01D-1205-05 TCGA-73-4677-01A-01D-1265-08 0f8cdcd1-bcf6-4591-97f1-43202071326b TCGA-73-4677-01A-01D-1204-01 0f8cdcd1-bcf6-4591-97f1-43202071326b TCGA-73-4677-01A-01D-1204-01 +TCGA-73-4677-11 TCGA-73-4677-11 C1-LUAD-enriched mutation cluster 7 TCGA-73-4677 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 74 R-Upper TCGA-73-4677-F12744 TCGA-73-4677 TCGA-73-4677-11A -27381 38 0 1 NO NO 2011-6-1 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.7 NO 80 NO Peripheral Lung 1.2 NO No M0 N0 T2a [Discrepancy] 4677 Adjuvant therapy WITH TUMOR Stable Disease NO R0 Solid Tissue Normal 11 0.3 1985 NO NO YES 73 3 Lung A DECEASED 2010 TCGA-73-4677-11A-01D-1205-05 +TCGA-73-7498-01 none none none none Y Y none none none Bronchioid none p.G12C none none none none none 0 Acinar predominant Adc p.M51fs TCGA-73-7498-01 BRCA-LUAD+ C1-LUAD-enriched Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 5 TCGA-73-7498 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 58 R-Lower TCGA-73-7498-F48755 TCGA-73-7498 TCGA-73-7498-01A -21527 0 1189 74.0 0 NO NO Scheduled Follow-up Submission Complete Remission/Response 2013-9-20 FEMALE Lung Bronchioloalveolar Carcinoma Nonmucinous No C34.3 8252/3 C34.3 YES 0.6 NO 100 NO Peripheral Lung 1 NO NO 28 Yes, History of Synchronous/Bilateral Malignancy M0 N0 T1b Stage IA TCGA-73-7498.c60ca2d8-4981-406a-9b8d-8efde4976001.pdf 7498 Pre-Adjuvant Therapy TUMOR FREE 89.6 60.1 91.9 61.2 Complete Remission/Response YES NO R0 Primary Tumor 01 0.3 1997 7th YES NO YES 73 4 Lung A LIVING 2010 1969 71772580-ecde-4cbb-a3b5-d58b50b496c5 71772580-ecde-4cbb-a3b5-d58b50b496c5 TCGA-73-7498-01A-12D-2185-05 TCGA-73-7498-01A-12D-2183-01 71772580-ecde-4cbb-a3b5-d58b50b496c5 TCGA-73-7498-01A-12D-2183-01 TCGA-73-7498-01A-23-2192-20 +TCGA-73-7499-01 none none none none N N none none none Squamoid none none none none none p.123_124MP>IA none 0 Acinar predominant Adc none TCGA-73-7499-01 High C1-LUAD-enriched Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 4 TCGA-73-7499 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung NO NO YES 81 R-Upper TCGA-73-7499-F69827 TCGA-73-7499 TCGA-73-7499-01A 1451 -29683 1531 0 519 1447 54 3 NO NO Scheduled Follow-up Submission Complete Remission/Response 2015-1-21 FEMALE Lung Adenocarcinoma Mixed Subtype No C34.1 8255/3 C34.1 YES 0.9 NO 40 NO Peripheral Lung 2.3 NO Distant Metastasis YES No M0 N0 T2a Stage IB TCGA-73-7499.8d4f6d68-7f74-4def-a235-a36a70f83ebe.pdf 7499 Other TUMOR FREE 103.7 91.5 Complete Remission/Response YES NO R0 Primary Tumor 01 0.7 7th NO NO YES 73 1 Lung A DECEASED 2010 0d423ac2-0d64-4956-a897-d7bc6e1293c2 0d423ac2-0d64-4956-a897-d7bc6e1293c2 TCGA-73-7499-01A-11D-2185-05 TCGA-73-7499-01A-11D-2183-01 0d423ac2-0d64-4956-a897-d7bc6e1293c2 TCGA-73-7499-01A-11D-2183-01 TCGA-73-7499-01A-13-2192-20 +TCGA-73-A9RS-01 TCGA-73-A9RS-01 TCGA-73-A9RS TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 41 R-Upper TCGA-73-A9RS-F64487 TCGA-73-A9RS TCGA-73-A9RS-01A -15162 162 340 0 305 1 YES FISH YES Scheduled Follow-up Submission Progressive Disease 2014-9-3 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8480/3 C34.1 YES 160 NO 80 YES NO Peripheral Lung NO NO 11 true No M0 N0 T3 Stage IIB TCGA-73-A9RS.7E029394-80EC-4B53-829E-8F1DA476D648.pdf A9RS Preoperative WITH TUMOR 81.9 60.2 81.5 59.6 Progressive Disease YES YES R0 Primary Tumor 01 7th NO NO YES 73 2 Lung A DECEASED 2013 1990 02bb3468-c1a4-405e-b721-68569b1b70d2 02bb3468-c1a4-405e-b721-68569b1b70d2 TCGA-73-A9RS-01A-11D-A411-05 TCGA-73-A9RS-01A-11D-A40Z-01 02bb3468-c1a4-405e-b721-68569b1b70d2 TCGA-73-A9RS-01A-11D-A40Z-01 +TCGA-75-5122-01 3.52 0.17 none none none none N N none none none 0.08 Squamoid none none none p.D1010_splice none none none Solid predominant Adc Solid predominant Adc none 0 TCGA-75-5122-01 High C1-LUAD-enriched Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 4 mutation c1uster 10 TCGA-75-5122 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung NO NO NO L-Upper TCGA-75-5122-F11750 TCGA-75-5122 TCGA-75-5122-01A NO NO Progressive Disease 2011-3-31 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.8 NO 0 NO Peripheral Lung 0.8 YES 20 No M0 N0 T2 Stage IB TCGA-75-5122.a664b87c-a7ef-4f18-9e4d-d37d0ccaaf70.pdf 5122 Adjuvant therapy WITH TUMOR Complete Remission/Response NO R0 Primary Tumor 01 0.5 1985 NO NO YES 75 3 Current reformed smoker for > 15 years Lung A DECEASED 2005 7540edef-3853-4293-bb00-41f790f27840 TCGA-75-5122-01A-01D-1753-08 7540edef-3853-4293-bb00-41f790f27840 TCGA-75-5122-01A-01D-1756-05 TCGA-75-5122-01A-01D-1752-01 7540edef-3853-4293-bb00-41f790f27840 TCGA-75-5122-01A-01D-1752-01 TCGA-75-5122-01A-21-2190-20 +TCGA-75-5125-01 TCGA-75-5125-01 High C1-LUAD-enriched Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 4 mutation cluster 13 TCGA-75-5125 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung NO YES NO R-Upper TCGA-75-5125-F72028 TCGA-75-5125 TCGA-75-5125-01A 2027 1752 NO NO Scheduled Follow-up Submission Progressive Disease 2015-4-2 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.7 NO NO Peripheral Lung 1.6 NO YES 25 No M0 N1 T2 Stage IIB TCGA-75-5125.a0af0de5-9022-4354-8b9b-fc80e9508889.pdf 5125 Other WITH TUMOR Complete Remission/Response NO R0 Primary Tumor 01 0.4 1987 6th NO NO YES 75 3 Lung A DECEASED dbe34afe-ea16-4faa-adab-9106a92dfde6 TCGA-75-5125-01A-01D-1753-08 dbe34afe-ea16-4faa-adab-9106a92dfde6 TCGA-75-5125-01A-01D-1756-05 TCGA-75-5125-01A-01D-1752-01 dbe34afe-ea16-4faa-adab-9106a92dfde6 TCGA-75-5125-01A-01D-1752-01 TCGA-75-5125-01A-21-2190-20 +TCGA-75-5126-01 2.01 0.27 none none none none Y Y none none none 0.13 Squamoid none p.G12C none none none none none NSCLC, favor Adeno NSCLC, favor Adeno none 0 TCGA-75-5126-01 Kirc+ C1-LUAD-enriched Cluster 5 LUAD-like c10 miRNA cluster 5 mutation cluster 12 TCGA-75-5126 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung NO NO NO L-Upper TCGA-75-5126-F11746 TCGA-75-5126 TCGA-75-5126-01A 1 NO NO Progressive Disease 2011-4-4 FEMALE Lung Papillary Adenocarcinoma No C34.1 8260/3 C34.1 YES 0.7 NO NO Peripheral Lung 1.2 YES 40 No M0 N2 T3 Stage IIIA TCGA-75-5126.ed7f326c-d2f5-46ef-bd92-ed2d0f81be26.pdf 5126 Adjuvant therapy WITH TUMOR Partial Remission/Response NO R2 Primary Tumor 01 0.2 2007 NO NO YES 75 4 Current reformed smoker for < or = 15 years Lung A LIVING 2007 6047b848-8fe8-4aab-81a7-2df3f31f7392 TCGA-75-5126-01A-01D-1753-08 6047b848-8fe8-4aab-81a7-2df3f31f7392 TCGA-75-5126-01A-01D-1756-05 TCGA-75-5126-01A-01D-1752-01 6047b848-8fe8-4aab-81a7-2df3f31f7392 TCGA-75-5126-01A-01D-1752-01 +TCGA-75-5146-01 1.8 0.57 none p.G469V none none N Y none none none 0.3 Bronchioid none none none none none none none Acinar predominant Adc Acinar predominant Adc p.W239C 0 TCGA-75-5146-01 Squamous C1-LUAD-enriched Cluster 5 LUAD-like c10 miRNA cluster 5 mutation cluster 8 TCGA-75-5146 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung YES NO R-Lower TCGA-75-5146-F72030 TCGA-75-5146 TCGA-75-5146-01A 2368 1773 NO NO Scheduled Follow-up Submission 2015-4-2 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8252/3 C34.3 YES 0.5 NO NO Peripheral Lung 0.8 NO New Primary Tumor YES No M0 N0 T2 Stage IB TCGA-75-5146.5ee0c2c4-3441-46d7-944e-3267f5c3abb6.pdf 5146 Other TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 0.3 1987 6th NO NO YES 75 3 Current reformed smoker for > 15 years Lung A LIVING aa7b5f63-ac8e-45bf-80e9-be4a576426a5 TCGA-75-5146-01A-01D-1625-08 aa7b5f63-ac8e-45bf-80e9-be4a576426a5 TCGA-75-5146-01A-01D-1626-05 TCGA-75-5146-01A-01D-1624-01 aa7b5f63-ac8e-45bf-80e9-be4a576426a5 TCGA-75-5146-01A-01D-1624-01 +TCGA-75-5147-01 3.27 0.4 none none none none N N none none none 0.16 Squamoid none none none none none none none Acinar predominant Adc Acinar predominant Adc none 0 TCGA-75-5147-01 BRCA-LUAD+ C1-LUAD-enriched Cluster 5 LUAD-like c10 miRNA cluster 5 mutation cluster 5 TCGA-75-5147 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung R-Upper TCGA-75-5147-F72031 TCGA-75-5147 TCGA-75-5147-01A 1333 NO NO Scheduled Follow-up Submission Complete Remission/Response 2015-4-2 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8252/3 C34.1 YES 0.6 NO NO Peripheral Lung 0.7 NO NO No M0 N0 T2 Stage IB TCGA-75-5147.ed8a2523-6046-402e-8ebd-a53b558800b2.pdf 5147 Other TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 0.2 6th NO NO YES 75 1 Lifelong Non-smoker Lung A LIVING dea6072e-021d-4984-87ba-2c624e07fa18 TCGA-75-5147-01A-01D-1625-08 dea6072e-021d-4984-87ba-2c624e07fa18 TCGA-75-5147-01A-01D-1626-05 TCGA-75-5147-01A-01D-1624-01 dea6072e-021d-4984-87ba-2c624e07fa18 TCGA-75-5147-01A-01D-1624-01 +TCGA-75-6203-01 2.21 0.26 none none none none N Y none none none 0.13 Bronchioid none none none none none none none Invasive mucinous Invasive mucinous Y - unknown binding partner none 0 TCGA-75-6203-01 Kirc+ C1-LUAD-enriched Low purity c2 squamous c3 LUAD-like c10 miRNA cluster 5 mutation c1uster 9 TCGA-75-6203 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung L-Lower TCGA-75-6203-F15862 TCGA-75-6203 TCGA-75-6203-01A Complete Remission/Response 2011-8-15 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 0.5 NO 1 No M0 N2 T2 Stage IIIA TCGA-75-6203.467f2c05-6b71-4901-a707-cf8f771fe956.pdf 6203 TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 0.4 6th YES NO YES 75 1 Lifelong Non-smoker Lung A LIVING 2008 ccf84703-a5c7-4995-a1c2-b3e4e15d99b7 TCGA-75-6203-01A-11D-1753-08 ccf84703-a5c7-4995-a1c2-b3e4e15d99b7 TCGA-75-6203-01A-11D-1756-05 TCGA-75-6203-01A-11D-1752-01 ccf84703-a5c7-4995-a1c2-b3e4e15d99b7 TCGA-75-6203-01A-11D-1752-01 TCGA-75-6203-01A-13-2191-20 +TCGA-75-6205-01 none none none none N N none none none Squamoid none none none p.Y1003* none none none Solid predominant Adc Solid predominant Adc none 0 TCGA-75-6205-01 Squamous C1-LUAD-enriched Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 5 mutation c1uster 9 TCGA-75-6205 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung NO NO NO NO L-Upper TCGA-75-6205-F15083 TCGA-75-6205 TCGA-75-6205-01A 2011-7-21 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.5 NO Peripheral Lung 0.7 YES No M0 N0 T2a Stage IB TCGA-75-6205.50af99e1-fe4a-4d65-86c0-59fd699433e3.pdf 6205 Adjuvant therapy WITH TUMOR Complete Remission/Response NO R0 Primary Tumor 01 0.3 7th NO NO YES 75 1 Lifelong Non-smoker Lung A DECEASED 2006 2e8a5454-24d7-4059-ac17-595dcfccaf0b TCGA-75-6205-01A-11D-1753-08 2e8a5454-24d7-4059-ac17-595dcfccaf0b TCGA-75-6205-01A-11D-1756-05 TCGA-75-6205-01A-11D-1752-01 2e8a5454-24d7-4059-ac17-595dcfccaf0b TCGA-75-6205-01A-11D-1752-01 TCGA-75-6205-01A-13-2191-20 +TCGA-75-6206-01 TCGA-75-6206-01 BRCA-LUAD+ C1-LUAD-enriched squamous c3 LUAD-like c10 miRNA cluster 5 mutation cluster 12 TCGA-75-6206 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung R-Upper TCGA-75-6206-F72036 TCGA-75-6206 TCGA-75-6206-01A 2590 Scheduled Follow-up Submission Complete Remission/Response 2015-4-2 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.6 NO Peripheral Lung 0.7 NO NO 20 No M0 N0 T2 Stage IB TCGA-75-6206.ad913d82-cb95-477f-8eeb-dba23f5c85c8.pdf 6206 TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 0.3 1962 6th NO NO YES 75 3 Lung A LIVING b74b611d-7090-4beb-ae34-13086884a7e3 TCGA-75-6206-01A-11D-1753-08 b74b611d-7090-4beb-ae34-13086884a7e3 TCGA-75-6206-01A-11D-1756-05 TCGA-75-6206-01A-11D-1752-01 b74b611d-7090-4beb-ae34-13086884a7e3 TCGA-75-6206-01A-11D-1752-01 TCGA-75-6206-01A-13-2191-20 +TCGA-75-6207-01 1.94 0.64 none none none none Y Y p.ELREA746del none none 0.33 Squamoid none none none none none none none Solid predominant Adc Solid predominant Adc none 0 TCGA-75-6207-01 Squamous C1-LUAD-enriched Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 4 mutation cluster 8 TCGA-75-6207 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung NO NO R-Upper TCGA-75-6207-F15092 TCGA-75-6207 TCGA-75-6207-01A 2011-7-21 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.9 YES 0.4 NO Peripheral Lung 1 10 No M0 N2 T2 Stage IIIA TCGA-75-6207.46e1c8e2-5603-41c4-8b84-552ba6537ff1.pdf 6207 Complete Remission/Response NO R0 Primary Tumor 01 0.2 1972 6th NO NO YES 75 3 Current reformed smoker for > 15 years Lung A DECEASED 2007 4b57bac2-6b38-435f-b935-8eb6a3369d1c TCGA-75-6207-01A-11D-1753-08 4b57bac2-6b38-435f-b935-8eb6a3369d1c TCGA-75-6207-01A-11D-1756-05 TCGA-75-6207-01A-11D-1752-01 4b57bac2-6b38-435f-b935-8eb6a3369d1c TCGA-75-6207-01A-11D-1752-01 TCGA-75-6207-01A-13-2191-20 +TCGA-75-6211-01 3.1 0.39 none none none none N N none none none 0.16 Magnoid none none p.F53L none none none none Solid predominant Adc Solid predominant Adc none 0 TCGA-75-6211-01 High C1-LUAD-enriched Cluster 6 squamous c3 LUAD-like c10 miRNA c1uster 10 mutation cluster 11 TCGA-75-6211 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung NO YES NO Bronchial TCGA-75-6211-F15095 TCGA-75-6211 TCGA-75-6211-01A Progressive Disease 2011-7-21 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.9 YES 0.6 NO 0.8 YES 34 No M0 N0 T2 Stage IB TCGA-75-6211.7dff638f-e4c9-495b-95a0-00bb2a753378.pdf 6211 Adjuvant therapy WITH TUMOR Complete Remission/Response NO R0 Primary Tumor 01 0.4 6th NO NO YES 75 2 Current smoker Lung A DECEASED 2009 9a28482f-36a7-490f-9d22-a69f82fbfc05 TCGA-75-6211-01A-11D-1753-08 9a28482f-36a7-490f-9d22-a69f82fbfc05 TCGA-75-6211-01A-11D-1756-05 TCGA-75-6211-01A-11D-1752-01 9a28482f-36a7-490f-9d22-a69f82fbfc05 TCGA-75-6211-01A-11D-1752-01 TCGA-75-6211-01A-13-2191-20 +TCGA-75-6212-01 2.76 0.41 none none none none Y Y p.ELR746del none none 0.18 Bronchioid none none none none none none none Papillary predominant Adc Papillary predominant Adc none 0 TCGA-75-6212-01 Kirc+ C1-LUAD-enriched KIRC-like c17 squamous c3 LUAD-like c10 miRNA cluster 7 mutation cluster 14 TCGA-75-6212 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung YES NO L-Lower TCGA-75-6212-F72037 TCGA-75-6212 TCGA-75-6212-01A 1516 1340 0 Scheduled Follow-up Submission Progressive Disease 2015-4-2 FEMALE Lung Micropapillary Adenocarcinoma No C34.3 8507/3 C34.3 YES 0.8 NO Peripheral Lung 2.5 NO New Primary Tumor YES No M0 N1 T2 Stage IIB TCGA-75-6212.6749d901-d37c-4ef9-b0a0-0ee0ee1d7f0e.pdf 6212 Post-Adjuvant Therapy WITH TUMOR Complete Remission/Response NO R0 Primary Tumor 01 0.2 6th YES NO YES 75 1 Lifelong Non-smoker Lung A DECEASED 69d106c0-b3e7-4918-a442-d142dce3adab TCGA-75-6212-01A-11D-1753-08 69d106c0-b3e7-4918-a442-d142dce3adab TCGA-75-6212-01A-11D-1756-05 TCGA-75-6212-01A-11D-1752-01 69d106c0-b3e7-4918-a442-d142dce3adab TCGA-75-6212-01A-11D-1752-01 TCGA-75-6212-01A-13-2191-20 +TCGA-75-6214-01 none none none p.E55K N N none none none Magnoid none none none none none p.E545K p.M82V Solid predominant Adc Solid predominant Adc none 0 TCGA-75-6214-01 COAD-READ C2-Squamous-like Cluster 5 squamous c3 squamous-like c4 miRNA cluster 11 TCGA-75-6214 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung NO YES YES R-Upper TCGA-75-6214-F72038 TCGA-75-6214 TCGA-75-6214-01A 524 1115 419 0 Scheduled Follow-up Submission Progressive Disease 2015-4-2 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.8 NO Peripheral Lung 1.9 NO Distant Metastasis YES 40 No M0 N2 T2 Stage IIIA TCGA-75-6214.e3473dc5-927a-466f-ac60-0ac0771a8b1f.pdf 6214 Post-Adjuvant Therapy WITH TUMOR Complete Remission/Response NO R0 Primary Tumor 01 0.2 6th NO NO YES 75 2 Current smoker Lung A DECEASED 1970 f398c31b-c947-4ba7-84c0-6d3b36daaf3f f398c31b-c947-4ba7-84c0-6d3b36daaf3f TCGA-75-6214-01A-41D-1947-05 TCGA-75-6214-01A-41D-1943-01 f398c31b-c947-4ba7-84c0-6d3b36daaf3f TCGA-75-6214-01A-41D-1943-01 TCGA-75-6214-01A-23-2192-20 +TCGA-75-7025-01 3.66 0.34 none none none none Y Y p.ELREA746del none none 0.13 Bronchioid none none none none none none none Acinar predominant Adc Acinar predominant Adc none 0 TCGA-75-7025-01 BRCA-LUAD+ Cluster 5 LUAD-like c10 miRNA c1uster 9 TCGA-75-7025 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung YES NO YES YES L-Lower TCGA-75-7025-F72041 TCGA-75-7025 TCGA-75-7025-01A 1481 2092 3305 1481 0 Scheduled Follow-up Submission Complete Remission/Response 2015-4-2 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.5 NO Peripheral Lung 0.6 NO Locoregional Recurrence|Distant Metastasis YES No M0 N0 T2 Stage IB TCGA-75-7025.6d05110b-1a5f-4002-b140-00a36c5c102b.pdf 7025 Preoperative TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 0.2 1986 6th NO NO YES 75 3 Current reformed smoker for > 15 years Lung A LIVING 1967 8966f44c-9452-4e21-9fad-142ea03c9bff 8966f44c-9452-4e21-9fad-142ea03c9bff TCGA-75-7025-01A-12D-1947-05 TCGA-75-7025-01A-12D-1943-01 8966f44c-9452-4e21-9fad-142ea03c9bff TCGA-75-7025-01A-12D-1943-01 +TCGA-75-7027-01 3.09 0.62 none none none none Y Y none none none 0.23 Magnoid none p.G12V none none none none none Solid predominant Adc Solid predominant Adc none 0 TCGA-75-7027-01 BRCA-LUAD+ C1-LUAD-enriched Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 4 TCGA-75-7027 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung YES YES NO L-Lower TCGA-75-7027-F72040 TCGA-75-7027 TCGA-75-7027-01A 3059 2949 0 Scheduled Follow-up Submission 2015-4-2 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 0.7 NO Peripheral Lung 1.4 NO Locoregional Recurrence YES 50 No M0 N0 T2 Stage IB TCGA-75-7027.04803f1d-6cb8-44ec-b4f1-11f1308dc840.pdf 7027 Preoperative TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 0.7 6th NO NO YES 75 2 Current smoker Lung A LIVING 1956 ef16aead-4eec-4c97-a393-dc7a54ce5264 ef16aead-4eec-4c97-a393-dc7a54ce5264 TCGA-75-7027-01A-11D-1947-05 TCGA-75-7027-01A-11D-1943-01 ef16aead-4eec-4c97-a393-dc7a54ce5264 TCGA-75-7027-01A-11D-1943-01 TCGA-75-7027-01A-13-2191-20 +TCGA-75-7030-01 2.01 0.17 none none none none Y Y none none none 0.08 Bronchioid none p.G12D none none none none none Papillary predominant Adc Papillary predominant Adc none 0 TCGA-75-7030-01 Quiet C1-LUAD-enriched Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 4 TCGA-75-7030 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung NO NO NO NO R-Lower TCGA-75-7030-F15878 TCGA-75-7030 TCGA-75-7030-01A 0 Complete Remission/Response 2011-8-16 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 0.6 NO Peripheral Lung 0.6 NO No M0 N0 T3 Stage IIB TCGA-75-7030.34fb09ff-9b3b-4197-8fb7-91fe66981ac2.pdf 7030 Post-Adjuvant Therapy TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 0.5 6th YES NO YES 75 1 Lifelong Non-smoker Lung A LIVING 2007 aa1dfe29-6e97-4b20-b439-1d06455dfc56 aa1dfe29-6e97-4b20-b439-1d06455dfc56 TCGA-75-7030-01A-11D-1947-05 TCGA-75-7030-01A-11D-1943-01 aa1dfe29-6e97-4b20-b439-1d06455dfc56 TCGA-75-7030-01A-11D-1943-01 TCGA-75-7030-01A-13-2191-20 +TCGA-75-7031-01 4.01 0.48 none none none none N N none none none 0.16 Magnoid none none none none none none none Acinar predominant Adc Acinar predominant Adc p.W239C 0 TCGA-75-7031-01 High C4-BRCA/Basal Low purity c2 BRCA basal-like c6 LUAD-like c10 miRNA cluster 4 TCGA-75-7031 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung NO NO NO NO R-Upper TCGA-75-7031-F15880 TCGA-75-7031 TCGA-75-7031-01A 0 2011-8-16 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.6 NO Peripheral Lung 0.9 NO 5 No M0 N0 T2 Stage IB TCGA-75-7031.0f516d64-bec9-42ff-9432-d626193c3dd2.pdf 7031 Preoperative TUMOR FREE NO R0 Primary Tumor 01 0.3 1975 6th NO NO YES 75 3 Current reformed smoker for > 15 years Lung A LIVING 2008 1965 66b0fb5a-0587-4d01-8960-29c19c0b0b20 66b0fb5a-0587-4d01-8960-29c19c0b0b20 TCGA-75-7031-01A-11D-1947-05 TCGA-75-7031-01A-11D-1943-01 66b0fb5a-0587-4d01-8960-29c19c0b0b20 TCGA-75-7031-01A-11D-1943-01 TCGA-75-7031-01A-13-2192-20 +TCGA-77-6842-01 TCGA-77-6842-01 High C2-Squamous-like Cluster 5 squamous c3 squamous-like c4 miRNA c1uster 9 TCGA-77-6842 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung NO YES 79 TCGA-77-6842-F16162 TCGA-77-6842 TCGA-77-6842-01A -28861 899 0 201 1 NO NO Scheduled Follow-up Submission 2011-9-15 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.8 8070/3 C34.8 YES 0.8 NO NO Central Lung 1.2 YES 22.5 No M0 N1 T2 Stage IIB TCGA-77-6842.4f5574a0-e1d7-427c-8f03-d08cb0b264a4.pdf 6842 Preoperative NO R0 Primary Tumor 01 0.5 2000 6th NO NO YES 77 4 Lung A DECEASED 2000 1950 20c383e0-a901-4a61-94d1-002a86a0d1c3 20c383e0-a901-4a61-94d1-002a86a0d1c3 TCGA-77-6842-01A-11D-1947-05 TCGA-77-6842-01A-11D-1943-01 20c383e0-a901-4a61-94d1-002a86a0d1c3 TCGA-77-6842-01A-11D-1943-01 TCGA-77-6842-01A-13-2194-20 +TCGA-77-6843-01 TCGA-77-6843-01 Squamous C2-Squamous-like Cluster 13 (HNSC-LUSC) squamous c3 squamous-like c4 miRNA cluster 11 TCGA-77-6843 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 74 R-Upper TCGA-77-6843-F16160 TCGA-77-6843 TCGA-77-6843-01A -27291 2224 0 2 NO NO Scheduled Follow-up Submission 2011-9-15 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.7 NO NO Central Lung 1 30 No M0 N1 T1 Stage IIA TCGA-77-6843.538c9962-002f-4415-b145-dd8710baa108.pdf 6843 Preoperative NO R0 Primary Tumor 01 0.5 6th NO NO YES 77 2 Lung A DECEASED 2002 1941 3fc2678f-e653-41c7-a106-4aed5df1dedb 3fc2678f-e653-41c7-a106-4aed5df1dedb TCGA-77-6843-01A-11D-1947-05 TCGA-77-6843-01A-11D-1943-01 3fc2678f-e653-41c7-a106-4aed5df1dedb TCGA-77-6843-01A-11D-1943-01 TCGA-77-6843-01A-13-2194-20 +TCGA-77-6844-01 TCGA-77-6844-01 Squamous C2-Squamous-like Cluster 5 squamous c3 squamous-like c4 miRNA cluster 11 TCGA-77-6844 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung NO NO YES NO 74 R-Lower TCGA-77-6844-F16280 TCGA-77-6844 TCGA-77-6844-01A 1788 -27220 2284 0 1788 1 NO NO Scheduled Follow-up Submission 2011-9-16 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.7 NO NO Central Lung 1.5 YES 45 No M0 N1 T3 Stage IIIA TCGA-77-6844.365db97d-4da1-455a-80b9-94273a693091.pdf 6844 Preoperative Complete Remission/Response YES R0 Primary Tumor 01 0.5 1987 6th NO NO YES 77 4 Lung A DECEASED 2002 1942 6474e097-3eaa-4741-a466-be378a1ca862 6474e097-3eaa-4741-a466-be378a1ca862 TCGA-77-6844-01A-11D-1947-05 TCGA-77-6844-01A-11D-1943-01 6474e097-3eaa-4741-a466-be378a1ca862 TCGA-77-6844-01A-11D-1943-01 TCGA-77-6844-01A-13-2194-20 +TCGA-77-6845-01 TCGA-77-6845-01 Squamous C2-Squamous-like Cluster 5 squamous c3 squamous-like c4 miRNA cluster 11 TCGA-77-6845 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung NO NO NO NO 69 R-Middle TCGA-77-6845-F16478 TCGA-77-6845 TCGA-77-6845-01A -25321 708 0 1 NO NO Scheduled Follow-up Submission 2011-9-20 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.2 8070/3 C34.2 YES 0.7 NO NO Central Lung 1.2 NO 51 No M0 N0 T3 Stage IIB TCGA-77-6845.105eaa92-2ebd-4a99-a01c-88816a776f49.pdf 6845 Preoperative NO R0 Primary Tumor 01 0.4 2003 6th NO NO YES 77 4 Lung A DECEASED 2003 1952 8ce70027-d230-4af0-ab5f-5a50fdaac5e5 8ce70027-d230-4af0-ab5f-5a50fdaac5e5 TCGA-77-6845-01A-11D-1947-05 TCGA-77-6845-01A-11D-1943-01 8ce70027-d230-4af0-ab5f-5a50fdaac5e5 TCGA-77-6845-01A-11D-1943-01 TCGA-77-6845-01A-13-2194-20 +TCGA-77-7138-01 TCGA-77-7138-01 High Low purity c2 squamous-like c4 miRNA cluster 11 TCGA-77-7138 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 67 L-Lower TCGA-77-7138-F19291 TCGA-77-7138 TCGA-77-7138-01A -24594 340 0 1 NO NO Scheduled Follow-up Submission 2011-12-8 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.7 NO NO Peripheral Lung 1 20 No M0 N0 T2 Stage IB TCGA-77-7138.baebd9a2-9ae7-462a-b5bd-8c5c7c03bf01.pdf 7138 Preoperative NO R0 Primary Tumor 01 0.6 1979 6th NO NO YES 77 3 Lung A DECEASED 1999 1959 7ea63ff9-467e-4645-bacb-d91fe95a8c62 7ea63ff9-467e-4645-bacb-d91fe95a8c62 TCGA-77-7138-01A-41D-2043-05 TCGA-77-7138-01A-41D-2041-01 7ea63ff9-467e-4645-bacb-d91fe95a8c62 TCGA-77-7138-01A-41D-2041-01 +TCGA-77-7138-11 TCGA-77-7138-11 TCGA-77-7138 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 67 L-Lower TCGA-77-7138-F19291 TCGA-77-7138 TCGA-77-7138-11A -24594 340 0 1 NO NO Scheduled Follow-up Submission 2011-12-8 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.9 NO NO Peripheral Lung 1.2 20 No M0 N0 T2 Stage IB 7138 Preoperative NO R0 Solid Tissue Normal 11 0.7 1979 6th NO NO YES 77 3 Lung A DECEASED 1999 1959 04523c86-295b-4343-843a-43e4dddf70d1 04523c86-295b-4343-843a-43e4dddf70d1 04523c86-295b-4343-843a-43e4dddf70d1 +TCGA-77-7139-01 TCGA-77-7139-01 Squamous C2-Squamous-like Cluster 13 (HNSC-LUSC) squamous c3 squamous-like c4 miRNA cluster 11 TCGA-77-7139 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 56 R-Lower TCGA-77-7139-F46101 TCGA-77-7139 TCGA-77-7139-01A -20632 0 4261 1 NO NO Scheduled Follow-up Submission 2013-8-6 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.5 NO NO Central Lung 0.7 NO 2 No M0 N1 T2 Stage IIB TCGA-77-7139.6e64f460-ab1c-478e-9b44-288ca9d5875f.pdf 7139 Preoperative NO R0 Primary Tumor 01 0.4 1991 6th NO YES 77 4 Lung A LIVING 2002 1968 aa7c9175-113a-4a7b-8577-18478b0fffd3 aa7c9175-113a-4a7b-8577-18478b0fffd3 TCGA-77-7139-01A-11D-2043-05 TCGA-77-7139-01A-11D-2041-01 aa7c9175-113a-4a7b-8577-18478b0fffd3 TCGA-77-7139-01A-11D-2041-01 TCGA-77-7139-01A-13-2195-20 +TCGA-77-7140-01 TCGA-77-7140-01 High Cluster 13 (HNSC-LUSC) squamous-like c4 miRNA cluster 11 TCGA-77-7140 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung YES NO YES 69 L-Upper TCGA-77-7140-F19327 TCGA-77-7140 TCGA-77-7140-01A 250 -25303 632 0 250 0 NO NO Scheduled Follow-up Submission 2011-12-9 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.9 NO NO Central Lung 1.2 YES Yes M0 N1 T2 Stage IIB TCGA-77-7140.bbc2cd8e-2a0f-4d9e-9e8a-f337febe9d27.pdf 7140 Preoperative NO R0 Primary Tumor 01 0.3 6th NO NO YES 77 1 Lung A DECEASED 2002 fffdafae-fae0-4ae9-8fd2-3c2bedd156e1 fffdafae-fae0-4ae9-8fd2-3c2bedd156e1 TCGA-77-7140-01A-41D-2043-05 TCGA-77-7140-01A-41D-2041-01 fffdafae-fae0-4ae9-8fd2-3c2bedd156e1 TCGA-77-7140-01A-41D-2041-01 +TCGA-77-7141-01 TCGA-77-7141-01 Squamous C2-Squamous-like BRCA CIMP c7 squamous c3 squamous-like c4 miRNA cluster 4 TCGA-77-7141 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 64 L-Upper TCGA-77-7141-F46102 TCGA-77-7141 TCGA-77-7141-01A -23584 0 15 1 NO NO Scheduled Follow-up Submission 2013-8-6 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.8 NO NO Central Lung 1 YES 70 No M0 N0 T2 Stage IB TCGA-77-7141.c8d8d890-f2a1-4b25-ba59-bcf0f69553b2.pdf 7141 Preoperative NO R0 Primary Tumor 01 0.3 1988 6th NO YES 77 4 Lung A LIVING 2003 1953 64353828-9b3b-491d-8d13-ce36e09fa6f9 64353828-9b3b-491d-8d13-ce36e09fa6f9 TCGA-77-7141-01A-11D-2043-05 TCGA-77-7141-01A-11D-2041-01 64353828-9b3b-491d-8d13-ce36e09fa6f9 TCGA-77-7141-01A-11D-2041-01 TCGA-77-7141-01A-13-2195-20 +TCGA-77-7142-01 TCGA-77-7142-01 Squamous C2-Squamous-like Cluster 13 (HNSC-LUSC) squamous c3 squamous-like c4 miRNA c1uster 9 TCGA-77-7142 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 59 L-Upper TCGA-77-7142-F46141 TCGA-77-7142 TCGA-77-7142-01A -21796 0 2227 1 NO NO Scheduled Follow-up Submission 2013-8-23 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.6 NO NO Peripheral Lung 0.9 NO 52.5 No M0 N0 T2 Stage IB TCGA-77-7142.31535f27-9a8d-4b0a-b20c-10e183939711.pdf 7142 Preoperative TUMOR FREE NO R0 Primary Tumor 01 0.5 2004 6th NO YES 77 4 Lung A LIVING 2007 1959 b7d58bd2-216f-4fdf-b97e-56d9cfb69e3b b7d58bd2-216f-4fdf-b97e-56d9cfb69e3b TCGA-77-7142-01A-11D-2043-05 TCGA-77-7142-01A-11D-2041-01 b7d58bd2-216f-4fdf-b97e-56d9cfb69e3b TCGA-77-7142-01A-11D-2041-01 TCGA-77-7142-01A-13-2195-20 +TCGA-77-7142-11 TCGA-77-7142-11 C2-Squamous-like TCGA-77-7142 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 59 L-Upper TCGA-77-7142-F46141 TCGA-77-7142 TCGA-77-7142-11A -21796 0 2227 1 NO NO Scheduled Follow-up Submission 2013-8-23 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 1 NO NO Peripheral Lung 1 NO 52.5 No M0 N0 T2 Stage IB 7142 Preoperative TUMOR FREE NO R0 Solid Tissue Normal 11 0.5 2004 6th NO YES 77 4 Lung A LIVING 2007 1959 d16a7dea-99ca-455e-80c7-4f182b25d382 d16a7dea-99ca-455e-80c7-4f182b25d382 d16a7dea-99ca-455e-80c7-4f182b25d382 +TCGA-77-7335-01 TCGA-77-7335-01 Kirc+ C2-Squamous-like Cluster 13 (HNSC-LUSC) squamous c3 squamous-like c4 miRNA cluster 4 TCGA-77-7335 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 62 TCGA-77-7335-F19288 TCGA-77-7335 TCGA-77-7335-01A -22863 2133 0 1 NO NO Scheduled Follow-up Submission 2011-12-8 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.9 8071/3 C34.9 YES 0.7 NO NO Central Lung 1 52 No M0 N2 T4 Stage IIIB TCGA-77-7335.b444c367-59c9-4e4e-9d58-829539c40296.pdf 7335 Preoperative NO R0 Primary Tumor 01 0.4 1980 6th NO NO YES 77 3 Lung A DECEASED 1996 1954 c291c855-abe4-4805-973f-e29ee22c4667 c291c855-abe4-4805-973f-e29ee22c4667 TCGA-77-7335-01A-11D-2043-05 TCGA-77-7335-01A-11D-2041-01 c291c855-abe4-4805-973f-e29ee22c4667 TCGA-77-7335-01A-11D-2041-01 TCGA-77-7335-01A-13-2195-20 +TCGA-77-7335-11 TCGA-77-7335-11 C2-Squamous-like TCGA-77-7335 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 62 TCGA-77-7335-F19288 TCGA-77-7335 TCGA-77-7335-11A -22863 2133 0 1 NO NO Scheduled Follow-up Submission 2011-12-8 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.9 8071/3 C34.9 YES 0.7 NO NO Central Lung 1.4 52 No M0 N2 T4 Stage IIIB 7335 Preoperative NO R0 Solid Tissue Normal 11 0.5 1980 6th NO NO YES 77 3 Lung A DECEASED 1996 1954 a7309f60-5fb7-4cd9-90e8-54d850b4b241 a7309f60-5fb7-4cd9-90e8-54d850b4b241 a7309f60-5fb7-4cd9-90e8-54d850b4b241 +TCGA-77-7337-01 TCGA-77-7337-01 High C2-Squamous-like Cluster 13 (HNSC-LUSC) squamous c3 squamous-like c4 miRNA cluster 4 TCGA-77-7337 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 65 L-Upper TCGA-77-7337-F19302 TCGA-77-7337 TCGA-77-7337-01A -24065 3253 0 0 NO NO Scheduled Follow-up Submission 2011-12-8 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.9 8070/3 C34.9 YES 0.7 NO NO Central Lung 0.9 79.5 No M0 N1 T2 Stage IIB TCGA-77-7337.486787b7-4d3f-4f98-85df-8daa3976bfb4.pdf 7337 Preoperative NO R0 Primary Tumor 01 0.6 1996 6th NO NO YES 77 4 Lung A DECEASED 2000 1942 86c13d00-9cb9-4cad-bf90-beb4115b69f5 86c13d00-9cb9-4cad-bf90-beb4115b69f5 TCGA-77-7337-01A-21D-2043-05 TCGA-77-7337-01A-21D-2041-01 86c13d00-9cb9-4cad-bf90-beb4115b69f5 TCGA-77-7337-01A-21D-2041-01 TCGA-77-7337-01A-23-2195-20 +TCGA-77-7337-11 TCGA-77-7337-11 C2-Squamous-like TCGA-77-7337 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 65 L-Upper TCGA-77-7337-F19302 TCGA-77-7337 TCGA-77-7337-11A -24065 3253 0 0 NO NO Scheduled Follow-up Submission 2011-12-8 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.9 8070/3 C34.9 YES 0.8 NO NO Central Lung 1.1 79.5 No M0 N1 T2 Stage IIB 7337 Preoperative NO R0 Solid Tissue Normal 11 0.6 1996 6th NO NO YES 77 4 Lung A DECEASED 2000 1942 eafca6a1-4558-4b8e-8fd9-111e6bbdba84 eafca6a1-4558-4b8e-8fd9-111e6bbdba84 eafca6a1-4558-4b8e-8fd9-111e6bbdba84 +TCGA-77-7338-01 TCGA-77-7338-01 Squamous C2-Squamous-like Cluster 13 (HNSC-LUSC) squamous c3 squamous-like c4 miRNA cluster 4 TCGA-77-7338 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 64 R-Upper TCGA-77-7338-F19304 TCGA-77-7338 TCGA-77-7338-01A -23480 5 0 1 NO NO Scheduled Follow-up Submission 2011-12-8 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.5 NO NO Peripheral Lung 1.4 NO 41.25 No M0 N0 T2 Stage IB TCGA-77-7338.be1035b5-a744-4574-add2-31d2ab9ccdc0.pdf 7338 Preoperative NO R1 Primary Tumor 01 0.5 6th NO NO YES 77 2 Lung A DECEASED 1995 1952 03e01fb5-4517-4820-bc3b-fe892a8ef896 03e01fb5-4517-4820-bc3b-fe892a8ef896 TCGA-77-7338-01A-11D-2043-05 TCGA-77-7338-01A-11D-2041-01 03e01fb5-4517-4820-bc3b-fe892a8ef896 TCGA-77-7338-01A-11D-2041-01 TCGA-77-7338-01A-13-2195-20 +TCGA-77-7338-11 TCGA-77-7338-11 C2-Squamous-like TCGA-77-7338 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 64 R-Upper TCGA-77-7338-F19304 TCGA-77-7338 TCGA-77-7338-11A -23480 5 0 1 NO NO Scheduled Follow-up Submission 2011-12-8 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.6 NO NO Peripheral Lung 1 NO 41.25 No M0 N0 T2 Stage IB 7338 Preoperative NO R1 Solid Tissue Normal 11 0.5 6th NO NO YES 77 2 Lung A DECEASED 1995 1952 02dbd205-c3a7-4643-ad0f-272dca20225d 02dbd205-c3a7-4643-ad0f-272dca20225d 02dbd205-c3a7-4643-ad0f-272dca20225d +TCGA-77-7463-01 TCGA-77-7463-01 Squamous C2-Squamous-like Cluster 5 squamous c3 squamous-like c4 miRNA cluster 11 TCGA-77-7463 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 75 L-Upper TCGA-77-7463-F20452 TCGA-77-7463 TCGA-77-7463-01A -27520 1423 0 1 NO NO Scheduled Follow-up Submission 2012-1-13 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.9 NO NO 1 42 No M0 N0 T2 Stage IB TCGA-77-7463.fd316526-b68e-491a-9e97-bf4d2146e977.pdf 7463 Preoperative NO R0 Primary Tumor 01 0.7 1996 6th NO NO YES 77 4 Lung A DECEASED 2001 1954 02f3b4c9-5c69-4bec-8897-15f5b9a948b4 02f3b4c9-5c69-4bec-8897-15f5b9a948b4 TCGA-77-7463-01A-11D-2043-05 TCGA-77-7463-01A-11D-2041-01 02f3b4c9-5c69-4bec-8897-15f5b9a948b4 TCGA-77-7463-01A-11D-2041-01 TCGA-77-7463-01A-13-2195-20 +TCGA-77-7465-01 TCGA-77-7465-01 High C2-Squamous-like Cluster 13 (HNSC-LUSC) squamous c3 squamous-like c4 miRNA cluster 4 TCGA-77-7465 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 58 R-Upper TCGA-77-7465-F46151 TCGA-77-7465 TCGA-77-7465-01A -21548 0 990 1 NO NO Scheduled Follow-up Submission 2013-8-28 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.5 NO NO 0.8 NO 120 No M0 N1 T2a Stage IIA TCGA-77-7465.260a21c6-7973-461c-b4cc-4aa32ad318f4.pdf 7465 Preoperative Complete Remission/Response NO R0 Primary Tumor 01 0.4 7th NO YES 77 2 Lung A LIVING 2010 1963 432b9ce2-3ef5-4343-896f-bc91c59035fd 432b9ce2-3ef5-4343-896f-bc91c59035fd TCGA-77-7465-01A-11D-2043-05 TCGA-77-7465-01A-11D-2041-01 432b9ce2-3ef5-4343-896f-bc91c59035fd TCGA-77-7465-01A-11D-2041-01 TCGA-77-7465-01A-13-2195-20 +TCGA-77-8007-01 TCGA-77-8007-01 High Cluster 6 LUAD-like c10 miRNA cluster 4 TCGA-77-8007 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 68 R-Upper TCGA-77-8007-F30478 TCGA-77-8007 TCGA-77-8007-01A -25102 198 0 139 84 1 NO NO Scheduled Follow-up Submission 2012-4-11 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.9 NO NO Central Lung 0.9 YES 100 No M0 N1 T2 Stage IIB TCGA-77-8007.af0112bd-a19f-4ddc-9261-aca3afd9831c.pdf 8007 Preoperative 60 79 YES R0 Primary Tumor 01 0.7 6th NO YES 77 2 Lung A DECEASED 2001 1960 514bfcb2-3eae-436d-aec3-540cab765c3c 514bfcb2-3eae-436d-aec3-540cab765c3c TCGA-77-8007-01A-11D-2185-05 TCGA-77-8007-01A-11D-2183-01 514bfcb2-3eae-436d-aec3-540cab765c3c TCGA-77-8007-01A-11D-2183-01 +TCGA-77-8007-11 TCGA-77-8007-11 TCGA-77-8007 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 68 R-Upper TCGA-77-8007-F30478 TCGA-77-8007 TCGA-77-8007-11A -25102 198 0 139 84 1 NO NO Scheduled Follow-up Submission 2012-4-11 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.7 NO NO Central Lung 0.8 YES 100 No M0 N1 T2 Stage IIB 8007 Preoperative 60 79 YES R0 Solid Tissue Normal 11 0.7 6th NO YES 77 2 Lung A DECEASED 2001 1960 0fc04e69-e44f-4789-86ea-75399f9c9f87 0fc04e69-e44f-4789-86ea-75399f9c9f87 0fc04e69-e44f-4789-86ea-75399f9c9f87 +TCGA-77-8008-01 TCGA-77-8008-01 Squamous Low purity c2 squamous-like c4 miRNA cluster 4 TCGA-77-8008 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 68 R-Lower TCGA-77-8008-F30471 TCGA-77-8008 TCGA-77-8008-01A -24948 2639 0 50 1 NO NO Scheduled Follow-up Submission 2012-4-11 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8071/3 C34.3 YES 1 NO NO Central Lung 1.1 61.5 No M0 N0 T2 Stage IB TCGA-77-8008.ae32fa6e-d42b-4e6e-93db-26b1651e8513.pdf 8008 Preoperative 66 72 YES NO R0 Primary Tumor 01 0.4 1986 6th NO NO YES 77 4 Lung A DECEASED 2001 1945 0116ccaf-9eaa-4f14-8255-586f587c29f8 0116ccaf-9eaa-4f14-8255-586f587c29f8 TCGA-77-8008-01A-21D-2185-05 TCGA-77-8008-01A-21D-2183-01 0116ccaf-9eaa-4f14-8255-586f587c29f8 TCGA-77-8008-01A-21D-2183-01 +TCGA-77-8008-11 TCGA-77-8008-11 TCGA-77-8008 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 68 R-Lower TCGA-77-8008-F30471 TCGA-77-8008 TCGA-77-8008-11A -24948 2639 0 50 1 NO NO Scheduled Follow-up Submission 2012-4-11 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8071/3 C34.3 YES 0.7 NO NO Central Lung 1 61.5 No M0 N0 T2 Stage IB 8008 Preoperative 66 72 YES NO R0 Solid Tissue Normal 11 0.6 1986 6th NO NO YES 77 4 Lung A DECEASED 2001 1945 1d8f158c-a625-4eb4-ace2-4e16db1922f8 1d8f158c-a625-4eb4-ace2-4e16db1922f8 1d8f158c-a625-4eb4-ace2-4e16db1922f8 +TCGA-77-8009-01 TCGA-77-8009-01 Squamous BRCA CIMP c7 squamous-like c4 miRNA cluster 4 TCGA-77-8009 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung NO 68 R-Lower TCGA-77-8009-F46145 TCGA-77-8009 TCGA-77-8009-01A -25037 1695 0 1641 607 102 0 NO NO Scheduled Follow-up Submission 2013-8-23 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.9 8070/3 C34.9 YES 0.7 NO NO Central Lung 0.9 NO New Primary Tumor YES 97.5 No M0 N1 T2 Stage IIB TCGA-77-8009.a6512534-eb58-4109-b45c-8c8e4e65b477.pdf 8009 Preoperative 68 75 Complete Remission/Response Convincing Imaging YES NO R0 Primary Tumor 01 0.4 2006 6th YES NO YES 77 4 Lung A DECEASED 2007 1967 0b9a03ce-d4c1-4192-a18c-de96c8b21bb2 0b9a03ce-d4c1-4192-a18c-de96c8b21bb2 TCGA-77-8009-01A-11D-2185-05 TCGA-77-8009-01A-11D-2183-01 0b9a03ce-d4c1-4192-a18c-de96c8b21bb2 TCGA-77-8009-01A-11D-2183-01 +TCGA-77-8128-01 TCGA-77-8128-01 High Cluster 13 (HNSC-LUSC) miRNA cluster 4 TCGA-77-8128 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 60 Other (please specify) Left lung TCGA-77-8128-F33144 TCGA-77-8128 TCGA-77-8128-01A -21986 1150 0 86 NO NO Scheduled Follow-up Submission 2012-7-2 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.9 8070/3 C34.9 YES 0.6 NO NO Central Lung 0.9 NO 113 No M0 N2 T2 Stage IIIA TCGA-77-8128.a1739ad2-a2df-4dc7-a15a-0db128651b03.pdf 8128 Preoperative 64.2 84 YES NO R0 Primary Tumor 01 0.4 6th NO NO YES 77 2 Lung A DECEASED 1999 1953 eb9fed2e-137c-4bcc-b69a-0da18e9bd6d9 eb9fed2e-137c-4bcc-b69a-0da18e9bd6d9 TCGA-77-8128-01A-11D-2245-05 TCGA-77-8128-01A-11D-2243-01 eb9fed2e-137c-4bcc-b69a-0da18e9bd6d9 TCGA-77-8128-01A-11D-2243-01 +TCGA-77-8130-01 TCGA-77-8130-01 High Cluster 13 (HNSC-LUSC) miRNA cluster 4 TCGA-77-8130 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung YES 69 L-Upper TCGA-77-8130-F47673 TCGA-77-8130 TCGA-77-8130-01A -25260 0 4765 4471 91 0 NO NO Scheduled Follow-up Submission 2013-8-29 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.7 NO NO Central Lung 1.1 NO New Primary Tumor YES 32.25 No M0 N1 T2 Stage IIB TCGA-77-8130.b070100c-d021-4d9f-b665-441bfc3df5b4.pdf 8130 Preoperative TUMOR FREE 55.9 66 Complete Remission/Response Biopsy with Histologic Confirmation YES NO R0 Primary Tumor 01 0.6 1996 6th NO NO YES 77 4 Lung A LIVING 2000 1945 525fe7e1-4337-45bc-ae5b-d8a219e6e245 525fe7e1-4337-45bc-ae5b-d8a219e6e245 TCGA-77-8130-01A-11D-2245-05 TCGA-77-8130-01A-11D-2243-01 525fe7e1-4337-45bc-ae5b-d8a219e6e245 TCGA-77-8130-01A-11D-2243-01 +TCGA-77-8131-01 TCGA-77-8131-01 Squamous Low purity c2 miRNA cluster 4 TCGA-77-8131 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 72 L-Lower TCGA-77-8131-F32880 TCGA-77-8131 TCGA-77-8131-01A -26611 383 0 87 1 NO NO Scheduled Follow-up Submission 2012-7-3 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.7 NO NO Peripheral Lung 0.8 YES 69 No M0 NX T2 Stage IB TCGA-77-8131.aaeea1bd-8a50-444b-82d1-74347a5bc304.pdf 8131 Preoperative 76 109 YES R0 Primary Tumor 01 0.6 1987 6th NO YES 77 4 Lung A DECEASED 2000 1941 84b37e1a-260f-42c8-92d2-377ba130168d 84b37e1a-260f-42c8-92d2-377ba130168d TCGA-77-8131-01A-11D-2245-05 TCGA-77-8131-01A-11D-2243-01 84b37e1a-260f-42c8-92d2-377ba130168d TCGA-77-8131-01A-11D-2243-01 +TCGA-77-8133-01 TCGA-77-8133-01 Squamous Cluster 13 (HNSC-LUSC) miRNA cluster 4 TCGA-77-8133 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 74 Other (please specify) Right middle/lower - unsure which lobe TCGA-77-8133-F32876 TCGA-77-8133 TCGA-77-8133-01A -27139 1640 0 55 0 NO NO Scheduled Follow-up Submission 2012-7-3 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.9 8070/3 C34.9 YES 0.6 NO NO Central Lung 1 YES 22 No M0 N1 T1 Stage IIA TCGA-77-8133.6ddd0cb2-fea0-4b27-9468-ca4f085192d6.pdf 8133 Preoperative 77.4 93 YES NO R0 Primary Tumor 01 0.5 6th NO NO YES 77 2 Lung A DECEASED 2001 1941 eee5c7c2-da4c-4d30-9001-7ca9f25c806a eee5c7c2-da4c-4d30-9001-7ca9f25c806a TCGA-77-8133-01A-12D-2245-05 TCGA-77-8133-01A-12D-2243-01 eee5c7c2-da4c-4d30-9001-7ca9f25c806a TCGA-77-8133-01A-12D-2243-01 +TCGA-77-8136-01 TCGA-77-8136-01 Squamous Cluster 5 miRNA cluster 4 TCGA-77-8136 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 74 Other (please specify) TCGA-77-8136-F33071 TCGA-77-8136 TCGA-77-8136-01A -27193 1189 0 101 0 NO NO Scheduled Follow-up Submission 2012-7-3 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.7 NO NO Central Lung 1.1 YES NO 135 No M0 N1 T2 Stage IIB TCGA-77-8136.bd7fbf72-bdfd-4828-9185-4de81c426f6c.pdf 8136 Preoperative 64 88 YES NO R0 Primary Tumor 01 0.6 6th NO NO YES 77 2 Lung A DECEASED 2002 1947 322593ce-4a52-4c15-9640-54ebccf7bf45 322593ce-4a52-4c15-9640-54ebccf7bf45 TCGA-77-8136-01A-11D-2245-05 TCGA-77-8136-01A-11D-2243-01 322593ce-4a52-4c15-9640-54ebccf7bf45 TCGA-77-8136-01A-11D-2243-01 +TCGA-77-8138-01 TCGA-77-8138-01 Squamous Cluster 5 miRNA cluster 4 TCGA-77-8138 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 74 L-Upper TCGA-77-8138-F33156 TCGA-77-8138 TCGA-77-8138-01A -27225 539 0 74 0 NO NO Scheduled Follow-up Submission 2012-7-26 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.7 NO NO Peripheral Lung 0.7 NO NO 54 No M0 N0 T2 Stage IB TCGA-77-8138.fab5161e-1a7a-4074-84e5-addba1379e1c.pdf 8138 Preoperative WITH TUMOR 60.9 72 YES NO R0 Primary Tumor 01 0.6 2000 6th NO NO YES 77 4 Lung A DECEASED 2003 1946 8382d0be-b114-40b4-9412-b0ae25ab0f5b 8382d0be-b114-40b4-9412-b0ae25ab0f5b TCGA-77-8138-01A-11D-2245-05 TCGA-77-8138-01A-11D-2243-01 8382d0be-b114-40b4-9412-b0ae25ab0f5b TCGA-77-8138-01A-11D-2243-01 +TCGA-77-8139-01 TCGA-77-8139-01 BRCA-LUAD+ Cluster 5 miRNA cluster 4 TCGA-77-8139 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 72 R-Upper TCGA-77-8139-F46142 TCGA-77-8139 TCGA-77-8139-01A -26464 0 3166 58 0 NO NO Scheduled Follow-up Submission 2013-8-6 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.6 NO NO Peripheral Lung 1.2 YES NO 52 No M0 N0 T3 Stage IIB TCGA-77-8139.ebfd7ba3-0f3b-4c90-9d26-10a8394c01f9.pdf 8139 Preoperative TUMOR FREE 60 69 Complete Remission/Response YES NO R0 Primary Tumor 01 0.5 6th NO NO YES 77 2 Lung A LIVING 2003 1951 d34945c6-2882-4e48-ada0-2f61d9f7a4e5 d34945c6-2882-4e48-ada0-2f61d9f7a4e5 TCGA-77-8139-01A-11D-2245-05 TCGA-77-8139-01A-11D-2243-01 d34945c6-2882-4e48-ada0-2f61d9f7a4e5 TCGA-77-8139-01A-11D-2243-01 +TCGA-77-8140-01 TCGA-77-8140-01 Squamous Cluster 5 miRNA cluster 4 TCGA-77-8140 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 66 R-Lower TCGA-77-8140-F33142 TCGA-77-8140 TCGA-77-8140-01A -24415 351 0 31 0 NO NO Scheduled Follow-up Submission 2012-7-3 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.9 NO NO Peripheral Lung 1 NO 78 No M0 N1 T2 Stage IIB TCGA-77-8140.c8a18693-4875-45d9-8a31-ed04b8b3566c.pdf 8140 Preoperative 52.3 57 YES NO R0 Primary Tumor 01 0.6 2001 6th NO NO YES 77 4 Lung A DECEASED 2003 1962 c3efe0fb-b62a-47b5-a50b-83433525dbc5 c3efe0fb-b62a-47b5-a50b-83433525dbc5 TCGA-77-8140-01A-11D-2245-05 TCGA-77-8140-01A-11D-2243-01 c3efe0fb-b62a-47b5-a50b-83433525dbc5 TCGA-77-8140-01A-11D-2243-01 +TCGA-77-8143-01 TCGA-77-8143-01 Squamous Cluster 5 miRNA cluster 11 TCGA-77-8143 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 76 L-Upper TCGA-77-8143-F33150 TCGA-77-8143 TCGA-77-8143-01A -27772 803 0 86 1 NO NO Scheduled Follow-up Submission 2012-7-2 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.7 NO NO Peripheral Lung 0.8 NO 30 No M0 N2 T2 Stage IIIA TCGA-77-8143.11ebd546-0402-4047-9568-a148c382cd23.pdf 8143 Preoperative WITH TUMOR 54.4 64 YES YES R0 Primary Tumor 01 0.4 6th NO NO YES 77 4 Lung A DECEASED 2004 66016ff6-5367-4560-a7d3-20f536f22ece 66016ff6-5367-4560-a7d3-20f536f22ece TCGA-77-8143-01A-11D-2245-05 TCGA-77-8143-01A-11D-2243-01 66016ff6-5367-4560-a7d3-20f536f22ece TCGA-77-8143-01A-11D-2243-01 +TCGA-77-8144-01 TCGA-77-8144-01 Squamous Cluster 13 (HNSC-LUSC) miRNA cluster 11 TCGA-77-8144 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 70 L-Lower TCGA-77-8144-F46147 TCGA-77-8144 TCGA-77-8144-01A -25796 0 833 73 1 NO NO Scheduled Follow-up Submission 2013-8-23 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.5 NO NO Central Lung 0.7 YES 59 No M0 N0 T2 Stage IB TCGA-77-8144.c1a4f906-63ec-4db6-ba0e-9b22a235ce48.pdf 8144 Preoperative 50.4 71 Complete Remission/Response YES NO R0 Primary Tumor 01 0.5 6th NO NO YES 77 2 Lung A LIVING 2004 1944 cf939eea-83dc-42ad-b9ce-0c3972ebf86b cf939eea-83dc-42ad-b9ce-0c3972ebf86b TCGA-77-8144-01A-11D-2245-05 TCGA-77-8144-01A-11D-2243-01 cf939eea-83dc-42ad-b9ce-0c3972ebf86b TCGA-77-8144-01A-11D-2243-01 +TCGA-77-8145-01 TCGA-77-8145-01 Squamous Cluster 5 miRNA cluster 4 TCGA-77-8145 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung NO YES NO NO 73 Other (please specify) TCGA-77-8145-F33068 TCGA-77-8145 TCGA-77-8145-01A -26707 212 0 82 0 NO NO Scheduled Follow-up Submission Progressive Disease 2012-7-3 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.9 8070/3 C34.9 YES 0.7 NO NO Central Lung 1 YES Distant Metastasis YES 57 No M0 N1 T4 Stage IIIB TCGA-77-8145.e046ea53-a90c-4483-9398-bf3961af868b.pdf 8145 Preoperative 48.6 68 YES YES R1 Primary Tumor 01 0.5 6th NO NO YES 77 2 Lung A DECEASED 2000 1943 4b0015ac-a48c-4a48-b32f-8f62a84ebecd 4b0015ac-a48c-4a48-b32f-8f62a84ebecd TCGA-77-8145-01A-11D-2245-05 TCGA-77-8145-01A-11D-2243-01 4b0015ac-a48c-4a48-b32f-8f62a84ebecd TCGA-77-8145-01A-11D-2243-01 +TCGA-77-8146-01 TCGA-77-8146-01 Cluster 5 miRNA cluster 4 TCGA-77-8146 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 72 R-Upper TCGA-77-8146-F46150 TCGA-77-8146 TCGA-77-8146-01A -26533 0 3189 57 0 NO NO Scheduled Follow-up Submission 2013-8-23 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.6 NO NO Peripheral Lung 0.8 NO 75 No M0 N0 T1 Stage IA TCGA-77-8146.5d6612d3-0a94-4b7c-9297-a9a5ada70c65.pdf 8146 Preoperative 76.5 76 Complete Remission/Response YES NO R0 Primary Tumor 01 0.6 6th NO NO YES 77 2 Lung A LIVING 2005 1954 39dcdd85-0535-43fa-a0bf-e3a9e324eea2 39dcdd85-0535-43fa-a0bf-e3a9e324eea2 TCGA-77-8146-01A-11D-2245-05 39dcdd85-0535-43fa-a0bf-e3a9e324eea2 +TCGA-77-8148-01 TCGA-77-8148-01 High Cluster 5 miRNA cluster 4 TCGA-77-8148 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 68 Other (please specify) Left upper and Left lower TCGA-77-8148-F46105 TCGA-77-8148 TCGA-77-8148-01A -24918 0 2023 78 1 NO NO Scheduled Follow-up Submission 2013-8-6 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.9 8070/3 C34.9 YES 0.6 NO NO Central Lung 0.8 NO 60 No M0 N1 T3 Stage IIIA TCGA-77-8148.2ccef95d-ec8e-4b8d-987b-b7bf8ab2aa99.pdf 8148 Preoperative 67.6 52 Complete Remission/Response YES NO R0 Primary Tumor 01 0.4 1999 6th NO NO YES 77 4 Lung A LIVING 2006 a825b1eb-e03b-44da-8587-899244ca6c0e a825b1eb-e03b-44da-8587-899244ca6c0e TCGA-77-8148-01A-11D-2245-05 TCGA-77-8148-01A-11D-2243-01 a825b1eb-e03b-44da-8587-899244ca6c0e TCGA-77-8148-01A-11D-2243-01 +TCGA-77-8150-01 TCGA-77-8150-01 High Cluster 13 (HNSC-LUSC) miRNA cluster 4 TCGA-77-8150 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung NO NO 64 R-Lower TCGA-77-8150-F33094 TCGA-77-8150 TCGA-77-8150-01A -23474 1655 0 1456 73 0 NO NO Scheduled Follow-up Submission Progressive Disease 2012-7-3 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.9 8070/3 C34.9 YES 0.8 NO NO Central Lung 0.9 NO Distant Metastasis YES 46 No M0 N1 T3 Stage IIIA TCGA-77-8150.d19c8493-374a-4b6a-9975-5f220c77834b.pdf 8150 Preoperative WITH TUMOR 59.6 59 YES NO R0 Primary Tumor 01 0.5 6th NO NO YES 77 2 Lung A DECEASED 2007 1961 b32d8bea-966a-4640-9a23-e20cd465771c b32d8bea-966a-4640-9a23-e20cd465771c TCGA-77-8150-01A-11D-2245-05 TCGA-77-8150-01A-11D-2243-01 b32d8bea-966a-4640-9a23-e20cd465771c TCGA-77-8150-01A-11D-2243-01 +TCGA-77-8153-01 TCGA-77-8153-01 TCGA-77-8153 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 77 R-Lower TCGA-77-8153-F47201 TCGA-77-8153 TCGA-77-8153-01A -28253 0 1992 1 NO NO Scheduled Follow-up Submission Complete Remission/Response 2013-8-29 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.8 NO NO Peripheral Lung 1.4 NO NO 25 No M0 N0 T2 Stage IB TCGA-77-8153.310be22d-8980-4d51-83a9-dfc620b73f5e.pdf 8153 Preoperative TUMOR FREE 70 85 Complete Remission/Response YES NO R0 Primary Tumor 01 0.5 1975 6th NO NO YES 77 3 Lung A LIVING 2008 1950 adda0fb6-b939-4fac-a005-3696d05d1971 adda0fb6-b939-4fac-a005-3696d05d1971 TCGA-77-8153-01A-11D-2398-05 TCGA-77-8153-01A-11D-2391-01 adda0fb6-b939-4fac-a005-3696d05d1971 TCGA-77-8153-01A-11D-2391-01 +TCGA-77-8154-01 TCGA-77-8154-01 Squamous Cluster 13 (HNSC-LUSC) miRNA cluster 11 TCGA-77-8154 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 67 R-Lower TCGA-77-8154-F46155 TCGA-77-8154 TCGA-77-8154-01A -24640 0 1841 90 1 NO NO Scheduled Follow-up Submission Complete Remission/Response 2013-8-23 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.5 NO NO Peripheral Lung 0.6 NO NO 40 No M0 N0 T1 Stage IA TCGA-77-8154.b8caa915-6710-4e03-b4b2-4641f6a8eacc.pdf 8154 Preoperative TUMOR FREE 69.6 95 Complete Remission/Response YES NO R0 Primary Tumor 01 0.4 2006 6th NO NO YES 77 4 Lung A LIVING 2008 1966 9a7bfae6-39b5-4d65-953c-9a029b093808 9a7bfae6-39b5-4d65-953c-9a029b093808 TCGA-77-8154-01A-11D-2245-05 TCGA-77-8154-01A-11D-2243-01 9a7bfae6-39b5-4d65-953c-9a029b093808 TCGA-77-8154-01A-11D-2243-01 +TCGA-77-8156-01 TCGA-77-8156-01 High Cluster 13 (HNSC-LUSC) miRNA cluster 4 TCGA-77-8156 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 60 L-Upper TCGA-77-8156-F46138 TCGA-77-8156 TCGA-77-8156-01A -22198 0 1106 43 0 NO NO Scheduled Follow-up Submission 2013-8-6 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.7 NO NO Central Lung 1 NO 57.5 No M0 N0 T2a Stage IB TCGA-77-8156.7ce15c6d-0640-47b2-a4cd-0d14f97e6ab7.pdf 8156 Preoperative 53 65 Complete Remission/Response YES NO R0 Primary Tumor 01 0.3 7th NO NO YES 77 2 Lung A LIVING 2010 1963 27232616-276d-4654-ba3a-697a0c83dd7e 27232616-276d-4654-ba3a-697a0c83dd7e TCGA-77-8156-01A-11D-2245-05 TCGA-77-8156-01A-11D-2243-01 27232616-276d-4654-ba3a-697a0c83dd7e TCGA-77-8156-01A-11D-2243-01 +TCGA-77-A5FZ-01 TCGA-77-A5FZ-01 TCGA-77-A5FZ TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 64 L-Upper TCGA-77-A5FZ TCGA-77-A5FZ-01A -23436 4283 3838 0 71 1 NO NO 2013-6-19 MALE Lung Papillary Squamous Cell Caricnoma No C34.1 8052/3 C34.1 YES 240 NO NO Central Lung 141 false No M0 N0 T4 Stage IIIB TCGA-77-A5FZ.7297BF03-518D-4643-8DA9-D8B360D9D3E9.pdf A5FZ Preoperative 59 89 Complete Remission/Response YES NO R0 Primary Tumor 01 2000 6th NO NO YES 77 4 Lung A DECEASED 2001 1953 c57a55f6-bce1-4d76-8edc-6a4f78056bdc c57a55f6-bce1-4d76-8edc-6a4f78056bdc TCGA-77-A5FZ-01A-31D-A27L-05 TCGA-77-A5FZ-01A-31D-A27J-01 c57a55f6-bce1-4d76-8edc-6a4f78056bdc TCGA-77-A5FZ-01A-31D-A27J-01 +TCGA-77-A5G1-01 TCGA-77-A5G1-01 TCGA-77-A5G1 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 75 R-Lower TCGA-77-A5G1-F54249 TCGA-77-A5G1 TCGA-77-A5G1-01A -27555 3821 0 4026 83 0 NO NO Scheduled Follow-up Submission 2013-12-20 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 250 NO NO Central Lung NO YES 53 false No M0 N1 T3 Stage IIIA TCGA-77-A5G1.AC3570CB-4A07-4E52-AD77-2857BDF35C87.pdf A5G1 Preoperative 67 79 Complete Remission/Response YES NO R0 Primary Tumor 01 1995 6th NO NO YES 77 4 Lung A LIVING 2002 1942 c9816883-ad45-4699-aafc-14247f03bbff c9816883-ad45-4699-aafc-14247f03bbff TCGA-77-A5G1-01A-11D-A27L-05 TCGA-77-A5G1-01A-11D-A27J-01 c9816883-ad45-4699-aafc-14247f03bbff TCGA-77-A5G1-01A-11D-A27J-01 +TCGA-77-A5G3-01 TCGA-77-A5G3-01 TCGA-77-A5G3 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 63 Bronchial TCGA-77-A5G3-F70498 TCGA-77-A5G3 TCGA-77-A5G3-01A -23171 3816 0 4570 91 1 NO NO Scheduled Follow-up Submission 2015-3-25 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 280 NO NO Central Lung NO NO 40 false No M0 N1 T2 Stage IIB TCGA-77-A5G3.4A08A36C-67BB-4372-B34D-04754F636E97.pdf A5G3 Preoperative TUMOR FREE 57 67 Complete Remission/Response YES NO R0 Primary Tumor 01 1999 6th NO NO YES 77 4 Lung A LIVING 2002 1959 9f1395e0-478f-49dd-8814-1ee57308db0d 9f1395e0-478f-49dd-8814-1ee57308db0d TCGA-77-A5G3-01A-31D-A27L-05 TCGA-77-A5G3-01A-31D-A27J-01 9f1395e0-478f-49dd-8814-1ee57308db0d TCGA-77-A5G3-01A-31D-A27J-01 +TCGA-77-A5G6-01 TCGA-77-A5G6-01 TCGA-77-A5G6 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 66 R-Upper TCGA-77-A5G6 TCGA-77-A5G6-01A -24215 1420 678 0 56 0 NO NO 2013-6-19 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 280 NO NO Peripheral Lung YES 74 false No M0 N2 T2 Stage IIIA TCGA-77-A5G6.1F983196-D523-4261-853B-98107B91F92D.pdf A5G6 Preoperative WITH TUMOR 40 53 Complete Remission/Response YES NO R0 Primary Tumor 01 6th NO NO YES 77 2 Lung A DECEASED 2009 1955 327ce5b0-ebfe-42f0-a277-a730dc467831 327ce5b0-ebfe-42f0-a277-a730dc467831 TCGA-77-A5G6-01A-11D-A27L-05 TCGA-77-A5G6-01A-11D-A27J-01 327ce5b0-ebfe-42f0-a277-a730dc467831 TCGA-77-A5G6-01A-11D-A27J-01 +TCGA-77-A5G7-01 TCGA-77-A5G7-01 TCGA-77-A5G7 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 63 L-Upper TCGA-77-A5G7 TCGA-77-A5G7-01B -23090 1317 180 0 1 NO NO 2013-6-19 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 60 NO NO Peripheral Lung 69 false No M0 N0 T1 Stage IA TCGA-77-A5G7.966AA667-7891-45FF-BD1F-9172455B57C4.pdf A5G7 Preoperative 105 95 Complete Remission/Response YES NO R0 Primary Tumor 01 6th NO NO YES 77 2 Lung B DECEASED 2009 1963 1d0f2179-a8a3-4a29-ace9-b627d0338b10 1d0f2179-a8a3-4a29-ace9-b627d0338b10 TCGA-77-A5G7-01B-11D-A27L-05 TCGA-77-A5G7-01B-11D-A27J-01 1d0f2179-a8a3-4a29-ace9-b627d0338b10 TCGA-77-A5G7-01B-11D-A27J-01 +TCGA-77-A5G8-01 TCGA-77-A5G8-01 TCGA-77-A5G8 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 70 R-Upper TCGA-77-A5G8-F70497 TCGA-77-A5G8 TCGA-77-A5G8-01B -25921 1140 0 1884 67 0 NO NO Scheduled Follow-up Submission 2015-3-25 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 50 NO NO Peripheral Lung NO 90 false No M0 N0 T3 Stage IIB TCGA-77-A5G8.10343021-36C0-4188-A1DF-2CA02BF64CA6.pdf A5G8 Preoperative 64 104 YES R0 Primary Tumor 01 2009 6th NO YES 77 4 Lung B LIVING 2009 1949 5db439d8-0190-4417-abf8-59b8cf25a168 5db439d8-0190-4417-abf8-59b8cf25a168 TCGA-77-A5G8-01B-11D-A27L-05 TCGA-77-A5G8-01B-11D-A27J-01 5db439d8-0190-4417-abf8-59b8cf25a168 TCGA-77-A5G8-01B-11D-A27J-01 +TCGA-77-A5GA-01 TCGA-77-A5GA-01 TCGA-77-A5GA TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 76 L-Upper TCGA-77-A5GA-F54251 TCGA-77-A5GA TCGA-77-A5GA-01A -27762 1044 0 1280 42 1 NO NO Scheduled Follow-up Submission 2013-12-20 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 70 NO NO Central Lung NO 99 false No M0 N0 T2a Stage IB TCGA-77-A5GA.98FCB868-1962-4738-868A-8F4958F27469.pdf A5GA Preoperative 68 132 Complete Remission/Response YES NO R0 Primary Tumor 01 1982 7th NO NO YES 77 3 Lung A LIVING 2010 1949 636bbdfd-25de-4068-921c-8982bed31c8c 636bbdfd-25de-4068-921c-8982bed31c8c TCGA-77-A5GA-01A-11D-A27L-05 TCGA-77-A5GA-01A-11D-A27J-01 636bbdfd-25de-4068-921c-8982bed31c8c TCGA-77-A5GA-01A-11D-A27J-01 +TCGA-77-A5GB-01 TCGA-77-A5GB-01 TCGA-77-A5GB TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 90 Other (please specify) Left Lingula TCGA-77-A5GB TCGA-77-A5GB-01B -32872 974 937 0 72 1 NO NO 2013-6-19 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8071/3 C34.1 YES 70 NO NO Peripheral Lung YES 52 false Yes, History of Prior Malignancy M0 NX T2a Stage IB TCGA-77-A5GB.15DE0F5C-3C0D-4EAB-90D2-5CC758066751.pdf A5GB Preoperative 76 103 Complete Remission/Response YES NO R0 Primary Tumor 01 7th NO NO YES 77 2 Lung B DECEASED 2010 1939 15758673-e515-438b-bd9b-26529dc6b673 15758673-e515-438b-bd9b-26529dc6b673 TCGA-77-A5GB-01B-11D-A27L-05 TCGA-77-A5GB-01B-11D-A27J-01 15758673-e515-438b-bd9b-26529dc6b673 TCGA-77-A5GB-01B-11D-A27J-01 +TCGA-77-A5GF-01 TCGA-77-A5GF-01 TCGA-77-A5GF TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 70 L-Lower TCGA-77-A5GF-F61670 TCGA-77-A5GF TCGA-77-A5GF-01A -25654 568 840 0 722 0 NO NO Scheduled Follow-up Submission 2014-8-11 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 270 NO NO Peripheral Lung NO YES 60 false No M0 N1 T2a Stage IIA TCGA-77-A5GF.DCAA6959-3E03-4CE6-83C3-02287C3E390B.pdf A5GF Preoperative WITH TUMOR 74 78 Complete Remission/Response YES NO R0 Primary Tumor 01 1996 7th NO NO YES 77 4 Lung A DECEASED 2011 1956 d0bc7698-a2fe-44ca-8d33-8ccc4d5eacd9 d0bc7698-a2fe-44ca-8d33-8ccc4d5eacd9 TCGA-77-A5GF-01A-21D-A27L-05 TCGA-77-A5GF-01A-21D-A27J-01 d0bc7698-a2fe-44ca-8d33-8ccc4d5eacd9 TCGA-77-A5GF-01A-21D-A27J-01 +TCGA-77-A5GH-01 TCGA-77-A5GH-01 TCGA-77-A5GH TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 81 Other (please specify) Left lingula TCGA-77-A5GH-F65865 TCGA-77-A5GH TCGA-77-A5GH-01A -29843 559 0 1182 1 NO NO Scheduled Follow-up Submission 2014-10-1 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 170 NO NO Peripheral Lung NO 11 false No M0 N0 T2a Stage IB TCGA-77-A5GH.853CD446-E942-410E-B38D-80EA6313A405.pdf A5GH Preoperative 69 74 Complete Remission/Response YES NO R0 Primary Tumor 01 1990 7th NO NO YES 77 3 Lung A LIVING 2011 1949 85f0c41e-c864-482a-b6f4-eac3e505afc1 85f0c41e-c864-482a-b6f4-eac3e505afc1 TCGA-77-A5GH-01A-11D-A27L-05 TCGA-77-A5GH-01A-11D-A27J-01 85f0c41e-c864-482a-b6f4-eac3e505afc1 TCGA-77-A5GH-01A-11D-A27J-01 +TCGA-78-7143-01 none none none none N N none none none Bronchioid none none none p.D963_splice none none none Adenocarcinoma, NOS Adenocarcinoma, NOS none 0 TCGA-78-7143-01 High C1-LUAD-enriched Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 5 TCGA-78-7143 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung NO NO NO NO 62 L-Upper TCGA-78-7143-F16669 TCGA-78-7143 TCGA-78-7143-01A -22673 4961 0 4608 0 NO NO Additional New Tumor Event 2011-9-23 FEMALE Lung Bronchioloalveolar Carcinoma Nonmucinous No C34.1 8252/3 C34.1 YES 1 NO NO Central Lung 1.1 YES No M0 N0 T2 Stage IB TCGA-78-7143.083bd90a-b596-4a8b-84f5-97ca17cee7fa.pdf 7143 Preoperative TUMOR FREE R0 Primary Tumor 01 0.7 6th NO YES 78 1 Lifelong Non-smoker Lung A DECEASED 1992 274a99f3-1b61-48f3-afab-11088c63f488 274a99f3-1b61-48f3-afab-11088c63f488 TCGA-78-7143-01A-11D-2037-05 TCGA-78-7143-01A-11D-2035-01 274a99f3-1b61-48f3-afab-11088c63f488 TCGA-78-7143-01A-11D-2035-01 TCGA-78-7143-01A-13-2192-20 +TCGA-78-7145-01 2.04 0.78 none none none none Y Y none none none 0.38 Squamoid none p.G12Y none none none none none Micropapillary predom Adc Micropapillary predom Adc none 0 TCGA-78-7145-01 High C1-LUAD-enriched Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 4 TCGA-78-7145 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung YES YES NO NO 52 R-Middle TCGA-78-7145-F16671 TCGA-78-7145 TCGA-78-7145-01A -19080 826 0 422 1 NO NO Scheduled Follow-up Submission Progressive Disease 2011-9-23 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.2 8140/3 C34.2 YES 1 NO NO Peripheral Lung 1.4 YES 25 No M1 N1 T4 Stage IV TCGA-78-7145.b9516a4e-5bc3-47f6-8ca3-f1e5abf71b34.pdf 7145 Preoperative WITH TUMOR NO R1 Primary Tumor 01 0.6 1998 6th YES NO YES 78 4 Current reformed smoker for < or = 15 years Lung A DECEASED 2000 1973 29f0cffb-22a7-40a7-964d-9b84d7c5b442 29f0cffb-22a7-40a7-964d-9b84d7c5b442 TCGA-78-7145-01A-11D-2037-05 TCGA-78-7145-01A-11D-2035-01 29f0cffb-22a7-40a7-964d-9b84d7c5b442 TCGA-78-7145-01A-11D-2035-01 TCGA-78-7145-01A-13-2192-20 +TCGA-78-7146-01 TCGA-78-7146-01 High C1-LUAD-enriched Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 4 TCGA-78-7146 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 71 L-Lower TCGA-78-7146-F16969 TCGA-78-7146 TCGA-78-7146-01A -26272 173 0 1 NO NO Scheduled Follow-up Submission 2011-9-28 FEMALE Lung Adenocarcinoma Mixed Subtype No C34.3 8255/3 C34.3 YES 0.8 NO NO Peripheral Lung 0.8 6 No M0 N2 T2 Stage IIIA TCGA-78-7146.3ff87253-3d93-4283-8052-499cd0edea85.pdf 7146 Preoperative NO R0 Primary Tumor 01 0.6 1998 6th NO NO YES 78 4 Lung A DECEASED 1999 1988 6a45204a-96c6-4617-a4cc-27f71c05170b 6a45204a-96c6-4617-a4cc-27f71c05170b TCGA-78-7146-01A-11D-2037-05 TCGA-78-7146-01A-11D-2035-01 6a45204a-96c6-4617-a4cc-27f71c05170b TCGA-78-7146-01A-11D-2035-01 TCGA-78-7146-01A-13-2192-20 +TCGA-78-7147-01 1.9 0.77 none none none none Y Y p.L387M, p.L861Q, p.D1083fs none none 0.4 Bronchioid none none none none none none none Acinar predominant Adc Acinar predominant Adc none 0 TCGA-78-7147-01 BRCA-LUAD+ C1-LUAD-enriched Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 4 TCGA-78-7147 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung NO NO NO NO 67 R-Upper TCGA-78-7147-F16971 TCGA-78-7147 TCGA-78-7147-01A -24809 586 0 578 1 NO NO Scheduled Follow-up Submission Progressive Disease 2011-9-28 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.8 NO NO Peripheral Lung 0.9 YES 50 No M0 N1 T2 Stage IIB TCGA-78-7147.0f5ad63e-a072-4f02-8f88-1d75fabd3a4b.pdf 7147 Preoperative WITH TUMOR NO R0 Primary Tumor 01 0.8 6th NO NO YES 78 2 Current smoker Lung A DECEASED 2001 1950 8c957960-d5a3-4d07-a3aa-6c13b16fff0e 8c957960-d5a3-4d07-a3aa-6c13b16fff0e TCGA-78-7147-01A-11D-2037-05 TCGA-78-7147-01A-11D-2035-01 8c957960-d5a3-4d07-a3aa-6c13b16fff0e TCGA-78-7147-01A-11D-2035-01 TCGA-78-7147-01A-13-2192-20 +TCGA-78-7148-01 none none none none Y Y none none p.R1304L Magnoid none p.G12C none none none none none Acinar predominant Adc Acinar predominant Adc p.E265fs 0 TCGA-78-7148-01 BRCA-LUAD+ C1-LUAD-enriched Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 4 TCGA-78-7148 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung NO YES 71 L-Upper TCGA-78-7148-F17170 TCGA-78-7148 TCGA-78-7148-01A 182 -25990 626 0 182 0 NO NO Scheduled Follow-up Submission 2011-10-4 MALE Lung Adenocarcinoma Mixed Subtype No C34.1 8255/3 C34.1 YES 0.8 NO NO Peripheral Lung 0.9 YES 57 No M0 N1 T2 Stage IIB TCGA-78-7148.5c97d03f-3dfc-4876-ab9e-ad2f4606d62b.pdf 7148 Preoperative NO R0 Primary Tumor 01 0.6 6th NO NO YES 78 2 Current smoker Lung A DECEASED 2001 1944 614ad2cf-7744-4ce1-b684-b6a57827e8c8 614ad2cf-7744-4ce1-b684-b6a57827e8c8 TCGA-78-7148-01A-11D-2037-05 TCGA-78-7148-01A-11D-2035-01 614ad2cf-7744-4ce1-b684-b6a57827e8c8 TCGA-78-7148-01A-11D-2035-01 TCGA-78-7148-01A-13-2192-20 +TCGA-78-7149-01 1.89 0.74 none none none none N N none none none 0.39 Magnoid none none none p.P1322H none none none Papillary predominant Adc Papillary predominant Adc none 0 TCGA-78-7149-01 BRCA-LUAD+ C1-LUAD-enriched Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 5 TCGA-78-7149 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 71 R-Lower TCGA-78-7149-F46148 TCGA-78-7149 TCGA-78-7149-01A -26285 0 3940 1 NO NO Scheduled Follow-up Submission 2013-8-23 MALE Lung Adenocarcinoma Mixed Subtype No C34.3 8255/3 C34.3 YES 0.9 NO NO Central Lung 1 NO 115 No M0 N0 T4 Stage IIIB TCGA-78-7149.2211dcab-03dd-493c-9131-684a9accea7a.pdf 7149 Preoperative Complete Remission/Response NO NO R0 Primary Tumor 01 0.5 6th NO NO YES 78 2 Current smoker Lung A LIVING 2002 1950 02e43817-47d3-4436-bcfa-37dd510eec4c 02e43817-47d3-4436-bcfa-37dd510eec4c TCGA-78-7149-01A-11D-2037-05 TCGA-78-7149-01A-11D-2035-01 02e43817-47d3-4436-bcfa-37dd510eec4c TCGA-78-7149-01A-11D-2035-01 TCGA-78-7149-01A-13-2192-20 +TCGA-78-7150-01 3 0.46 none none none none N N none none none 0.19 Magnoid none none none none none none none Solid predominant Adc Solid predominant Adc none 0 TCGA-78-7150-01 Squamous C1-LUAD-enriched Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 4 TCGA-78-7150 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung YES YES NO YES 59 L-Lower TCGA-78-7150-F16962 TCGA-78-7150 TCGA-78-7150-01A 164 -21891 666 0 139 0 NO NO Scheduled Follow-up Submission 2011-9-28 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 0.8 NO NO Central Lung 0.9 YES 37 No M0 N1 T2 Stage IIB TCGA-78-7150.99bec792-e05e-49fd-8601-5f51e876e614.pdf 7150 Preoperative WITH TUMOR NO R0 Primary Tumor 01 0.6 2000 6th NO NO YES 78 4 Current reformed smoker for < or = 15 years Lung A DECEASED 2002 1963 fb59e5ad-650a-4620-af05-9e8cb6c402ea fb59e5ad-650a-4620-af05-9e8cb6c402ea TCGA-78-7150-01A-21D-2037-05 TCGA-78-7150-01A-21D-2035-01 fb59e5ad-650a-4620-af05-9e8cb6c402ea TCGA-78-7150-01A-21D-2035-01 TCGA-78-7150-01A-23-2192-20 +TCGA-78-7152-01 1.99 0.56 none none none none N N none none none 0.28 Bronchioid none none none none none none none Acinar predominant Adc Acinar predominant Adc p.I29fs 0 TCGA-78-7152-01 Kirc+ C1-LUAD-enriched Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 5 TCGA-78-7152 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung NO YES NO 65 R-Upper TCGA-78-7152-F46144 TCGA-78-7152 TCGA-78-7152-01A -23782 1215 0 1202 1202 1 NO NO Scheduled Follow-up Submission Progressive Disease 2013-8-4 MALE Lung Adenocarcinoma Mixed Subtype No C34.1 8255/3 C34.1 YES 0.7 NO NO Peripheral Lung 0.9 NO Distant Metastasis YES 40 No M0 N0 T2 Stage IB TCGA-78-7152.4ee9aa80-a04b-4220-8657-0b05af9da97c.pdf 7152 Preoperative WITH TUMOR Complete Remission/Response Biopsy with Histologic Confirmation|Convincing Imaging NO NO R0 Primary Tumor 01 0.7 1999 6th NO NO YES 78 4 Current reformed smoker for < or = 15 years Lung A DECEASED 2003 1959 5a775e87-c4e5-4875-bc64-e2e2a59376e8 5a775e87-c4e5-4875-bc64-e2e2a59376e8 TCGA-78-7152-01A-11D-2037-05 TCGA-78-7152-01A-11D-2035-01 5a775e87-c4e5-4875-bc64-e2e2a59376e8 TCGA-78-7152-01A-11D-2035-01 TCGA-78-7152-01A-13-2192-20 +TCGA-78-7153-01 2.12 0.74 none p.G466A p.IVVD429del p.S33N N Y none none none 0.35 Magnoid none none none none none p.Q296E none Papillary predominant Adc Papillary predominant Adc none 0 TCGA-78-7153-01 Iq C1-LUAD-enriched Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 5 TCGA-78-7153 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 65 R-Upper TCGA-78-7153-F46077 TCGA-78-7153 TCGA-78-7153-01A -23922 0 3635 0 NO NO Scheduled Follow-up Submission 2013-8-23 FEMALE Lung Adenocarcinoma Mixed Subtype No C34.8 8255/3 C34.8 YES 0.8 NO NO Peripheral Lung 1 NO 20 No M0 N0 T2 Stage IB TCGA-78-7153.14c2a5e1-cef1-4076-952d-8cf9061befff.pdf 7153 Preoperative Complete Remission/Response NO NO R0 Primary Tumor 01 0.4 1988 6th NO NO YES 78 4 Current reformed smoker for < or = 15 years Lung A LIVING 2003 1948 e1bbe3cc-e58e-45d6-82a7-57e8d202e7e6 e1bbe3cc-e58e-45d6-82a7-57e8d202e7e6 TCGA-78-7153-01A-11D-2037-05 TCGA-78-7153-01A-11D-2035-01 e1bbe3cc-e58e-45d6-82a7-57e8d202e7e6 TCGA-78-7153-01A-11D-2035-01 TCGA-78-7153-01A-13-2192-20 +TCGA-78-7154-01 2.17 0.68 none none none none N N none none none 0.32 Magnoid none none none none none none none Papillary predominant Adc Papillary predominant Adc none 0 TCGA-78-7154-01 High C1-LUAD-enriched Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 4 TCGA-78-7154 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 72 L-Upper TCGA-78-7154-F16951 TCGA-78-7154 TCGA-78-7154-01A -26481 593 0 1 NO NO Scheduled Follow-up Submission 2011-9-28 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.5 NO NO Peripheral Lung 0.9 112.5 No M0 N2 T3 Stage IIIA TCGA-78-7154.00bdbfd9-ca96-4c34-b4c1-eae63818fa93.pdf 7154 Preoperative R0 Primary Tumor 01 0.3 1993 6th NO YES 78 4 Current reformed smoker for < or = 15 years Lung A DECEASED 2003 1948 dbe8b05d-9b51-4d93-9e04-9609a5dd4cb8 dbe8b05d-9b51-4d93-9e04-9609a5dd4cb8 TCGA-78-7154-01A-11D-2037-05 TCGA-78-7154-01A-11D-2035-01 dbe8b05d-9b51-4d93-9e04-9609a5dd4cb8 TCGA-78-7154-01A-11D-2035-01 TCGA-78-7154-01A-13-2192-20 +TCGA-78-7155-01 2.53 0.81 none none none none N N p.Q432H, p.K754I, p.G901V none none 0.33 Squamoid none none none none none none none Solid predominant Adc Solid predominant Adc none 0 TCGA-78-7155-01 High C1-LUAD-enriched Cluster 5 squamous c3 RNA cluster 14 miRNA cluster 12 TCGA-78-7155 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung YES YES NO NO 68 L-Upper TCGA-78-7155-F16958 TCGA-78-7155 TCGA-78-7155-01A -24863 1171 0 209 0 NO NO Scheduled Follow-up Submission Progressive Disease 2011-9-28 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.7 NO NO Peripheral Lung 0.9 YES 48 No M0 N0 T2 Stage IB TCGA-78-7155.0a07b1a2-095d-4da1-ba4f-112169b62971.pdf 7155 Preoperative R0 Primary Tumor 01 0.7 2005 6th NO YES 78 4 Current reformed smoker for < or = 15 years Lung A DECEASED 2005 1957 ddb17f24-f233-40dc-bbbd-731e50d4fce4 ddb17f24-f233-40dc-bbbd-731e50d4fce4 TCGA-78-7155-01A-11D-2037-05 TCGA-78-7155-01A-11D-2035-01 ddb17f24-f233-40dc-bbbd-731e50d4fce4 TCGA-78-7155-01A-11D-2035-01 TCGA-78-7155-01A-13-2192-20 +TCGA-78-7156-01 1.98 0.8 none none none none N N none none none 0.4 Magnoid none none none none none none none Papillary predominant Adc Papillary predominant Adc p.G279fs 0 TCGA-78-7156-01 BRCA-LUAD+ C1-LUAD-enriched Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 5 TCGA-78-7156 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 62 TCGA-78-7156-F16982 TCGA-78-7156 TCGA-78-7156-01A -22720 976 0 1 NO NO Scheduled Follow-up Submission 2011-9-29 MALE Lung Adenocarcinoma Mixed Subtype No C34.9 8255/3 C34.9 YES 0.7 NO NO Peripheral Lung 1.1 84 No M1 N1 T4 Stage IV TCGA-78-7156.28b28933-7e87-4a7b-a17b-170e494d1a30.pdf 7156 Preoperative NO R0 Primary Tumor 01 0.6 1989 6th NO NO YES 78 3 Current reformed smoker for > 15 years Lung A DECEASED 2006 1961 e6aecb65-29f2-48de-a8a0-55b25fbafef1 e6aecb65-29f2-48de-a8a0-55b25fbafef1 TCGA-78-7156-01A-11D-2037-05 TCGA-78-7156-01A-11D-2035-01 e6aecb65-29f2-48de-a8a0-55b25fbafef1 TCGA-78-7156-01A-11D-2035-01 TCGA-78-7156-01A-13-2192-20 +TCGA-78-7158-01 2.09 0.92 none none none p.S37F N N p.L907M none none 0.44 Bronchioid none none none none none none none Micropapillary predom Adc Micropapillary predom Adc none 0 TCGA-78-7158-01 BRCA-LUAD+ C1-LUAD-enriched Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 3 TCGA-78-7158 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung NO NO 59 L-Lower TCGA-78-7158-F16166 TCGA-78-7158 TCGA-78-7158-01A -21742 179 0 132 1 NO NO Scheduled Follow-up Submission 2011-9-15 FEMALE Lung Adenocarcinoma Mixed Subtype No C34.3 8255/3 C34.3 YES 0.9 NO NO Peripheral Lung 1.1 YES 14 No M0 N2 T4 Stage IIIB TCGA-78-7158.1ac638bd-3da2-472d-90bf-1e100bfcdb19.pdf 7158 Preoperative WITH TUMOR Progressive Disease NO R1 Primary Tumor 01 0.5 2005 6th YES NO YES 78 4 Current reformed smoker for < or = 15 years Lung A DECEASED 2007 1963 cc748956-075e-4433-9640-274ee42bdba8 cc748956-075e-4433-9640-274ee42bdba8 TCGA-78-7158-01A-11D-2037-05 TCGA-78-7158-01A-11D-2035-01 cc748956-075e-4433-9640-274ee42bdba8 TCGA-78-7158-01A-11D-2035-01 TCGA-78-7158-01A-13-2192-20 +TCGA-78-7159-01 2.13 0.71 none none none none N N none none none 0.34 Magnoid none none none none none none none Acinar predominant Adc Acinar predominant Adc p.N259fs 0 TCGA-78-7159-01 High C1-LUAD-enriched Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 6 TCGA-78-7159 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 60 L-Upper TCGA-78-7159-F46103 TCGA-78-7159 TCGA-78-7159-01A -22261 0 1974 1 NO NO Scheduled Follow-up Submission 2013-8-4 FEMALE Lung Adenocarcinoma Mixed Subtype No C34.1 8255/3 C34.1 YES 1 NO NO Peripheral Lung 1.1 NO 21 No M0 NX T1 Stage IA TCGA-78-7159.abb2f0e8-b167-4ffb-a52d-2116d4a919c6.pdf 7159 Preoperative Complete Remission/Response NO R0 Primary Tumor 01 0.7 2007 6th NO NO YES 78 4 Current smoker Lung A LIVING 2008 1965 cc6ff65b-c9fe-4992-971c-3c9a61caeec1 cc6ff65b-c9fe-4992-971c-3c9a61caeec1 TCGA-78-7159-01A-11D-2037-05 TCGA-78-7159-01A-11D-2035-01 cc6ff65b-c9fe-4992-971c-3c9a61caeec1 TCGA-78-7159-01A-11D-2035-01 TCGA-78-7159-01A-13-2192-20 +TCGA-78-7160-01 3.23 0.17 none none none none Y Y none none p.P1240H 0.08 Magnoid none p.G12D none none none none none Micropapillary predom Adc Micropapillary predom Adc p.M51fs 0 TCGA-78-7160-01 Squamous C1-LUAD-enriched Low purity c2 squamous c3 LUAD-like c10 miRNA cluster 5 TCGA-78-7160 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 61 R-Lower TCGA-78-7160-F46139 TCGA-78-7160 TCGA-78-7160-01A -22385 697 0 678 1 NO NO Scheduled Follow-up Submission 2013-8-4 MALE Lung Adenocarcinoma Mixed Subtype No C34.3 8255/3 C34.3 YES 0.8 NO NO Central Lung 0.8 NO 43.8 No M1 N2 T4 Stage IV TCGA-78-7160.a654d277-9f15-4e8b-b1a5-93fd802c5d36.pdf 7160 Preoperative Complete Remission/Response NO NO R0 Primary Tumor 01 0.7 1998 6th YES NO YES 78 4 Current reformed smoker for < or = 15 years Lung A DECEASED 2008 1963 d41fd6e3-f45d-40df-86bc-7fb9d2e3cdd3 d41fd6e3-f45d-40df-86bc-7fb9d2e3cdd3 TCGA-78-7160-01A-11D-2037-05 TCGA-78-7160-01A-11D-2035-01 d41fd6e3-f45d-40df-86bc-7fb9d2e3cdd3 TCGA-78-7160-01A-11D-2035-01 TCGA-78-7160-01A-13-2192-20 +TCGA-78-7161-01 none none none none Y Y none none none Magnoid none p.G12V none none none none none Acinar predominant Adc Acinar predominant Adc p.G155_splice 0 TCGA-78-7161-01 High C1-LUAD-enriched Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 6 TCGA-78-7161 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung NO 69 L-Upper TCGA-78-7161-F46153 TCGA-78-7161 TCGA-78-7161-01A -25294 291 0 215 162 1 YES NO Scheduled Follow-up Submission Progressive Disease 2013-8-23 FEMALE Lung Adenocarcinoma Mixed Subtype No C34.1 8255/3 C34.1 YES 0.6 NO NO Peripheral Lung 1 NO Locoregional Recurrence YES 27.8 No M0 N0 T3 Stage IIB TCGA-78-7161.0a86e747-a5e2-4d91-8ebd-6ef80e11cbc8.pdf 7161 Preoperative WITH TUMOR Progressive Disease Biopsy with Histologic Confirmation NO NO R1 Primary Tumor 01 0.5 1998 7th YES NO YES 78 4 Current reformed smoker for < or = 15 years Lung A DECEASED 2011 1961 3bc1fe5d-5eff-46f2-adf6-e6bc8b7e8f90 3bc1fe5d-5eff-46f2-adf6-e6bc8b7e8f90 TCGA-78-7161-01A-11D-2037-05 TCGA-78-7161-01A-11D-2035-01 3bc1fe5d-5eff-46f2-adf6-e6bc8b7e8f90 TCGA-78-7161-01A-11D-2035-01 TCGA-78-7161-01A-13-2192-20 +TCGA-78-7162-01 none none none none N N none none none Bronchioid none none none none none none none Adenocarcinoma, NOS Adenocarcinoma, NOS none 0 TCGA-78-7162-01 BRCA-LUAD+ C1-LUAD-enriched Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 5 TCGA-78-7162 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung YES NO NO NO 75 L-Upper TCGA-78-7162-F17127 TCGA-78-7162 TCGA-78-7162-01A -27593 3169 0 2740 0 NO NO Additional New Tumor Event 2011-10-3 MALE Lung Adenocarcinoma Mixed Subtype No C34.1 8255/3 C34.1 YES 0.6 NO NO Peripheral Lung 0.7 YES 12 No M0 N0 T1 Stage IA TCGA-78-7162.41e3d123-0a90-43e4-80b7-7be47de9fd16.pdf 7162 Preoperative NO R0 Primary Tumor 01 0.5 6th NO NO YES 78 2 Current smoker Lung A DECEASED 1991 1940 01a75809-bb4e-42f3-a3ca-25e4d1ca37a3 01a75809-bb4e-42f3-a3ca-25e4d1ca37a3 TCGA-78-7162-01A-21D-2064-05 TCGA-78-7162-01A-21D-2062-01 01a75809-bb4e-42f3-a3ca-25e4d1ca37a3 TCGA-78-7162-01A-21D-2062-01 TCGA-78-7162-01A-23-2192-20 +TCGA-78-7163-01 2.56 0.7 none Y none none none Y Y none none none 0.29 Bronchioid none none none none none none none Invasive mucinous Invasive mucinous none 0 TCGA-78-7163-01 Kirc+ C1-LUAD-enriched Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 4 TCGA-78-7163 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 60 R-Lower TCGA-78-7163-F46140 TCGA-78-7163 TCGA-78-7163-01A -22002 0 7248 1 NO NO Scheduled Follow-up Submission 2013-8-4 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 0.7 NO NO Peripheral Lung 1.2 NO 41 No M0 N0 T2 Stage IB TCGA-78-7163.40948ca8-3075-47ef-a679-94ea5dc29a08.pdf 7163 Preoperative TUMOR FREE Complete Remission/Response NO NO R0 Primary Tumor 01 0.4 1991 6th NO NO YES 78 4 Current reformed smoker for < or = 15 years Lung A LIVING 1992 1950 5deb51ff-a271-4fc4-90b6-3bdb0c508967 5deb51ff-a271-4fc4-90b6-3bdb0c508967 TCGA-78-7163-01A-12D-2064-05 TCGA-78-7163-01A-12D-2062-01 5deb51ff-a271-4fc4-90b6-3bdb0c508967 TCGA-78-7163-01A-12D-2062-01 TCGA-78-7163-01A-23-2192-20 +TCGA-78-7166-01 2.04 0.63 none none none none Y Y none none none 0.31 Magnoid none p.G12C none none none none none Invasive mucinous Invasive mucinous p.G56V, p.K78E 0 TCGA-78-7166-01 Iq C1-LUAD-enriched Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 4 TCGA-78-7166 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung NO NO 84 L-Lower TCGA-78-7166-F16954 TCGA-78-7166 TCGA-78-7166-01A -30869 258 0 2 NO NO Scheduled Follow-up Submission 2011-9-28 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 0.6 NO NO Central Lung 0.9 NO 38 Yes M0 N1 T2 Stage IIB TCGA-78-7166.e2ddc3ba-8151-4f3e-9219-cd3147ea5029.pdf 7166 Preoperative YES R0 Primary Tumor 01 0.4 1972 6th NO NO YES 78 3 Current reformed smoker for > 15 years Lung A DECEASED 2002 1934 3d86f6ec-741c-4da5-836e-28b029b32706 3d86f6ec-741c-4da5-836e-28b029b32706 TCGA-78-7166-01A-12D-2064-05 TCGA-78-7166-01A-12D-2062-01 3d86f6ec-741c-4da5-836e-28b029b32706 TCGA-78-7166-01A-12D-2062-01 TCGA-78-7166-01A-23-2192-20 +TCGA-78-7167-01 none none none none Y Y none none none Magnoid none p.G12F none none none none none Lepidic predominant Adc Lepidic predominant Adc p.R331fs 0 TCGA-78-7167-01 BRCA-LUAD+ C1-LUAD-enriched Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 6 TCGA-78-7167 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung NO NO NO NO 77 TCGA-78-7167-F17172 TCGA-78-7167 TCGA-78-7167-01A -28295 2681 0 726 1 NO NO Scheduled Follow-up Submission Progressive Disease 2011-10-4 MALE Lung Papillary Adenocarcinoma No C34.9 8260/3 C34.9 YES 0.6 NO NO Peripheral Lung 0.7 YES 64 No M1 N0 T2 Stage IV TCGA-78-7167.a164a9ae-8f90-4deb-83ce-8f111897e5d6.pdf 7167 Preoperative WITH TUMOR NO R0 Primary Tumor 01 0.6 6th NO NO YES 78 2 Current smoker Lung A DECEASED 2002 1937 30642287-a06f-46e0-8e37-839935a2d3dc 30642287-a06f-46e0-8e37-839935a2d3dc TCGA-78-7167-01A-11D-2064-05 TCGA-78-7167-01A-11D-2062-01 30642287-a06f-46e0-8e37-839935a2d3dc TCGA-78-7167-01A-11D-2062-01 TCGA-78-7167-01A-13-2192-20 +TCGA-78-7220-01 TCGA-78-7220-01 High Cluster 5 LUAD-like c10 miRNA cluster 4 TCGA-78-7220 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung NO YES NO NO 53 L-Upper TCGA-78-7220-F19298 TCGA-78-7220 TCGA-78-7220-01A -19480 807 0 531 0 NO NO Scheduled Follow-up Submission 2011-12-8 FEMALE Lung Adenocarcinoma Mixed Subtype No C34.1 8255/3 C34.1 YES 0.6 NO NO Peripheral Lung 0.7 YES 35 No M0 N2 T2 Stage IIIA TCGA-78-7220.b7e36c31-539e-4cab-81e3-23843b4c0068.pdf 7220 Preoperative WITH TUMOR YES R0 Primary Tumor 01 0.5 6th NO NO YES 78 2 Lung A DECEASED 2000 1965 aa29c7b0-8641-4a59-8b17-c007b3cb8726 aa29c7b0-8641-4a59-8b17-c007b3cb8726 TCGA-78-7220-01A-11D-2037-05 TCGA-78-7220-01A-11D-2035-01 aa29c7b0-8641-4a59-8b17-c007b3cb8726 TCGA-78-7220-01A-11D-2035-01 +TCGA-78-7535-01 1.53 0.75 none none none none N N none none none 0.46 Squamoid none none none none none none none Solid predominant Adc Solid predominant Adc p.L245_splice 0 TCGA-78-7535-01 BRCA-LUAD+ C1-LUAD-enriched Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 4 TCGA-78-7535 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung NO NO NO YES 45 L-Upper TCGA-78-7535-F20633 TCGA-78-7535 TCGA-78-7535-01A 809 -16571 949 0 809 0 NO NO Scheduled Follow-up Submission Progressive Disease 2012-1-19 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 1 NO NO 1.2 YES 35 No M0 N0 T2 Stage IB TCGA-78-7535.217e5c9a-950f-46c0-a022-5ece5205d9d4.pdf 7535 Preoperative WITH TUMOR Stable Disease NO R0 Primary Tumor 01 0.6 6th YES NO YES 78 2 Current smoker Lung A DECEASED 2000 1972 2cbd77bd-dece-4177-ace2-98d9d545b575 2cbd77bd-dece-4177-ace2-98d9d545b575 TCGA-78-7535-01A-11D-2064-05 TCGA-78-7535-01A-11D-2062-01 2cbd77bd-dece-4177-ace2-98d9d545b575 TCGA-78-7535-01A-11D-2062-01 TCGA-78-7535-01A-13-2192-20 +TCGA-78-7536-01 3.07 0.78 none none none none N N none none none 0.28 Magnoid none none none none none none p.E313* Solid predominant Adc Solid predominant Adc p.G279fs 0 TCGA-78-7536-01 High C1-LUAD-enriched Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 4 TCGA-78-7536 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung NO NO NO NO 69 R-Upper TCGA-78-7536-F20631 TCGA-78-7536 TCGA-78-7536-01A -25558 244 0 231 0 NO NO Scheduled Follow-up Submission Progressive Disease 2012-1-19 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.7 NO NO 1.1 YES 44 No M0 N2 T2 Stage IIIA TCGA-78-7536.543b5396-e92f-436e-93c5-1324b9171598.pdf 7536 Preoperative WITH TUMOR Progressive Disease YES R0 Primary Tumor 01 0.6 1993 6th NO NO YES 78 4 Current reformed smoker for < or = 15 years Lung A DECEASED 2001 1949 9334a61d-eb4f-4504-9f4d-b9d55a8733de 9334a61d-eb4f-4504-9f4d-b9d55a8733de TCGA-78-7536-01A-11D-2064-05 TCGA-78-7536-01A-11D-2062-01 9334a61d-eb4f-4504-9f4d-b9d55a8733de TCGA-78-7536-01A-11D-2062-01 TCGA-78-7536-01A-13-2192-20 +TCGA-78-7537-01 2.08 0.74 none p.G466V none none N Y none none none 0.36 Bronchioid none none none none none none none Papillary predominant Adc Papillary predominant Adc p.K175fs 0 TCGA-78-7537-01 Iq C1-LUAD-enriched Cluster 6 squamous c3 LUAD-like c10 miRNA c1uster 9 TCGA-78-7537 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 72 R-Upper TCGA-78-7537-F20455 TCGA-78-7537 TCGA-78-7537-01A -26610 1622 0 1 NO NO Scheduled Follow-up Submission 2012-1-13 MALE Lung Adenocarcinoma Mixed Subtype No C34.1 8255/3 C34.1 YES 0.6 NO NO 0.9 20 No M0 N0 T2 Stage IB TCGA-78-7537.0bb9490c-1fb1-4d36-85a4-435565e9db53.pdf 7537 Preoperative NO R0 Primary Tumor 01 0.5 1984 6th NO YES NO 78 3 Current reformed smoker for > 15 years Lung A DECEASED 2002 1944 a91960e0-f237-419e-aa57-f90ceb12fcde a91960e0-f237-419e-aa57-f90ceb12fcde TCGA-78-7537-01A-11D-2064-05 TCGA-78-7537-01A-11D-2062-01 a91960e0-f237-419e-aa57-f90ceb12fcde TCGA-78-7537-01A-11D-2062-01 TCGA-78-7537-01A-13-2192-20 +TCGA-78-7539-01 2.1 0.69 none none none none Y Y none none none 0.33 Bronchioid none p.G12C none none none none none Papillary predominant Adc Papillary predominant Adc none 0 TCGA-78-7539-01 High C1-LUAD-enriched Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 4 TCGA-78-7539 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung YES YES 75 R-Upper TCGA-78-7539-F46143 TCGA-78-7539 TCGA-78-7539-01A 688 -27445 0 791 688 1 NO NO Scheduled Follow-up Submission 2013-8-4 FEMALE Lung Adenocarcinoma Mixed Subtype No C34.1 8255/3 C34.1 YES 0.8 NO NO 0.9 NO Distant Metastasis YES 2.2 No M0 N0 T2b Stage IIA TCGA-78-7539.686bc9a9-71b6-4c27-a76d-4ca9713fbdbe.pdf 7539 Preoperative Complete Remission/Response Biopsy with Histologic Confirmation NO NO R0 Primary Tumor 01 0.7 1981 7th YES NO YES 78 3 Current smoker Lung A LIVING 2011 1953 479528a6-12ed-4e7b-8ca6-cf9fe6baa6de 479528a6-12ed-4e7b-8ca6-cf9fe6baa6de TCGA-78-7539-01A-11D-2064-05 TCGA-78-7539-01A-11D-2062-01 479528a6-12ed-4e7b-8ca6-cf9fe6baa6de TCGA-78-7539-01A-11D-2062-01 TCGA-78-7539-01A-13-2192-20 +TCGA-78-7540-01 2.02 0.58 none none none none Y Y none none none 0.29 Bronchioid none p.G12V none none none none none Invasive mucinous Invasive mucinous none 0 TCGA-78-7540-01 GBM C1-LUAD-enriched Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 5 TCGA-78-7540 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 66 L-Lower TCGA-78-7540-F46104 TCGA-78-7540 TCGA-78-7540-01A -24440 1197 0 881 0 NO NO Scheduled Follow-up Submission 2013-8-2 FEMALE Lung Bronchioloalveolar Carcinoma Mucinous No C34.3 8253/3 C34.3 YES 0.8 NO NO 1.3 NO No M0 N0 T2 Stage IB TCGA-78-7540.95cad21d-0a35-4ac7-9163-f5b7bb21e18d.pdf 7540 Preoperative Complete Remission/Response R0 Primary Tumor 01 0.5 6th NO YES 78 1 Lifelong Non-smoker Lung A DECEASED 1999 193873d4-f0ad-4e8d-918b-9beb83965483 193873d4-f0ad-4e8d-918b-9beb83965483 TCGA-78-7540-01A-11D-2064-05 TCGA-78-7540-01A-11D-2062-01 193873d4-f0ad-4e8d-918b-9beb83965483 TCGA-78-7540-01A-11D-2062-01 TCGA-78-7540-01A-13-2192-20 +TCGA-78-7542-01 3.49 0.44 none none none none N N none none none 0.17 Squamoid none none none none none none none Solid predominant Adc Solid predominant Adc none 0 TCGA-78-7542-01 High C2-Squamous-like Cluster 6 squamous c3 squamous-like c4 miRNA c1uster 9 TCGA-78-7542 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 56 R-Upper TCGA-78-7542-F20456 TCGA-78-7542 TCGA-78-7542-01A -20763 321 0 0 NO NO Scheduled Follow-up Submission 2012-1-13 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.8 NO NO 1 60 No M0 N0 T2 Stage IB TCGA-78-7542.07a2fac9-0532-442e-ae75-5a7cc5d298d4.pdf 7542 Preoperative R0 Primary Tumor 01 0.6 6th NO YES 78 2 Current smoker Lung A DECEASED 1993 1952 ff74b4c6-e938-4a40-ab1a-84525349a62e ff74b4c6-e938-4a40-ab1a-84525349a62e TCGA-78-7542-01A-21D-2064-05 TCGA-78-7542-01A-21D-2062-01 ff74b4c6-e938-4a40-ab1a-84525349a62e TCGA-78-7542-01A-21D-2062-01 TCGA-78-7542-01A-23-2192-20 +TCGA-78-7633-01 2.19 0.75 none p.G469L none none N Y none none none 0.35 Magnoid none none none none none none none Papillary predominant Adc Papillary predominant Adc none 0 TCGA-78-7633-01 Iq C1-LUAD-enriched Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 5 TCGA-78-7633 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 67 L-Upper TCGA-78-7633-F46157 TCGA-78-7633 TCGA-78-7633-01A -24713 1528 0 994 1450 57 0 NO NO Scheduled Follow-up Submission Progressive Disease 2013-8-29 MALE Lung Adenocarcinoma Mixed Subtype No C34.1 8255/3 C34.1 YES 0.9 NO NO 1 NO Locoregional Recurrence YES 94 Yes M0 N0 T2 Stage IB TCGA-78-7633.b1031a29-f3af-4f4f-a3d2-1be59c524222.pdf 7633 Preoperative WITH TUMOR 100 Complete Remission/Response Biopsy with Histologic Confirmation YES R0 Primary Tumor 01 0.5 2002 6th NO YES 78 4 Current reformed smoker for < or = 15 years Lung A DECEASED 2009 1955 006eb1bc-b058-49b9-8c2d-3c50f2427d95 006eb1bc-b058-49b9-8c2d-3c50f2427d95 TCGA-78-7633-01A-11D-2064-05 TCGA-78-7633-01A-11D-2062-01 006eb1bc-b058-49b9-8c2d-3c50f2427d95 TCGA-78-7633-01A-11D-2062-01 TCGA-78-7633-01A-13-2192-20 +TCGA-78-8640-01 TCGA-78-8640-01 TCGA-78-8640 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 59 L-Upper TCGA-78-8640-F70500 TCGA-78-8640 TCGA-78-8640-01A -21832 0 7062 0 NO NO Scheduled Follow-up Submission 2015-3-25 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.7 NO NO Peripheral Lung 0.8 NO NO 45 No M0 N1 T1 Stage IIA TCGA-78-8640.b39fa23e-bac4-49c9-919b-6e6d4cb8d90d.pdf 8640 Preoperative TUMOR FREE 73 66 Complete Remission/Response YES NO R0 Primary Tumor 01 0.3 6th NO NO YES 78 2 Lung A LIVING 1994 1949 5cb476d8-eae8-453c-8157-fdb71b4d5efa 5cb476d8-eae8-453c-8157-fdb71b4d5efa TCGA-78-8640-01A-11D-2398-05 TCGA-78-8640-01A-11D-2389-01 5cb476d8-eae8-453c-8157-fdb71b4d5efa TCGA-78-8640-01A-11D-2389-01 +TCGA-78-8648-01 TCGA-78-8648-01 TCGA-78-8648 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 58 R-Upper TCGA-78-8648 TCGA-78-8648-01A -21443 1209 0 69 2 NO NO 2012-10-23 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.8 NO NO Peripheral Lung 1.2 YES 45 No M0 N0 T3 Stage IIB TCGA-78-8648.a439594e-b536-4bd3-a77a-fb50304de9a2.pdf 8648 Preoperative 83 70 YES NO R0 Primary Tumor 01 0.4 6th NO NO YES 78 2 Lung A DECEASED 2002 1971 42ab0bc6-16cb-43e4-9729-9b947f2e6432 42ab0bc6-16cb-43e4-9729-9b947f2e6432 TCGA-78-8648-01A-11D-2398-05 TCGA-78-8648-01A-11D-2389-01 42ab0bc6-16cb-43e4-9729-9b947f2e6432 TCGA-78-8648-01A-11D-2389-01 +TCGA-78-8655-01 TCGA-78-8655-01 TCGA-78-8655 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 77 L-Lower TCGA-78-8655-F46154 TCGA-78-8655 TCGA-78-8655-01A -28379 0 2360 93 0 NO NO Scheduled Follow-up Submission 2013-8-28 FEMALE Lung Adenocarcinoma Mixed Subtype No C34.3 8255/3 C34.3 YES 0.6 NO NO Peripheral Lung 0.8 YES 10 No M0 N0 T1 Stage IA TCGA-78-8655.4290edb6-487a-4c0b-8569-aae7245a037b.pdf 8655 Preoperative 70 128 Complete Remission/Response YES NO R0 Primary Tumor 01 0.5 2001 6th NO NO YES 78 4 Lung A LIVING 2003 1981 a0e0a895-ce81-44a6-a21e-453e727acdbb a0e0a895-ce81-44a6-a21e-453e727acdbb TCGA-78-8655-01A-11D-2398-05 TCGA-78-8655-01A-11D-2389-01 a0e0a895-ce81-44a6-a21e-453e727acdbb TCGA-78-8655-01A-11D-2389-01 +TCGA-78-8660-01 TCGA-78-8660-01 TCGA-78-8660 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 69 R-Lower TCGA-78-8660 TCGA-78-8660-01A -25422 321 0 87 1 NO NO 2012-10-23 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 0.8 NO NO Peripheral Lung 1.1 YES 11 Yes, History of Prior Malignancy M0 N1 T2 Stage IIB TCGA-78-8660.2c53d65a-d792-41bc-a6c3-cd2d079a5386.pdf 8660 Preoperative WITH TUMOR 72 108 YES YES R0 Primary Tumor 01 0.5 2005 6th NO NO YES 78 4 Lung A DECEASED 2005 1954 664ffa40-4508-40ae-9505-84a10136b362 664ffa40-4508-40ae-9505-84a10136b362 TCGA-78-8660-01A-11D-2398-05 TCGA-78-8660-01A-11D-2389-01 664ffa40-4508-40ae-9505-84a10136b362 TCGA-78-8660-01A-11D-2389-01 +TCGA-78-8662-01 TCGA-78-8662-01 TCGA-78-8662 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 53 R-Upper TCGA-78-8662 TCGA-78-8662-01A -19563 3361 0 76 0 NO NO 2012-10-23 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES NO NO Peripheral Lung YES 45 No M0 N0 T2 Stage IB TCGA-78-8662.fb1023d3-d221-4dbb-80f9-0c3dd7b0750f.pdf 8662 Preoperative 64 96 Complete Remission/Response YES NO R0 Primary Tumor 01 6th NO NO YES 78 2 Lung A DECEASED 2000 1964 4c893780-d86b-4b01-a423-ca099e4fc007 4c893780-d86b-4b01-a423-ca099e4fc007 TCGA-78-8662-01A-11D-2398-05 TCGA-78-8662-01A-11D-2389-01 4c893780-d86b-4b01-a423-ca099e4fc007 TCGA-78-8662-01A-11D-2389-01 +TCGA-79-5596-01 TCGA-79-5596-01 Squamous C2-Squamous-like Cluster 13 (HNSC-LUSC) squamous c3 squamous-like c4 miRNA cluster 11 TCGA-79-5596 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung L-Upper TCGA-79-5596-F15882 TCGA-79-5596 TCGA-79-5596-01A 1 2011-8-12 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.7 NO Peripheral Lung 1.2 YES 40 No M0 N1 T3 Stage IIIA TCGA-79-5596.98472d25-91fd-4326-b8cc-809adcc9ebc3.pdf 5596 Preoperative TUMOR FREE NO R0 Primary Tumor 01 0.6 2006 6th NO NO YES 79 4 Lung A LIVING 2006 5f242fff-ab9b-4e49-89c2-3679974c2112 5f242fff-ab9b-4e49-89c2-3679974c2112 TCGA-79-5596-01A-31D-1947-05 TCGA-79-5596-01A-31D-1943-01 5f242fff-ab9b-4e49-89c2-3679974c2112 TCGA-79-5596-01A-31D-1943-01 TCGA-79-5596-01A-11-2194-20 +TCGA-80-5607-01 2.02 0.49 none p.V600E none none N Y none none none 0.24 Bronchioid none none none none none p.E545K none Acinar predominant Adc Acinar predominant Adc none 0 TCGA-80-5607-01 Kirc+ C1-LUAD-enriched Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 4 TCGA-80-5607 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung NO NO NO NO L-Upper TCGA-80-5607-F15867 TCGA-80-5607 TCGA-80-5607-01A 1 2011-8-15 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.8 NO Peripheral Lung 1.4 YES 15 Yes M0 N1 T2 Stage IIB TCGA-80-5607.6c775590-55a2-4e85-b511-afd2fa76cabc.pdf 5607 Preoperative WITH TUMOR NO R0 Primary Tumor 01 0.6 1985 6th NO NO YES 80 3 Current reformed smoker for > 15 years Lung A LIVING 2007 1965 0ddf256d-70a4-4dfc-ade0-1f51a4c115a3 0ddf256d-70a4-4dfc-ade0-1f51a4c115a3 TCGA-80-5607-01A-31D-1947-05 TCGA-80-5607-01A-31D-1943-01 0ddf256d-70a4-4dfc-ade0-1f51a4c115a3 TCGA-80-5607-01A-31D-1943-01 TCGA-80-5607-01A-11-2190-20 +TCGA-80-5608-01 3.11 0.48 none none none none Y Y none none p.H1303Q 0.19 Magnoid none p.G12A none none none none none Acinar predominant Adc Acinar predominant Adc p.K62* 0 TCGA-80-5608-01 High C1-LUAD-enriched Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 6 TCGA-80-5608 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung R-Upper TCGA-80-5608-F72033 TCGA-80-5608 TCGA-80-5608-01A 2832 1 Scheduled Follow-up Submission 2015-4-2 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.7 NO Peripheral Lung 1.2 NO NO 26 No M0 N0 T1 Stage IA TCGA-80-5608.a4f3469b-1aae-424f-9135-7e6bfcc08d03.pdf 5608 Preoperative TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 0.5 6th NO NO YES 80 2 Current smoker Lung A LIVING 1972 b93762e1-ee51-4768-8343-f49e241fd397 b93762e1-ee51-4768-8343-f49e241fd397 TCGA-80-5608-01A-31D-1947-05 TCGA-80-5608-01A-31D-1943-01 b93762e1-ee51-4768-8343-f49e241fd397 TCGA-80-5608-01A-31D-1943-01 TCGA-80-5608-01A-11-2190-20 +TCGA-80-5611-01 TCGA-80-5611-01 BRCA-LUAD+ C1-LUAD-enriched Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 4 mutation c1uster 9 TCGA-80-5611 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung L-Upper TCGA-80-5611-F72034 TCGA-80-5611 TCGA-80-5611-01A 2595 0 Scheduled Follow-up Submission 2015-4-2 MALE Lung Solid Pattern Predominant Adenocarcinoma No C34.1 8230/3 C34.1 YES 0.8 NO Peripheral Lung 1.2 NO NO 60 Yes M0 N0 T2 Stage IB TCGA-80-5611.42e15634-a742-4e7c-a795-e5fe6fd7b9aa.pdf 5611 Preoperative TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 0.6 2008 6th NO NO YES 80 4 Lung A LIVING 7f12f566-ca68-4528-b704-b3ef4cb9ba09 TCGA-80-5611-01A-01D-1625-08 7f12f566-ca68-4528-b704-b3ef4cb9ba09 TCGA-80-5611-01A-01D-1626-05 TCGA-80-5611-01A-01D-1624-01 7f12f566-ca68-4528-b704-b3ef4cb9ba09 TCGA-80-5611-01A-01D-1624-01 TCGA-80-5611-01A-31-2191-20 +TCGA-83-5908-01 TCGA-83-5908-01 Squamous C1-LUAD-enriched Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 4 TCGA-83-5908 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung NO NO NO NO 59 L-Upper TCGA-83-5908-F12196 TCGA-83-5908 TCGA-83-5908-01A -21760 0 824 1 NO NO Stable Disease 2011-5-25 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 1 NO 90 NO 1.9 NO 69 No M0 N0 T1 Stage IA TCGA-83-5908.bf81e5a3-26db-4476-b553-38d4f6897309.pdf 5908 Other TUMOR FREE Stable Disease NO R0 Primary Tumor 01 0.6 2007 6th NO YES NO 83 4 Lung A LIVING 2009 1962 772f9a82-9a03-4bf0-b7ce-877b15e3d017 772f9a82-9a03-4bf0-b7ce-877b15e3d017 TCGA-83-5908-01A-21D-2285-05 TCGA-83-5908-01A-21D-2283-01 772f9a82-9a03-4bf0-b7ce-877b15e3d017 TCGA-83-5908-01A-21D-2283-01 TCGA-83-5908-01A-31-2191-20 +TCGA-85-6175-01 TCGA-85-6175-01 High C2-Squamous-like Cluster 5 squamous c3 squamous-like c4 miRNA cluster 5 mutation c1uster 9 TCGA-85-6175 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 63 L-Upper TCGA-85-6175-F29248 TCGA-85-6175 TCGA-85-6175-01A -23228 294 0 0 NO NO Scheduled Follow-up Submission Stable Disease 2012-3-13 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 1.3 NO NO Central Lung 2.1 NO No M0 N0 T3 Stage IIB TCGA-85-6175.616d5519-7f8d-4eb0-b78a-6a90c84616ff.pdf 6175 WITH TUMOR Stable Disease NO NO R0 Primary Tumor 01 0.3 7th NO YES NO 85 1 Lung A DECEASED 2010 f5e09ce5-d3df-4c22-8607-63535c2d4611 TCGA-85-6175-01A-11D-1817-08 f5e09ce5-d3df-4c22-8607-63535c2d4611 TCGA-85-6175-01A-11D-1818-05 TCGA-85-6175-01A-11D-1816-01 f5e09ce5-d3df-4c22-8607-63535c2d4611 TCGA-85-6175-01A-11D-1816-01 TCGA-85-6175-01A-13-2194-20 +TCGA-85-6560-01 TCGA-85-6560-01 High C1-LUAD-enriched BRCA CIMP c7 squamous c3 RNA cluster 2 miRNA cluster 5 mutation cluster 2 TCGA-85-6560 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 59 R-Upper TCGA-85-6560-F66121 TCGA-85-6560 TCGA-85-6560-01A -21768 0 1259 0 Scheduled Follow-up Submission Complete Remission/Response 2014-10-2 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 1.2 NO 90 NO Peripheral Lung 2.4 NO NO 40 No M0 N1 T1b Stage IIA TCGA-85-6560.de1a9413-405b-4f15-ba7f-062ae63ea44b.pdf 6560 Post-Adjuvant Therapy TUMOR FREE Complete Remission/Response NO NO R0 Primary Tumor 01 0.4 2011 7th YES YES NO 85 4 Lung A LIVING 2011 1970 b6b63f14-21a2-456c-895a-a8cf032b729a TCGA-85-6560-01A-11D-1817-08 b6b63f14-21a2-456c-895a-a8cf032b729a TCGA-85-6560-01A-11D-1818-05 TCGA-85-6560-01A-11D-1816-01 b6b63f14-21a2-456c-895a-a8cf032b729a TCGA-85-6560-01A-11D-1816-01 TCGA-85-6560-01A-13-2194-20 +TCGA-85-6561-01 TCGA-85-6561-01 Squamous C2-Squamous-like Cluster 13 (HNSC-LUSC) squamous c3 squamous-like c4 miRNA cluster 5 mutation cluster 11 TCGA-85-6561 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 66 R-Upper TCGA-85-6561-F65767 TCGA-85-6561 TCGA-85-6561-01A -24234 0 1224 0 Scheduled Follow-up Submission Complete Remission/Response 2014-9-30 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 2.2 NO 100 NO Central Lung 2.6 NO NO 35 No M0 NX T2a Stage IB TCGA-85-6561.66456b4b-5859-4045-91e1-5d528c1cee18.pdf 6561 Post-Adjuvant Therapy TUMOR FREE Complete Remission/Response NO YES R0 Primary Tumor 01 0.4 2000 7th YES YES NO 85 4 Lung A LIVING 2011 1975 117806c9-4d1c-4b96-8f94-2fd3720d4609 TCGA-85-6561-01A-11D-1817-08 117806c9-4d1c-4b96-8f94-2fd3720d4609 TCGA-85-6561-01A-11D-1818-05 TCGA-85-6561-01A-11D-1816-01 117806c9-4d1c-4b96-8f94-2fd3720d4609 TCGA-85-6561-01A-11D-1816-01 TCGA-85-6561-01A-13-2194-20 +TCGA-85-6798-01 TCGA-85-6798-01 Squamous C2-Squamous-like Cluster 13 (HNSC-LUSC) squamous c3 squamous-like c4 miRNA cluster 4 TCGA-85-6798 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung NO NO NO 57 R-Upper TCGA-85-6798-F65759 TCGA-85-6798 TCGA-85-6798-01A -20837 195 0 34 180 Scheduled Follow-up Submission Progressive Disease 2014-9-30 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 2 NO NO Central Lung 3 NO Distant Metastasis YES 35 No M0 N1 T3 Stage IIIA TCGA-85-6798.5aa6ff8c-db98-4b5b-a8a6-d924730f1b77.pdf 6798 WITH TUMOR Complete Remission/Response Convincing Imaging NO NO R0 Primary Tumor 01 0.2 7th YES YES NO 85 2 Lung A DECEASED 2011 1976 63dc6159-f7a9-4ccb-86d0-ac495ebfadca 63dc6159-f7a9-4ccb-86d0-ac495ebfadca TCGA-85-6798-01A-11D-1947-05 TCGA-85-6798-01A-11D-1943-01 63dc6159-f7a9-4ccb-86d0-ac495ebfadca TCGA-85-6798-01A-11D-1943-01 TCGA-85-6798-01A-13-2194-20 +TCGA-85-7696-01 TCGA-85-7696-01 Squamous Cluster 13 (HNSC-LUSC) squamous c3 miRNA cluster 4 TCGA-85-7696 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 64 L-Upper TCGA-85-7696-F66122 TCGA-85-7696 TCGA-85-7696-01A -23413 0 1111 0 Scheduled Follow-up Submission Complete Remission/Response 2014-10-2 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 1.5 NO 100 NO Central Lung 2.3 NO NO 30 No M0 N0 T1 Stage IA TCGA-85-7696.79ad4a6b-d044-483e-ab53-b6d9badc2f51.pdf 7696 Other TUMOR FREE Complete Remission/Response NO NO R0 Primary Tumor 01 0.5 2010 7th NO YES NO 85 4 Lung A LIVING 2011 1970 923e19e4-d166-4950-b763-259603ded444 923e19e4-d166-4950-b763-259603ded444 TCGA-85-7696-01A-11D-2123-05 TCGA-85-7696-01A-11D-2121-01 923e19e4-d166-4950-b763-259603ded444 TCGA-85-7696-01A-11D-2121-01 TCGA-85-7696-01A-13-2195-20 +TCGA-85-7697-01 TCGA-85-7697-01 Squamous Cluster 5 squamous c3 miRNA cluster 11 TCGA-85-7697 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 49 L-Upper TCGA-85-7697-F65976 TCGA-85-7697 TCGA-85-7697-01A -17921 0 1063 0 Scheduled Follow-up Submission Complete Remission/Response 2014-10-1 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 1 NO 100 NO Central Lung 1.7 NO NO 30 No M0 N0 T3 Stage IIB TCGA-85-7697.f0531cc6-1691-4c66-8b6c-dd260f7ef1ac.pdf 7697 Other TUMOR FREE Complete Remission/Response NO NO R0 Primary Tumor 01 0.2 7th YES YES NO 85 3 Lung A LIVING 2011 1981 b4561112-1099-48a5-9bf9-beb2220cf597 b4561112-1099-48a5-9bf9-beb2220cf597 TCGA-85-7697-01A-11D-2123-05 TCGA-85-7697-01A-11D-2121-01 b4561112-1099-48a5-9bf9-beb2220cf597 TCGA-85-7697-01A-11D-2121-01 TCGA-85-7697-01A-13-2195-20 +TCGA-85-7698-01 TCGA-85-7698-01 Squamous Cluster 13 (HNSC-LUSC) squamous c3 miRNA cluster 4 TCGA-85-7698 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung YES NO NO 48 R-Upper TCGA-85-7698-F65984 TCGA-85-7698 TCGA-85-7698-01A -17651 0 952 650 0 Scheduled Follow-up Submission Complete Remission/Response 2014-10-15 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 1.5 NO 100 NO Central Lung 2.5 NO Distant Metastasis YES 44 No M0 N0 T1b Stage IA TCGA-85-7698.9e446be3-1696-4309-8e03-e49622fe01d5.pdf 7698 Other TUMOR FREE Complete Remission/Response Convincing Imaging NO NO R0 Primary Tumor 01 0.4 7th NO YES NO 85 3 Lung A LIVING 2011 1967 0ab02d97-2058-47bc-bc0d-3ec662c0b2d6 0ab02d97-2058-47bc-bc0d-3ec662c0b2d6 TCGA-85-7698-01A-11D-2123-05 TCGA-85-7698-01A-11D-2121-01 0ab02d97-2058-47bc-bc0d-3ec662c0b2d6 TCGA-85-7698-01A-11D-2121-01 TCGA-85-7698-01A-13-2195-20 +TCGA-85-7699-01 TCGA-85-7699-01 Squamous Cluster 13 (HNSC-LUSC) squamous c3 miRNA cluster 4 TCGA-85-7699 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung YES NO NO 73 L-Upper TCGA-85-7699-F65987 TCGA-85-7699 TCGA-85-7699-01A -26965 1001 0 1 760 Scheduled Follow-up Submission Progressive Disease 2014-10-15 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 1.3 NO NO Central Lung 1.9 NO Distant Metastasis YES 74 No M0 N0 T4 Stage IIIA TCGA-85-7699.c95b2907-7c16-4f93-81ff-d1f3aadcd413.pdf 7699 WITH TUMOR Complete Remission/Response Convincing Imaging NO NO R0 Primary Tumor 01 0.3 1990 7th YES YES NO 85 3 Lung A DECEASED 2011 1953 c9016384-8eed-48c1-9fb0-cdd96cd66b81 c9016384-8eed-48c1-9fb0-cdd96cd66b81 TCGA-85-7699-01A-11D-2123-05 TCGA-85-7699-01A-11D-2121-01 c9016384-8eed-48c1-9fb0-cdd96cd66b81 TCGA-85-7699-01A-11D-2121-01 TCGA-85-7699-01A-13-2195-20 +TCGA-85-7710-01 TCGA-85-7710-01 Squamous C2-Squamous-like Cluster 13 (HNSC-LUSC) squamous c3 squamous-like c4 miRNA cluster 4 TCGA-85-7710 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 59 L-Lower TCGA-85-7710-F53598 TCGA-85-7710 TCGA-85-7710-01A -21790 0 42 0 Scheduled Follow-up Submission Complete Remission/Response 2013-12-12 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 1.2 NO 100 NO 1.6 YES NO 45 No M0 N0 T1b Stage IA TCGA-85-7710.b20f51fd-6a9b-4a13-ae9c-af25d60c9bbd.pdf 7710 Post-Adjuvant Therapy TUMOR FREE Complete Remission/Response NO NO Primary Tumor 01 0.3 7th NO YES NO 85 2 Lung A LIVING 2011 1965 1c01b4ed-b807-4321-aa93-a26792f6283a 1c01b4ed-b807-4321-aa93-a26792f6283a TCGA-85-7710-01A-11D-2123-05 TCGA-85-7710-01A-11D-2121-01 1c01b4ed-b807-4321-aa93-a26792f6283a TCGA-85-7710-01A-11D-2121-01 TCGA-85-7710-01A-13-2195-20 +TCGA-85-7710-11 TCGA-85-7710-11 C2-Squamous-like TCGA-85-7710 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 59 L-Lower TCGA-85-7710-F53598 TCGA-85-7710 TCGA-85-7710-11A -21790 0 42 0 Scheduled Follow-up Submission Complete Remission/Response 2013-12-12 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 1.2 NO 100 NO 1.5 YES NO 45 No M0 N0 T1b Stage IA 7710 Post-Adjuvant Therapy TUMOR FREE Complete Remission/Response NO NO Solid Tissue Normal 11 0.5 7th NO YES NO 85 2 Lung A LIVING 2011 1965 dc79421f-367f-4be3-97ec-ea1dbb1e554c dc79421f-367f-4be3-97ec-ea1dbb1e554c dc79421f-367f-4be3-97ec-ea1dbb1e554c +TCGA-85-7843-01 TCGA-85-7843-01 Squamous Cluster 13 (HNSC-LUSC) squamous c3 miRNA cluster 11 TCGA-85-7843 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 50 L-Upper TCGA-85-7843-F40632 TCGA-85-7843 TCGA-85-7843-01A -18353 0 35 2 Scheduled Follow-up Submission 2013-2-26 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 1 NO 80 NO Central Lung 1.5 YES 35 No M0 N1 T2a Stage IIA TCGA-85-7843.e48c2d72-9664-44cf-9d54-684490e86544.pdf 7843 NO R0 Primary Tumor 01 0.3 7th YES NO 85 2 Lung A LIVING 2011 1980 ca5c5719-d6af-46a4-8abd-114cef627fc2 ca5c5719-d6af-46a4-8abd-114cef627fc2 TCGA-85-7843-01A-11D-2123-05 TCGA-85-7843-01A-11D-2121-01 ca5c5719-d6af-46a4-8abd-114cef627fc2 TCGA-85-7843-01A-11D-2121-01 TCGA-85-7843-01A-13-2195-20 +TCGA-85-7844-01 TCGA-85-7844-01 Squamous C2-Squamous-like Cluster 13 (HNSC-LUSC) squamous c3 squamous-like c4 miRNA cluster 4 TCGA-85-7844 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung NO 71 L-Upper TCGA-85-7844-F36492 TCGA-85-7844 TCGA-85-7844-01A -26141 0 911 0 NO Scheduled Follow-up Submission Complete Remission/Response 2012-10-31 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.8 NO 100 NO Central Lung 1.8 NO NO 40 No M0 N0 T2a Stage IB TCGA-85-7844.e6642481-1722-4f52-b411-8a2d06c68f98.pdf 7844 Other TUMOR FREE Complete Remission/Response NO NO R0 Primary Tumor 01 0.4 7th NO YES NO 85 2 Lung A LIVING 2011 1970 24a12bfa-0238-49c3-abe7-450402cce27c 24a12bfa-0238-49c3-abe7-450402cce27c TCGA-85-7844-01A-11D-2123-05 TCGA-85-7844-01A-11D-2121-01 24a12bfa-0238-49c3-abe7-450402cce27c TCGA-85-7844-01A-11D-2121-01 TCGA-85-7844-01A-13-2195-20 +TCGA-85-7950-01 TCGA-85-7950-01 Squamous C2-Squamous-like Cluster 5 squamous c3 squamous-like c4 miRNA cluster 4 TCGA-85-7950 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 46 L-Upper TCGA-85-7950-F65982 TCGA-85-7950 TCGA-85-7950-01A -16975 0 576 0 NO Scheduled Follow-up Submission Complete Remission/Response 2014-10-1 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 1.8 NO 100 NO Central Lung 2.7 NO NO 27 No M0 N0 T2a Stage IB TCGA-85-7950.1664b418-9f16-426a-b9dd-279995f3f8c1.pdf 7950 Other TUMOR FREE Complete Remission/Response NO NO RX Primary Tumor 01 0.5 7th NO YES NO 85 2 Lung A LIVING 2011 1984 15746ad6-9014-45b3-841f-3a3f39bc2f84 15746ad6-9014-45b3-841f-3a3f39bc2f84 TCGA-85-7950-01A-11D-2185-05 TCGA-85-7950-01A-11D-2183-01 15746ad6-9014-45b3-841f-3a3f39bc2f84 TCGA-85-7950-01A-11D-2183-01 TCGA-85-7950-01A-13-2195-20 +TCGA-85-8048-01 TCGA-85-8048-01 High Cluster 5 miRNA cluster 4 TCGA-85-8048 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 62 L-Lower TCGA-85-8048-F65973 TCGA-85-8048 TCGA-85-8048-01A -22907 0 765 0 Scheduled Follow-up Submission Complete Remission/Response 2014-10-1 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.9 NO 100 Peripheral Lung 1.5 NO NO 50 No M0 N0 T1 Stage IA TCGA-85-8048.623e4187-fd10-4780-94d9-febf2957a922.pdf 8048 Other TUMOR FREE Complete Remission/Response NO NO R0 Primary Tumor 01 0.3 7th NO YES NO 85 2 Lung A LIVING 2011 1960 52a23370-b94f-4043-b114-a6caf04df5b6 52a23370-b94f-4043-b114-a6caf04df5b6 TCGA-85-8048-01A-11D-2245-05 TCGA-85-8048-01A-11D-2243-01 52a23370-b94f-4043-b114-a6caf04df5b6 TCGA-85-8048-01A-11D-2243-01 +TCGA-85-8049-01 TCGA-85-8049-01 Squamous Cluster 13 (HNSC-LUSC) miRNA cluster 5 TCGA-85-8049 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 57 L-Lower TCGA-85-8049-F65983 TCGA-85-8049 TCGA-85-8049-01A -20995 0 579 0 NO NO Scheduled Follow-up Submission Complete Remission/Response 2014-10-1 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 2 NO 100 NO Central Lung 2.5 NO NO No M0 N0 T2a Stage IB TCGA-85-8049.1b2d0b4d-b259-4565-bcf9-3efb14ffb7d0.pdf 8049 Other TUMOR FREE Complete Remission/Response NO NO R0 Primary Tumor 01 0.3 7th NO YES NO 85 1 Lung A LIVING 2011 e57426eb-3223-41dc-b70e-ff7233e3403a e57426eb-3223-41dc-b70e-ff7233e3403a TCGA-85-8049-01A-11D-2245-05 TCGA-85-8049-01A-11D-2243-01 e57426eb-3223-41dc-b70e-ff7233e3403a TCGA-85-8049-01A-11D-2243-01 +TCGA-85-8052-01 TCGA-85-8052-01 Squamous Cluster 5 miRNA cluster 4 TCGA-85-8052 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 53 R-Upper TCGA-85-8052-F65975 TCGA-85-8052 TCGA-85-8052-01A -19671 0 734 0 NO NO Scheduled Follow-up Submission Complete Remission/Response 2014-10-1 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 1 NO 100 NO Peripheral Lung 2 NO NO 40 No M0 N0 T3 Stage IIB TCGA-85-8052.ebd98864-f24a-4773-8fba-51c2b23bbbd4.pdf 8052 Other TUMOR FREE Complete Remission/Response NO NO R0 Primary Tumor 01 0.5 7th NO YES NO 85 2 Lung A LIVING 2011 1970 328de22d-8700-4ee4-bf78-71a774e4e569 328de22d-8700-4ee4-bf78-71a774e4e569 TCGA-85-8052-01A-11D-2245-05 TCGA-85-8052-01A-11D-2243-01 328de22d-8700-4ee4-bf78-71a774e4e569 TCGA-85-8052-01A-11D-2243-01 +TCGA-85-8070-01 TCGA-85-8070-01 Squamous Cluster 13 (HNSC-LUSC) miRNA cluster 12 TCGA-85-8070 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 71 L-Upper TCGA-85-8070-F59730 TCGA-85-8070 TCGA-85-8070-01A -26183 0 960 2 NO NO Scheduled Follow-up Submission Complete Remission/Response 2014-5-20 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 1.5 NO 80 NO Peripheral Lung 1.5 NO NO 50 No M0 N0 T2 Stage IB TCGA-85-8070.f9544640-64f9-40c7-af40-001e509c4897.pdf 8070 Preoperative TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 0.4 7th NO YES NO 85 2 Lung A LIVING 2011 1960 13380c2f-2f59-40ac-ae0c-9f3dab833e39 13380c2f-2f59-40ac-ae0c-9f3dab833e39 TCGA-85-8070-01A-11D-2245-05 TCGA-85-8070-01A-11D-2243-01 13380c2f-2f59-40ac-ae0c-9f3dab833e39 TCGA-85-8070-01A-11D-2243-01 +TCGA-85-8071-01 TCGA-85-8071-01 Squamous Cluster 5 miRNA cluster 11 TCGA-85-8071 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 52 R-Upper TCGA-85-8071-F66118 TCGA-85-8071 TCGA-85-8071-01A -19158 0 815 2 NO NO Scheduled Follow-up Submission Complete Remission/Response 2014-10-2 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 1.4 NO 80 NO Central Lung 1.8 NO NO 30 No M0 N1 T1a Stage IIA TCGA-85-8071.8789b4d7-e9b3-475d-b805-1096d57ba266.pdf 8071 Preoperative TUMOR FREE Complete Remission/Response NO NO R0 Primary Tumor 01 0.5 7th NO YES NO 85 2 Lung A LIVING 2011 1981 a77afb11-3c0e-411b-b34b-84f827478e03 a77afb11-3c0e-411b-b34b-84f827478e03 TCGA-85-8071-01A-11D-2245-05 TCGA-85-8071-01A-11D-2243-01 a77afb11-3c0e-411b-b34b-84f827478e03 TCGA-85-8071-01A-11D-2243-01 +TCGA-85-8072-01 TCGA-85-8072-01 Squamous Cluster 13 (HNSC-LUSC) miRNA cluster 4 TCGA-85-8072 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 60 L-Upper TCGA-85-8072-F65772 TCGA-85-8072 TCGA-85-8072-01A -22069 0 932 0 NO NO Scheduled Follow-up Submission Complete Remission/Response 2014-9-30 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 1 NO 100 NO Central Lung 1.6 NO NO 15 No M0 N0 T1a Stage IA TCGA-85-8072.31100521-d4ea-4e5f-98ce-21010ccce324.pdf 8072 Preoperative TUMOR FREE Complete Remission/Response NO NO R0 Primary Tumor 01 0.5 7th NO YES NO 85 2 Lung A LIVING 2011 1991 a6bba875-e7ad-4a67-837e-bd2f7a50dae1 a6bba875-e7ad-4a67-837e-bd2f7a50dae1 TCGA-85-8072-01A-31D-2245-05 TCGA-85-8072-01A-31D-2243-01 a6bba875-e7ad-4a67-837e-bd2f7a50dae1 TCGA-85-8072-01A-31D-2243-01 +TCGA-85-8276-01 TCGA-85-8276-01 Squamous Cluster 14 (HNSC) miRNA cluster 4 TCGA-85-8276 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung YES NO NO 62 L-Upper TCGA-85-8276-F65992 TCGA-85-8276 TCGA-85-8276-01A -22707 0 1050 1048 Scheduled Follow-up Submission 2014-10-15 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 1.2 NO NO Central Lung 1.5 NO Distant Metastasis YES 20 No M0 N1 T1b Stage IIA TCGA-85-8276.f51ff537-cbef-46ef-bed9-b8ad20b8d2f6.pdf 8276 WITH TUMOR Complete Remission/Response Convincing Imaging NO NO R0 Primary Tumor 01 0.3 7th YES YES NO 85 2 Lung A LIVING 2011 1971 5cdb7ad7-0660-4e93-928c-655f0f9465e4 5cdb7ad7-0660-4e93-928c-655f0f9465e4 TCGA-85-8276-01A-11D-2294-05 TCGA-85-8276-01A-11D-2292-01 5cdb7ad7-0660-4e93-928c-655f0f9465e4 TCGA-85-8276-01A-11D-2292-01 +TCGA-85-8277-01 TCGA-85-8277-01 Squamous Cluster 13 (HNSC-LUSC) TCGA-85-8277 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 70 L-Upper TCGA-85-8277-F40634 TCGA-85-8277 TCGA-85-8277-01A -25793 307 0 11 2 Scheduled Follow-up Submission Complete Remission/Response 2013-2-26 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 1.2 NO 80 1.8 NO NO No M0 N1 T3 Stage IIIA TCGA-85-8277.60c19484-4fc6-4838-a9b9-527f4e79f93e.pdf 8277 TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 0.4 7th NO YES NO 85 1 Lung A DECEASED 2011 e6889ad6-caa9-429f-9123-0ff0c7ae195a e6889ad6-caa9-429f-9123-0ff0c7ae195a TCGA-85-8277-01A-11D-2294-05 TCGA-85-8277-01A-11D-2292-01 e6889ad6-caa9-429f-9123-0ff0c7ae195a TCGA-85-8277-01A-11D-2292-01 +TCGA-85-8287-01 TCGA-85-8287-01 Squamous Cluster 5 miRNA cluster 4 TCGA-85-8287 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 72 L-Upper TCGA-85-8287-F52849 TCGA-85-8287 TCGA-85-8287-01A -26401 23 0 13 0 Scheduled Follow-up Submission Complete Remission/Response 2013-12-6 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 1.3 NO 90 NO Central Lung 1.7 NO NO 50 No M0 N0 T1b Stage IA TCGA-85-8287.d57a750c-f51f-474e-8f4a-d2f01926a477.pdf 8287 Preoperative TUMOR FREE Complete Remission/Response NO NO R0 Primary Tumor 01 0.3 7th NO YES NO 85 2 Lung A DECEASED 2011 1965 f69543ea-f20b-4182-91c4-f5bad36be325 f69543ea-f20b-4182-91c4-f5bad36be325 TCGA-85-8287-01A-11D-2294-05 TCGA-85-8287-01A-11D-2292-01 f69543ea-f20b-4182-91c4-f5bad36be325 TCGA-85-8287-01A-11D-2292-01 +TCGA-85-8288-01 TCGA-85-8288-01 Squamous Cluster 13 (HNSC-LUSC) miRNA cluster 4 TCGA-85-8288 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 70 R-Middle TCGA-85-8288-F52845 TCGA-85-8288 TCGA-85-8288-01A -25629 402 0 54 0 Scheduled Follow-up Submission Complete Remission/Response 2013-12-6 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.2 8070/3 C34.2 YES 1 NO 70 NO Central Lung 2 NO NO 50 No M0 N1 T1b Stage IIA TCGA-85-8288.845e1733-b5fd-4b4b-893b-8f07c9030184.pdf 8288 TUMOR FREE Complete Remission/Response NO NO R0 Primary Tumor 01 0.2 7th NO YES NO 85 2 Lung A DECEASED 2011 1962 1695c22b-f771-45da-8627-394516eb87de 1695c22b-f771-45da-8627-394516eb87de TCGA-85-8288-01A-11D-2294-05 TCGA-85-8288-01A-11D-2292-01 1695c22b-f771-45da-8627-394516eb87de TCGA-85-8288-01A-11D-2292-01 +TCGA-85-8350-01 TCGA-85-8350-01 Kirc+ Low purity c2 miRNA cluster 4 TCGA-85-8350 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 61 R-Upper TCGA-85-8350-F66071 TCGA-85-8350 TCGA-85-8350-01A -22526 0 683 0 NO Scheduled Follow-up Submission Complete Remission/Response 2014-10-2 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.7 NO 100 NO Peripheral Lung 1.7 NO NO 40 No M0 N0 T1b Stage IA TCGA-85-8350.e784390f-9956-40f8-959d-01a869324d21.pdf 8350 Other TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 0.4 7th NO YES NO 85 2 Lung A LIVING 2011 1971 6d8a4777-88a1-41f0-9a30-354d52ce9e86 6d8a4777-88a1-41f0-9a30-354d52ce9e86 TCGA-85-8350-01A-11D-2294-05 TCGA-85-8350-01A-11D-2292-01 6d8a4777-88a1-41f0-9a30-354d52ce9e86 TCGA-85-8350-01A-11D-2292-01 +TCGA-85-8351-01 TCGA-85-8351-01 High Cluster 13 (HNSC-LUSC) miRNA cluster 4 TCGA-85-8351 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 72 R-Lower TCGA-85-8351-F66073 TCGA-85-8351 TCGA-85-8351-01A -26437 0 510 0 NO Scheduled Follow-up Submission Complete Remission/Response 2014-10-2 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 1.4 NO 100 NO Peripheral Lung 2.4 NO NO 60 No M0 N1 T2a Stage IIA TCGA-85-8351.7d10178f-b714-46be-a0f8-d2a03abb0478.pdf 8351 Other TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 0.5 7th YES YES NO 85 2 Lung A LIVING 2011 1951 7ab19c79-6e54-4c4e-a9bf-fd671d0aaa2e 7ab19c79-6e54-4c4e-a9bf-fd671d0aaa2e TCGA-85-8351-01A-11D-2294-05 TCGA-85-8351-01A-11D-2292-01 7ab19c79-6e54-4c4e-a9bf-fd671d0aaa2e TCGA-85-8351-01A-11D-2292-01 +TCGA-85-8352-01 TCGA-85-8352-01 Cluster 13 (HNSC-LUSC) miRNA cluster 4 TCGA-85-8352 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung NO NO NO 67 R-Upper TCGA-85-8352-F52841 TCGA-85-8352 TCGA-85-8352-01A -24788 161 0 67 128 Scheduled Follow-up Submission Progressive Disease 2013-12-6 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 1 NO 80 NO Peripheral Lung 1.5 NO Distant Metastasis YES 50 No M0 N1 T3 Stage IIIA TCGA-85-8352.ce4d6f68-1332-4dbf-ae7f-ec3e5c7cd790.pdf 8352 WITH TUMOR Complete Remission/Response NO NO R0 Primary Tumor 01 0.3 7th NO YES NO 85 2 Lung A DECEASED 2011 1962 e75b6682-1dc8-4f83-a4e2-ff511a1f656b e75b6682-1dc8-4f83-a4e2-ff511a1f656b TCGA-85-8352-01A-31D-2324-05 TCGA-85-8352-01A-31D-2322-01 e75b6682-1dc8-4f83-a4e2-ff511a1f656b TCGA-85-8352-01A-31D-2322-01 +TCGA-85-8353-01 TCGA-85-8353-01 High Cluster 13 (HNSC-LUSC) miRNA cluster 4 TCGA-85-8353 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 72 R-Lower TCGA-85-8353-F52847 TCGA-85-8353 TCGA-85-8353-01A -26549 94 0 54 NO Scheduled Follow-up Submission Stable Disease 2014-1-24 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 1.8 NO 70 NO Peripheral Lung 2.6 NO NO 50 No M0 N1 T3 Stage IIIA TCGA-85-8353.03371d1d-3d2a-4983-890b-eec3cdb34d90.pdf 8353 WITH TUMOR Stable Disease NO NO R0 Primary Tumor 01 0.5 7th NO YES NO 85 2 Lung A DECEASED 2011 1960 cf069f54-b570-43ff-9f85-ababd06ddddd cf069f54-b570-43ff-9f85-ababd06ddddd TCGA-85-8353-01A-21D-2294-05 TCGA-85-8353-01A-21D-2292-01 cf069f54-b570-43ff-9f85-ababd06ddddd TCGA-85-8353-01A-21D-2292-01 +TCGA-85-8354-01 TCGA-85-8354-01 Cluster 13 (HNSC-LUSC) miRNA cluster 12 TCGA-85-8354 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 53 R-Lower TCGA-85-8354-F65777 TCGA-85-8354 TCGA-85-8354-01A -19692 0 995 Scheduled Follow-up Submission Complete Remission/Response 2014-9-30 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 1.2 NO 70 NO Peripheral Lung 1.4 NO NO 30 No M0 N0 T2a Stage IB TCGA-85-8354.577d1d2a-e784-49eb-8a00-e28ea210db4e.pdf 8354 TUMOR FREE Complete Remission/Response NO NO R0 Primary Tumor 01 0.4 7th NO YES NO 85 2 Lung A LIVING 2011 1972 8ad4df1d-ed6e-4b76-981c-c8757499c801 8ad4df1d-ed6e-4b76-981c-c8757499c801 TCGA-85-8354-01A-31D-2324-05 TCGA-85-8354-01A-31D-2322-01 8ad4df1d-ed6e-4b76-981c-c8757499c801 TCGA-85-8354-01A-31D-2322-01 +TCGA-85-8355-01 TCGA-85-8355-01 Squamous Cluster 5 miRNA cluster 11 TCGA-85-8355 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 63 L-Upper TCGA-85-8355-F41716 TCGA-85-8355 TCGA-85-8355-01A -23227 0 61 Scheduled Follow-up Submission Complete Remission/Response 2013-3-26 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 1.6 NO Central Lung 2.7 YES NO No M0 N0 T1a Stage IA TCGA-85-8355.aa408276-ffde-4ea0-a510-3035f653f039.pdf 8355 TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 0.5 7th NO YES NO 85 1 Lung A LIVING 2011 c0e5b9a0-cbbf-4b4b-a880-93721969c9a5 c0e5b9a0-cbbf-4b4b-a880-93721969c9a5 TCGA-85-8355-01A-11D-2294-05 TCGA-85-8355-01A-11D-2292-01 c0e5b9a0-cbbf-4b4b-a880-93721969c9a5 TCGA-85-8355-01A-11D-2292-01 +TCGA-85-8479-01 TCGA-85-8479-01 BRCA CIMP c7 miRNA cluster 11 TCGA-85-8479 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 66 L-Lower TCGA-85-8479-F63130 TCGA-85-8479 TCGA-85-8479-01A -24350 0 22 1 NO NO Scheduled Follow-up Submission 2014-8-6 MALE Lung Papillary Squamous Cell Caricnoma No C34.3 8052/3 C34.3 YES 1 NO 80 NO Central Lung 2 YES 90 No M0 N0 T1a Stage IA TCGA-85-8479.815090dd-0f5f-4d63-bd1f-e8bd11eb99da.pdf 8479 Preoperative TUMOR FREE NO R0 Primary Tumor 01 0.4 2010 7th YES NO 85 4 Lung A LIVING 2012 d3452656-5eac-4d9f-9351-74f1128eb057 d3452656-5eac-4d9f-9351-74f1128eb057 TCGA-85-8479-01A-11D-2324-05 TCGA-85-8479-01A-11D-2322-01 d3452656-5eac-4d9f-9351-74f1128eb057 TCGA-85-8479-01A-11D-2322-01 +TCGA-85-8481-01 TCGA-85-8481-01 Cluster 5 miRNA cluster 4 TCGA-85-8481 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 70 L-Upper TCGA-85-8481-F48284 TCGA-85-8481 TCGA-85-8481-01A -25782 236 0 21 2 NO NO Scheduled Follow-up Submission 2013-9-11 MALE Lung Papillary Squamous Cell Caricnoma No C34.1 8070/3 C34.1 YES 1.4 NO 0 NO Peripheral Lung 2 NO 80 No M0 N0 T3 Stage IIB TCGA-85-8481.92102bff-29a9-4d0e-9c97-73883e8e4199.pdf 8481 Post-Adjuvant Therapy TUMOR FREE Partial Remission/Response NO NO R0 Primary Tumor 01 0.3 2008 7th NO YES NO 85 4 Lung A DECEASED 2012 e350f73a-df75-4956-a50d-f60a4295b85a e350f73a-df75-4956-a50d-f60a4295b85a TCGA-85-8481-01A-11D-2324-05 TCGA-85-8481-01A-11D-2322-01 e350f73a-df75-4956-a50d-f60a4295b85a TCGA-85-8481-01A-11D-2322-01 +TCGA-85-8580-01 TCGA-85-8580-01 TCGA-85-8580 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 52 R-Lower TCGA-85-8580-F71334 TCGA-85-8580 TCGA-85-8580-01A -19301 0 1113 NO NO Scheduled Follow-up Submission Complete Remission/Response 2015-3-24 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 2.2 NO NO 2.3 NO NO 38 No M0 N0 T2a Stage IB TCGA-85-8580.2f5077b2-40fa-4bb6-8aea-ff2e8de682a2.pdf 8580 TUMOR FREE Complete Remission/Response NO NO R0 Primary Tumor 01 0.5 2011 7th NO YES NO 85 4 Lung A LIVING 2012 1973 381536e9-3a91-4878-8d63-8961d6e3b6a2 381536e9-3a91-4878-8d63-8961d6e3b6a2 TCGA-85-8580-01A-31D-2398-05 TCGA-85-8580-01A-31D-2391-01 381536e9-3a91-4878-8d63-8961d6e3b6a2 TCGA-85-8580-01A-31D-2391-01 +TCGA-85-8582-01 TCGA-85-8582-01 TCGA-85-8582 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 49 L-Upper TCGA-85-8582-F71410 TCGA-85-8582 TCGA-85-8582-01A -18168 0 1160 NO NO Scheduled Follow-up Submission Complete Remission/Response 2015-3-25 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8071/3 C34.1 YES 2 NO 100 NO Central Lung 3 NO NO 40 No M0 N0 T1a Stage IA TCGA-85-8582.cccea878-6599-41b7-ba07-dbe073cd51b4.pdf 8582 TUMOR FREE Complete Remission/Response NO NO R0 Primary Tumor 01 0.4 7th NO YES NO 85 2 Lung A LIVING 2012 11918ff0-e8d4-4214-904a-8120ba648fec 11918ff0-e8d4-4214-904a-8120ba648fec TCGA-85-8582-01A-21D-2398-05 TCGA-85-8582-01A-21D-2391-01 11918ff0-e8d4-4214-904a-8120ba648fec TCGA-85-8582-01A-21D-2391-01 +TCGA-85-8584-01 TCGA-85-8584-01 TCGA-85-8584 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 71 R-Upper TCGA-85-8584-F48285 TCGA-85-8584 TCGA-85-8584-01A -26081 383 0 0 1 NO NO Scheduled Follow-up Submission Progressive Disease 2013-9-11 MALE Lung Papillary Squamous Cell Caricnoma No C34.1 8052/3 C34.1 YES 1.6 NO 0 NO Central Lung 2.2 NO 50 No M0 N1 T2a Stage IIA TCGA-85-8584.c7614470-d0e1-4f08-87f7-e16706c5b830.pdf 8584 Post-Adjuvant Therapy TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 0.5 7th YES NO 85 2 Lung A DECEASED 2012 1bc29a8a-19a4-4b79-ad7e-a64633b2c487 1bc29a8a-19a4-4b79-ad7e-a64633b2c487 TCGA-85-8584-01A-11D-2398-05 TCGA-85-8584-01A-11D-2391-01 1bc29a8a-19a4-4b79-ad7e-a64633b2c487 TCGA-85-8584-01A-11D-2391-01 +TCGA-85-8664-01 TCGA-85-8664-01 TCGA-85-8664 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung YES NO NO 73 R-Upper TCGA-85-8664-F59089 TCGA-85-8664 TCGA-85-8664-01A -26954 550 0 3 434 Scheduled Follow-up Submission Progressive Disease 2014-4-30 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 2 NO 2.5 NO Locoregional Recurrence YES 60 No M0 N1 T2b Stage IIB TCGA-85-8664.cd29dcf4-5b1a-4288-9113-182bc79ae361.pdf 8664 WITH TUMOR Complete Remission/Response NO NO R0 Primary Tumor 01 0.4 7th NO YES NO 85 2 Lung A DECEASED 2011 1961 2a39b6f1-c19d-4177-b825-bf14bf73f737 2a39b6f1-c19d-4177-b825-bf14bf73f737 TCGA-85-8664-01A-11D-2398-05 TCGA-85-8664-01A-11D-2391-01 2a39b6f1-c19d-4177-b825-bf14bf73f737 TCGA-85-8664-01A-11D-2391-01 +TCGA-85-8666-01 TCGA-85-8666-01 TCGA-85-8666 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 65 L-Upper TCGA-85-8666-F59087 TCGA-85-8666 TCGA-85-8666-01A -23906 687 0 14 NO Scheduled Follow-up Submission Complete Remission/Response 2014-4-30 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 2.1 NO 0 2.4 NO NO 55 No M0 N0 T2a Stage IB TCGA-85-8666.c9ec1868-c91e-4778-8411-fd8ad272e453.pdf 8666 Other TUMOR FREE Complete Remission/Response NO NO R0 Primary Tumor 01 0.5 7th NO YES NO 85 2 Lung A DECEASED 2011 1967 60652d7d-4da5-4e38-9f4d-8e9698c3e578 60652d7d-4da5-4e38-9f4d-8e9698c3e578 TCGA-85-8666-01A-11D-2398-05 TCGA-85-8666-01A-11D-2391-01 60652d7d-4da5-4e38-9f4d-8e9698c3e578 TCGA-85-8666-01A-11D-2391-01 +TCGA-85-A4CL-01 TCGA-85-A4CL-01 TCGA-85-A4CL TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 65 R-Lower TCGA-85-A4CL-F71408 TCGA-85-A4CL TCGA-85-A4CL-01A -24005 172 921 0 15 NO NO Scheduled Follow-up Submission 2015-3-25 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 1040 NO NO Central Lung NO 40 true No M0 N0 T1b Stage IA TCGA-85-A4CL.85FD4E7E-5365-4217-84FA-758275B18C93.pdf A4CL TUMOR FREE Complete Remission/Response NO NO R0 Primary Tumor 01 7th NO YES NO 85 2 Lung A DECEASED 2012 1970 fb3438ba-43d1-4c51-adaf-4326983496b6 fb3438ba-43d1-4c51-adaf-4326983496b6 TCGA-85-A4CL-01A-41D-A26N-05 TCGA-85-A4CL-01A-41D-A26L-01 fb3438ba-43d1-4c51-adaf-4326983496b6 TCGA-85-A4CL-01A-41D-A26L-01 +TCGA-85-A4CN-01 TCGA-85-A4CN-01 TCGA-85-A4CN TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 56 L-Lower TCGA-85-A4CN-F70750 TCGA-85-A4CN TCGA-85-A4CN-01A -20490 168 0 1038 0 NO NO Scheduled Follow-up Submission Complete Remission/Response 2015-3-4 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 1370 NO 100 NO Peripheral Lung NO NO true No M0 N1 T2b Stage IIB TCGA-85-A4CN.EE8604DB-464B-4B27-BD77-1CA923637F2D.pdf A4CN Post-Adjuvant Therapy TUMOR FREE Complete Remission/Response NO YES R0 Primary Tumor 01 2008 7th YES YES NO 85 4 Lung A LIVING 2012 d2853a6d-4853-42cc-9f5e-9cf057095dcf d2853a6d-4853-42cc-9f5e-9cf057095dcf TCGA-85-A4CN-01A-11D-A24I-05 TCGA-85-A4CN-01A-11D-A24C-01 d2853a6d-4853-42cc-9f5e-9cf057095dcf TCGA-85-A4CN-01A-11D-A24C-01 +TCGA-85-A4JB-01 TCGA-85-A4JB-01 TCGA-85-A4JB TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 74 R-Upper TCGA-85-A4JB-F70751 TCGA-85-A4JB TCGA-85-A4JB-01A -27315 140 0 942 0 NO NO Scheduled Follow-up Submission Complete Remission/Response 2015-3-4 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 1350 NO 100 NO Central Lung NO NO 25 true No M0 N0 T3 Stage IIB TCGA-85-A4JB.36440AEA-EB5D-42B9-B6BE-B395C54E0407.pdf A4JB Post-Adjuvant Therapy TUMOR FREE Complete Remission/Response NO NO R0 Primary Tumor 01 7th YES YES NO 85 2 Lung A LIVING 2012 dfc68f11-b26c-48a3-b43e-c907d9d12f87 dfc68f11-b26c-48a3-b43e-c907d9d12f87 TCGA-85-A4JB-01A-51D-A25R-05 TCGA-85-A4JB-01A-51D-A25M-01 dfc68f11-b26c-48a3-b43e-c907d9d12f87 TCGA-85-A4JB-01A-51D-A25M-01 +TCGA-85-A4JC-01 TCGA-85-A4JC-01 TCGA-85-A4JC TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung NO NO NO 84 L-Upper TCGA-85-A4JC-F70749 TCGA-85-A4JC TCGA-85-A4JC-01A -30942 140 604 0 -10 548 3 NO NO Scheduled Follow-up Submission Progressive Disease 2015-3-9 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 830 NO 50 NO Central Lung NO Locoregional Recurrence YES 25 true No M0 N0 T2b Stage IIA TCGA-85-A4JC.A084BBE7-0EFB-4C9A-9A68-FB98C7CCA0BE.pdf A4JC Post-Adjuvant Therapy WITH TUMOR 68.4 73.6 Complete Remission/Response Convincing Imaging YES NO R0 Primary Tumor 01 7th YES YES NO 85 2 Lung A DECEASED 2012 03f49b28-9ea3-446c-a9b1-633bcbedc3b4 03f49b28-9ea3-446c-a9b1-633bcbedc3b4 TCGA-85-A4JC-01A-11D-A258-05 TCGA-85-A4JC-01A-11D-A256-01 03f49b28-9ea3-446c-a9b1-633bcbedc3b4 TCGA-85-A4JC-01A-11D-A256-01 +TCGA-85-A4PA-01 TCGA-85-A4PA-01 TCGA-85-A4PA TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 61 L-Lower TCGA-85-A4PA-F58733 TCGA-85-A4PA TCGA-85-A4PA-01A -22614 190 0 741 NO NO Scheduled Follow-up Submission Complete Remission/Response 2014-4-22 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8072/3 C34.3 YES 1870 NO NO Central Lung NO NO 40 true No M0 N0 T2a Stage IB TCGA-85-A4PA.4CFDEC28-F3F6-484F-8C51-29429D7927DE.pdf A4PA TUMOR FREE Complete Remission/Response NO NO R0 Primary Tumor 01 2012 7th NO YES NO 85 4 Lung A LIVING 2012 1972 fdb289b5-14ba-4291-b997-b3b59f709052 fdb289b5-14ba-4291-b997-b3b59f709052 TCGA-85-A4PA-01A-11D-A258-05 TCGA-85-A4PA-01A-11D-A256-01 fdb289b5-14ba-4291-b997-b3b59f709052 TCGA-85-A4PA-01A-11D-A256-01 +TCGA-85-A4QQ-01 TCGA-85-A4QQ-01 TCGA-85-A4QQ TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 68 R-Lower TCGA-85-A4QQ-F71407 TCGA-85-A4QQ TCGA-85-A4QQ-01A -25065 55 927 0 -2 NO NO Scheduled Follow-up Submission 2015-3-25 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8071/3 C34.3 YES 360 NO NO Central Lung NO 50 true No M0 N0 T2a Stage IB TCGA-85-A4QQ.5265DA24-3D23-4CEA-9F1B-B7820BF83237.pdf A4QQ TUMOR FREE Complete Remission/Response NO NO R0 Primary Tumor 01 7th NO YES NO 85 2 Lung A DECEASED 2012 1960 fbead603-e53b-4b12-b9a9-d238b00c08e3 fbead603-e53b-4b12-b9a9-d238b00c08e3 TCGA-85-A4QQ-01A-41D-A25R-05 TCGA-85-A4QQ-01A-41D-A25M-01 fbead603-e53b-4b12-b9a9-d238b00c08e3 TCGA-85-A4QQ-01A-41D-A25M-01 +TCGA-85-A4QR-01 TCGA-85-A4QR-01 TCGA-85-A4QR TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 67 R-Upper TCGA-85-A4QR-F57671 TCGA-85-A4QR TCGA-85-A4QR-01A -24756 103 0 600 0 NO NO Scheduled Follow-up Submission Complete Remission/Response 2014-3-19 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 510 NO 100 NO Central Lung NO NO 50 true No M0 N0 T2a Stage IB TCGA-85-A4QR.78401F84-F4BA-4657-B6CD-0D137146474C.pdf A4QR TUMOR FREE Complete Remission/Response NO NO R0 Primary Tumor 01 2011 7th NO YES NO 85 4 Lung A LIVING 2012 1961 19c517ef-7e77-4033-9020-eef42285cb04 19c517ef-7e77-4033-9020-eef42285cb04 TCGA-85-A4QR-01A-11D-A258-05 TCGA-85-A4QR-01A-11D-A256-01 19c517ef-7e77-4033-9020-eef42285cb04 TCGA-85-A4QR-01A-11D-A256-01 +TCGA-85-A50M-01 TCGA-85-A50M-01 TCGA-85-A50M TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 47 R-Upper TCGA-85-A50M-F69504 TCGA-85-A50M TCGA-85-A50M-01A -17429 113 826 0 19 NO NO Scheduled Follow-up Submission 2015-1-12 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 1630 NO NO Peripheral Lung NO NO 15 true No M0 N0 T2b Stage IIA TCGA-85-A50M.22D952B9-47B2-409A-8177-56A2537BE21D.pdf A50M TUMOR FREE Complete Remission/Response NO NO R0 Primary Tumor 01 2012 7th NO YES NO 85 4 Lung A DECEASED 2012 1997 f68d990e-ed0b-46d2-8658-bf5e686e79c1 f68d990e-ed0b-46d2-8658-bf5e686e79c1 TCGA-85-A50M-01A-21D-A25R-05 TCGA-85-A50M-01A-21D-A25M-01 f68d990e-ed0b-46d2-8658-bf5e686e79c1 TCGA-85-A50M-01A-21D-A25M-01 +TCGA-85-A50Z-01 TCGA-85-A50Z-01 TCGA-85-A50Z TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung NO NO 57 R-Upper TCGA-85-A50Z-F55525 TCGA-85-A50Z TCGA-85-A50Z-01A -20941 143 0 493 462 0 Scheduled Follow-up Submission Complete Remission/Response 2014-1-8 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 1270 NO 100 NO Peripheral Lung NO New Primary Tumor YES 45 true No M0 N0 T2b Stage IIA TCGA-85-A50Z.3C1DB929-A01C-4274-B5A9-542237FEA832.pdf A50Z Other TUMOR FREE Complete Remission/Response Biopsy with Histologic Confirmation NO NO R0 Primary Tumor 01 7th YES YES NO 85 2 Lung A LIVING 2012 1973 8c5bf599-1fe3-419d-a83a-6c230c096735 8c5bf599-1fe3-419d-a83a-6c230c096735 TCGA-85-A50Z-01A-21D-A25R-05 TCGA-85-A50Z-01A-21D-A25M-01 8c5bf599-1fe3-419d-a83a-6c230c096735 TCGA-85-A50Z-01A-21D-A25M-01 +TCGA-85-A510-01 TCGA-85-A510-01 TCGA-85-A510 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung NO NO YES 74 L-Lower TCGA-85-A510-F53447 TCGA-85-A510 TCGA-85-A510-01A 419 -27067 142 0 482 363 0 NO NO Scheduled Follow-up Submission Complete Remission/Response 2013-12-11 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 860 NO 100 NO Peripheral Lung NO Distant Metastasis YES 45 true No M0 N1 T2b Stage IIB TCGA-85-A510.4F6022A3-A5E0-4124-B740-E9BB9A301102.pdf A510 Other TUMOR FREE Complete Remission/Response NO NO R0 Primary Tumor 01 7th NO YES NO 85 2 Lung A LIVING 2012 1967 732285be-4a85-4be6-b3b6-7e50934a5adb 732285be-4a85-4be6-b3b6-7e50934a5adb TCGA-85-A510-01A-11D-A26N-05 TCGA-85-A510-01A-11D-A26L-01 732285be-4a85-4be6-b3b6-7e50934a5adb TCGA-85-A510-01A-11D-A26L-01 +TCGA-85-A511-01 TCGA-85-A511-01 TCGA-85-A511 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung NO NO NO 62 L-Lower TCGA-85-A511-F65768 TCGA-85-A511 TCGA-85-A511-01A -22759 142 455 0 0 390 NO NO Scheduled Follow-up Submission Progressive Disease 2014-10-15 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 630 NO 90 NO Peripheral Lung NO Distant Metastasis YES 40 true No M0 N1 T2b Stage IIB TCGA-85-A511.63785892-9586-4C23-A6F6-794DF6D4A2F9.pdf A511 Preoperative WITH TUMOR Complete Remission/Response Convincing Imaging NO NO R0 Primary Tumor 01 7th NO YES NO 85 2 Lung A DECEASED 2012 1972 bdde9491-7b52-4655-bed9-708a4aa770f2 bdde9491-7b52-4655-bed9-708a4aa770f2 TCGA-85-A511-01A-21D-A25R-05 TCGA-85-A511-01A-21D-A25M-01 bdde9491-7b52-4655-bed9-708a4aa770f2 TCGA-85-A511-01A-21D-A25M-01 +TCGA-85-A512-01 TCGA-85-A512-01 TCGA-85-A512 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 46 L-Upper TCGA-85-A512-F55530 TCGA-85-A512 TCGA-85-A512-01A -16811 107 0 465 0 NO NO Scheduled Follow-up Submission Complete Remission/Response 2014-1-8 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 350 NO 100 NO Central Lung NO NO 25 true No M0 N1 T1b Stage IIA TCGA-85-A512.A49AF0B2-6C19-47D5-BD75-A6CB7F7057B9.pdf A512 Other TUMOR FREE Complete Remission/Response NO NO R0 Primary Tumor 01 7th YES YES NO 85 2 Lung A LIVING 2012 1987 3d8fc38f-1005-47c9-adb7-62525f5ccfad 3d8fc38f-1005-47c9-adb7-62525f5ccfad TCGA-85-A512-01A-11D-A26N-05 TCGA-85-A512-01A-11D-A26L-01 3d8fc38f-1005-47c9-adb7-62525f5ccfad TCGA-85-A512-01A-11D-A26L-01 +TCGA-85-A513-01 TCGA-85-A513-01 TCGA-85-A513 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 60 L-Upper TCGA-85-A513-F70192 TCGA-85-A513 TCGA-85-A513-01A -21967 97 0 910 1 NO NO Scheduled Follow-up Submission Complete Remission/Response 2015-1-30 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 400 NO 80 NO Peripheral Lung NO NO true No M0 NX T1a Stage IA TCGA-85-A513.47BE5F80-C50E-4B92-B0F9-7F93E73D356B.pdf A513 Post-Adjuvant Therapy TUMOR FREE Complete Remission/Response NO NO R0 Primary Tumor 01 7th YES NO 85 1 Lung A LIVING 2012 19df9b10-033c-4890-bf52-ad8dd72bdb0c 19df9b10-033c-4890-bf52-ad8dd72bdb0c TCGA-85-A513-01A-12D-A26N-05 TCGA-85-A513-01A-12D-A26L-01 19df9b10-033c-4890-bf52-ad8dd72bdb0c TCGA-85-A513-01A-12D-A26L-01 +TCGA-85-A53L-01 TCGA-85-A53L-01 TCGA-85-A53L TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 63 R-Middle TCGA-85-A53L-F56090 TCGA-85-A53L TCGA-85-A53L-01A -23065 72 0 377 2 NO NO Scheduled Follow-up Submission Complete Remission/Response 2014-1-27 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.2 8070/3 C34.2 YES 2200 NO 90 NO Peripheral Lung NO NO 30 true No M0 N0 T2b Stage IIA TCGA-85-A53L.3671CFAF-C10F-40F9-9FE4-0ADB566433E2.pdf A53L Post-Adjuvant Therapy TUMOR FREE Complete Remission/Response NO NO R0 Primary Tumor 01 2000 7th NO YES NO 85 4 Lung A LIVING 2012 1970 e5bf9cac-9a07-464f-bbd7-9d532bd1f30c e5bf9cac-9a07-464f-bbd7-9d532bd1f30c TCGA-85-A53L-01A-21D-A26N-05 TCGA-85-A53L-01A-21D-A26L-01 e5bf9cac-9a07-464f-bbd7-9d532bd1f30c TCGA-85-A53L-01A-21D-A26L-01 +TCGA-85-A5B5-01 TCGA-85-A5B5-01 TCGA-85-A5B5 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 58 R-Upper TCGA-85-A5B5-F64099 TCGA-85-A5B5 TCGA-85-A5B5-01A -21450 190 0 111 NO NO Scheduled Follow-up Submission 2014-9-30 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 115 NO NO Central Lung YES NO 15 true No M0 N0 T1b Stage IA TCGA-85-A5B5.DF0EBE84-145F-478E-8242-80A6B267F532.pdf A5B5 TUMOR FREE Complete Remission/Response NO NO R0 Primary Tumor 01 2011 7th NO YES NO 85 4 Lung A LIVING 2012 1982 18ffe99a-7e67-4ecc-9729-5aaa6efc7fbf 18ffe99a-7e67-4ecc-9729-5aaa6efc7fbf TCGA-85-A5B5-01A-21D-A26N-05 TCGA-85-A5B5-01A-21D-A26L-01 18ffe99a-7e67-4ecc-9729-5aaa6efc7fbf TCGA-85-A5B5-01A-21D-A26L-01 +TCGA-86-6562-01 3.43 0.45 none none none none N Y none p.776_776G>VC none 0.17 Squamoid none none none none none none none Micropapillary predom Adc Micropapillary predom Adc none 0 TCGA-86-6562-01 High C1-LUAD-enriched Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 4 mutation c1uster 9 TCGA-86-6562 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung NO NO NO 52 R-Upper TCGA-86-6562-F29765 TCGA-86-6562 TCGA-86-6562-01A -19301 376 0 0 274 Scheduled Follow-up Submission Progressive Disease 2012-3-28 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 1.4 NO 0 NO Central Lung 1.9 YES No M0 N1 T2a Stage IIA TCGA-86-6562.b0e49ac9-6b9c-4e70-a4a9-10e0686e61aa.pdf 6562 WITH TUMOR Progressive Disease NO NO R0 Primary Tumor 01 0.4 7th YES YES NO 86 1 Lifelong Non-smoker Lung A DECEASED 2011 a0c2dedc-803a-4097-8225-653262fbf394 TCGA-86-6562-01A-11D-1753-08 a0c2dedc-803a-4097-8225-653262fbf394 TCGA-86-6562-01A-11D-1756-05 TCGA-86-6562-01A-11D-1752-01 a0c2dedc-803a-4097-8225-653262fbf394 TCGA-86-6562-01A-11D-1752-01 TCGA-86-6562-01A-13-2191-20 +TCGA-86-6851-01 3.34 0.32 none none none none N N none none none 0.13 Squamoid none none none none none none none Acinar predominant Adc Acinar predominant Adc none 0 TCGA-86-6851-01 Squamous C1-LUAD-enriched Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 7 TCGA-86-6851 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 73 L-Upper TCGA-86-6851-F53594 TCGA-86-6851 TCGA-86-6851-01A -26808 0 179 0 Scheduled Follow-up Submission Complete Remission/Response 2013-12-12 FEMALE Lung Adenocarcinoma Mixed Subtype No C34.1 8255/3 C34.1 YES 0.7 NO 100 1 YES NO 52 No M0 N1 T1b Stage IIA TCGA-86-6851.519253c3-7e47-4c66-9149-65e622f1ba29.pdf 6851 Post-Adjuvant Therapy TUMOR FREE Complete Remission/Response NO NO Primary Tumor 01 0.4 7th NO YES NO 86 2 Current smoker Lung A LIVING 2011 1959 9214caa3-2ad2-41ff-ab77-cf22c4ccce97 9214caa3-2ad2-41ff-ab77-cf22c4ccce97 TCGA-86-6851-01A-11D-1947-05 TCGA-86-6851-01A-11D-1943-01 9214caa3-2ad2-41ff-ab77-cf22c4ccce97 TCGA-86-6851-01A-11D-1943-01 TCGA-86-6851-01A-13-2191-20 +TCGA-86-7701-01 TCGA-86-7701-01 BRCA-LUAD+ C1-LUAD-enriched Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 6 TCGA-86-7701 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung YES YES NO 66 R-Upper TCGA-86-7701-F58406 TCGA-86-7701 TCGA-86-7701-01A -24209 0 947 900 2 Scheduled Follow-up Submission Progressive Disease 2014-4-9 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 1.7 NO 80 Peripheral Lung 1.8 NO Distant Metastasis YES No M1 N0 T2 Stage IV TCGA-86-7701.711a97e9-ac1d-4f62-b488-a3eb8370841e.pdf 7701 Post-Adjuvant Therapy WITH TUMOR Complete Remission/Response NO NO R0 Primary Tumor 01 0.2 7th YES YES NO 86 1 Lung A LIVING 2011 7524ebc8-c57e-44d5-9a4e-b5ccce93bf55 7524ebc8-c57e-44d5-9a4e-b5ccce93bf55 TCGA-86-7701-01A-11D-2168-05 TCGA-86-7701-01A-11D-2166-01 7524ebc8-c57e-44d5-9a4e-b5ccce93bf55 TCGA-86-7701-01A-11D-2166-01 TCGA-86-7701-01A-13-2192-20 +TCGA-86-7711-01 TCGA-86-7711-01 High C1-LUAD-enriched Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 4 TCGA-86-7711 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 70 R-Lower TCGA-86-7711-F41203 TCGA-86-7711 TCGA-86-7711-01A -25719 1046 0 27 2 Scheduled Follow-up Submission Progressive Disease 2013-3-13 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 1.5 NO 80 NO Peripheral Lung 1.8 NO NO 50 No M0 N1 T2a Stage IIA TCGA-86-7711.5a85d8a6-3533-4ac8-9fc9-437a81b436d6.pdf 7711 WITH TUMOR Progressive Disease NO NO R0 Primary Tumor 01 0.4 7th YES YES NO 86 2 Lung A DECEASED 2011 1960 597e959c-bab8-4234-b57b-1b8413de7955 597e959c-bab8-4234-b57b-1b8413de7955 TCGA-86-7711-01A-11D-2064-05 TCGA-86-7711-01A-11D-2062-01 597e959c-bab8-4234-b57b-1b8413de7955 TCGA-86-7711-01A-11D-2062-01 TCGA-86-7711-01A-13-2192-20 +TCGA-86-7713-01 2.14 0.79 none none none none Y Y none none none 0.37 Magnoid none p.G12C none none none none none Micropapillary predom Adc Micropapillary predom Adc p.L245F 0 TCGA-86-7713-01 BRCA-LUAD+ C1-LUAD-enriched Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 4 TCGA-86-7713 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 70 R-Middle TCGA-86-7713-F63513 TCGA-86-7713 TCGA-86-7713-01A -25791 0 1157 0 Scheduled Follow-up Submission Complete Remission/Response 2014-8-12 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.2 8140/3 C34.2 YES 1.2 NO 100 NO Peripheral Lung 3 NO NO No M0 N0 T2b Stage IIA TCGA-86-7713.0ec59eb0-0640-4d6b-b191-76bad8bb38d8.pdf 7713 Post-Adjuvant Therapy TUMOR FREE Complete Remission/Response NO NO R0 Primary Tumor 01 0.5 7th YES YES NO 86 1 Lifelong Non-smoker Lung A LIVING 2011 2d1f10dd-a834-4c64-919c-2d9eea15c37a 2d1f10dd-a834-4c64-919c-2d9eea15c37a TCGA-86-7713-01A-11D-2064-05 TCGA-86-7713-01A-11D-2062-01 2d1f10dd-a834-4c64-919c-2d9eea15c37a TCGA-86-7713-01A-11D-2062-01 TCGA-86-7713-01A-13-2192-20 +TCGA-86-7714-01 none p.V600E none none N Y none none none Bronchioid none none none none none p.E726K none Lepidic predominant Adc Lepidic predominant Adc none 0 TCGA-86-7714-01 Kirc+ Cluster 6 LUAD-like c10 miRNA cluster 5 TCGA-86-7714 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 61 R-Lower TCGA-86-7714-F53595 TCGA-86-7714 TCGA-86-7714-01A -22619 625 0 0 0 NO Scheduled Follow-up Submission Progressive Disease 2013-12-12 FEMALE Lung Adenocarcinoma Mixed Subtype No C34.3 8255/3 C34.3 YES 1 NO 0 NO Peripheral Lung 1.5 NO NO 43 No M0 N2 T1b Stage IIIA TCGA-86-7714.ae0a324f-8658-46b6-b870-a2642eea57a8.pdf 7714 Post-Adjuvant Therapy WITH TUMOR Stable Disease NO NO R0 Primary Tumor 01 0.3 7th NO YES NO 86 2 Current smoker Lung A DECEASED 2011 1968 a6af2ef5-6774-422c-99d1-826a686334d0 a6af2ef5-6774-422c-99d1-826a686334d0 TCGA-86-7714-01A-12D-2168-05 TCGA-86-7714-01A-12D-2166-01 a6af2ef5-6774-422c-99d1-826a686334d0 TCGA-86-7714-01A-12D-2166-01 +TCGA-86-7953-01 TCGA-86-7953-01 BRCA-LUAD+ C1-LUAD-enriched Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 4 TCGA-86-7953 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 69 L-Upper TCGA-86-7953-F66262 TCGA-86-7953 TCGA-86-7953-01A -25315 0 997 1 NO Scheduled Follow-up Submission Complete Remission/Response 2014-10-7 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8250/3 C34.1 YES 1.2 NO 90 Peripheral Lung 3 NO NO No M0 N0 T1b Stage IA TCGA-86-7953.1af715d0-9b4b-444f-b93e-53478cde8e58.pdf 7953 Preoperative TUMOR FREE Complete Remission/Response NO NO RX Primary Tumor 01 0.2 7th NO YES NO 86 1 Lung A LIVING 2011 90865a55-659d-409f-a865-bae9e46c4a7c 90865a55-659d-409f-a865-bae9e46c4a7c TCGA-86-7953-01A-11D-2185-05 TCGA-86-7953-01A-11D-2183-01 90865a55-659d-409f-a865-bae9e46c4a7c TCGA-86-7953-01A-11D-2183-01 TCGA-86-7953-01A-13-2192-20 +TCGA-86-7954-01 TCGA-86-7954-01 High C1-LUAD-enriched Cluster 5 squamous c3 LUAD-like c10 miRNA c1uster 10 TCGA-86-7954 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 68 R-Lower TCGA-86-7954-F57948 TCGA-86-7954 TCGA-86-7954-01A -25062 0 605 0 NO Scheduled Follow-up Submission Complete Remission/Response 2014-3-28 FEMALE Lung Bronchioloalveolar Carcinoma Nonmucinous No C34.3 8250/3 C34.3 YES 1 NO 100 NO Peripheral Lung 1.1 NO NO 8 No M0 N0 T2 Stage IB TCGA-86-7954.6a0c9a64-8c57-412a-8b3c-efb8e0b184ea.pdf 7954 Post-Adjuvant Therapy TUMOR FREE Complete Remission/Response NO NO R0 Primary Tumor 01 0.3 1971 7th YES YES NO 86 3 Lung A LIVING 2011 1963 f84c748d-1296-44aa-b7b1-0795939a88fe f84c748d-1296-44aa-b7b1-0795939a88fe TCGA-86-7954-01A-11D-2185-05 TCGA-86-7954-01A-11D-2183-01 f84c748d-1296-44aa-b7b1-0795939a88fe TCGA-86-7954-01A-11D-2183-01 TCGA-86-7954-01A-13-2192-20 +TCGA-86-7955-01 TCGA-86-7955-01 High C1-LUAD-enriched Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 4 TCGA-86-7955 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung YES YES NO 62 R-Lower TCGA-86-7955-F63517 TCGA-86-7955 TCGA-86-7955-01A -22772 0 1072 820 0 NO Scheduled Follow-up Submission Complete Remission/Response 2014-8-12 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 1.5 NO 100 NO Peripheral Lung 2.1 NO Locoregional Recurrence YES No M0 N0 T2a Stage IB TCGA-86-7955.d6a25f15-9117-43b7-bbd4-132914a24d16.pdf 7955 Post-Adjuvant Therapy TUMOR FREE Complete Remission/Response NO YES RX Primary Tumor 01 0.4 7th YES YES NO 86 1 Lung A LIVING 2011 937a163b-b469-46a0-87b8-6d7c7e6105d7 937a163b-b469-46a0-87b8-6d7c7e6105d7 TCGA-86-7955-01A-11D-2185-05 TCGA-86-7955-01A-11D-2183-01 937a163b-b469-46a0-87b8-6d7c7e6105d7 TCGA-86-7955-01A-11D-2183-01 TCGA-86-7955-01A-21-2192-20 +TCGA-86-8054-01 TCGA-86-8054-01 BRCA-LUAD+ Cluster 5 LUAD-like c10 miRNA cluster 6 TCGA-86-8054 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 61 R-Upper TCGA-86-8054-F65792 TCGA-86-8054 TCGA-86-8054-01A -22584 0 1148 2 NO NO Scheduled Follow-up Submission Complete Remission/Response 2014-9-30 MALE Lung Acinar Adenocarcinoma No C34.1 8550/3 C34.1 YES 1.1 NO 80 NO Central Lung 1.7 NO NO 9 No M0 N1 T2b Stage IIB TCGA-86-8054.a47b8835-2314-4631-b55d-f99af91ad5e7.pdf 8054 Preoperative TUMOR FREE Complete Remission/Response NO NO R0 Primary Tumor 01 0.4 7th YES YES NO 86 2 Lung A LIVING 2011 1994 ed7e5789-ce06-4213-beda-f0892b103ce4 ed7e5789-ce06-4213-beda-f0892b103ce4 TCGA-86-8054-01A-11D-2239-05 TCGA-86-8054-01A-11D-2237-01 ed7e5789-ce06-4213-beda-f0892b103ce4 TCGA-86-8054-01A-11D-2237-01 +TCGA-86-8055-01 TCGA-86-8055-01 BRCA-LUAD+ Cluster 5 LUAD-like c10 miRNA c1uster 9 TCGA-86-8055 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung NO 79 L-Upper TCGA-86-8055-F40636 TCGA-86-8055 TCGA-86-8055-01A -29124 124 0 10 2 NO Scheduled Follow-up Submission Complete Remission/Response 2013-2-26 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 1.3 NO 80 NO Peripheral Lung 3.2 NO NO 60 No M0 N1 T2a Stage IIA TCGA-86-8055.b0f478a2-7696-4fc2-bdc9-839142556b6f.pdf 8055 Preoperative TUMOR FREE Complete Remission/Response NO NO R0 Primary Tumor 01 0.4 7th NO YES NO 86 2 Lung A DECEASED 2011 1955 b0b8fd4b-d725-417b-b17b-4cb6a7136459 b0b8fd4b-d725-417b-b17b-4cb6a7136459 TCGA-86-8055-01A-11D-2239-05 TCGA-86-8055-01A-11D-2237-01 b0b8fd4b-d725-417b-b17b-4cb6a7136459 TCGA-86-8055-01A-11D-2237-01 +TCGA-86-8056-01 TCGA-86-8056-01 BRCA-LUAD+ Cluster 6 LUAD-like c10 miRNA cluster 4 TCGA-86-8056 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 63 Other (please specify) Right upper, lower TCGA-86-8056-F57951 TCGA-86-8056 TCGA-86-8056-01A -23369 0 139 0 NO NO Scheduled Follow-up Submission 2014-3-28 FEMALE Lung Adenocarcinoma Mixed Subtype No C34.1 8255/3 C34.1 YES 1.1 NO 100 NO Peripheral Lung 1.4 YES NO 36 No M0 N0 T4 Stage IIIA TCGA-86-8056.b372fd6d-8c36-4642-b660-d353efb0bd89.pdf 8056 Preoperative TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 0.4 1975 7th YES NO 86 3 Lung A LIVING 2011 1963 8684c13a-9445-45a8-b37f-ce2b04b218bf 8684c13a-9445-45a8-b37f-ce2b04b218bf TCGA-86-8056-01A-11D-2239-05 TCGA-86-8056-01A-11D-2237-01 8684c13a-9445-45a8-b37f-ce2b04b218bf TCGA-86-8056-01A-11D-2237-01 +TCGA-86-8073-01 TCGA-86-8073-01 High Cluster 6 LUAD-like c10 miRNA c1uster 9 TCGA-86-8073 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 58 L-Upper TCGA-86-8073-F66082 TCGA-86-8073 TCGA-86-8073-01A -21214 0 740 0 NO NO Scheduled Follow-up Submission Complete Remission/Response 2014-10-2 MALE Lung Bronchioloalveolar Carcinoma Nonmucinous No C34.1 8250/3 C34.1 YES 1.5 NO 100 NO Peripheral Lung 1.8 NO NO 40 No M0 N0 T2a Stage IB TCGA-86-8073.2ae8592b-aa83-476a-b77f-dc53e8eb802b.pdf 8073 Other TUMOR FREE Complete Remission/Response NO NO R0 Primary Tumor 01 0.4 7th NO YES NO 86 2 Lung A LIVING 2011 1970 97c75ab2-4b91-4c26-992e-ed1252805aac 97c75ab2-4b91-4c26-992e-ed1252805aac TCGA-86-8073-01A-11D-2239-05 TCGA-86-8073-01A-11D-2237-01 97c75ab2-4b91-4c26-992e-ed1252805aac TCGA-86-8073-01A-11D-2237-01 +TCGA-86-8074-01 TCGA-86-8074-01 BRCA-LUAD+ Cluster 6 LUAD-like c10 miRNA cluster 4 TCGA-86-8074 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 62 L-Lower TCGA-86-8074-F41667 TCGA-86-8074 TCGA-86-8074-01A -22862 0 24 2 NO NO Scheduled Follow-up Submission 2013-3-26 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8260/3 C34.3 YES 1.3 NO 80 NO Peripheral Lung 2.3 YES 40 No M0 N1 T1b Stage IIA TCGA-86-8074.a1e9569b-0254-4be6-adb2-3a842e23613f.pdf 8074 TUMOR FREE NO R0 Primary Tumor 01 0.3 7th YES NO 86 2 Lung A LIVING 2011 1970 13549fc9-6145-4853-88a6-39c78cb3ab0a 13549fc9-6145-4853-88a6-39c78cb3ab0a TCGA-86-8074-01A-11D-2239-05 TCGA-86-8074-01A-11D-2237-01 13549fc9-6145-4853-88a6-39c78cb3ab0a TCGA-86-8074-01A-11D-2237-01 +TCGA-86-8075-01 TCGA-86-8075-01 BRCA-LUAD+ Cluster 5 LUAD-like c10 miRNA cluster 4 TCGA-86-8075 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 66 L-Upper TCGA-86-8075-F63521 TCGA-86-8075 TCGA-86-8075-01A -24402 694 0 43 1 NO NO Scheduled Follow-up Submission Complete Remission/Response 2014-8-12 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 1.6 NO 90 NO Peripheral Lung 1.8 NO NO No M0 N0 T2 Stage IB TCGA-86-8075.7988f9a9-584e-4ce9-b12c-f3e289af1d6d.pdf 8075 Preoperative TUMOR FREE Complete Remission/Response NO NO R0 Primary Tumor 01 0.4 7th NO YES NO 86 1 Lung A DECEASED 2011 fa3d0703-ce5e-49a9-96a6-0777f8e81cd3 fa3d0703-ce5e-49a9-96a6-0777f8e81cd3 TCGA-86-8075-01A-11D-2239-05 TCGA-86-8075-01A-11D-2237-01 fa3d0703-ce5e-49a9-96a6-0777f8e81cd3 TCGA-86-8075-01A-11D-2237-01 +TCGA-86-8076-01 TCGA-86-8076-01 Iq Cluster 5 LUAD-like c10 miRNA c1uster 9 TCGA-86-8076 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 42 R-Upper TCGA-86-8076-F63522 TCGA-86-8076 TCGA-86-8076-01A -15605 0 993 0 NO NO Scheduled Follow-up Submission Complete Remission/Response 2014-8-12 MALE Lung Papillary Adenocarcinoma No C34.1 8260/3 C34.1 YES 1.2 NO 100 NO Peripheral Lung 1.7 NO NO No M0 N0 T1 Stage IA TCGA-86-8076.c282d817-b99a-4bda-8073-9de1cac074f9.pdf 8076 Post-Adjuvant Therapy TUMOR FREE Complete Remission/Response NO NO R0 Primary Tumor 01 0.4 7th YES YES NO 86 1 Lung A LIVING 2011 c9cf5f5f-30de-4062-99c3-dcb9cfd55870 c9cf5f5f-30de-4062-99c3-dcb9cfd55870 TCGA-86-8076-01A-31D-2239-05 TCGA-86-8076-01A-31D-2237-01 c9cf5f5f-30de-4062-99c3-dcb9cfd55870 TCGA-86-8076-01A-31D-2237-01 +TCGA-86-8278-01 TCGA-86-8278-01 Kirc+ Cluster 6 miRNA c1uster 9 TCGA-86-8278 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 63 L-Lower TCGA-86-8278-F59732 TCGA-86-8278 TCGA-86-8278-01A -23117 0 944 1 Scheduled Follow-up Submission Stable Disease 2014-5-20 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.30 8480/3 C34.3 YES 1.2 NO 90 NO Peripheral Lung 2 NO NO No M0 N1 T2 Stage IIB TCGA-86-8278.75c05d77-d3b7-4cd1-9e6f-d8a18fc23f6c.pdf 8278 Preoperative WITH TUMOR Complete Remission/Response NO R0 Primary Tumor 01 0.3 7th NO YES NO 86 1 Lung A LIVING 2011 8719f9af-0876-4ec6-a4dc-4178ad964349 8719f9af-0876-4ec6-a4dc-4178ad964349 TCGA-86-8278-01A-11D-2285-05 TCGA-86-8278-01A-11D-2283-01 8719f9af-0876-4ec6-a4dc-4178ad964349 TCGA-86-8278-01A-11D-2283-01 +TCGA-86-8279-01 TCGA-86-8279-01 High Cluster 5 LUAD-like c10 miRNA cluster 4 TCGA-86-8279 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 46 R-Upper TCGA-86-8279-F59731 TCGA-86-8279 TCGA-86-8279-01A -17032 0 949 1 Scheduled Follow-up Submission Complete Remission/Response 2014-5-20 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 1.5 NO 90 NO Peripheral Lung 1.8 NO NO No M0 N1 T2a Stage IIA TCGA-86-8279.e7e4b4fd-f47d-4aab-826c-0ef1f620a739.pdf 8279 Preoperative TUMOR FREE Complete Remission/Response NO YES R0 Primary Tumor 01 0.3 7th YES YES NO 86 1 Lung A LIVING 2011 87e51ccb-9ded-43c6-bb1a-a8a85d2d9fa6 87e51ccb-9ded-43c6-bb1a-a8a85d2d9fa6 TCGA-86-8279-01A-11D-2285-05 TCGA-86-8279-01A-11D-2283-01 87e51ccb-9ded-43c6-bb1a-a8a85d2d9fa6 TCGA-86-8279-01A-11D-2283-01 +TCGA-86-8280-01 TCGA-86-8280-01 BRCA-LUAD+ Cluster 5 LUAD-like c10 miRNA cluster 7 TCGA-86-8280 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 54 L-Lower TCGA-86-8280-F66079 TCGA-86-8280 TCGA-86-8280-01A -19977 0 701 0 Scheduled Follow-up Submission Complete Remission/Response 2014-10-2 FEMALE Lung Bronchioloalveolar Carcinoma Nonmucinous No C34.3 8252/3 C34.3 YES 1.4 NO 100 NO Peripheral Lung 2.8 NO NO No M0 N0 T2b Stage IIA TCGA-86-8280.49459cae-eee4-4e46-a8fc-efbeb6cb1f5d.pdf 8280 Other TUMOR FREE Complete Remission/Response NO NO R0 Primary Tumor 01 0.4 7th YES YES NO 86 1 Lung A LIVING 2011 974f4223-c166-4ea2-a061-25e3f4b415e7 974f4223-c166-4ea2-a061-25e3f4b415e7 TCGA-86-8280-01A-11D-2285-05 TCGA-86-8280-01A-11D-2283-01 974f4223-c166-4ea2-a061-25e3f4b415e7 TCGA-86-8280-01A-11D-2283-01 +TCGA-86-8281-01 TCGA-86-8281-01 BRCA-LUAD+ Cluster 5 LUAD-like c10 miRNA cluster 4 TCGA-86-8281 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 75 R-Lower TCGA-86-8281-F57953 TCGA-86-8281 TCGA-86-8281-01A -27409 0 0 0 Scheduled Follow-up Submission 2014-4-21 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 0.6 NO 100 NO Peripheral Lung 1.6 YES NO 30 No M0 NX T1 Stage IA TCGA-86-8281.775debd9-a338-412e-86da-5c132df883c1.pdf 8281 Preoperative TUMOR FREE Complete Remission/Response NO Primary Tumor 01 0.4 1985 7th YES NO 86 3 Lung A LIVING 2011 1955 f9e17a94-37a3-4bac-bbfe-0128fc3a644b f9e17a94-37a3-4bac-bbfe-0128fc3a644b TCGA-86-8281-01A-11D-2285-05 TCGA-86-8281-01A-11D-2283-01 f9e17a94-37a3-4bac-bbfe-0128fc3a644b TCGA-86-8281-01A-11D-2283-01 +TCGA-86-8358-01 TCGA-86-8358-01 Cluster 6 miRNA cluster 6 TCGA-86-8358 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 44 R-Upper TCGA-86-8358-F58410 TCGA-86-8358 TCGA-86-8358-01A -16409 0 653 0 Scheduled Follow-up Submission Complete Remission/Response 2014-4-9 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 1.4 NO 100 NO Peripheral Lung 1.7 NO NO 20 No M0 N0 T2a Stage IB TCGA-86-8358.bdfc4ca3-ce4f-4206-b3ff-3733df596e9d.pdf 8358 Other TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 0.5 7th NO YES NO 86 2 Lung A LIVING 2012 1992 6addf668-7b4d-4e3d-9086-b95818648be2 6addf668-7b4d-4e3d-9086-b95818648be2 TCGA-86-8358-01A-11D-2324-05 TCGA-86-8358-01A-11D-2322-01 6addf668-7b4d-4e3d-9086-b95818648be2 TCGA-86-8358-01A-11D-2322-01 +TCGA-86-8359-01 TCGA-86-8359-01 Cluster 5 miRNA cluster 4 TCGA-86-8359 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 52 L-Lower TCGA-86-8359-F43296 TCGA-86-8359 TCGA-86-8359-01A -19088 444 0 26 4 Scheduled Follow-up Submission 2013-5-16 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 2 NO 20 Peripheral Lung 2.5 NO 36 No M0 N2 T3 Stage IIIA TCGA-86-8359.7525adb2-550a-4d65-beed-5fb0fef0b36d.pdf 8359 Post-Adjuvant Therapy TUMOR FREE NO R0 Primary Tumor 01 0.5 7th YES NO 86 2 Lung A DECEASED 2012 1982 1ed6d4b1-0a36-4515-9475-709ad876ffa9 1ed6d4b1-0a36-4515-9475-709ad876ffa9 TCGA-86-8359-01A-11D-2324-05 TCGA-86-8359-01A-11D-2322-01 1ed6d4b1-0a36-4515-9475-709ad876ffa9 TCGA-86-8359-01A-11D-2322-01 +TCGA-86-8585-01 TCGA-86-8585-01 TCGA-86-8585 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 57 L-Upper TCGA-86-8585-F46400 TCGA-86-8585 TCGA-86-8585-01A -20918 0 353 NO Scheduled Follow-up Submission Complete Remission/Response 2013-9-19 MALE Lung Solid Pattern Predominant Adenocarcinoma No C34.1 8230/3 C34.1 YES 2 NO NO Peripheral Lung 2.2 YES NO No M0 N0 T2a Stage IB TCGA-86-8585.6c3d5577-390c-4a80-8c02-dee4901c2a16.pdf 8585 TUMOR FREE Complete Remission/Response NO NO R0 Primary Tumor 01 0.4 7th NO YES NO 86 1 Lung A LIVING 2012 5642f9d8-a84b-4ab6-b841-910ac4010e16 5642f9d8-a84b-4ab6-b841-910ac4010e16 TCGA-86-8585-01A-11D-2398-05 TCGA-86-8585-01A-11D-2389-01 5642f9d8-a84b-4ab6-b841-910ac4010e16 TCGA-86-8585-01A-11D-2389-01 +TCGA-86-8668-01 TCGA-86-8668-01 TCGA-86-8668 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 61 L-Lower TCGA-86-8668-F66084 TCGA-86-8668 TCGA-86-8668-01A -22383 0 423 0 Scheduled Follow-up Submission Complete Remission/Response 2014-10-2 FEMALE Lung Bronchioloalveolar Carcinoma Mucinous No C34.3 8253/3 C34.3 YES 1.6 NO 100 NO Peripheral Lung 2 NO NO No M0 N0 T1b Stage IA TCGA-86-8668.be6c4ce2-4c88-41a7-bff6-e5bb157ad3ad.pdf 8668 Other TUMOR FREE Complete Remission/Response NO NO R0 Primary Tumor 01 0.5 7th NO YES NO 86 1 Lung A LIVING 2012 ae6e4491-f510-41b0-9279-d4887504a637 ae6e4491-f510-41b0-9279-d4887504a637 TCGA-86-8668-01A-11D-2398-05 TCGA-86-8668-01A-11D-2389-01 ae6e4491-f510-41b0-9279-d4887504a637 TCGA-86-8668-01A-11D-2389-01 +TCGA-86-8669-01 TCGA-86-8669-01 TCGA-86-8669 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung YES NO NO 64 R-Upper TCGA-86-8669-F66085 TCGA-86-8669 TCGA-86-8669-01A -23443 0 938 849 0 Scheduled Follow-up Submission Complete Remission/Response 2014-10-15 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 1.5 NO 100 NO Peripheral Lung 2.2 NO Distant Metastasis YES 47 No M0 N0 T1b Stage IA TCGA-86-8669.6c8d6319-a235-4757-be34-79286a8da60f.pdf 8669 Preoperative TUMOR FREE Complete Remission/Response Convincing Imaging NO NO R0 Primary Tumor 01 0.4 7th NO YES NO 86 2 Lung A LIVING 2012 1965 b363949d-cc43-4480-8afd-9f4693fe43cc b363949d-cc43-4480-8afd-9f4693fe43cc TCGA-86-8669-01A-11D-2398-05 TCGA-86-8669-01A-11D-2389-01 b363949d-cc43-4480-8afd-9f4693fe43cc TCGA-86-8669-01A-11D-2389-01 +TCGA-86-8671-01 TCGA-86-8671-01 TCGA-86-8671 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 72 R-Upper TCGA-86-8671-F66089 TCGA-86-8671 TCGA-86-8671-01A -26448 0 839 0 Scheduled Follow-up Submission Complete Remission/Response 2014-10-2 FEMALE Lung Papillary Adenocarcinoma No C34.1 8260/3 C34.1 YES 0.8 NO 100 Peripheral Lung 0.9 NO NO No M0 N1 T2b Stage IIB TCGA-86-8671.94c08fb3-35a3-494e-90ee-b8df1d8cf34f.pdf 8671 Other TUMOR FREE Complete Remission/Response NO NO R0 Primary Tumor 01 0.4 7th YES YES NO 86 1 Lung A LIVING 2012 00c7a308-6add-457c-9003-784d4e65c318 00c7a308-6add-457c-9003-784d4e65c318 TCGA-86-8671-01A-11D-2398-05 TCGA-86-8671-01A-11D-2389-01 00c7a308-6add-457c-9003-784d4e65c318 TCGA-86-8671-01A-11D-2389-01 +TCGA-86-8672-01 TCGA-86-8672-01 TCGA-86-8672 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 59 R-Upper TCGA-86-8672-F46401 TCGA-86-8672 TCGA-86-8672-01A -21682 19 0 15 Scheduled Follow-up Submission 2013-8-7 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 1.7 NO NO Central Lung 2.2 NO NO No M0 N0 T3 Stage IIB TCGA-86-8672.df3d9fe7-a56c-4100-9fdb-9fe3e7b11b2a.pdf 8672 TUMOR FREE Complete Remission/Response NO NO R0 Primary Tumor 01 0.4 7th NO YES NO 86 1 Lung A DECEASED 2012 764bce37-06d7-41e7-83d9-ce803dabd5f0 764bce37-06d7-41e7-83d9-ce803dabd5f0 TCGA-86-8672-01A-21D-2398-05 TCGA-86-8672-01A-21D-2389-01 764bce37-06d7-41e7-83d9-ce803dabd5f0 TCGA-86-8672-01A-21D-2389-01 +TCGA-86-8673-01 TCGA-86-8673-01 TCGA-86-8673 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung NO NO YES 61 L-Upper TCGA-86-8673-F59092 TCGA-86-8673 TCGA-86-8673-01A 639 -22571 0 862 636 Scheduled Follow-up Submission Complete Remission/Response 2014-4-30 MALE Lung Bronchioloalveolar Carcinoma Nonmucinous No C34.1 8252/3 C34.1 YES 1.8 NO 2.9 NO Locoregional Recurrence YES 54 No M0 N0 T2 Stage IB TCGA-86-8673.0e5c5229-2b1d-45d6-8fae-02a32fb84988.pdf 8673 TUMOR FREE Complete Remission/Response NO NO R0 Primary Tumor 01 0.5 7th NO YES NO 86 2 Lung A LIVING 2011 1968 ab39e99f-8967-4068-b1e2-49e1fe2298ff ab39e99f-8967-4068-b1e2-49e1fe2298ff TCGA-86-8673-01A-11D-2398-05 TCGA-86-8673-01A-11D-2389-01 ab39e99f-8967-4068-b1e2-49e1fe2298ff TCGA-86-8673-01A-11D-2389-01 +TCGA-86-8674-01 TCGA-86-8674-01 TCGA-86-8674 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 50 R-Middle TCGA-86-8674-F59096 TCGA-86-8674 TCGA-86-8674-01A -18479 0 806 Scheduled Follow-up Submission Complete Remission/Response 2014-4-30 MALE Lung Papillary Adenocarcinoma No C34.2 8260/3 C34.2 YES 1.5 NO Peripheral Lung 2.5 NO NO 37.5 No M0 N1 T2a Stage IIA TCGA-86-8674.463cd118-45ef-4e2f-aca3-39ce953dcb09.pdf 8674 TUMOR FREE Complete Remission/Response NO NO R0 Primary Tumor 01 0.5 2012 7th YES YES NO 86 4 Lung A LIVING 2012 1982 81be01d3-ad98-495f-910c-c33a7b100b53 81be01d3-ad98-495f-910c-c33a7b100b53 TCGA-86-8674-01A-21D-2398-05 TCGA-86-8674-01A-21D-2389-01 81be01d3-ad98-495f-910c-c33a7b100b53 TCGA-86-8674-01A-21D-2389-01 +TCGA-86-A456-01 TCGA-86-A456-01 TCGA-86-A456 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 78 L-Upper TCGA-86-A456-F67789 TCGA-86-A456 TCGA-86-A456-01A -28533 90 0 896 Scheduled Follow-up Submission Complete Remission/Response 2014-11-11 FEMALE Lung Papillary Adenocarcinoma No C34.1 8260/3 C34.1 YES 580 NO 80 Peripheral Lung NO NO true No M0 N0 T1a Stage IA TCGA-86-A456.56606792-5083-4F1E-ABEF-711BACF546E6.pdf A456 Post-Adjuvant Therapy TUMOR FREE Complete Remission/Response NO NO R0 Primary Tumor 01 2009 7th YES NO 86 4 Lung A LIVING 2012 1974 46749725-ef75-479b-9af9-1cb898682e1c 46749725-ef75-479b-9af9-1cb898682e1c TCGA-86-A456-01A-11D-A24I-05 TCGA-86-A456-01A-11D-A24C-01 46749725-ef75-479b-9af9-1cb898682e1c TCGA-86-A456-01A-11D-A24C-01 +TCGA-86-A4D0-01 TCGA-86-A4D0-01 TCGA-86-A4D0 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 48 R-Upper TCGA-86-A4D0-F52852 TCGA-86-A4D0 TCGA-86-A4D0-01A -17607 133 116 0 30 1 NO NO Scheduled Follow-up Submission Complete Remission/Response 2013-12-6 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 920 NO 90 NO NO NO true No M0 N0 T2b Stage IIA TCGA-86-A4D0.80C129A3-A5B6-4B1C-9979-44A307867744.pdf A4D0 Preoperative TUMOR FREE Complete Remission/Response NO NO R0 Primary Tumor 01 7th YES YES NO 86 2 Lung A DECEASED 2012 1983 ae82fe73-dc4c-403b-af98-1d01ad87e732 ae82fe73-dc4c-403b-af98-1d01ad87e732 TCGA-86-A4D0-01A-11D-A24I-05 TCGA-86-A4D0-01A-11D-A24C-01 ae82fe73-dc4c-403b-af98-1d01ad87e732 TCGA-86-A4D0-01A-11D-A24C-01 +TCGA-86-A4JF-01 TCGA-86-A4JF-01 TCGA-86-A4JF TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 56 R-Upper TCGA-86-A4JF-F70857 TCGA-86-A4JF TCGA-86-A4JF-01A -20491 140 737 0 0 4 NO NO Scheduled Follow-up Submission Progressive Disease 2015-3-10 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 940 NO 20 NO Central Lung NO NO true No M0 N0 T3 Stage IIB TCGA-86-A4JF.5D7BD5E2-4575-4169-B07F-DBF4C2307A13.pdf A4JF Post-Adjuvant Therapy WITH TUMOR Complete Remission/Response NO NO R0 Primary Tumor 01 2012 7th YES YES NO 86 4 Lung A DECEASED 2012 b30fef8e-9736-4f6d-9547-cfd9163ebbb9 b30fef8e-9736-4f6d-9547-cfd9163ebbb9 TCGA-86-A4JF-01A-11D-A24U-05 TCGA-86-A4JF-01A-11D-A24O-01 b30fef8e-9736-4f6d-9547-cfd9163ebbb9 TCGA-86-A4JF-01A-11D-A24O-01 +TCGA-86-A4P7-01 TCGA-86-A4P7-01 TCGA-86-A4P7 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 63 L-Lower TCGA-86-A4P7-F66092 TCGA-86-A4P7 TCGA-86-A4P7-01A -23330 220 0 415 0 NO NO Scheduled Follow-up Submission Complete Remission/Response 2014-10-2 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 350 NO 100 NO Peripheral Lung NO NO true No M0 N0 T2a Stage IB TCGA-86-A4P7.E6FEB175-8903-47D5-BBD4-3BF2E95C3B15.pdf A4P7 Other TUMOR FREE Complete Remission/Response NO NO R0 Primary Tumor 01 7th NO YES NO 86 1 Lung A LIVING 2012 3a401a11-c977-45b6-9900-87c6adb7dc09 3a401a11-c977-45b6-9900-87c6adb7dc09 TCGA-86-A4P7-01A-11D-A24U-05 TCGA-86-A4P7-01A-11D-A24O-01 3a401a11-c977-45b6-9900-87c6adb7dc09 TCGA-86-A4P7-01A-11D-A24O-01 +TCGA-86-A4P8-01 TCGA-86-A4P8-01 TCGA-86-A4P8 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 59 R-Lower TCGA-86-A4P8-F65331 TCGA-86-A4P8 TCGA-86-A4P8-01A -21738 98 0 805 85 0 YES FISH YES Scheduled Follow-up Submission Complete Remission/Response 2014-9-22 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 360 NO NO NO NO true No MX N2 T1b Stage IIIA TCGA-86-A4P8.72828D6C-9995-42E2-ABE7-D4BA29B8A987.pdf A4P8 Post-Adjuvant Therapy TUMOR FREE 78 89 74 84 Complete Remission/Response YES YES Primary Tumor 01 7th YES YES NO 86 1 Lung A LIVING 2012 fe82fe98-0116-4657-acb0-36b2093fb639 fe82fe98-0116-4657-acb0-36b2093fb639 TCGA-86-A4P8-01A-11D-A24U-05 TCGA-86-A4P8-01A-11D-A24O-01 fe82fe98-0116-4657-acb0-36b2093fb639 TCGA-86-A4P8-01A-11D-A24O-01 +TCGA-90-6837-01 TCGA-90-6837-01 Quiet C2-Squamous-like Low purity c2 squamous c3 squamous-like c4 miRNA c1uster 9 TCGA-90-6837 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 64 R-Upper TCGA-90-6837-F21659 TCGA-90-6837 TCGA-90-6837-01A -23511 0 758 0 Scheduled Follow-up Submission 2012-5-8 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.8 8070/3 C34.8 YES 0.6 NO NO 0.7 NO 40 No MX N0 T3 Stage IIB TCGA-90-6837.65ca38c2-7497-4dee-a054-5d2687171928.pdf 6837 Other TUMOR FREE Complete Remission/Response NO NO R0 Primary Tumor 01 0.3 2009 7th YES YES NO 90 4 Lung A LIVING 2011 91c5d28b-85af-49ff-8307-140707d13d0e 91c5d28b-85af-49ff-8307-140707d13d0e TCGA-90-6837-01A-11D-1947-05 TCGA-90-6837-01A-11D-1943-01 91c5d28b-85af-49ff-8307-140707d13d0e TCGA-90-6837-01A-11D-1943-01 TCGA-90-6837-01A-13-2194-20 +TCGA-90-6837-11 TCGA-90-6837-11 C2-Squamous-like TCGA-90-6837 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 64 R-Upper TCGA-90-6837-F21659 TCGA-90-6837 TCGA-90-6837-11A -23511 0 758 0 Scheduled Follow-up Submission 2012-5-8 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.8 8070/3 C34.8 YES 0.4 NO NO 0.7 NO 40 No MX N0 T3 Stage IIB 6837 Other TUMOR FREE Complete Remission/Response NO NO R0 Solid Tissue Normal 11 0.3 2009 7th YES YES NO 90 4 Lung A LIVING 2011 6178dbb9-01d2-4ba3-8315-f2add186879a 6178dbb9-01d2-4ba3-8315-f2add186879a 6178dbb9-01d2-4ba3-8315-f2add186879a +TCGA-90-7766-01 TCGA-90-7766-01 Squamous Cluster 5 squamous c3 miRNA cluster 7 TCGA-90-7766 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 66 R-Upper TCGA-90-7766-F37922 TCGA-90-7766 TCGA-90-7766-01A -24354 0 289 289 NO NO Scheduled Follow-up Submission 2012-12-6 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 1 NO NO 2.2 NO Locoregional Recurrence YES 30 Yes MX N0 T1b Stage IA TCGA-90-7766.820f1ee0-19ce-4e5e-a3f5-f42a669ff123.pdf 7766 WITH TUMOR Progressive Disease Biopsy with Histologic Confirmation NO NO R0 Primary Tumor 01 0.6 7th NO YES NO 90 2 Lung A LIVING 2011 1981 0c5d09fe-e0e0-4cfa-9cd8-802b5725a3f6 0c5d09fe-e0e0-4cfa-9cd8-802b5725a3f6 TCGA-90-7766-01A-21D-2123-05 TCGA-90-7766-01A-21D-2121-01 0c5d09fe-e0e0-4cfa-9cd8-802b5725a3f6 TCGA-90-7766-01A-21D-2121-01 TCGA-90-7766-01A-23-2195-20 +TCGA-90-7767-01 TCGA-90-7767-01 High Cluster 13 (HNSC-LUSC) squamous c3 miRNA cluster 4 TCGA-90-7767 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 56 R-Upper TCGA-90-7767-F37927 TCGA-90-7767 TCGA-90-7767-01A -20534 0 89 1 NO NO Scheduled Follow-up Submission 2012-12-6 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 1.1 NO NO 1.6 YES 25 No MX N1 T2b Stage IIB TCGA-90-7767.a9d672eb-90b2-4a1a-8540-d2d7370498d9.pdf 7767 Other TUMOR FREE NO R0 Primary Tumor 01 0.7 1991 7th YES NO 90 3 Lung A LIVING 2011 1981 2e83ed1e-fbff-4729-8dfa-c070aa13c78e 2e83ed1e-fbff-4729-8dfa-c070aa13c78e TCGA-90-7767-01A-11D-2123-05 TCGA-90-7767-01A-11D-2121-01 2e83ed1e-fbff-4729-8dfa-c070aa13c78e TCGA-90-7767-01A-11D-2121-01 TCGA-90-7767-01A-13-2195-20 +TCGA-90-7767-11 TCGA-90-7767-11 TCGA-90-7767 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 56 R-Upper TCGA-90-7767-F37927 TCGA-90-7767 TCGA-90-7767-11A -20534 0 89 1 NO NO Scheduled Follow-up Submission 2012-12-6 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.6 NO NO 1.7 YES 25 No MX N1 T2b Stage IIB 7767 Other TUMOR FREE NO R0 Solid Tissue Normal 11 0.6 1991 7th YES NO 90 3 Lung A LIVING 2011 1981 62f93124-31ae-499b-b550-4f24be28024e 62f93124-31ae-499b-b550-4f24be28024e 62f93124-31ae-499b-b550-4f24be28024e +TCGA-90-7769-01 TCGA-90-7769-01 High Cluster 13 (HNSC-LUSC) squamous c3 miRNA cluster 11 TCGA-90-7769 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 55 TCGA-90-7769-F37973 TCGA-90-7769 TCGA-90-7769-01A -20276 0 358 66 1 NO NO Scheduled Follow-up Submission Complete Remission/Response 2012-12-7 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.9 8070/3 C34.9 YES 1.3 NO NO 2.5 NO NO 36 No MX N1 T2b Stage IIB TCGA-90-7769.251df531-37e8-4728-92e4-3345f72685dc.pdf 7769 Other TUMOR FREE 59 53 62 52 Complete Remission/Response YES NO R0 Primary Tumor 01 1 1995 7th NO YES NO 90 3 Lung A LIVING 2011 1971 c2624390-7f99-4346-b10d-568de512a8f9 c2624390-7f99-4346-b10d-568de512a8f9 TCGA-90-7769-01A-11D-2123-05 TCGA-90-7769-01A-11D-2121-01 c2624390-7f99-4346-b10d-568de512a8f9 TCGA-90-7769-01A-11D-2121-01 TCGA-90-7769-01A-13-2195-20 +TCGA-90-7964-01 TCGA-90-7964-01 Squamous Cluster 5 squamous-like c4 miRNA cluster 4 TCGA-90-7964 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 70 R-Upper TCGA-90-7964-F42527 TCGA-90-7964 TCGA-90-7964-01A -25646 0 428 40 1 NO NO Scheduled Follow-up Submission Complete Remission/Response 2013-4-23 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 1.5 NO NO 2 NO NO 180 Yes MX N0 T2a Stage IB TCGA-90-7964.973e9adb-b9e8-419c-a3de-6f682ff684ab.pdf 7964 Post-Adjuvant Therapy TUMOR FREE 60 64 61 60 Complete Remission/Response YES NO R0 Primary Tumor 01 0.4 2011 7th NO YES NO 90 4 Lung A LIVING 2011 1951 295ea773-28fb-40fe-af98-d8126f09382b 295ea773-28fb-40fe-af98-d8126f09382b TCGA-90-7964-01A-21D-2185-05 TCGA-90-7964-01A-21D-2183-01 295ea773-28fb-40fe-af98-d8126f09382b TCGA-90-7964-01A-21D-2183-01 +TCGA-90-A4ED-01 TCGA-90-A4ED-01 TCGA-90-A4ED TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 69 R-Upper TCGA-90-A4ED-F58338 TCGA-90-A4ED TCGA-90-A4ED-01A -25453 168 0 615 63 0 NO NO Scheduled Follow-up Submission Complete Remission/Response 2014-4-7 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 150 NO NO NO NO 30 false No MX N0 T2a Stage IB TCGA-90-A4ED.D0C782A7-3180-4273-90C0-1A2F16FE293B.pdf A4ED Preoperative TUMOR FREE 125 Complete Remission/Response YES NO Primary Tumor 01 1992 7th NO YES NO 90 3 Lung A LIVING 2012 1972 c7fdad9d-8804-403c-8171-c6fff106b33d c7fdad9d-8804-403c-8171-c6fff106b33d TCGA-90-A4ED-01A-31D-A258-05 TCGA-90-A4ED-01A-31D-A256-01 c7fdad9d-8804-403c-8171-c6fff106b33d TCGA-90-A4ED-01A-31D-A256-01 +TCGA-90-A4EE-01 TCGA-90-A4EE-01 TCGA-90-A4EE TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 53 Bronchial TCGA-90-A4EE-F58339 TCGA-90-A4EE TCGA-90-A4EE-01A -19676 136 0 688 45 YES Other YES Scheduled Follow-up Submission Complete Remission/Response 2014-4-7 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.9 8070/3 C34.9 YES 190 NO YES YES Other NO NO 68 false No MX N1 T2a Stage IIA TCGA-90-A4EE.254583DA-8861-45AB-A261-7EFA42C20A98.pdf A4EE TUMOR FREE 60 60 Complete Remission/Response YES NO Primary Tumor 01 7th YES YES NO 90 2 Lung A LIVING 2012 1978 ce3fabfc-8842-4c41-bf9a-e1c75872c8c0 ce3fabfc-8842-4c41-bf9a-e1c75872c8c0 TCGA-90-A4EE-01A-11D-A258-05 TCGA-90-A4EE-01A-11D-A256-01 ce3fabfc-8842-4c41-bf9a-e1c75872c8c0 TCGA-90-A4EE-01A-11D-A256-01 +TCGA-90-A59Q-01 TCGA-90-A59Q-01 TCGA-90-A59Q TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung NO YES NO 61 R-Upper TCGA-90-A59Q-F62045 TCGA-90-A59Q TCGA-90-A59Q-01A -22420 52 322 0 269 274 84 2 NO Scheduled Follow-up Submission Progressive Disease 2014-7-11 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 190 NO NO NO Distant Metastasis YES 80 false No MX N1 T2a Stage IIA TCGA-90-A59Q.EB15D79B-A4EF-4393-8759-E623A7282E0C.pdf A59Q Post-Adjuvant Therapy WITH TUMOR 94 Complete Remission/Response Convincing Imaging YES YES R0 Primary Tumor 01 7th YES YES NO 90 2 Lung A DECEASED 2012 1972 1a270e7a-4611-41ee-9bfe-c123a45049f5 1a270e7a-4611-41ee-9bfe-c123a45049f5 TCGA-90-A59Q-01A-11D-A26N-05 TCGA-90-A59Q-01A-11D-A26L-01 1a270e7a-4611-41ee-9bfe-c123a45049f5 TCGA-90-A59Q-01A-11D-A26L-01 +TCGA-91-6828-01 none none none none Y Y none none none Magnoid none p.G12V none none none none none Acinar predominant Adc Acinar predominant Adc none 0 TCGA-91-6828-01 High C1-LUAD-enriched Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 6 mutation cluster 12 TCGA-91-6828 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 70 L-Lower TCGA-91-6828-F21014 TCGA-91-6828 TCGA-91-6828-01A -25870 0 323 71 2 Scheduled Follow-up Submission 2012-5-8 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 0.8 NO NO 1.5 NO No M0 N0 T1a Stage IA TCGA-91-6828.8b494f5f-5e6f-43bb-8748-0cb2d36eab37.pdf 6828 Preoperative TUMOR FREE 81 Complete Remission/Response YES NO R0 Primary Tumor 01 0.4 1993 7th NO YES NO 91 3 Current reformed smoker for > 15 years Lung A LIVING 2011 e3958992-3206-4cdd-8bc9-38fd43853800 TCGA-91-6828-01A-11D-1855-08 e3958992-3206-4cdd-8bc9-38fd43853800 TCGA-91-6828-01A-11D-1856-05 TCGA-91-6828-01A-11D-1854-01 e3958992-3206-4cdd-8bc9-38fd43853800 TCGA-91-6828-01A-11D-1854-01 TCGA-91-6828-01A-13-2191-20 +TCGA-91-6828-11 none none none none Y Y none none none Magnoid none p.G12V none none none none none Acinar predominant Adc Acinar predominant Adc none 0 TCGA-91-6828-11 C1-LUAD-enriched mutation cluster 12 TCGA-91-6828 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 70 L-Lower TCGA-91-6828-F21014 TCGA-91-6828 TCGA-91-6828-11A -25870 0 323 71 2 Scheduled Follow-up Submission 2012-5-8 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 0.9 NO NO 1.4 NO No M0 N0 T1a Stage IA 6828 Preoperative TUMOR FREE 81 Complete Remission/Response YES NO R0 Solid Tissue Normal 11 0.3 1993 7th NO YES NO 91 3 Current reformed smoker for > 15 years Lung A LIVING 2011 e7e90370-f414-4668-910c-c556613be671 e7e90370-f414-4668-910c-c556613be671 e7e90370-f414-4668-910c-c556613be671 +TCGA-91-6829-01 2.78 0.48 none none none none N N none none none 0.2 Squamoid none none none none none none none Acinar predominant Adc Acinar predominant Adc none 0 TCGA-91-6829-01 High C1-LUAD-enriched Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 5 mutation cluster 8 TCGA-91-6829 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 78 R-Lower TCGA-91-6829-F32591 TCGA-91-6829 TCGA-91-6829-01A -28841 1258 0 3 Scheduled Follow-up Submission Progressive Disease 2012-6-4 MALE Lung Bronchioloalveolar Carcinoma Nonmucinous No C34.3 8252/3 C34.3 YES 0.5 NO 0 NO 0.9 NO NO 94.5 No MX N0 T2 Stage IB TCGA-91-6829.d21d20d3-a384-417a-aa95-11f4b6930af0.pdf 6829 Other TUMOR FREE Progressive Disease NO R0 Primary Tumor 01 0.4 2003 5th NO NO YES 91 4 Current reformed smoker for < or = 15 years Lung A DECEASED 2001 1940 b4e31dbe-0923-401e-a664-e779914254b8 TCGA-91-6829-01A-21D-1855-08 b4e31dbe-0923-401e-a664-e779914254b8 TCGA-91-6829-01A-21D-1856-05 TCGA-91-6829-01A-21D-1854-01 b4e31dbe-0923-401e-a664-e779914254b8 TCGA-91-6829-01A-21D-1854-01 TCGA-91-6829-01A-23-2191-20 +TCGA-91-6829-11 2.78 0.48 none none none none N N none none none 0.2 Squamoid none none none none none none none Acinar predominant Adc Acinar predominant Adc none 0 TCGA-91-6829-11 C1-LUAD-enriched mutation cluster 8 TCGA-91-6829 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 78 R-Lower TCGA-91-6829-F32591 TCGA-91-6829 TCGA-91-6829-11A -28841 1258 0 3 Scheduled Follow-up Submission Progressive Disease 2012-6-4 MALE Lung Bronchioloalveolar Carcinoma Nonmucinous No C34.3 8252/3 C34.3 YES 0.8 NO 0 NO 1.1 NO NO 94.5 No MX N0 T2 Stage IB 6829 Other TUMOR FREE Progressive Disease NO R0 Solid Tissue Normal 11 0.4 2003 5th NO NO YES 91 4 Current reformed smoker for < or = 15 years Lung A DECEASED 2001 1940 d3b983d1-2665-4cdd-893e-4f120dc43346 d3b983d1-2665-4cdd-893e-4f120dc43346 d3b983d1-2665-4cdd-893e-4f120dc43346 +TCGA-91-6830-01 TCGA-91-6830-01 Squamous C1-LUAD-enriched Low purity c2 squamous c3 LUAD-like c10 miRNA c1uster 9 TCGA-91-6830 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung NO YES YES 65 L-Upper TCGA-91-6830-F32595 TCGA-91-6830 TCGA-91-6830-01A 18 -23922 0 60 18 Scheduled Follow-up Submission 2012-6-4 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.7 NO NO 1.6 YES Distant Metastasis YES 12 No MX N1 T1 Stage IIA TCGA-91-6830.b2952294-4a8a-4c55-bcd0-17ada4209841.pdf 6830 WITH TUMOR Biopsy with Histologic Confirmation NO Primary Tumor 01 0.3 2002 5th NO NO YES 91 4 Lung A LIVING 2002 1990 f61ba831-745d-468c-a3b0-0229000926f5 f61ba831-745d-468c-a3b0-0229000926f5 TCGA-91-6830-01A-11D-1947-05 TCGA-91-6830-01A-11D-1943-01 f61ba831-745d-468c-a3b0-0229000926f5 TCGA-91-6830-01A-11D-1943-01 TCGA-91-6830-01A-13-2191-20 +TCGA-91-6831-01 TCGA-91-6831-01 High C1-LUAD-enriched Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 4 mutation cluster 2 TCGA-91-6831 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 66 R-Middle TCGA-91-6831-F32636 TCGA-91-6831 TCGA-91-6831-01A -24436 0 310 Scheduled Follow-up Submission Complete Remission/Response 2012-6-5 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.2 8140/3 C34.2 YES 0.6 NO NO 0.6 YES NO No MX N0 T2 Stage IB TCGA-91-6831.21f30ab4-751e-4ef5-bffa-75d5086ea1cb.pdf 6831 TUMOR FREE Complete Remission/Response NO NO Primary Tumor 01 0.4 5th NO NO YES 91 2 Lung A LIVING 2001 860fa33f-75d9-480d-92e7-2a5a45b35433 TCGA-91-6831-01A-11D-1855-08 860fa33f-75d9-480d-92e7-2a5a45b35433 TCGA-91-6831-01A-11D-1856-05 TCGA-91-6831-01A-11D-1854-01 860fa33f-75d9-480d-92e7-2a5a45b35433 TCGA-91-6831-01A-11D-1854-01 TCGA-91-6831-01A-13-2191-20 +TCGA-91-6831-11 TCGA-91-6831-11 C1-LUAD-enriched mutation cluster 2 TCGA-91-6831 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 66 R-Middle TCGA-91-6831-F32636 TCGA-91-6831 TCGA-91-6831-11A -24436 0 310 Scheduled Follow-up Submission Complete Remission/Response 2012-6-5 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.2 8140/3 C34.2 YES 0.6 NO NO 1.3 YES NO No MX N0 T2 Stage IB 6831 TUMOR FREE Complete Remission/Response NO NO Solid Tissue Normal 11 0.4 5th NO NO YES 91 2 Lung A LIVING 2001 292dfcd4-8c49-4348-9622-87b52f593ac3 292dfcd4-8c49-4348-9622-87b52f593ac3 292dfcd4-8c49-4348-9622-87b52f593ac3 +TCGA-91-6835-01 none none none none Y Y p.L858R none none Squamoid none none none none none none none Solid predominant Adc Solid predominant Adc none 0 TCGA-91-6835-01 High C1-LUAD-enriched Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 4 mutation cluster 14 TCGA-91-6835 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 81 R-Lower TCGA-91-6835-F32643 TCGA-91-6835 TCGA-91-6835-01A -29887 0 79 78 NO Scheduled Follow-up Submission Complete Remission/Response 2012-6-5 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 0.5 NO NO 1.1 YES NO 25 No M0 N0 T1 Stage IA TCGA-91-6835.bb4510c1-addd-42a3-9439-dfc7e43078d3.pdf 6835 TUMOR FREE 91 75 Complete Remission/Response YES NO R0 Primary Tumor 01 0.4 1976 7th NO NO YES 91 3 Current reformed smoker for > 15 years Lung A LIVING 2010 4502921a-1650-4721-b814-c9435fe6042d TCGA-91-6835-01A-11D-1855-08 4502921a-1650-4721-b814-c9435fe6042d TCGA-91-6835-01A-11D-1856-05 TCGA-91-6835-01A-11D-1854-01 4502921a-1650-4721-b814-c9435fe6042d TCGA-91-6835-01A-11D-1854-01 TCGA-91-6835-01A-13-2191-20 +TCGA-91-6835-11 none none none none Y Y p.L858R none none Squamoid none none none none none none none Solid predominant Adc Solid predominant Adc none 0 TCGA-91-6835-11 C1-LUAD-enriched mutation cluster 14 TCGA-91-6835 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 81 R-Lower TCGA-91-6835-F32643 TCGA-91-6835 TCGA-91-6835-11A -29887 0 79 78 NO Scheduled Follow-up Submission Complete Remission/Response 2012-6-5 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 0.5 NO NO 1.5 YES NO 25 No M0 N0 T1 Stage IA 6835 TUMOR FREE 91 75 Complete Remission/Response YES NO R0 Solid Tissue Normal 11 0.4 1976 7th NO NO YES 91 3 Current reformed smoker for > 15 years Lung A LIVING 2010 183b2543-2665-403a-a8c0-7ae668082f2d 183b2543-2665-403a-a8c0-7ae668082f2d 183b2543-2665-403a-a8c0-7ae668082f2d +TCGA-91-6836-01 TCGA-91-6836-01 High C1-LUAD-enriched Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 4 mutation cluster 11 TCGA-91-6836 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 52 R-Upper TCGA-91-6836-F32646 TCGA-91-6836 TCGA-91-6836-01A -19216 0 417 97 NO Scheduled Follow-up Submission Complete Remission/Response 2012-6-5 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.6 NO NO 0.9 NO NO 50 Yes MX N0 T2 Stage IB TCGA-91-6836.89441c7c-1e09-4b73-8cc3-27cba26f3bd3.pdf 6836 TUMOR FREE 101 109 108 Complete Remission/Response YES NO Primary Tumor 01 0.4 7th NO NO YES 91 2 Lung A LIVING 2010 1973 8ccc7a37-a9a4-4d77-9126-c8513c20bb29 TCGA-91-6836-01A-21D-1855-08 8ccc7a37-a9a4-4d77-9126-c8513c20bb29 TCGA-91-6836-01A-21D-1856-05 TCGA-91-6836-01A-21D-1854-01 8ccc7a37-a9a4-4d77-9126-c8513c20bb29 TCGA-91-6836-01A-21D-1854-01 TCGA-91-6836-01A-23-2191-20 +TCGA-91-6836-11 TCGA-91-6836-11 C1-LUAD-enriched mutation cluster 11 TCGA-91-6836 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 52 R-Upper TCGA-91-6836-F32646 TCGA-91-6836 TCGA-91-6836-11A -19216 0 417 97 NO Scheduled Follow-up Submission Complete Remission/Response 2012-6-5 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.6 NO NO 0.6 NO NO 50 Yes MX N0 T2 Stage IB 6836 TUMOR FREE 101 109 108 Complete Remission/Response YES NO Solid Tissue Normal 11 0.5 7th NO NO YES 91 2 Lung A LIVING 2010 1973 de68950c-3885-4bfe-b23e-2d218787ca15 de68950c-3885-4bfe-b23e-2d218787ca15 de68950c-3885-4bfe-b23e-2d218787ca15 +TCGA-91-6840-01 2.83 0.62 none none none none N N none none none 0.25 Magnoid none none none none none none none Solid predominant Adc Solid predominant Adc none 0 TCGA-91-6840-01 High C1-LUAD-enriched Low purity c2 squamous c3 LUAD-like c10 miRNA cluster 2 TCGA-91-6840 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 59 R-Upper TCGA-91-6840-F21664 TCGA-91-6840 TCGA-91-6840-01A -21854 0 372 Scheduled Follow-up Submission 2012-5-8 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.5 NO NO 0.7 NO 50 No M0 N0 T1b Stage IA TCGA-91-6840.2f5322c3-f57f-4252-8e17-e5a964e81793.pdf 6840 TUMOR FREE Complete Remission/Response NO NO R0 Primary Tumor 01 0.4 1996 7th NO YES NO 91 3 Current reformed smoker for > 15 years Lung A LIVING 2011 1971 64f425a9-2260-4cd3-8ddd-c43ac410b1a4 64f425a9-2260-4cd3-8ddd-c43ac410b1a4 TCGA-91-6840-01A-11D-1947-05 TCGA-91-6840-01A-11D-1943-01 64f425a9-2260-4cd3-8ddd-c43ac410b1a4 TCGA-91-6840-01A-11D-1943-01 TCGA-91-6840-01A-13-2191-20 +TCGA-91-6847-01 3.86 0.86 none none none none Y Y p.L861Q none none 0.24 Squamoid none none none p.Y321H none none none Acinar predominant Adc Acinar predominant Adc none 0 TCGA-91-6847-01 BRCA-LUAD+ C1-LUAD-enriched Cluster 6 squamous c3 RNA cluster 14 miRNA cluster 12 TCGA-91-6847 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung NO YES NO 62 R-Lower TCGA-91-6847-F32637 TCGA-91-6847 TCGA-91-6847-01A -22862 0 842 772 Scheduled Follow-up Submission Stable Disease 2012-6-5 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 0.4 NO NO 1.1 YES Distant Metastasis YES No MX N0 T2 Stage IB TCGA-91-6847.4e40d97c-ca3c-41ec-b5c5-eb2f85ee29b3.pdf 6847 WITH TUMOR Progressive Disease Convincing Imaging YES Primary Tumor 01 0.3 1967 5th NO NO YES 91 3 Current reformed smoker for > 15 years Lung A LIVING 2002 0c96bb0f-11f1-421c-b2c5-55458ba95d97 0c96bb0f-11f1-421c-b2c5-55458ba95d97 TCGA-91-6847-01A-11D-1947-05 TCGA-91-6847-01A-11D-1943-01 0c96bb0f-11f1-421c-b2c5-55458ba95d97 TCGA-91-6847-01A-11D-1943-01 TCGA-91-6847-01A-13-2191-20 +TCGA-91-6847-11 3.86 0.86 none none none none Y Y p.L861Q none none 0.24 Squamoid none none none p.Y321H none none none Acinar predominant Adc Acinar predominant Adc none 0 TCGA-91-6847-11 C1-LUAD-enriched TCGA-91-6847 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung NO YES NO 62 R-Lower TCGA-91-6847-F32637 TCGA-91-6847 TCGA-91-6847-11A -22862 0 842 772 Scheduled Follow-up Submission Stable Disease 2012-6-5 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 0.5 NO NO 1.2 YES Distant Metastasis YES No MX N0 T2 Stage IB 6847 WITH TUMOR Progressive Disease Convincing Imaging YES Solid Tissue Normal 11 0.3 1967 5th NO NO YES 91 3 Current reformed smoker for > 15 years Lung A LIVING 2002 32f582db-018c-4134-9998-79138bf301f2 32f582db-018c-4134-9998-79138bf301f2 32f582db-018c-4134-9998-79138bf301f2 +TCGA-91-6848-01 TCGA-91-6848-01 BRCA-LUAD+ C12-small-various BRCA CIMP c7 squamous c3 RNA cluster 2 miRNA c1uster 9 TCGA-91-6848 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 59 L-Upper TCGA-91-6848-F32641 TCGA-91-6848 TCGA-91-6848-01A -21829 0 224 Scheduled Follow-up Submission Complete Remission/Response 2012-6-5 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.8 NO YES NO 1.1 YES NO No MX N2 T2 Stage IIIA TCGA-91-6848.a790e051-b741-4913-aff6-5a48c9e8e8cd.pdf 6848 TUMOR FREE Complete Remission/Response NO Primary Tumor 01 0.6 2007 6th YES NO YES 91 4 Lung A LIVING 2009 0cfbefba-24ff-474b-8bfa-b44a1f71b48c 0cfbefba-24ff-474b-8bfa-b44a1f71b48c TCGA-91-6848-01A-11D-1947-05 TCGA-91-6848-01A-11D-1943-01 0cfbefba-24ff-474b-8bfa-b44a1f71b48c TCGA-91-6848-01A-11D-1943-01 TCGA-91-6848-01A-13-2191-20 +TCGA-91-6849-01 1.93 0.6 none none none none Y Y none none p.G240* 0.31 Bronchioid none p.G12C none none none none none Acinar predominant Adc Acinar predominant Adc p.G288_splice 0 TCGA-91-6849-01 BRCA-LUAD+ C1-LUAD-enriched Cluster 6 squamous c3 LUAD-like c10 miRNA c1uster 9 TCGA-91-6849 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 75 L-Upper TCGA-91-6849-F32642 TCGA-91-6849 TCGA-91-6849-01A -27676 0 35 66 YES Scheduled Follow-up Submission 2012-6-5 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.5 NO 90 NO 1.5 YES 30 No MX N2 T2 Stage IIIA TCGA-91-6849.910d922e-8180-48ba-9e13-0f177dc71b2d.pdf 6849 Preoperative 75 86 76 88 YES Primary Tumor 01 0.4 1976 6th NO YES 91 3 Current reformed smoker for > 15 years Lung A LIVING 2009 1946 821a5315-e4a2-4005-b5fc-572b32a2386a 821a5315-e4a2-4005-b5fc-572b32a2386a TCGA-91-6849-01A-11D-1947-05 TCGA-91-6849-01A-11D-1943-01 821a5315-e4a2-4005-b5fc-572b32a2386a TCGA-91-6849-01A-11D-1943-01 TCGA-91-6849-01A-13-2191-20 +TCGA-91-6849-11 1.93 0.6 none none none none Y Y none none p.G240* 0.31 Bronchioid none p.G12C none none none none none Acinar predominant Adc Acinar predominant Adc p.G288_splice 0 TCGA-91-6849-11 C1-LUAD-enriched TCGA-91-6849 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 75 L-Upper TCGA-91-6849-F32642 TCGA-91-6849 TCGA-91-6849-11A -27676 0 35 66 YES Scheduled Follow-up Submission 2012-6-5 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.6 NO 90 NO 0.7 YES 30 No MX N2 T2 Stage IIIA 6849 Preoperative 75 86 76 88 YES Solid Tissue Normal 11 0.6 1976 6th NO YES 91 3 Current reformed smoker for > 15 years Lung A LIVING 2009 1946 9aec6b23-f6a0-4400-b72c-d7c3d16293f4 9aec6b23-f6a0-4400-b72c-d7c3d16293f4 9aec6b23-f6a0-4400-b72c-d7c3d16293f4 +TCGA-91-7771-01 none none none none N N none none p.R47G Bronchioid none none none none none none none Solid predominant Adc Solid predominant Adc none 0 TCGA-91-7771-01 High C1-LUAD-enriched Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 5 TCGA-91-7771 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 62 R-Upper TCGA-91-7771-F37916 TCGA-91-7771 TCGA-91-7771-01A -22926 0 492 NO Scheduled Follow-up Submission Complete Remission/Response 2012-12-6 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.9 NO NO 3 NO NO 75 Yes MX N0 T3 Stage IIB TCGA-91-7771.a8247167-a991-441b-b60a-9f69f4c5d9da.pdf 7771 TUMOR FREE Complete Remission/Response NO NO Primary Tumor 01 0.6 2011 7th YES YES NO 91 4 Current reformed smoker for < or = 15 years Lung A LIVING 2011 6f2e3098-e76b-411f-9d8e-cd8594ed1175 6f2e3098-e76b-411f-9d8e-cd8594ed1175 TCGA-91-7771-01A-11D-2168-05 TCGA-91-7771-01A-11D-2166-01 6f2e3098-e76b-411f-9d8e-cd8594ed1175 TCGA-91-7771-01A-11D-2166-01 TCGA-91-7771-01A-13-2192-20 +TCGA-91-8496-01 TCGA-91-8496-01 TCGA-91-8496 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 63 L-Lower TCGA-91-8496-F45467 TCGA-91-8496 TCGA-91-8496-01A -23358 0 505 0 NO NO Scheduled Follow-up Submission Complete Remission/Response 2013-7-15 FEMALE Lung Bronchioloalveolar Carcinoma Nonmucinous No C34.3 8252/3 C34.3 YES 0.4 NO NO 2 NO NO No MX NX T2a Stage IB TCGA-91-8496.d513e826-62f5-4e2d-95ef-7b48fea0643a.pdf 8496 Preoperative TUMOR FREE Complete Remission/Response NO NO Primary Tumor 01 0.3 7th NO YES NO 91 1 Lung A LIVING 2011 0a85f2bd-d169-44e4-bde3-c92ff92ddc94 0a85f2bd-d169-44e4-bde3-c92ff92ddc94 TCGA-91-8496-01A-11D-2398-05 TCGA-91-8496-01A-11D-2389-01 0a85f2bd-d169-44e4-bde3-c92ff92ddc94 TCGA-91-8496-01A-11D-2389-01 +TCGA-91-8497-01 TCGA-91-8497-01 TCGA-91-8497 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 75 R-Upper TCGA-91-8497-F58334 TCGA-91-8497 TCGA-91-8497-01A -27632 434 0 174 Scheduled Follow-up Submission Complete Remission/Response 2014-4-7 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.7 NO NO 1.8 NO NO No MX N0 T1a Stage IA TCGA-91-8497.e393a314-6d4d-41f4-a9d3-7d67ab25713b.pdf 8497 TUMOR FREE Complete Remission/Response NO NO Primary Tumor 01 0.4 7th NO YES NO 91 1 Lung A DECEASED 2012 f5c78889-7c7f-4b88-8660-6560b49b7be4 f5c78889-7c7f-4b88-8660-6560b49b7be4 TCGA-91-8497-01A-11D-2398-05 TCGA-91-8497-01A-11D-2389-01 f5c78889-7c7f-4b88-8660-6560b49b7be4 TCGA-91-8497-01A-11D-2389-01 +TCGA-91-8499-01 TCGA-91-8499-01 TCGA-91-8499 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 76 L-Lower TCGA-91-8499-F37976 TCGA-91-8499 TCGA-91-8499-01A -27853 0 36 YES Scheduled Follow-up Submission 2012-12-7 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 0.6 NO NO 1.2 YES NO 90 No MX N0 T1b Stage IA TCGA-91-8499.99ab423d-db99-4ef1-bf1f-a8dddb94e788.pdf 8499 49 YES NO Primary Tumor 01 0.4 7th NO YES NO 91 2 Lung A LIVING 2011 1945 9cf68c53-c1a5-4102-aeba-a2083335954e 9cf68c53-c1a5-4102-aeba-a2083335954e TCGA-91-8499-01A-11D-2398-05 TCGA-91-8499-01A-11D-2389-01 9cf68c53-c1a5-4102-aeba-a2083335954e TCGA-91-8499-01A-11D-2389-01 +TCGA-91-A4BC-01 TCGA-91-A4BC-01 TCGA-91-A4BC TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 59 R-Upper TCGA-91-A4BC-F45192 TCGA-91-A4BC TCGA-91-A4BC-01A -21565 225 0 44 44 NO Scheduled Follow-up Submission 2013-7-10 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 280 NO NO YES 30 false Yes, History of Synchronous/Bilateral Malignancy MX N0 T2b Stage IIA TCGA-91-A4BC.6C586925-8FAC-4A75-8A67-574B24B9D0BA.pdf A4BC 69 YES Primary Tumor 01 2001 7th YES NO 91 4 Lung A LIVING 2012 1976 439820e6-1011-461e-8002-5af1470a7827 439820e6-1011-461e-8002-5af1470a7827 TCGA-91-A4BC-01A-11D-A24I-05 TCGA-91-A4BC-01A-11D-A24C-01 439820e6-1011-461e-8002-5af1470a7827 TCGA-91-A4BC-01A-11D-A24C-01 +TCGA-91-A4BD-01 TCGA-91-A4BD-01 TCGA-91-A4BD TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 78 L-Lower TCGA-91-A4BD-F58335 TCGA-91-A4BD TCGA-91-A4BD-01A -28544 162 0 603 94 1 NO Scheduled Follow-up Submission Complete Remission/Response 2014-4-7 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 220 NO NO NO NO false No MX N1 T1b Stage IIA TCGA-91-A4BD.5767AA19-6B73-4FC8-BC3E-930044E249A3.pdf A4BD Other TUMOR FREE 70 92 Complete Remission/Response YES NO RX Primary Tumor 01 1981 7th NO YES NO 91 3 Lung A LIVING 2012 883fcc6f-4ef3-4c93-872a-a096b87bd85b 883fcc6f-4ef3-4c93-872a-a096b87bd85b TCGA-91-A4BD-01A-11D-A24I-05 TCGA-91-A4BD-01A-11D-A24C-01 883fcc6f-4ef3-4c93-872a-a096b87bd85b TCGA-91-A4BD-01A-11D-A24C-01 +TCGA-92-7340-01 TCGA-92-7340-01 Kirc+ C2-Squamous-like BRCA CIMP c7 squamous c3 squamous-like c4 miRNA cluster 4 TCGA-92-7340 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 45 R-Upper TCGA-92-7340-F18337 TCGA-92-7340 TCGA-92-7340-01A -16447 0 82 1 NO NO Scheduled Follow-up Submission Stable Disease 2011-11-14 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 1.1 NO 90 NO Central Lung 1.7 NO 15 No MX N1 T2a Stage IIA TCGA-92-7340.ec11729e-f821-4f7b-91c5-0ed2026e5881.pdf 7340 Adjuvant therapy WITH TUMOR Stable Disease NO R1 Primary Tumor 01 0.3 2000 7th YES YES NO 92 4 Lung A LIVING 2011 1985 7828187d-3fbc-4139-8546-c6d92fef3e0f 7828187d-3fbc-4139-8546-c6d92fef3e0f TCGA-92-7340-01A-21D-2043-05 TCGA-92-7340-01A-21D-2041-01 7828187d-3fbc-4139-8546-c6d92fef3e0f TCGA-92-7340-01A-21D-2041-01 TCGA-92-7340-01A-23-2195-20 +TCGA-92-7340-11 TCGA-92-7340-11 C2-Squamous-like TCGA-92-7340 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 45 R-Upper TCGA-92-7340-F18337 TCGA-92-7340 TCGA-92-7340-11A -16447 0 82 1 NO NO Scheduled Follow-up Submission Stable Disease 2011-11-14 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 1.1 NO 90 NO Central Lung 1.5 NO 15 No MX N1 T2a Stage IIA 7340 Adjuvant therapy WITH TUMOR Stable Disease NO R1 Solid Tissue Normal 11 0.3 2000 7th YES YES NO 92 4 Lung A LIVING 2011 1985 3a0a356b-ee3a-4084-81d7-04b74a62dd96 3a0a356b-ee3a-4084-81d7-04b74a62dd96 3a0a356b-ee3a-4084-81d7-04b74a62dd96 +TCGA-92-7341-01 TCGA-92-7341-01 High Cluster 13 (HNSC-LUSC) squamous-like c4 miRNA cluster 4 TCGA-92-7341 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 71 R-Upper TCGA-92-7341-F18330 TCGA-92-7341 TCGA-92-7341-01A -26134 0 106 0 NO NO Scheduled Follow-up Submission Partial Remission/Response 2011-11-14 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 1.4 NO 100 NO Central Lung 1.6 NO 50 No MX N0 T2a Stage IB TCGA-92-7341.31fc1b19-8a42-4d14-95d1-22e8358d0029.pdf 7341 Pre-Adjuvant Therapy WITH TUMOR Partial Remission/Response NO R0 Primary Tumor 01 0.2 7th NO YES NO 92 2 Lung A LIVING 2011 1961 4ff5e2c1-478c-4f0a-bffe-ea62b205da06 4ff5e2c1-478c-4f0a-bffe-ea62b205da06 TCGA-92-7341-01A-31D-2043-05 TCGA-92-7341-01A-31D-2041-01 4ff5e2c1-478c-4f0a-bffe-ea62b205da06 TCGA-92-7341-01A-31D-2041-01 +TCGA-92-8063-01 TCGA-92-8063-01 BRCA-LUAD+ Cluster 5 miRNA cluster 4 TCGA-92-8063 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 52 L-Upper TCGA-92-8063-F32177 TCGA-92-8063 TCGA-92-8063-01A -19193 0 122 76 1 NO NO Scheduled Follow-up Submission Complete Remission/Response 2012-5-18 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 1.4 NO 90 NO Central Lung 1.7 NO NO 74 No MX N2 T2b Stage IIIA TCGA-92-8063.517002a1-6e8c-400f-ae16-f23a061f6607.pdf 8063 Preoperative TUMOR FREE 82 91 78 84 Complete Remission/Response YES YES RX Primary Tumor 01 0.5 7th YES YES NO 92 2 Lung A LIVING 2011 1975 153f13af-43b9-4362-b18b-039b39611962 153f13af-43b9-4362-b18b-039b39611962 TCGA-92-8063-01A-11D-2245-05 TCGA-92-8063-01A-11D-2243-01 153f13af-43b9-4362-b18b-039b39611962 TCGA-92-8063-01A-11D-2243-01 +TCGA-92-8064-01 TCGA-92-8064-01 Squamous Cluster 13 (HNSC-LUSC) miRNA cluster 4 TCGA-92-8064 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 58 R-Upper TCGA-92-8064-F32180 TCGA-92-8064 TCGA-92-8064-01A -21417 0 160 80 1 NO NO Scheduled Follow-up Submission Complete Remission/Response 2012-5-18 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 1.5 NO NO Central Lung 1.5 NO NO 30 No MX N0 T2b [Discrepancy] TCGA-92-8064.38c3c16a-1a81-4812-9931-b5fb4b00615e.pdf 8064 Pre-Adjuvant Therapy TUMOR FREE 47 55 81 47 Complete Remission/Response YES NO RX Primary Tumor 01 0.6 2004 7th YES YES NO 92 4 Lung A LIVING 2011 1974 0a5d5dd8-9391-424e-905e-6359845a153d 0a5d5dd8-9391-424e-905e-6359845a153d TCGA-92-8064-01A-11D-2245-05 TCGA-92-8064-01A-11D-2243-01 0a5d5dd8-9391-424e-905e-6359845a153d TCGA-92-8064-01A-11D-2243-01 +TCGA-92-8065-01 TCGA-92-8065-01 Squamous Cluster 14 (HNSC) miRNA cluster 11 TCGA-92-8065 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 74 L-Lower TCGA-92-8065-F32188 TCGA-92-8065 TCGA-92-8065-01A -27049 0 70 55 0 NO NO Scheduled Follow-up Submission Complete Remission/Response 2012-5-18 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8071/3 C34.3 YES 1.2 NO NO Central Lung 2.5 NO NO 14 No MX N0 T3 Stage IIB TCGA-92-8065.68423fdb-e1a7-49b8-a531-f27850116a93.pdf 8065 Preoperative TUMOR FREE 67 86 72 92 Complete Remission/Response YES NO RX Primary Tumor 01 0.7 1995 7th NO YES NO 92 3 Lung A LIVING 2012 1968 d557d077-7341-4e0e-8994-9c36b45fe02d d557d077-7341-4e0e-8994-9c36b45fe02d TCGA-92-8065-01A-11D-2245-05 TCGA-92-8065-01A-11D-2243-01 d557d077-7341-4e0e-8994-9c36b45fe02d TCGA-92-8065-01A-11D-2243-01 +TCGA-93-7347-01 none none none none Y Y none none none Bronchioid none p.G12C none none none none none Acinar predominant Adc Acinar predominant Adc none 0 TCGA-93-7347-01 Kirc+ Cluster 5 LUAD-like c10 miRNA cluster 4 TCGA-93-7347 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 76 R-Upper TCGA-93-7347-F43155 TCGA-93-7347 TCGA-93-7347-01A -27949 0 683 70 NO NO Scheduled Follow-up Submission 2013-5-14 FEMALE Lung Adenocarcinoma Mixed Subtype No C34.1 8255/3 C34.1 YES 1 NO NO Central Lung 1 NO NO 11 No MX N0 T1a Stage IA TCGA-93-7347.a89ef8ab-8af7-4906-844e-eb216316f584.pdf 7347 TUMOR FREE 61 84 62 84 Complete Remission/Response YES NO R0 Primary Tumor 01 0.2 1967 7th NO YES NO 93 3 Current reformed smoker for > 15 years Lung A LIVING 2011 1952 2cb8a95d-20c3-4623-9b4d-b06b2a494b18 2cb8a95d-20c3-4623-9b4d-b06b2a494b18 TCGA-93-7347-01A-11D-2185-05 TCGA-93-7347-01A-11D-2183-01 2cb8a95d-20c3-4623-9b4d-b06b2a494b18 TCGA-93-7347-01A-11D-2183-01 +TCGA-93-7348-01 1.76 0.35 none none none none N N none none none 0.18 Bronchioid none none none p.D1010_splice none p.E542K none Acinar predominant Adc Acinar predominant Adc none 0 TCGA-93-7348-01 BRCA-LUAD+ C1-LUAD-enriched Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 5 TCGA-93-7348 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 75 R-Upper TCGA-93-7348-F43154 TCGA-93-7348 TCGA-93-7348-01A -27456 0 531 0 NO NO Scheduled Follow-up Submission 2013-5-14 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 1.2 NO 100 NO Central Lung 1.5 NO NO 42 No MX N0 T1a Stage IA TCGA-93-7348.2ad907ad-1005-4e89-91b8-d09a173bcd4d.pdf 7348 Preoperative TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 0.4 1999 7th NO YES NO 93 4 Current reformed smoker for < or = 15 years Lung A LIVING 2011 1957 6d1614e8-67cb-4551-a447-ae3b94990d70 6d1614e8-67cb-4551-a447-ae3b94990d70 TCGA-93-7348-01A-21D-2037-05 TCGA-93-7348-01A-21D-2035-01 6d1614e8-67cb-4551-a447-ae3b94990d70 TCGA-93-7348-01A-21D-2035-01 TCGA-93-7348-01A-23-2192-20 +TCGA-93-8067-01 TCGA-93-8067-01 High Cluster 6 LUAD-like c10 miRNA c1uster 9 TCGA-93-8067 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 77 L-Lower TCGA-93-8067-F32193 TCGA-93-8067 TCGA-93-8067-01A -28453 0 186 47 2 NO NO Scheduled Follow-up Submission Complete Remission/Response 2012-5-18 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 1.4 NO 80 NO Peripheral Lung 1.6 NO NO 20 Yes, History of Prior Malignancy MX N0 T2a Stage IB TCGA-93-8067.24b499ff-c99b-4d57-ac96-8978d0a44538.pdf 8067 Preoperative TUMOR FREE 94 103 89 94 Complete Remission/Response YES NO RX Primary Tumor 01 0.1 2001 7th NO YES NO 93 4 Lung A LIVING 2011 1961 bf359688-8652-4266-b4fd-e2f8f2782a97 bf359688-8652-4266-b4fd-e2f8f2782a97 TCGA-93-8067-01A-11D-2285-05 TCGA-93-8067-01A-11D-2283-01 bf359688-8652-4266-b4fd-e2f8f2782a97 TCGA-93-8067-01A-11D-2283-01 +TCGA-93-A4JN-01 TCGA-93-A4JN-01 TCGA-93-A4JN TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 71 L-Upper TCGA-93-A4JN-F56980 TCGA-93-A4JN TCGA-93-A4JN-01A -26273 209 0 718 1 YES FISH YES Scheduled Follow-up Submission Stable Disease 2014-2-27 MALE Lung Acinar Adenocarcinoma No C34.1 8550/3 C34.1 YES 330 NO 90 YES NO NO NO 40 true No M1a N0 T2a Stage IV TCGA-93-A4JN.BA9DB454-6107-4F98-8646-89129230D602.pdf A4JN Preoperative WITH TUMOR Stable Disease NO NO RX Primary Tumor 01 1991 7th YES YES NO 93 3 Lung A LIVING 2012 1971 b31f6ff5-bd06-43d7-966e-426b787222e8 b31f6ff5-bd06-43d7-966e-426b787222e8 TCGA-93-A4JN-01A-11D-A24U-05 TCGA-93-A4JN-01A-11D-A24O-01 b31f6ff5-bd06-43d7-966e-426b787222e8 TCGA-93-A4JN-01A-11D-A24O-01 +TCGA-93-A4JO-01 TCGA-93-A4JO-01 TCGA-93-A4JO TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 70 R-Lower TCGA-93-A4JO TCGA-93-A4JO-01A -25898 230 33 0 81 1 NO NO 2014-2-27 MALE Lung Adenocarcinoma Mixed Subtype No C34.3 8255/3 C34.3 YES 390 NO 90 NO NO 50 true No MX N0 T1a Stage IA TCGA-93-A4JO.54D7BAFD-D766-4EE6-A769-F57A858B5F44.pdf A4JO Preoperative TUMOR FREE 126 97 125 98 YES NO RX Primary Tumor 01 2006 7th NO YES NO 93 4 Lung A DECEASED 2012 1956 993626ac-469c-4d9d-8278-63fda45598c0 993626ac-469c-4d9d-8278-63fda45598c0 TCGA-93-A4JO-01A-21D-A24U-05 TCGA-93-A4JO-01A-21D-A24O-01 993626ac-469c-4d9d-8278-63fda45598c0 TCGA-93-A4JO-01A-21D-A24O-01 +TCGA-93-A4JP-01 TCGA-93-A4JP-01 TCGA-93-A4JP TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung YES YES NO 64 R-Lower TCGA-93-A4JP-F56970 TCGA-93-A4JP TCGA-93-A4JP-01A -23620 72 0 578 497 1 YES L861Q NO Scheduled Follow-up Submission Progressive Disease 2014-2-28 MALE Lung Papillary Adenocarcinoma No C34.3 8260/3 C34.3 YES 450 NO NO NO Distant Metastasis YES true No M1b NX TX Stage IV TCGA-93-A4JP.3AFDF9A9-8D19-4060-86E0-B24AE8C83A82.pdf A4JP Post-Adjuvant Therapy WITH TUMOR Partial Remission/Response Convincing Imaging NO NO RX Primary Tumor 01 7th YES YES NO 93 1 Lung A LIVING 2012 51705e9c-8423-4eb8-8839-09206d4d115b 51705e9c-8423-4eb8-8839-09206d4d115b TCGA-93-A4JP-01A-11D-A24U-05 TCGA-93-A4JP-01A-11D-A24O-01 51705e9c-8423-4eb8-8839-09206d4d115b TCGA-93-A4JP-01A-11D-A24O-01 +TCGA-93-A4JQ-01 TCGA-93-A4JQ-01 TCGA-93-A4JQ TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 49 R-Upper TCGA-93-A4JQ-F57022 TCGA-93-A4JQ TCGA-93-A4JQ-01A -17951 57 0 526 83 0 NO NO Scheduled Follow-up Submission Complete Remission/Response 2014-2-28 MALE Lung Acinar Adenocarcinoma No C34.1 8550/3 C34.1 YES 290 NO NO NO NO true Yes, History of Prior Malignancy MX N0 T1b Stage IA TCGA-93-A4JQ.B9CE532C-BACD-4123-B560-6671CABC5132.pdf A4JQ Preoperative TUMOR FREE 97 100 94 93 Complete Remission/Response YES NO RX Primary Tumor 01 1993 7th NO YES NO 93 3 Lung A LIVING 2012 1973 7c22c18e-b357-4f5d-a3c0-d947d9b95c15 7c22c18e-b357-4f5d-a3c0-d947d9b95c15 TCGA-93-A4JQ-01A-11D-A24U-05 TCGA-93-A4JQ-01A-11D-A24O-01 7c22c18e-b357-4f5d-a3c0-d947d9b95c15 TCGA-93-A4JQ-01A-11D-A24O-01 +TCGA-94-7033-01 TCGA-94-7033-01 High C2-Squamous-like Cluster 5 squamous c3 squamous-like c4 miRNA cluster 11 TCGA-94-7033 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 73 [Discrepancy] TCGA-94-7033-F40721 TCGA-94-7033 TCGA-94-7033-01A -26948 0 640 0 Scheduled Follow-up Submission 2013-2-27 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.5 NO 100 1.1 NO NO 30 Yes MX N0 T2 Stage IB TCGA-94-7033.a35d486d-6ddd-4e45-999c-3c66496da495.pdf 7033 Post-Adjuvant Therapy TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 0.2 2011 7th YES YES NO 94 4 Lung A LIVING 2011 fabfb417-8a39-4860-a60f-66fb98beaae3 fabfb417-8a39-4860-a60f-66fb98beaae3 TCGA-94-7033-01A-11D-1947-05 TCGA-94-7033-01A-11D-1943-01 fabfb417-8a39-4860-a60f-66fb98beaae3 TCGA-94-7033-01A-11D-1943-01 TCGA-94-7033-01A-13-2194-20 +TCGA-94-7557-01 TCGA-94-7557-01 Squamous C2-Squamous-like Cluster 5 squamous c3 squamous-like c4 miRNA cluster 4 TCGA-94-7557 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 73 L-Upper TCGA-94-7557-F21130 TCGA-94-7557 TCGA-94-7557-01A -26802 5 0 78 Scheduled Follow-up Submission 2012-2-1 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.7 NO 1.3 NO Yes M0 N0 T2 Stage IB TCGA-94-7557.9c906fe6-af3f-42d4-ad03-4cfe825c92d3.pdf 7557 TUMOR FREE 68 75 69 71 Complete Remission/Response YES NO Primary Tumor 01 0.2 7th NO YES NO 94 2 Lung A DECEASED 2011 318d06a1-77ea-4a5a-a886-d8b470713451 318d06a1-77ea-4a5a-a886-d8b470713451 TCGA-94-7557-01A-11D-2123-05 TCGA-94-7557-01A-11D-2121-01 318d06a1-77ea-4a5a-a886-d8b470713451 TCGA-94-7557-01A-11D-2121-01 TCGA-94-7557-01A-13-2195-20 +TCGA-94-7943-01 TCGA-94-7943-01 Squamous C2-Squamous-like Cluster 5 squamous c3 squamous-like c4 miRNA cluster 4 TCGA-94-7943 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung NO NO NO 80 L-Lower TCGA-94-7943-F65473 TCGA-94-7943 TCGA-94-7943-01A -29282 0 559 556 71 1 Scheduled Follow-up Submission Progressive Disease 2014-9-23 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.7 NO 1 NO Locoregional Recurrence YES 30 Yes MX NX T1b Stage IA TCGA-94-7943.45ec950b-c7d1-421e-a6a7-79adb212c169.pdf 7943 Preoperative WITH TUMOR 0 93 0 86 Complete Remission/Response Biopsy with Histologic Confirmation|Convincing Imaging YES NO R0 Primary Tumor 01 0.2 1991 7th NO YES NO 94 3 Lung A LIVING 2011 1961 16a43a5d-fe72-4b8a-887d-1b40342c1253 16a43a5d-fe72-4b8a-887d-1b40342c1253 TCGA-94-7943-01A-11D-2185-05 TCGA-94-7943-01A-11D-2183-01 16a43a5d-fe72-4b8a-887d-1b40342c1253 TCGA-94-7943-01A-11D-2183-01 TCGA-94-7943-01A-13-2195-20 +TCGA-94-8035-01 TCGA-94-8035-01 Squamous Cluster 5 miRNA cluster 11 TCGA-94-8035 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 64 L-Upper TCGA-94-8035-F69142 TCGA-94-8035 TCGA-94-8035-01A -23399 0 122 0 Scheduled Follow-up Submission 2014-12-30 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 1 NO 1.5 YES NO 50 No MX N0 T3 Stage IIB TCGA-94-8035.ba6dd2df-43b6-414f-a5a7-160f31af73fb.pdf 8035 TUMOR FREE 0 0 0 67 Complete Remission/Response YES NO R0 Primary Tumor 01 0.3 7th NO YES NO 94 2 Lung A LIVING 2011 1961 60b16987-41a4-4bcf-a550-939534eae800 60b16987-41a4-4bcf-a550-939534eae800 TCGA-94-8035-01A-11D-2245-05 TCGA-94-8035-01A-11D-2243-01 60b16987-41a4-4bcf-a550-939534eae800 TCGA-94-8035-01A-11D-2243-01 +TCGA-94-8490-01 TCGA-94-8490-01 Cluster 13 (HNSC-LUSC) miRNA cluster 11 TCGA-94-8490 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 70 R-Upper TCGA-94-8490-F58411 TCGA-94-8490 TCGA-94-8490-01A -25588 0 153 NO NO Scheduled Follow-up Submission 2014-4-9 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.9 NO NO 1.4 YES NO No M0 N0 T3 Stage IIB TCGA-94-8490.ef5af5e3-88f5-4651-a7fe-f56b0bea6ed8.pdf 8490 TUMOR FREE NO NO R0 Primary Tumor 01 0.4 7th YES NO 94 5 Lung A LIVING 2011 e0d001b0-05c9-4c1f-a1c4-fefa8a1e322f e0d001b0-05c9-4c1f-a1c4-fefa8a1e322f TCGA-94-8490-01A-11D-2324-05 TCGA-94-8490-01A-11D-2322-01 e0d001b0-05c9-4c1f-a1c4-fefa8a1e322f TCGA-94-8490-01A-11D-2322-01 +TCGA-94-8491-01 TCGA-94-8491-01 BRCA CIMP c7 miRNA c1uster 9 TCGA-94-8491 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung NO NO YES 73 R-Lower TCGA-94-8491-F58412 TCGA-94-8491 TCGA-94-8491-01A 641 -26698 0 810 641 0 NO NO Scheduled Follow-up Submission Complete Remission/Response 2014-4-9 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 1.5 NO NO 1.5 NO Distant Metastasis YES 56 No M0 N1 T2a Stage IIA TCGA-94-8491.c41a30ff-11d7-41eb-858a-d45300b7beb3.pdf 8491 Post-Adjuvant Therapy TUMOR FREE Progressive Disease Biopsy with Histologic Confirmation|Convincing Imaging|Positive Biomarker(s) NO NO Primary Tumor 01 0.4 1984 7th YES YES NO 94 3 Lung A LIVING 2012 1956 9e45ff91-c250-4956-9f86-1ecae2fc0a38 9e45ff91-c250-4956-9f86-1ecae2fc0a38 TCGA-94-8491-01A-11D-2324-05 TCGA-94-8491-01A-11D-2322-01 9e45ff91-c250-4956-9f86-1ecae2fc0a38 TCGA-94-8491-01A-11D-2322-01 +TCGA-94-A4VJ-01 TCGA-94-A4VJ-01 TCGA-94-A4VJ TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 71 Bronchial TCGA-94-A4VJ-F58416 TCGA-94-A4VJ TCGA-94-A4VJ-01A -25991 107 0 430 NO NO Scheduled Follow-up Submission 2014-4-9 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.9 8070/3 C34.9 YES 110 NO NO Central Lung NO NO 37.5 true No M0 N0 T1b Stage IA TCGA-94-A4VJ.361F56F8-52D2-434D-97DE-57E9EB5B1B3D.pdf A4VJ TUMOR FREE Complete Remission/Response NO NO Primary Tumor 01 2012 7th NO YES NO 94 4 Lung A LIVING 2012 1962 73e04325-b1c2-4c77-b335-f6616ac48f47 73e04325-b1c2-4c77-b335-f6616ac48f47 TCGA-94-A4VJ-01A-11D-A258-05 TCGA-94-A4VJ-01A-11D-A256-01 73e04325-b1c2-4c77-b335-f6616ac48f47 TCGA-94-A4VJ-01A-11D-A256-01 +TCGA-94-A5I4-01 TCGA-94-A5I4-01 TCGA-94-A5I4 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung NO YES YES 61 Bronchial TCGA-94-A5I4-F58418 TCGA-94-A5I4 TCGA-94-A5I4-01A 314 -22299 50 0 491 314 2 NO NO Scheduled Follow-up Submission Stable Disease 2014-4-9 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.0 8070/3 C34.0 YES 210 NO NO Central Lung NO Distant Metastasis YES 80 true Yes, History of Prior Malignancy MX N1 T2a Stage IIA TCGA-94-A5I4.8C32CD4E-3F9E-43E8-8E18-739561B9DA78.pdf A5I4 Pre-Adjuvant Therapy WITH TUMOR Complete Remission/Response Biopsy with Histologic Confirmation|Convincing Imaging NO NO RX Primary Tumor 01 2006 7th NO YES NO 94 4 Lung A LIVING 2012 ee589fc8-daf6-4da9-9708-f18a86b96b22 ee589fc8-daf6-4da9-9708-f18a86b96b22 TCGA-94-A5I4-01A-11D-A26N-05 TCGA-94-A5I4-01A-11D-A26L-01 ee589fc8-daf6-4da9-9708-f18a86b96b22 TCGA-94-A5I4-01A-11D-A26L-01 +TCGA-94-A5I6-01 TCGA-94-A5I6-01 TCGA-94-A5I6 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung YES NO NO 62 L-Lower TCGA-94-A5I6-F58420 TCGA-94-A5I6 TCGA-94-A5I6-01A -22949 68 0 538 481 1 NO NO Scheduled Follow-up Submission Progressive Disease 2014-4-9 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 390 NO NO Peripheral Lung NO Distant Metastasis YES 80 true No M0 N0 T3 Stage IIB TCGA-94-A5I6.7780499A-871F-48F5-932A-7E4C0BB62ED1.pdf A5I6 Post-Adjuvant Therapy WITH TUMOR Progressive Disease Biopsy with Histologic Confirmation|Convincing Imaging NO NO RX Primary Tumor 01 2012 7th YES YES NO 94 4 Lung A LIVING 2012 1972 272a19bb-8dc3-499e-b17f-2b0f58626c8e 272a19bb-8dc3-499e-b17f-2b0f58626c8e TCGA-94-A5I6-01A-21D-A27L-05 TCGA-94-A5I6-01A-21D-A27J-01 272a19bb-8dc3-499e-b17f-2b0f58626c8e TCGA-94-A5I6-01A-21D-A27J-01 +TCGA-95-7039-01 5.71 0.42 none p.D565_splice none none N N p.S921R none none 0.12 Squamoid none p.D33E none none none none none Micropapillary predom Adc Micropapillary predom Adc none 0 TCGA-95-7039-01 High C1-LUAD-enriched Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 4 TCGA-95-7039 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung NO NO NO 54 R-Upper TCGA-95-7039-F67192 TCGA-95-7039 TCGA-95-7039-01A -19981 0 1272 1258 1 Additional New Tumor Event Progressive Disease 2014-10-31 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.8 NO 0.8 NO Locoregional Recurrence YES 34 No MX N0 T3 Stage IIB TCGA-95-7039.8bb3ec39-1368-448f-8f75-36bac5f19f02.pdf 7039 Preoperative WITH TUMOR Complete Remission/Response Biopsy with Histologic Confirmation|Convincing Imaging|Positive Biomarker(s) NO Primary Tumor 01 0.2 7th NO YES NO 95 2 Current smoker Lung A LIVING 2011 a017b3e8-6e27-4f0c-aff2-166b73743991 a017b3e8-6e27-4f0c-aff2-166b73743991 TCGA-95-7039-01A-11D-1947-05 TCGA-95-7039-01A-11D-1943-01 a017b3e8-6e27-4f0c-aff2-166b73743991 TCGA-95-7039-01A-11D-1943-01 TCGA-95-7039-01A-13-2192-20 +TCGA-95-7043-01 3.72 0.77 none none none none N N none none none 0.23 Magnoid none none none none none none none Adenocarcinoma, NOS Adenocarcinoma, NOS none 0 TCGA-95-7043-01 Squamous C1-LUAD-enriched Cluster 6 BRCA basal-like c6 LUAD-like c10 miRNA c1uster 10 TCGA-95-7043 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 63 R-Upper TCGA-95-7043-F67188 TCGA-95-7043 TCGA-95-7043-01A -23165 503 0 2 Scheduled Follow-up Submission Progressive Disease 2014-10-31 FEMALE Lung Adenocarcinoma Mixed Subtype No C34.1 8255/3 C34.1 YES 0.6 NO 0.6 NO 40 Yes MX N0 T1a Stage IA TCGA-95-7043.a30ed7ec-19a9-4d15-b405-86132271a652.pdf 7043 WITH TUMOR Complete Remission/Response NO Primary Tumor 01 0.1 2003 7th YES YES NO 95 4 Current reformed smoker for > 15 years Lung A DECEASED 2011 1964 8a8e816b-8067-4ffe-ac37-f3ac2e0a29c4 8a8e816b-8067-4ffe-ac37-f3ac2e0a29c4 TCGA-95-7043-01A-11D-1947-05 TCGA-95-7043-01A-11D-1943-01 8a8e816b-8067-4ffe-ac37-f3ac2e0a29c4 TCGA-95-7043-01A-11D-1943-01 TCGA-95-7043-01A-13-2192-20 +TCGA-95-7562-01 TCGA-95-7562-01 BRCA-LUAD+ Cluster 6 LUAD-like c10 miRNA cluster 12 TCGA-95-7562 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 71 R-Lower TCGA-95-7562-F32832 TCGA-95-7562 TCGA-95-7562-01A -26000 87 0 57 1 Scheduled Follow-up Submission 2012-6-13 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 0.5 NO 0.8 NO NO 10 Yes, History of Prior Malignancy M0 N1 T2a Stage IIA TCGA-95-7562.dfdfa10e-5e7d-4a1d-b355-afc8c8418925.pdf 7562 Post-Adjuvant Therapy TUMOR FREE 72 90 76 80 YES NO RX Primary Tumor 01 0.2 1983 7th YES YES NO 95 3 Lung A DECEASED 2011 1973 c2842301-c4ec-41c6-96f7-53701541d93c c2842301-c4ec-41c6-96f7-53701541d93c TCGA-95-7562-01A-11D-2239-05 TCGA-95-7562-01A-11D-2237-01 c2842301-c4ec-41c6-96f7-53701541d93c TCGA-95-7562-01A-11D-2237-01 +TCGA-95-7567-01 2.66 0.53 none none none none Y Y none p.R1230fs p.A888T 0.23 Squamoid none p.G12V none none none none none Adenocarcinoma, NOS Adenocarcinoma, NOS none 0 TCGA-95-7567-01 High C1-LUAD-enriched Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 4 TCGA-95-7567 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 61 R-Upper TCGA-95-7567-F40935 TCGA-95-7567 TCGA-95-7567-01A -22437 0 568 0 Scheduled Follow-up Submission Complete Remission/Response 2013-3-6 MALE Lung Adenocarcinoma Mixed Subtype No C34.1 8255/3 C34.1 YES 0.7 NO 100 1 NO NO No M0 N1 T2b Stage IIB TCGA-95-7567.7b2574cb-ff02-4e3e-b64b-9d0265ef9335.pdf 7567 Post-Adjuvant Therapy TUMOR FREE Stable Disease NO NO Primary Tumor 01 0.2 2011 7th YES YES NO 95 4 Current reformed smoker for > 15 years Lung A LIVING 2011 1970 84c8990e-7656-4c48-8e5a-b03e2013013d 84c8990e-7656-4c48-8e5a-b03e2013013d TCGA-95-7567-01A-11D-2064-05 TCGA-95-7567-01A-11D-2062-01 84c8990e-7656-4c48-8e5a-b03e2013013d TCGA-95-7567-01A-11D-2062-01 TCGA-95-7567-01A-13-2192-20 +TCGA-95-7944-01 TCGA-95-7944-01 GBM C1-LUAD-enriched Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 4 TCGA-95-7944 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 71 L-Lower TCGA-95-7944-F40938 TCGA-95-7944 TCGA-95-7944-01A -26003 0 377 60 Scheduled Follow-up Submission Complete Remission/Response 2013-3-7 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 0.7 NO 1.3 NO NO 50 No M0 N0 T1a Stage IA TCGA-95-7944.567e989f-6896-4faf-84bb-8ef786461228.pdf 7944 TUMOR FREE 87 86 Stable Disease YES NO R0 Primary Tumor 01 0.2 7th NO YES NO 95 2 Lung A LIVING 2011 1961 f842dd09-8bea-47d4-8489-a9ac06ca5172 f842dd09-8bea-47d4-8489-a9ac06ca5172 TCGA-95-7944-01A-11D-2185-05 TCGA-95-7944-01A-11D-2183-01 f842dd09-8bea-47d4-8489-a9ac06ca5172 TCGA-95-7944-01A-11D-2183-01 TCGA-95-7944-01A-12-2192-20 +TCGA-95-7947-01 none none none none N N p.I91V, p.R1052I none none Squamoid none none none none none p.E453Q none 0 Acinar predominant Adc none TCGA-95-7947-01 High C1-LUAD-enriched Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 4 TCGA-95-7947 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 67 L-Upper TCGA-95-7947-F40940 TCGA-95-7947 TCGA-95-7947-01A -24752 0 477 Scheduled Follow-up Submission Complete Remission/Response 2013-3-7 MALE Lung Adenocarcinoma Mixed Subtype No C34.1 8255/3 C34.1 YES 0.6 NO 1.2 NO NO 100 Yes M0 N0 T1a Stage IA TCGA-95-7947.003c68cb-72ea-44c9-80e3-f62224ab3ee2.pdf 7947 TUMOR FREE 37 37 Complete Remission/Response YES NO R0 Primary Tumor 01 0.3 2006 7th NO YES NO 95 4 Lung A LIVING 2011 1956 5893078d-d8cd-4c74-b0e2-d412e367710b 5893078d-d8cd-4c74-b0e2-d412e367710b TCGA-95-7947-01A-11D-2185-05 TCGA-95-7947-01A-11D-2183-01 5893078d-d8cd-4c74-b0e2-d412e367710b TCGA-95-7947-01A-11D-2183-01 TCGA-95-7947-01A-13-2192-20 +TCGA-95-7948-01 none none none none N N none none none Squamoid none none none none none p.E545K none 0 Micropapillary predom Adc none TCGA-95-7948-01 Squamous C1-LUAD-enriched Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 12 TCGA-95-7948 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 42 R-Lower TCGA-95-7948-F40945 TCGA-95-7948 TCGA-95-7948-01A -15363 0 476 87 Scheduled Follow-up Submission Complete Remission/Response 2013-3-7 FEMALE Lung Adenocarcinoma Mixed Subtype No C34.3 8255/3 C34.3 YES 0.7 NO 1.3 NO NO .15 Yes M0 N0 T2a Stage IB TCGA-95-7948.1cee5f67-bdcc-41cb-8764-5e0d8e09ed61.pdf 7948 TUMOR FREE 79 72 Complete Remission/Response YES NO R0 Primary Tumor 01 0.3 1995 7th NO YES NO 95 3 Lung A LIVING 2011 1993 a5e6acbf-7027-4837-85d7-aacfe707900d a5e6acbf-7027-4837-85d7-aacfe707900d TCGA-95-7948-01A-11D-2185-05 TCGA-95-7948-01A-11D-2183-01 a5e6acbf-7027-4837-85d7-aacfe707900d TCGA-95-7948-01A-11D-2183-01 TCGA-95-7948-01A-13-2192-20 +TCGA-95-8039-01 TCGA-95-8039-01 BRCA-LUAD+ Cluster 6 LUAD-like c10 miRNA cluster 4 TCGA-95-8039 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung YES YES NO 72 R-Upper TCGA-95-8039-F61691 TCGA-95-8039 TCGA-95-8039-01A -26317 0 830 228 98 0 Scheduled Follow-up Submission Complete Remission/Response 2014-7-3 MALE Lung Acinar Adenocarcinoma No C34.1 8550/3 C34.1 YES 0.5 NO 0.9 NO Locoregional Recurrence YES No MX N0 T1 Stage IA TCGA-95-8039.2bc3d5a2-7341-44a1-a625-fbfdef9bba6c.pdf 8039 Post-Adjuvant Therapy TUMOR FREE 70 2.54 67 2.40 Complete Remission/Response Biopsy with Histologic Confirmation|Convincing Imaging YES NO RX Primary Tumor 01 0.4 7th NO YES NO 95 1 Lung A LIVING 2012 8deed508-4b81-4573-afc1-a3da5ca52c60 8deed508-4b81-4573-afc1-a3da5ca52c60 TCGA-95-8039-01A-11D-2239-05 TCGA-95-8039-01A-11D-2237-01 8deed508-4b81-4573-afc1-a3da5ca52c60 TCGA-95-8039-01A-11D-2237-01 +TCGA-95-8494-01 TCGA-95-8494-01 Cluster 6 miRNA cluster 4 TCGA-95-8494 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 67 R-Middle TCGA-95-8494-F58476 TCGA-95-8494 TCGA-95-8494-01A -24773 0 84 NO NO Scheduled Follow-up Submission 2014-4-10 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.2 8140/3 C34.2 YES 1.2 NO NO 1.4 YES NO No M0 N1 T2a Stage IIA TCGA-95-8494.978929c4-0d93-4192-9a72-22047960cfbd.pdf 8494 Complete Remission/Response NO NO Primary Tumor 01 0.4 7th NO YES NO 95 5 Lung A LIVING 2012 af100535-eaf2-49a6-b4bb-5a2b85a2d2c9 af100535-eaf2-49a6-b4bb-5a2b85a2d2c9 TCGA-95-8494-01A-11D-2324-05 TCGA-95-8494-01A-11D-2322-01 af100535-eaf2-49a6-b4bb-5a2b85a2d2c9 TCGA-95-8494-01A-11D-2322-01 +TCGA-95-A4VK-01 TCGA-95-A4VK-01 TCGA-95-A4VK TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung NO YES NO 74 R-Upper TCGA-95-A4VK-F58477 TCGA-95-A4VK TCGA-95-A4VK-01A -27040 155 0 651 496 81 1 YES NO Scheduled Follow-up Submission Stable Disease 2014-4-10 FEMALE Lung Adenocarcinoma Mixed Subtype No C34.1 8255/3 C34.1 YES 140 NO NO NO Distant Metastasis YES 45 true Yes, History of Prior Malignancy M0 N2 T2b Stage IIIA TCGA-95-A4VK.0B713E19-EE67-4C3B-8319-4C69019C00D0.pdf A4VK Post-Adjuvant Therapy WITH TUMOR 72 99 67 99 Stable Disease Convincing Imaging YES YES RX Primary Tumor 01 1986 7th YES YES NO 95 3 Lung A LIVING 2012 1956 f1a2ff30-bc18-4a82-b1a6-69f4b827fddd f1a2ff30-bc18-4a82-b1a6-69f4b827fddd TCGA-95-A4VK-01A-11D-A25R-05 TCGA-95-A4VK-01A-11D-A25M-01 f1a2ff30-bc18-4a82-b1a6-69f4b827fddd TCGA-95-A4VK-01A-11D-A25M-01 +TCGA-95-A4VN-01 TCGA-95-A4VN-01 TCGA-95-A4VN TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 62 R-Lower TCGA-95-A4VN-F58501 TCGA-95-A4VN TCGA-95-A4VN-01A -22927 23 0 553 50 1 YES NO Scheduled Follow-up Submission Stable Disease 2014-4-11 FEMALE Lung Solid Pattern Predominant Adenocarcinoma No C34.3 8140/3 C34.3 YES 150 NO NO NO NO 42 true Yes, History of Prior Malignancy M0 N1 T2a Stage IIA TCGA-95-A4VN.D348711A-FD65-4771-A604-D761C96F5C48.pdf A4VN Pre-Adjuvant Therapy TUMOR FREE 65 67 60 58 Stable Disease YES NO R0 Primary Tumor 01 2007 7th NO YES NO 95 4 Lung A LIVING 2012 1965 dd53f806-9971-4f03-960c-7753d6b29904 dd53f806-9971-4f03-960c-7753d6b29904 TCGA-95-A4VN-01A-11D-A25R-05 TCGA-95-A4VN-01A-11D-A25M-01 dd53f806-9971-4f03-960c-7753d6b29904 TCGA-95-A4VN-01A-11D-A25M-01 +TCGA-95-A4VP-01 TCGA-95-A4VP-01 TCGA-95-A4VP TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung NO YES NO 66 L-Lower TCGA-95-A4VP-F58502 TCGA-95-A4VP TCGA-95-A4VP-01A -24130 68 0 605 216 1 NO NO Scheduled Follow-up Submission Stable Disease 2014-4-11 FEMALE Lung Acinar Adenocarcinoma No C34.3 8550/3 C34.3 YES 640 NO NO NO Distant Metastasis YES 20 true No M0 N2 T2b Stage IIIA TCGA-95-A4VP.8892002E-D9B2-47FA-9540-A19E4A35B6C7.pdf A4VP Post-Adjuvant Therapy WITH TUMOR Stable Disease Biopsy with Histologic Confirmation|Convincing Imaging NO NO Primary Tumor 01 2012 7th YES YES NO 95 4 Lung A LIVING 2012 1972 680579c1-690f-444a-9b6e-f76f5cdd1ae8 680579c1-690f-444a-9b6e-f76f5cdd1ae8 TCGA-95-A4VP-01A-21D-A25R-05 TCGA-95-A4VP-01A-21D-A25M-01 680579c1-690f-444a-9b6e-f76f5cdd1ae8 TCGA-95-A4VP-01A-21D-A25M-01 +TCGA-96-7544-01 TCGA-96-7544-01 Squamous C2-Squamous-like Cluster 13 (HNSC-LUSC) squamous c3 squamous-like c4 miRNA cluster 4 TCGA-96-7544 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 83 L-Lower TCGA-96-7544-F72316 TCGA-96-7544 TCGA-96-7544-01A -30548 2160 0 1213 94 Scheduled Follow-up Submission 2015-5-19 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.8 NO 1.2 NO 65 No MX N1 T2 Stage IIB TCGA-96-7544.32baed4b-24e5-4b74-86b7-21a15e48e1df.pdf 7544 TUMOR FREE 59 83 59 79 Complete Remission/Response YES NO Primary Tumor 01 0.8 6th NO NO YES 96 2 Lung A DECEASED 2008 1943 9a3858ef-0bb9-4d26-977c-6e06d0f770a5 9a3858ef-0bb9-4d26-977c-6e06d0f770a5 TCGA-96-7544-01A-11D-2043-05 TCGA-96-7544-01A-11D-2041-01 9a3858ef-0bb9-4d26-977c-6e06d0f770a5 TCGA-96-7544-01A-11D-2041-01 TCGA-96-7544-01A-13-2195-20 +TCGA-96-7545-01 TCGA-96-7545-01 Squamous Cluster 13 (HNSC-LUSC) squamous-like c4 miRNA cluster 4 TCGA-96-7545 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung NO NO YES 73 R-Lower TCGA-96-7545-F37173 TCGA-96-7545 TCGA-96-7545-01A 1693 -26729 1736 0 1324 1693 57 Scheduled Follow-up Submission Progressive Disease 2012-11-29 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.4 NO 0.4 NO Locoregional Recurrence YES 116 Yes MX N0 T1 Stage IA TCGA-96-7545.c3a70c66-ae03-435f-a2e7-05af6a9f0759.pdf 7545 65 55 61 52 Progressive Disease Biopsy with Histologic Confirmation YES NO Primary Tumor 01 0.1 2005 6th NO NO YES 96 4 Lung A DECEASED 2008 11fd13bc-b0d4-490b-a678-78ecfda9c9ce 11fd13bc-b0d4-490b-a678-78ecfda9c9ce TCGA-96-7545-01A-21D-2043-05 TCGA-96-7545-01A-21D-2041-01 11fd13bc-b0d4-490b-a678-78ecfda9c9ce TCGA-96-7545-01A-21D-2041-01 +TCGA-96-8169-01 TCGA-96-8169-01 Squamous Cluster 5 miRNA cluster 4 TCGA-96-8169 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 67 R-Lower TCGA-96-8169-F44231 TCGA-96-8169 TCGA-96-8169-01A -24674 0 557 48.83 0 NO NO Scheduled Follow-up Submission Complete Remission/Response 2013-6-19 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 1.3 NO NO 1.9 NO NO 35 No M0 N0 T1a Stage IA TCGA-96-8169.d0a4557a-fc0f-4b4e-bae3-24b61f28719a.pdf 8169 Preoperative TUMOR FREE 110.59 98.55 104.09 93.7 Complete Remission/Response YES NO Primary Tumor 01 0.2 2005 7th NO YES NO 96 4 Lung A LIVING 2011 1970 12c6d713-3314-4458-914a-8247ec0fe292 12c6d713-3314-4458-914a-8247ec0fe292 TCGA-96-8169-01A-11D-2294-05 TCGA-96-8169-01A-11D-2292-01 12c6d713-3314-4458-914a-8247ec0fe292 TCGA-96-8169-01A-11D-2292-01 +TCGA-96-8170-01 TCGA-96-8170-01 Squamous Cluster 5 miRNA cluster 11 TCGA-96-8170 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 75 R-Lower TCGA-96-8170-F44341 TCGA-96-8170 TCGA-96-8170-01A -27558 0 531 2 NO NO Scheduled Follow-up Submission Complete Remission/Response 2013-6-19 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 1 NO NO 1.4 NO NO 50 No M0 N1 T1a Stage IIA TCGA-96-8170.424c9f5d-772d-4f6c-8f73-0090f4ff83ca.pdf 8170 Preoperative TUMOR FREE 68 59 67 61 Complete Remission/Response YES NO Primary Tumor 01 0.2 2011 7th NO YES NO 96 4 Lung A LIVING 2011 1961 eda6f268-91c6-4a18-a3bc-cc2590423b44 eda6f268-91c6-4a18-a3bc-cc2590423b44 TCGA-96-8170-01A-11D-2294-05 TCGA-96-8170-01A-11D-2292-01 eda6f268-91c6-4a18-a3bc-cc2590423b44 TCGA-96-8170-01A-11D-2292-01 +TCGA-96-A4JK-01 TCGA-96-A4JK-01 TCGA-96-A4JK TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 65 R-Upper TCGA-96-A4JK-F57387 TCGA-96-A4JK TCGA-96-A4JK-01A -23974 121 0 589 75 0 NO NO Scheduled Follow-up Submission Complete Remission/Response 2014-3-12 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) Yes, Pharmaceutical Treatment Prior to Resection C34.1 8070/3 C34.1 YES 230 NO NO NO NO 110 true Yes, History of Prior Malignancy M0 N1 T2a Stage IIA TCGA-96-A4JK.E86C3FFC-CD9C-46E4-BA1E-4A5226FB7044.pdf A4JK Preoperative TUMOR FREE 52 55 55 48 Complete Remission/Response YES NO R0 Primary Tumor 01 7th YES YES NO 96 2 Lung A LIVING 2012 1957 c5d7af42-6394-4315-bf63-2a2c51996bec c5d7af42-6394-4315-bf63-2a2c51996bec TCGA-96-A4JK-01A-11D-A258-05 TCGA-96-A4JK-01A-11D-A256-01 c5d7af42-6394-4315-bf63-2a2c51996bec TCGA-96-A4JK-01A-11D-A256-01 +TCGA-96-A4JL-01 TCGA-96-A4JL-01 TCGA-96-A4JL TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 78 L-Lower TCGA-96-A4JL-F66776 TCGA-96-A4JL TCGA-96-A4JL-01A -28686 86 0 842 70 0 NO NO Scheduled Follow-up Submission 2014-10-23 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 140 NO NO NO NO true No M0 N1 T2a Stage IIA TCGA-96-A4JL.7004E0F3-E9C5-4CF4-99ED-25C8401CBC87.pdf A4JL Post-Adjuvant Therapy TUMOR FREE 76 93 76 98 Complete Remission/Response YES NO R0 Primary Tumor 01 7th YES YES NO 96 1 Lung A LIVING 2012 f0913366-262e-4c6b-b687-cc6126d95c84 f0913366-262e-4c6b-b687-cc6126d95c84 TCGA-96-A4JL-01A-11D-A258-05 TCGA-96-A4JL-01A-11D-A256-01 f0913366-262e-4c6b-b687-cc6126d95c84 TCGA-96-A4JL-01A-11D-A256-01 +TCGA-97-7546-01 1.8 0.57 none none none none N N none none none 0.3 Bronchioid none none none none none none none Lepidic predominant Adc Lepidic predominant Adc none 0 TCGA-97-7546-01 BRCA-LUAD+ C1-LUAD-enriched Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 5 TCGA-97-7546 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung YES YES 76 L-Upper TCGA-97-7546-F31995 TCGA-97-7546 TCGA-97-7546-01A -27913 0 1285 1255 60 Additional New Tumor Event 2012-5-15 FEMALE Lung Acinar Adenocarcinoma No C34.1 8550/3 C34.1 YES 0.6 NO 1.2 NO New Primary Tumor YES 25 No MX N0 T1 Stage IA TCGA-97-7546.6d3d1827-e313-45ab-a388-406a3b26b427.pdf 7546 WITH TUMOR 96 84 100 85 Progressive Disease Convincing Imaging YES YES R0 Primary Tumor 01 0.6 1983 6th YES NO YES 97 3 Current reformed smoker for > 15 years Lung A LIVING 2008 1963 46ba6b5d-e758-4c4d-bbbf-8ec31fdd24e7 46ba6b5d-e758-4c4d-bbbf-8ec31fdd24e7 TCGA-97-7546-01A-11D-2037-05 TCGA-97-7546-01A-11D-2035-01 46ba6b5d-e758-4c4d-bbbf-8ec31fdd24e7 TCGA-97-7546-01A-11D-2035-01 TCGA-97-7546-01A-13-2192-20 +TCGA-97-7547-01 TCGA-97-7547-01 Iq Cluster 5 LUAD-like c10 miRNA cluster 5 TCGA-97-7547 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung YES NO YES 67 R-Upper TCGA-97-7547-F37177 TCGA-97-7547 TCGA-97-7547-01A 1894 -24737 0 1965 1147 94 Scheduled Follow-up Submission Progressive Disease 2012-11-29 FEMALE Lung Papillary Adenocarcinoma No C34.1 8260/3 C34.1 YES 0.2 NO 0.7 NO Locoregional Recurrence YES 30 No MX N0 T2 Stage IB TCGA-97-7547.4a96b27c-c641-4db1-abb2-d2f5ec4a404d.pdf 7547 WITH TUMOR 83 101 82 106 Progressive Disease Biopsy with Histologic Confirmation YES NO Primary Tumor 01 0.1 1986 6th YES NO YES 97 3 Lung A LIVING 2007 2680c851-cb71-4c87-a789-6448b1f66faf 2680c851-cb71-4c87-a789-6448b1f66faf TCGA-97-7547-01A-11D-2037-05 TCGA-97-7547-01A-11D-2035-01 2680c851-cb71-4c87-a789-6448b1f66faf TCGA-97-7547-01A-11D-2035-01 +TCGA-97-7552-01 1.95 0.18 none none none none N N none none none 0.09 Bronchioid none none none none none none none Invasive mucinous Invasive mucinous none 0 TCGA-97-7552-01 Kirc+ C1-LUAD-enriched Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 5 TCGA-97-7552 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung NO NO 70 L-Lower TCGA-97-7552-F37174 TCGA-97-7552 TCGA-97-7552-01A -25578 0 1932 798 Scheduled Follow-up Submission Complete Remission/Response 2012-11-29 MALE Lung Bronchioloalveolar Carcinoma Mucinous No C34.3 8253/3 C34.3 YES 1 NO 2.2 NO New Primary Tumor YES 40 No MX N0 T2 Stage IB TCGA-97-7552.201ed2f1-c4ed-42ac-81eb-b5a725c36b47.pdf 7552 TUMOR FREE 82 81 Stable Disease YES NO Primary Tumor 01 0.5 1985 6th NO NO YES 97 3 Current reformed smoker for > 15 years Lung A LIVING 2007 a8873600-a0a6-4880-b933-2cbcfb274233 a8873600-a0a6-4880-b933-2cbcfb274233 TCGA-97-7552-01A-11D-2037-05 TCGA-97-7552-01A-11D-2035-01 a8873600-a0a6-4880-b933-2cbcfb274233 TCGA-97-7552-01A-11D-2035-01 TCGA-97-7552-01A-13-2192-20 +TCGA-97-7553-01 1.47 0.3 none none none none N N none none none 0.16 Bronchioid none none none none none none none Acinar predominant Adc Acinar predominant Adc none 0 TCGA-97-7553-01 High C1-LUAD-enriched Low purity c2 squamous c3 LUAD-like c10 miRNA cluster 5 TCGA-97-7553 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 58 L-Lower TCGA-97-7553-F31865 TCGA-97-7553 TCGA-97-7553-01A -21518 0 1870 64 Scheduled Follow-up Submission 2012-5-14 FEMALE Lung Bronchioloalveolar Carcinoma Nonmucinous No C34.3 8252/3 C34.3 YES 1 NO Central Lung 1.5 NO NO 20 No MX N0 T1 Stage IA TCGA-97-7553.85eedad8-21be-4b10-910b-5b71802ae52f.pdf 7553 TUMOR FREE 70 99 70 99 Complete Remission/Response YES NO Primary Tumor 01 0.4 6th NO NO YES 97 2 Current smoker Lung A LIVING 2007 1967 4af52410-54ab-4307-96a0-b80579d18e0b 4af52410-54ab-4307-96a0-b80579d18e0b TCGA-97-7553-01A-21D-2037-05 TCGA-97-7553-01A-21D-2035-01 4af52410-54ab-4307-96a0-b80579d18e0b TCGA-97-7553-01A-21D-2035-01 TCGA-97-7553-01A-23-2192-20 +TCGA-97-7554-01 2.28 0.49 none none none none Y Y none none none 0.23 Squamoid none p.G12V none none none none none Acinar predominant Adc Acinar predominant Adc none 0 TCGA-97-7554-01 BRCA-LUAD+ C1-LUAD-enriched Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 4 TCGA-97-7554 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 83 L-Lower TCGA-97-7554-F20552 TCGA-97-7554 TCGA-97-7554-01A -30327 0 775 53 1 Scheduled Follow-up Submission 2012-1-17 FEMALE Lung Papillary Adenocarcinoma No C34.3 8260/3 C34.3 YES 1 NO YES YES G12V 1.7 NO 30 No M0 N2 T2a Stage IIIA TCGA-97-7554.17c2777e-782d-40e6-be44-8fad69d9abd1.pdf 7554 Post-Adjuvant Therapy TUMOR FREE 75 75 76 68 Complete Remission/Response YES NO R0 Primary Tumor 01 0.6 1983 7th YES NO YES 97 3 Current reformed smoker for > 15 years Lung A LIVING 2010 1945 db278ebc-bf83-43c0-8a60-a863786ea973 db278ebc-bf83-43c0-8a60-a863786ea973 TCGA-97-7554-01A-11D-2037-05 TCGA-97-7554-01A-11D-2035-01 db278ebc-bf83-43c0-8a60-a863786ea973 TCGA-97-7554-01A-11D-2035-01 TCGA-97-7554-01A-13-2192-20 +TCGA-97-7937-01 none none p.C401F none N N none none none Squamoid none none none none none none none Acinar predominant Adc Acinar predominant Adc none 0 TCGA-97-7937-01 High C1-LUAD-enriched Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 5 TCGA-97-7937 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung NO 65 L-Upper TCGA-97-7937-F33767 TCGA-97-7937 TCGA-97-7937-01A -23919 0 564 89 0 YES FISH YES Scheduled Follow-up Submission 2012-9-12 MALE Lung Micropapillary Adenocarcinoma No C34.1 8507/3 C34.1 YES 1.1 NO YES NO 1.1 NO NO 35 No MX N0 T2a Stage IB TCGA-97-7937.c52adb5c-9ab3-475b-b21c-c817ea5209f2.pdf 7937 Preoperative TUMOR FREE 77 120 Stable Disease YES NO Primary Tumor 01 0.5 1994 7th NO YES NO 97 3 Current reformed smoker for > 15 years Lung A LIVING 2011 4b847934-8dcb-451a-a0f1-a5f59bbd33db 4b847934-8dcb-451a-a0f1-a5f59bbd33db TCGA-97-7937-01A-11D-2168-05 TCGA-97-7937-01A-11D-2166-01 4b847934-8dcb-451a-a0f1-a5f59bbd33db TCGA-97-7937-01A-11D-2166-01 TCGA-97-7937-01A-13-2192-20 +TCGA-97-7938-01 none none none none Y Y none none none Bronchioid none p.G12C none none none none none Lepidic predominant Adc Lepidic predominant Adc none 0 TCGA-97-7938-01 BRCA-LUAD+ C1-LUAD-enriched Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 5 TCGA-97-7938 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 76 R-Upper TCGA-97-7938-F57460 TCGA-97-7938 TCGA-97-7938-01A -27980 18 0 53 YES NO Scheduled Follow-up Submission Complete Remission/Response 2014-3-11 FEMALE Lung Bronchioloalveolar Carcinoma Nonmucinous No C34.1 8252/3 C34.1 YES 0.8 NO YES YES G12C 1.2 NO NO 40 No MX N0 T1a Stage IA TCGA-97-7938.c1b81542-c8ad-43d1-a963-1584868e7fe7.pdf 7938 TUMOR FREE 59 54 58 50 Complete Remission/Response YES NO R0 Primary Tumor 01 0.2 1996 7th NO YES NO 97 3 Current reformed smoker for > 15 years Lung A DECEASED 2011 3163dcdb-7a0f-428d-94be-9fc140cca0ca 3163dcdb-7a0f-428d-94be-9fc140cca0ca TCGA-97-7938-01A-11D-2168-05 TCGA-97-7938-01A-11D-2166-01 3163dcdb-7a0f-428d-94be-9fc140cca0ca TCGA-97-7938-01A-11D-2166-01 TCGA-97-7938-01A-13-2192-20 +TCGA-97-7941-01 none none none none Y Y none none none Bronchioid none p.G12A none none none none none Acinar predominant Adc Acinar predominant Adc none 0 TCGA-97-7941-01 Kirc+ C1-LUAD-enriched Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 14 TCGA-97-7941 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 72 L-Upper TCGA-97-7941-F33765 TCGA-97-7941 TCGA-97-7941-01A -26298 0 484 57 0 YES NO Scheduled Follow-up Submission 2012-8-13 FEMALE Lung Acinar Adenocarcinoma No C34.1 8550/3 C34.1 YES 1 NO YES YES G12A 1.3 NO NO 22.5 No MX N0 T1b Stage IA TCGA-97-7941.f95131f4-d721-441f-86ee-d9981befc2a7.pdf 7941 Preoperative TUMOR FREE 81 98 94 97 Complete Remission/Response YES NO R0 Primary Tumor 01 0.2 1985 7th NO YES NO 97 3 Current reformed smoker for > 15 years Lung A LIVING 2011 1960 8f52d9f9-9077-4203-ac3a-d64b6589b536 8f52d9f9-9077-4203-ac3a-d64b6589b536 TCGA-97-7941-01A-11D-2185-05 TCGA-97-7941-01A-11D-2183-01 8f52d9f9-9077-4203-ac3a-d64b6589b536 TCGA-97-7941-01A-11D-2183-01 TCGA-97-7941-01A-13-2192-20 +TCGA-97-8171-01 TCGA-97-8171-01 BRCA-LUAD+ Cluster 5 LUAD-like c10 miRNA cluster 7 TCGA-97-8171 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung YES NO YES 81 Other (please specify) RUL and RML TCGA-97-8171-F44232 TCGA-97-8171 TCGA-97-8171-01A 441 -29627 0 568 441 110 1 YES Exon 19 Deletion NO Scheduled Follow-up Submission Progressive Disease 2013-6-19 MALE Lung Papillary Adenocarcinoma No C34.8 8260/3 C34.8 YES 0.8 NO YES NO 1.9 NO Distant Metastasis YES 65 No M1a N2 T2a Stage IV TCGA-97-8171.71aa5cff-eda0-47d0-97d8-caf4c02f5626.pdf 8171 Preoperative WITH TUMOR 55 104 55 99 Progressive Disease Biopsy with Histologic Confirmation YES NO Primary Tumor 01 0.5 7th YES YES NO 97 2 Lung A LIVING 2011 1946 8dedea58-fb63-44cc-860c-56e66b52d11b 8dedea58-fb63-44cc-860c-56e66b52d11b TCGA-97-8171-01A-11D-2285-05 TCGA-97-8171-01A-11D-2283-01 8dedea58-fb63-44cc-860c-56e66b52d11b TCGA-97-8171-01A-11D-2283-01 +TCGA-97-8172-01 TCGA-97-8172-01 Kirc+ Cluster 6 LUAD-like c10 miRNA c1uster 9 TCGA-97-8172 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 75 R-Upper TCGA-97-8172-F44230 TCGA-97-8172 TCGA-97-8172-01A -27416 0 545 64.98 1 YES NO Scheduled Follow-up Submission Complete Remission/Response 2013-6-19 FEMALE Lung Acinar Adenocarcinoma No C34.1 8550/3 C34.1 YES 1.2 NO YES YES G12V 1.7 NO NO 20 Yes, History of Prior Malignancy M0 N0 T2a Stage IB TCGA-97-8172.ef65fdd5-820a-4029-a667-56b5200276a7.pdf 8172 Preoperative TUMOR FREE 105.10 107.25 93.27 104.64 Complete Remission/Response YES NO Primary Tumor 01 0.5 1981 7th NO YES NO 97 3 Lung A LIVING 2011 1961 9b1118f0-743f-4186-b6cb-571ddb72bc74 9b1118f0-743f-4186-b6cb-571ddb72bc74 TCGA-97-8172-01A-11D-2285-05 TCGA-97-8172-01A-11D-2283-01 9b1118f0-743f-4186-b6cb-571ddb72bc74 TCGA-97-8172-01A-11D-2283-01 +TCGA-97-8174-01 TCGA-97-8174-01 BRCA-LUAD+ Cluster 5 LUAD-like c10 miRNA c1uster 9 TCGA-97-8174 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 67 R-Upper TCGA-97-8174 TCGA-97-8174-01A -24725 164 0 90 0 YES FISH YES 2012-6-13 MALE Lung Papillary Adenocarcinoma No C34.1 8260/3 C34.1 YES 1.5 NO YES NO 1.5 NO 40 No M0 N0 T2b Stage IIA TCGA-97-8174.f71782a0-0d9f-486e-9e17-cd5ff92d44d7.pdf 8174 Preoperative 86 99 81 91 YES NO Primary Tumor 01 0.5 1985 7th YES YES NO 97 3 Lung A DECEASED 2011 1965 076c0fa3-ca40-4362-9ba4-5d31fc27af41 076c0fa3-ca40-4362-9ba4-5d31fc27af41 TCGA-97-8174-01A-11D-2285-05 TCGA-97-8174-01A-11D-2283-01 076c0fa3-ca40-4362-9ba4-5d31fc27af41 TCGA-97-8174-01A-11D-2283-01 +TCGA-97-8175-01 TCGA-97-8175-01 GBM Cluster 6 LUAD-like c10 miRNA cluster 4 TCGA-97-8175 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung YES YES YES 55 L-Upper TCGA-97-8175-F44234 TCGA-97-8175 TCGA-97-8175-01A 294 -20206 0 551 294 YES FISH YES Scheduled Follow-up Submission Complete Remission/Response 2013-6-19 FEMALE Lung Solid Pattern Predominant Adenocarcinoma No C34.1 8230/3 C34.1 YES 1 NO YES NO Peripheral Lung 2 NO Locoregional Recurrence YES No M0 N0 T2a Stage IB TCGA-97-8175.19c71bba-794d-4245-bbd8-536740912c9f.pdf 8175 TUMOR FREE Complete Remission/Response Biopsy with Histologic Confirmation NO NO Primary Tumor 01 0.4 1981 7th NO YES NO 97 3 Lung A LIVING 2011 708e83be-4726-4eb6-a72c-ad855942551c 708e83be-4726-4eb6-a72c-ad855942551c TCGA-97-8175-01A-11D-2285-05 TCGA-97-8175-01A-11D-2283-01 708e83be-4726-4eb6-a72c-ad855942551c TCGA-97-8175-01A-11D-2283-01 +TCGA-97-8176-01 TCGA-97-8176-01 TCGA-97-8176 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 63 R-Lower TCGA-97-8176-F49542 TCGA-97-8176 TCGA-97-8176-01A -23170 468 0 252 61 0 YES NO Scheduled Follow-up Submission Progressive Disease 2013-10-11 MALE Lung Acinar Adenocarcinoma No C34.3 8550/3 C34.3 YES 2 NO YES YES G12S 2.1 NO NO 40 No M0 N1 T3 Stage IIIA TCGA-97-8176.348ab6f0-fcae-41ce-ae5c-0f0d3c3fd40f.pdf 8176 Preoperative TUMOR FREE 68 104 67 100 Stable Disease YES YES R0 Primary Tumor 01 0.3 2011 7th YES YES NO 97 4 Lung A DECEASED 2012 1971 a49c5cb5-9a31-456d-b55d-904081633729 a49c5cb5-9a31-456d-b55d-904081633729 TCGA-97-8176-01A-11D-2398-05 TCGA-97-8176-01A-11D-2389-01 a49c5cb5-9a31-456d-b55d-904081633729 TCGA-97-8176-01A-11D-2389-01 +TCGA-97-8177-01 TCGA-97-8177-01 Kirc+ Cluster 5 LUAD-like c10 miRNA cluster 4 TCGA-97-8177 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 59 L-Lower TCGA-97-8177-F44243 TCGA-97-8177 TCGA-97-8177-01A -21648 0 499 97 0 YES L858R NO Scheduled Follow-up Submission Complete Remission/Response 2013-6-19 FEMALE Lung Adenocarcinoma Mixed Subtype No C34.3 8255/3 C34.3 YES 1.7 NO YES NO 2.4 NO NO No M0 N0 T2a Stage IB TCGA-97-8177.addbe4e2-114d-4e38-aa21-c3e9695da8fa.pdf 8177 Preoperative TUMOR FREE 82 109 80 106 Complete Remission/Response YES NO Primary Tumor 01 0.3 7th YES YES NO 97 1 Lung A LIVING 2012 61e0c561-bf01-400c-843a-7c63e5a74b9f 61e0c561-bf01-400c-843a-7c63e5a74b9f TCGA-97-8177-01A-11D-2285-05 TCGA-97-8177-01A-11D-2283-01 61e0c561-bf01-400c-843a-7c63e5a74b9f TCGA-97-8177-01A-11D-2283-01 +TCGA-97-8179-01 TCGA-97-8179-01 High Cluster 6 LUAD-like c10 miRNA cluster 4 TCGA-97-8179 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 72 R-Upper TCGA-97-8179-F44247 TCGA-97-8179 TCGA-97-8179-01A -26305 0 435 73 0 YES FISH YES Scheduled Follow-up Submission Complete Remission/Response 2013-6-19 MALE Lung Acinar Adenocarcinoma No C34.1 8550/3 C34.1 YES 0.6 NO YES NO 0.8 NO NO 60 No M0 N0 T1a Stage IA TCGA-97-8179.8ed138ef-c9fe-45dd-870a-a438f6f22214.pdf 8179 Preoperative TUMOR FREE 91 95 86 90 Complete Remission/Response YES NO Primary Tumor 01 0.2 1988 7th NO YES NO 97 3 Lung A LIVING 2012 1958 1a331a89-0666-49c2-8f5c-915568d8cb31 1a331a89-0666-49c2-8f5c-915568d8cb31 TCGA-97-8179-01A-11D-2285-05 TCGA-97-8179-01A-11D-2283-01 1a331a89-0666-49c2-8f5c-915568d8cb31 TCGA-97-8179-01A-11D-2283-01 +TCGA-97-8547-01 TCGA-97-8547-01 TCGA-97-8547 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 78 R-Lower TCGA-97-8547-F49559 TCGA-97-8547 TCGA-97-8547-01A -28801 0 657 87 YES Exon 19 Deletion NO Scheduled Follow-up Submission Complete Remission/Response 2013-10-3 FEMALE Lung Adenocarcinoma Mixed Subtype No C34.3 8550/3 C34.3 YES 1.2 NO YES NO 1.9 NO NO No MX N2 T2a Stage IIIA TCGA-97-8547.7aa82152-5e34-43b3-81e2-77548d0d1c33.pdf 8547 TUMOR FREE 136 Complete Remission/Response YES NO Primary Tumor 01 0.5 7th YES YES NO 97 1 Lung A LIVING 2012 c11b849f-04dd-4599-8073-e2431bd68dd1 c11b849f-04dd-4599-8073-e2431bd68dd1 TCGA-97-8547-01A-11D-2398-05 TCGA-97-8547-01A-11D-2389-01 c11b849f-04dd-4599-8073-e2431bd68dd1 TCGA-97-8547-01A-11D-2389-01 +TCGA-97-8552-01 TCGA-97-8552-01 TCGA-97-8552 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 55 L-Lower TCGA-97-8552-F49557 TCGA-97-8552 TCGA-97-8552-01A -20331 0 626 75 0 YES Exon 19 Deletion NO Scheduled Follow-up Submission Complete Remission/Response 2013-10-3 FEMALE Lung Bronchioloalveolar Carcinoma Nonmucinous No C34.3 8252/3 C34.3 YES 1.1 NO YES NO 1.6 NO NO No MX N0 T1a Stage I TCGA-97-8552.0bfe6dee-7584-4803-be3e-5201cd5ad412.pdf 8552 Other TUMOR FREE 77 95 Complete Remission/Response YES NO Primary Tumor 01 0.4 7th NO YES NO 97 1 Lung A LIVING 2012 7d16518c-7da4-4b50-ae77-a708eccf5db0 7d16518c-7da4-4b50-ae77-a708eccf5db0 TCGA-97-8552-01A-11D-2398-05 TCGA-97-8552-01A-11D-2389-01 7d16518c-7da4-4b50-ae77-a708eccf5db0 TCGA-97-8552-01A-11D-2389-01 +TCGA-97-A4LX-01 TCGA-97-A4LX-01 TCGA-97-A4LX TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 81 Other (please specify) Lingula TCGA-97-A4LX-F57384 TCGA-97-A4LX TCGA-97-A4LX-01A -29915 127 0 614 61 0 NO NO Scheduled Follow-up Submission Complete Remission/Response 2014-3-10 MALE Lung Adenocarcinoma Mixed Subtype No C34.1 8255/3 C34.1 YES 50 NO YES YES G12A NO NO 120 true Yes, History of Synchronous/Bilateral Malignancy M0 N0 T2a Stage IB TCGA-97-A4LX.1D7E3689-7B7F-4916-BCD9-04C5A98F09DE.pdf A4LX Other TUMOR FREE 96 90 91 91 Complete Remission/Response YES NO Primary Tumor 01 1985 7th NO YES NO 97 3 Lung A LIVING 2012 1945 7d313d92-13f0-49f2-bff6-20e4fdd09337 7d313d92-13f0-49f2-bff6-20e4fdd09337 TCGA-97-A4LX-01A-11D-A24U-05 TCGA-97-A4LX-01A-11D-A24O-01 7d313d92-13f0-49f2-bff6-20e4fdd09337 TCGA-97-A4LX-01A-11D-A24O-01 +TCGA-97-A4M0-01 TCGA-97-A4M0-01 TCGA-97-A4M0 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 60 R-Upper TCGA-97-A4M0-F57385 TCGA-97-A4M0 TCGA-97-A4M0-01A -22206 136 0 652 0 NO NO Scheduled Follow-up Submission Complete Remission/Response 2014-3-10 FEMALE Lung Adenocarcinoma Mixed Subtype No C34.1 8255/3 C34.1 YES 150 NO YES YES G12C NO NO 34 true No M0 N0 T2a Stage IB TCGA-97-A4M0.0ACA9251-2F21-49E1-9E56-4D7359EF614F.pdf A4M0 Other TUMOR FREE 90 97 Complete Remission/Response YES NO Primary Tumor 01 2004 7th NO YES NO 97 4 Lung A LIVING 2012 1970 91128d24-c61a-47cf-938b-00ff80e4d0e7 91128d24-c61a-47cf-938b-00ff80e4d0e7 TCGA-97-A4M0-01A-11D-A24U-05 TCGA-97-A4M0-01A-11D-A24O-01 91128d24-c61a-47cf-938b-00ff80e4d0e7 TCGA-97-A4M0-01A-11D-A24O-01 +TCGA-97-A4M1-01 TCGA-97-A4M1-01 TCGA-97-A4M1 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 52 R-Upper TCGA-97-A4M1-F57386 TCGA-97-A4M1 TCGA-97-A4M1-01A -19272 126 0 601 111 0 NO NO Scheduled Follow-up Submission Complete Remission/Response 2014-3-10 FEMALE Lung Adenocarcinoma Mixed Subtype No C34.1 8255/3 C34.1 YES 70 NO NO NO NO 3 true No M0 N0 T1a Stage IA TCGA-97-A4M1.5482EF99-9D9B-4C29-A934-4808907EF37B.pdf A4M1 Other TUMOR FREE 92 105 87 100 Complete Remission/Response YES NO Primary Tumor 01 1975 7th NO YES NO 97 3 Lung A LIVING 2012 1972 da823ce3-fb4c-4626-824d-deef668836cf da823ce3-fb4c-4626-824d-deef668836cf TCGA-97-A4M1-01A-11D-A24U-05 TCGA-97-A4M1-01A-11D-A24O-01 da823ce3-fb4c-4626-824d-deef668836cf TCGA-97-A4M1-01A-11D-A24O-01 +TCGA-97-A4M2-01 TCGA-97-A4M2-01 TCGA-97-A4M2 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 66 R-Middle TCGA-97-A4M2-F57453 TCGA-97-A4M2 TCGA-97-A4M2-01A -24313 93 0 624 91 1 NO NO Scheduled Follow-up Submission Complete Remission/Response 2014-3-12 MALE Lung Adenocarcinoma Mixed Subtype No C34.2 8255/3 C34.2 YES 180 NO YES NO NO NO 100 true Yes, History of Prior Malignancy M0 N0 T1a Stage IA TCGA-97-A4M2.0D5976EC-5D41-44A2-AC0A-CBE90F2A908E.pdf A4M2 Preoperative TUMOR FREE 89 103 96 102 Complete Remission/Response YES NO R0 Primary Tumor 01 7th NO YES NO 97 2 Lung A LIVING 2012 1972 dc3f6cbd-8bf0-4b8e-bce8-eada0768499d dc3f6cbd-8bf0-4b8e-bce8-eada0768499d TCGA-97-A4M2-01A-12D-A24U-05 TCGA-97-A4M2-01A-12D-A24O-01 dc3f6cbd-8bf0-4b8e-bce8-eada0768499d TCGA-97-A4M2-01A-12D-A24O-01 +TCGA-97-A4M3-01 TCGA-97-A4M3-01 TCGA-97-A4M3 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung NO NO 69 R-Upper TCGA-97-A4M3-F57436 TCGA-97-A4M3 TCGA-97-A4M3-01A -25384 99 0 540 54 106 1 NO NO Scheduled Follow-up Submission Complete Remission/Response 2014-3-11 FEMALE Lung Adenocarcinoma Mixed Subtype No C34.1 8255/3 C34.1 YES 120 NO YES NO NO New Primary Tumor YES 37.5 true Yes, History of Prior Malignancy M0 N0 T1b Stage IA TCGA-97-A4M3.49E1FE02-A4A8-4805-88B1-ADB915F879DF.pdf A4M3 Other TUMOR FREE 69 73 61 61 Complete Remission/Response Biopsy with Histologic Confirmation YES NO Primary Tumor 01 1984 7th NO YES NO 97 3 Lung A LIVING 2012 1959 cb8f5c13-0ae8-4ec2-9249-3322ff220fff cb8f5c13-0ae8-4ec2-9249-3322ff220fff TCGA-97-A4M3-01A-11D-A24U-05 TCGA-97-A4M3-01A-11D-A24O-01 cb8f5c13-0ae8-4ec2-9249-3322ff220fff TCGA-97-A4M3-01A-11D-A24O-01 +TCGA-97-A4M5-01 TCGA-97-A4M5-01 TCGA-97-A4M5 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 83 R-Upper TCGA-97-A4M5-F57443 TCGA-97-A4M5 TCGA-97-A4M5-01A -30665 104 0 634 51 NO NO Scheduled Follow-up Submission Complete Remission/Response 2014-3-12 MALE Lung Adenocarcinoma Mixed Subtype No C34.1 8255/3 C34.1 YES 200 NO YES YES G12C NO NO 6 true No M0 N0 T1b Stage IA TCGA-97-A4M5.BD386F47-1CDC-46D5-A14D-F7D27F70982F.pdf A4M5 TUMOR FREE 84 94 85 98 Complete Remission/Response YES NO Primary Tumor 01 1982 7th NO YES NO 97 3 Lung A LIVING 2012 1952 a9b0abf6-d818-4aa0-a1bc-3e3c1cf2ff59 a9b0abf6-d818-4aa0-a1bc-3e3c1cf2ff59 TCGA-97-A4M5-01A-11D-A24U-05 TCGA-97-A4M5-01A-11D-A24O-01 a9b0abf6-d818-4aa0-a1bc-3e3c1cf2ff59 TCGA-97-A4M5-01A-11D-A24O-01 +TCGA-97-A4M6-01 TCGA-97-A4M6-01 TCGA-97-A4M6 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 45 R-Lower TCGA-97-A4M6-F57434 TCGA-97-A4M6 TCGA-97-A4M6-01A -16764 115 0 568 92 0 YES Exon 19 Deletion NO Scheduled Follow-up Submission Complete Remission/Response 2014-3-11 FEMALE Lung Adenocarcinoma Mixed Subtype No C34.3 8255/3 C34.3 YES 180 NO YES NO NO NO true No M0 N0 T1a Stage IA TCGA-97-A4M6.E697A53A-C377-4BC8-8D3F-79562DFF6F0A.pdf A4M6 Other TUMOR FREE 95 116 95 110 Complete Remission/Response YES NO Primary Tumor 01 7th NO YES NO 97 1 Lung A LIVING 2012 39408ce7-3fca-4e7e-8016-e8586b7bafad 39408ce7-3fca-4e7e-8016-e8586b7bafad TCGA-97-A4M6-01A-11D-A24U-05 TCGA-97-A4M6-01A-11D-A24O-01 39408ce7-3fca-4e7e-8016-e8586b7bafad TCGA-97-A4M6-01A-11D-A24O-01 +TCGA-97-A4M7-01 TCGA-97-A4M7-01 TCGA-97-A4M7 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 74 R-Middle TCGA-97-A4M7-F57383 TCGA-97-A4M7 TCGA-97-A4M7-01A -27062 132 0 629 99 0 YES L858R NO Scheduled Follow-up Submission Complete Remission/Response 2014-3-10 MALE Lung Adenocarcinoma Mixed Subtype No C34.2 8255/3 C34.2 YES 160 NO YES NO NO NO 40 true Yes, History of Synchronous/Bilateral Malignancy M0 N0 T1b Stage IA TCGA-97-A4M7.6E901848-BA21-4D4A-9CB5-0A5786D2843B.pdf A4M7 Other TUMOR FREE 82 101 74 91 Complete Remission/Response YES NO R0 Primary Tumor 01 1978 7th NO YES NO 97 3 Lung A LIVING 2012 1958 038898c8-e2f3-4bd9-9b8e-da45b86ea2ea 038898c8-e2f3-4bd9-9b8e-da45b86ea2ea TCGA-97-A4M7-01A-11D-A24U-05 TCGA-97-A4M7-01A-11D-A24O-01 038898c8-e2f3-4bd9-9b8e-da45b86ea2ea TCGA-97-A4M7-01A-11D-A24O-01 +TCGA-98-7454-01 TCGA-98-7454-01 Squamous C1-LUAD-enriched Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 4 TCGA-98-7454 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung NO 73 R-Upper TCGA-98-7454-F40775 TCGA-98-7454 TCGA-98-7454-01A -26827 0 652 0 YES YES Scheduled Follow-up Submission 2013-7-2 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 1.5 NO 100 YES 2.2 NO NO 60 No M0 N0 T2a Stage IB TCGA-98-7454.d2607098-3918-4967-9b7f-8ea9cd0e43b9.pdf 7454 Preoperative TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 0.5 1983 7th NO NO YES 98 3 Lung A LIVING 2011 1943 0e199130-3ee6-4172-93f9-db55c11e61b3 0e199130-3ee6-4172-93f9-db55c11e61b3 TCGA-98-7454-01A-11D-2043-05 TCGA-98-7454-01A-11D-2041-01 0e199130-3ee6-4172-93f9-db55c11e61b3 TCGA-98-7454-01A-11D-2041-01 TCGA-98-7454-01A-13-2195-20 +TCGA-98-8020-01 TCGA-98-8020-01 Squamous Cluster 14 (HNSC) miRNA cluster 11 TCGA-98-8020 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 56 R-Upper TCGA-98-8020 TCGA-98-8020-01A -20509 84 0 47 1 YES NO 2012-6-18 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 1 NO YES NO Central Lung 1.1 YES Yes, History of Prior Malignancy M0 N2 T2 Stage IIIA TCGA-98-8020.16358710-87d5-4ed9-9dd4-c60e7d8c59fc.pdf 8020 Preoperative WITH TUMOR 77 79 YES NO R0 Primary Tumor 01 0.5 7th NO NO YES 98 1 Lung A DECEASED 2011 e6628ef2-abe7-4fa1-9e12-9034179ebb63 e6628ef2-abe7-4fa1-9e12-9034179ebb63 TCGA-98-8020-01A-11D-2245-05 TCGA-98-8020-01A-11D-2243-01 e6628ef2-abe7-4fa1-9e12-9034179ebb63 TCGA-98-8020-01A-11D-2243-01 +TCGA-98-8021-01 TCGA-98-8021-01 Squamous Cluster 5 miRNA c1uster 9 TCGA-98-8021 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung NO NO YES 75 R-Upper TCGA-98-8021-F58644 TCGA-98-8021 TCGA-98-8021-01A 918 -27738 0 937 918 83 1 YES NO Scheduled Follow-up Submission Complete Remission/Response 2014-7-11 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 1.2 NO NO 2 NO Locoregional Recurrence YES 60 No M0 N0 T1a Stage IA TCGA-98-8021.76114a4d-45e7-48d6-b47c-f9952f973e1f.pdf 8021 Preoperative TUMOR FREE 68 101 Complete Remission/Response Biopsy with Histologic Confirmation YES NO R0 Primary Tumor 01 0.5 2010 7th NO NO YES 98 4 Lung A LIVING 2011 1950 1d2aec25-2f54-47da-b627-a6b312e027a1 1d2aec25-2f54-47da-b627-a6b312e027a1 TCGA-98-8021-01A-11D-2245-05 TCGA-98-8021-01A-11D-2243-01 1d2aec25-2f54-47da-b627-a6b312e027a1 TCGA-98-8021-01A-11D-2243-01 +TCGA-98-8022-01 TCGA-98-8022-01 High Cluster 5 miRNA cluster 4 TCGA-98-8022 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 61 R-Upper TCGA-98-8022-F58654 TCGA-98-8022 TCGA-98-8022-01A -22487 933 0 224 42 0 YES NO Scheduled Follow-up Submission 2014-7-11 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.7 NO YES NO 1.3 NO NO 117 No M0 N0 T1a Stage IA TCGA-98-8022.a43e983c-2c2a-4d8f-8eb9-4a46f9c4be43.pdf 8022 Preoperative TUMOR FREE 44 21 Complete Remission/Response YES NO R0 Primary Tumor 01 0.4 2008 7th NO NO YES 98 4 Lung A DECEASED 2011 1961 c66143ca-3cbb-4432-8013-cce080001918 c66143ca-3cbb-4432-8013-cce080001918 TCGA-98-8022-01A-11D-2245-05 TCGA-98-8022-01A-11D-2243-01 c66143ca-3cbb-4432-8013-cce080001918 TCGA-98-8022-01A-11D-2243-01 +TCGA-98-8023-01 TCGA-98-8023-01 High Cluster 5 miRNA cluster 4 TCGA-98-8023 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 70 Other (please specify) Right Upper and Right Middle TCGA-98-8023-F45009 TCGA-98-8023 TCGA-98-8023-01A -25732 0 649 69 0 YES NO Scheduled Follow-up Submission 2013-7-2 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.9 8070/3 C34.9 YES 1.4 NO YES NO 2.6 NO NO 75 No M0 N1 T3 Stage IIIA TCGA-98-8023.f1bfbafb-5cf1-414e-b14f-989573d4cbed.pdf 8023 Preoperative TUMOR FREE 46 54 Complete Remission/Response YES NO R0 Primary Tumor 01 0.5 7th NO YES NO 98 2 Lung A LIVING 2011 1961 29917460-f08a-4013-be64-ef7412d165dd 29917460-f08a-4013-be64-ef7412d165dd TCGA-98-8023-01A-11D-2245-05 TCGA-98-8023-01A-11D-2243-01 29917460-f08a-4013-be64-ef7412d165dd TCGA-98-8023-01A-11D-2243-01 +TCGA-98-A538-01 TCGA-98-A538-01 TCGA-98-A538 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 67 L-Upper TCGA-98-A538-F59855 TCGA-98-A538 TCGA-98-A538-01A -24698 266 0 826 77 2 YES NO Scheduled Follow-up Submission 2014-5-23 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 350 NO YES NO NO NO 35 true No M0 N0 T3 Stage IIB TCGA-98-A538.D297F1CF-8E9C-466C-8EE0-C589E5C74D29.pdf A538 Preoperative TUMOR FREE 65 76 Complete Remission/Response YES NO R0 Primary Tumor 01 2008 7th NO YES NO 98 4 Lung A LIVING 2012 1973 f6b2f5b6-b012-46ec-9ed9-9a37c22cac5d f6b2f5b6-b012-46ec-9ed9-9a37c22cac5d TCGA-98-A538-01A-11D-A25R-05 TCGA-98-A538-01A-11D-A25M-01 f6b2f5b6-b012-46ec-9ed9-9a37c22cac5d TCGA-98-A538-01A-11D-A25M-01 +TCGA-98-A539-01 TCGA-98-A539-01 TCGA-98-A539 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung NO 63 L-Upper TCGA-98-A539-F71610 TCGA-98-A539 TCGA-98-A539-01A -23098 327 0 173 173 55 1 YES FISH YES Scheduled Follow-up Submission 2015-3-26 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 180 NO YES NO YES Locoregional Recurrence YES 75 true Yes, History of Prior Malignancy M0 N0 T3 Stage IIB TCGA-98-A539.9CC9A747-F186-4BAE-B63F-82DC061B06FA.pdf A539 Preoperative WITH TUMOR 60 73 Convincing Imaging YES NO R0 Primary Tumor 01 7th NO YES NO 98 2 Lung A LIVING 2011 1962 63068ba8-f2cb-4e3d-a34b-ec219ab6b574 63068ba8-f2cb-4e3d-a34b-ec219ab6b574 TCGA-98-A539-01A-31D-A25R-05 TCGA-98-A539-01A-31D-A25M-01 63068ba8-f2cb-4e3d-a34b-ec219ab6b574 TCGA-98-A539-01A-31D-A25M-01 +TCGA-98-A53A-01 TCGA-98-A53A-01 TCGA-98-A53A TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 70 R-Middle TCGA-98-A53A-F58714 TCGA-98-A53A TCGA-98-A53A-01A -25662 161 552 0 274 43 1 YES FISH YES Scheduled Follow-up Submission 2014-10-23 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.2 8070/3 C34.2 YES 320 NO YES NO NO NO 80 true No M0 N0 T2a Stage IB TCGA-98-A53A.3E2F6DF6-5C59-4B1B-887E-B080532548A1.pdf A53A Preoperative 36 31 Complete Remission/Response YES NO R0 Primary Tumor 01 7th NO YES NO 98 2 Lung A DECEASED 2012 1972 b7a68734-2faf-41d2-9338-83ebacd3f044 b7a68734-2faf-41d2-9338-83ebacd3f044 TCGA-98-A53A-01A-11D-A25R-05 TCGA-98-A53A-01A-11D-A25M-01 b7a68734-2faf-41d2-9338-83ebacd3f044 TCGA-98-A53A-01A-11D-A25M-01 +TCGA-98-A53B-01 TCGA-98-A53B-01 TCGA-98-A53B TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 69 L-Upper TCGA-98-A53B TCGA-98-A53B-01A -25390 85 61 0 90 0 NO NO 2013-3-28 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 370 NO NO NO 40 true No M0 N0 T2a Stage IB TCGA-98-A53B.2BA70162-293A-4E9C-959C-0A735F18EA54.pdf A53B Preoperative TUMOR FREE 79 96 Complete Remission/Response YES NO R0 Primary Tumor 01 7th NO YES NO 98 2 Lung A DECEASED 2012 1972 c2c33653-e866-47a2-802c-7b842ed86ff4 c2c33653-e866-47a2-802c-7b842ed86ff4 TCGA-98-A53B-01A-11D-A25R-05 TCGA-98-A53B-01A-11D-A25M-01 c2c33653-e866-47a2-802c-7b842ed86ff4 TCGA-98-A53B-01A-11D-A25M-01 +TCGA-98-A53C-01 TCGA-98-A53C-01 TCGA-98-A53C TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 77 R-Lower TCGA-98-A53C-F58828 TCGA-98-A53C TCGA-98-A53C-01A -28146 289 0 822 86 2 NO NO Scheduled Follow-up Submission 2014-4-24 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 600 NO NO NO NO 112.5 true No M0 N0 T1a Stage IA TCGA-98-A53C.46281311-F538-417F-88E2-97DDD8055AFC.pdf A53C Preoperative TUMOR FREE 57 55 Complete Remission/Response YES NO R0 Primary Tumor 01 2000 7th NO YES NO 98 4 Lung A LIVING 2012 1955 af593182-a2e2-4bbf-9a11-35746bf4be9e af593182-a2e2-4bbf-9a11-35746bf4be9e TCGA-98-A53C-01A-11D-A25R-05 TCGA-98-A53C-01A-11D-A25M-01 af593182-a2e2-4bbf-9a11-35746bf4be9e TCGA-98-A53C-01A-11D-A25M-01 +TCGA-98-A53D-01 TCGA-98-A53D-01 TCGA-98-A53D TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung YES YES NO 68 R-Upper TCGA-98-A53D-F58825 TCGA-98-A53D TCGA-98-A53D-01A -24891 168 645 0 22 413 73 2 NO NO Scheduled Follow-up Submission Progressive Disease 2014-7-11 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8071/3 C34.1 YES 410 NO NO NO Locoregional Recurrence YES 90 true Yes, History of Prior Malignancy M0 N0 T3 Stage IIB TCGA-98-A53D.3B02DAE4-711E-46B4-AFE4-ED65A7DD1AD5.pdf A53D Preoperative WITH TUMOR 44 31 Complete Remission/Response Convincing Imaging YES NO R0 Primary Tumor 01 1990 7th NO YES NO 98 4 Lung A DECEASED 2012 1960 32618f86-4f65-4370-8339-5faad4fa59d5 32618f86-4f65-4370-8339-5faad4fa59d5 TCGA-98-A53D-01A-32D-A26N-05 TCGA-98-A53D-01A-32D-A26L-01 32618f86-4f65-4370-8339-5faad4fa59d5 TCGA-98-A53D-01A-32D-A26L-01 +TCGA-98-A53H-01 TCGA-98-A53H-01 TCGA-98-A53H TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung NO YES 76 R-Upper TCGA-98-A53H-F58831 TCGA-98-A53H TCGA-98-A53H-01A -27928 98 0 618 427 87 1 NO NO Scheduled Follow-up Submission 2014-10-23 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 210 NO NO NO New Primary Tumor YES 40 true No M0 N0 T1a Stage IA TCGA-98-A53H.70F9038F-903B-4726-8DEB-CF4867136B9B.pdf A53H Preoperative 54 75 Complete Remission/Response Convincing Imaging YES NO R0 Primary Tumor 01 7th NO YES NO 98 2 Lung A LIVING 2012 1973 b2eaf339-4cd4-4b99-a5d4-10957d3d49dd b2eaf339-4cd4-4b99-a5d4-10957d3d49dd TCGA-98-A53H-01A-12D-A25R-05 TCGA-98-A53H-01A-12D-A25M-01 b2eaf339-4cd4-4b99-a5d4-10957d3d49dd TCGA-98-A53H-01A-12D-A25M-01 +TCGA-98-A53I-01 TCGA-98-A53I-01 TCGA-98-A53I TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 64 R-Upper TCGA-98-A53I-F58930 TCGA-98-A53I TCGA-98-A53I-01A -23502 70 0 565 81 1 YES FISH YES Scheduled Follow-up Submission 2014-10-23 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 350 NO YES NO NO NO 70 true No M0 N1 T2a Stage IIA TCGA-98-A53I.D5167627-2D4D-4210-BAFC-CD73555488D9.pdf A53I Preoperative TUMOR FREE 80 56 Complete Remission/Response YES NO R0 Primary Tumor 01 2004 7th YES YES NO 98 4 Lung A LIVING 2012 1969 4f8626b1-b8cd-41a2-b9b0-63847d2168be 4f8626b1-b8cd-41a2-b9b0-63847d2168be TCGA-98-A53I-01A-31D-A25R-05 TCGA-98-A53I-01A-31D-A25M-01 4f8626b1-b8cd-41a2-b9b0-63847d2168be TCGA-98-A53I-01A-31D-A25M-01 +TCGA-98-A53J-01 TCGA-98-A53J-01 TCGA-98-A53J TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 77 R-Upper TCGA-98-A53J-F58713 TCGA-98-A53J TCGA-98-A53J-01A -28485 83 0 630 81 1 YES FISH YES Scheduled Follow-up Submission 2014-4-22 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 1050 NO YES NO NO NO 100 true No M0 N0 T2a Stage IB TCGA-98-A53J.DFE3709F-1806-4D6E-8E4A-F33BEE0BABFC.pdf A53J Preoperative TUMOR FREE 46 57 50 59 Complete Remission/Response YES NO R0 Primary Tumor 01 1982 7th NO YES NO 98 3 Lung A LIVING 2012 1957 92959314-e1b3-4b24-a9a1-080a61884135 92959314-e1b3-4b24-a9a1-080a61884135 TCGA-98-A53J-01A-11D-A26N-05 TCGA-98-A53J-01A-11D-A26L-01 92959314-e1b3-4b24-a9a1-080a61884135 TCGA-98-A53J-01A-11D-A26L-01 +TCGA-99-7458-01 1.79 0.36 none none none none Y Y none none none 0.19 Bronchioid none p.G12R none none none none none Micropapillary predom Adc Micropapillary predom Adc none 0 TCGA-99-7458-01 BRCA-LUAD+ C1-LUAD-enriched Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 5 TCGA-99-7458 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 74 R-Lower TCGA-99-7458-F40777 TCGA-99-7458 TCGA-99-7458-01A -27359 0 747 1 YES RT-PCR YES Scheduled Follow-up Submission Stable Disease 2013-4-17 FEMALE Lung Bronchioloalveolar Carcinoma Nonmucinous No C34.3 8252/3 C34.3 YES 0.7 NO 90 YES YES G12A 1.2 NO NO 52 No M0 N0 T4 Stage IIIA TCGA-99-7458.d17d08c5-429b-413f-8ed6-984bc2021392.pdf 7458 Preoperative WITH TUMOR Stable Disease NO R0 Primary Tumor 01 0.7 2010 7th YES NO YES 99 4 Current reformed smoker for < or = 15 years Lung A LIVING 2010 1958 38574f35-5845-4a7d-8657-da3d8757a0eb 38574f35-5845-4a7d-8657-da3d8757a0eb TCGA-99-7458-01A-11D-2037-05 TCGA-99-7458-01A-11D-2035-01 38574f35-5845-4a7d-8657-da3d8757a0eb TCGA-99-7458-01A-11D-2035-01 TCGA-99-7458-01A-13-2192-20 +TCGA-99-8025-01 TCGA-99-8025-01 High Cluster 6 LUAD-like c10 miRNA cluster 4 TCGA-99-8025 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 72 R-Upper TCGA-99-8025-F57698 TCGA-99-8025 TCGA-99-8025-01A -26634 0 1060 87 1 YES YES Scheduled Follow-up Submission Complete Remission/Response 2014-5-23 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.8 NO YES NO Central Lung 1.2 NO NO 20 No M0 N2 T3 Stage IIIA TCGA-99-8025.42373413-46df-4837-a01f-2659d92888cd.pdf 8025 Preoperative TUMOR FREE 111 Complete Remission/Response YES NO R0 Primary Tumor 01 0.4 1998 7th YES NO YES 99 4 Lung A LIVING 2010 1958 36c6906f-7f3e-4bb4-9813-246dc7669fc6 36c6906f-7f3e-4bb4-9813-246dc7669fc6 TCGA-99-8025-01A-11D-2239-05 TCGA-99-8025-01A-11D-2237-01 36c6906f-7f3e-4bb4-9813-246dc7669fc6 TCGA-99-8025-01A-11D-2237-01 +TCGA-99-8028-01 TCGA-99-8028-01 Kirc+ Cluster 5 LUAD-like c10 miRNA c1uster 9 TCGA-99-8028 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 50 L-Upper TCGA-99-8028-F57699 TCGA-99-8028 TCGA-99-8028-01A -18542 0 1118 71 0 YES RT-PCR YES Scheduled Follow-up Submission Complete Remission/Response 2014-4-17 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.6 NO YES YES G12C 1.3 NO NO 30 No M0 N0 T1a Stage IA TCGA-99-8028.c5b3fd4e-8e81-4b8f-b38d-e2a6bbded1ee.pdf 8028 Preoperative TUMOR FREE 91 98 91 94 Complete Remission/Response YES NO R0 Primary Tumor 01 0.5 2011 7th NO NO YES 99 4 Lung A LIVING 2011 1981 e4ac001e-f87e-4c46-8e0e-cee8a4f80965 e4ac001e-f87e-4c46-8e0e-cee8a4f80965 TCGA-99-8028-01A-11D-2239-05 TCGA-99-8028-01A-11D-2237-01 e4ac001e-f87e-4c46-8e0e-cee8a4f80965 TCGA-99-8028-01A-11D-2237-01 +TCGA-99-8032-01 TCGA-99-8032-01 BRCA-LUAD+ Cluster 5 LUAD-like c10 miRNA cluster 6 TCGA-99-8032 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 61 R-Upper TCGA-99-8032 TCGA-99-8032-01A -22635 0 44 54 0 YES NO 2012-6-15 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.7 NO YES YES G12C 1.3 90 No M0 N0 T1a Stage IA TCGA-99-8032.376597ef-e750-4f66-b744-2b042c0df836.pdf 8032 Preoperative TUMOR FREE 55 59 Complete Remission/Response YES NO R0 Primary Tumor 01 0.5 7th NO YES NO 99 2 Lung A LIVING 2011 1966 179cc9f5-4583-4c7c-945b-a2754234716f 179cc9f5-4583-4c7c-945b-a2754234716f TCGA-99-8032-01A-11D-2239-05 TCGA-99-8032-01A-11D-2237-01 179cc9f5-4583-4c7c-945b-a2754234716f TCGA-99-8032-01A-11D-2237-01 +TCGA-99-8033-01 TCGA-99-8033-01 High Cluster 5 LUAD-like c10 miRNA cluster 4 TCGA-99-8033 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 74 R-Upper TCGA-99-8033-F58623 TCGA-99-8033 TCGA-99-8033-01A -27342 656 0 170 2 YES NO Scheduled Follow-up Submission 2015-3-30 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.6 NO YES NO Peripheral Lung 0.6 NO NO No M1 NX TX Stage IV TCGA-99-8033.a7f10fd8-ab32-4adb-94a9-31632e286b11.pdf 8033 Post-Adjuvant Therapy WITH TUMOR Progressive Disease NO YES R0 Primary Tumor 01 0.5 7th YES YES NO 99 1 Lung A DECEASED 2011 1fd32c7c-73dd-4c17-a0ac-7b33f610976e 1fd32c7c-73dd-4c17-a0ac-7b33f610976e TCGA-99-8033-01A-11D-2239-05 TCGA-99-8033-01A-11D-2237-01 1fd32c7c-73dd-4c17-a0ac-7b33f610976e TCGA-99-8033-01A-11D-2237-01 +TCGA-99-AA5R-01 TCGA-99-AA5R-01 TCGA-99-AA5R TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 70 L-Lower TCGA-99-AA5R-F69298 TCGA-99-AA5R TCGA-99-AA5R-01A -25778 323 0 658 47 1 YES IHC YES Scheduled Follow-up Submission 2014-12-31 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 90 NO YES YES G12C NO NO 46 true No M0 N0 T1a Stage IA TCGA-99-AA5R.5541B103-6FD2-4767-B914-8A5B58E86D0A.pdf AA5R Preoperative TUMOR FREE 65 64 Complete Remission/Response YES NO R0 Primary Tumor 01 7th NO YES NO 99 2 Lung A LIVING 2013 1967 07f7b453-5716-466f-affd-74a24c4d5c53 07f7b453-5716-466f-affd-74a24c4d5c53 TCGA-99-AA5R-01A-11D-A398-05 TCGA-99-AA5R-01A-11D-A396-01 07f7b453-5716-466f-affd-74a24c4d5c53 TCGA-99-AA5R-01A-11D-A396-01 +TCGA-J1-A4AH-01 TCGA-J1-A4AH-01 TCGA-J1-A4AH TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 70 L-Lower TCGA-J1-A4AH-F55533 TCGA-J1-A4AH TCGA-J1-A4AH-01A -25893 104 0 581 77 NO NO Scheduled Follow-up Submission 2014-1-8 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 360 NO NO NO NO 100 true Yes, History of Synchronous/Bilateral Malignancy MX N0 T2b Stage IIA TCGA-J1-A4AH.27031EAD-6E93-4973-869E-EFE13B7F899A.pdf A4AH TUMOR FREE 75 Complete Remission/Response YES NO R0 Primary Tumor 01 2009 7th YES YES NO J1 4 Lung A LIVING 2012 657d4e74-c441-4ae1-8342-f789103bd461 657d4e74-c441-4ae1-8342-f789103bd461 TCGA-J1-A4AH-01A-31D-A24I-05 TCGA-J1-A4AH-01A-31D-A24C-01 657d4e74-c441-4ae1-8342-f789103bd461 TCGA-J1-A4AH-01A-31D-A24C-01 +TCGA-J2-8192-01 TCGA-J2-8192-01 Kirc+ Cluster 5 LUAD-like c10 miRNA cluster 4 TCGA-J2-8192 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung YES NO NO NO 65 L-Upper TCGA-J2-8192-F55390 TCGA-J2-8192 TCGA-J2-8192-01A -23892 0 739 482 112 YES Exon 19 Deletion NO Scheduled Follow-up Submission 2014-2-18 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.7 NO YES NO 1 NO Locoregional Recurrence YES Yes, History of Prior Malignancy MX N1 T2a Stage IIA TCGA-J2-8192.ab6bb598-f1a2-4691-90c4-e8d63dea8772.pdf 8192 TUMOR FREE 100 89 97 77 Progressive Disease Biopsy with Histologic Confirmation YES NO Primary Tumor 01 0.3 7th YES YES NO J2 1 Lung A LIVING 2011 54e59fdb-a377-4f69-84aa-8aa21312d270 54e59fdb-a377-4f69-84aa-8aa21312d270 TCGA-J2-8192-01A-11D-2239-05 TCGA-J2-8192-01A-11D-2237-01 54e59fdb-a377-4f69-84aa-8aa21312d270 TCGA-J2-8192-01A-11D-2237-01 +TCGA-J2-8194-01 TCGA-J2-8194-01 BRCA-LUAD+ Cluster 5 LUAD-like c10 miRNA cluster 4 TCGA-J2-8194 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung YES NO NO YES 69 R-Lower TCGA-J2-8194-F55317 TCGA-J2-8194 TCGA-J2-8194-01A 518 -25441 0 724 470 59 Scheduled Follow-up Submission Partial Remission/Response 2014-1-3 FEMALE Lung Adenocarcinoma Mixed Subtype No C34.3 8255/3 C34.3 YES 0.6 NO 0.8 NO Distant Metastasis YES 20 Yes, History of Prior Malignancy MX N0 T3 Stage IIB TCGA-J2-8194.9604f23f-f09c-480e-828f-5760b5fcdae4.pdf 8194 WITH TUMOR 2.04 83 2.04 83 Progressive Disease Biopsy with Histologic Confirmation|Convincing Imaging YES YES Primary Tumor 01 0.4 1982 7th YES YES NO J2 3 Lung A LIVING 2011 1956 c0639498-dcbb-432b-816a-1aa025c5ad60 c0639498-dcbb-432b-816a-1aa025c5ad60 TCGA-J2-8194-01A-11D-2239-05 TCGA-J2-8194-01A-11D-2237-01 c0639498-dcbb-432b-816a-1aa025c5ad60 TCGA-J2-8194-01A-11D-2237-01 +TCGA-J2-A4AD-01 TCGA-J2-A4AD-01 TCGA-J2-A4AD TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung NO NO 61 L-Upper TCGA-J2-A4AD-F55524 TCGA-J2-A4AD TCGA-J2-A4AD-01A -22414 178 550 0 287 524 NO NO Scheduled Follow-up Submission 2014-1-8 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 110 NO NO NO Locoregional Recurrence|Distant Metastasis YES 120 true No MX N0 T1a Stage IA TCGA-J2-A4AD.C7D2CA13-F82C-4B95-9161-E9D8C8D958E0.pdf A4AD WITH TUMOR 1.95 Convincing Imaging YES NO RX Primary Tumor 01 7th NO YES NO J2 2 Lung A DECEASED 2012 1970 2d6005de-b9ad-48ab-bfc9-60995838a002 2d6005de-b9ad-48ab-bfc9-60995838a002 TCGA-J2-A4AD-01A-11D-A24I-05 TCGA-J2-A4AD-01A-11D-A24C-01 2d6005de-b9ad-48ab-bfc9-60995838a002 TCGA-J2-A4AD-01A-11D-A24C-01 +TCGA-J2-A4AE-01 TCGA-J2-A4AE-01 TCGA-J2-A4AE TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 77 L-Upper TCGA-J2-A4AE-F70639 TCGA-J2-A4AE TCGA-J2-A4AE-01A -28163 177 0 1079 89 NO NO Scheduled Follow-up Submission Complete Remission/Response 2015-2-27 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 90 NO NO NO NO true No MX N0 T1a Stage IA TCGA-J2-A4AE.DF9C8900-3277-481F-82BD-335744EABD7A.pdf A4AE TUMOR FREE 0.72 92 Complete Remission/Response YES NO R0 Primary Tumor 01 7th NO YES NO J2 1 Lung A LIVING 2012 25b7445f-2f62-4303-b983-cdde19c12256 25b7445f-2f62-4303-b983-cdde19c12256 TCGA-J2-A4AE-01A-21D-A24I-05 TCGA-J2-A4AE-01A-21D-A24C-01 25b7445f-2f62-4303-b983-cdde19c12256 TCGA-J2-A4AE-01A-21D-A24C-01 +TCGA-J2-A4AG-01 TCGA-J2-A4AG-01 TCGA-J2-A4AG TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 66 L-Upper TCGA-J2-A4AG-F70848 TCGA-J2-A4AG TCGA-J2-A4AG-01A -24224 129 0 988 NO NO Scheduled Follow-up Submission Complete Remission/Response 2015-3-10 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 280 NO NO NO NO 25 true No MX N0 T1b Stage IA TCGA-J2-A4AG.E56191DA-873E-4506-8591-A6989706F8CB.pdf A4AG TUMOR FREE Complete Remission/Response NO NO R0 Primary Tumor 01 1981 7th NO YES NO J2 3 Lung A LIVING 2012 1956 34c74991-850e-4794-9603-a7212905e13b 34c74991-850e-4794-9603-a7212905e13b TCGA-J2-A4AG-01A-11D-A24I-05 TCGA-J2-A4AG-01A-11D-A24C-01 34c74991-850e-4794-9603-a7212905e13b TCGA-J2-A4AG-01A-11D-A24C-01 +TCGA-L3-A4E7-01 TCGA-L3-A4E7-01 TCGA-L3-A4E7 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung NO 71 R-Lower TCGA-L3-A4E7-F49026 TCGA-L3-A4E7 TCGA-L3-A4E7-01A -26232 36 0 392 87 1 NO NO Scheduled Follow-up Submission Complete Remission/Response 2013-9-25 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 110 NO NO Central Lung NO NO 25 true No M0 N0 T2a Stage IB TCGA-L3-A4E7.83686883-C3FA-43DA-9C85-F0A6319B7F57.pdf A4E7 Other TUMOR FREE 114 140 116 130 Complete Remission/Response YES NO R0 Primary Tumor 01 7th NO NO YES L3 2 Lung A LIVING 2012 1962 e873f2ee-21a1-48f9-a6d1-8062786148de e873f2ee-21a1-48f9-a6d1-8062786148de TCGA-L3-A4E7-01A-11D-A258-05 TCGA-L3-A4E7-01A-11D-A256-01 e873f2ee-21a1-48f9-a6d1-8062786148de TCGA-L3-A4E7-01A-11D-A256-01 +TCGA-L3-A524-01 TCGA-L3-A524-01 TCGA-L3-A524 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 45 R-Upper TCGA-L3-A524-F55375 TCGA-L3-A524 TCGA-L3-A524-01A -16765 393 490 0 449 69 1 NO NO Scheduled Follow-up Submission 2014-1-6 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 160 NO NO Central Lung NO NO 25.6 true No M0 N0 T3 Stage IIB TCGA-L3-A524.9E78715F-BAED-4724-A4DC-C432C9C26CCF.pdf A524 Preoperative TUMOR FREE 92 117 90 111 Complete Remission/Response YES NO R0 Primary Tumor 01 7th YES NO YES L3 2 Lung A DECEASED 2011 1979 d3a233c1-9696-4c48-9567-ff37bb343362 d3a233c1-9696-4c48-9567-ff37bb343362 TCGA-L3-A524-01A-11D-A25R-05 TCGA-L3-A524-01A-11D-A25M-01 d3a233c1-9696-4c48-9567-ff37bb343362 TCGA-L3-A524-01A-11D-A25M-01 +TCGA-L4-A4E5-01 TCGA-L4-A4E5-01 TCGA-L4-A4E5 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 48 L-Upper TCGA-L4-A4E5-F49031 TCGA-L4-A4E5 TCGA-L4-A4E5-01A -17680 227 0 578 93 1 NO NO Scheduled Follow-up Submission Complete Remission/Response 2013-9-25 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 160 NO NO Central Lung NO NO 33 true No M0 N0 T1 Stage I TCGA-L4-A4E5.22CFA28A-0CE4-4806-97B0-32635D6DCE3F.pdf A4E5 Other TUMOR FREE 94 82 94 82 Complete Remission/Response YES NO R0 Primary Tumor 01 2012 7th NO NO YES L4 4 Lung A LIVING 2012 1979 00481f66-1aad-4885-9162-bf802b1ed7f5 00481f66-1aad-4885-9162-bf802b1ed7f5 TCGA-L4-A4E5-01A-11D-A24U-05 TCGA-L4-A4E5-01A-11D-A24O-01 00481f66-1aad-4885-9162-bf802b1ed7f5 TCGA-L4-A4E5-01A-11D-A24O-01 +TCGA-L4-A4E6-01 TCGA-L4-A4E6-01 TCGA-L4-A4E6 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 67 R-Upper TCGA-L4-A4E6-F51277 TCGA-L4-A4E6 TCGA-L4-A4E6-01A -24631 22 0 435 98 NO NO Scheduled Follow-up Submission Complete Remission/Response 2013-11-14 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 210 NO NO Peripheral Lung NO NO 30 true No M0 N0 T1 Stage IA TCGA-L4-A4E6.A6FC7AD1-BE0E-4B6C-A71C-CBDC7CD58968.pdf A4E6 TUMOR FREE 82 85 84 69 Complete Remission/Response YES NO R0 Primary Tumor 01 1984 7th NO NO YES L4 3 Lung A LIVING 2012 1954 ff0e31ac-ee03-495a-97e0-a5283fd1c3ae ff0e31ac-ee03-495a-97e0-a5283fd1c3ae TCGA-L4-A4E6-01A-11D-A24I-05 TCGA-L4-A4E6-01A-11D-A24C-01 ff0e31ac-ee03-495a-97e0-a5283fd1c3ae TCGA-L4-A4E6-01A-11D-A24C-01 +TCGA-L9-A443-01 TCGA-L9-A443-01 TCGA-L9-A443 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 63 L-Lower TCGA-L9-A443-F46410 TCGA-L9-A443 TCGA-L9-A443-01A -23062 50 193 0 116 61 1 NO NO Scheduled Follow-up Submission 2013-8-7 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 230 NO NO Central Lung NO NO 90 false Yes, History of Prior Malignancy MX N0 T1a Stage IA TCGA-L9-A443.4D3DD711-7FC9-4CC8-B297-48036F42DCE7.pdf A443 Preoperative TUMOR FREE 74 69 Complete Remission/Response YES NO R0 Primary Tumor 01 2005 7th NO YES NO L9 4 Lung A DECEASED 2012 1960 12922017-4f50-4d3d-9bf9-8d9bf7a3b8d4 12922017-4f50-4d3d-9bf9-8d9bf7a3b8d4 TCGA-L9-A443-01A-12D-A24I-05 TCGA-L9-A443-01A-12D-A24C-01 12922017-4f50-4d3d-9bf9-8d9bf7a3b8d4 TCGA-L9-A443-01A-12D-A24C-01 +TCGA-L9-A444-01 TCGA-L9-A444-01 TCGA-L9-A444 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 60 R-Upper TCGA-L9-A444-F46270 TCGA-L9-A444 TCGA-L9-A444-01A -22202 8 0 307 57 0 NO NO Scheduled Follow-up Submission Complete Remission/Response 2013-8-5 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 150 NO NO Central Lung NO NO 10 false Yes, History of Prior Malignancy MX N0 T1a Stage IA TCGA-L9-A444.7356DDFB-ADA7-4809-85EC-1C6D51D5B32D.pdf A444 Preoperative TUMOR FREE 62 54 58 49 Complete Remission/Response YES NO R0 Primary Tumor 01 7th NO YES NO L9 2 Lung A LIVING 2012 1972 a3b81644-c1b8-4d12-b6f8-6160533758cc a3b81644-c1b8-4d12-b6f8-6160533758cc TCGA-L9-A444-01A-21D-A24I-05 TCGA-L9-A444-01A-21D-A24C-01 a3b81644-c1b8-4d12-b6f8-6160533758cc TCGA-L9-A444-01A-21D-A24C-01 +TCGA-L9-A50W-01 TCGA-L9-A50W-01 TCGA-L9-A50W TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung NO NO NO NO 75 L-Lower TCGA-L9-A50W-F50396 TCGA-L9-A50W TCGA-L9-A50W-01A -27414 205 442 0 266 389 0 YES T790M FISH YES Scheduled Follow-up Submission Progressive Disease 2013-10-23 MALE Lung Adenocarcinoma Mixed Subtype No C34.3 8255/3 C34.3 YES 240 NO NO NO Distant Metastasis YES 19 false No MX N1 T1b Stage IIA TCGA-L9-A50W.ADB0E9E3-62E7-4461-9254-14DC15DCB877.pdf A50W Preoperative WITH TUMOR 103 81 Stable Disease Biopsy with Histologic Confirmation|Convincing Imaging YES NO R0 Primary Tumor 01 1986 7th NO YES NO L9 3 Lung A DECEASED 2012 1967 717093f1-916b-4d01-a74c-18af938563c0 717093f1-916b-4d01-a74c-18af938563c0 TCGA-L9-A50W-01A-12D-A398-05 TCGA-L9-A50W-01A-12D-A396-01 717093f1-916b-4d01-a74c-18af938563c0 TCGA-L9-A50W-01A-12D-A396-01 +TCGA-L9-A5IP-01 TCGA-L9-A5IP-01 TCGA-L9-A5IP TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 40 R-Upper TCGA-L9-A5IP TCGA-L9-A5IP-01A -14681 94 58 0 YES FISH YES 2013-5-14 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 140 NO NO YES false No M1b N2 T3 Stage IV TCGA-L9-A5IP.0C79A75F-E3B3-4984-8406-2532E4A68D96.pdf A5IP WITH TUMOR Progressive Disease NO NO R1 Primary Tumor 01 2012 7th NO YES NO L9 4 Lung A DECEASED 2012 07cf4544-6ba1-4535-8bf5-18d5bf9e4123 07cf4544-6ba1-4535-8bf5-18d5bf9e4123 TCGA-L9-A5IP-01A-21D-A398-05 TCGA-L9-A5IP-01A-21D-A396-01 07cf4544-6ba1-4535-8bf5-18d5bf9e4123 TCGA-L9-A5IP-01A-21D-A396-01 +TCGA-L9-A743-01 TCGA-L9-A743-01 TCGA-L9-A743 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 56 L-Upper TCGA-L9-A743-F66554 TCGA-L9-A743 TCGA-L9-A743-01A -20780 97 0 664 45 0 NO NO Scheduled Follow-up Submission Complete Remission/Response 2014-10-20 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 520 NO NO Central Lung NO NO 40.5 false Yes, History of Prior Malignancy M0 N1 T2a Stage IIA TCGA-L9-A743.58EBD3CE-DB70-4A6C-A267-AEC8E50B6BD3.pdf A743 Preoperative TUMOR FREE 81 78 85 88 Complete Remission/Response YES NO R0 Primary Tumor 01 7th YES YES NO L9 2 Lung A LIVING 2013 1986 a16a9fdf-3aa3-431b-a680-082e1bde6aab a16a9fdf-3aa3-431b-a680-082e1bde6aab TCGA-L9-A743-01A-43D-A398-05 TCGA-L9-A743-01A-43D-A396-01 a16a9fdf-3aa3-431b-a680-082e1bde6aab TCGA-L9-A743-01A-43D-A396-01 +TCGA-L9-A7SV-01 TCGA-L9-A7SV-01 TCGA-L9-A7SV TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 69 L-Lower TCGA-L9-A7SV-F65116 TCGA-L9-A7SV TCGA-L9-A7SV-01A -25298 42 0 565 55 0 NO NO Scheduled Follow-up Submission Complete Remission/Response 2014-9-18 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 220 NO NO NO NO 93 false No M0 N1 T2a Stage IIA TCGA-L9-A7SV.C6014F3D-A7C4-455E-9DC8-A59244C81DF7.pdf A7SV Preoperative TUMOR FREE 40 45 38 40 Complete Remission/Response YES NO R0 Primary Tumor 01 1990 7th YES YES NO L9 3 Lung A LIVING 2013 1959 52592aa6-979e-4671-bc5a-4c6d31c3e8e1 52592aa6-979e-4671-bc5a-4c6d31c3e8e1 TCGA-L9-A7SV-01A-11D-A398-05 TCGA-L9-A7SV-01A-11D-A396-01 52592aa6-979e-4671-bc5a-4c6d31c3e8e1 TCGA-L9-A7SV-01A-11D-A396-01 +TCGA-L9-A8F4-01 TCGA-L9-A8F4-01 TCGA-L9-A8F4 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 64 L-Upper TCGA-L9-A8F4-F64972 TCGA-L9-A8F4 TCGA-L9-A8F4-01A -23617 93 0 476 35 0 NO NO Scheduled Follow-up Submission 2014-9-16 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 190 NO NO NO NO 14 false No MX N0 T2a Stage IB TCGA-L9-A8F4.FB592A19-E23C-465D-AEF4-55B9BBF7D486.pdf A8F4 Preoperative TUMOR FREE 48 54 45 53 YES YES R0 Primary Tumor 01 7th NO YES NO L9 2 Lung A LIVING 2013 1973 8fa61a97-acaa-4d5d-bc19-b1767afa356a 8fa61a97-acaa-4d5d-bc19-b1767afa356a TCGA-L9-A8F4-01A-11D-A398-05 TCGA-L9-A8F4-01A-11D-A396-01 8fa61a97-acaa-4d5d-bc19-b1767afa356a TCGA-L9-A8F4-01A-11D-A396-01 +TCGA-LA-A446-01 TCGA-LA-A446-01 TCGA-LA-A446 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung NO NO 68 R-Lower TCGA-LA-A446-F46272 TCGA-LA-A446 TCGA-LA-A446-01A -25199 67 0 401 0 NO NO Scheduled Follow-up Submission Complete Remission/Response 2013-8-5 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 160 NO NO Central Lung NO NO 26 false No MX N0 T1b Stage IA TCGA-LA-A446.45894ED8-CCB0-4FD7-8A28-DAFBA3C645AE.pdf A446 Preoperative TUMOR FREE 62 92 61 87 Complete Remission/Response YES NO R0 Primary Tumor 01 7th NO YES NO LA 2 Lung A LIVING 2012 1961 e0dd6dc3-dcae-478c-99f3-e060272c14ef e0dd6dc3-dcae-478c-99f3-e060272c14ef TCGA-LA-A446-01A-21D-A258-05 TCGA-LA-A446-01A-21D-A256-01 e0dd6dc3-dcae-478c-99f3-e060272c14ef TCGA-LA-A446-01A-21D-A256-01 +TCGA-LA-A7SW-01 TCGA-LA-A7SW-01 TCGA-LA-A7SW TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung NO NO NO 71 L-Upper TCGA-LA-A7SW-F67139 TCGA-LA-A7SW TCGA-LA-A7SW-01A -26116 42 408 0 146 311 41 1 NO NO Additional New Tumor Event Progressive Disease 2014-10-31 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 480 NO NO NO Locoregional Recurrence YES 37 false No MX N1 T3 Stage IIIA TCGA-LA-A7SW.9835D7E8-2217-4C88-BDE5-DC293B9A505F.pdf A7SW Preoperative 77 72 78 69 Convincing Imaging YES NO R0 Primary Tumor 01 2012 7th YES YES NO LA 4 Lung A DECEASED 2013 1962 9e3a09b0-267d-4ea4-9180-1ffa3b1d8159 9e3a09b0-267d-4ea4-9180-1ffa3b1d8159 TCGA-LA-A7SW-01A-11D-A408-05 TCGA-LA-A7SW-01A-11D-A400-01 9e3a09b0-267d-4ea4-9180-1ffa3b1d8159 TCGA-LA-A7SW-01A-11D-A400-01 +TCGA-MF-A522-01 TCGA-MF-A522-01 TCGA-MF-A522 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung NO YES YES 54 R-Upper TCGA-MF-A522-F60264 TCGA-MF-A522 TCGA-MF-A522-01A 178 -20051 132 360 0 83 173 4 Scheduled Follow-up Submission Progressive Disease 2014-6-4 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8071/3 C34.1 YES 430 NO 10 NO Distant Metastasis YES 45 true No MX N0 T2a Stage IB TCGA-MF-A522.E078E483-BF34-41CD-A55A-342E46BD928B.pdf A522 WITH TUMOR Partial Remission/Response Convincing Imaging YES NO Primary Tumor 01 2010 7th YES YES NO MF 4 Lung A DECEASED 2012 1967 42700ab7-f1fe-41de-97b0-3fba56091b82 42700ab7-f1fe-41de-97b0-3fba56091b82 TCGA-MF-A522-01A-11D-A25R-05 TCGA-MF-A522-01A-11D-A25M-01 42700ab7-f1fe-41de-97b0-3fba56091b82 TCGA-MF-A522-01A-11D-A25M-01 +TCGA-MN-A4N1-01 TCGA-MN-A4N1-01 TCGA-MN-A4N1 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 60 R-Upper TCGA-MN-A4N1-F56662 TCGA-MN-A4N1 TCGA-MN-A4N1-01A -21939 330 0 827 55 0 YES IHC YES Scheduled Follow-up Submission Complete Remission/Response 2014-2-17 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 140 NO 100 NO NO NO true Yes, History of Prior Malignancy M0 N1 T2a Stage IIA TCGA-MN-A4N1.F6E1C257-EE3E-4564-8DE9-445C60D78AB8.pdf A4N1 Preoperative TUMOR FREE 74 117 Complete Remission/Response YES NO R0 Primary Tumor 01 7th NO NO YES MN 2 Lung A LIVING 2011 1967 38843819-bf57-4c30-ae2f-408653860739 38843819-bf57-4c30-ae2f-408653860739 TCGA-MN-A4N1-01A-11D-A24U-05 TCGA-MN-A4N1-01A-11D-A24O-01 38843819-bf57-4c30-ae2f-408653860739 TCGA-MN-A4N1-01A-11D-A24O-01 +TCGA-MN-A4N4-01 TCGA-MN-A4N4-01 TCGA-MN-A4N4 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 57 L-Upper TCGA-MN-A4N4-F56667 TCGA-MN-A4N4 TCGA-MN-A4N4-01A -20888 664 0 1175 1 NO NO Scheduled Follow-up Submission Complete Remission/Response 2014-2-17 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 120 NO 100 NO NO NO true No M0 N0 T1b Stage IA TCGA-MN-A4N4.4D754ACD-90C1-4268-8E84-6A8A647A29C5.pdf A4N4 Preoperative TUMOR FREE 75 82 70 77 Complete Remission/Response YES NO R0 Primary Tumor 01 7th NO NO YES MN 2 Lung A LIVING 2010 1980 0d7719a9-58ac-4c27-99d3-0a6321c03ef6 0d7719a9-58ac-4c27-99d3-0a6321c03ef6 TCGA-MN-A4N4-01A-12D-A24U-05 TCGA-MN-A4N4-01A-12D-A24O-01 0d7719a9-58ac-4c27-99d3-0a6321c03ef6 TCGA-MN-A4N4-01A-12D-A24O-01 +TCGA-MN-A4N5-01 TCGA-MN-A4N5-01 TCGA-MN-A4N5 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 63 L-Upper TCGA-MN-A4N5-F56665 TCGA-MN-A4N5 TCGA-MN-A4N5-01A -23257 408 0 84 82 0 YES IHC YES Scheduled Follow-up Submission 2014-2-17 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 80 NO 100 NO YES NO true No M0 N0 T1a Stage IA TCGA-MN-A4N5.3F2359D8-9958-485B-B00F-BD8ADD34FB1E.pdf A4N5 Preoperative TUMOR FREE 77 105 Complete Remission/Response YES NO R0 Primary Tumor 01 2011 7th NO NO YES MN 4 Lung A LIVING 2011 1971 6b636016-1b27-4977-8632-85ce773f7db9 6b636016-1b27-4977-8632-85ce773f7db9 TCGA-MN-A4N5-01A-11D-A24U-05 TCGA-MN-A4N5-01A-11D-A24O-01 6b636016-1b27-4977-8632-85ce773f7db9 TCGA-MN-A4N5-01A-11D-A24O-01 +TCGA-MP-A4SV-01 TCGA-MP-A4SV-01 TCGA-MP-A4SV TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 67 L-Lower TCGA-MP-A4SV TCGA-MP-A4SV-01A -24516 3964 2620 0 48 NO NO 2013-4-2 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 160 NO NO 110 true No M0 N0 T2 Stage IB TCGA-MP-A4SV.8E809652-9783-4B7A-B92D-8C393A2940AB.pdf A4SV 78 62 Complete Remission/Response YES NO R0 Primary Tumor 01 5th NO NO YES MP 2 Lung A DECEASED 2001 1946 27a878b3-d7eb-49e3-9e1f-a12fcc33d67d 27a878b3-d7eb-49e3-9e1f-a12fcc33d67d TCGA-MP-A4SV-01A-11D-A24U-05 TCGA-MP-A4SV-01A-11D-A24O-01 27a878b3-d7eb-49e3-9e1f-a12fcc33d67d TCGA-MP-A4SV-01A-11D-A24O-01 +TCGA-MP-A4SW-01 TCGA-MP-A4SW-01 TCGA-MP-A4SW TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 53 L-Upper TCGA-MP-A4SW TCGA-MP-A4SW-01A -19640 3723 1778 0 102 NO NO 2013-4-2 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 130 NO NO 15 true No M0 N1 T2 Stage IIB TCGA-MP-A4SW.2A3C5E05-A4B8-4C01-B61D-3C46E9614707.pdf A4SW 101 90 Complete Remission/Response YES NO R0 Primary Tumor 01 1982 5th NO NO YES MP 3 Lung A DECEASED 2002 1967 f7301b53-0d6b-47ea-a7c4-6191ed59d3cb f7301b53-0d6b-47ea-a7c4-6191ed59d3cb TCGA-MP-A4SW-01A-21D-A24U-05 TCGA-MP-A4SW-01A-21D-A24O-01 f7301b53-0d6b-47ea-a7c4-6191ed59d3cb TCGA-MP-A4SW-01A-21D-A24O-01 +TCGA-MP-A4SY-01 TCGA-MP-A4SY-01 TCGA-MP-A4SY TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 61 R-Lower TCGA-MP-A4SY TCGA-MP-A4SY-01A -22448 3620 1501 0 73 0 NO NO 2013-4-2 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 130 NO NO Central Lung YES 40 true No M0 N1 T2 Stage IIB TCGA-MP-A4SY.C7A34958-C69B-4EDC-A4D6-503F52BA5330.pdf A4SY Pre-Adjuvant Therapy TUMOR FREE 74 54 Complete Remission/Response YES NO R0 Primary Tumor 01 2002 5th NO NO YES MP 4 Lung A DECEASED 2002 b695df40-ae14-490c-9d67-acda17494a35 b695df40-ae14-490c-9d67-acda17494a35 TCGA-MP-A4SY-01A-21D-A24U-05 TCGA-MP-A4SY-01A-21D-A24O-01 b695df40-ae14-490c-9d67-acda17494a35 TCGA-MP-A4SY-01A-21D-A24O-01 +TCGA-MP-A4T2-01 TCGA-MP-A4T2-01 TCGA-MP-A4T2 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung NO YES NO NO 71 L-Lower TCGA-MP-A4T2-F41327 TCGA-MP-A4T2 TCGA-MP-A4T2-01A -26010 3237 1136 0 1110 46 NO NO Additional New Tumor Event Progressive Disease 2013-3-14 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 240 NO NO NO Locoregional Recurrence|Distant Metastasis YES 75 true No M0 N0 T1 Stage IA TCGA-MP-A4T2.EC30FFC5-3C51-49E7-8996-18D9BCFC8552.pdf A4T2 WITH TUMOR 51 31 Complete Remission/Response Biopsy with Histologic Confirmation YES NO R0 Primary Tumor 01 2001 6th NO NO YES MP 4 Lung A DECEASED 2003 1951 TCGA-MP-A4T2-01A-11D-A24U-05 TCGA-MP-A4T2-01A-11D-A24O-01 TCGA-MP-A4T2-01A-11D-A24O-01 +TCGA-MP-A4T4-01 TCGA-MP-A4T4-01 TCGA-MP-A4T4 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 68 R-Lower TCGA-MP-A4T4 TCGA-MP-A4T4-01A -25052 2982 2617 0 53 0 NO NO 2013-4-2 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 440 NO NO 50 true No M0 N1 T2 Stage IIB TCGA-MP-A4T4.30003377-8D42-4189-BCCA-C04AB0669EBC.pdf A4T4 Preoperative 110 113 Complete Remission/Response YES NO R0 Primary Tumor 01 6th NO NO YES MP 2 Lung A DECEASED 2004 1954 fd1831a1-568b-4292-8d70-1450c392825f fd1831a1-568b-4292-8d70-1450c392825f TCGA-MP-A4T4-01A-11D-A25R-05 TCGA-MP-A4T4-01A-11D-A25M-01 fd1831a1-568b-4292-8d70-1450c392825f TCGA-MP-A4T4-01A-11D-A25M-01 +TCGA-MP-A4T6-01 TCGA-MP-A4T6-01 TCGA-MP-A4T6 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 76 L-Lower TCGA-MP-A4T6 TCGA-MP-A4T6-01A -27993 2778 1790 0 63 NO NO 2013-4-2 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 220 NO NO Peripheral Lung NO 50 true No MX N2 T1 Stage IIIA TCGA-MP-A4T6.2FAB9F3E-DD9B-45AF-9160-D23ECCA95A2D.pdf A4T6 TUMOR FREE 79 77 Complete Remission/Response YES NO R0 Primary Tumor 01 1989 6th NO NO YES MP 3 Lung A DECEASED 2005 225d40a7-eb72-4ee2-8a58-293a05df95e8 225d40a7-eb72-4ee2-8a58-293a05df95e8 TCGA-MP-A4T6-01A-32D-A25R-05 TCGA-MP-A4T6-01A-32D-A25M-01 225d40a7-eb72-4ee2-8a58-293a05df95e8 TCGA-MP-A4T6-01A-32D-A25M-01 +TCGA-MP-A4T7-01 TCGA-MP-A4T7-01 TCGA-MP-A4T7 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 75 R-Lower TCGA-MP-A4T7 TCGA-MP-A4T7-01A -27603 2710 167 0 57 NO NO 2013-4-2 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 280 NO NO 50 true No M1 N0 T2 Stage IV TCGA-MP-A4T7.D973F9E7-74DB-4880-B8F0-03E3887BDC36.pdf A4T7 91 87 YES NO R0 Primary Tumor 01 2004 6th NO NO YES MP 4 Lung A DECEASED 2005 1954 fc674e5c-f387-421e-9dc8-04272b876858 fc674e5c-f387-421e-9dc8-04272b876858 TCGA-MP-A4T7-01A-11D-A24U-05 TCGA-MP-A4T7-01A-11D-A24O-01 fc674e5c-f387-421e-9dc8-04272b876858 TCGA-MP-A4T7-01A-11D-A24O-01 +TCGA-MP-A4T8-01 TCGA-MP-A4T8-01 TCGA-MP-A4T8 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 68 L-Upper TCGA-MP-A4T8 TCGA-MP-A4T8-01A -25069 2352 161 0 102 1 NO NO 2013-4-2 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 130 NO NO 25 true Yes, History of Prior Malignancy M0 N2 T2 Stage IIIA TCGA-MP-A4T8.11D12F13-E03D-43D1-B0B1-AD9168960EE0.pdf A4T8 Pre-Adjuvant Therapy 72 60 YES NO R0 Primary Tumor 01 1972 6th YES NO YES MP 3 Lung A DECEASED 2006 1957 2ea1224b-66aa-48a4-a605-4d1262e84303 2ea1224b-66aa-48a4-a605-4d1262e84303 TCGA-MP-A4T8-01A-11D-A24U-05 TCGA-MP-A4T8-01A-11D-A24O-01 2ea1224b-66aa-48a4-a605-4d1262e84303 TCGA-MP-A4T8-01A-11D-A24O-01 +TCGA-MP-A4T9-01 TCGA-MP-A4T9-01 TCGA-MP-A4T9 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung NO NO YES 54 L-Upper TCGA-MP-A4T9-F41357 TCGA-MP-A4T9 TCGA-MP-A4T9-01A 1255 -19767 2332 1265 0 1248 106 NO NO Additional New Tumor Event Progressive Disease 2013-3-15 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 230 NO NO NO Locoregional Recurrence YES 24 true No MX N2 T2 Stage IIIA TCGA-MP-A4T9.FE06303C-736B-43C5-B692-FECA9A173EF6.pdf A4T9 WITH TUMOR 105 99 Complete Remission/Response Biopsy with Histologic Confirmation YES YES RX Primary Tumor 01 2004 6th YES NO YES MP 4 Lung A DECEASED 2006 1980 da2c0992-74c0-4380-8c6c-c9ffa73767f6 da2c0992-74c0-4380-8c6c-c9ffa73767f6 TCGA-MP-A4T9-01A-11D-A24U-05 TCGA-MP-A4T9-01A-11D-A24O-01 da2c0992-74c0-4380-8c6c-c9ffa73767f6 TCGA-MP-A4T9-01A-11D-A24O-01 +TCGA-MP-A4TA-01 TCGA-MP-A4TA-01 TCGA-MP-A4TA TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 75 R-Upper TCGA-MP-A4TA TCGA-MP-A4TA-01A -27513 2159 950 0 46 1 NO NO 2013-4-2 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 120 NO NO Peripheral Lung YES 55 true Yes, History of Prior Malignancy M0 N0 T1 Stage IA TCGA-MP-A4TA.B8573F06-EEC4-49A8-943E-7F2EFF3AFBEE.pdf A4TA Pre-Adjuvant Therapy WITH TUMOR 74 65 Complete Remission/Response YES NO R0 Primary Tumor 01 2006 6th NO NO YES MP 4 Lung A DECEASED 2006 1951 38534c34-666f-4319-86b8-8243ab76cb40 38534c34-666f-4319-86b8-8243ab76cb40 TCGA-MP-A4TA-01A-21D-A24U-05 TCGA-MP-A4TA-01A-21D-A24O-01 38534c34-666f-4319-86b8-8243ab76cb40 TCGA-MP-A4TA-01A-21D-A24O-01 +TCGA-MP-A4TC-01 TCGA-MP-A4TC-01 TCGA-MP-A4TC TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 77 R-Middle TCGA-MP-A4TC TCGA-MP-A4TC-01A -28471 1604 74 0 68 NO NO 2013-4-2 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.2 8140/3 C34.2 YES 230 NO NO NO 125 true Yes, History of Prior Malignancy M0 N2 T1 Stage IIIA TCGA-MP-A4TC.556F6F07-52C6-4FFA-AB6B-46FD9614EB0C.pdf A4TC TUMOR FREE 76 83 Complete Remission/Response YES NO R0 Primary Tumor 01 1976 6th YES NO YES MP 3 Lung A DECEASED 2008 1944 f2510b83-536a-4d29-bca7-ff3ca3ca9e44 f2510b83-536a-4d29-bca7-ff3ca3ca9e44 TCGA-MP-A4TC-01A-11D-A24U-05 TCGA-MP-A4TC-01A-11D-A24O-01 f2510b83-536a-4d29-bca7-ff3ca3ca9e44 TCGA-MP-A4TC-01A-11D-A24O-01 +TCGA-MP-A4TD-01 TCGA-MP-A4TD-01 TCGA-MP-A4TD TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 71 L-Lower TCGA-MP-A4TD TCGA-MP-A4TD-01A -25983 1471 307 0 61 0 NO NO 2013-5-8 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 230 NO NO Peripheral Lung YES 20 true Yes, History of Prior Malignancy M0 N2 T2 Stage IIIA TCGA-MP-A4TD.12D870FD-E7C7-470B-9303-63495911A5FE.pdf A4TD Post-Adjuvant Therapy 92 93 Complete Remission/Response YES NO RX Primary Tumor 01 1990 6th YES NO YES MP 3 Lung A DECEASED 2008 53aaf8ed-546d-493a-bde3-bead91b7691f 53aaf8ed-546d-493a-bde3-bead91b7691f TCGA-MP-A4TD-01A-32D-A25R-05 TCGA-MP-A4TD-01A-32D-A25M-01 53aaf8ed-546d-493a-bde3-bead91b7691f TCGA-MP-A4TD-01A-32D-A25M-01 +TCGA-MP-A4TE-01 TCGA-MP-A4TE-01 TCGA-MP-A4TE TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung NO 56 L-Lower TCGA-MP-A4TE-F41405 TCGA-MP-A4TE TCGA-MP-A4TE-01A -20627 1009 896 0 845 NO NO Additional New Tumor Event 2013-3-18 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 270 NO YES YES G12C Peripheral Lung NO Distant Metastasis YES 40 true No MX N0 T2b Stage IIA TCGA-MP-A4TE.3AC0F53B-A612-484B-9589-699F583F4F1D.pdf A4TE WITH TUMOR Complete Remission/Response Convincing Imaging NO NO RX Primary Tumor 01 2010 7th NO NO YES MP 4 Lung A DECEASED 2010 1970 686d6738-e29a-4039-8d97-b2f25b87a795 686d6738-e29a-4039-8d97-b2f25b87a795 TCGA-MP-A4TE-01A-22D-A25R-05 TCGA-MP-A4TE-01A-22D-A25M-01 686d6738-e29a-4039-8d97-b2f25b87a795 TCGA-MP-A4TE-01A-22D-A25M-01 +TCGA-MP-A4TF-01 TCGA-MP-A4TF-01 TCGA-MP-A4TF TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 58 R-Upper TCGA-MP-A4TF TCGA-MP-A4TF-01A -21387 784 336 0 77 NO NO 2013-4-2 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 240 NO NO Peripheral Lung YES 40 true No M0 N0 T2b Stage IIA TCGA-MP-A4TF.04511D30-B6E2-46F1-93B9-033B78257F1F.pdf A4TF WITH TUMOR 108 109 Partial Remission/Response YES NO R0 Primary Tumor 01 2010 7th YES NO YES MP 4 Lung A DECEASED 2010 1970 6028a290-48e8-400f-9ab6-39beda6051cd 6028a290-48e8-400f-9ab6-39beda6051cd TCGA-MP-A4TF-01A-11D-A25R-05 TCGA-MP-A4TF-01A-11D-A25M-01 6028a290-48e8-400f-9ab6-39beda6051cd TCGA-MP-A4TF-01A-11D-A25M-01 +TCGA-MP-A4TH-01 TCGA-MP-A4TH-01 TCGA-MP-A4TH TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 70 L-Lower TCGA-MP-A4TH-F69949 TCGA-MP-A4TH TCGA-MP-A4TH-01A -25759 78 0 741 73 NO NO Scheduled Follow-up Submission Complete Remission/Response 2015-1-22 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 200 NO NO Peripheral Lung NO NO 20 true No M0 N0 T1a Stage IA TCGA-MP-A4TH.842ADC9F-9FEE-49DC-A95D-37FCBF8FB764.pdf A4TH TUMOR FREE 117 115 110 115 Complete Remission/Response YES NO R0 Primary Tumor 01 1982 7th NO YES NO MP 3 Lung A LIVING 2012 1962 9b4f4156-947b-4c34-9153-021bc670a093 9b4f4156-947b-4c34-9153-021bc670a093 TCGA-MP-A4TH-01A-31D-A25R-05 TCGA-MP-A4TH-01A-31D-A25M-01 9b4f4156-947b-4c34-9153-021bc670a093 TCGA-MP-A4TH-01A-31D-A25M-01 +TCGA-MP-A4TI-01 TCGA-MP-A4TI-01 TCGA-MP-A4TI TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 72 R-Lower TCGA-MP-A4TI TCGA-MP-A4TI-01A -26565 780 429 0 YES NO 2013-4-2 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 200 NO YES YES G12C YES 35 true No M0 N1 T2a Stage IIA TCGA-MP-A4TI.FE74F98E-3131-4F7F-9899-AF5259B3A8C5.pdf A4TI WITH TUMOR NO R0 Primary Tumor 01 1990 7th NO YES MP 3 Lung A DECEASED 2010 1955 a117b181-a01e-49a7-a82b-13f4a385dd45 a117b181-a01e-49a7-a82b-13f4a385dd45 TCGA-MP-A4TI-01A-21D-A24U-05 TCGA-MP-A4TI-01A-21D-A24O-01 a117b181-a01e-49a7-a82b-13f4a385dd45 TCGA-MP-A4TI-01A-21D-A24O-01 +TCGA-MP-A4TJ-01 TCGA-MP-A4TJ-01 TCGA-MP-A4TJ TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 62 R-Upper TCGA-MP-A4TJ TCGA-MP-A4TJ-01A -22875 2204 339 0 29 NO NO 2013-4-2 FEMALE Lung Signet Ring Adenocarcinoma No C34.1 8490/3 C34.1 YES 270 NO NO Central Lung true No M0 N0 T1 Stage IA TCGA-MP-A4TJ.23EC6DA5-7109-4E11-B2BC-F1EDC7DF0ED3.pdf A4TJ 30.1 36 29.7 27 Complete Remission/Response YES NO R0 Primary Tumor 01 6th NO NO YES MP 2 Lung A DECEASED 2006 eaf5ff83-0419-4f44-bec0-93f8517a56c9 eaf5ff83-0419-4f44-bec0-93f8517a56c9 TCGA-MP-A4TJ-01A-51D-A25R-05 TCGA-MP-A4TJ-01A-51D-A25M-01 eaf5ff83-0419-4f44-bec0-93f8517a56c9 TCGA-MP-A4TJ-01A-51D-A25M-01 +TCGA-MP-A4TK-01 TCGA-MP-A4TK-01 TCGA-MP-A4TK TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung YES YES NO 56 R-Lower TCGA-MP-A4TK-F41426 TCGA-MP-A4TK TCGA-MP-A4TK-01A -20581 3744 582 0 545 88 NO NO Additional New Tumor Event Progressive Disease 2013-3-18 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 170 NO NO NO Distant Metastasis YES 28 true No MX N1 T2 Stage IIB TCGA-MP-A4TK.D590727D-0D9F-4986-A41F-A5031C432967.pdf A4TK WITH TUMOR 64 57 Complete Remission/Response Convincing Imaging YES NO R0 Primary Tumor 01 1999 5th NO NO YES MP 4 Lung A DECEASED 2002 1971 704d2001-9501-4426-b751-af5fc74a6378 704d2001-9501-4426-b751-af5fc74a6378 TCGA-MP-A4TK-01A-11D-A24U-05 TCGA-MP-A4TK-01A-11D-A24O-01 704d2001-9501-4426-b751-af5fc74a6378 TCGA-MP-A4TK-01A-11D-A24O-01 +TCGA-MP-A5C7-01 TCGA-MP-A5C7-01 TCGA-MP-A5C7 TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 76 L-Upper TCGA-MP-A5C7-F67079 TCGA-MP-A5C7 TCGA-MP-A5C7-01A -28015 1555 0 2248 105 1 NO NO Scheduled Follow-up Submission Complete Remission/Response 2014-10-30 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 170 NO NO Central Lung NO NO 15 true No M0 N0 T2 Stage IB TCGA-MP-A5C7.656F0756-05CC-437B-98D4-C2AED4B77DAB.pdf A5C7 Other TUMOR FREE 93 89 Complete Remission/Response YES NO R0 Primary Tumor 01 1968 6th NO NO YES MP 3 Lung A LIVING 2008 1953 d793a609-add1-4029-87fe-1e5c8cf0e173 d793a609-add1-4029-87fe-1e5c8cf0e173 TCGA-MP-A5C7-01A-11D-A25R-05 TCGA-MP-A5C7-01A-11D-A25M-01 d793a609-add1-4029-87fe-1e5c8cf0e173 TCGA-MP-A5C7-01A-11D-A25M-01 +TCGA-NC-A5HD-01 TCGA-NC-A5HD-01 TCGA-NC-A5HD TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 79 L-Upper TCGA-NC-A5HD TCGA-NC-A5HD-01A -28916 1697 2 0 63 NO NO 2013-4-16 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 110 NO NO Peripheral Lung NO 50 true Yes, History of Prior Malignancy M0 N0 T3 Stage IIB TCGA-NC-A5HD.414E245A-D9A7-4006-B197-656F8C6DB841.pdf A5HD TUMOR FREE 65 66 YES NO R0 Primary Tumor 01 2003 6th NO NO YES NC 4 Lung A DECEASED 2008 9c53a722-7e70-4bf4-b201-3df62ce501c4 9c53a722-7e70-4bf4-b201-3df62ce501c4 TCGA-NC-A5HD-01A-11D-A26N-05 TCGA-NC-A5HD-01A-11D-A26L-01 9c53a722-7e70-4bf4-b201-3df62ce501c4 TCGA-NC-A5HD-01A-11D-A26L-01 +TCGA-NC-A5HE-01 TCGA-NC-A5HE-01 TCGA-NC-A5HE TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 60 L-Upper TCGA-NC-A5HE-F69348 TCGA-NC-A5HE TCGA-NC-A5HE-01A -22179 1598 0 2336 79 0 NO NO Scheduled Follow-up Submission Complete Remission/Response 2015-1-7 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 110 NO NO Central Lung NO NO 30 true Yes, History of Prior Malignancy M0 N1 T2 Stage IIB TCGA-NC-A5HE.4845C8ED-6B22-4B64-A05E-48D5A7064797.pdf A5HE Pre-Adjuvant Therapy TUMOR FREE 71 71 66 67 Complete Remission/Response YES YES R0 Primary Tumor 01 1993 6th YES NO YES NC 4 Lung A LIVING 2008 1973 d9e4265e-0f8f-459a-915e-70fdc963668f d9e4265e-0f8f-459a-915e-70fdc963668f TCGA-NC-A5HE-01A-11D-A26N-05 TCGA-NC-A5HE-01A-11D-A26L-01 d9e4265e-0f8f-459a-915e-70fdc963668f TCGA-NC-A5HE-01A-11D-A26L-01 +TCGA-NC-A5HF-01 TCGA-NC-A5HF-01 TCGA-NC-A5HF TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 74 L-Lower TCGA-NC-A5HF TCGA-NC-A5HF-01A -27038 1458 138 0 103 NO NO 2013-4-16 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8071/3 C34.3 YES 80 NO NO Peripheral Lung YES true No MX N0 T4 Stage IIIB TCGA-NC-A5HF.049B234F-D323-4C0B-BF05-DDA265ADA66F.pdf A5HF WITH TUMOR 51 82 50 65 Progressive Disease YES NO R0 Primary Tumor 01 6th NO NO YES NC 2 Lung A DECEASED 2008 9b2c4413-d5e6-4d48-9ceb-4ba48e737f25 9b2c4413-d5e6-4d48-9ceb-4ba48e737f25 TCGA-NC-A5HF-01A-11D-A26N-05 TCGA-NC-A5HF-01A-11D-A26L-01 9b2c4413-d5e6-4d48-9ceb-4ba48e737f25 TCGA-NC-A5HF-01A-11D-A26L-01 +TCGA-NC-A5HG-01 TCGA-NC-A5HG-01 TCGA-NC-A5HG TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 59 R-Lower TCGA-NC-A5HG-F69349 TCGA-NC-A5HG TCGA-NC-A5HG-01A -21608 1424 0 1963 77 1 NO NO Scheduled Follow-up Submission Complete Remission/Response 2015-1-7 MALE Lung Basaloid Squamous Cell Carcinoma No C34.3 8083/3 C34.3 YES 40 NO NO Central Lung NO NO 80 true No M0 N2 T2 Stage IIIA TCGA-NC-A5HG.0E4B8213-E1E7-44B2-A086-F53CDE435C10.pdf A5HG Pre-Adjuvant Therapy TUMOR FREE 68 90 63 85 Complete Remission/Response YES YES R0 Primary Tumor 01 2008 6th YES NO YES NC 4 Lung A LIVING 2009 1968 121de962-5648-46eb-b745-4ec8875ace3e 121de962-5648-46eb-b745-4ec8875ace3e TCGA-NC-A5HG-01A-11D-A26N-05 TCGA-NC-A5HG-01A-11D-A26L-01 121de962-5648-46eb-b745-4ec8875ace3e TCGA-NC-A5HG-01A-11D-A26L-01 +TCGA-NC-A5HH-01 TCGA-NC-A5HH-01 TCGA-NC-A5HH TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 53 L-Lower TCGA-NC-A5HH-F55778 TCGA-NC-A5HH TCGA-NC-A5HH-01A -19485 1346 0 37 64 NO NO Scheduled Follow-up Submission 2014-1-15 MALE Lung Basaloid Squamous Cell Carcinoma No C34.3 8083/3 C34.3 YES 15 NO NO Peripheral Lung YES NO 60 true No M0 N0 T1 Stage IA TCGA-NC-A5HH.33B3A6BB-14EF-4CCB-B8C3-E4158FBCEA72.pdf A5HH TUMOR FREE 72 94 Complete Remission/Response YES NO R0 Primary Tumor 01 6th NO NO YES NC 2 Lung A LIVING 2009 eb7105cb-db03-4c01-b806-b9f613564a22 eb7105cb-db03-4c01-b806-b9f613564a22 TCGA-NC-A5HH-01A-11D-A26N-05 TCGA-NC-A5HH-01A-11D-A26L-01 eb7105cb-db03-4c01-b806-b9f613564a22 TCGA-NC-A5HH-01A-11D-A26L-01 +TCGA-NC-A5HI-01 TCGA-NC-A5HI-01 TCGA-NC-A5HI TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 68 R-Lower TCGA-NC-A5HI-F70561 TCGA-NC-A5HI TCGA-NC-A5HI-01A -24981 1228 0 1743 91 NO NO Scheduled Follow-up Submission Complete Remission/Response 2015-3-4 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 80 NO NO Peripheral Lung NO NO 60 true No M0 N0 T2 Stage IB TCGA-NC-A5HI.45450CB6-9903-40AD-97D4-18BEF2ED87CB.pdf A5HI TUMOR FREE 66 91 69 91 Complete Remission/Response YES NO R0 Primary Tumor 01 6th YES NO YES NC 2 Lung A LIVING 2009 1959 d1f64089-b3d5-490f-8800-d8b82cc7469c d1f64089-b3d5-490f-8800-d8b82cc7469c TCGA-NC-A5HI-01A-11D-A26N-05 TCGA-NC-A5HI-01A-11D-A26L-01 d1f64089-b3d5-490f-8800-d8b82cc7469c TCGA-NC-A5HI-01A-11D-A26L-01 +TCGA-NC-A5HJ-01 TCGA-NC-A5HJ-01 TCGA-NC-A5HJ TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 59 R-Middle TCGA-NC-A5HJ TCGA-NC-A5HJ-01A -21730 1213 418 0 87 1 NO NO 2013-4-17 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.2 8070/3 C34.2 YES 160 NO NO Peripheral Lung YES 78 true No M0 N0 T3 Stage IIB TCGA-NC-A5HJ.2CE6178F-3CFF-4E17-B5AE-1723C6AA6CF9.pdf A5HJ Pre-Adjuvant Therapy WITH TUMOR 68 110 68 107 Complete Remission/Response YES NO R0 Primary Tumor 01 2009 6th NO NO YES NC 4 Lung A DECEASED 2009 a6029e8e-f375-4843-989c-745b2bc64f94 a6029e8e-f375-4843-989c-745b2bc64f94 TCGA-NC-A5HJ-01A-11D-A26N-05 TCGA-NC-A5HJ-01A-11D-A26L-01 a6029e8e-f375-4843-989c-745b2bc64f94 TCGA-NC-A5HJ-01A-11D-A26L-01 +TCGA-NC-A5HK-01 TCGA-NC-A5HK-01 TCGA-NC-A5HK TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 58 Other (please specify) L-Upper+Lower TCGA-NC-A5HK-F55776 TCGA-NC-A5HK TCGA-NC-A5HK-01A -21531 1018 0 128 58 1 NO NO Scheduled Follow-up Submission 2014-1-15 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.8 8070/3 C34.8 YES 160 NO NO Peripheral Lung YES NO 40 true No M0 N0 T3 Stage IIB TCGA-NC-A5HK.074EAC41-3FC0-4686-8408-44B8351EE5C5.pdf A5HK Pre-Adjuvant Therapy TUMOR FREE 49 98 47 97 Complete Remission/Response YES NO R0 Primary Tumor 01 2009 7th YES NO YES NC 4 Lung A LIVING 2010 10db67e9-5b8f-4bda-b26b-c63e70c3c95e 10db67e9-5b8f-4bda-b26b-c63e70c3c95e TCGA-NC-A5HK-01A-11D-A26N-05 TCGA-NC-A5HK-01A-11D-A26L-01 10db67e9-5b8f-4bda-b26b-c63e70c3c95e TCGA-NC-A5HK-01A-11D-A26L-01 +TCGA-NC-A5HL-01 TCGA-NC-A5HL-01 TCGA-NC-A5HL TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 73 R-Upper TCGA-NC-A5HL TCGA-NC-A5HL-01A -26977 996 88 0 70 NO NO 2013-4-17 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 150 NO NO Central Lung NO 40 true No M0 N0 T2b Stage IIA TCGA-NC-A5HL.1B861502-417D-4B21-980A-DD2749660DD5.pdf A5HL TUMOR FREE 74 63 YES NO R0 Primary Tumor 01 1995 7th NO NO YES NC 4 Lung A DECEASED 2010 87d9eb58-9b87-462f-982d-8abc83f2205b 87d9eb58-9b87-462f-982d-8abc83f2205b TCGA-NC-A5HL-01A-11D-A26N-05 TCGA-NC-A5HL-01A-11D-A26L-01 87d9eb58-9b87-462f-982d-8abc83f2205b TCGA-NC-A5HL-01A-11D-A26L-01 +TCGA-NC-A5HM-01 TCGA-NC-A5HM-01 TCGA-NC-A5HM TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 76 R-Lower TCGA-NC-A5HM-F55779 TCGA-NC-A5HM TCGA-NC-A5HM-01A -27938 841 0 1212 80 NO NO Scheduled Follow-up Submission Complete Remission/Response 2014-1-15 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 220 NO NO Peripheral Lung NO NO 50 true Yes, History of Synchronous/Bilateral Malignancy M0 N0 T2a Stage IB TCGA-NC-A5HM.116B2CC4-B716-4CB4-852C-5EF15ED95FBA.pdf A5HM TUMOR FREE 70 Complete Remission/Response YES NO R0 Primary Tumor 01 1992 7th NO NO YES NC 3 Lung A LIVING 2010 02225067-9673-48cb-aa8e-6e28f9fbeffd 02225067-9673-48cb-aa8e-6e28f9fbeffd TCGA-NC-A5HM-01A-12D-A26N-05 TCGA-NC-A5HM-01A-12D-A26L-01 02225067-9673-48cb-aa8e-6e28f9fbeffd TCGA-NC-A5HM-01A-12D-A26L-01 +TCGA-NC-A5HN-01 TCGA-NC-A5HN-01 TCGA-NC-A5HN TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 77 L-Lower TCGA-NC-A5HN-F69350 TCGA-NC-A5HN TCGA-NC-A5HN-01A -28151 772 0 1499 64 NO NO Scheduled Follow-up Submission Complete Remission/Response 2015-1-7 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 120 NO NO Central Lung NO NO 100 true No M0 N1 T2a Stage IIA TCGA-NC-A5HN.25D64D5A-EE0A-4772-8714-022209C35D86.pdf A5HN TUMOR FREE 61 64 61 65 Complete Remission/Response YES NO R0 Primary Tumor 01 2001 7th NO NO YES NC 4 Lung A LIVING 2010 1953 564636b5-e3fb-46ce-91db-f64b9a5612a9 564636b5-e3fb-46ce-91db-f64b9a5612a9 TCGA-NC-A5HN-01A-11D-A26N-05 TCGA-NC-A5HN-01A-11D-A26L-01 564636b5-e3fb-46ce-91db-f64b9a5612a9 TCGA-NC-A5HN-01A-11D-A26L-01 +TCGA-NC-A5HO-01 TCGA-NC-A5HO-01 TCGA-NC-A5HO TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 70 L-Upper TCGA-NC-A5HO-F69351 TCGA-NC-A5HO TCGA-NC-A5HO-01A -25694 679 0 1336 64 1 NO NO Scheduled Follow-up Submission Complete Remission/Response 2015-1-7 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8071/3 C34.1 YES 130 NO NO Central Lung NO NO 30 true No M0 N1 T3 Stage IIIA TCGA-NC-A5HO.AC6B60E8-F47C-43CD-90C0-3C8DC9778BD6.pdf A5HO Pre-Adjuvant Therapy TUMOR FREE 70 96 67 96 Complete Remission/Response YES NO Primary Tumor 01 2010 7th YES NO YES NC 4 Lung A LIVING 2011 88b924eb-7bbb-449b-83f2-e2f496ced7df 88b924eb-7bbb-449b-83f2-e2f496ced7df TCGA-NC-A5HO-01A-11D-A26N-05 TCGA-NC-A5HO-01A-11D-A26L-01 88b924eb-7bbb-449b-83f2-e2f496ced7df TCGA-NC-A5HO-01A-11D-A26L-01 +TCGA-NC-A5HP-01 TCGA-NC-A5HP-01 TCGA-NC-A5HP TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 69 L-Upper TCGA-NC-A5HP-F69354 TCGA-NC-A5HP TCGA-NC-A5HP-01A -25286 654 770 0 730 NO NO Scheduled Follow-up Submission 2015-1-7 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8071/3 C34.1 YES 140 NO NO Peripheral Lung NO NO 50 true No M1b N0 T2a Stage IV TCGA-NC-A5HP.7C93B42D-DFF8-4B78-9C02-61296B787C2D.pdf A5HP WITH TUMOR 99 87 Progressive Disease YES NO R0 Primary Tumor 01 7th YES NO YES NC 2 Lung A DECEASED 2011 4ab07cc2-d5a1-48b5-a974-08bc48090920 4ab07cc2-d5a1-48b5-a974-08bc48090920 TCGA-NC-A5HP-01A-11D-A26N-05 TCGA-NC-A5HP-01A-11D-A26L-01 4ab07cc2-d5a1-48b5-a974-08bc48090920 TCGA-NC-A5HP-01A-11D-A26L-01 +TCGA-NC-A5HQ-01 TCGA-NC-A5HQ-01 TCGA-NC-A5HQ TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 70 R-Middle TCGA-NC-A5HQ TCGA-NC-A5HQ-01A -25781 568 448 0 142 1 NO NO 2013-4-17 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.2 8071/3 C34.2 YES 350 NO NO Central Lung NO true No M0 N2 T3 Stage IIIA TCGA-NC-A5HQ.A4B5AAFA-D22F-4DA0-A4ED-54630EF8156F.pdf A5HQ Pre-Adjuvant Therapy 76 97 79 104 Complete Remission/Response YES YES R0 Primary Tumor 01 7th YES NO YES NC 2 Lung A DECEASED 2011 fe68b038-e3af-4106-9358-0717d90dbc76 fe68b038-e3af-4106-9358-0717d90dbc76 TCGA-NC-A5HQ-01A-11D-A26N-05 TCGA-NC-A5HQ-01A-11D-A26L-01 fe68b038-e3af-4106-9358-0717d90dbc76 TCGA-NC-A5HQ-01A-11D-A26L-01 +TCGA-NC-A5HR-01 TCGA-NC-A5HR-01 TCGA-NC-A5HR TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 75 R-Lower TCGA-NC-A5HR-F69352 TCGA-NC-A5HR TCGA-NC-A5HR-01A -27629 513 0 1244 69 1 NO NO Scheduled Follow-up Submission Complete Remission/Response 2015-1-7 FEMALE Lung Basaloid Squamous Cell Carcinoma No C34.3 8083/3 C34.3 YES 120 NO NO Central Lung NO NO 35 true Yes, History of Prior Malignancy M0 N1 T2a Stage IIA TCGA-NC-A5HR.CB0090E7-0335-454E-BAFA-D2F8CBB4F131.pdf A5HR Pre-Adjuvant Therapy TUMOR FREE 72 112 Complete Remission/Response YES NO R0 Primary Tumor 01 2008 7th YES NO YES NC 4 Lung A LIVING 2011 1463072d-57f0-4b60-9a6f-e61567ce0c46 1463072d-57f0-4b60-9a6f-e61567ce0c46 TCGA-NC-A5HR-01A-21D-A26N-05 TCGA-NC-A5HR-01A-21D-A26L-01 1463072d-57f0-4b60-9a6f-e61567ce0c46 TCGA-NC-A5HR-01A-21D-A26L-01 +TCGA-NC-A5HT-01 TCGA-NC-A5HT-01 TCGA-NC-A5HT TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 69 Other (please specify) right upper + middle lobes TCGA-NC-A5HT-F69353 TCGA-NC-A5HT TCGA-NC-A5HT-01A -25466 337 0 804 69 NO NO Scheduled Follow-up Submission Stable Disease 2015-1-7 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.8 8070/3 C34.8 YES 100 NO NO Central Lung NO NO 50 true No M0 N1 T3 Stage IIIA TCGA-NC-A5HT.81068415-BBAA-432E-97C2-14E6B559D41A.pdf A5HT WITH TUMOR 46 75 56 Complete Remission/Response YES NO R0 Primary Tumor 01 2011 7th NO NO YES NC 4 Lung A LIVING 2012 1ab57556-a43b-4815-bb91-c050d3ecd801 1ab57556-a43b-4815-bb91-c050d3ecd801 TCGA-NC-A5HT-01A-11D-A26N-05 TCGA-NC-A5HT-01A-11D-A26L-01 1ab57556-a43b-4815-bb91-c050d3ecd801 TCGA-NC-A5HT-01A-11D-A26L-01 +TCGA-NJ-A4YF-01 TCGA-NJ-A4YF-01 TCGA-NJ-A4YF TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 50 R-Upper TCGA-NJ-A4YF-F50858 TCGA-NJ-A4YF TCGA-NJ-A4YF-01A -18584 1819 0 2161 77.5 NO NO Scheduled Follow-up Submission Stable Disease 2013-11-1 FEMALE Lung Adenocarcinoma Mixed Subtype No C34.1 8255/3 C34.1 YES 90 NO NO NO NO 30 true No M0 N0 T1 Stage IA TCGA-NJ-A4YF.1C272E41-4BE4-4E8A-BD33-A5EC5C33149C.pdf A4YF TUMOR FREE 95.1 83.9 96 80.7 Stable Disease YES NO Primary Tumor 01 6th NO NO YES NJ 3 Lung A LIVING 2007 dc1f01da-cff9-4b61-b743-0452e023e2a1 dc1f01da-cff9-4b61-b743-0452e023e2a1 TCGA-NJ-A4YF-01A-12D-A25R-05 TCGA-NJ-A4YF-01A-12D-A25M-01 dc1f01da-cff9-4b61-b743-0452e023e2a1 TCGA-NJ-A4YF-01A-12D-A25M-01 +TCGA-NJ-A4YG-01 TCGA-NJ-A4YG-01 TCGA-NJ-A4YG TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 65 L-Upper TCGA-NJ-A4YG-F70643 TCGA-NJ-A4YG TCGA-NJ-A4YG-01A -23812 1691 0 2261 Scheduled Follow-up Submission Stable Disease 2015-2-27 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8255/3 C34.1 YES 280 NO NO NO 104 true No M0 N0 T2 Stage IB TCGA-NJ-A4YG.6A90E23E-9E8F-4282-837C-120E3AE994D7.pdf A4YG TUMOR FREE Stable Disease NO NO Primary Tumor 01 2007 6th NO NO YES NJ 4 Lung A LIVING 2008 1955 b7989e5f-032a-478c-a882-b4db35bdd42c b7989e5f-032a-478c-a882-b4db35bdd42c TCGA-NJ-A4YG-01A-22D-A25R-05 TCGA-NJ-A4YG-01A-22D-A25M-01 b7989e5f-032a-478c-a882-b4db35bdd42c TCGA-NJ-A4YG-01A-22D-A25M-01 +TCGA-NJ-A4YI-01 TCGA-NJ-A4YI-01 TCGA-NJ-A4YI TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 87 R-Upper TCGA-NJ-A4YI-F50887 TCGA-NJ-A4YI TCGA-NJ-A4YI-01A -31867 1385 4 0 52 Scheduled Follow-up Submission Stable Disease 2013-11-1 FEMALE Lung Papillary Adenocarcinoma No C34.1 8550/3 C34.1 YES 200 NO NO NO 3 true No M0 N2 T2 Stage IIIA TCGA-NJ-A4YI.DEFC8FAD-A129-40CA-B0CF-E3773377D8A6.pdf A4YI 94 89 YES NO Primary Tumor 01 1976 6th NO NO YES NJ 3 Lung A DECEASED 2009 1936 628fb2b6-09b2-4460-8815-fda9b89ac0c2 628fb2b6-09b2-4460-8815-fda9b89ac0c2 TCGA-NJ-A4YI-01A-11D-A25R-05 TCGA-NJ-A4YI-01A-11D-A25M-01 628fb2b6-09b2-4460-8815-fda9b89ac0c2 TCGA-NJ-A4YI-01A-11D-A25M-01 +TCGA-NJ-A4YP-01 TCGA-NJ-A4YP-01 TCGA-NJ-A4YP TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 52 R-Lower TCGA-NJ-A4YP-F50888 TCGA-NJ-A4YP TCGA-NJ-A4YP-01A -19106 615 0 50 NO NO Scheduled Follow-up Submission Stable Disease 2013-11-1 MALE Lung Papillary Adenocarcinoma No C34.3 8255/3 C34.3 YES 70 NO NO YES NO 60 true No M0 N0 T2a Stage IB TCGA-NJ-A4YP.13552F62-0795-453F-A597-54B3214C6F24.pdf A4YP TUMOR FREE Stable Disease NO NO Primary Tumor 01 7th NO NJ 5 Lung A LIVING 2011 364051c3-87fd-4f4a-b2ae-8cc6cf883407 364051c3-87fd-4f4a-b2ae-8cc6cf883407 TCGA-NJ-A4YP-01A-11D-A25R-05 TCGA-NJ-A4YP-01A-11D-A25M-01 364051c3-87fd-4f4a-b2ae-8cc6cf883407 TCGA-NJ-A4YP-01A-11D-A25M-01 +TCGA-NJ-A4YQ-01 TCGA-NJ-A4YQ-01 TCGA-NJ-A4YQ TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 69 L-Upper TCGA-NJ-A4YQ-F70646 TCGA-NJ-A4YQ TCGA-NJ-A4YQ-01A -25427 592 0 1432 NO NO Scheduled Follow-up Submission Stable Disease 2015-2-27 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8255/3 C34.1 YES 80 NO NO NO NO 40 true No M0 N0 T1b Stage IA TCGA-NJ-A4YQ.232A989B-38EA-4BAC-8B08-075913ADA7EF.pdf A4YQ TUMOR FREE Stable Disease NO NO RX Primary Tumor 01 2011 7th NO NJ 4 Lung A LIVING 2011 72cad61d-c9cf-4507-b79a-9ecf459a119d 72cad61d-c9cf-4507-b79a-9ecf459a119d TCGA-NJ-A4YQ-01A-11D-A25R-05 TCGA-NJ-A4YQ-01A-11D-A25M-01 72cad61d-c9cf-4507-b79a-9ecf459a119d TCGA-NJ-A4YQ-01A-11D-A25M-01 +TCGA-NJ-A55A-01 TCGA-NJ-A55A-01 TCGA-NJ-A55A TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 76 R-Lower TCGA-NJ-A55A-F70649 TCGA-NJ-A55A TCGA-NJ-A55A-01A -28022 1199 0 15 NO NO Scheduled Follow-up Submission Stable Disease 2015-2-27 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8550/3 C34.3 YES 160 NO NO YES NO 25 true No M0 N0 T2 Stage IB TCGA-NJ-A55A.9D29FA79-BE75-4FA6-933E-4185C0B5D03C.pdf A55A TUMOR FREE Stable Disease NO NO Primary Tumor 01 1983 6th NO NJ 3 Lung A LIVING 2009 b964538d-a322-4632-8b32-b64b9ee66244 b964538d-a322-4632-8b32-b64b9ee66244 TCGA-NJ-A55A-01A-11D-A25R-05 TCGA-NJ-A55A-01A-11D-A25M-01 b964538d-a322-4632-8b32-b64b9ee66244 TCGA-NJ-A55A-01A-11D-A25M-01 +TCGA-NJ-A55O-01 TCGA-NJ-A55O-01 TCGA-NJ-A55O TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 56 R-Upper TCGA-NJ-A55O-F50898 TCGA-NJ-A55O TCGA-NJ-A55O-01A -20628 428 0 13 NO NO Scheduled Follow-up Submission Stable Disease 2013-11-1 FEMALE Mucinous (Colloid) Carcinoma No C34.1 8480/3 C34.1 YES 150 NO NO YES NO 30 true No M0 N1 T1b Stage IIA TCGA-NJ-A55O.FBB218E1-EB67-4C9D-8149-EE276C1E9BCE.pdf A55O TUMOR FREE Stable Disease NO NO Primary Tumor 01 2000 7th NO NJ 4 Lung A LIVING 2011 a5c91562-e870-451a-8255-9620fa5f8977 a5c91562-e870-451a-8255-9620fa5f8977 TCGA-NJ-A55O-01A-11D-A25R-05 TCGA-NJ-A55O-01A-11D-A25M-01 a5c91562-e870-451a-8255-9620fa5f8977 TCGA-NJ-A55O-01A-11D-A25M-01 +TCGA-NJ-A55R-01 TCGA-NJ-A55R-01 TCGA-NJ-A55R TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 67 L-Upper TCGA-NJ-A55R-F70652 TCGA-NJ-A55R TCGA-NJ-A55R-01A -24738 499 0 603 NO NO Scheduled Follow-up Submission Stable Disease 2015-2-27 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8230/3 C34.1 YES 200 NO NO YES NO 5 true No MX N0 T1b Stage IA TCGA-NJ-A55R.726A5F6E-4592-49AA-976F-556CABABDD3D.pdf A55R TUMOR FREE Stable Disease NO NO Primary Tumor 01 1986 7th NO NJ 3 Lung A LIVING 2011 71937412-13b3-4584-8b61-8a83e762e2d7 71937412-13b3-4584-8b61-8a83e762e2d7 TCGA-NJ-A55R-01A-11D-A25R-05 TCGA-NJ-A55R-01A-11D-A25M-01 71937412-13b3-4584-8b61-8a83e762e2d7 TCGA-NJ-A55R-01A-11D-A25M-01 +TCGA-NJ-A7XG-01 TCGA-NJ-A7XG-01 TCGA-NJ-A7XG TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 49 L-Upper TCGA-NJ-A7XG-F71390 TCGA-NJ-A7XG TCGA-NJ-A7XG-01A -18127 72 0 617 YES Other Scheduled Follow-up Submission Stable Disease 2015-3-25 MALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 140 NO YES NO NO NO true No M0 N1 T4 Stage IIIA TCGA-NJ-A7XG.8EFDF414-12F3-4DF8-BB21-9E8876B727E8.pdf A7XG WITH TUMOR Stable Disease NO NO Primary Tumor 01 7th YES NJ 3 Lung A LIVING 2013 885e59fd-b9e5-4c5a-85cc-c979232b1e77 885e59fd-b9e5-4c5a-85cc-c979232b1e77 TCGA-NJ-A7XG-01A-12D-A398-05 TCGA-NJ-A7XG-01A-12D-A396-01 885e59fd-b9e5-4c5a-85cc-c979232b1e77 TCGA-NJ-A7XG-01A-12D-A396-01 +TCGA-NK-A5CR-01 TCGA-NK-A5CR-01 TCGA-NK-A5CR TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 77 R-Upper TCGA-NK-A5CR-F53269 TCGA-NK-A5CR TCGA-NK-A5CR-01A -28126 1961 0 2542 84.7 NO NO Scheduled Follow-up Submission 2013-12-10 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 120 NO NO NO NO 40 true No MX N0 T2 Stage IB TCGA-NK-A5CR.487D0915-7A8B-4092-98F8-A0E7A757E79C.pdf A5CR TUMOR FREE 64.8 1.33 79.8 .94 Stable Disease YES NO Primary Tumor 01 6th NO NO YES NK 3 Lung A LIVING 2007 d497e10a-f8b7-4e9d-9c37-eb433a54fd2c d497e10a-f8b7-4e9d-9c37-eb433a54fd2c TCGA-NK-A5CR-01A-11D-A26N-05 TCGA-NK-A5CR-01A-11D-A26L-01 d497e10a-f8b7-4e9d-9c37-eb433a54fd2c TCGA-NK-A5CR-01A-11D-A26L-01 +TCGA-NK-A5CT-01 TCGA-NK-A5CT-01 TCGA-NK-A5CT TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung NO NO NO 70 L-Lower TCGA-NK-A5CT-F71462 TCGA-NK-A5CT TCGA-NK-A5CT-01A -25726 1473 0 1997 1990 NO NO Scheduled Follow-up Submission Progressive Disease 2015-3-25 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 220 NO NO YES Locoregional Recurrence YES 80 true Yes, History of Prior Malignancy M0 N0 T1 Stage IA TCGA-NK-A5CT.E336C87E-F021-4D95-BE95-ACA979B023CA.pdf A5CT WITH TUMOR Stable Disease Biopsy with Histologic Confirmation NO NO Primary Tumor 01 2003 6th NO NO YES NK [Discrepancy] Lung A LIVING 2008 494a3ad4-58a0-41f8-8187-46ce03900462 494a3ad4-58a0-41f8-8187-46ce03900462 TCGA-NK-A5CT-01A-31D-A26N-05 TCGA-NK-A5CT-01A-31D-A26L-01 494a3ad4-58a0-41f8-8187-46ce03900462 TCGA-NK-A5CT-01A-31D-A26L-01 +TCGA-NK-A5CX-01 TCGA-NK-A5CX-01 TCGA-NK-A5CX TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 73 R-Lower TCGA-NK-A5CX-F53273 TCGA-NK-A5CX TCGA-NK-A5CX-01A -26879 589 0 111 NO NO Scheduled Follow-up Submission 2013-12-10 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 40 NO NO YES NO 40 true No MX N0 T2b Stage IIA TCGA-NK-A5CX.ED75BACE-AC37-41FE-ACE7-8E1403C97094.pdf A5CX TUMOR FREE Stable Disease NO NO Primary Tumor 01 2005 7th NO NO YES NK 4 Lung A LIVING 2011 18298f92-c0c4-4772-ba76-8674ebeabb4c 18298f92-c0c4-4772-ba76-8674ebeabb4c TCGA-NK-A5CX-01A-11D-A26N-05 TCGA-NK-A5CX-01A-11D-A26L-01 18298f92-c0c4-4772-ba76-8674ebeabb4c TCGA-NK-A5CX-01A-11D-A26L-01 +TCGA-NK-A5D1-01 TCGA-NK-A5D1-01 TCGA-NK-A5D1 TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung YES YES NO YES 57 R-Upper TCGA-NK-A5D1-F53275 TCGA-NK-A5D1 TCGA-NK-A5D1-01A 453 -20909 356 0 511 151 NO NO Scheduled Follow-up Submission Progressive Disease 2013-12-10 MALE Lung Basaloid Squamous Cell Carcinoma No C34.1 8070/3 C34.1 YES 10 NO NO YES Distant Metastasis YES 90 true Yes, History of Prior Malignancy M0 N1 T2a Stage IIA TCGA-NK-A5D1.5578086D-1892-4413-ACAD-F5995036204C.pdf A5D1 WITH TUMOR Progressive Disease Biopsy with Histologic Confirmation|Convincing Imaging NO [Discrepancy] Primary Tumor 01 2000 7th YES NK [Discrepancy] Lung A LIVING 2011 5c727d2e-892d-4228-a7b8-062ed0e77672 5c727d2e-892d-4228-a7b8-062ed0e77672 TCGA-NK-A5D1-01A-11D-A26N-05 TCGA-NK-A5D1-01A-11D-A26L-01 5c727d2e-892d-4228-a7b8-062ed0e77672 TCGA-NK-A5D1-01A-11D-A26L-01 +TCGA-NK-A7XE-01 TCGA-NK-A7XE-01 TCGA-NK-A7XE TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 66 L-Upper TCGA-NK-A7XE-F61446 TCGA-NK-A7XE TCGA-NK-A7XE-01A -24319 50 0 13 NO NO Scheduled Follow-up Submission 2014-6-30 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 180 NO NO YES NO 80 true Yes, History of Prior Malignancy M0 N2 T4 Stage IIIB TCGA-NK-A7XE.72D0E0B9-F05B-458F-9036-91A8DE553E8A.pdf A7XE TUMOR FREE Stable Disease NO NO Primary Tumor 01 7th NO NK 5 Lung A LIVING 2013 55d4ea6c-f934-495e-9c48-e867bd7983d3 55d4ea6c-f934-495e-9c48-e867bd7983d3 TCGA-NK-A7XE-01A-12D-A408-05 TCGA-NK-A7XE-01A-12D-A400-01 55d4ea6c-f934-495e-9c48-e867bd7983d3 TCGA-NK-A7XE-01A-12D-A400-01 +TCGA-O1-A52J-01 TCGA-O1-A52J-01 TCGA-O1-A52J TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 74 L-Lower TCGA-O1-A52J TCGA-O1-A52J-01A -27223 2000 1798 0 1 NO NO 2013-4-11 FEMALE Lung Adenocarcinoma- Not Otherwise Specified (NOS) No C34.3 8140/3 C34.3 YES 50 NO NO YES 45 true No MX N0 T1 Stage IA TCGA-O1-A52J.E5C54019-F404-4F8D-847A-80CF65F65E19.pdf A52J WITH TUMOR NO NO Primary Tumor 01 1980 6th NO NO YES O1 3 Lung A DECEASED 2007 1950 ca467949-9170-4c3f-8e67-5b7762d31d4a ca467949-9170-4c3f-8e67-5b7762d31d4a TCGA-O1-A52J-01A-11D-A25R-05 TCGA-O1-A52J-01A-11D-A25M-01 ca467949-9170-4c3f-8e67-5b7762d31d4a TCGA-O1-A52J-01A-11D-A25M-01 +TCGA-O2-A52N-01 TCGA-O2-A52N-01 TCGA-O2-A52N TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 78 R-Upper TCGA-O2-A52N TCGA-O2-A52N-01A -28520 2730 1006 0 0 NO NO 2013-4-11 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 330 NO NO NO 4.125 true No MX N0 T2 Stage I TCGA-O2-A52N.357460FE-4E4F-4163-B3BA-EBD5DCCFADCB.pdf A52N TUMOR FREE NO NO Primary Tumor 01 1997 6th NO NO YES O2 4 Lung A DECEASED 2005 1942 5e4388cd-137c-4969-b273-7d067195c466 5e4388cd-137c-4969-b273-7d067195c466 TCGA-O2-A52N-01A-11D-A26N-05 TCGA-O2-A52N-01A-11D-A26L-01 5e4388cd-137c-4969-b273-7d067195c466 TCGA-O2-A52N-01A-11D-A26L-01 +TCGA-O2-A52Q-01 TCGA-O2-A52Q-01 TCGA-O2-A52Q TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 44 R-Upper TCGA-O2-A52Q TCGA-O2-A52Q-01A -16429 2558 113 0 3 NO NO 2013-4-11 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 110 NO NO YES 1 true No MX N1 T3 Stage III TCGA-O2-A52Q.9B7C77F8-7EFE-4598-8273-7C902EA77C55.pdf A52Q WITH TUMOR NO NO Primary Tumor 01 6th NO NO YES O2 2 Lung A DECEASED 2005 1985 7729ed42-e15f-4881-ada8-dd71457197e0 7729ed42-e15f-4881-ada8-dd71457197e0 TCGA-O2-A52Q-01A-11D-A26N-05 TCGA-O2-A52Q-01A-11D-A26L-01 7729ed42-e15f-4881-ada8-dd71457197e0 TCGA-O2-A52Q-01A-11D-A26L-01 +TCGA-O2-A52S-01 TCGA-O2-A52S-01 TCGA-O2-A52S TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 57 L-Lower TCGA-O2-A52S TCGA-O2-A52S-01A -21182 2429 387 0 1 NO NO 2013-4-11 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 60 NO NO YES 3 true No MX N2 T4 Stage III TCGA-O2-A52S.A5404A41-95B6-4290-A240-EAD96CD4B691.pdf A52S WITH TUMOR NO YES Primary Tumor 01 2006 6th NO NO YES O2 4 Lung A DECEASED 2006 1976 e3e7210a-a45e-47dc-aa2c-46aa17d47314 e3e7210a-a45e-47dc-aa2c-46aa17d47314 TCGA-O2-A52S-01A-11D-A25R-05 TCGA-O2-A52S-01A-11D-A25M-01 e3e7210a-a45e-47dc-aa2c-46aa17d47314 TCGA-O2-A52S-01A-11D-A25M-01 +TCGA-O2-A52V-01 TCGA-O2-A52V-01 TCGA-O2-A52V TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 75 L-Upper TCGA-O2-A52V TCGA-O2-A52V-01A -27449 2303 1335 0 1 NO NO 2013-5-19 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 190 NO NO YES 1 true No MX N0 T3 Stage II TCGA-O2-A52V.0C9E8CD7-55DF-4BFF-AE29-891BD33C2EB4.pdf A52V TUMOR FREE NO YES Primary Tumor 01 1996 6th NO NO YES O2 4 Lung A DECEASED 2006 1976 d353af66-1298-4da0-b7fd-08671d5dcda9 d353af66-1298-4da0-b7fd-08671d5dcda9 TCGA-O2-A52V-01A-31D-A25R-05 TCGA-O2-A52V-01A-31D-A25M-01 d353af66-1298-4da0-b7fd-08671d5dcda9 TCGA-O2-A52V-01A-31D-A25M-01 +TCGA-O2-A52W-01 TCGA-O2-A52W-01 TCGA-O2-A52W TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 63 R-Lower TCGA-O2-A52W TCGA-O2-A52W-01A -23156 2324 261 0 3 NO NO 2013-4-11 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.2 8070/3 C34.2 YES 70 NO NO NO 2.5 true Yes, History of Prior Malignancy MX N0 T2 Stage I TCGA-O2-A52W.40AC1B86-4305-482C-A6DE-45E1320676C6.pdf A52W TUMOR FREE NO NO Primary Tumor 01 2006 6th NO NO YES O2 4 Lung A DECEASED 2006 1956 e8c57cc1-0293-433a-8076-13cfa9935ce7 e8c57cc1-0293-433a-8076-13cfa9935ce7 TCGA-O2-A52W-01A-11D-A26N-05 TCGA-O2-A52W-01A-11D-A26L-01 e8c57cc1-0293-433a-8076-13cfa9935ce7 TCGA-O2-A52W-01A-11D-A26L-01 +TCGA-O2-A5IB-01 TCGA-O2-A5IB-01 TCGA-O2-A5IB TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 71 R-Middle TCGA-O2-A5IB TCGA-O2-A5IB-01A -26211 2666 340 0 0 NO NO 2013-5-19 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.2 8070/3 C34.2 YES 140 NO NO YES 2.5 true No MX N1 T3 Stage III TCGA-O2-A5IB.D8784E5D-007E-4768-8D0E-E7A3C0CD21DD.pdf A5IB WITH TUMOR NO NO Primary Tumor 01 2004 6th NO NO YES O2 4 Lung A DECEASED 2005 1954 5c99d6ce-742c-427c-a252-e2ce6b7f919c 5c99d6ce-742c-427c-a252-e2ce6b7f919c TCGA-O2-A5IB-01A-11D-A27L-05 TCGA-O2-A5IB-01A-11D-A27J-01 5c99d6ce-742c-427c-a252-e2ce6b7f919c TCGA-O2-A5IB-01A-11D-A27J-01 +TCGA-O2-A5IC-01 TCGA-O2-A5IC-01 TCGA-O2-A5IC TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung TCGA-O2-A5IC-01A 2477 50 NO true TCGA-O2-A5IC.B7F0D448-8551-4D89-AAE0-18F5CC8BFB78.pdf Primary Tumor 01 A TCGA-O2-A5IC-01A-11D-A27L-05 +TCGA-S2-AA1A-01 TCGA-S2-AA1A-01 TCGA-S2-AA1A TCGA Lung Cancer (LUNG) lung adenocarcinoma Lung 68 R-Upper TCGA-S2-AA1A-F67520 TCGA-S2-AA1A TCGA-S2-AA1A-01A -24903 95 0 513 65 NO NO Scheduled Follow-up Submission Complete Remission/Response 2014-11-7 FEMALE Lung Bronchioloalveolar Carcinoma Mucinous No C34.1 8253/3 C34.1 YES 170 NO NO NO NO 95 true No M0 N0 T1b Stage IA TCGA-S2-AA1A.83A6F838-3F30-411F-9982-B8985C7FA52E.pdf AA1A TUMOR FREE 83 2.16 79 2.01 Complete Remission/Response YES NO R0 Primary Tumor 01 1995 7th NO YES NO S2 3 Lung A LIVING 2013 1957 b129c3f7-a2ff-40ba-91b0-a9c96f1e2b00 b129c3f7-a2ff-40ba-91b0-a9c96f1e2b00 TCGA-S2-AA1A-01A-12D-A398-05 TCGA-S2-AA1A-01A-12D-A396-01 b129c3f7-a2ff-40ba-91b0-a9c96f1e2b00 TCGA-S2-AA1A-01A-12D-A396-01 +TCGA-XC-AA0X-01 TCGA-XC-AA0X-01 TCGA-XC-AA0X TCGA Lung Cancer (LUNG) lung squamous cell carcinoma Lung 77 R-Lower TCGA-XC-AA0X TCGA-XC-AA0X-01A -28211 81 6 0 73 NO NO 2014-4-22 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 350 NO NO Central Lung NO 30 true No M0 N0 T1a Stage IA TCGA-XC-AA0X.B22BD117-8DF0-47FF-BE25-9FE2DA916DB6.pdf AA0X TUMOR FREE 72 91 YES NO R0 Primary Tumor 01 2013 7th NO YES NO XC 2 Lung A DECEASED 2013 1953 5d5091c3-27b2-4152-a5b2-64bc7fd16942 5d5091c3-27b2-4152-a5b2-64bc7fd16942 TCGA-XC-AA0X-01A-32D-A408-05 TCGA-XC-AA0X-01A-32D-A400-01 5d5091c3-27b2-4152-a5b2-64bc7fd16942 TCGA-XC-AA0X-01A-32D-A400-01 diff --git a/input/TCGA/TCGA_Lung_Squamous_Cell_Carcinoma_(LUSC)/TCGA.LUSC.sampleMap_HiSeqV2_PANCAN.gz b/input/TCGA/TCGA_Lung_Squamous_Cell_Carcinoma_(LUSC)/TCGA.LUSC.sampleMap_HiSeqV2_PANCAN.gz new file mode 100644 index 0000000000000000000000000000000000000000..f8d7367c6b567ffea209257164334081dd45cc42 --- /dev/null +++ b/input/TCGA/TCGA_Lung_Squamous_Cell_Carcinoma_(LUSC)/TCGA.LUSC.sampleMap_HiSeqV2_PANCAN.gz @@ -0,0 +1,3 @@ +version https://git-lfs.github.com/spec/v1 +oid sha256:27ba1e9dd8a1b9afd34ddb73e51b2a0ea8aaee5935e54783cc329d4483e30edc +size 39930055 diff --git a/input/TCGA/TCGA_Lung_Squamous_Cell_Carcinoma_(LUSC)/TCGA.LUSC.sampleMap_LUSC_clinicalMatrix b/input/TCGA/TCGA_Lung_Squamous_Cell_Carcinoma_(LUSC)/TCGA.LUSC.sampleMap_LUSC_clinicalMatrix new file mode 100644 index 0000000000000000000000000000000000000000..4c2672893d87040828615ccc3790f732a1758a0d --- /dev/null +++ b/input/TCGA/TCGA_Lung_Squamous_Cell_Carcinoma_(LUSC)/TCGA.LUSC.sampleMap_LUSC_clinicalMatrix @@ -0,0 +1,627 @@ +sampleID _INTEGRATION _PANCAN_CNA_PANCAN_K8 _PANCAN_Cluster_Cluster_PANCAN _PANCAN_DNAMethyl_LUSC _PANCAN_DNAMethyl_PANCAN _PANCAN_RPPA_PANCAN_K8 _PANCAN_UNC_RNAseq_PANCAN_K16 _PANCAN_miRNA_PANCAN _PANCAN_mirna_LUSC _PANCAN_mutation_PANCAN _PATIENT _cohort _primary_disease _primary_site additional_pharmaceutical_therapy additional_radiation_therapy additional_surgery_locoregional_procedure additional_surgery_metastatic_procedure age_at_initial_pathologic_diagnosis anatomic_neoplasm_subdivision anatomic_neoplasm_subdivision_other bcr_followup_barcode bcr_patient_barcode bcr_sample_barcode days_to_additional_surgery_locoregional_procedure days_to_additional_surgery_metastatic_procedure days_to_birth days_to_collection days_to_death days_to_initial_pathologic_diagnosis days_to_last_followup days_to_new_tumor_event_after_initial_treatment dlco_predictive_percent eastern_cancer_oncology_group egfr_mutation_performed egfr_mutation_result eml4_alk_translocation_method eml4_alk_translocation_performed followup_case_report_form_submission_reason followup_treatment_success form_completion_date gender histological_type history_of_neoadjuvant_treatment icd_10 icd_o_3_histology icd_o_3_site informed_consent_verified initial_weight intermediate_dimension is_ffpe karnofsky_performance_score kras_gene_analysis_performed kras_mutation_found kras_mutation_result location_in_lung_parenchyma longest_dimension lost_follow_up new_neoplasm_event_type new_tumor_event_after_initial_treatment number_pack_years_smoked oct_embedded other_dx pathologic_M pathologic_N pathologic_T pathologic_stage pathology_report_file_name patient_id performance_status_scale_timing person_neoplasm_cancer_status post_bronchodilator_fev1_fvc_percent post_bronchodilator_fev1_percent pre_bronchodilator_fev1_fvc_percent pre_bronchodilator_fev1_percent primary_therapy_outcome_success progression_determined_by pulmonary_function_test_performed radiation_therapy residual_tumor sample_type sample_type_id shortest_dimension stopped_smoking_year system_version targeted_molecular_therapy tissue_prospective_collection_indicator tissue_retrospective_collection_indicator tissue_source_site tobacco_smoking_history tumor_tissue_site vial_number vital_status year_of_initial_pathologic_diagnosis year_of_tobacco_smoking_onset _GENOMIC_ID_TCGA_LUSC_mutation_broad_gene _GENOMIC_ID_TCGA_LUSC_hMethyl27 _GENOMIC_ID_TCGA_LUSC_exp_HiSeqV2 _GENOMIC_ID_data/public/TCGA/LUSC/miRNA_HiSeq_gene _GENOMIC_ID_TCGA_LUSC_miRNA_GA _GENOMIC_ID_TCGA_LUSC_mutation _GENOMIC_ID_TCGA_LUSC_PDMRNAseq _GENOMIC_ID_TCGA_LUSC_G4502A_07_3 _GENOMIC_ID_TCGA_LUSC_miRNA_HiSeq _GENOMIC_ID_TCGA_LUSC_exp_HiSeqV2_percentile _GENOMIC_ID_TCGA_LUSC_exp_u133a _GENOMIC_ID_TCGA_LUSC_RPPA_RBN _GENOMIC_ID_TCGA_LUSC_PDMRNAseqCNV _GENOMIC_ID_TCGA_LUSC_gistic2 _GENOMIC_ID_TCGA_LUSC_PDMarray _GENOMIC_ID_TCGA_LUSC_exp_HiSeqV2_exon _GENOMIC_ID_TCGA_LUSC_PDMarrayCNV _GENOMIC_ID_TCGA_LUSC_exp_HiSeqV2_PANCAN _GENOMIC_ID_data/public/TCGA/LUSC/miRNA_GA_gene _GENOMIC_ID_TCGA_LUSC_gistic2thd _GENOMIC_ID_TCGA_LUSC_hMethyl450 _GENOMIC_ID_TCGA_LUSC_RPPA +TCGA-18-3406-01 TCGA-18-3406-01 Squamous C2-Squamous-like cluster 1 Cluster 13 (HNSC-LUSC) squamous-like c4 miRNA cluster 11 cluster 1 mutation cluster 5 TCGA-18-3406 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung NO NO NO 67 L-Upper TCGA-18-3406-F69068 TCGA-18-3406 TCGA-18-3406-01A -24477 371 0 357 Scheduled Follow-up Submission 2014-12-29 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.5 NO 0 0.8 NO Locoregional Recurrence YES 200 Yes M0 N0 T1 Stage IA TCGA-18-3406.a0eef850-7543-4f82-8e46-3d81e203412d.pdf 3406 WITH TUMOR Progressive Disease Convincing Imaging NO R0 Primary Tumor 01 0.3 NO NO YES 18 4 Lung A DECEASED 2003 1951 TCGA-18-3406-01A-01D-0983-08 TCGA-18-3406-01A-01D-0979-05 99516b1e-9ee2-48d9-90e4-e78370eccef6 TCGA-18-3406-01 TCGA-18-3406-01A-01D-0983-08 TCGA-18-3406-01 TCGA-18-3406-01A-01R-0980-07 99516b1e-9ee2-48d9-90e4-e78370eccef6 c9b700c0-9518-4edd-8db9-e75301e00c08 TCGA-18-3406-01 TCGA-18-3406-01A-01D-0978-01 TCGA-18-3406-01 99516b1e-9ee2-48d9-90e4-e78370eccef6 TCGA-18-3406-01 99516b1e-9ee2-48d9-90e4-e78370eccef6 TCGA-18-3406-01 TCGA-18-3406-01A-01D-0978-01 +TCGA-18-3406-11 TCGA-18-3406-11 C2-Squamous-like mutation cluster 5 TCGA-18-3406 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung NO NO NO 67 L-Upper TCGA-18-3406-F69068 TCGA-18-3406 TCGA-18-3406-11A -24477 371 0 357 Scheduled Follow-up Submission 2014-12-29 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.4 NO 0 0.8 NO Locoregional Recurrence YES 200 Yes M0 N0 T1 Stage IA 3406 WITH TUMOR Progressive Disease Convincing Imaging NO R0 Solid Tissue Normal 11 0.2 NO NO YES 18 4 Lung A DECEASED 2003 1951 TCGA-18-3406-11A-01D-0979-05 +TCGA-18-3407-01 TCGA-18-3407-01 High C2-Squamous-like cluster 2 Cluster 14 (HNSC) squamous-like c4 miRNA cluster 4 cluster 2 mutation cluster 2 TCGA-18-3407 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 72 L-Upper TCGA-18-3407-F69081 TCGA-18-3407 TCGA-18-3407-01A -26615 136 0 Scheduled Follow-up Submission 2014-12-29 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.5 NO 0 0.5 NO NO 40 Yes M0 N0 T2 Stage IB TCGA-18-3407.c9b161d4-e3e2-43a9-8997-195db2fcc1d7.pdf 3407 TUMOR FREE NO R0 Primary Tumor 01 0.2 1988 NO NO YES 18 3 Lung A DECEASED 2003 TCGA-18-3407-01A-01D-0983-08 TCGA-18-3407-01A-01D-0979-05 0aea71d4-f403-474a-91d3-f9b0929c0acf TCGA-18-3407-01 TCGA-18-3407-01A-01D-0983-08 TCGA-18-3407-01 TCGA-18-3407-01A-01R-0980-07 0aea71d4-f403-474a-91d3-f9b0929c0acf b90d788b-037b-4e93-88ac-bdad05e52265 TCGA-18-3407-01 TCGA-18-3407-01A-01D-1969-01 TCGA-18-3407-01 0aea71d4-f403-474a-91d3-f9b0929c0acf TCGA-18-3407-01 0aea71d4-f403-474a-91d3-f9b0929c0acf TCGA-18-3407-01 TCGA-18-3407-01A-01D-1969-01 +TCGA-18-3407-11 TCGA-18-3407-11 C2-Squamous-like mutation cluster 2 TCGA-18-3407 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 72 L-Upper TCGA-18-3407-F69081 TCGA-18-3407 TCGA-18-3407-11A -26615 136 0 Scheduled Follow-up Submission 2014-12-29 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.7 NO 0 0.9 NO NO 40 Yes M0 N0 T2 Stage IB 3407 TUMOR FREE NO R0 Solid Tissue Normal 11 0.4 1988 NO NO YES 18 3 Lung A DECEASED 2003 TCGA-18-3407-11A-01D-0979-05 +TCGA-18-3408-01 TCGA-18-3408-01 Squamous C2-Squamous-like cluster 3 Cluster 13 (HNSC-LUSC) squamous-like c4 miRNA cluster 11 cluster 2 mutation cluster 5 TCGA-18-3408 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung NO YES NO 77 R-Lower TCGA-18-3408-F67568 TCGA-18-3408 TCGA-18-3408-01A -28171 2304 0 2099 1793 Scheduled Follow-up Submission Progressive Disease 2014-11-14 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.4 NO 0 0.5 NO Locoregional Recurrence YES 30 No M0 N0 T2 Stage IB TCGA-18-3408.ef586d16-0c67-42db-9d31-86df9476d49d.pdf 3408 WITH TUMOR Biopsy with Histologic Confirmation NO R0 Primary Tumor 01 0.3 2004 NO NO YES 18 4 Lung A DECEASED 2004 TCGA-18-3408-01A-01D-0983-08 TCGA-18-3408-01A-01D-0979-05 43672213-eb65-4206-bc57-56587b08259f TCGA-18-3408-01 TCGA-18-3408-01A-01D-0983-08 TCGA-18-3408-01 TCGA-18-3408-01A-01R-0980-07 43672213-eb65-4206-bc57-56587b08259f 6c8ee55e-562d-4624-b69c-a6987301f0d0 TCGA-18-3408-01 TCGA-18-3408-01A-01D-0978-01 TCGA-18-3408-01 43672213-eb65-4206-bc57-56587b08259f TCGA-18-3408-01 43672213-eb65-4206-bc57-56587b08259f TCGA-18-3408-01 TCGA-18-3408-01A-01D-0978-01 +TCGA-18-3408-11 TCGA-18-3408-11 C2-Squamous-like mutation cluster 5 TCGA-18-3408 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung NO YES NO 77 R-Lower TCGA-18-3408-F67568 TCGA-18-3408 TCGA-18-3408-11A -28171 2304 0 2099 1793 Scheduled Follow-up Submission Progressive Disease 2014-11-14 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.5 NO 0 0.5 NO Locoregional Recurrence YES 30 No M0 N0 T2 Stage IB 3408 WITH TUMOR Biopsy with Histologic Confirmation NO R0 Solid Tissue Normal 11 0.5 2004 NO NO YES 18 4 Lung A DECEASED 2004 TCGA-18-3408-11A-01D-0979-05 +TCGA-18-3409-01 TCGA-18-3409-01 COAD-READ C2-Squamous-like cluster 1 Cluster 5 squamous-like c4 mutation cluster 11 TCGA-18-3409 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung YES YES 74 L-Upper TCGA-18-3409-F72297 TCGA-18-3409 TCGA-18-3409-01A -27154 0 3747 2291 Additional New Tumor Event Complete Remission/Response 2015-5-6 MALE Lung Basaloid Squamous Cell Carcinoma No C34.1 8083/3 C34.1 YES 0.4 NO 0.9 NO New Primary Tumor YES 20 Yes M0 N0 T1 Stage IA TCGA-18-3409.978339c6-aea3-4ac1-87db-40388a3adf39.pdf 3409 TUMOR FREE Complete Remission/Response NO NO R0 Primary Tumor 01 0.2 1974 6th NO NO YES 18 3 Lung A LIVING 2004 TCGA-18-3409-01A-01D-0983-08 TCGA-18-3409-01A-01D-0979-05 c26af662-dd33-4073-bd97-1f79da7bfa43 TCGA-18-3409-01A-01D-0983-08 TCGA-18-3409-01 TCGA-18-3409-01A-01R-0980-07 c26af662-dd33-4073-bd97-1f79da7bfa43 8032999c-8ea9-494b-831a-30089dc606aa TCGA-18-3409-01 TCGA-18-3409-01A-01D-0978-01 TCGA-18-3409-01 c26af662-dd33-4073-bd97-1f79da7bfa43 TCGA-18-3409-01 c26af662-dd33-4073-bd97-1f79da7bfa43 TCGA-18-3409-01A-01D-0978-01 +TCGA-18-3409-11 TCGA-18-3409-11 C2-Squamous-like mutation cluster 11 TCGA-18-3409 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung YES YES 74 L-Upper TCGA-18-3409-F72297 TCGA-18-3409 TCGA-18-3409-11A -27154 0 3747 2291 Additional New Tumor Event Complete Remission/Response 2015-5-6 MALE Lung Basaloid Squamous Cell Carcinoma No C34.1 8083/3 C34.1 YES 0.4 NO 0.8 NO New Primary Tumor YES 20 Yes M0 N0 T1 Stage IA 3409 TUMOR FREE Complete Remission/Response NO NO R0 Solid Tissue Normal 11 0.2 1974 6th NO NO YES 18 3 Lung A LIVING 2004 TCGA-18-3409-11A-01D-0979-05 +TCGA-18-3410-01 TCGA-18-3410-01 Squamous C2-Squamous-like cluster 4 Cluster 5 squamous-like c4 miRNA cluster 12 cluster 3 mutation cluster 2 TCGA-18-3410 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 81 R-Lower TCGA-18-3410-F69095 TCGA-18-3410 TCGA-18-3410-01A -29827 146 0 Scheduled Follow-up Submission 2014-12-29 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.4 NO 0 Peripheral Lung 0.5 NO NO Yes M0 N0 T3 Stage IIB TCGA-18-3410.956030d1-c74c-4bb6-93d9-04eb5c786905.pdf 3410 TUMOR FREE NO R0 Primary Tumor 01 0.3 NO NO YES 18 3 Lung A DECEASED 2004 TCGA-18-3410-01A-01D-0983-08 TCGA-18-3410-01A-01D-0979-05 388eaf67-9d6d-4b9a-b404-a4ce171fbd18 TCGA-18-3410-01 TCGA-18-3410-01A-01D-0983-08 TCGA-18-3410-01 TCGA-18-3410-01A-01R-0980-07 388eaf67-9d6d-4b9a-b404-a4ce171fbd18 be7878de-22cb-48e2-9760-68b984833a90 TCGA-18-3410-01 TCGA-18-3410-01A-01D-1969-01 TCGA-18-3410-01 388eaf67-9d6d-4b9a-b404-a4ce171fbd18 TCGA-18-3410-01 388eaf67-9d6d-4b9a-b404-a4ce171fbd18 TCGA-18-3410-01 TCGA-18-3410-01A-01D-1969-01 +TCGA-18-3410-11 TCGA-18-3410-11 C2-Squamous-like mutation cluster 2 TCGA-18-3410 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 81 R-Lower TCGA-18-3410-F69095 TCGA-18-3410 TCGA-18-3410-11A -29827 146 0 Scheduled Follow-up Submission 2014-12-29 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.5 NO 0 Peripheral Lung 0.7 NO NO Yes M0 N0 T3 Stage IIB 3410 TUMOR FREE NO R0 Solid Tissue Normal 11 0.5 NO NO YES 18 3 Lung A DECEASED 2004 TCGA-18-3410-11A-01D-0979-05 +TCGA-18-3411-01 TCGA-18-3411-01 High C2-Squamous-like cluster 3 Cluster 13 (HNSC-LUSC) squamous-like c4 miRNA cluster 4 cluster 2 mutation cluster 13 TCGA-18-3411 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 63 R-Upper TCGA-18-3411-F68326 TCGA-18-3411 TCGA-18-3411-01A -23370 0 3576 Scheduled Follow-up Submission 2014-11-14 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.5 NO 0.6 NO 50 No M0 N2 T2 Stage IIIA TCGA-18-3411.03efa03c-f8f9-43c3-9244-265bc02cbb5c.pdf 3411 TUMOR FREE YES R0 Primary Tumor 01 0.5 YES NO YES 18 2 Lung A LIVING 2005 TCGA-18-3411-01A-01D-0983-08 TCGA-18-3411-01A-01D-0979-05 bc493a57-6821-4607-a841-5ffc39391910 TCGA-18-3411-01 TCGA-18-3411-01A-01D-0983-08 TCGA-18-3411-01 TCGA-18-3411-01A-01R-0980-07 bc493a57-6821-4607-a841-5ffc39391910 56b2e492-7ba4-4c00-bbb2-bb2cdd7a2c3f TCGA-18-3411-01 TCGA-18-3411-01A-01D-1969-01 TCGA-18-3411-01 bc493a57-6821-4607-a841-5ffc39391910 TCGA-18-3411-01 bc493a57-6821-4607-a841-5ffc39391910 TCGA-18-3411-01 TCGA-18-3411-01A-01D-1969-01 +TCGA-18-3411-11 TCGA-18-3411-11 C2-Squamous-like mutation cluster 13 TCGA-18-3411 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 63 R-Upper TCGA-18-3411-F68326 TCGA-18-3411 TCGA-18-3411-11A -23370 0 3576 Scheduled Follow-up Submission 2014-11-14 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.5 NO 0.9 NO 50 No M0 N2 T2 Stage IIIA 3411 TUMOR FREE YES R0 Solid Tissue Normal 11 0.3 YES NO YES 18 2 Lung A LIVING 2005 TCGA-18-3411-11A-01D-0979-05 +TCGA-18-3412-01 TCGA-18-3412-01 Squamous C2-Squamous-like cluster 2 Cluster 13 (HNSC-LUSC) squamous-like c4 miRNA cluster 11 cluster 1 mutation c1uster 9 TCGA-18-3412 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung YES NO NO NO 52 L-Lower TCGA-18-3412-F69101 TCGA-18-3412 TCGA-18-3412-01A -19025 345 0 273 Scheduled Follow-up Submission Progressive Disease 2014-12-29 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.5 NO 0 Central Lung 0.6 NO Distant Metastasis YES 25 No M0 N0 T2 Stage IB TCGA-18-3412.cae58929-ecc1-4c4a-8df6-cf48a32785ee.pdf 3412 WITH TUMOR Progressive Disease Convincing Imaging NO R0 Primary Tumor 01 0.3 1995 YES NO YES 18 4 Lung A DECEASED 2005 TCGA-18-3412-01A-01D-0983-08 TCGA-18-3412-01A-01D-0979-05 8539f984-feb7-4b21-ac81-1ae2b403b845 TCGA-18-3412-01 TCGA-18-3412-01A-01D-0983-08 TCGA-18-3412-01 TCGA-18-3412-01A-01R-0980-07 8539f984-feb7-4b21-ac81-1ae2b403b845 8518ddc1-112d-40ed-93e8-6c59a3b8c7c9 TCGA-18-3412-01 TCGA-18-3412-01A-01D-0978-01 TCGA-18-3412-01 8539f984-feb7-4b21-ac81-1ae2b403b845 TCGA-18-3412-01 8539f984-feb7-4b21-ac81-1ae2b403b845 TCGA-18-3412-01 TCGA-18-3412-01A-01D-0978-01 +TCGA-18-3412-11 TCGA-18-3412-11 C2-Squamous-like mutation c1uster 9 TCGA-18-3412 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung YES NO NO NO 52 L-Lower TCGA-18-3412-F69101 TCGA-18-3412 TCGA-18-3412-11A -19025 345 0 273 Scheduled Follow-up Submission Progressive Disease 2014-12-29 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.5 NO 0 Central Lung 0.7 NO Distant Metastasis YES 25 No M0 N0 T2 Stage IB 3412 WITH TUMOR Progressive Disease Convincing Imaging NO R0 Solid Tissue Normal 11 0.5 1995 YES NO YES 18 4 Lung A DECEASED 2005 TCGA-18-3412-11A-01D-0979-05 +TCGA-18-3414-01 TCGA-18-3414-01 Squamous C2-Squamous-like cluster 4 Cluster 5 squamous-like c4 miRNA cluster 4 cluster 2 mutation cluster 8 TCGA-18-3414 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 73 R-Lower TCGA-18-3414-F69131 TCGA-18-3414 TCGA-18-3414-01A -26938 716 0 Scheduled Follow-up Submission 2014-12-29 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.5 NO 0 0.7 NO NO 25 No M1 N1 T4 Stage IV TCGA-18-3414.f0bd5a6e-4ebf-4859-b139-80fbb3a54daf.pdf 3414 TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 0.4 1997 NO NO YES 18 4 Lung A DECEASED 2005 TCGA-18-3414-01A-01D-0983-08 TCGA-18-3414-01A-01D-0979-05 fddbc301-c80e-4ecd-b347-21783f885157 TCGA-18-3414-01 TCGA-18-3414-01A-01D-0983-08 TCGA-18-3414-01 TCGA-18-3414-01A-01R-0980-07 fddbc301-c80e-4ecd-b347-21783f885157 8bb4ca2e-9952-4f9d-9e10-0d0957a4f237 TCGA-18-3414-01 TCGA-18-3414-01A-01D-0978-01 TCGA-18-3414-01 fddbc301-c80e-4ecd-b347-21783f885157 TCGA-18-3414-01 fddbc301-c80e-4ecd-b347-21783f885157 TCGA-18-3414-01 TCGA-18-3414-01A-01D-0978-01 +TCGA-18-3414-11 TCGA-18-3414-11 C2-Squamous-like mutation cluster 8 TCGA-18-3414 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 73 R-Lower TCGA-18-3414-F69131 TCGA-18-3414 TCGA-18-3414-11A -26938 716 0 Scheduled Follow-up Submission 2014-12-29 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.5 NO 0 0.7 NO NO 25 No M1 N1 T4 Stage IV 3414 TUMOR FREE Complete Remission/Response NO R0 Solid Tissue Normal 11 0.5 1997 NO NO YES 18 4 Lung A DECEASED 2005 TCGA-18-3414-11A-01D-0979-05 +TCGA-18-3415-01 TCGA-18-3415-01 Squamous C2-Squamous-like cluster 3 Cluster 13 (HNSC-LUSC) squamous-like c4 miRNA cluster 11 cluster 2 mutation cluster 5 TCGA-18-3415 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 77 R-Upper TCGA-18-3415-F67627 TCGA-18-3415 TCGA-18-3415-01A -28430 2803 0 1810 Scheduled Follow-up Submission 2014-11-7 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.5 NO 0.8 NO NO 30 No M0 N0 T2 Stage IB TCGA-18-3415.a37738c0-91cf-4e7e-b16c-3737a61bea72.pdf 3415 TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 0.2 1975 YES NO YES 18 3 Lung A DECEASED 2006 TCGA-18-3415-01A-01D-0983-08 TCGA-18-3415-01A-01D-0979-05 539545e6-7309-4431-85bf-101159542bdb TCGA-18-3415-01 TCGA-18-3415-01A-01D-0983-08 TCGA-18-3415-01 TCGA-18-3415-01A-01R-0980-07 539545e6-7309-4431-85bf-101159542bdb e1e2326f-1e5e-44f5-816d-64e1e5f9fc9c TCGA-18-3415-01 TCGA-18-3415-01A-01D-0978-01 TCGA-18-3415-01 539545e6-7309-4431-85bf-101159542bdb TCGA-18-3415-01 539545e6-7309-4431-85bf-101159542bdb TCGA-18-3415-01 TCGA-18-3415-01A-01D-0978-01 +TCGA-18-3415-11 TCGA-18-3415-11 C2-Squamous-like mutation cluster 5 TCGA-18-3415 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 77 R-Upper TCGA-18-3415-F67627 TCGA-18-3415 TCGA-18-3415-11A -28430 2803 0 1810 Scheduled Follow-up Submission 2014-11-7 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.5 NO 1 NO NO 30 No M0 N0 T2 Stage IB 3415 TUMOR FREE Complete Remission/Response NO R0 Solid Tissue Normal 11 0.3 1975 YES NO YES 18 3 Lung A DECEASED 2006 TCGA-18-3415-11A-01D-0979-05 +TCGA-18-3416-01 TCGA-18-3416-01 High C2-Squamous-like cluster 2 Cluster 14 (HNSC) squamous-like c4 miRNA cluster 4 cluster 2 mutation cluster 2 TCGA-18-3416 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 83 L-Upper TCGA-18-3416-F67641 TCGA-18-3416 TCGA-18-3416-01A -30435 973 0 956 940 Scheduled Follow-up Submission Progressive Disease 2014-11-7 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.5 NO 0.5 NO Distant Metastasis YES 40 Yes M0 N1 T2 Stage IIB TCGA-18-3416.d313ac3e-6ce5-411c-b014-8b88c7b7198b.pdf 3416 WITH TUMOR Complete Remission/Response Biopsy with Histologic Confirmation NO R0 Primary Tumor 01 0.4 NO NO YES 18 3 Lung A DECEASED 2006 TCGA-18-3416-01A-01D-0983-08 TCGA-18-3416-01A-01D-0979-05 c5532e8c-8632-4e7a-8143-e062af4b1d60 TCGA-18-3416-01 TCGA-18-3416-01A-01D-0983-08 TCGA-18-3416-01 TCGA-18-3416-01A-01R-0980-07 c5532e8c-8632-4e7a-8143-e062af4b1d60 7c106a35-476b-4165-8d72-b756c3dd6458 TCGA-18-3416-01 TCGA-18-3416-01A-01D-0978-01 TCGA-18-3416-01 c5532e8c-8632-4e7a-8143-e062af4b1d60 TCGA-18-3416-01 c5532e8c-8632-4e7a-8143-e062af4b1d60 TCGA-18-3416-01 TCGA-18-3416-01A-01D-0978-01 +TCGA-18-3416-11 TCGA-18-3416-11 C2-Squamous-like mutation cluster 2 TCGA-18-3416 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 83 L-Upper TCGA-18-3416-F67641 TCGA-18-3416 TCGA-18-3416-11A -30435 973 0 956 940 Scheduled Follow-up Submission Progressive Disease 2014-11-7 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.6 NO 0.8 NO Distant Metastasis YES 40 Yes M0 N1 T2 Stage IIB 3416 WITH TUMOR Complete Remission/Response Biopsy with Histologic Confirmation NO R0 Solid Tissue Normal 11 0.2 NO NO YES 18 3 Lung A DECEASED 2006 TCGA-18-3416-11A-01D-0979-05 +TCGA-18-3417-01 TCGA-18-3417-01 High C2-Squamous-like cluster 1 Cluster 14 (HNSC) squamous-like c4 miRNA cluster 4 cluster 2 mutation cluster 6 TCGA-18-3417 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 65 R-Upper TCGA-18-3417-F67643 TCGA-18-3417 TCGA-18-3417-01A -24019 1097 0 758 Scheduled Follow-up Submission 2014-11-7 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.9 8070/3 C34.9 YES 0.4 NO 0.8 NO 25 No M1 N1 T2 Stage IV TCGA-18-3417.71b38c75-44cf-4f27-90c2-04caee0d55a6.pdf 3417 TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 0.3 1989 YES NO YES 18 3 Lung A DECEASED 2006 1963 TCGA-18-3417-01A-01D-1441-08 608a1e43-d38c-498f-99d8-e5539d43b636 TCGA-18-3417-01 TCGA-18-3417-01A-01D-1441-08 TCGA-18-3417-01 TCGA-18-3417-01A-01R-1443-07 608a1e43-d38c-498f-99d8-e5539d43b636 TCGA-18-3417-01 TCGA-18-3417-01A-01D-1439-01 TCGA-18-3417-01 608a1e43-d38c-498f-99d8-e5539d43b636 TCGA-18-3417-01 608a1e43-d38c-498f-99d8-e5539d43b636 TCGA-18-3417-01 TCGA-18-3417-01A-01D-1439-01 TCGA-18-3417-01A-01D-1440-05 +TCGA-18-3417-11 TCGA-18-3417-11 C2-Squamous-like mutation cluster 6 TCGA-18-3417 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 65 R-Upper TCGA-18-3417-F67643 TCGA-18-3417 TCGA-18-3417-11A -24019 1097 0 758 Scheduled Follow-up Submission 2014-11-7 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.9 8070/3 C34.9 YES 0.5 NO 0.5 NO 25 No M1 N1 T2 Stage IV 3417 TUMOR FREE Complete Remission/Response NO R0 Solid Tissue Normal 11 0.5 1989 YES NO YES 18 3 Lung A DECEASED 2006 1963 TCGA-18-3417-11A-01D-1440-05 +TCGA-18-3419-01 TCGA-18-3419-01 Squamous C2-Squamous-like cluster 2 Cluster 13 (HNSC-LUSC) squamous-like c4 miRNA cluster 11 cluster 1 mutation cluster 13 TCGA-18-3419 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 73 L-Lower TCGA-18-3419-F68328 TCGA-18-3419 TCGA-18-3419-01A -26813 0 2811 Scheduled Follow-up Submission 2014-11-14 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.6 NO 0.9 NO NO 50 No M0 N1 T2 Stage IIB TCGA-18-3419.be697b2e-96c7-401c-935b-5046a939f6af.pdf 3419 TUMOR FREE Complete Remission/Response R0 Primary Tumor 01 0.2 2002 NO YES 18 4 Lung A LIVING 2007 TCGA-18-3419-01A-01D-0983-08 TCGA-18-3419-01A-01D-0979-05 74c7652b-fa92-4fda-b52c-1b122d5a6462 TCGA-18-3419-01 TCGA-18-3419-01A-01D-0983-08 TCGA-18-3419-01 TCGA-18-3419-01A-01R-0980-07 74c7652b-fa92-4fda-b52c-1b122d5a6462 387ddf32-77f0-4449-812b-2e42f61a2377 TCGA-18-3419-01 TCGA-18-3419-01A-01D-0978-01 TCGA-18-3419-01 74c7652b-fa92-4fda-b52c-1b122d5a6462 TCGA-18-3419-01 74c7652b-fa92-4fda-b52c-1b122d5a6462 TCGA-18-3419-01 TCGA-18-3419-01A-01D-0978-01 +TCGA-18-3419-11 TCGA-18-3419-11 C2-Squamous-like mutation cluster 13 TCGA-18-3419 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 73 L-Lower TCGA-18-3419-F68328 TCGA-18-3419 TCGA-18-3419-11A -26813 0 2811 Scheduled Follow-up Submission 2014-11-14 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.3 NO 0.4 NO NO 50 No M0 N1 T2 Stage IIB 3419 TUMOR FREE Complete Remission/Response R0 Solid Tissue Normal 11 0.1 2002 NO YES 18 4 Lung A LIVING 2007 TCGA-18-3419-11A-01D-0979-05 +TCGA-18-3421-01 TCGA-18-3421-01 High C2-Squamous-like cluster 2 Cluster 14 (HNSC) squamous-like c4 miRNA cluster 4 cluster 4 mutation cluster 13 TCGA-18-3421 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 65 R-Lower TCGA-18-3421-F67656 TCGA-18-3421 -23972 0 2645 Scheduled Follow-up Submission Complete Remission/Response 2014-11-7 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES NO NO 40 No M0 N0 T2 Stage IB 3421 TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 2007 NO NO YES 18 4 Lung LIVING 2007 TCGA-18-3421-01A-01D-0983-08 TCGA-18-3421-01A-01D-0979-05 d0819fd7-9468-4da3-aade-ccf24cf3989d TCGA-18-3421-01 TCGA-18-3421-01A-01D-0983-08 TCGA-18-3421-01 TCGA-18-3421-01A-01R-0980-07 d0819fd7-9468-4da3-aade-ccf24cf3989d d4d54794-2f9c-415b-85bb-28ededb2f1ef TCGA-18-3421-01 TCGA-18-3421-01A-01D-0978-01 TCGA-18-3421-01 d0819fd7-9468-4da3-aade-ccf24cf3989d TCGA-18-3421-01 d0819fd7-9468-4da3-aade-ccf24cf3989d TCGA-18-3421-01 TCGA-18-3421-01A-01D-0978-01 +TCGA-18-3421-11 TCGA-18-3421-11 C2-Squamous-like mutation cluster 13 TCGA-18-3421 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 65 R-Lower TCGA-18-3421-F67656 TCGA-18-3421 TCGA-18-3421-11A -23972 0 2645 Scheduled Follow-up Submission Complete Remission/Response 2014-11-7 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.5 NO 1 NO NO 40 No M0 N0 T2 Stage IB 3421 TUMOR FREE Complete Remission/Response NO R0 Solid Tissue Normal 11 0.3 2007 NO NO YES 18 4 Lung A LIVING 2007 TCGA-18-3421-11A-01D-0979-05 +TCGA-18-4083-01 TCGA-18-4083-01 Squamous C2-Squamous-like cluster 2 Cluster 13 (HNSC-LUSC) squamous-like c4 mutation cluster 5 TCGA-18-4083 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 63 L-Lower TCGA-18-4083-F69111 TCGA-18-4083 TCGA-18-4083-01A -23125 188 0 Scheduled Follow-up Submission 2014-12-29 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.4 NO 0 0.5 NO 45 Yes M0 N1 T2 Stage IIB TCGA-18-4083.17a6525d-91d1-4cf5-b718-ea4c5e133a64.pdf 4083 TUMOR FREE NO R0 Primary Tumor 01 0.3 YES NO YES 18 2 Lung A DECEASED 2005 TCGA-18-4083-01A-01D-1352-08 TCGA-18-4083-01A-01D-1096-05 984b427f-6831-4ce5-8135-d25c0a2e62d2 TCGA-18-4083-01A-01D-1352-08 TCGA-18-4083-01 TCGA-18-4083-01A-01R-1100-07 984b427f-6831-4ce5-8135-d25c0a2e62d2 8316f2f9-440f-4bcd-a2bc-3e0103dbb423 TCGA-18-4083-01 TCGA-18-4083-01A-01D-1097-01 TCGA-18-4083-01 984b427f-6831-4ce5-8135-d25c0a2e62d2 TCGA-18-4083-01 984b427f-6831-4ce5-8135-d25c0a2e62d2 TCGA-18-4083-01A-01D-1097-01 +TCGA-18-4086-01 TCGA-18-4086-01 Squamous C2-Squamous-like cluster 4 Cluster 5 squamous-like c4 miRNA cluster 7 cluster 2 mutation cluster 5 TCGA-18-4086 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 64 R-Lower TCGA-18-4086 TCGA-18-4086-01A -23731 85 0 2011-4-4 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.5 NO 0.8 30 No M0 N0 T2 Stage IB TCGA-18-4086.f83c1343-f2dc-4602-a34c-3a259edfb343.pdf 4086 TUMOR FREE R0 Primary Tumor 01 0.3 2001 NO YES 18 4 Lung A DECEASED 2009 TCGA-18-4086-01A-01D-1352-08 TCGA-18-4086-01A-01D-1096-05 95eea5e6-b72a-4dc6-a285-1c79bcf99465 TCGA-18-4086-01 TCGA-18-4086-01A-01D-1352-08 TCGA-18-4086-01 TCGA-18-4086-01A-01R-1100-07 95eea5e6-b72a-4dc6-a285-1c79bcf99465 7fb85aa6-6c05-4f02-b68d-52084e2a304c TCGA-18-4086-01 TCGA-18-4086-01A-01D-1097-01 TCGA-18-4086-01 95eea5e6-b72a-4dc6-a285-1c79bcf99465 TCGA-18-4086-01 95eea5e6-b72a-4dc6-a285-1c79bcf99465 TCGA-18-4086-01 TCGA-18-4086-01A-01D-1097-01 +TCGA-18-4721-01 TCGA-18-4721-01 Squamous C2-Squamous-like cluster 3 Cluster 13 (HNSC-LUSC) squamous c3 squamous-like c4 miRNA cluster 7 cluster 2 mutation c1uster 9 TCGA-18-4721 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 74 L-Lower TCGA-18-4721-F68325 TCGA-18-4721 TCGA-18-4721-01A -27076 0 4694 Scheduled Follow-up Submission 2014-11-14 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.8 NO 1 NO No M0 N0 T1 Stage IA TCGA-18-4721.107fcb94-0216-4e11-90e0-31f2bdc044fb.pdf 4721 TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 0.3 2001 NO NO YES 18 4 Lung A LIVING 2002 TCGA-18-4721-01A-01D-1441-08 7bd328df-04eb-4500-b52e-59c8dba766a3 TCGA-18-4721-01 TCGA-18-4721-01A-01D-1441-08 TCGA-18-4721-01 7bd328df-04eb-4500-b52e-59c8dba766a3 TCGA-18-4721-01A-21-2193-20 TCGA-18-4721-01 TCGA-18-4721-01A-01D-1439-01 7bd328df-04eb-4500-b52e-59c8dba766a3 7bd328df-04eb-4500-b52e-59c8dba766a3 TCGA-18-4721-01 TCGA-18-4721-01A-01D-1439-01 TCGA-18-4721-01A-01D-1440-05 980eebae-fe8b-4121-8744-92b2448cb72b +TCGA-18-4721-11 TCGA-18-4721-11 C2-Squamous-like mutation c1uster 9 TCGA-18-4721 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 74 L-Lower TCGA-18-4721-F68325 TCGA-18-4721 TCGA-18-4721-11A -27076 0 4694 Scheduled Follow-up Submission 2014-11-14 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.4 NO 1 NO No M0 N0 T1 Stage IA 4721 TUMOR FREE Complete Remission/Response NO R0 Solid Tissue Normal 11 0.4 2001 NO NO YES 18 4 Lung A LIVING 2002 TCGA-18-4721-11A-01D-1440-05 +TCGA-18-5592-01 TCGA-18-5592-01 Squamous C2-Squamous-like cluster 3 Cluster 13 (HNSC-LUSC) squamous c3 squamous-like c4 mutation cluster 2 TCGA-18-5592 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 57 L-Upper TCGA-18-5592-F68323 TCGA-18-5592 -21020 0 1519 Scheduled Follow-up Submission 2014-11-14 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES NO 40 No M0 N0 T3 Stage IIB 5592 TUMOR FREE YES R0 Primary Tumor 01 YES NO YES 18 3 Lung LIVING 2010 TCGA-18-5592-01A-01D-1632-08 b1300b0f-5051-4e52-b1ff-5291f6653f0b TCGA-18-5592-01 TCGA-18-5592-01A-01D-1632-08 TCGA-18-5592-01 TCGA-18-5592-01 b1300b0f-5051-4e52-b1ff-5291f6653f0b TCGA-18-5592-01A-21-2194-20 TCGA-18-5592-01 TCGA-18-5592-01A-01D-1631-01 b1300b0f-5051-4e52-b1ff-5291f6653f0b b1300b0f-5051-4e52-b1ff-5291f6653f0b TCGA-18-5592-01A-01D-1631-01 TCGA-18-5592-01A-01D-1633-05 faeb872c-4711-4218-a772-c660855358f7 +TCGA-18-5592-11 TCGA-18-5592-11 C2-Squamous-like mutation cluster 2 TCGA-18-5592 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 57 L-Upper TCGA-18-5592-F68323 TCGA-18-5592 TCGA-18-5592-11A -21020 0 1519 Scheduled Follow-up Submission 2014-11-14 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.6 NO 0.6 NO 40 No M0 N0 T3 Stage IIB 5592 TUMOR FREE YES R0 Solid Tissue Normal 11 0.3 YES NO YES 18 3 Lung A LIVING 2010 TCGA-18-5592-11A-11D-1633-05 +TCGA-18-5595-01 TCGA-18-5595-01 Kirc+ C2-Squamous-like cluster 3 Cluster 14 (HNSC) squamous c3 squamous-like c4 mutation cluster 4 TCGA-18-5595 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 50 R-Lower TCGA-18-5595 -18611 827 0 2011-4-27 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES Yes M0 N0 T2 Stage IB 5595 R0 Primary Tumor 01 NO YES 18 1 Lung DECEASED 2008 TCGA-18-5595-01A-01D-1632-08 aace0b09-d6bd-4ebd-a694-c838e8724bd3 TCGA-18-5595-01A-01D-1632-08 TCGA-18-5595-01 aace0b09-d6bd-4ebd-a694-c838e8724bd3 TCGA-18-5595-01A-21-2194-20 TCGA-18-5595-01 TCGA-18-5595-01A-01D-1631-01 aace0b09-d6bd-4ebd-a694-c838e8724bd3 aace0b09-d6bd-4ebd-a694-c838e8724bd3 TCGA-18-5595-01A-01D-1631-01 TCGA-18-5595-01A-01D-1633-05 cf74338e-67f3-4979-a898-8a8c20bc9485 +TCGA-18-5595-11 TCGA-18-5595-11 C2-Squamous-like mutation cluster 4 TCGA-18-5595 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 50 R-Lower TCGA-18-5595 TCGA-18-5595-11A -18611 827 0 2011-4-27 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.5 NO 0.6 Yes M0 N0 T2 Stage IB 5595 R0 Solid Tissue Normal 11 0.3 NO YES 18 1 Lung A DECEASED 2008 TCGA-18-5595-11A-01D-1633-05 +TCGA-21-1070-01 TCGA-21-1070-01 High C2-Squamous-like cluster 1 Low purity c2 squamous c3 squamous-like c4 mutation c1uster 9 TCGA-21-1070 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung NO NO NO NO 60 L-Upper TCGA-21-1070-F4163 TCGA-21-1070 TCGA-21-1070-01A -22273 0 3636 2010-2-24 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 1 NO 1.2 NO 15 Yes M0 N0 T3 Stage IIIA TCGA-21-1070.32e48ff2-1c64-46c0-a1ff-eb77f4ad21b5.pdf 1070 TUMOR FREE NO R0 Primary Tumor 01 0.8 1992 NO NO YES 21 4 Lung A LIVING 2000 TCGA-21-1070-01A-01D-1521-08 TCGA-21-1070-01A-01D-0689-05 3a86e548-34d7-4677-9265-8ddd0e4ca4da TCGA-21-1070-01A-01D-1521-08 TCGA-21-1070-01 TCGA-21-1070-01A-01R-0692-07 3a86e548-34d7-4677-9265-8ddd0e4ca4da 1fd18179-22cc-4c21-b961-84e56acd54c9 TCGA-21-1070-01A-21-2193-20 TCGA-21-1070-01 TCGA-21-1070-01A-01D-0685-01 TCGA-21-1070-01 3a86e548-34d7-4677-9265-8ddd0e4ca4da TCGA-21-1070-01 3a86e548-34d7-4677-9265-8ddd0e4ca4da TCGA-21-1070-01A-01D-0685-01 c31cbb43-8115-476d-94eb-969f05a749ce +TCGA-21-1071-01 TCGA-21-1071-01 Squamous C2-Squamous-like cluster 1 Cluster 13 (HNSC-LUSC) squamous c3 squamous-like c4 mutation cluster 4 TCGA-21-1071 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung YES YES NO NO 67 R-Upper TCGA-21-1071-F4146 TCGA-21-1071 TCGA-21-1071-01A -24515 1426 0 1426 993 2010-2-23 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 1 NO 1.2 YES 90 No M0 N0 T2 Stage IB TCGA-21-1071.7e0fc9aa-af71-4605-a396-3edf6b1870f4.pdf 1071 WITH TUMOR NO R0 Primary Tumor 01 0.3 NO NO YES 21 2 Lung A DECEASED 2001 TCGA-21-1071-01A-01D-1521-08 TCGA-21-1071-01A-01D-0689-05 6b56c843-4716-4118-8312-c86c3218d02a TCGA-21-1071-01A-01D-1521-08 TCGA-21-1071-01 TCGA-21-1071-01A-01R-0692-07 6b56c843-4716-4118-8312-c86c3218d02a 85378206-6779-49f7-9188-8d800ce4ce04 TCGA-21-1071-01A-21-2193-20 TCGA-21-1071-01 TCGA-21-1071-01A-01D-0685-01 TCGA-21-1071-01 6b56c843-4716-4118-8312-c86c3218d02a TCGA-21-1071-01 6b56c843-4716-4118-8312-c86c3218d02a TCGA-21-1071-01A-01D-0685-01 d9fa8294-49b1-4474-bbfb-ffdf6d807382 +TCGA-21-1072-01 TCGA-21-1072-01 Squamous C2-Squamous-like BRCA CIMP c7 squamous c3 squamous-like c4 miRNA cluster 4 TCGA-21-1072 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 75 R-Upper TCGA-21-1072-F4150 TCGA-21-1072 TCGA-21-1072-01A -27397 0 3016 2010-2-23 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.9 8070/3 C34.9 YES 1.3 NO 1.6 NO No M0 N0 T2 Stage IB TCGA-21-1072.f035b8f2-1c3e-49b4-8ff5-101af46db322.pdf 1072 TUMOR FREE NO R0 Primary Tumor 01 0.4 NO NO YES 21 3 Lung A LIVING 2001 TCGA-21-1072-01A-01D-0689-05 adf7cabd-e763-4adf-923f-9f47fa86ea7a TCGA-21-1072-01 TCGA-21-1072-01 TCGA-21-1072-01A-01R-0692-07 adf7cabd-e763-4adf-923f-9f47fa86ea7a TCGA-21-1072-01A-21-2193-20 TCGA-21-1072-01 TCGA-21-1072-01A-01D-0685-01 TCGA-21-1072-01 adf7cabd-e763-4adf-923f-9f47fa86ea7a TCGA-21-1072-01 adf7cabd-e763-4adf-923f-9f47fa86ea7a TCGA-21-1072-01 TCGA-21-1072-01A-01D-0685-01 7ba5ebaa-df07-4f54-8721-67523cfddc60 +TCGA-21-1075-01 TCGA-21-1075-01 Squamous C2-Squamous-like Cluster 13 (HNSC-LUSC) squamous c3 squamous-like c4 miRNA cluster 12 TCGA-21-1075 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung NO NO NO NO 57 L-Lower TCGA-21-1075-F4151 TCGA-21-1075 TCGA-21-1075-01A -21093 0 2134 2010-3-3 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.8 NO 1 NO 74 No M0 N1 T2 Stage IIB TCGA-21-1075.8b3a07b0-b34e-4d70-b8be-7bb6bb30395a.pdf 1075 TUMOR FREE NO R0 Primary Tumor 01 0.8 NO NO YES 21 2 Lung A LIVING 2002 TCGA-21-1075-01A-01D-0689-05 76ad7c60-3911-478f-bb99-2161769fa380 TCGA-21-1075-01 TCGA-21-1075-01 TCGA-21-1075-01A-01R-0692-07 76ad7c60-3911-478f-bb99-2161769fa380 cf455c1a-1f5f-44ec-b8c7-7da181831939 TCGA-21-1075-01A-21-2193-20 TCGA-21-1075-01 TCGA-21-1075-01A-01D-0685-01 TCGA-21-1075-01 76ad7c60-3911-478f-bb99-2161769fa380 TCGA-21-1075-01 76ad7c60-3911-478f-bb99-2161769fa380 TCGA-21-1075-01 TCGA-21-1075-01A-01D-0685-01 11303d09-57ac-4b08-a3a4-efddc42857a3 +TCGA-21-1076-01 TCGA-21-1076-01 BRCA-LUAD+ C2-Squamous-like cluster 1 Cluster 5 squamous c3 squamous-like c4 miRNA cluster 11 cluster 2 mutation cluster 2 TCGA-21-1076 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung NO NO NO NO 54 L-Lower TCGA-21-1076-F4153 TCGA-21-1076 TCGA-21-1076-01A -19863 0 1852 1575 2010-3-3 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.8 NO 1 YES 35 No M0 N0 T2 Stage IB TCGA-21-1076.990cc93f-4af3-4af5-8cd7-0bb81133e1be.pdf 1076 TUMOR FREE NO R0 Primary Tumor 01 0.6 1994 NO NO YES 21 4 Lung A LIVING 2005 TCGA-21-1076-01A-02D-1521-08 TCGA-21-1076-01A-01D-0689-05,TCGA-21-1076-01A-02D-0689-05 db2c54e8-2023-49de-a116-7bec77297dee,0e4155e3-ff27-48f0-bc7d-c63b7c93d199 TCGA-21-1076-01 TCGA-21-1076-01A-02D-1521-08 TCGA-21-1076-01 TCGA-21-1076-01A-02R-0692-07,TCGA-21-1076-01A-01R-0692-07 db2c54e8-2023-49de-a116-7bec77297dee,0e4155e3-ff27-48f0-bc7d-c63b7c93d199 cc27ae96-52c5-452a-9028-6c8df7f2eb19,ac1890f5-90f6-4580-a5e1-76bd73d562bf TCGA-21-1076-01A-41-2193-20 TCGA-21-1076-01 TCGA-21-1076-01A-02D-0685-01 TCGA-21-1076-01 db2c54e8-2023-49de-a116-7bec77297dee,0e4155e3-ff27-48f0-bc7d-c63b7c93d199 TCGA-21-1076-01 db2c54e8-2023-49de-a116-7bec77297dee,0e4155e3-ff27-48f0-bc7d-c63b7c93d199 TCGA-21-1076-01 TCGA-21-1076-01A-02D-0685-01 865ca095-4591-4ca4-8237-a31e6481ccca +TCGA-21-1077-01 TCGA-21-1077-01 High C2-Squamous-like cluster 1 Cluster 13 (HNSC-LUSC) squamous-like c4 miRNA cluster 7 cluster 2 mutation cluster 12 TCGA-21-1077 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung NO NO NO NO 64 R-Upper TCGA-21-1077-F4164 TCGA-21-1077 -23523 1058 0 1058 644 2010-3-3 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES YES 56 Yes M0 N1 T2 Stage IIB 1077 WITH TUMOR NO R0 Primary Tumor 01 1996 NO NO YES 21 4 Lung DECEASED 2006 TCGA-21-1077-01A-01D-1521-08 TCGA-21-1077-01A-01D-0689-05 a80c9de4-3d81-4b05-a26a-285e9bbbfafa TCGA-21-1077-01A-01D-1521-08 TCGA-21-1077-01 TCGA-21-1077-01A-01R-0692-07 a80c9de4-3d81-4b05-a26a-285e9bbbfafa dae29089-610f-4e5e-bbe9-1443350b5c6d TCGA-21-1077-01 TCGA-21-1077-01A-01D-0685-01 TCGA-21-1077-01 a80c9de4-3d81-4b05-a26a-285e9bbbfafa TCGA-21-1077-01 a80c9de4-3d81-4b05-a26a-285e9bbbfafa TCGA-21-1077-01A-01D-0685-01 +TCGA-21-1078-01 TCGA-21-1078-01 COAD-READ C8-BLCA cluster 4 Cluster 5 squamous c3 BLCA nonsquamous-like c1 miRNA cluster 11 cluster 1 mutation cluster 1 TCGA-21-1078 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung NO NO NO NO 77 R-Lower TCGA-21-1078-F4165 TCGA-21-1078 TCGA-21-1078-01A -28125 474 0 469 257 2010-5-4 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 1 NO 2 YES 9 Yes M0 N0 T2 Stage IB TCGA-21-1078.8366df03-5b00-4476-9fd2-3bf80d53dc6e.pdf 1078 WITH TUMOR NO R0 Primary Tumor 01 0.8 2006 NO NO YES 21 4 Lung A DECEASED 2006 1947 TCGA-21-1078-01A-01D-1521-08 TCGA-21-1078-01A-01D-0689-05 320810be-bd11-40c7-9eee-7496f7564599 TCGA-21-1078-01A-01D-1521-08 TCGA-21-1078-01 TCGA-21-1078-01A-01R-0692-07 320810be-bd11-40c7-9eee-7496f7564599 926e9f69-a7ea-4e48-aef4-33d69f28a249 TCGA-21-1078-01A-21-2193-20 TCGA-21-1078-01 TCGA-21-1078-01A-01D-0685-01 TCGA-21-1078-01 320810be-bd11-40c7-9eee-7496f7564599 TCGA-21-1078-01 320810be-bd11-40c7-9eee-7496f7564599 TCGA-21-1078-01A-01D-0685-01 7c470e40-177f-45c5-96bc-e826294882c5 +TCGA-21-1079-01 TCGA-21-1079-01 Squamous C2-Squamous-like Cluster 14 (HNSC) squamous c3 squamous-like c4 miRNA cluster 4 TCGA-21-1079 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung NO NO NO NO 71 L-Upper TCGA-21-1079-F4154 TCGA-21-1079 TCGA-21-1079-01A -26176 965 0 965 317 2010-2-23 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 1 NO 2 YES 80 No M0 N0 T3 Stage IIIA TCGA-21-1079.ddcba444-a2bd-48cc-a035-553126bca0c6.pdf 1079 WITH TUMOR NO R0 Primary Tumor 01 0.8 1980 NO NO YES 21 3 Lung A DECEASED 1995 TCGA-21-1079-01A-01D-0689-05 f66b0cd6-fc69-4d6e-8c07-e5dc10c6628b TCGA-21-1079-01 TCGA-21-1079-01 TCGA-21-1079-01A-01R-0692-07 f66b0cd6-fc69-4d6e-8c07-e5dc10c6628b 7e84bb06-38a1-435c-9323-fd7c7ce0db8a TCGA-21-1079-01A-21-2193-20 TCGA-21-1079-01 TCGA-21-1079-01A-01D-0685-01 TCGA-21-1079-01 f66b0cd6-fc69-4d6e-8c07-e5dc10c6628b TCGA-21-1079-01 f66b0cd6-fc69-4d6e-8c07-e5dc10c6628b TCGA-21-1079-01 TCGA-21-1079-01A-01D-0685-01 9af4adc0-d07e-4e5d-a656-cfb61bfa2c82 +TCGA-21-1080-01 TCGA-21-1080-01 Squamous C2-Squamous-like Cluster 13 (HNSC-LUSC) squamous c3 squamous-like c4 miRNA cluster 4 TCGA-21-1080 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung NO NO NO NO 66 L-Lower TCGA-21-1080-F4157 TCGA-21-1080 TCGA-21-1080-01A -24253 0 3724 2010-2-23 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 1 NO 2 NO 100 No M0 N0 T2 Stage IB TCGA-21-1080.c5e7cfa9-2ee0-455f-80d2-e5ecc721d1ec.pdf 1080 TUMOR FREE NO R0 Primary Tumor 01 0.4 1991 NO NO YES 21 4 Lung A LIVING 1996 TCGA-21-1080-01A-01D-0689-05 263780bc-cbb0-426e-9c0c-cef110a83b51 TCGA-21-1080-01 TCGA-21-1080-01 TCGA-21-1080-01A-01R-0692-07 263780bc-cbb0-426e-9c0c-cef110a83b51 c621a9a0-16f7-4d33-ac38-0df8d8a4bee2 TCGA-21-1080-01A-21-2193-20 TCGA-21-1080-01 TCGA-21-1080-01A-01D-0685-01 TCGA-21-1080-01 263780bc-cbb0-426e-9c0c-cef110a83b51 TCGA-21-1080-01 263780bc-cbb0-426e-9c0c-cef110a83b51 TCGA-21-1080-01 TCGA-21-1080-01A-01D-0685-01 19c9ff90-4114-44a5-97be-310997f17334 +TCGA-21-1081-01 TCGA-21-1081-01 High C2-Squamous-like cluster 4 Cluster 5 squamous c3 squamous-like c4 mutation c1uster 9 TCGA-21-1081 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung NO NO NO NO 69 L-Lower TCGA-21-1081-F4160 TCGA-21-1081 TCGA-21-1081-01A -25440 284 0 284 2010-2-12 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 1.5 NO 0 2.2 NO 45 No M0 N1 T2 Stage IIB TCGA-21-1081.b7eb9e52-9c41-4398-9cfb-7832a6183258.pdf 1081 WITH TUMOR YES R0 Primary Tumor 01 0.8 1992 NO NO YES 21 4 Lung A DECEASED 1996 TCGA-21-1081-01A-01D-1521-08 TCGA-21-1081-01A-01D-0689-05 89aaa481-724a-44d3-a4f2-d1a058563b03 TCGA-21-1081-01A-01D-1521-08 TCGA-21-1081-01 TCGA-21-1081-01A-01R-0692-07 89aaa481-724a-44d3-a4f2-d1a058563b03 e33e6106-8e4a-4f7e-a5e3-9bcf3c76d506 TCGA-21-1081-01A-21-2193-20 TCGA-21-1081-01 TCGA-21-1081-01A-01D-0685-01 TCGA-21-1081-01 89aaa481-724a-44d3-a4f2-d1a058563b03 TCGA-21-1081-01 89aaa481-724a-44d3-a4f2-d1a058563b03 TCGA-21-1081-01A-01D-0685-01 2d90e6b8-02bf-4665-9803-285243e1ba55 +TCGA-21-1082-01 TCGA-21-1082-01 Squamous C2-Squamous-like Cluster 5 squamous c3 squamous-like c4 TCGA-21-1082 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung NO NO NO NO 61 L-Lower TCGA-21-1082-F4161 TCGA-21-1082 TCGA-21-1082-01A -22492 0 3644 2010-2-12 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 1 NO 1.3 NO No M0 N0 T2 Stage IB TCGA-21-1082.c5b2ca19-e38d-41f2-9530-65a610990954.pdf 1082 TUMOR FREE NO R0 Primary Tumor 01 0.3 NO NO YES 21 Lung A LIVING 1997 TCGA-21-1082-01A-01D-0689-05 fca05afb-d892-431c-a19a-e0c8c6e283eb TCGA-21-1082-01 TCGA-21-1082-01A-01R-0692-07 fca05afb-d892-431c-a19a-e0c8c6e283eb 1e884643-3dcc-4369-8050-9e6f73b7144e TCGA-21-1082-01A-21-2193-20 TCGA-21-1082-01 TCGA-21-1082-01A-01D-0685-01 TCGA-21-1082-01 fca05afb-d892-431c-a19a-e0c8c6e283eb TCGA-21-1082-01 fca05afb-d892-431c-a19a-e0c8c6e283eb TCGA-21-1082-01A-01D-0685-01 cc44dbbd-5a78-4440-82b5-a2c2d6ef4d7c +TCGA-21-1083-01 TCGA-21-1083-01 High C1-LUAD-enriched OV-like c1 squamous c3 RNA cluster 12 miRNA cluster 4 TCGA-21-1083 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung NO NO NO NO 75 L-Upper TCGA-21-1083-F4166 TCGA-21-1083 TCGA-21-1083-01A -27708 1315 0 267 2010-2-12 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.8 NO 1.5 NO 240 Yes M0 N0 T1 Stage IA TCGA-21-1083.568a237a-00c3-4160-a471-3ed3623ca233.pdf 1083 TUMOR FREE NO R0 Primary Tumor 01 0.6 NO NO YES 21 2 Lung A DECEASED 1997 TCGA-21-1083-01A-01D-0689-05 86452157-2294-4029-a61d-6702a7889b7e TCGA-21-1083-01 TCGA-21-1083-01A-01R-0692-07 86452157-2294-4029-a61d-6702a7889b7e b6597134-ebb9-4f77-b3c2-e80281e408d3 TCGA-21-1083-01A-21-2193-20 TCGA-21-1083-01 TCGA-21-1083-01A-01D-0685-01 TCGA-21-1083-01 86452157-2294-4029-a61d-6702a7889b7e TCGA-21-1083-01 86452157-2294-4029-a61d-6702a7889b7e TCGA-21-1083-01A-01D-0685-01 3e8610c1-5e34-4ea1-ad30-37225b06e71a +TCGA-21-5782-01 TCGA-21-5782-01 Squamous C2-Squamous-like cluster 4 Cluster 5 squamous c3 squamous-like c4 cluster 2 mutation cluster 11 TCGA-21-5782 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 68 L-Lower TCGA-21-5782-F11448 TCGA-21-5782 TCGA-21-5782-01A -24969 962 0 962 2011-5-2 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.9 NO 0 1.3 NO 48 No M0 N0 T2 Stage IB TCGA-21-5782.644e67c4-61cd-40f8-b2cb-287b8a868eb4.pdf 5782 Complete Remission/Response NO R0 Primary Tumor 01 0.3 2004 NO NO YES 21 4 Lung A DECEASED 2004 1953 TCGA-21-5782-01A-01D-1632-08 6ccc37a2-f073-4050-bfcd-de106d86236b TCGA-21-5782-01 TCGA-21-5782-01A-01D-1632-08 TCGA-21-5782-01 TCGA-21-5782-01 6ccc37a2-f073-4050-bfcd-de106d86236b TCGA-21-5782-01A-21-2194-20 TCGA-21-5782-01 TCGA-21-5782-01A-01D-1631-01 6ccc37a2-f073-4050-bfcd-de106d86236b 6ccc37a2-f073-4050-bfcd-de106d86236b TCGA-21-5782-01A-01D-1631-01 TCGA-21-5782-01A-01D-1633-05 5ad0c478-996f-4211-a829-ff7b0fec72d2 +TCGA-21-5783-01 TCGA-21-5783-01 Squamous Cluster 5 squamous-like c4 miRNA cluster 4 TCGA-21-5783 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 76 L-Upper TCGA-21-5783-F30661 TCGA-21-5783 TCGA-21-5783-01A -27904 2680 0 NO NO Scheduled Follow-up Submission 2012-3-12 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 1 NO 0 NO Peripheral Lung 1 No M0 N0 T2 Stage IB TCGA-21-5783.83eb92fc-a1f0-4fea-a7c4-3254e98735af.pdf 5783 83 YES NO R0 Primary Tumor 01 0.4 1974 6th NO NO YES 21 3 Lung A DECEASED 2004 4220f308-b671-4bf8-bf9c-5884a66e9797 TCGA-21-5783-01 TCGA-21-5783-01 TCGA-21-5783-01 4220f308-b671-4bf8-bf9c-5884a66e9797 TCGA-21-5783-01 TCGA-21-5783-01A-41D-2183-01 4220f308-b671-4bf8-bf9c-5884a66e9797 4220f308-b671-4bf8-bf9c-5884a66e9797 TCGA-21-5783-01A-41D-2183-01 TCGA-21-5783-01A-41D-2185-05 +TCGA-21-5784-01 TCGA-21-5784-01 High C2-Squamous-like cluster 1 Cluster 5 squamous c3 squamous-like c4 miRNA cluster 7 cluster 2 mutation cluster 2 TCGA-21-5784 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung NO NO 80 R-Upper TCGA-21-5784-F31486 TCGA-21-5784 TCGA-21-5784-01A -29362 0 1268 69 Scheduled Follow-up Submission Complete Remission/Response 2012-5-3 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 1 NO Central Lung 1 NO 14 No M0 N0 T2 Stage IB TCGA-21-5784.5d154faf-bb6e-4237-80cf-9d02e2127adb.pdf 5784 TUMOR FREE 74 80 Complete Remission/Response YES NO R0 Primary Tumor 01 0.4 1978 6th NO NO YES 21 3 Lung A LIVING 2008 TCGA-21-5784-01A-01D-1632-08 c541f28a-299d-4c21-9329-4922e204e2ab TCGA-21-5784-01 TCGA-21-5784-01A-01D-1632-08 TCGA-21-5784-01 TCGA-21-5784-01 c541f28a-299d-4c21-9329-4922e204e2ab TCGA-21-5784-01A-21-2194-20 TCGA-21-5784-01 TCGA-21-5784-01A-01D-1631-01 c541f28a-299d-4c21-9329-4922e204e2ab c541f28a-299d-4c21-9329-4922e204e2ab TCGA-21-5784-01A-01D-1631-01 TCGA-21-5784-01A-01D-1633-05 29d0b45f-ad9b-49a7-af41-979364bc1728 +TCGA-21-5786-01 TCGA-21-5786-01 High C2-Squamous-like cluster 1 Cluster 5 squamous c3 squamous-like c4 miRNA cluster 7 cluster 2 mutation cluster 2 TCGA-21-5786 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung NO NO YES NO 64 R-Upper TCGA-21-5786-F31485 TCGA-21-5786 TCGA-21-5786-01A 838 -23649 0 1032 817 71 Additional New Tumor Event Complete Remission/Response 2012-5-3 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 1 NO Central Lung 1 Locoregional Recurrence YES 75 No M0 N0 T2 Stage IB TCGA-21-5786.7c63d47f-0a73-415c-b4e5-d5c70886709e.pdf 5786 TUMOR FREE 76 76 Complete Remission/Response YES NO R0 Primary Tumor 01 0.3 6th NO NO YES 21 2 Lung A LIVING 2009 1959 TCGA-21-5786-01A-01D-1632-08 b8bcd42e-f1bc-4c93-8dac-933d94d33a0d TCGA-21-5786-01 TCGA-21-5786-01A-01D-1632-08 TCGA-21-5786-01 TCGA-21-5786-01 b8bcd42e-f1bc-4c93-8dac-933d94d33a0d TCGA-21-5786-01A-21-2194-20 TCGA-21-5786-01 TCGA-21-5786-01A-01D-1631-01 b8bcd42e-f1bc-4c93-8dac-933d94d33a0d b8bcd42e-f1bc-4c93-8dac-933d94d33a0d TCGA-21-5786-01A-01D-1631-01 TCGA-21-5786-01A-01D-1633-05 98c3c72d-b20b-400d-a53e-8e7d24c3e79a +TCGA-21-5787-01 TCGA-21-5787-01 High C1-LUAD-enriched cluster 1 Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 11 cluster 3 mutation cluster 5 TCGA-21-5787 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung NO YES NO NO 65 L-Upper TCGA-21-5787-F11443 TCGA-21-5787 TCGA-21-5787-01A -24071 329 0 329 103 Progressive Disease 2011-5-3 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 1 NO 0 1.1 YES 100 No M0 N2 T2 Stage IIIA TCGA-21-5787.fe205444-57af-48ab-8e50-ea8c4a42eb07.pdf 5787 WITH TUMOR Progressive Disease YES R0 Primary Tumor 01 0.2 2009 NO NO YES 21 4 Lung A DECEASED 2009 1956 TCGA-21-5787-01A-01D-1632-08 b45df1ad-f756-4ec6-ae76-264dd51fae7e TCGA-21-5787-01 TCGA-21-5787-01A-01D-1632-08 TCGA-21-5787-01 TCGA-21-5787-01 b45df1ad-f756-4ec6-ae76-264dd51fae7e TCGA-21-5787-01A-21-2194-20 TCGA-21-5787-01 TCGA-21-5787-01A-01D-1631-01 b45df1ad-f756-4ec6-ae76-264dd51fae7e b45df1ad-f756-4ec6-ae76-264dd51fae7e TCGA-21-5787-01A-01D-1631-01 TCGA-21-5787-01A-01D-1633-05 37941bbd-aee2-4a9d-891a-a0aa0e8c7714 +TCGA-21-A5DI-01 TCGA-21-A5DI-01 TCGA-21-A5DI TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 77 R-Lower TCGA-21-A5DI-F66358 TCGA-21-A5DI TCGA-21-A5DI-01A -28374 2379 0 979 Scheduled Follow-up Submission 2014-10-13 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 220 NO YES NO true Yes, History of Prior Malignancy M0 N0 T1b Stage IA TCGA-21-A5DI.54DCDFE6-FF29-4549-ACB2-420165FF391B.pdf A5DI TUMOR FREE Complete Remission/Response NO NO R0 Primary Tumor 01 6th NO NO YES 21 3 Lung A LIVING 2006 3a7a9459-d88c-4d0b-b32f-1623deba6cea TCGA-21-A5DI-01 3a7a9459-d88c-4d0b-b32f-1623deba6cea TCGA-21-A5DI-01 TCGA-21-A5DI-01A-31D-A26L-01 3a7a9459-d88c-4d0b-b32f-1623deba6cea 3a7a9459-d88c-4d0b-b32f-1623deba6cea TCGA-21-A5DI-01A-31D-A26L-01 TCGA-21-A5DI-01A-31D-A26N-05 ECBB4C1B-45E2-44CD-A131-E19ACB40ACF4 +TCGA-22-0940-01 TCGA-22-0940-01 BRCA-LUAD+ C2-Squamous-like Cluster 13 (HNSC-LUSC) squamous c3 squamous-like c4 miRNA cluster 4 TCGA-22-0940 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung NO YES 71 L-Lower TCGA-22-0940-F4132 TCGA-22-0940 TCGA-22-0940-01A -26272 669 0 608 NO NO 2010-2-3 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.9 8070/3 C34.9 YES 0.8 NO NO Peripheral Lung 1 25 No M0 N1 T1 Stage IIA TCGA-22-0940.4F7F45DC-0B14-4B61-AB61-F07030604AE9.pdf 0940 WITH TUMOR NO R0 Primary Tumor 01 0.4 1972 NO NO YES 22 3 Lung A DECEASED 2000 1948 TCGA-22-0940-01A-01D-0689-05 c322339f-28e6-480d-8cc3-5d63b07e66d0 TCGA-22-0940-01 TCGA-22-0940-01 TCGA-22-0940-01A-01R-0692-07 c322339f-28e6-480d-8cc3-5d63b07e66d0 8d2e6c9f-e229-400d-b38b-9cbcfde9da0c TCGA-22-0940-01A-21-2193-20 TCGA-22-0940-01 TCGA-22-0940-01A-01D-0685-01 TCGA-22-0940-01 c322339f-28e6-480d-8cc3-5d63b07e66d0 TCGA-22-0940-01 c322339f-28e6-480d-8cc3-5d63b07e66d0 TCGA-22-0940-01 TCGA-22-0940-01A-01D-0685-01 3d8cb3f0-482e-4acd-bb89-e8530456cd3c +TCGA-22-0944-01 TCGA-22-0944-01 Squamous C2-Squamous-like cluster 4 Cluster 5 squamous-like c4 miRNA cluster 4 cluster 2 mutation cluster 13 TCGA-22-0944 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 61 L-Upper TCGA-22-0944-F4097 TCGA-22-0944 TCGA-22-0944-01A -22329 223 0 223 NO NO 2010-2-12 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.9 8070/3 C34.9 YES 0.6 NO NO 0.6 NO 38 No M0 N0 T2 Stage IB TCGA-22-0944.A4E962A1-69D2-4D46-977B-DCDE3E696772.pdf 0944 TUMOR FREE R0 Primary Tumor 01 0.2 NO YES 22 2 Lung A DECEASED 2000 1970 TCGA-22-0944-01A-01D-1521-08 TCGA-22-0944-01A-01D-0689-05 c806fc33-7a1d-44a8-b67b-7f74363c3f01 TCGA-22-0944-01 TCGA-22-0944-01A-01D-1521-08 TCGA-22-0944-01 TCGA-22-0944-01A-01R-0692-07 c806fc33-7a1d-44a8-b67b-7f74363c3f01 295977c6-ca95-4197-9131-17b24a940d3e TCGA-22-0944-01 TCGA-22-0944-01A-01D-0685-01 TCGA-22-0944-01 c806fc33-7a1d-44a8-b67b-7f74363c3f01 TCGA-22-0944-01 c806fc33-7a1d-44a8-b67b-7f74363c3f01 TCGA-22-0944-01 TCGA-22-0944-01A-01D-0685-01 +TCGA-22-1000-01 TCGA-22-1000-01 Kirc+ Low purity c2 squamous c3 TCGA-22-1000 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung NO YES 76 R-Lower TCGA-22-1000-F4167 TCGA-22-1000 TCGA-22-1000-01A -27901 454 0 263 NO NO 2010-2-12 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.9 8070/3 C34.9 YES 0.4 NO NO Central Lung 1 YES 40 Yes M0 N0 T2 Stage IB TCGA-22-1000.B57BD00D-1719-4DB1-9CFE-14CD5E63D561.pdf 1000 WITH TUMOR Complete Remission/Response NO R0 Primary Tumor 01 0.3 1990 7th NO NO YES 22 4 Lung A DECEASED 2000 1945 TCGA-22-1000-01A-01D-0689-05 62710cd0-82b4-4746-ad7c-b320d933a542 TCGA-22-1000-01 TCGA-22-1000-01A-01R-0692-07 62710cd0-82b4-4746-ad7c-b320d933a542 b2a8e3fe-e5ca-4d60-9d48-d8b358253160 TCGA-22-1000-01A-21-2193-20 TCGA-22-1000-01 TCGA-22-1000-01A-01D-0685-01 TCGA-22-1000-01 62710cd0-82b4-4746-ad7c-b320d933a542 TCGA-22-1000-01 62710cd0-82b4-4746-ad7c-b320d933a542 TCGA-22-1000-01A-01D-0685-01 10ac4555-d3e6-4d70-a6ca-2253c0e92de1 +TCGA-22-1002-01 TCGA-22-1002-01 Squamous C2-Squamous-like cluster 4 Cluster 5 squamous-like c4 mutation cluster 4 TCGA-22-1002 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 69 R-Middle TCGA-22-1002-F4135 TCGA-22-1002 TCGA-22-1002-01A -25359 131 0 131 NO NO 2010-5-12 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.9 8070/3 C34.9 YES 0.5 NO NO 0.8 NO 85 No M0 N0 T1 Stage IA TCGA-22-1002.D486319E-ED8A-4F0A-BAEC-219B56AAF33E.pdf 1002 TUMOR FREE NO R0 Primary Tumor 01 0.2 2001 NO NO YES 22 4 Lung A DECEASED 2001 1952 TCGA-22-1002-01A-01D-1521-08 TCGA-22-1002-01A-01D-0689-05 32fa734c-e551-45fb-818a-9452d0c6557e TCGA-22-1002-01A-01D-1521-08 TCGA-22-1002-01 TCGA-22-1002-01A-01R-0692-07 32fa734c-e551-45fb-818a-9452d0c6557e dd2267de-9496-4221-82ad-dee163350dbb TCGA-22-1002-01 TCGA-22-1002-01A-01D-0685-01 TCGA-22-1002-01 32fa734c-e551-45fb-818a-9452d0c6557e TCGA-22-1002-01 32fa734c-e551-45fb-818a-9452d0c6557e TCGA-22-1002-01A-01D-0685-01 +TCGA-22-1005-01 TCGA-22-1005-01 Kirc+ Low purity c2 TCGA-22-1005 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung NO NO 63 R-Upper TCGA-22-1005-F4137 TCGA-22-1005 -23322 1953 0 1953 NO NO 2010-2-12 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.9 8070/3 C34.9 YES NO NO 40 No M0 N0 T1 Stage IA 1005 TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 1997 NO YES NO 22 4 Lung DECEASED 2001 1952 TCGA-22-1005-01A-01D-0689-05 e049e194-d224-41cf-99b6-a4e7490674f9 TCGA-22-1005-01 TCGA-22-1005-01A-01R-0692-07 e049e194-d224-41cf-99b6-a4e7490674f9 b61a914f-c0bb-4f92-a1fc-ea879309ddc2 TCGA-22-1005-01 TCGA-22-1005-01A-01D-0685-01 TCGA-22-1005-01 e049e194-d224-41cf-99b6-a4e7490674f9 TCGA-22-1005-01 e049e194-d224-41cf-99b6-a4e7490674f9 TCGA-22-1005-01A-01D-0685-01 +TCGA-22-1011-01 TCGA-22-1011-01 Squamous C2-Squamous-like cluster 1 Low purity c2 squamous c3 squamous-like c4 miRNA cluster 7 cluster 2 mutation cluster 13 TCGA-22-1011 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung NO NO 73 R-Upper TCGA-22-1011-F4138 TCGA-22-1011 TCGA-22-1011-01A -26732 53 0 53 NO NO 2010-2-15 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.9 8070/3 C34.9 YES 0.4 NO NO 1 NO 83 No M0 N0 T2 Stage IB TCGA-22-1011.5B20E854-19A2-422A-8ED2-9339845AB6CE.pdf 1011 TUMOR FREE NO R0 Primary Tumor 01 0.4 NO NO YES 22 2 Lung A DECEASED 2001 1946 TCGA-22-1011-01A-01D-1521-08 TCGA-22-1011-01A-01D-0689-05 fe3a32fe-6338-43d3-b134-39fab3447f42 TCGA-22-1011-01 TCGA-22-1011-01A-01D-1521-08 TCGA-22-1011-01 TCGA-22-1011-01A-01R-0692-07 fe3a32fe-6338-43d3-b134-39fab3447f42 63b147dc-21b2-44c8-80a7-8ce6cf29bc24 TCGA-22-1011-01A-31-2193-20 TCGA-22-1011-01 TCGA-22-1011-01A-01D-0685-01 TCGA-22-1011-01 fe3a32fe-6338-43d3-b134-39fab3447f42 TCGA-22-1011-01 fe3a32fe-6338-43d3-b134-39fab3447f42 TCGA-22-1011-01 TCGA-22-1011-01A-01D-0685-01 fcc5d2fc-0775-4e47-9ded-959aba2b92f5 +TCGA-22-1012-01 TCGA-22-1012-01 Squamous C2-Squamous-like cluster 4 Cluster 5 squamous-like c4 miRNA cluster 11 cluster 2 mutation cluster 5 TCGA-22-1012 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 80 R-Lower TCGA-22-1012-F4141 TCGA-22-1012 TCGA-22-1012-01A -29273 429 0 NO NO 2010-2-15 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.9 8070/3 C34.9 YES 0.4 NO NO 0.6 NO 60 No M0 N0 T2 Stage IB TCGA-22-1012.442C89DF-A3F3-44DD-960E-F4B26281D9AE.pdf 1012 TUMOR FREE Complete Remission/Response R0 Primary Tumor 01 0.2 2001 NO YES 22 4 Lung A DECEASED 2001 1940 TCGA-22-1012-01A-01D-1521-08 TCGA-22-1012-01A-01D-0689-05 de4a60ba-a4a6-4ff8-8768-4c47e3926eb3 TCGA-22-1012-01 TCGA-22-1012-01A-01D-1521-08 TCGA-22-1012-01 TCGA-22-1012-01A-01R-0692-07 de4a60ba-a4a6-4ff8-8768-4c47e3926eb3 45ba473f-ec80-4b94-bed5-9a72eb75de39 TCGA-22-1012-01 TCGA-22-1012-01A-01D-0685-01 TCGA-22-1012-01 de4a60ba-a4a6-4ff8-8768-4c47e3926eb3 TCGA-22-1012-01 de4a60ba-a4a6-4ff8-8768-4c47e3926eb3 TCGA-22-1012-01 TCGA-22-1012-01A-01D-0685-01 +TCGA-22-1016-01 TCGA-22-1016-01 High C2-Squamous-like cluster 4 Cluster 5 squamous-like c4 mutation cluster 13 TCGA-22-1016 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung NO NO 65 R-Upper TCGA-22-1016-F4144 TCGA-22-1016 TCGA-22-1016-01A -24078 822 0 802 NO NO 2010-2-15 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.9 8070/3 C34.9 YES 0.6 NO NO 1 NO 40 No M0 N0 T2 Stage IB TCGA-22-1016.DDA12CCE-0C66-4E29-9B36-BC4E24CFEC7B.pdf 1016 TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 0.1 1984 NO NO YES 22 3 Lung A DECEASED 2001 1954 TCGA-22-1016-01A-01D-1521-08 TCGA-22-1016-01A-01D-0689-05 10e6a64d-2d89-444f-ad6f-d4fde86d8a8a TCGA-22-1016-01A-01D-1521-08 TCGA-22-1016-01 TCGA-22-1016-01A-01R-0692-07 10e6a64d-2d89-444f-ad6f-d4fde86d8a8a dd03b640-699c-428a-8b3c-fbe65eeffd11 TCGA-22-1016-01 TCGA-22-1016-01A-01D-0685-01 TCGA-22-1016-01 10e6a64d-2d89-444f-ad6f-d4fde86d8a8a TCGA-22-1016-01 10e6a64d-2d89-444f-ad6f-d4fde86d8a8a TCGA-22-1016-01A-01D-0685-01 +TCGA-22-1017-01 TCGA-22-1017-01 High Cluster 6 LUAD-like c10 TCGA-22-1017 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung YES YES NO YES 62 L-Upper TCGA-22-1017-F58939 TCGA-22-1017 1022 -22880 1485 0 904 60 1 NO NO Scheduled Follow-up Submission Progressive Disease 2014-4-29 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) Yes C34.9 8070/3 C34.9 YES 0 NO Central Lung NO Locoregional Recurrence|Distant Metastasis YES Yes M0 N0 T1 Stage IA 1017 Preoperative WITH TUMOR 68 75 61 58 Complete Remission/Response Convincing Imaging YES NO R0 Primary Tumor 01 1999 5th NO NO YES 22 4 Lung DECEASED 1999 1959 TCGA-22-1017-01A-01D-0689-05 cf12415f-4487-4e0d-9c9b-2239f7c83599 TCGA-22-1017-01 TCGA-22-1017-01A-01R-0692-07 cf12415f-4487-4e0d-9c9b-2239f7c83599 d5ce9381-4572-498a-91c2-4c12186c2bb6 TCGA-22-1017-01 TCGA-22-1017-01A-01D-0685-01 TCGA-22-1017-01 cf12415f-4487-4e0d-9c9b-2239f7c83599 TCGA-22-1017-01 cf12415f-4487-4e0d-9c9b-2239f7c83599 TCGA-22-1017-01A-01D-0685-01 +TCGA-22-4591-01 TCGA-22-4591-01 High C2-Squamous-like cluster 2 Cluster 5 squamous c3 squamous-like c4 miRNA cluster 12 cluster 3 mutation cluster 12 TCGA-22-4591 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung YES NO NO NO 80 R-Lower TCGA-22-4591-F5692 TCGA-22-4591 TCGA-22-4591-01A -29250 623 0 623 443 NO NO Progressive Disease 2010-11-29 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.9 NO 0 NO Peripheral Lung 1.1 YES No M0 N2 T3 Stage IIIA TCGA-22-4591.97a5b9f1-ac4b-4744-abd9-03ccf04d1892.pdf 4591 Other WITH TUMOR Partial Remission/Response NO R0 Primary Tumor 01 0.4 NO NO YES 22 2 Lung A DECEASED 2001 1933 TCGA-22-4591-01A-01D-1267-08 TCGA-22-4591-01A-01D-1198-05 4e2f417c-e1db-4d99-b999-d3aab967c244 TCGA-22-4591-01 TCGA-22-4591-01A-01D-1267-08 TCGA-22-4591-01 TCGA-22-4591-01A-01R-1201-07 4e2f417c-e1db-4d99-b999-d3aab967c244 19a357c0-e26d-49a9-9cee-a296f7d2d9c1 TCGA-22-4591-01A-21-2193-20 TCGA-22-4591-01 TCGA-22-4591-01A-01D-1195-01 TCGA-22-4591-01 4e2f417c-e1db-4d99-b999-d3aab967c244 TCGA-22-4591-01 4e2f417c-e1db-4d99-b999-d3aab967c244 TCGA-22-4591-01 TCGA-22-4591-01A-01D-1195-01 5be370a5-e710-4625-8781-43856b8e39af +TCGA-22-4593-01 TCGA-22-4593-01 BRCA-LUAD+ C2-Squamous-like cluster 2 Cluster 13 (HNSC-LUSC) squamous-like c4 miRNA cluster 4 cluster 4 mutation cluster 5 TCGA-22-4593 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 77 R-Lower TCGA-22-4593-F14642 TCGA-22-4593 TCGA-22-4593-01A -28385 1067 0 1067 NO NO Scheduled Follow-up Submission 2011-8-5 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.8 NO 0 NO Central Lung 0.8 NO 30 No M0 N0 T2b Stage IIA TCGA-22-4593.d20d26e3-da2c-4456-894d-6f08d62856ea.pdf 4593 TUMOR FREE NO R0 Primary Tumor 01 0.2 2002 7th NO NO YES 22 4 Lung A DECEASED 2002 1942 TCGA-22-4593-01A-21D-1817-08 88d40fcc-c30a-437f-b514-ef0a60f8836e TCGA-22-4593-01 TCGA-22-4593-01A-21D-1817-08 TCGA-22-4593-01 TCGA-22-4593-01 88d40fcc-c30a-437f-b514-ef0a60f8836e TCGA-22-4593-01 TCGA-22-4593-01A-21D-1816-01 88d40fcc-c30a-437f-b514-ef0a60f8836e 88d40fcc-c30a-437f-b514-ef0a60f8836e TCGA-22-4593-01A-21D-1816-01 TCGA-22-4593-01A-21D-1818-05 +TCGA-22-4593-11 TCGA-22-4593-11 C2-Squamous-like mutation cluster 5 TCGA-22-4593 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 77 R-Lower TCGA-22-4593-F14642 TCGA-22-4593 TCGA-22-4593-11A -28385 1067 0 1067 NO NO Scheduled Follow-up Submission 2011-8-5 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.7 NO 0 NO Central Lung 0.9 NO 30 No M0 N0 T2b Stage IIA 4593 TUMOR FREE NO R0 Solid Tissue Normal 11 0.2 2002 7th NO NO YES 22 4 Lung A DECEASED 2002 1942 731aca7f-57bb-438d-927b-1be5adcdcf0e 731aca7f-57bb-438d-927b-1be5adcdcf0e 731aca7f-57bb-438d-927b-1be5adcdcf0e 731aca7f-57bb-438d-927b-1be5adcdcf0e +TCGA-22-4594-01 TCGA-22-4594-01 High Cluster 5 LUAD-like c10 miRNA cluster 7 TCGA-22-4594 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 60 L-Upper TCGA-22-4594-F7386 TCGA-22-4594 TCGA-22-4594-01A -22115 1470 0 1470 NO NO 2010-11-29 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.5 NO 0 NO Peripheral Lung 1.3 40 No M0 N2 T3 Stage IIIA TCGA-22-4594.fc15b2ea-bead-452d-9857-7380ff2ed628.pdf 4594 R0 Primary Tumor 01 0.3 NO YES 22 4 Lung A DECEASED 2002 TCGA-22-4594-01A-01D-1198-05 1cdc026e-58bc-424d-9cf4-6c6701e081ad TCGA-22-4594-01 TCGA-22-4594-01 TCGA-22-4594-01A-01R-1201-07 1cdc026e-58bc-424d-9cf4-6c6701e081ad 3df5a4c0-9062-4bc2-8cd9-a89ee6c47e07 TCGA-22-4594-01 TCGA-22-4594-01A-01D-1195-01 TCGA-22-4594-01 1cdc026e-58bc-424d-9cf4-6c6701e081ad TCGA-22-4594-01 1cdc026e-58bc-424d-9cf4-6c6701e081ad TCGA-22-4594-01 TCGA-22-4594-01A-01D-1195-01 +TCGA-22-4595-01 TCGA-22-4595-01 High C2-Squamous-like cluster 1 Cluster 5 squamous-like c4 miRNA cluster 11 cluster 1 mutation cluster 13 TCGA-22-4595 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung YES NO NO NO 57 L-Lower TCGA-22-4595-F7413 TCGA-22-4595 TCGA-22-4595-01A -21146 734 0 734 584 1 NO NO Progressive Disease 2011-2-9 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.5 NO 0 NO 1 YES 37 No N2 T3 Stage IIIA TCGA-22-4595.797ad94e-b3d2-44a4-8412-d8361a58bcd5.pdf 4595 Adjuvant therapy WITH TUMOR R0 Primary Tumor 01 0.2 NO YES 22 2 Lung A DECEASED 2002 TCGA-22-4595-01A-01D-1267-08 TCGA-22-4595-01A-01D-1198-05 66323357-708a-4b9e-b716-c8e7b24385d1 TCGA-22-4595-01 TCGA-22-4595-01A-01D-1267-08 TCGA-22-4595-01 TCGA-22-4595-01A-01R-1201-07 66323357-708a-4b9e-b716-c8e7b24385d1 668f6e1d-c6ca-46f3-8244-37d393fdedb0 TCGA-22-4595-01 TCGA-22-4595-01A-01D-1195-01 TCGA-22-4595-01 66323357-708a-4b9e-b716-c8e7b24385d1 TCGA-22-4595-01 66323357-708a-4b9e-b716-c8e7b24385d1 TCGA-22-4595-01 TCGA-22-4595-01A-01D-1195-01 +TCGA-22-4596-01 TCGA-22-4596-01 BRCA-LUAD+ C1-LUAD-enriched Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 4 TCGA-22-4596 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung NO NO 69 L-Upper TCGA-22-4596-F5730 TCGA-22-4596 TCGA-22-4596-01A -25448 17 0 17 NO NO 2010-11-30 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 1 NO 0 NO 1.4 NO 40 No M0 N0 T1b Stage IB TCGA-22-4596.fd87facc-8690-4f1a-bf75-1e6d2c1e8882.pdf 4596 Other TUMOR FREE NO R0 Primary Tumor 01 0.3 2002 NO NO YES 22 4 Lung A DECEASED 2002 1962 TCGA-22-4596-01A-01D-1198-05 cb61137c-aa73-433e-b7a8-f3e8b161a532 TCGA-22-4596-01 TCGA-22-4596-01 TCGA-22-4596-01A-01R-1201-07 cb61137c-aa73-433e-b7a8-f3e8b161a532 1a3ededb-05f7-4746-9091-4cff137073d5 TCGA-22-4596-01A-21-2194-20 TCGA-22-4596-01 TCGA-22-4596-01A-01D-1195-01 TCGA-22-4596-01 cb61137c-aa73-433e-b7a8-f3e8b161a532 TCGA-22-4596-01 cb61137c-aa73-433e-b7a8-f3e8b161a532 TCGA-22-4596-01 TCGA-22-4596-01A-01D-1195-01 4f5b1160-c56c-4696-90a5-2dffc0569b5f +TCGA-22-4599-01 TCGA-22-4599-01 Squamous C2-Squamous-like cluster 1 Cluster 13 (HNSC-LUSC) squamous-like c4 mutation cluster 5 TCGA-22-4599 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 73 TCGA-22-4599-F7558 TCGA-22-4599 -26925 1161 0 1161 NO NO 2010-11-30 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.8 8070/3 C34.8 YES 0 NO Central Lung 25 No M0 N0 T2a Stage IB 4599 R0 Primary Tumor 01 NO YES 22 2 Lung DECEASED 2002 TCGA-22-4599-01A-01D-1441-08 fb4a4126-ddff-4e71-b4d8-394ac8f03654 TCGA-22-4599-01A-01D-1441-08 TCGA-22-4599-01 TCGA-22-4599-01A-01R-1443-07 fb4a4126-ddff-4e71-b4d8-394ac8f03654 TCGA-22-4599-01 TCGA-22-4599-01A-01D-1439-01 TCGA-22-4599-01 fb4a4126-ddff-4e71-b4d8-394ac8f03654 TCGA-22-4599-01 fb4a4126-ddff-4e71-b4d8-394ac8f03654 TCGA-22-4599-01A-01D-1439-01 TCGA-22-4599-01A-01D-1440-05 +TCGA-22-4599-11 TCGA-22-4599-11 C2-Squamous-like mutation cluster 5 TCGA-22-4599 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 73 TCGA-22-4599-F7558 TCGA-22-4599 TCGA-22-4599-11A -26925 1161 0 1161 NO NO 2010-11-30 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.8 8070/3 C34.8 YES 0.7 NO 0 NO Central Lung 1.5 25 No M0 N0 T2a Stage IB 4599 R0 Solid Tissue Normal 11 0.2 NO YES 22 2 Lung A DECEASED 2002 TCGA-22-4599-11A-01D-1440-05 +TCGA-22-4601-01 TCGA-22-4601-01 Squamous C2-Squamous-like cluster 3 Cluster 13 (HNSC-LUSC) squamous-like c4 miRNA cluster 11 cluster 3 mutation cluster 11 TCGA-22-4601 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung NO NO NO 73 R-Upper TCGA-22-4601-F7567 TCGA-22-4601 -26937 1057 0 1057 525 NO NO 2010-11-30 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0 NO YES 60 No M0 N0 T4 Stage IIIA 4601 WITH TUMOR R0 Primary Tumor 01 NO NO YES 22 2 Lung DECEASED 2003 TCGA-22-4601-01A-01D-1441-08 e4e94ad0-a63b-43c1-928a-aa0333e72bed TCGA-22-4601-01 TCGA-22-4601-01A-01D-1441-08 TCGA-22-4601-01 TCGA-22-4601-01A-01R-1443-07 e4e94ad0-a63b-43c1-928a-aa0333e72bed TCGA-22-4601-01 TCGA-22-4601-01A-01D-1969-01 TCGA-22-4601-01 e4e94ad0-a63b-43c1-928a-aa0333e72bed TCGA-22-4601-01 e4e94ad0-a63b-43c1-928a-aa0333e72bed TCGA-22-4601-01 TCGA-22-4601-01A-01D-1969-01 TCGA-22-4601-01A-01D-1440-05 +TCGA-22-4601-11 TCGA-22-4601-11 C2-Squamous-like mutation cluster 11 TCGA-22-4601 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung NO NO NO 73 R-Upper TCGA-22-4601-F7567 TCGA-22-4601 TCGA-22-4601-11A -26937 1057 0 1057 525 NO NO 2010-11-30 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.8 NO 0 NO 0.8 YES 60 No M0 N0 T4 Stage IIIA 4601 WITH TUMOR R0 Solid Tissue Normal 11 0.2 NO NO YES 22 2 Lung A DECEASED 2003 TCGA-22-4601-11A-01D-1440-05 +TCGA-22-4604-01 TCGA-22-4604-01 Squamous C2-Squamous-like cluster 3 Cluster 13 (HNSC-LUSC) squamous-like c4 miRNA cluster 4 cluster 2 mutation cluster 3 TCGA-22-4604 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung NO YES NO NO 73 L-Upper TCGA-22-4604-F7520 TCGA-22-4604 TCGA-22-4604-01A -26952 399 0 306 0 NO NO Progressive Disease 2010-11-30 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.5 NO 0 NO Central Lung 1.5 YES 50 No M0 N1 T2a Stage IIA TCGA-22-4604.a66769a0-8ad7-4912-8eee-ec76d5aef626.pdf 4604 Adjuvant therapy WITH TUMOR NO R0 Primary Tumor 01 0.2 YES NO YES 22 2 Lung A DECEASED 2003 TCGA-22-4604-01A-01D-1267-08 TCGA-22-4604-01A-01D-1198-05 017e0cba-13b0-457a-80bb-8d6090506cc9 TCGA-22-4604-01 TCGA-22-4604-01A-01D-1267-08 TCGA-22-4604-01 TCGA-22-4604-01A-01R-1201-07 017e0cba-13b0-457a-80bb-8d6090506cc9 6199edd8-d4d8-4bff-a66a-78bbb39bf646 TCGA-22-4604-01 TCGA-22-4604-01A-01D-1195-01 TCGA-22-4604-01 017e0cba-13b0-457a-80bb-8d6090506cc9 TCGA-22-4604-01 017e0cba-13b0-457a-80bb-8d6090506cc9 TCGA-22-4604-01 TCGA-22-4604-01A-01D-1195-01 +TCGA-22-4605-01 TCGA-22-4605-01 Squamous C2-Squamous-like Cluster 5 squamous c3 squamous-like c4 miRNA cluster 11 TCGA-22-4605 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 78 R-Upper TCGA-22-4605-F20533 TCGA-22-4605 TCGA-22-4605-01A -28623 974 0 58 NO NO Scheduled Follow-up Submission 2012-1-16 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.10 8072/3 C34.1 YES 0.8 NO NO 1.3 NO 75 No M0 N0 T2 Stage IB TCGA-22-4605.6d8491df-72b3-46f8-96b4-016d8662eb15.pdf 4605 TUMOR FREE 81 80 Complete Remission/Response YES YES R0 Primary Tumor 01 0.2 1996 6th NO NO YES 22 4 Lung A DECEASED 2003 1946 f5255c17-4a9e-4532-88b1-880f3e933579 TCGA-22-4605-01 TCGA-22-4605-01 TCGA-22-4605-01 f5255c17-4a9e-4532-88b1-880f3e933579 TCGA-22-4605-01A-11-2193-20 TCGA-22-4605-01 TCGA-22-4605-01A-21D-2121-01 f5255c17-4a9e-4532-88b1-880f3e933579 f5255c17-4a9e-4532-88b1-880f3e933579 TCGA-22-4605-01A-21D-2121-01 TCGA-22-4605-01A-21D-2123-05 5e7c3893-5bf5-4bbb-a98f-ea293538f5ff +TCGA-22-4607-01 TCGA-22-4607-01 Squamous C2-Squamous-like cluster 1 Cluster 5 squamous c3 squamous-like c4 miRNA cluster 4 cluster 2 mutation cluster 3 TCGA-22-4607 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 75 R-Lower TCGA-22-4607-F7550 TCGA-22-4607 TCGA-22-4607-01A -27601 587 0 587 3 NO NO 2010-11-30 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.8 NO NO Peripheral Lung 1.1 NO 20 No M0 N0 T2a Stage IB TCGA-22-4607.261ab183-8f0c-4288-9bdb-53fd2754da31.pdf 4607 Other TUMOR FREE NO R0 Primary Tumor 01 0.4 1968 NO NO YES 22 3 Lung A DECEASED 2003 1948 TCGA-22-4607-01A-01D-1267-08 TCGA-22-4607-01A-01D-1198-05 4972964a-475f-4611-ab72-22543d9aa6fb TCGA-22-4607-01 TCGA-22-4607-01A-01D-1267-08 TCGA-22-4607-01 TCGA-22-4607-01A-01R-1201-07 4972964a-475f-4611-ab72-22543d9aa6fb 45b1d239-e546-4ed2-8266-d7af0a6077e1 TCGA-22-4607-01A-21-2194-20 TCGA-22-4607-01 TCGA-22-4607-01A-01D-1195-01 TCGA-22-4607-01 4972964a-475f-4611-ab72-22543d9aa6fb TCGA-22-4607-01 4972964a-475f-4611-ab72-22543d9aa6fb TCGA-22-4607-01 TCGA-22-4607-01A-01D-1195-01 79c272f1-478c-4a0a-845f-ba113df49b55 +TCGA-22-4609-01 TCGA-22-4609-01 Squamous Cluster 5 squamous c3 miRNA cluster 11 TCGA-22-4609 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 81 R-Upper TCGA-22-4609-F20535 TCGA-22-4609 -29844 291 0 58 NO NO Scheduled Follow-up Submission 2012-1-16 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES NO NO 77 No M0 N0 T1 Stage IA 4609 TUMOR FREE 81 58 Complete Remission/Response YES NO R0 Primary Tumor 01 6th NO NO YES 22 2 Lung DECEASED 2003 f6c0f677-2bd8-4406-8d44-f0d2d1c02763 TCGA-22-4609-01 TCGA-22-4609-01 TCGA-22-4609-01 f6c0f677-2bd8-4406-8d44-f0d2d1c02763 TCGA-22-4609-01A-11-2193-20 TCGA-22-4609-01 TCGA-22-4609-01A-21D-2121-01 f6c0f677-2bd8-4406-8d44-f0d2d1c02763 f6c0f677-2bd8-4406-8d44-f0d2d1c02763 TCGA-22-4609-01A-21D-2121-01 TCGA-22-4609-01A-21D-2123-05 f445dc4e-7f34-47ee-98d7-7f9586084719 +TCGA-22-4609-11 TCGA-22-4609-11 TCGA-22-4609 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 81 R-Upper TCGA-22-4609-F20535 TCGA-22-4609 -29844 291 0 58 NO NO Scheduled Follow-up Submission 2012-1-16 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES NO NO 77 No M0 N0 T1 Stage IA 4609 TUMOR FREE 81 58 Complete Remission/Response YES NO R0 Solid Tissue Normal 11 6th NO NO YES 22 2 Lung DECEASED 2003 e35ae11f-244b-42bf-b506-1dc1f612b414 TCGA-22-4609-11 TCGA-22-4609-11 e35ae11f-244b-42bf-b506-1dc1f612b414 e35ae11f-244b-42bf-b506-1dc1f612b414 e35ae11f-244b-42bf-b506-1dc1f612b414 +TCGA-22-4613-01 TCGA-22-4613-01 Squamous C2-Squamous-like cluster 4 Cluster 13 (HNSC-LUSC) squamous-like c4 miRNA cluster 7 cluster 2 mutation cluster 3 TCGA-22-4613 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 73 L-Upper TCGA-22-4613-F7570 TCGA-22-4613 TCGA-22-4613-01A -26722 358 0 358 NO NO 2010-11-30 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.8 NO 0 NO 1.1 30 No M0 N0 T1b Stage IA TCGA-22-4613.bbb6127c-7368-415d-b984-65e21e23c03a.pdf 4613 NO R0 Primary Tumor 01 0.3 1988 NO NO YES 22 3 Lung A DECEASED 2004 1958 TCGA-22-4613-01A-01D-1441-08 82586a59-47ac-4dba-b460-87e968a9d658 TCGA-22-4613-01 TCGA-22-4613-01A-01D-1441-08 TCGA-22-4613-01 TCGA-22-4613-01A-01R-1443-07 82586a59-47ac-4dba-b460-87e968a9d658 TCGA-22-4613-01 TCGA-22-4613-01A-01D-1439-01 TCGA-22-4613-01 82586a59-47ac-4dba-b460-87e968a9d658 TCGA-22-4613-01 82586a59-47ac-4dba-b460-87e968a9d658 TCGA-22-4613-01 TCGA-22-4613-01A-01D-1439-01 TCGA-22-4613-01A-01D-1440-05 +TCGA-22-4613-11 TCGA-22-4613-11 C2-Squamous-like mutation cluster 3 TCGA-22-4613 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 73 L-Upper TCGA-22-4613-F7570 TCGA-22-4613 TCGA-22-4613-11A -26722 358 0 358 NO NO 2010-11-30 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.9 NO 0 NO 1.1 30 No M0 N0 T1b Stage IA 4613 NO R0 Solid Tissue Normal 11 0.3 1988 NO NO YES 22 3 Lung A DECEASED 2004 1958 TCGA-22-4613-11A-01D-1440-05 +TCGA-22-5471-01 TCGA-22-5471-01 High C2-Squamous-like cluster 1 Cluster 13 (HNSC-LUSC) squamous c3 squamous-like c4 miRNA cluster 4 cluster 2 mutation cluster 13 TCGA-22-5471 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 75 L-Lower TCGA-22-5471-F69952 TCGA-22-5471 TCGA-22-5471-01A -27749 0 1845 1 NO NO Scheduled Follow-up Submission 2015-1-22 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.5 NO NO 0.9 YES 50 Yes M0 N0 T2 Stage IB TCGA-22-5471.139e042e-6971-4840-97b1-a54988346967.pdf 5471 Pre-Adjuvant Therapy Complete Remission/Response YES R2 Primary Tumor 01 0.4 2005 6th NO NO YES 22 4 Lung A LIVING 2005 TCGA-22-5471-01A-01D-1632-08 c7372404-46b6-415c-8084-2dac0e7f3cee TCGA-22-5471-01 TCGA-22-5471-01A-01D-1632-08 TCGA-22-5471-01 TCGA-22-5471-01 c7372404-46b6-415c-8084-2dac0e7f3cee TCGA-22-5471-01A-21-2194-20 TCGA-22-5471-01 TCGA-22-5471-01A-01D-1631-01 c7372404-46b6-415c-8084-2dac0e7f3cee c7372404-46b6-415c-8084-2dac0e7f3cee TCGA-22-5471-01A-01D-1631-01 TCGA-22-5471-01A-01D-1633-05 43c5c2ec-d9a9-4fa2-8f12-fa74a31d2e3f +TCGA-22-5471-11 TCGA-22-5471-11 C2-Squamous-like mutation cluster 13 TCGA-22-5471 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 75 L-Lower TCGA-22-5471-F69952 TCGA-22-5471 TCGA-22-5471-11A -27749 0 1845 1 NO NO Scheduled Follow-up Submission 2015-1-22 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.8 NO NO 1.5 YES 50 Yes M0 N0 T2 Stage IB 5471 Pre-Adjuvant Therapy Complete Remission/Response YES R2 Solid Tissue Normal 11 0.4 2005 6th NO NO YES 22 4 Lung A LIVING 2005 aac4936d-3550-4acd-8fd4-1b1951242d80 aac4936d-3550-4acd-8fd4-1b1951242d80 aac4936d-3550-4acd-8fd4-1b1951242d80 aac4936d-3550-4acd-8fd4-1b1951242d80 TCGA-22-5471-11A-01D-1633-05 +TCGA-22-5472-01 TCGA-22-5472-01 Kirc+ C2-Squamous-like cluster 1 Cluster 13 (HNSC-LUSC) squamous c3 squamous-like c4 miRNA cluster 11 cluster 2 mutation cluster 12 TCGA-22-5472 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung YES YES NO NO 67 R-Lower TCGA-22-5472-F11156 TCGA-22-5472 TCGA-22-5472-01A -24482 1975 0 1975 902 NO NO Progressive Disease 2011-5-4 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.8 NO 0 NO 1.2 YES 35 Yes M0 N0 T2a Stage IB TCGA-22-5472.a882eb26-0b08-463e-9700-4396fce9e8fd.pdf 5472 TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 0.3 1999 NO NO YES 22 4 Lung A DECEASED 2005 1964 TCGA-22-5472-01A-01D-1632-08 17d5f5c9-ed12-4dd7-810e-601b7545b47f TCGA-22-5472-01 TCGA-22-5472-01A-01D-1632-08 TCGA-22-5472-01 TCGA-22-5472-01 17d5f5c9-ed12-4dd7-810e-601b7545b47f TCGA-22-5472-01A-21-2194-20 TCGA-22-5472-01 TCGA-22-5472-01A-01D-1631-01 17d5f5c9-ed12-4dd7-810e-601b7545b47f 17d5f5c9-ed12-4dd7-810e-601b7545b47f TCGA-22-5472-01A-01D-1631-01 TCGA-22-5472-01A-01D-1633-05 61b44402-a6de-458c-9d45-4b4c258b1590 +TCGA-22-5472-11 TCGA-22-5472-11 C2-Squamous-like mutation cluster 12 TCGA-22-5472 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung YES YES NO NO 67 R-Lower TCGA-22-5472-F11156 TCGA-22-5472 -24482 1975 0 1975 902 NO NO Progressive Disease 2011-5-4 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0 NO YES 35 Yes M0 N0 T2a Stage IB 5472 TUMOR FREE Complete Remission/Response NO R0 Solid Tissue Normal 11 1999 NO NO YES 22 4 Lung DECEASED 2005 1964 a835eee9-b865-4e53-9b33-3db9fbcee18e TCGA-22-5472-11 TCGA-22-5472-11 a835eee9-b865-4e53-9b33-3db9fbcee18e a835eee9-b865-4e53-9b33-3db9fbcee18e a835eee9-b865-4e53-9b33-3db9fbcee18e TCGA-22-5472-11A-11D-1633-05 +TCGA-22-5473-01 TCGA-22-5473-01 Squamous C2-Squamous-like cluster 3 Cluster 13 (HNSC-LUSC) squamous c3 squamous-like c4 cluster 2 mutation cluster 2 TCGA-22-5473 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung NO NO YES 78 [Discrepancy] TCGA-22-5473-F11133 TCGA-22-5473 TCGA-22-5473-01A 1658 -28826 1933 0 1655 NO NO [Discrepancy] 2011-5-3 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 1 NO 0 NO 1.1 YES 45 No M0 N0 T3 [Discrepancy] TCGA-22-5473.12973d4a-4c25-43dc-920b-d32407d45461.pdf 5473 TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 0.5 1987 YES NO YES 22 3 Lung A DECEASED 2005 1942 TCGA-22-5473-01A-01D-1632-08 5c8d386c-5879-4b83-a899-4e731ae08d92 TCGA-22-5473-01 TCGA-22-5473-01A-01D-1632-08 TCGA-22-5473-01 TCGA-22-5473-01 5c8d386c-5879-4b83-a899-4e731ae08d92 TCGA-22-5473-01A-21-2194-20 TCGA-22-5473-01 TCGA-22-5473-01A-01D-1631-01 5c8d386c-5879-4b83-a899-4e731ae08d92 5c8d386c-5879-4b83-a899-4e731ae08d92 TCGA-22-5473-01A-01D-1631-01 TCGA-22-5473-01A-01D-1633-05 a79a1a5c-7c23-4c61-9e70-6f1e6c1f5317 +TCGA-22-5473-11 TCGA-22-5473-11 C2-Squamous-like mutation cluster 2 TCGA-22-5473 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung NO NO YES 78 [Discrepancy] TCGA-22-5473-F11133 TCGA-22-5473 TCGA-22-5473-11A 1658 -28826 1933 0 1655 NO NO [Discrepancy] 2011-5-3 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 1 NO 0 NO 1.3 YES 45 No M0 N0 T3 [Discrepancy] 5473 TUMOR FREE Complete Remission/Response NO R0 Solid Tissue Normal 11 0.3 1987 YES NO YES 22 3 Lung A DECEASED 2005 1942 TCGA-22-5473-11A-11D-1633-05 +TCGA-22-5474-01 TCGA-22-5474-01 Squamous C2-Squamous-like cluster 1 Cluster 13 (HNSC-LUSC) squamous c3 squamous-like c4 cluster 2 mutation cluster 5 TCGA-22-5474 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 74 L-Upper TCGA-22-5474-F11210 TCGA-22-5474 TCGA-22-5474-01A -27271 445 0 445 NO NO 2011-5-4 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 1 NO 0 NO 1 NO 50 No M0 N0 T2a Stage IB TCGA-22-5474.e0bf9b86-3d7e-4a37-9545-b74dd999e128.pdf 5474 TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 0.3 1994 NO NO YES 22 4 Lung A DECEASED 2005 1944 TCGA-22-5474-01A-01D-1632-08 0242dfba-2ab3-457e-b905-82dc83348e11 TCGA-22-5474-01 TCGA-22-5474-01A-01D-1632-08 TCGA-22-5474-01 TCGA-22-5474-01 0242dfba-2ab3-457e-b905-82dc83348e11 TCGA-22-5474-01A-21-2194-20 TCGA-22-5474-01 TCGA-22-5474-01A-01D-1631-01 0242dfba-2ab3-457e-b905-82dc83348e11 0242dfba-2ab3-457e-b905-82dc83348e11 TCGA-22-5474-01A-01D-1631-01 TCGA-22-5474-01A-01D-1633-05 78ec1e12-ed4e-44f3-abb8-aff8b543e2d1 +TCGA-22-5474-11 TCGA-22-5474-11 C2-Squamous-like mutation cluster 5 TCGA-22-5474 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 74 L-Upper TCGA-22-5474-F11210 TCGA-22-5474 TCGA-22-5474-11A -27271 445 0 445 NO NO 2011-5-4 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 1 NO 0 NO 1 NO 50 No M0 N0 T2a Stage IB 5474 TUMOR FREE Complete Remission/Response NO R0 Solid Tissue Normal 11 0.3 1994 NO NO YES 22 4 Lung A DECEASED 2005 1944 TCGA-22-5474-11A-01D-1633-05 +TCGA-22-5477-01 TCGA-22-5477-01 High C2-Squamous-like cluster 2 Cluster 13 (HNSC-LUSC) squamous c3 squamous-like c4 cluster 3 mutation cluster 5 TCGA-22-5477 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung NO NO 65 R-Lower TCGA-22-5477-F11237 TCGA-22-5477 TCGA-22-5477-01A -24055 1346 0 1346 511 NO NO Progressive Disease 2011-5-4 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.8 NO 0 NO 1.4 YES 100 No M0 N0 T1 Stage IA TCGA-22-5477.9dcdc788-4ebd-4376-ab97-b0602a684b90.pdf 5477 Complete Remission/Response NO R0 Primary Tumor 01 0.3 NO NO YES 22 2 Lung A DECEASED 2004 TCGA-22-5477-01A-01D-1632-08 b6cbe950-44d8-4da9-ba79-116f25015278 TCGA-22-5477-01 TCGA-22-5477-01A-01D-1632-08 TCGA-22-5477-01 TCGA-22-5477-01 b6cbe950-44d8-4da9-ba79-116f25015278 TCGA-22-5477-01A-21-2194-20 TCGA-22-5477-01 TCGA-22-5477-01A-01D-1631-01 b6cbe950-44d8-4da9-ba79-116f25015278 b6cbe950-44d8-4da9-ba79-116f25015278 TCGA-22-5477-01A-01D-1631-01 TCGA-22-5477-01A-01D-1633-05 5162d956-a988-4b03-ae52-d57aa76b1025 +TCGA-22-5477-11 TCGA-22-5477-11 C2-Squamous-like mutation cluster 5 TCGA-22-5477 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung NO NO 65 R-Lower TCGA-22-5477-F11237 TCGA-22-5477 TCGA-22-5477-11A -24055 1346 0 1346 511 NO NO Progressive Disease 2011-5-4 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.7 NO 0 NO 1.2 YES 100 No M0 N0 T1 Stage IA 5477 Complete Remission/Response NO R0 Solid Tissue Normal 11 0.4 NO NO YES 22 2 Lung A DECEASED 2004 TCGA-22-5477-11A-11D-1633-05 +TCGA-22-5478-01 TCGA-22-5478-01 BRCA-LUAD+ C1-LUAD-enriched cluster 4 Cluster 5 squamous c3 squamous-like c4 miRNA cluster 12 cluster 3 mutation cluster 5 TCGA-22-5478 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 79 R-Lower TCGA-22-5478-F11287 TCGA-22-5478 TCGA-22-5478-01A -28978 24 0 24 NO NO 2011-5-6 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.5 NO 0 NO Peripheral Lung 1.1 NO No M0 N0 T2a Stage IB TCGA-22-5478.912bf8ba-d6bb-4643-a5dd-3449c86ceec3.pdf 5478 TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 0.3 1994 NO NO YES 22 4 Lung A DECEASED 2004 TCGA-22-5478-01A-01D-1632-08 c68cacc1-3783-494b-aced-e06cea977a4f TCGA-22-5478-01 TCGA-22-5478-01A-01D-1632-08 TCGA-22-5478-01 TCGA-22-5478-01 c68cacc1-3783-494b-aced-e06cea977a4f TCGA-22-5478-01A-21-2194-20 TCGA-22-5478-01 TCGA-22-5478-01A-01D-1631-01 c68cacc1-3783-494b-aced-e06cea977a4f c68cacc1-3783-494b-aced-e06cea977a4f TCGA-22-5478-01A-01D-1631-01 TCGA-22-5478-01A-01D-1633-05 7554f5f0-1c1a-4f71-9d7a-836266435c78 +TCGA-22-5478-11 TCGA-22-5478-11 C1-LUAD-enriched mutation cluster 5 TCGA-22-5478 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 79 R-Lower TCGA-22-5478-F11287 TCGA-22-5478 TCGA-22-5478-11A -28978 24 0 24 NO NO 2011-5-6 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.7 NO 0 NO Peripheral Lung 1 NO No M0 N0 T2a Stage IB 5478 TUMOR FREE Complete Remission/Response NO R0 Solid Tissue Normal 11 0.2 1994 NO NO YES 22 4 Lung A DECEASED 2004 6a39f9d6-adbb-478f-a59e-93a8bafb4604 TCGA-22-5478-11 TCGA-22-5478-11 6a39f9d6-adbb-478f-a59e-93a8bafb4604 6a39f9d6-adbb-478f-a59e-93a8bafb4604 6a39f9d6-adbb-478f-a59e-93a8bafb4604 TCGA-22-5478-11A-11D-1633-05 +TCGA-22-5479-01 TCGA-22-5479-01 Squamous C2-Squamous-like Cluster 13 (HNSC-LUSC) squamous c3 squamous-like c4 miRNA cluster 7 TCGA-22-5479 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 64 L-Lower TCGA-22-5479-F69951 TCGA-22-5479 TCGA-22-5479-01A -23563 2625 0 1651 1 NO NO Scheduled Follow-up Submission 2015-1-22 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.6 NO NO Peripheral Lung 1.1 NO 35 No M0 N0 T2 Stage IB TCGA-22-5479.63ec0c23-5ffc-4c19-a40b-a314c1c91d36.pdf 5479 Pre-Adjuvant Therapy NO R0 Primary Tumor 01 0.3 2001 6th YES NO YES 22 4 Lung A DECEASED 2004 1966 d7086de7-6fd7-4709-b390-90f106977829 TCGA-22-5479-01 TCGA-22-5479-01 TCGA-22-5479-01 d7086de7-6fd7-4709-b390-90f106977829 TCGA-22-5479-01A-11-2194-20 TCGA-22-5479-01 TCGA-22-5479-01A-31D-1943-01 d7086de7-6fd7-4709-b390-90f106977829 d7086de7-6fd7-4709-b390-90f106977829 TCGA-22-5479-01A-31D-1943-01 TCGA-22-5479-01A-31D-1947-05 78c6397c-c479-4743-af4b-61c1bbdc4d3f +TCGA-22-5480-01 TCGA-22-5480-01 High C2-Squamous-like cluster 1 Cluster 13 (HNSC-LUSC) squamous c3 squamous-like c4 miRNA cluster 7 cluster 2 mutation cluster 13 TCGA-22-5480 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung YES YES NO 66 L-Upper TCGA-22-5480-F11296 TCGA-22-5480 TCGA-22-5480-01A -24245 2170 0 2170 1779 2 NO NO Progressive Disease 2011-5-6 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.6 NO 0 NO Central Lung 1.5 YES 50 No M0 N0 T1b Stage IA TCGA-22-5480.62c5d0aa-1dbd-456a-b16f-cb233be02a88.pdf 5480 Post-Adjuvant Therapy WITH TUMOR Complete Remission/Response NO R0 Primary Tumor 01 0.3 2002 NO NO YES 22 4 Lung A DECEASED 2002 1952 TCGA-22-5480-01A-01D-1632-08 2d8e77a9-f69e-4c27-acaa-1ae73dbc5997 TCGA-22-5480-01 TCGA-22-5480-01A-01D-1632-08 TCGA-22-5480-01 TCGA-22-5480-01 2d8e77a9-f69e-4c27-acaa-1ae73dbc5997 TCGA-22-5480-01A-21-2194-20 TCGA-22-5480-01 TCGA-22-5480-01A-01D-1631-01 2d8e77a9-f69e-4c27-acaa-1ae73dbc5997 2d8e77a9-f69e-4c27-acaa-1ae73dbc5997 TCGA-22-5480-01A-01D-1631-01 TCGA-22-5480-01A-01D-1633-05 52b7abd6-8f9d-4aac-bb99-f0f2c596dac8 +TCGA-22-5480-11 TCGA-22-5480-11 C2-Squamous-like mutation cluster 13 TCGA-22-5480 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung YES YES NO 66 L-Upper TCGA-22-5480-F11296 TCGA-22-5480 TCGA-22-5480-11A -24245 2170 0 2170 1779 2 NO NO Progressive Disease 2011-5-6 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.8 NO 0 NO Central Lung 0.9 YES 50 No M0 N0 T1b Stage IA 5480 Post-Adjuvant Therapy WITH TUMOR Complete Remission/Response NO R0 Solid Tissue Normal 11 0.2 2002 NO NO YES 22 4 Lung A DECEASED 2002 1952 TCGA-22-5480-11A-01D-1633-05 +TCGA-22-5481-01 TCGA-22-5481-01 High Cluster 5 RNA cluster 12 miRNA cluster 12 TCGA-22-5481 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung YES 72 L-Lower TCGA-22-5481-F17912 TCGA-22-5481 TCGA-22-5481-01A 366 -26419 2409 0 346 NO NO Scheduled Follow-up Submission 2011-10-27 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.8 NO NO 1 YES 75 No M0 N1 T2 Stage IIB TCGA-22-5481.71745674-14e0-47ac-b16c-95a18980a37d.pdf 5481 Complete Remission/Response NO R0 Primary Tumor 01 0.3 2002 5th NO NO YES 22 4 Lung A DECEASED 2002 1952 921b83c7-9731-4b26-9a91-f84347e36d5b TCGA-22-5481-01 TCGA-22-5481-01 TCGA-22-5481-01 921b83c7-9731-4b26-9a91-f84347e36d5b TCGA-22-5481-01 TCGA-22-5481-01A-31D-1943-01 921b83c7-9731-4b26-9a91-f84347e36d5b 921b83c7-9731-4b26-9a91-f84347e36d5b TCGA-22-5481-01A-31D-1943-01 TCGA-22-5481-01A-31D-1947-05 +TCGA-22-5481-11 TCGA-22-5481-11 TCGA-22-5481 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung YES 72 L-Lower TCGA-22-5481-F17912 TCGA-22-5481 TCGA-22-5481-11A 366 -26419 2409 0 346 NO NO Scheduled Follow-up Submission 2011-10-27 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 1 NO NO 1 YES 75 No M0 N1 T2 Stage IIB 5481 Complete Remission/Response NO R0 Solid Tissue Normal 11 0.3 2002 5th NO NO YES 22 4 Lung A DECEASED 2002 1952 02107e86-44c9-42bd-9a46-2a98e54bd54c 02107e86-44c9-42bd-9a46-2a98e54bd54c 02107e86-44c9-42bd-9a46-2a98e54bd54c 02107e86-44c9-42bd-9a46-2a98e54bd54c +TCGA-22-5482-01 TCGA-22-5482-01 Squamous C2-Squamous-like cluster 3 Cluster 13 (HNSC-LUSC) squamous c3 squamous-like c4 miRNA cluster 11 cluster 2 mutation cluster 8 TCGA-22-5482 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 81 L-Upper TCGA-22-5482-F11304 TCGA-22-5482 TCGA-22-5482-01A -29657 357 0 357 NO NO 2011-5-6 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 1 NO 0 NO 1.2 NO 60 No M0 N0 T2a Stage IB TCGA-22-5482.b98aff53-a7e3-4bf9-b0b3-608f20940ac3.pdf 5482 TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 0.5 2004 NO NO YES 22 4 Lung A DECEASED 2005 1944 TCGA-22-5482-01A-01D-1632-08 71a18be8-ea00-4006-81cd-7ce875f67077 TCGA-22-5482-01 TCGA-22-5482-01A-01D-1632-08 TCGA-22-5482-01 TCGA-22-5482-01 71a18be8-ea00-4006-81cd-7ce875f67077 TCGA-22-5482-01A-21-2194-20 TCGA-22-5482-01 TCGA-22-5482-01A-01D-1631-01 71a18be8-ea00-4006-81cd-7ce875f67077 71a18be8-ea00-4006-81cd-7ce875f67077 TCGA-22-5482-01A-01D-1631-01 TCGA-22-5482-01A-01D-1633-05 2536d089-b6cf-464e-bd43-9c97b0d8948f +TCGA-22-5482-11 TCGA-22-5482-11 C2-Squamous-like mutation cluster 8 TCGA-22-5482 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 81 L-Upper TCGA-22-5482-F11304 TCGA-22-5482 TCGA-22-5482-11A -29657 357 0 357 NO NO 2011-5-6 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 1 NO 0 NO 1.3 NO 60 No M0 N0 T2a Stage IB 5482 TUMOR FREE Complete Remission/Response NO R0 Solid Tissue Normal 11 0.5 2004 NO NO YES 22 4 Lung A DECEASED 2005 1944 eba3191c-d7bd-4af7-811e-8902edb70355 eba3191c-d7bd-4af7-811e-8902edb70355 eba3191c-d7bd-4af7-811e-8902edb70355 eba3191c-d7bd-4af7-811e-8902edb70355 TCGA-22-5482-11A-01D-1633-05 +TCGA-22-5483-01 TCGA-22-5483-01 Squamous C2-Squamous-like Cluster 13 (HNSC-LUSC) squamous c3 RNA cluster 3 miRNA cluster 12 TCGA-22-5483 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung NO NO NO 74 R-Upper TCGA-22-5483-F11477 TCGA-22-5483 TCGA-22-5483-01A -27109 573 0 573 568 NO NO Progressive Disease 2011-5-10 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.5 NO 0 NO 1.9 YES 50 No M0 N1 T1a Stage IIA TCGA-22-5483.45ffb097-f0d9-4850-895e-ce7ebef84502.pdf 5483 WITH TUMOR Complete Remission/Response NO R0 Primary Tumor 01 0.2 2004 YES NO YES 22 4 Lung A DECEASED 2005 bfff9773-9089-4b7e-9470-f0ddcabae065 TCGA-22-5483-01 TCGA-22-5483-01 TCGA-22-5483-01 bfff9773-9089-4b7e-9470-f0ddcabae065 TCGA-22-5483-01A-21-2194-20 TCGA-22-5483-01 TCGA-22-5483-01A-01D-1816-01 bfff9773-9089-4b7e-9470-f0ddcabae065 bfff9773-9089-4b7e-9470-f0ddcabae065 TCGA-22-5483-01A-01D-1816-01 TCGA-22-5483-01A-01D-1818-05 6ff0360e-5a35-4886-8277-c2883374ebb0 +TCGA-22-5483-11 TCGA-22-5483-11 C2-Squamous-like TCGA-22-5483 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung NO NO NO 74 R-Upper TCGA-22-5483-F11477 TCGA-22-5483 -27109 573 0 573 568 NO NO Progressive Disease 2011-5-10 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0 NO YES 50 No M0 N1 T1a Stage IIA 5483 WITH TUMOR Complete Remission/Response NO R0 Solid Tissue Normal 11 2004 YES NO YES 22 4 Lung DECEASED 2005 be550442-9380-47cb-b03f-14b84b0db775 TCGA-22-5483-11 TCGA-22-5483-11 be550442-9380-47cb-b03f-14b84b0db775 be550442-9380-47cb-b03f-14b84b0db775 be550442-9380-47cb-b03f-14b84b0db775 +TCGA-22-5485-01 TCGA-22-5485-01 High C2-Squamous-like cluster 3 Cluster 13 (HNSC-LUSC) squamous c3 squamous-like c4 miRNA cluster 12 cluster 3 mutation cluster 5 TCGA-22-5485 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung NO NO 58 R-Upper TCGA-22-5485-F11483 TCGA-22-5485 TCGA-22-5485-01A -21488 916 0 916 840 NO NO Progressive Disease 2011-5-10 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.7 NO 0 NO 1.2 YES 60 No M0 N0 T1a Stage IA TCGA-22-5485.1a1abb9b-fe80-4a56-a276-94135fcedf4b.pdf 5485 WITH TUMOR Complete Remission/Response NO R0 Primary Tumor 01 0.2 NO NO YES 22 2 Lung A DECEASED 2001 TCGA-22-5485-01A-01D-1632-08 0e17aa25-2993-4ea1-bbee-d600d8c0bf89 TCGA-22-5485-01 TCGA-22-5485-01A-01D-1632-08 TCGA-22-5485-01 TCGA-22-5485-01 0e17aa25-2993-4ea1-bbee-d600d8c0bf89 TCGA-22-5485-01A-21-2194-20 TCGA-22-5485-01 TCGA-22-5485-01A-01D-1631-01 0e17aa25-2993-4ea1-bbee-d600d8c0bf89 0e17aa25-2993-4ea1-bbee-d600d8c0bf89 TCGA-22-5485-01A-01D-1631-01 TCGA-22-5485-01A-01D-1633-05 74b2de24-102f-449b-bbf8-ed2e5aaedb63 +TCGA-22-5485-11 TCGA-22-5485-11 C2-Squamous-like mutation cluster 5 TCGA-22-5485 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung NO NO 58 R-Upper TCGA-22-5485-F11483 TCGA-22-5485 TCGA-22-5485-11A -21488 916 0 916 840 NO NO Progressive Disease 2011-5-10 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 1 NO 0 NO 1.1 YES 60 No M0 N0 T1a Stage IA 5485 WITH TUMOR Complete Remission/Response NO R0 Solid Tissue Normal 11 0.3 NO NO YES 22 2 Lung A DECEASED 2001 TCGA-22-5485-11A-01D-1633-05 +TCGA-22-5489-01 TCGA-22-5489-01 High C2-Squamous-like cluster 1 Cluster 13 (HNSC-LUSC) squamous c3 squamous-like c4 miRNA cluster 7 cluster 2 mutation cluster 2 TCGA-22-5489 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung YES NO NO NO 64 L-Upper TCGA-22-5489-F11536 TCGA-22-5489 TCGA-22-5489-01A -23618 1912 0 1912 730 1 NO NO Progressive Disease 2011-5-11 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.8 NO 0 NO 1.6 YES 70 No M0 N0 T1b Stage IA TCGA-22-5489.c83cbd0b-f2e0-42df-b68e-4ca20dfbce00.pdf 5489 Other WITH TUMOR Complete Remission/Response NO R0 Primary Tumor 01 0.2 2003 NO NO YES 22 4 Lung A DECEASED 2003 TCGA-22-5489-01A-01D-1632-08 142496ba-0118-475e-9169-a201e98e11b5 TCGA-22-5489-01 TCGA-22-5489-01A-01D-1632-08 TCGA-22-5489-01 TCGA-22-5489-01 142496ba-0118-475e-9169-a201e98e11b5 TCGA-22-5489-01A-21-2194-20 TCGA-22-5489-01 TCGA-22-5489-01A-01D-1631-01 142496ba-0118-475e-9169-a201e98e11b5 142496ba-0118-475e-9169-a201e98e11b5 TCGA-22-5489-01A-01D-1631-01 TCGA-22-5489-01A-01D-1633-05 04508643-b5be-4165-9d6e-4f3687afdfd7 +TCGA-22-5489-11 TCGA-22-5489-11 C2-Squamous-like mutation cluster 2 TCGA-22-5489 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung YES NO NO NO 64 L-Upper TCGA-22-5489-F11536 TCGA-22-5489 TCGA-22-5489-11A -23618 1912 0 1912 730 1 NO NO Progressive Disease 2011-5-11 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.6 NO 0 NO 0.8 YES 70 No M0 N0 T1b Stage IA 5489 Other WITH TUMOR Complete Remission/Response NO R0 Solid Tissue Normal 11 0.2 2003 NO NO YES 22 4 Lung A DECEASED 2003 5f4c103d-fd38-45c5-b2e6-da62eb63da6a 5f4c103d-fd38-45c5-b2e6-da62eb63da6a 5f4c103d-fd38-45c5-b2e6-da62eb63da6a 5f4c103d-fd38-45c5-b2e6-da62eb63da6a TCGA-22-5489-11A-01D-1633-05 +TCGA-22-5491-01 TCGA-22-5491-01 Squamous C2-Squamous-like cluster 3 Cluster 13 (HNSC-LUSC) squamous c3 squamous-like c4 cluster 1 mutation cluster 3 TCGA-22-5491 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 74 L-Lower TCGA-22-5491-F11545 TCGA-22-5491 TCGA-22-5491-01A -27145 1713 0 1713 NO NO 2011-5-11 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.7 NO 0 NO 0.8 57 No M0 N0 T1a Stage IA TCGA-22-5491.187ab883-e568-47db-a048-c39c4e9d0f29.pdf 5491 R0 Primary Tumor 01 0.2 NO YES 22 2 Lung A DECEASED 2003 TCGA-22-5491-01A-01D-1632-08 8ecb75cd-cf31-4cc8-a2eb-01d1346791e9 TCGA-22-5491-01 TCGA-22-5491-01A-01D-1632-08 TCGA-22-5491-01 TCGA-22-5491-01 8ecb75cd-cf31-4cc8-a2eb-01d1346791e9 TCGA-22-5491-01A-21-2194-20 TCGA-22-5491-01 TCGA-22-5491-01A-01D-1631-01 8ecb75cd-cf31-4cc8-a2eb-01d1346791e9 8ecb75cd-cf31-4cc8-a2eb-01d1346791e9 TCGA-22-5491-01A-01D-1631-01 TCGA-22-5491-01A-01D-1633-05 82d12699-72d1-4283-b45e-35680eb3670b +TCGA-22-5491-11 TCGA-22-5491-11 C2-Squamous-like mutation cluster 3 TCGA-22-5491 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 74 L-Lower TCGA-22-5491-F11545 TCGA-22-5491 TCGA-22-5491-11A -27145 1713 0 1713 NO NO 2011-5-11 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.5 NO 0 NO 1.2 57 No M0 N0 T1a Stage IA 5491 R0 Solid Tissue Normal 11 0.2 NO YES 22 2 Lung A DECEASED 2003 c06339ee-3381-47f0-bf81-9310acfd78b3 c06339ee-3381-47f0-bf81-9310acfd78b3 c06339ee-3381-47f0-bf81-9310acfd78b3 c06339ee-3381-47f0-bf81-9310acfd78b3 TCGA-22-5491-11A-01D-1633-05 +TCGA-22-5492-01 TCGA-22-5492-01 Squamous C2-Squamous-like cluster 4 Cluster 5 squamous c3 squamous-like c4 cluster 2 mutation cluster 8 TCGA-22-5492 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 73 L-Upper TCGA-22-5492-F11552 TCGA-22-5492 TCGA-22-5492-01A -26838 506 0 506 NO NO 2011-5-11 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 1 NO 0 NO 1.8 50 No M0 N2 T2a Stage IIIA TCGA-22-5492.d3432f86-2b6a-4c4b-81e5-827f8e5e918c.pdf 5492 R0 Primary Tumor 01 0.2 2003 NO NO YES 22 4 Lung A DECEASED 2003 1953 TCGA-22-5492-01A-01D-1632-08 8dc89366-a78f-4e41-983f-13dfbbe782a2 TCGA-22-5492-01 TCGA-22-5492-01A-01D-1632-08 TCGA-22-5492-01 TCGA-22-5492-01 8dc89366-a78f-4e41-983f-13dfbbe782a2 TCGA-22-5492-01A-21-2194-20 TCGA-22-5492-01 TCGA-22-5492-01A-01D-1631-01 8dc89366-a78f-4e41-983f-13dfbbe782a2 8dc89366-a78f-4e41-983f-13dfbbe782a2 TCGA-22-5492-01A-01D-1631-01 TCGA-22-5492-01A-01D-1633-05 d68eb7ee-e5c5-413b-973b-82cf3ae37d55 +TCGA-22-5492-11 TCGA-22-5492-11 C2-Squamous-like mutation cluster 8 TCGA-22-5492 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 73 L-Upper TCGA-22-5492-F11552 TCGA-22-5492 TCGA-22-5492-11A -26838 506 0 506 NO NO 2011-5-11 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.9 NO 0 NO 1.1 50 No M0 N2 T2a Stage IIIA 5492 R0 Solid Tissue Normal 11 0.3 2003 NO NO YES 22 4 Lung A DECEASED 2003 1953 TCGA-22-5492-11A-01D-1633-05 +TCGA-22-A5C4-01 TCGA-22-A5C4-01 TCGA-22-A5C4 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 70 R-Lower TCGA-22-A5C4-F63882 TCGA-22-A5C4 TCGA-22-A5C4-01A -25629 49 0 671 74 1 NO NO Scheduled Follow-up Submission Complete Remission/Response 2014-8-20 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 290 NO NO Central Lung NO NO 80 true Yes, History of Prior Malignancy M0 N0 T2b Stage IIA TCGA-22-A5C4.4B2F6A48-A414-45A6-A729-4BBA1EF29021.pdf A5C4 Other TUMOR FREE 82 73 Complete Remission/Response YES NO R0 Primary Tumor 01 2012 7th NO NO YES 22 4 Lung A LIVING 2012 1960 4548b282-a56a-4e93-989f-5e093122aa6d TCGA-22-A5C4-01 TCGA-22-A5C4-01 TCGA-22-A5C4-01 4548b282-a56a-4e93-989f-5e093122aa6d TCGA-22-A5C4-01 TCGA-22-A5C4-01A-12D-A27J-01 4548b282-a56a-4e93-989f-5e093122aa6d 4548b282-a56a-4e93-989f-5e093122aa6d TCGA-22-A5C4-01A-12D-A27J-01 TCGA-22-A5C4-01A-12D-A27L-05 945903F5-3AB3-4A56-9438-7036C09C4BEC +TCGA-33-4532-01 TCGA-33-4532-01 High C2-Squamous-like cluster 4 Cluster 5 squamous c3 squamous-like c4 miRNA cluster 11 cluster 1 mutation cluster 8 TCGA-33-4532 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 68 R-Lower TCGA-33-4532-F71134 TCGA-33-4532 TCGA-33-4532-01A -25169 3924 0 2524 27 1 Scheduled Follow-up Submission Complete Remission/Response 2015-3-18 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 1 NO 2 NO NO 53 Yes M0 N0 T2 Stage IB TCGA-33-4532.6ec80633-f41f-4a9d-abfe-b1c72f9f9d10.pdf 4532 TUMOR FREE 76 3 78 3 Complete Remission/Response YES NO R0 Primary Tumor 01 0.3 5th NO NO YES 33 2 Lung A DECEASED 2001 TCGA-33-4532-01A-01D-1267-08 TCGA-33-4532-01A-01D-1198-05 fa7be44d-ec78-4bbe-b5af-38e0744f14a9 TCGA-33-4532-01 TCGA-33-4532-01A-01D-1267-08 TCGA-33-4532-01 TCGA-33-4532-01A-01R-1201-07 fa7be44d-ec78-4bbe-b5af-38e0744f14a9 851e5dfe-dd35-4870-bb93-83843e8bccd3 TCGA-33-4532-01A-21-2193-20 TCGA-33-4532-01 TCGA-33-4532-01A-01D-1195-01 TCGA-33-4532-01 fa7be44d-ec78-4bbe-b5af-38e0744f14a9 TCGA-33-4532-01 fa7be44d-ec78-4bbe-b5af-38e0744f14a9 TCGA-33-4532-01 TCGA-33-4532-01A-01D-1195-01 145f9405-fb5b-432d-8928-063e0d3a7b43 +TCGA-33-4533-01 TCGA-33-4533-01 Squamous C10-GBM cluster 4 Cluster 5 GBM-like c6 miRNA c1uster 9 cluster 3 mutation cluster 5 TCGA-33-4533 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 76 L-Upper TCGA-33-4533-F58821 TCGA-33-4533 TCGA-33-4533-01A -28001 0 4068 11 1 Scheduled Follow-up Submission 2014-4-24 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.9 8070/3 C34.9 YES 1.3 NO 90 1.5 NO NO 50 Yes M0 N0 T2 Stage IB TCGA-33-4533.1791e931-cced-44e6-b530-21bba650cc8c.pdf 4533 Preoperative TUMOR FREE 63 1 63 1 Complete Remission/Response YES NO R0 Primary Tumor 01 0.2 1990 5th NO NO YES 33 4 Lung A LIVING 2001 1940 TCGA-33-4533-01A-01D-1267-08 TCGA-33-4533-01A-01D-1198-05 73c2db42-5c8b-4b21-a1a5-ad3b106f2b13 TCGA-33-4533-01 TCGA-33-4533-01A-01D-1267-08 TCGA-33-4533-01 TCGA-33-4533-01A-01R-1201-07 73c2db42-5c8b-4b21-a1a5-ad3b106f2b13 4db97a8e-c857-4ce1-91fb-5cc7176bfad8 TCGA-33-4533-01 TCGA-33-4533-01A-01D-1195-01 TCGA-33-4533-01 73c2db42-5c8b-4b21-a1a5-ad3b106f2b13 TCGA-33-4533-01 73c2db42-5c8b-4b21-a1a5-ad3b106f2b13 TCGA-33-4533-01 TCGA-33-4533-01A-01D-1195-01 +TCGA-33-4538-01 TCGA-33-4538-01 High C2-Squamous-like cluster 2 Cluster 13 (HNSC-LUSC) squamous-like c4 miRNA cluster 7 cluster 2 mutation cluster 2 TCGA-33-4538 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 66 L-Upper TCGA-33-4538-F58812 TCGA-33-4538 TCGA-33-4538-01A -24174 2979 0 20 1 Scheduled Follow-up Submission 2014-4-24 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) Yes C34.1 8070/3 C34.1 YES 0.6 NO 90 0.9 NO 51 No M0 N2 T2 Stage IIIA TCGA-33-4538.fcc5edd0-a274-49b7-83c8-ea8de74b9571.pdf 4538 Preoperative 3 2 Complete Remission/Response YES NO RX Primary Tumor 01 0.1 6th YES NO YES 33 2 Lung A DECEASED 2002 TCGA-33-4538-01A-01D-1267-08 TCGA-33-4538-01A-01D-1198-05 867b4c4f-b1d3-4702-80ff-74ba4e169e3b TCGA-33-4538-01 TCGA-33-4538-01A-01D-1267-08 TCGA-33-4538-01 TCGA-33-4538-01A-01R-1201-07 867b4c4f-b1d3-4702-80ff-74ba4e169e3b 9d745138-eca3-4b39-9b5b-bbe13558f7c0 TCGA-33-4538-01 TCGA-33-4538-01A-01D-1195-01 TCGA-33-4538-01 867b4c4f-b1d3-4702-80ff-74ba4e169e3b TCGA-33-4538-01 867b4c4f-b1d3-4702-80ff-74ba4e169e3b TCGA-33-4538-01 TCGA-33-4538-01A-01D-1195-01 +TCGA-33-4547-01 TCGA-33-4547-01 Squamous C2-Squamous-like cluster 4 Cluster 5 squamous c3 squamous-like c4 miRNA cluster 4 cluster 2 mutation cluster 3 TCGA-33-4547 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 68 R-Upper TCGA-33-4547-F58819 TCGA-33-4547 TCGA-33-4547-01A -25056 0 2419 0 Scheduled Follow-up Submission 2014-4-24 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 1.3 NO 100 NO 1.7 NO NO 40 No M0 N0 T2 Stage IB TCGA-33-4547.c2a8e692-5b5a-4a56-85e9-165e523a341c.pdf 4547 Other TUMOR FREE 62 Complete Remission/Response YES NO R0 Primary Tumor 01 0.4 1970 6th NO NO YES 33 3 Lung A LIVING 2007 1950 TCGA-33-4547-01A-01D-1267-08 TCGA-33-4547-01A-01D-1198-05 f31fd0a1-b600-42bc-a6fa-689c05a581ce TCGA-33-4547-01 TCGA-33-4547-01A-01D-1267-08 TCGA-33-4547-01 TCGA-33-4547-01A-01R-1201-07 f31fd0a1-b600-42bc-a6fa-689c05a581ce 421f2725-656a-4d75-a304-13f2d4d64318 TCGA-33-4547-01A-21-2193-20 TCGA-33-4547-01 TCGA-33-4547-01A-01D-1195-01 TCGA-33-4547-01 f31fd0a1-b600-42bc-a6fa-689c05a581ce TCGA-33-4547-01 f31fd0a1-b600-42bc-a6fa-689c05a581ce TCGA-33-4547-01 TCGA-33-4547-01A-01D-1195-01 843b8ba9-57ff-4db6-98fb-1c2a508f98b7 +TCGA-33-4566-01 TCGA-33-4566-01 High C1-LUAD-enriched cluster 1 Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 4 cluster 2 mutation cluster 11 TCGA-33-4566 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 40 R-Upper TCGA-33-4566-F58817 TCGA-33-4566 TCGA-33-4566-01A -14643 5287 0 23 1 Scheduled Follow-up Submission 2014-4-24 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.9 NO 1.5 NO 20 No M0 N0 T2 Stage IB TCGA-33-4566.cd1a9ba4-3ccf-4f10-b512-a76baa9d8d44.pdf 4566 Other 77 4 YES R0 Primary Tumor 01 0.3 4th NO YES 33 2 Lung A DECEASED 1996 TCGA-33-4566-01A-01D-1441-08 9c14d16a-7e54-492c-bc10-055d69b5dd80 TCGA-33-4566-01 TCGA-33-4566-01A-01D-1441-08 TCGA-33-4566-01 TCGA-33-4566-01A-01R-1443-07 9c14d16a-7e54-492c-bc10-055d69b5dd80 TCGA-33-4566-01A-21-2193-20 TCGA-33-4566-01 TCGA-33-4566-01A-01D-1439-01 TCGA-33-4566-01 9c14d16a-7e54-492c-bc10-055d69b5dd80 TCGA-33-4566-01 9c14d16a-7e54-492c-bc10-055d69b5dd80 TCGA-33-4566-01 TCGA-33-4566-01A-01D-1439-01 TCGA-33-4566-01A-01D-1440-05 585632a4-48ad-4dda-89f6-c6ad289305f0 +TCGA-33-4566-11 TCGA-33-4566-11 C1-LUAD-enriched mutation cluster 11 TCGA-33-4566 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 40 R-Upper TCGA-33-4566-F58817 TCGA-33-4566 TCGA-33-4566-11A -14643 5287 0 23 1 Scheduled Follow-up Submission 2014-4-24 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 1 NO 1.8 NO 20 No M0 N0 T2 Stage IB 4566 Other 77 4 YES R0 Solid Tissue Normal 11 0.2 4th NO YES 33 2 Lung A DECEASED 1996 TCGA-33-4566-11A-01D-1440-05 +TCGA-33-4579-01 TCGA-33-4579-01 TCGA-33-4579 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung TCGA-33-4579-01A 0.7 NO 1 TCGA-33-4579.5c0b7635-ab69-45d6-8ee4-71aeab582594.pdf Primary Tumor 01 0.3 A 3cc08419-e5dd-4dc9-ad6d-d9bac7dfac34 TCGA-33-4579-01A-01R-1443-07 3cc08419-e5dd-4dc9-ad6d-d9bac7dfac34 3cc08419-e5dd-4dc9-ad6d-d9bac7dfac34 3cc08419-e5dd-4dc9-ad6d-d9bac7dfac34 TCGA-33-4579-01A-01D-1440-05 +TCGA-33-4579-11 TCGA-33-4579-11 TCGA-33-4579 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung TCGA-33-4579-11A 0.5 NO 1.6 Solid Tissue Normal 11 0.3 A TCGA-33-4579-11A-01D-1440-05 +TCGA-33-4582-01 TCGA-33-4582-01 High C2-Squamous-like cluster 4 Cluster 5 squamous c3 squamous-like c4 miRNA cluster 4 cluster 2 mutation cluster 13 TCGA-33-4582 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung NO NO NO NO 55 L-Lower TCGA-33-4582-F58815 TCGA-33-4582 -20402 3149 0 2923 25 2 Scheduled Follow-up Submission Progressive Disease 2014-4-24 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 60 NO Locoregional Recurrence YES 86 No M0 N0 T1 Stage IA 4582 Post-Adjuvant Therapy WITH TUMOR 37 1 Complete Remission/Response Convincing Imaging YES YES R0 Primary Tumor 01 5th YES 33 2 Lung DECEASED 2000 1966 TCGA-33-4582-01A-01D-1441-08 c192c13f-7bc1-479f-b2e4-ba64b46b0d68 TCGA-33-4582-01 TCGA-33-4582-01A-01D-1441-08 TCGA-33-4582-01 TCGA-33-4582-01A-01R-1443-07 c192c13f-7bc1-479f-b2e4-ba64b46b0d68 TCGA-33-4582-01A-21-2193-20 TCGA-33-4582-01 TCGA-33-4582-01A-01D-1439-01 TCGA-33-4582-01 c192c13f-7bc1-479f-b2e4-ba64b46b0d68 TCGA-33-4582-01 c192c13f-7bc1-479f-b2e4-ba64b46b0d68 TCGA-33-4582-01 TCGA-33-4582-01A-01D-1439-01 TCGA-33-4582-01A-01D-1440-05 f6afdaa8-47c3-4483-9a13-62fdc67f4c16 +TCGA-33-4582-11 TCGA-33-4582-11 C2-Squamous-like mutation cluster 13 TCGA-33-4582 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung NO NO NO NO 55 L-Lower TCGA-33-4582-F58815 TCGA-33-4582 TCGA-33-4582-11A -20402 3149 0 2923 25 2 Scheduled Follow-up Submission Progressive Disease 2014-4-24 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.9 NO 60 1.1 NO Locoregional Recurrence YES 86 No M0 N0 T1 Stage IA 4582 Post-Adjuvant Therapy WITH TUMOR 37 1 Complete Remission/Response Convincing Imaging YES YES R0 Solid Tissue Normal 11 0.4 5th YES 33 2 Lung A DECEASED 2000 1966 TCGA-33-4582-11A-01D-1440-05 +TCGA-33-4583-01 TCGA-33-4583-01 BRCA-LUAD+ C2-Squamous-like cluster 3 Cluster 13 (HNSC-LUSC) squamous-like c4 miRNA cluster 11 cluster 2 mutation cluster 2 TCGA-33-4583 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 73 L-Lower TCGA-33-4583-F58820 TCGA-33-4583 TCGA-33-4583-01A -26799 4601 0 4299 29 1 Scheduled Follow-up Submission 2014-4-24 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 1 NO 90 1 NO NO 46 No M0 N0 T1 Stage IA TCGA-33-4583.535235c0-4540-4638-b799-b7dfd082f5b8.pdf 4583 Other TUMOR FREE 73 3 Complete Remission/Response YES NO R0 Primary Tumor 01 0.3 1987 5th NO 33 4 Lung A DECEASED 1999 1941 TCGA-33-4583-01A-01D-1441-08 4865a07c-0af4-4cdd-b55f-ec11670d6e29 TCGA-33-4583-01 TCGA-33-4583-01A-01D-1441-08 TCGA-33-4583-01 4865a07c-0af4-4cdd-b55f-ec11670d6e29 TCGA-33-4583-01 TCGA-33-4583-01A-01D-1439-01 4865a07c-0af4-4cdd-b55f-ec11670d6e29 4865a07c-0af4-4cdd-b55f-ec11670d6e29 TCGA-33-4583-01 TCGA-33-4583-01A-01D-1439-01 TCGA-33-4583-01A-01D-1440-05 +TCGA-33-4583-11 TCGA-33-4583-11 C2-Squamous-like mutation cluster 2 TCGA-33-4583 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 73 L-Lower TCGA-33-4583-F58820 TCGA-33-4583 TCGA-33-4583-11A -26799 4601 0 4299 29 1 Scheduled Follow-up Submission 2014-4-24 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 1.1 NO 90 1.2 NO NO 46 No M0 N0 T1 Stage IA 4583 Other TUMOR FREE 73 3 Complete Remission/Response YES NO R0 Solid Tissue Normal 11 0.4 1987 5th NO 33 4 Lung A DECEASED 1999 1941 TCGA-33-4583-11A-01D-1440-05 +TCGA-33-4586-01 TCGA-33-4586-01 High C2-Squamous-like cluster 3 Cluster 13 (HNSC-LUSC) squamous c3 squamous-like c4 miRNA cluster 4 cluster 2 mutation cluster 5 TCGA-33-4586 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung YES YES NO 57 L-Lower TCGA-33-4586-F58818 TCGA-33-4586 TCGA-33-4586-01A -21148 428 0 169 37 1 Scheduled Follow-up Submission Progressive Disease 2014-4-24 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.9 NO 80 1.5 NO Locoregional Recurrence YES 108 No M0 N2 T2 Stage IIIA TCGA-33-4586.7fbf4e5b-0ea6-4630-b35f-9af85414be08.pdf 4586 Post-Adjuvant Therapy 69 2 70 2 Complete Remission/Response Convincing Imaging YES YES Primary Tumor 01 0.3 2004 6th YES 33 4 Lung A DECEASED 2007 1961 TCGA-33-4586-01A-01D-1441-08 80444ef3-0ac2-45fc-b0c5-237cd8bb8fc0 TCGA-33-4586-01 TCGA-33-4586-01A-01D-1441-08 TCGA-33-4586-01 80444ef3-0ac2-45fc-b0c5-237cd8bb8fc0 TCGA-33-4586-01A-21-2193-20 TCGA-33-4586-01 TCGA-33-4586-01A-01D-1439-01 80444ef3-0ac2-45fc-b0c5-237cd8bb8fc0 80444ef3-0ac2-45fc-b0c5-237cd8bb8fc0 TCGA-33-4586-01 TCGA-33-4586-01A-01D-1439-01 TCGA-33-4586-01A-01D-1440-05 c153a3c3-eaff-4a5b-b4fd-dc4d467669e7 +TCGA-33-4586-11 TCGA-33-4586-11 C2-Squamous-like mutation cluster 5 TCGA-33-4586 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung YES YES NO 57 L-Lower TCGA-33-4586-F58818 TCGA-33-4586 TCGA-33-4586-11A -21148 428 0 169 37 1 Scheduled Follow-up Submission Progressive Disease 2014-4-24 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 1 NO 80 1 NO Locoregional Recurrence YES 108 No M0 N2 T2 Stage IIIA 4586 Post-Adjuvant Therapy 69 2 70 2 Complete Remission/Response Convincing Imaging YES YES Solid Tissue Normal 11 0.3 2004 6th YES 33 4 Lung A DECEASED 2007 1961 TCGA-33-4586-11A-01D-1440-05 +TCGA-33-4587-01 TCGA-33-4587-01 Squamous OV-like c1 RNA cluster 12 miRNA cluster 6 TCGA-33-4587 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 63 R-Middle TCGA-33-4587-F22037 TCGA-33-4587 TCGA-33-4587-01A -23062 1656 0 111 Scheduled Follow-up Submission Stable Disease 2012-2-23 FEMALE Lung Small Cell Squamous Cell Carcinoma No C34.2 8073/3 C34.2 YES 0.7 NO NO 1 NO No MX N0 T2 Stage IB TCGA-33-4587.6e5b11a3-0414-4af4-8cd2-0e80c02b8bcf.pdf 4587 WITH TUMOR 91 73 76 75 Progressive Disease YES NO R0 Primary Tumor 01 0.3 2003 6th YES NO YES 33 4 Lung A DECEASED 2003 1970 56dc0212-f15b-4a18-81db-7b8268106162 TCGA-33-4587-01 TCGA-33-4587-01 TCGA-33-4587-01 56dc0212-f15b-4a18-81db-7b8268106162 TCGA-33-4587-01 TCGA-33-4587-01A-11D-2121-01 56dc0212-f15b-4a18-81db-7b8268106162 56dc0212-f15b-4a18-81db-7b8268106162 TCGA-33-4587-01A-11D-2121-01 TCGA-33-4587-01A-11D-2123-05 +TCGA-33-4587-11 TCGA-33-4587-11 TCGA-33-4587 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 63 R-Middle TCGA-33-4587-F22037 TCGA-33-4587 TCGA-33-4587-11A -23062 1656 0 111 Scheduled Follow-up Submission Stable Disease 2012-2-23 FEMALE Lung Small Cell Squamous Cell Carcinoma No C34.2 8073/3 C34.2 YES 1.1 NO NO 1.9 NO No MX N0 T2 Stage IB 4587 WITH TUMOR 91 73 76 75 Progressive Disease YES NO R0 Solid Tissue Normal 11 0.3 2003 6th YES NO YES 33 4 Lung A DECEASED 2003 1970 3e8b3913-495f-488c-872c-9ab46b85c301 TCGA-33-4587-11 TCGA-33-4587-11 3e8b3913-495f-488c-872c-9ab46b85c301 3e8b3913-495f-488c-872c-9ab46b85c301 3e8b3913-495f-488c-872c-9ab46b85c301 +TCGA-33-4589-01 TCGA-33-4589-01 Squamous Cluster 14 (HNSC) squamous c3 miRNA cluster 11 TCGA-33-4589 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 62 R-Lower TCGA-33-4589-F58813 TCGA-33-4589 TCGA-33-4589-01A -22754 47 0 1 Scheduled Follow-up Submission 2014-4-24 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.9 8070/3 C34.9 YES 0.6 NO 80 1.4 NO NO 45 Yes M0 N1 T2 Stage IIB TCGA-33-4589.f77f14e6-c17d-4908-a5e3-77d1e11f26c9.pdf 4589 Preoperative TUMOR FREE Complete Remission/Response NO NO Primary Tumor 01 0.3 3rd NO 33 2 Lung A DECEASED 1992 1948 5a6bed81-2364-4681-b659-af68a1028512 TCGA-33-4589-01 TCGA-33-4589-01 TCGA-33-4589-01A-01R-1443-07 5a6bed81-2364-4681-b659-af68a1028512 TCGA-33-4589-01A-21-2193-20 TCGA-33-4589-01 TCGA-33-4589-01A-01D-1439-01 TCGA-33-4589-01 5a6bed81-2364-4681-b659-af68a1028512 TCGA-33-4589-01 5a6bed81-2364-4681-b659-af68a1028512 TCGA-33-4589-01 TCGA-33-4589-01A-01D-1439-01 TCGA-33-4589-01A-01D-1440-05 78114d62-a9cb-4bfa-8c47-a84e9c53802f +TCGA-33-4589-11 TCGA-33-4589-11 TCGA-33-4589 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 62 R-Lower TCGA-33-4589-F58813 TCGA-33-4589 TCGA-33-4589-11A -22754 47 0 1 Scheduled Follow-up Submission 2014-4-24 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.9 8070/3 C34.9 YES 0.6 NO 80 1.5 NO NO 45 Yes M0 N1 T2 Stage IIB 4589 Preoperative TUMOR FREE Complete Remission/Response NO NO Solid Tissue Normal 11 0.4 3rd NO 33 2 Lung A DECEASED 1992 1948 TCGA-33-4589-11A-01D-1440-05 +TCGA-33-6737-01 TCGA-33-6737-01 High C1-LUAD-enriched cluster 1 Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 4 cluster 4 mutation cluster 13 TCGA-33-6737 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 71 R-Upper TCGA-33-6737-F16690 TCGA-33-6737 TCGA-33-6737-01A -26033 601 0 Scheduled Follow-up Submission 2011-9-23 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.4 NO 2 NO 20 Yes M0 N2 T2 Stage IIIA TCGA-33-6737.d8a5d5d4-48a9-4b5a-bf57-ff32e7302d74.pdf 6737 WITH TUMOR Progressive Disease NO Primary Tumor 01 0.3 6th YES NO YES 33 4 Lung A DECEASED 2008 TCGA-33-6737-01A-11D-1817-08 38dbab79-7aeb-4153-b3ce-8feeb36b48e5 TCGA-33-6737-01A-11D-1817-08 TCGA-33-6737-01 38dbab79-7aeb-4153-b3ce-8feeb36b48e5 TCGA-33-6737-01A-13-2194-20 TCGA-33-6737-01 TCGA-33-6737-01A-11D-1816-01 38dbab79-7aeb-4153-b3ce-8feeb36b48e5 38dbab79-7aeb-4153-b3ce-8feeb36b48e5 TCGA-33-6737-01A-11D-1816-01 TCGA-33-6737-01A-11D-1818-05 f15f6e1d-a3f0-4de4-9060-833a3989022f +TCGA-33-6737-11 TCGA-33-6737-11 C1-LUAD-enriched mutation cluster 13 TCGA-33-6737 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 71 R-Upper TCGA-33-6737-F16690 TCGA-33-6737 TCGA-33-6737-11A -26033 601 0 Scheduled Follow-up Submission 2011-9-23 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.7 NO 0.9 NO 20 Yes M0 N2 T2 Stage IIIA 6737 WITH TUMOR Progressive Disease NO Solid Tissue Normal 11 0.3 6th YES NO YES 33 4 Lung A DECEASED 2008 d7ff5d57-d610-4ea9-a849-b974736121fa d7ff5d57-d610-4ea9-a849-b974736121fa d7ff5d57-d610-4ea9-a849-b974736121fa d7ff5d57-d610-4ea9-a849-b974736121fa +TCGA-33-6738-01 TCGA-33-6738-01 Squamous C2-Squamous-like BRCA CIMP c7 squamous c3 squamous-like c4 miRNA c1uster 9 TCGA-33-6738 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 80 L-Upper TCGA-33-6738-F71135 TCGA-33-6738 TCGA-33-6738-01A -29368 0 1927 0 Scheduled Follow-up Submission Complete Remission/Response 2015-3-18 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.8 NO 100 1 NO NO 50 No MX N2 T1 Stage IIIA TCGA-33-6738.ba07bb38-7742-4129-bdf2-f76ce3378b6f.pdf 6738 TUMOR FREE Complete Remission/Response NO NO Primary Tumor 01 0.3 6th YES NO YES 33 4 Lung A LIVING 2009 f62b601a-a8a2-4179-be5b-6b9548da05c2 TCGA-33-6738-01 TCGA-33-6738-01 TCGA-33-6738-01 f62b601a-a8a2-4179-be5b-6b9548da05c2 TCGA-33-6738-01A-13-2194-20 TCGA-33-6738-01 TCGA-33-6738-01A-11D-1943-01 f62b601a-a8a2-4179-be5b-6b9548da05c2 f62b601a-a8a2-4179-be5b-6b9548da05c2 TCGA-33-6738-01A-11D-1943-01 TCGA-33-6738-01A-11D-1947-05 5dcec6e8-27e0-4674-b842-8f2d2542d907 +TCGA-33-A4WN-01 TCGA-33-A4WN-01 TCGA-33-A4WN TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 60 R-Upper TCGA-33-A4WN-F58488 TCGA-33-A4WN TCGA-33-A4WN-01A -22268 327 143 0 4 Scheduled Follow-up Submission Complete Remission/Response 2014-4-11 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 350 NO 20 NO NO 60 true No MX N0 T2a Stage IB TCGA-33-A4WN.D4BD5AF3-DDC8-4724-A9E7-F54F5BDB9826.pdf A4WN Other TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 7th YES NO 33 2 Lung A DECEASED 2011 1970 ac66c676-f950-4565-82ac-a9d98adbcde9 TCGA-33-A4WN-01 TCGA-33-A4WN-01 TCGA-33-A4WN-01 ac66c676-f950-4565-82ac-a9d98adbcde9 TCGA-33-A4WN-01 TCGA-33-A4WN-01A-11D-A25M-01 ac66c676-f950-4565-82ac-a9d98adbcde9 ac66c676-f950-4565-82ac-a9d98adbcde9 TCGA-33-A4WN-01A-11D-A25M-01 TCGA-33-A4WN-01A-11D-A25R-05 3796867F-F4B5-4405-B804-67867B52A090 +TCGA-33-A5GW-01 TCGA-33-A5GW-01 TCGA-33-A5GW TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 67 R-Lower TCGA-33-A5GW-F58489 TCGA-33-A5GW TCGA-33-A5GW-01A -24586 301 9 0 9 4 Scheduled Follow-up Submission Complete Remission/Response 2014-4-11 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 50 NO 20 NO NO 50 true No MX N1 T1a Stage IIA TCGA-33-A5GW.67D1EB63-96A5-41C4-B324-0C8321F3B064.pdf A5GW Other TUMOR FREE 90.9 84.9 Complete Remission/Response YES NO R0 Primary Tumor 01 2008 7th NO YES NO 33 4 Lung A DECEASED 2012 425af988-b4b8-4476-ba67-8fc7148f4452 TCGA-33-A5GW-01 TCGA-33-A5GW-01 TCGA-33-A5GW-01 425af988-b4b8-4476-ba67-8fc7148f4452 TCGA-33-A5GW-01 TCGA-33-A5GW-01A-11D-A27J-01 425af988-b4b8-4476-ba67-8fc7148f4452 425af988-b4b8-4476-ba67-8fc7148f4452 TCGA-33-A5GW-01A-11D-A27J-01 TCGA-33-A5GW-01A-11D-A27L-05 E57A266E-511B-4A00-B3BE-54AAFB951012 +TCGA-33-AAS8-01 TCGA-33-AAS8-01 TCGA-33-AAS8 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 59 R-Upper TCGA-33-AAS8 -21675 1114 0 1 2014-6-13 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 90 NO 60 No MX N0 T1 Stage IA AAS8 Preoperative TUMOR FREE Complete Remission/Response NO NO R0 Primary Tumor 01 1991 5th YES NO YES 33 4 Lung DECEASED 1998 1971 c86cac86-41e9-453c-9de5-83d506990256 TCGA-33-AAS8-01 TCGA-33-AAS8-01 TCGA-33-AAS8-01 c86cac86-41e9-453c-9de5-83d506990256 TCGA-33-AAS8-01 TCGA-33-AAS8-01A-11D-A400-01 c86cac86-41e9-453c-9de5-83d506990256 c86cac86-41e9-453c-9de5-83d506990256 TCGA-33-AAS8-01A-11D-A400-01 TCGA-33-AAS8-01A-11D-A408-05 +TCGA-33-AASB-01 TCGA-33-AASB-01 TCGA-33-AASB TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 66 L-Upper TCGA-33-AASB TCGA-33-AASB-01A -24183 4286 211 0 84.6 1 2014-6-13 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 150 NO 90 YES 40 true No MX N0 T2 Stage IB TCGA-33-AASB.DF569855-8AF0-4930-97CC-8A65CA697106.pdf AASB Preoperative WITH TUMOR 62.1 103.1 64.6 107.2 Progressive Disease YES NO R0 Primary Tumor 01 5th YES NO YES 33 2 Lung A DECEASED 2002 1962 81fd0745-ced7-4eab-adeb-0588634e1fae TCGA-33-AASB-01 TCGA-33-AASB-01 TCGA-33-AASB-01 81fd0745-ced7-4eab-adeb-0588634e1fae TCGA-33-AASB-01 TCGA-33-AASB-01A-11D-A400-01 81fd0745-ced7-4eab-adeb-0588634e1fae 81fd0745-ced7-4eab-adeb-0588634e1fae TCGA-33-AASB-01A-11D-A400-01 TCGA-33-AASB-01A-11D-A408-05 B06885A0-8E03-4F23-9979-C7E39664D3D7 +TCGA-33-AASD-01 TCGA-33-AASD-01 TCGA-33-AASD TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 83 R-Lower TCGA-33-AASD TCGA-33-AASD-01A -30623 4641 3376 0 38.1 1 2014-6-13 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 120 NO 80 YES 84 true No MX N0 T1 Stage IA TCGA-33-AASD.00E9AF99-0DD2-447D-90F3-7F068E6C3E55.pdf AASD Preoperative WITH TUMOR 66.9 82.4 77.4 95.3 Progressive Disease YES NO R0 Primary Tumor 01 5th NO NO YES 33 2 Lung A DECEASED 2001 1950 95e1065f-3bd1-4249-b896-e8835c856582 TCGA-33-AASD-01 TCGA-33-AASD-01 TCGA-33-AASD-01 95e1065f-3bd1-4249-b896-e8835c856582 TCGA-33-AASD-01 TCGA-33-AASD-01A-11D-A400-01 95e1065f-3bd1-4249-b896-e8835c856582 95e1065f-3bd1-4249-b896-e8835c856582 TCGA-33-AASD-01A-11D-A400-01 TCGA-33-AASD-01A-11D-A408-05 69AC9F6E-915F-41E2-8638-4248EBA39703 +TCGA-33-AASI-01 TCGA-33-AASI-01 TCGA-33-AASI TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 65 L-Lower TCGA-33-AASI TCGA-33-AASI-01A -23965 2032 1344 0 1 2014-6-13 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 220 NO 90 NO 60 true No MX N1 T2 Stage IIB TCGA-33-AASI.A04F5C2E-6BDB-425D-9A4B-B5FDE0BC0EE9.pdf AASI Preoperative WITH TUMOR Stable Disease NO YES RX Primary Tumor 01 6th YES NO YES 33 4 Lung A DECEASED 2008 7dedcae7-dff0-4df0-9075-f368be9cb60b TCGA-33-AASI-01 TCGA-33-AASI-01 TCGA-33-AASI-01 7dedcae7-dff0-4df0-9075-f368be9cb60b TCGA-33-AASI-01 TCGA-33-AASI-01A-22D-A400-01 7dedcae7-dff0-4df0-9075-f368be9cb60b 7dedcae7-dff0-4df0-9075-f368be9cb60b TCGA-33-AASI-01A-22D-A400-01 TCGA-33-AASI-01A-22D-A408-05 E015EBD5-7ADF-4D54-9BB1-E9C80E4AA02C +TCGA-33-AASJ-01 TCGA-33-AASJ-01 TCGA-33-AASJ TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 60 R-Lower TCGA-33-AASJ TCGA-33-AASJ-01A -22179 5439 3600 0 80.9 1 2014-6-13 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 150 NO 90 YES true No MX N0 T2 Stage IB TCGA-33-AASJ.B6B6F820-32C4-4D60-9EC5-458F4D3676D8.pdf AASJ Preoperative WITH TUMOR 49.6 37.5 79.4 60.0 Complete Remission/Response YES NO R0 Primary Tumor 01 1991 5th NO NO YES 33 4 Lung A DECEASED 1999 1983 57162746-b63a-4560-aea4-a933e0051c63 TCGA-33-AASJ-01 TCGA-33-AASJ-01 TCGA-33-AASJ-01 57162746-b63a-4560-aea4-a933e0051c63 TCGA-33-AASJ-01 TCGA-33-AASJ-01A-11D-A400-01 57162746-b63a-4560-aea4-a933e0051c63 57162746-b63a-4560-aea4-a933e0051c63 TCGA-33-AASJ-01A-11D-A400-01 TCGA-33-AASJ-01A-11D-A408-05 EBE025AF-C10E-4B66-B276-01FDF4BFB346 +TCGA-33-AASL-01 TCGA-33-AASL-01 TCGA-33-AASL TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 57 R-Upper TCGA-33-AASL -20940 826 0 59.6 2 2014-6-13 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 90 YES 60 No MX N0 T1 Stage IA AASL Preoperative WITH TUMOR 71.2 56.2 80.0 63.1 Progressive Disease YES NO R0 Primary Tumor 01 5th NO NO YES 33 2 Lung DECEASED 2000 b9b42bfa-2222-4d21-a163-02f767c4db38 TCGA-33-AASL-01 TCGA-33-AASL-01 TCGA-33-AASL-01 b9b42bfa-2222-4d21-a163-02f767c4db38 TCGA-33-AASL-01 TCGA-33-AASL-01A-11D-A400-01 b9b42bfa-2222-4d21-a163-02f767c4db38 b9b42bfa-2222-4d21-a163-02f767c4db38 TCGA-33-AASL-01A-11D-A400-01 TCGA-33-AASL-01A-11D-A408-05 +TCGA-34-2596-01 TCGA-34-2596-01 High C2-Squamous-like cluster 3 Cluster 13 (HNSC-LUSC) squamous c3 squamous-like c4 miRNA cluster 4 cluster 2 mutation cluster 5 TCGA-34-2596 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung NO NO NO NO 70 Bronchial TCGA-34-2596-F5309 TCGA-34-2596 TCGA-34-2596-01A -25574 80 0 80 2010-8-26 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.9 8070/3 C34.9 YES 1.2 NO 1.8 NO 60 No M0 N1 T2 Stage IIB TCGA-34-2596.03af2ab8-fad5-49f6-94d7-8faaec71b63f.pdf 2596 TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 0.4 1974 NO NO YES 34 3 Lung A DECEASED 2004 TCGA-34-2596-01A-01D-1522-08 TCGA-34-2596-01A-01D-0848-05 3647c517-acfa-439c-85a2-e03a305b8ce1 TCGA-34-2596-01 TCGA-34-2596-01A-01D-1522-08 TCGA-34-2596-01 TCGA-34-2596-01A-01R-0851-07 3647c517-acfa-439c-85a2-e03a305b8ce1 bdda2c61-7ffb-44ad-9f4d-0d10480af9b4 TCGA-34-2596-01A-21-2193-20 TCGA-34-2596-01 TCGA-34-2596-01A-01D-0844-01 TCGA-34-2596-01 3647c517-acfa-439c-85a2-e03a305b8ce1 TCGA-34-2596-01 3647c517-acfa-439c-85a2-e03a305b8ce1 TCGA-34-2596-01 TCGA-34-2596-01A-01D-0844-01 9d1b859e-95d7-43d1-b71a-c0a0c240ccda +TCGA-34-2600-01 TCGA-34-2600-01 Squamous C2-Squamous-like cluster 4 Cluster 5 squamous-like c4 miRNA cluster 11 cluster 1 mutation cluster 8 TCGA-34-2600 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 76 R-Lower TCGA-34-2600-F19851 TCGA-34-2600 -28072 1874 0 1874 Scheduled Follow-up Submission 2011-12-29 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES Central Lung NO 50 No M0 N0 T1 Stage IA 2600 TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 1997 NO NO YES 34 4 Lung DECEASED 2000 TCGA-34-2600-01A-01D-1522-08 TCGA-34-2600-01A-01D-0848-05 e1d11ec9-09e9-4cbb-b3a6-6724f4379cc7 TCGA-34-2600-01 TCGA-34-2600-01A-01D-1522-08 TCGA-34-2600-01 TCGA-34-2600-01A-01R-0851-07 e1d11ec9-09e9-4cbb-b3a6-6724f4379cc7 f24c4723-737b-4a8c-a675-8adba72cb6f0 TCGA-34-2600-01 TCGA-34-2600-01A-01D-0844-01 TCGA-34-2600-01 e1d11ec9-09e9-4cbb-b3a6-6724f4379cc7 TCGA-34-2600-01 e1d11ec9-09e9-4cbb-b3a6-6724f4379cc7 TCGA-34-2600-01 TCGA-34-2600-01A-01D-0844-01 +TCGA-34-2604-01 TCGA-34-2604-01 Squamous Cluster 5 squamous c3 miRNA cluster 4 TCGA-34-2604 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 81 L-Lower TCGA-34-2604-F4217 TCGA-34-2604 -29827 958 0 958 NO NO 2010-11-4 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES NO NO 132 Yes M0 N0 T2 Stage IB 2604 TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 NO NO YES 34 2 Lung DECEASED 1999 1933 TCGA-34-2604-01A-01D-0848-05 TCGA-34-2604-01 TCGA-34-2604-01A-01R-0851-07 da7dc5b4-6621-43e3-bb78-edd916e723ac TCGA-34-2604-01A-21-2193-20 TCGA-34-2604-01A-01D-0844-01 TCGA-34-2604-01 TCGA-34-2604-01 TCGA-34-2604-01 TCGA-34-2604-01A-01D-0844-01 cf27663d-6ff3-4102-948c-c0c712af54d0 +TCGA-34-2605-01 TCGA-34-2605-01 High Cluster 13 (HNSC-LUSC) squamous c3 miRNA cluster 4 TCGA-34-2605 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung NO NO 76 R-Upper TCGA-34-2605-F4240 TCGA-34-2605 TCGA-34-2605-01A -27833 881 0 881 844 3 NO NO 2010-11-4 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.7 NO NO 2 YES 60 Yes M0 N1 T4 Stage IIIB TCGA-34-2605.53291789-2743-4446-b859-aa65568586a7.pdf 2605 Post-Adjuvant Therapy WITH TUMOR Complete Remission/Response NO R0 Primary Tumor 01 0.4 2006 YES NO YES 34 4 Lung A DECEASED 2006 1946 TCGA-34-2605-01A-01D-0848-05 TCGA-34-2605-01 TCGA-34-2605-01A-01R-0851-07 e4647361-e144-46ed-bc1e-d3ddca5059c6 TCGA-34-2605-01A-21-2193-20 TCGA-34-2605-01A-01D-0844-01 TCGA-34-2605-01 TCGA-34-2605-01 TCGA-34-2605-01 TCGA-34-2605-01A-01D-0844-01 79a77711-5efb-4811-9e36-c6823526a48a +TCGA-34-2608-01 TCGA-34-2608-01 Squamous C2-Squamous-like cluster 1 Low purity c2 squamous c3 squamous-like c4 miRNA cluster 4 cluster 2 mutation cluster 5 TCGA-34-2608 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung NO NO NO NO 84 L-Upper TCGA-34-2608-F5308 TCGA-34-2608 TCGA-34-2608-01A -30958 1000 0 1000 2010-8-26 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.7 NO 1.9 NO 60 No M0 N0 T2 Stage IB TCGA-34-2608.18c043ab-df83-40bf-bafc-e33aed1ebdea.pdf 2608 TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 0.6 1959 NO NO YES 34 3 Lung A DECEASED 1999 TCGA-34-2608-01A-02D-1522-08 TCGA-34-2608-01A-02D-0848-05 ea2e88e9-53f1-4fcd-b7b8-924ec8ed0aaa TCGA-34-2608-01 TCGA-34-2608-01A-02D-1522-08 TCGA-34-2608-01 TCGA-34-2608-01A-02R-0851-07 ea2e88e9-53f1-4fcd-b7b8-924ec8ed0aaa 2a62bb62-7427-4089-ac62-4cb0f27ddd6d TCGA-34-2608-01A-11-2193-20 TCGA-34-2608-01 TCGA-34-2608-01A-02D-0844-01 TCGA-34-2608-01 ea2e88e9-53f1-4fcd-b7b8-924ec8ed0aaa TCGA-34-2608-01 ea2e88e9-53f1-4fcd-b7b8-924ec8ed0aaa TCGA-34-2608-01 TCGA-34-2608-01A-02D-0844-01 f3b4f474-f6b9-47aa-bcf8-a06304109a51 +TCGA-34-2609-01 TCGA-34-2609-01 High Cluster 13 (HNSC-LUSC) squamous c3 miRNA cluster 7 TCGA-34-2609 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung YES NO NO NO 81 R-Lower TCGA-34-2609-F4225 TCGA-34-2609 TCGA-34-2609-01A -29871 951 0 951 898 NO NO Progressive Disease 2010-11-4 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.4 NO NO 2 YES 60 Yes M0 N1 T2 Stage IIB TCGA-34-2609.8101c165-87f1-4edc-9756-163156377cab.pdf 2609 WITH TUMOR Complete Remission/Response NO R0 Primary Tumor 01 0.3 2004 YES NO YES 34 4 Lung A DECEASED 2004 1941 TCGA-34-2609-01A-01D-0848-05 TCGA-34-2609-01 TCGA-34-2609-01A-01R-0851-07 141ac0a1-04cf-402f-acdb-cf061888ea56 TCGA-34-2609-01A-21-2193-20 TCGA-34-2609-01A-01D-0844-01 TCGA-34-2609-01 TCGA-34-2609-01 TCGA-34-2609-01 TCGA-34-2609-01A-01D-0844-01 ce27724e-e32d-4576-a458-17ee97966504 +TCGA-34-5231-01 TCGA-34-5231-01 Squamous C2-Squamous-like cluster 4 Cluster 13 (HNSC-LUSC) squamous c3 squamous-like c4 miRNA cluster 12 cluster 4 mutation cluster 12 TCGA-34-5231 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung NO NO NO 72 R-Upper TCGA-34-5231-F32187 TCGA-34-5231 TCGA-34-5231-01A -26525 1984 0 1528 YES Scheduled Follow-up Submission Stable Disease 2012-5-18 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 1 NO 1.5 NO NO 50 No M0 N0 T1 Stage IA TCGA-34-5231.f86f0624-ede3-4128-80c7-35d5f1d65fc4.pdf 5231 TUMOR FREE Stable Disease NO Primary Tumor 01 0.3 6th NO NO YES 34 3 Lung A DECEASED 2006 TCGA-34-5231-01A-21D-1817-08 cdae461e-021e-4e59-ac04-d640d29d29dc TCGA-34-5231-01 TCGA-34-5231-01A-21D-1817-08 TCGA-34-5231-01 TCGA-34-5231-01 cdae461e-021e-4e59-ac04-d640d29d29dc TCGA-34-5231-01A-22-2194-20 TCGA-34-5231-01 TCGA-34-5231-01A-21D-1816-01 cdae461e-021e-4e59-ac04-d640d29d29dc cdae461e-021e-4e59-ac04-d640d29d29dc TCGA-34-5231-01A-21D-1816-01 TCGA-34-5231-01A-21D-1818-05 70790e8d-ce93-491e-8b1f-f3a5b60871b5 +TCGA-34-5232-01 TCGA-34-5232-01 Squamous C2-Squamous-like cluster 1 Cluster 13 (HNSC-LUSC) squamous c3 squamous-like c4 miRNA cluster 11 cluster 4 mutation cluster 3 TCGA-34-5232 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 75 L-Upper TCGA-34-5232-F70378 TCGA-34-5232 -27633 0 2471 YES Scheduled Follow-up Submission Complete Remission/Response 2015-2-10 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES NO NO No M0 N1 T1 Stage IIA 5232 TUMOR FREE Complete Remission/Response NO NO Primary Tumor 01 6th NO NO YES 34 Lung LIVING 2006 TCGA-34-5232-01A-21D-1817-08 f1d662e9-e8dc-47d4-b350-c41798ad4584 TCGA-34-5232-01 TCGA-34-5232-01A-21D-1817-08 TCGA-34-5232-01 TCGA-34-5232-01 f1d662e9-e8dc-47d4-b350-c41798ad4584 TCGA-34-5232-01A-22-2194-20 TCGA-34-5232-01 TCGA-34-5232-01A-21D-1816-01 f1d662e9-e8dc-47d4-b350-c41798ad4584 f1d662e9-e8dc-47d4-b350-c41798ad4584 TCGA-34-5232-01A-21D-1816-01 TCGA-34-5232-01A-21D-1818-05 df107ef1-536f-4ba9-aed3-7bed52caa45c +TCGA-34-5234-01 TCGA-34-5234-01 COAD-READ C1-LUAD-enriched cluster 1 Low purity c2 squamous c3 squamous-like c4 miRNA cluster 7 cluster 2 mutation cluster 14 TCGA-34-5234 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 71 L-Upper TCGA-34-5234-F70379 TCGA-34-5234 TCGA-34-5234-01A -26072 0 2271 NO Scheduled Follow-up Submission Complete Remission/Response 2015-2-10 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.7 NO 90 NO Central Lung 1.5 NO NO 40 No M0 N0 T1 Stage IA TCGA-34-5234.ecde2410-dc20-4f6d-9215-4bf5452d530c.pdf 5234 TUMOR FREE Complete Remission/Response NO NO R0 Primary Tumor 01 0.3 2000 6th NO NO YES 34 4 Lung A LIVING 2007 1960 TCGA-34-5234-01A-01D-1632-08 523d5f7e-4980-4f87-be5d-3a81bb6f8314 TCGA-34-5234-01 TCGA-34-5234-01A-01D-1632-08 TCGA-34-5234-01 TCGA-34-5234-01 523d5f7e-4980-4f87-be5d-3a81bb6f8314 TCGA-34-5234-01A-21-2194-20 TCGA-34-5234-01 TCGA-34-5234-01A-01D-1631-01 523d5f7e-4980-4f87-be5d-3a81bb6f8314 523d5f7e-4980-4f87-be5d-3a81bb6f8314 TCGA-34-5234-01A-01D-1631-01 TCGA-34-5234-01A-01D-1633-05 a26c5140-ea1f-4fc1-adbb-a3c8203bd19c +TCGA-34-5236-01 TCGA-34-5236-01 Squamous C2-Squamous-like cluster 1 Cluster 13 (HNSC-LUSC) squamous c3 squamous-like c4 miRNA cluster 5 cluster 4 mutation cluster 5 TCGA-34-5236 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung YES YES NO 60 L-Upper TCGA-34-5236-F32198 TCGA-34-5236 TCGA-34-5236-01A -21935 276 0 113 YES Scheduled Follow-up Submission Progressive Disease 2012-5-18 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.7 NO 2.1 NO Locoregional Recurrence YES No M0 N0 T3 Stage IIB TCGA-34-5236.8aadcd05-f598-4c12-87eb-6769bbf24b51.pdf 5236 WITH TUMOR Progressive Disease Convincing Imaging NO Primary Tumor 01 0.2 6th NO NO YES 34 Lung A DECEASED 2007 TCGA-34-5236-01A-21D-1817-08 e6333a68-bb60-4450-af13-2a22a2335e03 TCGA-34-5236-01 TCGA-34-5236-01A-21D-1817-08 TCGA-34-5236-01 TCGA-34-5236-01 e6333a68-bb60-4450-af13-2a22a2335e03 TCGA-34-5236-01A-22-2194-20 TCGA-34-5236-01 TCGA-34-5236-01A-21D-1816-01 e6333a68-bb60-4450-af13-2a22a2335e03 e6333a68-bb60-4450-af13-2a22a2335e03 TCGA-34-5236-01A-21D-1816-01 TCGA-34-5236-01A-21D-1818-05 428e8766-529c-4372-8ea0-908252cd825c +TCGA-34-5239-01 TCGA-34-5239-01 BRCA-LUAD+ C2-Squamous-like cluster 2 Cluster 14 (HNSC) squamous c3 squamous-like c4 miRNA cluster 5 cluster 4 mutation cluster 8 TCGA-34-5239 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung YES NO NO 75 L-Upper TCGA-34-5239-F70380 TCGA-34-5239 -27528 0 1834 1530 YES YES Scheduled Follow-up Submission Progressive Disease 2015-2-10 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES NO Distant Metastasis YES No M0 N0 T4 Stage IIIA 5239 WITH TUMOR Complete Remission/Response NO NO Primary Tumor 01 7th NO NO YES 34 Lung LIVING 2010 TCGA-34-5239-01A-21D-1817-08 ca366b19-d82e-4e65-9fde-f3be38fbe038 TCGA-34-5239-01 TCGA-34-5239-01A-21D-1817-08 TCGA-34-5239-01 TCGA-34-5239-01 ca366b19-d82e-4e65-9fde-f3be38fbe038 TCGA-34-5239-01A-22-2194-20 TCGA-34-5239-01 TCGA-34-5239-01A-21D-1816-01 ca366b19-d82e-4e65-9fde-f3be38fbe038 ca366b19-d82e-4e65-9fde-f3be38fbe038 TCGA-34-5239-01A-21D-1816-01 TCGA-34-5239-01A-21D-1818-05 fc556f8e-523f-4dc1-926c-bdc0eb9debb9 +TCGA-34-5240-01 TCGA-34-5240-01 High C2-Squamous-like cluster 3 Cluster 13 (HNSC-LUSC) squamous-like c4 miRNA cluster 4 cluster 2 mutation cluster 3 TCGA-34-5240 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 73 L-Upper TCGA-34-5240-F70373 TCGA-34-5240 -26735 0 1541 NO NO Scheduled Follow-up Submission Complete Remission/Response 2015-2-10 FEMALE Lung Basaloid Squamous Cell Carcinoma No C34.1 8083/3 C34.1 YES NO Central Lung NO NO 56 No M0 N1 T2 Stage IIB 5240 TUMOR FREE Complete Remission/Response NO NO Primary Tumor 01 6th YES NO YES 34 2 Lung LIVING 2009 1953 TCGA-34-5240-01A-01D-1441-08 d3642776-8fd7-4cdd-b94a-1d558b5ac69d TCGA-34-5240-01 TCGA-34-5240-01A-01D-1441-08 TCGA-34-5240-01 TCGA-34-5240-01A-01R-1443-07 d3642776-8fd7-4cdd-b94a-1d558b5ac69d TCGA-34-5240-01 TCGA-34-5240-01A-01D-1439-01 TCGA-34-5240-01 d3642776-8fd7-4cdd-b94a-1d558b5ac69d TCGA-34-5240-01 d3642776-8fd7-4cdd-b94a-1d558b5ac69d TCGA-34-5240-01 TCGA-34-5240-01A-01D-1439-01 TCGA-34-5240-01A-01D-1440-05 +TCGA-34-5241-01 TCGA-34-5241-01 Squamous C2-Squamous-like cluster 4 Cluster 5 squamous c3 squamous-like c4 miRNA cluster 4 cluster 4 mutation c1uster 9 TCGA-34-5241 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung NO NO NO 79 R-Lower TCGA-34-5241-F32205 TCGA-34-5241 TCGA-34-5241-01A -29098 515 0 428 NO Scheduled Follow-up Submission Complete Remission/Response 2012-5-18 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 1 NO NO NO 1.5 NO NO 25 No M0 N0 T2 Stage IB TCGA-34-5241.9d9a1bba-2489-40b3-bad8-950bc742862d.pdf 5241 TUMOR FREE Stable Disease NO Primary Tumor 01 0.3 1979 NO NO YES 34 3 Lung A DECEASED 2009 1954 TCGA-34-5241-01A-01D-1441-08 e778c0a5-1f5b-4e94-9779-2f7386586ff1 TCGA-34-5241-01 TCGA-34-5241-01A-01D-1441-08 TCGA-34-5241-01 TCGA-34-5241-01A-01R-1443-07 e778c0a5-1f5b-4e94-9779-2f7386586ff1 TCGA-34-5241-01A-21-2194-20 TCGA-34-5241-01 TCGA-34-5241-01A-01D-1439-01 TCGA-34-5241-01 e778c0a5-1f5b-4e94-9779-2f7386586ff1 TCGA-34-5241-01 e778c0a5-1f5b-4e94-9779-2f7386586ff1 TCGA-34-5241-01 TCGA-34-5241-01A-01D-1439-01 TCGA-34-5241-01A-01D-1440-05 0140324e-7bca-4fbb-b771-73ccd1a4c15a +TCGA-34-5927-01 TCGA-34-5927-01 Squamous C2-Squamous-like cluster 4 Cluster 5 squamous c3 squamous-like c4 miRNA cluster 12 cluster 3 mutation cluster 2 TCGA-34-5927 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 70 R-Lower TCGA-34-5927-F70383 TCGA-34-5927 TCGA-34-5927-01A -25857 0 1361 Scheduled Follow-up Submission 2015-2-10 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.7 NO 1 NO NO No M0 N0 T1 Stage IA TCGA-34-5927.581a7cc6-ceab-4ba3-baec-fd675fd87732.pdf 5927 TUMOR FREE NO NO Primary Tumor 01 0.4 NO NO YES 34 Lung A LIVING 2009 TCGA-34-5927-01A-11D-1817-08 a67dbc0f-e3b6-4043-8512-8cfb675ddd99 TCGA-34-5927-01 TCGA-34-5927-01A-11D-1817-08 TCGA-34-5927-01 TCGA-34-5927-01 a67dbc0f-e3b6-4043-8512-8cfb675ddd99 TCGA-34-5927-01A-13-2194-20 TCGA-34-5927-01 TCGA-34-5927-01A-11D-1816-01 a67dbc0f-e3b6-4043-8512-8cfb675ddd99 a67dbc0f-e3b6-4043-8512-8cfb675ddd99 TCGA-34-5927-01A-11D-1816-01 TCGA-34-5927-01A-11D-1818-05 285a2366-5d39-41d4-ba6a-36515454fcb6 +TCGA-34-5928-01 TCGA-34-5928-01 High C2-Squamous-like cluster 1 Cluster 5 squamous c3 squamous-like c4 miRNA cluster 5 cluster 4 mutation cluster 2 TCGA-34-5928 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 83 L-Lower TCGA-34-5928-F70385 TCGA-34-5928 TCGA-34-5928-01A -30334 0 1196 Scheduled Follow-up Submission Complete Remission/Response 2015-2-10 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.6 NO 1 NO NO 40 No M0 N1 T2 Stage IIB TCGA-34-5928.0880181a-6d0e-4b59-82b3-46a4f44f49b6.pdf 5928 TUMOR FREE Complete Remission/Response NO NO Primary Tumor 01 0.3 1993 7th NO NO YES 34 3 Lung A LIVING 2010 TCGA-34-5928-01A-11D-1817-08 b9db5c2a-c5dd-4e58-905f-fefccd469f1f TCGA-34-5928-01 TCGA-34-5928-01A-11D-1817-08 TCGA-34-5928-01 TCGA-34-5928-01 b9db5c2a-c5dd-4e58-905f-fefccd469f1f TCGA-34-5928-01A-13-2194-20 TCGA-34-5928-01 TCGA-34-5928-01A-11D-1816-01 b9db5c2a-c5dd-4e58-905f-fefccd469f1f b9db5c2a-c5dd-4e58-905f-fefccd469f1f TCGA-34-5928-01A-11D-1816-01 TCGA-34-5928-01A-11D-1818-05 98d56989-dbfb-4d7a-91f5-13f9163bab5f +TCGA-34-5929-01 TCGA-34-5929-01 Squamous C2-Squamous-like cluster 4 Cluster 5 squamous c3 squamous-like c4 miRNA cluster 12 cluster 3 mutation cluster 5 TCGA-34-5929 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung NO NO NO 78 L-Upper TCGA-34-5929-F32179 TCGA-34-5929 TCGA-34-5929-01A -28844 151 0 YES YES Scheduled Follow-up Submission Stable Disease 2012-5-18 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 1 NO 1.5 NO NO 40 No M0 N0 T2 Stage IB TCGA-34-5929.9fcfe85f-c7ed-4c1f-b21a-dae956cf8616.pdf 5929 TUMOR FREE Stable Disease NO Primary Tumor 01 0.4 1985 7th NO NO YES 34 3 Lung A DECEASED 2010 TCGA-34-5929-01A-11D-1817-08 4686dc73-c481-4e93-977c-980887726234 TCGA-34-5929-01 TCGA-34-5929-01A-11D-1817-08 TCGA-34-5929-01 TCGA-34-5929-01 4686dc73-c481-4e93-977c-980887726234 TCGA-34-5929-01A-13-2194-20 TCGA-34-5929-01 TCGA-34-5929-01A-11D-1816-01 4686dc73-c481-4e93-977c-980887726234 4686dc73-c481-4e93-977c-980887726234 TCGA-34-5929-01A-11D-1816-01 TCGA-34-5929-01A-11D-1818-05 b2b7dd0b-8713-45ee-9dfe-351b895c2046 +TCGA-34-5929-11 TCGA-34-5929-11 C2-Squamous-like mutation cluster 5 TCGA-34-5929 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung NO NO NO 78 L-Upper TCGA-34-5929-F32179 TCGA-34-5929 TCGA-34-5929-11A -28844 151 0 YES YES Scheduled Follow-up Submission Stable Disease 2012-5-18 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 1.2 NO 1.7 NO NO 40 No M0 N0 T2 Stage IB 5929 TUMOR FREE Stable Disease NO Solid Tissue Normal 11 0.2 1985 7th NO NO YES 34 3 Lung A DECEASED 2010 TCGA-34-5929-11A-01D-1818-05 +TCGA-34-7107-01 TCGA-34-7107-01 High C2-Squamous-like Cluster 5 squamous c3 squamous-like c4 miRNA c1uster 9 TCGA-34-7107 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 70 R-Lower TCGA-34-7107 TCGA-34-7107-01A -25677 34 0 2012-1-11 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 1 NO 1.1 No M0 N0 T2a Stage II TCGA-34-7107.e944ec22-44f1-4a7c-a06c-50e0d2d167a9.pdf 7107 Primary Tumor 01 0.2 7th NO YES 34 4 Lung A DECEASED 2011 7db69d77-75ce-4f75-9e95-7205c55e5e6d TCGA-34-7107-01 TCGA-34-7107-01 TCGA-34-7107-01 7db69d77-75ce-4f75-9e95-7205c55e5e6d TCGA-34-7107-01A-13-2194-20 TCGA-34-7107-01 TCGA-34-7107-01A-11D-1943-01 7db69d77-75ce-4f75-9e95-7205c55e5e6d 7db69d77-75ce-4f75-9e95-7205c55e5e6d TCGA-34-7107-01A-11D-1943-01 TCGA-34-7107-01A-11D-1947-05 b00c4a7d-5025-40e5-be42-dac01b3de7fe +TCGA-34-7107-11 TCGA-34-7107-11 C2-Squamous-like TCGA-34-7107 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 70 R-Lower TCGA-34-7107 -25677 34 0 2012-1-11 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES No M0 N0 T2a Stage II 7107 Solid Tissue Normal 11 7th NO YES 34 4 Lung DECEASED 2011 ee465ac7-c842-4337-8bd4-58fb49fce9bb TCGA-34-7107-11 TCGA-34-7107-11 ee465ac7-c842-4337-8bd4-58fb49fce9bb ee465ac7-c842-4337-8bd4-58fb49fce9bb ee465ac7-c842-4337-8bd4-58fb49fce9bb +TCGA-34-8454-01 TCGA-34-8454-01 Cluster 5 miRNA cluster 4 TCGA-34-8454 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 62 R-Lower TCGA-34-8454-F70386 TCGA-34-8454 TCGA-34-8454-01A -22913 0 1180 Scheduled Follow-up Submission Complete Remission/Response 2015-2-10 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.9 NO 0.9 NO NO 90 No M0 N1 T3 Stage IIIA TCGA-34-8454.5a59ce20-3e53-4370-b09d-40d784c679e7.pdf 8454 TUMOR FREE Complete Remission/Response NO NO R0 Primary Tumor 01 0.2 7th YES YES NO 34 4 Lung A LIVING 2011 71b1bdd1-2a00-4fd9-a229-cbc5d535af03 TCGA-34-8454-01 TCGA-34-8454-01 TCGA-34-8454-01 71b1bdd1-2a00-4fd9-a229-cbc5d535af03 TCGA-34-8454-01 TCGA-34-8454-01A-11D-2322-01 71b1bdd1-2a00-4fd9-a229-cbc5d535af03 71b1bdd1-2a00-4fd9-a229-cbc5d535af03 TCGA-34-8454-01A-11D-2322-01 TCGA-34-8454-01A-11D-2324-05 29E35653-3F34-488F-91AE-67A0352E70B4 +TCGA-34-8454-11 TCGA-34-8454-11 TCGA-34-8454 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 62 R-Lower TCGA-34-8454-F70386 TCGA-34-8454 -22913 0 1180 Scheduled Follow-up Submission Complete Remission/Response 2015-2-10 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES NO NO 90 No M0 N1 T3 Stage IIIA 8454 TUMOR FREE Complete Remission/Response NO NO R0 Solid Tissue Normal 11 7th YES YES NO 34 4 Lung LIVING 2011 b193b90e-f4e8-4a3d-bfd5-2a805fb33735 TCGA-34-8454-11 TCGA-34-8454-11 b193b90e-f4e8-4a3d-bfd5-2a805fb33735 b193b90e-f4e8-4a3d-bfd5-2a805fb33735 b193b90e-f4e8-4a3d-bfd5-2a805fb33735 +TCGA-34-8455-01 TCGA-34-8455-01 Cluster 5 miRNA cluster 4 TCGA-34-8455 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung NO NO 67 L-Upper TCGA-34-8455-F69235 TCGA-34-8455 TCGA-34-8455-01A -24624 123 0 Scheduled Follow-up Submission Progressive Disease 2014-12-30 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 1.2 NO 1.5 NO YES 50 No M1a N0 T4 Stage IV TCGA-34-8455.85247b02-2995-4cc7-9238-387bda38dcee.pdf 8455 WITH TUMOR Progressive Disease NO NO R0 Primary Tumor 01 0.3 7th NO YES NO 34 4 Lung A DECEASED 2011 24531d9f-822b-4eb8-add6-79fa27816a4b TCGA-34-8455-01 TCGA-34-8455-01 TCGA-34-8455-01 24531d9f-822b-4eb8-add6-79fa27816a4b TCGA-34-8455-01 TCGA-34-8455-01A-11D-2322-01 24531d9f-822b-4eb8-add6-79fa27816a4b 24531d9f-822b-4eb8-add6-79fa27816a4b TCGA-34-8455-01A-11D-2322-01 TCGA-34-8455-01A-11D-2324-05 77D89ACA-4570-44AA-81B8-7150011C0453 +TCGA-34-8456-01 TCGA-34-8456-01 Cluster 5 miRNA cluster 11 TCGA-34-8456 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 71 R-Lower TCGA-34-8456-F69237 TCGA-34-8456 TCGA-34-8456-01A -26183 0 804 Scheduled Follow-up Submission 2014-12-30 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.7 NO 1.1 NO NO 20 No M0 N1 T2a Stage IIA TCGA-34-8456.650c7ad8-13aa-487b-922d-373e4e556054.pdf 8456 TUMOR FREE Complete Remission/Response NO NO R0 Primary Tumor 01 0.2 7th NO YES NO 34 5 Lung A LIVING 2011 c3ed3530-0c9c-497e-bf90-88df981d475a TCGA-34-8456-01 TCGA-34-8456-01 TCGA-34-8456-01 c3ed3530-0c9c-497e-bf90-88df981d475a TCGA-34-8456-01 TCGA-34-8456-01A-21D-2322-01 c3ed3530-0c9c-497e-bf90-88df981d475a c3ed3530-0c9c-497e-bf90-88df981d475a TCGA-34-8456-01A-21D-2322-01 TCGA-34-8456-01A-21D-2324-05 B692BA3C-B959-4C44-9FB2-845ECAB0BCB8 +TCGA-34-8456-11 TCGA-34-8456-11 TCGA-34-8456 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 71 R-Lower TCGA-34-8456-F69237 TCGA-34-8456 -26183 0 804 Scheduled Follow-up Submission 2014-12-30 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES NO NO 20 No M0 N1 T2a Stage IIA 8456 TUMOR FREE Complete Remission/Response NO NO R0 Solid Tissue Normal 11 7th NO YES NO 34 5 Lung LIVING 2011 TCGA-34-8456-11 TCGA-34-8456-11 +TCGA-34-A5IX-01 TCGA-34-A5IX-01 TCGA-34-A5IX TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 80 R-Lower TCGA-34-A5IX-F69241 TCGA-34-A5IX TCGA-34-A5IX-01A -29391 288 0 1031 Scheduled Follow-up Submission 2014-12-30 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 210 NO NO NO true No M0 N0 T3 Stage IIB TCGA-34-A5IX.7DFC893F-4AA7-4885-B2D3-AF0203ED536A.pdf A5IX TUMOR FREE Complete Remission/Response NO NO Primary Tumor 01 2008 7th NO YES NO 34 4 Lung A LIVING 2012 1b4f8b52-3d0b-4ba4-b1b8-be045cd67f86 TCGA-34-A5IX-01 TCGA-34-A5IX-01 TCGA-34-A5IX-01 1b4f8b52-3d0b-4ba4-b1b8-be045cd67f86 TCGA-34-A5IX-01 TCGA-34-A5IX-01A-12D-A27J-01 1b4f8b52-3d0b-4ba4-b1b8-be045cd67f86 1b4f8b52-3d0b-4ba4-b1b8-be045cd67f86 TCGA-34-A5IX-01A-12D-A27J-01 TCGA-34-A5IX-01A-12D-A27L-05 7ADB61A2-5E13-4E6B-B80D-5E47AE1235B8 +TCGA-37-3783-01 TCGA-37-3783-01 High C2-Squamous-like cluster 1 Cluster 14 (HNSC) squamous-like c4 mutation cluster 3 TCGA-37-3783 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 51 L-Upper TCGA-37-3783-F68931 TCGA-37-3783 TCGA-37-3783-01A -18728 0 122 NO NO Scheduled Follow-up Submission 2014-12-23 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.5 NO NO Central Lung 0.5 YES No M0 N2 T3 Stage IIIA TCGA-37-3783.b3f279c3-f3a4-45a3-a711-b61873a3ca0a.pdf 3783 TUMOR FREE YES R0 Primary Tumor 01 0.4 7th NO YES 37 Lung A LIVING 2006 TCGA-37-3783-01A-01D-1267-08 TCGA-37-3783-01A-01D-1198-05 4becf4e5-085b-442e-9b06-e2472c0dc239 TCGA-37-3783-01 TCGA-37-3783-01A-01D-1267-08 TCGA-37-3783-01 TCGA-37-3783-01A-01R-1201-07 TCGA-37-3783-01 4becf4e5-085b-442e-9b06-e2472c0dc239 afcd8021-aebd-4f67-aa7b-37e67d9a1949 TCGA-37-3783-01 TCGA-37-3783-01A-01D-1195-01 TCGA-37-3783-01 4becf4e5-085b-442e-9b06-e2472c0dc239 TCGA-37-3783-01 4becf4e5-085b-442e-9b06-e2472c0dc239 TCGA-37-3783-01A-01D-1195-01 +TCGA-37-3789-01 TCGA-37-3789-01 Squamous C2-Squamous-like cluster 4 Cluster 13 (HNSC-LUSC) squamous c3 squamous-like c4 miRNA cluster 11 cluster 1 mutation cluster 13 TCGA-37-3789 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 65 L-Upper TCGA-37-3789-F68932 TCGA-37-3789 TCGA-37-3789-01A -23782 0 13 NO NO Scheduled Follow-up Submission 2014-12-23 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.5 NO NO Central Lung 1 YES No N0 T2 Stage IB TCGA-37-3789.9051358f-5b74-4f6c-b7f2-fc83e8f43306.pdf 3789 TUMOR FREE YES R0 Primary Tumor 01 0.3 7th NO YES 37 1 Lung A LIVING 2006 TCGA-37-3789-01A-01D-0983-08 TCGA-37-3789-01A-01D-0979-05 d23adf22-4453-4144-9a70-2c60bad34d97 TCGA-37-3789-01 TCGA-37-3789-01A-01D-0983-08 TCGA-37-3789-01 TCGA-37-3789-01A-01R-0980-07 d23adf22-4453-4144-9a70-2c60bad34d97 1277d194-7c9f-460c-85e5-37013da5861c TCGA-37-3789-01A-21-2193-20 TCGA-37-3789-01 TCGA-37-3789-01A-01D-0978-01 TCGA-37-3789-01 d23adf22-4453-4144-9a70-2c60bad34d97 TCGA-37-3789-01 d23adf22-4453-4144-9a70-2c60bad34d97 TCGA-37-3789-01 TCGA-37-3789-01A-01D-0978-01 25a5c25c-2520-4a48-8f96-4b1798af4de6 +TCGA-37-3792-01 TCGA-37-3792-01 High C1-LUAD-enriched Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 4 TCGA-37-3792 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 69 R-Upper TCGA-37-3792-F68933 TCGA-37-3792 -25502 0 12 NO NO Scheduled Follow-up Submission 2014-12-23 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES NO Central Lung YES No M0 N0 T2 Stage IB 3792 TUMOR FREE YES R0 Primary Tumor 01 7th NO YES 37 1 Lung LIVING 2006 TCGA-37-3792-01A-01D-0979-05 f2956875-df61-4a7a-97dd-dd5d5a8f1d7a TCGA-37-3792-01 TCGA-37-3792-01 TCGA-37-3792-01A-01R-0980-07 f2956875-df61-4a7a-97dd-dd5d5a8f1d7a a08a3662-d92b-4c11-818a-4b2f5bd5a94b TCGA-37-3792-01A-21-2193-20 TCGA-37-3792-01 TCGA-37-3792-01A-01D-1969-01 TCGA-37-3792-01 f2956875-df61-4a7a-97dd-dd5d5a8f1d7a TCGA-37-3792-01 f2956875-df61-4a7a-97dd-dd5d5a8f1d7a TCGA-37-3792-01 TCGA-37-3792-01A-01D-1969-01 f7e9d4d4-3b43-4f96-aaaf-75dbc77f68d4 +TCGA-37-4129-01 TCGA-37-4129-01 Squamous C10-GBM Low purity c2 squamous c3 GBM-like c6 TCGA-37-4129 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung NO NO 52 R-Middle TCGA-37-4129-F68926 TCGA-37-4129 TCGA-37-4129-01A -19154 0 242 1 NO NO Scheduled Follow-up Submission Complete Remission/Response 2014-12-23 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.2 8070/3 C34.2 YES 0.9 NO 90 NO Central Lung 0.9 NO NO 30 No M0 N0 T1b Stage IA TCGA-37-4129.609db8ab-d13d-46ec-a247-a638da93e35b.pdf 4129 Preoperative TUMOR FREE Complete Remission/Response YES NO R0 Primary Tumor 01 0.3 2010 7th NO NO YES 37 4 Lung A LIVING 2010 1980 TCGA-37-4129-01A-01D-1096-05 26283541-2370-40ca-8687-e46b6cee1bc5 TCGA-37-4129-01 TCGA-37-4129-01A-01R-1100-07 26283541-2370-40ca-8687-e46b6cee1bc5 04ed3819-7e23-4c81-af97-f70819e23907 TCGA-37-4129-01A-21-2193-20 TCGA-37-4129-01 TCGA-37-4129-01A-01D-1969-01 TCGA-37-4129-01 26283541-2370-40ca-8687-e46b6cee1bc5 TCGA-37-4129-01 26283541-2370-40ca-8687-e46b6cee1bc5 TCGA-37-4129-01A-01D-1969-01 8db5bd89-429b-4872-9ca0-fb72e95cf504 +TCGA-37-4130-01 TCGA-37-4130-01 High Cluster 5 LAML-like c13 miRNA cluster 7 TCGA-37-4130 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 56 R-Upper TCGA-37-4130-F68927 TCGA-37-4130 TCGA-37-4130-01A -20652 0 247 1 NO NO Scheduled Follow-up Submission 2014-12-23 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.5 NO 90 NO Central Lung 1 YES 25 No M0 N0 T1b Stage IA TCGA-37-4130.ed6702d0-e9b6-4258-adde-a07b7ba681e6.pdf 4130 Preoperative TUMOR FREE YES R0 Primary Tumor 01 0.3 2010 7th NO YES 37 4 Lung A LIVING 2010 1985 TCGA-37-4130-01A-01D-1096-05 3f0ad86f-9713-4d26-a2b4-87a2204855fe TCGA-37-4130-01 TCGA-37-4130-01 TCGA-37-4130-01A-01R-1100-07 3f0ad86f-9713-4d26-a2b4-87a2204855fe 0e535111-7a0e-43f2-92b4-54a95ae47e38 TCGA-37-4130-01 TCGA-37-4130-01A-01D-1969-01 TCGA-37-4130-01 3f0ad86f-9713-4d26-a2b4-87a2204855fe TCGA-37-4130-01 3f0ad86f-9713-4d26-a2b4-87a2204855fe TCGA-37-4130-01 TCGA-37-4130-01A-01D-1969-01 +TCGA-37-4132-01 TCGA-37-4132-01 Squamous Low purity c2 RNA cluster 3 TCGA-37-4132 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 61 L-Lower TCGA-37-4132-F68928 TCGA-37-4132 TCGA-37-4132-01A -22520 0 227 2 NO NO Scheduled Follow-up Submission 2014-12-23 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.6 NO 50 NO Peripheral Lung 0.8 NO No M1 N0 T2 Stage IV TCGA-37-4132.1428fb74-8aab-487b-ace9-79bbe01de096.pdf 4132 Post-Adjuvant Therapy TUMOR FREE Complete Remission/Response YES NO R0 Primary Tumor 01 0.2 7th NO NO YES 37 1 Lung A LIVING 2010 TCGA-37-4132-01A-01D-1096-05 967fb40b-bea9-40fd-bab1-7c524e12ac0d TCGA-37-4132-01 TCGA-37-4132-01A-01R-1100-07 967fb40b-bea9-40fd-bab1-7c524e12ac0d 97a4d048-810e-41e7-8426-9d01fcad501c TCGA-37-4132-01 TCGA-37-4132-01A-01D-1969-01 TCGA-37-4132-01 967fb40b-bea9-40fd-bab1-7c524e12ac0d TCGA-37-4132-01 967fb40b-bea9-40fd-bab1-7c524e12ac0d TCGA-37-4132-01A-01D-1969-01 +TCGA-37-4133-01 TCGA-37-4133-01 High C2-Squamous-like cluster 2 Cluster 13 (HNSC-LUSC) squamous c3 squamous-like c4 miRNA cluster 4 cluster 3 mutation cluster 5 TCGA-37-4133 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 63 R-Lower TCGA-37-4133-F68929 TCGA-37-4133 TCGA-37-4133-01A -23083 0 238 2 NO NO Scheduled Follow-up Submission 2014-12-23 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.9 8070/3 C34.9 YES 0.7 NO 50 NO Peripheral Lung 1.8 YES 40 No M0 N0 T4 Stage IIIA TCGA-37-4133.7f0f7712-3db1-4f55-aa5d-724e58d5fb90.pdf 4133 Post-Adjuvant Therapy TUMOR FREE YES R0 Primary Tumor 01 0.4 2010 7th NO YES 37 4 Lung A LIVING 2010 1970 TCGA-37-4133-01A-01D-1352-08 TCGA-37-4133-01A-01D-1096-05 9ca70bc7-d228-46cb-afb5-ccb7c5e04770 TCGA-37-4133-01 TCGA-37-4133-01A-01D-1352-08 TCGA-37-4133-01 TCGA-37-4133-01A-01R-1100-07 9ca70bc7-d228-46cb-afb5-ccb7c5e04770 5571b830-b070-479d-8acf-3cc59dc1ca8d TCGA-37-4133-01A-21-2193-20 TCGA-37-4133-01 TCGA-37-4133-01A-01D-1097-01 TCGA-37-4133-01 9ca70bc7-d228-46cb-afb5-ccb7c5e04770 TCGA-37-4133-01 9ca70bc7-d228-46cb-afb5-ccb7c5e04770 TCGA-37-4133-01 TCGA-37-4133-01A-01D-1097-01 759891ff-ab70-4687-bd59-b6df4d18f93f +TCGA-37-4135-01 TCGA-37-4135-01 High C1-LUAD-enriched cluster 4 Cluster 5 squamous c3 RNA cluster 12 miRNA cluster 12 cluster 3 mutation cluster 2 TCGA-37-4135 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 68 R-Lower TCGA-37-4135-F68930 TCGA-37-4135 TCGA-37-4135-01A -25041 0 207 1 NO NO Scheduled Follow-up Submission 2014-12-23 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 1 NO 80 NO Peripheral Lung 1 YES 45 No M0 N0 T2a Stage IB TCGA-37-4135.27fd3de4-a7da-4dc1-a135-637bcb4b7316.pdf 4135 Other TUMOR FREE YES R0 Primary Tumor 01 0.4 2010 7th NO YES 37 4 Lung A LIVING 2010 1965 TCGA-37-4135-01A-01D-1352-08 TCGA-37-4135-01A-01D-1096-05 2adbe625-d7cc-45a9-b00b-e5e439e52deb TCGA-37-4135-01 TCGA-37-4135-01A-01D-1352-08 TCGA-37-4135-01 TCGA-37-4135-01A-01R-1100-07 2adbe625-d7cc-45a9-b00b-e5e439e52deb 9031b30c-287e-4bc3-8b3a-8c3b9c920853 TCGA-37-4135-01A-21-2193-20 TCGA-37-4135-01 TCGA-37-4135-01A-01D-1969-01 TCGA-37-4135-01 2adbe625-d7cc-45a9-b00b-e5e439e52deb TCGA-37-4135-01 2adbe625-d7cc-45a9-b00b-e5e439e52deb TCGA-37-4135-01 TCGA-37-4135-01A-01D-1969-01 7cdeb372-38d2-46a5-a868-cac875e0c524 +TCGA-37-4141-01 TCGA-37-4141-01 High C1-LUAD-enriched cluster 4 Cluster 5 squamous c3 RNA cluster 3 miRNA cluster 7 cluster 2 mutation cluster 2 TCGA-37-4141 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 65 R-Upper TCGA-37-4141-F68934 TCGA-37-4141 TCGA-37-4141-01A -24048 0 12 NO NO Scheduled Follow-up Submission 2014-12-23 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.6 NO NO Peripheral Lung 1.3 YES No M0 N0 T1b Stage IA TCGA-37-4141.6cf75b07-d6a7-4b78-af73-e37c3a0581f8.pdf 4141 TUMOR FREE YES R0 Primary Tumor 01 0.3 7th NO YES 37 1 Lung A LIVING 2010 TCGA-37-4141-01A-02D-1352-08 TCGA-37-4141-01A-02D-1096-05 2c6ccb67-23b3-4e1c-9136-30f373c7e40c TCGA-37-4141-01 TCGA-37-4141-01A-02D-1352-08 TCGA-37-4141-01 TCGA-37-4141-01A-02R-1100-07 2c6ccb67-23b3-4e1c-9136-30f373c7e40c 2e80dca3-a254-4405-a91e-83e437780419 TCGA-37-4141-01A-11-2193-20 TCGA-37-4141-01 TCGA-37-4141-01A-02D-1969-01 TCGA-37-4141-01 2c6ccb67-23b3-4e1c-9136-30f373c7e40c TCGA-37-4141-01 2c6ccb67-23b3-4e1c-9136-30f373c7e40c TCGA-37-4141-01 TCGA-37-4141-01A-02D-1969-01 b464e455-cab7-456b-89dc-ca193fd7a25f +TCGA-37-5819-01 TCGA-37-5819-01 Squamous C1-LUAD-enriched cluster 4 Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 6 cluster 3 mutation cluster 2 TCGA-37-5819 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 64 R-Upper TCGA-37-5819-F68935 TCGA-37-5819 TCGA-37-5819-01A -23726 0 103 1 Scheduled Follow-up Submission 2014-12-23 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.9 NO 90 Peripheral Lung 1.2 YES 45 No M0 N2 T2 Stage IIIA TCGA-37-5819.8c9b5277-0cbf-4ba1-bda0-2c84bdadc9bd.pdf 5819 Post-Adjuvant Therapy TUMOR FREE YES R0 Primary Tumor 01 0.6 2010 7th NO YES 37 4 Lung A LIVING 2010 1965 TCGA-37-5819-01A-01D-1632-08 21b53e5f-a306-46b8-a3a1-daf24a69264b TCGA-37-5819-01 TCGA-37-5819-01A-01D-1632-08 TCGA-37-5819-01 TCGA-37-5819-01 21b53e5f-a306-46b8-a3a1-daf24a69264b TCGA-37-5819-01A-21-2194-20 TCGA-37-5819-01 TCGA-37-5819-01A-01D-1631-01 21b53e5f-a306-46b8-a3a1-daf24a69264b 21b53e5f-a306-46b8-a3a1-daf24a69264b TCGA-37-5819-01A-01D-1631-01 TCGA-37-5819-01A-01D-1633-05 9218f291-efd3-41a3-a784-7934ea10fe03 +TCGA-37-A5EL-01 TCGA-37-A5EL-01 TCGA-37-A5EL TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung NO NO NO NO 53 L-Upper TCGA-37-A5EL-F68921 TCGA-37-A5EL TCGA-37-A5EL-01A -19371 524 1143 0 454 946 Scheduled Follow-up Submission 2014-12-23 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 140 NO Central Lung NO Distant Metastasis YES true No M0 N0 T3 Stage IIB TCGA-37-A5EL.EAE31B82-48BE-4659-B32B-BC59A30D97DC.pdf A5EL WITH TUMOR Partial Remission/Response NO YES Primary Tumor 01 7th YES YES NO 37 Lung A DECEASED 2011 cf34ea0c-75f2-485b-aab0-e06694d69171 TCGA-37-A5EL-01 TCGA-37-A5EL-01 TCGA-37-A5EL-01 cf34ea0c-75f2-485b-aab0-e06694d69171 TCGA-37-A5EL-01 TCGA-37-A5EL-01A-11D-A26L-01 cf34ea0c-75f2-485b-aab0-e06694d69171 cf34ea0c-75f2-485b-aab0-e06694d69171 TCGA-37-A5EL-01A-11D-A26L-01 TCGA-37-A5EL-01A-11D-A26N-05 3A464D1B-7162-416A-B539-400DF46BCDD3 +TCGA-37-A5EM-01 TCGA-37-A5EM-01 TCGA-37-A5EM TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 49 L-Upper TCGA-37-A5EM-F68923 TCGA-37-A5EM TCGA-37-A5EM-01A -18011 492 0 867 Scheduled Follow-up Submission Complete Remission/Response 2014-12-23 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 220 NO Central Lung NO NO true No M0 N0 T2 Stage II TCGA-37-A5EM.5D9E8908-FE51-46B4-917C-4A0F6FAA3E38.pdf A5EM TUMOR FREE Complete Remission/Response NO NO Primary Tumor 01 7th NO YES NO 37 Lung A LIVING 2011 cad49182-6517-442a-af4a-962e110826f9 TCGA-37-A5EM-01 TCGA-37-A5EM-01 TCGA-37-A5EM-01 cad49182-6517-442a-af4a-962e110826f9 cad49182-6517-442a-af4a-962e110826f9 cad49182-6517-442a-af4a-962e110826f9 TCGA-37-A5EM-01A-21D-A27L-05 134CA0C4-96CE-4A46-815D-AD2E7E78153C +TCGA-37-A5EN-01 TCGA-37-A5EN-01 TCGA-37-A5EN TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 59 R-Middle TCGA-37-A5EN-F68924 TCGA-37-A5EN TCGA-37-A5EN-01A -21600 376 0 660 Scheduled Follow-up Submission Complete Remission/Response 2014-12-23 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.2 8070/3 C34.2 YES 160 NO Central Lung NO NO true No M0 N2 T4 Stage IIIB TCGA-37-A5EN.CABD8B0D-315A-4134-BC68-E7ADD3A7CB39.pdf A5EN TUMOR FREE Complete Remission/Response NO NO Primary Tumor 01 7th NO YES NO 37 Lung A LIVING 2011 72c7d42b-8821-4702-8e55-081f3de759dc TCGA-37-A5EN-01 TCGA-37-A5EN-01 TCGA-37-A5EN-01 72c7d42b-8821-4702-8e55-081f3de759dc TCGA-37-A5EN-01 TCGA-37-A5EN-01A-21D-A26L-01 72c7d42b-8821-4702-8e55-081f3de759dc 72c7d42b-8821-4702-8e55-081f3de759dc TCGA-37-A5EN-01A-21D-A26L-01 TCGA-37-A5EN-01A-21D-A26N-05 64674BDC-AB5B-41E6-A1A3-13BE966ED501 +TCGA-39-5011-01 TCGA-39-5011-01 High C1-LUAD-enriched Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 4 TCGA-39-5011 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 70 R-Lower TCGA-39-5011-F45652 TCGA-39-5011 TCGA-39-5011-01A -25788 0 4053 75 NO NO Scheduled Follow-up Submission 2013-7-18 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.9 8070/3 C34.9 YES 1.4 NO NO Peripheral Lung 2.1 NO NO 45 No M0 N0 T1b Stage IA TCGA-39-5011.6d1ee212-f843-4e78-908a-4cfd5f01a0a8.pdf 5011 TUMOR FREE 72 66 63 Complete Remission/Response YES NO R0 Primary Tumor 01 0.4 1995 6th NO NO YES 39 4 Lung A LIVING 2002 04b90b6a-445b-4d52-bed6-32b574e0a2ed TCGA-39-5011-01 TCGA-39-5011-01 TCGA-39-5011-01A-01R-1443-07 04b90b6a-445b-4d52-bed6-32b574e0a2ed TCGA-39-5011-01A-21-2194-20 TCGA-39-5011-01 TCGA-39-5011-01A-01D-1439-01 TCGA-39-5011-01 04b90b6a-445b-4d52-bed6-32b574e0a2ed TCGA-39-5011-01 04b90b6a-445b-4d52-bed6-32b574e0a2ed TCGA-39-5011-01 TCGA-39-5011-01A-01D-1439-01 TCGA-39-5011-01A-01D-1440-05 543782e2-71d3-4cc2-80e4-11b9a0eb15ce +TCGA-39-5011-11 TCGA-39-5011-11 C1-LUAD-enriched TCGA-39-5011 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 70 R-Lower TCGA-39-5011-F45652 TCGA-39-5011 TCGA-39-5011-11A -25788 0 4053 75 NO NO Scheduled Follow-up Submission 2013-7-18 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.9 8070/3 C34.9 YES 1.6 NO NO Peripheral Lung 1.8 NO NO 45 No M0 N0 T1b Stage IA 5011 TUMOR FREE 72 66 63 Complete Remission/Response YES NO R0 Solid Tissue Normal 11 0.4 1995 6th NO NO YES 39 4 Lung A LIVING 2002 TCGA-39-5011-11A-01D-1440-05 +TCGA-39-5016-01 TCGA-39-5016-01 BRCA-LUAD+ C2-Squamous-like cluster 3 Cluster 13 (HNSC-LUSC) BRCA basal-like c6 squamous-like c4 mutation cluster 13 TCGA-39-5016 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 44 R-Lower TCGA-39-5016-F45653 TCGA-39-5016 TCGA-39-5016-01A -16306 0 3850 98 NO NO Scheduled Follow-up Submission 2013-7-18 MALE Lung Basaloid Squamous Cell Carcinoma No C34.3 8083/3 C34.3 YES 1.2 NO NO Central Lung 1.3 NO NO 40 No M0 N1 T2a Stage IIA TCGA-39-5016.7b50ffbc-010e-415b-8d85-b5639801e287.pdf 5016 TUMOR FREE 73 75 73 77 Complete Remission/Response YES NO R0 Primary Tumor 01 0.3 2003 6th NO NO YES 39 4 Lung A LIVING 2003 TCGA-39-5016-01A-01D-1441-08 3379dfb4-e4f0-492f-bdcd-0f76d3b94b0d TCGA-39-5016-01A-01D-1441-08 TCGA-39-5016-01 TCGA-39-5016-01A-01R-1443-07 3379dfb4-e4f0-492f-bdcd-0f76d3b94b0d TCGA-39-5016-01A-21-2194-20 TCGA-39-5016-01 TCGA-39-5016-01A-01D-1439-01 TCGA-39-5016-01 3379dfb4-e4f0-492f-bdcd-0f76d3b94b0d TCGA-39-5016-01 3379dfb4-e4f0-492f-bdcd-0f76d3b94b0d TCGA-39-5016-01A-01D-1439-01 TCGA-39-5016-01A-01D-1440-05 9d441074-5562-43c7-8158-903e11fb1eaa +TCGA-39-5016-11 TCGA-39-5016-11 C2-Squamous-like mutation cluster 13 TCGA-39-5016 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 44 R-Lower TCGA-39-5016-F45653 TCGA-39-5016 TCGA-39-5016-11A -16306 0 3850 98 NO NO Scheduled Follow-up Submission 2013-7-18 MALE Lung Basaloid Squamous Cell Carcinoma No C34.3 8083/3 C34.3 YES 1.6 NO NO Central Lung 1.7 NO NO 40 No M0 N1 T2a Stage IIA 5016 TUMOR FREE 73 75 73 77 Complete Remission/Response YES NO R0 Solid Tissue Normal 11 0.3 2003 6th NO NO YES 39 4 Lung A LIVING 2003 TCGA-39-5016-11A-01D-1440-05 +TCGA-39-5019-01 TCGA-39-5019-01 High C2-Squamous-like cluster 1 Cluster 13 (HNSC-LUSC) squamous c3 squamous-like c4 miRNA cluster 5 cluster 4 mutation cluster 5 TCGA-39-5019 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 70 R-Upper TCGA-39-5019-F45654 TCGA-39-5019 -25756 0 3387 96 NO NO Scheduled Follow-up Submission 2013-7-18 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES NO Peripheral Lung NO NO 30 No M0 N0 T2a Stage IB 5019 TUMOR FREE 72 62 76 57 Complete Remission/Response YES NO R0 Primary Tumor 01 7th NO NO YES 39 3 Lung LIVING 2004 TCGA-39-5019-01A-01D-1817-08 a3196a69-230e-4dfe-ba2d-d8c5a8310d29 TCGA-39-5019-01 TCGA-39-5019-01A-01D-1817-08 TCGA-39-5019-01 TCGA-39-5019-01 a3196a69-230e-4dfe-ba2d-d8c5a8310d29 TCGA-39-5019-01A-21-2194-20 TCGA-39-5019-01 TCGA-39-5019-01A-01D-1816-01 a3196a69-230e-4dfe-ba2d-d8c5a8310d29 a3196a69-230e-4dfe-ba2d-d8c5a8310d29 TCGA-39-5019-01A-01D-1816-01 TCGA-39-5019-01A-01D-1818-05 a928f1c8-ed6b-4908-8174-03bf26fd1fa4 +TCGA-39-5019-11 TCGA-39-5019-11 C2-Squamous-like mutation cluster 5 TCGA-39-5019 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 70 R-Upper TCGA-39-5019-F45654 TCGA-39-5019 TCGA-39-5019-11A -25756 0 3387 96 NO NO Scheduled Follow-up Submission 2013-7-18 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 1.3 NO NO Peripheral Lung 1.5 NO NO 30 No M0 N0 T2a Stage IB 5019 TUMOR FREE 72 62 76 57 Complete Remission/Response YES NO R0 Solid Tissue Normal 11 0.3 7th NO NO YES 39 3 Lung A LIVING 2004 TCGA-39-5019-11A-01D-1818-05 +TCGA-39-5021-01 TCGA-39-5021-01 High C2-Squamous-like cluster 4 Cluster 5 squamous c3 squamous-like c4 miRNA cluster 7 cluster 2 mutation cluster 5 TCGA-39-5021 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung YES NO NO NO 70 L-Upper TCGA-39-5021-F8453 TCGA-39-5021 TCGA-39-5021-01A -25895 2086 0 2057 1875 NO NO Progressive Disease 2010-12-4 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 1.6 NO NO NO Central Lung 1.8 YES 114 No M0 N0 T2a Stage IB TCGA-39-5021.84d7dc8e-29cd-4adc-93ea-cda77cf855b4.pdf 5021 WITH TUMOR Complete Remission/Response NO R0 Primary Tumor 01 0.4 2004 NO NO YES 39 4 Lung A DECEASED 2004 1947 TCGA-39-5021-01A-01D-1441-08 05e29bda-269a-4b56-b179-8b56867c036e TCGA-39-5021-01 TCGA-39-5021-01A-01D-1441-08 TCGA-39-5021-01 TCGA-39-5021-01A-01R-1443-07 05e29bda-269a-4b56-b179-8b56867c036e TCGA-39-5021-01A-21-2194-20 TCGA-39-5021-01 TCGA-39-5021-01A-01D-1439-01 TCGA-39-5021-01 05e29bda-269a-4b56-b179-8b56867c036e TCGA-39-5021-01 05e29bda-269a-4b56-b179-8b56867c036e TCGA-39-5021-01 TCGA-39-5021-01A-01D-1439-01 TCGA-39-5021-01A-01D-1440-05 34e208a6-3752-47a1-87f3-ae1c02612d17 +TCGA-39-5021-11 TCGA-39-5021-11 C2-Squamous-like mutation cluster 5 TCGA-39-5021 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung YES NO NO NO 70 L-Upper TCGA-39-5021-F8453 TCGA-39-5021 TCGA-39-5021-11A -25895 2086 0 2057 1875 NO NO Progressive Disease 2010-12-4 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 1.7 NO NO NO Central Lung 2 YES 114 No M0 N0 T2a Stage IB 5021 WITH TUMOR Complete Remission/Response NO R0 Solid Tissue Normal 11 0.2 2004 NO NO YES 39 4 Lung A DECEASED 2004 1947 TCGA-39-5021-11A-01D-1440-05 +TCGA-39-5022-01 TCGA-39-5022-01 Squamous C2-Squamous-like cluster 1 Cluster 5 squamous c3 miRNA cluster 5 cluster 4 mutation cluster 12 TCGA-39-5022 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung YES YES 76 R-Upper TCGA-39-5022-F17149 TCGA-39-5022 TCGA-39-5022-01A 1448 -27856 1679 0 1448 NO NO Scheduled Follow-up Submission 2011-9-19 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 1.2 NO NO Peripheral Lung 1.4 YES 35 No M0 N0 T2a Stage IB TCGA-39-5022.76f4d72a-526a-4b52-ba4d-067a81281984.pdf 5022 TUMOR FREE NO R0 Primary Tumor 01 0.4 2005 7th NO NO YES 39 4 Lung A DECEASED 2005 1996 TCGA-39-5022-01A-21D-1817-08 db85a3d4-61c8-4b3d-8d5e-f49fc9638cbb TCGA-39-5022-01 TCGA-39-5022-01A-21D-1817-08 TCGA-39-5022-01 TCGA-39-5022-01 db85a3d4-61c8-4b3d-8d5e-f49fc9638cbb TCGA-39-5022-01A-22-2194-20 TCGA-39-5022-01 TCGA-39-5022-01A-21D-1816-01 db85a3d4-61c8-4b3d-8d5e-f49fc9638cbb db85a3d4-61c8-4b3d-8d5e-f49fc9638cbb TCGA-39-5022-01A-21D-1816-01 TCGA-39-5022-01A-21D-1818-05 441d3e63-041c-48f0-bc13-9febd802aab8 +TCGA-39-5024-01 TCGA-39-5024-01 High C2-Squamous-like cluster 1 Cluster 5 squamous c3 squamous-like c4 miRNA cluster 4 cluster 4 mutation cluster 5 TCGA-39-5024 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 65 Bronchial TCGA-39-5024-F45655 TCGA-39-5024 TCGA-39-5024-01A -23975 0 2510 81 NO NO Scheduled Follow-up Submission 2013-7-18 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.9 8070/3 C34.9 YES 1.5 NO NO Central Lung 1.7 NO NO 40 No M0 N2 T2a Stage IIIA TCGA-39-5024.ec84ade8-8988-4735-be04-97a52b8b8033.pdf 5024 TUMOR FREE 96 87 91 88 Complete Remission/Response YES NO R0 Primary Tumor 01 0.4 2005 7th YES NO YES 39 4 Lung A LIVING 2005 1964 TCGA-39-5024-01A-21D-1817-08 e4d0c9ca-ecf9-4ded-a572-3c4cc9ce955a TCGA-39-5024-01 TCGA-39-5024-01A-21D-1817-08 TCGA-39-5024-01 TCGA-39-5024-01 e4d0c9ca-ecf9-4ded-a572-3c4cc9ce955a TCGA-39-5024-01A-22-2194-20 TCGA-39-5024-01 TCGA-39-5024-01A-21D-1816-01 e4d0c9ca-ecf9-4ded-a572-3c4cc9ce955a e4d0c9ca-ecf9-4ded-a572-3c4cc9ce955a TCGA-39-5024-01A-21D-1816-01 TCGA-39-5024-01A-21D-1818-05 82c886e2-5803-46e5-9553-949321c21d34 +TCGA-39-5027-01 TCGA-39-5027-01 Squamous C2-Squamous-like cluster 4 Cluster 13 (HNSC-LUSC) squamous c3 squamous-like c4 miRNA cluster 12 cluster 4 mutation cluster 5 TCGA-39-5027 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 73 R-Lower TCGA-39-5027-F45656 TCGA-39-5027 TCGA-39-5027-01A -26714 0 3108 3081 79 2 NO NO Scheduled Follow-up Submission 2013-7-18 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 1.3 NO NO Peripheral Lung 1.8 NO New Primary Tumor YES 40 No M0 N0 T2a Stage IB TCGA-39-5027.02693e05-2498-437a-9c26-7de09702c5ee.pdf 5027 Other WITH TUMOR 82 63 78 55 Complete Remission/Response Biopsy with Histologic Confirmation YES NO R0 Primary Tumor 01 0.4 2002 7th NO NO YES 39 4 Lung A LIVING 2006 1946 TCGA-39-5027-01A-21D-1817-08 94f47d71-e3ad-44ad-8ddd-370db58ff67d TCGA-39-5027-01 TCGA-39-5027-01A-21D-1817-08 TCGA-39-5027-01 TCGA-39-5027-01 94f47d71-e3ad-44ad-8ddd-370db58ff67d TCGA-39-5027-01A-22-2194-20 TCGA-39-5027-01 TCGA-39-5027-01A-21D-1816-01 94f47d71-e3ad-44ad-8ddd-370db58ff67d 94f47d71-e3ad-44ad-8ddd-370db58ff67d TCGA-39-5027-01A-21D-1816-01 TCGA-39-5027-01A-21D-1818-05 65da1c24-f058-4754-80b1-bb45247f835b +TCGA-39-5028-01 TCGA-39-5028-01 Squamous C2-Squamous-like cluster 1 Cluster 5 squamous c3 squamous-like c4 miRNA cluster 7 cluster 2 mutation cluster 13 TCGA-39-5028 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung NO NO 75 R-Upper TCGA-39-5028-F8459 TCGA-39-5028 TCGA-39-5028-01A -27707 52 0 52 NO NO 2010-12-4 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 1.5 NO NO NO Central Lung 1.9 NO 30 No M0 N1 T4 Stage IIIA TCGA-39-5028.3e8d3fab-2418-4860-8119-a011528f2f06.pdf 5028 NO R0 Primary Tumor 01 0.4 1981 NO NO YES 39 3 Lung A DECEASED 2006 1946 TCGA-39-5028-01A-01D-1441-08 fecc45b4-3293-4a47-837b-74e42c6cbf0f TCGA-39-5028-01 TCGA-39-5028-01A-01D-1441-08 TCGA-39-5028-01 fecc45b4-3293-4a47-837b-74e42c6cbf0f TCGA-39-5028-01A-21-2194-20 TCGA-39-5028-01 TCGA-39-5028-01A-01D-1439-01 fecc45b4-3293-4a47-837b-74e42c6cbf0f fecc45b4-3293-4a47-837b-74e42c6cbf0f TCGA-39-5028-01 TCGA-39-5028-01A-01D-1439-01 TCGA-39-5028-01A-01D-1440-05 424c5902-5b4c-4576-a19b-f3e7aab0ff1d +TCGA-39-5028-11 TCGA-39-5028-11 C2-Squamous-like mutation cluster 13 TCGA-39-5028 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung NO NO 75 R-Upper TCGA-39-5028-F8459 TCGA-39-5028 TCGA-39-5028-11A -27707 52 0 52 NO NO 2010-12-4 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.8 NO NO NO Central Lung 1.6 NO 30 No M0 N1 T4 Stage IIIA 5028 NO R0 Solid Tissue Normal 11 0.4 1981 NO NO YES 39 3 Lung A DECEASED 2006 1946 TCGA-39-5028-11A-01D-1440-05 +TCGA-39-5029-01 TCGA-39-5029-01 High C2-Squamous-like cluster 4 Cluster 13 (HNSC-LUSC) squamous c3 squamous-like c4 miRNA cluster 4 cluster 2 mutation cluster 5 TCGA-39-5029 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung YES YES NO YES 67 L-Lower TCGA-39-5029-F8462 TCGA-39-5029 612 -24713 740 0 491 NO NO Stable Disease 2010-12-4 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES NO [Discrepancy] Central Lung YES 192 No M0 N2 T1b Stage IIIA 5029 WITH TUMOR Stable Disease NO R0 Primary Tumor 01 2006 YES NO YES 39 4 Lung DECEASED 2006 1958 TCGA-39-5029-01A-01D-1441-08 d424d3e3-9055-4d6a-a7ce-debbd3537fcd TCGA-39-5029-01 TCGA-39-5029-01A-01D-1441-08 TCGA-39-5029-01 TCGA-39-5029-01A-01R-1443-07 d424d3e3-9055-4d6a-a7ce-debbd3537fcd TCGA-39-5029-01A-21-2194-20 TCGA-39-5029-01 TCGA-39-5029-01A-01D-1439-01 TCGA-39-5029-01 d424d3e3-9055-4d6a-a7ce-debbd3537fcd TCGA-39-5029-01 d424d3e3-9055-4d6a-a7ce-debbd3537fcd TCGA-39-5029-01 TCGA-39-5029-01A-01D-1439-01 TCGA-39-5029-01A-01D-1440-05 bcb62b1f-2852-4823-8028-9845e480e34f +TCGA-39-5029-11 TCGA-39-5029-11 C2-Squamous-like mutation cluster 5 TCGA-39-5029 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung YES YES NO YES 67 L-Lower TCGA-39-5029-F8462 TCGA-39-5029 TCGA-39-5029-11A 612 -24713 740 0 491 NO NO Stable Disease 2010-12-4 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 1.6 NO NO [Discrepancy] Central Lung 1.7 YES 192 No M0 N2 T1b Stage IIIA 5029 WITH TUMOR Stable Disease NO R0 Solid Tissue Normal 11 0.4 2006 YES NO YES 39 4 Lung A DECEASED 2006 1958 TCGA-39-5029-11A-01D-1440-05 +TCGA-39-5030-01 TCGA-39-5030-01 Squamous C2-Squamous-like cluster 1 Cluster 5 squamous c3 squamous-like c4 miRNA cluster 7 cluster 2 mutation cluster 14 TCGA-39-5030 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung NO NO 81 L-Lower TCGA-39-5030-F8486 TCGA-39-5030 TCGA-39-5030-01A -29893 59 0 59 NO NO Complete Remission/Response 2010-12-4 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 1.4 NO NO NO Peripheral Lung 2 NO 08 No M0 N2 T2a Stage IIIA TCGA-39-5030.ae1b3081-2545-4236-94b3-2d474b021363.pdf 5030 Complete Remission/Response NO R0 Primary Tumor 01 0.4 1971 NO NO YES 39 3 Lung A DECEASED 2006 1960 TCGA-39-5030-01A-01D-1441-08 87af5ba8-6e7d-4177-82d2-57b7268d6018 TCGA-39-5030-01 TCGA-39-5030-01A-01D-1441-08 TCGA-39-5030-01 TCGA-39-5030-01A-01R-1443-07 87af5ba8-6e7d-4177-82d2-57b7268d6018 TCGA-39-5030-01A-21-2194-20 TCGA-39-5030-01 TCGA-39-5030-01A-01D-1439-01 TCGA-39-5030-01 87af5ba8-6e7d-4177-82d2-57b7268d6018 TCGA-39-5030-01 87af5ba8-6e7d-4177-82d2-57b7268d6018 TCGA-39-5030-01 TCGA-39-5030-01A-01D-1439-01 TCGA-39-5030-01A-01D-1440-05 6bf62267-1f99-4080-ad9d-caf0f7b60b68 +TCGA-39-5030-11 TCGA-39-5030-11 C2-Squamous-like mutation cluster 14 TCGA-39-5030 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung NO NO 81 L-Lower TCGA-39-5030-F8486 TCGA-39-5030 TCGA-39-5030-11A -29893 59 0 59 NO NO Complete Remission/Response 2010-12-4 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 1.7 NO NO NO Peripheral Lung 2.3 NO 08 No M0 N2 T2a Stage IIIA 5030 Complete Remission/Response NO R0 Solid Tissue Normal 11 0.4 1971 NO NO YES 39 3 Lung A DECEASED 2006 1960 TCGA-39-5030-11A-01D-1440-05 +TCGA-39-5031-01 TCGA-39-5031-01 Squamous C2-Squamous-like cluster 1 Cluster 5 squamous c3 squamous-like c4 miRNA cluster 7 cluster 2 mutation cluster 2 TCGA-39-5031 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 76 L-Upper TCGA-39-5031-F45657 TCGA-39-5031 TCGA-39-5031-01A -28106 1841 0 833 58 NO NO Scheduled Follow-up Submission 2013-7-18 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 1 NO NO Peripheral Lung 1.9 NO NO 60 No M0 N0 T1a Stage IA TCGA-39-5031.45179ec8-08fe-4e6c-b5b3-e2ef7711b710.pdf 5031 TUMOR FREE 89 79 85 76 Complete Remission/Response YES NO R0 Primary Tumor 01 0.3 1997 6th NO NO YES 39 4 Lung A DECEASED 2007 1946 TCGA-39-5031-01A-01D-1441-08 3ab5fa89-ae39-40a2-92ac-d1721cea9f7e TCGA-39-5031-01 TCGA-39-5031-01A-01D-1441-08 TCGA-39-5031-01 3ab5fa89-ae39-40a2-92ac-d1721cea9f7e TCGA-39-5031-01A-21-2194-20 TCGA-39-5031-01 TCGA-39-5031-01A-01D-1439-01 3ab5fa89-ae39-40a2-92ac-d1721cea9f7e 3ab5fa89-ae39-40a2-92ac-d1721cea9f7e TCGA-39-5031-01 TCGA-39-5031-01A-01D-1439-01 TCGA-39-5031-01A-01D-1440-05 02171381-ad60-4e7b-a56d-c0a3f129dcaa +TCGA-39-5031-11 TCGA-39-5031-11 C2-Squamous-like mutation cluster 2 TCGA-39-5031 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 76 L-Upper TCGA-39-5031-F45657 TCGA-39-5031 TCGA-39-5031-11A -28106 1841 0 833 58 NO NO Scheduled Follow-up Submission 2013-7-18 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 1.5 NO NO Peripheral Lung 1.6 NO NO 60 No M0 N0 T1a Stage IA 5031 TUMOR FREE 89 79 85 76 Complete Remission/Response YES NO R0 Solid Tissue Normal 11 0.2 1997 6th NO NO YES 39 4 Lung A DECEASED 2007 1946 TCGA-39-5031-11A-01D-1440-05 +TCGA-39-5034-01 TCGA-39-5034-01 High C1-LUAD-enriched Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 7 TCGA-39-5034 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung NO NO NO NO 73 R-Upper TCGA-39-5034-F8491 TCGA-39-5034 TCGA-39-5034-01A -26682 1107 0 1107 352 YES NO Progressive Disease 2010-12-6 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 1.5 NO YES NO Peripheral Lung 1.6 YES 084 No M0 N0 T3 Stage IIB TCGA-39-5034.8d0c1256-1e5c-4db3-961d-15a4e1329224.pdf 5034 Complete Remission/Response NO R0 Primary Tumor 01 0.2 2007 NO NO YES 39 4 Lung A DECEASED 2007 1950 ea64d44e-32d1-40f6-b49f-e019401a76d5 TCGA-39-5034-01 TCGA-39-5034-01 TCGA-39-5034-01A-01R-1443-07 ea64d44e-32d1-40f6-b49f-e019401a76d5 TCGA-39-5034-01A-21-2194-20 TCGA-39-5034-01 TCGA-39-5034-01A-01D-1439-01 TCGA-39-5034-01 ea64d44e-32d1-40f6-b49f-e019401a76d5 TCGA-39-5034-01 ea64d44e-32d1-40f6-b49f-e019401a76d5 TCGA-39-5034-01 TCGA-39-5034-01A-01D-1439-01 TCGA-39-5034-01A-01D-1440-05 9088cd2b-f01a-4e61-949b-026e4be3479a +TCGA-39-5034-11 TCGA-39-5034-11 C1-LUAD-enriched TCGA-39-5034 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung NO NO NO NO 73 R-Upper TCGA-39-5034-F8491 TCGA-39-5034 TCGA-39-5034-11A -26682 1107 0 1107 352 YES NO Progressive Disease 2010-12-6 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 2 NO YES NO Peripheral Lung 2.3 YES 084 No M0 N0 T3 Stage IIB 5034 Complete Remission/Response NO R0 Solid Tissue Normal 11 0.4 2007 NO NO YES 39 4 Lung A DECEASED 2007 1950 TCGA-39-5034-11A-01D-1440-05 +TCGA-39-5035-01 TCGA-39-5035-01 Squamous C2-Squamous-like cluster 1 Cluster 13 (HNSC-LUSC) squamous c3 squamous-like c4 miRNA cluster 7 cluster 2 mutation cluster 5 TCGA-39-5035 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 72 R-Lower TCGA-39-5035-F45658 TCGA-39-5035 TCGA-39-5035-01A -26383 0 2080 39 NO NO Scheduled Follow-up Submission 2013-7-18 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 1.5 NO NO Central Lung 1.8 NO NO 47 No M0 N0 T1b Stage IA TCGA-39-5035.65d294e9-bdde-476e-8b45-dcee87915a69.pdf 5035 TUMOR FREE 67 71 63 68 Complete Remission/Response YES NO R0 Primary Tumor 01 0.4 1997 6th NO NO YES 39 4 Lung A LIVING 2007 1950 TCGA-39-5035-01A-01D-1441-08 2f3702b6-bd6e-4863-8b81-e7d3850a9017 TCGA-39-5035-01 TCGA-39-5035-01A-01D-1441-08 TCGA-39-5035-01 TCGA-39-5035-01A-01R-1443-07 2f3702b6-bd6e-4863-8b81-e7d3850a9017 TCGA-39-5035-01A-21-2194-20 TCGA-39-5035-01 TCGA-39-5035-01A-01D-1439-01 TCGA-39-5035-01 2f3702b6-bd6e-4863-8b81-e7d3850a9017 TCGA-39-5035-01 2f3702b6-bd6e-4863-8b81-e7d3850a9017 TCGA-39-5035-01 TCGA-39-5035-01A-01D-1439-01 TCGA-39-5035-01A-01D-1440-05 3c25960c-f4f3-493f-8cff-b039e73b921e +TCGA-39-5035-11 TCGA-39-5035-11 C2-Squamous-like mutation cluster 5 TCGA-39-5035 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 72 R-Lower TCGA-39-5035-F45658 TCGA-39-5035 TCGA-39-5035-11A -26383 0 2080 39 NO NO Scheduled Follow-up Submission 2013-7-18 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 1.3 NO NO Central Lung 1.7 NO NO 47 No M0 N0 T1b Stage IA 5035 TUMOR FREE 67 71 63 68 Complete Remission/Response YES NO R0 Solid Tissue Normal 11 0.4 1997 6th NO NO YES 39 4 Lung A LIVING 2007 1950 TCGA-39-5035-11A-01D-1440-05 +TCGA-39-5036-01 TCGA-39-5036-01 Squamous C2-Squamous-like cluster 3 Cluster 13 (HNSC-LUSC) squamous-like c4 miRNA cluster 11 cluster 2 mutation cluster 5 TCGA-39-5036 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 73 L-Upper TCGA-39-5036-F45659 TCGA-39-5036 -26963 0 2165 71 NO NO Scheduled Follow-up Submission 2013-7-18 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES NO Peripheral Lung NO NO 63 No M0 N0 T2 Stage IB 5036 TUMOR FREE 49 62 53 61 Complete Remission/Response YES NO R0 Primary Tumor 01 2000 6th NO NO YES 39 4 Lung LIVING 2007 1957 TCGA-39-5036-01A-01D-1441-08 cd60c90b-bd9a-4494-ad73-993664b12f33 TCGA-39-5036-01 TCGA-39-5036-01A-01D-1441-08 TCGA-39-5036-01 TCGA-39-5036-01A-01R-1443-07 cd60c90b-bd9a-4494-ad73-993664b12f33 TCGA-39-5036-01 TCGA-39-5036-01A-01D-1439-01 TCGA-39-5036-01 cd60c90b-bd9a-4494-ad73-993664b12f33 TCGA-39-5036-01 cd60c90b-bd9a-4494-ad73-993664b12f33 TCGA-39-5036-01 TCGA-39-5036-01A-01D-1439-01 TCGA-39-5036-01A-01D-1440-05 +TCGA-39-5036-11 TCGA-39-5036-11 C2-Squamous-like mutation cluster 5 TCGA-39-5036 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 73 L-Upper TCGA-39-5036-F45659 TCGA-39-5036 TCGA-39-5036-11A -26963 0 2165 71 NO NO Scheduled Follow-up Submission 2013-7-18 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 1.7 NO NO Peripheral Lung 1.7 NO NO 63 No M0 N0 T2 Stage IB 5036 TUMOR FREE 49 62 53 61 Complete Remission/Response YES NO R0 Solid Tissue Normal 11 0.2 2000 6th NO NO YES 39 4 Lung A LIVING 2007 1957 TCGA-39-5036-11A-01D-1440-05 +TCGA-39-5037-01 TCGA-39-5037-01 Squamous C2-Squamous-like cluster 3 Cluster 13 (HNSC-LUSC) squamous c3 squamous-like c4 miRNA cluster 11 cluster 1 mutation cluster 5 TCGA-39-5037 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 65 L-Lower TCGA-39-5037-F45660 TCGA-39-5037 TCGA-39-5037-01A -23868 0 1690 79 NO NO Scheduled Follow-up Submission 2013-7-18 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 1 NO NO Central Lung 1.3 NO NO 26 No M0 N1 T1b Stage IIA TCGA-39-5037.7a100e58-1e99-48b4-9db1-0228aaf4bb71.pdf 5037 TUMOR FREE 56 60 61 56 Complete Remission/Response YES NO R0 Primary Tumor 01 0.4 6th NO NO YES 39 2 Lung A LIVING 2007 1969 TCGA-39-5037-01A-01D-1441-08 f5debd70-0db6-42d6-8894-fd65c9f4c66e TCGA-39-5037-01 TCGA-39-5037-01A-01D-1441-08 TCGA-39-5037-01 TCGA-39-5037-01A-01R-1443-07 f5debd70-0db6-42d6-8894-fd65c9f4c66e TCGA-39-5037-01A-21-2194-20 TCGA-39-5037-01 TCGA-39-5037-01A-01D-1439-01 TCGA-39-5037-01 f5debd70-0db6-42d6-8894-fd65c9f4c66e TCGA-39-5037-01 f5debd70-0db6-42d6-8894-fd65c9f4c66e TCGA-39-5037-01 TCGA-39-5037-01A-01D-1439-01 TCGA-39-5037-01A-01D-1440-05 9864ab85-daea-4018-b513-0f577c9391f4 +TCGA-39-5037-11 TCGA-39-5037-11 C2-Squamous-like mutation cluster 5 TCGA-39-5037 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 65 L-Lower TCGA-39-5037-F45660 TCGA-39-5037 TCGA-39-5037-11A -23868 0 1690 79 NO NO Scheduled Follow-up Submission 2013-7-18 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 1.5 NO NO Central Lung 1.6 NO NO 26 No M0 N1 T1b Stage IIA 5037 TUMOR FREE 56 60 61 56 Complete Remission/Response YES NO R0 Solid Tissue Normal 11 0.4 6th NO NO YES 39 2 Lung A LIVING 2007 1969 TCGA-39-5037-11A-01D-1440-05 +TCGA-39-5039-01 TCGA-39-5039-01 High C2-Squamous-like cluster 4 Low purity c2 squamous-like c4 miRNA c1uster 9 cluster 2 mutation c1uster 9 TCGA-39-5039 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung NO NO NO NO 76 R-Upper TCGA-39-5039-F8512 TCGA-39-5039 -27781 544 0 544 NO NO Complete Remission/Response 2010-12-6 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES NO NO Central Lung NO 64 Yes M0 N0 T2b Stage IIA 5039 TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 1983 NO NO YES 39 3 Lung DECEASED 2008 1949 TCGA-39-5039-01A-01D-1441-08 ae96337f-1b6e-41e6-8045-35f4adec76f4 TCGA-39-5039-01 TCGA-39-5039-01A-01D-1441-08 TCGA-39-5039-01 ae96337f-1b6e-41e6-8045-35f4adec76f4 TCGA-39-5039-01 TCGA-39-5039-01A-01D-1439-01 ae96337f-1b6e-41e6-8045-35f4adec76f4 ae96337f-1b6e-41e6-8045-35f4adec76f4 TCGA-39-5039-01 TCGA-39-5039-01A-01D-1439-01 TCGA-39-5039-01A-01D-1440-05 +TCGA-39-5039-11 TCGA-39-5039-11 C2-Squamous-like mutation c1uster 9 TCGA-39-5039 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung NO NO NO NO 76 R-Upper TCGA-39-5039-F8512 TCGA-39-5039 TCGA-39-5039-11A -27781 544 0 544 NO NO Complete Remission/Response 2010-12-6 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 1.4 NO NO NO Central Lung 1.5 NO 64 Yes M0 N0 T2b Stage IIA 5039 TUMOR FREE Complete Remission/Response NO R0 Solid Tissue Normal 11 0.2 1983 NO NO YES 39 3 Lung A DECEASED 2008 1949 TCGA-39-5039-11A-01D-1440-05 +TCGA-39-5040-01 TCGA-39-5040-01 High BRCA CIMP c7 squamous c3 miRNA c1uster 9 TCGA-39-5040 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung YES NO NO 59 L-Upper TCGA-39-5040-F29963 TCGA-39-5040 TCGA-39-5040-01A -21790 519 0 442 80 NO NO Progressive Disease 2012-3-5 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 1.5 NO 80 NO Peripheral Lung 1.5 YES 60 No M0 N2 T2a Stage IIIA TCGA-39-5040.6bef6712-0d27-4032-9f72-3c9f13901223.pdf 5040 Post-Adjuvant Therapy WITH TUMOR 93 97 Stable Disease YES YES R0 Primary Tumor 01 0.4 2005 7th YES NO YES 39 4 Lung A DECEASED 2008 1964 48b4302e-03cd-4f73-ab52-fb8dc22a10d4 TCGA-39-5040-01 TCGA-39-5040-01 TCGA-39-5040-01 48b4302e-03cd-4f73-ab52-fb8dc22a10d4 TCGA-39-5040-01A-11-2194-20 TCGA-39-5040-01 TCGA-39-5040-01A-21D-2121-01 48b4302e-03cd-4f73-ab52-fb8dc22a10d4 48b4302e-03cd-4f73-ab52-fb8dc22a10d4 TCGA-39-5040-01A-21D-2121-01 TCGA-39-5040-01A-21D-2123-05 d5a08f32-ad9a-45d2-8f8b-66283eafad42 +TCGA-39-5040-11 TCGA-39-5040-11 TCGA-39-5040 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung YES NO NO 59 L-Upper TCGA-39-5040-F29963 TCGA-39-5040 TCGA-39-5040-11A -21790 519 0 442 80 NO NO Progressive Disease 2012-3-5 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 1 NO 80 NO Peripheral Lung 1.7 YES 60 No M0 N2 T2a Stage IIIA 5040 Post-Adjuvant Therapy WITH TUMOR 93 97 Stable Disease YES YES R0 Solid Tissue Normal 11 0.3 2005 7th YES NO YES 39 4 Lung A DECEASED 2008 1964 3b3b0303-49cd-47b5-83b9-5192fe6a6e58 TCGA-39-5040-11 TCGA-39-5040-11 3b3b0303-49cd-47b5-83b9-5192fe6a6e58 3b3b0303-49cd-47b5-83b9-5192fe6a6e58 3b3b0303-49cd-47b5-83b9-5192fe6a6e58 +TCGA-43-2576-01 TCGA-43-2576-01 Squamous miRNA cluster 4 TCGA-43-2576 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 62 L-Upper TCGA-43-2576-F39331 TCGA-43-2576 -22805 0 1223 72 Scheduled Follow-up Submission Complete Remission/Response 2013-1-17 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 90 NO NO NO 20 No M0 N2 T2 Stage IIIA 2576 Pre-Adjuvant Therapy TUMOR FREE 79 75 70 69 Complete Remission/Response YES YES R0 Primary Tumor 01 2004 6th YES YES NO 43 4 Lung LIVING 2009 1969 ac4077ca-1cc5-4df5-b621-94e2cb8ecd0f TCGA-43-2576-01 TCGA-43-2576-01 TCGA-43-2576-01A-01R-0851-07 ac4077ca-1cc5-4df5-b621-94e2cb8ecd0f baf7c378-4295-4f68-9f8e-2563152372fb TCGA-43-2576-01 TCGA-43-2576-01A-01D-0844-01 TCGA-43-2576-01 ac4077ca-1cc5-4df5-b621-94e2cb8ecd0f TCGA-43-2576-01 ac4077ca-1cc5-4df5-b621-94e2cb8ecd0f TCGA-43-2576-01 TCGA-43-2576-01A-01D-0844-01 +TCGA-43-2578-01 TCGA-43-2578-01 High C1-LUAD-enriched cluster 1 Cluster 5 squamous c3 RNA cluster 3 miRNA cluster 12 cluster 3 mutation cluster 4 TCGA-43-2578 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 59 L-Upper TCGA-43-2578-F13290 TCGA-43-2578 TCGA-43-2578-01A -21747 684 0 684 0 Complete Remission/Response 2011-6-23 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.7 NO NO 0.8 NO 64 Yes M0 N0 T1 Stage IA TCGA-43-2578.ebd86e31-d68f-404b-ad7d-bdfbee556f3b.pdf 2578 Preoperative TUMOR FREE 60 45 63 42 Complete Remission/Response YES NO R0 Primary Tumor 01 0.7 2000 6th NO YES NO 43 4 Lung A DECEASED 2009 1968 TCGA-43-2578-01A-01D-1522-08 TCGA-43-2578-01A-01D-0848-05 c7b94923-c28a-449e-962c-40d56a1b2e61 TCGA-43-2578-01 TCGA-43-2578-01A-01D-1522-08 TCGA-43-2578-01 TCGA-43-2578-01A-01R-0851-07 c7b94923-c28a-449e-962c-40d56a1b2e61 b21db811-a4fa-41a5-8466-9944845ffea1 TCGA-43-2578-01A-21-2193-20 TCGA-43-2578-01 TCGA-43-2578-01A-01D-1969-01 TCGA-43-2578-01 c7b94923-c28a-449e-962c-40d56a1b2e61 TCGA-43-2578-01 c7b94923-c28a-449e-962c-40d56a1b2e61 TCGA-43-2578-01 TCGA-43-2578-01A-01D-1969-01 8533dc60-fcd4-4b70-af5d-624df2d66eb2 +TCGA-43-2581-01 TCGA-43-2581-01 High C1-LUAD-enriched Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 4 TCGA-43-2581 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 47 R-Upper TCGA-43-2581-F39082 TCGA-43-2581 TCGA-43-2581-01A -17447 0 1176 50 1 Scheduled Follow-up Submission Complete Remission/Response 2013-1-11 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.7 NO NO 1.3 NO NO 30 No M0 N1 T3 Stage IIIA TCGA-43-2581.eb835b34-3938-4ace-9c89-11ebefb85da2.pdf 2581 Pre-Adjuvant Therapy TUMOR FREE 50 44 41 38 Complete Remission/Response YES NO R0 Primary Tumor 01 0.4 6th YES YES NO 43 2 Lung A LIVING 2009 1979 TCGA-43-2581-01A-01D-0848-05 9471e29a-1dcc-4de4-a213-15765427e8e5 TCGA-43-2581-01 TCGA-43-2581-01 TCGA-43-2581-01A-01R-0851-07 9471e29a-1dcc-4de4-a213-15765427e8e5 914746a2-a405-43a8-8d98-372fb0dd3926 TCGA-43-2581-01A-21-2193-20 TCGA-43-2581-01 TCGA-43-2581-01A-01D-0844-01 TCGA-43-2581-01 9471e29a-1dcc-4de4-a213-15765427e8e5 TCGA-43-2581-01 9471e29a-1dcc-4de4-a213-15765427e8e5 TCGA-43-2581-01 TCGA-43-2581-01A-01D-0844-01 25c27349-3d97-4602-aa07-8187a7c97788 +TCGA-43-3394-01 TCGA-43-3394-01 Squamous C2-Squamous-like cluster 1 Cluster 5 squamous c3 squamous-like c4 miRNA cluster 4 cluster 2 mutation cluster 5 TCGA-43-3394 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 52 L-Lower TCGA-43-3394-F38662 TCGA-43-3394 TCGA-43-3394-01A -19310 1190 0 352 81 0 Scheduled Follow-up Submission 2012-12-19 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.9 NO NO 0.9 NO NO 15 No M0 N0 T2a Stage IB TCGA-43-3394.ab2c3289-581e-4bb2-a41f-418b057ef54b.pdf 3394 Other WITH TUMOR 60 50 60 36 Complete Remission/Response YES NO R0 Primary Tumor 01 0.6 6th YES YES NO 43 2 Lung A DECEASED 2009 1979 TCGA-43-3394-01A-01D-0983-08 TCGA-43-3394-01A-01D-0979-05 27e89ada-fc8b-484f-8570-c26af5434438 TCGA-43-3394-01 TCGA-43-3394-01A-01D-0983-08 TCGA-43-3394-01 TCGA-43-3394-01A-01R-0980-07 27e89ada-fc8b-484f-8570-c26af5434438 4ba1b933-cdc6-4c2f-8e70-8cb6829f560d TCGA-43-3394-01A-21-2193-20 TCGA-43-3394-01 TCGA-43-3394-01A-01D-1549-01 TCGA-43-3394-01 27e89ada-fc8b-484f-8570-c26af5434438 TCGA-43-3394-01 27e89ada-fc8b-484f-8570-c26af5434438 TCGA-43-3394-01 TCGA-43-3394-01A-01D-1549-01 16838c14-8069-48d4-b57a-f06db613503b +TCGA-43-3394-11 TCGA-43-3394-11 C2-Squamous-like mutation cluster 5 TCGA-43-3394 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 52 L-Lower TCGA-43-3394-F38662 TCGA-43-3394 TCGA-43-3394-11A -19310 1190 0 352 81 0 Scheduled Follow-up Submission 2012-12-19 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.8 NO NO 4.4 NO NO 15 No M0 N0 T2a Stage IB 3394 Other WITH TUMOR 60 50 60 36 Complete Remission/Response YES NO R0 Solid Tissue Normal 11 0.8 6th YES YES NO 43 2 Lung A DECEASED 2009 1979 d5da6fea-e0ee-4da5-8f4a-45d850fead0c d5da6fea-e0ee-4da5-8f4a-45d850fead0c d5da6fea-e0ee-4da5-8f4a-45d850fead0c d5da6fea-e0ee-4da5-8f4a-45d850fead0c TCGA-43-3394-11A-01D-1551-05 +TCGA-43-3920-01 TCGA-43-3920-01 High C2-Squamous-like cluster 4 Cluster 5 squamous-like c4 miRNA cluster 7 cluster 2 mutation cluster 5 TCGA-43-3920 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 71 R-Upper TCGA-43-3920-F39254 TCGA-43-3920 TCGA-43-3920-01A -26059 0 1007 50 Scheduled Follow-up Submission Complete Remission/Response 2013-1-16 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.7 NO NO 1.3 NO NO 50 No M0 N0 T2 Stage IB TCGA-43-3920.93f563a8-23e6-4a60-a7ca-b51ab176f978.pdf 3920 TUMOR FREE 97 77 95 78 Complete Remission/Response YES NO R0 Primary Tumor 01 0.3 2009 7th NO YES NO 43 4 Lung A LIVING 2009 1959 TCGA-43-3920-01A-01D-0983-08 TCGA-43-3920-01A-01D-0979-05 185c6574-0d29-4078-9198-ed4f427331bd TCGA-43-3920-01 TCGA-43-3920-01A-01D-0983-08 TCGA-43-3920-01 TCGA-43-3920-01A-01R-0980-07 185c6574-0d29-4078-9198-ed4f427331bd 462d115b-c221-4e67-85da-6bfad4f7e105 TCGA-43-3920-01 TCGA-43-3920-01A-01D-1549-01 TCGA-43-3920-01 185c6574-0d29-4078-9198-ed4f427331bd TCGA-43-3920-01 185c6574-0d29-4078-9198-ed4f427331bd TCGA-43-3920-01 TCGA-43-3920-01A-01D-1549-01 +TCGA-43-3920-11 TCGA-43-3920-11 C2-Squamous-like mutation cluster 5 TCGA-43-3920 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 71 R-Upper TCGA-43-3920-F39254 TCGA-43-3920 TCGA-43-3920-11B -26059 0 1007 50 Scheduled Follow-up Submission Complete Remission/Response 2013-1-16 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.8 NO NO 2 NO NO 50 No M0 N0 T2 Stage IB 3920 TUMOR FREE 97 77 95 78 Complete Remission/Response YES NO R0 Solid Tissue Normal 11 0.8 2009 7th NO YES NO 43 4 Lung B LIVING 2009 1959 TCGA-43-3920-11B-01D-1551-05 +TCGA-43-5668-01 TCGA-43-5668-01 High C1-LUAD-enriched cluster 1 Cluster 6 squamous c3 RNA cluster 5 miRNA cluster 2 cluster 3 mutation cluster 11 TCGA-43-5668 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung YES NO NO NO 78 R-Upper TCGA-43-5668-F31287 TCGA-43-5668 TCGA-43-5668-01A -28635 559 0 258 470 61 1 Additional New Tumor Event Progressive Disease 2012-4-26 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.6 NO 1.3 YES 20 Yes M0 N1 T1b Stage IIA TCGA-43-5668.e41d4d1f-8334-42c6-8759-ad5366a11c93.pdf 5668 Pre-Adjuvant Therapy WITH TUMOR 89 83 84 74 Progressive Disease YES NO Primary Tumor 01 0.4 1983 7th YES YES NO 43 3 Lung A DECEASED 2010 TCGA-43-5668-01A-01D-1632-08 3cb7b861-6dba-4d54-bc04-c63a238e394e TCGA-43-5668-01 TCGA-43-5668-01A-01D-1632-08 TCGA-43-5668-01 TCGA-43-5668-01 3cb7b861-6dba-4d54-bc04-c63a238e394e TCGA-43-5668-01A-21-2194-20 TCGA-43-5668-01 TCGA-43-5668-01A-01D-1631-01 3cb7b861-6dba-4d54-bc04-c63a238e394e 3cb7b861-6dba-4d54-bc04-c63a238e394e TCGA-43-5668-01A-01D-1631-01 TCGA-43-5668-01A-01D-1633-05 e34afcb4-f3ec-4f28-b419-cf55da46f62e +TCGA-43-5668-11 TCGA-43-5668-11 C1-LUAD-enriched mutation cluster 11 TCGA-43-5668 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung YES NO NO NO 78 R-Upper TCGA-43-5668-F31287 TCGA-43-5668 TCGA-43-5668-11A -28635 559 0 258 470 61 1 Additional New Tumor Event Progressive Disease 2012-4-26 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.9 NO 1.1 YES 20 Yes M0 N1 T1b Stage IIA 5668 Pre-Adjuvant Therapy WITH TUMOR 89 83 84 74 Progressive Disease YES NO Solid Tissue Normal 11 0.9 1983 7th YES YES NO 43 3 Lung A DECEASED 2010 TCGA-43-5668-11A-01D-1633-05 +TCGA-43-5670-01 TCGA-43-5670-01 High Cluster 5 squamous c3 miRNA cluster 11 TCGA-43-5670 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung NO 70 L-Lower TCGA-43-5670-F40410 TCGA-43-5670 TCGA-43-5670-01A -25652 0 849 53 0 Scheduled Follow-up Submission Complete Remission/Response 2013-2-19 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 1 NO 1.3 NO NO 30 No M0 N0 T2b Stage IIA TCGA-43-5670.ca16f05f-5198-405b-91e4-cde6119a75bb.pdf 5670 Post-Adjuvant Therapy TUMOR FREE 98 108 92 100 Complete Remission/Response YES NO Primary Tumor 01 0.3 1980 7th YES YES NO 43 3 Lung A LIVING 2010 1970 8e49dba6-1d3d-4e60-aba7-a093fe5bbd41 TCGA-43-5670-01 TCGA-43-5670-01 TCGA-43-5670-01 8e49dba6-1d3d-4e60-aba7-a093fe5bbd41 TCGA-43-5670-01A-11-2194-20 TCGA-43-5670-01 TCGA-43-5670-01A-21D-2121-01 8e49dba6-1d3d-4e60-aba7-a093fe5bbd41 8e49dba6-1d3d-4e60-aba7-a093fe5bbd41 TCGA-43-5670-01A-21D-2121-01 TCGA-43-5670-01A-21D-2123-05 75fb3562-d7fc-459c-acc9-5b66d16eb7fa +TCGA-43-5670-11 TCGA-43-5670-11 TCGA-43-5670 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung NO 70 L-Lower TCGA-43-5670-F40410 TCGA-43-5670 -25652 0 849 53 0 Scheduled Follow-up Submission Complete Remission/Response 2013-2-19 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES NO NO 30 No M0 N0 T2b Stage IIA 5670 Post-Adjuvant Therapy TUMOR FREE 98 108 92 100 Complete Remission/Response YES NO Solid Tissue Normal 11 1980 7th YES YES NO 43 3 Lung LIVING 2010 1970 b0b31be8-d2f5-4543-90c4-52d88e1bff94 TCGA-43-5670-11 TCGA-43-5670-11 b0b31be8-d2f5-4543-90c4-52d88e1bff94 b0b31be8-d2f5-4543-90c4-52d88e1bff94 b0b31be8-d2f5-4543-90c4-52d88e1bff94 +TCGA-43-6143-01 TCGA-43-6143-01 Squamous C1-LUAD-enriched cluster 4 Cluster 5 squamous c3 RNA cluster 12 miRNA cluster 13 cluster 3 mutation cluster 2 TCGA-43-6143 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung NO 70 R-Lower TCGA-43-6143-F38926 TCGA-43-6143 TCGA-43-6143-01A -25820 0 699 40 1 Scheduled Follow-up Submission Complete Remission/Response 2013-1-4 MALE Lung Basaloid Squamous Cell Carcinoma No C34.3 8083/3 C34.3 YES 0.8 NO 80 1.6 NO NO 114 No M0 N0 T2 Stage IB TCGA-43-6143.0a88e8ad-53bb-4450-8131-f7ac7c79960a.pdf 6143 Other TUMOR FREE 77 50 78 45 Complete Remission/Response YES NO RX Primary Tumor 01 0.8 2010 7th YES YES NO 43 4 Lung A LIVING 2010 1953 TCGA-43-6143-01A-11D-1817-08 0896ba53-2761-4378-9042-de4895b173ac TCGA-43-6143-01 TCGA-43-6143-01A-11D-1817-08 TCGA-43-6143-01 TCGA-43-6143-01 0896ba53-2761-4378-9042-de4895b173ac TCGA-43-6143-01A-13-2194-20 TCGA-43-6143-01 TCGA-43-6143-01A-11D-1816-01 0896ba53-2761-4378-9042-de4895b173ac 0896ba53-2761-4378-9042-de4895b173ac TCGA-43-6143-01A-11D-1816-01 TCGA-43-6143-01A-11D-1818-05 01f9ec9b-2018-4773-aac3-afc9218f8057 +TCGA-43-6143-11 TCGA-43-6143-11 C1-LUAD-enriched mutation cluster 2 TCGA-43-6143 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung NO 70 R-Lower TCGA-43-6143-F38926 TCGA-43-6143 TCGA-43-6143-11A -25820 0 699 40 1 Scheduled Follow-up Submission Complete Remission/Response 2013-1-4 MALE Lung Basaloid Squamous Cell Carcinoma No C34.3 8083/3 C34.3 YES 1 NO 80 2.2 NO NO 114 No M0 N0 T2 Stage IB 6143 Other TUMOR FREE 77 50 78 45 Complete Remission/Response YES NO RX Solid Tissue Normal 11 1 2010 7th YES YES NO 43 4 Lung A LIVING 2010 1953 80fbe4ac-7a80-4b89-8fce-3caddfafee64 TCGA-43-6143-11 TCGA-43-6143-11 80fbe4ac-7a80-4b89-8fce-3caddfafee64 80fbe4ac-7a80-4b89-8fce-3caddfafee64 80fbe4ac-7a80-4b89-8fce-3caddfafee64 +TCGA-43-6647-01 TCGA-43-6647-01 Squamous C2-Squamous-like cluster 1 Cluster 5 squamous-like c4 miRNA cluster 5 cluster 4 mutation c1uster 10 TCGA-43-6647 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 69 R-Lower TCGA-43-6647-F39010 TCGA-43-6647 -25378 0 757 0 Scheduled Follow-up Submission Complete Remission/Response 2013-1-8 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 100 NO NO 36 No MX N1 T2b Stage IIB 6647 Post-Adjuvant Therapy TUMOR FREE 76 Complete Remission/Response YES NO RX Primary Tumor 01 1995 7th YES YES NO 43 4 Lung LIVING 2010 1959 TCGA-43-6647-01A-11D-1817-08 bd265674-2868-40d9-9d1a-72f4baf887f0 TCGA-43-6647-01 TCGA-43-6647-01A-11D-1817-08 TCGA-43-6647-01 TCGA-43-6647-01 bd265674-2868-40d9-9d1a-72f4baf887f0 TCGA-43-6647-01 TCGA-43-6647-01A-11D-1816-01 bd265674-2868-40d9-9d1a-72f4baf887f0 bd265674-2868-40d9-9d1a-72f4baf887f0 TCGA-43-6647-01A-11D-1816-01 TCGA-43-6647-01A-11D-1818-05 +TCGA-43-6647-11 TCGA-43-6647-11 C2-Squamous-like mutation c1uster 10 TCGA-43-6647 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 69 R-Lower TCGA-43-6647-F39010 TCGA-43-6647 TCGA-43-6647-11A -25378 0 757 0 Scheduled Follow-up Submission Complete Remission/Response 2013-1-8 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 1 NO 100 2.5 NO NO 36 No MX N1 T2b Stage IIB 6647 Post-Adjuvant Therapy TUMOR FREE 76 Complete Remission/Response YES NO RX Solid Tissue Normal 11 1 1995 7th YES YES NO 43 4 Lung A LIVING 2010 1959 d3ffdd2d-b156-4e82-92ab-37c9e48a736b d3ffdd2d-b156-4e82-92ab-37c9e48a736b d3ffdd2d-b156-4e82-92ab-37c9e48a736b d3ffdd2d-b156-4e82-92ab-37c9e48a736b +TCGA-43-6770-01 TCGA-43-6770-01 High C2-Squamous-like cluster 4 Cluster 5 squamous c3 squamous-like c4 miRNA cluster 12 cluster 4 mutation cluster 2 TCGA-43-6770 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 59 L-Upper TCGA-43-6770-F39906 TCGA-43-6770 TCGA-43-6770-01A -21683 0 653 59 Scheduled Follow-up Submission Complete Remission/Response 2013-2-5 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.7 NO 90 2 NO NO 34 No MX N0 T2a Stage IB TCGA-43-6770.cacfd9dd-aad5-48d8-9ecc-3db108bff2f8.pdf 6770 Other TUMOR FREE 96 93 99 97 Complete Remission/Response YES NO RX Primary Tumor 01 0.4 7th YES YES NO 43 2 Lung A LIVING 2011 1977 TCGA-43-6770-01A-11D-1817-08 6322257f-c99b-4562-95fb-1b26651bc876 TCGA-43-6770-01 TCGA-43-6770-01A-11D-1817-08 TCGA-43-6770-01 TCGA-43-6770-01 6322257f-c99b-4562-95fb-1b26651bc876 TCGA-43-6770-01A-13-2195-20 TCGA-43-6770-01 TCGA-43-6770-01A-11D-1816-01 6322257f-c99b-4562-95fb-1b26651bc876 6322257f-c99b-4562-95fb-1b26651bc876 TCGA-43-6770-01A-11D-1816-01 TCGA-43-6770-01A-11D-1818-05 ebc6f011-b3ec-4c3a-b834-042da6b23280 +TCGA-43-6771-01 TCGA-43-6771-01 Squamous C2-Squamous-like cluster 1 Cluster 6 squamous c3 squamous-like c4 miRNA cluster 11 cluster 1 mutation c1uster 9 TCGA-43-6771 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung NO 85 L-Upper TCGA-43-6771-F15614 TCGA-43-6771 TCGA-43-6771-01A -31052 166 0 154 101 Scheduled Follow-up Submission 2011-8-26 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.8 NO 1 YES 40 No MX N0 T2 Stage IB TCGA-43-6771.09fbd8e1-9f86-47c1-abea-fd8e96366908.pdf 6771 WITH TUMOR 121 109 117 104 Progressive Disease YES NO RX Primary Tumor 01 0.7 1976 6th NO NO YES 43 3 Lung A DECEASED 2006 1936 TCGA-43-6771-01A-11D-1817-08 b936c3f0-795b-4128-bca0-b797b3d86f8d TCGA-43-6771-01 TCGA-43-6771-01A-11D-1817-08 TCGA-43-6771-01 TCGA-43-6771-01 b936c3f0-795b-4128-bca0-b797b3d86f8d TCGA-43-6771-01A-13-2195-20 TCGA-43-6771-01 TCGA-43-6771-01A-11D-1816-01 b936c3f0-795b-4128-bca0-b797b3d86f8d b936c3f0-795b-4128-bca0-b797b3d86f8d TCGA-43-6771-01A-11D-1816-01 TCGA-43-6771-01A-11D-1818-05 6d6d5925-f180-4866-bcb1-f954a2da17f7 +TCGA-43-6771-11 TCGA-43-6771-11 C2-Squamous-like mutation c1uster 9 TCGA-43-6771 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung NO 85 L-Upper TCGA-43-6771-F15614 TCGA-43-6771 TCGA-43-6771-11A -31052 166 0 154 101 Scheduled Follow-up Submission 2011-8-26 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.8 NO 0.8 YES 40 No MX N0 T2 Stage IB 6771 WITH TUMOR 121 109 117 104 Progressive Disease YES NO RX Solid Tissue Normal 11 0.8 1976 6th NO NO YES 43 3 Lung A DECEASED 2006 1936 79b04aa9-2ebd-4891-8fe4-ea635dbafa2f TCGA-43-6771-11 TCGA-43-6771-11 79b04aa9-2ebd-4891-8fe4-ea635dbafa2f 79b04aa9-2ebd-4891-8fe4-ea635dbafa2f 79b04aa9-2ebd-4891-8fe4-ea635dbafa2f TCGA-43-6771-11A-01D-1818-05 +TCGA-43-6773-01 TCGA-43-6773-01 Quiet Low purity c2 miRNA cluster 7 TCGA-43-6773 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 76 R-Lower TCGA-43-6773-F17411 TCGA-43-6773 TCGA-43-6773-01A -28036 116 0 84 Scheduled Follow-up Submission 2011-10-12 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.2 8070/3 C34.2 YES 0.8 NO 1.3 No MX N1 T2 Stage IIB TCGA-43-6773.b09e0471-a726-41b4-90ed-b9e1e062896d.pdf 6773 TUMOR FREE 70 65 YES NO Primary Tumor 01 0.8 1988 6th NO NO YES 43 3 Lung A DECEASED 2008 25361c46-91f3-4b7b-80e0-ef8576ce00c1 TCGA-43-6773-01 TCGA-43-6773-01 TCGA-43-6773-01 25361c46-91f3-4b7b-80e0-ef8576ce00c1 TCGA-43-6773-01 TCGA-43-6773-01A-41D-1943-01 25361c46-91f3-4b7b-80e0-ef8576ce00c1 25361c46-91f3-4b7b-80e0-ef8576ce00c1 TCGA-43-6773-01A-41D-1943-01 TCGA-43-6773-01A-41D-1947-05 +TCGA-43-6773-11 TCGA-43-6773-11 TCGA-43-6773 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 76 R-Lower TCGA-43-6773-F17411 TCGA-43-6773 TCGA-43-6773-11A -28036 116 0 84 Scheduled Follow-up Submission 2011-10-12 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.2 8070/3 C34.2 YES 0.9 NO 1.2 No MX N1 T2 Stage IIB 6773 TUMOR FREE 70 65 YES NO Solid Tissue Normal 11 0.9 1988 6th NO NO YES 43 3 Lung A DECEASED 2008 2c3b36e7-3761-433c-976e-30aed0a82819 TCGA-43-6773-11 TCGA-43-6773-11 2c3b36e7-3761-433c-976e-30aed0a82819 2c3b36e7-3761-433c-976e-30aed0a82819 2c3b36e7-3761-433c-976e-30aed0a82819 +TCGA-43-7656-01 TCGA-43-7656-01 Squamous C2-Squamous-like Low purity c2 squamous c3 RNA cluster 12 miRNA cluster 4 TCGA-43-7656 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 71 R-Lower TCGA-43-7656-F39647 TCGA-43-7656 TCGA-43-7656-01A -25991 0 596 67 0 Scheduled Follow-up Submission 2013-1-28 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.5 NO NO 1 NO NO 45 No MX N0 T1b Stage IA TCGA-43-7656.57b4e426-72c1-43ba-b8f1-d17ce36e6478.pdf 7656 Other TUMOR FREE 75 62 73 60 Complete Remission/Response NO Primary Tumor 01 0.4 7th NO YES NO 43 4 Lung A LIVING 2011 1956 f7106ef9-450f-4952-8b64-c5d31317ae66 TCGA-43-7656-01 TCGA-43-7656-01 TCGA-43-7656-01 f7106ef9-450f-4952-8b64-c5d31317ae66 TCGA-43-7656-01A-13-2195-20 TCGA-43-7656-01 TCGA-43-7656-01A-11D-2121-01 f7106ef9-450f-4952-8b64-c5d31317ae66 f7106ef9-450f-4952-8b64-c5d31317ae66 TCGA-43-7656-01A-11D-2121-01 TCGA-43-7656-01A-11D-2123-05 8f489848-549d-41e4-9a75-db8aea47589f +TCGA-43-7657-01 TCGA-43-7657-01 Squamous Low purity c2 miRNA cluster 4 TCGA-43-7657 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 68 R-Upper TCGA-43-7657-F34027 TCGA-43-7657 TCGA-43-7657-01A -25042 0 236 64 0 Scheduled Follow-up Submission Complete Remission/Response 2012-7-25 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.7 NO NO 1 NO NO 45 Yes MX N0 T1 Stage IA TCGA-43-7657.24615ceb-b7aa-472d-9dc0-7af1fdf9f8c8.pdf 7657 Preoperative TUMOR FREE 95 103 90 91 Complete Remission/Response YES NO Primary Tumor 01 0.5 2002 7th NO YES NO 43 4 Lung A LIVING 2011 1957 56b4ee76-fe71-41fd-bb02-01cb4fcf5e38 TCGA-43-7657-01 TCGA-43-7657-01 TCGA-43-7657-01 56b4ee76-fe71-41fd-bb02-01cb4fcf5e38 TCGA-43-7657-01 TCGA-43-7657-01A-31D-2121-01 56b4ee76-fe71-41fd-bb02-01cb4fcf5e38 56b4ee76-fe71-41fd-bb02-01cb4fcf5e38 TCGA-43-7657-01A-31D-2121-01 TCGA-43-7657-01A-31D-2123-05 +TCGA-43-7657-11 TCGA-43-7657-11 TCGA-43-7657 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 68 R-Upper TCGA-43-7657-F34027 TCGA-43-7657 TCGA-43-7657-11A -25042 0 236 64 0 Scheduled Follow-up Submission Complete Remission/Response 2012-7-25 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 1 NO NO 1.4 NO NO 45 Yes MX N0 T1 Stage IA 7657 Preoperative TUMOR FREE 95 103 90 91 Complete Remission/Response YES NO Solid Tissue Normal 11 0.7 2002 7th NO YES NO 43 4 Lung A LIVING 2011 1957 148d34df-aec2-42bf-8e36-b91a68959606 TCGA-43-7657-11 TCGA-43-7657-11 148d34df-aec2-42bf-8e36-b91a68959606 148d34df-aec2-42bf-8e36-b91a68959606 148d34df-aec2-42bf-8e36-b91a68959606 +TCGA-43-7658-01 TCGA-43-7658-01 High Cluster 5 squamous c3 miRNA cluster 1 TCGA-43-7658 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung NO YES NO 75 R-Upper TCGA-43-7658-F39387 TCGA-43-7658 TCGA-43-7658-01A -27734 2378 0 2023 2305 0 Additional New Tumor Event Progressive Disease 2013-1-22 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.6 NO 50 0.8 NO Distant Metastasis|New Primary Tumor YES 12 Yes M0 N0 T1 Stage IA TCGA-43-7658.0c0d2eb2-af28-40f9-a4a3-067c1bc78cc6.pdf 7658 Other WITH TUMOR Complete Remission/Response Biopsy with Histologic Confirmation|Convincing Imaging YES NO Primary Tumor 01 0.1 1995 6th NO NO YES 43 4 Lung A DECEASED 2006 1970 c859b0e7-c582-41af-83d7-83ac07f53d13 TCGA-43-7658-01 TCGA-43-7658-01 TCGA-43-7658-01 c859b0e7-c582-41af-83d7-83ac07f53d13 TCGA-43-7658-01A-13-2195-20 TCGA-43-7658-01 TCGA-43-7658-01A-11D-2121-01 c859b0e7-c582-41af-83d7-83ac07f53d13 c859b0e7-c582-41af-83d7-83ac07f53d13 TCGA-43-7658-01A-11D-2121-01 TCGA-43-7658-01A-11D-2123-05 68a07bc1-8c04-4887-a120-c3efa5e439d2 +TCGA-43-7658-11 TCGA-43-7658-11 TCGA-43-7658 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung NO YES NO 75 R-Upper TCGA-43-7658-F39387 TCGA-43-7658 -27734 2378 0 2023 2305 0 Additional New Tumor Event Progressive Disease 2013-1-22 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 50 NO Distant Metastasis|New Primary Tumor YES 12 Yes M0 N0 T1 Stage IA 7658 Other WITH TUMOR Complete Remission/Response Biopsy with Histologic Confirmation|Convincing Imaging YES NO Solid Tissue Normal 11 1995 6th NO NO YES 43 4 Lung DECEASED 2006 1970 e22f0063-e7ec-4f86-b937-2fcd7797c103 TCGA-43-7658-11 TCGA-43-7658-11 e22f0063-e7ec-4f86-b937-2fcd7797c103 e22f0063-e7ec-4f86-b937-2fcd7797c103 e22f0063-e7ec-4f86-b937-2fcd7797c103 +TCGA-43-8115-01 TCGA-43-8115-01 Squamous Cluster 5 miRNA cluster 4 TCGA-43-8115 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung NO NO NO 72 L-Lower TCGA-43-8115-F37153 TCGA-43-8115 TCGA-43-8115-01A -26406 0 407 1 Scheduled Follow-up Submission Stable Disease 2012-11-28 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.7 NO 1.5 NO NO 55.83 No MX N1 T2a Stage IIA TCGA-43-8115.a18f4ec6-0500-4e01-98ff-e30faa481fa4.pdf 8115 Post-Adjuvant Therapy TUMOR FREE 66 54 Stable Disease YES NO R0 Primary Tumor 01 0.7 2011 7th YES YES NO 43 4 Lung A LIVING 2011 1955 3e1695a2-9716-466c-89a8-91a3c996cdbe TCGA-43-8115-01 TCGA-43-8115-01 TCGA-43-8115-01 3e1695a2-9716-466c-89a8-91a3c996cdbe TCGA-43-8115-01 TCGA-43-8115-01A-11D-2243-01 3e1695a2-9716-466c-89a8-91a3c996cdbe 3e1695a2-9716-466c-89a8-91a3c996cdbe TCGA-43-8115-01A-11D-2243-01 TCGA-43-8115-01A-11D-2245-05 430D8C93-EB7C-4DE6-A40B-703D60C10848 +TCGA-43-8116-01 TCGA-43-8116-01 Squamous Cluster 13 (HNSC-LUSC) miRNA cluster 4 TCGA-43-8116 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 73 L-Upper TCGA-43-8116-F36263 TCGA-43-8116 TCGA-43-8116-01A -26790 0 358 55 1 Scheduled Follow-up Submission 2012-10-25 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.8 NO 1.4 NO NO 35 No M0 N0 T1b Stage IA TCGA-43-8116.2038982b-7cfc-4a88-846f-f44f7e8ff78a.pdf 8116 Preoperative TUMOR FREE 102 99 102 94 Complete Remission/Response YES NO Primary Tumor 01 0.6 7th NO YES NO 43 2 Lung A LIVING 2011 1959 570cec62-e184-4e9b-a7fe-93f8615b2271 TCGA-43-8116-01 TCGA-43-8116-01 TCGA-43-8116-01 570cec62-e184-4e9b-a7fe-93f8615b2271 TCGA-43-8116-01 TCGA-43-8116-01A-11D-2243-01 570cec62-e184-4e9b-a7fe-93f8615b2271 570cec62-e184-4e9b-a7fe-93f8615b2271 TCGA-43-8116-01A-11D-2243-01 TCGA-43-8116-01A-11D-2245-05 +TCGA-43-8118-01 TCGA-43-8118-01 TCGA-43-8118 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 55 R-Upper TCGA-43-8118-F36773 TCGA-43-8118 TCGA-43-8118-01A -20224 89 0 50 1 NO NO 2012-11-13 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8140/3 C34.1 YES 0.7 NO NO 1 NO NO 20 Yes, History of Synchronous/Bilateral Malignancy M0 N0 T1b Stage IA TCGA-43-8118.52C7F12F-DA4C-4784-9B71-9EB385F25077.pdf 8118 Pre-Adjuvant Therapy 92 73 88 66 YES NO Primary Tumor 01 0.5 7th YES YES NO 43 2 Lung A DECEASED 2011 1971 8cebbeaa-9421-4012-becb-10de3f135a3e TCGA-43-8118-01 TCGA-43-8118-01 TCGA-43-8118-01 8cebbeaa-9421-4012-becb-10de3f135a3e TCGA-43-8118-01 TCGA-43-8118-01A-11D-2391-01 8cebbeaa-9421-4012-becb-10de3f135a3e 8cebbeaa-9421-4012-becb-10de3f135a3e TCGA-43-8118-01A-11D-2391-01 TCGA-43-8118-01A-11D-2398-05 8730A9A6-1A5E-44A2-8AD0-801609EF4835 +TCGA-43-A474-01 TCGA-43-A474-01 TCGA-43-A474 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 66 L-Upper TCGA-43-A474-F39908 TCGA-43-A474 TCGA-43-A474-01A -24286 214 0 353 73 Scheduled Follow-up Submission Complete Remission/Response 2013-2-5 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 230 NO 90 NO NO 47 false Yes, History of Prior Malignancy M0 N0 T2b Stage IIA TCGA-43-A474.31549DED-DB58-4FA2-A598-29B34B12AF4E.pdf A474 Post-Adjuvant Therapy TUMOR FREE 83 82 79 66 Complete Remission/Response YES NO R0 Primary Tumor 01 2012 7th YES YES NO 43 4 Lung A LIVING 2012 1965 7533fbaf-dbbd-4778-b213-741229a58f4c TCGA-43-A474-01 TCGA-43-A474-01 TCGA-43-A474-01 7533fbaf-dbbd-4778-b213-741229a58f4c TCGA-43-A474-01 TCGA-43-A474-01A-11D-A24C-01 7533fbaf-dbbd-4778-b213-741229a58f4c 7533fbaf-dbbd-4778-b213-741229a58f4c TCGA-43-A474-01A-11D-A24C-01 TCGA-43-A474-01A-11D-A24I-05 EA43BCFC-F61F-47BF-82A8-34B2B9D18D5E +TCGA-43-A475-01 TCGA-43-A475-01 TCGA-43-A475 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 67 R-Upper TCGA-43-A475-F41130 TCGA-43-A475 TCGA-43-A475-01A -24680 148 0 296 53 0 Scheduled Follow-up Submission 2013-3-12 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 320 NO 80 NO NO 100 false No M0 N0 T3 Stage IIB TCGA-43-A475.24B44F94-4883-492D-A373-626D240014A5.pdf A475 Other TUMOR FREE 77 71 77 67 Complete Remission/Response YES YES R1 Primary Tumor 01 2008 7th YES YES NO 43 4 Lung A LIVING 2012 1958 72a23d60-178c-4cd2-9204-c00aebc935b6 TCGA-43-A475-01 TCGA-43-A475-01 TCGA-43-A475-01 72a23d60-178c-4cd2-9204-c00aebc935b6 TCGA-43-A475-01 TCGA-43-A475-01A-11D-A24C-01 72a23d60-178c-4cd2-9204-c00aebc935b6 72a23d60-178c-4cd2-9204-c00aebc935b6 TCGA-43-A475-01A-11D-A24C-01 TCGA-43-A475-01A-11D-A24I-05 5D4ADE97-FB73-4F52-91C2-CF43C89D8F3F +TCGA-43-A56U-01 TCGA-43-A56U-01 TCGA-43-A56U TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 76 L-Upper TCGA-43-A56U-F51576 TCGA-43-A56U -27847 0 432 75 0 Scheduled Follow-up Submission Complete Remission/Response 2013-11-20 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES NO NO 20.5 No MX N0 T1b Stage IA A56U Preoperative TUMOR FREE 96 89 92 85 Complete Remission/Response YES NO R0 Primary Tumor 01 2012 7th NO YES NO 43 4 Lung LIVING 2012 1971 b9af6223-4001-41ad-adc1-be15c76d8150 TCGA-43-A56U-01 TCGA-43-A56U-01 TCGA-43-A56U-01 b9af6223-4001-41ad-adc1-be15c76d8150 TCGA-43-A56U-01 TCGA-43-A56U-01A-11D-A26L-01 b9af6223-4001-41ad-adc1-be15c76d8150 b9af6223-4001-41ad-adc1-be15c76d8150 TCGA-43-A56U-01A-11D-A26L-01 TCGA-43-A56U-01A-11D-A26N-05 +TCGA-43-A56V-01 TCGA-43-A56V-01 TCGA-43-A56V TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung NO NO NO NO 61 R-Middle TCGA-43-A56V-F51041 TCGA-43-A56V TCGA-43-A56V-01A -22475 27 0 366 355 58 Scheduled Follow-up Submission Progressive Disease 2013-11-6 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.2 8070/3 C34.2 YES 280 NO 70 NO Locoregional Recurrence|Distant Metastasis YES 48 false Yes, History of Synchronous/Bilateral Malignancy M0 N2 T2a Stage IIIA TCGA-43-A56V.716CE78F-14FC-43DE-96F9-A12874CA9648.pdf A56V Other WITH TUMOR 97 76 97 78 Complete Remission/Response Convincing Imaging YES NO Primary Tumor 01 1999 7th YES YES NO 43 4 Lung A LIVING 2012 1967 165b9f2f-04c6-44d0-a4ac-069ad04e4e42 TCGA-43-A56V-01 TCGA-43-A56V-01 TCGA-43-A56V-01 165b9f2f-04c6-44d0-a4ac-069ad04e4e42 TCGA-43-A56V-01 TCGA-43-A56V-01A-11D-A26L-01 165b9f2f-04c6-44d0-a4ac-069ad04e4e42 165b9f2f-04c6-44d0-a4ac-069ad04e4e42 TCGA-43-A56V-01A-11D-A26L-01 TCGA-43-A56V-01A-11D-A26N-05 07349AC8-4FEF-4003-A9CA-D1505CFCA300 +TCGA-46-3765-01 TCGA-46-3765-01 Squamous C2-Squamous-like cluster 3 Cluster 13 (HNSC-LUSC) squamous-like c4 miRNA cluster 7 cluster 2 mutation cluster 6 TCGA-46-3765 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 59 R-Upper TCGA-46-3765-F43470 TCGA-46-3765 TCGA-46-3765-01A -21762 0 405 NO NO Scheduled Follow-up Submission Complete Remission/Response 2015-9-17 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.5 NO NO Central Lung 0.8 NO NO No M0 N0 T1 Stage IA TCGA-46-3765.70f74440-e1da-4d78-9b0d-633342c3b4c3.pdf 3765 TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 0.3 NO YES NO 46 2 Lung A LIVING 2009 TCGA-46-3765-01A-01D-0983-08 TCGA-46-3765-01A-01D-0979-05 f4b89ed8-5cd7-4b62-b427-ba408a24a60f TCGA-46-3765-01 TCGA-46-3765-01A-01D-0983-08 TCGA-46-3765-01 TCGA-46-3765-01A-01R-0980-07 f4b89ed8-5cd7-4b62-b427-ba408a24a60f 27282d8e-f7e6-432e-aeea-2885fc47fa04 TCGA-46-3765-01 TCGA-46-3765-01A-01D-0978-01 TCGA-46-3765-01 f4b89ed8-5cd7-4b62-b427-ba408a24a60f TCGA-46-3765-01 f4b89ed8-5cd7-4b62-b427-ba408a24a60f TCGA-46-3765-01 TCGA-46-3765-01A-01D-0978-01 +TCGA-46-3766-01 TCGA-46-3766-01 Squamous C2-Squamous-like cluster 4 Cluster 5 squamous-like c4 miRNA cluster 4 cluster 4 mutation c1uster 9 TCGA-46-3766 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 62 R-Lower TCGA-46-3766-F43472 TCGA-46-3766 TCGA-46-3766-01A -22707 0 370 NO NO Scheduled Follow-up Submission Complete Remission/Response 2015-9-17 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.5 NO NO Central Lung 0.8 NO NO No M0 N0 T1 Stage IA TCGA-46-3766.188fd38f-839c-49ec-b8e6-41655c2a8479.pdf 3766 TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 0.1 NO YES NO 46 4 Lung A LIVING 2009 TCGA-46-3766-01A-01D-0983-08 TCGA-46-3766-01A-01D-0979-05 9718e096-a9bc-42fc-af97-1624c4ba6a9b TCGA-46-3766-01 TCGA-46-3766-01A-01D-0983-08 TCGA-46-3766-01 TCGA-46-3766-01A-01R-0980-07 9718e096-a9bc-42fc-af97-1624c4ba6a9b febf0677-d562-45db-b5f9-c3f3dc3d699a TCGA-46-3766-01 TCGA-46-3766-01A-01D-0978-01 TCGA-46-3766-01 9718e096-a9bc-42fc-af97-1624c4ba6a9b TCGA-46-3766-01 9718e096-a9bc-42fc-af97-1624c4ba6a9b TCGA-46-3766-01 TCGA-46-3766-01A-01D-0978-01 +TCGA-46-3767-01 TCGA-46-3767-01 Kirc+ C2-Squamous-like cluster 1 Cluster 5 squamous-like c4 miRNA cluster 4 cluster 4 mutation cluster 2 TCGA-46-3767 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 76 L-Lower TCGA-46-3767-F43441 TCGA-46-3767 TCGA-46-3767-01A -27912 0 388 NO NO Scheduled Follow-up Submission Complete Remission/Response 2015-9-17 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.8 NO NO Central Lung 0.8 NO NO No M0 N0 T1a Stage IA TCGA-46-3767.8e91ee2e-da06-49fe-aa5e-4faca1240a25.pdf 3767 TUMOR FREE Complete Remission/Response R0 Primary Tumor 01 0.1 YES NO 46 3 Lung A LIVING 2009 TCGA-46-3767-01A-01D-0983-08 TCGA-46-3767-01A-01D-0979-05 566b24cb-eb71-4b13-a0bd-9d3bb6d8f475 TCGA-46-3767-01 TCGA-46-3767-01A-01D-0983-08 TCGA-46-3767-01 TCGA-46-3767-01A-01R-0980-07 566b24cb-eb71-4b13-a0bd-9d3bb6d8f475 0dfab38e-fa15-4da5-be8a-a3296dce22bb TCGA-46-3767-01 TCGA-46-3767-01A-01D-0978-01 TCGA-46-3767-01 566b24cb-eb71-4b13-a0bd-9d3bb6d8f475 TCGA-46-3767-01 566b24cb-eb71-4b13-a0bd-9d3bb6d8f475 TCGA-46-3767-01 TCGA-46-3767-01A-01D-0978-01 +TCGA-46-3768-01 TCGA-46-3768-01 Squamous C2-Squamous-like cluster 3 Cluster 13 (HNSC-LUSC) squamous-like c4 miRNA cluster 4 cluster 2 mutation cluster 13 TCGA-46-3768 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 58 L-Upper TCGA-46-3768-F43464 TCGA-46-3768 TCGA-46-3768-01A -21307 299 0 1 NO NO Scheduled Follow-up Submission Complete Remission/Response 2015-9-17 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.6 NO NO Central Lung 0.7 YES NO No M0 N1 T3 Stage IIIA TCGA-46-3768.83e30a4b-4df4-41d8-aa7c-7ae95be3b9fb.pdf 3768 Post-Adjuvant Therapy TUMOR FREE Complete Remission/Response YES R0 Primary Tumor 01 0.3 YES YES NO 46 4 Lung A DECEASED 2010 TCGA-46-3768-01A-01D-0983-08 TCGA-46-3768-01A-01D-0979-05 e52ba522-f5b9-4f9c-b03c-7d317ca7a30e TCGA-46-3768-01 TCGA-46-3768-01A-01D-0983-08 TCGA-46-3768-01 TCGA-46-3768-01A-01R-0980-07 e52ba522-f5b9-4f9c-b03c-7d317ca7a30e 529cab7f-5fe2-4745-937f-66e0455ecbf8 TCGA-46-3768-01 TCGA-46-3768-01A-01D-0978-01 TCGA-46-3768-01 e52ba522-f5b9-4f9c-b03c-7d317ca7a30e TCGA-46-3768-01 e52ba522-f5b9-4f9c-b03c-7d317ca7a30e TCGA-46-3768-01 TCGA-46-3768-01A-01D-0978-01 +TCGA-46-3769-01 TCGA-46-3769-01 High C1-LUAD-enriched cluster 2 Cluster 6 LUAD-like c10 miRNA cluster 4 cluster 2 mutation cluster 11 TCGA-46-3769 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 57 R-Upper TCGA-46-3769-F9102 TCGA-46-3769 TCGA-46-3769-01A -20941 0 135 YES NO Complete Remission/Response 2013-5-21 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.8 NO NO Central Lung 0.9 NO No M0 N0 T4 [Discrepancy] TCGA-46-3769.edd4e055-6670-43a8-ba91-0b4ac766abfd.pdf 3769 TUMOR FREE Complete Remission/Response YES R1 Primary Tumor 01 0.2 YES YES NO 46 4 Lung A LIVING 2009 TCGA-46-3769-01A-01D-0983-08 TCGA-46-3769-01A-01D-0979-05 6606d696-1211-43ad-b7b0-43b183af7faa TCGA-46-3769-01 TCGA-46-3769-01A-01D-0983-08 TCGA-46-3769-01 TCGA-46-3769-01A-01R-0980-07 6606d696-1211-43ad-b7b0-43b183af7faa 98c74ed8-aaa6-44c1-ad44-35acdb324169 TCGA-46-3769-01 TCGA-46-3769-01A-01D-0978-01 TCGA-46-3769-01 6606d696-1211-43ad-b7b0-43b183af7faa TCGA-46-3769-01 6606d696-1211-43ad-b7b0-43b183af7faa TCGA-46-3769-01 TCGA-46-3769-01A-01D-0978-01 +TCGA-46-6025-01 TCGA-46-6025-01 High C2-Squamous-like cluster 3 Cluster 13 (HNSC-LUSC) squamous c3 squamous-like c4 miRNA cluster 4 cluster 4 mutation cluster 5 TCGA-46-6025 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 71 R-Lower TCGA-46-6025-F13454 TCGA-46-6025 TCGA-46-6025-01A -26168 0 324 1 NO NO Scheduled Follow-up Submission 2011-6-28 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.8 NO NO Central Lung 1 NO No M0 N1 T2b Stage IIB TCGA-46-6025.1664466d-20af-4e97-b5e1-a013803f5e6a.pdf 6025 Post-Adjuvant Therapy TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 0.3 2010 YES YES NO 46 4 Lung A LIVING 2010 TCGA-46-6025-01A-11D-1817-08 ba725298-74f8-4ff3-a28b-1e4a92331f07 TCGA-46-6025-01 TCGA-46-6025-01A-11D-1817-08 TCGA-46-6025-01 TCGA-46-6025-01 ba725298-74f8-4ff3-a28b-1e4a92331f07 TCGA-46-6025-01A-13-2194-20 TCGA-46-6025-01 TCGA-46-6025-01A-11D-1816-01 ba725298-74f8-4ff3-a28b-1e4a92331f07 ba725298-74f8-4ff3-a28b-1e4a92331f07 TCGA-46-6025-01A-11D-1816-01 TCGA-46-6025-01A-11D-1818-05 55f36d96-6b14-4aee-97fe-a846962e8512 +TCGA-46-6026-01 TCGA-46-6026-01 High C2-Squamous-like cluster 4 Cluster 13 (HNSC-LUSC) squamous c3 squamous-like c4 miRNA cluster 5 cluster 4 mutation cluster 5 TCGA-46-6026 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung NO NO NO NO 81 R-Lower TCGA-46-6026-F13515 TCGA-46-6026 TCGA-46-6026-01A -29890 0 423 3 NO NO Scheduled Follow-up Submission 2011-6-30 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.9 NO NO Central Lung 1 NO No M0 N1 T2a Stage IIB TCGA-46-6026.ad6737a0-c741-40d5-9548-34b0fc17f542.pdf 6026 Post-Adjuvant Therapy TUMOR FREE Complete Remission/Response YES R2 Primary Tumor 01 0.2 1985 YES YES NO 46 3 Lung A LIVING 2010 TCGA-46-6026-01A-11D-1817-08 3361fa31-f545-4a50-912e-3bab98eb7930 TCGA-46-6026-01 TCGA-46-6026-01A-11D-1817-08 TCGA-46-6026-01 TCGA-46-6026-01 3361fa31-f545-4a50-912e-3bab98eb7930 TCGA-46-6026-01A-13-2194-20 TCGA-46-6026-01 TCGA-46-6026-01A-11D-1816-01 3361fa31-f545-4a50-912e-3bab98eb7930 3361fa31-f545-4a50-912e-3bab98eb7930 TCGA-46-6026-01A-11D-1816-01 TCGA-46-6026-01A-11D-1818-05 1f974ba9-6993-4575-8372-32673ea3fdd9 +TCGA-51-4079-01 TCGA-51-4079-01 Squamous C2-Squamous-like cluster 3 Cluster 13 (HNSC-LUSC) squamous-like c4 miRNA cluster 4 cluster 2 mutation cluster 3 TCGA-51-4079 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 73 R-Upper TCGA-51-4079-F4465 TCGA-51-4079 TCGA-51-4079-01A -26899 12 0 NO NO 2010-12-7 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.4 NO NO Central Lung 0.8 NO 25 No N0 T2 Stage IB TCGA-51-4079.8bc3980d-0a81-419b-8383-400c03be01f0.pdf 4079 NO R0 Primary Tumor 01 0.2 2007 6th NO NO YES 51 4 Lung A DECEASED 2009 TCGA-51-4079-01A-01D-1458-08 TCGA-51-4079-01A-01D-1096-05 ca290d55-534f-47d9-a65a-1ba12dbaa233 TCGA-51-4079-01 TCGA-51-4079-01A-01D-1458-08 TCGA-51-4079-01 TCGA-51-4079-01A-01R-1100-07 ca290d55-534f-47d9-a65a-1ba12dbaa233 90fbdc22-29ea-4e43-aa0b-4d693cbe4b38 TCGA-51-4079-01 TCGA-51-4079-01A-01D-1097-01 TCGA-51-4079-01 ca290d55-534f-47d9-a65a-1ba12dbaa233 TCGA-51-4079-01 ca290d55-534f-47d9-a65a-1ba12dbaa233 TCGA-51-4079-01 TCGA-51-4079-01A-01D-1097-01 +TCGA-51-4079-11 TCGA-51-4079-11 C2-Squamous-like mutation cluster 3 TCGA-51-4079 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 73 R-Upper TCGA-51-4079-F4465 TCGA-51-4079 TCGA-51-4079-11A -26899 12 0 NO NO 2010-12-7 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.6 NO NO Central Lung 0.9 NO 25 No N0 T2 Stage IB 4079 NO R0 Solid Tissue Normal 11 0.2 2007 6th NO NO YES 51 4 Lung A DECEASED 2009 e21484e9-d9c3-463f-89bd-82f09cc2579a e21484e9-d9c3-463f-89bd-82f09cc2579a e21484e9-d9c3-463f-89bd-82f09cc2579a e21484e9-d9c3-463f-89bd-82f09cc2579a +TCGA-51-4080-01 TCGA-51-4080-01 Squamous C2-Squamous-like cluster 3 Cluster 13 (HNSC-LUSC) squamous-like c4 miRNA cluster 11 cluster 1 mutation cluster 13 TCGA-51-4080 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 65 R-Upper TCGA-51-4080-F4490 TCGA-51-4080 TCGA-51-4080-01A -24054 12 0 NO NO 2010-12-7 MALE Lung Basaloid Squamous Cell Carcinoma No C34.1 8083/3 C34.1 YES 0.6 NO NO Central Lung 1.3 NO No N1 T4 Stage IIIB TCGA-51-4080.4142077f-f67b-46f9-9302-18ba26e15e27.pdf 4080 TUMOR FREE NO R0 Primary Tumor 01 0.3 2005 NO NO YES 51 4 Lung A DECEASED 2009 TCGA-51-4080-01A-01D-1458-08 TCGA-51-4080-01A-01D-1096-05 6e6c90e7-2f98-4880-9e6e-d85966baa663 TCGA-51-4080-01 TCGA-51-4080-01A-01D-1458-08 TCGA-51-4080-01 TCGA-51-4080-01A-01R-1100-07 6e6c90e7-2f98-4880-9e6e-d85966baa663 19a039c8-1c8b-45ec-bab5-0886a9217cad TCGA-51-4080-01 TCGA-51-4080-01A-01D-1969-01 TCGA-51-4080-01 6e6c90e7-2f98-4880-9e6e-d85966baa663 TCGA-51-4080-01 6e6c90e7-2f98-4880-9e6e-d85966baa663 TCGA-51-4080-01 TCGA-51-4080-01A-01D-1969-01 +TCGA-51-4080-11 TCGA-51-4080-11 C2-Squamous-like mutation cluster 13 TCGA-51-4080 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 65 R-Upper TCGA-51-4080-F4490 TCGA-51-4080 TCGA-51-4080-11A -24054 12 0 NO NO 2010-12-7 MALE Lung Basaloid Squamous Cell Carcinoma No C34.1 8083/3 C34.1 YES 0.4 NO NO Central Lung 0.8 NO No N1 T4 Stage IIIB 4080 TUMOR FREE NO R0 Solid Tissue Normal 11 0.2 2005 NO NO YES 51 4 Lung A DECEASED 2009 80ee8813-997d-48b9-9853-520080e22e05 80ee8813-997d-48b9-9853-520080e22e05 80ee8813-997d-48b9-9853-520080e22e05 80ee8813-997d-48b9-9853-520080e22e05 +TCGA-51-4081-01 TCGA-51-4081-01 Squamous C2-Squamous-like cluster 3 Cluster 13 (HNSC-LUSC) squamous-like c4 miRNA cluster 11 cluster 1 mutation cluster 5 TCGA-51-4081 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 55 R-Upper TCGA-51-4081-F30894 TCGA-51-4081 TCGA-51-4081-01A -20261 0 911 NO NO Scheduled Follow-up Submission Complete Remission/Response 2012-4-18 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.3 NO NO Central Lung 1 NO 80 No M0 N1 T2a Stage IIB TCGA-51-4081.0bf5aacf-58ab-45dd-b257-2d56045b9877.pdf 4081 TUMOR FREE R0 Primary Tumor 01 0.3 YES NO YES 51 2 Lung A LIVING 2009 TCGA-51-4081-01A-01D-1458-08 TCGA-51-4081-01A-01D-1096-05 25c74ec3-c453-4ccb-94d1-a38bfc4aa0b2 TCGA-51-4081-01 TCGA-51-4081-01A-01D-1458-08 TCGA-51-4081-01 TCGA-51-4081-01A-01R-1100-07 25c74ec3-c453-4ccb-94d1-a38bfc4aa0b2 6e6d40cb-2791-4f85-af6d-c3df87010084 TCGA-51-4081-01 TCGA-51-4081-01A-01D-1097-01 TCGA-51-4081-01 25c74ec3-c453-4ccb-94d1-a38bfc4aa0b2 TCGA-51-4081-01 25c74ec3-c453-4ccb-94d1-a38bfc4aa0b2 TCGA-51-4081-01 TCGA-51-4081-01A-01D-1097-01 +TCGA-51-4081-11 TCGA-51-4081-11 C2-Squamous-like mutation cluster 5 TCGA-51-4081 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 55 R-Upper TCGA-51-4081-F30894 TCGA-51-4081 TCGA-51-4081-11A -20261 0 911 NO NO Scheduled Follow-up Submission Complete Remission/Response 2012-4-18 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.9 NO NO Central Lung 1 NO 80 No M0 N1 T2a Stage IIB 4081 TUMOR FREE R0 Solid Tissue Normal 11 0.4 YES NO YES 51 2 Lung A LIVING 2009 47bb130b-c5cc-40ba-b72f-7d337080c62f 47bb130b-c5cc-40ba-b72f-7d337080c62f 47bb130b-c5cc-40ba-b72f-7d337080c62f 47bb130b-c5cc-40ba-b72f-7d337080c62f +TCGA-51-6867-01 TCGA-51-6867-01 Squamous C2-Squamous-like Cluster 13 (HNSC-LUSC) squamous c3 squamous-like c4 miRNA cluster 4 TCGA-51-6867 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung NO NO NO NO 72 R-Upper TCGA-51-6867-F17331 TCGA-51-6867 TCGA-51-6867-01A -26523 1856 0 788 NO Additional New Tumor Event Stable Disease 2011-10-10 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.6 NO NO Peripheral Lung 0.8 YES 40 Yes M0 N0 T1 Stage I TCGA-51-6867.6eb25b3d-1446-47f3-b52e-e97157f4832f.pdf 6867 WITH TUMOR Complete Remission/Response NO R0 Primary Tumor 01 0.4 2002 6th NO NO YES 51 4 Lung A DECEASED 2003 67406266-5f84-4a8a-90a0-8655bece5a69 TCGA-51-6867-01 TCGA-51-6867-01 TCGA-51-6867-01 67406266-5f84-4a8a-90a0-8655bece5a69 TCGA-51-6867-01A-13-2194-20 67406266-5f84-4a8a-90a0-8655bece5a69 67406266-5f84-4a8a-90a0-8655bece5a69 TCGA-51-6867-01A-11D-2043-05 df2fd16f-c857-4ec5-8ed8-07db1d345f50 +TCGA-52-7622-01 TCGA-52-7622-01 Squamous Cluster 13 (HNSC-LUSC) miRNA c1uster 9 TCGA-52-7622 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 62 R-Lower TCGA-52-7622-F28782 TCGA-52-7622 -22807 0 862 88 1 NO NO Scheduled Follow-up Submission 2013-1-4 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 90 NO Central Lung NO 22 No M0 N0 T1a Stage IA 7622 Post-Adjuvant Therapy TUMOR FREE 69 91 67 90 Complete Remission/Response YES NO R0 Primary Tumor 01 2010 7th YES NO YES 52 4 Lung LIVING 2010 1965 dcfd52b5-c7d6-44e3-8137-405cf0fff780 TCGA-52-7622-01 TCGA-52-7622-01 TCGA-52-7622-01 dcfd52b5-c7d6-44e3-8137-405cf0fff780 TCGA-52-7622-01 TCGA-52-7622-01A-11D-2121-01 dcfd52b5-c7d6-44e3-8137-405cf0fff780 dcfd52b5-c7d6-44e3-8137-405cf0fff780 TCGA-52-7622-01A-11D-2121-01 TCGA-52-7622-01A-11D-2123-05 +TCGA-52-7809-01 TCGA-52-7809-01 High Cluster 5 miRNA c1uster 9 TCGA-52-7809 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 74 R-Upper TCGA-52-7809-F39788 TCGA-52-7809 TCGA-52-7809-01A -27233 166 0 NO NO Scheduled Follow-up Submission 2013-2-1 MALE Lung Basaloid Squamous Cell Carcinoma No C34.1 8083/3 C34.1 YES 0.7 NO 0 NO Peripheral Lung 1.2 NO 60 No M0 N0 T2 Stage IB TCGA-52-7809.83c514c4-6d90-4ff0-bda1-5615aa769bbd.pdf 7809 WITH TUMOR Progressive Disease NO R0 Primary Tumor 01 0.3 6th NO YES 52 2 Lung A DECEASED 2009 1948 9383278e-22a7-4ea3-8700-988b1c9d8fd9 TCGA-52-7809-01 TCGA-52-7809-01 TCGA-52-7809-01 9383278e-22a7-4ea3-8700-988b1c9d8fd9 TCGA-52-7809-01 TCGA-52-7809-01A-21D-2121-01 9383278e-22a7-4ea3-8700-988b1c9d8fd9 9383278e-22a7-4ea3-8700-988b1c9d8fd9 TCGA-52-7809-01A-21D-2121-01 TCGA-52-7809-01A-21D-2123-05 +TCGA-52-7810-01 TCGA-52-7810-01 Squamous Cluster 5 squamous c3 miRNA cluster 4 TCGA-52-7810 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 60 R-Upper TCGA-52-7810-F39789 TCGA-52-7810 TCGA-52-7810-01A -22241 0 923 0 NO NO Scheduled Follow-up Submission 2013-2-1 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.8 8070/3 C34.8 YES 0.7 NO 90 NO 0.8 NO NO 20 No M0 N0 T3 Stage IIB TCGA-52-7810.2da4232b-8a69-480f-a5f1-671cc7ed5213.pdf 7810 Pre-Adjuvant Therapy TUMOR FREE Complete Remission/Response NO YES Primary Tumor 01 0.4 1990 6th YES NO YES 52 3 Lung A LIVING 2008 1970 eefac675-8386-4ffe-a18a-8763f90b2056 TCGA-52-7810-01 TCGA-52-7810-01 TCGA-52-7810-01 eefac675-8386-4ffe-a18a-8763f90b2056 TCGA-52-7810-01A-13-2195-20 TCGA-52-7810-01 TCGA-52-7810-01A-11D-2121-01 eefac675-8386-4ffe-a18a-8763f90b2056 eefac675-8386-4ffe-a18a-8763f90b2056 TCGA-52-7810-01A-11D-2121-01 TCGA-52-7810-01A-11D-2123-05 6e66e4f7-d938-4cf6-85e3-ea40f8838b95 +TCGA-52-7811-01 TCGA-52-7811-01 Squamous Cluster 5 squamous c3 miRNA cluster 4 TCGA-52-7811 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung NO NO NO 67 L-Lower TCGA-52-7811-F39790 TCGA-52-7811 TCGA-52-7811-01A -24782 266 0 153 84 0 NO NO Scheduled Follow-up Submission Progressive Disease 2013-2-1 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.9 NO 0 NO 1.1 NO Distant Metastasis YES 50 No M0 N0 T2 Stage IB TCGA-52-7811.69e3e936-4a9d-4ab9-8402-2ee313244b7c.pdf 7811 Pre-Adjuvant Therapy WITH TUMOR 66 90 66 90 Progressive Disease Biopsy with Histologic Confirmation YES NO R0 Primary Tumor 01 0.4 6th NO NO YES 52 2 Lung A DECEASED 2009 1958 3f4f3e8c-af8c-405e-8fd4-c971f394e35f TCGA-52-7811-01 TCGA-52-7811-01 TCGA-52-7811-01 3f4f3e8c-af8c-405e-8fd4-c971f394e35f TCGA-52-7811-01A-13-2195-20 TCGA-52-7811-01 TCGA-52-7811-01A-11D-2121-01 3f4f3e8c-af8c-405e-8fd4-c971f394e35f 3f4f3e8c-af8c-405e-8fd4-c971f394e35f TCGA-52-7811-01A-11D-2121-01 TCGA-52-7811-01A-11D-2123-05 feb2a011-9826-4922-8fdb-e702a929a793 +TCGA-52-7812-01 TCGA-52-7812-01 High Cluster 6 squamous c3 miRNA cluster 4 TCGA-52-7812 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung YES NO NO YES 68 L-Upper TCGA-52-7812-F39282 TCGA-52-7812 TCGA-52-7812-01A -24887 835 0 791 1 NO NO Scheduled Follow-up Submission Progressive Disease 2013-1-30 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.9 8070/3 C34.9 YES 0.6 NO 0 NO Central Lung 1.1 NO Distant Metastasis YES 30 No M0 N2 T2 [Discrepancy] TCGA-52-7812.c7bb38e8-f472-437c-9d6e-7cfb6a5785b4.pdf 7812 Preoperative WITH TUMOR Progressive Disease Biopsy with Histologic Confirmation NO YES R0 Primary Tumor 01 0.4 1997 6th YES NO YES 52 4 Lung A DECEASED 2009 1967 2afa4dfe-6d9b-46b1-89bd-235c7b5cbebf TCGA-52-7812-01 TCGA-52-7812-01 TCGA-52-7812-01 2afa4dfe-6d9b-46b1-89bd-235c7b5cbebf TCGA-52-7812-01A-13-2195-20 TCGA-52-7812-01 TCGA-52-7812-01A-11D-2121-01 2afa4dfe-6d9b-46b1-89bd-235c7b5cbebf 2afa4dfe-6d9b-46b1-89bd-235c7b5cbebf TCGA-52-7812-01A-11D-2121-01 TCGA-52-7812-01A-11D-2123-05 e78b8041-fe48-46e1-b651-a19c69be92e6 +TCGA-56-1622-01 TCGA-56-1622-01 High C2-Squamous-like cluster 4 Cluster 5 squamous-like c4 miRNA cluster 4 cluster 3 mutation cluster 13 TCGA-56-1622 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 58 R-Lower TCGA-56-1622-F4096 TCGA-56-1622 TCGA-56-1622-01A -21371 881 0 2010-2-3 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.6 NO 0.9 NO 86 No M0 N0 T2 Stage IB TCGA-56-1622.8b6c2041-dff4-4ce6-bbd1-683736983803.pdf 1622 WITH TUMOR Complete Remission/Response NO R0 Primary Tumor 01 0.4 2006 NO YES NO 56 4 Lung A DECEASED 2007 1962 TCGA-56-1622-01A-01D-1521-08 TCGA-56-1622-01A-01D-0689-05 e912b601-aff4-49e1-924f-44d242699608 TCGA-56-1622-01 TCGA-56-1622-01A-01D-1521-08 TCGA-56-1622-01 TCGA-56-1622-01A-01R-0692-07 e912b601-aff4-49e1-924f-44d242699608 0193a0af-06ff-40a0-b105-2bd2084cdea8 TCGA-56-1622-01 TCGA-56-1622-01A-01D-0685-01 TCGA-56-1622-01 e912b601-aff4-49e1-924f-44d242699608 TCGA-56-1622-01 e912b601-aff4-49e1-924f-44d242699608 TCGA-56-1622-01 TCGA-56-1622-01A-01D-0685-01 +TCGA-56-5897-01 TCGA-56-5897-01 Squamous C2-Squamous-like cluster 4 Low purity c2 squamous c3 squamous-like c4 cluster 2 mutation cluster 5 TCGA-56-5897 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 74 R-Upper TCGA-56-5897-F43197 TCGA-56-5897 TCGA-56-5897-01A -27118 0 378 Scheduled Follow-up Submission Complete Remission/Response 2013-5-15 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.4 NO 0.6 NO NO No MX N0 T1b Stage IA TCGA-56-5897.8efc19c8-ab28-4ff9-a2c6-4caefe60d0f2.pdf 5897 TUMOR FREE Complete Remission/Response NO Primary Tumor 01 0.2 1983 7th NO NO YES 56 3 Lung A LIVING 2010 TCGA-56-5897-01A-11D-1632-08 31137a90-0e02-4c48-80c1-14c882eff26f TCGA-56-5897-01 TCGA-56-5897-01A-11D-1632-08 TCGA-56-5897-01 TCGA-56-5897-01 31137a90-0e02-4c48-80c1-14c882eff26f TCGA-56-5897-01A-12-2194-20 TCGA-56-5897-01 TCGA-56-5897-01A-11D-1631-01 31137a90-0e02-4c48-80c1-14c882eff26f 31137a90-0e02-4c48-80c1-14c882eff26f TCGA-56-5897-01A-11D-1631-01 TCGA-56-5897-01A-11D-1633-05 59c57cc0-8672-4e6d-8248-65c676f2db8b +TCGA-56-5898-01 TCGA-56-5898-01 Squamous C2-Squamous-like cluster 1 Cluster 13 (HNSC-LUSC) squamous c3 squamous-like c4 cluster 2 mutation cluster 8 TCGA-56-5898 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 69 R-Upper TCGA-56-5898-F43198 TCGA-56-5898 TCGA-56-5898-01A -25441 0 555 Scheduled Follow-up Submission Complete Remission/Response 2013-5-15 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.6 NO 0.8 NO NO No M0 N0 T1b Stage IA TCGA-56-5898.04ca3e3e-ca70-4616-b7ba-8d48d88007bd.pdf 5898 TUMOR FREE Complete Remission/Response NO NO R0 Primary Tumor 01 0.3 7th NO NO YES 56 2 Lung A LIVING 2010 1955 TCGA-56-5898-01A-11D-1632-08 2589ea8d-6306-4460-999f-c87a4b005420 TCGA-56-5898-01 TCGA-56-5898-01A-11D-1632-08 TCGA-56-5898-01 TCGA-56-5898-01 2589ea8d-6306-4460-999f-c87a4b005420 TCGA-56-5898-01A-12-2194-20 TCGA-56-5898-01 TCGA-56-5898-01A-11D-1631-01 2589ea8d-6306-4460-999f-c87a4b005420 2589ea8d-6306-4460-999f-c87a4b005420 TCGA-56-5898-01A-11D-1631-01 TCGA-56-5898-01A-11D-1633-05 f1648030-8469-478a-99e6-13ec906dca7e +TCGA-56-6545-01 TCGA-56-6545-01 High C2-Squamous-like cluster 1 Cluster 5 squamous c3 squamous-like c4 miRNA cluster 5 cluster 4 mutation cluster 13 TCGA-56-6545 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 77 R-Upper TCGA-56-6545-F46625 TCGA-56-6545 TCGA-56-6545-01A -28400 0 666 Scheduled Follow-up Submission Complete Remission/Response 2013-8-13 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.8 NO 1 NO NO No M0 N0 T2a Stage IB TCGA-56-6545.526beb21-7ffd-4d23-a870-47fcc5ec6b73.pdf 6545 TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 0.3 1996 7th NO YES NO 56 4 Lung A LIVING 2010 1952 TCGA-56-6545-01A-11D-1817-08 2e6e7411-9875-418e-97a7-8fd61866d5a6 TCGA-56-6545-01 TCGA-56-6545-01A-11D-1817-08 TCGA-56-6545-01 TCGA-56-6545-01 2e6e7411-9875-418e-97a7-8fd61866d5a6 TCGA-56-6545-01A-13-2194-20 TCGA-56-6545-01 TCGA-56-6545-01A-11D-1816-01 2e6e7411-9875-418e-97a7-8fd61866d5a6 2e6e7411-9875-418e-97a7-8fd61866d5a6 TCGA-56-6545-01A-11D-1816-01 TCGA-56-6545-01A-11D-1818-05 acdc06c7-b306-4fc8-9a28-68b2a9a78d4c +TCGA-56-6546-01 TCGA-56-6546-01 High C1-LUAD-enriched cluster 4 Cluster 5 squamous c3 RNA cluster 2 miRNA cluster 5 cluster 4 mutation cluster 13 TCGA-56-6546 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 67 R-Upper TCGA-56-6546-F45631 TCGA-56-6546 TCGA-56-6546-01A -24594 [Discrepancy] 0 [Discrepancy] Scheduled Follow-up Submission 2013-7-17 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.7 NO 0.9 NO NO No MX N0 T2b Stage IIA TCGA-56-6546.6bf4b1cb-22c2-45ec-b45f-9ccf5db582fe.pdf 6546 TUMOR FREE YES NO Primary Tumor 01 0.4 2011 7th NO YES NO 56 4 Lung A DECEASED 2011 1954 TCGA-56-6546-01A-11D-1817-08 8578f1c0-bec8-467e-9426-b2f18071eca8 TCGA-56-6546-01 TCGA-56-6546-01A-11D-1817-08 TCGA-56-6546-01 TCGA-56-6546-01 8578f1c0-bec8-467e-9426-b2f18071eca8 TCGA-56-6546-01A-13-2194-20 TCGA-56-6546-01 TCGA-56-6546-01A-11D-1816-01 8578f1c0-bec8-467e-9426-b2f18071eca8 8578f1c0-bec8-467e-9426-b2f18071eca8 TCGA-56-6546-01A-11D-1816-01 TCGA-56-6546-01A-11D-1818-05 d3df09a4-a843-49d4-84b3-e7822b797bdc +TCGA-56-7221-01 TCGA-56-7221-01 Squamous C2-Squamous-like Cluster 5 squamous c3 squamous-like c4 miRNA cluster 11 TCGA-56-7221 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 79 R-Lower TCGA-56-7221-F47791 TCGA-56-7221 TCGA-56-7221-01A -28873 0 608 Scheduled Follow-up Submission Complete Remission/Response 2013-8-28 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.7 NO 0.8 NO NO 25 Yes M0 N0 T2 Stage IB TCGA-56-7221.9c136f18-c53c-45f8-b20f-850086ee0f55.pdf 7221 TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 0.2 1982 7th NO YES NO 56 3 Lung A LIVING 2011 6d9dfd56-1006-46b7-89c0-efba05fe13e3 TCGA-56-7221-01 TCGA-56-7221-01 TCGA-56-7221-01 6d9dfd56-1006-46b7-89c0-efba05fe13e3 TCGA-56-7221-01A-13-2195-20 TCGA-56-7221-01 TCGA-56-7221-01A-11D-2041-01 6d9dfd56-1006-46b7-89c0-efba05fe13e3 6d9dfd56-1006-46b7-89c0-efba05fe13e3 TCGA-56-7221-01A-11D-2041-01 TCGA-56-7221-01A-11D-2043-05 ce08b9c6-00c0-45d0-b84d-f0bce0fdc469 +TCGA-56-7222-01 TCGA-56-7222-01 Squamous C2-Squamous-like Cluster 13 (HNSC-LUSC) squamous c3 squamous-like c4 miRNA cluster 4 TCGA-56-7222 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung YES NO NO NO 60 R-Upper TCGA-56-7222-F47055 TCGA-56-7222 TCGA-56-7222-01A -22097 562 0 13 427 62 3 NO NO Scheduled Follow-up Submission Progressive Disease 2013-8-21 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 1.3 NO 70 NO Central Lung 1.4 NO YES 23 No M0 N0 T2a Stage IB TCGA-56-7222.46f2eec5-0507-4d1b-83a5-2206d68e635d.pdf 7222 Preoperative WITH TUMOR 97 64 95 58 Complete Remission/Response YES NO Primary Tumor 01 0.2 7th YES YES NO 56 2 Lung A DECEASED 2011 1963 13daa1a0-a236-474e-b621-eb131be34af1 TCGA-56-7222-01 TCGA-56-7222-01 TCGA-56-7222-01 13daa1a0-a236-474e-b621-eb131be34af1 TCGA-56-7222-01A-13-2195-20 TCGA-56-7222-01 TCGA-56-7222-01A-11D-2041-01 13daa1a0-a236-474e-b621-eb131be34af1 13daa1a0-a236-474e-b621-eb131be34af1 TCGA-56-7222-01A-11D-2041-01 TCGA-56-7222-01A-11D-2043-05 727b199a-6c1b-4d39-9e96-e983ca7ba1c9 +TCGA-56-7222-11 TCGA-56-7222-11 C2-Squamous-like TCGA-56-7222 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung YES NO NO NO 60 R-Upper TCGA-56-7222-F47055 TCGA-56-7222 TCGA-56-7222-11A -22097 562 0 13 427 62 3 NO NO Scheduled Follow-up Submission Progressive Disease 2013-8-21 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 1 NO 70 NO Central Lung 1.3 NO YES 23 No M0 N0 T2a Stage IB 7222 Preoperative WITH TUMOR 97 64 95 58 Complete Remission/Response YES NO Solid Tissue Normal 11 0.3 7th YES YES NO 56 2 Lung A DECEASED 2011 1963 0241c7d8-a820-421e-821e-291d4575a121 TCGA-56-7222-11 TCGA-56-7222-11 0241c7d8-a820-421e-821e-291d4575a121 0241c7d8-a820-421e-821e-291d4575a121 0241c7d8-a820-421e-821e-291d4575a121 +TCGA-56-7223-01 TCGA-56-7223-01 BRCA-LUAD+ Cluster 13 (HNSC-LUSC) RNA cluster 3 miRNA cluster 12 TCGA-56-7223 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung YES NO NO 66 R-Lower TCGA-56-7223-F65844 TCGA-56-7223 TCGA-56-7223-01A -24288 442 0 30 132 Scheduled Follow-up Submission Progressive Disease 2014-9-30 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.8 8070/3 C34.8 YES 0.2 NO 0.5 NO Locoregional Recurrence YES No MX N1 T3 Stage IIIA TCGA-56-7223.58b457c7-7273-4cc2-8eb9-5d14c01ebb45.pdf 7223 WITH TUMOR Progressive Disease Convincing Imaging NO R0 Primary Tumor 01 0.1 2011 7th NO YES NO 56 4 Lung A DECEASED 2011 659acaaf-d086-4066-8d30-7e33de4b8825 TCGA-56-7223-01 TCGA-56-7223-01 TCGA-56-7223-01 659acaaf-d086-4066-8d30-7e33de4b8825 TCGA-56-7223-01 TCGA-56-7223-01A-11D-2041-01 659acaaf-d086-4066-8d30-7e33de4b8825 659acaaf-d086-4066-8d30-7e33de4b8825 TCGA-56-7223-01A-11D-2041-01 TCGA-56-7223-01A-11D-2043-05 +TCGA-56-7579-01 TCGA-56-7579-01 Squamous Cluster 13 (HNSC-LUSC) squamous-like c4 miRNA cluster 11 TCGA-56-7579 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung YES NO 61 L-Upper TCGA-56-7579-F60112 TCGA-56-7579 -22632 951 0 44 149 Scheduled Follow-up Submission Progressive Disease 2014-5-29 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES NO Locoregional Recurrence YES 2 No M0 N1 T3 Stage IIIA 7579 WITH TUMOR Progressive Disease Convincing Imaging YES R0 Primary Tumor 01 2003 7th YES YES NO 56 4 Lung DECEASED 2011 1986 e28b7dfd-d7ba-4645-bf2e-f4a5aa3873f7 TCGA-56-7579-01 TCGA-56-7579-01 TCGA-56-7579-01 e28b7dfd-d7ba-4645-bf2e-f4a5aa3873f7 TCGA-56-7579-01 TCGA-56-7579-01A-11D-2041-01 e28b7dfd-d7ba-4645-bf2e-f4a5aa3873f7 e28b7dfd-d7ba-4645-bf2e-f4a5aa3873f7 TCGA-56-7579-01A-11D-2041-01 TCGA-56-7579-01A-11D-2043-05 +TCGA-56-7579-11 TCGA-56-7579-11 TCGA-56-7579 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung YES NO 61 L-Upper TCGA-56-7579-F60112 TCGA-56-7579 -22632 951 0 44 149 Scheduled Follow-up Submission Progressive Disease 2014-5-29 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES NO Locoregional Recurrence YES 2 No M0 N1 T3 Stage IIIA 7579 WITH TUMOR Progressive Disease Convincing Imaging YES R0 Solid Tissue Normal 11 2003 7th YES YES NO 56 4 Lung DECEASED 2011 1986 f98e6150-605d-4d37-9add-b6da6eb19928 TCGA-56-7579-11 TCGA-56-7579-11 f98e6150-605d-4d37-9add-b6da6eb19928 f98e6150-605d-4d37-9add-b6da6eb19928 f98e6150-605d-4d37-9add-b6da6eb19928 +TCGA-56-7580-01 TCGA-56-7580-01 Squamous Cluster 5 squamous-like c4 miRNA c1uster 9 TCGA-56-7580 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 84 L-Lower TCGA-56-7580-F56184 TCGA-56-7580 -30740 0 925 Scheduled Follow-up Submission Complete Remission/Response 2014-1-29 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES NO NO No M0 N0 T2a Stage IB 7580 TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 1985 7th NO YES NO 56 3 Lung LIVING 2011 1947 cd804abb-1eb2-462b-bbe1-045e3f29569f TCGA-56-7580-01 TCGA-56-7580-01 TCGA-56-7580-01 cd804abb-1eb2-462b-bbe1-045e3f29569f TCGA-56-7580-01 TCGA-56-7580-01A-11D-2041-01 cd804abb-1eb2-462b-bbe1-045e3f29569f cd804abb-1eb2-462b-bbe1-045e3f29569f TCGA-56-7580-01A-11D-2041-01 TCGA-56-7580-01A-11D-2043-05 +TCGA-56-7580-11 TCGA-56-7580-11 TCGA-56-7580 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 84 L-Lower TCGA-56-7580-F56184 TCGA-56-7580 TCGA-56-7580-11A -30740 0 925 Scheduled Follow-up Submission Complete Remission/Response 2014-1-29 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 1 NO 1.1 NO NO No M0 N0 T2a Stage IB 7580 TUMOR FREE Complete Remission/Response NO R0 Solid Tissue Normal 11 0.5 1985 7th NO YES NO 56 3 Lung A LIVING 2011 1947 0ddf6059-1ce0-4bac-bea9-8106a4dc764e TCGA-56-7580-11 TCGA-56-7580-11 0ddf6059-1ce0-4bac-bea9-8106a4dc764e 0ddf6059-1ce0-4bac-bea9-8106a4dc764e 0ddf6059-1ce0-4bac-bea9-8106a4dc764e +TCGA-56-7582-01 TCGA-56-7582-01 Squamous Cluster 13 (HNSC-LUSC) squamous-like c4 miRNA cluster 4 TCGA-56-7582 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 83 R-Lower TCGA-56-7582-F57031 TCGA-56-7582 TCGA-56-7582-01A -30678 0 601 Scheduled Follow-up Submission Complete Remission/Response 2014-2-28 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.2 NO 100 0.5 NO NO No M0 N0 T2a Stage IB TCGA-56-7582.f7a77662-4bab-47e4-8768-4d9e62891531.pdf 7582 Post-Adjuvant Therapy TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 0.2 1995 7th NO YES NO 56 3 Lung A LIVING 2011 78ed13d4-1578-46b8-81fa-b4395643691d TCGA-56-7582-01 TCGA-56-7582-01 TCGA-56-7582-01 78ed13d4-1578-46b8-81fa-b4395643691d TCGA-56-7582-01 TCGA-56-7582-01A-11D-2041-01 78ed13d4-1578-46b8-81fa-b4395643691d 78ed13d4-1578-46b8-81fa-b4395643691d TCGA-56-7582-01A-11D-2041-01 TCGA-56-7582-01A-11D-2043-05 +TCGA-56-7582-11 TCGA-56-7582-11 TCGA-56-7582 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 83 R-Lower TCGA-56-7582-F57031 TCGA-56-7582 TCGA-56-7582-11A -30678 0 601 Scheduled Follow-up Submission Complete Remission/Response 2014-2-28 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.4 NO 100 0.6 NO NO No M0 N0 T2a Stage IB 7582 Post-Adjuvant Therapy TUMOR FREE Complete Remission/Response NO R0 Solid Tissue Normal 11 0.2 1995 7th NO YES NO 56 3 Lung A LIVING 2011 670b4f33-2935-45c1-99b1-57660da763bb TCGA-56-7582-11 TCGA-56-7582-11 670b4f33-2935-45c1-99b1-57660da763bb 670b4f33-2935-45c1-99b1-57660da763bb 670b4f33-2935-45c1-99b1-57660da763bb +TCGA-56-7730-01 TCGA-56-7730-01 Squamous Cluster 13 (HNSC-LUSC) squamous c3 miRNA cluster 11 TCGA-56-7730 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 73 R-Upper TCGA-56-7730-F64295 TCGA-56-7730 TCGA-56-7730-01A -26699 198 0 6 59 Scheduled Follow-up Submission Progressive Disease 2014-8-28 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.4 NO NO Peripheral Lung 1 NO NO No M0 N0 T2b Stage IIA TCGA-56-7730.a8561dcf-b71e-4f28-a8bb-f0ce96066934.pdf 7730 WITH TUMOR 76 72 Progressive Disease YES YES R1 Primary Tumor 01 0.2 7th YES YES NO 56 2 Lung A DECEASED 2011 a632cbdb-7a01-42e2-8118-20103917cc8e TCGA-56-7730-01 TCGA-56-7730-01 TCGA-56-7730-01 a632cbdb-7a01-42e2-8118-20103917cc8e TCGA-56-7730-01A-13-2195-20 TCGA-56-7730-01 TCGA-56-7730-01A-11D-2121-01 a632cbdb-7a01-42e2-8118-20103917cc8e a632cbdb-7a01-42e2-8118-20103917cc8e TCGA-56-7730-01A-11D-2121-01 TCGA-56-7730-01A-11D-2123-05 4b68ddb5-5d40-4009-8269-2262e4b2a97a +TCGA-56-7730-11 TCGA-56-7730-11 TCGA-56-7730 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 73 R-Upper TCGA-56-7730-F64295 TCGA-56-7730 -26699 198 0 6 59 Scheduled Follow-up Submission Progressive Disease 2014-8-28 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES NO Peripheral Lung NO NO No M0 N0 T2b Stage IIA 7730 WITH TUMOR 76 72 Progressive Disease YES YES R1 Solid Tissue Normal 11 7th YES YES NO 56 2 Lung DECEASED 2011 dc660b3d-255f-4239-8368-b21149caa61c TCGA-56-7730-11 TCGA-56-7730-11 dc660b3d-255f-4239-8368-b21149caa61c dc660b3d-255f-4239-8368-b21149caa61c dc660b3d-255f-4239-8368-b21149caa61c +TCGA-56-7731-01 TCGA-56-7731-01 Squamous Cluster 5 miRNA c1uster 9 TCGA-56-7731 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 66 R-Upper TCGA-56-7731-F56183 TCGA-56-7731 TCGA-56-7731-01A -24441 3 0 0 59 Scheduled Follow-up Submission 2014-1-29 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.3 NO 0.3 NO NO 100 No MX N0 T2a Stage IB TCGA-56-7731.afdaabb6-b65a-44b9-867f-b22c405df456.pdf 7731 TUMOR FREE 71 67 71 64 YES NO Primary Tumor 01 0.1 2011 7th NO YES NO 56 4 Lung A DECEASED 2011 1961 3f846f2e-41c5-4ce9-bccb-8142cbc76525 TCGA-56-7731-01 TCGA-56-7731-01 TCGA-56-7731-01 3f846f2e-41c5-4ce9-bccb-8142cbc76525 TCGA-56-7731-01 TCGA-56-7731-01A-11D-2121-01 3f846f2e-41c5-4ce9-bccb-8142cbc76525 3f846f2e-41c5-4ce9-bccb-8142cbc76525 TCGA-56-7731-01A-11D-2121-01 TCGA-56-7731-01A-11D-2123-05 +TCGA-56-7731-11 TCGA-56-7731-11 TCGA-56-7731 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 66 R-Upper TCGA-56-7731-F56183 TCGA-56-7731 TCGA-56-7731-11A -24441 3 0 0 59 Scheduled Follow-up Submission 2014-1-29 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.7 NO 0.7 NO NO 100 No MX N0 T2a Stage IB 7731 TUMOR FREE 71 67 71 64 YES NO Solid Tissue Normal 11 0.3 2011 7th NO YES NO 56 4 Lung A DECEASED 2011 1961 2952091b-1093-44b4-aa09-8aeefb609365 TCGA-56-7731-11 TCGA-56-7731-11 2952091b-1093-44b4-aa09-8aeefb609365 2952091b-1093-44b4-aa09-8aeefb609365 2952091b-1093-44b4-aa09-8aeefb609365 +TCGA-56-7822-01 TCGA-56-7822-01 Squamous Cluster 5 squamous-like c4 miRNA cluster 11 TCGA-56-7822 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung YES YES NO NO 75 R-Upper TCGA-56-7822-F66152 TCGA-56-7822 TCGA-56-7822-01A -27755 532 0 1 301 42 1 Scheduled Follow-up Submission Progressive Disease 2014-10-3 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.3 NO 80 0.4 NO YES 60 No M0 N1 T2b Stage IIB TCGA-56-7822.53197469-7424-4f46-b67c-b16364e8df79.pdf 7822 Preoperative WITH TUMOR 91 86 93 91 YES R0 Primary Tumor 01 0.2 2011 7th YES NO 56 4 Lung A DECEASED 2011 765af249-7e13-4b85-815d-081801889982 TCGA-56-7822-01 TCGA-56-7822-01 TCGA-56-7822-01 765af249-7e13-4b85-815d-081801889982 TCGA-56-7822-01 TCGA-56-7822-01A-11D-2121-01 765af249-7e13-4b85-815d-081801889982 765af249-7e13-4b85-815d-081801889982 TCGA-56-7822-01A-11D-2121-01 TCGA-56-7822-01A-11D-2123-05 +TCGA-56-7823-01 TCGA-56-7823-01 Squamous Cluster 13 (HNSC-LUSC) miRNA cluster 11 TCGA-56-7823 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 58 R-Upper TCGA-56-7823-F60128 TCGA-56-7823 -21344 0 1011 43 1 Scheduled Follow-up Submission Complete Remission/Response 2014-5-29 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 90 NO NO NO 80 No M0 N1 T1b Stage IIA 7823 Other TUMOR FREE 69 76 78 73 Complete Remission/Response YES NO Primary Tumor 01 2008 7th YES YES NO 56 4 Lung LIVING 2011 1968 f3c5b879-2ca4-4d16-972b-6ed8f82b97a1 TCGA-56-7823-01 TCGA-56-7823-01 TCGA-56-7823-01 f3c5b879-2ca4-4d16-972b-6ed8f82b97a1 TCGA-56-7823-01 TCGA-56-7823-01B-11D-2243-01 f3c5b879-2ca4-4d16-972b-6ed8f82b97a1 f3c5b879-2ca4-4d16-972b-6ed8f82b97a1 TCGA-56-7823-01B-11D-2243-01 TCGA-56-7823-01B-11D-2245-05 +TCGA-56-7823-11 TCGA-56-7823-11 TCGA-56-7823 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 58 R-Upper TCGA-56-7823-F60128 TCGA-56-7823 TCGA-56-7823-11A -21344 0 1011 43 1 Scheduled Follow-up Submission Complete Remission/Response 2014-5-29 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.3 NO 90 NO 0.3 NO NO 80 No M0 N1 T1b Stage IIA 7823 Other TUMOR FREE 69 76 78 73 Complete Remission/Response YES NO Solid Tissue Normal 11 0.3 2008 7th YES YES NO 56 4 Lung A LIVING 2011 1968 3a627bd6-6f7e-4dca-a480-71eeb76e03b0 TCGA-56-7823-11 TCGA-56-7823-11 3a627bd6-6f7e-4dca-a480-71eeb76e03b0 3a627bd6-6f7e-4dca-a480-71eeb76e03b0 3a627bd6-6f7e-4dca-a480-71eeb76e03b0 +TCGA-56-8082-01 TCGA-56-8082-01 High Cluster 5 miRNA cluster 11 TCGA-56-8082 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 80 R-Lower TCGA-56-8082-F47790 TCGA-56-8082 TCGA-56-8082-01A -29440 0 455 1 Scheduled Follow-up Submission Complete Remission/Response 2013-8-28 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.8 NO 0.9 NO NO No MX N0 T2b Stage IIA TCGA-56-8082.0dba1129-8d66-465d-9ab7-6b42515442f0.pdf 8082 Other TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 0.5 7th NO YES NO 56 3 Lung A LIVING 2011 4ec591d8-c168-4541-a685-f009d0c3da38 TCGA-56-8082-01 TCGA-56-8082-01 TCGA-56-8082-01 4ec591d8-c168-4541-a685-f009d0c3da38 TCGA-56-8082-01 TCGA-56-8082-01A-11D-2243-01 4ec591d8-c168-4541-a685-f009d0c3da38 4ec591d8-c168-4541-a685-f009d0c3da38 TCGA-56-8082-01A-11D-2243-01 TCGA-56-8082-01A-11D-2245-05 +TCGA-56-8082-11 TCGA-56-8082-11 TCGA-56-8082 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 80 R-Lower TCGA-56-8082-F47790 TCGA-56-8082 TCGA-56-8082-11A -29440 0 455 1 Scheduled Follow-up Submission Complete Remission/Response 2013-8-28 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.6 NO 1 NO NO No MX N0 T2b Stage IIA 8082 Other TUMOR FREE Complete Remission/Response NO R0 Solid Tissue Normal 11 0.3 7th NO YES NO 56 3 Lung A LIVING 2011 089dccc0-b701-4b4e-ae11-82ec54b42c39 TCGA-56-8082-11 TCGA-56-8082-11 089dccc0-b701-4b4e-ae11-82ec54b42c39 089dccc0-b701-4b4e-ae11-82ec54b42c39 089dccc0-b701-4b4e-ae11-82ec54b42c39 +TCGA-56-8083-01 TCGA-56-8083-01 Squamous Cluster 5 miRNA c1uster 9 TCGA-56-8083 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 56 L-Upper TCGA-56-8083-F65848 TCGA-56-8083 TCGA-56-8083-01A -20696 0 150 95 Scheduled Follow-up Submission 2014-9-30 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.8 NO 1 YES NO 30 No MX N0 T2a Stage IB TCGA-56-8083.9ec3009b-f666-48bc-acd6-ac15ff81eb44.pdf 8083 TUMOR FREE 109 83 YES R0 Primary Tumor 01 0.4 2000 7th YES NO 56 4 Lung A LIVING 2011 06460d4f-a32d-4e68-a02b-e047d491c3a5 TCGA-56-8083-01 TCGA-56-8083-01 TCGA-56-8083-01 06460d4f-a32d-4e68-a02b-e047d491c3a5 TCGA-56-8083-01 TCGA-56-8083-01A-11D-2243-01 06460d4f-a32d-4e68-a02b-e047d491c3a5 06460d4f-a32d-4e68-a02b-e047d491c3a5 TCGA-56-8083-01A-11D-2243-01 TCGA-56-8083-01A-11D-2245-05 0FF1CE11-D3CE-4D27-A310-BEE23FE06F3C +TCGA-56-8083-11 TCGA-56-8083-11 TCGA-56-8083 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 56 L-Upper TCGA-56-8083-F65848 TCGA-56-8083 -20696 0 150 95 Scheduled Follow-up Submission 2014-9-30 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES YES NO 30 No MX N0 T2a Stage IB 8083 TUMOR FREE 109 83 YES R0 Solid Tissue Normal 11 2000 7th YES NO 56 4 Lung LIVING 2011 cabf7b00-4cb0-4873-a632-a5ffc72df2c8 TCGA-56-8083-11 TCGA-56-8083-11 cabf7b00-4cb0-4873-a632-a5ffc72df2c8 cabf7b00-4cb0-4873-a632-a5ffc72df2c8 cabf7b00-4cb0-4873-a632-a5ffc72df2c8 +TCGA-56-8201-01 TCGA-56-8201-01 Squamous Cluster 14 (HNSC) miRNA cluster 4 TCGA-56-8201 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 74 R-Upper TCGA-56-8201-F65845 TCGA-56-8201 TCGA-56-8201-01A -27211 397 0 28 Scheduled Follow-up Submission Progressive Disease 2014-9-30 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.4 NO 0.7 NO YES Yes, History of Prior Malignancy MX N0 T3 Stage IIB TCGA-56-8201.8990e058-ecf1-4387-8cb5-96ebef082cac.pdf 8201 WITH TUMOR NO R0 Primary Tumor 01 0.3 7th NO YES NO 56 4 Lung A DECEASED 2011 24cbacbe-2de9-40b6-beea-d285eaf4c8b0 TCGA-56-8201-01 TCGA-56-8201-01 TCGA-56-8201-01 24cbacbe-2de9-40b6-beea-d285eaf4c8b0 TCGA-56-8201-01 TCGA-56-8201-01A-11D-2243-01 24cbacbe-2de9-40b6-beea-d285eaf4c8b0 24cbacbe-2de9-40b6-beea-d285eaf4c8b0 TCGA-56-8201-01A-11D-2243-01 TCGA-56-8201-01A-11D-2245-05 +TCGA-56-8201-11 TCGA-56-8201-11 TCGA-56-8201 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 74 R-Upper TCGA-56-8201-F65845 TCGA-56-8201 -27211 397 0 28 Scheduled Follow-up Submission Progressive Disease 2014-9-30 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES NO YES Yes, History of Prior Malignancy MX N0 T3 Stage IIB 8201 WITH TUMOR NO R0 Solid Tissue Normal 11 7th NO YES NO 56 4 Lung DECEASED 2011 eb47358f-9627-4d58-9397-b4e80a28f85c TCGA-56-8201-11 TCGA-56-8201-11 eb47358f-9627-4d58-9397-b4e80a28f85c eb47358f-9627-4d58-9397-b4e80a28f85c eb47358f-9627-4d58-9397-b4e80a28f85c +TCGA-56-8304-01 TCGA-56-8304-01 Cluster 5 miRNA cluster 7 TCGA-56-8304 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 73 R-Upper TCGA-56-8304-F61479 TCGA-56-8304 -26803 0 106 Scheduled Follow-up Submission 2014-6-30 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES YES NO 58 No MX N0 T1b Stage IA 8304 TUMOR FREE Complete Remission/Response R0 Primary Tumor 01 7th YES NO 56 2 Lung LIVING 2011 1953 d5af268a-0e5d-4115-a44e-866997aff778 TCGA-56-8304-01 TCGA-56-8304-01 TCGA-56-8304-01 d5af268a-0e5d-4115-a44e-866997aff778 TCGA-56-8304-01 TCGA-56-8304-01A-11D-2322-01 d5af268a-0e5d-4115-a44e-866997aff778 d5af268a-0e5d-4115-a44e-866997aff778 TCGA-56-8304-01A-11D-2322-01 TCGA-56-8304-01A-11D-2324-05 +TCGA-56-8305-01 TCGA-56-8305-01 Squamous Cluster 13 (HNSC-LUSC) miRNA cluster 11 TCGA-56-8305 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 72 R-Upper TCGA-56-8305 TCGA-56-8305-01A -26428 0 105 49 2012-9-28 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.4 NO 0.4 NO 100 Yes, History of Prior Malignancy M0 N0 T2a Stage IB TCGA-56-8305.d9665618-8c24-4c18-9449-7695df876a2d.pdf 8305 TUMOR FREE 56 70 55 63 Complete Remission/Response YES R0 Primary Tumor 01 0.3 1996 7th YES NO 56 3 Lung A LIVING 2011 1946 0956217d-5f82-40be-8165-d7bb64135f23 TCGA-56-8305-01 TCGA-56-8305-01 TCGA-56-8305-01 0956217d-5f82-40be-8165-d7bb64135f23 TCGA-56-8305-01 TCGA-56-8305-01A-11D-2292-01 0956217d-5f82-40be-8165-d7bb64135f23 0956217d-5f82-40be-8165-d7bb64135f23 TCGA-56-8305-01A-11D-2292-01 TCGA-56-8305-01A-11D-2294-05 +TCGA-56-8307-01 TCGA-56-8307-01 Squamous Cluster 5 miRNA cluster 12 TCGA-56-8307 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 55 R-Lower TCGA-56-8307-F66144 TCGA-56-8307 -20411 0 818 51 Scheduled Follow-up Submission Complete Remission/Response 2014-10-3 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES NO NO 35 No M0 N0 T3 Stage IIB 8307 TUMOR FREE 85 69 Complete Remission/Response YES NO R0 Primary Tumor 01 7th NO YES NO 56 2 Lung LIVING 2012 1977 f43b8267-4311-41ef-bd2f-92ac8f336e86 TCGA-56-8307-01 TCGA-56-8307-01 TCGA-56-8307-01 f43b8267-4311-41ef-bd2f-92ac8f336e86 TCGA-56-8307-01 TCGA-56-8307-01A-11D-2292-01 f43b8267-4311-41ef-bd2f-92ac8f336e86 f43b8267-4311-41ef-bd2f-92ac8f336e86 TCGA-56-8307-01A-11D-2292-01 TCGA-56-8307-01A-11D-2294-05 +TCGA-56-8308-01 TCGA-56-8308-01 Squamous Cluster 13 (HNSC-LUSC) miRNA cluster 4 TCGA-56-8308 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 79 L-Upper TCGA-56-8308-F57935 TCGA-56-8308 -29139 0 517 42 Scheduled Follow-up Submission Stable Disease 2014-3-28 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 80 NO NO 63 Yes, History of Prior Malignancy MX N0 T3 Stage IIB 8308 Post-Adjuvant Therapy WITH TUMOR 84 88 81 81 Stable Disease YES YES R1 Primary Tumor 01 1992 7th YES YES NO 56 3 Lung LIVING 2012 1967 e58c5f71-33ca-4443-890e-49b85916f080 TCGA-56-8308-01 TCGA-56-8308-01 TCGA-56-8308-01 e58c5f71-33ca-4443-890e-49b85916f080 TCGA-56-8308-01 TCGA-56-8308-01A-11D-2292-01 e58c5f71-33ca-4443-890e-49b85916f080 e58c5f71-33ca-4443-890e-49b85916f080 TCGA-56-8308-01A-11D-2292-01 TCGA-56-8308-01A-11D-2294-05 +TCGA-56-8309-01 TCGA-56-8309-01 Squamous Cluster 5 miRNA cluster 4 TCGA-56-8309 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 66 R-Lower TCGA-56-8309-F59049 TCGA-56-8309 TCGA-56-8309-01A -24382 0 428 Scheduled Follow-up Submission Complete Remission/Response 2014-4-30 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.7 NO 1 NO NO 50 No MX N0 T1b Stage IA TCGA-56-8309.a01bec0a-8ecc-40cd-9b25-885f31390ed8.pdf 8309 TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 0.4 7th NO YES NO 56 2 Lung A LIVING 2012 cee82dd8-a3d1-448c-814d-b9481a30fb38 TCGA-56-8309-01 TCGA-56-8309-01 TCGA-56-8309-01 cee82dd8-a3d1-448c-814d-b9481a30fb38 TCGA-56-8309-01 TCGA-56-8309-01A-11D-2292-01 cee82dd8-a3d1-448c-814d-b9481a30fb38 cee82dd8-a3d1-448c-814d-b9481a30fb38 TCGA-56-8309-01A-11D-2292-01 TCGA-56-8309-01A-11D-2294-05 2464ACA9-0D5A-4A49-A1AB-8496E10954BE +TCGA-56-8309-11 TCGA-56-8309-11 TCGA-56-8309 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 66 R-Lower TCGA-56-8309-F59049 TCGA-56-8309 -24382 0 428 Scheduled Follow-up Submission Complete Remission/Response 2014-4-30 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES NO NO 50 No MX N0 T1b Stage IA 8309 TUMOR FREE Complete Remission/Response NO R0 Solid Tissue Normal 11 7th NO YES NO 56 2 Lung LIVING 2012 b87b2d94-2d62-4892-85b4-8ee7a566294c TCGA-56-8309-11 TCGA-56-8309-11 b87b2d94-2d62-4892-85b4-8ee7a566294c b87b2d94-2d62-4892-85b4-8ee7a566294c b87b2d94-2d62-4892-85b4-8ee7a566294c +TCGA-56-8503-01 TCGA-56-8503-01 TCGA-56-8503 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 76 R-Lower TCGA-56-8503 -28095 0 41 2012-12-28 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES Peripheral Lung NO 91 No M0 N0 T3 Stage IIB 8503 TUMOR FREE R0 Primary Tumor 01 7th YES NO 56 2 Lung LIVING 2012 1951 bbbac47c-0764-4bdb-857d-bd218e9d76ca TCGA-56-8503-01 TCGA-56-8503-01 TCGA-56-8503-01 bbbac47c-0764-4bdb-857d-bd218e9d76ca TCGA-56-8503-01 TCGA-56-8503-01A-11D-2391-01 bbbac47c-0764-4bdb-857d-bd218e9d76ca bbbac47c-0764-4bdb-857d-bd218e9d76ca TCGA-56-8503-01A-11D-2391-01 TCGA-56-8503-01A-11D-2398-05 +TCGA-56-8504-01 TCGA-56-8504-01 TCGA-56-8504 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 74 L-Upper TCGA-56-8504-F64288 TCGA-56-8504 TCGA-56-8504-01A -27210 0 510 1 Scheduled Follow-up Submission Complete Remission/Response 2014-8-28 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.9 NO 90 0.9 NO NO Yes, History of Prior Malignancy MX N0 T2a Stage IB TCGA-56-8504.bd602ed5-b728-4e7f-8022-cb7d0064c863.pdf 8504 Other TUMOR FREE 82 65 80 65 Complete Remission/Response YES NO R0 Primary Tumor 01 0.5 2008 7th NO YES NO 56 4 Lung A LIVING 2012 3e456d4d-3c85-464d-a5e3-f837c6145abf TCGA-56-8504-01 TCGA-56-8504-01 TCGA-56-8504-01 3e456d4d-3c85-464d-a5e3-f837c6145abf TCGA-56-8504-01 TCGA-56-8504-01A-11D-2391-01 3e456d4d-3c85-464d-a5e3-f837c6145abf 3e456d4d-3c85-464d-a5e3-f837c6145abf TCGA-56-8504-01A-11D-2391-01 TCGA-56-8504-01A-11D-2398-05 +TCGA-56-8504-11 TCGA-56-8504-11 TCGA-56-8504 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 74 L-Upper TCGA-56-8504-F64288 TCGA-56-8504 -27210 0 510 1 Scheduled Follow-up Submission Complete Remission/Response 2014-8-28 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 90 NO NO Yes, History of Prior Malignancy MX N0 T2a Stage IB 8504 Other TUMOR FREE 82 65 80 65 Complete Remission/Response YES NO R0 Solid Tissue Normal 11 2008 7th NO YES NO 56 4 Lung LIVING 2012 TCGA-56-8504-11 TCGA-56-8504-11 +TCGA-56-8622-01 TCGA-56-8622-01 TCGA-56-8622 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 68 R-Lower TCGA-56-8622 -24861 0 55 2012-12-28 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES NO 40 No M0 N0 T2a Stage IB 8622 TUMOR FREE R0 Primary Tumor 01 2004 7th YES NO 56 3 Lung LIVING 2012 1984 f48f08fe-9fa5-4eea-85b1-6fa691515349 TCGA-56-8622-01 TCGA-56-8622-01 TCGA-56-8622-01 f48f08fe-9fa5-4eea-85b1-6fa691515349 TCGA-56-8622-01 TCGA-56-8622-01A-11D-2391-01 f48f08fe-9fa5-4eea-85b1-6fa691515349 f48f08fe-9fa5-4eea-85b1-6fa691515349 TCGA-56-8622-01A-11D-2391-01 TCGA-56-8622-01A-11D-2398-05 +TCGA-56-8623-01 TCGA-56-8623-01 TCGA-56-8623 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung NO NO YES 71 R-Upper TCGA-56-8623-F66147 TCGA-56-8623 TCGA-56-8623-01A 680 -26231 692 0 6 645 0 Scheduled Follow-up Submission Complete Remission/Response 2014-10-3 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.9 NO 90 Peripheral Lung 1.1 NO New Primary Tumor YES 45 No MX N0 T2a Stage IB TCGA-56-8623.8d223b19-5ef0-4e25-814e-97cfe32aea3b.pdf 8623 Preoperative TUMOR FREE Complete Remission/Response Biopsy with Histologic Confirmation NO R0 Primary Tumor 01 0.7 7th NO YES NO 56 2 Lung A DECEASED 2012 265c0257-54b6-4b79-8c9a-d56ca8bbdb48 TCGA-56-8623-01 TCGA-56-8623-01 TCGA-56-8623-01 265c0257-54b6-4b79-8c9a-d56ca8bbdb48 TCGA-56-8623-01 TCGA-56-8623-01A-11D-2391-01 265c0257-54b6-4b79-8c9a-d56ca8bbdb48 265c0257-54b6-4b79-8c9a-d56ca8bbdb48 TCGA-56-8623-01A-11D-2391-01 TCGA-56-8623-01A-11D-2398-05 +TCGA-56-8623-11 TCGA-56-8623-11 TCGA-56-8623 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung NO NO YES 71 R-Upper TCGA-56-8623-F66147 TCGA-56-8623 TCGA-56-8623-11A 680 -26231 692 0 6 645 0 Scheduled Follow-up Submission Complete Remission/Response 2014-10-3 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.8 NO 90 Peripheral Lung 1.1 NO New Primary Tumor YES 45 No MX N0 T2a Stage IB 8623 Preoperative TUMOR FREE Complete Remission/Response Biopsy with Histologic Confirmation NO R0 Solid Tissue Normal 11 0.2 7th NO YES NO 56 2 Lung A DECEASED 2012 9fe04d07-57ba-434f-8254-184fe00ab23e TCGA-56-8623-11 TCGA-56-8623-11 9fe04d07-57ba-434f-8254-184fe00ab23e 9fe04d07-57ba-434f-8254-184fe00ab23e 9fe04d07-57ba-434f-8254-184fe00ab23e +TCGA-56-8624-01 TCGA-56-8624-01 TCGA-56-8624 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 84 R-Lower TCGA-56-8624-F47792 TCGA-56-8624 TCGA-56-8624-01A -30798 0 420 84 YES YES Scheduled Follow-up Submission Complete Remission/Response 2013-8-28 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.8 NO 1.2 NO NO 20 No MX N0 T3 Stage IIB TCGA-56-8624.0c8899e7-79f4-46b1-9184-259f8315ef52.pdf 8624 TUMOR FREE 87 Complete Remission/Response YES NO R0 Primary Tumor 01 0.6 1952 7th YES YES NO 56 3 Lung A LIVING 2012 02da99c7-0a26-4857-9733-42e02c46cbe7 TCGA-56-8624-01 TCGA-56-8624-01 TCGA-56-8624-01 02da99c7-0a26-4857-9733-42e02c46cbe7 TCGA-56-8624-01 TCGA-56-8624-01A-11D-2391-01 02da99c7-0a26-4857-9733-42e02c46cbe7 02da99c7-0a26-4857-9733-42e02c46cbe7 TCGA-56-8624-01A-11D-2391-01 TCGA-56-8624-01A-11D-2398-05 +TCGA-56-8624-11 TCGA-56-8624-11 TCGA-56-8624 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 84 R-Lower TCGA-56-8624-F47792 TCGA-56-8624 -30798 0 420 84 YES YES Scheduled Follow-up Submission Complete Remission/Response 2013-8-28 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES NO NO 20 No MX N0 T3 Stage IIB 8624 TUMOR FREE 87 Complete Remission/Response YES NO R0 Solid Tissue Normal 11 1952 7th YES YES NO 56 3 Lung LIVING 2012 TCGA-56-8624-11 TCGA-56-8624-11 +TCGA-56-8625-01 TCGA-56-8625-01 TCGA-56-8625 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung NO NO NO NO 66 R-Lower TCGA-56-8625-F59027 TCGA-56-8625 -24188 315 0 63 272 31 Scheduled Follow-up Submission Progressive Disease 2014-4-30 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES Peripheral Lung NO Distant Metastasis YES No MX N1 T3 Stage IIIA 8625 WITH TUMOR 58 52 61 48 Progressive Disease Convincing Imaging YES NO RX Primary Tumor 01 7th YES YES NO 56 2 Lung DECEASED 2012 fed19371-74a4-414f-84a7-495d1ad86c6d TCGA-56-8625-01 TCGA-56-8625-01 TCGA-56-8625-01 fed19371-74a4-414f-84a7-495d1ad86c6d TCGA-56-8625-01 TCGA-56-8625-01A-11D-2391-01 fed19371-74a4-414f-84a7-495d1ad86c6d fed19371-74a4-414f-84a7-495d1ad86c6d TCGA-56-8625-01A-11D-2391-01 TCGA-56-8625-01A-11D-2398-05 +TCGA-56-8626-01 TCGA-56-8626-01 TCGA-56-8626 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 59 L-Upper TCGA-56-8626-F57930 TCGA-56-8626 -21908 302 0 17 Scheduled Follow-up Submission 2014-3-28 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES NO NO 50 No MX N0 T1a Stage IA 8626 TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 7th NO YES NO 56 2 Lung DECEASED 2012 1962 f9cc97c0-af9a-4d77-b68e-fcfe9ca9d238 TCGA-56-8626-01 TCGA-56-8626-01 TCGA-56-8626-01 f9cc97c0-af9a-4d77-b68e-fcfe9ca9d238 TCGA-56-8626-01 TCGA-56-8626-01A-11D-2391-01 f9cc97c0-af9a-4d77-b68e-fcfe9ca9d238 f9cc97c0-af9a-4d77-b68e-fcfe9ca9d238 TCGA-56-8626-01A-11D-2391-01 TCGA-56-8626-01A-11D-2398-05 +TCGA-56-8628-01 TCGA-56-8628-01 TCGA-56-8628 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 78 R-Upper TCGA-56-8628-F64290 TCGA-56-8628 -28805 0 616 3 Scheduled Follow-up Submission Complete Remission/Response 2014-8-28 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 70 NO NO No MX N0 T1b Stage IA 8628 Other TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 2007 7th NO YES NO 56 4 Lung LIVING 2012 ac7e54d7-3886-4da3-a569-dd59fe479dea TCGA-56-8628-01 TCGA-56-8628-01 TCGA-56-8628-01 ac7e54d7-3886-4da3-a569-dd59fe479dea TCGA-56-8628-01 TCGA-56-8628-01A-11D-2391-01 ac7e54d7-3886-4da3-a569-dd59fe479dea ac7e54d7-3886-4da3-a569-dd59fe479dea TCGA-56-8628-01A-11D-2391-01 TCGA-56-8628-01A-11D-2398-05 +TCGA-56-8629-01 TCGA-56-8629-01 TCGA-56-8629 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 63 L-Lower TCGA-56-8629-F57032 TCGA-56-8629 TCGA-56-8629-01A -23346 0 481 1 NO NO Scheduled Follow-up Submission Complete Remission/Response 2014-2-28 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.8 NO 80 NO 1.1 NO NO 66 No MX N0 T2b Stage IIA TCGA-56-8629.673bcff6-ef66-481f-baba-50c86f18d551.pdf 8629 Preoperative TUMOR FREE 98 51 Complete Remission/Response YES NO R0 Primary Tumor 01 0.3 2001 7th YES YES NO 56 4 Lung A LIVING 2012 1968 55d51796-c9c2-425b-8c94-bbd7475bc690 TCGA-56-8629-01 TCGA-56-8629-01 TCGA-56-8629-01 55d51796-c9c2-425b-8c94-bbd7475bc690 TCGA-56-8629-01 TCGA-56-8629-01A-11D-2391-01 55d51796-c9c2-425b-8c94-bbd7475bc690 55d51796-c9c2-425b-8c94-bbd7475bc690 TCGA-56-8629-01A-11D-2391-01 TCGA-56-8629-01A-11D-2398-05 +TCGA-56-8629-11 TCGA-56-8629-11 TCGA-56-8629 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 63 L-Lower TCGA-56-8629-F57032 TCGA-56-8629 -23346 0 481 1 NO NO Scheduled Follow-up Submission Complete Remission/Response 2014-2-28 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 80 NO NO NO 66 No MX N0 T2b Stage IIA 8629 Preoperative TUMOR FREE 98 51 Complete Remission/Response YES NO R0 Solid Tissue Normal 11 2001 7th YES YES NO 56 4 Lung LIVING 2012 1968 TCGA-56-8629-11 TCGA-56-8629-11 +TCGA-56-A49D-01 TCGA-56-A49D-01 TCGA-56-A49D TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 67 L-Upper TCGA-56-A49D-F66146 TCGA-56-A49D -24745 0 637 64 Scheduled Follow-up Submission Complete Remission/Response 2014-10-3 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES Central Lung NO NO 53 No MX N2 T2a Stage IIIA A49D TUMOR FREE 70 72 Complete Remission/Response YES NO R0 Primary Tumor 01 2005 7th NO YES NO 56 4 Lung LIVING 2012 1953 c9eb7517-0b47-407c-abaa-abae989044fd TCGA-56-A49D-01 TCGA-56-A49D-01 TCGA-56-A49D-01 c9eb7517-0b47-407c-abaa-abae989044fd TCGA-56-A49D-01 TCGA-56-A49D-01A-11D-A24C-01 c9eb7517-0b47-407c-abaa-abae989044fd c9eb7517-0b47-407c-abaa-abae989044fd TCGA-56-A49D-01A-11D-A24C-01 TCGA-56-A49D-01A-11D-A24I-05 +TCGA-56-A4BW-01 TCGA-56-A4BW-01 TCGA-56-A4BW TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 55 L-Upper TCGA-56-A4BW-F66149 TCGA-56-A4BW -20301 0 585 0 Scheduled Follow-up Submission Complete Remission/Response 2014-10-3 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 90 Central Lung NO NO 120 No M0 N1 T2a Stage IIA A4BW Preoperative TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 1999 7th YES YES NO 56 4 Lung LIVING 2012 1969 aa07fad1-0896-44c3-b8f8-289ac06d2d79 TCGA-56-A4BW-01 TCGA-56-A4BW-01 TCGA-56-A4BW-01 aa07fad1-0896-44c3-b8f8-289ac06d2d79 TCGA-56-A4BW-01 TCGA-56-A4BW-01A-11D-A24C-01 aa07fad1-0896-44c3-b8f8-289ac06d2d79 aa07fad1-0896-44c3-b8f8-289ac06d2d79 TCGA-56-A4BW-01A-11D-A24C-01 TCGA-56-A4BW-01A-11D-A24I-05 +TCGA-56-A4BX-01 TCGA-56-A4BX-01 TCGA-56-A4BX TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 70 R-Lower TCGA-56-A4BX-F60125 TCGA-56-A4BX TCGA-56-A4BX-01A -25745 89 0 405 53 2 NO NO Scheduled Follow-up Submission Complete Remission/Response 2014-5-29 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 80 NO 70 NO Central Lung NO NO 83 false No MX N0 T2b Stage IIA TCGA-56-A4BX.921CAB89-9289-4C98-9746-4BFB3569E338.pdf A4BX Preoperative TUMOR FREE 91 85 89 79 Complete Remission/Response YES NO R0 Primary Tumor 01 2012 7th YES YES NO 56 4 Lung A LIVING 2012 1957 35434208-98c0-4f0d-a487-03fec50b33df TCGA-56-A4BX-01 TCGA-56-A4BX-01 TCGA-56-A4BX-01 35434208-98c0-4f0d-a487-03fec50b33df TCGA-56-A4BX-01 TCGA-56-A4BX-01A-11D-A24C-01 35434208-98c0-4f0d-a487-03fec50b33df 35434208-98c0-4f0d-a487-03fec50b33df TCGA-56-A4BX-01A-11D-A24C-01 TCGA-56-A4BX-01A-11D-A24I-05 A590D904-ED74-45A5-BD8C-4E19B7C15F01 +TCGA-56-A4BY-01 TCGA-56-A4BY-01 TCGA-56-A4BY TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 66 L-Upper TCGA-56-A4BY-F59033 TCGA-56-A4BY TCGA-56-A4BY-01A -24445 67 543 0 31 16 2 NO NO Scheduled Follow-up Submission Complete Remission/Response 2014-4-30 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8071/3 C34.1 YES 50 NO 80 NO Central Lung NO NO 65 false Yes, History of Prior Malignancy MX N0 T2a Stage IB TCGA-56-A4BY.62DC00DE-B06C-4A85-A1DB-3B6498D617C1.pdf A4BY Preoperative WITH TUMOR 71 44 Complete Remission/Response YES YES RX Primary Tumor 01 2004 7th NO YES NO 56 4 Lung A DECEASED 2012 1961 3eec1382-92cb-44c8-b45d-38eda989e956 TCGA-56-A4BY-01 TCGA-56-A4BY-01 TCGA-56-A4BY-01 3eec1382-92cb-44c8-b45d-38eda989e956 TCGA-56-A4BY-01 TCGA-56-A4BY-01A-11D-A24C-01 3eec1382-92cb-44c8-b45d-38eda989e956 3eec1382-92cb-44c8-b45d-38eda989e956 TCGA-56-A4BY-01A-11D-A24C-01 TCGA-56-A4BY-01A-11D-A24I-05 +TCGA-56-A4ZJ-01 TCGA-56-A4ZJ-01 TCGA-56-A4ZJ TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 75 R-Lower TCGA-56-A4ZJ-F59037 TCGA-56-A4ZJ -27516 0 640 48 Scheduled Follow-up Submission Complete Remission/Response 2014-4-30 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8072/3 C34.3 YES NO NO 100 Yes, History of Prior Malignancy M0 N0 T1a Stage IA A4ZJ TUMOR FREE 75 118 77 115 Complete Remission/Response YES NO R0 Primary Tumor 01 2002 7th NO YES NO 56 4 Lung LIVING 2012 d57e41d2-e98e-4a24-b1cf-bfca3cb5e255 TCGA-56-A4ZJ-01 TCGA-56-A4ZJ-01 TCGA-56-A4ZJ-01 d57e41d2-e98e-4a24-b1cf-bfca3cb5e255 TCGA-56-A4ZJ-01 TCGA-56-A4ZJ-01A-11D-A25M-01 d57e41d2-e98e-4a24-b1cf-bfca3cb5e255 d57e41d2-e98e-4a24-b1cf-bfca3cb5e255 TCGA-56-A4ZJ-01A-11D-A25M-01 TCGA-56-A4ZJ-01A-11D-A25R-05 +TCGA-56-A4ZK-01 TCGA-56-A4ZK-01 TCGA-56-A4ZK TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 76 R-Lower TCGA-56-A4ZK-F59036 TCGA-56-A4ZK TCGA-56-A4ZK-01A -28039 54 0 570 1 NO NO Scheduled Follow-up Submission Complete Remission/Response 2014-4-30 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 30 NO 90 NO Central Lung NO NO false No M0 N0 T2 Stage IB TCGA-56-A4ZK.3F2B148C-7611-4F00-9483-B05A1CFD9EEF.pdf A4ZK Preoperative TUMOR FREE Complete Remission/Response NO R1 Primary Tumor 01 2007 7th NO YES NO 56 4 Lung A LIVING 2012 1955 9cf2d1c9-90c2-46a5-bdf2-ff27745b7808 TCGA-56-A4ZK-01 TCGA-56-A4ZK-01 TCGA-56-A4ZK-01 9cf2d1c9-90c2-46a5-bdf2-ff27745b7808 TCGA-56-A4ZK-01 TCGA-56-A4ZK-01A-11D-A25M-01 9cf2d1c9-90c2-46a5-bdf2-ff27745b7808 9cf2d1c9-90c2-46a5-bdf2-ff27745b7808 TCGA-56-A4ZK-01A-11D-A25M-01 TCGA-56-A4ZK-01A-11D-A25R-05 +TCGA-56-A5DR-01 TCGA-56-A5DR-01 TCGA-56-A5DR TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 81 L-Upper TCGA-56-A5DR-F61481 TCGA-56-A5DR -29828 0 4 64 NO NO Scheduled Follow-up Submission Complete Remission/Response 2014-6-30 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES NO YES NO Yes, History of Prior Malignancy MX N0 T1a Stage IA A5DR TUMOR FREE 52 70 Complete Remission/Response YES NO R0 Primary Tumor 01 7th NO YES NO 56 1 Lung LIVING 2012 eaf753de-dd57-49bf-b0ad-ffc019fdbef3 TCGA-56-A5DR-01 TCGA-56-A5DR-01 TCGA-56-A5DR-01 eaf753de-dd57-49bf-b0ad-ffc019fdbef3 TCGA-56-A5DR-01 TCGA-56-A5DR-01A-11D-A27J-01 eaf753de-dd57-49bf-b0ad-ffc019fdbef3 eaf753de-dd57-49bf-b0ad-ffc019fdbef3 TCGA-56-A5DR-01A-11D-A27J-01 TCGA-56-A5DR-01A-11D-A27L-05 +TCGA-56-A5DS-01 TCGA-56-A5DS-01 TCGA-56-A5DS TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 72 R-Lower TCGA-56-A5DS-F61483 TCGA-56-A5DS TCGA-56-A5DS-01A -26355 70 0 8 NO NO Scheduled Follow-up Submission Complete Remission/Response 2014-6-30 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 100 NO NO YES NO 50 false No MX N0 T2a Stage IB TCGA-56-A5DS.17B3CEDD-13C1-4E7A-8FE9-6710C61B1EE6.pdf A5DS TUMOR FREE Complete Remission/Response YES R0 Primary Tumor 01 7th YES NO 56 2 Lung A LIVING 2012 1962 165b20b1-cf41-442d-b08c-03bda738830a TCGA-56-A5DS-01 165b20b1-cf41-442d-b08c-03bda738830a TCGA-56-A5DS-01 TCGA-56-A5DS-01A-11D-A27J-01 165b20b1-cf41-442d-b08c-03bda738830a 165b20b1-cf41-442d-b08c-03bda738830a TCGA-56-A5DS-01A-11D-A27J-01 TCGA-56-A5DS-01A-11D-A27L-05 77E42462-7DB6-4B44-A32F-DB7B522F10CA +TCGA-56-A62T-01 TCGA-56-A62T-01 TCGA-56-A62T TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 78 L-Upper TCGA-56-A62T-F66644 TCGA-56-A62T TCGA-56-A62T-01A -28522 41 0 440 64 1 NO NO Scheduled Follow-up Submission Complete Remission/Response 2014-10-21 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 40 NO 90 NO Central Lung NO NO 102 false No MX N0 T2b Stage IIA TCGA-56-A62T.8A436D40-6B36-4A34-B589-BFCCCE228F5C.pdf A62T Preoperative TUMOR FREE 98 66 Complete Remission/Response YES YES R1 Primary Tumor 01 7th YES YES NO 56 2 Lung A LIVING 2013 1962 78bff220-61fb-4bcf-9520-6c8f287cdf0e TCGA-56-A62T-01 TCGA-56-A62T-01 TCGA-56-A62T-01 78bff220-61fb-4bcf-9520-6c8f287cdf0e TCGA-56-A62T-01 TCGA-56-A62T-01A-11D-A400-01 78bff220-61fb-4bcf-9520-6c8f287cdf0e 78bff220-61fb-4bcf-9520-6c8f287cdf0e TCGA-56-A62T-01A-11D-A400-01 TCGA-56-A62T-01A-11D-A408-05 +TCGA-58-8386-01 TCGA-58-8386-01 Squamous Cluster 13 (HNSC-LUSC) miRNA cluster 4 TCGA-58-8386 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 75 R-Upper TCGA-58-8386 TCGA-58-8386-01A -27455 1 0 NO NO 2012-7-4 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.6 NO 90 NO Central Lung 0.8 NO 65 No M1 NX T3 Stage IV TCGA-58-8386.f239ea75-1ebb-48ac-ab2a-10669e72a24d.pdf 8386 Preoperative TUMOR FREE 55 85 Complete Remission/Response YES NO R0 Primary Tumor 01 0.5 6th NO NO YES 58 2 Lung A DECEASED 2008 6e1fbe8d-8e83-4424-87e9-6e38313215d3 TCGA-58-8386-01 TCGA-58-8386-01 TCGA-58-8386-01 6e1fbe8d-8e83-4424-87e9-6e38313215d3 TCGA-58-8386-01 TCGA-58-8386-01A-11D-2292-01 6e1fbe8d-8e83-4424-87e9-6e38313215d3 6e1fbe8d-8e83-4424-87e9-6e38313215d3 TCGA-58-8386-01A-11D-2292-01 TCGA-58-8386-01A-11D-2294-05 05DF9851-E981-42E8-B877-7773147D3BF7 +TCGA-58-8386-11 TCGA-58-8386-11 TCGA-58-8386 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 75 R-Upper TCGA-58-8386 TCGA-58-8386-11A -27455 1 0 NO NO 2012-7-4 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.6 NO 90 NO Central Lung 0.6 NO 65 No M1 NX T3 Stage IV 8386 Preoperative TUMOR FREE 55 85 Complete Remission/Response YES NO R0 Solid Tissue Normal 11 0.5 6th NO NO YES 58 2 Lung A DECEASED 2008 153e5c1e-46ba-460f-a966-c3bb10dc490d TCGA-58-8386-11 TCGA-58-8386-11 153e5c1e-46ba-460f-a966-c3bb10dc490d 153e5c1e-46ba-460f-a966-c3bb10dc490d 153e5c1e-46ba-460f-a966-c3bb10dc490d +TCGA-58-8387-01 TCGA-58-8387-01 Squamous Cluster 5 miRNA cluster 4 TCGA-58-8387 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 60 R-Lower TCGA-58-8387 TCGA-58-8387-01A -21952 403 0 0 NO NO 2012-7-4 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.4 NO 90 NO Peripheral Lung 0.5 NO 40 No M0 N0 T2b Stage IIA TCGA-58-8387.f60b853b-5d1d-47cc-a961-db2da5aa837b.pdf 8387 Preoperative TUMOR FREE 74 74 Complete Remission/Response YES NO R0 Primary Tumor 01 0.2 2010 7th YES NO YES 58 4 Lung A DECEASED 2010 40c82f91-98b7-4c3f-8885-3ea4e383e7be TCGA-58-8387-01 TCGA-58-8387-01 TCGA-58-8387-01 40c82f91-98b7-4c3f-8885-3ea4e383e7be TCGA-58-8387-01 TCGA-58-8387-01A-11D-2292-01 40c82f91-98b7-4c3f-8885-3ea4e383e7be 40c82f91-98b7-4c3f-8885-3ea4e383e7be TCGA-58-8387-01A-11D-2292-01 TCGA-58-8387-01A-11D-2294-05 +TCGA-58-8388-01 TCGA-58-8388-01 Cluster 5 miRNA cluster 14 TCGA-58-8388 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 60 L-Upper TCGA-58-8388-F42095 TCGA-58-8388 TCGA-58-8388-01A -21949 412 0 378 0 NO NO Scheduled Follow-up Submission Complete Remission/Response 2013-5-15 MALE Lung Basaloid Squamous Cell Carcinoma No C34.1 8083/3 C34.1 YES 0.8 NO 90 NO Peripheral Lung 1 NO NO 80 No M0 N0 T2a Stage IB TCGA-58-8388.e7a3f2b5-cc34-47e1-8a36-a552b3150847.pdf 8388 Preoperative TUMOR FREE 65 71 Complete Remission/Response YES NO R0 Primary Tumor 01 0.5 7th NO NO YES 58 2 Lung A DECEASED 2010 68623699-7543-425b-93a1-e0947e3b897e TCGA-58-8388-01 TCGA-58-8388-01 TCGA-58-8388-01 68623699-7543-425b-93a1-e0947e3b897e TCGA-58-8388-01 TCGA-58-8388-01A-11D-2322-01 68623699-7543-425b-93a1-e0947e3b897e 68623699-7543-425b-93a1-e0947e3b897e TCGA-58-8388-01A-11D-2322-01 TCGA-58-8388-01A-11D-2324-05 9926C060-7DFA-4A50-8000-605112CFC998 +TCGA-58-8390-01 TCGA-58-8390-01 Cluster 5 miRNA cluster 4 TCGA-58-8390 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 70 R-Lower TCGA-58-8390-F42096 TCGA-58-8390 -25827 0 911 0 NO NO Scheduled Follow-up Submission Complete Remission/Response 2013-5-15 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 90 NO Central Lung NO NO 120 No M0 N0 T2b Stage IIA 8390 Preoperative TUMOR FREE 72 64 Complete Remission/Response YES NO R0 Primary Tumor 01 1998 7th NO NO YES 58 4 Lung LIVING 2010 f8789ef6-b073-463f-be80-1fe462adeee7 TCGA-58-8390-01 TCGA-58-8390-01 TCGA-58-8390-01 f8789ef6-b073-463f-be80-1fe462adeee7 TCGA-58-8390-01 TCGA-58-8390-01A-11D-2322-01 f8789ef6-b073-463f-be80-1fe462adeee7 f8789ef6-b073-463f-be80-1fe462adeee7 TCGA-58-8390-01A-11D-2322-01 TCGA-58-8390-01A-11D-2324-05 +TCGA-58-8391-01 TCGA-58-8391-01 Cluster 13 (HNSC-LUSC) miRNA cluster 4 TCGA-58-8391 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung NO 57 Bronchial TCGA-58-8391-F42097 TCGA-58-8391 TCGA-58-8391-01A -21102 0 2167 2033 NO NO Scheduled Follow-up Submission Progressive Disease 2013-5-15 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.9 8070/3 C34.9 YES 0.4 NO 100 NO Central Lung 0.7 NO Distant Metastasis|New Primary Tumor YES 30 No M0 N2 T2 Stage IIIA TCGA-58-8391.aca4cc6c-a56b-4936-b459-b4c48892924a.pdf 8391 Preoperative WITH TUMOR 74 75 Complete Remission/Response Convincing Imaging YES YES R0 Primary Tumor 01 0.4 6th YES NO YES 58 2 Lung A LIVING 2006 9bb5155e-25b8-41b7-a424-8aeb81853366 TCGA-58-8391-01 TCGA-58-8391-01 TCGA-58-8391-01 9bb5155e-25b8-41b7-a424-8aeb81853366 TCGA-58-8391-01 TCGA-58-8391-01A-11D-2322-01 9bb5155e-25b8-41b7-a424-8aeb81853366 9bb5155e-25b8-41b7-a424-8aeb81853366 TCGA-58-8391-01A-11D-2322-01 TCGA-58-8391-01A-11D-2324-05 EF9AC410-385E-4216-8C5A-9692F658EB22 +TCGA-58-8392-01 TCGA-58-8392-01 Cluster 13 (HNSC-LUSC) miRNA cluster 11 TCGA-58-8392 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 70 L-Upper TCGA-58-8392 TCGA-58-8392-01A -25710 501 0 1 YES L858R NO 2012-7-4 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.6 NO 70 NO Peripheral Lung 0.7 YES 80 No M0 N0 T2a Stage IB TCGA-58-8392.d98ba859-91e2-4de1-bb61-b925d77e33de.pdf 8392 Preoperative WITH TUMOR 33 31 Complete Remission/Response YES NO R0 Primary Tumor 01 0.4 7th NO NO YES 58 2 Lung A DECEASED 2010 4a3692a0-d9de-4cd3-9c4a-bbb087aa67c3 TCGA-58-8392-01 TCGA-58-8392-01 TCGA-58-8392-01 4a3692a0-d9de-4cd3-9c4a-bbb087aa67c3 TCGA-58-8392-01 TCGA-58-8392-01A-11D-2322-01 4a3692a0-d9de-4cd3-9c4a-bbb087aa67c3 4a3692a0-d9de-4cd3-9c4a-bbb087aa67c3 TCGA-58-8392-01A-11D-2322-01 TCGA-58-8392-01A-11D-2324-05 9DC55047-C604-434A-A5E8-07FD09171584 +TCGA-58-8393-01 TCGA-58-8393-01 Cluster 13 (HNSC-LUSC) miRNA cluster 4 TCGA-58-8393 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 68 R-Lower TCGA-58-8393-F42098 TCGA-58-8393 TCGA-58-8393-01A -25132 0 1058 0 NO NO Scheduled Follow-up Submission Complete Remission/Response 2013-5-15 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.7 NO 100 NO Central Lung 0.9 NO NO 7 No M0 N0 T2a Stage IB TCGA-58-8393.bbc15d06-72ec-47e4-a65b-e3f7934ab41b.pdf 8393 Preoperative TUMOR FREE 72 115 Complete Remission/Response YES NO R0 Primary Tumor 01 0.4 7th NO NO YES 58 2 Lung A LIVING 2010 bc95bdc7-553c-4b87-b546-899d8bd3fc41 TCGA-58-8393-01 TCGA-58-8393-01 TCGA-58-8393-01 bc95bdc7-553c-4b87-b546-899d8bd3fc41 TCGA-58-8393-01 TCGA-58-8393-01A-11D-2322-01 bc95bdc7-553c-4b87-b546-899d8bd3fc41 bc95bdc7-553c-4b87-b546-899d8bd3fc41 TCGA-58-8393-01A-11D-2322-01 TCGA-58-8393-01A-11D-2324-05 13528023-F9BF-43E6-867E-BE85BE0F630C +TCGA-58-8393-11 TCGA-58-8393-11 TCGA-58-8393 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 68 R-Lower TCGA-58-8393-F42098 TCGA-58-8393 -25132 0 1058 0 NO NO Scheduled Follow-up Submission Complete Remission/Response 2013-5-15 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 100 NO Central Lung NO NO 7 No M0 N0 T2a Stage IB 8393 Preoperative TUMOR FREE 72 115 Complete Remission/Response YES NO R0 Solid Tissue Normal 11 7th NO NO YES 58 2 Lung LIVING 2010 TCGA-58-8393-11 TCGA-58-8393-11 +TCGA-58-A46J-01 TCGA-58-A46J-01 TCGA-58-A46J TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 64 R-Upper TCGA-58-A46J-F51444 TCGA-58-A46J TCGA-58-A46J-01A -23653 2176 0 2589 NO NO Scheduled Follow-up Submission Complete Remission/Response 2013-11-19 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 130 NO 80 NO Central Lung NO NO true No M0 N1 T2 Stage IIB TCGA-58-A46J.18E403FA-639F-4E53-820B-0A756A039C73.pdf A46J Preoperative TUMOR FREE 79 48 Complete Remission/Response YES NO R0 Primary Tumor 01 6th YES NO YES 58 2 Lung A LIVING 2006 52925e7c-35c6-405c-982d-28a8a5ce1201 TCGA-58-A46J-01 TCGA-58-A46J-01 TCGA-58-A46J-01 52925e7c-35c6-405c-982d-28a8a5ce1201 TCGA-58-A46J-01 TCGA-58-A46J-01A-11D-A24C-01 52925e7c-35c6-405c-982d-28a8a5ce1201 52925e7c-35c6-405c-982d-28a8a5ce1201 TCGA-58-A46J-01A-11D-A24C-01 TCGA-58-A46J-01A-11D-A24I-05 DCBC263F-5BD1-4898-9BFB-73156B06AB6F +TCGA-58-A46K-01 TCGA-58-A46K-01 TCGA-58-A46K TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 59 R-Lower TCGA-58-A46K TCGA-58-A46K-01A -21867 1491 1045 0 0 NO NO 2012-10-29 MALE Lung Basaloid Squamous Cell Carcinoma No C34.3 8083/3 C34.3 YES 90 NO 100 NO Peripheral Lung YES 10 true No M0 N2 T2 Stage IIIA TCGA-58-A46K.526A34E6-B8D1-4A05-B6E9-1CDDA281BD7A.pdf A46K Preoperative WITH TUMOR 70 82 Complete Remission/Response YES YES R0 Primary Tumor 01 2005 6th YES NO YES 58 4 Lung A DECEASED 2008 3c6a4510-fc3e-4b40-9d15-2ccbce48dca2 TCGA-58-A46K-01 TCGA-58-A46K-01 TCGA-58-A46K-01 3c6a4510-fc3e-4b40-9d15-2ccbce48dca2 TCGA-58-A46K-01 TCGA-58-A46K-01A-11D-A24C-01 3c6a4510-fc3e-4b40-9d15-2ccbce48dca2 3c6a4510-fc3e-4b40-9d15-2ccbce48dca2 TCGA-58-A46K-01A-11D-A24C-01 TCGA-58-A46K-01A-11D-A24I-05 861C2CB9-3DF1-457C-ACA7-92DF2D82CBFD +TCGA-58-A46L-01 TCGA-58-A46L-01 TCGA-58-A46L TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 73 R-Upper TCGA-58-A46L-F51445 TCGA-58-A46L TCGA-58-A46L-01A -26685 1426 0 1723 0 NO NO Scheduled Follow-up Submission Complete Remission/Response 2013-11-19 MALE Lung Basaloid Squamous Cell Carcinoma No C34.1 8083/3 C34.1 YES 110 NO 100 NO Central Lung NO NO true No M0 N2 T2 Stage IIIA TCGA-58-A46L.56894615-979E-4A89-B6D4-F6639C0188FE.pdf A46L Preoperative TUMOR FREE 50 61 Complete Remission/Response YES NO R0 Primary Tumor 01 6th YES NO YES 58 5 Lung A LIVING 2008 9aa74fcf-9845-4708-a09b-a17aa4b9e94a TCGA-58-A46L-01 TCGA-58-A46L-01 TCGA-58-A46L-01 9aa74fcf-9845-4708-a09b-a17aa4b9e94a TCGA-58-A46L-01 TCGA-58-A46L-01A-11D-A24C-01 9aa74fcf-9845-4708-a09b-a17aa4b9e94a 9aa74fcf-9845-4708-a09b-a17aa4b9e94a TCGA-58-A46L-01A-11D-A24C-01 TCGA-58-A46L-01A-11D-A24I-05 8C6174F1-5DAC-4878-8A48-A007931FF333 +TCGA-58-A46M-01 TCGA-58-A46M-01 TCGA-58-A46M TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 61 L-Lower TCGA-58-A46M-F51443 TCGA-58-A46M TCGA-58-A46M-01A -22592 686 0 1072 0 NO NO Scheduled Follow-up Submission Complete Remission/Response 2013-11-19 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 100 NO 100 NO Central Lung NO NO true No M0 N1 T2b Stage IIB TCGA-58-A46M.29B1DF65-6310-4E01-9CBF-7678678A7D38.pdf A46M Preoperative TUMOR FREE 41 0 Complete Remission/Response YES NO R0 Primary Tumor 01 7th NO NO YES 58 2 Lung A LIVING 2010 f5b03cae-1e62-46aa-9c0b-a2fb62948aed TCGA-58-A46M-01 TCGA-58-A46M-01 TCGA-58-A46M-01 f5b03cae-1e62-46aa-9c0b-a2fb62948aed TCGA-58-A46M-01 TCGA-58-A46M-01A-11D-A24C-01 f5b03cae-1e62-46aa-9c0b-a2fb62948aed f5b03cae-1e62-46aa-9c0b-a2fb62948aed TCGA-58-A46M-01A-11D-A24C-01 TCGA-58-A46M-01A-11D-A24I-05 1444E38F-7DCE-4AA4-B8D0-D5410CE82CEA +TCGA-58-A46N-01 TCGA-58-A46N-01 TCGA-58-A46N TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung NO YES NO 52 R-Lower TCGA-58-A46N-F51446 TCGA-58-A46N TCGA-58-A46N-01A -19050 566 0 910 630 0 NO NO Scheduled Follow-up Submission Partial Remission/Response 2013-11-19 MALE Lung Basaloid Squamous Cell Carcinoma No C34.3 8083/3 C34.3 YES 100 NO 90 NO Central Lung NO Locoregional Recurrence YES 50 true No M0 N0 T2a Stage IB TCGA-58-A46N.95A2F9CB-DFB3-441E-9F24-467D9AB343F9.pdf A46N Preoperative WITH TUMOR 58 63 Complete Remission/Response Convincing Imaging YES NO R0 Primary Tumor 01 7th NO NO YES 58 2 Lung A LIVING 2011 14053697-8879-40ef-ad7d-9840ebae105a TCGA-58-A46N-01 TCGA-58-A46N-01 TCGA-58-A46N-01 14053697-8879-40ef-ad7d-9840ebae105a TCGA-58-A46N-01 TCGA-58-A46N-01A-11D-A24C-01 14053697-8879-40ef-ad7d-9840ebae105a 14053697-8879-40ef-ad7d-9840ebae105a TCGA-58-A46N-01A-11D-A24C-01 TCGA-58-A46N-01A-11D-A24I-05 CDE5855A-E696-4A1E-9E04-51225C3018E1 +TCGA-60-2695-01 TCGA-60-2695-01 High C1-LUAD-enriched Cluster 5 squamous c3 RNA cluster 12 miRNA c1uster 10 TCGA-60-2695 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung NO NO 74 L-Upper TCGA-60-2695-F5377 TCGA-60-2695 TCGA-60-2695-01A -27211 0 642 NO NO 2010-7-15 FEMALE Lung Basaloid Squamous Cell Carcinoma No C34.1 8083/3 C34.1 YES 0.8 NO NO 1 NO 64 No M0 N0 T2 Stage IB TCGA-60-2695.ee5f477a-e6f4-4c37-8ee1-f9dc269aef9b.pdf 2695 TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 0.4 1983 NO NO YES 60 3 Lung A LIVING 2009 1951 TCGA-60-2695-01A-01D-0848-05 9359bed2-0958-4cba-954e-3d548320e12e TCGA-60-2695-01 TCGA-60-2695-01 TCGA-60-2695-01A-01R-0851-07 9359bed2-0958-4cba-954e-3d548320e12e 7c4d6989-802d-4e17-b041-8c8958d4f4ad TCGA-60-2695-01A-21-2193-20 TCGA-60-2695-01 TCGA-60-2695-01A-01D-0844-01 TCGA-60-2695-01 9359bed2-0958-4cba-954e-3d548320e12e TCGA-60-2695-01 9359bed2-0958-4cba-954e-3d548320e12e TCGA-60-2695-01 TCGA-60-2695-01A-01D-0844-01 ec5712a3-b8ad-4fad-a544-e815bffacece +TCGA-60-2696-01 TCGA-60-2696-01 Squamous C2-Squamous-like Cluster 5 squamous c3 squamous-like c4 miRNA cluster 4 TCGA-60-2696 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung NO NO 76 L-Upper TCGA-60-2696-F5373 TCGA-60-2696 TCGA-60-2696-01A -27991 109 0 109 NO NO 2010-7-15 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) Yes C34.1 8070/3 C34.1 YES 0.6 NO 0 NO Central Lung 1 NO 15 Yes M0 N0 T2 Stage IIA TCGA-60-2696.afe56cab-1fd2-4503-899b-cbfeb79ee7a0.pdf 2696 NO RX Primary Tumor 01 0.5 1985 NO NO YES 60 3 Lung A DECEASED 2009 1955 TCGA-60-2696-01A-01D-0848-05 ff913d7b-73f5-4987-97f9-294463272f82 TCGA-60-2696-01 TCGA-60-2696-01A-01R-0851-07 ff913d7b-73f5-4987-97f9-294463272f82 ab4b034e-4273-4bd6-9453-f251bc34e157 TCGA-60-2696-01A-21-2193-20 TCGA-60-2696-01 TCGA-60-2696-01A-01D-0844-01 TCGA-60-2696-01 ff913d7b-73f5-4987-97f9-294463272f82 TCGA-60-2696-01 ff913d7b-73f5-4987-97f9-294463272f82 TCGA-60-2696-01A-01D-0844-01 3a198ed8-723a-4655-8fb2-74e042bea193 +TCGA-60-2697-01 TCGA-60-2697-01 Kirc+ Low purity c2 squamous c3 miRNA c1uster 9 TCGA-60-2697 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung YES YES NO 41 R-Middle TCGA-60-2697-F20962 TCGA-60-2697 TCGA-60-2697-01A -14984 372 0 200 NO NO Scheduled Follow-up Submission Progressive Disease 2012-1-18 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) Yes C34.9 8070/3 C34.9 YES 0.7 NO NO 1.5 YES No M0 N2 T2 Stage IIA TCGA-60-2697.a5d927b3-eb14-4127-a74f-5a53eb3cf536.pdf 2697 WITH TUMOR Complete Remission/Response NO RX Primary Tumor 01 0.3 3rd NO NO YES 60 Lung A DECEASED 1992 a4367d0e-d5a3-4865-8c58-4ef4c5493465 TCGA-60-2697-01 TCGA-60-2697-01 TCGA-60-2697-01 a4367d0e-d5a3-4865-8c58-4ef4c5493465 TCGA-60-2697-01A-21-2193-20 TCGA-60-2697-01 TCGA-60-2697-01A-11D-2121-01 a4367d0e-d5a3-4865-8c58-4ef4c5493465 a4367d0e-d5a3-4865-8c58-4ef4c5493465 TCGA-60-2697-01A-11D-2121-01 TCGA-60-2697-01A-11D-2123-05 7125f62c-3ad3-45a5-aa83-a9052c5669ed +TCGA-60-2698-01 TCGA-60-2698-01 High C2-Squamous-like cluster 1 Cluster 5 squamous c3 squamous-like c4 miRNA cluster 4 cluster 2 mutation cluster 8 TCGA-60-2698 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung YES YES 62 R-Lower TCGA-60-2698-F5379 TCGA-60-2698 TCGA-60-2698-01A -22800 311 0 114 NO NO Progressive Disease 2010-7-26 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 1.5 NO 0 NO 1.7 YES No M0 N1 T2 Stage IIB TCGA-60-2698.fd7aab4d-f043-48e5-af10-789c56debc41.pdf 2698 WITH TUMOR NO RX Primary Tumor 01 0.5 1993 NO NO YES 60 4 Lung A DECEASED 1993 TCGA-60-2698-01A-01D-1522-08 TCGA-60-2698-01A-01D-0848-05 cf406671-32e5-46c6-8e55-ac696c5d9bc9 TCGA-60-2698-01 TCGA-60-2698-01A-01D-1522-08 TCGA-60-2698-01 TCGA-60-2698-01A-01R-0851-07 cf406671-32e5-46c6-8e55-ac696c5d9bc9 4e3260fe-9386-4843-a2c5-e542a2c91814 TCGA-60-2698-01A-21-2193-20 TCGA-60-2698-01 TCGA-60-2698-01A-01D-0844-01 TCGA-60-2698-01 cf406671-32e5-46c6-8e55-ac696c5d9bc9 TCGA-60-2698-01 cf406671-32e5-46c6-8e55-ac696c5d9bc9 TCGA-60-2698-01 TCGA-60-2698-01A-01D-0844-01 f57a7f9b-23c2-4a93-9322-9df5bc51eb99 +TCGA-60-2703-01 TCGA-60-2703-01 Squamous C2-Squamous-like Cluster 5 squamous c3 squamous-like c4 miRNA cluster 4 TCGA-60-2703 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung NO NO YES YES 73 R-Lower TCGA-60-2703-F19864 TCGA-60-2703 TCGA-60-2703-01A 1757 2215 -27003 2945 0 1757 0 NO Scheduled Follow-up Submission Progressive Disease 2011-12-21 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.9 8070/3 C34.9 YES 0.5 NO NO Peripheral Lung 0.6 YES 50 No M0 N1 T2 Stage IIB TCGA-60-2703.880fe05a-3a40-430e-8254-1a0becdfc462.pdf 2703 Adjuvant therapy Complete Remission/Response NO R0 Primary Tumor 01 0.5 2000 5th NO NO YES 60 4 Lung A DECEASED 2002 1950 4228ef47-cd33-4bec-aa70-7a0cbe88de80 TCGA-60-2703-01 TCGA-60-2703-01 TCGA-60-2703-01 4228ef47-cd33-4bec-aa70-7a0cbe88de80 TCGA-60-2703-01A-21-2193-20 TCGA-60-2703-01 TCGA-60-2703-01A-11D-2041-01 4228ef47-cd33-4bec-aa70-7a0cbe88de80 4228ef47-cd33-4bec-aa70-7a0cbe88de80 TCGA-60-2703-01A-11D-2041-01 TCGA-60-2703-01A-11D-2043-05 68eb1b05-eb54-4b64-a7e5-6e76e09e6b11 +TCGA-60-2704-01 TCGA-60-2704-01 High C2-Squamous-like Cluster 5 squamous c3 squamous-like c4 miRNA cluster 4 TCGA-60-2704 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung YES YES NO NO 73 R-Upper TCGA-60-2704-F20241 TCGA-60-2704 TCGA-60-2704-01A -26927 1154 0 1045 0 NO NO Scheduled Follow-up Submission 2012-1-9 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 1.5 NO NO Central Lung 2.5 YES 60 No M0 N1 T2 Stage IIB TCGA-60-2704.5fc80d98-89c6-4bb4-bbf7-639f1d2c5647.pdf 2704 Post-Adjuvant Therapy WITH TUMOR NO R0 Primary Tumor 01 0.5 6th NO NO YES 60 2 Lung A DECEASED 2003 1943 790c2e10-c79a-412d-9a24-d571652ff80e TCGA-60-2704-01 TCGA-60-2704-01 TCGA-60-2704-01 790c2e10-c79a-412d-9a24-d571652ff80e TCGA-60-2704-01A-21-2193-20 TCGA-60-2704-01 TCGA-60-2704-01A-11D-2041-01 790c2e10-c79a-412d-9a24-d571652ff80e 790c2e10-c79a-412d-9a24-d571652ff80e TCGA-60-2704-01A-11D-2041-01 TCGA-60-2704-01A-11D-2043-05 ffb8aceb-b5f5-4722-8051-74a36e32cfe3 +TCGA-60-2706-01 TCGA-60-2706-01 Squamous C1-LUAD-enriched Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 4 TCGA-60-2706 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 58 R-Upper TCGA-60-2706-F13011 TCGA-60-2706 TCGA-60-2706-01A -21477 0 2820 0 NO NO Complete Remission/Response 2011-6-16 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.9 8070/3 C34.9 YES 0.4 NO 100 NO 1 NO 51 No M0 N0 T1 Stage IA TCGA-60-2706.94622916-d2d7-44da-8013-437e4370dc96.pdf 2706 Post-Adjuvant Therapy TUMOR FREE Complete Remission/Response NO Primary Tumor 01 0.4 NO NO YES 60 2 Lung A LIVING 2003 1958 TCGA-60-2706-01A-01D-0848-05 134503af-e10e-41f4-97a4-c1261144b36a TCGA-60-2706-01 TCGA-60-2706-01 TCGA-60-2706-01A-01R-0851-07 134503af-e10e-41f4-97a4-c1261144b36a ed54cae5-6301-4040-878e-674dddb0656a TCGA-60-2706-01A-21-2193-20 TCGA-60-2706-01 TCGA-60-2706-01A-01D-0844-01 TCGA-60-2706-01 134503af-e10e-41f4-97a4-c1261144b36a TCGA-60-2706-01 134503af-e10e-41f4-97a4-c1261144b36a TCGA-60-2706-01 TCGA-60-2706-01A-01D-0844-01 ef42af10-10c8-4c5f-92f7-aa8fec60634a +TCGA-60-2707-01 TCGA-60-2707-01 Squamous C2-Squamous-like cluster 4 Cluster 13 (HNSC-LUSC) squamous-like c4 mutation cluster 8 TCGA-60-2707 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung YES NO 70 L-Upper TCGA-60-2707-F5391 TCGA-60-2707 TCGA-60-2707-01A -25758 667 0 661 579 NO NO 2010-7-16 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 1 NO NO Peripheral Lung 1.5 YES 49 No M0 N0 T2 Stage IB TCGA-60-2707.c3e54948-6849-4bac-b04b-3e1a196e866b.pdf 2707 WITH TUMOR Complete Remission/Response NO RX Primary Tumor 01 0.4 1983 NO NO YES 60 3 Lung A DECEASED 2003 1950 TCGA-60-2707-01A-01D-1522-08 TCGA-60-2707-01A-01D-0848-05 2c299eb8-f688-487f-b0d8-9b2bd297193b TCGA-60-2707-01A-01D-1522-08 TCGA-60-2707-01 TCGA-60-2707-01A-01R-0851-07 2c299eb8-f688-487f-b0d8-9b2bd297193b 496f3037-93c6-4d1f-bda8-795553823aab TCGA-60-2707-01 TCGA-60-2707-01A-01D-0844-01 TCGA-60-2707-01 2c299eb8-f688-487f-b0d8-9b2bd297193b TCGA-60-2707-01 2c299eb8-f688-487f-b0d8-9b2bd297193b TCGA-60-2707-01A-01D-0844-01 +TCGA-60-2708-01 TCGA-60-2708-01 High C2-Squamous-like cluster 2 Cluster 13 (HNSC-LUSC) squamous c3 squamous-like c4 miRNA cluster 4 cluster 2 mutation cluster 8 TCGA-60-2708 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung NO NO 64 L-Lower TCGA-60-2708-F5393 TCGA-60-2708 TCGA-60-2708-01A -23691 0 2447 NO NO 2010-7-16 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.5 NO NO Central Lung 1.4 NO 20 No M0 N1 T2 Stage IIB TCGA-60-2708.7f0ed176-146a-4ea2-8f39-36d402d74757.pdf 2708 TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 0.5 2003 YES NO YES 60 4 Lung A LIVING 2004 1963 TCGA-60-2708-01A-01D-1522-08 TCGA-60-2708-01A-01D-0848-05 55aa5a0a-1fb8-4420-bcee-cf281b36fdab TCGA-60-2708-01 TCGA-60-2708-01A-01D-1522-08 TCGA-60-2708-01 TCGA-60-2708-01A-01R-0851-07 55aa5a0a-1fb8-4420-bcee-cf281b36fdab d0490cd3-6df5-4e40-a10b-e3341d330714 TCGA-60-2708-01A-21-2193-20 TCGA-60-2708-01 TCGA-60-2708-01A-01D-0844-01 TCGA-60-2708-01 55aa5a0a-1fb8-4420-bcee-cf281b36fdab TCGA-60-2708-01 55aa5a0a-1fb8-4420-bcee-cf281b36fdab TCGA-60-2708-01 TCGA-60-2708-01A-01D-0844-01 64455e1c-360e-4627-8c8a-55c27c7705c3 +TCGA-60-2709-01 TCGA-60-2709-01 Squamous C2-Squamous-like cluster 1 Cluster 5 squamous c3 squamous-like c4 miRNA cluster 4 cluster 4 mutation cluster 12 TCGA-60-2709 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 69 L-Upper TCGA-60-2709-F14659 TCGA-60-2709 TCGA-60-2709-01A -25453 0 1505 NO NO Scheduled Follow-up Submission Complete Remission/Response 2011-8-4 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 1 NO NO Peripheral Lung 2 NO 157.5 No MX N0 T2 Stage IB TCGA-60-2709.f1e99e51-52e3-4f5d-b483-3c1b1eadd977.pdf 2709 TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 0.4 6th NO NO YES 60 2 Lung A LIVING 2004 1959 TCGA-60-2709-01A-21D-1817-08 87fc2c1d-3072-40fb-bc36-5b7a5604d4d7 TCGA-60-2709-01 TCGA-60-2709-01A-21D-1817-08 TCGA-60-2709-01 TCGA-60-2709-01 87fc2c1d-3072-40fb-bc36-5b7a5604d4d7 TCGA-60-2709-01A-22-2193-20 TCGA-60-2709-01 TCGA-60-2709-01A-21D-1816-01 87fc2c1d-3072-40fb-bc36-5b7a5604d4d7 87fc2c1d-3072-40fb-bc36-5b7a5604d4d7 TCGA-60-2709-01A-21D-1816-01 TCGA-60-2709-01A-21D-1818-05 6542146d-b4b9-4ed7-9fcf-b511ad1c43d7 +TCGA-60-2709-11 TCGA-60-2709-11 C2-Squamous-like mutation cluster 12 TCGA-60-2709 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 69 L-Upper TCGA-60-2709-F14659 TCGA-60-2709 TCGA-60-2709-11A -25453 0 1505 NO NO Scheduled Follow-up Submission Complete Remission/Response 2011-8-4 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.7 NO NO Peripheral Lung 1.5 NO 157.5 No MX N0 T2 Stage IB 2709 TUMOR FREE Complete Remission/Response NO R0 Solid Tissue Normal 11 0.5 6th NO NO YES 60 2 Lung A LIVING 2004 1959 aacc0084-c133-4dc9-80af-a3f6b74618d9 aacc0084-c133-4dc9-80af-a3f6b74618d9 aacc0084-c133-4dc9-80af-a3f6b74618d9 aacc0084-c133-4dc9-80af-a3f6b74618d9 +TCGA-60-2710-01 TCGA-60-2710-01 Squamous C2-Squamous-like cluster 3 Cluster 13 (HNSC-LUSC) squamous c3 squamous-like c4 miRNA cluster 7 cluster 2 mutation cluster 8 TCGA-60-2710 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 67 L-Upper TCGA-60-2710-F13275 TCGA-60-2710 -24669 0 2024 61 1 NO NO Complete Remission/Response 2011-6-16 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) Yes C34.1 8070/3 C34.1 YES 80 NO Peripheral Lung NO 63 No M0 N1 T1 Stage IIA 2710 Post-Adjuvant Therapy TUMOR FREE 67 61 Complete Remission/Response YES NO Primary Tumor 01 2005 6th YES NO YES 60 4 Lung LIVING 2005 1963 TCGA-60-2710-01A-01D-1522-08 TCGA-60-2710-01A-01D-0848-05 cdcd386e-cbf8-474e-a79e-666fffcadcd0 TCGA-60-2710-01 TCGA-60-2710-01A-01D-1522-08 TCGA-60-2710-01 TCGA-60-2710-01A-01R-0851-07 cdcd386e-cbf8-474e-a79e-666fffcadcd0 e807b8b7-0428-4cd0-ac63-eb5303659288 TCGA-60-2710-01A-21-2193-20 TCGA-60-2710-01 TCGA-60-2710-01A-01D-1969-01 TCGA-60-2710-01 cdcd386e-cbf8-474e-a79e-666fffcadcd0 TCGA-60-2710-01 cdcd386e-cbf8-474e-a79e-666fffcadcd0 TCGA-60-2710-01 TCGA-60-2710-01A-01D-1969-01 fe48e710-052c-48da-a9ba-7705e7451700 +TCGA-60-2711-01 TCGA-60-2711-01 Squamous C2-Squamous-like cluster 4 Cluster 13 (HNSC-LUSC) squamous c3 squamous-like c4 miRNA cluster 7 cluster 2 mutation cluster 5 TCGA-60-2711 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 64 R-Lower TCGA-60-2711-F13356 TCGA-60-2711 TCGA-60-2711-01A -23651 0 1260 0 NO NO Complete Remission/Response 2011-6-16 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.9 8070/3 C34.9 YES 0.9 NO 90 NO Peripheral Lung 1.3 NO 39 Yes M0 N0 T2 Stage IB TCGA-60-2711.efc8dedf-808c-4872-87a0-4249493f59b3.pdf 2711 Post-Adjuvant Therapy TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 0.3 2008 NO NO YES 60 4 Lung A LIVING 2007 1969 TCGA-60-2711-01A-01D-1522-08 TCGA-60-2711-01A-01D-0848-05 7e152b9b-7115-4800-864e-e8162d617661 TCGA-60-2711-01 TCGA-60-2711-01A-01D-1522-08 TCGA-60-2711-01 TCGA-60-2711-01A-01R-0851-07 7e152b9b-7115-4800-864e-e8162d617661 e1ac89e5-ca9c-47f2-b2a6-dce3fc2ce0f7 TCGA-60-2711-01A-21-2193-20 TCGA-60-2711-01 TCGA-60-2711-01A-01D-0844-01 TCGA-60-2711-01 7e152b9b-7115-4800-864e-e8162d617661 TCGA-60-2711-01 7e152b9b-7115-4800-864e-e8162d617661 TCGA-60-2711-01 TCGA-60-2711-01A-01D-0844-01 00a75e05-8928-432f-ae8f-3acbb88a182b +TCGA-60-2712-01 TCGA-60-2712-01 Squamous C2-Squamous-like cluster 4 Cluster 5 squamous c3 squamous-like c4 miRNA cluster 7 cluster 2 mutation c1uster 9 TCGA-60-2712 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung NO NO 79 L-Upper TCGA-60-2712-F5398 TCGA-60-2712 TCGA-60-2712-01A -29131 274 0 274 NO NO 2010-7-16 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.9 NO 0 NO Central Lung 0.9 NO 10 Yes M0 N1 T2 Stage IIB TCGA-60-2712.dc936761-8bc0-4f4d-ba51-d6c9c0009c3b.pdf 2712 Complete Remission/Response NO R0 Primary Tumor 01 0.5 1979 NO NO YES 60 3 Lung A DECEASED 2006 1959 TCGA-60-2712-01A-01D-1522-08 TCGA-60-2712-01A-01D-0848-05 02311dd2-115e-452f-a5de-b3230a51d7f2 TCGA-60-2712-01A-01D-1522-08 TCGA-60-2712-01 TCGA-60-2712-01A-01R-0851-07 02311dd2-115e-452f-a5de-b3230a51d7f2 85ff07f7-6144-46a4-9d37-f163b1897b31 TCGA-60-2712-01A-21-2193-20 TCGA-60-2712-01 TCGA-60-2712-01A-01D-0844-01 TCGA-60-2712-01 02311dd2-115e-452f-a5de-b3230a51d7f2 TCGA-60-2712-01 02311dd2-115e-452f-a5de-b3230a51d7f2 TCGA-60-2712-01A-01D-0844-01 048d4992-bd37-46bb-97c0-7cfaf69cc61d +TCGA-60-2713-01 TCGA-60-2713-01 Squamous C2-Squamous-like cluster 4 Low purity c2 squamous c3 squamous-like c4 miRNA cluster 4 cluster 2 mutation cluster 2 TCGA-60-2713 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung YES NO YES NO 64 R-Lower TCGA-60-2713-F13270 TCGA-60-2713 TCGA-60-2713-01A 1433 -23630 0 1731 1433 1 NO NO 2011-6-16 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.8 NO 70 NO 0.9 YES 110 No M0 N0 T2 Stage IB TCGA-60-2713.55688ea3-81a1-45bc-92c6-431f7a53a734.pdf 2713 Post-Adjuvant Therapy Partial Remission/Response NO R0 Primary Tumor 01 0.4 NO NO YES 60 2 Lung A LIVING 2006 1955 TCGA-60-2713-01A-01D-1522-08 TCGA-60-2713-01A-01D-0848-05 4d65f6a2-ba96-4ef3-9a47-13808922e76a TCGA-60-2713-01 TCGA-60-2713-01A-01D-1522-08 TCGA-60-2713-01 TCGA-60-2713-01A-01R-0851-07 4d65f6a2-ba96-4ef3-9a47-13808922e76a fe660ce3-73d4-418c-8059-5329ea73146b TCGA-60-2713-01A-21-2193-20 TCGA-60-2713-01 TCGA-60-2713-01A-01D-0844-01 TCGA-60-2713-01 4d65f6a2-ba96-4ef3-9a47-13808922e76a TCGA-60-2713-01 4d65f6a2-ba96-4ef3-9a47-13808922e76a TCGA-60-2713-01 TCGA-60-2713-01A-01D-0844-01 aef657e5-4555-4842-946a-7883c8f8b362 +TCGA-60-2714-01 TCGA-60-2714-01 High C1-LUAD-enriched Cluster 6 squamous c3 LUAD-like c10 miRNA c1uster 9 TCGA-60-2714 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 66 R-Upper TCGA-60-2714-F13259 TCGA-60-2714 TCGA-60-2714-01A -24169 0 1531 47 0 NO NO Complete Remission/Response 2011-6-16 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) Yes C34.9 8070/3 C34.9 YES 0.7 NO 100 NO Peripheral Lung 0.7 NO 90 No M0 N1 T2 Stage IIB TCGA-60-2714.8c5c0056-9ae8-42e2-8a8f-cdf2f7bbbaa6.pdf 2714 Adjuvant therapy TUMOR FREE 73 81 Complete Remission/Response YES NO R0 Primary Tumor 01 0.3 2005 6th YES NO YES 60 4 Lung A LIVING 2006 1960 TCGA-60-2714-01A-01D-0848-05 92157a18-814f-41b7-9c7f-7bdd1f76e464 TCGA-60-2714-01 TCGA-60-2714-01 TCGA-60-2714-01A-01R-0851-07 92157a18-814f-41b7-9c7f-7bdd1f76e464 a54a6486-05a3-4eca-b780-4d2ad2baaf31 TCGA-60-2714-01A-21-2193-20 TCGA-60-2714-01 TCGA-60-2714-01A-01D-0844-01 TCGA-60-2714-01 92157a18-814f-41b7-9c7f-7bdd1f76e464 TCGA-60-2714-01 92157a18-814f-41b7-9c7f-7bdd1f76e464 TCGA-60-2714-01 TCGA-60-2714-01A-01D-0844-01 089deb86-da03-40f6-83c0-c6cc33a47ab3 +TCGA-60-2715-01 TCGA-60-2715-01 High C2-Squamous-like cluster 4 Low purity c2 squamous-like c4 mutation c1uster 9 TCGA-60-2715 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 51 L-Upper TCGA-60-2715-F12843 TCGA-60-2715 TCGA-60-2715-01A -18990 1075 0 134 1 NO NO Progressive Disease 2011-6-9 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.4 NO 80 NO 0.5 NO 25 Yes M0 N0 T1 Stage IA TCGA-60-2715.3378cd9a-00ea-42f9-9884-a72a54f1dd32.pdf 2715 Adjuvant therapy WITH TUMOR 61 86 Progressive Disease YES YES RX Primary Tumor 01 0.3 2006 6th YES NO YES 60 4 Lung A DECEASED 2008 1983 TCGA-60-2715-01A-01D-1522-08 TCGA-60-2715-01A-01D-0848-05 0929665a-9dba-4744-ab13-fd483ff70c3a TCGA-60-2715-01A-01D-1522-08 TCGA-60-2715-01 TCGA-60-2715-01A-01R-0851-07 0929665a-9dba-4744-ab13-fd483ff70c3a 5b9f3ebc-2e88-4f04-af1f-378c3bbbaed4 TCGA-60-2715-01 TCGA-60-2715-01A-01D-0844-01 TCGA-60-2715-01 0929665a-9dba-4744-ab13-fd483ff70c3a TCGA-60-2715-01 0929665a-9dba-4744-ab13-fd483ff70c3a TCGA-60-2715-01A-01D-0844-01 +TCGA-60-2716-01 TCGA-60-2716-01 Quiet C2-Squamous-like Low purity c2 COADREAD-like c7 squamous-like c4 miRNA cluster 11 TCGA-60-2716 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 39 L-Upper TCGA-60-2716-F13256 TCGA-60-2716 TCGA-60-2716-01A -14345 0 1475 0 NO NO [Discrepancy] 2011-6-17 MALE Lung Papillary Squamous Cell Caricnoma No C34.9 8070/3 C34.9 YES 0.7 NO 90 NO Central Lung 1 NO No M0 N1 T2 Stage IIB TCGA-60-2716.de896266-23c5-469b-a219-bb523657b822.pdf 2716 Post-Adjuvant Therapy TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 0.3 YES NO YES 60 1 Lung A LIVING 2007 TCGA-60-2716-01A-01D-0848-05 0b16749a-54a1-47f0-9534-4c3428fc7504 TCGA-60-2716-01 TCGA-60-2716-01 TCGA-60-2716-01A-01R-0851-07 0b16749a-54a1-47f0-9534-4c3428fc7504 62095f60-39e8-4d0d-a717-5d97fd23d284 TCGA-60-2716-01A-21-2193-20 TCGA-60-2716-01 TCGA-60-2716-01A-01D-0844-01 TCGA-60-2716-01 0b16749a-54a1-47f0-9534-4c3428fc7504 TCGA-60-2716-01 0b16749a-54a1-47f0-9534-4c3428fc7504 TCGA-60-2716-01 TCGA-60-2716-01A-01D-0844-01 b1371353-26af-4c41-b52e-dc7a0848ec98 +TCGA-60-2719-01 TCGA-60-2719-01 Squamous C2-Squamous-like cluster 4 Cluster 5 squamous c3 squamous-like c4 miRNA cluster 12 cluster 3 mutation cluster 13 TCGA-60-2719 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 83 R-Upper TCGA-60-2719-F13255 TCGA-60-2719 TCGA-60-2719-01A -30379 0 1297 2 NO NO Complete Remission/Response 2011-6-17 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.9 8070/3 C34.9 YES 1 NO 60 NO Central Lung 1.2 NO 7 No M0 N0 T1 Stage IB TCGA-60-2719.1843b1c7-9197-4595-ad5d-862e0f1ec3f8.pdf 2719 Post-Adjuvant Therapy TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 0.3 1978 NO NO YES 60 3 Lung A LIVING 2007 1950 TCGA-60-2719-01A-01D-1522-08 TCGA-60-2719-01A-01D-0848-05 b5e61a38-2067-473e-8eb3-0d8c259b7e67 TCGA-60-2719-01 TCGA-60-2719-01A-01D-1522-08 TCGA-60-2719-01 TCGA-60-2719-01A-01R-0851-07 b5e61a38-2067-473e-8eb3-0d8c259b7e67 fe5e997f-d5e3-42e4-a4f1-f21e78a7dcfe TCGA-60-2719-01A-21-2193-20 TCGA-60-2719-01 TCGA-60-2719-01A-01D-0844-01 TCGA-60-2719-01 b5e61a38-2067-473e-8eb3-0d8c259b7e67 TCGA-60-2719-01 b5e61a38-2067-473e-8eb3-0d8c259b7e67 TCGA-60-2719-01 TCGA-60-2719-01A-01D-0844-01 7d294b6d-9ac2-4e67-a2e0-5a7530db840c +TCGA-60-2720-01 TCGA-60-2720-01 Squamous C2-Squamous-like cluster 4 Cluster 5 squamous c3 squamous-like c4 miRNA cluster 4 cluster 2 mutation cluster 8 TCGA-60-2720 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung NO NO 60 R-Lower TCGA-60-2720-F8616 TCGA-60-2720 TCGA-60-2720-01A -22238 0 97 NO NO 2010-7-19 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.6 NO NO Central Lung 1.2 110 No M0 N0 T2 Stage IB TCGA-60-2720.02b1ae97-4962-46c8-9672-0597bdc85705.pdf 2720 TUMOR FREE R0 Primary Tumor 01 0.2 2007 YES NO YES 60 4 Lung A LIVING 2007 1967 TCGA-60-2720-01A-01D-1522-08 TCGA-60-2720-01A-01D-0848-05 590b397c-38e0-4d77-9c7c-0d6cde2e5757 TCGA-60-2720-01 TCGA-60-2720-01A-01D-1522-08 TCGA-60-2720-01 TCGA-60-2720-01A-01R-0851-07 590b397c-38e0-4d77-9c7c-0d6cde2e5757 46647c43-fc82-455f-9d72-9d54d8a454db TCGA-60-2720-01A-21-2193-20 TCGA-60-2720-01 TCGA-60-2720-01A-01D-1969-01 TCGA-60-2720-01 590b397c-38e0-4d77-9c7c-0d6cde2e5757 TCGA-60-2720-01 590b397c-38e0-4d77-9c7c-0d6cde2e5757 TCGA-60-2720-01 TCGA-60-2720-01A-01D-1969-01 2c8e7971-12b3-4301-856d-38e55ed745d5 +TCGA-60-2721-01 TCGA-60-2721-01 Squamous C2-Squamous-like cluster 4 Cluster 5 squamous c3 squamous-like c4 miRNA cluster 11 cluster 1 mutation cluster 5 TCGA-60-2721 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung NO NO 73 R-Upper TCGA-60-2721-F5407 TCGA-60-2721 TCGA-60-2721-01A -27007 0 983 1 NO NO 2010-7-20 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 1 NO 70 NO Central Lung 1.2 NO 93 Yes M0 N0 T2 Stage IB TCGA-60-2721.1447d27e-c268-4bc6-8919-b13878f8e862.pdf 2721 Post-Adjuvant Therapy TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 0.4 2008 NO NO YES 60 4 Lung A LIVING 2008 1946 TCGA-60-2721-01A-01D-1522-08 TCGA-60-2721-01A-01D-0848-05 ac70793d-cc2c-48c8-a6f7-12b4c319364a TCGA-60-2721-01 TCGA-60-2721-01A-01D-1522-08 TCGA-60-2721-01 TCGA-60-2721-01A-01R-0851-07 ac70793d-cc2c-48c8-a6f7-12b4c319364a 05718209-674a-4744-98a9-3ff09fb66cf9 TCGA-60-2721-01A-21-2193-20 TCGA-60-2721-01 TCGA-60-2721-01A-01D-0844-01 TCGA-60-2721-01 ac70793d-cc2c-48c8-a6f7-12b4c319364a TCGA-60-2721-01 ac70793d-cc2c-48c8-a6f7-12b4c319364a TCGA-60-2721-01 TCGA-60-2721-01A-01D-0844-01 d292d1eb-ee65-4573-8662-faedf11fa9ad +TCGA-60-2722-01 TCGA-60-2722-01 BRCA-LUAD+ C2-Squamous-like cluster 3 BRCA CIMP c7 squamous-like c4 miRNA cluster 11 cluster 1 mutation cluster 5 TCGA-60-2722 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung YES [Discrepancy] NO 66 R-Upper TCGA-60-2722-F5408 TCGA-60-2722 TCGA-60-2722-01A -24267 0 908 851 NO NO 2010-7-20 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.5 NO NO Central Lung 0.6 YES 90 No M0 N1 T2 Stage IIB TCGA-60-2722.1695c98e-f870-4a29-8987-acb46860b525.pdf 2722 TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 0.4 2008 YES NO YES 60 4 Lung A LIVING 2008 TCGA-60-2722-01A-01D-1522-08 TCGA-60-2722-01A-01D-0848-05 afac7352-d5be-4b87-baf0-0d22e761872b TCGA-60-2722-01 TCGA-60-2722-01A-01D-1522-08 TCGA-60-2722-01 TCGA-60-2722-01A-01R-0851-07 afac7352-d5be-4b87-baf0-0d22e761872b 8f6581d2-1ed7-448c-989d-b7d6817dd813 TCGA-60-2722-01 TCGA-60-2722-01A-01D-0844-01 TCGA-60-2722-01 afac7352-d5be-4b87-baf0-0d22e761872b TCGA-60-2722-01 afac7352-d5be-4b87-baf0-0d22e761872b TCGA-60-2722-01 TCGA-60-2722-01A-01D-0844-01 +TCGA-60-2723-01 TCGA-60-2723-01 High C2-Squamous-like cluster 1 Cluster 13 (HNSC-LUSC) squamous-like c4 miRNA cluster 4 cluster 2 mutation cluster 8 TCGA-60-2723 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 74 R-Middle TCGA-60-2723-F13248 TCGA-60-2723 TCGA-60-2723-01A -27225 0 1092 2 NO NO Complete Remission/Response 2011-6-17 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.9 8070/3 C34.9 YES 0.4 NO 60 NO Peripheral Lung 1.2 NO 58 No M0 N0 T2 Stage IB TCGA-60-2723.681ea3dd-7685-4dc2-aa6c-73de2ae4cc60.pdf 2723 Post-Adjuvant Therapy TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 0.3 2008 NO NO YES 60 4 Lung A LIVING 2008 1949 TCGA-60-2723-01A-01D-1522-08 TCGA-60-2723-01A-01D-0848-05 1eb4fd74-0fa3-4ec9-8fc4-aa5d26a5f690 TCGA-60-2723-01 TCGA-60-2723-01A-01D-1522-08 TCGA-60-2723-01 TCGA-60-2723-01A-01R-0851-07 1eb4fd74-0fa3-4ec9-8fc4-aa5d26a5f690 7bf75590-cadb-40c9-9fef-1c10fcb82ebc TCGA-60-2723-01 TCGA-60-2723-01A-01D-0844-01 TCGA-60-2723-01 1eb4fd74-0fa3-4ec9-8fc4-aa5d26a5f690 TCGA-60-2723-01 1eb4fd74-0fa3-4ec9-8fc4-aa5d26a5f690 TCGA-60-2723-01 TCGA-60-2723-01A-01D-0844-01 +TCGA-60-2724-01 TCGA-60-2724-01 Squamous C2-Squamous-like cluster 4 Cluster 5 squamous c3 squamous-like c4 miRNA c1uster 9 cluster 2 mutation cluster 2 TCGA-60-2724 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 47 Bronchial TCGA-60-2724-F5411 TCGA-60-2724 TCGA-60-2724-01A -17462 0 717 NO NO 2010-7-20 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.9 8070/3 C34.9 YES 0.9 NO NO 1.5 NO 60 No M0 N1 T3 Stage IIIA TCGA-60-2724.7a4d6104-67c3-4cbc-ab20-34babe747aba.pdf 2724 TUMOR FREE NO R0 Primary Tumor 01 0.4 2006 YES NO YES 60 4 Lung A LIVING 2008 1976 TCGA-60-2724-01A-01D-1522-08 TCGA-60-2724-01A-01D-0848-05 c3c18dde-e425-48c9-a6d6-6d55c31147f3 TCGA-60-2724-01 TCGA-60-2724-01A-01D-1522-08 TCGA-60-2724-01 TCGA-60-2724-01A-01R-0851-07 c3c18dde-e425-48c9-a6d6-6d55c31147f3 00d8a595-ef67-48f7-88bf-a03ea36e7b33 TCGA-60-2724-01A-21-2193-20 TCGA-60-2724-01 TCGA-60-2724-01A-01D-0844-01 TCGA-60-2724-01 c3c18dde-e425-48c9-a6d6-6d55c31147f3 TCGA-60-2724-01 c3c18dde-e425-48c9-a6d6-6d55c31147f3 TCGA-60-2724-01 TCGA-60-2724-01A-01D-0844-01 ec285ff7-4d23-4739-9946-065f534d6fe8 +TCGA-60-2725-01 TCGA-60-2725-01 Kirc+ C2-Squamous-like cluster 4 Cluster 5 squamous c3 squamous-like c4 miRNA c1uster 9 cluster 2 mutation c1uster 9 TCGA-60-2725 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 74 L-Upper TCGA-60-2725-F12454 TCGA-60-2725 -27073 0 816 0 NO NO Complete Remission/Response 2011-6-2 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 90 NO Central Lung NO 56 No M0 N0 T2 Stage IB 2725 Post-Adjuvant Therapy TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 1978 NO NO YES 60 3 Lung LIVING 2009 1950 TCGA-60-2725-01A-01D-1267-08 TCGA-60-2725-01A-01D-1198-05 d540849d-46de-4d86-b93e-c4eb220d9dd1 TCGA-60-2725-01 TCGA-60-2725-01A-01D-1267-08 TCGA-60-2725-01 TCGA-60-2725-01A-01R-1201-07 d540849d-46de-4d86-b93e-c4eb220d9dd1 c7637861-2739-4d56-aae6-94ba80f76d5a TCGA-60-2725-01A-21-2193-20 TCGA-60-2725-01 TCGA-60-2725-01A-01D-1195-01 TCGA-60-2725-01 d540849d-46de-4d86-b93e-c4eb220d9dd1 TCGA-60-2725-01 d540849d-46de-4d86-b93e-c4eb220d9dd1 TCGA-60-2725-01 TCGA-60-2725-01A-01D-1195-01 dc18de9c-9edf-48c8-9a00-3598aad84aa5 +TCGA-60-2726-01 TCGA-60-2726-01 High C2-Squamous-like cluster 4 Cluster 5 squamous c3 squamous-like c4 mutation cluster 4 TCGA-60-2726 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung NO NO 56 R-Middle TCGA-60-2726-F5413 TCGA-60-2726 TCGA-60-2726-01A -20618 358 0 358 NO NO 2010-7-20 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.2 8070/3 C34.2 YES 0.8 NO 0 NO Central Lung 1 NO 42 No M0 N1 T2 Stage IIA TCGA-60-2726.ef1d119f-abc8-4adf-bc23-53141a65cfff.pdf 2726 TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 0.3 2009 NO NO YES 60 4 Lung A DECEASED 2009 1967 TCGA-60-2726-01A-01D-1522-08 TCGA-60-2726-01A-01D-0848-05 7642842f-8f88-4ac5-a393-ec2d37655033 TCGA-60-2726-01A-01D-1522-08 TCGA-60-2726-01 TCGA-60-2726-01A-01R-0851-07 7642842f-8f88-4ac5-a393-ec2d37655033 6857a9d3-c4b9-43c3-9c4b-111efb1402e3 TCGA-60-2726-01A-21-2193-20 TCGA-60-2726-01 TCGA-60-2726-01A-01D-0844-01 TCGA-60-2726-01 7642842f-8f88-4ac5-a393-ec2d37655033 TCGA-60-2726-01 7642842f-8f88-4ac5-a393-ec2d37655033 TCGA-60-2726-01A-01D-0844-01 49bf0bf2-031f-4d67-83a4-abc14322c298 +TCGA-63-5128-01 TCGA-63-5128-01 Squamous C2-Squamous-like cluster 3 Cluster 13 (HNSC-LUSC) squamous c3 squamous-like c4 miRNA cluster 11 cluster 1 mutation cluster 8 TCGA-63-5128 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung NO NO NO L-Upper TCGA-63-5128-F11740 TCGA-63-5128 TCGA-63-5128-01A NO NO Progressive Disease 2011-4-4 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.8 NO NO 1.1 YES No M0 N0 T2 Stage IB TCGA-63-5128.0883f7aa-5aa8-45d8-89b2-6279d2088c72.pdf 5128 Adjuvant therapy WITH TUMOR 60 Complete Remission/Response NO R0 Primary Tumor 01 0.4 2002 6th NO NO YES 63 4 Lung A DECEASED 2007 TCGA-63-5128-01A-01D-1441-08 4609abbc-9257-40f5-aaa3-176ab36ddd51 TCGA-63-5128-01 TCGA-63-5128-01A-01D-1441-08 TCGA-63-5128-01 TCGA-63-5128-01A-01R-1443-07 4609abbc-9257-40f5-aaa3-176ab36ddd51 TCGA-63-5128-01A-21-2194-20 TCGA-63-5128-01 TCGA-63-5128-01A-01D-1439-01 TCGA-63-5128-01 4609abbc-9257-40f5-aaa3-176ab36ddd51 TCGA-63-5128-01 4609abbc-9257-40f5-aaa3-176ab36ddd51 TCGA-63-5128-01 TCGA-63-5128-01A-01D-1439-01 TCGA-63-5128-01A-01D-1440-05 c514a02d-1b88-48ad-8d47-e225eda23780 +TCGA-63-5131-01 TCGA-63-5131-01 Squamous C2-Squamous-like cluster 4 Cluster 5 squamous c3 squamous-like c4 miRNA cluster 4 cluster 2 mutation cluster 5 TCGA-63-5131 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung R-Lower TCGA-63-5131-F11737 TCGA-63-5131 TCGA-63-5131-01A NO NO Complete Remission/Response 2011-4-6 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.9 8070/3 C34.9 YES 0.6 NO 0 NO Central Lung 1.2 NO 50 No M0 N1 T2 Stage IIB TCGA-63-5131.de9fb170-d3d9-4642-a3d3-60639889df2d.pdf 5131 TUMOR FREE 60 Complete Remission/Response YES NO R0 Primary Tumor 01 0.6 2001 6th NO NO YES 63 4 Lung A DECEASED 2008 TCGA-63-5131-01A-01D-1441-08 d998fb64-f09e-462e-b7c4-d2e63e56a553 TCGA-63-5131-01 TCGA-63-5131-01A-01D-1441-08 TCGA-63-5131-01 TCGA-63-5131-01A-01R-1443-07 d998fb64-f09e-462e-b7c4-d2e63e56a553 TCGA-63-5131-01A-21-2194-20 TCGA-63-5131-01 TCGA-63-5131-01A-01D-1439-01 TCGA-63-5131-01 d998fb64-f09e-462e-b7c4-d2e63e56a553 TCGA-63-5131-01 d998fb64-f09e-462e-b7c4-d2e63e56a553 TCGA-63-5131-01 TCGA-63-5131-01A-01D-1439-01 TCGA-63-5131-01A-01D-1440-05 494e308b-4cd4-44ac-b556-9ea1a95be212 +TCGA-63-6202-01 TCGA-63-6202-01 High C1-LUAD-enriched cluster 1 Cluster 6 squamous c3 LUAD-like c10 miRNA cluster 4 cluster 4 mutation cluster 2 TCGA-63-6202 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung R-Upper TCGA-63-6202-F48025 TCGA-63-6202 TCGA-63-6202-01A 1602 1 Scheduled Follow-up Submission Complete Remission/Response 2013-9-4 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.5 NO Central Lung 1 NO NO 35 No M0 N0 T2 Stage IIA TCGA-63-6202.b8730165-2c60-469b-ae9a-f630fd97016a.pdf 6202 Preoperative TUMOR FREE Complete Remission/Response YES NO R0 Primary Tumor 01 0.4 2008 6th NO NO YES 63 4 Lung A LIVING 2008 1973 TCGA-63-6202-01A-11D-1817-08 a82887c2-9f01-41c0-8c74-2063aaf97261 TCGA-63-6202-01 TCGA-63-6202-01A-11D-1817-08 TCGA-63-6202-01 TCGA-63-6202-01 a82887c2-9f01-41c0-8c74-2063aaf97261 TCGA-63-6202-01A-13-2194-20 TCGA-63-6202-01 TCGA-63-6202-01A-11D-1816-01 a82887c2-9f01-41c0-8c74-2063aaf97261 a82887c2-9f01-41c0-8c74-2063aaf97261 TCGA-63-6202-01A-11D-1816-01 TCGA-63-6202-01A-11D-1818-05 52080758-70e0-4463-8ef4-ebb8ba5e19d2 +TCGA-63-7020-01 TCGA-63-7020-01 High C2-Squamous-like Cluster 5 squamous c3 squamous-like c4 miRNA cluster 4 TCGA-63-7020 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung R-Upper TCGA-63-7020-F48027 TCGA-63-7020 TCGA-63-7020-01A 2133 93 1 Scheduled Follow-up Submission Complete Remission/Response 2013-9-4 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.5 NO Peripheral Lung 0.8 NO NO 50 No M0 N0 T1 Stage IA TCGA-63-7020.16835e39-755e-4959-9014-7946bb7fed2d.pdf 7020 Other TUMOR FREE Complete Remission/Response YES NO R0 Primary Tumor 01 0.4 2010 6th NO NO YES 63 4 Lung A LIVING 2007 1957 5f76cbbf-fb21-4ec7-8ff3-5f7baf16488d TCGA-63-7020-01 TCGA-63-7020-01 TCGA-63-7020-01 5f76cbbf-fb21-4ec7-8ff3-5f7baf16488d TCGA-63-7020-01A-13-2194-20 TCGA-63-7020-01 TCGA-63-7020-01A-11D-1943-01 5f76cbbf-fb21-4ec7-8ff3-5f7baf16488d 5f76cbbf-fb21-4ec7-8ff3-5f7baf16488d TCGA-63-7020-01A-11D-1943-01 TCGA-63-7020-01A-11D-1947-05 ff0190fb-eb34-4331-9068-2c02bf067253 +TCGA-63-7021-01 TCGA-63-7021-01 Squamous C2-Squamous-like Low purity c2 squamous c3 squamous-like c4 miRNA cluster 11 TCGA-63-7021 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung NO NO L-Upper TCGA-63-7021-F48028 TCGA-63-7021 TCGA-63-7021-01A 2142 1503 62 0 Scheduled Follow-up Submission Complete Remission/Response 2013-9-4 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.4 NO Peripheral Lung 0.7 NO New Primary Tumor YES 21 No M0 N0 T1 Stage IA TCGA-63-7021.c5d87b3e-b93b-4a74-aee0-966187b1999e.pdf 7021 Other TUMOR FREE Complete Remission/Response YES NO R0 Primary Tumor 01 0.3 2007 6th NO NO YES 63 4 Lung A LIVING 2007 1955 18278118-50d2-4f87-9892-54d40d81391c TCGA-63-7021-01 TCGA-63-7021-01 TCGA-63-7021-01 18278118-50d2-4f87-9892-54d40d81391c TCGA-63-7021-01A-13-2194-20 TCGA-63-7021-01 TCGA-63-7021-01A-11D-1943-01 18278118-50d2-4f87-9892-54d40d81391c 18278118-50d2-4f87-9892-54d40d81391c TCGA-63-7021-01A-11D-1943-01 TCGA-63-7021-01A-11D-1947-05 81db3e1a-0540-49d0-a6fa-c2561c14fe7c +TCGA-63-7022-01 TCGA-63-7022-01 High C2-Squamous-like Low purity c2 squamous c3 squamous-like c4 miRNA cluster 7 TCGA-63-7022 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung L-Upper TCGA-63-7022-F48029 TCGA-63-7022 TCGA-63-7022-01A 2073 0 Scheduled Follow-up Submission Complete Remission/Response 2013-9-4 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.5 NO Peripheral Lung 0.9 NO NO 30 No M0 N0 T1 Stage IA TCGA-63-7022.ae7a8f69-0082-4dbe-839b-e16b5875c6e4.pdf 7022 Other TUMOR FREE Complete Remission/Response YES NO R0 Primary Tumor 01 0.4 2007 6th NO NO YES 63 4 Lung A LIVING 2007 1947 df4110b6-3360-4c78-bb4f-89ae7cffba0c TCGA-63-7022-01 TCGA-63-7022-01 TCGA-63-7022-01 df4110b6-3360-4c78-bb4f-89ae7cffba0c TCGA-63-7022-01A-13-2194-20 TCGA-63-7022-01 TCGA-63-7022-01A-11D-1943-01 df4110b6-3360-4c78-bb4f-89ae7cffba0c df4110b6-3360-4c78-bb4f-89ae7cffba0c TCGA-63-7022-01A-11D-1943-01 TCGA-63-7022-01A-11D-1947-05 51130a95-5996-4288-ab16-504f6d8b8314 +TCGA-63-7023-01 TCGA-63-7023-01 Squamous C2-Squamous-like Cluster 5 squamous c3 squamous-like c4 TCGA-63-7023 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung L-Lower TCGA-63-7023-F48030 TCGA-63-7023 TCGA-63-7023-01A 1682 70 1 Scheduled Follow-up Submission Complete Remission/Response 2013-9-4 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.8 NO Central Lung 1 NO NO 55 No M0 N1 T1 Stage IIA TCGA-63-7023.ed241575-c4e4-44c8-9692-428b82be431d.pdf 7023 Other TUMOR FREE 87 Complete Remission/Response YES YES R0 Primary Tumor 01 0.5 2008 6th YES NO YES 63 4 Lung A LIVING 2008 1952 8322db3e-e34c-469a-becd-a29ce4676473 TCGA-63-7023-01 8322db3e-e34c-469a-becd-a29ce4676473 TCGA-63-7023-01A-13-2194-20 TCGA-63-7023-01 TCGA-63-7023-01A-11D-1943-01 8322db3e-e34c-469a-becd-a29ce4676473 8322db3e-e34c-469a-becd-a29ce4676473 TCGA-63-7023-01A-11D-1943-01 TCGA-63-7023-01A-11D-1947-05 ab830587-6698-4cd1-9690-d620819ef10f +TCGA-63-A5M9-01 TCGA-63-A5M9-01 TCGA-63-A5M9 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung L-Lower TCGA-63-A5M9-F64766 TCGA-63-A5M9 TCGA-63-A5M9-01A 0 Scheduled Follow-up Submission 2014-9-11 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 40 NO YES 25 false M0 N1 T2 Stage IIB TCGA-63-A5M9.4125B48F-3D99-41B5-951A-6A7AF253DF1E.pdf A5M9 RX Primary Tumor 01 2010 6th NO YES 63 4 Lung A LIVING 9e35f111-e7b9-4238-bbfb-88a74d51f1b4 TCGA-63-A5M9-01 TCGA-63-A5M9-01 TCGA-63-A5M9-01 9e35f111-e7b9-4238-bbfb-88a74d51f1b4 TCGA-63-A5M9-01 TCGA-63-A5M9-01A-11D-A26L-01 9e35f111-e7b9-4238-bbfb-88a74d51f1b4 9e35f111-e7b9-4238-bbfb-88a74d51f1b4 TCGA-63-A5M9-01A-11D-A26L-01 TCGA-63-A5M9-01A-11D-A26N-05 +TCGA-63-A5MB-01 TCGA-63-A5MB-01 TCGA-63-A5MB TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 62 L-Upper TCGA-63-A5MB-F64768 TCGA-63-A5MB TCGA-63-A5MB-01A -22930 3123 NO NO Scheduled Follow-up Submission Complete Remission/Response 2014-9-11 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 210 NO NO NO NO 25 false No M0 N0 T2 Stage IB TCGA-63-A5MB.D830087F-913A-4E59-9EC4-A230E613B0DF.pdf A5MB TUMOR FREE Complete Remission/Response NO NO R0 Primary Tumor 01 1995 6th YES NO YES 63 3 Lung A LIVING 79fd09d5-1323-4370-b6fb-b8c01d9db6e9 TCGA-63-A5MB-01 TCGA-63-A5MB-01 TCGA-63-A5MB-01 79fd09d5-1323-4370-b6fb-b8c01d9db6e9 TCGA-63-A5MB-01 TCGA-63-A5MB-01A-11D-A26L-01 79fd09d5-1323-4370-b6fb-b8c01d9db6e9 79fd09d5-1323-4370-b6fb-b8c01d9db6e9 TCGA-63-A5MB-01A-11D-A26L-01 TCGA-63-A5MB-01A-11D-A26N-05 6E58BE6E-D89E-40DA-AC20-4E131CA16A02 +TCGA-63-A5MG-01 TCGA-63-A5MG-01 TCGA-63-A5MG TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 68 L-Lower TCGA-63-A5MG-F64777 TCGA-63-A5MG TCGA-63-A5MG-01A -24957 2148 NO Scheduled Follow-up Submission Complete Remission/Response 2014-9-11 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 120 NO NO NO NO false No M0 N0 T2 Stage IB TCGA-63-A5MG.5D9D3CB6-1FE3-4DAE-8C36-C94D802E430F.pdf A5MG TUMOR FREE Complete Remission/Response NO NO R0 Primary Tumor 01 1990 6th NO NO YES 63 3 Lung A LIVING 1cd8c21c-72a5-40df-9b65-3006bebdfa86 TCGA-63-A5MG-01 TCGA-63-A5MG-01 TCGA-63-A5MG-01 1cd8c21c-72a5-40df-9b65-3006bebdfa86 TCGA-63-A5MG-01 TCGA-63-A5MG-01A-12D-A27J-01 1cd8c21c-72a5-40df-9b65-3006bebdfa86 1cd8c21c-72a5-40df-9b65-3006bebdfa86 TCGA-63-A5MG-01A-12D-A27J-01 TCGA-63-A5MG-01A-12D-A27L-05 EC2735B6-75E6-4DD8-B1D7-93E27C608D16 +TCGA-63-A5MH-01 TCGA-63-A5MH-01 TCGA-63-A5MH TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 68 L-Lower TCGA-63-A5MH-F64779 TCGA-63-A5MH TCGA-63-A5MH-01A -25159 2026 NO NO Scheduled Follow-up Submission Complete Remission/Response 2014-9-11 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 80 NO NO NO NO 35 false Yes, History of Synchronous/Bilateral Malignancy M0 N0 T1 Stage IA TCGA-63-A5MH.E96A18CD-781D-49AD-BE80-91B42A3C6868.pdf A5MH TUMOR FREE Complete Remission/Response NO NO R0 Primary Tumor 01 6th NO NO YES 63 5 Lung A LIVING 76e9e0bd-c2d9-4659-b71e-c913094adc93 TCGA-63-A5MH-01 TCGA-63-A5MH-01 TCGA-63-A5MH-01 76e9e0bd-c2d9-4659-b71e-c913094adc93 TCGA-63-A5MH-01 TCGA-63-A5MH-01A-12D-A27J-01 76e9e0bd-c2d9-4659-b71e-c913094adc93 76e9e0bd-c2d9-4659-b71e-c913094adc93 TCGA-63-A5MH-01A-12D-A27J-01 TCGA-63-A5MH-01A-12D-A27L-05 +TCGA-63-A5MI-01 TCGA-63-A5MI-01 TCGA-63-A5MI TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 65 Bronchial TCGA-63-A5MI-F64782 TCGA-63-A5MI TCGA-63-A5MI-01A -24040 1784 NO NO Scheduled Follow-up Submission Complete Remission/Response 2014-9-11 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 230 NO NO Peripheral Lung NO NO 50 false No M0 N2 T2 Stage IIIA TCGA-63-A5MI.2B06F8A1-CAA2-4796-9FE0-DD46866654FB.pdf A5MI TUMOR FREE Complete Remission/Response YES NO R0 Primary Tumor 01 2008 6th YES NO YES 63 4 Lung A LIVING 56947d0d-2959-4746-9955-e085fd9afc32 TCGA-63-A5MI-01 TCGA-63-A5MI-01 TCGA-63-A5MI-01 56947d0d-2959-4746-9955-e085fd9afc32 TCGA-63-A5MI-01 TCGA-63-A5MI-01A-12D-A27J-01 56947d0d-2959-4746-9955-e085fd9afc32 56947d0d-2959-4746-9955-e085fd9afc32 TCGA-63-A5MI-01A-12D-A27J-01 TCGA-63-A5MI-01A-12D-A27L-05 1EEF26E7-D62E-482E-A39A-B17A21B4651F +TCGA-63-A5MJ-01 TCGA-63-A5MJ-01 TCGA-63-A5MJ TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 54 Other (please specify) Left lung, main bronchus TCGA-63-A5MJ-F64785 TCGA-63-A5MJ TCGA-63-A5MJ-01A -20018 1824 NO NO Scheduled Follow-up Submission Complete Remission/Response 2014-9-11 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.9 8070/3 C34.9 YES 90 NO NO NO NO false No M0 N1 T2 Stage IIB TCGA-63-A5MJ.3F93AE77-BCC1-45CE-B5BC-1ED86C002A88.pdf A5MJ TUMOR FREE Complete Remission/Response YES NO R0 Primary Tumor 01 6th YES NO YES 63 2 Lung A LIVING 1989 518b950c-2097-407c-afa5-a4779cb221aa TCGA-63-A5MJ-01 TCGA-63-A5MJ-01 TCGA-63-A5MJ-01 518b950c-2097-407c-afa5-a4779cb221aa TCGA-63-A5MJ-01 TCGA-63-A5MJ-01A-11D-A27J-01 518b950c-2097-407c-afa5-a4779cb221aa 518b950c-2097-407c-afa5-a4779cb221aa TCGA-63-A5MJ-01A-11D-A27J-01 TCGA-63-A5MJ-01A-11D-A27L-05 6CEC8D89-8545-4E4B-90D4-97F970C86DC3 +TCGA-63-A5ML-01 TCGA-63-A5ML-01 TCGA-63-A5ML TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 68 R-Lower TCGA-63-A5ML-F64786 TCGA-63-A5ML TCGA-63-A5ML-01A -24947 1386 NO NO Scheduled Follow-up Submission Complete Remission/Response 2014-9-11 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 280 NO NO NO NO 60 false No M0 N0 T2 Stage IB TCGA-63-A5ML.F595F7AB-559C-4FEF-A49A-E7B7DB8E9352.pdf A5ML TUMOR FREE Complete Remission/Response YES NO R0 Primary Tumor 01 2009 6th YES NO YES 63 4 Lung A LIVING f8dc8adc-22a6-4b4d-afd7-53a7c766c8cf TCGA-63-A5ML-01 TCGA-63-A5ML-01 TCGA-63-A5ML-01 f8dc8adc-22a6-4b4d-afd7-53a7c766c8cf TCGA-63-A5ML-01 TCGA-63-A5ML-01A-31D-A27J-01 f8dc8adc-22a6-4b4d-afd7-53a7c766c8cf f8dc8adc-22a6-4b4d-afd7-53a7c766c8cf TCGA-63-A5ML-01A-31D-A27J-01 TCGA-63-A5ML-01A-31D-A27L-05 A7503F24-73B6-4429-B265-EABDBADA32C6 +TCGA-63-A5MM-01 TCGA-63-A5MM-01 TCGA-63-A5MM TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung NO YES NO NO 69 Bronchial TCGA-63-A5MM-F64990 TCGA-63-A5MM TCGA-63-A5MM-01A -25348 456 218 88 NO NO Scheduled Follow-up Submission Progressive Disease 2014-9-17 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.8 8070/3 C34.8 YES 230 NO NO NO YES 30 false No M0 N1 T2 Stage IIB TCGA-63-A5MM.5174B6E7-5492-4E02-99D2-CD23D456E7F0.pdf A5MM WITH TUMOR 79 Complete Remission/Response YES NO R0 Primary Tumor 01 1989 6th YES NO YES 63 3 Lung A DECEASED 87f18dcb-093e-4dac-91e1-73183fc6a0d9 TCGA-63-A5MM-01 TCGA-63-A5MM-01 TCGA-63-A5MM-01 87f18dcb-093e-4dac-91e1-73183fc6a0d9 TCGA-63-A5MM-01 TCGA-63-A5MM-01A-11D-A26L-01 87f18dcb-093e-4dac-91e1-73183fc6a0d9 87f18dcb-093e-4dac-91e1-73183fc6a0d9 TCGA-63-A5MM-01A-11D-A26L-01 TCGA-63-A5MM-01A-11D-A26N-05 A571E38C-E7DF-4D4B-BD0B-4D5316CD9022 +TCGA-63-A5MN-01 TCGA-63-A5MN-01 TCGA-63-A5MN TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung NO NO NO NO 78 R-Upper TCGA-63-A5MN-F64991 TCGA-63-A5MN TCGA-63-A5MN-01A -28677 345 320 103 NO NO Scheduled Follow-up Submission Progressive Disease 2014-9-17 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 490 NO NO NO YES false No M0 N0 T3 Stage IIB TCGA-63-A5MN.DE0BDA98-3AB9-4CED-AB54-81226E239786.pdf A5MN WITH TUMOR 87 Complete Remission/Response YES YES R1 Primary Tumor 01 6th NO NO YES 63 1 Lung A DECEASED 6c120b12-014b-4722-9b9d-b37de6d3d8c0 TCGA-63-A5MN-01 TCGA-63-A5MN-01 TCGA-63-A5MN-01 6c120b12-014b-4722-9b9d-b37de6d3d8c0 TCGA-63-A5MN-01 TCGA-63-A5MN-01A-22D-A27J-01 6c120b12-014b-4722-9b9d-b37de6d3d8c0 6c120b12-014b-4722-9b9d-b37de6d3d8c0 TCGA-63-A5MN-01A-22D-A27J-01 TCGA-63-A5MN-01A-22D-A27L-05 10490DC7-68C0-4D3D-98B9-96DBA4604BC8 +TCGA-63-A5MP-01 TCGA-63-A5MP-01 TCGA-63-A5MP TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 56 R-Lower TCGA-63-A5MP TCGA-63-A5MP-01A -20818 769 66 0 NO NO 2013-9-24 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 150 NO NO Central Lung YES 41 false No M0 N1 T2 Stage IIB TCGA-63-A5MP.FCF08990-AEB1-437F-A6A5-29DC710B49B5.pdf A5MP Preoperative WITH TUMOR 62 Complete Remission/Response YES YES R0 Primary Tumor 01 1997 6th YES NO YES 63 4 Lung A LIVING 1956 e421b4a8-d6e0-4c30-adc2-1311d04f7696 TCGA-63-A5MP-01 TCGA-63-A5MP-01 TCGA-63-A5MP-01 e421b4a8-d6e0-4c30-adc2-1311d04f7696 TCGA-63-A5MP-01 TCGA-63-A5MP-01A-11D-A26L-01 e421b4a8-d6e0-4c30-adc2-1311d04f7696 e421b4a8-d6e0-4c30-adc2-1311d04f7696 TCGA-63-A5MP-01A-11D-A26L-01 TCGA-63-A5MP-01A-11D-A26N-05 472DD6A0-F0D3-444C-AF9F-68B424BC9960 +TCGA-63-A5MR-01 TCGA-63-A5MR-01 TCGA-63-A5MR TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 70 L-Upper TCGA-63-A5MR-F65002 TCGA-63-A5MR TCGA-63-A5MR-01A -25879 2716 61 1 NO NO Scheduled Follow-up Submission 2014-9-17 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 310 NO NO Peripheral Lung NO NO 120 false No M0 N0 T2 Stage IB TCGA-63-A5MR.F33B0128-A333-4E13-9403-93F01C2EFB77.pdf A5MR Other TUMOR FREE 60 56 Complete Remission/Response YES NO R0 Primary Tumor 01 1997 6th NO NO YES 63 4 Lung A LIVING 1957 0bb6e848-b69a-465d-9039-1aa75d98815f TCGA-63-A5MR-01 TCGA-63-A5MR-01 TCGA-63-A5MR-01 0bb6e848-b69a-465d-9039-1aa75d98815f TCGA-63-A5MR-01 TCGA-63-A5MR-01A-31D-A27J-01 0bb6e848-b69a-465d-9039-1aa75d98815f 0bb6e848-b69a-465d-9039-1aa75d98815f TCGA-63-A5MR-01A-31D-A27J-01 TCGA-63-A5MR-01A-31D-A27L-05 +TCGA-63-A5MS-01 TCGA-63-A5MS-01 TCGA-63-A5MS TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 78 L-Upper TCGA-63-A5MS-F65006 TCGA-63-A5MS TCGA-63-A5MS-01A -28827 2381 83 1 NO NO Scheduled Follow-up Submission 2014-9-17 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 130 NO NO Central Lung NO NO 6 false No M0 N0 T2 Stage IB TCGA-63-A5MS.931632DA-991E-455F-9C4B-51C787880EE7.pdf A5MS Other TUMOR FREE 94 Complete Remission/Response YES NO R0 Primary Tumor 01 6th NO NO YES 63 3 Lung A LIVING 920292b7-e792-4e3e-89f9-aa0c764aef74 TCGA-63-A5MS-01 TCGA-63-A5MS-01 TCGA-63-A5MS-01 920292b7-e792-4e3e-89f9-aa0c764aef74 TCGA-63-A5MS-01 TCGA-63-A5MS-01A-11D-A26L-01 920292b7-e792-4e3e-89f9-aa0c764aef74 920292b7-e792-4e3e-89f9-aa0c764aef74 TCGA-63-A5MS-01A-11D-A26L-01 TCGA-63-A5MS-01A-11D-A26N-05 FBFA2170-032E-4036-B69F-B6F59B99A869 +TCGA-63-A5MT-01 TCGA-63-A5MT-01 TCGA-63-A5MT TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 74 R-Upper TCGA-63-A5MT TCGA-63-A5MT-01A -27263 498 68 1 NO NO 2013-9-24 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 270 NO NO Peripheral Lung YES 100 false No M0 N0 T3 Stage IIB TCGA-63-A5MT.81E6FD63-4E66-426B-9221-853906532726.pdf A5MT Preoperative WITH TUMOR 86 Complete Remission/Response YES NO R0 Primary Tumor 01 2011 7th YES NO YES 63 4 Lung A LIVING 1961 6309a039-6d4a-4757-8c05-043b17010104 TCGA-63-A5MT-01 TCGA-63-A5MT-01 TCGA-63-A5MT-01 6309a039-6d4a-4757-8c05-043b17010104 TCGA-63-A5MT-01 TCGA-63-A5MT-01A-21D-A26L-01 6309a039-6d4a-4757-8c05-043b17010104 6309a039-6d4a-4757-8c05-043b17010104 TCGA-63-A5MT-01A-21D-A26L-01 TCGA-63-A5MT-01A-21D-A26N-05 28465EF1-05C6-4B71-953F-C2FFFE136A67 +TCGA-63-A5MU-01 TCGA-63-A5MU-01 TCGA-63-A5MU TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 48 R-Lower TCGA-63-A5MU-F65013 TCGA-63-A5MU TCGA-63-A5MU-01A -17801 [Discrepancy] 64 0 NO NO Scheduled Follow-up Submission 2014-9-17 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 280 NO 0 NO Central Lung NO NO 15 false No M0 N1 T2b Stage IIB TCGA-63-A5MU.AE73DEFC-421B-4F5D-8882-E15FC4483FF1.pdf A5MU Other WITH TUMOR 69 81 Complete Remission/Response YES NO R0 Primary Tumor 01 2011 7th YES NO YES 63 4 Lung A DECEASED 1981 fe0ee6d5-c68d-40ab-8892-678df4554aa6 TCGA-63-A5MU-01 TCGA-63-A5MU-01 TCGA-63-A5MU-01 fe0ee6d5-c68d-40ab-8892-678df4554aa6 TCGA-63-A5MU-01 TCGA-63-A5MU-01A-11D-A26L-01 fe0ee6d5-c68d-40ab-8892-678df4554aa6 fe0ee6d5-c68d-40ab-8892-678df4554aa6 TCGA-63-A5MU-01A-11D-A26L-01 TCGA-63-A5MU-01A-11D-A26N-05 B0743F37-2891-45A8-9919-2D3754D76091 +TCGA-63-A5MV-01 TCGA-63-A5MV-01 TCGA-63-A5MV TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 69 R-Lower TCGA-63-A5MV-F65014 TCGA-63-A5MV TCGA-63-A5MV-01A -25505 1100 60 0 NO NO Scheduled Follow-up Submission 2014-9-17 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 250 NO NO Peripheral Lung NO NO 50 false No M0 N0 T2b Stage IIA TCGA-63-A5MV.494B2443-C3FD-43A0-A735-29D9D801C9D1.pdf A5MV Other TUMOR FREE 71 64 66 55 Complete Remission/Response YES NO R0 Primary Tumor 01 2011 7th YES NO YES 63 4 Lung A LIVING 1961 34b3ffb2-9fd1-4521-856a-f465f537804b TCGA-63-A5MV-01 TCGA-63-A5MV-01 TCGA-63-A5MV-01 34b3ffb2-9fd1-4521-856a-f465f537804b TCGA-63-A5MV-01 TCGA-63-A5MV-01A-21D-A26L-01 34b3ffb2-9fd1-4521-856a-f465f537804b 34b3ffb2-9fd1-4521-856a-f465f537804b TCGA-63-A5MV-01A-21D-A26L-01 TCGA-63-A5MV-01A-21D-A26N-05 24187CDD-F021-4BFC-9ED9-6FAAD5D1592F +TCGA-63-A5MW-01 TCGA-63-A5MW-01 TCGA-63-A5MW TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 76 R-Upper TCGA-63-A5MW-F65023 TCGA-63-A5MW TCGA-63-A5MW-01A -27892 1639 41 0 Scheduled Follow-up Submission Complete Remission/Response 2014-9-17 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 70 NO Peripheral Lung NO NO 60 false No M0 N0 T2 Stage IB TCGA-63-A5MW.5D901376-7A8B-4171-A2B2-8449F24252CC.pdf A5MW Other TUMOR FREE 58 59 Complete Remission/Response YES NO R0 Primary Tumor 01 6th NO NO YES 63 4 Lung A LIVING 4daf4ef1-7b4e-4580-ba4c-1f8e81d8b250 TCGA-63-A5MW-01 TCGA-63-A5MW-01 TCGA-63-A5MW-01 4daf4ef1-7b4e-4580-ba4c-1f8e81d8b250 TCGA-63-A5MW-01 TCGA-63-A5MW-01A-11D-A26L-01 4daf4ef1-7b4e-4580-ba4c-1f8e81d8b250 4daf4ef1-7b4e-4580-ba4c-1f8e81d8b250 TCGA-63-A5MW-01A-11D-A26L-01 TCGA-63-A5MW-01A-11D-A26N-05 +TCGA-63-A5MY-01 TCGA-63-A5MY-01 TCGA-63-A5MY TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 63 L-Lower TCGA-63-A5MY-F65025 TCGA-63-A5MY TCGA-63-A5MY-01A -23276 1052 52 Scheduled Follow-up Submission Complete Remission/Response 2014-9-17 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 90 NO NO NO 40 false No M0 N0 T1b Stage IA TCGA-63-A5MY.E2D395F8-F5F6-4870-86D7-F55288204F65.pdf A5MY TUMOR FREE 69 67 69 67 Complete Remission/Response YES NO R0 Primary Tumor 01 2010 7th NO NO YES 63 4 Lung A LIVING 1966 621db48c-a6ba-4cd6-8c58-24a87d4b44b4 TCGA-63-A5MY-01 TCGA-63-A5MY-01 TCGA-63-A5MY-01 621db48c-a6ba-4cd6-8c58-24a87d4b44b4 TCGA-63-A5MY-01 TCGA-63-A5MY-01A-11D-A26L-01 621db48c-a6ba-4cd6-8c58-24a87d4b44b4 621db48c-a6ba-4cd6-8c58-24a87d4b44b4 TCGA-63-A5MY-01A-11D-A26L-01 TCGA-63-A5MY-01A-11D-A26N-05 60F7A648-DA20-4ACB-AC10-EB608D02EBE1 +TCGA-66-2727-01 TCGA-66-2727-01 Squamous C2-Squamous-like cluster 3 Cluster 13 (HNSC-LUSC) squamous c3 squamous-like c4 miRNA cluster 4 cluster 2 mutation cluster 8 TCGA-66-2727 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 55 L-Lower TCGA-66-2727 TCGA-66-2727-01A -20150 516 0 2011-3-7 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.8 NO 1 56 No M0 N0 T2 Stage IB TCGA-66-2727.97328404-08ac-4c35-b15c-79485d60c892.pdf 2727 R0 Primary Tumor 01 0.6 2004 5th NO YES 66 4 Lung A DECEASED 2004 1967 TCGA-66-2727-01A-01D-0983-08 TCGA-66-2727-01A-01D-0979-05 bec47a82-4a30-4206-bb40-f7674028db1d TCGA-66-2727-01 TCGA-66-2727-01A-01D-0983-08 TCGA-66-2727-01 TCGA-66-2727-01A-01R-0980-07 bec47a82-4a30-4206-bb40-f7674028db1d 8c4f7512-4541-4bfe-b30f-7cc89ddf0df3 TCGA-66-2727-01A-21-2193-20 TCGA-66-2727-01 TCGA-66-2727-01A-01D-0978-01 TCGA-66-2727-01 bec47a82-4a30-4206-bb40-f7674028db1d TCGA-66-2727-01 bec47a82-4a30-4206-bb40-f7674028db1d TCGA-66-2727-01 TCGA-66-2727-01A-01D-0978-01 d494adb7-9e76-4717-b142-47521c544e9a +TCGA-66-2727-11 TCGA-66-2727-11 C2-Squamous-like mutation cluster 8 TCGA-66-2727 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 55 L-Lower TCGA-66-2727 TCGA-66-2727-11A -20150 516 0 2011-3-7 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.6 NO 0.6 56 No M0 N0 T2 Stage IB 2727 R0 Solid Tissue Normal 11 0.3 2004 5th NO YES 66 4 Lung A DECEASED 2004 1967 TCGA-66-2727-11A-01D-0979-05 +TCGA-66-2734-01 TCGA-66-2734-01 Squamous C2-Squamous-like cluster 4 Cluster 5 squamous-like c4 miRNA cluster 4 cluster 2 mutation cluster 13 TCGA-66-2734 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 62 L-Lower TCGA-66-2734-F36597 TCGA-66-2734 TCGA-66-2734-01A -22919 0 1311 Scheduled Follow-up Submission Complete Remission/Response 2012-11-6 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.7 NO 1 NO NO 40 No M0 N0 T2 Stage IB TCGA-66-2734.5cda5b60-06f5-411c-805f-0ec3ee89de67.pdf 2734 TUMOR FREE NO R0 Primary Tumor 01 0.5 2005 5th NO NO YES 66 4 Lung A LIVING 2005 1965 TCGA-66-2734-01A-01D-0983-08 TCGA-66-2734-01A-01D-0979-05 eb104ebb-be06-4f91-be68-d3b4ef649d2a TCGA-66-2734-01 TCGA-66-2734-01A-01D-0983-08 TCGA-66-2734-01 TCGA-66-2734-01A-01R-0980-07 eb104ebb-be06-4f91-be68-d3b4ef649d2a 4d86425c-55f3-4dbd-b967-ba1b620d0622 TCGA-66-2734-01 TCGA-66-2734-01A-01D-0978-01 TCGA-66-2734-01 eb104ebb-be06-4f91-be68-d3b4ef649d2a TCGA-66-2734-01 eb104ebb-be06-4f91-be68-d3b4ef649d2a TCGA-66-2734-01 TCGA-66-2734-01A-01D-0978-01 +TCGA-66-2734-11 TCGA-66-2734-11 C2-Squamous-like mutation cluster 13 TCGA-66-2734 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 62 L-Lower TCGA-66-2734-F36597 TCGA-66-2734 TCGA-66-2734-11A -22919 0 1311 Scheduled Follow-up Submission Complete Remission/Response 2012-11-6 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.5 NO 0.6 NO NO 40 No M0 N0 T2 Stage IB 2734 TUMOR FREE NO R0 Solid Tissue Normal 11 0.3 2005 5th NO NO YES 66 4 Lung A LIVING 2005 1965 TCGA-66-2734-11A-01D-0979-05 +TCGA-66-2737-01 TCGA-66-2737-01 High C2-Squamous-like Cluster 5 squamous c3 squamous-like c4 miRNA cluster 4 TCGA-66-2737 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 72 R-Middle TCGA-66-2737 TCGA-66-2737-01A -26390 0 61 2011-3-7 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.2 8070/3 C34.2 YES 1 NO 1 40 No M0 N1 T2 Stage IIB TCGA-66-2737.81cc3e56-576f-4285-906c-75290f9ae4b0.pdf 2737 TUMOR FREE R0 Primary Tumor 01 0.5 1969 5th NO YES 66 3 Lung A LIVING 2005 1949 TCGA-66-2737-01A-01D-0979-05 b00d66ea-f8e2-4f18-8df8-e6248d929373 TCGA-66-2737-01 TCGA-66-2737-01 TCGA-66-2737-01A-01R-0980-07 b00d66ea-f8e2-4f18-8df8-e6248d929373 689045ee-8461-4486-b923-99d1dc6a0c24 TCGA-66-2737-01A-41-2193-20 TCGA-66-2737-01 TCGA-66-2737-01A-01D-0978-01 TCGA-66-2737-01 b00d66ea-f8e2-4f18-8df8-e6248d929373 TCGA-66-2737-01 b00d66ea-f8e2-4f18-8df8-e6248d929373 TCGA-66-2737-01 TCGA-66-2737-01A-01D-0978-01 46aec886-20f0-47f3-ba36-3ba0b036f764 +TCGA-66-2737-11 TCGA-66-2737-11 C2-Squamous-like TCGA-66-2737 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 72 R-Middle TCGA-66-2737 TCGA-66-2737-11A -26390 0 61 2011-3-7 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.2 8070/3 C34.2 YES 0.7 NO 0.8 40 No M0 N1 T2 Stage IIB 2737 TUMOR FREE R0 Solid Tissue Normal 11 0.3 1969 5th NO YES 66 3 Lung A LIVING 2005 1949 TCGA-66-2737-11A-01D-0979-05 +TCGA-66-2742-01 TCGA-66-2742-01 High C2-Squamous-like cluster 4 Cluster 13 (HNSC-LUSC) squamous-like c4 miRNA cluster 4 cluster 2 mutation cluster 8 TCGA-66-2742 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 70 R-Upper TCGA-66-2742-F36598 TCGA-66-2742 TCGA-66-2742-01A -25688 0 641 Scheduled Follow-up Submission Complete Remission/Response 2012-11-6 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.7 NO 1.2 NO NO 44 No M1 N1 T2 Stage IV TCGA-66-2742.07c5c025-c1cd-486e-b510-ebc19d3e53d0.pdf 2742 TUMOR FREE NO R0 Primary Tumor 01 0.6 1991 5th NO NO YES 66 3 Lung A LIVING 2006 1956 TCGA-66-2742-01A-01D-0983-08 TCGA-66-2742-01A-01D-0979-05 002e2fae-9e30-4800-b23e-8f23bd16ad56 TCGA-66-2742-01 TCGA-66-2742-01A-01D-0983-08 TCGA-66-2742-01 TCGA-66-2742-01A-01R-0980-07 002e2fae-9e30-4800-b23e-8f23bd16ad56 99b3f7e9-3a94-45d0-917e-be0003ec3a4a TCGA-66-2742-01 TCGA-66-2742-01A-01D-0978-01 TCGA-66-2742-01 002e2fae-9e30-4800-b23e-8f23bd16ad56 TCGA-66-2742-01 002e2fae-9e30-4800-b23e-8f23bd16ad56 TCGA-66-2742-01 TCGA-66-2742-01A-01D-0978-01 +TCGA-66-2742-11 TCGA-66-2742-11 C2-Squamous-like mutation cluster 8 TCGA-66-2742 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 70 R-Upper TCGA-66-2742-F36598 TCGA-66-2742 TCGA-66-2742-11A -25688 0 641 Scheduled Follow-up Submission Complete Remission/Response 2012-11-6 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.9 NO 1.2 NO NO 44 No M1 N1 T2 Stage IV 2742 TUMOR FREE NO R0 Solid Tissue Normal 11 0.5 1991 5th NO NO YES 66 3 Lung A LIVING 2006 1956 TCGA-66-2742-11A-01D-0979-05 +TCGA-66-2744-01 TCGA-66-2744-01 Kirc+ C2-Squamous-like cluster 1 Cluster 5 squamous-like c4 miRNA cluster 5 cluster 4 mutation cluster 2 TCGA-66-2744 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 71 R-Lower TCGA-66-2744 TCGA-66-2744-01A -26084 0 30 2011-3-7 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.6 NO 0.6 63 No M0 N1 T2 Stage IIB TCGA-66-2744.75ad62a3-0cf4-45ef-a1cf-4c710a3368d3.pdf 2744 TUMOR FREE R0 Primary Tumor 01 0.3 2006 5th NO YES 66 4 Lung A LIVING 2006 1956 TCGA-66-2744-01A-01D-0983-08 TCGA-66-2744-01A-01D-0979-05 2a016a06-5097-49b5-85b2-8ea5291fed23 TCGA-66-2744-01 TCGA-66-2744-01A-01D-0983-08 TCGA-66-2744-01 TCGA-66-2744-01A-01R-0980-07 2a016a06-5097-49b5-85b2-8ea5291fed23 a3cd4bed-74e6-4f7f-bacc-ab71c3e87096 TCGA-66-2744-01 TCGA-66-2744-01A-01D-1969-01 TCGA-66-2744-01 2a016a06-5097-49b5-85b2-8ea5291fed23 TCGA-66-2744-01 2a016a06-5097-49b5-85b2-8ea5291fed23 TCGA-66-2744-01 TCGA-66-2744-01A-01D-1969-01 +TCGA-66-2744-11 TCGA-66-2744-11 C2-Squamous-like mutation cluster 2 TCGA-66-2744 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 71 R-Lower TCGA-66-2744 TCGA-66-2744-11A -26084 0 30 2011-3-7 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.8 NO 0.9 63 No M0 N1 T2 Stage IIB 2744 TUMOR FREE R0 Solid Tissue Normal 11 0.3 2006 5th NO YES 66 4 Lung A LIVING 2006 1956 TCGA-66-2744-11A-01D-0979-05 +TCGA-66-2753-01 TCGA-66-2753-01 Squamous Cluster 13 (HNSC-LUSC) squamous-like c4 miRNA cluster 7 TCGA-66-2753 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 69 L-Lower TCGA-66-2753 -25506 0 31 2011-3-7 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 162 No M0 N0 T2 Stage IB 2753 TUMOR FREE R0 Primary Tumor 01 2007 5th NO YES 66 4 Lung LIVING 2007 1953 TCGA-66-2753-01A-01D-0979-05 a10bc546-eb5d-4022-8f77-ea993db1a9d3 TCGA-66-2753-01 TCGA-66-2753-01 TCGA-66-2753-01A-01R-0980-07 a10bc546-eb5d-4022-8f77-ea993db1a9d3 c08c22e4-34a3-42ae-8591-7c734a0c9b8a TCGA-66-2753-01 TCGA-66-2753-01A-01D-0978-01 TCGA-66-2753-01 a10bc546-eb5d-4022-8f77-ea993db1a9d3 TCGA-66-2753-01 a10bc546-eb5d-4022-8f77-ea993db1a9d3 TCGA-66-2753-01 TCGA-66-2753-01A-01D-0978-01 +TCGA-66-2753-11 TCGA-66-2753-11 TCGA-66-2753 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 69 L-Lower TCGA-66-2753 TCGA-66-2753-11A -25506 0 31 2011-3-7 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 1 NO 2 162 No M0 N0 T2 Stage IB 2753 TUMOR FREE R0 Solid Tissue Normal 11 0.4 2007 5th NO YES 66 4 Lung A LIVING 2007 1953 TCGA-66-2753-11A-01D-0979-05 +TCGA-66-2754-01 TCGA-66-2754-01 Squamous C1-LUAD-enriched cluster 4 Cluster 5 LUAD-like c10 miRNA cluster 6 cluster 3 mutation cluster 2 TCGA-66-2754 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 67 R-Upper TCGA-66-2754 TCGA-66-2754-01A -24471 0 61 2011-3-7 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.7 NO 0.7 40 No M0 N2 T2 Stage IIIA TCGA-66-2754.d291f110-97b0-4ef7-b9ef-552e445e8378.pdf 2754 TUMOR FREE R0 Primary Tumor 01 0.2 2007 6th NO YES 66 4 Lung A LIVING 2007 1967 TCGA-66-2754-01A-01D-0983-08 TCGA-66-2754-01A-01D-0979-05 98fef165-d1ea-40e8-9bc5-5e8e70b7aaa5 TCGA-66-2754-01 TCGA-66-2754-01A-01D-0983-08 TCGA-66-2754-01 TCGA-66-2754-01A-01R-0980-07 98fef165-d1ea-40e8-9bc5-5e8e70b7aaa5 78fa8575-bf3d-4d52-b01f-52af2b963bae TCGA-66-2754-01 TCGA-66-2754-01A-01D-0978-01 TCGA-66-2754-01 98fef165-d1ea-40e8-9bc5-5e8e70b7aaa5 TCGA-66-2754-01 98fef165-d1ea-40e8-9bc5-5e8e70b7aaa5 TCGA-66-2754-01 TCGA-66-2754-01A-01D-0978-01 +TCGA-66-2754-11 TCGA-66-2754-11 C1-LUAD-enriched mutation cluster 2 TCGA-66-2754 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 67 R-Upper TCGA-66-2754 TCGA-66-2754-11A -24471 0 61 2011-3-7 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.9 NO 0.9 40 No M0 N2 T2 Stage IIIA 2754 TUMOR FREE R0 Solid Tissue Normal 11 0.5 2007 6th NO YES 66 4 Lung A LIVING 2007 1967 TCGA-66-2754-11A-01D-0979-05 +TCGA-66-2755-01 TCGA-66-2755-01 Squamous C2-Squamous-like cluster 4 Cluster 5 squamous-like c4 miRNA cluster 4 cluster 2 mutation cluster 3 TCGA-66-2755 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 63 R-Upper TCGA-66-2755 TCGA-66-2755-01A -23348 0 28 2011-3-7 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.6 NO 0.6 20 No M0 N0 T2 Stage IB TCGA-66-2755.bbae44d1-526f-4dad-9224-cf2dc56d0852.pdf 2755 TUMOR FREE R0 Primary Tumor 01 0.6 1990 5th NO YES 66 3 Lung A LIVING 2007 1970 TCGA-66-2755-01A-01D-1522-08 TCGA-66-2755-01A-01D-0848-05 8c547100-3fac-4519-91e9-7976a49ec9c3 TCGA-66-2755-01 TCGA-66-2755-01A-01D-1522-08 TCGA-66-2755-01 TCGA-66-2755-01A-01R-0851-07 8c547100-3fac-4519-91e9-7976a49ec9c3 c3e8d7be-3099-4567-97e6-4ef20bc73a5b TCGA-66-2755-01 TCGA-66-2755-01A-01D-0844-01 TCGA-66-2755-01 8c547100-3fac-4519-91e9-7976a49ec9c3 TCGA-66-2755-01 8c547100-3fac-4519-91e9-7976a49ec9c3 TCGA-66-2755-01 TCGA-66-2755-01A-01D-0844-01 +TCGA-66-2756-01 TCGA-66-2756-01 High C1-LUAD-enriched cluster 4 Cluster 5 LUAD-like c10 mutation cluster 11 TCGA-66-2756 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 68 L-Upper TCGA-66-2756 TCGA-66-2756-01A -24929 0 30 2011-3-7 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 1 NO 1.2 No M0 N0 T4 Stage IIIB TCGA-66-2756.1ac41670-2aaf-428f-b8b5-d257951e6f5f.pdf 2756 TUMOR FREE R0 Primary Tumor 01 0.4 2002 6th NO YES 66 4 Lung A LIVING 2007 1962 TCGA-66-2756-01A-01D-1522-08 TCGA-66-2756-01A-01D-0848-05 77981a9c-ea15-47bb-bd1a-6600cdc50f09 TCGA-66-2756-01A-01D-1522-08 TCGA-66-2756-01 TCGA-66-2756-01A-01R-0851-07 77981a9c-ea15-47bb-bd1a-6600cdc50f09 d5a5b3cf-87a7-419b-938e-0c0e06af30a0 TCGA-66-2756-01 TCGA-66-2756-01A-01D-0844-01 TCGA-66-2756-01 77981a9c-ea15-47bb-bd1a-6600cdc50f09 TCGA-66-2756-01 77981a9c-ea15-47bb-bd1a-6600cdc50f09 TCGA-66-2756-01A-01D-0844-01 +TCGA-66-2757-01 TCGA-66-2757-01 High C1-LUAD-enriched cluster 4 Cluster 5 RNA cluster 12 mutation cluster 13 TCGA-66-2757 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 65 L-Upper TCGA-66-2757-F36596 TCGA-66-2757 TCGA-66-2757-01A -24014 1338 0 30 912 Scheduled Follow-up Submission Progressive Disease 2012-11-20 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.4 NO 1 NO YES 72 No M0 N0 T1 Stage IA TCGA-66-2757.b44205a6-8c17-4b6b-bb91-ec1ad1be0b3f.pdf 2757 WITH TUMOR YES R0 Primary Tumor 01 0.3 2007 6th YES NO YES 66 4 Lung A DECEASED 2007 1959 TCGA-66-2757-01A-01D-1522-08 TCGA-66-2757-01A-01D-0848-05 384dced4-1686-4f9d-bdd7-c5c54ca92bf8 TCGA-66-2757-01A-01D-1522-08 TCGA-66-2757-01 TCGA-66-2757-01A-01R-0851-07 384dced4-1686-4f9d-bdd7-c5c54ca92bf8 65ee758f-2716-478d-bdc6-2bc14d477774 TCGA-66-2757-01 TCGA-66-2757-01A-01D-0844-01 TCGA-66-2757-01 384dced4-1686-4f9d-bdd7-c5c54ca92bf8 TCGA-66-2757-01 384dced4-1686-4f9d-bdd7-c5c54ca92bf8 TCGA-66-2757-01A-01D-0844-01 +TCGA-66-2758-01 TCGA-66-2758-01 High C2-Squamous-like cluster 3 Cluster 13 (HNSC-LUSC) squamous c3 squamous-like c4 miRNA cluster 12 cluster 3 mutation cluster 3 TCGA-66-2758 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 71 L-Upper TCGA-66-2758-F36608 TCGA-66-2758 TCGA-66-2758-01A -26209 0 639 Scheduled Follow-up Submission Complete Remission/Response 2012-11-6 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.7 NO 1 NO NO 56 No M0 N0 T2 Stage IB TCGA-66-2758.c35772e8-176c-4572-80bd-e4ea7bd0684d.pdf 2758 TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 0.7 2007 5th YES NO YES 66 4 Lung A LIVING 2007 1951 TCGA-66-2758-01A-02D-1522-08 TCGA-66-2758-01A-02D-0848-05 a26c6cd1-144d-433a-b499-848ae93374c1 TCGA-66-2758-01 TCGA-66-2758-01A-02D-1522-08 TCGA-66-2758-01 TCGA-66-2758-01A-02R-0851-07 a26c6cd1-144d-433a-b499-848ae93374c1 2f7eee64-e4f8-41ea-a584-b834d7fa041e TCGA-66-2758-01A-11-2193-20 TCGA-66-2758-01 TCGA-66-2758-01A-02D-1969-01 TCGA-66-2758-01 a26c6cd1-144d-433a-b499-848ae93374c1 TCGA-66-2758-01 a26c6cd1-144d-433a-b499-848ae93374c1 TCGA-66-2758-01 TCGA-66-2758-01A-02D-1969-01 4dda1522-0094-4b54-b413-ad6d92df3ad9 +TCGA-66-2759-01 TCGA-66-2759-01 Squamous C2-Squamous-like cluster 2 Cluster 13 (HNSC-LUSC) squamous-like c4 miRNA cluster 4 cluster 2 mutation cluster 8 TCGA-66-2759 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 66 L-Lower TCGA-66-2759-F36687 TCGA-66-2759 -24287 0 762 Scheduled Follow-up Submission Complete Remission/Response 2012-11-12 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES NO NO 16 No M0 N2 T2 Stage IIIA 2759 TUMOR FREE Complete Remission/Response YES R0 Primary Tumor 01 1990 5th YES NO YES 66 3 Lung LIVING 2007 1959 TCGA-66-2759-01A-01D-1522-08 TCGA-66-2759-01A-01D-0848-05 adfbf8b6-405d-4887-b363-d130e20b70ef TCGA-66-2759-01 TCGA-66-2759-01A-01D-1522-08 TCGA-66-2759-01 TCGA-66-2759-01A-01R-0851-07 adfbf8b6-405d-4887-b363-d130e20b70ef a555571c-60da-4e13-a0e4-5b714919b896 TCGA-66-2759-01 TCGA-66-2759-01A-01D-1969-01 TCGA-66-2759-01 adfbf8b6-405d-4887-b363-d130e20b70ef TCGA-66-2759-01 adfbf8b6-405d-4887-b363-d130e20b70ef TCGA-66-2759-01 TCGA-66-2759-01A-01D-1969-01 +TCGA-66-2763-01 TCGA-66-2763-01 Squamous C2-Squamous-like cluster 2 Cluster 13 (HNSC-LUSC) squamous-like c4 miRNA cluster 11 cluster 1 mutation cluster 11 TCGA-66-2763 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 63 L-Upper TCGA-66-2763 -23315 0 30 2011-3-7 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 40 No M0 N0 T2 Stage IB 2763 TUMOR FREE R0 Primary Tumor 01 2007 6th NO YES 66 4 Lung LIVING 2007 1967 TCGA-66-2763-01A-01D-1522-08 TCGA-66-2763-01A-01D-0848-05 f1c8f94b-6397-4756-abf6-42a5e9e5c76e TCGA-66-2763-01 TCGA-66-2763-01A-01D-1522-08 TCGA-66-2763-01 TCGA-66-2763-01A-01R-0851-07 f1c8f94b-6397-4756-abf6-42a5e9e5c76e ceabf31f-5fe9-4cdd-a1d0-445965f1ee96 TCGA-66-2763-01 TCGA-66-2763-01A-01D-0844-01 TCGA-66-2763-01 f1c8f94b-6397-4756-abf6-42a5e9e5c76e TCGA-66-2763-01 f1c8f94b-6397-4756-abf6-42a5e9e5c76e TCGA-66-2763-01 TCGA-66-2763-01A-01D-0844-01 +TCGA-66-2765-01 TCGA-66-2765-01 Squamous C2-Squamous-like cluster 4 Cluster 5 squamous-like c4 miRNA cluster 4 cluster 2 mutation cluster 5 TCGA-66-2765 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 64 L-Lower TCGA-66-2765 TCGA-66-2765-01A -23465 0 61 2011-3-7 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.5 NO 1.3 108 No M0 N0 T2 Stage IB TCGA-66-2765.89c0d8ed-b798-4684-8c7f-1ef75968df1b.pdf 2765 TUMOR FREE R0 Primary Tumor 01 0.2 2007 6th NO YES 66 4 Lung A LIVING 2007 1953 TCGA-66-2765-01A-01D-1522-08 TCGA-66-2765-01A-01D-0848-05 02497ea4-eb86-4154-a7a2-63b4baaebc97 TCGA-66-2765-01 TCGA-66-2765-01A-01D-1522-08 TCGA-66-2765-01 TCGA-66-2765-01A-01R-0851-07 02497ea4-eb86-4154-a7a2-63b4baaebc97 71317df2-805e-4a2c-bc12-271568338a29 TCGA-66-2765-01 TCGA-66-2765-01A-01D-0844-01 TCGA-66-2765-01 02497ea4-eb86-4154-a7a2-63b4baaebc97 TCGA-66-2765-01 02497ea4-eb86-4154-a7a2-63b4baaebc97 TCGA-66-2765-01 TCGA-66-2765-01A-01D-0844-01 +TCGA-66-2766-01 TCGA-66-2766-01 High C2-Squamous-like cluster 2 Cluster 13 (HNSC-LUSC) squamous c3 squamous-like c4 miRNA cluster 4 cluster 2 mutation cluster 3 TCGA-66-2766 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 54 L-Upper TCGA-66-2766 TCGA-66-2766-01A -19814 0 31 2011-3-7 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.7 NO 2 80 No M0 N2 T2 Stage IIIA TCGA-66-2766.d210f986-d5a2-4490-87a4-e14564a6d0ff.pdf 2766 TUMOR FREE R0 Primary Tumor 01 0.5 2007 6th NO YES 66 4 Lung A LIVING 2007 1967 TCGA-66-2766-01A-01D-1522-08 TCGA-66-2766-01A-01D-0848-05 9a76d668-932a-47cd-a8c0-5840641e1aea TCGA-66-2766-01 TCGA-66-2766-01A-01D-1522-08 TCGA-66-2766-01 TCGA-66-2766-01A-01R-0851-07 9a76d668-932a-47cd-a8c0-5840641e1aea a3628d97-73b0-4ee3-a1f7-92f344ea3080 TCGA-66-2766-01A-21-2193-20 TCGA-66-2766-01 TCGA-66-2766-01A-01D-0844-01 TCGA-66-2766-01 9a76d668-932a-47cd-a8c0-5840641e1aea TCGA-66-2766-01 9a76d668-932a-47cd-a8c0-5840641e1aea TCGA-66-2766-01 TCGA-66-2766-01A-01D-0844-01 ba82b423-e845-4d6f-b8bf-aa44344e0e2e +TCGA-66-2767-01 TCGA-66-2767-01 Squamous C2-Squamous-like cluster 2 Cluster 13 (HNSC-LUSC) squamous c3 squamous-like c4 miRNA cluster 7 cluster 2 mutation cluster 11 TCGA-66-2767 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 62 R-Lower TCGA-66-2767 TCGA-66-2767-01A -22888 0 61 2011-3-7 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.8 NO 0.8 43 No M0 N3 T2 Stage IIIB TCGA-66-2767.bc27c9ee-26e1-4362-b03d-4e2c08ed6111.pdf 2767 TUMOR FREE R0 Primary Tumor 01 0.2 2007 6th NO YES 66 4 Lung A LIVING 2007 1964 TCGA-66-2767-01A-01D-1522-08 TCGA-66-2767-01A-01D-0848-05 f54e8f7c-75c2-4566-8696-06e5ac1b8a0d TCGA-66-2767-01 TCGA-66-2767-01A-01D-1522-08 TCGA-66-2767-01 TCGA-66-2767-01A-01R-0851-07 f54e8f7c-75c2-4566-8696-06e5ac1b8a0d 292e1b78-8789-46a0-b046-ff4efc5bd8b6 TCGA-66-2767-01A-21-2193-20 TCGA-66-2767-01 TCGA-66-2767-01A-01D-0844-01 TCGA-66-2767-01 f54e8f7c-75c2-4566-8696-06e5ac1b8a0d TCGA-66-2767-01 f54e8f7c-75c2-4566-8696-06e5ac1b8a0d TCGA-66-2767-01 TCGA-66-2767-01A-01D-0844-01 2046ba58-db49-44ba-b6ae-fb9eee38a211 +TCGA-66-2768-01 TCGA-66-2768-01 Squamous C2-Squamous-like cluster 1 Cluster 13 (HNSC-LUSC) squamous c3 squamous-like c4 miRNA cluster 11 cluster 1 mutation cluster 13 TCGA-66-2768 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 57 L-Lower TCGA-66-2768 TCGA-66-2768-01A -20970 0 61 2011-3-7 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.7 NO 1.1 No M0 N1 T2 Stage IIB TCGA-66-2768.ebd0c8a9-a96a-4e09-8498-3476d1faf292.pdf 2768 TUMOR FREE R0 Primary Tumor 01 0.3 6th NO YES 66 2 Lung A LIVING 2007 TCGA-66-2768-01A-01D-1522-08 TCGA-66-2768-01A-01D-0848-05 97454c59-eed0-470f-a234-ff8b25b4b8a6 TCGA-66-2768-01 TCGA-66-2768-01A-01D-1522-08 TCGA-66-2768-01 TCGA-66-2768-01A-01R-0851-07 97454c59-eed0-470f-a234-ff8b25b4b8a6 c6bd35b7-3153-47ff-992e-e6a098d25e37 TCGA-66-2768-01A-21-2193-20 TCGA-66-2768-01 TCGA-66-2768-01A-01D-0844-01 TCGA-66-2768-01 97454c59-eed0-470f-a234-ff8b25b4b8a6 TCGA-66-2768-01 97454c59-eed0-470f-a234-ff8b25b4b8a6 TCGA-66-2768-01 TCGA-66-2768-01A-01D-0844-01 28068872-a9b1-4e43-b5a4-92d1cdd03408 +TCGA-66-2769-01 TCGA-66-2769-01 Squamous C2-Squamous-like Cluster 5 squamous c3 squamous-like c4 TCGA-66-2769 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 75 L-Upper TCGA-66-2769 TCGA-66-2769-01A -27515 215 0 2011-3-7 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.9 NO 1 33 No M0 N0 T4 Stage IIIB TCGA-66-2769.3a61e4a8-b574-49a2-bea4-5479a1efb1f4.pdf 2769 R1 Primary Tumor 01 0.3 1980 6th NO YES 66 3 Lung A DECEASED 2007 1947 TCGA-66-2769-01A-02D-0848-05 41ab6249-4301-4c67-9b1f-83c295536b13 TCGA-66-2769-01 TCGA-66-2769-01A-02R-0851-07 41ab6249-4301-4c67-9b1f-83c295536b13 af83b94f-6b18-41ae-a911-e181e4c78877 TCGA-66-2769-01A-11-2193-20 TCGA-66-2769-01 TCGA-66-2769-01A-02D-0844-01 TCGA-66-2769-01 41ab6249-4301-4c67-9b1f-83c295536b13 TCGA-66-2769-01 41ab6249-4301-4c67-9b1f-83c295536b13 TCGA-66-2769-01A-02D-0844-01 5de8582a-34f9-4ea2-943d-bf46f07c06e0 +TCGA-66-2770-01 TCGA-66-2770-01 Squamous C2-Squamous-like cluster 1 Cluster 5 squamous c3 squamous-like c4 miRNA cluster 7 cluster 2 mutation cluster 5 TCGA-66-2770 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 79 R-Lower TCGA-66-2770 TCGA-66-2770-01A -28945 0 700 2011-3-7 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.9 NO 1.3 25 No M0 N0 T2 Stage IB TCGA-66-2770.495898f2-833b-4db0-9fac-680970795f2e.pdf 2770 R0 Primary Tumor 01 0.3 1967 6th NO YES 66 3 Lung A LIVING 2007 1942 TCGA-66-2770-01A-01D-1522-08 TCGA-66-2770-01A-01D-0848-05 8c1c733a-abed-468f-b4d0-d1ac34ba6d8b TCGA-66-2770-01 TCGA-66-2770-01A-01D-1522-08 TCGA-66-2770-01 TCGA-66-2770-01A-01R-0851-07 8c1c733a-abed-468f-b4d0-d1ac34ba6d8b b7e44e6e-ccf9-4b75-a258-159912ab51ca TCGA-66-2770-01A-21-2193-20 TCGA-66-2770-01 TCGA-66-2770-01A-01D-0844-01 TCGA-66-2770-01 8c1c733a-abed-468f-b4d0-d1ac34ba6d8b TCGA-66-2770-01 8c1c733a-abed-468f-b4d0-d1ac34ba6d8b TCGA-66-2770-01 TCGA-66-2770-01A-01D-0844-01 e858ee92-0438-48e9-a70d-80ef2c0ad539 +TCGA-66-2771-01 TCGA-66-2771-01 Squamous C2-Squamous-like cluster 4 Low purity c2 squamous-like c4 miRNA cluster 7 cluster 2 mutation cluster 12 TCGA-66-2771 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 60 R-Upper TCGA-66-2771-F36692 TCGA-66-2771 TCGA-66-2771-01A -22219 0 578 Scheduled Follow-up Submission Complete Remission/Response 2012-11-12 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.7 NO 0.9 NO NO 70 No M0 N1 T2 Stage IIB TCGA-66-2771.e09c6c36-88a1-4f23-8611-241130866096.pdf 2771 TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 0.2 2006 6th YES NO YES 66 4 Lung A LIVING 2007 1971 TCGA-66-2771-01A-01D-0983-08 TCGA-66-2771-01A-01D-0979-05 91102ced-5e0a-427b-8640-4dfddf2004a7 TCGA-66-2771-01 TCGA-66-2771-01A-01D-0983-08 TCGA-66-2771-01 TCGA-66-2771-01A-01R-0980-07 91102ced-5e0a-427b-8640-4dfddf2004a7 fea2e307-76bc-49a0-871a-073338e72653 TCGA-66-2771-01 TCGA-66-2771-01A-01D-0978-01 TCGA-66-2771-01 91102ced-5e0a-427b-8640-4dfddf2004a7 TCGA-66-2771-01 91102ced-5e0a-427b-8640-4dfddf2004a7 TCGA-66-2771-01 TCGA-66-2771-01A-01D-0978-01 +TCGA-66-2771-11 TCGA-66-2771-11 C2-Squamous-like mutation cluster 12 TCGA-66-2771 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 60 R-Upper TCGA-66-2771-F36692 TCGA-66-2771 TCGA-66-2771-11A -22219 0 578 Scheduled Follow-up Submission Complete Remission/Response 2012-11-12 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.7 NO 0.8 NO NO 70 No M0 N1 T2 Stage IIB 2771 TUMOR FREE Complete Remission/Response NO R0 Solid Tissue Normal 11 0.4 2006 6th YES NO YES 66 4 Lung A LIVING 2007 1971 TCGA-66-2771-11A-01D-0979-05 +TCGA-66-2773-01 TCGA-66-2773-01 Squamous C2-Squamous-like cluster 3 Cluster 13 (HNSC-LUSC) squamous c3 squamous-like c4 mutation cluster 4 TCGA-66-2773 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 69 L-Lower TCGA-66-2773 TCGA-66-2773-01A -25355 92 0 2011-3-7 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 1 NO 1.2 58 No M0 N0 T2 Stage IB TCGA-66-2773.406db03f-3258-48b3-b0de-b7388d63a559.pdf 2773 TUMOR FREE R0 Primary Tumor 01 0.4 1969 6th NO YES 66 3 Lung A DECEASED 2007 1946 TCGA-66-2773-01A-01D-1267-08 TCGA-66-2773-01A-01D-1198-05 b8152ff5-e2f1-44a5-8173-c6c75ec3a79c TCGA-66-2773-01A-01D-1267-08 TCGA-66-2773-01 TCGA-66-2773-01A-01R-1201-07 b8152ff5-e2f1-44a5-8173-c6c75ec3a79c 86fdc3ea-6a3e-45ca-9b83-d0436868a76b TCGA-66-2773-01A-21-2193-20 TCGA-66-2773-01 TCGA-66-2773-01A-01D-1195-01 TCGA-66-2773-01 b8152ff5-e2f1-44a5-8173-c6c75ec3a79c TCGA-66-2773-01 b8152ff5-e2f1-44a5-8173-c6c75ec3a79c TCGA-66-2773-01A-01D-1195-01 1d33bdef-845d-4bf8-bc13-72113614a4c8 +TCGA-66-2777-01 TCGA-66-2777-01 BRCA-LUAD+ C2-Squamous-like cluster 4 OV-like c1 squamous c3 squamous-like c4 miRNA cluster 4 cluster 2 mutation cluster 11 TCGA-66-2777 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 71 R-Middle TCGA-66-2777 TCGA-66-2777-01A -26085 0 61 2011-3-7 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.2 8070/3 C34.2 YES 0.8 NO 1 12 No M0 N0 T2 Stage IB TCGA-66-2777.32548c06-21b0-4a9c-a8b4-ead02948d323.pdf 2777 TUMOR FREE R0 Primary Tumor 01 0.3 2007 6th NO YES 66 4 Lung A LIVING 2007 1972 TCGA-66-2777-01A-01D-1267-08 TCGA-66-2777-01A-01D-1198-05 030f341f-bf04-4bc1-9572-721160a2ec28 TCGA-66-2777-01 TCGA-66-2777-01A-01D-1267-08 TCGA-66-2777-01 TCGA-66-2777-01A-01R-1201-07 030f341f-bf04-4bc1-9572-721160a2ec28 fb4b0ad3-510e-4ac0-91a1-13e4f787f2f3 TCGA-66-2777-01A-21-2193-20 TCGA-66-2777-01 TCGA-66-2777-01A-01D-1195-01 TCGA-66-2777-01 030f341f-bf04-4bc1-9572-721160a2ec28 TCGA-66-2777-01 030f341f-bf04-4bc1-9572-721160a2ec28 TCGA-66-2777-01 TCGA-66-2777-01A-01D-1195-01 129560c0-36c3-4f01-98ed-606e583390d4 +TCGA-66-2778-01 TCGA-66-2778-01 Squamous C2-Squamous-like cluster 4 Cluster 5 squamous c3 squamous-like c4 mutation c1uster 10 TCGA-66-2778 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 68 L-Lower TCGA-66-2778-F36696 TCGA-66-2778 TCGA-66-2778-01A -25080 0 578 Scheduled Follow-up Submission Complete Remission/Response 2012-11-12 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.6 NO 0.6 NO NO 37 No M0 N3 T2 Stage IIIB TCGA-66-2778.b4ddc4fa-5416-4a8b-8187-b328dbc0b946.pdf 2778 TUMOR FREE Complete Remission/Response YES R2 Primary Tumor 01 0.5 1995 6th YES NO YES 66 4 Lung A LIVING 2007 1958 TCGA-66-2778-01A-02D-1522-08 TCGA-66-2778-01A-02D-0848-05 30fd754a-0625-4435-877d-7dfaee227f8b TCGA-66-2778-01A-02D-1522-08 TCGA-66-2778-01 TCGA-66-2778-01A-02R-0851-07 30fd754a-0625-4435-877d-7dfaee227f8b 1aeb4e32-b5c4-45aa-a7af-e1f325f6c572 TCGA-66-2778-01A-11-2193-20 TCGA-66-2778-01 TCGA-66-2778-01A-02D-0844-01 TCGA-66-2778-01 30fd754a-0625-4435-877d-7dfaee227f8b TCGA-66-2778-01 30fd754a-0625-4435-877d-7dfaee227f8b TCGA-66-2778-01A-02D-0844-01 f5dca0d5-550d-4107-b6ad-9d347a39afa5 +TCGA-66-2780-01 TCGA-66-2780-01 Squamous C2-Squamous-like cluster 4 Cluster 5 squamous-like c4 miRNA cluster 4 cluster 2 mutation c1uster 10 TCGA-66-2780 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 65 L-Upper TCGA-66-2780 TCGA-66-2780-01A -23955 366 0 2011-3-7 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.6 NO 1.2 28 No M0 N0 T2 Stage IB TCGA-66-2780.56ff78fe-0830-483a-a8b9-72a62f80e101.pdf 2780 R0 Primary Tumor 01 0.2 1970 6th NO YES 66 3 Lung A DECEASED 2007 1956 TCGA-66-2780-01A-01D-1522-08 TCGA-66-2780-01A-01D-0848-05 518e09a8-84da-4247-b2f5-2c32e07ea046 TCGA-66-2780-01 TCGA-66-2780-01A-01D-1522-08 TCGA-66-2780-01 TCGA-66-2780-01A-01R-0851-07 518e09a8-84da-4247-b2f5-2c32e07ea046 935cc04e-0542-4da5-a8d5-e5abbb809124 TCGA-66-2780-01 TCGA-66-2780-01A-01D-0844-01 TCGA-66-2780-01 518e09a8-84da-4247-b2f5-2c32e07ea046 TCGA-66-2780-01 518e09a8-84da-4247-b2f5-2c32e07ea046 TCGA-66-2780-01 TCGA-66-2780-01A-01D-0844-01 +TCGA-66-2781-01 TCGA-66-2781-01 Squamous C2-Squamous-like cluster 4 Low purity c2 squamous c3 squamous-like c4 miRNA cluster 4 cluster 2 mutation c1uster 9 TCGA-66-2781 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 67 L-Upper TCGA-66-2781 TCGA-66-2781-01A -24471 0 121 2011-3-7 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.6 NO 1 80 No M0 N0 T2 Stage IB TCGA-66-2781.4227efe2-597d-4d53-91f5-73c3fa32f6f5.pdf 2781 TUMOR FREE R0 Primary Tumor 01 0.4 2007 6th NO YES 66 4 Lung A LIVING 2007 1954 TCGA-66-2781-01A-01D-1522-08 TCGA-66-2781-01A-01D-0848-05 87ef65df-919a-4c65-87db-364380aec736 TCGA-66-2781-01 TCGA-66-2781-01A-01D-1522-08 TCGA-66-2781-01 TCGA-66-2781-01A-01R-0851-07 87ef65df-919a-4c65-87db-364380aec736 7e6b713b-a8db-44e3-aca0-37898b78bdb4 TCGA-66-2781-01A-21-2193-20 TCGA-66-2781-01 TCGA-66-2781-01A-01D-0844-01 TCGA-66-2781-01 87ef65df-919a-4c65-87db-364380aec736 TCGA-66-2781-01 87ef65df-919a-4c65-87db-364380aec736 TCGA-66-2781-01 TCGA-66-2781-01A-01D-0844-01 b307a0f2-a455-4b20-b866-8da02f3d8fd4 +TCGA-66-2782-01 TCGA-66-2782-01 Squamous C2-Squamous-like cluster 4 Cluster 5 squamous c3 squamous-like c4 miRNA cluster 4 cluster 2 mutation cluster 5 TCGA-66-2782 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung YES NO 71 R-Upper TCGA-66-2782-F37032 TCGA-66-2782 TCGA-66-2782-01A -26237 365 0 304 Scheduled Follow-up Submission Progressive Disease 2012-11-21 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 1 NO 3.3 NO YES 50 No M0 N0 T3 Stage IIB TCGA-66-2782.bdae0797-b3e2-47fd-b95b-20d4510277b8.pdf 2782 WITH TUMOR Progressive Disease NO R0 Primary Tumor 01 0.5 2004 5th YES NO YES 66 4 Lung A DECEASED 2004 1954 TCGA-66-2782-01A-01D-1522-08 TCGA-66-2782-01A-01D-0848-05 f20dc5d8-5ad0-46ce-b5d7-02f3f2e8c27a TCGA-66-2782-01 TCGA-66-2782-01A-01D-1522-08 TCGA-66-2782-01 TCGA-66-2782-01A-01R-0851-07 f20dc5d8-5ad0-46ce-b5d7-02f3f2e8c27a 3f1209e2-d78e-4cc6-b357-84905b83bc1c TCGA-66-2782-01A-21-2193-20 TCGA-66-2782-01 TCGA-66-2782-01A-01D-0844-01 TCGA-66-2782-01 f20dc5d8-5ad0-46ce-b5d7-02f3f2e8c27a TCGA-66-2782-01 f20dc5d8-5ad0-46ce-b5d7-02f3f2e8c27a TCGA-66-2782-01 TCGA-66-2782-01A-01D-0844-01 6cafe140-32f0-40b7-8d8b-60e7c76e4c0c +TCGA-66-2783-01 TCGA-66-2783-01 Squamous C2-Squamous-like cluster 3 Cluster 13 (HNSC-LUSC) squamous c3 squamous-like c4 miRNA cluster 7 cluster 2 mutation cluster 5 TCGA-66-2783 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 67 L-Lower TCGA-66-2783-F37019 TCGA-66-2783 TCGA-66-2783-01A -24686 0 759 Complete Remission/Response 2012-11-20 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.9 NO 1 NO 65 No M0 N3 T2 Stage IIIB TCGA-66-2783.15cde679-e737-4f03-ae8b-ce80908fea17.pdf 2783 TUMOR FREE Complete Remission/Response YES R2 Primary Tumor 01 0.5 2003 6th YES NO YES 66 4 Lung A LIVING 2008 1960 TCGA-66-2783-01A-01D-1267-08 TCGA-66-2783-01A-01D-1198-05 bb854114-88f2-467c-a3f8-ce8f5ee4cdb9 TCGA-66-2783-01 TCGA-66-2783-01A-01D-1267-08 TCGA-66-2783-01 TCGA-66-2783-01A-01R-1201-07 bb854114-88f2-467c-a3f8-ce8f5ee4cdb9 242b3245-b8e4-4fa6-b999-ce19a7c9498e TCGA-66-2783-01A-21-2193-20 TCGA-66-2783-01 TCGA-66-2783-01A-01D-1195-01 TCGA-66-2783-01 bb854114-88f2-467c-a3f8-ce8f5ee4cdb9 TCGA-66-2783-01 bb854114-88f2-467c-a3f8-ce8f5ee4cdb9 TCGA-66-2783-01 TCGA-66-2783-01A-01D-1195-01 74291822-bcab-4871-ad7c-cf2023ec7c2f +TCGA-66-2785-01 TCGA-66-2785-01 High C4-BRCA/Basal cluster 4 Cluster 5 squamous c3 BRCA basal-like c8 miRNA cluster 11 cluster 2 mutation cluster 11 TCGA-66-2785 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 65 L-Upper TCGA-66-2785 TCGA-66-2785-01A -23772 0 60 2011-3-7 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.5 NO 1.4 70 No M0 N0 T2 Stage IB TCGA-66-2785.92f38512-f7c8-462c-b7f4-018648ad4f56.pdf 2785 TUMOR FREE R0 Primary Tumor 01 0.5 2008 6th NO YES 66 4 Lung A LIVING 2008 TCGA-66-2785-01A-01D-1522-08 TCGA-66-2785-01A-01D-0848-05 9083747c-9d2d-431f-ace5-3e55795e18af TCGA-66-2785-01 TCGA-66-2785-01A-01D-1522-08 TCGA-66-2785-01 TCGA-66-2785-01A-01R-0851-07 9083747c-9d2d-431f-ace5-3e55795e18af dbbb9661-42a2-40ae-9bef-4d8eba8d8bfd TCGA-66-2785-01A-21-2193-20 TCGA-66-2785-01 TCGA-66-2785-01A-01D-0844-01 TCGA-66-2785-01 9083747c-9d2d-431f-ace5-3e55795e18af TCGA-66-2785-01 9083747c-9d2d-431f-ace5-3e55795e18af TCGA-66-2785-01 TCGA-66-2785-01A-01D-0844-01 a8bd2e87-dee1-4801-8742-25eacf7d7484 +TCGA-66-2786-01 TCGA-66-2786-01 Squamous C2-Squamous-like cluster 4 Cluster 5 squamous-like c4 miRNA cluster 4 cluster 2 mutation cluster 5 TCGA-66-2786 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 68 R-Upper TCGA-66-2786-F37034 TCGA-66-2786 TCGA-66-2786-01A -25051 0 790 Scheduled Follow-up Submission Complete Remission/Response 2012-11-21 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.7 NO 0.9 NO NO 74 No M0 N0 T1 Stage IA TCGA-66-2786.1f8077d2-efa8-4e09-b4a2-e848c3723278.pdf 2786 TUMOR FREE NO R0 Primary Tumor 01 0.3 2007 5th NO NO YES 66 4 Lung A LIVING 2008 1959 TCGA-66-2786-01A-01D-1522-08 TCGA-66-2786-01A-01D-0848-05 1190c768-24c0-4762-8701-dea5d35e8fe1 TCGA-66-2786-01 TCGA-66-2786-01A-01D-1522-08 TCGA-66-2786-01 TCGA-66-2786-01A-01R-0851-07 1190c768-24c0-4762-8701-dea5d35e8fe1 111546c3-1923-4610-bbb5-0d98261d2f4f TCGA-66-2786-01 TCGA-66-2786-01A-01D-0844-01 TCGA-66-2786-01 1190c768-24c0-4762-8701-dea5d35e8fe1 TCGA-66-2786-01 1190c768-24c0-4762-8701-dea5d35e8fe1 TCGA-66-2786-01 TCGA-66-2786-01A-01D-0844-01 +TCGA-66-2787-01 TCGA-66-2787-01 Squamous C2-Squamous-like cluster 3 Cluster 13 (HNSC-LUSC) squamous-like c4 miRNA cluster 4 cluster 2 mutation cluster 11 TCGA-66-2787 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 57 R-Upper TCGA-66-2787-F37035 TCGA-66-2787 -21124 0 1217 Scheduled Follow-up Submission Complete Remission/Response 2012-11-21 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES NO NO 40 No M0 N0 T1 Stage IA 2787 TUMOR FREE NO R0 Primary Tumor 01 2004 6th NO NO YES 66 4 Lung LIVING 2004 1964 TCGA-66-2787-01A-01D-0983-08 TCGA-66-2787-01A-01D-0979-05 a7e57e13-7e54-4839-9b94-0c7d3dda0489 TCGA-66-2787-01 TCGA-66-2787-01A-01D-0983-08 TCGA-66-2787-01 TCGA-66-2787-01A-01R-0980-07 a7e57e13-7e54-4839-9b94-0c7d3dda0489 b11c1c4e-4e24-4603-939e-aa234ad7f272 TCGA-66-2787-01 TCGA-66-2787-01A-01D-0978-01 TCGA-66-2787-01 a7e57e13-7e54-4839-9b94-0c7d3dda0489 TCGA-66-2787-01 a7e57e13-7e54-4839-9b94-0c7d3dda0489 TCGA-66-2787-01 TCGA-66-2787-01A-01D-0978-01 +TCGA-66-2787-11 TCGA-66-2787-11 C2-Squamous-like mutation cluster 11 TCGA-66-2787 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 57 R-Upper TCGA-66-2787-F37035 TCGA-66-2787 TCGA-66-2787-11A -21124 0 1217 Scheduled Follow-up Submission Complete Remission/Response 2012-11-21 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.8 NO 1 NO NO 40 No M0 N0 T1 Stage IA 2787 TUMOR FREE NO R0 Solid Tissue Normal 11 0.3 2004 6th NO NO YES 66 4 Lung A LIVING 2004 1964 TCGA-66-2787-11A-01D-0979-05 +TCGA-66-2788-01 TCGA-66-2788-01 High C2-Squamous-like cluster 4 Low purity c2 squamous c3 squamous-like c4 miRNA cluster 7 cluster 2 mutation cluster 5 TCGA-66-2788 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 56 L-Lower TCGA-66-2788-F37036 TCGA-66-2788 TCGA-66-2788-01A -20637 0 699 Scheduled Follow-up Submission Complete Remission/Response 2012-11-21 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.9 NO 0.9 NO NO 80 No M0 N0 T2 Stage IB TCGA-66-2788.8ec97dec-6e60-43c6-97c6-c164f28e3639.pdf 2788 TUMOR FREE NO R0 Primary Tumor 01 0.4 2008 6th NO NO YES 66 4 Lung A LIVING 2008 1968 TCGA-66-2788-01A-01D-0983-08 TCGA-66-2788-01A-01D-0979-05 700121ee-a711-4ccc-9250-e2b299d0f46e TCGA-66-2788-01 TCGA-66-2788-01A-01D-0983-08 TCGA-66-2788-01 TCGA-66-2788-01A-01R-0980-07 700121ee-a711-4ccc-9250-e2b299d0f46e 0577650e-27aa-4653-96ca-e94db804fe1f TCGA-66-2788-01A-21-2193-20 TCGA-66-2788-01 TCGA-66-2788-01A-01D-0978-01 TCGA-66-2788-01 700121ee-a711-4ccc-9250-e2b299d0f46e TCGA-66-2788-01 700121ee-a711-4ccc-9250-e2b299d0f46e TCGA-66-2788-01 TCGA-66-2788-01A-01D-0978-01 c1620625-664d-4fec-9ddc-ace245378ca7 +TCGA-66-2788-11 TCGA-66-2788-11 C2-Squamous-like mutation cluster 5 TCGA-66-2788 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 56 L-Lower TCGA-66-2788-F37036 TCGA-66-2788 TCGA-66-2788-11A -20637 0 699 Scheduled Follow-up Submission Complete Remission/Response 2012-11-21 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.8 NO 1 NO NO 80 No M0 N0 T2 Stage IB 2788 TUMOR FREE NO R0 Solid Tissue Normal 11 0.6 2008 6th NO NO YES 66 4 Lung A LIVING 2008 1968 TCGA-66-2788-11A-01D-0979-05 +TCGA-66-2789-01 TCGA-66-2789-01 Squamous C2-Squamous-like cluster 4 Cluster 13 (HNSC-LUSC) squamous-like c4 miRNA cluster 4 cluster 2 mutation cluster 12 TCGA-66-2789 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 73 L-Lower TCGA-66-2789 TCGA-66-2789-01A -26753 123 0 2011-3-7 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.8 NO 1.5 40 No M0 N3 T1 Stage IIIB TCGA-66-2789.50601de1-9156-4793-9cdc-b140bb932cc0.pdf 2789 TUMOR FREE R0 Primary Tumor 01 0.2 1995 6th NO YES 66 4 Lung A DECEASED 2008 1955 TCGA-66-2789-01A-01D-0983-08 TCGA-66-2789-01A-01D-0979-05 4c91a673-ed50-41b5-8261-50c9b8716aa2 TCGA-66-2789-01 TCGA-66-2789-01A-01D-0983-08 TCGA-66-2789-01 TCGA-66-2789-01A-01R-0980-07 4c91a673-ed50-41b5-8261-50c9b8716aa2 c6966ec0-573d-4b47-a142-d69077928eae TCGA-66-2789-01 TCGA-66-2789-01A-01D-0978-01 TCGA-66-2789-01 4c91a673-ed50-41b5-8261-50c9b8716aa2 TCGA-66-2789-01 4c91a673-ed50-41b5-8261-50c9b8716aa2 TCGA-66-2789-01 TCGA-66-2789-01A-01D-0978-01 +TCGA-66-2789-11 TCGA-66-2789-11 C2-Squamous-like mutation cluster 12 TCGA-66-2789 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 73 L-Lower TCGA-66-2789 TCGA-66-2789-11A -26753 123 0 2011-3-7 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.9 NO 1 40 No M0 N3 T1 Stage IIIB 2789 TUMOR FREE R0 Solid Tissue Normal 11 0.3 1995 6th NO YES 66 4 Lung A DECEASED 2008 1955 TCGA-66-2789-11A-01D-0979-05 +TCGA-66-2790-01 TCGA-66-2790-01 Squamous C2-Squamous-like Cluster 13 (HNSC-LUSC) squamous c3 squamous-like c4 miRNA cluster 4 TCGA-66-2790 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung NO NO 72 L-Upper TCGA-66-2790-F37037 TCGA-66-2790 TCGA-66-2790-01A -26420 0 699 699 Scheduled Follow-up Submission Progressive Disease 2012-11-21 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.5 NO 1.3 NO YES 57 No M0 N1 T2 Stage IIB TCGA-66-2790.7e17dc53-b237-46db-b6d6-86b7eeb51bab.pdf 2790 WITH TUMOR Progressive Disease NO R0 Primary Tumor 01 0.3 2008 6th YES NO YES 66 4 Lung A LIVING 2008 1951 TCGA-66-2790-01A-01D-0979-05 37396d97-dda9-4ee3-a477-8281d8baf948 TCGA-66-2790-01 TCGA-66-2790-01 TCGA-66-2790-01A-01R-0980-07 37396d97-dda9-4ee3-a477-8281d8baf948 e6cab567-15c9-46be-b38b-87f6962ab246 TCGA-66-2790-01A-21-2193-20 TCGA-66-2790-01 TCGA-66-2790-01A-01D-0978-01 TCGA-66-2790-01 37396d97-dda9-4ee3-a477-8281d8baf948 TCGA-66-2790-01 37396d97-dda9-4ee3-a477-8281d8baf948 TCGA-66-2790-01 TCGA-66-2790-01A-01D-0978-01 03a83493-5aa7-4c60-9fb0-9d4112d0fec2 +TCGA-66-2790-11 TCGA-66-2790-11 C2-Squamous-like TCGA-66-2790 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung NO NO 72 L-Upper TCGA-66-2790-F37037 TCGA-66-2790 TCGA-66-2790-11A -26420 0 699 699 Scheduled Follow-up Submission Progressive Disease 2012-11-21 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 1 NO 1.3 NO YES 57 No M0 N1 T2 Stage IIB 2790 WITH TUMOR Progressive Disease NO R0 Solid Tissue Normal 11 0.3 2008 6th YES NO YES 66 4 Lung A LIVING 2008 1951 TCGA-66-2790-11A-01D-0979-05 +TCGA-66-2791-01 TCGA-66-2791-01 Squamous C2-Squamous-like cluster 3 Cluster 13 (HNSC-LUSC) squamous c3 squamous-like c4 miRNA cluster 4 cluster 2 mutation cluster 13 TCGA-66-2791 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 66 R-Lower TCGA-66-2791 TCGA-66-2791-01A -24138 153 0 2011-3-7 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.8 NO 1 25 No M0 N3 T2 Stage IIIB TCGA-66-2791.402c71d9-26d5-4e94-82a6-6ae5ea39a391.pdf 2791 R1 Primary Tumor 01 0.2 2002 6th NO YES 66 4 Lung A DECEASED 2008 1977 TCGA-66-2791-01A-01D-0983-08 TCGA-66-2791-01A-01D-0979-05 95d2741d-894f-447e-9010-844f1d8a6572 TCGA-66-2791-01 TCGA-66-2791-01A-01D-0983-08 TCGA-66-2791-01 TCGA-66-2791-01A-01R-0980-07 95d2741d-894f-447e-9010-844f1d8a6572 a5b520e7-aa19-4296-8993-c343c2fd643e TCGA-66-2791-01A-21-2193-20 TCGA-66-2791-01 TCGA-66-2791-01A-01D-1969-01 TCGA-66-2791-01 95d2741d-894f-447e-9010-844f1d8a6572 TCGA-66-2791-01 95d2741d-894f-447e-9010-844f1d8a6572 TCGA-66-2791-01 TCGA-66-2791-01A-01D-1969-01 cd4f93c9-f2fe-4271-ab18-78e528cfb9ad +TCGA-66-2791-11 TCGA-66-2791-11 C2-Squamous-like mutation cluster 13 TCGA-66-2791 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 66 R-Lower TCGA-66-2791 TCGA-66-2791-11A -24138 153 0 2011-3-7 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.8 NO 1 25 No M0 N3 T2 Stage IIIB 2791 R1 Solid Tissue Normal 11 0.5 2002 6th NO YES 66 4 Lung A DECEASED 2008 1977 TCGA-66-2791-11A-01D-0979-05 +TCGA-66-2792-01 TCGA-66-2792-01 Squamous C2-Squamous-like cluster 3 Cluster 13 (HNSC-LUSC) squamous-like c4 miRNA cluster 4 cluster 2 mutation cluster 8 TCGA-66-2792 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 58 L-Lower TCGA-66-2792-F37042 TCGA-66-2792 -21428 0 913 Scheduled Follow-up Submission Complete Remission/Response 2012-11-21 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES NO NO 10 No M0 N1 T2 Stage IIB 2792 TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 2008 6th YES NO YES 66 4 Lung LIVING 2008 1968 TCGA-66-2792-01A-01D-0983-08 TCGA-66-2792-01A-01D-0979-05 cb96190b-51ec-4380-ab8a-a3b33d3ef4d2 TCGA-66-2792-01 TCGA-66-2792-01A-01D-0983-08 TCGA-66-2792-01 TCGA-66-2792-01A-01R-0980-07 cb96190b-51ec-4380-ab8a-a3b33d3ef4d2 f2751b57-3bb0-45b1-894b-d6cdb10fe017 TCGA-66-2792-01 TCGA-66-2792-01A-01D-0978-01 TCGA-66-2792-01 cb96190b-51ec-4380-ab8a-a3b33d3ef4d2 TCGA-66-2792-01 cb96190b-51ec-4380-ab8a-a3b33d3ef4d2 TCGA-66-2792-01 TCGA-66-2792-01A-01D-0978-01 +TCGA-66-2792-11 TCGA-66-2792-11 C2-Squamous-like mutation cluster 8 TCGA-66-2792 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 58 L-Lower TCGA-66-2792-F37042 TCGA-66-2792 TCGA-66-2792-11A -21428 0 913 Scheduled Follow-up Submission Complete Remission/Response 2012-11-21 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.8 NO 0.8 NO NO 10 No M0 N1 T2 Stage IIB 2792 TUMOR FREE Complete Remission/Response NO R0 Solid Tissue Normal 11 0.8 2008 6th YES NO YES 66 4 Lung A LIVING 2008 1968 TCGA-66-2792-11A-01D-0979-05 +TCGA-66-2793-01 TCGA-66-2793-01 High C2-Squamous-like cluster 1 Cluster 5 squamous-like c4 miRNA cluster 12 cluster 3 mutation cluster 13 TCGA-66-2793 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 68 R-Middle TCGA-66-2793 TCGA-66-2793-01A -25111 306 0 2011-3-7 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.2 8070/3 C34.2 YES 0.5 NO 0.9 112 No M0 N1 T4 Stage IIIB TCGA-66-2793.c2a1ad10-926c-4bab-9a34-467b3496a453.pdf 2793 TUMOR FREE R0 Primary Tumor 01 0.4 2008 6th NO YES 66 4 Lung A DECEASED 2008 1952 TCGA-66-2793-01A-01D-1267-08 TCGA-66-2793-01A-01D-1198-05 df7bc5ee-3423-495a-bc08-c0053e1640ad TCGA-66-2793-01 TCGA-66-2793-01A-01D-1267-08 TCGA-66-2793-01 TCGA-66-2793-01A-01R-1201-07 df7bc5ee-3423-495a-bc08-c0053e1640ad 5340437d-1708-43b7-84db-b2debb2622ba TCGA-66-2793-01 TCGA-66-2793-01A-01D-1195-01 TCGA-66-2793-01 df7bc5ee-3423-495a-bc08-c0053e1640ad TCGA-66-2793-01 df7bc5ee-3423-495a-bc08-c0053e1640ad TCGA-66-2793-01 TCGA-66-2793-01A-01D-1195-01 +TCGA-66-2794-01 TCGA-66-2794-01 Squamous C2-Squamous-like cluster 2 Cluster 13 (HNSC-LUSC) squamous c3 squamous-like c4 miRNA cluster 4 cluster 2 mutation cluster 5 TCGA-66-2794 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 64 L-Upper TCGA-66-2794-F37017 TCGA-66-2794 TCGA-66-2794-01A -23710 0 1645 Complete Remission/Response 2012-11-20 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 1 NO 1.2 NO 100 No M0 N2 T4 Stage IIIB TCGA-66-2794.b0788a69-3dd0-42d6-8564-958a0108654b.pdf 2794 TUMOR FREE Complete Remission/Response YES R0 Primary Tumor 01 0.3 1993 6th NO NO YES 66 4 Lung A LIVING 2006 1957 TCGA-66-2794-01A-01D-1267-08 TCGA-66-2794-01A-01D-1198-05 70235f1f-1376-4326-99d0-e413fab24662 TCGA-66-2794-01 TCGA-66-2794-01A-01D-1267-08 TCGA-66-2794-01 TCGA-66-2794-01A-01R-1201-07 70235f1f-1376-4326-99d0-e413fab24662 e673c540-3b14-4ebb-8a24-0d09b3104d89 TCGA-66-2794-01A-21-2193-20 TCGA-66-2794-01 TCGA-66-2794-01A-01D-1195-01 TCGA-66-2794-01 70235f1f-1376-4326-99d0-e413fab24662 TCGA-66-2794-01 70235f1f-1376-4326-99d0-e413fab24662 TCGA-66-2794-01 TCGA-66-2794-01A-01D-1195-01 ab258a4f-7597-4592-81c1-9f8aa1b7bf0c +TCGA-66-2795-01 TCGA-66-2795-01 Squamous C2-Squamous-like cluster 3 Cluster 13 (HNSC-LUSC) squamous c3 squamous-like c4 miRNA cluster 4 cluster 4 mutation cluster 8 TCGA-66-2795 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 68 L-Upper TCGA-66-2795 TCGA-66-2795-01A -24897 0 122 2011-3-7 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 1 NO 1 86 No M0 N1 T4 Stage IIIB TCGA-66-2795.7993de3e-afeb-4eaf-96fa-4efbb5167130.pdf 2795 TUMOR FREE R0 Primary Tumor 01 0.3 2008 6th NO YES 66 4 Lung A LIVING 2008 1965 TCGA-66-2795-01A-02D-0983-08 TCGA-66-2795-01A-02D-0979-05 ae8b243b-3190-47e5-af8f-3ff76a403516 TCGA-66-2795-01 TCGA-66-2795-01A-02D-0983-08 TCGA-66-2795-01 TCGA-66-2795-01A-02R-0980-07 ae8b243b-3190-47e5-af8f-3ff76a403516 96103311-35be-4fe0-b698-6b07a621c9d0 TCGA-66-2795-01A-11-2193-20 TCGA-66-2795-01 TCGA-66-2795-01A-02D-0978-01 TCGA-66-2795-01 ae8b243b-3190-47e5-af8f-3ff76a403516 TCGA-66-2795-01 ae8b243b-3190-47e5-af8f-3ff76a403516 TCGA-66-2795-01 TCGA-66-2795-01A-02D-0978-01 e145986b-e6d4-4e31-bf1e-b242af22f436 +TCGA-66-2795-11 TCGA-66-2795-11 C2-Squamous-like mutation cluster 8 TCGA-66-2795 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 68 L-Upper TCGA-66-2795 TCGA-66-2795-11A -24897 0 122 2011-3-7 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.8 NO 1.2 86 No M0 N1 T4 Stage IIIB 2795 TUMOR FREE R0 Solid Tissue Normal 11 0.8 2008 6th NO YES 66 4 Lung A LIVING 2008 1965 TCGA-66-2795-11A-01D-0979-05 +TCGA-66-2800-01 TCGA-66-2800-01 Squamous C2-Squamous-like cluster 3 Cluster 13 (HNSC-LUSC) squamous c3 squamous-like c4 miRNA c1uster 9 cluster 2 mutation cluster 5 TCGA-66-2800 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 70 R-Upper TCGA-66-2800-F37048 TCGA-66-2800 TCGA-66-2800-01A -25810 0 1492 Scheduled Follow-up Submission Complete Remission/Response 2012-11-21 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 1 NO 2 NO NO 75 No M0 N0 T4 Stage IIIB TCGA-66-2800.06d8266a-1fc8-4082-8a06-178dc57639c6.pdf 2800 TUMOR FREE NO R0 Primary Tumor 01 0.6 2000 5th NO NO YES 66 4 Lung A LIVING 2004 1950 TCGA-66-2800-01A-01D-1267-08 TCGA-66-2800-01A-01D-1198-05 e24747be-f71a-488a-84bb-5872711cc40e TCGA-66-2800-01 TCGA-66-2800-01A-01D-1267-08 TCGA-66-2800-01 TCGA-66-2800-01A-01R-1201-07 e24747be-f71a-488a-84bb-5872711cc40e 23ad5650-58ab-4312-8f4b-aef48e06dca3 TCGA-66-2800-01A-21-2193-20 TCGA-66-2800-01 TCGA-66-2800-01A-01D-1195-01 TCGA-66-2800-01 e24747be-f71a-488a-84bb-5872711cc40e TCGA-66-2800-01 e24747be-f71a-488a-84bb-5872711cc40e TCGA-66-2800-01 TCGA-66-2800-01A-01D-1195-01 46d73760-a073-4776-a709-4c8a47d0d076 +TCGA-68-7755-01 TCGA-68-7755-01 Squamous Cluster 13 (HNSC-LUSC) miRNA cluster 4 TCGA-68-7755 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung NO NO 60 R-Lower TCGA-68-7755-F20819 TCGA-68-7755 TCGA-68-7755-01A -21936 0 83 NO NO Scheduled Follow-up Submission 2012-1-23 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.6 NO NO Peripheral Lung 0.7 NO 78 No M0 N1 T1b Stage IIA TCGA-68-7755.472f285d-d573-47af-95c7-9c4b45fbae40.pdf 7755 TUMOR FREE NO Primary Tumor 01 0.2 1999 7th YES YES NO 68 4 Lung A LIVING 2011 1973 990bafa2-fdcf-4e80-aeb3-702157438626 TCGA-68-7755-01 TCGA-68-7755-01 TCGA-68-7755-01 990bafa2-fdcf-4e80-aeb3-702157438626 TCGA-68-7755-01 TCGA-68-7755-01A-11D-2121-01 990bafa2-fdcf-4e80-aeb3-702157438626 990bafa2-fdcf-4e80-aeb3-702157438626 TCGA-68-7755-01A-11D-2121-01 TCGA-68-7755-01A-11D-2123-05 +TCGA-68-7756-01 TCGA-68-7756-01 Squamous Cluster 5 squamous c3 miRNA cluster 4 TCGA-68-7756 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung NO NO 84 L-Upper TCGA-68-7756-F20861 TCGA-68-7756 -30763 0 202 96 YES NO Scheduled Follow-up Submission 2012-1-24 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES NO Peripheral Lung NO 20 No MX N1 T4 Stage IIIA 7756 85 89 87 84 YES YES Primary Tumor 01 1971 7th YES YES NO 68 3 Lung LIVING 2011 f8243dda-830f-4c7e-bde2-20bad21725d0 TCGA-68-7756-01 TCGA-68-7756-01 TCGA-68-7756-01 f8243dda-830f-4c7e-bde2-20bad21725d0 TCGA-68-7756-01A-13-2195-20 TCGA-68-7756-01 TCGA-68-7756-01A-11D-2121-01 f8243dda-830f-4c7e-bde2-20bad21725d0 f8243dda-830f-4c7e-bde2-20bad21725d0 TCGA-68-7756-01A-11D-2121-01 TCGA-68-7756-01A-11D-2123-05 ed06c7b1-cc32-46c2-810c-310112f4c7a8 +TCGA-68-7757-01 TCGA-68-7757-01 Squamous Cluster 5 miRNA cluster 4 TCGA-68-7757 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung NO NO 74 L-Upper TCGA-68-7757-F32558 TCGA-68-7757 TCGA-68-7757-01A -27272 0 211 71 0 NO NO Scheduled Follow-up Submission 2012-6-1 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.6 NO NO 0.9 YES NO 25 No MX N0 T1b Stage IA TCGA-68-7757.87fd1307-e3eb-45da-b0ec-2e3cb95e06d5.pdf 7757 Preoperative 83 86 81 85 YES NO Primary Tumor 01 0.1 2010 7th NO NO YES 68 4 Lung A LIVING 2011 1960 bea8760d-cd7c-4d02-8032-cf32505fda56 TCGA-68-7757-01 TCGA-68-7757-01 TCGA-68-7757-01 bea8760d-cd7c-4d02-8032-cf32505fda56 TCGA-68-7757-01 TCGA-68-7757-01B-11D-2292-01 bea8760d-cd7c-4d02-8032-cf32505fda56 bea8760d-cd7c-4d02-8032-cf32505fda56 TCGA-68-7757-01B-11D-2292-01 TCGA-68-7757-01B-11D-2294-05 9AF85A2F-997D-47D0-9048-8A57BF46F48C +TCGA-68-8250-01 TCGA-68-8250-01 High Cluster 5 miRNA c1uster 9 TCGA-68-8250 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 66 R-Upper TCGA-68-8250-F32333 TCGA-68-8250 TCGA-68-8250-01A -24118 0 244 68 NO Scheduled Follow-up Submission 2012-5-23 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.4 NO 1.1 NO NO 50 Yes, History of Synchronous/Bilateral Malignancy MX N0 T1a Stage IA TCGA-68-8250.db0359b7-58b4-456f-a905-c8dc2b3ea8a4.pdf 8250 TUMOR FREE 88 YES NO Primary Tumor 01 0.3 2011 7th NO NO YES 68 4 Lung A LIVING 2011 2bdb8f96-2194-4541-bf8b-2798fb197a7c TCGA-68-8250-01 TCGA-68-8250-01 TCGA-68-8250-01 2bdb8f96-2194-4541-bf8b-2798fb197a7c TCGA-68-8250-01 TCGA-68-8250-01A-11D-2292-01 2bdb8f96-2194-4541-bf8b-2798fb197a7c 2bdb8f96-2194-4541-bf8b-2798fb197a7c TCGA-68-8250-01A-11D-2292-01 TCGA-68-8250-01A-11D-2294-05 +TCGA-68-8251-01 TCGA-68-8251-01 Squamous Cluster 13 (HNSC-LUSC) miRNA cluster 4 TCGA-68-8251 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 78 L-Upper TCGA-68-8251-F41951 TCGA-68-8251 TCGA-68-8251-01A -28739 0 406 75 0 Scheduled Follow-up Submission Stable Disease 2013-4-5 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.6 NO 1.2 NO NO 52 No M0 N0 T2a Stage IB TCGA-68-8251.ca919e01-66e2-4307-b0ef-2dda4c1ca840.pdf 8251 Preoperative TUMOR FREE 99 91 Stable Disease YES NO Primary Tumor 01 0.4 1979 7th YES NO YES 68 3 Lung A LIVING 2012 1944 9ceb9e31-6495-4ae8-8c41-58fe981f9ac7 TCGA-68-8251-01 TCGA-68-8251-01 TCGA-68-8251-01 9ceb9e31-6495-4ae8-8c41-58fe981f9ac7 TCGA-68-8251-01 TCGA-68-8251-01A-11D-2292-01 9ceb9e31-6495-4ae8-8c41-58fe981f9ac7 9ceb9e31-6495-4ae8-8c41-58fe981f9ac7 TCGA-68-8251-01A-11D-2292-01 TCGA-68-8251-01A-11D-2294-05 +TCGA-68-A59I-01 TCGA-68-A59I-01 TCGA-68-A59I TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung YES YES 73 L-Lower TCGA-68-A59I-F57691 TCGA-68-A59I TCGA-68-A59I-01A -26839 36 0 428 159 Scheduled Follow-up Submission 2014-3-20 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 220 NO NO New Primary Tumor YES 50 true No M0 N1 T3 Stage IIIA TCGA-68-A59I.B0897B1D-F870-489E-9D9C-C670982BB3E0.pdf A59I WITH TUMOR 101 66.09 Stable Disease Convincing Imaging YES YES Primary Tumor 01 2012 7th YES YES NO 68 4 Lung A LIVING 2012 1962 04082349-5790-405a-9bbb-13d745fd4c05 TCGA-68-A59I-01 TCGA-68-A59I-01 TCGA-68-A59I-01 04082349-5790-405a-9bbb-13d745fd4c05 TCGA-68-A59I-01 TCGA-68-A59I-01A-11D-A26L-01 04082349-5790-405a-9bbb-13d745fd4c05 04082349-5790-405a-9bbb-13d745fd4c05 TCGA-68-A59I-01A-11D-A26L-01 TCGA-68-A59I-01A-11D-A26N-05 A4CE7A1A-CE58-494A-97FB-B62E7C0C4FB5 +TCGA-68-A59J-01 TCGA-68-A59J-01 TCGA-68-A59J TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 74 R-Lower TCGA-68-A59J-F57690 TCGA-68-A59J TCGA-68-A59J-01A -27031 20 0 409 Scheduled Follow-up Submission 2014-3-20 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 240 NO NO NO 45 true No MX N0 T2a Stage IB TCGA-68-A59J.629F9E80-0846-48A6-A872-5250D66BD0F7.pdf A59J TUMOR FREE 67 62 Complete Remission/Response YES NO R0 Primary Tumor 01 2007 7th NO YES NO 68 4 Lung A LIVING 2012 1962 ba2a4e28-8085-4721-a72c-2f26b49b6776 TCGA-68-A59J-01 TCGA-68-A59J-01 TCGA-68-A59J-01 ba2a4e28-8085-4721-a72c-2f26b49b6776 TCGA-68-A59J-01 TCGA-68-A59J-01A-21D-A26L-01 ba2a4e28-8085-4721-a72c-2f26b49b6776 ba2a4e28-8085-4721-a72c-2f26b49b6776 TCGA-68-A59J-01A-21D-A26L-01 TCGA-68-A59J-01A-21D-A26N-05 758A444F-50E9-49D0-AC78-64B5DD2E0C68 +TCGA-6A-AB49-01 TCGA-6A-AB49-01 TCGA-6A-AB49 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 73 L-Lower TCGA-6A-AB49-F66619 TCGA-6A-AB49 TCGA-6A-AB49-01A 1691 [Discrepancy] 0 Scheduled Follow-up Submission Complete Remission/Response 2014-10-21 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 80 NO 0 Central Lung NO NO 50 false No MX N0 T2 Stage IB TCGA-6A-AB49.2424B47C-B6A9-449C-86C3-1B8C2604FA8F.pdf AB49 Other TUMOR FREE 70 71 72 70 Complete Remission/Response YES NO RX Primary Tumor 01 6th NO NO YES 6A 3 Lung A DECEASED 2009 1969 4f64d057-a632-4a38-a9fe-977a194bcd34 TCGA-6A-AB49-01 TCGA-6A-AB49-01 TCGA-6A-AB49-01 4f64d057-a632-4a38-a9fe-977a194bcd34 TCGA-6A-AB49-01 TCGA-6A-AB49-01A-12D-A400-01 4f64d057-a632-4a38-a9fe-977a194bcd34 4f64d057-a632-4a38-a9fe-977a194bcd34 TCGA-6A-AB49-01A-12D-A400-01 TCGA-6A-AB49-01A-12D-A408-05 +TCGA-70-6722-01 TCGA-70-6722-01 Squamous C2-Squamous-like cluster 1 Cluster 5 squamous c3 squamous-like c4 miRNA cluster 5 cluster 4 mutation cluster 6 TCGA-70-6722 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung NO NO NO 47 R-Upper TCGA-70-6722-F70936 TCGA-70-6722 TCGA-70-6722-01A -17328 0 367 293 2 Scheduled Follow-up Submission Progressive Disease 2015-3-10 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.6 NO 20 2.2 NO Locoregional Recurrence YES No M0 N1 T3 Stage IIIA TCGA-70-6722.09915ca9-3880-4aa5-aab2-3762bf1d162c.pdf 6722 Post-Adjuvant Therapy WITH TUMOR Progressive Disease YES RX Primary Tumor 01 0.6 6th NO YES NO 70 1 Lung A LIVING 2010 TCGA-70-6722-01A-11D-1817-08 c4298e1d-a255-4c7d-af91-48868b8a72ea TCGA-70-6722-01 TCGA-70-6722-01A-11D-1817-08 TCGA-70-6722-01 TCGA-70-6722-01 c4298e1d-a255-4c7d-af91-48868b8a72ea TCGA-70-6722-01A-13-2194-20 TCGA-70-6722-01 TCGA-70-6722-01A-11D-1816-01 c4298e1d-a255-4c7d-af91-48868b8a72ea c4298e1d-a255-4c7d-af91-48868b8a72ea TCGA-70-6722-01A-11D-1816-01 TCGA-70-6722-01A-11D-1818-05 7f55ab0d-c1e6-40bb-822c-a2a007f6f2aa +TCGA-70-6723-01 TCGA-70-6723-01 Squamous C2-Squamous-like cluster 2 Cluster 13 (HNSC-LUSC) squamous c3 squamous-like c4 miRNA cluster 12 cluster 3 mutation cluster 5 TCGA-70-6723 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung NO NO NO 65 R-Upper TCGA-70-6723-F70934 TCGA-70-6723 TCGA-70-6723-01A -24035 0 375 312 2 Scheduled Follow-up Submission Progressive Disease 2015-3-10 MALE Lung Papillary Squamous Cell Caricnoma No C34.1 8052/3 C34.1 YES 1 NO 40 1.5 NO Locoregional Recurrence YES No M0 N0 T3 Stage IIA TCGA-70-6723.09544798-db0a-443e-8f57-ca404db4f4ef.pdf 6723 Post-Adjuvant Therapy WITH TUMOR Progressive Disease YES RX Primary Tumor 01 0.8 6th NO YES NO 70 1 Lung A LIVING 2010 TCGA-70-6723-01A-11D-1817-08 88ef1c54-2210-429c-9cc4-6c12e6ee9d61 TCGA-70-6723-01 TCGA-70-6723-01A-11D-1817-08 TCGA-70-6723-01 TCGA-70-6723-01 88ef1c54-2210-429c-9cc4-6c12e6ee9d61 TCGA-70-6723-01A-13-2194-20 TCGA-70-6723-01 TCGA-70-6723-01A-11D-1816-01 88ef1c54-2210-429c-9cc4-6c12e6ee9d61 88ef1c54-2210-429c-9cc4-6c12e6ee9d61 TCGA-70-6723-01A-11D-1816-01 TCGA-70-6723-01A-11D-1818-05 c11267c5-85c9-41fc-9d22-9531b264afa3 +TCGA-77-6842-01 TCGA-77-6842-01 High C2-Squamous-like Cluster 5 squamous c3 squamous-like c4 miRNA c1uster 9 TCGA-77-6842 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung NO YES 79 TCGA-77-6842-F16162 TCGA-77-6842 TCGA-77-6842-01A -28861 899 0 201 1 NO NO Scheduled Follow-up Submission 2011-9-15 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.8 8070/3 C34.8 YES 0.8 NO NO Central Lung 1.2 YES 22.5 No M0 N1 T2 Stage IIB TCGA-77-6842.4f5574a0-e1d7-427c-8f03-d08cb0b264a4.pdf 6842 Preoperative NO R0 Primary Tumor 01 0.5 2000 6th NO NO YES 77 4 Lung A DECEASED 2000 1950 20c383e0-a901-4a61-94d1-002a86a0d1c3 TCGA-77-6842-01 TCGA-77-6842-01 TCGA-77-6842-01 20c383e0-a901-4a61-94d1-002a86a0d1c3 TCGA-77-6842-01A-13-2194-20 TCGA-77-6842-01 TCGA-77-6842-01A-11D-1943-01 20c383e0-a901-4a61-94d1-002a86a0d1c3 20c383e0-a901-4a61-94d1-002a86a0d1c3 TCGA-77-6842-01A-11D-1943-01 TCGA-77-6842-01A-11D-1947-05 0b3eb76b-445c-4a34-9e9c-d626c5a79b80 +TCGA-77-6843-01 TCGA-77-6843-01 Squamous C2-Squamous-like Cluster 13 (HNSC-LUSC) squamous c3 squamous-like c4 miRNA cluster 11 TCGA-77-6843 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 74 R-Upper TCGA-77-6843-F16160 TCGA-77-6843 TCGA-77-6843-01A -27291 2224 0 2 NO NO Scheduled Follow-up Submission 2011-9-15 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.7 NO NO Central Lung 1 30 No M0 N1 T1 Stage IIA TCGA-77-6843.538c9962-002f-4415-b145-dd8710baa108.pdf 6843 Preoperative NO R0 Primary Tumor 01 0.5 6th NO NO YES 77 2 Lung A DECEASED 2002 1941 3fc2678f-e653-41c7-a106-4aed5df1dedb TCGA-77-6843-01 TCGA-77-6843-01 TCGA-77-6843-01 3fc2678f-e653-41c7-a106-4aed5df1dedb TCGA-77-6843-01A-13-2194-20 TCGA-77-6843-01 TCGA-77-6843-01A-11D-1943-01 3fc2678f-e653-41c7-a106-4aed5df1dedb 3fc2678f-e653-41c7-a106-4aed5df1dedb TCGA-77-6843-01A-11D-1943-01 TCGA-77-6843-01A-11D-1947-05 ad48f945-91c3-4ef1-8ecd-4dfbb5449718 +TCGA-77-6844-01 TCGA-77-6844-01 Squamous C2-Squamous-like Cluster 5 squamous c3 squamous-like c4 miRNA cluster 11 TCGA-77-6844 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung NO NO YES NO 74 R-Lower TCGA-77-6844-F16280 TCGA-77-6844 TCGA-77-6844-01A 1788 -27220 2284 0 1788 1 NO NO Scheduled Follow-up Submission 2011-9-16 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.7 NO NO Central Lung 1.5 YES 45 No M0 N1 T3 Stage IIIA TCGA-77-6844.365db97d-4da1-455a-80b9-94273a693091.pdf 6844 Preoperative Complete Remission/Response YES R0 Primary Tumor 01 0.5 1987 6th NO NO YES 77 4 Lung A DECEASED 2002 1942 6474e097-3eaa-4741-a466-be378a1ca862 TCGA-77-6844-01 TCGA-77-6844-01 TCGA-77-6844-01 6474e097-3eaa-4741-a466-be378a1ca862 TCGA-77-6844-01A-13-2194-20 TCGA-77-6844-01 TCGA-77-6844-01A-11D-1943-01 6474e097-3eaa-4741-a466-be378a1ca862 6474e097-3eaa-4741-a466-be378a1ca862 TCGA-77-6844-01A-11D-1943-01 TCGA-77-6844-01A-11D-1947-05 7490a6fd-28ce-444d-800c-5d8da101263e +TCGA-77-6845-01 TCGA-77-6845-01 Squamous C2-Squamous-like Cluster 5 squamous c3 squamous-like c4 miRNA cluster 11 TCGA-77-6845 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung NO NO NO NO 69 R-Middle TCGA-77-6845-F16478 TCGA-77-6845 TCGA-77-6845-01A -25321 708 0 1 NO NO Scheduled Follow-up Submission 2011-9-20 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.2 8070/3 C34.2 YES 0.7 NO NO Central Lung 1.2 NO 51 No M0 N0 T3 Stage IIB TCGA-77-6845.105eaa92-2ebd-4a99-a01c-88816a776f49.pdf 6845 Preoperative NO R0 Primary Tumor 01 0.4 2003 6th NO NO YES 77 4 Lung A DECEASED 2003 1952 8ce70027-d230-4af0-ab5f-5a50fdaac5e5 TCGA-77-6845-01 TCGA-77-6845-01 TCGA-77-6845-01 8ce70027-d230-4af0-ab5f-5a50fdaac5e5 TCGA-77-6845-01A-13-2194-20 TCGA-77-6845-01 TCGA-77-6845-01A-11D-1943-01 8ce70027-d230-4af0-ab5f-5a50fdaac5e5 8ce70027-d230-4af0-ab5f-5a50fdaac5e5 TCGA-77-6845-01A-11D-1943-01 TCGA-77-6845-01A-11D-1947-05 53a0c948-51c5-45f0-ae9e-a27679f2849f +TCGA-77-7138-01 TCGA-77-7138-01 High Low purity c2 squamous-like c4 miRNA cluster 11 TCGA-77-7138 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 67 L-Lower TCGA-77-7138-F19291 TCGA-77-7138 TCGA-77-7138-01A -24594 340 0 1 NO NO Scheduled Follow-up Submission 2011-12-8 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.7 NO NO Peripheral Lung 1 20 No M0 N0 T2 Stage IB TCGA-77-7138.baebd9a2-9ae7-462a-b5bd-8c5c7c03bf01.pdf 7138 Preoperative NO R0 Primary Tumor 01 0.6 1979 6th NO NO YES 77 3 Lung A DECEASED 1999 1959 7ea63ff9-467e-4645-bacb-d91fe95a8c62 TCGA-77-7138-01 TCGA-77-7138-01 TCGA-77-7138-01 7ea63ff9-467e-4645-bacb-d91fe95a8c62 TCGA-77-7138-01 TCGA-77-7138-01A-41D-2041-01 7ea63ff9-467e-4645-bacb-d91fe95a8c62 7ea63ff9-467e-4645-bacb-d91fe95a8c62 TCGA-77-7138-01A-41D-2041-01 TCGA-77-7138-01A-41D-2043-05 +TCGA-77-7138-11 TCGA-77-7138-11 TCGA-77-7138 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 67 L-Lower TCGA-77-7138-F19291 TCGA-77-7138 TCGA-77-7138-11A -24594 340 0 1 NO NO Scheduled Follow-up Submission 2011-12-8 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.9 NO NO Peripheral Lung 1.2 20 No M0 N0 T2 Stage IB 7138 Preoperative NO R0 Solid Tissue Normal 11 0.7 1979 6th NO NO YES 77 3 Lung A DECEASED 1999 1959 04523c86-295b-4343-843a-43e4dddf70d1 TCGA-77-7138-11 TCGA-77-7138-11 04523c86-295b-4343-843a-43e4dddf70d1 04523c86-295b-4343-843a-43e4dddf70d1 04523c86-295b-4343-843a-43e4dddf70d1 +TCGA-77-7139-01 TCGA-77-7139-01 Squamous C2-Squamous-like Cluster 13 (HNSC-LUSC) squamous c3 squamous-like c4 miRNA cluster 11 TCGA-77-7139 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 56 R-Lower TCGA-77-7139-F46101 TCGA-77-7139 TCGA-77-7139-01A -20632 0 4261 1 NO NO Scheduled Follow-up Submission 2013-8-6 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.5 NO NO Central Lung 0.7 NO 2 No M0 N1 T2 Stage IIB TCGA-77-7139.6e64f460-ab1c-478e-9b44-288ca9d5875f.pdf 7139 Preoperative NO R0 Primary Tumor 01 0.4 1991 6th NO YES 77 4 Lung A LIVING 2002 1968 aa7c9175-113a-4a7b-8577-18478b0fffd3 TCGA-77-7139-01 TCGA-77-7139-01 TCGA-77-7139-01 aa7c9175-113a-4a7b-8577-18478b0fffd3 TCGA-77-7139-01A-13-2195-20 TCGA-77-7139-01 TCGA-77-7139-01A-11D-2041-01 aa7c9175-113a-4a7b-8577-18478b0fffd3 aa7c9175-113a-4a7b-8577-18478b0fffd3 TCGA-77-7139-01A-11D-2041-01 TCGA-77-7139-01A-11D-2043-05 170fc88b-90da-456b-b2d2-b8675c357b8e +TCGA-77-7140-01 TCGA-77-7140-01 High Cluster 13 (HNSC-LUSC) squamous-like c4 miRNA cluster 11 TCGA-77-7140 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung YES NO YES 69 L-Upper TCGA-77-7140-F19327 TCGA-77-7140 250 -25303 632 0 250 0 NO NO Scheduled Follow-up Submission 2011-12-9 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES NO Central Lung YES Yes M0 N1 T2 Stage IIB 7140 Preoperative NO R0 Primary Tumor 01 6th NO NO YES 77 1 Lung DECEASED 2002 fffdafae-fae0-4ae9-8fd2-3c2bedd156e1 TCGA-77-7140-01 TCGA-77-7140-01 TCGA-77-7140-01 fffdafae-fae0-4ae9-8fd2-3c2bedd156e1 TCGA-77-7140-01 TCGA-77-7140-01A-41D-2041-01 fffdafae-fae0-4ae9-8fd2-3c2bedd156e1 fffdafae-fae0-4ae9-8fd2-3c2bedd156e1 TCGA-77-7140-01A-41D-2041-01 TCGA-77-7140-01A-41D-2043-05 +TCGA-77-7141-01 TCGA-77-7141-01 Squamous C2-Squamous-like BRCA CIMP c7 squamous c3 squamous-like c4 miRNA cluster 4 TCGA-77-7141 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 64 L-Upper TCGA-77-7141-F46102 TCGA-77-7141 TCGA-77-7141-01A -23584 0 15 1 NO NO Scheduled Follow-up Submission 2013-8-6 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.8 NO NO Central Lung 1 YES 70 No M0 N0 T2 Stage IB TCGA-77-7141.c8d8d890-f2a1-4b25-ba59-bcf0f69553b2.pdf 7141 Preoperative NO R0 Primary Tumor 01 0.3 1988 6th NO YES 77 4 Lung A LIVING 2003 1953 64353828-9b3b-491d-8d13-ce36e09fa6f9 TCGA-77-7141-01 TCGA-77-7141-01 TCGA-77-7141-01 64353828-9b3b-491d-8d13-ce36e09fa6f9 TCGA-77-7141-01A-13-2195-20 TCGA-77-7141-01 TCGA-77-7141-01A-11D-2041-01 64353828-9b3b-491d-8d13-ce36e09fa6f9 64353828-9b3b-491d-8d13-ce36e09fa6f9 TCGA-77-7141-01A-11D-2041-01 TCGA-77-7141-01A-11D-2043-05 0f4cb2ec-80f5-4ecf-b1fe-87862265e560 +TCGA-77-7142-01 TCGA-77-7142-01 Squamous C2-Squamous-like Cluster 13 (HNSC-LUSC) squamous c3 squamous-like c4 miRNA c1uster 9 TCGA-77-7142 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 59 L-Upper TCGA-77-7142-F46141 TCGA-77-7142 -21796 0 2227 1 NO NO Scheduled Follow-up Submission 2013-8-23 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES NO Peripheral Lung NO 52.5 No M0 N0 T2 Stage IB 7142 Preoperative TUMOR FREE NO R0 Primary Tumor 01 2004 6th NO YES 77 4 Lung LIVING 2007 1959 b7d58bd2-216f-4fdf-b97e-56d9cfb69e3b TCGA-77-7142-01 TCGA-77-7142-01 TCGA-77-7142-01 b7d58bd2-216f-4fdf-b97e-56d9cfb69e3b TCGA-77-7142-01A-13-2195-20 TCGA-77-7142-01 TCGA-77-7142-01A-11D-2041-01 b7d58bd2-216f-4fdf-b97e-56d9cfb69e3b b7d58bd2-216f-4fdf-b97e-56d9cfb69e3b TCGA-77-7142-01A-11D-2041-01 TCGA-77-7142-01A-11D-2043-05 f8ffcd7b-8e62-42ab-a042-d9b8e2eb028e +TCGA-77-7142-11 TCGA-77-7142-11 C2-Squamous-like TCGA-77-7142 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 59 L-Upper TCGA-77-7142-F46141 TCGA-77-7142 -21796 0 2227 1 NO NO Scheduled Follow-up Submission 2013-8-23 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES NO Peripheral Lung NO 52.5 No M0 N0 T2 Stage IB 7142 Preoperative TUMOR FREE NO R0 Solid Tissue Normal 11 2004 6th NO YES 77 4 Lung LIVING 2007 1959 d16a7dea-99ca-455e-80c7-4f182b25d382 TCGA-77-7142-11 TCGA-77-7142-11 d16a7dea-99ca-455e-80c7-4f182b25d382 d16a7dea-99ca-455e-80c7-4f182b25d382 d16a7dea-99ca-455e-80c7-4f182b25d382 +TCGA-77-7335-01 TCGA-77-7335-01 Kirc+ C2-Squamous-like Cluster 13 (HNSC-LUSC) squamous c3 squamous-like c4 miRNA cluster 4 TCGA-77-7335 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 62 TCGA-77-7335-F19288 TCGA-77-7335 -22863 2133 0 1 NO NO Scheduled Follow-up Submission 2011-12-8 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.9 8071/3 C34.9 YES NO Central Lung 52 No M0 N2 T4 Stage IIIB 7335 Preoperative NO R0 Primary Tumor 01 1980 6th NO NO YES 77 3 Lung DECEASED 1996 1954 c291c855-abe4-4805-973f-e29ee22c4667 TCGA-77-7335-01 TCGA-77-7335-01 TCGA-77-7335-01 c291c855-abe4-4805-973f-e29ee22c4667 TCGA-77-7335-01A-13-2195-20 TCGA-77-7335-01 TCGA-77-7335-01A-11D-2041-01 c291c855-abe4-4805-973f-e29ee22c4667 c291c855-abe4-4805-973f-e29ee22c4667 TCGA-77-7335-01A-11D-2041-01 TCGA-77-7335-01A-11D-2043-05 cbbac7ba-2c9e-48da-a60b-d48636e498d9 +TCGA-77-7335-11 TCGA-77-7335-11 C2-Squamous-like TCGA-77-7335 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 62 TCGA-77-7335-F19288 TCGA-77-7335 TCGA-77-7335-11A -22863 2133 0 1 NO NO Scheduled Follow-up Submission 2011-12-8 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.9 8071/3 C34.9 YES 0.7 NO NO Central Lung 1.4 52 No M0 N2 T4 Stage IIIB 7335 Preoperative NO R0 Solid Tissue Normal 11 0.5 1980 6th NO NO YES 77 3 Lung A DECEASED 1996 1954 a7309f60-5fb7-4cd9-90e8-54d850b4b241 a7309f60-5fb7-4cd9-90e8-54d850b4b241 a7309f60-5fb7-4cd9-90e8-54d850b4b241 a7309f60-5fb7-4cd9-90e8-54d850b4b241 +TCGA-77-7337-01 TCGA-77-7337-01 High C2-Squamous-like Cluster 13 (HNSC-LUSC) squamous c3 squamous-like c4 miRNA cluster 4 TCGA-77-7337 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 65 L-Upper TCGA-77-7337-F19302 TCGA-77-7337 TCGA-77-7337-01A -24065 3253 0 0 NO NO Scheduled Follow-up Submission 2011-12-8 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.9 8070/3 C34.9 YES 0.7 NO NO Central Lung 0.9 79.5 No M0 N1 T2 Stage IIB TCGA-77-7337.486787b7-4d3f-4f98-85df-8daa3976bfb4.pdf 7337 Preoperative NO R0 Primary Tumor 01 0.6 1996 6th NO NO YES 77 4 Lung A DECEASED 2000 1942 86c13d00-9cb9-4cad-bf90-beb4115b69f5 TCGA-77-7337-01 TCGA-77-7337-01 TCGA-77-7337-01 86c13d00-9cb9-4cad-bf90-beb4115b69f5 TCGA-77-7337-01A-23-2195-20 TCGA-77-7337-01 TCGA-77-7337-01A-21D-2041-01 86c13d00-9cb9-4cad-bf90-beb4115b69f5 86c13d00-9cb9-4cad-bf90-beb4115b69f5 TCGA-77-7337-01A-21D-2041-01 TCGA-77-7337-01A-21D-2043-05 52200f31-4605-44ce-838c-91729bfe62fb +TCGA-77-7337-11 TCGA-77-7337-11 C2-Squamous-like TCGA-77-7337 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 65 L-Upper TCGA-77-7337-F19302 TCGA-77-7337 -24065 3253 0 0 NO NO Scheduled Follow-up Submission 2011-12-8 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.9 8070/3 C34.9 YES NO Central Lung 79.5 No M0 N1 T2 Stage IIB 7337 Preoperative NO R0 Solid Tissue Normal 11 1996 6th NO NO YES 77 4 Lung DECEASED 2000 1942 eafca6a1-4558-4b8e-8fd9-111e6bbdba84 TCGA-77-7337-11 TCGA-77-7337-11 eafca6a1-4558-4b8e-8fd9-111e6bbdba84 eafca6a1-4558-4b8e-8fd9-111e6bbdba84 eafca6a1-4558-4b8e-8fd9-111e6bbdba84 +TCGA-77-7338-01 TCGA-77-7338-01 Squamous C2-Squamous-like Cluster 13 (HNSC-LUSC) squamous c3 squamous-like c4 miRNA cluster 4 TCGA-77-7338 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 64 R-Upper TCGA-77-7338-F19304 TCGA-77-7338 TCGA-77-7338-01A -23480 5 0 1 NO NO Scheduled Follow-up Submission 2011-12-8 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.5 NO NO Peripheral Lung 1.4 NO 41.25 No M0 N0 T2 Stage IB TCGA-77-7338.be1035b5-a744-4574-add2-31d2ab9ccdc0.pdf 7338 Preoperative NO R1 Primary Tumor 01 0.5 6th NO NO YES 77 2 Lung A DECEASED 1995 1952 03e01fb5-4517-4820-bc3b-fe892a8ef896 TCGA-77-7338-01 TCGA-77-7338-01 TCGA-77-7338-01 03e01fb5-4517-4820-bc3b-fe892a8ef896 TCGA-77-7338-01A-13-2195-20 TCGA-77-7338-01 TCGA-77-7338-01A-11D-2041-01 03e01fb5-4517-4820-bc3b-fe892a8ef896 03e01fb5-4517-4820-bc3b-fe892a8ef896 TCGA-77-7338-01A-11D-2041-01 TCGA-77-7338-01A-11D-2043-05 79c97d84-243a-4530-b77f-9f1228a2217f +TCGA-77-7338-11 TCGA-77-7338-11 C2-Squamous-like TCGA-77-7338 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 64 R-Upper TCGA-77-7338-F19304 TCGA-77-7338 TCGA-77-7338-11A -23480 5 0 1 NO NO Scheduled Follow-up Submission 2011-12-8 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.6 NO NO Peripheral Lung 1 NO 41.25 No M0 N0 T2 Stage IB 7338 Preoperative NO R1 Solid Tissue Normal 11 0.5 6th NO NO YES 77 2 Lung A DECEASED 1995 1952 02dbd205-c3a7-4643-ad0f-272dca20225d TCGA-77-7338-11 TCGA-77-7338-11 02dbd205-c3a7-4643-ad0f-272dca20225d 02dbd205-c3a7-4643-ad0f-272dca20225d 02dbd205-c3a7-4643-ad0f-272dca20225d +TCGA-77-7463-01 TCGA-77-7463-01 Squamous C2-Squamous-like Cluster 5 squamous c3 squamous-like c4 miRNA cluster 11 TCGA-77-7463 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 75 L-Upper TCGA-77-7463-F20452 TCGA-77-7463 TCGA-77-7463-01A -27520 1423 0 1 NO NO Scheduled Follow-up Submission 2012-1-13 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.9 NO NO 1 42 No M0 N0 T2 Stage IB TCGA-77-7463.fd316526-b68e-491a-9e97-bf4d2146e977.pdf 7463 Preoperative NO R0 Primary Tumor 01 0.7 1996 6th NO NO YES 77 4 Lung A DECEASED 2001 1954 02f3b4c9-5c69-4bec-8897-15f5b9a948b4 TCGA-77-7463-01 TCGA-77-7463-01 TCGA-77-7463-01 02f3b4c9-5c69-4bec-8897-15f5b9a948b4 TCGA-77-7463-01A-13-2195-20 TCGA-77-7463-01 TCGA-77-7463-01A-11D-2041-01 02f3b4c9-5c69-4bec-8897-15f5b9a948b4 02f3b4c9-5c69-4bec-8897-15f5b9a948b4 TCGA-77-7463-01A-11D-2041-01 TCGA-77-7463-01A-11D-2043-05 a0e4c36a-85d9-44d7-9423-307a37ab300b +TCGA-77-7465-01 TCGA-77-7465-01 High C2-Squamous-like Cluster 13 (HNSC-LUSC) squamous c3 squamous-like c4 miRNA cluster 4 TCGA-77-7465 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 58 R-Upper TCGA-77-7465-F46151 TCGA-77-7465 TCGA-77-7465-01A -21548 0 990 1 NO NO Scheduled Follow-up Submission 2013-8-28 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.5 NO NO 0.8 NO 120 No M0 N1 T2a Stage IIA TCGA-77-7465.260a21c6-7973-461c-b4cc-4aa32ad318f4.pdf 7465 Preoperative Complete Remission/Response NO R0 Primary Tumor 01 0.4 7th NO YES 77 2 Lung A LIVING 2010 1963 432b9ce2-3ef5-4343-896f-bc91c59035fd TCGA-77-7465-01 TCGA-77-7465-01 TCGA-77-7465-01 432b9ce2-3ef5-4343-896f-bc91c59035fd TCGA-77-7465-01A-13-2195-20 TCGA-77-7465-01 TCGA-77-7465-01A-11D-2041-01 432b9ce2-3ef5-4343-896f-bc91c59035fd 432b9ce2-3ef5-4343-896f-bc91c59035fd TCGA-77-7465-01A-11D-2041-01 TCGA-77-7465-01A-11D-2043-05 9cbef841-960d-477c-8e8c-96a3c7353478 +TCGA-77-8007-01 TCGA-77-8007-01 High Cluster 6 LUAD-like c10 miRNA cluster 4 TCGA-77-8007 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 68 R-Upper TCGA-77-8007-F30478 TCGA-77-8007 TCGA-77-8007-01A -25102 198 0 139 84 1 NO NO Scheduled Follow-up Submission 2012-4-11 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.9 NO NO Central Lung 0.9 YES 100 No M0 N1 T2 Stage IIB TCGA-77-8007.af0112bd-a19f-4ddc-9261-aca3afd9831c.pdf 8007 Preoperative 60 79 YES R0 Primary Tumor 01 0.7 6th NO YES 77 2 Lung A DECEASED 2001 1960 514bfcb2-3eae-436d-aec3-540cab765c3c TCGA-77-8007-01 TCGA-77-8007-01 TCGA-77-8007-01 514bfcb2-3eae-436d-aec3-540cab765c3c TCGA-77-8007-01 TCGA-77-8007-01A-11D-2183-01 514bfcb2-3eae-436d-aec3-540cab765c3c 514bfcb2-3eae-436d-aec3-540cab765c3c TCGA-77-8007-01A-11D-2183-01 TCGA-77-8007-01A-11D-2185-05 +TCGA-77-8007-11 TCGA-77-8007-11 TCGA-77-8007 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 68 R-Upper TCGA-77-8007-F30478 TCGA-77-8007 TCGA-77-8007-11A -25102 198 0 139 84 1 NO NO Scheduled Follow-up Submission 2012-4-11 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.7 NO NO Central Lung 0.8 YES 100 No M0 N1 T2 Stage IIB 8007 Preoperative 60 79 YES R0 Solid Tissue Normal 11 0.7 6th NO YES 77 2 Lung A DECEASED 2001 1960 0fc04e69-e44f-4789-86ea-75399f9c9f87 TCGA-77-8007-11 TCGA-77-8007-11 0fc04e69-e44f-4789-86ea-75399f9c9f87 0fc04e69-e44f-4789-86ea-75399f9c9f87 0fc04e69-e44f-4789-86ea-75399f9c9f87 +TCGA-77-8008-01 TCGA-77-8008-01 Squamous Low purity c2 squamous-like c4 miRNA cluster 4 TCGA-77-8008 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 68 R-Lower TCGA-77-8008-F30471 TCGA-77-8008 TCGA-77-8008-01A -24948 2639 0 50 1 NO NO Scheduled Follow-up Submission 2012-4-11 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8071/3 C34.3 YES 1 NO NO Central Lung 1.1 61.5 No M0 N0 T2 Stage IB TCGA-77-8008.ae32fa6e-d42b-4e6e-93db-26b1651e8513.pdf 8008 Preoperative 66 72 YES NO R0 Primary Tumor 01 0.4 1986 6th NO NO YES 77 4 Lung A DECEASED 2001 1945 0116ccaf-9eaa-4f14-8255-586f587c29f8 TCGA-77-8008-01 TCGA-77-8008-01 TCGA-77-8008-01 0116ccaf-9eaa-4f14-8255-586f587c29f8 TCGA-77-8008-01 TCGA-77-8008-01A-21D-2183-01 0116ccaf-9eaa-4f14-8255-586f587c29f8 0116ccaf-9eaa-4f14-8255-586f587c29f8 TCGA-77-8008-01A-21D-2183-01 TCGA-77-8008-01A-21D-2185-05 +TCGA-77-8008-11 TCGA-77-8008-11 TCGA-77-8008 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 68 R-Lower TCGA-77-8008-F30471 TCGA-77-8008 TCGA-77-8008-11A -24948 2639 0 50 1 NO NO Scheduled Follow-up Submission 2012-4-11 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8071/3 C34.3 YES 0.7 NO NO Central Lung 1 61.5 No M0 N0 T2 Stage IB 8008 Preoperative 66 72 YES NO R0 Solid Tissue Normal 11 0.6 1986 6th NO NO YES 77 4 Lung A DECEASED 2001 1945 1d8f158c-a625-4eb4-ace2-4e16db1922f8 TCGA-77-8008-11 TCGA-77-8008-11 1d8f158c-a625-4eb4-ace2-4e16db1922f8 1d8f158c-a625-4eb4-ace2-4e16db1922f8 1d8f158c-a625-4eb4-ace2-4e16db1922f8 +TCGA-77-8009-01 TCGA-77-8009-01 Squamous BRCA CIMP c7 squamous-like c4 miRNA cluster 4 TCGA-77-8009 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung NO 68 R-Lower TCGA-77-8009-F46145 TCGA-77-8009 TCGA-77-8009-01A -25037 1695 0 1641 607 102 0 NO NO Scheduled Follow-up Submission 2013-8-23 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.9 8070/3 C34.9 YES 0.7 NO NO Central Lung 0.9 NO New Primary Tumor YES 97.5 No M0 N1 T2 Stage IIB TCGA-77-8009.a6512534-eb58-4109-b45c-8c8e4e65b477.pdf 8009 Preoperative 68 75 Complete Remission/Response Convincing Imaging YES NO R0 Primary Tumor 01 0.4 2006 6th YES NO YES 77 4 Lung A DECEASED 2007 1967 0b9a03ce-d4c1-4192-a18c-de96c8b21bb2 TCGA-77-8009-01 TCGA-77-8009-01 TCGA-77-8009-01 0b9a03ce-d4c1-4192-a18c-de96c8b21bb2 TCGA-77-8009-01 TCGA-77-8009-01A-11D-2183-01 0b9a03ce-d4c1-4192-a18c-de96c8b21bb2 0b9a03ce-d4c1-4192-a18c-de96c8b21bb2 TCGA-77-8009-01A-11D-2183-01 TCGA-77-8009-01A-11D-2185-05 +TCGA-77-8128-01 TCGA-77-8128-01 High Cluster 13 (HNSC-LUSC) miRNA cluster 4 TCGA-77-8128 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 60 Other (please specify) Left lung TCGA-77-8128-F33144 TCGA-77-8128 -21986 1150 0 86 NO NO Scheduled Follow-up Submission 2012-7-2 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.9 8070/3 C34.9 YES NO Central Lung NO 113 No M0 N2 T2 Stage IIIA 8128 Preoperative 64.2 84 YES NO R0 Primary Tumor 01 6th NO NO YES 77 2 Lung DECEASED 1999 1953 eb9fed2e-137c-4bcc-b69a-0da18e9bd6d9 TCGA-77-8128-01 TCGA-77-8128-01 TCGA-77-8128-01 eb9fed2e-137c-4bcc-b69a-0da18e9bd6d9 TCGA-77-8128-01 TCGA-77-8128-01A-11D-2243-01 eb9fed2e-137c-4bcc-b69a-0da18e9bd6d9 eb9fed2e-137c-4bcc-b69a-0da18e9bd6d9 TCGA-77-8128-01A-11D-2243-01 TCGA-77-8128-01A-11D-2245-05 +TCGA-77-8130-01 TCGA-77-8130-01 High Cluster 13 (HNSC-LUSC) miRNA cluster 4 TCGA-77-8130 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung YES 69 L-Upper TCGA-77-8130-F47673 TCGA-77-8130 TCGA-77-8130-01A -25260 0 4765 4471 91 0 NO NO Scheduled Follow-up Submission 2013-8-29 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.7 NO NO Central Lung 1.1 NO New Primary Tumor YES 32.25 No M0 N1 T2 Stage IIB TCGA-77-8130.b070100c-d021-4d9f-b665-441bfc3df5b4.pdf 8130 Preoperative TUMOR FREE 55.9 66 Complete Remission/Response Biopsy with Histologic Confirmation YES NO R0 Primary Tumor 01 0.6 1996 6th NO NO YES 77 4 Lung A LIVING 2000 1945 525fe7e1-4337-45bc-ae5b-d8a219e6e245 TCGA-77-8130-01 TCGA-77-8130-01 TCGA-77-8130-01 525fe7e1-4337-45bc-ae5b-d8a219e6e245 TCGA-77-8130-01 TCGA-77-8130-01A-11D-2243-01 525fe7e1-4337-45bc-ae5b-d8a219e6e245 525fe7e1-4337-45bc-ae5b-d8a219e6e245 TCGA-77-8130-01A-11D-2243-01 TCGA-77-8130-01A-11D-2245-05 +TCGA-77-8131-01 TCGA-77-8131-01 Squamous Low purity c2 miRNA cluster 4 TCGA-77-8131 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 72 L-Lower TCGA-77-8131-F32880 TCGA-77-8131 TCGA-77-8131-01A -26611 383 0 87 1 NO NO Scheduled Follow-up Submission 2012-7-3 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.7 NO NO Peripheral Lung 0.8 YES 69 No M0 NX T2 Stage IB TCGA-77-8131.aaeea1bd-8a50-444b-82d1-74347a5bc304.pdf 8131 Preoperative 76 109 YES R0 Primary Tumor 01 0.6 1987 6th NO YES 77 4 Lung A DECEASED 2000 1941 84b37e1a-260f-42c8-92d2-377ba130168d TCGA-77-8131-01 TCGA-77-8131-01 TCGA-77-8131-01 84b37e1a-260f-42c8-92d2-377ba130168d TCGA-77-8131-01 TCGA-77-8131-01A-11D-2243-01 84b37e1a-260f-42c8-92d2-377ba130168d 84b37e1a-260f-42c8-92d2-377ba130168d TCGA-77-8131-01A-11D-2243-01 TCGA-77-8131-01A-11D-2245-05 +TCGA-77-8133-01 TCGA-77-8133-01 Squamous Cluster 13 (HNSC-LUSC) miRNA cluster 4 TCGA-77-8133 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 74 Other (please specify) Right middle/lower - unsure which lobe TCGA-77-8133-F32876 TCGA-77-8133 -27139 1640 0 55 0 NO NO Scheduled Follow-up Submission 2012-7-3 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.9 8070/3 C34.9 YES NO Central Lung YES 22 No M0 N1 T1 Stage IIA 8133 Preoperative 77.4 93 YES NO R0 Primary Tumor 01 6th NO NO YES 77 2 Lung DECEASED 2001 1941 eee5c7c2-da4c-4d30-9001-7ca9f25c806a TCGA-77-8133-01 TCGA-77-8133-01 TCGA-77-8133-01 eee5c7c2-da4c-4d30-9001-7ca9f25c806a TCGA-77-8133-01 TCGA-77-8133-01A-12D-2243-01 eee5c7c2-da4c-4d30-9001-7ca9f25c806a eee5c7c2-da4c-4d30-9001-7ca9f25c806a TCGA-77-8133-01A-12D-2243-01 TCGA-77-8133-01A-12D-2245-05 +TCGA-77-8136-01 TCGA-77-8136-01 Squamous Cluster 5 miRNA cluster 4 TCGA-77-8136 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 74 Other (please specify) TCGA-77-8136-F33071 TCGA-77-8136 TCGA-77-8136-01A -27193 1189 0 101 0 NO NO Scheduled Follow-up Submission 2012-7-3 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.7 NO NO Central Lung 1.1 YES NO 135 No M0 N1 T2 Stage IIB TCGA-77-8136.bd7fbf72-bdfd-4828-9185-4de81c426f6c.pdf 8136 Preoperative 64 88 YES NO R0 Primary Tumor 01 0.6 6th NO NO YES 77 2 Lung A DECEASED 2002 1947 322593ce-4a52-4c15-9640-54ebccf7bf45 TCGA-77-8136-01 TCGA-77-8136-01 TCGA-77-8136-01 322593ce-4a52-4c15-9640-54ebccf7bf45 TCGA-77-8136-01 TCGA-77-8136-01A-11D-2243-01 322593ce-4a52-4c15-9640-54ebccf7bf45 322593ce-4a52-4c15-9640-54ebccf7bf45 TCGA-77-8136-01A-11D-2243-01 TCGA-77-8136-01A-11D-2245-05 +TCGA-77-8138-01 TCGA-77-8138-01 Squamous Cluster 5 miRNA cluster 4 TCGA-77-8138 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 74 L-Upper TCGA-77-8138-F33156 TCGA-77-8138 TCGA-77-8138-01A -27225 539 0 74 0 NO NO Scheduled Follow-up Submission 2012-7-26 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.7 NO NO Peripheral Lung 0.7 NO NO 54 No M0 N0 T2 Stage IB TCGA-77-8138.fab5161e-1a7a-4074-84e5-addba1379e1c.pdf 8138 Preoperative WITH TUMOR 60.9 72 YES NO R0 Primary Tumor 01 0.6 2000 6th NO NO YES 77 4 Lung A DECEASED 2003 1946 8382d0be-b114-40b4-9412-b0ae25ab0f5b TCGA-77-8138-01 TCGA-77-8138-01 TCGA-77-8138-01 8382d0be-b114-40b4-9412-b0ae25ab0f5b TCGA-77-8138-01 TCGA-77-8138-01A-11D-2243-01 8382d0be-b114-40b4-9412-b0ae25ab0f5b 8382d0be-b114-40b4-9412-b0ae25ab0f5b TCGA-77-8138-01A-11D-2243-01 TCGA-77-8138-01A-11D-2245-05 +TCGA-77-8139-01 TCGA-77-8139-01 BRCA-LUAD+ Cluster 5 miRNA cluster 4 TCGA-77-8139 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 72 R-Upper TCGA-77-8139-F46142 TCGA-77-8139 -26464 0 3166 58 0 NO NO Scheduled Follow-up Submission 2013-8-6 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES NO Peripheral Lung YES NO 52 No M0 N0 T3 Stage IIB 8139 Preoperative TUMOR FREE 60 69 Complete Remission/Response YES NO R0 Primary Tumor 01 6th NO NO YES 77 2 Lung LIVING 2003 1951 d34945c6-2882-4e48-ada0-2f61d9f7a4e5 TCGA-77-8139-01 TCGA-77-8139-01 TCGA-77-8139-01 d34945c6-2882-4e48-ada0-2f61d9f7a4e5 TCGA-77-8139-01 TCGA-77-8139-01A-11D-2243-01 d34945c6-2882-4e48-ada0-2f61d9f7a4e5 d34945c6-2882-4e48-ada0-2f61d9f7a4e5 TCGA-77-8139-01A-11D-2243-01 TCGA-77-8139-01A-11D-2245-05 +TCGA-77-8140-01 TCGA-77-8140-01 Squamous Cluster 5 miRNA cluster 4 TCGA-77-8140 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 66 R-Lower TCGA-77-8140-F33142 TCGA-77-8140 -24415 351 0 31 0 NO NO Scheduled Follow-up Submission 2012-7-3 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES NO Peripheral Lung NO 78 No M0 N1 T2 Stage IIB 8140 Preoperative 52.3 57 YES NO R0 Primary Tumor 01 2001 6th NO NO YES 77 4 Lung DECEASED 2003 1962 c3efe0fb-b62a-47b5-a50b-83433525dbc5 TCGA-77-8140-01 TCGA-77-8140-01 TCGA-77-8140-01 c3efe0fb-b62a-47b5-a50b-83433525dbc5 TCGA-77-8140-01 TCGA-77-8140-01A-11D-2243-01 c3efe0fb-b62a-47b5-a50b-83433525dbc5 c3efe0fb-b62a-47b5-a50b-83433525dbc5 TCGA-77-8140-01A-11D-2243-01 TCGA-77-8140-01A-11D-2245-05 +TCGA-77-8143-01 TCGA-77-8143-01 Squamous Cluster 5 miRNA cluster 11 TCGA-77-8143 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 76 L-Upper TCGA-77-8143-F33150 TCGA-77-8143 TCGA-77-8143-01A -27772 803 0 86 1 NO NO Scheduled Follow-up Submission 2012-7-2 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.7 NO NO Peripheral Lung 0.8 NO 30 No M0 N2 T2 Stage IIIA TCGA-77-8143.11ebd546-0402-4047-9568-a148c382cd23.pdf 8143 Preoperative WITH TUMOR 54.4 64 YES YES R0 Primary Tumor 01 0.4 6th NO NO YES 77 4 Lung A DECEASED 2004 66016ff6-5367-4560-a7d3-20f536f22ece TCGA-77-8143-01 TCGA-77-8143-01 TCGA-77-8143-01 66016ff6-5367-4560-a7d3-20f536f22ece TCGA-77-8143-01 TCGA-77-8143-01A-11D-2243-01 66016ff6-5367-4560-a7d3-20f536f22ece 66016ff6-5367-4560-a7d3-20f536f22ece TCGA-77-8143-01A-11D-2243-01 TCGA-77-8143-01A-11D-2245-05 6C39EDAF-BA4A-42F6-B565-CC3B444729D5 +TCGA-77-8144-01 TCGA-77-8144-01 Squamous Cluster 13 (HNSC-LUSC) miRNA cluster 11 TCGA-77-8144 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 70 L-Lower TCGA-77-8144-F46147 TCGA-77-8144 -25796 0 833 73 1 NO NO Scheduled Follow-up Submission 2013-8-23 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES NO Central Lung YES 59 No M0 N0 T2 Stage IB 8144 Preoperative 50.4 71 Complete Remission/Response YES NO R0 Primary Tumor 01 6th NO NO YES 77 2 Lung LIVING 2004 1944 cf939eea-83dc-42ad-b9ce-0c3972ebf86b TCGA-77-8144-01 TCGA-77-8144-01 TCGA-77-8144-01 cf939eea-83dc-42ad-b9ce-0c3972ebf86b TCGA-77-8144-01 TCGA-77-8144-01A-11D-2243-01 cf939eea-83dc-42ad-b9ce-0c3972ebf86b cf939eea-83dc-42ad-b9ce-0c3972ebf86b TCGA-77-8144-01A-11D-2243-01 TCGA-77-8144-01A-11D-2245-05 +TCGA-77-8145-01 TCGA-77-8145-01 Squamous Cluster 5 miRNA cluster 4 TCGA-77-8145 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung NO YES NO NO 73 Other (please specify) TCGA-77-8145-F33068 TCGA-77-8145 TCGA-77-8145-01A -26707 212 0 82 0 NO NO Scheduled Follow-up Submission Progressive Disease 2012-7-3 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.9 8070/3 C34.9 YES 0.7 NO NO Central Lung 1 YES Distant Metastasis YES 57 No M0 N1 T4 Stage IIIB TCGA-77-8145.e046ea53-a90c-4483-9398-bf3961af868b.pdf 8145 Preoperative 48.6 68 YES YES R1 Primary Tumor 01 0.5 6th NO NO YES 77 2 Lung A DECEASED 2000 1943 4b0015ac-a48c-4a48-b32f-8f62a84ebecd TCGA-77-8145-01 TCGA-77-8145-01 TCGA-77-8145-01 4b0015ac-a48c-4a48-b32f-8f62a84ebecd TCGA-77-8145-01 TCGA-77-8145-01A-11D-2243-01 4b0015ac-a48c-4a48-b32f-8f62a84ebecd 4b0015ac-a48c-4a48-b32f-8f62a84ebecd TCGA-77-8145-01A-11D-2243-01 TCGA-77-8145-01A-11D-2245-05 +TCGA-77-8146-01 TCGA-77-8146-01 Cluster 5 miRNA cluster 4 TCGA-77-8146 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 72 R-Upper TCGA-77-8146-F46150 TCGA-77-8146 TCGA-77-8146-01A -26533 0 3189 57 0 NO NO Scheduled Follow-up Submission 2013-8-23 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.6 NO NO Peripheral Lung 0.8 NO 75 No M0 N0 T1 Stage IA TCGA-77-8146.5d6612d3-0a94-4b7c-9297-a9a5ada70c65.pdf 8146 Preoperative 76.5 76 Complete Remission/Response YES NO R0 Primary Tumor 01 0.6 6th NO NO YES 77 2 Lung A LIVING 2005 1954 39dcdd85-0535-43fa-a0bf-e3a9e324eea2 TCGA-77-8146-01 TCGA-77-8146-01 TCGA-77-8146-01 39dcdd85-0535-43fa-a0bf-e3a9e324eea2 39dcdd85-0535-43fa-a0bf-e3a9e324eea2 39dcdd85-0535-43fa-a0bf-e3a9e324eea2 TCGA-77-8146-01A-11D-2245-05 +TCGA-77-8148-01 TCGA-77-8148-01 High Cluster 5 miRNA cluster 4 TCGA-77-8148 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 68 Other (please specify) Left upper and Left lower TCGA-77-8148-F46105 TCGA-77-8148 -24918 0 2023 78 1 NO NO Scheduled Follow-up Submission 2013-8-6 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.9 8070/3 C34.9 YES NO Central Lung NO 60 No M0 N1 T3 Stage IIIA 8148 Preoperative 67.6 52 Complete Remission/Response YES NO R0 Primary Tumor 01 1999 6th NO NO YES 77 4 Lung LIVING 2006 a825b1eb-e03b-44da-8587-899244ca6c0e TCGA-77-8148-01 TCGA-77-8148-01 TCGA-77-8148-01 a825b1eb-e03b-44da-8587-899244ca6c0e TCGA-77-8148-01 TCGA-77-8148-01A-11D-2243-01 a825b1eb-e03b-44da-8587-899244ca6c0e a825b1eb-e03b-44da-8587-899244ca6c0e TCGA-77-8148-01A-11D-2243-01 TCGA-77-8148-01A-11D-2245-05 +TCGA-77-8150-01 TCGA-77-8150-01 High Cluster 13 (HNSC-LUSC) miRNA cluster 4 TCGA-77-8150 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung NO NO 64 R-Lower TCGA-77-8150-F33094 TCGA-77-8150 TCGA-77-8150-01A -23474 1655 0 1456 73 0 NO NO Scheduled Follow-up Submission Progressive Disease 2012-7-3 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.9 8070/3 C34.9 YES 0.8 NO NO Central Lung 0.9 NO Distant Metastasis YES 46 No M0 N1 T3 Stage IIIA TCGA-77-8150.d19c8493-374a-4b6a-9975-5f220c77834b.pdf 8150 Preoperative WITH TUMOR 59.6 59 YES NO R0 Primary Tumor 01 0.5 6th NO NO YES 77 2 Lung A DECEASED 2007 1961 b32d8bea-966a-4640-9a23-e20cd465771c TCGA-77-8150-01 TCGA-77-8150-01 TCGA-77-8150-01 b32d8bea-966a-4640-9a23-e20cd465771c TCGA-77-8150-01 TCGA-77-8150-01A-11D-2243-01 b32d8bea-966a-4640-9a23-e20cd465771c b32d8bea-966a-4640-9a23-e20cd465771c TCGA-77-8150-01A-11D-2243-01 TCGA-77-8150-01A-11D-2245-05 9F80A41F-7CD9-43E9-B204-118B02412DD8 +TCGA-77-8153-01 TCGA-77-8153-01 TCGA-77-8153 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 77 R-Lower TCGA-77-8153-F47201 TCGA-77-8153 TCGA-77-8153-01A -28253 0 1992 1 NO NO Scheduled Follow-up Submission Complete Remission/Response 2013-8-29 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.8 NO NO Peripheral Lung 1.4 NO NO 25 No M0 N0 T2 Stage IB TCGA-77-8153.310be22d-8980-4d51-83a9-dfc620b73f5e.pdf 8153 Preoperative TUMOR FREE 70 85 Complete Remission/Response YES NO R0 Primary Tumor 01 0.5 1975 6th NO NO YES 77 3 Lung A LIVING 2008 1950 adda0fb6-b939-4fac-a005-3696d05d1971 TCGA-77-8153-01 TCGA-77-8153-01 TCGA-77-8153-01 adda0fb6-b939-4fac-a005-3696d05d1971 TCGA-77-8153-01 TCGA-77-8153-01A-11D-2391-01 adda0fb6-b939-4fac-a005-3696d05d1971 adda0fb6-b939-4fac-a005-3696d05d1971 TCGA-77-8153-01A-11D-2391-01 TCGA-77-8153-01A-11D-2398-05 59EA9D2B-46DD-4619-9F38-7ECA4D302F7C +TCGA-77-8153-11 TCGA-77-8153-11 TCGA-77-8153 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 77 R-Lower TCGA-77-8153-F47201 TCGA-77-8153 -28253 0 1992 1 NO NO Scheduled Follow-up Submission Complete Remission/Response 2013-8-29 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES NO Peripheral Lung NO NO 25 No M0 N0 T2 Stage IB 8153 Preoperative TUMOR FREE 70 85 Complete Remission/Response YES NO R0 Solid Tissue Normal 11 1975 6th NO NO YES 77 3 Lung LIVING 2008 1950 TCGA-77-8153-11 TCGA-77-8153-11 +TCGA-77-8154-01 TCGA-77-8154-01 Squamous Cluster 13 (HNSC-LUSC) miRNA cluster 11 TCGA-77-8154 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 67 R-Lower TCGA-77-8154-F46155 TCGA-77-8154 TCGA-77-8154-01A -24640 0 1841 90 1 NO NO Scheduled Follow-up Submission Complete Remission/Response 2013-8-23 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.5 NO NO Peripheral Lung 0.6 NO NO 40 No M0 N0 T1 Stage IA TCGA-77-8154.b8caa915-6710-4e03-b4b2-4641f6a8eacc.pdf 8154 Preoperative TUMOR FREE 69.6 95 Complete Remission/Response YES NO R0 Primary Tumor 01 0.4 2006 6th NO NO YES 77 4 Lung A LIVING 2008 1966 9a7bfae6-39b5-4d65-953c-9a029b093808 TCGA-77-8154-01 TCGA-77-8154-01 TCGA-77-8154-01 9a7bfae6-39b5-4d65-953c-9a029b093808 TCGA-77-8154-01 TCGA-77-8154-01A-11D-2243-01 9a7bfae6-39b5-4d65-953c-9a029b093808 9a7bfae6-39b5-4d65-953c-9a029b093808 TCGA-77-8154-01A-11D-2243-01 TCGA-77-8154-01A-11D-2245-05 E9C4F5BB-E7CE-4B00-B4F0-14067BA0A838 +TCGA-77-8156-01 TCGA-77-8156-01 High Cluster 13 (HNSC-LUSC) miRNA cluster 4 TCGA-77-8156 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 60 L-Upper TCGA-77-8156-F46138 TCGA-77-8156 TCGA-77-8156-01A -22198 0 1106 43 0 NO NO Scheduled Follow-up Submission 2013-8-6 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.7 NO NO Central Lung 1 NO 57.5 No M0 N0 T2a Stage IB TCGA-77-8156.7ce15c6d-0640-47b2-a4cd-0d14f97e6ab7.pdf 8156 Preoperative 53 65 Complete Remission/Response YES NO R0 Primary Tumor 01 0.3 7th NO NO YES 77 2 Lung A LIVING 2010 1963 27232616-276d-4654-ba3a-697a0c83dd7e TCGA-77-8156-01 TCGA-77-8156-01 TCGA-77-8156-01 27232616-276d-4654-ba3a-697a0c83dd7e TCGA-77-8156-01 TCGA-77-8156-01A-11D-2243-01 27232616-276d-4654-ba3a-697a0c83dd7e 27232616-276d-4654-ba3a-697a0c83dd7e TCGA-77-8156-01A-11D-2243-01 TCGA-77-8156-01A-11D-2245-05 +TCGA-77-A5FZ-01 TCGA-77-A5FZ-01 TCGA-77-A5FZ TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 64 L-Upper TCGA-77-A5FZ TCGA-77-A5FZ-01A -23436 4283 3838 0 71 1 NO NO 2013-6-19 MALE Lung Papillary Squamous Cell Caricnoma No C34.1 8052/3 C34.1 YES 240 NO NO Central Lung 141 false No M0 N0 T4 Stage IIIB TCGA-77-A5FZ.7297BF03-518D-4643-8DA9-D8B360D9D3E9.pdf A5FZ Preoperative 59 89 Complete Remission/Response YES NO R0 Primary Tumor 01 2000 6th NO NO YES 77 4 Lung A DECEASED 2001 1953 c57a55f6-bce1-4d76-8edc-6a4f78056bdc TCGA-77-A5FZ-01 TCGA-77-A5FZ-01 TCGA-77-A5FZ-01 c57a55f6-bce1-4d76-8edc-6a4f78056bdc TCGA-77-A5FZ-01 TCGA-77-A5FZ-01A-31D-A27J-01 c57a55f6-bce1-4d76-8edc-6a4f78056bdc c57a55f6-bce1-4d76-8edc-6a4f78056bdc TCGA-77-A5FZ-01A-31D-A27J-01 TCGA-77-A5FZ-01A-31D-A27L-05 238F5943-AACE-4F89-A07D-D64D8E149D4D +TCGA-77-A5G1-01 TCGA-77-A5G1-01 TCGA-77-A5G1 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 75 R-Lower TCGA-77-A5G1-F54249 TCGA-77-A5G1 TCGA-77-A5G1-01A -27555 3821 0 4026 83 0 NO NO Scheduled Follow-up Submission 2013-12-20 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 250 NO NO Central Lung NO YES 53 false No M0 N1 T3 Stage IIIA TCGA-77-A5G1.AC3570CB-4A07-4E52-AD77-2857BDF35C87.pdf A5G1 Preoperative 67 79 Complete Remission/Response YES NO R0 Primary Tumor 01 1995 6th NO NO YES 77 4 Lung A LIVING 2002 1942 c9816883-ad45-4699-aafc-14247f03bbff TCGA-77-A5G1-01 TCGA-77-A5G1-01 TCGA-77-A5G1-01 c9816883-ad45-4699-aafc-14247f03bbff TCGA-77-A5G1-01 TCGA-77-A5G1-01A-11D-A27J-01 c9816883-ad45-4699-aafc-14247f03bbff c9816883-ad45-4699-aafc-14247f03bbff TCGA-77-A5G1-01A-11D-A27J-01 TCGA-77-A5G1-01A-11D-A27L-05 0381947E-41FE-4BC0-B5B2-2D683F625335 +TCGA-77-A5G3-01 TCGA-77-A5G3-01 TCGA-77-A5G3 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 63 Bronchial TCGA-77-A5G3-F70498 TCGA-77-A5G3 TCGA-77-A5G3-01A -23171 3816 0 4570 91 1 NO NO Scheduled Follow-up Submission 2015-3-25 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 280 NO NO Central Lung NO NO 40 false No M0 N1 T2 Stage IIB TCGA-77-A5G3.4A08A36C-67BB-4372-B34D-04754F636E97.pdf A5G3 Preoperative TUMOR FREE 57 67 Complete Remission/Response YES NO R0 Primary Tumor 01 1999 6th NO NO YES 77 4 Lung A LIVING 2002 1959 9f1395e0-478f-49dd-8814-1ee57308db0d TCGA-77-A5G3-01 TCGA-77-A5G3-01 TCGA-77-A5G3-01 9f1395e0-478f-49dd-8814-1ee57308db0d TCGA-77-A5G3-01 TCGA-77-A5G3-01A-31D-A27J-01 9f1395e0-478f-49dd-8814-1ee57308db0d 9f1395e0-478f-49dd-8814-1ee57308db0d TCGA-77-A5G3-01A-31D-A27J-01 TCGA-77-A5G3-01A-31D-A27L-05 1BBBEF25-D8B9-4596-B617-FEEE8C601BF1 +TCGA-77-A5G6-01 TCGA-77-A5G6-01 TCGA-77-A5G6 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 66 R-Upper TCGA-77-A5G6 TCGA-77-A5G6-01A -24215 1420 678 0 56 0 NO NO 2013-6-19 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 280 NO NO Peripheral Lung YES 74 false No M0 N2 T2 Stage IIIA TCGA-77-A5G6.1F983196-D523-4261-853B-98107B91F92D.pdf A5G6 Preoperative WITH TUMOR 40 53 Complete Remission/Response YES NO R0 Primary Tumor 01 6th NO NO YES 77 2 Lung A DECEASED 2009 1955 327ce5b0-ebfe-42f0-a277-a730dc467831 TCGA-77-A5G6-01 TCGA-77-A5G6-01 TCGA-77-A5G6-01 327ce5b0-ebfe-42f0-a277-a730dc467831 TCGA-77-A5G6-01 TCGA-77-A5G6-01A-11D-A27J-01 327ce5b0-ebfe-42f0-a277-a730dc467831 327ce5b0-ebfe-42f0-a277-a730dc467831 TCGA-77-A5G6-01A-11D-A27J-01 TCGA-77-A5G6-01A-11D-A27L-05 5513AEEC-4BA7-4DE4-855D-A57D541BCF6A +TCGA-77-A5G7-01 TCGA-77-A5G7-01 TCGA-77-A5G7 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 63 L-Upper TCGA-77-A5G7 TCGA-77-A5G7-01B -23090 1317 180 0 1 NO NO 2013-6-19 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 60 NO NO Peripheral Lung 69 false No M0 N0 T1 Stage IA TCGA-77-A5G7.966AA667-7891-45FF-BD1F-9172455B57C4.pdf A5G7 Preoperative 105 95 Complete Remission/Response YES NO R0 Primary Tumor 01 6th NO NO YES 77 2 Lung B DECEASED 2009 1963 1d0f2179-a8a3-4a29-ace9-b627d0338b10 TCGA-77-A5G7-01 TCGA-77-A5G7-01 TCGA-77-A5G7-01 1d0f2179-a8a3-4a29-ace9-b627d0338b10 TCGA-77-A5G7-01 TCGA-77-A5G7-01B-11D-A27J-01 1d0f2179-a8a3-4a29-ace9-b627d0338b10 1d0f2179-a8a3-4a29-ace9-b627d0338b10 TCGA-77-A5G7-01B-11D-A27J-01 TCGA-77-A5G7-01B-11D-A27L-05 +TCGA-77-A5G8-01 TCGA-77-A5G8-01 TCGA-77-A5G8 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 70 R-Upper TCGA-77-A5G8-F70497 TCGA-77-A5G8 TCGA-77-A5G8-01B -25921 1140 0 1884 67 0 NO NO Scheduled Follow-up Submission 2015-3-25 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 50 NO NO Peripheral Lung NO 90 false No M0 N0 T3 Stage IIB TCGA-77-A5G8.10343021-36C0-4188-A1DF-2CA02BF64CA6.pdf A5G8 Preoperative 64 104 YES R0 Primary Tumor 01 2009 6th NO YES 77 4 Lung B LIVING 2009 1949 5db439d8-0190-4417-abf8-59b8cf25a168 TCGA-77-A5G8-01 TCGA-77-A5G8-01 TCGA-77-A5G8-01 5db439d8-0190-4417-abf8-59b8cf25a168 TCGA-77-A5G8-01 TCGA-77-A5G8-01B-11D-A27J-01 5db439d8-0190-4417-abf8-59b8cf25a168 5db439d8-0190-4417-abf8-59b8cf25a168 TCGA-77-A5G8-01B-11D-A27J-01 TCGA-77-A5G8-01B-11D-A27L-05 +TCGA-77-A5GA-01 TCGA-77-A5GA-01 TCGA-77-A5GA TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 76 L-Upper TCGA-77-A5GA-F54251 TCGA-77-A5GA TCGA-77-A5GA-01A -27762 1044 0 1280 42 1 NO NO Scheduled Follow-up Submission 2013-12-20 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 70 NO NO Central Lung NO 99 false No M0 N0 T2a Stage IB TCGA-77-A5GA.98FCB868-1962-4738-868A-8F4958F27469.pdf A5GA Preoperative 68 132 Complete Remission/Response YES NO R0 Primary Tumor 01 1982 7th NO NO YES 77 3 Lung A LIVING 2010 1949 636bbdfd-25de-4068-921c-8982bed31c8c TCGA-77-A5GA-01 636bbdfd-25de-4068-921c-8982bed31c8c TCGA-77-A5GA-01 TCGA-77-A5GA-01A-11D-A27J-01 636bbdfd-25de-4068-921c-8982bed31c8c 636bbdfd-25de-4068-921c-8982bed31c8c TCGA-77-A5GA-01A-11D-A27J-01 TCGA-77-A5GA-01A-11D-A27L-05 +TCGA-77-A5GB-01 TCGA-77-A5GB-01 TCGA-77-A5GB TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 90 Other (please specify) Left Lingula TCGA-77-A5GB TCGA-77-A5GB-01B -32872 974 937 0 72 1 NO NO 2013-6-19 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8071/3 C34.1 YES 70 NO NO Peripheral Lung YES 52 false Yes, History of Prior Malignancy M0 NX T2a Stage IB TCGA-77-A5GB.15DE0F5C-3C0D-4EAB-90D2-5CC758066751.pdf A5GB Preoperative 76 103 Complete Remission/Response YES NO R0 Primary Tumor 01 7th NO NO YES 77 2 Lung B DECEASED 2010 1939 15758673-e515-438b-bd9b-26529dc6b673 TCGA-77-A5GB-01 TCGA-77-A5GB-01 TCGA-77-A5GB-01 15758673-e515-438b-bd9b-26529dc6b673 TCGA-77-A5GB-01 TCGA-77-A5GB-01B-11D-A27J-01 15758673-e515-438b-bd9b-26529dc6b673 15758673-e515-438b-bd9b-26529dc6b673 TCGA-77-A5GB-01B-11D-A27J-01 TCGA-77-A5GB-01B-11D-A27L-05 +TCGA-77-A5GF-01 TCGA-77-A5GF-01 TCGA-77-A5GF TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 70 L-Lower TCGA-77-A5GF-F61670 TCGA-77-A5GF TCGA-77-A5GF-01A -25654 568 840 0 722 0 NO NO Scheduled Follow-up Submission 2014-8-11 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 270 NO NO Peripheral Lung NO YES 60 false No M0 N1 T2a Stage IIA TCGA-77-A5GF.DCAA6959-3E03-4CE6-83C3-02287C3E390B.pdf A5GF Preoperative WITH TUMOR 74 78 Complete Remission/Response YES NO R0 Primary Tumor 01 1996 7th NO NO YES 77 4 Lung A DECEASED 2011 1956 d0bc7698-a2fe-44ca-8d33-8ccc4d5eacd9 TCGA-77-A5GF-01 TCGA-77-A5GF-01 TCGA-77-A5GF-01 d0bc7698-a2fe-44ca-8d33-8ccc4d5eacd9 TCGA-77-A5GF-01 TCGA-77-A5GF-01A-21D-A27J-01 d0bc7698-a2fe-44ca-8d33-8ccc4d5eacd9 d0bc7698-a2fe-44ca-8d33-8ccc4d5eacd9 TCGA-77-A5GF-01A-21D-A27J-01 TCGA-77-A5GF-01A-21D-A27L-05 1173AE94-C7C9-4E81-83A1-D95623A880AF +TCGA-77-A5GH-01 TCGA-77-A5GH-01 TCGA-77-A5GH TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 81 Other (please specify) Left lingula TCGA-77-A5GH-F65865 TCGA-77-A5GH TCGA-77-A5GH-01A -29843 559 0 1182 1 NO NO Scheduled Follow-up Submission 2014-10-1 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 170 NO NO Peripheral Lung NO 11 false No M0 N0 T2a Stage IB TCGA-77-A5GH.853CD446-E942-410E-B38D-80EA6313A405.pdf A5GH Preoperative 69 74 Complete Remission/Response YES NO R0 Primary Tumor 01 1990 7th NO NO YES 77 3 Lung A LIVING 2011 1949 85f0c41e-c864-482a-b6f4-eac3e505afc1 TCGA-77-A5GH-01 TCGA-77-A5GH-01 TCGA-77-A5GH-01 85f0c41e-c864-482a-b6f4-eac3e505afc1 TCGA-77-A5GH-01 TCGA-77-A5GH-01A-11D-A27J-01 85f0c41e-c864-482a-b6f4-eac3e505afc1 85f0c41e-c864-482a-b6f4-eac3e505afc1 TCGA-77-A5GH-01A-11D-A27J-01 TCGA-77-A5GH-01A-11D-A27L-05 10949E2B-8838-4C1F-9F29-9C3321592D21 +TCGA-79-5596-01 TCGA-79-5596-01 Squamous C2-Squamous-like Cluster 13 (HNSC-LUSC) squamous c3 squamous-like c4 miRNA cluster 11 TCGA-79-5596 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung L-Upper TCGA-79-5596-F15882 TCGA-79-5596 TCGA-79-5596-01A 1 2011-8-12 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.7 NO Peripheral Lung 1.2 YES 40 No M0 N1 T3 Stage IIIA TCGA-79-5596.98472d25-91fd-4326-b8cc-809adcc9ebc3.pdf 5596 Preoperative TUMOR FREE NO R0 Primary Tumor 01 0.6 2006 6th NO NO YES 79 4 Lung A LIVING 2006 5f242fff-ab9b-4e49-89c2-3679974c2112 TCGA-79-5596-01 TCGA-79-5596-01 TCGA-79-5596-01 5f242fff-ab9b-4e49-89c2-3679974c2112 TCGA-79-5596-01A-11-2194-20 TCGA-79-5596-01 TCGA-79-5596-01A-31D-1943-01 5f242fff-ab9b-4e49-89c2-3679974c2112 5f242fff-ab9b-4e49-89c2-3679974c2112 TCGA-79-5596-01A-31D-1943-01 TCGA-79-5596-01A-31D-1947-05 7ffba9b0-d42d-4078-b1a5-f83bcb3c39e1 +TCGA-85-6175-01 TCGA-85-6175-01 High C2-Squamous-like cluster 1 Cluster 5 squamous c3 squamous-like c4 miRNA cluster 5 cluster 4 mutation c1uster 9 TCGA-85-6175 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 63 L-Upper TCGA-85-6175-F29248 TCGA-85-6175 TCGA-85-6175-01A -23228 294 0 0 NO NO Scheduled Follow-up Submission Stable Disease 2012-3-13 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 1.3 NO NO Central Lung 2.1 NO No M0 N0 T3 Stage IIB TCGA-85-6175.616d5519-7f8d-4eb0-b78a-6a90c84616ff.pdf 6175 WITH TUMOR Stable Disease NO NO R0 Primary Tumor 01 0.3 7th NO YES NO 85 1 Lung A DECEASED 2010 TCGA-85-6175-01A-11D-1817-08 f5e09ce5-d3df-4c22-8607-63535c2d4611 TCGA-85-6175-01 TCGA-85-6175-01A-11D-1817-08 TCGA-85-6175-01 TCGA-85-6175-01 f5e09ce5-d3df-4c22-8607-63535c2d4611 TCGA-85-6175-01A-13-2194-20 TCGA-85-6175-01 TCGA-85-6175-01A-11D-1816-01 f5e09ce5-d3df-4c22-8607-63535c2d4611 f5e09ce5-d3df-4c22-8607-63535c2d4611 TCGA-85-6175-01A-11D-1816-01 TCGA-85-6175-01A-11D-1818-05 1251f240-d00c-412d-bd87-07cffed92f72 +TCGA-85-6560-01 TCGA-85-6560-01 High C1-LUAD-enriched cluster 1 BRCA CIMP c7 squamous c3 RNA cluster 2 miRNA cluster 5 cluster 4 mutation cluster 2 TCGA-85-6560 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 59 R-Upper TCGA-85-6560-F66121 TCGA-85-6560 -21768 0 1259 0 Scheduled Follow-up Submission Complete Remission/Response 2014-10-2 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 90 NO Peripheral Lung NO NO 40 No M0 N1 T1b Stage IIA 6560 Post-Adjuvant Therapy TUMOR FREE Complete Remission/Response NO NO R0 Primary Tumor 01 2011 7th YES YES NO 85 4 Lung LIVING 2011 1970 TCGA-85-6560-01A-11D-1817-08 b6b63f14-21a2-456c-895a-a8cf032b729a TCGA-85-6560-01 TCGA-85-6560-01A-11D-1817-08 TCGA-85-6560-01 TCGA-85-6560-01 b6b63f14-21a2-456c-895a-a8cf032b729a TCGA-85-6560-01A-13-2194-20 TCGA-85-6560-01 TCGA-85-6560-01A-11D-1816-01 b6b63f14-21a2-456c-895a-a8cf032b729a b6b63f14-21a2-456c-895a-a8cf032b729a TCGA-85-6560-01A-11D-1816-01 TCGA-85-6560-01A-11D-1818-05 e70edfac-57af-42e6-a823-2b20b8e9e203 +TCGA-85-6561-01 TCGA-85-6561-01 Squamous C2-Squamous-like cluster 1 Cluster 13 (HNSC-LUSC) squamous c3 squamous-like c4 miRNA cluster 5 mutation cluster 11 TCGA-85-6561 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 66 R-Upper TCGA-85-6561-F65767 TCGA-85-6561 TCGA-85-6561-01A -24234 0 1224 0 Scheduled Follow-up Submission Complete Remission/Response 2014-9-30 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 2.2 NO 100 NO Central Lung 2.6 NO NO 35 No M0 NX T2a Stage IB TCGA-85-6561.66456b4b-5859-4045-91e1-5d528c1cee18.pdf 6561 Post-Adjuvant Therapy TUMOR FREE Complete Remission/Response NO YES R0 Primary Tumor 01 0.4 2000 7th YES YES NO 85 4 Lung A LIVING 2011 1975 TCGA-85-6561-01A-11D-1817-08 117806c9-4d1c-4b96-8f94-2fd3720d4609 TCGA-85-6561-01 TCGA-85-6561-01A-11D-1817-08 TCGA-85-6561-01 TCGA-85-6561-01 117806c9-4d1c-4b96-8f94-2fd3720d4609 TCGA-85-6561-01A-13-2194-20 TCGA-85-6561-01 TCGA-85-6561-01A-11D-1816-01 117806c9-4d1c-4b96-8f94-2fd3720d4609 117806c9-4d1c-4b96-8f94-2fd3720d4609 TCGA-85-6561-01A-11D-1816-01 TCGA-85-6561-01A-11D-1818-05 9a0f38cb-9131-4cb6-8874-853dd8c89a48 +TCGA-85-6798-01 TCGA-85-6798-01 Squamous C2-Squamous-like Cluster 13 (HNSC-LUSC) squamous c3 squamous-like c4 miRNA cluster 4 TCGA-85-6798 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung NO NO NO 57 R-Upper TCGA-85-6798-F65759 TCGA-85-6798 TCGA-85-6798-01A -20837 195 0 34 180 Scheduled Follow-up Submission Progressive Disease 2014-9-30 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 2 NO NO Central Lung 3 NO Distant Metastasis YES 35 No M0 N1 T3 Stage IIIA TCGA-85-6798.5aa6ff8c-db98-4b5b-a8a6-d924730f1b77.pdf 6798 WITH TUMOR Complete Remission/Response Convincing Imaging NO NO R0 Primary Tumor 01 0.2 7th YES YES NO 85 2 Lung A DECEASED 2011 1976 63dc6159-f7a9-4ccb-86d0-ac495ebfadca TCGA-85-6798-01 TCGA-85-6798-01 TCGA-85-6798-01 63dc6159-f7a9-4ccb-86d0-ac495ebfadca TCGA-85-6798-01A-13-2194-20 TCGA-85-6798-01 TCGA-85-6798-01A-11D-1943-01 63dc6159-f7a9-4ccb-86d0-ac495ebfadca 63dc6159-f7a9-4ccb-86d0-ac495ebfadca TCGA-85-6798-01A-11D-1943-01 TCGA-85-6798-01A-11D-1947-05 8e798033-e911-4140-9060-f2bdcfddb539 +TCGA-85-7696-01 TCGA-85-7696-01 Squamous Cluster 13 (HNSC-LUSC) squamous c3 miRNA cluster 4 TCGA-85-7696 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 64 L-Upper TCGA-85-7696-F66122 TCGA-85-7696 TCGA-85-7696-01A -23413 0 1111 0 Scheduled Follow-up Submission Complete Remission/Response 2014-10-2 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 1.5 NO 100 NO Central Lung 2.3 NO NO 30 No M0 N0 T1 Stage IA TCGA-85-7696.79ad4a6b-d044-483e-ab53-b6d9badc2f51.pdf 7696 Other TUMOR FREE Complete Remission/Response NO NO R0 Primary Tumor 01 0.5 2010 7th NO YES NO 85 4 Lung A LIVING 2011 1970 923e19e4-d166-4950-b763-259603ded444 TCGA-85-7696-01 TCGA-85-7696-01 TCGA-85-7696-01 923e19e4-d166-4950-b763-259603ded444 TCGA-85-7696-01A-13-2195-20 TCGA-85-7696-01 TCGA-85-7696-01A-11D-2121-01 923e19e4-d166-4950-b763-259603ded444 923e19e4-d166-4950-b763-259603ded444 TCGA-85-7696-01A-11D-2121-01 TCGA-85-7696-01A-11D-2123-05 f20b163a-ad2d-46b0-869e-f6a742d4b8ac +TCGA-85-7697-01 TCGA-85-7697-01 Squamous Cluster 5 squamous c3 miRNA cluster 11 TCGA-85-7697 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 49 L-Upper TCGA-85-7697-F65976 TCGA-85-7697 TCGA-85-7697-01A -17921 0 1063 0 Scheduled Follow-up Submission Complete Remission/Response 2014-10-1 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 1 NO 100 NO Central Lung 1.7 NO NO 30 No M0 N0 T3 Stage IIB TCGA-85-7697.f0531cc6-1691-4c66-8b6c-dd260f7ef1ac.pdf 7697 Other TUMOR FREE Complete Remission/Response NO NO R0 Primary Tumor 01 0.2 7th YES YES NO 85 3 Lung A LIVING 2011 1981 b4561112-1099-48a5-9bf9-beb2220cf597 TCGA-85-7697-01 TCGA-85-7697-01 TCGA-85-7697-01 b4561112-1099-48a5-9bf9-beb2220cf597 TCGA-85-7697-01A-13-2195-20 TCGA-85-7697-01 TCGA-85-7697-01A-11D-2121-01 b4561112-1099-48a5-9bf9-beb2220cf597 b4561112-1099-48a5-9bf9-beb2220cf597 TCGA-85-7697-01A-11D-2121-01 TCGA-85-7697-01A-11D-2123-05 2be75562-f756-4876-a44a-9c363f34530f +TCGA-85-7698-01 TCGA-85-7698-01 Squamous Cluster 13 (HNSC-LUSC) squamous c3 miRNA cluster 4 TCGA-85-7698 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung YES NO NO 48 R-Upper TCGA-85-7698-F65984 TCGA-85-7698 TCGA-85-7698-01A -17651 0 952 650 0 Scheduled Follow-up Submission Complete Remission/Response 2014-10-15 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 1.5 NO 100 NO Central Lung 2.5 NO Distant Metastasis YES 44 No M0 N0 T1b Stage IA TCGA-85-7698.9e446be3-1696-4309-8e03-e49622fe01d5.pdf 7698 Other TUMOR FREE Complete Remission/Response Convincing Imaging NO NO R0 Primary Tumor 01 0.4 7th NO YES NO 85 3 Lung A LIVING 2011 1967 0ab02d97-2058-47bc-bc0d-3ec662c0b2d6 TCGA-85-7698-01 TCGA-85-7698-01 TCGA-85-7698-01 0ab02d97-2058-47bc-bc0d-3ec662c0b2d6 TCGA-85-7698-01A-13-2195-20 TCGA-85-7698-01 TCGA-85-7698-01A-11D-2121-01 0ab02d97-2058-47bc-bc0d-3ec662c0b2d6 0ab02d97-2058-47bc-bc0d-3ec662c0b2d6 TCGA-85-7698-01A-11D-2121-01 TCGA-85-7698-01A-11D-2123-05 4906559e-b052-4afa-863c-afa098b38d54 +TCGA-85-7699-01 TCGA-85-7699-01 Squamous Cluster 13 (HNSC-LUSC) squamous c3 miRNA cluster 4 TCGA-85-7699 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung YES NO NO 73 L-Upper TCGA-85-7699-F65987 TCGA-85-7699 TCGA-85-7699-01A -26965 1001 0 1 760 Scheduled Follow-up Submission Progressive Disease 2014-10-15 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 1.3 NO NO Central Lung 1.9 NO Distant Metastasis YES 74 No M0 N0 T4 Stage IIIA TCGA-85-7699.c95b2907-7c16-4f93-81ff-d1f3aadcd413.pdf 7699 WITH TUMOR Complete Remission/Response Convincing Imaging NO NO R0 Primary Tumor 01 0.3 1990 7th YES YES NO 85 3 Lung A DECEASED 2011 1953 c9016384-8eed-48c1-9fb0-cdd96cd66b81 TCGA-85-7699-01 TCGA-85-7699-01 TCGA-85-7699-01 c9016384-8eed-48c1-9fb0-cdd96cd66b81 TCGA-85-7699-01A-13-2195-20 TCGA-85-7699-01 TCGA-85-7699-01A-11D-2121-01 c9016384-8eed-48c1-9fb0-cdd96cd66b81 c9016384-8eed-48c1-9fb0-cdd96cd66b81 TCGA-85-7699-01A-11D-2121-01 TCGA-85-7699-01A-11D-2123-05 097a545f-3da7-43fa-a441-f6417346ecb5 +TCGA-85-7710-01 TCGA-85-7710-01 Squamous C2-Squamous-like Cluster 13 (HNSC-LUSC) squamous c3 squamous-like c4 miRNA cluster 4 TCGA-85-7710 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 59 L-Lower TCGA-85-7710-F53598 TCGA-85-7710 TCGA-85-7710-01A -21790 0 42 0 Scheduled Follow-up Submission Complete Remission/Response 2013-12-12 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 1.2 NO 100 NO 1.6 YES NO 45 No M0 N0 T1b Stage IA TCGA-85-7710.b20f51fd-6a9b-4a13-ae9c-af25d60c9bbd.pdf 7710 Post-Adjuvant Therapy TUMOR FREE Complete Remission/Response NO NO Primary Tumor 01 0.3 7th NO YES NO 85 2 Lung A LIVING 2011 1965 1c01b4ed-b807-4321-aa93-a26792f6283a TCGA-85-7710-01 TCGA-85-7710-01 TCGA-85-7710-01 1c01b4ed-b807-4321-aa93-a26792f6283a TCGA-85-7710-01A-13-2195-20 TCGA-85-7710-01 TCGA-85-7710-01A-11D-2121-01 1c01b4ed-b807-4321-aa93-a26792f6283a 1c01b4ed-b807-4321-aa93-a26792f6283a TCGA-85-7710-01A-11D-2121-01 TCGA-85-7710-01A-11D-2123-05 d8a44db0-50c4-4f6e-bae7-6d42afa90554 +TCGA-85-7710-11 TCGA-85-7710-11 C2-Squamous-like TCGA-85-7710 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 59 L-Lower TCGA-85-7710-F53598 TCGA-85-7710 -21790 0 42 0 Scheduled Follow-up Submission Complete Remission/Response 2013-12-12 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 100 NO YES NO 45 No M0 N0 T1b Stage IA 7710 Post-Adjuvant Therapy TUMOR FREE Complete Remission/Response NO NO Solid Tissue Normal 11 7th NO YES NO 85 2 Lung LIVING 2011 1965 dc79421f-367f-4be3-97ec-ea1dbb1e554c TCGA-85-7710-11 TCGA-85-7710-11 dc79421f-367f-4be3-97ec-ea1dbb1e554c dc79421f-367f-4be3-97ec-ea1dbb1e554c dc79421f-367f-4be3-97ec-ea1dbb1e554c +TCGA-85-7843-01 TCGA-85-7843-01 Squamous Cluster 13 (HNSC-LUSC) squamous c3 miRNA cluster 11 TCGA-85-7843 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 50 L-Upper TCGA-85-7843-F40632 TCGA-85-7843 TCGA-85-7843-01A -18353 0 35 2 Scheduled Follow-up Submission 2013-2-26 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 1 NO 80 NO Central Lung 1.5 YES 35 No M0 N1 T2a Stage IIA TCGA-85-7843.e48c2d72-9664-44cf-9d54-684490e86544.pdf 7843 NO R0 Primary Tumor 01 0.3 7th YES NO 85 2 Lung A LIVING 2011 1980 ca5c5719-d6af-46a4-8abd-114cef627fc2 TCGA-85-7843-01 TCGA-85-7843-01 TCGA-85-7843-01 ca5c5719-d6af-46a4-8abd-114cef627fc2 TCGA-85-7843-01A-13-2195-20 TCGA-85-7843-01 TCGA-85-7843-01A-11D-2121-01 ca5c5719-d6af-46a4-8abd-114cef627fc2 ca5c5719-d6af-46a4-8abd-114cef627fc2 TCGA-85-7843-01A-11D-2121-01 TCGA-85-7843-01A-11D-2123-05 777f34fc-0425-4901-a25e-8f841fa64f26 +TCGA-85-7844-01 TCGA-85-7844-01 Squamous C2-Squamous-like Cluster 13 (HNSC-LUSC) squamous c3 squamous-like c4 miRNA cluster 4 TCGA-85-7844 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung NO 71 L-Upper TCGA-85-7844-F36492 TCGA-85-7844 TCGA-85-7844-01A -26141 0 911 0 NO Scheduled Follow-up Submission Complete Remission/Response 2012-10-31 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.8 NO 100 NO Central Lung 1.8 NO NO 40 No M0 N0 T2a Stage IB TCGA-85-7844.e6642481-1722-4f52-b411-8a2d06c68f98.pdf 7844 Other TUMOR FREE Complete Remission/Response NO NO R0 Primary Tumor 01 0.4 7th NO YES NO 85 2 Lung A LIVING 2011 1970 24a12bfa-0238-49c3-abe7-450402cce27c TCGA-85-7844-01 TCGA-85-7844-01 TCGA-85-7844-01 24a12bfa-0238-49c3-abe7-450402cce27c TCGA-85-7844-01A-13-2195-20 TCGA-85-7844-01 TCGA-85-7844-01A-11D-2121-01 24a12bfa-0238-49c3-abe7-450402cce27c 24a12bfa-0238-49c3-abe7-450402cce27c TCGA-85-7844-01A-11D-2121-01 TCGA-85-7844-01A-11D-2123-05 8e02f3ec-c4a3-447b-b2f3-c215bd907ac7 +TCGA-85-7950-01 TCGA-85-7950-01 Squamous C2-Squamous-like Cluster 5 squamous c3 squamous-like c4 miRNA cluster 4 TCGA-85-7950 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 46 L-Upper TCGA-85-7950-F65982 TCGA-85-7950 TCGA-85-7950-01A -16975 0 576 0 NO Scheduled Follow-up Submission Complete Remission/Response 2014-10-1 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 1.8 NO 100 NO Central Lung 2.7 NO NO 27 No M0 N0 T2a Stage IB TCGA-85-7950.1664b418-9f16-426a-b9dd-279995f3f8c1.pdf 7950 Other TUMOR FREE Complete Remission/Response NO NO RX Primary Tumor 01 0.5 7th NO YES NO 85 2 Lung A LIVING 2011 1984 15746ad6-9014-45b3-841f-3a3f39bc2f84 TCGA-85-7950-01 TCGA-85-7950-01 TCGA-85-7950-01 15746ad6-9014-45b3-841f-3a3f39bc2f84 TCGA-85-7950-01A-13-2195-20 TCGA-85-7950-01 TCGA-85-7950-01A-11D-2183-01 15746ad6-9014-45b3-841f-3a3f39bc2f84 15746ad6-9014-45b3-841f-3a3f39bc2f84 TCGA-85-7950-01A-11D-2183-01 TCGA-85-7950-01A-11D-2185-05 a454299d-b074-4dd9-adf3-3e48f4473543 +TCGA-85-8048-01 TCGA-85-8048-01 High Cluster 5 miRNA cluster 4 TCGA-85-8048 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 62 L-Lower TCGA-85-8048-F65973 TCGA-85-8048 TCGA-85-8048-01A -22907 0 765 0 Scheduled Follow-up Submission Complete Remission/Response 2014-10-1 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.9 NO 100 Peripheral Lung 1.5 NO NO 50 No M0 N0 T1 Stage IA TCGA-85-8048.623e4187-fd10-4780-94d9-febf2957a922.pdf 8048 Other TUMOR FREE Complete Remission/Response NO NO R0 Primary Tumor 01 0.3 7th NO YES NO 85 2 Lung A LIVING 2011 1960 52a23370-b94f-4043-b114-a6caf04df5b6 TCGA-85-8048-01 TCGA-85-8048-01 TCGA-85-8048-01 52a23370-b94f-4043-b114-a6caf04df5b6 TCGA-85-8048-01 TCGA-85-8048-01A-11D-2243-01 52a23370-b94f-4043-b114-a6caf04df5b6 52a23370-b94f-4043-b114-a6caf04df5b6 TCGA-85-8048-01A-11D-2243-01 TCGA-85-8048-01A-11D-2245-05 B7170FE2-1100-40EC-98DA-927BE26DA31B +TCGA-85-8049-01 TCGA-85-8049-01 Squamous Cluster 13 (HNSC-LUSC) miRNA cluster 5 TCGA-85-8049 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 57 L-Lower TCGA-85-8049-F65983 TCGA-85-8049 TCGA-85-8049-01A -20995 0 579 0 NO NO Scheduled Follow-up Submission Complete Remission/Response 2014-10-1 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 2 NO 100 NO Central Lung 2.5 NO NO No M0 N0 T2a Stage IB TCGA-85-8049.1b2d0b4d-b259-4565-bcf9-3efb14ffb7d0.pdf 8049 Other TUMOR FREE Complete Remission/Response NO NO R0 Primary Tumor 01 0.3 7th NO YES NO 85 1 Lung A LIVING 2011 e57426eb-3223-41dc-b70e-ff7233e3403a TCGA-85-8049-01 TCGA-85-8049-01 TCGA-85-8049-01 e57426eb-3223-41dc-b70e-ff7233e3403a TCGA-85-8049-01 TCGA-85-8049-01A-11D-2243-01 e57426eb-3223-41dc-b70e-ff7233e3403a e57426eb-3223-41dc-b70e-ff7233e3403a TCGA-85-8049-01A-11D-2243-01 TCGA-85-8049-01A-11D-2245-05 0770E4DB-1125-488C-B4BE-7B278A8D1E7E +TCGA-85-8052-01 TCGA-85-8052-01 Squamous Cluster 5 miRNA cluster 4 TCGA-85-8052 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 53 R-Upper TCGA-85-8052-F65975 TCGA-85-8052 TCGA-85-8052-01A -19671 0 734 0 NO NO Scheduled Follow-up Submission Complete Remission/Response 2014-10-1 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 1 NO 100 NO Peripheral Lung 2 NO NO 40 No M0 N0 T3 Stage IIB TCGA-85-8052.ebd98864-f24a-4773-8fba-51c2b23bbbd4.pdf 8052 Other TUMOR FREE Complete Remission/Response NO NO R0 Primary Tumor 01 0.5 7th NO YES NO 85 2 Lung A LIVING 2011 1970 328de22d-8700-4ee4-bf78-71a774e4e569 TCGA-85-8052-01 TCGA-85-8052-01 TCGA-85-8052-01 328de22d-8700-4ee4-bf78-71a774e4e569 TCGA-85-8052-01 TCGA-85-8052-01A-11D-2243-01 328de22d-8700-4ee4-bf78-71a774e4e569 328de22d-8700-4ee4-bf78-71a774e4e569 TCGA-85-8052-01A-11D-2243-01 TCGA-85-8052-01A-11D-2245-05 +TCGA-85-8070-01 TCGA-85-8070-01 Squamous Cluster 13 (HNSC-LUSC) miRNA cluster 12 TCGA-85-8070 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 71 L-Upper TCGA-85-8070-F59730 TCGA-85-8070 TCGA-85-8070-01A -26183 0 960 2 NO NO Scheduled Follow-up Submission Complete Remission/Response 2014-5-20 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 1.5 NO 80 NO Peripheral Lung 1.5 NO NO 50 No M0 N0 T2 Stage IB TCGA-85-8070.f9544640-64f9-40c7-af40-001e509c4897.pdf 8070 Preoperative TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 0.4 7th NO YES NO 85 2 Lung A LIVING 2011 1960 13380c2f-2f59-40ac-ae0c-9f3dab833e39 TCGA-85-8070-01 TCGA-85-8070-01 TCGA-85-8070-01 13380c2f-2f59-40ac-ae0c-9f3dab833e39 TCGA-85-8070-01 TCGA-85-8070-01A-11D-2243-01 13380c2f-2f59-40ac-ae0c-9f3dab833e39 13380c2f-2f59-40ac-ae0c-9f3dab833e39 TCGA-85-8070-01A-11D-2243-01 TCGA-85-8070-01A-11D-2245-05 +TCGA-85-8071-01 TCGA-85-8071-01 Squamous Cluster 5 miRNA cluster 11 TCGA-85-8071 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 52 R-Upper TCGA-85-8071-F66118 TCGA-85-8071 -19158 0 815 2 NO NO Scheduled Follow-up Submission Complete Remission/Response 2014-10-2 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 80 NO Central Lung NO NO 30 No M0 N1 T1a Stage IIA 8071 Preoperative TUMOR FREE Complete Remission/Response NO NO R0 Primary Tumor 01 7th NO YES NO 85 2 Lung LIVING 2011 1981 a77afb11-3c0e-411b-b34b-84f827478e03 TCGA-85-8071-01 TCGA-85-8071-01 TCGA-85-8071-01 a77afb11-3c0e-411b-b34b-84f827478e03 TCGA-85-8071-01 TCGA-85-8071-01A-11D-2243-01 a77afb11-3c0e-411b-b34b-84f827478e03 a77afb11-3c0e-411b-b34b-84f827478e03 TCGA-85-8071-01A-11D-2243-01 TCGA-85-8071-01A-11D-2245-05 +TCGA-85-8072-01 TCGA-85-8072-01 Squamous Cluster 13 (HNSC-LUSC) miRNA cluster 4 TCGA-85-8072 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 60 L-Upper TCGA-85-8072-F65772 TCGA-85-8072 TCGA-85-8072-01A -22069 0 932 0 NO NO Scheduled Follow-up Submission Complete Remission/Response 2014-9-30 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 1 NO 100 NO Central Lung 1.6 NO NO 15 No M0 N0 T1a Stage IA TCGA-85-8072.31100521-d4ea-4e5f-98ce-21010ccce324.pdf 8072 Preoperative TUMOR FREE Complete Remission/Response NO NO R0 Primary Tumor 01 0.5 7th NO YES NO 85 2 Lung A LIVING 2011 1991 a6bba875-e7ad-4a67-837e-bd2f7a50dae1 TCGA-85-8072-01 TCGA-85-8072-01 TCGA-85-8072-01 a6bba875-e7ad-4a67-837e-bd2f7a50dae1 TCGA-85-8072-01 TCGA-85-8072-01A-31D-2243-01 a6bba875-e7ad-4a67-837e-bd2f7a50dae1 a6bba875-e7ad-4a67-837e-bd2f7a50dae1 TCGA-85-8072-01A-31D-2243-01 TCGA-85-8072-01A-31D-2245-05 03B19C69-7A47-4602-8758-799F21DA12EC +TCGA-85-8276-01 TCGA-85-8276-01 Squamous Cluster 14 (HNSC) miRNA cluster 4 TCGA-85-8276 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung YES NO NO 62 L-Upper TCGA-85-8276-F65992 TCGA-85-8276 TCGA-85-8276-01A -22707 0 1050 1048 Scheduled Follow-up Submission 2014-10-15 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 1.2 NO NO Central Lung 1.5 NO Distant Metastasis YES 20 No M0 N1 T1b Stage IIA TCGA-85-8276.f51ff537-cbef-46ef-bed9-b8ad20b8d2f6.pdf 8276 WITH TUMOR Complete Remission/Response Convincing Imaging NO NO R0 Primary Tumor 01 0.3 7th YES YES NO 85 2 Lung A LIVING 2011 1971 5cdb7ad7-0660-4e93-928c-655f0f9465e4 TCGA-85-8276-01 TCGA-85-8276-01 TCGA-85-8276-01 5cdb7ad7-0660-4e93-928c-655f0f9465e4 TCGA-85-8276-01 TCGA-85-8276-01A-11D-2292-01 5cdb7ad7-0660-4e93-928c-655f0f9465e4 5cdb7ad7-0660-4e93-928c-655f0f9465e4 TCGA-85-8276-01A-11D-2292-01 TCGA-85-8276-01A-11D-2294-05 7DB8A546-2A71-4B0B-A636-06B41B1B2D07 +TCGA-85-8277-01 TCGA-85-8277-01 Squamous Cluster 13 (HNSC-LUSC) TCGA-85-8277 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 70 L-Upper TCGA-85-8277-F40634 TCGA-85-8277 -25793 307 0 11 2 Scheduled Follow-up Submission Complete Remission/Response 2013-2-26 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 80 NO NO No M0 N1 T3 Stage IIIA 8277 TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 7th NO YES NO 85 1 Lung DECEASED 2011 e6889ad6-caa9-429f-9123-0ff0c7ae195a TCGA-85-8277-01 e6889ad6-caa9-429f-9123-0ff0c7ae195a TCGA-85-8277-01 TCGA-85-8277-01A-11D-2292-01 e6889ad6-caa9-429f-9123-0ff0c7ae195a e6889ad6-caa9-429f-9123-0ff0c7ae195a TCGA-85-8277-01A-11D-2292-01 TCGA-85-8277-01A-11D-2294-05 +TCGA-85-8287-01 TCGA-85-8287-01 Squamous Cluster 5 miRNA cluster 4 TCGA-85-8287 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 72 L-Upper TCGA-85-8287-F52849 TCGA-85-8287 TCGA-85-8287-01A -26401 23 0 13 0 Scheduled Follow-up Submission Complete Remission/Response 2013-12-6 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 1.3 NO 90 NO Central Lung 1.7 NO NO 50 No M0 N0 T1b Stage IA TCGA-85-8287.d57a750c-f51f-474e-8f4a-d2f01926a477.pdf 8287 Preoperative TUMOR FREE Complete Remission/Response NO NO R0 Primary Tumor 01 0.3 7th NO YES NO 85 2 Lung A DECEASED 2011 1965 f69543ea-f20b-4182-91c4-f5bad36be325 TCGA-85-8287-01 TCGA-85-8287-01 TCGA-85-8287-01 f69543ea-f20b-4182-91c4-f5bad36be325 TCGA-85-8287-01 TCGA-85-8287-01A-11D-2292-01 f69543ea-f20b-4182-91c4-f5bad36be325 f69543ea-f20b-4182-91c4-f5bad36be325 TCGA-85-8287-01A-11D-2292-01 TCGA-85-8287-01A-11D-2294-05 630511E8-2C00-43A7-9655-1DCBD6042D31 +TCGA-85-8288-01 TCGA-85-8288-01 Squamous Cluster 13 (HNSC-LUSC) miRNA cluster 4 TCGA-85-8288 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 70 R-Middle TCGA-85-8288-F52845 TCGA-85-8288 TCGA-85-8288-01A -25629 402 0 54 0 Scheduled Follow-up Submission Complete Remission/Response 2013-12-6 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.2 8070/3 C34.2 YES 1 NO 70 NO Central Lung 2 NO NO 50 No M0 N1 T1b Stage IIA TCGA-85-8288.845e1733-b5fd-4b4b-893b-8f07c9030184.pdf 8288 TUMOR FREE Complete Remission/Response NO NO R0 Primary Tumor 01 0.2 7th NO YES NO 85 2 Lung A DECEASED 2011 1962 1695c22b-f771-45da-8627-394516eb87de TCGA-85-8288-01 TCGA-85-8288-01 TCGA-85-8288-01 1695c22b-f771-45da-8627-394516eb87de TCGA-85-8288-01 TCGA-85-8288-01A-11D-2292-01 1695c22b-f771-45da-8627-394516eb87de 1695c22b-f771-45da-8627-394516eb87de TCGA-85-8288-01A-11D-2292-01 TCGA-85-8288-01A-11D-2294-05 8D2ED846-5B28-4CB3-A353-8E41BA22DF70 +TCGA-85-8350-01 TCGA-85-8350-01 Kirc+ Low purity c2 miRNA cluster 4 TCGA-85-8350 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 61 R-Upper TCGA-85-8350-F66071 TCGA-85-8350 TCGA-85-8350-01A -22526 0 683 0 NO Scheduled Follow-up Submission Complete Remission/Response 2014-10-2 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.7 NO 100 NO Peripheral Lung 1.7 NO NO 40 No M0 N0 T1b Stage IA TCGA-85-8350.e784390f-9956-40f8-959d-01a869324d21.pdf 8350 Other TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 0.4 7th NO YES NO 85 2 Lung A LIVING 2011 1971 6d8a4777-88a1-41f0-9a30-354d52ce9e86 TCGA-85-8350-01 TCGA-85-8350-01 TCGA-85-8350-01 6d8a4777-88a1-41f0-9a30-354d52ce9e86 TCGA-85-8350-01 TCGA-85-8350-01A-11D-2292-01 6d8a4777-88a1-41f0-9a30-354d52ce9e86 6d8a4777-88a1-41f0-9a30-354d52ce9e86 TCGA-85-8350-01A-11D-2292-01 TCGA-85-8350-01A-11D-2294-05 F2CD7D39-833C-4ED1-96A7-0CF404FD6AEF +TCGA-85-8351-01 TCGA-85-8351-01 High Cluster 13 (HNSC-LUSC) miRNA cluster 4 TCGA-85-8351 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 72 R-Lower TCGA-85-8351-F66073 TCGA-85-8351 TCGA-85-8351-01A -26437 0 510 0 NO Scheduled Follow-up Submission Complete Remission/Response 2014-10-2 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 1.4 NO 100 NO Peripheral Lung 2.4 NO NO 60 No M0 N1 T2a Stage IIA TCGA-85-8351.7d10178f-b714-46be-a0f8-d2a03abb0478.pdf 8351 Other TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 0.5 7th YES YES NO 85 2 Lung A LIVING 2011 1951 7ab19c79-6e54-4c4e-a9bf-fd671d0aaa2e TCGA-85-8351-01 TCGA-85-8351-01 TCGA-85-8351-01 7ab19c79-6e54-4c4e-a9bf-fd671d0aaa2e TCGA-85-8351-01 TCGA-85-8351-01A-11D-2292-01 7ab19c79-6e54-4c4e-a9bf-fd671d0aaa2e 7ab19c79-6e54-4c4e-a9bf-fd671d0aaa2e TCGA-85-8351-01A-11D-2292-01 TCGA-85-8351-01A-11D-2294-05 B30BC4F8-7E4F-461C-8A10-9B6FC68D8C97 +TCGA-85-8352-01 TCGA-85-8352-01 Cluster 13 (HNSC-LUSC) miRNA cluster 4 TCGA-85-8352 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung NO NO NO 67 R-Upper TCGA-85-8352-F52841 TCGA-85-8352 TCGA-85-8352-01A -24788 161 0 67 128 Scheduled Follow-up Submission Progressive Disease 2013-12-6 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 1 NO 80 NO Peripheral Lung 1.5 NO Distant Metastasis YES 50 No M0 N1 T3 Stage IIIA TCGA-85-8352.ce4d6f68-1332-4dbf-ae7f-ec3e5c7cd790.pdf 8352 WITH TUMOR Complete Remission/Response NO NO R0 Primary Tumor 01 0.3 7th NO YES NO 85 2 Lung A DECEASED 2011 1962 e75b6682-1dc8-4f83-a4e2-ff511a1f656b TCGA-85-8352-01 TCGA-85-8352-01 TCGA-85-8352-01 e75b6682-1dc8-4f83-a4e2-ff511a1f656b TCGA-85-8352-01 TCGA-85-8352-01A-31D-2322-01 e75b6682-1dc8-4f83-a4e2-ff511a1f656b e75b6682-1dc8-4f83-a4e2-ff511a1f656b TCGA-85-8352-01A-31D-2322-01 TCGA-85-8352-01A-31D-2324-05 639C548F-6A5F-434E-84CB-ABDEBAB7C073 +TCGA-85-8353-01 TCGA-85-8353-01 High Cluster 13 (HNSC-LUSC) miRNA cluster 4 TCGA-85-8353 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 72 R-Lower TCGA-85-8353-F52847 TCGA-85-8353 TCGA-85-8353-01A -26549 94 0 54 NO Scheduled Follow-up Submission Stable Disease 2014-1-24 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 1.8 NO 70 NO Peripheral Lung 2.6 NO NO 50 No M0 N1 T3 Stage IIIA TCGA-85-8353.03371d1d-3d2a-4983-890b-eec3cdb34d90.pdf 8353 WITH TUMOR Stable Disease NO NO R0 Primary Tumor 01 0.5 7th NO YES NO 85 2 Lung A DECEASED 2011 1960 cf069f54-b570-43ff-9f85-ababd06ddddd TCGA-85-8353-01 TCGA-85-8353-01 TCGA-85-8353-01 cf069f54-b570-43ff-9f85-ababd06ddddd TCGA-85-8353-01 TCGA-85-8353-01A-21D-2292-01 cf069f54-b570-43ff-9f85-ababd06ddddd cf069f54-b570-43ff-9f85-ababd06ddddd TCGA-85-8353-01A-21D-2292-01 TCGA-85-8353-01A-21D-2294-05 99130BB8-998C-49C9-AFCB-410532A6EC19 +TCGA-85-8354-01 TCGA-85-8354-01 Cluster 13 (HNSC-LUSC) miRNA cluster 12 TCGA-85-8354 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 53 R-Lower TCGA-85-8354-F65777 TCGA-85-8354 TCGA-85-8354-01A -19692 0 995 Scheduled Follow-up Submission Complete Remission/Response 2014-9-30 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 1.2 NO 70 NO Peripheral Lung 1.4 NO NO 30 No M0 N0 T2a Stage IB TCGA-85-8354.577d1d2a-e784-49eb-8a00-e28ea210db4e.pdf 8354 TUMOR FREE Complete Remission/Response NO NO R0 Primary Tumor 01 0.4 7th NO YES NO 85 2 Lung A LIVING 2011 1972 8ad4df1d-ed6e-4b76-981c-c8757499c801 TCGA-85-8354-01 TCGA-85-8354-01 TCGA-85-8354-01 8ad4df1d-ed6e-4b76-981c-c8757499c801 TCGA-85-8354-01 TCGA-85-8354-01A-31D-2322-01 8ad4df1d-ed6e-4b76-981c-c8757499c801 8ad4df1d-ed6e-4b76-981c-c8757499c801 TCGA-85-8354-01A-31D-2322-01 TCGA-85-8354-01A-31D-2324-05 +TCGA-85-8355-01 TCGA-85-8355-01 Squamous Cluster 5 miRNA cluster 11 TCGA-85-8355 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 63 L-Upper TCGA-85-8355-F41716 TCGA-85-8355 TCGA-85-8355-01A -23227 0 61 Scheduled Follow-up Submission Complete Remission/Response 2013-3-26 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 1.6 NO Central Lung 2.7 YES NO No M0 N0 T1a Stage IA TCGA-85-8355.aa408276-ffde-4ea0-a510-3035f653f039.pdf 8355 TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 0.5 7th NO YES NO 85 1 Lung A LIVING 2011 c0e5b9a0-cbbf-4b4b-a880-93721969c9a5 TCGA-85-8355-01 TCGA-85-8355-01 TCGA-85-8355-01 c0e5b9a0-cbbf-4b4b-a880-93721969c9a5 TCGA-85-8355-01 TCGA-85-8355-01A-11D-2292-01 c0e5b9a0-cbbf-4b4b-a880-93721969c9a5 c0e5b9a0-cbbf-4b4b-a880-93721969c9a5 TCGA-85-8355-01A-11D-2292-01 TCGA-85-8355-01A-11D-2294-05 8C506D5D-5F4E-42EA-A542-BEDD98234B54 +TCGA-85-8479-01 TCGA-85-8479-01 BRCA CIMP c7 miRNA cluster 11 TCGA-85-8479 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 66 L-Lower TCGA-85-8479-F63130 TCGA-85-8479 TCGA-85-8479-01A -24350 0 22 1 NO NO Scheduled Follow-up Submission 2014-8-6 MALE Lung Papillary Squamous Cell Caricnoma No C34.3 8052/3 C34.3 YES 1 NO 80 NO Central Lung 2 YES 90 No M0 N0 T1a Stage IA TCGA-85-8479.815090dd-0f5f-4d63-bd1f-e8bd11eb99da.pdf 8479 Preoperative TUMOR FREE NO R0 Primary Tumor 01 0.4 2010 7th YES NO 85 4 Lung A LIVING 2012 d3452656-5eac-4d9f-9351-74f1128eb057 TCGA-85-8479-01 TCGA-85-8479-01 TCGA-85-8479-01 d3452656-5eac-4d9f-9351-74f1128eb057 TCGA-85-8479-01 TCGA-85-8479-01A-11D-2322-01 d3452656-5eac-4d9f-9351-74f1128eb057 d3452656-5eac-4d9f-9351-74f1128eb057 TCGA-85-8479-01A-11D-2322-01 TCGA-85-8479-01A-11D-2324-05 8BE09380-D399-4BFA-8D1D-1287EB5022C2 +TCGA-85-8481-01 TCGA-85-8481-01 Cluster 5 miRNA cluster 4 TCGA-85-8481 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 70 L-Upper TCGA-85-8481-F48284 TCGA-85-8481 -25782 236 0 21 2 NO NO Scheduled Follow-up Submission 2013-9-11 MALE Lung Papillary Squamous Cell Caricnoma No C34.1 8070/3 C34.1 YES 0 NO Peripheral Lung NO 80 No M0 N0 T3 Stage IIB 8481 Post-Adjuvant Therapy TUMOR FREE Partial Remission/Response NO NO R0 Primary Tumor 01 2008 7th NO YES NO 85 4 Lung DECEASED 2012 e350f73a-df75-4956-a50d-f60a4295b85a TCGA-85-8481-01 TCGA-85-8481-01 TCGA-85-8481-01 e350f73a-df75-4956-a50d-f60a4295b85a TCGA-85-8481-01 TCGA-85-8481-01A-11D-2322-01 e350f73a-df75-4956-a50d-f60a4295b85a e350f73a-df75-4956-a50d-f60a4295b85a TCGA-85-8481-01A-11D-2322-01 TCGA-85-8481-01A-11D-2324-05 +TCGA-85-8580-01 TCGA-85-8580-01 TCGA-85-8580 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 52 R-Lower TCGA-85-8580-F71334 TCGA-85-8580 TCGA-85-8580-01A -19301 0 1113 NO NO Scheduled Follow-up Submission Complete Remission/Response 2015-3-24 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 2.2 NO NO 2.3 NO NO 38 No M0 N0 T2a Stage IB TCGA-85-8580.2f5077b2-40fa-4bb6-8aea-ff2e8de682a2.pdf 8580 TUMOR FREE Complete Remission/Response NO NO R0 Primary Tumor 01 0.5 2011 7th NO YES NO 85 4 Lung A LIVING 2012 1973 381536e9-3a91-4878-8d63-8961d6e3b6a2 TCGA-85-8580-01 TCGA-85-8580-01 TCGA-85-8580-01 381536e9-3a91-4878-8d63-8961d6e3b6a2 TCGA-85-8580-01 TCGA-85-8580-01A-31D-2391-01 381536e9-3a91-4878-8d63-8961d6e3b6a2 381536e9-3a91-4878-8d63-8961d6e3b6a2 TCGA-85-8580-01A-31D-2391-01 TCGA-85-8580-01A-31D-2398-05 9C114494-56F8-40C4-B660-132374580581 +TCGA-85-8582-01 TCGA-85-8582-01 TCGA-85-8582 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 49 L-Upper TCGA-85-8582-F71410 TCGA-85-8582 TCGA-85-8582-01A -18168 0 1160 NO NO Scheduled Follow-up Submission Complete Remission/Response 2015-3-25 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8071/3 C34.1 YES 2 NO 100 NO Central Lung 3 NO NO 40 No M0 N0 T1a Stage IA TCGA-85-8582.cccea878-6599-41b7-ba07-dbe073cd51b4.pdf 8582 TUMOR FREE Complete Remission/Response NO NO R0 Primary Tumor 01 0.4 7th NO YES NO 85 2 Lung A LIVING 2012 11918ff0-e8d4-4214-904a-8120ba648fec TCGA-85-8582-01 TCGA-85-8582-01 TCGA-85-8582-01 11918ff0-e8d4-4214-904a-8120ba648fec TCGA-85-8582-01 TCGA-85-8582-01A-21D-2391-01 11918ff0-e8d4-4214-904a-8120ba648fec 11918ff0-e8d4-4214-904a-8120ba648fec TCGA-85-8582-01A-21D-2391-01 TCGA-85-8582-01A-21D-2398-05 +TCGA-85-8584-01 TCGA-85-8584-01 TCGA-85-8584 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 71 R-Upper TCGA-85-8584-F48285 TCGA-85-8584 TCGA-85-8584-01A -26081 383 0 0 1 NO NO Scheduled Follow-up Submission Progressive Disease 2013-9-11 MALE Lung Papillary Squamous Cell Caricnoma No C34.1 8052/3 C34.1 YES 1.6 NO 0 NO Central Lung 2.2 NO 50 No M0 N1 T2a Stage IIA TCGA-85-8584.c7614470-d0e1-4f08-87f7-e16706c5b830.pdf 8584 Post-Adjuvant Therapy TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 0.5 7th YES NO 85 2 Lung A DECEASED 2012 1bc29a8a-19a4-4b79-ad7e-a64633b2c487 TCGA-85-8584-01 TCGA-85-8584-01 TCGA-85-8584-01 1bc29a8a-19a4-4b79-ad7e-a64633b2c487 TCGA-85-8584-01 TCGA-85-8584-01A-11D-2391-01 1bc29a8a-19a4-4b79-ad7e-a64633b2c487 1bc29a8a-19a4-4b79-ad7e-a64633b2c487 TCGA-85-8584-01A-11D-2391-01 TCGA-85-8584-01A-11D-2398-05 +TCGA-85-8664-01 TCGA-85-8664-01 TCGA-85-8664 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung YES NO NO 73 R-Upper TCGA-85-8664-F59089 TCGA-85-8664 TCGA-85-8664-01A -26954 550 0 3 434 Scheduled Follow-up Submission Progressive Disease 2014-4-30 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 2 NO 2.5 NO Locoregional Recurrence YES 60 No M0 N1 T2b Stage IIB TCGA-85-8664.cd29dcf4-5b1a-4288-9113-182bc79ae361.pdf 8664 WITH TUMOR Complete Remission/Response NO NO R0 Primary Tumor 01 0.4 7th NO YES NO 85 2 Lung A DECEASED 2011 1961 2a39b6f1-c19d-4177-b825-bf14bf73f737 TCGA-85-8664-01 TCGA-85-8664-01 TCGA-85-8664-01 2a39b6f1-c19d-4177-b825-bf14bf73f737 TCGA-85-8664-01 TCGA-85-8664-01A-11D-2391-01 2a39b6f1-c19d-4177-b825-bf14bf73f737 2a39b6f1-c19d-4177-b825-bf14bf73f737 TCGA-85-8664-01A-11D-2391-01 TCGA-85-8664-01A-11D-2398-05 20ACC3C0-D031-4A4D-B051-733C31CDA29A +TCGA-85-8666-01 TCGA-85-8666-01 TCGA-85-8666 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 65 L-Upper TCGA-85-8666-F59087 TCGA-85-8666 TCGA-85-8666-01A -23906 687 0 14 NO Scheduled Follow-up Submission Complete Remission/Response 2014-4-30 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 2.1 NO 0 2.4 NO NO 55 No M0 N0 T2a Stage IB TCGA-85-8666.c9ec1868-c91e-4778-8411-fd8ad272e453.pdf 8666 Other TUMOR FREE Complete Remission/Response NO NO R0 Primary Tumor 01 0.5 7th NO YES NO 85 2 Lung A DECEASED 2011 1967 60652d7d-4da5-4e38-9f4d-8e9698c3e578 TCGA-85-8666-01 TCGA-85-8666-01 TCGA-85-8666-01 60652d7d-4da5-4e38-9f4d-8e9698c3e578 TCGA-85-8666-01 TCGA-85-8666-01A-11D-2391-01 60652d7d-4da5-4e38-9f4d-8e9698c3e578 60652d7d-4da5-4e38-9f4d-8e9698c3e578 TCGA-85-8666-01A-11D-2391-01 TCGA-85-8666-01A-11D-2398-05 AE22AF03-8DDA-49BA-A49C-D0F22F679D25 +TCGA-85-A4CL-01 TCGA-85-A4CL-01 TCGA-85-A4CL TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 65 R-Lower TCGA-85-A4CL-F71408 TCGA-85-A4CL TCGA-85-A4CL-01A -24005 172 921 0 15 NO NO Scheduled Follow-up Submission 2015-3-25 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 1040 NO NO Central Lung NO 40 true No M0 N0 T1b Stage IA TCGA-85-A4CL.85FD4E7E-5365-4217-84FA-758275B18C93.pdf A4CL TUMOR FREE Complete Remission/Response NO NO R0 Primary Tumor 01 7th NO YES NO 85 2 Lung A DECEASED 2012 1970 fb3438ba-43d1-4c51-adaf-4326983496b6 TCGA-85-A4CL-01 TCGA-85-A4CL-01 TCGA-85-A4CL-01 fb3438ba-43d1-4c51-adaf-4326983496b6 TCGA-85-A4CL-01 TCGA-85-A4CL-01A-41D-A26L-01 fb3438ba-43d1-4c51-adaf-4326983496b6 fb3438ba-43d1-4c51-adaf-4326983496b6 TCGA-85-A4CL-01A-41D-A26L-01 TCGA-85-A4CL-01A-41D-A26N-05 DB2DFEED-1ED4-497D-AA07-86F601D03968 +TCGA-85-A4CN-01 TCGA-85-A4CN-01 TCGA-85-A4CN TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 56 L-Lower TCGA-85-A4CN-F70750 TCGA-85-A4CN TCGA-85-A4CN-01A -20490 168 0 1038 0 NO NO Scheduled Follow-up Submission Complete Remission/Response 2015-3-4 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 1370 NO 100 NO Peripheral Lung NO NO true No M0 N1 T2b Stage IIB TCGA-85-A4CN.EE8604DB-464B-4B27-BD77-1CA923637F2D.pdf A4CN Post-Adjuvant Therapy TUMOR FREE Complete Remission/Response NO YES R0 Primary Tumor 01 2008 7th YES YES NO 85 4 Lung A LIVING 2012 d2853a6d-4853-42cc-9f5e-9cf057095dcf TCGA-85-A4CN-01 TCGA-85-A4CN-01 TCGA-85-A4CN-01 d2853a6d-4853-42cc-9f5e-9cf057095dcf TCGA-85-A4CN-01 TCGA-85-A4CN-01A-11D-A24C-01 d2853a6d-4853-42cc-9f5e-9cf057095dcf d2853a6d-4853-42cc-9f5e-9cf057095dcf TCGA-85-A4CN-01A-11D-A24C-01 TCGA-85-A4CN-01A-11D-A24I-05 1A13AEB4-D9B8-4AD4-99A2-EFAB7F7AC9CE +TCGA-85-A4JB-01 TCGA-85-A4JB-01 TCGA-85-A4JB TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 74 R-Upper TCGA-85-A4JB-F70751 TCGA-85-A4JB TCGA-85-A4JB-01A -27315 140 0 942 0 NO NO Scheduled Follow-up Submission Complete Remission/Response 2015-3-4 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 1350 NO 100 NO Central Lung NO NO 25 true No M0 N0 T3 Stage IIB TCGA-85-A4JB.36440AEA-EB5D-42B9-B6BE-B395C54E0407.pdf A4JB Post-Adjuvant Therapy TUMOR FREE Complete Remission/Response NO NO R0 Primary Tumor 01 7th YES YES NO 85 2 Lung A LIVING 2012 dfc68f11-b26c-48a3-b43e-c907d9d12f87 TCGA-85-A4JB-01 TCGA-85-A4JB-01 TCGA-85-A4JB-01 dfc68f11-b26c-48a3-b43e-c907d9d12f87 TCGA-85-A4JB-01 TCGA-85-A4JB-01A-51D-A25M-01 dfc68f11-b26c-48a3-b43e-c907d9d12f87 dfc68f11-b26c-48a3-b43e-c907d9d12f87 TCGA-85-A4JB-01A-51D-A25M-01 TCGA-85-A4JB-01A-51D-A25R-05 28F2BFC6-9659-4DCA-B3D7-F87150D0E570 +TCGA-85-A4JC-01 TCGA-85-A4JC-01 TCGA-85-A4JC TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung NO NO NO 84 L-Upper TCGA-85-A4JC-F70749 TCGA-85-A4JC TCGA-85-A4JC-01A -30942 140 604 0 -10 548 3 NO NO Scheduled Follow-up Submission Progressive Disease 2015-3-9 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 830 NO 50 NO Central Lung NO Locoregional Recurrence YES 25 true No M0 N0 T2b Stage IIA TCGA-85-A4JC.A084BBE7-0EFB-4C9A-9A68-FB98C7CCA0BE.pdf A4JC Post-Adjuvant Therapy WITH TUMOR 68.4 73.6 Complete Remission/Response Convincing Imaging YES NO R0 Primary Tumor 01 7th YES YES NO 85 2 Lung A DECEASED 2012 03f49b28-9ea3-446c-a9b1-633bcbedc3b4 TCGA-85-A4JC-01 TCGA-85-A4JC-01 TCGA-85-A4JC-01 03f49b28-9ea3-446c-a9b1-633bcbedc3b4 TCGA-85-A4JC-01 TCGA-85-A4JC-01A-11D-A256-01 03f49b28-9ea3-446c-a9b1-633bcbedc3b4 03f49b28-9ea3-446c-a9b1-633bcbedc3b4 TCGA-85-A4JC-01A-11D-A256-01 TCGA-85-A4JC-01A-11D-A258-05 ED90EEB3-1490-4794-8E0A-841BC5BC0EBC +TCGA-85-A4PA-01 TCGA-85-A4PA-01 TCGA-85-A4PA TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 61 L-Lower TCGA-85-A4PA-F58733 TCGA-85-A4PA TCGA-85-A4PA-01A -22614 190 0 741 NO NO Scheduled Follow-up Submission Complete Remission/Response 2014-4-22 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8072/3 C34.3 YES 1870 NO NO Central Lung NO NO 40 true No M0 N0 T2a Stage IB TCGA-85-A4PA.4CFDEC28-F3F6-484F-8C51-29429D7927DE.pdf A4PA TUMOR FREE Complete Remission/Response NO NO R0 Primary Tumor 01 2012 7th NO YES NO 85 4 Lung A LIVING 2012 1972 fdb289b5-14ba-4291-b997-b3b59f709052 TCGA-85-A4PA-01 TCGA-85-A4PA-01 TCGA-85-A4PA-01 fdb289b5-14ba-4291-b997-b3b59f709052 TCGA-85-A4PA-01 TCGA-85-A4PA-01A-11D-A256-01 fdb289b5-14ba-4291-b997-b3b59f709052 fdb289b5-14ba-4291-b997-b3b59f709052 TCGA-85-A4PA-01A-11D-A256-01 TCGA-85-A4PA-01A-11D-A258-05 594F6710-8171-43D2-9C04-3E123D6513D9 +TCGA-85-A4QQ-01 TCGA-85-A4QQ-01 TCGA-85-A4QQ TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 68 R-Lower TCGA-85-A4QQ-F71407 TCGA-85-A4QQ TCGA-85-A4QQ-01A -25065 55 927 0 -2 NO NO Scheduled Follow-up Submission 2015-3-25 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8071/3 C34.3 YES 360 NO NO Central Lung NO 50 true No M0 N0 T2a Stage IB TCGA-85-A4QQ.5265DA24-3D23-4CEA-9F1B-B7820BF83237.pdf A4QQ TUMOR FREE Complete Remission/Response NO NO R0 Primary Tumor 01 7th NO YES NO 85 2 Lung A DECEASED 2012 1960 fbead603-e53b-4b12-b9a9-d238b00c08e3 TCGA-85-A4QQ-01 TCGA-85-A4QQ-01 TCGA-85-A4QQ-01 fbead603-e53b-4b12-b9a9-d238b00c08e3 TCGA-85-A4QQ-01 TCGA-85-A4QQ-01A-41D-A25M-01 fbead603-e53b-4b12-b9a9-d238b00c08e3 fbead603-e53b-4b12-b9a9-d238b00c08e3 TCGA-85-A4QQ-01A-41D-A25M-01 TCGA-85-A4QQ-01A-41D-A25R-05 CE537BBF-03DB-43B5-BCDC-BA3C872289F8 +TCGA-85-A4QR-01 TCGA-85-A4QR-01 TCGA-85-A4QR TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 67 R-Upper TCGA-85-A4QR-F57671 TCGA-85-A4QR TCGA-85-A4QR-01A -24756 103 0 600 0 NO NO Scheduled Follow-up Submission Complete Remission/Response 2014-3-19 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 510 NO 100 NO Central Lung NO NO 50 true No M0 N0 T2a Stage IB TCGA-85-A4QR.78401F84-F4BA-4657-B6CD-0D137146474C.pdf A4QR TUMOR FREE Complete Remission/Response NO NO R0 Primary Tumor 01 2011 7th NO YES NO 85 4 Lung A LIVING 2012 1961 19c517ef-7e77-4033-9020-eef42285cb04 TCGA-85-A4QR-01 TCGA-85-A4QR-01 TCGA-85-A4QR-01 19c517ef-7e77-4033-9020-eef42285cb04 TCGA-85-A4QR-01 TCGA-85-A4QR-01A-11D-A256-01 19c517ef-7e77-4033-9020-eef42285cb04 19c517ef-7e77-4033-9020-eef42285cb04 TCGA-85-A4QR-01A-11D-A256-01 TCGA-85-A4QR-01A-11D-A258-05 8F1922B9-BCD0-40CB-9B8E-323329277C08 +TCGA-85-A50M-01 TCGA-85-A50M-01 TCGA-85-A50M TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 47 R-Upper TCGA-85-A50M-F69504 TCGA-85-A50M -17429 826 0 19 NO NO Scheduled Follow-up Submission 2015-1-12 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES NO Peripheral Lung NO NO 15 No M0 N0 T2b Stage IIA A50M TUMOR FREE Complete Remission/Response NO NO R0 Primary Tumor 01 2012 7th NO YES NO 85 4 Lung DECEASED 2012 1997 f68d990e-ed0b-46d2-8658-bf5e686e79c1 TCGA-85-A50M-01 TCGA-85-A50M-01 TCGA-85-A50M-01 f68d990e-ed0b-46d2-8658-bf5e686e79c1 TCGA-85-A50M-01 TCGA-85-A50M-01A-21D-A25M-01 f68d990e-ed0b-46d2-8658-bf5e686e79c1 f68d990e-ed0b-46d2-8658-bf5e686e79c1 TCGA-85-A50M-01A-21D-A25M-01 TCGA-85-A50M-01A-21D-A25R-05 +TCGA-85-A50Z-01 TCGA-85-A50Z-01 TCGA-85-A50Z TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung NO NO 57 R-Upper TCGA-85-A50Z-F55525 TCGA-85-A50Z TCGA-85-A50Z-01A -20941 143 0 493 462 0 Scheduled Follow-up Submission Complete Remission/Response 2014-1-8 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 1270 NO 100 NO Peripheral Lung NO New Primary Tumor YES 45 true No M0 N0 T2b Stage IIA TCGA-85-A50Z.3C1DB929-A01C-4274-B5A9-542237FEA832.pdf A50Z Other TUMOR FREE Complete Remission/Response Biopsy with Histologic Confirmation NO NO R0 Primary Tumor 01 7th YES YES NO 85 2 Lung A LIVING 2012 1973 8c5bf599-1fe3-419d-a83a-6c230c096735 TCGA-85-A50Z-01 TCGA-85-A50Z-01 TCGA-85-A50Z-01 8c5bf599-1fe3-419d-a83a-6c230c096735 TCGA-85-A50Z-01 TCGA-85-A50Z-01A-21D-A25M-01 8c5bf599-1fe3-419d-a83a-6c230c096735 8c5bf599-1fe3-419d-a83a-6c230c096735 TCGA-85-A50Z-01A-21D-A25M-01 TCGA-85-A50Z-01A-21D-A25R-05 D0300DDE-23D2-464A-8481-4DB99AA74F6B +TCGA-85-A510-01 TCGA-85-A510-01 TCGA-85-A510 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung NO NO YES 74 L-Lower TCGA-85-A510-F53447 TCGA-85-A510 TCGA-85-A510-01A 419 -27067 142 0 482 363 0 NO NO Scheduled Follow-up Submission Complete Remission/Response 2013-12-11 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 860 NO 100 NO Peripheral Lung NO Distant Metastasis YES 45 true No M0 N1 T2b Stage IIB TCGA-85-A510.4F6022A3-A5E0-4124-B740-E9BB9A301102.pdf A510 Other TUMOR FREE Complete Remission/Response NO NO R0 Primary Tumor 01 7th NO YES NO 85 2 Lung A LIVING 2012 1967 732285be-4a85-4be6-b3b6-7e50934a5adb TCGA-85-A510-01 TCGA-85-A510-01 TCGA-85-A510-01 732285be-4a85-4be6-b3b6-7e50934a5adb TCGA-85-A510-01 TCGA-85-A510-01A-11D-A26L-01 732285be-4a85-4be6-b3b6-7e50934a5adb 732285be-4a85-4be6-b3b6-7e50934a5adb TCGA-85-A510-01A-11D-A26L-01 TCGA-85-A510-01A-11D-A26N-05 85780898-FD8E-462A-83FF-6090E2994E13 +TCGA-85-A511-01 TCGA-85-A511-01 TCGA-85-A511 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung NO NO NO 62 L-Lower TCGA-85-A511-F65768 TCGA-85-A511 TCGA-85-A511-01A -22759 142 455 0 0 390 NO NO Scheduled Follow-up Submission Progressive Disease 2014-10-15 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 630 NO 90 NO Peripheral Lung NO Distant Metastasis YES 40 true No M0 N1 T2b Stage IIB TCGA-85-A511.63785892-9586-4C23-A6F6-794DF6D4A2F9.pdf A511 Preoperative WITH TUMOR Complete Remission/Response Convincing Imaging NO NO R0 Primary Tumor 01 7th NO YES NO 85 2 Lung A DECEASED 2012 1972 bdde9491-7b52-4655-bed9-708a4aa770f2 TCGA-85-A511-01 TCGA-85-A511-01 TCGA-85-A511-01 bdde9491-7b52-4655-bed9-708a4aa770f2 TCGA-85-A511-01 TCGA-85-A511-01A-21D-A25M-01 bdde9491-7b52-4655-bed9-708a4aa770f2 bdde9491-7b52-4655-bed9-708a4aa770f2 TCGA-85-A511-01A-21D-A25M-01 TCGA-85-A511-01A-21D-A25R-05 B12697A2-1E50-4352-B361-1E9FA1B1EBD4 +TCGA-85-A512-01 TCGA-85-A512-01 TCGA-85-A512 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 46 L-Upper TCGA-85-A512-F55530 TCGA-85-A512 TCGA-85-A512-01A -16811 107 0 465 0 NO NO Scheduled Follow-up Submission Complete Remission/Response 2014-1-8 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 350 NO 100 NO Central Lung NO NO 25 true No M0 N1 T1b Stage IIA TCGA-85-A512.A49AF0B2-6C19-47D5-BD75-A6CB7F7057B9.pdf A512 Other TUMOR FREE Complete Remission/Response NO NO R0 Primary Tumor 01 7th YES YES NO 85 2 Lung A LIVING 2012 1987 3d8fc38f-1005-47c9-adb7-62525f5ccfad TCGA-85-A512-01 TCGA-85-A512-01 TCGA-85-A512-01 3d8fc38f-1005-47c9-adb7-62525f5ccfad TCGA-85-A512-01 TCGA-85-A512-01A-11D-A26L-01 3d8fc38f-1005-47c9-adb7-62525f5ccfad 3d8fc38f-1005-47c9-adb7-62525f5ccfad TCGA-85-A512-01A-11D-A26L-01 TCGA-85-A512-01A-11D-A26N-05 B1BF9DC2-40F5-4F4C-BCF8-BD156B2A9437 +TCGA-85-A513-01 TCGA-85-A513-01 TCGA-85-A513 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 60 L-Upper TCGA-85-A513-F70192 TCGA-85-A513 TCGA-85-A513-01A -21967 97 0 910 1 NO NO Scheduled Follow-up Submission Complete Remission/Response 2015-1-30 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 400 NO 80 NO Peripheral Lung NO NO true No M0 NX T1a Stage IA TCGA-85-A513.47BE5F80-C50E-4B92-B0F9-7F93E73D356B.pdf A513 Post-Adjuvant Therapy TUMOR FREE Complete Remission/Response NO NO R0 Primary Tumor 01 7th YES NO 85 1 Lung A LIVING 2012 19df9b10-033c-4890-bf52-ad8dd72bdb0c TCGA-85-A513-01 TCGA-85-A513-01 TCGA-85-A513-01 19df9b10-033c-4890-bf52-ad8dd72bdb0c TCGA-85-A513-01 TCGA-85-A513-01A-12D-A26L-01 19df9b10-033c-4890-bf52-ad8dd72bdb0c 19df9b10-033c-4890-bf52-ad8dd72bdb0c TCGA-85-A513-01A-12D-A26L-01 TCGA-85-A513-01A-12D-A26N-05 ACCF32D0-570C-4BD6-8A51-F4738EFFD972 +TCGA-85-A53L-01 TCGA-85-A53L-01 TCGA-85-A53L TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 63 R-Middle TCGA-85-A53L-F56090 TCGA-85-A53L TCGA-85-A53L-01A -23065 72 0 377 2 NO NO Scheduled Follow-up Submission Complete Remission/Response 2014-1-27 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.2 8070/3 C34.2 YES 2200 NO 90 NO Peripheral Lung NO NO 30 true No M0 N0 T2b Stage IIA TCGA-85-A53L.3671CFAF-C10F-40F9-9FE4-0ADB566433E2.pdf A53L Post-Adjuvant Therapy TUMOR FREE Complete Remission/Response NO NO R0 Primary Tumor 01 2000 7th NO YES NO 85 4 Lung A LIVING 2012 1970 e5bf9cac-9a07-464f-bbd7-9d532bd1f30c TCGA-85-A53L-01 TCGA-85-A53L-01 TCGA-85-A53L-01 e5bf9cac-9a07-464f-bbd7-9d532bd1f30c TCGA-85-A53L-01 TCGA-85-A53L-01A-21D-A26L-01 e5bf9cac-9a07-464f-bbd7-9d532bd1f30c e5bf9cac-9a07-464f-bbd7-9d532bd1f30c TCGA-85-A53L-01A-21D-A26L-01 TCGA-85-A53L-01A-21D-A26N-05 9E792A76-C4DB-400F-933D-20817755DE08 +TCGA-85-A5B5-01 TCGA-85-A5B5-01 TCGA-85-A5B5 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 58 R-Upper TCGA-85-A5B5-F64099 TCGA-85-A5B5 TCGA-85-A5B5-01A -21450 190 0 111 NO NO Scheduled Follow-up Submission 2014-9-30 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 115 NO NO Central Lung YES NO 15 true No M0 N0 T1b Stage IA TCGA-85-A5B5.DF0EBE84-145F-478E-8242-80A6B267F532.pdf A5B5 TUMOR FREE Complete Remission/Response NO NO R0 Primary Tumor 01 2011 7th NO YES NO 85 4 Lung A LIVING 2012 1982 18ffe99a-7e67-4ecc-9729-5aaa6efc7fbf TCGA-85-A5B5-01 TCGA-85-A5B5-01 TCGA-85-A5B5-01 18ffe99a-7e67-4ecc-9729-5aaa6efc7fbf TCGA-85-A5B5-01 TCGA-85-A5B5-01A-21D-A26L-01 18ffe99a-7e67-4ecc-9729-5aaa6efc7fbf 18ffe99a-7e67-4ecc-9729-5aaa6efc7fbf TCGA-85-A5B5-01A-21D-A26L-01 TCGA-85-A5B5-01A-21D-A26N-05 2A023578-88AF-46F3-9B83-F57F0AEEC84E +TCGA-90-6837-01 TCGA-90-6837-01 Quiet C2-Squamous-like Low purity c2 squamous c3 squamous-like c4 miRNA c1uster 9 TCGA-90-6837 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 64 R-Upper TCGA-90-6837-F21659 TCGA-90-6837 TCGA-90-6837-01A -23511 0 758 0 Scheduled Follow-up Submission 2012-5-8 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.8 8070/3 C34.8 YES 0.6 NO NO 0.7 NO 40 No MX N0 T3 Stage IIB TCGA-90-6837.65ca38c2-7497-4dee-a054-5d2687171928.pdf 6837 Other TUMOR FREE Complete Remission/Response NO NO R0 Primary Tumor 01 0.3 2009 7th YES YES NO 90 4 Lung A LIVING 2011 91c5d28b-85af-49ff-8307-140707d13d0e TCGA-90-6837-01 TCGA-90-6837-01 TCGA-90-6837-01 91c5d28b-85af-49ff-8307-140707d13d0e TCGA-90-6837-01A-13-2194-20 TCGA-90-6837-01 TCGA-90-6837-01A-11D-1943-01 91c5d28b-85af-49ff-8307-140707d13d0e 91c5d28b-85af-49ff-8307-140707d13d0e TCGA-90-6837-01A-11D-1943-01 TCGA-90-6837-01A-11D-1947-05 56eec851-cabd-46ab-af62-812dae018005 +TCGA-90-6837-11 TCGA-90-6837-11 C2-Squamous-like TCGA-90-6837 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 64 R-Upper TCGA-90-6837-F21659 TCGA-90-6837 TCGA-90-6837-11A -23511 0 758 0 Scheduled Follow-up Submission 2012-5-8 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.8 8070/3 C34.8 YES 0.4 NO NO 0.7 NO 40 No MX N0 T3 Stage IIB 6837 Other TUMOR FREE Complete Remission/Response NO NO R0 Solid Tissue Normal 11 0.3 2009 7th YES YES NO 90 4 Lung A LIVING 2011 6178dbb9-01d2-4ba3-8315-f2add186879a TCGA-90-6837-11 TCGA-90-6837-11 6178dbb9-01d2-4ba3-8315-f2add186879a 6178dbb9-01d2-4ba3-8315-f2add186879a 6178dbb9-01d2-4ba3-8315-f2add186879a +TCGA-90-7766-01 TCGA-90-7766-01 Squamous Cluster 5 squamous c3 miRNA cluster 7 TCGA-90-7766 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 66 R-Upper TCGA-90-7766-F37922 TCGA-90-7766 TCGA-90-7766-01A -24354 0 289 289 NO NO Scheduled Follow-up Submission 2012-12-6 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 1 NO NO 2.2 NO Locoregional Recurrence YES 30 Yes MX N0 T1b Stage IA TCGA-90-7766.820f1ee0-19ce-4e5e-a3f5-f42a669ff123.pdf 7766 WITH TUMOR Progressive Disease Biopsy with Histologic Confirmation NO NO R0 Primary Tumor 01 0.6 7th NO YES NO 90 2 Lung A LIVING 2011 1981 0c5d09fe-e0e0-4cfa-9cd8-802b5725a3f6 TCGA-90-7766-01 TCGA-90-7766-01 TCGA-90-7766-01 0c5d09fe-e0e0-4cfa-9cd8-802b5725a3f6 TCGA-90-7766-01A-23-2195-20 TCGA-90-7766-01 TCGA-90-7766-01A-21D-2121-01 0c5d09fe-e0e0-4cfa-9cd8-802b5725a3f6 0c5d09fe-e0e0-4cfa-9cd8-802b5725a3f6 TCGA-90-7766-01A-21D-2121-01 TCGA-90-7766-01A-21D-2123-05 dd8497bc-44e4-4128-80b0-64b3ca838c64 +TCGA-90-7767-01 TCGA-90-7767-01 High Cluster 13 (HNSC-LUSC) squamous c3 miRNA cluster 4 TCGA-90-7767 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 56 R-Upper TCGA-90-7767-F37927 TCGA-90-7767 TCGA-90-7767-01A -20534 0 89 1 NO NO Scheduled Follow-up Submission 2012-12-6 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 1.1 NO NO 1.6 YES 25 No MX N1 T2b Stage IIB TCGA-90-7767.a9d672eb-90b2-4a1a-8540-d2d7370498d9.pdf 7767 Other TUMOR FREE NO R0 Primary Tumor 01 0.7 1991 7th YES NO 90 3 Lung A LIVING 2011 1981 2e83ed1e-fbff-4729-8dfa-c070aa13c78e TCGA-90-7767-01 TCGA-90-7767-01 TCGA-90-7767-01 2e83ed1e-fbff-4729-8dfa-c070aa13c78e TCGA-90-7767-01A-13-2195-20 TCGA-90-7767-01 TCGA-90-7767-01A-11D-2121-01 2e83ed1e-fbff-4729-8dfa-c070aa13c78e 2e83ed1e-fbff-4729-8dfa-c070aa13c78e TCGA-90-7767-01A-11D-2121-01 TCGA-90-7767-01A-11D-2123-05 4a4135f8-825b-457a-a65c-edf07e0215cb +TCGA-90-7767-11 TCGA-90-7767-11 TCGA-90-7767 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 56 R-Upper TCGA-90-7767-F37927 TCGA-90-7767 TCGA-90-7767-11A -20534 0 89 1 NO NO Scheduled Follow-up Submission 2012-12-6 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.6 NO NO 1.7 YES 25 No MX N1 T2b Stage IIB 7767 Other TUMOR FREE NO R0 Solid Tissue Normal 11 0.6 1991 7th YES NO 90 3 Lung A LIVING 2011 1981 62f93124-31ae-499b-b550-4f24be28024e TCGA-90-7767-11 TCGA-90-7767-11 62f93124-31ae-499b-b550-4f24be28024e 62f93124-31ae-499b-b550-4f24be28024e 62f93124-31ae-499b-b550-4f24be28024e +TCGA-90-7769-01 TCGA-90-7769-01 High Cluster 13 (HNSC-LUSC) squamous c3 miRNA cluster 11 TCGA-90-7769 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 55 TCGA-90-7769-F37973 TCGA-90-7769 TCGA-90-7769-01A -20276 0 358 66 1 NO NO Scheduled Follow-up Submission Complete Remission/Response 2012-12-7 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.9 8070/3 C34.9 YES 1.3 NO NO 2.5 NO NO 36 No MX N1 T2b Stage IIB TCGA-90-7769.251df531-37e8-4728-92e4-3345f72685dc.pdf 7769 Other TUMOR FREE 59 53 62 52 Complete Remission/Response YES NO R0 Primary Tumor 01 1 1995 7th NO YES NO 90 3 Lung A LIVING 2011 1971 c2624390-7f99-4346-b10d-568de512a8f9 TCGA-90-7769-01 TCGA-90-7769-01 TCGA-90-7769-01 c2624390-7f99-4346-b10d-568de512a8f9 TCGA-90-7769-01A-13-2195-20 TCGA-90-7769-01 TCGA-90-7769-01A-11D-2121-01 c2624390-7f99-4346-b10d-568de512a8f9 c2624390-7f99-4346-b10d-568de512a8f9 TCGA-90-7769-01A-11D-2121-01 TCGA-90-7769-01A-11D-2123-05 71d2cccb-ba7a-47f2-96d0-11b7b3f0c20f +TCGA-90-7964-01 TCGA-90-7964-01 Squamous Cluster 5 squamous-like c4 miRNA cluster 4 TCGA-90-7964 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 70 R-Upper TCGA-90-7964-F42527 TCGA-90-7964 TCGA-90-7964-01A -25646 0 428 40 1 NO NO Scheduled Follow-up Submission Complete Remission/Response 2013-4-23 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 1.5 NO NO 2 NO NO 180 Yes MX N0 T2a Stage IB TCGA-90-7964.973e9adb-b9e8-419c-a3de-6f682ff684ab.pdf 7964 Post-Adjuvant Therapy TUMOR FREE 60 64 61 60 Complete Remission/Response YES NO R0 Primary Tumor 01 0.4 2011 7th NO YES NO 90 4 Lung A LIVING 2011 1951 295ea773-28fb-40fe-af98-d8126f09382b TCGA-90-7964-01 TCGA-90-7964-01 TCGA-90-7964-01 295ea773-28fb-40fe-af98-d8126f09382b TCGA-90-7964-01 TCGA-90-7964-01A-21D-2183-01 295ea773-28fb-40fe-af98-d8126f09382b 295ea773-28fb-40fe-af98-d8126f09382b TCGA-90-7964-01A-21D-2183-01 TCGA-90-7964-01A-21D-2185-05 +TCGA-90-A4ED-01 TCGA-90-A4ED-01 TCGA-90-A4ED TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 69 R-Upper TCGA-90-A4ED-F58338 TCGA-90-A4ED TCGA-90-A4ED-01A -25453 168 0 615 63 0 NO NO Scheduled Follow-up Submission Complete Remission/Response 2014-4-7 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 150 NO NO NO NO 30 false No MX N0 T2a Stage IB TCGA-90-A4ED.D0C782A7-3180-4273-90C0-1A2F16FE293B.pdf A4ED Preoperative TUMOR FREE 125 Complete Remission/Response YES NO Primary Tumor 01 1992 7th NO YES NO 90 3 Lung A LIVING 2012 1972 c7fdad9d-8804-403c-8171-c6fff106b33d TCGA-90-A4ED-01 TCGA-90-A4ED-01 TCGA-90-A4ED-01 c7fdad9d-8804-403c-8171-c6fff106b33d TCGA-90-A4ED-01 TCGA-90-A4ED-01A-31D-A256-01 c7fdad9d-8804-403c-8171-c6fff106b33d c7fdad9d-8804-403c-8171-c6fff106b33d TCGA-90-A4ED-01A-31D-A256-01 TCGA-90-A4ED-01A-31D-A258-05 1F1F3712-A0E2-470A-A0B5-289C67B871DF +TCGA-90-A4EE-01 TCGA-90-A4EE-01 TCGA-90-A4EE TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 53 Bronchial TCGA-90-A4EE-F58339 TCGA-90-A4EE TCGA-90-A4EE-01A -19676 136 0 688 45 YES Other YES Scheduled Follow-up Submission Complete Remission/Response 2014-4-7 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.9 8070/3 C34.9 YES 190 NO YES YES Other NO NO 68 false No MX N1 T2a Stage IIA TCGA-90-A4EE.254583DA-8861-45AB-A261-7EFA42C20A98.pdf A4EE TUMOR FREE 60 60 Complete Remission/Response YES NO Primary Tumor 01 7th YES YES NO 90 2 Lung A LIVING 2012 1978 ce3fabfc-8842-4c41-bf9a-e1c75872c8c0 TCGA-90-A4EE-01 TCGA-90-A4EE-01 TCGA-90-A4EE-01 ce3fabfc-8842-4c41-bf9a-e1c75872c8c0 TCGA-90-A4EE-01 TCGA-90-A4EE-01A-11D-A256-01 ce3fabfc-8842-4c41-bf9a-e1c75872c8c0 ce3fabfc-8842-4c41-bf9a-e1c75872c8c0 TCGA-90-A4EE-01A-11D-A256-01 TCGA-90-A4EE-01A-11D-A258-05 011E388E-E296-4A12-969A-57440B16F451 +TCGA-90-A59Q-01 TCGA-90-A59Q-01 TCGA-90-A59Q TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung NO YES NO 61 R-Upper TCGA-90-A59Q-F62045 TCGA-90-A59Q TCGA-90-A59Q-01A -22420 52 322 0 269 274 84 2 NO Scheduled Follow-up Submission Progressive Disease 2014-7-11 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 190 NO NO NO Distant Metastasis YES 80 false No MX N1 T2a Stage IIA TCGA-90-A59Q.EB15D79B-A4EF-4393-8759-E623A7282E0C.pdf A59Q Post-Adjuvant Therapy WITH TUMOR 94 Complete Remission/Response Convincing Imaging YES YES R0 Primary Tumor 01 7th YES YES NO 90 2 Lung A DECEASED 2012 1972 1a270e7a-4611-41ee-9bfe-c123a45049f5 TCGA-90-A59Q-01 TCGA-90-A59Q-01 TCGA-90-A59Q-01 1a270e7a-4611-41ee-9bfe-c123a45049f5 TCGA-90-A59Q-01 TCGA-90-A59Q-01A-11D-A26L-01 1a270e7a-4611-41ee-9bfe-c123a45049f5 1a270e7a-4611-41ee-9bfe-c123a45049f5 TCGA-90-A59Q-01A-11D-A26L-01 TCGA-90-A59Q-01A-11D-A26N-05 AABF81BF-7175-445F-BCBE-59ED28A3CA6B +TCGA-92-7340-01 TCGA-92-7340-01 Kirc+ C2-Squamous-like BRCA CIMP c7 squamous c3 squamous-like c4 miRNA cluster 4 TCGA-92-7340 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 45 R-Upper TCGA-92-7340-F18337 TCGA-92-7340 TCGA-92-7340-01A -16447 0 82 1 NO NO Scheduled Follow-up Submission Stable Disease 2011-11-14 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 1.1 NO 90 NO Central Lung 1.7 NO 15 No MX N1 T2a Stage IIA TCGA-92-7340.ec11729e-f821-4f7b-91c5-0ed2026e5881.pdf 7340 Adjuvant therapy WITH TUMOR Stable Disease NO R1 Primary Tumor 01 0.3 2000 7th YES YES NO 92 4 Lung A LIVING 2011 1985 7828187d-3fbc-4139-8546-c6d92fef3e0f TCGA-92-7340-01 TCGA-92-7340-01 TCGA-92-7340-01 7828187d-3fbc-4139-8546-c6d92fef3e0f TCGA-92-7340-01A-23-2195-20 TCGA-92-7340-01 TCGA-92-7340-01A-21D-2041-01 7828187d-3fbc-4139-8546-c6d92fef3e0f 7828187d-3fbc-4139-8546-c6d92fef3e0f TCGA-92-7340-01A-21D-2041-01 TCGA-92-7340-01A-21D-2043-05 bbdcf945-baf7-42ed-ab05-6f2dcb81c323 +TCGA-92-7340-11 TCGA-92-7340-11 C2-Squamous-like TCGA-92-7340 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 45 R-Upper TCGA-92-7340-F18337 TCGA-92-7340 TCGA-92-7340-11A -16447 0 82 1 NO NO Scheduled Follow-up Submission Stable Disease 2011-11-14 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 1.1 NO 90 NO Central Lung 1.5 NO 15 No MX N1 T2a Stage IIA 7340 Adjuvant therapy WITH TUMOR Stable Disease NO R1 Solid Tissue Normal 11 0.3 2000 7th YES YES NO 92 4 Lung A LIVING 2011 1985 3a0a356b-ee3a-4084-81d7-04b74a62dd96 TCGA-92-7340-11 TCGA-92-7340-11 3a0a356b-ee3a-4084-81d7-04b74a62dd96 3a0a356b-ee3a-4084-81d7-04b74a62dd96 3a0a356b-ee3a-4084-81d7-04b74a62dd96 +TCGA-92-7341-01 TCGA-92-7341-01 High Cluster 13 (HNSC-LUSC) squamous-like c4 miRNA cluster 4 TCGA-92-7341 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 71 R-Upper TCGA-92-7341-F18330 TCGA-92-7341 TCGA-92-7341-01A -26134 0 106 0 NO NO Scheduled Follow-up Submission Partial Remission/Response 2011-11-14 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 1.4 NO 100 NO Central Lung 1.6 NO 50 No MX N0 T2a Stage IB TCGA-92-7341.31fc1b19-8a42-4d14-95d1-22e8358d0029.pdf 7341 Pre-Adjuvant Therapy WITH TUMOR Partial Remission/Response NO R0 Primary Tumor 01 0.2 7th NO YES NO 92 2 Lung A LIVING 2011 1961 4ff5e2c1-478c-4f0a-bffe-ea62b205da06 TCGA-92-7341-01 TCGA-92-7341-01 TCGA-92-7341-01 4ff5e2c1-478c-4f0a-bffe-ea62b205da06 TCGA-92-7341-01 TCGA-92-7341-01A-31D-2041-01 4ff5e2c1-478c-4f0a-bffe-ea62b205da06 4ff5e2c1-478c-4f0a-bffe-ea62b205da06 TCGA-92-7341-01A-31D-2041-01 TCGA-92-7341-01A-31D-2043-05 +TCGA-92-7341-11 TCGA-92-7341-11 TCGA-92-7341 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 71 R-Upper TCGA-92-7341-F18330 TCGA-92-7341 -26134 0 106 0 NO NO Scheduled Follow-up Submission Partial Remission/Response 2011-11-14 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 100 NO Central Lung NO 50 No MX N0 T2a Stage IB 7341 Pre-Adjuvant Therapy WITH TUMOR Partial Remission/Response NO R0 Solid Tissue Normal 11 7th NO YES NO 92 2 Lung LIVING 2011 1961 TCGA-92-7341-11 TCGA-92-7341-11 +TCGA-92-8063-01 TCGA-92-8063-01 BRCA-LUAD+ Cluster 5 miRNA cluster 4 TCGA-92-8063 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 52 L-Upper TCGA-92-8063-F32177 TCGA-92-8063 TCGA-92-8063-01A -19193 0 122 76 1 NO NO Scheduled Follow-up Submission Complete Remission/Response 2012-5-18 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 1.4 NO 90 NO Central Lung 1.7 NO NO 74 No MX N2 T2b Stage IIIA TCGA-92-8063.517002a1-6e8c-400f-ae16-f23a061f6607.pdf 8063 Preoperative TUMOR FREE 82 91 78 84 Complete Remission/Response YES YES RX Primary Tumor 01 0.5 7th YES YES NO 92 2 Lung A LIVING 2011 1975 153f13af-43b9-4362-b18b-039b39611962 TCGA-92-8063-01 TCGA-92-8063-01 TCGA-92-8063-01 153f13af-43b9-4362-b18b-039b39611962 TCGA-92-8063-01 TCGA-92-8063-01A-11D-2243-01 153f13af-43b9-4362-b18b-039b39611962 153f13af-43b9-4362-b18b-039b39611962 TCGA-92-8063-01A-11D-2243-01 TCGA-92-8063-01A-11D-2245-05 +TCGA-92-8064-01 TCGA-92-8064-01 Squamous Cluster 13 (HNSC-LUSC) miRNA cluster 4 TCGA-92-8064 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 58 R-Upper TCGA-92-8064-F32180 TCGA-92-8064 TCGA-92-8064-01A -21417 0 160 80 1 NO NO Scheduled Follow-up Submission Complete Remission/Response 2012-5-18 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 1.5 NO NO Central Lung 1.5 NO NO 30 No MX N0 T2b [Discrepancy] TCGA-92-8064.38c3c16a-1a81-4812-9931-b5fb4b00615e.pdf 8064 Pre-Adjuvant Therapy TUMOR FREE 47 55 81 47 Complete Remission/Response YES NO RX Primary Tumor 01 0.6 2004 7th YES YES NO 92 4 Lung A LIVING 2011 1974 0a5d5dd8-9391-424e-905e-6359845a153d TCGA-92-8064-01 TCGA-92-8064-01 TCGA-92-8064-01 0a5d5dd8-9391-424e-905e-6359845a153d TCGA-92-8064-01 TCGA-92-8064-01A-11D-2243-01 0a5d5dd8-9391-424e-905e-6359845a153d 0a5d5dd8-9391-424e-905e-6359845a153d TCGA-92-8064-01A-11D-2243-01 TCGA-92-8064-01A-11D-2245-05 +TCGA-92-8065-01 TCGA-92-8065-01 Squamous Cluster 14 (HNSC) miRNA cluster 11 TCGA-92-8065 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 74 L-Lower TCGA-92-8065-F32188 TCGA-92-8065 -27049 0 70 55 0 NO NO Scheduled Follow-up Submission Complete Remission/Response 2012-5-18 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8071/3 C34.3 YES NO Central Lung NO NO 14 No MX N0 T3 Stage IIB 8065 Preoperative TUMOR FREE 67 86 72 92 Complete Remission/Response YES NO RX Primary Tumor 01 1995 7th NO YES NO 92 3 Lung LIVING 2012 1968 d557d077-7341-4e0e-8994-9c36b45fe02d TCGA-92-8065-01 TCGA-92-8065-01 TCGA-92-8065-01 d557d077-7341-4e0e-8994-9c36b45fe02d TCGA-92-8065-01 TCGA-92-8065-01A-11D-2243-01 d557d077-7341-4e0e-8994-9c36b45fe02d d557d077-7341-4e0e-8994-9c36b45fe02d TCGA-92-8065-01A-11D-2243-01 TCGA-92-8065-01A-11D-2245-05 +TCGA-94-7033-01 TCGA-94-7033-01 High C2-Squamous-like Cluster 5 squamous c3 squamous-like c4 miRNA cluster 11 TCGA-94-7033 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 73 [Discrepancy] TCGA-94-7033-F40721 TCGA-94-7033 TCGA-94-7033-01A -26948 0 640 0 Scheduled Follow-up Submission 2013-2-27 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.5 NO 100 1.1 NO NO 30 Yes MX N0 T2 Stage IB TCGA-94-7033.a35d486d-6ddd-4e45-999c-3c66496da495.pdf 7033 Post-Adjuvant Therapy TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 0.2 2011 7th YES YES NO 94 4 Lung A LIVING 2011 fabfb417-8a39-4860-a60f-66fb98beaae3 TCGA-94-7033-01 TCGA-94-7033-01 TCGA-94-7033-01 fabfb417-8a39-4860-a60f-66fb98beaae3 TCGA-94-7033-01A-13-2194-20 TCGA-94-7033-01 TCGA-94-7033-01A-11D-1943-01 fabfb417-8a39-4860-a60f-66fb98beaae3 fabfb417-8a39-4860-a60f-66fb98beaae3 TCGA-94-7033-01A-11D-1943-01 TCGA-94-7033-01A-11D-1947-05 95f1fbdc-e59b-4825-b63e-c71b23b2f6e9 +TCGA-94-7557-01 TCGA-94-7557-01 Squamous C2-Squamous-like Cluster 5 squamous c3 squamous-like c4 miRNA cluster 4 TCGA-94-7557 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 73 L-Upper TCGA-94-7557-F21130 TCGA-94-7557 TCGA-94-7557-01A -26802 5 0 78 Scheduled Follow-up Submission 2012-2-1 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.7 NO 1.3 NO Yes M0 N0 T2 Stage IB TCGA-94-7557.9c906fe6-af3f-42d4-ad03-4cfe825c92d3.pdf 7557 TUMOR FREE 68 75 69 71 Complete Remission/Response YES NO Primary Tumor 01 0.2 7th NO YES NO 94 2 Lung A DECEASED 2011 318d06a1-77ea-4a5a-a886-d8b470713451 TCGA-94-7557-01 TCGA-94-7557-01 TCGA-94-7557-01 318d06a1-77ea-4a5a-a886-d8b470713451 TCGA-94-7557-01A-13-2195-20 TCGA-94-7557-01 TCGA-94-7557-01A-11D-2121-01 318d06a1-77ea-4a5a-a886-d8b470713451 318d06a1-77ea-4a5a-a886-d8b470713451 TCGA-94-7557-01A-11D-2121-01 TCGA-94-7557-01A-11D-2123-05 b55c5cd9-2ac9-4b08-bebd-acd943bf9521 +TCGA-94-7943-01 TCGA-94-7943-01 Squamous C2-Squamous-like Cluster 5 squamous c3 squamous-like c4 miRNA cluster 4 TCGA-94-7943 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung NO NO NO 80 L-Lower TCGA-94-7943-F65473 TCGA-94-7943 TCGA-94-7943-01A -29282 0 559 556 71 1 Scheduled Follow-up Submission Progressive Disease 2014-9-23 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.7 NO 1 NO Locoregional Recurrence YES 30 Yes MX NX T1b Stage IA TCGA-94-7943.45ec950b-c7d1-421e-a6a7-79adb212c169.pdf 7943 Preoperative WITH TUMOR 0 93 0 86 Complete Remission/Response Biopsy with Histologic Confirmation|Convincing Imaging YES NO R0 Primary Tumor 01 0.2 1991 7th NO YES NO 94 3 Lung A LIVING 2011 1961 16a43a5d-fe72-4b8a-887d-1b40342c1253 TCGA-94-7943-01 TCGA-94-7943-01 TCGA-94-7943-01 16a43a5d-fe72-4b8a-887d-1b40342c1253 TCGA-94-7943-01A-13-2195-20 TCGA-94-7943-01 TCGA-94-7943-01A-11D-2183-01 16a43a5d-fe72-4b8a-887d-1b40342c1253 16a43a5d-fe72-4b8a-887d-1b40342c1253 TCGA-94-7943-01A-11D-2183-01 TCGA-94-7943-01A-11D-2185-05 78584fca-e293-47bf-b2a0-bcaa476544a7 +TCGA-94-8035-01 TCGA-94-8035-01 Squamous Cluster 5 miRNA cluster 11 TCGA-94-8035 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 64 L-Upper TCGA-94-8035-F69142 TCGA-94-8035 TCGA-94-8035-01A -23399 0 122 0 Scheduled Follow-up Submission 2014-12-30 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 1 NO 1.5 YES NO 50 No MX N0 T3 Stage IIB TCGA-94-8035.ba6dd2df-43b6-414f-a5a7-160f31af73fb.pdf 8035 TUMOR FREE 0 0 0 67 Complete Remission/Response YES NO R0 Primary Tumor 01 0.3 7th NO YES NO 94 2 Lung A LIVING 2011 1961 60b16987-41a4-4bcf-a550-939534eae800 TCGA-94-8035-01 TCGA-94-8035-01 TCGA-94-8035-01 60b16987-41a4-4bcf-a550-939534eae800 TCGA-94-8035-01 TCGA-94-8035-01A-11D-2243-01 60b16987-41a4-4bcf-a550-939534eae800 60b16987-41a4-4bcf-a550-939534eae800 TCGA-94-8035-01A-11D-2243-01 TCGA-94-8035-01A-11D-2245-05 693F9CD5-AD46-4236-8BA0-B1192D749845 +TCGA-94-8490-01 TCGA-94-8490-01 Cluster 13 (HNSC-LUSC) miRNA cluster 11 TCGA-94-8490 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 70 R-Upper TCGA-94-8490-F58411 TCGA-94-8490 TCGA-94-8490-01A -25588 0 153 NO NO Scheduled Follow-up Submission 2014-4-9 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 0.9 NO NO 1.4 YES NO No M0 N0 T3 Stage IIB TCGA-94-8490.ef5af5e3-88f5-4651-a7fe-f56b0bea6ed8.pdf 8490 TUMOR FREE NO NO R0 Primary Tumor 01 0.4 7th YES NO 94 5 Lung A LIVING 2011 e0d001b0-05c9-4c1f-a1c4-fefa8a1e322f TCGA-94-8490-01 TCGA-94-8490-01 TCGA-94-8490-01 e0d001b0-05c9-4c1f-a1c4-fefa8a1e322f TCGA-94-8490-01 TCGA-94-8490-01A-11D-2322-01 e0d001b0-05c9-4c1f-a1c4-fefa8a1e322f e0d001b0-05c9-4c1f-a1c4-fefa8a1e322f TCGA-94-8490-01A-11D-2322-01 TCGA-94-8490-01A-11D-2324-05 4718D7BC-7975-4940-86A3-D8F89C12A5C5 +TCGA-94-8491-01 TCGA-94-8491-01 BRCA CIMP c7 miRNA c1uster 9 TCGA-94-8491 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung NO NO YES 73 R-Lower TCGA-94-8491-F58412 TCGA-94-8491 TCGA-94-8491-01A 641 -26698 0 810 641 0 NO NO Scheduled Follow-up Submission Complete Remission/Response 2014-4-9 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 1.5 NO NO 1.5 NO Distant Metastasis YES 56 No M0 N1 T2a Stage IIA TCGA-94-8491.c41a30ff-11d7-41eb-858a-d45300b7beb3.pdf 8491 Post-Adjuvant Therapy TUMOR FREE Progressive Disease Biopsy with Histologic Confirmation|Convincing Imaging|Positive Biomarker(s) NO NO Primary Tumor 01 0.4 1984 7th YES YES NO 94 3 Lung A LIVING 2012 1956 9e45ff91-c250-4956-9f86-1ecae2fc0a38 TCGA-94-8491-01 TCGA-94-8491-01 TCGA-94-8491-01 9e45ff91-c250-4956-9f86-1ecae2fc0a38 TCGA-94-8491-01 TCGA-94-8491-01A-11D-2322-01 9e45ff91-c250-4956-9f86-1ecae2fc0a38 9e45ff91-c250-4956-9f86-1ecae2fc0a38 TCGA-94-8491-01A-11D-2322-01 TCGA-94-8491-01A-11D-2324-05 A611F180-B556-47A8-B9DC-C7D5642233D6 +TCGA-94-A4VJ-01 TCGA-94-A4VJ-01 TCGA-94-A4VJ TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 71 Bronchial TCGA-94-A4VJ-F58416 TCGA-94-A4VJ TCGA-94-A4VJ-01A -25991 107 0 430 NO NO Scheduled Follow-up Submission 2014-4-9 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.9 8070/3 C34.9 YES 110 NO NO Central Lung NO NO 37.5 true No M0 N0 T1b Stage IA TCGA-94-A4VJ.361F56F8-52D2-434D-97DE-57E9EB5B1B3D.pdf A4VJ TUMOR FREE Complete Remission/Response NO NO Primary Tumor 01 2012 7th NO YES NO 94 4 Lung A LIVING 2012 1962 73e04325-b1c2-4c77-b335-f6616ac48f47 TCGA-94-A4VJ-01 TCGA-94-A4VJ-01 TCGA-94-A4VJ-01 73e04325-b1c2-4c77-b335-f6616ac48f47 TCGA-94-A4VJ-01 TCGA-94-A4VJ-01A-11D-A256-01 73e04325-b1c2-4c77-b335-f6616ac48f47 73e04325-b1c2-4c77-b335-f6616ac48f47 TCGA-94-A4VJ-01A-11D-A256-01 TCGA-94-A4VJ-01A-11D-A258-05 1A3A7B76-B545-4F93-90A7-1D275B4A352F +TCGA-94-A5I4-01 TCGA-94-A5I4-01 TCGA-94-A5I4 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung NO YES YES 61 Bronchial TCGA-94-A5I4-F58418 TCGA-94-A5I4 TCGA-94-A5I4-01A 314 -22299 50 0 491 314 2 NO NO Scheduled Follow-up Submission Stable Disease 2014-4-9 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.0 8070/3 C34.0 YES 210 NO NO Central Lung NO Distant Metastasis YES 80 true Yes, History of Prior Malignancy MX N1 T2a Stage IIA TCGA-94-A5I4.8C32CD4E-3F9E-43E8-8E18-739561B9DA78.pdf A5I4 Pre-Adjuvant Therapy WITH TUMOR Complete Remission/Response Biopsy with Histologic Confirmation|Convincing Imaging NO NO RX Primary Tumor 01 2006 7th NO YES NO 94 4 Lung A LIVING 2012 ee589fc8-daf6-4da9-9708-f18a86b96b22 TCGA-94-A5I4-01 TCGA-94-A5I4-01 TCGA-94-A5I4-01 ee589fc8-daf6-4da9-9708-f18a86b96b22 TCGA-94-A5I4-01 TCGA-94-A5I4-01A-11D-A26L-01 ee589fc8-daf6-4da9-9708-f18a86b96b22 ee589fc8-daf6-4da9-9708-f18a86b96b22 TCGA-94-A5I4-01A-11D-A26L-01 TCGA-94-A5I4-01A-11D-A26N-05 B93FB8F0-14F2-4725-B016-C77EEAFD6211 +TCGA-94-A5I6-01 TCGA-94-A5I6-01 TCGA-94-A5I6 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung YES NO NO 62 L-Lower TCGA-94-A5I6-F58420 TCGA-94-A5I6 TCGA-94-A5I6-01A -22949 68 0 538 481 1 NO NO Scheduled Follow-up Submission Progressive Disease 2014-4-9 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 390 NO NO Peripheral Lung NO Distant Metastasis YES 80 true No M0 N0 T3 Stage IIB TCGA-94-A5I6.7780499A-871F-48F5-932A-7E4C0BB62ED1.pdf A5I6 Post-Adjuvant Therapy WITH TUMOR Progressive Disease Biopsy with Histologic Confirmation|Convincing Imaging NO NO RX Primary Tumor 01 2012 7th YES YES NO 94 4 Lung A LIVING 2012 1972 272a19bb-8dc3-499e-b17f-2b0f58626c8e TCGA-94-A5I6-01 TCGA-94-A5I6-01 TCGA-94-A5I6-01 272a19bb-8dc3-499e-b17f-2b0f58626c8e TCGA-94-A5I6-01 TCGA-94-A5I6-01A-21D-A27J-01 272a19bb-8dc3-499e-b17f-2b0f58626c8e 272a19bb-8dc3-499e-b17f-2b0f58626c8e TCGA-94-A5I6-01A-21D-A27J-01 TCGA-94-A5I6-01A-21D-A27L-05 C5CE8B24-78A1-4CE3-81C8-8AA55ABFB66C +TCGA-96-7544-01 TCGA-96-7544-01 Squamous C2-Squamous-like Cluster 13 (HNSC-LUSC) squamous c3 squamous-like c4 miRNA cluster 4 TCGA-96-7544 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 83 L-Lower TCGA-96-7544-F72316 TCGA-96-7544 TCGA-96-7544-01A -30548 2160 0 1213 94 Scheduled Follow-up Submission 2015-5-19 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.8 NO 1.2 NO 65 No MX N1 T2 Stage IIB TCGA-96-7544.32baed4b-24e5-4b74-86b7-21a15e48e1df.pdf 7544 TUMOR FREE 59 83 59 79 Complete Remission/Response YES NO Primary Tumor 01 0.8 6th NO NO YES 96 2 Lung A DECEASED 2008 1943 9a3858ef-0bb9-4d26-977c-6e06d0f770a5 TCGA-96-7544-01 TCGA-96-7544-01 TCGA-96-7544-01 9a3858ef-0bb9-4d26-977c-6e06d0f770a5 TCGA-96-7544-01A-13-2195-20 TCGA-96-7544-01 TCGA-96-7544-01A-11D-2041-01 9a3858ef-0bb9-4d26-977c-6e06d0f770a5 9a3858ef-0bb9-4d26-977c-6e06d0f770a5 TCGA-96-7544-01A-11D-2041-01 TCGA-96-7544-01A-11D-2043-05 f2806a36-bdd6-48dc-9c91-c5eddff6a4ec +TCGA-96-7545-01 TCGA-96-7545-01 Squamous Cluster 13 (HNSC-LUSC) squamous-like c4 miRNA cluster 4 TCGA-96-7545 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung NO NO YES 73 R-Lower TCGA-96-7545-F37173 TCGA-96-7545 TCGA-96-7545-01A 1693 -26729 1736 0 1324 1693 57 Scheduled Follow-up Submission Progressive Disease 2012-11-29 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 0.4 NO 0.4 NO Locoregional Recurrence YES 116 Yes MX N0 T1 Stage IA TCGA-96-7545.c3a70c66-ae03-435f-a2e7-05af6a9f0759.pdf 7545 65 55 61 52 Progressive Disease Biopsy with Histologic Confirmation YES NO Primary Tumor 01 0.1 2005 6th NO NO YES 96 4 Lung A DECEASED 2008 11fd13bc-b0d4-490b-a678-78ecfda9c9ce TCGA-96-7545-01 TCGA-96-7545-01 TCGA-96-7545-01 11fd13bc-b0d4-490b-a678-78ecfda9c9ce TCGA-96-7545-01 TCGA-96-7545-01A-21D-2041-01 11fd13bc-b0d4-490b-a678-78ecfda9c9ce 11fd13bc-b0d4-490b-a678-78ecfda9c9ce TCGA-96-7545-01A-21D-2041-01 TCGA-96-7545-01A-21D-2043-05 +TCGA-96-8169-01 TCGA-96-8169-01 Squamous Cluster 5 miRNA cluster 4 TCGA-96-8169 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 67 R-Lower TCGA-96-8169-F44231 TCGA-96-8169 TCGA-96-8169-01A -24674 0 557 48.83 0 NO NO Scheduled Follow-up Submission Complete Remission/Response 2013-6-19 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 1.3 NO NO 1.9 NO NO 35 No M0 N0 T1a Stage IA TCGA-96-8169.d0a4557a-fc0f-4b4e-bae3-24b61f28719a.pdf 8169 Preoperative TUMOR FREE 110.59 98.55 104.09 93.7 Complete Remission/Response YES NO Primary Tumor 01 0.2 2005 7th NO YES NO 96 4 Lung A LIVING 2011 1970 12c6d713-3314-4458-914a-8247ec0fe292 TCGA-96-8169-01 TCGA-96-8169-01 TCGA-96-8169-01 12c6d713-3314-4458-914a-8247ec0fe292 TCGA-96-8169-01 TCGA-96-8169-01A-11D-2292-01 12c6d713-3314-4458-914a-8247ec0fe292 12c6d713-3314-4458-914a-8247ec0fe292 TCGA-96-8169-01A-11D-2292-01 TCGA-96-8169-01A-11D-2294-05 +TCGA-96-8170-01 TCGA-96-8170-01 Squamous Cluster 5 miRNA cluster 11 TCGA-96-8170 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 75 R-Lower TCGA-96-8170-F44341 TCGA-96-8170 -27558 0 531 2 NO NO Scheduled Follow-up Submission Complete Remission/Response 2013-6-19 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES NO NO NO 50 No M0 N1 T1a Stage IIA 8170 Preoperative TUMOR FREE 68 59 67 61 Complete Remission/Response YES NO Primary Tumor 01 2011 7th NO YES NO 96 4 Lung LIVING 2011 1961 eda6f268-91c6-4a18-a3bc-cc2590423b44 TCGA-96-8170-01 TCGA-96-8170-01 TCGA-96-8170-01 eda6f268-91c6-4a18-a3bc-cc2590423b44 TCGA-96-8170-01 TCGA-96-8170-01A-11D-2292-01 eda6f268-91c6-4a18-a3bc-cc2590423b44 eda6f268-91c6-4a18-a3bc-cc2590423b44 TCGA-96-8170-01A-11D-2292-01 TCGA-96-8170-01A-11D-2294-05 +TCGA-96-A4JK-01 TCGA-96-A4JK-01 TCGA-96-A4JK TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 65 R-Upper TCGA-96-A4JK-F57387 TCGA-96-A4JK TCGA-96-A4JK-01A -23974 121 0 589 75 0 NO NO Scheduled Follow-up Submission Complete Remission/Response 2014-3-12 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) Yes, Pharmaceutical Treatment Prior to Resection C34.1 8070/3 C34.1 YES 230 NO NO NO NO 110 true Yes, History of Prior Malignancy M0 N1 T2a Stage IIA TCGA-96-A4JK.E86C3FFC-CD9C-46E4-BA1E-4A5226FB7044.pdf A4JK Preoperative TUMOR FREE 52 55 55 48 Complete Remission/Response YES NO R0 Primary Tumor 01 7th YES YES NO 96 2 Lung A LIVING 2012 1957 c5d7af42-6394-4315-bf63-2a2c51996bec TCGA-96-A4JK-01 c5d7af42-6394-4315-bf63-2a2c51996bec TCGA-96-A4JK-01 TCGA-96-A4JK-01A-11D-A256-01 c5d7af42-6394-4315-bf63-2a2c51996bec c5d7af42-6394-4315-bf63-2a2c51996bec TCGA-96-A4JK-01A-11D-A256-01 TCGA-96-A4JK-01A-11D-A258-05 D58D5CEB-652A-4C30-BEBF-31ABE20283DE +TCGA-96-A4JL-01 TCGA-96-A4JL-01 TCGA-96-A4JL TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 78 L-Lower TCGA-96-A4JL-F66776 TCGA-96-A4JL TCGA-96-A4JL-01A -28686 86 0 842 70 0 NO NO Scheduled Follow-up Submission 2014-10-23 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 140 NO NO NO NO true No M0 N1 T2a Stage IIA TCGA-96-A4JL.7004E0F3-E9C5-4CF4-99ED-25C8401CBC87.pdf A4JL Post-Adjuvant Therapy TUMOR FREE 76 93 76 98 Complete Remission/Response YES NO R0 Primary Tumor 01 7th YES YES NO 96 1 Lung A LIVING 2012 f0913366-262e-4c6b-b687-cc6126d95c84 TCGA-96-A4JL-01 TCGA-96-A4JL-01 TCGA-96-A4JL-01 f0913366-262e-4c6b-b687-cc6126d95c84 TCGA-96-A4JL-01 TCGA-96-A4JL-01A-11D-A256-01 f0913366-262e-4c6b-b687-cc6126d95c84 f0913366-262e-4c6b-b687-cc6126d95c84 TCGA-96-A4JL-01A-11D-A256-01 TCGA-96-A4JL-01A-11D-A258-05 BAA93F45-6655-4FC8-9749-E088DCFA147E +TCGA-98-7454-01 TCGA-98-7454-01 Squamous C1-LUAD-enriched Cluster 5 squamous c3 LUAD-like c10 miRNA cluster 4 TCGA-98-7454 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung NO 73 R-Upper TCGA-98-7454-F40775 TCGA-98-7454 TCGA-98-7454-01A -26827 0 652 0 YES YES Scheduled Follow-up Submission 2013-7-2 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 1.5 NO 100 YES 2.2 NO NO 60 No M0 N0 T2a Stage IB TCGA-98-7454.d2607098-3918-4967-9b7f-8ea9cd0e43b9.pdf 7454 Preoperative TUMOR FREE Complete Remission/Response NO R0 Primary Tumor 01 0.5 1983 7th NO NO YES 98 3 Lung A LIVING 2011 1943 0e199130-3ee6-4172-93f9-db55c11e61b3 TCGA-98-7454-01 TCGA-98-7454-01 TCGA-98-7454-01 0e199130-3ee6-4172-93f9-db55c11e61b3 TCGA-98-7454-01A-13-2195-20 TCGA-98-7454-01 TCGA-98-7454-01A-11D-2041-01 0e199130-3ee6-4172-93f9-db55c11e61b3 0e199130-3ee6-4172-93f9-db55c11e61b3 TCGA-98-7454-01A-11D-2041-01 TCGA-98-7454-01A-11D-2043-05 fed5fc80-909c-45a8-a5d1-06c865837c32 +TCGA-98-8020-01 TCGA-98-8020-01 Squamous Cluster 14 (HNSC) miRNA cluster 11 TCGA-98-8020 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 56 R-Upper TCGA-98-8020 -20509 84 0 47 1 YES NO 2012-6-18 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES YES NO Central Lung YES Yes, History of Prior Malignancy M0 N2 T2 Stage IIIA 8020 Preoperative WITH TUMOR 77 79 YES NO R0 Primary Tumor 01 7th NO NO YES 98 1 Lung DECEASED 2011 e6628ef2-abe7-4fa1-9e12-9034179ebb63 TCGA-98-8020-01 TCGA-98-8020-01 TCGA-98-8020-01 e6628ef2-abe7-4fa1-9e12-9034179ebb63 TCGA-98-8020-01 TCGA-98-8020-01A-11D-2243-01 e6628ef2-abe7-4fa1-9e12-9034179ebb63 e6628ef2-abe7-4fa1-9e12-9034179ebb63 TCGA-98-8020-01A-11D-2243-01 TCGA-98-8020-01A-11D-2245-05 +TCGA-98-8021-01 TCGA-98-8021-01 Squamous Cluster 5 miRNA c1uster 9 TCGA-98-8021 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung NO NO YES 75 R-Upper TCGA-98-8021-F58644 TCGA-98-8021 TCGA-98-8021-01A 918 -27738 0 937 918 83 1 YES NO Scheduled Follow-up Submission Complete Remission/Response 2014-7-11 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 1.2 NO NO 2 NO Locoregional Recurrence YES 60 No M0 N0 T1a Stage IA TCGA-98-8021.76114a4d-45e7-48d6-b47c-f9952f973e1f.pdf 8021 Preoperative TUMOR FREE 68 101 Complete Remission/Response Biopsy with Histologic Confirmation YES NO R0 Primary Tumor 01 0.5 2010 7th NO NO YES 98 4 Lung A LIVING 2011 1950 1d2aec25-2f54-47da-b627-a6b312e027a1 TCGA-98-8021-01 TCGA-98-8021-01 TCGA-98-8021-01 1d2aec25-2f54-47da-b627-a6b312e027a1 TCGA-98-8021-01 TCGA-98-8021-01A-11D-2243-01 1d2aec25-2f54-47da-b627-a6b312e027a1 1d2aec25-2f54-47da-b627-a6b312e027a1 TCGA-98-8021-01A-11D-2243-01 TCGA-98-8021-01A-11D-2245-05 +TCGA-98-8022-01 TCGA-98-8022-01 High Cluster 5 miRNA cluster 4 TCGA-98-8022 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 61 R-Upper TCGA-98-8022-F58654 TCGA-98-8022 -22487 933 0 224 42 0 YES NO Scheduled Follow-up Submission 2014-7-11 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES YES NO NO NO 117 No M0 N0 T1a Stage IA 8022 Preoperative TUMOR FREE 44 21 Complete Remission/Response YES NO R0 Primary Tumor 01 2008 7th NO NO YES 98 4 Lung DECEASED 2011 1961 c66143ca-3cbb-4432-8013-cce080001918 TCGA-98-8022-01 TCGA-98-8022-01 TCGA-98-8022-01 c66143ca-3cbb-4432-8013-cce080001918 TCGA-98-8022-01 TCGA-98-8022-01A-11D-2243-01 c66143ca-3cbb-4432-8013-cce080001918 c66143ca-3cbb-4432-8013-cce080001918 TCGA-98-8022-01A-11D-2243-01 TCGA-98-8022-01A-11D-2245-05 +TCGA-98-8023-01 TCGA-98-8023-01 High Cluster 5 miRNA cluster 4 TCGA-98-8023 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 70 Other (please specify) Right Upper and Right Middle TCGA-98-8023-F45009 TCGA-98-8023 TCGA-98-8023-01A -25732 0 649 69 0 YES NO Scheduled Follow-up Submission 2013-7-2 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.9 8070/3 C34.9 YES 1.4 NO YES NO 2.6 NO NO 75 No M0 N1 T3 Stage IIIA TCGA-98-8023.f1bfbafb-5cf1-414e-b14f-989573d4cbed.pdf 8023 Preoperative TUMOR FREE 46 54 Complete Remission/Response YES NO R0 Primary Tumor 01 0.5 7th NO YES NO 98 2 Lung A LIVING 2011 1961 29917460-f08a-4013-be64-ef7412d165dd TCGA-98-8023-01 TCGA-98-8023-01 TCGA-98-8023-01 29917460-f08a-4013-be64-ef7412d165dd TCGA-98-8023-01 TCGA-98-8023-01A-11D-2243-01 29917460-f08a-4013-be64-ef7412d165dd 29917460-f08a-4013-be64-ef7412d165dd TCGA-98-8023-01A-11D-2243-01 TCGA-98-8023-01A-11D-2245-05 +TCGA-98-A538-01 TCGA-98-A538-01 TCGA-98-A538 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 67 L-Upper TCGA-98-A538-F59855 TCGA-98-A538 TCGA-98-A538-01A -24698 266 0 826 77 2 YES NO Scheduled Follow-up Submission 2014-5-23 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 350 NO YES NO NO NO 35 true No M0 N0 T3 Stage IIB TCGA-98-A538.D297F1CF-8E9C-466C-8EE0-C589E5C74D29.pdf A538 Preoperative TUMOR FREE 65 76 Complete Remission/Response YES NO R0 Primary Tumor 01 2008 7th NO YES NO 98 4 Lung A LIVING 2012 1973 f6b2f5b6-b012-46ec-9ed9-9a37c22cac5d TCGA-98-A538-01 TCGA-98-A538-01 TCGA-98-A538-01 f6b2f5b6-b012-46ec-9ed9-9a37c22cac5d TCGA-98-A538-01 TCGA-98-A538-01A-11D-A25M-01 f6b2f5b6-b012-46ec-9ed9-9a37c22cac5d f6b2f5b6-b012-46ec-9ed9-9a37c22cac5d TCGA-98-A538-01A-11D-A25M-01 TCGA-98-A538-01A-11D-A25R-05 C2801501-04FA-49D6-8B3A-4082A202053E +TCGA-98-A539-01 TCGA-98-A539-01 TCGA-98-A539 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung NO 63 L-Upper TCGA-98-A539-F71610 TCGA-98-A539 TCGA-98-A539-01A -23098 327 0 173 173 55 1 YES FISH YES Scheduled Follow-up Submission 2015-3-26 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 180 NO YES NO YES Locoregional Recurrence YES 75 true Yes, History of Prior Malignancy M0 N0 T3 Stage IIB TCGA-98-A539.9CC9A747-F186-4BAE-B63F-82DC061B06FA.pdf A539 Preoperative WITH TUMOR 60 73 Convincing Imaging YES NO R0 Primary Tumor 01 7th NO YES NO 98 2 Lung A LIVING 2011 1962 63068ba8-f2cb-4e3d-a34b-ec219ab6b574 TCGA-98-A539-01 TCGA-98-A539-01 TCGA-98-A539-01 63068ba8-f2cb-4e3d-a34b-ec219ab6b574 TCGA-98-A539-01 TCGA-98-A539-01A-31D-A25M-01 63068ba8-f2cb-4e3d-a34b-ec219ab6b574 63068ba8-f2cb-4e3d-a34b-ec219ab6b574 TCGA-98-A539-01A-31D-A25M-01 TCGA-98-A539-01A-31D-A25R-05 A4F0E0EA-EB11-4A51-8CD7-992AC52C2ABC +TCGA-98-A53A-01 TCGA-98-A53A-01 TCGA-98-A53A TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 70 R-Middle TCGA-98-A53A-F58714 TCGA-98-A53A TCGA-98-A53A-01A -25662 161 552 0 274 43 1 YES FISH YES Scheduled Follow-up Submission 2014-10-23 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.2 8070/3 C34.2 YES 320 NO YES NO NO NO 80 true No M0 N0 T2a Stage IB TCGA-98-A53A.3E2F6DF6-5C59-4B1B-887E-B080532548A1.pdf A53A Preoperative 36 31 Complete Remission/Response YES NO R0 Primary Tumor 01 7th NO YES NO 98 2 Lung A DECEASED 2012 1972 b7a68734-2faf-41d2-9338-83ebacd3f044 TCGA-98-A53A-01 TCGA-98-A53A-01 TCGA-98-A53A-01 b7a68734-2faf-41d2-9338-83ebacd3f044 TCGA-98-A53A-01 TCGA-98-A53A-01A-11D-A25M-01 b7a68734-2faf-41d2-9338-83ebacd3f044 b7a68734-2faf-41d2-9338-83ebacd3f044 TCGA-98-A53A-01A-11D-A25M-01 TCGA-98-A53A-01A-11D-A25R-05 673F20BA-893B-4B5A-AAE1-860E2934F0D8 +TCGA-98-A53B-01 TCGA-98-A53B-01 TCGA-98-A53B TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 69 L-Upper TCGA-98-A53B TCGA-98-A53B-01A -25390 85 61 0 90 0 NO NO 2013-3-28 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 370 NO NO NO 40 true No M0 N0 T2a Stage IB TCGA-98-A53B.2BA70162-293A-4E9C-959C-0A735F18EA54.pdf A53B Preoperative TUMOR FREE 79 96 Complete Remission/Response YES NO R0 Primary Tumor 01 7th NO YES NO 98 2 Lung A DECEASED 2012 1972 c2c33653-e866-47a2-802c-7b842ed86ff4 TCGA-98-A53B-01 TCGA-98-A53B-01 TCGA-98-A53B-01 c2c33653-e866-47a2-802c-7b842ed86ff4 TCGA-98-A53B-01 TCGA-98-A53B-01A-11D-A25M-01 c2c33653-e866-47a2-802c-7b842ed86ff4 c2c33653-e866-47a2-802c-7b842ed86ff4 TCGA-98-A53B-01A-11D-A25M-01 TCGA-98-A53B-01A-11D-A25R-05 27AA7DD5-9B3C-44E9-906D-923AAEEB2854 +TCGA-98-A53C-01 TCGA-98-A53C-01 TCGA-98-A53C TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 77 R-Lower TCGA-98-A53C-F58828 TCGA-98-A53C TCGA-98-A53C-01A -28146 289 0 822 86 2 NO NO Scheduled Follow-up Submission 2014-4-24 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 600 NO NO NO NO 112.5 true No M0 N0 T1a Stage IA TCGA-98-A53C.46281311-F538-417F-88E2-97DDD8055AFC.pdf A53C Preoperative TUMOR FREE 57 55 Complete Remission/Response YES NO R0 Primary Tumor 01 2000 7th NO YES NO 98 4 Lung A LIVING 2012 1955 af593182-a2e2-4bbf-9a11-35746bf4be9e TCGA-98-A53C-01 TCGA-98-A53C-01 TCGA-98-A53C-01 af593182-a2e2-4bbf-9a11-35746bf4be9e TCGA-98-A53C-01 TCGA-98-A53C-01A-11D-A25M-01 af593182-a2e2-4bbf-9a11-35746bf4be9e af593182-a2e2-4bbf-9a11-35746bf4be9e TCGA-98-A53C-01A-11D-A25M-01 TCGA-98-A53C-01A-11D-A25R-05 6977FF33-28C4-48CB-9031-115A0B5944AF +TCGA-98-A53D-01 TCGA-98-A53D-01 TCGA-98-A53D TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung YES YES NO 68 R-Upper TCGA-98-A53D-F58825 TCGA-98-A53D TCGA-98-A53D-01A -24891 168 645 0 22 413 73 2 NO NO Scheduled Follow-up Submission Progressive Disease 2014-7-11 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8071/3 C34.1 YES 410 NO NO NO Locoregional Recurrence YES 90 true Yes, History of Prior Malignancy M0 N0 T3 Stage IIB TCGA-98-A53D.3B02DAE4-711E-46B4-AFE4-ED65A7DD1AD5.pdf A53D Preoperative WITH TUMOR 44 31 Complete Remission/Response Convincing Imaging YES NO R0 Primary Tumor 01 1990 7th NO YES NO 98 4 Lung A DECEASED 2012 1960 32618f86-4f65-4370-8339-5faad4fa59d5 TCGA-98-A53D-01 TCGA-98-A53D-01 TCGA-98-A53D-01 32618f86-4f65-4370-8339-5faad4fa59d5 TCGA-98-A53D-01 TCGA-98-A53D-01A-32D-A26L-01 32618f86-4f65-4370-8339-5faad4fa59d5 32618f86-4f65-4370-8339-5faad4fa59d5 TCGA-98-A53D-01A-32D-A26L-01 TCGA-98-A53D-01A-32D-A26N-05 +TCGA-98-A53H-01 TCGA-98-A53H-01 TCGA-98-A53H TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung NO YES 76 R-Upper TCGA-98-A53H-F58831 TCGA-98-A53H TCGA-98-A53H-01A -27928 98 0 618 427 87 1 NO NO Scheduled Follow-up Submission 2014-10-23 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 210 NO NO NO New Primary Tumor YES 40 true No M0 N0 T1a Stage IA TCGA-98-A53H.70F9038F-903B-4726-8DEB-CF4867136B9B.pdf A53H Preoperative 54 75 Complete Remission/Response Convincing Imaging YES NO R0 Primary Tumor 01 7th NO YES NO 98 2 Lung A LIVING 2012 1973 b2eaf339-4cd4-4b99-a5d4-10957d3d49dd TCGA-98-A53H-01 TCGA-98-A53H-01 TCGA-98-A53H-01 b2eaf339-4cd4-4b99-a5d4-10957d3d49dd TCGA-98-A53H-01 TCGA-98-A53H-01A-12D-A25M-01 b2eaf339-4cd4-4b99-a5d4-10957d3d49dd b2eaf339-4cd4-4b99-a5d4-10957d3d49dd TCGA-98-A53H-01A-12D-A25M-01 TCGA-98-A53H-01A-12D-A25R-05 C1B7B390-74AC-4EEC-A24E-6A016BB33735 +TCGA-98-A53I-01 TCGA-98-A53I-01 TCGA-98-A53I TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 64 R-Upper TCGA-98-A53I-F58930 TCGA-98-A53I TCGA-98-A53I-01A -23502 70 0 565 81 1 YES FISH YES Scheduled Follow-up Submission 2014-10-23 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 350 NO YES NO NO NO 70 true No M0 N1 T2a Stage IIA TCGA-98-A53I.D5167627-2D4D-4210-BAFC-CD73555488D9.pdf A53I Preoperative TUMOR FREE 80 56 Complete Remission/Response YES NO R0 Primary Tumor 01 2004 7th YES YES NO 98 4 Lung A LIVING 2012 1969 4f8626b1-b8cd-41a2-b9b0-63847d2168be TCGA-98-A53I-01 TCGA-98-A53I-01 TCGA-98-A53I-01 4f8626b1-b8cd-41a2-b9b0-63847d2168be TCGA-98-A53I-01 TCGA-98-A53I-01A-31D-A25M-01 4f8626b1-b8cd-41a2-b9b0-63847d2168be 4f8626b1-b8cd-41a2-b9b0-63847d2168be TCGA-98-A53I-01A-31D-A25M-01 TCGA-98-A53I-01A-31D-A25R-05 +TCGA-98-A53J-01 TCGA-98-A53J-01 TCGA-98-A53J TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 77 R-Upper TCGA-98-A53J-F58713 TCGA-98-A53J TCGA-98-A53J-01A -28485 83 0 630 81 1 YES FISH YES Scheduled Follow-up Submission 2014-4-22 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 1050 NO YES NO NO NO 100 true No M0 N0 T2a Stage IB TCGA-98-A53J.DFE3709F-1806-4D6E-8E4A-F33BEE0BABFC.pdf A53J Preoperative TUMOR FREE 46 57 50 59 Complete Remission/Response YES NO R0 Primary Tumor 01 1982 7th NO YES NO 98 3 Lung A LIVING 2012 1957 92959314-e1b3-4b24-a9a1-080a61884135 TCGA-98-A53J-01 TCGA-98-A53J-01 TCGA-98-A53J-01 92959314-e1b3-4b24-a9a1-080a61884135 TCGA-98-A53J-01 TCGA-98-A53J-01A-11D-A26L-01 92959314-e1b3-4b24-a9a1-080a61884135 92959314-e1b3-4b24-a9a1-080a61884135 TCGA-98-A53J-01A-11D-A26L-01 TCGA-98-A53J-01A-11D-A26N-05 E8ECE6FB-080A-4E24-8C71-D3015A5AB556 +TCGA-J1-A4AH-01 TCGA-J1-A4AH-01 TCGA-J1-A4AH TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 70 L-Lower TCGA-J1-A4AH-F55533 TCGA-J1-A4AH TCGA-J1-A4AH-01A -25893 104 0 581 77 NO NO Scheduled Follow-up Submission 2014-1-8 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 360 NO NO NO NO 100 true Yes, History of Synchronous/Bilateral Malignancy MX N0 T2b Stage IIA TCGA-J1-A4AH.27031EAD-6E93-4973-869E-EFE13B7F899A.pdf A4AH TUMOR FREE 75 Complete Remission/Response YES NO R0 Primary Tumor 01 2009 7th YES YES NO J1 4 Lung A LIVING 2012 657d4e74-c441-4ae1-8342-f789103bd461 TCGA-J1-A4AH-01 TCGA-J1-A4AH-01 TCGA-J1-A4AH-01 657d4e74-c441-4ae1-8342-f789103bd461 TCGA-J1-A4AH-01 TCGA-J1-A4AH-01A-31D-A24C-01 657d4e74-c441-4ae1-8342-f789103bd461 657d4e74-c441-4ae1-8342-f789103bd461 TCGA-J1-A4AH-01A-31D-A24C-01 TCGA-J1-A4AH-01A-31D-A24I-05 +TCGA-L3-A4E7-01 TCGA-L3-A4E7-01 TCGA-L3-A4E7 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung NO 71 R-Lower TCGA-L3-A4E7-F49026 TCGA-L3-A4E7 TCGA-L3-A4E7-01A -26232 36 0 392 87 1 NO NO Scheduled Follow-up Submission Complete Remission/Response 2013-9-25 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 110 NO NO Central Lung NO NO 25 true No M0 N0 T2a Stage IB TCGA-L3-A4E7.83686883-C3FA-43DA-9C85-F0A6319B7F57.pdf A4E7 Other TUMOR FREE 114 140 116 130 Complete Remission/Response YES NO R0 Primary Tumor 01 7th NO NO YES L3 2 Lung A LIVING 2012 1962 e873f2ee-21a1-48f9-a6d1-8062786148de TCGA-L3-A4E7-01 TCGA-L3-A4E7-01 TCGA-L3-A4E7-01 e873f2ee-21a1-48f9-a6d1-8062786148de TCGA-L3-A4E7-01 TCGA-L3-A4E7-01A-11D-A256-01 e873f2ee-21a1-48f9-a6d1-8062786148de e873f2ee-21a1-48f9-a6d1-8062786148de TCGA-L3-A4E7-01A-11D-A256-01 TCGA-L3-A4E7-01A-11D-A258-05 9F2F88A5-D895-49B1-BCFE-A0BC45D4B84B +TCGA-L3-A524-01 TCGA-L3-A524-01 TCGA-L3-A524 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 45 R-Upper TCGA-L3-A524-F55375 TCGA-L3-A524 TCGA-L3-A524-01A -16765 393 490 0 449 69 1 NO NO Scheduled Follow-up Submission 2014-1-6 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 160 NO NO Central Lung NO NO 25.6 true No M0 N0 T3 Stage IIB TCGA-L3-A524.9E78715F-BAED-4724-A4DC-C432C9C26CCF.pdf A524 Preoperative TUMOR FREE 92 117 90 111 Complete Remission/Response YES NO R0 Primary Tumor 01 7th YES NO YES L3 2 Lung A DECEASED 2011 1979 d3a233c1-9696-4c48-9567-ff37bb343362 TCGA-L3-A524-01 TCGA-L3-A524-01 TCGA-L3-A524-01 d3a233c1-9696-4c48-9567-ff37bb343362 TCGA-L3-A524-01 TCGA-L3-A524-01A-11D-A25M-01 d3a233c1-9696-4c48-9567-ff37bb343362 d3a233c1-9696-4c48-9567-ff37bb343362 TCGA-L3-A524-01A-11D-A25M-01 TCGA-L3-A524-01A-11D-A25R-05 EBAEFE59-058B-45D5-82B3-B688ED4FCFE7 +TCGA-LA-A446-01 TCGA-LA-A446-01 TCGA-LA-A446 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung NO NO 68 R-Lower TCGA-LA-A446-F46272 TCGA-LA-A446 TCGA-LA-A446-01A -25199 67 0 401 0 NO NO Scheduled Follow-up Submission Complete Remission/Response 2013-8-5 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 160 NO NO Central Lung NO NO 26 false No MX N0 T1b Stage IA TCGA-LA-A446.45894ED8-CCB0-4FD7-8A28-DAFBA3C645AE.pdf A446 Preoperative TUMOR FREE 62 92 61 87 Complete Remission/Response YES NO R0 Primary Tumor 01 7th NO YES NO LA 2 Lung A LIVING 2012 1961 e0dd6dc3-dcae-478c-99f3-e060272c14ef TCGA-LA-A446-01 TCGA-LA-A446-01 TCGA-LA-A446-01 e0dd6dc3-dcae-478c-99f3-e060272c14ef TCGA-LA-A446-01 TCGA-LA-A446-01A-21D-A256-01 e0dd6dc3-dcae-478c-99f3-e060272c14ef e0dd6dc3-dcae-478c-99f3-e060272c14ef TCGA-LA-A446-01A-21D-A256-01 TCGA-LA-A446-01A-21D-A258-05 FAE2316B-A1EE-4666-B393-7F11D81E5036 +TCGA-LA-A7SW-01 TCGA-LA-A7SW-01 TCGA-LA-A7SW TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung NO NO NO 71 L-Upper TCGA-LA-A7SW-F67139 TCGA-LA-A7SW TCGA-LA-A7SW-01A -26116 42 408 0 146 311 41 1 NO NO Additional New Tumor Event Progressive Disease 2014-10-31 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 480 NO NO NO Locoregional Recurrence YES 37 false No MX N1 T3 Stage IIIA TCGA-LA-A7SW.9835D7E8-2217-4C88-BDE5-DC293B9A505F.pdf A7SW Preoperative 77 72 78 69 Convincing Imaging YES NO R0 Primary Tumor 01 2012 7th YES YES NO LA 4 Lung A DECEASED 2013 1962 9e3a09b0-267d-4ea4-9180-1ffa3b1d8159 TCGA-LA-A7SW-01 TCGA-LA-A7SW-01 TCGA-LA-A7SW-01 9e3a09b0-267d-4ea4-9180-1ffa3b1d8159 TCGA-LA-A7SW-01 TCGA-LA-A7SW-01A-11D-A400-01 9e3a09b0-267d-4ea4-9180-1ffa3b1d8159 9e3a09b0-267d-4ea4-9180-1ffa3b1d8159 TCGA-LA-A7SW-01A-11D-A400-01 TCGA-LA-A7SW-01A-11D-A408-05 42CC6481-E2A1-44CA-B9AE-8F4B462A7811 +TCGA-MF-A522-01 TCGA-MF-A522-01 TCGA-MF-A522 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung NO YES YES 54 R-Upper TCGA-MF-A522-F60264 TCGA-MF-A522 TCGA-MF-A522-01A 178 -20051 132 360 0 83 173 4 Scheduled Follow-up Submission Progressive Disease 2014-6-4 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8071/3 C34.1 YES 430 NO 10 NO Distant Metastasis YES 45 true No MX N0 T2a Stage IB TCGA-MF-A522.E078E483-BF34-41CD-A55A-342E46BD928B.pdf A522 WITH TUMOR Partial Remission/Response Convincing Imaging YES NO Primary Tumor 01 2010 7th YES YES NO MF 4 Lung A DECEASED 2012 1967 42700ab7-f1fe-41de-97b0-3fba56091b82 TCGA-MF-A522-01 TCGA-MF-A522-01 TCGA-MF-A522-01 42700ab7-f1fe-41de-97b0-3fba56091b82 TCGA-MF-A522-01 TCGA-MF-A522-01A-11D-A25M-01 42700ab7-f1fe-41de-97b0-3fba56091b82 42700ab7-f1fe-41de-97b0-3fba56091b82 TCGA-MF-A522-01A-11D-A25M-01 TCGA-MF-A522-01A-11D-A25R-05 2CEA48BB-35AD-417B-BFE3-C5774AD56713 +TCGA-NC-A5HD-01 TCGA-NC-A5HD-01 TCGA-NC-A5HD TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 79 L-Upper TCGA-NC-A5HD TCGA-NC-A5HD-01A -28916 1697 2 0 63 NO NO 2013-4-16 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 110 NO NO Peripheral Lung NO 50 true Yes, History of Prior Malignancy M0 N0 T3 Stage IIB TCGA-NC-A5HD.414E245A-D9A7-4006-B197-656F8C6DB841.pdf A5HD TUMOR FREE 65 66 YES NO R0 Primary Tumor 01 2003 6th NO NO YES NC 4 Lung A DECEASED 2008 9c53a722-7e70-4bf4-b201-3df62ce501c4 TCGA-NC-A5HD-01 TCGA-NC-A5HD-01 TCGA-NC-A5HD-01 9c53a722-7e70-4bf4-b201-3df62ce501c4 TCGA-NC-A5HD-01 TCGA-NC-A5HD-01A-11D-A26L-01 9c53a722-7e70-4bf4-b201-3df62ce501c4 9c53a722-7e70-4bf4-b201-3df62ce501c4 TCGA-NC-A5HD-01A-11D-A26L-01 TCGA-NC-A5HD-01A-11D-A26N-05 197B73DB-0F58-42B1-BB0C-958FAE67C50C +TCGA-NC-A5HE-01 TCGA-NC-A5HE-01 TCGA-NC-A5HE TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 60 L-Upper TCGA-NC-A5HE-F69348 TCGA-NC-A5HE TCGA-NC-A5HE-01A -22179 1598 0 2336 79 0 NO NO Scheduled Follow-up Submission Complete Remission/Response 2015-1-7 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 110 NO NO Central Lung NO NO 30 true Yes, History of Prior Malignancy M0 N1 T2 Stage IIB TCGA-NC-A5HE.4845C8ED-6B22-4B64-A05E-48D5A7064797.pdf A5HE Pre-Adjuvant Therapy TUMOR FREE 71 71 66 67 Complete Remission/Response YES YES R0 Primary Tumor 01 1993 6th YES NO YES NC 4 Lung A LIVING 2008 1973 d9e4265e-0f8f-459a-915e-70fdc963668f TCGA-NC-A5HE-01 TCGA-NC-A5HE-01 TCGA-NC-A5HE-01 d9e4265e-0f8f-459a-915e-70fdc963668f TCGA-NC-A5HE-01 TCGA-NC-A5HE-01A-11D-A26L-01 d9e4265e-0f8f-459a-915e-70fdc963668f d9e4265e-0f8f-459a-915e-70fdc963668f TCGA-NC-A5HE-01A-11D-A26L-01 TCGA-NC-A5HE-01A-11D-A26N-05 85A34339-73D2-4E28-9121-FE634216E765 +TCGA-NC-A5HF-01 TCGA-NC-A5HF-01 TCGA-NC-A5HF TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 74 L-Lower TCGA-NC-A5HF TCGA-NC-A5HF-01A -27038 1458 138 0 103 NO NO 2013-4-16 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8071/3 C34.3 YES 80 NO NO Peripheral Lung YES true No MX N0 T4 Stage IIIB TCGA-NC-A5HF.049B234F-D323-4C0B-BF05-DDA265ADA66F.pdf A5HF WITH TUMOR 51 82 50 65 Progressive Disease YES NO R0 Primary Tumor 01 6th NO NO YES NC 2 Lung A DECEASED 2008 9b2c4413-d5e6-4d48-9ceb-4ba48e737f25 TCGA-NC-A5HF-01 TCGA-NC-A5HF-01 TCGA-NC-A5HF-01 9b2c4413-d5e6-4d48-9ceb-4ba48e737f25 TCGA-NC-A5HF-01 TCGA-NC-A5HF-01A-11D-A26L-01 9b2c4413-d5e6-4d48-9ceb-4ba48e737f25 9b2c4413-d5e6-4d48-9ceb-4ba48e737f25 TCGA-NC-A5HF-01A-11D-A26L-01 TCGA-NC-A5HF-01A-11D-A26N-05 0298CF49-FD4C-40A9-B4B1-7BA369D723DE +TCGA-NC-A5HG-01 TCGA-NC-A5HG-01 TCGA-NC-A5HG TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 59 R-Lower TCGA-NC-A5HG-F69349 TCGA-NC-A5HG TCGA-NC-A5HG-01A -21608 1424 0 1963 77 1 NO NO Scheduled Follow-up Submission Complete Remission/Response 2015-1-7 MALE Lung Basaloid Squamous Cell Carcinoma No C34.3 8083/3 C34.3 YES 40 NO NO Central Lung NO NO 80 true No M0 N2 T2 Stage IIIA TCGA-NC-A5HG.0E4B8213-E1E7-44B2-A086-F53CDE435C10.pdf A5HG Pre-Adjuvant Therapy TUMOR FREE 68 90 63 85 Complete Remission/Response YES YES R0 Primary Tumor 01 2008 6th YES NO YES NC 4 Lung A LIVING 2009 1968 121de962-5648-46eb-b745-4ec8875ace3e TCGA-NC-A5HG-01 TCGA-NC-A5HG-01 TCGA-NC-A5HG-01 121de962-5648-46eb-b745-4ec8875ace3e TCGA-NC-A5HG-01 TCGA-NC-A5HG-01A-11D-A26L-01 121de962-5648-46eb-b745-4ec8875ace3e 121de962-5648-46eb-b745-4ec8875ace3e TCGA-NC-A5HG-01A-11D-A26L-01 TCGA-NC-A5HG-01A-11D-A26N-05 +TCGA-NC-A5HH-01 TCGA-NC-A5HH-01 TCGA-NC-A5HH TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 53 L-Lower TCGA-NC-A5HH-F55778 TCGA-NC-A5HH -19485 0 37 64 NO NO Scheduled Follow-up Submission 2014-1-15 MALE Lung Basaloid Squamous Cell Carcinoma No C34.3 8083/3 C34.3 YES NO Peripheral Lung YES NO 60 No M0 N0 T1 Stage IA A5HH TUMOR FREE 72 94 Complete Remission/Response YES NO R0 Primary Tumor 01 6th NO NO YES NC 2 Lung LIVING 2009 eb7105cb-db03-4c01-b806-b9f613564a22 TCGA-NC-A5HH-01 TCGA-NC-A5HH-01 TCGA-NC-A5HH-01 eb7105cb-db03-4c01-b806-b9f613564a22 TCGA-NC-A5HH-01 TCGA-NC-A5HH-01A-11D-A26L-01 eb7105cb-db03-4c01-b806-b9f613564a22 eb7105cb-db03-4c01-b806-b9f613564a22 TCGA-NC-A5HH-01A-11D-A26L-01 TCGA-NC-A5HH-01A-11D-A26N-05 +TCGA-NC-A5HI-01 TCGA-NC-A5HI-01 TCGA-NC-A5HI TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 68 R-Lower TCGA-NC-A5HI-F70561 TCGA-NC-A5HI TCGA-NC-A5HI-01A -24981 1228 0 1743 91 NO NO Scheduled Follow-up Submission Complete Remission/Response 2015-3-4 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 80 NO NO Peripheral Lung NO NO 60 true No M0 N0 T2 Stage IB TCGA-NC-A5HI.45450CB6-9903-40AD-97D4-18BEF2ED87CB.pdf A5HI TUMOR FREE 66 91 69 91 Complete Remission/Response YES NO R0 Primary Tumor 01 6th YES NO YES NC 2 Lung A LIVING 2009 1959 d1f64089-b3d5-490f-8800-d8b82cc7469c TCGA-NC-A5HI-01 TCGA-NC-A5HI-01 TCGA-NC-A5HI-01 d1f64089-b3d5-490f-8800-d8b82cc7469c TCGA-NC-A5HI-01 TCGA-NC-A5HI-01A-11D-A26L-01 d1f64089-b3d5-490f-8800-d8b82cc7469c d1f64089-b3d5-490f-8800-d8b82cc7469c TCGA-NC-A5HI-01A-11D-A26L-01 TCGA-NC-A5HI-01A-11D-A26N-05 30964681-BA2B-4354-AB4B-EDF7A3846F22 +TCGA-NC-A5HJ-01 TCGA-NC-A5HJ-01 TCGA-NC-A5HJ TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 59 R-Middle TCGA-NC-A5HJ TCGA-NC-A5HJ-01A -21730 1213 418 0 87 1 NO NO 2013-4-17 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.2 8070/3 C34.2 YES 160 NO NO Peripheral Lung YES 78 true No M0 N0 T3 Stage IIB TCGA-NC-A5HJ.2CE6178F-3CFF-4E17-B5AE-1723C6AA6CF9.pdf A5HJ Pre-Adjuvant Therapy WITH TUMOR 68 110 68 107 Complete Remission/Response YES NO R0 Primary Tumor 01 2009 6th NO NO YES NC 4 Lung A DECEASED 2009 a6029e8e-f375-4843-989c-745b2bc64f94 TCGA-NC-A5HJ-01 TCGA-NC-A5HJ-01 TCGA-NC-A5HJ-01 a6029e8e-f375-4843-989c-745b2bc64f94 TCGA-NC-A5HJ-01 TCGA-NC-A5HJ-01A-11D-A26L-01 a6029e8e-f375-4843-989c-745b2bc64f94 a6029e8e-f375-4843-989c-745b2bc64f94 TCGA-NC-A5HJ-01A-11D-A26L-01 TCGA-NC-A5HJ-01A-11D-A26N-05 4F623109-4F85-4B06-8842-2504B9F78BFA +TCGA-NC-A5HK-01 TCGA-NC-A5HK-01 TCGA-NC-A5HK TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 58 Other (please specify) L-Upper+Lower TCGA-NC-A5HK-F55776 TCGA-NC-A5HK TCGA-NC-A5HK-01A -21531 1018 0 128 58 1 NO NO Scheduled Follow-up Submission 2014-1-15 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.8 8070/3 C34.8 YES 160 NO NO Peripheral Lung YES NO 40 true No M0 N0 T3 Stage IIB TCGA-NC-A5HK.074EAC41-3FC0-4686-8408-44B8351EE5C5.pdf A5HK Pre-Adjuvant Therapy TUMOR FREE 49 98 47 97 Complete Remission/Response YES NO R0 Primary Tumor 01 2009 7th YES NO YES NC 4 Lung A LIVING 2010 10db67e9-5b8f-4bda-b26b-c63e70c3c95e TCGA-NC-A5HK-01 TCGA-NC-A5HK-01 TCGA-NC-A5HK-01 10db67e9-5b8f-4bda-b26b-c63e70c3c95e TCGA-NC-A5HK-01 TCGA-NC-A5HK-01A-11D-A26L-01 10db67e9-5b8f-4bda-b26b-c63e70c3c95e 10db67e9-5b8f-4bda-b26b-c63e70c3c95e TCGA-NC-A5HK-01A-11D-A26L-01 TCGA-NC-A5HK-01A-11D-A26N-05 40FBBBDA-4992-41AB-BE32-B0816026FF9A +TCGA-NC-A5HL-01 TCGA-NC-A5HL-01 TCGA-NC-A5HL TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 73 R-Upper TCGA-NC-A5HL TCGA-NC-A5HL-01A -26977 996 88 0 70 NO NO 2013-4-17 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 150 NO NO Central Lung NO 40 true No M0 N0 T2b Stage IIA TCGA-NC-A5HL.1B861502-417D-4B21-980A-DD2749660DD5.pdf A5HL TUMOR FREE 74 63 YES NO R0 Primary Tumor 01 1995 7th NO NO YES NC 4 Lung A DECEASED 2010 87d9eb58-9b87-462f-982d-8abc83f2205b TCGA-NC-A5HL-01 TCGA-NC-A5HL-01 TCGA-NC-A5HL-01 87d9eb58-9b87-462f-982d-8abc83f2205b TCGA-NC-A5HL-01 TCGA-NC-A5HL-01A-11D-A26L-01 87d9eb58-9b87-462f-982d-8abc83f2205b 87d9eb58-9b87-462f-982d-8abc83f2205b TCGA-NC-A5HL-01A-11D-A26L-01 TCGA-NC-A5HL-01A-11D-A26N-05 EDDA02B1-5CC5-4935-AC56-7D911406BF62 +TCGA-NC-A5HM-01 TCGA-NC-A5HM-01 TCGA-NC-A5HM TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 76 R-Lower TCGA-NC-A5HM-F55779 TCGA-NC-A5HM TCGA-NC-A5HM-01A -27938 841 0 1212 80 NO NO Scheduled Follow-up Submission Complete Remission/Response 2014-1-15 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 220 NO NO Peripheral Lung NO NO 50 true Yes, History of Synchronous/Bilateral Malignancy M0 N0 T2a Stage IB TCGA-NC-A5HM.116B2CC4-B716-4CB4-852C-5EF15ED95FBA.pdf A5HM TUMOR FREE 70 Complete Remission/Response YES NO R0 Primary Tumor 01 1992 7th NO NO YES NC 3 Lung A LIVING 2010 02225067-9673-48cb-aa8e-6e28f9fbeffd TCGA-NC-A5HM-01 TCGA-NC-A5HM-01 TCGA-NC-A5HM-01 02225067-9673-48cb-aa8e-6e28f9fbeffd TCGA-NC-A5HM-01 TCGA-NC-A5HM-01A-12D-A26L-01 02225067-9673-48cb-aa8e-6e28f9fbeffd 02225067-9673-48cb-aa8e-6e28f9fbeffd TCGA-NC-A5HM-01A-12D-A26L-01 TCGA-NC-A5HM-01A-12D-A26N-05 74028244-F05D-4AF7-B3EB-764601DB5814 +TCGA-NC-A5HN-01 TCGA-NC-A5HN-01 TCGA-NC-A5HN TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 77 L-Lower TCGA-NC-A5HN-F69350 TCGA-NC-A5HN TCGA-NC-A5HN-01A -28151 772 0 1499 64 NO NO Scheduled Follow-up Submission Complete Remission/Response 2015-1-7 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 120 NO NO Central Lung NO NO 100 true No M0 N1 T2a Stage IIA TCGA-NC-A5HN.25D64D5A-EE0A-4772-8714-022209C35D86.pdf A5HN TUMOR FREE 61 64 61 65 Complete Remission/Response YES NO R0 Primary Tumor 01 2001 7th NO NO YES NC 4 Lung A LIVING 2010 1953 564636b5-e3fb-46ce-91db-f64b9a5612a9 TCGA-NC-A5HN-01 TCGA-NC-A5HN-01 TCGA-NC-A5HN-01 564636b5-e3fb-46ce-91db-f64b9a5612a9 TCGA-NC-A5HN-01 TCGA-NC-A5HN-01A-11D-A26L-01 564636b5-e3fb-46ce-91db-f64b9a5612a9 564636b5-e3fb-46ce-91db-f64b9a5612a9 TCGA-NC-A5HN-01A-11D-A26L-01 TCGA-NC-A5HN-01A-11D-A26N-05 23D1F8C1-E87E-4EF5-9555-E55A0BB0D331 +TCGA-NC-A5HO-01 TCGA-NC-A5HO-01 TCGA-NC-A5HO TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 70 L-Upper TCGA-NC-A5HO-F69351 TCGA-NC-A5HO TCGA-NC-A5HO-01A -25694 679 0 1336 64 1 NO NO Scheduled Follow-up Submission Complete Remission/Response 2015-1-7 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8071/3 C34.1 YES 130 NO NO Central Lung NO NO 30 true No M0 N1 T3 Stage IIIA TCGA-NC-A5HO.AC6B60E8-F47C-43CD-90C0-3C8DC9778BD6.pdf A5HO Pre-Adjuvant Therapy TUMOR FREE 70 96 67 96 Complete Remission/Response YES NO Primary Tumor 01 2010 7th YES NO YES NC 4 Lung A LIVING 2011 88b924eb-7bbb-449b-83f2-e2f496ced7df TCGA-NC-A5HO-01 TCGA-NC-A5HO-01 TCGA-NC-A5HO-01 88b924eb-7bbb-449b-83f2-e2f496ced7df TCGA-NC-A5HO-01 TCGA-NC-A5HO-01A-11D-A26L-01 88b924eb-7bbb-449b-83f2-e2f496ced7df 88b924eb-7bbb-449b-83f2-e2f496ced7df TCGA-NC-A5HO-01A-11D-A26L-01 TCGA-NC-A5HO-01A-11D-A26N-05 92872E74-6B73-4634-B72D-A55A23FC875A +TCGA-NC-A5HP-01 TCGA-NC-A5HP-01 TCGA-NC-A5HP TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 69 L-Upper TCGA-NC-A5HP-F69354 TCGA-NC-A5HP TCGA-NC-A5HP-01A -25286 654 770 0 730 NO NO Scheduled Follow-up Submission 2015-1-7 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8071/3 C34.1 YES 140 NO NO Peripheral Lung NO NO 50 true No M1b N0 T2a Stage IV TCGA-NC-A5HP.7C93B42D-DFF8-4B78-9C02-61296B787C2D.pdf A5HP WITH TUMOR 99 87 Progressive Disease YES NO R0 Primary Tumor 01 7th YES NO YES NC 2 Lung A DECEASED 2011 4ab07cc2-d5a1-48b5-a974-08bc48090920 TCGA-NC-A5HP-01 TCGA-NC-A5HP-01 TCGA-NC-A5HP-01 4ab07cc2-d5a1-48b5-a974-08bc48090920 TCGA-NC-A5HP-01 TCGA-NC-A5HP-01A-11D-A26L-01 4ab07cc2-d5a1-48b5-a974-08bc48090920 4ab07cc2-d5a1-48b5-a974-08bc48090920 TCGA-NC-A5HP-01A-11D-A26L-01 TCGA-NC-A5HP-01A-11D-A26N-05 31434D9B-03F0-477B-91B2-4F94A7054F43 +TCGA-NC-A5HQ-01 TCGA-NC-A5HQ-01 TCGA-NC-A5HQ TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 70 R-Middle TCGA-NC-A5HQ TCGA-NC-A5HQ-01A -25781 568 448 0 142 1 NO NO 2013-4-17 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.2 8071/3 C34.2 YES 350 NO NO Central Lung NO true No M0 N2 T3 Stage IIIA TCGA-NC-A5HQ.A4B5AAFA-D22F-4DA0-A4ED-54630EF8156F.pdf A5HQ Pre-Adjuvant Therapy 76 97 79 104 Complete Remission/Response YES YES R0 Primary Tumor 01 7th YES NO YES NC 2 Lung A DECEASED 2011 fe68b038-e3af-4106-9358-0717d90dbc76 TCGA-NC-A5HQ-01 TCGA-NC-A5HQ-01 TCGA-NC-A5HQ-01 fe68b038-e3af-4106-9358-0717d90dbc76 TCGA-NC-A5HQ-01 TCGA-NC-A5HQ-01A-11D-A26L-01 fe68b038-e3af-4106-9358-0717d90dbc76 fe68b038-e3af-4106-9358-0717d90dbc76 TCGA-NC-A5HQ-01A-11D-A26L-01 TCGA-NC-A5HQ-01A-11D-A26N-05 E9E93E87-DF06-4BD2-9EF6-218D807F4726 +TCGA-NC-A5HR-01 TCGA-NC-A5HR-01 TCGA-NC-A5HR TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 75 R-Lower TCGA-NC-A5HR-F69352 TCGA-NC-A5HR TCGA-NC-A5HR-01A -27629 513 0 1244 69 1 NO NO Scheduled Follow-up Submission Complete Remission/Response 2015-1-7 FEMALE Lung Basaloid Squamous Cell Carcinoma No C34.3 8083/3 C34.3 YES 120 NO NO Central Lung NO NO 35 true Yes, History of Prior Malignancy M0 N1 T2a Stage IIA TCGA-NC-A5HR.CB0090E7-0335-454E-BAFA-D2F8CBB4F131.pdf A5HR Pre-Adjuvant Therapy TUMOR FREE 72 112 Complete Remission/Response YES NO R0 Primary Tumor 01 2008 7th YES NO YES NC 4 Lung A LIVING 2011 1463072d-57f0-4b60-9a6f-e61567ce0c46 TCGA-NC-A5HR-01 TCGA-NC-A5HR-01 TCGA-NC-A5HR-01 1463072d-57f0-4b60-9a6f-e61567ce0c46 TCGA-NC-A5HR-01 TCGA-NC-A5HR-01A-21D-A26L-01 1463072d-57f0-4b60-9a6f-e61567ce0c46 1463072d-57f0-4b60-9a6f-e61567ce0c46 TCGA-NC-A5HR-01A-21D-A26L-01 TCGA-NC-A5HR-01A-21D-A26N-05 37255369-E115-4DD7-B29C-3EEE99A9E198 +TCGA-NC-A5HT-01 TCGA-NC-A5HT-01 TCGA-NC-A5HT TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 69 Other (please specify) right upper + middle lobes TCGA-NC-A5HT-F69353 TCGA-NC-A5HT TCGA-NC-A5HT-01A -25466 337 0 804 69 NO NO Scheduled Follow-up Submission Stable Disease 2015-1-7 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.8 8070/3 C34.8 YES 100 NO NO Central Lung NO NO 50 true No M0 N1 T3 Stage IIIA TCGA-NC-A5HT.81068415-BBAA-432E-97C2-14E6B559D41A.pdf A5HT WITH TUMOR 46 75 56 Complete Remission/Response YES NO R0 Primary Tumor 01 2011 7th NO NO YES NC 4 Lung A LIVING 2012 1ab57556-a43b-4815-bb91-c050d3ecd801 TCGA-NC-A5HT-01 TCGA-NC-A5HT-01 TCGA-NC-A5HT-01 1ab57556-a43b-4815-bb91-c050d3ecd801 TCGA-NC-A5HT-01 TCGA-NC-A5HT-01A-11D-A26L-01 1ab57556-a43b-4815-bb91-c050d3ecd801 1ab57556-a43b-4815-bb91-c050d3ecd801 TCGA-NC-A5HT-01A-11D-A26L-01 TCGA-NC-A5HT-01A-11D-A26N-05 5EE5BAF1-BCC8-4D77-9DA9-43EE23ACE5F1 +TCGA-NK-A5CR-01 TCGA-NK-A5CR-01 TCGA-NK-A5CR TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 77 R-Upper TCGA-NK-A5CR-F53269 TCGA-NK-A5CR TCGA-NK-A5CR-01A -28126 1961 0 2542 84.7 NO NO Scheduled Follow-up Submission 2013-12-10 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 120 NO NO NO NO 40 true No MX N0 T2 Stage IB TCGA-NK-A5CR.487D0915-7A8B-4092-98F8-A0E7A757E79C.pdf A5CR TUMOR FREE 64.8 1.33 79.8 .94 Stable Disease YES NO Primary Tumor 01 6th NO NO YES NK 3 Lung A LIVING 2007 d497e10a-f8b7-4e9d-9c37-eb433a54fd2c TCGA-NK-A5CR-01 TCGA-NK-A5CR-01 TCGA-NK-A5CR-01 d497e10a-f8b7-4e9d-9c37-eb433a54fd2c TCGA-NK-A5CR-01 TCGA-NK-A5CR-01A-11D-A26L-01 d497e10a-f8b7-4e9d-9c37-eb433a54fd2c d497e10a-f8b7-4e9d-9c37-eb433a54fd2c TCGA-NK-A5CR-01A-11D-A26L-01 TCGA-NK-A5CR-01A-11D-A26N-05 E05EF29C-4C90-42B8-96CF-441103BD4E9B +TCGA-NK-A5CT-01 TCGA-NK-A5CT-01 TCGA-NK-A5CT TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung NO NO NO 70 L-Lower TCGA-NK-A5CT-F71462 TCGA-NK-A5CT TCGA-NK-A5CT-01A -25726 1473 0 1997 1990 NO NO Scheduled Follow-up Submission Progressive Disease 2015-3-25 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 220 NO NO YES Locoregional Recurrence YES 80 true Yes, History of Prior Malignancy M0 N0 T1 Stage IA TCGA-NK-A5CT.E336C87E-F021-4D95-BE95-ACA979B023CA.pdf A5CT WITH TUMOR Stable Disease Biopsy with Histologic Confirmation NO NO Primary Tumor 01 2003 6th NO NO YES NK [Discrepancy] Lung A LIVING 2008 494a3ad4-58a0-41f8-8187-46ce03900462 TCGA-NK-A5CT-01 TCGA-NK-A5CT-01 TCGA-NK-A5CT-01 494a3ad4-58a0-41f8-8187-46ce03900462 TCGA-NK-A5CT-01 TCGA-NK-A5CT-01A-31D-A26L-01 494a3ad4-58a0-41f8-8187-46ce03900462 494a3ad4-58a0-41f8-8187-46ce03900462 TCGA-NK-A5CT-01A-31D-A26L-01 TCGA-NK-A5CT-01A-31D-A26N-05 51EC641A-4870-4582-AB79-6348834079B3 +TCGA-NK-A5CX-01 TCGA-NK-A5CX-01 TCGA-NK-A5CX TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 73 R-Lower TCGA-NK-A5CX-F53273 TCGA-NK-A5CX TCGA-NK-A5CX-01A -26879 589 0 111 NO NO Scheduled Follow-up Submission 2013-12-10 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 40 NO NO YES NO 40 true No MX N0 T2b Stage IIA TCGA-NK-A5CX.ED75BACE-AC37-41FE-ACE7-8E1403C97094.pdf A5CX TUMOR FREE Stable Disease NO NO Primary Tumor 01 2005 7th NO NO YES NK 4 Lung A LIVING 2011 18298f92-c0c4-4772-ba76-8674ebeabb4c TCGA-NK-A5CX-01 TCGA-NK-A5CX-01 TCGA-NK-A5CX-01 18298f92-c0c4-4772-ba76-8674ebeabb4c TCGA-NK-A5CX-01 TCGA-NK-A5CX-01A-11D-A26L-01 18298f92-c0c4-4772-ba76-8674ebeabb4c 18298f92-c0c4-4772-ba76-8674ebeabb4c TCGA-NK-A5CX-01A-11D-A26L-01 TCGA-NK-A5CX-01A-11D-A26N-05 +TCGA-NK-A5D1-01 TCGA-NK-A5D1-01 TCGA-NK-A5D1 TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung YES YES NO YES 57 R-Upper TCGA-NK-A5D1-F53275 TCGA-NK-A5D1 TCGA-NK-A5D1-01A 453 -20909 356 0 511 151 NO NO Scheduled Follow-up Submission Progressive Disease 2013-12-10 MALE Lung Basaloid Squamous Cell Carcinoma No C34.1 8070/3 C34.1 YES 10 NO NO YES Distant Metastasis YES 90 true Yes, History of Prior Malignancy M0 N1 T2a Stage IIA TCGA-NK-A5D1.5578086D-1892-4413-ACAD-F5995036204C.pdf A5D1 WITH TUMOR Progressive Disease Biopsy with Histologic Confirmation|Convincing Imaging NO [Discrepancy] Primary Tumor 01 2000 7th YES NK [Discrepancy] Lung A LIVING 2011 5c727d2e-892d-4228-a7b8-062ed0e77672 TCGA-NK-A5D1-01 5c727d2e-892d-4228-a7b8-062ed0e77672 TCGA-NK-A5D1-01 TCGA-NK-A5D1-01A-11D-A26L-01 5c727d2e-892d-4228-a7b8-062ed0e77672 5c727d2e-892d-4228-a7b8-062ed0e77672 TCGA-NK-A5D1-01A-11D-A26L-01 TCGA-NK-A5D1-01A-11D-A26N-05 +TCGA-NK-A7XE-01 TCGA-NK-A7XE-01 TCGA-NK-A7XE TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 66 L-Upper TCGA-NK-A7XE-F61446 TCGA-NK-A7XE TCGA-NK-A7XE-01A -24319 50 0 13 NO NO Scheduled Follow-up Submission 2014-6-30 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 180 NO NO YES NO 80 true Yes, History of Prior Malignancy M0 N2 T4 Stage IIIB TCGA-NK-A7XE.72D0E0B9-F05B-458F-9036-91A8DE553E8A.pdf A7XE TUMOR FREE Stable Disease NO NO Primary Tumor 01 7th NO NK 5 Lung A LIVING 2013 55d4ea6c-f934-495e-9c48-e867bd7983d3 TCGA-NK-A7XE-01 TCGA-NK-A7XE-01 TCGA-NK-A7XE-01 55d4ea6c-f934-495e-9c48-e867bd7983d3 TCGA-NK-A7XE-01 TCGA-NK-A7XE-01A-12D-A400-01 55d4ea6c-f934-495e-9c48-e867bd7983d3 55d4ea6c-f934-495e-9c48-e867bd7983d3 TCGA-NK-A7XE-01A-12D-A400-01 TCGA-NK-A7XE-01A-12D-A408-05 C61310BF-17EB-48EB-9E95-B708F55F3E34 +TCGA-O2-A52N-01 TCGA-O2-A52N-01 TCGA-O2-A52N TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 78 R-Upper TCGA-O2-A52N TCGA-O2-A52N-01A -28520 2730 1006 0 0 NO NO 2013-4-11 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 330 NO NO NO 4.125 true No MX N0 T2 Stage I TCGA-O2-A52N.357460FE-4E4F-4163-B3BA-EBD5DCCFADCB.pdf A52N TUMOR FREE NO NO Primary Tumor 01 1997 6th NO NO YES O2 4 Lung A DECEASED 2005 1942 5e4388cd-137c-4969-b273-7d067195c466 TCGA-O2-A52N-01 TCGA-O2-A52N-01 TCGA-O2-A52N-01 5e4388cd-137c-4969-b273-7d067195c466 TCGA-O2-A52N-01 TCGA-O2-A52N-01A-11D-A26L-01 5e4388cd-137c-4969-b273-7d067195c466 5e4388cd-137c-4969-b273-7d067195c466 TCGA-O2-A52N-01A-11D-A26L-01 TCGA-O2-A52N-01A-11D-A26N-05 D365C8E3-733A-4163-A3C0-FD35DF218AF9 +TCGA-O2-A52Q-01 TCGA-O2-A52Q-01 TCGA-O2-A52Q TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 44 R-Upper TCGA-O2-A52Q TCGA-O2-A52Q-01A -16429 2558 113 0 3 NO NO 2013-4-11 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 110 NO NO YES 1 true No MX N1 T3 Stage III TCGA-O2-A52Q.9B7C77F8-7EFE-4598-8273-7C902EA77C55.pdf A52Q WITH TUMOR NO NO Primary Tumor 01 6th NO NO YES O2 2 Lung A DECEASED 2005 1985 7729ed42-e15f-4881-ada8-dd71457197e0 TCGA-O2-A52Q-01 TCGA-O2-A52Q-01 TCGA-O2-A52Q-01 7729ed42-e15f-4881-ada8-dd71457197e0 TCGA-O2-A52Q-01 TCGA-O2-A52Q-01A-11D-A26L-01 7729ed42-e15f-4881-ada8-dd71457197e0 7729ed42-e15f-4881-ada8-dd71457197e0 TCGA-O2-A52Q-01A-11D-A26L-01 TCGA-O2-A52Q-01A-11D-A26N-05 0D3D627F-D829-4F0C-8307-7AB93C286AB5 +TCGA-O2-A52S-01 TCGA-O2-A52S-01 TCGA-O2-A52S TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 57 L-Lower TCGA-O2-A52S -21182 387 0 1 NO NO 2013-4-11 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES NO YES 3 No MX N2 T4 Stage III A52S WITH TUMOR NO YES Primary Tumor 01 2006 6th NO NO YES O2 4 Lung DECEASED 2006 1976 e3e7210a-a45e-47dc-aa2c-46aa17d47314 TCGA-O2-A52S-01 TCGA-O2-A52S-01 TCGA-O2-A52S-01 e3e7210a-a45e-47dc-aa2c-46aa17d47314 TCGA-O2-A52S-01 TCGA-O2-A52S-01A-11D-A25M-01 e3e7210a-a45e-47dc-aa2c-46aa17d47314 e3e7210a-a45e-47dc-aa2c-46aa17d47314 TCGA-O2-A52S-01A-11D-A25M-01 TCGA-O2-A52S-01A-11D-A25R-05 +TCGA-O2-A52V-01 TCGA-O2-A52V-01 TCGA-O2-A52V TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 75 L-Upper TCGA-O2-A52V TCGA-O2-A52V-01A -27449 2303 1335 0 1 NO NO 2013-5-19 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.1 8070/3 C34.1 YES 190 NO NO YES 1 true No MX N0 T3 Stage II TCGA-O2-A52V.0C9E8CD7-55DF-4BFF-AE29-891BD33C2EB4.pdf A52V TUMOR FREE NO YES Primary Tumor 01 1996 6th NO NO YES O2 4 Lung A DECEASED 2006 1976 d353af66-1298-4da0-b7fd-08671d5dcda9 TCGA-O2-A52V-01 TCGA-O2-A52V-01 TCGA-O2-A52V-01 d353af66-1298-4da0-b7fd-08671d5dcda9 TCGA-O2-A52V-01 TCGA-O2-A52V-01A-31D-A25M-01 d353af66-1298-4da0-b7fd-08671d5dcda9 d353af66-1298-4da0-b7fd-08671d5dcda9 TCGA-O2-A52V-01A-31D-A25M-01 TCGA-O2-A52V-01A-31D-A25R-05 50D8AC77-9CFD-4854-802E-B89FDC15FAFD +TCGA-O2-A52W-01 TCGA-O2-A52W-01 TCGA-O2-A52W TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 63 R-Lower TCGA-O2-A52W -23156 261 0 3 NO NO 2013-4-11 MALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.2 8070/3 C34.2 YES NO NO 2.5 Yes, History of Prior Malignancy MX N0 T2 Stage I A52W TUMOR FREE NO NO Primary Tumor 01 2006 6th NO NO YES O2 4 Lung DECEASED 2006 1956 e8c57cc1-0293-433a-8076-13cfa9935ce7 TCGA-O2-A52W-01 TCGA-O2-A52W-01 TCGA-O2-A52W-01 e8c57cc1-0293-433a-8076-13cfa9935ce7 TCGA-O2-A52W-01 TCGA-O2-A52W-01A-11D-A26L-01 e8c57cc1-0293-433a-8076-13cfa9935ce7 e8c57cc1-0293-433a-8076-13cfa9935ce7 TCGA-O2-A52W-01A-11D-A26L-01 TCGA-O2-A52W-01A-11D-A26N-05 +TCGA-O2-A5IB-01 TCGA-O2-A5IB-01 TCGA-O2-A5IB TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 71 R-Middle TCGA-O2-A5IB TCGA-O2-A5IB-01A -26211 2666 340 0 0 NO NO 2013-5-19 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.2 8070/3 C34.2 YES 140 NO NO YES 2.5 true No MX N1 T3 Stage III TCGA-O2-A5IB.D8784E5D-007E-4768-8D0E-E7A3C0CD21DD.pdf A5IB WITH TUMOR NO NO Primary Tumor 01 2004 6th NO NO YES O2 4 Lung A DECEASED 2005 1954 5c99d6ce-742c-427c-a252-e2ce6b7f919c TCGA-O2-A5IB-01 TCGA-O2-A5IB-01 TCGA-O2-A5IB-01 5c99d6ce-742c-427c-a252-e2ce6b7f919c TCGA-O2-A5IB-01 TCGA-O2-A5IB-01A-11D-A27J-01 5c99d6ce-742c-427c-a252-e2ce6b7f919c 5c99d6ce-742c-427c-a252-e2ce6b7f919c TCGA-O2-A5IB-01A-11D-A27J-01 TCGA-O2-A5IB-01A-11D-A27L-05 05A9E5F4-BCF8-49DB-A189-24B03B5A9821 +TCGA-O2-A5IC-01 TCGA-O2-A5IC-01 TCGA-O2-A5IC TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung TCGA-O2-A5IC-01A 2477 50 NO true TCGA-O2-A5IC.B7F0D448-8551-4D89-AAE0-18F5CC8BFB78.pdf Primary Tumor 01 A TCGA-O2-A5IC-01A-11D-A27L-05 +TCGA-XC-AA0X-01 TCGA-XC-AA0X-01 TCGA-XC-AA0X TCGA Lung Squamous Cell Carcinoma (LUSC) lung squamous cell carcinoma Lung 77 R-Lower TCGA-XC-AA0X TCGA-XC-AA0X-01A -28211 81 6 0 73 NO NO 2014-4-22 FEMALE Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS) No C34.3 8070/3 C34.3 YES 350 NO NO Central Lung NO 30 true No M0 N0 T1a Stage IA TCGA-XC-AA0X.B22BD117-8DF0-47FF-BE25-9FE2DA916DB6.pdf AA0X TUMOR FREE 72 91 YES NO R0 Primary Tumor 01 2013 7th NO YES NO XC 2 Lung A DECEASED 2013 1953 5d5091c3-27b2-4152-a5b2-64bc7fd16942 TCGA-XC-AA0X-01 TCGA-XC-AA0X-01 TCGA-XC-AA0X-01 5d5091c3-27b2-4152-a5b2-64bc7fd16942 TCGA-XC-AA0X-01 TCGA-XC-AA0X-01A-32D-A400-01 5d5091c3-27b2-4152-a5b2-64bc7fd16942 5d5091c3-27b2-4152-a5b2-64bc7fd16942 TCGA-XC-AA0X-01A-32D-A400-01 TCGA-XC-AA0X-01A-32D-A408-05 diff --git a/input/TCGA/TCGA_Melanoma_(SKCM)/TCGA.SKCM.sampleMap_HiSeqV2_PANCAN.gz b/input/TCGA/TCGA_Melanoma_(SKCM)/TCGA.SKCM.sampleMap_HiSeqV2_PANCAN.gz new file mode 100644 index 0000000000000000000000000000000000000000..75265cbec8f1884dbca7d4ce61c5584d9e4ef17b --- /dev/null +++ b/input/TCGA/TCGA_Melanoma_(SKCM)/TCGA.SKCM.sampleMap_HiSeqV2_PANCAN.gz @@ -0,0 +1,3 @@ +version https://git-lfs.github.com/spec/v1 +oid sha256:a2f9b9be6525bcb98e7c7f618b9439d845a66a5421d11dda90ceb6606d10c24b +size 33498554 diff --git a/input/TCGA/TCGA_Melanoma_(SKCM)/TCGA.SKCM.sampleMap_SKCM_clinicalMatrix b/input/TCGA/TCGA_Melanoma_(SKCM)/TCGA.SKCM.sampleMap_SKCM_clinicalMatrix new file mode 100644 index 0000000000000000000000000000000000000000..8b3a0e29e75e75f68ea5ab51fa22324954335032 --- /dev/null +++ b/input/TCGA/TCGA_Melanoma_(SKCM)/TCGA.SKCM.sampleMap_SKCM_clinicalMatrix @@ -0,0 +1,482 @@ +sampleID _INTEGRATION _PATIENT _cohort _primary_disease _primary_site additional_pharmaceutical_therapy additional_radiation_therapy age_at_initial_pathologic_diagnosis bcr_followup_barcode bcr_patient_barcode bcr_sample_barcode breslow_depth_value days_to_birth days_to_collection days_to_death days_to_initial_pathologic_diagnosis days_to_last_followup days_to_new_tumor_event_additional_surgery_procedure days_to_new_tumor_event_after_initial_treatment days_to_submitted_specimen_dx distant_metastasis_anatomic_site followup_case_report_form_submission_reason form_completion_date gender height history_of_neoadjuvant_treatment icd_10 icd_o_3_histology icd_o_3_site informed_consent_verified initial_weight interferon_90_day_prior_excision_admin_indicator is_ffpe lactate_dehydrogenase_result lost_follow_up malignant_neoplasm_mitotic_count_rate melanoma_clark_level_value melanoma_origin_skin_anatomic_site melanoma_ulceration_indicator new_neoplasm_event_occurrence_anatomic_site new_neoplasm_event_type new_non_melanoma_event_histologic_type_text new_primary_melanoma_anatomic_site new_tumor_dx_prior_submitted_specimen_dx new_tumor_event_additional_surgery_procedure new_tumor_event_after_initial_treatment new_tumor_metastasis_anatomic_site new_tumor_metastasis_anatomic_site_other_text oct_embedded other_dx pathologic_M pathologic_N pathologic_T pathologic_stage pathology_report_file_name patient_id person_neoplasm_cancer_status postoperative_rx_tx primary_anatomic_site_count primary_melanoma_at_diagnosis_count primary_neoplasm_melanoma_dx primary_tumor_multiple_present_ind prior_systemic_therapy_type radiation_therapy sample_type sample_type_id subsequent_primary_melanoma_during_followup system_version tissue_prospective_collection_indicator tissue_retrospective_collection_indicator tissue_source_site tissue_type tumor_descriptor tumor_tissue_site vial_number vital_status weight year_of_initial_pathologic_diagnosis _GENOMIC_ID_TCGA_SKCM_exp_HiSeqV2 _GENOMIC_ID_TCGA_SKCM_hMethyl450 _GENOMIC_ID_TCGA_SKCM_exp_HiSeqV2_PANCAN _GENOMIC_ID_TCGA_SKCM_miRNA_HiSeq _GENOMIC_ID_TCGA_SKCM_gistic2thd _GENOMIC_ID_data/public/TCGA/SKCM/miRNA_HiSeq_gene _GENOMIC_ID_TCGA_SKCM_RPPA _GENOMIC_ID_TCGA_SKCM_mutation_bcm_gene _GENOMIC_ID_TCGA_SKCM_mutation_broad_gene _GENOMIC_ID_TCGA_SKCM_gistic2 _GENOMIC_ID_TCGA_SKCM_mutation _GENOMIC_ID_TCGA_SKCM_exp_HiSeqV2_exon _GENOMIC_ID_TCGA_SKCM_PDMRNAseqCNV _GENOMIC_ID_TCGA_SKCM_PDMRNAseq _GENOMIC_ID_TCGA_SKCM_exp_HiSeqV2_percentile +TCGA-3N-A9WB-06 TCGA-3N-A9WB-06 TCGA-3N-A9WB TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 71 TCGA-3N-A9WB TCGA-3N-A9WB-06A 0.7 -26176 552 518 0 426 Left Flank 2014-5-29 MALE 175 No C44.5 8720/3 C44.5 YES 90 NO 2 III Non-glabrous skin NO NO YES false No M0 NX T1a Stage IA TCGA-3N-A9WB.773FA4D0-E15C-4138-A961-4F610C1DE2AA.pdf A9WB WITH TUMOR NO 1 YES NO NO Metastatic 06 7th YES NO 3N Distant Metastasis A DECEASED 78 2012 4c243ea9-dfe1-42f0-a887-3c901fb38542 TCGA-3N-A9WB-06A-11D-A38H-05 4c243ea9-dfe1-42f0-a887-3c901fb38542 TCGA-3N-A9WB-06A-11D-A38F-01 TCGA-3N-A9WB-06A-11D-A38G-08 TCGA-3N-A9WB-06A-11D-A38F-01 4c243ea9-dfe1-42f0-a887-3c901fb38542 4c243ea9-dfe1-42f0-a887-3c901fb38542 +TCGA-3N-A9WC-06 TCGA-3N-A9WC-06 TCGA-3N-A9WC TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 82 TCGA-3N-A9WC-F67104 TCGA-3N-A9WC TCGA-3N-A9WC-06A 1.8 -30286 1709 0 2022 1644 2014-11-4 MALE 183 No C77.3 8720/3 C77.3 YES 220 NO NO 4 IV Non-glabrous skin YES NO NO false No M0 NX T2b Stage IIA TCGA-3N-A9WC.DF472314-0643-473F-9233-EC77505148C7.pdf A9WC WITH TUMOR NO 1 1 YES NO NO Metastatic 06 NO 6th YES NO 3N Regional Lymph Node A LIVING 68 2009 a64ae1f5-a189-4173-be13-903bd7637869 TCGA-3N-A9WC-06A-11D-A38H-05 a64ae1f5-a189-4173-be13-903bd7637869 TCGA-3N-A9WC-06 TCGA-3N-A9WC-06A-11D-A38F-01 TCGA-3N-A9WC-06 F9B0B31B-24AB-4F30-8EF8-4A4ED282EF04 TCGA-3N-A9WC-06A-11D-A38G-08 TCGA-3N-A9WC-06A-11D-A38F-01 a64ae1f5-a189-4173-be13-903bd7637869 a64ae1f5-a189-4173-be13-903bd7637869 +TCGA-3N-A9WD-06 TCGA-3N-A9WD-06 TCGA-3N-A9WD TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 82 TCGA-3N-A9WD TCGA-3N-A9WD-06A 1.25 -30163 248 395 0 183 2014-5-29 MALE 183 No C77.0 8720/3 C77.0 YES 170 NO 4 III Non-glabrous skin NO NO YES false No M0 N1a T2a Stage IIIA TCGA-3N-A9WD.92AC35B1-3F7C-4062-B06F-BDA530145C88.pdf A9WD WITH TUMOR NO 1 1 YES NO NO Metastatic 06 7th YES NO 3N Regional Lymph Node A DECEASED 116 2013 ac19f7cf-670b-4dcc-a26b-db0f56377231 TCGA-3N-A9WD-06A-11D-A38H-05 ac19f7cf-670b-4dcc-a26b-db0f56377231 TCGA-3N-A9WD-06 TCGA-3N-A9WD-06A-11D-A38F-01 TCGA-3N-A9WD-06 6AFC3678-9499-49A6-AD7A-30F3D185B4BD TCGA-3N-A9WD-06A-11D-A38G-08 TCGA-3N-A9WD-06A-11D-A38F-01 ac19f7cf-670b-4dcc-a26b-db0f56377231 ac19f7cf-670b-4dcc-a26b-db0f56377231 +TCGA-BF-A1PU-01 TCGA-BF-A1PU-01 TCGA-BF-A1PU TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 46 TCGA-BF-A1PU-F68906 TCGA-BF-A1PU TCGA-BF-A1PU-01A 13 -17025 338 0 387 0 2014-12-23 FEMALE 160 No C44.9 8720/3 C44.9 YES 90 NO YES III Non-glabrous skin YES NO YES true No M0 N0 T4b Stage IIC TCGA-BF-A1PU.D6618B79-299C-4EDB-8EC4-7AFC61D6E460.pdf A1PU TUMOR FREE NO 1 1 YES NO NO Primary Tumor 01 7th YES NO BF Primary Tumor A LIVING 58 2010 9ff4d588-da73-4e26-975d-2b098fe74984 TCGA-BF-A1PU-01A-11D-A19D-05 9ff4d588-da73-4e26-975d-2b098fe74984 TCGA-BF-A1PU-01 TCGA-BF-A1PU-01 7E74CAFD-C47B-4F98-A349-BBD2AC699D2D TCGA-BF-A1PU-01A-11D-A19A-08 TCGA-BF-A1PU-01A-11D-A19A-08 TCGA-BF-A1PU-01A-11D-A19A-08 9ff4d588-da73-4e26-975d-2b098fe74984 9ff4d588-da73-4e26-975d-2b098fe74984 +TCGA-BF-A1PV-01 TCGA-BF-A1PV-01 TCGA-BF-A1PV TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 74 TCGA-BF-A1PV-F68907 TCGA-BF-A1PV 9 -27124 0 14 0 2014-12-23 FEMALE 160 No C44.9 8720/3 C44.9 YES YES IV Non-glabrous skin YES NO No M0 N0 T4b Stage IIC A1PV TUMOR FREE 1 1 YES NO NO Primary Tumor 01 7th YES NO BF Primary Tumor LIVING 70 2010 a57841bb-fa68-4d84-85e0-2d5e4f3ce828 TCGA-BF-A1PV-01A-11D-A19D-05 a57841bb-fa68-4d84-85e0-2d5e4f3ce828 TCGA-BF-A1PV-01 TCGA-BF-A1PV-01 TCGA-BF-A1PV-01A-11D-A19A-08 TCGA-BF-A1PV-01A-11D-A19A-08 TCGA-BF-A1PV-01A-11D-A19A-08 a57841bb-fa68-4d84-85e0-2d5e4f3ce828 a57841bb-fa68-4d84-85e0-2d5e4f3ce828 +TCGA-BF-A1PX-01 TCGA-BF-A1PX-01 TCGA-BF-A1PX TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 56 TCGA-BF-A1PX TCGA-BF-A1PX-01A 12 -20626 122 282 0 0 2013-4-25 MALE 175 No C44.9 8720/3 C44.9 YES 260 NO 10 III Non-glabrous skin YES NO true No M0 N2a T4b Stage IIIB TCGA-BF-A1PX.4BF0286A-D82F-4ACF-AE53-4B03518D2362.pdf A1PX TUMOR FREE NO 1 1 YES NO NO Primary Tumor 01 7th YES NO BF Primary Tumor A DECEASED 78 2010 73b2e2ac-aafd-40e7-8759-ffa226f04a3b TCGA-BF-A1PX-01A-12D-A19D-05 73b2e2ac-aafd-40e7-8759-ffa226f04a3b TCGA-BF-A1PX-01 TCGA-BF-A1PX-01 67011E4A-74D3-4291-B6A3-155B33654BA0 TCGA-BF-A1PX-01A-12D-A19A-08 TCGA-BF-A1PX-01A-12D-A19A-08 TCGA-BF-A1PX-01A-12D-A19A-08 73b2e2ac-aafd-40e7-8759-ffa226f04a3b 73b2e2ac-aafd-40e7-8759-ffa226f04a3b +TCGA-BF-A1PZ-01 TCGA-BF-A1PZ-01 TCGA-BF-A1PZ TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 71 TCGA-BF-A1PZ-F68909 TCGA-BF-A1PZ TCGA-BF-A1PZ-01A 8 -26240 97 0 853 0 2014-12-23 FEMALE 163 No C44.9 8720/3 C44.9 YES 130 NO NO III Non-glabrous skin NO NO true No M0 N0 T4a Stage IIB TCGA-BF-A1PZ.1FAA6F42-BEE4-47B5-9D6A-87D310719766.pdf A1PZ TUMOR FREE NO 1 1 YES NO NO Primary Tumor 01 7th YES NO BF Primary Tumor A LIVING 56 2010 27bf4227-d8a9-4048-af7e-01c6d5d0e777 TCGA-BF-A1PZ-01A-11D-A19D-05 27bf4227-d8a9-4048-af7e-01c6d5d0e777 TCGA-BF-A1PZ-01 TCGA-BF-A1PZ-01 5237F9F9-789E-462F-BC0D-940C625BA7BC TCGA-BF-A1PZ-01A-11D-A19A-08 TCGA-BF-A1PZ-01A-11D-A19A-08 TCGA-BF-A1PZ-01A-11D-A19A-08 27bf4227-d8a9-4048-af7e-01c6d5d0e777 27bf4227-d8a9-4048-af7e-01c6d5d0e777 +TCGA-BF-A1Q0-01 TCGA-BF-A1Q0-01 TCGA-BF-A1Q0 TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 80 TCGA-BF-A1Q0-F68910 TCGA-BF-A1Q0 5 -29380 0 831 0 2014-12-23 MALE 173 No C44.9 8720/3 C44.9 YES NO III Non-glabrous skin YES NO No M0 N0 T4b Stage IIC A1Q0 TUMOR FREE NO 1 1 YES NO NO Primary Tumor 01 7th YES NO BF Primary Tumor LIVING 69 2010 c8600bba-b4bd-400e-ab67-03d66be9da31 TCGA-BF-A1Q0-01A-21D-A19D-05 c8600bba-b4bd-400e-ab67-03d66be9da31 TCGA-BF-A1Q0-01 TCGA-BF-A1Q0-01 TCGA-BF-A1Q0-01A-21D-A19A-08 TCGA-BF-A1Q0-01A-21D-A19A-08 TCGA-BF-A1Q0-01A-21D-A19A-08 c8600bba-b4bd-400e-ab67-03d66be9da31 c8600bba-b4bd-400e-ab67-03d66be9da31 +TCGA-BF-A3DJ-01 TCGA-BF-A3DJ-01 TCGA-BF-A3DJ TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 36 TCGA-BF-A3DJ-F65978 TCGA-BF-A3DJ TCGA-BF-A3DJ-01A 11 -13332 183 0 464 0 2014-12-23 FEMALE 165 No C44.9 8720/3 C44.9 YES 110 NO YES III Non-glabrous skin YES NO YES true No M0 N1 T4b Stage IIIB TCGA-BF-A3DJ.BF41787D-E227-4BD0-A090-A6A44B5763E0.pdf A3DJ TUMOR FREE NO 1 1 YES NO NO Primary Tumor 01 7th YES NO BF Primary Tumor A LIVING 70 2011 4a78ff4a-a904-4fbe-abe6-2aa51b15c0ab TCGA-BF-A3DJ-01A-11D-A211-05 4a78ff4a-a904-4fbe-abe6-2aa51b15c0ab TCGA-BF-A3DJ-01 TCGA-BF-A3DJ-01 398B9FCC-A92B-4E4F-AAD3-28A3E63CE9FE TCGA-BF-A3DJ-01A-11D-A20D-08 TCGA-BF-A3DJ-01A-11D-A20D-08 TCGA-BF-A3DJ-01A-11D-A20D-08 4a78ff4a-a904-4fbe-abe6-2aa51b15c0ab 4a78ff4a-a904-4fbe-abe6-2aa51b15c0ab +TCGA-BF-A3DL-01 TCGA-BF-A3DL-01 TCGA-BF-A3DL TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 84 TCGA-BF-A3DL-F68911 TCGA-BF-A3DL TCGA-BF-A3DL-01A 3.0 -30805 229 0 769 0 2014-12-23 FEMALE 158 No C44.9 8720/3 C44.9 YES 180 NO NO IV Non-glabrous skin YES NO true No M0 N2 T3b Stage IIIB TCGA-BF-A3DL.EDB2BE60-AB50-4C1D-8B73-410E8B4A9AED.pdf A3DL TUMOR FREE NO 1 1 YES NO NO Primary Tumor 01 7th YES NO BF Primary Tumor A LIVING 62 2011 2e00b580-b6b7-433e-88e8-69a75fae592f TCGA-BF-A3DL-01A-11D-A211-05 2e00b580-b6b7-433e-88e8-69a75fae592f TCGA-BF-A3DL-01 TCGA-BF-A3DL-01 BD0E5379-6FBD-4860-9F17-55A180CE36E2 TCGA-BF-A3DL-01A-11D-A20D-08 TCGA-BF-A3DL-01A-11D-A20D-08 TCGA-BF-A3DL-01A-11D-A20D-08 2e00b580-b6b7-433e-88e8-69a75fae592f 2e00b580-b6b7-433e-88e8-69a75fae592f +TCGA-BF-A3DM-01 TCGA-BF-A3DM-01 TCGA-BF-A3DM TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 63 TCGA-BF-A3DM-F68913 TCGA-BF-A3DM TCGA-BF-A3DM-01A 1.5 -23076 61 0 601 0 2014-12-23 MALE 172 No C44.9 8720/3 C44.9 YES 210 NO NO V Non-glabrous skin YES NO true No M0 N0 T2b Stage IIA TCGA-BF-A3DM.62947184-2FA4-4C16-B1DD-54C7C78293A7.pdf A3DM TUMOR FREE NO 1 1 YES NO NO Primary Tumor 01 7th YES NO BF Primary Tumor A LIVING 97 2011 ca667c68-e9fb-4003-8639-5fa1d00a7a95 TCGA-BF-A3DM-01A-11D-A211-05 ca667c68-e9fb-4003-8639-5fa1d00a7a95 TCGA-BF-A3DM-01 TCGA-BF-A3DM-01 2BC4EA45-1CCC-4FDF-A2BA-E8F61C36C61E TCGA-BF-A3DM-01A-11D-A20D-08 TCGA-BF-A3DM-01A-11D-A20D-08 TCGA-BF-A3DM-01A-11D-A20D-08 ca667c68-e9fb-4003-8639-5fa1d00a7a95 ca667c68-e9fb-4003-8639-5fa1d00a7a95 +TCGA-BF-A3DN-01 TCGA-BF-A3DN-01 TCGA-BF-A3DN TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 81 TCGA-BF-A3DN-F68914 TCGA-BF-A3DN TCGA-BF-A3DN-01A 3 -29801 177 0 717 0 2014-12-23 FEMALE 157 No C44.9 8720/3 C44.9 YES 160 NO NO IV Non-glabrous skin YES NO true No M0 N3 T3b Stage IIIC TCGA-BF-A3DN.4CBF8716-B8CC-4A4C-8ACC-59F0AF1A7A79.pdf A3DN TUMOR FREE NO 1 1 YES NO NO Primary Tumor 01 7th YES NO BF Primary Tumor A LIVING 58 2011 bbdc1eec-bfa5-4be6-ac9b-80426e1f7fdd TCGA-BF-A3DN-01A-11D-A211-05 bbdc1eec-bfa5-4be6-ac9b-80426e1f7fdd TCGA-BF-A3DN-01 TCGA-BF-A3DN-01 514C3AD1-248D-4B4B-B64F-06F853C19663 TCGA-BF-A3DN-01A-11D-A20D-08 TCGA-BF-A3DN-01A-11D-A20D-08 TCGA-BF-A3DN-01A-11D-A20D-08 bbdc1eec-bfa5-4be6-ac9b-80426e1f7fdd bbdc1eec-bfa5-4be6-ac9b-80426e1f7fdd +TCGA-BF-A5EO-01 TCGA-BF-A5EO-01 TCGA-BF-A5EO TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 65 TCGA-BF-A5EO-F68880 TCGA-BF-A5EO TCGA-BF-A5EO-01A 8 -23940 134 0 703 0 2014-12-23 MALE 182 No C44.5 8720/3 C44.5 YES 14 NO NO III Non-glabrous skin YES NO true No M0 N0 T4b Stage IIC TCGA-BF-A5EO.FD5F5903-7586-4388-970A-36FBE8AE473D.pdf A5EO TUMOR FREE NO 1 1 YES NO NO Primary Tumor 01 7th YES NO BF Primary Tumor A LIVING 110 2012 51627bee-72ff-4b4d-8df1-df5043766d43 TCGA-BF-A5EO-01A-12D-A27L-05 51627bee-72ff-4b4d-8df1-df5043766d43 BE2B6D1F-6603-4EBA-B2CB-C1BC42EDC9C0 TCGA-BF-A5EO-01A-12D-A27K-08 TCGA-BF-A5EO-01A-12D-A27K-08 51627bee-72ff-4b4d-8df1-df5043766d43 51627bee-72ff-4b4d-8df1-df5043766d43 +TCGA-BF-A5EP-01 TCGA-BF-A5EP-01 TCGA-BF-A5EP TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 75 TCGA-BF-A5EP-F68885 TCGA-BF-A5EP TCGA-BF-A5EP-01A 70 -27622 131 0 335 0 2014-12-23 FEMALE 165 No C44.5 8720/3 C44.5 YES 310 NO NO V Non-glabrous skin YES NO true No M0 N3 T4b Stage IIIC TCGA-BF-A5EP.83D63B00-735C-492C-ACF2-697DAA5FB55E.pdf A5EP TUMOR FREE NO 1 1 YES NO NO Primary Tumor 01 7th YES NO BF Primary Tumor A LIVING 83 2012 97f5e1fa-9706-4237-9e18-437b59dea594 TCGA-BF-A5EP-01A-12D-A27L-05 97f5e1fa-9706-4237-9e18-437b59dea594 TCGA-BF-A5EP-01 TCGA-BF-A5EP-01 B731E777-F518-4499-9DB7-A2F4C247E572 TCGA-BF-A5EP-01A-12D-A27K-08 97f5e1fa-9706-4237-9e18-437b59dea594 97f5e1fa-9706-4237-9e18-437b59dea594 +TCGA-BF-A5EQ-01 TCGA-BF-A5EQ-01 TCGA-BF-A5EQ TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 63 TCGA-BF-A5EQ-F68886 TCGA-BF-A5EQ TCGA-BF-A5EQ-01A 5 -23353 119 0 323 0 2014-12-23 MALE 178 No C44.5 8720/3 C44.5 YES 230 NO NO III Non-glabrous skin NO true No M0 N0 T4b Stage IIC TCGA-BF-A5EQ.AE7A4A09-97F1-43C5-BD47-89FDE4EC8678.pdf A5EQ TUMOR FREE NO 1 1 YES NO NO Primary Tumor 01 7th YES NO BF Primary Tumor A LIVING 90 2012 66a4ff31-c95c-4c76-8e91-1ae3c76e313c TCGA-BF-A5EQ-01A-21D-A27L-05 66a4ff31-c95c-4c76-8e91-1ae3c76e313c TCGA-BF-A5EQ-01 TCGA-BF-A5EQ-01 5AAF1CFF-B9B0-4CD4-9DB3-0C504E1DE1A4 TCGA-BF-A5EQ-01A-21D-A27K-08 TCGA-BF-A5EQ-01A-21D-A27K-08 66a4ff31-c95c-4c76-8e91-1ae3c76e313c 66a4ff31-c95c-4c76-8e91-1ae3c76e313c +TCGA-BF-A5ER-01 TCGA-BF-A5ER-01 TCGA-BF-A5ER TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 63 TCGA-BF-A5ER-F68887 TCGA-BF-A5ER TCGA-BF-A5ER-01A 14 -23199 91 0 327 0 2014-12-23 MALE 180 No C44.5 8720/3 C44.5 YES 170 NO NO IV Non-glabrous skin YES NO true No M0 N0 T4b Stage IIC TCGA-BF-A5ER.957FBBB2-381C-455F-84E2-42942EA49D72.pdf A5ER TUMOR FREE NO 1 1 YES NO NO Primary Tumor 01 7th YES NO BF Primary Tumor A LIVING 93 2012 1a8747a6-dc84-4a6e-9d32-ebd2c517775e TCGA-BF-A5ER-01A-12D-A27L-05 1a8747a6-dc84-4a6e-9d32-ebd2c517775e TCGA-BF-A5ER-01 TCGA-BF-A5ER-01 D93FEDB8-A0B7-4BA2-986A-F2955558A531 TCGA-BF-A5ER-01A-12D-A27K-08 1a8747a6-dc84-4a6e-9d32-ebd2c517775e 1a8747a6-dc84-4a6e-9d32-ebd2c517775e +TCGA-BF-A5ES-01 TCGA-BF-A5ES-01 TCGA-BF-A5ES TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 76 TCGA-BF-A5ES-F68888 TCGA-BF-A5ES TCGA-BF-A5ES-01A 8 -28092 89 0 490 0 2014-12-23 FEMALE 160 No C44.5 8720/3 C44.5 YES 160 NO NO IV Non-glabrous skin YES NO true No M0 N0 T4b Stage IIC TCGA-BF-A5ES.89406688-2097-4F89-ADC3-414894203BC3.pdf A5ES TUMOR FREE NO 1 1 YES NO NO Primary Tumor 01 7th YES NO BF Primary Tumor A LIVING 56 2012 8b04f9ea-ffb8-4a51-a20e-64e6889f6d5f TCGA-BF-A5ES-01A-11D-A27L-05 8b04f9ea-ffb8-4a51-a20e-64e6889f6d5f TCGA-BF-A5ES-01 TCGA-BF-A5ES-01 5F749CD4-8D04-4CF5-90CE-FCDA4D796611 TCGA-BF-A5ES-01A-11D-A27K-08 8b04f9ea-ffb8-4a51-a20e-64e6889f6d5f 8b04f9ea-ffb8-4a51-a20e-64e6889f6d5f +TCGA-BF-A9VF-01 TCGA-BF-A9VF-01 TCGA-BF-A9VF TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 77 TCGA-BF-A9VF-F68889 TCGA-BF-A9VF TCGA-BF-A9VF-01A 12 -28312 154 0 440 0 2014-12-23 MALE 174 No C49.2 8770/3 C49.2 YES 90 NO NO III Non-glabrous skin YES NO true No M0 N0 T4b Stage IIC TCGA-BF-A9VF.FDBA635C-E51D-4E19-8084-ED2EF54FAC0B.pdf A9VF TUMOR FREE NO 1 1 YES NO NO Primary Tumor 01 7th YES NO BF Primary Tumor A LIVING 77 2013 9e04fd71-518e-4c8d-9eea-70df71afaaaf TCGA-BF-A9VF-01A-11D-A373-05 9e04fd71-518e-4c8d-9eea-70df71afaaaf TCGA-BF-A9VF-01 TCGA-BF-A9VF-01 TCGA-BF-A9VF-01A-11D-A372-08 9e04fd71-518e-4c8d-9eea-70df71afaaaf 9e04fd71-518e-4c8d-9eea-70df71afaaaf +TCGA-BF-AAOU-01 TCGA-BF-AAOU-01 TCGA-BF-AAOU TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 73 TCGA-BF-AAOU-F68896 TCGA-BF-AAOU TCGA-BF-AAOU-01A 12 -26750 199 0 476 0 2014-12-23 FEMALE 160 No C44.5 8730/3 C44.5 YES 150 NO NO IV Non-glabrous skin YES NO true No M0 N0 T4b Stage IIC TCGA-BF-AAOU.C4F6EF2D-447C-43CA-ADF8-88A511B05D77.pdf AAOU TUMOR FREE NO 1 1 YES NO NO Primary Tumor 01 7th YES NO BF Primary Tumor A LIVING 50 2013 6e57fc3b-7e9d-4a9b-a1e7-77d4435c5b72 TCGA-BF-AAOU-01A-12D-A398-05 6e57fc3b-7e9d-4a9b-a1e7-77d4435c5b72 TCGA-BF-AAOU-01 TCGA-BF-AAOU-01 92A0C14F-8095-4FED-88A1-4A49A886A9E7 TCGA-BF-AAOU-01A-12D-A397-08 6e57fc3b-7e9d-4a9b-a1e7-77d4435c5b72 6e57fc3b-7e9d-4a9b-a1e7-77d4435c5b72 +TCGA-BF-AAOX-01 TCGA-BF-AAOX-01 TCGA-BF-AAOX TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 83 TCGA-BF-AAOX-F68897 TCGA-BF-AAOX TCGA-BF-AAOX-01A 11 -30318 167 0 444 0 2014-12-23 MALE 175 No C44.601 8771/3 C44.6 YES 180 NO NO IV Non-glabrous skin YES NO true No M0 N0 T4b Stage IIC TCGA-BF-AAOX.FF31BD7E-A8BE-4362-A25E-861038A556EE.pdf AAOX TUMOR FREE NO 1 1 YES NO NO Primary Tumor 01 7th YES NO BF Primary Tumor A LIVING 80 2013 ba2ba71d-2d57-4154-a712-84a3ef19247d TCGA-BF-AAOX-01A-11D-A398-05 ba2ba71d-2d57-4154-a712-84a3ef19247d TCGA-BF-AAOX-01 TCGA-BF-AAOX-01 C8B8B629-D156-4B19-83AE-FC57A1DF99EE TCGA-BF-AAOX-01A-11D-A397-08 ba2ba71d-2d57-4154-a712-84a3ef19247d ba2ba71d-2d57-4154-a712-84a3ef19247d +TCGA-BF-AAP0-06 TCGA-BF-AAP0-06 TCGA-BF-AAP0 TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 40 TCGA-BF-AAP0-F68898 TCGA-BF-AAP0 TCGA-BF-AAP0-06A -14773 177 0 454 0 2014-12-23 FEMALE 170 No C77.3 8720/3 C77.3 YES 120 NO NO Non-glabrous skin NO true No M1 NX T4 Stage IV TCGA-BF-AAP0.EFF48970-C0F0-4FFE-8891-26A96BBF54FC.pdf AAP0 TUMOR FREE NO 1 1 YES NO NO Metastatic 06 7th YES NO BF Regional Lymph Node A LIVING 57 2013 faf23517-4aeb-4ad0-8d86-cce2e3e89390 TCGA-BF-AAP0-06A-11D-A398-05 faf23517-4aeb-4ad0-8d86-cce2e3e89390 TCGA-BF-AAP0-06 TCGA-BF-AAP0-06A-11D-A396-01 TCGA-BF-AAP0-06 C12B49FF-2A14-4667-BC81-CF498741C85C TCGA-BF-AAP0-06A-11D-A397-08 TCGA-BF-AAP0-06A-11D-A396-01 faf23517-4aeb-4ad0-8d86-cce2e3e89390 faf23517-4aeb-4ad0-8d86-cce2e3e89390 +TCGA-BF-AAP1-01 TCGA-BF-AAP1-01 TCGA-BF-AAP1 TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 86 TCGA-BF-AAP1-F68899 TCGA-BF-AAP1 TCGA-BF-AAP1-01A 15 -31666 132 0 409 0 2014-12-23 MALE 167 No C44.601 8771/3 C44.6 YES 340 NO NO IV Non-glabrous skin YES NO true No M0 N0 T4b Stage IIC TCGA-BF-AAP1.FAAB1959-5595-4FE8-8EAD-EB753B658F03.pdf AAP1 TUMOR FREE NO 1 1 YES NO NO Primary Tumor 01 7th YES NO BF Primary Tumor A LIVING 68 2013 50b143bf-7283-468a-855b-63aadd98496a TCGA-BF-AAP1-01A-11D-A398-05 50b143bf-7283-468a-855b-63aadd98496a TCGA-BF-AAP1-01 TCGA-BF-AAP1-01 FE62A533-5E8A-4FB3-B651-94D197862A77 TCGA-BF-AAP1-01A-11D-A397-08 50b143bf-7283-468a-855b-63aadd98496a 50b143bf-7283-468a-855b-63aadd98496a +TCGA-BF-AAP2-01 TCGA-BF-AAP2-01 TCGA-BF-AAP2 TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 62 TCGA-BF-AAP2-F68900 TCGA-BF-AAP2 3 -22734 0 405 0 2014-12-23 MALE 173 No C44.601 8771/3 C44.6 YES NO III Non-glabrous skin YES NO No M0 N0 T3b Stage IIB AAP2 TUMOR FREE NO 1 YES NO NO Primary Tumor 01 7th YES NO BF Primary Tumor LIVING 75 2013 b43d4426-a4be-4b4d-9615-14e4b0c043f7 TCGA-BF-AAP2-01A-11D-A408-05 b43d4426-a4be-4b4d-9615-14e4b0c043f7 TCGA-BF-AAP2-01 TCGA-BF-AAP2-01 TCGA-BF-AAP2-01A-11D-A401-08 b43d4426-a4be-4b4d-9615-14e4b0c043f7 b43d4426-a4be-4b4d-9615-14e4b0c043f7 +TCGA-BF-AAP4-01 TCGA-BF-AAP4-01 TCGA-BF-AAP4 TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 61 TCGA-BF-AAP4-F68901 TCGA-BF-AAP4 TCGA-BF-AAP4-01A 15 -22303 58 0 335 0 2014-12-23 MALE 176 No C44.50 8771/3 C44.5 YES 120 NO NO V Non-glabrous skin YES NO true No M0 N0 T4b Stage IIC TCGA-BF-AAP4.B25BC3BC-1D2B-4980-8B2F-2C037370087B.pdf AAP4 TUMOR FREE NO 1 1 YES NO NO Primary Tumor 01 7th YES NO BF Primary Tumor A LIVING 86 2013 2f479383-aae6-4537-8230-d095722078be TCGA-BF-AAP4-01A-11D-A408-05 2f479383-aae6-4537-8230-d095722078be TCGA-BF-AAP4-01 TCGA-BF-AAP4-01 B2AB6550-AB39-4766-8A61-7CDEBCD25160 TCGA-BF-AAP4-01A-11D-A401-08 2f479383-aae6-4537-8230-d095722078be 2f479383-aae6-4537-8230-d095722078be +TCGA-BF-AAP6-01 TCGA-BF-AAP6-01 TCGA-BF-AAP6 TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 55 TCGA-BF-AAP6-F68902 TCGA-BF-AAP6 TCGA-BF-AAP6-01A 20 -20384 48 0 325 0 2014-12-23 MALE 170 No C44.701 8771/3 C44.7 YES 150 NO NO IV Non-glabrous skin YES NO true No M0 N2 T4b Stage III TCGA-BF-AAP6.D3B99086-110C-4DE5-BBF7-65C4ABD29959.pdf AAP6 TUMOR FREE NO 1 1 YES NO NO Primary Tumor 01 7th YES NO BF Primary Tumor A LIVING 75 2013 6b3487fa-abd6-4b9a-8e6e-6897b8461e46 TCGA-BF-AAP6-01A-11D-A408-05 6b3487fa-abd6-4b9a-8e6e-6897b8461e46 TCGA-BF-AAP6-01 TCGA-BF-AAP6-01 B84C2292-8A8E-42AB-8546-B9F6680CAE43 TCGA-BF-AAP6-01A-11D-A401-08 6b3487fa-abd6-4b9a-8e6e-6897b8461e46 6b3487fa-abd6-4b9a-8e6e-6897b8461e46 +TCGA-BF-AAP7-01 TCGA-BF-AAP7-01 TCGA-BF-AAP7 TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 76 TCGA-BF-AAP7-F68903 TCGA-BF-AAP7 TCGA-BF-AAP7-01A 5 -28073 41 0 318 0 2014-12-23 FEMALE 158 No C44.701 8771/3 C44.7 YES 110 NO NO IV Non-glabrous skin YES NO true No M0 N0 T4b Stage IIC TCGA-BF-AAP7.7AC6ABBA-DA58-4361-B349-19F950959BA3.pdf AAP7 TUMOR FREE NO 1 1 YES NO NO Primary Tumor 01 7th YES NO BF Primary Tumor A LIVING 67 2013 03bceee5-96ca-49f6-af6b-ce54eea549c0 TCGA-BF-AAP7-01A-11D-A408-05 03bceee5-96ca-49f6-af6b-ce54eea549c0 TCGA-BF-AAP7-01 TCGA-BF-AAP7-01 07AB735B-CAEE-42AA-A3FA-5C51D06788DC TCGA-BF-AAP7-01A-11D-A401-08 03bceee5-96ca-49f6-af6b-ce54eea549c0 03bceee5-96ca-49f6-af6b-ce54eea549c0 +TCGA-BF-AAP8-01 TCGA-BF-AAP8-01 TCGA-BF-AAP8 TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 58 TCGA-BF-AAP8-F68904 TCGA-BF-AAP8 TCGA-BF-AAP8-01A 6 -21414 181 0 447 0 2014-12-23 MALE 159 No C44.601 8771/3 C44.6 YES 260 NO NO IV Non-glabrous skin YES NO true No M0 N0 T4b Stage IIC TCGA-BF-AAP8.97478FA2-9022-4C07-B5B5-6BAC330BF94F.pdf AAP8 TUMOR FREE NO 1 1 YES NO NO Primary Tumor 01 7th YES NO BF Primary Tumor A LIVING 65 2013 c63ade29-1f1b-4290-8c2f-8d63fa96616c TCGA-BF-AAP8-01A-11D-A408-05 c63ade29-1f1b-4290-8c2f-8d63fa96616c TCGA-BF-AAP8-01 TCGA-BF-AAP8-01 0063BA5B-F169-4538-A8A4-160A7AC15C85 TCGA-BF-AAP8-01A-11D-A401-08 c63ade29-1f1b-4290-8c2f-8d63fa96616c c63ade29-1f1b-4290-8c2f-8d63fa96616c +TCGA-D3-A1Q1-06 TCGA-D3-A1Q1-06 TCGA-D3-A1Q1 TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 79 TCGA-D3-A1Q1 TCGA-D3-A1Q1-06A 0.4 -29212 2305 504 0 3 2012-10-2 FEMALE 162 No C77.9 8720/3 C77.9 YES 120 NO 3 II Non-glabrous skin NO NO YES true No M0 N3 T1b Stage IIIC TCGA-D3-A1Q1.14A845B4-E16D-4BC3-9562-B077E9C363F3.pdf A1Q1 WITH TUMOR YES 1 YES NO NO Metastatic 06 7th NO YES D3 Regional Lymph Node A DECEASED 59 2004 ec79139b-a1a8-4c38-9db6-b8570fb49a88 TCGA-D3-A1Q1-06A-21D-A19B-05 ec79139b-a1a8-4c38-9db6-b8570fb49a88 TCGA-D3-A1Q1-06 TCGA-D3-A1Q1-06A-21D-A194-01 TCGA-D3-A1Q1-06 C1E96D25-B19A-4F27-9BCA-62F1990121D9 TCGA-D3-A1Q1-06A-21D-A196-08 TCGA-D3-A1Q1-06A-21D-A196-08 TCGA-D3-A1Q1-06A-21D-A194-01 TCGA-D3-A1Q1-06A-21D-A196-08 ec79139b-a1a8-4c38-9db6-b8570fb49a88 ec79139b-a1a8-4c38-9db6-b8570fb49a88 +TCGA-D3-A1Q3-06 TCGA-D3-A1Q3-06 TCGA-D3-A1Q3 TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 64 TCGA-D3-A1Q3 TCGA-D3-A1Q3-06A 4.6 -23604 3491 507 0 248 2013-1-8 MALE 182 Yes C77.9 8720/3 C77.9 YES 70 NO NO 15 Non-glabrous skin YES NO true No M0 N0 T4b Stage IIC TCGA-D3-A1Q3.FCC5E470-C979-4265-917E-DD6C25B19606.pdf A1Q3 WITH TUMOR YES YES NO Interferon NO Metastatic 06 7th NO YES D3 Regional Lymph Node A DECEASED 108 2001 03903d4c-2420-49e3-bdb0-8e452333af62 TCGA-D3-A1Q3-06A-11D-A19B-05 03903d4c-2420-49e3-bdb0-8e452333af62 TCGA-D3-A1Q3-06 TCGA-D3-A1Q3-06A-11D-A194-01 TCGA-D3-A1Q3-06 TCGA-D3-A1Q3-06A-11D-A196-08 TCGA-D3-A1Q3-06A-11D-A196-08 TCGA-D3-A1Q3-06A-11D-A194-01 TCGA-D3-A1Q3-06A-11D-A196-08 03903d4c-2420-49e3-bdb0-8e452333af62 03903d4c-2420-49e3-bdb0-8e452333af62 +TCGA-D3-A1Q4-06 TCGA-D3-A1Q4-06 TCGA-D3-A1Q4 TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 53 TCGA-D3-A1Q4-F35869 TCGA-D3-A1Q4 TCGA-D3-A1Q4-06A 1.45 -19687 2752 0 3408 29 2013-2-22 FEMALE 155 No C77.9 8720/3 C77.9 YES 210 NO NO 0 IV Non-glabrous skin YES NO true No M0 N1b T2b Stage IIIC TCGA-D3-A1Q4.17F12722-DFAB-4D9B-8B1A-ECD55E4C70FC.pdf A1Q4 TUMOR FREE NO 1 YES NO NO Metastatic 06 NO 7th NO YES D3 Regional Lymph Node A LIVING 83 2003 58b46ddc-3b28-4b48-a981-27ac9ef23283 TCGA-D3-A1Q4-06A-11D-A19B-05 58b46ddc-3b28-4b48-a981-27ac9ef23283 TCGA-D3-A1Q4-06 TCGA-D3-A1Q4-06A-11D-A194-01 TCGA-D3-A1Q4-06 FD76559D-EC68-4009-955B-3A35CD186768 TCGA-D3-A1Q4-06A-11D-A196-08 TCGA-D3-A1Q4-06A-11D-A196-08 TCGA-D3-A1Q4-06A-11D-A194-01 TCGA-D3-A1Q4-06A-11D-A196-08 58b46ddc-3b28-4b48-a981-27ac9ef23283 58b46ddc-3b28-4b48-a981-27ac9ef23283 +TCGA-D3-A1Q5-06 TCGA-D3-A1Q5-06 TCGA-D3-A1Q5 TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 60 TCGA-D3-A1Q5 TCGA-D3-A1Q5-06A -22200 5194 3424 0 2438 2012-10-2 MALE 179 No C77.9 8720/3 C77.9 YES 340 NO Non-glabrous skin NO YES true No M0 N0 TX I/II NOS TCGA-D3-A1Q5.0BF62172-ADA2-4078-AEBD-C0FC71F4A8E2.pdf A1Q5 NO 1 YES NO NO Metastatic 06 7th NO YES D3 Regional Lymph Node A DECEASED 125 1996 f8c4acd4-f42f-409b-a710-970611f0cc0a TCGA-D3-A1Q5-06A-11D-A19B-05 f8c4acd4-f42f-409b-a710-970611f0cc0a TCGA-D3-A1Q5-06 TCGA-D3-A1Q5-06A-11D-A194-01 TCGA-D3-A1Q5-06 887FD24C-84CF-4077-A930-4EBF2732CD48 TCGA-D3-A1Q5-06A-11D-A196-08 TCGA-D3-A1Q5-06A-11D-A196-08 TCGA-D3-A1Q5-06A-11D-A194-01 TCGA-D3-A1Q5-06A-11D-A196-08 f8c4acd4-f42f-409b-a710-970611f0cc0a f8c4acd4-f42f-409b-a710-970611f0cc0a +TCGA-D3-A1Q6-06 TCGA-D3-A1Q6-06 TCGA-D3-A1Q6 TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 55 TCGA-D3-A1Q6 TCGA-D3-A1Q6-06A 50.0 -20230 2654 2184 0 50 2012-10-2 MALE 175 No C77.9 8720/3 C77.9 YES 250 NO V Non-glabrous skin YES YES true No M0 N1b T4 Stage III TCGA-D3-A1Q6.5BA4EDD7-8462-4028-8CB9-8FE2DDC51D3E.pdf A1Q6 TUMOR FREE YES 1 YES NO NO Metastatic 06 7th NO YES D3 Regional Cutaneous or Subcutaneous Tissue (includes satellite and in-transit metastasis) A DECEASED 81 2003 d4388885-339b-430e-8034-81c019b6dc43 TCGA-D3-A1Q6-06A-11D-A19B-05 d4388885-339b-430e-8034-81c019b6dc43 TCGA-D3-A1Q6-06 TCGA-D3-A1Q6-06A-11D-A194-01 TCGA-D3-A1Q6-06 9E3BC515-618A-47DC-812E-BAED13FC0115 TCGA-D3-A1Q6-06A-11D-A196-08 TCGA-D3-A1Q6-06A-11D-A196-08 TCGA-D3-A1Q6-06A-11D-A194-01 TCGA-D3-A1Q6-06A-11D-A196-08 d4388885-339b-430e-8034-81c019b6dc43 d4388885-339b-430e-8034-81c019b6dc43 +TCGA-D3-A1Q6-07 TCGA-D3-A1Q6-07 TCGA-D3-A1Q6 TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 55 TCGA-D3-A1Q6 TCGA-D3-A1Q6-07A 50.0 -20230 2871 2184 0 50 2012-10-2 MALE 175 No C77.9 8720/3 C77.9 YES 400 NO V Non-glabrous skin YES YES true No M0 N1b T4 Stage III TCGA-D3-A1Q6.7E74D698-CA50-40D9-8A06-6CECFD8580DA.pdf A1Q6 TUMOR FREE YES 1 YES NO NO Additional Metastatic 07 7th NO YES D3 Regional Cutaneous or Subcutaneous Tissue (includes satellite and in-transit metastasis) A DECEASED 81 2003 20EE3A64-2E03-4D8B-82B8-57A31D166658 +TCGA-D3-A1Q7-06 TCGA-D3-A1Q7-06 TCGA-D3-A1Q7 TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 42 TCGA-D3-A1Q7-F45521 TCGA-D3-A1Q7 TCGA-D3-A1Q7-06A 0.68 -15531 3246 0 4053 683 2013-7-16 FEMALE 170 No C77.9 8720/3 C77.9 YES 180 NO NO 1 III Non-glabrous skin NO NO NO true No M0 N0 T1b Stage IB TCGA-D3-A1Q7.6B4EBE5E-8C55-4820-8FB2-317F530A1007.pdf A1Q7 TUMOR FREE NO 1 YES NO YES Metastatic 06 NO 7th NO YES D3 Regional Lymph Node A LIVING 79 2002 f313d8ac-14aa-4171-b649-942458529230 TCGA-D3-A1Q7-06A-11D-A19D-05 f313d8ac-14aa-4171-b649-942458529230 TCGA-D3-A1Q7-06 TCGA-D3-A1Q7-06A-11D-A192-01 TCGA-D3-A1Q7-06 4BDE9930-905A-40A0-8045-2F6EE9E462E7 TCGA-D3-A1Q7-06A-11D-A19A-08 TCGA-D3-A1Q7-06A-11D-A19A-08 TCGA-D3-A1Q7-06A-11D-A192-01 TCGA-D3-A1Q7-06A-11D-A19A-08 f313d8ac-14aa-4171-b649-942458529230 f313d8ac-14aa-4171-b649-942458529230 +TCGA-D3-A1Q8-06 TCGA-D3-A1Q8-06 TCGA-D3-A1Q8 TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 33 TCGA-D3-A1Q8 TCGA-D3-A1Q8-06A -12330 2388 854 0 0 2012-10-2 MALE 187 No C77.9 8720/3 C77.9 YES 100 NO Normal Non-glabrous skin NO YES true No M1b N3 T0 Stage IV TCGA-D3-A1Q8.F0634F7F-0FFB-4317-A808-00BB4F612B3E.pdf A1Q8 WITH TUMOR NO NO YES Metastatic 06 7th NO YES D3 Regional Lymph Node A DECEASED 161 2004 18bfebc6-f546-4154-ad8d-b65706af6547 TCGA-D3-A1Q8-06A-11D-A19D-05 18bfebc6-f546-4154-ad8d-b65706af6547 TCGA-D3-A1Q8-06 TCGA-D3-A1Q8-06A-11D-A192-01 TCGA-D3-A1Q8-06 8A80F9B1-F4B7-4A3A-B0DB-780896CE3351 TCGA-D3-A1Q8-06A-11D-A19A-08 TCGA-D3-A1Q8-06A-11D-A19A-08 TCGA-D3-A1Q8-06A-11D-A192-01 TCGA-D3-A1Q8-06A-11D-A19A-08 18bfebc6-f546-4154-ad8d-b65706af6547 18bfebc6-f546-4154-ad8d-b65706af6547 +TCGA-D3-A1Q9-06 TCGA-D3-A1Q9-06 TCGA-D3-A1Q9 TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 72 TCGA-D3-A1Q9 TCGA-D3-A1Q9-06A 6 -26471 2065 961 0 275 2012-10-2 MALE 177 No C77.9 8720/3 C77.9 YES 490 NO 10 V Non-glabrous skin YES YES YES true No M0 N2a T4b Stage IIIB TCGA-D3-A1Q9.CE9771F8-4BE0-4B91-AD6B-2C4FB39AE1C8.pdf A1Q9 WITH TUMOR YES 1 YES NO NO Metastatic 06 7th NO YES D3 Regional Lymph Node A DECEASED 98 2005 83e1f144-8970-4d50-961d-51493ba417f3 TCGA-D3-A1Q9-06A-11D-A19D-05 83e1f144-8970-4d50-961d-51493ba417f3 TCGA-D3-A1Q9-06 TCGA-D3-A1Q9-06A-11D-A192-01 TCGA-D3-A1Q9-06 B197C9B8-B3CA-4156-9558-5E9FA74885FC TCGA-D3-A1Q9-06A-11D-A19A-08 TCGA-D3-A1Q9-06A-11D-A19A-08 TCGA-D3-A1Q9-06A-11D-A192-01 TCGA-D3-A1Q9-06A-11D-A19A-08 83e1f144-8970-4d50-961d-51493ba417f3 83e1f144-8970-4d50-961d-51493ba417f3 +TCGA-D3-A1QA-06 TCGA-D3-A1QA-06 TCGA-D3-A1QA TCGA Melanoma (SKCM) skin cutaneous melanoma Skin NO|YES NO|NO 55 TCGA-D3-A1QA-F45518 TCGA-D3-A1QA TCGA-D3-A1QA-06A 1.12 -20223 1960 0 2765 2553| 2553|2553 1371 2013-7-16 MALE 175 No C77.9 8720/3 C77.9 YES 100 NO NO 2 III Non-glabrous skin NO Distant Metastasis|Distant Metastasis NO YES|NO YES Other, Specify|Other, Specify Colon|Adrenal true No M0 N0 T2a Stage IB TCGA-D3-A1QA.7061E1EB-4CDD-4AB2-A0E5-D84373260890.pdf A1QA WITH TUMOR NO 1 YES NO NO Metastatic 06 NO 7th NO YES D3 Regional Lymph Node A LIVING 90 2005 194ed685-060c-4577-99b9-86238e24c17c TCGA-D3-A1QA-06A-11D-A19B-05 194ed685-060c-4577-99b9-86238e24c17c TCGA-D3-A1QA-06 TCGA-D3-A1QA-06A-11D-A194-01 TCGA-D3-A1QA-06 89A059E0-F233-4C84-B4C4-C610117D4530 TCGA-D3-A1QA-06A-11D-A196-08 TCGA-D3-A1QA-06A-11D-A196-08 TCGA-D3-A1QA-06A-11D-A194-01 TCGA-D3-A1QA-06A-11D-A196-08 194ed685-060c-4577-99b9-86238e24c17c 194ed685-060c-4577-99b9-86238e24c17c +TCGA-D3-A1QA-07 TCGA-D3-A1QA-07 TCGA-D3-A1QA TCGA Melanoma (SKCM) skin cutaneous melanoma Skin NO|YES NO|NO 55 TCGA-D3-A1QA-F45518 TCGA-D3-A1QA TCGA-D3-A1QA-07A 1.12 -20223 2933 0 2765 2553| 2553|2553 1371 2013-7-16 MALE 175 No C77.9 8720/3 C77.9 YES 130 NO NO 2 III Non-glabrous skin NO Distant Metastasis|Distant Metastasis NO YES|NO YES Other, Specify|Other, Specify Colon|Adrenal true No M0 N0 T2a Stage IB TCGA-D3-A1QA.0895B97D-2BB1-4E6E-A59F-AAE9579B46EF.pdf A1QA WITH TUMOR NO 1 YES NO NO Additional Metastatic 07 NO 7th NO YES D3 Regional Lymph Node A LIVING 90 2005 278783a2-646d-4669-b153-c0ba3deab9cf TCGA-D3-A1QA-07A-11D-A373-05 278783a2-646d-4669-b153-c0ba3deab9cf TCGA-D3-A1QA-07 TCGA-D3-A1QA-07 278783a2-646d-4669-b153-c0ba3deab9cf 278783a2-646d-4669-b153-c0ba3deab9cf +TCGA-D3-A1QB-06 TCGA-D3-A1QB-06 TCGA-D3-A1QB TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 75 TCGA-D3-A1QB-F45519 TCGA-D3-A1QB TCGA-D3-A1QB-06A -27566 2135 0 2912 441 2013-7-16 FEMALE 147 No C77.9 8720/3 C77.9 YES 100 NO NO Non-glabrous skin YES NO true No M0 N2c T0 Stage III TCGA-D3-A1QB.EA89AFF8-7133-4B7F-89E4-9AF1901C300D.pdf A1QB TUMOR FREE NO NO NO Metastatic 06 NO 7th NO YES D3 Regional Lymph Node A LIVING 86 2005 36ef1cbb-f448-464b-9727-4d3f2f63d76c TCGA-D3-A1QB-06A-11D-A19D-05 36ef1cbb-f448-464b-9727-4d3f2f63d76c TCGA-D3-A1QB-06 TCGA-D3-A1QB-06A-11D-A192-01 TCGA-D3-A1QB-06 4D6B40F5-DC5A-45ED-9357-EEB4EE80BDC1 TCGA-D3-A1QB-06A-11D-A19A-08 TCGA-D3-A1QB-06A-11D-A19A-08 TCGA-D3-A1QB-06A-11D-A192-01 TCGA-D3-A1QB-06A-11D-A19A-08 36ef1cbb-f448-464b-9727-4d3f2f63d76c 36ef1cbb-f448-464b-9727-4d3f2f63d76c +TCGA-D3-A2J6-06 TCGA-D3-A2J6-06 TCGA-D3-A2J6 TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 65 TCGA-D3-A2J6 TCGA-D3-A2J6-06A 3.20 -24066 3403 1321 0 1008 2012-10-2 MALE 185 No C77.4 8720/3 C77.4 YES 90 NO 13 IV Non-glabrous skin YES YES YES true No M0 N0 T3b Stage IIB TCGA-D3-A2J6.2A171FA8-1131-410A-BEDB-EB38849D34A9.pdf A2J6 WITH TUMOR NO 1 YES NO NO Metastatic 06 7th NO YES D3 Regional Lymph Node A DECEASED 141 2002 ebd47503-5ea0-4c00-bd06-9b011fc5efb5 TCGA-D3-A2J6-06A-11D-A19D-05 ebd47503-5ea0-4c00-bd06-9b011fc5efb5 TCGA-D3-A2J6-06 TCGA-D3-A2J6-06A-11D-A192-01 TCGA-D3-A2J6-06 27B758FD-2E08-4C4B-AA61-5D8A7CBCAF58 TCGA-D3-A2J6-06A-11D-A19A-08 TCGA-D3-A2J6-06A-11D-A19A-08 TCGA-D3-A2J6-06A-11D-A192-01 TCGA-D3-A2J6-06A-11D-A19A-08 ebd47503-5ea0-4c00-bd06-9b011fc5efb5 ebd47503-5ea0-4c00-bd06-9b011fc5efb5 +TCGA-D3-A2J7-06 TCGA-D3-A2J7-06 TCGA-D3-A2J7 TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 67 TCGA-D3-A2J7 TCGA-D3-A2J7-06A 3.6 -24692 3003 3136 0 541 2012-10-2 MALE 175 No C77.9 8720/3 C77.9 YES 40 NO 2 III Non-glabrous skin YES YES YES true No M0 N1b T3b Stage IIIC TCGA-D3-A2J7.11EC83A8-0B02-4D96-B795-66317F21B3FF.pdf A2J7 WITH TUMOR NO 1 YES NO NO Metastatic 06 7th NO YES D3 Regional Lymph Node A DECEASED 93 2003 53542d3e-e875-46b5-9ace-a736f2ad1ac8 TCGA-D3-A2J7-06A-11D-A19B-05 53542d3e-e875-46b5-9ace-a736f2ad1ac8 TCGA-D3-A2J7-06 TCGA-D3-A2J7-06A-11D-A194-01 TCGA-D3-A2J7-06 TCGA-D3-A2J7-06A-11D-A196-08 TCGA-D3-A2J7-06A-11D-A196-08 TCGA-D3-A2J7-06A-11D-A194-01 TCGA-D3-A2J7-06A-11D-A196-08 53542d3e-e875-46b5-9ace-a736f2ad1ac8 53542d3e-e875-46b5-9ace-a736f2ad1ac8 +TCGA-D3-A2J8-06 TCGA-D3-A2J8-06 TCGA-D3-A2J8 TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 48 TCGA-D3-A2J8 TCGA-D3-A2J8-06A 1.4 -17626 2962 1992 0 1737 2012-10-2 MALE 183 No C77.4 8720/3 C77.4 YES 160 NO 1 IV Non-glabrous skin NO NO YES true No M0 N0 T2a Stage IB TCGA-D3-A2J8.3D702708-2EC9-4FB6-A091-2958A7656A42.pdf A2J8 WITH TUMOR NO 1 YES NO NO Metastatic 06 7th NO YES D3 Regional Lymph Node A DECEASED 79 2003 3c8801a6-e38d-43bd-a9d4-7bc5186f0617 TCGA-D3-A2J8-06A-11D-A19B-05 3c8801a6-e38d-43bd-a9d4-7bc5186f0617 TCGA-D3-A2J8-06 TCGA-D3-A2J8-06A-11D-A194-01 TCGA-D3-A2J8-06 08AC3B52-4783-42A2-93CD-BBB82F7EB60F TCGA-D3-A2J8-06A-11D-A196-08 TCGA-D3-A2J8-06A-11D-A196-08 TCGA-D3-A2J8-06A-11D-A194-01 TCGA-D3-A2J8-06A-11D-A196-08 3c8801a6-e38d-43bd-a9d4-7bc5186f0617 3c8801a6-e38d-43bd-a9d4-7bc5186f0617 +TCGA-D3-A2J9-06 TCGA-D3-A2J9-06 TCGA-D3-A2J9 TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 75 TCGA-D3-A2J9 21 -27428 723 0 80 2012-10-2 MALE 183 No C77.3 8720/3 C77.3 YES V Non-glabrous skin YES NO YES No M0 N3 T4b Stage IIIC A2J9 WITH TUMOR NO 1|1 2 YES YES NO Metastatic 06 7th NO YES D3 Regional Lymph Node DECEASED 70 2003 f109e380-99e8-42f3-a0c3-d3f459f71ae8 TCGA-D3-A2J9-06A-11D-A19B-05 f109e380-99e8-42f3-a0c3-d3f459f71ae8 TCGA-D3-A2J9-06 TCGA-D3-A2J9-06A-11D-A194-01 TCGA-D3-A2J9-06 TCGA-D3-A2J9-06A-11D-A196-08 TCGA-D3-A2J9-06A-11D-A196-08 TCGA-D3-A2J9-06A-11D-A194-01 TCGA-D3-A2J9-06A-11D-A196-08 f109e380-99e8-42f3-a0c3-d3f459f71ae8 f109e380-99e8-42f3-a0c3-d3f459f71ae8 +TCGA-D3-A2JA-06 TCGA-D3-A2JA-06 TCGA-D3-A2JA TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 68 TCGA-D3-A2JA-F40740 TCGA-D3-A2JA 1.2 -25085 0 3514 822 2013-3-7 MALE 175 No C49.6 8720/3 C49.6 YES NO 0 III Non-glabrous skin NO YES NO No M0 N1a T2a Stage IIIA A2JA TUMOR FREE NO 1 YES NO NO Metastatic 06 NO 7th NO YES D3 Regional Cutaneous or Subcutaneous Tissue (includes satellite and in-transit metastasis) LIVING 113 2003 eea5dc11-94fe-4ebf-b352-f70c2d358236 TCGA-D3-A2JA-06A-11D-A19B-05 eea5dc11-94fe-4ebf-b352-f70c2d358236 TCGA-D3-A2JA-06 TCGA-D3-A2JA-06A-11D-A194-01 TCGA-D3-A2JA-06 TCGA-D3-A2JA-06A-11D-A196-08 TCGA-D3-A2JA-06A-11D-A196-08 TCGA-D3-A2JA-06A-11D-A194-01 TCGA-D3-A2JA-06A-11D-A196-08 eea5dc11-94fe-4ebf-b352-f70c2d358236 eea5dc11-94fe-4ebf-b352-f70c2d358236 +TCGA-D3-A2JB-06 TCGA-D3-A2JB-06 TCGA-D3-A2JB TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 70 TCGA-D3-A2JB TCGA-D3-A2JB-06A -25784 4955 5110 0 3035 2012-10-10 FEMALE 163 No C77.4 8720/3 C77.4 YES 70 NO Non-glabrous skin NO YES true No M0 N0 Tis Stage 0 TCGA-D3-A2JB.3678202C-DFD7-4D37-AA08-3C2C63001AB4.pdf A2JB TUMOR FREE NO 1 YES NO NO Metastatic 06 7th NO YES D3 Regional Lymph Node A DECEASED 57 1997 275c0be2-e74b-4926-8490-cc5ad687b240 TCGA-D3-A2JB-06A-11D-A19B-05 275c0be2-e74b-4926-8490-cc5ad687b240 TCGA-D3-A2JB-06 TCGA-D3-A2JB-06A-11D-A194-01 TCGA-D3-A2JB-06 TCGA-D3-A2JB-06A-11D-A196-08 TCGA-D3-A2JB-06A-11D-A196-08 TCGA-D3-A2JB-06A-11D-A194-01 TCGA-D3-A2JB-06A-11D-A196-08 275c0be2-e74b-4926-8490-cc5ad687b240 275c0be2-e74b-4926-8490-cc5ad687b240 +TCGA-D3-A2JC-06 TCGA-D3-A2JC-06 TCGA-D3-A2JC TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 53 TCGA-D3-A2JC-F55295 TCGA-D3-A2JC TCGA-D3-A2JC-06A -19644 1778 0 2639 0 2014-1-3 FEMALE 168 No C77.3 8720/3 C77.3 YES 90 NO NO Non-glabrous skin NO true No M0 N2b T0 Stage III TCGA-D3-A2JC.1371FB43-AB0B-439A-837C-4A052D11725D.pdf A2JC TUMOR FREE YES NO NO Metastatic 06 NO 7th NO YES D3 Regional Lymph Node A LIVING 83 2006 898969f3-0879-46c7-b641-3c0c53d62422 TCGA-D3-A2JC-06A-11D-A19D-05 898969f3-0879-46c7-b641-3c0c53d62422 TCGA-D3-A2JC-06 TCGA-D3-A2JC-06A-11D-A192-01 TCGA-D3-A2JC-06 61C80DC7-B34B-435B-8A56-68B65B778D98 TCGA-D3-A2JC-06A-11D-A19A-08 TCGA-D3-A2JC-06A-11D-A19A-08 TCGA-D3-A2JC-06A-11D-A192-01 TCGA-D3-A2JC-06A-11D-A19A-08 898969f3-0879-46c7-b641-3c0c53d62422 898969f3-0879-46c7-b641-3c0c53d62422 +TCGA-D3-A2JD-06 TCGA-D3-A2JD-06 TCGA-D3-A2JD TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 58 TCGA-D3-A2JD TCGA-D3-A2JD-06A 18 -21440 1542 361 0 14 2012-10-10 MALE 183 No C77.3 8720/3 C77.3 YES 130 NO 14 V Non-glabrous skin YES NO YES true No M0 N1b T4b Stage IIIC TCGA-D3-A2JD.406DB335-5288-4A83-95D4-8CCE4A94B141.pdf A2JD WITH TUMOR NO 1 YES NO NO Metastatic 06 7th NO YES D3 Regional Lymph Node A DECEASED 73 2007 fa5354d8-ce4c-4b8d-b7cc-e4708e6eae5f TCGA-D3-A2JD-06A-11D-A19D-05 fa5354d8-ce4c-4b8d-b7cc-e4708e6eae5f TCGA-D3-A2JD-06 TCGA-D3-A2JD-06A-11D-A192-01 TCGA-D3-A2JD-06 0F5EB08C-9DC4-4ABC-BC65-F7A881282B93 TCGA-D3-A2JD-06A-11D-A19A-08 TCGA-D3-A2JD-06A-11D-A19A-08 TCGA-D3-A2JD-06A-11D-A192-01 TCGA-D3-A2JD-06A-11D-A19A-08 fa5354d8-ce4c-4b8d-b7cc-e4708e6eae5f fa5354d8-ce4c-4b8d-b7cc-e4708e6eae5f +TCGA-D3-A2JE-06 TCGA-D3-A2JE-06 TCGA-D3-A2JE TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 75 TCGA-D3-A2JE TCGA-D3-A2JE-06A -27604 890 841 0 140 2014-7-22 FEMALE 160 No C77.3 8720/3 C77.3 YES 170 NO Non-glabrous skin NO YES true Yes M0 N3 TX Stage IIIC TCGA-D3-A2JE.B07C0D10-3397-4F61-A119-F1D7CDB9E792.pdf A2JE WITH TUMOR NO 1 YES NO NO Metastatic 06 6th NO YES D3 Regional Lymph Node A DECEASED 81 2009 f73824ee-cfc9-47fe-bae2-7a2de48c51bc TCGA-D3-A2JE-06A-11D-A373-05 f73824ee-cfc9-47fe-bae2-7a2de48c51bc TCGA-D3-A2JE-06 TCGA-D3-A2JE-06A-11D-A371-01 TCGA-D3-A2JE-06 4DCC3E87-6C33-4F2C-B80F-0BF961DC2517 TCGA-D3-A2JE-06A-11D-A372-08 TCGA-D3-A2JE-06A-11D-A371-01 f73824ee-cfc9-47fe-bae2-7a2de48c51bc f73824ee-cfc9-47fe-bae2-7a2de48c51bc +TCGA-D3-A2JF-06 TCGA-D3-A2JF-06 TCGA-D3-A2JF TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 74 TCGA-D3-A2JF-F55300 TCGA-D3-A2JF TCGA-D3-A2JF-06A 0.28 -27255 1062 0 1888 544 Left arm, soft tissue 2014-1-3 MALE 170 No C49.1 8720/3 C49.1 YES 70 NO NO 0 III Non-glabrous skin NO YES NO true Yes M0 N0 T1a Stage IA TCGA-D3-A2JF.80C97CF8-9325-48B5-A944-F6DF61ADD6A1.pdf A2JF TUMOR FREE NO 1|1 YES NO NO Metastatic 06 NO 7th NO YES D3 Distant Metastasis A LIVING 80 2008 4837761d-62c2-42b1-aea5-22caca405637 TCGA-D3-A2JF-06A-11D-A19B-05 4837761d-62c2-42b1-aea5-22caca405637 TCGA-D3-A2JF-06 TCGA-D3-A2JF-06A-11D-A194-01 TCGA-D3-A2JF-06 TCGA-D3-A2JF-06A-11D-A196-08 TCGA-D3-A2JF-06A-11D-A196-08 TCGA-D3-A2JF-06A-11D-A194-01 TCGA-D3-A2JF-06A-11D-A196-08 4837761d-62c2-42b1-aea5-22caca405637 4837761d-62c2-42b1-aea5-22caca405637 +TCGA-D3-A2JG-06 TCGA-D3-A2JG-06 TCGA-D3-A2JG TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 30 TCGA-D3-A2JG 2.5 -11105 3453 0 3225 2012-10-10 FEMALE 165 Yes C77.5 8720/3 C77.5 YES YES 1 IV Non-glabrous skin NO NO YES No M0 N1a T3a Stage IIIA A2JG WITH TUMOR NO 1 YES NO Interferon NO Metastatic 06 7th NO YES D3 Regional Lymph Node DECEASED 89 2001 a4a2d2e8-d2cd-4551-942d-8cc066d332a6 TCGA-D3-A2JG-06A-11D-A19B-05 a4a2d2e8-d2cd-4551-942d-8cc066d332a6 TCGA-D3-A2JG-06 TCGA-D3-A2JG-06A-11D-A194-01 TCGA-D3-A2JG-06 TCGA-D3-A2JG-06A-11D-A196-08 TCGA-D3-A2JG-06A-11D-A196-08 TCGA-D3-A2JG-06A-11D-A194-01 TCGA-D3-A2JG-06A-11D-A196-08 a4a2d2e8-d2cd-4551-942d-8cc066d332a6 a4a2d2e8-d2cd-4551-942d-8cc066d332a6 +TCGA-D3-A2JH-06 TCGA-D3-A2JH-06 TCGA-D3-A2JH TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 68 TCGA-D3-A2JH-F49197 TCGA-D3-A2JH TCGA-D3-A2JH-06A 1.0 -24882 531 0 1280 180 2013-9-26 MALE 175 No C49.6 8720/3 C49.6 YES 150 NO NO 1 II Non-glabrous skin NO NO NO true No M0 N0 T1b Stage IB TCGA-D3-A2JH.06022361-4A6B-41E4-BEE8-222596939BD3.pdf A2JH TUMOR FREE YES 1 YES NO YES Metastatic 06 NO 7th NO YES D3 Regional Cutaneous or Subcutaneous Tissue (includes satellite and in-transit metastasis) A LIVING 123 2010 93199f13-52a9-4c92-81a3-7be55eb10e94 TCGA-D3-A2JH-06A-11D-A19B-05 93199f13-52a9-4c92-81a3-7be55eb10e94 TCGA-D3-A2JH-06 TCGA-D3-A2JH-06A-11D-A194-01 TCGA-D3-A2JH-06 TCGA-D3-A2JH-06A-11D-A196-08 TCGA-D3-A2JH-06A-11D-A196-08 TCGA-D3-A2JH-06A-11D-A194-01 TCGA-D3-A2JH-06A-11D-A196-08 93199f13-52a9-4c92-81a3-7be55eb10e94 93199f13-52a9-4c92-81a3-7be55eb10e94 +TCGA-D3-A2JK-06 TCGA-D3-A2JK-06 TCGA-D3-A2JK TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 24 TCGA-D3-A2JK TCGA-D3-A2JK-06A 4.3 -8952 2346 368 0 176 2012-10-10 MALE 185 No C77.3 8720/3 C77.3 YES 50 NO 4 IV Non-glabrous skin YES NO YES true No M0 N2b T4b Stage IIIC TCGA-D3-A2JK.72B16AA4-3708-485B-8DC2-20BCD5BDF9DE.pdf A2JK WITH TUMOR NO 1 YES NO NO Metastatic 06 7th NO YES D3 Regional Lymph Node A DECEASED 92 2005 4a74dbdf-f817-47ce-a162-415535183bf4 TCGA-D3-A2JK-06A-11D-A19B-05 4a74dbdf-f817-47ce-a162-415535183bf4 TCGA-D3-A2JK-06 TCGA-D3-A2JK-06A-11D-A194-01 TCGA-D3-A2JK-06 TCGA-D3-A2JK-06A-11D-A196-08 TCGA-D3-A2JK-06A-11D-A196-08 TCGA-D3-A2JK-06A-11D-A194-01 TCGA-D3-A2JK-06A-11D-A196-08 4a74dbdf-f817-47ce-a162-415535183bf4 4a74dbdf-f817-47ce-a162-415535183bf4 +TCGA-D3-A2JL-06 TCGA-D3-A2JL-06 TCGA-D3-A2JL TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 43 TCGA-D3-A2JL-F46539 TCGA-D3-A2JL TCGA-D3-A2JL-06A -15710 4472 0 5219 2408 2013-8-8 FEMALE 165 No C77.4 8720/3 C77.4 YES 40 NO NO Non-glabrous skin NO NO true No M0 N0 TX I/II NOS TCGA-D3-A2JL.9D32B522-7FD4-47F6-9302-934185AEAD0B.pdf A2JL TUMOR FREE YES 1 YES NO NO Metastatic 06 NO 7th NO YES D3 Regional Lymph Node A LIVING 72 1999 1a3eaaf1-b020-4db5-abc0-dfce056649fb TCGA-D3-A2JL-06A-11D-A19B-05 1a3eaaf1-b020-4db5-abc0-dfce056649fb TCGA-D3-A2JL-06 TCGA-D3-A2JL-06A-11D-A194-01 TCGA-D3-A2JL-06 TCGA-D3-A2JL-06A-11D-A196-08 TCGA-D3-A2JL-06A-11D-A196-08 TCGA-D3-A2JL-06A-11D-A194-01 TCGA-D3-A2JL-06A-11D-A196-08 1a3eaaf1-b020-4db5-abc0-dfce056649fb 1a3eaaf1-b020-4db5-abc0-dfce056649fb +TCGA-D3-A2JN-06 TCGA-D3-A2JN-06 TCGA-D3-A2JN TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 46 TCGA-D3-A2JN-F40742 TCGA-D3-A2JN TCGA-D3-A2JN-06A -17128 1520 2022 0 1709 0 2013-3-7 FEMALE 163 No C77.3 8720/3 C77.3 YES 110 NO NO Non-glabrous skin NO true No M0 N1b T0 Stage III TCGA-D3-A2JN.3509C797-78F7-46DC-B140-13C3FA25C00C.pdf A2JN TUMOR FREE NO NO NO Metastatic 06 NO 7th NO YES D3 Regional Lymph Node A DECEASED 76 2007 68856b27-6609-4a25-b470-d11b74452374 TCGA-D3-A2JN-06A-11D-A19B-05 68856b27-6609-4a25-b470-d11b74452374 TCGA-D3-A2JN-06 TCGA-D3-A2JN-06A-11D-A194-01 TCGA-D3-A2JN-06 0406F878-DF03-499C-867F-EC420E7707AF TCGA-D3-A2JN-06A-11D-A196-08 TCGA-D3-A2JN-06A-11D-A196-08 TCGA-D3-A2JN-06A-11D-A194-01 TCGA-D3-A2JN-06A-11D-A196-08 68856b27-6609-4a25-b470-d11b74452374 68856b27-6609-4a25-b470-d11b74452374 +TCGA-D3-A2JO-06 TCGA-D3-A2JO-06 TCGA-D3-A2JO TCGA Melanoma (SKCM) skin cutaneous melanoma Skin NO NO 50 TCGA-D3-A2JO-F49192 TCGA-D3-A2JO TCGA-D3-A2JO-06A -18577 1227 0 2010 2010 50 2013-9-26 FEMALE 174 No C49.3 8720/3 C49.3 YES 90 NO NO Non-glabrous skin YES New primary melanoma Head & Neck YES NO YES true No M0 N3 TX Stage IIIC TCGA-D3-A2JO.526BF4D7-C1DD-4128-9274-50AEF7DA463D.pdf A2JO WITH TUMOR NO 1 YES NO YES Metastatic 06 YES 7th NO YES D3 Regional Cutaneous or Subcutaneous Tissue (includes satellite and in-transit metastasis) A LIVING 77 2008 8105c994-1a91-4514-a22e-64a2bdc5fec2 TCGA-D3-A2JO-06A-11D-A19B-05 8105c994-1a91-4514-a22e-64a2bdc5fec2 TCGA-D3-A2JO-06 TCGA-D3-A2JO-06A-11D-A194-01 TCGA-D3-A2JO-06 D24DB5A9-C6CE-45A7-9511-3DB0C2BBF6D9 TCGA-D3-A2JO-06A-11D-A196-08 TCGA-D3-A2JO-06A-11D-A196-08 TCGA-D3-A2JO-06A-11D-A194-01 TCGA-D3-A2JO-06A-11D-A196-08 8105c994-1a91-4514-a22e-64a2bdc5fec2 8105c994-1a91-4514-a22e-64a2bdc5fec2 +TCGA-D3-A2JP-06 TCGA-D3-A2JP-06 TCGA-D3-A2JP TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 37 TCGA-D3-A2JP-F55299 TCGA-D3-A2JP TCGA-D3-A2JP-06A -13552 982 0 1812 0 2014-1-3 MALE 175 No C77.3 8720/3 C77.3 YES 150 NO NO Non-glabrous skin NO NO true No M0 N3 T0 Stage IIIC TCGA-D3-A2JP.F23E963F-A9CF-4241-882E-385254FA5E97.pdf A2JP WITH TUMOR NO NO NO Metastatic 06 NO 7th NO YES D3 Regional Lymph Node A LIVING 75 2008 b4833ecc-2007-401c-b216-94d1daa8aaad TCGA-D3-A2JP-06A-11D-A19D-05 b4833ecc-2007-401c-b216-94d1daa8aaad TCGA-D3-A2JP-06 TCGA-D3-A2JP-06A-11D-A192-01 TCGA-D3-A2JP-06 7B3B3283-E869-4C77-8627-8C83C168B490 TCGA-D3-A2JP-06A-11D-A19A-08 TCGA-D3-A2JP-06A-11D-A19A-08 TCGA-D3-A2JP-06A-11D-A192-01 TCGA-D3-A2JP-06A-11D-A19A-08 b4833ecc-2007-401c-b216-94d1daa8aaad b4833ecc-2007-401c-b216-94d1daa8aaad +TCGA-D3-A3BZ-06 TCGA-D3-A3BZ-06 TCGA-D3-A3BZ TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 63 TCGA-D3-A3BZ-F45520 TCGA-D3-A3BZ 4.6 -23286 0 3976 488 2013-7-16 MALE 170 No C77.0 8720/3 C77.0 YES NO 1 V Non-glabrous skin NO NO NO No M0 N0 T4a Stage IIB A3BZ TUMOR FREE NO 1 YES NO YES Metastatic 06 NO 7th NO YES D3 Regional Lymph Node LIVING 99 2002 c572c558-9451-46c1-817b-2322f4d0d61a TCGA-D3-A3BZ-06A-12D-A19B-05 c572c558-9451-46c1-817b-2322f4d0d61a TCGA-D3-A3BZ-06 TCGA-D3-A3BZ-06A-12D-A194-01 TCGA-D3-A3BZ-06 TCGA-D3-A3BZ-06A-12D-A196-08 TCGA-D3-A3BZ-06A-12D-A196-08 TCGA-D3-A3BZ-06A-12D-A194-01 TCGA-D3-A3BZ-06A-12D-A196-08 c572c558-9451-46c1-817b-2322f4d0d61a c572c558-9451-46c1-817b-2322f4d0d61a +TCGA-D3-A3C1-06 TCGA-D3-A3C1-06 TCGA-D3-A3C1 TCGA Melanoma (SKCM) skin cutaneous melanoma Skin TCGA-D3-A3C1-F49195 TCGA-D3-A3C1 TCGA-D3-A3C1-06A 2013-9-26 MALE 179 No C77.3 8720/3 C77.3 YES 90 NO NO Non-glabrous skin NO NO true No M0 N0 TX I/II NOS TCGA-D3-A3C1.C22DE920-6E63-40EE-B58B-D33C37817C49.pdf A3C1 WITH TUMOR YES 1 YES NO YES Metastatic 06 NO 7th NO YES D3 Regional Lymph Node A LIVING 83 1998 dfdbba8f-c811-4881-81e5-3ca233071a03 TCGA-D3-A3C1-06A-12D-A19B-05 dfdbba8f-c811-4881-81e5-3ca233071a03 TCGA-D3-A3C1-06 TCGA-D3-A3C1-06A-12D-A194-01 TCGA-D3-A3C1-06 2A30DBEB-30AD-4709-A456-E79B0D9E538A TCGA-D3-A3C1-06A-12D-A196-08 TCGA-D3-A3C1-06A-12D-A196-08 TCGA-D3-A3C1-06A-12D-A194-01 TCGA-D3-A3C1-06A-12D-A196-08 dfdbba8f-c811-4881-81e5-3ca233071a03 dfdbba8f-c811-4881-81e5-3ca233071a03 +TCGA-D3-A3C3-06 TCGA-D3-A3C3-06 TCGA-D3-A3C3 TCGA Melanoma (SKCM) skin cutaneous melanoma Skin TCGA-D3-A3C3-F49198 TCGA-D3-A3C3 TCGA-D3-A3C3-06A 2013-9-26 FEMALE 170 No C77.4 8720/3 C77.4 YES 160 NO NO Non-glabrous skin NO NO true No M0 N0 TX I/II NOS TCGA-D3-A3C3.17FA69D3-C9F6-4B26-BD22-CEB331C8A153.pdf A3C3 WITH TUMOR NO 1 YES NO NO Metastatic 06 NO 7th NO YES D3 Regional Lymph Node A LIVING 80 1985 bb7b6ff1-29df-4d89-b11e-1b83f5dc1c41 TCGA-D3-A3C3-06A-12D-A19D-05 bb7b6ff1-29df-4d89-b11e-1b83f5dc1c41 TCGA-D3-A3C3-06 TCGA-D3-A3C3-06A-12D-A192-01 TCGA-D3-A3C3-06 FA69B4B3-62E7-4D40-B511-275DD4CE464D TCGA-D3-A3C3-06A-12D-A19A-08 TCGA-D3-A3C3-06A-12D-A19A-08 TCGA-D3-A3C3-06A-12D-A192-01 TCGA-D3-A3C3-06A-12D-A19A-08 bb7b6ff1-29df-4d89-b11e-1b83f5dc1c41 bb7b6ff1-29df-4d89-b11e-1b83f5dc1c41 +TCGA-D3-A3C6-06 TCGA-D3-A3C6-06 TCGA-D3-A3C6 TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 54 TCGA-D3-A3C6 TCGA-D3-A3C6-06A 1.3 -19858 1779 1766 0 1302 2012-10-10 FEMALE 165 No C77.4 8720/3 C77.4 YES 80 NO 7 IV Non-glabrous skin NO NO YES true No M0 N0 T2a Stage IB TCGA-D3-A3C6.FAA72A58-CAB5-45ED-8727-9D9811AE0FA2.pdf A3C6 WITH TUMOR NO 1 YES NO NO Metastatic 06 7th NO YES D3 Regional Lymph Node A DECEASED 85 2006 7085dbbb-eb5b-4aa9-af1f-280c9dbc98e5 TCGA-D3-A3C6-06A-12D-A19B-05 7085dbbb-eb5b-4aa9-af1f-280c9dbc98e5 TCGA-D3-A3C6-06 TCGA-D3-A3C6-06A-12D-A194-01 TCGA-D3-A3C6-06 TCGA-D3-A3C6-06A-12D-A196-08 TCGA-D3-A3C6-06A-12D-A196-08 TCGA-D3-A3C6-06A-12D-A194-01 TCGA-D3-A3C6-06A-12D-A196-08 7085dbbb-eb5b-4aa9-af1f-280c9dbc98e5 7085dbbb-eb5b-4aa9-af1f-280c9dbc98e5 +TCGA-D3-A3C7-06 TCGA-D3-A3C7-06 TCGA-D3-A3C7 TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 57 TCGA-D3-A3C7-F49193 TCGA-D3-A3C7 TCGA-D3-A3C7-06A -20979 720 0 1429 0 2013-9-26 FEMALE 162 No C77.4 8720/3 C77.4 YES 90 NO NO Non-glabrous skin NO true No M0 N1b T0 Stage III TCGA-D3-A3C7.9FABC766-7052-4352-8DC7-5160C9D768AB.pdf A3C7 TUMOR FREE YES NO NO Metastatic 06 NO 7th NO YES D3 Regional Lymph Node A LIVING 72 2009 75838292-c5fe-45f1-8fa5-94403cfc3bdf TCGA-D3-A3C7-06A-11D-A19B-05 75838292-c5fe-45f1-8fa5-94403cfc3bdf TCGA-D3-A3C7-06 TCGA-D3-A3C7-06A-11D-A194-01 TCGA-D3-A3C7-06 TCGA-D3-A3C7-06A-11D-A196-08 TCGA-D3-A3C7-06A-11D-A196-08 TCGA-D3-A3C7-06A-11D-A194-01 TCGA-D3-A3C7-06A-11D-A196-08 75838292-c5fe-45f1-8fa5-94403cfc3bdf 75838292-c5fe-45f1-8fa5-94403cfc3bdf +TCGA-D3-A3C8-06 TCGA-D3-A3C8-06 TCGA-D3-A3C8 TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 58 TCGA-D3-A3C8-F46540 TCGA-D3-A3C8 -21281 0 1409 0 2013-8-8 FEMALE 164 No C49.0 8720/3 C49.0 YES NO Non-glabrous skin NO NO Yes M0 N3 TX Stage IIIC A3C8 WITH TUMOR NO 1 YES NO YES Metastatic 06 NO 7th NO YES D3 Regional Cutaneous or Subcutaneous Tissue (includes satellite and in-transit metastasis) LIVING 132 2009 a43aa841-8bb9-467b-8e51-76c30d5856df TCGA-D3-A3C8-06A-12D-A19D-05 a43aa841-8bb9-467b-8e51-76c30d5856df TCGA-D3-A3C8-06 TCGA-D3-A3C8-06A-12D-A192-01 TCGA-D3-A3C8-06 TCGA-D3-A3C8-06A-12D-A19A-08 TCGA-D3-A3C8-06A-12D-A19A-08 TCGA-D3-A3C8-06A-12D-A192-01 TCGA-D3-A3C8-06A-12D-A19A-08 a43aa841-8bb9-467b-8e51-76c30d5856df a43aa841-8bb9-467b-8e51-76c30d5856df +TCGA-D3-A3CB-06 TCGA-D3-A3CB-06 TCGA-D3-A3CB TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 39 TCGA-D3-A3CB-F40735 TCGA-D3-A3CB TCGA-D3-A3CB-06A 1.75 -14563 4615 0 5065 2562 2013-3-7 MALE 173 No C77.3 8720/3 C77.3 YES 320 NO NO III Non-glabrous skin NO true No M0 N0 T2 I/II NOS TCGA-D3-A3CB.5C8072EF-06A4-4E06-83EA-295E7D169107.pdf A3CB TUMOR FREE NO 1 YES NO NO Metastatic 06 NO 7th NO YES D3 Regional Lymph Node A LIVING 86 1999 3628e70e-e657-4c7c-a2ba-e3781a3b2c96 TCGA-D3-A3CB-06A-11D-A19B-05 3628e70e-e657-4c7c-a2ba-e3781a3b2c96 TCGA-D3-A3CB-06 TCGA-D3-A3CB-06A-11D-A194-01 TCGA-D3-A3CB-06 5342834A-7202-43E4-8E26-B91574803B0C TCGA-D3-A3CB-06A-11D-A196-08 TCGA-D3-A3CB-06A-11D-A196-08 TCGA-D3-A3CB-06A-11D-A194-01 TCGA-D3-A3CB-06A-11D-A196-08 3628e70e-e657-4c7c-a2ba-e3781a3b2c96 3628e70e-e657-4c7c-a2ba-e3781a3b2c96 +TCGA-D3-A3CC-06 TCGA-D3-A3CC-06 TCGA-D3-A3CC TCGA Melanoma (SKCM) skin cutaneous melanoma Skin YES NO 69 TCGA-D3-A3CC-F40739 TCGA-D3-A3CC 7.2 -25396 0 2644 2637 2561 777 2013-3-7 FEMALE 164 Yes C49.9 8720/3 C49.9 YES YES NO 7 V Non-glabrous skin YES Locoregional Recurrence YES YES YES No M0 N0 T4b Stage IIC A3CC WITH TUMOR NO 1 YES NO Interferon NO Metastatic 06 NO 7th NO YES D3 Regional Cutaneous or Subcutaneous Tissue (includes satellite and in-transit metastasis) LIVING 87 2005 d21a874e-36ef-4f5c-800a-6c682a3d4831 TCGA-D3-A3CC-06A-11D-A19D-05 d21a874e-36ef-4f5c-800a-6c682a3d4831 TCGA-D3-A3CC-06 TCGA-D3-A3CC-06A-11D-A192-01 TCGA-D3-A3CC-06 TCGA-D3-A3CC-06A-11D-A19A-08 TCGA-D3-A3CC-06A-11D-A19A-08 TCGA-D3-A3CC-06A-11D-A192-01 TCGA-D3-A3CC-06A-11D-A19A-08 d21a874e-36ef-4f5c-800a-6c682a3d4831 d21a874e-36ef-4f5c-800a-6c682a3d4831 +TCGA-D3-A3CE-06 TCGA-D3-A3CE-06 TCGA-D3-A3CE TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 74 TCGA-D3-A3CE TCGA-D3-A3CE-06A -27355 3814 1832 0 1427 2012-10-10 FEMALE 165 No C77.9 8720/3 C77.9 YES 290 NO Non-glabrous skin YES YES true No M0 N1b T0 Stage III TCGA-D3-A3CE.913F7FE1-97D5-4729-B40F-9EC419903493.pdf A3CE WITH TUMOR NO NO YES Metastatic 06 7th NO YES D3 Regional Lymph Node A DECEASED 75 2001 6a0f60ed-8539-4963-84a9-4796ca46f505 TCGA-D3-A3CE-06A-11D-A19D-05 6a0f60ed-8539-4963-84a9-4796ca46f505 TCGA-D3-A3CE-06 TCGA-D3-A3CE-06A-11D-A192-01 TCGA-D3-A3CE-06 04E7CFA1-4A8C-4807-AF7E-BAFA0E760F51 TCGA-D3-A3CE-06A-11D-A19A-08 TCGA-D3-A3CE-06A-11D-A19A-08 TCGA-D3-A3CE-06A-11D-A192-01 TCGA-D3-A3CE-06A-11D-A19A-08 6a0f60ed-8539-4963-84a9-4796ca46f505 6a0f60ed-8539-4963-84a9-4796ca46f505 +TCGA-D3-A3CF-06 TCGA-D3-A3CF-06 TCGA-D3-A3CF TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 61 TCGA-D3-A3CF 9.0 -22409 746 0 16 2012-10-10 FEMALE 162 No C77.4 8720/3 C77.4 YES 2 V Non-glabrous skin YES NO YES No M0 N3 T4b Stage IIIC A3CF WITH TUMOR NO 1 YES NO NO Metastatic 06 7th NO YES D3 Regional Lymph Node DECEASED 129 2009 cde6162b-199e-42f0-a0fb-547bed209e8b TCGA-D3-A3CF-06A-11D-A19B-05 cde6162b-199e-42f0-a0fb-547bed209e8b TCGA-D3-A3CF-06 TCGA-D3-A3CF-06A-11D-A194-01 TCGA-D3-A3CF-06 TCGA-D3-A3CF-06A-11D-A196-08 TCGA-D3-A3CF-06A-11D-A196-08 TCGA-D3-A3CF-06A-11D-A194-01 TCGA-D3-A3CF-06A-11D-A196-08 cde6162b-199e-42f0-a0fb-547bed209e8b cde6162b-199e-42f0-a0fb-547bed209e8b +TCGA-D3-A3ML-06 TCGA-D3-A3ML-06 TCGA-D3-A3ML TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 70 TCGA-D3-A3ML TCGA-D3-A3ML-06A 2.3 -25643 3205 422 0 230 2012-11-8 MALE 178 Yes C77.0 8720/3 C77.0 YES 120 NO 3 IV Non-glabrous skin NO YES YES true Yes M0 N2a T3a Stage IIIA TCGA-D3-A3ML.80F131FA-7E24-4210-800F-3E6F442CAB6F.pdf A3ML WITH TUMOR NO 1 YES NO Chemotherapy NO Metastatic 06 7th NO YES D3 Regional Lymph Node A DECEASED 76 2003 558ff190-9821-4d09-a9cd-dcc5f3e11b49 TCGA-D3-A3ML-06A-11D-A21B-05 558ff190-9821-4d09-a9cd-dcc5f3e11b49 TCGA-D3-A3ML-06 TCGA-D3-A3ML-06A-11D-A219-01 TCGA-D3-A3ML-06 02FD92ED-73A1-465A-8121-24DA4CE0DAAE TCGA-D3-A3ML-06A-11D-A21A-08 TCGA-D3-A3ML-06A-11D-A21A-08 TCGA-D3-A3ML-06A-11D-A219-01 TCGA-D3-A3ML-06A-11D-A21A-08 558ff190-9821-4d09-a9cd-dcc5f3e11b49 558ff190-9821-4d09-a9cd-dcc5f3e11b49 +TCGA-D3-A3MO-06 TCGA-D3-A3MO-06 TCGA-D3-A3MO TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 47 TCGA-D3-A3MO TCGA-D3-A3MO-06A -17220 1071 284 0 0 2012-10-10 MALE 178 No C49.4 8720/3 C49.4 YES 270 NO Non-glabrous skin NO YES true No M0 N2c TX Stage III TCGA-D3-A3MO.BA63F881-DCF0-4B39-ACD5-DD5E1CBEE609.pdf A3MO WITH TUMOR NO YES NO NO Metastatic 06 7th NO YES D3 Regional Cutaneous or Subcutaneous Tissue (includes satellite and in-transit metastasis) A DECEASED 70 2009 7eb0de2d-f2b7-4bbd-bfdf-38f9205dfcd9 TCGA-D3-A3MO-06A-11D-A21B-05 7eb0de2d-f2b7-4bbd-bfdf-38f9205dfcd9 TCGA-D3-A3MO-06 TCGA-D3-A3MO-06A-11D-A219-01 TCGA-D3-A3MO-06 A9ED29CB-1AB6-4C4B-AD43-2DCFF0315041 TCGA-D3-A3MO-06A-11D-A21A-08 TCGA-D3-A3MO-06A-11D-A21A-08 TCGA-D3-A3MO-06A-11D-A219-01 TCGA-D3-A3MO-06A-11D-A21A-08 7eb0de2d-f2b7-4bbd-bfdf-38f9205dfcd9 7eb0de2d-f2b7-4bbd-bfdf-38f9205dfcd9 +TCGA-D3-A3MR-06 TCGA-D3-A3MR-06 TCGA-D3-A3MR TCGA Melanoma (SKCM) skin cutaneous melanoma Skin NO NO 42 TCGA-D3-A3MR-F40737 TCGA-D3-A3MR TCGA-D3-A3MR-06A -15695 2827 0 3151 3108 3108 0 2013-3-7 MALE 180 No C49.9 8720/3 C49.9 YES 90 NO NO Non-glabrous skin Extremities Squamous Cell Carcinoma YES YES true No M0 N1b T0 Stage III TCGA-D3-A3MR.E77E1BEF-E39E-415E-B8F8-BB73BE263C6C.pdf A3MR TUMOR FREE NO NO NO Metastatic 06 NO 7th NO YES D3 Regional Cutaneous or Subcutaneous Tissue (includes satellite and in-transit metastasis) A LIVING 86 2004 74eca830-636b-4549-8887-f2d73312ef21 TCGA-D3-A3MR-06A-11D-A21B-05 74eca830-636b-4549-8887-f2d73312ef21 TCGA-D3-A3MR-06 TCGA-D3-A3MR-06A-11D-A219-01 TCGA-D3-A3MR-06 B45291A8-66FD-40F7-8BB5-AD0945B24D28 TCGA-D3-A3MR-06A-11D-A21A-08 TCGA-D3-A3MR-06A-11D-A21A-08 TCGA-D3-A3MR-06A-11D-A219-01 TCGA-D3-A3MR-06A-11D-A21A-08 74eca830-636b-4549-8887-f2d73312ef21 74eca830-636b-4549-8887-f2d73312ef21 +TCGA-D3-A3MU-06 TCGA-D3-A3MU-06 TCGA-D3-A3MU TCGA Melanoma (SKCM) skin cutaneous melanoma Skin NO|NO|NO NO|NO|NO 53 TCGA-D3-A3MU-F49196 TCGA-D3-A3MU 2.9 -19423 0 1209 854|1021| 845|951|1063 407 2013-9-26 MALE 181 Yes C77.3 8720/3 C77.3 YES NO NO 10 IV Non-glabrous skin NO Regional lymph node|Distant Metastasis|Regional lymph node NO YES|YES|NO YES |Lung| No M0 N2a T3a Stage IIIA A3MU WITH TUMOR NO 1 YES NO Interferon NO Metastatic 06 NO 7th NO YES D3 Regional Lymph Node LIVING 110 2010 a6e57220-d8bc-46d6-afa7-51a5756351ab TCGA-D3-A3MU-06A-11D-A21B-05 a6e57220-d8bc-46d6-afa7-51a5756351ab TCGA-D3-A3MU-06 TCGA-D3-A3MU-06A-11D-A219-01 TCGA-D3-A3MU-06 TCGA-D3-A3MU-06A-11D-A21A-08 TCGA-D3-A3MU-06A-11D-A21A-08 TCGA-D3-A3MU-06A-11D-A219-01 TCGA-D3-A3MU-06A-11D-A21A-08 a6e57220-d8bc-46d6-afa7-51a5756351ab a6e57220-d8bc-46d6-afa7-51a5756351ab +TCGA-D3-A3MV-06 TCGA-D3-A3MV-06 TCGA-D3-A3MV TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 38 TCGA-D3-A3MV-F56212 TCGA-D3-A3MV TCGA-D3-A3MV-06A 1.2 -14236 616 0 1378 489 2014-1-30 FEMALE 156 No C49.2 8720/3 C49.2 YES 120 NO NO 5 IV Non-glabrous skin YES YES NO true No M0 N2a T2b Stage IIIB TCGA-D3-A3MV.89056039-2FD8-4F96-9977-753DC4C4FE3F.pdf A3MV TUMOR FREE YES 1 YES NO NO Metastatic 06 NO 7th NO YES D3 Regional Cutaneous or Subcutaneous Tissue (includes satellite and in-transit metastasis) A LIVING 135 2010 dbb086b3-17fe-4bc6-9fa7-b3b26a2263ee TCGA-D3-A3MV-06A-11D-A21B-05 dbb086b3-17fe-4bc6-9fa7-b3b26a2263ee TCGA-D3-A3MV-06 TCGA-D3-A3MV-06A-11D-A219-01 TCGA-D3-A3MV-06 05023E58-AB2D-4BCB-99FA-7FE17DC8E768 TCGA-D3-A3MV-06A-11D-A21A-08 TCGA-D3-A3MV-06A-11D-A21A-08 TCGA-D3-A3MV-06A-11D-A219-01 TCGA-D3-A3MV-06A-11D-A21A-08 dbb086b3-17fe-4bc6-9fa7-b3b26a2263ee dbb086b3-17fe-4bc6-9fa7-b3b26a2263ee +TCGA-D3-A51E-06 TCGA-D3-A51E-06 TCGA-D3-A51E TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 39 TCGA-D3-A51E-F56213 TCGA-D3-A51E TCGA-D3-A51E-06A 1.2 -14305 4887 0 5318 2483 2014-1-30 FEMALE 163 No C49.2 8720/3 C49.2 YES 160 NO NO III Non-glabrous skin NO true No M0 N0 T2 I/II NOS TCGA-D3-A51E.C05E459C-5273-47B4-B828-8CAEAF1CB2C4.pdf A51E TUMOR FREE YES 1 YES NO NO Metastatic 06 NO 7th NO YES D3 Regional Cutaneous or Subcutaneous Tissue (includes satellite and in-transit metastasis) A LIVING 61 1999 0770ad2b-1ae6-40bc-9b15-6b5509b8cd84 TCGA-D3-A51E-06A-11D-A25S-05 0770ad2b-1ae6-40bc-9b15-6b5509b8cd84 TCGA-D3-A51E-06 TCGA-D3-A51E-06A-11D-A25P-01 TCGA-D3-A51E-06 8A525868-910C-408E-A712-83916DF24433 TCGA-D3-A51E-06A-11D-A25O-08 TCGA-D3-A51E-06A-11D-A25O-08 TCGA-D3-A51E-06A-11D-A25P-01 0770ad2b-1ae6-40bc-9b15-6b5509b8cd84 0770ad2b-1ae6-40bc-9b15-6b5509b8cd84 +TCGA-D3-A51F-06 TCGA-D3-A51F-06 TCGA-D3-A51F TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 51 TCGA-D3-A51F-F58065 TCGA-D3-A51F TCGA-D3-A51F-06A 7 -18776 1233 0 1695 30 2014-3-31 MALE 187 No C77.4 8721/3 C77.4 YES 350 NO NO 11 IV Non-glabrous skin YES NO true No M0 N1b T4b Stage IIIC TCGA-D3-A51F.55E412FF-1606-413F-A456-E75D3D6ED226.pdf A51F TUMOR FREE NO 1 YES NO NO Metastatic 06 NO 7th NO YES D3 Regional Lymph Node A LIVING 90 2009 8b886e63-05aa-461c-ae8a-2f82271f3bf6 TCGA-D3-A51F-06A-11D-A25S-05 8b886e63-05aa-461c-ae8a-2f82271f3bf6 TCGA-D3-A51F-06 TCGA-D3-A51F-06A-11D-A25P-01 TCGA-D3-A51F-06 D1D0935B-341F-43DD-BAC1-358281D47E3E TCGA-D3-A51F-06A-11D-A25O-08 TCGA-D3-A51F-06A-11D-A25O-08 TCGA-D3-A51F-06A-11D-A25P-01 8b886e63-05aa-461c-ae8a-2f82271f3bf6 8b886e63-05aa-461c-ae8a-2f82271f3bf6 +TCGA-D3-A51G-06 TCGA-D3-A51G-06 TCGA-D3-A51G TCGA Melanoma (SKCM) skin cutaneous melanoma Skin TCGA-D3-A51G-F60911 TCGA-D3-A51G TCGA-D3-A51G-06A 0 2014-6-18 MALE 190 No C49.2 8720/3 C49.2 YES 70 NO NO I Non-glabrous skin YES NO true Yes M0 N0 Tis Stage 0 TCGA-D3-A51G.27A8D7FA-6317-4B5E-9CE6-D65790474BDF.pdf A51G TUMOR FREE YES 1 YES NO NO Metastatic 06 NO 7th NO YES D3 Regional Cutaneous or Subcutaneous Tissue (includes satellite and in-transit metastasis) A LIVING 112 1990 05e46b8a-14f5-4315-9418-25bc9de5c436 TCGA-D3-A51G-06A-11D-A25S-05 05e46b8a-14f5-4315-9418-25bc9de5c436 TCGA-D3-A51G-06 TCGA-D3-A51G-06A-11D-A25P-01 TCGA-D3-A51G-06 TCGA-D3-A51G-06A-11D-A25O-08 TCGA-D3-A51G-06A-11D-A25O-08 TCGA-D3-A51G-06A-11D-A25P-01 05e46b8a-14f5-4315-9418-25bc9de5c436 05e46b8a-14f5-4315-9418-25bc9de5c436 +TCGA-D3-A51H-06 TCGA-D3-A51H-06 TCGA-D3-A51H TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 60 TCGA-D3-A51H-F60913 TCGA-D3-A51H TCGA-D3-A51H-06A .91 -22119 1161 0 1714 762 2014-6-18 MALE 183 No C77.3 8720/3 C77.3 YES 130 NO NO 0 IV Non-glabrous skin YES NO NO true No M0 N3 T1b Stage IIIC TCGA-D3-A51H.7A6F8B74-E5BC-4447-90CF-AE24F44FBFED.pdf A51H TUMOR FREE YES 1 YES NO NO Metastatic 06 NO 7th NO YES D3 Regional Lymph Node A LIVING 78 2009 2e36ce5c-b206-49d8-a5b9-3280c8054550 TCGA-D3-A51H-06A-12D-A25S-05 2e36ce5c-b206-49d8-a5b9-3280c8054550 TCGA-D3-A51H-06 TCGA-D3-A51H-06A-12D-A25P-01 TCGA-D3-A51H-06 46F2AA0A-22C7-4CC1-9876-CA2042481D84 TCGA-D3-A51H-06A-12D-A25O-08 TCGA-D3-A51H-06A-12D-A25O-08 TCGA-D3-A51H-06A-12D-A25P-01 2e36ce5c-b206-49d8-a5b9-3280c8054550 2e36ce5c-b206-49d8-a5b9-3280c8054550 +TCGA-D3-A51J-06 TCGA-D3-A51J-06 TCGA-D3-A51J TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 19 TCGA-D3-A51J-F56214 TCGA-D3-A51J TCGA-D3-A51J-06A -7194 3969 0 4414 2762 2014-1-30 MALE 185 Yes C49.5 8720/3 C49.5 YES 60 YES NO NO Non-glabrous skin YES NO true No M0 N1b T0 Stage III TCGA-D3-A51J.B244C527-3631-4829-B8E3-969D263CD08F.pdf A51J TUMOR FREE NO NO Interferon NO Metastatic 06 NO 7th NO YES D3 Regional Cutaneous or Subcutaneous Tissue (includes satellite and in-transit metastasis) A LIVING 126 2001 248f1608-e917-430a-9ac0-130c5bed3a29 TCGA-D3-A51J-06A-11D-A25S-05 248f1608-e917-430a-9ac0-130c5bed3a29 TCGA-D3-A51J-06 TCGA-D3-A51J-06A-11D-A25P-01 TCGA-D3-A51J-06 TCGA-D3-A51J-06A-11D-A25O-08 TCGA-D3-A51J-06A-11D-A25O-08 TCGA-D3-A51J-06A-11D-A25P-01 248f1608-e917-430a-9ac0-130c5bed3a29 248f1608-e917-430a-9ac0-130c5bed3a29 +TCGA-D3-A51K-06 TCGA-D3-A51K-06 TCGA-D3-A51K TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 51 TCGA-D3-A51K-F56215 TCGA-D3-A51K TCGA-D3-A51K-06A 0 -18971 561 0 1002 20 2014-1-30 MALE 173 No C77.4 8720/3 C77.4 YES 180 NO NO I Non-glabrous skin NO true No M0 N2b Tis Stage IIIB TCGA-D3-A51K.3E9F0953-298F-4A01-88F7-D469A078244F.pdf A51K TUMOR FREE NO 1 YES NO NO Metastatic 06 NO 7th NO YES D3 Regional Lymph Node A LIVING 90 2011 1cbf47c5-0030-42fd-801c-2188a84008b4 TCGA-D3-A51K-06A-11D-A25S-05 1cbf47c5-0030-42fd-801c-2188a84008b4 TCGA-D3-A51K-06 TCGA-D3-A51K-06A-11D-A25P-01 TCGA-D3-A51K-06 B12EF9B6-62F8-4169-94F2-392AB58516C3 TCGA-D3-A51K-06A-11D-A25O-08 TCGA-D3-A51K-06A-11D-A25O-08 TCGA-D3-A51K-06A-11D-A25P-01 1cbf47c5-0030-42fd-801c-2188a84008b4 1cbf47c5-0030-42fd-801c-2188a84008b4 +TCGA-D3-A51N-06 TCGA-D3-A51N-06 TCGA-D3-A51N TCGA Melanoma (SKCM) skin cutaneous melanoma Skin YES|YES NO|NO 56 TCGA-D3-A51N-F56220 TCGA-D3-A51N TCGA-D3-A51N-06A -20559 248 0 688 570|570 36 2014-1-30 FEMALE 163 No C77.4 8720/3 C77.4 YES 140 NO NO Non-glabrous skin Distant Metastasis|Distant Metastasis NO|NO YES Other, Specify|Other, Specify Left Adrenal Gland|Soft Tissue of right thigh/hip true No M1c N3 T0 Stage IV TCGA-D3-A51N.A0357EE6-DEF6-47B5-A106-CEBB387D55C2.pdf A51N WITH TUMOR NO NO NO Metastatic 06 NO 7th NO YES D3 Regional Lymph Node A LIVING 84 2012 9b1452ff-77d5-4ab0-8cb4-bc568396b0f1 TCGA-D3-A51N-06A-11D-A25S-05 9b1452ff-77d5-4ab0-8cb4-bc568396b0f1 TCGA-D3-A51N-06 TCGA-D3-A51N-06A-11D-A25P-01 TCGA-D3-A51N-06 5FABAD3E-7EAD-4725-B96F-152162B04CC7 TCGA-D3-A51N-06A-11D-A25O-08 TCGA-D3-A51N-06A-11D-A25O-08 TCGA-D3-A51N-06A-11D-A25P-01 9b1452ff-77d5-4ab0-8cb4-bc568396b0f1 9b1452ff-77d5-4ab0-8cb4-bc568396b0f1 +TCGA-D3-A51R-06 TCGA-D3-A51R-06 TCGA-D3-A51R TCGA Melanoma (SKCM) skin cutaneous melanoma Skin YES|YES|YES NO|NO|NO 60 TCGA-D3-A51R-F56227 TCGA-D3-A51R 2.5 -22040 0 1941 1662|1662|1662 949 2014-1-30 MALE 181 No C49.3 8720/3 C49.3 YES NO 2 IV Non-glabrous skin NO Distant Metastasis|Distant Metastasis|Distant Metastasis NO NO|NO|NO YES Other, Specify|Other, Specify|Other, Specify Subcarinal Lymph Nodes|Perigastric Lymph Nodes|Diaphragmatic Lymph Nodes No M0 N0 T3a Stage IIA A51R WITH TUMOR NO 1 YES NO NO Metastatic 06 NO 7th NO YES D3 Regional Lymph Node LIVING 72 2008 a1dbd4f4-b4a6-454c-b68d-06297e48323e TCGA-D3-A51R-06A-11D-A25S-05 a1dbd4f4-b4a6-454c-b68d-06297e48323e TCGA-D3-A51R-06 TCGA-D3-A51R-06A-11D-A25P-01 TCGA-D3-A51R-06 TCGA-D3-A51R-06A-11D-A25O-08 TCGA-D3-A51R-06A-11D-A25O-08 TCGA-D3-A51R-06A-11D-A25P-01 a1dbd4f4-b4a6-454c-b68d-06297e48323e a1dbd4f4-b4a6-454c-b68d-06297e48323e +TCGA-D3-A51T-06 TCGA-D3-A51T-06 TCGA-D3-A51T TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 59 TCGA-D3-A51T-F56233 TCGA-D3-A51T TCGA-D3-A51T-06A 4.2 -21823 387 0 818 34 2014-1-30 FEMALE 152 No C77.3 8720/3 C77.3 YES 100 NO NO 16 IV Non-glabrous skin YES NO NO true No M0 N1b T4b Stage IIIC TCGA-D3-A51T.886880FB-23ED-44C6-8565-8FB26F51F4AB.pdf A51T TUMOR FREE NO 1 YES NO YES Metastatic 06 NO 7th NO YES D3 Regional Lymph Node A LIVING 92 2011 279e2d3b-f060-4afa-a26e-673a4af821d4 TCGA-D3-A51T-06A-11D-A25S-05 279e2d3b-f060-4afa-a26e-673a4af821d4 TCGA-D3-A51T-06 TCGA-D3-A51T-06A-11D-A25P-01 TCGA-D3-A51T-06 DFB9BF78-53F3-4C94-B340-3907485FC3A7 TCGA-D3-A51T-06A-11D-A25O-08 TCGA-D3-A51T-06A-11D-A25O-08 TCGA-D3-A51T-06A-11D-A25P-01 279e2d3b-f060-4afa-a26e-673a4af821d4 279e2d3b-f060-4afa-a26e-673a4af821d4 +TCGA-D3-A5GL-06 TCGA-D3-A5GL-06 TCGA-D3-A5GL TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 74 TCGA-D3-A5GL-F55307 TCGA-D3-A5GL TCGA-D3-A5GL-06A 1.6 -27095 3549 0 3826 473 2014-1-3 MALE 185 No C77.3 8720/3 C77.3 YES 10 NO NO 1 IV Non-glabrous skin NO NO NO true No M0 N0 T2a Stage IB TCGA-D3-A5GL.AEA99FF4-044A-45F7-B2F2-9F17F675FA79.pdf A5GL TUMOR FREE NO 1 YES NO YES Metastatic 06 NO 7th NO YES D3 Regional Lymph Node A LIVING 113 2003 12751dec-ada5-46b2-a86e-090c82a830cb TCGA-D3-A5GL-06A-11D-A27L-05 12751dec-ada5-46b2-a86e-090c82a830cb TCGA-D3-A5GL-06 TCGA-D3-A5GL-06A-11D-A27J-01 TCGA-D3-A5GL-06 TCGA-D3-A5GL-06A-11D-A27K-08 TCGA-D3-A5GL-06A-11D-A27J-01 12751dec-ada5-46b2-a86e-090c82a830cb 12751dec-ada5-46b2-a86e-090c82a830cb +TCGA-D3-A5GN-06 TCGA-D3-A5GN-06 TCGA-D3-A5GN TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 15 TCGA-D3-A5GN-F60914 TCGA-D3-A5GN TCGA-D3-A5GN-06A .6 -5684 4206 0 4129 2547 2014-6-18 FEMALE 167 Yes C77.0 8720/3 C77.0 YES 140 YES NO YES III Non-glabrous skin YES YES true No M0 N0 T1 Stage I TCGA-D3-A5GN.67484CF7-02EB-460F-B604-17FB1CFA0BAD.pdf A5GN TUMOR FREE NO 1 YES NO Interferon YES Metastatic 06 7th NO YES D3 Regional Lymph Node A LIVING 68 2001 73a8105e-c356-4a7e-888c-feb5339074fb TCGA-D3-A5GN-06A-11D-A27L-05 73a8105e-c356-4a7e-888c-feb5339074fb TCGA-D3-A5GN-06 TCGA-D3-A5GN-06A-11D-A27J-01 TCGA-D3-A5GN-06 FADDEB55-F40B-47EB-91AD-C3861EDAEB41 TCGA-D3-A5GN-06A-11D-A27K-08 TCGA-D3-A5GN-06A-11D-A27K-08 TCGA-D3-A5GN-06A-11D-A27J-01 73a8105e-c356-4a7e-888c-feb5339074fb 73a8105e-c356-4a7e-888c-feb5339074fb +TCGA-D3-A5GO-06 TCGA-D3-A5GO-06 TCGA-D3-A5GO TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 61 TCGA-D3-A5GO-F60915 TCGA-D3-A5GO TCGA-D3-A5GO-06A 4.3 -22287 4259 0 4195 2739 Soft tissue of right upper arm 2014-6-18 MALE 169 No C44.6 8720/3 C44.6 YES 50 NO YES V Non-glabrous skin YES YES true No M0 N0 T4 Stage II TCGA-D3-A5GO.FFFA2FD5-C008-4583-99C9-EE71B0F21F07.pdf A5GO TUMOR FREE NO 1 YES NO NO Metastatic 06 7th NO YES D3 Distant Metastasis A LIVING 83 2001 1d1a1d5e-fdfe-4251-93ec-c89b65bb341e TCGA-D3-A5GO-06A-12D-A27L-05 1d1a1d5e-fdfe-4251-93ec-c89b65bb341e TCGA-D3-A5GO-06A-12D-A27J-01 TCGA-D3-A5GO-06A-12D-A27K-08 TCGA-D3-A5GO-06A-12D-A27K-08 TCGA-D3-A5GO-06A-12D-A27J-01 1d1a1d5e-fdfe-4251-93ec-c89b65bb341e 1d1a1d5e-fdfe-4251-93ec-c89b65bb341e +TCGA-D3-A5GR-06 TCGA-D3-A5GR-06 TCGA-D3-A5GR TCGA Melanoma (SKCM) skin cutaneous melanoma Skin NO NO 23 TCGA-D3-A5GR-F55314 TCGA-D3-A5GR TCGA-D3-A5GR-06A .98 -8637 5119 0 5424 5355 5354 5008 2014-1-3 FEMALE 162 Yes C77.4 8720/3 C77.4 YES 40 YES NO NO 1 III Non-glabrous skin Distant Metastasis YES YES YES Brain true No M0 N1 T1b Stage III TCGA-D3-A5GR.2055FAF3-FB7C-4E13-8A17-FF4B9964F49F.pdf A5GR WITH TUMOR NO 1 YES NO Interferon NO Metastatic 06 NO 7th NO YES D3 Regional Lymph Node A LIVING 114 1998 4f8a1027-ed36-4171-8d23-c6a4b089fe5e TCGA-D3-A5GR-06A-11D-A27L-05 4f8a1027-ed36-4171-8d23-c6a4b089fe5e TCGA-D3-A5GR-06A-11D-A27J-01 TCGA-D3-A5GR-06A-11D-A27K-08 TCGA-D3-A5GR-06A-11D-A27K-08 TCGA-D3-A5GR-06A-11D-A27J-01 4f8a1027-ed36-4171-8d23-c6a4b089fe5e 4f8a1027-ed36-4171-8d23-c6a4b089fe5e +TCGA-D3-A5GS-06 TCGA-D3-A5GS-06 TCGA-D3-A5GS TCGA Melanoma (SKCM) skin cutaneous melanoma Skin NO NO 58 TCGA-D3-A5GS-F58068 TCGA-D3-A5GS .62 -21379 0 553 161 14 2014-3-31 MALE 172 No C77.4 8720/3 C77.4 YES NO 1 II Non-glabrous skin NO Distant Metastasis NO NO YES Brain No M1c N1b T1b Stage IV A5GS WITH TUMOR NO 1 YES NO NO Metastatic 06 NO 7th NO YES D3 Regional Lymph Node LIVING 99 2012 fe14ca77-d5f6-4951-be78-6e65efdfc8aa TCGA-D3-A5GS-06A-11D-A27L-05 fe14ca77-d5f6-4951-be78-6e65efdfc8aa TCGA-D3-A5GS-06 TCGA-D3-A5GS-06A-11D-A27J-01 TCGA-D3-A5GS-06 TCGA-D3-A5GS-06A-11D-A27K-08 TCGA-D3-A5GS-06A-11D-A27K-08 TCGA-D3-A5GS-06A-11D-A27J-01 fe14ca77-d5f6-4951-be78-6e65efdfc8aa fe14ca77-d5f6-4951-be78-6e65efdfc8aa +TCGA-D3-A5GT-01 TCGA-D3-A5GT-01 TCGA-D3-A5GT TCGA Melanoma (SKCM) skin cutaneous melanoma Skin YES|YES|YES NO|NO|NO 43 TCGA-D3-A5GT-F56241 TCGA-D3-A5GT 1.92 -15935 0 487 291|291|291 25 2014-1-30 MALE 155 No C44.5 8720/3 C44.5 YES NO 4 IV Non-glabrous skin YES Distant Metastasis|Distant Metastasis|Regional lymph node NO|NO|NO YES Lung|Liver| No M0 N3 T2b Stage IIIC A5GT WITH TUMOR YES 1 YES NO NO Primary Tumor 01 NO 7th NO YES D3 Primary Tumor LIVING 79 2012 c170e900-9e39-4164-838a-199dcaac1463 TCGA-D3-A5GT-01A-12D-A30Z-05 c170e900-9e39-4164-838a-199dcaac1463 TCGA-D3-A5GT-01 TCGA-D3-A5GT-01 TCGA-D3-A5GT-01A-12D-A30X-08 TCGA-D3-A5GT-01A-12D-A30X-08 c170e900-9e39-4164-838a-199dcaac1463 c170e900-9e39-4164-838a-199dcaac1463 +TCGA-D3-A5GU-06 TCGA-D3-A5GU-06 TCGA-D3-A5GU TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 36 TCGA-D3-A5GU-F58069 TCGA-D3-A5GU TCGA-D3-A5GU-06A 0.48 -13296 3720 0 3808 3105 2014-6-18 MALE 177 No C77.3 8720/3 C77.3 YES 10 NO YES 2 III Non-glabrous skin NO YES YES true No M0 N0 T1b Stage IB TCGA-D3-A5GU.61348895-5985-4B59-9B2A-E81B6481372D.pdf A5GU WITH TUMOR NO 1 YES NO NO Metastatic 06 7th NO YES D3 Regional Lymph Node A LIVING 75 2002 0a0e5ca8-09fd-495d-b8df-b7a58c426716 TCGA-D3-A5GU-06A-11D-A27L-05 0a0e5ca8-09fd-495d-b8df-b7a58c426716 TCGA-D3-A5GU-06 TCGA-D3-A5GU-06A-11D-A27J-01 TCGA-D3-A5GU-06 TCGA-D3-A5GU-06A-11D-A27K-08 TCGA-D3-A5GU-06A-11D-A27K-08 TCGA-D3-A5GU-06A-11D-A27J-01 0a0e5ca8-09fd-495d-b8df-b7a58c426716 0a0e5ca8-09fd-495d-b8df-b7a58c426716 +TCGA-D3-A8GB-06 TCGA-D3-A8GB-06 TCGA-D3-A8GB TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 48 TCGA-D3-A8GB TCGA-D3-A8GB-06A 3.5 -17871 3681 938 0 34 2013-12-12 MALE 183 No C77.4 8720/3 C77.4 YES 130 NO 4 IV Non-glabrous skin NO NO YES true No M0 N1b T3a Stage IIIB TCGA-D3-A8GB.724AF606-850F-4A3F-B794-89639DDB610A.pdf A8GB WITH TUMOR YES 1 YES NO NO Metastatic 06 7th NO YES D3 Regional Lymph Node A DECEASED 89 2003 7c990bc0-5ce0-452a-afc5-0b42f3bbddbd TCGA-D3-A8GB-06A-11D-A373-05 7c990bc0-5ce0-452a-afc5-0b42f3bbddbd TCGA-D3-A8GB-06 TCGA-D3-A8GB-06A-11D-A371-01 TCGA-D3-A8GB-06 9AEB61CC-FA8B-423C-B342-78888ABBFCB9 TCGA-D3-A8GB-06A-11D-A372-08 TCGA-D3-A8GB-06A-11D-A371-01 7c990bc0-5ce0-452a-afc5-0b42f3bbddbd 7c990bc0-5ce0-452a-afc5-0b42f3bbddbd +TCGA-D3-A8GC-06 TCGA-D3-A8GC-06 TCGA-D3-A8GC TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 48 TCGA-D3-A8GC TCGA-D3-A8GC-06A -17668 4835 2421 0 1750 2013-12-12 MALE 180 Yes C77.3 8720/3 C77.3 YES 120 YES NO Non-glabrous skin NO YES true No M0 N3 TX Stage IIIC TCGA-D3-A8GC.2ED84430-A136-4A59-87EE-A9B7147BD719.pdf A8GC WITH TUMOR NO NO NO Interferon YES Metastatic 06 7th NO YES D3 Regional Lymph Node A DECEASED 114 2000 95d95f15-e6ac-4359-be92-94e2b93da795 TCGA-D3-A8GC-06A-11D-A373-05 95d95f15-e6ac-4359-be92-94e2b93da795 TCGA-D3-A8GC-06 TCGA-D3-A8GC-06A-11D-A371-01 TCGA-D3-A8GC-06 0CBD66D6-9E22-448B-8E41-CCA00B6C62F9 TCGA-D3-A8GC-06A-11D-A372-08 TCGA-D3-A8GC-06A-11D-A371-01 95d95f15-e6ac-4359-be92-94e2b93da795 95d95f15-e6ac-4359-be92-94e2b93da795 +TCGA-D3-A8GD-06 TCGA-D3-A8GD-06 TCGA-D3-A8GD TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 63 TCGA-D3-A8GD-F66643 TCGA-D3-A8GD TCGA-D3-A8GD-06A 20 -23109 359 0 718 42 2014-10-21 FEMALE 168 No C77.4 8720/3 C77.4 YES 140 NO NO 18 IV Non-glabrous skin YES NO NO true No M0 N3 T4b Stage IIIC TCGA-D3-A8GD.394D0E1F-21DE-45BB-9D03-AB9326D95BA2.pdf A8GD TUMOR FREE NO 1 YES NO NO Metastatic 06 NO 7th NO YES D3 Regional Lymph Node A LIVING 79 2012 c8a18d2b-fc77-44e6-8f1f-1064cb5a91a2 TCGA-D3-A8GD-06A-11D-A373-05 c8a18d2b-fc77-44e6-8f1f-1064cb5a91a2 TCGA-D3-A8GD-06 TCGA-D3-A8GD-06A-11D-A371-01 TCGA-D3-A8GD-06 EB3A7E4A-45E0-439F-8931-DD9FF86B8C0F TCGA-D3-A8GD-06A-11D-A372-08 TCGA-D3-A8GD-06A-11D-A371-01 c8a18d2b-fc77-44e6-8f1f-1064cb5a91a2 c8a18d2b-fc77-44e6-8f1f-1064cb5a91a2 +TCGA-D3-A8GE-06 TCGA-D3-A8GE-06 TCGA-D3-A8GE TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 26 TCGA-D3-A8GE-F68026 TCGA-D3-A8GE TCGA-D3-A8GE-06A -9517 425 0 804 0 2014-11-14 MALE 176 No C44.6 8772/3 C44.6 YES 120 NO NO Non-glabrous skin NO NO true No M1b N0 TX Stage IV TCGA-D3-A8GE.4C9A9F9A-CD40-4ED3-9999-030256E1BB57.pdf A8GE WITH TUMOR NO NO NO Metastatic 06 NO 7th NO YES D3 Regional Cutaneous or Subcutaneous Tissue (includes satellite and in-transit metastasis) A LIVING 97 2012 38341bc7-a1b6-4599-adba-03163cf0a5c0 TCGA-D3-A8GE-06A-11D-A373-05 38341bc7-a1b6-4599-adba-03163cf0a5c0 TCGA-D3-A8GE-06 TCGA-D3-A8GE-06A-11D-A371-01 TCGA-D3-A8GE-06 D3A6AF47-C5CB-444A-B047-2946B048003D TCGA-D3-A8GE-06A-11D-A372-08 TCGA-D3-A8GE-06A-11D-A371-01 38341bc7-a1b6-4599-adba-03163cf0a5c0 38341bc7-a1b6-4599-adba-03163cf0a5c0 +TCGA-D3-A8GI-06 TCGA-D3-A8GI-06 TCGA-D3-A8GI TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 68 TCGA-D3-A8GI TCGA-D3-A8GI-06A .98 -25069 1849 1780 0 1653 2013-12-17 MALE 183 No C77.0 8720/3 C77.0 YES 40 NO 4 IV Non-glabrous skin NO YES YES true Yes M0 N0 T1a Stage IA TCGA-D3-A8GI.15C6CB85-4DCD-4233-82A5-2A408AD8E310.pdf A8GI WITH TUMOR NO 1 YES NO NO Metastatic 06 7th NO YES D3 Regional Lymph Node A DECEASED 88 2008 d98bb16b-e009-4fb3-8cf5-33da33bc652e TCGA-D3-A8GI-06A-11D-A373-05 d98bb16b-e009-4fb3-8cf5-33da33bc652e TCGA-D3-A8GI-06A-11D-A371-01 TCGA-D3-A8GI-06A-11D-A372-08 TCGA-D3-A8GI-06A-11D-A371-01 d98bb16b-e009-4fb3-8cf5-33da33bc652e d98bb16b-e009-4fb3-8cf5-33da33bc652e +TCGA-D3-A8GJ-06 TCGA-D3-A8GJ-06 TCGA-D3-A8GJ TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 18 TCGA-D3-A8GJ-F62200 TCGA-D3-A8GJ 2.4 -6684 0 7342 2632 Small Intestine 2014-7-14 MALE 192 No C17.9 8720/3 C17.9 YES NO III Non-glabrous skin YES NO No M0 N0 T3 Stage II A8GJ TUMOR FREE NO 1 YES NO NO Metastatic 06 NO 7th NO YES D3 Distant Metastasis LIVING 85 1994 ab5436ab-e50b-4be6-aec5-6ad0236dd63e TCGA-D3-A8GJ-06A-11D-A373-05 ab5436ab-e50b-4be6-aec5-6ad0236dd63e TCGA-D3-A8GJ-06 TCGA-D3-A8GJ-06A-11D-A371-01 TCGA-D3-A8GJ-06 TCGA-D3-A8GJ-06A-11D-A372-08 TCGA-D3-A8GJ-06A-11D-A371-01 ab5436ab-e50b-4be6-aec5-6ad0236dd63e ab5436ab-e50b-4be6-aec5-6ad0236dd63e +TCGA-D3-A8GK-06 TCGA-D3-A8GK-06 TCGA-D3-A8GK TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 45 TCGA-D3-A8GK-F58929 TCGA-D3-A8GK TCGA-D3-A8GK-06A 2.6 -16569 4997 0 5177 1868 Left buttock mass 2014-4-28 MALE 178 No C49.5 8720/3 C49.5 YES 140 NO NO 5 IV Non-glabrous skin NO YES NO true No M0 N0 T3a Stage IIA TCGA-D3-A8GK.42B80510-CCC7-4934-9D6B-6D0097B7F061.pdf A8GK TUMOR FREE YES 1 YES NO YES Metastatic 06 NO 7th NO YES D3 Distant Metastasis A LIVING 80 2000 42017e68-f474-4c5c-8849-9d85534f73cf TCGA-D3-A8GK-06A-11D-A373-05 42017e68-f474-4c5c-8849-9d85534f73cf TCGA-D3-A8GK-06A-11D-A371-01 9CAEEAA1-0823-4E48-8CC2-BAA29F1A7934 TCGA-D3-A8GK-06A-11D-A372-08 TCGA-D3-A8GK-06A-11D-A371-01 42017e68-f474-4c5c-8849-9d85534f73cf 42017e68-f474-4c5c-8849-9d85534f73cf +TCGA-D3-A8GL-06 TCGA-D3-A8GL-06 TCGA-D3-A8GL TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 43 TCGA-D3-A8GL TCGA-D3-A8GL-06A 1.32 -15947 6154 2711 0 1527 2013-12-19 MALE 183 Yes C49.2 8720/3 C49.2 YES 60 YES NO 2 IV Non-glabrous skin NO YES YES true No M0 N1b T2a Stage IIIB TCGA-D3-A8GL.A0641060-FDDC-4DF0-BB13-9978B74F7D1A.pdf A8GL WITH TUMOR NO 1 YES NO Interferon NO Metastatic 06 7th NO YES D3 Regional Cutaneous or Subcutaneous Tissue (includes satellite and in-transit metastasis) A DECEASED 107 1996 25f18340-6e6a-4d7e-a8c8-51466d436794 TCGA-D3-A8GL-06A-11D-A373-05 25f18340-6e6a-4d7e-a8c8-51466d436794 TCGA-D3-A8GL-06 TCGA-D3-A8GL-06A-11D-A371-01 TCGA-D3-A8GL-06 TCGA-D3-A8GL-06A-11D-A372-08 TCGA-D3-A8GL-06A-11D-A371-01 25f18340-6e6a-4d7e-a8c8-51466d436794 25f18340-6e6a-4d7e-a8c8-51466d436794 +TCGA-D3-A8GM-06 TCGA-D3-A8GM-06 TCGA-D3-A8GM TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 73 TCGA-D3-A8GM-F60916 TCGA-D3-A8GM TCGA-D3-A8GM-06A 3.8 -26782 3095 3259 0 2897 596 2014-6-18 MALE 168 No C77.0 8720/3 C77.0 YES 350 NO NO 9 IV Non-glabrous skin YES NO true No M0 N0 T3b Stage IIB TCGA-D3-A8GM.38FCA07B-7313-438C-BE20-4C370BAAFC66.pdf A8GM TUMOR FREE NO 1 YES NO YES Metastatic 06 NO 7th NO YES D3 Regional Lymph Node A DECEASED 75 2005 b1b529ee-df72-4e05-b342-eb31a28eaf64 TCGA-D3-A8GM-06A-11D-A373-05 b1b529ee-df72-4e05-b342-eb31a28eaf64 TCGA-D3-A8GM-06 TCGA-D3-A8GM-06A-11D-A371-01 TCGA-D3-A8GM-06 F0F82B08-DD0B-4674-9E5E-C6C60D7C2B7B TCGA-D3-A8GM-06A-11D-A372-08 TCGA-D3-A8GM-06A-11D-A371-01 b1b529ee-df72-4e05-b342-eb31a28eaf64 b1b529ee-df72-4e05-b342-eb31a28eaf64 +TCGA-D3-A8GN-06 TCGA-D3-A8GN-06 TCGA-D3-A8GN TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 27 TCGA-D3-A8GN-F60917 TCGA-D3-A8GN TCGA-D3-A8GN-06A -10185 4759 0 4897 1111 Duodenum 2014-6-18 FEMALE 165 Yes C17.9 8720/3 C17.9 YES 180 YES NO NO YES NO true No M0 N0 TX I/II NOS TCGA-D3-A8GN.13164D83-422C-4C2B-95DB-3F9F075F9F9C.pdf A8GN TUMOR FREE YES NO Interferon NO Metastatic 06 NO 7th NO YES D3 Distant Metastasis A LIVING 64 2000 8e6e3942-0def-4129-ab8c-8346bf6283ab TCGA-D3-A8GN-06A-11D-A373-05 8e6e3942-0def-4129-ab8c-8346bf6283ab TCGA-D3-A8GN-06 TCGA-D3-A8GN-06A-11D-A371-01 TCGA-D3-A8GN-06 E12C5D8F-505F-4DDB-A9F8-15FEB82A35F5 TCGA-D3-A8GN-06A-11D-A372-08 TCGA-D3-A8GN-06A-11D-A371-01 8e6e3942-0def-4129-ab8c-8346bf6283ab 8e6e3942-0def-4129-ab8c-8346bf6283ab +TCGA-D3-A8GO-06 TCGA-D3-A8GO-06 TCGA-D3-A8GO TCGA Melanoma (SKCM) skin cutaneous melanoma Skin TCGA-D3-A8GO 1.2 2013-12-20 FEMALE 167 No C77.3 8720/3 C77.3 YES III NO YES No M0 N0 T2 I/II NOS A8GO WITH TUMOR NO 1 YES NO NO Metastatic 06 7th NO YES D3 Regional Lymph Node DECEASED 69 1996 dd6114ab-b5af-4cfd-93f8-67429b2a6c94 TCGA-D3-A8GO-06A-11D-A373-05 dd6114ab-b5af-4cfd-93f8-67429b2a6c94 TCGA-D3-A8GO-06 TCGA-D3-A8GO-06A-11D-A371-01 TCGA-D3-A8GO-06 TCGA-D3-A8GO-06A-11D-A372-08 TCGA-D3-A8GO-06A-11D-A371-01 dd6114ab-b5af-4cfd-93f8-67429b2a6c94 dd6114ab-b5af-4cfd-93f8-67429b2a6c94 +TCGA-D3-A8GP-06 TCGA-D3-A8GP-06 TCGA-D3-A8GP TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 77 TCGA-D3-A8GP-F62202 TCGA-D3-A8GP TCGA-D3-A8GP-06A 1.8 -28234 4268 0 4646 1526 Colon 2014-7-14 MALE 175 No C18.9 8771/3 C18.9 YES 300 NO NO IV YES NO true No M0 N2c T2 Stage III TCGA-D3-A8GP.C4123D5F-FAC1-4FCF-96B5-9D8B9090371D.pdf A8GP TUMOR FREE NO 1 YES NO NO Metastatic 06 NO 7th NO YES D3 Distant Metastasis A LIVING 72 2002 15a623d2-4076-4e40-a3d9-31869b56b0e9 TCGA-D3-A8GP-06A-11D-A373-05 15a623d2-4076-4e40-a3d9-31869b56b0e9 TCGA-D3-A8GP-06 TCGA-D3-A8GP-06A-11D-A371-01 TCGA-D3-A8GP-06 FCEA2A64-EB9F-4B58-9656-50A0B00DE829 TCGA-D3-A8GP-06A-11D-A372-08 TCGA-D3-A8GP-06A-11D-A371-01 15a623d2-4076-4e40-a3d9-31869b56b0e9 15a623d2-4076-4e40-a3d9-31869b56b0e9 +TCGA-D3-A8GQ-06 TCGA-D3-A8GQ-06 TCGA-D3-A8GQ TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 66 TCGA-D3-A8GQ TCGA-D3-A8GQ-06A 2.6 -24348 3453 884 0 536 Small Bowel 2013-12-20 MALE 174 No C17.9 8720/3 C17.9 YES 70 NO III NO YES true No M0 N0 T3 Stage II TCGA-D3-A8GQ.73155A8A-95D1-4F01-9DC5-561B6E9CAEA5.pdf A8GQ WITH TUMOR NO 1 YES NO NO Metastatic 06 7th NO YES D3 Distant Metastasis A DECEASED 82 2004 1306850b-f5cf-457d-bf51-0caab2b7b834 TCGA-D3-A8GQ-06A-11D-A373-05 1306850b-f5cf-457d-bf51-0caab2b7b834 TCGA-D3-A8GQ-06 TCGA-D3-A8GQ-06A-11D-A371-01 TCGA-D3-A8GQ-06 TCGA-D3-A8GQ-06A-11D-A372-08 TCGA-D3-A8GQ-06A-11D-A371-01 1306850b-f5cf-457d-bf51-0caab2b7b834 1306850b-f5cf-457d-bf51-0caab2b7b834 +TCGA-D3-A8GR-06 TCGA-D3-A8GR-06 TCGA-D3-A8GR TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 54 TCGA-D3-A8GR TCGA-D3-A8GR-06A .01 -19973 5145 3943 0 3774 Small Intestine 2013-12-20 FEMALE 168 No C17.9 8720/3 C17.9 YES 160 NO I NO YES true No M0 N0 Tis Stage 0 TCGA-D3-A8GR.1C004953-8203-4865-8331-8C2A4224C129.pdf A8GR WITH TUMOR NO 1 YES NO NO Metastatic 06 7th NO YES D3 Distant Metastasis A DECEASED 84 1999 e6124a2c-05cf-4c70-9b4c-404d0a9d38b2 TCGA-D3-A8GR-06A-11D-A373-05 e6124a2c-05cf-4c70-9b4c-404d0a9d38b2 TCGA-D3-A8GR-06 TCGA-D3-A8GR-06A-11D-A371-01 TCGA-D3-A8GR-06 E0843893-C669-479E-8CEE-7CC6918D1D0B TCGA-D3-A8GR-06A-11D-A372-08 TCGA-D3-A8GR-06A-11D-A371-01 e6124a2c-05cf-4c70-9b4c-404d0a9d38b2 e6124a2c-05cf-4c70-9b4c-404d0a9d38b2 +TCGA-D3-A8GS-06 TCGA-D3-A8GS-06 TCGA-D3-A8GS TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 52 TCGA-D3-A8GS TCGA-D3-A8GS-06A .6 -19127 5986 3564 0 2832 Small bowel 2013-12-20 MALE 181 No C17.9 8720/3 C17.9 YES 520 NO III YES YES true No M0 N0 T1 Stage I TCGA-D3-A8GS.8D6DEB33-27CC-453A-8D79-F80AD386A6C6.pdf A8GS WITH TUMOR NO 1 YES NO NO Metastatic 06 7th NO YES D3 Distant Metastasis A DECEASED 111 1997 cac7aecd-c473-42d4-8c88-5054f2a6865d TCGA-D3-A8GS-06A-12D-A373-05 cac7aecd-c473-42d4-8c88-5054f2a6865d TCGA-D3-A8GS-06 TCGA-D3-A8GS-06A-12D-A371-01 TCGA-D3-A8GS-06 103506AD-1008-4A03-ABDC-E70D8C4A6D6B TCGA-D3-A8GS-06A-12D-A372-08 TCGA-D3-A8GS-06A-12D-A371-01 cac7aecd-c473-42d4-8c88-5054f2a6865d cac7aecd-c473-42d4-8c88-5054f2a6865d +TCGA-D3-A8GV-06 TCGA-D3-A8GV-06 TCGA-D3-A8GV TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 25 TCGA-D3-A8GV TCGA-D3-A8GV-06A -9344 7259 5101 0 4482 Back, soft tissue 2014-1-2 MALE 182 Yes C49.6 8720/3 C49.6 YES 260 YES NO Non-glabrous skin YES YES true No M0 N0 TX I/II NOS TCGA-D3-A8GV.FB1B3792-289C-4EC4-A08A-DD2CCDAAC218.pdf A8GV WITH TUMOR NO 1 YES NO Interferon NO Metastatic 06 7th NO YES D3 Distant Metastasis A DECEASED 102 1993 dbadd723-4f2b-4197-866e-90ac6857ad64 TCGA-D3-A8GV-06A-11D-A373-05 dbadd723-4f2b-4197-866e-90ac6857ad64 TCGA-D3-A8GV-06 TCGA-D3-A8GV-06A-11D-A371-01 TCGA-D3-A8GV-06 B31F3A3C-0B76-473B-BA90-6D5CAACADD6C TCGA-D3-A8GV-06A-11D-A372-08 TCGA-D3-A8GV-06A-11D-A371-01 dbadd723-4f2b-4197-866e-90ac6857ad64 dbadd723-4f2b-4197-866e-90ac6857ad64 +TCGA-D9-A148-06 TCGA-D9-A148-06 TCGA-D9-A148 TCGA Melanoma (SKCM) skin cutaneous melanoma Skin YES YES 40 TCGA-D9-A148-F20724 TCGA-D9-A148 TCGA-D9-A148-06A -14805 4183 0 4609 4540 4287 Scheduled Follow-up Submission 2012-1-19 MALE 179 No C50.9 8720/3 C50.9 YES 230 NO NO Non-glabrous skin NO Lung Distant Metastasis YES YES false No M1b N3 TX TCGA-D9-A148.5361D1E9-BC8D-44F6-BE42-63AA2DE70982.pdf A148 WITH TUMOR YES YES NO Immunotherapy/Vaccine YES Metastatic 06 7th YES NO D9 Regional Lymph Node A LIVING 84 1999 6881e2cc-96b3-4d5b-a0b5-852b4d94bfea TCGA-D9-A148-06A-11D-A19D-05 6881e2cc-96b3-4d5b-a0b5-852b4d94bfea TCGA-D9-A148-06 TCGA-D9-A148-06A-11D-A192-01 TCGA-D9-A148-06 80B5654B-96D6-4FB2-8EC9-450A83D61E69 TCGA-D9-A148-06A-11D-A19A-08 TCGA-D9-A148-06A-11D-A19A-08 TCGA-D9-A148-06A-11D-A192-01 TCGA-D9-A148-06A-11D-A19A-08 6881e2cc-96b3-4d5b-a0b5-852b4d94bfea 6881e2cc-96b3-4d5b-a0b5-852b4d94bfea +TCGA-D9-A149-06 TCGA-D9-A149-06 TCGA-D9-A149 TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 65 TCGA-D9-A149-F20727 TCGA-D9-A149 TCGA-D9-A149-06A -23779 1237 0 1663 Scheduled Follow-up Submission 2012-1-19 FEMALE 164 No C44.9 8720/3 C44.9 YES 230 NO NO Non-glabrous skin NO NO false No M0 N1b TX TCGA-D9-A149.AE78269F-A0EB-44DE-A8AF-CDE49CC7A63E.pdf A149 TUMOR FREE NO YES NO NO Metastatic 06 7th YES NO D9 Regional Cutaneous or Subcutaneous Tissue (includes satellite and in-transit metastasis) A LIVING 87 2007 fa7aa15e-c39b-47ad-b80b-b24c4532b20e TCGA-D9-A149-06A-11D-A19B-05 fa7aa15e-c39b-47ad-b80b-b24c4532b20e TCGA-D9-A149-06 TCGA-D9-A149-06A-11D-A194-01 TCGA-D9-A149-06 0D36758C-C8F8-4237-B1CD-041B72D569EC TCGA-D9-A149-06A-11D-A196-08 TCGA-D9-A149-06A-11D-A196-08 TCGA-D9-A149-06A-11D-A194-01 TCGA-D9-A149-06A-11D-A196-08 fa7aa15e-c39b-47ad-b80b-b24c4532b20e fa7aa15e-c39b-47ad-b80b-b24c4532b20e +TCGA-D9-A1JW-06 TCGA-D9-A1JW-06 TCGA-D9-A1JW TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 82 TCGA-D9-A1JW-F72332 TCGA-D9-A1JW TCGA-D9-A1JW-06A -30142 273 0 111 2015-5-25 MALE 160 No C77.0 8720/3 C77.0 YES NO YES Non-glabrous skin NO YES false No M0 N2a T1a TCGA-D9-A1JW.E532715E-CC41-4AFF-A783-BB3A02E53309.pdf A1JW TUMOR FREE NO YES NO NO Metastatic 06 NO 7th YES NO D9 Regional Lymph Node A LIVING 86 2010 dd9cd802-af40-4c9b-a1f8-ff2ce09503af TCGA-D9-A1JW-06A-11D-A19D-05 dd9cd802-af40-4c9b-a1f8-ff2ce09503af TCGA-D9-A1JW-06 TCGA-D9-A1JW-06A-11D-A192-01 TCGA-D9-A1JW-06 72A056EB-E726-4C32-92BD-292A29491369 TCGA-D9-A1JW-06A-11D-A19A-08 TCGA-D9-A1JW-06A-11D-A19A-08 TCGA-D9-A1JW-06A-11D-A192-01 TCGA-D9-A1JW-06A-11D-A19A-08 dd9cd802-af40-4c9b-a1f8-ff2ce09503af dd9cd802-af40-4c9b-a1f8-ff2ce09503af +TCGA-D9-A1JX-06 TCGA-D9-A1JX-06 TCGA-D9-A1JX TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 80 TCGA-D9-A1JX-F20728 TCGA-D9-A1JX TCGA-D9-A1JX-06A -29323 329 216 0 195 Scheduled Follow-up Submission 2012-1-19 FEMALE 160 No C77.4 8720/3 C77.4 YES 220 NO NO III Non-glabrous skin NO NO false No M0 NX TX TCGA-D9-A1JX.696460B6-BF6C-456E-873F-D99A95FEBFA0.pdf A1JX WITH TUMOR NO YES NO NO Metastatic 06 7th YES NO D9 Regional Lymph Node A DECEASED 86 2010 c8ab76f4-ea65-40d3-94d8-42be5477641e TCGA-D9-A1JX-06A-11D-A19D-05 c8ab76f4-ea65-40d3-94d8-42be5477641e TCGA-D9-A1JX-06 TCGA-D9-A1JX-06A-11D-A192-01 TCGA-D9-A1JX-06 9410BC88-9DA9-47F1-8CF9-AE3E17E7BC0E TCGA-D9-A1JX-06A-11D-A19A-08 TCGA-D9-A1JX-06A-11D-A19A-08 TCGA-D9-A1JX-06A-11D-A192-01 TCGA-D9-A1JX-06A-11D-A19A-08 c8ab76f4-ea65-40d3-94d8-42be5477641e c8ab76f4-ea65-40d3-94d8-42be5477641e +TCGA-D9-A1X3-01 TCGA-D9-A1X3-01 TCGA-D9-A1X3 TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 63 TCGA-D9-A1X3-F29461 TCGA-D9-A1X3 12 -23171 0 551 Scheduled Follow-up Submission 2012-2-20 MALE 170 No C44.9 8720/3 C44.9 YES NO V Non-glabrous skin YES NO NO No N2b T4b A1X3 WITH TUMOR NO YES NO YES 7th YES NO D9 Regional Cutaneous or Subcutaneous Tissue (includes satellite and in-transit metastasis) LIVING 95 2010 TCGA-D9-A1X3-01A-11D-A197-08 +TCGA-D9-A1X3-06 TCGA-D9-A1X3-06 TCGA-D9-A1X3 TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 63 TCGA-D9-A1X3-F29461 TCGA-D9-A1X3 TCGA-D9-A1X3-06A 12 -23171 217 0 551 Scheduled Follow-up Submission 2012-2-20 MALE 170 No C44.9 8720/3 C44.9 YES 210 NO NO V Non-glabrous skin YES NO NO false No N2b T4b TCGA-D9-A1X3.E9DE4FCE-52CD-42FA-B20D-7DEB0F2B3BEE.pdf A1X3 WITH TUMOR NO YES NO YES Metastatic 06 7th YES NO D9 Regional Cutaneous or Subcutaneous Tissue (includes satellite and in-transit metastasis) A LIVING 95 2010 1589f6a7-211a-458f-a2ad-72c2c175b5e5 TCGA-D9-A1X3-06A-11D-A19C-05 1589f6a7-211a-458f-a2ad-72c2c175b5e5 TCGA-D9-A1X3-06 TCGA-D9-A1X3-06A-11D-A191-01 TCGA-D9-A1X3-06 6A4EB324-B27A-479A-AAF3-4A7E3EE543E4 TCGA-D9-A1X3-06A-11D-A197-08 TCGA-D9-A1X3-06A-11D-A197-08 TCGA-D9-A1X3-06A-11D-A191-01 1589f6a7-211a-458f-a2ad-72c2c175b5e5 1589f6a7-211a-458f-a2ad-72c2c175b5e5 +TCGA-D9-A3Z1-06 TCGA-D9-A3Z1-06 TCGA-D9-A3Z1 TCGA Melanoma (SKCM) skin cutaneous melanoma Skin NO NO 66 TCGA-D9-A3Z1-F51373 TCGA-D9-A3Z1 TCGA-D9-A3Z1-06A 1.7 -24192 370 468 0 345 335 223 2013-11-18 MALE 180 No C77.3 8720/3 C77.3 YES 190 NO Normal NO IV Locoregional Recurrence NO YES Lung false No M0 N3 T2a Stage IIIC TCGA-D9-A3Z1.88D7BFE1-8B3C-451A-A901-9B0C3C9D0A28.pdf A3Z1 WITH TUMOR NO 1 YES NO NO Metastatic 06 NO 7th YES NO D9 Regional Lymph Node A DECEASED 80 2011 02486980-eb4f-4930-ba27-356e346929b6 TCGA-D9-A3Z1-06A-11D-A23D-05 02486980-eb4f-4930-ba27-356e346929b6 TCGA-D9-A3Z1-06 TCGA-D9-A3Z1-06A-11D-A238-01 TCGA-D9-A3Z1-06 02C207AB-BC56-4626-8D71-9A8B2A888938 TCGA-D9-A3Z1-06A-11D-A23B-08 TCGA-D9-A3Z1-06A-11D-A23B-08 TCGA-D9-A3Z1-06A-11D-A238-01 02486980-eb4f-4930-ba27-356e346929b6 02486980-eb4f-4930-ba27-356e346929b6 +TCGA-D9-A3Z3-06 TCGA-D9-A3Z3-06 TCGA-D9-A3Z3 TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 39 TCGA-D9-A3Z3-F57867 TCGA-D9-A3Z3 TCGA-D9-A3Z3-06A 3.9 -14489 122 0 678 11 2014-3-28 FEMALE 164 No C77.3 8720/3 C77.3 YES 80 NO NO 6 IV Non-glabrous skin NO NO false No M0 N1b T3a Stage IIIB TCGA-D9-A3Z3.29C111B1-5E65-4CCE-A513-D40CF02069E9.pdf A3Z3 TUMOR FREE NO 1 YES NO NO Metastatic 06 NO 7th YES NO D9 Regional Lymph Node A LIVING 61 2012 26641854-14ae-4797-b404-f3a143892bc9 TCGA-D9-A3Z3-06A-11D-A23D-05 26641854-14ae-4797-b404-f3a143892bc9 TCGA-D9-A3Z3-06 TCGA-D9-A3Z3-06A-11D-A238-01 TCGA-D9-A3Z3-06 TCGA-D9-A3Z3-06A-11D-A23B-08 TCGA-D9-A3Z3-06A-11D-A23B-08 TCGA-D9-A3Z3-06A-11D-A238-01 26641854-14ae-4797-b404-f3a143892bc9 26641854-14ae-4797-b404-f3a143892bc9 +TCGA-D9-A3Z4-01 TCGA-D9-A3Z4-01 TCGA-D9-A3Z4 TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 54 TCGA-D9-A3Z4-F57866 TCGA-D9-A3Z4 TCGA-D9-A3Z4-01A 12 -19749 112 519 0 119 192 0 2014-3-28 MALE 175 No C44.6 8720/3 C44.6 YES 160 NO NO V Non-glabrous skin YES Regional lymph node NO YES Other, Specify lymph node false No M0 N3 T4b Stage IIIC TCGA-D9-A3Z4.48B52D74-74EA-43BE-918A-4A4E3BDB76B7.pdf A3Z4 WITH TUMOR NO 1 YES NO NO Primary Tumor 01 YES 7th YES NO D9 Primary Tumor A DECEASED 90 2012 596101f8-7371-46ab-b3c6-d54355719064 TCGA-D9-A3Z4-01A-11D-A23D-05 596101f8-7371-46ab-b3c6-d54355719064 TCGA-D9-A3Z4-01 TCGA-D9-A3Z4-01 05E931B9-CD15-43F9-977A-ABA91D486F36 TCGA-D9-A3Z4-01A-11D-A23B-08 TCGA-D9-A3Z4-01A-11D-A23B-08 596101f8-7371-46ab-b3c6-d54355719064 596101f8-7371-46ab-b3c6-d54355719064 +TCGA-D9-A4Z2-01 TCGA-D9-A4Z2-01 TCGA-D9-A4Z2 TCGA Melanoma (SKCM) skin cutaneous melanoma Skin NO NO 50 TCGA-D9-A4Z2-F57868 TCGA-D9-A4Z2 TCGA-D9-A4Z2-01A 25 -18462 66 190 0 93 80 7 2014-3-28 MALE 164 No C44.5 8721/3 C44.5 YES 160 NO NO 10 IV Non-glabrous skin YES Distant Metastasis NO NO YES Lung false No M0 N3 T4b Stage IIIC TCGA-D9-A4Z2.FEA752ED-7670-4D44-8402-009CF8356C44.pdf A4Z2 WITH TUMOR NO 2 YES YES NO Primary Tumor 01 NO 7th YES NO D9 Primary Tumor A DECEASED 54 2012 fab24bb5-a75b-4840-bcc3-713a0359d797 TCGA-D9-A4Z2-01A-11D-A24V-05 fab24bb5-a75b-4840-bcc3-713a0359d797 TCGA-D9-A4Z2-01 TCGA-D9-A4Z2-01 0AACEABD-F7D3-4492-AD6D-8FE7326A6E20 TCGA-D9-A4Z2-01A-11D-A24R-08 TCGA-D9-A4Z2-01A-11D-A24R-08 fab24bb5-a75b-4840-bcc3-713a0359d797 fab24bb5-a75b-4840-bcc3-713a0359d797 +TCGA-D9-A4Z3-01 TCGA-D9-A4Z3-01 TCGA-D9-A4Z3 TCGA Melanoma (SKCM) skin cutaneous melanoma Skin NO NO 73 TCGA-D9-A4Z3-F58483 TCGA-D9-A4Z3 TCGA-D9-A4Z3-01A 75 -26812 16 0 505 199 100 0 2014-4-11 FEMALE 170 No C44.6 8721/3 C44.6 YES 170 NO NO 10 V Non-glabrous skin YES Locoregional Recurrence YES YES false No M0 N1b T4b Stage IIIC TCGA-D9-A4Z3.9B96B7FD-D3BA-42C8-A0C6-1C93C48F4BB2.pdf A4Z3 TUMOR FREE NO 1 YES NO NO Primary Tumor 01 NO 7th YES NO D9 Primary Tumor A LIVING 70 2012 789b2b10-3286-44ba-af24-a8f176a51ad8 TCGA-D9-A4Z3-01A-11D-A25S-05 789b2b10-3286-44ba-af24-a8f176a51ad8 TCGA-D9-A4Z3-01 TCGA-D9-A4Z3-01 DB388743-09D3-44AE-8B8F-5F981C728CA1 TCGA-D9-A4Z3-01A-11D-A25O-08 TCGA-D9-A4Z3-01A-11D-A25O-08 789b2b10-3286-44ba-af24-a8f176a51ad8 789b2b10-3286-44ba-af24-a8f176a51ad8 +TCGA-D9-A4Z5-01 TCGA-D9-A4Z5-01 TCGA-D9-A4Z5 TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 68 TCGA-D9-A4Z5-F58051 TCGA-D9-A4Z5 TCGA-D9-A4Z5-01A -24979 38 0 218 0 2014-3-31 MALE 176 No C44.31 8720/3 C30.0 YES 160 NO NO III Non-glabrous skin NO NO false No M0 N0 T4a Stage IIB TCGA-D9-A4Z5.93502F24-F9FE-4978-811E-E3B7F47A7BF0.pdf A4Z5 TUMOR FREE NO 1 YES NO NO Primary Tumor 01 NO 7th YES NO D9 A LIVING 112 2012 a952260d-78c3-4d99-9007-75150ac3151f TCGA-D9-A4Z5-01A-11D-A25S-05 a952260d-78c3-4d99-9007-75150ac3151f TCGA-D9-A4Z5-01 TCGA-D9-A4Z5-01 F03D0181-0A63-4685-AC4E-C63F43373B26 TCGA-D9-A4Z5-01A-11D-A25O-08 TCGA-D9-A4Z5-01A-11D-A25O-08 a952260d-78c3-4d99-9007-75150ac3151f a952260d-78c3-4d99-9007-75150ac3151f +TCGA-D9-A4Z6-06 TCGA-D9-A4Z6-06 TCGA-D9-A4Z6 TCGA Melanoma (SKCM) skin cutaneous melanoma Skin YES YES 54 TCGA-D9-A4Z6-F58484 TCGA-D9-A4Z6 TCGA-D9-A4Z6-06A -20072 234 561 0 338 324 213 164 2014-4-11 MALE 178 No C77.3 8720/3 C77.3 YES 140 NO NO Non-glabrous skin Distant Metastasis YES YES Brain false No M0 N1b T3b Stage IIIC TCGA-D9-A4Z6.27F7E39C-039F-4CDA-99DA-191E6E7FE843.pdf A4Z6 WITH TUMOR NO 1 YES NO NO Metastatic 06 NO 7th YES NO D9 Regional Lymph Node A DECEASED 88 2012 88d7b0f7-b9cf-49e7-b310-900e87f7cd21 TCGA-D9-A4Z6-06A-12D-A25S-05 88d7b0f7-b9cf-49e7-b310-900e87f7cd21 TCGA-D9-A4Z6-06 TCGA-D9-A4Z6-06A-12D-A25P-01 TCGA-D9-A4Z6-06 33D0A567-5DEB-4E41-A98B-354927651798 TCGA-D9-A4Z6-06A-12D-A25O-08 TCGA-D9-A4Z6-06A-12D-A25O-08 TCGA-D9-A4Z6-06A-12D-A25P-01 88d7b0f7-b9cf-49e7-b310-900e87f7cd21 88d7b0f7-b9cf-49e7-b310-900e87f7cd21 +TCGA-D9-A6E9-06 TCGA-D9-A6E9-06 TCGA-D9-A6E9 TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 75 TCGA-D9-A6E9-F57862 TCGA-D9-A6E9 TCGA-D9-A6E9-06A 4 -27537 23 0 301 0 2014-3-28 FEMALE 165 No C77.4 8720/3 C77.4 YES 220 NO [Discrepancy] NO IV Non-glabrous skin NO NO true No M0 N1 T3a Stage IIIA TCGA-D9-A6E9.C715D5BB-268B-4F22-8BA3-85E8F65A383B.pdf A6E9 TUMOR FREE NO 1 YES NO NO Metastatic 06 NO 7th YES NO D9 Primary Tumor A LIVING 89 2013 6f7cf94c-44f1-4ad0-816b-6100e53ea887 TCGA-D9-A6E9-06A-12D-A30Z-05 6f7cf94c-44f1-4ad0-816b-6100e53ea887 TCGA-D9-A6E9-06 TCGA-D9-A6E9-06A-12D-A30W-01 TCGA-D9-A6E9-06 6116880D-4BEB-4C3B-BBD7-2436951D6877 TCGA-D9-A6E9-06A-12D-A30X-08 TCGA-D9-A6E9-06A-12D-A30X-08 TCGA-D9-A6E9-06A-12D-A30W-01 6f7cf94c-44f1-4ad0-816b-6100e53ea887 6f7cf94c-44f1-4ad0-816b-6100e53ea887 +TCGA-D9-A6EA-06 TCGA-D9-A6EA-06 TCGA-D9-A6EA TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 70 TCGA-D9-A6EA-F72212 TCGA-D9-A6EA TCGA-D9-A6EA-06A 6 -25582 478 0 [Discrepancy] 422 2015-4-29 MALE 166 No C77.3 8720/3 C77.3 YES 270 NO Normal NO IV Non-glabrous skin NO [Discrepancy] true No M0 N3 T4a Stage IIIC TCGA-D9-A6EA.78D2592F-845C-4A33-AC8B-48C109E4D50B.pdf A6EA TUMOR FREE NO 1 YES NO NO Metastatic 06 7th YES NO D9 [Discrepancy] A LIVING 58 2012 3b2af3d9-31f1-4075-8a42-2e4f371cd0a6 TCGA-D9-A6EA-06A-11D-A30Z-05 3b2af3d9-31f1-4075-8a42-2e4f371cd0a6 TCGA-D9-A6EA-06 TCGA-D9-A6EA-06A-11D-A30W-01 TCGA-D9-A6EA-06 19F19986-CEED-4AD1-B92C-FDF8670AB00F TCGA-D9-A6EA-06A-11D-A30X-08 TCGA-D9-A6EA-06A-11D-A30X-08 TCGA-D9-A6EA-06A-11D-A30W-01 3b2af3d9-31f1-4075-8a42-2e4f371cd0a6 3b2af3d9-31f1-4075-8a42-2e4f371cd0a6 +TCGA-D9-A6EC-06 TCGA-D9-A6EC-06 TCGA-D9-A6EC TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 56 TCGA-D9-A6EC-F72211 TCGA-D9-A6EC TCGA-D9-A6EC-06A 3 -20493 1716 0 2359 1613 2015-4-29 MALE 175 No C77.3 8720/3 C77.3 YES 330 NO NO III Non-glabrous skin NO NO true No M0 N1 T3a Stage IIIA TCGA-D9-A6EC.57FE7B94-1751-417D-8D31-25F06A952E71.pdf A6EC TUMOR FREE NO 1 YES NO NO Metastatic 06 NO 6th YES NO D9 Regional Lymph Node A LIVING 130 2008 6cf6c8d5-4883-40a2-9a5c-0041f8f073de TCGA-D9-A6EC-06A-11D-A30Z-05 6cf6c8d5-4883-40a2-9a5c-0041f8f073de TCGA-D9-A6EC-06 TCGA-D9-A6EC-06A-11D-A30W-01 TCGA-D9-A6EC-06 7A2CA507-9DFE-40B4-AEC9-746E7A344548 TCGA-D9-A6EC-06A-11D-A30X-08 TCGA-D9-A6EC-06A-11D-A30X-08 TCGA-D9-A6EC-06A-11D-A30W-01 6cf6c8d5-4883-40a2-9a5c-0041f8f073de 6cf6c8d5-4883-40a2-9a5c-0041f8f073de +TCGA-D9-A6EG-06 TCGA-D9-A6EG-06 TCGA-D9-A6EG TCGA Melanoma (SKCM) skin cutaneous melanoma Skin NO NO 56 TCGA-D9-A6EG-F57864 TCGA-D9-A6EG TCGA-D9-A6EG-06A 5 -20570 457 698 0 398 254 2014-3-28 MALE 165 No C49.9 8720/3 C49.9 YES 70 NO Normal NO IV Non-glabrous skin YES Distant Metastasis NO NO YES Bone true No M0 N1 T4a Stage IIIA TCGA-D9-A6EG.13D80C78-FF04-4168-8592-CAC94E7EE1DA.pdf A6EG NO YES NO NO Metastatic 06 NO 7th YES NO D9 Regional Cutaneous or Subcutaneous Tissue (includes satellite and in-transit metastasis) A DECEASED 70 2012 da7b3bf7-8f1f-4776-a314-46177f73965e TCGA-D9-A6EG-06A-12D-A32S-05 da7b3bf7-8f1f-4776-a314-46177f73965e TCGA-D9-A6EG-06A-12D-A32M-01 TCGA-D9-A6EG-06A-12D-A32N-08 TCGA-D9-A6EG-06A-12D-A32M-01 da7b3bf7-8f1f-4776-a314-46177f73965e da7b3bf7-8f1f-4776-a314-46177f73965e +TCGA-DA-A1HV-06 TCGA-DA-A1HV-06 TCGA-DA-A1HV TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 75 TCGA-DA-A1HV-F71097 TCGA-DA-A1HV TCGA-DA-A1HV-06A -27553 893 0 2329 3 2015-5-7 FEMALE No C77.9 8720/3 C77.9 YES 320 NO NO Non-glabrous skin NO true No M0 N2b T0 Stage IIIB TCGA-DA-A1HV.4FC1592D-0BF9-4658-A498-E4F18C2EFE08.pdf A1HV TUMOR FREE NO NO NO Metastatic 06 6th NO YES DA Regional Lymph Node A LIVING 2008 11e4b666-d6e8-4b8d-9340-5ac8ac3979e6 TCGA-DA-A1HV-06A-21D-A19B-05 11e4b666-d6e8-4b8d-9340-5ac8ac3979e6 TCGA-DA-A1HV-06 TCGA-DA-A1HV-06A-21D-A194-01 TCGA-DA-A1HV-06 0E6BA812-FE16-4D7F-B2FF-0DF491BC631A TCGA-DA-A1HV-06A-21D-A196-08 TCGA-DA-A1HV-06A-21D-A196-08 TCGA-DA-A1HV-06A-21D-A194-01 TCGA-DA-A1HV-06A-21D-A196-08 11e4b666-d6e8-4b8d-9340-5ac8ac3979e6 11e4b666-d6e8-4b8d-9340-5ac8ac3979e6 +TCGA-DA-A1HW-06 TCGA-DA-A1HW-06 TCGA-DA-A1HW TCGA Melanoma (SKCM) skin cutaneous melanoma Skin YES 37 TCGA-DA-A1HW-F71099 TCGA-DA-A1HW TCGA-DA-A1HW-06A 0.7 -13585 611 1096 0 59 852 7 2015-5-12 FEMALE No C77.9 8720/3 C77.9 YES 90 NO NO III Non-glabrous skin NO YES true No M0 N1b T1a Stage IIIB TCGA-DA-A1HW.B0F2FD1C-03C7-49BF-BD36-EFCC1E205D79.pdf A1HW WITH TUMOR NO 1 YES NO NO Metastatic 06 6th NO YES DA Regional Lymph Node A DECEASED 69 2009 5d4390cc-c091-4844-b40c-f936ab881e61 TCGA-DA-A1HW-06A-11D-A19D-05 5d4390cc-c091-4844-b40c-f936ab881e61 TCGA-DA-A1HW-06 TCGA-DA-A1HW-06A-11D-A192-01 TCGA-DA-A1HW-06 3ABDF893-14A8-41B9-B700-7896C5EE10FE TCGA-DA-A1HW-06A-11D-A19A-08 TCGA-DA-A1HW-06A-11D-A19A-08 TCGA-DA-A1HW-06A-11D-A192-01 TCGA-DA-A1HW-06A-11D-A19A-08 5d4390cc-c091-4844-b40c-f936ab881e61 5d4390cc-c091-4844-b40c-f936ab881e61 +TCGA-DA-A1HY-06 TCGA-DA-A1HY-06 TCGA-DA-A1HY TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 42 TCGA-DA-A1HY-F71101 TCGA-DA-A1HY TCGA-DA-A1HY-06A 1.13 -15357 2971 0 4407 2010 2015-5-12 MALE 178 No C77.9 8720/3 C77.9 YES 90 NO NO IV Non-glabrous skin YES NO true No M0 N1 T2b Stage III TCGA-DA-A1HY.ACCF42A2-F4C6-4B69-AF2B-BF158D58900C.pdf A1HY TUMOR FREE NO 1 YES NO NO Metastatic 06 5th NO YES DA Regional Lymph Node A LIVING 80 2002 1e4be071-ebc0-4eba-b66f-abd178f60ea1 TCGA-DA-A1HY-06A-11D-A19D-05 1e4be071-ebc0-4eba-b66f-abd178f60ea1 TCGA-DA-A1HY-06 TCGA-DA-A1HY-06A-11D-A192-01 TCGA-DA-A1HY-06 A98E24C2-93D7-42B3-AE48-92E289A834D2 TCGA-DA-A1HY-06A-11D-A19A-08 TCGA-DA-A1HY-06A-11D-A19A-08 TCGA-DA-A1HY-06A-11D-A192-01 TCGA-DA-A1HY-06A-11D-A19A-08 1e4be071-ebc0-4eba-b66f-abd178f60ea1 1e4be071-ebc0-4eba-b66f-abd178f60ea1 +TCGA-DA-A1I0-06 TCGA-DA-A1I0-06 TCGA-DA-A1I0 TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 63 TCGA-DA-A1I0-F71102 TCGA-DA-A1I0 TCGA-DA-A1I0-06A 4.5 -23157 1010 620 0 215 599 189 2015-3-20 MALE No C44.9 8720/3 C44.9 YES 130 NO NO IV Non-glabrous skin YES Distant Metastasis YES Brain true No M1a N3 T4b Stage IV TCGA-DA-A1I0.9221E424-4B17-4C47-8E62-8E6B588E8770.pdf A1I0 WITH TUMOR NO 1 YES NO NO Metastatic 06 6th NO YES DA Regional Cutaneous or Subcutaneous Tissue (includes satellite and in-transit metastasis) A DECEASED 2008 df1c6f54-51a3-4a76-9ba7-281904144ffc TCGA-DA-A1I0-06A-11D-A211-05 df1c6f54-51a3-4a76-9ba7-281904144ffc TCGA-DA-A1I0-06 TCGA-DA-A1I0-06A-11D-A20B-01 TCGA-DA-A1I0-06 BF81B4C4-04B8-4543-81F9-0B2DFB357170 TCGA-DA-A1I0-06A-11D-A20D-08 TCGA-DA-A1I0-06A-11D-A20D-08 TCGA-DA-A1I0-06A-11D-A20B-01 TCGA-DA-A1I0-06A-11D-A20D-08 df1c6f54-51a3-4a76-9ba7-281904144ffc df1c6f54-51a3-4a76-9ba7-281904144ffc +TCGA-DA-A1I1-06 TCGA-DA-A1I1-06 TCGA-DA-A1I1 TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 55 TCGA-DA-A1I1-F71106 TCGA-DA-A1I1 -20399 0 6768 4734 2015-3-20 MALE No C44.9 8720/3 C44.9 YES NO Non-glabrous skin NO No M0 N2a T0 Stage III A1I1 TUMOR FREE NO NO NO Metastatic 06 4th NO YES DA Regional Cutaneous or Subcutaneous Tissue (includes satellite and in-transit metastasis) LIVING 1996 a835c374-32b1-491b-811e-e3a0c5012818 TCGA-DA-A1I1-06A-12D-A19B-05 a835c374-32b1-491b-811e-e3a0c5012818 TCGA-DA-A1I1-06 TCGA-DA-A1I1-06A-12D-A194-01 TCGA-DA-A1I1-06 TCGA-DA-A1I1-06A-12D-A196-08 TCGA-DA-A1I1-06A-12D-A196-08 TCGA-DA-A1I1-06A-12D-A194-01 TCGA-DA-A1I1-06A-12D-A196-08 a835c374-32b1-491b-811e-e3a0c5012818 a835c374-32b1-491b-811e-e3a0c5012818 +TCGA-DA-A1I2-06 TCGA-DA-A1I2-06 TCGA-DA-A1I2 TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 45 TCGA-DA-A1I2-F71088 TCGA-DA-A1I2 TCGA-DA-A1I2-06A -16701 5332 5370 0 4719 5305 4679 2015-6-30 MALE No C77.9 8720/3 C77.9 YES 170 NO NO IV Non-glabrous skin YES Distant Metastasis YES Brain true No M0 N2b T4b Stage III TCGA-DA-A1I2.7F6F7F9F-CDE1-4129-8161-B87F78029488.pdf A1I2 WITH TUMOR NO 1 YES NO NO Metastatic 06 4th NO YES DA Regional Lymph Node A DECEASED 92 1996 92767f50-7543-4312-93ff-f17a084bda26 TCGA-DA-A1I2-06A-21D-A19D-05 92767f50-7543-4312-93ff-f17a084bda26 TCGA-DA-A1I2-06 TCGA-DA-A1I2-06A-21D-A192-01 TCGA-DA-A1I2-06 D3D6BCB5-A7F0-424A-BF94-FD5675F1B609 TCGA-DA-A1I2-06A-21D-A19A-08 TCGA-DA-A1I2-06A-21D-A19A-08 TCGA-DA-A1I2-06A-21D-A192-01 TCGA-DA-A1I2-06A-21D-A19A-08 92767f50-7543-4312-93ff-f17a084bda26 92767f50-7543-4312-93ff-f17a084bda26 +TCGA-DA-A1I4-06 TCGA-DA-A1I4-06 TCGA-DA-A1I4 TCGA Melanoma (SKCM) skin cutaneous melanoma Skin NO YES 51 TCGA-DA-A1I4-F70086 TCGA-DA-A1I4 TCGA-DA-A1I4-06A 3.4 -18961 1528 1093 0 823 889 789 2015-1-27 MALE 170 No C44.9 8720/3 C44.9 YES 80 NO NO IV Non-glabrous skin YES Distant Metastasis NO YES Brain true No M0 N2b T3b Stage IIIC TCGA-DA-A1I4.2E4DF07F-4B5A-4CCA-A824-D6FE54D82B0F.pdf A1I4 WITH TUMOR NO 1 YES NO NO Metastatic 06 NO 6th NO YES DA Regional Cutaneous or Subcutaneous Tissue (includes satellite and in-transit metastasis) A DECEASED 72 2006 2c685f5e-c907-48f1-aec9-ff4fa365823c TCGA-DA-A1I4-06A-11D-A19B-05 2c685f5e-c907-48f1-aec9-ff4fa365823c TCGA-DA-A1I4-06 TCGA-DA-A1I4-06A-11D-A194-01 TCGA-DA-A1I4-06 590DC250-B794-4BE8-936B-699B8432A0EE TCGA-DA-A1I4-06A-11D-A196-08 TCGA-DA-A1I4-06A-11D-A196-08 TCGA-DA-A1I4-06A-11D-A194-01 TCGA-DA-A1I4-06A-11D-A196-08 2c685f5e-c907-48f1-aec9-ff4fa365823c 2c685f5e-c907-48f1-aec9-ff4fa365823c +TCGA-DA-A1I5-06 TCGA-DA-A1I5-06 TCGA-DA-A1I5 TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 27 TCGA-DA-A1I5-F71108 TCGA-DA-A1I5 TCGA-DA-A1I5-06A 0.6 -10017 2671 0 4107 1911 bone(ulna) 2015-3-20 FEMALE No C44.9 8720/3 C44.9 YES 110 NO NO IV Non-glabrous skin NO NO true No M1c N0 T1a Stage IV TCGA-DA-A1I5.C10C801B-11B3-4F10-92B3-306806FBC6EA.pdf A1I5 TUMOR FREE NO 1 YES NO NO Metastatic 06 6th NO YES DA Distant Metastasis A LIVING 2003 641b06e6-a787-4ad1-9bfa-ea27eb675829 TCGA-DA-A1I5-06A-11D-A19C-05 641b06e6-a787-4ad1-9bfa-ea27eb675829 TCGA-DA-A1I5-06 TCGA-DA-A1I5-06A-11D-A191-01 TCGA-DA-A1I5-06 E7D6A33F-6F24-4B1B-BF05-3BF6FFF3673F TCGA-DA-A1I5-06A-11D-A197-08 TCGA-DA-A1I5-06A-11D-A197-08 TCGA-DA-A1I5-06A-11D-A191-01 TCGA-DA-A1I5-06A-11D-A197-08 641b06e6-a787-4ad1-9bfa-ea27eb675829 641b06e6-a787-4ad1-9bfa-ea27eb675829 +TCGA-DA-A1I7-06 TCGA-DA-A1I7-06 TCGA-DA-A1I7 TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 62 TCGA-DA-A1I7-F71104 TCGA-DA-A1I7 TCGA-DA-A1I7-06A -22940 1267 0 2703 745 2015-3-20 MALE 193 No C44.9 8720/3 C44.9 YES 150 NO NO Non-glabrous skin NO NO true No M0 N2b T0 Stage IIIB TCGA-DA-A1I7.430B9506-DAC2-472F-B051-3B542F2D5243.pdf A1I7 WITH TUMOR NO NO NO Metastatic 06 6th NO YES DA Regional Cutaneous or Subcutaneous Tissue (includes satellite and in-transit metastasis) A LIVING 87 2007 8000da33-0855-41b1-8ff8-503c8a7293a0 TCGA-DA-A1I7-06A-22D-A19C-05 8000da33-0855-41b1-8ff8-503c8a7293a0 TCGA-DA-A1I7-06 TCGA-DA-A1I7-06A-22D-A191-01 TCGA-DA-A1I7-06 TCGA-DA-A1I7-06A-22D-A197-08 TCGA-DA-A1I7-06A-22D-A197-08 TCGA-DA-A1I7-06A-22D-A191-01 TCGA-DA-A1I7-06A-22D-A197-08 8000da33-0855-41b1-8ff8-503c8a7293a0 8000da33-0855-41b1-8ff8-503c8a7293a0 +TCGA-DA-A1I8-06 TCGA-DA-A1I8-06 TCGA-DA-A1I8 TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 63 TCGA-DA-A1I8-F71089 TCGA-DA-A1I8 TCGA-DA-A1I8-06A 8 -23286 2069 1640 0 999 1308 875 2015-3-20 FEMALE 168 No C44.9 8720/3 C44.9 YES 210 NO NO IV Non-glabrous skin YES Distant Metastasis YES Brain true No M0 N0 T4b Stage IIC TCGA-DA-A1I8.C0A87BE5-E61F-4E46-B1F5-FB0571454CE8.pdf A1I8 WITH TUMOR NO 1 YES NO NO Metastatic 06 6th NO YES DA Regional Cutaneous or Subcutaneous Tissue (includes satellite and in-transit metastasis) A DECEASED 71 2005 a4f282c0-b938-44b1-a34d-bd7e2ece4dc5 TCGA-DA-A1I8-06A-11D-A19C-05 a4f282c0-b938-44b1-a34d-bd7e2ece4dc5 TCGA-DA-A1I8-06 TCGA-DA-A1I8-06A-11D-A191-01 TCGA-DA-A1I8-06 620C0254-F7DF-4F22-907C-C9A817BA3C91 TCGA-DA-A1I8-06A-11D-A197-08 TCGA-DA-A1I8-06A-11D-A197-08 TCGA-DA-A1I8-06A-11D-A191-01 TCGA-DA-A1I8-06A-11D-A197-08 a4f282c0-b938-44b1-a34d-bd7e2ece4dc5 a4f282c0-b938-44b1-a34d-bd7e2ece4dc5 +TCGA-DA-A1IA-06 TCGA-DA-A1IA-06 TCGA-DA-A1IA TCGA Melanoma (SKCM) skin cutaneous melanoma Skin YES 32 TCGA-DA-A1IA-F70089 TCGA-DA-A1IA TCGA-DA-A1IA-06A 1.3 -11744 2074 2005 0 1887 2195 1855 brain 2015-1-27 FEMALE No C71.1 8720/3 C71.1 YES 280 NO NO IV Non-glabrous skin NO Distant Metastasis YES Brain true No M0 N1b T2a Stage IIIB TCGA-DA-A1IA.A8C5B4DF-C8BD-43FF-9613-04942F68DCAB.pdf A1IA WITH TUMOR NO 1 YES NO NO Metastatic 06 NO 6th NO YES DA Distant Metastasis A DECEASED 2005 6638cd8e-932b-438a-8c14-9aa5c87e9cf3 TCGA-DA-A1IA-06A-11D-A19B-05 6638cd8e-932b-438a-8c14-9aa5c87e9cf3 TCGA-DA-A1IA-06 TCGA-DA-A1IA-06A-11D-A194-01 TCGA-DA-A1IA-06 5ED8E9E9-E304-458E-81DC-6137E908107B TCGA-DA-A1IA-06A-11D-A196-08 TCGA-DA-A1IA-06A-11D-A196-08 TCGA-DA-A1IA-06A-11D-A194-01 TCGA-DA-A1IA-06A-11D-A196-08 6638cd8e-932b-438a-8c14-9aa5c87e9cf3 6638cd8e-932b-438a-8c14-9aa5c87e9cf3 +TCGA-DA-A1IB-06 TCGA-DA-A1IB-06 TCGA-DA-A1IB TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 69 TCGA-DA-A1IB-F71110 TCGA-DA-A1IB TCGA-DA-A1IB-06A 1.5 -25219 119 1235 0 73 33 2015-3-20 FEMALE No C77.9 8720/3 C77.9 YES 110 NO NO IV Non-glabrous skin YES NO true No M0 N2b T2b Stage IIIC TCGA-DA-A1IB.F717BD5E-0E66-4DE9-930C-68BB7E3AB8E7.pdf A1IB WITH TUMOR NO YES NO Metastatic 06 7th NO YES DA Regional Lymph Node A DECEASED 2010 25672b5b-2ac2-41dc-9aa0-a9968d05430d TCGA-DA-A1IB-06A-11D-A19B-05 25672b5b-2ac2-41dc-9aa0-a9968d05430d TCGA-DA-A1IB-06 TCGA-DA-A1IB-06A-11D-A194-01 TCGA-DA-A1IB-06 4E1B94A2-8F93-4F36-869F-5976A0197778 TCGA-DA-A1IB-06A-11D-A196-08 TCGA-DA-A1IB-06A-11D-A196-08 TCGA-DA-A1IB-06A-11D-A194-01 TCGA-DA-A1IB-06A-11D-A196-08 25672b5b-2ac2-41dc-9aa0-a9968d05430d 25672b5b-2ac2-41dc-9aa0-a9968d05430d +TCGA-DA-A1IC-06 TCGA-DA-A1IC-06 TCGA-DA-A1IC TCGA Melanoma (SKCM) skin cutaneous melanoma Skin NO 81 TCGA-DA-A1IC-F70093 TCGA-DA-A1IC TCGA-DA-A1IC-06A 2.5 -29859 1929 2071 0 1926 1930 1869 2015-1-27 MALE 175 No C49.9 8720/3 C49.9 YES 200 NO NO IV Non-glabrous skin NO Distant Metastasis NO YES Lung true No M0 N2c T3a Stage IIIB TCGA-DA-A1IC.74F640BD-4FC1-469B-9089-B7E3C04EA671.pdf A1IC WITH TUMOR NO 1 YES NO NO Metastatic 06 NO 6th NO YES DA Regional Cutaneous or Subcutaneous Tissue (includes satellite and in-transit metastasis) A DECEASED 81 2005 7e21edf0-fc0d-416d-82f0-a29e97f683d3 TCGA-DA-A1IC-06A-11D-A19C-05 7e21edf0-fc0d-416d-82f0-a29e97f683d3 TCGA-DA-A1IC-06 TCGA-DA-A1IC-06A-11D-A191-01 TCGA-DA-A1IC-06 FDAFDE58-2919-4980-BEB5-1B100CD60981 TCGA-DA-A1IC-06A-11D-A197-08 TCGA-DA-A1IC-06A-11D-A197-08 TCGA-DA-A1IC-06A-11D-A191-01 TCGA-DA-A1IC-06A-11D-A197-08 7e21edf0-fc0d-416d-82f0-a29e97f683d3 7e21edf0-fc0d-416d-82f0-a29e97f683d3 +TCGA-DA-A3F2-06 TCGA-DA-A3F2-06 TCGA-DA-A3F2 TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 55 TCGA-DA-A3F2-F71112 TCGA-DA-A3F2 TCGA-DA-A3F2-06A 5.1 -20365 534 1032 0 287 281 2015-3-20 MALE No C49.6 8720/3 C49.6 YES 140 NO NO V Non-glabrous skin NO NO true No M0 N2b T4a Stage IIIB TCGA-DA-A3F2.557E3055-9BFB-4849-AD98-E6D6510FAA42.pdf A3F2 WITH TUMOR NO 1 YES NO NO Metastatic 06 7th NO YES DA Regional Cutaneous or Subcutaneous Tissue (includes satellite and in-transit metastasis) A DECEASED 87 2010 c2ea4b59-2525-4c6c-a46a-a8d0bdeef9f3 TCGA-DA-A3F2-06A-11D-A211-05 c2ea4b59-2525-4c6c-a46a-a8d0bdeef9f3 TCGA-DA-A3F2-06 TCGA-DA-A3F2-06A-11D-A20B-01 TCGA-DA-A3F2-06 D82C6787-33E5-4C52-BA2A-86A48F566156 TCGA-DA-A3F2-06A-11D-A20D-08 TCGA-DA-A3F2-06A-11D-A20D-08 TCGA-DA-A3F2-06A-11D-A20B-01 TCGA-DA-A3F2-06A-11D-A20D-08 c2ea4b59-2525-4c6c-a46a-a8d0bdeef9f3 c2ea4b59-2525-4c6c-a46a-a8d0bdeef9f3 +TCGA-DA-A3F3-06 TCGA-DA-A3F3-06 TCGA-DA-A3F3 TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 52 TCGA-DA-A3F3-F70096 TCGA-DA-A3F3 TCGA-DA-A3F3-06A -19330 353 319 0 151 106 2015-1-27 MALE No C77.0 8720/3 C77.0 YES 250 NO NO Non-glabrous skin NO true No M0 N2b T0 Stage IIIB TCGA-DA-A3F3.66035FA9-7600-46C5-A5F5-CBD1CC1C1AD4.pdf A3F3 WITH TUMOR NO NO NO Metastatic 06 NO 7th NO YES DA Regional Lymph Node A DECEASED 2010 a4bc78e7-1b6e-47de-8209-0beaa63dd4b9 TCGA-DA-A3F3-06A-11D-A211-05 a4bc78e7-1b6e-47de-8209-0beaa63dd4b9 TCGA-DA-A3F3-06 TCGA-DA-A3F3-06A-11D-A20B-01 TCGA-DA-A3F3-06 ABC11FCD-ADA0-468E-A66B-0DA518E65418 TCGA-DA-A3F3-06A-11D-A20D-08 TCGA-DA-A3F3-06A-11D-A20D-08 TCGA-DA-A3F3-06A-11D-A20B-01 TCGA-DA-A3F3-06A-11D-A20D-08 a4bc78e7-1b6e-47de-8209-0beaa63dd4b9 a4bc78e7-1b6e-47de-8209-0beaa63dd4b9 +TCGA-DA-A3F5-06 TCGA-DA-A3F5-06 TCGA-DA-A3F5 TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 45 TCGA-DA-A3F5-F71114 TCGA-DA-A3F5 TCGA-DA-A3F5-06A 0.4 -16701 6217 6873 0 6076 6841 6019 2015-3-20 MALE No C77.0 8720/3 C77.0 YES 260 NO NO NO III Non-glabrous skin Distant Metastasis YES Lung true No M0 N0 T1a Stage I TCGA-DA-A3F5.7F4353B8-A593-4795-BB6A-BBB8C9F2BE9C.pdf A3F5 WITH TUMOR NO 1 YES NO NO Metastatic 06 4th NO YES DA Regional Lymph Node A DECEASED 1994 2b6b5499-a092-4fb6-a670-ad599db4f2cb TCGA-DA-A3F5-06A-11D-A211-05 2b6b5499-a092-4fb6-a670-ad599db4f2cb TCGA-DA-A3F5-06 TCGA-DA-A3F5-06A-11D-A20B-01 TCGA-DA-A3F5-06 58FFD48E-8ED7-49A8-8E58-2E64E213059F TCGA-DA-A3F5-06A-11D-A20D-08 TCGA-DA-A3F5-06A-11D-A20D-08 TCGA-DA-A3F5-06A-11D-A20B-01 TCGA-DA-A3F5-06A-11D-A20D-08 2b6b5499-a092-4fb6-a670-ad599db4f2cb 2b6b5499-a092-4fb6-a670-ad599db4f2cb +TCGA-DA-A3F8-06 TCGA-DA-A3F8-06 TCGA-DA-A3F8 TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 39 TCGA-DA-A3F8-F71116 TCGA-DA-A3F8 TCGA-DA-A3F8-06A 1.9 -14327 141 0 1319 26 2015-3-20 MALE No C77.0 8720/3 C77.0 YES 280 NO NO IV Non-glabrous skin NO NO true No M0 N2b T2a Stage IIIB TCGA-DA-A3F8.7FA3301F-4D8C-4785-BC7A-83A5C8080C46.pdf A3F8 TUMOR FREE NO 1 YES NO NO Metastatic 06 7th NO YES DA Regional Lymph Node A LIVING 2011 1beadfbe-9b12-4acb-85bf-3becb75fd573 TCGA-DA-A3F8-06A-11D-A211-05 1beadfbe-9b12-4acb-85bf-3becb75fd573 TCGA-DA-A3F8-06 TCGA-DA-A3F8-06A-11D-A20B-01 TCGA-DA-A3F8-06 4602A1EA-E1DF-461E-B8FD-1663DE3CEFA2 TCGA-DA-A3F8-06A-11D-A20D-08 TCGA-DA-A3F8-06A-11D-A20D-08 TCGA-DA-A3F8-06A-11D-A20B-01 TCGA-DA-A3F8-06A-11D-A20D-08 1beadfbe-9b12-4acb-85bf-3becb75fd573 1beadfbe-9b12-4acb-85bf-3becb75fd573 +TCGA-DA-A95V-06 TCGA-DA-A95V-06 TCGA-DA-A95V TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 83 TCGA-DA-A95V-F71091 TCGA-DA-A95V TCGA-DA-A95V-06A 4.10 -30623 1799 0 2193 1054 Right neck 2015-3-20 FEMALE No C77.0 8720/3 C77.0 YES 100 NO NO IV Non-glabrous skin YES NO NO true No N0 T4b Stage IIC TCGA-DA-A95V.0BCAC5F8-C578-4AF2-96AD-E632A5D92470.pdf A95V TUMOR FREE NO YES NO NO Metastatic 06 6th YES NO DA Regional Lymph Node A LIVING 2009 8bfc4614-3807-4915-8140-ad1fd72b9d2f TCGA-DA-A95V-06A-11D-A373-05 8bfc4614-3807-4915-8140-ad1fd72b9d2f TCGA-DA-A95V-06 TCGA-DA-A95V-06A-11D-A371-01 TCGA-DA-A95V-06 0F8D8D35-EF71-47B7-89F6-89285A8B3B14 TCGA-DA-A95V-06A-11D-A372-08 TCGA-DA-A95V-06A-11D-A371-01 8bfc4614-3807-4915-8140-ad1fd72b9d2f 8bfc4614-3807-4915-8140-ad1fd72b9d2f +TCGA-DA-A95W-06 TCGA-DA-A95W-06 TCGA-DA-A95W TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 52 TCGA-DA-A95W-F71093 TCGA-DA-A95W TCGA-DA-A95W-06A -19105 742 0 1136 0 2015-3-20 MALE No C77.0 8720/3 C77.0 YES 550 NO NO NO true No M0 N1b TX Stage IIIB TCGA-DA-A95W.9BCAE0D2-7454-4CCD-9850-5260ED6A192C.pdf A95W TUMOR FREE NO NO NO Metastatic 06 7th NO YES DA Regional Lymph Node A LIVING 2011 8c0fd12a-dea1-406a-891c-dd5a17e3c16b TCGA-DA-A95W-06A-11D-A373-05 8c0fd12a-dea1-406a-891c-dd5a17e3c16b TCGA-DA-A95W-06 TCGA-DA-A95W-06A-11D-A371-01 TCGA-DA-A95W-06 D0097FC2-FF06-4EA8-BFF3-5350B3F5632F TCGA-DA-A95W-06A-11D-A372-08 TCGA-DA-A95W-06A-11D-A371-01 8c0fd12a-dea1-406a-891c-dd5a17e3c16b 8c0fd12a-dea1-406a-891c-dd5a17e3c16b +TCGA-DA-A95X-06 TCGA-DA-A95X-06 TCGA-DA-A95X TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 62 TCGA-DA-A95X-F71095 TCGA-DA-A95X TCGA-DA-A95X-06A 1.45 -22718 1795 0 2249 1113 2015-3-20 MALE No C49.3 8720/3 C49.3 YES 200 NO NO IV Non-glabrous skin NO NO NO true No M0 N0 T2a Stage IB TCGA-DA-A95X.0B5B3212-7704-4CF4-BE35-E922F8A66670.pdf A95X TUMOR FREE NO 1 YES NO NO Metastatic 06 6th NO YES DA Regional Lymph Node A LIVING 2009 88441fa0-588f-4829-a353-a6b845c90333 TCGA-DA-A95X-06A-11D-A373-05 88441fa0-588f-4829-a353-a6b845c90333 TCGA-DA-A95X-06 TCGA-DA-A95X-06A-11D-A371-01 TCGA-DA-A95X-06 455D48D1-E2DF-45EE-9175-76E75078B5A0 TCGA-DA-A95X-06A-11D-A372-08 TCGA-DA-A95X-06A-11D-A371-01 88441fa0-588f-4829-a353-a6b845c90333 88441fa0-588f-4829-a353-a6b845c90333 +TCGA-DA-A95Y-06 TCGA-DA-A95Y-06 TCGA-DA-A95Y TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 68 TCGA-DA-A95Y-F70077 TCGA-DA-A95Y TCGA-DA-A95Y-06A 5.03 -25083 435 430 0 302 338 271 2015-1-27 MALE No C77.3 8720/3 C77.3 YES 360 NO NO IV Non-glabrous skin YES Distant Metastasis NO NO Lung true No M0 N0 T4b Stage IIC TCGA-DA-A95Y.1DD005AC-A9DF-4424-B859-1C0E238CC3CC.pdf A95Y WITH TUMOR NO 1 YES NO NO Metastatic 06 NO 7th NO YES DA Regional Lymph Node A DECEASED 2012 391d3fdd-34fb-4ac3-ac85-fe7b374c144b TCGA-DA-A95Y-06A-11D-A373-05 391d3fdd-34fb-4ac3-ac85-fe7b374c144b TCGA-DA-A95Y-06 TCGA-DA-A95Y-06A-11D-A371-01 TCGA-DA-A95Y-06 1E299225-798C-4936-B834-727B49E3A504 TCGA-DA-A95Y-06A-11D-A372-08 TCGA-DA-A95Y-06A-11D-A371-01 391d3fdd-34fb-4ac3-ac85-fe7b374c144b 391d3fdd-34fb-4ac3-ac85-fe7b374c144b +TCGA-DA-A95Z-06 TCGA-DA-A95Z-06 TCGA-DA-A95Z TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 87 TCGA-DA-A95Z-F70079 TCGA-DA-A95Z TCGA-DA-A95Z-06A -31837 99 0 396 0 2015-1-27 MALE No C49.6 8720/3 C49.6 YES 180 NO NO Non-glabrous skin NO NO true No M1a N0 TX Stage IV TCGA-DA-A95Z.3FB8693E-F050-46DE-BDFB-307D53713FFF.pdf A95Z TUMOR FREE NO NO NO Metastatic 06 NO 7th NO YES DA Regional Cutaneous or Subcutaneous Tissue (includes satellite and in-transit metastasis) A LIVING 2013 8d6eedc0-70d4-4e68-a706-6fdea2d87918 TCGA-DA-A95Z-06A-11D-A373-05 8d6eedc0-70d4-4e68-a706-6fdea2d87918 TCGA-DA-A95Z-06 TCGA-DA-A95Z-06A-11D-A371-01 TCGA-DA-A95Z-06 60BD401F-76B9-482E-8997-84142D2AB3C1 TCGA-DA-A95Z-06A-11D-A372-08 TCGA-DA-A95Z-06A-11D-A371-01 8d6eedc0-70d4-4e68-a706-6fdea2d87918 8d6eedc0-70d4-4e68-a706-6fdea2d87918 +TCGA-DA-A960-01 TCGA-DA-A960-01 TCGA-DA-A960 TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 73 TCGA-DA-A960-F70081 TCGA-DA-A960 TCGA-DA-A960-01A 2.32 -26708 476 0 804 396 2015-1-27 MALE No C49.1 8720/3 C49.1 YES 350 NO NO IV Non-glabrous skin YES NO NO true No M0 N0 T3b Stage IIB TCGA-DA-A960.C16D404A-9A44-4752-9CA2-623477887CF2.pdf A960 TUMOR FREE NO 1 1 YES NO NO Primary Tumor 01 NO 7th NO YES DA Regional Cutaneous or Subcutaneous Tissue (includes satellite and in-transit metastasis) A LIVING 2012 3be3b469-ecaa-4dc7-899b-8dede47b28d7 TCGA-DA-A960-01A-11D-A373-05 3be3b469-ecaa-4dc7-899b-8dede47b28d7 TCGA-DA-A960-01 TCGA-DA-A960-01 A43B7185-3599-4E78-8607-3FD11D44B8DC TCGA-DA-A960-01A-11D-A372-08 3be3b469-ecaa-4dc7-899b-8dede47b28d7 3be3b469-ecaa-4dc7-899b-8dede47b28d7 +TCGA-EB-A1NK-01 TCGA-EB-A1NK-01 TCGA-EB-A1NK TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 48 TCGA-EB-A1NK-F41212 TCGA-EB-A1NK TCGA-EB-A1NK-01A 8 -17569 63 0 1039 0 2013-3-13 MALE 184 No C44.9 8720/3 C44.9 YES 130 NO NO IV Non-glabrous skin YES NO true No M0 N0 T4b Stage IIC TCGA-EB-A1NK.F97E7885-4128-46AC-8BF3-BAE05A4413D0.pdf A1NK TUMOR FREE NO YES NO NO Primary Tumor 01 NO 7th YES NO EB Primary Tumor A LIVING 132 2010 132fbce2-00f3-4ae7-ba18-03bd55529d5a TCGA-EB-A1NK-01A-11D-A19B-05 132fbce2-00f3-4ae7-ba18-03bd55529d5a TCGA-EB-A1NK-01 TCGA-EB-A1NK-01 D5DD32C9-E481-4F24-952A-E36F3A366A25 TCGA-EB-A1NK-01A-11D-A196-08 TCGA-EB-A1NK-01A-11D-A196-08 TCGA-EB-A1NK-01A-11D-A196-08 132fbce2-00f3-4ae7-ba18-03bd55529d5a 132fbce2-00f3-4ae7-ba18-03bd55529d5a +TCGA-EB-A24C-01 TCGA-EB-A24C-01 TCGA-EB-A24C TCGA Melanoma (SKCM) skin cutaneous melanoma Skin YES NO 56 TCGA-EB-A24C-F31685 TCGA-EB-A24C TCGA-EB-A24C-01A 10 -20539 51 0 632 547 465 0 2012-5-8 MALE 180 No C44.5 8720/3 C44.5 YES 610 NO NO YES Non-glabrous skin YES Regional lymph node YES YES true No M0 NX T4b TCGA-EB-A24C.C8324D05-F859-41E1-AF45-8211A305E3CF.pdf A24C TUMOR FREE YES YES NO NO Primary Tumor 01 NO 7th YES NO EB Primary Tumor A LIVING 74 2011 cc0cd3e6-a133-4796-ab06-5adb905d5184 TCGA-EB-A24C-01A-11D-A19C-05 cc0cd3e6-a133-4796-ab06-5adb905d5184 TCGA-EB-A24C-01 TCGA-EB-A24C-01 B686E2D3-BADF-46B5-88E1-F801B9522320 TCGA-EB-A24C-01A-11D-A197-08 TCGA-EB-A24C-01A-11D-A197-08 TCGA-EB-A24C-01A-11D-A197-08 cc0cd3e6-a133-4796-ab06-5adb905d5184 cc0cd3e6-a133-4796-ab06-5adb905d5184 +TCGA-EB-A24D-01 TCGA-EB-A24D-01 TCGA-EB-A24D TCGA Melanoma (SKCM) skin cutaneous melanoma Skin YES NO 72 TCGA-EB-A24D-F31695 TCGA-EB-A24D 36 -26439 0 645 500 500 0 2012-5-8 MALE 175 No C44.6 8720/3 C44.6 YES YES Non-glabrous skin NO Regional lymph node YES YES No M0 N2b T4a Stage IIIB A24D TUMOR FREE YES YES NO NO Primary Tumor 01 NO 7th YES NO EB Primary Tumor LIVING 86 2011 f684abbc-ff21-4042-a5d8-2a0f3e22bd59 TCGA-EB-A24D-01A-11D-A19C-05 f684abbc-ff21-4042-a5d8-2a0f3e22bd59 TCGA-EB-A24D-01 TCGA-EB-A24D-01 TCGA-EB-A24D-01A-11D-A197-08 TCGA-EB-A24D-01A-11D-A197-08 TCGA-EB-A24D-01A-11D-A197-08 f684abbc-ff21-4042-a5d8-2a0f3e22bd59 f684abbc-ff21-4042-a5d8-2a0f3e22bd59 +TCGA-EB-A299-01 TCGA-EB-A299-01 TCGA-EB-A299 TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 63 TCGA-EB-A299-F36405 TCGA-EB-A299 TCGA-EB-A299-01A 2 -23322 45 0 378 0 2012-10-30 MALE 170 No C44.9 8721/3 C44.9 YES 160 NO NO NO 4 III Non-glabrous skin YES NO true No M0 N0 T2b Stage IIA TCGA-EB-A299.A5C7EB35-65E4-4544-80BA-6F20860F0571.pdf A299 TUMOR FREE NO YES NO NO Primary Tumor 01 NO 7th YES NO EB Primary Tumor A LIVING 90 2011 e1be8377-176c-4f4c-b3aa-86bbb6cd0f3a TCGA-EB-A299-01A-21D-A19C-05 e1be8377-176c-4f4c-b3aa-86bbb6cd0f3a TCGA-EB-A299-01 TCGA-EB-A299-01 7796C9E9-AAF6-469B-BB13-C5319F5DCC98 TCGA-EB-A299-01A-21D-A197-08 TCGA-EB-A299-01A-21D-A197-08 TCGA-EB-A299-01A-21D-A197-08 e1be8377-176c-4f4c-b3aa-86bbb6cd0f3a e1be8377-176c-4f4c-b3aa-86bbb6cd0f3a +TCGA-EB-A3HV-01 TCGA-EB-A3HV-01 TCGA-EB-A3HV TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 37 TCGA-EB-A3HV-F41110 TCGA-EB-A3HV TCGA-EB-A3HV-01A 13 -13712 217 0 39 0 2013-3-12 MALE 180 No C44.9 8721/3 C44.9 YES 340 NO YES IV Non-glabrous skin YES NO true No M0 N0 T4b Stage IIC TCGA-EB-A3HV.BA0FAD4F-F42F-4BE2-932B-A2908260130C.pdf A3HV WITH TUMOR YES NO NO Primary Tumor 01 7th YES NO EB Primary Tumor A LIVING 69 2011 698d84bf-2cf3-4d9e-b899-8152052a7fbc TCGA-EB-A3HV-01A-11D-A21B-05 698d84bf-2cf3-4d9e-b899-8152052a7fbc TCGA-EB-A3HV-01 TCGA-EB-A3HV-01 61956C97-68E7-41DE-8E0E-9C2EC3CCFF7A TCGA-EB-A3HV-01A-11D-A21A-08 TCGA-EB-A3HV-01A-11D-A21A-08 TCGA-EB-A3HV-01A-11D-A21A-08 698d84bf-2cf3-4d9e-b899-8152052a7fbc 698d84bf-2cf3-4d9e-b899-8152052a7fbc +TCGA-EB-A3XB-01 TCGA-EB-A3XB-01 TCGA-EB-A3XB TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 63 TCGA-EB-A3XB-F66272 TCGA-EB-A3XB TCGA-EB-A3XB-01A -23091 225 0 796 0 2014-10-7 MALE 164 No C44.9 8720/3 C44.9 YES 540 NO NO IV Non-glabrous skin NO true No M0 NX T4 Stage II TCGA-EB-A3XB.73D45CD8-5E91-4A51-B3E2-BE6B071F1A04.pdf A3XB TUMOR FREE NO YES NO Primary Tumor 01 NO 7th YES NO EB Primary Tumor A LIVING 80 2011 16e9cf50-2b80-4501-b7c9-b44494842a14 TCGA-EB-A3XB-01A-11D-A23D-05 16e9cf50-2b80-4501-b7c9-b44494842a14 TCGA-EB-A3XB-01 TCGA-EB-A3XB-01 FD88CE7F-112F-4E49-BC49-775B3CA0D788 TCGA-EB-A3XB-01A-11D-A23B-08 TCGA-EB-A3XB-01A-11D-A23B-08 16e9cf50-2b80-4501-b7c9-b44494842a14 16e9cf50-2b80-4501-b7c9-b44494842a14 +TCGA-EB-A3XC-01 TCGA-EB-A3XC-01 TCGA-EB-A3XC TCGA Melanoma (SKCM) skin cutaneous melanoma Skin NO|YES NO|NO 74 TCGA-EB-A3XC-F53288 TCGA-EB-A3XC TCGA-EB-A3XC-01A -27124 112 0 650 75|375 74|372 0 2013-12-10 MALE 178 No C44.9 8720/3 C44.9 YES 180 NO NO Non-glabrous skin YES Distant Metastasis|Regional lymph node YES|YES YES Other, Specify| Chest wall| true No M0 N0 T4b Stage IIC TCGA-EB-A3XC.F2263A67-85EC-4478-BFCD-56C8BE4874DC.pdf A3XC TUMOR FREE NO 1 YES NO NO Primary Tumor 01 NO 7th YES NO EB Primary Tumor A LIVING 70 2012 8b4c42a9-7d09-4989-a0e2-43abb6097137 TCGA-EB-A3XC-01A-11D-A23D-05 8b4c42a9-7d09-4989-a0e2-43abb6097137 TCGA-EB-A3XC-01 TCGA-EB-A3XC-01 F5B679EB-B613-4A61-9B75-A5E6233C00BF TCGA-EB-A3XC-01A-11D-A23B-08 TCGA-EB-A3XC-01A-11D-A23B-08 8b4c42a9-7d09-4989-a0e2-43abb6097137 8b4c42a9-7d09-4989-a0e2-43abb6097137 +TCGA-EB-A3XD-01 TCGA-EB-A3XD-01 TCGA-EB-A3XD TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 53 TCGA-EB-A3XD-F71530 TCGA-EB-A3XD TCGA-EB-A3XD-01A -19431 170 0 1160 0 2015-3-26 FEMALE 164 No C44.9 8720/3 C44.9 YES 430 NO NO Non-glabrous skin NO true No M0 NX T4b Stage IIC TCGA-EB-A3XD.BDCBD4B2-6F4E-4D85-9B28-2B33BF7222F1.pdf A3XD TUMOR FREE NO 1 YES NO NO Primary Tumor 01 NO 7th YES NO EB Primary Tumor A LIVING 80 2011 b045331f-5cb5-4be4-896f-e4c60d5aad8f TCGA-EB-A3XD-01A-22D-A23D-05 b045331f-5cb5-4be4-896f-e4c60d5aad8f TCGA-EB-A3XD-01 TCGA-EB-A3XD-01 632DE212-AE49-442B-B196-30E06E89628C TCGA-EB-A3XD-01A-22D-A23B-08 TCGA-EB-A3XD-01A-22D-A23B-08 b045331f-5cb5-4be4-896f-e4c60d5aad8f b045331f-5cb5-4be4-896f-e4c60d5aad8f +TCGA-EB-A3XE-01 TCGA-EB-A3XE-01 TCGA-EB-A3XE TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 77 TCGA-EB-A3XE-F42007 TCGA-EB-A3XE TCGA-EB-A3XE-01A 3 -28148 113 0 180 0 2013-4-9 FEMALE 158 No C44.9 8720/3 C44.9 YES 590 NO YES Non-glabrous skin NO NO true No M0 N0 T3a Stage IIA TCGA-EB-A3XE.0495197B-B5CD-484A-8531-34ADE693294B.pdf A3XE TUMOR FREE NO 1 YES NO NO Primary Tumor 01 NO 7th YES NO EB Primary Tumor A LIVING 62 2012 b28d2b0f-9c6c-451c-a77b-5beaa8c46fad TCGA-EB-A3XE-01A-12D-A23D-05 b28d2b0f-9c6c-451c-a77b-5beaa8c46fad TCGA-EB-A3XE-01 TCGA-EB-A3XE-01 005189AA-606F-494A-8DF5-A4AACD586032 TCGA-EB-A3XE-01A-12D-A23B-08 TCGA-EB-A3XE-01A-12D-A23B-08 b28d2b0f-9c6c-451c-a77b-5beaa8c46fad b28d2b0f-9c6c-451c-a77b-5beaa8c46fad +TCGA-EB-A3XF-01 TCGA-EB-A3XF-01 TCGA-EB-A3XF TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 57 TCGA-EB-A3XF-F42010 TCGA-EB-A3XF TCGA-EB-A3XF-01A 10 -20910 112 0 278 0 2013-4-9 MALE 182 No C44.9 8720/3 C44.9 YES 930 NO YES Non-glabrous skin YES NO true No M0 N0 T4b Stage IIC TCGA-EB-A3XF.33B18494-DFE3-45C4-9EDB-75A8747632D6.pdf A3XF TUMOR FREE NO YES NO NO Primary Tumor 01 NO 7th YES NO EB Primary Tumor A LIVING 88 2012 fe6954b6-8214-41d8-b7f9-2ced8727408d TCGA-EB-A3XF-01A-31D-A23D-05 fe6954b6-8214-41d8-b7f9-2ced8727408d TCGA-EB-A3XF-01 TCGA-EB-A3XF-01 BA854542-CA49-4192-A242-03D3BC272820 TCGA-EB-A3XF-01A-31D-A23B-08 fe6954b6-8214-41d8-b7f9-2ced8727408d fe6954b6-8214-41d8-b7f9-2ced8727408d +TCGA-EB-A3Y6-01 TCGA-EB-A3Y6-01 TCGA-EB-A3Y6 TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 56 TCGA-EB-A3Y6-F46393 TCGA-EB-A3Y6 TCGA-EB-A3Y6-01A 4.5 -20605 129 0 126 0 2013-9-19 FEMALE 168 No C49.2 8720/3 C49.2 YES 470 NO YES Non-glabrous skin YES NO true No M0 N0 T4b Stage IIC TCGA-EB-A3Y6.BD058487-A37C-4BB1-AC9E-FE492F83F0E6.pdf A3Y6 TUMOR FREE YES YES NO NO Primary Tumor 01 NO 7th YES NO EB Primary Tumor A LIVING 65 2012 263de7ad-d70e-4e10-b406-1d2e368a99b2 TCGA-EB-A3Y6-01A-21D-A23D-05 263de7ad-d70e-4e10-b406-1d2e368a99b2 TCGA-EB-A3Y6-01 TCGA-EB-A3Y6-01 911D8AF3-FF61-4DC5-AB6B-AABF1327B6E4 TCGA-EB-A3Y6-01A-21D-A23B-08 TCGA-EB-A3Y6-01A-21D-A23B-08 263de7ad-d70e-4e10-b406-1d2e368a99b2 263de7ad-d70e-4e10-b406-1d2e368a99b2 +TCGA-EB-A3Y7-01 TCGA-EB-A3Y7-01 TCGA-EB-A3Y7 TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 86 TCGA-EB-A3Y7-F46394 TCGA-EB-A3Y7 TCGA-EB-A3Y7-01A 4 -31622 111 326 0 0 0 2013-8-7 FEMALE 146 No C49.0 8720/3 C49.0 YES 460 NO NO Non-glabrous skin NO NO true No M0 N2c T3a Stage IIIB TCGA-EB-A3Y7.E9D3A87B-37FB-4FAF-854F-373DE709EE14.pdf A3Y7 TUMOR FREE NO YES NO NO Primary Tumor 01 NO 7th YES NO EB Primary Tumor A DECEASED 55 2012 ba8ba1ac-8313-49f7-be6f-10a6aa774dfe TCGA-EB-A3Y7-01A-11D-A23D-05 ba8ba1ac-8313-49f7-be6f-10a6aa774dfe TCGA-EB-A3Y7-01 TCGA-EB-A3Y7-01 DA4DBE3A-5455-4D5A-864A-2229E4EAC8D6 TCGA-EB-A3Y7-01A-11D-A23B-08 TCGA-EB-A3Y7-01A-11D-A23B-08 ba8ba1ac-8313-49f7-be6f-10a6aa774dfe ba8ba1ac-8313-49f7-be6f-10a6aa774dfe +TCGA-EB-A41A-01 TCGA-EB-A41A-01 TCGA-EB-A41A TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 90 TCGA-EB-A41A-F46395 TCGA-EB-A41A TCGA-EB-A41A-01A 7 -32872 121 0 262 0 2013-9-19 MALE 162 No C44.3 8772/3 C44.3 YES 840 NO YES Non-glabrous skin YES NO true No M0 N0 T4b Stage IIC TCGA-EB-A41A.C9E916B1-F244-483F-8627-4596CD27B6F8.pdf A41A TUMOR FREE NO YES NO NO Primary Tumor 01 NO 7th YES NO EB Primary Tumor A LIVING 63 2012 57e2418c-e87f-4dcd-9e9d-1e2eb4e68ef0 TCGA-EB-A41A-01A-11D-A24V-05 57e2418c-e87f-4dcd-9e9d-1e2eb4e68ef0 TCGA-EB-A41A-01 TCGA-EB-A41A-01 7EDF79D6-D520-4E79-861E-5BCE682B6BD6 TCGA-EB-A41A-01A-11D-A24R-08 TCGA-EB-A41A-01A-11D-A24R-08 57e2418c-e87f-4dcd-9e9d-1e2eb4e68ef0 57e2418c-e87f-4dcd-9e9d-1e2eb4e68ef0 +TCGA-EB-A41B-01 TCGA-EB-A41B-01 TCGA-EB-A41B TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 76 TCGA-EB-A41B-F42011 TCGA-EB-A41B TCGA-EB-A41B-01A 28 -27998 119 0 291 0 2013-4-9 FEMALE 150 No C44.6 8721/3 C44.6 YES 780 NO YES V Non-glabrous skin YES NO true No M0 N0 T4b Stage IIC TCGA-EB-A41B.D40D44B2-6D36-45BF-9203-C7A9BD420DE6.pdf A41B TUMOR FREE NO YES NO NO Primary Tumor 01 NO 7th YES NO EB Primary Tumor A LIVING 53 2012 53bce93f-fa43-4596-839b-5d7d258de40c TCGA-EB-A41B-01A-11D-A24V-05 53bce93f-fa43-4596-839b-5d7d258de40c TCGA-EB-A41B-01 TCGA-EB-A41B-01 7EBFA686-045C-460A-9803-A54008F41204 TCGA-EB-A41B-01A-11D-A24R-08 TCGA-EB-A41B-01A-11D-A24R-08 53bce93f-fa43-4596-839b-5d7d258de40c 53bce93f-fa43-4596-839b-5d7d258de40c +TCGA-EB-A42Y-01 TCGA-EB-A42Y-01 TCGA-EB-A42Y TCGA Melanoma (SKCM) skin cutaneous melanoma Skin NO NO 73 TCGA-EB-A42Y-F68081 TCGA-EB-A42Y TCGA-EB-A42Y-01A 5 -26712 99 721 0 6 721 0 2014-11-13 FEMALE 152 No C44.6 8720/3 C44.6 YES 650 NO NO Non-glabrous skin YES Regional lymph node NO YES true No M0 N0 T4b Stage IIC TCGA-EB-A42Y.B7081129-C993-4046-829F-4CECF0DCB12E.pdf A42Y WITH TUMOR NO YES NO NO Primary Tumor 01 NO 7th YES NO EB Primary Tumor A DECEASED 43 2012 c64dae2c-79f4-475b-92cc-b6080752040e TCGA-EB-A42Y-01A-12D-A24V-05 c64dae2c-79f4-475b-92cc-b6080752040e TCGA-EB-A42Y-01 TCGA-EB-A42Y-01 C3A2DE32-605E-4CF3-BA30-F1B43ACE2269 TCGA-EB-A42Y-01A-12D-A24R-08 TCGA-EB-A42Y-01A-12D-A24R-08 c64dae2c-79f4-475b-92cc-b6080752040e c64dae2c-79f4-475b-92cc-b6080752040e +TCGA-EB-A42Z-01 TCGA-EB-A42Z-01 TCGA-EB-A42Z TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 49 TCGA-EB-A42Z-F68083 TCGA-EB-A42Z TCGA-EB-A42Z-01A 10 -18157 100 0 12 0 2014-11-24 MALE 165 No C44.9 8720/3 C44.9 YES 1050 NO YES Non-glabrous skin YES NO true No M0 N1b T4b Stage IIIC TCGA-EB-A42Z.71C108F9-92F6-4DB0-BD3B-6E3DC8427E03.pdf A42Z TUMOR FREE NO YES NO NO Primary Tumor 01 7th YES NO EB Primary Tumor A LIVING 50 2012 211b5190-b873-4c7c-858e-d0b321ac8ffb TCGA-EB-A42Z-01A-12D-A24V-05 211b5190-b873-4c7c-858e-d0b321ac8ffb TCGA-EB-A42Z-01 TCGA-EB-A42Z-01 664A1C71-9372-4C2F-8C90-BD4FF43EDADE TCGA-EB-A42Z-01A-12D-A24R-08 TCGA-EB-A42Z-01A-12D-A24R-08 211b5190-b873-4c7c-858e-d0b321ac8ffb 211b5190-b873-4c7c-858e-d0b321ac8ffb +TCGA-EB-A430-01 TCGA-EB-A430-01 TCGA-EB-A430 TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 83 TCGA-EB-A430-F57899 TCGA-EB-A430 TCGA-EB-A430-01A 18 -30344 125 0 -2 0 2014-4-21 MALE 168 No C44.5 8721/3 C44.5 YES 1800 NO YES IV Non-glabrous skin YES NO true No M0 N0 T4b Stage IIC TCGA-EB-A430.CAF377CF-8A98-4334-B6A7-831024B5A5A6.pdf A430 TUMOR FREE NO YES NO NO Primary Tumor 01 7th YES NO EB Primary Tumor A LIVING 85 2012 99fa82f0-527e-4ed6-bead-516c21ab97be TCGA-EB-A430-01A-11D-A24V-05 99fa82f0-527e-4ed6-bead-516c21ab97be TCGA-EB-A430-01 TCGA-EB-A430-01 8D4D9BF5-1594-4B70-988E-1830891FAB4A TCGA-EB-A430-01A-11D-A24R-08 TCGA-EB-A430-01A-11D-A24R-08 99fa82f0-527e-4ed6-bead-516c21ab97be 99fa82f0-527e-4ed6-bead-516c21ab97be +TCGA-EB-A431-01 TCGA-EB-A431-01 TCGA-EB-A431 TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 34 TCGA-EB-A431-F53430 TCGA-EB-A431 TCGA-EB-A431-01A 15 -12484 135 0 568 0 2013-12-11 MALE 170 No C44.9 8721/3 C44.9 YES 160 NO NO III Non-glabrous skin YES NO true No M0 N0 T4b Stage IIC TCGA-EB-A431.BE192A00-38C3-4374-AC39-B27E66D83F10.pdf A431 TUMOR FREE NO YES NO NO Primary Tumor 01 NO 7th YES NO EB Primary Tumor A LIVING 62 2012 d19e0e12-91bc-4ba0-b966-f29e3ba9c1c4 TCGA-EB-A431-01A-11D-A25S-05 d19e0e12-91bc-4ba0-b966-f29e3ba9c1c4 TCGA-EB-A431-01 TCGA-EB-A431-01 95AE8436-716A-4FAF-A3BC-9FF97EAC808F TCGA-EB-A431-01A-11D-A25O-08 TCGA-EB-A431-01A-11D-A25O-08 d19e0e12-91bc-4ba0-b966-f29e3ba9c1c4 d19e0e12-91bc-4ba0-b966-f29e3ba9c1c4 +TCGA-EB-A44N-01 TCGA-EB-A44N-01 TCGA-EB-A44N TCGA Melanoma (SKCM) skin cutaneous melanoma Skin NO|NO|NO NO|NO|NO 59 TCGA-EB-A44N-F53295 TCGA-EB-A44N TCGA-EB-A44N-01A 5 -21623 150 205 0 45 134 115|162|162 0 2013-12-10 MALE 183 No C44.9 8721/3 C44.9 YES 100 NO NO III Non-glabrous skin YES Regional lymph node|Distant Metastasis|Distant Metastasis YES|NO|NO YES |Bone|Liver true No M0 N0 T4b Stage IIC TCGA-EB-A44N.506BDF80-398A-48F9-B1D4-FAF8FBB4BD1A.pdf A44N WITH TUMOR NO YES NO NO Primary Tumor 01 NO 7th YES NO EB Primary Tumor A DECEASED 70 2012 bccae620-c677-4793-afe6-942ca71b8aa9 TCGA-EB-A44N-01A-11D-A25S-05 bccae620-c677-4793-afe6-942ca71b8aa9 TCGA-EB-A44N-01 TCGA-EB-A44N-01 8D774A51-9737-4A5D-A8F6-229E4B839EC9 TCGA-EB-A44N-01A-11D-A25O-08 TCGA-EB-A44N-01A-11D-A25O-08 bccae620-c677-4793-afe6-942ca71b8aa9 bccae620-c677-4793-afe6-942ca71b8aa9 +TCGA-EB-A44O-01 TCGA-EB-A44O-01 TCGA-EB-A44O TCGA Melanoma (SKCM) skin cutaneous melanoma Skin NO NO 69 TCGA-EB-A44O-F49896 TCGA-EB-A44O TCGA-EB-A44O-01A 5 -25537 126 0 81 61 60 0 2013-10-14 MALE 182 No C44.5 8720/3 C44.5 YES 370 NO YES Non-glabrous skin NO Regional lymph node YES YES true No M0 N0 T4a Stage IIB TCGA-EB-A44O.3278362B-3B5D-4369-B9B7-CC5B33C4303B.pdf A44O WITH TUMOR NO YES NO NO Primary Tumor 01 NO 7th YES NO EB Primary Tumor A LIVING 89 2012 ca261986-2f65-4998-89b7-e9c55a972574 TCGA-EB-A44O-01A-11D-A25S-05 ca261986-2f65-4998-89b7-e9c55a972574 TCGA-EB-A44O-01 TCGA-EB-A44O-01 933F3E71-37D0-458C-9881-B9EE1501210D TCGA-EB-A44O-01A-11D-A25O-08 TCGA-EB-A44O-01A-11D-A25O-08 ca261986-2f65-4998-89b7-e9c55a972574 ca261986-2f65-4998-89b7-e9c55a972574 +TCGA-EB-A44P-01 TCGA-EB-A44P-01 TCGA-EB-A44P TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 58 TCGA-EB-A44P-F61876 TCGA-EB-A44P TCGA-EB-A44P-01A -21519 94 0 741 0 2014-7-9 FEMALE 164 No C44.5 8720/3 C44.5 YES 790 NO NO Non-glabrous skin NO NO true No M0 N0 T4b Stage IIC TCGA-EB-A44P.820D5744-25BF-46E9-8832-57953EF4ECC1.pdf A44P TUMOR FREE NO YES NO Primary Tumor 01 NO 7th YES NO EB Primary Tumor A LIVING 68 2012 b52048c3-ea1d-43b4-8276-c2476181b0aa TCGA-EB-A44P-01A-11D-A25S-05 b52048c3-ea1d-43b4-8276-c2476181b0aa TCGA-EB-A44P-01 TCGA-EB-A44P-01 1C5B2E01-8DAA-4CB8-8BDF-E1AAC0A062BC TCGA-EB-A44P-01A-11D-A25O-08 TCGA-EB-A44P-01A-11D-A25O-08 b52048c3-ea1d-43b4-8276-c2476181b0aa b52048c3-ea1d-43b4-8276-c2476181b0aa +TCGA-EB-A44Q-06 TCGA-EB-A44Q-06 TCGA-EB-A44Q TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 51 TCGA-EB-A44Q-F68084 TCGA-EB-A44Q TCGA-EB-A44Q-06A -18910 92 0 28 22 2014-11-24 FEMALE 154 No C77.4 8720/3 C77.4 YES 1720 NO YES Non-glabrous skin YES YES true No M0 N3 TX Stage IIIC TCGA-EB-A44Q.AC3C89E0-DE03-45B9-8360-1207D39A261B.pdf A44Q TUMOR FREE YES NO NO Metastatic 06 7th YES NO EB Regional Lymph Node A LIVING 47 2012 9468dafd-1f25-4bb6-a92b-478a2e3347d0 TCGA-EB-A44Q-06A-11D-A25S-05 9468dafd-1f25-4bb6-a92b-478a2e3347d0 TCGA-EB-A44Q-06 TCGA-EB-A44Q-06A-11D-A25P-01 TCGA-EB-A44Q-06 55C05882-BA89-4C48-82A8-2F2680B75F15 TCGA-EB-A44Q-06A-11D-A25O-08 TCGA-EB-A44Q-06A-11D-A25O-08 TCGA-EB-A44Q-06A-11D-A25P-01 9468dafd-1f25-4bb6-a92b-478a2e3347d0 9468dafd-1f25-4bb6-a92b-478a2e3347d0 +TCGA-EB-A44R-06 TCGA-EB-A44R-06 TCGA-EB-A44R TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 52 TCGA-EB-A44R-F46033 TCGA-EB-A44R TCGA-EB-A44R-06A -19298 372 315 0 309 303 2013-9-10 MALE 164 No C77.4 8720/3 C77.4 YES 940 NO NO Non-glabrous skin NO true No M0 N2b TX Stage IIIB TCGA-EB-A44R.A1170F13-22F2-4A5B-9316-D35C17863E76.pdf A44R TUMOR FREE NO 1 1 YES NO NO Metastatic 06 NO 7th YES NO EB Regional Lymph Node A DECEASED 53 2011 6d6ae00d-66bd-4a2b-9715-9b7347d1035e TCGA-EB-A44R-06A-41D-A25S-05 6d6ae00d-66bd-4a2b-9715-9b7347d1035e TCGA-EB-A44R-06 TCGA-EB-A44R-06A-41D-A25P-01 TCGA-EB-A44R-06 A23B646B-37F6-46B2-A9EC-E3ED19AD381A TCGA-EB-A44R-06A-41D-A25O-08 TCGA-EB-A44R-06A-41D-A25O-08 TCGA-EB-A44R-06A-41D-A25P-01 6d6ae00d-66bd-4a2b-9715-9b7347d1035e 6d6ae00d-66bd-4a2b-9715-9b7347d1035e +TCGA-EB-A4IQ-01 TCGA-EB-A4IQ-01 TCGA-EB-A4IQ TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 42 TCGA-EB-A4IQ-F68558 TCGA-EB-A4IQ TCGA-EB-A4IQ-01A 15 -15516 71 636 0 4 0 2014-11-26 FEMALE 150 No C44.5 8720/3 C44.5 YES 880 NO NO Non-glabrous skin YES NO true No M0 N1 T4b Stage IIIB TCGA-EB-A4IQ.9EA1A9DE-540F-4DDA-BF6C-203342F47C7A.pdf A4IQ TUMOR FREE 1 YES NO NO Primary Tumor 01 NO 7th YES NO EB Primary Tumor A DECEASED 40 2012 627117b2-d9b5-4549-92e3-8677ddfdd1c9 TCGA-EB-A4IQ-01A-12D-A25S-05 627117b2-d9b5-4549-92e3-8677ddfdd1c9 TCGA-EB-A4IQ-01 TCGA-EB-A4IQ-01 B66ADA0D-CE44-4B12-AB16-F489611EE7E3 TCGA-EB-A4IQ-01A-12D-A25O-08 TCGA-EB-A4IQ-01A-12D-A25O-08 627117b2-d9b5-4549-92e3-8677ddfdd1c9 627117b2-d9b5-4549-92e3-8677ddfdd1c9 +TCGA-EB-A4IS-01 TCGA-EB-A4IS-01 TCGA-EB-A4IS TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 77 TCGA-EB-A4IS-F66482 TCGA-EB-A4IS TCGA-EB-A4IS-01A 2.5 -28315 70 0 774 0 2014-10-16 MALE 155 No C44.5 8720/3 C44.5 YES 470 NO NO Non-glabrous skin YES NO true No M0 NX T3b Stage IIB TCGA-EB-A4IS.5BFDB360-698E-40AB-A36A-09CD794C9BA7.pdf A4IS TUMOR FREE NO YES NO NO Primary Tumor 01 NO 7th YES NO EB Primary Tumor A LIVING 80 2012 eb7d8769-1014-4a97-bf28-c6bdd257b9b7 TCGA-EB-A4IS-01A-21D-A25S-05 eb7d8769-1014-4a97-bf28-c6bdd257b9b7 TCGA-EB-A4IS-01 TCGA-EB-A4IS-01 5FCA54C7-0928-4728-B7CF-E952ED67CB2A TCGA-EB-A4IS-01A-21D-A25O-08 TCGA-EB-A4IS-01A-21D-A25O-08 eb7d8769-1014-4a97-bf28-c6bdd257b9b7 eb7d8769-1014-4a97-bf28-c6bdd257b9b7 +TCGA-EB-A4OY-01 TCGA-EB-A4OY-01 TCGA-EB-A4OY TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 65 TCGA-EB-A4OY-F68729 TCGA-EB-A4OY TCGA-EB-A4OY-01A 10 -23773 186 0 977 -2 2014-12-12 FEMALE 172 No C44.7 8720/3 C44.7 YES 670 NO NO V Non-glabrous skin NO true No M0 N1a T4b Stage IIIB TCGA-EB-A4OY.F5BCA762-3B92-4B86-96D9-A88C7D06967A.pdf A4OY TUMOR FREE YES YES NO Primary Tumor 01 NO 7th YES NO EB Primary Tumor A LIVING 87 2012 3f0e21a1-5cc9-4ff0-81c2-4d67a440dca2 TCGA-EB-A4OY-01A-11D-A25S-05 3f0e21a1-5cc9-4ff0-81c2-4d67a440dca2 TCGA-EB-A4OY-01 TCGA-EB-A4OY-01 28AF974E-342D-4DD9-99DA-31217DF9BF7D TCGA-EB-A4OY-01A-11D-A25O-08 TCGA-EB-A4OY-01A-11D-A25O-08 3f0e21a1-5cc9-4ff0-81c2-4d67a440dca2 3f0e21a1-5cc9-4ff0-81c2-4d67a440dca2 +TCGA-EB-A4OZ-01 TCGA-EB-A4OZ-01 TCGA-EB-A4OZ TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 41 TCGA-EB-A4OZ-F57681 TCGA-EB-A4OZ TCGA-EB-A4OZ-01A 18 -15337 118 0 620 0 2014-3-19 FEMALE 170 No C44.5 8720/3 C44.5 YES 1230 NO NO V Non-glabrous skin NO NO true No M0 N3 T4a Stage IIIC TCGA-EB-A4OZ.4FBDBC67-99E1-4BB5-B713-34054272207A.pdf A4OZ TUMOR FREE YES YES NO Primary Tumor 01 NO 7th YES NO EB Primary Tumor A LIVING 80 2012 fbbc0349-e189-4f35-8c96-15c57b53f602 TCGA-EB-A4OZ-01A-12D-A25S-05 fbbc0349-e189-4f35-8c96-15c57b53f602 TCGA-EB-A4OZ-01 TCGA-EB-A4OZ-01 A5D6E7E9-F734-4AD8-8FB3-C9877935D637 TCGA-EB-A4OZ-01A-12D-A25O-08 TCGA-EB-A4OZ-01A-12D-A25O-08 fbbc0349-e189-4f35-8c96-15c57b53f602 fbbc0349-e189-4f35-8c96-15c57b53f602 +TCGA-EB-A4P0-01 TCGA-EB-A4P0-01 TCGA-EB-A4P0 TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 82 TCGA-EB-A4P0-F57682 TCGA-EB-A4P0 8 -30225 326 0 -2 0 2014-3-19 MALE 178 No C44.5 8730/3 C44.5 YES NO IV Non-glabrous skin YES NO No M0 N0 T4b Stage IIC A4P0 TUMOR FREE NO YES NO Primary Tumor 01 NO 7th YES NO EB Primary Tumor DECEASED 76 2012 f1106aed-99c5-4504-9297-7e4e6c722182 TCGA-EB-A4P0-01A-41D-A25S-05 f1106aed-99c5-4504-9297-7e4e6c722182 TCGA-EB-A4P0-01 TCGA-EB-A4P0-01 TCGA-EB-A4P0-01A-41D-A25O-08 TCGA-EB-A4P0-01A-41D-A25O-08 f1106aed-99c5-4504-9297-7e4e6c722182 f1106aed-99c5-4504-9297-7e4e6c722182 +TCGA-EB-A4XL-01 TCGA-EB-A4XL-01 TCGA-EB-A4XL TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 56 TCGA-EB-A4XL-F59743 TCGA-EB-A4XL TCGA-EB-A4XL-01A 7 -20486 218 0 777 0 2014-5-20 FEMALE 168 No C44.9 8721/3 C44.9 YES 220 NO NO IV Non-glabrous skin YES NO true No M0 NX T4b Stage IIC TCGA-EB-A4XL.7578E846-075C-47C6-ABAC-C6F2F54D0199.pdf A4XL TUMOR FREE NO 1 1 YES NO NO Primary Tumor 01 NO 7th YES NO EB Primary Tumor A LIVING 52 2012 f77473c0-198d-4993-9a5e-8b345ad0a485 TCGA-EB-A4XL-01A-11D-A27L-05 f77473c0-198d-4993-9a5e-8b345ad0a485 TCGA-EB-A4XL-01 TCGA-EB-A4XL-01 0659F445-FF28-482A-B535-45F26EF9DC0F TCGA-EB-A4XL-01A-11D-A27K-08 f77473c0-198d-4993-9a5e-8b345ad0a485 f77473c0-198d-4993-9a5e-8b345ad0a485 +TCGA-EB-A51B-01 TCGA-EB-A51B-01 TCGA-EB-A51B TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 53 TCGA-EB-A51B-F70558 TCGA-EB-A51B TCGA-EB-A51B-01A 10 -19645 100 0 931 0 2015-2-24 MALE 173 No C44.6 8720/3 C44.6 YES 670 NO NO III Non-glabrous skin YES NO true No M0 NX T4b Stage IIC TCGA-EB-A51B.1A6396C6-C927-4A05-ADA3-0206DD8AA6AD.pdf A51B TUMOR FREE NO 1 YES NO Primary Tumor 01 NO 7th YES NO EB Primary Tumor A LIVING 94 2012 035590dc-c5f6-461e-9160-b4e2b6faea29 TCGA-EB-A51B-01A-11D-A27L-05 035590dc-c5f6-461e-9160-b4e2b6faea29 TCGA-EB-A51B-01 TCGA-EB-A51B-01 TCGA-EB-A51B-01A-11D-A27K-08 035590dc-c5f6-461e-9160-b4e2b6faea29 035590dc-c5f6-461e-9160-b4e2b6faea29 +TCGA-EB-A550-01 TCGA-EB-A550-01 TCGA-EB-A550 TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 75 TCGA-EB-A550-F57901 TCGA-EB-A550 TCGA-EB-A550-01A 15 -27556 125 264 0 6 0 2014-3-28 FEMALE 158 No C44.5 8720/3 C44.5 YES 1130 NO NO IV Non-glabrous skin YES NO true No M0 NX T4b Stage IIC TCGA-EB-A550.3927A15E-DD1B-42A2-8B23-D9BA20D1287A.pdf A550 TUMOR FREE YES YES NO Primary Tumor 01 NO 7th YES NO EB Primary Tumor A DECEASED 70 2012 d1bbd8aa-a941-4640-ac65-0d8335f8f998 TCGA-EB-A550-01A-61D-A27L-05 d1bbd8aa-a941-4640-ac65-0d8335f8f998 TCGA-EB-A550-01 TCGA-EB-A550-01 18AAC49E-173B-4813-A7A4-A15C9623063E TCGA-EB-A550-01A-61D-A27K-08 d1bbd8aa-a941-4640-ac65-0d8335f8f998 d1bbd8aa-a941-4640-ac65-0d8335f8f998 +TCGA-EB-A551-01 TCGA-EB-A551-01 TCGA-EB-A551 TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 78 TCGA-EB-A551-F57900 TCGA-EB-A551 TCGA-EB-A551-01A 10 -28671 107 0 590 0 2014-3-28 FEMALE 172 No C44.7 8730/3 C44.7 YES 1570 NO NO V Non-glabrous skin YES NO true No M0 N2b T4b Stage IIIC TCGA-EB-A551.29982C1C-609A-41B3-BB1E-47B568E3F035.pdf A551 TUMOR FREE NO YES NO Primary Tumor 01 NO 7th YES NO EB Primary Tumor A LIVING 65 2012 f6a82106-49f5-41e7-99e1-36aaa9815760 TCGA-EB-A551-01A-21D-A27L-05 f6a82106-49f5-41e7-99e1-36aaa9815760 TCGA-EB-A551-01 TCGA-EB-A551-01 6FDE03DD-47D0-4E8B-8FCB-AACAE5C3DAA4 TCGA-EB-A551-01A-21D-A27K-08 TCGA-EB-A551-01A-21D-A27K-08 f6a82106-49f5-41e7-99e1-36aaa9815760 f6a82106-49f5-41e7-99e1-36aaa9815760 +TCGA-EB-A553-01 TCGA-EB-A553-01 TCGA-EB-A553 TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 62 TCGA-EB-A553-F51474 TCGA-EB-A553 TCGA-EB-A553-01A 10 -22972 95 0 226 0 2013-11-19 MALE 164 No C44.5 8720/3 C44.5 YES 540 NO YES Non-glabrous skin YES NO true No M0 N0 T4b Stage IIC TCGA-EB-A553.4AD7A32C-248E-4BF1-99B3-505367A18DDC.pdf A553 TUMOR FREE YES YES NO Primary Tumor 01 NO 7th YES NO EB Primary Tumor A LIVING 74 2012 d3cfdddc-7b8b-4bc4-9e6c-8912894a2e52 TCGA-EB-A553-01A-12D-A27L-05 d3cfdddc-7b8b-4bc4-9e6c-8912894a2e52 76CDB10E-D02F-4196-B962-3A4E361BDE62 TCGA-EB-A553-01A-12D-A27K-08 TCGA-EB-A553-01A-12D-A27K-08 d3cfdddc-7b8b-4bc4-9e6c-8912894a2e52 d3cfdddc-7b8b-4bc4-9e6c-8912894a2e52 +TCGA-EB-A57M-01 TCGA-EB-A57M-01 TCGA-EB-A57M TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 56 TCGA-EB-A57M-F70325 TCGA-EB-A57M TCGA-EB-A57M-01A 8 -20698 93 472 0 8 0 2015-2-4 MALE 168 No C44.7 8720/3 C44.7 YES 1010 NO NO Non-glabrous skin YES NO true No M0 N1 T4b Stage IIIB TCGA-EB-A57M.CE05E5B1-1D6C-4B7E-A32E-846E80477075.pdf A57M TUMOR FREE YES 1 1 YES NO NO Primary Tumor 01 NO 7th YES NO EB Primary Tumor A DECEASED 61 2012 9b4ef47f-4141-4d84-b5e8-a7b6e6c2a7ef TCGA-EB-A57M-01A-51D-A30Z-05 9b4ef47f-4141-4d84-b5e8-a7b6e6c2a7ef TCGA-EB-A57M-01 TCGA-EB-A57M-01 EE6C89AB-D5F3-481A-8ED6-780F2ED3DEEB TCGA-EB-A57M-01A-51D-A30X-08 TCGA-EB-A57M-01A-51D-A30X-08 9b4ef47f-4141-4d84-b5e8-a7b6e6c2a7ef 9b4ef47f-4141-4d84-b5e8-a7b6e6c2a7ef +TCGA-EB-A5FP-01 TCGA-EB-A5FP-01 TCGA-EB-A5FP TCGA Melanoma (SKCM) skin cutaneous melanoma Skin YES|YES NO|NO 65 TCGA-EB-A5FP-F56483 TCGA-EB-A5FP TCGA-EB-A5FP-01A 8 -23833 83 454 0 6 24|24 11 2014-2-10 FEMALE 180 No C44.9 8720/3 C44.9 YES 230 NO NO Non-glabrous skin YES Regional lymph node|Distant Metastasis NO|NO YES |Lung true No M1b NX T4b Stage IV TCGA-EB-A5FP.2AE044E0-B794-48DB-9A3A-1E0D7CBE9301.pdf A5FP WITH TUMOR NO 1 1 YES NO NO Primary Tumor 01 NO 7th YES NO EB Primary Tumor A DECEASED 82 2012 83b592f7-21ce-4e32-aaf4-3f9402f48284 TCGA-EB-A5FP-01A-11D-A27L-05 83b592f7-21ce-4e32-aaf4-3f9402f48284 TCGA-EB-A5FP-01 TCGA-EB-A5FP-01 1D1780B7-56E7-4BE9-9EE3-EB0214E55F77 TCGA-EB-A5FP-01A-11D-A27K-08 83b592f7-21ce-4e32-aaf4-3f9402f48284 83b592f7-21ce-4e32-aaf4-3f9402f48284 +TCGA-EB-A5KH-06 TCGA-EB-A5KH-06 TCGA-EB-A5KH TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 55 TCGA-EB-A5KH-F51001 TCGA-EB-A5KH TCGA-EB-A5KH-06A -20424 648 619 0 543 539 2013-11-5 MALE 172 No C77.4 8720/3 C77.4 YES 830 NO NO Non-glabrous skin NO true No M0 N1 T0 Stage III TCGA-EB-A5KH.D02E858C-F41F-403C-BA85-D507FE5D125C.pdf A5KH TUMOR FREE YES 1 1 YES NO NO Metastatic 06 NO 7th YES NO EB Regional Lymph Node A DECEASED 62 2011 a02a0949-aefd-479a-913b-aa682a880af4 TCGA-EB-A5KH-06A-11D-A27L-05 a02a0949-aefd-479a-913b-aa682a880af4 TCGA-EB-A5KH-06 TCGA-EB-A5KH-06A-11D-A27J-01 TCGA-EB-A5KH-06 82573D23-61C6-4019-ACE8-544D5428CE9F TCGA-EB-A5KH-06A-11D-A27K-08 TCGA-EB-A5KH-06A-11D-A27J-01 a02a0949-aefd-479a-913b-aa682a880af4 a02a0949-aefd-479a-913b-aa682a880af4 +TCGA-EB-A5SE-01 TCGA-EB-A5SE-01 TCGA-EB-A5SE TCGA Melanoma (SKCM) skin cutaneous melanoma Skin NO NO 73 TCGA-EB-A5SE-F63493 TCGA-EB-A5SE TCGA-EB-A5SE-01A 4 -26965 170 401 0 0 367 0 2014-8-11 MALE 183 No C44.5 8721/3 C44.5 YES 120 NO NO IV Non-glabrous skin YES Distant Metastasis NO YES Brain true No M0 NX T3b Stage IIB TCGA-EB-A5SE.8B3EA5BA-D6BD-4952-8586-57D842351441.pdf A5SE WITH TUMOR NO 1 1 YES NO NO Primary Tumor 01 NO 7th YES NO EB Primary Tumor A DECEASED 77 2012 7a6ac7a6-7668-42eb-a64d-7af67b3a7da3 TCGA-EB-A5SE-01A-11D-A30Z-05 7a6ac7a6-7668-42eb-a64d-7af67b3a7da3 C4E8C83E-ED1C-414E-9428-C069DE3D7B92 TCGA-EB-A5SE-01A-11D-A30X-08 TCGA-EB-A5SE-01A-11D-A30X-08 7a6ac7a6-7668-42eb-a64d-7af67b3a7da3 7a6ac7a6-7668-42eb-a64d-7af67b3a7da3 +TCGA-EB-A5SF-01 TCGA-EB-A5SF-01 TCGA-EB-A5SF TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 78 TCGA-EB-A5SF-F63500 TCGA-EB-A5SF TCGA-EB-A5SF-01A 11 -28772 155 369 0 0 0 2014-8-11 FEMALE 161 No C44.9 8721/3 C44.9 YES 200 NO NO V Non-glabrous skin YES NO true No M0 NX T4b Stage IIC TCGA-EB-A5SF.B846EC32-BF45-498A-B136-324AE678F890.pdf A5SF TUMOR FREE NO YES NO Primary Tumor 01 NO 7th YES NO EB Primary Tumor A DECEASED 57 2012 f3f33ed0-a747-45dd-8999-b1a46079a6dc TCGA-EB-A5SF-01A-11D-A30Z-05 f3f33ed0-a747-45dd-8999-b1a46079a6dc 6817E994-1B09-4CCF-ADDA-A50A0464C992 TCGA-EB-A5SF-01A-11D-A30X-08 TCGA-EB-A5SF-01A-11D-A30X-08 f3f33ed0-a747-45dd-8999-b1a46079a6dc f3f33ed0-a747-45dd-8999-b1a46079a6dc +TCGA-EB-A5SG-06 TCGA-EB-A5SG-06 TCGA-EB-A5SG TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 57 TCGA-EB-A5SG-F63494 TCGA-EB-A5SG TCGA-EB-A5SG-06A -20978 1539 0 2076 1372 2014-8-11 FEMALE 162 No C77.3 8720/3 C77.3 YES 470 NO NO NO YES NO true No TCGA-EB-A5SG.67845F3E-781C-4AFD-BF48-E3C533AECA4A.pdf A5SG TUMOR FREE NO YES NO NO Metastatic 06 NO YES NO EB Regional Lymph Node A LIVING 61 2008 1a52c8ac-cabd-4623-98d8-93ee225ab57a TCGA-EB-A5SG-06A-11D-A30Z-05 1a52c8ac-cabd-4623-98d8-93ee225ab57a TCGA-EB-A5SG-06 TCGA-EB-A5SG-06A-11D-A30W-01 TCGA-EB-A5SG-06 B40A8D68-EC23-44A3-ACBF-56F6D0783A24 TCGA-EB-A5SG-06A-11D-A30X-08 TCGA-EB-A5SG-06A-11D-A30X-08 TCGA-EB-A5SG-06A-11D-A30W-01 1a52c8ac-cabd-4623-98d8-93ee225ab57a 1a52c8ac-cabd-4623-98d8-93ee225ab57a +TCGA-EB-A5SH-06 TCGA-EB-A5SH-06 TCGA-EB-A5SH TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 60 TCGA-EB-A5SH-F63495 TCGA-EB-A5SH TCGA-EB-A5SH-06A 5 -21920 1231 0 1643 1065 2014-8-11 FEMALE 168 No C77.9 8720/3 C77.9 YES 320 NO NO V YES NO NO true No M0 N0 T4 Stage III TCGA-EB-A5SH.147D1052-01D6-4FA0-B757-D9AD0C32C00A.pdf A5SH TUMOR FREE YES YES NO NO Metastatic 06 NO 6th YES NO EB Regional Lymph Node A LIVING 56 2009 1b2499f7-bb3e-472a-8216-68b2e137357c TCGA-EB-A5SH-06A-11D-A30Z-05 1b2499f7-bb3e-472a-8216-68b2e137357c TCGA-EB-A5SH-06 TCGA-EB-A5SH-06A-11D-A30W-01 TCGA-EB-A5SH-06 0940B81D-3A8D-48D6-88DB-A05BFB2D18DB TCGA-EB-A5SH-06A-11D-A30X-08 TCGA-EB-A5SH-06A-11D-A30X-08 TCGA-EB-A5SH-06A-11D-A30W-01 1b2499f7-bb3e-472a-8216-68b2e137357c 1b2499f7-bb3e-472a-8216-68b2e137357c +TCGA-EB-A5UL-06 TCGA-EB-A5UL-06 TCGA-EB-A5UL TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 71 TCGA-EB-A5UL-F70480 TCGA-EB-A5UL TCGA-EB-A5UL-06A 4 -26058 204 0 891 120 2015-2-18 MALE 183 No C77.3 8720/3 C77.3 YES 390 NO NO Non-glabrous skin NO true No M0 N1 TX Stage III TCGA-EB-A5UL.4AD68ABB-FE4F-45FA-9248-CEFF249ABB75.pdf A5UL TUMOR FREE YES 1 1 YES NO NO Metastatic 06 NO 7th YES NO EB Regional Lymph Node A LIVING 80 2012 1df21d4e-5070-4d13-897a-a6f124758589 TCGA-EB-A5UL-06A-11D-A30Z-05 1df21d4e-5070-4d13-897a-a6f124758589 TCGA-EB-A5UL-06 TCGA-EB-A5UL-06A-11D-A30W-01 TCGA-EB-A5UL-06 16047703-4287-4A3F-AC8B-16B5891E4FC1 TCGA-EB-A5UL-06A-11D-A30X-08 TCGA-EB-A5UL-06A-11D-A30X-08 TCGA-EB-A5UL-06A-11D-A30W-01 1df21d4e-5070-4d13-897a-a6f124758589 1df21d4e-5070-4d13-897a-a6f124758589 +TCGA-EB-A5UM-01 TCGA-EB-A5UM-01 TCGA-EB-A5UM TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 48 TCGA-EB-A5UM-F70212 TCGA-EB-A5UM TCGA-EB-A5UM-01A 5 -17867 92 0 779 0 2015-1-30 FEMALE 162 No C44.5 8720/3 C44.5 YES 300 NO NO Non-glabrous skin YES NO true No M0 N0 T4b Stage IIC TCGA-EB-A5UM.6CBB8671-BC4A-4986-9440-E12BED23DD38.pdf A5UM TUMOR FREE NO YES NO Primary Tumor 01 NO 7th YES NO EB Primary Tumor A LIVING 60 2012 8e85bc75-8765-4c92-b167-94ed8390f5e9 TCGA-EB-A5UM-01A-11D-A30Z-05 8e85bc75-8765-4c92-b167-94ed8390f5e9 TCGA-EB-A5UM-01 TCGA-EB-A5UM-01 DB2BF34F-463B-4451-8924-7616C1E9FD3E TCGA-EB-A5UM-01A-11D-A30X-08 TCGA-EB-A5UM-01A-11D-A30X-08 8e85bc75-8765-4c92-b167-94ed8390f5e9 8e85bc75-8765-4c92-b167-94ed8390f5e9 +TCGA-EB-A5UN-06 TCGA-EB-A5UN-06 TCGA-EB-A5UN TCGA Melanoma (SKCM) skin cutaneous melanoma Skin NO NO 49 TCGA-EB-A5UN-F68912 TCGA-EB-A5UN TCGA-EB-A5UN-06A 14 -18226 1290 0 1792 1697 1689 1180 Small bowel 2014-12-23 MALE 180 No C17.9 8720/3 C17.9 YES 380 NO YES 4 IV Non-glabrous skin YES Distant Metastasis YES YES Brain true No M0 NX T4b Stage IIC TCGA-EB-A5UN.BAEBDC12-0ADC-45AC-A604-1825CE629DC3.pdf A5UN NO 1 1 YES NO NO Metastatic 06 NO 6th YES NO EB Distant Metastasis A LIVING 62 2009 2ab62da1-4896-4aab-b598-a95d033d93de TCGA-EB-A5UN-06A-11D-A30Z-05 2ab62da1-4896-4aab-b598-a95d033d93de TCGA-EB-A5UN-06 TCGA-EB-A5UN-06A-11D-A30W-01 TCGA-EB-A5UN-06 FAC52A2E-4FBA-4746-9FF7-97852607939D TCGA-EB-A5UN-06A-11D-A30X-08 TCGA-EB-A5UN-06A-11D-A30X-08 TCGA-EB-A5UN-06A-11D-A30W-01 2ab62da1-4896-4aab-b598-a95d033d93de 2ab62da1-4896-4aab-b598-a95d033d93de +TCGA-EB-A5VU-01 TCGA-EB-A5VU-01 TCGA-EB-A5VU TCGA Melanoma (SKCM) skin cutaneous melanoma Skin NO NO 56 TCGA-EB-A5VU-F55515 TCGA-EB-A5VU TCGA-EB-A5VU-01A 15 -20610 97 321 0 12 219 217 8 2014-1-8 MALE 160 No C44.7 8720/3 C44.7 YES 330 NO NO Non-glabrous skin YES Locoregional Recurrence YES YES true No M0 N1 T4b Stage IIIB TCGA-EB-A5VU.960FB267-8E01-4343-B798-E9A806E55BE0.pdf A5VU WITH TUMOR NO 1 1 YES NO NO Primary Tumor 01 YES 7th YES NO EB Primary Tumor A DECEASED 60 2012 904651ef-61fe-4452-b9ee-0e2821794a1e TCGA-EB-A5VU-01A-21D-A32S-05 904651ef-61fe-4452-b9ee-0e2821794a1e TCGA-EB-A5VU-01 TCGA-EB-A5VU-01 3CAF2048-6D09-4B66-99B8-0B801BC9DBAD TCGA-EB-A5VU-01A-21D-A32N-08 904651ef-61fe-4452-b9ee-0e2821794a1e 904651ef-61fe-4452-b9ee-0e2821794a1e +TCGA-EB-A5VV-06 TCGA-EB-A5VV-06 TCGA-EB-A5VV TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 74 TCGA-EB-A5VV-F57708 TCGA-EB-A5VV TCGA-EB-A5VV-06A 4 -27364 291 0 214 198 2014-3-21 FEMALE 160 No C77.4 8720/3 C77.4 YES 510 NO YES Non-glabrous skin YES NO NO true No M0 N1 T3b Stage IIIB TCGA-EB-A5VV.19D99676-CF74-4E8F-B6EF-CCF5A7578D77.pdf A5VV TUMOR FREE NO 1 1 YES NO NO Metastatic 06 NO 7th YES NO EB Regional Lymph Node A LIVING 96 2012 02c76d24-f1d2-4029-95b4-8be3bda8fdbe TCGA-EB-A5VV-06A-11D-A32S-05 02c76d24-f1d2-4029-95b4-8be3bda8fdbe TCGA-EB-A5VV-06 TCGA-EB-A5VV-06A-11D-A32M-01 TCGA-EB-A5VV-06 5E06DC0D-89B3-4A1D-9A86-4AC9BC18F03D TCGA-EB-A5VV-06A-11D-A32N-08 TCGA-EB-A5VV-06A-11D-A32M-01 02c76d24-f1d2-4029-95b4-8be3bda8fdbe 02c76d24-f1d2-4029-95b4-8be3bda8fdbe +TCGA-EB-A6L9-06 TCGA-EB-A6L9-06 TCGA-EB-A6L9 TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 55 TCGA-EB-A6L9-F71638 TCGA-EB-A6L9 TCGA-EB-A6L9-06A -20172 464 0 1109 365 2015-3-27 MALE 156 No C77.5 8720/3 C77.5 YES 1620 NO NO Non-glabrous skin YES NO true No M0 N3 TX Stage IIIC TCGA-EB-A6L9.B2E9DBA6-54D6-42D5-B48E-185CE46054B5.pdf A6L9 TUMOR FREE NO YES NO Metastatic 06 NO 7th YES NO EB Regional Lymph Node A LIVING 58 2012 e70174b7-a2d3-4136-9da4-28a9cf123759 TCGA-EB-A6L9-06A-11D-A32S-05 e70174b7-a2d3-4136-9da4-28a9cf123759 TCGA-EB-A6L9-06 TCGA-EB-A6L9-06A-11D-A32M-01 TCGA-EB-A6L9-06 E50E77E5-8D83-45F6-8865-7D66E43647AB TCGA-EB-A6L9-06A-11D-A32N-08 TCGA-EB-A6L9-06A-11D-A32M-01 e70174b7-a2d3-4136-9da4-28a9cf123759 e70174b7-a2d3-4136-9da4-28a9cf123759 +TCGA-EB-A6QY-01 TCGA-EB-A6QY-01 TCGA-EB-A6QY TCGA Melanoma (SKCM) skin cutaneous melanoma Skin YES YES 71 TCGA-EB-A6QY-F57709 TCGA-EB-A6QY TCGA-EB-A6QY-01A 10 -26216 169 0 382 37 36 0 2014-3-21 MALE 169 No C44.9 8720/3 C44.9 YES 500 NO NO Non-glabrous skin YES Regional lymph node YES YES true No M0 N0 T4b Stage IIC TCGA-EB-A6QY.FD4116F2-8A21-48DF-9639-E840F7010657.pdf A6QY TUMOR FREE NO YES NO Primary Tumor 01 NO 7th YES NO EB Primary Tumor A LIVING 97 2013 bb63bf5c-23d6-426f-96e2-db77aff678b3 TCGA-EB-A6QY-01A-12D-A32S-05 bb63bf5c-23d6-426f-96e2-db77aff678b3 TCGA-EB-A6QY-01 TCGA-EB-A6QY-01 A958E7F4-2FAE-4333-917D-0218F2DEDE3B TCGA-EB-A6QY-01A-12D-A32N-08 bb63bf5c-23d6-426f-96e2-db77aff678b3 bb63bf5c-23d6-426f-96e2-db77aff678b3 +TCGA-EB-A6QZ-01 TCGA-EB-A6QZ-01 TCGA-EB-A6QZ TCGA Melanoma (SKCM) skin cutaneous melanoma Skin YES|NO NO|NO 76 TCGA-EB-A6QZ-F58782 TCGA-EB-A6QZ TCGA-EB-A6QZ-01A 3 -28078 172 352 0 -3 136| 129|341 0 2014-6-13 FEMALE 162 No C44.9 8720/3 C44.9 YES 130 NO NO Non-glabrous skin NO Regional lymph node|Distant Metastasis YES|NO YES |Brain true No M0 N0 T3a Stage IIA TCGA-EB-A6QZ.95BB2C71-EB77-4A68-A4FB-1067A845CBAF.pdf A6QZ WITH TUMOR NO YES YES Primary Tumor 01 NO 7th YES NO EB Primary Tumor A DECEASED 60 2013 90acf286-18d7-40ff-ac1a-d56e0ced5c89 TCGA-EB-A6QZ-01A-12D-A32S-05 90acf286-18d7-40ff-ac1a-d56e0ced5c89 TCGA-EB-A6QZ-01 TCGA-EB-A6QZ-01 5060041F-2278-4BD7-AED9-E0DE38DBFAE3 TCGA-EB-A6QZ-01A-12D-A32N-08 90acf286-18d7-40ff-ac1a-d56e0ced5c89 90acf286-18d7-40ff-ac1a-d56e0ced5c89 +TCGA-EB-A6R0-01 TCGA-EB-A6R0-01 TCGA-EB-A6R0 TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 58 TCGA-EB-A6R0-F71427 TCGA-EB-A6R0 TCGA-EB-A6R0-01A 10 -21367 207 608 0 -2 0 2015-3-25 FEMALE 160 No C44.9 8720/3 C44.9 YES 720 NO NO IV Non-glabrous skin YES NO true No M0 N0 T4b Stage IIC TCGA-EB-A6R0.95E9EB7F-81A7-4A4F-848B-59D1710E024A.pdf A6R0 TUMOR FREE YES YES NO Primary Tumor 01 NO 7th YES NO EB Primary Tumor A DECEASED 115 2012 10f253bd-1cdd-4515-a7fa-b9ed6e1a1790 TCGA-EB-A6R0-01A-12D-A32S-05 10f253bd-1cdd-4515-a7fa-b9ed6e1a1790 TCGA-EB-A6R0-01 TCGA-EB-A6R0-01 6579B15C-AC95-438B-B1E3-10BF7B162F6D TCGA-EB-A6R0-01A-12D-A32N-08 10f253bd-1cdd-4515-a7fa-b9ed6e1a1790 10f253bd-1cdd-4515-a7fa-b9ed6e1a1790 +TCGA-EB-A82B-01 TCGA-EB-A82B-01 TCGA-EB-A82B TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 58 TCGA-EB-A82B-F63589 TCGA-EB-A82B TCGA-EB-A82B-01A 20 -21239 92 0 390 10 2014-8-13 FEMALE 160 No C44.7 8720/3 C44.7 YES 1560 NO NO V Non-glabrous skin YES NO true No M0 N2 T4b Stage III TCGA-EB-A82B.23E186C6-739C-4EF1-8788-79AA89C6E87A.pdf A82B TUMOR FREE NO 1 YES NO NO Primary Tumor 01 NO 7th YES NO EB Primary Tumor A LIVING 55 2013 48b96bbc-d36e-4f95-ae88-ea708d2d33ff TCGA-EB-A82B-01A-11D-A34V-05 48b96bbc-d36e-4f95-ae88-ea708d2d33ff TCGA-EB-A82B-01 TCGA-EB-A82B-01 AD6DCA0B-576B-4336-8383-CA39DB46D325 TCGA-EB-A82B-01A-11D-A34U-08 48b96bbc-d36e-4f95-ae88-ea708d2d33ff 48b96bbc-d36e-4f95-ae88-ea708d2d33ff +TCGA-EB-A82C-01 TCGA-EB-A82C-01 TCGA-EB-A82C TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 70 TCGA-EB-A82C-F65364 TCGA-EB-A82C TCGA-EB-A82C-01A 10 -25850 83 0 17 13 2014-9-30 FEMALE 150 No C44.7 8720/3 C44.7 YES 890 NO YES V Non-glabrous skin YES NO true No M0 N0 T4b Stage IIC TCGA-EB-A82C.F6E5A5AD-0C3A-4E70-82B5-C814BBAF8987.pdf A82C TUMOR FREE 1 YES NO NO Primary Tumor 01 7th YES NO EB Primary Tumor A LIVING 42 2013 c7225e98-bd83-450e-9792-6983424f5726 TCGA-EB-A82C-01A-11D-A34V-05 c7225e98-bd83-450e-9792-6983424f5726 TCGA-EB-A82C-01 TCGA-EB-A82C-01 2B3C2ABB-1DB4-4BDD-B5A3-1B2764B74A6E TCGA-EB-A82C-01A-11D-A34U-08 c7225e98-bd83-450e-9792-6983424f5726 c7225e98-bd83-450e-9792-6983424f5726 +TCGA-EB-A85I-01 TCGA-EB-A85I-01 TCGA-EB-A85I TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 66 TCGA-EB-A85I-F61877 TCGA-EB-A85I TCGA-EB-A85I-01A 10 -24408 135 0 362 0 2014-7-9 MALE 170 No C44.7 8720/3 C44.7 YES 370 NO NO Non-glabrous skin YES NO true No M0 N0 T4b Stage IIC TCGA-EB-A85I.D35BCE2A-8132-4CAA-8E22-559B68BDAF07.pdf A85I TUMOR FREE NO 1 1 YES NO Primary Tumor 01 NO 7th YES NO EB Primary Tumor A LIVING 82 2013 a5a16312-b50a-4c79-a2b9-530bd0fc66b1 TCGA-EB-A85I-01A-11D-A34V-05 a5a16312-b50a-4c79-a2b9-530bd0fc66b1 TCGA-EB-A85I-01 TCGA-EB-A85I-01 5DDD85CF-D17A-4A09-9417-64BAC105428C TCGA-EB-A85I-01A-11D-A34U-08 a5a16312-b50a-4c79-a2b9-530bd0fc66b1 a5a16312-b50a-4c79-a2b9-530bd0fc66b1 +TCGA-EB-A85J-01 TCGA-EB-A85J-01 TCGA-EB-A85J TCGA Melanoma (SKCM) skin cutaneous melanoma Skin NO YES 66 TCGA-EB-A85J-F61878 TCGA-EB-A85J TCGA-EB-A85J-01A 5.5 -24263 133 0 360 139 138 0 2014-7-9 FEMALE 166 No C44.7 8720/3 C44.7 YES 220 NO NO Non-glabrous skin NO Regional lymph node YES YES true No M0 N0 T4a Stage IIB TCGA-EB-A85J.AD298262-1D6D-4023-9DBA-A38A8ED1E3EB.pdf A85J TUMOR FREE YES 1 1 YES NO Primary Tumor 01 NO 7th YES NO EB Primary Tumor A LIVING 128 2013 5c49d176-0f55-4312-91f9-32457304966e TCGA-EB-A85J-01A-12D-A34V-05 5c49d176-0f55-4312-91f9-32457304966e TCGA-EB-A85J-01 TCGA-EB-A85J-01 9114D404-8AE4-43F9-A045-701B0608C394 TCGA-EB-A85J-01A-12D-A34U-08 5c49d176-0f55-4312-91f9-32457304966e 5c49d176-0f55-4312-91f9-32457304966e +TCGA-EB-A97M-01 TCGA-EB-A97M-01 TCGA-EB-A97M TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 66 TCGA-EB-A97M-F67796 TCGA-EB-A97M TCGA-EB-A97M-01A 15 -24228 87 0 414 0 2014-11-11 MALE 171 No C44.5 8720/3 C44.5 YES 790 NO NO IV Non-glabrous skin YES NO true No M0 N0 T4b Stage IIC TCGA-EB-A97M.4EFD3127-7414-49F4-838A-D1050EDDEE31.pdf A97M TUMOR FREE NO YES NO Primary Tumor 01 NO 7th YES NO EB Primary Tumor A LIVING 68 2013 bae5b50b-e671-4df9-92e9-aad3cfe8a26e TCGA-EB-A97M-01A-11D-A38H-05 bae5b50b-e671-4df9-92e9-aad3cfe8a26e TCGA-EB-A97M-01 TCGA-EB-A97M-01 5F90DDEB-8C88-4049-B679-161E47CFB905 TCGA-EB-A97M-01A-11D-A38G-08 bae5b50b-e671-4df9-92e9-aad3cfe8a26e bae5b50b-e671-4df9-92e9-aad3cfe8a26e +TCGA-EE-A17X-06 TCGA-EE-A17X-06 TCGA-EE-A17X TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 54 TCGA-EE-A17X TCGA-EE-A17X-06A 0.8 -20021 1647 907 0 555 2013-1-8 MALE No C44.5 8720/3 C44.5 YES 180 NO 6 III Non-glabrous skin NO YES YES true No M0 N0 T1a Stage IA TCGA-EE-A17X.B3EC3F2A-D4BF-4BA9-921C-BE4852EFEE8B.pdf A17X WITH TUMOR NO YES NO NO Metastatic 06 6th NO YES EE Regional Lymph Node A DECEASED 2006 99301c38-4cf4-4c9d-ba8c-3d56c066db9c TCGA-EE-A17X-06A-11D-A19C-05 99301c38-4cf4-4c9d-ba8c-3d56c066db9c TCGA-EE-A17X-06 TCGA-EE-A17X-06A-11D-A191-01 TCGA-EE-A17X-06 48672154-0D6A-4E14-B7C3-EFFBF0E0899E TCGA-EE-A17X-06A-11D-A197-08 TCGA-EE-A17X-06A-11D-A197-08 TCGA-EE-A17X-06A-11D-A191-01 TCGA-EE-A17X-06A-11D-A197-08 99301c38-4cf4-4c9d-ba8c-3d56c066db9c 99301c38-4cf4-4c9d-ba8c-3d56c066db9c +TCGA-EE-A17Y-06 TCGA-EE-A17Y-06 TCGA-EE-A17Y TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 69 TCGA-EE-A17Y TCGA-EE-A17Y-06A 2.8 -25281 1326 828 0 507 2013-7-12 MALE No C44.5 8720/3 C44.5 YES 60 NO 17 IV Non-glabrous skin YES YES YES true No M0 N1a T3b Stage IIIB TCGA-EE-A17Y.C52B9022-0B12-4759-9B2E-431E001366C4.pdf A17Y WITH TUMOR NO YES NO NO Metastatic 06 6th NO YES EE Regional Cutaneous or Subcutaneous Tissue (includes satellite and in-transit metastasis) A DECEASED 2007 55f50a7b-5448-4895-81bc-578eecbd7680 TCGA-EE-A17Y-06A-11D-A19B-05 55f50a7b-5448-4895-81bc-578eecbd7680 TCGA-EE-A17Y-06 TCGA-EE-A17Y-06A-11D-A194-01 TCGA-EE-A17Y-06 TCGA-EE-A17Y-06A-11D-A196-08 TCGA-EE-A17Y-06A-11D-A196-08 TCGA-EE-A17Y-06A-11D-A194-01 TCGA-EE-A17Y-06A-11D-A196-08 55f50a7b-5448-4895-81bc-578eecbd7680 55f50a7b-5448-4895-81bc-578eecbd7680 +TCGA-EE-A17Z-06 TCGA-EE-A17Z-06 TCGA-EE-A17Z TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 57 TCGA-EE-A17Z TCGA-EE-A17Z-06A 29 -20970 959 263 0 71 2013-1-8 MALE No C44.5 8720/3 C44.5 YES 50 NO 9 V Non-glabrous skin NO NO YES true No M0 N0 T4a Stage IIB TCGA-EE-A17Z.837DDC06-26E8-44F2-BE68-62A81ED42795.pdf A17Z WITH TUMOR NO YES NO NO Metastatic 06 6th NO YES EE Regional Lymph Node A DECEASED 2008 03b25565-6f06-410e-96fc-cd7cfc59ba72 TCGA-EE-A17Z-06A-11D-A19B-05 03b25565-6f06-410e-96fc-cd7cfc59ba72 TCGA-EE-A17Z-06 TCGA-EE-A17Z-06A-11D-A194-01 TCGA-EE-A17Z-06 TCGA-EE-A17Z-06A-11D-A196-08 TCGA-EE-A17Z-06A-11D-A196-08 TCGA-EE-A17Z-06A-11D-A194-01 TCGA-EE-A17Z-06A-11D-A196-08 03b25565-6f06-410e-96fc-cd7cfc59ba72 03b25565-6f06-410e-96fc-cd7cfc59ba72 +TCGA-EE-A180-06 TCGA-EE-A180-06 TCGA-EE-A180 TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 69 TCGA-EE-A180 TCGA-EE-A180-06A 4.9 -25523 3412 2889 0 2642 Left posterior shoulder 2012-6-3 MALE No C44.6 8720/3 C44.6 YES 150 NO 33 IV Non-glabrous skin NO YES YES true Yes M0 N0 T4a Stage III TCGA-EE-A180.5E0C8993-FA2B-4856-A850-7764D7F132D0.pdf A180 WITH TUMOR NO 1 1 YES NO NO Metastatic 06 5th NO YES EE Distant Metastasis A DECEASED 2001 8f22fb80-0400-435e-8a3b-7500a7002963 TCGA-EE-A180-06A-11D-A21B-05 8f22fb80-0400-435e-8a3b-7500a7002963 TCGA-EE-A180-06 TCGA-EE-A180-06A-11D-A219-01 TCGA-EE-A180-06 FCBE8A0F-CF1B-4F32-AFE2-F852C6D1490B TCGA-EE-A180-06A-11D-A21A-08 TCGA-EE-A180-06A-11D-A21A-08 TCGA-EE-A180-06A-11D-A219-01 TCGA-EE-A180-06A-11D-A21A-08 8f22fb80-0400-435e-8a3b-7500a7002963 8f22fb80-0400-435e-8a3b-7500a7002963 +TCGA-EE-A181-06 TCGA-EE-A181-06 TCGA-EE-A181 TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 82 TCGA-EE-A181 TCGA-EE-A181-06A 2.5 -30003 2038 1026 0 992 2013-1-8 FEMALE No C77.4 8720/3 C77.4 YES 110 NO 4 IV Non-glabrous skin YES YES true No M0 N0 T3 Stage II TCGA-EE-A181.FF6D6361-9BE7-4367-ABBE-9A34753D7D51.pdf A181 TUMOR FREE NO YES NO NO Metastatic 06 6th NO YES EE Regional Lymph Node A DECEASED 2005 eca521e3-f15c-4709-9a2d-ce6c34dcf342 TCGA-EE-A181-06A-11D-A19B-05 eca521e3-f15c-4709-9a2d-ce6c34dcf342 TCGA-EE-A181-06 TCGA-EE-A181-06A-11D-A194-01 TCGA-EE-A181-06 1640ACD3-1552-4ABB-95DD-94BDA4911529 TCGA-EE-A181-06A-11D-A196-08 TCGA-EE-A181-06A-11D-A196-08 TCGA-EE-A181-06A-11D-A194-01 TCGA-EE-A181-06A-11D-A196-08 eca521e3-f15c-4709-9a2d-ce6c34dcf342 eca521e3-f15c-4709-9a2d-ce6c34dcf342 +TCGA-EE-A182-06 TCGA-EE-A182-06 TCGA-EE-A182 TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 84 TCGA-EE-A182 TCGA-EE-A182-06A 14 -30718 954 447 0 406 Left thigh 2013-1-8 FEMALE No C49.2 8720/3 C49.2 YES 460 NO 5 V Non-glabrous skin YES YES YES true No M0 N1b T4b Stage IIIC TCGA-EE-A182.FE5C64E4-A121-41C9-BB33-1894105A4DE1.pdf A182 WITH TUMOR NO YES NO NO Metastatic 06 6th NO YES EE Distant Metastasis A DECEASED 2008 9d2aecbe-06b9-43ae-bdcc-ae8c9f896fdb TCGA-EE-A182-06A-11D-A19B-05 9d2aecbe-06b9-43ae-bdcc-ae8c9f896fdb TCGA-EE-A182-06 TCGA-EE-A182-06A-11D-A194-01 TCGA-EE-A182-06 68E07D83-767E-4F85-8E57-57FDE2CF9E07 TCGA-EE-A182-06A-11D-A196-08 TCGA-EE-A182-06A-11D-A196-08 TCGA-EE-A182-06A-11D-A194-01 TCGA-EE-A182-06A-11D-A196-08 9d2aecbe-06b9-43ae-bdcc-ae8c9f896fdb 9d2aecbe-06b9-43ae-bdcc-ae8c9f896fdb +TCGA-EE-A183-06 TCGA-EE-A183-06 TCGA-EE-A183 TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 48 TCGA-EE-A183 TCGA-EE-A183-06A -17788 1381 818 0 447 2013-1-8 MALE No C77.3 8720/3 C77.3 YES 70 NO I Non-glabrous skin NO YES true No M0 N0 Tis Stage 0 TCGA-EE-A183.DCCFD53E-8725-40D5-AD32-216A54B08F2F.pdf A183 WITH TUMOR NO YES NO NO Metastatic 06 6th NO YES EE Regional Lymph Node A DECEASED 2007 5ad500eb-a97f-42cf-b0cd-1d5ce0f3584d TCGA-EE-A183-06A-11D-A19B-05 5ad500eb-a97f-42cf-b0cd-1d5ce0f3584d TCGA-EE-A183-06 TCGA-EE-A183-06A-11D-A194-01 TCGA-EE-A183-06 TCGA-EE-A183-06A-11D-A196-08 TCGA-EE-A183-06A-11D-A196-08 TCGA-EE-A183-06A-11D-A194-01 TCGA-EE-A183-06A-11D-A196-08 5ad500eb-a97f-42cf-b0cd-1d5ce0f3584d 5ad500eb-a97f-42cf-b0cd-1d5ce0f3584d +TCGA-EE-A184-06 TCGA-EE-A184-06 TCGA-EE-A184 TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 72 TCGA-EE-A184 TCGA-EE-A184-06A 1.95 -26447 2731 2073 0 1917 Right wrist 2013-7-12 MALE No C44.6 8720/3 C44.6 YES 410 NO 2 IV Non-glabrous skin NO YES YES true Yes M0 N0 T2a Stage IB TCGA-EE-A184.00238EE4-0014-4CB6-9E79-C93B8EF7BD04.pdf A184 NO YES NO NO Metastatic 06 6th NO YES EE Distant Metastasis A DECEASED 2003 2555472f-e74d-48c6-8c4f-54a52767e8c4 TCGA-EE-A184-06A-11D-A19B-05 2555472f-e74d-48c6-8c4f-54a52767e8c4 TCGA-EE-A184-06 TCGA-EE-A184-06A-11D-A194-01 TCGA-EE-A184-06 34612D6C-1CDE-4291-A77E-25B91F84E6DA TCGA-EE-A184-06A-11D-A196-08 TCGA-EE-A184-06A-11D-A196-08 TCGA-EE-A184-06A-11D-A194-01 TCGA-EE-A184-06A-11D-A196-08 2555472f-e74d-48c6-8c4f-54a52767e8c4 2555472f-e74d-48c6-8c4f-54a52767e8c4 +TCGA-EE-A185-06 TCGA-EE-A185-06 TCGA-EE-A185 TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 55 TCGA-EE-A185 TCGA-EE-A185-06A 6 -20235 751 151 0 20 2013-1-8 FEMALE No C44.5 8720/3 C44.5 YES 90 NO 12 IV Non-glabrous skin YES NO YES true No M0 N3 T4b Stage IIIC TCGA-EE-A185.B031620A-AE3E-408C-8CBB-52E0CC56C51E.pdf A185 WITH TUMOR NO YES NO NO Metastatic 06 6th NO YES EE Regional Lymph Node A DECEASED 2008 94bd0768-0e03-4387-b980-09b5efcd21c5 TCGA-EE-A185-06A-11D-A19B-05 94bd0768-0e03-4387-b980-09b5efcd21c5 TCGA-EE-A185-06 TCGA-EE-A185-06A-11D-A194-01 TCGA-EE-A185-06 C80FBD69-CE3B-4D98-A9A5-F4B24DDB9EAC TCGA-EE-A185-06A-11D-A196-08 TCGA-EE-A185-06A-11D-A196-08 TCGA-EE-A185-06A-11D-A194-01 TCGA-EE-A185-06A-11D-A196-08 94bd0768-0e03-4387-b980-09b5efcd21c5 94bd0768-0e03-4387-b980-09b5efcd21c5 +TCGA-EE-A20B-06 TCGA-EE-A20B-06 TCGA-EE-A20B TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 66 TCGA-EE-A20B-F52022 TCGA-EE-A20B 2.6 -24445 0 4070 2238 2013-11-27 FEMALE No C44.7 8720/3 C44.7 YES NO 10 III Non-glabrous skin NO No M0 N0 T3 Stage II A20B TUMOR FREE NO YES NO NO Metastatic 06 NO 5th NO YES EE Regional Cutaneous or Subcutaneous Tissue (includes satellite and in-transit metastasis) LIVING 2002 bbcc0f70-85ae-409a-a108-1cabc60d2532 TCGA-EE-A20B-06A-11D-A19B-05 bbcc0f70-85ae-409a-a108-1cabc60d2532 TCGA-EE-A20B-06 TCGA-EE-A20B-06A-11D-A194-01 TCGA-EE-A20B-06 TCGA-EE-A20B-06A-11D-A196-08 TCGA-EE-A20B-06A-11D-A196-08 TCGA-EE-A20B-06A-11D-A194-01 TCGA-EE-A20B-06A-11D-A196-08 bbcc0f70-85ae-409a-a108-1cabc60d2532 bbcc0f70-85ae-409a-a108-1cabc60d2532 +TCGA-EE-A20C-06 TCGA-EE-A20C-06 TCGA-EE-A20C TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 59 TCGA-EE-A20C TCGA-EE-A20C-06A -21660 5168 4601 0 4469 Right back 2013-7-31 MALE No C44.5 8720/3 C44.5 YES 240 NO I Non-glabrous skin YES YES true No M0 N0 Tis Stage 0 TCGA-EE-A20C.F625D202-CF68-4EEF-A962-360AEA6978CB.pdf A20C WITH TUMOR NO YES NO NO Metastatic 06 4th NO YES EE Distant Metastasis A DECEASED 1997 f3fe7192-c115-4c74-927b-b3d824995205 TCGA-EE-A20C-06A-11D-A19B-05 f3fe7192-c115-4c74-927b-b3d824995205 TCGA-EE-A20C-06 TCGA-EE-A20C-06A-11D-A194-01 TCGA-EE-A20C-06 772D88F9-84CD-4028-B640-0F0C4A7A9D50 TCGA-EE-A20C-06A-11D-A196-08 TCGA-EE-A20C-06A-11D-A196-08 TCGA-EE-A20C-06A-11D-A194-01 TCGA-EE-A20C-06A-11D-A196-08 f3fe7192-c115-4c74-927b-b3d824995205 f3fe7192-c115-4c74-927b-b3d824995205 +TCGA-EE-A20F-06 TCGA-EE-A20F-06 TCGA-EE-A20F TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 53 TCGA-EE-A20F-F63335 TCGA-EE-A20F TCGA-EE-A20F-06A 0.5 -19372 3177 0 2785 2303 2014-8-5 MALE No C77.5 8720/3 C77.5 YES 410 NO NO Non-glabrous skin NO true No M0 N0 T1 Stage I TCGA-EE-A20F.9B0E65BC-811F-461B-9A15-21F8BEC96667.pdf A20F TUMOR FREE NO YES NO YES Metastatic 06 NO 5th NO YES EE Regional Lymph Node A LIVING 2002 9d120ffc-51e1-496f-87e0-298ec882691b TCGA-EE-A20F-06A-21D-A19B-05 9d120ffc-51e1-496f-87e0-298ec882691b TCGA-EE-A20F-06 TCGA-EE-A20F-06A-21D-A194-01 TCGA-EE-A20F-06 84F039FB-8919-4536-B8DD-89A27E5F3D3F TCGA-EE-A20F-06A-21D-A196-08 TCGA-EE-A20F-06A-21D-A196-08 TCGA-EE-A20F-06A-21D-A194-01 TCGA-EE-A20F-06A-21D-A196-08 9d120ffc-51e1-496f-87e0-298ec882691b 9d120ffc-51e1-496f-87e0-298ec882691b +TCGA-EE-A20H-06 TCGA-EE-A20H-06 TCGA-EE-A20H TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 56 TCGA-EE-A20H 1.05 -20476 5118 0 4838 Right upper back 2013-1-8 MALE No C44.5 8720/3 C44.5 YES III Non-glabrous skin YES YES Yes M0 N0 T2 Stage I A20H WITH TUMOR NO YES NO NO Metastatic 06 4th NO YES EE Distant Metastasis DECEASED 1995 b971d290-ba1f-46f3-8605-31e1502adf69 TCGA-EE-A20H-06A-11D-A19C-05 b971d290-ba1f-46f3-8605-31e1502adf69 TCGA-EE-A20H-06 TCGA-EE-A20H-06A-11D-A191-01 TCGA-EE-A20H-06 TCGA-EE-A20H-06A-11D-A197-08 TCGA-EE-A20H-06A-11D-A197-08 TCGA-EE-A20H-06A-11D-A191-01 TCGA-EE-A20H-06A-11D-A197-08 b971d290-ba1f-46f3-8605-31e1502adf69 b971d290-ba1f-46f3-8605-31e1502adf69 +TCGA-EE-A20I-06 TCGA-EE-A20I-06 TCGA-EE-A20I TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 79 TCGA-EE-A20I -28883 412 0 376 2013-7-11 MALE No C44.7 8720/3 C44.7 YES 12 Non-glabrous skin YES YES YES No M1c N0 TX Stage IV A20I WITH TUMOR NO YES NO NO Metastatic 06 6th NO YES EE Regional Cutaneous or Subcutaneous Tissue (includes satellite and in-transit metastasis) DECEASED 2008 cfc5a7ec-fd48-4944-85f8-40f755b4111e TCGA-EE-A20I-06A-11D-A19B-05 cfc5a7ec-fd48-4944-85f8-40f755b4111e TCGA-EE-A20I-06 TCGA-EE-A20I-06A-11D-A194-01 TCGA-EE-A20I-06 TCGA-EE-A20I-06A-11D-A196-08 TCGA-EE-A20I-06A-11D-A196-08 TCGA-EE-A20I-06A-11D-A194-01 TCGA-EE-A20I-06A-11D-A196-08 cfc5a7ec-fd48-4944-85f8-40f755b4111e cfc5a7ec-fd48-4944-85f8-40f755b4111e +TCGA-EE-A29A-06 TCGA-EE-A29A-06 TCGA-EE-A29A TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 68 TCGA-EE-A29A TCGA-EE-A29A-06A 2.3 -25095 2974 1927 0 1684 Abdominal wall 2013-1-8 MALE No C49.4 8720/3 C49.4 YES 80 NO 6 IV Non-glabrous skin NO YES YES true No M0 N1a T3a Stage IIIA TCGA-EE-A29A.C2052509-2335-4B8B-8581-4D2B79D36B25.pdf A29A WITH TUMOR NO YES NO NO Metastatic 06 6th NO YES EE Distant Metastasis A DECEASED 2003 471aa847-0e7e-4ec5-bb50-c0df66260f91 TCGA-EE-A29A-06A-12D-A19B-05 471aa847-0e7e-4ec5-bb50-c0df66260f91 TCGA-EE-A29A-06 TCGA-EE-A29A-06A-12D-A194-01 TCGA-EE-A29A-06 TCGA-EE-A29A-06A-12D-A196-08 TCGA-EE-A29A-06A-12D-A196-08 TCGA-EE-A29A-06A-12D-A194-01 TCGA-EE-A29A-06A-12D-A196-08 471aa847-0e7e-4ec5-bb50-c0df66260f91 471aa847-0e7e-4ec5-bb50-c0df66260f91 +TCGA-EE-A29B-06 TCGA-EE-A29B-06 TCGA-EE-A29B TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 67 TCGA-EE-A29B-F52023 TCGA-EE-A29B TCGA-EE-A29B-06A 4 -24618 2404 2588 0 2452 2151 Left thigh 2013-11-27 MALE No C44.7 8720/3 C44.7 YES 180 NO NO III Non-glabrous skin YES YES NO true No M0 N0 T3b Stage IIB TCGA-EE-A29B.7D858F97-4834-40FF-99EE-D01385FA0479.pdf A29B WITH TUMOR NO YES NO NO Metastatic 06 NO 6th YES NO EE Distant Metastasis A DECEASED 2004 9c14ff17-4b8d-448f-acac-6dd769559bed TCGA-EE-A29B-06A-11D-A19C-05 9c14ff17-4b8d-448f-acac-6dd769559bed TCGA-EE-A29B-06 TCGA-EE-A29B-06A-11D-A191-01 TCGA-EE-A29B-06 026ED6EE-AF73-423D-80CD-6602312F9845 TCGA-EE-A29B-06A-11D-A197-08 TCGA-EE-A29B-06A-11D-A197-08 TCGA-EE-A29B-06A-11D-A191-01 TCGA-EE-A29B-06A-11D-A197-08 9c14ff17-4b8d-448f-acac-6dd769559bed 9c14ff17-4b8d-448f-acac-6dd769559bed +TCGA-EE-A29C-06 TCGA-EE-A29C-06 TCGA-EE-A29C TCGA Melanoma (SKCM) skin cutaneous melanoma Skin YES NO 20 TCGA-EE-A29C-F65638 TCGA-EE-A29C TCGA-EE-A29C-06A 1.7 -7510 1351 2402 0 1455 2212 300 2014-9-26 MALE No C44.5 8720/3 C44.5 YES 150 NO NO 4 IV Non-glabrous skin NO Regional lymph node YES NO YES true No M0 N0 T2a Stage IB TCGA-EE-A29C.9358D777-DE2E-4AE2-937D-AC2D922CD848.pdf A29C WITH TUMOR NO YES NO NO Metastatic 06 NO 6th NO YES EE Regional Lymph Node A DECEASED 2007 a0c48f0a-061f-4b7c-9d70-b90aca5afd5d TCGA-EE-A29C-06A-21D-A19C-05 a0c48f0a-061f-4b7c-9d70-b90aca5afd5d TCGA-EE-A29C-06 TCGA-EE-A29C-06A-21D-A191-01 TCGA-EE-A29C-06 1CD2193E-C5D6-45A8-A1CA-29FDBA2B6A72 TCGA-EE-A29C-06A-21D-A197-08 TCGA-EE-A29C-06A-21D-A197-08 TCGA-EE-A29C-06A-21D-A191-01 TCGA-EE-A29C-06A-21D-A197-08 a0c48f0a-061f-4b7c-9d70-b90aca5afd5d a0c48f0a-061f-4b7c-9d70-b90aca5afd5d +TCGA-EE-A29D-06 TCGA-EE-A29D-06 TCGA-EE-A29D TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 87 TCGA-EE-A29D TCGA-EE-A29D-06A 3.2 -31790 892 425 0 86 2013-1-8 MALE No C77.0 8720/3 C77.0 YES 80 NO 7 IV Non-glabrous skin YES NO true No M0 N1b T3b Stage IIIC TCGA-EE-A29D.FA9448E8-537D-4200-90AE-7A67332E5DDB.pdf A29D NO YES NO NO Metastatic 06 6th NO YES EE Regional Lymph Node A DECEASED 2008 5c8adf9a-05bc-4690-a057-4638de231d93 TCGA-EE-A29D-06A-11D-A19C-05 5c8adf9a-05bc-4690-a057-4638de231d93 TCGA-EE-A29D-06 TCGA-EE-A29D-06A-11D-A191-01 TCGA-EE-A29D-06 TCGA-EE-A29D-06A-11D-A197-08 TCGA-EE-A29D-06A-11D-A197-08 TCGA-EE-A29D-06A-11D-A191-01 TCGA-EE-A29D-06A-11D-A197-08 5c8adf9a-05bc-4690-a057-4638de231d93 5c8adf9a-05bc-4690-a057-4638de231d93 +TCGA-EE-A29E-06 TCGA-EE-A29E-06 TCGA-EE-A29E TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 54 TCGA-EE-A29E-F55039 TCGA-EE-A29E TCGA-EE-A29E-06A 3.2 -19961 1108 0 1940 30 2013-12-26 MALE No C77.3 8720/3 C77.3 YES 110 NO NO 6 IV Non-glabrous skin NO NO true No M0 N1b T3a Stage IIIB TCGA-EE-A29E.C3C1DB41-46B0-4162-BAEE-5FCFF18A696D.pdf A29E TUMOR FREE NO YES NO NO Metastatic 06 NO 6th NO YES EE Regional Lymph Node A LIVING 2008 24e9d763-4fc9-4806-90f7-6aeda279bc8f TCGA-EE-A29E-06A-11D-A19C-05 24e9d763-4fc9-4806-90f7-6aeda279bc8f TCGA-EE-A29E-06 TCGA-EE-A29E-06A-11D-A191-01 TCGA-EE-A29E-06 D705EA02-15CE-4B0A-9292-42FAE7D00945 TCGA-EE-A29E-06A-11D-A197-08 TCGA-EE-A29E-06A-11D-A197-08 TCGA-EE-A29E-06A-11D-A191-01 TCGA-EE-A29E-06A-11D-A197-08 24e9d763-4fc9-4806-90f7-6aeda279bc8f 24e9d763-4fc9-4806-90f7-6aeda279bc8f +TCGA-EE-A29G-06 TCGA-EE-A29G-06 TCGA-EE-A29G TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 53 TCGA-EE-A29G TCGA-EE-A29G-06A 7.4 -19664 2983 2192 0 1932 2013-7-11 MALE No C44.4 8720/3 C44.4 YES 100 NO 14 V Non-glabrous skin NO YES YES true No M0 N2a T4a Stage IIIA TCGA-EE-A29G.69D08E23-4BA3-4C50-9544-801889AB74AB.pdf A29G WITH TUMOR NO YES NO NO Metastatic 06 6th NO YES EE Regional Cutaneous or Subcutaneous Tissue (includes satellite and in-transit metastasis) A DECEASED 2003 4806a9ce-6f74-4e66-a45f-1ff7bbe39aea TCGA-EE-A29G-06A-12D-A19B-05 4806a9ce-6f74-4e66-a45f-1ff7bbe39aea TCGA-EE-A29G-06 TCGA-EE-A29G-06A-12D-A194-01 TCGA-EE-A29G-06 289CB745-D9FF-48AA-9A2D-240DB85B0DA6 TCGA-EE-A29G-06A-12D-A196-08 TCGA-EE-A29G-06A-12D-A196-08 TCGA-EE-A29G-06A-12D-A194-01 TCGA-EE-A29G-06A-12D-A196-08 4806a9ce-6f74-4e66-a45f-1ff7bbe39aea 4806a9ce-6f74-4e66-a45f-1ff7bbe39aea +TCGA-EE-A29H-06 TCGA-EE-A29H-06 TCGA-EE-A29H TCGA Melanoma (SKCM) skin cutaneous melanoma Skin YES|YES NO|NO 59 TCGA-EE-A29H-F55040 TCGA-EE-A29H TCGA-EE-A29H-06A 1 -21552 1043 0 1966 1231|1237 845 2013-12-26 FEMALE No C77.3 8720/3 C77.3 YES 290 NO NO 1 II Non-glabrous skin NO Distant Metastasis|Locoregional Recurrence NO|NO YES Other, Specify| Perihilar lymph nodes| true No M0 N0 T1a Stage IA TCGA-EE-A29H.F04F8CC7-26F1-4916-8FA2-6790E023047E.pdf A29H TUMOR FREE YES YES NO NO Metastatic 06 NO 6th YES NO EE Regional Lymph Node A LIVING 2008 3663854a-fbf6-4734-a968-7a64b16b63b0 TCGA-EE-A29H-06A-12D-A19C-05 3663854a-fbf6-4734-a968-7a64b16b63b0 TCGA-EE-A29H-06 TCGA-EE-A29H-06A-12D-A191-01 TCGA-EE-A29H-06 9056CD38-9CFE-4DFD-B966-A0C08AF14F04 TCGA-EE-A29H-06A-12D-A197-08 TCGA-EE-A29H-06A-12D-A197-08 TCGA-EE-A29H-06A-12D-A191-01 TCGA-EE-A29H-06A-12D-A197-08 3663854a-fbf6-4734-a968-7a64b16b63b0 3663854a-fbf6-4734-a968-7a64b16b63b0 +TCGA-EE-A29L-06 TCGA-EE-A29L-06 TCGA-EE-A29L TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 78 TCGA-EE-A29L TCGA-EE-A29L-06A 7 -28824 804 79 0 46 2013-1-8 MALE No C77.3 8720/3 C77.3 YES 330 NO 16 V Non-glabrous skin YES NO YES true Yes M0 N3 T4b Stage IIIC TCGA-EE-A29L.99F4D416-52E2-4225-9682-28802B61F9AC.pdf A29L NO YES NO NO Metastatic 06 6th NO YES EE Regional Lymph Node A DECEASED 2009 ee9fecf0-91d4-4ff2-8a88-a59f6208d4b2 TCGA-EE-A29L-06A-12D-A19B-05 ee9fecf0-91d4-4ff2-8a88-a59f6208d4b2 TCGA-EE-A29L-06 TCGA-EE-A29L-06A-12D-A194-01 TCGA-EE-A29L-06 971E49E5-34BD-4DFC-AF24-3C9835B4AB56 TCGA-EE-A29L-06A-12D-A196-08 TCGA-EE-A29L-06A-12D-A196-08 TCGA-EE-A29L-06A-12D-A194-01 TCGA-EE-A29L-06A-12D-A196-08 ee9fecf0-91d4-4ff2-8a88-a59f6208d4b2 ee9fecf0-91d4-4ff2-8a88-a59f6208d4b2 +TCGA-EE-A29M-06 TCGA-EE-A29M-06 TCGA-EE-A29M TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 33 TCGA-EE-A29M-F55043 TCGA-EE-A29M TCGA-EE-A29M-06A 1.02 -12350 1296 0 1729 524 2013-12-26 FEMALE No C77.3 8720/3 C77.3 YES 240 NO NO 3 III Non-glabrous skin NO NO true No M0 N0 T2a Stage IB TCGA-EE-A29M.62B8E490-9790-4D86-93B4-24AE7F909A32.pdf A29M TUMOR FREE NO YES NO NO Metastatic 06 NO 6th NO YES EE Regional Lymph Node A LIVING 2007 8fba87be-9062-49e8-ab5d-95b4c4c6a721 TCGA-EE-A29M-06A-11D-A19B-05 8fba87be-9062-49e8-ab5d-95b4c4c6a721 TCGA-EE-A29M-06 TCGA-EE-A29M-06A-11D-A194-01 TCGA-EE-A29M-06 E2E654FD-5CC1-4041-8977-35C25534DB2E TCGA-EE-A29M-06A-11D-A196-08 TCGA-EE-A29M-06A-11D-A196-08 TCGA-EE-A29M-06A-11D-A194-01 TCGA-EE-A29M-06A-11D-A196-08 8fba87be-9062-49e8-ab5d-95b4c4c6a721 8fba87be-9062-49e8-ab5d-95b4c4c6a721 +TCGA-EE-A29N-06 TCGA-EE-A29N-06 TCGA-EE-A29N TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 78 TCGA-EE-A29N TCGA-EE-A29N-06A -28805 809 566 0 277 2013-1-8 MALE No C77.3 8720/3 C77.3 YES 240 NO Non-glabrous skin NO YES true No M0 N0 TX I/II NOS TCGA-EE-A29N.08CCE4A2-2A10-4E4A-9DD2-2AA5AE02A9E7.pdf A29N WITH TUMOR NO YES NO NO Metastatic 06 6th NO YES EE Regional Lymph Node A DECEASED 2009 7390099e-8926-4ae0-a0cd-99426c6e4a1d TCGA-EE-A29N-06A-12D-A19C-05 7390099e-8926-4ae0-a0cd-99426c6e4a1d TCGA-EE-A29N-06 TCGA-EE-A29N-06A-12D-A191-01 TCGA-EE-A29N-06 ECCEA58D-C724-46C0-BEBD-FDB0A1D3556B TCGA-EE-A29N-06A-12D-A197-08 TCGA-EE-A29N-06A-12D-A197-08 TCGA-EE-A29N-06A-12D-A191-01 TCGA-EE-A29N-06A-12D-A197-08 7390099e-8926-4ae0-a0cd-99426c6e4a1d 7390099e-8926-4ae0-a0cd-99426c6e4a1d +TCGA-EE-A29P-06 TCGA-EE-A29P-06 TCGA-EE-A29P TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 73 TCGA-EE-A29P-F55044 TCGA-EE-A29P TCGA-EE-A29P-06A 4.5 -26899 1793 0 1716 1350 2013-12-26 FEMALE No C77.3 8720/3 C77.3 YES 160 NO YES 16 IV Non-glabrous skin YES NO YES true No M0 N0 T4b Stage IIC TCGA-EE-A29P.CD9AA141-2F94-4C67-9D53-C43C2A316BDA.pdf A29P WITH TUMOR NO YES NO NO Metastatic 06 6th NO YES EE Regional Lymph Node A LIVING 2006 1b970dc3-8bf2-4b48-8631-d9d61b05535d TCGA-EE-A29P-06A-11D-A19C-05 1b970dc3-8bf2-4b48-8631-d9d61b05535d TCGA-EE-A29P-06 TCGA-EE-A29P-06A-11D-A191-01 TCGA-EE-A29P-06 7D023BEF-6B38-434F-AE9C-589D1ACF479B TCGA-EE-A29P-06A-11D-A197-08 TCGA-EE-A29P-06A-11D-A197-08 TCGA-EE-A29P-06A-11D-A191-01 TCGA-EE-A29P-06A-11D-A197-08 1b970dc3-8bf2-4b48-8631-d9d61b05535d 1b970dc3-8bf2-4b48-8631-d9d61b05535d +TCGA-EE-A29Q-06 TCGA-EE-A29Q-06 TCGA-EE-A29Q TCGA Melanoma (SKCM) skin cutaneous melanoma Skin NO|YES|YES|YES|YES|NO|NO YES|NO|NO|YES|NO|YES|YES 70 TCGA-EE-A29Q-F55045 TCGA-EE-A29Q TCGA-EE-A29Q-06A 2.3 -25847 1263 2030 0 1136 1298|1800| 1256|1796|1796|1796|1796|1800|1574 890 2013-12-27 FEMALE No C49.1 8720/3 C49.1 YES 60 NO NO 8 IV Non-glabrous skin YES Regional lymph node|Distant Metastasis|Distant Metastasis|Distant Metastasis|Distant Metastasis|Locoregional Recurrence|Distant Metastasis YES|NO|NO|NO|NO|YES|NO YES |Other, Specify|Other, Specify|Lung|BoneBrain |mediastinal lymph nodes|adrenal true No M0 N0 T3b Stage IIB TCGA-EE-A29Q.4ED10518-B475-433F-945A-1A97C8B6041C.pdf A29Q WITH TUMOR NO YES NO NO Metastatic 06 NO 6th NO YES EE Regional Cutaneous or Subcutaneous Tissue (includes satellite and in-transit metastasis) A DECEASED 2007 50c829d7-c1cb-46dc-a17d-f2cdcfa8e8a6 TCGA-EE-A29Q-06A-11D-A19C-05 50c829d7-c1cb-46dc-a17d-f2cdcfa8e8a6 TCGA-EE-A29Q-06 TCGA-EE-A29Q-06A-11D-A191-01 TCGA-EE-A29Q-06 TCGA-EE-A29Q-06A-11D-A197-08 TCGA-EE-A29Q-06A-11D-A197-08 TCGA-EE-A29Q-06A-11D-A191-01 TCGA-EE-A29Q-06A-11D-A197-08 50c829d7-c1cb-46dc-a17d-f2cdcfa8e8a6 50c829d7-c1cb-46dc-a17d-f2cdcfa8e8a6 +TCGA-EE-A29R-06 TCGA-EE-A29R-06 TCGA-EE-A29R TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 48 TCGA-EE-A29R-F59763 TCGA-EE-A29R TCGA-EE-A29R-06A 3.5 -17857 359 0 440 171 2014-5-20 FEMALE No C49.0 8720/3 C49.0 YES 520 NO YES 6 V Non-glabrous skin YES NO YES true No M0 N1b T3b Stage IIIC TCGA-EE-A29R.8DEEF9EA-3585-4047-A2BD-E7AB4DD1306F.pdf A29R WITH TUMOR NO YES NO NO Metastatic 06 7th YES NO EE Regional Lymph Node A LIVING 2010 3bf6d735-504c-4d36-be6d-ca1a7aaad836 TCGA-EE-A29R-06A-11D-A19C-05 3bf6d735-504c-4d36-be6d-ca1a7aaad836 TCGA-EE-A29R-06 TCGA-EE-A29R-06A-11D-A191-01 TCGA-EE-A29R-06 4A84B7A8-998D-4CDF-B41D-98EB81437FB5 TCGA-EE-A29R-06A-11D-A197-08 TCGA-EE-A29R-06A-11D-A197-08 TCGA-EE-A29R-06A-11D-A191-01 TCGA-EE-A29R-06A-11D-A197-08 3bf6d735-504c-4d36-be6d-ca1a7aaad836 3bf6d735-504c-4d36-be6d-ca1a7aaad836 +TCGA-EE-A29S-06 TCGA-EE-A29S-06 TCGA-EE-A29S TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 79 TCGA-EE-A29S-F55051 TCGA-EE-A29S TCGA-EE-A29S-06A 2.5 -29087 1659 1864 0 1701 1397 2014-5-20 MALE No C77.3 8720/3 C77.3 YES 250 NO NO 7 IV Non-glabrous skin NO NO YES true No M0 N0 T3a Stage IIA TCGA-EE-A29S.4014EA1A-EB3B-461C-B8C9-AFC32B67DA0B.pdf A29S WITH TUMOR NO YES NO NO Metastatic 06 NO 6th NO YES EE Regional Lymph Node A DECEASED 2006 5d3aa73e-ce8e-409d-ab73-bdc6d28bb956 TCGA-EE-A29S-06A-11D-A19C-05 5d3aa73e-ce8e-409d-ab73-bdc6d28bb956 TCGA-EE-A29S-06 TCGA-EE-A29S-06A-11D-A191-01 TCGA-EE-A29S-06 C55B5409-EA08-46F0-A30A-FA95B20EA17E TCGA-EE-A29S-06A-11D-A197-08 TCGA-EE-A29S-06A-11D-A197-08 TCGA-EE-A29S-06A-11D-A191-01 TCGA-EE-A29S-06A-11D-A197-08 5d3aa73e-ce8e-409d-ab73-bdc6d28bb956 5d3aa73e-ce8e-409d-ab73-bdc6d28bb956 +TCGA-EE-A29T-06 TCGA-EE-A29T-06 TCGA-EE-A29T TCGA Melanoma (SKCM) skin cutaneous melanoma Skin NO|NO|NO|NO|YES|YES|YES NO|NO|NO|NO|NO|NO|NO 51 TCGA-EE-A29T-F55117 TCGA-EE-A29T TCGA-EE-A29T-06A -18779 10559 0 11252 10916|11007|11007|10916| 10888|10990|10990|10916|11006|11006|11006 10326 2013-12-29 FEMALE No C77.9 8720/3 C77.9 YES 200 NO NO Non-glabrous skin Locoregional Recurrence|Locoregional Recurrence|Distant Metastasis|Distant Metastasis|Distant Metastasis|Distant Metastasis|Distant Metastasis YES YES|YES|YES|YES|NO|NO|NO YES Other, Specify|Other, Specify|Other, Specify|Other, Specify|Other, Specify right breast skin and soft tissue|left breast LN|right supraspinatus muscle|left upper arm skin and soft tissue|left occipito-parietal scalp - skin and soft tissue true No M0 NX TX TCGA-EE-A29T.4F109FA0-76B1-46AA-B90C-AB1CA81C387B.pdf A29T TUMOR FREE NO YES NO NO Metastatic 06 NO 1st NO YES EE Regional Lymph Node A LIVING 1982 73290cd5-d727-49d3-b054-c40e15ebc233 TCGA-EE-A29T-06A-11D-A19C-05 73290cd5-d727-49d3-b054-c40e15ebc233 TCGA-EE-A29T-06 TCGA-EE-A29T-06A-11D-A191-01 TCGA-EE-A29T-06 C0A60ECC-AE70-4E99-A291-C79A3D6ADF45 TCGA-EE-A29T-06A-11D-A197-08 TCGA-EE-A29T-06A-11D-A191-01 TCGA-EE-A29T-06A-11D-A197-08 73290cd5-d727-49d3-b054-c40e15ebc233 73290cd5-d727-49d3-b054-c40e15ebc233 +TCGA-EE-A29V-06 TCGA-EE-A29V-06 TCGA-EE-A29V TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 85 TCGA-EE-A29V TCGA-EE-A29V-06A 3.5 -31092 1064 787 0 713 Chest 2013-1-8 MALE No C44.5 8720/3 C44.5 YES 130 NO 14 IV Non-glabrous skin YES YES YES true No M0 N1b T3b Stage IIIC TCGA-EE-A29V.24E328F1-3272-4386-A8B5-8E8E7CD0EE48.pdf A29V WITH TUMOR YES YES NO NO Metastatic 06 6th NO YES EE Distant Metastasis A DECEASED 2008 0fce8c31-15af-4558-9c50-341d447ff5d5 TCGA-EE-A29V-06A-12D-A19C-05 0fce8c31-15af-4558-9c50-341d447ff5d5 TCGA-EE-A29V-06 TCGA-EE-A29V-06A-12D-A191-01 TCGA-EE-A29V-06 E4ACE376-4431-46D1-8156-295DB9155B6D TCGA-EE-A29V-06A-12D-A197-08 TCGA-EE-A29V-06A-12D-A197-08 TCGA-EE-A29V-06A-12D-A191-01 TCGA-EE-A29V-06A-12D-A197-08 0fce8c31-15af-4558-9c50-341d447ff5d5 0fce8c31-15af-4558-9c50-341d447ff5d5 +TCGA-EE-A29W-06 TCGA-EE-A29W-06 TCGA-EE-A29W TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 42 TCGA-EE-A29W-F55119 TCGA-EE-A29W TCGA-EE-A29W-06A 0.0 -15396 5186 0 5932 4954 2013-12-29 MALE No C77.4 8720/3 C77.4 YES 390 NO NO I Non-glabrous skin YES NO true No M0 N0 Tis Stage 0 TCGA-EE-A29W.E700FE5C-7451-4C73-A966-8382C08C51F1.pdf A29W TUMOR FREE NO YES NO YES Metastatic 06 NO 4th NO YES EE Regional Lymph Node A LIVING 1997 3bdd32fc-608b-4559-b219-bd57548cb29a TCGA-EE-A29W-06A-11D-A19B-05 3bdd32fc-608b-4559-b219-bd57548cb29a TCGA-EE-A29W-06 TCGA-EE-A29W-06A-11D-A194-01 TCGA-EE-A29W-06 21D81271-7264-47B6-9725-94402F4083DA TCGA-EE-A29W-06A-11D-A196-08 TCGA-EE-A29W-06A-11D-A196-08 TCGA-EE-A29W-06A-11D-A194-01 TCGA-EE-A29W-06A-11D-A196-08 3bdd32fc-608b-4559-b219-bd57548cb29a 3bdd32fc-608b-4559-b219-bd57548cb29a +TCGA-EE-A29X-06 TCGA-EE-A29X-06 TCGA-EE-A29X TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 58 TCGA-EE-A29X TCGA-EE-A29X-06A 2 -21363 763 545 0 299 2013-1-8 FEMALE No C49.0 8720/3 C49.0 YES 80 NO 8 IV Non-glabrous skin NO NO YES true No M0 N0 T2a Stage IB TCGA-EE-A29X.26C1B87F-9E43-4D68-9F89-6831FCAA1044.pdf A29X WITH TUMOR NO YES NO NO Metastatic 06 6th NO YES EE Regional Lymph Node A DECEASED 2009 58d8d333-2db3-414a-b8c6-22e28d79403b TCGA-EE-A29X-06A-11D-A19B-05 58d8d333-2db3-414a-b8c6-22e28d79403b TCGA-EE-A29X-06 TCGA-EE-A29X-06A-11D-A194-01 TCGA-EE-A29X-06 TCGA-EE-A29X-06A-11D-A196-08 TCGA-EE-A29X-06A-11D-A196-08 TCGA-EE-A29X-06A-11D-A194-01 TCGA-EE-A29X-06A-11D-A196-08 58d8d333-2db3-414a-b8c6-22e28d79403b 58d8d333-2db3-414a-b8c6-22e28d79403b +TCGA-EE-A2A0-06 TCGA-EE-A2A0-06 TCGA-EE-A2A0 TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 77 TCGA-EE-A2A0 TCGA-EE-A2A0-06A 2.2 -28319 1801 1424 0 1080 2013-1-8 FEMALE No C77.4 8720/3 C77.4 YES 230 NO 2 IV Non-glabrous skin NO NO YES true No M0 N0 T3a Stage IIA TCGA-EE-A2A0.5A3258EA-F7DF-478F-A079-D12BC543078E.pdf A2A0 WITH TUMOR NO YES NO NO Metastatic 06 6th NO YES EE Regional Lymph Node A DECEASED 2006 8f259997-f80c-4516-a7e6-f8c888f008d4 TCGA-EE-A2A0-06A-11D-A19B-05 8f259997-f80c-4516-a7e6-f8c888f008d4 TCGA-EE-A2A0-06 TCGA-EE-A2A0-06A-11D-A194-01 TCGA-EE-A2A0-06 BBEEC31B-4C3F-4082-AA90-50CEEC534628 TCGA-EE-A2A0-06A-11D-A196-08 TCGA-EE-A2A0-06A-11D-A196-08 TCGA-EE-A2A0-06A-11D-A194-01 TCGA-EE-A2A0-06A-11D-A196-08 8f259997-f80c-4516-a7e6-f8c888f008d4 8f259997-f80c-4516-a7e6-f8c888f008d4 +TCGA-EE-A2A1-06 TCGA-EE-A2A1-06 TCGA-EE-A2A1 TCGA Melanoma (SKCM) skin cutaneous melanoma Skin NO NO 46 TCGA-EE-A2A1-F65641 TCGA-EE-A2A1 TCGA-EE-A2A1-06A 1.3 -17109 2339 0 3527 3515 3488 1633 2014-9-26 MALE No C77.3 8720/3 C77.3 YES 50 NO NO 7 IV Non-glabrous skin NO Regional lymph node YES YES true No M0 N0 T2a Stage IB TCGA-EE-A2A1.5F6CE73D-DD0C-4BB3-B572-4FABE2983B0C.pdf A2A1 TUMOR FREE NO YES NO NO Metastatic 06 NO 6th NO YES EE Regional Lymph Node A LIVING 2004 1e140ddc-259f-4f83-b5c5-5cbeb3617fb3 TCGA-EE-A2A1-06A-11D-A19C-05 1e140ddc-259f-4f83-b5c5-5cbeb3617fb3 TCGA-EE-A2A1-06 TCGA-EE-A2A1-06A-11D-A191-01 TCGA-EE-A2A1-06 TCGA-EE-A2A1-06A-11D-A197-08 TCGA-EE-A2A1-06A-11D-A197-08 TCGA-EE-A2A1-06A-11D-A191-01 TCGA-EE-A2A1-06A-11D-A197-08 1e140ddc-259f-4f83-b5c5-5cbeb3617fb3 1e140ddc-259f-4f83-b5c5-5cbeb3617fb3 +TCGA-EE-A2A2-06 TCGA-EE-A2A2-06 TCGA-EE-A2A2 TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 71 TCGA-EE-A2A2-F65642 TCGA-EE-A2A2 TCGA-EE-A2A2-06A 7 -26048 612 0 1814 16 2014-9-26 MALE No C77.3 8720/3 C77.3 YES 440 NO NO 8 IV Non-glabrous skin YES NO true No M0 N1b T4b Stage IIIC TCGA-EE-A2A2.2BADECFD-49E1-416A-8DC4-C3E72FD2E847.pdf A2A2 TUMOR FREE NO YES NO NO Metastatic 06 NO 6th NO YES EE Regional Lymph Node A LIVING 2009 cc38cfd7-4ade-4834-812d-109d152a45b8 TCGA-EE-A2A2-06A-11D-A19B-05 cc38cfd7-4ade-4834-812d-109d152a45b8 TCGA-EE-A2A2-06 TCGA-EE-A2A2-06A-11D-A194-01 TCGA-EE-A2A2-06 B4722870-8EF0-4419-97F2-6C65DD721D7E TCGA-EE-A2A2-06A-11D-A196-08 TCGA-EE-A2A2-06A-11D-A196-08 TCGA-EE-A2A2-06A-11D-A194-01 TCGA-EE-A2A2-06A-11D-A196-08 cc38cfd7-4ade-4834-812d-109d152a45b8 cc38cfd7-4ade-4834-812d-109d152a45b8 +TCGA-EE-A2A5-06 TCGA-EE-A2A5-06 TCGA-EE-A2A5 TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 43 TCGA-EE-A2A5 TCGA-EE-A2A5-06A 1.1 -16041 1252 1195 0 901 2013-1-8 MALE No C49.1 8720/3 C49.1 YES 50 NO 3 IV Non-glabrous skin NO NO YES true No M0 N0 T2a Stage IB TCGA-EE-A2A5.FE4DB085-F3A6-4AAC-88C2-AD1936EBDA1E.pdf A2A5 WITH TUMOR NO YES NO NO Metastatic 06 6th NO YES EE Regional Cutaneous or Subcutaneous Tissue (includes satellite and in-transit metastasis) A DECEASED 2007 8d88024d-1da6-4497-be57-1bb50e18a9a4 TCGA-EE-A2A5-06A-11D-A19C-05 8d88024d-1da6-4497-be57-1bb50e18a9a4 TCGA-EE-A2A5-06 TCGA-EE-A2A5-06A-11D-A191-01 TCGA-EE-A2A5-06 TCGA-EE-A2A5-06A-11D-A197-08 TCGA-EE-A2A5-06A-11D-A197-08 TCGA-EE-A2A5-06A-11D-A191-01 TCGA-EE-A2A5-06A-11D-A197-08 8d88024d-1da6-4497-be57-1bb50e18a9a4 8d88024d-1da6-4497-be57-1bb50e18a9a4 +TCGA-EE-A2A6-06 TCGA-EE-A2A6-06 TCGA-EE-A2A6 TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 43 TCGA-EE-A2A6-F55125 TCGA-EE-A2A6 TCGA-EE-A2A6-06A .55 -15953 1766 0 2620 1515 2013-12-29 MALE No C77.4 8720/3 C77.4 YES 330 NO NO 0.0 II Non-glabrous skin NO YES NO true No M0 N0 T1a Stage IA TCGA-EE-A2A6.8B6460D2-6763-420C-9912-E17F429EE9F9.pdf A2A6 TUMOR FREE NO YES NO NO Metastatic 06 NO 6th YES NO EE Regional Lymph Node A LIVING 2006 5f92f983-1ec8-4bfd-b477-8118d31a02e3 TCGA-EE-A2A6-06A-11D-A19C-05 5f92f983-1ec8-4bfd-b477-8118d31a02e3 TCGA-EE-A2A6-06 TCGA-EE-A2A6-06A-11D-A191-01 TCGA-EE-A2A6-06 9297F678-2744-4D42-B3EA-C5BB9FCE72A4 TCGA-EE-A2A6-06A-11D-A197-08 TCGA-EE-A2A6-06A-11D-A197-08 TCGA-EE-A2A6-06A-11D-A191-01 TCGA-EE-A2A6-06A-11D-A197-08 5f92f983-1ec8-4bfd-b477-8118d31a02e3 5f92f983-1ec8-4bfd-b477-8118d31a02e3 +TCGA-EE-A2GB-06 TCGA-EE-A2GB-06 TCGA-EE-A2GB TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 51 TCGA-EE-A2GB-F55126 TCGA-EE-A2GB TCGA-EE-A2GB-06A 1.65 -18876 1535 0 1803 248 2013-12-29 MALE No C77.3 8720/3 C77.3 YES 80 NO NO 9 III Non-glabrous skin YES NO true No M0 N1a T2b Stage IIIB TCGA-EE-A2GB.4BBF4BC4-A1B1-4DCE-8DC8-5410D7A336C2.pdf A2GB TUMOR FREE NO YES NO YES Metastatic 06 NO 6th NO YES EE Regional Lymph Node A LIVING 2007 9d3eb977-6020-42db-804b-a1139511a979 TCGA-EE-A2GB-06A-11D-A19C-05 9d3eb977-6020-42db-804b-a1139511a979 TCGA-EE-A2GB-06 TCGA-EE-A2GB-06A-11D-A191-01 TCGA-EE-A2GB-06 TCGA-EE-A2GB-06A-11D-A197-08 TCGA-EE-A2GB-06A-11D-A197-08 TCGA-EE-A2GB-06A-11D-A191-01 TCGA-EE-A2GB-06A-11D-A197-08 9d3eb977-6020-42db-804b-a1139511a979 9d3eb977-6020-42db-804b-a1139511a979 +TCGA-EE-A2GC-06 TCGA-EE-A2GC-06 TCGA-EE-A2GC TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 82 TCGA-EE-A2GC-F55127 TCGA-EE-A2GC TCGA-EE-A2GC-06A 2.3 -30084 1246 0 2051 1008 2013-12-29 MALE No C77.0 8720/3 C77.0 YES 470 NO NO 35 III Non-glabrous skin YES NO true No M0 N0 T3b Stage IIB TCGA-EE-A2GC.F2DE0CF5-7EE7-430E-AB09-BF8487D27A0B.pdf A2GC TUMOR FREE NO YES NO NO Metastatic 06 NO 6th YES NO EE Regional Lymph Node A LIVING 2008 5ac1f533-a9f3-4a5e-a25f-4b04ffcf50b6 TCGA-EE-A2GC-06A-11D-A19C-05 5ac1f533-a9f3-4a5e-a25f-4b04ffcf50b6 TCGA-EE-A2GC-06 TCGA-EE-A2GC-06A-11D-A191-01 TCGA-EE-A2GC-06 719542BE-AC43-456D-92DD-32F19CD10007 TCGA-EE-A2GC-06A-11D-A197-08 TCGA-EE-A2GC-06A-11D-A197-08 TCGA-EE-A2GC-06A-11D-A191-01 TCGA-EE-A2GC-06A-11D-A197-08 5ac1f533-a9f3-4a5e-a25f-4b04ffcf50b6 5ac1f533-a9f3-4a5e-a25f-4b04ffcf50b6 +TCGA-EE-A2GD-06 TCGA-EE-A2GD-06 TCGA-EE-A2GD TCGA Melanoma (SKCM) skin cutaneous melanoma Skin NO NO 58 TCGA-EE-A2GD-F55128 TCGA-EE-A2GD TCGA-EE-A2GD-06A 4.4 -21526 10016 10346 0 9568 10143 9021 2013-12-29 FEMALE No C49.2 8720/3 C49.2 YES 60 NO NO IV Non-glabrous skin YES Locoregional Recurrence YES NO YES true Yes M0 N0 T4 Stage IIB TCGA-EE-A2GD.E7219620-4E00-4484-BBF1-3311C52321F7.pdf A2GD WITH TUMOR NO YES NO NO Metastatic 06 NO 2nd NO YES EE Regional Cutaneous or Subcutaneous Tissue (includes satellite and in-transit metastasis) A DECEASED 1984 55cb57c2-be44-4e16-94b7-aa58307b12b8 TCGA-EE-A2GD-06A-11D-A19B-05 55cb57c2-be44-4e16-94b7-aa58307b12b8 TCGA-EE-A2GD-06 TCGA-EE-A2GD-06A-11D-A194-01 TCGA-EE-A2GD-06 TCGA-EE-A2GD-06A-11D-A196-08 TCGA-EE-A2GD-06A-11D-A196-08 TCGA-EE-A2GD-06A-11D-A194-01 TCGA-EE-A2GD-06A-11D-A196-08 55cb57c2-be44-4e16-94b7-aa58307b12b8 55cb57c2-be44-4e16-94b7-aa58307b12b8 +TCGA-EE-A2GE-06 TCGA-EE-A2GE-06 TCGA-EE-A2GE TCGA Melanoma (SKCM) skin cutaneous melanoma Skin NO|NO NO|NO 44 TCGA-EE-A2GE-F65643 TCGA-EE-A2GE .9 -16353 0 5286 5286|5286 5276|5276 3073 2014-9-26 MALE No C77.3 8730/3 C77.3 YES NO 0 III Non-glabrous skin NO Extremities|Extremities SCC|BCC YES|YES YES No M0 N0 T2 Stage I A2GE TUMOR FREE NO YES NO YES Metastatic 06 NO 5th NO YES EE Regional Lymph Node LIVING 1999 fec63465-f926-4fce-a88a-898cac637305 TCGA-EE-A2GE-06A-11D-A19B-05 fec63465-f926-4fce-a88a-898cac637305 TCGA-EE-A2GE-06 TCGA-EE-A2GE-06A-11D-A194-01 TCGA-EE-A2GE-06 TCGA-EE-A2GE-06A-11D-A196-08 TCGA-EE-A2GE-06A-11D-A196-08 TCGA-EE-A2GE-06A-11D-A194-01 TCGA-EE-A2GE-06A-11D-A196-08 fec63465-f926-4fce-a88a-898cac637305 fec63465-f926-4fce-a88a-898cac637305 +TCGA-EE-A2GH-06 TCGA-EE-A2GH-06 TCGA-EE-A2GH TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 34 TCGA-EE-A2GH-F65644 TCGA-EE-A2GH TCGA-EE-A2GH-06A .8 -12727 5501 0 6699 4892 2014-9-26 MALE No C77.3 8720/3 C77.3 YES 320 NO NO 2 III Non-glabrous skin NO true No M0 N0 T2 Stage I TCGA-EE-A2GH.4FF6F797-FFBC-4C27-8195-3A7F36B2D8AC.pdf A2GH TUMOR FREE YES YES NO NO Metastatic 06 NO 4th NO YES EE Regional Lymph Node A LIVING 1996 e5c59c1c-fc25-47b1-b8ab-dc0767a4ebe7 TCGA-EE-A2GH-06A-11D-A19B-05 e5c59c1c-fc25-47b1-b8ab-dc0767a4ebe7 TCGA-EE-A2GH-06 TCGA-EE-A2GH-06A-11D-A194-01 TCGA-EE-A2GH-06 0A05821B-300D-4690-9BE1-CDFEBC86851F TCGA-EE-A2GH-06A-11D-A196-08 TCGA-EE-A2GH-06A-11D-A196-08 TCGA-EE-A2GH-06A-11D-A194-01 TCGA-EE-A2GH-06A-11D-A196-08 e5c59c1c-fc25-47b1-b8ab-dc0767a4ebe7 e5c59c1c-fc25-47b1-b8ab-dc0767a4ebe7 +TCGA-EE-A2GI-06 TCGA-EE-A2GI-06 TCGA-EE-A2GI TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 39 TCGA-EE-A2GI-F55132 TCGA-EE-A2GI TCGA-EE-A2GI-06A .65 -14498 1126 0 1482 567 2013-12-29 MALE No C77.3 8720/3 C77.3 YES 680 NO NO III Non-glabrous skin NO NO true No M0 N0 T1a Stage IA TCGA-EE-A2GI.99CDD070-FBAF-4310-9022-7F3DFD9E7043.pdf A2GI TUMOR FREE YES YES NO NO Metastatic 06 NO 6th NO YES EE Regional Lymph Node A LIVING 2008 5f75a7a1-a36b-4ddc-adc7-7de26854f0b2 TCGA-EE-A2GI-06A-11D-A19B-05 5f75a7a1-a36b-4ddc-adc7-7de26854f0b2 TCGA-EE-A2GI-06 TCGA-EE-A2GI-06A-11D-A194-01 TCGA-EE-A2GI-06 E1A12DE5-51E1-48C8-BB1F-51499D801E16 TCGA-EE-A2GI-06A-11D-A196-08 TCGA-EE-A2GI-06A-11D-A196-08 TCGA-EE-A2GI-06A-11D-A194-01 TCGA-EE-A2GI-06A-11D-A196-08 5f75a7a1-a36b-4ddc-adc7-7de26854f0b2 5f75a7a1-a36b-4ddc-adc7-7de26854f0b2 +TCGA-EE-A2GJ-06 TCGA-EE-A2GJ-06 TCGA-EE-A2GJ TCGA Melanoma (SKCM) skin cutaneous melanoma Skin NO|NO|NO|NO|NO NO|NO|NO|NO|NO 83 TCGA-EE-A2GJ-F55134 TCGA-EE-A2GJ .4 -30602 3266 0 2717 3037 3014|3121|3121|3121|3121 2126 2013-12-29 MALE No C77.4 8720/3 C77.4 YES NO 0 II Non-glabrous skin NO Locoregional Recurrence|Distant Metastasis|Distant Metastasis|Distant Metastasis|Distant Metastasis YES YES|NO|NO|NO|NO YES |Lung|Bone|Other, Specify|Liver |mediastinal lymph nodes| No M0 N0 T1a Stage IA A2GJ WITH TUMOR NO YES YES NO Metastatic 06 NO 6th NO YES EE Regional Lymph Node DECEASED 2004 c0e841a4-6638-4e17-a3eb-5a900f616b0c TCGA-EE-A2GJ-06A-11D-A19B-05 c0e841a4-6638-4e17-a3eb-5a900f616b0c TCGA-EE-A2GJ-06 TCGA-EE-A2GJ-06A-11D-A194-01 TCGA-EE-A2GJ-06 TCGA-EE-A2GJ-06A-11D-A196-08 TCGA-EE-A2GJ-06A-11D-A196-08 TCGA-EE-A2GJ-06A-11D-A194-01 TCGA-EE-A2GJ-06A-11D-A196-08 c0e841a4-6638-4e17-a3eb-5a900f616b0c c0e841a4-6638-4e17-a3eb-5a900f616b0c +TCGA-EE-A2GK-06 TCGA-EE-A2GK-06 TCGA-EE-A2GK TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 46 TCGA-EE-A2GK-F59756 TCGA-EE-A2GK TCGA-EE-A2GK-06A .8 -16879 1583 0 1665 1178 2014-5-20 FEMALE No C77.4 8720/3 C77.4 YES 360 NO YES III Non-glabrous skin NO YES true No M0 N0 T1 Stage I TCGA-EE-A2GK.D96AE7E1-5518-4D08-9CD4-57D6C21E1B3A.pdf A2GK TUMOR FREE NO YES NO NO Metastatic 06 6th NO YES EE Regional Lymph Node A LIVING 2007 a9b12880-decd-416f-805b-f3484cd25e8a TCGA-EE-A2GK-06A-11D-A19B-05 a9b12880-decd-416f-805b-f3484cd25e8a TCGA-EE-A2GK-06 TCGA-EE-A2GK-06A-11D-A194-01 TCGA-EE-A2GK-06 5BC6C2A8-E5A1-4C5E-81AF-43343263EB78 TCGA-EE-A2GK-06A-11D-A196-08 TCGA-EE-A2GK-06A-11D-A196-08 TCGA-EE-A2GK-06A-11D-A194-01 TCGA-EE-A2GK-06A-11D-A196-08 a9b12880-decd-416f-805b-f3484cd25e8a a9b12880-decd-416f-805b-f3484cd25e8a +TCGA-EE-A2GL-06 TCGA-EE-A2GL-06 TCGA-EE-A2GL TCGA Melanoma (SKCM) skin cutaneous melanoma Skin NO|NO|NO|NO|NO|NO|NO|NO|NO|NO NO|NO|YES|NO|NO|NO|NO|NO|NO|NO 40 TCGA-EE-A2GL-F55172 TCGA-EE-A2GL TCGA-EE-A2GL-06A 3.1 -14701 1708 0 2423 2329|2367|2367|2367|2367|2367|2367|2367|2367|2367 1342 2013-12-30 FEMALE No C77.3 8720/3 C77.3 YES 470 NO NO 3 IV Non-glabrous skin NO Distant Metastasis|Distant Metastasis|Distant Metastasis|Distant Metastasis|Distant Metastasis|Distant Metastasis|Distant Metastasis|Distant Metastasis|Distant Metastasis|Distant Metastasis NO|NO|NO|NO|NO|NO|NO|NO|NO|NO YES Lung|Other, Specify|Bone|Other, Specify|Other, Specify|Other, Specify|Other, Specify|Other, Specify|Other, Specify|Other, Specify |right anterior chest - skin and soft tissueLN left neck|left head - skin and soft tissue|spleen|left anterior chest - skin and soft tissue|LN right neck|right head - skin and soft tissue|LN left pelvic true No M0 N0 T3a Stage IIA TCGA-EE-A2GL.6196044A-FF65-4757-B6EC-3557985DA2BF.pdf A2GL WITH TUMOR YES YES NO NO Metastatic 06 NO 6th NO YES EE Regional Lymph Node A LIVING 2006 478d662b-3ca6-48ba-85ce-efd70fa86f92 TCGA-EE-A2GL-06A-11D-A19B-05 478d662b-3ca6-48ba-85ce-efd70fa86f92 TCGA-EE-A2GL-06 TCGA-EE-A2GL-06A-11D-A194-01 TCGA-EE-A2GL-06 F3787448-6F3E-49CA-8A40-583467BFB0CB TCGA-EE-A2GL-06A-11D-A196-08 TCGA-EE-A2GL-06A-11D-A196-08 TCGA-EE-A2GL-06A-11D-A194-01 TCGA-EE-A2GL-06A-11D-A196-08 478d662b-3ca6-48ba-85ce-efd70fa86f92 478d662b-3ca6-48ba-85ce-efd70fa86f92 +TCGA-EE-A2GM-06 TCGA-EE-A2GM-06 TCGA-EE-A2GM TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 70 TCGA-EE-A2GM-F55176 TCGA-EE-A2GM TCGA-EE-A2GM-06B 6.5 -25711 2519 0 2296 1435 2013-12-30 FEMALE No C49.6 8720/3 C49.6 YES 30 NO YES 1 IV Non-glabrous skin YES YES YES true No M0 N0 T4b Stage IIC TCGA-EE-A2GM.D5563BB2-1989-4AEC-8013-098ED9C1DA08.pdf A2GM TUMOR FREE NO YES NO NO Metastatic 06 6th NO YES EE Regional Cutaneous or Subcutaneous Tissue (includes satellite and in-transit metastasis) B LIVING 2004 64995aa9-6bc3-4518-8694-4fa5a8d9b081 TCGA-EE-A2GM-06B-11D-A19B-05 64995aa9-6bc3-4518-8694-4fa5a8d9b081 TCGA-EE-A2GM-06 TCGA-EE-A2GM-06B-11D-A194-01 TCGA-EE-A2GM-06 TCGA-EE-A2GM-06B-11D-A196-08 TCGA-EE-A2GM-06B-11D-A196-08 TCGA-EE-A2GM-06B-11D-A194-01 TCGA-EE-A2GM-06B-11D-A196-08 64995aa9-6bc3-4518-8694-4fa5a8d9b081 64995aa9-6bc3-4518-8694-4fa5a8d9b081 +TCGA-EE-A2GN-06 TCGA-EE-A2GN-06 TCGA-EE-A2GN TCGA Melanoma (SKCM) skin cutaneous melanoma Skin NO|NO|NO|NO YES|NO|NO|NO 67 TCGA-EE-A2GN-F55177 TCGA-EE-A2GN TCGA-EE-A2GN-06A 1.9 -24683 2766 3106 0 2767 3062| 3050|3053|3053|3053 1738 2013-12-30 MALE Yes C49.3 8720/3 C49.3 YES 80 YES NO NO 9 IV Non-glabrous skin YES Distant Metastasis|Distant Metastasis|Distant Metastasis|Distant Metastasis NO YES|NO|NO|NO YES Brain|Lung|Bone|Liver true No M0 N0 T2b Stage IIA TCGA-EE-A2GN.AC0FD9F4-3181-47B7-A454-AE3E5C7D95B6.pdf A2GN WITH TUMOR NO YES NO Interferon NO Metastatic 06 NO 6th NO YES EE Regional Cutaneous or Subcutaneous Tissue (includes satellite and in-transit metastasis) A DECEASED 2003 0f3ce1eb-6393-4c42-bd47-2cf67ba378ca TCGA-EE-A2GN-06A-11D-A19B-05 0f3ce1eb-6393-4c42-bd47-2cf67ba378ca TCGA-EE-A2GN-06 TCGA-EE-A2GN-06A-11D-A194-01 TCGA-EE-A2GN-06 TCGA-EE-A2GN-06A-11D-A196-08 TCGA-EE-A2GN-06A-11D-A196-08 TCGA-EE-A2GN-06A-11D-A194-01 TCGA-EE-A2GN-06A-11D-A196-08 0f3ce1eb-6393-4c42-bd47-2cf67ba378ca 0f3ce1eb-6393-4c42-bd47-2cf67ba378ca +TCGA-EE-A2GO-06 TCGA-EE-A2GO-06 TCGA-EE-A2GO TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 66 TCGA-EE-A2GO-F55180 TCGA-EE-A2GO TCGA-EE-A2GO-06A 3.4 -24159 3162 0 3857 3766 3716 2163 2013-12-30 FEMALE No C49.2 8730/3 C49.2 YES 70 NO NO 2 IV Non-glabrous skin NO Extremities SCC NO YES YES true Yes M0 N0 T3b Stage II TCGA-EE-A2GO.FCD0B833-0944-43BE-837F-8E2F38E937DE.pdf A2GO TUMOR FREE NO YES NO NO Metastatic 06 NO 5th NO YES EE Regional Cutaneous or Subcutaneous Tissue (includes satellite and in-transit metastasis) A LIVING 2002 12fc6374-32ac-45d4-a09a-8fb71d69d953 TCGA-EE-A2GO-06A-11D-A19B-05 12fc6374-32ac-45d4-a09a-8fb71d69d953 TCGA-EE-A2GO-06 TCGA-EE-A2GO-06A-11D-A194-01 TCGA-EE-A2GO-06 TCGA-EE-A2GO-06A-11D-A196-08 TCGA-EE-A2GO-06A-11D-A196-08 TCGA-EE-A2GO-06A-11D-A194-01 TCGA-EE-A2GO-06A-11D-A196-08 12fc6374-32ac-45d4-a09a-8fb71d69d953 12fc6374-32ac-45d4-a09a-8fb71d69d953 +TCGA-EE-A2GP-06 TCGA-EE-A2GP-06 TCGA-EE-A2GP TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 80 TCGA-EE-A2GP TCGA-EE-A2GP-06A 4.2 -29501 831 423 0 258 2012-12-20 MALE No C77.3 8720/3 C77.3 YES 180 NO 30 IV Non-glabrous skin YES YES true No M0 N1a T4b Stage IIIB TCGA-EE-A2GP.2EDF33EE-2FF5-42B4-A15B-A57E6368C944.pdf A2GP WITH TUMOR NO YES NO NO Metastatic 06 6th NO YES EE Regional Cutaneous or Subcutaneous Tissue (includes satellite and in-transit metastasis) A DECEASED 2009 34049292-a4b9-4a3a-94be-e1febcecc848 TCGA-EE-A2GP-06A-11D-A19C-05 34049292-a4b9-4a3a-94be-e1febcecc848 TCGA-EE-A2GP-06 TCGA-EE-A2GP-06A-11D-A191-01 TCGA-EE-A2GP-06 4F2BA4B2-FC46-4410-9A27-C4BA181BCE11 TCGA-EE-A2GP-06A-11D-A197-08 TCGA-EE-A2GP-06A-11D-A197-08 TCGA-EE-A2GP-06A-11D-A191-01 TCGA-EE-A2GP-06A-11D-A197-08 34049292-a4b9-4a3a-94be-e1febcecc848 34049292-a4b9-4a3a-94be-e1febcecc848 +TCGA-EE-A2GR-06 TCGA-EE-A2GR-06 TCGA-EE-A2GR TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 78 TCGA-EE-A2GR-F55184 TCGA-EE-A2GR TCGA-EE-A2GR-06A 6.9 -28510 622 1301 0 435 400 2013-12-30 MALE No C49.1 8720/3 C49.1 YES 160 NO NO 8 IV Non-glabrous skin YES true No M0 N0 T4 Stage II TCGA-EE-A2GR.845FD905-B92B-4D98-95A0-3E24164CC1A2.pdf A2GR WITH TUMOR NO 2 YES YES NO Metastatic 06 6th YES NO EE Regional Cutaneous or Subcutaneous Tissue (includes satellite and in-transit metastasis) A DECEASED 2009 30fbb6c0-c79f-493b-b5c7-d8f820da9821 TCGA-EE-A2GR-06A-11D-A19C-05 30fbb6c0-c79f-493b-b5c7-d8f820da9821 TCGA-EE-A2GR-06 TCGA-EE-A2GR-06A-11D-A191-01 TCGA-EE-A2GR-06 AE280258-C2ED-4BAE-A475-B4453C5F007A TCGA-EE-A2GR-06A-11D-A197-08 TCGA-EE-A2GR-06A-11D-A197-08 TCGA-EE-A2GR-06A-11D-A191-01 TCGA-EE-A2GR-06A-11D-A197-08 30fbb6c0-c79f-493b-b5c7-d8f820da9821 30fbb6c0-c79f-493b-b5c7-d8f820da9821 +TCGA-EE-A2GS-06 TCGA-EE-A2GS-06 TCGA-EE-A2GS TCGA Melanoma (SKCM) skin cutaneous melanoma Skin YES|YES|YES|YES|YES|YES NO|NO|NO|NO|NO|NO|NO|NO 28 TCGA-EE-A2GS-F59674 TCGA-EE-A2GS TCGA-EE-A2GS-06A 1.8 -10421 1804 2470 0 1691 1831|1973|19652085|2253|2408|2455 1831|1945|1965|2072|2072|2253|2408|2455 1295 2014-5-20 FEMALE No C49.2 8730/3 C49.2 YES 110 NO NO 6 IV Non-glabrous skin NO Distant Metastasis|Distant Metastasis|Distant Metastasis|Distant Metastasis|Distant Metastasis|Distant Metastasis|Distant Metastasis|Distant Metastasis NO YES|YES|YES|NO|YES|YES|YES|YES YES Other, Specify|Other, Specify|Other, Specify|Lung|Brain|Brain|Brain|Brain upper back|right atrial tumour|right abdominal wall nodule| true No M0 N0 T2a Stage IB TCGA-EE-A2GS.57868CFE-20D2-4893-BF42-8E94E290D42F.pdf A2GS WITH TUMOR YES YES NO NO Metastatic 06 NO 6th NO YES EE Regional Cutaneous or Subcutaneous Tissue (includes satellite and in-transit metastasis) A DECEASED 2006 d4c47b15-bf2c-42b4-9aa1-c26f9ddbe4da TCGA-EE-A2GS-06A-12D-A19C-05 d4c47b15-bf2c-42b4-9aa1-c26f9ddbe4da TCGA-EE-A2GS-06 TCGA-EE-A2GS-06A-12D-A191-01 TCGA-EE-A2GS-06 699911C1-DFEE-491C-A2E3-447A8A34603D TCGA-EE-A2GS-06A-12D-A197-08 TCGA-EE-A2GS-06A-12D-A197-08 TCGA-EE-A2GS-06A-12D-A191-01 TCGA-EE-A2GS-06A-12D-A197-08 d4c47b15-bf2c-42b4-9aa1-c26f9ddbe4da d4c47b15-bf2c-42b4-9aa1-c26f9ddbe4da +TCGA-EE-A2GT-06 TCGA-EE-A2GT-06 TCGA-EE-A2GT TCGA Melanoma (SKCM) skin cutaneous melanoma Skin NO NO 77 TCGA-EE-A2GT-F55186 TCGA-EE-A2GT TCGA-EE-A2GT-06A 2.2 -28364 650 0 1365 1365 1357 301 2013-12-30 MALE No C77.3 8720/3 C77.3 YES 90 NO NO 5 IV Non-glabrous skin NO Locoregional Recurrence YES YES YES true No M0 N0 T3a Stage IIA TCGA-EE-A2GT.EB8A3520-4249-4DF4-AC19-80B4C9599974.pdf A2GT WITH TUMOR NO YES NO NO Metastatic 06 NO 6th NO YES EE Regional Lymph Node A LIVING 2009 32cf555c-9de8-4de4-ba4a-a729ac88e8ba TCGA-EE-A2GT-06A-12D-A19C-05 32cf555c-9de8-4de4-ba4a-a729ac88e8ba TCGA-EE-A2GT-06 TCGA-EE-A2GT-06A-12D-A191-01 TCGA-EE-A2GT-06 2661E369-72E5-45A3-A207-6855640A7CE7 TCGA-EE-A2GT-06A-12D-A197-08 TCGA-EE-A2GT-06A-12D-A197-08 TCGA-EE-A2GT-06A-12D-A191-01 TCGA-EE-A2GT-06A-12D-A197-08 32cf555c-9de8-4de4-ba4a-a729ac88e8ba 32cf555c-9de8-4de4-ba4a-a729ac88e8ba +TCGA-EE-A2GU-06 TCGA-EE-A2GU-06 TCGA-EE-A2GU TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 65 TCGA-EE-A2GU-F59767 TCGA-EE-A2GU TCGA-EE-A2GU-06A 0.3 -23784 1995 0 2884 1779 2014-5-21 FEMALE No C77.4 8720/3 C77.4 YES 290 NO NO 0 II Non-glabrous skin NO NO true No M0 N0 T1a Stage IA TCGA-EE-A2GU.83D3B219-4C20-405C-B432-A6948F54E97E.pdf A2GU TUMOR FREE YES YES NO NO Metastatic 06 NO 6th YES NO EE Regional Lymph Node A LIVING 2005 284fadfc-0c63-44ef-a464-0a62f1173e6b TCGA-EE-A2GU-06A-11D-A19B-05 284fadfc-0c63-44ef-a464-0a62f1173e6b TCGA-EE-A2GU-06 TCGA-EE-A2GU-06A-11D-A194-01 TCGA-EE-A2GU-06 8E969919-1F4B-4870-A538-813B8BDE1598 TCGA-EE-A2GU-06A-11D-A196-08 TCGA-EE-A2GU-06A-11D-A196-08 TCGA-EE-A2GU-06A-11D-A194-01 TCGA-EE-A2GU-06A-11D-A196-08 284fadfc-0c63-44ef-a464-0a62f1173e6b 284fadfc-0c63-44ef-a464-0a62f1173e6b +TCGA-EE-A2M5-06 TCGA-EE-A2M5-06 TCGA-EE-A2M5 TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 49 TCGA-EE-A2M5 TCGA-EE-A2M5-06A 0.8 -17950 4562 659 0 390 2012-12-20 MALE No C77.3 8720/3 C77.3 YES 310 NO 1 III Non-glabrous skin NO NO YES true No M0 N0 T2 Stage I TCGA-EE-A2M5.00A02AC4-3B9A-4FA0-B0B7-EA8307FF17E1.pdf A2M5 WITH TUMOR NO YES NO NO Metastatic 06 5th NO YES EE Regional Lymph Node A DECEASED 1999 800e0be9-64ca-43ff-8518-f18c15d0cefa TCGA-EE-A2M5-06A-12D-A19C-05 800e0be9-64ca-43ff-8518-f18c15d0cefa TCGA-EE-A2M5-06 TCGA-EE-A2M5-06A-12D-A191-01 TCGA-EE-A2M5-06 B137BD7D-AE10-44FD-B856-3C6C1D18EB67 TCGA-EE-A2M5-06A-12D-A197-08 TCGA-EE-A2M5-06A-12D-A197-08 TCGA-EE-A2M5-06A-12D-A191-01 TCGA-EE-A2M5-06A-12D-A197-08 800e0be9-64ca-43ff-8518-f18c15d0cefa 800e0be9-64ca-43ff-8518-f18c15d0cefa +TCGA-EE-A2M6-06 TCGA-EE-A2M6-06 TCGA-EE-A2M6 TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 61 TCGA-EE-A2M6-F55187 TCGA-EE-A2M6 TCGA-EE-A2M6-06A 0.7 -22564 5010 0 3932 943 2013-12-30 MALE No C77.3 8720/3 C77.3 YES 100 NO YES 0 II Non-glabrous skin NO YES true No M0 N0 T1 Stage I TCGA-EE-A2M6.C1B5AEF2-669A-4153-BD01-A0280D98F277.pdf A2M6 TUMOR FREE YES YES NO NO Metastatic 06 4th NO YES EE Regional Lymph Node A LIVING 1997 0d53cf3e-63d6-465b-b1b6-763b9a29dc64 TCGA-EE-A2M6-06A-12D-A19C-05 0d53cf3e-63d6-465b-b1b6-763b9a29dc64 TCGA-EE-A2M6-06 TCGA-EE-A2M6-06A-12D-A191-01 TCGA-EE-A2M6-06 0346C7E6-58C5-4A34-AA8D-3ED6FF96B4E7 TCGA-EE-A2M6-06A-12D-A197-08 TCGA-EE-A2M6-06A-12D-A197-08 TCGA-EE-A2M6-06A-12D-A191-01 TCGA-EE-A2M6-06A-12D-A197-08 0d53cf3e-63d6-465b-b1b6-763b9a29dc64 0d53cf3e-63d6-465b-b1b6-763b9a29dc64 +TCGA-EE-A2M7-06 TCGA-EE-A2M7-06 TCGA-EE-A2M7 TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 66 TCGA-EE-A2M7 TCGA-EE-A2M7-06A 2.2 -24371 4553 877 0 795 2012-12-20 MALE No C77.3 8720/3 C77.3 YES 50 NO 2 III Non-glabrous skin NO YES true No M0 N0 T3a Stage II TCGA-EE-A2M7.8CDEC44A-0A01-4598-B165-871290AF0FEA.pdf A2M7 WITH TUMOR NO YES NO NO Metastatic 06 5th NO YES EE Regional Lymph Node A DECEASED 1999 98f08cdf-bfca-480d-80ed-bb83b74fb738 TCGA-EE-A2M7-06A-11D-A19C-05 98f08cdf-bfca-480d-80ed-bb83b74fb738 TCGA-EE-A2M7-06 TCGA-EE-A2M7-06A-11D-A191-01 TCGA-EE-A2M7-06 TCGA-EE-A2M7-06A-11D-A197-08 TCGA-EE-A2M7-06A-11D-A197-08 TCGA-EE-A2M7-06A-11D-A191-01 TCGA-EE-A2M7-06A-11D-A197-08 98f08cdf-bfca-480d-80ed-bb83b74fb738 98f08cdf-bfca-480d-80ed-bb83b74fb738 +TCGA-EE-A2M8-06 TCGA-EE-A2M8-06 TCGA-EE-A2M8 TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 54 TCGA-EE-A2M8 TCGA-EE-A2M8-06A 2 -19808 4157 601 0 413 2012-12-20 FEMALE No C77.4 8720/3 C77.4 YES 130 NO 4 IV Non-glabrous skin NO NO YES true No M0 N1 T3a Stage III TCGA-EE-A2M8.37DF4914-EC1C-4DDC-BEA5-F5887856BB38.pdf A2M8 WITH TUMOR NO YES NO NO Metastatic 06 5th NO YES EE Regional Lymph Node A DECEASED 2000 21a2d09c-5447-4a58-b6eb-b4d167d7b370 TCGA-EE-A2M8-06A-12D-A19B-05 21a2d09c-5447-4a58-b6eb-b4d167d7b370 TCGA-EE-A2M8-06 TCGA-EE-A2M8-06A-12D-A194-01 TCGA-EE-A2M8-06 A0C301AC-0EEE-49C1-9008-58C6D1876A0C TCGA-EE-A2M8-06A-12D-A196-08 TCGA-EE-A2M8-06A-12D-A196-08 TCGA-EE-A2M8-06A-12D-A194-01 TCGA-EE-A2M8-06A-12D-A196-08 21a2d09c-5447-4a58-b6eb-b4d167d7b370 21a2d09c-5447-4a58-b6eb-b4d167d7b370 +TCGA-EE-A2MC-06 TCGA-EE-A2MC-06 TCGA-EE-A2MC TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 73 TCGA-EE-A2MC TCGA-EE-A2MC-06A 1 -26872 3981 1871 0 426 2012-12-21 MALE No C77.3 8720/3 C77.3 YES 90 NO 2 III Non-glabrous skin NO NO YES true No M0 N0 T2 Stage I TCGA-EE-A2MC.3974002B-D305-46D6-B11C-BEE7260FA18B.pdf A2MC TUMOR FREE NO YES NO NO Metastatic 06 5th NO YES EE Regional Lymph Node A DECEASED 2000 a2e7de4e-d673-40ae-aa00-37e1a8cebbf5 TCGA-EE-A2MC-06A-12D-A19C-05 a2e7de4e-d673-40ae-aa00-37e1a8cebbf5 TCGA-EE-A2MC-06 TCGA-EE-A2MC-06A-12D-A191-01 TCGA-EE-A2MC-06 0FF3C272-3CAE-464E-9B2F-C0B91ECFBB21 TCGA-EE-A2MC-06A-12D-A197-08 TCGA-EE-A2MC-06A-12D-A197-08 TCGA-EE-A2MC-06A-12D-A191-01 TCGA-EE-A2MC-06A-12D-A197-08 a2e7de4e-d673-40ae-aa00-37e1a8cebbf5 a2e7de4e-d673-40ae-aa00-37e1a8cebbf5 +TCGA-EE-A2MD-06 TCGA-EE-A2MD-06 TCGA-EE-A2MD TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 52 TCGA-EE-A2MD TCGA-EE-A2MD-06A 3 -19333 4683 1438 0 1148 2012-12-21 MALE No C77.5 8720/3 C77.5 YES NO 13 III Non-glabrous skin YES NO YES true No M0 N0 T3a Stage II TCGA-EE-A2MD.02DFE38B-6371-4F97-AAD1-9A129A6F6FB1.pdf A2MD WITH TUMOR NO YES NO NO Metastatic 06 5th NO YES EE Regional Lymph Node A DECEASED 1998 c862a72f-d317-4419-905f-bf42adb784d9 TCGA-EE-A2MD-06A-11D-A19C-05 c862a72f-d317-4419-905f-bf42adb784d9 TCGA-EE-A2MD-06 TCGA-EE-A2MD-06A-11D-A191-01 TCGA-EE-A2MD-06 8132F72C-9B2C-41AB-9C43-966684DF8F16 TCGA-EE-A2MD-06A-11D-A197-08 TCGA-EE-A2MD-06A-11D-A197-08 TCGA-EE-A2MD-06A-11D-A191-01 TCGA-EE-A2MD-06A-11D-A197-08 c862a72f-d317-4419-905f-bf42adb784d9 c862a72f-d317-4419-905f-bf42adb784d9 +TCGA-EE-A2ME-06 TCGA-EE-A2ME-06 TCGA-EE-A2ME TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 51 TCGA-EE-A2ME 0.52 -18841 3141 0 2245 2012-12-20 MALE No C77.4 8720/3 C77.4 YES 0 III Non-glabrous skin NO NO YES No M0 N0 T2 Stage I A2ME WITH TUMOR YES YES NO NO Metastatic 06 4th NO YES EE Regional Lymph Node DECEASED 1995 c3bf2363-4bb5-4de7-ac82-0c4fa11eee7b TCGA-EE-A2ME-06A-11D-A19C-05 c3bf2363-4bb5-4de7-ac82-0c4fa11eee7b TCGA-EE-A2ME-06 TCGA-EE-A2ME-06A-11D-A191-01 TCGA-EE-A2ME-06 TCGA-EE-A2ME-06A-11D-A197-08 TCGA-EE-A2ME-06A-11D-A197-08 TCGA-EE-A2ME-06A-11D-A191-01 TCGA-EE-A2ME-06A-11D-A197-08 c3bf2363-4bb5-4de7-ac82-0c4fa11eee7b c3bf2363-4bb5-4de7-ac82-0c4fa11eee7b +TCGA-EE-A2MF-06 TCGA-EE-A2MF-06 TCGA-EE-A2MF TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 39 TCGA-EE-A2MF 1.5 -14312 8174 0 8091 2014-5-20 FEMALE No C77.4 8720/3 C77.4 YES IV Non-glabrous skin YES YES No M0 N0 T2 Stage I A2MF WITH TUMOR NO 1 1 YES NO NO Metastatic 06 1st NO YES EE Regional Lymph Node DECEASED 1979 f7ca3f9e-6de3-4c37-aecc-a5ac2782ec1f TCGA-EE-A2MF-06A-11D-A21B-05 f7ca3f9e-6de3-4c37-aecc-a5ac2782ec1f TCGA-EE-A2MF-06 TCGA-EE-A2MF-06A-11D-A219-01 TCGA-EE-A2MF-06 TCGA-EE-A2MF-06A-11D-A21A-08 TCGA-EE-A2MF-06A-11D-A21A-08 TCGA-EE-A2MF-06A-11D-A219-01 TCGA-EE-A2MF-06A-11D-A21A-08 f7ca3f9e-6de3-4c37-aecc-a5ac2782ec1f f7ca3f9e-6de3-4c37-aecc-a5ac2782ec1f +TCGA-EE-A2MG-06 TCGA-EE-A2MG-06 TCGA-EE-A2MG TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 23 TCGA-EE-A2MG TCGA-EE-A2MG-06A 0.7 -8405 5286 3139 0 1793 2012-12-20 MALE No C77.3 8720/3 C77.3 YES 70 NO 0 III Non-glabrous skin NO YES true No M0 N0 T2 Stage I TCGA-EE-A2MG.11CFC905-FDAC-49D4-B159-F4E93803E460.pdf A2MG WITH TUMOR YES 1 YES NO NO Metastatic 06 4th NO YES EE Regional Lymph Node A DECEASED 1997 89d28931-1552-4274-8abb-9fba776c06f7 TCGA-EE-A2MG-06A-11D-A19C-05 89d28931-1552-4274-8abb-9fba776c06f7 TCGA-EE-A2MG-06 TCGA-EE-A2MG-06A-11D-A191-01 TCGA-EE-A2MG-06 TCGA-EE-A2MG-06A-11D-A197-08 TCGA-EE-A2MG-06A-11D-A197-08 TCGA-EE-A2MG-06A-11D-A191-01 TCGA-EE-A2MG-06A-11D-A197-08 89d28931-1552-4274-8abb-9fba776c06f7 89d28931-1552-4274-8abb-9fba776c06f7 +TCGA-EE-A2MH-06 TCGA-EE-A2MH-06 TCGA-EE-A2MH TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 66 TCGA-EE-A2MH TCGA-EE-A2MH-06A 3.4 -24125 3765 516 0 274 2012-12-20 MALE No C77.3 8720/3 C77.3 YES 70 NO 2 V Non-glabrous skin NO NO YES true No M0 N0 T4a Stage III TCGA-EE-A2MH.6C91C359-E679-46F3-9ADA-8958F1D1949E.pdf A2MH WITH TUMOR YES YES NO NO Metastatic 06 5th NO YES EE Regional Lymph Node A DECEASED 2001 90e347db-bfa3-4ee0-9441-d4f275648023 TCGA-EE-A2MH-06A-11D-A19C-05 90e347db-bfa3-4ee0-9441-d4f275648023 TCGA-EE-A2MH-06 TCGA-EE-A2MH-06A-11D-A191-01 TCGA-EE-A2MH-06 TCGA-EE-A2MH-06A-11D-A197-08 TCGA-EE-A2MH-06A-11D-A197-08 TCGA-EE-A2MH-06A-11D-A191-01 TCGA-EE-A2MH-06A-11D-A197-08 90e347db-bfa3-4ee0-9441-d4f275648023 90e347db-bfa3-4ee0-9441-d4f275648023 +TCGA-EE-A2MI-06 TCGA-EE-A2MI-06 TCGA-EE-A2MI TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 43 TCGA-EE-A2MI TCGA-EE-A2MI-06A 0.4 -15880 9247 6225 0 5782 2012-12-20 MALE No C77.3 8720/3 C77.3 YES 140 NO NO II Non-glabrous skin YES YES true No M0 N0 T4 Stage IIB TCGA-EE-A2MI.B9B99EA2-EB57-4C49-9BB3-35F3D9E7CF07.pdf A2MI WITH TUMOR NO YES YES NO Metastatic 06 2nd NO YES EE Regional Lymph Node A DECEASED 1986 a8b63750-fd87-4129-98e8-54e778671520 TCGA-EE-A2MI-06A-11D-A19C-05 a8b63750-fd87-4129-98e8-54e778671520 TCGA-EE-A2MI-06 TCGA-EE-A2MI-06A-11D-A191-01 TCGA-EE-A2MI-06 DD8F3051-972C-4056-A774-2A7CA23F6D81 TCGA-EE-A2MI-06A-11D-A197-08 TCGA-EE-A2MI-06A-11D-A197-08 TCGA-EE-A2MI-06A-11D-A191-01 TCGA-EE-A2MI-06A-11D-A197-08 a8b63750-fd87-4129-98e8-54e778671520 a8b63750-fd87-4129-98e8-54e778671520 +TCGA-EE-A2MJ-06 TCGA-EE-A2MJ-06 TCGA-EE-A2MJ TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 60 TCGA-EE-A2MJ TCGA-EE-A2MJ-06A 11 -22050 4444 2927 0 998 2012-12-20 MALE No C77.3 8720/3 C77.3 YES 110 NO 8 V Non-glabrous skin NO YES YES true No M0 N0 T4b Stage III TCGA-EE-A2MJ.E1EB9123-2749-42DA-9981-C9C4C7D72B5D.pdf A2MJ TUMOR FREE NO YES NO NO Metastatic 06 5th NO YES EE Regional Lymph Node A DECEASED 1999 3669c448-0958-458b-a4f8-6fe064deb817 TCGA-EE-A2MJ-06A-11D-A19C-05 3669c448-0958-458b-a4f8-6fe064deb817 TCGA-EE-A2MJ-06 TCGA-EE-A2MJ-06A-11D-A191-01 TCGA-EE-A2MJ-06 CD908036-E556-439F-A79C-65D46C22049A TCGA-EE-A2MJ-06A-11D-A197-08 TCGA-EE-A2MJ-06A-11D-A197-08 TCGA-EE-A2MJ-06A-11D-A191-01 TCGA-EE-A2MJ-06A-11D-A197-08 3669c448-0958-458b-a4f8-6fe064deb817 3669c448-0958-458b-a4f8-6fe064deb817 +TCGA-EE-A2MK-06 TCGA-EE-A2MK-06 TCGA-EE-A2MK TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 18 TCGA-EE-A2MK-F65645 TCGA-EE-A2MK TCGA-EE-A2MK-06A 5.2 -6831 4341 0 5487 1003 2014-9-26 FEMALE No C77.4 8720/3 C77.4 YES 120 NO NO 8 IV Non-glabrous skin NO NO true No M0 N0 T4a Stage III TCGA-EE-A2MK.8517BF69-FC60-4BAC-B034-E7D5B43627BF.pdf A2MK TUMOR FREE NO YES NO NO Metastatic 06 NO 5th NO YES EE Regional Lymph Node A LIVING 1999 634e6e3a-bbfa-4be9-bcde-b8d0c53b22d9 TCGA-EE-A2MK-06A-11D-A19B-05 634e6e3a-bbfa-4be9-bcde-b8d0c53b22d9 TCGA-EE-A2MK-06 TCGA-EE-A2MK-06A-11D-A194-01 TCGA-EE-A2MK-06 C5DBFE28-6966-42BF-BFD4-30D08A936025 TCGA-EE-A2MK-06A-11D-A196-08 TCGA-EE-A2MK-06A-11D-A196-08 TCGA-EE-A2MK-06A-11D-A194-01 TCGA-EE-A2MK-06A-11D-A196-08 634e6e3a-bbfa-4be9-bcde-b8d0c53b22d9 634e6e3a-bbfa-4be9-bcde-b8d0c53b22d9 +TCGA-EE-A2ML-06 TCGA-EE-A2ML-06 TCGA-EE-A2ML TCGA Melanoma (SKCM) skin cutaneous melanoma Skin YES|YES|YES|YES|YES|YES|YES|NO|NO NO|NO|NO|NO|NO|NO|NO|NO|NO 35 TCGA-EE-A2ML-F59745 TCGA-EE-A2ML TCGA-EE-A2ML-06A 3 -13140 6083 6590 0 6176 |6218|6218|62536505| 6210|6210|6210|6210|6165|6249|6271|6505|6525 2772 2014-5-20 MALE No C77.3 8720/3 C77.3 YES NO NO 8 III Non-glabrous skin NO Distant Metastasis|Distant Metastasis|Distant Metastasis|Distant Metastasis|Distant Metastasis|Distant Metastasis|Distant Metastasis|Distant Metastasis|Distant Metastasis NO NO|NO|NO|YES|YES|YES|NO|YES| YES Other, Specify|Lung|Liver|Other, Specify|Other, Specify|Other, Specify|Other, Specify|Other, Specify|Other, Specify mediastinal lymph nodes|small bowel|mesenteric lymph nodes|left parotid tumour|upper abdomen subcutaneous deposits|posterior neck|small bowel true No M0 N0 T3a Stage II TCGA-EE-A2ML.079D6017-ED18-4D0B-88DA-DD9CAD850454.pdf A2ML WITH TUMOR YES YES NO NO Metastatic 06 NO 4th NO YES EE Regional Lymph Node A DECEASED 1994 5f104bd0-e54a-4896-805e-7c51024fb826 TCGA-EE-A2ML-06A-11D-A19C-05 5f104bd0-e54a-4896-805e-7c51024fb826 TCGA-EE-A2ML-06 TCGA-EE-A2ML-06A-11D-A191-01 TCGA-EE-A2ML-06 F53220D5-F98C-4527-8F57-14E832D26BD2 TCGA-EE-A2ML-06A-11D-A197-08 TCGA-EE-A2ML-06A-11D-A197-08 TCGA-EE-A2ML-06A-11D-A191-01 TCGA-EE-A2ML-06A-11D-A197-08 5f104bd0-e54a-4896-805e-7c51024fb826 5f104bd0-e54a-4896-805e-7c51024fb826 +TCGA-EE-A2MM-06 TCGA-EE-A2MM-06 TCGA-EE-A2MM TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 63 TCGA-EE-A2MM TCGA-EE-A2MM-06A 0.6 -23132 6699 5107 0 3403 2012-12-20 FEMALE No C77.3 8720/3 C77.3 YES 110 NO 1 III Non-glabrous skin YES YES true No M0 N0 T2 Stage I TCGA-EE-A2MM.B23219CD-5473-42D0-A0BB-49EC8A1756FB.pdf A2MM WITH TUMOR YES 1 1 YES NO NO Metastatic 06 4th NO YES EE Regional Lymph Node A DECEASED 1993 6e4145d0-e417-4690-8956-c5d1c1194fe3 TCGA-EE-A2MM-06A-11D-A19B-05 6e4145d0-e417-4690-8956-c5d1c1194fe3 TCGA-EE-A2MM-06 TCGA-EE-A2MM-06A-11D-A194-01 TCGA-EE-A2MM-06 B90B1EA1-61BC-41B4-8FC5-D6303BBADFC5 TCGA-EE-A2MM-06A-11D-A196-08 TCGA-EE-A2MM-06A-11D-A196-08 TCGA-EE-A2MM-06A-11D-A194-01 TCGA-EE-A2MM-06A-11D-A196-08 6e4145d0-e417-4690-8956-c5d1c1194fe3 6e4145d0-e417-4690-8956-c5d1c1194fe3 +TCGA-EE-A2MN-06 TCGA-EE-A2MN-06 TCGA-EE-A2MN TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 58 TCGA-EE-A2MN TCGA-EE-A2MN-06A 1 -21202 3943 1446 0 683 2012-12-20 MALE No C77.3 8720/3 C77.3 YES 120 NO 0 III Non-glabrous skin NO NO YES true No M0 N0 T2 Stage I TCGA-EE-A2MN.6377A574-F2AA-4A18-B31B-7A368CE07A3D.pdf A2MN WITH TUMOR NO YES NO NO Metastatic 06 5th NO YES EE Regional Lymph Node A DECEASED 2000 3c377bc7-e299-437b-89b5-62ae8a82675d TCGA-EE-A2MN-06A-11D-A19C-05 3c377bc7-e299-437b-89b5-62ae8a82675d TCGA-EE-A2MN-06 TCGA-EE-A2MN-06A-11D-A191-01 TCGA-EE-A2MN-06 239F60E2-AA7F-4BAD-B8E2-2BBC3A42950F TCGA-EE-A2MN-06A-11D-A197-08 TCGA-EE-A2MN-06A-11D-A197-08 TCGA-EE-A2MN-06A-11D-A191-01 TCGA-EE-A2MN-06A-11D-A197-08 3c377bc7-e299-437b-89b5-62ae8a82675d 3c377bc7-e299-437b-89b5-62ae8a82675d +TCGA-EE-A2MP-06 TCGA-EE-A2MP-06 TCGA-EE-A2MP TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 34 TCGA-EE-A2MP-F59750 TCGA-EE-A2MP TCGA-EE-A2MP-06A 1.05 -12474 7519 0 7563 6742 2014-5-20 FEMALE No C77.4 8720/3 C77.4 YES 170 NO YES Non-glabrous skin YES YES true No M0 N0 T2 Stage I TCGA-EE-A2MP.F725CFD4-E7FE-47E3-A77E-13AF89304C29.pdf A2MP WITH TUMOR NO YES NO NO Metastatic 06 3rd NO YES EE Regional Lymph Node A LIVING 1991 6b3cfa2d-5fe6-43d6-b032-2938f83cbf21 TCGA-EE-A2MP-06A-11D-A19C-05 6b3cfa2d-5fe6-43d6-b032-2938f83cbf21 TCGA-EE-A2MP-06 TCGA-EE-A2MP-06A-11D-A191-01 TCGA-EE-A2MP-06 3EBF0750-FE53-43C4-8A24-557F523E775E TCGA-EE-A2MP-06A-11D-A197-08 TCGA-EE-A2MP-06A-11D-A197-08 TCGA-EE-A2MP-06A-11D-A191-01 TCGA-EE-A2MP-06A-11D-A197-08 6b3cfa2d-5fe6-43d6-b032-2938f83cbf21 6b3cfa2d-5fe6-43d6-b032-2938f83cbf21 +TCGA-EE-A2MQ-06 TCGA-EE-A2MQ-06 TCGA-EE-A2MQ TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 70 TCGA-EE-A2MQ 3.1 -25926 1315 0 658 2012-12-21 FEMALE No C77.3 8720/3 C77.3 YES 5 IV Non-glabrous skin NO NO YES No M0 N2a T3a Stage IIIA A2MQ WITH TUMOR NO YES NO NO Metastatic 06 6th NO YES EE Regional Lymph Node DECEASED 2006 ade35c8d-30dd-4e45-9f7c-9818072a02db TCGA-EE-A2MQ-06A-11D-A19C-05 ade35c8d-30dd-4e45-9f7c-9818072a02db TCGA-EE-A2MQ-06 TCGA-EE-A2MQ-06A-11D-A191-01 TCGA-EE-A2MQ-06 TCGA-EE-A2MQ-06A-11D-A197-08 TCGA-EE-A2MQ-06A-11D-A197-08 TCGA-EE-A2MQ-06A-11D-A191-01 TCGA-EE-A2MQ-06A-11D-A197-08 ade35c8d-30dd-4e45-9f7c-9818072a02db ade35c8d-30dd-4e45-9f7c-9818072a02db +TCGA-EE-A2MR-06 TCGA-EE-A2MR-06 TCGA-EE-A2MR TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 61 TCGA-EE-A2MR-F55189 TCGA-EE-A2MR TCGA-EE-A2MR-06A 1.25 -22535 3288 0 4088 3773 3773 2248 2013-12-30 MALE No C77.3 8720/3 C77.3 YES 450 NO NO III Non-glabrous skin NO Trunk SCC NO YES YES true Yes M0 N0 T2 Stage I TCGA-EE-A2MR.5835D1B9-D1BB-4582-A9D0-5A441DDA28B7.pdf A2MR TUMOR FREE NO YES NO YES Metastatic 06 NO 5th NO YES EE Regional Lymph Node A LIVING 2002 e42f3ef2-94ff-4661-8926-1c01b0d60211 TCGA-EE-A2MR-06A-11D-A19B-05 e42f3ef2-94ff-4661-8926-1c01b0d60211 TCGA-EE-A2MR-06 TCGA-EE-A2MR-06A-11D-A194-01 TCGA-EE-A2MR-06 EBF795E1-6CBD-46AC-8EC9-766B97D8F5A8 TCGA-EE-A2MR-06A-11D-A196-08 TCGA-EE-A2MR-06A-11D-A196-08 TCGA-EE-A2MR-06A-11D-A194-01 TCGA-EE-A2MR-06A-11D-A196-08 e42f3ef2-94ff-4661-8926-1c01b0d60211 e42f3ef2-94ff-4661-8926-1c01b0d60211 +TCGA-EE-A2MS-06 TCGA-EE-A2MS-06 TCGA-EE-A2MS TCGA Melanoma (SKCM) skin cutaneous melanoma Skin NO NO 72 TCGA-EE-A2MS-F55191 TCGA-EE-A2MS TCGA-EE-A2MS-06A 1.8 -26466 4271 0 4942 4522 4522 3325 2013-12-30 MALE No C77.3 8720/3 C77.3 YES 130 NO NO 4 IV Non-glabrous skin NO New primary melanoma Extremities YES YES YES true No M0 N0 T3a Stage II TCGA-EE-A2MS.26FFB127-64C5-41C3-9C9C-68A722B3CF66.pdf A2MS TUMOR FREE NO 1 YES YES NO Metastatic 06 YES 5th NO YES EE Regional Lymph Node A LIVING 1999 926ac720-e414-4e84-ae09-9df5a7359cfb TCGA-EE-A2MS-06A-11D-A19C-05 926ac720-e414-4e84-ae09-9df5a7359cfb TCGA-EE-A2MS-06 TCGA-EE-A2MS-06A-11D-A191-01 TCGA-EE-A2MS-06 5E3B8AD8-FB0F-4731-B583-07CBC11F96C4 TCGA-EE-A2MS-06A-11D-A197-08 TCGA-EE-A2MS-06A-11D-A197-08 TCGA-EE-A2MS-06A-11D-A191-01 TCGA-EE-A2MS-06A-11D-A197-08 926ac720-e414-4e84-ae09-9df5a7359cfb 926ac720-e414-4e84-ae09-9df5a7359cfb +TCGA-EE-A2MT-06 TCGA-EE-A2MT-06 TCGA-EE-A2MT TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 45 TCGA-EE-A2MT-F55192 TCGA-EE-A2MT TCGA-EE-A2MT-06A 1.5 -16768 1391 0 2166 564 2013-12-30 MALE No C77.3 8720/3 C77.3 YES 390 NO NO 4 IV Non-glabrous skin NO NO true No M0 N0 T2a Stage IB TCGA-EE-A2MT.9AA313AC-45CD-437B-AB84-8FF08EAC1EE2.pdf A2MT TUMOR FREE NO YES NO YES Metastatic 06 NO 6th NO YES EE Regional Lymph Node A LIVING 2007 c4b1fa78-db04-4352-92cd-ba94589424c3 TCGA-EE-A2MT-06A-11D-A19C-05 c4b1fa78-db04-4352-92cd-ba94589424c3 TCGA-EE-A2MT-06 TCGA-EE-A2MT-06A-11D-A191-01 TCGA-EE-A2MT-06 F793C867-A7A8-4371-A613-DA1ECD5C8C67 TCGA-EE-A2MT-06A-11D-A197-08 TCGA-EE-A2MT-06A-11D-A197-08 TCGA-EE-A2MT-06A-11D-A191-01 TCGA-EE-A2MT-06A-11D-A197-08 c4b1fa78-db04-4352-92cd-ba94589424c3 c4b1fa78-db04-4352-92cd-ba94589424c3 +TCGA-EE-A2MU-06 TCGA-EE-A2MU-06 TCGA-EE-A2MU TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 71 TCGA-EE-A2MU-F55193 TCGA-EE-A2MU TCGA-EE-A2MU-06A 0.5 -26237 2109 0 1620 1451 2013-12-30 MALE No C49.1 8720/3 C49.1 YES 140 NO YES 2 II Non-glabrous skin NO YES true No M0 N0 T1a Stage IA TCGA-EE-A2MU.E6F4543C-6487-4B2B-9BFB-E59002823BF7.pdf A2MU TUMOR FREE NO YES NO NO Metastatic 06 6th NO YES EE Regional Cutaneous or Subcutaneous Tissue (includes satellite and in-transit metastasis) A LIVING 2005 1fd474c9-0ccd-44f3-bf7b-9bb6a2a1e297 TCGA-EE-A2MU-06A-21D-A19B-05 1fd474c9-0ccd-44f3-bf7b-9bb6a2a1e297 TCGA-EE-A2MU-06 TCGA-EE-A2MU-06A-21D-A194-01 TCGA-EE-A2MU-06 CBE3AD8B-C4FF-426F-BFD4-367CC2539D4C TCGA-EE-A2MU-06A-21D-A196-08 TCGA-EE-A2MU-06A-21D-A196-08 TCGA-EE-A2MU-06A-21D-A194-01 TCGA-EE-A2MU-06A-21D-A196-08 1fd474c9-0ccd-44f3-bf7b-9bb6a2a1e297 1fd474c9-0ccd-44f3-bf7b-9bb6a2a1e297 +TCGA-EE-A3AA-06 TCGA-EE-A3AA-06 TCGA-EE-A3AA TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 47 TCGA-EE-A3AA-F59759 TCGA-EE-A3AA TCGA-EE-A3AA-06A -17196 3731 0 3781 0 2014-5-20 MALE No C77.3 8720/3 C77.3 YES 180 NO YES Non-glabrous skin NO true No M0 N2a T0 Stage III TCGA-EE-A3AA.8EEE31CE-9D42-4D14-95C3-0AB0B00CE41B.pdf A3AA TUMOR FREE YES NO NO Metastatic 06 5th NO YES EE Regional Lymph Node A LIVING 2001 b8a63774-db74-4cd6-9ac0-065f1126448d TCGA-EE-A3AA-06A-11D-A19B-05 b8a63774-db74-4cd6-9ac0-065f1126448d TCGA-EE-A3AA-06 TCGA-EE-A3AA-06A-11D-A194-01 TCGA-EE-A3AA-06 8D238990-D783-497C-93A7-4AA967C5CAC6 TCGA-EE-A3AA-06A-11D-A196-08 TCGA-EE-A3AA-06A-11D-A196-08 TCGA-EE-A3AA-06A-11D-A194-01 TCGA-EE-A3AA-06A-11D-A196-08 b8a63774-db74-4cd6-9ac0-065f1126448d b8a63774-db74-4cd6-9ac0-065f1126448d +TCGA-EE-A3AB-06 TCGA-EE-A3AB-06 TCGA-EE-A3AB TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 30 TCGA-EE-A3AB-F59751 TCGA-EE-A3AB TCGA-EE-A3AB-06A -11054 3725 0 3733 0 2014-5-20 MALE No C77.3 8720/3 C77.3 YES 160 NO YES Non-glabrous skin NO true No M0 N2a T0 Stage III TCGA-EE-A3AB.0782D02E-4CD6-4031-B62B-41E1C408E4BC.pdf A3AB TUMOR FREE NO NO YES Metastatic 06 5th NO YES EE Regional Lymph Node A LIVING 2001 ab9918f6-7417-47ec-aaf7-0e30a40e2bdc TCGA-EE-A3AB-06A-11D-A19B-05 ab9918f6-7417-47ec-aaf7-0e30a40e2bdc TCGA-EE-A3AB-06 TCGA-EE-A3AB-06A-11D-A194-01 TCGA-EE-A3AB-06 D093819C-D215-4A82-995A-0ED078EA0508 TCGA-EE-A3AB-06A-11D-A196-08 TCGA-EE-A3AB-06A-11D-A196-08 TCGA-EE-A3AB-06A-11D-A194-01 TCGA-EE-A3AB-06A-11D-A196-08 ab9918f6-7417-47ec-aaf7-0e30a40e2bdc ab9918f6-7417-47ec-aaf7-0e30a40e2bdc +TCGA-EE-A3AC-06 TCGA-EE-A3AC-06 TCGA-EE-A3AC TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 47 TCGA-EE-A3AC-F65646 TCGA-EE-A3AC TCGA-EE-A3AC-06A -17319 855 0 1948 0 2014-9-26 MALE No C77.3 8720/3 C77.3 YES 140 NO NO NO true No M0 N2b T0 Stage III TCGA-EE-A3AC.C1635466-8CE4-42B0-ABE5-2720F412BA97.pdf A3AC TUMOR FREE NO NO NO Metastatic 06 NO 6th NO YES EE Regional Lymph Node A LIVING 2009 7c9fd31d-7fea-4178-be9f-75619ff9ff08 TCGA-EE-A3AC-06A-11D-A19B-05 7c9fd31d-7fea-4178-be9f-75619ff9ff08 TCGA-EE-A3AC-06 TCGA-EE-A3AC-06A-11D-A194-01 TCGA-EE-A3AC-06 95174DFF-1CE4-4ED5-B47E-2AA030FE6AB8 TCGA-EE-A3AC-06A-11D-A196-08 TCGA-EE-A3AC-06A-11D-A196-08 TCGA-EE-A3AC-06A-11D-A194-01 TCGA-EE-A3AC-06A-11D-A196-08 7c9fd31d-7fea-4178-be9f-75619ff9ff08 7c9fd31d-7fea-4178-be9f-75619ff9ff08 +TCGA-EE-A3AD-06 TCGA-EE-A3AD-06 TCGA-EE-A3AD TCGA Melanoma (SKCM) skin cutaneous melanoma Skin NO|YES|YES|YES|YES|YES YES|NO|NO|NO|NO|NO 50 TCGA-EE-A3AD-F55195 TCGA-EE-A3AD TCGA-EE-A3AD-06A -18491 790 875 0 112 554771| 554|567|567|567|648|648 0 2013-12-30 MALE No C77.0 8720/3 C77.0 YES 90 NO NO Distant Metastasis|Distant Metastasis|Distant Metastasis|Distant Metastasis|Distant Metastasis|Distant Metastasis YES|NO|NO|NO|YES|NO YES Other, Specify|Lung|Other, Specify|Other, Specify|Brain|Liver spinal cordright anterior abdomen - skin and soft tissue|right anterior chest - skin and soft tissue true No M0 N1b T0 Stage III TCGA-EE-A3AD.B9063550-43F3-47DC-82D8-46C426998629.pdf A3AD WITH TUMOR NO NO NO Metastatic 06 NO 6th NO YES EE Regional Lymph Node A DECEASED 2009 08997d9f-db88-4f45-9d76-772cb9acc75d TCGA-EE-A3AD-06A-11D-A19B-05 08997d9f-db88-4f45-9d76-772cb9acc75d TCGA-EE-A3AD-06 TCGA-EE-A3AD-06A-11D-A194-01 TCGA-EE-A3AD-06 1CC786D0-CB47-4F90-A806-C7B0867D004D TCGA-EE-A3AD-06A-11D-A196-08 TCGA-EE-A3AD-06A-11D-A196-08 TCGA-EE-A3AD-06A-11D-A194-01 TCGA-EE-A3AD-06A-11D-A196-08 08997d9f-db88-4f45-9d76-772cb9acc75d 08997d9f-db88-4f45-9d76-772cb9acc75d +TCGA-EE-A3AE-06 TCGA-EE-A3AE-06 TCGA-EE-A3AE TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 52 TCGA-EE-A3AE-F59862 TCGA-EE-A3AE TCGA-EE-A3AE-06A 0.9 -19216 894 0 1658 741 2014-5-22 FEMALE No C77.4 8720/3 C77.4 YES 320 NO NO 4 III Non-glabrous skin NO NO true No M0 N0 T1a Stage IA TCGA-EE-A3AE.E31E9171-62C3-4DD9-B756-62D4DE599976.pdf A3AE TUMOR FREE YES YES NO NO Metastatic 06 NO 6th NO YES EE Regional Lymph Node A LIVING 2009 55ad742e-cc71-4ebe-9f91-8242d60b46e0 TCGA-EE-A3AE-06A-11D-A19B-05 55ad742e-cc71-4ebe-9f91-8242d60b46e0 TCGA-EE-A3AE-06 TCGA-EE-A3AE-06A-11D-A194-01 TCGA-EE-A3AE-06 55FE86A2-CE11-472A-88E5-8568BEAA28B4 TCGA-EE-A3AE-06A-11D-A196-08 TCGA-EE-A3AE-06A-11D-A196-08 TCGA-EE-A3AE-06A-11D-A194-01 TCGA-EE-A3AE-06A-11D-A196-08 55ad742e-cc71-4ebe-9f91-8242d60b46e0 55ad742e-cc71-4ebe-9f91-8242d60b46e0 +TCGA-EE-A3AF-06 TCGA-EE-A3AF-06 TCGA-EE-A3AF TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 48 TCGA-EE-A3AF TCGA-EE-A3AF-06A -17731 809 420 0 0 2012-12-21 FEMALE No C77.0 8720/3 C77.0 YES 140 NO NO YES true No M0 N3 T0 Stage IIIC TCGA-EE-A3AF.C85811B7-FD83-436B-BFEE-1C2B794A1DD4.pdf A3AF WITH TUMOR NO NO YES Metastatic 06 6th NO YES EE Regional Lymph Node A DECEASED 2009 62a9e3ff-39a3-4a87-ae5b-9f5b0bd312a5 TCGA-EE-A3AF-06A-11D-A19B-05 62a9e3ff-39a3-4a87-ae5b-9f5b0bd312a5 TCGA-EE-A3AF-06 TCGA-EE-A3AF-06A-11D-A194-01 TCGA-EE-A3AF-06 0AAA9F26-9E06-4E67-BC4D-14AA2EEF56E7 TCGA-EE-A3AF-06A-11D-A196-08 TCGA-EE-A3AF-06A-11D-A196-08 TCGA-EE-A3AF-06A-11D-A194-01 TCGA-EE-A3AF-06A-11D-A196-08 62a9e3ff-39a3-4a87-ae5b-9f5b0bd312a5 62a9e3ff-39a3-4a87-ae5b-9f5b0bd312a5 +TCGA-EE-A3AG-06 TCGA-EE-A3AG-06 TCGA-EE-A3AG TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 25 TCGA-EE-A3AG-F59764 TCGA-EE-A3AG TCGA-EE-A3AG-06A -9161 838 1265 0 714 755 229 2014-5-20 MALE No C49.2 8720/3 C49.2 YES 170 NO NO Non-glabrous skin Other, specify CML NO YES true No M0 N2c T0 Stage III TCGA-EE-A3AG.FD06B6F0-A12E-40C3-8823-A6346660B943.pdf A3AG WITH TUMOR YES NO NO Metastatic 06 NO NO YES EE Regional Cutaneous or Subcutaneous Tissue (includes satellite and in-transit metastasis) A DECEASED 2009 faa7c094-e5c2-4ae7-b984-7377fcfff9ac TCGA-EE-A3AG-06A-31D-A19B-05 faa7c094-e5c2-4ae7-b984-7377fcfff9ac TCGA-EE-A3AG-06 TCGA-EE-A3AG-06A-31D-A194-01 TCGA-EE-A3AG-06 4F423ECB-DE67-4FB4-B5E8-51FF3F774B92 TCGA-EE-A3AG-06A-31D-A196-08 TCGA-EE-A3AG-06A-31D-A196-08 TCGA-EE-A3AG-06A-31D-A194-01 TCGA-EE-A3AG-06A-31D-A196-08 faa7c094-e5c2-4ae7-b984-7377fcfff9ac faa7c094-e5c2-4ae7-b984-7377fcfff9ac +TCGA-EE-A3AH-06 TCGA-EE-A3AH-06 TCGA-EE-A3AH TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 30 TCGA-EE-A3AH TCGA-EE-A3AH-06A 3.7 -10988 4955 4222 0 3835 2012-12-21 MALE No C77.4 8720/3 C77.4 YES 60 NO 40 III Non-glabrous skin NO YES YES true No M0 N0 T3b Stage II TCGA-EE-A3AH.DDD46A19-CD8A-40EE-91C4-6CB78FAC80DC.pdf A3AH WITH TUMOR NO YES NO NO Metastatic 06 5th NO YES EE Regional Lymph Node A DECEASED 1998 5355bc61-3358-4261-9a6a-cd9950b91ee5 TCGA-EE-A3AH-06A-11D-A19B-05 5355bc61-3358-4261-9a6a-cd9950b91ee5 TCGA-EE-A3AH-06 TCGA-EE-A3AH-06A-11D-A194-01 TCGA-EE-A3AH-06 TCGA-EE-A3AH-06A-11D-A196-08 TCGA-EE-A3AH-06A-11D-A196-08 TCGA-EE-A3AH-06A-11D-A194-01 TCGA-EE-A3AH-06A-11D-A196-08 5355bc61-3358-4261-9a6a-cd9950b91ee5 5355bc61-3358-4261-9a6a-cd9950b91ee5 +TCGA-EE-A3J3-06 TCGA-EE-A3J3-06 TCGA-EE-A3J3 TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 42 TCGA-EE-A3J3 TCGA-EE-A3J3-06A 0.98 -15446 9396 5237 0 5139 2012-6-5 MALE No C77.3 8730/3 C77.3 YES 110 NO Non-glabrous skin YES YES true No M0 N0 T2 Stage IB TCGA-EE-A3J3.DAE45D1C-F834-48DD-A557-44F38B1C0C43.pdf A3J3 WITH TUMOR 1 1 YES NO NO Metastatic 06 2nd NO YES EE Regional Cutaneous or Subcutaneous Tissue (includes satellite and in-transit metastasis) A DECEASED 1986 c494f4cb-475a-4a4a-9b85-586c2e3e341a TCGA-EE-A3J3-06A-11D-A211-05 c494f4cb-475a-4a4a-9b85-586c2e3e341a TCGA-EE-A3J3-06 TCGA-EE-A3J3-06A-11D-A20B-01 TCGA-EE-A3J3-06 561A24C9-95BB-453E-B1C5-F86A265CB7E6 TCGA-EE-A3J3-06A-11D-A20D-08 TCGA-EE-A3J3-06A-11D-A20D-08 TCGA-EE-A3J3-06A-11D-A20B-01 TCGA-EE-A3J3-06A-11D-A20D-08 c494f4cb-475a-4a4a-9b85-586c2e3e341a c494f4cb-475a-4a4a-9b85-586c2e3e341a +TCGA-EE-A3J4-06 TCGA-EE-A3J4-06 TCGA-EE-A3J4 TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 72 TCGA-EE-A3J4 2.00 -26540 3869 0 3172 2012-6-5 MALE No C49.5 8720/3 C49.5 YES 6 IV Non-glabrous skin YES YES YES No M0 N0 T3a Stage II A3J4 WITH TUMOR NO 1 1 YES NO NO Metastatic 06 3rd NO YES EE Regional Cutaneous or Subcutaneous Tissue (includes satellite and in-transit metastasis) DECEASED 1991 fce35066-a840-4101-b28c-8a584d8c5e54 TCGA-EE-A3J4-06A-11D-A211-05 fce35066-a840-4101-b28c-8a584d8c5e54 TCGA-EE-A3J4-06 TCGA-EE-A3J4-06A-11D-A20B-01 TCGA-EE-A3J4-06 TCGA-EE-A3J4-06A-11D-A20D-08 TCGA-EE-A3J4-06A-11D-A20D-08 TCGA-EE-A3J4-06A-11D-A20B-01 TCGA-EE-A3J4-06A-11D-A20D-08 fce35066-a840-4101-b28c-8a584d8c5e54 fce35066-a840-4101-b28c-8a584d8c5e54 +TCGA-EE-A3J5-06 TCGA-EE-A3J5-06 TCGA-EE-A3J5 TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 71 TCGA-EE-A3J5 TCGA-EE-A3J5-06A 4.80 -26226 4025 1124 0 467 2012-6-8 MALE No C44.5 8720/3 C44.5 YES 40 NO 8 V Non-glabrous skin NO NO YES true No M0 N1 T4a Stage III TCGA-EE-A3J5.86A187C5-2FAC-4DEA-9431-020F323E6E5D.pdf A3J5 WITH TUMOR NO 1 1 YES NO NO Metastatic 06 5th NO YES EE Regional Cutaneous or Subcutaneous Tissue (includes satellite and in-transit metastasis) A DECEASED 2000 315e9fee-404c-4f59-829b-d769e965c87e TCGA-EE-A3J5-06A-11D-A211-05 315e9fee-404c-4f59-829b-d769e965c87e TCGA-EE-A3J5-06 TCGA-EE-A3J5-06A-11D-A20B-01 TCGA-EE-A3J5-06 TCGA-EE-A3J5-06A-11D-A20D-08 TCGA-EE-A3J5-06A-11D-A20D-08 TCGA-EE-A3J5-06A-11D-A20B-01 TCGA-EE-A3J5-06A-11D-A20D-08 315e9fee-404c-4f59-829b-d769e965c87e 315e9fee-404c-4f59-829b-d769e965c87e +TCGA-EE-A3J7-06 TCGA-EE-A3J7-06 TCGA-EE-A3J7 TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 43 TCGA-EE-A3J7-F59752 TCGA-EE-A3J7 TCGA-EE-A3J7-06A 1.12 -15896 4744 0 1949 1292 2014-5-20 MALE No C49.1 8720/3 C49.1 YES 100 NO YES II Non-glabrous skin YES YES YES true No M0 N0 T2 Stage I TCGA-EE-A3J7.F2479711-8EEC-44A5-877C-7804A631FCBD.pdf A3J7 TUMOR FREE NO 1 1 YES NO NO Metastatic 06 5th NO YES EE Regional Cutaneous or Subcutaneous Tissue (includes satellite and in-transit metastasis) A LIVING 1998 1dcb8c9f-677e-4884-a119-50460646ba33 TCGA-EE-A3J7-06A-11D-A211-05 1dcb8c9f-677e-4884-a119-50460646ba33 TCGA-EE-A3J7-06 TCGA-EE-A3J7-06A-11D-A20B-01 TCGA-EE-A3J7-06 F18A0CE7-5C7C-4705-BF23-061F6CDF2672 TCGA-EE-A3J7-06A-11D-A20D-08 TCGA-EE-A3J7-06A-11D-A20D-08 TCGA-EE-A3J7-06A-11D-A20B-01 TCGA-EE-A3J7-06A-11D-A20D-08 1dcb8c9f-677e-4884-a119-50460646ba33 1dcb8c9f-677e-4884-a119-50460646ba33 +TCGA-EE-A3J8-06 TCGA-EE-A3J8-06 TCGA-EE-A3J8 TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 59 TCGA-EE-A3J8 4.80 -21688 1044 0 553 2012-6-8 MALE No C49.3 8720/3 C49.3 YES 5 IV Non-glabrous skin NO NO YES No M0 N1a T4a Stage IIIA A3J8 TUMOR FREE NO 1 1 YES NO NO Metastatic 06 6th NO YES EE Regional Cutaneous or Subcutaneous Tissue (includes satellite and in-transit metastasis) DECEASED 2006 cb033feb-06ad-4674-bc0b-6539efb9aa85 TCGA-EE-A3J8-06A-11D-A211-05 cb033feb-06ad-4674-bc0b-6539efb9aa85 TCGA-EE-A3J8-06 TCGA-EE-A3J8-06A-11D-A20B-01 TCGA-EE-A3J8-06 TCGA-EE-A3J8-06A-11D-A20D-08 TCGA-EE-A3J8-06A-11D-A20D-08 TCGA-EE-A3J8-06A-11D-A20B-01 TCGA-EE-A3J8-06A-11D-A20D-08 cb033feb-06ad-4674-bc0b-6539efb9aa85 cb033feb-06ad-4674-bc0b-6539efb9aa85 +TCGA-EE-A3JA-06 TCGA-EE-A3JA-06 TCGA-EE-A3JA TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 44 TCGA-EE-A3JA TCGA-EE-A3JA-06A 1.50 -16430 1986 1618 0 942 2012-6-8 MALE No C49.9 8720/3 C49.9 YES 140 NO IV Non-glabrous skin NO YES YES true No M0 N0 T2a Stage IB TCGA-EE-A3JA.9AD98E02-1774-4BA5-9162-141C95B546F0.pdf A3JA WITH TUMOR NO 1 1 YES NO NO Metastatic 06 6th NO YES EE Regional Lymph Node A DECEASED 2006 68e90f56-7070-47e8-874f-9e7c45bd84fd TCGA-EE-A3JA-06A-11D-A211-05 68e90f56-7070-47e8-874f-9e7c45bd84fd TCGA-EE-A3JA-06 TCGA-EE-A3JA-06A-11D-A20B-01 TCGA-EE-A3JA-06 2B840B3A-8B89-4956-8A80-0FF172C8DCF9 TCGA-EE-A3JA-06A-11D-A20D-08 TCGA-EE-A3JA-06A-11D-A20D-08 TCGA-EE-A3JA-06A-11D-A20B-01 TCGA-EE-A3JA-06A-11D-A20D-08 68e90f56-7070-47e8-874f-9e7c45bd84fd 68e90f56-7070-47e8-874f-9e7c45bd84fd +TCGA-EE-A3JB-06 TCGA-EE-A3JB-06 TCGA-EE-A3JB TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 60 TCGA-EE-A3JB-F59762 TCGA-EE-A3JB 1.86 -22150 0 6138 6109 2014-5-20 FEMALE Yes C49.1 8720/3 C49.1 YES YES 5 IV Non-glabrous skin YES YES No M0 N1 T3a Stage III A3JB WITH TUMOR NO 1 1 YES NO NO Metastatic 06 3rd NO YES EE Regional Cutaneous or Subcutaneous Tissue (includes satellite and in-transit metastasis) LIVING 1992 a4c3676d-fc5d-4d26-8627-6f494657b84a TCGA-EE-A3JB-06A-11D-A21B-05 a4c3676d-fc5d-4d26-8627-6f494657b84a TCGA-EE-A3JB-06 TCGA-EE-A3JB-06A-11D-A219-01 TCGA-EE-A3JB-06 TCGA-EE-A3JB-06A-11D-A21A-08 TCGA-EE-A3JB-06A-11D-A21A-08 TCGA-EE-A3JB-06A-11D-A219-01 TCGA-EE-A3JB-06A-11D-A21A-08 a4c3676d-fc5d-4d26-8627-6f494657b84a a4c3676d-fc5d-4d26-8627-6f494657b84a +TCGA-EE-A3JD-06 TCGA-EE-A3JD-06 TCGA-EE-A3JD TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 70 TCGA-EE-A3JD TCGA-EE-A3JD-06A -25930 825 832 0 0 2014-5-22 MALE No C77.3 8720/3 C77.3 YES 150 NO Non-glabrous skin NO YES true No M0 N2b TX Stage III TCGA-EE-A3JD.39EF7A3E-370F-43FF-ABA8-9C98B3252A2D.pdf A3JD WITH TUMOR NO NO NO Metastatic 06 6th NO YES EE Regional Lymph Node A DECEASED 2009 3ada0d86-a7dd-4ef8-ab88-bff478010c5e TCGA-EE-A3JD-06A-11D-A211-05 3ada0d86-a7dd-4ef8-ab88-bff478010c5e TCGA-EE-A3JD-06 TCGA-EE-A3JD-06A-11D-A20B-01 TCGA-EE-A3JD-06 5648C7B6-87F2-4128-A251-8C5EB45384B7 TCGA-EE-A3JD-06A-11D-A20D-08 TCGA-EE-A3JD-06A-11D-A20D-08 TCGA-EE-A3JD-06A-11D-A20B-01 TCGA-EE-A3JD-06A-11D-A20D-08 3ada0d86-a7dd-4ef8-ab88-bff478010c5e 3ada0d86-a7dd-4ef8-ab88-bff478010c5e +TCGA-EE-A3JE-06 TCGA-EE-A3JE-06 TCGA-EE-A3JE TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 75 TCGA-EE-A3JE-F59672 TCGA-EE-A3JE TCGA-EE-A3JE-06A 3.70 -27463 1050 0 1562 1002 2014-5-20 MALE No C49.6 8720/3 C49.6 YES 230 NO NO 6 IV Non-glabrous skin YES YES NO true No M0 N1a T3b Stage IIIB TCGA-EE-A3JE.177DEE22-9A8E-48B2-AAD0-8E5E30865F1A.pdf A3JE TUMOR FREE NO 1 1 YES NO NO Metastatic 06 NO 6th YES NO EE Regional Cutaneous or Subcutaneous Tissue (includes satellite and in-transit metastasis) A LIVING 2009 4a379a56-c92f-4ed8-8d9f-513b4737ec31 TCGA-EE-A3JE-06A-11D-A211-05 4a379a56-c92f-4ed8-8d9f-513b4737ec31 TCGA-EE-A3JE-06 TCGA-EE-A3JE-06A-11D-A20B-01 TCGA-EE-A3JE-06 295324CB-A9DB-49BA-BA12-9C01F1FDCFA6 TCGA-EE-A3JE-06A-11D-A20D-08 TCGA-EE-A3JE-06A-11D-A20D-08 TCGA-EE-A3JE-06A-11D-A20B-01 TCGA-EE-A3JE-06A-11D-A20D-08 4a379a56-c92f-4ed8-8d9f-513b4737ec31 4a379a56-c92f-4ed8-8d9f-513b4737ec31 +TCGA-EE-A3JH-06 TCGA-EE-A3JH-06 TCGA-EE-A3JH TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 54 TCGA-EE-A3JH-F68800 TCGA-EE-A3JH TCGA-EE-A3JH-06A 1.3 -19852 3192 0 4086 2672 2014-12-16 MALE No C77.3 8720/3 C77.3 YES 100 NO NO 2 III Non-glabrous skin YES NO true No M0 N0 T2 Stage IB TCGA-EE-A3JH.0ABDF8B5-C0D2-4F4A-8BE1-B8FA03F0026C.pdf A3JH TUMOR FREE NO 1 1 YES NO NO Metastatic 06 NO 6th NO YES EE Regional Lymph Node A LIVING 2003 9557fb82-baa4-4adf-a33e-7c50774fb604 TCGA-EE-A3JH-06A-11D-A21B-05 9557fb82-baa4-4adf-a33e-7c50774fb604 TCGA-EE-A3JH-06 TCGA-EE-A3JH-06A-11D-A219-01 TCGA-EE-A3JH-06 F433DF4C-0C7E-4571-8906-80BFB8EC8B73 TCGA-EE-A3JH-06A-11D-A21A-08 TCGA-EE-A3JH-06A-11D-A21A-08 TCGA-EE-A3JH-06A-11D-A219-01 TCGA-EE-A3JH-06A-11D-A21A-08 9557fb82-baa4-4adf-a33e-7c50774fb604 9557fb82-baa4-4adf-a33e-7c50774fb604 +TCGA-EE-A3JI-06 TCGA-EE-A3JI-06 TCGA-EE-A3JI TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 48 TCGA-EE-A3JI-F59753 TCGA-EE-A3JI 1.20 -17835 4648 0 4504 3482 2014-5-20 MALE No C77.3 8720/3 C77.3 YES NO 1 IV Non-glabrous skin NO YES NO No M0 N0 T2 Stage I A3JI WITH TUMOR NO 1|2 3 YES YES YES Metastatic 06 NO 5th NO YES EE Regional Lymph Node DECEASED 1999 dca3aac8-2cc3-41fb-b030-0b0084ca6217 TCGA-EE-A3JI-06A-11D-A21B-05 dca3aac8-2cc3-41fb-b030-0b0084ca6217 TCGA-EE-A3JI-06 TCGA-EE-A3JI-06A-11D-A219-01 TCGA-EE-A3JI-06 TCGA-EE-A3JI-06A-11D-A21A-08 TCGA-EE-A3JI-06A-11D-A21A-08 TCGA-EE-A3JI-06A-11D-A219-01 TCGA-EE-A3JI-06A-11D-A21A-08 dca3aac8-2cc3-41fb-b030-0b0084ca6217 dca3aac8-2cc3-41fb-b030-0b0084ca6217 +TCGA-ER-A193-06 TCGA-ER-A193-06 TCGA-ER-A193 TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 62 TCGA-ER-A193 TCGA-ER-A193-06A -22702 1638 955 0 0 2012-4-10 MALE No C49.0 8720/3 C49.0 YES 430 NO Non-glabrous skin NO NO YES true Yes M0 N0 T3b Stage IIB TCGA-ER-A193.DCC32120-A9D1-424C-A2BE-1FA2F77962F2.pdf A193 WITH TUMOR NO 2 2 YES YES NO Metastatic 06 6th YES NO ER Regional Lymph Node A DECEASED 2006 33f43961-b32d-46fc-ba11-264f1101e78d TCGA-ER-A193-06A-12D-A19C-05 33f43961-b32d-46fc-ba11-264f1101e78d TCGA-ER-A193-06 TCGA-ER-A193-06A-12D-A191-01 TCGA-ER-A193-06 690D3B12-A61D-42FD-AF2A-5A7A9A3E5DE8 TCGA-ER-A193-06A-12D-A197-08 TCGA-ER-A193-06A-12D-A197-08 TCGA-ER-A193-06A-12D-A191-01 TCGA-ER-A193-06A-12D-A197-08 33f43961-b32d-46fc-ba11-264f1101e78d 33f43961-b32d-46fc-ba11-264f1101e78d +TCGA-ER-A194-01 TCGA-ER-A194-01 TCGA-ER-A194 TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 77 TCGA-ER-A194 TCGA-ER-A194-01A 4.5 -28175 1940 1354 0 78 2012-4-11 MALE No C49.1 8720/3 C49.1 YES 120 NO 1 IV Non-glabrous skin YES NO true No M0 N0 TCGA-ER-A194.76553A5D-46A4-48C4-947D-1CE09B486987.pdf A194 WITH TUMOR NO YES NO NO Primary Tumor 01 6th YES NO ER Primary Tumor A DECEASED 2005 376614bb-480e-4a7f-9539-da6ce053988a TCGA-ER-A194-01A-11D-A19C-05 376614bb-480e-4a7f-9539-da6ce053988a TCGA-ER-A194-01 TCGA-ER-A194-01 12FA4294-AB28-4135-AA4D-17E1EC103E78 TCGA-ER-A194-01A-11D-A197-08 TCGA-ER-A194-01A-11D-A197-08 TCGA-ER-A194-01A-11D-A197-08 376614bb-480e-4a7f-9539-da6ce053988a 376614bb-480e-4a7f-9539-da6ce053988a +TCGA-ER-A195-06 TCGA-ER-A195-06 TCGA-ER-A195 TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 46 TCGA-ER-A195 TCGA-ER-A195-06A -16948 2130 1078 0 512 2012-4-11 MALE No C49.6 8720/3 C49.6 YES 140 NO Non-glabrous skin NO true No M0 N0 TX TCGA-ER-A195.4F82982F-C63B-4038-9D89-8ABF41B328A3.pdf A195 WITH TUMOR YES 1 1 YES NO NO Metastatic 06 6th YES NO ER Regional Lymph Node A DECEASED 2005 5f9b87f7-a92d-49c6-b84e-b84b92a637cf TCGA-ER-A195-06A-11D-A19B-05 5f9b87f7-a92d-49c6-b84e-b84b92a637cf TCGA-ER-A195-06 TCGA-ER-A195-06A-11D-A194-01 TCGA-ER-A195-06 820D5076-3552-4F8E-98F5-3B981AC57D4A TCGA-ER-A195-06A-11D-A196-08 TCGA-ER-A195-06A-11D-A196-08 TCGA-ER-A195-06A-11D-A194-01 TCGA-ER-A195-06A-11D-A196-08 5f9b87f7-a92d-49c6-b84e-b84b92a637cf 5f9b87f7-a92d-49c6-b84e-b84b92a637cf +TCGA-ER-A196-01 TCGA-ER-A196-01 TCGA-ER-A196 TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 64 TCGA-ER-A196-F48970 TCGA-ER-A196 TCGA-ER-A196-01A 22 -23533 1106 0 1785 0 2013-9-24 FEMALE No C44.7 8744/3 C44.7 YES 140 NO NO 10 IV Non-glabrous skin YES NO true No M0 N0 T4b Stage IIC TCGA-ER-A196.A80CD991-4AF1-4C22-8F05-EC4CA14D0828.pdf A196 TUMOR FREE NO YES NO NO Primary Tumor 01 6th YES NO ER Primary Tumor A LIVING 2007 7f8bad33-c92b-48f6-99b1-2165784efd8f TCGA-ER-A196-01A-11D-A19C-05 7f8bad33-c92b-48f6-99b1-2165784efd8f TCGA-ER-A196-01 TCGA-ER-A196-01 47C22FA2-6E3A-4AE1-B2BF-70DF4D10CA57 TCGA-ER-A196-01A-11D-A197-08 TCGA-ER-A196-01A-11D-A197-08 TCGA-ER-A196-01A-11D-A197-08 7f8bad33-c92b-48f6-99b1-2165784efd8f 7f8bad33-c92b-48f6-99b1-2165784efd8f +TCGA-ER-A197-06 TCGA-ER-A197-06 TCGA-ER-A197 TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 83 TCGA-ER-A197 TCGA-ER-A197-06A 8.0 -30454 1725 424 0 30 2012-4-12 FEMALE No C51.9 8720/3 C51.9 YES 390 NO Non-glabrous skin YES NO YES true No M0 N1a T4b Stage IIIB TCGA-ER-A197.1286EE66-0342-45E4-A6E9-DCF8E1E94651.pdf A197 WITH TUMOR NO YES NO NO Metastatic 06 6th YES NO ER A DECEASED 2006 30e65995-e4e6-40c0-a8af-823cc6fde4a8 TCGA-ER-A197-06A-32D-A19C-05 30e65995-e4e6-40c0-a8af-823cc6fde4a8 TCGA-ER-A197-06 TCGA-ER-A197-06A-32D-A191-01 TCGA-ER-A197-06 B199B938-CF11-4ABD-A384-7C71603FE093 TCGA-ER-A197-06A-32D-A197-08 TCGA-ER-A197-06A-32D-A197-08 TCGA-ER-A197-06A-32D-A191-01 TCGA-ER-A197-06A-32D-A197-08 30e65995-e4e6-40c0-a8af-823cc6fde4a8 30e65995-e4e6-40c0-a8af-823cc6fde4a8 +TCGA-ER-A198-06 TCGA-ER-A198-06 TCGA-ER-A198 TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 45 TCGA-ER-A198 TCGA-ER-A198-06A 10 -16540 2862 1544 0 376 2012-4-13 MALE No C49.3 8720/3 C49.3 YES 350 NO Non-glabrous skin YES YES YES true Yes M0 NX TCGA-ER-A198.C2698BDC-DB70-48DC-B2CF-AA155C9923F2.pdf A198 WITH TUMOR YES 1 1 YES NO NO Metastatic 06 6th YES NO ER Regional Cutaneous or Subcutaneous Tissue (includes satellite and in-transit metastasis) A DECEASED 2003 e9cf2488-2eb5-4187-97a5-9dd98971a015 TCGA-ER-A198-06A-11D-A19B-05 e9cf2488-2eb5-4187-97a5-9dd98971a015 TCGA-ER-A198-06 TCGA-ER-A198-06A-11D-A194-01 TCGA-ER-A198-06 94075210-4D49-43CA-9B02-0249045CB08D TCGA-ER-A198-06A-11D-A196-08 TCGA-ER-A198-06A-11D-A196-08 TCGA-ER-A198-06A-11D-A194-01 TCGA-ER-A198-06A-11D-A196-08 e9cf2488-2eb5-4187-97a5-9dd98971a015 e9cf2488-2eb5-4187-97a5-9dd98971a015 +TCGA-ER-A199-06 TCGA-ER-A199-06 TCGA-ER-A199 TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 86 TCGA-ER-A199 TCGA-ER-A199-06A 3 -31661 1280 279 0 105 2012-4-13 FEMALE No C77.4 8720/3 C77.4 YES 590 NO 8 IV YES NO YES true No M0 N3 T4b Stage IIIC TCGA-ER-A199.FAD38303-F164-4868-BBB9-F32EA9C97DF9.pdf A199 WITH TUMOR 1 YES NO NO Metastatic 06 6th YES NO ER Regional Lymph Node A DECEASED 2007 862b334e-5cdd-4e05-b2db-8a5cbe64b097 TCGA-ER-A199-06A-11D-A19C-05 862b334e-5cdd-4e05-b2db-8a5cbe64b097 TCGA-ER-A199-06 TCGA-ER-A199-06A-11D-A191-01 TCGA-ER-A199-06 2332E515-4367-4F95-8B6A-AC7552B53B93 TCGA-ER-A199-06A-11D-A197-08 TCGA-ER-A199-06A-11D-A197-08 TCGA-ER-A199-06A-11D-A191-01 TCGA-ER-A199-06A-11D-A197-08 862b334e-5cdd-4e05-b2db-8a5cbe64b097 862b334e-5cdd-4e05-b2db-8a5cbe64b097 +TCGA-ER-A19A-06 TCGA-ER-A19A-06 TCGA-ER-A19A TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 79 TCGA-ER-A19A-F48977 TCGA-ER-A19A TCGA-ER-A19A-06A -29167 1672 0 2365 41 2013-9-24 MALE No C49.6 8720/3 C49.6 YES 110 NO NO Non-glabrous skin NO NO true No M1 N0 TX Stage IV TCGA-ER-A19A.B48FFC2C-4D9A-4451-B237-3B004D773260.pdf A19A TUMOR FREE NO NO NO Metastatic 06 6th YES NO ER Regional Cutaneous or Subcutaneous Tissue (includes satellite and in-transit metastasis) A LIVING 2006 386af7d3-6cfb-458e-a451-1faece442b9e TCGA-ER-A19A-06A-21D-A19C-05 386af7d3-6cfb-458e-a451-1faece442b9e TCGA-ER-A19A-06 TCGA-ER-A19A-06A-21D-A191-01 TCGA-ER-A19A-06 7DBA8B6C-2F53-4030-9B7A-71432C70ACDB TCGA-ER-A19A-06A-21D-A197-08 TCGA-ER-A19A-06A-21D-A197-08 TCGA-ER-A19A-06A-21D-A191-01 TCGA-ER-A19A-06A-21D-A197-08 386af7d3-6cfb-458e-a451-1faece442b9e 386af7d3-6cfb-458e-a451-1faece442b9e +TCGA-ER-A19B-06 TCGA-ER-A19B-06 TCGA-ER-A19B TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 42 TCGA-ER-A19B TCGA-ER-A19B-06A -15437 3775 2993 0 2227 2012-4-16 MALE Yes C49.6 8720/3 C49.6 YES 450 NO Non-glabrous skin YES YES true No M0 N0 TX TCGA-ER-A19B.E9F013EB-73E0-4674-8F3A-C6BB07CCA742.pdf A19B WITH TUMOR NO YES NO Other NO Metastatic 06 5th YES NO ER Regional Cutaneous or Subcutaneous Tissue (includes satellite and in-transit metastasis) A DECEASED 2000 5eb1264b-f257-4b2e-8078-9baaefd51b7a TCGA-ER-A19B-06A-11D-A19B-05 5eb1264b-f257-4b2e-8078-9baaefd51b7a TCGA-ER-A19B-06 TCGA-ER-A19B-06A-11D-A194-01 TCGA-ER-A19B-06 F7A4BAA3-AF74-4E85-9410-16F269604825 TCGA-ER-A19B-06A-11D-A196-08 TCGA-ER-A19B-06A-11D-A196-08 TCGA-ER-A19B-06A-11D-A194-01 TCGA-ER-A19B-06A-11D-A196-08 5eb1264b-f257-4b2e-8078-9baaefd51b7a 5eb1264b-f257-4b2e-8078-9baaefd51b7a +TCGA-ER-A19C-06 TCGA-ER-A19C-06 TCGA-ER-A19C TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 77 TCGA-ER-A19C TCGA-ER-A19C-06A 0.75 -28383 4431 1487 0 1372 2012-4-19 MALE No C77.3 8720/3 C77.3 YES 340 NO III Non-glabrous skin NO NO true No M0 NX T2a Stage I TCGA-ER-A19C.34DA05F3-09C0-47C2-ABCB-F05B191A5A89.pdf A19C WITH TUMOR NO 1 YES NO NO Metastatic 06 5th YES NO ER Regional Lymph Node A DECEASED 1998 533156e6-19df-4bef-9d3f-e78c6361b4da TCGA-ER-A19C-06A-11D-A19B-05 533156e6-19df-4bef-9d3f-e78c6361b4da TCGA-ER-A19C-06 TCGA-ER-A19C-06A-11D-A194-01 TCGA-ER-A19C-06 733F7D73-DDE9-4B7C-95E8-569123BFD941 TCGA-ER-A19C-06A-11D-A196-08 TCGA-ER-A19C-06A-11D-A196-08 TCGA-ER-A19C-06A-11D-A194-01 TCGA-ER-A19C-06A-11D-A196-08 533156e6-19df-4bef-9d3f-e78c6361b4da 533156e6-19df-4bef-9d3f-e78c6361b4da +TCGA-ER-A19D-06 TCGA-ER-A19D-06 TCGA-ER-A19D TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 46 TCGA-ER-A19D TCGA-ER-A19D-06A 1.75 -16968 2418 383 0 276 2012-4-19 FEMALE No C49.3 8720/3 C49.3 YES 440 NO IV Non-glabrous skin NO NO YES true No M0 N0 T2a Stage IB TCGA-ER-A19D.20CEC313-3D84-4D2D-B229-1AF7CCF4354C.pdf A19D WITH TUMOR NO YES NO NO Metastatic 06 6th YES NO ER Regional Cutaneous or Subcutaneous Tissue (includes satellite and in-transit metastasis) A DECEASED 2004 d48f5bc7-1cca-4435-8f59-d802fde708a8 TCGA-ER-A19D-06A-11D-A19C-05 d48f5bc7-1cca-4435-8f59-d802fde708a8 TCGA-ER-A19D-06 TCGA-ER-A19D-06A-11D-A191-01 TCGA-ER-A19D-06 0563BD16-D786-426B-8449-AC52A5331707 TCGA-ER-A19D-06A-11D-A197-08 TCGA-ER-A19D-06A-11D-A197-08 TCGA-ER-A19D-06A-11D-A191-01 TCGA-ER-A19D-06A-11D-A197-08 d48f5bc7-1cca-4435-8f59-d802fde708a8 d48f5bc7-1cca-4435-8f59-d802fde708a8 +TCGA-ER-A19E-06 TCGA-ER-A19E-06 TCGA-ER-A19E TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 36 TCGA-ER-A19E TCGA-ER-A19E-06A 1.1 -13297 917 396 0 34 2012-4-19 FEMALE No C44.5 8720/3 C44.5 YES 390 NO III Non-glabrous skin NO NO YES true No M0 N0 T2a Stage IB TCGA-ER-A19E.C25995F9-1AD7-41E9-9DE9-372262733947.pdf A19E WITH TUMOR YES YES NO NO Metastatic 06 6th YES NO ER Regional Lymph Node A DECEASED 2008 7c23f39f-6b3f-41d8-bb17-c35788b2b060 TCGA-ER-A19E-06A-11D-A19C-05 7c23f39f-6b3f-41d8-bb17-c35788b2b060 TCGA-ER-A19E-06 TCGA-ER-A19E-06A-11D-A191-01 TCGA-ER-A19E-06 E4C9D57B-AADB-4BC6-958D-4F74E873F1D8 TCGA-ER-A19E-06A-11D-A197-08 TCGA-ER-A19E-06A-11D-A197-08 TCGA-ER-A19E-06A-11D-A191-01 TCGA-ER-A19E-06A-11D-A197-08 7c23f39f-6b3f-41d8-bb17-c35788b2b060 7c23f39f-6b3f-41d8-bb17-c35788b2b060 +TCGA-ER-A19F-06 TCGA-ER-A19F-06 TCGA-ER-A19F TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 82 TCGA-ER-A19F TCGA-ER-A19F-06A 6.7 -30176 2662 802 0 464 2012-4-19 MALE No C44.6 8720/3 C44.6 YES 310 NO Non-glabrous skin NO true No M0 N0 TCGA-ER-A19F.7453A5D2-5558-42C8-B8AA-A5A554D1EAAE.pdf A19F TUMOR FREE NO YES NO NO Metastatic 06 6th YES NO ER Regional Lymph Node A DECEASED 2003 c063e297-0583-4b7c-b1b9-3aaaae108aa6 TCGA-ER-A19F-06A-11D-A19B-05 c063e297-0583-4b7c-b1b9-3aaaae108aa6 TCGA-ER-A19F-06 TCGA-ER-A19F-06A-11D-A194-01 TCGA-ER-A19F-06 AEA2B4B2-EDAC-4A89-96EC-56EE83469A4C TCGA-ER-A19F-06A-11D-A196-08 TCGA-ER-A19F-06A-11D-A196-08 TCGA-ER-A19F-06A-11D-A194-01 TCGA-ER-A19F-06A-11D-A196-08 c063e297-0583-4b7c-b1b9-3aaaae108aa6 c063e297-0583-4b7c-b1b9-3aaaae108aa6 +TCGA-ER-A19G-06 TCGA-ER-A19G-06 TCGA-ER-A19G TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 48 TCGA-ER-A19G-F48981 TCGA-ER-A19G TCGA-ER-A19G-06A 1.6 -17820 8484 0 9188 4708 2013-9-24 FEMALE No C44.5 8720/3 C44.5 YES 360 NO NO II Non-glabrous skin NO NO true No M0 N0 TCGA-ER-A19G.4F69932E-54F7-487B-A7D2-7787F9544AE8.pdf A19G TUMOR FREE NO 1 YES NO NO Metastatic 06 2nd YES NO ER Regional Lymph Node A LIVING 1987 b7f93347-5337-44ee-b26c-d6f10092dee6 TCGA-ER-A19G-06A-11D-A19B-05 b7f93347-5337-44ee-b26c-d6f10092dee6 TCGA-ER-A19G-06 TCGA-ER-A19G-06A-11D-A194-01 TCGA-ER-A19G-06 083039BC-09E7-4867-B68F-25F50B14E9F7 TCGA-ER-A19G-06A-11D-A196-08 TCGA-ER-A19G-06A-11D-A196-08 TCGA-ER-A19G-06A-11D-A194-01 TCGA-ER-A19G-06A-11D-A196-08 b7f93347-5337-44ee-b26c-d6f10092dee6 b7f93347-5337-44ee-b26c-d6f10092dee6 +TCGA-ER-A19H-06 TCGA-ER-A19H-06 TCGA-ER-A19H TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 40 TCGA-ER-A19H TCGA-ER-A19H-06A 0.4 -14935 5757 4634 0 3573 2012-4-19 MALE No C49.3 8720/3 C49.3 YES 620 NO II Non-glabrous skin NO true No M0 N0 TCGA-ER-A19H.8C9DBA9E-E8F5-4080-938D-B58F675461ED.pdf A19H TUMOR FREE YES 1 YES NO NO Metastatic 06 4th YES NO ER Regional Cutaneous or Subcutaneous Tissue (includes satellite and in-transit metastasis) A DECEASED 1995 2a49e3c0-0263-422e-9fb9-6eea8727353e TCGA-ER-A19H-06A-12D-A19B-05 2a49e3c0-0263-422e-9fb9-6eea8727353e TCGA-ER-A19H-06 TCGA-ER-A19H-06A-12D-A194-01 TCGA-ER-A19H-06 561C35CA-7E28-46C2-8DAA-CFBC32AC1F96 TCGA-ER-A19H-06A-12D-A196-08 TCGA-ER-A19H-06A-12D-A196-08 TCGA-ER-A19H-06A-12D-A194-01 TCGA-ER-A19H-06A-12D-A196-08 2a49e3c0-0263-422e-9fb9-6eea8727353e 2a49e3c0-0263-422e-9fb9-6eea8727353e +TCGA-ER-A19J-06 TCGA-ER-A19J-06 TCGA-ER-A19J TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 54 TCGA-ER-A19J-F48986 TCGA-ER-A19J TCGA-ER-A19J-06A -19733 2218 196 0 196 68 2013-9-24 MALE No C49.0 8720/3 C49.0 YES 560 NO YES Non-glabrous skin NO NO true No M1 N3 TX Stage IV TCGA-ER-A19J.BEFD8A84-630A-4ED9-B223-491147223D45.pdf A19J WITH TUMOR NO NO NO Metastatic 06 6th YES NO ER Regional Lymph Node A DECEASED 2004 098ef6ce-5605-407d-90ca-e5ce9c27878f TCGA-ER-A19J-06A-11D-A19B-05 098ef6ce-5605-407d-90ca-e5ce9c27878f TCGA-ER-A19J-06 TCGA-ER-A19J-06A-11D-A194-01 TCGA-ER-A19J-06 959EC2FB-FF7E-4286-8662-0E7EB3A710AB TCGA-ER-A19J-06A-11D-A196-08 TCGA-ER-A19J-06A-11D-A196-08 TCGA-ER-A19J-06A-11D-A194-01 TCGA-ER-A19J-06A-11D-A196-08 098ef6ce-5605-407d-90ca-e5ce9c27878f 098ef6ce-5605-407d-90ca-e5ce9c27878f +TCGA-ER-A19K-01 TCGA-ER-A19K-01 TCGA-ER-A19K TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 79 TCGA-ER-A19K TCGA-ER-A19K-01A 6.8 -28916 1689 469 0 30 2012-4-19 FEMALE No C44.4 8720/3 C44.4 YES 310 NO V Non-glabrous skin YES NO YES true No M0 N0 T4b Stage IIC TCGA-ER-A19K.8EE44608-F186-46BB-ADA5-88888ED75A15.pdf A19K WITH TUMOR YES YES NO NO Primary Tumor 01 6th YES NO ER Primary Tumor A DECEASED 2006 30f9edcc-a7d4-40fd-82d9-238fcd6c08b0 TCGA-ER-A19K-01A-21D-A19C-05 30f9edcc-a7d4-40fd-82d9-238fcd6c08b0 TCGA-ER-A19K-01 TCGA-ER-A19K-01 56B8FE03-A14E-4620-A1E4-DC031B1FCEC8 TCGA-ER-A19K-01A-21D-A197-08 TCGA-ER-A19K-01A-21D-A197-08 TCGA-ER-A19K-01A-21D-A197-08 30f9edcc-a7d4-40fd-82d9-238fcd6c08b0 30f9edcc-a7d4-40fd-82d9-238fcd6c08b0 +TCGA-ER-A19L-06 TCGA-ER-A19L-06 TCGA-ER-A19L TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 35 TCGA-ER-A19L TCGA-ER-A19L-06A -13061 6028 4000 0 3591 2012-4-20 MALE No C49.5 8720/3 C49.5 YES 460 NO Non-glabrous skin NO YES true No TCGA-ER-A19L.08B5D63E-87BC-4AA3-909B-36DF82127712.pdf A19L WITH TUMOR NO YES NO NO Metastatic 06 4th YES NO ER Regional Lymph Node A DECEASED 1994 9f46343e-180d-4313-97fe-9810754ff66e TCGA-ER-A19L-06A-12D-A19C-05 9f46343e-180d-4313-97fe-9810754ff66e TCGA-ER-A19L-06 TCGA-ER-A19L-06A-12D-A191-01 TCGA-ER-A19L-06 28D085E6-BC61-4234-AA42-EEEE9E4A3D62 TCGA-ER-A19L-06A-12D-A197-08 TCGA-ER-A19L-06A-12D-A197-08 TCGA-ER-A19L-06A-12D-A191-01 TCGA-ER-A19L-06A-12D-A197-08 9f46343e-180d-4313-97fe-9810754ff66e 9f46343e-180d-4313-97fe-9810754ff66e +TCGA-ER-A19M-06 TCGA-ER-A19M-06 TCGA-ER-A19M TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 36 TCGA-ER-A19M TCGA-ER-A19M-06A 1.9 -13300 1806 1857 0 987 2012-7-6 MALE No C44.5 8720/3 C44.5 YES 390 NO IV Non-glabrous skin NO NO YES true No M0 N0 T2a Stage IB TCGA-ER-A19M.9B318F5F-AA12-480C-91AA-757CEBEBD1A1.pdf A19M WITH TUMOR YES YES NO NO Metastatic 06 6th YES NO ER Regional Lymph Node A DECEASED 2006 6d0395f6-4eb7-4dba-bfbe-e2e728482e37 TCGA-ER-A19M-06A-61D-A23D-05 6d0395f6-4eb7-4dba-bfbe-e2e728482e37 TCGA-ER-A19M-06 TCGA-ER-A19M-06A-61D-A238-01 TCGA-ER-A19M-06 170A580C-EDA2-4849-8FA9-E7615B5DE868 TCGA-ER-A19M-06A-61D-A23B-08 TCGA-ER-A19M-06A-61D-A23B-08 TCGA-ER-A19M-06A-61D-A238-01 6d0395f6-4eb7-4dba-bfbe-e2e728482e37 6d0395f6-4eb7-4dba-bfbe-e2e728482e37 +TCGA-ER-A19N-06 TCGA-ER-A19N-06 TCGA-ER-A19N TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 47 TCGA-ER-A19N-F69363 TCGA-ER-A19N TCGA-ER-A19N-06A -17443 877 1341 0 0 37 2015-1-7 MALE No C49.3 8720/3 C49.3 YES 1170 NO NO Non-glabrous skin YES true No TCGA-ER-A19N.2E469A4B-8F47-45F4-9DCC-27E2EB8D3B35.pdf A19N TUMOR FREE YES NO YES Metastatic 06 YES NO ER Regional Lymph Node A DECEASED 2008 f2ee248c-017e-4765-98c2-dd4de98ed71b TCGA-ER-A19N-06A-11D-A19C-05 f2ee248c-017e-4765-98c2-dd4de98ed71b TCGA-ER-A19N-06 TCGA-ER-A19N-06A-11D-A191-01 TCGA-ER-A19N-06 1B60174B-CBAE-4265-8EBE-1AAF504D926B TCGA-ER-A19N-06A-11D-A197-08 TCGA-ER-A19N-06A-11D-A197-08 TCGA-ER-A19N-06A-11D-A191-01 TCGA-ER-A19N-06A-11D-A197-08 f2ee248c-017e-4765-98c2-dd4de98ed71b f2ee248c-017e-4765-98c2-dd4de98ed71b +TCGA-ER-A19O-06 TCGA-ER-A19O-06 TCGA-ER-A19O TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 56 TCGA-ER-A19O TCGA-ER-A19O-06A -20740 1799 0 48 2012-4-20 MALE No C44.6 8720/3 C44.6 YES 320 NO Non-glabrous skin NO YES true No M0 N1b T3b Stage IIIB TCGA-ER-A19O.11852245-286C-47F4-A97B-A83A6441348B.pdf A19O WITH TUMOR YES 1 YES NO NO Metastatic 06 6th YES NO ER Regional Lymph Node A DECEASED 2006 c96ea91e-37ce-479c-85d9-a85a8ce92fab TCGA-ER-A19O-06A-11D-A19C-05 c96ea91e-37ce-479c-85d9-a85a8ce92fab TCGA-ER-A19O-06 TCGA-ER-A19O-06A-11D-A191-01 TCGA-ER-A19O-06 88237294-EC32-4765-BD76-8E054074F483 TCGA-ER-A19O-06A-11D-A197-08 TCGA-ER-A19O-06A-11D-A197-08 TCGA-ER-A19O-06A-11D-A191-01 TCGA-ER-A19O-06A-11D-A197-08 c96ea91e-37ce-479c-85d9-a85a8ce92fab c96ea91e-37ce-479c-85d9-a85a8ce92fab +TCGA-ER-A19P-06 TCGA-ER-A19P-06 TCGA-ER-A19P TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 47 TCGA-ER-A19P TCGA-ER-A19P-06A -17511 5297 4930 0 3875 2012-4-20 FEMALE No C49.5 8720/3 C49.5 YES 250 NO IV Non-glabrous skin NO YES true No M0 N0 TCGA-ER-A19P.555A37D4-F9BD-4CC2-8AC3-B3525FCE9A4B.pdf A19P WITH TUMOR NO 1 YES NO NO Metastatic 06 4th YES NO ER Regional Lymph Node A DECEASED 1996 3119d879-fd30-4eab-8abd-3a787a9929ba TCGA-ER-A19P-06A-11D-A19B-05 3119d879-fd30-4eab-8abd-3a787a9929ba TCGA-ER-A19P-06 TCGA-ER-A19P-06A-11D-A194-01 TCGA-ER-A19P-06 AF299005-763A-4155-8C7B-4C9D2DFB9F8F TCGA-ER-A19P-06A-11D-A196-08 TCGA-ER-A19P-06A-11D-A196-08 TCGA-ER-A19P-06A-11D-A194-01 TCGA-ER-A19P-06A-11D-A196-08 3119d879-fd30-4eab-8abd-3a787a9929ba 3119d879-fd30-4eab-8abd-3a787a9929ba +TCGA-ER-A19Q-06 TCGA-ER-A19Q-06 TCGA-ER-A19Q TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 37 TCGA-ER-A19Q TCGA-ER-A19Q-06A 1.2 -13648 3496 1548 0 1257 2012-4-23 FEMALE No C44.5 8720/3 C44.5 YES 660 NO III Non-glabrous skin NO NO YES true No M0 N0 TCGA-ER-A19Q.9D272406-BF65-4CF2-BF52-620EFC21E209.pdf A19Q WITH TUMOR YES YES NO NO Metastatic 06 5th YES NO ER Regional Lymph Node A DECEASED 2001 28732e92-e7b8-43bf-8c40-0053b54bcc96 TCGA-ER-A19Q-06A-11D-A19C-05 28732e92-e7b8-43bf-8c40-0053b54bcc96 TCGA-ER-A19Q-06 TCGA-ER-A19Q-06A-11D-A191-01 TCGA-ER-A19Q-06 699FF436-559F-4F2E-AF29-7BF6E22381FD TCGA-ER-A19Q-06A-11D-A197-08 TCGA-ER-A19Q-06A-11D-A197-08 TCGA-ER-A19Q-06A-11D-A191-01 TCGA-ER-A19Q-06A-11D-A197-08 28732e92-e7b8-43bf-8c40-0053b54bcc96 28732e92-e7b8-43bf-8c40-0053b54bcc96 +TCGA-ER-A19S-06 TCGA-ER-A19S-06 TCGA-ER-A19S TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 81 TCGA-ER-A19S-F48984 TCGA-ER-A19S TCGA-ER-A19S-06A -29603 827 0 1505 36 2013-9-24 FEMALE No C44.5 8720/3 C44.5 YES 650 NO NO Non-glabrous skin NO true No TCGA-ER-A19S.7CEBB665-0B8E-42E8-A2CE-24E428991004.pdf A19S TUMOR FREE NO NO NO Metastatic 06 YES NO ER Regional Lymph Node A LIVING 2008 42369f63-d51b-481e-867b-d0b398cf4c88 TCGA-ER-A19S-06A-11D-A19B-05 42369f63-d51b-481e-867b-d0b398cf4c88 TCGA-ER-A19S-06 TCGA-ER-A19S-06A-11D-A194-01 TCGA-ER-A19S-06 1E06D0E2-0ADD-4591-BEED-DF19D257C69F TCGA-ER-A19S-06A-11D-A196-08 TCGA-ER-A19S-06A-11D-A196-08 TCGA-ER-A19S-06A-11D-A194-01 TCGA-ER-A19S-06A-11D-A196-08 42369f63-d51b-481e-867b-d0b398cf4c88 42369f63-d51b-481e-867b-d0b398cf4c88 +TCGA-ER-A19T-01 TCGA-ER-A19T-01 TCGA-ER-A19T TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 51 TCGA-ER-A19T-F48988 TCGA-ER-A19T TCGA-ER-A19T-01A 15 -18732 1597 270 0 70 2013-9-24 MALE 167 No C44.7 8744/3 C44.7 YES 490 NO NO NO 16 V Non-glabrous skin NO NO NO true No M1a N3 T4a Stage IV TCGA-ER-A19T.ACB25638-B64D-494B-A7C2-4AA2F9C737CE.pdf A19T WITH TUMOR NO YES NO Interferon YES Primary Tumor 01 6th YES NO ER Primary Tumor A DECEASED 78 2006 5df3d0b7-2531-4e68-b076-8780763dd6cc TCGA-ER-A19T-01A-11D-A19D-05 5df3d0b7-2531-4e68-b076-8780763dd6cc TCGA-ER-A19T-01 TCGA-ER-A19T-01 7734FD33-5E52-4F98-9292-996E5554CECB TCGA-ER-A19T-01A-11D-A19A-08 TCGA-ER-A19T-01A-11D-A19A-08 TCGA-ER-A19T-01A-11D-A19A-08 5df3d0b7-2531-4e68-b076-8780763dd6cc 5df3d0b7-2531-4e68-b076-8780763dd6cc +TCGA-ER-A19T-06 TCGA-ER-A19T-06 TCGA-ER-A19T TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 51 TCGA-ER-A19T-F48988 TCGA-ER-A19T TCGA-ER-A19T-06A 15 -18732 1597 270 0 70 2013-9-24 MALE 167 No C44.7 8744/3 C44.7 YES 90 NO NO NO 16 V Non-glabrous skin NO NO NO true No M1a N3 T4a Stage IV TCGA-ER-A19T.C8DBB901-F139-48AD-AF1F-7F2CED1E21FC.pdf A19T WITH TUMOR NO YES NO Interferon YES Metastatic 06 6th YES NO ER Primary Tumor A DECEASED 78 2006 12273db4-5bb3-4529-aaad-cc4b486c85c5 TCGA-ER-A19T-06A-11D-A19D-05 12273db4-5bb3-4529-aaad-cc4b486c85c5 TCGA-ER-A19T-06A-11D-A192-01 TCGA-ER-A19T-06A-11D-A19A-08 TCGA-ER-A19T-06A-11D-A192-01 12273db4-5bb3-4529-aaad-cc4b486c85c5 12273db4-5bb3-4529-aaad-cc4b486c85c5 +TCGA-ER-A19W-06 TCGA-ER-A19W-06 TCGA-ER-A19W TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 48 TCGA-ER-A19W TCGA-ER-A19W-06A 0.75 -17830 6075 4507 0 3968 2012-7-6 FEMALE No C49.3 8720/3 C49.3 YES 600 NO II Non-glabrous skin NO NO YES true No TCGA-ER-A19W.A2959CAA-E51A-48EB-9FCD-60E5E5A0B43D.pdf A19W WITH TUMOR NO YES NO NO Metastatic 06 4th YES NO ER Regional Cutaneous or Subcutaneous Tissue (includes satellite and in-transit metastasis) A DECEASED 1994 381b7a17-fcac-45cf-90e8-8663262ec2ac TCGA-ER-A19W-06A-41D-A23D-05 381b7a17-fcac-45cf-90e8-8663262ec2ac TCGA-ER-A19W-06 TCGA-ER-A19W-06A-41D-A238-01 TCGA-ER-A19W-06 221E57ED-7522-4153-BE40-2246C209051B TCGA-ER-A19W-06A-41D-A23B-08 TCGA-ER-A19W-06A-41D-A23B-08 TCGA-ER-A19W-06A-41D-A238-01 381b7a17-fcac-45cf-90e8-8663262ec2ac 381b7a17-fcac-45cf-90e8-8663262ec2ac +TCGA-ER-A1A1-06 TCGA-ER-A1A1-06 TCGA-ER-A1A1 TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 58 TCGA-ER-A1A1-F69364 TCGA-ER-A1A1 TCGA-ER-A1A1-06A -21209 2002 0 3196 1971 47 2015-1-8 MALE No C44.4 8720/3 C44.4 YES 150 NO NO Non-glabrous skin YES true No M0 N3 TX Stage IIIC TCGA-ER-A1A1.91EF4517-2AC4-4DF9-BD96-CF60236F350A.pdf A1A1 TUMOR FREE YES NO YES Metastatic 06 6th YES NO ER Regional Lymph Node A LIVING 2005 41c85504-a18f-437e-a05a-740e7faaea41 TCGA-ER-A1A1-06A-11D-A19C-05 41c85504-a18f-437e-a05a-740e7faaea41 TCGA-ER-A1A1-06 TCGA-ER-A1A1-06A-11D-A191-01 TCGA-ER-A1A1-06 783C9943-B3F8-46E6-9CF9-C6055A7C0F2E TCGA-ER-A1A1-06A-11D-A197-08 TCGA-ER-A1A1-06A-11D-A197-08 TCGA-ER-A1A1-06A-11D-A191-01 TCGA-ER-A1A1-06A-11D-A197-08 41c85504-a18f-437e-a05a-740e7faaea41 41c85504-a18f-437e-a05a-740e7faaea41 +TCGA-ER-A2NB-01 TCGA-ER-A2NB-01 TCGA-ER-A2NB TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 57 TCGA-ER-A2NB-F69365 TCGA-ER-A2NB TCGA-ER-A2NB-01A 4.39 -20938 230 857 0 486 461 124 2015-1-8 MALE No C44.5 8720/3 C44.5 YES 180 NO NO 1.3 IV Non-glabrous skin YES NO YES true No M0 N2 T4b Stage IIIB TCGA-ER-A2NB.7A71CD0E-93A6-4AFF-90D7-D40FE351A92D.pdf A2NB WITH TUMOR NO YES NO Immunotherapy/Vaccine NO Primary Tumor 01 7th YES NO ER Primary Tumor A DECEASED 2010 9d8a2471-74af-4bbd-be10-78ca3aac6761 TCGA-ER-A2NB-01A-12D-A19B-05 9d8a2471-74af-4bbd-be10-78ca3aac6761 TCGA-ER-A2NB-01 TCGA-ER-A2NB-01 BA3E99AF-BDE1-46CD-A25A-D5E8E3B2FE66 TCGA-ER-A2NB-01A-12D-A196-08 TCGA-ER-A2NB-01A-12D-A196-08 TCGA-ER-A2NB-01A-12D-A196-08 9d8a2471-74af-4bbd-be10-78ca3aac6761 9d8a2471-74af-4bbd-be10-78ca3aac6761 +TCGA-ER-A2NC-06 TCGA-ER-A2NC-06 TCGA-ER-A2NC TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 50 TCGA-ER-A2NC TCGA-ER-A2NC-06A 1.97 -18582 1753 1333 0 974 Chest wall 2012-4-26 MALE No C76.1 8720/3 C76.1 YES 170 YES NO Non-glabrous skin NO NO YES true No M0 N0 T2a Stage IB TCGA-ER-A2NC.F0F5FECE-CED1-4907-863F-6B9A60C777D5.pdf A2NC WITH TUMOR NO YES NO Interferon NO Metastatic 06 6th YES NO ER Distant Metastasis A DECEASED 2006 71c7d343-4528-450f-b743-b8e7988714ea TCGA-ER-A2NC-06A-11D-A19C-05 71c7d343-4528-450f-b743-b8e7988714ea TCGA-ER-A2NC-06 TCGA-ER-A2NC-06A-11D-A191-01 TCGA-ER-A2NC-06 0F91FE10-6DBE-4D21-944D-A70BD0B8641F TCGA-ER-A2NC-06A-11D-A197-08 TCGA-ER-A2NC-06A-11D-A197-08 TCGA-ER-A2NC-06A-11D-A191-01 TCGA-ER-A2NC-06A-11D-A197-08 71c7d343-4528-450f-b743-b8e7988714ea 71c7d343-4528-450f-b743-b8e7988714ea +TCGA-ER-A2ND-06 TCGA-ER-A2ND-06 TCGA-ER-A2ND TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 57 TCGA-ER-A2ND TCGA-ER-A2ND-06A 1.0 -20867 2594 710 0 653 Right Flank 2012-4-30 FEMALE No C44.5 8720/3 C44.5 YES 140 YES NO IV Non-glabrous skin NO NO true No M0 N3 T1b Stage IIIC TCGA-ER-A2ND.790BDDA5-3565-4B59-8784-DE32AC75C38B.pdf A2ND WITH TUMOR NO YES NO Interferon NO Metastatic 06 6th YES NO ER Distant Metastasis A DECEASED 2004 0b0a2e4a-d939-426b-ba2f-71ad4fcb2565 TCGA-ER-A2ND-06A-11D-A19B-05 0b0a2e4a-d939-426b-ba2f-71ad4fcb2565 TCGA-ER-A2ND-06 TCGA-ER-A2ND-06A-11D-A194-01 TCGA-ER-A2ND-06 459A059C-1B2C-47E0-A15E-BFD008546EB1 TCGA-ER-A2ND-06A-11D-A196-08 TCGA-ER-A2ND-06A-11D-A196-08 TCGA-ER-A2ND-06A-11D-A194-01 TCGA-ER-A2ND-06A-11D-A196-08 0b0a2e4a-d939-426b-ba2f-71ad4fcb2565 0b0a2e4a-d939-426b-ba2f-71ad4fcb2565 +TCGA-ER-A2NE-06 TCGA-ER-A2NE-06 TCGA-ER-A2NE TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 39 TCGA-ER-A2NE TCGA-ER-A2NE-06A -14259 1457 613 0 567 Ileum (serosa) 2012-6-29 MALE Yes C49.9 8720/3 C49.9 YES 150 NO NO true No M0 N0 Tis Stage 0 TCGA-ER-A2NE.26929BC1-E319-4104-9B08-0B90EACE2022.pdf A2NE WITH TUMOR NO YES NO YES Metastatic 06 6th YES NO ER Distant Metastasis A DECEASED 2007 3cce17b1-469d-4eae-98d1-e20b472c4176 TCGA-ER-A2NE-06A-21D-A19B-05 3cce17b1-469d-4eae-98d1-e20b472c4176 TCGA-ER-A2NE-06 TCGA-ER-A2NE-06A-21D-A194-01 TCGA-ER-A2NE-06 AF216E2D-A3F7-4F35-A5D5-FCAA781EE4B5 TCGA-ER-A2NE-06A-21D-A196-08 TCGA-ER-A2NE-06A-21D-A196-08 TCGA-ER-A2NE-06A-21D-A194-01 TCGA-ER-A2NE-06A-21D-A196-08 3cce17b1-469d-4eae-98d1-e20b472c4176 3cce17b1-469d-4eae-98d1-e20b472c4176 +TCGA-ER-A2NF-01 TCGA-ER-A2NF-01 TCGA-ER-A2NF TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 53 TCGA-ER-A2NF-F69366 TCGA-ER-A2NF TCGA-ER-A2NF-01A 4 -19499 246 877 0 498 230 100 2015-1-8 MALE No C44.4 8721/3 C44.4 YES 310 NO NO NO V Non-glabrous skin YES NO YES true No M0 N3 T3b Stage IIIB TCGA-ER-A2NF.7DE6C23D-B810-4A4D-BD59-FC23D49338A7.pdf A2NF WITH TUMOR YES 2 YES YES Interferon NO Primary Tumor 01 7th YES NO ER Primary Tumor A DECEASED 2010 24b64a2a-72d2-49a7-b6ac-33654632b85a TCGA-ER-A2NF-01A-11D-A19D-05 24b64a2a-72d2-49a7-b6ac-33654632b85a TCGA-ER-A2NF-01 TCGA-ER-A2NF-01 1BCAAABE-65B8-45A9-9F41-F0A341ACB08B TCGA-ER-A2NF-01A-11D-A19A-08 TCGA-ER-A2NF-01A-11D-A19A-08 TCGA-ER-A2NF-01A-11D-A19A-08 24b64a2a-72d2-49a7-b6ac-33654632b85a 24b64a2a-72d2-49a7-b6ac-33654632b85a +TCGA-ER-A2NF-06 TCGA-ER-A2NF-06 TCGA-ER-A2NF TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 53 TCGA-ER-A2NF-F69366 TCGA-ER-A2NF TCGA-ER-A2NF-06A 4 -19499 246 877 0 498 230 100 2015-1-8 MALE No C44.4 8721/3 C44.4 YES 160 NO NO NO V Non-glabrous skin YES NO YES true No M0 N3 T3b Stage IIIB TCGA-ER-A2NF.19EC6528-7DCE-43AD-A353-3B1ECD4B703A.pdf A2NF WITH TUMOR YES 2 YES YES Interferon NO Metastatic 06 7th YES NO ER Primary Tumor A DECEASED 2010 55ef7beb-1c9f-47e4-805a-900b935a5d8c TCGA-ER-A2NF-06A-11D-A19D-05 55ef7beb-1c9f-47e4-805a-900b935a5d8c TCGA-ER-A2NF-06 TCGA-ER-A2NF-06A-11D-A192-01 TCGA-ER-A2NF-06 C342A8D0-21AD-49F2-BE57-97288146E963 TCGA-ER-A2NF-06A-11D-A19A-08 TCGA-ER-A2NF-06A-11D-A192-01 55ef7beb-1c9f-47e4-805a-900b935a5d8c 55ef7beb-1c9f-47e4-805a-900b935a5d8c +TCGA-ER-A2NG-06 TCGA-ER-A2NG-06 TCGA-ER-A2NG TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 43 TCGA-ER-A2NG-F69367 TCGA-ER-A2NG TCGA-ER-A2NG-06A 3 -15903 693 1490 0 951 1153 567 2015-1-8 FEMALE No C77.3 8720/3 C77.3 YES 260 NO NO 9 III Non-glabrous skin YES NO YES true No M0 N3 T3b Stage IIIC TCGA-ER-A2NG.31E2C9E4-8AE8-4303-9440-DC608E8ED9A1.pdf A2NG WITH TUMOR YES YES NO NO Metastatic 06 6th YES NO ER Regional Lymph Node A DECEASED 2009 5545eb61-9b5e-4a93-964a-480597237267 TCGA-ER-A2NG-06A-11D-A19B-05 5545eb61-9b5e-4a93-964a-480597237267 TCGA-ER-A2NG-06 TCGA-ER-A2NG-06A-11D-A194-01 TCGA-ER-A2NG-06 4AA55C16-DF96-41B9-8A91-86FCAD3B57F8 TCGA-ER-A2NG-06A-11D-A196-08 TCGA-ER-A2NG-06A-11D-A196-08 TCGA-ER-A2NG-06A-11D-A194-01 TCGA-ER-A2NG-06A-11D-A196-08 5545eb61-9b5e-4a93-964a-480597237267 5545eb61-9b5e-4a93-964a-480597237267 +TCGA-ER-A2NH-06 TCGA-ER-A2NH-06 TCGA-ER-A2NH TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 49 TCGA-ER-A2NH-F69370 TCGA-ER-A2NH TCGA-ER-A2NH-06A 4 -18220 744 0 1264 618 2015-1-7 MALE No C77.3 8720/3 C77.3 YES NO NO 1 IV Non-glabrous skin NO NO true No M0 N3 T3a Stage IIIC TCGA-ER-A2NH.875D53B1-DFAE-4DA3-84B0-70B14B280EA1.pdf A2NH WITH TUMOR NO YES NO NO Metastatic 06 6th YES NO ER Regional Lymph Node A LIVING 2009 3c286a47-d3f3-4ef8-acb5-203a6e75881c TCGA-ER-A2NH-06A-11D-A19B-05 3c286a47-d3f3-4ef8-acb5-203a6e75881c TCGA-ER-A2NH-06 TCGA-ER-A2NH-06A-11D-A194-01 TCGA-ER-A2NH-06 C1237E91-933A-46F3-B067-405BADB20EAC TCGA-ER-A2NH-06A-11D-A196-08 TCGA-ER-A2NH-06A-11D-A196-08 TCGA-ER-A2NH-06A-11D-A194-01 TCGA-ER-A2NH-06A-11D-A196-08 3c286a47-d3f3-4ef8-acb5-203a6e75881c 3c286a47-d3f3-4ef8-acb5-203a6e75881c +TCGA-ER-A3ES-06 TCGA-ER-A3ES-06 TCGA-ER-A3ES TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 25 TCGA-ER-A3ES TCGA-ER-A3ES-06A -9366 8892 7514 0 7239 Peritoneal tumor 2012-5-2 MALE Yes C48.2 8720/3 C48.2 YES 310 NO NO true No TCGA-ER-A3ES.096BC4D5-2921-447D-BCF1-18CE550249A8.pdf A3ES WITH TUMOR NO YES NO Immunotherapy/Vaccine NO Metastatic 06 YES NO ER Distant Metastasis A DECEASED 1987 d69bc8fa-8015-46d5-a80d-4ff4cdc2eb46 TCGA-ER-A3ES-06A-11D-A211-05 d69bc8fa-8015-46d5-a80d-4ff4cdc2eb46 TCGA-ER-A3ES-06 TCGA-ER-A3ES-06A-11D-A20B-01 TCGA-ER-A3ES-06 77238111-94A2-490D-948E-82E463A18E0E TCGA-ER-A3ES-06A-11D-A20D-08 TCGA-ER-A3ES-06A-11D-A20D-08 TCGA-ER-A3ES-06A-11D-A20B-01 TCGA-ER-A3ES-06A-11D-A20D-08 d69bc8fa-8015-46d5-a80d-4ff4cdc2eb46 d69bc8fa-8015-46d5-a80d-4ff4cdc2eb46 +TCGA-ER-A3ET-06 TCGA-ER-A3ET-06 TCGA-ER-A3ET TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 64 TCGA-ER-A3ET-F69372 TCGA-ER-A3ET TCGA-ER-A3ET-06A 3.55 -23650 2362 2829 0 2443 2243 2015-1-7 FEMALE No C49.9 8720/3 C49.9 YES 150 NO NO IV Non-glabrous skin NO NO true No M0 N1a T3a Stage IIIA TCGA-ER-A3ET.49CF1653-1EE3-4C4C-B79D-1DEC59490210.pdf A3ET WITH TUMOR NO YES NO YES Metastatic 06 6th YES NO ER Regional Cutaneous or Subcutaneous Tissue (includes satellite and in-transit metastasis) A DECEASED 2005 f3320aca-c30a-4542-9778-2fd278d9bb83 TCGA-ER-A3ET-06A-11D-A211-05 f3320aca-c30a-4542-9778-2fd278d9bb83 TCGA-ER-A3ET-06 TCGA-ER-A3ET-06A-11D-A20B-01 TCGA-ER-A3ET-06 B68458FA-F28E-4F2F-9660-829C9E365EEB TCGA-ER-A3ET-06A-11D-A20D-08 TCGA-ER-A3ET-06A-11D-A20D-08 TCGA-ER-A3ET-06A-11D-A20B-01 TCGA-ER-A3ET-06A-11D-A20D-08 f3320aca-c30a-4542-9778-2fd278d9bb83 f3320aca-c30a-4542-9778-2fd278d9bb83 +TCGA-ER-A3EV-06 TCGA-ER-A3EV-06 TCGA-ER-A3EV TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 55 TCGA-ER-A3EV-F48990 TCGA-ER-A3EV TCGA-ER-A3EV-06A 4.4 -20354 3678 1429 0 1429 884 728 745 Lymph node, pericardial 2013-9-24 MALE 182 No C77.9 8720/3 C77.9 YES 80 NO YES NO YES YES true No M0 N0 T4 Stage III TCGA-ER-A3EV.DB3E0EA0-11E9-4803-ADD9-61D79908BD1D.pdf A3EV WITH TUMOR NO YES NO NO Metastatic 06 5th YES NO ER Distant Metastasis A DECEASED 90 2001 88e86824-599f-4063-9977-f6db333b9b44 TCGA-ER-A3EV-06A-11D-A211-05 88e86824-599f-4063-9977-f6db333b9b44 TCGA-ER-A3EV-06 TCGA-ER-A3EV-06A-11D-A20B-01 TCGA-ER-A3EV-06 TCGA-ER-A3EV-06A-11D-A20D-08 TCGA-ER-A3EV-06A-11D-A20D-08 TCGA-ER-A3EV-06A-11D-A20B-01 TCGA-ER-A3EV-06A-11D-A20D-08 88e86824-599f-4063-9977-f6db333b9b44 88e86824-599f-4063-9977-f6db333b9b44 +TCGA-ER-A3PL-06 TCGA-ER-A3PL-06 TCGA-ER-A3PL TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 30 TCGA-ER-A3PL-F69342 TCGA-ER-A3PL TCGA-ER-A3PL-06A 2.2 -11032 1017 0 1010 958 958 958 2015-1-6 MALE No C49.1 8720/3 C49.1 YES 440 NO NO V Non-glabrous skin YES Distant Metastasis Extremities NO YES YES Other, Specify Right flank true No M1a N0 T3b Stage IV TCGA-ER-A3PL.249C231D-FD24-4E23-87D3-11D844B41EBF.pdf A3PL WITH TUMOR NO YES NO NO Metastatic 06 6th YES NO ER Regional Cutaneous or Subcutaneous Tissue (includes satellite and in-transit metastasis) A LIVING 2009 76df8bb7-5ea9-4eec-91f3-0aa571aa0660 TCGA-ER-A3PL-06A-11D-A23D-05 76df8bb7-5ea9-4eec-91f3-0aa571aa0660 TCGA-ER-A3PL-06 TCGA-ER-A3PL-06A-11D-A238-01 TCGA-ER-A3PL-06 0EE49D15-EB36-4058-9FEF-538FA210B5AF TCGA-ER-A3PL-06A-11D-A23B-08 TCGA-ER-A3PL-06A-11D-A23B-08 TCGA-ER-A3PL-06A-11D-A238-01 76df8bb7-5ea9-4eec-91f3-0aa571aa0660 76df8bb7-5ea9-4eec-91f3-0aa571aa0660 +TCGA-ER-A42H-01 TCGA-ER-A42H-01 TCGA-ER-A42H TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 76 TCGA-ER-A42H TCGA-ER-A42H-01A -28110 736 426 0 114 2013-6-14 MALE No C43.51 8720/3 C21.8 YES 220 NO Non-glabrous skin NO YES true No TCGA-ER-A42H.A0ED997A-DE1F-4339-B149-9B0C2A8FF8EB.pdf A42H WITH TUMOR NO 5 YES YES NO Primary Tumor 01 YES NO ER Primary Tumor A DECEASED 2010 ee4fbf8c-8a2d-4dab-90cf-382239ab0940 TCGA-ER-A42H-01A-11D-A24V-05 ee4fbf8c-8a2d-4dab-90cf-382239ab0940 TCGA-ER-A42H-01 TCGA-ER-A42H-01 7D11D75E-BEF8-414B-8242-563B3E3D842F TCGA-ER-A42H-01A-11D-A24R-08 TCGA-ER-A42H-01A-11D-A24R-08 ee4fbf8c-8a2d-4dab-90cf-382239ab0940 ee4fbf8c-8a2d-4dab-90cf-382239ab0940 +TCGA-ER-A42K-06 TCGA-ER-A42K-06 TCGA-ER-A42K TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 40 TCGA-ER-A42K-F69356 TCGA-ER-A42K TCGA-ER-A42K-06A 5.5 -14628 101 394 0 206 35 2015-1-7 FEMALE No C77.3 8720/3 C77.3 YES 60 NO NO 18.3 IV Non-glabrous skin YES NO NO true No M0 N3 T4b Stage IIIC TCGA-ER-A42K.E9A8E763-DC34-4284-9CCE-455578172A5A.pdf A42K WITH TUMOR NO YES NO Metastatic 06 7th YES NO ER Regional Lymph Node A DECEASED 2012 8706ced2-3f6d-412e-872b-2d5c08996ee1 TCGA-ER-A42K-06A-11D-A24V-05 8706ced2-3f6d-412e-872b-2d5c08996ee1 TCGA-ER-A42K-06 TCGA-ER-A42K-06A-11D-A24Q-01 TCGA-ER-A42K-06 B1C8E806-BD7C-4475-A650-15DD73FD4EAA TCGA-ER-A42K-06A-11D-A24R-08 TCGA-ER-A42K-06A-11D-A24R-08 TCGA-ER-A42K-06A-11D-A24Q-01 8706ced2-3f6d-412e-872b-2d5c08996ee1 8706ced2-3f6d-412e-872b-2d5c08996ee1 +TCGA-ER-A42L-06 TCGA-ER-A42L-06 TCGA-ER-A42L TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 49 TCGA-ER-A42L-F69359 TCGA-ER-A42L TCGA-ER-A42L-06A 1.46 -17984 3969 0 4533 3812 3389 Adrenal gland 2015-1-7 MALE No C74.9 8720/3 C74.9 YES 160 NO YES 1 IV Non-glabrous skin NO NO YES true No M0 N0 T3 Stage II TCGA-ER-A42L.5E762EB5-6918-4664-BE67-DDB70F19056D.pdf A42L TUMOR FREE NO YES NO NO Metastatic 06 5th YES NO ER Distant Metastasis A LIVING 2001 935241d0-0054-4eb4-8dba-e85ca47cc100 TCGA-ER-A42L-06A-11D-A24V-05 935241d0-0054-4eb4-8dba-e85ca47cc100 TCGA-ER-A42L-06 TCGA-ER-A42L-06A-11D-A24Q-01 TCGA-ER-A42L-06 C9038ED9-5E93-43B1-B1A8-B81A3C952A25 TCGA-ER-A42L-06A-11D-A24R-08 TCGA-ER-A42L-06A-11D-A24R-08 TCGA-ER-A42L-06A-11D-A24Q-01 935241d0-0054-4eb4-8dba-e85ca47cc100 935241d0-0054-4eb4-8dba-e85ca47cc100 +TCGA-FR-A2OS-01 TCGA-FR-A2OS-01 TCGA-FR-A2OS TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 49 TCGA-FR-A2OS-F31116 TCGA-FR-A2OS TCGA-FR-A2OS-01A -18122 1257 368 0 0 2012-4-24 FEMALE 164 No C44.7 8720/3 C44.7 YES 70 NO Elevated NO V Non-glabrous skin YES NO NO false No M0 N0 T4b Stage IIC TCGA-FR-A2OS.518D48F1-6A74-4376-85CB-E1F2C8C46011.pdf A2OS WITH TUMOR NO 1 1 YES NO NO Primary Tumor 01 NO 6th NO YES FR Primary Tumor A DECEASED 84 2008 8d5256fb-7bc0-4e43-b0f0-f6870278039e TCGA-FR-A2OS-01A-11D-A21B-05 8d5256fb-7bc0-4e43-b0f0-f6870278039e TCGA-FR-A2OS-01 TCGA-FR-A2OS-01 TCGA-FR-A2OS-01A-11D-A21A-08 TCGA-FR-A2OS-01A-11D-A21A-08 TCGA-FR-A2OS-01A-11D-A21A-08 8d5256fb-7bc0-4e43-b0f0-f6870278039e 8d5256fb-7bc0-4e43-b0f0-f6870278039e +TCGA-FR-A3R1-01 TCGA-FR-A3R1-01 TCGA-FR-A3R1 TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 69 TCGA-FR-A3R1-F47359 TCGA-FR-A3R1 TCGA-FR-A3R1-01A 6.30 -25271 126 0 685 678 0 2013-8-26 MALE 178 No C44.6 8721/3 C44.6 YES 480 NO NO 3.75 V Non-glabrous skin YES Locoregional Recurrence NO YES false No M0 N0 T4b Stage IIC TCGA-FR-A3R1.C9C95AC5-22B2-4C6C-A1C0-9D5F920AFB72.pdf A3R1 WITH TUMOR NO 1 YES NO NO Primary Tumor 01 NO 7th YES NO FR Primary Tumor A LIVING 84 2011 207051f1-5725-4c9b-9ac8-e4df261b4c94 TCGA-FR-A3R1-01A-11D-A23D-05 207051f1-5725-4c9b-9ac8-e4df261b4c94 TCGA-FR-A3R1-01 TCGA-FR-A3R1-01 51BAD147-030C-42FD-BF09-290A5DD9A055 TCGA-FR-A3R1-01A-11D-A23B-08 TCGA-FR-A3R1-01A-11D-A23B-08 207051f1-5725-4c9b-9ac8-e4df261b4c94 207051f1-5725-4c9b-9ac8-e4df261b4c94 +TCGA-FR-A3YN-06 TCGA-FR-A3YN-06 TCGA-FR-A3YN TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 44 TCGA-FR-A3YN-F47372 TCGA-FR-A3YN TCGA-FR-A3YN-06A 1.25 -16278 2347 0 2828 2268 2013-10-28 MALE 179 No C77.4 8720/3 C77.4 YES 460 NO NO IV NO NO false No M0 N0 T2a Stage IB TCGA-FR-A3YN.E2BF0131-CC97-4816-A7FA-E21E3F8932D4.pdf A3YN TUMOR FREE YES 1 YES NO NO Metastatic 06 NO 6th YES NO FR Regional Lymph Node A LIVING 89 2005 36669a48-fd56-4718-aa90-b9d39a65bb57 TCGA-FR-A3YN-06A-11D-A23D-05 36669a48-fd56-4718-aa90-b9d39a65bb57 TCGA-FR-A3YN-06 TCGA-FR-A3YN-06A-11D-A238-01 TCGA-FR-A3YN-06 9A59CD8F-D5E9-4987-8CC4-CA0CB44F6CFC TCGA-FR-A3YN-06A-11D-A23B-08 TCGA-FR-A3YN-06A-11D-A23B-08 TCGA-FR-A3YN-06A-11D-A238-01 36669a48-fd56-4718-aa90-b9d39a65bb57 36669a48-fd56-4718-aa90-b9d39a65bb57 +TCGA-FR-A3YO-06 TCGA-FR-A3YO-06 TCGA-FR-A3YO TCGA Melanoma (SKCM) skin cutaneous melanoma Skin YES|YES NO|NO TCGA-FR-A3YO-F47381 TCGA-FR-A3YO TCGA-FR-A3YO-06A Jejunum 2013-8-26 FEMALE 165 No C77.5 8720/3 C77.5 YES 540 NO NO Distant Metastasis|Distant Metastasis NO|NO YES Other, Specify|Other, Specify L internal iliac LN|Para-aortic LN false Yes M0 N0 T2 I/II NOS TCGA-FR-A3YO.1B823F22-738D-450F-A1D8-9A7840D316A4.pdf A3YO WITH TUMOR YES 1 YES NO NO Metastatic 06 NO 6th YES NO FR Distant Metastasis A LIVING 48 2007 f787b8fd-80da-4103-9102-18b08df2bf58 TCGA-FR-A3YO-06A-11D-A23D-05 f787b8fd-80da-4103-9102-18b08df2bf58 TCGA-FR-A3YO-06 TCGA-FR-A3YO-06A-11D-A238-01 TCGA-FR-A3YO-06 D0097E61-F429-4D37-97A1-C0F58CE1B5BF TCGA-FR-A3YO-06A-11D-A23B-08 TCGA-FR-A3YO-06A-11D-A23B-08 TCGA-FR-A3YO-06A-11D-A238-01 f787b8fd-80da-4103-9102-18b08df2bf58 f787b8fd-80da-4103-9102-18b08df2bf58 +TCGA-FR-A44A-06 TCGA-FR-A44A-06 TCGA-FR-A44A TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 29 TCGA-FR-A44A-F47383 TCGA-FR-A44A TCGA-FR-A44A-06A 2.51 -10707 4931 0 5299 2691 2013-8-26 FEMALE No C77.3 8720/3 C77.3 YES 100 NO NO 9 IV NO NO NO false No M0 N0 T3a Stage II TCGA-FR-A44A.8633CB6A-51C3-456D-9725-174016440BF1.pdf A44A TUMOR FREE YES 1 1 YES NO YES Metastatic 06 NO 5th NO YES FR Regional Lymph Node A LIVING 105 1999 03a38948-5a2d-4451-8103-12f6e0cf4984 TCGA-FR-A44A-06A-11D-A24V-05 03a38948-5a2d-4451-8103-12f6e0cf4984 TCGA-FR-A44A-06A-11D-A24Q-01 AAFF8407-B09B-4870-ABD3-A09487509117 TCGA-FR-A44A-06A-11D-A24R-08 TCGA-FR-A44A-06A-11D-A24R-08 TCGA-FR-A44A-06A-11D-A24Q-01 03a38948-5a2d-4451-8103-12f6e0cf4984 03a38948-5a2d-4451-8103-12f6e0cf4984 +TCGA-FR-A69P-06 TCGA-FR-A69P-06 TCGA-FR-A69P TCGA Melanoma (SKCM) skin cutaneous melanoma Skin YES NO 34 TCGA-FR-A69P-F59406 TCGA-FR-A69P TCGA-FR-A69P-06A -12679 108 0 478 287 274 0 2014-5-12 FEMALE 173 No C77.4 8720/3 C77.4 YES 400 NO NO Regional lymph node YES YES false No N3 TX Stage IIIC TCGA-FR-A69P.E0EA0F08-1A13-4D3E-BA89-1192DE2FC8A3.pdf A69P TUMOR FREE YES NO YES Metastatic 06 NO 7th YES NO FR Regional Lymph Node A LIVING 76 2013 2d65394f-fb80-49ef-9f3e-f37f77ac404f TCGA-FR-A69P-06A-21D-A30Z-05 2d65394f-fb80-49ef-9f3e-f37f77ac404f TCGA-FR-A69P-06 TCGA-FR-A69P-06A-21D-A30W-01 TCGA-FR-A69P-06 9FFCBCD7-7111-4185-9C47-9E64C8370BB5 TCGA-FR-A69P-06A-21D-A30X-08 TCGA-FR-A69P-06A-21D-A30X-08 TCGA-FR-A69P-06A-21D-A30W-01 2d65394f-fb80-49ef-9f3e-f37f77ac404f 2d65394f-fb80-49ef-9f3e-f37f77ac404f +TCGA-FR-A726-01 TCGA-FR-A726-01 TCGA-FR-A726 TCGA Melanoma (SKCM) skin cutaneous melanoma Skin NO NO 90 TCGA-FR-A726-F66609 TCGA-FR-A726 TCGA-FR-A726-01A 14.00 -32873 140 305 0 263 273 31 2014-10-21 MALE 179 No C44.2 8742/3 C44.2 YES 140 NO NO 26 IV Non-glabrous skin YES Locoregional Recurrence NO YES false No M0 N0 T4b Stage IIC TCGA-FR-A726.B9FC0FCB-B439-4354-BFBE-CAC6BCDEC588.pdf A726 WITH TUMOR NO 1 YES NO NO Primary Tumor 01 NO 7th YES NO FR Primary Tumor A DECEASED 81 2013 327c179d-b8d0-4e9b-9e0a-54d1b2e649b2 TCGA-FR-A726-01A-11D-A32S-05 327c179d-b8d0-4e9b-9e0a-54d1b2e649b2 05EE30BD-12D1-404E-A9BA-78DB96125C40 TCGA-FR-A726-01A-11D-A32N-08 327c179d-b8d0-4e9b-9e0a-54d1b2e649b2 327c179d-b8d0-4e9b-9e0a-54d1b2e649b2 +TCGA-FR-A728-01 TCGA-FR-A728-01 TCGA-FR-A728 TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 54 TCGA-FR-A728-F66624 TCGA-FR-A728 TCGA-FR-A728-01A 12.00 -19936 136 0 583 16 2014-10-21 FEMALE 165 No C44.6 8743/3 C44.6 YES 170 NO NO 6 IV Non-glabrous skin YES NO NO false No M0 N2a T4b Stage IIIB TCGA-FR-A728.F3C14D17-8681-4925-BDC5-CFE56F68342E.pdf A728 TUMOR FREE YES 1 YES NO NO Primary Tumor 01 NO 7th YES NO FR Primary Tumor A LIVING 87 2013 9072817e-8a67-4f62-a0a6-8afc42b7037b TCGA-FR-A728-01A-11D-A32S-05 9072817e-8a67-4f62-a0a6-8afc42b7037b TCGA-FR-A728-01 TCGA-FR-A728-01 8FE0DDDB-35C3-4BEA-BA29-3DDA40023B16 TCGA-FR-A728-01A-11D-A32N-08 9072817e-8a67-4f62-a0a6-8afc42b7037b 9072817e-8a67-4f62-a0a6-8afc42b7037b +TCGA-FR-A729-06 TCGA-FR-A729-06 TCGA-FR-A729 TCGA Melanoma (SKCM) skin cutaneous melanoma Skin YES NO 38 TCGA-FR-A729-F66634 TCGA-FR-A729 TCGA-FR-A729-06A 0.25 -14043 6307 0 6716 6299 6186 2014-10-21 FEMALE 174 No C77.4 8720/3 C77.4 YES 400 NO NO II NO Distant Metastasis NO YES Other, Specify spleen false No M0 N0 T1 Stage I TCGA-FR-A729.E1B37296-5114-47F3-A48E-2046B7939823.pdf A729 WITH TUMOR YES 1 YES NO NO Metastatic 06 NO 4th YES NO FR Regional Lymph Node A LIVING 83 1996 1b01e4e9-83b9-4bb0-8bef-c6e5d8c78280 TCGA-FR-A729-06A-11D-A34V-05 1b01e4e9-83b9-4bb0-8bef-c6e5d8c78280 TCGA-FR-A729-06A-11D-A34T-01 BD8C3CCC-3787-4B0C-A08B-99EDFCA02BE3 TCGA-FR-A729-06A-11D-A34U-08 TCGA-FR-A729-06A-11D-A34T-01 1b01e4e9-83b9-4bb0-8bef-c6e5d8c78280 1b01e4e9-83b9-4bb0-8bef-c6e5d8c78280 +TCGA-FR-A7U8-06 TCGA-FR-A7U8-06 TCGA-FR-A7U8 TCGA Melanoma (SKCM) skin cutaneous melanoma Skin YES YES 50 TCGA-FR-A7U8-F68771 TCGA-FR-A7U8 -18346 0 847 572 567 352 small intestine 2014-12-15 MALE 183 Yes C17.9 8720/3 C17.9 YES YES NO Distant Metastasis YES YES Brain No M0 N3 TX Stage IIIC A7U8 WITH TUMOR NO NO Interferon NO Metastatic 06 NO 7th YES NO FR Distant Metastasis LIVING 75 2012 f62984d7-b596-4417-a435-c02076d116cc TCGA-FR-A7U8-06A-21D-A34V-05 f62984d7-b596-4417-a435-c02076d116cc TCGA-FR-A7U8-06 TCGA-FR-A7U8-06A-21D-A34T-01 TCGA-FR-A7U8-06 TCGA-FR-A7U8-06A-21D-A34U-08 TCGA-FR-A7U8-06A-21D-A34T-01 f62984d7-b596-4417-a435-c02076d116cc f62984d7-b596-4417-a435-c02076d116cc +TCGA-FR-A7U9-06 TCGA-FR-A7U9-06 TCGA-FR-A7U9 TCGA Melanoma (SKCM) skin cutaneous melanoma Skin YES 63 TCGA-FR-A7U9-F68772 TCGA-FR-A7U9 TCGA-FR-A7U9-06A 2.80 -23245 129 0 571 231 50 2014-12-15 FEMALE 160 No C77.4 8720/3 C77.4 YES NO NO 11 IV Non-glabrous skin YES Distant Metastasis NO NO YES Other, Specify SCV LN false No M0 N3 T3b Stage IIIC TCGA-FR-A7U9.CEAE4ACD-340C-4BB2-A606-98445E57FED7.pdf A7U9 TUMOR FREE YES 1 YES NO NO Metastatic 06 NO 7th YES NO FR Regional Lymph Node A LIVING 67 2013 48b5606d-060d-4026-a899-4c4f9bfe64f9 TCGA-FR-A7U9-06A-11D-A34V-05 48b5606d-060d-4026-a899-4c4f9bfe64f9 TCGA-FR-A7U9-06 TCGA-FR-A7U9-06A-11D-A34T-01 TCGA-FR-A7U9-06 FD205507-90F8-4501-8A31-A8CDD4B83D73 TCGA-FR-A7U9-06A-11D-A34U-08 TCGA-FR-A7U9-06A-11D-A34T-01 48b5606d-060d-4026-a899-4c4f9bfe64f9 48b5606d-060d-4026-a899-4c4f9bfe64f9 +TCGA-FR-A7UA-06 TCGA-FR-A7UA-06 TCGA-FR-A7UA TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 65 TCGA-FR-A7UA-F63891 TCGA-FR-A7UA 1.02 -24032 0 1164 760 2014-8-20 FEMALE 162 No C77.3 8720/3 C77.3 YES NO 29 IV NO NO No M0 N0 T2a Stage IB A7UA TUMOR FREE NO 1 YES NO YES Metastatic 06 NO 7th YES NO FR Regional Lymph Node LIVING 87 2011 adb4622b-d3a2-414a-83a9-57ac28c52a7f TCGA-FR-A7UA-06A-32D-A34V-05 adb4622b-d3a2-414a-83a9-57ac28c52a7f TCGA-FR-A7UA-06 TCGA-FR-A7UA-06A-32D-A34T-01 TCGA-FR-A7UA-06 TCGA-FR-A7UA-06A-32D-A34U-08 TCGA-FR-A7UA-06A-32D-A34T-01 adb4622b-d3a2-414a-83a9-57ac28c52a7f adb4622b-d3a2-414a-83a9-57ac28c52a7f +TCGA-FR-A8YC-06 TCGA-FR-A8YC-06 TCGA-FR-A8YC TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 78 TCGA-FR-A8YC TCGA-FR-A8YC-06A 2.60 -28680 1042 1059 0 992 Jejunum 2014-3-11 MALE 168 No C17.9 8720/3 C17.9 YES 500 NO 16.6 IV YES YES false No M0 N0 T3b Stage IIB TCGA-FR-A8YC.2BC29A43-F39D-4B09-B645-8A1AF83D11D1.pdf A8YC WITH TUMOR YES 1 YES NO NO Metastatic 06 7th YES NO FR Distant Metastasis A DECEASED 74 2011 a696be4d-8576-43a3-8137-30778dff9b89 TCGA-FR-A8YC-06A-11D-A373-05 a696be4d-8576-43a3-8137-30778dff9b89 TCGA-FR-A8YC-06 TCGA-FR-A8YC-06A-11D-A371-01 TCGA-FR-A8YC-06 94A6A16C-BCB2-49E4-80E6-18E8EA77D08E TCGA-FR-A8YC-06A-11D-A372-08 TCGA-FR-A8YC-06A-11D-A371-01 a696be4d-8576-43a3-8137-30778dff9b89 a696be4d-8576-43a3-8137-30778dff9b89 +TCGA-FR-A8YD-06 TCGA-FR-A8YD-06 TCGA-FR-A8YD TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 56 TCGA-FR-A8YD-F70035 TCGA-FR-A8YD TCGA-FR-A8YD-06A 4.50 -20782 811 1103 0 896 753 LLL lung 2015-1-26 FEMALE 158 No C34.3 8720/3 C34.3 YES 220 NO NO 5 IV YES NO false No M0 N0 T4b Stage IIC TCGA-FR-A8YD.363E1FAC-6DC8-4CCE-913F-3745AA27C602.pdf A8YD WITH TUMOR YES 1 YES NO NO Metastatic 06 7th YES NO FR Distant Metastasis A DECEASED 77 2011 72f09d56-23d1-4cd8-9312-52ea1dfd94c8 TCGA-FR-A8YD-06A-11D-A373-05 72f09d56-23d1-4cd8-9312-52ea1dfd94c8 TCGA-FR-A8YD-06 TCGA-FR-A8YD-06A-11D-A371-01 TCGA-FR-A8YD-06 363FA0B6-1307-40E5-A699-BF94E94C9BDE TCGA-FR-A8YD-06A-11D-A372-08 TCGA-FR-A8YD-06A-11D-A371-01 72f09d56-23d1-4cd8-9312-52ea1dfd94c8 72f09d56-23d1-4cd8-9312-52ea1dfd94c8 +TCGA-FR-A8YE-06 TCGA-FR-A8YE-06 TCGA-FR-A8YE TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 41 TCGA-FR-A8YE-F68774 TCGA-FR-A8YE TCGA-FR-A8YE-06A 0.79 -15159 2836 0 3176 2771 2014-12-15 MALE 175 No C77.3 8720/3 C77.3 YES 490 NO NO III NO NO false No M0 N0 T1a Stage IA TCGA-FR-A8YE.FDE8D45A-BFC5-4A27-A0E3-F683FA318EFF.pdf A8YE TUMOR FREE NO 1 YES NO NO Metastatic 06 NO 6th YES NO FR Regional Lymph Node A LIVING 79 2006 5e9cd2f3-9d5e-4a76-88ab-4928c712981f TCGA-FR-A8YE-06A-11D-A373-05 5e9cd2f3-9d5e-4a76-88ab-4928c712981f TCGA-FR-A8YE-06 TCGA-FR-A8YE-06A-11D-A371-01 TCGA-FR-A8YE-06 A8952325-79D0-4B4E-94D1-CE9632244E01 TCGA-FR-A8YE-06A-11D-A372-08 TCGA-FR-A8YE-06A-11D-A371-01 5e9cd2f3-9d5e-4a76-88ab-4928c712981f 5e9cd2f3-9d5e-4a76-88ab-4928c712981f +TCGA-FS-A1YW-06 TCGA-FS-A1YW-06 TCGA-FS-A1YW TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 52 TCGA-FS-A1YW TCGA-FS-A1YW-06A 1 -19078 8597 6598 0 4637 2012-11-12 MALE No C77.9 8720/3 C77.9 YES 130 NO IV Non-glabrous skin NO NO false No M0 N0 T1b Stage IB TCGA-FS-A1YW.E3BF4EA9-D93C-4469-88E1-D78F18EA4C13.pdf A1YW WITH TUMOR YES 1 YES NO NO Metastatic 06 2nd NO YES FS Regional Lymph Node A DECEASED 1987 5d1230b6-ab63-417c-bf40-de9316043024 TCGA-FS-A1YW-06A-11D-A19C-05 5d1230b6-ab63-417c-bf40-de9316043024 TCGA-FS-A1YW-06 TCGA-FS-A1YW-06A-11D-A191-01 TCGA-FS-A1YW-06 C223248D-A2FF-4F32-A171-CB2AE8152019 TCGA-FS-A1YW-06A-11D-A197-08 TCGA-FS-A1YW-06A-11D-A197-08 TCGA-FS-A1YW-06A-11D-A191-01 TCGA-FS-A1YW-06A-11D-A197-08 5d1230b6-ab63-417c-bf40-de9316043024 5d1230b6-ab63-417c-bf40-de9316043024 +TCGA-FS-A1YX-06 TCGA-FS-A1YX-06 TCGA-FS-A1YX TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 39 TCGA-FS-A1YX TCGA-FS-A1YX-06A 1.1 -14387 3485 1478 0 1373 2012-11-12 FEMALE No C49.9 8720/3 C49.9 YES 70 YES NO IV Non-glabrous skin NO YES false No M0 N0 T2 Stage I TCGA-FS-A1YX.5EA2F816-4993-428A-8D97-97496E5F1360.pdf A1YX WITH TUMOR NO 1 YES NO NO Metastatic 06 5th NO YES FS Regional Cutaneous or Subcutaneous Tissue (includes satellite and in-transit metastasis) A DECEASED 2001 789ad7d7-2428-4ca2-a05f-0930b093e1d8 TCGA-FS-A1YX-06A-11D-A19C-05 789ad7d7-2428-4ca2-a05f-0930b093e1d8 TCGA-FS-A1YX-06 TCGA-FS-A1YX-06A-11D-A191-01 TCGA-FS-A1YX-06 TCGA-FS-A1YX-06A-11D-A197-08 TCGA-FS-A1YX-06A-11D-A197-08 TCGA-FS-A1YX-06A-11D-A191-01 TCGA-FS-A1YX-06A-11D-A197-08 789ad7d7-2428-4ca2-a05f-0930b093e1d8 789ad7d7-2428-4ca2-a05f-0930b093e1d8 +TCGA-FS-A1YY-06 TCGA-FS-A1YY-06 TCGA-FS-A1YY TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 55 TCGA-FS-A1YY TCGA-FS-A1YY-06A 2.7 -20396 8800 6953 0 6618 abdomen 2012-11-12 FEMALE No C76.2 8720/3 C76.2 YES 60 NO IV Non-glabrous skin NO YES false No M0 N0 T3a Stage IIA TCGA-FS-A1YY.A91D1EF0-6010-4536-8071-39A935247466.pdf A1YY WITH TUMOR NO 1 YES NO NO Metastatic 06 2nd NO YES FS Distant Metastasis A DECEASED 1987 1fbac9dc-90e1-4421-a65d-292ddbad0b4e TCGA-FS-A1YY-06A-11D-A19C-05 1fbac9dc-90e1-4421-a65d-292ddbad0b4e TCGA-FS-A1YY-06 TCGA-FS-A1YY-06A-11D-A191-01 TCGA-FS-A1YY-06 TCGA-FS-A1YY-06A-11D-A197-08 TCGA-FS-A1YY-06A-11D-A197-08 TCGA-FS-A1YY-06A-11D-A191-01 TCGA-FS-A1YY-06A-11D-A197-08 1fbac9dc-90e1-4421-a65d-292ddbad0b4e 1fbac9dc-90e1-4421-a65d-292ddbad0b4e +TCGA-FS-A1Z0-06 TCGA-FS-A1Z0-06 TCGA-FS-A1Z0 TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 32 TCGA-FS-A1Z0 TCGA-FS-A1Z0-06A 0.95 -11815 7435 6164 0 5440 Skin 2012-11-12 FEMALE No C44.9 8720/3 C44.9 YES 360 NO III Non-glabrous skin NO YES false No M0 N0 T1a Stage IA TCGA-FS-A1Z0.6B076E9D-9F82-49EC-A74F-3C4C0CAA567B.pdf A1Z0 WITH TUMOR NO 1 YES NO NO Metastatic 06 3rd NO YES FS Distant Metastasis A DECEASED 1990 020f448b-0242-4ff7-912a-4598d0b49055 TCGA-FS-A1Z0-06A-11D-A19C-05 020f448b-0242-4ff7-912a-4598d0b49055 TCGA-FS-A1Z0-06 TCGA-FS-A1Z0-06A-11D-A191-01 TCGA-FS-A1Z0-06 7672F4F1-2EB6-4A9D-9FA4-46C3C8AFAA61 TCGA-FS-A1Z0-06A-11D-A197-08 TCGA-FS-A1Z0-06A-11D-A197-08 TCGA-FS-A1Z0-06A-11D-A191-01 TCGA-FS-A1Z0-06A-11D-A197-08 020f448b-0242-4ff7-912a-4598d0b49055 020f448b-0242-4ff7-912a-4598d0b49055 +TCGA-FS-A1Z3-06 TCGA-FS-A1Z3-06 TCGA-FS-A1Z3 TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 72 TCGA-FS-A1Z3 TCGA-FS-A1Z3-06A -26435 3152 636 0 203 Skin 2012-11-12 FEMALE No C44.9 8720/3 C44.9 YES 340 NO Non-glabrous skin YES false No M1 N0 TX Stage IV TCGA-FS-A1Z3.6C91D798-AA14-4566-BDA1-DA3E639A76E1.pdf A1Z3 WITH TUMOR NO 0 NO NO Metastatic 06 5th NO YES FS Distant Metastasis A DECEASED 2002 22b2c106-e714-4289-bdfc-a9933f055023 TCGA-FS-A1Z3-06A-11D-A19C-05 22b2c106-e714-4289-bdfc-a9933f055023 TCGA-FS-A1Z3-06 TCGA-FS-A1Z3-06A-11D-A191-01 TCGA-FS-A1Z3-06 71C24F98-8E10-49EC-9CB9-45582CE9B5D2 TCGA-FS-A1Z3-06A-11D-A197-08 TCGA-FS-A1Z3-06A-11D-A197-08 TCGA-FS-A1Z3-06A-11D-A191-01 TCGA-FS-A1Z3-06A-11D-A197-08 22b2c106-e714-4289-bdfc-a9933f055023 22b2c106-e714-4289-bdfc-a9933f055023 +TCGA-FS-A1Z4-06 TCGA-FS-A1Z4-06 TCGA-FS-A1Z4 TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 62 TCGA-FS-A1Z4 TCGA-FS-A1Z4-06A 0.85 -22932 3575 854 0 382 2012-11-12 MALE No C77.9 8720/3 C77.9 YES 420 NO III Non-glabrous skin NO false No M0 N0 T1 Stage I TCGA-FS-A1Z4.D364F280-C02C-4D3F-AE1A-E6439EFFB6D6.pdf A1Z4 WITH TUMOR NO 1 YES NO NO Metastatic 06 5th NO YES FS Regional Lymph Node A DECEASED 2001 a6d27c0b-24c5-4633-a6d1-3f7f6c8525fd TCGA-FS-A1Z4-06A-11D-A19C-05 a6d27c0b-24c5-4633-a6d1-3f7f6c8525fd TCGA-FS-A1Z4-06 TCGA-FS-A1Z4-06A-11D-A191-01 TCGA-FS-A1Z4-06 63F37D71-1B77-4B73-AB62-5BF21DD31884 TCGA-FS-A1Z4-06A-11D-A197-08 TCGA-FS-A1Z4-06A-11D-A197-08 TCGA-FS-A1Z4-06A-11D-A191-01 TCGA-FS-A1Z4-06A-11D-A197-08 a6d27c0b-24c5-4633-a6d1-3f7f6c8525fd a6d27c0b-24c5-4633-a6d1-3f7f6c8525fd +TCGA-FS-A1Z7-06 TCGA-FS-A1Z7-06 TCGA-FS-A1Z7 TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 19 TCGA-FS-A1Z7 TCGA-FS-A1Z7-06A 17 -7293 2256 237 0 14 2012-11-12 MALE No C77.9 8720/3 C77.9 YES 40 NO V Non-glabrous skin YES YES false No M0 N1b T4b Stage IIIC TCGA-FS-A1Z7.E4C4CE99-0D2E-4C63-9695-0489B2A634AA.pdf A1Z7 WITH TUMOR NO 1 YES NO NO Metastatic 06 6th NO YES FS Regional Lymph Node A DECEASED 2005 4673424c-68f8-4ee3-aacc-926e4a32c2be TCGA-FS-A1Z7-06A-11D-A19C-05 4673424c-68f8-4ee3-aacc-926e4a32c2be TCGA-FS-A1Z7-06 TCGA-FS-A1Z7-06A-11D-A191-01 TCGA-FS-A1Z7-06 TCGA-FS-A1Z7-06A-11D-A197-08 TCGA-FS-A1Z7-06A-11D-A197-08 TCGA-FS-A1Z7-06A-11D-A191-01 TCGA-FS-A1Z7-06A-11D-A197-08 4673424c-68f8-4ee3-aacc-926e4a32c2be 4673424c-68f8-4ee3-aacc-926e4a32c2be +TCGA-FS-A1ZA-06 TCGA-FS-A1ZA-06 TCGA-FS-A1ZA TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 45 TCGA-FS-A1ZA TCGA-FS-A1ZA-06A 4.5 -16705 2925 843 0 621 lymphnode 2012-11-12 FEMALE No C77.9 8720/3 C77.9 YES 160 NO IV Non-glabrous skin YES YES false No M0 N2c T4b Stage IIIB TCGA-FS-A1ZA.D9CDFC6A-FA48-4EBF-999C-E941A596780A.pdf A1ZA WITH TUMOR NO 1 YES NO NO Metastatic 06 6th NO YES FS Distant Metastasis A DECEASED 2003 16568b2b-562c-4f74-b1b9-a3888d6dfc04 TCGA-FS-A1ZA-06A-11D-A19C-05 16568b2b-562c-4f74-b1b9-a3888d6dfc04 TCGA-FS-A1ZA-06 TCGA-FS-A1ZA-06A-11D-A191-01 TCGA-FS-A1ZA-06 1ABA8B41-A8DB-4ABA-8118-82B54A2BDEF8 TCGA-FS-A1ZA-06A-11D-A197-08 TCGA-FS-A1ZA-06A-11D-A197-08 TCGA-FS-A1ZA-06A-11D-A191-01 TCGA-FS-A1ZA-06A-11D-A197-08 16568b2b-562c-4f74-b1b9-a3888d6dfc04 16568b2b-562c-4f74-b1b9-a3888d6dfc04 +TCGA-FS-A1ZB-06 TCGA-FS-A1ZB-06 TCGA-FS-A1ZB TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 57 TCGA-FS-A1ZB TCGA-FS-A1ZB-06A 3 -20963 3180 1486 0 1383 lymphnode 2012-11-13 MALE No C77.9 8720/3 C77.9 YES 80 NO II Non-glabrous skin NO YES false No M0 N0 T3a Stage II TCGA-FS-A1ZB.A35D43B3-B388-4CED-AF6A-7C48B3792E47.pdf A1ZB WITH TUMOR NO 1 YES NO NO Metastatic 06 5th NO YES FS Distant Metastasis A DECEASED 2002 67bb0e7f-a5f6-44c4-b5d4-6566094de00a TCGA-FS-A1ZB-06A-12D-A19C-05 67bb0e7f-a5f6-44c4-b5d4-6566094de00a TCGA-FS-A1ZB-06 TCGA-FS-A1ZB-06A-12D-A191-01 TCGA-FS-A1ZB-06 TCGA-FS-A1ZB-06A-12D-A197-08 TCGA-FS-A1ZB-06A-12D-A197-08 TCGA-FS-A1ZB-06A-12D-A191-01 TCGA-FS-A1ZB-06A-12D-A197-08 67bb0e7f-a5f6-44c4-b5d4-6566094de00a 67bb0e7f-a5f6-44c4-b5d4-6566094de00a +TCGA-FS-A1ZC-06 TCGA-FS-A1ZC-06 TCGA-FS-A1ZC TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 51 TCGA-FS-A1ZC TCGA-FS-A1ZC-06A -18843 11991 10870 0 10250 Skin 2012-11-12 MALE No C44.9 8720/3 C44.9 YES 470 YES NO III Non-glabrous skin YES false No M0 N0 TX I/II NOS TCGA-FS-A1ZC.4A08AB50-3D1F-4E95-BD50-F83E4053E05E.pdf A1ZC WITH TUMOR NO 1 YES NO NO Metastatic 06 1st NO YES FS Distant Metastasis A DECEASED 1978 ecef38b8-540b-4b38-b0e5-46479bc30eb6 TCGA-FS-A1ZC-06A-11D-A19C-05 ecef38b8-540b-4b38-b0e5-46479bc30eb6 TCGA-FS-A1ZC-06 TCGA-FS-A1ZC-06A-11D-A191-01 TCGA-FS-A1ZC-06 A880FAE1-C16E-46A3-9B82-EDB2890C5714 TCGA-FS-A1ZC-06A-11D-A197-08 TCGA-FS-A1ZC-06A-11D-A197-08 TCGA-FS-A1ZC-06A-11D-A191-01 TCGA-FS-A1ZC-06A-11D-A197-08 ecef38b8-540b-4b38-b0e5-46479bc30eb6 ecef38b8-540b-4b38-b0e5-46479bc30eb6 +TCGA-FS-A1ZD-06 TCGA-FS-A1ZD-06 TCGA-FS-A1ZD TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 63 TCGA-FS-A1ZD TCGA-FS-A1ZD-06A 1.18 -23344 3458 1628 0 1378 2012-11-12 MALE No C77.9 8720/3 C77.9 YES 190 NO III Non-glabrous skin YES YES false No M0 N0 T2b Stage IIA TCGA-FS-A1ZD.F2E83C04-966D-46D7-B852-119F39400666.pdf A1ZD WITH TUMOR YES 1 YES NO NO Metastatic 06 6th NO YES FS Regional Lymph Node A DECEASED 2001 0ca8b8b7-f805-4c2a-834d-01790c9d7504 TCGA-FS-A1ZD-06A-11D-A19C-05 0ca8b8b7-f805-4c2a-834d-01790c9d7504 TCGA-FS-A1ZD-06 TCGA-FS-A1ZD-06A-11D-A191-01 TCGA-FS-A1ZD-06 C810DB39-39E1-4506-B8F5-FD21D20495B1 TCGA-FS-A1ZD-06A-11D-A197-08 TCGA-FS-A1ZD-06A-11D-A197-08 TCGA-FS-A1ZD-06A-11D-A191-01 TCGA-FS-A1ZD-06A-11D-A197-08 0ca8b8b7-f805-4c2a-834d-01790c9d7504 0ca8b8b7-f805-4c2a-834d-01790c9d7504 +TCGA-FS-A1ZE-06 TCGA-FS-A1ZE-06 TCGA-FS-A1ZE TCGA Melanoma (SKCM) skin cutaneous melanoma Skin NO|NO NO|NO 40 TCGA-FS-A1ZE-F62034 TCGA-FS-A1ZE TCGA-FS-A1ZE-06A 5 -14618 1064 1413 0 1225 1007| 1007|1096 631 Skin 2014-7-11 MALE No C44.9 8720/3 C44.9 YES 50 NO NO III Non-glabrous skin YES Distant Metastasis|Distant Metastasis YES|NO YES Other, Specify|Brain kidney| false No M0 N0 T4b Stage IIC TCGA-FS-A1ZE.DE9DD1BA-13E1-4DD2-BE00-5CA99D1C6FB9.pdf A1ZE WITH TUMOR NO 1 YES NO NO Metastatic 06 NO 6th NO YES FS Distant Metastasis A DECEASED 2008 3267f325-3689-4fe6-b539-44678ba7dd84 TCGA-FS-A1ZE-06A-11D-A19C-05 3267f325-3689-4fe6-b539-44678ba7dd84 TCGA-FS-A1ZE-06 TCGA-FS-A1ZE-06A-11D-A191-01 TCGA-FS-A1ZE-06 TCGA-FS-A1ZE-06A-11D-A197-08 TCGA-FS-A1ZE-06A-11D-A197-08 TCGA-FS-A1ZE-06A-11D-A191-01 TCGA-FS-A1ZE-06A-11D-A197-08 3267f325-3689-4fe6-b539-44678ba7dd84 3267f325-3689-4fe6-b539-44678ba7dd84 +TCGA-FS-A1ZF-06 TCGA-FS-A1ZF-06 TCGA-FS-A1ZF TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 78 TCGA-FS-A1ZF TCGA-FS-A1ZF-06A 4.3 -28491 1309 470 0 133 Lymphnode 2012-11-12 FEMALE No C77.9 8720/3 C77.9 YES 80 YES NO IV Non-glabrous skin YES YES false Yes M0 N0 T4b Stage IIC TCGA-FS-A1ZF.C9A75CE5-5E6D-44F4-B81A-CCAE2CEAECB1.pdf A1ZF WITH TUMOR NO 1 YES NO NO Metastatic 06 6th NO YES FS Distant Metastasis A DECEASED 2007 589feea4-d8ea-4c3f-9d63-367ba1488465 TCGA-FS-A1ZF-06A-12D-A19C-05 589feea4-d8ea-4c3f-9d63-367ba1488465 TCGA-FS-A1ZF-06 TCGA-FS-A1ZF-06A-12D-A191-01 TCGA-FS-A1ZF-06 TCGA-FS-A1ZF-06A-12D-A197-08 TCGA-FS-A1ZF-06A-12D-A197-08 TCGA-FS-A1ZF-06A-12D-A191-01 TCGA-FS-A1ZF-06A-12D-A197-08 589feea4-d8ea-4c3f-9d63-367ba1488465 589feea4-d8ea-4c3f-9d63-367ba1488465 +TCGA-FS-A1ZG-06 TCGA-FS-A1ZG-06 TCGA-FS-A1ZG TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 60 TCGA-FS-A1ZG TCGA-FS-A1ZG-06A 6 -22252 1463 295 0 77 2012-11-12 FEMALE No C77.9 8720/3 C77.9 YES 220 NO V Non-glabrous skin YES YES false No M0 N2b T4b Stage IIIC TCGA-FS-A1ZG.14921CE4-D107-432E-B64E-EAC70E1C415E.pdf A1ZG WITH TUMOR NO 1 YES NO NO Metastatic 06 6th NO YES FS Regional Lymph Node A DECEASED 2007 40cd8ac3-db5e-4295-9dbd-d891885cead5 TCGA-FS-A1ZG-06A-11D-A19C-05 40cd8ac3-db5e-4295-9dbd-d891885cead5 TCGA-FS-A1ZG-06 TCGA-FS-A1ZG-06A-11D-A191-01 TCGA-FS-A1ZG-06 E854429F-5CAF-44FE-8A6C-101EC61BEC43 TCGA-FS-A1ZG-06A-11D-A197-08 TCGA-FS-A1ZG-06A-11D-A197-08 TCGA-FS-A1ZG-06A-11D-A191-01 TCGA-FS-A1ZG-06A-11D-A197-08 40cd8ac3-db5e-4295-9dbd-d891885cead5 40cd8ac3-db5e-4295-9dbd-d891885cead5 +TCGA-FS-A1ZH-06 TCGA-FS-A1ZH-06 TCGA-FS-A1ZH TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 71 TCGA-FS-A1ZH TCGA-FS-A1ZH-06A 3 -26232 2661 996 0 57 2012-11-12 FEMALE No C77.9 8720/3 C77.9 YES 310 NO IV Non-glabrous skin YES YES false No M1c N2c T3b Stage IV TCGA-FS-A1ZH.8DAD99A6-254F-4280-9CA8-E1D9F896F77C.pdf A1ZH WITH TUMOR NO 1 YES NO NO Metastatic 06 6th NO YES FS Regional Lymph Node A DECEASED 2003 b295bda8-db61-49c4-912c-5c1f987e9d53 TCGA-FS-A1ZH-06A-11D-A19C-05 b295bda8-db61-49c4-912c-5c1f987e9d53 TCGA-FS-A1ZH-06 TCGA-FS-A1ZH-06A-11D-A191-01 TCGA-FS-A1ZH-06 7633E2BC-75E4-4F1B-9644-CA8C1C492EAA TCGA-FS-A1ZH-06A-11D-A197-08 TCGA-FS-A1ZH-06A-11D-A197-08 TCGA-FS-A1ZH-06A-11D-A191-01 TCGA-FS-A1ZH-06A-11D-A197-08 b295bda8-db61-49c4-912c-5c1f987e9d53 b295bda8-db61-49c4-912c-5c1f987e9d53 +TCGA-FS-A1ZJ-06 TCGA-FS-A1ZJ-06 TCGA-FS-A1ZJ TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 75 TCGA-FS-A1ZJ TCGA-FS-A1ZJ-06A 1.22 -27476 3589 1441 0 1048 2012-11-12 FEMALE No C77.9 8720/3 C77.9 YES 330 NO IV Non-glabrous skin NO YES false No M0 N0 T2 Stage I TCGA-FS-A1ZJ.F5EB706B-EB45-4B30-B73D-60AE5B6AFA80.pdf A1ZJ WITH TUMOR NO 1 YES NO NO Metastatic 06 5th NO YES FS Regional Lymph Node A DECEASED 2001 9beb01e0-62e4-4103-9a7c-f967fdb06608 TCGA-FS-A1ZJ-06A-12D-A19C-05 9beb01e0-62e4-4103-9a7c-f967fdb06608 TCGA-FS-A1ZJ-06 TCGA-FS-A1ZJ-06A-12D-A191-01 TCGA-FS-A1ZJ-06 D1329292-F48F-4D72-A784-740126EB783B TCGA-FS-A1ZJ-06A-12D-A197-08 TCGA-FS-A1ZJ-06A-12D-A197-08 TCGA-FS-A1ZJ-06A-12D-A191-01 TCGA-FS-A1ZJ-06A-12D-A197-08 9beb01e0-62e4-4103-9a7c-f967fdb06608 9beb01e0-62e4-4103-9a7c-f967fdb06608 +TCGA-FS-A1ZK-06 TCGA-FS-A1ZK-06 TCGA-FS-A1ZK TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 68 TCGA-FS-A1ZK TCGA-FS-A1ZK-06A 5 -24839 2009 728 0 336 Skin 2012-11-12 MALE No C44.9 8720/3 C44.9 YES 210 NO IV Non-glabrous skin YES false No M0 N0 T4 Stage II TCGA-FS-A1ZK.836F0DD7-AE54-44B8-A62F-9882C94B7105.pdf A1ZK WITH TUMOR NO 1 YES NO NO Metastatic 06 6th NO YES FS Distant Metastasis A DECEASED 2005 d17f1df8-d3de-4a01-930c-a066942e9fe4 TCGA-FS-A1ZK-06A-11D-A19C-05 d17f1df8-d3de-4a01-930c-a066942e9fe4 TCGA-FS-A1ZK-06 TCGA-FS-A1ZK-06A-11D-A191-01 TCGA-FS-A1ZK-06 8D63093A-952C-41F7-83BD-303FC103B0F0 TCGA-FS-A1ZK-06A-11D-A197-08 TCGA-FS-A1ZK-06A-11D-A197-08 TCGA-FS-A1ZK-06A-11D-A191-01 TCGA-FS-A1ZK-06A-11D-A197-08 d17f1df8-d3de-4a01-930c-a066942e9fe4 d17f1df8-d3de-4a01-930c-a066942e9fe4 +TCGA-FS-A1ZM-06 TCGA-FS-A1ZM-06 TCGA-FS-A1ZM TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 74 TCGA-FS-A1ZM-F62233 TCGA-FS-A1ZM TCGA-FS-A1ZM-06A 1.2 -27210 3515 0 3080 1639 2014-7-15 MALE No C77.9 8720/3 C77.9 YES 230 NO YES IV Non-glabrous skin YES false No M0 N2c T2 Stage III TCGA-FS-A1ZM.D87C02BE-28DE-4BEB-9388-4A6DF4C88348.pdf A1ZM TUMOR FREE NO 1 YES NO NO Metastatic 06 5th NO YES FS Regional Cutaneous or Subcutaneous Tissue (includes satellite and in-transit metastasis) A LIVING 2001 fd452f28-1ef9-4582-b31b-9ce98dc7a114 TCGA-FS-A1ZM-06A-12D-A19C-05 fd452f28-1ef9-4582-b31b-9ce98dc7a114 TCGA-FS-A1ZM-06 TCGA-FS-A1ZM-06A-12D-A191-01 TCGA-FS-A1ZM-06 A71E39F2-01B0-4EF8-95B7-8AB960347163 TCGA-FS-A1ZM-06A-12D-A197-08 TCGA-FS-A1ZM-06A-12D-A197-08 TCGA-FS-A1ZM-06A-12D-A191-01 TCGA-FS-A1ZM-06A-12D-A197-08 fd452f28-1ef9-4582-b31b-9ce98dc7a114 fd452f28-1ef9-4582-b31b-9ce98dc7a114 +TCGA-FS-A1ZN-01 TCGA-FS-A1ZN-01 TCGA-FS-A1ZN TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 43 TCGA-FS-A1ZN TCGA-FS-A1ZN-01A 8 -15890 3050 730 0 0 2012-11-12 MALE No C44.9 8720/3 C44.9 YES 100 YES NO IV Non-glabrous skin YES YES false No M0 N1a T4b Stage IIIA TCGA-FS-A1ZN.CD5AE9AD-B35F-4953-87E7-223CCD8C2500.pdf A1ZN WITH TUMOR YES 1 YES NO NO Primary Tumor 01 5th NO YES FS Primary Tumor A DECEASED 2002 96541be7-77b9-4859-9762-c439f22e6c4a TCGA-FS-A1ZN-01A-11D-A19C-05 96541be7-77b9-4859-9762-c439f22e6c4a TCGA-FS-A1ZN-01 TCGA-FS-A1ZN-01 A8285B8D-7038-42A4-AF73-D64A4578C8C3 TCGA-FS-A1ZN-01A-11D-A197-08 TCGA-FS-A1ZN-01A-11D-A197-08 TCGA-FS-A1ZN-01A-11D-A197-08 96541be7-77b9-4859-9762-c439f22e6c4a 96541be7-77b9-4859-9762-c439f22e6c4a +TCGA-FS-A1ZP-06 TCGA-FS-A1ZP-06 TCGA-FS-A1ZP TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 52 TCGA-FS-A1ZP TCGA-FS-A1ZP-06A 2.5 -19175 4897 2273 0 689 2012-11-13 MALE No C77.9 8720/3 C77.9 YES 190 NO III Non-glabrous skin false No M0 N0 T3 Stage II TCGA-FS-A1ZP.ABE11586-2784-4738-9B28-17269D07BEA9.pdf A1ZP WITH TUMOR NO 1 YES NO NO Metastatic 06 5th NO YES FS Regional Lymph Node A DECEASED 1997 c970e2a6-4393-4641-9eea-33a022e23c53 TCGA-FS-A1ZP-06A-11D-A19C-05 c970e2a6-4393-4641-9eea-33a022e23c53 TCGA-FS-A1ZP-06 TCGA-FS-A1ZP-06A-11D-A191-01 TCGA-FS-A1ZP-06 D4F53B67-6323-4579-B086-BB6FAA213B5A TCGA-FS-A1ZP-06A-11D-A197-08 TCGA-FS-A1ZP-06A-11D-A197-08 TCGA-FS-A1ZP-06A-11D-A191-01 TCGA-FS-A1ZP-06A-11D-A197-08 c970e2a6-4393-4641-9eea-33a022e23c53 c970e2a6-4393-4641-9eea-33a022e23c53 +TCGA-FS-A1ZQ-06 TCGA-FS-A1ZQ-06 TCGA-FS-A1ZQ TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 31 TCGA-FS-A1ZQ TCGA-FS-A1ZQ-06A -11599 4897 4062 0 3799 lung 2012-11-13 MALE No C34.9 8720/3 C34.9 YES 300 NO Non-glabrous skin YES false No M0 N0 TX I/II NOS TCGA-FS-A1ZQ.A1E704CD-0D4D-4CCC-82B2-19289EEE84EB.pdf A1ZQ WITH TUMOR YES 1 YES NO YES Metastatic 06 6th NO YES FS Distant Metastasis A DECEASED 1997 6ec8e49a-35db-469e-9e7a-0d8cdfcc0607 TCGA-FS-A1ZQ-06A-11D-A19C-05 6ec8e49a-35db-469e-9e7a-0d8cdfcc0607 TCGA-FS-A1ZQ-06 TCGA-FS-A1ZQ-06A-11D-A191-01 TCGA-FS-A1ZQ-06 C770E5F8-2482-4710-A3CB-17762939744D TCGA-FS-A1ZQ-06A-11D-A197-08 TCGA-FS-A1ZQ-06A-11D-A197-08 TCGA-FS-A1ZQ-06A-11D-A191-01 TCGA-FS-A1ZQ-06A-11D-A197-08 6ec8e49a-35db-469e-9e7a-0d8cdfcc0607 6ec8e49a-35db-469e-9e7a-0d8cdfcc0607 +TCGA-FS-A1ZR-06 TCGA-FS-A1ZR-06 TCGA-FS-A1ZR TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 36 TCGA-FS-A1ZR 2 -13325 347 0 79 2012-11-13 MALE No C77.9 8720/3 C77.9 YES IV Non-glabrous skin YES No M0 N0 T2 Stage II A1ZR WITH TUMOR NO 1 YES NO NO Metastatic 06 4th NO YES FS Regional Cutaneous or Subcutaneous Tissue (includes satellite and in-transit metastasis) DECEASED 1995 c67a7631-4bbf-4bee-9743-0e470d0bdf86 TCGA-FS-A1ZR-06A-21D-A19C-05 c67a7631-4bbf-4bee-9743-0e470d0bdf86 TCGA-FS-A1ZR-06 TCGA-FS-A1ZR-06A-21D-A191-01 TCGA-FS-A1ZR-06 TCGA-FS-A1ZR-06A-21D-A197-08 TCGA-FS-A1ZR-06A-21D-A197-08 TCGA-FS-A1ZR-06A-21D-A191-01 TCGA-FS-A1ZR-06A-21D-A197-08 c67a7631-4bbf-4bee-9743-0e470d0bdf86 c67a7631-4bbf-4bee-9743-0e470d0bdf86 +TCGA-FS-A1ZS-06 TCGA-FS-A1ZS-06 TCGA-FS-A1ZS TCGA Melanoma (SKCM) skin cutaneous melanoma Skin NO|NO|NO|NO|NO|NO YES|NO|NO|NO|NO|NO 54 TCGA-FS-A1ZS-F62237 TCGA-FS-A1ZS TCGA-FS-A1ZS-06A 1.15 -19813 4822 0 4526 2861|3031|3896| 2861|3031|3896|4049|4049|4049 3031 2014-7-15 MALE No C77.9 8720/3 C77.9 YES 140 YES NO NO Non-glabrous skin Regional lymph node|Regional lymph node|Distant Metastasis|Regional lymph node|Distant Metastasis|Distant Metastasis YES|YES|YES|NO|NO|NO YES LungLung|Liver false No M0 N0 T2 Stage I TCGA-FS-A1ZS.A0C6A7D2-56B6-412D-88B0-5C0391D7B731.pdf A1ZS WITH TUMOR NO 1 YES NO Interferon NO Metastatic 06 NO 5th NO YES FS Regional Lymph Node A LIVING 1998 4bf69802-8bd2-4463-8c33-cf5360bf0262 TCGA-FS-A1ZS-06A-12D-A19C-05 4bf69802-8bd2-4463-8c33-cf5360bf0262 TCGA-FS-A1ZS-06 TCGA-FS-A1ZS-06A-12D-A191-01 TCGA-FS-A1ZS-06 TCGA-FS-A1ZS-06A-12D-A197-08 TCGA-FS-A1ZS-06A-12D-A197-08 TCGA-FS-A1ZS-06A-12D-A191-01 TCGA-FS-A1ZS-06A-12D-A197-08 4bf69802-8bd2-4463-8c33-cf5360bf0262 4bf69802-8bd2-4463-8c33-cf5360bf0262 +TCGA-FS-A1ZT-06 TCGA-FS-A1ZT-06 TCGA-FS-A1ZT TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 55 TCGA-FS-A1ZT-F62241 TCGA-FS-A1ZT TCGA-FS-A1ZT-06A 1.15 -20284 2025 0 1617 381 lymphnode 2014-7-15 MALE No C77.9 8720/3 C77.9 YES 140 YES NO NO IV Non-glabrous skin NO false No M0 N1b T2 Stage III TCGA-FS-A1ZT.36EA6335-EA9A-456B-BB17-803AA853BB7A.pdf A1ZT TUMOR FREE YES 1 YES NO Interferon NO Metastatic 06 NO 6th NO YES FS Distant Metastasis A LIVING 2005 31f009cc-8211-45db-b74b-416bab8c30df TCGA-FS-A1ZT-06A-11D-A19C-05 31f009cc-8211-45db-b74b-416bab8c30df TCGA-FS-A1ZT-06 TCGA-FS-A1ZT-06A-11D-A191-01 TCGA-FS-A1ZT-06 E990B4C9-C44D-4BB2-8B6B-C32216379649 TCGA-FS-A1ZT-06A-11D-A197-08 TCGA-FS-A1ZT-06A-11D-A197-08 TCGA-FS-A1ZT-06A-11D-A191-01 TCGA-FS-A1ZT-06A-11D-A197-08 31f009cc-8211-45db-b74b-416bab8c30df 31f009cc-8211-45db-b74b-416bab8c30df +TCGA-FS-A1ZU-06 TCGA-FS-A1ZU-06 TCGA-FS-A1ZU TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 70 TCGA-FS-A1ZU TCGA-FS-A1ZU-06A 8.4 -25856 3164 808 0 544 skin 2012-11-13 FEMALE No C44.9 8720/3 C44.9 YES 130 YES NO V Non-glabrous skin YES YES false No M0 N0 T4b Stage IIC TCGA-FS-A1ZU.9FE3EDA1-2FF1-44A4-9619-C403F2A44D73.pdf A1ZU WITH TUMOR NO 1 YES NO Interferon NO Metastatic 06 5th NO YES FS Distant Metastasis A DECEASED 2002 23f183f4-735e-4361-940c-e09edd6f2d2a TCGA-FS-A1ZU-06A-12D-A19B-05 23f183f4-735e-4361-940c-e09edd6f2d2a TCGA-FS-A1ZU-06 TCGA-FS-A1ZU-06A-12D-A194-01 TCGA-FS-A1ZU-06 266EDC15-3567-49CA-B033-59C86C60A202 TCGA-FS-A1ZU-06A-12D-A196-08 TCGA-FS-A1ZU-06A-12D-A196-08 TCGA-FS-A1ZU-06A-12D-A194-01 TCGA-FS-A1ZU-06A-12D-A196-08 23f183f4-735e-4361-940c-e09edd6f2d2a 23f183f4-735e-4361-940c-e09edd6f2d2a +TCGA-FS-A1ZW-06 TCGA-FS-A1ZW-06 TCGA-FS-A1ZW TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 65 TCGA-FS-A1ZW-F62251 TCGA-FS-A1ZW 1.2 -24087 0 1505 672 2014-7-15 MALE No C77.9 8720/3 C77.9 YES YES NO III Non-glabrous skin YES NO No M0 N1a T2b Stage IIIB A1ZW TUMOR FREE YES 1 YES NO Interferon NO Metastatic 06 NO 6th NO YES FS Regional Lymph Node LIVING 2005 ce894d3c-c781-4e3a-a32c-1b3f85c84df3 TCGA-FS-A1ZW-06A-12D-A19C-05 ce894d3c-c781-4e3a-a32c-1b3f85c84df3 TCGA-FS-A1ZW-06 TCGA-FS-A1ZW-06A-12D-A191-01 TCGA-FS-A1ZW-06 TCGA-FS-A1ZW-06A-12D-A197-08 TCGA-FS-A1ZW-06A-12D-A197-08 TCGA-FS-A1ZW-06A-12D-A191-01 TCGA-FS-A1ZW-06A-12D-A197-08 ce894d3c-c781-4e3a-a32c-1b3f85c84df3 ce894d3c-c781-4e3a-a32c-1b3f85c84df3 +TCGA-FS-A1ZY-06 TCGA-FS-A1ZY-06 TCGA-FS-A1ZY TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 71 TCGA-FS-A1ZY TCGA-FS-A1ZY-06A 2.9 -26197 1848 824 0 799 skin 2012-11-13 MALE Yes C44.9 8720/3 C44.9 YES 80 YES NO IV Non-glabrous skin YES YES false No M0 N0 T3b Stage IIB TCGA-FS-A1ZY.B6F1051D-4991-4496-A211-2F4FEC470AAF.pdf A1ZY WITH TUMOR NO 1 YES NO Interferon NO Metastatic 06 6th NO YES FS Distant Metastasis A DECEASED 2006 390a7d6b-023d-4895-9b5c-f65bbb628ff1 TCGA-FS-A1ZY-06A-11D-A19C-05 390a7d6b-023d-4895-9b5c-f65bbb628ff1 TCGA-FS-A1ZY-06 TCGA-FS-A1ZY-06A-11D-A191-01 TCGA-FS-A1ZY-06 TCGA-FS-A1ZY-06A-11D-A197-08 TCGA-FS-A1ZY-06A-11D-A197-08 TCGA-FS-A1ZY-06A-11D-A191-01 TCGA-FS-A1ZY-06A-11D-A197-08 390a7d6b-023d-4895-9b5c-f65bbb628ff1 390a7d6b-023d-4895-9b5c-f65bbb628ff1 +TCGA-FS-A1ZZ-06 TCGA-FS-A1ZZ-06 TCGA-FS-A1ZZ TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 54 TCGA-FS-A1ZZ TCGA-FS-A1ZZ-06A 3.8 -19733 1780 822 0 663 lymphnode 2012-11-13 FEMALE Yes C77.9 8720/3 C77.9 YES 270 YES NO IV Non-glabrous skin YES false No M0 N0 T3b Stage IIB TCGA-FS-A1ZZ.E65D23A7-1FD6-4672-9B26-5B087AE90370.pdf A1ZZ WITH TUMOR NO 1 YES NO Interferon YES Metastatic 06 6th NO YES FS Distant Metastasis A DECEASED 2006 c209a152-e7e3-4960-8ad6-781f9da74542 TCGA-FS-A1ZZ-06A-11D-A19C-05 c209a152-e7e3-4960-8ad6-781f9da74542 TCGA-FS-A1ZZ-06 TCGA-FS-A1ZZ-06A-11D-A191-01 TCGA-FS-A1ZZ-06 E944EF8A-F202-4D33-8656-F49D44A84787 TCGA-FS-A1ZZ-06A-11D-A197-08 TCGA-FS-A1ZZ-06A-11D-A197-08 TCGA-FS-A1ZZ-06A-11D-A191-01 TCGA-FS-A1ZZ-06A-11D-A197-08 c209a152-e7e3-4960-8ad6-781f9da74542 c209a152-e7e3-4960-8ad6-781f9da74542 +TCGA-FS-A4F0-06 TCGA-FS-A4F0-06 TCGA-FS-A4F0 TCGA Melanoma (SKCM) skin cutaneous melanoma Skin NO|YES|YES|YES|NO NO|NO|NO|NO|NO 67 TCGA-FS-A4F0-F62029 TCGA-FS-A4F0 TCGA-FS-A4F0-06A 14 -24717 3223 0 2367 858|1055|13281828 872|1055|1328|1359|1828 729 2014-7-11 FEMALE Yes C49.9 8720/3 C49.9 YES 20 YES NO NO V Non-glabrous skin NO Locoregional Recurrence|Locoregional Recurrence|Locoregional Recurrence|Distant Metastasis|Distant Metastasis YES|YES|YES|NO|YES YES |Lung|Other, Specify lymphnode false No M0 N0 T4a Stage IIB TCGA-FS-A4F0.F41C37C8-62FD-42F3-B376-9D8E291836E4.pdf A4F0 TUMOR FREE YES 1 YES NO Interferon NO Metastatic 06 NO 6th NO YES FS Regional Cutaneous or Subcutaneous Tissue (includes satellite and in-transit metastasis) A LIVING 2003 2d882bfb-7efe-404c-8431-3cbfe3957ee0 TCGA-FS-A4F0-06A-11D-A24V-05 2d882bfb-7efe-404c-8431-3cbfe3957ee0 TCGA-FS-A4F0-06 TCGA-FS-A4F0-06A-11D-A24Q-01 TCGA-FS-A4F0-06 TCGA-FS-A4F0-06A-11D-A24R-08 TCGA-FS-A4F0-06A-11D-A24R-08 TCGA-FS-A4F0-06A-11D-A24Q-01 2d882bfb-7efe-404c-8431-3cbfe3957ee0 2d882bfb-7efe-404c-8431-3cbfe3957ee0 +TCGA-FS-A4F2-06 TCGA-FS-A4F2-06 TCGA-FS-A4F2 TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 46 TCGA-FS-A4F2 TCGA-FS-A4F2-06A 4.7 -16944 3432 1525 0 1427 2012-6-12 FEMALE No C49.9 8720/3 C49.9 YES 10 NO V Non-glabrous skin YES YES false No M0 N0 T4b Stage IIC TCGA-FS-A4F2.DE510F4B-B8C8-44AA-8470-736E6B027E2D.pdf A4F2 WITH TUMOR NO 1 YES NO NO Metastatic 06 6th NO YES FS Regional Cutaneous or Subcutaneous Tissue (includes satellite and in-transit metastasis) A DECEASED 2003 12a67d85-e880-4c38-9987-1f25741b5968 TCGA-FS-A4F2-06A-11D-A24V-05 12a67d85-e880-4c38-9987-1f25741b5968 TCGA-FS-A4F2-06A-11D-A24Q-01 TCGA-FS-A4F2-06A-11D-A24R-08 TCGA-FS-A4F2-06A-11D-A24Q-01 12a67d85-e880-4c38-9987-1f25741b5968 12a67d85-e880-4c38-9987-1f25741b5968 +TCGA-FS-A4F4-06 TCGA-FS-A4F4-06 TCGA-FS-A4F4 TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 64 TCGA-FS-A4F4 2.0 -23663 2028 0 1804 2012-6-12 MALE No C49.9 8720/3 C49.9 YES IV Non-glabrous skin YES YES No M0 N0 T3a Stage II A4F4 WITH TUMOR NO 1 YES NO NO Metastatic 06 5th NO YES FS Regional Cutaneous or Subcutaneous Tissue (includes satellite and in-transit metastasis) DECEASED 2001 d982be0f-c01a-403f-8cb0-b868e07b918d TCGA-FS-A4F4-06A-12D-A25S-05 d982be0f-c01a-403f-8cb0-b868e07b918d TCGA-FS-A4F4-06 TCGA-FS-A4F4-06A-12D-A25P-01 TCGA-FS-A4F4-06 TCGA-FS-A4F4-06A-12D-A25O-08 TCGA-FS-A4F4-06A-12D-A25O-08 TCGA-FS-A4F4-06A-12D-A25P-01 d982be0f-c01a-403f-8cb0-b868e07b918d d982be0f-c01a-403f-8cb0-b868e07b918d +TCGA-FS-A4F5-06 TCGA-FS-A4F5-06 TCGA-FS-A4F5 TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 77 TCGA-FS-A4F5 TCGA-FS-A4F5-06A 1.48 -28412 2522 874 0 0 2012-6-12 FEMALE No C49.9 8720/3 C49.9 YES 30 NO IV Non-glabrous skin NO YES false No M0 N0 T2a Stage IB TCGA-FS-A4F5.4C3D0EB8-5A80-4D5D-B555-3A9F7CC31134.pdf A4F5 WITH TUMOR NO 1 YES NO NO Metastatic 06 6th NO YES FS Regional Cutaneous or Subcutaneous Tissue (includes satellite and in-transit metastasis) A DECEASED 2005 835b36a5-39ab-4c39-ae0a-50d235b19b93 TCGA-FS-A4F5-06A-11D-A25S-05 835b36a5-39ab-4c39-ae0a-50d235b19b93 TCGA-FS-A4F5-06 TCGA-FS-A4F5-06A-11D-A25P-01 TCGA-FS-A4F5-06 TCGA-FS-A4F5-06A-11D-A25O-08 TCGA-FS-A4F5-06A-11D-A25O-08 TCGA-FS-A4F5-06A-11D-A25P-01 835b36a5-39ab-4c39-ae0a-50d235b19b93 835b36a5-39ab-4c39-ae0a-50d235b19b93 +TCGA-FS-A4F8-06 TCGA-FS-A4F8-06 TCGA-FS-A4F8 TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 52 TCGA-FS-A4F8 0.9 -19137 5318 0 4886 2012-6-12 MALE No C77.9 8720/3 C77.9 YES Non-glabrous skin YES No M0 N0 T1 Stage I A4F8 WITH TUMOR NO 1 YES NO NO Metastatic 06 4th NO YES FS Regional Lymph Node DECEASED 1997 aa805078-cbab-4f1a-ac2e-86ab4eb6e9c4 TCGA-FS-A4F8-06A-11D-A25S-05 aa805078-cbab-4f1a-ac2e-86ab4eb6e9c4 TCGA-FS-A4F8-06 TCGA-FS-A4F8-06A-11D-A25P-01 TCGA-FS-A4F8-06 TCGA-FS-A4F8-06A-11D-A25O-08 TCGA-FS-A4F8-06A-11D-A25O-08 TCGA-FS-A4F8-06A-11D-A25P-01 aa805078-cbab-4f1a-ac2e-86ab4eb6e9c4 aa805078-cbab-4f1a-ac2e-86ab4eb6e9c4 +TCGA-FS-A4F9-06 TCGA-FS-A4F9-06 TCGA-FS-A4F9 TCGA Melanoma (SKCM) skin cutaneous melanoma Skin NO|YES YES|NO 80 TCGA-FS-A4F9-F62027 TCGA-FS-A4F9 TCGA-FS-A4F9-06A 10 -29324 625 0 1035 376|696 376|696 50 2014-7-11 MALE No C77.9 8720/3 C77.9 YES 110 NO NO Non-glabrous skin YES Locoregional Recurrence|Distant Metastasis NO YES|YES YES |Brain false No M0 N3 T4b Stage IIIC TCGA-FS-A4F9.26AF9F70-F736-4B7A-ACDD-83189D9AE66E.pdf A4F9 WITH TUMOR NO 1 YES NO NO Metastatic 06 NO 7th NO YES FS Regional Lymph Node A LIVING 2011 a44ecade-befb-4514-9873-03c70438d9c7 TCGA-FS-A4F9-06A-11D-A24V-05 a44ecade-befb-4514-9873-03c70438d9c7 TCGA-FS-A4F9-06A-11D-A24Q-01 2BA8E7F3-AB40-402B-8C2F-59B3AC0E8795 TCGA-FS-A4F9-06A-11D-A24R-08 TCGA-FS-A4F9-06A-11D-A24R-08 TCGA-FS-A4F9-06A-11D-A24Q-01 a44ecade-befb-4514-9873-03c70438d9c7 a44ecade-befb-4514-9873-03c70438d9c7 +TCGA-FS-A4FB-06 TCGA-FS-A4FB-06 TCGA-FS-A4FB TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 46 TCGA-FS-A4FB 2 -16896 813 0 631 2012-6-13 FEMALE No C77.9 8720/3 C77.9 YES IV YES No M0 N1a T2 Stage III A4FB WITH TUMOR NO 1 YES NO NO Metastatic 06 6th NO YES FS Regional Lymph Node DECEASED 2009 f97b34e3-6933-4ab5-8e7a-2f4ea4da27ff TCGA-FS-A4FB-06A-11D-A25S-05 f97b34e3-6933-4ab5-8e7a-2f4ea4da27ff TCGA-FS-A4FB-06 TCGA-FS-A4FB-06A-11D-A25P-01 TCGA-FS-A4FB-06 TCGA-FS-A4FB-06A-11D-A25O-08 TCGA-FS-A4FB-06A-11D-A25O-08 TCGA-FS-A4FB-06A-11D-A25P-01 f97b34e3-6933-4ab5-8e7a-2f4ea4da27ff f97b34e3-6933-4ab5-8e7a-2f4ea4da27ff +TCGA-FS-A4FC-06 TCGA-FS-A4FC-06 TCGA-FS-A4FC TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 75 TCGA-FS-A4FC-F62032 TCGA-FS-A4FC TCGA-FS-A4FC-06A 4 -27482 1908 1655 0 1504 1309 2014-7-11 FEMALE No C44.9 8720/3 C44.9 YES 210 NO NO IV Non-glabrous skin NO YES false No M0 N0 T3a Stage IIA TCGA-FS-A4FC.44438FCE-0F81-41FB-B63A-7512726C8A42.pdf A4FC WITH TUMOR NO 1 YES NO NO Metastatic 06 NO 6th NO YES FS Regional Cutaneous or Subcutaneous Tissue (includes satellite and in-transit metastasis) A DECEASED 2007 9aca1f40-cecc-41ca-9a4c-1dd79edec185 TCGA-FS-A4FC-06A-11D-A24V-05 9aca1f40-cecc-41ca-9a4c-1dd79edec185 TCGA-FS-A4FC-06A-11D-A24Q-01 4F5EA5A8-E527-4CB9-8BEB-5607E3688004 TCGA-FS-A4FC-06A-11D-A24R-08 TCGA-FS-A4FC-06A-11D-A24R-08 TCGA-FS-A4FC-06A-11D-A24Q-01 9aca1f40-cecc-41ca-9a4c-1dd79edec185 9aca1f40-cecc-41ca-9a4c-1dd79edec185 +TCGA-FS-A4FD-06 TCGA-FS-A4FD-06 TCGA-FS-A4FD TCGA Melanoma (SKCM) skin cutaneous melanoma Skin NO|NO|NO|NO NO|NO|NO|NO 39 TCGA-FS-A4FD-F62033 TCGA-FS-A4FD TCGA-FS-A4FD-06A 2 -14426 3065 2454 0 2369 2010| 2010|2252|2307|2315 2300 2014-7-11 MALE Yes C77.9 8720/3 C77.9 YES 80 YES NO NO IV Distant Metastasis|Distant Metastasis|Distant Metastasis|Distant Metastasis YES|NO|NO|NO YES Lung|Lung|Bone|Brain false No M0 N3 T2 Stage IIIC TCGA-FS-A4FD.6412A296-EDCB-4C6F-B2A7-BC3D4643B843.pdf A4FD WITH TUMOR NO 1 YES YES Interferon NO Metastatic 06 NO 6th NO YES FS Regional Lymph Node A DECEASED 2004 0a760a83-c33d-4aa6-bbbb-3dc330d376f7 TCGA-FS-A4FD-06A-11D-A25S-05 0a760a83-c33d-4aa6-bbbb-3dc330d376f7 TCGA-FS-A4FD-06 TCGA-FS-A4FD-06A-11D-A25P-01 TCGA-FS-A4FD-06 TCGA-FS-A4FD-06A-11D-A25O-08 TCGA-FS-A4FD-06A-11D-A25O-08 TCGA-FS-A4FD-06A-11D-A25P-01 0a760a83-c33d-4aa6-bbbb-3dc330d376f7 0a760a83-c33d-4aa6-bbbb-3dc330d376f7 +TCGA-FW-A3I3-06 TCGA-FW-A3I3-06 TCGA-FW-A3I3 TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 59 TCGA-FW-A3I3-F46702 TCGA-FW-A3I3 TCGA-FW-A3I3-06A -21731 79 0 531 0 vaginal wall/vagina 2013-8-14 FEMALE 173 No C52 8720/3 C52.9 YES 130 NO NO NO false No M1 N0 Stage IV TCGA-FW-A3I3.6B26B4FD-8A1B-4869-AC81-8465323C56FE.pdf A3I3 TUMOR FREE NO NO NO Metastatic 06 NO 7th YES NO FW Distant Metastasis A LIVING 105 2011 13dd0afe-2ac9-4a9a-a7f1-a807dc33a787 TCGA-FW-A3I3-06A-11D-A21B-05 13dd0afe-2ac9-4a9a-a7f1-a807dc33a787 TCGA-FW-A3I3-06 TCGA-FW-A3I3-06A-11D-A219-01 TCGA-FW-A3I3-06 ED26A575-A0EF-4FA5-92A3-D7F394A92714 TCGA-FW-A3I3-06A-11D-A21A-08 TCGA-FW-A3I3-06A-11D-A21A-08 TCGA-FW-A3I3-06A-11D-A219-01 TCGA-FW-A3I3-06A-11D-A21A-08 13dd0afe-2ac9-4a9a-a7f1-a807dc33a787 13dd0afe-2ac9-4a9a-a7f1-a807dc33a787 +TCGA-FW-A3R5-06 TCGA-FW-A3R5-06 TCGA-FW-A3R5 TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 68 TCGA-FW-A3R5-F42773 TCGA-FW-A3R5 TCGA-FW-A3R5-06A -24868 745 0 1124 667 2013-4-30 MALE No C77.0 8720/3 C77.0 YES 30 NO NO Non-glabrous skin NO true Yes M0 N2 TX Stage III TCGA-FW-A3R5.D424CB2C-47D2-4182-85F8-9605C5613C1E.pdf A3R5 TUMOR FREE YES 1 1 YES NO NO Metastatic 06 NO 7th YES NO FW Regional Lymph Node A LIVING 2010 2a382958-2b06-4f44-8e21-e2a5bf2f5d15 TCGA-FW-A3R5-06A-11D-A23D-05 2a382958-2b06-4f44-8e21-e2a5bf2f5d15 TCGA-FW-A3R5-06 TCGA-FW-A3R5-06A-11D-A238-01 TCGA-FW-A3R5-06 TCGA-FW-A3R5-06A-11D-A23B-08 TCGA-FW-A3R5-06A-11D-A23B-08 TCGA-FW-A3R5-06A-11D-A238-01 2a382958-2b06-4f44-8e21-e2a5bf2f5d15 2a382958-2b06-4f44-8e21-e2a5bf2f5d15 +TCGA-FW-A3R5-11 TCGA-FW-A3R5-11 TCGA-FW-A3R5 TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 68 TCGA-FW-A3R5-F42773 TCGA-FW-A3R5 -24868 0 1124 667 2013-4-30 MALE No C77.0 8720/3 C77.0 YES NO Non-glabrous skin NO Yes M0 N2 TX Stage III A3R5 TUMOR FREE YES 1 1 YES NO NO Solid Tissue Normal 11 NO 7th YES NO FW Regional Lymph Node LIVING 2010 TCGA-FW-A3R5-11A-11D-A23D-05 TCGA-FW-A3R5-11 TCGA-FW-A3R5-11 +TCGA-FW-A3TU-06 TCGA-FW-A3TU-06 TCGA-FW-A3TU TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 72 TCGA-FW-A3TU-F65994 TCGA-FW-A3TU TCGA-FW-A3TU-06A -26589 1579 1691 0 1446 1442 Lung 2014-10-1 FEMALE No C34.1 8720/3 C34.1 YES 20 NO NO IV Non-glabrous skin YES false No TCGA-FW-A3TU.8C43518B-770C-48B6-A58D-B6A9AC9232FC.pdf A3TU WITH TUMOR NO 1 YES NO NO Metastatic 06 YES NO FW Distant Metastasis A DECEASED 2007 45b849c2-a006-4b63-90ff-206182dfc5a3 TCGA-FW-A3TU-06A-11D-A23D-05 45b849c2-a006-4b63-90ff-206182dfc5a3 TCGA-FW-A3TU-06 TCGA-FW-A3TU-06A-11D-A238-01 TCGA-FW-A3TU-06 TCGA-FW-A3TU-06A-11D-A23B-08 TCGA-FW-A3TU-06A-11D-A23B-08 TCGA-FW-A3TU-06A-11D-A238-01 45b849c2-a006-4b63-90ff-206182dfc5a3 45b849c2-a006-4b63-90ff-206182dfc5a3 +TCGA-FW-A3TV-06 TCGA-FW-A3TV-06 TCGA-FW-A3TV TCGA Melanoma (SKCM) skin cutaneous melanoma Skin YES NO 57 TCGA-FW-A3TV-F58958 TCGA-FW-A3TV TCGA-FW-A3TV-06A 0.5 -20972 44 0 411 139 139 0 2014-4-29 FEMALE 165 No C77.3 8720/3 C77.3 YES 210 NO NO III Non-glabrous skin Locoregional Recurrence YES YES false No M0 N2b T1 Stage IIIB TCGA-FW-A3TV.5F24E2F6-D00F-4F0E-B640-B4688AA97B86.pdf A3TV WITH TUMOR YES YES NO NO Metastatic 06 NO 7th YES NO FW Regional Lymph Node A LIVING 86 2012 204579ec-d4c2-4a36-9231-f0c82f62de12 TCGA-FW-A3TV-06A-11D-A23D-05 204579ec-d4c2-4a36-9231-f0c82f62de12 TCGA-FW-A3TV-06 TCGA-FW-A3TV-06A-11D-A238-01 TCGA-FW-A3TV-06 5474EF0B-A79A-4D6F-A54E-A226D4CF7A07 TCGA-FW-A3TV-06A-11D-A23B-08 TCGA-FW-A3TV-06A-11D-A23B-08 TCGA-FW-A3TV-06A-11D-A238-01 204579ec-d4c2-4a36-9231-f0c82f62de12 204579ec-d4c2-4a36-9231-f0c82f62de12 +TCGA-FW-A5DX-01 TCGA-FW-A5DX-01 TCGA-FW-A5DX TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 71 TCGA-FW-A5DX-F65837 TCGA-FW-A5DX TCGA-FW-A5DX-01A 7.0 -26056 96 0 640 11 2014-9-30 MALE No C44.5 8720/3 C44.5 YES 60 NO NO Non-glabrous skin NO NO false No N3 T4a Stage IIIC TCGA-FW-A5DX.D34CA06D-F2E8-47A5-85D1-CA627AE0BE9A.pdf A5DX TUMOR FREE NO 1 1 YES NO NO Primary Tumor 01 NO 7th YES NO FW Primary Tumor A LIVING 2012 8b7dde02-aa71-4df6-b108-d3f083fdaf8c TCGA-FW-A5DX-01A-11D-A27L-05 8b7dde02-aa71-4df6-b108-d3f083fdaf8c TCGA-FW-A5DX-01 TCGA-FW-A5DX-01 TCGA-FW-A5DX-01A-11D-A27K-08 TCGA-FW-A5DX-01A-11D-A27K-08 8b7dde02-aa71-4df6-b108-d3f083fdaf8c 8b7dde02-aa71-4df6-b108-d3f083fdaf8c +TCGA-FW-A5DY-06 TCGA-FW-A5DY-06 TCGA-FW-A5DY TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 48 TCGA-FW-A5DY-F64266 TCGA-FW-A5DY TCGA-FW-A5DY-06A -17730 111 0 587 60 2014-8-28 FEMALE No C77.3 8720/3 C77.3 YES 100 NO NO Non-glabrous skin NO false No N1 T3 Stage III TCGA-FW-A5DY.464976CF-0739-43BA-AD4D-788C924F92E0.pdf A5DY TUMOR FREE NO 1 YES NO NO Metastatic 06 NO 7th YES NO FW Regional Lymph Node A LIVING 2012 3b07667b-295b-41c9-a3b7-28ebb409fef1 TCGA-FW-A5DY-06A-11D-A30Z-05 3b07667b-295b-41c9-a3b7-28ebb409fef1 TCGA-FW-A5DY-06A-11D-A30W-01 BBCD983E-DCCB-4229-AE8C-07408D23539C TCGA-FW-A5DY-06A-11D-A30X-08 TCGA-FW-A5DY-06A-11D-A30X-08 TCGA-FW-A5DY-06A-11D-A30W-01 3b07667b-295b-41c9-a3b7-28ebb409fef1 3b07667b-295b-41c9-a3b7-28ebb409fef1 +TCGA-GF-A2C7-01 TCGA-GF-A2C7-01 TCGA-GF-A2C7 TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 48 TCGA-GF-A2C7-F21013 TCGA-GF-A2C7 TCGA-GF-A2C7-01A -17545 9 0 21 Scheduled Follow-up Submission 2012-5-8 MALE No C44.4 8720/3 C44.4 YES 210 NO 2 IV Non-glabrous skin YES NO false No M0 N0 T4b Stage IIC TCGA-GF-A2C7.C878CC4A-C645-419F-A8A5-4E80066AAFFE.pdf A2C7 TUMOR FREE NO YES NO NO Primary Tumor 01 7th YES NO GF Primary Tumor A LIVING 2011 5798deb1-2248-474f-b0cd-20c966128d9d TCGA-GF-A2C7-01A-11D-A19C-05 5798deb1-2248-474f-b0cd-20c966128d9d TCGA-GF-A2C7-01 TCGA-GF-A2C7-01 B4D2A4A2-DDD7-45D1-91E5-9B6AC905DB4C TCGA-GF-A2C7-01A-11D-A197-08 TCGA-GF-A2C7-01A-11D-A197-08 TCGA-GF-A2C7-01A-11D-A197-08 5798deb1-2248-474f-b0cd-20c966128d9d 5798deb1-2248-474f-b0cd-20c966128d9d +TCGA-GF-A3OT-06 TCGA-GF-A3OT-06 TCGA-GF-A3OT TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 58 TCGA-GF-A3OT-F40988 TCGA-GF-A3OT TCGA-GF-A3OT-06A -21359 160 0 301 0 2013-3-8 FEMALE No C77.3 8720/3 C77.3 YES 330 NO YES Non-glabrous skin NO YES false No M0 N3 T3 Stage IIIC TCGA-GF-A3OT.B41FFF2A-C253-47D3-9C22-BCCF724F7519.pdf A3OT WITH TUMOR YES 1 YES NO NO Metastatic 06 7th YES NO GF Regional Lymph Node A LIVING 66 2011 bc638135-8e42-44bf-924e-679ec5ce2f7c TCGA-GF-A3OT-06A-23D-A23D-05 bc638135-8e42-44bf-924e-679ec5ce2f7c TCGA-GF-A3OT-06 TCGA-GF-A3OT-06A-23D-A238-01 TCGA-GF-A3OT-06 B2EABD9B-A4C6-47DE-8F03-B3C1B6C2D6C7 TCGA-GF-A3OT-06A-23D-A23B-08 TCGA-GF-A3OT-06A-23D-A23B-08 TCGA-GF-A3OT-06A-23D-A238-01 bc638135-8e42-44bf-924e-679ec5ce2f7c bc638135-8e42-44bf-924e-679ec5ce2f7c +TCGA-GF-A4EO-06 TCGA-GF-A4EO-06 TCGA-GF-A4EO TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 74 TCGA-GF-A4EO-F58340 TCGA-GF-A4EO TCGA-GF-A4EO-06A -27114 51 0 591 0 left axillary lymph node 2014-4-7 FEMALE 166 No C77.3 8720/3 C77.3 YES 150 NO NO Non-glabrous skin NO false No M0 N3 T0 Stage IIIC TCGA-GF-A4EO.D0E07D23-49D0-4B7B-9F44-62685191A272.pdf A4EO TUMOR FREE NO NO NO YES Metastatic 06 NO 7th YES NO GF Regional Lymph Node A LIVING 105 2012 e6ea1a59-d3b3-44ef-9f81-ea80b7e60a0d TCGA-GF-A4EO-06A-12D-A24V-05 e6ea1a59-d3b3-44ef-9f81-ea80b7e60a0d TCGA-GF-A4EO-06 TCGA-GF-A4EO-06A-12D-A24Q-01 TCGA-GF-A4EO-06 AC08E796-D24B-4E28-A3E9-73FC7E767A4A TCGA-GF-A4EO-06A-12D-A24R-08 TCGA-GF-A4EO-06A-12D-A24R-08 TCGA-GF-A4EO-06A-12D-A24Q-01 e6ea1a59-d3b3-44ef-9f81-ea80b7e60a0d e6ea1a59-d3b3-44ef-9f81-ea80b7e60a0d +TCGA-GF-A6C8-06 TCGA-GF-A6C8-06 TCGA-GF-A6C8 TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 62 TCGA-GF-A6C8-F58356 TCGA-GF-A6C8 TCGA-GF-A6C8-06A 4.0 -22731 198 0 62 36 2014-4-7 FEMALE 167 No C77.3 8720/3 C77.3 YES 300 NO YES 11 IV Non-glabrous skin YES YES false No M0 NX T3b Stage IIB TCGA-GF-A6C8.45CC145C-9611-4A54-8284-186F233020FF.pdf A6C8 1 1 YES NO NO Metastatic 06 7th YES NO GF Regional Lymph Node A LIVING 67 2012 261b4ef8-1e68-4179-826b-8c4122502df4 TCGA-GF-A6C8-06A-12D-A30Z-05 261b4ef8-1e68-4179-826b-8c4122502df4 TCGA-GF-A6C8-06A-12D-A30W-01 680CB3AB-C855-4CE7-AD21-F0069AD12021 TCGA-GF-A6C8-06A-12D-A30X-08 TCGA-GF-A6C8-06A-12D-A30X-08 TCGA-GF-A6C8-06A-12D-A30W-01 261b4ef8-1e68-4179-826b-8c4122502df4 261b4ef8-1e68-4179-826b-8c4122502df4 +TCGA-GF-A6C9-06 TCGA-GF-A6C9-06 TCGA-GF-A6C9 TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 78 TCGA-GF-A6C9-F63938 TCGA-GF-A6C9 TCGA-GF-A6C9-06A -28774 154 0 480 4 parotid 2014-8-21 MALE 172 No C07 8720/3 C07.9 YES 160 NO NO NO false No Stage IIIB TCGA-GF-A6C9.2A307856-4434-47EA-AA17-DAA48E3EA1BC.pdf A6C9 TUMOR FREE NO NO YES Metastatic 06 NO 7th YES NO GF Distant Metastasis A LIVING 87 2012 454aa611-1004-4e70-ba50-276f75b72113 TCGA-GF-A6C9-06A-11D-A30Z-05 454aa611-1004-4e70-ba50-276f75b72113 TCGA-GF-A6C9-06A-11D-A30W-01 C50015A9-CD06-4D2E-B037-A518D7957D50 TCGA-GF-A6C9-06A-11D-A30X-08 TCGA-GF-A6C9-06A-11D-A30X-08 TCGA-GF-A6C9-06A-11D-A30W-01 454aa611-1004-4e70-ba50-276f75b72113 454aa611-1004-4e70-ba50-276f75b72113 +TCGA-GF-A769-01 TCGA-GF-A769-01 TCGA-GF-A769 TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 39 TCGA-GF-A769 74 -14304 1070 0 0 2014-1-23 MALE 182 No C44.7 8721/3 C44.7 YES 10 IV Non-glabrous skin YES NO No M0 NX T4b Stage IIC A769 WITH TUMOR NO 1 1 YES NO NO Primary Tumor 01 7th YES NO GF Primary Tumor DECEASED 88 2010 c0b48dda-b719-4a9d-b732-1b0b10efd1ad TCGA-GF-A769-01A-32D-A32S-05 c0b48dda-b719-4a9d-b732-1b0b10efd1ad TCGA-GF-A769-01 TCGA-GF-A769-01 TCGA-GF-A769-01A-32D-A32N-08 c0b48dda-b719-4a9d-b732-1b0b10efd1ad c0b48dda-b719-4a9d-b732-1b0b10efd1ad +TCGA-GN-A261-06 TCGA-GN-A261-06 TCGA-GN-A261 TCGA Melanoma (SKCM) skin cutaneous melanoma Skin TCGA-GN-A261-06A 3934 310 NO true TCGA-GN-A261.95C4E2FC-E6F1-4ED6-A7CE-E690807E12A0.pdf Metastatic 06 A d82ddab6-63f5-4298-bca9-4f3e690539b1 TCGA-GN-A261-06A-12D-A19C-05 d82ddab6-63f5-4298-bca9-4f3e690539b1 TCGA-GN-A261-06A-12D-A197-08 TCGA-GN-A261-06A-12D-A197-08 d82ddab6-63f5-4298-bca9-4f3e690539b1 d82ddab6-63f5-4298-bca9-4f3e690539b1 +TCGA-GN-A262-06 TCGA-GN-A262-06 TCGA-GN-A262 TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 47 TCGA-GN-A262-F61870 TCGA-GN-A262 TCGA-GN-A262-06A 3 -17239 3476 0 4255 2908 2014-7-9 FEMALE 159 Yes C44.5 8720/3 C44.5 YES 160 YES NO NO Non-glabrous skin NO NO true No TCGA-GN-A262.7F620D7C-8D45-4E7F-9A6B-C702EB26EBF1.pdf A262 WITH TUMOR NO 1 1 YES NO Interferon NO Metastatic 06 NO NO YES GN Regional Cutaneous or Subcutaneous Tissue (includes satellite and in-transit metastasis) A LIVING 72 2001 2988e553-2978-4d25-b6b0-0c2d2147c5d8 TCGA-GN-A262-06A-11D-A19B-05 2988e553-2978-4d25-b6b0-0c2d2147c5d8 TCGA-GN-A262-06 TCGA-GN-A262-06A-11D-A194-01 TCGA-GN-A262-06 1CE5BFA1-396E-467B-88CD-69AC4877A92B TCGA-GN-A262-06A-11D-A196-08 TCGA-GN-A262-06A-11D-A196-08 TCGA-GN-A262-06A-11D-A194-01 TCGA-GN-A262-06A-11D-A196-08 2988e553-2978-4d25-b6b0-0c2d2147c5d8 2988e553-2978-4d25-b6b0-0c2d2147c5d8 +TCGA-GN-A263-01 TCGA-GN-A263-01 TCGA-GN-A263 TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 24 TCGA-GN-A263 TCGA-GN-A263-01A -8952 2417 467 0 0 2012-4-20 MALE 170 No C44.5 8720/3 C44.5 YES 180 NO Elevated 1.25 V Non-glabrous skin YES NO YES true No M1c N3 T4b Stage IV TCGA-GN-A263.817B9EA7-3D5C-433A-AF6D-6701FFBBF8B1.pdf A263 WITH TUMOR NO 1 1 YES NO NO Primary Tumor 01 6th NO YES GN Primary Tumor A DECEASED 92 2004 aaea9670-416a-4293-af12-8bfeb47b0150 TCGA-GN-A263-01A-11D-A19B-05 aaea9670-416a-4293-af12-8bfeb47b0150 TCGA-GN-A263-01 TCGA-GN-A263-01 AB5B94AE-FBC7-43C1-89A9-184F5BF27DDE TCGA-GN-A263-01A-11D-A196-08 TCGA-GN-A263-01A-11D-A196-08 TCGA-GN-A263-01A-11D-A196-08 aaea9670-416a-4293-af12-8bfeb47b0150 aaea9670-416a-4293-af12-8bfeb47b0150 +TCGA-GN-A264-06 TCGA-GN-A264-06 TCGA-GN-A264 TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 60 TCGA-GN-A264 TCGA-GN-A264-06A 7 -22254 5008 3587 0 2634 2012-4-20 MALE No C44.5 8720/3 C44.5 YES 210 NO 0.42 V Non-glabrous skin NO NO YES true No TCGA-GN-A264.4C110E59-4624-4A8E-9B5C-C348FA62420A.pdf A264 WITH TUMOR YES 1 1 YES NO NO Metastatic 06 NO YES GN Regional Lymph Node A DECEASED 104 1997 a9c381e2-9f6a-4b07-a804-f7c3b7e976da TCGA-GN-A264-06A-11D-A19B-05 a9c381e2-9f6a-4b07-a804-f7c3b7e976da TCGA-GN-A264-06 TCGA-GN-A264-06A-11D-A194-01 TCGA-GN-A264-06 71FDE27E-2410-4159-BCF1-FBA8C1DE114D TCGA-GN-A264-06A-11D-A196-08 TCGA-GN-A264-06A-11D-A196-08 TCGA-GN-A264-06A-11D-A194-01 TCGA-GN-A264-06A-11D-A196-08 a9c381e2-9f6a-4b07-a804-f7c3b7e976da a9c381e2-9f6a-4b07-a804-f7c3b7e976da +TCGA-GN-A265-06 TCGA-GN-A265-06 TCGA-GN-A265 TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 53 TCGA-GN-A265-F42471 TCGA-GN-A265 TCGA-GN-A265-06A -19712 2400 0 2948 0 2013-4-22 MALE No C77.3 8720/3 C77.3 YES 220 NO NO Non-glabrous skin NO NO true No TCGA-GN-A265.B268C2CF-D98F-4A7F-A708-244442C0B169.pdf A265 TUMOR FREE NO NO NO Metastatic 06 NO NO YES GN Regional Lymph Node A LIVING 85 2004 2dd91279-ad0a-4ea5-b30a-df8c1c622da6 TCGA-GN-A265-06A-21D-A19C-05 2dd91279-ad0a-4ea5-b30a-df8c1c622da6 TCGA-GN-A265-06 TCGA-GN-A265-06A-21D-A191-01 TCGA-GN-A265-06 2F1E2D7C-C872-4283-ACEC-7037BE600AF0 TCGA-GN-A265-06A-21D-A197-08 TCGA-GN-A265-06A-21D-A197-08 TCGA-GN-A265-06A-21D-A191-01 TCGA-GN-A265-06A-21D-A197-08 2dd91279-ad0a-4ea5-b30a-df8c1c622da6 2dd91279-ad0a-4ea5-b30a-df8c1c622da6 +TCGA-GN-A266-06 TCGA-GN-A266-06 TCGA-GN-A266 TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 45 TCGA-GN-A266 TCGA-GN-A266-06A -16456 2354 308 0 0 2012-4-20 MALE 173 No C44.4 8720/3 C44.4 YES 110 NO Non-glabrous skin NO YES true No TCGA-GN-A266.0E9DDC94-6AC6-44D2-AE57-DEF276F10CB2.pdf A266 WITH TUMOR NO NO YES Metastatic 06 NO YES GN Regional Cutaneous or Subcutaneous Tissue (includes satellite and in-transit metastasis) A DECEASED 103 2004 400b226d-d5a5-444a-9b0e-33c6c7252d1e TCGA-GN-A266-06A-11D-A19C-05 400b226d-d5a5-444a-9b0e-33c6c7252d1e TCGA-GN-A266-06 TCGA-GN-A266-06A-11D-A191-01 TCGA-GN-A266-06 ADDAF9D8-058E-4DB4-AAC3-C8CDF6BCCDCD TCGA-GN-A266-06A-11D-A197-08 TCGA-GN-A266-06A-11D-A197-08 TCGA-GN-A266-06A-11D-A191-01 TCGA-GN-A266-06A-11D-A197-08 400b226d-d5a5-444a-9b0e-33c6c7252d1e 400b226d-d5a5-444a-9b0e-33c6c7252d1e +TCGA-GN-A267-06 TCGA-GN-A267-06 TCGA-GN-A267 TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 38 TCGA-GN-A267 TCGA-GN-A267-06A 5.2 -14055 2297 1960 0 1466 2012-4-20 MALE 167 No C77.3 8720/3 C77.3 YES 110 YES NO 8.6 IV Non-glabrous skin NO YES YES true No M0 N1a T4a Stage IIIA TCGA-GN-A267.410A571A-0EA2-496D-9F1F-B99834338C52.pdf A267 WITH TUMOR YES 1 1 YES NO Interferon NO Metastatic 06 6th NO YES GN Regional Lymph Node A DECEASED 96 2005 58fd742d-535c-494e-bb28-1bb908bfa294 TCGA-GN-A267-06A-21D-A19B-05 58fd742d-535c-494e-bb28-1bb908bfa294 TCGA-GN-A267-06 TCGA-GN-A267-06A-21D-A194-01 TCGA-GN-A267-06 91035E84-2C1F-46E8-ADEF-5387E50079EB TCGA-GN-A267-06A-21D-A196-08 TCGA-GN-A267-06A-21D-A196-08 TCGA-GN-A267-06A-21D-A194-01 TCGA-GN-A267-06A-21D-A196-08 58fd742d-535c-494e-bb28-1bb908bfa294 58fd742d-535c-494e-bb28-1bb908bfa294 +TCGA-GN-A268-06 TCGA-GN-A268-06 TCGA-GN-A268 TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 83 TCGA-GN-A268 TCGA-GN-A268-06A 9.8 -30430 2256 1910 0 1441 2012-4-20 FEMALE 155 No C77.3 8720/3 C77.3 YES 130 NO 1.67 V Non-glabrous skin NO YES YES true No M0 N0 T4a Stage IIB TCGA-GN-A268.DD8A1957-38F8-4436-8F6A-ADAD5AE479B5.pdf A268 WITH TUMOR NO 1 1 YES NO NO Metastatic 06 6th NO YES GN Regional Lymph Node A DECEASED 55 2005 1898ace6-5eda-42da-a355-5e55203d7e13 TCGA-GN-A268-06A-11D-A19B-05 1898ace6-5eda-42da-a355-5e55203d7e13 TCGA-GN-A268-06 TCGA-GN-A268-06A-11D-A194-01 TCGA-GN-A268-06 CFB5E4A0-DDC4-4475-96D0-D31E3064A6AF TCGA-GN-A268-06A-11D-A196-08 TCGA-GN-A268-06A-11D-A196-08 TCGA-GN-A268-06A-11D-A194-01 TCGA-GN-A268-06A-11D-A196-08 1898ace6-5eda-42da-a355-5e55203d7e13 1898ace6-5eda-42da-a355-5e55203d7e13 +TCGA-GN-A269-01 TCGA-GN-A269-01 TCGA-GN-A269 TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 70 TCGA-GN-A269 TCGA-GN-A269-01A 5 -25583 1780 170 0 0 2012-4-20 MALE 170 No C44.5 8743/3 C44.5 YES 170 NO 1.6 V Non-glabrous skin YES NO true No M0 N3 T4b Stage IIIC TCGA-GN-A269.AFB70554-E2A6-4CB5-9C16-0B5B82F03537.pdf A269 WITH TUMOR NO 1 1 YES NO NO Primary Tumor 01 6th NO YES GN Primary Tumor A DECEASED 77 2006 TCGA-GN-A269-01A-11D-A19D-05 019464AF-3A71-4087-B28E-18B4E2E0E9A0 TCGA-GN-A269-01A-11D-A19A-08 TCGA-GN-A269-01A-11D-A19A-08 TCGA-GN-A269-01A-11D-A19A-08 +TCGA-GN-A26A-06 TCGA-GN-A26A-06 TCGA-GN-A26A TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 63 TCGA-GN-A26A TCGA-GN-A26A-06A 2.3 -23288 1766 988 0 618 2012-4-20 FEMALE 165 No C44.5 8720/3 C44.5 YES 270 NO 11 IV Non-glabrous skin NO NO YES true No M0 N1a T3a Stage IIIA TCGA-GN-A26A.5F794422-0A58-4224-8108-E0E4DE11D4C6.pdf A26A WITH TUMOR NO 1 1 YES NO NO Metastatic 06 6th NO YES GN Regional Cutaneous or Subcutaneous Tissue (includes satellite and in-transit metastasis) A DECEASED 66 2006 74d3061c-1507-45bb-9aea-f8a8046f8046 TCGA-GN-A26A-06A-11D-A19D-05 74d3061c-1507-45bb-9aea-f8a8046f8046 TCGA-GN-A26A-06 TCGA-GN-A26A-06A-11D-A192-01 TCGA-GN-A26A-06 DED2C049-675A-42DC-A957-A4236F53276F TCGA-GN-A26A-06A-11D-A19A-08 TCGA-GN-A26A-06A-11D-A19A-08 TCGA-GN-A26A-06A-11D-A192-01 TCGA-GN-A26A-06A-11D-A19A-08 74d3061c-1507-45bb-9aea-f8a8046f8046 74d3061c-1507-45bb-9aea-f8a8046f8046 +TCGA-GN-A26C-01 TCGA-GN-A26C-01 TCGA-GN-A26C TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 77 TCGA-GN-A26C TCGA-GN-A26C-01A 14 -28336 1609 821 0 91 2012-4-24 MALE No C44.5 8772/3 C44.5 YES 250 NO 0.4 IV Non-glabrous skin YES NO YES true No M0 N2b T4b Stage IIIC TCGA-GN-A26C.5D0A4FFF-76E6-4F84-8F84-141A77E0BB82.pdf A26C WITH TUMOR NO 1 1 YES NO NO Primary Tumor 01 6th NO YES GN Primary Tumor A DECEASED 101 2006 c55d0f65-fa13-4bb5-a556-2bd78bac2ccf TCGA-GN-A26C-01A-11D-A19D-05 c55d0f65-fa13-4bb5-a556-2bd78bac2ccf TCGA-GN-A26C-01 TCGA-GN-A26C-01 E97A7409-5207-4050-AF8C-190FFE945480 TCGA-GN-A26C-01A-11D-A19A-08 TCGA-GN-A26C-01A-11D-A19A-08 TCGA-GN-A26C-01A-11D-A19A-08 c55d0f65-fa13-4bb5-a556-2bd78bac2ccf c55d0f65-fa13-4bb5-a556-2bd78bac2ccf +TCGA-GN-A26D-06 TCGA-GN-A26D-06 TCGA-GN-A26D TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 72 TCGA-GN-A26D-F42472 TCGA-GN-A26D TCGA-GN-A26D-06A 12 -26494 1093 1460 0 1204 1420|1420 757 2013-4-22 FEMALE 156 No C44.5 8720/3 C44.5 YES 250 NO NO 5 V Non-glabrous skin YES Distant Metastasis|Locoregional Recurrence YES NO|NO YES Brain| true No N0 T4b Stage IIC TCGA-GN-A26D.BDAC6146-CB80-499E-A75F-B4A82FA56333.pdf A26D WITH TUMOR YES 1 1 YES NO NO Metastatic 06 NO 6th NO YES GN Regional Lymph Node A DECEASED 68 2008 3baa2420-61dc-4896-85d2-035be9927bd1 TCGA-GN-A26D-06A-11D-A19D-05 3baa2420-61dc-4896-85d2-035be9927bd1 TCGA-GN-A26D-06 TCGA-GN-A26D-06A-11D-A192-01 TCGA-GN-A26D-06 9E5699CD-2A1B-4D78-B2A6-FEC8733E30FC TCGA-GN-A26D-06A-11D-A19A-08 TCGA-GN-A26D-06A-11D-A19A-08 TCGA-GN-A26D-06A-11D-A192-01 TCGA-GN-A26D-06A-11D-A19A-08 3baa2420-61dc-4896-85d2-035be9927bd1 3baa2420-61dc-4896-85d2-035be9927bd1 +TCGA-GN-A4U3-06 TCGA-GN-A4U3-06 TCGA-GN-A4U3 TCGA Melanoma (SKCM) skin cutaneous melanoma Skin YES|NO NO|YES 30 TCGA-GN-A4U3-F66876 TCGA-GN-A4U3 TCGA-GN-A4U3-06A 3 -11294 3001 0 3708 2274|2749 2230 Brain 2014-10-24 MALE 180 No C71.1 8720/3 C71.1 YES 180 NO NO IV Non-glabrous skin NO Distant Metastasis|Distant Metastasis NO NO|NO YES Lung|Brain false No M0 N1a T3a Stage III TCGA-GN-A4U3.F2797B06-305A-457F-9CC7-13F7908408A8.pdf A4U3 TUMOR FREE NO 1 1 YES NO YES Metastatic 06 NO 6th NO YES GN Distant Metastasis A LIVING 84 2004 7cecef67-73bf-4003-821c-e42ce6adfab7 TCGA-GN-A4U3-06A-11D-A32S-05 7cecef67-73bf-4003-821c-e42ce6adfab7 TCGA-GN-A4U3-06 TCGA-GN-A4U3-06A-11D-A32M-01 TCGA-GN-A4U3-06 TCGA-GN-A4U3-06A-11D-A32N-08 TCGA-GN-A4U3-06A-11D-A32M-01 7cecef67-73bf-4003-821c-e42ce6adfab7 7cecef67-73bf-4003-821c-e42ce6adfab7 +TCGA-GN-A4U4-06 TCGA-GN-A4U4-06 TCGA-GN-A4U4 TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 73 TCGA-GN-A4U4-F64517 TCGA-GN-A4U4 TCGA-GN-A4U4-06A 1.7 -26761 526 0 1197 42 2014-9-4 MALE 175 No C77.3 8720/3 C77.3 YES 340 NO NO 4 IV Non-glabrous skin YES NO NO false No M0 NX T2b Stage IIA TCGA-GN-A4U4.FEA743A2-070D-48B1-BB64-8E2A0044B170.pdf A4U4 TUMOR FREE NO 1 YES NO NO Metastatic 06 NO 7th NO YES GN Regional Lymph Node A LIVING 85 2011 166144b5-1d22-4a3a-84a9-31bc04e3560f TCGA-GN-A4U4-06A-11D-A32S-05 166144b5-1d22-4a3a-84a9-31bc04e3560f TCGA-GN-A4U4-06 TCGA-GN-A4U4-06A-11D-A32M-01 TCGA-GN-A4U4-06 TCGA-GN-A4U4-06A-11D-A32N-08 TCGA-GN-A4U4-06A-11D-A32M-01 166144b5-1d22-4a3a-84a9-31bc04e3560f 166144b5-1d22-4a3a-84a9-31bc04e3560f +TCGA-GN-A4U5-01 TCGA-GN-A4U5-01 TCGA-GN-A4U5 TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 61 TCGA-GN-A4U5-F64515 TCGA-GN-A4U5 TCGA-GN-A4U5-01A 1.15 -22499 519 0 1156 0 2014-9-4 FEMALE 157 No C49.6 8720/3 C49.6 YES 90 NO NO 0 IV Non-glabrous skin NO NO false No M0 NX T2a Stage IB TCGA-GN-A4U5.4FC4C20F-487A-432C-8845-9298636A5098.pdf A4U5 TUMOR FREE YES 1 1 YES NO NO Primary Tumor 01 NO 7th NO YES GN Primary Tumor A LIVING 84 2011 38755f31-a099-45fa-bb17-d78773e405ca TCGA-GN-A4U5-01A-11D-A32S-05 38755f31-a099-45fa-bb17-d78773e405ca TCGA-GN-A4U5-01 TCGA-GN-A4U5-01 TCGA-GN-A4U5-01A-11D-A32N-08 38755f31-a099-45fa-bb17-d78773e405ca 38755f31-a099-45fa-bb17-d78773e405ca +TCGA-GN-A4U7-06 TCGA-GN-A4U7-06 TCGA-GN-A4U7 TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 56 TCGA-GN-A4U7-F61143 TCGA-GN-A4U7 TCGA-GN-A4U7-06A 1.39 -20458 421 317 0 266 148 2014-6-25 FEMALE 161 No C77.5 8720/3 C77.5 YES 230 NO NO 8 IV Non-glabrous skin NO NO NO false No M0 N3 T2b Stage IIIC TCGA-GN-A4U7.D46EC94E-5D88-420B-97EB-D5754C299A29.pdf A4U7 WITH TUMOR NO 1 1 YES NO NO Metastatic 06 NO 7th NO YES GN Regional Lymph Node A DECEASED 48 2011 00624286-41dd-476f-a63b-d2a5f484bb45 TCGA-GN-A4U7-06A-21D-A32S-05 00624286-41dd-476f-a63b-d2a5f484bb45 TCGA-GN-A4U7-06 TCGA-GN-A4U7-06A-21D-A32M-01 TCGA-GN-A4U7-06 0122AF57-905A-4642-A2B5-663D062D7C4D TCGA-GN-A4U7-06A-21D-A32N-08 TCGA-GN-A4U7-06A-21D-A32M-01 00624286-41dd-476f-a63b-d2a5f484bb45 00624286-41dd-476f-a63b-d2a5f484bb45 +TCGA-GN-A4U8-06 TCGA-GN-A4U8-06 TCGA-GN-A4U8 TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 51 TCGA-GN-A4U8-F67433 TCGA-GN-A4U8 TCGA-GN-A4U8-06A -18953 1293 0 1487 1050 2014-11-5 MALE 180 No C77.3 8720/3 C77.3 YES 270 NO NO Non-glabrous skin NO false No TCGA-GN-A4U8.DD76E9F7-E667-4D5A-840E-980679252584.pdf A4U8 TUMOR FREE YES 1 YES NO YES Metastatic 06 NO 6th NO YES GN Regional Lymph Node A LIVING 2009 c7abd76a-60ff-4329-b93a-2a5939c93aac TCGA-GN-A4U8-06A-11D-A32S-05 c7abd76a-60ff-4329-b93a-2a5939c93aac TCGA-GN-A4U8-06 TCGA-GN-A4U8-06A-11D-A32M-01 TCGA-GN-A4U8-06 426C3F49-652B-469F-AB1B-1CD5789814EA TCGA-GN-A4U8-06A-11D-A32N-08 TCGA-GN-A4U8-06A-11D-A32M-01 c7abd76a-60ff-4329-b93a-2a5939c93aac c7abd76a-60ff-4329-b93a-2a5939c93aac +TCGA-GN-A4U8-11 TCGA-GN-A4U8-11 TCGA-GN-A4U8 TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 51 TCGA-GN-A4U8-F67433 TCGA-GN-A4U8 -18953 0 1487 1050 2014-11-5 MALE 180 No C77.3 8720/3 C77.3 YES NO Non-glabrous skin NO No A4U8 TUMOR FREE YES 1 YES NO YES Solid Tissue Normal 11 NO 6th NO YES GN Regional Lymph Node LIVING 2009 ff7431a9-243a-4651-80bb-096379925bbe TCGA-GN-A4U8-11A-11D-A32S-05 ff7431a9-243a-4651-80bb-096379925bbe TCGA-GN-A4U8-11 TCGA-GN-A4U8-11 ff7431a9-243a-4651-80bb-096379925bbe ff7431a9-243a-4651-80bb-096379925bbe +TCGA-GN-A4U9-06 TCGA-GN-A4U9-06 TCGA-GN-A4U9 TCGA Melanoma (SKCM) skin cutaneous melanoma Skin NO|YES|NO YES|NO|NO 71 TCGA-GN-A4U9-F61269 TCGA-GN-A4U9 TCGA-GN-A4U9-06A 1.7 -26118 167 673 0 384 384|503|579 60 2014-6-26 MALE 176 No C77.4 8720/3 C77.4 YES 170 NO NO 5 IV Non-glabrous skin YES Distant Metastasis|Distant Metastasis|Distant Metastasis NO NO|NO|NO YES Other, Specify|Lung|Other, Specify infra-hilumliver and intestine false No M0 N3 T2b Stage IIIC TCGA-GN-A4U9.13096A76-D4DF-412C-B713-B2BB538B23DA.pdf A4U9 WITH TUMOR YES 1 1 YES NO NO Metastatic 06 NO 7th NO YES GN Regional Lymph Node A DECEASED 104 2012 5a2bb92e-0429-42c3-90af-816fff63e202 TCGA-GN-A4U9-06A-11D-A32S-05 5a2bb92e-0429-42c3-90af-816fff63e202 TCGA-GN-A4U9-06 TCGA-GN-A4U9-06A-11D-A32M-01 TCGA-GN-A4U9-06 EEEB730F-49AC-4309-A96D-58999A4BD1C1 TCGA-GN-A4U9-06A-11D-A32N-08 TCGA-GN-A4U9-06A-11D-A32M-01 5a2bb92e-0429-42c3-90af-816fff63e202 5a2bb92e-0429-42c3-90af-816fff63e202 +TCGA-GN-A8LK-06 TCGA-GN-A8LK-06 TCGA-GN-A8LK TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 70 TCGA-GN-A8LK TCGA-GN-A8LK-06A 0.7 -25725 1456 1524 0 1083 Lung 2014-4-3 MALE 175 No C34.3 8720/3 C34.3 YES 120 NO 0 IV Non-glabrous skin NO YES YES true No NX T1b Stage IB TCGA-GN-A8LK.37CF73D1-6A5A-4675-A4C6-B477248C4FA1.pdf A8LK WITH TUMOR NO 1 1 YES NO NO Metastatic 06 6th NO YES GN Distant Metastasis A DECEASED 93 2009 122a3171-ae69-4f0b-874d-8563ad05a510 TCGA-GN-A8LK-06A-11D-A373-05 122a3171-ae69-4f0b-874d-8563ad05a510 TCGA-GN-A8LK-06 TCGA-GN-A8LK-06A-11D-A371-01 TCGA-GN-A8LK-06 660524D1-D092-4EFE-83E7-DFA4D44B8B7A TCGA-GN-A8LK-06A-11D-A372-08 TCGA-GN-A8LK-06A-11D-A371-01 122a3171-ae69-4f0b-874d-8563ad05a510 122a3171-ae69-4f0b-874d-8563ad05a510 +TCGA-GN-A8LL-06 TCGA-GN-A8LL-06 TCGA-GN-A8LL TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 68 TCGA-GN-A8LL TCGA-GN-A8LL-06A 5 -25000 593 650 0 209 Left Groin Lymph Node 2014-4-1 FEMALE 154 No C77.5 8720/3 C77.5 YES 210 NO Non-glabrous skin YES YES true No M0 NX T4b Stage IIC TCGA-GN-A8LL.B7B7B00E-578B-49B5-9250-A75C6A1C2933.pdf A8LL WITH TUMOR NO YES NO NO Metastatic 06 7th NO YES GN Regional Lymph Node A DECEASED 89 2012 c4e94980-3db3-4190-92cf-b2c562c664de TCGA-GN-A8LL-06A-21D-A373-05 c4e94980-3db3-4190-92cf-b2c562c664de TCGA-GN-A8LL-06 TCGA-GN-A8LL-06A-21D-A371-01 TCGA-GN-A8LL-06 E85EB069-656D-4305-8B48-3C7C4FBFB090 TCGA-GN-A8LL-06A-21D-A372-08 TCGA-GN-A8LL-06A-21D-A371-01 c4e94980-3db3-4190-92cf-b2c562c664de c4e94980-3db3-4190-92cf-b2c562c664de +TCGA-GN-A8LN-01 TCGA-GN-A8LN-01 TCGA-GN-A8LN TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 68 TCGA-GN-A8LN-F72288 TCGA-GN-A8LN TCGA-GN-A8LN-01A 4.85 -24872 247 0 772 24 2015-5-4 MALE 180 No C77.5 8720/3 C77.5 YES 140 NO NO 1.6 IV Non-glabrous skin YES NO NO true No M0 NX T4b Stage IIC TCGA-GN-A8LN.D6200075-438B-4BB6-A5A1-E1919FBEF131.pdf A8LN WITH TUMOR NO 1 1 YES NO NO Primary Tumor 01 NO 7th NO YES GN Primary Tumor A LIVING 108 2013 7cdb2990-a8b2-4a0c-b7ed-80e65fef466a TCGA-GN-A8LN-01A-11D-A373-05 7cdb2990-a8b2-4a0c-b7ed-80e65fef466a TCGA-GN-A8LN-01 TCGA-GN-A8LN-01 BBDCF631-21DC-43D6-89CB-D22C3ECE2CF2 TCGA-GN-A8LN-01A-11D-A372-08 7cdb2990-a8b2-4a0c-b7ed-80e65fef466a 7cdb2990-a8b2-4a0c-b7ed-80e65fef466a +TCGA-GN-A9SD-06 TCGA-GN-A9SD-06 TCGA-GN-A9SD TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 59 TCGA-GN-A9SD TCGA-GN-A9SD-06A 0.5 -21851 1757 1807 0 1366 2014-6-26 FEMALE 158 Yes C77.4 8720/3 C77.4 YES 170 NO 1 III Non-glabrous skin NO YES YES true No M0 NX T1a Stage IA TCGA-GN-A9SD.5DB9F1BC-9654-4F38-90E4-2F93237E357C.pdf A9SD WITH TUMOR YES 1 1 YES NO NO Metastatic 06 6th NO YES GN Regional Lymph Node A DECEASED 97 2009 c7636fd5-9a24-4035-b6bd-beddb590a4ee TCGA-GN-A9SD-06A-11D-A408-05 c7636fd5-9a24-4035-b6bd-beddb590a4ee TCGA-GN-A9SD-06 TCGA-GN-A9SD-06A-11D-A400-01 TCGA-GN-A9SD-06 977BAFA6-2180-486B-BDCA-F443B6D54711 TCGA-GN-A9SD-06A-11D-A401-08 TCGA-GN-A9SD-06A-11D-A400-01 c7636fd5-9a24-4035-b6bd-beddb590a4ee c7636fd5-9a24-4035-b6bd-beddb590a4ee +TCGA-HR-A2OG-01 TCGA-HR-A2OG-01 TCGA-HR-A2OG TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 50 TCGA-HR-A2OG-F35941 TCGA-HR-A2OG -21767 0 7 0 Right Thigh (Subcutaneous Tissue) 2012-10-16 FEMALE No C44.6 8720/3 C44.6 YES YES Non-glabrous skin YES No A2OG TUMOR FREE NO 1 YES NO NO NO YES HR Distant Metastasis LIVING TCGA-HR-A2OG-01A-21D-A197-08 +TCGA-HR-A2OG-06 TCGA-HR-A2OG-06 TCGA-HR-A2OG TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 50 TCGA-HR-A2OG-F35941 TCGA-HR-A2OG TCGA-HR-A2OG-06A -21767 0 7 0 Right Thigh (Subcutaneous Tissue) 2012-10-16 FEMALE No C44.6 8720/3 C44.6 YES 340 NO YES Non-glabrous skin YES false No TCGA-HR-A2OG.08CD8EB8-B0B1-4328-92A8-C4AB10A38202.pdf A2OG TUMOR FREE NO 1 YES NO NO Metastatic 06 NO YES HR Distant Metastasis A LIVING cecff6a7-eb65-4ad2-b801-11340a75d93d TCGA-HR-A2OG-06A-21D-A19C-05 cecff6a7-eb65-4ad2-b801-11340a75d93d TCGA-HR-A2OG-06 TCGA-HR-A2OG-06A-21D-A191-01 TCGA-HR-A2OG-06 666B440D-5131-44CF-B4A6-31E9E70C4A3A TCGA-HR-A2OG-06A-21D-A197-08 TCGA-HR-A2OG-06A-21D-A197-08 TCGA-HR-A2OG-06A-21D-A191-01 cecff6a7-eb65-4ad2-b801-11340a75d93d cecff6a7-eb65-4ad2-b801-11340a75d93d +TCGA-HR-A2OH-01 TCGA-HR-A2OH-01 TCGA-HR-A2OH TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 46 TCGA-HR-A2OH-F35732 TCGA-HR-A2OH 3.4 -16910 2004 0 1523 left adnexa/ pelvic side wall 2012-10-16 FEMALE 169 No C76.3 8720/3 C76.3 YES YES Normal NO Non-glabrous skin YES NO No M0 N2a T3b Stage IIIB A2OH WITH TUMOR YES 1 1 YES NO Interferon YES NO 6th NO YES HR Distant Metastasis DECEASED TCGA-HR-A2OH-01A-11D-A197-08 +TCGA-HR-A2OH-06 TCGA-HR-A2OH-06 TCGA-HR-A2OH TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 46 TCGA-HR-A2OH-F35732 TCGA-HR-A2OH TCGA-HR-A2OH-06A 3.4 -16910 2004 0 1523 left adnexa/ pelvic side wall 2012-10-16 FEMALE 169 No C76.3 8720/3 C76.3 YES 370 YES NO Normal NO Non-glabrous skin YES NO false No M0 N2a T3b Stage IIIB TCGA-HR-A2OH.78BAE58A-AA05-4234-AB26-5C3A373741D4.pdf A2OH WITH TUMOR YES 1 1 YES NO Interferon YES Metastatic 06 NO 6th NO YES HR Distant Metastasis A DECEASED 973491e1-8cb1-4a4e-9df9-dc31b95804c1 TCGA-HR-A2OH-06A-11D-A19C-05 973491e1-8cb1-4a4e-9df9-dc31b95804c1 TCGA-HR-A2OH-06 TCGA-HR-A2OH-06A-11D-A191-01 TCGA-HR-A2OH-06 B63E3BE0-19B2-400E-A42C-97435F54A43D TCGA-HR-A2OH-06A-11D-A197-08 TCGA-HR-A2OH-06A-11D-A197-08 TCGA-HR-A2OH-06A-11D-A191-01 973491e1-8cb1-4a4e-9df9-dc31b95804c1 973491e1-8cb1-4a4e-9df9-dc31b95804c1 +TCGA-HR-A5NC-01 TCGA-HR-A5NC-01 TCGA-HR-A5NC TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 90 TCGA-HR-A5NC-F70729 TCGA-HR-A5NC TCGA-HR-A5NC-01A 8 -32872 0 1000 0 2015-3-2 FEMALE 152 No C44.5 8720/3 C44.5 YES 150 NO YES V Non-glabrous skin NO YES false No M0 NX T4 TCGA-HR-A5NC.B8892054-09BB-4E2F-90FC-E84EBA310C7D.pdf A5NC TUMOR FREE NO 1 1 YES NO NO Primary Tumor 01 6th NO YES HR Primary Tumor A LIVING d301aa79-d2c6-462e-883f-fd4130e1d0f6 TCGA-HR-A5NC-01A-11D-A27L-05 d301aa79-d2c6-462e-883f-fd4130e1d0f6 TCGA-HR-A5NC-01 TCGA-HR-A5NC-01 6A009F81-26FB-4EA6-B70D-F2BD83857CEE TCGA-HR-A5NC-01A-11D-A27K-08 d301aa79-d2c6-462e-883f-fd4130e1d0f6 d301aa79-d2c6-462e-883f-fd4130e1d0f6 +TCGA-IH-A3EA-01 TCGA-IH-A3EA-01 TCGA-IH-A3EA TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 61 TCGA-IH-A3EA-F39720 TCGA-IH-A3EA TCGA-IH-A3EA-01A -22577 1119 0 524 141 2013-1-31 MALE 175 No C44.4 8721/3 C44.4 YES 90 NO YES Non-glabrous skin YES NO YES true No M0 N0 T4b Stage IIC TCGA-IH-A3EA.EA214BC5-6B10-41AF-B29A-3D52EDA21CCC.pdf A3EA WITH TUMOR NO YES NO Primary Tumor 01 6th NO YES IH Primary Tumor A LIVING 81 2008 6fc0166f-628f-4ff4-9f50-99ecc4c54337 TCGA-IH-A3EA-01A-11D-A211-05 6fc0166f-628f-4ff4-9f50-99ecc4c54337 TCGA-IH-A3EA-01 TCGA-IH-A3EA-01 AF410FB4-4798-4931-B432-181F62FAC451 TCGA-IH-A3EA-01A-11D-A20D-08 TCGA-IH-A3EA-01A-11D-A20D-08 TCGA-IH-A3EA-01A-11D-A20D-08 6fc0166f-628f-4ff4-9f50-99ecc4c54337 6fc0166f-628f-4ff4-9f50-99ecc4c54337 +TCGA-LH-A9QB-06 TCGA-LH-A9QB-06 TCGA-LH-A9QB TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 24 TCGA-LH-A9QB-F69191 TCGA-LH-A9QB TCGA-LH-A9QB-06A -9058 10915 0 11217 10847 Soft tissue, right axilla 2014-12-30 FEMALE 160 No C44.5 8720/3 C44.5 YES 760 NO NO III Non-glabrous skin NO NO true No TCGA-LH-A9QB.887B3F48-DB76-471A-A270-7E76ABD4E001.pdf A9QB TUMOR FREE NO 1 1 YES NO NO Metastatic 06 NO 2nd YES NO LH Distant Metastasis A LIVING 86 1984 f955924e-fe7b-4998-b2ad-066113fa1bcb TCGA-LH-A9QB-06A-11D-A38H-05 f955924e-fe7b-4998-b2ad-066113fa1bcb TCGA-LH-A9QB-06 TCGA-LH-A9QB-06A-11D-A38F-01 TCGA-LH-A9QB-06 61F00913-66FC-4B0E-9014-1DDFE3286AEB TCGA-LH-A9QB-06A-11D-A38G-08 TCGA-LH-A9QB-06A-11D-A38F-01 f955924e-fe7b-4998-b2ad-066113fa1bcb f955924e-fe7b-4998-b2ad-066113fa1bcb +TCGA-OD-A75X-06 TCGA-OD-A75X-06 TCGA-OD-A75X TCGA Melanoma (SKCM) skin cutaneous melanoma Skin NO|NO|NO YES|NO|NO 49 TCGA-OD-A75X-F66395 TCGA-OD-A75X TCGA-OD-A75X-06A -17910 8926 9061 0 8966 9011 8987|9044|9045 8630 left upper lung lobe 2014-10-16 MALE 182 No C34.1 8720/3 C34.1 YES 390 NO NO Non-glabrous skin Distant Metastasis|Distant Metastasis|Distant Metastasis YES|NO|NO YES Brain|Other, Specify|Lung |stomach| true No M0 NX TX TCGA-OD-A75X.ADB81B04-707A-48A3-ACCF-685BC6908F93.pdf A75X WITH TUMOR NO 1 YES NO NO Metastatic 06 NO 3rd YES NO OD Distant Metastasis A DECEASED 103 1989 4eadf1bf-2a42-4de6-9710-86350c2fe144 TCGA-OD-A75X-06A-12D-A32S-05 4eadf1bf-2a42-4de6-9710-86350c2fe144 TCGA-OD-A75X-06 TCGA-OD-A75X-06A-12D-A32M-01 TCGA-OD-A75X-06 1DFDB2CC-6483-4781-B68F-B83E284132A7 TCGA-OD-A75X-06A-12D-A32N-08 TCGA-OD-A75X-06A-12D-A32M-01 4eadf1bf-2a42-4de6-9710-86350c2fe144 4eadf1bf-2a42-4de6-9710-86350c2fe144 +TCGA-QB-A6FS-06 TCGA-QB-A6FS-06 TCGA-QB-A6FS TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 49 TCGA-QB-A6FS-F67064 TCGA-QB-A6FS TCGA-QB-A6FS-06A -18134 114 0 220 27 2014-10-30 MALE 184 No C77.4 8720/3 C77.4 YES 750 NO NO NO NO true No M0 N3 T0 Stage IIIC TCGA-QB-A6FS.FEB2C1FD-2611-41B3-A240-666D61B9A580.pdf A6FS WITH TUMOR NO NO NO Metastatic 06 NO 7th YES NO QB Regional Lymph Node A LIVING 78 2013 702fd339-2f1b-4db8-8948-8a58f69f53fb TCGA-QB-A6FS-06A-11D-A30Z-05 702fd339-2f1b-4db8-8948-8a58f69f53fb TCGA-QB-A6FS-06 TCGA-QB-A6FS-06A-11D-A30W-01 TCGA-QB-A6FS-06 979D522F-5A29-449C-82CA-ED044FCE9C23 TCGA-QB-A6FS-06A-11D-A30X-08 TCGA-QB-A6FS-06A-11D-A30X-08 TCGA-QB-A6FS-06A-11D-A30W-01 702fd339-2f1b-4db8-8948-8a58f69f53fb 702fd339-2f1b-4db8-8948-8a58f69f53fb +TCGA-QB-AA9O-06 TCGA-QB-AA9O-06 TCGA-QB-AA9O TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 73 TCGA-QB-AA9O TCGA-QB-AA9O-06A -27009 465 549 0 0 2014-6-12 MALE 180 No C49.1 8720/3 C49.1 YES 50 NO YES true Yes M0 N3 TX Stage IIIC TCGA-QB-AA9O.29D0A7CE-8D23-4433-B857-8348A03475C8.pdf AA9O WITH TUMOR YES NO NO Metastatic 06 7th NO YES QB Regional Lymph Node A DECEASED 119 2012 22023637-13d9-45d0-9641-0a6bf3eb9e53 TCGA-QB-AA9O-06A-11D-A398-05 22023637-13d9-45d0-9641-0a6bf3eb9e53 TCGA-QB-AA9O-06 TCGA-QB-AA9O-06A-11D-A396-01 TCGA-QB-AA9O-06 TCGA-QB-AA9O-06A-11D-A397-08 TCGA-QB-AA9O-06A-11D-A396-01 22023637-13d9-45d0-9641-0a6bf3eb9e53 22023637-13d9-45d0-9641-0a6bf3eb9e53 +TCGA-RP-A690-06 TCGA-RP-A690-06 TCGA-RP-A690 TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 66 TCGA-RP-A690-F71472 TCGA-RP-A690 TCGA-RP-A690-06A -24450 2858 0 6 0 spinal cord 2015-3-25 FEMALE 162 No C72.0 8720/3 C72.0 YES 80 NO YES Non-glabrous skin true No TCGA-RP-A690.91AC7534-6DD2-4048-B217-0A0704C18339.pdf A690 TUMOR FREE 1 NO Metastatic 06 6th NO YES RP Distant Metastasis A LIVING 49 2005 0e4d53ba-dd42-41b7-bcfe-ff8b9b5dab07 TCGA-RP-A690-06A-11D-A30Z-05 0e4d53ba-dd42-41b7-bcfe-ff8b9b5dab07 TCGA-RP-A690-06 TCGA-RP-A690-06A-11D-A30W-01 TCGA-RP-A690-06 TCGA-RP-A690-06A-11D-A30X-08 TCGA-RP-A690-06A-11D-A30X-08 TCGA-RP-A690-06A-11D-A30W-01 0e4d53ba-dd42-41b7-bcfe-ff8b9b5dab07 0e4d53ba-dd42-41b7-bcfe-ff8b9b5dab07 +TCGA-RP-A693-06 TCGA-RP-A693-06 TCGA-RP-A693 TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 77 TCGA-RP-A693-F71186 TCGA-RP-A693 TCGA-RP-A693-06A -28394 1585 0 10 0 Brain 2015-3-20 MALE 178 No C71.9 8720/3 C71.9 YES 160 NO YES Non-glabrous skin NO true No M1c NX TX Stage IV TCGA-RP-A693.1BC61B6F-622F-4D98-BBDB-7E48B0271318.pdf A693 TUMOR FREE NO NO NO Metastatic 06 6th NO YES RP Distant Metastasis A LIVING 81 2008 d48d8c30-082c-4cbe-a26e-db4f9652b5c2 TCGA-RP-A693-06A-13D-A30Z-05 d48d8c30-082c-4cbe-a26e-db4f9652b5c2 TCGA-RP-A693-06 TCGA-RP-A693-06A-13D-A30W-01 TCGA-RP-A693-06 900AD04B-6D4A-4C1A-91D4-77DAC2D2B002 TCGA-RP-A693-06A-13D-A30X-08 TCGA-RP-A693-06A-13D-A30X-08 TCGA-RP-A693-06A-13D-A30W-01 d48d8c30-082c-4cbe-a26e-db4f9652b5c2 d48d8c30-082c-4cbe-a26e-db4f9652b5c2 +TCGA-RP-A694-06 TCGA-RP-A694-06 TCGA-RP-A694 TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 71 TCGA-RP-A694-F71187 TCGA-RP-A694 TCGA-RP-A694-06A -26044 1456 0 21 0 brain 2015-3-20 MALE 185 No C71.3 8720/3 C71.3 YES 110 NO YES Non-glabrous skin NO true No M1c NX TX Stage IV TCGA-RP-A694.3A14A7BA-1435-4A30-878D-ED7591B67227.pdf A694 TUMOR FREE NO NO NO Metastatic 06 6th NO YES RP Distant Metastasis A LIVING 99 2009 daf9b208-dd9e-4281-89f6-ea9d7d0eda7e TCGA-RP-A694-06A-11D-A30Z-05 daf9b208-dd9e-4281-89f6-ea9d7d0eda7e TCGA-RP-A694-06 TCGA-RP-A694-06A-11D-A30W-01 TCGA-RP-A694-06 847E0013-0173-4519-98BA-BC923F7801B1 TCGA-RP-A694-06A-11D-A30X-08 TCGA-RP-A694-06A-11D-A30X-08 TCGA-RP-A694-06A-11D-A30W-01 daf9b208-dd9e-4281-89f6-ea9d7d0eda7e daf9b208-dd9e-4281-89f6-ea9d7d0eda7e +TCGA-RP-A695-06 TCGA-RP-A695-06 TCGA-RP-A695 TCGA Melanoma (SKCM) skin cutaneous melanoma Skin TCGA-RP-A695-F71188 TCGA-RP-A695 TCGA-RP-A695-06A brain 2015-3-20 MALE 182 No C71.9 8720/3 C71.9 YES 130 NO YES Non-glabrous skin YES true No M1c NX TX Stage IV TCGA-RP-A695.7C850C79-9129-4730-8C76-9FE4EEDBBEA7.pdf A695 TUMOR FREE NO 1 YES NO NO Metastatic 06 5th NO YES RP Distant Metastasis A LIVING 95 1999 ef3db400-ac1d-42e2-ad80-47cda1baa489 TCGA-RP-A695-06A-11D-A30Z-05 ef3db400-ac1d-42e2-ad80-47cda1baa489 TCGA-RP-A695-06 TCGA-RP-A695-06A-11D-A30W-01 TCGA-RP-A695-06 494EF8E1-53EF-42F4-AEA4-5E2A92912AA8 TCGA-RP-A695-06A-11D-A30X-08 TCGA-RP-A695-06A-11D-A30X-08 TCGA-RP-A695-06A-11D-A30W-01 ef3db400-ac1d-42e2-ad80-47cda1baa489 ef3db400-ac1d-42e2-ad80-47cda1baa489 +TCGA-RP-A6K9-06 TCGA-RP-A6K9-06 TCGA-RP-A6K9 TCGA Melanoma (SKCM) skin cutaneous melanoma Skin TCGA-RP-A6K9-F68330 TCGA-RP-A6K9 TCGA-RP-A6K9-06A posterior skull 2014-11-14 FEMALE 162 No C41.0 8720/3 C41.0 YES 560 NO YES Non-glabrous skin YES YES true No TCGA-RP-A6K9.D5597CA4-9FD6-49BA-AC66-B6BFAAA1592A.pdf A6K9 YES Chemotherapy NO Metastatic 06 5th NO YES RP Distant Metastasis A LIVING 48 2001 6bf0259e-8b61-4b97-97a3-ccea8a0fa44f TCGA-RP-A6K9-06A-41D-A34V-05 6bf0259e-8b61-4b97-97a3-ccea8a0fa44f TCGA-RP-A6K9-06 TCGA-RP-A6K9-06A-41D-A34T-01 TCGA-RP-A6K9-06 78D0B3FD-7991-4EEE-858F-FD66440F77EF TCGA-RP-A6K9-06A-41D-A34U-08 TCGA-RP-A6K9-06A-41D-A34T-01 6bf0259e-8b61-4b97-97a3-ccea8a0fa44f 6bf0259e-8b61-4b97-97a3-ccea8a0fa44f +TCGA-W3-A824-06 TCGA-W3-A824-06 TCGA-W3-A824 TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 63 TCGA-W3-A824-F64489 TCGA-W3-A824 TCGA-W3-A824-06A 1.5 -23131 6686 0 6940 6940|6940 1461 2014-9-26 MALE 170 No C77.3 8720/3 C77.3 YES 80 NO NO Non-glabrous skin |Other, specify Distant Metastasis| |Adenocarcinoma NO YES Liver| true No M0 N0 T2 Stage I TCGA-W3-A824.E8E86625-8D7E-419F-A4BB-86499B9E4E88.pdf A824 WITH TUMOR YES YES NO NO Metastatic 06 YES 4th NO YES W3 Regional Lymph Node A LIVING 79 1995 2535f39c-5024-4596-8e96-76ccae28e9ca TCGA-W3-A824-06A-21D-A34V-05 2535f39c-5024-4596-8e96-76ccae28e9ca TCGA-W3-A824-06 TCGA-W3-A824-06A-21D-A34T-01 TCGA-W3-A824-06 TCGA-W3-A824-06A-21D-A34U-08 TCGA-W3-A824-06A-21D-A34T-01 2535f39c-5024-4596-8e96-76ccae28e9ca 2535f39c-5024-4596-8e96-76ccae28e9ca +TCGA-W3-A825-06 TCGA-W3-A825-06 TCGA-W3-A825 TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 60 TCGA-W3-A825 TCGA-W3-A825-06A 1.3 -22097 5651 1917 0 1644 Lung 2014-3-31 FEMALE 162 No C34.3 8720/3 C34.3 YES 70 NO IV Non-glabrous skin YES true No M0 N0 T3 Stage II TCGA-W3-A825.B8EDB8FD-8FB4-4245-A218-E8CF051497E5.pdf A825 WITH TUMOR YES 1 YES NO NO Metastatic 06 5th NO YES W3 Distant Metastasis A DECEASED 77 1998 2553c98d-ef57-4a19-881a-556c5aca29b4 TCGA-W3-A825-06A-11D-A34V-05 2553c98d-ef57-4a19-881a-556c5aca29b4 TCGA-W3-A825-06 TCGA-W3-A825-06A-11D-A34T-01 TCGA-W3-A825-06 TCGA-W3-A825-06A-11D-A34U-08 TCGA-W3-A825-06A-11D-A34T-01 2553c98d-ef57-4a19-881a-556c5aca29b4 2553c98d-ef57-4a19-881a-556c5aca29b4 +TCGA-W3-A828-06 TCGA-W3-A828-06 TCGA-W3-A828 TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 66 TCGA-W3-A828 0.5 -24258 3683 0 1857 Lung 2014-3-31 MALE 180 No C34.3 8772/0 C34.3 YES 3 IV Non-glabrous skin NO YES No M0 N0 T3 Stage II A828 YES YES NO NO Metastatic 06 4th NO YES W3 Distant Metastasis DECEASED 91 1997 af11c773-592d-436b-9045-66985689345c TCGA-W3-A828-06A-11D-A34V-05 af11c773-592d-436b-9045-66985689345c TCGA-W3-A828-06 TCGA-W3-A828-06A-11D-A34T-01 TCGA-W3-A828-06 TCGA-W3-A828-06A-11D-A34U-08 TCGA-W3-A828-06A-11D-A34T-01 af11c773-592d-436b-9045-66985689345c af11c773-592d-436b-9045-66985689345c +TCGA-W3-AA1O-06 TCGA-W3-AA1O-06 TCGA-W3-AA1O TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 85 TCGA-W3-AA1O TCGA-W3-AA1O-06A -31351 6123 122 0 31 2014-7-9 MALE 183 No C77.3 8720/3 C77.3 YES 100 NO NO true No M0 N2 TX Stage III TCGA-W3-AA1O.4D210AC6-A8D1-4AA0-8930-B98E81B5FC9F.pdf AA1O WITH TUMOR YES NO NO Metastatic 06 4th NO YES W3 Regional Lymph Node A DECEASED 89 1997 cb797021-9c9f-483c-88b8-0dc876fea489 TCGA-W3-AA1O-06A-11D-A38H-05 cb797021-9c9f-483c-88b8-0dc876fea489 TCGA-W3-AA1O-06 TCGA-W3-AA1O-06A-11D-A38F-01 TCGA-W3-AA1O-06 FBE593C9-B00F-418B-8E99-D06D03D016E7 TCGA-W3-AA1O-06A-11D-A38G-08 TCGA-W3-AA1O-06A-11D-A38F-01 cb797021-9c9f-483c-88b8-0dc876fea489 cb797021-9c9f-483c-88b8-0dc876fea489 +TCGA-W3-AA1Q-06 TCGA-W3-AA1Q-06 TCGA-W3-AA1Q TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 57 TCGA-W3-AA1Q TCGA-W3-AA1Q-06A -21033 6944 2101 0 882 Adrenal Gland 2014-7-17 MALE 178 No C74.9 8720/3 C74.9 YES 90 NO Non-glabrous skin YES true No M0 N1 TX Stage III TCGA-W3-AA1Q.A4B45987-C6B8-4CA0-8CCA-FAE49C1A6EB1.pdf AA1Q WITH TUMOR YES NO NO Metastatic 06 4th NO YES W3 Distant Metastasis A DECEASED 73 1994 e1d52c4c-7521-496a-b91d-3facafe4716b TCGA-W3-AA1Q-06A-11D-A38H-05 e1d52c4c-7521-496a-b91d-3facafe4716b TCGA-W3-AA1Q-06 TCGA-W3-AA1Q-06A-11D-A38F-01 TCGA-W3-AA1Q-06 093E5FE8-0C64-48FF-B042-F7F0EE1BA20C TCGA-W3-AA1Q-06A-11D-A38G-08 TCGA-W3-AA1Q-06A-11D-A38F-01 e1d52c4c-7521-496a-b91d-3facafe4716b e1d52c4c-7521-496a-b91d-3facafe4716b +TCGA-W3-AA1R-06 TCGA-W3-AA1R-06 TCGA-W3-AA1R TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 71 TCGA-W3-AA1R -26145 3379 0 761 2014-7-17 MALE 180 No C77.0 8720/3 C77.0 YES 5.5 V Non-glabrous skin NO YES No M0 N0 T3 Stage II AA1R WITH TUMOR YES YES NO NO Metastatic 06 4th NO YES W3 Regional Lymph Node DECEASED 86 1995 f6677842-9fa2-4d4e-8ef1-06610311eecd TCGA-W3-AA1R-06A-11D-A398-05 f6677842-9fa2-4d4e-8ef1-06610311eecd TCGA-W3-AA1R-06 TCGA-W3-AA1R-06A-11D-A396-01 TCGA-W3-AA1R-06 TCGA-W3-AA1R-06A-11D-A397-08 TCGA-W3-AA1R-06A-11D-A396-01 f6677842-9fa2-4d4e-8ef1-06610311eecd f6677842-9fa2-4d4e-8ef1-06610311eecd +TCGA-W3-AA1V-06 TCGA-W3-AA1V-06 TCGA-W3-AA1V TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 63 TCGA-W3-AA1V TCGA-W3-AA1V-06B 1.3 -23314 7097 1280 0 946 2014-7-17 MALE 180 No C77.3 8720/3 C77.3 YES 60 NO IV Non-glabrous skin NO NO YES true No M0 N0 T3 Stage II TCGA-W3-AA1V.11DF82C1-C746-4D00-9119-1FEBE3FBC0A2.pdf AA1V WITH TUMOR YES 1 YES NO NO Metastatic 06 4th NO YES W3 Regional Lymph Node B DECEASED 91 1994 01c6644f-c721-4f5e-afbc-c220218941d8 TCGA-W3-AA1V-06B-11D-A408-05 01c6644f-c721-4f5e-afbc-c220218941d8 TCGA-W3-AA1V-06 TCGA-W3-AA1V-06B-11D-A400-01 TCGA-W3-AA1V-06 TCGA-W3-AA1V-06B-11D-A401-08 TCGA-W3-AA1V-06B-11D-A400-01 01c6644f-c721-4f5e-afbc-c220218941d8 01c6644f-c721-4f5e-afbc-c220218941d8 +TCGA-W3-AA1W-06 TCGA-W3-AA1W-06 TCGA-W3-AA1W TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 64 TCGA-W3-AA1W-F64495 TCGA-W3-AA1W TCGA-W3-AA1W-06A 1.54 -23711 6427 0 6666 1034 Periaortic Lymph Nodes 2014-9-23 MALE 170 Yes C77.2 8720/3 C77.2 YES 40 YES NO NO 0 IV Non-glabrous skin NO YES NO true No M0 N0 T3 Stage II TCGA-W3-AA1W.1DF225A2-C9D3-449B-BEAC-35A685E30A38.pdf AA1W TUMOR FREE YES YES NO Interferon YES Metastatic 06 NO 4th NO YES W3 Distant Metastasis A LIVING 101 1996 050132b1-5052-4af0-bfc0-fae1b5f0f15a TCGA-W3-AA1W-06A-11D-A38H-05 050132b1-5052-4af0-bfc0-fae1b5f0f15a TCGA-W3-AA1W-06 TCGA-W3-AA1W-06A-11D-A38F-01 TCGA-W3-AA1W-06 TCGA-W3-AA1W-06A-11D-A38G-08 TCGA-W3-AA1W-06A-11D-A38F-01 050132b1-5052-4af0-bfc0-fae1b5f0f15a 050132b1-5052-4af0-bfc0-fae1b5f0f15a +TCGA-W3-AA21-06 TCGA-W3-AA21-06 TCGA-W3-AA21 TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 26 TCGA-W3-AA21 TCGA-W3-AA21-06A 1.1 -9527 7127 3195 0 1035 2014-7-17 MALE 175 No C77.3 8720/3 C77.3 YES 50 NO 3 III Non-glabrous skin NO NO YES true No M0 N0 T2 Stage I TCGA-W3-AA21.045B3EAC-1D48-4902-B1F3-54CF1DB34E48.pdf AA21 WITH TUMOR YES YES NO NO Metastatic 06 4th NO YES W3 Regional Lymph Node A DECEASED 99 1994 430b47b5-5751-4443-8c73-642f79fc1ccd TCGA-W3-AA21-06A-11D-A38H-05 430b47b5-5751-4443-8c73-642f79fc1ccd TCGA-W3-AA21-06 TCGA-W3-AA21-06A-11D-A38F-01 TCGA-W3-AA21-06 TCGA-W3-AA21-06A-11D-A38G-08 TCGA-W3-AA21-06A-11D-A38F-01 430b47b5-5751-4443-8c73-642f79fc1ccd 430b47b5-5751-4443-8c73-642f79fc1ccd +TCGA-WE-A8JZ-06 TCGA-WE-A8JZ-06 TCGA-WE-A8JZ TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 70 TCGA-WE-A8JZ-F63158 TCGA-WE-A8JZ TCGA-WE-A8JZ-06A 14 -25884 642 0 731 371 2014-11-3 MALE No C77.4 8721/3 C77.4 YES 120 NO YES 9 Non-glabrous skin YES YES true No M0 N1a T4b Stage IIIB TCGA-WE-A8JZ.4B38EB1A-A675-4BA7-ADD2-C12E46F5BB38.pdf A8JZ TUMOR FREE YES 1 2 YES YES NO Metastatic 06 7th YES NO WE Regional Lymph Node A LIVING 2012 7b989b5a-5fa8-4996-afe7-1d1192d82437 TCGA-WE-A8JZ-06A-11D-A373-05 7b989b5a-5fa8-4996-afe7-1d1192d82437 TCGA-WE-A8JZ-06 TCGA-WE-A8JZ-06A-11D-A371-01 TCGA-WE-A8JZ-06 C1B7CCE7-9433-4B22-852D-CA5ACAB6A534 TCGA-WE-A8JZ-06A-11D-A372-08 TCGA-WE-A8JZ-06A-11D-A371-01 7b989b5a-5fa8-4996-afe7-1d1192d82437 7b989b5a-5fa8-4996-afe7-1d1192d82437 +TCGA-WE-A8K1-06 TCGA-WE-A8K1-06 TCGA-WE-A8K1 TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 74 TCGA-WE-A8K1-F64596 TCGA-WE-A8K1 TCGA-WE-A8K1-06A 3 -27191 1140 0 1492 1006 2014-11-3 MALE No C49.20 8743/3 C49.2 YES 110 NO NO 5 Non-glabrous skin YES NO true No M0 N3 T3b Stage IIIC TCGA-WE-A8K1.3BB08AA2-7C56-4C47-B587-400C73DA930E.pdf A8K1 TUMOR FREE NO 1 1 YES NO NO Metastatic 06 NO 7th YES NO WE Regional Cutaneous or Subcutaneous Tissue (includes satellite and in-transit metastasis) A LIVING 2010 652715e1-ffe5-4913-9dce-457f8ed8c337 TCGA-WE-A8K1-06A-21D-A373-05 652715e1-ffe5-4913-9dce-457f8ed8c337 TCGA-WE-A8K1-06 TCGA-WE-A8K1-06A-21D-A371-01 TCGA-WE-A8K1-06 31BCB1AD-7CDA-4DFD-977D-C00600C769CA TCGA-WE-A8K1-06A-21D-A372-08 TCGA-WE-A8K1-06A-21D-A371-01 652715e1-ffe5-4913-9dce-457f8ed8c337 652715e1-ffe5-4913-9dce-457f8ed8c337 +TCGA-WE-A8K4-01 TCGA-WE-A8K4-01 TCGA-WE-A8K4 TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 85 TCGA-WE-A8K4-F70274 TCGA-WE-A8K4 TCGA-WE-A8K4-01A 12 -31308 203 0 614 0 2015-2-9 MALE No C44.6 8721/3 C44.6 YES 220 NO NO 4 Non-glabrous skin NO true Yes M0 NX T4a Stage IIB TCGA-WE-A8K4.1B421DA3-59DD-4246-8D3B-58F4AE13F36B.pdf A8K4 TUMOR FREE NO 1 1 YES NO NO Primary Tumor 01 NO 7th YES NO WE Primary Tumor A LIVING 2013 0bdb4dc0-c3d9-4a84-8ad3-6b3d3b532eb0 TCGA-WE-A8K4-01A-12D-A373-05 0bdb4dc0-c3d9-4a84-8ad3-6b3d3b532eb0 D478636F-E4BC-4756-892E-36A08ECC5076 TCGA-WE-A8K4-01A-12D-A372-08 0bdb4dc0-c3d9-4a84-8ad3-6b3d3b532eb0 0bdb4dc0-c3d9-4a84-8ad3-6b3d3b532eb0 +TCGA-WE-A8K5-06 TCGA-WE-A8K5-06 TCGA-WE-A8K5 TCGA Melanoma (SKCM) skin cutaneous melanoma Skin YES YES 65 TCGA-WE-A8K5-F67278 TCGA-WE-A8K5 TCGA-WE-A8K5-06A 1.7 -23837 1562 1860 0 1654 1498 1457 2014-11-3 MALE No C49.20 8742/3 C49.2 YES 120 NO NO 12 III Non-glabrous skin NO Distant Metastasis YES Brain true Yes M1c N3 T2a Stage IV TCGA-WE-A8K5.144B09EE-F6F6-4151-A20C-BD2B9243C61F.pdf A8K5 WITH TUMOR NO 1 1 YES NO NO Metastatic 06 NO 6th YES NO WE Regional Cutaneous or Subcutaneous Tissue (includes satellite and in-transit metastasis) A DECEASED 2009 42b44ed6-6b89-478f-a045-0e52d49ed062 TCGA-WE-A8K5-06A-11D-A373-05 42b44ed6-6b89-478f-a045-0e52d49ed062 TCGA-WE-A8K5-06 TCGA-WE-A8K5-06A-11D-A371-01 TCGA-WE-A8K5-06 55DA124E-B496-4005-8DD6-D44E1E3F0315 TCGA-WE-A8K5-06A-11D-A372-08 TCGA-WE-A8K5-06A-11D-A371-01 42b44ed6-6b89-478f-a045-0e52d49ed062 42b44ed6-6b89-478f-a045-0e52d49ed062 +TCGA-WE-A8K6-06 TCGA-WE-A8K6-06 TCGA-WE-A8K6 TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 79 TCGA-WE-A8K6-F70251 TCGA-WE-A8K6 TCGA-WE-A8K6-06A -29216 156 0 546 46 2015-2-9 MALE No C77.4 8720/3 C77.4 YES 440 NO NO Non-glabrous skin NO NO true No M0 N1b TX Stage IIIB TCGA-WE-A8K6.D8730383-F277-40B1-A7F0-D230E4BCD836.pdf A8K6 WITH TUMOR NO 1 1 YES NO NO Metastatic 06 NO 7th YES NO WE Regional Lymph Node A LIVING 2013 c791ef65-1860-4817-9234-15620399255a TCGA-WE-A8K6-06A-11D-A373-05 c791ef65-1860-4817-9234-15620399255a TCGA-WE-A8K6-06 TCGA-WE-A8K6-06A-11D-A371-01 TCGA-WE-A8K6-06 6DD0934A-9609-4E84-B6BD-9F596FD4C5A3 TCGA-WE-A8K6-06A-11D-A372-08 TCGA-WE-A8K6-06A-11D-A371-01 c791ef65-1860-4817-9234-15620399255a c791ef65-1860-4817-9234-15620399255a +TCGA-WE-A8ZM-06 TCGA-WE-A8ZM-06 TCGA-WE-A8ZM TCGA Melanoma (SKCM) skin cutaneous melanoma Skin NO 70 TCGA-WE-A8ZM-F70118 TCGA-WE-A8ZM TCGA-WE-A8ZM-06A -25869 2682 0 3082 3082 2178 2015-2-9 MALE No C49.3 8720/3 C49.3 YES 40 NO NO Non-glabrous skin Locoregional Recurrence YES YES Other, Specify subcutaneous skin chest wall true No M0 N1b TX Stage IIIB TCGA-WE-A8ZM.154EBBD1-E741-40D4-B7AD-F5BDF49DD1C0.pdf A8ZM WITH TUMOR NO 1 1 YES NO YES Metastatic 06 NO 6th NO YES WE Regional Cutaneous or Subcutaneous Tissue (includes satellite and in-transit metastasis) A LIVING 2006 92679a1c-2b16-4b27-841f-e21f5f932f1e TCGA-WE-A8ZM-06A-11D-A373-05 92679a1c-2b16-4b27-841f-e21f5f932f1e TCGA-WE-A8ZM-06 TCGA-WE-A8ZM-06A-11D-A371-01 TCGA-WE-A8ZM-06 TCGA-WE-A8ZM-06A-11D-A372-08 TCGA-WE-A8ZM-06A-11D-A371-01 92679a1c-2b16-4b27-841f-e21f5f932f1e 92679a1c-2b16-4b27-841f-e21f5f932f1e +TCGA-WE-A8ZN-06 TCGA-WE-A8ZN-06 TCGA-WE-A8ZN TCGA Melanoma (SKCM) skin cutaneous melanoma Skin YES|YES|YES|YES|YES|YES NO|NO|NO|NO|NO|NO 57 TCGA-WE-A8ZN-F64415 TCGA-WE-A8ZN TCGA-WE-A8ZN-06A 4.5 -20942 1487 0 1794 1463|1463|1463|1463|1463|1605 1092 2014-9-8 MALE No C77.9 8720/3 C77.9 YES 40 NO NO Non-glabrous skin NO Locoregional Recurrence|Distant Metastasis|Distant Metastasis|Distant Metastasis|Distant Metastasis|Distant Metastasis NO|NO|NO|NO|NO|NO YES |Other, Specify|Other, Specify|Other, Specify|Other, Specify|Brain |skin/subcutaneous tissue|muscle|adrenal glands|thoracic node| true No M0 NX T4a Stage IIB TCGA-WE-A8ZN.BE0832E4-B3D5-4193-96CC-F296F99F96E4.pdf A8ZN WITH TUMOR YES 1 1 YES NO NO Metastatic 06 NO 6th NO YES WE Regional Cutaneous or Subcutaneous Tissue (includes satellite and in-transit metastasis) A LIVING 2009 18310f27-87d8-4c31-bba8-2f80f400ee17 TCGA-WE-A8ZN-06A-11D-A373-05 18310f27-87d8-4c31-bba8-2f80f400ee17 TCGA-WE-A8ZN-06 TCGA-WE-A8ZN-06A-11D-A371-01 TCGA-WE-A8ZN-06 TCGA-WE-A8ZN-06A-11D-A372-08 TCGA-WE-A8ZN-06A-11D-A371-01 18310f27-87d8-4c31-bba8-2f80f400ee17 18310f27-87d8-4c31-bba8-2f80f400ee17 +TCGA-WE-A8ZO-06 TCGA-WE-A8ZO-06 TCGA-WE-A8ZO TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 73 TCGA-WE-A8ZO-F70119 TCGA-WE-A8ZO TCGA-WE-A8ZO-06A 2.4 -26946 1745 0 2145 1408 2015-2-9 FEMALE No C77.4 8743/3 C77.4 YES 320 NO NO 14 IV Non-glabrous skin NO YES NO true No M0 N1b T3a Stage IIIB TCGA-WE-A8ZO.EB6FA57A-000C-4B57-AD4B-59B4D3B4C450.pdf A8ZO TUMOR FREE NO 1 1 YES NO YES Metastatic 06 NO 6th NO YES WE Regional Lymph Node A LIVING 2009 e25942e1-70e7-425d-b2fc-f26e9be00b4a TCGA-WE-A8ZO-06A-11D-A373-05 e25942e1-70e7-425d-b2fc-f26e9be00b4a TCGA-WE-A8ZO-06 TCGA-WE-A8ZO-06A-11D-A371-01 TCGA-WE-A8ZO-06 D622B738-545D-40DE-9610-BFD5FAF364D6 TCGA-WE-A8ZO-06A-11D-A372-08 TCGA-WE-A8ZO-06A-11D-A371-01 e25942e1-70e7-425d-b2fc-f26e9be00b4a e25942e1-70e7-425d-b2fc-f26e9be00b4a +TCGA-WE-A8ZQ-06 TCGA-WE-A8ZQ-06 TCGA-WE-A8ZQ TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 48 TCGA-WE-A8ZQ-F70246 TCGA-WE-A8ZQ TCGA-WE-A8ZQ-06A 2.3 -17824 1518 0 1923 1479 2015-2-9 MALE No C77.4 8721/3 C77.4 YES 290 NO NO 6 Non-glabrous skin NO NO true No M0 N0 T3a Stage IIA TCGA-WE-A8ZQ.E5763CB1-3912-44EF-855B-B6363E31E74F.pdf A8ZQ WITH TUMOR NO 1 1 YES NO NO Metastatic 06 NO 6th YES NO WE Regional Lymph Node A LIVING 2009 3df4a91c-dae7-45e4-90e5-2b4fc1ae0925 TCGA-WE-A8ZQ-06A-41D-A373-05 3df4a91c-dae7-45e4-90e5-2b4fc1ae0925 TCGA-WE-A8ZQ-06 TCGA-WE-A8ZQ-06A-41D-A371-01 TCGA-WE-A8ZQ-06 23956AA7-3D8C-4808-B4E9-5DA438233558 TCGA-WE-A8ZQ-06A-41D-A372-08 TCGA-WE-A8ZQ-06A-41D-A371-01 3df4a91c-dae7-45e4-90e5-2b4fc1ae0925 3df4a91c-dae7-45e4-90e5-2b4fc1ae0925 +TCGA-WE-A8ZR-06 TCGA-WE-A8ZR-06 TCGA-WE-A8ZR TCGA Melanoma (SKCM) skin cutaneous melanoma Skin YES|YES|YES|YES|YES NO|NO|NO|NO|NO 49 TCGA-WE-A8ZR-F67323 TCGA-WE-A8ZR TCGA-WE-A8ZR-06A 7.3 -18051 66 274 0 133 126|126|126|126|126 24 2014-11-4 MALE No C77.4 8721/3 C77.4 YES 340 NO NO 18 Non-glabrous skin YES Distant Metastasis|Distant Metastasis|Distant Metastasis|Distant Metastasis|Locoregional Recurrence NO|NO|NO|NO|NO YES Liver|Lung|Bone|Other, Specify|Other, Specify |spleen|subcutaneous chest wall true No M0 N1b T4b Stage IIIC TCGA-WE-A8ZR.693528B1-CE0F-4008-8257-3E981A778AFC.pdf A8ZR WITH TUMOR NO 1 1 YES NO YES Metastatic 06 NO 7th YES NO WE Regional Lymph Node A DECEASED 2013 bbfd29b5-5d8d-4850-a9a5-def31a843842 TCGA-WE-A8ZR-06A-11D-A373-05 bbfd29b5-5d8d-4850-a9a5-def31a843842 TCGA-WE-A8ZR-06 TCGA-WE-A8ZR-06 C7A3693A-697A-4EF8-AF06-9E6B453B4FC4 TCGA-WE-A8ZR-06A-11D-A372-08 bbfd29b5-5d8d-4850-a9a5-def31a843842 bbfd29b5-5d8d-4850-a9a5-def31a843842 +TCGA-WE-A8ZT-06 TCGA-WE-A8ZT-06 TCGA-WE-A8ZT TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 25 TCGA-WE-A8ZT-F67327 TCGA-WE-A8ZT TCGA-WE-A8ZT-06A 4 -9379 40 0 359 10 2014-11-4 FEMALE No C77.3 8720/3 C77.3 YES 220 NO NO 14 YES NO NO true No M1b N1b T3b Stage IV TCGA-WE-A8ZT.25D3659C-B499-41FE-BE09-D79A76C843F7.pdf A8ZT TUMOR FREE NO 1 1 YES NO NO Metastatic 06 NO 7th YES NO WE Regional Lymph Node A LIVING 2013 a2eacae1-57f4-4db3-8abb-ed09fe1db757 TCGA-WE-A8ZT-06A-11D-A373-05 a2eacae1-57f4-4db3-8abb-ed09fe1db757 TCGA-WE-A8ZT-06 TCGA-WE-A8ZT-06A-11D-A371-01 TCGA-WE-A8ZT-06 835991B7-9AA4-47DE-8369-412501F697DC TCGA-WE-A8ZT-06A-11D-A372-08 TCGA-WE-A8ZT-06A-11D-A371-01 a2eacae1-57f4-4db3-8abb-ed09fe1db757 a2eacae1-57f4-4db3-8abb-ed09fe1db757 +TCGA-WE-A8ZX-06 TCGA-WE-A8ZX-06 TCGA-WE-A8ZX TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 45 TCGA-WE-A8ZX-F70292 TCGA-WE-A8ZX TCGA-WE-A8ZX-06A -16736 665 0 1089 26 2015-2-9 MALE No C77.3 8720/3 C77.3 YES 40 NO NO Non-glabrous skin NO NO true No M0 N1b TX Stage IIIB TCGA-WE-A8ZX.9FF6D78B-6DEA-4780-A790-5E1A9C6AC432.pdf A8ZX TUMOR FREE NO NO YES Metastatic 06 NO 7th NO YES WE Regional Lymph Node A LIVING 2012 024d98cb-3e52-4b3e-a07b-aefdee10e571 TCGA-WE-A8ZX-06A-11D-A373-05 024d98cb-3e52-4b3e-a07b-aefdee10e571 TCGA-WE-A8ZX-06A-11D-A371-01 TCGA-WE-A8ZX-06A-11D-A372-08 TCGA-WE-A8ZX-06A-11D-A371-01 024d98cb-3e52-4b3e-a07b-aefdee10e571 024d98cb-3e52-4b3e-a07b-aefdee10e571 +TCGA-WE-A8ZY-06 TCGA-WE-A8ZY-06 TCGA-WE-A8ZY TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 62 TCGA-WE-A8ZY-F67332 TCGA-WE-A8ZY TCGA-WE-A8ZY-06A 3 -22676 1294 1506 0 1330 1389|1389 1167 2014-11-4 MALE No C44.5 8720/3 C44.5 YES 510 NO NO 3 Non-glabrous skin NO |Other, specify Distant Metastasis| |adenocarcinoma pancreas YES Liver| true No M0 NX T3a Stage IIA TCGA-WE-A8ZY.F5CF804D-52CC-4E83-9FD5-E6B5DE63CC61.pdf A8ZY WITH TUMOR NO 1 1 YES NO NO Metastatic 06 NO 7th YES NO WE Regional Cutaneous or Subcutaneous Tissue (includes satellite and in-transit metastasis) A DECEASED 2010 2cb0b819-6151-41ae-8c9a-e1e5d928e8d5 TCGA-WE-A8ZY-06A-11D-A373-05 2cb0b819-6151-41ae-8c9a-e1e5d928e8d5 TCGA-WE-A8ZY-06 TCGA-WE-A8ZY-06A-11D-A371-01 TCGA-WE-A8ZY-06 FBB51BB2-CFA7-4584-AD0E-FC15AEF7ED1A TCGA-WE-A8ZY-06A-11D-A372-08 TCGA-WE-A8ZY-06A-11D-A371-01 2cb0b819-6151-41ae-8c9a-e1e5d928e8d5 2cb0b819-6151-41ae-8c9a-e1e5d928e8d5 +TCGA-WE-AA9Y-06 TCGA-WE-AA9Y-06 TCGA-WE-AA9Y TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 37 TCGA-WE-AA9Y-F67337 TCGA-WE-AA9Y TCGA-WE-AA9Y-06A 1.4 -13850 63 0 370 34 2014-11-4 MALE No C77.4 8743/3 C77.4 YES 380 NO NO 4 Non-glabrous skin NO NO false No M0 N3 T2a Stage IIIC TCGA-WE-AA9Y.B5BEF8CE-C74B-4B8D-97F9-EE45B94994A2.pdf AA9Y TUMOR FREE NO 1 1 YES NO NO Metastatic 06 NO 7th YES NO WE Regional Lymph Node A LIVING 2013 a310308c-57cf-4bb2-82e3-db1518bb79af TCGA-WE-AA9Y-06A-12D-A38H-05 a310308c-57cf-4bb2-82e3-db1518bb79af TCGA-WE-AA9Y-06 TCGA-WE-AA9Y-06A-12D-A38F-01 TCGA-WE-AA9Y-06 64513C6C-A473-40A0-9379-B3292341753F TCGA-WE-AA9Y-06A-12D-A38G-08 TCGA-WE-AA9Y-06A-12D-A38F-01 a310308c-57cf-4bb2-82e3-db1518bb79af a310308c-57cf-4bb2-82e3-db1518bb79af +TCGA-WE-AAA0-06 TCGA-WE-AAA0-06 TCGA-WE-AAA0 TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 47 TCGA-WE-AAA0-F70280 TCGA-WE-AAA0 TCGA-WE-AAA0-06A 0.8 -17261 819 0 1229 311 2015-2-9 MALE No C77.9 8720/3 C77.9 YES 60 NO NO 0 Non-glabrous skin NO NO false No M0 N0 T1a Stage IA TCGA-WE-AAA0.7C5BE93A-F3F3-4DE3-84EC-5BC54C644E18.pdf AAA0 TUMOR FREE NO 1 1 YES NO YES Metastatic 06 NO 7th NO YES WE Regional Lymph Node A LIVING 2011 0fcd83db-c7e1-4522-a567-fd22ae73202f TCGA-WE-AAA0-06A-11D-A38H-05 0fcd83db-c7e1-4522-a567-fd22ae73202f TCGA-WE-AAA0-06 TCGA-WE-AAA0-06A-11D-A38F-01 TCGA-WE-AAA0-06 TCGA-WE-AAA0-06A-11D-A38G-08 TCGA-WE-AAA0-06A-11D-A38F-01 0fcd83db-c7e1-4522-a567-fd22ae73202f 0fcd83db-c7e1-4522-a567-fd22ae73202f +TCGA-WE-AAA3-06 TCGA-WE-AAA3-06 TCGA-WE-AAA3 TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 84 TCGA-WE-AAA3-F70356 TCGA-WE-AAA3 TCGA-WE-AAA3-06A 7 -30843 293 0 651 256 2015-2-9 FEMALE No C77.4 8720/3 C77.4 YES 200 NO NO 12 Non-glabrous skin YES NO false Yes M0 N2b T4b Stage IIIC TCGA-WE-AAA3.EF9CAD09-A258-420F-87F0-C3CF4ED1E4EE.pdf AAA3 TUMOR FREE NO 1 1 YES NO NO Metastatic 06 NO 7th YES NO WE Regional Lymph Node A LIVING 2013 fbd2eeac-ae28-4948-bf57-91f65375fa77 TCGA-WE-AAA3-06A-11D-A38H-05 fbd2eeac-ae28-4948-bf57-91f65375fa77 TCGA-WE-AAA3-06 TCGA-WE-AAA3-06A-11D-A38F-01 TCGA-WE-AAA3-06 316D8A87-7E3F-449B-A3CF-008453BEED10 TCGA-WE-AAA3-06A-11D-A38G-08 TCGA-WE-AAA3-06A-11D-A38F-01 fbd2eeac-ae28-4948-bf57-91f65375fa77 fbd2eeac-ae28-4948-bf57-91f65375fa77 +TCGA-WE-AAA4-06 TCGA-WE-AAA4-06 TCGA-WE-AAA4 TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 56 TCGA-WE-AAA4-F70349 TCGA-WE-AAA4 TCGA-WE-AAA4-06A -20708 376 0 760 94 2015-2-9 FEMALE No C44.7 8720/3 C44.7 YES 170 NO NO Non-glabrous skin NO false No M0 N3 TX Stage IIIC TCGA-WE-AAA4.F35E0D94-9073-4C6D-8F2C-C30A1756742B.pdf AAA4 WITH TUMOR YES 1 1 YES NO NO Metastatic 06 NO 7th YES NO WE Regional Cutaneous or Subcutaneous Tissue (includes satellite and in-transit metastasis) A LIVING 2012 4151ec0a-ecb0-4b7f-bd88-24ff382d2010 TCGA-WE-AAA4-06A-12D-A38H-05 4151ec0a-ecb0-4b7f-bd88-24ff382d2010 TCGA-WE-AAA4-06 TCGA-WE-AAA4-06A-12D-A38F-01 TCGA-WE-AAA4-06 D5892018-D649-4AFB-9C62-67A23705B95E TCGA-WE-AAA4-06A-12D-A38G-08 TCGA-WE-AAA4-06A-12D-A38F-01 4151ec0a-ecb0-4b7f-bd88-24ff382d2010 4151ec0a-ecb0-4b7f-bd88-24ff382d2010 +TCGA-XV-A9VZ-01 TCGA-XV-A9VZ-01 TCGA-XV-A9VZ TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 90 TCGA-XV-A9VZ-F68253 TCGA-XV-A9VZ TCGA-XV-A9VZ-01A 5 -32873 99 0 11 0 2014-11-14 FEMALE 158 No C44.7 8720/3 C44.7 YES 120 NO YES IV Non-glabrous skin true No M0 N0 T4 Stage II TCGA-XV-A9VZ.E7F88623-7C02-432C-BA63-F141937F22A5.pdf A9VZ TUMOR FREE NO YES NO NO Primary Tumor 01 7th YES NO XV Primary Tumor A LIVING 52 2013 99106f6c-2f6f-4b14-8d47-df22b7862153 TCGA-XV-A9VZ-01A-11D-A38H-05 99106f6c-2f6f-4b14-8d47-df22b7862153 TCGA-XV-A9VZ-01 TCGA-XV-A9VZ-01 A1178495-F8FC-4D92-8333-92D1F48713A1 TCGA-XV-A9VZ-01A-11D-A38G-08 99106f6c-2f6f-4b14-8d47-df22b7862153 99106f6c-2f6f-4b14-8d47-df22b7862153 +TCGA-XV-A9W2-01 TCGA-XV-A9W2-01 TCGA-XV-A9W2 TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 81 TCGA-XV-A9W2-F68262 TCGA-XV-A9W2 TCGA-XV-A9W2-01A 1 -29836 74 0 417 0 2014-11-24 MALE 157 No C44.6 8720/3 C44.6 YES 200 NO NO II Non-glabrous skin NO true No M0 N0 T1 Stage I TCGA-XV-A9W2.D9061311-BEFE-49D0-8240-EA7381603A8D.pdf A9W2 TUMOR FREE NO YES NO Primary Tumor 01 7th YES NO XV Primary Tumor A LIVING 56 2013 eee95aed-9ab0-42cf-80ca-f8bd5e994037 TCGA-XV-A9W2-01A-11D-A398-05 eee95aed-9ab0-42cf-80ca-f8bd5e994037 TCGA-XV-A9W2-01 TCGA-XV-A9W2-01 57FC512F-00E2-4518-BBA2-0B79DAAA03A9 TCGA-XV-A9W2-01A-11D-A397-08 eee95aed-9ab0-42cf-80ca-f8bd5e994037 eee95aed-9ab0-42cf-80ca-f8bd5e994037 +TCGA-XV-A9W5-01 TCGA-XV-A9W5-01 TCGA-XV-A9W5 TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 51 TCGA-XV-A9W5-F68266 TCGA-XV-A9W5 TCGA-XV-A9W5-01A 2 -18739 49 0 392 0 2014-11-24 MALE 180 No C44.6 8720/3 C44.6 YES 110 NO NO IV Non-glabrous skin NO true No M0 N0 T2 I/II NOS TCGA-XV-A9W5.F2915AF4-7C62-4510-A02A-D0AB7C896FA0.pdf A9W5 WITH TUMOR YES YES NO Primary Tumor 01 NO 7th YES NO XV Primary Tumor A LIVING 105 2013 f473687f-b6b0-41cd-95a9-d5051299507c TCGA-XV-A9W5-01A-11D-A38H-05 f473687f-b6b0-41cd-95a9-d5051299507c TCGA-XV-A9W5-01 TCGA-XV-A9W5-01 29A9B7C4-B579-4E58-8860-5C0493DBD668 TCGA-XV-A9W5-01A-11D-A38G-08 f473687f-b6b0-41cd-95a9-d5051299507c f473687f-b6b0-41cd-95a9-d5051299507c +TCGA-XV-AAZV-01 TCGA-XV-AAZV-01 TCGA-XV-AAZV TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 56 TCGA-XV-AAZV-F68269 TCGA-XV-AAZV TCGA-XV-AAZV-01A 10 -20545 88 0 412 0 2014-11-24 FEMALE 172 No C44.5 8720/3 C44.5 YES 170 NO NO IV Non-glabrous skin NO true No M0 N0 T4 Stage II TCGA-XV-AAZV.7B7341E3-1A97-4A69-9E3B-064E6CC07475.pdf AAZV TUMOR FREE NO YES NO Primary Tumor 01 7th YES NO XV Primary Tumor A LIVING 83 2013 248868a4-376a-41fa-869f-e2bfedc14f42 TCGA-XV-AAZV-01A-11D-A408-05 248868a4-376a-41fa-869f-e2bfedc14f42 TCGA-XV-AAZV-01 TCGA-XV-AAZV-01 D4A86012-BA78-4D3E-8639-15F97C20A8D7 TCGA-XV-AAZV-01A-11D-A401-08 248868a4-376a-41fa-869f-e2bfedc14f42 248868a4-376a-41fa-869f-e2bfedc14f42 +TCGA-XV-AAZW-01 TCGA-XV-AAZW-01 TCGA-XV-AAZW TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 62 TCGA-XV-AAZW-F68270 TCGA-XV-AAZW TCGA-XV-AAZW-01A 13 -22778 88 393 0 18 0 2014-11-24 FEMALE 170 No C44.7 8720/3 C44.7 YES 290 NO YES V Non-glabrous skin NO true No M0 N0 T4 Stage II TCGA-XV-AAZW.D95D24B2-4A20-4C7B-963A-3C7F89CAA6BC.pdf AAZW WITH TUMOR NO YES NO Primary Tumor 01 NO 7th YES NO XV Primary Tumor A DECEASED 74 2013 7355574a-71bd-48a1-adaa-1390d173fca3 TCGA-XV-AAZW-01A-12D-A408-05 7355574a-71bd-48a1-adaa-1390d173fca3 TCGA-XV-AAZW-01 TCGA-XV-AAZW-01 4E9B7116-C1B2-49C5-9C7D-CB34EC47358A TCGA-XV-AAZW-01A-12D-A401-08 7355574a-71bd-48a1-adaa-1390d173fca3 7355574a-71bd-48a1-adaa-1390d173fca3 +TCGA-XV-AAZY-01 TCGA-XV-AAZY-01 TCGA-XV-AAZY TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 76 TCGA-XV-AAZY-F68271 TCGA-XV-AAZY TCGA-XV-AAZY-01A 16 -27938 112 0 405 0 2014-11-24 FEMALE 167 No C44.5 8720/3 C44.5 YES 340 NO NO V Non-glabrous skin NO true No M0 N3 T4 Stage IIIC TCGA-XV-AAZY.D775C305-10CA-4545-8352-EA87BCAB8304.pdf AAZY TUMOR FREE NO YES NO Primary Tumor 01 NO 7th YES NO XV Primary Tumor A LIVING 67 2013 5a1b46dc-3819-4e1b-b5e6-a4240da025a8 TCGA-XV-AAZY-01A-12D-A408-05 5a1b46dc-3819-4e1b-b5e6-a4240da025a8 TCGA-XV-AAZY-01 TCGA-XV-AAZY-01 CBDCEF89-C06B-48A1-851E-008D5CDA99D7 TCGA-XV-AAZY-01A-12D-A401-08 5a1b46dc-3819-4e1b-b5e6-a4240da025a8 5a1b46dc-3819-4e1b-b5e6-a4240da025a8 +TCGA-XV-AB01-01 TCGA-XV-AB01-01 TCGA-XV-AB01 TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 54 TCGA-XV-AB01-F68273 TCGA-XV-AB01 -20058 0 403 0 2014-11-24 FEMALE 164 No C77.3 8720/3 C77.3 YES NO Non-glabrous skin NO No M0 NX T3 Stage II AB01 WITH TUMOR YES YES NO NO 7th YES NO XV Regional Lymph Node LIVING 78 2013 b6e6842a-3e5d-43ac-ac7f-e983b0614d76 TCGA-XV-AB01-01A-12D-A408-05 b6e6842a-3e5d-43ac-ac7f-e983b0614d76 A6077659-6C4F-4817-BD34-4FF94E8DBEBD b6e6842a-3e5d-43ac-ac7f-e983b0614d76 b6e6842a-3e5d-43ac-ac7f-e983b0614d76 +TCGA-XV-AB01-06 TCGA-XV-AB01-06 TCGA-XV-AB01 TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 54 TCGA-XV-AB01-F68273 TCGA-XV-AB01 -20058 0 403 0 2014-11-24 FEMALE 164 No C77.3 8720/3 C77.3 YES NO Non-glabrous skin NO No M0 NX T3 Stage II AB01 WITH TUMOR YES YES NO Metastatic 06 NO 7th YES NO XV Regional Lymph Node LIVING 78 2013 TCGA-XV-AB01-06 TCGA-XV-AB01-06A-12D-A400-01 TCGA-XV-AB01-06 TCGA-XV-AB01-06A-12D-A401-08 TCGA-XV-AB01-06A-12D-A400-01 +TCGA-YD-A89C-06 TCGA-YD-A89C-06 TCGA-YD-A89C TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 43 TCGA-YD-A89C-F67405 TCGA-YD-A89C TCGA-YD-A89C-06A 1 -15804 253 0 210 202 Liver 2014-11-11 FEMALE 164 No C22.0 8720/3 C22.0 YES 200 NO YES 5 IV Non-glabrous skin NO YES false No M0 NX T1a Stage IA TCGA-YD-A89C.4AD900DD-AAC6-493D-A2C8-286FE3F43391.pdf A89C TUMOR FREE NO 1 YES NO NO Metastatic 06 7th NO YES YD Distant Metastasis A LIVING 59 2013 348e83c0-ddd5-49ab-982e-1741990cbd2a TCGA-YD-A89C-06A-11D-A373-05 348e83c0-ddd5-49ab-982e-1741990cbd2a TCGA-YD-A89C-06 TCGA-YD-A89C-06A-11D-A371-01 TCGA-YD-A89C-06 EE1BED3C-6C05-4177-A61E-F44B9CA77BA6 TCGA-YD-A89C-06A-11D-A372-08 TCGA-YD-A89C-06A-11D-A371-01 348e83c0-ddd5-49ab-982e-1741990cbd2a 348e83c0-ddd5-49ab-982e-1741990cbd2a +TCGA-YD-A9TA-06 TCGA-YD-A9TA-06 TCGA-YD-A9TA TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 75 TCGA-YD-A9TA-F66805 TCGA-YD-A9TA 1.5 -27498 0 1496 926 Lung 2014-11-11 MALE 175 No C34.1 8720/3 C34.1 YES NO III Non-glabrous skin NO No A9TA TUMOR FREE NO 1 YES NO NO Metastatic 06 NO NO YES YD Distant Metastasis LIVING 67 2010 fb71ca5f-3349-488f-95e9-772028da98c1 TCGA-YD-A9TA-06A-11D-A398-05 fb71ca5f-3349-488f-95e9-772028da98c1 TCGA-YD-A9TA-06 TCGA-YD-A9TA-06A-11D-A396-01 TCGA-YD-A9TA-06 TCGA-YD-A9TA-06A-11D-A397-08 TCGA-YD-A9TA-06A-11D-A396-01 fb71ca5f-3349-488f-95e9-772028da98c1 fb71ca5f-3349-488f-95e9-772028da98c1 +TCGA-YD-A9TB-06 TCGA-YD-A9TB-06 TCGA-YD-A9TB TCGA Melanoma (SKCM) skin cutaneous melanoma Skin TCGA-YD-A9TB-F67658 TCGA-YD-A9TB TCGA-YD-A9TB-06A 1.5 uterus 2014-11-11 FEMALE 162 No C54.1 8720/3 C54.1 YES 210 NO NO 3 IV Non-glabrous skin NO NO NO false No TCGA-YD-A9TB.9985BBA4-AD5A-45C5-B7A8-9641B5A85B55.pdf A9TB WITH TUMOR NO 1 1 YES NO NO Metastatic 06 NO YES NO YD Distant Metastasis A LIVING 56 1987 b4dbcc0c-750f-4787-8c32-5a50cdb2b27c TCGA-YD-A9TB-06A-12D-A408-05 b4dbcc0c-750f-4787-8c32-5a50cdb2b27c TCGA-YD-A9TB-06 TCGA-YD-A9TB-06A-12D-A400-01 TCGA-YD-A9TB-06 FB440DB2-F3DB-4A85-8A9E-BDAC2D8AD99A TCGA-YD-A9TB-06A-12D-A401-08 TCGA-YD-A9TB-06A-12D-A400-01 b4dbcc0c-750f-4787-8c32-5a50cdb2b27c b4dbcc0c-750f-4787-8c32-5a50cdb2b27c +TCGA-YG-AA3N-01 TCGA-YG-AA3N-01 TCGA-YG-AA3N TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 67 TCGA-YG-AA3N-F67868 TCGA-YG-AA3N 17 -24525 0 306 0 2014-11-12 MALE 152 No C44.5 8721/3 C44.5 YES NO 7 IV Non-glabrous skin NO No M0 N0 T4b Stage IIC AA3N TUMOR FREE NO 1 YES NO NO Primary Tumor 01 NO 7th YES NO YG Primary Tumor LIVING 80 2013 b4b4736d-32bf-4577-af49-f35e7da87c2c TCGA-YG-AA3N-01A-11D-A38H-05 b4b4736d-32bf-4577-af49-f35e7da87c2c TCGA-YG-AA3N-01 TCGA-YG-AA3N-01 TCGA-YG-AA3N-01A-11D-A38G-08 b4b4736d-32bf-4577-af49-f35e7da87c2c b4b4736d-32bf-4577-af49-f35e7da87c2c +TCGA-YG-AA3O-06 TCGA-YG-AA3O-06 TCGA-YG-AA3O TCGA Melanoma (SKCM) skin cutaneous melanoma Skin YES YES 62 TCGA-YG-AA3O-F67869 TCGA-YG-AA3O TCGA-YG-AA3O-06A -22999 956 1154 0 1096 1036 999 908 2014-11-13 MALE 173 No C77.3 8720/3 C77.3 YES 170 NO NO Non-glabrous skin Regional lymph node YES YES false No TCGA-YG-AA3O.4C358082-E41F-491D-8F0D-39B2B698995A.pdf AA3O WITH TUMOR YES 1 YES NO NO Metastatic 06 YES YES NO YG Regional Lymph Node A DECEASED 92 2011 1ae15391-868a-4aa6-993a-c06e3b4e37ba TCGA-YG-AA3O-06A-11D-A38H-05 1ae15391-868a-4aa6-993a-c06e3b4e37ba TCGA-YG-AA3O-06 TCGA-YG-AA3O-06A-11D-A38F-01 TCGA-YG-AA3O-06 A6868CDE-BF01-4A24-93F8-319C85D60AEF TCGA-YG-AA3O-06A-11D-A38G-08 TCGA-YG-AA3O-06A-11D-A38F-01 1ae15391-868a-4aa6-993a-c06e3b4e37ba 1ae15391-868a-4aa6-993a-c06e3b4e37ba +TCGA-YG-AA3P-06 TCGA-YG-AA3P-06 TCGA-YG-AA3P TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 63 TCGA-YG-AA3P-F68298 TCGA-YG-AA3P TCGA-YG-AA3P-06A 10.00 -23219 335 0 439 296 Skin Upper Back 2014-11-14 FEMALE 160 No C49.6 8720/3 C49.6 YES 230 NO NO 6 V Non-glabrous skin NO YES false No M0 N0 T4a Stage IIB TCGA-YG-AA3P.9FE4AE17-704F-4480-9329-45B5D532C253.pdf AA3P WITH TUMOR YES 1 YES NO NO Metastatic 06 7th YES NO YG Distant Metastasis A LIVING 64 2013 601934c4-5d48-440e-a17d-29c98e3d93fd TCGA-YG-AA3P-06A-11D-A38H-05 601934c4-5d48-440e-a17d-29c98e3d93fd TCGA-YG-AA3P-06 TCGA-YG-AA3P-06A-11D-A38F-01 TCGA-YG-AA3P-06 D63E270E-CF00-435B-9226-CCBB2BFF6592 TCGA-YG-AA3P-06A-11D-A38G-08 TCGA-YG-AA3P-06A-11D-A38F-01 601934c4-5d48-440e-a17d-29c98e3d93fd 601934c4-5d48-440e-a17d-29c98e3d93fd +TCGA-Z2-A8RT-06 TCGA-Z2-A8RT-06 TCGA-Z2-A8RT TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 42 TCGA-Z2-A8RT-F68264 TCGA-Z2-A8RT TCGA-Z2-A8RT-06A 4 -15342 515 0 839 469 2014-11-14 FEMALE 155 No C44.6 8720/3 C44.6 YES 90 NO NO III Non-glabrous skin YES NO true No M0 N0 T3b Stage IIB TCGA-Z2-A8RT.890104FC-665B-4FD5-8C2C-601B3453694E.pdf A8RT TUMOR FREE YES 1 YES NO NO Metastatic 06 NO 7th YES NO Z2 Regional Cutaneous or Subcutaneous Tissue (includes satellite and in-transit metastasis) A LIVING 77 2012 8e916902-ce63-4b1c-a636-cfc552ec6c9a TCGA-Z2-A8RT-06A-11D-A373-05 8e916902-ce63-4b1c-a636-cfc552ec6c9a TCGA-Z2-A8RT-06 TCGA-Z2-A8RT-06A-11D-A371-01 TCGA-Z2-A8RT-06 TCGA-Z2-A8RT-06A-11D-A372-08 TCGA-Z2-A8RT-06A-11D-A371-01 8e916902-ce63-4b1c-a636-cfc552ec6c9a 8e916902-ce63-4b1c-a636-cfc552ec6c9a +TCGA-Z2-AA3S-06 TCGA-Z2-AA3S-06 TCGA-Z2-AA3S TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 58 TCGA-Z2-AA3S-F68278 TCGA-Z2-AA3S TCGA-Z2-AA3S-06A 0.5 -21318 2646 0 2950 2846 2628 2014-11-14 MALE 172 No C77.3 8720/3 C77.3 YES 270 NO NO II Non-glabrous skin NO NO YES true No M0 N0 T1a Stage IA TCGA-Z2-AA3S.48FB1191-7102-4E62-8A56-A3991807AB6D.pdf AA3S WITH TUMOR NO 1 YES NO YES Metastatic 06 NO 6th YES NO Z2 Regional Lymph Node A LIVING 78 2006 06873136-901e-4987-8700-55a85ae939af TCGA-Z2-AA3S-06A-11D-A398-05 06873136-901e-4987-8700-55a85ae939af TCGA-Z2-AA3S-06 TCGA-Z2-AA3S-06A-11D-A396-01 TCGA-Z2-AA3S-06 44C8C192-4FD6-4BE4-979B-0C754E3BE5B4 TCGA-Z2-AA3S-06A-11D-A397-08 TCGA-Z2-AA3S-06A-11D-A396-01 06873136-901e-4987-8700-55a85ae939af 06873136-901e-4987-8700-55a85ae939af +TCGA-Z2-AA3V-06 TCGA-Z2-AA3V-06 TCGA-Z2-AA3V TCGA Melanoma (SKCM) skin cutaneous melanoma Skin 57 TCGA-Z2-AA3V-F68267 TCGA-Z2-AA3V TCGA-Z2-AA3V-06A 0.5 -20937 172 0 486 175 2014-11-14 FEMALE 166 No C77.3 8720/3 C77.3 YES 160 NO NO 0.9 Non-glabrous skin NO NO true No M0 N0 T1a Stage IA TCGA-Z2-AA3V.170DD4A4-10A3-4600-99F5-FF5C81F09157.pdf AA3V TUMOR FREE YES 1 YES NO NO Metastatic 06 NO 7th YES NO Z2 Regional Lymph Node A LIVING 63 2013 f6cf68ce-65b5-42ef-aff4-7fdaef9d7fd3 TCGA-Z2-AA3V-06A-11D-A398-05 f6cf68ce-65b5-42ef-aff4-7fdaef9d7fd3 TCGA-Z2-AA3V-06 TCGA-Z2-AA3V-06A-11D-A396-01 TCGA-Z2-AA3V-06 16EFF89A-B91C-45E8-8BEB-ED2730F21B2F TCGA-Z2-AA3V-06A-11D-A397-08 TCGA-Z2-AA3V-06A-11D-A396-01 f6cf68ce-65b5-42ef-aff4-7fdaef9d7fd3 f6cf68ce-65b5-42ef-aff4-7fdaef9d7fd3 diff --git a/input/TCGA/TCGA_Mesothelioma_(MESO)/TCGA.MESO.sampleMap_HiSeqV2_PANCAN.gz b/input/TCGA/TCGA_Mesothelioma_(MESO)/TCGA.MESO.sampleMap_HiSeqV2_PANCAN.gz new file mode 100644 index 0000000000000000000000000000000000000000..4d51e975f63dded9f5b591a0072dd1a2d93c080a --- /dev/null +++ b/input/TCGA/TCGA_Mesothelioma_(MESO)/TCGA.MESO.sampleMap_HiSeqV2_PANCAN.gz @@ -0,0 +1,3 @@ +version https://git-lfs.github.com/spec/v1 +oid sha256:a8d31e403d0dc7b60c4e9e34d9e3d0e82d089e5b3f68e492c3554d71f33369a9 +size 6970772 diff --git a/input/TCGA/TCGA_Mesothelioma_(MESO)/TCGA.MESO.sampleMap_MESO_clinicalMatrix b/input/TCGA/TCGA_Mesothelioma_(MESO)/TCGA.MESO.sampleMap_MESO_clinicalMatrix new file mode 100644 index 0000000000000000000000000000000000000000..27b04ea83bf5e0da48124a8e6657eeac3b22cfec --- /dev/null +++ b/input/TCGA/TCGA_Mesothelioma_(MESO)/TCGA.MESO.sampleMap_MESO_clinicalMatrix @@ -0,0 +1,88 @@ +sampleID _INTEGRATION _PATIENT _cohort _primary_disease _primary_site additional_pharmaceutical_therapy additional_radiation_therapy age_at_initial_pathologic_diagnosis asbestos_exposure_age asbestos_exposure_age_last asbestos_exposure_source asbestos_exposure_type asbestos_exposure_years assessment_timepoint_category bcr_followup_barcode bcr_patient_barcode bcr_sample_barcode creatinine_norm_range_lower creatinine_norm_range_upper creatinine_prior_tx days_to_birth days_to_collection days_to_death days_to_initial_pathologic_diagnosis days_to_last_followup days_to_new_tumor_event_after_initial_treatment eastern_cancer_oncology_group family_history_cancer_type family_history_cancer_type_other family_member_relationship_type form_completion_date gender histological_type history_asbestos_exposure history_of_neoadjuvant_treatment icd_10 icd_o_3_histology icd_o_3_site informed_consent_verified initial_weight is_ffpe karnofsky_performance_score laterality lost_follow_up mesothelioma_detection_method new_neoplasm_event_occurrence_anatomic_site new_neoplasm_event_type new_neoplasm_occurrence_anatomic_site_text new_tumor_event_additional_surgery_procedure new_tumor_event_after_initial_treatment oct_embedded other_dx pathologic_M pathologic_N pathologic_T pathologic_stage pathology_report_file_name patient_id performance_status_scale_timing person_neoplasm_cancer_status person_occupation_years_number pleurodesis_performed pleurodesis_performed_90_days postoperative_rx_tx primary_occupation primary_occupation_other radiation_therapy residual_tumor sample_type sample_type_id serum_mesothelin_lower_limit serum_mesothelin_prior_tx serum_mesothelin_upper_limit suv_of_pleura_max system_version tissue_prospective_collection_indicator tissue_retrospective_collection_indicator tissue_source_site tumor_tissue_site vial_number vital_status year_of_initial_pathologic_diagnosis _GENOMIC_ID_TCGA_MESO_PDMRNAseq _GENOMIC_ID_data/public/TCGA/MESO/miRNA_HiSeq_gene _GENOMIC_ID_TCGA_MESO_exp_HiSeqV2_exon _GENOMIC_ID_TCGA_MESO_mutation_broad_gene _GENOMIC_ID_TCGA_MESO_mutation_bcgsc_gene _GENOMIC_ID_TCGA_MESO_exp_HiSeqV2_percentile _GENOMIC_ID_TCGA_MESO_RPPA _GENOMIC_ID_TCGA_MESO_gistic2 _GENOMIC_ID_TCGA_MESO_exp_HiSeqV2_PANCAN _GENOMIC_ID_TCGA_MESO_miRNA_HiSeq _GENOMIC_ID_TCGA_MESO_exp_HiSeqV2 _GENOMIC_ID_TCGA_MESO_PDMRNAseqCNV _GENOMIC_ID_TCGA_MESO_gistic2thd _GENOMIC_ID_TCGA_MESO_hMethyl450 +TCGA-3H-AB3K-01 TCGA-3H-AB3K-01 TCGA-3H-AB3K TCGA Mesothelioma (MESO) mesothelioma Lining of body cavities 64 TCGA-3H-AB3K TCGA-3H-AB3K-01A 0.8 1.5 1.0 -23591 1935 1715 0 2014-8-11 MALE Diffuse malignant mesothelioma - NOS No No C45.0 9050/3 C38.4 YES 90 NO Right Biopsy YES false No M0 N0 T2 Stage II TCGA-3H-AB3K.2E921E98-CB9D-4FA5-B67F-A20BB5455CA2.pdf AB3K WITH TUMOR 30 YES No YES Other, please specify meat manager YES Primary Tumor 01 3.7 6th NO YES 3H Pleura A DECEASED 2008 TCGA-3H-AB3K-01 TCGA-3H-AB3K-01 919d8bde-c3b7-4cd9-8463-938afdb89ad7 TCGA-3H-AB3K-01A-11D-A39R-32 TCGA-3H-AB3K-01A-11D-A39R-32 919d8bde-c3b7-4cd9-8463-938afdb89ad7 FA2214BC-2F60-4767-BB8F-09679A9C0BD5 TCGA-3H-AB3K-01A-11D-A39Q-01 919d8bde-c3b7-4cd9-8463-938afdb89ad7 TCGA-3H-AB3K-01 919d8bde-c3b7-4cd9-8463-938afdb89ad7 TCGA-3H-AB3K-01 TCGA-3H-AB3K-01A-11D-A39Q-01 TCGA-3H-AB3K-01A-11D-A39S-05 +TCGA-3H-AB3L-01 TCGA-3H-AB3L-01 TCGA-3H-AB3L TCGA Mesothelioma (MESO) mesothelioma Lining of body cavities 60 TCGA-3H-AB3L TCGA-3H-AB3L-01A 0.7 1.3 1.3 -21972 1941 361 0 1 2014-8-13 MALE Epithelioid mesothelioma No C45.0 9052/3 C38.4 YES 130 NO Left Biopsy YES false No M0 N2 TX Stage III TCGA-3H-AB3L.162C8370-35C9-4B65-A9F2-6133E343390A.pdf AB3L WITH TUMOR YES No YES Construction and Extraction NO Primary Tumor 01 16.7 6th NO YES 3H Pleura A DECEASED 2008 TCGA-3H-AB3L-01 TCGA-3H-AB3L-01 3baf5546-99d9-417b-97bb-e00dda7ebcdd TCGA-3H-AB3L-01A-11D-A39R-32 TCGA-3H-AB3L-01A-11D-A39R-32 3baf5546-99d9-417b-97bb-e00dda7ebcdd 81F9016D-1F8D-4902-AA68-2002130CF41F TCGA-3H-AB3L-01A-11D-A39Q-01 3baf5546-99d9-417b-97bb-e00dda7ebcdd TCGA-3H-AB3L-01 3baf5546-99d9-417b-97bb-e00dda7ebcdd TCGA-3H-AB3L-01 TCGA-3H-AB3L-01A-11D-A39Q-01 TCGA-3H-AB3L-01A-11D-A39S-05 +TCGA-3H-AB3M-01 TCGA-3H-AB3M-01 TCGA-3H-AB3M TCGA Mesothelioma (MESO) mesothelioma Lining of body cavities 53 Occupational TCGA-3H-AB3M TCGA-3H-AB3M-01A 0.8 1.5 0.8 -19503 1998 885 0 1 Other, specify ovarian Parent 2014-6-11 FEMALE Epithelioid mesothelioma Yes No C45.0 9052/3 C38.4 YES 160 NO Left Biopsy YES false No M0 N2 T3 Stage III TCGA-3H-AB3M.3D2B553B-192D-4300-AF57-781143D0F10B.pdf AB3M Preoperative WITH TUMOR NO YES Other, please specify school district secretary NO Primary Tumor 01 14.2 6th NO YES 3H Pleura A DECEASED 2008 TCGA-3H-AB3M-01 TCGA-3H-AB3M-01 f0b52bcf-d7b4-4daa-82bb-e13e2d753be9 TCGA-3H-AB3M-01A-11D-A39R-32 TCGA-3H-AB3M-01A-11D-A39R-32 f0b52bcf-d7b4-4daa-82bb-e13e2d753be9 F98B8A5F-23ED-477D-833E-71730A4BE6B9 TCGA-3H-AB3M-01A-11D-A39Q-01 f0b52bcf-d7b4-4daa-82bb-e13e2d753be9 TCGA-3H-AB3M-01 f0b52bcf-d7b4-4daa-82bb-e13e2d753be9 TCGA-3H-AB3M-01 TCGA-3H-AB3M-01A-11D-A39Q-01 TCGA-3H-AB3M-01A-11D-A39S-05 +TCGA-3H-AB3O-01 TCGA-3H-AB3O-01 TCGA-3H-AB3O TCGA Mesothelioma (MESO) mesothelioma Lining of body cavities 58 25 31 Occupational Crocidolite 6 TCGA-3H-AB3O TCGA-3H-AB3O-01A 0.7 1.3 0.7 -21423 1897 1302 0 1 2014-6-10 MALE Epithelioid mesothelioma Yes No C45.0 9052/3 C38.4 YES 230 NO Right Biopsy YES false Yes M0 N0 T3 Stage III TCGA-3H-AB3O.D5828CA0-5ED9-4AF6-9E3C-CBE57826E43F.pdf AB3O Pre-Adjuvant Therapy WITH TUMOR 6 NO YES Other, please specify Engineer working on machines lined with asbestos YES Primary Tumor 01 14 6th NO YES 3H Pleura A DECEASED 2008 TCGA-3H-AB3O-01 TCGA-3H-AB3O-01 de645724-4408-4771-9814-cdeffec79758 TCGA-3H-AB3O-01A-11D-A39R-32 TCGA-3H-AB3O-01A-11D-A39R-32 de645724-4408-4771-9814-cdeffec79758 3B2C605A-9789-400E-B1B5-A8CEDA10E484 TCGA-3H-AB3O-01A-11D-A39Q-01 de645724-4408-4771-9814-cdeffec79758 TCGA-3H-AB3O-01 de645724-4408-4771-9814-cdeffec79758 TCGA-3H-AB3O-01 TCGA-3H-AB3O-01A-11D-A39Q-01 TCGA-3H-AB3O-01A-11D-A39S-05 +TCGA-3H-AB3S-01 TCGA-3H-AB3S-01 TCGA-3H-AB3S TCGA Mesothelioma (MESO) mesothelioma Lining of body cavities 69 Occupational TCGA-3H-AB3S TCGA-3H-AB3S-01A 0.7 1.3 0.8 -25471 1743 385 0 1 Other, specify|Other, specify|Other, specify|Other, specify skin cancer|leukemia|skin cancer|colon cancer Parent|Parent|Grandparent|Grandparent 2014-6-9 MALE Epithelioid mesothelioma Yes No C45.0 9052/3 C38.4 YES 170 NO Right Biopsy YES false Yes M0 N0 T2 Stage II TCGA-3H-AB3S.3A7D0D05-505C-4BA4-997E-E6BC9941BA72.pdf AB3S Preoperative WITH TUMOR NO YES Construction and Extraction YES Primary Tumor 01 9.6 6th NO YES 3H Pleura A DECEASED 2009 TCGA-3H-AB3S-01 TCGA-3H-AB3S-01 34787f03-da7e-4f3e-b33f-73b1bf51fb74 TCGA-3H-AB3S-01A-21D-A39R-32 TCGA-3H-AB3S-01A-21D-A39R-32 34787f03-da7e-4f3e-b33f-73b1bf51fb74 BF706147-4C7D-4C10-B27A-C4851B1B4DFA TCGA-3H-AB3S-01A-21D-A39Q-01 34787f03-da7e-4f3e-b33f-73b1bf51fb74 TCGA-3H-AB3S-01 34787f03-da7e-4f3e-b33f-73b1bf51fb74 TCGA-3H-AB3S-01 TCGA-3H-AB3S-01A-21D-A39Q-01 TCGA-3H-AB3S-01A-21D-A39S-05 +TCGA-3H-AB3T-01 TCGA-3H-AB3T-01 TCGA-3H-AB3T TCGA Mesothelioma (MESO) mesothelioma Lining of body cavities 79 Occupational TCGA-3H-AB3T TCGA-3H-AB3T-01A 0.7 1.3 0.9 -28925 1709 414 0 0 2014-6-9 MALE Biphasic mesothelioma Yes No C45.0 9053/3 C38.4 YES 80 NO Right Biopsy YES false No M0 N0 T1 Stage I TCGA-3H-AB3T.4F0240DA-BF51-4D8D-A378-1B39EEFD5FEA.pdf AB3T Preoperative WITH TUMOR NO YES Other, please specify oil refinery YES Primary Tumor 01 7.9 6th NO YES 3H Pleura A DECEASED 2009 TCGA-3H-AB3T-01 TCGA-3H-AB3T-01 b5bda3f8-1a43-4847-88b6-6a17ce11d29b TCGA-3H-AB3T-01A-11D-A39R-32 TCGA-3H-AB3T-01A-11D-A39R-32 b5bda3f8-1a43-4847-88b6-6a17ce11d29b D34E3172-8FAF-4BE1-828D-2C158A0290FF TCGA-3H-AB3T-01A-11D-A39Q-01 b5bda3f8-1a43-4847-88b6-6a17ce11d29b TCGA-3H-AB3T-01 b5bda3f8-1a43-4847-88b6-6a17ce11d29b TCGA-3H-AB3T-01 TCGA-3H-AB3T-01A-11D-A39Q-01 TCGA-3H-AB3T-01A-11D-A39S-05 +TCGA-3H-AB3U-01 TCGA-3H-AB3U-01 TCGA-3H-AB3U TCGA Mesothelioma (MESO) mesothelioma Lining of body cavities 71 17 Occupational TCGA-3H-AB3U TCGA-3H-AB3U-01A 0.7 1.3 0.9 -26220 1666 826 0 1 Other, specify|Other, specify Ovarian|Breast Parent|Child 2014-5-30 MALE Epithelioid mesothelioma Yes No C45.0 9052/3 C38.4 YES 200 NO Right Biopsy YES false No M0 N0 T3 Stage III TCGA-3H-AB3U.BA7F7532-3137-4D3B-8F51-3F5ABFC03471.pdf AB3U Preoperative WITH TUMOR NO YES Construction and Extraction NO Primary Tumor 01 5.3 6th NO YES 3H Pleura A DECEASED 2009 TCGA-3H-AB3U-01 TCGA-3H-AB3U-01 a2b8f7d7-3e9b-4e7f-9198-fb1d75a2eb0a TCGA-3H-AB3U-01A-21D-A39R-32 TCGA-3H-AB3U-01A-21D-A39R-32 a2b8f7d7-3e9b-4e7f-9198-fb1d75a2eb0a BD4648D5-BB45-4A96-888C-0584F8A9E820 TCGA-3H-AB3U-01A-21D-A39Q-01 a2b8f7d7-3e9b-4e7f-9198-fb1d75a2eb0a TCGA-3H-AB3U-01 a2b8f7d7-3e9b-4e7f-9198-fb1d75a2eb0a TCGA-3H-AB3U-01 TCGA-3H-AB3U-01A-21D-A39Q-01 TCGA-3H-AB3U-01A-21D-A39S-05 +TCGA-3H-AB3X-01 TCGA-3H-AB3X-01 TCGA-3H-AB3X TCGA Mesothelioma (MESO) mesothelioma Lining of body cavities 62 Occupational TCGA-3H-AB3X-F70235 TCGA-3H-AB3X TCGA-3H-AB3X-01A 0.70 1.30 0.92 -22702 1106 0 1490 0 2015-1-30 MALE Epithelioid mesothelioma Yes No C34.90 9052/3 C34.9 YES 60 NO Right NO Biopsy NO false No M0 N0 T3 Stage III TCGA-3H-AB3X.D1001F1F-5707-4D67-B915-C8899511D3EA.pdf AB3X Preoperative TUMOR FREE 30 NO YES Other, please specify petrochemical industry YES Primary Tumor 01 9.5 7th NO YES 3H Pleura A LIVING 2010 TCGA-3H-AB3X-01 TCGA-3H-AB3X-01 4a21ef3b-2d39-4588-8763-d2c26254932a TCGA-3H-AB3X-01A-11D-A39R-32 TCGA-3H-AB3X-01A-11D-A39R-32 4a21ef3b-2d39-4588-8763-d2c26254932a TCGA-3H-AB3X-01A-11D-A39Q-01 4a21ef3b-2d39-4588-8763-d2c26254932a TCGA-3H-AB3X-01 4a21ef3b-2d39-4588-8763-d2c26254932a TCGA-3H-AB3X-01 TCGA-3H-AB3X-01A-11D-A39Q-01 TCGA-3H-AB3X-01A-11D-A39S-05 +TCGA-3U-A98D-01 TCGA-3U-A98D-01 TCGA-3U-A98D TCGA Mesothelioma (MESO) mesothelioma Lining of body cavities 80 Occupational TCGA-3U-A98D-F65083 TCGA-3U-A98D TCGA-3U-A98D-01A 0.5 1.4 0.9 -29500 628 142 0 125 0 Other, specify Brain cancer Sibling 2015-1-22 MALE Biphasic mesothelioma Yes No C45.0 9053/3 C38.4 YES 230 NO Right NO Biopsy NO true No M0 N2 T2 Stage III TCGA-3U-A98D.8F55DF05-CE3D-42FF-9247-480F3CADD030.pdf A98D Preoperative NO NO Other, please specify Foreman at manufacturing plant NO Primary Tumor 01 7th NO YES 3U Pleura A DECEASED 2012 TCGA-3U-A98D-01 TCGA-3U-A98D-01 abd6f1e5-2772-4baf-809b-58209f8d525f TCGA-3U-A98D-01A-12D-A39R-32 TCGA-3U-A98D-01A-12D-A39R-32 abd6f1e5-2772-4baf-809b-58209f8d525f E67E8913-6A04-4D40-AC1C-E89B9FFD23BB TCGA-3U-A98D-01A-12D-A39Q-01 abd6f1e5-2772-4baf-809b-58209f8d525f TCGA-3U-A98D-01 abd6f1e5-2772-4baf-809b-58209f8d525f TCGA-3U-A98D-01 TCGA-3U-A98D-01A-12D-A39Q-01 TCGA-3U-A98D-01A-12D-A39S-05 +TCGA-3U-A98E-01 TCGA-3U-A98E-01 TCGA-3U-A98E TCGA Mesothelioma (MESO) mesothelioma Lining of body cavities 71 TCGA-3U-A98E-F72783 TCGA-3U-A98E TCGA-3U-A98E-01A 0.5 1.4 0.9 -26264 1321 0 1916 117 1 2015-11-24 FEMALE Epithelioid mesothelioma No C45.0 9052/3 C38.4 YES 390 NO Left NO Biopsy Other, specify Ipsilateral Chest Cavity YES true Yes M0 N2 T4 Stage IV TCGA-3U-A98E.11FB2902-12C0-4F01-ADF1-172E8736B378.pdf A98E Post-Adjuvant Therapy WITH TUMOR NO YES NO Primary Tumor 01 7th NO YES 3U Pleura A LIVING 2010 TCGA-3U-A98E-01 TCGA-3U-A98E-01 ddfdcd45-0d1c-4efd-89a4-2fe6bc789bfe TCGA-3U-A98E-01A-11D-A39R-32 TCGA-3U-A98E-01A-11D-A39R-32 ddfdcd45-0d1c-4efd-89a4-2fe6bc789bfe CB38692F-586E-49DE-ABC9-5353EA487390 TCGA-3U-A98E-01A-11D-A39Q-01 ddfdcd45-0d1c-4efd-89a4-2fe6bc789bfe TCGA-3U-A98E-01 ddfdcd45-0d1c-4efd-89a4-2fe6bc789bfe TCGA-3U-A98E-01 TCGA-3U-A98E-01A-11D-A39Q-01 TCGA-3U-A98E-01A-11D-A39S-05 +TCGA-3U-A98F-01 TCGA-3U-A98F-01 TCGA-3U-A98F TCGA Mesothelioma (MESO) mesothelioma Lining of body cavities 73 Occupational TCGA-3U-A98F-F65115 TCGA-3U-A98F TCGA-3U-A98F-01A 0.5 1.4 0.7 -26926 498 536 0 463 365 1 Other, specify|Other, specify Prostate Cancer|Thyroid Cancer Parent|Sibling 2015-1-22 MALE Biphasic mesothelioma Yes No C45.0 9053/3 C38.4 YES 490 NO Right NO Biopsy Ipsilateral Chest Cavity Locoregional Recurrence NO YES true No M0 N0 T3 Stage III TCGA-3U-A98F.44D82403-023E-455C-94DC-2D5FFB25D3D5.pdf A98F Post-Adjuvant Therapy WITH TUMOR NO YES Other, please specify Helped build recreational vehicles (manufacturing). Worked at industrial plant, steam operated with asbestos insulated pipes. YES Primary Tumor 01 8.7 7th NO YES 3U Pleura A DECEASED 2012 TCGA-3U-A98F-01 TCGA-3U-A98F-01 c7721620-0a0f-47b6-9901-b5c2ded85b15 TCGA-3U-A98F-01A-11D-A39R-32 TCGA-3U-A98F-01A-11D-A39R-32 c7721620-0a0f-47b6-9901-b5c2ded85b15 6A1B7BAD-8505-4666-BA42-E073CCDA9881 TCGA-3U-A98F-01A-11D-A39Q-01 c7721620-0a0f-47b6-9901-b5c2ded85b15 TCGA-3U-A98F-01 c7721620-0a0f-47b6-9901-b5c2ded85b15 TCGA-3U-A98F-01 TCGA-3U-A98F-01A-11D-A39Q-01 TCGA-3U-A98F-01A-11D-A39S-05 +TCGA-3U-A98G-01 TCGA-3U-A98G-01 TCGA-3U-A98G TCGA Mesothelioma (MESO) mesothelioma Lining of body cavities 71 Occupational Postoperative TCGA-3U-A98G-F65351 TCGA-3U-A98G TCGA-3U-A98G-01A 0.5 1.4 0.9 -26185 392 630 0 501 497 2 Other, specify|Other, specify|Other, specify Colorectal|Breast Cancer|Pancreatic Cancer Parent|Parent|Sibling 2015-1-22 MALE Biphasic mesothelioma Yes No C45.0 9053/3 C38.4 YES 500 NO Right NO Thorascopy Other, specify Intrapleural Progression Ipsilateral Chest Cavity NO YES true Yes M0 N0 T4 Stage IV TCGA-3U-A98G.7462A92B-C657-4D38-BF7C-0EC9639E7E4D.pdf A98G Other WITH TUMOR NO NO Other, please specify As a child, coated outside of boiler with asbestos. As adult, cleaned boilers as a facilities manager. NO R0 Primary Tumor 01 7th NO YES 3U Pleura A DECEASED 2012 TCGA-3U-A98G-01 TCGA-3U-A98G-01 9fe4c0e2-bd31-453d-a6a2-3ceac8314fe8 TCGA-3U-A98G-01A-11D-A39R-32 TCGA-3U-A98G-01A-11D-A39R-32 9fe4c0e2-bd31-453d-a6a2-3ceac8314fe8 1949CEE7-E31D-4C2C-AACF-64529DB763C0 TCGA-3U-A98G-01A-11D-A39Q-01 9fe4c0e2-bd31-453d-a6a2-3ceac8314fe8 TCGA-3U-A98G-01 9fe4c0e2-bd31-453d-a6a2-3ceac8314fe8 TCGA-3U-A98G-01 TCGA-3U-A98G-01A-11D-A39Q-01 TCGA-3U-A98G-01A-11D-A39S-05 +TCGA-3U-A98H-01 TCGA-3U-A98H-01 TCGA-3U-A98H TCGA Mesothelioma (MESO) mesothelioma Lining of body cavities 57 TCGA-3U-A98H-F65140 TCGA-3U-A98H TCGA-3U-A98H-01A 0.5 1.4 0.9 -21034 1197 1156 0 1150 798 1 2015-1-22 MALE Biphasic mesothelioma No C45.0 9052/3 C38.4 YES 110 NO Right NO Thorascopy NO YES true No M0 N2 T4 Stage IV TCGA-3U-A98H.F5BDA912-7354-442E-956A-A986D219F2D2.pdf A98H Post-Adjuvant Therapy WITH TUMOR NO NO NO Primary Tumor 01 7th NO YES 3U Pleura A DECEASED 2010 TCGA-3U-A98H-01 TCGA-3U-A98H-01 5c72dba2-2949-4168-8430-0e3804cdcbf3 TCGA-3U-A98H-01A-11D-A39R-32 TCGA-3U-A98H-01A-11D-A39R-32 5c72dba2-2949-4168-8430-0e3804cdcbf3 EC2EEF76-3BE7-4779-B0D9-330D8124E019 TCGA-3U-A98H-01A-11D-A39Q-01 5c72dba2-2949-4168-8430-0e3804cdcbf3 TCGA-3U-A98H-01 5c72dba2-2949-4168-8430-0e3804cdcbf3 TCGA-3U-A98H-01 TCGA-3U-A98H-01A-11D-A39Q-01 TCGA-3U-A98H-01A-11D-A39S-05 +TCGA-3U-A98I-01 TCGA-3U-A98I-01 TCGA-3U-A98I TCGA Mesothelioma (MESO) mesothelioma Lining of body cavities 68 22 Occupational 34 TCGA-3U-A98I-F72786 TCGA-3U-A98I TCGA-3U-A98I-01A 0.5 1.4 0.9 -25108 341 860 0 439 404 0 Other, specify|Other, specify Prostate Cancer|Gastric Cancer Parent|Grandparent 2015-11-24 MALE Biphasic mesothelioma Yes No C45.0 9053/3 C38.4 YES 420 NO Left NO Thorascopy Other, specify Ipsilateral Chest Cavity YES true No M0 N3 T4 Stage IV TCGA-3U-A98I.034C160F-20F8-42D2-A1EE-DF8ED1B569B3.pdf A98I Post-Adjuvant Therapy WITH TUMOR NO YES Other, please specify Submarine worker in Navy and then engineer in a nuclear power plant NO Primary Tumor 01 9.4 7th NO YES 3U Pleura A DECEASED 2013 TCGA-3U-A98I-01 TCGA-3U-A98I-01 a3ef039b-9282-470d-a031-2c0572a43053 TCGA-3U-A98I-01A-11D-A39R-32 TCGA-3U-A98I-01A-11D-A39R-32 a3ef039b-9282-470d-a031-2c0572a43053 1E922C88-2C74-4E9F-970F-38173A31A28F TCGA-3U-A98I-01A-11D-A39Q-01 a3ef039b-9282-470d-a031-2c0572a43053 TCGA-3U-A98I-01 a3ef039b-9282-470d-a031-2c0572a43053 TCGA-3U-A98I-01 TCGA-3U-A98I-01A-11D-A39Q-01 TCGA-3U-A98I-01A-11D-A39S-05 +TCGA-3U-A98J-01 TCGA-3U-A98J-01 TCGA-3U-A98J TCGA Mesothelioma (MESO) mesothelioma Lining of body cavities YES 55 Occupational TCGA-3U-A98J-F65234 TCGA-3U-A98J TCGA-3U-A98J-01A 0.9 1.4 0.6 -20338 438 741 0 485 620 2 2015-1-22 MALE Epithelioid mesothelioma Yes No C45.0 9052/3 C38.4 YES 350 NO 80 Right NO Thorascopy Other, specify Intrapleural Progression Ipsilateral Chest Cavity NO YES true No M0 N2 T3 Stage III TCGA-3U-A98J.B8F92EDC-3074-4BAA-99AA-B62741D65285.pdf A98J Post-Adjuvant Therapy WITH TUMOR NO YES Other, please specify Machinist in a molding company, home remodeler, and brake fixer NO Primary Tumor 01 10.2 7th NO YES 3U Pleura A DECEASED 2012 TCGA-3U-A98J-01 TCGA-3U-A98J-01 0ea136b8-d90d-4614-b77b-301e77f84598 TCGA-3U-A98J-01A-11D-A39R-32 TCGA-3U-A98J-01A-11D-A39R-32 0ea136b8-d90d-4614-b77b-301e77f84598 B1A0ABB3-ED1F-4BAD-AFA7-2109EFF73DC1 TCGA-3U-A98J-01A-11D-A39Q-01 0ea136b8-d90d-4614-b77b-301e77f84598 TCGA-3U-A98J-01 0ea136b8-d90d-4614-b77b-301e77f84598 TCGA-3U-A98J-01 TCGA-3U-A98J-01A-11D-A39Q-01 TCGA-3U-A98J-01A-11D-A39S-05 +TCGA-LK-A4NW-01 TCGA-LK-A4NW-01 TCGA-LK-A4NW TCGA Mesothelioma (MESO) mesothelioma Lining of body cavities 60 Occupational TCGA-LK-A4NW TCGA-LK-A4NW-01A -21922 1863 546 0 2013-2-6 MALE Diffuse malignant mesothelioma - NOS Yes No C45.0 9050/3 C38.4 YES 530 NO Left Biopsy NO true No M0 N2 T4 Stage IV TCGA-LK-A4NW.9FA130FA-B7F3-44C9-824D-4B332B72CB3E.pdf A4NW WITH TUMOR NO YES Other, please specify Steel Mill NO RX Primary Tumor 01 6th YES NO LK Pleura A DECEASED 2007 TCGA-LK-A4NW-01 TCGA-LK-A4NW-01 18e0c9ca-059f-4042-a790-de9a3881c177 TCGA-LK-A4NW-01A-11D-A34C-32 TCGA-LK-A4NW-01A-11D-A34C-32 18e0c9ca-059f-4042-a790-de9a3881c177 B15A9C8B-01D7-4936-A62C-E41D58EE8682 TCGA-LK-A4NW-01A-11D-A34B-01 18e0c9ca-059f-4042-a790-de9a3881c177 TCGA-LK-A4NW-01 18e0c9ca-059f-4042-a790-de9a3881c177 TCGA-LK-A4NW-01 TCGA-LK-A4NW-01A-11D-A34B-01 TCGA-LK-A4NW-01A-11D-A34E-05 +TCGA-LK-A4NY-01 TCGA-LK-A4NY-01 TCGA-LK-A4NY TCGA Mesothelioma (MESO) mesothelioma Lining of body cavities 66 TCGA-LK-A4NY TCGA-LK-A4NY-01A -24391 1111 168 0 2013-2-6 FEMALE Biphasic mesothelioma No C45.0 9053/3 C38.4 YES 630 NO Right Biopsy NO true No M0 N0 T3 Stage III TCGA-LK-A4NY.841AD538-D6BE-4560-BA50-D33557B130CB.pdf A4NY TUMOR FREE NO YES NO R0 Primary Tumor 01 6th YES NO LK Pleura A DECEASED 2009 TCGA-LK-A4NY-01 TCGA-LK-A4NY-01 21409174-cb24-46a1-9228-a89d1ba65643 TCGA-LK-A4NY-01A-11D-A34C-32 TCGA-LK-A4NY-01A-11D-A34C-32 21409174-cb24-46a1-9228-a89d1ba65643 26B35059-8A99-47AF-A22F-816DE29CF78C TCGA-LK-A4NY-01A-11D-A34B-01 21409174-cb24-46a1-9228-a89d1ba65643 TCGA-LK-A4NY-01 21409174-cb24-46a1-9228-a89d1ba65643 TCGA-LK-A4NY-01 TCGA-LK-A4NY-01A-11D-A34B-01 TCGA-LK-A4NY-01A-11D-A34E-05 +TCGA-LK-A4NZ-01 TCGA-LK-A4NZ-01 TCGA-LK-A4NZ TCGA Mesothelioma (MESO) mesothelioma Lining of body cavities 75 TCGA-LK-A4NZ TCGA-LK-A4NZ-01A -27720 1087 244 0 Other, specify|Other, specify|Other, specify breast|prostate and basal cell carcinoma|pancreatic cancer Sibling|Sibling|Parent 2013-2-6 MALE Epithelioid mesothelioma No No C45.0 9052/3 C38.4 YES 400 NO Right Biopsy NO true No M0 N0 T2 Stage II TCGA-LK-A4NZ.ABE9C586-6C72-42F3-8007-22762DA9C7A9.pdf A4NZ WITH TUMOR NO YES NO R2 Primary Tumor 01 6th YES NO LK Pleura A DECEASED 2009 TCGA-LK-A4NZ-01 TCGA-LK-A4NZ-01 8bd3266c-43d0-46d0-bbf9-19050864f11d TCGA-LK-A4NZ-01A-12D-A34C-32 TCGA-LK-A4NZ-01A-12D-A34C-32 8bd3266c-43d0-46d0-bbf9-19050864f11d 629B69B0-AEF6-46F8-A1ED-BEE5891948FA TCGA-LK-A4NZ-01A-12D-A34B-01 8bd3266c-43d0-46d0-bbf9-19050864f11d TCGA-LK-A4NZ-01 8bd3266c-43d0-46d0-bbf9-19050864f11d TCGA-LK-A4NZ-01 TCGA-LK-A4NZ-01A-12D-A34B-01 TCGA-LK-A4NZ-01A-12D-A34E-05 +TCGA-LK-A4O0-01 TCGA-LK-A4O0-01 TCGA-LK-A4O0 TCGA Mesothelioma (MESO) mesothelioma Lining of body cavities 81 TCGA-LK-A4O0 TCGA-LK-A4O0-01A -29798 1024 185 0 Other, specify|Other, specify Breast|Pancreas Parent|Sibling 2013-2-6 MALE Sarcomatoid mesothelioma No No C45.0 9050/3 C38.4 YES 380 NO Left Biopsy NO true No M0 N0 T1a Stage IA TCGA-LK-A4O0.2BDA3DE7-2BBC-4D52-B5C7-AAD0043881AF.pdf A4O0 TUMOR FREE NO YES NO R0 Primary Tumor 01 6th YES NO LK Pleura A DECEASED 2009 TCGA-LK-A4O0-01 TCGA-LK-A4O0-01 a68ddba5-e6c9-47a0-b657-7c8b76603108 TCGA-LK-A4O0-01A-11D-A34C-32 TCGA-LK-A4O0-01A-11D-A34C-32 a68ddba5-e6c9-47a0-b657-7c8b76603108 9894FC2D-1402-4D09-B5D1-9FCA819763B8 TCGA-LK-A4O0-01A-11D-A34B-01 a68ddba5-e6c9-47a0-b657-7c8b76603108 TCGA-LK-A4O0-01 a68ddba5-e6c9-47a0-b657-7c8b76603108 TCGA-LK-A4O0-01 TCGA-LK-A4O0-01A-11D-A34B-01 TCGA-LK-A4O0-01A-11D-A34E-05 +TCGA-LK-A4O2-01 TCGA-LK-A4O2-01 TCGA-LK-A4O2 TCGA Mesothelioma (MESO) mesothelioma Lining of body cavities 56 TCGA-LK-A4O2 TCGA-LK-A4O2-01A -20757 630 57 0 2013-2-7 FEMALE Epithelioid mesothelioma No C45.0 9052/3 C38.4 YES 310 NO Right Biopsy NO true No M0 N0 T3 Stage III TCGA-LK-A4O2.D4751900-6378-445D-B82E-D9459A292CBF.pdf A4O2 WITH TUMOR NO NO NO R2 Primary Tumor 01 7th YES NO LK Pleura A DECEASED 2011 TCGA-LK-A4O2-01 TCGA-LK-A4O2-01 17361c24-a448-41b1-b653-172347c660a5 TCGA-LK-A4O2-01A-11D-A34C-32 TCGA-LK-A4O2-01A-11D-A34C-32 17361c24-a448-41b1-b653-172347c660a5 7E2D2964-218B-4630-A2E1-F3B485B9B5A4 TCGA-LK-A4O2-01A-11D-A34B-01 17361c24-a448-41b1-b653-172347c660a5 TCGA-LK-A4O2-01 17361c24-a448-41b1-b653-172347c660a5 TCGA-LK-A4O2-01 TCGA-LK-A4O2-01A-11D-A34B-01 TCGA-LK-A4O2-01A-11D-A34E-05 +TCGA-LK-A4O4-01 TCGA-LK-A4O4-01 TCGA-LK-A4O4 TCGA Mesothelioma (MESO) mesothelioma Lining of body cavities 69 Occupational TCGA-LK-A4O4 TCGA-LK-A4O4-01A -25298 1654 949 0 2013-2-7 MALE Epithelioid mesothelioma Yes No C45.0 9052/3 C38.4 YES 350 NO Left Cytology NO true Yes M0 N1 T2 Stage III TCGA-LK-A4O4.2F75B668-8CE5-4228-AE5C-4C4F087C6930.pdf A4O4 TUMOR FREE NO YES Other, please specify Maintenance supervisor NO R0 Primary Tumor 01 6th YES NO LK Pleura A DECEASED 2008 TCGA-LK-A4O4-01 TCGA-LK-A4O4-01 7e002796-b2b7-4ea4-9ecf-8e9d94373804 TCGA-LK-A4O4-01A-11D-A34C-32 TCGA-LK-A4O4-01A-11D-A34C-32 7e002796-b2b7-4ea4-9ecf-8e9d94373804 6565DB18-2C4D-4EAB-B316-775474E4978A TCGA-LK-A4O4-01A-11D-A34B-01 7e002796-b2b7-4ea4-9ecf-8e9d94373804 TCGA-LK-A4O4-01 7e002796-b2b7-4ea4-9ecf-8e9d94373804 TCGA-LK-A4O4-01 TCGA-LK-A4O4-01A-11D-A34B-01 TCGA-LK-A4O4-01A-11D-A34E-05 +TCGA-LK-A4O5-01 TCGA-LK-A4O5-01 TCGA-LK-A4O5 TCGA Mesothelioma (MESO) mesothelioma Lining of body cavities 68 TCGA-LK-A4O5-F69530 TCGA-LK-A4O5 TCGA-LK-A4O5-01A -25000 384 387 0 371 2015-1-13 FEMALE Epithelioid mesothelioma No C45.0 9052/3 C38.4 YES 330 NO Right NO Cytology YES true No M0 N0 T3 Stage III TCGA-LK-A4O5.3592A658-BEB9-4DC5-9B27-D13D1552322A.pdf A4O5 WITH TUMOR YES Yes YES NO R1 Primary Tumor 01 7th YES NO LK Pleura A DECEASED 2011 TCGA-LK-A4O5-01 TCGA-LK-A4O5-01 635c048b-b3a3-4321-985d-4896ec4af74c TCGA-LK-A4O5-01A-11D-A34C-32 TCGA-LK-A4O5-01A-11D-A34C-32 635c048b-b3a3-4321-985d-4896ec4af74c 9CFBE526-2C93-4C0B-8DBC-9163789E6534 TCGA-LK-A4O5-01A-11D-A34B-01 635c048b-b3a3-4321-985d-4896ec4af74c TCGA-LK-A4O5-01 635c048b-b3a3-4321-985d-4896ec4af74c TCGA-LK-A4O5-01 TCGA-LK-A4O5-01A-11D-A34B-01 TCGA-LK-A4O5-01A-11D-A34E-05 +TCGA-LK-A4O6-01 TCGA-LK-A4O6-01 TCGA-LK-A4O6 TCGA Mesothelioma (MESO) mesothelioma Lining of body cavities 66 TCGA-LK-A4O6-F69531 TCGA-LK-A4O6 TCGA-LK-A4O6-01A -24449 183 448 0 49 2015-1-13 FEMALE Biphasic mesothelioma No C45.0 9053/3 C38.4 YES 370 NO Left NO Biopsy YES true No M0 N1 T3 Stage III TCGA-LK-A4O6.5A8CDA1B-CD49-4177-9716-FD42DE663E29.pdf A4O6 WITH TUMOR NO NO NO RX Primary Tumor 01 7th YES NO LK Pleura A DECEASED 2012 TCGA-LK-A4O6-01 TCGA-LK-A4O6-01 7b1862eb-f21c-4ef4-93c5-e81e353bf5a2 TCGA-LK-A4O6-01A-11D-A34C-32 TCGA-LK-A4O6-01A-11D-A34C-32 7b1862eb-f21c-4ef4-93c5-e81e353bf5a2 22008594-07EE-4647-BDE4-CB91BF3E271F TCGA-LK-A4O6-01A-11D-A34B-01 7b1862eb-f21c-4ef4-93c5-e81e353bf5a2 TCGA-LK-A4O6-01 7b1862eb-f21c-4ef4-93c5-e81e353bf5a2 TCGA-LK-A4O6-01 TCGA-LK-A4O6-01A-11D-A34B-01 TCGA-LK-A4O6-01A-11D-A34E-05 +TCGA-LK-A4O7-01 TCGA-LK-A4O7-01 TCGA-LK-A4O7 TCGA Mesothelioma (MESO) mesothelioma Lining of body cavities 64 Occupational TCGA-LK-A4O7-F69544 TCGA-LK-A4O7 TCGA-LK-A4O7-01A -23606 219 350 0 108 2015-1-13 MALE Epithelioid mesothelioma Yes No C45.0 9052/3 C38.4 YES 190 NO Left NO Biopsy YES true No M0 N1 T3 Stage III TCGA-LK-A4O7.A9C93568-D495-49A1-BF59-B14B9B1D90CC.pdf A4O7 WITH TUMOR NO YES Construction and Extraction YES R0 Primary Tumor 01 7th YES NO LK Pleura A DECEASED 2012 TCGA-LK-A4O7-01 TCGA-LK-A4O7-01 109738bc-13fb-4c2e-bb39-59006ba50306 TCGA-LK-A4O7-01A-11D-A34C-32 TCGA-LK-A4O7-01A-11D-A34C-32 109738bc-13fb-4c2e-bb39-59006ba50306 A3BA775E-99F3-47E3-A1BC-AA0E3F980AF9 TCGA-LK-A4O7-01A-11D-A34B-01 109738bc-13fb-4c2e-bb39-59006ba50306 TCGA-LK-A4O7-01 109738bc-13fb-4c2e-bb39-59006ba50306 TCGA-LK-A4O7-01 TCGA-LK-A4O7-01A-11D-A34B-01 TCGA-LK-A4O7-01A-11D-A34E-05 +TCGA-MQ-A4KX-01 TCGA-MQ-A4KX-01 TCGA-MQ-A4KX TCGA Mesothelioma (MESO) mesothelioma Lining of body cavities 55 TCGA-MQ-A4KX TCGA-MQ-A4KX-01A -20336 3607 2459 0 2013-8-9 MALE Epithelioid mesothelioma Yes No C45.0 9052/3 C38.4 YES 290 NO Right Thorascopy YES true No M0 N0 T1 Stage I TCGA-MQ-A4KX.22C75817-2D45-433A-8838-0E02FC00D12A.pdf A4KX NO YES NO R0 Primary Tumor 01 5th NO YES MQ Pleura A DECEASED 2002 TCGA-MQ-A4KX-01 TCGA-MQ-A4KX-01 87923f16-7136-4bc6-a217-ca6d13b49455 TCGA-MQ-A4KX-01A-11D-A34C-32 TCGA-MQ-A4KX-01A-11D-A34C-32 87923f16-7136-4bc6-a217-ca6d13b49455 55DE94FD-4B59-4648-B2BF-D1DD964D0DD4 TCGA-MQ-A4KX-01A-11D-A34B-01 87923f16-7136-4bc6-a217-ca6d13b49455 TCGA-MQ-A4KX-01 87923f16-7136-4bc6-a217-ca6d13b49455 TCGA-MQ-A4KX-01 TCGA-MQ-A4KX-01A-11D-A34B-01 TCGA-MQ-A4KX-01A-11D-A34E-05 +TCGA-MQ-A4LC-01 TCGA-MQ-A4LC-01 TCGA-MQ-A4LC TCGA Mesothelioma (MESO) mesothelioma Lining of body cavities 54 TCGA-MQ-A4LC TCGA-MQ-A4LC-01A -19866 4241 2790 0 2013-8-9 MALE Epithelioid mesothelioma Yes No C45.0 9052/3 C38.4 YES 470 NO Right Thorascopy YES true No M0 N0 T2 Stage II TCGA-MQ-A4LC.731F15DB-25D3-41A5-AEA5-4C96F1249ABA.pdf A4LC TUMOR FREE NO YES NO R0 Primary Tumor 01 6th NO YES MQ Pleura A DECEASED 2001 TCGA-MQ-A4LC-01 TCGA-MQ-A4LC-01 14b7877d-da22-478c-ba7d-65a2a1c19faa TCGA-MQ-A4LC-01A-31D-A34C-32 TCGA-MQ-A4LC-01A-31D-A34C-32 14b7877d-da22-478c-ba7d-65a2a1c19faa TCGA-MQ-A4LC-01A-31D-A34B-01 14b7877d-da22-478c-ba7d-65a2a1c19faa TCGA-MQ-A4LC-01 14b7877d-da22-478c-ba7d-65a2a1c19faa TCGA-MQ-A4LC-01 TCGA-MQ-A4LC-01A-31D-A34B-01 TCGA-MQ-A4LC-01A-31D-A34E-05 +TCGA-MQ-A4LI-01 TCGA-MQ-A4LI-01 TCGA-MQ-A4LI TCGA Mesothelioma (MESO) mesothelioma Lining of body cavities 60 TCGA-MQ-A4LI TCGA-MQ-A4LI-01A -21951 4903 572 0 1 2013-5-1 FEMALE Epithelioid mesothelioma Yes No C45.0 9052/3 C38.4 YES 320 NO Left Biopsy YES true No M0 N0 T2 Stage II TCGA-MQ-A4LI.15AE69C3-52C2-4CD3-A1BD-6E4EAD5B6631.pdf A4LI Preoperative WITH TUMOR NO YES NO R1 Primary Tumor 01 6th NO YES MQ Pleura A DECEASED 1999 TCGA-MQ-A4LI-01 TCGA-MQ-A4LI-01 a5af7ad5-30cc-43c2-85a6-676517c04234 TCGA-MQ-A4LI-01A-11D-A34C-32 TCGA-MQ-A4LI-01A-11D-A34C-32 a5af7ad5-30cc-43c2-85a6-676517c04234 947DAA05-3418-463F-9D51-3E3025DA150F TCGA-MQ-A4LI-01A-11D-A34B-01 a5af7ad5-30cc-43c2-85a6-676517c04234 TCGA-MQ-A4LI-01 a5af7ad5-30cc-43c2-85a6-676517c04234 TCGA-MQ-A4LI-01 TCGA-MQ-A4LI-01A-11D-A34B-01 TCGA-MQ-A4LI-01A-11D-A34E-05 +TCGA-MQ-A4LJ-01 TCGA-MQ-A4LJ-01 TCGA-MQ-A4LJ TCGA Mesothelioma (MESO) mesothelioma Lining of body cavities 53 TCGA-MQ-A4LJ TCGA-MQ-A4LJ-01A -19437 4922 709 0 2013-8-9 MALE Epithelioid mesothelioma Yes No C45.0 9052/3 C38.4 YES 130 NO Left Thorascopy YES true No M0 N1 T2 Stage III TCGA-MQ-A4LJ.19CD856A-FF63-412E-BB66-E49415C63D94.pdf A4LJ NO YES YES Primary Tumor 01 6th NO YES MQ Pleura A DECEASED 1999 TCGA-MQ-A4LJ-01 TCGA-MQ-A4LJ-01 ce6862ae-e619-4f42-9200-52c75d5a22e7 TCGA-MQ-A4LJ-01A-11D-A34C-32 TCGA-MQ-A4LJ-01A-11D-A34C-32 ce6862ae-e619-4f42-9200-52c75d5a22e7 E9BC18A4-C2A6-4661-8B07-538E219D29D4 TCGA-MQ-A4LJ-01A-11D-A34B-01 ce6862ae-e619-4f42-9200-52c75d5a22e7 TCGA-MQ-A4LJ-01 ce6862ae-e619-4f42-9200-52c75d5a22e7 TCGA-MQ-A4LJ-01 TCGA-MQ-A4LJ-01A-11D-A34B-01 TCGA-MQ-A4LJ-01A-11D-A34E-05 +TCGA-MQ-A4LM-01 TCGA-MQ-A4LM-01 TCGA-MQ-A4LM TCGA Mesothelioma (MESO) mesothelioma Lining of body cavities 67 10 TCGA-MQ-A4LM -24704 158 0 Other, specify Throat Grandparent 2013-8-9 MALE Biphasic mesothelioma Yes No C45.0 9053/3 C38.4 YES Right Thorascopy YES No M0 N0 T3 Stage III A4LM 10 NO YES Other, please specify He grounded granite counter tops for a living for about 10 years NO Primary Tumor 01 5th NO YES MQ Pleura DECEASED 2002 TCGA-MQ-A4LM-01 TCGA-MQ-A4LM-01 f5487583-cdac-42ba-8f7f-b1704ea21cad TCGA-MQ-A4LM-01A-11D-A34C-32 TCGA-MQ-A4LM-01A-11D-A34C-32 f5487583-cdac-42ba-8f7f-b1704ea21cad TCGA-MQ-A4LM-01A-11D-A34B-01 f5487583-cdac-42ba-8f7f-b1704ea21cad TCGA-MQ-A4LM-01 f5487583-cdac-42ba-8f7f-b1704ea21cad TCGA-MQ-A4LM-01 TCGA-MQ-A4LM-01A-11D-A34B-01 TCGA-MQ-A4LM-01A-11D-A34E-05 +TCGA-MQ-A4LP-01 TCGA-MQ-A4LP-01 TCGA-MQ-A4LP TCGA Mesothelioma (MESO) mesothelioma Lining of body cavities 67 TCGA-MQ-A4LP TCGA-MQ-A4LP-01A -24652 4447 527 0 2013-8-9 MALE Biphasic mesothelioma Yes No C45.0 9053/3 C38.4 YES 410 NO Right Thorascopy true No M0 N0 T3 Stage III TCGA-MQ-A4LP.43C3017A-16AC-4184-B2CE-68DFC3F81472.pdf A4LP NO NO NO Primary Tumor 01 5th NO YES MQ Pleura A DECEASED 2000 TCGA-MQ-A4LP-01 TCGA-MQ-A4LP-01 1c4a8707-e85f-4868-b06d-97cf991c74e1 TCGA-MQ-A4LP-01A-11D-A34C-32 TCGA-MQ-A4LP-01A-11D-A34C-32 1c4a8707-e85f-4868-b06d-97cf991c74e1 47281FF5-171B-4B79-A64B-745FDE158EB9 TCGA-MQ-A4LP-01A-11D-A34B-01 1c4a8707-e85f-4868-b06d-97cf991c74e1 TCGA-MQ-A4LP-01 1c4a8707-e85f-4868-b06d-97cf991c74e1 TCGA-MQ-A4LP-01 TCGA-MQ-A4LP-01A-11D-A34B-01 TCGA-MQ-A4LP-01A-11D-A34E-05 +TCGA-MQ-A4LV-01 TCGA-MQ-A4LV-01 TCGA-MQ-A4LV TCGA Mesothelioma (MESO) mesothelioma Lining of body cavities 63 TCGA-MQ-A4LV TCGA-MQ-A4LV-01A -23110 3618 107 0 Other, specify|Other, specify Prostate|Gynecologic Parent|Sibling 2013-8-9 MALE Biphasic mesothelioma Yes No C45.0 9052/3 C38.4 YES 160 NO Left Thorascopy YES true No M0 N0 T3 Stage III TCGA-MQ-A4LV.B58C2E00-6E35-4A56-AF0D-0A62335BBD89.pdf A4LV TUMOR FREE YES Yes YES Other, please specify Shipping department for mechanical transplater industries NO R0 Primary Tumor 01 5th NO YES MQ Pleura A DECEASED 2002 TCGA-MQ-A4LV-01 TCGA-MQ-A4LV-01 a55363ab-18f6-4200-9c76-628786e26d11 TCGA-MQ-A4LV-01A-11D-A34C-32 TCGA-MQ-A4LV-01A-11D-A34C-32 a55363ab-18f6-4200-9c76-628786e26d11 C5733DD6-C26C-4119-846E-CDC4CE62953B TCGA-MQ-A4LV-01A-11D-A34B-01 a55363ab-18f6-4200-9c76-628786e26d11 TCGA-MQ-A4LV-01 a55363ab-18f6-4200-9c76-628786e26d11 TCGA-MQ-A4LV-01 TCGA-MQ-A4LV-01A-11D-A34B-01 TCGA-MQ-A4LV-01A-11D-A34E-05 +TCGA-MQ-A6BL-01 TCGA-MQ-A6BL-01 TCGA-MQ-A6BL TCGA Mesothelioma (MESO) mesothelioma Lining of body cavities 78 TCGA-MQ-A6BL TCGA-MQ-A6BL-01A -28590 2287 333 0 2013-8-9 MALE Biphasic mesothelioma No C45.0 9053/3 C38.4 YES 20 NO Right Biopsy YES true No M0 N0 T2 Stage II TCGA-MQ-A6BL.C2E205E9-C239-49A6-B725-0785545207B8.pdf A6BL NO YES NO Primary Tumor 01 6th NO YES MQ Pleura A DECEASED 2007 TCGA-MQ-A6BL-01 TCGA-MQ-A6BL-01 6c7bd630-bd5d-45b6-9936-56ad3e4f72a6 TCGA-MQ-A6BL-01A-11D-A34C-32 TCGA-MQ-A6BL-01A-11D-A34C-32 6c7bd630-bd5d-45b6-9936-56ad3e4f72a6 TCGA-MQ-A6BL-01A-11D-A34B-01 6c7bd630-bd5d-45b6-9936-56ad3e4f72a6 TCGA-MQ-A6BL-01 6c7bd630-bd5d-45b6-9936-56ad3e4f72a6 TCGA-MQ-A6BL-01 TCGA-MQ-A6BL-01A-11D-A34B-01 TCGA-MQ-A6BL-01A-11D-A34E-05 +TCGA-MQ-A6BN-01 TCGA-MQ-A6BN-01 TCGA-MQ-A6BN TCGA Mesothelioma (MESO) mesothelioma Lining of body cavities 73 Occupational TCGA-MQ-A6BN TCGA-MQ-A6BN-01A -26790 2193 757 0 Other, specify|Other, specify Gastric|Breast Sibling|Sibling 2013-8-9 FEMALE Epithelioid mesothelioma Yes No C45.0 9052/3 C38.4 YES 60 NO Right Biopsy YES true No MX N1 T2 Stage III TCGA-MQ-A6BN.7FEC6780-415F-42E4-B996-E091CA424621.pdf A6BN TUMOR FREE NO YES Other, please specify Building Superintendent NO R0 Primary Tumor 01 6th NO YES MQ Pleura A DECEASED 2007 TCGA-MQ-A6BN-01 TCGA-MQ-A6BN-01 390bf39f-06bf-45b0-8225-38a0694f43f6 390bf39f-06bf-45b0-8225-38a0694f43f6 TCGA-MQ-A6BN-01A-12D-A34B-01 390bf39f-06bf-45b0-8225-38a0694f43f6 TCGA-MQ-A6BN-01 390bf39f-06bf-45b0-8225-38a0694f43f6 TCGA-MQ-A6BN-01 TCGA-MQ-A6BN-01A-12D-A34B-01 TCGA-MQ-A6BN-01A-12D-A34E-05 +TCGA-MQ-A6BQ-01 TCGA-MQ-A6BQ-01 TCGA-MQ-A6BQ TCGA Mesothelioma (MESO) mesothelioma Lining of body cavities 58 TCGA-MQ-A6BQ-F72790 TCGA-MQ-A6BQ TCGA-MQ-A6BQ-01A -21236 1519 0 2359 Mesothelioma|Mesothelioma Sibling|Sibling 2015-11-24 MALE Epithelioid mesothelioma No C45.0 9052/3 C38.4 YES 50 NO Left NO Biopsy NO true No MX N0 T2 Stage II TCGA-MQ-A6BQ.476705A9-0D92-4852-8204-8CA7807688B6.pdf A6BQ WITH TUMOR NO YES Other, please specify Farmer YES R1 Primary Tumor 01 6th NO YES MQ Pleura A LIVING 2009 TCGA-MQ-A6BQ-01 TCGA-MQ-A6BQ-01 25e3cf1c-d40b-45ab-b987-2370cc638868 TCGA-MQ-A6BQ-01A-11D-A34C-32 TCGA-MQ-A6BQ-01A-11D-A34C-32 25e3cf1c-d40b-45ab-b987-2370cc638868 TCGA-MQ-A6BQ-01A-11D-A34B-01 25e3cf1c-d40b-45ab-b987-2370cc638868 TCGA-MQ-A6BQ-01 25e3cf1c-d40b-45ab-b987-2370cc638868 TCGA-MQ-A6BQ-01 TCGA-MQ-A6BQ-01A-11D-A34B-01 TCGA-MQ-A6BQ-01A-11D-A34E-05 +TCGA-MQ-A6BR-01 TCGA-MQ-A6BR-01 TCGA-MQ-A6BR TCGA Mesothelioma (MESO) mesothelioma Lining of body cavities 55 TCGA-MQ-A6BR-F72791 TCGA-MQ-A6BR TCGA-MQ-A6BR-01A -20134 1594 0 2090 629 2015-11-24 FEMALE Epithelioid mesothelioma No No C45.0 9052/3 C38.4 YES 40 NO Left NO Biopsy Other, specify Ipsilateral Chest Cavity YES true No MX N1 T1b Stage III TCGA-MQ-A6BR.F7C5D3ED-657F-4586-9CEE-F7CA8D37FC54.pdf A6BR WITH TUMOR NO YES NO RX Primary Tumor 01 6th NO YES MQ Pleura A LIVING 2008 TCGA-MQ-A6BR-01 TCGA-MQ-A6BR-01 6e3a2a2a-40c4-499c-bb8b-5b6a10862eb9 TCGA-MQ-A6BR-01A-11D-A34C-32 TCGA-MQ-A6BR-01A-11D-A34C-32 6e3a2a2a-40c4-499c-bb8b-5b6a10862eb9 TCGA-MQ-A6BR-01A-11D-A34B-01 6e3a2a2a-40c4-499c-bb8b-5b6a10862eb9 TCGA-MQ-A6BR-01 6e3a2a2a-40c4-499c-bb8b-5b6a10862eb9 TCGA-MQ-A6BR-01 TCGA-MQ-A6BR-01A-11D-A34B-01 TCGA-MQ-A6BR-01A-11D-A34E-05 +TCGA-MQ-A6BS-01 TCGA-MQ-A6BS-01 TCGA-MQ-A6BS TCGA Mesothelioma (MESO) mesothelioma Lining of body cavities 55 Occupational TCGA-MQ-A6BS-F57455 TCGA-MQ-A6BS TCGA-MQ-A6BS-01A -20384 441 608 0 414 332 0 Other, specify|Other, specify Lung|Brain Parent|Parent 2014-8-15 MALE Epithelioid mesothelioma Yes No C45.0 9052/3 C38.4 YES 260 NO Right NO Thorascopy Other, specify Ipsilateral Chest Cavity YES true No MX N0 T2 Stage II TCGA-MQ-A6BS.83140BDC-6F68-411D-A30D-A99FD2112609.pdf A6BS Preoperative TUMOR FREE 20 YES No YES Other, please specify Worked in a brick yard NO R0 Primary Tumor 01 7th NO YES MQ Pleura A DECEASED 2012 TCGA-MQ-A6BS-01 TCGA-MQ-A6BS-01 818c7f77-a481-41bb-b5e0-57972e0b1bdf TCGA-MQ-A6BS-01A-12D-A34C-32 TCGA-MQ-A6BS-01A-12D-A34C-32 818c7f77-a481-41bb-b5e0-57972e0b1bdf EF851316-4DB9-4194-B25A-F2C39CEBFFB9 TCGA-MQ-A6BS-01A-12D-A34B-01 818c7f77-a481-41bb-b5e0-57972e0b1bdf TCGA-MQ-A6BS-01 818c7f77-a481-41bb-b5e0-57972e0b1bdf TCGA-MQ-A6BS-01 TCGA-MQ-A6BS-01A-12D-A34B-01 TCGA-MQ-A6BS-01A-12D-A34E-05 +TCGA-NQ-A57I-01 TCGA-NQ-A57I-01 TCGA-NQ-A57I TCGA Mesothelioma (MESO) mesothelioma Lining of body cavities 71 TCGA-NQ-A57I-F58941 TCGA-NQ-A57I TCGA-NQ-A57I-01A -26212 253 20 0 7 2014-4-29 MALE Biphasic mesothelioma No C45.0 9053/3 C38.4 YES 60 NO Right NO NO false No MX NX T1b Stage IB TCGA-NQ-A57I.5BAF43B9-899B-499A-A326-199ACD954BF6.pdf A57I WITH TUMOR NO NO NO R2 Primary Tumor 01 7th YES NO NQ Pleura A DECEASED 2012 TCGA-NQ-A57I-01 TCGA-NQ-A57I-01 4baa577f-afc5-4df6-9307-d73dca8ea70e TCGA-NQ-A57I-01A-11D-A34C-32 TCGA-NQ-A57I-01A-11D-A34C-32 4baa577f-afc5-4df6-9307-d73dca8ea70e TCGA-NQ-A57I-01A-11D-A34B-01 4baa577f-afc5-4df6-9307-d73dca8ea70e TCGA-NQ-A57I-01 4baa577f-afc5-4df6-9307-d73dca8ea70e TCGA-NQ-A57I-01 TCGA-NQ-A57I-01A-11D-A34B-01 TCGA-NQ-A57I-01A-11D-A34E-05 +TCGA-NQ-A638-01 TCGA-NQ-A638-01 TCGA-NQ-A638 TCGA Mesothelioma (MESO) mesothelioma Lining of body cavities 66 TCGA-NQ-A638-F61511 TCGA-NQ-A638 -24410 0 -8 2014-6-30 MALE Epithelioid mesothelioma No C45.0 9050/3 C38.4 YES Right YES Biopsy NO No M0 NX T2 Stage II A638 TUMOR FREE NO R0 Primary Tumor 01 7th YES NO NQ Pleura LIVING 2012 TCGA-NQ-A638-01 TCGA-NQ-A638-01 d9bb2e43-26d3-49f8-92bb-604b4d3005ec TCGA-NQ-A638-01A-11D-A34C-32 TCGA-NQ-A638-01A-11D-A34C-32 d9bb2e43-26d3-49f8-92bb-604b4d3005ec TCGA-NQ-A638-01A-11D-A34B-01 d9bb2e43-26d3-49f8-92bb-604b4d3005ec TCGA-NQ-A638-01 d9bb2e43-26d3-49f8-92bb-604b4d3005ec TCGA-NQ-A638-01 TCGA-NQ-A638-01A-11D-A34B-01 TCGA-NQ-A638-01A-11D-A34E-05 +TCGA-SC-A6LM-01 TCGA-SC-A6LM-01 TCGA-SC-A6LM TCGA Mesothelioma (MESO) mesothelioma Lining of body cavities 64 Secondary TCGA-SC-A6LM TCGA-SC-A6LM-01A 0.6 1.3 0.9 -23400 1169 881 0 0 Mesothelioma|Mesothelioma|Mesothelioma Parent|Sibling|Sibling 2013-10-23 FEMALE Epithelioid mesothelioma Yes No C45.0 9052/3 C38.4 YES 140 NO 90 Left Thorascopy YES true No M0 NX T4 Stage IV TCGA-SC-A6LM.6CF9AD5C-60BE-418D-AA95-F12B661361D8.pdf A6LM Preoperative WITH TUMOR NO YES YES R2 Primary Tumor 01 0 1.3 1.5 8.3 7th NO YES SC Pleura A DECEASED 2010 TCGA-SC-A6LM-01 TCGA-SC-A6LM-01 85b225f2-d4dc-4701-b63f-e3a3b0e5c459 TCGA-SC-A6LM-01A-11D-A34C-32 TCGA-SC-A6LM-01A-11D-A34C-32 85b225f2-d4dc-4701-b63f-e3a3b0e5c459 1AB8E91D-8565-4FF1-A064-DBE800F0C17F TCGA-SC-A6LM-01A-11D-A34B-01 85b225f2-d4dc-4701-b63f-e3a3b0e5c459 TCGA-SC-A6LM-01 85b225f2-d4dc-4701-b63f-e3a3b0e5c459 TCGA-SC-A6LM-01 TCGA-SC-A6LM-01A-11D-A34B-01 TCGA-SC-A6LM-01A-11D-A34E-05 +TCGA-SC-A6LN-01 TCGA-SC-A6LN-01 TCGA-SC-A6LN TCGA Mesothelioma (MESO) mesothelioma Lining of body cavities 76 TCGA-SC-A6LN-F65619 TCGA-SC-A6LN TCGA-SC-A6LN-01A 0.6 1.3 0.7 -27917 182 414 0 200 1 2014-9-25 MALE Biphasic mesothelioma No No C45.0 9053/3 C38.4 YES 100 NO 80 Right NO Biopsy NO true No M0 N2 T2 Stage III TCGA-SC-A6LN.579769F3-E1A6-4ACA-9217-B83152A63958.pdf A6LN Preoperative TUMOR FREE NO YES YES R0 Primary Tumor 01 2.6 7th NO YES SC Pleura A DECEASED 2012 TCGA-SC-A6LN-01 TCGA-SC-A6LN-01 4dda7ac4-588a-4d4c-ba34-b19411817d52 TCGA-SC-A6LN-01A-11D-A34C-32 TCGA-SC-A6LN-01A-11D-A34C-32 4dda7ac4-588a-4d4c-ba34-b19411817d52 DDC1F4E4-4A37-41C6-A260-8213FC95D8E7 TCGA-SC-A6LN-01A-11D-A34B-01 4dda7ac4-588a-4d4c-ba34-b19411817d52 TCGA-SC-A6LN-01 4dda7ac4-588a-4d4c-ba34-b19411817d52 TCGA-SC-A6LN-01 TCGA-SC-A6LN-01A-11D-A34B-01 TCGA-SC-A6LN-01A-11D-A34E-05 +TCGA-SC-A6LP-01 TCGA-SC-A6LP-01 TCGA-SC-A6LP TCGA Mesothelioma (MESO) mesothelioma Lining of body cavities 58 TCGA-SC-A6LP TCGA-SC-A6LP-01A 0.6 1.3 1 -21411 295 78 0 2013-10-23 MALE Biphasic mesothelioma No No C45.0 9053/3 C38.4 YES 80 NO 90 Right Biopsy NO true No M0 N0 T2 Stage II TCGA-SC-A6LP.EB455F1C-C1BC-45CA-898B-051739D39D1B.pdf A6LP Preoperative WITH TUMOR NO YES NO RX Primary Tumor 01 0 1.4 1.5 11.5 7th NO YES SC Pleura A DECEASED 2012 TCGA-SC-A6LP-01 TCGA-SC-A6LP-01 7713e075-01d5-466b-ae5b-aa019a9f4db8 TCGA-SC-A6LP-01A-11D-A34C-32 TCGA-SC-A6LP-01A-11D-A34C-32 7713e075-01d5-466b-ae5b-aa019a9f4db8 TCGA-SC-A6LP-01A-11D-A34B-01 7713e075-01d5-466b-ae5b-aa019a9f4db8 TCGA-SC-A6LP-01 7713e075-01d5-466b-ae5b-aa019a9f4db8 TCGA-SC-A6LP-01 TCGA-SC-A6LP-01A-11D-A34B-01 TCGA-SC-A6LP-01A-11D-A34E-05 +TCGA-SC-A6LQ-01 TCGA-SC-A6LQ-01 TCGA-SC-A6LQ TCGA Mesothelioma (MESO) mesothelioma Lining of body cavities 60 TCGA-SC-A6LQ TCGA-SC-A6LQ-01A 0.6 1.3 0.7 -22014 392 297 0 2013-10-23 FEMALE Epithelioid mesothelioma No No C45.0 9052/3 C38.4 YES 450 NO Right Thoracentesis YES true No M0 N2 T3 Stage III TCGA-SC-A6LQ.DDDDE403-9903-4955-8F1F-CB5266E2B2D9.pdf A6LQ WITH TUMOR NO YES YES R0 Primary Tumor 01 3.2 7th NO YES SC Pleura A DECEASED 2012 TCGA-SC-A6LQ-01 TCGA-SC-A6LQ-01 8515de6f-3572-4bf3-9dae-bc9b05579e76 TCGA-SC-A6LQ-01A-11D-A34C-32 TCGA-SC-A6LQ-01A-11D-A34C-32 8515de6f-3572-4bf3-9dae-bc9b05579e76 2F57D138-D850-4E15-85F4-731DB72B02F0 TCGA-SC-A6LQ-01A-11D-A34B-01 8515de6f-3572-4bf3-9dae-bc9b05579e76 TCGA-SC-A6LQ-01 8515de6f-3572-4bf3-9dae-bc9b05579e76 TCGA-SC-A6LQ-01 TCGA-SC-A6LQ-01A-11D-A34B-01 TCGA-SC-A6LQ-01A-11D-A34E-05 +TCGA-SC-A6LR-01 TCGA-SC-A6LR-01 TCGA-SC-A6LR TCGA Mesothelioma (MESO) mesothelioma Lining of body cavities 73 Occupational TCGA-SC-A6LR-F72795 TCGA-SC-A6LR TCGA-SC-A6LR-01A 0.6 1.3 0.8 -26773 443 0 1168 2015-11-24 MALE Epithelioid mesothelioma Yes No C45.0 9052/3 C38.4 YES 480 NO 80 Right NO Biopsy NO true No M0 N2 T1b Stage III TCGA-SC-A6LR.E1F77E03-1351-48F3-9AE8-906F910F8883.pdf A6LR Preoperative TUMOR FREE NO YES Other, please specify Naval ship work YES R2 Primary Tumor 01 0 0.6 1.5 7th NO YES SC Pleura A LIVING 2012 TCGA-SC-A6LR-01 TCGA-SC-A6LR-01 35aae416-bae3-44d6-8b74-d95e0dc0c0f7 TCGA-SC-A6LR-01A-11D-A34C-32 TCGA-SC-A6LR-01A-11D-A34C-32 35aae416-bae3-44d6-8b74-d95e0dc0c0f7 DA708986-265C-4AEA-8F46-CC454D2BE070 TCGA-SC-A6LR-01A-11D-A34B-01 35aae416-bae3-44d6-8b74-d95e0dc0c0f7 TCGA-SC-A6LR-01 35aae416-bae3-44d6-8b74-d95e0dc0c0f7 TCGA-SC-A6LR-01 TCGA-SC-A6LR-01A-11D-A34B-01 TCGA-SC-A6LR-01A-11D-A34E-05 +TCGA-SC-AA5Z-01 TCGA-SC-AA5Z-01 TCGA-SC-AA5Z TCGA Mesothelioma (MESO) mesothelioma Lining of body cavities NO NO 54 TCGA-SC-AA5Z-F71145 TCGA-SC-AA5Z TCGA-SC-AA5Z-01A 0.9 1.3 0.9 -19746 231 0 664 591 Other, specify Colon cancer Parent 2015-11-24 MALE Epithelioid mesothelioma No No C45.0 9052/3 C38.4 YES 350 NO Left NO Thorascopy Lung Intrapleural Progression NO NO true Yes M0 N2 T4 Stage IV TCGA-SC-AA5Z.6510EC39-20FA-40AB-B640-7E02E98F3FC7.pdf AA5Z WITH TUMOR NO YES YES R2 Primary Tumor 01 6.3 7th NO YES SC Pleura A LIVING 2013 TCGA-SC-AA5Z-01 TCGA-SC-AA5Z-01 190b146c-1fb5-43dc-a1da-37eab64cf84f TCGA-SC-AA5Z-01A-21D-A39R-32 TCGA-SC-AA5Z-01A-21D-A39R-32 190b146c-1fb5-43dc-a1da-37eab64cf84f 15E80E88-8AD4-46D4-8396-0F366698DEB9 TCGA-SC-AA5Z-01A-21D-A39Q-01 190b146c-1fb5-43dc-a1da-37eab64cf84f TCGA-SC-AA5Z-01 190b146c-1fb5-43dc-a1da-37eab64cf84f TCGA-SC-AA5Z-01 TCGA-SC-AA5Z-01A-21D-A39Q-01 TCGA-SC-AA5Z-01A-21D-A39S-05 +TCGA-SH-A7BC-01 TCGA-SH-A7BC-01 TCGA-SH-A7BC TCGA Mesothelioma (MESO) mesothelioma Lining of body cavities 66 Occupational TCGA-SH-A7BC TCGA-SH-A7BC-01A 35 125 68 -24459 706 727 0 0 2013-12-2 MALE Epithelioid mesothelioma Yes No C45.0 9052/3 C38.4 YES 170 NO Right Biopsy YES true No M0 N2 T3 Stage III TCGA-SH-A7BC.55D84C00-324B-4CBE-A478-0AD5401C44C6.pdf A7BC Preoperative WITH TUMOR NO YES Other, please specify Electrician YES R2 Primary Tumor 01 7th NO YES SH Pleura A DECEASED 2011 TCGA-SH-A7BC-01 TCGA-SH-A7BC-01 3e52792e-2ad1-4140-930e-3ce0ec01df84 TCGA-SH-A7BC-01A-11D-A34C-32 TCGA-SH-A7BC-01A-11D-A34C-32 3e52792e-2ad1-4140-930e-3ce0ec01df84 87905BAB-0EAF-4878-BB86-7A403B10A3DD TCGA-SH-A7BC-01A-11D-A34B-01 3e52792e-2ad1-4140-930e-3ce0ec01df84 TCGA-SH-A7BC-01 3e52792e-2ad1-4140-930e-3ce0ec01df84 TCGA-SH-A7BC-01 TCGA-SH-A7BC-01A-11D-A34B-01 TCGA-SH-A7BC-01A-11D-A34E-05 +TCGA-SH-A7BD-01 TCGA-SH-A7BD-01 TCGA-SH-A7BD TCGA Mesothelioma (MESO) mesothelioma Lining of body cavities 68 Occupational TCGA-SH-A7BD 35 125 109 -25019 459 0 3 2013-12-2 MALE Epithelioid mesothelioma Yes No C45.0 9052/3 C38.4 YES Right Biopsy YES No M1 N0 T2 Stage IV A7BD Post-Adjuvant Therapy WITH TUMOR NO YES Other, please specify Engineer YES R2 Primary Tumor 01 7th NO YES SH Pleura DECEASED 2012 TCGA-SH-A7BD-01 TCGA-SH-A7BD-01 f140c04c-d178-4462-8e18-f7b6e8b11d40 TCGA-SH-A7BD-01A-11D-A34C-32 TCGA-SH-A7BD-01A-11D-A34C-32 f140c04c-d178-4462-8e18-f7b6e8b11d40 TCGA-SH-A7BD-01A-11D-A34B-01 f140c04c-d178-4462-8e18-f7b6e8b11d40 TCGA-SH-A7BD-01 f140c04c-d178-4462-8e18-f7b6e8b11d40 TCGA-SH-A7BD-01 TCGA-SH-A7BD-01A-11D-A34B-01 TCGA-SH-A7BD-01A-11D-A34E-05 +TCGA-SH-A7BH-01 TCGA-SH-A7BH-01 TCGA-SH-A7BH TCGA Mesothelioma (MESO) mesothelioma Lining of body cavities 65 Occupational TCGA-SH-A7BH 35 125 64 -23850 243 0 2 Other, specify|Other, specify Lung Cancer|Pancreatic Cancer Parent|Sibling 2013-11-20 FEMALE Biphasic mesothelioma Yes No C45.0 9053/3 C38.4 YES 0 Right Biopsy YES No M0 N0 T3 Stage III A7BH Post-Adjuvant Therapy WITH TUMOR 50 NO YES Other, please specify Chef in industrial kitchens NO R2 Primary Tumor 01 7th NO YES SH Pleura DECEASED 2012 TCGA-SH-A7BH-01 TCGA-SH-A7BH-01 b44ca533-fb1e-4f34-b85c-a8b47f972332 TCGA-SH-A7BH-01A-11D-A34C-32 TCGA-SH-A7BH-01A-11D-A34C-32 b44ca533-fb1e-4f34-b85c-a8b47f972332 TCGA-SH-A7BH-01A-11D-A34B-01 b44ca533-fb1e-4f34-b85c-a8b47f972332 TCGA-SH-A7BH-01 b44ca533-fb1e-4f34-b85c-a8b47f972332 TCGA-SH-A7BH-01 TCGA-SH-A7BH-01A-11D-A34B-01 TCGA-SH-A7BH-01A-11D-A34E-05 +TCGA-SH-A9CT-01 TCGA-SH-A9CT-01 TCGA-SH-A9CT TCGA Mesothelioma (MESO) mesothelioma Lining of body cavities 67 TCGA-SH-A9CT-F67991 TCGA-SH-A9CT TCGA-SH-A9CT-01A 35 125 126 -24528 187 449 0 256 43 1 2014-11-13 MALE Epithelioid mesothelioma No C45.0 9052/3 C38.4 YES 570 NO 0 Right NO Thorascopy Other, specify Ipsilateral Chest Wall YES true No M0 N0 T2 Stage II TCGA-SH-A9CT.D7747749-3C50-4563-A68D-AE29D0C22749.pdf A9CT Preoperative WITH TUMOR 45 NO YES Other, please specify Carpenter NO Primary Tumor 01 7th NO YES SH Pleura A DECEASED 2013 TCGA-SH-A9CT-01 TCGA-SH-A9CT-01 25a2da7a-d1a3-4c08-9158-41d70772a5f0 TCGA-SH-A9CT-01A-11D-A39R-32 TCGA-SH-A9CT-01A-11D-A39R-32 25a2da7a-d1a3-4c08-9158-41d70772a5f0 AC72E453-A4C6-4ED2-B36E-5C86AA716C7B TCGA-SH-A9CT-01A-11D-A39Q-01 25a2da7a-d1a3-4c08-9158-41d70772a5f0 TCGA-SH-A9CT-01 25a2da7a-d1a3-4c08-9158-41d70772a5f0 TCGA-SH-A9CT-01 TCGA-SH-A9CT-01A-11D-A39Q-01 TCGA-SH-A9CT-01A-11D-A39S-05 +TCGA-SH-A9CU-01 TCGA-SH-A9CU-01 TCGA-SH-A9CU TCGA Mesothelioma (MESO) mesothelioma Lining of body cavities 60 30 TCGA-SH-A9CU-F72798 TCGA-SH-A9CU TCGA-SH-A9CU-01A 35 125 89 -22135 188 732 0 285 90 0 2015-11-24 MALE Epithelioid mesothelioma Yes No C45.0 9052/3 C38.4 YES 550 NO Right NO Thorascopy Other, specify Ipsilateral Chest Cavity YES true No M0 N2 T4 Stage IV TCGA-SH-A9CU.E4AE74A7-7144-41B1-A791-0FE1A00124E0.pdf A9CU Preoperative WITH TUMOR NO YES Construction and Extraction NO RX Primary Tumor 01 7th NO YES SH Pleura A DECEASED 2013 TCGA-SH-A9CU-01 TCGA-SH-A9CU-01 54486038-2cb9-48e7-a3ca-d6b02fb5f807 TCGA-SH-A9CU-01A-11D-A39R-32 TCGA-SH-A9CU-01A-11D-A39R-32 54486038-2cb9-48e7-a3ca-d6b02fb5f807 3C0D4F48-DDE7-45A0-A76A-CB9D8AC86A36 TCGA-SH-A9CU-01A-11D-A39Q-01 54486038-2cb9-48e7-a3ca-d6b02fb5f807 TCGA-SH-A9CU-01 54486038-2cb9-48e7-a3ca-d6b02fb5f807 TCGA-SH-A9CU-01 TCGA-SH-A9CU-01A-11D-A39Q-01 TCGA-SH-A9CU-01A-11D-A39S-05 +TCGA-TS-A7OU-01 TCGA-TS-A7OU-01 TCGA-TS-A7OU TCGA Mesothelioma (MESO) mesothelioma Lining of body cavities 56 TCGA-TS-A7OU TCGA-TS-A7OU-01B -20747 2384 1675 0 2014-10-14 MALE Epithelioid mesothelioma No C45.0 9052/3 C38.4 YES 410 NO Left true No MX N0 T4 Stage IV TCGA-TS-A7OU.662BCE15-BB09-43E6-813C-8713199581C6.pdf A7OU NO NO NO Primary Tumor 01 6th NO YES TS Pleura B DECEASED 2007 TCGA-TS-A7OU-01 TCGA-TS-A7OU-01 99d6fe5c-a560-4df9-b85d-3d657d9be33e TCGA-TS-A7OU-01B-11D-A39R-32 TCGA-TS-A7OU-01B-11D-A39R-32 99d6fe5c-a560-4df9-b85d-3d657d9be33e 1647FAA9-6637-4C69-82BF-B0DA09A54071 TCGA-TS-A7OU-01B-11D-A39Q-01 99d6fe5c-a560-4df9-b85d-3d657d9be33e TCGA-TS-A7OU-01 99d6fe5c-a560-4df9-b85d-3d657d9be33e TCGA-TS-A7OU-01 TCGA-TS-A7OU-01B-11D-A39Q-01 TCGA-TS-A7OU-01B-11D-A39S-05 +TCGA-TS-A7OY-01 TCGA-TS-A7OY-01 TCGA-TS-A7OY TCGA Mesothelioma (MESO) mesothelioma Lining of body cavities 62 5 TCGA-TS-A7OY TCGA-TS-A7OY-01A -22720 1618 255 0 2014-4-2 MALE Epithelioid mesothelioma Yes No C45.0 9052/3 C38.4 YES 810 NO Right YES true No MX N3 T3 Stage IV TCGA-TS-A7OY.6342557E-F0C7-499E-8726-6FF0533AE95F.pdf A7OY YES Yes NO Other, please specify Pipefitter in Navy Shipyard NO Primary Tumor 01 6th NO YES TS Pleura A DECEASED 2009 TCGA-TS-A7OY-01 TCGA-TS-A7OY-01 145d7c19-c3fd-4244-95af-f11d5e113306 TCGA-TS-A7OY-01A-11D-A34C-32 TCGA-TS-A7OY-01A-11D-A34C-32 145d7c19-c3fd-4244-95af-f11d5e113306 2463210F-38CC-421E-BA41-8B6891448B3F TCGA-TS-A7OY-01A-11D-A34B-01 145d7c19-c3fd-4244-95af-f11d5e113306 TCGA-TS-A7OY-01 145d7c19-c3fd-4244-95af-f11d5e113306 TCGA-TS-A7OY-01 TCGA-TS-A7OY-01A-11D-A34B-01 TCGA-TS-A7OY-01A-11D-A34E-05 +TCGA-TS-A7OZ-01 TCGA-TS-A7OZ-01 TCGA-TS-A7OZ TCGA Mesothelioma (MESO) mesothelioma Lining of body cavities 67 TCGA-TS-A7OZ TCGA-TS-A7OZ-01A -24745 1231 844 0 2014-10-21 MALE Epithelioid mesothelioma No No C45.0 9052/3 C38.4 YES 400 NO Bilateral true No MX N1 T3 Stage III TCGA-TS-A7OZ.EB690ABE-CEB6-4840-B2FC-B12CDE60A8C3.pdf A7OZ NO NO NO Primary Tumor 01 6th NO YES TS Pleura A DECEASED 2010 TCGA-TS-A7OZ-01 TCGA-TS-A7OZ-01 1273ee99-65c0-4eb7-a083-429f3316f099 TCGA-TS-A7OZ-01A-21D-A39R-32 TCGA-TS-A7OZ-01A-21D-A39R-32 1273ee99-65c0-4eb7-a083-429f3316f099 9442658E-4044-471A-B10E-BCDE9CF63BD2 TCGA-TS-A7OZ-01A-21D-A39Q-01 1273ee99-65c0-4eb7-a083-429f3316f099 TCGA-TS-A7OZ-01 1273ee99-65c0-4eb7-a083-429f3316f099 TCGA-TS-A7OZ-01 TCGA-TS-A7OZ-01A-21D-A39Q-01 TCGA-TS-A7OZ-01A-21D-A39S-05 +TCGA-TS-A7P0-01 TCGA-TS-A7P0-01 TCGA-TS-A7P0 TCGA Mesothelioma (MESO) mesothelioma Lining of body cavities 42 TCGA-TS-A7P0 TCGA-TS-A7P0-01A -15656 1178 1261 0 Other, specify Prostate Parent 2014-4-2 MALE Epithelioid mesothelioma No No C45.0 9052/3 C38.4 YES 550 NO Bilateral Biopsy YES true No MX N0 T3 Stage III TCGA-TS-A7P0.887CA21D-BC50-446A-B804-98147E5604AA.pdf A7P0 NO NO NO Primary Tumor 01 6th NO YES TS Pleura A DECEASED 2010 TCGA-TS-A7P0-01 TCGA-TS-A7P0-01 a2c96f81-12eb-4c6d-9e17-bc8bff343539 TCGA-TS-A7P0-01A-11D-A34C-32 TCGA-TS-A7P0-01A-11D-A34C-32 a2c96f81-12eb-4c6d-9e17-bc8bff343539 397C732C-9AE9-47F5-9DF9-BAD976DA4604 TCGA-TS-A7P0-01A-11D-A34B-01 a2c96f81-12eb-4c6d-9e17-bc8bff343539 TCGA-TS-A7P0-01 a2c96f81-12eb-4c6d-9e17-bc8bff343539 TCGA-TS-A7P0-01 TCGA-TS-A7P0-01A-11D-A34B-01 TCGA-TS-A7P0-01A-11D-A34E-05 +TCGA-TS-A7P1-01 TCGA-TS-A7P1-01 TCGA-TS-A7P1 TCGA Mesothelioma (MESO) mesothelioma Lining of body cavities 52 16 TCGA-TS-A7P1 TCGA-TS-A7P1-01A -19191 1161 563 0 2014-4-2 MALE Epithelioid mesothelioma Yes No C45.0 9052/3 C38.4 YES 570 NO Right Biopsy YES true No MX N0 T1 Stage I TCGA-TS-A7P1.0FAC8AE9-5E06-44F7-9327-0A3DB528C946.pdf A7P1 NO NO Other, please specify Tax Collector NO Primary Tumor 01 6th NO YES TS Pleura A DECEASED 2010 TCGA-TS-A7P1-01 TCGA-TS-A7P1-01 10d765a5-8f18-45ef-b218-4784efe1ade0 TCGA-TS-A7P1-01A-41D-A39R-32 TCGA-TS-A7P1-01A-41D-A39R-32 10d765a5-8f18-45ef-b218-4784efe1ade0 46F401ED-AF5F-42C8-B44F-41AC43198B74 TCGA-TS-A7P1-01A-41D-A39Q-01 10d765a5-8f18-45ef-b218-4784efe1ade0 TCGA-TS-A7P1-01 10d765a5-8f18-45ef-b218-4784efe1ade0 TCGA-TS-A7P1-01 TCGA-TS-A7P1-01A-41D-A39Q-01 TCGA-TS-A7P1-01A-41D-A39S-05 +TCGA-TS-A7P3-01 TCGA-TS-A7P3-01 TCGA-TS-A7P3 TCGA Mesothelioma (MESO) mesothelioma Lining of body cavities 57 TCGA-TS-A7P3 TCGA-TS-A7P3-01A -20964 917 689 0 Other, specify Brain Sibling 2014-4-25 MALE Epithelioid mesothelioma No No C45.0 9052/3 C38.4 YES 300 NO Left YES true No MX N2 T3 Stage III TCGA-TS-A7P3.6A28A050-677F-4544-9BA2-6825A191CC6E.pdf A7P3 NO NO Other, please specify Police Officer NO Primary Tumor 01 6th NO YES TS Pleura A DECEASED 2011 TCGA-TS-A7P3-01 TCGA-TS-A7P3-01 050c2191-b96c-41e7-abdb-e52cbe82f268 TCGA-TS-A7P3-01A-12D-A34C-32 TCGA-TS-A7P3-01A-12D-A34C-32 050c2191-b96c-41e7-abdb-e52cbe82f268 62CA1B6C-BB6B-494D-B477-5CC3C175CA62 TCGA-TS-A7P3-01A-12D-A34B-01 050c2191-b96c-41e7-abdb-e52cbe82f268 TCGA-TS-A7P3-01 050c2191-b96c-41e7-abdb-e52cbe82f268 TCGA-TS-A7P3-01 TCGA-TS-A7P3-01A-12D-A34B-01 TCGA-TS-A7P3-01A-12D-A34E-05 +TCGA-TS-A7P6-01 TCGA-TS-A7P6-01 TCGA-TS-A7P6 TCGA Mesothelioma (MESO) mesothelioma Lining of body cavities 61 TCGA-TS-A7P6 -22338 283 0 2014-4-25 MALE Epithelioid mesothelioma Yes No C45.0 9052/3 C38.4 YES Left No MX N2 T3 Stage III A7P6 NO NO Other, please specify Operations Instructor, Navy Shipyard NO Primary Tumor 01 6th NO YES TS Pleura DECEASED 2011 TCGA-TS-A7P6-01 TCGA-TS-A7P6-01 f2dddb70-466e-4457-9841-c353233fb5ab TCGA-TS-A7P6-01A-21D-A34C-32 TCGA-TS-A7P6-01A-21D-A34C-32 f2dddb70-466e-4457-9841-c353233fb5ab TCGA-TS-A7P6-01A-21D-A34B-01 f2dddb70-466e-4457-9841-c353233fb5ab TCGA-TS-A7P6-01 f2dddb70-466e-4457-9841-c353233fb5ab TCGA-TS-A7P6-01 TCGA-TS-A7P6-01A-21D-A34B-01 TCGA-TS-A7P6-01A-21D-A34E-05 +TCGA-TS-A7P7-01 TCGA-TS-A7P7-01 TCGA-TS-A7P7 TCGA Mesothelioma (MESO) mesothelioma Lining of body cavities 62 TCGA-TS-A7P7 TCGA-TS-A7P7-01A -22670 542 591 0 2014-10-21 MALE Epithelioid mesothelioma Yes No C45.0 9052/3 C38.4 YES 570 NO Bilateral YES true No MX N2 T3 Stage III TCGA-TS-A7P7.809D0A50-C963-491E-87B7-A15E4BF2FC07.pdf A7P7 NO NO NO Primary Tumor 01 7th NO YES TS Pleura A DECEASED 2012 TCGA-TS-A7P7-01 TCGA-TS-A7P7-01 c8d6068e-338c-4d0e-b956-07dc2e5906fe c8d6068e-338c-4d0e-b956-07dc2e5906fe 5C3C6EB6-B787-4BB1-A630-695317A75CB5 TCGA-TS-A7P7-01A-11D-A39Q-01 c8d6068e-338c-4d0e-b956-07dc2e5906fe TCGA-TS-A7P7-01 c8d6068e-338c-4d0e-b956-07dc2e5906fe TCGA-TS-A7P7-01 TCGA-TS-A7P7-01A-11D-A39Q-01 TCGA-TS-A7P7-01A-11D-A39S-05 +TCGA-TS-A7P8-01 TCGA-TS-A7P8-01 TCGA-TS-A7P8 TCGA Mesothelioma (MESO) mesothelioma Lining of body cavities 80 TCGA-TS-A7P8 TCGA-TS-A7P8-01A -29464 534 457 0 2014-4-25 MALE Epithelioid mesothelioma No No C45.0 9053/3 C38.4 YES 230 NO Left YES true No MX N1 TX Stage III TCGA-TS-A7P8.9B0C36C1-5A4F-4A97-8EF0-0D8C6D812D0A.pdf A7P8 NO NO Other, please specify Electrical Engineer NO Primary Tumor 01 7th NO YES TS Pleura A DECEASED 2012 TCGA-TS-A7P8-01 TCGA-TS-A7P8-01 bdfb1fda-ce7b-403a-9a15-375c1d041c11 TCGA-TS-A7P8-01A-11D-A34C-32 TCGA-TS-A7P8-01A-11D-A34C-32 bdfb1fda-ce7b-403a-9a15-375c1d041c11 C25267A6-3ADC-4D55-BEF9-534C83AA7387 TCGA-TS-A7P8-01A-11D-A34B-01 bdfb1fda-ce7b-403a-9a15-375c1d041c11 TCGA-TS-A7P8-01 bdfb1fda-ce7b-403a-9a15-375c1d041c11 TCGA-TS-A7P8-01 TCGA-TS-A7P8-01A-11D-A34B-01 TCGA-TS-A7P8-01A-11D-A34E-05 +TCGA-TS-A7PB-01 TCGA-TS-A7PB-01 TCGA-TS-A7PB TCGA Mesothelioma (MESO) mesothelioma Lining of body cavities 62 TCGA-TS-A7PB TCGA-TS-A7PB-01A -22822 869 982 0 2014-4-25 MALE Biphasic mesothelioma Yes No C45.0 9053/3 C38.4 YES 800 NO Left YES true No MX N2 T3 Stage III TCGA-TS-A7PB.10F97F63-EE6F-448D-98E1-8AAA21F55753.pdf A7PB NO NO Other, please specify Nuclear Physicist NO Primary Tumor 01 6th NO YES TS Pleura A DECEASED 2011 TCGA-TS-A7PB-01 TCGA-TS-A7PB-01 d8e252a9-d0a7-4c62-a0ab-3631df93f0e5 TCGA-TS-A7PB-01A-11D-A34C-32 TCGA-TS-A7PB-01A-11D-A34C-32 d8e252a9-d0a7-4c62-a0ab-3631df93f0e5 08B4C0D9-0555-4218-9A1A-F12A25E8CB07 TCGA-TS-A7PB-01A-11D-A34B-01 d8e252a9-d0a7-4c62-a0ab-3631df93f0e5 TCGA-TS-A7PB-01 d8e252a9-d0a7-4c62-a0ab-3631df93f0e5 TCGA-TS-A7PB-01 TCGA-TS-A7PB-01A-11D-A34B-01 TCGA-TS-A7PB-01A-11D-A34E-05 +TCGA-TS-A8AF-01 TCGA-TS-A8AF-01 TCGA-TS-A8AF TCGA Mesothelioma (MESO) mesothelioma Lining of body cavities 69 TCGA-TS-A8AF TCGA-TS-A8AF-01A -25486 2185 358 0 2014-4-25 MALE Epithelioid mesothelioma Yes No C45.0 9052/3 C38.4 YES 630 NO Right YES true No MX N2 T2 Stage III TCGA-TS-A8AF.7BB8D997-D3AB-4336-8B3C-D9D23AAA221C.pdf A8AF NO No NO Other, please specify Inspector Gas NO Primary Tumor 01 6th NO YES TS Pleura A DECEASED 2007 TCGA-TS-A8AF-01 TCGA-TS-A8AF-01 cab8720a-5ee4-48da-aae3-6b426e5348dc cab8720a-5ee4-48da-aae3-6b426e5348dc 6FA1F5AD-0DB1-46D7-B99E-C14F0DC0944F TCGA-TS-A8AF-01A-11D-A39Q-01 cab8720a-5ee4-48da-aae3-6b426e5348dc TCGA-TS-A8AF-01 cab8720a-5ee4-48da-aae3-6b426e5348dc TCGA-TS-A8AF-01 TCGA-TS-A8AF-01A-11D-A39Q-01 TCGA-TS-A8AF-01A-11D-A39S-05 +TCGA-TS-A8AI-01 TCGA-TS-A8AI-01 TCGA-TS-A8AI TCGA Mesothelioma (MESO) mesothelioma Lining of body cavities 58 TCGA-TS-A8AI TCGA-TS-A8AI-01A -21323 1681 328 0 Other, specify|Other, specify lymphoma|renal Child|Parent 2014-4-25 MALE Epithelioid mesothelioma No No C45.0 9052/3 C38.4 YES 350 NO Left YES true No MX N1 T4 Stage IV TCGA-TS-A8AI.3D48DFF8-B505-478C-B90B-28015E22B38D.pdf A8AI NO NO Other, please specify Navy Shipyard NO Primary Tumor 01 6th NO YES TS Pleura A DECEASED 2009 TCGA-TS-A8AI-01 TCGA-TS-A8AI-01 d99b331d-7994-4fff-b91f-2ab1e933660c TCGA-TS-A8AI-01A-11D-A39R-32 TCGA-TS-A8AI-01A-11D-A39R-32 d99b331d-7994-4fff-b91f-2ab1e933660c 2C70AD9F-C0E9-4F0B-91A5-42131D4306E9 TCGA-TS-A8AI-01A-11D-A39Q-01 d99b331d-7994-4fff-b91f-2ab1e933660c TCGA-TS-A8AI-01 d99b331d-7994-4fff-b91f-2ab1e933660c TCGA-TS-A8AI-01 TCGA-TS-A8AI-01A-11D-A39Q-01 TCGA-TS-A8AI-01A-11D-A39S-05 +TCGA-TS-A8AS-01 TCGA-TS-A8AS-01 TCGA-TS-A8AS TCGA Mesothelioma (MESO) mesothelioma Lining of body cavities 77 TCGA-TS-A8AS TCGA-TS-A8AS-01A -28273 692 795 0 2014-4-25 MALE Epithelioid mesothelioma Yes No C45.0 9052/3 C38.4 YES 160 NO Right true Yes MX N0 T1a Stage IA TCGA-TS-A8AS.28EF5137-69F0-4F69-95AF-8B604EDE9DD5.pdf A8AS NO NO Other, please specify US Navy NO Primary Tumor 01 7th NO YES TS Pleura A DECEASED 2011 TCGA-TS-A8AS-01 TCGA-TS-A8AS-01 2efa5115-b02b-4a85-ae82-3054cd3d646a TCGA-TS-A8AS-01A-21D-A39R-32 TCGA-TS-A8AS-01A-21D-A39R-32 2efa5115-b02b-4a85-ae82-3054cd3d646a TCGA-TS-A8AS-01A-21D-A39Q-01 2efa5115-b02b-4a85-ae82-3054cd3d646a TCGA-TS-A8AS-01 2efa5115-b02b-4a85-ae82-3054cd3d646a TCGA-TS-A8AS-01 TCGA-TS-A8AS-01A-21D-A39Q-01 TCGA-TS-A8AS-01A-21D-A39S-05 +TCGA-TS-A8AV-01 TCGA-TS-A8AV-01 TCGA-TS-A8AV TCGA Mesothelioma (MESO) mesothelioma Lining of body cavities 55 TCGA-TS-A8AV TCGA-TS-A8AV-01A -20437 707 [Discrepancy] 0 Other, specify|Other, specify skin|breast Parent|Parent 2014-4-25 MALE Sarcomatoid mesothelioma Yes No C38.4 9051/3 C38.4 YES 370 NO Right YES true No MX N2 T2 Stage III TCGA-TS-A8AV.63E2F152-246D-43A2-8E02-D8F69FFBFBEF.pdf A8AV NO NO Other, please specify Firefighter NO Primary Tumor 01 6th NO YES TS Pleura A DECEASED 2011 TCGA-TS-A8AV-01 TCGA-TS-A8AV-01 ebf56b30-bfce-4782-a66c-84b8e054fd2a TCGA-TS-A8AV-01A-12D-A39R-32 TCGA-TS-A8AV-01A-12D-A39R-32 ebf56b30-bfce-4782-a66c-84b8e054fd2a F4D70F81-5EA4-4105-80FD-EF9E204AC4C9 TCGA-TS-A8AV-01A-12D-A39Q-01 ebf56b30-bfce-4782-a66c-84b8e054fd2a TCGA-TS-A8AV-01 ebf56b30-bfce-4782-a66c-84b8e054fd2a TCGA-TS-A8AV-01 TCGA-TS-A8AV-01A-12D-A39Q-01 TCGA-TS-A8AV-01A-12D-A39S-05 +TCGA-TS-A8AY-01 TCGA-TS-A8AY-01 TCGA-TS-A8AY TCGA Mesothelioma (MESO) mesothelioma Lining of body cavities 48 TCGA-TS-A8AY TCGA-TS-A8AY-01A -17894 223 469 0 2014-4-25 FEMALE Epithelioid mesothelioma No No C45.0 9052/3 C38.4 YES 680 NO Left true No MX N1 T3 Stage III TCGA-TS-A8AY.86750CA3-218B-4F37-BAB7-CCED5112C826.pdf A8AY NO NO NO Primary Tumor 01 7th NO YES TS Pleura A DECEASED 2013 TCGA-TS-A8AY-01 TCGA-TS-A8AY-01 46f45cc1-9766-4233-8b17-e2345bde7ce5 TCGA-TS-A8AY-01A-21D-A39R-32 TCGA-TS-A8AY-01A-21D-A39R-32 46f45cc1-9766-4233-8b17-e2345bde7ce5 B079039C-6367-4364-B691-E5FF1604FAEE TCGA-TS-A8AY-01A-21D-A39Q-01 46f45cc1-9766-4233-8b17-e2345bde7ce5 TCGA-TS-A8AY-01 46f45cc1-9766-4233-8b17-e2345bde7ce5 TCGA-TS-A8AY-01 TCGA-TS-A8AY-01A-21D-A39Q-01 TCGA-TS-A8AY-01A-21D-A39S-05 +TCGA-UD-AABY-01 TCGA-UD-AABY-01 TCGA-UD-AABY TCGA Mesothelioma (MESO) mesothelioma Lining of body cavities NO NO 50 15 34 Occupational 11 TCGA-UD-AABY-F49716 TCGA-UD-AABY TCGA-UD-AABY-01A -18315 5129 843 0 47 1 2014-6-6 MALE Diffuse malignant mesothelioma - NOS Yes No C45.0 9052/3 C38.4 YES 190 NO Right NO Cytology Other, specify Intrapleural Progression ipsilateral NO YES true No M0 N0 T3 Stage III TCGA-UD-AABY.BED6A020-507B-41BD-8658-C092DBC9F369.pdf AABY Preoperative WITH TUMOR YES Yes NO Other, please specify Carpenter/building industry NO RX Primary Tumor 01 0.3 0.3 2.5 5th NO YES UD Pleura A DECEASED 1999 TCGA-UD-AABY-01 TCGA-UD-AABY-01 0057f9f7-779b-4914-8290-abbad2a0d81e 0057f9f7-779b-4914-8290-abbad2a0d81e 8B365FF2-51A2-4882-A4E2-50C42DADE2A6 TCGA-UD-AABY-01A-12D-A39Q-01 0057f9f7-779b-4914-8290-abbad2a0d81e TCGA-UD-AABY-01 0057f9f7-779b-4914-8290-abbad2a0d81e TCGA-UD-AABY-01 TCGA-UD-AABY-01A-12D-A39Q-01 TCGA-UD-AABY-01A-12D-A39S-05 +TCGA-UD-AABZ-01 TCGA-UD-AABZ-01 TCGA-UD-AABZ TCGA Mesothelioma (MESO) mesothelioma Lining of body cavities 46 27 Secondary Post surgery and vaccine TCGA-UD-AABZ-F59789 TCGA-UD-AABZ TCGA-UD-AABZ-01A 0.679 1.188 0.837 -16913 3610 197 0 2 Other, specify Lung Parent 2014-6-6 MALE Epithelioid mesothelioma Yes No C45.0 9052/3 C38.4 YES 110 NO Left NO Biopsy true No M0 N0 T2 Stage II TCGA-UD-AABZ.FA7A0AF7-06C4-4F15-B3B6-8B9E39D526B2.pdf AABZ Other WITH TUMOR NO YES Other, please specify Information services YES RX Primary Tumor 01 0.3 5.169 2.5 6th NO YES UD Pleura A DECEASED 2004 TCGA-UD-AABZ-01 TCGA-UD-AABZ-01 11dbf166-e0e8-4183-bd7f-465ed95deba2 TCGA-UD-AABZ-01A-12D-A39R-32 TCGA-UD-AABZ-01A-12D-A39R-32 11dbf166-e0e8-4183-bd7f-465ed95deba2 6CB8020C-F12D-4D3E-8F30-AE90EA557951 TCGA-UD-AABZ-01A-12D-A39Q-01 11dbf166-e0e8-4183-bd7f-465ed95deba2 TCGA-UD-AABZ-01 11dbf166-e0e8-4183-bd7f-465ed95deba2 TCGA-UD-AABZ-01 TCGA-UD-AABZ-01A-12D-A39Q-01 TCGA-UD-AABZ-01A-12D-A39S-05 +TCGA-UD-AAC1-01 TCGA-UD-AAC1-01 TCGA-UD-AAC1 TCGA Mesothelioma (MESO) mesothelioma Lining of body cavities YES NO 71 37 47 Secondary 1 TCGA-UD-AAC1-F59857 TCGA-UD-AAC1 TCGA-UD-AAC1-01A 0.566 1.075 1.029 -26057 3080 789 0 85 1 2014-6-6 FEMALE Epithelioid mesothelioma Yes No C45.0 9052/3 C38.4 YES 710 NO Right NO Biopsy Intrapleural Progression NO YES true No M0 N2 T2 Stage III TCGA-UD-AAC1.97EA8988-20F9-4E07-B2A5-C0B584DAC700.pdf AAC1 Pre-Adjuvant Therapy WITH TUMOR 11 NO YES Other, please specify Sales person NO R2 Primary Tumor 01 6th NO YES UD Pleura A DECEASED 2005 TCGA-UD-AAC1-01 TCGA-UD-AAC1-01 11c4219b-60ec-4730-9ea4-5d7922a7bb6c TCGA-UD-AAC1-01A-11D-A39R-32 TCGA-UD-AAC1-01A-11D-A39R-32 11c4219b-60ec-4730-9ea4-5d7922a7bb6c 42A3FCA6-0E1A-4B95-BF80-1AE6883852B1 TCGA-UD-AAC1-01A-11D-A39Q-01 11c4219b-60ec-4730-9ea4-5d7922a7bb6c TCGA-UD-AAC1-01 11c4219b-60ec-4730-9ea4-5d7922a7bb6c TCGA-UD-AAC1-01 TCGA-UD-AAC1-01A-11D-A39Q-01 TCGA-UD-AAC1-01A-11D-A39S-05 +TCGA-UD-AAC4-01 TCGA-UD-AAC4-01 TCGA-UD-AAC4 TCGA Mesothelioma (MESO) mesothelioma Lining of body cavities YES NO 65 16 21 05 TCGA-UD-AAC4-F59342 TCGA-UD-AAC4 TCGA-UD-AAC4-01A 0.803 1.301 0.837 -23949 3302 719 0 555 3 Other, specify Lung cancer Parent 2014-6-6 MALE Diffuse malignant mesothelioma - NOS Yes No C45.0 9050/3 C38.4 YES 490 NO Left NO Cytology Intrapleural Progression NO YES true Yes M0 N2 T2 Stage III TCGA-UD-AAC4.8FDC47D6-2DD0-428A-96C1-C6F70D67A07C.pdf AAC4 Post-Adjuvant Therapy WITH TUMOR 42 NO YES Other, please specify Draughting manager NO R2 Primary Tumor 01 0.3 1.302 2.5 6th NO YES UD Pleura A DECEASED 2004 TCGA-UD-AAC4-01 TCGA-UD-AAC4-01 68f8a449-b41e-471d-b82c-bc5f309f6b8e TCGA-UD-AAC4-01A-11D-A39R-32 TCGA-UD-AAC4-01A-11D-A39R-32 68f8a449-b41e-471d-b82c-bc5f309f6b8e 9029DE52-EA70-4EBE-8E3A-367E985293F4 TCGA-UD-AAC4-01A-11D-A39Q-01 68f8a449-b41e-471d-b82c-bc5f309f6b8e TCGA-UD-AAC4-01 68f8a449-b41e-471d-b82c-bc5f309f6b8e TCGA-UD-AAC4-01 TCGA-UD-AAC4-01A-11D-A39Q-01 TCGA-UD-AAC4-01A-11D-A39S-05 +TCGA-UD-AAC5-01 TCGA-UD-AAC5-01 TCGA-UD-AAC5 TCGA Mesothelioma (MESO) mesothelioma Lining of body cavities NO NO 66 14 58 Occupational 32 TCGA-UD-AAC5-F53086 TCGA-UD-AAC5 TCGA-UD-AAC5-01A 0.679 1.357 0.928 -24314 2910 253 0 230 0 2014-6-6 MALE Epithelioid mesothelioma Yes Yes C45.0 9052/3 C38.4 YES 60 NO Left NO Biopsy Other, specify Distant Metastasis Abdomen NO YES true No M0 N0 T1 Stage I TCGA-UD-AAC5.5BB63340-2A48-4ACB-A6D0-D8DF68A058B9.pdf AAC5 Preoperative WITH TUMOR 32 NO YES Other, please specify carpenter/builder YES RX Primary Tumor 01 0.3 1.355 2.5 6th NO YES UD Pleura A DECEASED 2005 TCGA-UD-AAC5-01 TCGA-UD-AAC5-01 57511dd9-3408-4595-9a86-82c5f6b3268b TCGA-UD-AAC5-01A-11D-A39R-32 TCGA-UD-AAC5-01A-11D-A39R-32 57511dd9-3408-4595-9a86-82c5f6b3268b TCGA-UD-AAC5-01A-11D-A39Q-01 57511dd9-3408-4595-9a86-82c5f6b3268b TCGA-UD-AAC5-01 57511dd9-3408-4595-9a86-82c5f6b3268b TCGA-UD-AAC5-01 TCGA-UD-AAC5-01A-11D-A39Q-01 TCGA-UD-AAC5-01A-11D-A39S-05 +TCGA-UD-AAC6-01 TCGA-UD-AAC6-01 TCGA-UD-AAC6 TCGA Mesothelioma (MESO) mesothelioma Lining of body cavities YES NO 67 24 25 Occupational 1 TCGA-UD-AAC6-F53083 TCGA-UD-AAC6 TCGA-UD-AAC6-01A 0.679 1.244 0.905 -24571 2817 456 0 126 2 2014-6-9 MALE Biphasic mesothelioma Yes No C45.0 9053/3 C38.4 YES 170 NO Left NO Biopsy Intrapleural Progression NO YES true No M0 N0 T2 Stage II TCGA-UD-AAC6.A033FA57-9895-4942-B3D5-0DA6134881AB.pdf AAC6 Post-Adjuvant Therapy WITH TUMOR 30 NO YES Other, please specify Window tinting YES R2 Primary Tumor 01 0.3 13.421 2.5 6th NO YES UD Pleura A DECEASED 2006 TCGA-UD-AAC6-01 TCGA-UD-AAC6-01 763a76b6-9065-4a53-8c9e-e39580d908d9 TCGA-UD-AAC6-01A-11D-A39R-32 TCGA-UD-AAC6-01A-11D-A39R-32 763a76b6-9065-4a53-8c9e-e39580d908d9 19D0E7AC-7CA1-40AB-B26F-00BF621A0EFE TCGA-UD-AAC6-01A-11D-A39Q-01 763a76b6-9065-4a53-8c9e-e39580d908d9 TCGA-UD-AAC6-01 763a76b6-9065-4a53-8c9e-e39580d908d9 TCGA-UD-AAC6-01 TCGA-UD-AAC6-01A-11D-A39Q-01 TCGA-UD-AAC6-01A-11D-A39S-05 +TCGA-UD-AAC7-01 TCGA-UD-AAC7-01 TCGA-UD-AAC7 TCGA Mesothelioma (MESO) mesothelioma Lining of body cavities NO 47 Occupational TCGA-UD-AAC7-F59422 TCGA-UD-AAC7 TCGA-UD-AAC7-01A 15 110 71 -17299 1951 406 0 265 2014-6-9 MALE Epithelioid mesothelioma Yes No C45.0 9052/3 C38.4 YES 570 NO Right NO Biopsy Other, specify Intrapleural Progression Pleura NO YES true No M0 N0 T2 Stage II TCGA-UD-AAC7.2CF5E13F-7B32-4D60-BD15-A50AC112DBEB.pdf AAC7 WITH TUMOR NO YES YES R2 Primary Tumor 01 0.3 3.121 2.5 6th NO YES UD Pleura A DECEASED 2008 TCGA-UD-AAC7-01 TCGA-UD-AAC7-01 19aa7fd7-e119-41a5-a6d4-ea36f9f1aaab TCGA-UD-AAC7-01A-11D-A39R-32 TCGA-UD-AAC7-01A-11D-A39R-32 19aa7fd7-e119-41a5-a6d4-ea36f9f1aaab C74A7608-0BE6-4F69-8ABB-0417950F505A TCGA-UD-AAC7-01A-11D-A39Q-01 19aa7fd7-e119-41a5-a6d4-ea36f9f1aaab TCGA-UD-AAC7-01 19aa7fd7-e119-41a5-a6d4-ea36f9f1aaab TCGA-UD-AAC7-01 TCGA-UD-AAC7-01A-11D-A39Q-01 TCGA-UD-AAC7-01A-11D-A39S-05 +TCGA-UT-A88C-01 TCGA-UT-A88C-01 TCGA-UT-A88C TCGA Mesothelioma (MESO) mesothelioma Lining of body cavities 62 16 32 Occupational 15 TCGA-UT-A88C-F68698 TCGA-UT-A88C TCGA-UT-A88C-01B 0.45 1.36 0.90 -23002 531 863 0 577 479 0 2014-12-11 MALE Epithelioid mesothelioma Yes No C45.0 9052/3 C38.4 YES 60 NO 100 Right NO Biopsy Other, specify Intrapleural Progression Mediastinum and Contralateral pleura NO YES true No M0 N2 T3 Stage III TCGA-UT-A88C.1ED5E6B0-FEBE-447E-B5A1-3771DAEC0513.pdf A88C Preoperative WITH TUMOR 40 NO YES Other, please specify Navy Personnel YES R0 Primary Tumor 01 7th NO YES UT Pleura B DECEASED 2012 TCGA-UT-A88C-01 TCGA-UT-A88C-01 9890e951-c9aa-4397-ab84-2af7e04429da TCGA-UT-A88C-01B-11D-A39R-32 TCGA-UT-A88C-01B-11D-A39R-32 9890e951-c9aa-4397-ab84-2af7e04429da TCGA-UT-A88C-01B-11D-A39Q-01 9890e951-c9aa-4397-ab84-2af7e04429da TCGA-UT-A88C-01 9890e951-c9aa-4397-ab84-2af7e04429da TCGA-UT-A88C-01 TCGA-UT-A88C-01B-11D-A39Q-01 TCGA-UT-A88C-01B-11D-A39S-05 +TCGA-UT-A88D-01 TCGA-UT-A88D-01 TCGA-UT-A88D TCGA Mesothelioma (MESO) mesothelioma Lining of body cavities 66 17 35 Occupational Amosite 18 TCGA-UT-A88D-F72803 TCGA-UT-A88D TCGA-UT-A88D-01B 0.79 1.24 0.96 -24300 461 823 0 444 568 0 2015-11-24 MALE Epithelioid mesothelioma Yes No C45.0 9052/3 C38.4 YES 70 NO Left NO Biopsy Abdomen Distant Metastasis YES true Yes M0 N0 T2 Stage II TCGA-UT-A88D.4C85EB8F-AC6C-4DD6-8B53-378667002491.pdf A88D Preoperative TUMOR FREE 18 NO NO Other, please specify Asbestos Product Manufacturing YES R0 Primary Tumor 01 7th NO YES UT Pleura B DECEASED 2012 TCGA-UT-A88D-01 TCGA-UT-A88D-01 9b173f02-ee88-4b4e-bbce-40e30a7eb229 TCGA-UT-A88D-01B-11D-A39R-32 TCGA-UT-A88D-01B-11D-A39R-32 9b173f02-ee88-4b4e-bbce-40e30a7eb229 TCGA-UT-A88D-01B-11D-A39Q-01 9b173f02-ee88-4b4e-bbce-40e30a7eb229 TCGA-UT-A88D-01 9b173f02-ee88-4b4e-bbce-40e30a7eb229 TCGA-UT-A88D-01 TCGA-UT-A88D-01B-11D-A39Q-01 TCGA-UT-A88D-01B-11D-A39S-05 +TCGA-UT-A88E-01 TCGA-UT-A88E-01 TCGA-UT-A88E TCGA Mesothelioma (MESO) mesothelioma Lining of body cavities 74 15 22 Occupational 7 TCGA-UT-A88E 0.45 1.36 1.70 -27347 434 0 0 2014-4-16 MALE Epithelioid mesothelioma Yes No C45.0 9052/3 C38.4 YES Right Biopsy YES No M0 N0 T1 Stage I A88E Preoperative WITH TUMOR 39 NO NO Construction and Extraction NO RX Primary Tumor 01 7th NO YES UT Pleura DECEASED 2012 TCGA-UT-A88E-01 TCGA-UT-A88E-01 f058f6e2-2e68-4ae5-97ab-32bad4c51a4b TCGA-UT-A88E-01B-11D-A39R-32 TCGA-UT-A88E-01B-11D-A39R-32 f058f6e2-2e68-4ae5-97ab-32bad4c51a4b TCGA-UT-A88E-01B-11D-A39Q-01 f058f6e2-2e68-4ae5-97ab-32bad4c51a4b TCGA-UT-A88E-01 f058f6e2-2e68-4ae5-97ab-32bad4c51a4b TCGA-UT-A88E-01 TCGA-UT-A88E-01B-11D-A39Q-01 TCGA-UT-A88E-01B-11D-A39S-05 +TCGA-UT-A88G-01 TCGA-UT-A88G-01 TCGA-UT-A88G TCGA Mesothelioma (MESO) mesothelioma Lining of body cavities 73 Occupational TCGA-UT-A88G TCGA-UT-A88G-01B 0.62 1.24 1.05 -26704 685 76 0 1 2014-4-16 MALE Biphasic mesothelioma Yes No C45.0 9053/3 C38.4 YES 30 NO Right Biopsy YES true No M0 N0 T3 Stage III TCGA-UT-A88G.0A21CA31-B711-4E7D-8616-7F0A064C1A03.pdf A88G Preoperative WITH TUMOR NO NO Construction and Extraction NO RX Primary Tumor 01 7th NO YES UT Pleura B DECEASED 2012 TCGA-UT-A88G-01 TCGA-UT-A88G-01 4684fde1-545e-4ae3-a987-c736772d0cf8 TCGA-UT-A88G-01B-11D-A39R-32 TCGA-UT-A88G-01B-11D-A39R-32 4684fde1-545e-4ae3-a987-c736772d0cf8 TCGA-UT-A88G-01B-11D-A39Q-01 4684fde1-545e-4ae3-a987-c736772d0cf8 TCGA-UT-A88G-01 4684fde1-545e-4ae3-a987-c736772d0cf8 TCGA-UT-A88G-01 TCGA-UT-A88G-01B-11D-A39Q-01 TCGA-UT-A88G-01B-11D-A39S-05 +TCGA-UT-A97Y-01 TCGA-UT-A97Y-01 TCGA-UT-A97Y TCGA Mesothelioma (MESO) mesothelioma Lining of body cavities 81 Secondary 30 TCGA-UT-A97Y TCGA-UT-A97Y-01A 0.34 1.13 0.98 -29905 735 144 0 2 Other, specify|Other, specify Breast|Breast Child|Grandparent 2014-4-16 FEMALE Epithelioid mesothelioma Yes No C45.0 9052/3 C38.4 YES 280 NO Right Biopsy NO true No M0 N0 T1 Stage I TCGA-UT-A97Y.81859C99-1011-4421-A5E3-87844EB925F0.pdf A97Y Other WITH TUMOR NO NO Other, please specify Office worker NO RX Primary Tumor 01 7th NO YES UT Pleura A DECEASED 2011 TCGA-UT-A97Y-01 TCGA-UT-A97Y-01 6704e7a7-975f-424d-976b-69f8db50f05f TCGA-UT-A97Y-01A-21D-A39R-32 TCGA-UT-A97Y-01A-21D-A39R-32 6704e7a7-975f-424d-976b-69f8db50f05f D64F211C-0993-440B-8AE7-5FD73CA4CEBD TCGA-UT-A97Y-01A-21D-A39Q-01 6704e7a7-975f-424d-976b-69f8db50f05f TCGA-UT-A97Y-01 6704e7a7-975f-424d-976b-69f8db50f05f TCGA-UT-A97Y-01 TCGA-UT-A97Y-01A-21D-A39Q-01 TCGA-UT-A97Y-01A-21D-A39S-05 +TCGA-XT-AASU-01 TCGA-XT-AASU-01 TCGA-XT-AASU TCGA Mesothelioma (MESO) mesothelioma Lining of body cavities 60 TCGA-XT-AASU TCGA-XT-AASU-01A -22021 2943 142 0 2 Other, specify|Other, specify bone|ovarian Parent|Sibling 2014-6-13 MALE Biphasic mesothelioma Yes No C45.0 9053/3 C38.4 YES 160 NO 80 Right YES true No MX NX T3 Stage III TCGA-XT-AASU.C8BD557C-7182-404C-A6BB-066CD61D2654.pdf AASU Preoperative WITH TUMOR NO YES Other, please specify sheet mill worker NO R0 Primary Tumor 01 6th NO YES XT Pleura A DECEASED 2005 TCGA-XT-AASU-01 TCGA-XT-AASU-01 76be312d-44cf-427f-af75-878538e7b38b TCGA-XT-AASU-01A-11D-A39R-32 TCGA-XT-AASU-01A-11D-A39R-32 76be312d-44cf-427f-af75-878538e7b38b CDDC2E6D-1892-4004-95EE-FB3922D38B00 TCGA-XT-AASU-01A-11D-A39Q-01 76be312d-44cf-427f-af75-878538e7b38b TCGA-XT-AASU-01 76be312d-44cf-427f-af75-878538e7b38b TCGA-XT-AASU-01 TCGA-XT-AASU-01A-11D-A39Q-01 TCGA-XT-AASU-01A-11D-A39S-05 +TCGA-YS-A95B-01 TCGA-YS-A95B-01 TCGA-YS-A95B TCGA Mesothelioma (MESO) mesothelioma Lining of body cavities 28 TCGA-YS-A95B TCGA-YS-A95B-01A 0.5 0.9 0.53 -10510 1638 39 0 2014-6-25 FEMALE Epithelioid mesothelioma No C45.0 9052/3 C38.4 YES 90 NO Left Biopsy NO false No M0 N3 T4 Stage IV TCGA-YS-A95B.F57E6E47-4A8E-42C2-ABB8-DD81EF21DBF6.pdf A95B WITH TUMOR NO NO Other, please specify Teacher NO R2 Primary Tumor 01 6th NO YES YS Pleura A DECEASED 2009 TCGA-YS-A95B-01 TCGA-YS-A95B-01 316b3a1a-89a5-4cff-9528-34f564af605d TCGA-YS-A95B-01A-11D-A39R-32 TCGA-YS-A95B-01A-11D-A39R-32 316b3a1a-89a5-4cff-9528-34f564af605d 137178BF-6236-4858-A0BC-F64902535571 TCGA-YS-A95B-01A-11D-A39Q-01 316b3a1a-89a5-4cff-9528-34f564af605d TCGA-YS-A95B-01 316b3a1a-89a5-4cff-9528-34f564af605d TCGA-YS-A95B-01 TCGA-YS-A95B-01A-11D-A39Q-01 TCGA-YS-A95B-01A-11D-A39S-05 +TCGA-YS-A95C-01 TCGA-YS-A95C-01 TCGA-YS-A95C TCGA Mesothelioma (MESO) mesothelioma Lining of body cavities 54 TCGA-YS-A95C TCGA-YS-A95C-01A -19818 177 133 0 Other, specify Prostate Parent 2014-9-5 MALE Epithelioid mesothelioma No C45.0 9052/3 C38.4 YES 770 NO Right Biopsy NO false No M0 N2 T1 Stage III TCGA-YS-A95C.6067AFDB-9347-4212-BA91-FD839E999AEC.pdf A95C TUMOR FREE YES Yes NO NO R0 Primary Tumor 01 7th NO YES YS Pleura A DECEASED 2013 TCGA-YS-A95C-01 TCGA-YS-A95C-01 dfd27367-2e2a-4aff-80da-a9ec4a445370 TCGA-YS-A95C-01A-11D-A39R-32 TCGA-YS-A95C-01A-11D-A39R-32 dfd27367-2e2a-4aff-80da-a9ec4a445370 ED5DD6B3-7D33-4AF5-8EEE-B3861D1AF639 TCGA-YS-A95C-01A-11D-A39Q-01 dfd27367-2e2a-4aff-80da-a9ec4a445370 TCGA-YS-A95C-01 dfd27367-2e2a-4aff-80da-a9ec4a445370 TCGA-YS-A95C-01 TCGA-YS-A95C-01A-11D-A39Q-01 TCGA-YS-A95C-01A-11D-A39S-05 +TCGA-YS-AA4M-01 TCGA-YS-AA4M-01 TCGA-YS-AA4M TCGA Mesothelioma (MESO) mesothelioma Lining of body cavities 66 TCGA-YS-AA4M TCGA-YS-AA4M-01A -24176 91 84 0 2 2014-6-25 MALE Diffuse malignant mesothelioma - NOS No C45.0 9050/3 C38.4 YES 30 NO Right Biopsy YES false No M1 N0 T1b Stage IV TCGA-YS-AA4M.90EF92D1-7D02-4A39-8C93-5F88EAC28516.pdf AA4M Preoperative WITH TUMOR NO NO Other, please specify Farmer NO R2 Primary Tumor 01 7th NO YES YS Pleura A DECEASED 2013 TCGA-YS-AA4M-01 TCGA-YS-AA4M-01 23c5df47-2ae6-49e0-b34c-92d348a5e87f TCGA-YS-AA4M-01A-11D-A39R-32 TCGA-YS-AA4M-01A-11D-A39R-32 23c5df47-2ae6-49e0-b34c-92d348a5e87f TCGA-YS-AA4M-01A-11D-A39Q-01 23c5df47-2ae6-49e0-b34c-92d348a5e87f TCGA-YS-AA4M-01 23c5df47-2ae6-49e0-b34c-92d348a5e87f TCGA-YS-AA4M-01 TCGA-YS-AA4M-01A-11D-A39Q-01 TCGA-YS-AA4M-01A-11D-A39S-05 +TCGA-ZN-A9VO-01 TCGA-ZN-A9VO-01 TCGA-ZN-A9VO TCGA Mesothelioma (MESO) mesothelioma Lining of body cavities 36 Secondary TCGA-ZN-A9VO-F72460 TCGA-ZN-A9VO TCGA-ZN-A9VO-01A 0.50 1.20 0.81 -13243 765 0 261 2015-6-29 MALE Epithelioid mesothelioma Yes No C45.0 9052/3 C38.4 YES 90 NO 90 Right YES Biopsy NO true No M1 N2 T4 Stage IV TCGA-ZN-A9VO.D10B7DE3-1AE6-42A3-BC9A-53CECC84BD96.pdf A9VO Preoperative TUMOR FREE NO YES Other, please specify IT YES Primary Tumor 01 0.0 7.9 1.5 8.8 7th NO YES ZN Pleura A LIVING 2011 TCGA-ZN-A9VO-01 TCGA-ZN-A9VO-01 5f6c1690-7f39-4fbb-bee2-266c6f6fc307 TCGA-ZN-A9VO-01A-11D-A39R-32 TCGA-ZN-A9VO-01A-11D-A39R-32 5f6c1690-7f39-4fbb-bee2-266c6f6fc307 TCGA-ZN-A9VO-01A-11D-A39Q-01 5f6c1690-7f39-4fbb-bee2-266c6f6fc307 TCGA-ZN-A9VO-01 5f6c1690-7f39-4fbb-bee2-266c6f6fc307 TCGA-ZN-A9VO-01 TCGA-ZN-A9VO-01A-11D-A39Q-01 TCGA-ZN-A9VO-01A-11D-A39S-05 +TCGA-ZN-A9VP-01 TCGA-ZN-A9VP-01 TCGA-ZN-A9VP TCGA Mesothelioma (MESO) mesothelioma Lining of body cavities 51 Occupational TCGA-ZN-A9VP-F72461 TCGA-ZN-A9VP 0.5 1.20 1.45 -18697 0 228 Other, specify Prostate and lymphoma Parent 2015-6-29 MALE Epithelioid mesothelioma Yes No C45.0 9052/3 C38.4 YES 100 Right YES Biopsy NO No MX N2 T3 Stage III A9VP Preoperative TUMOR FREE NO YES Other, please specify UPS employee NO Primary Tumor 01 0.0 6.7 1.5 4.6 7th NO YES ZN Pleura LIVING 2012 TCGA-ZN-A9VP-01 TCGA-ZN-A9VP-01 a432d310-ef23-415e-bfb9-d0110ecd418c TCGA-ZN-A9VP-01A-11D-A39R-32 TCGA-ZN-A9VP-01A-11D-A39R-32 a432d310-ef23-415e-bfb9-d0110ecd418c TCGA-ZN-A9VP-01A-11D-A39Q-01 a432d310-ef23-415e-bfb9-d0110ecd418c TCGA-ZN-A9VP-01 a432d310-ef23-415e-bfb9-d0110ecd418c TCGA-ZN-A9VP-01 TCGA-ZN-A9VP-01A-11D-A39Q-01 TCGA-ZN-A9VP-01A-11D-A39S-05 +TCGA-ZN-A9VQ-01 TCGA-ZN-A9VQ-01 TCGA-ZN-A9VQ TCGA Mesothelioma (MESO) mesothelioma Lining of body cavities 61 Occupational 23 TCGA-ZN-A9VQ-F72462 TCGA-ZN-A9VQ TCGA-ZN-A9VQ-01A 0.50 1.20 0.93 -22443 420 0 499 2015-6-29 MALE Biphasic mesothelioma Yes No C45.0 9053/3 C38.4 YES 160 NO 90 Right YES Biopsy NO true No MX N0 T1 Stage I TCGA-ZN-A9VQ.9FAAD3FA-195F-48A3-A09C-603C8635990A.pdf A9VQ Preoperative WITH TUMOR 23 NO NO Other, please specify Navy and corrections officer NO Primary Tumor 01 0.0 1.5 1.5 7th NO YES ZN Pleura A LIVING 2012 TCGA-ZN-A9VQ-01 TCGA-ZN-A9VQ-01 0b2cbe7c-8392-4072-95af-9ded20aa3888 TCGA-ZN-A9VQ-01A-11D-A39R-32 TCGA-ZN-A9VQ-01A-11D-A39R-32 0b2cbe7c-8392-4072-95af-9ded20aa3888 AE23FDA4-25AC-44AD-BFBA-75E393B4BEC5 TCGA-ZN-A9VQ-01A-11D-A39Q-01 0b2cbe7c-8392-4072-95af-9ded20aa3888 TCGA-ZN-A9VQ-01 0b2cbe7c-8392-4072-95af-9ded20aa3888 TCGA-ZN-A9VQ-01 TCGA-ZN-A9VQ-01A-11D-A39Q-01 TCGA-ZN-A9VQ-01A-11D-A39S-05 +TCGA-ZN-A9VS-01 TCGA-ZN-A9VS-01 TCGA-ZN-A9VS TCGA Mesothelioma (MESO) mesothelioma Lining of body cavities 67 Occupational TCGA-ZN-A9VS-F72464 TCGA-ZN-A9VS TCGA-ZN-A9VS-01A 0.5 1.20 0.90 -24490 772 0 1228 1025 Other, specify|Melanoma pancreatice tumor| Parent|Sibling 2015-6-21 MALE Epithelioid mesothelioma Yes No C45.0 9052/3 C38.4 YES 60 NO 100 Right NO Biopsy Lung Intrapleural Progression NO YES true No MX N0 T3 Stage III TCGA-ZN-A9VS.B47307E4-CEA2-4965-BAE9-16184AFFC8BA.pdf A9VS Preoperative WITH TUMOR NO NO Welding NO Primary Tumor 01 0.0 2.8 1.5 5.6 7th NO YES ZN Pleura A LIVING 2011 TCGA-ZN-A9VS-01 TCGA-ZN-A9VS-01 152c3c10-0e7f-4294-aa47-499777063161 TCGA-ZN-A9VS-01A-11D-A39R-32 TCGA-ZN-A9VS-01A-11D-A39R-32 152c3c10-0e7f-4294-aa47-499777063161 TCGA-ZN-A9VS-01A-11D-A39Q-01 152c3c10-0e7f-4294-aa47-499777063161 TCGA-ZN-A9VS-01 152c3c10-0e7f-4294-aa47-499777063161 TCGA-ZN-A9VS-01 TCGA-ZN-A9VS-01A-11D-A39Q-01 TCGA-ZN-A9VS-01A-11D-A39S-05 +TCGA-ZN-A9VU-01 TCGA-ZN-A9VU-01 TCGA-ZN-A9VU TCGA Mesothelioma (MESO) mesothelioma Lining of body cavities 70 Occupational TCGA-ZN-A9VU-F72465 TCGA-ZN-A9VU TCGA-ZN-A9VU-01A 0.50 1.20 0.82 -25714 490 0 977 Other, specify lung cancer Parent 2015-6-21 MALE Epithelioid mesothelioma Yes No C45.0 9052/3 C38.4 YES 70 NO 100 Left NO Biopsy NO true No MX N0 T2 Stage II TCGA-ZN-A9VU.671AF4AB-2F31-4C7B-AA46-B066EE103CF7.pdf A9VU Preoperative TUMOR FREE NO Other, please specify plumber NO Primary Tumor 01 0.0 2.3 1.5 6.0 7th NO YES ZN Pleura A LIVING 2012 TCGA-ZN-A9VU-01 TCGA-ZN-A9VU-01 1fb2c97b-ed35-45f6-a7bb-ad55ad668d1f TCGA-ZN-A9VU-01A-11D-A39R-32 TCGA-ZN-A9VU-01A-11D-A39R-32 1fb2c97b-ed35-45f6-a7bb-ad55ad668d1f TCGA-ZN-A9VU-01A-11D-A39Q-01 1fb2c97b-ed35-45f6-a7bb-ad55ad668d1f TCGA-ZN-A9VU-01 1fb2c97b-ed35-45f6-a7bb-ad55ad668d1f TCGA-ZN-A9VU-01 TCGA-ZN-A9VU-01A-11D-A39Q-01 TCGA-ZN-A9VU-01A-11D-A39S-05 +TCGA-ZN-A9VV-01 TCGA-ZN-A9VV-01 TCGA-ZN-A9VV TCGA Mesothelioma (MESO) mesothelioma Lining of body cavities 68 TCGA-ZN-A9VV-F72466 TCGA-ZN-A9VV TCGA-ZN-A9VV-01A 0.50 1.20 1.11 -25096 1182 0 1309 1299 2015-6-21 MALE Biphasic mesothelioma No C45.0 9053/3 C38.4 YES 260 NO Right NO Biopsy Lung Intrapleural Progression NO YES true No MX N2 T3 Stage III TCGA-ZN-A9VV.E6BF6C0B-1B9E-42A3-964F-5F9A12817496.pdf A9VV WITH TUMOR NO YES Automotive NO Primary Tumor 01 0.0 1.5 6.1 7th NO YES ZN Pleura A LIVING 2010 TCGA-ZN-A9VV-01 TCGA-ZN-A9VV-01 52721a41-bb67-4e05-b718-18315be16624 TCGA-ZN-A9VV-01A-11D-A39R-32 TCGA-ZN-A9VV-01A-11D-A39R-32 52721a41-bb67-4e05-b718-18315be16624 A327904B-D5DF-41AD-9C96-41625F38B018 TCGA-ZN-A9VV-01A-11D-A39Q-01 52721a41-bb67-4e05-b718-18315be16624 TCGA-ZN-A9VV-01 52721a41-bb67-4e05-b718-18315be16624 TCGA-ZN-A9VV-01 TCGA-ZN-A9VV-01A-11D-A39Q-01 TCGA-ZN-A9VV-01A-11D-A39S-05 +TCGA-ZN-A9VW-01 TCGA-ZN-A9VW-01 TCGA-ZN-A9VW TCGA Mesothelioma (MESO) mesothelioma Lining of body cavities 61 Occupational TCGA-ZN-A9VW TCGA-ZN-A9VW-01A 0.5 1.20 0.86 -22588 1246 84 0 Other, specify black lung Grandparent 2014-9-26 MALE Biphasic mesothelioma Yes No C45.0 9053/3 C38.4 YES 200 NO Right Biopsy YES true No MX N0 T4 Stage IV TCGA-ZN-A9VW.C3231F34-1580-4BBC-ABEF-BF2693249E3C.pdf A9VW WITH TUMOR NO NO Other, please specify military, trucking, environmental exposures NO Primary Tumor 01 0.0 2.7 1.5 8.6 7th NO YES ZN Pleura A DECEASED 2010 TCGA-ZN-A9VW-01 TCGA-ZN-A9VW-01 2f773549-6729-45df-9d58-485eb019cde9 TCGA-ZN-A9VW-01A-11D-A39R-32 TCGA-ZN-A9VW-01A-11D-A39R-32 2f773549-6729-45df-9d58-485eb019cde9 36FD8ABA-7A9A-4D88-AB0E-CE0CD094F618 TCGA-ZN-A9VW-01A-11D-A39Q-01 2f773549-6729-45df-9d58-485eb019cde9 TCGA-ZN-A9VW-01 2f773549-6729-45df-9d58-485eb019cde9 TCGA-ZN-A9VW-01 TCGA-ZN-A9VW-01A-11D-A39Q-01 TCGA-ZN-A9VW-01A-11D-A39S-05 diff --git a/input/TCGA/TCGA_Ocular_melanomas_(UVM)/TCGA.UVM.sampleMap_HiSeqV2_PANCAN.gz b/input/TCGA/TCGA_Ocular_melanomas_(UVM)/TCGA.UVM.sampleMap_HiSeqV2_PANCAN.gz new file mode 100644 index 0000000000000000000000000000000000000000..f0f24e7a7299bf79adf757f0c50c6d18e6543900 --- /dev/null +++ b/input/TCGA/TCGA_Ocular_melanomas_(UVM)/TCGA.UVM.sampleMap_HiSeqV2_PANCAN.gz @@ -0,0 +1,3 @@ +version https://git-lfs.github.com/spec/v1 +oid sha256:31a8b44fb966d247dbf0cc11c3b99ce2e07b0ed1b5fdb7e4aeb759365946be9e +size 6012339 diff --git a/input/TCGA/TCGA_lower_grade_glioma_and_glioblastoma_(GBMLGG)/TCGA.GBMLGG.sampleMap_GBMLGG_clinicalMatrix b/input/TCGA/TCGA_lower_grade_glioma_and_glioblastoma_(GBMLGG)/TCGA.GBMLGG.sampleMap_GBMLGG_clinicalMatrix new file mode 100644 index 0000000000000000000000000000000000000000..9766049167045bacad17f00959fb4a480f337959 --- /dev/null +++ b/input/TCGA/TCGA_lower_grade_glioma_and_glioblastoma_(GBMLGG)/TCGA.GBMLGG.sampleMap_GBMLGG_clinicalMatrix @@ -0,0 +1,1149 @@ +sampleID _INTEGRATION _PANCAN_CNA_PANCAN_K8 _PANCAN_Cluster_Cluster_PANCAN _PANCAN_DNAMethyl_PANCAN _PANCAN_RPPA_PANCAN_K8 _PANCAN_UNC_RNAseq_PANCAN_K16 _PANCAN_mutation_PANCAN _PATIENT _cohort _primary_disease _primary_site additional_pharmaceutical_therapy additional_radiation_therapy additional_surgery_locoregional_procedure additional_surgery_metastatic_procedure age_at_initial_pathologic_diagnosis animal_insect_allergy_history animal_insect_allergy_types asthma_history bcr_followup_barcode bcr_patient_barcode bcr_sample_barcode days_to_additional_surgery_locoregional_procedure days_to_additional_surgery_metastatic_procedure days_to_birth days_to_collection days_to_death days_to_initial_pathologic_diagnosis days_to_last_followup days_to_new_tumor_event_additional_surgery_procedure days_to_new_tumor_event_after_initial_treatment days_to_performance_status_assessment eastern_cancer_oncology_group eczema_history family_history_of_cancer family_history_of_primary_brain_tumor first_diagnosis_age_asth_ecz_hay_fev_mold_dust first_diagnosis_age_of_animal_insect_allergy first_diagnosis_age_of_food_allergy first_presenting_symptom first_presenting_symptom_longest_duration followup_case_report_form_submission_reason followup_treatment_success food_allergy_history food_allergy_types form_completion_date gender hay_fever_history headache_history histological_type history_ionizing_rt_to_head history_of_neoadjuvant_treatment icd_10 icd_o_3_histology icd_o_3_site informed_consent_verified inherited_genetic_syndrome_found inherited_genetic_syndrome_result initial_pathologic_diagnosis_method initial_weight intermediate_dimension is_ffpe karnofsky_performance_score laterality ldh1_mutation_found ldh1_mutation_test_method ldh1_mutation_tested longest_dimension lost_follow_up mental_status_changes mold_or_dust_allergy_history motor_movement_changes neoplasm_histologic_grade new_neoplasm_event_type new_tumor_event_additional_surgery_procedure new_tumor_event_after_initial_treatment oct_embedded other_dx pathology_report_file_name patient_id performance_status_scale_timing person_neoplasm_cancer_status postoperative_rx_tx preoperative_antiseizure_meds preoperative_corticosteroids primary_therapy_outcome_success prior_glioma radiation_therapy sample_type sample_type_id seizure_history sensory_changes shortest_dimension supratentorial_localization targeted_molecular_therapy tissue_prospective_collection_indicator tissue_retrospective_collection_indicator tissue_source_site tumor_location tumor_tissue_site vial_number visual_changes vital_status year_of_initial_pathologic_diagnosis _GENOMIC_ID_TCGA_GBMLGG_exp_HiSeqV2 _GENOMIC_ID_TCGA_GBMLGG_PDMarrayCNV _GENOMIC_ID_TCGA_GBMLGG_mutation _GENOMIC_ID_TCGA_GBMLGG_hMethyl450 _GENOMIC_ID_TCGA_GBMLGG_PDMarray _GENOMIC_ID_TCGA_GBMLGG_gistic2 _GENOMIC_ID_TCGA_GBMLGG_PDMRNAseq _GENOMIC_ID_TCGA_GBMLGG_exp_HiSeqV2_PANCAN _GENOMIC_ID_TCGA_GBMLGG_PDMRNAseqCNV _GENOMIC_ID_TCGA_GBMLGG_gistic2thd _GENOMIC_ID_TCGA_GBMLGG_exp_HiSeqV2_exon +TCGA-02-0001-01 TCGA-02-0001-01 High GBM non-CIMP c15 TCGA-02-0001 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain NO NO 44 TCGA-02-0001-F22169 TCGA-02-0001 -16179 358 0 279 137 2008-12-16 FEMALE Untreated primary (de novo) GBM Yes C71.9 9440/3 C71.9 YES Tumor resection 80 Recurrence 0001 WITH TUMOR YES NO YES Primary Tumor 01 02 Brain DECEASED 2002 TCGA-02-0001-01 TCGA-02-0001-01 TCGA-02-0001-01C-01D-0182-01 TCGA-02-0001-01C-01D-0182-01 +TCGA-02-0003-01 TCGA-02-0003-01 GBM C10-GBM GBM non-CIMP c15 KIRC-like c1 mutation cluster 8 TCGA-02-0003 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain NO NO 50 TCGA-02-0003-F22176 TCGA-02-0003 -18341 144 0 144 40 2008-12-16 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 100 Recurrence 0003 WITH TUMOR YES NO YES Primary Tumor 01 02 Brain DECEASED 2003 TCGA-02-0003-01 TCGA-02-0003-01A-01D-1490-08 TCGA-02-0003-01 TCGA-02-0003-01A-01D-0182-01 TCGA-02-0003-01A-01D-0182-01 +TCGA-02-0004-01 TCGA-02-0004-01 GBM KIRC-like c1 TCGA-02-0004 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain NO NO 59 TCGA-02-0004-F22180 TCGA-02-0004 -21617 345 0 345 314 2008-12-17 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 80 Progression of Disease 0004 WITH TUMOR YES NO YES Primary Tumor 01 02 Brain DECEASED 2002 TCGA-02-0004-01 +TCGA-02-0006-01 TCGA-02-0006-01 GBM GBM non-CIMP c15 TCGA-02-0006 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES NO 56 TCGA-02-0006-F22185 TCGA-02-0006 TCGA-02-0006-01B -20516 558 0 558 302 2008-12-17 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 1.3 NO 80 1.3 Recurrence TCGA-02-0006.84B8590B-E638-422E-BC44-EAE6C3C5527E.pdf 0006 WITH TUMOR YES NO YES Primary Tumor 01 0.1 02 Brain B DECEASED 2002 TCGA-02-0006-01B-01D-0182-01 TCGA-02-0006-01B-01D-0182-01 +TCGA-02-0007-01 TCGA-02-0007-01 GBM GBM non-CIMP c15 TCGA-02-0007 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain NO YES 40 TCGA-02-0007-F22191 TCGA-02-0007 -14806 705 0 705 518 2008-12-16 FEMALE Treated primary GBM Yes C71.9 9440/3 C71.9 YES Tumor resection 80 Progression of Disease 0007 WITH TUMOR YES NO YES Primary Tumor 01 02 Brain DECEASED 2002 TCGA-02-0007-01 TCGA-02-0007-01 TCGA-02-0007-01A-01D-0182-01 TCGA-02-0007-01A-01D-0182-01 +TCGA-02-0009-01 TCGA-02-0009-01 GBM GBM non-CIMP c15 TCGA-02-0009 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain NO 61 TCGA-02-0009-F22196 TCGA-02-0009 -22457 322 0 322 264 2008-12-16 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 80 Progression of Disease 0009 WITH TUMOR NO YES Primary Tumor 01 02 Brain DECEASED 2003 TCGA-02-0009-01 TCGA-02-0009-01 TCGA-02-0009-01A-01D-0182-01 TCGA-02-0009-01A-01D-0182-01 +TCGA-02-0010-01 TCGA-02-0010-01 Kirc+ GBM CIMP c16 TCGA-02-0010 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES NO 20 TCGA-02-0010-F22198 TCGA-02-0010 -7452 1077 0 1077 351 2008-12-16 FEMALE Treated primary GBM Yes C71.9 9440/3 C71.9 YES Tumor resection 80 Progression of Disease 0010 WITH TUMOR YES NO YES Primary Tumor 01 02 Brain DECEASED 2002 TCGA-02-0010-01 TCGA-02-0010-01 TCGA-02-0010-01A-01D-0182-01 TCGA-02-0010-01A-01D-0182-01 +TCGA-02-0011-01 TCGA-02-0011-01 Squamous GBM non-CIMP c15 GBM-like c2 TCGA-02-0011 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES NO 18 TCGA-02-0011-F22204 TCGA-02-0011 -6926 630 0 630 145 2008-12-17 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 80 Progression of Disease 0011 WITH TUMOR YES NO YES Primary Tumor 01 02 Brain DECEASED 2004 TCGA-02-0011-01 TCGA-02-0011-01 TCGA-02-0011-01B-01D-0182-01 TCGA-02-0011-01B-01D-0182-01 +TCGA-02-0014-01 TCGA-02-0014-01 Squamous GBM CIMP c16 GBM-like c2 TCGA-02-0014 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES NO 25 TCGA-02-0014-F22211 TCGA-02-0014 -9369 2512 0 2512 2243 2008-12-17 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 100 Progression of Disease 0014 WITH TUMOR YES NO YES Primary Tumor 01 02 Brain DECEASED 1997 TCGA-02-0014-01 TCGA-02-0014-01 TCGA-02-0014-01A-01D-0182-01 TCGA-02-0014-01A-01D-0182-01 +TCGA-02-0015-01 TCGA-02-0015-01 GBM TCGA-02-0015 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES NO 50 TCGA-02-0015-F22216 TCGA-02-0015 -18404 627 0 627 456 2008-12-16 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 80 Recurrence 0015 WITH TUMOR YES NO YES Primary Tumor 01 02 Brain DECEASED 2002 TCGA-02-0015-01 TCGA-02-0015-01 TCGA-02-0015-01A-01G-0293-01 TCGA-02-0015-01A-01G-0293-01 +TCGA-02-0016-01 TCGA-02-0016-01 GBM TCGA-02-0016 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain NO NO 50 TCGA-02-0016-F22221 TCGA-02-0016 -18271 0 1699 1699 2008-12-16 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 100 Recurrence 0016 WITH TUMOR YES NO YES Primary Tumor 01 02 Brain LIVING 2004 TCGA-02-0016-01 TCGA-02-0016-01 TCGA-02-0016-01A-01G-0293-01 TCGA-02-0016-01A-01G-0293-01 +TCGA-02-0021-01 TCGA-02-0021-01 GBM GBM non-CIMP c15 TCGA-02-0021 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain NO NO 43 TCGA-02-0021-F22225 TCGA-02-0021 -16035 2362 0 2362 255 2008-12-16 FEMALE Untreated primary (de novo) GBM Yes C71.9 9440/3 C71.9 YES Tumor resection 80 Progression of Disease 0021 WITH TUMOR YES NO YES Primary Tumor 01 02 Brain DECEASED 1999 TCGA-02-0021-01 TCGA-02-0021-01 TCGA-02-0021-01A-01D-0182-01 TCGA-02-0021-01A-01D-0182-01 +TCGA-02-0023-01 TCGA-02-0023-01 GBM TCGA-02-0023 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES NO 38 TCGA-02-0023-F22233 TCGA-02-0023 -14003 612 0 612 435 2008-12-17 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 80 Progression of Disease 0023 WITH TUMOR YES NO YES Primary Tumor 01 02 Brain DECEASED 2003 TCGA-02-0023-01 TCGA-02-0023-01 TCGA-02-0023-01B-01G-0293-01 TCGA-02-0023-01B-01G-0293-01 +TCGA-02-0024-01 TCGA-02-0024-01 GBM GBM non-CIMP c15 TCGA-02-0024 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain NO 35 TCGA-02-0024-F22238 TCGA-02-0024 -13116 1615 0 1615 1401 2008-12-16 MALE Treated primary GBM Yes C71.9 9440/3 C71.9 YES Tumor resection 100 Recurrence 0024 WITH TUMOR YES NO YES Primary Tumor 01 02 Brain DECEASED 2000 TCGA-02-0024-01 TCGA-02-0024-01 TCGA-02-0024-01B-01D-0182-01 TCGA-02-0024-01B-01D-0182-01 +TCGA-02-0025-01 TCGA-02-0025-01 COAD-READ TCGA-02-0025 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES NO 47 TCGA-02-0025-F22242 TCGA-02-0025 -17402 1300 0 1300 656 2008-12-17 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 100 Progression of Disease 0025 WITH TUMOR YES NO YES Primary Tumor 01 02 Brain DECEASED 2002 TCGA-02-0025-01 TCGA-02-0025-01 TCGA-02-0025-01A-01G-0293-01 TCGA-02-0025-01A-01G-0293-01 +TCGA-02-0026-01 TCGA-02-0026-01 Kirc+ TCGA-02-0026 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES NO 27 TCGA-02-0026-F22248 TCGA-02-0026 -10022 748 0 748 462 2008-12-17 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 80 Progression of Disease 0026 WITH TUMOR YES NO YES Primary Tumor 01 02 Brain DECEASED 2003 TCGA-02-0026-01 TCGA-02-0026-01 TCGA-02-0026-01B-01G-0293-01 TCGA-02-0026-01B-01G-0293-01 +TCGA-02-0027-01 TCGA-02-0027-01 GBM GBM non-CIMP c15 TCGA-02-0027 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES NO 33 TCGA-02-0027-F22254 TCGA-02-0027 -12369 370 0 315 257 2008-12-17 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 100 Progression of Disease 0027 WITH TUMOR YES NO YES Primary Tumor 01 02 Brain DECEASED 2005 TCGA-02-0027-01 TCGA-02-0027-01 TCGA-02-0027-01A-01D-0182-01 TCGA-02-0027-01A-01D-0182-01 +TCGA-02-0028-01 TCGA-02-0028-01 Iq GBM CIMP c16 TCGA-02-0028 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES NO 39 TCGA-02-0028-F22262 TCGA-02-0028 -14304 2755 0 2755 1921 2008-12-17 MALE Treated primary GBM Yes C71.9 9440/3 C71.9 YES Tumor resection 100 Progression of Disease 0028 WITH TUMOR YES NO YES Primary Tumor 01 02 Brain DECEASED 1998 TCGA-02-0028-01 TCGA-02-0028-01 TCGA-02-0028-01A-01D-0182-01 TCGA-02-0028-01A-01D-0182-01 +TCGA-02-0033-01 TCGA-02-0033-01 GBM GBM non-CIMP c15 mutation cluster 3 TCGA-02-0033 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain NO 54 TCGA-02-0033-F22269 TCGA-02-0033 -20070 86 0 86 32 2008-12-17 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 100 Progression of Disease 0033 WITH TUMOR NO YES Primary Tumor 01 02 Brain DECEASED 2003 TCGA-02-0033-01 TCGA-02-0033-01A-01D-1490-08 TCGA-02-0033-01 TCGA-02-0033-01A-01D-0182-01 TCGA-02-0033-01A-01D-0182-01 +TCGA-02-0034-01 TCGA-02-0034-01 GBM GBM non-CIMP c15 TCGA-02-0034 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain NO NO 60 TCGA-02-0034-F22271 TCGA-02-0034 -22166 430 0 430 386 2008-12-17 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 80 Progression of Disease 0034 WITH TUMOR YES NO YES Primary Tumor 01 02 Brain DECEASED 2003 TCGA-02-0034-01 TCGA-02-0034-01 TCGA-02-0034-01A-01D-0182-01 TCGA-02-0034-01A-01D-0182-01 +TCGA-02-0037-01 TCGA-02-0037-01 GBM GBM non-CIMP c15 TCGA-02-0037 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain NO NO 74 TCGA-02-0037-F22275 TCGA-02-0037 TCGA-02-0037-01A -27063 110 0 110 37 2008-12-17 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection NO 80 Progression of Disease TCGA-02-0037.AB4312D6-534C-4A04-88F2-FE2211CDCF4D.pdf 0037 WITH TUMOR NO NO YES Primary Tumor 01 02 Brain A DECEASED 2004 TCGA-02-0037-01A-01D-0182-01 TCGA-02-0037-01A-01D-0182-01 +TCGA-02-0038-01 TCGA-02-0038-01 GBM GBM non-CIMP c15 TCGA-02-0038 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain NO NO 48 TCGA-02-0038-F22277 TCGA-02-0038 -17749 326 0 326 239 2008-12-17 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 80 Progression of Disease 0038 WITH TUMOR YES NO YES Primary Tumor 01 02 Brain DECEASED 2004 TCGA-02-0038-01 TCGA-02-0038-01 TCGA-02-0038-01A-01D-0182-01 TCGA-02-0038-01A-01D-0182-01 +TCGA-02-0039-01 TCGA-02-0039-01 Kirc+ TCGA-02-0039 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain NO 54 TCGA-02-0039-F22281 TCGA-02-0039 -20065 320 0 320 102 2008-12-16 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 60 Progression of Disease 0039 WITH TUMOR YES NO YES Primary Tumor 01 02 Brain DECEASED 2005 TCGA-02-0039-01 TCGA-02-0039-01 TCGA-02-0039-01A-01G-0293-01 TCGA-02-0039-01A-01G-0293-01 +TCGA-02-0043-01 TCGA-02-0043-01 GBM GBM non-CIMP c15 TCGA-02-0043 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES NO 54 TCGA-02-0043-F22283 TCGA-02-0043 -19882 557 0 557 282 2008-12-17 FEMALE Treated primary GBM Yes C71.9 9440/3 C71.9 YES Tumor resection 80 Progression of Disease 0043 WITH TUMOR YES NO YES Primary Tumor 01 02 Brain DECEASED 2004 TCGA-02-0043-01 TCGA-02-0043-01 TCGA-02-0043-01A-01D-0182-01 TCGA-02-0043-01A-01D-0182-01 +TCGA-02-0046-01 TCGA-02-0046-01 GBM GBM non-CIMP c15 TCGA-02-0046 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain NO 61 TCGA-02-0046-F22291 TCGA-02-0046 -22417 209 0 209 195 2008-12-16 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 60 Progression of Disease 0046 WITH TUMOR NO YES Primary Tumor 01 02 Brain DECEASED 2004 TCGA-02-0046-01 TCGA-02-0046-01 TCGA-02-0046-01A-01D-0182-01 TCGA-02-0046-01A-01D-0182-01 +TCGA-02-0047-01 TCGA-02-0047-01 Kirc+ C10-GBM GBM non-CIMP c15 GBM-like c6 mutation cluster 4 TCGA-02-0047 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain NO NO 78 TCGA-02-0047-F22293 TCGA-02-0047 TCGA-02-0047-01A -28759 448 0 448 57 2008-12-16 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection NO 80 Progression of Disease TCGA-02-0047.66F4DDD0-A0E6-4EA9-97AF-8691C0457D2B.pdf 0047 WITH TUMOR NO NO YES Primary Tumor 01 02 Brain A DECEASED 2005 95d8884d-0961-4070-be07-55dce4c7bc8f TCGA-02-0047-01 TCGA-02-0047-01A-01D-1490-08 TCGA-02-0047-01 TCGA-02-0047-01A-01D-0182-01 TCGA-02-0047-01 95d8884d-0961-4070-be07-55dce4c7bc8f TCGA-02-0047-01 TCGA-02-0047-01A-01D-0182-01 95d8884d-0961-4070-be07-55dce4c7bc8f +TCGA-02-0048-01 TCGA-02-0048-01 Kirc+ TCGA-02-0048 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 80 TCGA-02-0048-F22295 TCGA-02-0048 -29299 98 0 98 23 2008-12-16 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Progression of Disease 0048 NO YES Primary Tumor 01 02 Brain DECEASED 2005 TCGA-02-0048-01 TCGA-02-0048-01 TCGA-02-0048-01A-01G-0293-01 TCGA-02-0048-01A-01G-0293-01 +TCGA-02-0051-01 TCGA-02-0051-01 Kirc+ TCGA-02-0051 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES NO 43 TCGA-02-0051-F22297 TCGA-02-0051 -15983 459 0 459 89 2008-12-16 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 100 Progression of Disease 0051 WITH TUMOR YES NO YES Primary Tumor 01 02 Brain DECEASED 2005 TCGA-02-0051-01 TCGA-02-0051-01 TCGA-02-0051-01A-01G-0293-01 TCGA-02-0051-01A-01G-0293-01 +TCGA-02-0052-01 TCGA-02-0052-01 GBM GBM non-CIMP c15 TCGA-02-0052 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain NO NO 49 TCGA-02-0052-F22299 TCGA-02-0052 -18061 383 0 383 204 2008-12-16 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 80 Progression of Disease 0052 WITH TUMOR YES NO YES Primary Tumor 01 02 Brain DECEASED 2005 TCGA-02-0052-01 TCGA-02-0052-01 TCGA-02-0052-01A-01D-0182-01 TCGA-02-0052-01A-01D-0182-01 +TCGA-02-0054-01 TCGA-02-0054-01 GBM GBM non-CIMP c15 TCGA-02-0054 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES NO 44 TCGA-02-0054-F22303 TCGA-02-0054 -16224 199 0 199 72 2008-12-16 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 80 Progression of Disease 0054 WITH TUMOR YES NO YES Primary Tumor 01 02 Brain DECEASED 2005 TCGA-02-0054-01 TCGA-02-0054-01 TCGA-02-0054-01A-01D-0182-01 TCGA-02-0054-01A-01D-0182-01 +TCGA-02-0055-01 TCGA-02-0055-01 GBM C10-GBM GBM non-CIMP c15 GBM-like c6 mutation cluster 5 TCGA-02-0055 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain NO NO 62 TCGA-02-0055-F22311 TCGA-02-0055 TCGA-02-0055-01A -22798 76 0 76 6 2008-12-16 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection NO 80 Progression of Disease TCGA-02-0055.9CD99ACE-FAD5-436B-A5B0-73E5C60082E8.pdf 0055 WITH TUMOR YES NO YES Primary Tumor 01 02 Brain A DECEASED 2005 065048d0-ecbf-4de2-b12a-55e52f8d1279 TCGA-02-0055-01A-01D-1490-08 TCGA-02-0055-01A-01D-0182-01 TCGA-02-0055-01 065048d0-ecbf-4de2-b12a-55e52f8d1279 TCGA-02-0055-01 TCGA-02-0055-01A-01D-0182-01 065048d0-ecbf-4de2-b12a-55e52f8d1279 +TCGA-02-0057-01 TCGA-02-0057-01 GBM GBM non-CIMP c15 TCGA-02-0057 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES NO 66 TCGA-02-0057-F22316 TCGA-02-0057 -24140 604 0 604 473 2008-12-16 FEMALE Treated primary GBM Yes C71.9 9440/3 C71.9 YES Tumor resection 80 Progression of Disease 0057 WITH TUMOR YES NO YES Primary Tumor 01 02 Brain DECEASED 2004 TCGA-02-0057-01 TCGA-02-0057-01 TCGA-02-0057-01A-01D-0182-01 TCGA-02-0057-01A-01D-0182-01 +TCGA-02-0058-01 TCGA-02-0058-01 Kirc+ GBM CIMP c16 TCGA-02-0058 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain NO NO 28 TCGA-02-0058-F22321 TCGA-02-0058 -10517 254 0 254 172 2008-12-16 FEMALE Treated primary GBM No C71.9 9440/3 C71.9 YES Tumor resection 80 Progression of Disease 0058 WITH TUMOR YES YES YES Primary Tumor 01 02 Brain DECEASED 2005 TCGA-02-0058-01 TCGA-02-0058-01 TCGA-02-0058-01A-01D-0182-01 TCGA-02-0058-01A-01D-0182-01 +TCGA-02-0059-01 TCGA-02-0059-01 GBM TCGA-02-0059 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain NO 68 TCGA-02-0059-F22325 TCGA-02-0059 -25097 291 0 291 21 2008-12-16 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 80 Recurrence 0059 WITH TUMOR NO YES Primary Tumor 01 02 Brain DECEASED 2005 TCGA-02-0059-01 TCGA-02-0059-01 TCGA-02-0059-01A-01G-0293-01 TCGA-02-0059-01A-01G-0293-01 +TCGA-02-0060-01 TCGA-02-0060-01 Kirc+ GBM non-CIMP c15 TCGA-02-0060 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain NO NO 66 TCGA-02-0060-F22327 TCGA-02-0060 -24151 183 0 183 183 2008-12-16 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 80 Progression of Disease 0060 WITH TUMOR YES NO YES Primary Tumor 01 02 Brain DECEASED 2006 TCGA-02-0060-01 TCGA-02-0060-01 TCGA-02-0060-01A-01D-0182-01 TCGA-02-0060-01A-01D-0182-01 +TCGA-02-0064-01 TCGA-02-0064-01 GBM GBM non-CIMP c15 TCGA-02-0064 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES NO 50 TCGA-02-0064-F22332 TCGA-02-0064 -18280 600 0 600 496 2008-12-16 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 100 Recurrence 0064 WITH TUMOR YES NO YES Primary Tumor 01 02 Brain DECEASED 2005 TCGA-02-0064-01 TCGA-02-0064-01 TCGA-02-0064-01A-01D-0193-01 TCGA-02-0064-01A-01D-0193-01 +TCGA-02-0068-01 TCGA-02-0068-01 GBM squamous c3 TCGA-02-0068 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES NO 57 TCGA-02-0068-F22338 TCGA-02-0068 -21160 804 0 804 175 2008-12-16 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 80 Recurrence 0068 WITH TUMOR YES NO YES Primary Tumor 01 02 Brain DECEASED 2006 TCGA-02-0068-01 TCGA-02-0068-01 TCGA-02-0068-01A-01G-0293-01 TCGA-02-0068-01A-01G-0293-01 +TCGA-02-0069-01 TCGA-02-0069-01 High GBM non-CIMP c15 GBM-like c2 TCGA-02-0069 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain NO NO 31 TCGA-02-0069-F22345 TCGA-02-0069 -11668 0 873 873 2008-12-16 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 80 Progression of Disease 0069 WITH TUMOR YES NO YES Primary Tumor 01 02 Brain LIVING 2006 TCGA-02-0069-01 TCGA-02-0069-01 TCGA-02-0069-01A-01D-0193-01 TCGA-02-0069-01A-01D-0193-01 +TCGA-02-0070-01 TCGA-02-0070-01 GBM TCGA-02-0070 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain NO NO 70 TCGA-02-0070-F22350 TCGA-02-0070 -25916 0 762 762 2008-12-16 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 80 Recurrence 0070 WITH TUMOR YES NO YES Primary Tumor 01 02 Brain LIVING 2006 TCGA-02-0070-01 TCGA-02-0070-01 TCGA-02-0070-01A-01G-0293-01 TCGA-02-0070-01A-01G-0293-01 +TCGA-02-0071-01 TCGA-02-0071-01 GBM GBM non-CIMP c15 TCGA-02-0071 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain NO 53 TCGA-02-0071-F22354 TCGA-02-0071 -19425 167 0 167 8 2008-12-16 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 80 Progression of Disease 0071 WITH TUMOR NO YES Primary Tumor 01 02 Brain DECEASED 2005 TCGA-02-0071-01 TCGA-02-0071-01 TCGA-02-0071-01A-01D-0193-01 TCGA-02-0071-01A-01D-0193-01 +TCGA-02-0074-01 TCGA-02-0074-01 GBM GBM non-CIMP c15 TCGA-02-0074 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain NO NO 68 TCGA-02-0074-F22356 TCGA-02-0074 -24906 310 0 310 154 2008-12-16 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 80 Progression of Disease 0074 WITH TUMOR YES NO YES Primary Tumor 01 02 Brain DECEASED 2005 TCGA-02-0074-01 TCGA-02-0074-01 TCGA-02-0074-01A-01D-0193-01 TCGA-02-0074-01A-01D-0193-01 +TCGA-02-0075-01 TCGA-02-0075-01 GBM GBM non-CIMP c15 TCGA-02-0075 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain NO NO 63 TCGA-02-0075-F22361 TCGA-02-0075 -23205 634 0 634 336 2008-12-16 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 80 Progression of Disease 0075 WITH TUMOR YES NO YES Primary Tumor 01 02 Brain DECEASED 2005 TCGA-02-0075-01 TCGA-02-0075-01 TCGA-02-0075-01A-01D-0193-01 TCGA-02-0075-01A-01D-0193-01 +TCGA-02-0079-01 TCGA-02-0079-01 GBM TCGA-02-0079 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain NO 57 TCGA-02-0079-F22365 TCGA-02-0079 -21173 829 0 829 798 2008-12-17 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 80 Progression of Disease 0079 WITH TUMOR NO YES Primary Tumor 01 02 Brain DECEASED 2005 TCGA-02-0079-01 TCGA-02-0079-01 TCGA-02-0079-01A-01D-0310-01 TCGA-02-0079-01A-01D-0310-01 +TCGA-02-0080-01 TCGA-02-0080-01 Kirc+ GBM CIMP c16 TCGA-02-0080 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES NO 28 TCGA-02-0080-F22367 TCGA-02-0080 -10310 2729 0 2729 2339 2008-12-16 MALE Untreated primary (de novo) GBM Yes C71.9 9440/3 C71.9 YES Tumor resection 80 Progression of Disease 0080 WITH TUMOR YES NO YES Primary Tumor 01 02 Brain DECEASED 1999 TCGA-02-0080-01 TCGA-02-0080-01 TCGA-02-0080-01A-01D-0193-01 TCGA-02-0080-01A-01D-0193-01 +TCGA-02-0083-01 TCGA-02-0083-01 GBM GBM non-CIMP c15 TCGA-02-0083 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain NO 59 TCGA-02-0083-F22372 TCGA-02-0083 -21626 691 0 691 463 2008-12-16 FEMALE Treated primary GBM Yes C71.9 9440/3 C71.9 YES Tumor resection 80 Progression of Disease 0083 WITH TUMOR YES NO YES Primary Tumor 01 02 Brain DECEASED 2005 TCGA-02-0083-01 TCGA-02-0083-01 TCGA-02-0083-01A-01D-0193-01 TCGA-02-0083-01A-01D-0193-01 +TCGA-02-0084-01 TCGA-02-0084-01 Kirc+ TCGA-02-0084 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 36 TCGA-02-0084-F22376 TCGA-02-0084 -13263 384 0 7 2008-12-17 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 80 0084 NO Primary Tumor 01 02 Brain DECEASED 2005 TCGA-02-0084-01 TCGA-02-0084-01 TCGA-02-0084-01A-01D-0310-01 TCGA-02-0084-01A-01D-0310-01 +TCGA-02-0085-01 TCGA-02-0085-01 GBM GBM non-CIMP c15 TCGA-02-0085 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain NO NO 63 TCGA-02-0085-F22378 TCGA-02-0085 -23289 1561 0 1561 976 2008-12-16 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 80 Progression of Disease 0085 WITH TUMOR YES NO YES Primary Tumor 01 02 Brain DECEASED 2003 TCGA-02-0085-01 TCGA-02-0085-01 TCGA-02-0085-01A-01D-0193-01 TCGA-02-0085-01A-01D-0193-01 +TCGA-02-0086-01 TCGA-02-0086-01 BRCA-LUAD+ GBM non-CIMP c15 TCGA-02-0086 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES NO 45 TCGA-02-0086-F22382 TCGA-02-0086 -16763 268 0 268 97 2008-12-16 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 100 Progression of Disease 0086 WITH TUMOR YES NO YES Primary Tumor 01 02 Brain DECEASED 2005 TCGA-02-0086-01 TCGA-02-0086-01 TCGA-02-0086-01A-01D-0193-01 TCGA-02-0086-01A-01D-0193-01 +TCGA-02-0087-01 TCGA-02-0087-01 Kirc+ TCGA-02-0087 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain NO 27 TCGA-02-0087-F22390 TCGA-02-0087 -10185 0 1757 1757 2008-12-16 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 80 Recurrence 0087 NO YES Primary Tumor 01 02 Brain LIVING 2004 TCGA-02-0087-01 TCGA-02-0087-01 TCGA-02-0087-01A-01D-0275-01 TCGA-02-0087-01A-01D-0275-01 +TCGA-02-0089-01 TCGA-02-0089-01 GBM GBM non-CIMP c15 TCGA-02-0089 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain NO NO 52 TCGA-02-0089-F22392 TCGA-02-0089 -19233 516 0 516 358 2008-12-16 MALE Treated primary GBM Yes C71.9 9440/3 C71.9 YES Tumor resection 100 Progression of Disease 0089 WITH TUMOR YES NO YES Primary Tumor 01 02 Brain DECEASED 2005 TCGA-02-0089-01 TCGA-02-0089-01 TCGA-02-0089-01A-01D-0193-01 TCGA-02-0089-01A-01D-0193-01 +TCGA-02-0099-01 TCGA-02-0099-01 GBM GBM non-CIMP c15 TCGA-02-0099 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 46 TCGA-02-0099-F22396 TCGA-02-0099 -17080 106 0 106 2009-4-6 MALE Untreated primary (de novo) GBM Yes C71.9 9440/3 C71.9 YES Tumor resection 80 0099 WITH TUMOR YES NO YES Primary Tumor 01 02 Brain DECEASED 2004 TCGA-02-0099-01 TCGA-02-0099-01 TCGA-02-0099-01A-01D-0193-01 TCGA-02-0099-01A-01D-0193-01 +TCGA-02-0102-01 TCGA-02-0102-01 GBM GBM non-CIMP c15 TCGA-02-0102 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES NO 42 TCGA-02-0102-F22401 TCGA-02-0102 -15660 822 0 822 450 2008-12-16 MALE Treated primary GBM Yes C71.9 9440/3 C71.9 YES Tumor resection 100 Progression of Disease 0102 WITH TUMOR YES NO YES Primary Tumor 01 02 Brain DECEASED 2004 TCGA-02-0102-01 TCGA-02-0102-01 TCGA-02-0102-01A-01D-0193-01 TCGA-02-0102-01A-01D-0193-01 +TCGA-02-0104-01 TCGA-02-0104-01 Kirc+ TCGA-02-0104 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain NO NO 29 TCGA-02-0104-F22407 TCGA-02-0104 -10699 1977 0 1977 1457 2008-12-16 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 80 Recurrence 0104 WITH TUMOR YES NO YES Primary Tumor 01 02 Brain DECEASED 2001 TCGA-02-0104-01 TCGA-02-0104-01 TCGA-02-0104-01A-01G-0293-01 TCGA-02-0104-01A-01G-0293-01 +TCGA-02-0106-01 TCGA-02-0106-01 BRCA-LUAD+ TCGA-02-0106 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES NO 54 TCGA-02-0106-F22412 TCGA-02-0106 -19883 355 0 355 196 2008-12-16 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 80 Recurrence 0106 WITH TUMOR YES NO YES Primary Tumor 01 02 Brain DECEASED 2004 TCGA-02-0106-01 TCGA-02-0106-01 TCGA-02-0106-01A-01D-0275-01 TCGA-02-0106-01A-01D-0275-01 +TCGA-02-0107-01 TCGA-02-0107-01 GBM Low purity c2 TCGA-02-0107 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain NO 56 TCGA-02-0107-F22418 TCGA-02-0107 -20557 537 0 537 146 2008-12-17 MALE Treated primary GBM Yes C71.9 9440/3 C71.9 YES Tumor resection 80 Recurrence 0107 WITH TUMOR YES NO YES Primary Tumor 01 02 Brain DECEASED 2004 TCGA-02-0107-01 TCGA-02-0107-01 TCGA-02-0107-01A-01D-0193-01 TCGA-02-0107-01A-01D-0193-01 +TCGA-02-0111-01 TCGA-02-0111-01 GBM TCGA-02-0111 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain NO 56 TCGA-02-0111-F22422 TCGA-02-0111 -20813 705 0 705 74 2008-12-16 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 80 Progression of Disease 0111 WITH TUMOR YES NO YES Primary Tumor 01 02 Brain DECEASED 2004 TCGA-02-0111-01 TCGA-02-0111-01 TCGA-02-0111-01A-01D-0275-01 TCGA-02-0111-01A-01D-0275-01 +TCGA-02-0113-01 TCGA-02-0113-01 High GBM non-CIMP c15 TCGA-02-0113 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain NO 43 TCGA-02-0113-F22426 TCGA-02-0113 -15836 0 2818 1560 2008-12-17 FEMALE Treated primary GBM Yes C71.9 9440/3 C71.9 YES Tumor resection 100 Recurrence 0113 WITH TUMOR YES NO YES Primary Tumor 01 02 Brain LIVING 2001 TCGA-02-0113-01 TCGA-02-0113-01 TCGA-02-0113-01A-01D-0193-01 TCGA-02-0113-01A-01D-0193-01 +TCGA-02-0114-01 TCGA-02-0114-01 Squamous GBM CIMP c16 TCGA-02-0114 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES NO 37 TCGA-02-0114-F22430 TCGA-02-0114 -13681 3041 0 3041 2296 2008-12-17 FEMALE Treated primary GBM Yes C71.9 9440/3 C71.9 YES Tumor resection 80 Recurrence 0114 WITH TUMOR YES NO YES Primary Tumor 01 02 Brain DECEASED 1998 TCGA-02-0114-01 TCGA-02-0114-01 TCGA-02-0114-01A-01D-0193-01 TCGA-02-0114-01A-01D-0193-01 +TCGA-02-0115-01 TCGA-02-0115-01 GBM GBM non-CIMP c15 TCGA-02-0115 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES NO 52 TCGA-02-0115-F22438 TCGA-02-0115 -19257 476 0 476 91 2008-12-17 MALE Treated primary GBM No C71.9 9440/3 C71.9 YES Tumor resection 80 Progression of Disease 0115 WITH TUMOR YES NO YES Primary Tumor 01 02 Brain DECEASED 2006 TCGA-02-0115-01 TCGA-02-0115-01 TCGA-02-0115-01A-01D-0193-01 TCGA-02-0115-01A-01D-0193-01 +TCGA-02-0116-01 TCGA-02-0116-01 GBM GBM non-CIMP c15 squamous c3 TCGA-02-0116 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES NO 51 TCGA-02-0116-F22443 TCGA-02-0116 -18657 1489 0 1489 1231 2008-12-16 MALE Treated primary GBM Yes C71.9 9440/3 C71.9 YES Tumor resection 80 Progression of Disease 0116 WITH TUMOR YES NO YES Primary Tumor 01 02 Brain DECEASED 2003 TCGA-02-0116-01 TCGA-02-0116-01 TCGA-02-0116-01A-01D-0193-01 TCGA-02-0116-01A-01D-0193-01 +TCGA-02-0258-01 TCGA-02-0258-01 Kirc+ TCGA-02-0258 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain NO 36 TCGA-02-0258-F22449 TCGA-02-0258 -13269 503 0 503 503 2008-12-16 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection Recurrence 0258 WITH TUMOR NO YES Primary Tumor 01 02 Brain DECEASED 1989 TCGA-02-0258-01 TCGA-02-0258-01 TCGA-02-0258-01A-01D-0275-01 TCGA-02-0258-01A-01D-0275-01 +TCGA-02-0260-01 TCGA-02-0260-01 GBM TCGA-02-0260 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain NO 54 TCGA-02-0260-F22451 TCGA-02-0260 -19956 515 0 515 379 2008-12-16 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection Locoregional Disease YES 0260 WITH TUMOR NO YES Primary Tumor 01 02 Brain DECEASED 1989 TCGA-02-0260-01 TCGA-02-0260-01 TCGA-02-0260-01A-03D-0275-01 TCGA-02-0260-01A-03D-0275-01 +TCGA-02-0266-01 TCGA-02-0266-01 High TCGA-02-0266 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain NO 14 TCGA-02-0266-F22453 TCGA-02-0266 -5303 539 0 539 293 2008-12-17 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection Progression of Disease 0266 WITH TUMOR NO YES Primary Tumor 01 02 Brain DECEASED 1990 TCGA-02-0266-01 TCGA-02-0266-01 TCGA-02-0266-01A-01D-0275-01 TCGA-02-0266-01A-01D-0275-01 +TCGA-02-0269-01 TCGA-02-0269-01 BRCA-LUAD+ TCGA-02-0269 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain NO 68 TCGA-02-0269-F22455 TCGA-02-0269 -25194 327 0 327 99 2008-12-17 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection Progression of Disease 0269 WITH TUMOR NO YES Primary Tumor 01 02 Brain DECEASED 1990 TCGA-02-0269-01 TCGA-02-0269-01 TCGA-02-0269-01B-01D-0275-01 TCGA-02-0269-01B-01D-0275-01 +TCGA-02-0271-01 TCGA-02-0271-01 GBM TCGA-02-0271 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 26 TCGA-02-0271-F22457 TCGA-02-0271 -9578 440 0 440 2008-12-17 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES 0271 NO YES Primary Tumor 01 02 Brain DECEASED 1990 TCGA-02-0271-01 TCGA-02-0271-01 TCGA-02-0271-01A-01D-0275-01 TCGA-02-0271-01A-01D-0275-01 +TCGA-02-0281-01 TCGA-02-0281-01 Kirc+ TCGA-02-0281 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 78 TCGA-02-0281-F22459 TCGA-02-0281 -28696 121 0 121 2008-12-17 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 0281 WITH TUMOR NO YES Primary Tumor 01 02 Brain DECEASED 1991 TCGA-02-0281-01 TCGA-02-0281-01 TCGA-02-0281-01A-01D-0275-01 TCGA-02-0281-01A-01D-0275-01 +TCGA-02-0285-01 TCGA-02-0285-01 GBM TCGA-02-0285 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 50 TCGA-02-0285-F22461 TCGA-02-0285 -18353 422 0 422 2008-12-17 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 0285 WITH TUMOR NO YES Primary Tumor 01 02 Brain DECEASED 1991 TCGA-02-0285-01 TCGA-02-0285-01 TCGA-02-0285-01A-01D-0275-01 TCGA-02-0285-01A-01D-0275-01 +TCGA-02-0289-01 TCGA-02-0289-01 GBM TCGA-02-0289 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain NO NO 57 TCGA-02-0289-F22463 TCGA-02-0289 -21031 432 0 432 245 2008-12-17 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 80 Progression of Disease 0289 WITH TUMOR YES NO YES Primary Tumor 01 02 Brain DECEASED 1992 TCGA-02-0289-01 TCGA-02-0289-01 TCGA-02-0289-01A-01D-0275-01 TCGA-02-0289-01A-01D-0275-01 +TCGA-02-0290-01 TCGA-02-0290-01 GBM TCGA-02-0290 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain NO NO 49 TCGA-02-0290-F22469 TCGA-02-0290 -18066 485 0 485 374 2008-12-17 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 80 Progression of Disease 0290 WITH TUMOR YES NO YES Primary Tumor 01 02 Brain DECEASED 1992 TCGA-02-0290-01 TCGA-02-0290-01 TCGA-02-0290-01A-01D-0275-01 TCGA-02-0290-01A-01D-0275-01 +TCGA-02-0317-01 TCGA-02-0317-01 GBM TCGA-02-0317 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain NO 40 TCGA-02-0317-F22475 TCGA-02-0317 -14636 372 0 372 238 2008-12-17 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 80 Progression of Disease 0317 WITH TUMOR YES NO YES Primary Tumor 01 02 Brain DECEASED 1994 TCGA-02-0317-01 TCGA-02-0317-01 TCGA-02-0317-01A-01D-0275-01 TCGA-02-0317-01A-01D-0275-01 +TCGA-02-0321-01 TCGA-02-0321-01 GBM TCGA-02-0321 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain NO 74 TCGA-02-0321-F22479 TCGA-02-0321 -27125 301 0 301 73 2008-12-17 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 80 Progression of Disease 0321 WITH TUMOR NO YES Primary Tumor 01 02 Brain DECEASED 1995 TCGA-02-0321-01 TCGA-02-0321-01 TCGA-02-0321-01A-01D-0275-01 TCGA-02-0321-01A-01D-0275-01 +TCGA-02-0324-01 TCGA-02-0324-01 GBM TCGA-02-0324 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain NO 69 TCGA-02-0324-F22481 TCGA-02-0324 -25352 235 0 235 164 2008-12-17 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 80 Progression of Disease 0324 WITH TUMOR NO YES Primary Tumor 01 02 Brain DECEASED 1995 TCGA-02-0324-01 TCGA-02-0324-01 TCGA-02-0324-01A-01D-0275-01 TCGA-02-0324-01A-01D-0275-01 +TCGA-02-0325-01 TCGA-02-0325-01 GBM TCGA-02-0325 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES NO 61 TCGA-02-0325-F22483 TCGA-02-0325 -22598 323 0 323 284 2008-12-17 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 80 Progression of Disease 0325 WITH TUMOR YES NO YES Primary Tumor 01 02 Brain DECEASED 1996 TCGA-02-0325-01 TCGA-02-0325-01 TCGA-02-0325-01A-01D-0275-01 TCGA-02-0325-01A-01D-0275-01 +TCGA-02-0326-01 TCGA-02-0326-01 Kirc+ TCGA-02-0326 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain NO 82 TCGA-02-0326-F22490 TCGA-02-0326 -30160 223 0 5 5 2008-12-17 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 80 Progression of Disease 0326 WITH TUMOR NO YES Primary Tumor 01 02 Brain DECEASED 1995 TCGA-02-0326-01 TCGA-02-0326-01 TCGA-02-0326-01A-01D-0275-01 TCGA-02-0326-01A-01D-0275-01 +TCGA-02-0330-01 TCGA-02-0330-01 GBM TCGA-02-0330 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES NO 51 TCGA-02-0330-F22492 TCGA-02-0330 -18654 484 0 484 120 2008-12-17 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 80 Progression of Disease 0330 WITH TUMOR YES NO YES Primary Tumor 01 02 Brain DECEASED 1995 TCGA-02-0330-01 TCGA-02-0330-01 TCGA-02-0330-01A-01D-0275-01 TCGA-02-0330-01A-01D-0275-01 +TCGA-02-0332-01 TCGA-02-0332-01 GBM TCGA-02-0332 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain NO NO 46 TCGA-02-0332-F22500 TCGA-02-0332 -17021 782 0 782 438 2008-12-17 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 80 Progression of Disease 0332 WITH TUMOR YES NO YES Primary Tumor 01 02 Brain DECEASED 1995 TCGA-02-0332-01 TCGA-02-0332-01 TCGA-02-0332-01A-01D-0275-01 TCGA-02-0332-01A-01D-0275-01 +TCGA-02-0333-01 TCGA-02-0333-01 GBM TCGA-02-0333 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain NO 77 TCGA-02-0333-F22506 TCGA-02-0333 -28449 133 0 133 4 2008-12-17 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection Progression of Disease 0333 WITH TUMOR NO YES Primary Tumor 01 02 Brain DECEASED 1996 TCGA-02-0333-01 TCGA-02-0333-01 TCGA-02-0333-01A-02D-0275-01 TCGA-02-0333-01A-02D-0275-01 +TCGA-02-0337-01 TCGA-02-0337-01 GBM TCGA-02-0337 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain NO NO 48 TCGA-02-0337-F22508 TCGA-02-0337 -17643 764 0 764 691 2008-12-17 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 80 Progression of Disease 0337 WITH TUMOR YES NO YES Primary Tumor 01 02 Brain DECEASED 1996 TCGA-02-0337-01 TCGA-02-0337-01 TCGA-02-0337-01A-01D-0275-01 TCGA-02-0337-01A-01D-0275-01 +TCGA-02-0338-01 TCGA-02-0338-01 Kirc+ TCGA-02-0338 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain NO 41 TCGA-02-0338-F22514 TCGA-02-0338 -15231 322 0 322 168 2008-12-17 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 80 Progression of Disease 0338 WITH TUMOR NO YES Primary Tumor 01 02 Brain DECEASED 1996 TCGA-02-0338-01 TCGA-02-0338-01 TCGA-02-0338-01A-01D-0275-01 TCGA-02-0338-01A-01D-0275-01 +TCGA-02-0339-01 TCGA-02-0339-01 Kirc+ TCGA-02-0339 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain NO 67 TCGA-02-0339-F22516 TCGA-02-0339 -24524 377 0 377 148 2008-12-17 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 80 Progression of Disease 0339 WITH TUMOR NO YES Primary Tumor 01 02 Brain DECEASED 1995 TCGA-02-0339-01 TCGA-02-0339-01 TCGA-02-0339-01A-01D-0275-01 TCGA-02-0339-01A-01D-0275-01 +TCGA-02-0422-01 TCGA-02-0422-01 GBM TCGA-02-0422 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain NO 50 TCGA-02-0422-F22518 TCGA-02-0422 -18368 441 0 441 125 2008-12-17 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 80 Progression of Disease 0422 WITH TUMOR YES NO YES Primary Tumor 01 02 Brain DECEASED 1996 TCGA-02-0422-01 TCGA-02-0422-01 TCGA-02-0422-01A-01D-0275-01 TCGA-02-0422-01A-01D-0275-01 +TCGA-02-0430-01 TCGA-02-0430-01 GBM TCGA-02-0430 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain NO NO 67 TCGA-02-0430-F22520 TCGA-02-0430 -24641 321 0 321 2008-12-17 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 100 Locoregional Disease YES 0430 WITH TUMOR YES NO YES Primary Tumor 01 02 Brain DECEASED 1997 TCGA-02-0430-01 TCGA-02-0430-01 TCGA-02-0430-01A-01D-0275-01 TCGA-02-0430-01A-01D-0275-01 +TCGA-02-0432-01 TCGA-02-0432-01 Kirc+ TCGA-02-0432 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain NO 36 TCGA-02-0432-F22522 TCGA-02-0432 -13260 1433 0 1433 1053 2008-12-17 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 80 Progression of Disease 0432 WITH TUMOR YES NO YES Primary Tumor 01 02 Brain DECEASED 1997 TCGA-02-0432-01 TCGA-02-0432-01 TCGA-02-0432-01A-02D-0275-01 TCGA-02-0432-01A-02D-0275-01 +TCGA-02-0439-01 TCGA-02-0439-01 Kirc+ TCGA-02-0439 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain NO 70 TCGA-02-0439-F22526 TCGA-02-0439 -25624 20 0 20 13 1 2008-12-17 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 80 Progression of Disease 0439 Preoperative WITH TUMOR NO YES Primary Tumor 01 02 Brain DECEASED 1997 TCGA-02-0439-01 +TCGA-02-0440-01 TCGA-02-0440-01 GBM TCGA-02-0440 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain NO 62 TCGA-02-0440-F22528 TCGA-02-0440 -22955 345 0 345 212 2008-12-17 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 80 Progression of Disease 0440 WITH TUMOR YES NO YES Primary Tumor 01 02 Brain DECEASED 1997 TCGA-02-0440-01 TCGA-02-0440-01 TCGA-02-0440-01A-01D-0275-01 TCGA-02-0440-01A-01D-0275-01 +TCGA-02-0446-01 TCGA-02-0446-01 GBM TCGA-02-0446 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain NO 61 TCGA-02-0446-F22532 TCGA-02-0446 -22541 282 0 282 15 2008-12-17 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 80 Recurrence 0446 WITH TUMOR NO YES Primary Tumor 01 02 Brain DECEASED 1997 TCGA-02-0446-01 TCGA-02-0446-01 TCGA-02-0446-01A-01D-0275-01 TCGA-02-0446-01A-01D-0275-01 +TCGA-02-0451-01 TCGA-02-0451-01 BRCA-LUAD+ TCGA-02-0451 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain NO 62 TCGA-02-0451-F22534 TCGA-02-0451 -22662 493 0 493 428 2008-12-17 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 80 Recurrence 0451 WITH TUMOR NO YES Primary Tumor 01 02 Brain DECEASED 1998 TCGA-02-0451-01 TCGA-02-0451-01 TCGA-02-0451-01A-01D-0275-01 TCGA-02-0451-01A-01D-0275-01 +TCGA-02-0456-01 TCGA-02-0456-01 BRCA-LUAD+ TCGA-02-0456 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain NO 67 TCGA-02-0456-F22536 TCGA-02-0456 -24796 102 0 102 12 2008-12-16 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 60 Recurrence 0456 WITH TUMOR NO YES Primary Tumor 01 02 Brain DECEASED 1998 TCGA-02-0456-01 TCGA-02-0456-01 TCGA-02-0456-01A-01D-0275-01 TCGA-02-0456-01A-01D-0275-01 +TCGA-02-2466-01 TCGA-02-2466-01 GBM GBM non-CIMP c15 TCGA-02-2466 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES NO 61 TCGA-02-2466-F22538 TCGA-02-2466 -22457 511 0 511 128 2010-5-6 MALE Treated primary GBM No C71.9 9440/3 C71.9 YES Excisional Biopsy 80 Progression of Disease 2466 Post-Adjuvant Therapy WITH TUMOR YES NO YES Primary Tumor 01 02 Brain DECEASED 2007 TCGA-02-2466-01 TCGA-02-2466-01 TCGA-02-2466-01A-01D-0784-01 TCGA-02-2466-01A-01D-0784-01 +TCGA-02-2470-01 TCGA-02-2470-01 Kirc+ C10-GBM GBM non-CIMP c15 KIRC-like c1 mutation c1uster 9 TCGA-02-2470 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES NO 57 TCGA-02-2470-F22543 TCGA-02-2470 -21021 393 0 393 183 2010-5-6 MALE Treated primary GBM Yes C71.9 9440/3 C71.9 YES Tumor resection 60 Progression of Disease 2470 Post-Adjuvant Therapy WITH TUMOR YES NO YES Primary Tumor 01 02 Brain DECEASED 2007 TCGA-02-2470-01 TCGA-02-2470-01A-01D-1494-08 TCGA-02-2470-01 TCGA-02-2470-01A-01D-0784-01 TCGA-02-2470-01A-01D-0784-01 +TCGA-02-2483-01 TCGA-02-2483-01 Kirc+ C10-GBM GBM CIMP c16 GBM-like c6 mutation cluster 5 TCGA-02-2483 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 43 TCGA-02-2483-F22548 TCGA-02-2483 TCGA-02-2483-01A -15964 0 466 2010-5-6 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Excisional Biopsy 1 NO 80 1.6 TCGA-02-2483.e73f6ba1-564c-4fea-b088-f2357ff49ee7.pdf 2483 Pre-Adjuvant Therapy WITH TUMOR YES NO YES Primary Tumor 01 0.2 02 Brain A LIVING 2008 35578669-fb40-49fa-b6b5-3bd0f239fa7e TCGA-02-2483-01 TCGA-02-2483-01A-01D-1494-08 TCGA-02-2483-01 TCGA-02-2483-01A-01D-0784-01 TCGA-02-2483-01 35578669-fb40-49fa-b6b5-3bd0f239fa7e TCGA-02-2483-01 TCGA-02-2483-01A-01D-0784-01 35578669-fb40-49fa-b6b5-3bd0f239fa7e +TCGA-02-2485-01 TCGA-02-2485-01 GBM C10-GBM GBM non-CIMP c15 GBM-like c2 GBM-like c6 mutation cluster 8 TCGA-02-2485 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain NO NO 53 TCGA-02-2485-F22553 TCGA-02-2485 TCGA-02-2485-01A -19494 0 470 186 2010-5-6 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Excisional Biopsy 2 NO 80 2.1 Progression of Disease TCGA-02-2485.5b0be7bb-15b5-429b-9bc0-94e435c1a164.pdf 2485 WITH TUMOR YES NO YES Primary Tumor 01 0.4 02 Brain A LIVING 2009 102a0737-7d27-46b8-a433-4f1bb5300858 TCGA-02-2485-01 TCGA-02-2485-01A-01D-1494-08 TCGA-02-2485-01 TCGA-02-2485-01A-01D-0784-01 TCGA-02-2485-01 102a0737-7d27-46b8-a433-4f1bb5300858 TCGA-02-2485-01 TCGA-02-2485-01A-01D-0784-01 102a0737-7d27-46b8-a433-4f1bb5300858 +TCGA-02-2486-01 TCGA-02-2486-01 GBM C10-GBM GBM non-CIMP c15 GBM-like c6 mutation c1uster 9 TCGA-02-2486 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 64 TCGA-02-2486-F22558 TCGA-02-2486 TCGA-02-2486-01A -23394 0 493 2010-5-6 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Excisional Biopsy 0.9 NO 80 1 TCGA-02-2486.26e31c62-06a2-4906-a1d5-985dc0f961e4.pdf 2486 Pre-Adjuvant Therapy WITH TUMOR YES NO YES Primary Tumor 01 0.1 02 Brain A LIVING 2008 92972663-4231-4e24-96d1-23857a445e03 TCGA-02-2486-01 TCGA-02-2486-01A-01D-1494-08 TCGA-02-2486-01 TCGA-02-2486-01A-01D-0784-01 TCGA-02-2486-01 92972663-4231-4e24-96d1-23857a445e03 TCGA-02-2486-01 TCGA-02-2486-01A-01D-0784-01 92972663-4231-4e24-96d1-23857a445e03 +TCGA-06-0119-01 TCGA-06-0119-01 Quiet GBM non-CIMP c15 mutation cluster 4 TCGA-06-0119 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 81 TCGA-06-0119-F40087 TCGA-06-0119 TCGA-06-0119-01A -29606 82 0 [Discrepancy] 2013-2-12 FEMALE Glioblastoma Multiforme (GBM) No C71.9 9440/3 C71.9 YES Tumor resection 1 NO 1.4 [Discrepancy] No TCGA-06-0119.6DD3FF54-D5D7-48ED-8C14-2AD8172B2A16.pdf 0119 Pre-Adjuvant Therapy WITH TUMOR YES NO NO Primary Tumor 01 0.4 [Discrepancy] [Discrepancy] 06 Brain A DECEASED 2005 TCGA-06-0119-01A-08D-1490-08 TCGA-06-0119-01A-08D-0214-01 TCGA-06-0119-01A-08D-0214-01 +TCGA-06-0121-01 TCGA-06-0121-01 Kirc+ GBM non-CIMP c15 TCGA-06-0121 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain TCGA-06-0121-01A 1 NO 2 TCGA-06-0121.8A91BDA2-B037-4B68-A3E4-8D6AB00BE2E9.pdf Primary Tumor 01 1 A TCGA-06-0121-01A-04D-0214-01 TCGA-06-0121-01A-04D-0214-01 +TCGA-06-0122-01 TCGA-06-0122-01 GBM GBM non-CIMP c15 mutation c1uster 9 TCGA-06-0122 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 84 TCGA-06-0122-F22564 TCGA-06-0122 -30968 187 0 8 2008-12-10 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 0122 NO Primary Tumor 01 06 Brain DECEASED 2006 TCGA-06-0122-01 TCGA-06-0122-01A-01D-1490-08 TCGA-06-0122-01 TCGA-06-0122-01A-01D-0214-01 TCGA-06-0122-01A-01D-0214-01 +TCGA-06-0124-01 TCGA-06-0124-01 GBM GBM non-CIMP c15 mutation c1uster 10 TCGA-06-0124 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 67 TCGA-06-0124-F22566 TCGA-06-0124 -24591 620 0 123 2008-12-10 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 0124 WITH TUMOR YES NO YES Primary Tumor 01 06 Brain DECEASED 1998 TCGA-06-0124-01 TCGA-06-0124-01A-01D-1490-08 TCGA-06-0124-01 TCGA-06-0124-01A-01D-0214-01 TCGA-06-0124-01A-01D-0214-01 +TCGA-06-0125-01 TCGA-06-0125-01 GBM C10-GBM GBM non-CIMP c15 GBM-like c2 GBM-like c6 TCGA-06-0125 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES YES 63 TCGA-06-0125-F22569 TCGA-06-0125 -23343 1448 0 1439 797 2008-12-8 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 60 Progression of Disease 0125 Preoperative WITH TUMOR YES NO YES Primary Tumor 01 06 Brain DECEASED 2001 ea85c76f-5334-495d-9615-d3f503c0d088 TCGA-06-0125-01 TCGA-06-0125-01A-01D-A45W-05 TCGA-06-0125-01 TCGA-06-0125-01A-01D-0214-01 TCGA-06-0125-01 ea85c76f-5334-495d-9615-d3f503c0d088 TCGA-06-0125-01 TCGA-06-0125-01A-01D-0214-01 ea85c76f-5334-495d-9615-d3f503c0d088 +TCGA-06-0125-02 TCGA-06-0125-02 C10-GBM GBM non-CIMP c15 GBM-like c6 TCGA-06-0125 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES YES 63 TCGA-06-0125-F22569 TCGA-06-0125 TCGA-06-0125-02A -23343 1448 0 1439 797 2008-12-8 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 0.8 NO 60 1.2 Progression of Disease TCGA-06-0125.372DBF0F-48D7-457F-B1AB-C38287C61A35.pdf 0125 Preoperative WITH TUMOR YES NO YES Recurrent Tumor 02 0.6 06 Brain A DECEASED 2001 2e5a4130-bc62-4986-948b-b741b3fbdc7a TCGA-06-0125-02A-11D-2280-08 TCGA-06-0125-02A-11D-2004-05 2e5a4130-bc62-4986-948b-b741b3fbdc7a 2e5a4130-bc62-4986-948b-b741b3fbdc7a +TCGA-06-0126-01 TCGA-06-0126-01 GBM C10-GBM GBM non-CIMP c15 GBM-like c2 mutation c1uster 9 TCGA-06-0126 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 86 TCGA-06-0126-F51988 TCGA-06-0126 -31627 211 0 3 Scheduled Follow-up Submission 2013-11-26 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 60 YES 0126 Preoperative NO Primary Tumor 01 06 Brain DECEASED 2001 TCGA-06-0126-01 TCGA-06-0126-01A-01D-1490-08 TCGA-06-0126-01 TCGA-06-0126-01A-01D-0214-01 TCGA-06-0126-01A-01D-0214-01 +TCGA-06-0127-01 TCGA-06-0127-01 GBM TCGA-06-0127 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain NO NO 67 TCGA-06-0127-F22578 TCGA-06-0127 -24502 121 0 109 91 2008-12-10 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 60 Progression of Disease 0127 Preoperative WITH TUMOR YES NO YES Primary Tumor 01 06 Brain DECEASED 2002 TCGA-06-0127-01 TCGA-06-0127-01 TCGA-06-0127-01A-01D-0310-01 TCGA-06-0127-01A-01D-0310-01 +TCGA-06-0128-01 TCGA-06-0128-01 Kirc+ C10-GBM GBM CIMP c16 squamous c3 mutation cluster 3 TCGA-06-0128 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES YES 66 TCGA-06-0128-F22582 TCGA-06-0128 -24217 691 0 691 190 2008-12-8 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 80 Progression of Disease 0128 Preoperative WITH TUMOR YES NO YES Primary Tumor 01 06 Brain DECEASED 2000 TCGA-06-0128-01 TCGA-06-0128-01A-01D-1490-08 TCGA-06-0128-01 TCGA-06-0128-01A-01D-0214-01 TCGA-06-0128-01A-01D-0214-01 +TCGA-06-0129-01 TCGA-06-0129-01 Kirc+ C10-GBM GBM CIMP c16 GBM-like c2 GBM-like c6 mutation cluster 3 TCGA-06-0129 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES NO 30 TCGA-06-0129-F22591 TCGA-06-0129 TCGA-06-0129-01A -11284 1024 0 989 148 2008-12-10 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 0.9 NO 100 1.2 Progression of Disease TCGA-06-0129.8495b7bf-2bc1-4ea8-8c66-09fee094e120.pdf 0129 Preoperative WITH TUMOR YES NO YES Primary Tumor 01 0.9 06 Brain A DECEASED 2002 17c98d8c-8bd4-4b16-a384-0497d730f497 TCGA-06-0129-01 TCGA-06-0129-01A-01D-1490-08 TCGA-06-0129-01 TCGA-06-0129-01A-01D-0214-01 TCGA-06-0129-01 17c98d8c-8bd4-4b16-a384-0497d730f497 TCGA-06-0129-01 TCGA-06-0129-01A-01D-0214-01 17c98d8c-8bd4-4b16-a384-0497d730f497 +TCGA-06-0130-01 TCGA-06-0130-01 BRCA-LUAD+ C10-GBM GBM non-CIMP c15 GBM-like c2 GBM-like c6 mutation cluster 5 TCGA-06-0130 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain NO NO 54 TCGA-06-0130-F22596 TCGA-06-0130 -19812 394 0 320 244 2008-12-10 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 80 Progression of Disease 0130 Preoperative WITH TUMOR YES NO YES Primary Tumor 01 06 Brain DECEASED 2003 cf7e2358-7542-4381-90f4-782663ddc63a TCGA-06-0130-01 TCGA-06-0130-01A-01D-1490-08 TCGA-06-0130-01 TCGA-06-0130-01A-01D-0214-01 TCGA-06-0130-01 cf7e2358-7542-4381-90f4-782663ddc63a TCGA-06-0130-01 TCGA-06-0130-01A-01D-0214-01 cf7e2358-7542-4381-90f4-782663ddc63a +TCGA-06-0132-01 TCGA-06-0132-01 GBM GBM-like c6 mutation c1uster 9 TCGA-06-0132 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES NO 49 TCGA-06-0132-F22600 TCGA-06-0132 TCGA-06-0132-01A -18125 771 0 570 482 2008-12-5 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 0.9 NO 0.9 Progression of Disease TCGA-06-0132.b572cee6-5c7e-402b-a25d-cd380594c7dd.pdf 0132 WITH TUMOR YES NO YES Primary Tumor 01 0.8 06 Brain A DECEASED 2007 66f6da01-b85b-4e29-8059-0bb6a32d709f TCGA-06-0132-01 TCGA-06-0132-01A-02D-1491-08 TCGA-06-0132-01 TCGA-06-0132-01A-02D-0236-01 TCGA-06-0132-01 66f6da01-b85b-4e29-8059-0bb6a32d709f TCGA-06-0132-01 TCGA-06-0132-01A-02D-0236-01 66f6da01-b85b-4e29-8059-0bb6a32d709f +TCGA-06-0133-01 TCGA-06-0133-01 BRCA-LUAD+ GBM non-CIMP c15 TCGA-06-0133 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES NO 64 TCGA-06-0133-F22602 TCGA-06-0133 -23402 435 0 428 78 2008-12-10 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection Progression of Disease 0133 WITH TUMOR YES NO YES Primary Tumor 01 06 Brain DECEASED 2007 TCGA-06-0133-01 TCGA-06-0133-01 TCGA-06-0133-01A-02D-0214-01 TCGA-06-0133-01A-02D-0214-01 +TCGA-06-0137-01 TCGA-06-0137-01 GBM GBM non-CIMP c15 mutation cluster 14 TCGA-06-0137 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES NO 63 TCGA-06-0137-F22609 TCGA-06-0137 -23273 812 0 702 487 2008-12-10 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection Progression of Disease 0137 WITH TUMOR YES NO YES Primary Tumor 01 06 Brain DECEASED 2003 TCGA-06-0137-01 TCGA-06-0137-01A-01D-1490-08 TCGA-06-0137-01 TCGA-06-0137-01A-02D-0214-01 TCGA-06-0137-01A-02D-0214-01 +TCGA-06-0138-01 TCGA-06-0138-01 GBM GBM-like c6 TCGA-06-0138 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES YES 43 TCGA-06-0138-F22612 TCGA-06-0138 TCGA-06-0138-01A -15736 737 0 674 394 2008-12-9 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 0.9 NO 80 1.7 Progression of Disease TCGA-06-0138.9a7ac58b-1ece-4196-aa88-5924f5fbe853.pdf 0138 Preoperative WITH TUMOR YES NO YES Primary Tumor 01 0.8 06 Brain A DECEASED 2004 6f2fedb4-66e2-48fd-8744-cbd30075bb03 TCGA-06-0138-01 TCGA-06-0138-01 TCGA-06-0138-01A-02D-0236-01 TCGA-06-0138-01 6f2fedb4-66e2-48fd-8744-cbd30075bb03 TCGA-06-0138-01 TCGA-06-0138-01A-02D-0236-01 6f2fedb4-66e2-48fd-8744-cbd30075bb03 +TCGA-06-0139-01 TCGA-06-0139-01 Quiet Low purity c2 mutation c1uster 9 TCGA-06-0139 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES NO 40 TCGA-06-0139-F22614 TCGA-06-0139 -14729 362 0 327 152 2008-12-10 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 60 Progression of Disease 0139 Preoperative WITH TUMOR YES NO YES Primary Tumor 01 06 Brain DECEASED 2006 TCGA-06-0139-01 TCGA-06-0139-01A-01D-1490-08 TCGA-06-0139-01 TCGA-06-0139-01B-05D-0214-01 TCGA-06-0139-01B-05D-0214-01 +TCGA-06-0140-01 TCGA-06-0140-01 GBM GBM non-CIMP c15 mutation c1uster 9 TCGA-06-0140 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 86 TCGA-06-0140 -31566 6 0 2013-2-12 MALE Glioblastoma Multiforme (GBM) No C71.9 9440/3 C71.9 YES Tumor resection 90 No 0140 Preoperative WITH TUMOR NO NO NO Primary Tumor 01 [Discrepancy] [Discrepancy] 06 Brain DECEASED 2003 TCGA-06-0140-01 TCGA-06-0140-01A-01D-1490-08 TCGA-06-0140-01 TCGA-06-0140-01A-01D-0214-01 TCGA-06-0140-01A-01D-0214-01 +TCGA-06-0141-01 TCGA-06-0141-01 Quiet C1-LUAD-enriched Cluster 5 GBM-like c6 mutation c1uster 9 TCGA-06-0141 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES NO 62 TCGA-06-0141-F22618 TCGA-06-0141 TCGA-06-0141-01A -22926 313 0 280 145 2008-12-8 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 0.9 NO 80 1.1 Progression of Disease TCGA-06-0141.caa0b0ec-7b94-4326-99d5-483fed429ed4.pdf 0141 Preoperative WITH TUMOR YES NO YES Primary Tumor 01 0.9 06 Brain A DECEASED 2000 689fb14c-d3c5-414f-8c7a-8aa73ebbfc37 TCGA-06-0141-01 TCGA-06-0141-01A-01D-1490-08 TCGA-06-0141-01 TCGA-06-0141-01A-01D-0214-01 TCGA-06-0141-01 689fb14c-d3c5-414f-8c7a-8aa73ebbfc37 TCGA-06-0141-01 TCGA-06-0141-01A-01D-0214-01 689fb14c-d3c5-414f-8c7a-8aa73ebbfc37 +TCGA-06-0142-01 TCGA-06-0142-01 GBM GBM non-CIMP c15 mutation cluster 14 TCGA-06-0142 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 81 TCGA-06-0142 -29642 67 0 2013-2-12 MALE Glioblastoma Multiforme (GBM) No C71.9 9440/3 C71.9 YES Tumor resection No 0142 WITH TUMOR NO NO NO Primary Tumor 01 [Discrepancy] [Discrepancy] 06 Brain DECEASED 2002 TCGA-06-0142-01 TCGA-06-0142-01A-01D-1490-08 TCGA-06-0142-01 TCGA-06-0142-01A-01D-0214-01 TCGA-06-0142-01A-01D-0214-01 +TCGA-06-0143-01 TCGA-06-0143-01 GBM GBM non-CIMP c15 TCGA-06-0143 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES NO 58 TCGA-06-0143-F22624 TCGA-06-0143 -21386 357 0 357 265 2008-12-11 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 60 Recurrence 0143 WITH TUMOR YES NO YES Primary Tumor 01 06 Brain DECEASED 2006 TCGA-06-0143-01 TCGA-06-0143-01 TCGA-06-0143-01A-01D-0214-01 TCGA-06-0143-01A-01D-0214-01 +TCGA-06-0145-01 TCGA-06-0145-01 GBM GBM non-CIMP c15 mutation c1uster 10 TCGA-06-0145 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 53 TCGA-06-0145-F22626 TCGA-06-0145 -19661 71 0 71 2008-12-10 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 0145 WITH TUMOR YES NO NO Primary Tumor 01 06 Brain DECEASED 2002 TCGA-06-0145-01 TCGA-06-0145-01A-01W-0224-08 TCGA-06-0145-01 TCGA-06-0145-01A-05D-0214-01 TCGA-06-0145-01A-05D-0214-01 +TCGA-06-0146-01 TCGA-06-0146-01 Kirc+ TCGA-06-0146 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain NO NO 33 TCGA-06-0146-F22629 TCGA-06-0146 -12253 611 0 611 530 2008-12-11 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection Progression of Disease 0146 WITH TUMOR YES NO YES Primary Tumor 01 06 Brain DECEASED 1995 TCGA-06-0146-01 TCGA-06-0146-01 TCGA-06-0146-01A-01D-0275-01 TCGA-06-0146-01A-01D-0275-01 +TCGA-06-0147-01 TCGA-06-0147-01 Quiet GBM non-CIMP c15 TCGA-06-0147 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES YES 51 TCGA-06-0147-F22634 TCGA-06-0147 -18743 541 0 508 92 2008-12-10 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection Progression of Disease 0147 WITH TUMOR YES NO YES Primary Tumor 01 06 Brain DECEASED 1999 TCGA-06-0147-01 TCGA-06-0147-01 TCGA-06-0147-01A-02D-0236-01 TCGA-06-0147-01A-02D-0236-01 +TCGA-06-0148-01 TCGA-06-0148-01 GBM GBM non-CIMP c15 TCGA-06-0148 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain NO NO 76 TCGA-06-0148-F22642 TCGA-06-0148 -27842 307 0 298 189 2008-12-10 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection Progression of Disease 0148 WITH TUMOR NO NO YES Primary Tumor 01 06 Brain DECEASED 2002 TCGA-06-0148-01 TCGA-06-0148-01 TCGA-06-0148-01A-01D-0214-01 TCGA-06-0148-01A-01D-0214-01 +TCGA-06-0149-01 TCGA-06-0149-01 GBM TCGA-06-0149 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain NO NO 74 TCGA-06-0149-F22645 TCGA-06-0149 -27315 262 0 239 204 2008-12-8 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 80 Progression of Disease 0149 Preoperative WITH TUMOR YES NO YES Primary Tumor 01 06 Brain DECEASED 2005 TCGA-06-0149-01 TCGA-06-0149-01 TCGA-06-0149-01A-05D-0275-01 TCGA-06-0149-01A-05D-0275-01 +TCGA-06-0150-01 TCGA-06-0150-01 GBM TCGA-06-0150 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 45 TCGA-06-0150 TCGA-06-0150-01A -16442 592 0 2013-2-12 MALE Glioblastoma Multiforme (GBM) No C71.9 9440/3 C71.9 YES Tumor resection 0.9 NO 1.5 No TCGA-06-0150.4854A37F-5F68-4EA0-99F7-E0572EA9533F.pdf 0150 WITH TUMOR YES NO YES Primary Tumor 01 0.9 [Discrepancy] [Discrepancy] 06 Brain A DECEASED 1995 TCGA-06-0150-01A-01D-0236-01 TCGA-06-0150-01A-01D-0236-01 +TCGA-06-0151-01 TCGA-06-0151-01 Kirc+ mutation c1uster 9 TCGA-06-0151 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 32 TCGA-06-0151 TCGA-06-0151-01A -11956 1417 0 2013-2-13 FEMALE Glioblastoma Multiforme (GBM) No C71.9 9440/3 C71.9 YES Tumor resection 0.9 NO 70 1 No TCGA-06-0151.1F3FA2E7-E496-439C-8396-B6CEB738E6B4.pdf 0151 Post-Adjuvant Therapy WITH TUMOR YES NO YES Primary Tumor 01 0.9 [Discrepancy] [Discrepancy] 06 Brain A DECEASED 1995 TCGA-06-0151-01A-01D-1491-08 TCGA-06-0151-01A-01D-0236-01 TCGA-06-0151-01A-01D-0236-01 +TCGA-06-0152-01 TCGA-06-0152-01 GBM mutation cluster 12 TCGA-06-0152 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES NO 68 TCGA-06-0152-F22647 TCGA-06-0152 -24844 375 0 359 299 2008-12-11 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection Progression of Disease 0152 Preoperative WITH TUMOR YES NO YES Primary Tumor 01 06 Brain DECEASED 1995 TCGA-06-0152-01 TCGA-06-0152-01A-02W-0323-08 TCGA-06-0152-01A-02D-A45W-05 TCGA-06-0152-01 TCGA-06-0152-01A-02D-0310-01 TCGA-06-0152-01A-02D-0310-01 +TCGA-06-0152-02 TCGA-06-0152-02 GBM non-CIMP c15 GBM-like c6 mutation cluster 12 TCGA-06-0152 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES NO 68 TCGA-06-0152-F22647 TCGA-06-0152 TCGA-06-0152-02A -24844 375 0 359 299 2008-12-11 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 0.8 NO 1 Progression of Disease TCGA-06-0152.DBD8D383-7A03-4A1B-B665-BDAF66C743E0.pdf 0152 Preoperative WITH TUMOR YES NO YES Recurrent Tumor 02 0.6 06 Brain A DECEASED 1995 75ed138d-252f-4179-b93f-4ae8eb2524ee TCGA-06-0152-02A-01D-2004-05 75ed138d-252f-4179-b93f-4ae8eb2524ee 75ed138d-252f-4179-b93f-4ae8eb2524ee +TCGA-06-0154-01 TCGA-06-0154-01 GBM GBM-like c2 mutation cluster 14 TCGA-06-0154 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES YES 54 TCGA-06-0154-F22654 TCGA-06-0154 -20018 424 0 389 208 2008-12-8 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 100 Progression of Disease 0154 Preoperative WITH TUMOR YES NO YES Primary Tumor 01 06 Brain DECEASED 1998 TCGA-06-0154-01 TCGA-06-0154-01A-03D-1491-08 TCGA-06-0154-01 TCGA-06-0154-01A-03D-0236-01 TCGA-06-0154-01A-03D-0236-01 +TCGA-06-0155-01 TCGA-06-0155-01 GBM C10-GBM GBM non-CIMP c15 GBM-like c2 mutation cluster 14 TCGA-06-0155 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES NO 61 TCGA-06-0155-F22662 TCGA-06-0155 -22498 318 0 263 256 2009-5-11 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 80 Progression of Disease 0155 Preoperative WITH TUMOR YES NO YES Primary Tumor 01 06 Brain DECEASED 1998 TCGA-06-0155-01 TCGA-06-0155-01B-01D-1492-08 TCGA-06-0155-01 TCGA-06-0155-01B-01D-0517-01 TCGA-06-0155-01B-01D-0517-01 +TCGA-06-0156-01 TCGA-06-0156-01 GBM-like c2 GBM-like c6 TCGA-06-0156 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 57 TCGA-06-0156-F22669 TCGA-06-0156 TCGA-06-0156-01A -20932 178 0 164 2008-12-8 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 0.9 NO 0.9 TCGA-06-0156.8153dcf5-1f5c-4c26-a0cb-05e2209a62dd.pdf 0156 WITH TUMOR YES NO YES Primary Tumor 01 0.4 06 Brain A DECEASED 1998 67b4bd07-77fd-4595-b2a0-5f3a3a43a221,88958da0-8140-466c-8183-bf4995529b16 TCGA-06-0156-01 TCGA-06-0156-01 67b4bd07-77fd-4595-b2a0-5f3a3a43a221,88958da0-8140-466c-8183-bf4995529b16 67b4bd07-77fd-4595-b2a0-5f3a3a43a221,88958da0-8140-466c-8183-bf4995529b16 +TCGA-06-0157-01 TCGA-06-0157-01 GBM GBM-like c6 mutation cluster 14 TCGA-06-0157 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 63 TCGA-06-0157-F22673 TCGA-06-0157 -23128 97 0 97 2008-12-9 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 40 0157 Preoperative WITH TUMOR NO NO YES Primary Tumor 01 06 Brain DECEASED 1998 e50235f8-f8cf-44c8-9d5e-ca5bbbb6291a TCGA-06-0157-01 TCGA-06-0157-01A-01D-1491-08 TCGA-06-0157-01 TCGA-06-0157-01A-01D-0236-01 TCGA-06-0157-01 e50235f8-f8cf-44c8-9d5e-ca5bbbb6291a TCGA-06-0157-01 TCGA-06-0157-01A-01D-0236-01 e50235f8-f8cf-44c8-9d5e-ca5bbbb6291a +TCGA-06-0158-01 TCGA-06-0158-01 GBM GBM-like c6 mutation cluster 14 TCGA-06-0158 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES NO 73 TCGA-06-0158-F22676 TCGA-06-0158 TCGA-06-0158-01A -26856 329 0 166 90 2008-12-10 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 0.9 NO 80 1.8 Progression of Disease TCGA-06-0158.584952b9-bbd0-4da2-9a40-cd0291e8f780.pdf 0158 Preoperative WITH TUMOR NO NO YES Primary Tumor 01 0.9 06 Brain A DECEASED 1998 4df60632-cb31-4c0f-8929-d18129668469 TCGA-06-0158-01 TCGA-06-0158-01A-01D-1491-08 TCGA-06-0158-01 TCGA-06-0158-01A-01D-0236-01 TCGA-06-0158-01 4df60632-cb31-4c0f-8929-d18129668469 TCGA-06-0158-01 TCGA-06-0158-01A-01D-0236-01 4df60632-cb31-4c0f-8929-d18129668469 +TCGA-06-0159-01 TCGA-06-0159-01 GBM TCGA-06-0159 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 74 TCGA-06-0159 TCGA-06-0159-01A -27368 287 0 2013-2-13 MALE Glioblastoma Multiforme (GBM) No C71.9 9440/3 C71.9 YES Tumor resection 0.9 NO 90 0.9 No TCGA-06-0159.5C189EAA-AD1E-4957-B2F4-E253BC9953C7.pdf 0159 Post-Adjuvant Therapy WITH TUMOR YES NO YES Primary Tumor 01 0.8 [Discrepancy] [Discrepancy] 06 Brain A DECEASED 1998 TCGA-06-0159-01A-01D-0236-01 TCGA-06-0159-01A-01D-0236-01 +TCGA-06-0160-01 TCGA-06-0160-01 Quiet TCGA-06-0160 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 56 TCGA-06-0160 -20684 359 0 2013-2-13 FEMALE Glioblastoma Multiforme (GBM) No C71.9 9440/3 C71.9 YES Tumor resection No 0160 WITH TUMOR YES [Discrepancy] NO [Discrepancy] Primary Tumor 01 [Discrepancy] [Discrepancy] 06 Brain DECEASED 1999 TCGA-06-0160-01 TCGA-06-0160-01 TCGA-06-0160-01A-01D-0236-01 TCGA-06-0160-01A-01D-0236-01 +TCGA-06-0162-01 TCGA-06-0162-01 GBM TCGA-06-0162 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 47 TCGA-06-0162-F22680 TCGA-06-0162 -17272 104 0 78 2008-12-8 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 60 0162 Preoperative WITH TUMOR YES YES YES Primary Tumor 01 06 Brain DECEASED 2000 TCGA-06-0162-01 TCGA-06-0162-01 TCGA-06-0162-01A-01D-0275-01 TCGA-06-0162-01A-01D-0275-01 +TCGA-06-0164-01 TCGA-06-0164-01 GBM TCGA-06-0164 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES NO 47 TCGA-06-0164-F22684 TCGA-06-0164 -17510 1731 0 1730 1428 2008-12-8 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 100 Progression of Disease 0164 Preoperative WITH TUMOR YES NO YES Primary Tumor 01 06 Brain DECEASED 2000 TCGA-06-0164-01 TCGA-06-0164-01 TCGA-06-0164-01A-01D-0275-01 TCGA-06-0164-01A-01D-0275-01 +TCGA-06-0165-01 TCGA-06-0165-01 Quiet mutation c1uster 9 TCGA-06-0165 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 52 TCGA-06-0165 TCGA-06-0165-01A -19198 324 0 2013-2-13 MALE Glioblastoma Multiforme (GBM) No C71.9 9440/3 C71.9 YES Tumor resection 0.9 NO 90 0.9 No TCGA-06-0165.CEE9E681-17BA-493C-BB08-16624A50825C.pdf 0165 Pre-Adjuvant Therapy WITH TUMOR YES NO YES Primary Tumor 01 0.9 [Discrepancy] [Discrepancy] 06 Brain A DECEASED 2001 TCGA-06-0165-01A-01D-1491-08 TCGA-06-0165-01A-01D-0236-01 TCGA-06-0165-01A-01D-0236-01 +TCGA-06-0166-01 TCGA-06-0166-01 Kirc+ mutation cluster 14 TCGA-06-0166 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain NO YES 51 TCGA-06-0166-F22686 TCGA-06-0166 -18902 178 0 161 66 2008-12-8 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection Progression of Disease 0166 WITH TUMOR YES NO NO Primary Tumor 01 06 Brain DECEASED 2001 TCGA-06-0166-01 TCGA-06-0166-01A-01D-1491-08 TCGA-06-0166-01 TCGA-06-0166-01A-01D-0236-01 TCGA-06-0166-01A-01D-0236-01 +TCGA-06-0167-01 TCGA-06-0167-01 Quiet mutation c1uster 9 TCGA-06-0167 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 44 TCGA-06-0167 -16170 347 0 2013-2-13 MALE Glioblastoma Multiforme (GBM) No C71.9 9440/3 C71.9 YES Tumor resection 90 No 0167 Pre-Adjuvant Therapy WITH TUMOR YES NO YES Primary Tumor 01 [Discrepancy] [Discrepancy] 06 Brain DECEASED 2001 TCGA-06-0167-01A-01D-1491-08 TCGA-06-0167-01 +TCGA-06-0168-01 TCGA-06-0168-01 BRCA-LUAD+ GBM-like c6 mutation c1uster 9 TCGA-06-0168 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES YES 59 TCGA-06-0168-F22690 TCGA-06-0168 -21776 598 0 579 461 2008-12-10 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 100 Progression of Disease 0168 Preoperative WITH TUMOR YES NO YES Primary Tumor 01 06 Brain DECEASED 2002 db5b5af5-c221-4268-a978-e12c550989e7 TCGA-06-0168-01 TCGA-06-0168-01A-01D-1491-08 TCGA-06-0168-01 TCGA-06-0168-01A-02D-0236-01 TCGA-06-0168-01 db5b5af5-c221-4268-a978-e12c550989e7 TCGA-06-0168-01 TCGA-06-0168-01A-02D-0236-01 db5b5af5-c221-4268-a978-e12c550989e7 +TCGA-06-0169-01 TCGA-06-0169-01 GBM GBM non-CIMP c15 mutation c1uster 9 TCGA-06-0169 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain NO NO 68 TCGA-06-0169-F22697 TCGA-06-0169 -25127 100 0 95 92 2008-12-10 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 80 Progression of Disease 0169 Preoperative WITH TUMOR YES NO YES Primary Tumor 01 06 Brain DECEASED 2002 TCGA-06-0169-01 TCGA-06-0169-01A-01D-1490-08 TCGA-06-0169-01 TCGA-06-0169-01A-01D-0214-01 TCGA-06-0169-01A-01D-0214-01 +TCGA-06-0171-01 TCGA-06-0171-01 GBM squamous c3 TCGA-06-0171 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES NO 65 TCGA-06-0171-F22701 TCGA-06-0171 -24085 399 0 396 117 2008-12-10 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 100 Progression of Disease 0171 Preoperative WITH TUMOR YES NO YES Primary Tumor 01 06 Brain DECEASED 2002 TCGA-06-0171-01 TCGA-06-0171-01A-02D-A45W-05 TCGA-06-0171-01 TCGA-06-0171-01A-02D-0236-01 TCGA-06-0171-01A-02D-0236-01 +TCGA-06-0171-02 TCGA-06-0171-02 GBM non-CIMP c15 GBM-like c6 TCGA-06-0171 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES NO 65 TCGA-06-0171-F22701 TCGA-06-0171 TCGA-06-0171-02A -24085 399 0 396 117 2008-12-10 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 0.8 NO 100 1.1 Progression of Disease TCGA-06-0171.67747995-B764-412D-B8BE-E78094120153.pdf 0171 Preoperative WITH TUMOR YES NO YES Recurrent Tumor 02 0.8 06 Brain A DECEASED 2002 01b7a29e-0d3a-4a18-8cb6-f8a329f9d6e6 TCGA-06-0171-02A-11D-2280-08 TCGA-06-0171-02A-11D-2004-05 01b7a29e-0d3a-4a18-8cb6-f8a329f9d6e6 01b7a29e-0d3a-4a18-8cb6-f8a329f9d6e6 +TCGA-06-0173-01 TCGA-06-0173-01 GBM mutation c1uster 9 TCGA-06-0173 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 72 TCGA-06-0173-F22706 TCGA-06-0173 -26549 136 0 7 2008-12-10 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 0173 WITH TUMOR NO NO NO Primary Tumor 01 06 Brain DECEASED 2003 TCGA-06-0173-01 TCGA-06-0173-01A-01D-1491-08 TCGA-06-0173-01 TCGA-06-0173-01A-01D-0236-01 TCGA-06-0173-01A-01D-0236-01 +TCGA-06-0174-01 TCGA-06-0174-01 GBM GBM-like c6 mutation cluster 14 TCGA-06-0174 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain NO NO 54 TCGA-06-0174-F22708 TCGA-06-0174 TCGA-06-0174-01A -19824 98 0 67 47 2008-12-10 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 0.6 NO 80 1 Progression of Disease TCGA-06-0174.b93eb902-cea8-4bf5-830b-ddbaceab7444.pdf 0174 Preoperative WITH TUMOR YES NO YES Primary Tumor 01 0.4 06 Brain A DECEASED 2003 2cd6082b-d5e7-45a1-96f9-8ef4cccf8533 TCGA-06-0174-01 TCGA-06-0174-01A-01D-1491-08 TCGA-06-0174-01 TCGA-06-0174-01A-01D-0236-01 TCGA-06-0174-01 2cd6082b-d5e7-45a1-96f9-8ef4cccf8533 TCGA-06-0174-01 TCGA-06-0174-01A-01D-0236-01 2cd6082b-d5e7-45a1-96f9-8ef4cccf8533 +TCGA-06-0175-01 TCGA-06-0175-01 GBM TCGA-06-0175 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain NO YES 69 TCGA-06-0175-F22712 TCGA-06-0175 -25559 123 0 83 39 2008-12-10 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 100 Progression of Disease 0175 Preoperative WITH TUMOR YES NO NO Primary Tumor 01 06 Brain DECEASED 2003 TCGA-06-0175-01 TCGA-06-0175-01 TCGA-06-0175-01A-01D-0275-01 TCGA-06-0175-01A-01D-0275-01 +TCGA-06-0176-01 TCGA-06-0176-01 Kirc+ TCGA-06-0176 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain NO YES 34 TCGA-06-0176-F22716 TCGA-06-0176 -12777 0 1562 41 2008-12-10 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 80 Progression of Disease 0176 Preoperative TUMOR FREE YES NO YES Primary Tumor 01 06 Brain LIVING 2004 TCGA-06-0176-01 TCGA-06-0176-01 TCGA-06-0176-01A-03D-0236-01 TCGA-06-0176-01A-03D-0236-01 +TCGA-06-0177-01 TCGA-06-0177-01 GBM TCGA-06-0177 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 64 TCGA-06-0177-F22718 TCGA-06-0177 -23498 127 0 61 2008-12-10 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 60 0177 Preoperative WITH TUMOR NO NO NO Primary Tumor 01 06 Brain DECEASED 2004 TCGA-06-0177-01 TCGA-06-0177-01 TCGA-06-0177-01A-01D-0275-01 TCGA-06-0177-01A-01D-0275-01 +TCGA-06-0178-01 TCGA-06-0178-01 Quiet GBM-like c6 mutation c1uster 9 TCGA-06-0178 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES NO 38 TCGA-06-0178-F22720 TCGA-06-0178 TCGA-06-0178-01A -14235 0 1642 192 2008-12-9 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 0.9 NO 0.9 Progression of Disease TCGA-06-0178.efa462f1-142c-45de-8234-7f9b12d7b701.pdf 0178 Preoperative TUMOR FREE YES NO YES Primary Tumor 01 0.2 06 Brain A LIVING 2004 271ec214-e83b-4fcb-85cf-f35f3c39f0aa TCGA-06-0178-01 TCGA-06-0178-01A-01D-1491-08 TCGA-06-0178-01 TCGA-06-0178-01A-01D-0236-01 TCGA-06-0178-01 271ec214-e83b-4fcb-85cf-f35f3c39f0aa TCGA-06-0178-01 TCGA-06-0178-01A-01D-0236-01 271ec214-e83b-4fcb-85cf-f35f3c39f0aa +TCGA-06-0179-01 TCGA-06-0179-01 GBM TCGA-06-0179 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES YES 64 TCGA-06-0179-F22722 TCGA-06-0179 -23450 616 0 578 250 2008-12-10 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 60 Progression of Disease 0179 Preoperative WITH TUMOR YES NO YES Primary Tumor 01 06 Brain DECEASED 2004 TCGA-06-0179-01 TCGA-06-0179-01 TCGA-06-0179-01A-02D-0275-01 TCGA-06-0179-01A-02D-0275-01 +TCGA-06-0182-01 TCGA-06-0182-01 GBM TCGA-06-0182 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 76 TCGA-06-0182-F22724 TCGA-06-0182 -27964 111 0 77 2008-12-10 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 60 0182 Preoperative WITH TUMOR NO NO NO Primary Tumor 01 06 Brain DECEASED 2004 TCGA-06-0182-01 TCGA-06-0182-01 TCGA-06-0182-01A-01D-0275-01 TCGA-06-0182-01A-01D-0275-01 +TCGA-06-0184-01 TCGA-06-0184-01 GBM GBM-like c6 mutation cluster 5 TCGA-06-0184 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES YES 63 TCGA-06-0184-F19255 TCGA-06-0184 TCGA-06-0184-01A -23317 0 1228 1276 2008-12-10 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection NO 80 TCGA-06-0184.ce516253-acf1-4186-8998-dc089161e261.pdf 0184 Preoperative TUMOR FREE YES NO YES Primary Tumor 01 06 Brain A LIVING 2005 7522ddf3-0d35-4085-9f94-1ca2e38aa804 TCGA-06-0184-01 TCGA-06-0184-01A-01D-1491-08 TCGA-06-0184-01 TCGA-06-0184-01A-01D-0236-01 TCGA-06-0184-01 7522ddf3-0d35-4085-9f94-1ca2e38aa804 TCGA-06-0184-01 TCGA-06-0184-01A-01D-0236-01 7522ddf3-0d35-4085-9f94-1ca2e38aa804 +TCGA-06-0185-01 TCGA-06-0185-01 GBM mutation cluster 14 TCGA-06-0185 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES NO 54 TCGA-06-0185-F22728 TCGA-06-0185 -19923 0 1126 711 2008-12-8 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 100 Progression of Disease 0185 Preoperative WITH TUMOR YES NO YES Primary Tumor 01 06 Brain LIVING 2005 TCGA-06-0185-01 TCGA-06-0185-01A-01W-0254-08 TCGA-06-0185-01 TCGA-06-0185-01A-01D-0236-01 TCGA-06-0185-01A-01D-0236-01 +TCGA-06-0187-01 TCGA-06-0187-01 GBM GBM-like c6 TCGA-06-0187 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES NO 69 TCGA-06-0187-F22730 TCGA-06-0187 TCGA-06-0187-01A -25318 828 0 801 531 2008-12-10 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection NO 60 Recurrence TCGA-06-0187.17f164b8-9dc6-48f0-830b-60fc0efa83b4.pdf 0187 Preoperative WITH TUMOR YES NO YES Primary Tumor 01 06 Brain A DECEASED 2006 4e8e7e01-95a7-4724-bbc5-91436d80d0f7 TCGA-06-0187-01 TCGA-06-0187-01 TCGA-06-0187-01A-01D-0236-01 TCGA-06-0187-01 4e8e7e01-95a7-4724-bbc5-91436d80d0f7 TCGA-06-0187-01 TCGA-06-0187-01A-01D-0236-01 4e8e7e01-95a7-4724-bbc5-91436d80d0f7 +TCGA-06-0188-01 TCGA-06-0188-01 GBM mutation cluster 5 TCGA-06-0188 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES NO 71 TCGA-06-0188-F20854 TCGA-06-0188 -26080 0 866 310 2008-12-9 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 100 0188 Preoperative WITH TUMOR YES NO YES Primary Tumor 01 06 Brain LIVING 2006 TCGA-06-0188-01 TCGA-06-0188-01A-01W-0254-08 TCGA-06-0188-01 TCGA-06-0188-01A-01D-0236-01 TCGA-06-0188-01A-01D-0236-01 +TCGA-06-0189-01 TCGA-06-0189-01 Kirc+ GBM-like c2 mutation cluster 5 TCGA-06-0189 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 55 TCGA-06-0189-F22734 TCGA-06-0189 -20297 469 0 454 2008-12-10 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 0189 WITH TUMOR YES NO YES Primary Tumor 01 06 Brain DECEASED 2006 TCGA-06-0189-01 TCGA-06-0189-01A-01D-1491-08 TCGA-06-0189-01 TCGA-06-0189-01A-01D-0236-01 TCGA-06-0189-01A-01D-0236-01 +TCGA-06-0190-01 TCGA-06-0190-01 GBM GBM-like c6 TCGA-06-0190 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES NO 62 TCGA-06-0190-F22736 TCGA-06-0190 TCGA-06-0190-01A -22835 317 0 313 88 2008-12-11 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 0.9 NO 80 1.4 Progression of Disease TCGA-06-0190.46FE21C6-F2DC-4A8A-8E1E-C278DD5FF009.pdf 0190 WITH TUMOR YES NO YES Primary Tumor 01 0.9 06 Brain A DECEASED 2006 612ef912-5a28-4c11-8703-3376f51afef5 TCGA-06-0190-01 TCGA-06-0190-01A-01D-A45W-05 TCGA-06-0190-01 TCGA-06-0190-01A-01D-0236-01 TCGA-06-0190-01 612ef912-5a28-4c11-8703-3376f51afef5 TCGA-06-0190-01 TCGA-06-0190-01A-01D-0236-01 612ef912-5a28-4c11-8703-3376f51afef5 +TCGA-06-0190-02 TCGA-06-0190-02 GBM non-CIMP c15 GBM-like c6 TCGA-06-0190 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES NO 62 TCGA-06-0190-F22736 TCGA-06-0190 TCGA-06-0190-02A -22835 317 0 313 88 2008-12-11 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 0.8 NO 80 1.3 Progression of Disease TCGA-06-0190.46FE21C6-F2DC-4A8A-8E1E-C278DD5FF009.pdf 0190 WITH TUMOR YES NO YES Recurrent Tumor 02 0.5 06 Brain A DECEASED 2006 0ffc2552-883a-4e8f-9f76-4f37dfce3278 TCGA-06-0190-02A-01D-2280-08 TCGA-06-0190-02A-01D-2004-05 0ffc2552-883a-4e8f-9f76-4f37dfce3278 0ffc2552-883a-4e8f-9f76-4f37dfce3278 +TCGA-06-0192-01 TCGA-06-0192-01 GBM mutation cluster 4 TCGA-06-0192 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES YES 58 TCGA-06-0192-F20865 TCGA-06-0192 -21243 0 557 670 648 2009-2-3 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 100 Locoregional Disease YES 0192 Preoperative TUMOR FREE YES NO YES Primary Tumor 01 06 Brain LIVING 2007 TCGA-06-0192-01 TCGA-06-0192-01B-01W-0348-08 TCGA-06-0192-01 TCGA-06-0192-01B-01D-0333-01 TCGA-06-0192-01B-01D-0333-01 +TCGA-06-0194-01 TCGA-06-0194-01 GBM TCGA-06-0194 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain NO NO 37 TCGA-06-0194-F22740 TCGA-06-0194 -13852 142 0 142 125 2008-12-10 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection Progression of Disease 0194 Preoperative WITH TUMOR YES NO YES Primary Tumor 01 06 Brain DECEASED 1994 TCGA-06-0194-01 TCGA-06-0194-01 TCGA-06-0194-01A-01D-0275-01 TCGA-06-0194-01A-01D-0275-01 +TCGA-06-0195-01 TCGA-06-0195-01 BRCA-LUAD+ mutation cluster 5 TCGA-06-0195 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain NO NO 63 TCGA-06-0195-F22742 TCGA-06-0195 -23132 225 0 214 147 2008-12-10 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 100 Progression of Disease 0195 Preoperative WITH TUMOR YES NO YES Primary Tumor 01 06 Brain DECEASED 1994 TCGA-06-0195-01 TCGA-06-0195-01B-01D-1491-08 TCGA-06-0195-01 TCGA-06-0195-01B-01D-0236-01 TCGA-06-0195-01B-01D-0236-01 +TCGA-06-0197-01 TCGA-06-0197-01 GBM TCGA-06-0197 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain NO NO 65 TCGA-06-0197-F22750 TCGA-06-0197 -24095 169 0 79 47 2008-12-10 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection Progression of Disease 0197 WITH TUMOR YES NO NO Primary Tumor 01 06 Brain DECEASED 1994 TCGA-06-0197-01 TCGA-06-0197-01 TCGA-06-0197-01A-02D-0236-01 TCGA-06-0197-01A-02D-0236-01 +TCGA-06-0201-01 TCGA-06-0201-01 GBM TCGA-06-0201 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 51 TCGA-06-0201-F22753 TCGA-06-0201 -18649 12 0 12 2008-12-11 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 0201 WITH TUMOR NO NO NO Primary Tumor 01 06 Brain DECEASED 1995 TCGA-06-0201-01 TCGA-06-0201-01 TCGA-06-0201-01A-01D-0236-01 TCGA-06-0201-01A-01D-0236-01 +TCGA-06-0206-01 TCGA-06-0206-01 BRCA-LUAD+ TCGA-06-0206 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain NO NO 40 TCGA-06-0206-F22755 TCGA-06-0206 -14937 233 0 197 106 2008-12-9 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection Recurrence 0206 WITH TUMOR YES NO YES Primary Tumor 01 06 Brain DECEASED 1996 TCGA-06-0206-01 TCGA-06-0206-01 TCGA-06-0206-01A-01D-0236-01 TCGA-06-0206-01A-01D-0236-01 +TCGA-06-0208-01 TCGA-06-0208-01 GBM TCGA-06-0208 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain NO NO 52 TCGA-06-0208-F22759 TCGA-06-0208 -19108 256 0 167 149 2008-12-5 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 80 Progression of Disease 0208 Preoperative WITH TUMOR YES NO YES Primary Tumor 01 06 Brain DECEASED 1997 TCGA-06-0208-01 TCGA-06-0208-01 TCGA-06-0208-01B-01D-0236-01 TCGA-06-0208-01B-01D-0236-01 +TCGA-06-0209-01 TCGA-06-0209-01 GBM mutation c1uster 9 TCGA-06-0209 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 76 TCGA-06-0209-F22764 TCGA-06-0209 TCGA-06-0209-01A -27877 232 0 119 2008-12-5 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection NO TCGA-06-0209.93a70661-a507-4b57-bee6-b9bf201f31c6.pdf 0209 WITH TUMOR NO NO YES Primary Tumor 01 06 Brain A DECEASED 1997 TCGA-06-0209-01A-01D-1491-08 TCGA-06-0209-01A-01D-0236-01 TCGA-06-0209-01A-01D-0236-01 +TCGA-06-0210-01 TCGA-06-0210-01 GBM GBM-like c6 TCGA-06-0210 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain NO NO 72 TCGA-06-0210-F22767 TCGA-06-0210 -26600 225 0 151 67 2008-12-5 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection Progression of Disease 0210 WITH TUMOR NO NO YES Primary Tumor 01 06 Brain DECEASED 1997 a0dfc338-c576-4a9c-8db3-3bbbcd5dc960 TCGA-06-0210-01 TCGA-06-0210-01A-01D-A45W-05 TCGA-06-0210-01 TCGA-06-0210-01B-01D-0236-01 TCGA-06-0210-01 a0dfc338-c576-4a9c-8db3-3bbbcd5dc960 TCGA-06-0210-01 TCGA-06-0210-01B-01D-0236-01 a0dfc338-c576-4a9c-8db3-3bbbcd5dc960 +TCGA-06-0210-02 TCGA-06-0210-02 GBM non-CIMP c15 GBM-like c6 TCGA-06-0210 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain NO NO 72 TCGA-06-0210-F22767 TCGA-06-0210 TCGA-06-0210-02A -26600 225 0 151 67 2008-12-5 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 0.6 NO 0.8 Progression of Disease TCGA-06-0210.5617D8A4-BB27-4643-A3FD-8DDCF659CB3B.pdf 0210 WITH TUMOR NO NO YES Recurrent Tumor 02 0.4 06 Brain A DECEASED 1997 26200b50-c40c-4e09-89c4-083b873bcf25 TCGA-06-0210-02A-01D-2280-08 TCGA-06-0210-02A-01D-2004-05 26200b50-c40c-4e09-89c4-083b873bcf25 26200b50-c40c-4e09-89c4-083b873bcf25 +TCGA-06-0211-01 TCGA-06-0211-01 GBM GBM-like c6 TCGA-06-0211 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES NO 47 TCGA-06-0211-F22770 TCGA-06-0211 TCGA-06-0211-01B -17515 360 0 360 53 2008-12-5 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection NO 100 Progression of Disease TCGA-06-0211.528DED4E-C801-4F67-BB1E-62470B39B41E.pdf 0211 Preoperative WITH TUMOR YES NO YES Primary Tumor 01 06 Brain B DECEASED 1997 51fff807-cfea-4ff5-bd35-093b0c18f0fb,6b59b1e5-4593-49f9-add7-b41e719d7af6 TCGA-06-0211-01 TCGA-06-0211-01A-01D-A45W-05 TCGA-06-0211-01 TCGA-06-0211-01B-01D-0236-01 TCGA-06-0211-01 51fff807-cfea-4ff5-bd35-093b0c18f0fb,6b59b1e5-4593-49f9-add7-b41e719d7af6 TCGA-06-0211-01 TCGA-06-0211-01B-01D-0236-01 6b59b1e5-4593-49f9-add7-b41e719d7af6,51fff807-cfea-4ff5-bd35-093b0c18f0fb +TCGA-06-0211-02 TCGA-06-0211-02 GBM non-CIMP c15 GBM-like c6 TCGA-06-0211 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES NO 47 TCGA-06-0211-F22770 TCGA-06-0211 TCGA-06-0211-02A -17515 360 0 360 53 2008-12-5 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 1.2 NO 100 1.4 Progression of Disease TCGA-06-0211.528DED4E-C801-4F67-BB1E-62470B39B41E.pdf 0211 Preoperative WITH TUMOR YES NO YES Recurrent Tumor 02 0.3 06 Brain A DECEASED 1997 152afe8c-f67c-4d7c-93ac-e1b7edd56c54 TCGA-06-0211-02A-02D-2280-08 TCGA-06-0211-02A-02D-2004-05 152afe8c-f67c-4d7c-93ac-e1b7edd56c54 152afe8c-f67c-4d7c-93ac-e1b7edd56c54 +TCGA-06-0213-01 TCGA-06-0213-01 GBM mutation cluster 12 TCGA-06-0213 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 55 TCGA-06-0213-F22776 TCGA-06-0213 -20134 16 0 6 2008-12-10 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 0213 WITH TUMOR NO NO NO Primary Tumor 01 06 Brain DECEASED 1998 TCGA-06-0213-01 TCGA-06-0213-01A-01D-1491-08 TCGA-06-0213-01 TCGA-06-0213-01A-01D-0236-01 TCGA-06-0213-01A-01D-0236-01 +TCGA-06-0214-01 TCGA-06-0214-01 GBM mutation cluster 6 TCGA-06-0214 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES YES 66 TCGA-06-0214-F22778 TCGA-06-0214 -24187 457 0 378 48 2008-12-8 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 100 Progression of Disease 0214 Preoperative WITH TUMOR YES NO NO Primary Tumor 01 06 Brain DECEASED 1998 TCGA-06-0214-01 TCGA-06-0214-01A-02D-1491-08 TCGA-06-0214-01 TCGA-06-0214-01A-02D-0236-01 TCGA-06-0214-01A-02D-0236-01 +TCGA-06-0216-01 TCGA-06-0216-01 BRCA-LUAD+ mutation cluster 14 TCGA-06-0216 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES YES 61 TCGA-06-0216-F22784 TCGA-06-0216 -22524 735 0 684 175 2008-12-10 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 80 Progression of Disease 0216 Preoperative WITH TUMOR YES NO YES Primary Tumor 01 06 Brain DECEASED 1999 TCGA-06-0216-01 TCGA-06-0216-01B-01D-1492-08 TCGA-06-0216-01 TCGA-06-0216-01B-01D-0333-01 TCGA-06-0216-01B-01D-0333-01 +TCGA-06-0219-01 TCGA-06-0219-01 Kirc+ GBM-like c6 mutation c1uster 9 TCGA-06-0219 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 67 TCGA-06-0219-F22791 TCGA-06-0219 TCGA-06-0219-01A -24488 22 0 11 2008-12-8 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection NO TCGA-06-0219.90027ed9-92a4-4326-a531-be06db61e922.pdf 0219 WITH TUMOR NO NO NO Primary Tumor 01 06 Brain A DECEASED 2000 559a1178-052c-4452-876c-ba2468a3160a TCGA-06-0219-01 TCGA-06-0219-01A-01D-1491-08 TCGA-06-0219-01 TCGA-06-0219-01A-01D-0236-01 TCGA-06-0219-01 559a1178-052c-4452-876c-ba2468a3160a TCGA-06-0219-01 TCGA-06-0219-01A-01D-0236-01 559a1178-052c-4452-876c-ba2468a3160a +TCGA-06-0221-01 TCGA-06-0221-01 Kirc+ TCGA-06-0221 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES NO 31 TCGA-06-0221-F22793 TCGA-06-0221 -11333 603 0 548 260 2008-12-10 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 100 Progression of Disease 0221 Preoperative WITH TUMOR YES NO YES Primary Tumor 01 06 Brain DECEASED 2000 TCGA-06-0221-01 TCGA-06-0221-01A-01D-A45W-05 TCGA-06-0221-01 TCGA-06-0221-01A-01D-0236-01 TCGA-06-0221-01A-01D-0236-01 +TCGA-06-0221-02 TCGA-06-0221-02 GBM CIMP c16 GBM-like c6 TCGA-06-0221 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES NO 31 TCGA-06-0221-F22793 TCGA-06-0221 TCGA-06-0221-02A -11333 603 0 548 260 2008-12-10 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 1 NO 100 1.5 Progression of Disease TCGA-06-0221.8B5EF62B-5387-4395-A80D-0986E16DC5C7.pdf 0221 Preoperative WITH TUMOR YES NO YES Recurrent Tumor 02 0.3 06 Brain A DECEASED 2000 10c78528-13e4-4ce1-b171-939c9e4492d8 TCGA-06-0221-02A-11D-2280-08 TCGA-06-0221-02A-11D-2004-05 10c78528-13e4-4ce1-b171-939c9e4492d8 10c78528-13e4-4ce1-b171-939c9e4492d8 +TCGA-06-0237-01 TCGA-06-0237-01 GBM mutation cluster 8 TCGA-06-0237 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 75 TCGA-06-0237-F22804 TCGA-06-0237 -27735 415 0 315 2008-12-10 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 0237 WITH TUMOR YES NO YES Primary Tumor 01 06 Brain DECEASED 2006 TCGA-06-0237-01 TCGA-06-0237-01A-02D-1491-08 TCGA-06-0237-01 TCGA-06-0237-01A-02D-0236-01 TCGA-06-0237-01A-02D-0236-01 +TCGA-06-0238-01 TCGA-06-0238-01 GBM C10-GBM GBM-like c2 GBM-like c6 mutation cluster 5 TCGA-06-0238 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain NO NO 46 TCGA-06-0238-F22806 TCGA-06-0238 -17037 405 0 359 311 2008-12-11 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 80 Progression of Disease 0238 Preoperative WITH TUMOR YES NO YES Primary Tumor 01 06 Brain DECEASED 2007 a748d693-fae0-4fb6-ab1e-a347b4e9b7d2 TCGA-06-0238-01 TCGA-06-0238-01A-02D-1492-08 TCGA-06-0238-01 TCGA-06-0238-01A-02D-0310-01 TCGA-06-0238-01 a748d693-fae0-4fb6-ab1e-a347b4e9b7d2 TCGA-06-0238-01 TCGA-06-0238-01A-02D-0310-01 a748d693-fae0-4fb6-ab1e-a347b4e9b7d2 +TCGA-06-0240-01 TCGA-06-0240-01 Kirc+ mutation c1uster 9 TCGA-06-0240 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 57 TCGA-06-0240 -20937 621 0 2013-2-13 MALE Glioblastoma Multiforme (GBM) No C71.9 9440/3 C71.9 YES Tumor resection 90 No 0240 Preoperative WITH TUMOR YES NO YES Primary Tumor 01 [Discrepancy] [Discrepancy] 06 Brain DECEASED 2007 TCGA-06-0240-01 TCGA-06-0240-01A-03D-1491-08 TCGA-06-0240-01 TCGA-06-0240-01A-03D-0236-01 TCGA-06-0240-01A-03D-0236-01 +TCGA-06-0241-01 TCGA-06-0241-01 GBM mutation cluster 5 TCGA-06-0241 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES NO 65 TCGA-06-0241-F22808 TCGA-06-0241 -24101 0 455 196 2008-12-5 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 100 Recurrence 0241 Preoperative WITH TUMOR YES NO YES Primary Tumor 01 06 Brain LIVING 2007 TCGA-06-0241-01 TCGA-06-0241-01A-02D-1491-08 TCGA-06-0241-01 TCGA-06-0241-01A-02D-0236-01 TCGA-06-0241-01A-02D-0236-01 +TCGA-06-0394-01 TCGA-06-0394-01 GBM TCGA-06-0394 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES NO 51 TCGA-06-0394-F22810 TCGA-06-0394 -18913 329 0 314 87 2008-12-10 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection Progression of Disease 0394 Preoperative WITH TUMOR NO NO YES Primary Tumor 01 06 Brain DECEASED 1992 TCGA-06-0394-01 TCGA-06-0394-01 TCGA-06-0394-01A-01D-0275-01 TCGA-06-0394-01A-01D-0275-01 +TCGA-06-0397-01 TCGA-06-0397-01 Kirc+ TCGA-06-0397 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain NO NO 57 TCGA-06-0397-F22817 TCGA-06-0397 -20845 274 0 168 20 2008-12-10 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection Locoregional Disease YES 0397 Preoperative WITH TUMOR YES NO YES Primary Tumor 01 06 Brain DECEASED 1993 TCGA-06-0397-01 TCGA-06-0397-01 TCGA-06-0397-01A-01D-0275-01 TCGA-06-0397-01A-01D-0275-01 +TCGA-06-0402-01 TCGA-06-0402-01 GBM TCGA-06-0402 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 71 TCGA-06-0402-F22823 TCGA-06-0402 -26059 8 0 8 2008-12-10 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 0402 Preoperative WITH TUMOR NO NO NO Primary Tumor 01 06 Brain DECEASED 1993 TCGA-06-0402-01 TCGA-06-0402-01 TCGA-06-0402-01A-01D-0275-01 TCGA-06-0402-01A-01D-0275-01 +TCGA-06-0409-01 TCGA-06-0409-01 GBM TCGA-06-0409 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES YES 43 TCGA-06-0409-F22825 TCGA-06-0409 -16023 2201 0 2145 334 2008-12-10 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection Progression of Disease 0409 WITH TUMOR YES NO YES Primary Tumor 01 06 Brain DECEASED 1994 TCGA-06-0409-01 TCGA-06-0409-01 TCGA-06-0409-01A-02D-0275-01 TCGA-06-0409-01A-02D-0275-01 +TCGA-06-0410-01 TCGA-06-0410-01 Kirc+ TCGA-06-0410 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 76 TCGA-06-0410-F22838 TCGA-06-0410 -28084 143 0 143 2008-12-11 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 0410 WITH TUMOR NO NO NO Primary Tumor 01 06 Brain DECEASED 1995 TCGA-06-0410-01 TCGA-06-0410-01 TCGA-06-0410-01A-01D-0275-01 TCGA-06-0410-01A-01D-0275-01 +TCGA-06-0412-01 TCGA-06-0412-01 GBM TCGA-06-0412 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES NO 56 TCGA-06-0412-F22840 TCGA-06-0412 -20619 291 0 245 130 2008-12-11 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection Progression of Disease 0412 WITH TUMOR YES NO YES Primary Tumor 01 06 Brain DECEASED 1995 TCGA-06-0412-01 TCGA-06-0412-01 TCGA-06-0412-01A-01D-0275-01 TCGA-06-0412-01A-01D-0275-01 +TCGA-06-0413-01 TCGA-06-0413-01 GBM TCGA-06-0413 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 77 TCGA-06-0413-F22846 TCGA-06-0413 -28433 96 0 5 2008-12-8 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 0413 Preoperative WITH TUMOR NO NO NO Primary Tumor 01 06 Brain DECEASED 1995 TCGA-06-0413-01 TCGA-06-0413-01 TCGA-06-0413-01A-01D-0275-01 TCGA-06-0413-01A-01D-0275-01 +TCGA-06-0414-01 TCGA-06-0414-01 BRCA-LUAD+ TCGA-06-0414 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain NO NO 63 TCGA-06-0414-F22848 TCGA-06-0414 -23215 1068 0 1065 1013 2009-2-25 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection Recurrence 0414 TUMOR FREE YES NO YES Primary Tumor 01 06 Brain DECEASED 1996 TCGA-06-0414-01 TCGA-06-0414-01 TCGA-06-0414-01A-01D-0275-01 TCGA-06-0414-01A-01D-0275-01 +TCGA-06-0644-01 TCGA-06-0644-01 GBM C10-GBM KIRC-like c1 GBM-like c6 mutation cluster 11 TCGA-06-0644 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES YES 71 TCGA-06-0644-F22853 TCGA-06-0644 -26247 0 375 85 2008-12-10 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 80 Recurrence 0644 Preoperative WITH TUMOR YES NO YES Primary Tumor 01 06 Brain LIVING 2007 d52e7499-1325-4506-ae20-bd683d37318e TCGA-06-0644-01 TCGA-06-0644-01A-02D-1492-08 TCGA-06-0644-01 TCGA-06-0644-01A-02D-0310-01 TCGA-06-0644-01 d52e7499-1325-4506-ae20-bd683d37318e TCGA-06-0644-01 TCGA-06-0644-01A-02D-0310-01 d52e7499-1325-4506-ae20-bd683d37318e +TCGA-06-0645-01 TCGA-06-0645-01 GBM GBM-like c6 mutation c1uster 9 TCGA-06-0645 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 55 TCGA-06-0645-F22855 TCGA-06-0645 TCGA-06-0645-01A -20449 175 0 98 2008-12-9 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 0.9 NO 1.3 TCGA-06-0645.b006fa12-7893-48f9-81f1-93b28989ffe1.pdf 0645 Preoperative WITH TUMOR NO NO NO Primary Tumor 01 0.9 06 Brain A DECEASED 2007 6f9d76f0-ff61-4c58-ab2f-a7c84e9726e9 TCGA-06-0645-01 TCGA-06-0645-01A-01D-1492-08 TCGA-06-0645-01 TCGA-06-0645-01A-01D-0310-01 TCGA-06-0645-01 6f9d76f0-ff61-4c58-ab2f-a7c84e9726e9 TCGA-06-0645-01 TCGA-06-0645-01A-01D-0310-01 6f9d76f0-ff61-4c58-ab2f-a7c84e9726e9 +TCGA-06-0646-01 TCGA-06-0646-01 GBM GBM-like c6 mutation cluster 7 TCGA-06-0646 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain NO NO 60 TCGA-06-0646-F22857 TCGA-06-0646 -22273 175 0 136 90 2009-1-26 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 80 Progression of Disease 0646 Preoperative WITH TUMOR YES NO YES Primary Tumor 01 06 Brain DECEASED 2007 d694ad12-0ae4-4bee-9f7f-0c6adf5bf09d TCGA-06-0646-01 TCGA-06-0646-01A-01D-1492-08 TCGA-06-0646-01 TCGA-06-0646-01A-01D-0310-01 TCGA-06-0646-01 d694ad12-0ae4-4bee-9f7f-0c6adf5bf09d TCGA-06-0646-01 TCGA-06-0646-01A-01D-0310-01 d694ad12-0ae4-4bee-9f7f-0c6adf5bf09d +TCGA-06-0648-01 TCGA-06-0648-01 GBM mutation c1uster 9 TCGA-06-0648 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES NO 77 TCGA-06-0648-F22859 TCGA-06-0648 -28477 298 0 294 202 2008-12-8 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 80 Progression of Disease 0648 Preoperative WITH TUMOR YES NO YES Primary Tumor 01 06 Brain DECEASED 2007 TCGA-06-0648-01 TCGA-06-0648-01A-01W-0323-08 TCGA-06-0648-01 TCGA-06-0648-01A-01D-0310-01 TCGA-06-0648-01A-01D-0310-01 +TCGA-06-0649-01 TCGA-06-0649-01 GBM GBM-like c6 mutation cluster 6 TCGA-06-0649 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 73 TCGA-06-0649-F22861 TCGA-06-0649 -26796 64 0 62 2008-12-8 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 0649 Preoperative WITH TUMOR NO NO NO Primary Tumor 01 06 Brain DECEASED 2007 acb1160e-036a-4108-a9ce-d5f954191593 TCGA-06-0649-01 TCGA-06-0649-01B-01W-0348-08 TCGA-06-0649-01 TCGA-06-0649-01B-01D-0333-01 TCGA-06-0649-01 acb1160e-036a-4108-a9ce-d5f954191593 TCGA-06-0649-01 TCGA-06-0649-01B-01D-0333-01 acb1160e-036a-4108-a9ce-d5f954191593 +TCGA-06-0650-01 TCGA-06-0650-01 GBM C10-GBM Low purity c2 KIRC-like c1 mutation cluster 14 TCGA-06-0650 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES YES 39 TCGA-06-0650-F23088 TCGA-06-0650 -14560 717 0 717 351 0 2011-10-4 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection Progression of Disease 0650 Pre-Adjuvant Therapy WITH TUMOR YES NO YES Primary Tumor 01 06 Brain DECEASED 2007 TCGA-06-0650-01 TCGA-06-0650-01A-02D-1696-08 TCGA-06-0650-01A-02D-1697-05 TCGA-06-0650-01 TCGA-06-0650-01A-02D-1694-01 TCGA-06-0650-01A-02D-1694-01 +TCGA-06-0675-11 TCGA-06-0675-11 TCGA-06-0675 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain TCGA-06-0675-11A 0.8 NO 1.5 Solid Tissue Normal 11 0.8 A d4934e65-dc47-4f98-b4d4-e9034a96f446 d4934e65-dc47-4f98-b4d4-e9034a96f446 d4934e65-dc47-4f98-b4d4-e9034a96f446 +TCGA-06-0678-11 TCGA-06-0678-11 TCGA-06-0678 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain TCGA-06-0678-11A 0.8 NO 1.3 Solid Tissue Normal 11 0.8 A aba4cde6-c407-4cfb-922e-5b4402aae727 aba4cde6-c407-4cfb-922e-5b4402aae727 aba4cde6-c407-4cfb-922e-5b4402aae727 +TCGA-06-0680-11 TCGA-06-0680-11 TCGA-06-0680 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain TCGA-06-0680-11A 0.9 NO 0.9 Solid Tissue Normal 11 0.8 A 94f66829-3cef-4af2-9f97-2352ac85efee 94f66829-3cef-4af2-9f97-2352ac85efee 94f66829-3cef-4af2-9f97-2352ac85efee +TCGA-06-0681-11 TCGA-06-0681-11 TCGA-06-0681 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain TCGA-06-0681-11A 0.9 NO 1.2 Solid Tissue Normal 11 0.9 A bbd74b84-fee5-45ee-9b76-b84d54a42a08 bbd74b84-fee5-45ee-9b76-b84d54a42a08 bbd74b84-fee5-45ee-9b76-b84d54a42a08 +TCGA-06-0686-01 TCGA-06-0686-01 GBM GBM-like c6 mutation c1uster 9 TCGA-06-0686 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES NO 53 TCGA-06-0686-F22863 TCGA-06-0686 -19503 432 0 286 160 Scheduled Follow-up Submission 2012-1-25 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 90 Progression of Disease 0686 Post-Adjuvant Therapy WITH TUMOR YES NO YES Primary Tumor 01 06 Brain DECEASED 2008 f2d1056f-1329-44e4-8269-0e7dde93d64a TCGA-06-0686-01 TCGA-06-0686-01A-01W-0348-08 TCGA-06-0686-01 TCGA-06-0686-01A-01D-0333-01 TCGA-06-0686-01 f2d1056f-1329-44e4-8269-0e7dde93d64a TCGA-06-0686-01 TCGA-06-0686-01A-01D-0333-01 f2d1056f-1329-44e4-8269-0e7dde93d64a +TCGA-06-0743-01 TCGA-06-0743-01 GBM GBM-like c6 mutation cluster 8 TCGA-06-0743 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES NO 69 TCGA-06-0743-F29624 TCGA-06-0743 TCGA-06-0743-01A -25434 803 0 679 755 176 Scheduled Follow-up Submission 2011-12-7 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection NO 90 Locoregional Disease YES TCGA-06-0743.e5a35d11-6d87-4d7e-ac41-73bfe35871ff.pdf 0743 Post-Adjuvant Therapy WITH TUMOR YES NO YES Primary Tumor 01 06 Brain A DECEASED 2006 61677ea1-64a7-46e3-8b99-784ee9af1ba5 TCGA-06-0743-01 TCGA-06-0743-01A-01D-1492-08 TCGA-06-0743-01 TCGA-06-0743-01A-01D-0333-01 TCGA-06-0743-01 61677ea1-64a7-46e3-8b99-784ee9af1ba5 TCGA-06-0743-01 TCGA-06-0743-01A-01D-0333-01 61677ea1-64a7-46e3-8b99-784ee9af1ba5 +TCGA-06-0744-01 TCGA-06-0744-01 GBM GBM-like c6 mutation cluster 5 TCGA-06-0744 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain NO NO 66 TCGA-06-0744-F20885 TCGA-06-0744 -24471 0 595 1277 2008-12-5 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 80 0744 Preoperative TUMOR FREE YES YES YES Primary Tumor 01 06 Brain LIVING 2007 d29e5a15-6ad2-41f9-b4e8-5c4b0f3fda9e TCGA-06-0744-01 TCGA-06-0744-01A-01W-0348-08 TCGA-06-0744-01 TCGA-06-0744-01A-01D-0333-01 TCGA-06-0744-01 d29e5a15-6ad2-41f9-b4e8-5c4b0f3fda9e TCGA-06-0744-01 TCGA-06-0744-01A-01D-0333-01 d29e5a15-6ad2-41f9-b4e8-5c4b0f3fda9e +TCGA-06-0745-01 TCGA-06-0745-01 GBM GBM-like c6 mutation c1uster 9 TCGA-06-0745 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain NO NO 59 TCGA-06-0745-F22869 TCGA-06-0745 TCGA-06-0745-01A -21884 239 0 164 92 2008-12-5 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection NO 80 Progression of Disease TCGA-06-0745.f46f4b25-6e54-4c40-842a-1c5c6dd99cab.pdf 0745 Preoperative WITH TUMOR YES NO YES Primary Tumor 01 06 Brain A DECEASED 2007 616011aa-5aad-4078-85a6-e61f98d83363 TCGA-06-0745-01 TCGA-06-0745-01A-01W-0348-08 TCGA-06-0745-01 TCGA-06-0745-01A-01D-0333-01 TCGA-06-0745-01 616011aa-5aad-4078-85a6-e61f98d83363 TCGA-06-0745-01 TCGA-06-0745-01A-01D-0333-01 616011aa-5aad-4078-85a6-e61f98d83363 +TCGA-06-0747-01 TCGA-06-0747-01 GBM GBM-like c6 mutation cluster 14 TCGA-06-0747 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 53 TCGA-06-0747-F22871 TCGA-06-0747 TCGA-06-0747-01A -19657 82 0 82 2008-12-5 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection NO 80 TCGA-06-0747.41920fbe-be2c-4f3b-b8ee-6f2915a2ae3f.pdf 0747 Preoperative WITH TUMOR YES NO YES Primary Tumor 01 06 Brain A DECEASED 2007 04e97d81-96bb-40e7-9e8c-1efb19179a62 TCGA-06-0747-01 TCGA-06-0747-01A-01W-0348-08 TCGA-06-0747-01 TCGA-06-0747-01A-01D-0333-01 TCGA-06-0747-01 04e97d81-96bb-40e7-9e8c-1efb19179a62 TCGA-06-0747-01 TCGA-06-0747-01A-01D-0333-01 04e97d81-96bb-40e7-9e8c-1efb19179a62 +TCGA-06-0749-01 TCGA-06-0749-01 GBM GBM-like c6 mutation cluster 14 TCGA-06-0749 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 50 TCGA-06-0749-F22873 TCGA-06-0749 -18571 82 0 66 2008-12-8 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 0749 WITH TUMOR YES NO YES Primary Tumor 01 06 Brain DECEASED 2008 eb455c55-74ac-4303-b149-475ffe21e3c6 TCGA-06-0749-01 TCGA-06-0749-01A-01W-0348-08 TCGA-06-0749-01 TCGA-06-0749-01A-01D-0333-01 TCGA-06-0749-01 eb455c55-74ac-4303-b149-475ffe21e3c6 TCGA-06-0749-01 TCGA-06-0749-01A-01D-0333-01 eb455c55-74ac-4303-b149-475ffe21e3c6 +TCGA-06-0750-01 TCGA-06-0750-01 GBM GBM-like c6 mutation cluster 14 TCGA-06-0750 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 43 TCGA-06-0750-F22875 TCGA-06-0750 TCGA-06-0750-01A -16018 28 0 28 2008-12-8 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection NO 80 TCGA-06-0750.723b1f21-67a7-4a47-ac10-d297ea428c8a.pdf 0750 Preoperative WITH TUMOR NO NO NO Primary Tumor 01 06 Brain A DECEASED 2008 47fbba7a-4914-4bcd-9fea-7ebb84fb4b47 TCGA-06-0750-01 TCGA-06-0750-01A-01W-0348-08 TCGA-06-0750-01 TCGA-06-0750-01A-01D-0333-01 TCGA-06-0750-01 47fbba7a-4914-4bcd-9fea-7ebb84fb4b47 TCGA-06-0750-01 TCGA-06-0750-01A-01D-0333-01 47fbba7a-4914-4bcd-9fea-7ebb84fb4b47 +TCGA-06-0875-01 TCGA-06-0875-01 GBM C10-GBM GBM non-CIMP c15 GBM-like c2 mutation cluster 5 TCGA-06-0875 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain NO NO 61 TCGA-06-0875-F22877 TCGA-06-0875 -22312 0 1322 279 Scheduled Follow-up Submission 2012-1-31 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 100 Progression of Disease 0875 Post-Adjuvant Therapy TUMOR FREE YES NO YES Primary Tumor 01 06 Brain LIVING 2008 TCGA-06-0875-01 TCGA-06-0875-01A-01W-0424-08 TCGA-06-0875-01 TCGA-06-0875-01A-01D-0384-01 TCGA-06-0875-01A-01D-0384-01 +TCGA-06-0876-01 TCGA-06-0876-01 GBM C10-GBM GBM non-CIMP c15 GBM-like c2 mutation cluster 8 TCGA-06-0876 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES YES 72 TCGA-06-0876-F31562 TCGA-06-0876 -26372 0 1405 424 Scheduled Follow-up Submission 2012-1-31 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 70 0876 Post-Adjuvant Therapy WITH TUMOR YES NO YES Primary Tumor 01 06 Brain LIVING 2008 TCGA-06-0876-01 TCGA-06-0876-01A-01W-0424-08 TCGA-06-0876-01 TCGA-06-0876-01A-01D-0384-01 TCGA-06-0876-01A-01D-0384-01 +TCGA-06-0877-01 TCGA-06-0877-01 GBM C10-GBM GBM non-CIMP c15 GBM-like c2 mutation cluster 4 TCGA-06-0877 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 78 TCGA-06-0877-F31556 TCGA-06-0877 -28760 [Discrepancy] 0 204 Scheduled Follow-up Submission 2012-1-31 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 0877 WITH TUMOR NO NO YES Primary Tumor 01 06 Brain DECEASED 2008 TCGA-06-0877-01 TCGA-06-0877-01A-01W-0424-08 TCGA-06-0877-01 TCGA-06-0877-01A-01D-0384-01 TCGA-06-0877-01A-01D-0384-01 +TCGA-06-0878-01 TCGA-06-0878-01 GBM C10-GBM GBM non-CIMP c15 GBM-like c2 GBM-like c6 mutation cluster 14 TCGA-06-0878 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES NO 74 TCGA-06-0878-F22888 TCGA-06-0878 TCGA-06-0878-01A -27319 0 218 66 2009-2-25 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 0.7 NO 80 1.2 Recurrence TCGA-06-0878.31037a8e-696a-4858-90ca-84578f350b7f.pdf 0878 Preoperative WITH TUMOR YES NO YES Primary Tumor 01 0.7 06 Brain A LIVING 2008 903d756b-42ba-49bd-9a53-085b3211d8a7 TCGA-06-0878-01 TCGA-06-0878-01A-01W-0424-08 TCGA-06-0878-01 TCGA-06-0878-01A-01D-0384-01 TCGA-06-0878-01 903d756b-42ba-49bd-9a53-085b3211d8a7 TCGA-06-0878-01 TCGA-06-0878-01A-01D-0384-01 903d756b-42ba-49bd-9a53-085b3211d8a7 +TCGA-06-0879-01 TCGA-06-0879-01 GBM C10-GBM GBM non-CIMP c15 GBM-like c2 mutation cluster 14 TCGA-06-0879 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES YES 52 TCGA-06-0879-F31541 TCGA-06-0879 -19154 1229 0 699 699 Scheduled Follow-up Submission 2012-1-31 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 100 Progression of Disease 0879 Post-Adjuvant Therapy WITH TUMOR YES NO YES Primary Tumor 01 06 Brain DECEASED 2008 TCGA-06-0879-01 TCGA-06-0879-01A-01W-0424-08 TCGA-06-0879-01 TCGA-06-0879-01A-01D-0384-01 TCGA-06-0879-01A-01D-0384-01 +TCGA-06-0881-01 TCGA-06-0881-01 GBM Low purity c2 mutation cluster 14 TCGA-06-0881 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES YES 50 TCGA-06-0881-F31567 TCGA-06-0881 -18278 504 0 178 141 Scheduled Follow-up Submission 2012-1-31 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 100 Recurrence 0881 Post-Adjuvant Therapy WITH TUMOR YES NO YES Primary Tumor 01 06 Brain DECEASED 2008 TCGA-06-0881-01 TCGA-06-0881-01A-02W-0424-08 TCGA-06-0881-01 TCGA-06-0881-01A-02D-0384-01 TCGA-06-0881-01A-02D-0384-01 +TCGA-06-0882-01 TCGA-06-0882-01 GBM C10-GBM Low purity c2 GBM-like c2 GBM-like c6 mutation c1uster 9 TCGA-06-0882 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES YES 30 TCGA-06-0882-F31551 TCGA-06-0882 TCGA-06-0882-01A -11112 632 0 165 213 Scheduled Follow-up Submission 2012-2-8 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 0.8 NO 100 1.4 Recurrence TCGA-06-0882.f2de8883-bc9a-4578-a154-a70335786740.pdf 0882 Post-Adjuvant Therapy WITH TUMOR YES NO YES Primary Tumor 01 0.6 06 Brain A DECEASED 2008 25315562-5f8e-46d0-ab77-d1f6ce75270b TCGA-06-0882-01 TCGA-06-0882-01A-01W-0424-08 TCGA-06-0882-01 TCGA-06-0882-01A-01D-0384-01 TCGA-06-0882-01 25315562-5f8e-46d0-ab77-d1f6ce75270b TCGA-06-0882-01 TCGA-06-0882-01A-01D-0384-01 25315562-5f8e-46d0-ab77-d1f6ce75270b +TCGA-06-0939-01 TCGA-06-0939-01 GBM C10-GBM GBM non-CIMP c15 GBM-like c2 mutation c1uster 10 TCGA-06-0939 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES NO 79 TCGA-06-0939-F22909 TCGA-06-0939 -28893 0 637 329 2010-6-14 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 80 Progression of Disease 0939 Preoperative WITH TUMOR YES NO YES Primary Tumor 01 06 Brain LIVING 2008 TCGA-06-0939-01 TCGA-06-0939-01A-01D-1353-08 TCGA-06-0939-01 TCGA-06-0939-01A-01D-1224-01 TCGA-06-0939-01A-01D-1224-01 +TCGA-06-1084-01 TCGA-06-1084-01 BRCA-LUAD+ GBM non-CIMP c15 KIRC-like c1 TCGA-06-1084 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES NO 54 TCGA-06-1084-F22911 TCGA-06-1084 -19899 0 226 208 2009-5-11 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 80 Progression of Disease 1084 Preoperative WITH TUMOR YES NO YES Primary Tumor 01 06 Brain LIVING 2008 TCGA-06-1084-01 TCGA-06-1084-01 TCGA-06-1084-01A-01D-0517-01 TCGA-06-1084-01A-01D-0517-01 +TCGA-06-1086-01 TCGA-06-1086-01 Kirc+ GBM non-CIMP c15 GBM-like c2 TCGA-06-1086 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 42 TCGA-06-1086-F22917 TCGA-06-1086 -15645 208 0 193 2009-5-11 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 80 1086 Preoperative WITH TUMOR YES NO YES Primary Tumor 01 06 Brain DECEASED 2008 TCGA-06-1086-01 TCGA-06-1086-01 TCGA-06-1086-01A-02D-0517-01 TCGA-06-1086-01A-02D-0517-01 +TCGA-06-1087-01 TCGA-06-1087-01 GBM GBM non-CIMP c15 KIRC-like c1 TCGA-06-1087 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain NO NO 75 TCGA-06-1087-F22921 TCGA-06-1087 -27658 123 0 109 109 2009-5-11 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 60 Recurrence 1087 Preoperative WITH TUMOR YES NO YES Primary Tumor 01 06 Brain DECEASED 2008 TCGA-06-1087-01 TCGA-06-1087-01 TCGA-06-1087-01A-02D-0517-01 TCGA-06-1087-01A-02D-0517-01 +TCGA-06-1800-01 TCGA-06-1800-01 GBM GBM non-CIMP c15 GBM-like c2 TCGA-06-1800 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain NO NO 61 TCGA-06-1800-F22925 TCGA-06-1800 -22332 815 0 815 750 2009-8-19 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 60 Recurrence 1800 Preoperative WITH TUMOR YES NO YES Primary Tumor 01 06 Brain DECEASED 2006 TCGA-06-1800-01 TCGA-06-1800-01 TCGA-06-1800-01A-01D-0591-01 TCGA-06-1800-01A-01D-0591-01 +TCGA-06-1801-01 TCGA-06-1801-01 GBM GBM non-CIMP c15 TCGA-06-1801 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES NO 56 TCGA-06-1801-F22929 TCGA-06-1801 -20538 0 263 232 2009-8-19 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 80 Recurrence 1801 Preoperative WITH TUMOR YES NO YES Primary Tumor 01 06 Brain LIVING 2008 TCGA-06-1801-01 TCGA-06-1801-01 TCGA-06-1801-01A-02D-0591-01 TCGA-06-1801-01A-02D-0591-01 +TCGA-06-1802-01 TCGA-06-1802-01 GBM GBM non-CIMP c15 GBM-like c2 TCGA-06-1802 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES NO 61 TCGA-06-1802-F22931 TCGA-06-1802 -22537 0 240 81 2009-8-19 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 80 Recurrence 1802 Preoperative WITH TUMOR YES NO YES Primary Tumor 01 06 Brain LIVING 2008 TCGA-06-1802-01 TCGA-06-1802-01 TCGA-06-1802-01A-01D-0591-01 TCGA-06-1802-01A-01D-0591-01 +TCGA-06-1804-01 TCGA-06-1804-01 GBM C10-GBM GBM non-CIMP c15 GBM-like c2 GBM-like c6 mutation cluster 14 TCGA-06-1804 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 81 TCGA-06-1804-F23101 TCGA-06-1804 TCGA-06-1804-01A -29802 414 0 414 2011-9-26 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 0.8 NO 0.8 TCGA-06-1804.136737bf-4365-470b-a34a-3c578b041a71.pdf 1804 WITH TUMOR NO NO NO Primary Tumor 01 0.7 06 Brain A DECEASED 2009 07775763-1931-4f95-ad0a-094a228a3770 TCGA-06-1804-01 TCGA-06-1804-01A-01D-1696-08 TCGA-06-1804-01A-01D-1697-05 TCGA-06-1804-01 TCGA-06-1804-01A-01D-1694-01 TCGA-06-1804-01 07775763-1931-4f95-ad0a-094a228a3770 TCGA-06-1804-01 TCGA-06-1804-01A-01D-1694-01 07775763-1931-4f95-ad0a-094a228a3770 +TCGA-06-1805-01 TCGA-06-1805-01 Kirc+ GBM CIMP c16 GBM-like c2 TCGA-06-1805 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 28 TCGA-06-1805-F31555 TCGA-06-1805 -10542 0 1031 1 Scheduled Follow-up Submission 2012-2-8 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 90 1805 Post-Adjuvant Therapy TUMOR FREE YES NO YES Primary Tumor 01 06 Brain LIVING 2009 TCGA-06-1805-01 TCGA-06-1805-01 TCGA-06-1805-01A-01D-0591-01 TCGA-06-1805-01A-01D-0591-01 +TCGA-06-1806-01 TCGA-06-1806-01 Kirc+ C10-GBM GBM non-CIMP c15 GBM-like c2 mutation cluster 14 TCGA-06-1806 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 47 TCGA-06-1806 TCGA-06-1806-01A -17296 466 0 2013-9-18 MALE Glioblastoma Multiforme (GBM) No C71.9 9440/3 C71.9 YES Tumor resection 0.6 NO 90 0.6 No TCGA-06-1806.5b8c6b1f-deef-489e-ba9c-41088ca2ed87.pdf 1806 Pre-Adjuvant Therapy WITH TUMOR YES Progressive Disease NO YES Primary Tumor 01 0.6 YES NO 06 Brain A DECEASED 2009 TCGA-06-1806-01A-02D-1845-08 TCGA-06-1806-01A-02D-1844-05 TCGA-06-1806-01A-02D-1842-01 TCGA-06-1806-01A-02D-1842-01 +TCGA-06-2557-01 TCGA-06-2557-01 GBM C10-GBM GBM non-CIMP c15 GBM-like c2 GBM-like c6 mutation cluster 14 TCGA-06-2557 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 76 TCGA-06-2557-F22937 TCGA-06-2557 TCGA-06-2557-01A -27980 33 0 33 2010-3-22 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 0.9 NO 40 1.4 TCGA-06-2557.d3ed0551-1ec4-4146-ab0c-af6371a4c708.pdf 2557 Preoperative WITH TUMOR NO NO NO Primary Tumor 01 0.9 06 Brain A DECEASED 2008 84d56a0b-6ee1-4fe7-9491-d8815af1d6f5 TCGA-06-2557-01 TCGA-06-2557-01A-01D-1494-08 TCGA-06-2557-01 TCGA-06-2557-01A-01D-0784-01 TCGA-06-2557-01 84d56a0b-6ee1-4fe7-9491-d8815af1d6f5 TCGA-06-2557-01 TCGA-06-2557-01A-01D-0784-01 84d56a0b-6ee1-4fe7-9491-d8815af1d6f5 +TCGA-06-2558-01 TCGA-06-2558-01 GBM C10-GBM GBM non-CIMP c15 GBM-like c2 GBM-like c6 mutation cluster 5 TCGA-06-2558 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 75 TCGA-06-2558-F22939 TCGA-06-2558 TCGA-06-2558-01A -27511 380 0 23 2010-3-22 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 1 NO 60 2 TCGA-06-2558.15262baa-42ba-49a8-a63d-071e1b34ab89.pdf 2558 Preoperative NO YES Primary Tumor 01 0.5 06 Brain A DECEASED 2008 8fdc3c56-a96b-4cad-983a-12e6ef373069 TCGA-06-2558-01 TCGA-06-2558-01A-01D-1494-08 TCGA-06-2558-01 TCGA-06-2558-01A-01D-0784-01 TCGA-06-2558-01 8fdc3c56-a96b-4cad-983a-12e6ef373069 TCGA-06-2558-01 TCGA-06-2558-01A-01D-0784-01 8fdc3c56-a96b-4cad-983a-12e6ef373069 +TCGA-06-2559-01 TCGA-06-2559-01 GBM C10-GBM GBM non-CIMP c15 GBM-like c2 GBM-like c6 mutation cluster 5 TCGA-06-2559 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 83 TCGA-06-2559-F22942 TCGA-06-2559 -30580 150 0 150 2010-3-22 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 60 2559 Preoperative WITH TUMOR YES NO YES Primary Tumor 01 06 Brain DECEASED 2009 e623cbaa-d406-4c82-b9e8-21acfc9e630a TCGA-06-2559-01 TCGA-06-2559-01A-01D-1494-08 TCGA-06-2559-01 TCGA-06-2559-01A-01D-0784-01 TCGA-06-2559-01 e623cbaa-d406-4c82-b9e8-21acfc9e630a TCGA-06-2559-01 TCGA-06-2559-01A-01D-0784-01 e623cbaa-d406-4c82-b9e8-21acfc9e630a +TCGA-06-2561-01 TCGA-06-2561-01 GBM C10-GBM GBM non-CIMP c15 GBM-like c6 mutation cluster 7 TCGA-06-2561 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES YES 53 TCGA-06-2561-F29202 TCGA-06-2561 -19505 537 0 282 91 78 Scheduled Follow-up Submission 2012-2-8 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 90 Locoregional Disease YES 2561 Post-Adjuvant Therapy WITH TUMOR YES NO YES Primary Tumor 01 06 Brain DECEASED 2009 ec85fbac-e181-4559-b601-d2efe44e37a8 TCGA-06-2561-01 TCGA-06-2561-01A-02D-1494-08 TCGA-06-2561-01 TCGA-06-2561-01A-02D-0784-01 TCGA-06-2561-01 ec85fbac-e181-4559-b601-d2efe44e37a8 TCGA-06-2561-01 TCGA-06-2561-01A-02D-0784-01 ec85fbac-e181-4559-b601-d2efe44e37a8 +TCGA-06-2562-01 TCGA-06-2562-01 GBM C10-GBM GBM non-CIMP c15 GBM-like c2 GBM-like c6 mutation cluster 4 TCGA-06-2562 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain NO NO 81 TCGA-06-2562-F22953 TCGA-06-2562 TCGA-06-2562-01A -29753 382 0 86 151 Scheduled Follow-up Submission 2012-2-8 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 0.8 NO 50 0.8 Progression of Disease TCGA-06-2562.9e6cd324-7e45-4736-86ad-92b44321b0d7.pdf 2562 Post-Adjuvant Therapy WITH TUMOR YES NO YES Primary Tumor 01 0.6 06 Brain A DECEASED 2009 497767ca-3148-46d2-b4fc-15530c678b0b TCGA-06-2562-01 TCGA-06-2562-01A-01D-1494-08 TCGA-06-2562-01 TCGA-06-2562-01A-01D-0784-01 TCGA-06-2562-01 497767ca-3148-46d2-b4fc-15530c678b0b TCGA-06-2562-01 TCGA-06-2562-01A-01D-0784-01 497767ca-3148-46d2-b4fc-15530c678b0b +TCGA-06-2563-01 TCGA-06-2563-01 GBM C10-GBM GBM non-CIMP c15 GBM-like c2 GBM-like c6 mutation cluster 8 TCGA-06-2563 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES YES 72 TCGA-06-2563-F29198 TCGA-06-2563 -26643 0 932 554 Scheduled Follow-up Submission 2012-2-8 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 70 2563 Post-Adjuvant Therapy WITH TUMOR YES NO YES Primary Tumor 01 06 Brain LIVING 2009 c893538c-d12c-4dd1-a3fd-cba6a847c14e TCGA-06-2563-01 TCGA-06-2563-01A-01D-1494-08 TCGA-06-2563-01 TCGA-06-2563-01A-01D-0784-01 TCGA-06-2563-01 c893538c-d12c-4dd1-a3fd-cba6a847c14e TCGA-06-2563-01 TCGA-06-2563-01A-01D-0784-01 c893538c-d12c-4dd1-a3fd-cba6a847c14e +TCGA-06-2564-01 TCGA-06-2564-01 GBM C10-GBM GBM non-CIMP c15 GBM-like c2 GBM-like c6 mutation c1uster 9 TCGA-06-2564 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 50 TCGA-06-2564-F22961 TCGA-06-2564 TCGA-06-2564-01A -18435 0 181 2010-3-22 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 0.8 NO 100 1.3 TCGA-06-2564.d89f8307-b898-47ac-957b-a9b76f58bd01.pdf 2564 Post-Adjuvant Therapy WITH TUMOR NO YES Primary Tumor 01 0.8 06 Brain A LIVING 2009 6245a56e-eec6-4e7b-b9ef-bf0d1a3dcf36 TCGA-06-2564-01 TCGA-06-2564-01A-01D-1494-08 TCGA-06-2564-01 TCGA-06-2564-01A-01D-0784-01 TCGA-06-2564-01 6245a56e-eec6-4e7b-b9ef-bf0d1a3dcf36 TCGA-06-2564-01 TCGA-06-2564-01A-01D-0784-01 6245a56e-eec6-4e7b-b9ef-bf0d1a3dcf36 +TCGA-06-2565-01 TCGA-06-2565-01 GBM C10-GBM GBM non-CIMP c15 GBM-like c2 GBM-like c6 mutation cluster 14 TCGA-06-2565 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES YES 59 TCGA-06-2565-F31566 TCGA-06-2565 TCGA-06-2565-01A -21559 506 0 207 178 Scheduled Follow-up Submission 2012-2-8 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 0.8 NO 70 1.5 Recurrence TCGA-06-2565.2888b563-470d-4600-ab7d-f6b86bd11f7b.pdf 2565 Post-Adjuvant Therapy WITH TUMOR YES NO YES Primary Tumor 01 0.8 06 Brain A DECEASED 2009 2ee686c6-da57-4371-90a9-db02ab6cb278 TCGA-06-2565-01 TCGA-06-2565-01A-01D-1494-08 TCGA-06-2565-01 TCGA-06-2565-01A-01D-0784-01 TCGA-06-2565-01 2ee686c6-da57-4371-90a9-db02ab6cb278 TCGA-06-2565-01 TCGA-06-2565-01A-01D-0784-01 2ee686c6-da57-4371-90a9-db02ab6cb278 +TCGA-06-2566-01 TCGA-06-2566-01 Kirc+ GBM non-CIMP c15 GBM-like c2 TCGA-06-2566 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 23 TCGA-06-2566-F22975 TCGA-06-2566 -8428 182 0 182 2010-3-22 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 80 2566 Preoperative WITH TUMOR YES NO YES Primary Tumor 01 06 Brain DECEASED 2009 TCGA-06-2566-01 TCGA-06-2566-01 TCGA-06-2566-01A-01D-0784-01 TCGA-06-2566-01A-01D-0784-01 +TCGA-06-2567-01 TCGA-06-2567-01 Kirc+ C10-GBM GBM non-CIMP c15 GBM-like c2 GBM-like c6 mutation cluster 8 TCGA-06-2567 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 65 TCGA-06-2567-F22980 TCGA-06-2567 -23759 133 0 133 2010-3-22 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 80 2567 Preoperative WITH TUMOR YES NO YES Primary Tumor 01 06 Brain DECEASED 2009 e99614f9-51d8-4096-83af-8effd5266881 TCGA-06-2567-01 TCGA-06-2567-01A-01D-1494-08 TCGA-06-2567-01 TCGA-06-2567-01A-01D-0784-01 TCGA-06-2567-01 e99614f9-51d8-4096-83af-8effd5266881 TCGA-06-2567-01 TCGA-06-2567-01A-01D-0784-01 e99614f9-51d8-4096-83af-8effd5266881 +TCGA-06-2569-01 TCGA-06-2569-01 High C1-LUAD-enriched Cluster 5 GBM-like c6 mutation cluster 5 TCGA-06-2569 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 24 TCGA-06-2569-F22984 TCGA-06-2569 TCGA-06-2569-01A -8922 0 13 2010-3-22 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 0.8 NO 80 0.8 TCGA-06-2569.3713fba7-46ff-4499-9027-dc719227e0bd.pdf 2569 Preoperative WITH TUMOR NO Primary Tumor 01 0.3 06 Brain A LIVING 2009 57e8e300-2cd1-4af1-a84c-02e1d3fc3555 TCGA-06-2569-01 TCGA-06-2569-01A-01D-1494-08 TCGA-06-2569-01 TCGA-06-2569-01A-01D-0784-01 TCGA-06-2569-01 57e8e300-2cd1-4af1-a84c-02e1d3fc3555 TCGA-06-2569-01 TCGA-06-2569-01A-01D-0784-01 57e8e300-2cd1-4af1-a84c-02e1d3fc3555 +TCGA-06-2570-01 TCGA-06-2570-01 Kirc+ C10-GBM GBM CIMP c16 GBM-like c2 GBM-like c6 mutation cluster 3 TCGA-06-2570 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 21 TCGA-06-2570-F29197 TCGA-06-2570 TCGA-06-2570-01A -7936 0 958 0 Scheduled Follow-up Submission 2012-2-8 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 0.9 NO 100 1.5 TCGA-06-2570.e01ea83a-97eb-41bc-841a-3f45576604ff.pdf 2570 Post-Adjuvant Therapy TUMOR FREE YES NO YES Primary Tumor 01 0.9 06 Brain A LIVING 2009 48724ea4-25f1-463c-883a-69897e7d9a41 TCGA-06-2570-01 TCGA-06-2570-01A-01D-1495-08 TCGA-06-2570-01 TCGA-06-2570-01A-01D-0784-01 TCGA-06-2570-01 48724ea4-25f1-463c-883a-69897e7d9a41 TCGA-06-2570-01 TCGA-06-2570-01A-01D-0784-01 48724ea4-25f1-463c-883a-69897e7d9a41 +TCGA-06-5408-01 TCGA-06-5408-01 GBM C10-GBM GBM non-CIMP c15 GBM-like c2 GBM-like c6 mutation cluster 13 TCGA-06-5408 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain NO NO 54 TCGA-06-5408-F22991 TCGA-06-5408 TCGA-06-5408-01A -20063 357 0 342 158 2011-1-24 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 1 NO 80 1.1 Progression of Disease TCGA-06-5408.dafe8753-d5cc-415b-a1df-8317a027c088.pdf 5408 Pre-Adjuvant Therapy WITH TUMOR YES NO YES Primary Tumor 01 0.3 06 Brain A DECEASED 2009 37218c7d-74ed-43db-9556-a09006645998 TCGA-06-5408-01 TCGA-06-5408-01A-01D-1696-08 TCGA-06-5408-01A-01D-1697-05 TCGA-06-5408-01 TCGA-06-5408-01A-01D-1694-01 TCGA-06-5408-01 37218c7d-74ed-43db-9556-a09006645998 TCGA-06-5408-01 TCGA-06-5408-01A-01D-1694-01 37218c7d-74ed-43db-9556-a09006645998 +TCGA-06-5410-01 TCGA-06-5410-01 Quiet C5-KIRC Low purity c2 KIRC-like c1 GBM-like c6 mutation c1uster 9 TCGA-06-5410 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 72 TCGA-06-5410-F22997 TCGA-06-5410 TCGA-06-5410-01A -26395 108 0 108 2011-1-25 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 0.9 NO 60 1 TCGA-06-5410.cac1b60d-9ca3-4196-9e74-fba7a5490f2d.pdf 5410 Preoperative WITH TUMOR NO NO NO Primary Tumor 01 0.5 06 Brain A DECEASED 2010 39580733-5ff1-43a1-b9fd-53b6f6e879bd TCGA-06-5410-01 TCGA-06-5410-01A-01D-1696-08 TCGA-06-5410-01A-01D-1697-05 TCGA-06-5410-01 TCGA-06-5410-01A-01D-1694-01 TCGA-06-5410-01 39580733-5ff1-43a1-b9fd-53b6f6e879bd TCGA-06-5410-01 TCGA-06-5410-01A-01D-1694-01 39580733-5ff1-43a1-b9fd-53b6f6e879bd +TCGA-06-5411-01 TCGA-06-5411-01 GBM C10-GBM GBM non-CIMP c15 GBM-like c2 GBM-like c6 mutation c1uster 9 TCGA-06-5411 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES YES 51 TCGA-06-5411-F22999 TCGA-06-5411 TCGA-06-5411-01A -18832 254 0 254 214 2011-1-25 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 1.1 NO 80 1.1 Progression of Disease TCGA-06-5411.3c5b40a1-47ca-4a9d-b967-bfc34bdc785c.pdf 5411 Preoperative WITH TUMOR YES NO YES Primary Tumor 01 0.3 06 Brain A DECEASED 2010 98937e70-6d2c-4057-b5ef-e01d0006486f TCGA-06-5411-01 TCGA-06-5411-01A-01D-1696-08 TCGA-06-5411-01A-01D-1697-05 TCGA-06-5411-01 TCGA-06-5411-01A-01D-1694-01 TCGA-06-5411-01 98937e70-6d2c-4057-b5ef-e01d0006486f TCGA-06-5411-01 TCGA-06-5411-01A-01D-1694-01 98937e70-6d2c-4057-b5ef-e01d0006486f +TCGA-06-5412-01 TCGA-06-5412-01 GBM C10-GBM GBM non-CIMP c15 KIRC-like c1 GBM-like c6 mutation c1uster 9 TCGA-06-5412 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain NO NO 78 TCGA-06-5412-F23005 TCGA-06-5412 -28762 138 0 138 88 2011-1-25 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 80 Progression of Disease 5412 Pre-Adjuvant Therapy WITH TUMOR YES NO YES Primary Tumor 01 06 Brain DECEASED 2010 d39f75a1-3216-4f0a-86d2-0055feced3dd TCGA-06-5412-01 TCGA-06-5412-01A-01D-1696-08 TCGA-06-5412-01A-01D-1697-05 TCGA-06-5412-01 TCGA-06-5412-01A-01D-1694-01 TCGA-06-5412-01 d39f75a1-3216-4f0a-86d2-0055feced3dd TCGA-06-5412-01 TCGA-06-5412-01A-01D-1694-01 d39f75a1-3216-4f0a-86d2-0055feced3dd +TCGA-06-5413-01 TCGA-06-5413-01 GBM C10-GBM GBM non-CIMP c15 GBM-like c2 GBM-like c6 mutation cluster 14 TCGA-06-5413 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES NO 67 TCGA-06-5413-F23010 TCGA-06-5413 TCGA-06-5413-01A -24477 0 268 195 2011-1-25 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 0.8 NO 60 1 Progression of Disease TCGA-06-5413.81757237-a9c0-49ad-ac5a-68601083be40.pdf 5413 Pre-Adjuvant Therapy WITH TUMOR YES NO YES Primary Tumor 01 0.5 06 Brain A LIVING 2010 48f886d5-bb04-4fd1-809c-4b85730c4208 TCGA-06-5413-01 TCGA-06-5413-01A-01D-1696-08 TCGA-06-5413-01A-01D-1697-05 TCGA-06-5413-01 TCGA-06-5413-01A-01D-1694-01 TCGA-06-5413-01 48f886d5-bb04-4fd1-809c-4b85730c4208 TCGA-06-5413-01 TCGA-06-5413-01A-01D-1694-01 48f886d5-bb04-4fd1-809c-4b85730c4208 +TCGA-06-5414-01 TCGA-06-5414-01 GBM C10-GBM GBM non-CIMP c15 GBM-like c2 GBM-like c6 mutation c1uster 9 TCGA-06-5414 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain NO NO 61 TCGA-06-5414-F23015 TCGA-06-5414 TCGA-06-5414-01A -22527 0 273 167 2011-1-24 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 1.1 NO 80 1.1 Progression of Disease TCGA-06-5414.40314de5-33f1-4b29-85a1-d6292c6e2fc3.pdf 5414 Preoperative WITH TUMOR YES NO YES Primary Tumor 01 0.3 06 Brain A LIVING 2010 051cda00-0007-4e35-9044-fd0c03c8ed4b TCGA-06-5414-01 TCGA-06-5414-01A-01D-1486-08 TCGA-06-5414-01A-01D-1481-05 TCGA-06-5414-01 TCGA-06-5414-01A-01D-1479-01 TCGA-06-5414-01 051cda00-0007-4e35-9044-fd0c03c8ed4b TCGA-06-5414-01 TCGA-06-5414-01A-01D-1479-01 051cda00-0007-4e35-9044-fd0c03c8ed4b +TCGA-06-5415-01 TCGA-06-5415-01 GBM C10-GBM GBM non-CIMP c15 GBM-like c2 GBM-like c6 mutation cluster 14 TCGA-06-5415 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 60 TCGA-06-5415-F23020 TCGA-06-5415 -22213 0 260 2011-1-24 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Incisional Biopsy 100 5415 Preoperative WITH TUMOR YES NO YES Primary Tumor 01 06 Brain LIVING 2010 b147bdcd-f5b6-41be-bca4-3ef7efcb9ec6 TCGA-06-5415-01 TCGA-06-5415-01A-01D-1486-08 TCGA-06-5415-01A-01D-1481-05 TCGA-06-5415-01 TCGA-06-5415-01A-01D-1479-01 TCGA-06-5415-01 b147bdcd-f5b6-41be-bca4-3ef7efcb9ec6 TCGA-06-5415-01 TCGA-06-5415-01A-01D-1479-01 b147bdcd-f5b6-41be-bca4-3ef7efcb9ec6 +TCGA-06-5416-01 TCGA-06-5416-01 Kirc+ C10-GBM Low purity c2 GBM-like c2 GBM-like c6 TCGA-06-5416 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 23 TCGA-06-5416-F23024 TCGA-06-5416 TCGA-06-5416-01A -8533 0 204 2011-1-24 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 1 NO 80 1.5 TCGA-06-5416.95607f05-091a-4f35-9a8b-446773c316f6.pdf 5416 Pre-Adjuvant Therapy WITH TUMOR YES NO YES Primary Tumor 01 0.4 06 Brain A LIVING 2010 69336246-eb91-424b-9cd2-8cbdcf7adfe7 TCGA-06-5416-01 TCGA-06-5416-01A-01D-1481-05 TCGA-06-5416-01 TCGA-06-5416-01A-01D-1479-01 TCGA-06-5416-01 69336246-eb91-424b-9cd2-8cbdcf7adfe7 TCGA-06-5416-01 TCGA-06-5416-01A-01D-1479-01 69336246-eb91-424b-9cd2-8cbdcf7adfe7 +TCGA-06-5417-01 TCGA-06-5417-01 C10-GBM GBM CIMP c16 GBM-like c2 GBM-like c6 mutation cluster 3 TCGA-06-5417 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 45 TCGA-06-5417-F23028 TCGA-06-5417 -16572 0 155 2011-1-24 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 80 5417 Pre-Adjuvant Therapy WITH TUMOR YES NO YES Primary Tumor 01 06 Brain LIVING 2010 b1019532-963f-4c8e-ba55-b03dea8b5498 TCGA-06-5417-01A-01D-1486-08 TCGA-06-5417-01A-01D-1481-05 TCGA-06-5417-01 TCGA-06-5417-01 b1019532-963f-4c8e-ba55-b03dea8b5498 b1019532-963f-4c8e-ba55-b03dea8b5498 +TCGA-06-5418-01 TCGA-06-5418-01 GBM C10-GBM GBM non-CIMP c15 GBM-like c2 GBM-like c6 mutation c1uster 9 TCGA-06-5418 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 75 TCGA-06-5418-F23032 TCGA-06-5418 -27584 83 0 83 2011-1-31 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 60 5418 Pre-Adjuvant Therapy WITH TUMOR NO NO NO Primary Tumor 01 06 Brain DECEASED 2010 e48c8261-5e7b-4cbe-95ed-8a7d1c356d70 TCGA-06-5418-01 TCGA-06-5418-01A-01D-1486-08 TCGA-06-5418-01A-01D-1481-05 TCGA-06-5418-01 TCGA-06-5418-01A-01D-1479-01 TCGA-06-5418-01 e48c8261-5e7b-4cbe-95ed-8a7d1c356d70 TCGA-06-5418-01 TCGA-06-5418-01A-01D-1479-01 e48c8261-5e7b-4cbe-95ed-8a7d1c356d70 +TCGA-06-5856-01 TCGA-06-5856-01 GBM C10-GBM GBM non-CIMP c15 GBM-like c2 GBM-like c6 mutation cluster 14 TCGA-06-5856 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 58 TCGA-06-5856-F23034 TCGA-06-5856 TCGA-06-5856-01A -21232 114 0 114 2011-8-9 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 0.9 NO 1 TCGA-06-5856.7bbecef6-9b0c-43b8-be9b-55821f9ac49b.pdf 5856 WITH TUMOR NO NO NO Primary Tumor 01 0.9 06 Brain A DECEASED 2010 748dc9ed-758b-43c9-af66-111f6ab3d6ce TCGA-06-5856-01 TCGA-06-5856-01A-01D-1696-08 TCGA-06-5856-01A-01D-1697-05 TCGA-06-5856-01 TCGA-06-5856-01A-01D-1694-01 TCGA-06-5856-01 748dc9ed-758b-43c9-af66-111f6ab3d6ce TCGA-06-5856-01 TCGA-06-5856-01A-01D-1694-01 748dc9ed-758b-43c9-af66-111f6ab3d6ce +TCGA-06-5858-01 TCGA-06-5858-01 Kirc+ C10-GBM GBM non-CIMP c15 GBM-like c2 GBM-like c6 mutation cluster 13 TCGA-06-5858 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain NO NO 45 TCGA-06-5858-F23036 TCGA-06-5858 TCGA-06-5858-01A -16662 0 187 97 0 2011-8-8 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 0.9 NO 100 0.9 Progression of Disease TCGA-06-5858.2d08daa7-75ae-4fe0-8c06-311b585de812.pdf 5858 Pre-Adjuvant Therapy WITH TUMOR YES NO YES Primary Tumor 01 0.9 06 Brain A LIVING 2010 67068dc6-6270-4e7b-a857-3008dadc2d59 TCGA-06-5858-01 TCGA-06-5858-01A-01D-1696-08 TCGA-06-5858-01A-01D-1697-05 TCGA-06-5858-01 TCGA-06-5858-01A-01D-1694-01 TCGA-06-5858-01 67068dc6-6270-4e7b-a857-3008dadc2d59 TCGA-06-5858-01 TCGA-06-5858-01A-01D-1694-01 67068dc6-6270-4e7b-a857-3008dadc2d59 +TCGA-06-5859-01 TCGA-06-5859-01 GBM C10-GBM GBM non-CIMP c15 GBM-like c2 GBM-like c6 mutation c1uster 9 TCGA-06-5859 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 63 TCGA-06-5859-F23043 TCGA-06-5859 TCGA-06-5859-01A -23211 0 139 2011-8-9 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 0.6 NO 40 0.8 TCGA-06-5859.9baeb8a0-e852-4729-bfc6-e4666a1f0a37.pdf 5859 Post-Adjuvant Therapy WITH TUMOR YES NO YES Primary Tumor 01 0.6 06 Brain A LIVING 2011 76ad0a38-a2a2-4533-8baf-5f94c0c59a02 TCGA-06-5859-01 TCGA-06-5859-01A-01D-1696-08 TCGA-06-5859-01A-01D-1697-05 TCGA-06-5859-01 TCGA-06-5859-01A-01D-1694-01 TCGA-06-5859-01 76ad0a38-a2a2-4533-8baf-5f94c0c59a02 TCGA-06-5859-01 TCGA-06-5859-01A-01D-1694-01 76ad0a38-a2a2-4533-8baf-5f94c0c59a02 +TCGA-06-6388-01 TCGA-06-6388-01 GBM C10-GBM GBM non-CIMP c15 GBM-like c2 mutation cluster 4 TCGA-06-6388 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES NO 64 TCGA-06-6388-F23048 TCGA-06-6388 TCGA-06-6388-01A -23519 159 0 120 85 2011-8-8 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 1 NO 80 1.2 Progression of Disease TCGA-06-6388.fc0566bf-e3a2-417d-8bce-ba5238521cd5.pdf 6388 Pre-Adjuvant Therapy WITH TUMOR YES NO YES Primary Tumor 01 0.9 06 Brain A DECEASED 2011 TCGA-06-6388-01A-12D-1845-08 TCGA-06-6388-01A-12D-1844-05 TCGA-06-6388-01A-12D-1842-01 TCGA-06-6388-01A-12D-1842-01 +TCGA-06-6389-01 TCGA-06-6389-01 Squamous C10-GBM GBM CIMP c16 GBM-like c2 mutation cluster 5 TCGA-06-6389 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 49 TCGA-06-6389-F23103 TCGA-06-6389 -18248 0 237 2011-11-7 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 100 6389 Pre-Adjuvant Therapy WITH TUMOR YES NO YES Primary Tumor 01 06 Brain LIVING 2011 TCGA-06-6389-01 TCGA-06-6389-01A-11D-1696-08 TCGA-06-6389-01A-11D-1697-05 TCGA-06-6389-01 TCGA-06-6389-01A-11D-1694-01 TCGA-06-6389-01A-11D-1694-01 +TCGA-06-6390-01 TCGA-06-6390-01 GBM C10-GBM GBM non-CIMP c15 GBM-like c2 mutation c1uster 9 TCGA-06-6390 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 58 TCGA-06-6390-F23108 TCGA-06-6390 -21328 164 0 164 2011-11-7 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 80 6390 Preoperative WITH TUMOR YES NO YES Primary Tumor 01 06 Brain DECEASED 2011 TCGA-06-6390-01 TCGA-06-6390-01A-11D-1696-08 TCGA-06-6390-01A-11D-1697-05 TCGA-06-6390-01 TCGA-06-6390-01A-11D-1694-01 TCGA-06-6390-01A-11D-1694-01 +TCGA-06-6391-01 TCGA-06-6391-01 Kirc+ C10-GBM GBM non-CIMP c15 GBM-like c2 mutation cluster 4 TCGA-06-6391 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 44 TCGA-06-6391-F23055 TCGA-06-6391 -16206 45 0 1 2011-8-8 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 6391 Preoperative WITH TUMOR NO NO NO Primary Tumor 01 06 Brain DECEASED 2011 TCGA-06-6391-01 TCGA-06-6391-01A-11D-1696-08 TCGA-06-6391-01A-11D-1697-05 TCGA-06-6391-01 TCGA-06-6391-01A-11D-1694-01 TCGA-06-6391-01A-11D-1694-01 +TCGA-06-6693-01 TCGA-06-6693-01 GBM C10-GBM GBM non-CIMP c15 GBM-like c2 mutation c1uster 9 TCGA-06-6693 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 64 TCGA-06-6693-F23113 TCGA-06-6693 TCGA-06-6693-01A -23585 3667 0 15 2011-9-26 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 1 NO 1.1 TCGA-06-6693.73d0f748-136f-4000-ae46-de505f8bee47.pdf 6693 WITH TUMOR NO NO NO Primary Tumor 01 1 06 Brain A DECEASED 1993 TCGA-06-6693-01A-11D-1845-08 TCGA-06-6693-01A-11D-1844-05 TCGA-06-6693-01A-11D-1842-01 TCGA-06-6693-01A-11D-1842-01 +TCGA-06-6694-01 TCGA-06-6694-01 GBM C10-GBM GBM non-CIMP c15 GBM-like c2 mutation cluster 5 TCGA-06-6694 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 76 TCGA-06-6694-F23115 TCGA-06-6694 TCGA-06-6694-01A -27909 224 0 224 2011-9-26 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 1 NO 1 TCGA-06-6694.bfd32e29-52a6-4ccf-ad99-0c595e3127ec.pdf 6694 WITH TUMOR NO Primary Tumor 01 0.8 06 Brain A DECEASED 1994 TCGA-06-6694-01A-12D-1845-08 TCGA-06-6694-01A-12D-1844-05 TCGA-06-6694-01A-12D-1842-01 TCGA-06-6694-01A-12D-1842-01 +TCGA-06-6695-01 TCGA-06-6695-01 GBM C10-GBM GBM non-CIMP c15 GBM-like c2 mutation cluster 14 TCGA-06-6695 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain NO NO 64 TCGA-06-6695-F23057 TCGA-06-6695 TCGA-06-6695-01A -23426 0 253 133 2011-9-14 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 1 NO 40 1 Progression of Disease TCGA-06-6695.3e41fbb4-4032-4931-b91c-ade80781ea25.pdf 6695 Pre-Adjuvant Therapy WITH TUMOR YES NO YES Primary Tumor 01 1 06 Brain A LIVING 2010 TCGA-06-6695-01A-11D-1845-08 TCGA-06-6695-01A-11D-1844-05 TCGA-06-6695-01A-11D-1842-01 TCGA-06-6695-01A-11D-1842-01 +TCGA-06-6697-01 TCGA-06-6697-01 GBM C10-GBM GBM non-CIMP c15 GBM-like c2 mutation c1uster 9 TCGA-06-6697 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES NO 65 TCGA-06-6697-F23062 TCGA-06-6697 TCGA-06-6697-01A -23763 0 391 306 2011-9-14 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 0.6 NO 80 0.8 Progression of Disease TCGA-06-6697.6d372549-29b6-4a4f-b8f5-d9267b1b91d9.pdf 6697 Pre-Adjuvant Therapy WITH TUMOR YES NO YES Primary Tumor 01 0.6 06 Brain A LIVING 2010 TCGA-06-6697-01A-11D-1845-08 TCGA-06-6697-01A-11D-1844-05 TCGA-06-6697-01A-11D-1842-01 TCGA-06-6697-01A-11D-1842-01 +TCGA-06-6698-01 TCGA-06-6698-01 High C10-GBM GBM non-CIMP c15 GBM-like c2 mutation cluster 5 TCGA-06-6698 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 53 TCGA-06-6698-F23069 TCGA-06-6698 TCGA-06-6698-01A -19591 0 145 2011-9-14 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 1 NO 1 TCGA-06-6698.73d3d6fe-216d-48d6-aaa5-afe8776964dd.pdf 6698 WITH TUMOR YES NO YES Primary Tumor 01 0.7 06 Brain A LIVING 2011 TCGA-06-6698-01A-11D-1845-08 TCGA-06-6698-01A-11D-1844-05 TCGA-06-6698-01A-11D-1842-01 TCGA-06-6698-01A-11D-1842-01 +TCGA-06-6699-01 TCGA-06-6699-01 GBM C10-GBM GBM non-CIMP c15 GBM-like c2 mutation c1uster 9 TCGA-06-6699 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 58 TCGA-06-6699-F23074 TCGA-06-6699 TCGA-06-6699-01A -21190 0 47 2011-9-14 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 1 NO 1 TCGA-06-6699.f4be21b6-ef74-4a59-b8d1-9a0f76719ab9.pdf 6699 WITH TUMOR YES NO YES Primary Tumor 01 0.8 06 Brain A LIVING 2011 TCGA-06-6699-01A-11D-1845-08 TCGA-06-6699-01A-11D-1844-05 TCGA-06-6699-01A-11D-1842-01 TCGA-06-6699-01A-11D-1842-01 +TCGA-06-6700-01 TCGA-06-6700-01 GBM C10-GBM GBM non-CIMP c15 GBM-like c2 mutation cluster 14 TCGA-06-6700 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 76 TCGA-06-6700-F23078 TCGA-06-6700 TCGA-06-6700-01A -27850 0 145 2011-9-14 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 1 NO 100 1 TCGA-06-6700.7217dc7f-5df1-4b92-a7a7-6bf85dc8856e.pdf 6700 Pre-Adjuvant Therapy WITH TUMOR YES NO YES Primary Tumor 01 0.9 06 Brain A LIVING 2011 TCGA-06-6700-01A-12D-1845-08 TCGA-06-6700-01A-12D-1844-05 TCGA-06-6700-01A-12D-1842-01 TCGA-06-6700-01A-12D-1842-01 +TCGA-06-6701-01 TCGA-06-6701-01 Kirc+ C10-GBM GBM CIMP c16 GBM-like c2 mutation cluster 5 TCGA-06-6701 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 60 TCGA-06-6701-F23084 TCGA-06-6701 TCGA-06-6701-01A -22051 0 151 2011-9-14 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 1 NO 1 TCGA-06-6701.a124f2d0-f289-4a57-84b6-051ba2c3736f.pdf 6701 WITH TUMOR YES NO YES Primary Tumor 01 0.6 06 Brain A LIVING 2011 TCGA-06-6701-01A-11D-1845-08 TCGA-06-6701-01A-11D-1844-05 TCGA-06-6701-01A-11D-1842-01 TCGA-06-6701-01A-11D-1842-01 +TCGA-06-A5U0-01 TCGA-06-A5U0-01 TCGA-06-A5U0 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES NO 21 TCGA-06-A5U0-F71293 TCGA-06-A5U0 TCGA-06-A5U0-01A -7958 48 0 815 100 Scheduled Follow-up Submission Progressive Disease 2015-3-24 FEMALE Glioblastoma Multiforme (GBM) No C71.4 9440/3 C71.4 YES Tumor resection 390 NO 90 NO Progression of Disease YES false No TCGA-06-A5U0.53494270-D299-4D89-8C66-05C361CFFA90.pdf A5U0 Post-Adjuvant Therapy WITH TUMOR YES Progressive Disease NO YES Primary Tumor 01 YES NO 06 Brain A LIVING 2012 TCGA-06-A5U0-01A-11D-A33U-05 TCGA-06-A5U0-01A-11D-A33S-01 TCGA-06-A5U0-01A-11D-A33S-01 +TCGA-06-A5U1-01 TCGA-06-A5U1-01 TCGA-06-A5U1 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 78 TCGA-06-A5U1 TCGA-06-A5U1-01A -28545 450 57 0 2013-5-13 FEMALE Glioblastoma Multiforme (GBM) No C71.4 9440/3 C71.4 YES Tumor resection 410 NO false No TCGA-06-A5U1.5F19F1F8-73BF-4E7D-9169-2F2C25F33F2B.pdf A5U1 WITH TUMOR NO Progressive Disease NO NO Primary Tumor 01 NO YES 06 Brain A DECEASED 2011 TCGA-06-A5U1-01A-11D-A33U-05 TCGA-06-A5U1-01A-11D-A33S-01 TCGA-06-A5U1-01A-11D-A33S-01 +TCGA-06-A6S0-01 TCGA-06-A6S0-01 TCGA-06-A6S0 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 79 TCGA-06-A6S0 TCGA-06-A6S0-01A -29037 678 95 0 2013-10-1 MALE Glioblastoma Multiforme (GBM) No C71.9 9440/3 C71.9 YES Excisional Biopsy 180 NO false No TCGA-06-A6S0.E69F47F2-D127-46D7-BE0A-109BE0EF97E7.pdf A6S0 WITH TUMOR NO Stable Disease NO YES Primary Tumor 01 YES NO 06 Brain A DECEASED 2011 TCGA-06-A6S0-01A-11D-A33U-05 TCGA-06-A6S0-01A-11D-A33S-01 TCGA-06-A6S0-01A-11D-A33S-01 +TCGA-06-A6S1-01 TCGA-06-A6S1-01 TCGA-06-A6S1 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 53 TCGA-06-A6S1 TCGA-06-A6S1-01A -19443 282 78 0 2013-10-1 FEMALE Glioblastoma Multiforme (GBM) No C71.9 9440/3 C71.9 YES Tumor resection 300 NO 60 false No TCGA-06-A6S1.0BAB6F0A-77A8-4D16-B4E6-1AC173521399.pdf A6S1 Pre-Adjuvant Therapy WITH TUMOR YES Progressive Disease NO YES Primary Tumor 01 YES NO 06 Brain A DECEASED 2012 TCGA-06-A6S1-01A-11D-A33U-05 TCGA-06-A6S1-01A-11D-A33S-01 TCGA-06-A6S1-01A-11D-A33S-01 +TCGA-06-A7TK-01 TCGA-06-A7TK-01 TCGA-06-A7TK TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES NO 64 TCGA-06-A7TK-F71298 TCGA-06-A7TK TCGA-06-A7TK-01A -23674 71 444 0 164 342 Scheduled Follow-up Submission Progressive Disease 2015-3-24 MALE Glioblastoma Multiforme (GBM) No C71.1 9440/3 C71.1 YES 440 NO 70 NO Progression of Disease YES false No TCGA-06-A7TK.5A1F6CD8-15C3-4D80-8496-340B0A9616D7.pdf A7TK Pre-Adjuvant Therapy WITH TUMOR YES Progressive Disease NO YES Primary Tumor 01 YES NO 06 Brain A DECEASED 2013 TCGA-06-A7TK-01A-21D-A392-05 TCGA-06-A7TK-01A-21D-A390-01 TCGA-06-A7TK-01A-21D-A390-01 +TCGA-06-A7TL-01 TCGA-06-A7TL-01 TCGA-06-A7TL TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES NO 30 TCGA-06-A7TL-F71295 TCGA-06-A7TL TCGA-06-A7TL-01A -11297 27 0 539 188 Scheduled Follow-up Submission Stable Disease 2015-3-24 FEMALE Glioblastoma Multiforme (GBM) No C71.8 9440/3 C71.8 YES Tumor resection 520 NO 100 NO Progression of Disease NO false No TCGA-06-A7TL.A492E3BF-5ABE-4D39-A40C-6028BB6DDBEA.pdf A7TL Preoperative WITH TUMOR YES Progressive Disease NO YES Primary Tumor 01 YES NO 06 Brain A LIVING 2013 TCGA-06-A7TL-01A-11D-A392-05 TCGA-06-A7TL-01A-11D-A390-01 TCGA-06-A7TL-01A-11D-A390-01 +TCGA-06-AABW-11 TCGA-06-AABW-11 TCGA-06-AABW TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain TCGA-06-AABW-11A 0.8 NO 1.2 Solid Tissue Normal 11 0.4 A 85ef1d2f-2371-4fc7-a6f4-d102f4430b8a TCGA-06-AABW-11A-31D-A368-05 85ef1d2f-2371-4fc7-a6f4-d102f4430b8a 85ef1d2f-2371-4fc7-a6f4-d102f4430b8a +TCGA-08-0244-01 TCGA-08-0244-01 GBM TCGA-08-0244 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 62 TCGA-08-0244-F23117 TCGA-08-0244 -22684 690 0 690 484 2008-12-19 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 80 Recurrence 0244 Other WITH TUMOR YES NO YES Primary Tumor 01 08 Brain DECEASED 2001 TCGA-08-0244-01 TCGA-08-0244-01 TCGA-08-0244-01A-01G-0293-01 TCGA-08-0244-01A-01G-0293-01 +TCGA-08-0245-01 TCGA-08-0245-01 GBM squamous c3 TCGA-08-0245 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES YES 31 TCGA-08-0245-F23122 TCGA-08-0245 -11613 1151 0 1057 463 2008-12-11 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 80 Progression of Disease 0245 Post-Adjuvant Therapy WITH TUMOR NO NO YES Primary Tumor 01 08 Brain DECEASED 2001 TCGA-08-0245-01 TCGA-08-0245-01 TCGA-08-0245-01A-01G-0293-01 TCGA-08-0245-01A-01G-0293-01 +TCGA-08-0246-01 TCGA-08-0246-01 Kirc+ TCGA-08-0246 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain NO NO 57 TCGA-08-0246-F23131 TCGA-08-0246 -20974 127 0 119 103 2008-12-19 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 80 Progression of Disease 0246 Other WITH TUMOR YES NO YES Primary Tumor 01 08 Brain DECEASED 2001 TCGA-08-0246-01 TCGA-08-0246-01 TCGA-08-0246-01A-01G-0293-01 TCGA-08-0246-01A-01G-0293-01 +TCGA-08-0344-01 TCGA-08-0344-01 Kirc+ GBM-like c2 TCGA-08-0344 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES YES 66 TCGA-08-0344-F23135 TCGA-08-0344 -24253 3524 0 3310 1880 2008-12-19 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 80 Recurrence 0344 Other WITH TUMOR NO NO YES Primary Tumor 01 08 Brain DECEASED 1992 TCGA-08-0344-01 TCGA-08-0344-01 TCGA-08-0344-01A-01G-0293-01 TCGA-08-0344-01A-01G-0293-01 +TCGA-08-0345-01 TCGA-08-0345-01 GBM GBM-like c2 TCGA-08-0345 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 71 TCGA-08-0345-F23141 TCGA-08-0345 -25960 53 0 53 2008-12-11 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 60 0345 Pre-Adjuvant Therapy WITH TUMOR NO NO YES Primary Tumor 01 08 Brain DECEASED 1992 TCGA-08-0345-01 TCGA-08-0345-01 TCGA-08-0345-01A-01D-0310-01 TCGA-08-0345-01A-01D-0310-01 +TCGA-08-0346-01 TCGA-08-0346-01 GBM GBM-like c2 TCGA-08-0346 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain NO NO 69 TCGA-08-0346-F23144 TCGA-08-0346 -25409 256 0 132 75 2008-12-12 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 80 Progression of Disease 0346 Pre-Adjuvant Therapy WITH TUMOR YES NO YES Primary Tumor 01 08 Brain DECEASED 1993 TCGA-08-0346-01 TCGA-08-0346-01 TCGA-08-0346-01A-01G-0293-01 TCGA-08-0346-01A-01G-0293-01 +TCGA-08-0347-01 TCGA-08-0347-01 GBM GBM-like c2 TCGA-08-0347 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES YES 50 TCGA-08-0347-F23148 TCGA-08-0347 -18384 782 0 419 59 2008-12-19 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 100 Progression of Disease 0347 Other WITH TUMOR YES NO YES Primary Tumor 01 08 Brain DECEASED 1993 TCGA-08-0347-01 TCGA-08-0347-01 TCGA-08-0347-01A-01G-0293-01 TCGA-08-0347-01A-01G-0293-01 +TCGA-08-0348-01 TCGA-08-0348-01 GBM KIRC-like c1 TCGA-08-0348 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES YES 63 TCGA-08-0348-F23157 TCGA-08-0348 -23373 370 0 316 198 2008-12-19 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 80 Recurrence 0348 Other WITH TUMOR YES NO YES Primary Tumor 01 08 Brain DECEASED 2000 TCGA-08-0348-01 TCGA-08-0348-01 TCGA-08-0348-01A-01G-0293-01 TCGA-08-0348-01A-01G-0293-01 +TCGA-08-0349-01 TCGA-08-0349-01 BRCA-LUAD+ GBM-like c2 TCGA-08-0349 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES NO 46 TCGA-08-0349-F23165 TCGA-08-0349 -16964 298 0 231 93 2008-12-19 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection Progression of Disease 0349 WITH TUMOR YES NO YES Primary Tumor 01 08 Brain DECEASED 2000 TCGA-08-0349-01 TCGA-08-0349-01 TCGA-08-0349-01A-01D-0310-01 TCGA-08-0349-01A-01D-0310-01 +TCGA-08-0350-01 TCGA-08-0350-01 BRCA-LUAD+ GBM-like c2 TCGA-08-0350 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES NO 32 TCGA-08-0350-F23172 TCGA-08-0350 -11905 889 0 104 439 2008-12-19 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 80 Recurrence 0350 Post-Adjuvant Therapy WITH TUMOR NO NO YES Primary Tumor 01 08 Brain DECEASED 2001 TCGA-08-0350-01 TCGA-08-0350-01 TCGA-08-0350-01A-01G-0293-01 TCGA-08-0350-01A-01G-0293-01 +TCGA-08-0351-01 TCGA-08-0351-01 Kirc+ GBM-like c2 TCGA-08-0351 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES NO 40 TCGA-08-0351-F23178 TCGA-08-0351 -14838 1987 0 1637 1542 2008-12-17 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Other method, specify: 80 Recurrence 0351 Other WITH TUMOR YES YES YES Primary Tumor 01 08 Brain DECEASED 2001 TCGA-08-0351-01 TCGA-08-0351-01 TCGA-08-0351-01A-01G-0293-01 TCGA-08-0351-01A-01G-0293-01 +TCGA-08-0352-01 TCGA-08-0352-01 GBM GBM-like c2 TCGA-08-0352 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 79 TCGA-08-0352-F23185 TCGA-08-0352 -29106 39 0 39 2008-12-11 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 0352 WITH TUMOR NO NO NO Primary Tumor 01 08 Brain DECEASED 2003 TCGA-08-0352-01 TCGA-08-0352-01 TCGA-08-0352-01A-01D-0310-01 TCGA-08-0352-01A-01D-0310-01 +TCGA-08-0353-01 TCGA-08-0353-01 GBM GBM-like c2 TCGA-08-0353 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES 58 TCGA-08-0353-F23187 TCGA-08-0353 -21332 256 0 195 164 2008-12-11 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 80 Progression of Disease 0353 Post-Adjuvant Therapy WITH TUMOR YES NO YES Primary Tumor 01 08 Brain DECEASED 2003 TCGA-08-0353-01 TCGA-08-0353-01 TCGA-08-0353-01A-01G-0293-01 TCGA-08-0353-01A-01G-0293-01 +TCGA-08-0354-01 TCGA-08-0354-01 GBM GBM-like c2 TCGA-08-0354 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES NO 52 TCGA-08-0354-F23193 TCGA-08-0354 -19199 546 0 458 253 2008-12-17 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 60 Progression of Disease 0354 Post-Adjuvant Therapy WITH TUMOR YES NO YES Primary Tumor 01 08 Brain DECEASED 2003 TCGA-08-0354-01 TCGA-08-0354-01 TCGA-08-0354-01A-01G-0293-01 TCGA-08-0354-01A-01G-0293-01 +TCGA-08-0355-01 TCGA-08-0355-01 GBM GBM-like c2 TCGA-08-0355 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES NO 30 TCGA-08-0355-F23201 TCGA-08-0355 -11099 747 0 685 519 2008-12-16 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 100 Recurrence 0355 Other WITH TUMOR YES NO YES Primary Tumor 01 08 Brain DECEASED 2003 TCGA-08-0355-01 TCGA-08-0355-01 TCGA-08-0355-01A-01G-0293-01 TCGA-08-0355-01A-01G-0293-01 +TCGA-08-0356-01 TCGA-08-0356-01 GBM GBM-like c2 TCGA-08-0356 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain NO NO 59 TCGA-08-0356-F23211 TCGA-08-0356 -21900 946 0 447 447 2008-12-18 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 80 Recurrence 0356 Pre-Adjuvant Therapy WITH TUMOR YES NO YES Primary Tumor 01 08 Brain DECEASED 2004 TCGA-08-0356-01 TCGA-08-0356-01 TCGA-08-0356-01A-01G-0293-01 TCGA-08-0356-01A-01G-0293-01 +TCGA-08-0357-01 TCGA-08-0357-01 GBM GBM-like c2 TCGA-08-0357 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES NO 49 TCGA-08-0357-F23216 TCGA-08-0357 -18144 1143 0 1084 155 2008-12-18 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 80 Recurrence 0357 Other WITH TUMOR YES NO YES Primary Tumor 01 08 Brain DECEASED 2004 TCGA-08-0357-01 TCGA-08-0357-01 TCGA-08-0357-01A-01G-0293-01 TCGA-08-0357-01A-01G-0293-01 +TCGA-08-0358-01 TCGA-08-0358-01 GBM GBM-like c2 TCGA-08-0358 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES NO 50 TCGA-08-0358-F23234 TCGA-08-0358 -18383 678 0 594 264 2008-12-12 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 80 Recurrence 0358 Pre-Adjuvant Therapy WITH TUMOR YES NO YES Primary Tumor 01 08 Brain DECEASED 2005 TCGA-08-0358-01 TCGA-08-0358-01 TCGA-08-0358-01A-01D-0310-01 TCGA-08-0358-01A-01D-0310-01 +TCGA-08-0359-01 TCGA-08-0359-01 GBM GBM-like c2 TCGA-08-0359 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 59 TCGA-08-0359-F23244 TCGA-08-0359 -21748 103 0 29 2008-12-12 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 0359 WITH TUMOR NO NO YES Primary Tumor 01 08 Brain DECEASED 2005 TCGA-08-0359-01 TCGA-08-0359-01 TCGA-08-0359-01A-01G-0293-01 TCGA-08-0359-01A-01G-0293-01 +TCGA-08-0360-01 TCGA-08-0360-01 GBM GBM-like c2 TCGA-08-0360 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES NO 76 TCGA-08-0360-F23246 TCGA-08-0360 -27895 468 0 352 112 2008-12-18 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 80 Recurrence 0360 Pre-Adjuvant Therapy WITH TUMOR YES NO YES Primary Tumor 01 08 Brain DECEASED 2005 TCGA-08-0360-01 +TCGA-08-0373-01 TCGA-08-0373-01 GBM GBM-like c2 TCGA-08-0373 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 69 TCGA-08-0373 -25274 134 0 134 2008-12-19 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 0373 WITH TUMOR NO Primary Tumor 01 08 Brain DECEASED 1994 TCGA-08-0373-01 +TCGA-08-0375-01 TCGA-08-0375-01 GBM GBM-like c2 TCGA-08-0375 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain NO YES 51 TCGA-08-0375-F23251 TCGA-08-0375 -18941 372 0 279 161 2008-12-17 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Excisional Biopsy 100 Recurrence 0375 Post-Adjuvant Therapy WITH TUMOR NO YES YES Primary Tumor 01 08 Brain DECEASED 1994 TCGA-08-0375-01 TCGA-08-0375-01 TCGA-08-0375-01A-01G-0293-01 TCGA-08-0375-01A-01G-0293-01 +TCGA-08-0380-01 TCGA-08-0380-01 GBM GBM-like c2 TCGA-08-0380 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES NO 74 TCGA-08-0380-F23255 TCGA-08-0380 -27277 454 0 330 151 2008-12-19 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 80 Progression of Disease 0380 Pre-Adjuvant Therapy WITH TUMOR YES NO YES Primary Tumor 01 08 Brain DECEASED 1997 TCGA-08-0380-01 TCGA-08-0380-01 TCGA-08-0380-01A-01G-0293-01 TCGA-08-0380-01A-01G-0293-01 +TCGA-08-0385-01 TCGA-08-0385-01 Kirc+ GBM-like c2 TCGA-08-0385 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 71 TCGA-08-0385-F23263 TCGA-08-0385 -26234 82 0 31 2008-12-11 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 60 0385 Pre-Adjuvant Therapy WITH TUMOR NO Primary Tumor 01 08 Brain DECEASED 2003 TCGA-08-0385-01 +TCGA-08-0386-01 TCGA-08-0386-01 BRCA-LUAD+ C10-GBM GBM-like c2 GBM-like c6 mutation c1uster 9 TCGA-08-0386 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES NO 74 TCGA-08-0386-F23265 TCGA-08-0386 TCGA-08-0386-01A -27053 548 0 478 427 2008-12-18 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 0.7 NO 80 0.7 Recurrence TCGA-08-0386.56C0205D-CE55-4FC7-A55A-2D1AF5E8F13F.pdf 0386 Pre-Adjuvant Therapy WITH TUMOR YES NO YES Primary Tumor 01 0.6 08 Brain A DECEASED 2005 49516e85-eebe-491b-90eb-c76e4425f130 TCGA-08-0386-01 TCGA-08-0386-01A-01D-1492-08 TCGA-08-0386-01 TCGA-08-0386-01A-01D-0310-01 TCGA-08-0386-01 49516e85-eebe-491b-90eb-c76e4425f130 TCGA-08-0386-01 TCGA-08-0386-01A-01D-0310-01 49516e85-eebe-491b-90eb-c76e4425f130 +TCGA-08-0389-01 TCGA-08-0389-01 GBM GBM-like c2 TCGA-08-0389 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 59 TCGA-08-0389-F23273 TCGA-08-0389 -21638 467 0 97 2008-12-19 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 80 0389 Other WITH TUMOR YES NO YES Primary Tumor 01 08 Brain DECEASED 2005 TCGA-08-0389-01 TCGA-08-0389-01 TCGA-08-0389-01A-01G-0293-01 TCGA-08-0389-01A-01G-0293-01 +TCGA-08-0390-01 TCGA-08-0390-01 GBM GBM-like c2 TCGA-08-0390 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 69 TCGA-08-0390-F23278 TCGA-08-0390 -25304 425 0 322 2008-12-12 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 60 0390 Post-Adjuvant Therapy WITH TUMOR YES NO YES Primary Tumor 01 08 Brain DECEASED 2005 TCGA-08-0390-01 TCGA-08-0390-01 TCGA-08-0390-01A-01G-0293-01 TCGA-08-0390-01A-01G-0293-01 +TCGA-08-0392-01 TCGA-08-0392-01 GBM KIRC-like c1 TCGA-08-0392 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 60 TCGA-08-0392-F23285 TCGA-08-0392 -22056 22 0 9 2008-12-12 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Excisional Biopsy 0392 WITH TUMOR NO NO NO Primary Tumor 01 08 Brain DECEASED 2005 TCGA-08-0392-01 TCGA-08-0392-01 TCGA-08-0392-01A-01G-0293-01 TCGA-08-0392-01A-01G-0293-01 +TCGA-08-0509-01 TCGA-08-0509-01 GBM TCGA-08-0509 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 63 TCGA-08-0509 -23273 382 0 17 2008-12-11 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 60 0509 Pre-Adjuvant Therapy WITH TUMOR NO Primary Tumor 01 08 Brain DECEASED 1999 TCGA-08-0509-01 TCGA-08-0509-01 TCGA-08-0509-01A-01D-0275-01 TCGA-08-0509-01A-01D-0275-01 +TCGA-08-0510-01 TCGA-08-0510-01 GBM TCGA-08-0510 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES NO 75 TCGA-08-0510-F23288 TCGA-08-0510 -27675 130 0 107 90 2008-12-17 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 80 Recurrence 0510 Other WITH TUMOR YES NO YES Primary Tumor 01 08 Brain DECEASED 2000 TCGA-08-0510-01 TCGA-08-0510-01 TCGA-08-0510-01A-01D-0275-01 TCGA-08-0510-01A-01D-0275-01 +TCGA-08-0511-01 TCGA-08-0511-01 Kirc+ TCGA-08-0511 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 69 TCGA-08-0511-F23293 TCGA-08-0511 -25300 235 0 235 2008-12-19 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 80 0511 Other WITH TUMOR YES NO YES Primary Tumor 01 08 Brain DECEASED 2000 TCGA-08-0511-01 +TCGA-08-0512-01 TCGA-08-0512-01 Kirc+ TCGA-08-0512 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain NO NO 48 TCGA-08-0512-F23297 TCGA-08-0512 -17821 1282 0 358 231 2008-12-11 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 100 Progression of Disease 0512 Preoperative WITH TUMOR NO NO YES Primary Tumor 01 08 Brain DECEASED 2000 TCGA-08-0512-01 TCGA-08-0512-01 TCGA-08-0512-01A-01D-0275-01 TCGA-08-0512-01A-01D-0275-01 +TCGA-08-0514-01 TCGA-08-0514-01 GBM TCGA-08-0514 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 69 TCGA-08-0514-F23300 TCGA-08-0514 -25457 337 0 259 2008-12-11 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 40 0514 Post-Adjuvant Therapy WITH TUMOR NO NO YES Primary Tumor 01 08 Brain DECEASED 2001 TCGA-08-0514-01 TCGA-08-0514-01 TCGA-08-0514-01A-01D-0275-01 TCGA-08-0514-01A-01D-0275-01 +TCGA-08-0516-01 TCGA-08-0516-01 COAD-READ TCGA-08-0516 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES 14 TCGA-08-0516-F23303 TCGA-08-0516 -5309 596 0 561 40 2008-12-11 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection Progression of Disease 0516 WITH TUMOR NO NO YES Primary Tumor 01 08 Brain DECEASED 2001 TCGA-08-0516-01 TCGA-08-0516-01 TCGA-08-0516-01A-01D-0275-01 TCGA-08-0516-01A-01D-0275-01 +TCGA-08-0517-01 TCGA-08-0517-01 Kirc+ TCGA-08-0517 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES NO 34 TCGA-08-0517-F23307 TCGA-08-0517 -12771 1785 0 1770 1024 2008-12-17 FEMALE Untreated primary (de novo) GBM Yes C71.9 9440/3 C71.9 YES Tumor resection 80 Recurrence 0517 Post-Adjuvant Therapy WITH TUMOR NO NO YES Primary Tumor 01 08 Brain DECEASED 1996 TCGA-08-0517-01 TCGA-08-0517-01 TCGA-08-0517-01A-01D-0275-01 TCGA-08-0517-01A-01D-0275-01 +TCGA-08-0518-01 TCGA-08-0518-01 GBM TCGA-08-0518 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 60 TCGA-08-0518-F23312 TCGA-08-0518 -21995 588 0 39 134 2008-12-11 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 80 Progression of Disease 0518 Pre-Adjuvant Therapy WITH TUMOR NO NO YES Primary Tumor 01 08 Brain DECEASED 2001 TCGA-08-0518-01 TCGA-08-0518-01 TCGA-08-0518-01A-01D-0275-01 TCGA-08-0518-01A-01D-0275-01 +TCGA-08-0520-01 TCGA-08-0520-01 GBM TCGA-08-0520 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES YES 70 TCGA-08-0520-F23315 TCGA-08-0520 -25766 327 0 327 105 2008-12-18 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection Recurrence 0520 WITH TUMOR NO NO YES Primary Tumor 01 08 Brain DECEASED 2001 TCGA-08-0520-01 TCGA-08-0520-01 TCGA-08-0520-01A-01D-0275-01 TCGA-08-0520-01A-01D-0275-01 +TCGA-08-0521-01 TCGA-08-0521-01 Kirc+ TCGA-08-0521 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain NO NO 17 TCGA-08-0521-F23320 TCGA-08-0521 -6377 146 0 146 125 2008-12-11 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 60 Progression of Disease 0521 Post-Adjuvant Therapy WITH TUMOR YES NO YES Primary Tumor 01 08 Brain DECEASED 2002 TCGA-08-0521-01 TCGA-08-0521-01 TCGA-08-0521-01A-01D-0275-01 TCGA-08-0521-01A-01D-0275-01 +TCGA-08-0522-01 TCGA-08-0522-01 Kirc+ TCGA-08-0522 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES NO 61 TCGA-08-0522-F23325 TCGA-08-0522 -22414 635 0 555 266 2008-12-11 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 80 Progression of Disease 0522 Other WITH TUMOR YES NO YES Primary Tumor 01 08 Brain DECEASED 2002 TCGA-08-0522-01 +TCGA-08-0524-01 TCGA-08-0524-01 Iq TCGA-08-0524 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES NO 17 TCGA-08-0524-F23333 TCGA-08-0524 -6464 221 0 199 61 2008-12-19 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 80 Progression of Disease 0524 Other WITH TUMOR YES NO YES Primary Tumor 01 08 Brain DECEASED 2002 TCGA-08-0524-01 TCGA-08-0524-01 TCGA-08-0524-01A-01D-0275-01 TCGA-08-0524-01A-01D-0275-01 +TCGA-08-0525-01 TCGA-08-0525-01 GBM TCGA-08-0525 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES NO 52 TCGA-08-0525-F23341 TCGA-08-0525 -19013 486 0 486 343 2008-12-19 MALE Untreated primary (de novo) GBM Yes C71.9 9440/3 C71.9 YES Tumor resection 80 Progression of Disease 0525 Other WITH TUMOR YES NO YES Primary Tumor 01 08 Brain DECEASED 2001 TCGA-08-0525-01 TCGA-08-0525-01 TCGA-08-0525-01A-01D-0275-01 TCGA-08-0525-01A-01D-0275-01 +TCGA-08-0529-01 TCGA-08-0529-01 GBM TCGA-08-0529 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES NO 56 TCGA-08-0529-F23347 TCGA-08-0529 -20556 560 0 527 328 2008-12-18 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 80 Recurrence 0529 Pre-Adjuvant Therapy WITH TUMOR YES NO YES Primary Tumor 01 08 Brain DECEASED 2004 TCGA-08-0529-01 TCGA-08-0529-01 TCGA-08-0529-01A-02D-0275-01 TCGA-08-0529-01A-02D-0275-01 +TCGA-08-0531-01 TCGA-08-0531-01 GBM TCGA-08-0531 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 64 TCGA-08-0531-F23353 TCGA-08-0531 -23482 230 0 168 2008-12-12 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 80 0531 Pre-Adjuvant Therapy WITH TUMOR YES NO YES Primary Tumor 01 08 Brain DECEASED 2005 TCGA-08-0531-01 TCGA-08-0531-01 TCGA-08-0531-01A-01D-0275-01 TCGA-08-0531-01A-01D-0275-01 +TCGA-12-0615-01 TCGA-12-0615-01 BRCA-LUAD+ mutation c1uster 9 TCGA-12-0615 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES NO 78 TCGA-12-0615-F23452 TCGA-12-0615 TCGA-12-0615-01A -28583 467 0 426 160 2008-12-19 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Excisional Biopsy 0.8 NO 60 1.3 Progression of Disease TCGA-12-0615.FC27926B-3010-4E8E-8E3D-D2323B63C41A.pdf 0615 Pre-Adjuvant Therapy WITH TUMOR YES NO YES Primary Tumor 01 0.4 12 Brain A DECEASED 2005 TCGA-12-0615-01A-01D-1492-08 TCGA-12-0615-01A-01D-0310-01 TCGA-12-0615-01A-01D-0310-01 +TCGA-12-0616-01 TCGA-12-0616-01 GBM GBM-like c6 mutation cluster 14 TCGA-12-0616 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES NO 36 TCGA-12-0616-F23461 TCGA-12-0616 TCGA-12-0616-01A -13451 448 0 439 398 2008-12-12 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Excisional Biopsy 0.7 NO 100 0.8 Progression of Disease TCGA-12-0616.21756D63-F663-4955-8F8E-F88C5250DC1B.pdf 0616 Preoperative WITH TUMOR YES NO YES Primary Tumor 01 0.5 12 Brain A DECEASED 2006 23c2c2d5-d035-4875-a109-aa0a4c34c20e TCGA-12-0616-01 TCGA-12-0616-01A-01D-1492-08 TCGA-12-0616-01 TCGA-12-0616-01A-01D-0310-01 TCGA-12-0616-01 23c2c2d5-d035-4875-a109-aa0a4c34c20e TCGA-12-0616-01 TCGA-12-0616-01A-01D-0310-01 23c2c2d5-d035-4875-a109-aa0a4c34c20e +TCGA-12-0618-01 TCGA-12-0618-01 GBM GBM-like c6 mutation cluster 5 TCGA-12-0618 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 49 TCGA-12-0618-F23472 TCGA-12-0618 -18071 395 0 50 2009-1-23 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Excisional Biopsy 60 0618 Pre-Adjuvant Therapy YES NO YES Primary Tumor 01 12 Brain DECEASED 2003 df36c4af-258e-4cfb-9550-d3580d097547 TCGA-12-0618-01 TCGA-12-0618-01A-01D-1492-08 TCGA-12-0618-01 TCGA-12-0618-01A-01D-0310-01 TCGA-12-0618-01 df36c4af-258e-4cfb-9550-d3580d097547 TCGA-12-0618-01 TCGA-12-0618-01A-01D-0310-01 df36c4af-258e-4cfb-9550-d3580d097547 +TCGA-12-0619-01 TCGA-12-0619-01 BRCA-LUAD+ GBM-like c6 mutation cluster 11 TCGA-12-0619 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES NO 60 TCGA-12-0619-F23477 TCGA-12-0619 -21920 1062 0 316 203 2008-12-19 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Excisional Biopsy 80 Progression of Disease 0619 Preoperative WITH TUMOR YES NO YES Primary Tumor 01 12 Brain DECEASED 2003 d1431a36-5c68-4e6e-9aea-72afe374efd1 TCGA-12-0619-01 TCGA-12-0619-01A-01D-1492-08 TCGA-12-0619-01 TCGA-12-0619-01A-01D-0310-01 TCGA-12-0619-01 d1431a36-5c68-4e6e-9aea-72afe374efd1 TCGA-12-0619-01 TCGA-12-0619-01A-01D-0310-01 d1431a36-5c68-4e6e-9aea-72afe374efd1 +TCGA-12-0620-01 TCGA-12-0620-01 GBM TCGA-12-0620 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 57 TCGA-12-0620-F23487 TCGA-12-0620 -21069 318 0 181 2008-12-4 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Excisional Biopsy 100 0620 Pre-Adjuvant Therapy WITH TUMOR YES NO YES Primary Tumor 01 12 Brain DECEASED 2005 TCGA-12-0620-01 TCGA-12-0620-01 TCGA-12-0620-01A-01D-0310-01 TCGA-12-0620-01A-01D-0310-01 +TCGA-12-0654-01 TCGA-12-0654-01 GBM TCGA-12-0654 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES YES 48 TCGA-12-0654-F23492 TCGA-12-0654 -17625 231 0 218 216 2008-12-17 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Excisional Biopsy Progression of Disease 0654 WITH TUMOR YES NO YES Primary Tumor 01 12 Brain DECEASED 2000 TCGA-12-0654-01 TCGA-12-0654-01 TCGA-12-0654-01B-01D-0333-01 TCGA-12-0654-01B-01D-0333-01 +TCGA-12-0656-01 TCGA-12-0656-01 GBM TCGA-12-0656 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES NO 48 TCGA-12-0656-F23497 TCGA-12-0656 -17865 2883 0 2005 1467 2008-12-10 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Excisional Biopsy 80 Progression of Disease 0656 Post-Adjuvant Therapy WITH TUMOR YES NO YES Primary Tumor 01 12 Brain DECEASED 1997 TCGA-12-0656-01 TCGA-12-0656-01 TCGA-12-0656-01A-03D-0333-01 TCGA-12-0656-01A-03D-0333-01 +TCGA-12-0657-01 TCGA-12-0657-01 GBM TCGA-12-0657 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 69 TCGA-12-0657-F23509 TCGA-12-0657 -25413 3 0 3 2008-12-11 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Excisional Biopsy 0657 WITH TUMOR NO NO NO Primary Tumor 01 12 Brain DECEASED 1996 TCGA-12-0657-01 TCGA-12-0657-01 TCGA-12-0657-01A-01D-0333-01 TCGA-12-0657-01A-01D-0333-01 +TCGA-12-0662-01 TCGA-12-0662-01 BRCA-LUAD+ TCGA-12-0662 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES NO 51 TCGA-12-0662-F23511 TCGA-12-0662 TCGA-12-0662-01A -18717 1161 0 1161 600 2009-1-23 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Excisional Biopsy 0.8 NO 80 0.9 Progression of Disease TCGA-12-0662.1E3F5991-807F-44F3-94A9-FF6A1837A4F1.pdf 0662 Post-Adjuvant Therapy WITH TUMOR YES NO YES Primary Tumor 01 0.3 12 Brain A DECEASED 1998 TCGA-12-0662-01A-01D-0333-01 TCGA-12-0662-01A-01D-0333-01 +TCGA-12-0670-01 TCGA-12-0670-01 GBM GBM non-CIMP c15 TCGA-12-0670 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain NO NO 60 TCGA-12-0670-F23531 TCGA-12-0670 -22189 790 0 790 379 2009-5-28 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Excisional Biopsy 100 Progression of Disease 0670 Pre-Adjuvant Therapy YES NO YES Primary Tumor 01 12 Brain DECEASED 2001 TCGA-12-0670-01 TCGA-12-0670-01 TCGA-12-0670-01B-01D-0384-01 TCGA-12-0670-01B-01D-0384-01 +TCGA-12-0688-01 TCGA-12-0688-01 GBM mutation cluster 1 TCGA-12-0688 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES NO 74 TCGA-12-0688-F23555 TCGA-12-0688 -27085 811 0 734 228 2008-12-19 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Excisional Biopsy 100 Progression of Disease 0688 Post-Adjuvant Therapy WITH TUMOR YES NO YES Primary Tumor 01 12 Brain DECEASED 1998 TCGA-12-0688-01 TCGA-12-0688-01A-02D-1492-08 TCGA-12-0688-01 TCGA-12-0688-01A-02D-0333-01 TCGA-12-0688-01A-02D-0333-01 +TCGA-12-0691-01 TCGA-12-0691-01 GBM GBM-like c2 TCGA-12-0691 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES NO 63 TCGA-12-0691-F23565 TCGA-12-0691 TCGA-12-0691-01A -23019 369 0 186 98 2008-12-11 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Excisional Biopsy 0.6 NO 100 1 Progression of Disease TCGA-12-0691.EB10CA1A-A753-4B87-8336-5E75D2785B23.pdf 0691 Post-Adjuvant Therapy WITH TUMOR YES NO YES Primary Tumor 01 0.5 12 Brain A DECEASED 1999 TCGA-12-0691-01A-01D-0333-01 TCGA-12-0691-01A-01D-0333-01 +TCGA-12-0692-01 TCGA-12-0692-01 GBM GBM-like c2 mutation c1uster 9 TCGA-12-0692 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain NO NO 75 TCGA-12-0692-F23570 TCGA-12-0692 -27519 111 0 80 35 2008-12-11 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Excisional Biopsy 60 Progression of Disease 0692 Pre-Adjuvant Therapy WITH TUMOR YES NO NO Primary Tumor 01 12 Brain DECEASED 2000 TCGA-12-0692-01 TCGA-12-0692-01A-01W-0348-08 TCGA-12-0692-01 TCGA-12-0692-01A-01D-0333-01 TCGA-12-0692-01A-01D-0333-01 +TCGA-12-0703-01 TCGA-12-0703-01 GBM TCGA-12-0703 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES YES 46 TCGA-12-0703-F23573 TCGA-12-0703 -17125 620 0 551 208 2008-12-11 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Excisional Biopsy 80 Progression of Disease 0703 Post-Adjuvant Therapy WITH TUMOR YES NO YES Primary Tumor 01 12 Brain DECEASED 1996 TCGA-12-0703-01 TCGA-12-0703-01 TCGA-12-0703-01A-02D-0333-01 TCGA-12-0703-01A-02D-0333-01 +TCGA-12-0707-01 TCGA-12-0707-01 GBM TCGA-12-0707 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 55 TCGA-12-0707 -20136 864 0 0 2008-12-11 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Excisional Biopsy 0707 NO Primary Tumor 01 12 Brain DECEASED 1997 TCGA-12-0707-01 TCGA-12-0707-01 TCGA-12-0707-01A-01D-0333-01 TCGA-12-0707-01A-01D-0333-01 +TCGA-12-0769-01 TCGA-12-0769-01 GBM TCGA-12-0769 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES YES 52 TCGA-12-0769-F23582 TCGA-12-0769 TCGA-12-0769-01A -19171 458 0 378 378 2008-12-10 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Excisional Biopsy 0.7 NO 100 0.9 Progression of Disease TCGA-12-0769.5A036E89-7445-4F1C-8486-FD5F3482960B.pdf 0769 Pre-Adjuvant Therapy WITH TUMOR YES NO YES Primary Tumor 01 0.4 12 Brain A DECEASED 2002 TCGA-12-0769-01A-01D-0333-01 TCGA-12-0769-01A-01D-0333-01 +TCGA-12-0772-01 TCGA-12-0772-01 GBM TCGA-12-0772 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES YES 46 TCGA-12-0772-F23589 TCGA-12-0772 -17019 1638 0 1615 607 2008-12-18 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Excisional Biopsy 80 Progression of Disease 0772 Pre-Adjuvant Therapy WITH TUMOR YES NO YES Primary Tumor 01 12 Brain DECEASED 2003 TCGA-12-0772-01 TCGA-12-0772-01 TCGA-12-0772-01A-01D-0333-01 TCGA-12-0772-01A-01D-0333-01 +TCGA-12-0773-01 TCGA-12-0773-01 BRCA-LUAD+ TCGA-12-0773 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES NO 24 TCGA-12-0773-F23607 TCGA-12-0773 -8849 1315 0 1311 725 2008-12-11 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Excisional Biopsy 100 Progression of Disease 0773 Pre-Adjuvant Therapy WITH TUMOR YES NO YES Primary Tumor 01 12 Brain DECEASED 2003 TCGA-12-0773-01 TCGA-12-0773-01 TCGA-12-0773-01A-01D-0333-01 TCGA-12-0773-01A-01D-0333-01 +TCGA-12-0775-01 TCGA-12-0775-01 GBM TCGA-12-0775 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES NO 75 TCGA-12-0775-F23626 TCGA-12-0775 -27565 232 0 167 94 2009-1-23 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Excisional Biopsy 60 Progression of Disease 0775 Post-Adjuvant Therapy WITH TUMOR YES NO YES Primary Tumor 01 12 Brain DECEASED 2004 TCGA-12-0775-01 TCGA-12-0775-01 TCGA-12-0775-01A-01D-0333-01 TCGA-12-0775-01A-01D-0333-01 +TCGA-12-0776-01 TCGA-12-0776-01 GBM TCGA-12-0776 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES NO 52 TCGA-12-0776-F23631 TCGA-12-0776 -19228 296 0 277 127 2008-12-10 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Excisional Biopsy 80 Progression of Disease 0776 Pre-Adjuvant Therapy WITH TUMOR YES NO YES Primary Tumor 01 12 Brain DECEASED 2005 TCGA-12-0776-01 TCGA-12-0776-01 TCGA-12-0776-01A-01D-0333-01 TCGA-12-0776-01A-01D-0333-01 +TCGA-12-0778-01 TCGA-12-0778-01 GBM TCGA-12-0778 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES YES 53 TCGA-12-0778-F23638 TCGA-12-0778 -19460 454 0 452 232 2008-12-17 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Excisional Biopsy 80 Progression of Disease 0778 Post-Adjuvant Therapy WITH TUMOR YES NO YES Primary Tumor 01 12 Brain DECEASED 2006 TCGA-12-0778-01 TCGA-12-0778-01 TCGA-12-0778-01A-01D-0333-01 TCGA-12-0778-01A-01D-0333-01 +TCGA-12-0780-01 TCGA-12-0780-01 GBM TCGA-12-0780 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES NO 51 TCGA-12-0780-F23654 TCGA-12-0780 -18646 452 0 434 91 2008-12-10 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Excisional Biopsy 80 Progression of Disease 0780 Pre-Adjuvant Therapy WITH TUMOR YES NO YES Primary Tumor 01 12 Brain DECEASED 2006 TCGA-12-0780-01 TCGA-12-0780-01 TCGA-12-0780-01A-01D-0333-01 TCGA-12-0780-01A-01D-0333-01 +TCGA-12-0818-01 TCGA-12-0818-01 Kirc+ GBM CIMP c16 TCGA-12-0818 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain NO NO 45 TCGA-12-0818-F23664 TCGA-12-0818 -16666 2791 0 2791 1643 2009-5-27 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Excisional Biopsy Locoregional Disease YES 0818 YES NO YES Primary Tumor 01 12 Brain DECEASED 1994 TCGA-12-0818-01 TCGA-12-0818-01 TCGA-12-0818-01A-01D-0384-01 TCGA-12-0818-01A-01D-0384-01 +TCGA-12-0819-01 TCGA-12-0819-01 GBM GBM non-CIMP c15 TCGA-12-0819 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES NO 49 TCGA-12-0819-F23673 TCGA-12-0819 -18160 754 0 754 428 2009-5-27 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Excisional Biopsy 60 Recurrence 0819 Post-Adjuvant Therapy WITH TUMOR YES NO YES Primary Tumor 01 12 Brain DECEASED 1995 TCGA-12-0819-01 TCGA-12-0819-01 TCGA-12-0819-01A-01D-0384-01 TCGA-12-0819-01A-01D-0384-01 +TCGA-12-0820-01 TCGA-12-0820-01 GBM GBM non-CIMP c15 TCGA-12-0820 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES NO 40 TCGA-12-0820-F23683 TCGA-12-0820 -14878 562 0 562 272 2009-5-27 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Excisional Biopsy 100 Recurrence 0820 Preoperative WITH TUMOR YES NO YES Primary Tumor 01 12 Brain DECEASED 1997 TCGA-12-0820-01 TCGA-12-0820-01 TCGA-12-0820-01A-01D-0384-01 TCGA-12-0820-01A-01D-0384-01 +TCGA-12-0821-01 TCGA-12-0821-01 GBM C10-GBM GBM non-CIMP c15 GBM-like c6 mutation cluster 14 TCGA-12-0821 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES NO 62 TCGA-12-0821-F23695 TCGA-12-0821 -22949 323 0 323 259 2009-5-27 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Excisional Biopsy 60 Recurrence 0821 Post-Adjuvant Therapy WITH TUMOR YES NO YES Primary Tumor 01 12 Brain DECEASED 1998 e454530c-3b94-444c-bd1a-682b6048aa94 TCGA-12-0821-01 TCGA-12-0821-01A-01W-0424-08 TCGA-12-0821-01 TCGA-12-0821-01A-01D-0384-01 TCGA-12-0821-01 e454530c-3b94-444c-bd1a-682b6048aa94 TCGA-12-0821-01 TCGA-12-0821-01A-01D-0384-01 e454530c-3b94-444c-bd1a-682b6048aa94 +TCGA-12-0822-01 TCGA-12-0822-01 GBM GBM non-CIMP c15 TCGA-12-0822 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES NO 46 TCGA-12-0822-F23701 TCGA-12-0822 -16803 715 0 715 91 2009-5-27 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Excisional Biopsy 80 Recurrence 0822 Post-Adjuvant Therapy WITH TUMOR YES NO YES Primary Tumor 01 12 Brain DECEASED 1998 TCGA-12-0822-01 TCGA-12-0822-01 TCGA-12-0822-01A-01D-0384-01 TCGA-12-0822-01A-01D-0384-01 +TCGA-12-0826-01 TCGA-12-0826-01 GBM GBM non-CIMP c15 TCGA-12-0826 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 38 TCGA-12-0826-F23712 TCGA-12-0826 -13887 845 0 845 2009-5-27 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Excisional Biopsy 0826 NO YES Primary Tumor 01 12 Brain DECEASED 1999 TCGA-12-0826-01 TCGA-12-0826-01 TCGA-12-0826-01A-01D-0384-01 TCGA-12-0826-01A-01D-0384-01 +TCGA-12-0827-01 TCGA-12-0827-01 Kirc+ GBM CIMP c16 TCGA-12-0827 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain NO NO 38 TCGA-12-0827-F23714 TCGA-12-0827 -14093 1179 0 1179 452 2009-5-27 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Excisional Biopsy 100 Locoregional Disease YES 0827 Post-Adjuvant Therapy WITH TUMOR YES NO YES Primary Tumor 01 12 Brain DECEASED 1999 TCGA-12-0827-01 TCGA-12-0827-01 TCGA-12-0827-01A-01D-0384-01 TCGA-12-0827-01A-01D-0384-01 +TCGA-12-0828-01 TCGA-12-0828-01 GBM GBM non-CIMP c15 TCGA-12-0828 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain NO NO 57 TCGA-12-0828-F23726 TCGA-12-0828 -20909 272 0 272 13 2009-5-27 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Excisional Biopsy 60 Progression of Disease 0828 Pre-Adjuvant Therapy WITH TUMOR YES NO YES Primary Tumor 01 12 Brain DECEASED 2000 TCGA-12-0828-01 TCGA-12-0828-01 TCGA-12-0828-01A-01D-0384-01 TCGA-12-0828-01A-01D-0384-01 +TCGA-12-0829-01 TCGA-12-0829-01 GBM GBM non-CIMP c15 TCGA-12-0829 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES NO 75 TCGA-12-0829-F23730 TCGA-12-0829 -27471 626 0 626 473 2009-5-27 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Excisional Biopsy 80 Recurrence 0829 Pre-Adjuvant Therapy WITH TUMOR YES NO YES Primary Tumor 01 12 Brain DECEASED 2006 TCGA-12-0829-01 TCGA-12-0829-01 TCGA-12-0829-01A-01D-0384-01 TCGA-12-0829-01A-01D-0384-01 +TCGA-12-1088-01 TCGA-12-1088-01 GBM GBM non-CIMP c15 TCGA-12-1088 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 53 TCGA-12-1088-F23358 TCGA-12-1088 -19667 3881 0 3881 2009-7-6 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 80 1088 Pre-Adjuvant Therapy YES NO YES Primary Tumor 01 12 Brain DECEASED 1989 TCGA-12-1088-01 TCGA-12-1088-01 TCGA-12-1088-01A-01D-0517-01 TCGA-12-1088-01A-01D-0517-01 +TCGA-12-1089-01 TCGA-12-1089-01 GBM GBM non-CIMP c15 TCGA-12-1089 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 64 TCGA-12-1089-F23363 TCGA-12-1089 -23419 177 0 177 2009-7-2 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Excisional Biopsy 1089 WITH TUMOR YES NO YES Primary Tumor 01 12 Brain DECEASED 2000 TCGA-12-1089-01 TCGA-12-1089-01 TCGA-12-1089-01A-01D-0517-01 TCGA-12-1089-01A-01D-0517-01 +TCGA-12-1090-01 TCGA-12-1090-01 Kirc+ GBM non-CIMP c15 TCGA-12-1090 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 58 TCGA-12-1090-F23367 TCGA-12-1090 -21377 231 0 190 2009-3-17 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Excisional Biopsy 60 1090 Post-Adjuvant Therapy WITH TUMOR YES NO YES Primary Tumor 01 12 Brain DECEASED 2001 TCGA-12-1090-01 TCGA-12-1090-01 TCGA-12-1090-01A-01D-0517-01 TCGA-12-1090-01A-01D-0517-01 +TCGA-12-1091-01 TCGA-12-1091-01 Kirc+ GBM non-CIMP c15 TCGA-12-1091 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES YES 10 TCGA-12-1091-F23373 TCGA-12-1091 -3982 1010 0 929 56 2009-3-17 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Excisional Biopsy 80 Recurrence 1091 Pre-Adjuvant Therapy WITH TUMOR YES NO YES Primary Tumor 01 12 Brain DECEASED 2001 TCGA-12-1091-01 TCGA-12-1091-01 TCGA-12-1091-01A-01D-0517-01 TCGA-12-1091-01A-01D-0517-01 +TCGA-12-1092-01 TCGA-12-1092-01 GBM GBM non-CIMP c15 TCGA-12-1092 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES NO 58 TCGA-12-1092-F23390 TCGA-12-1092 -21411 661 0 658 637 2009-7-2 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Excisional Biopsy 80 Recurrence 1092 Pre-Adjuvant Therapy WITH TUMOR YES NO YES Primary Tumor 01 12 Brain DECEASED 2006 TCGA-12-1092-01 TCGA-12-1092-01 TCGA-12-1092-01B-01D-0517-01 TCGA-12-1092-01B-01D-0517-01 +TCGA-12-1093-01 TCGA-12-1093-01 GBM GBM non-CIMP c15 TCGA-12-1093 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES NO 66 TCGA-12-1093-F23402 TCGA-12-1093 -24297 486 0 364 322 2009-3-17 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Excisional Biopsy 80 Recurrence 1093 Pre-Adjuvant Therapy WITH TUMOR YES NO YES Primary Tumor 01 12 Brain DECEASED 2006 TCGA-12-1093-01 TCGA-12-1093-01 TCGA-12-1093-01A-01D-0517-01 TCGA-12-1093-01A-01D-0517-01 +TCGA-12-1094-01 TCGA-12-1094-01 GBM GBM non-CIMP c15 TCGA-12-1094 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES NO 56 TCGA-12-1094-F23410 TCGA-12-1094 -20586 372 0 346 186 2009-3-17 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Excisional Biopsy 100 Recurrence 1094 Pre-Adjuvant Therapy WITH TUMOR YES NO YES Primary Tumor 01 12 Brain DECEASED 2006 TCGA-12-1094-01 TCGA-12-1094-01 TCGA-12-1094-01A-01D-0517-01 TCGA-12-1094-01A-01D-0517-01 +TCGA-12-1095-01 TCGA-12-1095-01 GBM GBM non-CIMP c15 TCGA-12-1095 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES NO 65 TCGA-12-1095-F23419 TCGA-12-1095 -23775 482 0 482 96 2009-7-6 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Excisional Biopsy 100 Progression of Disease 1095 Pre-Adjuvant Therapy WITH TUMOR YES NO YES Primary Tumor 01 12 Brain DECEASED 2006 TCGA-12-1095-01 TCGA-12-1095-01 TCGA-12-1095-01A-01D-0517-01 TCGA-12-1095-01A-01D-0517-01 +TCGA-12-1096-01 TCGA-12-1096-01 GBM GBM non-CIMP c15 TCGA-12-1096 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain NO NO 55 TCGA-12-1096-F23428 TCGA-12-1096 -20321 277 0 270 2009-3-17 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Excisional Biopsy 80 Recurrence 1096 Pre-Adjuvant Therapy WITH TUMOR YES NO NO Primary Tumor 01 12 Brain DECEASED 2007 TCGA-12-1096-01 TCGA-12-1096-01 TCGA-12-1096-01A-01D-0517-01 TCGA-12-1096-01A-01D-0517-01 +TCGA-12-1097-01 TCGA-12-1097-01 GBM GBM non-CIMP c15 TCGA-12-1097 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES NO 61 TCGA-12-1097-F23435 TCGA-12-1097 -22526 442 0 442 166 2009-7-6 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Excisional Biopsy 100 Progression of Disease 1097 Preoperative WITH TUMOR YES NO YES Primary Tumor 01 12 Brain DECEASED 2007 TCGA-12-1097-01 TCGA-12-1097-01 TCGA-12-1097-01B-01D-0517-01 TCGA-12-1097-01B-01D-0517-01 +TCGA-12-1098-01 TCGA-12-1098-01 GBM GBM non-CIMP c15 TCGA-12-1098 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain NO NO 75 TCGA-12-1098-F23443 TCGA-12-1098 -27726 121 0 121 93 2009-7-6 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 60 Recurrence 1098 Pre-Adjuvant Therapy WITH TUMOR YES NO YES Primary Tumor 01 12 Brain DECEASED 2007 TCGA-12-1098-01 TCGA-12-1098-01 TCGA-12-1098-01C-01D-0517-01 TCGA-12-1098-01C-01D-0517-01 +TCGA-12-1099-01 TCGA-12-1099-01 BRCA-LUAD+ GBM non-CIMP c15 TCGA-12-1099 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES YES 68 TCGA-12-1099-F23447 TCGA-12-1099 -25034 126 0 104 62 2009-3-17 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Excisional Biopsy 80 Recurrence 1099 Pre-Adjuvant Therapy WITH TUMOR YES NO YES Primary Tumor 01 12 Brain DECEASED 2008 TCGA-12-1099-01 TCGA-12-1099-01 TCGA-12-1099-01A-01D-0517-01 TCGA-12-1099-01A-01D-0517-01 +TCGA-12-1597-01 TCGA-12-1597-01 GBM C10-GBM GBM non-CIMP c15 GBM-like c2 GBM-like c6 mutation cluster 14 TCGA-12-1597 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES NO 62 TCGA-12-1597-F23740 TCGA-12-1597 TCGA-12-1597-01B -22865 675 0 427 180 2011-3-9 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 1 NO 80 1 Progression of Disease TCGA-12-1597.c29d6544-408e-4628-9b49-f3191f96bb0b.pdf 1597 Post-Adjuvant Therapy WITH TUMOR YES NO YES Primary Tumor 01 0.4 12 Brain B DECEASED 2002 6f54bcd2-99e9-4f9b-a9b8-6963b922f783 TCGA-12-1597-01B-01D-1495-08 TCGA-12-1597-01 TCGA-12-1597-01 6f54bcd2-99e9-4f9b-a9b8-6963b922f783 6f54bcd2-99e9-4f9b-a9b8-6963b922f783 +TCGA-12-1598-01 TCGA-12-1598-01 BRCA-LUAD+ GBM non-CIMP c15 GBM-like c2 TCGA-12-1598 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 75 TCGA-12-1598-F23749 TCGA-12-1598 -27730 476 0 287 2009-11-16 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 1598 WITH TUMOR YES NO YES Primary Tumor 01 12 Brain DECEASED 2006 TCGA-12-1598-01 TCGA-12-1598-01 TCGA-12-1598-01A-01D-0591-01 TCGA-12-1598-01A-01D-0591-01 +TCGA-12-1599-01 TCGA-12-1599-01 GBM GBM non-CIMP c15 GBM-like c2 TCGA-12-1599 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES NO 47 TCGA-12-1599-F23754 TCGA-12-1599 -17432 781 0 769 89 2009-11-16 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 80 Progression of Disease 1599 Pre-Adjuvant Therapy WITH TUMOR YES NO YES Primary Tumor 01 12 Brain DECEASED 2006 TCGA-12-1599-01 TCGA-12-1599-01 TCGA-12-1599-01A-01D-0591-01 TCGA-12-1599-01A-01D-0591-01 +TCGA-12-1600-01 TCGA-12-1600-01 GBM GBM non-CIMP c15 TCGA-12-1600 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain NO NO 86 TCGA-12-1600-F23770 TCGA-12-1600 -31419 448 0 414 404 2009-11-16 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 80 Progression of Disease 1600 Post-Adjuvant Therapy WITH TUMOR YES NO YES Primary Tumor 01 12 Brain DECEASED 2006 TCGA-12-1600-01 TCGA-12-1600-01 TCGA-12-1600-01A-01D-0591-01 TCGA-12-1600-01A-01D-0591-01 +TCGA-12-1602-01 TCGA-12-1602-01 GBM GBM non-CIMP c15 TCGA-12-1602 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES NO 58 TCGA-12-1602-F23775 TCGA-12-1602 -21492 206 0 195 140 2009-11-16 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 60 Progression of Disease 1602 Pre-Adjuvant Therapy WITH TUMOR YES NO YES Primary Tumor 01 12 Brain DECEASED 2008 TCGA-12-1602-01 TCGA-12-1602-01 TCGA-12-1602-01A-01D-0591-01 TCGA-12-1602-01A-01D-0591-01 +TCGA-12-3644-01 TCGA-12-3644-01 GBM GBM non-CIMP c15 TCGA-12-3644 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES YES 47 TCGA-12-3644-F23780 TCGA-12-3644 -17468 1818 0 1807 1142 2010-6-18 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Excisional Biopsy 60 Progression of Disease 3644 Post-Adjuvant Therapy WITH TUMOR YES NO YES Primary Tumor 01 12 Brain DECEASED 2004 TCGA-12-3644-01 TCGA-12-3644-01 TCGA-12-3644-01A-01D-0911-01 TCGA-12-3644-01A-01D-0911-01 +TCGA-12-3646-01 TCGA-12-3646-01 GBM GBM non-CIMP c15 GBM-like c2 TCGA-12-3646 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES YES 59 TCGA-12-3646-F23812 TCGA-12-3646 -21855 1339 0 1315 1315 2010-6-17 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Excisional Biopsy 80 Progression of Disease 3646 Pre-Adjuvant Therapy WITH TUMOR YES NO YES Primary Tumor 01 12 Brain DECEASED 2005 TCGA-12-3646-01 TCGA-12-3646-01 TCGA-12-3646-01A-01D-0911-01 TCGA-12-3646-01A-01D-0911-01 +TCGA-12-3648-01 TCGA-12-3648-01 GBM GBM non-CIMP c15 TCGA-12-3648 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES YES 61 TCGA-12-3648-F23823 TCGA-12-3648 -22463 819 0 784 86 2010-6-17 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Excisional Biopsy 80 Progression of Disease 3648 Post-Adjuvant Therapy WITH TUMOR YES NO YES Primary Tumor 01 12 Brain DECEASED 2007 TCGA-12-3648-01 TCGA-12-3648-01 TCGA-12-3648-01A-01D-0911-01 TCGA-12-3648-01A-01D-0911-01 +TCGA-12-3649-01 TCGA-12-3649-01 GBM C10-GBM GBM non-CIMP c15 GBM-like c2 mutation c1uster 9 TCGA-12-3649 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain NO NO 76 TCGA-12-3649-F23834 TCGA-12-3649 -27846 463 0 351 351 2010-6-18 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Excisional Biopsy 80 Progression of Disease 3649 Pre-Adjuvant Therapy WITH TUMOR YES NO NO Primary Tumor 01 12 Brain DECEASED 2008 TCGA-12-3649-01 TCGA-12-3649-01A-01D-1495-08 TCGA-12-3649-01 TCGA-12-3649-01A-01D-0911-01 TCGA-12-3649-01A-01D-0911-01 +TCGA-12-3650-01 TCGA-12-3650-01 GBM C10-GBM GBM non-CIMP c15 GBM-like c2 GBM-like c6 mutation cluster 14 TCGA-12-3650 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES NO 46 TCGA-12-3650-F23844 TCGA-12-3650 TCGA-12-3650-01A -17138 333 0 333 239 2010-6-17 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Excisional Biopsy 0.9 NO 80 1 Progression of Disease TCGA-12-3650.2a696ad0-69a3-435c-b4a4-c3ceb5fe28a6.pdf 3650 Pre-Adjuvant Therapy WITH TUMOR YES NO YES Primary Tumor 01 0.2 12 Brain A DECEASED 2008 5522993c-6439-483c-97a6-843026d5198b TCGA-12-3650-01 TCGA-12-3650-01A-01D-1495-08 TCGA-12-3650-01 TCGA-12-3650-01A-01D-0911-01 TCGA-12-3650-01 5522993c-6439-483c-97a6-843026d5198b TCGA-12-3650-01 TCGA-12-3650-01A-01D-0911-01 5522993c-6439-483c-97a6-843026d5198b +TCGA-12-3651-01 TCGA-12-3651-01 GBM GBM non-CIMP c15 GBM-like c2 TCGA-12-3651 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES YES 77 TCGA-12-3651-F23859 TCGA-12-3651 -28277 386 0 358 358 2010-6-17 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Excisional Biopsy 80 Progression of Disease 3651 Pre-Adjuvant Therapy WITH TUMOR YES NO YES Primary Tumor 01 12 Brain DECEASED 2008 TCGA-12-3651-01 TCGA-12-3651-01 TCGA-12-3651-01A-01D-0911-01 TCGA-12-3651-01A-01D-0911-01 +TCGA-12-3652-01 TCGA-12-3652-01 GBM C10-GBM GBM non-CIMP c15 GBM-like c2 GBM-like c6 mutation cluster 14 TCGA-12-3652 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES NO 60 TCGA-12-3652-F23868 TCGA-12-3652 TCGA-12-3652-01A -21920 1062 0 1050 203 2010-6-17 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Excisional Biopsy 0.8 NO 80 1 Progression of Disease TCGA-12-3652.ee607e3d-3aed-4b43-a0cf-ff0e4ca7375b.pdf 3652 Pre-Adjuvant Therapy WITH TUMOR YES NO YES Primary Tumor 01 0.3 12 Brain A DECEASED 2003 125927b5-24fd-4910-8b21-6fe37adb8a7c TCGA-12-3652-01 TCGA-12-3652-01A-01D-1495-08 TCGA-12-3652-01 TCGA-12-3652-01A-01D-0911-01 TCGA-12-3652-01 125927b5-24fd-4910-8b21-6fe37adb8a7c TCGA-12-3652-01 TCGA-12-3652-01A-01D-0911-01 125927b5-24fd-4910-8b21-6fe37adb8a7c +TCGA-12-3653-01 TCGA-12-3653-01 GBM C10-GBM GBM non-CIMP c15 GBM-like c2 GBM-like c6 mutation cluster 14 TCGA-12-3653 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES NO 34 TCGA-12-3653-F23881 TCGA-12-3653 TCGA-12-3653-01A -12529 442 0 357 224 2010-6-17 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Excisional Biopsy 0.8 NO 80 1.1 Progression of Disease TCGA-12-3653.b2ea02b9-4f9f-474e-88fe-7306aeac14ec.pdf 3653 Pre-Adjuvant Therapy WITH TUMOR YES NO YES Primary Tumor 01 0.3 12 Brain A DECEASED 2008 82d0310c-7bd8-422e-97a7-7e73be8d8a30 TCGA-12-3653-01 TCGA-12-3653-01A-01D-1495-08 TCGA-12-3653-01 TCGA-12-3653-01A-01D-0911-01 TCGA-12-3653-01 82d0310c-7bd8-422e-97a7-7e73be8d8a30 TCGA-12-3653-01 TCGA-12-3653-01A-01D-0911-01 82d0310c-7bd8-422e-97a7-7e73be8d8a30 +TCGA-12-5295-01 TCGA-12-5295-01 GBM C10-GBM GBM non-CIMP c15 GBM-like c2 GBM-like c6 mutation cluster 14 TCGA-12-5295 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain NO NO 60 TCGA-12-5295-F23890 TCGA-12-5295 TCGA-12-5295-01A -22161 454 0 399 399 1 2011-2-7 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 0.9 NO 1.3 Progression of Disease TCGA-12-5295.ad20d555-7675-41c6-a22e-0c30db820b0d.pdf 5295 Pre-Adjuvant Therapy WITH TUMOR YES NO YES Primary Tumor 01 0.4 12 Brain A DECEASED 2008 9f591278-eec9-422f-9b78-77f65fa84f18 TCGA-12-5295-01 TCGA-12-5295-01A-01D-1486-08 TCGA-12-5295-01A-01D-1481-05 TCGA-12-5295-01 TCGA-12-5295-01A-01D-1479-01 TCGA-12-5295-01 9f591278-eec9-422f-9b78-77f65fa84f18 TCGA-12-5295-01 TCGA-12-5295-01A-01D-1479-01 9f591278-eec9-422f-9b78-77f65fa84f18 +TCGA-12-5299-01 TCGA-12-5299-01 GBM C10-GBM GBM non-CIMP c15 GBM-like c6 mutation c1uster 9 TCGA-12-5299 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 56 TCGA-12-5299-F23897 TCGA-12-5299 -20463 98 0 98 2011-2-7 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 80 5299 Pre-Adjuvant Therapy WITH TUMOR YES NO YES Primary Tumor 01 12 Brain DECEASED 2009 f4d31bec-0bf5-4f59-ae0e-37170f1b692e TCGA-12-5299-01 TCGA-12-5299-01A-02D-1486-08 TCGA-12-5299-01A-02D-1481-05 TCGA-12-5299-01 TCGA-12-5299-01A-02D-1479-01 TCGA-12-5299-01 f4d31bec-0bf5-4f59-ae0e-37170f1b692e TCGA-12-5299-01 TCGA-12-5299-01A-02D-1479-01 f4d31bec-0bf5-4f59-ae0e-37170f1b692e +TCGA-12-5301-01 TCGA-12-5301-01 GBM C10-GBM GBM non-CIMP c15 GBM-like c2 mutation cluster 4 TCGA-12-5301 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 59 TCGA-12-5301-F23902 TCGA-12-5301 -21768 62 0 62 2011-2-7 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 80 5301 Pre-Adjuvant Therapy WITH TUMOR YES NO YES Primary Tumor 01 12 Brain DECEASED 2010 TCGA-12-5301-01 TCGA-12-5301-01A-01D-1486-08 TCGA-12-5301-01A-01D-1481-05 TCGA-12-5301-01 TCGA-12-5301-01A-01D-1479-01 TCGA-12-5301-01A-01D-1479-01 +TCGA-14-0736-01 TCGA-14-0736-01 Kirc+ GBM non-CIMP c15 TCGA-14-0736 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES NO 49 TCGA-14-0736-F25026 TCGA-14-0736 -18219 460 0 460 128 2009-6-4 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 100 Recurrence 0736 Pre-Adjuvant Therapy WITH TUMOR YES NO YES Primary Tumor 01 14 Brain DECEASED 1999 TCGA-14-0736-01 TCGA-14-0736-01A-01D-A45W-05 TCGA-14-0736-01 TCGA-14-0736-01A-01D-0517-01 TCGA-14-0736-01A-01D-0517-01 +TCGA-14-0736-02 TCGA-14-0736-02 GBM non-CIMP c15 GBM-like c6 TCGA-14-0736 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES NO 49 TCGA-14-0736-F25026 TCGA-14-0736 TCGA-14-0736-02A -18219 460 0 460 128 2009-6-4 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 1 NO 100 1.5 Recurrence TCGA-14-0736.C8D784A0-08C8-40F4-A6E2-C7FFAE4D91F5.pdf 0736 Pre-Adjuvant Therapy WITH TUMOR YES NO YES Recurrent Tumor 02 0.3 14 Brain A DECEASED 1999 b469eb7c-723f-4870-b4e4-ebfaae7a118b TCGA-14-0736-02A-01D-2004-05 b469eb7c-723f-4870-b4e4-ebfaae7a118b b469eb7c-723f-4870-b4e4-ebfaae7a118b +TCGA-14-0740-01 TCGA-14-0740-01 Kirc+ GBM non-CIMP c15 mutation cluster 5 TCGA-14-0740 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 70 TCGA-14-0740-F25255 TCGA-14-0740 TCGA-14-0740-01B -25627 364 0 364 2010-6-24 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 0.4 NO 60 1 TCGA-14-0740.909215ba-8f90-4ec1-bcc6-11c75548f3f2.pdf 0740 Pre-Adjuvant Therapy WITH TUMOR YES NO YES Primary Tumor 01 0.2 14 Brain B DECEASED 2002 TCGA-14-0740-01B-01D-1845-08 TCGA-14-0740-01B-01D-1844-05 TCGA-14-0740-01B-01D-1842-01 TCGA-14-0740-01B-01D-1842-01 +TCGA-14-0781-01 TCGA-14-0781-01 GBM C10-GBM GBM non-CIMP c15 GBM-like c6 mutation c1uster 9 TCGA-14-0781 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 49 TCGA-14-0781-F25033 TCGA-14-0781 TCGA-14-0781-01B -17903 29 0 29 2010-6-24 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 1.1 NO 1.5 TCGA-14-0781.0ca697b0-9c0e-45a7-aac1-72480cfccd9b.pdf 0781 WITH TUMOR YES NO NO Primary Tumor 01 0.3 14 Brain B DECEASED 2003 66b268a8-8652-4efc-8b2e-cf4ac6e00516 TCGA-14-0781-01 TCGA-14-0781-01B-01D-1696-08 TCGA-14-0781-01B-01D-1697-05 TCGA-14-0781-01 TCGA-14-0781-01B-01D-1694-01 TCGA-14-0781-01 66b268a8-8652-4efc-8b2e-cf4ac6e00516 TCGA-14-0781-01 TCGA-14-0781-01B-01D-1694-01 66b268a8-8652-4efc-8b2e-cf4ac6e00516 +TCGA-14-0783-01 TCGA-14-0783-01 BRCA-LUAD+ GBM non-CIMP c15 TCGA-14-0783 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 36 TCGA-14-0783-F25036 TCGA-14-0783 -13159 189 0 189 2009-8-4 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 80 0783 Pre-Adjuvant Therapy WITH TUMOR YES NO YES Primary Tumor 01 14 Brain DECEASED 2000 TCGA-14-0783-01 TCGA-14-0783-01 TCGA-14-0783-01B-01D-0517-01 TCGA-14-0783-01B-01D-0517-01 +TCGA-14-0786-01 TCGA-14-0786-01 GBM GBM non-CIMP c15 mutation cluster 14 TCGA-14-0786 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES NO 50 TCGA-14-0786-F25041 TCGA-14-0786 -18592 701 0 701 127 2009-8-4 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 80 Recurrence 0786 Pre-Adjuvant Therapy WITH TUMOR YES NO YES Primary Tumor 01 14 Brain DECEASED 1998 TCGA-14-0786-01 TCGA-14-0786-01B-01D-1492-08 TCGA-14-0786-01 TCGA-14-0786-01B-01D-0517-01 TCGA-14-0786-01B-01D-0517-01 +TCGA-14-0787-01 TCGA-14-0787-01 GBM C10-GBM GBM non-CIMP c15 GBM-like c6 mutation c1uster 9 TCGA-14-0787 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 69 TCGA-14-0787-F25057 TCGA-14-0787 -25326 68 0 68 2009-1-20 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Incisional Biopsy 60 0787 Post-Adjuvant Therapy YES NO NO Primary Tumor 01 14 Brain DECEASED 1999 a77fc356-53b6-4932-a369-4bb7b89f8ed2 TCGA-14-0787-01 TCGA-14-0787-01A-01W-0424-08 TCGA-14-0787-01 TCGA-14-0787-01A-01D-0384-01 TCGA-14-0787-01 a77fc356-53b6-4932-a369-4bb7b89f8ed2 TCGA-14-0787-01 TCGA-14-0787-01A-01D-0384-01 a77fc356-53b6-4932-a369-4bb7b89f8ed2 +TCGA-14-0789-01 TCGA-14-0789-01 GBM C10-GBM GBM non-CIMP c15 GBM-like c6 mutation cluster 14 TCGA-14-0789 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES NO 54 TCGA-14-0789-F25061 TCGA-14-0789 TCGA-14-0789-01A -20050 342 0 342 105 2009-1-20 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection NO 40 Progression of Disease TCGA-14-0789.ed9f8678-240b-4029-8bc4-a73103b56cf2.pdf 0789 Post-Adjuvant Therapy YES NO YES Primary Tumor 01 14 Brain A DECEASED 2005 48a2ae8d-a9c4-4d06-8619-ad49502b3721 TCGA-14-0789-01 TCGA-14-0789-01A-01W-0424-08 TCGA-14-0789-01 TCGA-14-0789-01A-01D-0384-01 TCGA-14-0789-01 48a2ae8d-a9c4-4d06-8619-ad49502b3721 TCGA-14-0789-01 TCGA-14-0789-01A-01D-0384-01 48a2ae8d-a9c4-4d06-8619-ad49502b3721 +TCGA-14-0790-01 TCGA-14-0790-01 GBM C10-GBM GBM non-CIMP c15 GBM-like c6 mutation cluster 14 TCGA-14-0790 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 64 TCGA-14-0790-F25068 TCGA-14-0790 TCGA-14-0790-01B -23674 419 0 419 2010-2-5 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 0.6 NO 60 1.2 TCGA-14-0790.ed7342f3-4567-466c-a82a-ae6ef040a7c7.pdf 0790 Post-Adjuvant Therapy WITH TUMOR YES NO YES Primary Tumor 01 0.2 14 Brain B DECEASED 2006 68de1b36-afde-4fb9-bd5a-38037cd7df11 TCGA-14-0790-01 TCGA-14-0790-01B-01D-1494-08 TCGA-14-0790-01 TCGA-14-0790-01B-01D-0784-01 TCGA-14-0790-01 68de1b36-afde-4fb9-bd5a-38037cd7df11 TCGA-14-0790-01 TCGA-14-0790-01B-01D-0784-01 68de1b36-afde-4fb9-bd5a-38037cd7df11 +TCGA-14-0812-01 TCGA-14-0812-01 GBM GBM non-CIMP c15 TCGA-14-0812 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 65 TCGA-14-0812-F25074 TCGA-14-0812 -24085 99 0 99 2009-8-4 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 40 0812 Post-Adjuvant Therapy WITH TUMOR YES NO NO Primary Tumor 01 14 Brain DECEASED 2003 TCGA-14-0812-01 TCGA-14-0812-01 TCGA-14-0812-01B-01D-0591-01 TCGA-14-0812-01B-01D-0591-01 +TCGA-14-0813-01 TCGA-14-0813-01 GBM C10-GBM GBM non-CIMP c15 GBM-like c2 mutation cluster 8 TCGA-14-0813 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 78 TCGA-14-0813-F25078 TCGA-14-0813 -28582 41 0 41 2008-12-19 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 60 0813 Other YES NO NO Primary Tumor 01 14 Brain DECEASED 2004 TCGA-14-0813-01 TCGA-14-0813-01A-01W-0424-08 TCGA-14-0813-01 TCGA-14-0813-01A-01D-0384-01 TCGA-14-0813-01A-01D-0384-01 +TCGA-14-0817-01 TCGA-14-0817-01 Kirc+ C10-GBM GBM non-CIMP c15 GBM-like c6 mutation cluster 13 TCGA-14-0817 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 69 TCGA-14-0817-F25081 TCGA-14-0817 TCGA-14-0817-01A -25425 164 0 164 2008-12-19 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 1 NO 60 1 TCGA-14-0817.c93c85d6-fda0-4aed-8846-624fa502ee41.pdf 0817 Other YES NO NO Primary Tumor 01 0.3 14 Brain A DECEASED 2002 60003a9d-4fed-4131-839d-13d72f6d9c28 TCGA-14-0817-01 TCGA-14-0817-01A-01W-0424-08 TCGA-14-0817-01 TCGA-14-0817-01A-01D-0384-01 TCGA-14-0817-01 60003a9d-4fed-4131-839d-13d72f6d9c28 TCGA-14-0817-01 TCGA-14-0817-01A-01D-0384-01 60003a9d-4fed-4131-839d-13d72f6d9c28 +TCGA-14-0862-01 TCGA-14-0862-01 Kirc+ C10-GBM GBM non-CIMP c15 GBM-like c2 mutation cluster 4 TCGA-14-0862 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 60 TCGA-14-0862-F25259 TCGA-14-0862 TCGA-14-0862-01B -22179 88 0 88 2010-6-24 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 1 NO 40 1 TCGA-14-0862.2E28A596-50BF-495B-ACD1-199392D3C84B.pdf 0862 Other WITH TUMOR YES NO NO Primary Tumor 01 0.3 14 Brain B DECEASED 2002 TCGA-14-0862-01B-01D-1845-08 TCGA-14-0862-01B-01D-1844-05 TCGA-14-0862-01B-01D-1842-01 TCGA-14-0862-01B-01D-1842-01 +TCGA-14-0865-01 TCGA-14-0865-01 Kirc+ GBM non-CIMP c15 TCGA-14-0865 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES YES 67 TCGA-14-0865-F25084 TCGA-14-0865 -24797 502 0 502 215 2009-8-4 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 60 Progression of Disease 0865 Pre-Adjuvant Therapy WITH TUMOR YES NO YES Primary Tumor 01 14 Brain DECEASED 2002 TCGA-14-0865-01 TCGA-14-0865-01 TCGA-14-0865-01B-01D-0591-01 TCGA-14-0865-01B-01D-0591-01 +TCGA-14-0866-01 TCGA-14-0866-01 GBM GBM non-CIMP c15 TCGA-14-0866 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES NO 55 TCGA-14-0866-F25091 TCGA-14-0866 -20179 801 0 801 97 2009-9-1 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 80 Recurrence 0866 Pre-Adjuvant Therapy YES NO YES Primary Tumor 01 14 Brain DECEASED 2002 TCGA-14-0866-01 TCGA-14-0866-01 TCGA-14-0866-01B-01D-0591-01 TCGA-14-0866-01B-01D-0591-01 +TCGA-14-0867-01 TCGA-14-0867-01 BRCA-LUAD+ GBM non-CIMP c15 TCGA-14-0867 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 67 TCGA-14-0867-F25096 TCGA-14-0867 -24815 62 0 62 2008-12-19 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 60 0867 Other YES NO NO Primary Tumor 01 14 Brain DECEASED 2002 TCGA-14-0867-01 TCGA-14-0867-01 TCGA-14-0867-01A-01D-0384-01 TCGA-14-0867-01A-01D-0384-01 +TCGA-14-0871-01 TCGA-14-0871-01 BRCA-LUAD+ C1-LUAD-enriched Cluster 5 KIRC-like c1 mutation cluster 5 TCGA-14-0871 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 74 TCGA-14-0871-F25099 TCGA-14-0871 TCGA-14-0871-01A -27387 880 0 880 2008-12-19 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 0.7 NO 60 1.2 TCGA-14-0871.3c96ffd0-6aa2-4d06-a59a-d70e79d05822.pdf 0871 Post-Adjuvant Therapy YES NO YES Primary Tumor 01 0.3 14 Brain A DECEASED 1998 4bd8bbae-7370-43c7-89cb-0fe0028553dd TCGA-14-0871-01 TCGA-14-0871-01A-01W-0424-08 TCGA-14-0871-01 TCGA-14-0871-01A-01D-0384-01 4bd8bbae-7370-43c7-89cb-0fe0028553dd TCGA-14-0871-01A-01D-0384-01 4bd8bbae-7370-43c7-89cb-0fe0028553dd +TCGA-14-1034-01 TCGA-14-1034-01 BRCA-LUAD+ GBM non-CIMP c15 GBM-like c6 TCGA-14-1034 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES NO 60 TCGA-14-1034-F25103 TCGA-14-1034 TCGA-14-1034-01A -22029 485 0 485 282 2009-6-18 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection NO 60 Progression of Disease TCGA-14-1034.CDDBA95B-1894-48C6-B99B-CAB435DBCD75.pdf 1034 Pre-Adjuvant Therapy WITH TUMOR YES NO YES Primary Tumor 01 14 Brain A DECEASED 1999 28239a0e-9990-49ef-a159-ba63fb078c77 TCGA-14-1034-01 TCGA-14-1034-01 TCGA-14-1034-01A-01D-0517-01 TCGA-14-1034-01 28239a0e-9990-49ef-a159-ba63fb078c77 TCGA-14-1034-01 TCGA-14-1034-01A-01D-0517-01 28239a0e-9990-49ef-a159-ba63fb078c77 +TCGA-14-1034-02 TCGA-14-1034-02 GBM non-CIMP c15 GBM-like c6 TCGA-14-1034 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES NO 60 TCGA-14-1034-F25103 TCGA-14-1034 TCGA-14-1034-02B -22029 485 0 485 282 2009-6-18 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 0.5 NO 60 1.3 Progression of Disease TCGA-14-1034.490E1C09-0B6A-469D-8DB8-846EB33FFCB8.pdf 1034 Pre-Adjuvant Therapy WITH TUMOR YES NO YES Recurrent Tumor 02 0.3 14 Brain B DECEASED 1999 ee783da8-98c4-4107-8e9b-af8580ac2f24 TCGA-14-1034-02B-01D-2280-08 TCGA-14-1034-02B-01D-2004-05 ee783da8-98c4-4107-8e9b-af8580ac2f24 ee783da8-98c4-4107-8e9b-af8580ac2f24 +TCGA-14-1037-01 TCGA-14-1037-01 GBM GBM non-CIMP c15 TCGA-14-1037 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES NO 66 TCGA-14-1037-F25109 TCGA-14-1037 -24426 587 0 587 326 2009-9-24 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 60 Recurrence 1037 Pre-Adjuvant Therapy WITH TUMOR YES NO YES Primary Tumor 01 14 Brain DECEASED 2002 TCGA-14-1037-01 TCGA-14-1037-01 TCGA-14-1037-01A-01D-0591-01 TCGA-14-1037-01A-01D-0591-01 +TCGA-14-1043-01 TCGA-14-1043-01 GBM GBM non-CIMP c15 mutation c1uster 9 TCGA-14-1043 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 61 TCGA-14-1043-F25262 TCGA-14-1043 TCGA-14-1043-01B -22392 24 0 24 2010-6-24 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 0.4 NO 40 1.3 TCGA-14-1043.2F65E83C-F29A-4BB8-9872-5E796A6360A3.pdf 1043 Pre-Adjuvant Therapy WITH TUMOR YES NO YES Primary Tumor 01 0.3 14 Brain B DECEASED 2004 TCGA-14-1043-01B-11D-1845-08 TCGA-14-1043-01B-11D-1844-05 TCGA-14-1043-01B-11D-1842-01 TCGA-14-1043-01B-11D-1842-01 +TCGA-14-1395-01 TCGA-14-1395-01 GBM GBM non-CIMP c15 mutation cluster 14 TCGA-14-1395 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 52 TCGA-14-1395-F25266 TCGA-14-1395 TCGA-14-1395-01B -19237 42 0 42 2009-8-5 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 0.6 NO 80 2 TCGA-14-1395.C9DD5452-29C7-47EC-97CE-089774514ED5.pdf 1395 Preoperative WITH TUMOR YES NO NO Primary Tumor 01 0.4 14 Brain B DECEASED 2003 TCGA-14-1395-01B-11D-1845-08 TCGA-14-1395-01B-11D-1844-05 TCGA-14-1395-01B-11D-1842-01 TCGA-14-1395-01B-11D-1842-01 +TCGA-14-1396-01 TCGA-14-1396-01 GBM GBM non-CIMP c15 TCGA-14-1396 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 78 TCGA-14-1396-F25117 TCGA-14-1396 -28753 34 0 34 2009-6-4 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 60 1396 Other WITH TUMOR YES NO NO Primary Tumor 01 14 Brain DECEASED 2003 TCGA-14-1396-01 TCGA-14-1396-01 TCGA-14-1396-01A-01D-0517-01 TCGA-14-1396-01A-01D-0517-01 +TCGA-14-1401-01 TCGA-14-1401-01 GBM GBM non-CIMP c15 TCGA-14-1401 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 54 TCGA-14-1401-F25120 TCGA-14-1401 -19921 114 0 114 2009-6-4 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 80 1401 Other WITH TUMOR YES NO NO Primary Tumor 01 14 Brain DECEASED 2004 TCGA-14-1401-01 TCGA-14-1401-01 TCGA-14-1401-01A-01D-0517-01 TCGA-14-1401-01A-01D-0517-01 +TCGA-14-1402-01 TCGA-14-1402-01 GBM GBM non-CIMP c15 TCGA-14-1402 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES NO 58 TCGA-14-1402-F25123 TCGA-14-1402 -21421 975 0 975 333 2009-6-18 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 80 Progression of Disease 1402 Pre-Adjuvant Therapy WITH TUMOR YES NO YES Primary Tumor 01 14 Brain DECEASED 2005 TCGA-14-1402-01 TCGA-14-1402-01A-01D-A45W-05 TCGA-14-1402-01 TCGA-14-1402-01A-01D-0517-01 TCGA-14-1402-01A-01D-0517-01 +TCGA-14-1402-02 TCGA-14-1402-02 GBM non-CIMP c15 GBM-like c6 TCGA-14-1402 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES NO 58 TCGA-14-1402-F25123 TCGA-14-1402 TCGA-14-1402-02A -21421 975 0 975 333 2009-6-18 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 0.6 NO 80 1 Progression of Disease TCGA-14-1402.14AD9309-B729-490D-BD16-9CFDD0CD6C18.pdf 1402 Pre-Adjuvant Therapy WITH TUMOR YES NO YES Recurrent Tumor 02 0.2 14 Brain A DECEASED 2005 d8164b02-4b3c-454d-945b-2838edb1b5b1 TCGA-14-1402-02A-01D-2004-05 d8164b02-4b3c-454d-945b-2838edb1b5b1 d8164b02-4b3c-454d-945b-2838edb1b5b1 +TCGA-14-1450-01 TCGA-14-1450-01 GBM GBM non-CIMP c15 mutation c1uster 9 TCGA-14-1450 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES NO 57 TCGA-14-1450-F25270 TCGA-14-1450 TCGA-14-1450-01B -20960 0 1788 826 2010-6-24 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 0.3 NO 80 0.8 Progression of Disease TCGA-14-1450.c8086688-b70d-4b74-bd4d-9cc2568dc76b.pdf 1450 Post-Adjuvant Therapy WITH TUMOR YES NO YES Primary Tumor 01 0.1 14 Brain B LIVING 2005 TCGA-14-1450-01B-01D-1845-08 TCGA-14-1450-01B-01D-1844-05 TCGA-14-1450-01B-01D-1842-01 TCGA-14-1450-01B-01D-1842-01 +TCGA-14-1451-01 TCGA-14-1451-01 GBM GBM non-CIMP c15 TCGA-14-1451 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES YES 39 TCGA-14-1451-F25134 TCGA-14-1451 -14401 703 0 703 19 2009-9-1 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 80 Recurrence 1451 Pre-Adjuvant Therapy WITH TUMOR YES NO NO Primary Tumor 01 14 Brain DECEASED 2005 TCGA-14-1451-01 TCGA-14-1451-01 TCGA-14-1451-01A-01D-0517-01 TCGA-14-1451-01A-01D-0517-01 +TCGA-14-1452-01 TCGA-14-1452-01 BRCA-LUAD+ GBM non-CIMP c15 TCGA-14-1452 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES NO 60 TCGA-14-1452-F25147 TCGA-14-1452 -22106 216 0 216 172 2009-6-4 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 80 Recurrence 1452 Post-Adjuvant Therapy WITH TUMOR YES NO YES Primary Tumor 01 14 Brain DECEASED 2005 TCGA-14-1452-01 TCGA-14-1452-01 TCGA-14-1452-01A-01D-0517-01 TCGA-14-1452-01A-01D-0517-01 +TCGA-14-1453-01 TCGA-14-1453-01 Kirc+ GBM non-CIMP c15 TCGA-14-1453 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 69 TCGA-14-1453-F25154 TCGA-14-1453 -25297 35 0 35 2009-6-4 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 60 1453 Other WITH TUMOR YES NO NO Primary Tumor 01 14 Brain DECEASED 2005 TCGA-14-1453-01 TCGA-14-1453-01 TCGA-14-1453-01A-01D-0517-01 TCGA-14-1453-01A-01D-0517-01 +TCGA-14-1454-01 TCGA-14-1454-01 BRCA-LUAD+ GBM non-CIMP c15 TCGA-14-1454 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES NO 54 TCGA-14-1454-F25157 TCGA-14-1454 -19887 918 0 918 291 2009-6-4 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 60 Recurrence 1454 Other WITH TUMOR YES NO YES Primary Tumor 01 14 Brain DECEASED 2005 TCGA-14-1454-01 TCGA-14-1454-01 TCGA-14-1454-01A-01D-0517-01 TCGA-14-1454-01A-01D-0517-01 +TCGA-14-1455-01 TCGA-14-1455-01 GBM GBM non-CIMP c15 TCGA-14-1455 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 61 TCGA-14-1455-F25166 TCGA-14-1455 -22562 28 0 28 2009-8-5 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 1455 WITH TUMOR YES NO NO Primary Tumor 01 14 Brain DECEASED 2005 TCGA-14-1455-01 TCGA-14-1455-01 TCGA-14-1455-01A-01D-0591-01 TCGA-14-1455-01A-01D-0591-01 +TCGA-14-1456-01 TCGA-14-1456-01 BRCA-LUAD+ GBM CIMP c16 mutation cluster 8 TCGA-14-1456 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES NO 23 TCGA-14-1456-F25170 TCGA-14-1456 -8710 0 1246 98 2010-5-28 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 80 Progression of Disease 1456 Post-Adjuvant Therapy WITH TUMOR YES NO YES Primary Tumor 01 14 Brain LIVING 2006 TCGA-14-1456-01 TCGA-14-1456-01B-01D-1494-08 TCGA-14-1456-01 TCGA-14-1456-01B-01D-0784-01 TCGA-14-1456-01B-01D-0784-01 +TCGA-14-1458-01 TCGA-14-1458-01 Kirc+ GBM CIMP c16 TCGA-14-1458 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES NO 54 TCGA-14-1458-F25179 TCGA-14-1458 -19899 203 0 187 81 2009-8-5 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 80 Recurrence 1458 Pre-Adjuvant Therapy YES NO YES Primary Tumor 01 14 Brain DECEASED 2008 TCGA-14-1458-01 TCGA-14-1458-01 TCGA-14-1458-01A-01D-0591-01 TCGA-14-1458-01A-01D-0591-01 +TCGA-14-1459-01 TCGA-14-1459-01 GBM GBM non-CIMP c15 TCGA-14-1459 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES NO 63 TCGA-14-1459-F25187 TCGA-14-1459 -23231 378 0 378 275 2009-6-18 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 100 Progression of Disease 1459 Pre-Adjuvant Therapy WITH TUMOR YES NO YES Primary Tumor 01 14 Brain DECEASED 2007 TCGA-14-1459-01 TCGA-14-1459-01 TCGA-14-1459-01A-01D-0517-01 TCGA-14-1459-01A-01D-0517-01 +TCGA-14-1794-01 TCGA-14-1794-01 GBM GBM non-CIMP c15 TCGA-14-1794 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 59 TCGA-14-1794-F25193 TCGA-14-1794 -21628 30 0 30 2009-8-4 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 1794 WITH TUMOR YES NO YES Primary Tumor 01 14 Brain DECEASED 2005 TCGA-14-1794-01 TCGA-14-1794-01 TCGA-14-1794-01A-01D-0591-01 TCGA-14-1794-01A-01D-0591-01 +TCGA-14-1795-01 TCGA-14-1795-01 GBM GBM non-CIMP c15 TCGA-14-1795 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 66 TCGA-14-1795-F25197 TCGA-14-1795 -24375 60 0 60 2009-8-4 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 60 1795 Post-Adjuvant Therapy WITH TUMOR YES NO NO Primary Tumor 01 14 Brain DECEASED 2006 TCGA-14-1795-01 TCGA-14-1795-01 TCGA-14-1795-01A-01D-0591-01 TCGA-14-1795-01A-01D-0591-01 +TCGA-14-1821-01 TCGA-14-1821-01 Squamous GBM CIMP c16 TCGA-14-1821 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES NO 31 TCGA-14-1821-F25201 TCGA-14-1821 -11329 541 0 541 331 2009-9-1 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 80 Recurrence 1821 Pre-Adjuvant Therapy WITH TUMOR YES NO YES Primary Tumor 01 14 Brain DECEASED 2005 TCGA-14-1821-01 TCGA-14-1821-01 TCGA-14-1821-01A-01D-0591-01 TCGA-14-1821-01A-01D-0591-01 +TCGA-14-1823-01 TCGA-14-1823-01 GBM C10-GBM GBM non-CIMP c15 GBM-like c2 GBM-like c6 mutation cluster 14 TCGA-14-1823 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES NO 58 TCGA-14-1823-F25207 TCGA-14-1823 -21384 543 0 543 140 2009-9-1 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 80 Recurrence 1823 Pre-Adjuvant Therapy WITH TUMOR YES YES YES Primary Tumor 01 14 Brain DECEASED 2007 addc558d-d718-4f50-a0dc-92f7c3341f61 TCGA-14-1823-01 TCGA-14-1823-01A-01W-0643-08 TCGA-14-1823-01 TCGA-14-1823-01A-01D-0591-01 TCGA-14-1823-01 addc558d-d718-4f50-a0dc-92f7c3341f61 TCGA-14-1823-01 TCGA-14-1823-01A-01D-0591-01 addc558d-d718-4f50-a0dc-92f7c3341f61 +TCGA-14-1825-01 TCGA-14-1825-01 Kirc+ C10-GBM GBM non-CIMP c15 GBM-like c6 mutation cluster 5 TCGA-14-1825 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES NO 70 TCGA-14-1825-F25216 TCGA-14-1825 TCGA-14-1825-01A -25684 232 0 82 2009-9-23 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 0.5 NO 80 1.2 Progression of Disease TCGA-14-1825.67478a3b-8b41-4571-bc63-36780f0d19e2.pdf 1825 Pre-Adjuvant Therapy WITH TUMOR YES NO YES Primary Tumor 01 0.2 14 Brain A DECEASED 2007 33daf82d-0b4d-474e-84d7-f21c47077c95 TCGA-14-1825-01 TCGA-14-1825-01A-01W-0643-08 TCGA-14-1825-01 TCGA-14-1825-01A-01D-0591-01 TCGA-14-1825-01 33daf82d-0b4d-474e-84d7-f21c47077c95 TCGA-14-1825-01 TCGA-14-1825-01A-01D-0591-01 33daf82d-0b4d-474e-84d7-f21c47077c95 +TCGA-14-1827-01 TCGA-14-1827-01 GBM GBM non-CIMP c15 TCGA-14-1827 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 51 TCGA-14-1827-F25221 TCGA-14-1827 -18828 179 0 179 2009-9-23 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 100 1827 Pre-Adjuvant Therapy YES NO NO Primary Tumor 01 14 Brain DECEASED 1998 TCGA-14-1827-01 TCGA-14-1827-01 TCGA-14-1827-01A-01D-0591-01 TCGA-14-1827-01A-01D-0591-01 +TCGA-14-1829-01 TCGA-14-1829-01 GBM C10-GBM GBM non-CIMP c15 GBM-like c6 mutation cluster 14 TCGA-14-1829 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 57 TCGA-14-1829-F25226 TCGA-14-1829 TCGA-14-1829-01A -20929 0 218 2009-9-24 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 1 NO 60 1.2 TCGA-14-1829.a56c7808-d310-4d94-b0fa-5fcf5289555d.pdf 1829 Preoperative WITH TUMOR YES NO YES Primary Tumor 01 0.2 14 Brain A LIVING 2009 098b8eb6-2e55-4628-8eca-e1068e74d9e6 TCGA-14-1829-01 TCGA-14-1829-01A-01W-0643-08 TCGA-14-1829-01 TCGA-14-1829-01A-01D-0591-01 TCGA-14-1829-01 098b8eb6-2e55-4628-8eca-e1068e74d9e6 TCGA-14-1829-01 TCGA-14-1829-01A-01D-0591-01 098b8eb6-2e55-4628-8eca-e1068e74d9e6 +TCGA-14-2554-01 TCGA-14-2554-01 GBM C10-GBM GBM non-CIMP c15 GBM-like c6 mutation cluster 14 TCGA-14-2554 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain NO NO 52 TCGA-14-2554-F25231 TCGA-14-2554 -19090 532 0 532 29 2010-2-5 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 60 Locoregional Disease YES 2554 Pre-Adjuvant Therapy WITH TUMOR YES NO YES Primary Tumor 01 14 Brain DECEASED 2002 fbf2f1c0-fb91-4548-8653-68021e6541f9 TCGA-14-2554-01 TCGA-14-2554-01A-01D-1494-08 TCGA-14-2554-01 TCGA-14-2554-01A-01D-0784-01 TCGA-14-2554-01 fbf2f1c0-fb91-4548-8653-68021e6541f9 TCGA-14-2554-01 TCGA-14-2554-01A-01D-0784-01 fbf2f1c0-fb91-4548-8653-68021e6541f9 +TCGA-14-2555-01 TCGA-14-2555-01 GBM GBM non-CIMP c15 TCGA-14-2555 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 44 TCGA-14-2555-F25235 TCGA-14-2555 -16259 0 242 2010-5-11 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 80 2555 Pre-Adjuvant Therapy YES NO YES Primary Tumor 01 14 Brain LIVING 2009 TCGA-14-2555-01 TCGA-14-2555-01 TCGA-14-2555-01B-01D-0911-01 TCGA-14-2555-01B-01D-0911-01 +TCGA-14-3476-01 TCGA-14-3476-01 GBM GBM non-CIMP c15 mutation cluster 7 TCGA-14-3476 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain NO NO 74 TCGA-14-3476-F25240 TCGA-14-3476 -27172 12 0 12 9 2010-7-12 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection Progression of Disease 3476 YES NO NO Primary Tumor 01 14 Brain DECEASED 2009 TCGA-14-3476-01B-01D-1353-08 TCGA-14-3476-01 +TCGA-14-3477-01 TCGA-14-3477-01 High GBM non-CIMP c15 TCGA-14-3477 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 38 TCGA-14-3477-F25243 TCGA-14-3477 -14082 0 115 2010-5-11 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 80 3477 Pre-Adjuvant Therapy WITH TUMOR YES NO YES Primary Tumor 01 14 Brain LIVING 2009 TCGA-14-3477-01 TCGA-14-3477-01 TCGA-14-3477-01A-01D-0911-01 TCGA-14-3477-01A-01D-0911-01 +TCGA-14-4157-01 TCGA-14-4157-01 Kirc+ GBM CIMP c16 mutation cluster 13 TCGA-14-4157 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain NO NO 40 TCGA-14-4157-F25249 TCGA-14-4157 -14816 0 104 96 2010-7-12 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 60 Progression of Disease 4157 Pre-Adjuvant Therapy YES NO YES Primary Tumor 01 14 Brain LIVING 2010 TCGA-14-4157-01 TCGA-14-4157-01A-01D-1353-08 TCGA-14-4157-01 TCGA-14-4157-01A-01D-1224-01 TCGA-14-4157-01A-01D-1224-01 +TCGA-15-0742-01 TCGA-15-0742-01 GBM GBM-like c6 mutation cluster 7 TCGA-15-0742 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES NO 65 TCGA-15-0742-F25278 TCGA-15-0742 TCGA-15-0742-01A -24050 419 0 232 2008-12-19 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection NO 80 Progression of Disease TCGA-15-0742.e9fc50d8-86a1-451d-8b2d-caa8729a1bf4.pdf 0742 Pre-Adjuvant Therapy YES NO YES Primary Tumor 01 15 Brain A DECEASED 2005 3721666c-f46f-4b43-9f5d-b3cf85af176c TCGA-15-0742-01 TCGA-15-0742-01A-01W-0348-08 TCGA-15-0742-01 TCGA-15-0742-01A-01D-0333-01 TCGA-15-0742-01 3721666c-f46f-4b43-9f5d-b3cf85af176c TCGA-15-0742-01 TCGA-15-0742-01A-01D-0333-01 3721666c-f46f-4b43-9f5d-b3cf85af176c +TCGA-15-1444-01 TCGA-15-1444-01 Kirc+ C10-GBM GBM CIMP c16 GBM-like c6 mutation cluster 3 TCGA-15-1444 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 21 TCGA-15-1444 TCGA-15-1444-01A -7827 1537 0 2013-4-4 MALE Glioblastoma Multiforme (GBM) No C71.9 9440/3 C71.9 YES Tumor resection 1.1 NO 1.8 NO No TCGA-15-1444.bdc60487-8aea-4657-bac9-736f204fe65b.pdf 1444 WITH TUMOR YES Complete Remission/Response NO YES Primary Tumor 01 0.5 NO YES 15 Brain A DECEASED 2004 95e1423d-5a12-49cf-841d-1521593a874f TCGA-15-1444-01 TCGA-15-1444-01A-02D-1696-08 TCGA-15-1444-01A-02D-1697-05 TCGA-15-1444-01 TCGA-15-1444-01A-02D-1694-01 TCGA-15-1444-01 95e1423d-5a12-49cf-841d-1521593a874f TCGA-15-1444-01 TCGA-15-1444-01A-02D-1694-01 95e1423d-5a12-49cf-841d-1521593a874f +TCGA-15-1446-01 TCGA-15-1446-01 GBM GBM non-CIMP c15 GBM-like c2 TCGA-15-1446 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain NO 55 TCGA-15-1446-F25283 TCGA-15-1446 -20355 0 581 443 1 2009-5-11 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Fine needle aspiration biopsy 80 Recurrence 1446 Pre-Adjuvant Therapy WITH TUMOR YES NO YES Primary Tumor 01 15 Brain LIVING 2006 TCGA-15-1446-01 TCGA-15-1446-01 TCGA-15-1446-01A-01D-0517-01 TCGA-15-1446-01A-01D-0517-01 +TCGA-15-1447-01 TCGA-15-1447-01 Kirc+ GBM non-CIMP c15 GBM-like c2 TCGA-15-1447 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain NO NO 36 TCGA-15-1447-F25287 TCGA-15-1447 -13326 0 1618 340 1 2009-5-11 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 80 Recurrence 1447 Preoperative WITH TUMOR YES NO YES Primary Tumor 01 15 Brain LIVING 2004 TCGA-15-1447-01 TCGA-15-1447-01 TCGA-15-1447-01A-01D-0517-01 TCGA-15-1447-01A-01D-0517-01 +TCGA-15-1449-01 TCGA-15-1449-01 GBM GBM non-CIMP c15 GBM-like c2 TCGA-15-1449 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain NO NO 65 TCGA-15-1449-F25293 TCGA-15-1449 -23828 404 0 74 2 2009-5-11 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 60 Recurrence 1449 Pre-Adjuvant Therapy WITH TUMOR YES YES YES Primary Tumor 01 15 Brain DECEASED 2006 TCGA-15-1449-01 TCGA-15-1449-01 TCGA-15-1449-01A-01D-0517-01 TCGA-15-1449-01A-01D-0517-01 +TCGA-16-0846-01 TCGA-16-0846-01 GBM C10-GBM GBM non-CIMP c15 GBM-like c2 GBM-like c6 mutation cluster 5 TCGA-16-0846 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 85 TCGA-16-0846-F25297 TCGA-16-0846 TCGA-16-0846-01A -31111 119 0 119 2009-7-17 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 0.7 NO 2 TCGA-16-0846.3AF0506F-002C-4FDD-A111-63C08424A867.pdf 0846 WITH TUMOR NO NO NO Primary Tumor 01 0.5 16 Brain A DECEASED 2006 8dd4d862-180f-479b-8d87-0eaae4fc9236 TCGA-16-0846-01 TCGA-16-0846-01A-01W-0424-08 TCGA-16-0846-01 TCGA-16-0846-01A-01D-0384-01 TCGA-16-0846-01 8dd4d862-180f-479b-8d87-0eaae4fc9236 TCGA-16-0846-01 TCGA-16-0846-01A-01D-0384-01 8dd4d862-180f-479b-8d87-0eaae4fc9236 +TCGA-16-0848-01 TCGA-16-0848-01 GBM GBM non-CIMP c15 TCGA-16-0848 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES NO 57 TCGA-16-0848-F25299 TCGA-16-0848 -20848 535 0 302 129 2009-7-17 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection Recurrence 0848 WITH TUMOR YES NO YES Primary Tumor 01 16 Brain DECEASED 2007 TCGA-16-0848-01 TCGA-16-0848-01 TCGA-16-0848-01A-01D-0384-01 TCGA-16-0848-01A-01D-0384-01 +TCGA-16-0849-01 TCGA-16-0849-01 Kirc+ GBM CIMP c16 TCGA-16-0849 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 54 TCGA-16-0849-F25302 TCGA-16-0849 -19939 0 793 2009-7-17 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 0849 YES NO YES Primary Tumor 01 16 Brain LIVING 2007 TCGA-16-0849-01 TCGA-16-0849-01 TCGA-16-0849-01A-01D-0384-01 TCGA-16-0849-01A-01D-0384-01 +TCGA-16-0850-01 TCGA-16-0850-01 Kirc+ GBM CIMP c16 TCGA-16-0850 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain NO NO 52 TCGA-16-0850-F25305 TCGA-16-0850 -19281 498 0 496 83 2009-7-17 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection Recurrence 0850 WITH TUMOR YES NO YES Primary Tumor 01 16 Brain DECEASED 2007 TCGA-16-0850-01 TCGA-16-0850-01 TCGA-16-0850-01A-01D-0384-01 TCGA-16-0850-01A-01D-0384-01 +TCGA-16-0861-01 TCGA-16-0861-01 GBM GBM non-CIMP c15 mutation c1uster 9 TCGA-16-0861 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain NO NO 65 TCGA-16-0861-F25309 TCGA-16-0861 -23778 0 131 94 2009-7-17 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection Recurrence 0861 YES NO YES Primary Tumor 01 16 Brain 2008 TCGA-16-0861-01 TCGA-16-0861-01A-01W-0424-08 TCGA-16-0861-01 TCGA-16-0861-01A-01D-0384-01 TCGA-16-0861-01A-01D-0384-01 +TCGA-16-1045-01 TCGA-16-1045-01 Kirc+ C10-GBM GBM non-CIMP c15 GBM-like c6 mutation cluster 14 TCGA-16-1045 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES NO 49 TCGA-16-1045-F25312 TCGA-16-1045 -18195 883 0 883 654 2009-7-27 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection Recurrence 1045 WITH TUMOR YES YES YES Primary Tumor 01 16 Brain DECEASED 2006 f4398f60-1a5f-426f-8d4c-ab52d815bb98 TCGA-16-1045-01 TCGA-16-1045-01B-01W-0611-08 TCGA-16-1045-01 TCGA-16-1045-01B-01D-0517-01 TCGA-16-1045-01 f4398f60-1a5f-426f-8d4c-ab52d815bb98 TCGA-16-1045-01 TCGA-16-1045-01B-01D-0517-01 f4398f60-1a5f-426f-8d4c-ab52d815bb98 +TCGA-16-1047-01 TCGA-16-1047-01 GBM GBM non-CIMP c15 TCGA-16-1047 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain NO NO 66 TCGA-16-1047-F25316 TCGA-16-1047 -24301 139 0 25 25 2009-7-27 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection Progression of Disease 1047 WITH TUMOR NO YES NO Primary Tumor 01 16 Brain DECEASED 2005 TCGA-16-1047-01 TCGA-16-1047-01 TCGA-16-1047-01B-01D-0517-01 TCGA-16-1047-01B-01D-0517-01 +TCGA-16-1048-01 TCGA-16-1048-01 GBM GBM non-CIMP c15 mutation cluster 7 TCGA-16-1048 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain Primary Tumor 01 TCGA-16-1048-01 TCGA-16-1048-01B-01D-1353-08 TCGA-16-1048-01 TCGA-16-1048-01B-01D-1224-01 TCGA-16-1048-01B-01D-1224-01 +TCGA-16-1055-01 TCGA-16-1055-01 GBM GBM non-CIMP c15 TCGA-16-1055 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain NO NO 48 TCGA-16-1055-F25318 TCGA-16-1055 -17840 313 0 301 288 2009-7-27 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection Recurrence 1055 WITH TUMOR YES NO YES Primary Tumor 01 16 Brain DECEASED 2004 TCGA-16-1055-01 TCGA-16-1055-01 TCGA-16-1055-01B-01D-0517-01 TCGA-16-1055-01B-01D-0517-01 +TCGA-16-1056-01 TCGA-16-1056-01 GBM GBM non-CIMP c15 TCGA-16-1056 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain NO NO 55 TCGA-16-1056-F25321 TCGA-16-1056 -20310 426 0 406 239 2009-7-27 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection Recurrence 1056 WITH TUMOR YES NO YES Primary Tumor 01 16 Brain DECEASED 2006 TCGA-16-1056-01 TCGA-16-1056-01 TCGA-16-1056-01B-01D-0517-01 TCGA-16-1056-01B-01D-0517-01 +TCGA-16-1060-01 TCGA-16-1060-01 GBM GBM non-CIMP c15 TCGA-16-1060 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain NO NO 70 TCGA-16-1060-F25324 TCGA-16-1060 -25813 278 0 111 111 2009-7-27 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection Progression of Disease 1060 WITH TUMOR NO NO YES Primary Tumor 01 16 Brain DECEASED 2005 TCGA-16-1060-01 TCGA-16-1060-01 TCGA-16-1060-01A-01D-0517-01 TCGA-16-1060-01A-01D-0517-01 +TCGA-16-1062-01 TCGA-16-1062-01 GBM GBM non-CIMP c15 TCGA-16-1062 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain NO NO 57 TCGA-16-1062-F25327 TCGA-16-1062 -21148 646 0 556 518 2009-7-27 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection Progression of Disease 1062 WITH TUMOR YES NO YES Primary Tumor 01 16 Brain DECEASED 2006 TCGA-16-1062-01 TCGA-16-1062-01 TCGA-16-1062-01A-01D-0517-01 TCGA-16-1062-01A-01D-0517-01 +TCGA-16-1063-01 TCGA-16-1063-01 GBM GBM non-CIMP c15 TCGA-16-1063 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain NO NO 72 TCGA-16-1063-F25330 TCGA-16-1063 -26313 425 0 425 369 2009-7-27 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection Progression of Disease 1063 WITH TUMOR YES NO YES Primary Tumor 01 16 Brain DECEASED 2006 TCGA-16-1063-01 TCGA-16-1063-01 TCGA-16-1063-01B-01D-0517-01 TCGA-16-1063-01B-01D-0517-01 +TCGA-16-1460-01 TCGA-16-1460-01 Kirc+ GBM CIMP c16 GBM-like c2 TCGA-16-1460 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 36 TCGA-16-1460-F25333 TCGA-16-1460 -13208 0 195 2009-7-27 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 1460 YES YES YES Primary Tumor 01 16 Brain LIVING 2008 TCGA-16-1460-01 TCGA-16-1460-01 TCGA-16-1460-01A-01D-0591-01 TCGA-16-1460-01A-01D-0591-01 +TCGA-19-0955-01 TCGA-19-0955-01 GBM GBM non-CIMP c15 TCGA-19-0955 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 71 TCGA-19-0955-F25335 TCGA-19-0955 -25974 0 358 2008-12-19 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Fine needle aspiration biopsy 0955 TUMOR FREE YES NO YES Primary Tumor 01 19 Brain LIVING 2007 TCGA-19-0955-01 TCGA-19-0955-01 TCGA-19-0955-01A-02D-0517-01 TCGA-19-0955-01A-02D-0517-01 +TCGA-19-0957-01 TCGA-19-0957-01 GBM GBM non-CIMP c15 GBM-like c2 TCGA-19-0957 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES NO 48 TCGA-19-0957-F25340 TCGA-19-0957 -17714 666 0 666 50 1 2009-9-18 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection Recurrence 0957 Post-Adjuvant Therapy WITH TUMOR YES NO YES Primary Tumor 01 19 Brain DECEASED 2007 TCGA-19-0957-01 TCGA-19-0957-01C-01D-A45W-05 TCGA-19-0957-01 TCGA-19-0957-01C-01D-0591-01 TCGA-19-0957-01C-01D-0591-01 +TCGA-19-0957-02 TCGA-19-0957-02 GBM non-CIMP c15 GBM-like c6 TCGA-19-0957 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES NO 48 TCGA-19-0957-F25340 TCGA-19-0957 TCGA-19-0957-02A -17714 666 0 666 50 1 2009-9-18 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 0.7 NO 1 Recurrence TCGA-19-0957.B89E0536-FA53-4891-967E-01E283A72103.pdf 0957 Post-Adjuvant Therapy WITH TUMOR YES NO YES Recurrent Tumor 02 0.5 19 Brain A DECEASED 2007 8401d72d-a286-4541-b566-c6212ef4c89c TCGA-19-0957-02A-11D-2004-05 8401d72d-a286-4541-b566-c6212ef4c89c 8401d72d-a286-4541-b566-c6212ef4c89c +TCGA-19-0960-01 TCGA-19-0960-01 Kirc+ GBM non-CIMP c15 TCGA-19-0960 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 83 TCGA-19-0960-F25351 TCGA-19-0960 -30364 0 262 2008-12-19 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Excisional Biopsy 60 0960 Post-Adjuvant Therapy YES NO YES Primary Tumor 01 19 Brain LIVING 2008 TCGA-19-0960-01 TCGA-19-0960-01 TCGA-19-0960-01A-02D-0517-01 TCGA-19-0960-01A-02D-0517-01 +TCGA-19-0962-01 TCGA-19-0962-01 GBM GBM non-CIMP c15 GBM-like c2 TCGA-19-0962 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 77 TCGA-19-0962-F25355 TCGA-19-0962 -28382 20 0 13 2009-5-4 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 40 0962 Pre-Adjuvant Therapy NO NO NO Primary Tumor 01 19 Brain DECEASED 2008 TCGA-19-0962-01 TCGA-19-0962-01 TCGA-19-0962-01B-01D-0517-01 TCGA-19-0962-01B-01D-0517-01 +TCGA-19-0963-01 TCGA-19-0963-01 GBM GBM non-CIMP c15 TCGA-19-0963 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain NO NO 61 TCGA-19-0963-F25357 TCGA-19-0963 -22326 434 0 434 310 2009-5-4 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection Recurrence 0963 WITH TUMOR YES NO YES Primary Tumor 01 19 Brain DECEASED 2008 TCGA-19-0963-01 TCGA-19-0963-01 TCGA-19-0963-01B-01D-0517-01 TCGA-19-0963-01B-01D-0517-01 +TCGA-19-0964-01 TCGA-19-0964-01 GBM GBM non-CIMP c15 TCGA-19-0964 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 70 TCGA-19-0964-F25362 TCGA-19-0964 -25800 0 103 2008-12-19 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 60 0964 Post-Adjuvant Therapy WITH TUMOR YES NO YES Primary Tumor 01 19 Brain LIVING 2008 TCGA-19-0964-01 TCGA-19-0964-01 TCGA-19-0964-01A-01D-0517-01 TCGA-19-0964-01A-01D-0517-01 +TCGA-19-1385-01 TCGA-19-1385-01 Kirc+ GBM non-CIMP c15 TCGA-19-1385 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES NO 69 TCGA-19-1385-F25366 TCGA-19-1385 -25459 327 0 327 177 2 2009-9-18 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection Recurrence 1385 Post-Adjuvant Therapy WITH TUMOR YES NO YES Primary Tumor 01 19 Brain DECEASED 2008 TCGA-19-1385-01 TCGA-19-1385-01 TCGA-19-1385-01A-02D-0591-01 TCGA-19-1385-01A-02D-0591-01 +TCGA-19-1386-01 TCGA-19-1386-01 GBM GBM non-CIMP c15 GBM-like c2 TCGA-19-1386 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain NO NO 51 TCGA-19-1386-F25371 TCGA-19-1386 -18678 276 0 276 237 2009-9-18 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 80 Recurrence 1386 Post-Adjuvant Therapy WITH TUMOR YES NO YES Primary Tumor 01 19 Brain DECEASED 2008 TCGA-19-1386-01 TCGA-19-1386-01 TCGA-19-1386-01A-01D-0591-01 TCGA-19-1386-01A-01D-0591-01 +TCGA-19-1387-01 TCGA-19-1387-01 GBM GBM non-CIMP c15 TCGA-19-1387 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain NO NO 81 TCGA-19-1387-F25379 TCGA-19-1387 -29892 0 181 79 2009-9-18 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 60 Recurrence 1387 Post-Adjuvant Therapy WITH TUMOR YES NO YES Primary Tumor 01 19 Brain LIVING 2008 TCGA-19-1387-01 TCGA-19-1387-01 TCGA-19-1387-01A-01D-0591-01 TCGA-19-1387-01A-01D-0591-01 +TCGA-19-1388-01 TCGA-19-1388-01 Squamous GBM non-CIMP c15 TCGA-19-1388 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES NO 58 TCGA-19-1388-F25383 TCGA-19-1388 -21368 394 0 394 148 3 2009-9-18 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection Progression of Disease 1388 Post-Adjuvant Therapy WITH TUMOR YES NO YES Primary Tumor 01 19 Brain DECEASED 2008 TCGA-19-1388-01 TCGA-19-1388-01 TCGA-19-1388-01A-01D-0591-01 TCGA-19-1388-01A-01D-0591-01 +TCGA-19-1389-01 TCGA-19-1389-01 GBM GBM non-CIMP c15 GBM-like c2 TCGA-19-1389 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain NO NO 51 TCGA-19-1389-F25390 TCGA-19-1389 -18659 141 0 141 81 2009-9-18 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 80 Recurrence 1389 Pre-Adjuvant Therapy WITH TUMOR YES NO YES Primary Tumor 01 19 Brain DECEASED 2008 TCGA-19-1389-01 TCGA-19-1389-01A-01D-A45W-05 TCGA-19-1389-01 TCGA-19-1389-01A-01D-0591-01 TCGA-19-1389-01A-01D-0591-01 +TCGA-19-1389-02 TCGA-19-1389-02 GBM non-CIMP c15 GBM-like c6 TCGA-19-1389 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain NO NO 51 TCGA-19-1389-F25390 TCGA-19-1389 TCGA-19-1389-02A -18659 141 0 141 81 2009-9-18 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 0.9 NO 80 1.1 Recurrence TCGA-19-1389.3D1C69CB-761A-475B-9F7F-B045C5DA634E.pdf 1389 Pre-Adjuvant Therapy WITH TUMOR YES NO YES Recurrent Tumor 02 0.5 19 Brain A DECEASED 2008 d722657b-e5b6-4476-94e9-1135ce8aecad TCGA-19-1389-02A-21D-2004-05 d722657b-e5b6-4476-94e9-1135ce8aecad d722657b-e5b6-4476-94e9-1135ce8aecad +TCGA-19-1390-01 TCGA-19-1390-01 BRCA-LUAD+ C10-GBM GBM non-CIMP c15 GBM-like c2 GBM-like c6 mutation cluster 5 TCGA-19-1390 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 63 TCGA-19-1390-F25396 TCGA-19-1390 -23063 772 0 772 2010-8-31 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 60 1390 Pre-Adjuvant Therapy NO NO NO Primary Tumor 01 19 Brain DECEASED 2007 f2a757d2-2574-4840-88ea-5ffd09d0103c TCGA-19-1390-01 TCGA-19-1390-01A-01D-1495-08 TCGA-19-1390-01 TCGA-19-1390-01A-01D-0911-01 TCGA-19-1390-01 f2a757d2-2574-4840-88ea-5ffd09d0103c TCGA-19-1390-01 TCGA-19-1390-01A-01D-0911-01 f2a757d2-2574-4840-88ea-5ffd09d0103c +TCGA-19-1392-01 TCGA-19-1392-01 BRCA-LUAD+ GBM non-CIMP c15 GBM-like c2 TCGA-19-1392 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 72 TCGA-19-1392-F25398 TCGA-19-1392 -26593 111 0 106 2009-5-4 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 60 1392 Pre-Adjuvant Therapy NO NO NO Primary Tumor 01 19 Brain DECEASED 2008 TCGA-19-1392-01 TCGA-19-1392-01 TCGA-19-1392-01A-01D-0517-01 TCGA-19-1392-01A-01D-0517-01 +TCGA-19-1786-01 TCGA-19-1786-01 GBM GBM non-CIMP c15 GBM-like c2 TCGA-19-1786 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 64 TCGA-19-1786-F25400 TCGA-19-1786 -23568 0 218 2009-9-21 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 40 1786 TUMOR FREE NO NO YES Primary Tumor 01 19 Brain LIVING 2008 TCGA-19-1786-01 TCGA-19-1786-01 TCGA-19-1786-01A-01D-0591-01 TCGA-19-1786-01A-01D-0591-01 +TCGA-19-1787-01 TCGA-19-1787-01 GBM GBM non-CIMP c15 GBM-like c6 TCGA-19-1787 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES NO 48 TCGA-19-1787-F25403 TCGA-19-1787 TCGA-19-1787-01B -17894 385 0 385 308 2010-8-31 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 0.5 NO 80 0.5 Recurrence TCGA-19-1787.bbfa055e-efc5-4f81-971f-7bdea4726b36.pdf 1787 Pre-Adjuvant Therapy WITH TUMOR YES NO YES Primary Tumor 01 0.3 19 Brain B DECEASED 2008 5d40c2af-b2e9-407c-be1f-780a9071fbe7 TCGA-19-1787-01 TCGA-19-1787-01 TCGA-19-1787-01B-01D-0911-01 TCGA-19-1787-01 5d40c2af-b2e9-407c-be1f-780a9071fbe7 TCGA-19-1787-01 TCGA-19-1787-01B-01D-0911-01 5d40c2af-b2e9-407c-be1f-780a9071fbe7 +TCGA-19-1788-01 TCGA-19-1788-01 Kirc+ GBM CIMP c16 GBM-like c2 TCGA-19-1788 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 39 TCGA-19-1788-F25410 TCGA-19-1788 -14301 112 0 112 2009-9-21 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 60 1788 Pre-Adjuvant Therapy NO NO NO Primary Tumor 01 19 Brain DECEASED 2009 TCGA-19-1788-01 +TCGA-19-1789-01 TCGA-19-1789-01 GBM GBM non-CIMP c15 GBM-like c2 TCGA-19-1789 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 69 TCGA-19-1789-F25414 TCGA-19-1789 -25282 99 0 99 2009-9-21 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 60 1789 Post-Adjuvant Therapy YES NO YES Primary Tumor 01 19 Brain DECEASED 2009 TCGA-19-1789-01 TCGA-19-1789-01 TCGA-19-1789-01A-01D-0591-01 TCGA-19-1789-01A-01D-0591-01 +TCGA-19-1790-01 TCGA-19-1790-01 GBM C10-GBM GBM non-CIMP c15 KIRC-like c1 mutation cluster 14 TCGA-19-1790 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain NO NO 56 TCGA-19-1790-F25418 TCGA-19-1790 -20626 154 0 154 88 2010-6-7 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 60 Progression of Disease 1790 Post-Adjuvant Therapy WITH TUMOR YES NO YES Primary Tumor 01 19 Brain DECEASED 2008 TCGA-19-1790-01B-01D-1353-08 TCGA-19-1790-01 +TCGA-19-1791-01 TCGA-19-1791-01 BRCA-LUAD+ GBM non-CIMP c15 GBM-like c2 TCGA-19-1791 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 82 TCGA-19-1791-F25422 TCGA-19-1791 -30065 0 4 2009-9-21 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 1791 WITH TUMOR NO NO NO Primary Tumor 01 19 Brain LIVING 2009 TCGA-19-1791-01 TCGA-19-1791-01 TCGA-19-1791-01A-01D-0591-01 TCGA-19-1791-01A-01D-0591-01 +TCGA-19-2619-01 TCGA-19-2619-01 BRCA-LUAD+ C10-GBM GBM non-CIMP c15 GBM-like c2 GBM-like c6 mutation c1uster 9 TCGA-19-2619 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES NO 55 TCGA-19-2619-F25424 TCGA-19-2619 -20159 0 294 146 2010-5-14 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 40 Progression of Disease 2619 Pre-Adjuvant Therapy WITH TUMOR YES YES YES Primary Tumor 01 19 Brain LIVING 2009 adafa15c-5834-427e-bc93-24d3c4f775a9 TCGA-19-2619-01 TCGA-19-2619-01A-01D-1495-08 TCGA-19-2619-01 TCGA-19-2619-01A-01D-0911-01 TCGA-19-2619-01 adafa15c-5834-427e-bc93-24d3c4f775a9 TCGA-19-2619-01 TCGA-19-2619-01A-01D-0911-01 adafa15c-5834-427e-bc93-24d3c4f775a9 +TCGA-19-2620-01 TCGA-19-2620-01 GBM C10-GBM GBM non-CIMP c15 GBM-like c2 GBM-like c6 mutation cluster 14 TCGA-19-2620 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 70 TCGA-19-2620-F25431 TCGA-19-2620 TCGA-19-2620-01A -25665 148 0 148 2010-5-12 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 1 NO 40 1.5 TCGA-19-2620.dedd3bd8-b885-498e-a305-50b727240d09.pdf 2620 Pre-Adjuvant Therapy TUMOR FREE YES NO YES Primary Tumor 01 0.4 19 Brain A DECEASED 2009 497fcc98-1eeb-4696-88eb-22fc99627695 TCGA-19-2620-01 TCGA-19-2620-01A-01D-1495-08 TCGA-19-2620-01 TCGA-19-2620-01A-01D-0911-01 TCGA-19-2620-01 497fcc98-1eeb-4696-88eb-22fc99627695 TCGA-19-2620-01 TCGA-19-2620-01A-01D-0911-01 497fcc98-1eeb-4696-88eb-22fc99627695 +TCGA-19-2621-01 TCGA-19-2621-01 GBM GBM non-CIMP c15 TCGA-19-2621 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 83 TCGA-19-2621-F25435 TCGA-19-2621 -30429 33 0 33 2010-5-12 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 2621 NO NO NO Primary Tumor 01 19 Brain DECEASED 2009 TCGA-19-2621-01 TCGA-19-2621-01 TCGA-19-2621-01B-01D-0911-01 TCGA-19-2621-01B-01D-0911-01 +TCGA-19-2623-01 TCGA-19-2623-01 GBM GBM non-CIMP c15 mutation cluster 8 TCGA-19-2623 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 65 TCGA-19-2623-F25437 TCGA-19-2623 -23835 0 229 2010-5-12 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 80 2623 Post-Adjuvant Therapy TUMOR FREE YES NO YES Primary Tumor 01 19 Brain LIVING 2009 TCGA-19-2623-01 TCGA-19-2623-01A-01D-1495-08 TCGA-19-2623-01 TCGA-19-2623-01A-01D-0911-01 TCGA-19-2623-01A-01D-0911-01 +TCGA-19-2624-01 TCGA-19-2624-01 GBM C10-GBM GBM non-CIMP c15 GBM-like c6 mutation cluster 14 TCGA-19-2624 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 51 TCGA-19-2624-F25443 TCGA-19-2624 -18891 5 0 5 2010-5-12 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 2624 TUMOR FREE NO NO NO Primary Tumor 01 19 Brain DECEASED 2009 d5a281fd-c004-477f-af62-c55fe20f1dee TCGA-19-2624-01 TCGA-19-2624-01A-01D-1495-08 TCGA-19-2624-01 TCGA-19-2624-01A-01D-0911-01 TCGA-19-2624-01 d5a281fd-c004-477f-af62-c55fe20f1dee TCGA-19-2624-01 TCGA-19-2624-01A-01D-0911-01 d5a281fd-c004-477f-af62-c55fe20f1dee +TCGA-19-2625-01 TCGA-19-2625-01 Iq C10-GBM GBM non-CIMP c15 KIRC-like c1 GBM-like c6 mutation cluster 8 TCGA-19-2625 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 76 TCGA-19-2625-F25445 TCGA-19-2625 -27930 124 0 124 2010-5-12 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 2625 TUMOR FREE NO NO NO Primary Tumor 01 19 Brain DECEASED 2009 febcf9af-1a79-4234-a095-4efa3c3aa2bc TCGA-19-2625-01 TCGA-19-2625-01A-01D-1495-08 TCGA-19-2625-01 TCGA-19-2625-01A-01D-0911-01 TCGA-19-2625-01 febcf9af-1a79-4234-a095-4efa3c3aa2bc TCGA-19-2625-01 TCGA-19-2625-01A-01D-0911-01 febcf9af-1a79-4234-a095-4efa3c3aa2bc +TCGA-19-2629-01 TCGA-19-2629-01 Kirc+ C10-GBM GBM CIMP c16 GBM-like c6 mutation cluster 8 TCGA-19-2629 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES NO 60 TCGA-19-2629-F25447 TCGA-19-2629 TCGA-19-2629-01A -22257 737 0 501 145 2010-5-12 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 1 NO 1.7 Progression of Disease TCGA-19-2629.974b6590-7b55-4d77-94e0-f5c48204fdd7.pdf 2629 WITH TUMOR YES NO YES Primary Tumor 01 0.3 19 Brain A DECEASED 2009 56a705f4-fd28-44ff-8a3c-85bc4300c760 TCGA-19-2629-01 TCGA-19-2629-01A-01D-1495-08 TCGA-19-2629-01 TCGA-19-2629-01A-01D-0911-01 TCGA-19-2629-01 56a705f4-fd28-44ff-8a3c-85bc4300c760 TCGA-19-2629-01 TCGA-19-2629-01A-01D-0911-01 56a705f4-fd28-44ff-8a3c-85bc4300c760 +TCGA-19-2631-01 TCGA-19-2631-01 GBM C10-GBM GBM non-CIMP c15 GBM-like c2 mutation cluster 14 TCGA-19-2631 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 74 TCGA-19-2631-F25453 TCGA-19-2631 -27200 213 0 213 2010-6-16 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 60 2631 Pre-Adjuvant Therapy TUMOR FREE NO NO YES Primary Tumor 01 19 Brain DECEASED 2009 TCGA-19-2631-01 TCGA-19-2631-01A-01D-1353-08 TCGA-19-2631-01 TCGA-19-2631-01A-01D-1224-01 TCGA-19-2631-01A-01D-1224-01 +TCGA-19-4065-01 TCGA-19-4065-01 BRCA-LUAD+ GBM non-CIMP c15 GBM-like c6 TCGA-19-4065 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES NO 36 TCGA-19-4065-F25511 TCGA-19-4065 TCGA-19-4065-01A -13257 0 214 70 2010-6-8 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 0.8 NO 1 Recurrence TCGA-19-4065.E3EB10CD-611E-4424-8F2F-E771156168E0.pdf 4065 WITH TUMOR YES NO YES Primary Tumor 01 0.3 19 Brain A LIVING 2009 3053a2c5-4426-4d56-85b0-50567f1e81c9 TCGA-19-4065-01A-01D-2004-05 TCGA-19-4065-01A-01D-2002-01 TCGA-19-4065-01 3053a2c5-4426-4d56-85b0-50567f1e81c9 TCGA-19-4065-01 TCGA-19-4065-01A-01D-2002-01 3053a2c5-4426-4d56-85b0-50567f1e81c9 +TCGA-19-4065-02 TCGA-19-4065-02 GBM non-CIMP c15 GBM-like c6 TCGA-19-4065 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES NO 36 TCGA-19-4065-F25511 TCGA-19-4065 TCGA-19-4065-02A -13257 0 214 70 2010-6-8 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 0.7 NO 0.9 Recurrence TCGA-19-4065.E375DF88-891E-4DE4-89A9-B394429C445A.pdf 4065 WITH TUMOR YES NO YES Recurrent Tumor 02 0.6 19 Brain A LIVING 2009 6287ca85-ad7b-4656-9c6e-8c3c44833462 TCGA-19-4065-02A-11D-2004-05 6287ca85-ad7b-4656-9c6e-8c3c44833462 6287ca85-ad7b-4656-9c6e-8c3c44833462 +TCGA-19-4068-01 TCGA-19-4068-01 GBM C10-GBM GBM non-CIMP c15 GBM-like c2 mutation c1uster 9 TCGA-19-4068 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 68 TCGA-19-4068-F25456 TCGA-19-4068 -24945 0 137 2010-6-8 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 80 4068 Pre-Adjuvant Therapy TUMOR FREE YES NO YES Primary Tumor 01 19 Brain LIVING 2009 TCGA-19-4068-01A-01D-1353-08 TCGA-19-4068-01 +TCGA-19-5947-01 TCGA-19-5947-01 GBM C10-GBM GBM non-CIMP c15 KIRC-like c1 mutation cluster 14 TCGA-19-5947 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain NO NO 47 TCGA-19-5947-F25462 TCGA-19-5947 -17218 202 0 202 43 2011-6-3 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 40 Progression of Disease 5947 Pre-Adjuvant Therapy WITH TUMOR NO YES YES Primary Tumor 01 19 Brain DECEASED 2010 TCGA-19-5947-01 TCGA-19-5947-01A-11D-1696-08 TCGA-19-5947-01A-11D-1697-05 TCGA-19-5947-01 TCGA-19-5947-01A-11D-1694-01 TCGA-19-5947-01A-11D-1694-01 +TCGA-19-5950-01 TCGA-19-5950-01 GBM C10-GBM GBM non-CIMP c15 GBM-like c2 mutation c1uster 9 TCGA-19-5950 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES NO 52 TCGA-19-5950-F43163 TCGA-19-5950 -19244 523 0 343 294 Progressive Disease 2013-5-14 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 100 Recurrence 5950 Pre-Adjuvant Therapy WITH TUMOR YES Progressive Disease NO YES Primary Tumor 01 19 Brain DECEASED 2010 TCGA-19-5950-01 TCGA-19-5950-01A-11D-1696-08 TCGA-19-5950-01A-11D-1697-05 TCGA-19-5950-01 TCGA-19-5950-01A-11D-1694-01 TCGA-19-5950-01A-11D-1694-01 +TCGA-19-5951-01 TCGA-19-5951-01 GBM C10-GBM GBM non-CIMP c15 GBM-like c2 mutation cluster 14 TCGA-19-5951 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 76 TCGA-19-5951-F25471 TCGA-19-5951 -27995 244 0 244 2011-6-3 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 80 5951 Pre-Adjuvant Therapy WITH TUMOR YES NO YES Primary Tumor 01 19 Brain DECEASED 2010 TCGA-19-5951-01 TCGA-19-5951-01A-11D-1696-08 TCGA-19-5951-01A-11D-1697-05 TCGA-19-5951-01 TCGA-19-5951-01A-11D-1694-01 TCGA-19-5951-01A-11D-1694-01 +TCGA-19-5952-01 TCGA-19-5952-01 GBM C10-GBM GBM non-CIMP c15 GBM-like c2 mutation c1uster 9 TCGA-19-5952 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 62 TCGA-19-5952-F25475 TCGA-19-5952 -22841 575 0 567 2011-6-3 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 60 5952 Pre-Adjuvant Therapy NO NO YES Primary Tumor 01 19 Brain DECEASED 2010 TCGA-19-5952-01 TCGA-19-5952-01A-11D-1696-08 TCGA-19-5952-01A-11D-1697-05 TCGA-19-5952-01 TCGA-19-5952-01A-11D-1694-01 TCGA-19-5952-01A-11D-1694-01 +TCGA-19-5953-01 TCGA-19-5953-01 GBM C10-GBM GBM non-CIMP c15 KIRC-like c1 mutation c1uster 9 TCGA-19-5953 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain NO NO 58 TCGA-19-5953-F25509 TCGA-19-5953 TCGA-19-5953-01B -21204 144 0 144 119 2011-9-15 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 0.8 NO 1 Progression of Disease TCGA-19-5953.3c12ddbb-84f3-46ee-a68d-51b82b8397a9.pdf 5953 WITH TUMOR NO Primary Tumor 01 0.6 19 Brain B DECEASED 2010 TCGA-19-5953-01B-12D-1845-08 TCGA-19-5953-01B-12D-1844-05 TCGA-19-5953-01B-12D-1842-01 TCGA-19-5953-01B-12D-1842-01 +TCGA-19-5954-01 TCGA-19-5954-01 GBM C10-GBM GBM non-CIMP c15 GBM-like c2 mutation cluster 4 TCGA-19-5954 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 72 TCGA-19-5954-F43172 TCGA-19-5954 -26355 368 0 242 2013-5-14 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 60 5954 Post-Adjuvant Therapy WITH TUMOR YES Stable Disease NO YES Primary Tumor 01 19 Brain DECEASED 2010 TCGA-19-5954-01 TCGA-19-5954-01A-11D-1696-08 TCGA-19-5954-01A-11D-1697-05 TCGA-19-5954-01 TCGA-19-5954-01A-11D-1694-01 TCGA-19-5954-01A-11D-1694-01 +TCGA-19-5955-01 TCGA-19-5955-01 GBM C10-GBM GBM non-CIMP c15 GBM-like c2 mutation cluster 14 TCGA-19-5955 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 83 TCGA-19-5955-F25483 TCGA-19-5955 -30550 54 0 54 2011-6-3 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 5955 NO NO NO Primary Tumor 01 19 Brain DECEASED 2010 TCGA-19-5955-01 TCGA-19-5955-01A-11D-1696-08 TCGA-19-5955-01A-11D-1697-05 TCGA-19-5955-01 TCGA-19-5955-01A-11D-1694-01 TCGA-19-5955-01A-11D-1694-01 +TCGA-19-5956-01 TCGA-19-5956-01 Kirc+ GBM non-CIMP c15 GBM-like c2 TCGA-19-5956 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain NO NO 53 TCGA-19-5956-F43175 TCGA-19-5956 -19591 684 0 198 647 Scheduled Follow-up Submission Progressive Disease 2013-5-14 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 80 NO Progression of Disease YES 5956 Pre-Adjuvant Therapy WITH TUMOR YES Stable Disease NO YES Primary Tumor 01 19 Brain DECEASED 2010 TCGA-19-5956-01 TCGA-19-5956-01A-11D-1697-05 TCGA-19-5956-01 TCGA-19-5956-01A-11D-1694-01 TCGA-19-5956-01A-11D-1694-01 +TCGA-19-5958-01 TCGA-19-5958-01 GBM C10-GBM GBM non-CIMP c15 GBM-like c2 mutation cluster 4 TCGA-19-5958 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain NO NO 56 TCGA-19-5958-F43233 TCGA-19-5958 -20466 428 0 164 356 Scheduled Follow-up Submission Progressive Disease 2013-5-15 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 80 NO Recurrence YES 5958 Post-Adjuvant Therapy WITH TUMOR YES Progressive Disease NO YES Primary Tumor 01 19 Brain DECEASED 2010 TCGA-19-5958-01 TCGA-19-5958-01A-11D-1696-08 TCGA-19-5958-01A-11D-1697-05 TCGA-19-5958-01 TCGA-19-5958-01A-11D-1694-01 TCGA-19-5958-01A-11D-1694-01 +TCGA-19-5959-01 TCGA-19-5959-01 GBM C10-GBM GBM non-CIMP c15 GBM-like c2 mutation cluster 12 TCGA-19-5959 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES NO 77 TCGA-19-5959-F43159 TCGA-19-5959 -28449 511 0 161 318 Additional New Tumor Event Progressive Disease 2013-5-14 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 80 NO Progression of Disease NO 5959 Post-Adjuvant Therapy WITH TUMOR YES Progressive Disease NO YES Primary Tumor 01 19 Brain DECEASED 2010 TCGA-19-5959-01 TCGA-19-5959-01A-11D-1696-08 TCGA-19-5959-01A-11D-1697-05 TCGA-19-5959-01 TCGA-19-5959-01A-11D-1694-01 TCGA-19-5959-01A-11D-1694-01 +TCGA-19-5960-01 TCGA-19-5960-01 GBM C10-GBM GBM non-CIMP c15 GBM-like c2 GBM-like c6 mutation c1uster 10 TCGA-19-5960 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain NO NO 56 TCGA-19-5960-F43299 TCGA-19-5960 -20641 455 0 165 382 Scheduled Follow-up Submission Progressive Disease 2013-5-16 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 80 NO Recurrence YES 5960 Pre-Adjuvant Therapy WITH TUMOR YES Stable Disease NO YES Primary Tumor 01 19 Brain DECEASED 2010 c0c714ac-aa74-4702-8c3b-704f6e549276 TCGA-19-5960-01 TCGA-19-5960-01A-11D-1696-08 TCGA-19-5960-01A-11D-1697-05 TCGA-19-5960-01 TCGA-19-5960-01A-11D-1694-01 TCGA-19-5960-01 c0c714ac-aa74-4702-8c3b-704f6e549276 TCGA-19-5960-01 TCGA-19-5960-01A-11D-1694-01 c0c714ac-aa74-4702-8c3b-704f6e549276 +TCGA-19-A60I-01 TCGA-19-A60I-01 TCGA-19-A60I TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 39 TCGA-19-A60I-F63167 TCGA-19-A60I TCGA-19-A60I-01A -14437 107 0 541 Scheduled Follow-up Submission Stable Disease 2014-8-1 MALE Glioblastoma Multiforme (GBM) No C71.9 9440/3 C71.9 YES Tumor resection 160 NO NO NO false No TCGA-19-A60I.4E59C6BF-3B94-43C4-8269-1C0F271ACB7C.pdf A60I WITH TUMOR YES Stable Disease NO YES Primary Tumor 01 YES NO 19 Brain A LIVING 2012 TCGA-19-A60I-01A-12D-A33U-05 TCGA-19-A60I-01A-12D-A33S-01 TCGA-19-A60I-01A-12D-A33S-01 +TCGA-19-A6J4-01 TCGA-19-A6J4-01 TCGA-19-A6J4 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 68 TCGA-19-A6J4 TCGA-19-A6J4-01A -25058 77 121 0 2013-9-16 MALE Glioblastoma Multiforme (GBM) No C71.9 9440/3 C71.9 YES Tumor resection 200 NO true Yes, History of Prior Malignancy TCGA-19-A6J4.39E56F35-C780-4461-8FDF-D0754CF38351.pdf A6J4 WITH TUMOR NO Primary Tumor 01 YES NO 19 Brain A DECEASED 2013 TCGA-19-A6J4-01A-11D-A33U-05 TCGA-19-A6J4-01A-11D-A33S-01 TCGA-19-A6J4-01A-11D-A33S-01 +TCGA-19-A6J5-01 TCGA-19-A6J5-01 TCGA-19-A6J5 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES NO 40 TCGA-19-A6J5-F64477 TCGA-19-A6J5 TCGA-19-A6J5-01A -14970 444 0 868 784 0 Scheduled Follow-up Submission Progressive Disease 2014-9-3 MALE Glioblastoma Multiforme (GBM) No C71.9 9440/3 C71.9 YES Tumor resection 130 NO 100 NO Progression of Disease NO true No TCGA-19-A6J5.C90FBF2D-9022-4E19-8AB6-DD008E82F12B.pdf A6J5 Post-Adjuvant Therapy WITH TUMOR YES Stable Disease NO YES Primary Tumor 01 YES NO 19 Brain A LIVING 2012 TCGA-19-A6J5-01A-21D-A33U-05 TCGA-19-A6J5-01A-21D-A33S-01 TCGA-19-A6J5-01A-21D-A33S-01 +TCGA-26-1438-01 TCGA-26-1438-01 GBM GBM non-CIMP c15 TCGA-26-1438 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES NO 36 TCGA-26-1438-F26846 TCGA-26-1438 -13489 0 305 158 0 2009-6-2 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 100 Progression of Disease 1438 Pre-Adjuvant Therapy WITH TUMOR YES NO YES Primary Tumor 01 26 Brain LIVING 2008 TCGA-26-1438-01 TCGA-26-1438-01 TCGA-26-1438-01A-01D-0517-01 TCGA-26-1438-01A-01D-0517-01 +TCGA-26-1439-01 TCGA-26-1439-01 Kirc+ GBM non-CIMP c15 mutation cluster 14 TCGA-26-1439 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain NO NO 63 TCGA-26-1439-F26853 TCGA-26-1439 -23302 422 0 284 2010-12-27 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection Progression of Disease 1439 WITH TUMOR YES NO YES Primary Tumor 01 26 Brain DECEASED 2007 TCGA-26-1439-01 TCGA-26-1439-01A-01D-1353-08 TCGA-26-1439-01 TCGA-26-1439-01A-01D-1224-01 TCGA-26-1439-01A-01D-1224-01 +TCGA-26-1440-01 TCGA-26-1440-01 BRCA-LUAD+ GBM non-CIMP c15 GBM-like c2 TCGA-26-1440 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain NO NO 48 TCGA-26-1440-F26857 TCGA-26-1440 -17684 0 296 233 1 2009-6-2 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 80 Recurrence 1440 Pre-Adjuvant Therapy WITH TUMOR YES NO YES Primary Tumor 01 26 Brain LIVING 2008 TCGA-26-1440-01 TCGA-26-1440-01 TCGA-26-1440-01A-01D-0517-01 TCGA-26-1440-01A-01D-0517-01 +TCGA-26-1442-01 TCGA-26-1442-01 Squamous C10-GBM GBM CIMP c16 GBM-like c2 GBM-like c6 mutation cluster 5 TCGA-26-1442 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 43 TCGA-26-1442-F26889 TCGA-26-1442 TCGA-26-1442-01A -15950 0 953 1 2011-7-5 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 1.3 NO 80 1.3 TCGA-26-1442.d371cef9-7c69-4a72-93a2-33b9741c44cb.pdf 1442 Post-Adjuvant Therapy WITH TUMOR YES YES YES Primary Tumor 01 0.3 26 Brain A LIVING 2008 049eb561-95ee-4584-b9eb-0715c80e0a95 TCGA-26-1442-01 TCGA-26-1442-01A-01D-1696-08 TCGA-26-1442-01A-01D-1697-05 TCGA-26-1442-01 TCGA-26-1442-01A-01D-1694-01 TCGA-26-1442-01 049eb561-95ee-4584-b9eb-0715c80e0a95 TCGA-26-1442-01 TCGA-26-1442-01A-01D-1694-01 049eb561-95ee-4584-b9eb-0715c80e0a95 +TCGA-26-1443-01 TCGA-26-1443-01 GBM GBM non-CIMP c15 TCGA-26-1443 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain NO NO 60 TCGA-26-1443-F26862 TCGA-26-1443 -21990 0 217 217 2 2009-5-18 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 60 Progression of Disease 1443 Other WITH TUMOR YES NO YES Primary Tumor 01 26 Brain LIVING 2008 TCGA-26-1443-01 TCGA-26-1443-01 TCGA-26-1443-01A-01D-0517-01 TCGA-26-1443-01A-01D-0517-01 +TCGA-26-1799-01 TCGA-26-1799-01 GBM GBM non-CIMP c15 TCGA-26-1799 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain NO NO 68 TCGA-26-1799-F26867 TCGA-26-1799 -25171 285 0 285 213 2 2009-9-22 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 60 Recurrence 1799 Pre-Adjuvant Therapy WITH TUMOR YES NO YES Primary Tumor 01 26 Brain DECEASED 2008 TCGA-26-1799-01 TCGA-26-1799-01 TCGA-26-1799-01A-02D-0591-01 TCGA-26-1799-01A-02D-0591-01 +TCGA-26-5132-01 TCGA-26-5132-01 GBM C10-GBM GBM non-CIMP c15 GBM-like c2 GBM-like c6 mutation c1uster 9 TCGA-26-5132 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 74 TCGA-26-5132-F26871 TCGA-26-5132 TCGA-26-5132-01A -27196 0 286 2 2010-12-21 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 0.5 NO 60 1.5 TCGA-26-5132.a2075373-4a3f-4f19-bc80-a46537c888df.pdf 5132 Pre-Adjuvant Therapy TUMOR FREE YES NO YES Primary Tumor 01 0.4 26 Brain A LIVING 2009 31398055-e000-4ca1-a37d-aac2df5920b4 TCGA-26-5132-01 TCGA-26-5132-01A-01D-1486-08 TCGA-26-5132-01A-01D-1481-05 TCGA-26-5132-01 TCGA-26-5132-01A-01D-1479-01 TCGA-26-5132-01 31398055-e000-4ca1-a37d-aac2df5920b4 TCGA-26-5132-01 TCGA-26-5132-01A-01D-1479-01 31398055-e000-4ca1-a37d-aac2df5920b4 +TCGA-26-5133-01 TCGA-26-5133-01 Kirc+ C10-GBM GBM CIMP c16 GBM-like c2 GBM-like c6 mutation cluster 13 TCGA-26-5133 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain NO NO 59 TCGA-26-5133-F26876 TCGA-26-5133 -21560 0 452 370 1 2010-12-21 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 80 Progression of Disease 5133 TUMOR FREE YES NO YES Primary Tumor 01 26 Brain LIVING 2009 e64a2789-9b0e-41ca-9447-b17d8968f4cd TCGA-26-5133-01 TCGA-26-5133-01A-01D-1486-08 TCGA-26-5133-01A-01D-1481-05 TCGA-26-5133-01 TCGA-26-5133-01A-01D-1479-01 TCGA-26-5133-01 e64a2789-9b0e-41ca-9447-b17d8968f4cd TCGA-26-5133-01 TCGA-26-5133-01A-01D-1479-01 e64a2789-9b0e-41ca-9447-b17d8968f4cd +TCGA-26-5134-01 TCGA-26-5134-01 GBM C10-GBM GBM non-CIMP c15 GBM-like c2 GBM-like c6 mutation c1uster 9 TCGA-26-5134 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 74 TCGA-26-5134-F26882 TCGA-26-5134 TCGA-26-5134-01A -27111 0 167 2 2010-12-27 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 0.5 NO 60 0.5 TCGA-26-5134.bc937071-ca55-4002-b4fa-44326be2ac1b.pdf 5134 Pre-Adjuvant Therapy TUMOR FREE NO NO YES Primary Tumor 01 0.4 26 Brain A LIVING 2009 49280503-5136-4c10-8e42-061abbb6fa05 TCGA-26-5134-01 TCGA-26-5134-01A-01D-1486-08 TCGA-26-5134-01A-01D-1481-05 TCGA-26-5134-01 TCGA-26-5134-01A-01D-1479-01 TCGA-26-5134-01 49280503-5136-4c10-8e42-061abbb6fa05 TCGA-26-5134-01 TCGA-26-5134-01A-01D-1479-01 49280503-5136-4c10-8e42-061abbb6fa05 +TCGA-26-5135-01 TCGA-26-5135-01 GBM C10-GBM GBM non-CIMP c15 GBM-like c6 mutation c1uster 9 TCGA-26-5135 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 72 TCGA-26-5135-F68870 TCGA-26-5135 -26490 270 0 Scheduled Follow-up Submission 2014-12-22 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection NO 5135 NO Primary Tumor 01 26 Brain DECEASED 2009 cea49633-24f0-48c4-b2d0-fed47d5364e6 TCGA-26-5135-01 TCGA-26-5135-01A-01D-1486-08 TCGA-26-5135-01A-01D-1481-05 TCGA-26-5135-01 TCGA-26-5135-01A-01D-1479-01 TCGA-26-5135-01 cea49633-24f0-48c4-b2d0-fed47d5364e6 TCGA-26-5135-01 TCGA-26-5135-01A-01D-1479-01 cea49633-24f0-48c4-b2d0-fed47d5364e6 +TCGA-26-5136-01 TCGA-26-5136-01 GBM C10-GBM GBM non-CIMP c15 GBM-like c6 mutation cluster 3 TCGA-26-5136 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 78 TCGA-26-5136-F61146 TCGA-26-5136 TCGA-26-5136-01B -28496 577 0 37 Scheduled Follow-up Submission 2014-6-25 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 0.5 NO 1 NO TCGA-26-5136.9b31db65-32f7-49c1-bcc3-28455e2d3b6f.pdf 5136 WITH TUMOR NO Primary Tumor 01 0.1 26 Brain B DECEASED 2009 39b5a7b5-e2ec-442d-94c4-ba938ee79b97 TCGA-26-5136-01 TCGA-26-5136-01B-01D-1486-08 TCGA-26-5136-01B-01D-1481-05 TCGA-26-5136-01 TCGA-26-5136-01B-01D-1479-01 TCGA-26-5136-01 39b5a7b5-e2ec-442d-94c4-ba938ee79b97 TCGA-26-5136-01 TCGA-26-5136-01B-01D-1479-01 39b5a7b5-e2ec-442d-94c4-ba938ee79b97 +TCGA-26-5139-01 TCGA-26-5139-01 GBM C10-GBM GBM non-CIMP c15 GBM-like c6 mutation cluster 14 TCGA-26-5139 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 65 TCGA-26-5139-F26887 TCGA-26-5139 TCGA-26-5139-01A -23782 0 48 2 2010-12-27 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 0.4 NO 60 1 TCGA-26-5139.caf0e16d-4f03-48e2-b5df-04c0e5720b22.pdf 5139 Pre-Adjuvant Therapy WITH TUMOR NO NO NO Primary Tumor 01 0.2 26 Brain A LIVING 2010 10bfa2d8-228f-43d8-ae15-1f58c25d1be3 TCGA-26-5139-01 TCGA-26-5139-01A-01D-1486-08 TCGA-26-5139-01A-01D-1481-05 TCGA-26-5139-01 TCGA-26-5139-01A-01D-1479-01 TCGA-26-5139-01 10bfa2d8-228f-43d8-ae15-1f58c25d1be3 TCGA-26-5139-01 TCGA-26-5139-01A-01D-1479-01 10bfa2d8-228f-43d8-ae15-1f58c25d1be3 +TCGA-26-6173-01 TCGA-26-6173-01 BRCA-LUAD+ C10-GBM GBM non-CIMP c15 GBM-like c2 mutation cluster 12 TCGA-26-6173 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 57 TCGA-26-6173-F26895 TCGA-26-6173 TCGA-26-6173-01A -21093 0 241 1 2011-5-2 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 0.7 NO 80 1.8 TCGA-26-6173.436138e9-3119-4b20-bbb5-e494c68e48cd.pdf 6173 Pre-Adjuvant Therapy TUMOR FREE YES NO YES Primary Tumor 01 0.5 26 Brain A LIVING 2010 TCGA-26-6173-01A-11D-1845-08 TCGA-26-6173-01A-11D-1844-05 TCGA-26-6173-01A-11D-1842-01 TCGA-26-6173-01A-11D-1842-01 +TCGA-26-6174-01 TCGA-26-6174-01 Kirc+ C10-GBM GBM non-CIMP c15 GBM-like c2 mutation cluster 4 TCGA-26-6174 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 65 TCGA-26-6174-F26902 TCGA-26-6174 TCGA-26-6174-01A -23884 0 71 1 2011-5-2 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 0.4 NO 80 1 TCGA-26-6174.b5ef9cb5-a4c5-4d0e-9a94-279bbf646905.pdf 6174 Post-Adjuvant Therapy YES NO YES Primary Tumor 01 0.4 26 Brain A LIVING 2011 TCGA-26-6174-01A-21D-1845-08 TCGA-26-6174-01A-21D-1844-05 TCGA-26-6174-01A-21D-1842-01 TCGA-26-6174-01A-21D-1842-01 +TCGA-26-A7UX-01 TCGA-26-A7UX-01 TCGA-26-A7UX TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES NO 47 TCGA-26-A7UX-F68744 TCGA-26-A7UX TCGA-26-A7UX-01B -17365 141 0 588 407 Scheduled Follow-up Submission Stable Disease 2014-12-22 MALE Glioblastoma Multiforme (GBM) No C71.9 9440/3 C71.9 YES Tumor resection 90 NO NO Recurrence YES false No TCGA-26-A7UX.616868BB-6EDC-40F1-984B-95F279A7D60E.pdf A7UX WITH TUMOR YES Stable Disease NO YES Primary Tumor 01 YES NO 26 Brain B LIVING 2013 TCGA-26-A7UX-01B-11D-A392-05 TCGA-26-A7UX-01B-11D-A390-01 TCGA-26-A7UX-01B-11D-A390-01 +TCGA-27-1830-01 TCGA-27-1830-01 GBM C10-GBM GBM non-CIMP c15 GBM-like c2 GBM-like c6 mutation cluster 5 TCGA-27-1830 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain NO NO 57 TCGA-27-1830-F26906 TCGA-27-1830 -21131 154 0 146 124 1 2009-10-2 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 80 Recurrence 1830 Preoperative WITH TUMOR YES NO YES Primary Tumor 01 27 Brain DECEASED 2007 f2ab5972-46e6-4d13-bf8e-dffc1dc8a9e9 TCGA-27-1830-01 TCGA-27-1830-01A-01W-0643-08 TCGA-27-1830-01 TCGA-27-1830-01A-01D-0591-01 TCGA-27-1830-01 f2ab5972-46e6-4d13-bf8e-dffc1dc8a9e9 TCGA-27-1830-01 TCGA-27-1830-01A-01D-0591-01 f2ab5972-46e6-4d13-bf8e-dffc1dc8a9e9 +TCGA-27-1831-01 TCGA-27-1831-01 GBM C10-GBM GBM non-CIMP c15 GBM-like c2 GBM-like c6 mutation cluster 7 TCGA-27-1831 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain NO NO 66 TCGA-27-1831-F26913 TCGA-27-1831 -24447 505 0 505 144 1 2010-3-12 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 80 Progression of Disease 1831 Preoperative WITH TUMOR YES NO YES Primary Tumor 01 27 Brain DECEASED 2006 d577af6d-d9f1-435d-8429-73b5c5962238 TCGA-27-1831-01 TCGA-27-1831-01A-01D-1494-08 TCGA-27-1831-01 TCGA-27-1831-01A-01D-0784-01 TCGA-27-1831-01 d577af6d-d9f1-435d-8429-73b5c5962238 TCGA-27-1831-01 TCGA-27-1831-01A-01D-0784-01 d577af6d-d9f1-435d-8429-73b5c5962238 +TCGA-27-1832-01 TCGA-27-1832-01 GBM C10-GBM GBM non-CIMP c15 GBM-like c2 GBM-like c6 mutation c1uster 9 TCGA-27-1832 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES NO 59 TCGA-27-1832-F26920 TCGA-27-1832 TCGA-27-1832-01A -21678 300 0 0 176 0 2009-10-2 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 0.6 NO 100 1 Progression of Disease TCGA-27-1832.535d412f-ed27-467a-b373-8e26e940c07b.pdf 1832 Preoperative WITH TUMOR YES NO YES Primary Tumor 01 0.6 27 Brain A DECEASED 2007 11a0e909-11e7-40f3-be04-5bd2143ee6ab TCGA-27-1832-01 TCGA-27-1832-01A-01W-0643-08 TCGA-27-1832-01 TCGA-27-1832-01A-01D-0591-01 TCGA-27-1832-01 11a0e909-11e7-40f3-be04-5bd2143ee6ab TCGA-27-1832-01 TCGA-27-1832-01A-01D-0591-01 11a0e909-11e7-40f3-be04-5bd2143ee6ab +TCGA-27-1833-01 TCGA-27-1833-01 GBM C10-GBM GBM non-CIMP c15 GBM-like c2 mutation c1uster 9 TCGA-27-1833 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES NO 67 TCGA-27-1833-F26926 TCGA-27-1833 -24592 737 0 555 469 1 2009-10-2 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 80 Recurrence 1833 Preoperative WITH TUMOR YES NO YES Primary Tumor 01 27 Brain DECEASED 2006 TCGA-27-1833-01 TCGA-27-1833-01A-01W-0643-08 TCGA-27-1833-01 TCGA-27-1833-01A-01D-0591-01 TCGA-27-1833-01A-01D-0591-01 +TCGA-27-1834-01 TCGA-27-1834-01 GBM C10-GBM GBM non-CIMP c15 GBM-like c2 GBM-like c6 mutation c1uster 9 TCGA-27-1834 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES NO 56 TCGA-27-1834-F26934 TCGA-27-1834 TCGA-27-1834-01A -20568 1233 0 1008 335 1 2009-10-2 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 0.8 NO 80 1.5 Recurrence TCGA-27-1834.ae312505-e73d-44c5-a3df-4096fada821b.pdf 1834 Pre-Adjuvant Therapy WITH TUMOR YES NO YES Primary Tumor 01 0.8 27 Brain A DECEASED 2006 5f19c351-94d4-4164-aa7e-4a0f44640cbb TCGA-27-1834-01 TCGA-27-1834-01A-01W-0643-08 TCGA-27-1834-01 TCGA-27-1834-01A-01D-0591-01 TCGA-27-1834-01 5f19c351-94d4-4164-aa7e-4a0f44640cbb TCGA-27-1834-01 TCGA-27-1834-01A-01D-0591-01 5f19c351-94d4-4164-aa7e-4a0f44640cbb +TCGA-27-1835-01 TCGA-27-1835-01 GBM C10-GBM GBM non-CIMP c15 GBM-like c6 mutation cluster 5 TCGA-27-1835 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES NO 53 TCGA-27-1835-F26943 TCGA-27-1835 TCGA-27-1835-01A -19444 648 0 648 157 1 2010-3-12 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 0.3 NO 80 0.5 Progression of Disease TCGA-27-1835.5f1de659-7d7f-4a96-a9fc-058eff128012.pdf 1835 Preoperative WITH TUMOR YES NO YES Primary Tumor 01 0.1 27 Brain A DECEASED 2007 5cb5c8ef-740d-4f9d-b081-107a3e4390f6 TCGA-27-1835-01 TCGA-27-1835-01A-01D-1494-08 TCGA-27-1835-01 TCGA-27-1835-01A-01D-0784-01 TCGA-27-1835-01 5cb5c8ef-740d-4f9d-b081-107a3e4390f6 TCGA-27-1835-01 TCGA-27-1835-01A-01D-0784-01 5cb5c8ef-740d-4f9d-b081-107a3e4390f6 +TCGA-27-1836-01 TCGA-27-1836-01 GBM C10-GBM GBM non-CIMP c15 GBM-like c2 mutation cluster 5 TCGA-27-1836 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES NO 33 TCGA-27-1836-F26953 TCGA-27-1836 -12060 914 0 172 1 2010-3-12 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 80 Progression of Disease 1836 Preoperative WITH TUMOR YES NO YES Primary Tumor 01 27 Brain DECEASED 2007 TCGA-27-1836-01 TCGA-27-1836-01A-01D-1494-08 TCGA-27-1836-01 TCGA-27-1836-01A-01D-0784-01 TCGA-27-1836-01A-01D-0784-01 +TCGA-27-1837-01 TCGA-27-1837-01 GBM C10-GBM GBM non-CIMP c15 GBM-like c6 mutation cluster 12 TCGA-27-1837 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain NO NO 36 TCGA-27-1837-F26965 TCGA-27-1837 TCGA-27-1837-01A -13368 427 0 427 136 1 2010-3-12 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 0.4 NO 80 1 Progression of Disease TCGA-27-1837.fab9682a-0940-4815-8789-81799ff395f6.pdf 1837 Preoperative WITH TUMOR YES NO YES Primary Tumor 01 0.2 27 Brain A DECEASED 2007 6a85fda0-3e2d-4bd8-ba44-5ce821c39504 TCGA-27-1837-01 TCGA-27-1837-01A-01D-1494-08 TCGA-27-1837-01 TCGA-27-1837-01A-01D-0784-01 TCGA-27-1837-01 6a85fda0-3e2d-4bd8-ba44-5ce821c39504 TCGA-27-1837-01 TCGA-27-1837-01A-01D-0784-01 6a85fda0-3e2d-4bd8-ba44-5ce821c39504 +TCGA-27-1838-01 TCGA-27-1838-01 GBM GBM non-CIMP c15 mutation cluster 11 TCGA-27-1838 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain NO NO 59 TCGA-27-1838-F26973 TCGA-27-1838 -21706 350 0 350 119 1 2010-3-12 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 80 Progression of Disease 1838 Preoperative WITH TUMOR YES NO YES Primary Tumor 01 27 Brain DECEASED 2008 TCGA-27-1838-01 TCGA-27-1838-01A-01D-1494-08 TCGA-27-1838-01 TCGA-27-1838-01A-01D-0784-01 TCGA-27-1838-01A-01D-0784-01 +TCGA-27-2518-01 TCGA-27-2518-01 GBM C10-GBM GBM non-CIMP c15 GBM-like c2 mutation c1uster 9 TCGA-27-2518 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES NO 52 TCGA-27-2518-F26980 TCGA-27-2518 -19130 753 0 753 539 1 2010-3-12 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 80 Progression of Disease 2518 Preoperative WITH TUMOR YES NO YES Primary Tumor 01 27 Brain DECEASED 2007 TCGA-27-2518-01 TCGA-27-2518-01A-01D-1494-08 TCGA-27-2518-01 TCGA-27-2518-01A-01D-0784-01 TCGA-27-2518-01A-01D-0784-01 +TCGA-27-2519-01 TCGA-27-2519-01 GBM C10-GBM GBM non-CIMP c15 GBM-like c6 mutation cluster 5 TCGA-27-2519 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES NO 48 TCGA-27-2519-F26989 TCGA-27-2519 TCGA-27-2519-01A -17715 550 0 316 256 1 Scheduled Follow-up Submission 2014-11-13 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 0.4 NO 80 0.6 NO Progression of Disease TCGA-27-2519.fd339d84-0063-4f89-b81d-6c0cff9c28f5.pdf 2519 Preoperative WITH TUMOR NO Primary Tumor 01 0.3 27 Brain A DECEASED 2009 6870c515-1f0e-4481-82bf-7cde66292278 TCGA-27-2519-01 TCGA-27-2519-01A-01D-1494-08 TCGA-27-2519-01 TCGA-27-2519-01A-01D-0784-01 TCGA-27-2519-01 6870c515-1f0e-4481-82bf-7cde66292278 TCGA-27-2519-01 TCGA-27-2519-01A-01D-0784-01 6870c515-1f0e-4481-82bf-7cde66292278 +TCGA-27-2521-01 TCGA-27-2521-01 COAD-READ C10-GBM GBM CIMP c16 GBM-like c6 mutation cluster 5 TCGA-27-2521 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 34 TCGA-27-2521-F68018 TCGA-27-2521 TCGA-27-2521-01A -12685 510 0 316 1 Scheduled Follow-up Submission 2014-11-13 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 0.6 NO 80 0.7 NO TCGA-27-2521.3b0eadc8-f7c7-4458-a24f-5391314b8490.pdf 2521 Preoperative WITH TUMOR NO Primary Tumor 01 0.2 27 Brain A DECEASED 2009 9afb2af1-ea34-41ad-8a5d-5f24df2aba0b TCGA-27-2521-01 TCGA-27-2521-01A-01D-1494-08 TCGA-27-2521-01 TCGA-27-2521-01A-01D-0784-01 TCGA-27-2521-01 9afb2af1-ea34-41ad-8a5d-5f24df2aba0b TCGA-27-2521-01 TCGA-27-2521-01A-01D-0784-01 9afb2af1-ea34-41ad-8a5d-5f24df2aba0b +TCGA-27-2523-01 TCGA-27-2523-01 GBM C10-GBM GBM non-CIMP c15 GBM-like c6 mutation c1uster 9 TCGA-27-2523 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain NO NO 63 TCGA-27-2523-F27003 TCGA-27-2523 -23034 489 0 489 402 1 2010-3-12 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 80 Progression of Disease 2523 Preoperative WITH TUMOR YES NO YES Primary Tumor 01 27 Brain DECEASED 2005 b337121c-9821-4644-820e-b8c477f6c38a TCGA-27-2523-01 TCGA-27-2523-01A-01D-1494-08 TCGA-27-2523-01 TCGA-27-2523-01A-01D-0784-01 TCGA-27-2523-01 b337121c-9821-4644-820e-b8c477f6c38a TCGA-27-2523-01 TCGA-27-2523-01A-01D-0784-01 b337121c-9821-4644-820e-b8c477f6c38a +TCGA-27-2524-01 TCGA-27-2524-01 GBM C10-GBM GBM non-CIMP c15 GBM-like c6 mutation c1uster 9 TCGA-27-2524 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 56 TCGA-27-2524-F27013 TCGA-27-2524 TCGA-27-2524-01A -20555 231 0 231 1 2010-3-12 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 0.6 NO 80 0.9 TCGA-27-2524.db1e1c7f-a262-4c77-a593-a833eefebeb1.pdf 2524 Preoperative WITH TUMOR YES NO YES Primary Tumor 01 0.3 27 Brain A DECEASED 2008 8604df30-9170-41e2-8dfb-2feb813807ac TCGA-27-2524-01 TCGA-27-2524-01A-01D-1494-08 TCGA-27-2524-01 TCGA-27-2524-01A-01D-0784-01 TCGA-27-2524-01 8604df30-9170-41e2-8dfb-2feb813807ac TCGA-27-2524-01 TCGA-27-2524-01A-01D-0784-01 8604df30-9170-41e2-8dfb-2feb813807ac +TCGA-27-2526-01 TCGA-27-2526-01 GBM C10-GBM GBM non-CIMP c15 GBM-like c6 mutation c1uster 9 TCGA-27-2526 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 79 TCGA-27-2526-F27021 TCGA-27-2526 -28977 87 0 87 3 2010-3-15 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 40 2526 Preoperative WITH TUMOR YES NO NO Primary Tumor 01 27 Brain DECEASED 2007 f026a95f-89a7-464f-a8f2-ea036fe1774f TCGA-27-2526-01 TCGA-27-2526-01A-01D-1494-08 TCGA-27-2526-01 TCGA-27-2526-01A-01D-0784-01 TCGA-27-2526-01 f026a95f-89a7-464f-a8f2-ea036fe1774f TCGA-27-2526-01 TCGA-27-2526-01A-01D-0784-01 f026a95f-89a7-464f-a8f2-ea036fe1774f +TCGA-27-2527-01 TCGA-27-2527-01 Kirc+ GBM non-CIMP c15 mutation cluster 4 TCGA-27-2527 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 81 TCGA-27-2527-F27024 TCGA-27-2527 -29619 438 0 438 1 2010-3-15 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 80 2527 Preoperative WITH TUMOR YES NO YES Primary Tumor 01 27 Brain DECEASED 2007 TCGA-27-2527-01 TCGA-27-2527-01A-01D-1494-08 TCGA-27-2527-01 TCGA-27-2527-01A-01D-0784-01 TCGA-27-2527-01A-01D-0784-01 +TCGA-27-2528-01 TCGA-27-2528-01 GBM C10-GBM GBM non-CIMP c15 GBM-like c2 GBM-like c6 mutation cluster 14 TCGA-27-2528 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES NO 62 TCGA-27-2528-F27030 TCGA-27-2528 TCGA-27-2528-01A -22867 480 0 480 72 1 2010-3-15 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 0.7 NO 80 1 Progression of Disease TCGA-27-2528.08b4c97d-4213-4897-bf40-0327eefe8385.pdf 2528 Preoperative WITH TUMOR YES NO YES Primary Tumor 01 0.3 27 Brain A DECEASED 2008 2de8f5dd-decd-47f4-856a-bda678ee6ab8 TCGA-27-2528-01 TCGA-27-2528-01A-01D-1494-08 TCGA-27-2528-01 TCGA-27-2528-01A-01D-0784-01 TCGA-27-2528-01 2de8f5dd-decd-47f4-856a-bda678ee6ab8 TCGA-27-2528-01 TCGA-27-2528-01A-01D-0784-01 2de8f5dd-decd-47f4-856a-bda678ee6ab8 +TCGA-28-1745-01 TCGA-28-1745-01 Quiet GBM non-CIMP c15 TCGA-28-1745 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain NO NO 76 TCGA-28-1745-F27038 TCGA-28-1745 -27817 0 345 317 1 2009-11-30 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 60 Progression of Disease 1745 Post-Adjuvant Therapy WITH TUMOR YES NO YES Primary Tumor 01 28 Brain LIVING 2008 TCGA-28-1745-01 +TCGA-28-1746-01 TCGA-28-1746-01 BRCA-LUAD+ GBM non-CIMP c15 GBM-like c2 TCGA-28-1746 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 77 TCGA-28-1746-F27045 TCGA-28-1746 -28302 0 6 1 2009-11-30 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 80 1746 Pre-Adjuvant Therapy YES NO YES Primary Tumor 01 28 Brain LIVING 2008 TCGA-28-1746-01 TCGA-28-1746-01 TCGA-28-1746-01A-01D-0591-01 TCGA-28-1746-01A-01D-0591-01 +TCGA-28-1747-01 TCGA-28-1747-01 GBM C10-GBM GBM non-CIMP c15 GBM-like c2 GBM-like c6 mutation cluster 14 TCGA-28-1747 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 44 TCGA-28-1747-F27047 TCGA-28-1747 TCGA-28-1747-01C -16301 77 0 77 2010-3-3 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Fine needle aspiration biopsy 0.9 NO 0.9 TCGA-28-1747.f1f20dd1-f50b-4f3c-a7fa-8307f08d0757.pdf 1747 YES NO YES Primary Tumor 01 0.4 28 Brain C DECEASED 2008 06fcbf45-4b5a-4c5a-976e-9b7bf57479dd TCGA-28-1747-01 TCGA-28-1747-01C-01D-1494-08 TCGA-28-1747-01 TCGA-28-1747-01C-01D-0784-01 TCGA-28-1747-01 06fcbf45-4b5a-4c5a-976e-9b7bf57479dd TCGA-28-1747-01 TCGA-28-1747-01C-01D-0784-01 06fcbf45-4b5a-4c5a-976e-9b7bf57479dd +TCGA-28-1749-01 TCGA-28-1749-01 GBM GBM non-CIMP c15 TCGA-28-1749 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain NO NO 73 TCGA-28-1749-F27051 TCGA-28-1749 -26765 0 280 280 1 2009-11-30 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 80 Progression of Disease 1749 Post-Adjuvant Therapy WITH TUMOR YES NO YES Primary Tumor 01 28 Brain LIVING 2009 TCGA-28-1749-01 TCGA-28-1749-01 TCGA-28-1749-01A-01D-0591-01 TCGA-28-1749-01A-01D-0591-01 +TCGA-28-1750-01 TCGA-28-1750-01 GBM GBM non-CIMP c15 GBM-like c2 TCGA-28-1750 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain NO YES 40 TCGA-28-1750-F27057 TCGA-28-1750 -14817 0 254 116 2 2009-11-30 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 60 Progression of Disease 1750 Post-Adjuvant Therapy WITH TUMOR YES NO YES Primary Tumor 01 28 Brain LIVING 2009 TCGA-28-1750-01 TCGA-28-1750-01 TCGA-28-1750-01A-01D-0591-01 TCGA-28-1750-01A-01D-0591-01 +TCGA-28-1751-01 TCGA-28-1751-01 GBM GBM non-CIMP c15 TCGA-28-1751 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 61 TCGA-28-1751-F27064 TCGA-28-1751 -22291 0 232 219 1 2009-11-30 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 80 Progression of Disease 1751 Post-Adjuvant Therapy WITH TUMOR YES NO YES Primary Tumor 01 28 Brain LIVING 2009 TCGA-28-1751-01 TCGA-28-1751-01 TCGA-28-1751-01A-02D-0591-01 TCGA-28-1751-01A-02D-0591-01 +TCGA-28-1752-01 TCGA-28-1752-01 GBM GBM non-CIMP c15 GBM-like c2 TCGA-28-1752 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 42 TCGA-28-1752-F27071 TCGA-28-1752 -15565 0 258 1 2009-11-30 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 80 1752 Post-Adjuvant Therapy WITH TUMOR YES NO YES Primary Tumor 01 28 Brain LIVING 2009 TCGA-28-1752-01 TCGA-28-1752-01 TCGA-28-1752-01A-01D-0591-01 TCGA-28-1752-01A-01D-0591-01 +TCGA-28-1753-01 TCGA-28-1753-01 GBM C10-GBM GBM non-CIMP c15 KIRC-like c1 GBM-like c6 mutation cluster 5 TCGA-28-1753 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 53 TCGA-28-1753-F27079 TCGA-28-1753 TCGA-28-1753-01A -19366 0 37 2010-3-3 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 0.6 NO 1.5 TCGA-28-1753.e6085b8d-d1b3-4f2d-a0f4-c8c823acc762.pdf 1753 WITH TUMOR NO NO YES Primary Tumor 01 0.4 28 Brain A LIVING 2009 23b23702-8e0f-4b4c-ad92-ce7ea44939e6 TCGA-28-1753-01 TCGA-28-1753-01A-01D-1494-08 TCGA-28-1753-01 TCGA-28-1753-01A-01D-0784-01 TCGA-28-1753-01 23b23702-8e0f-4b4c-ad92-ce7ea44939e6 TCGA-28-1753-01 TCGA-28-1753-01A-01D-0784-01 23b23702-8e0f-4b4c-ad92-ce7ea44939e6 +TCGA-28-1755-01 TCGA-28-1755-01 GBM GBM non-CIMP c15 TCGA-28-1755 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 52 TCGA-28-1755-F27082 TCGA-28-1755 -19263 47 0 47 2 2009-11-30 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 60 1755 Post-Adjuvant Therapy WITH TUMOR YES NO YES Primary Tumor 01 28 Brain DECEASED 2009 TCGA-28-1755-01 TCGA-28-1755-01 TCGA-28-1755-01A-01D-0591-01 TCGA-28-1755-01A-01D-0591-01 +TCGA-28-1756-01 TCGA-28-1756-01 Squamous GBM CIMP c16 TCGA-28-1756 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 78 TCGA-28-1756-F27086 TCGA-28-1756 -28649 0 86 2010-3-3 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 80 1756 Other TUMOR FREE YES NO YES Primary Tumor 01 28 Brain LIVING 2009 TCGA-28-1756-01 TCGA-28-1756-01 TCGA-28-1756-01C-01D-0784-01 TCGA-28-1756-01C-01D-0784-01 +TCGA-28-1757-01 TCGA-28-1757-01 GBM GBM non-CIMP c15 GBM-like c2 TCGA-28-1757 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 71 TCGA-28-1757 -26189 0 4 0 2009-11-30 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 80 1757 Pre-Adjuvant Therapy NO Primary Tumor 01 28 Brain LIVING 2009 TCGA-28-1757-01 TCGA-28-1757-01 TCGA-28-1757-01A-02D-0591-01 TCGA-28-1757-01A-02D-0591-01 +TCGA-28-1760-01 TCGA-28-1760-01 BRCA-LUAD+ GBM non-CIMP c15 GBM-like c2 TCGA-28-1760 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain NO NO 48 TCGA-28-1760-F27092 TCGA-28-1760 -17758 0 143 105 2009-11-30 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection Progression of Disease 1760 WITH TUMOR YES NO YES Primary Tumor 01 28 Brain LIVING 2009 TCGA-28-1760-01 +TCGA-28-2499-01 TCGA-28-2499-01 GBM non-CIMP c15 GBM-like c6 mutation c1uster 9 TCGA-28-2499 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 59 TCGA-28-2499 TCGA-28-2499-01A -21838 0 95 2012-1-17 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES 0.4 NO 0.6 TCGA-28-2499.5a1dd9da-df75-41b7-a37f-3005b4e1d7b9.pdf 2499 NO Primary Tumor 01 0.3 28 Brain A 2009 1dd740dc-2752-4511-ac12-45766c8e2737 TCGA-28-2499-01A-01D-1494-08 TCGA-28-2499-01 1dd740dc-2752-4511-ac12-45766c8e2737 1dd740dc-2752-4511-ac12-45766c8e2737 +TCGA-28-2501-01 TCGA-28-2501-01 GBM C10-GBM GBM non-CIMP c15 GBM-like c2 mutation c1uster 9 TCGA-28-2501 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain Primary Tumor 01 TCGA-28-2501-01 TCGA-28-2501-01A-01D-1696-08 TCGA-28-2501-01A-01D-1697-05 TCGA-28-2501-01 TCGA-28-2501-01A-01D-1694-01 TCGA-28-2501-01A-01D-1694-01 +TCGA-28-2502-01 TCGA-28-2502-01 GBM GBM non-CIMP c15 mutation c1uster 9 TCGA-28-2502 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 65 TCGA-28-2502-F27098 TCGA-28-2502 -23807 0 20 2010-3-3 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 20 2502 Post-Adjuvant Therapy NO NO YES Primary Tumor 01 28 Brain LIVING 2009 TCGA-28-2502-01 TCGA-28-2502-01B-01D-1494-08 TCGA-28-2502-01 TCGA-28-2502-01B-01D-0784-01 TCGA-28-2502-01B-01D-0784-01 +TCGA-28-2506-01 TCGA-28-2506-01 GBM GBM non-CIMP c15 TCGA-28-2506 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain NO NO 63 TCGA-28-2506-F27101 TCGA-28-2506 -23292 0 205 84 2010-3-5 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 80 Progression of Disease 2506 Post-Adjuvant Therapy WITH TUMOR YES NO YES Primary Tumor 01 28 Brain LIVING 2009 TCGA-28-2506-01 TCGA-28-2506-01 TCGA-28-2506-01A-02D-0784-01 TCGA-28-2506-01A-02D-0784-01 +TCGA-28-2509-01 TCGA-28-2509-01 BRCA-LUAD+ C10-GBM GBM non-CIMP c15 GBM-like c6 mutation cluster 5 TCGA-28-2509 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 77 TCGA-28-2509-F27107 TCGA-28-2509 TCGA-28-2509-01A -28240 0 145 2010-3-5 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 0.5 NO 80 0.8 TCGA-28-2509.31042590-2b1f-4926-a12e-5e0a22bdb420.pdf 2509 Post-Adjuvant Therapy YES NO YES Primary Tumor 01 0.3 28 Brain A LIVING 2009 0cbec58e-f95e-4c60-a85d-210dc56bdf3c TCGA-28-2509-01 TCGA-28-2509-01A-01D-1494-08 TCGA-28-2509-01 TCGA-28-2509-01A-01D-0784-01 TCGA-28-2509-01 0cbec58e-f95e-4c60-a85d-210dc56bdf3c TCGA-28-2509-01 TCGA-28-2509-01A-01D-0784-01 0cbec58e-f95e-4c60-a85d-210dc56bdf3c +TCGA-28-2510-01 TCGA-28-2510-01 GBM C10-GBM Low purity c2 GBM-like c6 mutation c1uster 9 TCGA-28-2510 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain TCGA-28-2510-01A 0.9 NO 2.1 TCGA-28-2510.ba885e83-e893-407b-b080-6c68f74b758e.pdf Primary Tumor 01 0.4 A 8880d24b-a72e-4472-8d14-19e58e0a61ae TCGA-28-2510-01 TCGA-28-2510-01A-01D-1696-08 TCGA-28-2510-01A-01D-1697-05 TCGA-28-2510-01 TCGA-28-2510-01A-01D-1694-01 TCGA-28-2510-01 8880d24b-a72e-4472-8d14-19e58e0a61ae TCGA-28-2510-01 TCGA-28-2510-01A-01D-1694-01 8880d24b-a72e-4472-8d14-19e58e0a61ae +TCGA-28-2513-01 TCGA-28-2513-01 GBM C10-GBM GBM non-CIMP c15 GBM-like c6 mutation cluster 4 TCGA-28-2513 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES YES 69 TCGA-28-2513-F27113 TCGA-28-2513 TCGA-28-2513-01A -25421 0 222 75 2010-3-5 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 0.4 NO 80 0.6 Progression of Disease TCGA-28-2513.c7ba045f-48dd-42ea-8da8-a5811b74e9fa.pdf 2513 Post-Adjuvant Therapy WITH TUMOR YES NO YES Primary Tumor 01 0.4 28 Brain A LIVING 2009 9b9ba1cf-67be-4d74-90c5-fd86f4a5317f TCGA-28-2513-01 TCGA-28-2513-01A-01D-1494-08 TCGA-28-2513-01 TCGA-28-2513-01A-01D-0784-01 TCGA-28-2513-01 9b9ba1cf-67be-4d74-90c5-fd86f4a5317f TCGA-28-2513-01 TCGA-28-2513-01A-01D-0784-01 9b9ba1cf-67be-4d74-90c5-fd86f4a5317f +TCGA-28-2514-01 TCGA-28-2514-01 GBM C10-GBM GBM non-CIMP c15 GBM-like c6 mutation c1uster 9 TCGA-28-2514 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 45 TCGA-28-2514-F27120 TCGA-28-2514 TCGA-28-2514-01A -16737 0 160 2010-3-5 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 1 NO 60 1.4 TCGA-28-2514.d2cbb615-c4b7-4ae0-9de7-b31241302ce7.pdf 2514 Post-Adjuvant Therapy YES NO YES Primary Tumor 01 0.3 28 Brain A LIVING 2009 94985059-d992-4f1f-ae67-36cf287f443d TCGA-28-2514-01 TCGA-28-2514-01A-02D-1494-08 TCGA-28-2514-01 TCGA-28-2514-01A-02D-0784-01 TCGA-28-2514-01 94985059-d992-4f1f-ae67-36cf287f443d TCGA-28-2514-01 TCGA-28-2514-01A-02D-0784-01 94985059-d992-4f1f-ae67-36cf287f443d +TCGA-28-5204-01 TCGA-28-5204-01 GBM C10-GBM GBM non-CIMP c15 GBM-like c6 mutation c1uster 9 TCGA-28-5204 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 72 TCGA-28-5204-F28858 TCGA-28-5204 TCGA-28-5204-01A -26490 454 0 2011-7-22 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 0.5 NO 80 1 TCGA-28-5204.3e248730-bc16-4d33-a304-2e1093a3b45c.pdf 5204 Pre-Adjuvant Therapy WITH TUMOR YES NO YES Primary Tumor 01 0.2 28 Brain A DECEASED 2009 6f987110-3dbf-4f06-952a-e1aea4b81b44 TCGA-28-5204-01 TCGA-28-5204-01A-01D-1486-08 TCGA-28-5204-01A-01D-1481-05 TCGA-28-5204-01 TCGA-28-5204-01A-01D-1479-01 TCGA-28-5204-01 6f987110-3dbf-4f06-952a-e1aea4b81b44 TCGA-28-5204-01 TCGA-28-5204-01A-01D-1479-01 6f987110-3dbf-4f06-952a-e1aea4b81b44 +TCGA-28-5207-01 TCGA-28-5207-01 GBM C10-GBM GBM non-CIMP c15 GBM-like c6 mutation cluster 8 TCGA-28-5207 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 71 TCGA-28-5207-F28862 TCGA-28-5207 TCGA-28-5207-01A -25975 343 0 275 2011-7-22 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 0.8 NO 70 1 TCGA-28-5207.0bafbc8d-023d-4c05-a802-5c32767c0e55.pdf 5207 Pre-Adjuvant Therapy WITH TUMOR YES NO YES Primary Tumor 01 0.3 28 Brain A DECEASED 2010 6251a0df-d7ff-4a1b-9aa6-7d12ea04bd2c TCGA-28-5207-01 TCGA-28-5207-01A-01D-1486-08 TCGA-28-5207-01A-01D-1481-05 TCGA-28-5207-01 TCGA-28-5207-01A-01D-1479-01 TCGA-28-5207-01 6251a0df-d7ff-4a1b-9aa6-7d12ea04bd2c TCGA-28-5207-01 TCGA-28-5207-01A-01D-1479-01 6251a0df-d7ff-4a1b-9aa6-7d12ea04bd2c +TCGA-28-5208-01 TCGA-28-5208-01 GBM C10-GBM GBM non-CIMP c15 GBM-like c2 GBM-like c6 mutation c1uster 9 TCGA-28-5208 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain NO YES 52 TCGA-28-5208-F45609 TCGA-28-5208 TCGA-28-5208-01A -19053 544 0 474 Scheduled Follow-up Submission Progressive Disease 2013-7-18 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 0.7 NO 70 1.1 NO Progression of Disease TCGA-28-5208.c683e7a3-f811-4f52-bcce-cf6eea75df12.pdf 5208 Pre-Adjuvant Therapy WITH TUMOR YES Progressive Disease NO YES Primary Tumor 01 0.4 28 Brain A DECEASED 2010 63f989ff-890b-4db8-973f-ab675912635f TCGA-28-5208-01 TCGA-28-5208-01A-01D-1486-08 TCGA-28-5208-01A-01D-1481-05 TCGA-28-5208-01 TCGA-28-5208-01A-01D-1479-01 TCGA-28-5208-01 63f989ff-890b-4db8-973f-ab675912635f TCGA-28-5208-01 TCGA-28-5208-01A-01D-1479-01 63f989ff-890b-4db8-973f-ab675912635f +TCGA-28-5209-01 TCGA-28-5209-01 GBM C10-GBM GBM non-CIMP c15 GBM-like c6 mutation cluster 14 TCGA-28-5209 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 66 TCGA-28-5209-F28876 TCGA-28-5209 TCGA-28-5209-01A -24362 0 77 2011-7-22 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 0.4 NO 0.7 TCGA-28-5209.0bad36fe-5622-4d30-8005-24c247a4ce32.pdf 5209 YES NO YES Primary Tumor 01 0.1 28 Brain A LIVING 2010 7a904020-5345-4d1f-8493-8dd07d45faa3 TCGA-28-5209-01 TCGA-28-5209-01A-01D-1486-08 TCGA-28-5209-01A-01D-1481-05 TCGA-28-5209-01 TCGA-28-5209-01A-01D-1479-01 TCGA-28-5209-01 7a904020-5345-4d1f-8493-8dd07d45faa3 TCGA-28-5209-01 TCGA-28-5209-01A-01D-1479-01 7a904020-5345-4d1f-8493-8dd07d45faa3 +TCGA-28-5211-01 TCGA-28-5211-01 GBM GBM non-CIMP c15 mutation c1uster 9 TCGA-28-5211 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES NO 42 TCGA-28-5211-F28880 TCGA-28-5211 TCGA-28-5211-01C -15507 0 358 225 2011-7-22 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 0.3 NO 100 1 Progression of Disease TCGA-28-5211.67615e78-229a-4923-956e-3e7e5e25bb15.pdf 5211 Pre-Adjuvant Therapy WITH TUMOR YES NO YES Primary Tumor 01 0.2 28 Brain C LIVING 2010 TCGA-28-5211-01C-11D-1845-08 TCGA-28-5211-01C-11D-1844-05 TCGA-28-5211-01C-11D-1842-01 TCGA-28-5211-01C-11D-1842-01 +TCGA-28-5213-01 TCGA-28-5213-01 GBM C10-GBM GBM non-CIMP c15 GBM-like c6 mutation cluster 14 TCGA-28-5213 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 72 TCGA-28-5213-F45674 TCGA-28-5213 -26491 0 951 2013-7-24 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 80 5213 Pre-Adjuvant Therapy WITH TUMOR YES NO YES Primary Tumor 01 28 Brain LIVING 2010 ff4d089b-8f65-46f1-b3bc-dab1271725fb TCGA-28-5213-01 TCGA-28-5213-01A-01D-1486-08 TCGA-28-5213-01A-01D-1481-05 TCGA-28-5213-01 TCGA-28-5213-01A-01D-1479-01 TCGA-28-5213-01 ff4d089b-8f65-46f1-b3bc-dab1271725fb TCGA-28-5213-01 TCGA-28-5213-01A-01D-1479-01 ff4d089b-8f65-46f1-b3bc-dab1271725fb +TCGA-28-5214-01 TCGA-28-5214-01 GBM C10-GBM GBM non-CIMP c15 GBM-like c2 mutation c1uster 9 TCGA-28-5214 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES YES 53 TCGA-28-5214-F28890 TCGA-28-5214 -19520 713 0 432 247 2013-7-24 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 70 NO Progression of Disease 5214 Pre-Adjuvant Therapy WITH TUMOR YES NO YES Primary Tumor 01 28 Brain DECEASED 2010 TCGA-28-5214-01 TCGA-28-5214-01A-01D-1486-08 TCGA-28-5214-01A-01D-1481-05 TCGA-28-5214-01 TCGA-28-5214-01A-01D-1479-01 TCGA-28-5214-01A-01D-1479-01 +TCGA-28-5215-01 TCGA-28-5215-01 Kirc+ C10-GBM GBM non-CIMP c15 GBM-like c6 mutation c1uster 9 TCGA-28-5215 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES NO 62 TCGA-28-5215-F28897 TCGA-28-5215 TCGA-28-5215-01A -22686 335 0 237 164 2011-7-22 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 0.5 NO 90 0.8 Progression of Disease TCGA-28-5215.3a06f0a3-5eb6-4fef-948b-8067976886e0.pdf 5215 Pre-Adjuvant Therapy WITH TUMOR YES NO YES Primary Tumor 01 0.2 28 Brain A DECEASED 2010 05a2eea8-f366-4ae7-80f3-03324fb6e66e TCGA-28-5215-01 TCGA-28-5215-01A-01D-1486-08 TCGA-28-5215-01A-01D-1481-05 TCGA-28-5215-01 TCGA-28-5215-01A-01D-1479-01 TCGA-28-5215-01 05a2eea8-f366-4ae7-80f3-03324fb6e66e TCGA-28-5215-01 TCGA-28-5215-01A-01D-1479-01 05a2eea8-f366-4ae7-80f3-03324fb6e66e +TCGA-28-5216-01 TCGA-28-5216-01 Kirc+ C10-GBM GBM non-CIMP c15 GBM-like c6 mutation cluster 5 TCGA-28-5216 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 52 TCGA-28-5216-F45765 TCGA-28-5216 TCGA-28-5216-01A -19239 0 415 2013-7-24 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 0.6 NO 80 0.8 NO NO TCGA-28-5216.69f3d1ff-0b60-4841-b83c-ab9e707b5ff2.pdf 5216 Pre-Adjuvant Therapy WITH TUMOR YES NO YES Primary Tumor 01 0.1 28 Brain A LIVING 2010 570d3a26-6bcf-4442-aba9-95a01e84aa16 TCGA-28-5216-01 TCGA-28-5216-01A-01D-1486-08 TCGA-28-5216-01A-01D-1481-05 TCGA-28-5216-01 TCGA-28-5216-01A-01D-1479-01 TCGA-28-5216-01 570d3a26-6bcf-4442-aba9-95a01e84aa16 TCGA-28-5216-01 TCGA-28-5216-01A-01D-1479-01 570d3a26-6bcf-4442-aba9-95a01e84aa16 +TCGA-28-5218-01 TCGA-28-5218-01 High C10-GBM GBM non-CIMP c15 GBM-like c6 mutation c1uster 9 TCGA-28-5218 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 63 TCGA-28-5218-F28906 TCGA-28-5218 TCGA-28-5218-01A -23096 157 0 128 2011-7-22 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 0.6 NO 0.7 TCGA-28-5218.461dabe9-5c81-4bce-abd6-ba60a652094d.pdf 5218 YES NO YES Primary Tumor 01 0.2 28 Brain A DECEASED 2010 9146c99d-fa73-433d-8460-f2587ce674bb TCGA-28-5218-01 TCGA-28-5218-01A-01D-1486-08 TCGA-28-5218-01A-01D-1481-05 TCGA-28-5218-01 TCGA-28-5218-01A-01D-1479-01 TCGA-28-5218-01 9146c99d-fa73-433d-8460-f2587ce674bb TCGA-28-5218-01 TCGA-28-5218-01A-01D-1479-01 9146c99d-fa73-433d-8460-f2587ce674bb +TCGA-28-5219-01 TCGA-28-5219-01 GBM GBM non-CIMP c15 mutation cluster 11 TCGA-28-5219 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 47 TCGA-28-5219-F28910 TCGA-28-5219 -17254 0 690 258 2013-7-24 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 70 NO Progression of Disease 5219 Pre-Adjuvant Therapy TUMOR FREE YES NO YES Primary Tumor 01 28 Brain LIVING 2010 TCGA-28-5219-01 TCGA-28-5219-01A-01D-1486-08 TCGA-28-5219-01A-01D-1481-05 TCGA-28-5219-01 TCGA-28-5219-01A-01D-1479-01 TCGA-28-5219-01A-01D-1479-01 +TCGA-28-5220-01 TCGA-28-5220-01 GBM C10-GBM GBM non-CIMP c15 GBM-like c6 mutation cluster 12 TCGA-28-5220 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 67 TCGA-28-5220-F28914 TCGA-28-5220 TCGA-28-5220-01A -24622 388 0 319 262 2013-7-24 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 0.4 NO 90 0.7 NO Progression of Disease TCGA-28-5220.29d77292-b31a-4839-a603-63f355f71368.pdf 5220 Pre-Adjuvant Therapy WITH TUMOR YES NO YES Primary Tumor 01 0.1 28 Brain A DECEASED 2010 2d1481b0-3bdd-4b9e-b1e1-813d0c624c25 TCGA-28-5220-01 TCGA-28-5220-01A-01D-1486-08 TCGA-28-5220-01A-01D-1481-05 TCGA-28-5220-01 TCGA-28-5220-01A-01D-1479-01 TCGA-28-5220-01 2d1481b0-3bdd-4b9e-b1e1-813d0c624c25 TCGA-28-5220-01 TCGA-28-5220-01A-01D-1479-01 2d1481b0-3bdd-4b9e-b1e1-813d0c624c25 +TCGA-28-6450-01 TCGA-28-6450-01 GBM GBM non-CIMP c15 mutation cluster 4 TCGA-28-6450 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 60 TCGA-28-6450-F28918 TCGA-28-6450 -22177 165 0 165 2011-7-22 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 6450 WITH TUMOR YES NO YES Primary Tumor 01 28 Brain DECEASED 2010 TCGA-28-6450-01 TCGA-28-6450-01A-11D-1696-08 TCGA-28-6450-01A-11D-1697-05 TCGA-28-6450-01 TCGA-28-6450-01A-11D-1694-01 TCGA-28-6450-01A-11D-1694-01 +TCGA-32-1970-01 TCGA-32-1970-01 GBM C10-GBM GBM non-CIMP c15 GBM-like c2 GBM-like c6 mutation cluster 8 TCGA-32-1970 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain NO NO 59 TCGA-32-1970-F27719 TCGA-32-1970 -21613 468 0 468 408 1 2010-3-15 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection Progression of Disease 1970 Pre-Adjuvant Therapy WITH TUMOR YES NO YES Primary Tumor 01 32 Brain DECEASED 2005 a344de7b-5980-4612-9d58-1c8058a2bfd9 TCGA-32-1970-01 TCGA-32-1970-01A-01D-1494-08 TCGA-32-1970-01 TCGA-32-1970-01A-01D-0784-01 TCGA-32-1970-01 a344de7b-5980-4612-9d58-1c8058a2bfd9 TCGA-32-1970-01 TCGA-32-1970-01A-01D-0784-01 a344de7b-5980-4612-9d58-1c8058a2bfd9 +TCGA-32-1973-01 TCGA-32-1973-01 Kirc+ GBM non-CIMP c15 TCGA-32-1973 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain NO NO 21 TCGA-32-1973-F27724 TCGA-32-1973 -7756 641 0 641 507 2010-12-14 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection Progression of Disease 1973 WITH TUMOR YES NO YES Primary Tumor 01 32 Brain DECEASED 2008 TCGA-32-1973-01 TCGA-32-1973-01 TCGA-32-1973-01A-01D-1224-01 TCGA-32-1973-01A-01D-1224-01 +TCGA-32-1976-01 TCGA-32-1976-01 GBM GBM non-CIMP c15 GBM-like c2 TCGA-32-1976 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 65 TCGA-32-1976-F27734 TCGA-32-1976 -23798 15 0 15 2010-3-8 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 60 1976 Pre-Adjuvant Therapy NO NO NO Primary Tumor 01 32 Brain DECEASED 2008 TCGA-32-1976-01 TCGA-32-1976-01 TCGA-32-1976-01A-01D-0784-01 TCGA-32-1976-01A-01D-0784-01 +TCGA-32-1977-01 TCGA-32-1977-01 GBM GBM non-CIMP c15 mutation cluster 14 TCGA-32-1977 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 63 TCGA-32-1977-F15815 TCGA-32-1977 -23205 0 3 Scheduled Follow-up Submission 2011-8-15 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 1977 WITH TUMOR NO Primary Tumor 01 32 Brain LIVING 2009 TCGA-32-1977-01 TCGA-32-1977-01A-01D-1353-08 TCGA-32-1977-01 TCGA-32-1977-01A-01D-1224-01 TCGA-32-1977-01A-01D-1224-01 +TCGA-32-1978-01 TCGA-32-1978-01 BRCA-LUAD+ GBM non-CIMP c15 GBM-like c2 TCGA-32-1978 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 57 TCGA-32-1978-F27737 TCGA-32-1978 -21054 482 0 482 2010-12-20 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 1978 WITH TUMOR NO Primary Tumor 01 32 Brain DECEASED 2008 TCGA-32-1978-01 TCGA-32-1978-01 TCGA-32-1978-01A-01D-1224-01 TCGA-32-1978-01A-01D-1224-01 +TCGA-32-1979-01 TCGA-32-1979-01 GBM GBM non-CIMP c15 mutation cluster 14 TCGA-32-1979 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 69 TCGA-32-1979-F27846 TCGA-32-1979 -25252 593 0 593 265 2011-6-13 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection Progression of Disease 1979 WITH TUMOR NO Primary Tumor 01 32 Brain DECEASED 2008 TCGA-32-1979-01 TCGA-32-1979-01A-01D-1696-08 TCGA-32-1979-01A-01D-1697-05 TCGA-32-1979-01 TCGA-32-1979-01A-01D-1694-01 TCGA-32-1979-01A-01D-1694-01 +TCGA-32-1980-01 TCGA-32-1980-01 Quiet C5-KIRC Low purity c2 GBM-like c6 mutation c1uster 9 TCGA-32-1980 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 72 TCGA-32-1980-F27848 TCGA-32-1980 -26467 36 0 36 2011-6-13 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 1980 WITH TUMOR NO NO NO Primary Tumor 01 32 Brain DECEASED 2008 ebe88950-c783-4487-9bfc-ccaaeacf256c TCGA-32-1980-01 TCGA-32-1980-01A-01D-1696-08 TCGA-32-1980-01A-01D-1697-05 TCGA-32-1980-01 TCGA-32-1980-01A-01D-1694-01 TCGA-32-1980-01 ebe88950-c783-4487-9bfc-ccaaeacf256c TCGA-32-1980-01 TCGA-32-1980-01A-01D-1694-01 ebe88950-c783-4487-9bfc-ccaaeacf256c +TCGA-32-1982-01 TCGA-32-1982-01 GBM C10-GBM GBM non-CIMP c15 GBM-like c2 GBM-like c6 mutation cluster 14 TCGA-32-1982 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 76 TCGA-32-1982-F27739 TCGA-32-1982 TCGA-32-1982-01A -27764 142 0 142 2010-3-8 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 0.4 NO 80 0.9 TCGA-32-1982.cd26781a-ec25-4240-beac-f45cc7a2b7a3.pdf 1982 Pre-Adjuvant Therapy WITH TUMOR NO Primary Tumor 01 0.3 32 Brain A DECEASED 2008 3a5d8c95-260e-471a-bdf8-2fa489a069d8 TCGA-32-1982-01 TCGA-32-1982-01A-01D-1494-08 TCGA-32-1982-01 TCGA-32-1982-01A-01D-0784-01 TCGA-32-1982-01 3a5d8c95-260e-471a-bdf8-2fa489a069d8 TCGA-32-1982-01 TCGA-32-1982-01A-01D-0784-01 3a5d8c95-260e-471a-bdf8-2fa489a069d8 +TCGA-32-1986-01 TCGA-32-1986-01 GBM C10-GBM GBM non-CIMP c15 KIRC-like c1 mutation c1uster 9 TCGA-32-1986 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain NO NO 68 TCGA-32-1986-F27742 TCGA-32-1986 -25061 386 0 386 233 2010-3-8 MALE Untreated primary (de novo) GBM No C71.2 9440/3 C71.2 YES Tumor resection 20 Progression of Disease 1986 Post-Adjuvant Therapy WITH TUMOR YES NO YES Primary Tumor 01 32 Brain DECEASED 2008 TCGA-32-1986-01 TCGA-32-1986-01A-01D-1494-08 TCGA-32-1986-01 TCGA-32-1986-01A-01D-0784-01 TCGA-32-1986-01A-01D-0784-01 +TCGA-32-1987-01 TCGA-32-1987-01 BRCA-LUAD+ GBM non-CIMP c15 GBM-like c2 TCGA-32-1987 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES NO 49 TCGA-32-1987-F27746 TCGA-32-1987 -18091 452 0 452 68 2010-12-14 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection Recurrence 1987 WITH TUMOR YES NO YES Primary Tumor 01 32 Brain DECEASED 2009 TCGA-32-1987-01 TCGA-32-1987-01 TCGA-32-1987-01A-01D-1224-01 TCGA-32-1987-01A-01D-1224-01 +TCGA-32-1991-01 TCGA-32-1991-01 GBM C10-GBM GBM non-CIMP c15 GBM-like c2 mutation cluster 14 TCGA-32-1991 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain NO NO 60 TCGA-32-1991-F27753 TCGA-32-1991 -22021 515 0 515 345 2010-12-14 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection Recurrence 1991 WITH TUMOR YES NO YES Primary Tumor 01 32 Brain DECEASED 2009 TCGA-32-1991-01 TCGA-32-1991-01A-01D-1353-08 TCGA-32-1991-01 TCGA-32-1991-01A-01D-1224-01 TCGA-32-1991-01A-01D-1224-01 +TCGA-32-2491-01 TCGA-32-2491-01 GBM GBM non-CIMP c15 mutation cluster 8 TCGA-32-2491 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES NO 63 TCGA-32-2491-F27762 TCGA-32-2491 -23131 372 0 372 70 2010-12-14 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection Recurrence 2491 WITH TUMOR YES NO YES Primary Tumor 01 32 Brain DECEASED 2005 TCGA-32-2491-01 TCGA-32-2491-01A-01D-1353-08 TCGA-32-2491-01 TCGA-32-2491-01A-01D-1224-01 TCGA-32-2491-01A-01D-1224-01 +TCGA-32-2494-01 TCGA-32-2494-01 GBM GBM non-CIMP c15 mutation c1uster 9 TCGA-32-2494 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES YES 58 TCGA-32-2494-F27767 TCGA-32-2494 -21198 632 0 632 488 2010-12-20 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection Progression of Disease 2494 WITH TUMOR YES NO YES Primary Tumor 01 32 Brain DECEASED 2008 TCGA-32-2494-01 TCGA-32-2494-01A-01D-1353-08 TCGA-32-2494-01 TCGA-32-2494-01A-01D-1224-01 TCGA-32-2494-01A-01D-1224-01 +TCGA-32-2495-01 TCGA-32-2495-01 GBM GBM non-CIMP c15 mutation cluster 14 TCGA-32-2495 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES YES 59 TCGA-32-2495-F27779 TCGA-32-2495 -21860 457 0 457 252 2010-12-20 FEMALE Treated primary GBM Yes C71.9 9440/3 C71.9 YES Tumor resection Recurrence 2495 WITH TUMOR YES YES YES Primary Tumor 01 32 Brain DECEASED 2008 TCGA-32-2495-01 TCGA-32-2495-01A-01D-1353-08 TCGA-32-2495-01 TCGA-32-2495-01A-01D-1224-01 TCGA-32-2495-01A-01D-1224-01 +TCGA-32-2498-01 TCGA-32-2498-01 High Low purity c2 TCGA-32-2498 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain TCGA-32-2498-01A 0.3 NO 0.4 TCGA-32-2498.c5ab9dce-0eb3-4dbb-afd2-2aec5e0569e6.pdf Primary Tumor 01 0.3 A TCGA-32-2498-01A-01D-1353-08 +TCGA-32-2615-01 TCGA-32-2615-01 Kirc+ C10-GBM GBM non-CIMP c15 GBM-like c6 mutation c1uster 9 TCGA-32-2615 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES YES 62 TCGA-32-2615-F27788 TCGA-32-2615 TCGA-32-2615-01A -22916 485 0 485 131 2010-6-1 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 0.9 NO 80 0.9 Progression of Disease TCGA-32-2615.420A0546-892D-4F05-BA60-4E0F3EF20FFA.pdf 2615 Preoperative WITH TUMOR YES NO YES Primary Tumor 01 0.4 32 Brain A DECEASED 2009 2db5af77-d0af-4c3c-bd2a-779e0a7228e0 TCGA-32-2615-01 TCGA-32-2615-01A-01D-1495-08 TCGA-32-2615-01 TCGA-32-2615-01A-01D-0911-01 TCGA-32-2615-01 2db5af77-d0af-4c3c-bd2a-779e0a7228e0 TCGA-32-2615-01 TCGA-32-2615-01A-01D-0911-01 2db5af77-d0af-4c3c-bd2a-779e0a7228e0 +TCGA-32-2616-01 TCGA-32-2616-01 GBM GBM non-CIMP c15 GBM-like c6 TCGA-32-2616 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain NO YES 48 TCGA-32-2616-F30224 TCGA-32-2616 TCGA-32-2616-01A -17781 224 0 224 182 1 2010-7-6 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 0.4 NO 0.6 Progression of Disease TCGA-32-2616.317C0826-2B8D-4071-AC55-BAE793FD7CE9.pdf 2616 Pre-Adjuvant Therapy WITH TUMOR YES NO YES Primary Tumor 01 0.2 32 Brain A DECEASED 2008 6ced4dca-5999-4063-90e9-6ba1851ab054 TCGA-32-2616-01 TCGA-32-2616-01 TCGA-32-2616-01A-01D-0911-01 TCGA-32-2616-01 6ced4dca-5999-4063-90e9-6ba1851ab054 TCGA-32-2616-01 TCGA-32-2616-01A-01D-0911-01 6ced4dca-5999-4063-90e9-6ba1851ab054 +TCGA-32-2632-01 TCGA-32-2632-01 BRCA-LUAD+ C10-GBM GBM non-CIMP c15 GBM-like c6 mutation cluster 7 TCGA-32-2632 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 80 TCGA-32-2632-F48468 TCGA-32-2632 TCGA-32-2632-01A -29281 269 0 Scheduled Follow-up Submission Progressive Disease 2013-9-13 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 0.5 NO 1.2 NO TCGA-32-2632.37cd6d1c-c10e-4ca0-ad18-3d707e9b1691.pdf 2632 WITH TUMOR Progressive Disease NO Primary Tumor 01 0.3 32 Brain A DECEASED 2008 2b467bcc-e33f-4209-92c0-dcff843027ea TCGA-32-2632-01 TCGA-32-2632-01A-01D-1495-08 TCGA-32-2632-01 TCGA-32-2632-01A-01D-0911-01 TCGA-32-2632-01 2b467bcc-e33f-4209-92c0-dcff843027ea TCGA-32-2632-01 TCGA-32-2632-01A-01D-0911-01 2b467bcc-e33f-4209-92c0-dcff843027ea +TCGA-32-2634-01 TCGA-32-2634-01 COAD-READ C10-GBM GBM non-CIMP c15 GBM-like c6 mutation cluster 3 TCGA-32-2634 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 82 TCGA-32-2634-F27800 TCGA-32-2634 -29964 0 270 1 2010-7-30 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 2634 TUMOR FREE YES NO YES Primary Tumor 01 32 Brain LIVING 2009 ecd3ecba-4d25-4995-91df-e076f0cbe2bc TCGA-32-2634-01 TCGA-32-2634-01A-01D-1495-08 TCGA-32-2634-01 TCGA-32-2634-01A-01D-0911-01 TCGA-32-2634-01 ecd3ecba-4d25-4995-91df-e076f0cbe2bc TCGA-32-2634-01 TCGA-32-2634-01A-01D-0911-01 ecd3ecba-4d25-4995-91df-e076f0cbe2bc +TCGA-32-2638-01 TCGA-32-2638-01 GBM C10-GBM GBM non-CIMP c15 GBM-like c6 mutation c1uster 9 TCGA-32-2638 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 67 TCGA-32-2638-F30533 TCGA-32-2638 -24658 766 0 224 0 Scheduled Follow-up Submission 2012-4-3 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 2638 Pre-Adjuvant Therapy WITH TUMOR NO Primary Tumor 01 32 Brain DECEASED 2009 eab1e09d-1ca3-484d-95d8-9fd5fa857f3d TCGA-32-2638-01 TCGA-32-2638-01A-01D-1495-08 TCGA-32-2638-01 TCGA-32-2638-01A-01D-0911-01 TCGA-32-2638-01 eab1e09d-1ca3-484d-95d8-9fd5fa857f3d TCGA-32-2638-01 TCGA-32-2638-01A-01D-0911-01 eab1e09d-1ca3-484d-95d8-9fd5fa857f3d +TCGA-32-4208-01 TCGA-32-4208-01 BRCA-LUAD+ GBM CIMP c16 mutation cluster 5 TCGA-32-4208 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 25 TCGA-32-4208-F27812 TCGA-32-4208 -9213 0 400 2010-12-14 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 4208 WITH TUMOR YES NO YES Primary Tumor 01 32 Brain LIVING 2009 TCGA-32-4208-01 TCGA-32-4208-01A-01D-1353-08 TCGA-32-4208-01 TCGA-32-4208-01A-01D-1224-01 TCGA-32-4208-01A-01D-1224-01 +TCGA-32-4209-01 TCGA-32-4209-01 Kirc+ GBM non-CIMP c15 mutation c1uster 9 TCGA-32-4209 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES NO 40 TCGA-32-4209-F27818 TCGA-32-4209 -14903 618 0 338 94 Additional New Tumor Event 2012-3-5 MALE Treated primary GBM No C71.9 9440/3 C71.9 YES Tumor resection Recurrence 4209 WITH TUMOR NO YES NO Primary Tumor 01 32 Brain DECEASED 2009 TCGA-32-4209-01A-01D-1353-08 TCGA-32-4209-01 +TCGA-32-4210-01 TCGA-32-4210-01 BRCA-LUAD+ C10-GBM GBM non-CIMP c15 GBM-like c2 mutation cluster 5 TCGA-32-4210 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 73 TCGA-32-4210-F27822 TCGA-32-4210 -26768 113 0 113 2010-12-14 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 4210 WITH TUMOR NO Primary Tumor 01 32 Brain DECEASED 2010 TCGA-32-4210-01 TCGA-32-4210-01A-01D-1353-08 TCGA-32-4210-01 TCGA-32-4210-01A-01D-1224-01 TCGA-32-4210-01A-01D-1224-01 +TCGA-32-4211-01 TCGA-32-4211-01 GBM C10-GBM GBM non-CIMP c15 KIRC-like c1 mutation c1uster 9 TCGA-32-4211 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 56 TCGA-32-4211-F27824 TCGA-32-4211 -20748 383 0 383 2010-12-14 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 4211 WITH TUMOR YES NO YES Primary Tumor 01 32 Brain DECEASED 2010 TCGA-32-4211-01 TCGA-32-4211-01A-01D-1353-08 TCGA-32-4211-01 TCGA-32-4211-01A-01D-1224-01 TCGA-32-4211-01A-01D-1224-01 +TCGA-32-4213-01 TCGA-32-4213-01 GBM C10-GBM GBM non-CIMP c15 GBM-like c6 mutation c1uster 9 TCGA-32-4213 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES YES 47 TCGA-32-4213-F27830 TCGA-32-4213 -17237 0 357 353 2010-12-14 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection Recurrence 4213 WITH TUMOR YES NO YES Primary Tumor 01 32 Brain LIVING 2009 c6d836ec-710d-4559-ba66-2715f6a55d4c TCGA-32-4213-01 TCGA-32-4213-01A-01D-1353-08 TCGA-32-4213-01 TCGA-32-4213-01A-01D-1224-01 TCGA-32-4213-01 c6d836ec-710d-4559-ba66-2715f6a55d4c TCGA-32-4213-01 TCGA-32-4213-01A-01D-1224-01 c6d836ec-710d-4559-ba66-2715f6a55d4c +TCGA-32-4719-01 TCGA-32-4719-01 Kirc+ GBM non-CIMP c15 mutation c1uster 9 TCGA-32-4719 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 73 TCGA-32-4719-F27837 TCGA-32-4719 -26691 330 0 330 2010-12-14 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 4719 WITH TUMOR YES NO YES Primary Tumor 01 32 Brain DECEASED 2010 TCGA-32-4719-01 TCGA-32-4719-01A-01D-1353-08 TCGA-32-4719-01 TCGA-32-4719-01A-01D-1224-01 TCGA-32-4719-01A-01D-1224-01 +TCGA-32-5222-01 TCGA-32-5222-01 GBM C10-GBM GBM non-CIMP c15 GBM-like c2 GBM-like c6 mutation c1uster 9 TCGA-32-5222 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain NO NO 66 TCGA-32-5222-F27842 TCGA-32-5222 -24134 585 0 165 118 Scheduled Follow-up Submission 2012-4-3 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection Progression of Disease 5222 WITH TUMOR NO Primary Tumor 01 32 Brain DECEASED 2010 f5fffae0-0fbe-40f8-93d7-525407048620 TCGA-32-5222-01 TCGA-32-5222-01A-01D-1486-08 TCGA-32-5222-01A-01D-1481-05 TCGA-32-5222-01 TCGA-32-5222-01A-01D-1479-01 TCGA-32-5222-01 f5fffae0-0fbe-40f8-93d7-525407048620 TCGA-32-5222-01 TCGA-32-5222-01A-01D-1479-01 f5fffae0-0fbe-40f8-93d7-525407048620 +TCGA-41-2571-01 TCGA-41-2571-01 GBM C10-GBM GBM non-CIMP c15 GBM-like c6 mutation cluster 4 TCGA-41-2571 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain NO NO 89 TCGA-41-2571-F27980 TCGA-41-2571 -32612 26 0 26 26 2010-6-3 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Incisional Biopsy 60 Progression of Disease 2571 Pre-Adjuvant Therapy WITH TUMOR YES NO NO Primary Tumor 01 41 Brain DECEASED 2009 a7433808-7fb3-4909-92ae-2d74b32886b0 TCGA-41-2571-01 TCGA-41-2571-01A-01D-1495-08 TCGA-41-2571-01 TCGA-41-2571-01A-01D-0911-01 TCGA-41-2571-01 a7433808-7fb3-4909-92ae-2d74b32886b0 TCGA-41-2571-01 TCGA-41-2571-01A-01D-0911-01 a7433808-7fb3-4909-92ae-2d74b32886b0 +TCGA-41-2572-01 TCGA-41-2572-01 GBM C10-GBM GBM non-CIMP c15 GBM-like c6 mutation cluster 14 TCGA-41-2572 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES NO 67 TCGA-41-2572-F27983 TCGA-41-2572 -24505 406 0 406 122 1 2010-10-26 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Excisional Biopsy Progression of Disease 2572 Post-Adjuvant Therapy WITH TUMOR YES NO YES Primary Tumor 01 41 Brain DECEASED 2009 f46e05f2-56b9-4a31-b0ec-882414a7aaf6 TCGA-41-2572-01 TCGA-41-2572-01A-01D-1353-08 TCGA-41-2572-01 TCGA-41-2572-01A-01D-1224-01 TCGA-41-2572-01 f46e05f2-56b9-4a31-b0ec-882414a7aaf6 TCGA-41-2572-01 TCGA-41-2572-01A-01D-1224-01 f46e05f2-56b9-4a31-b0ec-882414a7aaf6 +TCGA-41-2573-01 TCGA-41-2573-01 GBM C10-GBM GBM non-CIMP c15 GBM-like c2 mutation cluster 14 TCGA-41-2573 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain NO NO 59 TCGA-41-2573-F27989 TCGA-41-2573 -21911 0 272 167 2010-6-3 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Excisional Biopsy 60 Progression of Disease 2573 Post-Adjuvant Therapy WITH TUMOR YES NO YES Primary Tumor 01 41 Brain LIVING 2009 TCGA-41-2573-01 TCGA-41-2573-01A-01D-1495-08 TCGA-41-2573-01 TCGA-41-2573-01A-01D-0911-01 TCGA-41-2573-01A-01D-0911-01 +TCGA-41-2575-01 TCGA-41-2575-01 GBM C10-GBM GBM non-CIMP c15 GBM-like c2 mutation cluster 5 TCGA-41-2575 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES YES 75 TCGA-41-2575-F27996 TCGA-41-2575 -27587 290 0 290 131 2010-6-3 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Excisional Biopsy 60 Progression of Disease 2575 Post-Adjuvant Therapy WITH TUMOR YES NO YES Primary Tumor 01 41 Brain DECEASED 2009 TCGA-41-2575-01 TCGA-41-2575-01A-01D-1495-08 TCGA-41-2575-01 TCGA-41-2575-01A-01D-0911-01 TCGA-41-2575-01A-01D-0911-01 +TCGA-41-3392-01 TCGA-41-3392-01 GBM C10-GBM GBM non-CIMP c15 GBM-like c2 mutation c1uster 9 TCGA-41-3392 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 88 TCGA-41-3392-F28002 TCGA-41-3392 -32351 30 0 30 2010-6-3 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 3392 WITH TUMOR NO NO NO Primary Tumor 01 41 Brain DECEASED 2009 TCGA-41-3392-01 TCGA-41-3392-01A-01D-1495-08 TCGA-41-3392-01 TCGA-41-3392-01A-01D-0911-01 TCGA-41-3392-01A-01D-0911-01 +TCGA-41-3393-01 TCGA-41-3393-01 GBM C10-GBM GBM non-CIMP c15 GBM-like c2 mutation c1uster 9 TCGA-41-3393 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 81 TCGA-41-3393-F28004 TCGA-41-3393 -29904 135 0 135 4 2010-10-26 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Other method, specify: 3393 Post-Adjuvant Therapy WITH TUMOR YES NO YES Primary Tumor 01 41 Brain DECEASED 2009 TCGA-41-3393-01 TCGA-41-3393-01A-01D-1353-08 TCGA-41-3393-01 TCGA-41-3393-01A-01D-1224-01 TCGA-41-3393-01A-01D-1224-01 +TCGA-41-3915-01 TCGA-41-3915-01 GBM C10-GBM GBM non-CIMP c15 GBM-like c2 GBM-like c6 mutation cluster 4 TCGA-41-3915 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain NO NO 48 TCGA-41-3915-F12837 TCGA-41-3915 -17880 360 0 360 301 288 3 2011-5-5 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Incisional Biopsy Locoregional Disease YES 3915 Other WITH TUMOR YES NO YES Primary Tumor 01 41 Brain DECEASED 2010 da360144-ffaf-4f38-bd87-96319fa8d2d4 TCGA-41-3915-01 TCGA-41-3915-01A-01D-1353-08 TCGA-41-3915-01 TCGA-41-3915-01A-01D-1224-01 TCGA-41-3915-01 da360144-ffaf-4f38-bd87-96319fa8d2d4 TCGA-41-3915-01 TCGA-41-3915-01A-01D-1224-01 da360144-ffaf-4f38-bd87-96319fa8d2d4 +TCGA-41-4097-01 TCGA-41-4097-01 Kirc+ C10-GBM GBM non-CIMP c15 GBM-like c2 GBM-like c6 mutation c1uster 9 TCGA-41-4097 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 63 TCGA-41-4097-F28013 TCGA-41-4097 TCGA-41-4097-01A -23107 6 0 6 2010-10-26 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Excisional Biopsy 1 NO 1.9 TCGA-41-4097.38e71ada-a221-41fd-9283-5750413305b8.pdf 4097 WITH TUMOR NO NO NO Primary Tumor 01 0.5 41 Brain A DECEASED 2010 4d2bc147-bed8-4621-be86-f32559f0ed91 TCGA-41-4097-01 TCGA-41-4097-01A-01D-1353-08 TCGA-41-4097-01 TCGA-41-4097-01A-01D-1224-01 TCGA-41-4097-01 4d2bc147-bed8-4621-be86-f32559f0ed91 TCGA-41-4097-01 TCGA-41-4097-01A-01D-1224-01 4d2bc147-bed8-4621-be86-f32559f0ed91 +TCGA-41-5651-01 TCGA-41-5651-01 GBM C10-GBM GBM non-CIMP c15 GBM-like c2 GBM-like c6 mutation cluster 3 TCGA-41-5651 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES NO 59 TCGA-41-5651-F28015 TCGA-41-5651 TCGA-41-5651-01A -21698 0 351 210 1 2011-7-21 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 0.8 NO 1.7 Progression of Disease TCGA-41-5651.f02981ba-f5ac-4182-864e-dc0cf37e7413.pdf 5651 Other WITH TUMOR YES NO YES Primary Tumor 01 0.8 41 Brain A LIVING 2010 4aa70762-1a0e-4b38-be77-a89db0955193 TCGA-41-5651-01 TCGA-41-5651-01A-01D-1696-08 TCGA-41-5651-01A-01D-1697-05 TCGA-41-5651-01 TCGA-41-5651-01A-01D-1694-01 TCGA-41-5651-01 4aa70762-1a0e-4b38-be77-a89db0955193 TCGA-41-5651-01 TCGA-41-5651-01A-01D-1694-01 4aa70762-1a0e-4b38-be77-a89db0955193 +TCGA-41-6646-01 TCGA-41-6646-01 GBM C10-GBM GBM non-CIMP c15 KIRC-like c1 mutation c1uster 9 TCGA-41-6646 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain NO NO 73 TCGA-41-6646-F28022 TCGA-41-6646 TCGA-41-6646-01A -26667 379 0 236 200 4 2012-4-11 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 0.9 NO 2.3 Progression of Disease TCGA-41-6646.6b3cf1a0-d385-4211-a68d-6cb8ae1a551f.pdf 6646 Other WITH TUMOR NO Primary Tumor 01 0.7 41 Brain A DECEASED 2011 TCGA-41-6646-01A-11D-1845-08 TCGA-41-6646-01A-11D-1844-05 TCGA-41-6646-01A-11D-1842-01 TCGA-41-6646-01A-11D-1842-01 +TCGA-4W-AA9R-01 TCGA-4W-AA9R-01 TCGA-4W-AA9R TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 61 TCGA-4W-AA9R-F71038 TCGA-4W-AA9R TCGA-4W-AA9R-01A -22317 617 0 124 Scheduled Follow-up Submission 2015-3-25 MALE Glioblastoma Multiforme (GBM) No C71.9 9440/3 C71.9 YES Tumor resection 150 NO NO true No TCGA-4W-AA9R.B41500A8-E606-4B03-AD04-55989B30C041.pdf AA9R TUMOR FREE Progressive Disease NO YES Primary Tumor 01 YES NO 4W Brain A LIVING 2012 TCGA-4W-AA9R-01A-11D-A392-05 TCGA-4W-AA9R-01A-11D-A390-01 TCGA-4W-AA9R-01A-11D-A390-01 +TCGA-4W-AA9S-01 TCGA-4W-AA9S-01 TCGA-4W-AA9S TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 69 TCGA-4W-AA9S-F71150 TCGA-4W-AA9S TCGA-4W-AA9S-01A -25545 282 0 44 Scheduled Follow-up Submission 2015-3-20 MALE Glioblastoma Multiforme (GBM) No C71.9 9440/3 C71.9 YES Tumor resection 800 NO YES true No TCGA-4W-AA9S.87CEFA2B-7AA8-40DA-A987-9050F449D828.pdf AA9S TUMOR FREE YES Stable Disease NO YES Primary Tumor 01 YES NO 4W Brain A LIVING 2013 TCGA-4W-AA9S-01A-11D-A392-05 TCGA-4W-AA9S-01A-11D-A390-01 TCGA-4W-AA9S-01A-11D-A390-01 +TCGA-4W-AA9T-01 TCGA-4W-AA9T-01 TCGA-4W-AA9T TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain NO 54 TCGA-4W-AA9T-F71040 TCGA-4W-AA9T TCGA-4W-AA9T-01A -19801 366 0 778 749 1 Scheduled Follow-up Submission Progressive Disease 2015-3-18 FEMALE Glioblastoma Multiforme (GBM) No C71.9 9440/3 C71.9 YES Tumor resection 800 NO 70 NO YES true No TCGA-4W-AA9T.F1D9DB81-6170-4A62-B16E-0D826CD0D173.pdf AA9T Post-Adjuvant Therapy TUMOR FREE YES Progressive Disease NO YES Primary Tumor 01 NO YES 4W Brain A LIVING 2012 TCGA-4W-AA9T-01A-11D-A392-05 TCGA-4W-AA9T-01A-11D-A390-01 TCGA-4W-AA9T-01A-11D-A390-01 +TCGA-74-6573-01 TCGA-74-6573-01 GBM C10-GBM GBM non-CIMP c15 GBM-like c2 mutation cluster 3 TCGA-74-6573 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 67 TCGA-74-6573-F28507 TCGA-74-6573 TCGA-74-6573-01A -24632 105 0 2011-9-14 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 0.9 NO 100 1.8 TCGA-74-6573.d33e2186-48d8-44da-84b6-e7f88daac1e2.pdf 6573 Preoperative WITH TUMOR YES NO YES Primary Tumor 01 0.6 74 Brain A DECEASED 2009 TCGA-74-6573-01A-12D-1845-08 TCGA-74-6573-01A-12D-1844-05 TCGA-74-6573-01A-12D-1842-01 TCGA-74-6573-01A-12D-1842-01 +TCGA-74-6573-11 TCGA-74-6573-11 C10-GBM mutation cluster 3 TCGA-74-6573 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 67 TCGA-74-6573-F28507 TCGA-74-6573 TCGA-74-6573-11A -24632 105 0 2011-9-14 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 0.6 NO 100 1.1 6573 Preoperative WITH TUMOR YES NO YES Solid Tissue Normal 11 0.5 74 Brain A DECEASED 2009 TCGA-74-6573-11A-02D-1844-05 +TCGA-74-6575-01 TCGA-74-6575-01 GBM C10-GBM GBM non-CIMP c15 GBM-like c2 mutation cluster 4 TCGA-74-6575 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES NO 73 TCGA-74-6575-F28509 TCGA-74-6575 TCGA-74-6575-01A -26827 0 534 460 2011-9-14 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 1 NO 90 1.8 Progression of Disease TCGA-74-6575.5ecedd86-01d1-40c8-896f-1566e6d2dffd.pdf 6575 Preoperative WITH TUMOR YES NO YES Primary Tumor 01 0.8 74 Brain A LIVING 2009 TCGA-74-6575-01A-11D-1845-08 TCGA-74-6575-01A-11D-1844-05 TCGA-74-6575-01A-11D-1842-01 TCGA-74-6575-01A-11D-1842-01 +TCGA-74-6577-01 TCGA-74-6577-01 GBM C10-GBM GBM non-CIMP c15 GBM-like c2 mutation cluster 12 TCGA-74-6577 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES NO 51 TCGA-74-6577-F28511 TCGA-74-6577 TCGA-74-6577-01A -18740 0 132 132 2011-9-14 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 0.9 NO 90 1.7 Progression of Disease TCGA-74-6577.0fe10a6d-e211-43c7-8a89-56ed221cbb96.pdf 6577 Preoperative WITH TUMOR YES NO YES Primary Tumor 01 0.6 74 Brain A LIVING 2010 TCGA-74-6577-01A-11D-1845-08 TCGA-74-6577-01A-11D-1844-05 TCGA-74-6577-01A-11D-1842-01 TCGA-74-6577-01A-11D-1842-01 +TCGA-74-6578-01 TCGA-74-6578-01 GBM C10-GBM GBM non-CIMP c15 GBM-like c2 mutation cluster 1 TCGA-74-6578 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES NO 58 TCGA-74-6578-F28513 TCGA-74-6578 TCGA-74-6578-01A -21464 0 436 222 2011-9-14 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 0.9 NO 100 1 Progression of Disease TCGA-74-6578.35f9320c-f804-47e5-904f-4d1a87fddd35.pdf 6578 Preoperative WITH TUMOR YES NO YES Primary Tumor 01 0.3 74 Brain A LIVING 2010 TCGA-74-6578-01A-11D-1845-08 TCGA-74-6578-01A-11D-1844-05 TCGA-74-6578-01A-11D-1842-01 TCGA-74-6578-01A-11D-1842-01 +TCGA-74-6581-01 TCGA-74-6581-01 GBM GBM non-CIMP c15 GBM-like c2 TCGA-74-6581 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 77 TCGA-74-6581-F28515 TCGA-74-6581 TCGA-74-6581-01A -28263 0 250 2011-9-14 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 0.6 NO 100 1.2 TCGA-74-6581.7ab73575-cd7d-434f-b21d-fcffb52c3a4d.pdf 6581 Preoperative WITH TUMOR YES NO YES Primary Tumor 01 0.4 74 Brain A LIVING 2010 TCGA-74-6581-01A-11D-1844-05 TCGA-74-6581-01A-11D-1842-01 TCGA-74-6581-01A-11D-1842-01 +TCGA-74-6584-01 TCGA-74-6584-01 GBM C10-GBM GBM non-CIMP c15 GBM-like c2 mutation c1uster 9 TCGA-74-6584 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES YES 55 TCGA-74-6584-F28517 TCGA-74-6584 TCGA-74-6584-01A -20232 0 228 91 2011-9-14 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 1 NO 80 1.5 Progression of Disease TCGA-74-6584.315ce84d-6870-4a44-bf59-e5b1ba0d94bb.pdf 6584 Preoperative WITH TUMOR YES NO YES Primary Tumor 01 0.7 74 Brain A LIVING 2010 TCGA-74-6584-01A-11D-1845-08 TCGA-74-6584-01A-11D-1844-05 TCGA-74-6584-01A-11D-1842-01 TCGA-74-6584-01A-11D-1842-01 +TCGA-76-4925-01 TCGA-76-4925-01 GBM C10-GBM GBM non-CIMP c15 GBM-like c6 mutation cluster 5 TCGA-76-4925 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain NO NO 76 TCGA-76-4925-F28519 TCGA-76-4925 TCGA-76-4925-01A -28011 146 0 146 88 0 2011-4-6 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 0.8 NO 100 1 Progression of Disease TCGA-76-4925.886c961a-cfef-4f2c-8b58-7708e216db0e.pdf 4925 Preoperative YES NO YES Primary Tumor 01 0.2 76 Brain A DECEASED 2005 03422479-a670-44ed-a9f7-33f4554ef6f6 TCGA-76-4925-01 TCGA-76-4925-01A-01D-1486-08 TCGA-76-4925-01A-01D-1481-05 TCGA-76-4925-01 TCGA-76-4925-01A-01D-1479-01 TCGA-76-4925-01 03422479-a670-44ed-a9f7-33f4554ef6f6 TCGA-76-4925-01 TCGA-76-4925-01A-01D-1479-01 03422479-a670-44ed-a9f7-33f4554ef6f6 +TCGA-76-4926-01 TCGA-76-4926-01 GBM C10-GBM GBM non-CIMP c15 GBM-like c2 GBM-like c6 mutation cluster 14 TCGA-76-4926 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES YES 68 TCGA-76-4926-F28523 TCGA-76-4926 TCGA-76-4926-01B -25085 138 0 138 34 2011-4-6 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 0.6 NO 80 1.1 Progression of Disease TCGA-76-4926.1dc2749e-bfe1-4f6f-ba92-c916f8aaedd8.pdf 4926 WITH TUMOR YES NO YES Primary Tumor 01 0.4 76 Brain B DECEASED 2005 110100d2-bfb8-42d2-875f-9424a8bd2086 TCGA-76-4926-01 TCGA-76-4926-01B-01D-1486-08 TCGA-76-4926-01B-01D-1481-05 TCGA-76-4926-01 TCGA-76-4926-01B-01D-1479-01 TCGA-76-4926-01 110100d2-bfb8-42d2-875f-9424a8bd2086 TCGA-76-4926-01 TCGA-76-4926-01B-01D-1479-01 110100d2-bfb8-42d2-875f-9424a8bd2086 +TCGA-76-4927-01 TCGA-76-4927-01 C10-GBM GBM non-CIMP c15 GBM-like c2 GBM-like c6 mutation cluster 14 TCGA-76-4927 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 58 TCGA-76-4927-F28527 TCGA-76-4927 TCGA-76-4927-01A -21193 535 0 535 416 2011-4-6 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 0.7 NO 80 1.7 Progression of Disease TCGA-76-4927.5f1a707b-6acd-45b3-8540-0ff1ec834ab7.pdf 4927 WITH TUMOR NO Primary Tumor 01 0.3 76 Brain A DECEASED 2005 777c1ad8-ae6d-4c17-ad59-8b26adb67a1b TCGA-76-4927-01A-01D-1486-08 TCGA-76-4927-01A-01D-1481-05 TCGA-76-4927-01 TCGA-76-4927-01 777c1ad8-ae6d-4c17-ad59-8b26adb67a1b 777c1ad8-ae6d-4c17-ad59-8b26adb67a1b +TCGA-76-4928-01 TCGA-76-4928-01 GBM C10-GBM GBM non-CIMP c15 squamous c3 GBM-like c6 mutation cluster 4 TCGA-76-4928 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 85 TCGA-76-4928-F28529 TCGA-76-4928 -31267 94 0 94 2011-4-6 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 80 4928 WITH TUMOR YES NO YES Primary Tumor 01 76 Brain DECEASED 2005 ca6d5ed3-f6f7-4dde-be24-7652d7dfab16 TCGA-76-4928-01 TCGA-76-4928-01B-01D-1486-08 TCGA-76-4928-01B-01D-1481-05 TCGA-76-4928-01 TCGA-76-4928-01B-01D-1479-01 TCGA-76-4928-01 ca6d5ed3-f6f7-4dde-be24-7652d7dfab16 TCGA-76-4928-01 TCGA-76-4928-01B-01D-1479-01 ca6d5ed3-f6f7-4dde-be24-7652d7dfab16 +TCGA-76-4929-01 TCGA-76-4929-01 Kirc+ C10-GBM GBM non-CIMP c15 GBM-like c2 GBM-like c6 mutation cluster 11 TCGA-76-4929 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 76 TCGA-76-4929-F28533 TCGA-76-4929 -27831 111 0 111 2011-4-6 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 80 4929 WITH TUMOR NO Primary Tumor 01 76 Brain DECEASED 2005 faadb03e-20bc-4308-a86b-2bdb6aad8a23 TCGA-76-4929-01 TCGA-76-4929-01A-01D-1486-08 TCGA-76-4929-01A-01D-1481-05 TCGA-76-4929-01 TCGA-76-4929-01A-01D-1479-01 TCGA-76-4929-01 faadb03e-20bc-4308-a86b-2bdb6aad8a23 TCGA-76-4929-01 TCGA-76-4929-01A-01D-1479-01 faadb03e-20bc-4308-a86b-2bdb6aad8a23 +TCGA-76-4931-01 TCGA-76-4931-01 GBM C10-GBM GBM non-CIMP c15 GBM-like c2 GBM-like c6 mutation cluster 14 TCGA-76-4931 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES YES 70 TCGA-76-4931-F28535 TCGA-76-4931 -25812 279 0 279 112 2011-4-6 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 80 Progression of Disease 4931 WITH TUMOR YES NO YES Primary Tumor 01 76 Brain DECEASED 2005 ca803595-2792-4d7d-81f6-cce8d96d0119 TCGA-76-4931-01 TCGA-76-4931-01A-01D-1486-08 TCGA-76-4931-01A-01D-1481-05 TCGA-76-4931-01 TCGA-76-4931-01A-01D-1479-01 TCGA-76-4931-01 ca803595-2792-4d7d-81f6-cce8d96d0119 TCGA-76-4931-01 TCGA-76-4931-01A-01D-1479-01 ca803595-2792-4d7d-81f6-cce8d96d0119 +TCGA-76-4932-01 TCGA-76-4932-01 BRCA-LUAD+ C10-GBM GBM non-CIMP c15 GBM-like c2 GBM-like c6 mutation c1uster 9 TCGA-76-4932 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 50 TCGA-76-4932-F28539 TCGA-76-4932 -18433 1458 0 1458 2011-4-6 FEMALE Treated primary GBM No C71.9 9440/3 C71.9 YES Tumor resection 80 4932 WITH TUMOR YES NO YES Primary Tumor 01 76 Brain DECEASED 2006 ebadf417-08e8-4e89-bc8b-f7a74b0fc781 TCGA-76-4932-01A-01D-1486-08 TCGA-76-4932-01A-01D-1481-05 TCGA-76-4932-01 TCGA-76-4932-01 ebadf417-08e8-4e89-bc8b-f7a74b0fc781 ebadf417-08e8-4e89-bc8b-f7a74b0fc781 +TCGA-76-4934-01 TCGA-76-4934-01 Kirc+ GBM non-CIMP c15 mutation cluster 5 TCGA-76-4934 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 66 TCGA-76-4934-F28543 TCGA-76-4934 -24319 77 0 77 2011-4-6 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 80 4934 TUMOR FREE NO NO NO Primary Tumor 01 76 Brain DECEASED 2009 TCGA-76-4934-01 TCGA-76-4934-01A-01D-1486-08 TCGA-76-4934-01A-01D-1481-05 TCGA-76-4934-01 TCGA-76-4934-01A-01D-1479-01 TCGA-76-4934-01A-01D-1479-01 +TCGA-76-4935-01 TCGA-76-4935-01 GBM GBM non-CIMP c15 mutation c1uster 9 TCGA-76-4935 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain NO 52 TCGA-76-4935-F28545 TCGA-76-4935 -19231 1121 0 328 [Discrepancy] 2015-3-26 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 80 NO Progression of Disease 4935 TUMOR FREE NO Primary Tumor 01 76 Brain DECEASED 2010 TCGA-76-4935-01 TCGA-76-4935-01A-01D-1486-08 TCGA-76-4935-01A-01D-1481-05 TCGA-76-4935-01 TCGA-76-4935-01A-01D-1479-01 TCGA-76-4935-01A-01D-1479-01 +TCGA-76-6191-01 TCGA-76-6191-01 GBM GBM non-CIMP c15 mutation cluster 14 TCGA-76-6191 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES YES 57 TCGA-76-6191-F28550 TCGA-76-6191 -20937 508 0 508 323 1 2011-9-22 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 80 Progression of Disease 6191 Pre-Adjuvant Therapy WITH TUMOR YES NO YES Primary Tumor 01 76 Brain DECEASED 2009 TCGA-76-6191-01 TCGA-76-6191-01A-12D-1696-08 TCGA-76-6191-01A-12D-1697-05 TCGA-76-6191-01 TCGA-76-6191-01A-12D-1694-01 TCGA-76-6191-01A-12D-1694-01 +TCGA-76-6192-01 TCGA-76-6192-01 GBM C10-GBM GBM non-CIMP c15 GBM-like c2 mutation c1uster 9 TCGA-76-6192 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain NO NO 74 TCGA-76-6192-F28557 TCGA-76-6192 -27322 100 0 100 76 1 2011-9-22 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 80 Progression of Disease 6192 Preoperative WITH TUMOR YES NO YES Primary Tumor 01 76 Brain DECEASED 2010 TCGA-76-6192-01 TCGA-76-6192-01A-11D-1696-08 TCGA-76-6192-01A-11D-1697-05 TCGA-76-6192-01 TCGA-76-6192-01A-11D-1694-01 TCGA-76-6192-01A-11D-1694-01 +TCGA-76-6193-01 TCGA-76-6193-01 Kirc+ C10-GBM GBM non-CIMP c15 GBM-like c2 mutation cluster 3 TCGA-76-6193 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain NO NO 78 TCGA-76-6193-F28561 TCGA-76-6193 -28742 82 0 82 64 2011-9-22 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 60 Progression of Disease 6193 YES NO YES Primary Tumor 01 76 Brain DECEASED 2010 TCGA-76-6193-01 TCGA-76-6193-01A-11D-1696-08 TCGA-76-6193-01A-11D-1697-05 TCGA-76-6193-01 TCGA-76-6193-01A-11D-1694-01 TCGA-76-6193-01A-11D-1694-01 +TCGA-76-6280-01 TCGA-76-6280-01 GBM GBM non-CIMP c15 mutation cluster 4 TCGA-76-6280 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain NO YES 57 TCGA-76-6280-F30214 TCGA-76-6280 TCGA-76-6280-01A -20931 346 0 346 108 1 2011-12-9 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 0.4 NO 80 1.5 Progression of Disease TCGA-76-6280.6c77527e-b771-4544-bd9a-8468f2ff593e.pdf 6280 Post-Adjuvant Therapy WITH TUMOR YES NO YES Primary Tumor 01 0.3 76 Brain A DECEASED 2007 TCGA-76-6280-01A-21D-1845-08 TCGA-76-6280-01A-21D-1844-05 TCGA-76-6280-01A-21D-1842-01 TCGA-76-6280-01A-21D-1842-01 +TCGA-76-6282-01 TCGA-76-6282-01 GBM C10-GBM GBM non-CIMP c15 GBM-like c2 mutation cluster 14 TCGA-76-6282 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain NO NO 63 TCGA-76-6282-F28565 TCGA-76-6282 -23323 519 0 519 458 1 2011-10-21 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 80 Progression of Disease 6282 Preoperative WITH TUMOR YES NO YES Primary Tumor 01 76 Brain DECEASED 2007 TCGA-76-6282-01 TCGA-76-6282-01A-11D-1696-08 TCGA-76-6282-01A-11D-1697-05 TCGA-76-6282-01 TCGA-76-6282-01A-11D-1694-01 TCGA-76-6282-01A-11D-1694-01 +TCGA-76-6283-01 TCGA-76-6283-01 BRCA-LUAD+ C10-GBM GBM non-CIMP c15 GBM-like c2 mutation cluster 5 TCGA-76-6283 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 71 TCGA-76-6283-F71528 TCGA-76-6283 TCGA-76-6283-01A -26002 165 0 Scheduled Follow-up Submission 2015-3-26 FEMALE Glioblastoma Multiforme (GBM) No C71.9 9440/3 C71.9 YES Tumor resection 0.6 NO 0 1 NO No TCGA-76-6283.a4576d26-9f8e-472d-be41-4b8632080c4a.pdf 6283 WITH TUMOR NO Primary Tumor 01 0.3 YES NO 76 Brain A DECEASED 2007 TCGA-76-6283-01A-11D-1845-08 TCGA-76-6283-01A-11D-1844-05 TCGA-76-6283-01A-11D-1842-01 TCGA-76-6283-01A-11D-1842-01 +TCGA-76-6285-01 TCGA-76-6285-01 GBM C10-GBM GBM non-CIMP c15 GBM-like c2 mutation c1uster 9 TCGA-76-6285 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 64 TCGA-76-6285-F28570 TCGA-76-6285 -23674 254 0 254 2011-9-22 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 80 6285 Preoperative WITH TUMOR YES NO NO Primary Tumor 01 76 Brain DECEASED 2008 TCGA-76-6285-01 TCGA-76-6285-01A-11D-1696-08 TCGA-76-6285-01A-11D-1697-05 TCGA-76-6285-01 TCGA-76-6285-01A-11D-1694-01 TCGA-76-6285-01A-11D-1694-01 +TCGA-76-6286-01 TCGA-76-6286-01 GBM GBM non-CIMP c15 mutation cluster 2 TCGA-76-6286 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES YES 60 TCGA-76-6286-F28573 TCGA-76-6286 TCGA-76-6286-01A -22173 638 0 638 180 1 2011-11-15 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 0.3 NO 80 0.4 Progression of Disease TCGA-76-6286.3b124818-8d8c-46b9-a8e8-60b6f22e75ea.pdf 6286 Preoperative WITH TUMOR YES NO YES Primary Tumor 01 0.2 76 Brain A DECEASED 2009 TCGA-76-6286-01A-11D-1845-08 TCGA-76-6286-01A-11D-1844-05 TCGA-76-6286-01A-11D-1842-01 TCGA-76-6286-01A-11D-1842-01 +TCGA-76-6656-01 TCGA-76-6656-01 GBM C10-GBM GBM non-CIMP c15 GBM-like c2 mutation cluster 14 TCGA-76-6656 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 66 TCGA-76-6656-F28579 TCGA-76-6656 TCGA-76-6656-01A -24265 147 0 147 2 2011-11-15 MALE Untreated primary (de novo) GBM C71.9 9440/3 C71.9 YES Tumor resection 0.8 NO 60 2 TCGA-76-6656.916da87b-e1f7-43fc-91b6-8db07a5ba0b2.pdf 6656 Preoperative YES NO YES Primary Tumor 01 0.5 76 Brain A DECEASED 2010 TCGA-76-6656-01A-11D-1845-08 TCGA-76-6656-01A-11D-1844-05 TCGA-76-6656-01A-11D-1842-01 TCGA-76-6656-01A-11D-1842-01 +TCGA-76-6657-01 TCGA-76-6657-01 GBM C10-GBM GBM non-CIMP c15 GBM-like c2 mutation cluster 4 TCGA-76-6657 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain NO NO 74 TCGA-76-6657-F28583 TCGA-76-6657 TCGA-76-6657-01A -27341 153 0 153 135 1 2011-11-15 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 0.8 NO 80 1.5 Progression of Disease TCGA-76-6657.476eed15-94af-4c24-9a4f-17fbde281c66.pdf 6657 Preoperative WITH TUMOR YES NO YES Primary Tumor 01 0.2 76 Brain A DECEASED 2010 TCGA-76-6657-01A-11D-1845-08 TCGA-76-6657-01A-11D-1844-05 TCGA-76-6657-01A-11D-1842-01 TCGA-76-6657-01A-11D-1842-01 +TCGA-76-6660-01 TCGA-76-6660-01 BRCA-LUAD+ C10-GBM GBM non-CIMP c15 KIRC-like c1 mutation c1uster 10 TCGA-76-6660 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 73 TCGA-76-6660-F71538 TCGA-76-6660 TCGA-76-6660-01A -26913 114 0 2015-3-26 MALE Glioblastoma Multiforme (GBM) No C71.9 9440/3 C71.9 YES Tumor resection 0.6 NO 0 1 NO No TCGA-76-6660.230f31a8-f9b9-46a9-b7d3-d09a4fad5ee1.pdf 6660 WITH TUMOR NO Primary Tumor 01 0.2 YES YES 76 Brain A DECEASED 2010 TCGA-76-6660-01A-11D-1845-08 TCGA-76-6660-01A-11D-1844-05 TCGA-76-6660-01A-11D-1842-01 TCGA-76-6660-01A-11D-1842-01 +TCGA-76-6661-01 TCGA-76-6661-01 GBM C10-GBM GBM non-CIMP c15 squamous c3 mutation cluster 14 TCGA-76-6661 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 54 TCGA-76-6661-F71543 TCGA-76-6661 TCGA-76-6661-01B -19965 727 0 7 2 2015-3-26 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 0.8 NO 60 1 NO TCGA-76-6661.ebdc6747-57b5-4d88-a9cd-9222a7f71129.pdf 6661 Preoperative WITH TUMOR NO Primary Tumor 01 0.6 76 Brain B DECEASED 2011 TCGA-76-6661-01B-11D-1845-08 TCGA-76-6661-01B-11D-1844-05 TCGA-76-6661-01B-11D-1842-01 TCGA-76-6661-01B-11D-1842-01 +TCGA-76-6662-01 TCGA-76-6662-01 GBM C10-GBM GBM non-CIMP c15 GBM-like c2 mutation cluster 3 TCGA-76-6662 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES NO 58 TCGA-76-6662-F30219 TCGA-76-6662 TCGA-76-6662-01A -21511 1048 0 282 205 1 2015-3-26 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 0.9 NO 80 1.2 NO Progression of Disease TCGA-76-6662.58dd362c-d11c-4b10-9b2b-40e3d2ba3192.pdf 6662 Post-Adjuvant Therapy WITH TUMOR NO Primary Tumor 01 0.4 76 Brain A DECEASED 2011 TCGA-76-6662-01A-11D-1845-08 TCGA-76-6662-01A-11D-1844-05 TCGA-76-6662-01A-11D-1842-01 TCGA-76-6662-01A-11D-1842-01 +TCGA-76-6663-01 TCGA-76-6663-01 GBM C10-GBM GBM non-CIMP c15 GBM-like c2 mutation cluster 13 TCGA-76-6663 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 44 TCGA-76-6663-F71545 TCGA-76-6663 TCGA-76-6663-01A -16126 567 0 235 1 2015-3-26 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 0.9 NO 80 1 NO TCGA-76-6663.e6733441-1472-4deb-9654-8f5059b0b72c.pdf 6663 Preoperative WITH TUMOR NO Primary Tumor 01 0.5 76 Brain A DECEASED 2011 TCGA-76-6663-01A-11D-1845-08 TCGA-76-6663-01A-11D-1844-05 TCGA-76-6663-01A-11D-1842-01 TCGA-76-6663-01A-11D-1842-01 +TCGA-76-6664-01 TCGA-76-6664-01 GBM C10-GBM GBM non-CIMP c15 GBM-like c2 mutation cluster 8 TCGA-76-6664 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 49 TCGA-76-6664-F71546 TCGA-76-6664 TCGA-76-6664-01A -18054 0 1101 1 2015-3-31 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 0.6 NO 80 1 NO TCGA-76-6664.140f178d-a96f-4f36-bace-1199ebb43964.pdf 6664 Preoperative WITH TUMOR NO Primary Tumor 01 0.5 76 Brain A LIVING 2011 TCGA-76-6664-01A-11D-1845-08 TCGA-76-6664-01A-11D-1844-05 TCGA-76-6664-01A-11D-1842-01 TCGA-76-6664-01A-11D-1842-01 +TCGA-81-5910-01 TCGA-81-5910-01 GBM C10-GBM GBM non-CIMP c15 GBM-like c2 mutation cluster 7 TCGA-81-5910 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 64 TCGA-81-5910-F28600 TCGA-81-5910 -23567 49 0 3 2011-6-7 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 40 5910 Other WITH TUMOR NO NO NO Primary Tumor 01 81 Brain DECEASED 2009 TCGA-81-5910-01 TCGA-81-5910-01A-11D-1696-08 TCGA-81-5910-01A-11D-1697-05 TCGA-81-5910-01 TCGA-81-5910-01A-11D-1694-01 TCGA-81-5910-01A-11D-1694-01 +TCGA-81-5911-01 TCGA-81-5911-01 GBM GBM non-CIMP c15 mutation cluster 7 TCGA-81-5911 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain YES YES 33 TCGA-81-5911-F28602 TCGA-81-5911 TCGA-81-5911-01A -12292 0 539 277 1 2011-11-14 MALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection 0.6 NO 1 Progression of Disease TCGA-81-5911.ceff84e7-7dac-4312-92fe-174cb3da3205.pdf 5911 Pre-Adjuvant Therapy WITH TUMOR YES NO YES Primary Tumor 01 0.5 81 Brain A LIVING 2010 TCGA-81-5911-01A-12D-1845-08 TCGA-81-5911-01A-12D-1844-05 TCGA-81-5911-01A-12D-1842-01 TCGA-81-5911-01A-12D-1842-01 +TCGA-87-5896-01 TCGA-87-5896-01 GBM GBM non-CIMP c15 mutation cluster 12 TCGA-87-5896 TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 50 TCGA-87-5896-F43207 TCGA-87-5896 -18391 0 800 Scheduled Follow-up Submission Complete Remission/Response 2013-5-15 FEMALE Untreated primary (de novo) GBM No C71.9 9440/3 C71.9 YES Tumor resection NO NO 5896 TUMOR FREE YES Complete Remission/Response NO YES Primary Tumor 01 87 Brain LIVING 2010 TCGA-87-5896-01 TCGA-87-5896-01A-01D-1696-08 TCGA-87-5896-01A-01D-1697-05 TCGA-87-5896-01 TCGA-87-5896-01A-01D-1694-01 TCGA-87-5896-01A-01D-1694-01 +TCGA-CS-4938-01 TCGA-CS-4938-01 TCGA-CS-4938 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 31 YES Dog, Cat NO TCGA-CS-4938-F71559 TCGA-CS-4938 TCGA-CS-4938-01B -11509 0 3574 -1 1 NO YES YES 12 - 20 Years Seizures > 181 Days Stable Disease NO 2015-3-30 FEMALE NO NO Astrocytoma NO No C71.9 9400/3 C71.9 YES 0.6 NO 90 Right NO 1.5 NO NO NO NO G2 No TCGA-CS-4938.36632fe7-c93d-4cad-bd58-2d259d36127c.pdf 4938 Preoperative WITH TUMOR NO NO Primary Tumor 01 YES NO 0.3 Cerebral Cortex NO YES CS Supratentorial, Frontal Lobe Central nervous system B NO LIVING 2005 0270b7ae-ef7f-4dd7-b019-3e10afa191ff TCGA-CS-4938-01B-11D-1893-08 TCGA-CS-4938-01B-11D-1894-05 TCGA-CS-4938-01B-11D-1892-01 TCGA-CS-4938-01 0270b7ae-ef7f-4dd7-b019-3e10afa191ff TCGA-CS-4938-01 TCGA-CS-4938-01B-11D-1892-01 0270b7ae-ef7f-4dd7-b019-3e10afa191ff +TCGA-CS-4941-01 TCGA-CS-4941-01 TCGA-CS-4941 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain NO YES YES NO 67 NO NO TCGA-CS-4941-F10024 TCGA-CS-4941 77 77 -24578 234 0 9 82 1 NO Headaches 0 - 30 Days Progressive Disease NO 2011-3-16 MALE NO YES Astrocytoma NO No C71.9 9401/3 C71.9 YES NO 90 Right NO NO G3 YES No 4941 Post-Adjuvant Therapy WITH TUMOR Stable Disease YES Primary Tumor 01 Cerebral Cortex YES NO YES CS Supratentorial, Frontal Lobe Central nervous system DECEASED 2005 f48c7bd0-048b-411e-a99c-4a6af9df51e4 TCGA-CS-4941-01A-01D-1468-08 TCGA-CS-4941-01A-01D-1467-05 TCGA-CS-4941-01A-01D-1466-01 TCGA-CS-4941-01 f48c7bd0-048b-411e-a99c-4a6af9df51e4 TCGA-CS-4941-01 TCGA-CS-4941-01A-01D-1466-01 f48c7bd0-048b-411e-a99c-4a6af9df51e4 +TCGA-CS-4942-01 TCGA-CS-4942-01 TCGA-CS-4942 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain YES YES YES NO 44 NO NO TCGA-CS-4942-F10210 TCGA-CS-4942 1189 1189 -16297 1335 0 1184 1226 2 NO NO NO Mental Status Changes 0 - 30 Days Progressive Disease NO 2011-3-14 FEMALE NO NO Astrocytoma NO No C71.9 9401/3 C71.9 YES NO 70 Right NO YES NO YES G3 YES No 4942 Preoperative WITH TUMOR NO NO Progressive Disease YES Primary Tumor 01 YES YES White Matter NO NO YES CS Supratentorial, Frontal Lobe Central nervous system NO DECEASED 2006 ff2d7d80-5256-4f05-bcd8-aa9d2816676d TCGA-CS-4942-01A-01D-1468-08 TCGA-CS-4942-01A-01D-1467-05 TCGA-CS-4942-01A-01D-1466-01 TCGA-CS-4942-01 ff2d7d80-5256-4f05-bcd8-aa9d2816676d TCGA-CS-4942-01 TCGA-CS-4942-01A-01D-1466-01 ff2d7d80-5256-4f05-bcd8-aa9d2816676d +TCGA-CS-4943-01 TCGA-CS-4943-01 TCGA-CS-4943 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 37 TCGA-CS-4943-F71549 TCGA-CS-4943 TCGA-CS-4943-01A -13565 1106 0 481 9 4 Seizures > 181 Days 2015-3-26 MALE YES Astrocytoma NO No C71.9 9401/3 C71.9 YES 0.5 NO 50 Left NO 0.6 NO G3 No TCGA-CS-4943.c7cbbdb2-8ec4-4e6e-836e-2577cda328dc.pdf 4943 Preoperative WITH TUMOR YES Primary Tumor 01 YES 0.1 Cerebral Cortex NO YES CS Supratentorial, Frontal Lobe Central nervous system A DECEASED 2009 910af7ad-94b5-478e-a2ac-e9f524ef020b TCGA-CS-4943-01A-01D-1468-08 TCGA-CS-4943-01A-01D-1467-05 TCGA-CS-4943-01A-01D-1466-01 TCGA-CS-4943-01 910af7ad-94b5-478e-a2ac-e9f524ef020b TCGA-CS-4943-01 TCGA-CS-4943-01A-01D-1466-01 910af7ad-94b5-478e-a2ac-e9f524ef020b +TCGA-CS-4944-01 TCGA-CS-4944-01 TCGA-CS-4944 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 50 TCGA-CS-4944-F71553 TCGA-CS-4944 TCGA-CS-4944-01A -18494 0 1828 -2 1 Mental Status Changes Progressive Disease 2015-3-30 MALE NO Astrocytoma NO No C71.9 9400/3 C71.9 YES NO 0.7 NO 90 Right NO 1 NO YES NO G2 NO No TCGA-CS-4944.6845998b-b702-4f92-85bb-ed8405bf0051.pdf 4944 Preoperative WITH TUMOR Primary Tumor 01 NO 0.3 Cerebral Cortex NO YES CS Supratentorial, Temporal Lobe Central nervous system A NO LIVING 2010 3ddd5316-2077-41c0-87fa-80be17d77f2b TCGA-CS-4944-01A-01D-1468-08 TCGA-CS-4944-01A-01D-1467-05 TCGA-CS-4944-01A-01D-1466-01 TCGA-CS-4944-01 3ddd5316-2077-41c0-87fa-80be17d77f2b TCGA-CS-4944-01 TCGA-CS-4944-01A-01D-1466-01 3ddd5316-2077-41c0-87fa-80be17d77f2b +TCGA-CS-5390-01 TCGA-CS-5390-01 TCGA-CS-5390 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 47 NO TCGA-CS-5390-F71691 TCGA-CS-5390 -17460 0 1848 0 NO NO NO Sensory Changes Stable Disease 2015-3-30 FEMALE NO Oligodendroglioma NO No C71.9 9450/3 C71.9 YES 100 Right NO NO NO NO YES G2 [Discrepancy] No 5390 Post-Adjuvant Therapy WITH TUMOR NO [Discrepancy] Primary Tumor 01 NO YES Cerebral Cortex NO YES CS Supratentorial, Parietal Lobe Central nervous system DECEASED 2005 d6d3dab0-2580-41f9-975b-f12b390034fd TCGA-CS-5390-01A-02D-1468-08 TCGA-CS-5390-01A-02D-1467-05 TCGA-CS-5390-01A-02D-1466-01 TCGA-CS-5390-01 d6d3dab0-2580-41f9-975b-f12b390034fd TCGA-CS-5390-01 TCGA-CS-5390-01A-02D-1466-01 d6d3dab0-2580-41f9-975b-f12b390034fd +TCGA-CS-5393-01 TCGA-CS-5393-01 TCGA-CS-5393 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 39 NO TCGA-CS-5393-F10073 TCGA-CS-5393 TCGA-CS-5393-01A -14418 0 1222 857 0 NO NO Headaches 91 - 180 Days Complete Remission/Response 2011-3-13 MALE YES Astrocytoma YES No C71.9 9401/3 C71.9 YES 1 NO 100 Left NO 1.6 NO NO G3 NO No TCGA-CS-5393.760b381f-f65d-4a68-a1e6-381afda2d805.pdf 5393 Post-Adjuvant Therapy TUMOR FREE NO Complete Remission/Response YES Primary Tumor 01 NO NO 0.3 Cerebral Cortex YES NO YES CS Supratentorial, Temporal Lobe Central nervous system A NO LIVING 2008 05e8c2a3-20fa-4324-b147-8a94948bda68 TCGA-CS-5393-01A-01D-1468-08 TCGA-CS-5393-01A-01D-1467-05 TCGA-CS-5393-01A-01D-1466-01 TCGA-CS-5393-01 05e8c2a3-20fa-4324-b147-8a94948bda68 TCGA-CS-5393-01 TCGA-CS-5393-01A-01D-1466-01 05e8c2a3-20fa-4324-b147-8a94948bda68 +TCGA-CS-5394-01 TCGA-CS-5394-01 TCGA-CS-5394 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 40 NO NO TCGA-CS-5394-F71692 TCGA-CS-5394 TCGA-CS-5394-01A -14920 0 8 -1 NO Seizures 0 - 30 Days NO 2015-3-31 MALE NO NO Astrocytoma NO No C71.9 9401/3 C71.9 YES 0.7 NO Left 1.2 YES NO NO NO G3 No TCGA-CS-5394.e2716cb5-e02c-4867-ba99-fe8337878d9c.pdf 5394 YES YES Primary Tumor 01 YES NO 0.6 Cerebral Cortex NO YES CS Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2005 84c59879-1b8a-4750-8069-9d0e434fa0dc TCGA-CS-5394-01A-01D-1467-05 TCGA-CS-5394-01A-01D-1466-01 TCGA-CS-5394-01 84c59879-1b8a-4750-8069-9d0e434fa0dc TCGA-CS-5394-01 TCGA-CS-5394-01A-01D-1466-01 84c59879-1b8a-4750-8069-9d0e434fa0dc +TCGA-CS-5395-01 TCGA-CS-5395-01 TCGA-CS-5395 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain NO NO YES YES 43 TCGA-CS-5395-F10075 TCGA-CS-5395 TCGA-CS-5395-01A 287 287 -15848 639 0 287 379 2 Progressive Disease 2011-3-13 MALE Oligodendroglioma NO No C71.9 9382/3 C71.9 YES 1 NO 80 Right NO 1.5 G2 YES No TCGA-CS-5395.509c2da8-c6cf-4803-a643-e42ad2e4d1f0.pdf 5395 Preoperative WITH TUMOR Progressive Disease YES Primary Tumor 01 0.1 Cerebral Cortex YES NO YES CS Supratentorial, Parietal Lobe Central nervous system A DECEASED 2007 6ff35e89-30b4-447e-9ef5-b67210b7859d TCGA-CS-5395-01A-01D-1468-08 TCGA-CS-5395-01A-01D-1467-05 TCGA-CS-5395-01A-01D-1466-01 TCGA-CS-5395-01 6ff35e89-30b4-447e-9ef5-b67210b7859d TCGA-CS-5395-01 TCGA-CS-5395-01A-01D-1466-01 6ff35e89-30b4-447e-9ef5-b67210b7859d +TCGA-CS-5396-01 TCGA-CS-5396-01 TCGA-CS-5396 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 53 NO TCGA-CS-5396-F71560 TCGA-CS-5396 TCGA-CS-5396-01A -19399 0 1631 20 1 NO YES YES Headaches Stable Disease 2015-3-30 FEMALE YES Oligodendroglioma NO No C71.9 9451/3 C71.9 YES NO 0.9 NO 90 Right NO 1.6 NO NO NO G3 No TCGA-CS-5396.7ae9d388-1145-4549-91fe-0b8dc6d180fa.pdf 5396 Preoperative WITH TUMOR [Discrepancy] Primary Tumor 01 NO 0.8 Cerebral Cortex NO YES CS Supratentorial, Frontal Lobe Central nervous system A LIVING 2010 772424b5-73f8-434e-a565-1cde4aaa1126 TCGA-CS-5396-01A-02D-1468-08 TCGA-CS-5396-01A-02D-1467-05 TCGA-CS-5396-01A-02D-1466-01 TCGA-CS-5396-01 772424b5-73f8-434e-a565-1cde4aaa1126 TCGA-CS-5396-01 TCGA-CS-5396-01A-02D-1466-01 772424b5-73f8-434e-a565-1cde4aaa1126 +TCGA-CS-5397-01 TCGA-CS-5397-01 TCGA-CS-5397 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 54 NO NO TCGA-CS-5397-F17567 TCGA-CS-5397 -19866 194 0 -1 1 NO YES NO Sensory Changes NO 2011-9-23 FEMALE NO NO Astrocytoma NO No C71.9 9401/3 C71.9 YES 80 Left NO NO NO YES G3 NO No 5397 Preoperative WITH TUMOR NO NO Progressive Disease YES Primary Tumor 01 NO YES Cerebral Cortex YES NO YES CS Supratentorial, Temporal Lobe Central nervous system NO DECEASED 2010 c1d8d162-5154-4d6a-8166-6e4e8bf5cc8d TCGA-CS-5397-01A-01D-1893-08 TCGA-CS-5397-01A-01D-1894-05 TCGA-CS-5397-01A-01D-1892-01 TCGA-CS-5397-01 c1d8d162-5154-4d6a-8166-6e4e8bf5cc8d TCGA-CS-5397-01 TCGA-CS-5397-01A-01D-1892-01 c1d8d162-5154-4d6a-8166-6e4e8bf5cc8d +TCGA-CS-6186-01 TCGA-CS-6186-01 TCGA-CS-6186 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain YES YES YES NO 58 NO NO TCGA-CS-6186-F18628 TCGA-CS-6186 213 -21321 538 0 188 212 1 NO NO NO Seizures 0 - 30 Days Scheduled Follow-up Submission Progressive Disease NO 2011-11-18 MALE NO NO Oligoastrocytoma NO No C71.9 9382/3 C71.9 YES NO 80 Right NO NO NO NO G3 YES No 6186 Post-Adjuvant Therapy WITH TUMOR NO NO Progressive Disease YES Primary Tumor 01 YES NO Cerebral Cortex YES NO YES CS Supratentorial, Frontal Lobe Central nervous system NO DECEASED 2009 f09a51df-011a-419e-b90a-7cd2037c5690 TCGA-CS-6186-01A-12D-2024-08 TCGA-CS-6186-01A-12D-2025-05 TCGA-CS-6186-01A-12D-2023-01 TCGA-CS-6186-01 f09a51df-011a-419e-b90a-7cd2037c5690 TCGA-CS-6186-01 TCGA-CS-6186-01A-12D-2023-01 f09a51df-011a-419e-b90a-7cd2037c5690 +TCGA-CS-6188-01 TCGA-CS-6188-01 TCGA-CS-6188 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 48 NO NO TCGA-CS-6188-F71551 TCGA-CS-6188 TCGA-CS-6188-01A -17729 814 0 725 -1 1 NO YES YES Seizures 0 - 30 Days NO 2015-3-26 MALE NO NO Astrocytoma NO No C71.9 9401/3 C71.9 YES 0.8 NO 90 Right NO 1.2 NO NO NO NO G3 No TCGA-CS-6188.e85d2ddf-98e1-4a02-bde1-47603463f7fd.pdf 6188 Preoperative WITH TUMOR NO NO Primary Tumor 01 YES NO 0.4 Cerebral Cortex NO YES CS Supratentorial, Temporal Lobe Central nervous system A NO DECEASED 2009 66770b06-2cd6-4773-b8e8-5b38faa4f5a4 TCGA-CS-6188-01A-11D-1893-08 TCGA-CS-6188-01A-11D-1894-05 TCGA-CS-6188-01A-11D-1892-01 TCGA-CS-6188-01 66770b06-2cd6-4773-b8e8-5b38faa4f5a4 TCGA-CS-6188-01 TCGA-CS-6188-01A-11D-1892-01 66770b06-2cd6-4773-b8e8-5b38faa4f5a4 +TCGA-CS-6290-01 TCGA-CS-6290-01 TCGA-CS-6290 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 31 NO NO TCGA-CS-6290-F71693 TCGA-CS-6290 TCGA-CS-6290-01A -11666 1137 0 546 -1 1 NO YES NO Seizures 0 - 30 Days NO 2015-3-30 MALE NO NO Astrocytoma NO No C71.9 9401/3 C71.9 YES 0.4 NO 90 Left NO 0.4 NO NO NO NO G3 No TCGA-CS-6290.4d5bdf18-7799-463d-a33a-beb8322b0621.pdf 6290 Preoperative NO NO Primary Tumor 01 YES NO 0.4 Cerebral Cortex NO YES CS Supratentorial, Temporal Lobe Central nervous system A NO DECEASED 2009 59b2f45a-f731-4ebc-9e7c-c9748aee3f60 TCGA-CS-6290-01A-11D-1705-08 TCGA-CS-6290-01A-11D-1706-05 TCGA-CS-6290-01A-11D-1704-01 TCGA-CS-6290-01 59b2f45a-f731-4ebc-9e7c-c9748aee3f60 TCGA-CS-6290-01 TCGA-CS-6290-01A-11D-1704-01 59b2f45a-f731-4ebc-9e7c-c9748aee3f60 +TCGA-CS-6665-01 TCGA-CS-6665-01 TCGA-CS-6665 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 51 NO NO TCGA-CS-6665-F71561 TCGA-CS-6665 -18977 0 1568 -1 1 NO NO NO Seizures 0 - 30 Days Stable Disease YES Hazelnuts 2015-3-30 FEMALE NO NO Astrocytoma NO No C71.9 9401/3 C71.9 YES 90 Right NO NO NO NO NO G3 Yes 6665 Preoperative WITH TUMOR NO NO Stable Disease Primary Tumor 01 YES NO Cerebral Cortex NO YES CS Supratentorial, Temporal Lobe Central nervous system NO LIVING 2010 cb2bd908-4900-4fc2-93c6-7f7ef3efbbed TCGA-CS-6665-01A-11D-1893-08 TCGA-CS-6665-01A-11D-1894-05 TCGA-CS-6665-01A-11D-1892-01 TCGA-CS-6665-01 cb2bd908-4900-4fc2-93c6-7f7ef3efbbed TCGA-CS-6665-01 TCGA-CS-6665-01A-11D-1892-01 cb2bd908-4900-4fc2-93c6-7f7ef3efbbed +TCGA-CS-6666-01 TCGA-CS-6666-01 TCGA-CS-6666 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 22 NO NO TCGA-CS-6666-F71562 TCGA-CS-6666 -8340 0 1428 -1 1 NO YES NO Headaches Complete Remission/Response NO 2015-3-30 MALE NO YES Astrocytoma NO No C71.9 9401/3 C71.9 YES 90 Right NO NO NO NO NO G3 NO No 6666 Preoperative TUMOR FREE NO NO Complete Remission/Response Primary Tumor 01 NO NO Cerebral Cortex NO YES CS Supratentorial, Parietal Lobe Central nervous system NO LIVING 2010 a990f055-6b58-49c2-8424-4a3f3f5f91f9 TCGA-CS-6666-01A-11D-1893-08 TCGA-CS-6666-01A-11D-1894-05 TCGA-CS-6666-01A-11D-1892-01 TCGA-CS-6666-01 a990f055-6b58-49c2-8424-4a3f3f5f91f9 TCGA-CS-6666-01 TCGA-CS-6666-01A-11D-1892-01 a990f055-6b58-49c2-8424-4a3f3f5f91f9 +TCGA-CS-6667-01 TCGA-CS-6667-01 TCGA-CS-6667 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 39 NO NO TCGA-CS-6667-F71563 TCGA-CS-6667 TCGA-CS-6667-01A -14375 0 1469 -1 1 NO YES NO Motor/Movement Changes 91 - 180 Days Stable Disease NO 2015-3-30 FEMALE YES NO Astrocytoma NO No C71.9 9400/3 C71.9 YES 0.6 NO 90 Left NO 0.6 NO NO YES YES G2 No TCGA-CS-6667.18c7ebd7-0bdc-42e2-97a7-bf8715b01183.pdf 6667 Preoperative WITH TUMOR NO NO Stable Disease Primary Tumor 01 NO YES 0.2 Cerebral Cortex NO YES CS Supratentorial, Parietal Lobe Central nervous system A NO LIVING 2010 20108871-61a3-4160-8a9d-c5e4481143a6 TCGA-CS-6667-01A-12D-2024-08 TCGA-CS-6667-01A-12D-2025-05 TCGA-CS-6667-01A-12D-2023-01 TCGA-CS-6667-01 20108871-61a3-4160-8a9d-c5e4481143a6 TCGA-CS-6667-01 TCGA-CS-6667-01A-12D-2023-01 20108871-61a3-4160-8a9d-c5e4481143a6 +TCGA-CS-6668-01 TCGA-CS-6668-01 TCGA-CS-6668 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 57 NO NO TCGA-CS-6668-F71564 TCGA-CS-6668 TCGA-CS-6668-01A -20836 0 1519 -1 1 NO YES NO Seizures > 181 Days Stable Disease NO 2015-3-30 FEMALE NO NO Oligodendroglioma NO No C71.9 9450/3 C71.9 YES 0.6 NO 90 Left NO 1 NO NO NO YES G2 No TCGA-CS-6668.d5604d22-f9c7-4eb3-af92-44d0f999a905.pdf 6668 Preoperative WITH TUMOR NO NO Stable Disease Primary Tumor 01 YES NO 0.5 Cerebral Cortex NO YES CS Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2011 129df624-1d84-49b8-ab0e-0001cc150607 TCGA-CS-6668-01A-11D-1893-08 TCGA-CS-6668-01A-11D-1894-05 TCGA-CS-6668-01A-11D-1892-01 TCGA-CS-6668-01 129df624-1d84-49b8-ab0e-0001cc150607 TCGA-CS-6668-01 TCGA-CS-6668-01A-11D-1892-01 129df624-1d84-49b8-ab0e-0001cc150607 +TCGA-CS-6669-01 TCGA-CS-6669-01 TCGA-CS-6669 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 26 NO NO TCGA-CS-6669-F71567 TCGA-CS-6669 -9809 0 1494 0 1 NO YES NO Headaches 31 - 90 Days Stable Disease NO 2015-3-30 FEMALE NO YES Oligodendroglioma NO No C71.9 9450/3 C71.9 YES 90 Right NO NO NO NO NO G2 No 6669 Preoperative WITH TUMOR NO NO Stable Disease Primary Tumor 01 YES NO Cerebral Cortex NO YES CS Supratentorial, Temporal Lobe Central nervous system NO LIVING 2011 f107ba9e-f52a-4a6b-b659-8dabf17c9120 TCGA-CS-6669-01A-11D-1893-08 TCGA-CS-6669-01A-11D-1894-05 TCGA-CS-6669-01A-11D-1892-01 TCGA-CS-6669-01 f107ba9e-f52a-4a6b-b659-8dabf17c9120 TCGA-CS-6669-01 TCGA-CS-6669-01A-11D-1892-01 f107ba9e-f52a-4a6b-b659-8dabf17c9120 +TCGA-CS-6670-01 TCGA-CS-6670-01 TCGA-CS-6670 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 43 NO NO TCGA-CS-6670-F71568 TCGA-CS-6670 -16066 0 1426 NO NO NO Headaches 31 - 90 Days Progressive Disease NO 2015-3-30 MALE NO YES Oligodendroglioma NO Yes C71.9 9451/3 C71.9 YES Right NO NO NO NO NO G3 Yes 6670 WITH TUMOR NO NO [Discrepancy] Primary Tumor 01 NO NO Cerebral Cortex CS Supratentorial, Temporal Lobe Central nervous system NO LIVING 2011 a51a4c9e-c160-4a29-8b72-3c1ff60b0107 TCGA-CS-6670-01A-11D-1893-08 TCGA-CS-6670-01A-11D-1894-05 TCGA-CS-6670-01A-11D-1892-01 TCGA-CS-6670-01 a51a4c9e-c160-4a29-8b72-3c1ff60b0107 TCGA-CS-6670-01 TCGA-CS-6670-01A-11D-1892-01 a51a4c9e-c160-4a29-8b72-3c1ff60b0107 +TCGA-DB-5270-01 TCGA-DB-5270-01 TCGA-DB-5270 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 38 YES Bee/Wasp NO TCGA-DB-5270-F42829 TCGA-DB-5270 TCGA-DB-5270-01A -13904 0 3733 NO NO Seizures 0 - 30 Days Scheduled Follow-up Submission Complete Remission/Response NO 2013-5-1 FEMALE NO NO Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES NO 1 NO Left NO 1 NO NO NO NO G3 NO No TCGA-DB-5270.dd42d675-2630-4ae6-9f3b-9595dafee3ea.pdf 5270 TUMOR FREE YES NO Complete Remission/Response NO Primary Tumor 01 YES NO 0.7 Cerebral Cortex NO NO YES DB Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2002 6679ab80-6b49-4779-88e8-a311e16c96f7 TCGA-DB-5270-01A-02D-1468-08 TCGA-DB-5270-01A-02D-1467-05 TCGA-DB-5270-01A-02D-1466-01 TCGA-DB-5270-01 6679ab80-6b49-4779-88e8-a311e16c96f7 TCGA-DB-5270-01 TCGA-DB-5270-01A-02D-1466-01 6679ab80-6b49-4779-88e8-a311e16c96f7 +TCGA-DB-5273-01 TCGA-DB-5273-01 TCGA-DB-5273 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 33 NO NO TCGA-DB-5273-F42830 TCGA-DB-5273 -12152 0 2493 NO NO NO Seizures 0 - 30 Days Scheduled Follow-up Submission Complete Remission/Response NO 2013-5-1 MALE NO NO Astrocytoma NO No C71.0 9401/3 C71.0 YES NO Right NO NO NO NO YES G3 NO No 5273 TUMOR FREE YES NO Complete Remission/Response YES Primary Tumor 01 YES NO Cerebral Cortex YES NO YES DB Supratentorial, Frontal Lobe Central nervous system NO LIVING 2006 ed075623-6495-4eab-a15d-ab68d5ca0999 TCGA-DB-5273-01A-01D-1468-08 TCGA-DB-5273-01A-01D-1467-05 TCGA-DB-5273-01A-01D-1466-01 TCGA-DB-5273-01 ed075623-6495-4eab-a15d-ab68d5ca0999 TCGA-DB-5273-01 TCGA-DB-5273-01A-01D-1466-01 ed075623-6495-4eab-a15d-ab68d5ca0999 +TCGA-DB-5274-01 TCGA-DB-5274-01 TCGA-DB-5274 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 37 NO TCGA-DB-5274-F42834 TCGA-DB-5274 -13680 0 2289 12 1 NO NO NO Headaches 31 - 90 Days Scheduled Follow-up Submission Complete Remission/Response NO 2013-5-1 FEMALE NO YES Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES NO 80 Left NO NO NO NO G3 NO No 5274 Preoperative TUMOR FREE YES YES Complete Remission/Response YES Primary Tumor 01 NO NO Cerebral Cortex YES NO YES DB Supratentorial, Frontal Lobe Central nervous system NO LIVING 2006 e42fd909-d0b3-4b6d-8b2b-008ad7b7945c TCGA-DB-5274-01A-01D-1468-08 TCGA-DB-5274-01A-01D-1467-05 TCGA-DB-5274-01A-01D-1466-01 TCGA-DB-5274-01 e42fd909-d0b3-4b6d-8b2b-008ad7b7945c TCGA-DB-5274-01 TCGA-DB-5274-01A-01D-1466-01 e42fd909-d0b3-4b6d-8b2b-008ad7b7945c +TCGA-DB-5275-01 TCGA-DB-5275-01 TCGA-DB-5275 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 36 NO NO TCGA-DB-5275-F67391 TCGA-DB-5275 -13371 0 1458 NO NO NO Headaches Scheduled Follow-up Submission YES lactose containing products 2014-11-4 MALE NO YES Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES NO Right YES YES NO NO G3 No 5275 TUMOR FREE NO NO Complete Remission/Response YES Primary Tumor 01 NO NO Cerebral Cortex YES NO YES DB Supratentorial, Temporal Lobe Central nervous system NO LIVING 2006 eecd47a0-bde3-438b-b87a-f4e440228579 TCGA-DB-5275-01A-01D-1468-08 TCGA-DB-5275-01A-01D-1467-05 TCGA-DB-5275-01A-01D-1466-01 TCGA-DB-5275-01 eecd47a0-bde3-438b-b87a-f4e440228579 TCGA-DB-5275-01 TCGA-DB-5275-01A-01D-1466-01 eecd47a0-bde3-438b-b87a-f4e440228579 +TCGA-DB-5276-01 TCGA-DB-5276-01 TCGA-DB-5276 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 32 NO TCGA-DB-5276-F42832 TCGA-DB-5276 -11738 0 2218 NO NO NO Seizures 0 - 30 Days Scheduled Follow-up Submission Complete Remission/Response NO 2013-5-1 MALE NO NO Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES NO Left NO NO NO NO G3 NO No 5276 TUMOR FREE YES YES Complete Remission/Response YES Primary Tumor 01 YES NO Cerebral Cortex YES NO YES DB Supratentorial, Frontal Lobe Central nervous system NO LIVING 2007 e93a5c0b-9c66-46d2-a8d6-ae969b28a501 TCGA-DB-5276-01A-01D-1468-08 TCGA-DB-5276-01A-01D-1467-05 TCGA-DB-5276-01A-01D-1466-01 TCGA-DB-5276-01 e93a5c0b-9c66-46d2-a8d6-ae969b28a501 TCGA-DB-5276-01 TCGA-DB-5276-01A-01D-1466-01 e93a5c0b-9c66-46d2-a8d6-ae969b28a501 +TCGA-DB-5277-01 TCGA-DB-5277-01 TCGA-DB-5277 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain YES YES NO 34 NO TCGA-DB-5277-F42826 TCGA-DB-5277 TCGA-DB-5277-01A -12725 1547 0 1419 1156 YES YES NO Seizures 0 - 30 Days Scheduled Follow-up Submission Progressive Disease YES seafood 2013-5-1 MALE YES YES Astrocytoma NO No C71.0 9401/3 C71.0 YES NO 1 NO Left 1.5 NO NO YES NO G3 YES No TCGA-DB-5277.5dd3f674-5ffa-45ce-98fd-db55ac716f8e.pdf 5277 WITH TUMOR YES NO Complete Remission/Response YES Primary Tumor 01 YES NO 0.1 Cerebral Cortex YES NO YES DB Supratentorial, Frontal Lobe Central nervous system A NO DECEASED 2007 6a2acb28-0ccb-4f10-aba9-4d8b2aa29b1d TCGA-DB-5277-01A-01D-1468-08 TCGA-DB-5277-01A-01D-1467-05 TCGA-DB-5277-01A-01D-1466-01 TCGA-DB-5277-01 6a2acb28-0ccb-4f10-aba9-4d8b2aa29b1d TCGA-DB-5277-01 TCGA-DB-5277-01A-01D-1466-01 6a2acb28-0ccb-4f10-aba9-4d8b2aa29b1d +TCGA-DB-5278-01 TCGA-DB-5278-01 TCGA-DB-5278 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 17 NO NO TCGA-DB-5278-F67393 TCGA-DB-5278 TCGA-DB-5278-01A -6480 0 2772 NO NO NO Seizures > 181 Days Scheduled Follow-up Submission NO 2014-11-7 MALE NO NO Oligodendroglioma NO No C71.0 9450/3 C71.0 YES NO 1.3 NO Left 1.8 NO YES NO YES G2 NO No TCGA-DB-5278.b9380181-eb0c-458b-b0c4-38cdf7e06edc.pdf 5278 WITH TUMOR YES NO Stable Disease NO Primary Tumor 01 YES NO 0.4 Cerebral Cortex NO NO YES DB Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2007 3cd458e4-4e4a-4360-b667-5953c1425f75 TCGA-DB-5278-01A-01D-1468-08 TCGA-DB-5278-01A-01D-1467-05 TCGA-DB-5278-01A-01D-1466-01 TCGA-DB-5278-01 3cd458e4-4e4a-4360-b667-5953c1425f75 TCGA-DB-5278-01 TCGA-DB-5278-01A-01D-1466-01 3cd458e4-4e4a-4360-b667-5953c1425f75 +TCGA-DB-5279-01 TCGA-DB-5279-01 TCGA-DB-5279 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 59 NO NO TCGA-DB-5279-F67396 TCGA-DB-5279 TCGA-DB-5279-01A -21908 0 1354 NO NO NO Seizures > 181 Days Scheduled Follow-up Submission Complete Remission/Response NO 2014-11-4 MALE NO NO Oligodendroglioma NO No C71.0 9450/3 C71.0 YES NO 1 NO Right 1.3 YES NO NO NO G2 No TCGA-DB-5279.74052ac9-36de-45e7-8716-c3e74245d43d.pdf 5279 TUMOR FREE YES YES Complete Remission/Response NO Primary Tumor 01 YES NO 0.4 Cerebral Cortex NO NO YES DB Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2007 4af34323-4cc9-4b69-b0cf-558bb9d8ee1a TCGA-DB-5279-01A-01D-1468-08 TCGA-DB-5279-01A-01D-1467-05 TCGA-DB-5279-01A-01D-1466-01 TCGA-DB-5279-01 4af34323-4cc9-4b69-b0cf-558bb9d8ee1a TCGA-DB-5279-01 TCGA-DB-5279-01A-01D-1466-01 4af34323-4cc9-4b69-b0cf-558bb9d8ee1a +TCGA-DB-5280-01 TCGA-DB-5280-01 TCGA-DB-5280 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 43 NO NO TCGA-DB-5280-F42831 TCGA-DB-5280 -15836 0 1112 NO NO NO Seizures 0 - 30 Days Scheduled Follow-up Submission Complete Remission/Response NO 2013-5-1 MALE NO NO Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES NO Right NO NO NO NO G2 NO No 5280 TUMOR FREE YES NO Complete Remission/Response NO Primary Tumor 01 YES NO Cerebral Cortex NO NO YES DB Supratentorial, Frontal Lobe Central nervous system NO LIVING 2007 b946f1d5-835d-4d78-a74d-2d19fa78eb0a TCGA-DB-5280-01A-01D-1468-08 TCGA-DB-5280-01A-01D-1467-05 TCGA-DB-5280-01A-01D-1466-01 TCGA-DB-5280-01 b946f1d5-835d-4d78-a74d-2d19fa78eb0a TCGA-DB-5280-01 TCGA-DB-5280-01A-01D-1466-01 b946f1d5-835d-4d78-a74d-2d19fa78eb0a +TCGA-DB-5281-01 TCGA-DB-5281-01 TCGA-DB-5281 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 61 NO NO TCGA-DB-5281-F42828 TCGA-DB-5281 TCGA-DB-5281-01A -22342 0 2381 NO NO NO Seizures 91 - 180 Days Scheduled Follow-up Submission Stable Disease NO 2013-5-1 MALE NO NO Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES NO 1 NO Left NO 2 NO YES NO NO G3 NO No TCGA-DB-5281.40462852-7dc3-4a3f-a4f3-7cd5a4adbd0d.pdf 5281 WITH TUMOR YES NO Stable Disease YES Primary Tumor 01 YES NO 0.5 Deep Gray (e.g.basal ganglia, thalamus) YES NO YES DB Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2006 59da9ec2-3d50-4c01-94ce-6da99d100adb TCGA-DB-5281-01A-01D-1468-08 TCGA-DB-5281-01A-01D-1467-05 TCGA-DB-5281-01A-01D-1466-01 TCGA-DB-5281-01 59da9ec2-3d50-4c01-94ce-6da99d100adb TCGA-DB-5281-01 TCGA-DB-5281-01A-01D-1466-01 59da9ec2-3d50-4c01-94ce-6da99d100adb +TCGA-DB-A4X9-01 TCGA-DB-A4X9-01 TCGA-DB-A4X9 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 33 NO TCGA-DB-A4X9-F60941 TCGA-DB-A4X9 TCGA-DB-A4X9-01A -12131 832 0 1412 NO YES NO Seizures > 181 Days Scheduled Follow-up Submission Complete Remission/Response 2014-6-19 FEMALE NO NO Oligoastrocytoma NO No C71.2 9382/3 C71.2 YES NO 460 NO Left YES IHC YES NO NO NO NO G2 NO true No TCGA-DB-A4X9.8C541033-3F59-4F35-9BA8-C5499B944094.pdf A4X9 TUMOR FREE YES NO Complete Remission/Response NO Primary Tumor 01 YES NO Cerebral Cortex NO YES NO DB Supratentorial, Temporal Lobe Central nervous system A NO LIVING 2010 66a0dece-b8d0-4d6a-a6d9-53985a507f77 TCGA-DB-A4X9-01A-11D-A26N-05 TCGA-DB-A4X9-01A-11D-A26L-01 TCGA-DB-A4X9-01 66a0dece-b8d0-4d6a-a6d9-53985a507f77 TCGA-DB-A4X9-01 TCGA-DB-A4X9-01A-11D-A26L-01 66a0dece-b8d0-4d6a-a6d9-53985a507f77 +TCGA-DB-A4XA-01 TCGA-DB-A4XA-01 TCGA-DB-A4XA TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 30 NO NO TCGA-DB-A4XA-F60947 TCGA-DB-A4XA TCGA-DB-A4XA-01A -11195 224 0 573 NO NO NO Seizures > 181 Days Scheduled Follow-up Submission NO 2014-6-19 MALE NO NO Oligoastrocytoma NO No C71.2 9382/3 C71.2 YES NO 140 NO Left YES IHC YES YES NO NO NO G2 NO true No TCGA-DB-A4XA.8DCE6400-9767-46DD-A965-5B02FEB3F156.pdf A4XA WITH TUMOR YES NO Stable Disease YES Primary Tumor 01 YES NO Cerebral Cortex NO YES NO DB Supratentorial, Parietal Lobe Central nervous system A NO LIVING 2012 9ea1bff8-51a1-4773-851c-5c8da0e79565 TCGA-DB-A4XA-01A-11D-A26N-05 TCGA-DB-A4XA-01A-11D-A26L-01 TCGA-DB-A4XA-01 9ea1bff8-51a1-4773-851c-5c8da0e79565 TCGA-DB-A4XA-01 TCGA-DB-A4XA-01A-11D-A26L-01 9ea1bff8-51a1-4773-851c-5c8da0e79565 +TCGA-DB-A4XB-01 TCGA-DB-A4XB-01 TCGA-DB-A4XB TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 38 NO TCGA-DB-A4XB-F60944 TCGA-DB-A4XB -13990 0 919 NO NO NO Seizures 31 - 90 Days Scheduled Follow-up Submission Complete Remission/Response 2014-6-19 MALE NO Astrocytoma NO No C71.4 9401/3 C71.4 YES NO Left YES IHC YES NO NO NO G3 NO No A4XB TUMOR FREE YES NO Stable Disease YES Primary Tumor 01 YES NO Cerebral Cortex YES YES NO DB Supratentorial, Parietal Lobe Central nervous system NO LIVING 2011 e10cc5f8-4d2e-4de5-a31c-5df6889e4ba8 TCGA-DB-A4XB-01A-11D-A26N-05 TCGA-DB-A4XB-01A-11D-A26L-01 TCGA-DB-A4XB-01 e10cc5f8-4d2e-4de5-a31c-5df6889e4ba8 TCGA-DB-A4XB-01 TCGA-DB-A4XB-01A-11D-A26L-01 e10cc5f8-4d2e-4de5-a31c-5df6889e4ba8 +TCGA-DB-A4XC-01 TCGA-DB-A4XC-01 TCGA-DB-A4XC TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 26 NO TCGA-DB-A4XC-F60948 TCGA-DB-A4XC -9705 0 1421 NO YES NO Seizures 0 - 30 Days Scheduled Follow-up Submission Stable Disease 2014-6-19 MALE NO Oligoastrocytoma NO No C71.2 9382/3 C71.2 YES NO Left NO NO NO NO G2 NO Yes, History of Synchronous/Bilateral Malignancy A4XC TUMOR FREE Partial Remission/Response YES Primary Tumor 01 YES NO Cerebral Cortex NO YES NO DB Supratentorial, Temporal Lobe Central nervous system NO LIVING 2010 ae83a679-8155-4f3a-9c9b-a3b73c8cd332 TCGA-DB-A4XC-01A-11D-A26N-05 TCGA-DB-A4XC-01A-11D-A26L-01 TCGA-DB-A4XC-01 ae83a679-8155-4f3a-9c9b-a3b73c8cd332 TCGA-DB-A4XC-01 TCGA-DB-A4XC-01A-11D-A26L-01 ae83a679-8155-4f3a-9c9b-a3b73c8cd332 +TCGA-DB-A4XD-01 TCGA-DB-A4XD-01 TCGA-DB-A4XD TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 32 NO TCGA-DB-A4XD-F60950 TCGA-DB-A4XD -11741 0 1210 YES NO NO 0 - 30 Days Scheduled Follow-up Submission Complete Remission/Response 2014-6-19 MALE NO Astrocytoma NO No C71.2 9401/3 C71.2 YES NO Right NO NO NO NO G3 NO No A4XD TUMOR FREE NO NO Complete Remission/Response YES Primary Tumor 01 NO NO Cerebral Cortex YES YES NO DB Supratentorial, Temporal Lobe Central nervous system NO LIVING 2010 e948362f-2ae6-437b-a01b-6a1026a8da72 TCGA-DB-A4XD-01A-11D-A27L-05 TCGA-DB-A4XD-01A-11D-A27J-01 TCGA-DB-A4XD-01 e948362f-2ae6-437b-a01b-6a1026a8da72 TCGA-DB-A4XD-01 TCGA-DB-A4XD-01A-11D-A27J-01 e948362f-2ae6-437b-a01b-6a1026a8da72 +TCGA-DB-A4XE-01 TCGA-DB-A4XE-01 TCGA-DB-A4XE TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 27 NO NO TCGA-DB-A4XE-F60953 TCGA-DB-A4XE -10150 0 1139 294 0 NO NO NO Seizures 31 - 90 Days Scheduled Follow-up Submission Complete Remission/Response NO 2014-6-19 FEMALE NO NO Oligoastrocytoma NO No C71.2 9382/3 C71.2 YES NO 90 Left NO NO NO NO G3 NO No A4XE Preoperative TUMOR FREE YES NO Complete Remission/Response YES Primary Tumor 01 YES NO Cerebral Cortex NO YES NO DB Supratentorial, Temporal Lobe Central nervous system NO LIVING 2011 a622534d-0108-4890-a0c5-4d1e12c25e44 TCGA-DB-A4XE-01A-11D-A27L-05 TCGA-DB-A4XE-01A-11D-A27J-01 TCGA-DB-A4XE-01 a622534d-0108-4890-a0c5-4d1e12c25e44 TCGA-DB-A4XE-01 TCGA-DB-A4XE-01A-11D-A27J-01 a622534d-0108-4890-a0c5-4d1e12c25e44 +TCGA-DB-A4XF-01 TCGA-DB-A4XF-01 TCGA-DB-A4XF TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 41 NO TCGA-DB-A4XF-F60956 TCGA-DB-A4XF TCGA-DB-A4XF-01A -15066 456 0 1021 NO YES NO Seizures 0 - 30 Days Scheduled Follow-up Submission Complete Remission/Response 2014-6-19 FEMALE YES Astrocytoma NO No C71.1 9401/3 C71.1 YES NO 300 NO Right NO NO NO NO G3 NO true No TCGA-DB-A4XF.E9D4CC67-D5FC-4E81-91EB-869D93114475.pdf A4XF TUMOR FREE YES NO Stable Disease YES Primary Tumor 01 YES NO Cerebral Cortex YES YES NO DB Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2011 276b4801-2b93-4224-99a2-d3fb73fca361 TCGA-DB-A4XF-01A-11D-A27L-05 TCGA-DB-A4XF-01A-11D-A27J-01 TCGA-DB-A4XF-01 276b4801-2b93-4224-99a2-d3fb73fca361 TCGA-DB-A4XF-01 TCGA-DB-A4XF-01A-11D-A27J-01 276b4801-2b93-4224-99a2-d3fb73fca361 +TCGA-DB-A4XG-01 TCGA-DB-A4XG-01 TCGA-DB-A4XG TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 34 NO NO TCGA-DB-A4XG-F60957 TCGA-DB-A4XG TCGA-DB-A4XG-01A -12550 2137 0 2219 NO NO NO Seizures 0 - 30 Days Scheduled Follow-up Submission NO 2014-6-19 MALE NO NO Oligodendroglioma NO No C71.1 9451/3 C71.1 YES NO 210 NO Right NO IHC YES YES NO NO NO G3 NO true No TCGA-DB-A4XG.A0776539-C1FE-4798-9F65-F807B3414E7C.pdf A4XG WITH TUMOR YES Stable Disease NO Primary Tumor 01 YES NO Cerebral Cortex YES YES NO DB Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2006 10bc3c22-c4ff-4d44-a44b-dc8dd2cbec2d TCGA-DB-A4XG-01A-11D-A27L-05 TCGA-DB-A4XG-01A-11D-A27J-01 TCGA-DB-A4XG-01 10bc3c22-c4ff-4d44-a44b-dc8dd2cbec2d TCGA-DB-A4XG-01 TCGA-DB-A4XG-01A-11D-A27J-01 10bc3c22-c4ff-4d44-a44b-dc8dd2cbec2d +TCGA-DB-A4XH-01 TCGA-DB-A4XH-01 TCGA-DB-A4XH TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 53 NO TCGA-DB-A4XH-F60959 TCGA-DB-A4XH -19710 0 962 NO NO NO Seizures 0 - 30 Days Scheduled Follow-up Submission Complete Remission/Response 2014-7-22 FEMALE NO Oligoastrocytoma NO No C71.1 9382/3 C71.1 YES NO Left NO NO NO NO G2 NO No A4XH TUMOR FREE YES YES Stable Disease NO Primary Tumor 01 YES NO Cerebral Cortex NO YES NO DB Supratentorial, Frontal Lobe Central nervous system NO LIVING 2011 c335d5b6-f135-4bbc-825a-f6ed1746fa0e TCGA-DB-A4XH-01A-11D-A27L-05 TCGA-DB-A4XH-01A-11D-A27J-01 TCGA-DB-A4XH-01 c335d5b6-f135-4bbc-825a-f6ed1746fa0e TCGA-DB-A4XH-01 TCGA-DB-A4XH-01A-11D-A27J-01 c335d5b6-f135-4bbc-825a-f6ed1746fa0e +TCGA-DB-A64L-01 TCGA-DB-A64L-01 TCGA-DB-A64L TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain NO NO NO NO 67 NO NO TCGA-DB-A64L-F62609 TCGA-DB-A64L -24690 0 736 724 8 NO YES NO Seizures 0 - 30 Days Scheduled Follow-up Submission Stable Disease 2014-11-7 FEMALE NO NO Oligodendroglioma NO No C71.0 9450/3 C71.0 YES YES 70 Right YES IHC YES NO NO NO NO G2 YES No A64L Preoperative WITH TUMOR YES Complete Remission/Response NO Primary Tumor 01 YES NO Cerebral Cortex NO YES NO DB Supratentorial, Frontal Lobe Central nervous system NO LIVING 2012 c0727365-8495-4a96-85b0-4a685627839e TCGA-DB-A64L-01A-11D-A29T-05 TCGA-DB-A64L-01A-11D-A323-01 TCGA-DB-A64L-01 c0727365-8495-4a96-85b0-4a685627839e TCGA-DB-A64L-01 TCGA-DB-A64L-01A-11D-A323-01 c0727365-8495-4a96-85b0-4a685627839e +TCGA-DB-A64O-01 TCGA-DB-A64O-01 TCGA-DB-A64O TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 59 NO TCGA-DB-A64O-F62610 TCGA-DB-A64O TCGA-DB-A64O-01A -21811 533 775 0 573 NO YES NO Motor/Movement Changes 91 - 180 Days Scheduled Follow-up Submission 2014-7-22 MALE NO NO Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES NO 290 NO Left NO IHC YES YES NO YES G2 YES true No TCGA-DB-A64O.67251C0F-7DD0-4736-A614-523DFD359C63.pdf A64O WITH TUMOR YES YES Stable Disease YES Primary Tumor 01 NO NO Cerebral Cortex NO YES NO DB Supratentorial, Temporal Lobe Central nervous system A NO DECEASED 2011 3eca387f-17e0-438d-8bae-f31f0ce7396d TCGA-DB-A64O-01A-11D-A29T-05 TCGA-DB-A64O-01A-11D-A323-01 TCGA-DB-A64O-01 3eca387f-17e0-438d-8bae-f31f0ce7396d TCGA-DB-A64O-01 TCGA-DB-A64O-01A-11D-A323-01 3eca387f-17e0-438d-8bae-f31f0ce7396d +TCGA-DB-A64P-01 TCGA-DB-A64P-01 TCGA-DB-A64P TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 40 NO TCGA-DB-A64P-F62612 TCGA-DB-A64P TCGA-DB-A64P-01A -14936 443 0 916 NO YES NO Seizures 0 - 30 Days Scheduled Follow-up Submission Complete Remission/Response 2014-7-22 MALE NO NO Oligodendroglioma NO No C71.0 9451/3 C71.0 YES NO 280 NO Left YES IHC YES NO NO NO G3 NO true No TCGA-DB-A64P.3D2EEE2E-B4EB-4603-B4D2-AA4B0F790200.pdf A64P TUMOR FREE YES YES Complete Remission/Response NO Primary Tumor 01 YES NO Cerebral Cortex YES YES NO DB Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2012 5635d2de-4a0b-4988-8ff7-2056857d0d34 TCGA-DB-A64P-01A-11D-A29T-05 TCGA-DB-A64P-01A-11D-A323-01 TCGA-DB-A64P-01 5635d2de-4a0b-4988-8ff7-2056857d0d34 TCGA-DB-A64P-01 TCGA-DB-A64P-01A-11D-A323-01 5635d2de-4a0b-4988-8ff7-2056857d0d34 +TCGA-DB-A64Q-01 TCGA-DB-A64Q-01 TCGA-DB-A64Q TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 31 NO TCGA-DB-A64Q-F62614 TCGA-DB-A64Q -11637 0 182 -3 NO NO NO Seizures 31 - 90 Days Scheduled Follow-up Submission 2014-7-22 FEMALE NO NO Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES NO 90 Left YES IHC YES YES NO NO G2 NO No A64Q Preoperative TUMOR FREE YES NO Stable Disease NO Primary Tumor 01 YES NO Cerebral Cortex YES YES NO DB Supratentorial, Frontal Lobe Central nervous system NO LIVING 2012 f2249fe9-e838-4895-9e46-98fa8f30655e TCGA-DB-A64Q-01A-11D-A29T-05 TCGA-DB-A64Q-01A-11D-A323-01 TCGA-DB-A64Q-01 f2249fe9-e838-4895-9e46-98fa8f30655e TCGA-DB-A64Q-01 TCGA-DB-A64Q-01A-11D-A323-01 f2249fe9-e838-4895-9e46-98fa8f30655e +TCGA-DB-A64R-01 TCGA-DB-A64R-01 TCGA-DB-A64R TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 24 YES NO TCGA-DB-A64R-F62622 TCGA-DB-A64R TCGA-DB-A64R-01A -8947 436 0 955 -6 NO NO NO Seizures 91 - 180 Days Scheduled Follow-up Submission Complete Remission/Response YES lactose 2014-11-4 FEMALE NO Oligodendroglioma NO No C71.0 9450/3 C71.0 YES NO 90 NO 90 Right YES IHC YES NO NO NO G2 NO true No TCGA-DB-A64R.A9F5EDE4-1FC5-4E6D-BEA1-70B6223A49FE.pdf A64R Preoperative TUMOR FREE YES NO Complete Remission/Response NO Primary Tumor 01 YES NO Cerebral Cortex NO YES NO DB Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2012 6589bdbc-b3a3-4949-8a08-3fd17952bf24 TCGA-DB-A64R-01A-11D-A29T-05 TCGA-DB-A64R-01A-11D-A323-01 TCGA-DB-A64R-01 6589bdbc-b3a3-4949-8a08-3fd17952bf24 TCGA-DB-A64R-01 TCGA-DB-A64R-01A-11D-A323-01 6589bdbc-b3a3-4949-8a08-3fd17952bf24 +TCGA-DB-A64S-01 TCGA-DB-A64S-01 TCGA-DB-A64S TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 20 NO NO TCGA-DB-A64S-F67351 TCGA-DB-A64S TCGA-DB-A64S-01A -7389 352 0 835 -29 NO NO NO Scheduled Follow-up Submission Complete Remission/Response 2014-11-4 MALE NO NO Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES NO 220 NO 100 NO NO NO NO G2 NO true No TCGA-DB-A64S.31AB0B8C-9300-4508-B653-CB898986E68F.pdf A64S Preoperative TUMOR FREE NO NO Complete Remission/Response NO Primary Tumor 01 NO NO Cerebral Cortex NO YES NO DB Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2012 7ac5d653-615d-4ace-a94a-2c1e09b598f4 TCGA-DB-A64S-01A-11D-A29T-05 TCGA-DB-A64S-01A-11D-A323-01 TCGA-DB-A64S-01 7ac5d653-615d-4ace-a94a-2c1e09b598f4 TCGA-DB-A64S-01 TCGA-DB-A64S-01A-11D-A323-01 7ac5d653-615d-4ace-a94a-2c1e09b598f4 +TCGA-DB-A64U-01 TCGA-DB-A64U-01 TCGA-DB-A64U TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 38 YES ant stings NO TCGA-DB-A64U-F67353 TCGA-DB-A64U -14019 0 846 118 NO NO NO Scheduled Follow-up Submission YES shellfish 2014-11-4 FEMALE NO NO Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES NO 90 Right NO YES NO NO NO G2 NO No A64U Preoperative TUMOR FREE YES NO Complete Remission/Response NO Primary Tumor 01 NO NO Cerebral Cortex NO YES NO DB Supratentorial, Frontal Lobe Central nervous system NO LIVING 2011 cc3a055a-6e86-43d1-9266-b16c172b27d6 TCGA-DB-A64U-01A-11D-A29T-05 TCGA-DB-A64U-01A-11D-A323-01 TCGA-DB-A64U-01 cc3a055a-6e86-43d1-9266-b16c172b27d6 TCGA-DB-A64U-01 TCGA-DB-A64U-01A-11D-A323-01 cc3a055a-6e86-43d1-9266-b16c172b27d6 +TCGA-DB-A64V-01 TCGA-DB-A64V-01 TCGA-DB-A64V TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 54 NO TCGA-DB-A64V-F67368 TCGA-DB-A64V TCGA-DB-A64V-01A -19950 352 0 889 -17 NO YES NO Seizures 0 - 30 Days Scheduled Follow-up Submission Complete Remission/Response 2014-11-4 MALE NO NO Oligodendroglioma NO No C71.0 9450/3 C71.0 YES NO 200 NO 90 Left NO NO NO NO G2 NO true No TCGA-DB-A64V.9675813D-E747-4768-835C-447B53418966.pdf A64V Preoperative TUMOR FREE YES NO Stable Disease NO Primary Tumor 01 YES NO Cerebral Cortex YES YES NO DB Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2012 72b6a847-016f-4565-a5aa-e277c5cffb08 TCGA-DB-A64V-01A-11D-A29T-05 TCGA-DB-A64V-01A-11D-A323-01 TCGA-DB-A64V-01 72b6a847-016f-4565-a5aa-e277c5cffb08 TCGA-DB-A64V-01 TCGA-DB-A64V-01A-11D-A323-01 72b6a847-016f-4565-a5aa-e277c5cffb08 +TCGA-DB-A64W-01 TCGA-DB-A64W-01 TCGA-DB-A64W TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 65 NO TCGA-DB-A64W-F62623 TCGA-DB-A64W -23936 438 0 415 -20 NO Seizures > 181 Days Scheduled Follow-up Submission Stable Disease 2014-7-22 FEMALE NO Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES NO 90 Right YES IHC YES NO NO NO G3 NO No A64W Preoperative TUMOR FREE YES YES Stable Disease YES Primary Tumor 01 YES NO Cerebral Cortex YES YES NO DB Supratentorial, Frontal Lobe Central nervous system NO DECEASED 2012 b8ee7519-8052-4ac2-b331-7196e3f0d30f TCGA-DB-A64W-01A-11D-A29T-05 TCGA-DB-A64W-01A-11D-A323-01 TCGA-DB-A64W-01 b8ee7519-8052-4ac2-b331-7196e3f0d30f TCGA-DB-A64W-01 TCGA-DB-A64W-01A-11D-A323-01 b8ee7519-8052-4ac2-b331-7196e3f0d30f +TCGA-DB-A64X-01 TCGA-DB-A64X-01 TCGA-DB-A64X TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 56 NO TCGA-DB-A64X-F67369 TCGA-DB-A64X -20625 0 563 -19 NO YES NO Motor/Movement Changes 91 - 180 Days Scheduled Follow-up Submission Complete Remission/Response 2014-11-7 FEMALE NO NO Astrocytoma NO No C71.0 9401/3 C71.0 YES NO 90 Right YES IHC YES NO NO YES G3 NO No A64X Preoperative TUMOR FREE NO NO Stable Disease YES Primary Tumor 01 NO NO Cerebral Cortex YES YES NO DB Supratentorial, Frontal Lobe Central nervous system NO LIVING 2012 fd77ef17-3190-4889-a51b-456313411882 TCGA-DB-A64X-01A-11D-A29T-05 TCGA-DB-A64X-01A-11D-A323-01 TCGA-DB-A64X-01 fd77ef17-3190-4889-a51b-456313411882 TCGA-DB-A64X-01 TCGA-DB-A64X-01A-11D-A323-01 fd77ef17-3190-4889-a51b-456313411882 +TCGA-DB-A75K-01 TCGA-DB-A75K-01 TCGA-DB-A75K TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 55 NO NO TCGA-DB-A75K-F67635 TCGA-DB-A75K -20241 0 368 NO NO NO Seizures 0 - 30 Days Scheduled Follow-up Submission Complete Remission/Response NO 2014-11-7 FEMALE NO NO Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES NO Right YES IHC YES NO NO NO NO G3 NO No A75K TUMOR FREE YES Complete Remission/Response YES Primary Tumor 01 YES NO Cerebral Cortex YES YES NO DB Supratentorial, Frontal Lobe Central nervous system NO LIVING 2013 a956aa35-fb64-4fce-bece-044bd71692f5 TCGA-DB-A75K-01A-11D-A32C-05 TCGA-DB-A75K-01A-11D-A32A-01 TCGA-DB-A75K-01 a956aa35-fb64-4fce-bece-044bd71692f5 TCGA-DB-A75K-01 TCGA-DB-A75K-01A-11D-A32A-01 a956aa35-fb64-4fce-bece-044bd71692f5 +TCGA-DB-A75L-01 TCGA-DB-A75L-01 TCGA-DB-A75L TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 36 NO NO TCGA-DB-A75L-F67636 TCGA-DB-A75L TCGA-DB-A75L-01A -13338 75 0 342 NO NO NO Seizures 91 - 180 Days Scheduled Follow-up Submission Complete Remission/Response YES lactose intolerance 2014-11-7 FEMALE NO NO Astrocytoma NO No C71.0 9401/3 C71.0 YES NO 100 NO 90 Left YES IHC YES NO NO NO NO G3 NO true No TCGA-DB-A75L.A725AA31-18ED-47A2-9393-E811952AD9B3.pdf A75L Preoperative TUMOR FREE YES NO Complete Remission/Response YES Primary Tumor 01 YES NO Cerebral Cortex YES YES NO DB Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2013 05b85bc7-87db-49bb-85cf-e494554ab191 TCGA-DB-A75L-01A-11D-A32C-05 TCGA-DB-A75L-01A-11D-A32A-01 TCGA-DB-A75L-01 05b85bc7-87db-49bb-85cf-e494554ab191 TCGA-DB-A75L-01 TCGA-DB-A75L-01A-11D-A32A-01 05b85bc7-87db-49bb-85cf-e494554ab191 +TCGA-DB-A75M-01 TCGA-DB-A75M-01 TCGA-DB-A75M TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 47 NO NO TCGA-DB-A75M-F67637 TCGA-DB-A75M TCGA-DB-A75M-01A -17289 189 0 544 NO YES NO Seizures > 181 Days Scheduled Follow-up Submission Complete Remission/Response NO 2014-11-7 MALE NO NO Astrocytoma NO No C71.0 9400/3 C71.0 YES NO 250 NO Right YES Sequence Analysis YES NO NO NO NO G2 NO true No TCGA-DB-A75M.C19F2C06-B479-44A0-8BE2-A7DDD650D879.pdf A75M TUMOR FREE YES NO Complete Remission/Response YES Primary Tumor 01 YES NO Cerebral Cortex YES YES NO DB Supratentorial, Parietal Lobe Central nervous system A NO LIVING 2013 6bcd916f-8522-40d7-bd66-bf509789e34d TCGA-DB-A75M-01A-11D-A32C-05 TCGA-DB-A75M-01A-11D-A32A-01 TCGA-DB-A75M-01 6bcd916f-8522-40d7-bd66-bf509789e34d TCGA-DB-A75M-01 TCGA-DB-A75M-01A-11D-A32A-01 6bcd916f-8522-40d7-bd66-bf509789e34d +TCGA-DB-A75O-01 TCGA-DB-A75O-01 TCGA-DB-A75O TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 29 NO NO TCGA-DB-A75O-F67378 TCGA-DB-A75O TCGA-DB-A75O-01A -10812 981 0 935 NO NO NO Seizures 31 - 90 Days Scheduled Follow-up Submission NO 2014-11-4 MALE NO NO Astrocytoma NO No C71.0 9401/3 C71.0 YES NO 240 NO 90 Left NO YES NO NO NO G3 true No TCGA-DB-A75O.CADF06CC-B405-4CFF-AB8D-92DA06CB345C.pdf A75O Preoperative YES NO Partial Remission/Response Primary Tumor 01 YES NO Cerebral Cortex YES NO DB Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2010 46154213-1bd9-4de6-b396-bb0016d56bbd TCGA-DB-A75O-01A-11D-A32C-05 TCGA-DB-A75O-01A-11D-A32A-01 TCGA-DB-A75O-01 46154213-1bd9-4de6-b396-bb0016d56bbd TCGA-DB-A75O-01 TCGA-DB-A75O-01A-11D-A32A-01 46154213-1bd9-4de6-b396-bb0016d56bbd +TCGA-DB-A75P-01 TCGA-DB-A75P-01 TCGA-DB-A75P TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 25 NO NO TCGA-DB-A75P-F67380 TCGA-DB-A75P -9413 0 492 NO NO NO Seizures 31 - 90 Days Scheduled Follow-up Submission Complete Remission/Response NO 2014-11-4 FEMALE NO NO Astrocytoma NO No C71.0 9400/3 C71.0 YES NO Right NO IHC YES NO NO NO NO G2 NO No A75P TUMOR FREE YES NO Complete Remission/Response NO Primary Tumor 01 YES NO Cerebral Cortex NO YES NO DB Supratentorial, Temporal Lobe Central nervous system NO LIVING 2013 eaf06648-a8ec-4813-8618-0ccf86d0f809 TCGA-DB-A75P-01A-11D-A32C-05 TCGA-DB-A75P-01A-11D-A32A-01 TCGA-DB-A75P-01 eaf06648-a8ec-4813-8618-0ccf86d0f809 TCGA-DB-A75P-01 TCGA-DB-A75P-01A-11D-A32A-01 eaf06648-a8ec-4813-8618-0ccf86d0f809 +TCGA-DH-5140-01 TCGA-DH-5140-01 TCGA-DH-5140 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 38 NO NO TCGA-DH-5140-F6484 TCGA-DH-5140 -13943 607 0 259 1 NO YES NO Headaches 91 - 180 Days Progressive Disease NO 2010-12-8 FEMALE NO YES Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES 90 Left NO NO NO NO G3 NO No 5140 Other WITH TUMOR YES YES Progressive Disease YES Primary Tumor 01 NO NO Cerebral Cortex YES NO YES DH Supratentorial, Temporal Lobe Central nervous system NO DECEASED 2007 be3eca27-9d48-4e21-9146-fb47c7ac4233 TCGA-DH-5140-01A-01D-1468-08 TCGA-DH-5140-01A-01D-1467-05 TCGA-DH-5140-01A-01D-1466-01 TCGA-DH-5140-01 be3eca27-9d48-4e21-9146-fb47c7ac4233 TCGA-DH-5140-01 TCGA-DH-5140-01A-01D-1466-01 be3eca27-9d48-4e21-9146-fb47c7ac4233 +TCGA-DH-5141-01 TCGA-DH-5141-01 TCGA-DH-5141 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 32 NO NO TCGA-DH-5141-F66668 TCGA-DH-5141 TCGA-DH-5141-01A -11846 0 968 NO YES NO Headaches Scheduled Follow-up Submission NO 2014-10-22 MALE NO YES Oligodendroglioma NO No C71.0 9451/3 C71.0 YES 0.3 NO Left NO 0.6 YES YES NO NO G3 No TCGA-DH-5141.15a0f3ec-2bdc-4fb9-ae65-e1c38277ff11.pdf 5141 YES YES Stable Disease YES Primary Tumor 01 NO NO 0.2 Cerebral Cortex YES NO YES DH Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2005 9e952754-f768-47fd-9580-d9770e9eb45e TCGA-DH-5141-01A-01D-1468-08 TCGA-DH-5141-01A-01D-1467-05 TCGA-DH-5141-01A-01D-1466-01 TCGA-DH-5141-01 9e952754-f768-47fd-9580-d9770e9eb45e TCGA-DH-5141-01 TCGA-DH-5141-01A-01D-1466-01 9e952754-f768-47fd-9580-d9770e9eb45e +TCGA-DH-5142-01 TCGA-DH-5142-01 TCGA-DH-5142 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain YES NO NO 29 NO YES TCGA-DH-5142-F66689 TCGA-DH-5142 -10678 0 1943 1627 10 0 NO Seizures 0 - 30 Days Scheduled Follow-up Submission NO 2014-10-22 MALE NO NO Astrocytoma NO No C71.0 9401/3 C71.0 YES 90 Left NO YES NO NO NO G3 YES No 5142 Pre-Adjuvant Therapy WITH TUMOR NO NO Stable Disease YES Primary Tumor 01 YES NO Cerebral Cortex YES NO YES DH Supratentorial, Frontal Lobe Central nervous system NO LIVING 2008 ce2a4f0a-e77f-446b-9412-432daaf5d351 TCGA-DH-5142-01A-01D-1468-08 TCGA-DH-5142-01A-01D-1467-05 TCGA-DH-5142-01A-01D-1466-01 TCGA-DH-5142-01 ce2a4f0a-e77f-446b-9412-432daaf5d351 TCGA-DH-5142-01 TCGA-DH-5142-01A-01D-1466-01 ce2a4f0a-e77f-446b-9412-432daaf5d351 +TCGA-DH-5143-01 TCGA-DH-5143-01 TCGA-DH-5143 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 30 TCGA-DH-5143-F66710 TCGA-DH-5143 -11291 0 1401 13 1 Seizures 91 - 180 Days Scheduled Follow-up Submission Stable Disease 2014-10-22 MALE NO Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES 80 Left NO YES YES G3 NO No 5143 Pre-Adjuvant Therapy WITH TUMOR YES YES Stable Disease YES Primary Tumor 01 YES Cerebral Cortex YES NO YES DH Supratentorial, Temporal Lobe Central nervous system NO LIVING 2009 ae0546ae-4f2e-4824-94d6-91fefd7fddbb TCGA-DH-5143-01A-01D-1468-08 TCGA-DH-5143-01A-01D-1467-05 TCGA-DH-5143-01A-01D-1466-01 TCGA-DH-5143-01 ae0546ae-4f2e-4824-94d6-91fefd7fddbb TCGA-DH-5143-01 TCGA-DH-5143-01A-01D-1466-01 ae0546ae-4f2e-4824-94d6-91fefd7fddbb +TCGA-DH-5144-01 TCGA-DH-5144-01 TCGA-DH-5144 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 56 NO NO TCGA-DH-5144-F66726 TCGA-DH-5144 -20558 0 748 19 0 NO NO Seizures 0 - 30 Days Scheduled Follow-up Submission Stable Disease NO 2014-10-22 FEMALE NO NO Oligodendroglioma NO No C71.0 9451/3 C71.0 YES 100 Right NO NO NO NO NO G3 NO No 5144 Pre-Adjuvant Therapy TUMOR FREE YES NO Complete Remission/Response YES Primary Tumor 01 YES NO Cerebral Cortex NO NO YES DH Supratentorial, Frontal Lobe Central nervous system NO LIVING 2009 c0a8b929-166d-4227-a0e1-fe8ab8abac11 TCGA-DH-5144-01A-01D-1468-08 TCGA-DH-5144-01A-01D-1467-05 TCGA-DH-5144-01A-01D-1466-01 TCGA-DH-5144-01 c0a8b929-166d-4227-a0e1-fe8ab8abac11 TCGA-DH-5144-01 TCGA-DH-5144-01A-01D-1466-01 c0a8b929-166d-4227-a0e1-fe8ab8abac11 +TCGA-DH-A669-01 TCGA-DH-A669-01 TCGA-DH-A669 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 70 NO TCGA-DH-A669 -25809 919 0 NO NO NO Mental Status Changes > 181 Days NO 2013-6-25 MALE NO NO Oligodendroglioma NO No C71.0 9451/3 C71.0 YES NO Left NO YES NO YES G3 YES No A669 TUMOR FREE NO YES Stable Disease NO Primary Tumor 01 NO NO Not listed in Medical Record NO NO YES DH Supratentorial, Parietal Lobe Central nervous system NO DECEASED 2007 cb9ff749-d103-418f-b0f3-52ef1f5fcb7d TCGA-DH-A669-01A-12D-A31M-05 TCGA-DH-A669-01A-12D-A31K-01 TCGA-DH-A669-01 cb9ff749-d103-418f-b0f3-52ef1f5fcb7d TCGA-DH-A669-01 TCGA-DH-A669-01A-12D-A31K-01 cb9ff749-d103-418f-b0f3-52ef1f5fcb7d +TCGA-DH-A669-02 TCGA-DH-A669-02 TCGA-DH-A669 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 70 NO TCGA-DH-A669 TCGA-DH-A669-02A -25809 2274 919 0 NO NO NO Mental Status Changes > 181 Days NO 2013-6-25 MALE NO NO Oligodendroglioma NO No C71.0 9451/3 C71.0 YES NO 50 NO Left NO YES NO YES G3 YES false No TCGA-DH-A669.B34CDA94-75EB-42E4-AAF8-70C69BBDDD84.pdf A669 TUMOR FREE NO YES Stable Disease NO Recurrent Tumor 02 NO NO Not listed in Medical Record NO NO YES DH Supratentorial, Parietal Lobe Central nervous system A NO DECEASED 2007 2b35c088-4a94-44a1-9809-6666bc0c877f TCGA-DH-A669-02A-11D-A31M-05 2b35c088-4a94-44a1-9809-6666bc0c877f 2b35c088-4a94-44a1-9809-6666bc0c877f +TCGA-DH-A66B-01 TCGA-DH-A66B-01 TCGA-DH-A66B TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 52 NO TCGA-DH-A66B-F60629 TCGA-DH-A66B TCGA-DH-A66B-01A -19156 845 0 1279 901 1 NO YES NO Mental Status Changes > 181 Days Scheduled Follow-up Submission Stable Disease NO 2014-6-13 MALE NO NO Astrocytoma NO No C71.0 9401/3 C71.0 YES NO 100 NO 90 Left NO NO YES NO NO G3 NO false Yes, History of Prior Malignancy TCGA-DH-A66B.7D6D3FE4-FA4C-4827-B141-9E323AC6B1A8.pdf A66B Post-Adjuvant Therapy WITH TUMOR YES NO Stable Disease YES Primary Tumor 01 NO NO Not listed in Medical Record YES NO YES DH Supratentorial, Temporal Lobe Central nervous system A NO LIVING 2010 90199c77-d6ef-4a7a-b08c-28bed0c888b1 TCGA-DH-A66B-01A-11D-A29T-05 TCGA-DH-A66B-01A-11D-A323-01 TCGA-DH-A66B-01 90199c77-d6ef-4a7a-b08c-28bed0c888b1 TCGA-DH-A66B-01 TCGA-DH-A66B-01A-11D-A323-01 90199c77-d6ef-4a7a-b08c-28bed0c888b1 +TCGA-DH-A66D-01 TCGA-DH-A66D-01 TCGA-DH-A66D TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 43 NO TCGA-DH-A66D-F60638 TCGA-DH-A66D -15866 0 846 404 1 NO NO NO Seizures 0 - 30 Days Scheduled Follow-up Submission Stable Disease YES lactose, cheese, gluten 2014-6-13 FEMALE NO NO Astrocytoma NO No C71.0 9401/3 C71.0 YES NO 80 Right YES IHC YES NO YES NO NO G3 NO No A66D Post-Adjuvant Therapy WITH TUMOR NO NO Stable Disease YES Primary Tumor 01 YES NO Not listed in Medical Record YES NO YES DH Supratentorial, Frontal Lobe Central nervous system NO LIVING 2012 a3ea8ef1-79f5-48fc-906d-dfb2b550c466 TCGA-DH-A66D-01A-11D-A31M-05 TCGA-DH-A66D-01A-11D-A31K-01 TCGA-DH-A66D-01 a3ea8ef1-79f5-48fc-906d-dfb2b550c466 TCGA-DH-A66D-01 TCGA-DH-A66D-01A-11D-A31K-01 a3ea8ef1-79f5-48fc-906d-dfb2b550c466 +TCGA-DH-A66F-01 TCGA-DH-A66F-01 TCGA-DH-A66F TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 49 NO TCGA-DH-A66F-F68872 TCGA-DH-A66F TCGA-DH-A66F-01A -18193 166 0 523 18 1 NO NO NO Seizures 0 - 30 Days Scheduled Follow-up Submission NO 2015-3-12 MALE NO Oligodendroglioma NO No C71.0 9450/3 C71.0 YES NO 90 NO 90 Left YES IHC YES YES NO NO G2 NO false No TCGA-DH-A66F.8D9C9718-7904-4C45-8217-D8110552BA51.pdf A66F Other TUMOR FREE YES YES Complete Remission/Response NO Primary Tumor 01 YES NO Not listed in Medical Record NO YES NO DH Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2012 10b6c170-88d1-4cea-87c7-b23d6810ea6a TCGA-DH-A66F-01A-11D-A29T-05 TCGA-DH-A66F-01A-11D-A323-01 TCGA-DH-A66F-01 10b6c170-88d1-4cea-87c7-b23d6810ea6a TCGA-DH-A66F-01 TCGA-DH-A66F-01A-11D-A323-01 10b6c170-88d1-4cea-87c7-b23d6810ea6a +TCGA-DH-A66G-01 TCGA-DH-A66G-01 TCGA-DH-A66G TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 49 NO TCGA-DH-A66G-F61145 TCGA-DH-A66G -18199 0 523 19 1 NO YES NO Headaches > 181 Days Scheduled Follow-up Submission Partial Remission/Response NO 2014-6-25 FEMALE NO YES Oligodendroglioma NO No C71.0 9451/3 C71.0 YES NO 80 Left YES IHC YES NO NO NO NO G3 NO No A66G Pre-Adjuvant Therapy WITH TUMOR YES YES Stable Disease YES Primary Tumor 01 YES NO Not listed in Medical Record YES YES NO DH Supratentorial, Frontal Lobe Central nervous system NO LIVING 2013 eab993b0-cf52-4a95-8da3-8e1c5eaa3eff TCGA-DH-A66G-01A-21D-A31M-05 TCGA-DH-A66G-01A-21D-A31K-01 TCGA-DH-A66G-01 eab993b0-cf52-4a95-8da3-8e1c5eaa3eff TCGA-DH-A66G-01 TCGA-DH-A66G-01A-21D-A31K-01 eab993b0-cf52-4a95-8da3-8e1c5eaa3eff +TCGA-DH-A7UR-01 TCGA-DH-A7UR-01 TCGA-DH-A7UR TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 59 NO TCGA-DH-A7UR-F64479 TCGA-DH-A7UR -21803 0 1650 1174 0 NO NO NO Headaches > 181 Days Scheduled Follow-up Submission NO 2014-9-3 FEMALE NO YES Oligodendroglioma NO No C71.0 9451/3 C71.0 YES NO 90 Right NO YES YES NO NO G3 NO No A7UR Post-Adjuvant Therapy TUMOR FREE YES NO Complete Remission/Response YES Primary Tumor 01 YES NO Not listed in Medical Record YES NO YES DH Supratentorial, Frontal Lobe Central nervous system NO LIVING 2008 b9eab491-6fa4-4eee-a2f6-ef923935845e TCGA-DH-A7UR-01A-11D-A33U-05 TCGA-DH-A7UR-01A-11D-A33S-01 TCGA-DH-A7UR-01 b9eab491-6fa4-4eee-a2f6-ef923935845e TCGA-DH-A7UR-01 TCGA-DH-A7UR-01A-11D-A33S-01 b9eab491-6fa4-4eee-a2f6-ef923935845e +TCGA-DH-A7US-01 TCGA-DH-A7US-01 TCGA-DH-A7US TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 50 NO TCGA-DH-A7US-F70994 TCGA-DH-A7US -18429 0 706 NO NO NO Seizures > 181 Days Scheduled Follow-up Submission Stable Disease NO 2015-3-12 MALE NO NO Oligodendroglioma NO No C71.0 9450/3 C71.0 YES NO Right YES IHC YES NO NO NO NO G2 NO No A7US WITH TUMOR YES NO Stable Disease NO Primary Tumor 01 YES NO Not listed in Medical Record NO YES NO DH Supratentorial, Temporal Lobe Central nervous system NO LIVING 2013 f2996be3-1bd5-43c8-9d91-728948c78994 TCGA-DH-A7US-01A-11D-A33U-05 TCGA-DH-A7US-01A-11D-A33S-01 TCGA-DH-A7US-01 f2996be3-1bd5-43c8-9d91-728948c78994 TCGA-DH-A7US-01 TCGA-DH-A7US-01A-11D-A33S-01 f2996be3-1bd5-43c8-9d91-728948c78994 +TCGA-DH-A7UT-01 TCGA-DH-A7UT-01 TCGA-DH-A7UT TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 30 NO TCGA-DH-A7UT-F70996 TCGA-DH-A7UT TCGA-DH-A7UT-01A -11014 118 531 0 200 407 NO NO NO Seizures 31 - 90 Days Scheduled Follow-up Submission NO 2015-3-12 MALE NO NO Astrocytoma NO No C71.0 9401/3 C71.0 YES NO 70 NO Left YES IHC YES NO NO NO NO G3 YES false No TCGA-DH-A7UT.D737A708-EBF5-41F9-9245-7438F71891F1.pdf A7UT WITH TUMOR YES YES Stable Disease YES Primary Tumor 01 YES NO Not listed in Medical Record YES YES NO DH Supratentorial, Frontal Lobe Central nervous system A NO DECEASED 2013 4c09b51b-d52a-49f2-b5df-5fc38193bd3c TCGA-DH-A7UT-01A-12D-A34D-05 TCGA-DH-A7UT-01A-12D-A349-01 TCGA-DH-A7UT-01 4c09b51b-d52a-49f2-b5df-5fc38193bd3c TCGA-DH-A7UT-01 TCGA-DH-A7UT-01A-12D-A349-01 4c09b51b-d52a-49f2-b5df-5fc38193bd3c +TCGA-DH-A7UU-01 TCGA-DH-A7UU-01 TCGA-DH-A7UU TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 43 NO TCGA-DH-A7UU-F66738 TCGA-DH-A7UU -16037 0 417 18 NO YES NO Sensory Changes 91 - 180 Days Scheduled Follow-up Submission Stable Disease NO 2014-10-22 MALE YES NO Astrocytoma NO No C71.0 9401/3 C71.0 YES NO 90 Right YES IHC YES NO YES YES NO G3 NO No A7UU Pre-Adjuvant Therapy WITH TUMOR NO NO Stable Disease YES Primary Tumor 01 NO YES Not listed in Medical Record YES YES NO DH Supratentorial, Frontal Lobe Central nervous system YES LIVING 2013 b2641e23-6021-4679-90d9-1cfd67619dbc TCGA-DH-A7UU-01A-12D-A34D-05 TCGA-DH-A7UU-01A-12D-A349-01 TCGA-DH-A7UU-01 b2641e23-6021-4679-90d9-1cfd67619dbc TCGA-DH-A7UU-01 TCGA-DH-A7UU-01A-12D-A349-01 b2641e23-6021-4679-90d9-1cfd67619dbc +TCGA-DH-A7UV-01 TCGA-DH-A7UV-01 TCGA-DH-A7UV TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 49 TCGA-DH-A7UV-F68876 TCGA-DH-A7UV -18161 0 566 19 NO NO Headaches 91 - 180 Days Scheduled Follow-up Submission Stable Disease 2014-12-22 MALE YES Astrocytoma NO No C71.0 9401/3 C71.0 YES NO 90 Right NO IHC YES NO YES YES G3 NO No A7UV Pre-Adjuvant Therapy WITH TUMOR YES NO Stable Disease YES Primary Tumor 01 NO NO Not listed in Medical Record YES YES NO DH Supratentorial, Temporal Lobe Central nervous system NO LIVING 2013 ca0eaf1f-36a4-4322-b262-118d4cfc6ae2 TCGA-DH-A7UV-01A-12D-A34D-05 TCGA-DH-A7UV-01A-12D-A349-01 TCGA-DH-A7UV-01 ca0eaf1f-36a4-4322-b262-118d4cfc6ae2 TCGA-DH-A7UV-01 TCGA-DH-A7UV-01A-12D-A349-01 ca0eaf1f-36a4-4322-b262-118d4cfc6ae2 +TCGA-DU-5847-01 TCGA-DU-5847-01 TCGA-DU-5847 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 34 NO NO TCGA-DU-5847-F14822 TCGA-DU-5847 TCGA-DU-5847-01A -12606 0 548 YES NO NO Seizures 0 - 30 Days NO 2011-5-25 FEMALE NO Astrocytoma NO No C71.9 9401/3 C71.9 YES 0.8 NO Right NO 1 NO NO NO G3 NO No TCGA-DU-5847.d9f2d994-5d17-46c6-a6c9-0f25703ffb22.pdf 5847 WITH TUMOR YES NO Stable Disease YES Primary Tumor 01 YES NO 0.4 White Matter YES YES NO DU Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2009 5a559e30-17cb-4467-b54c-18dcfdb93fde TCGA-DU-5847-01A-11D-1705-08 TCGA-DU-5847-01A-11D-1706-05 TCGA-DU-5847-01A-11D-1704-01 TCGA-DU-5847-01 5a559e30-17cb-4467-b54c-18dcfdb93fde TCGA-DU-5847-01 TCGA-DU-5847-01A-11D-1704-01 5a559e30-17cb-4467-b54c-18dcfdb93fde +TCGA-DU-5849-01 TCGA-DU-5849-01 TCGA-DU-5849 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 48 TCGA-DU-5849-F14889 TCGA-DU-5849 -17663 0 443 NO Seizures 0 - 30 Days 2011-5-25 MALE NO Oligodendroglioma NO No C71.9 9450/3 C71.9 YES Left NO NO NO G2 NO No 5849 TUMOR FREE YES YES Stable Disease NO Primary Tumor 01 YES NO White Matter YES YES NO DU Supratentorial, Frontal Lobe Central nervous system NO LIVING 2010 e1ecb6d0-8ceb-46b8-9959-86f8d53b0882 TCGA-DU-5849-01A-11D-1705-08 TCGA-DU-5849-01A-11D-1706-05 TCGA-DU-5849-01A-11D-1704-01 TCGA-DU-5849-01 e1ecb6d0-8ceb-46b8-9959-86f8d53b0882 TCGA-DU-5849-01 TCGA-DU-5849-01A-11D-1704-01 e1ecb6d0-8ceb-46b8-9959-86f8d53b0882 +TCGA-DU-5851-01 TCGA-DU-5851-01 TCGA-DU-5851 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 40 TCGA-DU-5851-F15071 TCGA-DU-5851 TCGA-DU-5851-01A -14802 0 531 17 Seizures 0 - 30 Days 2011-8-8 FEMALE NO Oligoastrocytoma NO No C71.9 9382/3 C71.9 YES 1 NO 90 Right NO 1 NO NO G3 NO No TCGA-DU-5851.beb751ed-b79d-43de-93b6-bcbbb47ea6f4.pdf 5851 Pre-Adjuvant Therapy WITH TUMOR YES YES Stable Disease YES Primary Tumor 01 YES YES 1 Cerebral Cortex YES YES NO DU Supratentorial, Temporal Lobe Central nervous system A NO LIVING 2010 5966170d-1c88-4b55-ad39-2ace3c9230d3 TCGA-DU-5851-01A-13D-1893-08 TCGA-DU-5851-01A-13D-1894-05 TCGA-DU-5851-01A-13D-1892-01 TCGA-DU-5851-01 5966170d-1c88-4b55-ad39-2ace3c9230d3 TCGA-DU-5851-01 TCGA-DU-5851-01A-13D-1892-01 5966170d-1c88-4b55-ad39-2ace3c9230d3 +TCGA-DU-5852-01 TCGA-DU-5852-01 TCGA-DU-5852 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain YES YES NO NO 61 TCGA-DU-5852-F17044 TCGA-DU-5852 -22348 205 0 24 26 Seizures > 181 Days Progressive Disease 2011-9-26 FEMALE NO Oligoastrocytoma NO No C71.9 9382/3 C71.9 YES 50 Left NO NO YES G3 YES No 5852 Pre-Adjuvant Therapy WITH TUMOR YES NO Progressive Disease NO Primary Tumor 01 YES NO White Matter NO NO YES DU Supratentorial, Temporal Lobe Central nervous system NO DECEASED 2010 dad44966-2a17-4813-abf8-16b476984948 TCGA-DU-5852-01A-11D-1705-08 TCGA-DU-5852-01A-11D-1706-05 TCGA-DU-5852-01A-11D-1704-01 TCGA-DU-5852-01 dad44966-2a17-4813-abf8-16b476984948 TCGA-DU-5852-01 TCGA-DU-5852-01A-11D-1704-01 dad44966-2a17-4813-abf8-16b476984948 +TCGA-DU-5853-01 TCGA-DU-5853-01 TCGA-DU-5853 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 29 TCGA-DU-5853-F16881 TCGA-DU-5853 TCGA-DU-5853-01A -10624 0 407 18 YES NO Seizures 0 - 30 Days 2011-9-20 MALE NO Oligoastrocytoma NO No C71.9 9382/3 C71.9 YES 0.9 NO 100 Left NO 0.9 NO NO G2 NO No TCGA-DU-5853.d4bda6a8-21ef-4395-9091-dcd87e011d9d.pdf 5853 Pre-Adjuvant Therapy WITH TUMOR YES NO Stable Disease YES Primary Tumor 01 YES NO 0.8 Not listed in Medical Record YES YES NO DU Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2010 3fd8286a-b9a6-42b8-9ecd-7ed96744251a TCGA-DU-5853-01A-11D-1893-08 TCGA-DU-5853-01A-11D-1894-05 TCGA-DU-5853-01A-11D-1892-01 TCGA-DU-5853-01 3fd8286a-b9a6-42b8-9ecd-7ed96744251a TCGA-DU-5853-01 TCGA-DU-5853-01A-11D-1892-01 3fd8286a-b9a6-42b8-9ecd-7ed96744251a +TCGA-DU-5854-01 TCGA-DU-5854-01 TCGA-DU-5854 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain YES NO NO NO 57 TCGA-DU-5854-F14893 TCGA-DU-5854 TCGA-DU-5854-01A -21106 0 257 202 202 YES NO Motor/Movement Changes 91 - 180 Days 2011-5-25 FEMALE NO Astrocytoma NO No C71.9 9401/3 C71.9 YES 0.9 NO 100 Right NO 1 NO YES G3 YES No TCGA-DU-5854.e057679f-9741-4a4e-bb60-e03879b1c723.pdf 5854 Pre-Adjuvant Therapy WITH TUMOR YES YES Progressive Disease YES Primary Tumor 01 NO YES 0.7 Not listed in Medical Record YES YES NO DU Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2010 10fb1701-1d93-4b24-aa8b-2814e80de197 TCGA-DU-5854-01A-11D-1705-08 TCGA-DU-5854-01A-11D-1706-05 TCGA-DU-5854-01A-11D-1704-01 TCGA-DU-5854-01 10fb1701-1d93-4b24-aa8b-2814e80de197 TCGA-DU-5854-01 TCGA-DU-5854-01A-11D-1704-01 10fb1701-1d93-4b24-aa8b-2814e80de197 +TCGA-DU-5855-01 TCGA-DU-5855-01 TCGA-DU-5855 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 49 TCGA-DU-5855-F14801 TCGA-DU-5855 TCGA-DU-5855-01A -18234 0 207 19 NO NO Headaches 0 - 30 Days 2011-5-25 FEMALE YES Oligoastrocytoma NO No C71.9 9382/3 C71.9 YES 0.7 NO 100 Right NO 1.1 YES NO G3 NO No TCGA-DU-5855.ba07cd68-b0ac-4e98-bc4b-abe3b9c9d4f6.pdf 5855 Pre-Adjuvant Therapy WITH TUMOR YES YES Stable Disease YES Primary Tumor 01 NO NO 0.7 Not listed in Medical Record YES YES NO DU Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2010 9f678cb6-26c7-4c76-831c-e541319648d1 TCGA-DU-5855-01A-11D-1705-08 TCGA-DU-5855-01A-11D-1706-05 TCGA-DU-5855-01A-11D-1704-01 TCGA-DU-5855-01 9f678cb6-26c7-4c76-831c-e541319648d1 TCGA-DU-5855-01 TCGA-DU-5855-01A-11D-1704-01 9f678cb6-26c7-4c76-831c-e541319648d1 +TCGA-DU-5870-01 TCGA-DU-5870-01 TCGA-DU-5870 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain YES YES YES NO 34 TCGA-DU-5870-F14719 TCGA-DU-5870 4437 -12764 0 5546 4347 4671 NO Headaches > 181 Days Stable Disease 2011-7-27 FEMALE YES Oligodendroglioma NO No C71.9 9450/3 C71.9 YES 70 Right NO YES NO G2 YES No 5870 Post-Adjuvant Therapy WITH TUMOR Progressive Disease YES Primary Tumor 01 NO YES Not listed in Medical Record NO NO YES DU Supratentorial, Temporal Lobe Central nervous system NO LIVING 1995 f0b0d0c2-4b26-4cf9-b3c7-2f973f958729 TCGA-DU-5870-01A-11D-1705-08 TCGA-DU-5870-01A-11D-1706-05 TCGA-DU-5870-01A-11D-1704-01 TCGA-DU-5870-01 f0b0d0c2-4b26-4cf9-b3c7-2f973f958729 TCGA-DU-5870-01 TCGA-DU-5870-01A-11D-1704-01 f0b0d0c2-4b26-4cf9-b3c7-2f973f958729 +TCGA-DU-5870-02 TCGA-DU-5870-02 TCGA-DU-5870 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain YES YES YES NO 34 TCGA-DU-5870-F14719 TCGA-DU-5870 TCGA-DU-5870-02A 4437 -12764 6469 0 5546 4347 4671 NO Headaches > 181 Days Stable Disease 2011-7-27 FEMALE YES Oligodendroglioma NO No C71.9 9450/3 C71.9 YES 390 NO 70 Right NO YES NO G2 YES false No TCGA-DU-5870.5A7D5219-AFF1-4DC0-9A8B-F6403D021501.pdf 5870 Post-Adjuvant Therapy WITH TUMOR Progressive Disease YES Recurrent Tumor 02 NO YES Not listed in Medical Record NO NO YES DU Supratentorial, Temporal Lobe Central nervous system A NO LIVING 1995 387f62fd-dfeb-4f05-88d1-64d8de9a031a TCGA-DU-5870-02A-12D-A368-05 387f62fd-dfeb-4f05-88d1-64d8de9a031a 387f62fd-dfeb-4f05-88d1-64d8de9a031a +TCGA-DU-5871-01 TCGA-DU-5871-01 TCGA-DU-5871 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain NO NO NO NO 37 TCGA-DU-5871-F15057 TCGA-DU-5871 -13673 0 576 -6 YES NO Seizures 0 - 30 Days 2011-5-27 FEMALE NO Oligoastrocytoma NO No C71.9 9382/3 C71.9 YES 100 Left NO NO NO G2 NO No 5871 Preoperative TUMOR FREE YES YES Stable Disease YES Primary Tumor 01 YES NO White Matter YES YES NO DU Supratentorial, Frontal Lobe Central nervous system NO LIVING 2009 e04bbaf8-d646-4c00-8d72-72fcdb073ec3 TCGA-DU-5871-01A-12D-1705-08 TCGA-DU-5871-01A-12D-1706-05 TCGA-DU-5871-01A-12D-1704-01 TCGA-DU-5871-01 e04bbaf8-d646-4c00-8d72-72fcdb073ec3 TCGA-DU-5871-01 TCGA-DU-5871-01A-12D-1704-01 e04bbaf8-d646-4c00-8d72-72fcdb073ec3 +TCGA-DU-5872-01 TCGA-DU-5872-01 TCGA-DU-5872 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain YES NO YES NO 43 TCGA-DU-5872-F14771 TCGA-DU-5872 283 -15986 0 532 265 NO NO Headaches 0 - 30 Days Progressive Disease 2011-6-20 FEMALE YES Oligoastrocytoma NO No C71.9 9382/3 C71.9 YES Left NO NO NO G2 YES No 5872 WITH TUMOR YES YES Progressive Disease YES Primary Tumor 01 NO NO Not listed in Medical Record YES YES NO DU Supratentorial, Frontal Lobe Central nervous system NO LIVING 2009 bf5bd9e6-0623-4aac-9336-4ff9dd538c7c TCGA-DU-5872-01A-11D-1705-08 TCGA-DU-5872-01A-11D-1706-05 TCGA-DU-5872-01A-11D-1704-01 TCGA-DU-5872-01 bf5bd9e6-0623-4aac-9336-4ff9dd538c7c TCGA-DU-5872-01 TCGA-DU-5872-01A-11D-1704-01 bf5bd9e6-0623-4aac-9336-4ff9dd538c7c +TCGA-DU-5872-02 TCGA-DU-5872-02 TCGA-DU-5872 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain YES NO YES NO 43 TCGA-DU-5872-F14771 TCGA-DU-5872 TCGA-DU-5872-02A 283 -15986 1317 0 532 265 NO NO Headaches 0 - 30 Days Progressive Disease 2011-6-20 FEMALE YES Oligoastrocytoma NO No C71.9 9382/3 C71.9 YES 430 NO Left NO NO NO G2 YES false No TCGA-DU-5872.86EEC915-5F91-4C9E-B243-A26C2ACC04CF.pdf 5872 WITH TUMOR YES YES Progressive Disease YES Recurrent Tumor 02 NO NO Not listed in Medical Record YES YES NO DU Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2009 0d0edd5c-226b-4dae-a881-24dba9d3caab TCGA-DU-5872-02A-21D-A368-05 0d0edd5c-226b-4dae-a881-24dba9d3caab 0d0edd5c-226b-4dae-a881-24dba9d3caab +TCGA-DU-5874-01 TCGA-DU-5874-01 TCGA-DU-5874 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 62 TCGA-DU-5874-F14706 TCGA-DU-5874 TCGA-DU-5874-01A -22847 0 461 380 Seizures 31 - 90 Days 2011-6-17 FEMALE NO Oligodendroglioma NO No C71.9 9450/3 C71.9 YES 1 NO 100 Left NO 1 NO NO G2 NO No TCGA-DU-5874.edd1c152-5b40-4f2f-a7bc-454f1837142a.pdf 5874 Pre-Adjuvant Therapy TUMOR FREE YES NO Stable Disease NO Primary Tumor 01 YES NO 0.7 Not listed in Medical Record YES YES NO DU Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2010 40b5eda3-8b01-4cd7-acb5-0ea4e9ff4312 TCGA-DU-5874-01A-11D-1705-08 TCGA-DU-5874-01A-11D-1706-05 TCGA-DU-5874-01A-11D-1704-01 TCGA-DU-5874-01 40b5eda3-8b01-4cd7-acb5-0ea4e9ff4312 TCGA-DU-5874-01 TCGA-DU-5874-01A-11D-1704-01 40b5eda3-8b01-4cd7-acb5-0ea4e9ff4312 +TCGA-DU-6392-01 TCGA-DU-6392-01 TCGA-DU-6392 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain NO NO YES YES 35 TCGA-DU-6392-F14726 TCGA-DU-6392 950 1055 -12836 0 6423 950 Seizures 0 - 30 Days Stable Disease 2011-5-27 FEMALE Astrocytoma NO No C71.0 9401/3 C71.0 YES Right NO G3 YES No 6392 TUMOR FREE Progressive Disease YES Primary Tumor 01 YES White Matter YES NO YES DU Supratentorial, Parietal Lobe Central nervous system LIVING 1993 d224765a-980f-4212-acf8-c38d0d9b7610 TCGA-DU-6392-01A-11D-1705-08 TCGA-DU-6392-01A-11D-1706-05 TCGA-DU-6392-01A-11D-1704-01 TCGA-DU-6392-01 d224765a-980f-4212-acf8-c38d0d9b7610 TCGA-DU-6392-01 TCGA-DU-6392-01A-11D-1704-01 d224765a-980f-4212-acf8-c38d0d9b7610 +TCGA-DU-6393-01 TCGA-DU-6393-01 TCGA-DU-6393 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 66 TCGA-DU-6393-F14735 TCGA-DU-6393 TCGA-DU-6393-01A -24282 1585 0 2011-5-27 MALE Oligodendroglioma NO No C71.0 9451/3 C71.0 YES 0.7 NO Left NO 0.7 G3 No TCGA-DU-6393.13d53e5b-0ff2-4903-91a4-b183b2a4fd62.pdf 6393 YES Primary Tumor 01 0.5 White Matter YES NO YES DU Supratentorial, Occipital Lobe Central nervous system A DECEASED 1993 1bb006de-b90b-43fe-8f1e-2357faf7c73f TCGA-DU-6393-01A-11D-1705-08 TCGA-DU-6393-01A-11D-1706-05 TCGA-DU-6393-01A-11D-1704-01 TCGA-DU-6393-01 1bb006de-b90b-43fe-8f1e-2357faf7c73f TCGA-DU-6393-01 TCGA-DU-6393-01A-11D-1704-01 1bb006de-b90b-43fe-8f1e-2357faf7c73f +TCGA-DU-6394-01 TCGA-DU-6394-01 TCGA-DU-6394 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain YES YES NO NO 53 TCGA-DU-6394-F14761 TCGA-DU-6394 -19541 682 0 353 Progressive Disease 2011-5-27 MALE Oligodendroglioma NO No C71.0 9451/3 C71.0 YES Midline G3 YES No 6394 WITH TUMOR Progressive Disease YES Primary Tumor 01 White Matter YES NO YES DU Supratentorial, Frontal Lobe Central nervous system DECEASED 1994 fb8d125a-badb-4b4a-ab74-916c93ebbf21 TCGA-DU-6394-01A-11D-1705-08 TCGA-DU-6394-01A-11D-1706-05 TCGA-DU-6394-01A-11D-1704-01 TCGA-DU-6394-01 fb8d125a-badb-4b4a-ab74-916c93ebbf21 TCGA-DU-6394-01 TCGA-DU-6394-01A-11D-1704-01 fb8d125a-badb-4b4a-ab74-916c93ebbf21 +TCGA-DU-6395-01 TCGA-DU-6395-01 TCGA-DU-6395 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain YES NO YES NO 31 TCGA-DU-6395-F14942 TCGA-DU-6395 1197 -11584 1491 0 1197 NO NO Seizures 91 - 180 Days Progressive Disease 2011-5-26 MALE NO Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES Left NO NO NO G2 YES No 6395 WITH TUMOR Progressive Disease YES Primary Tumor 01 YES NO Not listed in Medical Record NO NO YES DU Supratentorial, Frontal Lobe Central nervous system NO DECEASED 1994 c1c9f44f-935f-47b9-80cd-5116d52001c3 TCGA-DU-6395-01A-12D-1705-08 TCGA-DU-6395-01A-12D-1706-05 TCGA-DU-6395-01A-12D-1704-01 TCGA-DU-6395-01 c1c9f44f-935f-47b9-80cd-5116d52001c3 TCGA-DU-6395-01 TCGA-DU-6395-01A-12D-1704-01 c1c9f44f-935f-47b9-80cd-5116d52001c3 +TCGA-DU-6396-01 TCGA-DU-6396-01 TCGA-DU-6396 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain YES YES YES NO 31 TCGA-DU-6396-F14916 TCGA-DU-6396 TCGA-DU-6396-01A 169 -11427 2286 0 106 19 0 NO NO Motor/Movement Changes 0 - 30 Days Progressive Disease 2011-7-27 FEMALE YES Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES 1 NO 90 Right NO 1 NO YES G3 YES No TCGA-DU-6396.23ea2bb8-e87f-4956-8a97-b53537885a69.pdf 6396 Post-Adjuvant Therapy WITH TUMOR Progressive Disease YES Primary Tumor 01 NO YES 1 White Matter YES NO YES DU Supratentorial, Frontal Lobe Central nervous system A NO DECEASED 1996 128dd28f-7f33-4fc2-a131-e64adbab6ba8 TCGA-DU-6396-01A-11D-1705-08 TCGA-DU-6396-01A-11D-1706-05 TCGA-DU-6396-01A-11D-1704-01 TCGA-DU-6396-01 128dd28f-7f33-4fc2-a131-e64adbab6ba8 TCGA-DU-6396-01 TCGA-DU-6396-01A-11D-1704-01 128dd28f-7f33-4fc2-a131-e64adbab6ba8 +TCGA-DU-6397-01 TCGA-DU-6397-01 TCGA-DU-6397 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain YES YES YES NO 45 TCGA-DU-6397-F14794 TCGA-DU-6397 TCGA-DU-6397-01A 837 -16695 1401 0 837 YES NO Headaches 0 - 30 Days Progressive Disease 2011-5-26 MALE YES Oligodendroglioma NO No C71.0 9451/3 C71.0 YES 1 NO Right NO 1.3 YES G3 YES No TCGA-DU-6397.54C5D9F8-8737-49DA-81CF-F9A95B0DB456.pdf 6397 WITH TUMOR Progressive Disease YES Primary Tumor 01 NO 0.8 Not listed in Medical Record NO NO YES DU Supratentorial, Temporal Lobe Central nervous system A YES DECEASED 1997 32192c9c-9ab2-4709-b419-9beb7853ca2f TCGA-DU-6397-01A-11D-1705-08 TCGA-DU-6397-01A-11D-1706-05 TCGA-DU-6397-01A-11D-1704-01 TCGA-DU-6397-01 32192c9c-9ab2-4709-b419-9beb7853ca2f TCGA-DU-6397-01 TCGA-DU-6397-01A-11D-1704-01 32192c9c-9ab2-4709-b419-9beb7853ca2f +TCGA-DU-6397-02 TCGA-DU-6397-02 TCGA-DU-6397 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain YES YES YES NO 45 TCGA-DU-6397-F14794 TCGA-DU-6397 TCGA-DU-6397-02A 837 -16695 5830 1401 0 837 YES NO Headaches 0 - 30 Days Progressive Disease 2011-5-26 MALE YES Oligodendroglioma NO No C71.0 9451/3 C71.0 YES 200 NO Right NO YES G3 YES false No TCGA-DU-6397.54C5D9F8-8737-49DA-81CF-F9A95B0DB456.pdf 6397 WITH TUMOR Progressive Disease YES Recurrent Tumor 02 NO Not listed in Medical Record NO NO YES DU Supratentorial, Temporal Lobe Central nervous system A YES DECEASED 1997 5154656a-156d-4118-8415-75b9253ad3f9 TCGA-DU-6397-02A-12D-A368-05 5154656a-156d-4118-8415-75b9253ad3f9 5154656a-156d-4118-8415-75b9253ad3f9 +TCGA-DU-6399-01 TCGA-DU-6399-01 TCGA-DU-6399 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain NO NO YES NO 54 TCGA-DU-6399-F14710 TCGA-DU-6399 1629 -19906 2000 0 1629 NO 31 - 90 Days Progressive Disease 2011-5-31 MALE NO Oligodendroglioma NO No C71.0 9450/3 C71.0 YES Right NO NO NO G2 YES No 6399 WITH TUMOR Progressive Disease YES Primary Tumor 01 NO NO White Matter NO NO YES DU Supratentorial, Temporal Lobe Central nervous system NO DECEASED 1998 f1a80ad7-316b-4bf7-a428-3d46f498b571 TCGA-DU-6399-01A-12D-1705-08 TCGA-DU-6399-01A-12D-1706-05 TCGA-DU-6399-01A-12D-1704-01 TCGA-DU-6399-01 f1a80ad7-316b-4bf7-a428-3d46f498b571 TCGA-DU-6399-01 TCGA-DU-6399-01A-12D-1704-01 f1a80ad7-316b-4bf7-a428-3d46f498b571 +TCGA-DU-6400-01 TCGA-DU-6400-01 TCGA-DU-6400 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 66 TCGA-DU-6400-F14782 TCGA-DU-6400 TCGA-DU-6400-01A -24122 37 0 Mental Status Changes 91 - 180 Days 2011-5-31 FEMALE YES Oligodendroglioma NO No C71.0 9450/3 C71.0 YES 0.6 NO Left NO 1 YES YES G2 NO No TCGA-DU-6400.a61be291-6258-47f2-8404-18615093f168.pdf 6400 WITH TUMOR YES YES NO Primary Tumor 01 NO NO 0.5 Not listed in Medical Record NO NO YES DU Supratentorial, Temporal Lobe Central nervous system A NO DECEASED 1998 3e095f21-2bc5-4ee8-bf9f-0035164d2113 TCGA-DU-6400-01A-12D-1705-08 TCGA-DU-6400-01A-12D-1706-05 TCGA-DU-6400-01A-12D-1704-01 TCGA-DU-6400-01 3e095f21-2bc5-4ee8-bf9f-0035164d2113 TCGA-DU-6400-01 TCGA-DU-6400-01A-12D-1704-01 3e095f21-2bc5-4ee8-bf9f-0035164d2113 +TCGA-DU-6401-01 TCGA-DU-6401-01 TCGA-DU-6401 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain YES NO YES NO 31 TCGA-DU-6401-F14751 TCGA-DU-6401 TCGA-DU-6401-01A 2464 -11595 2660 0 1886 2454 Headaches > 181 Days Progressive Disease 2011-5-31 FEMALE YES Oligodendroglioma NO No C71.0 9450/3 C71.0 YES 0.8 NO 100 Left NO 1.5 NO NO G2 YES No TCGA-DU-6401.8B65EAA0-2BE6-4648-9CF0-9E97AAB0073C.pdf 6401 Preoperative WITH TUMOR YES YES Progressive Disease YES Primary Tumor 01 NO NO 0.5 Not listed in Medical Record NO NO YES DU Supratentorial, Frontal Lobe Central nervous system A YES DECEASED 1998 2692f7b0-3203-455f-b9b8-23b18eff2de1 TCGA-DU-6401-01A-11D-1705-08 TCGA-DU-6401-01A-11D-1706-05 TCGA-DU-6401-01A-11D-1704-01 TCGA-DU-6401-01 2692f7b0-3203-455f-b9b8-23b18eff2de1 TCGA-DU-6401-01 TCGA-DU-6401-01A-11D-1704-01 2692f7b0-3203-455f-b9b8-23b18eff2de1 +TCGA-DU-6402-01 TCGA-DU-6402-01 TCGA-DU-6402 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain NO NO NO 52 TCGA-DU-6402-F14714 TCGA-DU-6402 TCGA-DU-6402-01A -19207 214 0 103 Seizures 0 - 30 Days Progressive Disease 2011-5-31 MALE Astrocytoma NO No C71.0 9401/3 C71.0 YES 1 NO Right NO 1.5 G3 YES No TCGA-DU-6402.cf00fc85-c4be-4d4a-987a-074fcf53aca3.pdf 6402 WITH TUMOR Progressive Disease YES Primary Tumor 01 YES 0.5 Not listed in Medical Record YES NO YES DU Supratentorial, Frontal Lobe Central nervous system A DECEASED 1998 51f1ccc5-2481-4a1a-8892-c0728d1c9869 TCGA-DU-6402-01A-11D-1705-08 TCGA-DU-6402-01A-11D-1706-05 TCGA-DU-6402-01A-11D-1704-01 TCGA-DU-6402-01 51f1ccc5-2481-4a1a-8892-c0728d1c9869 TCGA-DU-6402-01 TCGA-DU-6402-01A-11D-1704-01 51f1ccc5-2481-4a1a-8892-c0728d1c9869 +TCGA-DU-6403-01 TCGA-DU-6403-01 TCGA-DU-6403 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 60 TCGA-DU-6403-F14743 TCGA-DU-6403 -22031 354 0 207 Headaches 0 - 30 Days 2011-5-31 FEMALE YES Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES 90 Right NO NO NO G3 No 6403 Post-Adjuvant Therapy WITH TUMOR YES YES Primary Tumor 01 NO NO Not listed in Medical Record YES NO YES DU Supratentorial, Temporal Lobe Central nervous system NO DECEASED 1999 d4cd474d-abe3-423c-9772-a8edce3bb8c7 TCGA-DU-6403-01A-11D-1705-08 TCGA-DU-6403-01A-11D-1706-05 TCGA-DU-6403-01A-11D-1704-01 TCGA-DU-6403-01 d4cd474d-abe3-423c-9772-a8edce3bb8c7 TCGA-DU-6403-01 TCGA-DU-6403-01A-11D-1704-01 d4cd474d-abe3-423c-9772-a8edce3bb8c7 +TCGA-DU-6404-01 TCGA-DU-6404-01 TCGA-DU-6404 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain YES YES YES NO 24 NO NO TCGA-DU-6404-F14781 TCGA-DU-6404 TCGA-DU-6404-01A 1194 -9021 4068 0 1154 1398 NO YES NO 12 - 20 Years Seizures 31 - 90 Days Progressive Disease YES beef 2011-5-31 FEMALE NO NO Oligodendroglioma NO No C71.0 9451/3 C71.0 YES 0.6 NO 100 Right NO 1 NO NO NO G3 YES No 6404 Post-Adjuvant Therapy WITH TUMOR YES NO Progressive Disease YES Primary Tumor 01 YES NO 0.3 Not listed in Medical Record YES NO YES DU Supratentorial, Frontal Lobe Central nervous system A NO DECEASED 2000 50ec944a-3bb5-41b1-965e-e5cf7f5bd24b TCGA-DU-6404-01A-11D-1705-08 TCGA-DU-6404-01A-11D-1706-05 TCGA-DU-6404-01A-11D-1704-01 TCGA-DU-6404-01 50ec944a-3bb5-41b1-965e-e5cf7f5bd24b TCGA-DU-6404-01 TCGA-DU-6404-01A-11D-1704-01 50ec944a-3bb5-41b1-965e-e5cf7f5bd24b +TCGA-DU-6404-02 TCGA-DU-6404-02 TCGA-DU-6404 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain YES YES YES NO 24 NO NO TCGA-DU-6404-F14781 TCGA-DU-6404 TCGA-DU-6404-02A 1194 -9021 4892 4068 0 1154 1398 NO YES NO 12 - 20 Years Seizures 31 - 90 Days Progressive Disease YES beef 2011-5-31 FEMALE NO NO Oligodendroglioma NO No C71.0 9451/3 C71.0 YES 200 NO 100 Right NO NO NO NO G3 YES false No TCGA-DU-6404.C13F0838-3BA3-4C58-BDCC-926F470FFD34.pdf 6404 Post-Adjuvant Therapy WITH TUMOR YES NO Progressive Disease YES Recurrent Tumor 02 YES NO Not listed in Medical Record YES NO YES DU Supratentorial, Frontal Lobe Central nervous system A NO DECEASED 2000 6297b8d1-8f4e-499c-b95f-422f0a574b35,af6191bb-b4c3-42ea-adc9-f6d45b00f0b0 TCGA-DU-6404-02B-11D-A368-05,TCGA-DU-6404-02A-21D-A368-05 6297b8d1-8f4e-499c-b95f-422f0a574b35,af6191bb-b4c3-42ea-adc9-f6d45b00f0b0 6297b8d1-8f4e-499c-b95f-422f0a574b35,af6191bb-b4c3-42ea-adc9-f6d45b00f0b0 +TCGA-DU-6405-01 TCGA-DU-6405-01 TCGA-DU-6405 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain YES NO NO 51 TCGA-DU-6405-F14683 TCGA-DU-6405 -18686 605 0 486 571 Seizures 0 - 30 Days Progressive Disease 2011-6-20 FEMALE Astrocytoma NO No C71.0 9401/3 C71.0 YES 60 Right NO G3 YES No 6405 Post-Adjuvant Therapy WITH TUMOR YES NO Progressive Disease YES Primary Tumor 01 YES Not listed in Medical Record YES NO YES DU Supratentorial, Frontal Lobe Central nervous system DECEASED 2000 ab2b78d1-773b-4935-b458-60befcf470af TCGA-DU-6405-01A-11D-1705-08 TCGA-DU-6405-01A-11D-1706-05 TCGA-DU-6405-01A-11D-1704-01 TCGA-DU-6405-01 ab2b78d1-773b-4935-b458-60befcf470af TCGA-DU-6405-01 TCGA-DU-6405-01A-11D-1704-01 ab2b78d1-773b-4935-b458-60befcf470af +TCGA-DU-6406-01 TCGA-DU-6406-01 TCGA-DU-6406 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 59 TCGA-DU-6406-F14899 TCGA-DU-6406 TCGA-DU-6406-01A -21634 512 0 Motor/Movement Changes 91 - 180 Days 2011-6-1 FEMALE NO Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES 0.5 NO Left NO 1 NO YES G3 No TCGA-DU-6406.84775a3e-6deb-477c-bd7b-65f84d5701dd.pdf 6406 YES Primary Tumor 01 NO YES 0.5 Not listed in Medical Record YES NO YES DU Supratentorial, Frontal Lobe Central nervous system A YES DECEASED 2001 9af14bce-1e74-4b8a-aa17-049ff4d45db6 TCGA-DU-6406-01A-11D-1705-08 TCGA-DU-6406-01A-11D-1706-05 TCGA-DU-6406-01A-11D-1704-01 TCGA-DU-6406-01 9af14bce-1e74-4b8a-aa17-049ff4d45db6 TCGA-DU-6406-01 TCGA-DU-6406-01A-11D-1704-01 9af14bce-1e74-4b8a-aa17-049ff4d45db6 +TCGA-DU-6407-01 TCGA-DU-6407-01 TCGA-DU-6407 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain YES YES YES YES 35 TCGA-DU-6407-F14950 TCGA-DU-6407 TCGA-DU-6407-01A 2415 2797 -13021 2875 0 2397 2838 NO NO Seizures Progressive Disease 2011-6-20 FEMALE NO Oligodendroglioma NO No C71.0 9450/3 C71.0 YES 0.8 NO 80 Right NO 0.8 NO NO G2 YES No 6407 Pre-Adjuvant Therapy WITH TUMOR YES NO Progressive Disease YES Primary Tumor 01 YES NO 0.5 Not listed in Medical Record NO NO YES DU [Discrepancy] Central nervous system A NO DECEASED 2001 106c0a27-64c4-4496-83f3-1c05df492fd2 TCGA-DU-6407-01A-13D-1705-08 TCGA-DU-6407-01A-13D-1706-05 TCGA-DU-6407-01A-13D-1704-01 TCGA-DU-6407-01 106c0a27-64c4-4496-83f3-1c05df492fd2 TCGA-DU-6407-01 TCGA-DU-6407-01A-13D-1704-01 106c0a27-64c4-4496-83f3-1c05df492fd2 +TCGA-DU-6407-02 TCGA-DU-6407-02 TCGA-DU-6407 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain YES YES YES YES 35 TCGA-DU-6407-F14950 TCGA-DU-6407 TCGA-DU-6407-02B 2415 2797 -13021 4524 2875 0 2397 2838 NO NO Seizures Progressive Disease 2011-6-20 FEMALE NO Oligodendroglioma NO No C71.0 9450/3 C71.0 YES 390 NO 80 Right NO NO NO G2 YES false No TCGA-DU-6407.49BAF246-AE0A-4627-AF91-35932D00F105.pdf 6407 Pre-Adjuvant Therapy WITH TUMOR YES NO Progressive Disease YES Recurrent Tumor 02 YES NO Not listed in Medical Record NO NO YES DU [Discrepancy] Central nervous system B NO DECEASED 2001 1cd76b6a-a698-46cd-9594-decc4ebf24e4,d63ec2f9-d8ca-4738-9d0f-00f93e7ac897 TCGA-DU-6407-02A-12D-A368-05,TCGA-DU-6407-02B-11D-A368-05 1cd76b6a-a698-46cd-9594-decc4ebf24e4,d63ec2f9-d8ca-4738-9d0f-00f93e7ac897 1cd76b6a-a698-46cd-9594-decc4ebf24e4,d63ec2f9-d8ca-4738-9d0f-00f93e7ac897 +TCGA-DU-6408-01 TCGA-DU-6408-01 TCGA-DU-6408 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain YES YES YES 23 TCGA-DU-6408-F14907 TCGA-DU-6408 TCGA-DU-6408-01A 2552 2552 -8752 3470 0 2097 NO Motor/Movement Changes 0 - 30 Days Progressive Disease 2011-6-20 FEMALE NO Oligodendroglioma NO No C71.0 9451/3 C71.0 YES 1 NO 90 Right NO 1 YES YES G3 YES No TCGA-DU-6408.83c5c547-8f79-4b30-9883-3a146c5053ef.pdf 6408 Post-Adjuvant Therapy YES YES Progressive Disease YES Primary Tumor 01 YES NO 0.5 Not listed in Medical Record YES NO YES DU Supratentorial, Frontal Lobe Central nervous system A NO DECEASED 1998 0c562903-7b09-49f2-b59e-fa697d69f810 TCGA-DU-6408-01A-11D-1705-08 TCGA-DU-6408-01A-11D-1706-05 TCGA-DU-6408-01A-11D-1704-01 TCGA-DU-6408-01 0c562903-7b09-49f2-b59e-fa697d69f810 TCGA-DU-6408-01 TCGA-DU-6408-01A-11D-1704-01 0c562903-7b09-49f2-b59e-fa697d69f810 +TCGA-DU-6410-01 TCGA-DU-6410-01 TCGA-DU-6410 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 56 TCGA-DU-6410-F15160 TCGA-DU-6410 TCGA-DU-6410-01A -20567 0 242 35 Mental Status Changes 0 - 30 Days 2011-6-20 MALE Oligodendroglioma NO No C71.0 9451/3 C71.0 YES 0.8 NO 50 Midline NO 0.8 YES G3 NO No TCGA-DU-6410.d7745e3b-3ccd-40ff-8634-9a0f71e088d4.pdf 6410 Pre-Adjuvant Therapy WITH TUMOR NO Primary Tumor 01 0.6 Not listed in Medical Record YES YES NO DU Supratentorial, Frontal Lobe Central nervous system A LIVING 2010 015b3ae9-dee4-495a-9c4d-78ee51082715 TCGA-DU-6410-01A-11D-1893-08 TCGA-DU-6410-01A-11D-1894-05 TCGA-DU-6410-01A-11D-1892-01 TCGA-DU-6410-01 015b3ae9-dee4-495a-9c4d-78ee51082715 TCGA-DU-6410-01 TCGA-DU-6410-01A-11D-1892-01 015b3ae9-dee4-495a-9c4d-78ee51082715 +TCGA-DU-6542-01 TCGA-DU-6542-01 TCGA-DU-6542 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 25 TCGA-DU-6542-F46623 TCGA-DU-6542 -9380 0 73 Visual Changes 31 - 90 Days Scheduled Follow-up Submission 2013-8-13 MALE YES Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES Right NO YES NO NO G3 No 6542 WITH TUMOR YES YES YES Primary Tumor 01 NO NO Not listed in Medical Record YES YES NO DU Supratentorial, Temporal Lobe Central nervous system YES LIVING 2011 da02270f-1191-446e-af1d-eabc4e1c3556 TCGA-DU-6542-01A-11D-1893-08 TCGA-DU-6542-01A-11D-1894-05 TCGA-DU-6542-01A-11D-1892-01 TCGA-DU-6542-01 da02270f-1191-446e-af1d-eabc4e1c3556 TCGA-DU-6542-01 TCGA-DU-6542-01A-11D-1892-01 da02270f-1191-446e-af1d-eabc4e1c3556 +TCGA-DU-7006-01 TCGA-DU-7006-01 TCGA-DU-7006 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 60 TCGA-DU-7006-F17927 TCGA-DU-7006 TCGA-DU-7006-01A -21990 349 0 Seizures 2011-10-25 FEMALE NO Astrocytoma NO No C71.0 9401/3 C71.0 YES 0.8 NO Left NO 1 NO NO G3 No TCGA-DU-7006.1341bbae-b2bf-43fb-be7e-c49cfd28fbb2.pdf 7006 WITH TUMOR Progressive Disease YES Primary Tumor 01 YES NO 0.4 Cerebral Cortex YES NO YES DU Supratentorial, Temporal Lobe Central nervous system A NO DECEASED 1995 2c1bdff1-365e-42f2-8fc6-772e9e5fa274 TCGA-DU-7006-01A-11D-2024-08 TCGA-DU-7006-01A-11D-2025-05 TCGA-DU-7006-01A-11D-2023-01 TCGA-DU-7006-01 2c1bdff1-365e-42f2-8fc6-772e9e5fa274 TCGA-DU-7006-01 TCGA-DU-7006-01A-11D-2023-01 2c1bdff1-365e-42f2-8fc6-772e9e5fa274 +TCGA-DU-7007-01 TCGA-DU-7007-01 TCGA-DU-7007 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 33 YES TCGA-DU-7007-F17216 TCGA-DU-7007 TCGA-DU-7007-01A -12245 1915 0 Headaches > 181 Days 2011-9-28 MALE YES Astrocytoma NO No C71.0 9400/3 C71.0 YES 1 NO Right 1 NO NO G2 NO No TCGA-DU-7007.ffbbe732-9a5a-4269-b0a7-99f993906030.pdf 7007 Primary Tumor 01 NO YES 0.6 Not listed in Medical Record NO YES DU Supratentorial, Frontal Lobe Central nervous system A NO DECEASED 1997 338cef4b-d790-4823-8dad-40bf78c29c68 TCGA-DU-7007-01A-11D-2024-08 TCGA-DU-7007-01A-11D-2025-05 TCGA-DU-7007-01A-11D-2023-01 TCGA-DU-7007-01 338cef4b-d790-4823-8dad-40bf78c29c68 TCGA-DU-7007-01 TCGA-DU-7007-01A-11D-2023-01 338cef4b-d790-4823-8dad-40bf78c29c68 +TCGA-DU-7008-01 TCGA-DU-7008-01 TCGA-DU-7008 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain NO YES YES NO 41 TCGA-DU-7008-F17219 TCGA-DU-7008 330 -15289 0 4752 330 Seizures > 181 Days Stable Disease 2011-9-28 FEMALE YES Oligodendroglioma NO No C71.0 9450/3 C71.0 YES Right NO NO NO G2 YES No 7008 TUMOR FREE YES YES Progressive Disease NO Primary Tumor 01 YES NO Not listed in Medical Record YES NO YES DU Supratentorial, Frontal Lobe Central nervous system NO LIVING 1998 a5a2a97b-91dd-45a8-b76c-05d6d40cbe9f TCGA-DU-7008-01A-11D-2024-08 TCGA-DU-7008-01A-11D-2025-05 TCGA-DU-7008-01A-11D-2023-01 TCGA-DU-7008-01 a5a2a97b-91dd-45a8-b76c-05d6d40cbe9f TCGA-DU-7008-01 TCGA-DU-7008-01A-11D-2023-01 a5a2a97b-91dd-45a8-b76c-05d6d40cbe9f +TCGA-DU-7009-01 TCGA-DU-7009-01 TCGA-DU-7009 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain YES YES YES 32 TCGA-DU-7009-F46593 TCGA-DU-7009 TCGA-DU-7009-01A 3091 -11854 4695 0 4206 2960 NO NO Sensory Changes 31 - 90 Days Additional New Tumor Event Progressive Disease 2013-8-12 FEMALE NO Oligodendroglioma NO No C71.0 9450/3 C71.0 YES 1 NO Left NO 1 NO NO NO G2 YES No TCGA-DU-7009.bc350788-3a70-47d5-b2ef-45deebd89fa0.pdf 7009 WITH TUMOR Progressive Disease YES Primary Tumor 01 NO YES 0.5 Cerebral Cortex YES NO YES DU Supratentorial, Frontal Lobe Central nervous system A NO DECEASED 2000 748811da-49b0-4ff6-a718-0549921871be TCGA-DU-7009-01A-11D-2024-08 TCGA-DU-7009-01A-11D-2025-05 TCGA-DU-7009-01A-11D-2023-01 TCGA-DU-7009-01 748811da-49b0-4ff6-a718-0549921871be TCGA-DU-7009-01 TCGA-DU-7009-01A-11D-2023-01 748811da-49b0-4ff6-a718-0549921871be +TCGA-DU-7010-01 TCGA-DU-7010-01 TCGA-DU-7010 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain YES NO 58 TCGA-DU-7010-F17059 TCGA-DU-7010 TCGA-DU-7010-01A 193 -21199 456 0 193 Seizures 31 - 90 Days Progressive Disease 2011-9-28 FEMALE NO Astrocytoma NO No C71.0 9401/3 C71.0 YES 1 NO Left NO 1.1 NO NO G3 YES No TCGA-DU-7010.B62E7173-FC3E-4D4C-B9C0-37110B1B58E8.pdf 7010 WITH TUMOR YES YES Progressive Disease YES Primary Tumor 01 YES NO 0.5 Not listed in Medical Record YES NO YES DU Supratentorial, Frontal Lobe Central nervous system A NO DECEASED 2001 72721695-e7f3-48c8-82a1-84156e174cad TCGA-DU-7010-01A-11D-2025-05 TCGA-DU-7010-01A-11D-2023-01 TCGA-DU-7010-01 72721695-e7f3-48c8-82a1-84156e174cad TCGA-DU-7010-01 TCGA-DU-7010-01A-11D-2023-01 72721695-e7f3-48c8-82a1-84156e174cad +TCGA-DU-7011-01 TCGA-DU-7011-01 TCGA-DU-7011 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 25 TCGA-DU-7011-F17074 TCGA-DU-7011 -9322 3200 0 149 Seizures 91 - 180 Days 2011-9-28 MALE NO Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES 80 Right NO NO NO G2 No 7011 Pre-Adjuvant Therapy WITH TUMOR YES YES Stable Disease YES Primary Tumor 01 YES NO Cerebral Cortex NO YES DU Supratentorial, Frontal Lobe Central nervous system NO DECEASED 2000 ef7cd9b2-f363-40db-bdc1-a07c10e31fd2 TCGA-DU-7011-01A-11D-2025-05 TCGA-DU-7011-01A-11D-2023-01 TCGA-DU-7011-01 ef7cd9b2-f363-40db-bdc1-a07c10e31fd2 TCGA-DU-7011-01 TCGA-DU-7011-01A-11D-2023-01 ef7cd9b2-f363-40db-bdc1-a07c10e31fd2 +TCGA-DU-7012-01 TCGA-DU-7012-01 TCGA-DU-7012 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain NO NO 74 TCGA-DU-7012-F17089 TCGA-DU-7012 TCGA-DU-7012-01A -27039 199 0 Mental Status Changes 0 - 30 Days Progressive Disease 2011-9-28 FEMALE NO Astrocytoma NO No C71.0 9401/3 C71.0 YES 1 NO Left NO 1.1 YES NO G3 NO No TCGA-DU-7012.097539a1-a885-478d-9a11-087d6dbf8970.pdf 7012 WITH TUMOR Progressive Disease YES Primary Tumor 01 YES NO 0.9 Not listed in Medical Record NO NO YES DU Supratentorial, Temporal Lobe Central nervous system A NO DECEASED 2001 61051f5f-b74b-4b31-ae20-b91491f571d6 TCGA-DU-7012-01A-11D-2025-05 TCGA-DU-7012-01A-11D-2023-01 TCGA-DU-7012-01 61051f5f-b74b-4b31-ae20-b91491f571d6 TCGA-DU-7012-01 TCGA-DU-7012-01A-11D-2023-01 61051f5f-b74b-4b31-ae20-b91491f571d6 +TCGA-DU-7013-01 TCGA-DU-7013-01 TCGA-DU-7013 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain NO NO NO NO 59 TCGA-DU-7013-F17092 TCGA-DU-7013 TCGA-DU-7013-01A -21824 269 0 187 211 Seizures 31 - 90 Days Progressive Disease 2011-9-26 MALE NO Astrocytoma NO No C71.0 9401/3 C71.0 YES 1 NO 70 Left NO 1 NO NO G3 YES No TCGA-DU-7013.a39cad6f-249d-4bc5-8d67-9a3fa7e4dcd6.pdf 7013 Post-Adjuvant Therapy WITH TUMOR YES YES Progressive Disease YES Primary Tumor 01 YES NO 0.5 White Matter YES NO YES DU Supratentorial, Temporal Lobe Central nervous system A NO DECEASED 2001 5fd57857-2f5d-4cfd-a365-bf4d5369f926 TCGA-DU-7013-01A-11D-2024-08 TCGA-DU-7013-01A-11D-2025-05 TCGA-DU-7013-01A-11D-2023-01 TCGA-DU-7013-01 5fd57857-2f5d-4cfd-a365-bf4d5369f926 TCGA-DU-7013-01 TCGA-DU-7013-01A-11D-2023-01 5fd57857-2f5d-4cfd-a365-bf4d5369f926 +TCGA-DU-7014-01 TCGA-DU-7014-01 TCGA-DU-7014 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain NO NO NO NO 59 TCGA-DU-7014-F17101 TCGA-DU-7014 -21865 3571 0 3437 3558 Seizures 0 - 30 Days Progressive Disease 2011-9-26 MALE YES Oligodendroglioma NO No C71.0 9450/3 C71.0 YES 50 Right YES NO NO G2 YES No 7014 Pre-Adjuvant Therapy WITH TUMOR YES YES Progressive Disease YES Primary Tumor 01 YES NO White Matter NO NO YES DU Supratentorial, Frontal Lobe Central nervous system NO DECEASED 2001 e1355ed5-ae8c-47ba-9b60-a72038142b89 TCGA-DU-7014-01A-11D-2025-05 TCGA-DU-7014-01A-11D-2023-01 TCGA-DU-7014-01 e1355ed5-ae8c-47ba-9b60-a72038142b89 TCGA-DU-7014-01 TCGA-DU-7014-01A-11D-2023-01 e1355ed5-ae8c-47ba-9b60-a72038142b89 +TCGA-DU-7015-01 TCGA-DU-7015-01 TCGA-DU-7015 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain YES YES YES NO 41 TCGA-DU-7015-F18631 TCGA-DU-7015 591 -15041 0 2761 591 613 YES NO Seizures 0 - 30 Days Progressive Disease 2011-11-8 FEMALE NO Oligodendroglioma NO No C71.0 9450/3 C71.0 YES 90 Right NO NO NO G2 YES No 7015 Pre-Adjuvant Therapy WITH TUMOR YES YES Progressive Disease NO Primary Tumor 01 YES NO Cerebral Cortex NO NO YES DU Supratentorial, Temporal Lobe Central nervous system NO LIVING 2004 c036ae2f-3de5-49ba-a7f6-32d8c5d78a4e TCGA-DU-7015-01A-11D-2025-05 TCGA-DU-7015-01A-11D-2023-01 TCGA-DU-7015-01 c036ae2f-3de5-49ba-a7f6-32d8c5d78a4e TCGA-DU-7015-01 TCGA-DU-7015-01A-11D-2023-01 c036ae2f-3de5-49ba-a7f6-32d8c5d78a4e +TCGA-DU-7018-01 TCGA-DU-7018-01 TCGA-DU-7018 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain YES NO YES NO 57 TCGA-DU-7018-F17070 TCGA-DU-7018 TCGA-DU-7018-01A 844 -21019 933 0 338 343 Seizures > 181 Days Progressive Disease 2011-9-23 FEMALE NO Oligodendroglioma NO No C71.0 9451/3 C71.0 YES 1 NO 90 Right YES 1 YES NO G3 YES No TCGA-DU-7018.caa41707-cb2e-4c3f-bae9-ddf6b21d5d4f.pdf 7018 Pre-Adjuvant Therapy WITH TUMOR YES Progressive Disease NO Primary Tumor 01 YES NO 0.5 Not listed in Medical Record YES NO YES DU Supratentorial, Frontal Lobe Central nervous system A NO DECEASED 2006 2ef476c6-ffb6-45b0-b92c-47808e9b4f10 TCGA-DU-7018-01A-11D-2024-08 TCGA-DU-7018-01A-11D-2025-05 TCGA-DU-7018-01A-11D-2023-01 TCGA-DU-7018-01 2ef476c6-ffb6-45b0-b92c-47808e9b4f10 TCGA-DU-7018-01 TCGA-DU-7018-01A-11D-2023-01 2ef476c6-ffb6-45b0-b92c-47808e9b4f10 +TCGA-DU-7019-01 TCGA-DU-7019-01 TCGA-DU-7019 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 39 TCGA-DU-7019-F17096 TCGA-DU-7019 -14279 0 800 21 Headaches 0 - 30 Days 2011-9-26 MALE YES Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES 100 Right NO NO NO [Discrepancy] NO No 7019 Pre-Adjuvant Therapy TUMOR FREE YES YES Stable Disease YES Primary Tumor 01 NO NO Cerebral Cortex YES YES NO DU Supratentorial, Temporal Lobe Central nervous system YES LIVING 2009 dbd2c9f3-4a21-4f9f-8346-62551d1c609b TCGA-DU-7019-01A-11D-2024-08 TCGA-DU-7019-01A-11D-2025-05 TCGA-DU-7019-01A-11D-2023-01 TCGA-DU-7019-01 dbd2c9f3-4a21-4f9f-8346-62551d1c609b TCGA-DU-7019-01 TCGA-DU-7019-01A-11D-2023-01 dbd2c9f3-4a21-4f9f-8346-62551d1c609b +TCGA-DU-7290-01 TCGA-DU-7290-01 TCGA-DU-7290 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 45 TCGA-DU-7290-F17541 TCGA-DU-7290 -16667 315 0 Headaches 0 - 30 Days 2011-10-11 FEMALE YES Astrocytoma NO No C71.0 9401/3 C71.0 YES Right NO NO NO G3 No 7290 WITH TUMOR NO Primary Tumor 01 NO YES Cerebral Cortex NO NO YES DU Supratentorial, Temporal Lobe Central nervous system YES DECEASED 1995 fbf30d45-d36c-49f8-8f5b-7ebcd226f777 TCGA-DU-7290-01A-11D-2024-08 TCGA-DU-7290-01A-11D-2025-05 TCGA-DU-7290-01A-11D-2023-01 TCGA-DU-7290-01 fbf30d45-d36c-49f8-8f5b-7ebcd226f777 TCGA-DU-7290-01 TCGA-DU-7290-01A-11D-2023-01 fbf30d45-d36c-49f8-8f5b-7ebcd226f777 +TCGA-DU-7292-01 TCGA-DU-7292-01 TCGA-DU-7292 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain YES YES NO NO 69 YES TCGA-DU-7292-F17515 TCGA-DU-7292 -25266 242 0 91 < 12 Years Seizures 91 - 180 Days Progressive Disease 2011-10-5 MALE NO Astrocytoma NO No C71.0 9401/3 C71.0 YES NO Left NO NO NO G3 YES No 7292 WITH TUMOR Progressive Disease YES Primary Tumor 01 YES NO Not listed in Medical Record NO NO YES DU Supratentorial, Temporal Lobe Central nervous system NO DECEASED 1997 fe9eb79d-a750-4830-9db4-32ea4034cb39 TCGA-DU-7292-01A-11D-2024-08 TCGA-DU-7292-01A-11D-2025-05 TCGA-DU-7292-01A-11D-2023-01 TCGA-DU-7292-01 fe9eb79d-a750-4830-9db4-32ea4034cb39 TCGA-DU-7292-01 TCGA-DU-7292-01A-11D-2023-01 fe9eb79d-a750-4830-9db4-32ea4034cb39 +TCGA-DU-7294-01 TCGA-DU-7294-01 TCGA-DU-7294 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 53 TCGA-DU-7294-F17513 TCGA-DU-7294 TCGA-DU-7294-01A -19616 0 2869 793 Stable Disease 2011-10-5 FEMALE NO Oligodendroglioma NO No C71.0 9450/3 C71.0 YES 1 NO 100 Right NO 1.1 NO NO G2 NO No TCGA-DU-7294.3f73eaa4-67da-4c34-98a1-8d4db2997272.pdf 7294 Pre-Adjuvant Therapy TUMOR FREE NO NO Stable Disease NO Primary Tumor 01 NO NO 0.9 Not listed in Medical Record NO NO YES DU Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2003 25a13ca2-fb62-40aa-bec5-a8bf83a9360b TCGA-DU-7294-01A-11D-2024-08 TCGA-DU-7294-01A-11D-2025-05 TCGA-DU-7294-01A-11D-2023-01 TCGA-DU-7294-01 25a13ca2-fb62-40aa-bec5-a8bf83a9360b TCGA-DU-7294-01 TCGA-DU-7294-01A-11D-2023-01 25a13ca2-fb62-40aa-bec5-a8bf83a9360b +TCGA-DU-7298-01 TCGA-DU-7298-01 TCGA-DU-7298 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain NO NO YES NO 38 TCGA-DU-7298-F17497 TCGA-DU-7298 TCGA-DU-7298-01A 546 -14205 576 0 200 -2 Headaches 0 - 30 Days 2011-10-12 FEMALE YES Astrocytoma NO No C71.0 9401/3 C71.0 YES 0.7 NO 80 Left NO 1 NO NO G3 YES No TCGA-DU-7298.14bf3d59-284e-40d0-ba0b-0f88815a8a3f.pdf 7298 Preoperative WITH TUMOR YES YES Progressive Disease YES Primary Tumor 01 NO NO 0.5 Cerebral Cortex YES NO YES DU Supratentorial, Temporal Lobe Central nervous system A YES DECEASED 2006 796ff6a5-e27c-4e86-8ac3-7aa29d3b6bd8 TCGA-DU-7298-01A-11D-2024-08 TCGA-DU-7298-01A-11D-2025-05 TCGA-DU-7298-01A-11D-2023-01 TCGA-DU-7298-01 796ff6a5-e27c-4e86-8ac3-7aa29d3b6bd8 TCGA-DU-7298-01 TCGA-DU-7298-01A-11D-2023-01 796ff6a5-e27c-4e86-8ac3-7aa29d3b6bd8 +TCGA-DU-7299-01 TCGA-DU-7299-01 TCGA-DU-7299 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain YES YES NO NO 33 TCGA-DU-7299-F18389 TCGA-DU-7299 TCGA-DU-7299-01A -12266 1339 0 675 428 NO NO Seizures 31 - 90 Days Progressive Disease 2011-11-8 MALE NO Astrocytoma NO No C71.0 9401/3 C71.0 YES 1 NO 90 Left NO 1 NO NO G3 YES No TCGA-DU-7299.36ca34b7-04ee-4cbb-aba8-1171ae076abd.pdf 7299 Post-Adjuvant Therapy WITH TUMOR YES YES Progressive Disease YES Primary Tumor 01 YES NO 0.3 Not listed in Medical Record YES NO YES DU Supratentorial, Parietal Lobe Central nervous system A NO DECEASED 2006 118ba2f8-3a61-41f3-9b4c-18a34181b1bb TCGA-DU-7299-01A-21D-2024-08 TCGA-DU-7299-01A-21D-2025-05 TCGA-DU-7299-01A-21D-2023-01 TCGA-DU-7299-01 118ba2f8-3a61-41f3-9b4c-18a34181b1bb TCGA-DU-7299-01 TCGA-DU-7299-01A-21D-2023-01 118ba2f8-3a61-41f3-9b4c-18a34181b1bb +TCGA-DU-7300-01 TCGA-DU-7300-01 TCGA-DU-7300 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain YES YES NO NO 53 TCGA-DU-7300-F17524 TCGA-DU-7300 TCGA-DU-7300-01A -19610 1886 0 317 317 NO NO Seizures 0 - 30 Days Progressive Disease 2011-10-9 FEMALE NO Oligodendroglioma NO No C71.0 9451/3 C71.0 YES 1 NO 100 Right NO 1 NO NO G3 YES Yes TCGA-DU-7300.6a6a701f-4276-4ee8-9d47-9dd470f1f3ea.pdf 7300 Post-Adjuvant Therapy WITH TUMOR YES NO Progressive Disease NO Primary Tumor 01 YES NO 0.4 Not listed in Medical Record YES NO YES DU Supratentorial, Frontal Lobe Central nervous system A NO DECEASED 2006 94bf61a3-9b70-4429-b538-a32163d186cb TCGA-DU-7300-01A-21D-2086-08 TCGA-DU-7300-01A-21D-2087-05 TCGA-DU-7300-01A-21D-2085-01 TCGA-DU-7300-01 94bf61a3-9b70-4429-b538-a32163d186cb TCGA-DU-7300-01 TCGA-DU-7300-01A-21D-2085-01 94bf61a3-9b70-4429-b538-a32163d186cb +TCGA-DU-7301-01 TCGA-DU-7301-01 TCGA-DU-7301 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain YES NO NO NO 53 TCGA-DU-7301-F17533 TCGA-DU-7301 TCGA-DU-7301-01A -19644 788 0 366 366 Seizures > 181 Days Progressive Disease 2011-10-12 MALE NO Oligodendroglioma NO No C71.0 9450/3 C71.0 YES 1 NO 60 Left NO 1 NO NO G2 YES No TCGA-DU-7301.8ff62d9f-003f-4194-8cc6-bce45a7cdf1d.pdf 7301 Post-Adjuvant Therapy WITH TUMOR YES NO Progressive Disease YES Primary Tumor 01 YES YES 0.5 Not listed in Medical Record YES NO YES DU Supratentorial, Temporal Lobe Central nervous system A NO DECEASED 2006 46359f28-97f8-42ee-9b7b-6652ac0f469a TCGA-DU-7301-01A-11D-2086-08 TCGA-DU-7301-01A-11D-2087-05 TCGA-DU-7301-01A-11D-2085-01 TCGA-DU-7301-01 46359f28-97f8-42ee-9b7b-6652ac0f469a TCGA-DU-7301-01 TCGA-DU-7301-01A-11D-2085-01 46359f28-97f8-42ee-9b7b-6652ac0f469a +TCGA-DU-7302-01 TCGA-DU-7302-01 TCGA-DU-7302 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain YES NO NO NO 48 TCGA-DU-7302-F17543 TCGA-DU-7302 TCGA-DU-7302-01A -17656 0 1834 1374 1404 Seizures 0 - 30 Days Progressive Disease 2011-10-11 FEMALE NO Oligodendroglioma NO No C71.0 9451/3 C71.0 YES 0.9 NO 70 Left NO 1 NO NO G3 YES No TCGA-DU-7302.ad715b7b-52a2-493a-99d2-b5ec2b18a709.pdf 7302 Post-Adjuvant Therapy WITH TUMOR YES YES Progressive Disease NO Primary Tumor 01 YES NO 0.7 Not listed in Medical Record YES NO YES DU Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2006 10336d59-9732-4305-9062-75bc76ee9c93 TCGA-DU-7302-01A-11D-2086-08 TCGA-DU-7302-01A-11D-2087-05 TCGA-DU-7302-01A-11D-2085-01 TCGA-DU-7302-01 10336d59-9732-4305-9062-75bc76ee9c93 TCGA-DU-7302-01 TCGA-DU-7302-01A-11D-2085-01 10336d59-9732-4305-9062-75bc76ee9c93 +TCGA-DU-7304-01 TCGA-DU-7304-01 TCGA-DU-7304 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain YES NO YES NO 43 TCGA-DU-7304-F17502 TCGA-DU-7304 TCGA-DU-7304-01A 332 -15931 709 0 309 350 NO NO Seizures 0 - 30 Days Progressive Disease 2011-10-4 MALE NO Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES 0.8 NO 80 Left NO 1 NO NO G3 YES No TCGA-DU-7304.EFF2E68D-4795-413F-B5B1-EF9E5703A2B2.pdf 7304 Post-Adjuvant Therapy WITH TUMOR YES YES Progressive Disease YES Primary Tumor 01 YES NO 0.6 Not listed in Medical Record YES NO YES DU Supratentorial, Frontal Lobe Central nervous system A NO DECEASED 2008 9e8a108f-c2a6-4947-9512-72609d13ade1 TCGA-DU-7304-01A-12D-2086-08 TCGA-DU-7304-01A-12D-2087-05 TCGA-DU-7304-01A-12D-2085-01 TCGA-DU-7304-01 9e8a108f-c2a6-4947-9512-72609d13ade1 TCGA-DU-7304-01 TCGA-DU-7304-01A-12D-2085-01 9e8a108f-c2a6-4947-9512-72609d13ade1 +TCGA-DU-7304-02 TCGA-DU-7304-02 TCGA-DU-7304 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain YES NO YES NO 43 TCGA-DU-7304-F17502 TCGA-DU-7304 TCGA-DU-7304-02A 332 -15931 2066 709 0 309 350 NO NO Seizures 0 - 30 Days Progressive Disease 2011-10-4 MALE NO Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES 280 NO 80 Left NO NO NO G3 YES false No TCGA-DU-7304.EFF2E68D-4795-413F-B5B1-EF9E5703A2B2.pdf 7304 Post-Adjuvant Therapy WITH TUMOR YES YES Progressive Disease YES Recurrent Tumor 02 YES NO Not listed in Medical Record YES NO YES DU Supratentorial, Frontal Lobe Central nervous system A NO DECEASED 2008 44b1a976-76e2-4c4d-9348-bb399d986794 TCGA-DU-7304-02A-12D-A368-05 44b1a976-76e2-4c4d-9348-bb399d986794 44b1a976-76e2-4c4d-9348-bb399d986794 +TCGA-DU-7306-01 TCGA-DU-7306-01 TCGA-DU-7306 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain YES NO NO NO 67 TCGA-DU-7306-F17490 TCGA-DU-7306 TCGA-DU-7306-01A -24800 0 1277 1250 -11 Seizures 0 - 30 Days 2011-10-11 MALE NO Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES 1.1 NO 100 Right NO 1.1 NO NO G2 YES No TCGA-DU-7306.dfe1d2e3-a9c7-4d49-984d-5956eea6ccf3.pdf 7306 Preoperative WITH TUMOR YES YES Progressive Disease YES Primary Tumor 01 YES NO 0.7 Not listed in Medical Record YES NO YES DU Supratentorial, Temporal Lobe Central nervous system A NO LIVING 2008 12113ec4-2f73-488b-9926-89f1301e1fb9 TCGA-DU-7306-01A-11D-2086-08 TCGA-DU-7306-01A-11D-2087-05 TCGA-DU-7306-01A-11D-2085-01 TCGA-DU-7306-01 12113ec4-2f73-488b-9926-89f1301e1fb9 TCGA-DU-7306-01 TCGA-DU-7306-01A-11D-2085-01 12113ec4-2f73-488b-9926-89f1301e1fb9 +TCGA-DU-7309-01 TCGA-DU-7309-01 TCGA-DU-7309 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain NO NO NO NO 41 TCGA-DU-7309-F17509 TCGA-DU-7309 -15197 0 84 11 YES YES Seizures 31 - 90 Days 2011-10-4 FEMALE YES Oligodendroglioma NO No C71.0 9451/3 C71.0 YES 90 Left NO NO YES G3 NO No 7309 Pre-Adjuvant Therapy WITH TUMOR YES NO Stable Disease YES Primary Tumor 01 YES YES Cerebral Cortex YES YES NO DU Supratentorial, Frontal Lobe Central nervous system YES LIVING 2011 ef3a0956-e7bf-4f1b-bc54-7e21fd318bbd TCGA-DU-7309-01A-11D-2086-08 TCGA-DU-7309-01A-11D-2087-05 TCGA-DU-7309-01A-11D-2085-01 TCGA-DU-7309-01 ef3a0956-e7bf-4f1b-bc54-7e21fd318bbd TCGA-DU-7309-01 TCGA-DU-7309-01A-11D-2085-01 ef3a0956-e7bf-4f1b-bc54-7e21fd318bbd +TCGA-DU-8158-01 TCGA-DU-8158-01 TCGA-DU-8158 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 57 TCGA-DU-8158 -21129 155 0 8 Mental Status Changes 0 - 30 Days 2012-6-15 FEMALE Astrocytoma NO No C71.0 9401/3 C71.0 YES 80 Left NO YES G3 No 8158 Pre-Adjuvant Therapy WITH TUMOR Primary Tumor 01 NO YES DU Supratentorial, Frontal Lobe Central nervous system DECEASED 2001 ba2365d8-1217-4630-8181-b46bfeed3207 TCGA-DU-8158-01A-11D-2253-08 TCGA-DU-8158-01A-11D-2254-05 TCGA-DU-8158-01A-11D-2252-01 TCGA-DU-8158-01 ba2365d8-1217-4630-8181-b46bfeed3207 TCGA-DU-8158-01 TCGA-DU-8158-01A-11D-2252-01 ba2365d8-1217-4630-8181-b46bfeed3207 +TCGA-DU-8161-01 TCGA-DU-8161-01 TCGA-DU-8161 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain YES NO YES 63 TCGA-DU-8161-F51985 TCGA-DU-8161 TCGA-DU-8161-01A 113 -23064 722 0 111 14 Sensory Changes 31 - 90 Days Scheduled Follow-up Submission Progressive Disease 2013-11-26 FEMALE NO Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES 1 NO 70 Left NO 1 NO NO NO G3 YES No TCGA-DU-8161.867daa2d-0b54-4ac8-9203-ea592ea23953.pdf 8161 Pre-Adjuvant Therapy WITH TUMOR YES Progressive Disease YES Primary Tumor 01 NO YES 0.7 Not listed in Medical Record YES NO YES DU Supratentorial, Not Otherwise Specified Central nervous system A NO DECEASED 2009 6928f894-9d97-40c9-8284-3fd9456152de TCGA-DU-8161-01A-11D-2253-08 TCGA-DU-8161-01A-11D-2254-05 TCGA-DU-8161-01A-11D-2252-01 TCGA-DU-8161-01 6928f894-9d97-40c9-8284-3fd9456152de TCGA-DU-8161-01 TCGA-DU-8161-01A-11D-2252-01 6928f894-9d97-40c9-8284-3fd9456152de +TCGA-DU-8162-01 TCGA-DU-8162-01 TCGA-DU-8162 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain NO YES 61 TCGA-DU-8162-F44364 TCGA-DU-8162 -22596 444 0 121 402 21 1 YES NO Headaches 0 - 30 Days Scheduled Follow-up Submission 2013-6-19 FEMALE YES Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES 80 Right NO NO NO NO G3 YES No 8162 Pre-Adjuvant Therapy WITH TUMOR Progressive Disease YES Primary Tumor 01 NO NO Not listed in Medical Record YES YES NO DU Supratentorial, Temporal Lobe Central nervous system NO DECEASED 2011 c67538d7-7e64-4325-878e-53fd324a11f9 TCGA-DU-8162-01A-21D-2253-08 TCGA-DU-8162-01A-21D-2254-05 TCGA-DU-8162-01A-21D-2252-01 TCGA-DU-8162-01 c67538d7-7e64-4325-878e-53fd324a11f9 TCGA-DU-8162-01 TCGA-DU-8162-01A-21D-2252-01 c67538d7-7e64-4325-878e-53fd324a11f9 +TCGA-DU-8163-01 TCGA-DU-8163-01 TCGA-DU-8163 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain YES NO 29 TCGA-DU-8163-F44371 TCGA-DU-8163 TCGA-DU-8163-01A -10824 0 629 509 106 NO NO Seizures 31 - 90 Days Scheduled Follow-up Submission 2013-6-19 MALE NO Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES 1 NO 90 Left NO 1 NO NO NO G3 YES No TCGA-DU-8163.7c9b671f-e8f9-4b12-b497-6bc252fe9b15.pdf 8163 WITH TUMOR YES NO Progressive Disease YES Primary Tumor 01 YES NO 0.6 Not listed in Medical Record YES YES NO DU Supratentorial, Temporal Lobe Central nervous system A NO LIVING 2011 654ea6d9-1a5b-442a-8627-5d6f4baa8460 TCGA-DU-8163-01A-11D-2253-08 TCGA-DU-8163-01A-11D-2254-05 TCGA-DU-8163-01A-11D-2252-01 TCGA-DU-8163-01 654ea6d9-1a5b-442a-8627-5d6f4baa8460 TCGA-DU-8163-01 TCGA-DU-8163-01A-11D-2252-01 654ea6d9-1a5b-442a-8627-5d6f4baa8460 +TCGA-DU-8164-01 TCGA-DU-8164-01 TCGA-DU-8164 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 51 TCGA-DU-8164-F44373 TCGA-DU-8164 TCGA-DU-8164-01A -18735 0 651 NO NO Seizures 31 - 90 Days Scheduled Follow-up Submission Stable Disease 2013-6-19 MALE NO Oligodendroglioma NO No C71.0 9450/3 C71.0 YES NO 0.8 NO Right YES IHC YES 0.8 NO NO NO G2 NO No TCGA-DU-8164.452cb553-ee9b-44e3-bbc4-fcb36f015309.pdf 8164 TUMOR FREE YES NO Stable Disease NO Primary Tumor 01 YES NO 0.6 Cerebral Cortex YES YES NO DU Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2011 7fcd4e64-e758-4418-b19e-02a4e7ee1fef TCGA-DU-8164-01A-11D-2253-08 TCGA-DU-8164-01A-11D-2254-05 TCGA-DU-8164-01A-11D-2252-01 TCGA-DU-8164-01 7fcd4e64-e758-4418-b19e-02a4e7ee1fef TCGA-DU-8164-01 TCGA-DU-8164-01A-11D-2252-01 7fcd4e64-e758-4418-b19e-02a4e7ee1fef +TCGA-DU-8165-01 TCGA-DU-8165-01 TCGA-DU-8165 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 60 TCGA-DU-8165-F46668 TCGA-DU-8165 -21964 0 582 11 YES NO Seizures 31 - 90 Days Scheduled Follow-up Submission Stable Disease 2013-8-13 FEMALE NO Oligodendroglioma NO No C71.0 9450/3 C71.0 YES 90 Left NO NO NO NO G3 NO No 8165 Pre-Adjuvant Therapy TUMOR FREE YES NO Stable Disease YES Primary Tumor 01 YES NO Not listed in Medical Record YES YES NO DU Supratentorial, Temporal Lobe Central nervous system NO LIVING 2011 a6f7a064-b3af-41aa-9e80-fc2f728b0d83 TCGA-DU-8165-01A-11D-2253-08 TCGA-DU-8165-01A-11D-2254-05 TCGA-DU-8165-01A-11D-2252-01 TCGA-DU-8165-01 a6f7a064-b3af-41aa-9e80-fc2f728b0d83 TCGA-DU-8165-01 TCGA-DU-8165-01A-11D-2252-01 a6f7a064-b3af-41aa-9e80-fc2f728b0d83 +TCGA-DU-8166-01 TCGA-DU-8166-01 TCGA-DU-8166 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain YES NO NO 29 TCGA-DU-8166-F46665 TCGA-DU-8166 TCGA-DU-8166-01A -10641 0 516 193 NO NO Seizures 0 - 30 Days Scheduled Follow-up Submission Stable Disease 2013-8-13 FEMALE NO Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES 0.9 NO Left NO 0.9 NO NO NO G2 YES No TCGA-DU-8166.d4140f71-f42d-4b23-bff6-9f0c00a7e6ff.pdf 8166 WITH TUMOR YES YES Progressive Disease YES Primary Tumor 01 YES NO 0.5 Cerebral Cortex YES YES NO DU Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2012 12953bc4-8704-4fcc-9efa-3801a1a6c4b7 TCGA-DU-8166-01A-11D-2253-08 TCGA-DU-8166-01A-11D-2254-05 TCGA-DU-8166-01A-11D-2252-01 TCGA-DU-8166-01 12953bc4-8704-4fcc-9efa-3801a1a6c4b7 TCGA-DU-8166-01 TCGA-DU-8166-01A-11D-2252-01 12953bc4-8704-4fcc-9efa-3801a1a6c4b7 +TCGA-DU-8167-01 TCGA-DU-8167-01 TCGA-DU-8167 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 69 TCGA-DU-8167-F44357 TCGA-DU-8167 TCGA-DU-8167-01A -25262 0 471 -69 Seizures > 181 Days Scheduled Follow-up Submission Stable Disease 2013-6-19 FEMALE NO Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES 1.2 NO 100 Right NO 1.2 NO NO NO G2 NO No TCGA-DU-8167.8c93cc66-38b1-451f-b941-fca73c10c651.pdf 8167 Preoperative TUMOR FREE YES NO Stable Disease YES Primary Tumor 01 YES NO 0.4 Not listed in Medical Record NO YES NO DU Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2012 62ddc24c-ffff-4459-95e7-bc2cb08769c9 TCGA-DU-8167-01A-11D-2253-08 TCGA-DU-8167-01A-11D-2254-05 TCGA-DU-8167-01A-11D-2252-01 TCGA-DU-8167-01 62ddc24c-ffff-4459-95e7-bc2cb08769c9 TCGA-DU-8167-01 TCGA-DU-8167-01A-11D-2252-01 62ddc24c-ffff-4459-95e7-bc2cb08769c9 +TCGA-DU-8168-01 TCGA-DU-8168-01 TCGA-DU-8168 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 55 TCGA-DU-8168-F44360 TCGA-DU-8168 -20136 0 431 14 1 YES NO Headaches 0 - 30 Days Scheduled Follow-up Submission Stable Disease 2013-6-19 FEMALE YES Oligodendroglioma NO No C71.0 9451/3 C71.0 YES 70 Right NO NO NO NO G3 NO No 8168 Pre-Adjuvant Therapy TUMOR FREE NO YES Stable Disease YES Primary Tumor 01 NO NO Not listed in Medical Record YES YES NO DU Supratentorial, Frontal Lobe Central nervous system NO LIVING 2012 dd69f2af-4ec7-4fb5-bc82-cc93686e2790 TCGA-DU-8168-01A-11D-2253-08 TCGA-DU-8168-01A-11D-2254-05 TCGA-DU-8168-01A-11D-2252-01 TCGA-DU-8168-01 dd69f2af-4ec7-4fb5-bc82-cc93686e2790 TCGA-DU-8168-01 TCGA-DU-8168-01A-11D-2252-01 dd69f2af-4ec7-4fb5-bc82-cc93686e2790 +TCGA-DU-A5TP-01 TCGA-DU-A5TP-01 TCGA-DU-A5TP TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain YES NO 33 NO NO TCGA-DU-A5TP-F71612 TCGA-DU-A5TP TCGA-DU-A5TP-01A -12111 301 0 1012 203 6 YES YES YES > 20 Years Seizures 0 - 30 Days Scheduled Follow-up Submission Stable Disease NO 2015-3-27 MALE YES NO Astrocytoma YES No C71.0 9401/3 C71.0 YES 280 NO 70 Right NO NO NO NO NO G3 YES false No TCGA-DU-A5TP.CD515D5F-80C5-4571-B431-6091CA4B4848.pdf A5TP Pre-Adjuvant Therapy TUMOR FREE YES NO [Discrepancy] YES Primary Tumor 01 YES NO Not listed in Medical Record YES YES NO DU Supratentorial, Parietal Lobe Central nervous system A NO LIVING 2012 9eaedfe9-a6f0-46e3-8961-7a222df9127c TCGA-DU-A5TP-01A-11D-A28N-05 TCGA-DU-A5TP-01A-11D-A288-01 TCGA-DU-A5TP-01 9eaedfe9-a6f0-46e3-8961-7a222df9127c TCGA-DU-A5TP-01 TCGA-DU-A5TP-01A-11D-A288-01 9eaedfe9-a6f0-46e3-8961-7a222df9127c +TCGA-DU-A5TR-01 TCGA-DU-A5TR-01 TCGA-DU-A5TR TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain NO NO YES 51 NO NO TCGA-DU-A5TR-F71611 TCGA-DU-A5TR 848 -18791 0 908 848 11 NO YES YES Seizures 0 - 30 Days Scheduled Follow-up Submission Stable Disease NO 2015-3-27 MALE NO NO Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES 90 Left NO NO YES NO NO G2 YES No A5TR Pre-Adjuvant Therapy TUMOR FREE YES YES [Discrepancy] NO Primary Tumor 01 YES NO Not listed in Medical Record YES YES NO DU Supratentorial, Temporal Lobe Central nervous system NO LIVING 2012 f23834b0-13c3-4dd5-a20b-0f20cd92ec23 TCGA-DU-A5TR-01A-11D-A28N-05 TCGA-DU-A5TR-01A-11D-A288-01 TCGA-DU-A5TR-01 f23834b0-13c3-4dd5-a20b-0f20cd92ec23 TCGA-DU-A5TR-01 TCGA-DU-A5TR-01A-11D-A288-01 f23834b0-13c3-4dd5-a20b-0f20cd92ec23 +TCGA-DU-A5TS-01 TCGA-DU-A5TS-01 TCGA-DU-A5TS TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain YES NO NO NO 42 TCGA-DU-A5TS-F71496 TCGA-DU-A5TS TCGA-DU-A5TS-01A -15650 259 0 964 551 13 YES NO Headaches > 181 Days Scheduled Follow-up Submission Stable Disease 2015-3-26 MALE YES Oligodendroglioma NO No C71.0 9450/3 C71.0 YES 360 NO 100 Right NO NO NO NO G2 YES false No TCGA-DU-A5TS.1D94A4FE-F273-4DD4-AB30-FE47A22542B9.pdf A5TS Pre-Adjuvant Therapy TUMOR FREE NO YES Stable Disease YES Primary Tumor 01 NO NO Not listed in Medical Record YES YES NO DU Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2012 03fd710d-d09a-4cf1-b513-5eaaa37d56da TCGA-DU-A5TS-01A-11D-A28N-05 TCGA-DU-A5TS-01A-11D-A288-01 TCGA-DU-A5TS-01 03fd710d-d09a-4cf1-b513-5eaaa37d56da TCGA-DU-A5TS-01 TCGA-DU-A5TS-01A-11D-A288-01 03fd710d-d09a-4cf1-b513-5eaaa37d56da +TCGA-DU-A5TT-01 TCGA-DU-A5TT-01 TCGA-DU-A5TT TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain NO YES NO NO 70 YES cat NO TCGA-DU-A5TT-F71494 TCGA-DU-A5TT TCGA-DU-A5TT-01A -25726 24 0 743 584 NO YES NO > 20 Years > 20 Years Seizures 91 - 180 Days Scheduled Follow-up Submission Progressive Disease NO 2015-3-26 MALE YES NO Oligodendroglioma NO No C71.0 9451/3 C71.0 YES 420 NO Left NO IHC YES NO NO NO NO G3 YES false No TCGA-DU-A5TT.6E55B698-D0BA-4834-91EE-0210657A9791.pdf A5TT WITH TUMOR YES NO [Discrepancy] YES Primary Tumor 01 YES NO Not listed in Medical Record YES YES NO DU Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2013 8d1c0907-a5f9-4fcb-a04a-d554e40c23d3 TCGA-DU-A5TT-01A-11D-A28N-05 TCGA-DU-A5TT-01A-11D-A288-01 TCGA-DU-A5TT-01 8d1c0907-a5f9-4fcb-a04a-d554e40c23d3 TCGA-DU-A5TT-01 TCGA-DU-A5TT-01A-11D-A288-01 8d1c0907-a5f9-4fcb-a04a-d554e40c23d3 +TCGA-DU-A5TU-01 TCGA-DU-A5TU-01 TCGA-DU-A5TU TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain YES NO NO 62 NO NO TCGA-DU-A5TU-F71322 TCGA-DU-A5TU -22811 0 796 186 47 NO YES NO 12 - 20 Years Mental Status Changes 0 - 30 Days Scheduled Follow-up Submission Stable Disease YES Eggs 2015-3-24 FEMALE NO NO Astrocytoma NO No C71.0 9400/3 C71.0 YES NO 50 Left NO NO YES NO NO G2 YES No A5TU Other WITH TUMOR NO YES Progressive Disease YES Primary Tumor 01 NO NO Cerebral Cortex NO YES NO DU Supratentorial, Frontal Lobe Central nervous system NO LIVING 2013 ac3caaa0-3464-4a39-aa98-fe0e82d6d36c TCGA-DU-A5TU-01A-11D-A28N-05 TCGA-DU-A5TU-01A-11D-A288-01 TCGA-DU-A5TU-01 ac3caaa0-3464-4a39-aa98-fe0e82d6d36c TCGA-DU-A5TU-01 TCGA-DU-A5TU-01A-11D-A288-01 ac3caaa0-3464-4a39-aa98-fe0e82d6d36c +TCGA-DU-A5TW-01 TCGA-DU-A5TW-01 TCGA-DU-A5TW TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain NO NO NO 33 TCGA-DU-A5TW-F71321 TCGA-DU-A5TW TCGA-DU-A5TW-01A -12107 42 0 760 53 Seizures > 181 Days Scheduled Follow-up Submission Progressive Disease 2015-3-24 FEMALE NO Astrocytoma NO No C71.0 9401/3 C71.0 YES 320 NO 100 Right YES IHC YES NO YES NO G3 NO false No TCGA-DU-A5TW.CE930C5F-0F10-4CC9-AF72-C38273BEF1E4.pdf A5TW Other WITH TUMOR YES YES Progressive Disease NO Primary Tumor 01 YES NO Not listed in Medical Record NO YES NO DU Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2012 88c0efcd-cbd2-4c36-b19e-dcb675c4aaae TCGA-DU-A5TW-01A-11D-A28N-05 TCGA-DU-A5TW-01A-11D-A288-01 TCGA-DU-A5TW-01 88c0efcd-cbd2-4c36-b19e-dcb675c4aaae TCGA-DU-A5TW-01 TCGA-DU-A5TW-01A-11D-A288-01 88c0efcd-cbd2-4c36-b19e-dcb675c4aaae +TCGA-DU-A5TY-01 TCGA-DU-A5TY-01 TCGA-DU-A5TY TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain YES YES YES YES 46 NO TCGA-DU-A5TY-F71302 TCGA-DU-A5TY 536 955 -16945 1033 0 371 526 NO NO NO Seizures 0 - 30 Days Scheduled Follow-up Submission Progressive Disease NO 2015-3-24 FEMALE NO NO Astrocytoma NO No C71.0 9401/3 C71.0 YES Left NO IHC YES NO YES NO NO G3 YES No A5TY WITH TUMOR YES YES [Discrepancy] YES Primary Tumor 01 YES NO Not listed in Medical Record YES YES NO DU Supratentorial, Parietal Lobe Central nervous system NO DECEASED 2012 c38bbaa0-6752-4301-9e44-c1cd13c03625 TCGA-DU-A5TY-01A-11D-A28N-05 TCGA-DU-A5TY-01A-11D-A288-01 TCGA-DU-A5TY-01 c38bbaa0-6752-4301-9e44-c1cd13c03625 TCGA-DU-A5TY-01 TCGA-DU-A5TY-01A-11D-A288-01 c38bbaa0-6752-4301-9e44-c1cd13c03625 +TCGA-DU-A6S2-01 TCGA-DU-A6S2-01 TCGA-DU-A6S2 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain NO NO 37 YES long hair cats NO TCGA-DU-A6S2-F71620 TCGA-DU-A6S2 TCGA-DU-A6S2-01A -13597 153 0 777 11 YES YES NO > 20 Years < 12 Years Headaches 31 - 90 Days Scheduled Follow-up Submission Stable Disease NO 2015-3-27 FEMALE NO YES Oligodendroglioma NO No C71.0 9450/3 C71.0 YES NO 110 NO 70 Right YES IHC YES NO NO YES NO G2 NO false No TCGA-DU-A6S2.163325D0-4CEA-4AC4-AC8A-117D492E4B06.pdf A6S2 Pre-Adjuvant Therapy TUMOR FREE NO YES Stable Disease NO Primary Tumor 01 NO NO Cerebral Cortex NO YES NO DU Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2013 4c7061f2-ff48-4079-97b6-7ae3c7c0f905 TCGA-DU-A6S2-01A-21D-A32C-05 TCGA-DU-A6S2-01A-21D-A32A-01 TCGA-DU-A6S2-01 4c7061f2-ff48-4079-97b6-7ae3c7c0f905 TCGA-DU-A6S2-01 TCGA-DU-A6S2-01A-21D-A32A-01 4c7061f2-ff48-4079-97b6-7ae3c7c0f905 +TCGA-DU-A6S3-01 TCGA-DU-A6S3-01 TCGA-DU-A6S3 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain NO NO 60 TCGA-DU-A6S3-F71619 TCGA-DU-A6S3 -22038 0 656 Motor/Movement Changes 91 - 180 Days Scheduled Follow-up Submission 2015-3-27 MALE NO Oligodendroglioma NO No C71.0 9450/3 C71.0 YES NO Right NO NO NO YES G2 NO No A6S3 TUMOR FREE NO NO Stable Disease NO Primary Tumor 01 NO NO Not listed in Medical Record YES YES NO DU Supratentorial, Frontal Lobe Central nervous system NO LIVING 2013 b8244afb-224b-4bd4-bd6d-caf6619f0e2a TCGA-DU-A6S3-01A-12D-A32C-05 TCGA-DU-A6S3-01A-12D-A32A-01 TCGA-DU-A6S3-01 b8244afb-224b-4bd4-bd6d-caf6619f0e2a TCGA-DU-A6S3-01 TCGA-DU-A6S3-01A-12D-A32A-01 b8244afb-224b-4bd4-bd6d-caf6619f0e2a +TCGA-DU-A6S6-01 TCGA-DU-A6S6-01 TCGA-DU-A6S6 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain YES NO YES 35 NO NO TCGA-DU-A6S6-F71617 TCGA-DU-A6S6 2277 -12809 0 2893 2277 184 NO NO NO < 12 Years Headaches 31 - 90 Days Scheduled Follow-up Submission Stable Disease NO 2015-3-27 FEMALE YES YES Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES NO 90 Right NO NO NO NO NO G2 YES No A6S6 Other TUMOR FREE NO NO [Discrepancy] NO Primary Tumor 01 NO NO White Matter YES NO YES DU Supratentorial, Frontal Lobe Central nervous system NO LIVING 2007 f523f957-9d71-49a4-8c2d-b6a1301f49ed TCGA-DU-A6S6-01A-21D-A32C-05 TCGA-DU-A6S6-01A-21D-A32A-01 TCGA-DU-A6S6-01 f523f957-9d71-49a4-8c2d-b6a1301f49ed TCGA-DU-A6S6-01 TCGA-DU-A6S6-01A-21D-A32A-01 f523f957-9d71-49a4-8c2d-b6a1301f49ed +TCGA-DU-A6S7-01 TCGA-DU-A6S7-01 TCGA-DU-A6S7 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain NO NO 27 NO NO TCGA-DU-A6S7-F71615 TCGA-DU-A6S7 -10170 0 638 -14 NO NO NO 12 - 20 Years Seizures > 181 Days Scheduled Follow-up Submission Stable Disease NO 2015-3-27 FEMALE YES NO Astrocytoma NO No C71.0 9401/3 C71.0 YES NO 90 Left YES IHC YES NO NO NO NO G3 NO No A6S7 Preoperative TUMOR FREE YES NO Stable Disease YES Primary Tumor 01 YES NO Not listed in Medical Record YES YES NO DU Supratentorial, Frontal Lobe Central nervous system NO LIVING 2013 b3450230-a250-4c22-ac3b-639abe51fc7b TCGA-DU-A6S7-01A-21D-A32C-05 TCGA-DU-A6S7-01A-21D-A32A-01 TCGA-DU-A6S7-01 b3450230-a250-4c22-ac3b-639abe51fc7b TCGA-DU-A6S7-01 TCGA-DU-A6S7-01A-21D-A32A-01 b3450230-a250-4c22-ac3b-639abe51fc7b +TCGA-DU-A6S8-01 TCGA-DU-A6S8-01 TCGA-DU-A6S8 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain NO NO 74 NO NO TCGA-DU-A6S8-F71614 TCGA-DU-A6S8 -27084 0 678 641 14 NO NO NO Mental Status Changes > 181 Days Scheduled Follow-up Submission NO 2015-3-27 FEMALE NO NO Oligodendroglioma NO No C71.0 9451/3 C71.0 YES NO 90 Right YES IHC YES NO YES NO NO G3 YES No A6S8 Pre-Adjuvant Therapy WITH TUMOR NO NO Progressive Disease NO Primary Tumor 01 NO NO Not listed in Medical Record YES YES NO DU Supratentorial, Frontal Lobe Central nervous system NO LIVING 2013 a4d5d968-7d95-4f41-b0ce-b2dcc9a073ea TCGA-DU-A6S8-01A-12D-A32C-05 TCGA-DU-A6S8-01A-12D-A32A-01 TCGA-DU-A6S8-01 a4d5d968-7d95-4f41-b0ce-b2dcc9a073ea TCGA-DU-A6S8-01 TCGA-DU-A6S8-01A-12D-A32A-01 a4d5d968-7d95-4f41-b0ce-b2dcc9a073ea +TCGA-DU-A76K-01 TCGA-DU-A76K-01 TCGA-DU-A76K TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 87 TCGA-DU-A76K -31776 347 0 Headaches > 181 Days 2013-10-22 MALE YES Oligodendroglioma NO No C71.0 9450/3 C71.0 YES Right NO NO NO G2 YES No A76K WITH TUMOR Progressive Disease YES Primary Tumor 01 NO NO Not listed in Medical Record NO NO YES DU Supratentorial, Parietal Lobe Central nervous system NO DECEASED 1999 f547ce5b-634d-4faa-b662-70de36194dfc TCGA-DU-A76K-01A-11D-A33U-05 TCGA-DU-A76K-01A-11D-A33S-01 TCGA-DU-A76K-01 f547ce5b-634d-4faa-b662-70de36194dfc TCGA-DU-A76K-01 TCGA-DU-A76K-01A-11D-A33S-01 f547ce5b-634d-4faa-b662-70de36194dfc +TCGA-DU-A76L-01 TCGA-DU-A76L-01 TCGA-DU-A76L TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 54 TCGA-DU-A76L TCGA-DU-A76L-01A -19823 4769 814 0 YES Headaches 0 - 30 Days 2013-10-22 MALE YES Oligodendroglioma NO No C71.0 9451/3 C71.0 YES 290 NO Right NO NO NO G3 YES false No TCGA-DU-A76L.E66BD7A0-E6D5-4773-9718-154F4D4253A2.pdf A76L WITH TUMOR Progressive Disease YES Primary Tumor 01 NO NO Not listed in Medical Record YES NO YES DU Supratentorial, Temporal Lobe Central nervous system A NO DECEASED 2000 8e2c16f2-38cc-49ad-adca-dbe5f4e0bf7f TCGA-DU-A76L-01A-11D-A32C-05 TCGA-DU-A76L-01A-11D-A32A-01 TCGA-DU-A76L-01 8e2c16f2-38cc-49ad-adca-dbe5f4e0bf7f TCGA-DU-A76L-01 TCGA-DU-A76L-01A-11D-A32A-01 8e2c16f2-38cc-49ad-adca-dbe5f4e0bf7f +TCGA-DU-A76O-01 TCGA-DU-A76O-01 TCGA-DU-A76O TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 30 NO NO TCGA-DU-A76O-F71621 TCGA-DU-A76O TCGA-DU-A76O-01A -10960 138 0 522 NO NO NO Seizures > 181 Days Scheduled Follow-up Submission NO 2015-3-27 MALE NO NO Astrocytoma NO No C71.0 9400/3 C71.0 YES NO 150 NO Left NO IHC YES YES NO NO NO G2 NO false Yes, History of Prior Malignancy TCGA-DU-A76O.64ED6980-61B9-4F1C-B7EE-B3459BD7E398.pdf A76O WITH TUMOR YES NO YES Primary Tumor 01 YES NO Not listed in Medical Record YES YES NO DU Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2013 481d7eb6-90ed-4d5c-8b98-4a46777a1b8c TCGA-DU-A76O-01A-11D-A32C-05 TCGA-DU-A76O-01A-11D-A32A-01 TCGA-DU-A76O-01 481d7eb6-90ed-4d5c-8b98-4a46777a1b8c TCGA-DU-A76O-01 TCGA-DU-A76O-01A-11D-A32A-01 481d7eb6-90ed-4d5c-8b98-4a46777a1b8c +TCGA-DU-A76R-01 TCGA-DU-A76R-01 TCGA-DU-A76R TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 51 TCGA-DU-A76R TCGA-DU-A76R-01A -18939 2739 648 0 60 Mental Status Changes 0 - 30 Days 2013-10-22 MALE NO Oligodendroglioma NO No C71.0 9451/3 C71.0 YES 250 NO 50 Right NO YES YES G3 YES false No TCGA-DU-A76R.7D334156-3FCB-4C90-AD99-60778721193D.pdf A76R Pre-Adjuvant Therapy WITH TUMOR YES YES Progressive Disease YES Primary Tumor 01 NO NO Not listed in Medical Record NO NO YES DU Supratentorial, Frontal Lobe Central nervous system A NO DECEASED 2006 22609052-fb11-4d62-bbfa-4837b30f37ac TCGA-DU-A76R-01A-11D-A32C-05 TCGA-DU-A76R-01A-11D-A32A-01 TCGA-DU-A76R-01 22609052-fb11-4d62-bbfa-4837b30f37ac TCGA-DU-A76R-01 TCGA-DU-A76R-01A-11D-A32A-01 22609052-fb11-4d62-bbfa-4837b30f37ac +TCGA-DU-A7T6-01 TCGA-DU-A7T6-01 TCGA-DU-A7T6 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 73 TCGA-DU-A7T6 TCGA-DU-A7T6-01A -26766 4265 547 0 53 Headaches > 181 Days 2013-12-23 FEMALE YES Oligodendroglioma NO No C71.0 9451/3 C71.0 YES 250 NO 60 Right NO NO NO G3 false No TCGA-DU-A7T6.B14319BC-DB5D-41E4-9954-5E6641791D54.pdf A7T6 Pre-Adjuvant Therapy WITH TUMOR Primary Tumor 01 NO NO Not listed in Medical Record NO YES DU Supratentorial, Frontal Lobe Central nervous system A NO DECEASED 2002 063e82c8-a923-4ca5-94cb-9fce3cccd226 TCGA-DU-A7T6-01A-11D-A33U-05 TCGA-DU-A7T6-01A-11D-A33S-01 TCGA-DU-A7T6-01 063e82c8-a923-4ca5-94cb-9fce3cccd226 TCGA-DU-A7T6-01 TCGA-DU-A7T6-01A-11D-A33S-01 063e82c8-a923-4ca5-94cb-9fce3cccd226 +TCGA-DU-A7T8-01 TCGA-DU-A7T8-01 TCGA-DU-A7T8 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain YES NO YES YES 35 NO NO TCGA-DU-A7T8-F71629 TCGA-DU-A7T8 TCGA-DU-A7T8-01A 3028 3759 -13108 3705 4229 0 3787 3009 80 YES NO NO < 12 Years Mental Status Changes 91 - 180 Days Scheduled Follow-up Submission Progressive Disease NO 2015-3-27 MALE NO YES Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES 280 NO 100 Right NO NO YES NO YES G3 YES false No TCGA-DU-A7T8.342A92BA-BEF9-40C6-85FF-71328B8C1DCF.pdf A7T8 Other WITH TUMOR Progressive Disease YES Primary Tumor 01 NO YES Not listed in Medical Record YES NO YES DU Supratentorial, Frontal Lobe Central nervous system A NO DECEASED 2003 05c3a0c4-87d0-409d-a4d4-7b5f6c3ab9e2 TCGA-DU-A7T8-01A-21D-A34K-05 TCGA-DU-A7T8-01A-21D-A34I-01 TCGA-DU-A7T8-01 05c3a0c4-87d0-409d-a4d4-7b5f6c3ab9e2 TCGA-DU-A7T8-01 TCGA-DU-A7T8-01A-21D-A34I-01 05c3a0c4-87d0-409d-a4d4-7b5f6c3ab9e2 +TCGA-DU-A7TA-01 TCGA-DU-A7TA-01 TCGA-DU-A7TA TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 32 NO NO TCGA-DU-A7TA-F71628 TCGA-DU-A7TA -11764 0 2565 17 NO NO NO 12 - 20 Years Visual Changes > 181 Days Scheduled Follow-up Submission NO 2015-3-27 MALE YES NO Oligodendroglioma NO No C71.0 9450/3 C71.0 YES 80 Right NO NO NO NO NO G2 NO No A7TA Pre-Adjuvant Therapy TUMOR FREE NO NO Stable Disease YES Primary Tumor 01 NO NO Not listed in Medical Record YES NO YES DU Supratentorial, Occipital Lobe Central nervous system YES LIVING 2007 a3966107-19e4-467c-a692-9a154cc09c20 TCGA-DU-A7TA-01A-11D-A33U-05 TCGA-DU-A7TA-01A-11D-A33S-01 TCGA-DU-A7TA-01 a3966107-19e4-467c-a692-9a154cc09c20 TCGA-DU-A7TA-01 TCGA-DU-A7TA-01A-11D-A33S-01 a3966107-19e4-467c-a692-9a154cc09c20 +TCGA-DU-A7TB-01 TCGA-DU-A7TB-01 TCGA-DU-A7TB TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain YES YES NO 56 TCGA-DU-A7TB-F71627 TCGA-DU-A7TB TCGA-DU-A7TB-01A -20704 1168 0 1567 74 1111 NO NO Seizures 0 - 30 Days Scheduled Follow-up Submission Stable Disease 2015-3-27 MALE NO Oligodendroglioma NO No C71.0 9450/3 C71.0 YES 250 NO 100 Right NO NO NO NO G2 YES false No TCGA-DU-A7TB.3D167AD9-276F-47F4-9C77-D7AD8B24D59F.pdf A7TB Post-Adjuvant Therapy TUMOR FREE YES YES Progressive Disease NO Primary Tumor 01 YES NO Not listed in Medical Record YES YES NO DU Supratentorial, Temporal Lobe Central nervous system A NO LIVING 2010 08199c9b-9dc5-4f59-a1b8-324bd0a5f7c3 TCGA-DU-A7TB-01A-11D-A33U-05 TCGA-DU-A7TB-01A-11D-A33S-01 TCGA-DU-A7TB-01 08199c9b-9dc5-4f59-a1b8-324bd0a5f7c3 TCGA-DU-A7TB-01 TCGA-DU-A7TB-01A-11D-A33S-01 08199c9b-9dc5-4f59-a1b8-324bd0a5f7c3 +TCGA-DU-A7TC-01 TCGA-DU-A7TC-01 TCGA-DU-A7TC TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 32 NO TCGA-DU-A7TC-F71626 TCGA-DU-A7TC -11884 0 1137 1114 [Discrepancy] NO YES NO Headaches > 181 Days Scheduled Follow-up Submission 2015-3-27 MALE NO YES Astrocytoma No C71.0 9400/3 C71.0 YES 90 Right NO NO YES NO NO G2 YES No A7TC [Discrepancy] WITH TUMOR NO NO [Discrepancy] NO Primary Tumor 01 NO NO Not listed in Medical Record NO YES NO DU Supratentorial, Frontal Lobe Central nervous system NO LIVING 2011 aa0da5cf-b997-4e3e-83eb-b01e7488b714 TCGA-DU-A7TC-01A-21D-A34K-05 TCGA-DU-A7TC-01A-21D-A34I-01 TCGA-DU-A7TC-01 aa0da5cf-b997-4e3e-83eb-b01e7488b714 TCGA-DU-A7TC-01 TCGA-DU-A7TC-01A-21D-A34I-01 aa0da5cf-b997-4e3e-83eb-b01e7488b714 +TCGA-DU-A7TD-01 TCGA-DU-A7TD-01 TCGA-DU-A7TD TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 52 TCGA-DU-A7TD TCGA-DU-A7TD-01A -19025 616 228 0 170 Motor/Movement Changes 0 - 30 Days 2014-2-3 MALE NO Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES 530 NO 60 Right NO NO YES G3 YES false No TCGA-DU-A7TD.0DDAB8E8-54DA-495A-9A4B-9D9A3CFE5DB7.pdf A7TD Post-Adjuvant Therapy WITH TUMOR YES YES Progressive Disease YES Primary Tumor 01 NO NO YES YES NO DU Supratentorial, Temporal Lobe Central nervous system A NO DECEASED 2012 03eb7467-7dd5-4228-86b9-7b3b31ba1496 TCGA-DU-A7TD-01A-12D-A34D-05 TCGA-DU-A7TD-01A-12D-A349-01 TCGA-DU-A7TD-01 03eb7467-7dd5-4228-86b9-7b3b31ba1496 TCGA-DU-A7TD-01 TCGA-DU-A7TD-01A-12D-A349-01 03eb7467-7dd5-4228-86b9-7b3b31ba1496 +TCGA-DU-A7TG-01 TCGA-DU-A7TG-01 TCGA-DU-A7TG TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 40 TCGA-DU-A7TG TCGA-DU-A7TG-01A -14671 1804 1351 0 59 YES NO Mental Status Changes 0 - 30 Days 2014-2-3 MALE NO Oligodendroglioma NO No C71.0 9450/3 C71.0 YES 300 NO 70 Right NO YES NO G2 false No TCGA-DU-A7TG.B8C5F2FE-1618-4AB8-924E-4C2C60EF7611.pdf A7TG Post-Adjuvant Therapy NO Primary Tumor 01 NO NO Not listed in Medical Record YES NO YES DU Supratentorial, Frontal Lobe Central nervous system A NO DECEASED 2008 32d4e5fa-74d7-40c7-96ae-a6fb0707524d TCGA-DU-A7TG-01A-21D-A34K-05 TCGA-DU-A7TG-01A-21D-A34I-01 TCGA-DU-A7TG-01 32d4e5fa-74d7-40c7-96ae-a6fb0707524d TCGA-DU-A7TG-01 TCGA-DU-A7TG-01A-21D-A34I-01 32d4e5fa-74d7-40c7-96ae-a6fb0707524d +TCGA-DU-A7TI-01 TCGA-DU-A7TI-01 TCGA-DU-A7TI TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 32 TCGA-DU-A7TI TCGA-DU-A7TI-01A -11906 5441 1183 0 Seizures 91 - 180 Days 2014-2-5 MALE NO Astrocytoma No C71.0 9401/3 C71.0 YES 180 NO Left NO YES NO G3 YES false No TCGA-DU-A7TI.F365952B-D839-4B07-953A-7EBE3B9A45BF.pdf A7TI WITH TUMOR YES Progressive Disease YES Primary Tumor 01 YES NO Cerebral Cortex YES NO YES DU Supratentorial, Frontal Lobe Central nervous system A NO DECEASED 1998 4b078458-3461-4e86-974f-11b677908e29 TCGA-DU-A7TI-01A-11D-A33U-05 TCGA-DU-A7TI-01A-11D-A33S-01 TCGA-DU-A7TI-01 4b078458-3461-4e86-974f-11b677908e29 TCGA-DU-A7TI-01 TCGA-DU-A7TI-01A-11D-A33S-01 4b078458-3461-4e86-974f-11b677908e29 +TCGA-DU-A7TJ-01 TCGA-DU-A7TJ-01 TCGA-DU-A7TJ TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 55 TCGA-DU-A7TJ-F71624 TCGA-DU-A7TJ TCGA-DU-A7TJ-01A -20394 29 0 17 Seizures 31 - 90 Days Scheduled Follow-up Submission 2015-3-27 MALE YES Astrocytoma NO No C71.0 9401/3 C71.0 YES NO 470 NO Right YES IHC YES YES G3 false No TCGA-DU-A7TJ.039F34B6-70E4-42E2-A93C-AD9BEDAC507D.pdf A7TJ WITH TUMOR YES YES Primary Tumor 01 YES Not listed in Medical Record YES NO DU Supratentorial, Temporal Lobe Central nervous system A LIVING 2013 9b0933e8-1da1-427b-8d3f-ef4742888ebd TCGA-DU-A7TJ-01A-11D-A34K-05 TCGA-DU-A7TJ-01A-11D-A34I-01 TCGA-DU-A7TJ-01 9b0933e8-1da1-427b-8d3f-ef4742888ebd TCGA-DU-A7TJ-01 TCGA-DU-A7TJ-01A-11D-A34I-01 9b0933e8-1da1-427b-8d3f-ef4742888ebd +TCGA-E1-5302-01 TCGA-E1-5302-01 TCGA-E1-5302 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain YES YES NO NO 41 NO TCGA-E1-5302-F7572 TCGA-E1-5302 TCGA-E1-5302-01A -15230 1525 0 1242 1254 NO YES NO Seizures 0 - 30 Days Progressive Disease 2011-1-13 MALE NO Astrocytoma NO No C71.9 9401/3 C71.9 YES 0.7 NO 100 Left NO 1.1 NO NO G3 YES No TCGA-E1-5302.cd1ef6bc-41bf-4b2c-80dc-ad9c7169f4c3.pdf 5302 Post-Adjuvant Therapy WITH TUMOR YES YES Stable Disease YES Primary Tumor 01 YES NO 0.3 Not listed in Medical Record YES NO YES E1 Supratentorial, Frontal Lobe Central nervous system A NO DECEASED 1998 468e10c6-3ce9-4334-97d4-55d91799daf9 TCGA-E1-5302-01A-01D-1468-08 TCGA-E1-5302-01A-01D-1467-05 TCGA-E1-5302-01A-01D-1466-01 TCGA-E1-5302-01 468e10c6-3ce9-4334-97d4-55d91799daf9 TCGA-E1-5302-01 TCGA-E1-5302-01A-01D-1466-01 468e10c6-3ce9-4334-97d4-55d91799daf9 +TCGA-E1-5303-01 TCGA-E1-5303-01 TCGA-E1-5303 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain YES NO NO NO 38 NO TCGA-E1-5303-F7453 TCGA-E1-5303 TCGA-E1-5303-01A -14212 2052 0 156 582 NO YES NO Seizures 0 - 30 Days Progressive Disease 2011-1-19 MALE NO Astrocytoma NO No C71.9 9401/3 C71.9 YES NO 0.6 NO 80 Left 0.8 NO NO G3 YES No TCGA-E1-5303.20e5b4f2-6555-4bf9-80c3-9b472fe8eedb.pdf 5303 Post-Adjuvant Therapy WITH TUMOR YES YES Progressive Disease YES Primary Tumor 01 YES NO 0.6 Not listed in Medical Record [Discrepancy] NO YES E1 Supratentorial, Frontal Lobe Central nervous system A NO DECEASED 1998 0edca07e-a874-4cfc-ae79-1080fee6a5f7 TCGA-E1-5303-01A-01D-1468-08 TCGA-E1-5303-01A-01D-1467-05 TCGA-E1-5303-01A-01D-1466-01 TCGA-E1-5303-01 0edca07e-a874-4cfc-ae79-1080fee6a5f7 TCGA-E1-5303-01 TCGA-E1-5303-01A-01D-1466-01 0edca07e-a874-4cfc-ae79-1080fee6a5f7 +TCGA-E1-5304-01 TCGA-E1-5304-01 TCGA-E1-5304 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain YES YES NO 42 NO NO TCGA-E1-5304-F7470 TCGA-E1-5304 980 -15481 1251 0 903 160 NO YES NO Headaches > 181 Days Stable Disease NO 2011-1-20 MALE NO YES Astrocytoma NO No C71.9 9401/3 C71.9 YES 90 Right NO NO NO G3 YES No 5304 Post-Adjuvant Therapy WITH TUMOR YES YES Stable Disease YES Primary Tumor 01 NO YES Not listed in Medical Record YES NO YES E1 Supratentorial, Frontal Lobe Central nervous system NO DECEASED 1999 b6e08ea4-8a3b-4e8e-9a3a-387e6fc6a94a TCGA-E1-5304-01A-01D-1468-08 TCGA-E1-5304-01A-01D-1467-05 TCGA-E1-5304-01A-01D-1466-01 TCGA-E1-5304-01 b6e08ea4-8a3b-4e8e-9a3a-387e6fc6a94a TCGA-E1-5304-01 TCGA-E1-5304-01A-01D-1466-01 b6e08ea4-8a3b-4e8e-9a3a-387e6fc6a94a +TCGA-E1-5305-01 TCGA-E1-5305-01 TCGA-E1-5305 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain YES NO YES NO 34 YES TCGA-E1-5305-F16185 TCGA-E1-5305 TCGA-E1-5305-01A 1623 -12655 2433 0 1604 1631 NO YES NO Seizures 0 - 30 Days Progressive Disease 2011-8-8 MALE NO NO Astrocytoma NO No C71.9 9401/3 C71.9 YES 0.8 NO 90 Right 1 NO YES NO G3 YES No TCGA-E1-5305.7c854147-edeb-47ca-9b46-444a18d12c43.pdf 5305 Post-Adjuvant Therapy WITH TUMOR YES YES Stable Disease YES Primary Tumor 01 YES NO 0.4 Not listed in Medical Record [Discrepancy] NO YES E1 Supratentorial, Frontal Lobe Central nervous system A NO DECEASED 2000 35db896d-9e7c-47df-933f-4eb547913394 TCGA-E1-5305-01A-01D-1893-08 TCGA-E1-5305-01A-01D-1894-05 TCGA-E1-5305-01A-01D-1892-01 TCGA-E1-5305-01 35db896d-9e7c-47df-933f-4eb547913394 TCGA-E1-5305-01 TCGA-E1-5305-01A-01D-1892-01 35db896d-9e7c-47df-933f-4eb547913394 +TCGA-E1-5307-01 TCGA-E1-5307-01 TCGA-E1-5307 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain YES YES NO NO 62 NO TCGA-E1-5307-F16198 TCGA-E1-5307 TCGA-E1-5307-01A -22837 1762 0 1452 [Discrepancy] NO Mental Status Changes > 181 Days Progressive Disease 2011-8-12 FEMALE YES Astrocytoma NO No C71.9 9401/3 C71.9 YES 1 NO 80 Left 1.3 YES NO G3 YES No TCGA-E1-5307.60b202db-3c7c-4c86-be48-9ef37c9039a8.pdf 5307 Pre-Adjuvant Therapy WITH TUMOR YES YES Stable Disease YES Primary Tumor 01 NO NO 0.6 Not listed in Medical Record YES NO YES E1 Supratentorial, Temporal Lobe Central nervous system A NO DECEASED 2000 8f248b27-4433-493d-87d7-e9e174317470 TCGA-E1-5307-01A-01D-1893-08 TCGA-E1-5307-01A-01D-1894-05 TCGA-E1-5307-01A-01D-1892-01 TCGA-E1-5307-01 8f248b27-4433-493d-87d7-e9e174317470 TCGA-E1-5307-01 TCGA-E1-5307-01A-01D-1892-01 8f248b27-4433-493d-87d7-e9e174317470 +TCGA-E1-5311-01 TCGA-E1-5311-01 TCGA-E1-5311 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain YES YES YES NO 31 NO NO TCGA-E1-5311-F7600 TCGA-E1-5311 TCGA-E1-5311-01A 2602 -11332 4084 0 2602 -8 NO NO NO Headaches > 181 Days Progressive Disease NO 2011-1-25 MALE NO YES Oligodendroglioma NO No C71.9 9451/3 C71.9 YES 0.6 NO 100 Right 1.1 NO NO NO G3 YES No TCGA-E1-5311.f4d55755-105e-4740-b13e-801c5d3bde5c.pdf 5311 Pre-Adjuvant Therapy WITH TUMOR YES YES Stable Disease YES Primary Tumor 01 NO NO 0.2 Not listed in Medical Record YES NO YES E1 Supratentorial, Temporal Lobe Central nervous system A NO DECEASED 1994 4daa80a9-f1f3-4b9e-ac8c-e5ee9f276360 TCGA-E1-5311-01A-01D-1468-08 TCGA-E1-5311-01A-01D-1467-05 TCGA-E1-5311-01A-01D-1466-01 TCGA-E1-5311-01 4daa80a9-f1f3-4b9e-ac8c-e5ee9f276360 TCGA-E1-5311-01 TCGA-E1-5311-01A-01D-1466-01 4daa80a9-f1f3-4b9e-ac8c-e5ee9f276360 +TCGA-E1-5318-01 TCGA-E1-5318-01 TCGA-E1-5318 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain YES YES YES NO 42 NO NO TCGA-E1-5318-F7616 TCGA-E1-5318 TCGA-E1-5318-01A 362 -15372 2379 0 2379 362 362 NO YES NO Headaches 31 - 90 Days Stable Disease NO 2011-1-26 FEMALE NO YES Oligodendroglioma NO No C71.9 9450/3 C71.9 YES 0.5 NO 100 Left 0.7 NO NO NO G2 YES No TCGA-E1-5318.9a5db4fd-190b-448c-a22a-1b599b9007c5.pdf 5318 Pre-Adjuvant Therapy WITH TUMOR YES YES Progressive Disease YES Primary Tumor 01 NO NO 0.2 Not listed in Medical Record YES NO YES E1 Supratentorial, Frontal Lobe Central nervous system A NO DECEASED 1997 149fe971-260e-4cbf-a5aa-41eca339847a TCGA-E1-5318-01A-01D-1468-08 TCGA-E1-5318-01A-01D-1467-05 TCGA-E1-5318-01A-01D-1466-01 TCGA-E1-5318-01 149fe971-260e-4cbf-a5aa-41eca339847a TCGA-E1-5318-01 TCGA-E1-5318-01A-01D-1466-01 149fe971-260e-4cbf-a5aa-41eca339847a +TCGA-E1-5319-01 TCGA-E1-5319-01 TCGA-E1-5319 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain YES YES YES NO 48 NO TCGA-E1-5319-F16173 TCGA-E1-5319 TCGA-E1-5319-01A 923 -17612 2907 0 923 952 NO YES Visual Changes 0 - 30 Days Stable Disease 2011-8-17 FEMALE NO NO Oligodendroglioma NO No C71.9 9450/3 C71.9 YES 0.8 NO 100 Right 1 NO NO G2 YES No TCGA-E1-5319.31d5346f-9f29-4eee-86e4-bd01faf9935d.pdf 5319 Pre-Adjuvant Therapy WITH TUMOR YES YES Stable Disease NO Primary Tumor 01 NO NO 0.5 Not listed in Medical Record NO NO YES E1 Supratentorial, Frontal Lobe Central nervous system A YES DECEASED 1998 927d20e2-da09-42ca-a70c-2b203a8297a6 TCGA-E1-5319-01A-01D-1893-08 TCGA-E1-5319-01A-01D-1894-05 TCGA-E1-5319-01A-01D-1892-01 TCGA-E1-5319-01 927d20e2-da09-42ca-a70c-2b203a8297a6 TCGA-E1-5319-01 TCGA-E1-5319-01A-01D-1892-01 927d20e2-da09-42ca-a70c-2b203a8297a6 +TCGA-E1-5322-01 TCGA-E1-5322-01 TCGA-E1-5322 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain YES YES YES NO 38 TCGA-E1-5322-F7464 TCGA-E1-5322 1085 -13903 3978 0 1085 3305 NO NO Seizures Stable Disease 2011-1-27 FEMALE Oligoastrocytoma NO No C71.9 9382/3 C71.9 YES 90 Right G2 YES No 5322 Post-Adjuvant Therapy YES YES Stable Disease [Discrepancy] Primary Tumor 01 YES Not listed in Medical Record [Discrepancy] NO YES E1 Supratentorial, Temporal Lobe Central nervous system DECEASED 1999 d7d5e04b-d563-418b-b312-0fe69b4bec29 TCGA-E1-5322-01A-01D-1468-08 TCGA-E1-5322-01A-01D-1467-05 TCGA-E1-5322-01A-01D-1466-01 TCGA-E1-5322-01 d7d5e04b-d563-418b-b312-0fe69b4bec29 TCGA-E1-5322-01 TCGA-E1-5322-01A-01D-1466-01 d7d5e04b-d563-418b-b312-0fe69b4bec29 +TCGA-E1-A7YD-01 TCGA-E1-A7YD-01 TCGA-E1-A7YD TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 57 NO TCGA-E1-A7YD TCGA-E1-A7YD-01A -21020 5445 435 0 NO NO NO Headaches 0 - 30 Days 2014-5-12 MALE YES Astrocytoma NO No C71.0 9401/3 C71.0 YES NO 80 NO Left NO NO NO G3 YES true No TCGA-E1-A7YD.B371FF08-C874-4A6E-9CF9-C1931F28ADED.pdf A7YD WITH TUMOR YES Stable Disease YES Primary Tumor 01 YES NO Not listed in Medical Record YES NO YES E1 Supratentorial, Temporal Lobe Central nervous system A NO DECEASED 1998 0eb7a942-eea5-4de3-add4-724f69a6f80c TCGA-E1-A7YD-01A-11D-A34D-05 TCGA-E1-A7YD-01A-11D-A349-01 TCGA-E1-A7YD-01 0eb7a942-eea5-4de3-add4-724f69a6f80c TCGA-E1-A7YD-01 TCGA-E1-A7YD-01A-11D-A349-01 0eb7a942-eea5-4de3-add4-724f69a6f80c +TCGA-E1-A7YE-01 TCGA-E1-A7YE-01 TCGA-E1-A7YE TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain NO NO NO NO 32 NO NO TCGA-E1-A7YE-F61220 TCGA-E1-A7YE -11971 886 0 846 81 NO NO NO Seizures 0 - 30 Days Additional New Tumor Event Progressive Disease NO 2014-8-14 FEMALE NO NO Astrocytoma NO No C71.0 9401/3 C71.0 YES 90 Left NO NO NO NO NO G3 YES No A7YE Post-Adjuvant Therapy WITH TUMOR YES NO Stable Disease YES Primary Tumor 01 YES YES Not listed in Medical Record YES NO YES E1 Supratentorial, Frontal Lobe Central nervous system NO DECEASED 2001 cd935b60-ed16-4f34-98ad-1e6cf0671683 TCGA-E1-A7YE-01A-11D-A34D-05 TCGA-E1-A7YE-01A-11D-A349-01 TCGA-E1-A7YE-01 cd935b60-ed16-4f34-98ad-1e6cf0671683 TCGA-E1-A7YE-01 TCGA-E1-A7YE-01A-11D-A349-01 cd935b60-ed16-4f34-98ad-1e6cf0671683 +TCGA-E1-A7YH-01 TCGA-E1-A7YH-01 TCGA-E1-A7YH TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain NO NO NO NO 47 NO TCGA-E1-A7YH-F61239 TCGA-E1-A7YH -17465 2835 0 1629 17 NO YES NO Seizures > 181 Days Additional New Tumor Event Progressive Disease 2014-8-14 FEMALE NO Astrocytoma NO No C71.0 9401/3 C71.0 YES NO 80 Right NO NO NO NO G3 YES No A7YH Pre-Adjuvant Therapy WITH TUMOR YES NO Stable Disease YES Primary Tumor 01 YES NO White Matter YES NO YES E1 Supratentorial, Temporal Lobe Central nervous system NO DECEASED 2005 b5c4c513-4800-405f-94d6-9fa4303292ef TCGA-E1-A7YH-01A-11D-A34D-05 TCGA-E1-A7YH-01A-11D-A349-01 TCGA-E1-A7YH-01 b5c4c513-4800-405f-94d6-9fa4303292ef TCGA-E1-A7YH-01 TCGA-E1-A7YH-01A-11D-A349-01 b5c4c513-4800-405f-94d6-9fa4303292ef +TCGA-E1-A7YI-01 TCGA-E1-A7YI-01 TCGA-E1-A7YI TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 33 NO TCGA-E1-A7YI TCGA-E1-A7YI-01A -12229 2022 111 0 11 NO YES NO Motor/Movement Changes 31 - 90 Days 2014-5-12 FEMALE NO Astrocytoma NO No C71.0 9401/3 C71.0 YES NO 330 NO 80 Right NO NO YES G3 YES true No TCGA-E1-A7YI.17841D2A-99A8-4F1D-900B-70F6324591DC.pdf A7YI Pre-Adjuvant Therapy WITH TUMOR YES NO Primary Tumor 01 NO YES Not listed in Medical Record NO NO YES E1 Supratentorial, Occipital Lobe Central nervous system A YES DECEASED 2008 696dc339-8d57-4b97-bce3-7bd3b2746dcc TCGA-E1-A7YI-01A-11D-A34D-05 TCGA-E1-A7YI-01A-11D-A349-01 TCGA-E1-A7YI-01 696dc339-8d57-4b97-bce3-7bd3b2746dcc TCGA-E1-A7YI-01 TCGA-E1-A7YI-01A-11D-A349-01 696dc339-8d57-4b97-bce3-7bd3b2746dcc +TCGA-E1-A7YJ-01 TCGA-E1-A7YJ-01 TCGA-E1-A7YJ TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain NO NO NO NO 55 NO TCGA-E1-A7YJ-F61259 TCGA-E1-A7YJ -20180 592 0 573 12 NO NO NO Motor/Movement Changes 0 - 30 Days Additional New Tumor Event Progressive Disease 2014-8-15 MALE YES Astrocytoma NO No C71.0 9401/3 C71.0 YES NO 80 Right NO NO NO YES G3 YES No A7YJ Pre-Adjuvant Therapy WITH TUMOR YES YES Stable Disease YES Primary Tumor 01 NO NO White Matter YES NO YES E1 Supratentorial, Frontal Lobe Central nervous system NO DECEASED 2008 f786ecc3-b6e1-4fb2-9658-25d2831982d9 TCGA-E1-A7YJ-01A-11D-A34D-05 TCGA-E1-A7YJ-01A-11D-A349-01 TCGA-E1-A7YJ-01 f786ecc3-b6e1-4fb2-9658-25d2831982d9 TCGA-E1-A7YJ-01 TCGA-E1-A7YJ-01A-11D-A349-01 f786ecc3-b6e1-4fb2-9658-25d2831982d9 +TCGA-E1-A7YK-01 TCGA-E1-A7YK-01 TCGA-E1-A7YK TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 52 NO TCGA-E1-A7YK-F61287 TCGA-E1-A7YK -19236 378 0 6 NO NO NO Seizures 0 - 30 Days 2014-8-15 MALE NO Astrocytoma NO No C71.0 9401/3 C71.0 YES 90 Left NO NO NO G3 NO No A7YK Pre-Adjuvant Therapy YES YES Stable Disease YES Primary Tumor 01 YES NO Cerebral Cortex YES NO YES E1 Supratentorial, Temporal Lobe Central nervous system NO DECEASED 2009 b42c2efe-b9d1-49da-8aa0-3d49bb3fb02f TCGA-E1-A7YK-01A-11D-A34D-05 TCGA-E1-A7YK-01A-11D-A349-01 TCGA-E1-A7YK-01 b42c2efe-b9d1-49da-8aa0-3d49bb3fb02f TCGA-E1-A7YK-01 TCGA-E1-A7YK-01A-11D-A349-01 b42c2efe-b9d1-49da-8aa0-3d49bb3fb02f +TCGA-E1-A7YL-01 TCGA-E1-A7YL-01 TCGA-E1-A7YL TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain NO NO NO NO 46 NO NO TCGA-E1-A7YL-F61302 TCGA-E1-A7YL -16982 492 0 329 14 NO YES YES Headaches 31 - 90 Days Additional New Tumor Event Progressive Disease NO 2014-8-15 MALE NO YES Astrocytoma NO No C71.0 9401/3 C71.0 YES NO 80 Right NO IHC YES NO NO NO NO G3 YES No A7YL Pre-Adjuvant Therapy WITH TUMOR YES YES Progressive Disease YES Primary Tumor 01 NO YES Not listed in Medical Record YES NO YES E1 Supratentorial, Frontal Lobe Central nervous system YES DECEASED 2009 f42762c7-478e-497f-82c2-fc36a359a6ba TCGA-E1-A7YL-01A-11D-A34D-05 TCGA-E1-A7YL-01A-11D-A349-01 TCGA-E1-A7YL-01 f42762c7-478e-497f-82c2-fc36a359a6ba TCGA-E1-A7YL-01 TCGA-E1-A7YL-01A-11D-A349-01 f42762c7-478e-497f-82c2-fc36a359a6ba +TCGA-E1-A7YM-01 TCGA-E1-A7YM-01 TCGA-E1-A7YM TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain YES NO NO NO 63 NO NO TCGA-E1-A7YM-F61425 TCGA-E1-A7YM -23263 648 0 497 11 NO YES NO Headaches > 181 Days Additional New Tumor Event Progressive Disease NO 2014-8-15 MALE NO YES Astrocytoma NO No C71.0 9401/3 C71.0 YES NO 80 Left YES IHC YES NO YES NO NO G3 YES No A7YM Pre-Adjuvant Therapy WITH TUMOR NO YES Progressive Disease YES Primary Tumor 01 YES NO Not listed in Medical Record YES NO YES E1 Supratentorial, Temporal Lobe Central nervous system NO DECEASED 2010 a51ba688-a2f0-4ad4-82eb-d549e99d1acb TCGA-E1-A7YM-01A-11D-A34D-05 TCGA-E1-A7YM-01A-11D-A349-01 TCGA-E1-A7YM-01 a51ba688-a2f0-4ad4-82eb-d549e99d1acb TCGA-E1-A7YM-01 TCGA-E1-A7YM-01A-11D-A349-01 a51ba688-a2f0-4ad4-82eb-d549e99d1acb +TCGA-E1-A7YN-01 TCGA-E1-A7YN-01 TCGA-E1-A7YN TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain YES YES NO NO 63 NO NO TCGA-E1-A7YN-F61445 TCGA-E1-A7YN -23180 727 0 485 20 NO YES NO Visual Changes 0 - 30 Days Additional New Tumor Event Progressive Disease NO 2014-8-15 FEMALE NO NO Astrocytoma NO No C71.0 9401/3 C71.0 YES NO 80 Right NO IHC YES NO NO NO NO G3 YES Yes, History of Prior Malignancy A7YN Pre-Adjuvant Therapy WITH TUMOR YES YES Stable Disease YES Primary Tumor 01 NO YES Not listed in Medical Record YES NO YES E1 Supratentorial, Temporal Lobe Central nervous system YES DECEASED 2010 cf481f1e-9bb2-4682-ac16-31b0db7f444e TCGA-E1-A7YN-01A-11D-A34D-05 TCGA-E1-A7YN-01A-11D-A349-01 TCGA-E1-A7YN-01 cf481f1e-9bb2-4682-ac16-31b0db7f444e TCGA-E1-A7YN-01 TCGA-E1-A7YN-01A-11D-A349-01 cf481f1e-9bb2-4682-ac16-31b0db7f444e +TCGA-E1-A7YO-01 TCGA-E1-A7YO-01 TCGA-E1-A7YO TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain NO NO NO NO 45 NO NO TCGA-E1-A7YO-F61455 TCGA-E1-A7YO TCGA-E1-A7YO-01A -16770 6582 2282 0 2192 1408 NO Seizures 0 - 30 Days Additional New Tumor Event Progressive Disease NO 2014-8-15 MALE NO NO Oligodendroglioma NO No C71.0 9451/3 C71.0 YES NO 50 NO 100 Right NO NO NO NO NO G3 YES true No TCGA-E1-A7YO.3A005836-F7CF-4423-8548-06C956BC96B9.pdf A7YO Post-Adjuvant Therapy WITH TUMOR YES Stable Disease NO Primary Tumor 01 YES NO Not listed in Medical Record YES NO YES E1 Supratentorial, Frontal Lobe Central nervous system A NO DECEASED 1995 47b76f26-6ac6-482c-bb3d-315a18400927 TCGA-E1-A7YO-01A-11D-A34D-05 TCGA-E1-A7YO-01A-11D-A349-01 TCGA-E1-A7YO-01 47b76f26-6ac6-482c-bb3d-315a18400927 TCGA-E1-A7YO-01 TCGA-E1-A7YO-01A-11D-A349-01 47b76f26-6ac6-482c-bb3d-315a18400927 +TCGA-E1-A7YQ-01 TCGA-E1-A7YQ-01 TCGA-E1-A7YQ TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain NO NO NO NO 58 NO NO TCGA-E1-A7YQ-F61543 TCGA-E1-A7YQ TCGA-E1-A7YQ-01A -21341 4796 1578 0 1149 346 NO Headaches 91 - 180 Days Additional New Tumor Event Progressive Disease NO 2014-8-15 FEMALE NO YES Oligodendroglioma NO No C71.0 9451/3 C71.0 YES NO 180 NO 60 Right NO NO NO NO NO G3 YES true No TCGA-E1-A7YQ.FECABDF2-3EBF-4C3C-AEAD-08D5494852FA.pdf A7YQ Post-Adjuvant Therapy WITH TUMOR YES YES Stable Disease YES Primary Tumor 01 NO NO White Matter YES NO YES E1 Supratentorial, Temporal Lobe Central nervous system A YES DECEASED 2000 0c179490-c0fc-4ac1-abdb-f5256abf1ef6 TCGA-E1-A7YQ-01A-11D-A34K-05 TCGA-E1-A7YQ-01A-11D-A34I-01 TCGA-E1-A7YQ-01 0c179490-c0fc-4ac1-abdb-f5256abf1ef6 TCGA-E1-A7YQ-01 TCGA-E1-A7YQ-01A-11D-A34I-01 0c179490-c0fc-4ac1-abdb-f5256abf1ef6 +TCGA-E1-A7YS-01 TCGA-E1-A7YS-01 TCGA-E1-A7YS TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 71 NO NO TCGA-E1-A7YS-F61561 TCGA-E1-A7YS TCGA-E1-A7YS-01A -26159 2123 466 0 16 NO NO NO Mental Status Changes 0 - 30 Days Stable Disease NO 2014-8-15 MALE NO NO Oligodendroglioma NO No C71.0 9451/3 C71.0 YES NO 180 NO 80 Left NO NO YES NO G3 NO true No TCGA-E1-A7YS.8C44E399-41A8-455E-86EA-CA05A8105540.pdf A7YS Pre-Adjuvant Therapy WITH TUMOR YES YES Stable Disease YES Primary Tumor 01 NO NO Not listed in Medical Record YES NO YES E1 Supratentorial, Temporal Lobe Central nervous system A NO DECEASED 2007 6a8d76ce-107a-48a4-ada7-d136ef547915 TCGA-E1-A7YS-01A-11D-A34D-05 TCGA-E1-A7YS-01A-11D-A349-01 TCGA-E1-A7YS-01 6a8d76ce-107a-48a4-ada7-d136ef547915 TCGA-E1-A7YS-01 TCGA-E1-A7YS-01A-11D-A349-01 6a8d76ce-107a-48a4-ada7-d136ef547915 +TCGA-E1-A7YU-01 TCGA-E1-A7YU-01 TCGA-E1-A7YU TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 42 NO TCGA-E1-A7YU -15345 23 0 NO YES YES Headaches 31 - 90 Days 2014-8-11 MALE YES Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES NO NO NO NO G3 No A7YU WITH TUMOR YES NO Primary Tumor 01 YES Not listed in Medical Record YES NO YES E1 Supratentorial, Frontal Lobe Central nervous system NO DECEASED 1996 e6ae4f3a-a375-424d-8f22-b07d1b4904ef TCGA-E1-A7YU-01A-11D-A34K-05 TCGA-E1-A7YU-01A-11D-A34I-01 TCGA-E1-A7YU-01 e6ae4f3a-a375-424d-8f22-b07d1b4904ef TCGA-E1-A7YU-01 TCGA-E1-A7YU-01A-11D-A34I-01 e6ae4f3a-a375-424d-8f22-b07d1b4904ef +TCGA-E1-A7YV-01 TCGA-E1-A7YV-01 TCGA-E1-A7YV TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain NO NO NO NO 26 NO NO TCGA-E1-A7YV-F61594 TCGA-E1-A7YV TCGA-E1-A7YV-01A -9546 1314 987 0 948 6 NO NO NO Headaches 0 - 30 Days Additional New Tumor Event Progressive Disease NO 2014-8-15 FEMALE NO YES Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES YES 3 X chromosomes (super female) Osler-Weber-Rendu syndrome 230 NO 90 Left YES IHC YES NO NO NO NO G3 YES true No TCGA-E1-A7YV.96974491-20AD-491B-A475-80DB896312C8.pdf A7YV Pre-Adjuvant Therapy WITH TUMOR NO YES Progressive Disease YES Primary Tumor 01 NO NO Not listed in Medical Record YES NO YES E1 Supratentorial, Frontal Lobe Central nervous system A NO DECEASED 2010 234d1db1-82a5-4b7d-b5f3-044a440b4233 TCGA-E1-A7YV-01A-11D-A34K-05 TCGA-E1-A7YV-01A-11D-A34I-01 TCGA-E1-A7YV-01 234d1db1-82a5-4b7d-b5f3-044a440b4233 TCGA-E1-A7YV-01 TCGA-E1-A7YV-01A-11D-A34I-01 234d1db1-82a5-4b7d-b5f3-044a440b4233 +TCGA-E1-A7YW-01 TCGA-E1-A7YW-01 TCGA-E1-A7YW TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain NO YES NO NO 28 NO NO TCGA-E1-A7YW-F61613 TCGA-E1-A7YW TCGA-E1-A7YW-01A -10571 4072 1120 0 613 13 NO NO NO Seizures 91 - 180 Days Additional New Tumor Event Progressive Disease NO 2014-8-15 MALE NO NO Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES NO 100 NO 90 Left NO NO NO NO NO G2 YES true No TCGA-E1-A7YW.821A037A-B968-4A91-9D3F-6DD2BD09B05F.pdf A7YW Pre-Adjuvant Therapy WITH TUMOR YES Progressive Disease YES Primary Tumor 01 YES NO Cerebral Cortex YES NO YES E1 Supratentorial, Parietal Lobe Central nervous system A NO DECEASED 2002 5db0c888-986f-4a3e-af64-c15ad413e14d TCGA-E1-A7YW-01A-11D-A34K-05 TCGA-E1-A7YW-01A-11D-A34I-01 TCGA-E1-A7YW-01 5db0c888-986f-4a3e-af64-c15ad413e14d TCGA-E1-A7YW-01 TCGA-E1-A7YW-01A-11D-A34I-01 5db0c888-986f-4a3e-af64-c15ad413e14d +TCGA-E1-A7YY-01 TCGA-E1-A7YY-01 TCGA-E1-A7YY TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain YES NO NO NO 27 NO YES TCGA-E1-A7YY-F61637 TCGA-E1-A7YY TCGA-E1-A7YY-01A -9867 5621 4445 0 4266 428 NO Seizures 0 - 30 Days Additional New Tumor Event Progressive Disease NO 2014-8-15 FEMALE NO NO Oligodendroglioma NO No C71.0 9450/3 C71.0 YES NO 140 NO 100 Right NO NO NO NO NO G2 YES true No TCGA-E1-A7YY.EBCF38D8-E69D-4F12-B7F5-29578E560B44.pdf A7YY Pre-Adjuvant Therapy WITH TUMOR YES YES Stable Disease YES Primary Tumor 01 YES NO Not listed in Medical Record YES NO YES E1 Supratentorial, Frontal Lobe Central nervous system A NO DECEASED 1998 701fe7aa-5ad5-489d-be6f-54a39afe9e0e TCGA-E1-A7YY-01A-11D-A34K-05 TCGA-E1-A7YY-01A-11D-A34I-01 TCGA-E1-A7YY-01 701fe7aa-5ad5-489d-be6f-54a39afe9e0e TCGA-E1-A7YY-01 TCGA-E1-A7YY-01A-11D-A34I-01 701fe7aa-5ad5-489d-be6f-54a39afe9e0e +TCGA-E1-A7Z2-01 TCGA-E1-A7Z2-01 TCGA-E1-A7Z2 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain YES YES NO NO 58 NO NO TCGA-E1-A7Z2-F61680 TCGA-E1-A7Z2 TCGA-E1-A7Z2-01A -21341 614 398 0 269 39 NO YES NO Seizures 31 - 90 Days Additional New Tumor Event Progressive Disease YES clams 2014-8-15 FEMALE NO NO Oligodendroglioma NO No C71.0 9450/3 C71.0 YES NO 160 NO 80 Left NO IHC YES NO NO NO NO G2 YES true No TCGA-E1-A7Z2.2729C641-D25B-4C92-94C8-0BC4C7CE74DE.pdf A7Z2 Pre-Adjuvant Therapy WITH TUMOR YES YES Progressive Disease NO Primary Tumor 01 YES NO Cerebral Cortex YES NO YES E1 Supratentorial, Frontal Lobe Central nervous system A NO DECEASED 2012 4976d0a2-11d3-4132-96c9-b418ffe0e5e7 TCGA-E1-A7Z2-01A-21D-A34K-05 TCGA-E1-A7Z2-01A-21D-A34I-01 TCGA-E1-A7Z2-01 4976d0a2-11d3-4132-96c9-b418ffe0e5e7 TCGA-E1-A7Z2-01 TCGA-E1-A7Z2-01A-21D-A34I-01 4976d0a2-11d3-4132-96c9-b418ffe0e5e7 +TCGA-E1-A7Z3-01 TCGA-E1-A7Z3-01 TCGA-E1-A7Z3 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain NO NO NO 31 NO TCGA-E1-A7Z3-F61703 TCGA-E1-A7Z3 TCGA-E1-A7Z3-01A -11330 7912 2235 0 2072 NO Seizures 0 - 30 Days Additional New Tumor Event Progressive Disease 2014-8-18 FEMALE NO Astrocytoma NO No C71.0 9400/3 C71.0 YES NO 260 NO Right NO NO NO NO G2 YES true No TCGA-E1-A7Z3.A522B02B-1349-44FD-9AEA-3FDA3BBFE4D8.pdf A7Z3 WITH TUMOR YES Progressive Disease YES Primary Tumor 01 YES NO Cerebral Cortex YES NO YES E1 Supratentorial, Parietal Lobe Central nervous system A NO DECEASED 1992 6967eb73-0b93-48d3-bb43-583652eef2a4 TCGA-E1-A7Z3-01A-11D-A34K-05 TCGA-E1-A7Z3-01A-11D-A34I-01 TCGA-E1-A7Z3-01 6967eb73-0b93-48d3-bb43-583652eef2a4 TCGA-E1-A7Z3-01 TCGA-E1-A7Z3-01A-11D-A34I-01 6967eb73-0b93-48d3-bb43-583652eef2a4 +TCGA-E1-A7Z4-01 TCGA-E1-A7Z4-01 TCGA-E1-A7Z4 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain NO NO NO NO 35 NO NO TCGA-E1-A7Z4-F61765 TCGA-E1-A7Z4 -12849 4412 0 4339 974 NO YES NO Headaches 31 - 90 Days Additional New Tumor Event Progressive Disease NO 2014-8-18 MALE NO YES Astrocytoma NO No C71.0 9400/3 C71.0 YES NO 90 Left YES IHC YES NO NO NO NO G2 YES No A7Z4 Post-Adjuvant Therapy WITH TUMOR YES YES Progressive Disease YES Primary Tumor 01 NO NO Not listed in Medical Record YES NO YES E1 Supratentorial, Frontal Lobe Central nervous system YES DECEASED 1999 e53c6e65-37e8-4523-b336-d1bc89381a80 TCGA-E1-A7Z4-01A-11D-A34K-05 TCGA-E1-A7Z4-01A-11D-A34I-01 TCGA-E1-A7Z4-01 e53c6e65-37e8-4523-b336-d1bc89381a80 TCGA-E1-A7Z4-01 TCGA-E1-A7Z4-01A-11D-A34I-01 e53c6e65-37e8-4523-b336-d1bc89381a80 +TCGA-E1-A7Z6-01 TCGA-E1-A7Z6-01 TCGA-E1-A7Z6 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain NO NO NO NO 41 NO NO TCGA-E1-A7Z6-F61776 TCGA-E1-A7Z6 TCGA-E1-A7Z6-01A -14985 1588 984 0 971 19 NO YES NO Headaches > 181 Days Additional New Tumor Event Progressive Disease NO 2014-8-19 FEMALE NO YES Astrocytoma NO No C71.0 9400/3 C71.0 YES NO 160 NO 90 Right YES IHC YES NO NO NO NO G2 YES true No TCGA-E1-A7Z6.096B03E5-82A9-41E6-BC6D-CA25D748EBDC.pdf A7Z6 Pre-Adjuvant Therapy WITH TUMOR NO YES Progressive Disease YES Primary Tumor 01 NO NO Not listed in Medical Record YES NO YES E1 Supratentorial, Frontal Lobe Central nervous system A NO DECEASED 2009 1adce1ae-0823-4259-82bf-2b8b72827d58 TCGA-E1-A7Z6-01A-11D-A34K-05 TCGA-E1-A7Z6-01A-11D-A34I-01 TCGA-E1-A7Z6-01 1adce1ae-0823-4259-82bf-2b8b72827d58 TCGA-E1-A7Z6-01 TCGA-E1-A7Z6-01A-11D-A34I-01 1adce1ae-0823-4259-82bf-2b8b72827d58 +TCGA-EZ-7264-01 TCGA-EZ-7264-01 TCGA-EZ-7264 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 47 NO NO TCGA-EZ-7264-F66594 TCGA-EZ-7264 -17432 0 1201 NO NO NO Mental Status Changes 0 - 30 Days Scheduled Follow-up Submission Stable Disease NO 2014-10-21 FEMALE NO NO Oligodendroglioma NO No C71.0 9450/3 C71.0 YES Right NO YES NO NO G2 NO No 7264 WITH TUMOR YES YES Stable Disease NO Primary Tumor 01 YES NO White Matter NO YES NO EZ Supratentorial, Frontal Lobe Central nervous system NO LIVING 2011 c34a63cc-746b-4502-a1ff-d7bece07b679 TCGA-EZ-7264-01A-11D-2024-08 TCGA-EZ-7264-01A-11D-2025-05 TCGA-EZ-7264-01A-11D-2023-01 TCGA-EZ-7264-01 c34a63cc-746b-4502-a1ff-d7bece07b679 TCGA-EZ-7264-01 TCGA-EZ-7264-01A-11D-2023-01 c34a63cc-746b-4502-a1ff-d7bece07b679 +TCGA-F6-A8O3-01 TCGA-F6-A8O3-01 TCGA-F6-A8O3 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 34 NO NO TCGA-F6-A8O3-F67155 TCGA-F6-A8O3 -12578 0 7 NO NO NO Headaches Scheduled Follow-up Submission NO 2014-11-24 MALE NO YES Oligodendroglioma NO No C71.0 9450/3 C71.0 YES NO NO YES NO NO NO G2 NO No A8O3 TUMOR FREE NO NO Complete Remission/Response Primary Tumor 01 NO NO Not listed in Medical Record YES NO F6 Supratentorial, Frontal Lobe Central nervous system NO LIVING 2013 c7a90fef-6f1f-49ea-a8b8-b0e03e7584b1 TCGA-F6-A8O3-01A-11D-A368-05 TCGA-F6-A8O3-01A-11D-A36N-01 TCGA-F6-A8O3-01 c7a90fef-6f1f-49ea-a8b8-b0e03e7584b1 TCGA-F6-A8O3-01 TCGA-F6-A8O3-01A-11D-A36N-01 c7a90fef-6f1f-49ea-a8b8-b0e03e7584b1 +TCGA-F6-A8O4-01 TCGA-F6-A8O4-01 TCGA-F6-A8O4 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 44 NO NO TCGA-F6-A8O4-F67156 TCGA-F6-A8O4 -16202 0 6 NO NO NO Headaches Scheduled Follow-up Submission NO 2014-11-24 MALE NO YES Astrocytoma NO No C71.9 9400/3 C71.9 YES NO Left NO YES NO NO NO G2 NO No A8O4 TUMOR FREE NO NO Complete Remission/Response Primary Tumor 01 NO NO Not listed in Medical Record YES NO F6 Supratentorial, Frontal Lobe Central nervous system NO LIVING 2013 f46aa5a4-ff0e-42cf-aea9-fd776ebf04cd TCGA-F6-A8O4-01A-11D-A368-05 TCGA-F6-A8O4-01A-11D-A36N-01 TCGA-F6-A8O4-01 f46aa5a4-ff0e-42cf-aea9-fd776ebf04cd TCGA-F6-A8O4-01 TCGA-F6-A8O4-01A-11D-A36N-01 f46aa5a4-ff0e-42cf-aea9-fd776ebf04cd +TCGA-FG-5962-01 TCGA-FG-5962-01 TCGA-FG-5962 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 54 NO NO TCGA-FG-5962-F43040 TCGA-FG-5962 TCGA-FG-5962-01B -19818 0 1453 NO YES NO > 20 Years Visual Changes > 181 Days Scheduled Follow-up Submission Stable Disease NO 2013-5-9 MALE YES NO Oligodendroglioma NO No C71.0 9451/3 C71.0 YES NO 1 NO Left NO 1 NO NO NO NO G3 NO No TCGA-FG-5962.1ed7f628-f222-41e4-a83c-b0884c4c4d81.pdf 5962 WITH TUMOR NO NO Stable Disease YES Primary Tumor 01 NO NO 0.5 White Matter YES NO YES FG Supratentorial, Occipital Lobe Central nervous system B YES LIVING 2009 2480b239-1454-4f49-9c13-381b9f0d0506 TCGA-FG-5962-01B-11D-1893-08 TCGA-FG-5962-01B-11D-1894-05 TCGA-FG-5962-01B-11D-1892-01 TCGA-FG-5962-01 2480b239-1454-4f49-9c13-381b9f0d0506 TCGA-FG-5962-01 TCGA-FG-5962-01B-11D-1892-01 2480b239-1454-4f49-9c13-381b9f0d0506 +TCGA-FG-5963-01 TCGA-FG-5963-01 TCGA-FG-5963 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain YES NO NO 23 YES NO TCGA-FG-5963-F42259 TCGA-FG-5963 -8571 775 0 547 497 0 NO YES NO 12 - 20 Years 12 - 20 Years Seizures 0 - 30 Days Scheduled Follow-up Submission Progressive Disease NO 2013-5-7 MALE NO NO Astrocytoma NO No C71.0 9401/3 C71.0 YES NO 90 Right NO NO YES YES NO G3 YES No 5963 Post-Adjuvant Therapy WITH TUMOR YES Progressive Disease YES Primary Tumor 01 YES NO White Matter YES NO YES FG Supratentorial, Frontal Lobe Central nervous system NO DECEASED 2009 b6bdb9e4-c456-4d5b-8aa1-22c8c33b77ef TCGA-FG-5963-01A-11D-1705-08 TCGA-FG-5963-01A-11D-1706-05 TCGA-FG-5963-01A-11D-1704-01 TCGA-FG-5963-01 b6bdb9e4-c456-4d5b-8aa1-22c8c33b77ef TCGA-FG-5963-01 TCGA-FG-5963-01A-11D-1704-01 b6bdb9e4-c456-4d5b-8aa1-22c8c33b77ef +TCGA-FG-5963-02 TCGA-FG-5963-02 TCGA-FG-5963 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain YES NO NO 23 YES NO TCGA-FG-5963-F42259 TCGA-FG-5963 TCGA-FG-5963-02A -8571 1095 775 0 547 497 0 NO YES NO 12 - 20 Years 12 - 20 Years Seizures 0 - 30 Days Scheduled Follow-up Submission Progressive Disease NO 2013-5-7 MALE NO NO Astrocytoma NO No C71.0 9401/3 C71.0 YES NO 130 NO 90 Right NO NO YES YES NO G3 YES false No TCGA-FG-5963.6BDCE0AC-CDC9-45A2-B796-7A06284251FB.pdf 5963 Post-Adjuvant Therapy WITH TUMOR YES Progressive Disease YES Recurrent Tumor 02 YES NO White Matter YES NO YES FG Supratentorial, Frontal Lobe Central nervous system A NO DECEASED 2009 d231f3e4-48e2-4e94-a995-dcbfc9f0d471 TCGA-FG-5963-02A-12D-A29T-05 d231f3e4-48e2-4e94-a995-dcbfc9f0d471 d231f3e4-48e2-4e94-a995-dcbfc9f0d471 +TCGA-FG-5964-01 TCGA-FG-5964-01 TCGA-FG-5964 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 62 NO NO TCGA-FG-5964-F63736 TCGA-FG-5964 TCGA-FG-5964-01A -22735 0 1588 NO YES NO > 20 Years > 20 Years Seizures 0 - 30 Days Scheduled Follow-up Submission Stable Disease YES Processed food 2014-8-15 MALE NO NO Oligodendroglioma NO No C71.0 9450/3 C71.0 YES NO 0.7 NO Left NO 0.7 NO NO YES NO G2 NO No TCGA-FG-5964.bcaff494-0ef3-42b0-8d93-54d6a8598397.pdf 5964 WITH TUMOR YES YES Stable Disease YES Primary Tumor 01 YES NO 0.6 White Matter NO NO YES FG Supratentorial, Parietal Lobe Central nervous system A NO LIVING 2010 69f6df2f-7cd7-4477-b464-1fd06bd1e9c8 TCGA-FG-5964-01A-11D-1705-08 TCGA-FG-5964-01A-11D-1706-05 TCGA-FG-5964-01A-11D-1704-01 TCGA-FG-5964-01 69f6df2f-7cd7-4477-b464-1fd06bd1e9c8 TCGA-FG-5964-01 TCGA-FG-5964-01A-11D-1704-01 69f6df2f-7cd7-4477-b464-1fd06bd1e9c8 +TCGA-FG-5965-01 TCGA-FG-5965-01 TCGA-FG-5965 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain YES NO YES NO 39 NO NO TCGA-FG-5965-F32837 TCGA-FG-5965 TCGA-FG-5965-01B 1069 -14249 1120 0 979 1035 259 NO YES NO Seizures 0 - 30 Days Additional New Tumor Event Progressive Disease NO 2012-6-13 FEMALE NO YES Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES NO 1 NO 90 Right NO 1.1 NO NO NO G2 YES No 5965 Post-Adjuvant Therapy WITH TUMOR NO NO Progressive Disease NO Primary Tumor 01 YES NO 0.8 White Matter YES NO YES FG Supratentorial, Frontal Lobe Central nervous system B YES DECEASED 2008 54cd0c71-61e8-47b1-a03b-9badeac15ca2 TCGA-FG-5965-01B-11D-1893-08 TCGA-FG-5965-01B-11D-1894-05 TCGA-FG-5965-01B-11D-1892-01 TCGA-FG-5965-01 54cd0c71-61e8-47b1-a03b-9badeac15ca2 TCGA-FG-5965-01 TCGA-FG-5965-01B-11D-1892-01 54cd0c71-61e8-47b1-a03b-9badeac15ca2 +TCGA-FG-5965-02 TCGA-FG-5965-02 TCGA-FG-5965 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain YES NO YES NO 39 NO NO TCGA-FG-5965-F32837 TCGA-FG-5965 TCGA-FG-5965-02B 1069 -14249 1437 1120 0 979 1035 259 NO YES NO Seizures 0 - 30 Days Additional New Tumor Event Progressive Disease NO 2012-6-13 FEMALE NO YES Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES NO 120 NO 90 Right NO NO NO NO G2 YES false No TCGA-FG-5965.DD2349DD-E128-4C2D-962B-F8644121FB16.pdf 5965 Post-Adjuvant Therapy WITH TUMOR NO NO Progressive Disease NO Recurrent Tumor 02 YES NO White Matter YES NO YES FG Supratentorial, Frontal Lobe Central nervous system B YES DECEASED 2008 013bac31-4670-460a-9108-7b4ae57a2e21,74361c55-c785-4d24-8687-be8adbd75de7 TCGA-FG-5965-02A-11D-A29T-05,TCGA-FG-5965-02B-11D-A29T-05 013bac31-4670-460a-9108-7b4ae57a2e21,74361c55-c785-4d24-8687-be8adbd75de7 74361c55-c785-4d24-8687-be8adbd75de7,013bac31-4670-460a-9108-7b4ae57a2e21 +TCGA-FG-6688-01 TCGA-FG-6688-01 TCGA-FG-6688 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain YES NO NO NO 59 NO NO TCGA-FG-6688-F32791 TCGA-FG-6688 TCGA-FG-6688-01A -21745 0 571 405 405 NO YES NO Seizures 0 - 30 Days Additional New Tumor Event Stable Disease NO 2012-6-12 FEMALE NO NO Astrocytoma NO No C71.0 9401/3 C71.0 YES NO 1 NO 50 Left NO 1 NO NO NO G3 YES No TCGA-FG-6688.b889306a-615a-4c0e-8acd-6bfbf08c8bf4.pdf 6688 Post-Adjuvant Therapy WITH TUMOR YES YES Progressive Disease YES Primary Tumor 01 YES YES 0.8 Not listed in Medical Record YES YES NO FG Supratentorial, Parietal Lobe Central nervous system A YES LIVING 2010 3cf6d88f-d583-448e-a3c1-fd8131738114 TCGA-FG-6688-01A-11D-1893-08 TCGA-FG-6688-01A-11D-1894-05 TCGA-FG-6688-01A-11D-1892-01 TCGA-FG-6688-01 3cf6d88f-d583-448e-a3c1-fd8131738114 TCGA-FG-6688-01 TCGA-FG-6688-01A-11D-1892-01 3cf6d88f-d583-448e-a3c1-fd8131738114 +TCGA-FG-6689-01 TCGA-FG-6689-01 TCGA-FG-6689 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain NO 30 YES cats NO TCGA-FG-6689-F43039 TCGA-FG-6689 TCGA-FG-6689-01A -11312 0 190 218 -10 NO YES NO < 12 Years > 20 Years Headaches 31 - 90 Days Scheduled Follow-up Submission NO 2013-5-20 MALE YES YES Astrocytoma NO No C71.0 9400/3 C71.0 YES NO 1 NO 70 Right NO 1 YES YES YES NO G2 YES No TCGA-FG-6689.cc32ee60-c475-48dd-acd3-7e9c817507ba.pdf 6689 Preoperative WITH TUMOR NO YES Progressive Disease YES Primary Tumor 01 NO NO 1 Not listed in Medical Record NO YES NO FG Supratentorial, Frontal Lobe Central nervous system A YES LIVING 2011 625da09e-ed21-4b10-95f2-c889171194d1 TCGA-FG-6689-01A-11D-1893-08 TCGA-FG-6689-01A-11D-1894-05 TCGA-FG-6689-01A-11D-1892-01 TCGA-FG-6689-01 625da09e-ed21-4b10-95f2-c889171194d1 TCGA-FG-6689-01 TCGA-FG-6689-01A-11D-1892-01 625da09e-ed21-4b10-95f2-c889171194d1 +TCGA-FG-6690-01 TCGA-FG-6690-01 TCGA-FG-6690 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 70 NO NO TCGA-FG-6690-F63742 TCGA-FG-6690 -25667 0 1294 -23 NO NO NO Seizures 0 - 30 Days Scheduled Follow-up Submission Stable Disease NO 2014-8-15 MALE NO NO Oligodendroglioma NO No C71.0 9450/3 C71.0 YES NO 90 Left NO NO NO NO NO G2 NO No 6690 Preoperative WITH TUMOR YES YES Stable Disease YES Primary Tumor 01 YES NO Not listed in Medical Record NO YES NO FG Supratentorial, Frontal Lobe Central nervous system NO LIVING 2011 d90e0cc1-db21-49e6-87f4-a3328ffc1396 TCGA-FG-6690-01A-11D-1893-08 TCGA-FG-6690-01A-11D-1894-05 TCGA-FG-6690-01A-11D-1892-01 TCGA-FG-6690-01 d90e0cc1-db21-49e6-87f4-a3328ffc1396 TCGA-FG-6690-01 TCGA-FG-6690-01A-11D-1892-01 d90e0cc1-db21-49e6-87f4-a3328ffc1396 +TCGA-FG-6691-01 TCGA-FG-6691-01 TCGA-FG-6691 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain YES YES YES 23 NO NO TCGA-FG-6691-F63744 TCGA-FG-6691 TCGA-FG-6691-01A 984 -8403 0 1257 913 -9 NO NO NO Headaches 0 - 30 Days Scheduled Follow-up Submission Stable Disease NO 2014-8-15 FEMALE NO YES Astrocytoma NO No C71.0 9400/3 C71.0 YES NO 0.9 NO 100 Right NO 1.1 NO NO NO NO G2 YES No TCGA-FG-6691.799a7cc3-b435-4208-9996-f4360f80e5be.pdf 6691 Preoperative WITH TUMOR NO NO Complete Remission/Response NO Primary Tumor 01 NO NO 0.9 White Matter NO YES NO FG Supratentorial, Temporal Lobe Central nervous system A NO LIVING 2011 58c05288-0bc7-4e19-8055-5284c2714c21 TCGA-FG-6691-01A-11D-1893-08 TCGA-FG-6691-01A-11D-1894-05 TCGA-FG-6691-01A-11D-1892-01 TCGA-FG-6691-01 58c05288-0bc7-4e19-8055-5284c2714c21 TCGA-FG-6691-01 TCGA-FG-6691-01A-11D-1892-01 58c05288-0bc7-4e19-8055-5284c2714c21 +TCGA-FG-6692-01 TCGA-FG-6692-01 TCGA-FG-6692 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 63 TCGA-FG-6692-F41569 TCGA-FG-6692 -23374 561 0 126 42 1 YES NO Seizures 0 - 30 Days Scheduled Follow-up Submission 2013-3-21 MALE NO Oligodendroglioma NO No C71.0 9451/3 C71.0 YES NO Right NO NO YES NO G3 No 6692 Pre-Adjuvant Therapy WITH TUMOR YES NO Stable Disease YES Primary Tumor 01 YES NO Not listed in Medical Record YES YES NO FG Supratentorial, Frontal Lobe Central nervous system NO DECEASED 2011 fca6dae9-687d-418d-bf8b-61bbf6927f61 TCGA-FG-6692-01A-11D-1893-08 TCGA-FG-6692-01A-11D-1894-05 TCGA-FG-6692-01A-11D-1892-01 TCGA-FG-6692-01 fca6dae9-687d-418d-bf8b-61bbf6927f61 TCGA-FG-6692-01 TCGA-FG-6692-01A-11D-1892-01 fca6dae9-687d-418d-bf8b-61bbf6927f61 +TCGA-FG-7634-01 TCGA-FG-7634-01 TCGA-FG-7634 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 28 NO NO TCGA-FG-7634-F41580 TCGA-FG-7634 -10476 0 467 NO YES NO Seizures 0 - 30 Days Scheduled Follow-up Submission NO 2013-3-21 MALE NO NO Oligodendroglioma NO No C71.0 9450/3 C71.0 YES NO Left NO YES NO NO NO G2 No 7634 WITH TUMOR YES NO Stable Disease Primary Tumor 01 YES NO Not listed in Medical Record YES NO FG Supratentorial, Frontal Lobe Central nervous system NO LIVING 2008 afbe6025-3c74-403b-ad84-c89f312d50c5 TCGA-FG-7634-01A-11D-2086-08 TCGA-FG-7634-01A-11D-2087-05 TCGA-FG-7634-01A-11D-2085-01 TCGA-FG-7634-01 afbe6025-3c74-403b-ad84-c89f312d50c5 TCGA-FG-7634-01 TCGA-FG-7634-01A-11D-2085-01 afbe6025-3c74-403b-ad84-c89f312d50c5 +TCGA-FG-7636-01 TCGA-FG-7636-01 TCGA-FG-7636 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 48 NO NO TCGA-FG-7636-F43425 TCGA-FG-7636 TCGA-FG-7636-01A -17843 0 544 -7 0 NO NO NO Headaches > 181 Days Scheduled Follow-up Submission Complete Remission/Response NO 2013-5-21 MALE NO YES Astrocytoma NO No C71.0 9401/3 C71.0 YES NO 0.6 NO 90 Left NO 1.1 NO YES NO YES G3 NO No TCGA-FG-7636.f257e22a-45d4-4c1d-b18e-8dcd42ac04b4.pdf 7636 Preoperative TUMOR FREE YES YES Complete Remission/Response YES Primary Tumor 01 YES YES 0.4 Not listed in Medical Record YES YES NO FG Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2011 89e158ef-3b5a-4d90-9206-b2200a5a343e TCGA-FG-7636-01A-11D-2086-08 TCGA-FG-7636-01A-11D-2087-05 TCGA-FG-7636-01A-11D-2085-01 TCGA-FG-7636-01 89e158ef-3b5a-4d90-9206-b2200a5a343e TCGA-FG-7636-01 TCGA-FG-7636-01A-11D-2085-01 89e158ef-3b5a-4d90-9206-b2200a5a343e +TCGA-FG-7637-01 TCGA-FG-7637-01 TCGA-FG-7637 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 49 NO NO TCGA-FG-7637-F41579 TCGA-FG-7637 TCGA-FG-7637-01A -18084 0 1219 NO YES NO > 20 Years Seizures > 181 Days Scheduled Follow-up Submission Stable Disease NO 2013-3-21 MALE YES NO Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES NO 0.6 NO Right NO 1 NO YES NO NO G2 NO No TCGA-FG-7637.9fdc723f-1cba-4660-8b6e-9c81e86a24e1.pdf 7637 WITH TUMOR YES NO Stable Disease NO Primary Tumor 01 YES NO 0.5 Not listed in Medical Record NO YES NO FG Supratentorial, Temporal Lobe Central nervous system A NO LIVING 2009 8204b99d-4224-4bb9-b297-413956b203ee TCGA-FG-7637-01A-11D-2086-08 TCGA-FG-7637-01A-11D-2087-05 TCGA-FG-7637-01 8204b99d-4224-4bb9-b297-413956b203ee 8204b99d-4224-4bb9-b297-413956b203ee +TCGA-FG-7638-01 TCGA-FG-7638-01 TCGA-FG-7638 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain YES NO NO 31 NO NO TCGA-FG-7638-F43363 TCGA-FG-7638 TCGA-FG-7638-01B -11528 0 686 407 -13 0 NO NO NO Headaches 0 - 30 Days Scheduled Follow-up Submission Stable Disease NO 2013-5-20 FEMALE NO YES Oligodendroglioma NO No C71.0 9451/3 C71.0 YES NO 1 NO 100 Left NO 1.3 NO NO NO YES G3 YES No TCGA-FG-7638.2a94afdc-2504-4b73-8b1e-c9be3183654d.pdf 7638 Preoperative WITH TUMOR YES YES Stable Disease YES Primary Tumor 01 YES NO 0.6 Not listed in Medical Record YES YES NO FG Supratentorial, Frontal Lobe Central nervous system B NO LIVING 2011 11b3ce08-d237-4e4e-8656-a235d3964f8f TCGA-FG-7638-01B-11D-2086-08 TCGA-FG-7638-01B-11D-2087-05 TCGA-FG-7638-01B-11D-2085-01 TCGA-FG-7638-01 11b3ce08-d237-4e4e-8656-a235d3964f8f TCGA-FG-7638-01 TCGA-FG-7638-01B-11D-2085-01 11b3ce08-d237-4e4e-8656-a235d3964f8f +TCGA-FG-7641-01 TCGA-FG-7641-01 TCGA-FG-7641 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 31 NO NO TCGA-FG-7641-F43341 TCGA-FG-7641 -11357 0 627 NO NO NO Headaches > 181 Days Scheduled Follow-up Submission Stable Disease NO 2013-5-17 MALE NO YES Oligodendroglioma NO No C71.0 9450/3 C71.0 YES NO Left NO NO NO NO NO G2 NO No 7641 TUMOR FREE NO YES Complete Remission/Response NO Primary Tumor 01 NO NO Not listed in Medical Record NO YES NO FG Supratentorial, Frontal Lobe Central nervous system YES LIVING 2011 ce5f6628-79c7-414b-8ad1-5714016c44ab TCGA-FG-7641-01B-11D-2253-08 TCGA-FG-7641-01B-11D-2254-05 TCGA-FG-7641-01B-11D-2252-01 TCGA-FG-7641-01 ce5f6628-79c7-414b-8ad1-5714016c44ab TCGA-FG-7641-01 TCGA-FG-7641-01B-11D-2252-01 ce5f6628-79c7-414b-8ad1-5714016c44ab +TCGA-FG-7643-01 TCGA-FG-7643-01 TCGA-FG-7643 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain NO NO YES 49 YES Cats NO TCGA-FG-7643-F45156 TCGA-FG-7643 TCGA-FG-7643-01A 286 -18206 0 611 254 NO YES NO > 20 Years > 20 Years Seizures 91 - 180 Days Scheduled Follow-up Submission Stable Disease NO 2013-7-10 FEMALE YES NO Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES NO 0.8 NO Right NO 1.3 NO NO YES NO G2 YES No TCGA-FG-7643.e6f58f35-8608-4620-b170-552a8a4ff85d.pdf 7643 WITH TUMOR YES NO Progressive Disease NO Primary Tumor 01 YES NO 0.6 Cerebral Cortex NO YES NO FG Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2011 5a558400-4b95-4d48-abb3-a7b9576d9d94 TCGA-FG-7643-01A-11D-2086-08 TCGA-FG-7643-01A-11D-2087-05 TCGA-FG-7643-01A-11D-2085-01 TCGA-FG-7643-01 5a558400-4b95-4d48-abb3-a7b9576d9d94 TCGA-FG-7643-01 TCGA-FG-7643-01A-11D-2085-01 5a558400-4b95-4d48-abb3-a7b9576d9d94 +TCGA-FG-8181-01 TCGA-FG-8181-01 TCGA-FG-8181 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 23 TCGA-FG-8181-F64421 TCGA-FG-8181 TCGA-FG-8181-01A -8642 0 862 -13 Scheduled Follow-up Submission Stable Disease 2014-9-2 MALE Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES NO 1.7 NO 90 Left NO 1.9 NO G3 NO No TCGA-FG-8181.6b2e8993-f8a8-400a-bc49-b283ca7221fe.pdf 8181 Preoperative WITH TUMOR Stable Disease YES Primary Tumor 01 0.7 Not listed in Medical Record YES YES NO FG Supratentorial, Frontal Lobe Central nervous system A LIVING 2012 8d64e025-7822-4888-bd98-dd39ab8c73f1 TCGA-FG-8181-01A-11D-2253-08 TCGA-FG-8181-01A-11D-2254-05 TCGA-FG-8181-01A-11D-2252-01 TCGA-FG-8181-01 8d64e025-7822-4888-bd98-dd39ab8c73f1 TCGA-FG-8181-01 TCGA-FG-8181-01A-11D-2252-01 8d64e025-7822-4888-bd98-dd39ab8c73f1 +TCGA-FG-8182-01 TCGA-FG-8182-01 TCGA-FG-8182 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 35 NO NO TCGA-FG-8182-F43399 TCGA-FG-8182 -12972 0 416 NO NO NO Seizures 0 - 30 Days Scheduled Follow-up Submission Stable Disease NO 2013-5-20 MALE NO NO Oligodendroglioma NO No C71.0 9450/3 C71.0 YES NO Left NO NO NO NO NO G2 NO No 8182 WITH TUMOR Stable Disease NO Primary Tumor 01 YES NO Not listed in Medical Record NO YES NO FG Supratentorial, Frontal Lobe Central nervous system NO LIVING 2012 e47cae41-4eee-4164-a58c-4aeb83fed7fc TCGA-FG-8182-01A-11D-2253-08 TCGA-FG-8182-01A-11D-2254-05 TCGA-FG-8182-01A-11D-2252-01 TCGA-FG-8182-01 e47cae41-4eee-4164-a58c-4aeb83fed7fc TCGA-FG-8182-01 TCGA-FG-8182-01A-11D-2252-01 e47cae41-4eee-4164-a58c-4aeb83fed7fc +TCGA-FG-8185-01 TCGA-FG-8185-01 TCGA-FG-8185 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 37 NO NO TCGA-FG-8185-F43366 TCGA-FG-8185 -13621 0 433 21 NO NO NO > 20 Years Headaches 91 - 180 Days Scheduled Follow-up Submission Complete Remission/Response YES 2013-5-20 MALE NO YES Astrocytoma NO No C71.0 9401/3 C71.0 YES NO 90 Right NO NO NO NO G3 NO No 8185 Pre-Adjuvant Therapy TUMOR FREE Complete Remission/Response YES Primary Tumor 01 NO NO White Matter YES YES NO FG Supratentorial, Frontal Lobe Central nervous system YES LIVING 2012 fa83a73a-1157-42a7-9ed6-7eb73f71724c TCGA-FG-8185-01A-11D-2253-08 TCGA-FG-8185-01A-11D-2254-05 TCGA-FG-8185-01A-11D-2252-01 TCGA-FG-8185-01 fa83a73a-1157-42a7-9ed6-7eb73f71724c TCGA-FG-8185-01 TCGA-FG-8185-01A-11D-2252-01 fa83a73a-1157-42a7-9ed6-7eb73f71724c +TCGA-FG-8186-01 TCGA-FG-8186-01 TCGA-FG-8186 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 42 NO NO TCGA-FG-8186-F42521 TCGA-FG-8186 TCGA-FG-8186-01A -15431 0 487 13 NO YES NO Seizures 0 - 30 Days Scheduled Follow-up Submission Stable Disease NO 2013-4-23 FEMALE NO YES Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES NO 1 NO 70 Right NO 1.5 NO NO NO NO G3 NO No TCGA-FG-8186.7e694f9c-b221-40a9-a63a-f5d2db4e9761.pdf 8186 Pre-Adjuvant Therapy WITH TUMOR YES NO Stable Disease YES Primary Tumor 01 YES NO 0.9 Not listed in Medical Record NO YES NO FG Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2011 7f5d8015-9a38-4d1c-b63d-2d5a0b882259 TCGA-FG-8186-01A-11D-2253-08 TCGA-FG-8186-01A-11D-2254-05 TCGA-FG-8186-01A-11D-2252-01 TCGA-FG-8186-01 7f5d8015-9a38-4d1c-b63d-2d5a0b882259 TCGA-FG-8186-01 TCGA-FG-8186-01A-11D-2252-01 7f5d8015-9a38-4d1c-b63d-2d5a0b882259 +TCGA-FG-8187-01 TCGA-FG-8187-01 TCGA-FG-8187 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 31 TCGA-FG-8187-F43456 TCGA-FG-8187 TCGA-FG-8187-01A -11684 0 611 0 Scheduled Follow-up Submission Stable Disease 2013-5-22 MALE Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES NO 1.2 NO 90 Right NO 1.4 NO G2 NO Yes TCGA-FG-8187.7fee5178-b1ff-4d7c-beed-673236f8d485.pdf 8187 Other TUMOR FREE Complete Remission/Response NO Primary Tumor 01 0.7 Not listed in Medical Record NO YES NO FG Supratentorial, Frontal Lobe Central nervous system A LIVING 2011 642ac0c8-44f2-452b-98d8-3ad56c82e3b1 TCGA-FG-8187-01A-11D-2253-08 TCGA-FG-8187-01A-11D-2254-05 TCGA-FG-8187-01A-11D-2252-01 TCGA-FG-8187-01 642ac0c8-44f2-452b-98d8-3ad56c82e3b1 TCGA-FG-8187-01 TCGA-FG-8187-01A-11D-2252-01 642ac0c8-44f2-452b-98d8-3ad56c82e3b1 +TCGA-FG-8188-01 TCGA-FG-8188-01 TCGA-FG-8188 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain NO YES NO 41 NO NO TCGA-FG-8188-F43454 TCGA-FG-8188 TCGA-FG-8188-01A -15051 0 455 384 -15 NO NO NO Mental Status Changes 0 - 30 Days Scheduled Follow-up Submission NO 2013-5-22 MALE NO NO Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES NO 0.6 NO 90 Left NO 1.1 NO YES NO NO G2 YES No TCGA-FG-8188.7f0c279e-aecb-4bb2-925b-53a3b9bd866d.pdf 8188 Preoperative WITH TUMOR YES Stable Disease NO Primary Tumor 01 NO NO 0.6 Not listed in Medical Record NO YES NO FG Supratentorial, Temporal Lobe Central nervous system A NO LIVING 2012 42862121-daed-47fa-932d-3df4c9efa4cb TCGA-FG-8188-01A-11D-2253-08 TCGA-FG-8188-01A-11D-2254-05 TCGA-FG-8188-01A-11D-2252-01 TCGA-FG-8188-01 42862121-daed-47fa-932d-3df4c9efa4cb TCGA-FG-8188-01 TCGA-FG-8188-01A-11D-2252-01 42862121-daed-47fa-932d-3df4c9efa4cb +TCGA-FG-8189-01 TCGA-FG-8189-01 TCGA-FG-8189 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 33 NO YES TCGA-FG-8189-F58503 TCGA-FG-8189 -12384 0 685 83 YES NO NO > 20 Years Seizures > 181 Days Scheduled Follow-up Submission Stable Disease NO 2014-4-11 FEMALE YES NO Oligodendroglioma NO No C71.0 9450/3 C71.0 YES NO 70 Right NO NO NO NO NO G2 NO No 8189 Pre-Adjuvant Therapy WITH TUMOR YES NO Stable Disease YES Primary Tumor 01 YES NO Not listed in Medical Record YES YES NO FG Supratentorial, Temporal Lobe Central nervous system NO LIVING 2012 bd0752a4-59b6-4f0d-b08c-45d12ae97a3e TCGA-FG-8189-01B-11D-A28N-05 TCGA-FG-8189-01B-11D-A288-01 TCGA-FG-8189-01 bd0752a4-59b6-4f0d-b08c-45d12ae97a3e TCGA-FG-8189-01 TCGA-FG-8189-01B-11D-A288-01 bd0752a4-59b6-4f0d-b08c-45d12ae97a3e +TCGA-FG-8191-01 TCGA-FG-8191-01 TCGA-FG-8191 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 30 NO NO TCGA-FG-8191-F66698 TCGA-FG-8191 TCGA-FG-8191-01A -11252 0 992 NO NO NO Sensory Changes > 181 Days Scheduled Follow-up Submission Stable Disease NO 2014-10-22 MALE NO NO Oligodendroglioma NO No C71.0 9451/3 C71.0 YES NO 0.7 NO Right NO 1.3 NO NO NO NO G3 NO No TCGA-FG-8191.33d30363-b7fb-479f-a985-a9f3c468ab95.pdf 8191 WITH TUMOR Stable Disease YES Primary Tumor 01 NO YES 0.7 Not listed in Medical Record YES YES NO FG Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2011 355c3ccb-f1c3-4e73-a41a-7a3ece9a5f6b TCGA-FG-8191-01A-11D-2253-08 TCGA-FG-8191-01A-11D-2254-05 TCGA-FG-8191-01A-11D-2252-01 TCGA-FG-8191-01 355c3ccb-f1c3-4e73-a41a-7a3ece9a5f6b TCGA-FG-8191-01 TCGA-FG-8191-01A-11D-2252-01 355c3ccb-f1c3-4e73-a41a-7a3ece9a5f6b +TCGA-FG-A4MT-01 TCGA-FG-A4MT-01 TCGA-FG-A4MT TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain NO YES YES 27 NO NO TCGA-FG-A4MT-F56666 TCGA-FG-A4MT 647 -10082 0 1164 499 499 NO NO NO Seizures 0 - 30 Days Scheduled Follow-up Submission Complete Remission/Response NO 2014-2-17 FEMALE NO YES Oligodendroglioma NO No C71.2 9450/3 C71.2 YES NO 100 Left NO NO NO NO NO G2 YES No A4MT Pre-Adjuvant Therapy TUMOR FREE YES YES Complete Remission/Response NO Primary Tumor 01 YES NO Not listed in Medical Record NO YES NO FG Supratentorial, Temporal Lobe Central nervous system NO LIVING 2010 f7f89edd-0409-43c7-ab5d-3d35337de34f TCGA-FG-A4MT-01A-11D-A26N-05 TCGA-FG-A4MT-01A-11D-A26L-01 TCGA-FG-A4MT-01 f7f89edd-0409-43c7-ab5d-3d35337de34f TCGA-FG-A4MT-01 TCGA-FG-A4MT-01A-11D-A26L-01 f7f89edd-0409-43c7-ab5d-3d35337de34f +TCGA-FG-A4MT-02 TCGA-FG-A4MT-02 TCGA-FG-A4MT TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain NO YES YES 27 NO NO TCGA-FG-A4MT-F56666 TCGA-FG-A4MT TCGA-FG-A4MT-02A 647 -10082 827 0 1164 499 499 NO NO NO Seizures 0 - 30 Days Scheduled Follow-up Submission Complete Remission/Response NO 2014-2-17 FEMALE NO YES Oligodendroglioma NO No C71.2 9450/3 C71.2 YES NO 250 NO 100 Left NO NO NO NO NO G2 YES false No TCGA-FG-A4MT.592AF347-5CB0-43E7-8950-D78B9A2D670B.pdf A4MT Pre-Adjuvant Therapy TUMOR FREE YES YES Complete Remission/Response NO Recurrent Tumor 02 YES NO Not listed in Medical Record NO YES NO FG Supratentorial, Temporal Lobe Central nervous system A NO LIVING 2010 9f4e522f-d1c3-4fa9-9ab4-b6886426a77c TCGA-FG-A4MT-02A-11D-A29T-05 9f4e522f-d1c3-4fa9-9ab4-b6886426a77c 9f4e522f-d1c3-4fa9-9ab4-b6886426a77c +TCGA-FG-A4MU-01 TCGA-FG-A4MU-01 TCGA-FG-A4MU TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 58 NO NO TCGA-FG-A4MU-F63739 TCGA-FG-A4MU TCGA-FG-A4MU-01B -21450 258 0 326 NO NO NO Headaches 0 - 30 Days Scheduled Follow-up Submission NO 2014-8-15 MALE NO YES Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES NO 700 NO Right NO IHC YES NO YES NO NO G3 false No TCGA-FG-A4MU.25B6CCE5-DF7C-483D-AA5D-C6870FB6EFC5.pdf A4MU WITH TUMOR NO YES Primary Tumor 01 NO NO Not listed in Medical Record YES NO FG Supratentorial, Temporal Lobe Central nervous system B YES LIVING 2012 554bddc2-3afe-47d6-83c7-46cb30352df1 TCGA-FG-A4MU-01B-11D-A28N-05 TCGA-FG-A4MU-01B-11D-A288-01 TCGA-FG-A4MU-01 554bddc2-3afe-47d6-83c7-46cb30352df1 TCGA-FG-A4MU-01 TCGA-FG-A4MU-01B-11D-A288-01 554bddc2-3afe-47d6-83c7-46cb30352df1 +TCGA-FG-A4MW-01 TCGA-FG-A4MW-01 TCGA-FG-A4MW TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain YES NO NO 63 NO YES TCGA-FG-A4MW-F61644 TCGA-FG-A4MW TCGA-FG-A4MW-01A -23077 64 559 0 160 226 141 1 NO YES NO Seizures 0 - 30 Days Scheduled Follow-up Submission Progressive Disease NO 2014-7-2 MALE NO NO Oligoastrocytoma NO No C71.1 9382/3 C71.1 YES NO 220 NO 80 Right NO IHC YES NO NO NO NO G3 YES false No TCGA-FG-A4MW.E9D4D450-3905-4D11-A814-7B1049A8F3A4.pdf A4MW Post-Adjuvant Therapy WITH TUMOR YES YES Stable Disease YES Primary Tumor 01 YES NO Not listed in Medical Record YES YES NO FG Supratentorial, Frontal Lobe Central nervous system A NO DECEASED 2012 4f8e3c28-cdc9-43bb-a27c-2dd02c4c9c71 TCGA-FG-A4MW-01A-11D-A26N-05 TCGA-FG-A4MW-01A-11D-A26L-01 TCGA-FG-A4MW-01 4f8e3c28-cdc9-43bb-a27c-2dd02c4c9c71 TCGA-FG-A4MW-01 TCGA-FG-A4MW-01A-11D-A26L-01 4f8e3c28-cdc9-43bb-a27c-2dd02c4c9c71 +TCGA-FG-A4MX-01 TCGA-FG-A4MX-01 TCGA-FG-A4MX TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 47 NO NO TCGA-FG-A4MX-F57707 TCGA-FG-A4MX -17381 0 569 -23 0 NO NO NO Motor/Movement Changes 0 - 30 Days Scheduled Follow-up Submission Complete Remission/Response NO 2014-3-21 MALE NO NO Astrocytoma NO No C71.1 9400/3 C71.1 YES NO 100 Right NO IHC YES NO NO NO YES G2 NO No A4MX Preoperative TUMOR FREE NO NO Complete Remission/Response YES Primary Tumor 01 NO NO Not listed in Medical Record NO YES NO FG Supratentorial, Frontal Lobe Central nervous system NO LIVING 2012 ccf08a46-d1e6-4f3d-a511-6a1560a8dc52 TCGA-FG-A4MX-01A-11D-A26N-05 TCGA-FG-A4MX-01A-11D-A26L-01 TCGA-FG-A4MX-01 ccf08a46-d1e6-4f3d-a511-6a1560a8dc52 TCGA-FG-A4MX-01 TCGA-FG-A4MX-01A-11D-A26L-01 ccf08a46-d1e6-4f3d-a511-6a1560a8dc52 +TCGA-FG-A4MY-01 TCGA-FG-A4MY-01 TCGA-FG-A4MY TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 44 NO NO TCGA-FG-A4MY-F58505 TCGA-FG-A4MY -16310 0 721 NO NO NO Seizures 31 - 90 Days Scheduled Follow-up Submission Stable Disease NO 2014-4-11 FEMALE NO YES Oligoastrocytoma NO No C71.3 9382/3 C71.3 YES NO Right NO NO YES NO NO G2 NO No A4MY WITH TUMOR Stable Disease YES Primary Tumor 01 YES NO Not listed in Medical Record NO YES NO FG Supratentorial, Parietal Lobe Central nervous system NO LIVING 2012 c58aae77-ec2e-4988-b6c6-4cde7f4b60e1 TCGA-FG-A4MY-01A-11D-A26N-05 TCGA-FG-A4MY-01A-11D-A26L-01 TCGA-FG-A4MY-01 c58aae77-ec2e-4988-b6c6-4cde7f4b60e1 TCGA-FG-A4MY-01 TCGA-FG-A4MY-01A-11D-A26L-01 c58aae77-ec2e-4988-b6c6-4cde7f4b60e1 +TCGA-FG-A60J-01 TCGA-FG-A60J-01 TCGA-FG-A60J TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 47 NO NO TCGA-FG-A60J-F65604 TCGA-FG-A60J -17339 0 449 -18 1 NO NO NO Seizures 31 - 90 Days Scheduled Follow-up Submission NO 2014-9-25 FEMALE NO NO Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES NO 90 Left YES IHC YES YES NO NO NO G2 NO No A60J Preoperative TUMOR FREE YES NO Complete Remission/Response NO Primary Tumor 01 YES NO Not listed in Medical Record NO YES NO FG Supratentorial, Frontal Lobe Central nervous system NO LIVING 2012 d1c8d59f-1ab1-4450-8d3f-b7bc6e05cd7f TCGA-FG-A60J-01A-11D-A28N-05 TCGA-FG-A60J-01A-11D-A288-01 TCGA-FG-A60J-01 d1c8d59f-1ab1-4450-8d3f-b7bc6e05cd7f TCGA-FG-A60J-01 TCGA-FG-A60J-01A-11D-A288-01 d1c8d59f-1ab1-4450-8d3f-b7bc6e05cd7f +TCGA-FG-A60K-01 TCGA-FG-A60K-01 TCGA-FG-A60K TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 34 YES Dogs NO TCGA-FG-A60K-F61189 TCGA-FG-A60K -12445 0 542 NO YES NO > 20 Years > 20 Years Mental Status Changes 0 - 30 Days Scheduled Follow-up Submission Stable Disease NO 2014-6-25 FEMALE YES NO Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES NO Right NO NO YES NO NO G2 NO Yes, History of Prior Malignancy A60K WITH TUMOR NO NO Stable Disease NO Primary Tumor 01 NO NO Not listed in Medical Record NO YES NO FG Supratentorial, Frontal Lobe Central nervous system NO LIVING 2012 a8be2bbb-f0a6-40e6-af7a-ee9289e8ad44 TCGA-FG-A60K-01A-11D-A29T-05 TCGA-FG-A60K-01A-11D-A323-01 TCGA-FG-A60K-01 a8be2bbb-f0a6-40e6-af7a-ee9289e8ad44 TCGA-FG-A60K-01 TCGA-FG-A60K-01A-11D-A323-01 a8be2bbb-f0a6-40e6-af7a-ee9289e8ad44 +TCGA-FG-A60L-01 TCGA-FG-A60L-01 TCGA-FG-A60L TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 34 NO TCGA-FG-A60L-F65511 TCGA-FG-A60L -12580 0 655 8 0 NO NO Seizures 0 - 30 Days Scheduled Follow-up Submission Complete Remission/Response 2014-9-24 FEMALE NO Astrocytoma NO No C71.0 9400/3 C71.0 YES NO 100 Left NO NO NO NO G2 NO No A60L Other TUMOR FREE YES NO Complete Remission/Response NO Primary Tumor 01 YES NO Not listed in Medical Record NO YES NO FG Supratentorial, Temporal Lobe Central nervous system NO LIVING 2012 d215a4d3-4990-4771-8665-de92aaeb454b TCGA-FG-A60L-01A-12D-A31M-05 TCGA-FG-A60L-01A-12D-A31K-01 TCGA-FG-A60L-01 d215a4d3-4990-4771-8665-de92aaeb454b TCGA-FG-A60L-01 TCGA-FG-A60L-01A-12D-A31K-01 d215a4d3-4990-4771-8665-de92aaeb454b +TCGA-FG-A6IZ-01 TCGA-FG-A6IZ-01 TCGA-FG-A6IZ TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 60 NO NO TCGA-FG-A6IZ-F63721 TCGA-FG-A6IZ TCGA-FG-A6IZ-01A -22275 157 0 457 NO NO NO > 20 Years Seizures 0 - 30 Days Scheduled Follow-up Submission Complete Remission/Response NO 2014-8-15 MALE YES NO Oligodendroglioma NO No C71.0 9450/3 C71.0 YES NO 240 NO Left YES IHC YES NO NO NO YES G2 NO true No TCGA-FG-A6IZ.999D85F3-3DE0-4A08-BCB7-46078C8349A8.pdf A6IZ TUMOR FREE YES NO Complete Remission/Response YES Primary Tumor 01 YES NO Cerebral Cortex NO YES NO FG Supratentorial, Not Otherwise Specified Central nervous system A NO LIVING 2013 3730c75e-f1cc-46ca-a26e-92f74858663b TCGA-FG-A6IZ-01A-11D-A31M-05 TCGA-FG-A6IZ-01A-11D-A31K-01 TCGA-FG-A6IZ-01 3730c75e-f1cc-46ca-a26e-92f74858663b TCGA-FG-A6IZ-01 TCGA-FG-A6IZ-01A-11D-A31K-01 3730c75e-f1cc-46ca-a26e-92f74858663b +TCGA-FG-A6J1-01 TCGA-FG-A6J1-01 TCGA-FG-A6J1 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 44 NO NO TCGA-FG-A6J1-F63724 TCGA-FG-A6J1 TCGA-FG-A6J1-01A -16106 91 0 500 27 NO YES NO Seizures 0 - 30 Days Scheduled Follow-up Submission Stable Disease NO 2014-8-15 FEMALE NO NO Oligodendroglioma NO No C71.0 9450/3 C71.0 YES NO 60 NO 70 Left YES IHC YES NO NO NO NO G2 NO true No TCGA-FG-A6J1.9421C492-5E69-4641-B4CD-29A4D2C7A4CD.pdf A6J1 Pre-Adjuvant Therapy WITH TUMOR NO NO Stable Disease YES Primary Tumor 01 YES NO Not listed in Medical Record NO YES NO FG Supratentorial, Not Otherwise Specified Central nervous system A NO LIVING 2013 16b68870-facd-4071-ba84-b30b2c60bc81 TCGA-FG-A6J1-01A-11D-A31M-05 TCGA-FG-A6J1-01A-11D-A31K-01 TCGA-FG-A6J1-01 16b68870-facd-4071-ba84-b30b2c60bc81 TCGA-FG-A6J1-01 TCGA-FG-A6J1-01A-11D-A31K-01 16b68870-facd-4071-ba84-b30b2c60bc81 +TCGA-FG-A6J3-01 TCGA-FG-A6J3-01 TCGA-FG-A6J3 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 52 NO TCGA-FG-A6J3-F64032 TCGA-FG-A6J3 -19138 0 677 106 1 NO Sensory Changes 0 - 30 Days Scheduled Follow-up Submission Stable Disease NO 2014-8-25 FEMALE NO NO Astrocytoma NO No C71.0 9401/3 C71.0 YES 90 Right YES IHC YES NO NO NO NO G3 NO No A6J3 Post-Adjuvant Therapy WITH TUMOR YES NO Progressive Disease YES Primary Tumor 01 NO YES Cerebral Cortex YES YES NO FG Supratentorial, Frontal Lobe Central nervous system NO LIVING 2012 eba2b96d-21f8-4091-b8c4-0ef2b9c00075 TCGA-FG-A6J3-01A-11D-A31M-05 TCGA-FG-A6J3-01A-11D-A31K-01 TCGA-FG-A6J3-01 eba2b96d-21f8-4091-b8c4-0ef2b9c00075 TCGA-FG-A6J3-01 TCGA-FG-A6J3-01A-11D-A31K-01 eba2b96d-21f8-4091-b8c4-0ef2b9c00075 +TCGA-FG-A70Y-01 TCGA-FG-A70Y-01 TCGA-FG-A70Y TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 20 NO TCGA-FG-A70Y-F65608 TCGA-FG-A70Y TCGA-FG-A70Y-01A -7421 804 0 868 NO NO NO Headaches 0 - 30 Days Scheduled Follow-up Submission 2014-9-25 FEMALE YES Oligodendroglioma NO No C71.0 9450/3 C71.0 YES NO 170 NO Left NO YES NO YES G2 YES false No TCGA-FG-A70Y.C736A839-8853-478E-BB5E-2A1ADCB0A46C.pdf A70Y WITH TUMOR NO NO Complete Remission/Response NO Primary Tumor 01 NO NO Not listed in Medical Record NO YES NO FG Supratentorial, Temporal Lobe Central nervous system A YES LIVING 2011 74d15e51-1d60-4e97-ae99-e412e454d6b1 TCGA-FG-A70Y-01A-12D-A34K-05 TCGA-FG-A70Y-01A-12D-A34I-01 TCGA-FG-A70Y-01 74d15e51-1d60-4e97-ae99-e412e454d6b1 TCGA-FG-A70Y-01 TCGA-FG-A70Y-01A-12D-A34I-01 74d15e51-1d60-4e97-ae99-e412e454d6b1 +TCGA-FG-A70Z-01 TCGA-FG-A70Z-01 TCGA-FG-A70Z TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 53 NO TCGA-FG-A70Z-F64424 TCGA-FG-A70Z -19717 0 328 NO YES Headaches 31 - 90 Days Scheduled Follow-up Submission Stable Disease 2014-9-2 FEMALE YES Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES NO Left NO YES NO NO G3 No A70Z WITH TUMOR NO YES Stable Disease YES Primary Tumor 01 NO YES Not listed in Medical Record YES YES NO FG Supratentorial, Temporal Lobe Central nervous system YES LIVING 2011 bf983be3-abeb-44d7-a9e5-12186d6d303d TCGA-FG-A70Z-01A-12D-A33U-05 TCGA-FG-A70Z-01A-12D-A33S-01 TCGA-FG-A70Z-01 bf983be3-abeb-44d7-a9e5-12186d6d303d TCGA-FG-A70Z-01 TCGA-FG-A70Z-01A-12D-A33S-01 bf983be3-abeb-44d7-a9e5-12186d6d303d +TCGA-FG-A710-01 TCGA-FG-A710-01 TCGA-FG-A710 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 50 TCGA-FG-A710-F64423 TCGA-FG-A710 TCGA-FG-A710-01A -18415 823 0 1115 NO NO Headaches 91 - 180 Days Scheduled Follow-up Submission Stable Disease 2014-9-2 FEMALE YES Oligodendroglioma NO No C71.0 9450/3 C71.0 YES NO 460 NO Left NO NO NO YES G2 NO false No TCGA-FG-A710.0D50F154-43CC-4916-9D8E-A5C16F626971.pdf A710 WITH TUMOR YES NO Stable Disease NO Primary Tumor 01 YES NO Not listed in Medical Record YES YES NO FG Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2011 0aefc6e0-fd5e-430d-b4b7-e1d6c2168ae7 TCGA-FG-A710-01A-12D-A33U-05 TCGA-FG-A710-01A-12D-A33S-01 TCGA-FG-A710-01 0aefc6e0-fd5e-430d-b4b7-e1d6c2168ae7 TCGA-FG-A710-01 TCGA-FG-A710-01A-12D-A33S-01 0aefc6e0-fd5e-430d-b4b7-e1d6c2168ae7 +TCGA-FG-A711-01 TCGA-FG-A711-01 TCGA-FG-A711 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain YES NO NO 33 NO NO TCGA-FG-A711-F65436 TCGA-FG-A711 TCGA-FG-A711-01A -12248 1265 1481 0 1329 1277 871 YES NO NO < 12 Years Seizures 0 - 30 Days Scheduled Follow-up Submission Progressive Disease NO 2014-9-23 FEMALE NO NO Oligodendroglioma NO No C71.0 9450/3 C71.0 YES NO 410 NO 90 Left NO NO YES NO NO G2 YES false No TCGA-FG-A711.5E5F767F-755E-4361-AA92-42D09DE41386.pdf A711 Post-Adjuvant Therapy WITH TUMOR YES YES Progressive Disease NO Primary Tumor 01 YES YES Not listed in Medical Record NO YES NO FG Supratentorial, Frontal Lobe Central nervous system A NO DECEASED 2010 9f0c08da-bb32-4888-b560-0f5762594304 TCGA-FG-A711-01A-21D-A33U-05 TCGA-FG-A711-01A-21D-A33S-01 TCGA-FG-A711-01 9f0c08da-bb32-4888-b560-0f5762594304 TCGA-FG-A711-01 TCGA-FG-A711-01A-21D-A33S-01 9f0c08da-bb32-4888-b560-0f5762594304 +TCGA-FG-A713-01 TCGA-FG-A713-01 TCGA-FG-A713 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 74 NO NO TCGA-FG-A713-F70642 TCGA-FG-A713 TCGA-FG-A713-01A -27232 82 0 622 13 YES NO NO > 20 Years > 20 Years Headaches > 181 Days Scheduled Follow-up Submission Complete Remission/Response YES Melon 2015-2-27 FEMALE YES YES Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES NO 200 NO 60 Right NO NO YES YES NO G2 NO false Yes, History of Prior Malignancy TCGA-FG-A713.B44387B9-C120-4F55-87B5-484C23D6070C.pdf A713 Pre-Adjuvant Therapy TUMOR FREE NO NO Complete Remission/Response YES Primary Tumor 01 NO NO Not listed in Medical Record NO YES NO FG Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2013 570cae57-25b0-401d-a911-da8d44e8b291 TCGA-FG-A713-01A-11D-A32C-05 TCGA-FG-A713-01A-11D-A32A-01 TCGA-FG-A713-01 570cae57-25b0-401d-a911-da8d44e8b291 TCGA-FG-A713-01 TCGA-FG-A713-01A-11D-A32A-01 570cae57-25b0-401d-a911-da8d44e8b291 +TCGA-FG-A87N-01 TCGA-FG-A87N-01 TCGA-FG-A87N TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 37 NO TCGA-FG-A87N-F70255 TCGA-FG-A87N -13606 0 567 NO NO NO Seizures 0 - 30 Days Scheduled Follow-up Submission Stable Disease NO 2015-2-2 FEMALE NO YES Astrocytoma NO No C71.0 9401/3 C71.0 YES NO Left YES IHC YES NO NO YES G3 NO Yes, History of Prior Malignancy A87N WITH TUMOR Stable Disease YES Primary Tumor 01 YES Not listed in Medical Record YES YES NO FG Supratentorial, Frontal Lobe Central nervous system YES LIVING 2013 e5686a63-293f-4d7e-bb7a-c0ad2769cfb4 TCGA-FG-A87N-01A-11D-A368-05 TCGA-FG-A87N-01A-11D-A36N-01 TCGA-FG-A87N-01 e5686a63-293f-4d7e-bb7a-c0ad2769cfb4 TCGA-FG-A87N-01 TCGA-FG-A87N-01A-11D-A36N-01 e5686a63-293f-4d7e-bb7a-c0ad2769cfb4 +TCGA-FG-A87Q-01 TCGA-FG-A87Q-01 TCGA-FG-A87Q TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 61 NO TCGA-FG-A87Q-F72685 TCGA-FG-A87Q -22565 0 174 174 NO Seizures 0 - 30 Days Scheduled Follow-up Submission YES Dairy/lactose 2015-7-31 FEMALE NO NO Astrocytoma NO No C71.0 9401/3 C71.0 YES NO 80 Right NO IHC YES YES NO NO NO G3 NO No A87Q Post-Adjuvant Therapy TUMOR FREE YES YES Complete Remission/Response YES Primary Tumor 01 YES NO White Matter YES YES NO FG Supratentorial, Parietal Lobe Central nervous system NO LIVING 2013 d1d2cb40-28df-41a6-af66-1d11168e0803 TCGA-FG-A87Q-01A-11D-A368-05 TCGA-FG-A87Q-01A-11D-A36N-01 TCGA-FG-A87Q-01 d1d2cb40-28df-41a6-af66-1d11168e0803 TCGA-FG-A87Q-01 TCGA-FG-A87Q-01A-11D-A36N-01 d1d2cb40-28df-41a6-af66-1d11168e0803 +TCGA-FN-7833-01 TCGA-FN-7833-01 TCGA-FN-7833 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 25 TCGA-FN-7833-F66000 TCGA-FN-7833 TCGA-FN-7833-01A -9228 0 837 Mental Status Changes Scheduled Follow-up Submission Complete Remission/Response 2014-10-1 MALE NO Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES 0.3 NO Midline 0.5 NO YES YES G3 NO No TCGA-FN-7833.a6b649b5-cf85-4f4e-bf5f-4870a16c1f93.pdf 7833 TUMOR FREE Complete Remission/Response YES Primary Tumor 01 YES NO 0.2 Not listed in Medical Record YES YES NO FN Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2011 8ddbc97b-376a-4851-906d-efe41fa45eee TCGA-FN-7833-01A-11D-2086-08 TCGA-FN-7833-01A-11D-2087-05 TCGA-FN-7833-01A-11D-2085-01 TCGA-FN-7833-01 8ddbc97b-376a-4851-906d-efe41fa45eee TCGA-FN-7833-01 TCGA-FN-7833-01A-11D-2085-01 8ddbc97b-376a-4851-906d-efe41fa45eee +TCGA-HT-7467-01 TCGA-HT-7467-01 TCGA-HT-7467 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 54 NO NO TCGA-HT-7467-F28641 TCGA-HT-7467 -19944 0 3 NO YES NO Sensory Changes 0 - 30 Days Scheduled Follow-up Submission Complete Remission/Response NO 2012-2-27 MALE NO NO Oligodendroglioma NO No C71.9 9450/3 C71.9 YES NO Right NO NO NO YES G2 No 7467 TUMOR FREE YES NO Complete Remission/Response Primary Tumor 01 NO YES White Matter NO YES HT Supratentorial, Parietal Lobe Central nervous system YES LIVING 2011 e752561a-f5e2-4390-93f1-a487447b6557 TCGA-HT-7467-01A-11D-2024-08 TCGA-HT-7467-01A-11D-2025-05 TCGA-HT-7467-01A-11D-2023-01 TCGA-HT-7467-01 e752561a-f5e2-4390-93f1-a487447b6557 TCGA-HT-7467-01 TCGA-HT-7467-01A-11D-2023-01 e752561a-f5e2-4390-93f1-a487447b6557 +TCGA-HT-7468-01 TCGA-HT-7468-01 TCGA-HT-7468 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 30 NO NO TCGA-HT-7468-F21233 TCGA-HT-7468 -11209 0 203 203 NO NO NO Seizures > 181 Days Scheduled Follow-up Submission Stable Disease YES shellfish 2012-2-7 MALE NO YES Oligodendroglioma NO No C71.0 9451/3 C71.0 YES NO 1p and 19Q deleted 80 Right NO NO NO NO G3 NO No 7468 Post-Adjuvant Therapy TUMOR FREE YES NO Stable Disease NO Primary Tumor 01 YES NO White Matter YES NO YES HT Supratentorial, Parietal Lobe Central nervous system NO LIVING 2011 a40ec658-73b1-48d5-b9d1-51931e76bff0 TCGA-HT-7468-01A-11D-2024-08 TCGA-HT-7468-01A-11D-2025-05 TCGA-HT-7468-01A-11D-2023-01 TCGA-HT-7468-01 a40ec658-73b1-48d5-b9d1-51931e76bff0 TCGA-HT-7468-01 TCGA-HT-7468-01A-11D-2023-01 a40ec658-73b1-48d5-b9d1-51931e76bff0 +TCGA-HT-7469-01 TCGA-HT-7469-01 TCGA-HT-7469 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain YES NO YES NO 30 NO NO TCGA-HT-7469-F28780 TCGA-HT-7469 TCGA-HT-7469-01A 92 -11097 351 0 238 92 NO YES NO Motor/Movement Changes 0 - 30 Days Additional New Tumor Event Progressive Disease NO 2012-4-6 MALE NO YES Oligodendroglioma NO No C71.0 9451/3 C71.0 YES 1 NO Left NO 1.5 NO YES G3 YES No TCGA-HT-7469.d79ea6e7-ce40-4e9a-9e82-61a6a517a571.pdf 7469 WITH TUMOR NO NO Progressive Disease YES Primary Tumor 01 1 Cerebral Cortex YES NO YES HT Supratentorial, Temporal Lobe Central nervous system A DECEASED 2011 905404ec-68c8-45d8-a9ad-ec08cbe207f4 TCGA-HT-7469-01A-11D-2253-08 TCGA-HT-7469-01A-11D-2254-05 TCGA-HT-7469-01A-11D-2252-01 TCGA-HT-7469-01 905404ec-68c8-45d8-a9ad-ec08cbe207f4 TCGA-HT-7469-01 TCGA-HT-7469-01A-11D-2252-01 905404ec-68c8-45d8-a9ad-ec08cbe207f4 +TCGA-HT-7470-01 TCGA-HT-7470-01 TCGA-HT-7470 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 37 NO NO TCGA-HT-7470-F66413 TCGA-HT-7470 TCGA-HT-7470-01A -13611 1220 0 268 133 0 NO NO NO Headaches > 181 Days Scheduled Follow-up Submission Progressive Disease NO 2014-10-14 MALE NO YES Oligodendroglioma NO No C71.9 9451/3 C71.9 YES 1 NO 90 Right NO 1.3 NO NO NO NO G3 NO No TCGA-HT-7470.55af0dfb-afa8-4333-a0be-cb7addf4fee6.pdf 7470 Post-Adjuvant Therapy TUMOR FREE NO NO Progressive Disease YES Primary Tumor 01 YES YES 0.8 White Matter YES NO YES HT Supratentorial, Temporal Lobe Central nervous system A YES DECEASED 2011 31f32186-f631-434d-9c00-f2bbd4cced40 TCGA-HT-7470-01A-12D-2086-08 TCGA-HT-7470-01A-12D-2087-05 TCGA-HT-7470-01A-12D-2085-01 TCGA-HT-7470-01 31f32186-f631-434d-9c00-f2bbd4cced40 TCGA-HT-7470-01 TCGA-HT-7470-01A-12D-2085-01 31f32186-f631-434d-9c00-f2bbd4cced40 +TCGA-HT-7471-01 TCGA-HT-7471-01 TCGA-HT-7471 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 37 NO NO TCGA-HT-7471-F50543 TCGA-HT-7471 TCGA-HT-7471-01A -13564 0 4 NO Motor/Movement Changes 0 - 30 Days Scheduled Follow-up Submission NO 2013-10-24 FEMALE NO NO Oligodendroglioma NO No C71.9 9451/3 C71.9 YES 0.9 NO Left 1.5 YES NO NO YES G3 No TCGA-HT-7471.424d1ea1-6333-45bb-b04e-027b47e6581e.pdf 7471 TUMOR FREE YES NO Primary Tumor 01 YES NO 0.4 Not listed in Medical Record NO YES HT Supratentorial, Temporal Lobe Central nervous system A NO LIVING 2010 80dac2db-4e32-4854-ba10-2d9aa059bf45 TCGA-HT-7471-01A-11D-2253-08 TCGA-HT-7471-01A-11D-2254-05 TCGA-HT-7471-01A-11D-2252-01 TCGA-HT-7471-01 80dac2db-4e32-4854-ba10-2d9aa059bf45 TCGA-HT-7471-01 TCGA-HT-7471-01A-11D-2252-01 80dac2db-4e32-4854-ba10-2d9aa059bf45 +TCGA-HT-7472-01 TCGA-HT-7472-01 TCGA-HT-7472 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 38 NO NO TCGA-HT-7472-F28774 TCGA-HT-7472 -13968 0 1 NO NO NO Seizures 91 - 180 Days Scheduled Follow-up Submission Stable Disease NO 2012-3-1 MALE NO NO Oligodendroglioma NO No C71.0 9450/3 C71.0 YES NO Right NO NO NO NO G2 NO No 7472 TUMOR FREE YES NO Stable Disease NO Primary Tumor 01 YES NO Cerebral Cortex NO NO YES HT Supratentorial, Frontal Lobe Central nervous system NO LIVING 2010 cf6bfd15-1f21-48ab-975d-5e211c8b2fba TCGA-HT-7472-01A-11D-2024-08 TCGA-HT-7472-01A-11D-2025-05 TCGA-HT-7472-01A-11D-2023-01 TCGA-HT-7472-01 cf6bfd15-1f21-48ab-975d-5e211c8b2fba TCGA-HT-7472-01 TCGA-HT-7472-01A-11D-2023-01 cf6bfd15-1f21-48ab-975d-5e211c8b2fba +TCGA-HT-7473-01 TCGA-HT-7473-01 TCGA-HT-7473 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 28 NO NO TCGA-HT-7473-F29569 TCGA-HT-7473 TCGA-HT-7473-01A -10306 0 503 NO NO NO Headaches 0 - 30 Days Scheduled Follow-up Submission NO 2012-3-19 MALE NO YES Oligoastrocytoma NO No C71.9 9382/3 C71.9 YES 1.2 NO Right NO 1.5 NO NO YES G2 NO No TCGA-HT-7473.6f87a2ee-cb07-4d62-9f16-f5a47c866b01.pdf 7473 TUMOR FREE YES YES Complete Remission/Response YES Primary Tumor 01 NO NO 0.5 White Matter NO NO YES HT Supratentorial, Temporal Lobe Central nervous system A NO LIVING 2010 34f24020-97fd-4ead-a681-fb4d3957ea83 TCGA-HT-7473-01A-11D-2024-08 TCGA-HT-7473-01A-11D-2025-05 TCGA-HT-7473-01A-11D-2023-01 TCGA-HT-7473-01 34f24020-97fd-4ead-a681-fb4d3957ea83 TCGA-HT-7473-01 TCGA-HT-7473-01A-11D-2023-01 34f24020-97fd-4ead-a681-fb4d3957ea83 +TCGA-HT-7474-01 TCGA-HT-7474-01 TCGA-HT-7474 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 52 NO NO TCGA-HT-7474-F28779 TCGA-HT-7474 -19149 0 114 NO YES NO Seizures 0 - 30 Days Scheduled Follow-up Submission Stable Disease NO 2012-3-1 MALE NO NO Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES NO Right NO NO NO YES G2 NO No 7474 TUMOR FREE YES NO Stable Disease NO Primary Tumor 01 YES NO Not listed in Medical Record NO NO YES HT Supratentorial, Frontal Lobe Central nervous system NO LIVING 2011 f6a8512b-7649-4ca0-aa55-5bf468e8931e TCGA-HT-7474-01A-11D-2024-08 TCGA-HT-7474-01A-11D-2025-05 TCGA-HT-7474-01A-11D-2023-01 TCGA-HT-7474-01 f6a8512b-7649-4ca0-aa55-5bf468e8931e TCGA-HT-7474-01 TCGA-HT-7474-01A-11D-2023-01 f6a8512b-7649-4ca0-aa55-5bf468e8931e +TCGA-HT-7475-01 TCGA-HT-7475-01 TCGA-HT-7475 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 67 NO NO TCGA-HT-7475-F29411 TCGA-HT-7475 -24686 0 530 209 NO YES NO Seizures 0 - 30 Days Scheduled Follow-up Submission Complete Remission/Response NO 2012-3-16 MALE NO NO Oligoastrocytoma NO No C71.9 9382/3 C71.9 YES NO 70 Right NO NO NO NO G3 NO No 7475 Post-Adjuvant Therapy TUMOR FREE NO NO Complete Remission/Response YES Primary Tumor 01 YES NO White Matter YES NO YES HT Supratentorial, Frontal Lobe Central nervous system NO LIVING 2010 c57ba10b-0485-4566-be4b-def8197360a4 TCGA-HT-7475-01A-11D-2024-08 TCGA-HT-7475-01A-11D-2025-05 TCGA-HT-7475-01A-11D-2023-01 TCGA-HT-7475-01 c57ba10b-0485-4566-be4b-def8197360a4 TCGA-HT-7475-01 TCGA-HT-7475-01A-11D-2023-01 c57ba10b-0485-4566-be4b-def8197360a4 +TCGA-HT-7476-01 TCGA-HT-7476-01 TCGA-HT-7476 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 26 NO NO TCGA-HT-7476-F21240 TCGA-HT-7476 -9614 0 199 NO YES NO Seizures 31 - 90 Days Scheduled Follow-up Submission NO 2012-2-7 MALE NO YES Astrocytoma NO No C71.0 9400/3 C71.0 YES NO Left NO YES NO NO G2 NO No 7476 TUMOR FREE YES NO Stable Disease YES Primary Tumor 01 YES YES Cerebral Cortex YES NO YES HT Supratentorial, Temporal Lobe Central nervous system NO LIVING 2011 cda7debf-70f9-4ea5-9018-35c560bd5ab0 TCGA-HT-7476-01A-11D-2024-08 TCGA-HT-7476-01A-11D-2025-05 TCGA-HT-7476-01A-11D-2023-01 TCGA-HT-7476-01 cda7debf-70f9-4ea5-9018-35c560bd5ab0 TCGA-HT-7476-01 TCGA-HT-7476-01A-11D-2023-01 cda7debf-70f9-4ea5-9018-35c560bd5ab0 +TCGA-HT-7477-01 TCGA-HT-7477-01 TCGA-HT-7477 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 62 NO NO TCGA-HT-7477-F45880 TCGA-HT-7477 TCGA-HT-7477-01B -22948 417 0 738 24 NO NO NO Motor/Movement Changes 31 - 90 Days Scheduled Follow-up Submission Complete Remission/Response NO 2013-7-24 MALE NO NO Astrocytoma NO No C71.0 9401/3 C71.0 YES 280 NO 80 Left NO NO NO YES G3 NO true No TCGA-HT-7477.0BCE1BFA-C7D1-4A3E-A9DE-E24ABF6E5C4F.pdf 7477 Post-Adjuvant Therapy TUMOR FREE Complete Remission/Response YES Primary Tumor 01 YES NO Not listed in Medical Record YES NO YES HT Supratentorial, Frontal Lobe Central nervous system B NO LIVING 2011 5acf54e5-2288-4b40-b6f1-3ce549eceb36 TCGA-HT-7477-01B-11D-A28N-05 TCGA-HT-7477-01B-11D-A288-01 TCGA-HT-7477-01 5acf54e5-2288-4b40-b6f1-3ce549eceb36 TCGA-HT-7477-01 TCGA-HT-7477-01B-11D-A288-01 5acf54e5-2288-4b40-b6f1-3ce549eceb36 +TCGA-HT-7478-01 TCGA-HT-7478-01 TCGA-HT-7478 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 36 NO NO TCGA-HT-7478-F29409 TCGA-HT-7478 -13216 0 194 NO Seizures > 181 Days Scheduled Follow-up Submission Complete Remission/Response NO 2012-3-16 MALE NO YES Astrocytoma NO No C71.0 9400/3 C71.0 YES NO Left NO YES NO YES G2 NO No 7478 TUMOR FREE YES NO Complete Remission/Response YES Primary Tumor 01 YES YES White Matter NO NO YES HT Supratentorial, Frontal Lobe Central nervous system NO LIVING 2011 ced731fa-332e-4c23-b3f9-2cea76a73029 TCGA-HT-7478-01A-11D-2025-05 TCGA-HT-7478-01A-11D-2023-01 TCGA-HT-7478-01 ced731fa-332e-4c23-b3f9-2cea76a73029 TCGA-HT-7478-01 TCGA-HT-7478-01A-11D-2023-01 ced731fa-332e-4c23-b3f9-2cea76a73029 +TCGA-HT-7479-01 TCGA-HT-7479-01 TCGA-HT-7479 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain NO NO YES 44 NO NO TCGA-HT-7479-F66425 TCGA-HT-7479 TCGA-HT-7479-01A 705 -16137 0 1227 705 NO YES YES Headaches > 181 Days Scheduled Follow-up Submission Complete Remission/Response NO 2014-10-14 MALE YES YES Astrocytoma NO No C71.9 9401/3 C71.9 YES NO 0.8 NO Right NO 1 NO NO NO NO G3 YES No TCGA-HT-7479.9bdf94b6-7e28-4c01-a392-c1ff7fd150d7.pdf 7479 TUMOR FREE NO NO Complete Remission/Response YES Primary Tumor 01 NO NO 0.6 White Matter YES NO YES HT Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2011 52c20e74-8d7a-4e11-8981-8d2d32a33a32 TCGA-HT-7479-01A-11D-2025-05 TCGA-HT-7479-01A-11D-2023-01 TCGA-HT-7479-01 52c20e74-8d7a-4e11-8981-8d2d32a33a32 TCGA-HT-7479-01 TCGA-HT-7479-01A-11D-2023-01 52c20e74-8d7a-4e11-8981-8d2d32a33a32 +TCGA-HT-7480-01 TCGA-HT-7480-01 TCGA-HT-7480 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain YES NO YES 33 NO NO TCGA-HT-7480-F28787 TCGA-HT-7480 TCGA-HT-7480-01A 1943 -12291 0 2287 1943 NO YES NO Seizures > 181 Days Scheduled Follow-up Submission Progressive Disease NO 2012-3-1 MALE YES NO Oligodendroglioma NO No C71.9 9450/3 C71.9 YES NO 1.2 NO Right NO 1.8 NO NO YES G2 YES No TCGA-HT-7480.289b59d0-0a44-4d34-a991-b94846e470c3.pdf 7480 WITH TUMOR YES NO Stable Disease YES Primary Tumor 01 YES NO 0.3 Cerebral Cortex YES NO YES HT Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2005 1eb669bc-04cc-474a-baae-cba7bea98a18 TCGA-HT-7480-01A-11D-2086-08 TCGA-HT-7480-01A-11D-2087-05 TCGA-HT-7480-01A-11D-2085-01 TCGA-HT-7480-01 1eb669bc-04cc-474a-baae-cba7bea98a18 TCGA-HT-7480-01 TCGA-HT-7480-01A-11D-2085-01 1eb669bc-04cc-474a-baae-cba7bea98a18 +TCGA-HT-7481-01 TCGA-HT-7481-01 TCGA-HT-7481 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain NO NO YES 39 NO NO TCGA-HT-7481-F66422 TCGA-HT-7481 TCGA-HT-7481-01A 3071 -14306 0 2918 3071 NO NO NO Seizures 0 - 30 Days Scheduled Follow-up Submission Partial Remission/Response NO 2014-10-14 MALE NO YES Oligodendroglioma NO No C71.9 9450/3 C71.9 YES NO 1 NO Right NO 2 NO NO NO YES G2 YES No TCGA-HT-7481.879a7f04-519f-44c0-bad3-32c637ab5955.pdf 7481 WITH TUMOR YES YES Partial Remission/Response YES Primary Tumor 01 YES NO 0.9 White Matter NO NO YES HT Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2006 82a92ead-9cb1-473e-9a21-a6be1ddfbaba TCGA-HT-7481-01A-11D-2025-05 TCGA-HT-7481-01A-11D-2023-01 TCGA-HT-7481-01 82a92ead-9cb1-473e-9a21-a6be1ddfbaba TCGA-HT-7481-01 TCGA-HT-7481-01A-11D-2023-01 82a92ead-9cb1-473e-9a21-a6be1ddfbaba +TCGA-HT-7482-01 TCGA-HT-7482-01 TCGA-HT-7482 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain NO NO YES 18 NO NO TCGA-HT-7482-F66423 TCGA-HT-7482 377 -6857 0 3253 374 NO NO NO Seizures 0 - 30 Days Scheduled Follow-up Submission Complete Remission/Response NO 2014-10-14 FEMALE NO NO Oligoastrocytoma NO No C71.9 9382/3 C71.9 YES NO Left NO NO NO NO NO G2 YES No 7482 TUMOR FREE YES NO Partial Remission/Response YES Primary Tumor 01 YES NO Not listed in Medical Record YES NO YES HT Supratentorial, Frontal Lobe Central nervous system NO LIVING 2005 ba0661be-f70f-4273-af82-911f189b2adb TCGA-HT-7482-01A-11D-2024-08 TCGA-HT-7482-01A-11D-2025-05 TCGA-HT-7482-01A-11D-2023-01 TCGA-HT-7482-01 ba0661be-f70f-4273-af82-911f189b2adb TCGA-HT-7482-01 TCGA-HT-7482-01A-11D-2023-01 ba0661be-f70f-4273-af82-911f189b2adb +TCGA-HT-7483-01 TCGA-HT-7483-01 TCGA-HT-7483 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 14 NO NO TCGA-HT-7483-F45917 TCGA-HT-7483 TCGA-HT-7483-01A -5267 0 5255 NO YES NO Seizures Scheduled Follow-up Submission Complete Remission/Response NO 2013-7-25 MALE NO YES Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES 1 NO Right NO 1.3 NO YES NO YES G2 NO No TCGA-HT-7483.a5c5d547-2d3d-41df-a490-76350dc7e7c8.pdf 7483 TUMOR FREE Complete Remission/Response YES Primary Tumor 01 YES NO 0.5 White Matter YES NO YES HT Supratentorial, Frontal Lobe Central nervous system A NO LIVING 1998 9dae5e73-aec6-461b-94e7-785065eea36e TCGA-HT-7483-01A-11D-2024-08 TCGA-HT-7483-01A-11D-2025-05 TCGA-HT-7483-01A-11D-2023-01 TCGA-HT-7483-01 9dae5e73-aec6-461b-94e7-785065eea36e TCGA-HT-7483-01 TCGA-HT-7483-01A-11D-2023-01 9dae5e73-aec6-461b-94e7-785065eea36e +TCGA-HT-7485-01 TCGA-HT-7485-01 TCGA-HT-7485 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 42 NO NO TCGA-HT-7485-F28639 TCGA-HT-7485 TCGA-HT-7485-01A -15589 0 122 24 NO NO NO Headaches 91 - 180 Days Scheduled Follow-up Submission Complete Remission/Response NO 2012-3-2 MALE NO YES Astrocytoma NO No C71.9 9400/3 C71.9 YES NO 1.1 NO 100 Right NO 1.6 NO NO YES G2 NO No TCGA-HT-7485.5af016f0-9c44-4b57-8477-26e25f087c0f.pdf 7485 Post-Adjuvant Therapy TUMOR FREE NO NO Complete Remission/Response NO Primary Tumor 01 NO YES 0.7 White Matter NO NO YES HT Supratentorial, Parietal Lobe Central nervous system A NO LIVING 2006 33ceeccf-d800-4e8b-928a-35765299cbaf TCGA-HT-7485-01A-11D-2025-05 TCGA-HT-7485-01A-11D-2023-01 TCGA-HT-7485-01 33ceeccf-d800-4e8b-928a-35765299cbaf TCGA-HT-7485-01 TCGA-HT-7485-01A-11D-2023-01 33ceeccf-d800-4e8b-928a-35765299cbaf +TCGA-HT-7601-01 TCGA-HT-7601-01 TCGA-HT-7601 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 30 NO NO TCGA-HT-7601-F29577 TCGA-HT-7601 TCGA-HT-7601-01A -10989 0 153 NO NO NO Seizures 0 - 30 Days Scheduled Follow-up Submission NO 2012-3-8 FEMALE NO NO Astrocytoma NO No C71.9 9401/3 C71.9 YES NO 1 NO Left NO 2.7 NO NO YES G3 NO No TCGA-HT-7601.2a8341ad-9d93-4a5f-b3f8-0ff0dfda1be7.pdf 7601 TUMOR FREE YES NO Partial Remission/Response YES Primary Tumor 01 YES NO 0.9 White Matter YES NO YES HT Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2008 0b28fcb7-a5a5-41d1-b830-5f7c52d18e25 TCGA-HT-7601-01A-11D-2086-08 TCGA-HT-7601-01A-11D-2087-05 TCGA-HT-7601-01A-11D-2085-01 TCGA-HT-7601-01 0b28fcb7-a5a5-41d1-b830-5f7c52d18e25 TCGA-HT-7601-01 TCGA-HT-7601-01A-11D-2085-01 0b28fcb7-a5a5-41d1-b830-5f7c52d18e25 +TCGA-HT-7602-01 TCGA-HT-7602-01 TCGA-HT-7602 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 21 NO NO TCGA-HT-7602-F29573 TCGA-HT-7602 TCGA-HT-7602-01A -7946 0 908 NO NO NO Headaches 0 - 30 Days Scheduled Follow-up Submission NO 2012-3-16 MALE NO YES Oligodendroglioma NO No C71.9 9450/3 C71.9 YES NO 1 NO Right NO 2.8 NO NO NO G2 No TCGA-HT-7602.0ae8d27a-943e-48ac-8c70-c7fa3511ad2f.pdf 7602 TUMOR FREE NO Primary Tumor 01 NO NO 1 White Matter NO NO YES HT Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2008 71fddbd0-c910-40f0-80fb-09148065220b TCGA-HT-7602-01A-21D-2086-08 TCGA-HT-7602-01A-21D-2087-05 TCGA-HT-7602-01A-21D-2085-01 TCGA-HT-7602-01 71fddbd0-c910-40f0-80fb-09148065220b TCGA-HT-7602-01 TCGA-HT-7602-01A-21D-2085-01 71fddbd0-c910-40f0-80fb-09148065220b +TCGA-HT-7603-01 TCGA-HT-7603-01 TCGA-HT-7603 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 29 NO NO TCGA-HT-7603-F29571 TCGA-HT-7603 -10883 0 705 NO NO NO Headaches 0 - 30 Days Scheduled Follow-up Submission NO 2012-3-7 MALE NO YES Oligodendroglioma NO No C71.9 9450/3 C71.9 YES NO NO NO NO NO G2 NO No 7603 TUMOR FREE NO YES Complete Remission/Response YES Primary Tumor 01 NO NO White Matter NO NO YES HT Supratentorial, Frontal Lobe Central nervous system YES LIVING 2008 fb8000a5-63e3-44ec-813d-e81482d53d07 TCGA-HT-7603-01A-21D-2086-08 TCGA-HT-7603-01A-21D-2087-05 TCGA-HT-7603-01A-21D-2085-01 TCGA-HT-7603-01 fb8000a5-63e3-44ec-813d-e81482d53d07 TCGA-HT-7603-01 TCGA-HT-7603-01A-21D-2085-01 fb8000a5-63e3-44ec-813d-e81482d53d07 +TCGA-HT-7604-01 TCGA-HT-7604-01 TCGA-HT-7604 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 50 NO NO TCGA-HT-7604-F48641 TCGA-HT-7604 TCGA-HT-7604-01A -18443 0 3725 NO NO NO Headaches 31 - 90 Days Scheduled Follow-up Submission Partial Remission/Response NO 2013-9-18 MALE NO YES Astrocytoma NO No C71.0 9400/3 C71.0 YES 1.2 NO Left NO 1.7 NO YES NO YES G2 NO No TCGA-HT-7604.ecac7160-5404-42f2-90d3-c43d1b8bb747.pdf 7604 TUMOR FREE YES YES Partial Remission/Response YES Primary Tumor 01 YES NO 0.4 Not listed in Medical Record YES NO YES HT Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2003 09500c89-0578-415c-9df3-73ae02acbdab TCGA-HT-7604-01A-11D-2086-08 TCGA-HT-7604-01A-11D-2087-05 TCGA-HT-7604-01A-11D-2085-01 TCGA-HT-7604-01 09500c89-0578-415c-9df3-73ae02acbdab TCGA-HT-7604-01 TCGA-HT-7604-01A-11D-2085-01 09500c89-0578-415c-9df3-73ae02acbdab +TCGA-HT-7605-01 TCGA-HT-7605-01 TCGA-HT-7605 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 38 NO NO TCGA-HT-7605-F29603 TCGA-HT-7605 -13892 0 139 NO YES NO < 12 Years Motor/Movement Changes Scheduled Follow-up Submission NO 2012-3-15 MALE YES NO Oligodendroglioma NO No C71.9 9450/3 C71.9 YES Right NO NO YES YES G2 NO No 7605 NO Primary Tumor 01 NO NO White Matter NO NO YES HT Supratentorial, Frontal Lobe Central nervous system NO LIVING 2008 ba1613b5-3076-4fc5-8da0-f0e951d077ef TCGA-HT-7605-01A-11D-2086-08 TCGA-HT-7605-01A-11D-2087-05 TCGA-HT-7605-01A-11D-2085-01 TCGA-HT-7605-01 ba1613b5-3076-4fc5-8da0-f0e951d077ef TCGA-HT-7605-01 TCGA-HT-7605-01A-11D-2085-01 ba1613b5-3076-4fc5-8da0-f0e951d077ef +TCGA-HT-7606-01 TCGA-HT-7606-01 TCGA-HT-7606 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 30 NO TCGA-HT-7606-F29692 TCGA-HT-7606 -11233 0 526 NO NO NO Headaches > 181 Days Scheduled Follow-up Submission NO 2012-3-27 FEMALE NO YES Astrocytoma NO No C71.9 9400/3 C71.9 YES Left NO NO NO G2 NO No 7606 TUMOR FREE Complete Remission/Response YES Primary Tumor 01 NO NO Not listed in Medical Record YES NO YES HT Supratentorial, Frontal Lobe Central nervous system NO LIVING 2008 faeb1918-077c-417e-9acc-9733b756511c TCGA-HT-7606-01A-11D-2086-08 TCGA-HT-7606-01A-11D-2087-05 TCGA-HT-7606-01A-11D-2085-01 TCGA-HT-7606-01 faeb1918-077c-417e-9acc-9733b756511c TCGA-HT-7606-01 TCGA-HT-7606-01A-11D-2085-01 faeb1918-077c-417e-9acc-9733b756511c +TCGA-HT-7607-01 TCGA-HT-7607-01 TCGA-HT-7607 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 61 NO NO TCGA-HT-7607-F35003 TCGA-HT-7607 -22585 96 0 8 NO NO NO Seizures 31 - 90 Days Scheduled Follow-up Submission Progressive Disease NO 2012-9-12 FEMALE YES YES Astrocytoma NO No C71.0 9400/3 C71.0 YES NO 1p19q codeleted 70 Left NO NO YES NO NO G2 NO No 7607 Pre-Adjuvant Therapy WITH TUMOR YES NO Progressive Disease NO Primary Tumor 01 YES NO White Matter NO NO YES HT Supratentorial, Frontal Lobe Central nervous system NO DECEASED 2008 a0187097-fff8-497c-87df-ae5d5cc151c1 TCGA-HT-7607-01A-11D-2086-08 TCGA-HT-7607-01A-11D-2087-05 TCGA-HT-7607-01A-11D-2085-01 TCGA-HT-7607-01 a0187097-fff8-497c-87df-ae5d5cc151c1 TCGA-HT-7607-01 TCGA-HT-7607-01A-11D-2085-01 a0187097-fff8-497c-87df-ae5d5cc151c1 +TCGA-HT-7608-01 TCGA-HT-7608-01 TCGA-HT-7608 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 61 NO NO TCGA-HT-7608-F28803 TCGA-HT-7608 TCGA-HT-7608-01A -22302 0 671 NO NO NO Motor/Movement Changes 0 - 30 Days Scheduled Follow-up Submission Stable Disease NO 2012-3-1 MALE NO NO Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES NO 1p19q deletion 0.9 NO Right NO 2.2 NO NO YES G2 NO No TCGA-HT-7608.3e9306b1-c5bc-48e4-9bc2-cd928aef0584.pdf 7608 TUMOR FREE NO NO Stable Disease NO Primary Tumor 01 YES NO 0.5 White Matter NO NO YES HT Supratentorial, Temporal Lobe Central nervous system A NO LIVING 2007 65a188b3-1fc9-4021-bc3e-158c0cce2c8e TCGA-HT-7608-01A-11D-2086-08 TCGA-HT-7608-01A-11D-2087-05 TCGA-HT-7608-01A-11D-2085-01 TCGA-HT-7608-01 65a188b3-1fc9-4021-bc3e-158c0cce2c8e TCGA-HT-7608-01 TCGA-HT-7608-01A-11D-2085-01 65a188b3-1fc9-4021-bc3e-158c0cce2c8e +TCGA-HT-7609-01 TCGA-HT-7609-01 TCGA-HT-7609 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 34 NO YES TCGA-HT-7609-F28823 TCGA-HT-7609 -12607 0 1399 1 NO NO NO Headaches 31 - 90 Days Scheduled Follow-up Submission Stable Disease NO 2012-3-1 MALE NO YES Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES NO 90 Right NO YES NO NO G3 NO No 7609 Pre-Adjuvant Therapy TUMOR FREE NO NO Stable Disease YES Primary Tumor 01 NO NO White Matter YES NO YES HT Supratentorial, Frontal Lobe Central nervous system NO LIVING 2007 b520d7b8-846f-4ba1-93eb-4891a0d99e72 TCGA-HT-7609-01A-11D-2086-08 TCGA-HT-7609-01A-11D-2087-05 TCGA-HT-7609-01A-11D-2085-01 TCGA-HT-7609-01 b520d7b8-846f-4ba1-93eb-4891a0d99e72 TCGA-HT-7609-01 TCGA-HT-7609-01A-11D-2085-01 b520d7b8-846f-4ba1-93eb-4891a0d99e72 +TCGA-HT-7610-01 TCGA-HT-7610-01 TCGA-HT-7610 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain NO YES YES 25 NO NO TCGA-HT-7610-F28944 TCGA-HT-7610 1205 -9447 0 1706 1205 NO NO NO Seizures > 181 Days Scheduled Follow-up Submission Stable Disease NO 2012-3-2 FEMALE NO YES Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES NO Left NO NO NO NO G2 YES No 7610 TUMOR FREE YES NO Stable Disease NO Primary Tumor 01 YES NO White Matter NO NO YES HT Supratentorial, Temporal Lobe Central nervous system NO LIVING 2007 a48f9376-bff1-4939-8d52-349e471b650f TCGA-HT-7610-01A-21D-2086-08 TCGA-HT-7610-01A-21D-2087-05 TCGA-HT-7610-01A-21D-2085-01 TCGA-HT-7610-01 a48f9376-bff1-4939-8d52-349e471b650f TCGA-HT-7610-01 TCGA-HT-7610-01A-21D-2085-01 a48f9376-bff1-4939-8d52-349e471b650f +TCGA-HT-7611-01 TCGA-HT-7611-01 TCGA-HT-7611 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 36 NO NO TCGA-HT-7611-F51026 TCGA-HT-7611 -13314 0 1752 NO NO NO Scheduled Follow-up Submission NO 2013-11-5 MALE NO NO Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES 90 Right YES NO NO NO G2 NO No 7611 Other TUMOR FREE Complete Remission/Response NO Primary Tumor 01 NO NO Not listed in Medical Record NO NO YES HT Supratentorial, Frontal Lobe Central nervous system NO LIVING 2007 e4762187-c19b-40d5-8385-ecb21f3ec6c3 TCGA-HT-7611-01A-11D-2399-05 TCGA-HT-7611-01A-11D-2391-01 TCGA-HT-7611-01 e4762187-c19b-40d5-8385-ecb21f3ec6c3 TCGA-HT-7611-01 TCGA-HT-7611-01A-11D-2391-01 e4762187-c19b-40d5-8385-ecb21f3ec6c3 +TCGA-HT-7616-01 TCGA-HT-7616-01 TCGA-HT-7616 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 75 NO NO TCGA-HT-7616-F28640 TCGA-HT-7616 TCGA-HT-7616-01A -27685 7 0 NO NO NO Seizures 0 - 30 Days Scheduled Follow-up Submission Progressive Disease 2012-2-27 MALE NO NO Oligodendroglioma NO No C71.9 9451/3 C71.9 YES NO 0.9 NO Right NO 1.3 YES NO YES G3 NO No TCGA-HT-7616.d8e58500-52b1-4fad-8a36-7ddec42b5632.pdf 7616 WITH TUMOR NO NO Progressive Disease NO Primary Tumor 01 YES NO 0.3 Not listed in Medical Record NO NO YES HT Supratentorial, Frontal Lobe Central nervous system A NO DECEASED 2007 31a34ec1-460d-4768-a8aa-03c81c3226be TCGA-HT-7616-01A-11D-2253-08 TCGA-HT-7616-01A-11D-2254-05 TCGA-HT-7616-01A-11D-2252-01 TCGA-HT-7616-01 31a34ec1-460d-4768-a8aa-03c81c3226be TCGA-HT-7616-01 TCGA-HT-7616-01A-11D-2252-01 31a34ec1-460d-4768-a8aa-03c81c3226be +TCGA-HT-7620-01 TCGA-HT-7620-01 TCGA-HT-7620 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain YES NO NO 40 NO NO TCGA-HT-7620-F29125 TCGA-HT-7620 TCGA-HT-7620-01A -14659 0 434 280 NO NO NO Headaches 0 - 30 Days Scheduled Follow-up Submission Progressive Disease NO 2012-3-8 MALE YES YES Oligodendroglioma NO No C71.9 9451/3 C71.9 YES NO 1.1 NO Left NO 3.7 NO NO YES G3 YES No TCGA-HT-7620.4115a114-29b2-4f53-a7df-fb4e60b3e76a.pdf 7620 TUMOR FREE YES YES Complete Remission/Response YES Primary Tumor 01 NO YES 0.6 White Matter YES NO YES HT Supratentorial, Frontal Lobe Central nervous system A YES LIVING 2007 62b17846-7d74-4a34-bbed-48c4c9e462f9 TCGA-HT-7620-01A-11D-2253-08 TCGA-HT-7620-01A-11D-2254-05 TCGA-HT-7620-01A-11D-2252-01 TCGA-HT-7620-01 62b17846-7d74-4a34-bbed-48c4c9e462f9 TCGA-HT-7620-01 TCGA-HT-7620-01A-11D-2252-01 62b17846-7d74-4a34-bbed-48c4c9e462f9 +TCGA-HT-7676-01 TCGA-HT-7676-01 TCGA-HT-7676 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 26 TCGA-HT-7676-F51023 TCGA-HT-7676 -9667 0 5 Headaches 0 - 30 Days Scheduled Follow-up Submission 2013-11-5 MALE YES Oligodendroglioma NO No C71.0 9450/3 C71.0 YES Left YES NO NO G2 No 7676 TUMOR FREE Primary Tumor 01 YES NO Not listed in Medical Record NO YES HT Supratentorial, Frontal Lobe Central nervous system NO LIVING 2009 cb18ceb5-73e7-44d7-8ab0-96b832e980bd TCGA-HT-7676-01A-11D-2399-05 TCGA-HT-7676-01A-11D-2391-01 TCGA-HT-7676-01 cb18ceb5-73e7-44d7-8ab0-96b832e980bd TCGA-HT-7676-01 TCGA-HT-7676-01A-11D-2391-01 cb18ceb5-73e7-44d7-8ab0-96b832e980bd +TCGA-HT-7677-01 TCGA-HT-7677-01 TCGA-HT-7677 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 53 NO NO TCGA-HT-7677-F28945 TCGA-HT-7677 TCGA-HT-7677-01A -19610 0 494 NO NO NO Motor/Movement Changes > 181 Days Scheduled Follow-up Submission Stable Disease NO 2012-3-2 MALE NO NO Oligodendroglioma NO No C71.0 9451/3 C71.0 YES NO 1.1 NO Left NO 2.1 YES NO YES G3 NO No TCGA-HT-7677.816ea52a-dca4-48f4-8fbb-4a6ff64d1fb4.pdf 7677 WITH TUMOR NO NO Stable Disease YES Primary Tumor 01 NO NO 0.7 White Matter YES NO YES HT Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2009 22dcbc1b-95f2-4343-b1e4-18daacd66e28 TCGA-HT-7677-01A-11D-2253-08 TCGA-HT-7677-01A-11D-2254-05 TCGA-HT-7677-01A-11D-2252-01 TCGA-HT-7677-01 22dcbc1b-95f2-4343-b1e4-18daacd66e28 TCGA-HT-7677-01 TCGA-HT-7677-01A-11D-2252-01 22dcbc1b-95f2-4343-b1e4-18daacd66e28 +TCGA-HT-7680-01 TCGA-HT-7680-01 TCGA-HT-7680 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain NO NO 32 NO NO TCGA-HT-7680-F28949 TCGA-HT-7680 TCGA-HT-7680-01A -11970 0 23 NO NO NO Headaches > 181 Days Scheduled Follow-up Submission Stable Disease NO 2012-3-2 FEMALE NO YES Astrocytoma NO No C71.9 9400/3 C71.9 YES NO 1 NO Midline NO 1.6 NO NO YES G2 NO No TCGA-HT-7680.156c9439-4f38-45cb-ab67-d0be08fa04fc.pdf 7680 TUMOR FREE NO NO Stable Disease NO Primary Tumor 01 NO NO 0.5 White Matter NO NO YES HT Posterior Fossa, Cerebellum Central nervous system A NO LIVING 2010 3042bdd7-5fc9-4428-afcc-ecd76f71d68d TCGA-HT-7680-01A-11D-2253-08 TCGA-HT-7680-01A-11D-2254-05 TCGA-HT-7680-01A-11D-2252-01 TCGA-HT-7680-01 3042bdd7-5fc9-4428-afcc-ecd76f71d68d TCGA-HT-7680-01 TCGA-HT-7680-01A-11D-2252-01 3042bdd7-5fc9-4428-afcc-ecd76f71d68d +TCGA-HT-7681-01 TCGA-HT-7681-01 TCGA-HT-7681 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 29 TCGA-HT-7681-F45882 TCGA-HT-7681 TCGA-HT-7681-01A -10790 0 1359 Scheduled Follow-up Submission Complete Remission/Response 2013-7-24 FEMALE Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES 0.9 NO Right 2.8 NO G2 NO No TCGA-HT-7681.d6ca1fd7-edd7-432c-a296-1cce50ce71df.pdf 7681 TUMOR FREE Complete Remission/Response NO Primary Tumor 01 0.6 Not listed in Medical Record NO NO YES HT Supratentorial, Frontal Lobe Central nervous system A LIVING 2009 12391798-07e4-44bd-9689-db2f95f6d710 TCGA-HT-7681-01A-11D-2399-05 TCGA-HT-7681-01A-11D-2391-01 TCGA-HT-7681-01 12391798-07e4-44bd-9689-db2f95f6d710 TCGA-HT-7681-01 TCGA-HT-7681-01A-11D-2391-01 12391798-07e4-44bd-9689-db2f95f6d710 +TCGA-HT-7684-01 TCGA-HT-7684-01 TCGA-HT-7684 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 58 NO NO TCGA-HT-7684-F29412 TCGA-HT-7684 TCGA-HT-7684-01A -21352 0 184 NO NO NO Headaches 0 - 30 Days Scheduled Follow-up Submission Complete Remission/Response NO 2012-3-16 MALE NO YES Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES NO 0.9 NO Left NO 1.7 YES NO NO G3 NO No TCGA-HT-7684.02500cb1-2f28-4624-b001-f5913284295e.pdf 7684 TUMOR FREE NO NO Complete Remission/Response NO Primary Tumor 01 NO YES 0.9 White Matter NO NO YES HT Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2008 2d0cb65e-cd71-431a-9eaa-9e0844446d63 TCGA-HT-7684-01A-11D-2253-08 TCGA-HT-7684-01A-11D-2254-05 TCGA-HT-7684-01A-11D-2252-01 TCGA-HT-7684-01 2d0cb65e-cd71-431a-9eaa-9e0844446d63 TCGA-HT-7684-01 TCGA-HT-7684-01A-11D-2252-01 2d0cb65e-cd71-431a-9eaa-9e0844446d63 +TCGA-HT-7686-01 TCGA-HT-7686-01 TCGA-HT-7686 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 29 NO NO TCGA-HT-7686-F29415 TCGA-HT-7686 TCGA-HT-7686-01A -10724 0 1300 231 NO Headaches > 181 Days Scheduled Follow-up Submission Complete Remission/Response NO 2012-3-16 FEMALE NO YES Astrocytoma NO No C71.0 9401/3 C71.0 YES NO 0.9 NO 90 Left NO 2 NO NO NO G3 NO No TCGA-HT-7686.1be5b4db-9b53-4b2f-b44b-1383788d473c.pdf 7686 Post-Adjuvant Therapy TUMOR FREE YES YES Complete Remission/Response YES Primary Tumor 01 NO NO 0.6 Not listed in Medical Record YES NO YES HT Supratentorial, Parietal Lobe Central nervous system A YES LIVING 2008 65955c38-4907-4b09-8ef6-94a6b9ff5817 TCGA-HT-7686-01A-11D-2253-08 TCGA-HT-7686-01A-11D-2254-05 TCGA-HT-7686-01A-11D-2252-01 TCGA-HT-7686-01 65955c38-4907-4b09-8ef6-94a6b9ff5817 TCGA-HT-7686-01 TCGA-HT-7686-01A-11D-2252-01 65955c38-4907-4b09-8ef6-94a6b9ff5817 +TCGA-HT-7687-01 TCGA-HT-7687-01 TCGA-HT-7687 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 74 TCGA-HT-7687-F28642 TCGA-HT-7687 -27186 0 3 YES NO Visual Changes > 181 Days Scheduled Follow-up Submission 2012-2-27 MALE NO Oligodendroglioma NO No C71.0 9451/3 C71.0 YES NO Right NO NO NO G3 No 7687 TUMOR FREE NO NO Stable Disease Primary Tumor 01 NO YES Not listed in Medical Record NO YES HT Supratentorial, Frontal Lobe Central nervous system YES LIVING 2010 fc4a13f0-831a-4e31-a2a1-29486bf9d006 TCGA-HT-7687-01A-11D-2253-08 TCGA-HT-7687-01A-11D-2254-05 TCGA-HT-7687-01A-11D-2252-01 TCGA-HT-7687-01 fc4a13f0-831a-4e31-a2a1-29486bf9d006 TCGA-HT-7687-01 TCGA-HT-7687-01A-11D-2252-01 fc4a13f0-831a-4e31-a2a1-29486bf9d006 +TCGA-HT-7688-01 TCGA-HT-7688-01 TCGA-HT-7688 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 59 NO NO TCGA-HT-7688-F29413 TCGA-HT-7688 TCGA-HT-7688-01A -21844 0 964 NO YES NO Headaches > 181 Days Scheduled Follow-up Submission Complete Remission/Response NO 2012-3-16 MALE YES YES Oligodendroglioma NO No C71.0 9451/3 C71.0 YES NO 0.9 NO Left NO 2.3 NO NO YES G3 NO No TCGA-HT-7688.35d09648-037f-4e5e-b70b-4f17cc8f2fb3.pdf 7688 TUMOR FREE YES YES Complete Remission/Response YES Primary Tumor 01 YES NO 0.6 White Matter YES NO YES HT Supratentorial, Frontal Lobe Central nervous system A YES LIVING 2009 049ee2d6-c67a-42e2-a39d-2eb15650ca63 TCGA-HT-7688-01A-11D-2253-08 TCGA-HT-7688-01A-11D-2254-05 TCGA-HT-7688-01A-11D-2252-01 TCGA-HT-7688-01 049ee2d6-c67a-42e2-a39d-2eb15650ca63 TCGA-HT-7688-01 TCGA-HT-7688-01A-11D-2252-01 049ee2d6-c67a-42e2-a39d-2eb15650ca63 +TCGA-HT-7689-01 TCGA-HT-7689-01 TCGA-HT-7689 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 58 NO NO TCGA-HT-7689-F29648 TCGA-HT-7689 TCGA-HT-7689-01A -21331 0 455 455 NO NO NO Mental Status Changes 0 - 30 Days Scheduled Follow-up Submission NO 2012-3-27 FEMALE NO NO Oligodendroglioma NO No C71.0 9450/3 C71.0 YES 1 NO 70 Left 1.2 YES NO YES G2 NO No TCGA-HT-7689.21e316fb-fd2b-4890-a34a-832781031216.pdf 7689 Post-Adjuvant Therapy TUMOR FREE Complete Remission/Response YES Primary Tumor 01 NO NO 0.7 Not listed in Medical Record YES NO YES HT Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2009 477e059b-1b0a-4f2b-b14d-8e1362fc38ee TCGA-HT-7689-01A-11D-2253-08 TCGA-HT-7689-01A-11D-2254-05 TCGA-HT-7689-01A-11D-2252-01 TCGA-HT-7689-01 477e059b-1b0a-4f2b-b14d-8e1362fc38ee TCGA-HT-7689-01 TCGA-HT-7689-01A-11D-2252-01 477e059b-1b0a-4f2b-b14d-8e1362fc38ee +TCGA-HT-7690-01 TCGA-HT-7690-01 TCGA-HT-7690 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 29 NO NO TCGA-HT-7690-F29644 TCGA-HT-7690 -10673 0 3 NO NO NO Headaches 31 - 90 Days Scheduled Follow-up Submission NO 2012-3-15 MALE NO YES Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES Right NO YES NO NO G3 NO No 7690 TUMOR FREE NO Primary Tumor 01 NO NO White Matter NO NO YES HT Supratentorial, Frontal Lobe Central nervous system NO LIVING 2009 a00de36d-7c6d-453a-b791-08c752ccfefc TCGA-HT-7690-01A-11D-2253-08 TCGA-HT-7690-01A-11D-2254-05 TCGA-HT-7690-01A-11D-2252-01 TCGA-HT-7690-01 a00de36d-7c6d-453a-b791-08c752ccfefc TCGA-HT-7690-01 TCGA-HT-7690-01A-11D-2252-01 a00de36d-7c6d-453a-b791-08c752ccfefc +TCGA-HT-7691-01 TCGA-HT-7691-01 TCGA-HT-7691 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 31 NO NO TCGA-HT-7691-F29641 TCGA-HT-7691 TCGA-HT-7691-01A -11465 0 3 NO NO NO Headaches > 181 Days Scheduled Follow-up Submission NO 2012-3-27 FEMALE NO YES Astrocytoma NO No C71.0 9400/3 C71.0 YES 1 NO Right NO 1.4 NO NO NO G2 NO No TCGA-HT-7691.f6b38096-6209-4c37-a545-b4d1643dcc58.pdf 7691 TUMOR FREE NO NO NO Primary Tumor 01 NO NO 0.8 Not listed in Medical Record NO NO YES HT Supratentorial, Not Otherwise Specified Central nervous system A YES LIVING 2008 162b8ed0-de59-46cd-8e16-52b55e0f5467 TCGA-HT-7691-01A-11D-2253-08 TCGA-HT-7691-01A-11D-2254-05 TCGA-HT-7691-01A-11D-2252-01 TCGA-HT-7691-01 162b8ed0-de59-46cd-8e16-52b55e0f5467 TCGA-HT-7691-01 TCGA-HT-7691-01A-11D-2252-01 162b8ed0-de59-46cd-8e16-52b55e0f5467 +TCGA-HT-7692-01 TCGA-HT-7692-01 TCGA-HT-7692 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 43 NO NO TCGA-HT-7692-F29616 TCGA-HT-7692 -15727 0 90 29 NO YES YES Seizures 0 - 30 Days Scheduled Follow-up Submission NO 2012-3-16 MALE NO YES Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES 100 Left YES NO NO G2 NO No 7692 Pre-Adjuvant Therapy TUMOR FREE YES YES Complete Remission/Response YES Primary Tumor 01 YES NO YES NO YES HT Supratentorial, Frontal Lobe Central nervous system NO LIVING 2009 b497a736-d140-47f4-8429-f53a7c005334 TCGA-HT-7692-01A-12D-2253-08 TCGA-HT-7692-01A-12D-2254-05 TCGA-HT-7692-01A-12D-2252-01 TCGA-HT-7692-01 b497a736-d140-47f4-8429-f53a7c005334 TCGA-HT-7692-01 TCGA-HT-7692-01A-12D-2252-01 b497a736-d140-47f4-8429-f53a7c005334 +TCGA-HT-7693-01 TCGA-HT-7693-01 TCGA-HT-7693 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 51 NO YES TCGA-HT-7693-F29610 TCGA-HT-7693 TCGA-HT-7693-01A -18956 0 533 472 NO YES NO Seizures 0 - 30 Days Scheduled Follow-up Submission NO 2012-3-16 FEMALE NO YES Oligodendroglioma NO No C71.0 9450/3 C71.0 YES 1 NO 90 Right 1.1 NO NO YES G2 NO No TCGA-HT-7693.7ad7aac7-df39-4f13-9038-a6685012e8b0.pdf 7693 Post-Adjuvant Therapy TUMOR FREE Partial Remission/Response YES Primary Tumor 01 YES NO 0.7 YES NO YES HT Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2008 26c57d9f-1ee1-4c64-9b42-e00aed49d22d TCGA-HT-7693-01A-11D-2253-08 TCGA-HT-7693-01A-11D-2254-05 TCGA-HT-7693-01A-11D-2252-01 TCGA-HT-7693-01 26c57d9f-1ee1-4c64-9b42-e00aed49d22d TCGA-HT-7693-01 TCGA-HT-7693-01A-11D-2252-01 26c57d9f-1ee1-4c64-9b42-e00aed49d22d +TCGA-HT-7694-01 TCGA-HT-7694-01 TCGA-HT-7694 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 60 NO NO TCGA-HT-7694-F29607 TCGA-HT-7694 TCGA-HT-7694-01A -21930 0 210 210 NO YES NO Motor/Movement Changes 0 - 30 Days Scheduled Follow-up Submission NO 2012-3-9 MALE NO NO Oligodendroglioma NO No C71.0 9451/3 C71.0 YES 0.9 NO 90 Right NO 2.5 YES NO YES G3 NO No TCGA-HT-7694.09cb8fc6-43e0-484f-9897-b2df70d0a16e.pdf 7694 Post-Adjuvant Therapy TUMOR FREE NO YES Complete Remission/Response YES Primary Tumor 01 NO NO 0.5 White Matter YES NO YES HT Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2008 17d328ce-367a-47c4-8f70-7f4644b37506 TCGA-HT-7694-01A-11D-2253-08 TCGA-HT-7694-01A-11D-2254-05 TCGA-HT-7694-01A-11D-2252-01 TCGA-HT-7694-01 17d328ce-367a-47c4-8f70-7f4644b37506 TCGA-HT-7694-01 TCGA-HT-7694-01A-11D-2252-01 17d328ce-367a-47c4-8f70-7f4644b37506 +TCGA-HT-7695-01 TCGA-HT-7695-01 TCGA-HT-7695 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 29 NO NO TCGA-HT-7695-F29604 TCGA-HT-7695 TCGA-HT-7695-01A -10827 0 442 NO YES NO Seizures 31 - 90 Days Scheduled Follow-up Submission NO 2012-3-16 FEMALE NO NO Oligodendroglioma NO No C71.0 9450/3 C71.0 YES 0.9 NO Left NO 1.8 NO NO NO G2 NO No TCGA-HT-7695.351859ed-9826-4414-958d-dafc1f741a33.pdf 7695 TUMOR FREE Complete Remission/Response YES Primary Tumor 01 YES NO 0.7 White Matter YES NO YES HT Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2009 4ae49c4c-909f-48f0-8905-f27879c29426 TCGA-HT-7695-01A-11D-2253-08 TCGA-HT-7695-01A-11D-2254-05 TCGA-HT-7695-01A-11D-2252-01 TCGA-HT-7695-01 4ae49c4c-909f-48f0-8905-f27879c29426 TCGA-HT-7695-01 TCGA-HT-7695-01A-11D-2252-01 4ae49c4c-909f-48f0-8905-f27879c29426 +TCGA-HT-7854-01 TCGA-HT-7854-01 TCGA-HT-7854 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain NO NO YES 62 NO NO TCGA-HT-7854-F48001 TCGA-HT-7854 TCGA-HT-7854-01A 1191 -22738 0 1201 1147 208 NO NO NO Visual Changes 31 - 90 Days Scheduled Follow-up Submission NO 2013-9-3 MALE NO YES Astrocytoma NO No C71.0 9400/3 C71.0 YES NO 1.1 NO 100 Left NO 1.5 NO YES NO NO G2 YES No TCGA-HT-7854.abff42e8-3d5d-438c-91a8-6ddca2225169.pdf 7854 Post-Adjuvant Therapy TUMOR FREE YES YES YES Primary Tumor 01 NO NO 0.6 White Matter NO NO YES HT Supratentorial, Temporal Lobe Central nervous system A YES LIVING 2010 3e7df498-0263-483e-98e8-e09324b5fae8 TCGA-HT-7854-01A-11D-2253-08 TCGA-HT-7854-01A-11D-2254-05 TCGA-HT-7854-01A-11D-2252-01 TCGA-HT-7854-01 3e7df498-0263-483e-98e8-e09324b5fae8 TCGA-HT-7854-01 TCGA-HT-7854-01A-11D-2252-01 3e7df498-0263-483e-98e8-e09324b5fae8 +TCGA-HT-7855-01 TCGA-HT-7855-01 TCGA-HT-7855 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 39 NO NO TCGA-HT-7855-F29420 TCGA-HT-7855 TCGA-HT-7855-01A -14496 0 585 151 NO NO NO Headaches 91 - 180 Days Scheduled Follow-up Submission Complete Remission/Response NO 2012-3-16 MALE NO YES Astrocytoma NO No C71.0 9401/3 C71.0 YES NO 1.5 NO 80 Left NO 1.6 YES NO YES G3 NO No TCGA-HT-7855.77a245ba-4e68-4215-86d4-2cba5a981189.pdf 7855 Post-Adjuvant Therapy TUMOR FREE NO YES Complete Remission/Response YES Primary Tumor 01 NO NO 0.6 Cerebral Cortex YES NO YES HT Supratentorial, Parietal Lobe Central nervous system A NO LIVING 2008 3fea413e-d892-461c-b0e3-cf07efaf860c TCGA-HT-7855-01A-11D-2399-05 TCGA-HT-7855-01A-11D-2391-01 TCGA-HT-7855-01 3fea413e-d892-461c-b0e3-cf07efaf860c TCGA-HT-7855-01 TCGA-HT-7855-01A-11D-2391-01 3fea413e-d892-461c-b0e3-cf07efaf860c +TCGA-HT-7856-01 TCGA-HT-7856-01 TCGA-HT-7856 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 35 NO NO TCGA-HT-7856-F29423 TCGA-HT-7856 -13145 0 1189 383 NO NO NO Mental Status Changes > 181 Days Scheduled Follow-up Submission Complete Remission/Response NO 2012-3-16 MALE NO YES Oligodendroglioma NO No C71.0 9451/3 C71.0 YES NO 80 Left NO YES NO YES G3 NO No 7856 Adjuvant therapy TUMOR FREE YES YES Complete Remission/Response YES Primary Tumor 01 NO NO White Matter YES NO YES HT Supratentorial, Frontal Lobe Central nervous system NO LIVING 2008 b64f0c76-9109-4e22-9070-0e43837a10b3 TCGA-HT-7856-01A-11D-2399-05 TCGA-HT-7856-01A-11D-2391-01 TCGA-HT-7856-01 b64f0c76-9109-4e22-9070-0e43837a10b3 TCGA-HT-7856-01 TCGA-HT-7856-01A-11D-2391-01 b64f0c76-9109-4e22-9070-0e43837a10b3 +TCGA-HT-7857-01 TCGA-HT-7857-01 TCGA-HT-7857 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 24 NO NO TCGA-HT-7857-F29669 TCGA-HT-7857 TCGA-HT-7857-01A -8912 0 7 NO Motor/Movement Changes 0 - 30 Days Scheduled Follow-up Submission NO 2012-3-15 FEMALE NO YES Astrocytoma NO No C71.0 9401/3 C71.0 YES 1 NO Left 2.3 NO NO YES G3 NO No TCGA-HT-7857.3779c43d-34b9-426a-a59e-9e2379dc2634.pdf 7857 TUMOR FREE YES YES NO Primary Tumor 01 NO NO 0.3 Not listed in Medical Record NO HT Supratentorial, Not Otherwise Specified Central nervous system A YES LIVING 2006 7acf607e-4078-49ff-b3f3-8dcd8eee5db5 TCGA-HT-7857-01A-11D-2399-05 TCGA-HT-7857-01A-11D-2391-01 TCGA-HT-7857-01 7acf607e-4078-49ff-b3f3-8dcd8eee5db5 TCGA-HT-7857-01 TCGA-HT-7857-01A-11D-2391-01 7acf607e-4078-49ff-b3f3-8dcd8eee5db5 +TCGA-HT-7858-01 TCGA-HT-7858-01 TCGA-HT-7858 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 28 NO NO TCGA-HT-7858-F29426 TCGA-HT-7858 TCGA-HT-7858-01A -10422 0 1540 673 NO NO NO Headaches > 181 Days Scheduled Follow-up Submission Complete Remission/Response NO 2012-3-16 MALE NO YES Astrocytoma NO No C71.0 9400/3 C71.0 YES NO 1.8 NO 90 Right NO 2.3 NO NO NO G2 NO No TCGA-HT-7858.203f03ef-f7ed-46ce-9f5f-1c7a41b7fc4f.pdf 7858 Post-Adjuvant Therapy TUMOR FREE Complete Remission/Response YES Primary Tumor 01 NO NO 0.6 White Matter NO NO YES HT Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2007 80d3ddd2-1dbe-4f47-b1f1-b1ea99970332 TCGA-HT-7858-01A-11D-2399-05 TCGA-HT-7858-01A-11D-2391-01 TCGA-HT-7858-01 80d3ddd2-1dbe-4f47-b1f1-b1ea99970332 TCGA-HT-7858-01 TCGA-HT-7858-01A-11D-2391-01 80d3ddd2-1dbe-4f47-b1f1-b1ea99970332 +TCGA-HT-7860-01 TCGA-HT-7860-01 TCGA-HT-7860 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 60 NO NO TCGA-HT-7860-F28643 TCGA-HT-7860 TCGA-HT-7860-01A -22034 0 15 NO Seizures > 181 Days Scheduled Follow-up Submission NO 2012-2-27 FEMALE NO NO Astrocytoma NO No C71.0 9401/3 C71.0 YES NO 1.1 NO Left NO 1.1 NO NO YES G3 No TCGA-HT-7860.281dc713-88c3-485f-96a9-3b84b49d5d6a.pdf 7860 TUMOR FREE YES YES Primary Tumor 01 YES NO 0.6 White Matter NO YES HT Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2009 5ee6524b-9289-45a8-949e-ba0ce44913fe TCGA-HT-7860-01A-11D-2399-05 TCGA-HT-7860-01A-11D-2391-01 TCGA-HT-7860-01 5ee6524b-9289-45a8-949e-ba0ce44913fe TCGA-HT-7860-01 TCGA-HT-7860-01A-11D-2391-01 5ee6524b-9289-45a8-949e-ba0ce44913fe +TCGA-HT-7873-01 TCGA-HT-7873-01 TCGA-HT-7873 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain NO NO 29 NO NO TCGA-HT-7873-F48004 TCGA-HT-7873 TCGA-HT-7873-01B -10805 0 718 NO NO NO Headaches > 181 Days Scheduled Follow-up Submission 2013-9-3 MALE NO YES Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES NO 0.6 NO Right NO 1 NO YES NO YES G2 NO No TCGA-HT-7873.0efa1cbb-8b95-4b63-94bd-3e8829316a90.pdf 7873 WITH TUMOR NO NO Stable Disease YES Primary Tumor 01 NO NO 0.3 White Matter NO NO YES HT Supratentorial, Frontal Lobe Central nervous system B YES LIVING 2011 6c47a99a-ad05-4478-82fd-d57fe8f54f32 TCGA-HT-7873-01B-11D-2399-05 TCGA-HT-7873-01B-11D-2391-01 TCGA-HT-7873-01 6c47a99a-ad05-4478-82fd-d57fe8f54f32 TCGA-HT-7873-01 TCGA-HT-7873-01B-11D-2391-01 6c47a99a-ad05-4478-82fd-d57fe8f54f32 +TCGA-HT-7874-01 TCGA-HT-7874-01 TCGA-HT-7874 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 41 NO NO TCGA-HT-7874-F29422 TCGA-HT-7874 TCGA-HT-7874-01A -15045 0 1130 NO YES NO Headaches > 181 Days Scheduled Follow-up Submission Complete Remission/Response NO 2012-3-16 FEMALE NO YES Oligodendroglioma NO No C71.0 9451/3 C71.0 YES NO 1 NO Right NO 2 YES NO NO G3 NO No TCGA-HT-7874.dee7aaf7-0e9a-454b-a9aa-c31eaed09359.pdf 7874 TUMOR FREE YES YES Complete Remission/Response YES Primary Tumor 01 YES NO 0.6 Not listed in Medical Record YES NO YES HT Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2008 77366e1e-618f-433c-8e6b-e2046a876231 TCGA-HT-7874-01A-11D-2399-05 TCGA-HT-7874-01A-11D-2391-01 TCGA-HT-7874-01 77366e1e-618f-433c-8e6b-e2046a876231 TCGA-HT-7874-01 TCGA-HT-7874-01A-11D-2391-01 77366e1e-618f-433c-8e6b-e2046a876231 +TCGA-HT-7875-01 TCGA-HT-7875-01 TCGA-HT-7875 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 56 NO NO TCGA-HT-7875-F28953 TCGA-HT-7875 TCGA-HT-7875-01A -20613 0 10 0 NO YES NO Seizures 91 - 180 Days Scheduled Follow-up Submission Stable Disease NO 2012-3-2 MALE NO NO Oligodendroglioma NO No C71.0 9450/3 C71.0 YES NO 1.1 NO 80 Left NO 2.4 NO NO NO G2 NO No TCGA-HT-7875.f247c5ba-6d4d-4d31-b3c5-c0dfc3211e9d.pdf 7875 Pre-Adjuvant Therapy TUMOR FREE YES NO Stable Disease YES Primary Tumor 01 YES NO 0.6 White Matter NO NO YES HT Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2008 8028a19b-10cf-4eb9-84ec-d61558b9976b TCGA-HT-7875-01A-11D-2399-05 TCGA-HT-7875-01A-11D-2391-01 TCGA-HT-7875-01 8028a19b-10cf-4eb9-84ec-d61558b9976b TCGA-HT-7875-01 TCGA-HT-7875-01A-11D-2391-01 8028a19b-10cf-4eb9-84ec-d61558b9976b +TCGA-HT-7877-01 TCGA-HT-7877-01 TCGA-HT-7877 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 20 NO NO TCGA-HT-7877-F29672 TCGA-HT-7877 TCGA-HT-7877-01A -7581 0 4 NO NO NO Headaches > 181 Days Scheduled Follow-up Submission NO 2012-3-19 FEMALE YES YES Oligodendroglioma NO No C71.0 9450/3 C71.0 YES 0.8 NO Left 1.2 NO NO YES G2 NO No TCGA-HT-7877.c9bdae23-9523-46e1-8f14-e3c2a94e0200.pdf 7877 TUMOR FREE NO NO NO Primary Tumor 01 NO NO 0.6 White Matter NO NO YES HT Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2011 266003f1-3a9d-413b-9d18-1b2c40c48a22 TCGA-HT-7877-01A-11D-2399-05 TCGA-HT-7877-01A-11D-2391-01 TCGA-HT-7877-01 266003f1-3a9d-413b-9d18-1b2c40c48a22 TCGA-HT-7877-01 TCGA-HT-7877-01A-11D-2391-01 266003f1-3a9d-413b-9d18-1b2c40c48a22 +TCGA-HT-7879-01 TCGA-HT-7879-01 TCGA-HT-7879 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 31 NO NO TCGA-HT-7879-F29673 TCGA-HT-7879 -11622 0 112 NO NO NO Seizures 0 - 30 Days Scheduled Follow-up Submission NO 2012-3-19 MALE NO YES Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES Right NO NO NO G3 NO No 7879 TUMOR FREE YES NO Complete Remission/Response YES Primary Tumor 01 YES NO YES NO YES HT Supratentorial, Temporal Lobe Central nervous system YES LIVING 2011 b74282a3-9f58-4342-8ae5-2fc1cbb4933c TCGA-HT-7879-01A-11D-2399-05 TCGA-HT-7879-01A-11D-2391-01 TCGA-HT-7879-01 b74282a3-9f58-4342-8ae5-2fc1cbb4933c TCGA-HT-7879-01 TCGA-HT-7879-01A-11D-2391-01 b74282a3-9f58-4342-8ae5-2fc1cbb4933c +TCGA-HT-7880-01 TCGA-HT-7880-01 TCGA-HT-7880 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 30 NO NO TCGA-HT-7880-F29680 TCGA-HT-7880 -11043 0 162 NO NO NO Seizures 31 - 90 Days Scheduled Follow-up Submission YES peanuts 2012-3-19 MALE NO YES Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES Right NO NO NO G2 NO No 7880 TUMOR FREE YES YES NO Primary Tumor 01 YES YES White Matter NO NO YES HT Supratentorial, Parietal Lobe Central nervous system NO LIVING 2011 aed81cc7-515a-45f8-9017-bf6df58f2235 TCGA-HT-7880-01A-11D-2399-05 TCGA-HT-7880-01A-11D-2391-01 TCGA-HT-7880-01 aed81cc7-515a-45f8-9017-bf6df58f2235 TCGA-HT-7880-01 TCGA-HT-7880-01A-11D-2391-01 aed81cc7-515a-45f8-9017-bf6df58f2235 +TCGA-HT-7881-01 TCGA-HT-7881-01 TCGA-HT-7881 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 38 NO NO TCGA-HT-7881-F66426 TCGA-HT-7881 -14171 0 1079 NO YES NO Seizures > 181 Days Scheduled Follow-up Submission Complete Remission/Response 2014-10-14 MALE NO NO Oligodendroglioma NO No C71.0 9450/3 C71.0 YES Left NO NO NO NO G2 NO No 7881 TUMOR FREE YES YES Complete Remission/Response YES Primary Tumor 01 YES NO Not listed in Medical Record YES NO YES HT Supratentorial, Temporal Lobe Central nervous system NO LIVING 2011 b675a1c5-e16c-427d-9c47-1b75e8e51f4d TCGA-HT-7881-01A-11D-2399-05 TCGA-HT-7881-01A-11D-2391-01 TCGA-HT-7881-01 b675a1c5-e16c-427d-9c47-1b75e8e51f4d TCGA-HT-7881-01 TCGA-HT-7881-01A-11D-2391-01 b675a1c5-e16c-427d-9c47-1b75e8e51f4d +TCGA-HT-7882-01 TCGA-HT-7882-01 TCGA-HT-7882 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 66 NO NO TCGA-HT-7882-F28952 TCGA-HT-7882 -24450 113 0 52 NO NO NO Seizures > 181 Days Scheduled Follow-up Submission Progressive Disease NO 2012-3-2 MALE NO NO Oligodendroglioma NO No C71.0 9451/3 C71.0 YES NO Left NO YES NO YES G3 NO No 7882 WITH TUMOR YES NO Progressive Disease NO Primary Tumor 01 YES NO Not listed in Medical Record NO NO YES HT Supratentorial, Frontal Lobe Central nervous system NO DECEASED 2010 ad6cc53a-1a99-4e1b-8701-9abf0c975adb TCGA-HT-7882-01A-11D-2399-05 TCGA-HT-7882-01A-11D-2391-01 TCGA-HT-7882-01 ad6cc53a-1a99-4e1b-8701-9abf0c975adb TCGA-HT-7882-01 TCGA-HT-7882-01A-11D-2391-01 ad6cc53a-1a99-4e1b-8701-9abf0c975adb +TCGA-HT-7884-01 TCGA-HT-7884-01 TCGA-HT-7884 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 44 NO YES TCGA-HT-7884-F35005 TCGA-HT-7884 -16280 0 343 112 NO NO NO < 12 Years Mental Status Changes 0 - 30 Days Scheduled Follow-up Submission Stable Disease NO 2012-9-12 FEMALE NO YES Astrocytoma NO No C71.0 9400/3 C71.0 YES NO 80 Left NO NO YES NO NO G2 NO No 7884 Post-Adjuvant Therapy TUMOR FREE YES NO Stable Disease YES Primary Tumor 01 YES NO White Matter YES NO YES HT Supratentorial, Frontal Lobe Central nervous system YES LIVING 2011 aedec7d6-da5f-414f-b200-3b2dc7535182 TCGA-HT-7884-01B-11D-2399-05 TCGA-HT-7884-01B-11D-2391-01 TCGA-HT-7884-01 aedec7d6-da5f-414f-b200-3b2dc7535182 TCGA-HT-7884-01 TCGA-HT-7884-01B-11D-2391-01 aedec7d6-da5f-414f-b200-3b2dc7535182 +TCGA-HT-7902-01 TCGA-HT-7902-01 TCGA-HT-7902 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 30 NO YES TCGA-HT-7902-F28951 TCGA-HT-7902 TCGA-HT-7902-01A -11118 0 956 NO YES YES Visual Changes 31 - 90 Days Scheduled Follow-up Submission Stable Disease NO 2012-3-2 FEMALE NO YES Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES NO 0.8 NO Right NO 1.5 NO NO NO G2 NO No TCGA-HT-7902.bb55771d-e5dc-4625-8c3c-0a6c1aae487d.pdf 7902 TUMOR FREE NO NO Stable Disease NO Primary Tumor 01 NO NO 0.8 Cerebral Cortex NO NO YES HT Supratentorial, Frontal Lobe Central nervous system A YES LIVING 2009 6fbc1aba-a377-4b7e-90ee-d86053187a67 TCGA-HT-7902-01A-12D-2399-05 TCGA-HT-7902-01A-12D-2391-01 TCGA-HT-7902-01 6fbc1aba-a377-4b7e-90ee-d86053187a67 TCGA-HT-7902-01 TCGA-HT-7902-01A-12D-2391-01 6fbc1aba-a377-4b7e-90ee-d86053187a67 +TCGA-HT-8010-01 TCGA-HT-8010-01 TCGA-HT-8010 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 64 NO NO TCGA-HT-8010-F32622 TCGA-HT-8010 -23680 0 50 NO YES NO Motor/Movement Changes > 181 Days Scheduled Follow-up Submission Stable Disease NO 2012-6-4 FEMALE NO YES Oligodendroglioma NO No C71.0 9450/3 C71.0 YES NO Right NO NO NO YES G2 NO No 8010 TUMOR FREE NO NO Stable Disease NO Primary Tumor 01 NO NO Not listed in Medical Record NO NO YES HT Supratentorial, Frontal Lobe Central nervous system NO LIVING 2011 f4a540b2-5ad6-442b-b454-cdb23a4cbacc TCGA-HT-8010-01A-11D-2399-05 TCGA-HT-8010-01A-11D-2391-01 TCGA-HT-8010-01 f4a540b2-5ad6-442b-b454-cdb23a4cbacc TCGA-HT-8010-01 TCGA-HT-8010-01A-11D-2391-01 f4a540b2-5ad6-442b-b454-cdb23a4cbacc +TCGA-HT-8011-01 TCGA-HT-8011-01 TCGA-HT-8011 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain NO NO YES NO 55 NO NO TCGA-HT-8011-F32623 TCGA-HT-8011 TCGA-HT-8011-01A 278 -20175 0 494 278 NO YES YES Seizures 0 - 30 Days Scheduled Follow-up Submission Progressive Disease NO 2012-6-4 MALE NO YES Astrocytoma NO No C71.0 9401/3 C71.0 YES NO 1 NO Right NO 1.3 NO NO NO G3 YES No TCGA-HT-8011.67c30fd5-6ff5-49b7-b0e6-4006ef4510fc.pdf 8011 WITH TUMOR YES NO Stable Disease YES Primary Tumor 01 YES NO 0.6 Not listed in Medical Record YES NO YES HT Supratentorial, Temporal Lobe Central nervous system A NO LIVING 2009 11a26b32-d4df-468f-9a17-b89fba51cf88 TCGA-HT-8011-01A-11D-2399-05 TCGA-HT-8011-01A-11D-2391-01 TCGA-HT-8011-01 11a26b32-d4df-468f-9a17-b89fba51cf88 TCGA-HT-8011-01 TCGA-HT-8011-01A-11D-2391-01 11a26b32-d4df-468f-9a17-b89fba51cf88 +TCGA-HT-8012-01 TCGA-HT-8012-01 TCGA-HT-8012 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain NO NO YES NO 30 NO NO TCGA-HT-8012-F32626 TCGA-HT-8012 133 -11295 0 286 133 NO NO NO Seizures 0 - 30 Days Scheduled Follow-up Submission Stable Disease NO 2012-6-4 FEMALE NO NO Oligodendroglioma NO No C71.0 9450/3 C71.0 YES NO Right NO NO NO NO G2 YES No 8012 WITH TUMOR YES NO Stable Disease NO Primary Tumor 01 YES NO Not listed in Medical Record NO NO YES HT Supratentorial, Temporal Lobe Central nervous system NO LIVING 2010 f389cc26-dd87-44ca-8ceb-fc926d073f4a TCGA-HT-8012-01A-11D-2399-05 TCGA-HT-8012-01A-11D-2391-01 TCGA-HT-8012-01 f389cc26-dd87-44ca-8ceb-fc926d073f4a TCGA-HT-8012-01 TCGA-HT-8012-01A-11D-2391-01 f389cc26-dd87-44ca-8ceb-fc926d073f4a +TCGA-HT-8013-01 TCGA-HT-8013-01 TCGA-HT-8013 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain YES YES YES NO 37 NO NO TCGA-HT-8013-F32627 TCGA-HT-8013 TCGA-HT-8013-01A 1306 -13753 1933 0 1306 1587 NO NO NO Seizures 0 - 30 Days Scheduled Follow-up Submission NO 2012-6-4 FEMALE NO NO Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES NO 0.8 NO 70 Left NO 0.8 YES NO NO G2 YES No TCGA-HT-8013.9f364b5b-ead4-42a4-a802-f398e08f1dfc.pdf 8013 Post-Adjuvant Therapy WITH TUMOR YES NO Stable Disease YES Primary Tumor 01 YES NO 0.8 Cerebral Cortex YES NO YES HT Supratentorial, Frontal Lobe Central nervous system A NO DECEASED 2005 2181e8a6-db87-49e9-ad56-582b345abcc2 TCGA-HT-8013-01A-11D-2399-05 TCGA-HT-8013-01A-11D-2391-01 TCGA-HT-8013-01 2181e8a6-db87-49e9-ad56-582b345abcc2 TCGA-HT-8013-01 TCGA-HT-8013-01A-11D-2391-01 2181e8a6-db87-49e9-ad56-582b345abcc2 +TCGA-HT-8015-01 TCGA-HT-8015-01 TCGA-HT-8015 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 21 TCGA-HT-8015 TCGA-HT-8015-01B -7760 1483 0 3 2013-9-12 MALE Astrocytoma NO No C71.0 9400/3 C71.0 YES 660 NO Left G2 true No TCGA-HT-8015.555DEE9A-4BA2-4E0A-A76E-06972079094A.pdf 8015 TUMOR FREE Complete Remission/Response Primary Tumor 01 Deep Gray (e.g.basal ganglia, thalamus) NO YES HT Supratentorial, Temporal Lobe Central nervous system B LIVING 2008 32791ace-3fb3-43cb-8f98-278ac1e18a25 TCGA-HT-8015-01B-11D-A28N-05 TCGA-HT-8015-01B-11D-A288-01 TCGA-HT-8015-01 32791ace-3fb3-43cb-8f98-278ac1e18a25 TCGA-HT-8015-01 TCGA-HT-8015-01B-11D-A288-01 32791ace-3fb3-43cb-8f98-278ac1e18a25 +TCGA-HT-8018-01 TCGA-HT-8018-01 TCGA-HT-8018 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 40 NO NO TCGA-HT-8018-F45912 TCGA-HT-8018 TCGA-HT-8018-01A -14910 1152 0 654 NO NO NO Seizures 0 - 30 Days Scheduled Follow-up Submission Progressive Disease NO 2013-7-25 FEMALE NO YES Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES NO 0.9 NO Left NO 1.3 NO NO NO YES G2 NO No TCGA-HT-8018.3c1686b7-7a13-43cd-9d42-e4f564b75423.pdf 8018 TUMOR FREE Partial Remission/Response YES Primary Tumor 01 YES NO 0.9 White Matter YES NO YES HT Supratentorial, Temporal Lobe Central nervous system A NO DECEASED 2010 2398c528-0e80-4c72-a5cc-cd82c7895468 TCGA-HT-8018-01A-11D-2399-05 TCGA-HT-8018-01A-11D-2391-01 TCGA-HT-8018-01 2398c528-0e80-4c72-a5cc-cd82c7895468 TCGA-HT-8018-01 TCGA-HT-8018-01A-11D-2391-01 2398c528-0e80-4c72-a5cc-cd82c7895468 +TCGA-HT-8019-01 TCGA-HT-8019-01 TCGA-HT-8019 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 34 NO NO TCGA-HT-8019-F46178 TCGA-HT-8019 -12669 0 1004 NO YES NO Seizures 0 - 30 Days Scheduled Follow-up Submission Complete Remission/Response NO 2013-9-18 FEMALE NO YES Oligodendroglioma NO No C71.0 9451/3 C71.0 YES NO Right NO NO NO NO NO G3 NO No 8019 TUMOR FREE Complete Remission/Response YES Primary Tumor 01 YES NO White Matter YES NO YES HT Supratentorial, Frontal Lobe Central nervous system NO LIVING 2009 e73d9fe9-8abb-454e-9b62-90bde2e5c5a9 TCGA-HT-8019-01A-21D-2399-05 TCGA-HT-8019-01A-21D-2391-01 TCGA-HT-8019-01 e73d9fe9-8abb-454e-9b62-90bde2e5c5a9 TCGA-HT-8019-01 TCGA-HT-8019-01A-21D-2391-01 e73d9fe9-8abb-454e-9b62-90bde2e5c5a9 +TCGA-HT-8104-01 TCGA-HT-8104-01 TCGA-HT-8104 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 51 NO NO TCGA-HT-8104-F45987 TCGA-HT-8104 TCGA-HT-8104-01A -18748 0 372 NO NO NO Motor/Movement Changes 0 - 30 Days Scheduled Follow-up Submission NO 2013-7-26 FEMALE NO NO Astrocytoma NO No C71.0 9401/3 C71.0 YES NO 0.7 NO Left NO 1.3 YES NO NO YES G3 No TCGA-HT-8104.be808788-d11d-4e91-8b52-6d830d1cb5ce.pdf 8104 TUMOR FREE NO NO Primary Tumor 01 NO NO 0.7 White Matter NO YES HT Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2010 3c4590d9-788e-4e04-a7e8-b912698ebb74 TCGA-HT-8104-01A-11D-2399-05 TCGA-HT-8104-01A-11D-2391-01 TCGA-HT-8104-01 3c4590d9-788e-4e04-a7e8-b912698ebb74 TCGA-HT-8104-01 TCGA-HT-8104-01A-11D-2391-01 3c4590d9-788e-4e04-a7e8-b912698ebb74 +TCGA-HT-8105-01 TCGA-HT-8105-01 TCGA-HT-8105 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 54 NO NO TCGA-HT-8105-F32624 TCGA-HT-8105 TCGA-HT-8105-01A -20041 0 190 190 NO NO NO Mental Status Changes 31 - 90 Days Scheduled Follow-up Submission Stable Disease NO 2012-6-4 MALE NO NO Oligodendroglioma NO No C71.0 9451/3 C71.0 YES NO 1 NO 70 Right NO 1.6 YES NO YES G3 NO No TCGA-HT-8105.d7c51467-5baa-4858-86bd-cfb6d9344a05.pdf 8105 TUMOR FREE NO NO Stable Disease YES Primary Tumor 01 YES NO 1 Not listed in Medical Record NO NO YES HT Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2011 75016f4c-257e-4e24-9e91-5ab4b8c53e5a TCGA-HT-8105-01A-11D-2399-05 TCGA-HT-8105-01A-11D-2391-01 TCGA-HT-8105-01 75016f4c-257e-4e24-9e91-5ab4b8c53e5a TCGA-HT-8105-01 TCGA-HT-8105-01A-11D-2391-01 75016f4c-257e-4e24-9e91-5ab4b8c53e5a +TCGA-HT-8106-01 TCGA-HT-8106-01 TCGA-HT-8106 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 53 NO NO TCGA-HT-8106-F32632 TCGA-HT-8106 TCGA-HT-8106-01A -19555 0 3 NO NO NO Seizures 0 - 30 Days Scheduled Follow-up Submission Stable Disease NO 2012-6-4 MALE NO NO Astrocytoma NO No C71.0 9401/3 C71.0 YES NO 0.9 NO Midline NO 1.2 NO NO NO G3 NO No TCGA-HT-8106.aebc4408-92f6-404c-b9e6-9bb7e46c700f.pdf 8106 TUMOR FREE NO NO Stable Disease NO Primary Tumor 01 YES NO 0.5 Not listed in Medical Record NO NO YES HT Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2010 1b95fcab-d55c-49b8-b3eb-0b156ca02812 TCGA-HT-8106-01A-11D-2399-05 TCGA-HT-8106-01A-11D-2391-01 TCGA-HT-8106-01 1b95fcab-d55c-49b8-b3eb-0b156ca02812 TCGA-HT-8106-01 TCGA-HT-8106-01A-11D-2391-01 1b95fcab-d55c-49b8-b3eb-0b156ca02812 +TCGA-HT-8107-01 TCGA-HT-8107-01 TCGA-HT-8107 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 62 NO NO TCGA-HT-8107-F32633 TCGA-HT-8107 TCGA-HT-8107-01A -22880 0 14 NO NO NO Mental Status Changes 0 - 30 Days Scheduled Follow-up Submission Stable Disease NO 2012-6-4 MALE NO NO Oligodendroglioma NO No C71.0 9450/3 C71.0 YES NO 0.6 NO Left NO 1 YES NO NO G2 NO No TCGA-HT-8107.4e4564f4-1ebf-4d0d-a461-90f866c4ec42.pdf 8107 TUMOR FREE YES NO Stable Disease NO Primary Tumor 01 YES NO 0.4 Not listed in Medical Record NO NO YES HT Supratentorial, Parietal Lobe Central nervous system A NO LIVING 2011 3129849c-97e6-4e22-b7d1-dd3ab7fb81d8 TCGA-HT-8107-01A-13D-2399-05 TCGA-HT-8107-01A-13D-2391-01 TCGA-HT-8107-01 3129849c-97e6-4e22-b7d1-dd3ab7fb81d8 TCGA-HT-8107-01 TCGA-HT-8107-01A-13D-2391-01 3129849c-97e6-4e22-b7d1-dd3ab7fb81d8 +TCGA-HT-8108-01 TCGA-HT-8108-01 TCGA-HT-8108 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 26 NO NO TCGA-HT-8108-F32634 TCGA-HT-8108 TCGA-HT-8108-01A -9539 0 76 NO YES YES Headaches 0 - 30 Days Scheduled Follow-up Submission Stable Disease NO 2012-6-4 FEMALE NO YES Oligodendroglioma NO No C71.0 9450/3 C71.0 YES NO 0.6 NO Left NO 0.7 NO NO NO G2 NO No TCGA-HT-8108.8e2e0a3b-afd5-4077-b95f-ddc7014c08cb.pdf 8108 TUMOR FREE NO NO Stable Disease NO Primary Tumor 01 NO NO 0.3 White Matter NO NO YES HT Supratentorial, Parietal Lobe Central nervous system A YES LIVING 2011 4743ae20-4a24-475b-9d1a-3def852738b3 TCGA-HT-8108-01A-11D-2399-05 TCGA-HT-8108-01A-11D-2391-01 TCGA-HT-8108-01 4743ae20-4a24-475b-9d1a-3def852738b3 TCGA-HT-8108-01 TCGA-HT-8108-01A-11D-2391-01 4743ae20-4a24-475b-9d1a-3def852738b3 +TCGA-HT-8109-01 TCGA-HT-8109-01 TCGA-HT-8109 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 64 NO NO TCGA-HT-8109-F45921 TCGA-HT-8109 TCGA-HT-8109-01A -23486 0 169 NO NO NO Mental Status Changes > 181 Days Scheduled Follow-up Submission NO 2013-7-25 MALE NO NO Oligodendroglioma NO No C71.0 9451/3 C71.0 YES NO 0.8 NO Right NO 1.1 YES YES NO NO G3 No TCGA-HT-8109.ae84e661-5ec1-46e2-ac49-4b01e0bc288a.pdf 8109 TUMOR FREE YES YES YES Primary Tumor 01 NO NO 0.6 White Matter YES NO YES HT Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2011 2242fa55-5ea8-4143-92aa-f5bab77f6cec TCGA-HT-8109-01A-11D-2399-05 TCGA-HT-8109-01A-11D-2391-01 TCGA-HT-8109-01 2242fa55-5ea8-4143-92aa-f5bab77f6cec TCGA-HT-8109-01 TCGA-HT-8109-01A-11D-2391-01 2242fa55-5ea8-4143-92aa-f5bab77f6cec +TCGA-HT-8110-01 TCGA-HT-8110-01 TCGA-HT-8110 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 57 NO NO TCGA-HT-8110-F43794 TCGA-HT-8110 TCGA-HT-8110-01A -21183 0 419 NO YES NO Visual Changes 0 - 30 Days Scheduled Follow-up Submission Complete Remission/Response NO 2013-7-26 MALE NO YES Astrocytoma NO No C71.0 9401/3 C71.0 YES NO 0.9 NO Right NO 1.6 NO YES NO NO G3 NO No TCGA-HT-8110.c423008b-608e-4260-b36c-21135a7fcd82.pdf 8110 TUMOR FREE Complete Remission/Response YES Primary Tumor 01 NO NO 0.9 White Matter NO YES HT Supratentorial, Parietal Lobe Central nervous system A YES LIVING 2011 3a1dd504-78ab-4d25-8f28-2f077a511946 TCGA-HT-8110-01A-11D-2399-05 TCGA-HT-8110-01A-11D-2391-01 TCGA-HT-8110-01 3a1dd504-78ab-4d25-8f28-2f077a511946 TCGA-HT-8110-01 TCGA-HT-8110-01A-11D-2391-01 3a1dd504-78ab-4d25-8f28-2f077a511946 +TCGA-HT-8111-01 TCGA-HT-8111-01 TCGA-HT-8111 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 32 NO NO TCGA-HT-8111-F66396 TCGA-HT-8111 -11810 0 7 NO NO Seizures 0 - 30 Days Scheduled Follow-up Submission NO 2014-10-14 MALE NO YES Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES Left NO YES YES NO NO G3 No 8111 YES NO Primary Tumor 01 YES NO White Matter NO YES HT Supratentorial, Frontal Lobe Central nervous system NO LIVING 2011 f68cffac-4db9-470c-b726-01fb876a381a TCGA-HT-8111-01A-11D-2399-05 TCGA-HT-8111-01A-11D-2391-01 TCGA-HT-8111-01 f68cffac-4db9-470c-b726-01fb876a381a TCGA-HT-8111-01 TCGA-HT-8111-01A-11D-2391-01 f68cffac-4db9-470c-b726-01fb876a381a +TCGA-HT-8113-01 TCGA-HT-8113-01 TCGA-HT-8113 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 49 NO YES TCGA-HT-8113-F32197 TCGA-HT-8113 -18173 0 900 102 NO NO NO Seizures 0 - 30 Days Scheduled Follow-up Submission NO 2012-5-17 FEMALE NO YES Oligodendroglioma NO No C71.0 9450/3 C71.0 YES 90 Left NO NO NO G2 NO No 8113 TUMOR FREE YES NO Complete Remission/Response YES Primary Tumor 01 YES NO White Matter YES NO YES HT Supratentorial, Frontal Lobe Central nervous system NO LIVING 2006 fad69aee-febe-4893-86a4-e71c0b22b9f4 TCGA-HT-8113-01A-11D-2399-05 TCGA-HT-8113-01A-11D-2391-01 TCGA-HT-8113-01 fad69aee-febe-4893-86a4-e71c0b22b9f4 TCGA-HT-8113-01 TCGA-HT-8113-01A-11D-2391-01 fad69aee-febe-4893-86a4-e71c0b22b9f4 +TCGA-HT-8114-01 TCGA-HT-8114-01 TCGA-HT-8114 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 36 NO NO TCGA-HT-8114-F66394 TCGA-HT-8114 TCGA-HT-8114-01A -13198 0 1040 NO NO NO Headaches 0 - 30 Days Scheduled Follow-up Submission Complete Remission/Response NO 2014-10-14 MALE NO YES Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES 0.8 NO Left NO 2 NO YES NO YES G3 NO No TCGA-HT-8114.8aa9d827-a738-4750-af50-c0886cc64aeb.pdf 8114 TUMOR FREE NO NO Complete Remission/Response YES Primary Tumor 01 NO NO 0.6 White Matter YES NO YES HT Supratentorial, Parietal Lobe Central nervous system A YES LIVING 2011 5007c6f5-2134-4d0e-8d53-13a0f1439d9e TCGA-HT-8114-01A-11D-2399-05 TCGA-HT-8114-01A-11D-2391-01 TCGA-HT-8114-01 5007c6f5-2134-4d0e-8d53-13a0f1439d9e TCGA-HT-8114-01 TCGA-HT-8114-01A-11D-2391-01 5007c6f5-2134-4d0e-8d53-13a0f1439d9e +TCGA-HT-8558-01 TCGA-HT-8558-01 TCGA-HT-8558 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 29 NO NO TCGA-HT-8558-F48474 TCGA-HT-8558 -10950 0 418 Seizures 31 - 90 Days Scheduled Follow-up Submission Complete Remission/Response NO 2013-9-13 FEMALE NO YES Oligodendroglioma NO No C71.0 9450/3 C71.0 YES Left YES NO NO NO G2 NO No 8558 TUMOR FREE YES YES Complete Remission/Response NO Primary Tumor 01 YES NO Not listed in Medical Record NO NO YES HT Supratentorial, Temporal Lobe Central nervous system NO LIVING 2011 db75b249-f02e-47d8-ba4c-37a5ba7c4b33 TCGA-HT-8558-01A-21D-2399-05 TCGA-HT-8558-01 db75b249-f02e-47d8-ba4c-37a5ba7c4b33 db75b249-f02e-47d8-ba4c-37a5ba7c4b33 +TCGA-HT-8563-01 TCGA-HT-8563-01 TCGA-HT-8563 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 30 TCGA-HT-8563-F61084 TCGA-HT-8563 TCGA-HT-8563-01A -11305 0 860 NO > 20 Years Headaches 0 - 30 Days Scheduled Follow-up Submission Complete Remission/Response 2014-6-23 FEMALE YES YES Astrocytoma NO No C71.0 9401/3 C71.0 YES 0.6 NO Right 0.7 NO NO NO G3 NO No TCGA-HT-8563.5a5ea09f-fbc2-43a7-a135-7db5b681ae76.pdf 8563 TUMOR FREE Complete Remission/Response YES Primary Tumor 01 NO NO 0.2 Cerebral Cortex NO NO YES HT Supratentorial, Frontal Lobe Central nervous system A YES LIVING 2011 456b83a3-79b9-41ec-8745-95c57c67ab60 TCGA-HT-8563-01A-11D-2399-05 TCGA-HT-8563-01A-11D-2391-01 TCGA-HT-8563-01 456b83a3-79b9-41ec-8745-95c57c67ab60 TCGA-HT-8563-01 TCGA-HT-8563-01A-11D-2391-01 456b83a3-79b9-41ec-8745-95c57c67ab60 +TCGA-HT-8564-01 TCGA-HT-8564-01 TCGA-HT-8564 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain YES NO 47 NO NO TCGA-HT-8564-F48467 TCGA-HT-8564 TCGA-HT-8564-01A -17499 0 478 120 NO NO NO Mental Status Changes > 181 Days Scheduled Follow-up Submission Progressive Disease NO 2013-9-13 MALE NO NO Astrocytoma NO No C71.0 9401/3 C71.0 YES 0.4 NO 80 Left 0.7 NO YES NO NO G3 YES No TCGA-HT-8564.2809249b-fed4-4b7a-b221-10a606c30bce.pdf 8564 Post-Adjuvant Therapy WITH TUMOR Progressive Disease NO Primary Tumor 01 NO NO 0.3 Not listed in Medical Record YES NO YES HT Supratentorial, Temporal Lobe Central nervous system A NO LIVING 2012 6899de21-8648-45fa-a519-679b0438f848 TCGA-HT-8564-01A-11D-2399-05 TCGA-HT-8564-01A-11D-2391-01 TCGA-HT-8564-01 6899de21-8648-45fa-a519-679b0438f848 TCGA-HT-8564-01 TCGA-HT-8564-01A-11D-2391-01 6899de21-8648-45fa-a519-679b0438f848 +TCGA-HT-A4DS-01 TCGA-HT-A4DS-01 TCGA-HT-A4DS TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 55 TCGA-HT-A4DS-F61277 TCGA-HT-A4DS TCGA-HT-A4DS-01A -20296 137 0 7 NO YES NO Seizures 0 - 30 Days Scheduled Follow-up Submission 2014-6-26 FEMALE NO Astrocytoma NO No C71.0 9401/3 C71.0 YES 80 NO Right NO YES NO NO G3 true No TCGA-HT-A4DS.3E2FDB9A-0295-493E-8F8D-C501FA1B3172.pdf A4DS TUMOR FREE YES YES Primary Tumor 01 YES YES Not listed in Medical Record NO YES HT Supratentorial, Temporal Lobe Central nervous system A NO LIVING 2012 8aa3351e-ac40-409f-a2b9-4febbf3e0c47 TCGA-HT-A4DS-01A-11D-A26N-05 TCGA-HT-A4DS-01A-11D-A26L-01 TCGA-HT-A4DS-01 8aa3351e-ac40-409f-a2b9-4febbf3e0c47 TCGA-HT-A4DS-01 TCGA-HT-A4DS-01A-11D-A26L-01 8aa3351e-ac40-409f-a2b9-4febbf3e0c47 +TCGA-HT-A4DV-01 TCGA-HT-A4DV-01 TCGA-HT-A4DV TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 51 TCGA-HT-A4DV-F61274 TCGA-HT-A4DV TCGA-HT-A4DV-01A -18799 141 0 792 14 YES NO Seizures 31 - 90 Days Scheduled Follow-up Submission 2014-6-26 FEMALE NO Oligodendroglioma NO No C71.0 9451/3 C71.0 YES 360 NO 90 Left NO NO NO NO G3 NO true No TCGA-HT-A4DV.A5D9C1B2-9F81-42BD-927B-F6FC22F38F62.pdf A4DV Post-Adjuvant Therapy TUMOR FREE YES YES Partial Remission/Response YES Primary Tumor 01 YES NO White Matter YES NO YES HT Supratentorial, Frontal Lobe Central nervous system A YES LIVING 2012 8d03eb0d-b6f2-4b28-aa26-4de13bd37270 TCGA-HT-A4DV-01A-11D-A26N-05 TCGA-HT-A4DV-01A-11D-A26L-01 TCGA-HT-A4DV-01 8d03eb0d-b6f2-4b28-aa26-4de13bd37270 TCGA-HT-A4DV-01 TCGA-HT-A4DV-01A-11D-A26L-01 8d03eb0d-b6f2-4b28-aa26-4de13bd37270 +TCGA-HT-A5R5-01 TCGA-HT-A5R5-01 TCGA-HT-A5R5 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 33 TCGA-HT-A5R5-F61085 TCGA-HT-A5R5 TCGA-HT-A5R5-01A -12403 194 0 4 NO NO Seizures 31 - 90 Days Scheduled Follow-up Submission 2014-6-23 FEMALE Oligodendroglioma NO No C71.0 9450/3 C71.0 YES 260 NO Left YES NO YES G2 true No TCGA-HT-A5R5.9A308F04-2E34-40CB-97FC-A3A5D111FA25.pdf A5R5 TUMOR FREE Complete Remission/Response Primary Tumor 01 YES NO Not listed in Medical Record NO YES HT Supratentorial, Temporal Lobe Central nervous system A NO LIVING 2012 3d55fa54-f618-4790-840a-7d2a02ee3b3d TCGA-HT-A5R5-01A-11D-A28N-05 TCGA-HT-A5R5-01A-11D-A288-01 TCGA-HT-A5R5-01 3d55fa54-f618-4790-840a-7d2a02ee3b3d TCGA-HT-A5R5-01 TCGA-HT-A5R5-01A-11D-A288-01 3d55fa54-f618-4790-840a-7d2a02ee3b3d +TCGA-HT-A5R7-01 TCGA-HT-A5R7-01 TCGA-HT-A5R7 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 33 TCGA-HT-A5R7-F61086 TCGA-HT-A5R7 TCGA-HT-A5R7-01A -12092 147 0 615 YES NO Seizures 0 - 30 Days Scheduled Follow-up Submission Complete Remission/Response 2014-6-23 FEMALE NO Astrocytoma NO No C71.0 9401/3 C71.0 YES 310 NO 90 Right YES NO NO YES G3 NO true No TCGA-HT-A5R7.0C8ED6F2-0B6A-4316-A53C-EF42BCB47E39.pdf A5R7 Post-Adjuvant Therapy TUMOR FREE YES Complete Remission/Response YES Primary Tumor 01 YES NO Not listed in Medical Record YES NO YES HT Supratentorial, Parietal Lobe Central nervous system A NO LIVING 2012 8022301e-d815-4601-922b-027399c9d279 TCGA-HT-A5R7-01A-11D-A28N-05 TCGA-HT-A5R7-01A-11D-A288-01 TCGA-HT-A5R7-01 8022301e-d815-4601-922b-027399c9d279 TCGA-HT-A5R7-01 TCGA-HT-A5R7-01A-11D-A288-01 8022301e-d815-4601-922b-027399c9d279 +TCGA-HT-A5R9-01 TCGA-HT-A5R9-01 TCGA-HT-A5R9 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 48 NO TCGA-HT-A5R9-F61080 TCGA-HT-A5R9 TCGA-HT-A5R9-01A -17775 79 0 2 NO NO NO Seizures 0 - 30 Days Scheduled Follow-up Submission 2014-6-26 FEMALE NO NO Oligodendroglioma NO No C71.0 9451/3 C71.0 YES 390 NO Right NO YES NO NO NO G3 true No TCGA-HT-A5R9.D35BB9FB-030C-4B30-AE08-FFB1B39CAD6D.pdf A5R9 Primary Tumor 01 YES NO Not listed in Medical Record NO YES HT Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2012 922a7345-64a7-43e8-9c11-bb0bd85dd847 TCGA-HT-A5R9-01A-11D-A28N-05 TCGA-HT-A5R9-01A-11D-A288-01 TCGA-HT-A5R9-01 922a7345-64a7-43e8-9c11-bb0bd85dd847 TCGA-HT-A5R9-01 TCGA-HT-A5R9-01A-11D-A288-01 922a7345-64a7-43e8-9c11-bb0bd85dd847 +TCGA-HT-A5RA-01 TCGA-HT-A5RA-01 TCGA-HT-A5RA TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 65 NO NO TCGA-HT-A5RA-F61263 TCGA-HT-A5RA TCGA-HT-A5RA-01A -23769 385 0 832 244 NO YES NO Seizures 31 - 90 Days Scheduled Follow-up Submission Partial Remission/Response NO 2014-6-26 FEMALE NO NO Astrocytoma NO No C71.0 9401/3 C71.0 YES 70 NO 70 Right NO NO NO NO G3 NO true No TCGA-HT-A5RA.4FF0C3AD-41E6-4814-9ED9-ED40691DE316.pdf A5RA Post-Adjuvant Therapy WITH TUMOR Partial Remission/Response YES Primary Tumor 01 YES NO Not listed in Medical Record YES NO YES HT Supratentorial, Temporal Lobe Central nervous system A NO LIVING 2012 2b4e9c4e-0f22-4251-947f-0e23a1fbbe62 TCGA-HT-A5RA-01A-11D-A28N-05 TCGA-HT-A5RA-01A-11D-A288-01 TCGA-HT-A5RA-01 2b4e9c4e-0f22-4251-947f-0e23a1fbbe62 TCGA-HT-A5RA-01 TCGA-HT-A5RA-01A-11D-A288-01 2b4e9c4e-0f22-4251-947f-0e23a1fbbe62 +TCGA-HT-A5RB-01 TCGA-HT-A5RB-01 TCGA-HT-A5RB TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 24 NO TCGA-HT-A5RB-F61266 TCGA-HT-A5RB TCGA-HT-A5RB-01A -8820 597 0 3 NO NO NO Seizures 0 - 30 Days Scheduled Follow-up Submission 2014-6-26 MALE NO NO Astrocytoma NO No C71.0 9400/3 C71.0 YES 320 NO Right YES NO NO NO G2 true No TCGA-HT-A5RB.3DDDF9B9-4EB3-4098-8898-98868D2416D3.pdf A5RB YES NO Primary Tumor 01 YES NO Not listed in Medical Record NO YES HT Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2011 53caa54a-c88e-423e-a33c-9e8d69daf2cd TCGA-HT-A5RB-01A-11D-A28N-05 TCGA-HT-A5RB-01A-11D-A288-01 TCGA-HT-A5RB-01 53caa54a-c88e-423e-a33c-9e8d69daf2cd TCGA-HT-A5RB-01 TCGA-HT-A5RB-01A-11D-A288-01 53caa54a-c88e-423e-a33c-9e8d69daf2cd +TCGA-HT-A5RC-01 TCGA-HT-A5RC-01 TCGA-HT-A5RC TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 70 TCGA-HT-A5RC TCGA-HT-A5RC-01A -25772 140 162 0 NO NO Mental Status Changes 0 - 30 Days 2013-7-29 FEMALE NO Astrocytoma NO No C71.0 9401/3 C71.0 YES 60 NO 40 Left YES YES G3 NO true No TCGA-HT-A5RC.A17D7270-D512-4F3F-B40C-588337E9222E.pdf A5RC Post-Adjuvant Therapy WITH TUMOR Progressive Disease YES Primary Tumor 01 NO NO Not listed in Medical Record YES NO YES HT Supratentorial, Frontal Lobe Central nervous system A NO DECEASED 2012 07c85322-ff5e-4e17-b6d8-bec6305fe14e TCGA-HT-A5RC-01A-11D-A28N-05 TCGA-HT-A5RC-01A-11D-A288-01 TCGA-HT-A5RC-01 07c85322-ff5e-4e17-b6d8-bec6305fe14e TCGA-HT-A5RC-01 TCGA-HT-A5RC-01A-11D-A288-01 07c85322-ff5e-4e17-b6d8-bec6305fe14e +TCGA-HT-A614-01 TCGA-HT-A614-01 TCGA-HT-A614 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 47 TCGA-HT-A614-F61087 TCGA-HT-A614 TCGA-HT-A614-01A -17392 78 0 82 Headaches > 181 Days Scheduled Follow-up Submission Partial Remission/Response 2014-6-23 MALE YES Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES 130 NO Right YES YES YES G2 false No TCGA-HT-A614.9E38FBA2-A9D8-4428-B586-A0C7E711EA14.pdf A614 WITH TUMOR YES Partial Remission/Response Primary Tumor 01 YES YES Not listed in Medical Record NO YES HT Supratentorial, Not Otherwise Specified Central nervous system A NO LIVING 2013 5a3d8ba7-dea1-4155-9345-c542719b29f4 TCGA-HT-A614-01A-11D-A29T-05 TCGA-HT-A614-01A-11D-A323-01 TCGA-HT-A614-01 5a3d8ba7-dea1-4155-9345-c542719b29f4 TCGA-HT-A614-01 TCGA-HT-A614-01A-11D-A323-01 5a3d8ba7-dea1-4155-9345-c542719b29f4 +TCGA-HT-A615-01 TCGA-HT-A615-01 TCGA-HT-A615 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 38 NO TCGA-HT-A615-F66402 TCGA-HT-A615 TCGA-HT-A615-01A -13892 300 0 515 271 NO YES NO Seizures 0 - 30 Days Scheduled Follow-up Submission Complete Remission/Response 2014-10-14 FEMALE NO Oligodendroglioma NO No C71.0 9450/3 C71.0 YES 140 NO 90 Left NO NO NO G2 NO false No TCGA-HT-A615.34BD1967-CF9D-4B21-866A-BB100739E1C9.pdf A615 Post-Adjuvant Therapy TUMOR FREE Complete Remission/Response YES Primary Tumor 01 YES NO Not listed in Medical Record NO NO YES HT Supratentorial, Temporal Lobe Central nervous system A NO LIVING 2012 6a2adcf5-fc75-46a4-a029-dd84d1a019c0 TCGA-HT-A615-01A-11D-A29T-05 TCGA-HT-A615-01A-11D-A323-01 TCGA-HT-A615-01 6a2adcf5-fc75-46a4-a029-dd84d1a019c0 TCGA-HT-A615-01 TCGA-HT-A615-01A-11D-A323-01 6a2adcf5-fc75-46a4-a029-dd84d1a019c0 +TCGA-HT-A616-01 TCGA-HT-A616-01 TCGA-HT-A616 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 36 NO NO TCGA-HT-A616-F61270 TCGA-HT-A616 TCGA-HT-A616-01A -13222 70 0 55 NO YES NO Seizures 31 - 90 Days Scheduled Follow-up Submission 2014-6-26 FEMALE NO NO Astrocytoma NO No C71.0 9400/3 C71.0 YES 290 NO Left YES NO NO NO G2 false No TCGA-HT-A616.65CCB3E5-56CE-4D6F-A6F5-4D1729A9BBF8.pdf A616 NO Primary Tumor 01 YES NO Not listed in Medical Record NO NO YES HT Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2013 80f78f2f-4e63-4561-905e-a81528b79cab TCGA-HT-A616-01A-11D-A29T-05 TCGA-HT-A616-01A-11D-A323-01 TCGA-HT-A616-01 80f78f2f-4e63-4561-905e-a81528b79cab TCGA-HT-A616-01 TCGA-HT-A616-01A-11D-A323-01 80f78f2f-4e63-4561-905e-a81528b79cab +TCGA-HT-A617-01 TCGA-HT-A617-01 TCGA-HT-A617 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 47 NO TCGA-HT-A617-F61272 TCGA-HT-A617 -17331 0 491 486 NO NO NO Seizures 31 - 90 Days Scheduled Follow-up Submission 2014-6-26 MALE NO NO Oligodendroglioma NO No C71.0 9450/3 C71.0 YES 60 Right NO YES NO NO NO G2 YES No A617 Post-Adjuvant Therapy YES NO Progressive Disease Primary Tumor 01 YES NO Not listed in Medical Record NO YES HT Supratentorial, Not Otherwise Specified Central nervous system NO LIVING 2010 e621d7be-8167-4260-adff-ce1b57202eaf TCGA-HT-A617-01A-11D-A29T-05 TCGA-HT-A617-01A-11D-A323-01 TCGA-HT-A617-01 e621d7be-8167-4260-adff-ce1b57202eaf TCGA-HT-A617-01 TCGA-HT-A617-01A-11D-A323-01 e621d7be-8167-4260-adff-ce1b57202eaf +TCGA-HT-A618-01 TCGA-HT-A618-01 TCGA-HT-A618 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 37 TCGA-HT-A618-F61273 TCGA-HT-A618 TCGA-HT-A618-01A -13595 71 0 512 62 NO NO Mental Status Changes 0 - 30 Days Scheduled Follow-up Submission Complete Remission/Response 2014-6-26 FEMALE NO Astrocytoma NO No C71.0 9401/3 C71.0 YES 130 NO 80 NO YES YES G3 NO false No TCGA-HT-A618.1E45E711-0DF2-43BD-8E84-888813B93769.pdf A618 Pre-Adjuvant Therapy TUMOR FREE Complete Remission/Response NO Primary Tumor 01 YES Not listed in Medical Record NO NO YES HT Supratentorial, Temporal Lobe Central nervous system A NO LIVING 2013 08a9d6fb-2367-4bd2-b828-c1d970dc62a8 TCGA-HT-A618-01A-11D-A29T-05 TCGA-HT-A618-01A-11D-A323-01 TCGA-HT-A618-01 08a9d6fb-2367-4bd2-b828-c1d970dc62a8 TCGA-HT-A618-01 TCGA-HT-A618-01A-11D-A323-01 08a9d6fb-2367-4bd2-b828-c1d970dc62a8 +TCGA-HT-A619-01 TCGA-HT-A619-01 TCGA-HT-A619 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 51 TCGA-HT-A619-F66412 TCGA-HT-A619 TCGA-HT-A619-01A -18857 84 0 651 Motor/Movement Changes 0 - 30 Days Scheduled Follow-up Submission Complete Remission/Response 2014-10-14 FEMALE NO Oligodendroglioma YES Yes, Radiation Prior to Resection C71.0 9451/3 C71.0 YES 130 NO Left NO NO YES G3 NO false Yes, History of Prior Malignancy TCGA-HT-A619.1425BF47-215A-486A-BA84-73E0F3F34A57.pdf A619 Preoperative TUMOR FREE Complete Remission/Response NO Primary Tumor 01 NO NO Not listed in Medical Record YES NO YES HT Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2012 56d6ee3a-08b5-41ad-8ec2-574870987201 TCGA-HT-A619-01A-11D-A29T-05 TCGA-HT-A619-01A-11D-A323-01 TCGA-HT-A619-01 56d6ee3a-08b5-41ad-8ec2-574870987201 TCGA-HT-A619-01 TCGA-HT-A619-01A-11D-A323-01 56d6ee3a-08b5-41ad-8ec2-574870987201 +TCGA-HT-A61A-01 TCGA-HT-A61A-01 TCGA-HT-A61A TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 20 TCGA-HT-A61A -7664 0 194 NO Seizures 31 - 90 Days 2013-9-18 FEMALE NO Oligodendroglioma NO No C71.0 9450/3 C71.0 YES 80 Left NO NO G2 No A61A Other TUMOR FREE YES Complete Remission/Response YES Primary Tumor 01 YES NO Not listed in Medical Record YES NO YES HT Supratentorial, Temporal Lobe Central nervous system NO LIVING 2013 c68ca414-0567-4349-8ad4-55df8cbcc35d TCGA-HT-A61A-01A-11D-A29T-05 TCGA-HT-A61A-01 c68ca414-0567-4349-8ad4-55df8cbcc35d c68ca414-0567-4349-8ad4-55df8cbcc35d +TCGA-HT-A61B-01 TCGA-HT-A61B-01 TCGA-HT-A61B TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 22 TCGA-HT-A61B-F61305 TCGA-HT-A61B TCGA-HT-A61B-01A -8335 101 0 533 NO NO Seizures 0 - 30 Days Scheduled Follow-up Submission Complete Remission/Response 2014-6-26 MALE NO Astrocytoma NO No C71.0 9401/3 C71.0 YES 260 NO 80 Left NO YES NO G3 NO false No TCGA-HT-A61B.24042BE1-BDC3-41A3-93EE-872D5E3B99F3.pdf A61B Post-Adjuvant Therapy TUMOR FREE YES Complete Remission/Response YES Primary Tumor 01 YES NO Not listed in Medical Record YES NO YES HT Supratentorial, Temporal Lobe Central nervous system A NO LIVING 2012 6740d6ab-1321-4806-961a-116ce5be8d29 TCGA-HT-A61B-01A-11D-A29T-05 TCGA-HT-A61B-01A-11D-A323-01 TCGA-HT-A61B-01 6740d6ab-1321-4806-961a-116ce5be8d29 TCGA-HT-A61B-01 TCGA-HT-A61B-01A-11D-A323-01 6740d6ab-1321-4806-961a-116ce5be8d29 +TCGA-HT-A61C-01 TCGA-HT-A61C-01 TCGA-HT-A61C TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain YES 66 NO NO TCGA-HT-A61C-F61306 TCGA-HT-A61C TCGA-HT-A61C-01A 501 -24276 56 537 0 103 476 19 NO YES Motor/Movement Changes 0 - 30 Days Scheduled Follow-up Submission Progressive Disease NO 2014-7-15 MALE NO NO Oligodendroglioma NO No C71.0 9451/3 C71.0 YES 40 NO 100 Left NO NO NO YES G3 YES false No TCGA-HT-A61C.D3039C78-0727-4215-8EE9-DBADCA775531.pdf A61C Post-Adjuvant Therapy WITH TUMOR YES YES Complete Remission/Response YES Primary Tumor 01 YES NO Not listed in Medical Record YES NO YES HT Supratentorial, Temporal Lobe Central nervous system A NO DECEASED 2013 8139b1af-5d6d-4fd4-b834-08cc4a18d0a9 TCGA-HT-A61C-01A-11D-A29T-05 TCGA-HT-A61C-01A-11D-A323-01 TCGA-HT-A61C-01 8139b1af-5d6d-4fd4-b834-08cc4a18d0a9 TCGA-HT-A61C-01 TCGA-HT-A61C-01A-11D-A323-01 8139b1af-5d6d-4fd4-b834-08cc4a18d0a9 +TCGA-HT-A74H-01 TCGA-HT-A74H-01 TCGA-HT-A74H TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 62 NO NO TCGA-HT-A74H-F65103 TCGA-HT-A74H -22850 0 74 NO NO NO Seizures > 181 Days Scheduled Follow-up Submission NO 2014-9-18 MALE NO NO Astrocytoma NO No C71.0 9401/3 C71.0 YES Left NO YES YES NO NO G3 No A74H YES NO Stable Disease YES Primary Tumor 01 YES NO Not listed in Medical Record YES NO YES HT Supratentorial, Temporal Lobe Central nervous system NO LIVING 2013 d450a178-59b3-4dd1-9eeb-8ef305df02ef TCGA-HT-A74H-01A-11D-A32C-05 TCGA-HT-A74H-01A-11D-A32A-01 TCGA-HT-A74H-01 d450a178-59b3-4dd1-9eeb-8ef305df02ef TCGA-HT-A74H-01 TCGA-HT-A74H-01A-11D-A32A-01 d450a178-59b3-4dd1-9eeb-8ef305df02ef +TCGA-HT-A74J-01 TCGA-HT-A74J-01 TCGA-HT-A74J TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 33 TCGA-HT-A74J -12393 0 320 Seizures 0 - 30 Days 2014-6-26 MALE YES Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES Left YES IHC YES NO YES G2 NO No A74J YES Partial Remission/Response NO Primary Tumor 01 YES NO Cerebral Cortex NO NO YES HT Supratentorial, Temporal Lobe Central nervous system NO LIVING 2013 fec08c47-a556-4bef-a20f-b3985d30a500 TCGA-HT-A74J-01A-12D-A32C-05 TCGA-HT-A74J-01A-12D-A32A-01 TCGA-HT-A74J-01 fec08c47-a556-4bef-a20f-b3985d30a500 TCGA-HT-A74J-01 TCGA-HT-A74J-01A-12D-A32A-01 fec08c47-a556-4bef-a20f-b3985d30a500 +TCGA-HT-A74K-01 TCGA-HT-A74K-01 TCGA-HT-A74K TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 58 TCGA-HT-A74K TCGA-HT-A74K-01A -21189 293 0 467 Seizures > 181 Days 2014-6-26 FEMALE NO Oligodendroglioma NO No C71.0 9451/3 C71.0 YES 80 NO Right NO NO G3 NO true No TCGA-HT-A74K.CB30199B-FBD0-494A-8A61-5B58E5D61BB9.pdf A74K TUMOR FREE Complete Remission/Response YES Primary Tumor 01 YES NO Cerebral Cortex YES NO YES HT Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2012 46bc5230-2912-4e5e-a5c0-7a2f5aa6b682 TCGA-HT-A74K-01A-11D-A32C-05 TCGA-HT-A74K-01A-11D-A32A-01 TCGA-HT-A74K-01 46bc5230-2912-4e5e-a5c0-7a2f5aa6b682 TCGA-HT-A74K-01 TCGA-HT-A74K-01A-11D-A32A-01 46bc5230-2912-4e5e-a5c0-7a2f5aa6b682 +TCGA-HT-A74L-01 TCGA-HT-A74L-01 TCGA-HT-A74L TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 22 NO NO TCGA-HT-A74L-F65345 TCGA-HT-A74L TCGA-HT-A74L-01A -8240 103 0 336 NO YES NO Seizures 31 - 90 Days Scheduled Follow-up Submission Partial Remission/Response NO 2014-9-22 FEMALE NO NO Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES 230 NO 90 Right YES IHC YES NO NO NO YES G2 NO true No TCGA-HT-A74L.FFB289B9-552E-4232-B2F7-9E93D72A7DD0.pdf A74L Pre-Adjuvant Therapy WITH TUMOR Partial Remission/Response Primary Tumor 01 YES NO Cerebral Cortex NO YES HT Supratentorial, Parietal Lobe Central nervous system A NO LIVING 2013 5e6fdaa5-ce70-4f0a-a2d8-d66854cb9875 TCGA-HT-A74L-01A-11D-A32C-05 TCGA-HT-A74L-01A-11D-A32A-01 TCGA-HT-A74L-01 5e6fdaa5-ce70-4f0a-a2d8-d66854cb9875 TCGA-HT-A74L-01 TCGA-HT-A74L-01A-11D-A32A-01 5e6fdaa5-ce70-4f0a-a2d8-d66854cb9875 +TCGA-HT-A74O-01 TCGA-HT-A74O-01 TCGA-HT-A74O TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 34 NO NO TCGA-HT-A74O-F63075 TCGA-HT-A74O TCGA-HT-A74O-01A -12460 124 0 3 NO NO NO Headaches > 181 Days Scheduled Follow-up Submission NO 2014-7-30 MALE NO YES Astrocytoma NO No C71.0 9401/3 C71.0 YES 140 NO Left NO YES NO NO YES G3 true No TCGA-HT-A74O.0EA28E1A-D342-4149-95BB-EF81B43DA423.pdf A74O YES NO Primary Tumor 01 NO YES Not listed in Medical Record NO YES HT Supratentorial, Temporal Lobe Central nervous system A YES LIVING 2013 6563f101-9cbe-4126-a5dd-fa33c694c257 TCGA-HT-A74O-01A-11D-A32C-05 TCGA-HT-A74O-01A-11D-A32A-01 TCGA-HT-A74O-01 6563f101-9cbe-4126-a5dd-fa33c694c257 TCGA-HT-A74O-01 TCGA-HT-A74O-01A-11D-A32A-01 6563f101-9cbe-4126-a5dd-fa33c694c257 +TCGA-HW-7486-01 TCGA-HW-7486-01 TCGA-HW-7486 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 37 TCGA-HW-7486-F71504 TCGA-HW-7486 TCGA-HW-7486-01A -13546 0 1721 Scheduled Follow-up Submission Stable Disease 2015-3-31 MALE Oligodendroglioma NO No C71.0 9450/3 C71.0 YES 0.9 NO Right NO 1 NO G2 NO No TCGA-HW-7486.d98d840c-4acf-4312-98b5-c9f35f3517f4.pdf 7486 TUMOR FREE NO Stable Disease NO Primary Tumor 01 YES 0.8 White Matter YES HW Supratentorial, Frontal Lobe Central nervous system A LIVING 2010 2c56dc64-28cf-4b56-ac9d-1d7b906fd56d TCGA-HW-7486-01A-11D-2024-08 TCGA-HW-7486-01A-11D-2025-05 TCGA-HW-7486-01A-11D-2023-01 TCGA-HW-7486-01 2c56dc64-28cf-4b56-ac9d-1d7b906fd56d TCGA-HW-7486-01 TCGA-HW-7486-01A-11D-2023-01 2c56dc64-28cf-4b56-ac9d-1d7b906fd56d +TCGA-HW-7487-01 TCGA-HW-7487-01 TCGA-HW-7487 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain YES NO 39 TCGA-HW-7487-F63127 TCGA-HW-7487 TCGA-HW-7487-01A -14535 0 1382 1356 Additional New Tumor Event 2014-7-31 MALE Oligodendroglioma NO No C71.0 9450/3 C71.0 YES 0.9 NO Left NO 0.9 NO G2 YES No TCGA-HW-7487.1aa8b50f-bce6-4ce5-9922-7a852a1d57ea.pdf 7487 WITH TUMOR YES Progressive Disease NO Primary Tumor 01 YES 0.2 White Matter YES HW Supratentorial, Frontal Lobe Central nervous system A LIVING 2010 75082199-c190-4838-8570-d172058bc98b TCGA-HW-7487-01A-11D-2024-08 TCGA-HW-7487-01A-11D-2025-05 TCGA-HW-7487-01A-11D-2023-01 TCGA-HW-7487-01 75082199-c190-4838-8570-d172058bc98b TCGA-HW-7487-01 TCGA-HW-7487-01A-11D-2023-01 75082199-c190-4838-8570-d172058bc98b +TCGA-HW-7489-01 TCGA-HW-7489-01 TCGA-HW-7489 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 38 TCGA-HW-7489-F65183 TCGA-HW-7489 TCGA-HW-7489-01A -14201 1262 0 142 Scheduled Follow-up Submission 2014-9-19 MALE Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES 0.8 NO Right YES Sequence Analysis YES 1.2 NO G2 NO No TCGA-HW-7489.e79ae11e-5076-4e1e-a077-c0488606af9f.pdf 7489 WITH TUMOR YES Progressive Disease NO Primary Tumor 01 YES 0.3 White Matter NO HW Supratentorial, Frontal Lobe Central nervous system A DECEASED 2011 9ebc9830-2f01-4528-bd95-ae8dfcb2c0a6 TCGA-HW-7489-01A-11D-2024-08 TCGA-HW-7489-01A-11D-2025-05 TCGA-HW-7489-01A-11D-2023-01 TCGA-HW-7489-01 9ebc9830-2f01-4528-bd95-ae8dfcb2c0a6 TCGA-HW-7489-01 TCGA-HW-7489-01A-11D-2023-01 9ebc9830-2f01-4528-bd95-ae8dfcb2c0a6 +TCGA-HW-7490-01 TCGA-HW-7490-01 TCGA-HW-7490 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 41 TCGA-HW-7490-F71515 TCGA-HW-7490 -15092 0 1387 Scheduled Follow-up Submission Progressive Disease 2015-3-31 MALE Astrocytoma NO No C71.0 9400/3 C71.0 YES Left YES YES NO G2 NO Yes 7490 WITH TUMOR NO Progressive Disease NO Primary Tumor 01 NO White Matter NO HW Supratentorial, Occipital Lobe Central nervous system LIVING 2011 cb3b19a0-fb0a-49c8-a4e1-c2e3215a192f TCGA-HW-7490-01A-11D-2024-08 TCGA-HW-7490-01A-11D-2025-05 TCGA-HW-7490-01A-11D-2023-01 TCGA-HW-7490-01 cb3b19a0-fb0a-49c8-a4e1-c2e3215a192f TCGA-HW-7490-01 TCGA-HW-7490-01A-11D-2023-01 cb3b19a0-fb0a-49c8-a4e1-c2e3215a192f +TCGA-HW-7491-01 TCGA-HW-7491-01 TCGA-HW-7491 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain NO NO 35 TCGA-HW-7491-F71510 TCGA-HW-7491 TCGA-HW-7491-01A -12874 0 2078 2197 Scheduled Follow-up Submission 2015-3-31 MALE Oligodendroglioma NO No C71.0 9450/3 C71.0 YES 0.7 NO Right NO 1.1 NO G2 YES No TCGA-HW-7491.8e93a347-6300-4a66-b5f2-c462867c5801.pdf 7491 WITH TUMOR NO Progressive Disease NO Primary Tumor 01 NO 0.5 White Matter YES HW Supratentorial, Frontal Lobe Central nervous system A LIVING 2009 1a2ee9d7-2ef4-4247-9f29-cc1caaabaa5f TCGA-HW-7491-01A-11D-2024-08 TCGA-HW-7491-01A-11D-2025-05 TCGA-HW-7491-01A-11D-2023-01 TCGA-HW-7491-01 1a2ee9d7-2ef4-4247-9f29-cc1caaabaa5f TCGA-HW-7491-01 TCGA-HW-7491-01A-11D-2023-01 1a2ee9d7-2ef4-4247-9f29-cc1caaabaa5f +TCGA-HW-7493-01 TCGA-HW-7493-01 TCGA-HW-7493 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 40 TCGA-HW-7493-F71516 TCGA-HW-7493 TCGA-HW-7493-01A -14767 0 2107 Scheduled Follow-up Submission Stable Disease 2015-3-31 FEMALE Astrocytoma NO No C71.0 9400/3 C71.0 YES 0.8 NO Right NO 1.1 NO G2 NO No TCGA-HW-7493.19b2a34c-33d1-49a2-ac5b-2775542ff1e2.pdf 7493 WITH TUMOR YES Stable Disease YES Primary Tumor 01 YES 0.7 White Matter NO HW Supratentorial, Temporal Lobe Central nervous system A LIVING 2009 663ec986-6cdd-4b8c-8d16-5f2afb5caad0 TCGA-HW-7493-01A-11D-2025-05 TCGA-HW-7493-01A-11D-2023-01 TCGA-HW-7493-01 663ec986-6cdd-4b8c-8d16-5f2afb5caad0 TCGA-HW-7493-01 TCGA-HW-7493-01A-11D-2023-01 663ec986-6cdd-4b8c-8d16-5f2afb5caad0 +TCGA-HW-7495-01 TCGA-HW-7495-01 TCGA-HW-7495 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 45 TCGA-HW-7495-F66931 TCGA-HW-7495 -16460 0 1078 Scheduled Follow-up Submission Progressive Disease 2014-10-28 FEMALE Oligodendroglioma NO No C71.0 9450/3 C71.0 YES Right NO NO G2 NO No 7495 WITH TUMOR NO Progressive Disease NO Primary Tumor 01 YES White Matter NO HW Supratentorial, Frontal Lobe Central nervous system LIVING 2011 ba53832f-dfbc-4581-b7b1-cdc476174d72 TCGA-HW-7495-01A-11D-2024-08 TCGA-HW-7495-01A-11D-2025-05 TCGA-HW-7495-01A-11D-2023-01 TCGA-HW-7495-01 ba53832f-dfbc-4581-b7b1-cdc476174d72 TCGA-HW-7495-01 TCGA-HW-7495-01A-11D-2023-01 ba53832f-dfbc-4581-b7b1-cdc476174d72 +TCGA-HW-8319-01 TCGA-HW-8319-01 TCGA-HW-8319 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain YES NO 34 TCGA-HW-8319-F71526 TCGA-HW-8319 TCGA-HW-8319-01A -12557 1209 0 262 997 Scheduled Follow-up Submission 2015-3-31 FEMALE Astrocytoma NO No C71.0 9401/3 C71.0 YES 1.2 NO Left 1.3 NO G3 YES No TCGA-HW-8319.c90e82a8-f877-40d8-b75f-f67e1714f58e.pdf 8319 WITH TUMOR NO Progressive Disease YES Primary Tumor 01 NO 0.6 YES YES NO HW Supratentorial, Frontal Lobe Central nervous system A DECEASED 2011 196025a7-8bda-4361-b2f6-8ac98c753564 TCGA-HW-8319-01A-11D-2399-05 TCGA-HW-8319-01A-11D-2391-01 TCGA-HW-8319-01 196025a7-8bda-4361-b2f6-8ac98c753564 TCGA-HW-8319-01 TCGA-HW-8319-01A-11D-2391-01 196025a7-8bda-4361-b2f6-8ac98c753564 +TCGA-HW-8320-01 TCGA-HW-8320-01 TCGA-HW-8320 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 36 TCGA-HW-8320-F71522 TCGA-HW-8320 TCGA-HW-8320-01A -13503 0 1217 Scheduled Follow-up Submission Stable Disease 2015-3-31 MALE Astrocytoma NO No C71.0 9401/3 C71.0 YES 1 NO Right Sequence Analysis YES 1.7 NO G3 NO No TCGA-HW-8320.75564dac-fb13-4214-b588-ec14c3550880.pdf 8320 WITH TUMOR YES Stable Disease YES Primary Tumor 01 YES 1 YES YES NO HW Supratentorial, Parietal Lobe Central nervous system A LIVING 2011 8fe3cf69-3d71-4d77-aa05-60e619708e06 TCGA-HW-8320-01A-11D-2399-05 TCGA-HW-8320-01A-11D-2391-01 TCGA-HW-8320-01 8fe3cf69-3d71-4d77-aa05-60e619708e06 TCGA-HW-8320-01 TCGA-HW-8320-01A-11D-2391-01 8fe3cf69-3d71-4d77-aa05-60e619708e06 +TCGA-HW-8321-01 TCGA-HW-8321-01 TCGA-HW-8321 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 31 TCGA-HW-8321-F71520 TCGA-HW-8321 TCGA-HW-8321-01A -11474 0 1294 Scheduled Follow-up Submission Stable Disease 2015-3-31 MALE Astrocytoma NO No C71.0 9400/3 C71.0 YES 1 NO Left 1.6 NO G3 NO No TCGA-HW-8321.985f7f28-3f83-4cda-bfc8-6676bbffd7b2.pdf 8321 WITH TUMOR YES Stable Disease YES Primary Tumor 01 NO 0.5 YES YES NO HW Supratentorial, Frontal Lobe Central nervous system A LIVING 2011 1c2c32ad-2bd5-4e5f-9784-014d41b96196 TCGA-HW-8321-01A-11D-2399-05 TCGA-HW-8321-01A-11D-2391-01 TCGA-HW-8321-01 1c2c32ad-2bd5-4e5f-9784-014d41b96196 TCGA-HW-8321-01 TCGA-HW-8321-01A-11D-2391-01 1c2c32ad-2bd5-4e5f-9784-014d41b96196 +TCGA-HW-8322-01 TCGA-HW-8322-01 TCGA-HW-8322 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 39 TCGA-HW-8322-F71499 TCGA-HW-8322 TCGA-HW-8322-01A -14548 0 758 Scheduled Follow-up Submission Progressive Disease 2015-3-31 MALE Oligodendroglioma NO No C71.0 9450/3 C71.0 YES 0.9 NO Left 1.5 NO G2 NO No TCGA-HW-8322.43aea5c8-29ec-4f1e-b948-101b645b4cf1.pdf 8322 WITH TUMOR NO Stable Disease NO Primary Tumor 01 YES 0.5 YES YES NO HW Supratentorial, Frontal Lobe Central nervous system A LIVING 2012 83071fd2-bdb5-4135-97cd-dc6d68120a02 TCGA-HW-8322-01A-11D-2399-05 TCGA-HW-8322-01A-11D-2391-01 TCGA-HW-8322-01 83071fd2-bdb5-4135-97cd-dc6d68120a02 TCGA-HW-8322-01 TCGA-HW-8322-01A-11D-2391-01 83071fd2-bdb5-4135-97cd-dc6d68120a02 +TCGA-HW-A5KJ-01 TCGA-HW-A5KJ-01 TCGA-HW-A5KJ TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 68 TCGA-HW-A5KJ-F71524 TCGA-HW-A5KJ -24966 962 0 321 Scheduled Follow-up Submission Stable Disease 2015-3-31 MALE Oligodendroglioma NO No C71.0 9451/3 C71.0 YES Right NO G3 NO No A5KJ WITH TUMOR NO Progressive Disease YES Primary Tumor 01 NO White Matter YES YES NO HW Supratentorial, Frontal Lobe Central nervous system DECEASED 2012 c026a9de-ad2b-4959-89c0-484f9d622dd9 TCGA-HW-A5KJ-01A-12D-A27L-05 TCGA-HW-A5KJ-01A-12D-A27J-01 TCGA-HW-A5KJ-01 c026a9de-ad2b-4959-89c0-484f9d622dd9 TCGA-HW-A5KJ-01 TCGA-HW-A5KJ-01A-12D-A27J-01 c026a9de-ad2b-4959-89c0-484f9d622dd9 +TCGA-HW-A5KK-01 TCGA-HW-A5KK-01 TCGA-HW-A5KK TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 64 TCGA-HW-A5KK-F59869 TCGA-HW-A5KK -23484 388 0 240 Scheduled Follow-up Submission 2014-5-22 MALE Astrocytoma NO No C71.0 9401/3 C71.0 YES Right NO G3 NO No A5KK WITH TUMOR YES Progressive Disease YES Primary Tumor 01 YES White Matter YES YES NO HW Supratentorial, Temporal Lobe Central nervous system DECEASED 2012 bff2060f-591c-4634-a9cb-06d3538d532a TCGA-HW-A5KK-01A-11D-A27L-05 TCGA-HW-A5KK-01A-11D-A27J-01 TCGA-HW-A5KK-01 bff2060f-591c-4634-a9cb-06d3538d532a TCGA-HW-A5KK-01 TCGA-HW-A5KK-01A-11D-A27J-01 bff2060f-591c-4634-a9cb-06d3538d532a +TCGA-HW-A5KL-01 TCGA-HW-A5KL-01 TCGA-HW-A5KL TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 42 TCGA-HW-A5KL-F71508 TCGA-HW-A5KL -15513 0 878 Scheduled Follow-up Submission Stable Disease 2015-3-31 FEMALE Astrocytoma NO No C71.0 9400/3 C71.0 YES Right NO G2 NO No A5KL WITH TUMOR NO Stable Disease YES Primary Tumor 01 YES White Matter YES YES NO HW Supratentorial, Temporal Lobe Central nervous system LIVING 2012 f9caf12e-40d1-4eec-ae39-2067f78c86c6 TCGA-HW-A5KL-01A-11D-A27L-05 TCGA-HW-A5KL-01A-11D-A27J-01 TCGA-HW-A5KL-01 f9caf12e-40d1-4eec-ae39-2067f78c86c6 TCGA-HW-A5KL-01 TCGA-HW-A5KL-01A-11D-A27J-01 f9caf12e-40d1-4eec-ae39-2067f78c86c6 +TCGA-HW-A5KM-01 TCGA-HW-A5KM-01 TCGA-HW-A5KM TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 35 TCGA-HW-A5KM-F59872 TCGA-HW-A5KM TCGA-HW-A5KM-01A -12845 139 0 630 Scheduled Follow-up Submission Progressive Disease 2014-5-22 MALE Astrocytoma NO No C71.0 9400/3 C71.0 YES 160 NO Left NO G2 NO true No TCGA-HW-A5KM.1DA8A802-EC7A-4452-91AD-720ECCE85D8A.pdf A5KM WITH TUMOR NO Progressive Disease NO Primary Tumor 01 YES White Matter NO YES NO HW Supratentorial, Frontal Lobe Central nervous system A LIVING 2012 65913e2c-bc8a-44b3-9f14-a4ca9c49042d TCGA-HW-A5KM-01A-11D-A27L-05 TCGA-HW-A5KM-01A-11D-A27J-01 TCGA-HW-A5KM-01 65913e2c-bc8a-44b3-9f14-a4ca9c49042d TCGA-HW-A5KM-01 TCGA-HW-A5KM-01A-11D-A27J-01 65913e2c-bc8a-44b3-9f14-a4ca9c49042d +TCGA-IK-7675-01 TCGA-IK-7675-01 TCGA-IK-7675 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain YES 43 NO TCGA-IK-7675-F33064 TCGA-IK-7675 TCGA-IK-7675-01A -15900 578 0 123 48 NO NO Motor/Movement Changes 0 - 30 Days Scheduled Follow-up Submission Progressive Disease 2012-6-19 MALE YES Oligodendroglioma NO No C71.0 9450/3 C71.0 YES 0.8 NO 90 Right 1 NO YES G2 YES No TCGA-IK-7675.bb5fc5df-bc8d-4603-a924-c2cbe7cd2e7d.pdf 7675 Other WITH TUMOR YES YES Progressive Disease YES Primary Tumor 01 NO NO 0.4 White Matter NO YES NO IK Supratentorial, Frontal Lobe Central nervous system A NO DECEASED 2009 97d4524f-bd35-4dfe-9ef5-e1298713aaa4 TCGA-IK-7675-01A-11D-2086-08 TCGA-IK-7675-01A-11D-2087-05 TCGA-IK-7675-01A-11D-2085-01 TCGA-IK-7675-01 97d4524f-bd35-4dfe-9ef5-e1298713aaa4 TCGA-IK-7675-01 TCGA-IK-7675-01A-11D-2085-01 97d4524f-bd35-4dfe-9ef5-e1298713aaa4 +TCGA-IK-8125-01 TCGA-IK-8125-01 TCGA-IK-8125 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 62 NO TCGA-IK-8125-F40395 TCGA-IK-8125 TCGA-IK-8125-01A -22745 0 1301 42 0 YES YES NO > 20 Years Seizures 0 - 30 Days Scheduled Follow-up Submission Complete Remission/Response NO 2013-2-18 MALE NO Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES 0.8 NO Left 0.9 NO NO NO G3 NO Yes TCGA-IK-8125.77a2c310-8f8b-4e45-92d8-52379e34f11f.pdf 8125 Pre-Adjuvant Therapy TUMOR FREE YES YES Complete Remission/Response YES Primary Tumor 01 YES NO 0.6 YES YES NO IK Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2009 65c41ecc-29dc-4deb-bfbc-11ca732065f7 TCGA-IK-8125-01A-11D-2253-08 TCGA-IK-8125-01A-11D-2254-05 TCGA-IK-8125-01A-11D-2252-01 TCGA-IK-8125-01 65c41ecc-29dc-4deb-bfbc-11ca732065f7 TCGA-IK-8125-01 TCGA-IK-8125-01A-11D-2252-01 65c41ecc-29dc-4deb-bfbc-11ca732065f7 +TCGA-KT-A74X-01 TCGA-KT-A74X-01 TCGA-KT-A74X TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 26 YES Cat Dander TCGA-KT-A74X-F69145 TCGA-KT-A74X -9590 0 438 NO NO Seizures Scheduled Follow-up Submission Stable Disease 2014-12-30 MALE NO YES Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES 90 Left YES IHC YES NO YES NO YES G3 NO No A74X WITH TUMOR Stable Disease YES Primary Tumor 01 YES Not listed in Medical Record YES YES NO KT Supratentorial, Parietal Lobe Central nervous system NO LIVING 2013 bc32671c-a95d-4a44-a42a-dcc617cf68f1 TCGA-KT-A74X-01A-11D-A32C-05 TCGA-KT-A74X-01A-11D-A32A-01 TCGA-KT-A74X-01 bc32671c-a95d-4a44-a42a-dcc617cf68f1 TCGA-KT-A74X-01 TCGA-KT-A74X-01A-11D-A32A-01 bc32671c-a95d-4a44-a42a-dcc617cf68f1 +TCGA-KT-A7W1-01 TCGA-KT-A7W1-01 TCGA-KT-A7W1 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 45 TCGA-KT-A7W1-F69146 TCGA-KT-A7W1 -16560 0 438 10 YES NO Seizures 0 - 30 Days Scheduled Follow-up Submission Stable Disease 2014-12-30 FEMALE Astrocytoma NO No C71.0 9401/3 C71.0 YES NO 80 Right NO IHC YES NO NO YES G3 NO No A7W1 Pre-Adjuvant Therapy TUMOR FREE YES YES Progressive Disease YES Primary Tumor 01 YES NO White Matter YES YES NO KT Supratentorial, Frontal Lobe Central nervous system NO LIVING 2013 b817310e-3a4b-4622-8564-350ccb0a9e69 TCGA-KT-A7W1-01A-11D-A34D-05 TCGA-KT-A7W1-01A-11D-A349-01 TCGA-KT-A7W1-01 b817310e-3a4b-4622-8564-350ccb0a9e69 TCGA-KT-A7W1-01 TCGA-KT-A7W1-01A-11D-A349-01 b817310e-3a4b-4622-8564-350ccb0a9e69 +TCGA-OX-A56R-01 TCGA-OX-A56R-01 TCGA-OX-A56R TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 68 TCGA-OX-A56R TCGA-OX-A56R-01A -25178 265 180 0 2013-2-27 MALE Glioblastoma Multiforme (GBM) No C71.2 9440/3 C71.2 YES Tumor resection 260 NO false No TCGA-OX-A56R.9EF7E637-46F9-4498-B41C-D1219D20636A.pdf A56R WITH TUMOR Partial Remission/Response NO Primary Tumor 01 YES NO OX Brain A DECEASED 2012 TCGA-OX-A56R-01A-11D-A33U-05 TCGA-OX-A56R-01A-11D-A33S-01 TCGA-OX-A56R-01A-11D-A33S-01 +TCGA-P5-A5ET-01 TCGA-P5-A5ET-01 TCGA-P5-A5ET TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 27 NO NO TCGA-P5-A5ET-F69038 TCGA-P5-A5ET TCGA-P5-A5ET-01A -10027 98 0 -10 NO Headaches 91 - 180 Days Scheduled Follow-up Submission NO 2014-12-24 MALE NO YES Oligodendroglioma NO No C71.0 9450/3 C71.0 YES NO 400 NO Right NO YES NO G2 NO true No TCGA-P5-A5ET.A28115C7-0F60-442C-BE10-8B93D06F5CEB.pdf A5ET TUMOR FREE YES Primary Tumor 01 Not listed in Medical Record YES NO P5 Supratentorial, Frontal Lobe Central nervous system A LIVING 2012 669947ca-d955-4bcd-b593-bf86f1edb8df TCGA-P5-A5ET-01A-11D-A27L-05 TCGA-P5-A5ET-01A-11D-A27J-01 TCGA-P5-A5ET-01 669947ca-d955-4bcd-b593-bf86f1edb8df TCGA-P5-A5ET-01 TCGA-P5-A5ET-01A-11D-A27J-01 669947ca-d955-4bcd-b593-bf86f1edb8df +TCGA-P5-A5EU-01 TCGA-P5-A5EU-01 TCGA-P5-A5EU TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 35 TCGA-P5-A5EU-F69039 TCGA-P5-A5EU -12851 0 0 Headaches > 181 Days Scheduled Follow-up Submission 2014-12-24 MALE YES Astrocytoma NO No C71.0 9401/3 C71.0 YES 60 Right NO YES NO G3 No A5EU YES YES NO Primary Tumor 01 YES Not listed in Medical Record NO YES NO P5 Supratentorial, Frontal Lobe Central nervous system YES LIVING 2012 af4c730b-9886-4cf1-b859-735c424bc06a TCGA-P5-A5EU-01A-11D-A27L-05 TCGA-P5-A5EU-01A-11D-A27J-01 TCGA-P5-A5EU-01 af4c730b-9886-4cf1-b859-735c424bc06a TCGA-P5-A5EU-01 TCGA-P5-A5EU-01A-11D-A27J-01 af4c730b-9886-4cf1-b859-735c424bc06a +TCGA-P5-A5EV-01 TCGA-P5-A5EV-01 TCGA-P5-A5EV TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 39 TCGA-P5-A5EV-F69040 TCGA-P5-A5EV -14310 0 7 Seizures 31 - 90 Days Scheduled Follow-up Submission 2014-12-24 MALE YES Astrocytoma NO No C71.0 9400/3 C71.0 YES 60 Left YES YES YES G2 No A5EV WITH TUMOR YES YES Primary Tumor 01 YES YES Not listed in Medical Record NO YES NO P5 Supratentorial, Temporal Lobe Central nervous system YES LIVING 2012 c19b30b4-b9cc-41cb-ac23-b27a1b6e6889 TCGA-P5-A5EV-01A-11D-A27L-05 TCGA-P5-A5EV-01A-11D-A27J-01 TCGA-P5-A5EV-01 c19b30b4-b9cc-41cb-ac23-b27a1b6e6889 TCGA-P5-A5EV-01 TCGA-P5-A5EV-01A-11D-A27J-01 c19b30b4-b9cc-41cb-ac23-b27a1b6e6889 +TCGA-P5-A5EW-01 TCGA-P5-A5EW-01 TCGA-P5-A5EW TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 20 YES cats TCGA-P5-A5EW-F69041 TCGA-P5-A5EW -7612 0 204 -2 < 12 Years Headaches 91 - 180 Days Scheduled Follow-up Submission NO 2014-12-24 FEMALE NO YES Astrocytoma NO No C71.0 9400/3 C71.0 YES 80 Right NO YES NO G2 NO No A5EW Preoperative TUMOR FREE YES NO Primary Tumor 01 Not listed in Medical Record YES NO P5 Supratentorial, Frontal Lobe Central nervous system LIVING 2012 ab00d03b-2579-491b-a23a-7ec63d0852ff TCGA-P5-A5EW-01A-11D-A27L-05 TCGA-P5-A5EW-01A-11D-A27J-01 TCGA-P5-A5EW-01 ab00d03b-2579-491b-a23a-7ec63d0852ff TCGA-P5-A5EW-01 TCGA-P5-A5EW-01A-11D-A27J-01 ab00d03b-2579-491b-a23a-7ec63d0852ff +TCGA-P5-A5EX-01 TCGA-P5-A5EX-01 TCGA-P5-A5EX TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 41 NO TCGA-P5-A5EX-F69042 TCGA-P5-A5EX TCGA-P5-A5EX-01A -15091 65 0 243 NO Headaches > 181 Days Scheduled Follow-up Submission 2014-12-24 FEMALE NO YES Oligodendroglioma NO No C71.0 9451/3 C71.0 YES NO 280 NO 80 Right NO NO NO NO NO G3 NO true No TCGA-P5-A5EX.C2C64F70-4E69-4A52-97AE-04E0D8D627EC.pdf A5EX TUMOR FREE NO NO Partial Remission/Response YES Primary Tumor 01 NO YES Not listed in Medical Record YES YES NO P5 Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2012 7b4d9c91-80eb-4d3e-8e3f-76a13c7fbf76 TCGA-P5-A5EX-01A-12D-A28N-05 TCGA-P5-A5EX-01A-12D-A288-01 TCGA-P5-A5EX-01 7b4d9c91-80eb-4d3e-8e3f-76a13c7fbf76 TCGA-P5-A5EX-01 TCGA-P5-A5EX-01A-12D-A288-01 7b4d9c91-80eb-4d3e-8e3f-76a13c7fbf76 +TCGA-P5-A5EY-01 TCGA-P5-A5EY-01 TCGA-P5-A5EY TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 21 TCGA-P5-A5EY-F69043 TCGA-P5-A5EY -7716 0 72 Seizures 0 - 30 Days Scheduled Follow-up Submission 2014-12-24 MALE Astrocytoma No C71.0 9400/3 C71.0 YES Right YES G2 No A5EY YES Primary Tumor 01 YES Not listed in Medical Record YES NO P5 Supratentorial, Temporal Lobe Central nervous system LIVING 2012 c0c1d679-b9d4-4146-bf2e-7816648ef557 TCGA-P5-A5EY-01A-11D-A27L-05 TCGA-P5-A5EY-01A-11D-A27J-01 TCGA-P5-A5EY-01 c0c1d679-b9d4-4146-bf2e-7816648ef557 TCGA-P5-A5EY-01 TCGA-P5-A5EY-01A-11D-A27J-01 c0c1d679-b9d4-4146-bf2e-7816648ef557 +TCGA-P5-A5EZ-01 TCGA-P5-A5EZ-01 TCGA-P5-A5EZ TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 39 YES bee TCGA-P5-A5EZ-F69044 TCGA-P5-A5EZ TCGA-P5-A5EZ-01A -14375 65 0 70 > 20 Years Seizures 31 - 90 Days Scheduled Follow-up Submission 2014-12-24 MALE YES Astrocytoma NO No C71.0 9401/3 C71.0 YES 200 NO Left NO YES G3 NO true No TCGA-P5-A5EZ.F12771D2-103F-423A-A619-D648A8443DF1.pdf A5EZ TUMOR FREE Primary Tumor 01 YES Not listed in Medical Record YES NO P5 Supratentorial, Frontal Lobe Central nervous system A LIVING 2012 3b93e6fa-c53b-4f8d-8d28-43926a1dae9d TCGA-P5-A5EZ-01A-11D-A27L-05 TCGA-P5-A5EZ-01A-11D-A27J-01 TCGA-P5-A5EZ-01 3b93e6fa-c53b-4f8d-8d28-43926a1dae9d TCGA-P5-A5EZ-01 TCGA-P5-A5EZ-01A-11D-A27J-01 3b93e6fa-c53b-4f8d-8d28-43926a1dae9d +TCGA-P5-A5F0-01 TCGA-P5-A5F0-01 TCGA-P5-A5F0 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 33 NO TCGA-P5-A5F0-F69045 TCGA-P5-A5F0 TCGA-P5-A5F0-01A -12157 62 0 287 NO Seizures > 181 Days Scheduled Follow-up Submission 2014-12-24 MALE NO YES Oligodendroglioma NO No C71.9 9450/3 C71.9 YES NO 110 NO 80 Right NO NO NO NO YES G2 NO true No TCGA-P5-A5F0.6E1C12F5-85C4-4A43-8F05-F08A774CC9E4.pdf A5F0 TUMOR FREE NO NO Partial Remission/Response YES Primary Tumor 01 YES YES Not listed in Medical Record YES YES NO P5 Supratentorial, Frontal Lobe Central nervous system A YES LIVING 2012 35d073e9-06bc-4ccd-af39-c9fb4c268d7a TCGA-P5-A5F0-01A-11D-A28N-05 TCGA-P5-A5F0-01A-11D-A288-01 TCGA-P5-A5F0-01 35d073e9-06bc-4ccd-af39-c9fb4c268d7a TCGA-P5-A5F0-01 TCGA-P5-A5F0-01A-11D-A288-01 35d073e9-06bc-4ccd-af39-c9fb4c268d7a +TCGA-P5-A5F1-01 TCGA-P5-A5F1-01 TCGA-P5-A5F1 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 30 TCGA-P5-A5F1-F69046 TCGA-P5-A5F1 -11070 0 179 Motor/Movement Changes 31 - 90 Days Scheduled Follow-up Submission 2014-12-24 MALE Astrocytoma NO No C71.0 9400/3 C71.0 YES Left NO YES YES G2 NO No A5F1 TUMOR FREE Primary Tumor 01 Not listed in Medical Record YES NO P5 Supratentorial, Temporal Lobe Central nervous system LIVING 2012 a9db06e4-4069-4533-b85e-9e2fbbaaec7d TCGA-P5-A5F1-01A-11D-A28N-05 TCGA-P5-A5F1-01A-11D-A288-01 TCGA-P5-A5F1-01 a9db06e4-4069-4533-b85e-9e2fbbaaec7d TCGA-P5-A5F1-01 TCGA-P5-A5F1-01A-11D-A288-01 a9db06e4-4069-4533-b85e-9e2fbbaaec7d +TCGA-P5-A5F2-01 TCGA-P5-A5F2-01 TCGA-P5-A5F2 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 36 TCGA-P5-A5F2-F69047 TCGA-P5-A5F2 TCGA-P5-A5F2-01A -13396 48 0 242 Seizures 91 - 180 Days Scheduled Follow-up Submission 2014-12-24 FEMALE YES Astrocytoma NO No C71.0 9400/3 C71.0 YES 610 NO 80 Right NO NO NO G2 NO true No TCGA-P5-A5F2.0DC839C0-415F-48FB-92A8-44B06A7A5309.pdf A5F2 WITH TUMOR Partial Remission/Response NO Primary Tumor 01 YES NO Not listed in Medical Record YES YES NO P5 Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2012 52284719-7a37-4969-905b-dde2068409c2 TCGA-P5-A5F2-01A-11D-A28N-05 TCGA-P5-A5F2-01A-11D-A288-01 TCGA-P5-A5F2-01 52284719-7a37-4969-905b-dde2068409c2 TCGA-P5-A5F2-01 TCGA-P5-A5F2-01A-11D-A288-01 52284719-7a37-4969-905b-dde2068409c2 +TCGA-P5-A5F4-01 TCGA-P5-A5F4-01 TCGA-P5-A5F4 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 35 TCGA-P5-A5F4-F69048 TCGA-P5-A5F4 TCGA-P5-A5F4-01A -12851 37 0 231 Headaches 31 - 90 Days Scheduled Follow-up Submission 2014-12-24 FEMALE YES Oligodendroglioma NO No C71.0 9451/3 C71.0 YES 700 NO 70 Right NO G3 true No TCGA-P5-A5F4.52CF242F-7062-4258-A991-BB69FD3EE06C.pdf A5F4 TUMOR FREE Partial Remission/Response YES Primary Tumor 01 YES Not listed in Medical Record YES YES NO P5 Supratentorial, Temporal Lobe Central nervous system A YES LIVING 2012 77b73b66-5ad9-49f4-9e75-f242cd316e2e TCGA-P5-A5F4-01A-11D-A28N-05 TCGA-P5-A5F4-01A-11D-A288-01 TCGA-P5-A5F4-01 77b73b66-5ad9-49f4-9e75-f242cd316e2e TCGA-P5-A5F4-01 TCGA-P5-A5F4-01A-11D-A288-01 77b73b66-5ad9-49f4-9e75-f242cd316e2e +TCGA-P5-A5F6-01 TCGA-P5-A5F6-01 TCGA-P5-A5F6 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 26 TCGA-P5-A5F6-F69049 TCGA-P5-A5F6 -9575 0 39 Headaches Scheduled Follow-up Submission 2014-12-24 MALE YES Oligodendroglioma NO No C71.0 9450/3 C71.0 YES 70 Left YES G2 NO No A5F6 TUMOR FREE Primary Tumor 01 Not listed in Medical Record YES NO P5 Supratentorial, Frontal Lobe Central nervous system LIVING 2012 c66d3098-98b5-4e0a-a592-39ce259b2c86 TCGA-P5-A5F6-01A-11D-A28N-05 TCGA-P5-A5F6-01A-11D-A288-01 TCGA-P5-A5F6-01 c66d3098-98b5-4e0a-a592-39ce259b2c86 TCGA-P5-A5F6-01 TCGA-P5-A5F6-01A-11D-A288-01 c66d3098-98b5-4e0a-a592-39ce259b2c86 +TCGA-P5-A72U-01 TCGA-P5-A72U-01 TCGA-P5-A72U TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 71 TCGA-P5-A72U-F69015 TCGA-P5-A72U TCGA-P5-A72U-01A -26002 196 0 7 Additional New Tumor Event 2014-12-24 FEMALE Oligodendroglioma No C71.0 9451/3 C71.0 YES 240 NO Right NO G3 NO true No TCGA-P5-A72U.5C661E0D-6AC0-47DD-851F-8ED068BEF14D.pdf A72U TUMOR FREE Complete Remission/Response NO Primary Tumor 01 NO YES NO P5 Supratentorial, Parietal Lobe Central nervous system A LIVING 2013 0c53d4ad-c5b9-4bdc-8154-99cf0b715dd5 TCGA-P5-A72U-01A-31D-A32C-05 TCGA-P5-A72U-01A-31D-A32A-01 TCGA-P5-A72U-01 0c53d4ad-c5b9-4bdc-8154-99cf0b715dd5 TCGA-P5-A72U-01 TCGA-P5-A72U-01A-31D-A32A-01 0c53d4ad-c5b9-4bdc-8154-99cf0b715dd5 +TCGA-P5-A72W-01 TCGA-P5-A72W-01 TCGA-P5-A72W TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 35 TCGA-P5-A72W-F69016 TCGA-P5-A72W -12848 0 317 Scheduled Follow-up Submission 2014-12-24 MALE Astrocytoma No C71.0 9401/3 C71.0 YES Left NO G3 NO No A72W TUMOR FREE Complete Remission/Response YES Primary Tumor 01 YES NO P5 Supratentorial, Frontal Lobe Central nervous system LIVING 2013 e60804b1-edc8-40e6-b9a1-9a02682f30d6 TCGA-P5-A72W-01A-11D-A32C-05 TCGA-P5-A72W-01A-11D-A32A-01 TCGA-P5-A72W-01 e60804b1-edc8-40e6-b9a1-9a02682f30d6 TCGA-P5-A72W-01 TCGA-P5-A72W-01A-11D-A32A-01 e60804b1-edc8-40e6-b9a1-9a02682f30d6 +TCGA-P5-A72X-01 TCGA-P5-A72X-01 TCGA-P5-A72X TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 21 TCGA-P5-A72X-F69018 TCGA-P5-A72X -7913 0 403 Scheduled Follow-up Submission 2014-12-24 MALE Astrocytoma No C71.0 9401/3 C71.0 YES Left NO G3 No A72X TUMOR FREE Complete Remission/Response YES Primary Tumor 01 YES NO P5 Supratentorial, Temporal Lobe Central nervous system LIVING 2013 c5284e5c-9566-4248-a168-362eb039ffe7 TCGA-P5-A72X-01A-11D-A32C-05 TCGA-P5-A72X-01A-11D-A32A-01 TCGA-P5-A72X-01 c5284e5c-9566-4248-a168-362eb039ffe7 TCGA-P5-A72X-01 TCGA-P5-A72X-01A-11D-A32A-01 c5284e5c-9566-4248-a168-362eb039ffe7 +TCGA-P5-A72Z-01 TCGA-P5-A72Z-01 TCGA-P5-A72Z TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 64 TCGA-P5-A72Z-F69020 TCGA-P5-A72Z TCGA-P5-A72Z-01A -23482 178 0 354 Scheduled Follow-up Submission 2014-12-24 FEMALE Oligodendroglioma No C71.0 9451/3 C71.0 YES 160 NO Left NO G3 true No TCGA-P5-A72Z.99B1BF7C-E68F-4546-B13B-BF603738796C.pdf A72Z TUMOR FREE Complete Remission/Response YES Primary Tumor 01 YES YES NO P5 Supratentorial, Temporal Lobe Central nervous system A LIVING 2013 7b9b3507-bd43-4915-8f53-89cee202ad6e TCGA-P5-A72Z-01A-11D-A32C-05 TCGA-P5-A72Z-01A-11D-A32A-01 TCGA-P5-A72Z-01 7b9b3507-bd43-4915-8f53-89cee202ad6e TCGA-P5-A72Z-01 TCGA-P5-A72Z-01A-11D-A32A-01 7b9b3507-bd43-4915-8f53-89cee202ad6e +TCGA-P5-A730-01 TCGA-P5-A730-01 TCGA-P5-A730 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 22 TCGA-P5-A730-F69023 TCGA-P5-A730 TCGA-P5-A730-01A -8043 161 0 333 Scheduled Follow-up Submission 2014-12-24 MALE Oligoastrocytoma No C71.0 9382/3 C71.0 YES 510 NO Right NO G3 NO true No TCGA-P5-A730.D03B2072-0B67-431A-9C5E-0D0B4191E846.pdf A730 TUMOR FREE Complete Remission/Response NO Primary Tumor 01 NO YES NO P5 Supratentorial, Occipital Lobe Central nervous system A LIVING 2013 059686a6-baf9-4609-a26f-2d0fa3b7a685 TCGA-P5-A730-01A-11D-A32C-05 TCGA-P5-A730-01A-11D-A32A-01 TCGA-P5-A730-01 059686a6-baf9-4609-a26f-2d0fa3b7a685 TCGA-P5-A730-01 TCGA-P5-A730-01A-11D-A32A-01 059686a6-baf9-4609-a26f-2d0fa3b7a685 +TCGA-P5-A731-01 TCGA-P5-A731-01 TCGA-P5-A731 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 59 TCGA-P5-A731-F69010 TCGA-P5-A731 TCGA-P5-A731-01A -21715 143 0 274 Scheduled Follow-up Submission 2014-12-24 FEMALE YES Oligoastrocytoma No C71.0 9382/3 C71.0 YES 220 NO 90 Right NO YES G2 true No TCGA-P5-A731.F22D0DFD-A361-4735-B391-82975EA64AE5.pdf A731 TUMOR FREE YES Primary Tumor 01 NO YES NO P5 Supratentorial, Frontal Lobe Central nervous system A LIVING 2013 5a57bf22-5617-4ea0-887e-0610fff74790 TCGA-P5-A731-01A-11D-A32C-05 TCGA-P5-A731-01A-11D-A32A-01 TCGA-P5-A731-01 5a57bf22-5617-4ea0-887e-0610fff74790 TCGA-P5-A731-01 TCGA-P5-A731-01A-11D-A32A-01 5a57bf22-5617-4ea0-887e-0610fff74790 +TCGA-P5-A733-01 TCGA-P5-A733-01 TCGA-P5-A733 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 52 TCGA-P5-A733-F69012 TCGA-P5-A733 TCGA-P5-A733-01A -19142 134 0 414 Scheduled Follow-up Submission 2014-12-24 FEMALE Astrocytoma No C71.0 9400/3 C71.0 YES 300 NO Left NO G2 true No TCGA-P5-A733.4F732BEF-ADE0-4381-8D60-FB0034115C6D.pdf A733 TUMOR FREE Complete Remission/Response YES Primary Tumor 01 YES YES NO P5 Supratentorial, Frontal Lobe Central nervous system A LIVING 2013 0d3127f8-b7f0-4752-af62-4b093f959b27 TCGA-P5-A733-01A-11D-A32C-05 TCGA-P5-A733-01A-11D-A32A-01 TCGA-P5-A733-01 0d3127f8-b7f0-4752-af62-4b093f959b27 TCGA-P5-A733-01 TCGA-P5-A733-01A-11D-A32A-01 0d3127f8-b7f0-4752-af62-4b093f959b27 +TCGA-P5-A735-01 TCGA-P5-A735-01 TCGA-P5-A735 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 38 TCGA-P5-A735-F69024 TCGA-P5-A735 -14152 0 292 Scheduled Follow-up Submission Complete Remission/Response 2014-12-24 FEMALE Astrocytoma No C71.0 9400/3 C71.0 YES Left NO G2 No A735 TUMOR FREE Complete Remission/Response NO Primary Tumor 01 NO YES NO P5 Supratentorial, Temporal Lobe Central nervous system LIVING 2013 cc2965b7-e059-4cf7-8f10-133903d70a4c TCGA-P5-A735-01A-11D-A32C-05 TCGA-P5-A735-01A-11D-A32A-01 TCGA-P5-A735-01 cc2965b7-e059-4cf7-8f10-133903d70a4c TCGA-P5-A735-01 TCGA-P5-A735-01A-11D-A32A-01 cc2965b7-e059-4cf7-8f10-133903d70a4c +TCGA-P5-A736-01 TCGA-P5-A736-01 TCGA-P5-A736 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 44 TCGA-P5-A736-F69025 TCGA-P5-A736 TCGA-P5-A736-01A -16300 126 0 230 Scheduled Follow-up Submission Complete Remission/Response 2014-12-24 FEMALE Astrocytoma No C71.0 9401/3 C71.0 YES 1110 NO Right NO G3 true No TCGA-P5-A736.46EF7549-943C-45E2-98AA-8A75A518FE51.pdf A736 TUMOR FREE Complete Remission/Response YES Primary Tumor 01 NO YES NO P5 Supratentorial, Parietal Lobe Central nervous system A LIVING 2013 322513c4-e082-45aa-82c4-930f0ca2bada TCGA-P5-A736-01A-11D-A32C-05 TCGA-P5-A736-01A-11D-A32A-01 TCGA-P5-A736-01 322513c4-e082-45aa-82c4-930f0ca2bada TCGA-P5-A736-01 TCGA-P5-A736-01A-11D-A32A-01 322513c4-e082-45aa-82c4-930f0ca2bada +TCGA-P5-A737-01 TCGA-P5-A737-01 TCGA-P5-A737 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 47 TCGA-P5-A737-F69027 TCGA-P5-A737 -17390 0 372 Scheduled Follow-up Submission 2014-12-24 MALE Oligoastrocytoma No C71.0 9400/3 C71.0 YES Right NO G2 No A737 TUMOR FREE Complete Remission/Response NO Primary Tumor 01 NO YES NO P5 Supratentorial, Frontal Lobe Central nervous system LIVING 2012 f2efed52-3995-4a64-a845-2b50517c9554 TCGA-P5-A737-01A-11D-A32C-05 TCGA-P5-A737-01A-11D-A32A-01 TCGA-P5-A737-01 f2efed52-3995-4a64-a845-2b50517c9554 TCGA-P5-A737-01 TCGA-P5-A737-01A-11D-A32A-01 f2efed52-3995-4a64-a845-2b50517c9554 +TCGA-P5-A77W-01 TCGA-P5-A77W-01 TCGA-P5-A77W TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 37 TCGA-P5-A77W-F69028 TCGA-P5-A77W TCGA-P5-A77W-01A -13545 114 0 584 Scheduled Follow-up Submission 2014-12-24 FEMALE Oligoastrocytoma No C71.0 9382/3 C71.0 YES 300 NO Left NO G3 true No TCGA-P5-A77W.E3E86605-648A-4153-A364-A2C313B9FFF2.pdf A77W TUMOR FREE Complete Remission/Response NO Primary Tumor 01 NO YES NO P5 Supratentorial, Frontal Lobe Central nervous system A LIVING 2013 4ecc68c5-c6d1-4c12-a026-1eed1a40e28d TCGA-P5-A77W-01A-11D-A32C-05 TCGA-P5-A77W-01A-11D-A32A-01 TCGA-P5-A77W-01 4ecc68c5-c6d1-4c12-a026-1eed1a40e28d TCGA-P5-A77W-01 TCGA-P5-A77W-01A-11D-A32A-01 4ecc68c5-c6d1-4c12-a026-1eed1a40e28d +TCGA-P5-A77X-01 TCGA-P5-A77X-01 TCGA-P5-A77X TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 55 TCGA-P5-A77X-F69029 TCGA-P5-A77X -20128 0 105 Scheduled Follow-up Submission Complete Remission/Response 2014-12-24 FEMALE Oligoastrocytoma No C71.0 9382/3 C71.0 YES Right NO G2 No A77X TUMOR FREE Complete Remission/Response YES Primary Tumor 01 NO YES NO P5 Supratentorial, Frontal Lobe Central nervous system LIVING 2013 ef9256b0-f4e0-4a1e-9ea2-d4afb75b7ba9 TCGA-P5-A77X-01A-11D-A32C-05 TCGA-P5-A77X-01A-11D-A32A-01 TCGA-P5-A77X-01 ef9256b0-f4e0-4a1e-9ea2-d4afb75b7ba9 TCGA-P5-A77X-01 TCGA-P5-A77X-01A-11D-A32A-01 ef9256b0-f4e0-4a1e-9ea2-d4afb75b7ba9 +TCGA-P5-A780-01 TCGA-P5-A780-01 TCGA-P5-A780 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 44 TCGA-P5-A780-F69031 TCGA-P5-A780 TCGA-P5-A780-01A -16161 92 0 72 Scheduled Follow-up Submission Complete Remission/Response 2014-12-24 FEMALE Astrocytoma No C71.0 9401/3 C71.0 YES 230 NO Right NO G3 true No TCGA-P5-A780.6EBF635A-6875-4843-815A-3E4E25B61BA6.pdf A780 TUMOR FREE Complete Remission/Response YES Primary Tumor 01 YES NO P5 Supratentorial, Temporal Lobe Central nervous system A LIVING 2013 05511b6c-4529-4081-a8aa-aeed061c5159 TCGA-P5-A780-01A-12D-A32C-05 TCGA-P5-A780-01A-12D-A32A-01 TCGA-P5-A780-01 05511b6c-4529-4081-a8aa-aeed061c5159 TCGA-P5-A780-01 TCGA-P5-A780-01A-12D-A32A-01 05511b6c-4529-4081-a8aa-aeed061c5159 +TCGA-P5-A781-01 TCGA-P5-A781-01 TCGA-P5-A781 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 34 TCGA-P5-A781-F69033 TCGA-P5-A781 TCGA-P5-A781-01A -12757 86 0 134 Scheduled Follow-up Submission Complete Remission/Response 2014-12-24 FEMALE Astrocytoma No C71.0 9401/3 C71.0 YES 2980 NO Right NO G3 true No TCGA-P5-A781.32064991-35D2-489F-836E-8646482DA73D.pdf A781 TUMOR FREE Complete Remission/Response YES Primary Tumor 01 NO YES NO P5 Supratentorial, Temporal Lobe Central nervous system A LIVING 2013 7e4fcbe3-07e2-4f26-8a7d-5655d0be0f6a TCGA-P5-A781-01A-11D-A32C-05 TCGA-P5-A781-01A-11D-A32A-01 TCGA-P5-A781-01 7e4fcbe3-07e2-4f26-8a7d-5655d0be0f6a TCGA-P5-A781-01 TCGA-P5-A781-01A-11D-A32A-01 7e4fcbe3-07e2-4f26-8a7d-5655d0be0f6a +TCGA-QH-A65R-01 TCGA-QH-A65R-01 TCGA-QH-A65R TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 38 YES CAT NO TCGA-QH-A65R-F59571 TCGA-QH-A65R -14073 0 461 -10 0 NO YES NO < 12 Years > 20 Years Scheduled Follow-up Submission Stable Disease NO 2014-6-10 FEMALE YES NO Oligodendroglioma NO No C71.9 9451/3 C71.9 YES NO 100 Left YES IHC YES NO NO YES NO G3 NO No A65R Preoperative WITH TUMOR NO NO Partial Remission/Response YES Primary Tumor 01 NO NO White Matter YES NO YES QH Supratentorial, Frontal Lobe Central nervous system NO LIVING 2013 b168cb27-2676-40ed-9743-5046d5b0eb8c TCGA-QH-A65R-01A-21D-A31M-05 TCGA-QH-A65R-01A-21D-A31K-01 TCGA-QH-A65R-01 b168cb27-2676-40ed-9743-5046d5b0eb8c TCGA-QH-A65R-01 TCGA-QH-A65R-01A-21D-A31K-01 b168cb27-2676-40ed-9743-5046d5b0eb8c +TCGA-QH-A65S-01 TCGA-QH-A65S-01 TCGA-QH-A65S TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain NO NO 32 NO NO TCGA-QH-A65S-F42106 TCGA-QH-A65S TCGA-QH-A65S-01A -11861 56 0 77 -7 1 NO YES NO Seizures 0 - 30 Days Scheduled Follow-up Submission Partial Remission/Response NO 2014-11-14 FEMALE NO NO Oligoastrocytoma NO No C71.9 9382/3 C71.9 YES NO 100 NO 90 Left YES IHC YES NO YES NO NO G2 NO false No TCGA-QH-A65S.D970F3D5-D401-4BC0-A2FF-DBF7D0EDBA81.pdf A65S Preoperative WITH TUMOR YES YES Partial Remission/Response NO Primary Tumor 01 YES NO White Matter NO NO YES QH Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2013 7ee7ec4c-236b-4d28-94ee-a9e284f03afd TCGA-QH-A65S-01A-11D-A29T-05 TCGA-QH-A65S-01A-11D-A323-01 TCGA-QH-A65S-01 7ee7ec4c-236b-4d28-94ee-a9e284f03afd TCGA-QH-A65S-01 TCGA-QH-A65S-01A-11D-A323-01 7ee7ec4c-236b-4d28-94ee-a9e284f03afd +TCGA-QH-A65V-01 TCGA-QH-A65V-01 TCGA-QH-A65V TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain NO NO NO 43 NO NO TCGA-QH-A65V-F59561 TCGA-QH-A65V -15850 0 384 -9 1 NO NO NO Seizures 0 - 30 Days Scheduled Follow-up Submission NO 2014-5-15 FEMALE NO NO Oligodendroglioma NO No C71.0 9450/3 C71.0 YES NO 90 Right YES IHC YES NO NO NO NO G2 NO No A65V Preoperative WITH TUMOR YES YES Stable Disease NO Primary Tumor 01 YES NO White Matter YES YES NO QH Supratentorial, Temporal Lobe Central nervous system NO LIVING 2013 dbee8779-dd28-4a2b-a485-9fa8b3a9fc88 TCGA-QH-A65V-01A-11D-A29T-05 TCGA-QH-A65V-01A-11D-A323-01 TCGA-QH-A65V-01 dbee8779-dd28-4a2b-a485-9fa8b3a9fc88 TCGA-QH-A65V-01 TCGA-QH-A65V-01A-11D-A323-01 dbee8779-dd28-4a2b-a485-9fa8b3a9fc88 +TCGA-QH-A65X-01 TCGA-QH-A65X-01 TCGA-QH-A65X TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 28 NO NO TCGA-QH-A65X-F67754 TCGA-QH-A65X TCGA-QH-A65X-01A -10440 39 0 482 237 1 NO NO NO Seizures 0 - 30 Days Scheduled Follow-up Submission Stable Disease NO 2014-11-11 FEMALE NO NO Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES NO 230 NO 90 Right NO Sequence Analysis YES NO NO NO NO G3 NO false No TCGA-QH-A65X.D7B970B7-6910-4926-AD60-F24EEFAFE54A.pdf A65X Post-Adjuvant Therapy TUMOR FREE YES NO Stable Disease YES Primary Tumor 01 YES NO White Matter YES YES NO QH Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2013 551f30d8-5382-4705-b81f-9d29ea31178d TCGA-QH-A65X-01A-11D-A32C-05 TCGA-QH-A65X-01A-11D-A32A-01 TCGA-QH-A65X-01 551f30d8-5382-4705-b81f-9d29ea31178d TCGA-QH-A65X-01 TCGA-QH-A65X-01A-11D-A32A-01 551f30d8-5382-4705-b81f-9d29ea31178d +TCGA-QH-A65Z-01 TCGA-QH-A65Z-01 TCGA-QH-A65Z TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain NO NO 54 NO NO TCGA-QH-A65Z-F59568 TCGA-QH-A65Z TCGA-QH-A65Z-01A -19921 19 0 427 -10 1 NO YES NO Seizures 0 - 30 Days Scheduled Follow-up Submission NO 2014-6-10 MALE NO NO Oligodendroglioma NO No C71.0 9450/3 C71.0 YES NO 210 NO 90 Right YES IHC YES NO NO NO YES G2 NO false No TCGA-QH-A65Z.BA60EA12-509F-4699-AADC-BA0CA105BDAB.pdf A65Z Preoperative TUMOR FREE YES YES Stable Disease YES Primary Tumor 01 YES YES White Matter YES YES NO QH Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2013 671edd73-dbd4-4ab5-8988-864b8a7fe01a TCGA-QH-A65Z-01A-11D-A29T-05 TCGA-QH-A65Z-01A-11D-A323-01 TCGA-QH-A65Z-01 671edd73-dbd4-4ab5-8988-864b8a7fe01a TCGA-QH-A65Z-01 TCGA-QH-A65Z-01A-11D-A323-01 671edd73-dbd4-4ab5-8988-864b8a7fe01a +TCGA-QH-A6CS-01 TCGA-QH-A6CS-01 TCGA-QH-A6CS TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain YES NO NO 41 NO NO TCGA-QH-A6CS-F67755 TCGA-QH-A6CS -15092 0 588 498 -25 1 NO YES NO Seizures 0 - 30 Days Scheduled Follow-up Submission NO 2014-11-13 MALE NO YES Astrocytoma NO No C71.0 9401/3 C71.0 YES NO 90 Right NO IHC YES NO NO NO YES G3 YES No A6CS Preoperative WITH TUMOR YES YES Stable Disease YES Primary Tumor 01 YES NO White Matter YES YES NO QH Supratentorial, Frontal Lobe Central nervous system NO LIVING 2013 a3ea6fd3-7570-4cf5-93c9-33dccdc3d026 TCGA-QH-A6CS-01A-11D-A31M-05 TCGA-QH-A6CS-01A-11D-A31K-01 TCGA-QH-A6CS-01 a3ea6fd3-7570-4cf5-93c9-33dccdc3d026 TCGA-QH-A6CS-01 TCGA-QH-A6CS-01A-11D-A31K-01 a3ea6fd3-7570-4cf5-93c9-33dccdc3d026 +TCGA-QH-A6CU-01 TCGA-QH-A6CU-01 TCGA-QH-A6CU TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain NO NO NO 52 NO NO TCGA-QH-A6CU-F60341 TCGA-QH-A6CU TCGA-QH-A6CU-01A -19149 59 0 451 -13 1 NO YES NO > 20 Years Seizures 0 - 30 Days Scheduled Follow-up Submission Stable Disease NO 2014-6-6 FEMALE YES NO Oligodendroglioma NO No C71.0 9451/3 C71.0 YES NO 470 NO 90 Left YES IHC YES NO YES YES NO G3 NO false No TCGA-QH-A6CU.F87EBF56-A3DC-4790-98AB-1B93FB917CAC.pdf A6CU Preoperative TUMOR FREE YES YES Stable Disease YES Primary Tumor 01 YES NO White Matter YES YES NO QH Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2013 43d6f3d2-2bd6-41e1-9d85-735f5f60e25a TCGA-QH-A6CU-01A-11D-A31M-05 TCGA-QH-A6CU-01A-11D-A31K-01 TCGA-QH-A6CU-01 43d6f3d2-2bd6-41e1-9d85-735f5f60e25a TCGA-QH-A6CU-01 TCGA-QH-A6CU-01A-11D-A31K-01 43d6f3d2-2bd6-41e1-9d85-735f5f60e25a +TCGA-QH-A6CV-01 TCGA-QH-A6CV-01 TCGA-QH-A6CV TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain NO NO NO 51 NO NO TCGA-QH-A6CV-F60218 TCGA-QH-A6CV TCGA-QH-A6CV-01A -18955 52 0 442 -42 1 NO NO NO Headaches 0 - 30 Days Scheduled Follow-up Submission Stable Disease NO 2014-6-6 MALE NO YES Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES 190 NO 90 Right YES Sequence Analysis YES NO NO NO NO G3 NO false No TCGA-QH-A6CV.DC5685CF-74DF-45C6-B530-831FC33228C6.pdf A6CV Preoperative WITH TUMOR YES NO Stable Disease YES Primary Tumor 01 YES NO White Matter NO YES NO QH Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2013 3dd53b9a-6683-42ed-9594-5458c655cf8f TCGA-QH-A6CV-01A-11D-A31M-05 TCGA-QH-A6CV-01A-11D-A31K-01 TCGA-QH-A6CV-01 3dd53b9a-6683-42ed-9594-5458c655cf8f TCGA-QH-A6CV-01 TCGA-QH-A6CV-01A-11D-A31K-01 3dd53b9a-6683-42ed-9594-5458c655cf8f +TCGA-QH-A6CW-01 TCGA-QH-A6CW-01 TCGA-QH-A6CW TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain NO NO NO 43 NO YES TCGA-QH-A6CW-F60337 TCGA-QH-A6CW TCGA-QH-A6CW-01A -15847 24 0 414 -8 1 NO NO NO > 20 Years Seizures 31 - 90 Days Scheduled Follow-up Submission Partial Remission/Response NO 2014-6-6 MALE YES NO Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES 270 NO 90 Right YES IHC YES NO NO YES NO G3 NO false No TCGA-QH-A6CW.0D917D08-E23D-4158-8049-1B0A9775868B.pdf A6CW Preoperative TUMOR FREE YES NO Partial Remission/Response NO Primary Tumor 01 YES NO White Matter NO YES NO QH Supratentorial, Temporal Lobe Central nervous system A NO LIVING 2013 6cc3ae71-fe99-4dcb-b5c6-b4e8eb7b336c TCGA-QH-A6CW-01A-11D-A32C-05 TCGA-QH-A6CW-01A-11D-A32A-01 TCGA-QH-A6CW-01 6cc3ae71-fe99-4dcb-b5c6-b4e8eb7b336c TCGA-QH-A6CW-01 TCGA-QH-A6CW-01A-11D-A32A-01 6cc3ae71-fe99-4dcb-b5c6-b4e8eb7b336c +TCGA-QH-A6CX-01 TCGA-QH-A6CX-01 TCGA-QH-A6CX TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain NO NO NO 66 NO NO TCGA-QH-A6CX-F60335 TCGA-QH-A6CX -24252 372 0 -1 273 -7 1 NO NO NO Seizures 0 - 30 Days Scheduled Follow-up Submission NO 2014-6-6 MALE NO NO Astrocytoma NO No C71.0 9400/3 C71.0 YES NO 90 Left NO IHC YES NO NO NO NO G2 YES No A6CX Preoperative WITH TUMOR YES YES Progressive Disease YES Primary Tumor 01 YES NO White Matter NO YES NO QH Supratentorial, Temporal Lobe Central nervous system NO DECEASED 2013 caba02b8-ffcf-440f-ab03-6141aa19752f TCGA-QH-A6CX-01A-11D-A32C-05 TCGA-QH-A6CX-01A-11D-A32A-01 TCGA-QH-A6CX-01 caba02b8-ffcf-440f-ab03-6141aa19752f TCGA-QH-A6CX-01 TCGA-QH-A6CX-01A-11D-A32A-01 caba02b8-ffcf-440f-ab03-6141aa19752f +TCGA-QH-A6CY-01 TCGA-QH-A6CY-01 TCGA-QH-A6CY TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 38 NO NO TCGA-QH-A6CY-F60215 TCGA-QH-A6CY TCGA-QH-A6CY-01A -14140 18 0 408 -26 1 NO NO NO Headaches 0 - 30 Days Scheduled Follow-up Submission Stable Disease NO 2014-6-6 MALE NO YES Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES 360 NO 90 Right YES IHC YES NO NO NO NO G3 NO false No TCGA-QH-A6CY.F47D9AFD-E511-450E-9F15-E1EDBF0FC87F.pdf A6CY Preoperative WITH TUMOR YES YES Stable Disease YES Primary Tumor 01 YES NO White Matter YES YES NO QH Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2013 6369f5c8-dbd0-4c80-a621-5c3310ebad45 TCGA-QH-A6CY-01A-11D-A32C-05 TCGA-QH-A6CY-01A-11D-A32A-01 TCGA-QH-A6CY-01 6369f5c8-dbd0-4c80-a621-5c3310ebad45 TCGA-QH-A6CY-01 TCGA-QH-A6CY-01A-11D-A32A-01 6369f5c8-dbd0-4c80-a621-5c3310ebad45 +TCGA-QH-A6CZ-01 TCGA-QH-A6CZ-01 TCGA-QH-A6CZ TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain NO NO NO 38 NO NO TCGA-QH-A6CZ-F60216 TCGA-QH-A6CZ TCGA-QH-A6CZ-01A -14007 16 0 279 -51 1 NO NO NO Seizures 0 - 30 Days Scheduled Follow-up Submission Stable Disease NO 2014-6-3 MALE NO NO Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES 360 NO 90 Right YES IHC YES NO NO NO NO G2 NO false No TCGA-QH-A6CZ.B346A105-9790-4B51-B83E-7272FF381FA1.pdf A6CZ Preoperative TUMOR FREE YES YES Stable Disease NO Primary Tumor 01 YES NO White Matter NO YES NO QH Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2013 3d2e42a7-d83f-471b-ac4c-19f3d62eb0ee TCGA-QH-A6CZ-01A-11D-A32C-05 TCGA-QH-A6CZ-01A-11D-A32A-01 TCGA-QH-A6CZ-01 3d2e42a7-d83f-471b-ac4c-19f3d62eb0ee TCGA-QH-A6CZ-01 TCGA-QH-A6CZ-01A-11D-A32A-01 3d2e42a7-d83f-471b-ac4c-19f3d62eb0ee +TCGA-QH-A6X3-01 TCGA-QH-A6X3-01 TCGA-QH-A6X3 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 27 NO TCGA-QH-A6X3-F67748 TCGA-QH-A6X3 -10184 0 313 16 1 NO NO NO Seizures 0 - 30 Days Scheduled Follow-up Submission Complete Remission/Response 2014-11-11 MALE NO NO Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES NO 90 Right YES IHC YES NO NO NO NO G2 NO No A6X3 Other TUMOR FREE NO NO Complete Remission/Response NO Primary Tumor 01 YES NO White Matter NO YES NO QH Supratentorial, Parietal Lobe Central nervous system NO LIVING 2013 f514a04f-e20a-497f-98a0-747474815ecd TCGA-QH-A6X3-01A-21D-A32C-05 TCGA-QH-A6X3-01A-21D-A32A-01 TCGA-QH-A6X3-01 f514a04f-e20a-497f-98a0-747474815ecd TCGA-QH-A6X3-01 TCGA-QH-A6X3-01A-21D-A32A-01 f514a04f-e20a-497f-98a0-747474815ecd +TCGA-QH-A6X4-01 TCGA-QH-A6X4-01 TCGA-QH-A6X4 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 47 NO NO TCGA-QH-A6X4-F67744 TCGA-QH-A6X4 TCGA-QH-A6X4-01A -17258 129 0 442 192 1 NO NO NO Sensory Changes 0 - 30 Days Scheduled Follow-up Submission Complete Remission/Response 2014-11-11 MALE NO NO Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES NO 550 NO 90 Left YES Sequence Analysis YES NO NO NO YES G3 NO false No TCGA-QH-A6X4.638A5F85-FA2A-4E1D-B1BC-DC1922E9BAD9.pdf A6X4 Pre-Adjuvant Therapy TUMOR FREE YES YES Complete Remission/Response YES Primary Tumor 01 YES YES Cerebral Cortex YES YES NO QH Supratentorial, Temporal Lobe Central nervous system A NO LIVING 2013 0ba1f5ce-704d-4a40-854a-fcde2b4dee86 TCGA-QH-A6X4-01A-51D-A32C-05 TCGA-QH-A6X4-01A-51D-A32A-01 TCGA-QH-A6X4-01 0ba1f5ce-704d-4a40-854a-fcde2b4dee86 TCGA-QH-A6X4-01 TCGA-QH-A6X4-01A-51D-A32A-01 0ba1f5ce-704d-4a40-854a-fcde2b4dee86 +TCGA-QH-A6X5-01 TCGA-QH-A6X5-01 TCGA-QH-A6X5 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 58 NO NO TCGA-QH-A6X5-F67745 TCGA-QH-A6X5 -21239 0 497 119 1 NO NO NO Seizures 0 - 30 Days Scheduled Follow-up Submission 2014-11-11 FEMALE NO NO Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES NO 90 Left YES Sequence Analysis YES NO NO NO YES G2 NO No A6X5 Other NO NO NO Primary Tumor 01 YES NO White Matter NO YES NO QH Supratentorial, Frontal Lobe Central nervous system NO LIVING 2013 d6e91e40-d498-45eb-8cc7-e191c50f077e TCGA-QH-A6X5-01A-12D-A32C-05 TCGA-QH-A6X5-01A-12D-A32A-01 TCGA-QH-A6X5-01 d6e91e40-d498-45eb-8cc7-e191c50f077e TCGA-QH-A6X5-01 TCGA-QH-A6X5-01A-12D-A32A-01 d6e91e40-d498-45eb-8cc7-e191c50f077e +TCGA-QH-A6X8-01 TCGA-QH-A6X8-01 TCGA-QH-A6X8 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 56 NO NO TCGA-QH-A6X8-F67753 TCGA-QH-A6X8 TCGA-QH-A6X8-01A -20771 54 0 509 144 0 NO NO NO Mental Status Changes 0 - 30 Days Scheduled Follow-up Submission Stable Disease 2014-11-11 FEMALE NO NO Oligodendroglioma NO No C71.0 9451/3 C71.0 YES NO 330 NO 100 Left YES IHC YES NO YES NO YES G3 NO false No TCGA-QH-A6X8.01982953-8F6F-4BDE-B645-824E04C6CAAB.pdf A6X8 Post-Adjuvant Therapy WITH TUMOR YES NO Stable Disease YES Primary Tumor 01 YES NO White Matter YES YES NO QH Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2013 701594b8-2848-4c06-be1b-ab49c2ca71ea TCGA-QH-A6X8-01A-12D-A32C-05 TCGA-QH-A6X8-01A-12D-A32A-01 TCGA-QH-A6X8-01 701594b8-2848-4c06-be1b-ab49c2ca71ea TCGA-QH-A6X8-01 TCGA-QH-A6X8-01A-12D-A32A-01 701594b8-2848-4c06-be1b-ab49c2ca71ea +TCGA-QH-A6X9-01 TCGA-QH-A6X9-01 TCGA-QH-A6X9 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 73 NO NO TCGA-QH-A6X9-F67996 TCGA-QH-A6X9 TCGA-QH-A6X9-01A -26992 22 0 58 58 3 NO YES NO Seizures 0 - 30 Days Scheduled Follow-up Submission NO 2014-11-13 FEMALE NO NO Oligodendroglioma NO No C71.0 9450/3 C71.0 YES NO 190 NO 40 Right YES Sequence Analysis YES NO YES NO NO G2 NO false No TCGA-QH-A6X9.62469927-D0A5-4C27-9ABA-1DEFAB93B304.pdf A6X9 Pre-Adjuvant Therapy YES NO NO Primary Tumor 01 YES NO White Matter NO YES NO QH Supratentorial, Temporal Lobe Central nervous system A NO LIVING 2013 5089e59f-7c52-4c4d-a1f3-a4cbd84877ae TCGA-QH-A6X9-01A-12D-A32C-05 TCGA-QH-A6X9-01A-12D-A32A-01 TCGA-QH-A6X9-01 5089e59f-7c52-4c4d-a1f3-a4cbd84877ae TCGA-QH-A6X9-01 TCGA-QH-A6X9-01A-12D-A32A-01 5089e59f-7c52-4c4d-a1f3-a4cbd84877ae +TCGA-QH-A6XA-01 TCGA-QH-A6XA-01 TCGA-QH-A6XA TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 23 NO NO TCGA-QH-A6XA-F67837 TCGA-QH-A6XA -8508 0 502 7 0 NO NO NO Scheduled Follow-up Submission Complete Remission/Response NO 2014-11-12 FEMALE NO NO Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES NO 100 Left YES Sequence Analysis YES NO NO YES NO G2 NO No A6XA Pre-Adjuvant Therapy TUMOR FREE NO NO Complete Remission/Response NO Primary Tumor 01 NO NO White Matter NO YES NO QH Supratentorial, Frontal Lobe Central nervous system NO LIVING 2013 fdced5ba-d0d5-4e07-b001-9d740cc48898 TCGA-QH-A6XA-01A-12D-A32C-05 TCGA-QH-A6XA-01A-12D-A32A-01 TCGA-QH-A6XA-01 fdced5ba-d0d5-4e07-b001-9d740cc48898 TCGA-QH-A6XA-01 TCGA-QH-A6XA-01A-12D-A32A-01 fdced5ba-d0d5-4e07-b001-9d740cc48898 +TCGA-QH-A6XC-01 TCGA-QH-A6XC-01 TCGA-QH-A6XC TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain YES YES YES 48 YES TCGA-QH-A6XC-F67756 TCGA-QH-A6XC 440 -17692 0 508 438 153 1 NO YES NO Seizures 0 - 30 Days Scheduled Follow-up Submission NO 2014-11-12 MALE NO NO Astrocytoma NO No C71.0 9401/3 C71.0 YES NO 70 Right NO Sequence Analysis YES NO NO NO G3 YES No A6XC Post-Adjuvant Therapy WITH TUMOR YES NO [Discrepancy] YES Primary Tumor 01 YES NO White Matter YES YES NO QH Supratentorial, Frontal Lobe Central nervous system NO LIVING 2013 acf520e1-55ec-41e7-a2a5-1e9eabac0b93 TCGA-QH-A6XC-01A-12D-A32C-05 TCGA-QH-A6XC-01A-12D-A32A-01 TCGA-QH-A6XC-01 acf520e1-55ec-41e7-a2a5-1e9eabac0b93 TCGA-QH-A6XC-01 TCGA-QH-A6XC-01A-12D-A32A-01 acf520e1-55ec-41e7-a2a5-1e9eabac0b93 +TCGA-QH-A86X-01 TCGA-QH-A86X-01 TCGA-QH-A86X TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 33 NO NO TCGA-QH-A86X-F67829 TCGA-QH-A86X TCGA-QH-A86X-01A -12385 7 0 337 106 0 NO YES Seizures 91 - 180 Days Scheduled Follow-up Submission Complete Remission/Response NO 2014-11-12 MALE NO NO Oligodendroglioma NO No C71.0 9450/3 C71.0 YES NO 240 NO 100 Left YES IHC YES NO NO NO NO G2 NO false No TCGA-QH-A86X.CC0201F5-5747-4A46-A364-8EC6F16D67C1.pdf A86X Other TUMOR FREE YES NO Complete Remission/Response NO Primary Tumor 01 YES NO Cerebral Cortex NO YES NO QH Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2013 3c8ebeb7-68ef-4d11-80b0-fc5560dd01d6 TCGA-QH-A86X-01A-11D-A368-05 TCGA-QH-A86X-01A-11D-A36N-01 TCGA-QH-A86X-01 3c8ebeb7-68ef-4d11-80b0-fc5560dd01d6 TCGA-QH-A86X-01 TCGA-QH-A86X-01A-11D-A36N-01 3c8ebeb7-68ef-4d11-80b0-fc5560dd01d6 +TCGA-QH-A870-01 TCGA-QH-A870-01 TCGA-QH-A870 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain YES NO NO 38 NO NO TCGA-QH-A870-F67994 TCGA-QH-A870 TCGA-QH-A870-01A -14082 1 0 395 335 2 1 NO YES NO Headaches > 181 Days Scheduled Follow-up Submission Progressive Disease 2014-11-14 FEMALE NO YES Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES NO 450 NO 80 Right YES IHC YES NO NO NO NO G3 YES false No TCGA-QH-A870.C84F6D0C-3879-4D63-8CE8-10D03D3C71A3.pdf A870 Other WITH TUMOR YES YES Complete Remission/Response NO Primary Tumor 01 NO NO White Matter NO YES NO QH Supratentorial, Occipital Lobe Central nervous system A YES LIVING 2013 2c8a4bf0-f9dd-4fb3-8415-782434a12ceb TCGA-QH-A870-01A-11D-A368-05 TCGA-QH-A870-01A-11D-A36N-01 TCGA-QH-A870-01 2c8a4bf0-f9dd-4fb3-8415-782434a12ceb TCGA-QH-A870-01 TCGA-QH-A870-01A-11D-A36N-01 2c8a4bf0-f9dd-4fb3-8415-782434a12ceb +TCGA-R8-A6MK-01 TCGA-R8-A6MK-01 TCGA-R8-A6MK TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 40 TCGA-R8-A6MK TCGA-R8-A6MK-01A -14716 2841 0 2702 YES NO 2013-12-30 MALE Oligodendroglioma NO No C71.0 9450/3 C71.0 YES 260 NO Right G2 true No TCGA-R8-A6MK.0E083D5C-1EE1-4BDA-9D6E-93420C3BAE39.pdf A6MK NO Primary Tumor 01 YES YES NO YES R8 Supratentorial, Frontal Lobe Central nervous system A LIVING 2005 849208d7-caaf-488e-a489-5638858f6883 TCGA-R8-A6MK-01A-11D-A32C-05 TCGA-R8-A6MK-01A-11D-A32A-01 TCGA-R8-A6MK-01 849208d7-caaf-488e-a489-5638858f6883 TCGA-R8-A6MK-01 TCGA-R8-A6MK-01A-11D-A32A-01 849208d7-caaf-488e-a489-5638858f6883 +TCGA-R8-A6ML-01 TCGA-R8-A6ML-01 TCGA-R8-A6ML TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 52 TCGA-R8-A6ML TCGA-R8-A6ML-01A -19185 2735 0 2860 NO NO 2013-12-30 MALE Oligodendroglioma Yes, Pharmaceutical Treatment Prior to Resection C71.0 9451/3 C71.0 YES 130 NO Left G3 true No TCGA-R8-A6ML.E87BD3AD-C060-4DF5-8396-0DE9A036C5EB.pdf A6ML YES Primary Tumor 01 YES YES NO YES R8 Supratentorial, Frontal Lobe Central nervous system A LIVING 2005 58e03221-6257-4bf1-984f-ee7a92418c13 TCGA-R8-A6ML-01A-11D-A32C-05 TCGA-R8-A6ML-01A-11D-A32A-01 TCGA-R8-A6ML-01 58e03221-6257-4bf1-984f-ee7a92418c13 TCGA-R8-A6ML-01 TCGA-R8-A6ML-01A-11D-A32A-01 58e03221-6257-4bf1-984f-ee7a92418c13 +TCGA-R8-A6MO-01 TCGA-R8-A6MO-01 TCGA-R8-A6MO TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 53 TCGA-R8-A6MO -19432 0 993 NO NO 2013-12-30 FEMALE Oligodendroglioma No C71.0 9450/3 C71.0 YES Right G2 No A6MO NO Primary Tumor 01 YES NO NO YES R8 Supratentorial, Frontal Lobe Central nervous system LIVING 2009 cfdc2b0d-f87c-46fd-81b0-0eab963f8871 TCGA-R8-A6MO-01A-11D-A33U-05 TCGA-R8-A6MO-01A-11D-A33S-01 TCGA-R8-A6MO-01 cfdc2b0d-f87c-46fd-81b0-0eab963f8871 TCGA-R8-A6MO-01 TCGA-R8-A6MO-01A-11D-A33S-01 cfdc2b0d-f87c-46fd-81b0-0eab963f8871 +TCGA-R8-A6YH-01 TCGA-R8-A6YH-01 TCGA-R8-A6YH TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain TCGA-R8-A6YH-01A 200 NO true TCGA-R8-A6YH.911537EB-E3CE-4D30-B3A2-90932D94A4DA.pdf Primary Tumor 01 A 500000a8-420b-43e1-9ed1-e0d66fe2aece TCGA-R8-A6YH-01A-21D-A32C-05 TCGA-R8-A6YH-01A-21D-A32A-01 TCGA-R8-A6YH-01 500000a8-420b-43e1-9ed1-e0d66fe2aece TCGA-R8-A6YH-01 TCGA-R8-A6YH-01A-21D-A32A-01 500000a8-420b-43e1-9ed1-e0d66fe2aece +TCGA-R8-A73M-01 TCGA-R8-A73M-01 TCGA-R8-A73M TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 48 TCGA-R8-A73M -17610 0 1806 YES NO 2013-12-30 FEMALE YES Oligodendroglioma No C71.0 9450/3 C71.0 YES Left G2 NO Yes, History of Prior Malignancy A73M NO Primary Tumor 01 YES NO YES R8 Supratentorial, Parietal Lobe Central nervous system YES LIVING 2008 e49a9619-3446-4862-8b91-d429d95197cb TCGA-R8-A73M-01A-11D-A32C-05 TCGA-R8-A73M-01A-11D-A32A-01 TCGA-R8-A73M-01 e49a9619-3446-4862-8b91-d429d95197cb TCGA-R8-A73M-01 TCGA-R8-A73M-01A-11D-A32A-01 e49a9619-3446-4862-8b91-d429d95197cb +TCGA-RR-A6KA-01 TCGA-RR-A6KA-01 TCGA-RR-A6KA TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 72 TCGA-RR-A6KA TCGA-RR-A6KA-01A -26582 282 191 0 2014-8-18 FEMALE Glioblastoma Multiforme (GBM) No C71.1 9440/3 C71.1 YES Tumor resection 100 NO true No TCGA-RR-A6KA.F58558E1-9BB7-4991-9CDD-6C18DCB448E5.pdf A6KA WITH TUMOR NO Partial Remission/Response NO NO Primary Tumor 01 NO YES RR Brain A DECEASED 2012 TCGA-RR-A6KA-01A-21D-A33U-05 TCGA-RR-A6KA-01A-21D-A33S-01 TCGA-RR-A6KA-01A-21D-A33S-01 +TCGA-RR-A6KB-01 TCGA-RR-A6KB-01 TCGA-RR-A6KB TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 51 TCGA-RR-A6KB-F67184 TCGA-RR-A6KB TCGA-RR-A6KB-01A -18713 2271 0 0 Scheduled Follow-up Submission 2014-10-31 MALE Glioblastoma Multiforme (GBM) No C71.1 9440/3 C71.1 YES Tumor resection 320 NO YES true No TCGA-RR-A6KB.FE890D7D-5BB3-4A91-804E-894CA44AA71B.pdf A6KB NO Primary Tumor 01 NO YES RR Brain A LIVING 2007 TCGA-RR-A6KB-01A-12D-A33U-05 TCGA-RR-A6KB-01A-12D-A33S-01 TCGA-RR-A6KB-01A-12D-A33S-01 +TCGA-RR-A6KC-01 TCGA-RR-A6KC-01 TCGA-RR-A6KC TCGA lower grade glioma and glioblastoma (GBMLGG) glioblastoma multiforme Brain 55 TCGA-RR-A6KC TCGA-RR-A6KC-01A -20302 959 625 0 2014-9-23 MALE Glioblastoma Multiforme (GBM) No C71.2 9440/3 C71.2 YES Tumor resection 180 NO true No TCGA-RR-A6KC.53E9E4FC-DBC4-41F0-8AA6-BB5493B324CB.pdf A6KC YES Complete Remission/Response NO YES Primary Tumor 01 NO YES RR Brain A DECEASED 2010 TCGA-RR-A6KC-01A-31D-A33U-05 TCGA-RR-A6KC-01A-31D-A33S-01 TCGA-RR-A6KC-01A-31D-A33S-01 +TCGA-RY-A83X-01 TCGA-RY-A83X-01 TCGA-RY-A83X TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 46 NO TCGA-RY-A83X-F69371 TCGA-RY-A83X -16911 0 939 NO NO NO Mental Status Changes > 181 Days Scheduled Follow-up Submission Stable Disease 2015-1-7 FEMALE NO NO Oligodendroglioma NO No C71.0 9450/3 C71.0 YES NO Right YES IHC YES NO YES NO NO G2 NO No A83X TUMOR FREE NO Primary Tumor 01 NO NO Cerebral Cortex NO YES NO RY Supratentorial, Frontal Lobe Central nervous system NO LIVING 2012 c44e9cfc-d595-4098-b55b-8275d7284f05 TCGA-RY-A83X-01A-11D-A368-05 TCGA-RY-A83X-01A-11D-A36N-01 TCGA-RY-A83X-01 c44e9cfc-d595-4098-b55b-8275d7284f05 TCGA-RY-A83X-01 TCGA-RY-A83X-01A-11D-A36N-01 c44e9cfc-d595-4098-b55b-8275d7284f05 +TCGA-RY-A83Y-01 TCGA-RY-A83Y-01 TCGA-RY-A83Y TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 45 NO TCGA-RY-A83Y-F69684 TCGA-RY-A83Y TCGA-RY-A83Y-01A -16470 485 0 166 2 NO NO NO Seizures 0 - 30 Days Scheduled Follow-up Submission 2015-1-15 MALE NO NO Oligodendroglioma NO No C71.0 9450/3 C71.0 YES NO 150 NO 80 Left YES IHC YES YES YES NO NO G2 false No TCGA-RY-A83Y.EEC58176-5007-4A8F-9BBB-ABE5B1D13772.pdf A83Y Other TUMOR FREE NO Primary Tumor 01 YES NO Cerebral Cortex YES NO RY Supratentorial, Parietal Lobe Central nervous system A NO LIVING 2012 55c39d1f-7300-42e9-8205-d919cdddf558 TCGA-RY-A83Y-01A-11D-A368-05 TCGA-RY-A83Y-01A-11D-A36N-01 TCGA-RY-A83Y-01 55c39d1f-7300-42e9-8205-d919cdddf558 TCGA-RY-A83Y-01 TCGA-RY-A83Y-01A-11D-A36N-01 55c39d1f-7300-42e9-8205-d919cdddf558 +TCGA-RY-A83Z-01 TCGA-RY-A83Z-01 TCGA-RY-A83Z TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 54 NO TCGA-RY-A83Z-F69683 TCGA-RY-A83Z -19903 0 301 NO NO NO Seizures 0 - 30 Days Scheduled Follow-up Submission 2015-1-15 FEMALE NO NO Astrocytoma NO No C71.9 9401/3 C71.9 YES NO Left YES IHC NO YES NO NO NO G3 NO No A83Z WITH TUMOR Stable Disease YES Primary Tumor 01 YES NO Cerebral Cortex YES YES NO RY Supratentorial, Frontal Lobe Central nervous system NO LIVING 2012 f5dd58db-4834-4d0e-aeb6-15d6b8f05826 TCGA-RY-A83Z-01A-11D-A368-05 TCGA-RY-A83Z-01A-11D-A36N-01 TCGA-RY-A83Z-01 f5dd58db-4834-4d0e-aeb6-15d6b8f05826 TCGA-RY-A83Z-01 TCGA-RY-A83Z-01A-11D-A36N-01 f5dd58db-4834-4d0e-aeb6-15d6b8f05826 +TCGA-RY-A840-01 TCGA-RY-A840-01 TCGA-RY-A840 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 47 NO TCGA-RY-A840-F69714 TCGA-RY-A840 TCGA-RY-A840-01A -17501 444 0 854 22 0 NO NO NO < 12 Years Seizures 0 - 30 Days Scheduled Follow-up Submission Stable Disease NO 2015-1-16 MALE YES YES Oligodendroglioma NO No C71.0 9451/3 C71.0 YES NO 60 NO 90 Left YES IHC YES NO NO NO NO G3 NO false No TCGA-RY-A840.D0ABD0C6-7F14-4CC3-9B44-0566D3384727.pdf A840 Pre-Adjuvant Therapy WITH TUMOR Stable Disease NO Primary Tumor 01 YES NO Cerebral Cortex YES YES NO RY Supratentorial, Temporal Lobe Central nervous system A NO LIVING 2012 2e4d2d19-c416-4ff3-986e-66e40fca946c TCGA-RY-A840-01A-11D-A368-05 TCGA-RY-A840-01A-11D-A36N-01 TCGA-RY-A840-01 2e4d2d19-c416-4ff3-986e-66e40fca946c TCGA-RY-A840-01 TCGA-RY-A840-01A-11D-A36N-01 2e4d2d19-c416-4ff3-986e-66e40fca946c +TCGA-RY-A843-01 TCGA-RY-A843-01 TCGA-RY-A843 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 30 NO TCGA-RY-A843-F69739 TCGA-RY-A843 TCGA-RY-A843-01A -11083 312 0 63 NO NO NO Seizures > 181 Days Scheduled Follow-up Submission Stable Disease 2015-1-16 MALE NO NO Astrocytoma NO No C71.0 9401/3 C71.0 YES NO 300 NO Left NO IHC YES YES NO NO NO G3 NO false No TCGA-RY-A843.2C380241-843C-4301-8891-78345D97CC08.pdf A843 WITH TUMOR NO Primary Tumor 01 YES NO Cerebral Cortex YES YES NO RY Supratentorial, Temporal Lobe Central nervous system A NO LIVING 2012 2dc97660-d26f-49a4-9e47-3678a3768724 TCGA-RY-A843-01A-11D-A368-05 TCGA-RY-A843-01A-11D-A36N-01 TCGA-RY-A843-01 2dc97660-d26f-49a4-9e47-3678a3768724 TCGA-RY-A843-01 TCGA-RY-A843-01A-11D-A36N-01 2dc97660-d26f-49a4-9e47-3678a3768724 +TCGA-RY-A845-01 TCGA-RY-A845-01 TCGA-RY-A845 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 40 NO TCGA-RY-A845-F69753 TCGA-RY-A845 -14617 0 596 1 NO NO NO < 12 Years Mental Status Changes 0 - 30 Days Scheduled Follow-up Submission NO 2015-1-16 FEMALE YES NO Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES NO 80 Left NO IHC YES NO YES NO NO G2 NO No A845 TUMOR FREE NO Primary Tumor 01 YES NO Cerebral Cortex NO YES NO RY Supratentorial, Parietal Lobe Central nervous system NO LIVING 2013 a57d41bc-71b6-4215-804a-d66071f60594 TCGA-RY-A845-01A-11D-A368-05 TCGA-RY-A845-01A-11D-A36N-01 TCGA-RY-A845-01 a57d41bc-71b6-4215-804a-d66071f60594 TCGA-RY-A845-01 TCGA-RY-A845-01A-11D-A36N-01 a57d41bc-71b6-4215-804a-d66071f60594 +TCGA-RY-A847-01 TCGA-RY-A847-01 TCGA-RY-A847 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 45 TCGA-RY-A847-F69806 TCGA-RY-A847 TCGA-RY-A847-01A -16732 471 0 933 62 NO NO Scheduled Follow-up Submission Stable Disease 2015-1-20 MALE NO Oligodendroglioma NO No C71.0 9450/3 C71.0 YES NO 60 NO 90 Right YES IHC YES NO NO NO G2 NO false No TCGA-RY-A847.E1F9B39F-DE08-45CD-ABCC-5D7C3B6CE090.pdf A847 Other TUMOR FREE NO Primary Tumor 01 NO NO Cerebral Cortex NO YES NO RY Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2012 1d7d22de-0bfc-4357-8c5a-7289aa0d97b8 TCGA-RY-A847-01A-11D-A368-05 TCGA-RY-A847-01A-11D-A36N-01 TCGA-RY-A847-01 1d7d22de-0bfc-4357-8c5a-7289aa0d97b8 TCGA-RY-A847-01 TCGA-RY-A847-01A-11D-A36N-01 1d7d22de-0bfc-4357-8c5a-7289aa0d97b8 +TCGA-S9-A6TS-01 TCGA-S9-A6TS-01 TCGA-S9-A6TS TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain YES NO YES 48 NO NO TCGA-S9-A6TS-F51945 TCGA-S9-A6TS TCGA-S9-A6TS-01A 1324 -17857 2402 1891 0 1324 -10 0 NO Scheduled Follow-up Submission Progressive Disease NO 2013-11-26 FEMALE NO NO Astrocytoma NO No C71.0 9401/3 C71.0 YES NO 150 NO 100 Right NO NO NO NO NO G3 YES false No TCGA-S9-A6TS.A6DF65CD-E78C-4CF8-ACC7-B35F2EF33ECA.pdf A6TS Preoperative WITH TUMOR NO NO Progressive Disease YES Primary Tumor 01 NO NO Cerebral Cortex NO NO YES S9 Supratentorial, Frontal Lobe Central nervous system A NO DECEASED 2006 735919a3-a98f-41d9-84cf-0bc3983b9f3b TCGA-S9-A6TS-01A-12D-A33U-05 TCGA-S9-A6TS-01A-12D-A33S-01 TCGA-S9-A6TS-01 735919a3-a98f-41d9-84cf-0bc3983b9f3b TCGA-S9-A6TS-01 TCGA-S9-A6TS-01A-12D-A33S-01 735919a3-a98f-41d9-84cf-0bc3983b9f3b +TCGA-S9-A6TU-01 TCGA-S9-A6TU-01 TCGA-S9-A6TU TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain NO NO NO 38 NO NO TCGA-S9-A6TU-F63758 TCGA-S9-A6TU -14108 0 2650 2650 -2 0 NO Sensory Changes 31 - 90 Days Additional New Tumor Event Progressive Disease NO 2014-8-18 MALE NO NO Astrocytoma NO No C71.0 9400/3 C71.0 YES 100 Left YES IHC YES NO NO NO NO G2 YES No A6TU Preoperative WITH TUMOR NO NO Partial Remission/Response NO Primary Tumor 01 YES YES Cerebral Cortex NO NO YES S9 Supratentorial, Temporal Lobe Central nervous system NO LIVING 2007 deff8fdc-d2f8-422a-b5bb-57a65241cf51 TCGA-S9-A6TU-01A-12D-A32C-05 TCGA-S9-A6TU-01A-12D-A32A-01 TCGA-S9-A6TU-01 deff8fdc-d2f8-422a-b5bb-57a65241cf51 TCGA-S9-A6TU-01 TCGA-S9-A6TU-01A-12D-A32A-01 deff8fdc-d2f8-422a-b5bb-57a65241cf51 +TCGA-S9-A6TV-01 TCGA-S9-A6TV-01 TCGA-S9-A6TV TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 50 NO NO TCGA-S9-A6TV-F67222 TCGA-S9-A6TV -18321 0 571 -14 1 NO Headaches 0 - 30 Days Scheduled Follow-up Submission NO 2014-11-3 MALE NO YES Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES 90 Right YES IHC YES YES NO NO YES G3 NO No A6TV Preoperative TUMOR FREE NO YES Complete Remission/Response YES Primary Tumor 01 NO NO Cerebral Cortex YES NO YES S9 Supratentorial, Frontal Lobe Central nervous system YES LIVING 2010 d5c2aa43-35e2-41b9-9b55-c0a6618dfb20 TCGA-S9-A6TV-01A-12D-A34K-05 TCGA-S9-A6TV-01A-12D-A34I-01 TCGA-S9-A6TV-01 d5c2aa43-35e2-41b9-9b55-c0a6618dfb20 TCGA-S9-A6TV-01 TCGA-S9-A6TV-01A-12D-A34I-01 d5c2aa43-35e2-41b9-9b55-c0a6618dfb20 +TCGA-S9-A6TW-01 TCGA-S9-A6TW-01 TCGA-S9-A6TW TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 40 NO NO TCGA-S9-A6TW-F69523 TCGA-S9-A6TW -14679 0 1250 -8 1 NO Motor/Movement Changes 31 - 90 Days Scheduled Follow-up Submission Complete Remission/Response NO 2015-1-13 MALE YES YES Oligodendroglioma NO No C71.0 9451/3 C71.0 YES 90 Left YES IHC YES NO NO NO YES G3 NO No A6TW Preoperative TUMOR FREE NO YES Partial Remission/Response NO Primary Tumor 01 NO YES Cerebral Cortex YES NO YES S9 Supratentorial, Frontal Lobe Central nervous system NO LIVING 2011 e32dbf45-c066-454e-8b38-85d52151f623 TCGA-S9-A6TW-01A-12D-A32C-05 TCGA-S9-A6TW-01A-12D-A32A-01 TCGA-S9-A6TW-01 e32dbf45-c066-454e-8b38-85d52151f623 TCGA-S9-A6TW-01 TCGA-S9-A6TW-01A-12D-A32A-01 e32dbf45-c066-454e-8b38-85d52151f623 +TCGA-S9-A6TX-01 TCGA-S9-A6TX-01 TCGA-S9-A6TX TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 46 NO NO TCGA-S9-A6TX-F69524 TCGA-S9-A6TX TCGA-S9-A6TX-01A -17025 776 0 1245 -34 0 NO Headaches 0 - 30 Days Scheduled Follow-up Submission Partial Remission/Response NO 2015-1-13 MALE NO YES Oligodendroglioma NO No C71.0 9451/3 C71.0 YES 150 NO 100 Left YES IHC YES NO NO NO NO G3 NO false No TCGA-S9-A6TX.B2F18877-6F79-40BE-8F35-38713A54DD58.pdf A6TX Preoperative WITH TUMOR NO NO Complete Remission/Response NO Primary Tumor 01 NO YES Cerebral Cortex YES NO YES S9 Supratentorial, Temporal Lobe Central nervous system A NO LIVING 2011 0eba2b04-9c32-4432-999a-ba53fe1137ea TCGA-S9-A6TX-01A-21D-A32C-05 TCGA-S9-A6TX-01A-21D-A32A-01 TCGA-S9-A6TX-01 0eba2b04-9c32-4432-999a-ba53fe1137ea TCGA-S9-A6TX-01 TCGA-S9-A6TX-01A-21D-A32A-01 0eba2b04-9c32-4432-999a-ba53fe1137ea +TCGA-S9-A6TY-01 TCGA-S9-A6TY-01 TCGA-S9-A6TY TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 50 YES hair of animals, not further specified NO TCGA-S9-A6TY-F69979 TCGA-S9-A6TY -18564 0 1076 -18 0 NO Seizures 0 - 30 Days Scheduled Follow-up Submission Stable Disease NO 2015-1-26 MALE NO NO Oligodendroglioma NO No C71.0 9450/3 C71.0 YES 100 Left NO IHC YES NO NO YES NO G2 NO No A6TY Preoperative WITH TUMOR YES NO Partial Remission/Response NO Primary Tumor 01 YES NO Cerebral Cortex YES NO YES S9 Supratentorial, Temporal Lobe Central nervous system NO LIVING 2011 fcac06b5-0096-4004-b3a6-1af7c708b82d TCGA-S9-A6TY-01A-12D-A32C-05 TCGA-S9-A6TY-01A-12D-A32A-01 TCGA-S9-A6TY-01 fcac06b5-0096-4004-b3a6-1af7c708b82d TCGA-S9-A6TY-01 TCGA-S9-A6TY-01A-12D-A32A-01 fcac06b5-0096-4004-b3a6-1af7c708b82d +TCGA-S9-A6TZ-01 TCGA-S9-A6TZ-01 TCGA-S9-A6TZ TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 39 NO NO TCGA-S9-A6TZ-F69980 TCGA-S9-A6TZ -14592 0 1120 -15 0 NO Mental Status Changes > 181 Days Scheduled Follow-up Submission Stable Disease 2015-1-26 FEMALE NO NO Astrocytoma NO No C71.0 9400/3 C71.0 YES 100 Left YES IHC YES NO YES NO NO G2 NO No A6TZ Preoperative WITH TUMOR NO YES Partial Remission/Response NO Primary Tumor 01 NO NO Cerebral Cortex NO NO YES S9 Supratentorial, Frontal Lobe Central nervous system NO LIVING 2011 ede9effc-6462-4ecc-9be3-2ec0bb4d7c2f TCGA-S9-A6TZ-01A-21D-A32C-05 TCGA-S9-A6TZ-01A-21D-A32A-01 TCGA-S9-A6TZ-01 ede9effc-6462-4ecc-9be3-2ec0bb4d7c2f TCGA-S9-A6TZ-01 TCGA-S9-A6TZ-01A-21D-A32A-01 ede9effc-6462-4ecc-9be3-2ec0bb4d7c2f +TCGA-S9-A6U0-01 TCGA-S9-A6U0-01 TCGA-S9-A6U0 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 46 NO NO TCGA-S9-A6U0-F72340 TCGA-S9-A6U0 -16890 742 0 498 -18 0 NO Seizures 0 - 30 Days Scheduled Follow-up Submission Progressive Disease NO 2015-5-27 MALE NO NO Astrocytoma NO No C71.0 9401/3 C71.0 YES 100 Right NO IHC YES NO NO NO NO G3 NO No A6U0 Preoperative WITH TUMOR NO NO Partial Remission/Response YES Primary Tumor 01 YES NO Cerebral Cortex YES NO YES S9 Supratentorial, Temporal Lobe Central nervous system NO DECEASED 2012 f64b490b-d38e-4c20-aa98-a6c636d81123 TCGA-S9-A6U0-01A-12D-A32C-05 TCGA-S9-A6U0-01A-12D-A32A-01 TCGA-S9-A6U0-01 f64b490b-d38e-4c20-aa98-a6c636d81123 TCGA-S9-A6U0-01 TCGA-S9-A6U0-01A-12D-A32A-01 f64b490b-d38e-4c20-aa98-a6c636d81123 +TCGA-S9-A6U1-01 TCGA-S9-A6U1-01 TCGA-S9-A6U1 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 22 NO NO TCGA-S9-A6U1-F69560 TCGA-S9-A6U1 TCGA-S9-A6U1-01A -8271 260 0 785 -13 0 NO NO NO Sensory Changes 0 - 30 Days Scheduled Follow-up Submission Complete Remission/Response NO 2015-1-14 FEMALE NO NO Astrocytoma NO No C71.0 9401/3 C71.0 YES 230 NO 100 Right NO IHC YES NO NO NO NO G3 NO false No TCGA-S9-A6U1.400A5278-9C45-4FF9-AEF8-2155624D1168.pdf A6U1 Preoperative TUMOR FREE NO NO Complete Remission/Response NO Primary Tumor 01 NO YES Cerebral Cortex YES NO YES S9 Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2012 25e9f832-aae2-463f-ad18-9d5ac9fb506c TCGA-S9-A6U1-01A-21D-A33U-05 TCGA-S9-A6U1-01A-21D-A33S-01 TCGA-S9-A6U1-01 25e9f832-aae2-463f-ad18-9d5ac9fb506c TCGA-S9-A6U1-01 TCGA-S9-A6U1-01A-21D-A33S-01 25e9f832-aae2-463f-ad18-9d5ac9fb506c +TCGA-S9-A6U2-01 TCGA-S9-A6U2-01 TCGA-S9-A6U2 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 48 NO NO TCGA-S9-A6U2-F69983 TCGA-S9-A6U2 TCGA-S9-A6U2-01A -17800 430 0 908 -6 0 NO Seizures 0 - 30 Days Scheduled Follow-up Submission Stable Disease NO 2015-1-26 FEMALE NO NO Oligodendroglioma NO No C71.0 9450/3 C71.0 YES 140 NO 100 Right YES IHC YES NO NO NO NO G2 NO false No TCGA-S9-A6U2.C9E09216-EB85-433E-897C-874F3BBBC252.pdf A6U2 Preoperative WITH TUMOR YES NO Partial Remission/Response YES Primary Tumor 01 YES NO Cerebral Cortex NO NO YES S9 Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2012 108d720f-7f3f-481e-ad11-5a30f4c4f9a4 TCGA-S9-A6U2-01A-21D-A33U-05 TCGA-S9-A6U2-01A-21D-A33S-01 TCGA-S9-A6U2-01 108d720f-7f3f-481e-ad11-5a30f4c4f9a4 TCGA-S9-A6U2-01 TCGA-S9-A6U2-01A-21D-A33S-01 108d720f-7f3f-481e-ad11-5a30f4c4f9a4 +TCGA-S9-A6U5-01 TCGA-S9-A6U5-01 TCGA-S9-A6U5 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain NO NO 33 NO NO TCGA-S9-A6U5-F62932 TCGA-S9-A6U5 -12417 0 992 -6 0 NO Seizures 31 - 90 Days Scheduled Follow-up Submission Stable Disease NO 2014-7-29 MALE NO NO Astrocytoma NO No C71.0 9400/3 C71.0 YES 100 Right YES IHC YES NO NO NO NO G2 NO No A6U5 Preoperative TUMOR FREE YES NO Complete Remission/Response NO Primary Tumor 01 YES NO Cerebral Cortex NO NO YES S9 Supratentorial, Temporal Lobe Central nervous system NO LIVING 2011 bf011a58-857d-4191-ab61-56e2a0b9e181 TCGA-S9-A6U5-01A-12D-A33U-05 TCGA-S9-A6U5-01A-12D-A33S-01 TCGA-S9-A6U5-01 bf011a58-857d-4191-ab61-56e2a0b9e181 TCGA-S9-A6U5-01 TCGA-S9-A6U5-01A-12D-A33S-01 bf011a58-857d-4191-ab61-56e2a0b9e181 +TCGA-S9-A6U6-01 TCGA-S9-A6U6-01 TCGA-S9-A6U6 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 28 NO NO TCGA-S9-A6U6-F72342 TCGA-S9-A6U6 -10253 0 1069 -3 0 NO Scheduled Follow-up Submission NO 2015-5-27 MALE NO NO Astrocytoma NO No C71.0 9401/3 C71.0 YES NO 100 Left YES IHC YES NO NO NO NO G3 NO No A6U6 Preoperative TUMOR FREE NO NO Complete Remission/Response YES Primary Tumor 01 NO NO Cerebral Cortex NO NO YES S9 Supratentorial, Temporal Lobe Central nervous system NO LIVING 2012 dfcfc10d-04ed-495a-9fc4-a5d7af4d5b03 TCGA-S9-A6U6-01A-12D-A33U-05 TCGA-S9-A6U6-01A-12D-A33S-01 TCGA-S9-A6U6-01 dfcfc10d-04ed-495a-9fc4-a5d7af4d5b03 TCGA-S9-A6U6-01 TCGA-S9-A6U6-01A-12D-A33S-01 dfcfc10d-04ed-495a-9fc4-a5d7af4d5b03 +TCGA-S9-A6U8-01 TCGA-S9-A6U8-01 TCGA-S9-A6U8 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain NO NO 24 NO NO TCGA-S9-A6U8-F65495 TCGA-S9-A6U8 TCGA-S9-A6U8-01A -9044 2962 2988 0 2878 367 -31 0 NO Seizures > 181 Days Scheduled Follow-up Submission Progressive Disease NO 2014-9-24 MALE NO NO Astrocytoma NO No C71.0 9400/3 C71.0 YES 100 NO 100 Left NO NO NO NO NO G2 YES false No TCGA-S9-A6U8.6999D0D0-E961-478C-8935-71765A100941.pdf A6U8 Preoperative WITH TUMOR NO NO Partial Remission/Response NO Primary Tumor 01 YES NO White Matter NO NO YES S9 Supratentorial, Temporal Lobe Central nervous system A NO DECEASED 2005 6ff9c39a-7992-411e-a14a-631589199c3a TCGA-S9-A6U8-01A-21D-A33U-05 TCGA-S9-A6U8-01A-21D-A33S-01 TCGA-S9-A6U8-01 6ff9c39a-7992-411e-a14a-631589199c3a TCGA-S9-A6U8-01 TCGA-S9-A6U8-01A-21D-A33S-01 6ff9c39a-7992-411e-a14a-631589199c3a +TCGA-S9-A6U9-01 TCGA-S9-A6U9-01 TCGA-S9-A6U9 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain NO NO 36 NO NO TCGA-S9-A6U9-F62934 TCGA-S9-A6U9 TCGA-S9-A6U9-01A -13460 2706 0 2918 NO NO NO Seizures > 181 Days Scheduled Follow-up Submission Stable Disease NO 2014-7-29 MALE NO NO Astrocytoma NO No C71.0 9401/3 C71.0 YES 160 NO Right NO NO YES NO NO G3 NO false No TCGA-S9-A6U9.3F2EBA7C-1491-4995-9AE4-CE0875950F1E.pdf A6U9 WITH TUMOR YES NO Partial Remission/Response YES Primary Tumor 01 YES NO White Matter NO NO YES S9 Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2006 9070435a-8d76-4107-8d96-900db04b0d94 TCGA-S9-A6U9-01A-11D-A32C-05 TCGA-S9-A6U9-01A-11D-A32A-01 TCGA-S9-A6U9-01 9070435a-8d76-4107-8d96-900db04b0d94 TCGA-S9-A6U9-01 TCGA-S9-A6U9-01A-11D-A32A-01 9070435a-8d76-4107-8d96-900db04b0d94 +TCGA-S9-A6UA-01 TCGA-S9-A6UA-01 TCGA-S9-A6UA TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain NO NO NO 66 NO NO TCGA-S9-A6UA-F51947 TCGA-S9-A6UA TCGA-S9-A6UA-01A -24242 1989 178 0 161 -6 2 NO Mental Status Changes > 181 Days Scheduled Follow-up Submission Progressive Disease NO 2013-11-26 MALE NO NO Astrocytoma NO No C71.0 9401/3 C71.0 YES 80 NO 60 Right NO NO YES NO NO G3 YES false No TCGA-S9-A6UA.7F0ED679-C54A-4B51-ACD8-CF1E2EB2BCFA.pdf A6UA Preoperative WITH TUMOR NO NO Progressive Disease NO Primary Tumor 01 NO NO Deep Gray (e.g.basal ganglia, thalamus) NO NO YES S9 Supratentorial, Temporal Lobe Central nervous system A NO DECEASED 2008 73227e22-1131-49b2-90d6-f30a6a076d8b TCGA-S9-A6UA-01A-12D-A33U-05 TCGA-S9-A6UA-01A-12D-A33S-01 TCGA-S9-A6UA-01 73227e22-1131-49b2-90d6-f30a6a076d8b TCGA-S9-A6UA-01 TCGA-S9-A6UA-01A-12D-A33S-01 73227e22-1131-49b2-90d6-f30a6a076d8b +TCGA-S9-A6UB-01 TCGA-S9-A6UB-01 TCGA-S9-A6UB TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 52 NO YES TCGA-S9-A6UB-F72418 TCGA-S9-A6UB TCGA-S9-A6UB-01A -19223 3073 0 3761 -1 0 NO Scheduled Follow-up Submission NO 2015-6-15 MALE NO NO Oligodendroglioma NO No C71.0 9450/3 C71.0 YES 120 NO 100 Right NO NO NO NO NO G2 NO false No TCGA-S9-A6UB.F71CEABA-8472-49C7-B618-47CDE4C43AC3.pdf A6UB Preoperative TUMOR FREE NO NO Complete Remission/Response NO Primary Tumor 01 NO NO Cerebral Cortex NO NO YES S9 Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2005 0836116d-5b2e-4445-9019-a5c5ad7aac50 TCGA-S9-A6UB-01A-21D-A33U-05 TCGA-S9-A6UB-01A-21D-A33S-01 TCGA-S9-A6UB-01 0836116d-5b2e-4445-9019-a5c5ad7aac50 TCGA-S9-A6UB-01 TCGA-S9-A6UB-01A-21D-A33S-01 0836116d-5b2e-4445-9019-a5c5ad7aac50 +TCGA-S9-A6WD-01 TCGA-S9-A6WD-01 TCGA-S9-A6WD TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 58 NO NO TCGA-S9-A6WD-F69986 TCGA-S9-A6WD TCGA-S9-A6WD-01A -21231 1922 0 2289 -2 0 NO Seizures > 181 Days Scheduled Follow-up Submission Stable Disease NO 2015-1-26 MALE NO NO Oligodendroglioma NO No C71.0 9451/3 C71.0 YES 160 NO 100 Left NO NO NO NO NO G3 NO false No TCGA-S9-A6WD.5F24A61F-39AA-426A-89D2-03205E9563D7.pdf A6WD Preoperative WITH TUMOR YES NO Partial Remission/Response NO Primary Tumor 01 YES NO Cerebral Cortex YES NO YES S9 Supratentorial, Parietal Lobe Central nervous system A NO LIVING 2008 450ee18e-9d9b-4873-a882-8b8f123d104c TCGA-S9-A6WD-01A-12D-A33U-05 TCGA-S9-A6WD-01A-12D-A33S-01 TCGA-S9-A6WD-01 450ee18e-9d9b-4873-a882-8b8f123d104c TCGA-S9-A6WD-01 TCGA-S9-A6WD-01A-12D-A33S-01 450ee18e-9d9b-4873-a882-8b8f123d104c +TCGA-S9-A6WE-01 TCGA-S9-A6WE-01 TCGA-S9-A6WE TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 34 NO NO TCGA-S9-A6WE-F72356 TCGA-S9-A6WE TCGA-S9-A6WE-01A -12488 3434 0 4113 -4 0 NO Sensory Changes > 181 Days Scheduled Follow-up Submission NO 2015-6-2 MALE NO NO Oligodendroglioma NO No C71.0 9450/3 C71.0 YES 140 NO 100 Right NO NO NO NO NO G2 NO false No TCGA-S9-A6WE.F17B7D4A-F22C-472A-A84F-51CABBA8BE44.pdf A6WE Preoperative WITH TUMOR YES YES Partial Remission/Response NO Primary Tumor 01 NO YES Cerebral Cortex YES NO YES S9 Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2004 617f1516-010f-4eaf-95cf-f27de12eb2c4 TCGA-S9-A6WE-01A-12D-A33U-05 TCGA-S9-A6WE-01A-12D-A33S-01 TCGA-S9-A6WE-01 617f1516-010f-4eaf-95cf-f27de12eb2c4 TCGA-S9-A6WE-01 TCGA-S9-A6WE-01A-12D-A33S-01 617f1516-010f-4eaf-95cf-f27de12eb2c4 +TCGA-S9-A6WG-01 TCGA-S9-A6WG-01 TCGA-S9-A6WG TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 31 NO NO TCGA-S9-A6WG-F69988 TCGA-S9-A6WG TCGA-S9-A6WG-01A -11509 2098 0 2602 -12 0 NO Seizures 0 - 30 Days Scheduled Follow-up Submission Stable Disease NO 2015-1-26 MALE NO NO Astrocytoma NO No C71.0 9401/3 C71.0 YES 90 NO 100 Right NO NO NO NO NO G3 NO false No TCGA-S9-A6WG.82E91E98-4371-46DC-912C-6D4B3621601E.pdf A6WG Preoperative WITH TUMOR YES YES Progressive Disease YES Primary Tumor 01 YES NO Cerebral Cortex YES NO YES S9 Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2007 93b27804-df60-4755-928c-88a156ae008c TCGA-S9-A6WG-01A-11D-A33U-05 TCGA-S9-A6WG-01A-11D-A33S-01 TCGA-S9-A6WG-01 93b27804-df60-4755-928c-88a156ae008c TCGA-S9-A6WG-01 TCGA-S9-A6WG-01A-11D-A33S-01 93b27804-df60-4755-928c-88a156ae008c +TCGA-S9-A6WH-01 TCGA-S9-A6WH-01 TCGA-S9-A6WH TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 73 NO NO TCGA-S9-A6WH-F69989 TCGA-S9-A6WH TCGA-S9-A6WH-01A -26904 697 0 1173 -14 1 NO Motor/Movement Changes Scheduled Follow-up Submission Stable Disease NO 2015-1-26 FEMALE NO NO Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES 180 NO 80 Right YES IHC YES NO YES NO YES G2 NO false No TCGA-S9-A6WH.ED9DEB9C-4DC6-4743-8402-2CF3B0D171B3.pdf A6WH Preoperative WITH TUMOR NO NO Partial Remission/Response YES Primary Tumor 01 NO YES Cerebral Cortex NO NO YES S9 Supratentorial, Temporal Lobe Central nervous system A NO LIVING 2011 99fc1613-6b74-4177-a326-e8442a489571 TCGA-S9-A6WH-01A-12D-A33U-05 TCGA-S9-A6WH-01A-12D-A33S-01 TCGA-S9-A6WH-01 99fc1613-6b74-4177-a326-e8442a489571 TCGA-S9-A6WH-01 TCGA-S9-A6WH-01A-12D-A33S-01 99fc1613-6b74-4177-a326-e8442a489571 +TCGA-S9-A6WI-01 TCGA-S9-A6WI-01 TCGA-S9-A6WI TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain NO NO 56 NO NO TCGA-S9-A6WI-F63762 TCGA-S9-A6WI -20609 0 2585 -1 0 NO Headaches Scheduled Follow-up Submission Stable Disease NO 2014-8-18 FEMALE YES YES Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES 100 Right NO NO YES NO NO G2 NO No A6WI Preoperative WITH TUMOR NO NO Partial Remission/Response YES Primary Tumor 01 NO NO White Matter NO NO YES S9 Supratentorial, Frontal Lobe Central nervous system NO LIVING 2006 fc484082-81a8-4feb-bd85-c0f067ad2f4f TCGA-S9-A6WI-01A-21D-A33U-05 TCGA-S9-A6WI-01A-21D-A33S-01 TCGA-S9-A6WI-01 fc484082-81a8-4feb-bd85-c0f067ad2f4f TCGA-S9-A6WI-01 TCGA-S9-A6WI-01A-21D-A33S-01 fc484082-81a8-4feb-bd85-c0f067ad2f4f +TCGA-S9-A6WL-01 TCGA-S9-A6WL-01 TCGA-S9-A6WL TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain NO YES 52 NO NO TCGA-S9-A6WL-F67227 TCGA-S9-A6WL -19234 0 946 -2 0 NO Seizures 0 - 30 Days Scheduled Follow-up Submission NO 2014-11-3 MALE NO NO Astrocytoma NO No C71.0 9401/3 C71.0 YES 100 Right YES IHC YES NO NO NO NO G3 NO No A6WL Preoperative WITH TUMOR YES NO Progressive Disease NO Primary Tumor 01 YES NO Cerebral Cortex NO NO YES S9 Supratentorial, Frontal Lobe Central nervous system NO LIVING 2012 e6d20c89-a4d1-4c0f-b31d-8e1262e425d5 TCGA-S9-A6WL-01A-21D-A33U-05 TCGA-S9-A6WL-01A-21D-A33S-01 TCGA-S9-A6WL-01 e6d20c89-a4d1-4c0f-b31d-8e1262e425d5 TCGA-S9-A6WL-01 TCGA-S9-A6WL-01A-21D-A33S-01 e6d20c89-a4d1-4c0f-b31d-8e1262e425d5 +TCGA-S9-A6WM-01 TCGA-S9-A6WM-01 TCGA-S9-A6WM TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain YES NO NO 59 NO NO TCGA-S9-A6WM-F63843 TCGA-S9-A6WM -21761 0 604 505 -9 1 NO Headaches 0 - 30 Days Additional New Tumor Event Progressive Disease NO 2014-8-20 FEMALE NO YES Astrocytoma NO No C71.0 9401/3 C71.0 YES 90 Left NO IHC YES NO NO NO NO G3 YES No A6WM Preoperative WITH TUMOR NO NO Partial Remission/Response YES Primary Tumor 01 NO NO Cerebral Cortex YES NO YES S9 Supratentorial, Temporal Lobe Central nervous system NO LIVING 2012 fcbffc2c-702c-4c32-95ae-beac08a46f2b TCGA-S9-A6WM-01A-12D-A33U-05 TCGA-S9-A6WM-01A-12D-A33S-01 TCGA-S9-A6WM-01 fcbffc2c-702c-4c32-95ae-beac08a46f2b TCGA-S9-A6WM-01 TCGA-S9-A6WM-01A-12D-A33S-01 fcbffc2c-702c-4c32-95ae-beac08a46f2b +TCGA-S9-A6WN-01 TCGA-S9-A6WN-01 TCGA-S9-A6WN TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain YES NO 38 NO NO TCGA-S9-A6WN-F72374 TCGA-S9-A6WN TCGA-S9-A6WN-01A -13961 181 0 805 805 -14 1 NO Seizures 0 - 30 Days Additional New Tumor Event Progressive Disease NO 2015-6-9 FEMALE NO NO Astrocytoma NO No C71.0 9401/3 C71.0 YES 140 NO 90 Left NO IHC YES NO NO NO NO G3 YES false No TCGA-S9-A6WN.DF6F3A7F-700B-4AB7-8E0A-87F81AEB3C59.pdf A6WN Preoperative WITH TUMOR YES YES Progressive Disease YES Primary Tumor 01 YES YES Cerebral Cortex YES NO YES S9 Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2013 74cb268c-d8bc-44f2-8872-f176fa8221be TCGA-S9-A6WN-01A-12D-A33U-05 TCGA-S9-A6WN-01A-12D-A33S-01 TCGA-S9-A6WN-01 74cb268c-d8bc-44f2-8872-f176fa8221be TCGA-S9-A6WN-01 TCGA-S9-A6WN-01A-12D-A33S-01 74cb268c-d8bc-44f2-8872-f176fa8221be +TCGA-S9-A6WO-01 TCGA-S9-A6WO-01 TCGA-S9-A6WO TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain NO NO 29 NO NO TCGA-S9-A6WO-F65749 TCGA-S9-A6WO -10933 0 566 -4 0 NO Seizures 31 - 90 Days Scheduled Follow-up Submission Stable Disease NO 2014-9-30 MALE NO NO Astrocytoma NO No C71.0 9400/3 C71.0 YES 100 Left YES IHC YES NO NO NO NO G2 NO No A6WO Preoperative WITH TUMOR YES NO Progressive Disease NO Primary Tumor 01 YES NO White Matter NO NO YES S9 Supratentorial, Frontal Lobe Central nervous system NO LIVING 2013 da513205-f0c5-4649-9db4-edf417fbf53f TCGA-S9-A6WO-01A-21D-A34D-05 TCGA-S9-A6WO-01A-21D-A349-01 TCGA-S9-A6WO-01 da513205-f0c5-4649-9db4-edf417fbf53f TCGA-S9-A6WO-01 TCGA-S9-A6WO-01A-21D-A349-01 da513205-f0c5-4649-9db4-edf417fbf53f +TCGA-S9-A6WP-01 TCGA-S9-A6WP-01 TCGA-S9-A6WP TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 42 NO NO TCGA-S9-A6WP-F69994 TCGA-S9-A6WP TCGA-S9-A6WP-01A -15658 111 0 567 -3 0 NO Seizures 0 - 30 Days Scheduled Follow-up Submission Stable Disease NO 2015-1-26 MALE NO NO Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES 180 NO 100 Right YES IHC YES NO NO NO NO G3 NO false No TCGA-S9-A6WP.55030C3A-6D25-4EB0-9B6C-FC0096472EE1.pdf A6WP Preoperative WITH TUMOR NO NO Partial Remission/Response NO Primary Tumor 01 YES NO Cerebral Cortex YES NO YES S9 Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2013 6c13f651-a7da-46b9-b422-7fa8f314b901 TCGA-S9-A6WP-01A-12D-A34D-05 TCGA-S9-A6WP-01A-12D-A349-01 TCGA-S9-A6WP-01 6c13f651-a7da-46b9-b422-7fa8f314b901 TCGA-S9-A6WP-01 TCGA-S9-A6WP-01A-12D-A349-01 6c13f651-a7da-46b9-b422-7fa8f314b901 +TCGA-S9-A6WQ-01 TCGA-S9-A6WQ-01 TCGA-S9-A6WQ TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain NO NO 57 NO NO TCGA-S9-A6WQ-F62938 TCGA-S9-A6WQ -21133 0 428 -7 0 NO Seizures 91 - 180 Days Scheduled Follow-up Submission Stable Disease NO 2014-7-29 FEMALE NO NO Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES NO 100 Left YES IHC YES NO YES YES NO G2 NO No A6WQ Preoperative WITH TUMOR NO NO Partial Remission/Response NO Primary Tumor 01 YES YES Cerebral Cortex NO NO YES S9 Supratentorial, Frontal Lobe Central nervous system NO LIVING 2013 be1d4fc0-02a0-4932-b836-bf68f89455c7 TCGA-S9-A6WQ-01A-12D-A34D-05 TCGA-S9-A6WQ-01A-12D-A349-01 TCGA-S9-A6WQ-01 be1d4fc0-02a0-4932-b836-bf68f89455c7 TCGA-S9-A6WQ-01 TCGA-S9-A6WQ-01A-12D-A349-01 be1d4fc0-02a0-4932-b836-bf68f89455c7 +TCGA-S9-A7IQ-01 TCGA-S9-A7IQ-01 TCGA-S9-A7IQ TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain NO NO 45 NO NO TCGA-S9-A7IQ-F65750 TCGA-S9-A7IQ -16512 0 1099 -14 0 NO Sensory Changes 0 - 30 Days Scheduled Follow-up Submission Stable Disease NO 2014-9-30 FEMALE NO NO Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES 100 Left YES IHC YES NO NO NO NO G2 NO No A7IQ Preoperative WITH TUMOR NO NO Partial Remission/Response NO Primary Tumor 01 NO YES Cerebral Cortex NO NO YES S9 Supratentorial, Frontal Lobe Central nervous system NO LIVING 2011 a107f9da-3537-4adf-a543-39cb692bdb80 TCGA-S9-A7IQ-01A-21D-A34D-05 TCGA-S9-A7IQ-01A-21D-A349-01 TCGA-S9-A7IQ-01 a107f9da-3537-4adf-a543-39cb692bdb80 TCGA-S9-A7IQ-01 TCGA-S9-A7IQ-01A-21D-A349-01 a107f9da-3537-4adf-a543-39cb692bdb80 +TCGA-S9-A7IS-01 TCGA-S9-A7IS-01 TCGA-S9-A7IS TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 33 NO NO TCGA-S9-A7IS-F51948 TCGA-S9-A7IS TCGA-S9-A7IS-01A -12402 3506 241 0 -2 2 NO Mental Status Changes Scheduled Follow-up Submission Progressive Disease NO 2013-11-26 FEMALE NO NO Astrocytoma NO No C71.0 9401/3 C71.0 YES 160 NO 60 Right NO NO YES NO NO G3 NO false No TCGA-S9-A7IS.B8C99516-595F-4A10-B400-BEA806E9A6FA.pdf A7IS Preoperative WITH TUMOR NO NO Progressive Disease YES Primary Tumor 01 NO NO Not listed in Medical Record NO NO YES S9 Supratentorial, Frontal Lobe Central nervous system A NO DECEASED 2004 2550796d-132e-4387-a730-b7fb2e1ee16e TCGA-S9-A7IS-01A-11D-A34D-05 TCGA-S9-A7IS-01A-11D-A349-01 TCGA-S9-A7IS-01 2550796d-132e-4387-a730-b7fb2e1ee16e TCGA-S9-A7IS-01 TCGA-S9-A7IS-01A-11D-A349-01 2550796d-132e-4387-a730-b7fb2e1ee16e +TCGA-S9-A7IX-01 TCGA-S9-A7IX-01 TCGA-S9-A7IX TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 57 NO NO TCGA-S9-A7IX-F72344 TCGA-S9-A7IX TCGA-S9-A7IX-01A -21095 540 819 0 597 -2 0 NO Motor/Movement Changes 31 - 90 Days Scheduled Follow-up Submission NO 2015-5-27 MALE YES NO Astrocytoma NO No C71.0 9401/3 C71.0 YES 80 NO 100 Right NO NO NO NO YES G3 YES false No TCGA-S9-A7IX.BCA5F1A6-7BAB-416F-81A1-C88B83511A2D.pdf A7IX Preoperative WITH TUMOR YES NO Progressive Disease YES Primary Tumor 01 NO NO White Matter NO NO YES S9 Supratentorial, Temporal Lobe Central nervous system A NO DECEASED 2012 89b94310-c189-405f-8d43-5c52922f2eea TCGA-S9-A7IX-01A-12D-A34D-05 TCGA-S9-A7IX-01A-12D-A349-01 TCGA-S9-A7IX-01 89b94310-c189-405f-8d43-5c52922f2eea TCGA-S9-A7IX-01 TCGA-S9-A7IX-01A-12D-A349-01 89b94310-c189-405f-8d43-5c52922f2eea +TCGA-S9-A7IY-01 TCGA-S9-A7IY-01 TCGA-S9-A7IY TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain NO NO 39 NO NO TCGA-S9-A7IY-F65751 TCGA-S9-A7IY TCGA-S9-A7IY-01A -14422 398 0 715 -6 2 NO Motor/Movement Changes 0 - 30 Days Scheduled Follow-up Submission Partial Remission/Response NO 2014-9-30 MALE NO NO Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES 100 NO 80 Right YES IHC YES NO YES NO YES G3 NO false No TCGA-S9-A7IY.9223C347-C93C-4B31-BEEE-40B481139D7B.pdf A7IY Preoperative WITH TUMOR NO YES Partial Remission/Response YES Primary Tumor 01 NO NO White Matter YES NO YES S9 Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2012 10f6eea5-bfb0-4203-92c8-5572a81d0b8e TCGA-S9-A7IY-01A-11D-A34D-05 TCGA-S9-A7IY-01A-11D-A349-01 TCGA-S9-A7IY-01 10f6eea5-bfb0-4203-92c8-5572a81d0b8e TCGA-S9-A7IY-01 TCGA-S9-A7IY-01A-11D-A349-01 10f6eea5-bfb0-4203-92c8-5572a81d0b8e +TCGA-S9-A7IZ-01 TCGA-S9-A7IZ-01 TCGA-S9-A7IZ TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain YES NO 48 NO NO TCGA-S9-A7IZ-F69998 TCGA-S9-A7IZ -17874 0 608 467 -5 1 NO Seizures 0 - 30 Days Additional New Tumor Event Stable Disease NO 2015-1-26 FEMALE NO NO Astrocytoma NO No C71.0 9401/3 C71.0 YES 90 Left YES IHC YES NO NO NO NO G3 YES No A7IZ Preoperative WITH TUMOR YES NO Partial Remission/Response YES Primary Tumor 01 YES NO Cerebral Cortex NO NO YES S9 Supratentorial, Frontal Lobe Central nervous system NO LIVING 2013 dfe8bcb5-829d-4f70-8731-e3289383bc95 TCGA-S9-A7IZ-01A-11D-A34D-05 TCGA-S9-A7IZ-01A-11D-A349-01 TCGA-S9-A7IZ-01 dfe8bcb5-829d-4f70-8731-e3289383bc95 TCGA-S9-A7IZ-01 TCGA-S9-A7IZ-01A-11D-A349-01 dfe8bcb5-829d-4f70-8731-e3289383bc95 +TCGA-S9-A7J0-01 TCGA-S9-A7J0-01 TCGA-S9-A7J0 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain YES NO 30 NO NO TCGA-S9-A7J0-F65752 TCGA-S9-A7J0 -10989 0 609 390 -7 0 NO Seizures 0 - 30 Days Additional New Tumor Event Progressive Disease YES Citrus fruits 2014-9-30 FEMALE NO NO Oligodendroglioma NO No C71.0 9451/3 C71.0 YES 100 Right NO IHC YES NO NO NO NO G3 YES No A7J0 Preoperative WITH TUMOR YES NO Partial Remission/Response YES Primary Tumor 01 YES NO Cerebral Cortex YES NO YES S9 Supratentorial, Frontal Lobe Central nervous system NO LIVING 2013 a29047f8-3b74-4bf4-87ec-2f8b5435eba7 TCGA-S9-A7J0-01A-11D-A34D-05 TCGA-S9-A7J0-01A-11D-A349-01 TCGA-S9-A7J0-01 a29047f8-3b74-4bf4-87ec-2f8b5435eba7 TCGA-S9-A7J0-01 TCGA-S9-A7J0-01A-11D-A349-01 a29047f8-3b74-4bf4-87ec-2f8b5435eba7 +TCGA-S9-A7J1-01 TCGA-S9-A7J1-01 TCGA-S9-A7J1 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 43 NO NO TCGA-S9-A7J1-F71265 TCGA-S9-A7J1 -15926 0 249 -17 3 NO Seizures 31 - 90 Days Scheduled Follow-up Submission NO 2015-3-24 MALE NO NO Oligodendroglioma NO No C71.0 9450/3 C71.0 YES 60 Right YES IHC YES YES NO NO NO G2 NO No A7J1 Preoperative WITH TUMOR YES NO Partial Remission/Response NO Primary Tumor 01 YES NO Cerebral Cortex NO NO YES S9 Supratentorial, Temporal Lobe Central nervous system NO LIVING 2013 ba3ea21e-4806-4eaa-99df-d7544248cb37 TCGA-S9-A7J1-01A-21D-A34K-05 TCGA-S9-A7J1-01A-21D-A34I-01 TCGA-S9-A7J1-01 ba3ea21e-4806-4eaa-99df-d7544248cb37 TCGA-S9-A7J1-01 TCGA-S9-A7J1-01A-21D-A34I-01 ba3ea21e-4806-4eaa-99df-d7544248cb37 +TCGA-S9-A7J2-01 TCGA-S9-A7J2-01 TCGA-S9-A7J2 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 25 NO NO TCGA-S9-A7J2-F71266 TCGA-S9-A7J2 TCGA-S9-A7J2-01A -9345 194 0 62 -4 1 NO Mental Status Changes > 181 Days Scheduled Follow-up Submission NO 2015-3-24 MALE NO NO Oligodendroglioma NO No C71.0 9451/3 C71.0 YES 200 NO 80 Left YES IHC YES YES YES NO NO G3 NO false No TCGA-S9-A7J2.F7F8D6E7-0C27-4FAC-96E0-66EED6274122.pdf A7J2 Preoperative WITH TUMOR YES NO Partial Remission/Response NO Primary Tumor 01 YES NO Cerebral Cortex YES NO YES S9 Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2013 8b99cc75-d8cc-4d18-9a6b-c66f8bd7ea0d TCGA-S9-A7J2-01A-11D-A34D-05 TCGA-S9-A7J2-01A-11D-A349-01 TCGA-S9-A7J2-01 8b99cc75-d8cc-4d18-9a6b-c66f8bd7ea0d TCGA-S9-A7J2-01 TCGA-S9-A7J2-01A-11D-A349-01 8b99cc75-d8cc-4d18-9a6b-c66f8bd7ea0d +TCGA-S9-A7J3-01 TCGA-S9-A7J3-01 TCGA-S9-A7J3 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 52 NO NO TCGA-S9-A7J3-F70008 TCGA-S9-A7J3 TCGA-S9-A7J3-01A -19056 182 0 629 -14 0 NO Seizures 31 - 90 Days Scheduled Follow-up Submission Stable Disease NO 2015-1-26 FEMALE NO NO Oligodendroglioma NO No C71.0 9451/3 C71.0 YES 120 NO 100 Left YES IHC YES NO NO NO NO G3 NO false No TCGA-S9-A7J3.EC6B158C-2D75-43CF-8D80-7FF9DEBCB199.pdf A7J3 Preoperative WITH TUMOR YES YES Partial Remission/Response YES Primary Tumor 01 YES NO White Matter YES NO YES S9 Supratentorial, Parietal Lobe Central nervous system A NO LIVING 2013 4799ffc2-7be5-48f3-9ab1-624eeb3ec6ee TCGA-S9-A7J3-01A-21D-A34K-05 TCGA-S9-A7J3-01A-21D-A34I-01 TCGA-S9-A7J3-01 4799ffc2-7be5-48f3-9ab1-624eeb3ec6ee TCGA-S9-A7J3-01 TCGA-S9-A7J3-01A-21D-A34I-01 4799ffc2-7be5-48f3-9ab1-624eeb3ec6ee +TCGA-S9-A7QW-01 TCGA-S9-A7QW-01 TCGA-S9-A7QW TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain YES NO 54 NO NO TCGA-S9-A7QW-F66223 TCGA-S9-A7QW -19869 0 458 382 -4 0 NO Additional New Tumor Event Stable Disease NO 2014-10-6 FEMALE NO NO Astrocytoma NO No C71.0 9401/3 C71.0 YES 100 Left YES IHC YES NO NO NO NO G3 YES No A7QW Preoperative WITH TUMOR NO NO Complete Remission/Response YES Primary Tumor 01 NO NO Cerebral Cortex NO YES NO S9 Supratentorial, Frontal Lobe Central nervous system NO LIVING 2013 f2dba2e9-157b-494b-9650-e17d0ccc421b TCGA-S9-A7QW-01A-11D-A34D-05 TCGA-S9-A7QW-01A-11D-A349-01 TCGA-S9-A7QW-01 f2dba2e9-157b-494b-9650-e17d0ccc421b TCGA-S9-A7QW-01 TCGA-S9-A7QW-01A-11D-A349-01 f2dba2e9-157b-494b-9650-e17d0ccc421b +TCGA-S9-A7QX-01 TCGA-S9-A7QX-01 TCGA-S9-A7QX TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 36 NO NO TCGA-S9-A7QX-F70010 TCGA-S9-A7QX TCGA-S9-A7QX-01A -13332 81 0 564 -3 0 NO NO NO Sensory Changes > 181 Days Scheduled Follow-up Submission Stable Disease NO 2015-1-26 FEMALE NO NO Astrocytoma NO No C71.0 9401/3 C71.0 YES 150 NO 100 Right YES IHC YES NO NO NO NO G3 NO false No TCGA-S9-A7QX.C0F30532-18DA-4E77-A2CC-EFE67B476FA9.pdf A7QX Preoperative WITH TUMOR YES NO Partial Remission/Response YES Primary Tumor 01 YES YES Cerebral Cortex YES YES NO S9 Supratentorial, Temporal Lobe Central nervous system A NO LIVING 2013 61e3d965-e391-4699-b862-37000eadef7f TCGA-S9-A7QX-01A-11D-A34D-05 TCGA-S9-A7QX-01A-11D-A349-01 TCGA-S9-A7QX-01 61e3d965-e391-4699-b862-37000eadef7f TCGA-S9-A7QX-01 TCGA-S9-A7QX-01A-11D-A349-01 61e3d965-e391-4699-b862-37000eadef7f +TCGA-S9-A7QY-01 TCGA-S9-A7QY-01 TCGA-S9-A7QY TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain NO NO 35 NO NO TCGA-S9-A7QY-F62949 TCGA-S9-A7QY TCGA-S9-A7QY-01A -12853 560 0 863 -2 0 NO Seizures > 181 Days Scheduled Follow-up Submission Stable Disease NO 2014-7-29 FEMALE NO NO Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES 60 NO 100 Left NO IHC YES NO NO NO NO G2 NO false No TCGA-S9-A7QY.7833FCD6-2858-4428-9E9C-A8AEA10F42F8.pdf A7QY Preoperative WITH TUMOR YES YES Partial Remission/Response NO Primary Tumor 01 YES NO Cerebral Cortex YES NO YES S9 Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2012 4df02ab4-fe42-4f21-9678-858ecd99763c TCGA-S9-A7QY-01A-11D-A34D-05 TCGA-S9-A7QY-01A-11D-A349-01 TCGA-S9-A7QY-01 4df02ab4-fe42-4f21-9678-858ecd99763c TCGA-S9-A7QY-01 TCGA-S9-A7QY-01A-11D-A349-01 4df02ab4-fe42-4f21-9678-858ecd99763c +TCGA-S9-A7QZ-01 TCGA-S9-A7QZ-01 TCGA-S9-A7QZ TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain NO NO YES 41 NO NO TCGA-S9-A7QZ-F70012 TCGA-S9-A7QZ TCGA-S9-A7QZ-01A 826 -15300 368 0 826 774 -3 0 NO Seizures > 181 Days Additional New Tumor Event Partial Remission/Response NO 2015-1-26 MALE YES NO Oligodendroglioma NO No C71.0 9450/3 C71.0 YES 120 NO 100 Left YES IHC YES NO NO NO NO G2 YES false No TCGA-S9-A7QZ.2DBE4A35-E160-47C2-B000-B44DC125BAEB.pdf A7QZ Preoperative WITH TUMOR YES NO Partial Remission/Response NO Primary Tumor 01 YES NO Cerebral Cortex NO NO YES S9 Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2012 738ae7fd-6fa8-4aa4-b01f-34a519dc279f TCGA-S9-A7QZ-01A-12D-A34K-05 TCGA-S9-A7QZ-01A-12D-A34I-01 TCGA-S9-A7QZ-01 738ae7fd-6fa8-4aa4-b01f-34a519dc279f TCGA-S9-A7QZ-01 TCGA-S9-A7QZ-01A-12D-A34I-01 738ae7fd-6fa8-4aa4-b01f-34a519dc279f +TCGA-S9-A7R1-01 TCGA-S9-A7R1-01 TCGA-S9-A7R1 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain NO NO 35 NO NO TCGA-S9-A7R1-F67312 TCGA-S9-A7R1 -12828 5166 0 5000 -122 1 NO Seizures > 181 Days Scheduled Follow-up Submission NO 2014-11-4 MALE NO NO Oligodendroglioma NO No C71.0 9450/3 C71.0 YES 90 Midline NO NO NO NO NO G2 NO No A7R1 Preoperative WITH TUMOR NO NO Partial Remission/Response YES Primary Tumor 01 YES NO Not listed in Medical Record NO NO YES S9 Supratentorial, Frontal Lobe Central nervous system YES DECEASED 1999 e07c8a75-c54b-4b5e-bec3-f1df709c16d8 TCGA-S9-A7R1-01A-12D-A34K-05 TCGA-S9-A7R1-01A-12D-A34I-01 TCGA-S9-A7R1-01 e07c8a75-c54b-4b5e-bec3-f1df709c16d8 TCGA-S9-A7R1-01 TCGA-S9-A7R1-01A-12D-A34I-01 e07c8a75-c54b-4b5e-bec3-f1df709c16d8 +TCGA-S9-A7R2-01 TCGA-S9-A7R2-01 TCGA-S9-A7R2 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 69 NO NO TCGA-S9-A7R2 TCGA-S9-A7R2-01A -25419 2027 316 0 -2 1 NO Seizures > 181 Days NO 2013-12-12 MALE NO NO Astrocytoma NO No C71.0 9401/3 C71.0 YES 120 NO 90 Left NO NO NO NO G3 NO false No TCGA-S9-A7R2.2907EB1D-32CC-4BB7-B485-AFF04CA01E7F.pdf A7R2 Preoperative WITH TUMOR YES NO Progressive Disease YES Primary Tumor 01 YES NO White Matter NO NO YES S9 Supratentorial, Temporal Lobe Central nervous system A NO DECEASED 2008 315a7141-0f36-4cac-94a7-748849ee8926 TCGA-S9-A7R2-01A-21D-A34K-05 TCGA-S9-A7R2-01A-21D-A34I-01 TCGA-S9-A7R2-01 315a7141-0f36-4cac-94a7-748849ee8926 TCGA-S9-A7R2-01 TCGA-S9-A7R2-01A-21D-A34I-01 315a7141-0f36-4cac-94a7-748849ee8926 +TCGA-S9-A7R3-01 TCGA-S9-A7R3-01 TCGA-S9-A7R3 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain NO NO 28 NO NO TCGA-S9-A7R3-F62951 TCGA-S9-A7R3 TCGA-S9-A7R3-01A -10342 2706 0 3013 -2 0 NO Headaches > 181 Days Scheduled Follow-up Submission Stable Disease NO 2014-7-29 FEMALE NO YES Astrocytoma NO No C71.0 9400/3 C71.0 YES 80 NO 100 Left NO NO NO NO NO G2 NO false No TCGA-S9-A7R3.769B080E-C2D2-492E-9B82-89BB55627F2B.pdf A7R3 Preoperative TUMOR FREE NO NO Partial Remission/Response NO Primary Tumor 01 NO NO Cerebral Cortex NO NO YES S9 Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2006 2a73d13f-1bbb-4591-9524-181d9539d3ae TCGA-S9-A7R3-01A-11D-A34K-05 TCGA-S9-A7R3-01A-11D-A34I-01 TCGA-S9-A7R3-01 2a73d13f-1bbb-4591-9524-181d9539d3ae TCGA-S9-A7R3-01 TCGA-S9-A7R3-01A-11D-A34I-01 2a73d13f-1bbb-4591-9524-181d9539d3ae +TCGA-S9-A7R4-01 TCGA-S9-A7R4-01 TCGA-S9-A7R4 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 46 NO NO TCGA-S9-A7R4-F67313 TCGA-S9-A7R4 -17134 0 914 -8 1 NO Seizures 0 - 30 Days Scheduled Follow-up Submission NO 2014-11-4 MALE NO NO Astrocytoma NO No C71.0 9401/3 C71.0 YES 90 Left YES IHC YES NO NO NO NO G3 NO No A7R4 Preoperative WITH TUMOR YES NO Partial Remission/Response YES Primary Tumor 01 YES NO Cerebral Cortex YES NO YES S9 Supratentorial, Frontal Lobe Central nervous system NO LIVING 2012 eeaff3a7-d9d4-41b9-8c58-52e16f6a71a0 TCGA-S9-A7R4-01A-12D-A34K-05 TCGA-S9-A7R4-01A-12D-A34I-01 TCGA-S9-A7R4-01 eeaff3a7-d9d4-41b9-8c58-52e16f6a71a0 TCGA-S9-A7R4-01 TCGA-S9-A7R4-01A-12D-A34I-01 eeaff3a7-d9d4-41b9-8c58-52e16f6a71a0 +TCGA-S9-A7R7-01 TCGA-S9-A7R7-01 TCGA-S9-A7R7 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain YES YES YES 27 NO NO TCGA-S9-A7R7-F66258 TCGA-S9-A7R7 TCGA-S9-A7R7-01A 2976 -10108 2647 0 3000 2894 -8 1 NO Seizures 0 - 30 Days Additional New Tumor Event Progressive Disease NO 2014-10-7 MALE NO NO Astrocytoma NO No C71.0 9400/3 C71.0 YES 70 NO 80 Left YES IHC YES NO NO NO NO G2 YES false No TCGA-S9-A7R7.0C30BB62-F9E0-4702-B488-79621EA74BFA.pdf A7R7 Preoperative WITH TUMOR YES YES Progressive Disease YES Primary Tumor 01 YES NO Cerebral Cortex NO NO YES S9 Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2006 2f398759-636a-4d58-9fbc-deb15e5beff6 TCGA-S9-A7R7-01A-11D-A34K-05 TCGA-S9-A7R7-01A-11D-A34I-01 TCGA-S9-A7R7-01 2f398759-636a-4d58-9fbc-deb15e5beff6 TCGA-S9-A7R7-01 TCGA-S9-A7R7-01A-11D-A34I-01 2f398759-636a-4d58-9fbc-deb15e5beff6 +TCGA-S9-A7R8-01 TCGA-S9-A7R8-01 TCGA-S9-A7R8 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 44 NO NO TCGA-S9-A7R8 TCGA-S9-A7R8-01A -16275 3282 961 0 -1 1 NO Seizures 31 - 90 Days NO 2013-12-11 FEMALE NO NO Astrocytoma NO No C71.0 9401/3 C71.0 YES 110 NO 90 Right NO NO NO NO G3 YES false No TCGA-S9-A7R8.7287E887-2783-4416-8C61-718C6247C982.pdf A7R8 Preoperative WITH TUMOR YES YES Progressive Disease YES Primary Tumor 01 YES NO Not listed in Medical Record NO NO YES S9 Supratentorial, Frontal Lobe Central nervous system A NO DECEASED 2004 28107f81-2e82-4bc9-99e4-f1b24444c811 TCGA-S9-A7R8-01A-11D-A34K-05 TCGA-S9-A7R8-01A-11D-A34I-01 TCGA-S9-A7R8-01 28107f81-2e82-4bc9-99e4-f1b24444c811 TCGA-S9-A7R8-01 TCGA-S9-A7R8-01A-11D-A34I-01 28107f81-2e82-4bc9-99e4-f1b24444c811 +TCGA-S9-A89V-01 TCGA-S9-A89V-01 TCGA-S9-A89V TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 70 NO NO TCGA-S9-A89V-F67315 TCGA-S9-A89V -25570 0 569 221 -32 1 NO Motor/Movement Changes > 181 Days Additional New Tumor Event NO 2014-11-4 MALE NO NO Astrocytoma NO No C71.0 9401/3 C71.0 YES 80 Right NO IHC YES NO NO NO YES G3 YES No A89V Preoperative WITH TUMOR NO NO Progressive Disease YES Primary Tumor 01 NO YES Cerebral Cortex YES NO YES S9 Posterior Fossa, Cerebellum Central nervous system NO LIVING 2012 b5f07863-11fa-46c7-a915-7f643ac57711 TCGA-S9-A89V-01A-11D-A368-05 TCGA-S9-A89V-01A-11D-A36N-01 TCGA-S9-A89V-01 b5f07863-11fa-46c7-a915-7f643ac57711 TCGA-S9-A89V-01 TCGA-S9-A89V-01A-11D-A36N-01 b5f07863-11fa-46c7-a915-7f643ac57711 +TCGA-S9-A89Z-01 TCGA-S9-A89Z-01 TCGA-S9-A89Z TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 40 NO NO TCGA-S9-A89Z-F72341 TCGA-S9-A89Z TCGA-S9-A89Z-01A -14858 63 0 623 -10 1 NO YES NO Seizures 31 - 90 Days Scheduled Follow-up Submission Stable Disease NO 2015-5-27 MALE NO NO Astrocytoma NO No C71.0 9401/3 C71.0 YES NO 70 NO 70 Right YES IHC YES NO NO NO NO G3 NO false No TCGA-S9-A89Z.DAAF016F-5C66-4E31-B57A-1F0857B181AD.pdf A89Z Preoperative WITH TUMOR YES YES Partial Remission/Response YES Primary Tumor 01 YES NO White Matter YES YES NO S9 Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2013 58ecffdf-6f33-4a8e-b983-f6f4261cde2b TCGA-S9-A89Z-01A-11D-A368-05 TCGA-S9-A89Z-01A-11D-A36N-01 TCGA-S9-A89Z-01 58ecffdf-6f33-4a8e-b983-f6f4261cde2b TCGA-S9-A89Z-01 TCGA-S9-A89Z-01A-11D-A36N-01 58ecffdf-6f33-4a8e-b983-f6f4261cde2b +TCGA-TM-A7C3-01 TCGA-TM-A7C3-01 TCGA-TM-A7C3 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 43 NO YES TCGA-TM-A7C3-F63557 TCGA-TM-A7C3 TCGA-TM-A7C3-01A -16021 1409 1666 0 1504 0 0 YES YES NO < 12 Years Seizures 0 - 30 Days Scheduled Follow-up Submission Progressive Disease NO 2014-8-12 FEMALE YES NO Astrocytoma NO No C71.0 9401/3 C71.0 YES NO 80 NO 90 Left NO NO NO NO NO G3 NO false No TCGA-TM-A7C3.8716B17F-6119-4999-8F12-F9C123FEA60F.pdf A7C3 Preoperative WITH TUMOR Complete Remission/Response NO Primary Tumor 01 YES NO Not listed in Medical Record NO NO YES TM Supratentorial, Temporal Lobe Central nervous system A NO DECEASED 2009 5f56116d-79cb-4213-ae59-1b2922d79d17 TCGA-TM-A7C3-01A-11D-A32C-05 TCGA-TM-A7C3-01A-11D-A32A-01 TCGA-TM-A7C3-01 5f56116d-79cb-4213-ae59-1b2922d79d17 TCGA-TM-A7C3-01 TCGA-TM-A7C3-01A-11D-A32A-01 5f56116d-79cb-4213-ae59-1b2922d79d17 +TCGA-TM-A7C4-01 TCGA-TM-A7C4-01 TCGA-TM-A7C4 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 39 NO NO TCGA-TM-A7C4-F63553 TCGA-TM-A7C4 TCGA-TM-A7C4-01A -14603 1215 0 1470 0 0 YES NO NO > 20 Years Seizures 0 - 30 Days Scheduled Follow-up Submission Complete Remission/Response NO 2014-8-12 FEMALE NO NO Astrocytoma NO No C71.0 9400/3 C71.0 YES NO 80 NO 90 Right NO NO NO NO G2 NO false No TCGA-TM-A7C4.4097D689-A950-486D-9CDA-30C81E56722D.pdf A7C4 Preoperative TUMOR FREE Complete Remission/Response NO Primary Tumor 01 YES NO Not listed in Medical Record NO NO YES TM Supratentorial, Temporal Lobe Central nervous system A NO LIVING 2010 21ff9c47-d971-4c0f-b9ff-103a817f5eb4 TCGA-TM-A7C4-01A-11D-A32C-05 TCGA-TM-A7C4-01A-11D-A32A-01 TCGA-TM-A7C4-01 21ff9c47-d971-4c0f-b9ff-103a817f5eb4 TCGA-TM-A7C4-01 TCGA-TM-A7C4-01A-11D-A32A-01 21ff9c47-d971-4c0f-b9ff-103a817f5eb4 +TCGA-TM-A7C5-01 TCGA-TM-A7C5-01 TCGA-TM-A7C5 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 30 NO YES TCGA-TM-A7C5-F63554 TCGA-TM-A7C5 TCGA-TM-A7C5-01A -11286 1194 0 1500 0 0 NO NO NO < 12 Years Seizures 0 - 30 Days Scheduled Follow-up Submission Complete Remission/Response NO 2014-8-12 MALE NO NO Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES NO 140 NO 100 Left NO NO NO NO NO G2 NO false No TCGA-TM-A7C5.CEA3E51F-5E16-4778-9684-C670C8E4DC8E.pdf A7C5 Preoperative TUMOR FREE Complete Remission/Response NO Primary Tumor 01 YES NO Not listed in Medical Record NO NO YES TM Supratentorial, Parietal Lobe Central nervous system A NO LIVING 2010 4e7bf9e5-e1a5-4a5b-8e32-0768fdf4a3cf TCGA-TM-A7C5-01A-11D-A32C-05 TCGA-TM-A7C5-01A-11D-A32A-01 TCGA-TM-A7C5-01 4e7bf9e5-e1a5-4a5b-8e32-0768fdf4a3cf TCGA-TM-A7C5-01 TCGA-TM-A7C5-01A-11D-A32A-01 4e7bf9e5-e1a5-4a5b-8e32-0768fdf4a3cf +TCGA-TM-A7CA-01 TCGA-TM-A7CA-01 TCGA-TM-A7CA TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 44 NO YES TCGA-TM-A7CA-F63555 TCGA-TM-A7CA TCGA-TM-A7CA-01A -16415 830 0 1058 0 0 NO YES NO > 20 Years Seizures 0 - 30 Days Scheduled Follow-up Submission Complete Remission/Response NO 2014-8-12 MALE NO NO Astrocytoma NO No C71.0 9400/3 C71.0 YES NO 60 NO 100 Left NO NO NO NO NO G2 NO false No TCGA-TM-A7CA.FA7FFEBC-9D1C-42E6-BD8E-BB957EE8C870.pdf A7CA Preoperative TUMOR FREE Complete Remission/Response NO Primary Tumor 01 YES NO Not listed in Medical Record NO NO YES TM Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2011 3fa4bf80-8a79-4a49-9b1e-40cf5696ad28 TCGA-TM-A7CA-01A-21D-A33U-05 TCGA-TM-A7CA-01A-21D-A33S-01 TCGA-TM-A7CA-01 3fa4bf80-8a79-4a49-9b1e-40cf5696ad28 TCGA-TM-A7CA-01 TCGA-TM-A7CA-01A-21D-A33S-01 3fa4bf80-8a79-4a49-9b1e-40cf5696ad28 +TCGA-TM-A7CF-01 TCGA-TM-A7CF-01 TCGA-TM-A7CF TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 41 NO YES TCGA-TM-A7CF-F70345 TCGA-TM-A7CF TCGA-TM-A7CF-01A -15178 1453 0 1989 0 0 NO NO NO < 12 Years Seizures 0 - 30 Days Scheduled Follow-up Submission Stable Disease NO 2015-2-5 FEMALE YES NO Astrocytoma NO No C71.0 9400/3 C71.0 YES 80 NO 100 Right NO NO NO NO NO G2 NO false No TCGA-TM-A7CF.CC5699A6-8FC6-438D-ACC4-907481E6A580.pdf A7CF Preoperative WITH TUMOR Complete Remission/Response YES Primary Tumor 01 YES NO Not listed in Medical Record YES NO YES TM Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2009 413a35b5-9151-44ca-85af-543683c8194b TCGA-TM-A7CF-01A-11D-A32C-05 TCGA-TM-A7CF-01A-11D-A32A-01 TCGA-TM-A7CF-01 413a35b5-9151-44ca-85af-543683c8194b TCGA-TM-A7CF-01 TCGA-TM-A7CF-01A-11D-A32A-01 413a35b5-9151-44ca-85af-543683c8194b +TCGA-TM-A7CF-02 TCGA-TM-A7CF-02 TCGA-TM-A7CF TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 41 NO YES TCGA-TM-A7CF-F70345 TCGA-TM-A7CF TCGA-TM-A7CF-02A -15178 1453 0 1989 0 0 NO NO NO < 12 Years Seizures 0 - 30 Days Scheduled Follow-up Submission Stable Disease NO 2015-2-5 FEMALE YES NO Astrocytoma NO No C71.0 9400/3 C71.0 YES 100 NO 100 Right NO NO NO NO NO G2 NO false No TCGA-TM-A7CF.E7D22CFE-C4C9-4E2F-AB45-713180E95C00.pdf A7CF Preoperative WITH TUMOR Complete Remission/Response YES Recurrent Tumor 02 YES NO Not listed in Medical Record YES NO YES TM Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2009 f5bb6d6f-70b2-495b-9638-2527ba6b8aa1 TCGA-TM-A7CF-02A-11D-A32C-05 f5bb6d6f-70b2-495b-9638-2527ba6b8aa1 f5bb6d6f-70b2-495b-9638-2527ba6b8aa1 +TCGA-TM-A84B-01 TCGA-TM-A84B-01 TCGA-TM-A84B TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 40 NO NO TCGA-TM-A84B-F65302 TCGA-TM-A84B -14933 758 0 365 0 0 NO NO NO Seizures 0 - 30 Days Scheduled Follow-up Submission Progressive Disease NO 2014-9-22 MALE NO NO Astrocytoma NO No C71.0 9401/3 C71.0 YES 90 Left NO IHC YES NO NO NO YES G3 NO No A84B Preoperative WITH TUMOR Progressive Disease NO Primary Tumor 01 YES YES Not listed in Medical Record YES NO YES TM Supratentorial, Parietal Lobe Central nervous system NO DECEASED 2012 c7554894-f361-4d97-8c1b-91925679143c TCGA-TM-A84B-01A-11D-A368-05 TCGA-TM-A84B-01A-11D-A36N-01 TCGA-TM-A84B-01 c7554894-f361-4d97-8c1b-91925679143c TCGA-TM-A84B-01 TCGA-TM-A84B-01A-11D-A36N-01 c7554894-f361-4d97-8c1b-91925679143c +TCGA-TM-A84C-01 TCGA-TM-A84C-01 TCGA-TM-A84C TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 32 NO YES TCGA-TM-A84C-F64988 TCGA-TM-A84C TCGA-TM-A84C-01A -11849 459 492 0 459 0 1 NO YES NO < 12 Years Visual Changes 31 - 90 Days Scheduled Follow-up Submission Progressive Disease NO 2014-9-17 MALE NO NO Astrocytoma NO No C71.0 9400/3 C71.0 YES 80 NO 80 Midline NO IHC YES NO YES NO YES G2 NO false No TCGA-TM-A84C.506E57F2-58E8-44D0-BEBC-CA06F874ABFD.pdf A84C Preoperative WITH TUMOR Progressive Disease NO Primary Tumor 01 NO YES Not listed in Medical Record YES NO YES TM Posterior Fossa, Brain Stem Central nervous system A YES DECEASED 2012 2111b1a5-6018-4647-83dc-96a70dac667b TCGA-TM-A84C-01A-11D-A368-05 TCGA-TM-A84C-01A-11D-A36N-01 TCGA-TM-A84C-01 2111b1a5-6018-4647-83dc-96a70dac667b TCGA-TM-A84C-01 TCGA-TM-A84C-01A-11D-A36N-01 2111b1a5-6018-4647-83dc-96a70dac667b +TCGA-TM-A84F-01 TCGA-TM-A84F-01 TCGA-TM-A84F TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 48 NO NO TCGA-TM-A84F-F65393 TCGA-TM-A84F TCGA-TM-A84F-01A -17744 1471 0 1796 0 0 NO NO NO Visual Changes 0 - 30 Days Scheduled Follow-up Submission Complete Remission/Response NO 2014-10-8 MALE NO YES Astrocytoma NO No C71.0 9401/3 C71.0 YES 60 NO 100 Right NO NO NO NO NO G3 NO false No TCGA-TM-A84F.5142804B-6A45-44E9-99A1-711C9C14F576.pdf A84F Preoperative TUMOR FREE Complete Remission/Response YES Primary Tumor 01 NO NO Not listed in Medical Record NO NO YES TM Supratentorial, Frontal Lobe Central nervous system A YES LIVING 2009 56d2252e-b66f-405f-9d97-7ea5432f1f68 TCGA-TM-A84F-01A-11D-A368-05 TCGA-TM-A84F-01A-11D-A36N-01 TCGA-TM-A84F-01 56d2252e-b66f-405f-9d97-7ea5432f1f68 TCGA-TM-A84F-01 TCGA-TM-A84F-01A-11D-A36N-01 56d2252e-b66f-405f-9d97-7ea5432f1f68 +TCGA-TM-A84G-01 TCGA-TM-A84G-01 TCGA-TM-A84G TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 54 NO NO TCGA-TM-A84G-F65394 TCGA-TM-A84G -20014 0 1236 0 0 NO NO NO Headaches 0 - 30 Days Scheduled Follow-up Submission Complete Remission/Response NO 2014-9-23 FEMALE NO YES Oligodendroglioma NO No C71.0 9451/3 C71.0 YES 100 Right NO NO NO NO NO G3 NO No A84G Preoperative TUMOR FREE Complete Remission/Response YES Primary Tumor 01 NO NO Not listed in Medical Record NO NO YES TM Supratentorial, Frontal Lobe Central nervous system YES LIVING 2010 bdbde24d-9270-4e7b-84f3-1ba0b7d54e55 TCGA-TM-A84G-01A-11D-A368-05 TCGA-TM-A84G-01A-11D-A36N-01 TCGA-TM-A84G-01 bdbde24d-9270-4e7b-84f3-1ba0b7d54e55 TCGA-TM-A84G-01 TCGA-TM-A84G-01A-11D-A36N-01 bdbde24d-9270-4e7b-84f3-1ba0b7d54e55 +TCGA-TM-A84H-01 TCGA-TM-A84H-01 TCGA-TM-A84H TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 44 NO NO TCGA-TM-A84H-F65389 TCGA-TM-A84H TCGA-TM-A84H-01A -16277 627 0 926 0 0 NO YES NO Headaches 0 - 30 Days Scheduled Follow-up Submission Complete Remission/Response NO 2014-9-22 FEMALE NO YES Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES 60 NO 90 Right NO NO YES NO NO G3 NO false No TCGA-TM-A84H.654A67F7-8755-4BF6-9674-69ADA7C976DA.pdf A84H Preoperative TUMOR FREE Complete Remission/Response YES Primary Tumor 01 NO NO Not listed in Medical Record NO NO YES TM Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2012 784d798d-12cd-4714-ab4d-2191011c4a44 TCGA-TM-A84H-01A-11D-A368-05 TCGA-TM-A84H-01A-11D-A36N-01 TCGA-TM-A84H-01 784d798d-12cd-4714-ab4d-2191011c4a44 TCGA-TM-A84H-01 TCGA-TM-A84H-01A-11D-A36N-01 784d798d-12cd-4714-ab4d-2191011c4a44 +TCGA-TM-A84I-01 TCGA-TM-A84I-01 TCGA-TM-A84I TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 30 NO NO TCGA-TM-A84I-F65390 TCGA-TM-A84I -11221 0 854 0 0 NO YES NO Motor/Movement Changes 0 - 30 Days Scheduled Follow-up Submission Complete Remission/Response NO 2014-9-22 MALE NO NO Astrocytoma NO No C71.0 9401/3 C71.0 YES 90 Left NO NO NO NO YES G3 NO No A84I Preoperative TUMOR FREE Complete Remission/Response YES Primary Tumor 01 NO NO Not listed in Medical Record NO NO YES TM Supratentorial, Parietal Lobe Central nervous system NO LIVING 2012 e7549428-1144-41c1-98cd-d077fc258567 TCGA-TM-A84I-01A-11D-A368-05 TCGA-TM-A84I-01A-11D-A36N-01 TCGA-TM-A84I-01 e7549428-1144-41c1-98cd-d077fc258567 TCGA-TM-A84I-01 TCGA-TM-A84I-01A-11D-A36N-01 e7549428-1144-41c1-98cd-d077fc258567 +TCGA-TM-A84J-01 TCGA-TM-A84J-01 TCGA-TM-A84J TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain YES NO 63 NO NO TCGA-TM-A84J-F65391 TCGA-TM-A84J TCGA-TM-A84J-01A -23091 415 0 735 454 0 1 NO NO NO Visual Changes 0 - 30 Days Scheduled Follow-up Submission Progressive Disease NO 2014-9-30 MALE NO NO Oligodendroglioma NO No C71.0 9451/3 C71.0 YES 50 NO 80 Left NO NO YES NO YES G3 YES false No TCGA-TM-A84J.D3563493-4083-479F-A172-8E856AD793C2.pdf A84J Preoperative WITH TUMOR Progressive Disease YES Primary Tumor 01 YES NO Not listed in Medical Record YES NO YES TM Supratentorial, Occipital Lobe Central nervous system A YES LIVING 2012 549b2c27-188c-4c0b-b451-4507ef46a561 TCGA-TM-A84J-01A-11D-A368-05 TCGA-TM-A84J-01A-11D-A36N-01 TCGA-TM-A84J-01 549b2c27-188c-4c0b-b451-4507ef46a561 TCGA-TM-A84J-01 TCGA-TM-A84J-01A-11D-A36N-01 549b2c27-188c-4c0b-b451-4507ef46a561 +TCGA-TM-A84L-01 TCGA-TM-A84L-01 TCGA-TM-A84L TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain YES YES YES 31 NO NO TCGA-TM-A84L-F56505 TCGA-TM-A84L 1045 -11498 1242 0 1045 0 0 NO NO NO Seizures 31 - 90 Days Scheduled Follow-up Submission Progressive Disease NO 2014-2-17 MALE NO NO Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES 90 Left NO NO NO NO NO G2 YES No A84L Preoperative WITH TUMOR Complete Remission/Response NO Primary Tumor 01 YES NO Not listed in Medical Record NO NO YES TM Supratentorial, Temporal Lobe Central nervous system NO DECEASED 2010 d0f9781b-f735-4dd2-8813-f513692c0525 TCGA-TM-A84L-01A-11D-A368-05 TCGA-TM-A84L-01A-11D-A36N-01 TCGA-TM-A84L-01 d0f9781b-f735-4dd2-8813-f513692c0525 TCGA-TM-A84L-01 TCGA-TM-A84L-01A-11D-A36N-01 d0f9781b-f735-4dd2-8813-f513692c0525 +TCGA-TM-A84M-01 TCGA-TM-A84M-01 TCGA-TM-A84M TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 40 NO NO TCGA-TM-A84M-F65392 TCGA-TM-A84M TCGA-TM-A84M-01A -14660 455 0 754 0 0 NO NO NO Motor/Movement Changes 31 - 90 Days Scheduled Follow-up Submission Complete Remission/Response NO 2014-9-23 MALE NO NO Oligodendroglioma NO No C71.0 9451/3 C71.0 YES 10 NO 100 Right NO NO NO NO YES G3 NO false No TCGA-TM-A84M.A9063552-B6AE-4CD9-9A0C-BF7BA476411C.pdf A84M Preoperative TUMOR FREE Complete Remission/Response YES Primary Tumor 01 NO NO Not listed in Medical Record YES NO YES TM Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2012 4d4f086b-9706-4fc5-b19b-33270daf8970 TCGA-TM-A84M-01A-11D-A368-05 TCGA-TM-A84M-01A-11D-A36N-01 TCGA-TM-A84M-01 4d4f086b-9706-4fc5-b19b-33270daf8970 TCGA-TM-A84M-01 TCGA-TM-A84M-01A-11D-A36N-01 4d4f086b-9706-4fc5-b19b-33270daf8970 +TCGA-TM-A84O-01 TCGA-TM-A84O-01 TCGA-TM-A84O TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 61 NO NO TCGA-TM-A84O-F65303 TCGA-TM-A84O TCGA-TM-A84O-01A -22327 920 1011 0 0 0 NO Seizures 0 - 30 Days Scheduled Follow-up Submission Progressive Disease NO 2014-9-22 FEMALE NO NO Oligodendroglioma NO No C71.0 9451/3 C71.0 YES 60 NO 90 Right NO NO NO NO NO G3 NO false No TCGA-TM-A84O.6E28D951-BB27-4E32-A681-46D1DEF900BB.pdf A84O Preoperative WITH TUMOR Complete Remission/Response YES Primary Tumor 01 YES NO Not listed in Medical Record NO NO YES TM Supratentorial, Not Otherwise Specified Central nervous system A NO DECEASED 2011 4ad229f0-dae4-485e-8f36-a79dd071a812 TCGA-TM-A84O-01A-11D-A368-05 TCGA-TM-A84O-01A-11D-A36N-01 TCGA-TM-A84O-01 4ad229f0-dae4-485e-8f36-a79dd071a812 TCGA-TM-A84O-01 TCGA-TM-A84O-01A-11D-A36N-01 4ad229f0-dae4-485e-8f36-a79dd071a812 +TCGA-TM-A84Q-01 TCGA-TM-A84Q-01 TCGA-TM-A84Q TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain NO NO 31 NO YES TCGA-TM-A84Q-F65305 TCGA-TM-A84Q TCGA-TM-A84Q-01A -11668 592 0 772 455 0 1 NO NO NO > 20 Years Mental Status Changes 0 - 30 Days Scheduled Follow-up Submission Complete Remission/Response NO 2014-9-22 MALE NO NO Astrocytoma NO No C71.0 9400/3 C71.0 YES 50 NO 80 Left NO NO YES NO NO G2 YES false No TCGA-TM-A84Q.CE780D35-9DBE-4596-812C-D44B2B57466D.pdf A84Q Preoperative TUMOR FREE Complete Remission/Response YES Primary Tumor 01 NO NO Not listed in Medical Record NO NO YES TM Supratentorial, Temporal Lobe Central nervous system A NO LIVING 2012 31cec6a7-3560-4837-a220-a34d1e45ed24 TCGA-TM-A84Q-01A-11D-A368-05 TCGA-TM-A84Q-01A-11D-A36N-01 TCGA-TM-A84Q-01 31cec6a7-3560-4837-a220-a34d1e45ed24 TCGA-TM-A84Q-01 TCGA-TM-A84Q-01A-11D-A36N-01 31cec6a7-3560-4837-a220-a34d1e45ed24 +TCGA-TM-A84R-01 TCGA-TM-A84R-01 TCGA-TM-A84R TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 46 NO NO TCGA-TM-A84R-F65388 TCGA-TM-A84R TCGA-TM-A84R-01A -16843 346 0 566 0 1 NO NO NO Seizures 0 - 30 Days Scheduled Follow-up Submission Complete Remission/Response NO 2014-9-22 MALE NO YES Oligodendroglioma NO No C71.0 9450/3 C71.0 YES 140 NO 80 Left NO Sequence Analysis YES NO NO NO NO G2 NO false No TCGA-TM-A84R.3182D6DB-4B2D-49B0-A907-5DD62812D470.pdf A84R Preoperative TUMOR FREE Complete Remission/Response NO Primary Tumor 01 YES NO Not listed in Medical Record NO NO YES TM Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2012 67eda5bc-a945-480a-8d69-c517cb265f5d TCGA-TM-A84R-01A-21D-A368-05 TCGA-TM-A84R-01A-21D-A36N-01 TCGA-TM-A84R-01 67eda5bc-a945-480a-8d69-c517cb265f5d TCGA-TM-A84R-01 TCGA-TM-A84R-01A-21D-A36N-01 67eda5bc-a945-480a-8d69-c517cb265f5d +TCGA-TM-A84S-01 TCGA-TM-A84S-01 TCGA-TM-A84S TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 36 NO NO TCGA-TM-A84S-F65304 TCGA-TM-A84S -13424 0 454 0 1 NO YES YES Seizures 31 - 90 Days Scheduled Follow-up Submission Complete Remission/Response NO 2014-9-22 MALE NO NO Oligodendroglioma NO No C71.0 9451/3 C71.0 YES 80 Left YES IHC YES NO NO NO YES G3 NO No A84S Preoperative TUMOR FREE Complete Remission/Response NO Primary Tumor 01 YES NO Not listed in Medical Record NO NO YES TM Supratentorial, Frontal Lobe Central nervous system YES LIVING 2013 b37064bc-6eec-4387-a09b-8d7b853e0a90 TCGA-TM-A84S-01A-11D-A368-05 TCGA-TM-A84S-01A-11D-A36N-01 TCGA-TM-A84S-01 b37064bc-6eec-4387-a09b-8d7b853e0a90 TCGA-TM-A84S-01 TCGA-TM-A84S-01A-11D-A36N-01 b37064bc-6eec-4387-a09b-8d7b853e0a90 +TCGA-TM-A84T-01 TCGA-TM-A84T-01 TCGA-TM-A84T TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 19 NO NO TCGA-TM-A84T-F65306 TCGA-TM-A84T -6994 0 724 0 0 NO NO NO Seizures 0 - 30 Days Scheduled Follow-up Submission Stable Disease NO 2014-9-22 MALE NO NO Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES 90 Left YES IHC YES NO NO NO NO G2 NO No A84T Preoperative WITH TUMOR Stable Disease NO Primary Tumor 01 YES YES Not listed in Medical Record NO NO YES TM Supratentorial, Frontal Lobe Central nervous system NO LIVING 2012 c1ccfad6-dc2b-49ea-97bd-044b1bf195dd TCGA-TM-A84T-01A-11D-A368-05 TCGA-TM-A84T-01A-11D-A36N-01 TCGA-TM-A84T-01 c1ccfad6-dc2b-49ea-97bd-044b1bf195dd TCGA-TM-A84T-01 TCGA-TM-A84T-01A-11D-A36N-01 c1ccfad6-dc2b-49ea-97bd-044b1bf195dd +TCGA-TQ-A7RF-01 TCGA-TQ-A7RF-01 TCGA-TQ-A7RF TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 27 NO NO TCGA-TQ-A7RF-F61331 TCGA-TQ-A7RF -9919 0 650 NO NO NO Headaches > 181 Days NO 2015-2-19 FEMALE NO YES Oligodendroglioma NO No C71.0 9451/3 C71.0 YES Right NO NO YES NO NO G3 NO No A7RF Preoperative WITH TUMOR YES YES Partial Remission/Response YES Primary Tumor 01 YES YES White Matter YES NO YES TQ Supratentorial, Temporal Lobe Central nervous system YES LIVING 2012 b3c8bb05-15a1-483a-a93e-a7733e32f983 TCGA-TQ-A7RF-01A-11D-A33U-05 TCGA-TQ-A7RF-01A-11D-A33S-01 TCGA-TQ-A7RF-01 b3c8bb05-15a1-483a-a93e-a7733e32f983 TCGA-TQ-A7RF-01 TCGA-TQ-A7RF-01A-11D-A33S-01 b3c8bb05-15a1-483a-a93e-a7733e32f983 +TCGA-TQ-A7RG-01 TCGA-TQ-A7RG-01 TCGA-TQ-A7RG TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 36 NO NO TCGA-TQ-A7RG-F65500 TCGA-TQ-A7RG TCGA-TQ-A7RG-01A -13227 287 0 599 -32 NO NO NO Seizures > 181 Days NO 2015-2-19 MALE NO Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES NO 530 NO 100 Left NO NO NO NO G2 NO false No TCGA-TQ-A7RG.396F6EAB-2B8F-4054-AACA-31BC916FB9D4.pdf A7RG Preoperative WITH TUMOR YES YES Partial Remission/Response NO Primary Tumor 01 YES NO White Matter YES NO YES TQ Supratentorial, Temporal Lobe Central nervous system A YES LIVING 2012 3e1936a4-80e8-42a0-8af6-4db305987cb0 TCGA-TQ-A7RG-01A-11D-A33U-05 TCGA-TQ-A7RG-01A-11D-A33S-01 TCGA-TQ-A7RG-01 3e1936a4-80e8-42a0-8af6-4db305987cb0 TCGA-TQ-A7RG-01 TCGA-TQ-A7RG-01A-11D-A33S-01 3e1936a4-80e8-42a0-8af6-4db305987cb0 +TCGA-TQ-A7RH-01 TCGA-TQ-A7RH-01 TCGA-TQ-A7RH TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 39 NO NO TCGA-TQ-A7RH-F65502 TCGA-TQ-A7RH TCGA-TQ-A7RH-01A -14524 167 0 486 NO NO NO Seizures > 181 Days NO 2014-9-25 MALE NO YES Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES NO 130 NO Right NO NO YES NO NO G2 NO false No TCGA-TQ-A7RH.489D1069-B12F-4250-9FD0-BA5997ADAC8D.pdf A7RH WITH TUMOR YES YES Partial Remission/Response YES Primary Tumor 01 YES NO White Matter YES NO YES TQ Supratentorial, Temporal Lobe Central nervous system A NO LIVING 2013 2797760a-c82d-44d8-bec2-92fe1d6ef271 TCGA-TQ-A7RH-01A-12D-A34D-05 TCGA-TQ-A7RH-01A-12D-A349-01 TCGA-TQ-A7RH-01 2797760a-c82d-44d8-bec2-92fe1d6ef271 TCGA-TQ-A7RH-01 TCGA-TQ-A7RH-01A-12D-A349-01 2797760a-c82d-44d8-bec2-92fe1d6ef271 +TCGA-TQ-A7RI-01 TCGA-TQ-A7RI-01 TCGA-TQ-A7RI TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 37 NO NO TCGA-TQ-A7RI-F65497 TCGA-TQ-A7RI -13799 0 62 NO NO NO Seizures 0 - 30 Days NO 2014-9-25 FEMALE NO NO Oligodendroglioma NO No C71.0 9450/3 C71.0 YES NO Left NO YES NO NO NO G2 NO No A7RI Preoperative TUMOR FREE YES YES NO Primary Tumor 01 YES NO White Matter NO NO YES TQ Supratentorial, Parietal Lobe Central nervous system NO LIVING 2012 d071f7d9-cc1c-4b7d-8555-b8aab5730bb6 TCGA-TQ-A7RI-01A-11D-A33U-05 TCGA-TQ-A7RI-01A-11D-A33S-01 TCGA-TQ-A7RI-01 d071f7d9-cc1c-4b7d-8555-b8aab5730bb6 TCGA-TQ-A7RI-01 TCGA-TQ-A7RI-01A-11D-A33S-01 d071f7d9-cc1c-4b7d-8555-b8aab5730bb6 +TCGA-TQ-A7RJ-01 TCGA-TQ-A7RJ-01 TCGA-TQ-A7RJ TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 25 NO NO TCGA-TQ-A7RJ-F65494 TCGA-TQ-A7RJ TCGA-TQ-A7RJ-01A -9209 924 0 1229 NO NO NO Sensory Changes > 181 Days NO 2014-9-25 FEMALE NO NO Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES NO 50 NO Left NO NO NO NO YES G2 NO false No TCGA-TQ-A7RJ.9C4E4467-F9B6-456F-8138-B81D42E6A5AA.pdf A7RJ Preoperative WITH TUMOR NO NO Stable Disease YES Primary Tumor 01 NO YES White Matter YES NO YES TQ Supratentorial, Parietal Lobe Central nervous system A NO LIVING 2011 2ad4f620-2c9a-4bc0-a24d-fddfee88ba32 TCGA-TQ-A7RJ-01A-11D-A33U-05 TCGA-TQ-A7RJ-01A-11D-A33S-01 TCGA-TQ-A7RJ-01 2ad4f620-2c9a-4bc0-a24d-fddfee88ba32 TCGA-TQ-A7RJ-01 TCGA-TQ-A7RJ-01A-11D-A33S-01 2ad4f620-2c9a-4bc0-a24d-fddfee88ba32 +TCGA-TQ-A7RK-01 TCGA-TQ-A7RK-01 TCGA-TQ-A7RK TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain YES YES YES 29 NO NO TCGA-TQ-A7RK-F61519 TCGA-TQ-A7RK TCGA-TQ-A7RK-01A 882 -10742 1057 0 1341 858 -115 0 NO NO NO Mental Status Changes 0 - 30 Days Additional New Tumor Event Complete Remission/Response NO 2014-6-30 MALE NO NO Oligoastrocytoma NO No C71.0 9450/3 C71.0 YES NO 330 NO 90 Left NO NO YES NO NO G2 YES false No TCGA-TQ-A7RK.740E07A6-7579-4967-827C-7DC0D56EFF98.pdf A7RK Preoperative TUMOR FREE YES NO Complete Remission/Response NO Primary Tumor 01 NO NO White Matter NO NO YES TQ Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2010 9730d6b2-f458-4475-a66c-e99aa49e4161 TCGA-TQ-A7RK-01A-11D-A33U-05 TCGA-TQ-A7RK-01A-11D-A33S-01 TCGA-TQ-A7RK-01 9730d6b2-f458-4475-a66c-e99aa49e4161 TCGA-TQ-A7RK-01 TCGA-TQ-A7RK-01A-11D-A33S-01 9730d6b2-f458-4475-a66c-e99aa49e4161 +TCGA-TQ-A7RK-02 TCGA-TQ-A7RK-02 TCGA-TQ-A7RK TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain YES YES YES 29 NO NO TCGA-TQ-A7RK-F61519 TCGA-TQ-A7RK TCGA-TQ-A7RK-02B 882 -10742 1131 0 1341 858 -115 0 NO NO NO Mental Status Changes 0 - 30 Days Additional New Tumor Event Complete Remission/Response NO 2014-6-30 MALE NO NO Oligoastrocytoma NO No C71.0 9450/3 C71.0 YES NO 60 NO 90 Left NO NO YES NO NO G2 YES true No TCGA-TQ-A7RK.5452FDC5-EB15-49DE-A0CC-9A9CA7018A5B.pdf A7RK Preoperative TUMOR FREE YES NO Complete Remission/Response NO Recurrent Tumor 02 NO NO White Matter NO NO YES TQ Supratentorial, Frontal Lobe Central nervous system B NO LIVING 2010 25aa5be1-62ec-4bd7-9509-bafbcd1adddb,707a0918-ae88-4c3c-9a94-e9fad5cdbc7b TCGA-TQ-A7RK-02B-11D-A408-05,TCGA-TQ-A7RK-02A-11D-A368-05 25aa5be1-62ec-4bd7-9509-bafbcd1adddb,707a0918-ae88-4c3c-9a94-e9fad5cdbc7b 25aa5be1-62ec-4bd7-9509-bafbcd1adddb,707a0918-ae88-4c3c-9a94-e9fad5cdbc7b +TCGA-TQ-A7RM-01 TCGA-TQ-A7RM-01 TCGA-TQ-A7RM TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 41 NO NO TCGA-TQ-A7RM-F65552 TCGA-TQ-A7RM -15154 0 1116 45 0 NO NO NO Seizures > 181 Days Scheduled Follow-up Submission Partial Remission/Response NO 2015-2-17 FEMALE NO NO Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES NO 90 Left NO NO YES NO NO G3 NO No A7RM Pre-Adjuvant Therapy WITH TUMOR YES NO Partial Remission/Response YES Primary Tumor 01 YES NO Cerebral Cortex YES NO YES TQ Supratentorial, Temporal Lobe Central nervous system NO LIVING 2011 ea076ed3-74cd-4313-83d0-a99873058fd7 TCGA-TQ-A7RM-01A-11D-A33U-05 TCGA-TQ-A7RM-01A-11D-A33S-01 TCGA-TQ-A7RM-01 ea076ed3-74cd-4313-83d0-a99873058fd7 TCGA-TQ-A7RM-01 TCGA-TQ-A7RM-01A-11D-A33S-01 ea076ed3-74cd-4313-83d0-a99873058fd7 +TCGA-TQ-A7RN-01 TCGA-TQ-A7RN-01 TCGA-TQ-A7RN TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 32 NO NO TCGA-TQ-A7RN-F65559 TCGA-TQ-A7RN -11823 0 1026 11 0 NO NO NO Headaches > 181 Days Scheduled Follow-up Submission Partial Remission/Response NO 2015-2-17 MALE NO YES Oligodendroglioma NO No C71.0 9450/3 C71.0 YES NO 100 Left NO NO NO NO NO G2 NO No A7RN Pre-Adjuvant Therapy WITH TUMOR YES NO Partial Remission/Response YES Primary Tumor 01 YES NO Cerebral Cortex YES NO YES TQ Supratentorial, Temporal Lobe Central nervous system NO LIVING 2011 e6d2870a-4ba2-4064-a5a9-d701e6b5e3dd TCGA-TQ-A7RN-01A-11D-A33U-05 TCGA-TQ-A7RN-01A-11D-A33S-01 TCGA-TQ-A7RN-01 e6d2870a-4ba2-4064-a5a9-d701e6b5e3dd TCGA-TQ-A7RN-01 TCGA-TQ-A7RN-01A-11D-A33S-01 e6d2870a-4ba2-4064-a5a9-d701e6b5e3dd +TCGA-TQ-A7RO-01 TCGA-TQ-A7RO-01 TCGA-TQ-A7RO TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 29 NO NO TCGA-TQ-A7RO-F65562 TCGA-TQ-A7RO TCGA-TQ-A7RO-01A -10890 665 0 949 123 0 NO YES NO 12 - 20 Years Seizures 31 - 90 Days Scheduled Follow-up Submission Partial Remission/Response YES Seafood 2015-2-17 MALE NO NO Oligoastrocytoma YES No C71.0 9382/3 C71.0 YES NO 80 NO 100 Left NO NO NO NO NO G2 NO false No TCGA-TQ-A7RO.41735167-9814-4D95-A3D4-E1C0B8575C9D.pdf A7RO Other WITH TUMOR YES YES Partial Remission/Response NO Primary Tumor 01 YES NO Cerebral Cortex NO NO YES TQ Supratentorial, Temporal Lobe Central nervous system A NO LIVING 2011 1de2f338-b16d-40ab-ac9b-8b175c9bb459 TCGA-TQ-A7RO-01A-11D-A33U-05 TCGA-TQ-A7RO-01A-11D-A33S-01 TCGA-TQ-A7RO-01 1de2f338-b16d-40ab-ac9b-8b175c9bb459 TCGA-TQ-A7RO-01 TCGA-TQ-A7RO-01A-11D-A33S-01 1de2f338-b16d-40ab-ac9b-8b175c9bb459 +TCGA-TQ-A7RP-01 TCGA-TQ-A7RP-01 TCGA-TQ-A7RP TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 66 NO NO TCGA-TQ-A7RP-F65564 TCGA-TQ-A7RP TCGA-TQ-A7RP-01A -24109 553 0 914 152 0 NO NO NO Seizures > 181 Days Scheduled Follow-up Submission Partial Remission/Response NO 2015-2-17 MALE NO NO Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES NO 400 NO 90 Left NO YES NO NO NO G2 NO false No TCGA-TQ-A7RP.27A97401-6DB1-4439-A06D-E0CC46BD5CC0.pdf A7RP Pre-Adjuvant Therapy WITH TUMOR YES NO Partial Remission/Response YES Primary Tumor 01 YES NO Cerebral Cortex YES NO YES TQ Supratentorial, Temporal Lobe Central nervous system A NO LIVING 2012 264d433e-545e-47cd-9779-7fce4237278b TCGA-TQ-A7RP-01A-21D-A34D-05 TCGA-TQ-A7RP-01A-21D-A349-01 TCGA-TQ-A7RP-01 264d433e-545e-47cd-9779-7fce4237278b TCGA-TQ-A7RP-01 TCGA-TQ-A7RP-01A-21D-A349-01 264d433e-545e-47cd-9779-7fce4237278b +TCGA-TQ-A7RQ-01 TCGA-TQ-A7RQ-01 TCGA-TQ-A7RQ TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 38 NO NO TCGA-TQ-A7RQ-F65566 TCGA-TQ-A7RQ TCGA-TQ-A7RQ-01A -14187 504 0 795 53 0 NO Seizures 91 - 180 Days Scheduled Follow-up Submission Complete Remission/Response NO 2014-10-30 FEMALE NO NO Oligodendroglioma NO No C71.0 9450/3 C71.0 YES NO 140 NO 90 Left NO NO NO NO NO G2 NO false No TCGA-TQ-A7RQ.627A2B25-6FC6-4CF3-9EA8-D9159B49B205.pdf A7RQ Pre-Adjuvant Therapy TUMOR FREE YES YES Complete Remission/Response NO Primary Tumor 01 YES NO Cerebral Cortex YES NO YES TQ Supratentorial, Temporal Lobe Central nervous system A NO LIVING 2012 02221ced-8f59-4a00-ae01-6096648b34fc TCGA-TQ-A7RQ-01A-11D-A33U-05 TCGA-TQ-A7RQ-01A-11D-A33S-01 TCGA-TQ-A7RQ-01 02221ced-8f59-4a00-ae01-6096648b34fc TCGA-TQ-A7RQ-01 TCGA-TQ-A7RQ-01A-11D-A33S-01 02221ced-8f59-4a00-ae01-6096648b34fc +TCGA-TQ-A7RR-01 TCGA-TQ-A7RR-01 TCGA-TQ-A7RR TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 38 NO NO TCGA-TQ-A7RR-F65569 TCGA-TQ-A7RR TCGA-TQ-A7RR-01A -14022 454 0 787 31 0 NO NO NO Seizures > 181 Days Scheduled Follow-up Submission Partial Remission/Response NO 2014-10-30 MALE NO NO Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES NO 220 NO 100 Right NO NO NO NO NO G2 NO false No TCGA-TQ-A7RR.34C9D741-8075-4FE1-8144-318C2AB176E2.pdf A7RR Pre-Adjuvant Therapy TUMOR FREE NO NO Partial Remission/Response YES Primary Tumor 01 YES NO Cerebral Cortex YES NO YES TQ Supratentorial, Parietal Lobe Central nervous system A NO LIVING 2012 76a648cc-8673-478f-a2f5-c0830378f1e4 TCGA-TQ-A7RR-01A-21D-A34D-05 TCGA-TQ-A7RR-01A-21D-A349-01 TCGA-TQ-A7RR-01 76a648cc-8673-478f-a2f5-c0830378f1e4 TCGA-TQ-A7RR-01 TCGA-TQ-A7RR-01A-21D-A349-01 76a648cc-8673-478f-a2f5-c0830378f1e4 +TCGA-TQ-A7RS-01 TCGA-TQ-A7RS-01 TCGA-TQ-A7RS TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 25 NO NO TCGA-TQ-A7RS-F65577 TCGA-TQ-A7RS TCGA-TQ-A7RS-01A -9172 398 0 -1 -1 0 NO Motor/Movement Changes > 181 Days Scheduled Follow-up Submission Complete Remission/Response 2014-10-30 FEMALE NO NO Oligodendroglioma NO No C71.0 9450/3 C71.0 YES NO 250 NO 90 Left NO YES NO NO YES G2 NO false No TCGA-TQ-A7RS.90135819-8DF8-4410-BC80-816551A3AE46.pdf A7RS Preoperative TUMOR FREE NO NO Complete Remission/Response NO Primary Tumor 01 NO NO Cerebral Cortex NO NO YES TQ Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2012 65f141fb-b893-4254-83e8-b8989bf01cf1 TCGA-TQ-A7RS-01A-12D-A33U-05 TCGA-TQ-A7RS-01A-12D-A33S-01 TCGA-TQ-A7RS-01 65f141fb-b893-4254-83e8-b8989bf01cf1 TCGA-TQ-A7RS-01 TCGA-TQ-A7RS-01A-12D-A33S-01 65f141fb-b893-4254-83e8-b8989bf01cf1 +TCGA-TQ-A7RU-01 TCGA-TQ-A7RU-01 TCGA-TQ-A7RU TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 51 NO NO TCGA-TQ-A7RU-F65649 TCGA-TQ-A7RU -18990 0 1032 158 0 NO NO NO Seizures > 181 Days Scheduled Follow-up Submission Partial Remission/Response NO 2014-10-30 MALE NO YES Oligodendroglioma NO No C71.0 9450/3 C71.0 YES NO 80 Left NO NO NO NO NO G2 NO No A7RU Preoperative WITH TUMOR YES NO Partial Remission/Response NO Primary Tumor 01 YES NO Cerebral Cortex NO NO YES TQ Supratentorial, Temporal Lobe Central nervous system NO LIVING 2011 c1132808-3c5c-47d8-90ad-b47f8d2d48c7 TCGA-TQ-A7RU-01A-21D-A34D-05 TCGA-TQ-A7RU-01A-21D-A349-01 TCGA-TQ-A7RU-01 c1132808-3c5c-47d8-90ad-b47f8d2d48c7 TCGA-TQ-A7RU-01 TCGA-TQ-A7RU-01A-21D-A349-01 c1132808-3c5c-47d8-90ad-b47f8d2d48c7 +TCGA-TQ-A7RV-01 TCGA-TQ-A7RV-01 TCGA-TQ-A7RV TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain YES YES 27 NO NO TCGA-TQ-A7RV-F61501 TCGA-TQ-A7RV TCGA-TQ-A7RV-01A 1141 -10167 1470 0 1868 530 -42 1 NO NO NO Sensory Changes > 181 Days Scheduled Follow-up Submission Progressive Disease NO 2014-10-7 MALE NO YES Astrocytoma NO No C71.0 9382/3 C71.0 YES NO 120 NO 80 Left NO NO YES NO YES G2 YES false No TCGA-TQ-A7RV.5316A44B-CF13-4A3B-AE9D-115383B906E2.pdf A7RV Preoperative WITH TUMOR YES NO Partial Remission/Response NO Primary Tumor 01 YES YES White Matter NO NO YES TQ Supratentorial, Temporal Lobe Central nervous system A NO LIVING 2009 44347235-2162-41f1-892e-1cf85f157ece TCGA-TQ-A7RV-01A-21D-A34D-05 TCGA-TQ-A7RV-01A-21D-A349-01 TCGA-TQ-A7RV-01 44347235-2162-41f1-892e-1cf85f157ece TCGA-TQ-A7RV-01 TCGA-TQ-A7RV-01A-21D-A349-01 44347235-2162-41f1-892e-1cf85f157ece +TCGA-TQ-A7RV-02 TCGA-TQ-A7RV-02 TCGA-TQ-A7RV TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain YES YES 27 NO NO TCGA-TQ-A7RV-F61501 TCGA-TQ-A7RV TCGA-TQ-A7RV-02A 1141 -10167 1544 0 1868 530 -42 1 NO NO NO Sensory Changes > 181 Days Scheduled Follow-up Submission Progressive Disease NO 2014-10-7 MALE NO YES Astrocytoma NO No C71.0 9382/3 C71.0 YES NO 200 NO 80 Left NO NO YES NO YES G2 YES true No TCGA-TQ-A7RV.98CC2EDE-4503-4D22-8F18-50E97255B658.pdf A7RV Preoperative WITH TUMOR YES NO Partial Remission/Response NO Recurrent Tumor 02 YES YES White Matter NO NO YES TQ Supratentorial, Temporal Lobe Central nervous system A NO LIVING 2009 5f1ec365-a309-4042-abc8-b8937497804f TCGA-TQ-A7RV-02A-11D-A368-05 5f1ec365-a309-4042-abc8-b8937497804f 5f1ec365-a309-4042-abc8-b8937497804f +TCGA-TQ-A7RW-01 TCGA-TQ-A7RW-01 TCGA-TQ-A7RW TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain YES YES YES 32 NO NO TCGA-TQ-A7RW-F65651 TCGA-TQ-A7RW TCGA-TQ-A7RW-01A [Discrepancy] -11804 1022 821 0 511 529 0 NO NO NO Seizures 31 - 90 Days Scheduled Follow-up Submission Progressive Disease NO 2014-9-26 MALE NO NO Oligodendroglioma NO No C71.0 9382/3 C71.0 YES NO 90 NO 90 Left NO NO NO NO NO G2 YES false No TCGA-TQ-A7RW.CD826C0A-8057-4BD6-A79A-51277F0E09A7.pdf A7RW Pre-Adjuvant Therapy WITH TUMOR YES NO Progressive Disease YES Primary Tumor 01 YES NO Cerebral Cortex YES NO YES TQ Supratentorial, Temporal Lobe Central nervous system A NO DECEASED 2010 5c27c4d4-b3e7-4e44-a2c4-764b665d1bc0 TCGA-TQ-A7RW-01A-11D-A33U-05 TCGA-TQ-A7RW-01A-11D-A33S-01 TCGA-TQ-A7RW-01 5c27c4d4-b3e7-4e44-a2c4-764b665d1bc0 TCGA-TQ-A7RW-01 TCGA-TQ-A7RW-01A-11D-A33S-01 5c27c4d4-b3e7-4e44-a2c4-764b665d1bc0 +TCGA-TQ-A8XE-01 TCGA-TQ-A8XE-01 TCGA-TQ-A8XE TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain YES YES NO 42 NO NO TCGA-TQ-A8XE-F61509 TCGA-TQ-A8XE TCGA-TQ-A8XE-01A -15629 1308 954 0 455 0 1 NO NO NO Headaches 91 - 180 Days Additional New Tumor Event Progressive Disease 2014-6-30 FEMALE NO YES Oligodendroglioma NO No C71.0 9450/3 C71.0 YES NO 130 NO 70 Left NO NO NO YES G2 YES true No TCGA-TQ-A8XE.431037B9-36D3-4978-AEED-F316933DC782.pdf A8XE Preoperative WITH TUMOR NO NO Partial Remission/Response NO Primary Tumor 01 NO YES White Matter NO NO NO TQ Supratentorial, Temporal Lobe Central nervous system A NO DECEASED 2010 2593a422-98ab-4221-b22b-476e05df9ca0 TCGA-TQ-A8XE-01A-11D-A368-05 TCGA-TQ-A8XE-01A-11D-A36N-01 TCGA-TQ-A8XE-01 2593a422-98ab-4221-b22b-476e05df9ca0 TCGA-TQ-A8XE-01 TCGA-TQ-A8XE-01A-11D-A36N-01 2593a422-98ab-4221-b22b-476e05df9ca0 +TCGA-TQ-A8XE-02 TCGA-TQ-A8XE-02 TCGA-TQ-A8XE TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain YES YES NO 42 NO NO TCGA-TQ-A8XE-F61509 TCGA-TQ-A8XE TCGA-TQ-A8XE-02A -15629 1308 954 0 455 0 1 NO NO NO Headaches 91 - 180 Days Additional New Tumor Event Progressive Disease 2014-6-30 FEMALE NO YES Oligodendroglioma NO No C71.0 9450/3 C71.0 YES NO 200 NO 70 Left NO NO NO YES G2 YES true No TCGA-TQ-A8XE.845B196D-DB8C-4AA6-A506-ED4D4364B51B.pdf A8XE Preoperative WITH TUMOR NO NO Partial Remission/Response NO Recurrent Tumor 02 NO YES White Matter NO NO NO TQ Supratentorial, Temporal Lobe Central nervous system A NO DECEASED 2010 10d307ce-8b3b-4486-b199-d2722a964a35 TCGA-TQ-A8XE-02A-11D-A368-05 10d307ce-8b3b-4486-b199-d2722a964a35 10d307ce-8b3b-4486-b199-d2722a964a35 +TCGA-VM-A8C8-01 TCGA-VM-A8C8-01 TCGA-VM-A8C8 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain NO NO 50 TCGA-VM-A8C8-F69643 TCGA-VM-A8C8 TCGA-VM-A8C8-01A -18494 959 0 1397 19 YES NO Motor/Movement Changes > 181 Days Scheduled Follow-up Submission 2015-1-15 FEMALE YES NO Oligodendroglioma NO No C71.0 9450/3 C71.0 YES NO 90 Right YES IHC YES NO NO YES G2 NO false No TCGA-VM-A8C8.11BD5D8D-FB5B-4D96-A421-EC8524E8AA6C.pdf A8C8 Pre-Adjuvant Therapy YES Primary Tumor 01 NO NO Not listed in Medical Record YES NO YES VM Supratentorial, Temporal Lobe Central nervous system A NO LIVING 2011 23a4b76d-a3d3-4206-acd5-2eab6bd4face TCGA-VM-A8C8-01A-11D-A368-05 TCGA-VM-A8C8-01A-11D-A36N-01 TCGA-VM-A8C8-01 23a4b76d-a3d3-4206-acd5-2eab6bd4face TCGA-VM-A8C8-01 TCGA-VM-A8C8-01A-11D-A36N-01 23a4b76d-a3d3-4206-acd5-2eab6bd4face +TCGA-VM-A8C9-01 TCGA-VM-A8C9-01 TCGA-VM-A8C9 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain NO NO 37 TCGA-VM-A8C9-F70437 TCGA-VM-A8C9 -13663 0 1314 NO NO Seizures > 181 Days Scheduled Follow-up Submission Complete Remission/Response 2015-2-16 FEMALE YES Astrocytoma NO No C71.0 9400/3 C71.0 YES Left NO NO NO NO G2 NO No A8C9 TUMOR FREE Complete Remission/Response NO Primary Tumor 01 YES NO Not listed in Medical Record NO NO YES VM Supratentorial, Temporal Lobe Central nervous system NO LIVING 2011 ea214bab-dd3f-4594-9c93-e60fa586b3a4 TCGA-VM-A8C9-01A-11D-A368-05 TCGA-VM-A8C9-01A-11D-A36N-01 TCGA-VM-A8C9-01 ea214bab-dd3f-4594-9c93-e60fa586b3a4 TCGA-VM-A8C9-01 TCGA-VM-A8C9-01A-11D-A36N-01 ea214bab-dd3f-4594-9c93-e60fa586b3a4 +TCGA-VM-A8CA-01 TCGA-VM-A8CA-01 TCGA-VM-A8CA TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 54 NO TCGA-VM-A8CA-F63647 TCGA-VM-A8CA TCGA-VM-A8CA-01A -19991 798 0 411 19 NO NO Mental Status Changes 0 - 30 Days Scheduled Follow-up Submission 2014-10-24 MALE NO Oligodendroglioma NO No C71.0 9450/3 C71.0 YES NO 160 NO 70 Left NO YES YES NO G2 false No TCGA-VM-A8CA.44E81259-80C6-4665-95DE-6D114AEE7761.pdf A8CA Pre-Adjuvant Therapy WITH TUMOR NO Primary Tumor 01 NO NO Not listed in Medical Record YES NO YES VM Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2011 9fd5e9bf-8c29-4efc-bd33-1ed483153175 TCGA-VM-A8CA-01A-11D-A368-05 TCGA-VM-A8CA-01A-11D-A36N-01 TCGA-VM-A8CA-01 9fd5e9bf-8c29-4efc-bd33-1ed483153175 TCGA-VM-A8CA-01 TCGA-VM-A8CA-01A-11D-A36N-01 9fd5e9bf-8c29-4efc-bd33-1ed483153175 +TCGA-VM-A8CB-01 TCGA-VM-A8CB-01 TCGA-VM-A8CB TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 33 TCGA-VM-A8CB-F66847 TCGA-VM-A8CB -12340 0 3 NO NO Seizures 0 - 30 Days Scheduled Follow-up Submission 2014-10-24 MALE YES Oligodendroglioma NO No C71.0 9451/3 C71.0 YES NO Left NO YES NO NO G3 No A8CB TUMOR FREE YES YES Primary Tumor 01 YES NO Not listed in Medical Record NO YES VM Supratentorial, Frontal Lobe Central nervous system NO LIVING 2011 b22b56c2-3e66-430b-b1a5-3441b30551c3 TCGA-VM-A8CB-01A-11D-A368-05 TCGA-VM-A8CB-01A-11D-A36N-01 TCGA-VM-A8CB-01 b22b56c2-3e66-430b-b1a5-3441b30551c3 TCGA-VM-A8CB-01 TCGA-VM-A8CB-01A-11D-A36N-01 b22b56c2-3e66-430b-b1a5-3441b30551c3 +TCGA-VM-A8CD-01 TCGA-VM-A8CD-01 TCGA-VM-A8CD TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain NO NO 58 NO TCGA-VM-A8CD-F66848 TCGA-VM-A8CD TCGA-VM-A8CD-01A -21200 517 240 0 -43 YES NO Seizures > 181 Days Scheduled Follow-up Submission 2014-10-24 MALE YES Astrocytoma NO No C71.0 9401/3 C71.0 YES 110 NO 100 Right NO IHC YES NO YES NO G3 NO false No TCGA-VM-A8CD.CB64BE55-522F-4634-A7B4-17603D50EA3D.pdf A8CD Pre-Adjuvant Therapy WITH TUMOR YES NO YES Primary Tumor 01 YES NO Not listed in Medical Record NO NO YES VM Supratentorial, Temporal Lobe Central nervous system A YES DECEASED 2012 721a570e-56ea-4054-98c1-9ac2105c33ca TCGA-VM-A8CD-01A-11D-A368-05 TCGA-VM-A8CD-01A-11D-A36N-01 TCGA-VM-A8CD-01 721a570e-56ea-4054-98c1-9ac2105c33ca TCGA-VM-A8CD-01 TCGA-VM-A8CD-01A-11D-A36N-01 721a570e-56ea-4054-98c1-9ac2105c33ca +TCGA-VM-A8CE-01 TCGA-VM-A8CE-01 TCGA-VM-A8CE TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain NO NO 25 NO TCGA-VM-A8CE-F69636 TCGA-VM-A8CE -9363 0 1191 15 NO NO Seizures 0 - 30 Days Scheduled Follow-up Submission 2015-1-15 MALE NO Oligodendroglioma NO No C71.0 9450/3 C71.0 YES NO 90 Left NO NO NO NO G2 NO No A8CE Pre-Adjuvant Therapy WITH TUMOR YES NO NO Primary Tumor 01 YES NO Not listed in Medical Record YES NO YES VM Supratentorial, Frontal Lobe Central nervous system NO LIVING 2011 fc4a708f-1f6c-4ee8-bbc1-0a0ce1f37044 TCGA-VM-A8CE-01A-11D-A368-05 TCGA-VM-A8CE-01A-11D-A36N-01 TCGA-VM-A8CE-01 fc4a708f-1f6c-4ee8-bbc1-0a0ce1f37044 TCGA-VM-A8CE-01 TCGA-VM-A8CE-01A-11D-A36N-01 fc4a708f-1f6c-4ee8-bbc1-0a0ce1f37044 +TCGA-VM-A8CF-01 TCGA-VM-A8CF-01 TCGA-VM-A8CF TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 44 TCGA-VM-A8CF-F66857 TCGA-VM-A8CF TCGA-VM-A8CF-01A -16334 280 0 609 26 NO NO Motor/Movement Changes > 181 Days Scheduled Follow-up Submission Stable Disease 2014-10-24 FEMALE NO Astrocytoma NO No C71.0 9401/3 C71.0 YES NO 90 NO 60 Left YES IHC YES NO NO YES G3 NO false No TCGA-VM-A8CF.3D01CE9E-83E3-4D46-A3C2-43D63BAE212B.pdf A8CF Pre-Adjuvant Therapy TUMOR FREE NO NO YES Primary Tumor 01 NO NO Not listed in Medical Record YES NO YES VM Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2013 6f1fe75a-f3ef-4f1b-9781-e340db9bab45 TCGA-VM-A8CF-01A-11D-A368-05 TCGA-VM-A8CF-01A-11D-A36N-01 TCGA-VM-A8CF-01 6f1fe75a-f3ef-4f1b-9781-e340db9bab45 TCGA-VM-A8CF-01 TCGA-VM-A8CF-01A-11D-A36N-01 6f1fe75a-f3ef-4f1b-9781-e340db9bab45 +TCGA-VM-A8CH-01 TCGA-VM-A8CH-01 TCGA-VM-A8CH TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 24 TCGA-VM-A8CH-F69641 TCGA-VM-A8CH -9005 0 714 -38 YES NO Seizures > 181 Days Scheduled Follow-up Submission 2015-1-15 FEMALE YES Astrocytoma NO No C71.0 9400/3 C71.0 YES NO 90 Right YES IHC YES NO NO YES G2 NO No A8CH Preoperative TUMOR FREE YES NO Complete Remission/Response NO Primary Tumor 01 YES YES Not listed in Medical Record NO NO YES VM Supratentorial, Frontal Lobe Central nervous system YES LIVING 2013 bd46f867-070c-49a3-9180-8c78b72183a8 TCGA-VM-A8CH-01A-12D-A368-05 TCGA-VM-A8CH-01A-12D-A36N-01 TCGA-VM-A8CH-01 bd46f867-070c-49a3-9180-8c78b72183a8 TCGA-VM-A8CH-01 TCGA-VM-A8CH-01A-12D-A36N-01 bd46f867-070c-49a3-9180-8c78b72183a8 +TCGA-VV-A829-01 TCGA-VV-A829-01 TCGA-VV-A829 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 44 NO NO TCGA-VV-A829-F65521 TCGA-VV-A829 TCGA-VV-A829-01A -16163 720 0 1127 YES NO Motor/Movement Changes 0 - 30 Days Scheduled Follow-up Submission Complete Remission/Response NO 2014-10-2 MALE NO NO Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES 140 NO Left NO NO NO NO YES G3 NO true No TCGA-VV-A829.CD914F13-6DA0-47EE-90AD-DD2C3F2A727B.pdf A829 TUMOR FREE Stable Disease YES Primary Tumor 01 NO NO Not listed in Medical Record YES NO YES VV Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2011 13d82ac1-eecc-41bb-af05-4fd4f614f260 TCGA-VV-A829-01A-21D-A368-05 TCGA-VV-A829-01A-21D-A36N-01 TCGA-VV-A829-01 13d82ac1-eecc-41bb-af05-4fd4f614f260 TCGA-VV-A829-01 TCGA-VV-A829-01A-21D-A36N-01 13d82ac1-eecc-41bb-af05-4fd4f614f260 +TCGA-VV-A86M-01 TCGA-VV-A86M-01 TCGA-VV-A86M TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 36 NO NO TCGA-VV-A86M-F66128 TCGA-VV-A86M -13453 0 487 Sensory Changes > 181 Days Scheduled Follow-up Submission Complete Remission/Response NO 2014-10-2 FEMALE NO NO Astrocytoma NO No C71.0 9401/3 C71.0 YES Left NO YES NO NO G3 NO No A86M TUMOR FREE YES Primary Tumor 01 YES YES Not listed in Medical Record YES NO YES VV Supratentorial, Frontal Lobe Central nervous system NO LIVING 2013 b1a7c6af-dc87-43c9-9394-5907e610446f TCGA-VV-A86M-01A-11D-A368-05 TCGA-VV-A86M-01A-11D-A36N-01 TCGA-VV-A86M-01 b1a7c6af-dc87-43c9-9394-5907e610446f TCGA-VV-A86M-01 TCGA-VV-A86M-01A-11D-A36N-01 b1a7c6af-dc87-43c9-9394-5907e610446f +TCGA-VW-A7QS-01 TCGA-VW-A7QS-01 TCGA-VW-A7QS TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 35 NO NO TCGA-VW-A7QS -12820 0 706 NO NO NO Headaches 31 - 90 Days NO 2013-12-12 FEMALE NO YES Oligodendroglioma NO No C71.0 9451/3 C71.0 YES NO Right NO YES NO NO G3 NO No A7QS WITH TUMOR YES YES Stable Disease NO Primary Tumor 01 NO NO Not listed in Medical Record YES NO YES VW Supratentorial, Frontal Lobe Central nervous system NO LIVING 2011 adb5aa16-9fe9-4369-a80e-e6eecda07322 TCGA-VW-A7QS-01A-12D-A33U-05 TCGA-VW-A7QS-01A-12D-A33S-01 TCGA-VW-A7QS-01 adb5aa16-9fe9-4369-a80e-e6eecda07322 TCGA-VW-A7QS-01 TCGA-VW-A7QS-01A-12D-A33S-01 adb5aa16-9fe9-4369-a80e-e6eecda07322 +TCGA-VW-A8FI-01 TCGA-VW-A8FI-01 TCGA-VW-A8FI TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 66 NO NO TCGA-VW-A8FI TCGA-VW-A8FI-01A -24411 154 245 0 NO NO NO Mental Status Changes 31 - 90 Days NO 2014-3-10 MALE NO NO Astrocytoma NO No C71.0 9401/3 C71.0 YES NO 40 NO Left NO YES NO NO G3 NO true No TCGA-VW-A8FI.B073A7FE-1986-4EF7-B186-F6017EE50452.pdf A8FI WITH TUMOR NO NO Stable Disease YES Primary Tumor 01 NO NO White Matter YES YES NO VW Supratentorial, Temporal Lobe Central nervous system A NO DECEASED 2013 9b6fc8d2-b1a5-4b8e-81d3-18258860b4b5 TCGA-VW-A8FI-01A-11D-A368-05 TCGA-VW-A8FI-01A-11D-A36N-01 TCGA-VW-A8FI-01 9b6fc8d2-b1a5-4b8e-81d3-18258860b4b5 TCGA-VW-A8FI-01 TCGA-VW-A8FI-01A-11D-A36N-01 9b6fc8d2-b1a5-4b8e-81d3-18258860b4b5 +TCGA-W9-A837-01 TCGA-W9-A837-01 TCGA-W9-A837 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 47 NO TCGA-W9-A837-F66176 TCGA-W9-A837 0 1553 610 1 NO NO NO Seizures > 181 Days Scheduled Follow-up Submission Stable Disease 2014-10-3 MALE NO NO Oligodendroglioma NO No C71.0 9450/3 C71.0 YES Right NO NO NO NO NO G2 NO No A837 WITH TUMOR YES Stable Disease NO Primary Tumor 01 YES NO Not listed in Medical Record NO NO YES W9 Supratentorial, Frontal Lobe Central nervous system NO LIVING 2010 d48e6a92-05f9-4400-828c-e3fdb17c99ac TCGA-W9-A837-01A-11D-A368-05 TCGA-W9-A837-01A-11D-A36N-01 TCGA-W9-A837-01 d48e6a92-05f9-4400-828c-e3fdb17c99ac TCGA-W9-A837-01 TCGA-W9-A837-01A-11D-A36N-01 d48e6a92-05f9-4400-828c-e3fdb17c99ac +TCGA-WH-A86K-01 TCGA-WH-A86K-01 TCGA-WH-A86K TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 65 NO NO TCGA-WH-A86K-F67062 TCGA-WH-A86K TCGA-WH-A86K-01A -24055 112 0 405 20 0 NO NO NO Motor/Movement Changes 0 - 30 Days Scheduled Follow-up Submission Stable Disease NO 2014-11-4 MALE NO NO Astrocytoma NO No C71.0 9400/3 C71.0 YES 30 NO Right YES IHC YES NO NO NO YES G2 NO false No TCGA-WH-A86K.BA54C0C4-01A6-4764-ABEC-F38C6F89F1BA.pdf A86K Pre-Adjuvant Therapy WITH TUMOR Stable Disease NO Primary Tumor 01 YES NO Not listed in Medical Record NO NO YES WH Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2013 9102949f-fd0d-4b62-bc30-6451f6dd8fb4 TCGA-WH-A86K-01A-11D-A368-05 TCGA-WH-A86K-01A-11D-A36N-01 TCGA-WH-A86K-01 9102949f-fd0d-4b62-bc30-6451f6dd8fb4 TCGA-WH-A86K-01 TCGA-WH-A86K-01A-11D-A36N-01 9102949f-fd0d-4b62-bc30-6451f6dd8fb4 +TCGA-WY-A858-01 TCGA-WY-A858-01 TCGA-WY-A858 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 32 NO TCGA-WY-A858 -11855 0 1337 45 0 NO NO Headaches 0 - 30 Days YES fresh pitted fruit 2014-2-10 FEMALE YES YES Astrocytoma NO No C71.0 9401/3 C71.0 YES NO 100 Left NO NO G3 NO No A858 Pre-Adjuvant Therapy TUMOR FREE NO NO Complete Remission/Response YES Primary Tumor 01 NO NO Not listed in Medical Record YES NO YES WY Supratentorial, Frontal Lobe Central nervous system NO LIVING 2010 cd61bf43-fca1-49b2-824e-133484a6e069 TCGA-WY-A858-01A-11D-A368-05 TCGA-WY-A858-01A-11D-A36N-01 TCGA-WY-A858-01 cd61bf43-fca1-49b2-824e-133484a6e069 TCGA-WY-A858-01 TCGA-WY-A858-01A-11D-A36N-01 cd61bf43-fca1-49b2-824e-133484a6e069 +TCGA-WY-A859-01 TCGA-WY-A859-01 TCGA-WY-A859 TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 34 NO NO TCGA-WY-A859 -12631 0 1213 293 0 NO NO Seizures 0 - 30 Days NO 2014-2-20 FEMALE NO NO Astrocytoma NO No C71.0 9400/3 C71.0 YES NO 100 Left NO NO NO G2 NO No A859 Pre-Adjuvant Therapy WITH TUMOR YES Stable Disease YES Primary Tumor 01 YES NO Not listed in Medical Record NO NO YES WY Supratentorial, Frontal Lobe Central nervous system NO LIVING 2010 d8c06e36-816f-420e-9b5b-68f2e9417e96 TCGA-WY-A859-01A-12D-A368-05 TCGA-WY-A859-01A-12D-A36N-01 TCGA-WY-A859-01 d8c06e36-816f-420e-9b5b-68f2e9417e96 TCGA-WY-A859-01 TCGA-WY-A859-01A-12D-A36N-01 d8c06e36-816f-420e-9b5b-68f2e9417e96 +TCGA-WY-A85A-01 TCGA-WY-A85A-01 TCGA-WY-A85A TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 20 NO NO TCGA-WY-A85A TCGA-WY-A85A-01A -7380 1203 0 1320 718 0 NO NO NO Seizures 0 - 30 Days NO 2014-2-27 MALE NO NO Astrocytoma NO No C71.0 9400/3 C71.0 YES NO 500 NO Right NO NO NO NO G2 NO true No TCGA-WY-A85A.AEC260E5-995F-439A-8042-788A2EEAB136.pdf A85A TUMOR FREE YES YES Partial Remission/Response NO Primary Tumor 01 YES NO Not listed in Medical Record NO NO YES WY Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2010 055357fc-1a16-4ff4-a826-2e87a9e99190 TCGA-WY-A85A-01A-21D-A368-05 TCGA-WY-A85A-01A-21D-A36N-01 TCGA-WY-A85A-01 055357fc-1a16-4ff4-a826-2e87a9e99190 TCGA-WY-A85A-01 TCGA-WY-A85A-01A-21D-A36N-01 055357fc-1a16-4ff4-a826-2e87a9e99190 +TCGA-WY-A85B-01 TCGA-WY-A85B-01 TCGA-WY-A85B TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 24 NO NO TCGA-WY-A85B-F65769 TCGA-WY-A85B TCGA-WY-A85B-01A -8817 1073 0 1393 0 YES NO Seizures 0 - 30 Days Scheduled Follow-up Submission NO 2015-1-22 MALE NO YES Astrocytoma NO No C71.0 9400/3 C71.0 YES NO 420 NO Right NO NO NO NO G2 NO true No TCGA-WY-A85B.3BB27604-CFD2-4C1D-A53A-BB6EFA5F1D67.pdf A85B TUMOR FREE YES Complete Remission/Response NO Primary Tumor 01 YES YES Not listed in Medical Record NO NO YES WY Supratentorial, Temporal Lobe Central nervous system A NO LIVING 2010 48ffe5e4-5aec-41fd-8b5f-78466a593eef TCGA-WY-A85B-01A-11D-A368-05 TCGA-WY-A85B-01A-11D-A36N-01 TCGA-WY-A85B-01 48ffe5e4-5aec-41fd-8b5f-78466a593eef TCGA-WY-A85B-01 TCGA-WY-A85B-01A-11D-A36N-01 48ffe5e4-5aec-41fd-8b5f-78466a593eef +TCGA-WY-A85C-01 TCGA-WY-A85C-01 TCGA-WY-A85C TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain YES 36 NO NO TCGA-WY-A85C-F65786 TCGA-WY-A85C TCGA-WY-A85C-01A 1337 -13506 1119 0 1426 1261 1 NO NO Headaches 0 - 30 Days Scheduled Follow-up Submission Progressive Disease NO 2015-1-22 MALE NO YES Astrocytoma NO No C71.0 9400/3 C71.0 YES NO 300 NO Right NO NO NO NO YES G2 YES true No TCGA-WY-A85C.2CB63EDD-F6C4-4CE9-AB8D-E6A5172E43FD.pdf A85C WITH TUMOR YES YES Progressive Disease YES Primary Tumor 01 NO YES Not listed in Medical Record YES NO YES WY Supratentorial, Frontal Lobe Central nervous system A NO LIVING 2010 5a4d2d74-6bf6-455c-87ad-5b51725bd04f TCGA-WY-A85C-01A-11D-A368-05 TCGA-WY-A85C-01A-11D-A36N-01 TCGA-WY-A85C-01 5a4d2d74-6bf6-455c-87ad-5b51725bd04f TCGA-WY-A85C-01 TCGA-WY-A85C-01A-11D-A36N-01 5a4d2d74-6bf6-455c-87ad-5b51725bd04f +TCGA-WY-A85D-01 TCGA-WY-A85D-01 TCGA-WY-A85D TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain 60 NO NO TCGA-WY-A85D TCGA-WY-A85D-01A -21979 1035 0 1147 1 NO YES NO Sensory Changes > 181 Days NO 2014-2-26 MALE NO NO Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES NO 120 NO Right NO NO NO NO G2 YES true No TCGA-WY-A85D.82FFEB3D-5C1C-4FF0-A824-5C24F3B82B3C.pdf A85D WITH TUMOR NO YES Partial Remission/Response NO Primary Tumor 01 NO YES Not listed in Medical Record NO NO YES WY Supratentorial, Frontal Lobe Central nervous system A YES LIVING 2010 0b4aa4f0-32cb-4974-892c-6dba516cc85b TCGA-WY-A85D-01A-11D-A368-05 TCGA-WY-A85D-01A-11D-A36N-01 TCGA-WY-A85D-01 0b4aa4f0-32cb-4974-892c-6dba516cc85b TCGA-WY-A85D-01 TCGA-WY-A85D-01A-11D-A36N-01 0b4aa4f0-32cb-4974-892c-6dba516cc85b +TCGA-WY-A85E-01 TCGA-WY-A85E-01 TCGA-WY-A85E TCGA lower grade glioma and glioblastoma (GBMLGG) brain lower grade glioma Brain YES YES YES 48 NO NO TCGA-WY-A85E-F65805 TCGA-WY-A85E TCGA-WY-A85E-01A 536 -17878 794 0 633 532 311 1 NO NO Seizures 31 - 90 Days Scheduled Follow-up Submission Progressive Disease YES seafood, nuts 2015-1-22 FEMALE NO NO Oligoastrocytoma NO No C71.0 9382/3 C71.0 YES NO 60 NO Left NO NO NO NO NO G2 YES true No TCGA-WY-A85E.BD5E04AC-1E0D-400E-B5A8-A08844543CE4.pdf A85E WITH TUMOR YES NO Partial Remission/Response NO Primary Tumor 01 YES NO NO NO YES WY Supratentorial, Frontal Lobe Central nervous system A YES LIVING 2011 478c54a0-9aff-4f34-adfd-477eaf62b896 TCGA-WY-A85E-01A-11D-A368-05 TCGA-WY-A85E-01A-11D-A40C-01 TCGA-WY-A85E-01 478c54a0-9aff-4f34-adfd-477eaf62b896 TCGA-WY-A85E-01 TCGA-WY-A85E-01A-11D-A40C-01 478c54a0-9aff-4f34-adfd-477eaf62b896 diff --git a/input/TCGA/TCGA_lower_grade_glioma_and_glioblastoma_(GBMLGG)/TCGA.GBMLGG.sampleMap_HiSeqV2_PANCAN.gz b/input/TCGA/TCGA_lower_grade_glioma_and_glioblastoma_(GBMLGG)/TCGA.GBMLGG.sampleMap_HiSeqV2_PANCAN.gz new file mode 100644 index 0000000000000000000000000000000000000000..94559edb8dd458e45a1b8ba6289270e10f37b4ab --- /dev/null +++ b/input/TCGA/TCGA_lower_grade_glioma_and_glioblastoma_(GBMLGG)/TCGA.GBMLGG.sampleMap_HiSeqV2_PANCAN.gz @@ -0,0 +1,3 @@ +version https://git-lfs.github.com/spec/v1 +oid sha256:975ea706f66585b656319802b09ee37037de7a333d59e02ab0b454d100c1bed5 +size 45221191